datetime,channel,message_id,url,raw,lm_json
2025-12-06T11:02:43+00:00,@bezrec,6902,https://t.me/bezrec/6902,"–û—Ç–¥—ã—Ö–∞–µ–º –∏ —á–∏—Ç–∞–µ–º –ø–µ—Ä–≤—ã–π –∑–∏–º–Ω–∏–π –≤—ã–ø—É—Å–∫ —Ä—É–±—Ä–∏–∫–∏ #–∑–∞—Ü–µ–Ω–∏–ª–∏. üíä –í –†–æ—Å—Å–∏–π—Å–∫–æ–π –¥–µ—Ç—Å–∫–æ–π –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–π –±–æ–ª—å–Ω–∏—Ü–µ –≤–ø–µ—Ä–≤—ã–µ –ø—Ä–∏–º–µ–Ω—ë–Ω –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –ø—Ä–æ—Ç–∏–≤ —Å–∏–Ω–¥—Ä–æ–º–∞ –•–∞–Ω—Ç–µ—Ä–∞ - –•–∞–Ω—Ç–µ—Ä–∞–∑–∞ –ù–µ–π—Ä–æ (–∏–¥—É—Ä—Å—É–ª—å—Ñ–∞–∑–∞ –±–µ—Ç–∞). –†–æ—Å—Å–∏—è —Å—Ç–∞–ª–∞ –≤—Ç–æ—Ä–æ–π —Å—Ç—Ä–∞–Ω–æ–π –≤ –º–∏—Ä–µ –ø–æ—Å–ª–µ –Ø–ø–æ–Ω–∏–∏, –≥–¥–µ –¥–æ—Å—Ç—É–ø–Ω–∞ –ø–æ–¥–æ–±–Ω–∞—è —Ç–µ—Ä–∞–ø–∏—è. –ü—Ä–µ–ø–∞—Ä–∞—Ç, —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–Ω—ã–π —é–∂–Ω–æ–∫–æ—Ä–µ–π—Å–∫–æ–π GC Biopharma, –≤ –†–§ –ø—Ä–∏–≤—ë–∑ ¬´–ù–∞–Ω–æ–ª–µ–∫¬ª. üíä –†–æ—Å—Å–∏–π—Å–∫–∏–µ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –ø—Ä–∏—Å–º–∞—Ç—Ä–∏–≤–∞—é—Ç—Å—è –∫ –û–ê–≠. –ö–∞–∫ —Å–æ–æ–±—â–∏–ª–∏ –≤ –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–µ, –Ω–µ–∫–æ—Ç–æ—Ä—ã–µ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø–ª–∞–Ω–∏—Ä—É—é—Ç –≤—ã–π—Ç–∏ –Ω–∞ —Ä—ã–Ω–æ–∫ –∞—Ä–∞–±—Å–∫–æ–π —Å—Ç—Ä–∞–Ω—ã. –¢–∞–∫—É—é –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –≤–µ—Å–Ω–æ–π –ú–∏—Ö–∞–∏–ª –ú—É—Ä–∞—à–∫–æ –æ–±—Å—É–∂–¥–∞–ª —Å –ø–æ—Å–ª–æ–º –û–ê–≠ –≤ –†–æ—Å—Å–∏–∏ –ú—É—Ö–∞–º–º–µ–¥–æ–º –ê—Ö–º–µ–¥–æ–º –∞–ª—å-–î–∂–∞–±–µ—Ä–æ–º. üíä –í–û–ó —Ä–µ–∫–æ–º–µ–Ω–¥–æ–≤–∞–ª–∞ –∞–≥–æ–Ω–∏—Å—Ç—ã –ì–ü–ü-1 –¥–ª—è –ª–µ—á–µ–Ω–∏—è –æ–∂–∏—Ä–µ–Ω–∏–∏ —É –≤–∑—Ä–æ—Å–ª—ã—Ö, –Ω–æ —Å –æ–≥–æ–≤–æ—Ä–∫–∞–º–∏. –í –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –æ—Ç–º–µ—Ç–∏–ª–∏, —á—Ç–æ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –∏–º–µ—é—Ç —Å—Ç–∞—Ç—É—Å —É—Å–ª–æ–≤–Ω—ã—Ö, –∏ —É —Ç–∞–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –µ—Å—Ç—å –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏—è, —Å–≤—è–∑–∞–Ω–Ω—ã–µ —Å ¬´–Ω–µ–¥–æ—Å—Ç–∞—Ç–∫–æ–º –¥–æ–ª–≥–æ—Å—Ä–æ—á–Ω—ã—Ö –¥–∞–Ω–Ω—ã—Ö, —Å—Ç–æ–∏–º–æ—Å—Ç—å—é, –≥–æ—Ç–æ–≤–Ω–æ—Å—Ç—å—é —Å–∏—Å—Ç–µ–º –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è, —Ä–∞–≤–µ–Ω—Å—Ç–≤–æ–º –¥–æ—Å—Ç—É–ø–∞, –∫–æ–Ω—Ç–µ–∫—Å—Ç–æ–º –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –∏ –¥—Ä—É–≥–∏–º–∏ —Ñ–∞–∫—Ç–æ—Ä–∞–º–∏¬ª. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –ª–µ—á–µ–Ω–∏–µ —Å–ª–µ–¥—É–µ—Ç —Å–æ—á–µ—Ç–∞—Ç—å —Å –ø–æ–≤–µ–¥–µ–Ω—á–µ—Å–∫–æ–π —Ç–µ—Ä–∞–ø–∏–µ–π. üíä –†–æ—Å—Å–∏–π—Å–∫–∞—è —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª—å –∑–∞–∏–Ω—Ç–µ—Ä–µ—Å–æ–≤–∞–Ω–∞ –≤ –∏–Ω–¥–∏–π—Å–∫–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –¥–ª—è –≤—ã–ø—É—Å–∫–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤. –≠—Ç–æ –∫–∞—Å–∞–µ—Ç—Å—è, –≤ –ø–µ—Ä–≤—É—é –æ—á–µ—Ä–µ–¥—å, –∞–∫—Ç–∏–≤–Ω–æ–π —Å—É–±—Å—Ç–∞–Ω—Ü–∏–∏, –∏–Ω–≥—Ä–µ–¥–∏–µ–Ω—Ç–æ–≤, –∏–Ω—Ç–µ—Ä–º–µ–¥–∏–∞—Ç–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ –Ω–∞–º –Ω—É–∂–Ω—ã. –≠—Ç–æ –∫–∞—Å–∞–µ—Ç—Å—è —Ö–∏–º–∏–∏ –¥–ª—è —É–ø–∞–∫–æ–≤–∫–∏ –∏ —á–∞—Å—Ç–∏—á–Ω–æ —Å–∞–º–æ–π —É–ø–∞–∫–æ–≤–∫–∏, ‚Äî —Å–∫–∞–∑–∞–ª –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä –ê—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –í–∏–∫—Ç–æ—Ä –î–º–∏—Ç—Ä–∏–µ–≤, –ø–æ–æ–±–µ—â–∞–≤ –¥–µ–ª–∞—Ç—å –≤—Å—ë –≤–æ–∑–º–æ–∂–Ω–æ–µ –¥–ª—è –≥–∞—Ä–º–æ–Ω–∏–∑–∞—Ü–∏–∏ –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω–æ-–ø—Ä–∞–≤–æ–≤—ã—Ö –±–∞–∑ –¥–≤—É—Ö —Å—Ç—Ä–∞–Ω. üíä –ú–∏–Ω–∑–¥—Ä–∞–≤ –ú–æ—Ä–¥–æ–≤–∏–∏ –æ–±—ä—è–≤–∏–ª –æ—Ñ—Å–µ—Ç –Ω–∞ –ø–æ—Å—Ç–∞–≤–∫—É –ª–µ–∫–∞—Ä—Å—Ç–≤. –ü–æ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ —Å —Å–∞–π—Ç–∞ –≥–æ—Å–∑–∞–∫—É–ø–æ–∫, –Ω–∞—á–∞–ª—å–Ω–∞—è —Ü–µ–Ω–∞ ‚Äî 835,6 –º–ª–Ω —Ä—É–±–ª–µ–π. –ó–∞—è–≤–∫–∏ –ø—Ä–∏–Ω–∏–º–∞—é—Ç—Å—è –¥–æ 15 –¥–µ–∫–∞–±—Ä—è. –ü–æ–±–µ–¥–∏—Ç–µ–ª—é –ø—Ä–µ–¥—Å—Ç–æ–∏—Ç –≤–ª–æ–∂–∏—Ç—å –≤ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—é –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ —Ä–µ–≥–∏–æ–Ω–∞ –Ω–µ –º–µ–Ω–µ–µ 100 –º–ª–Ω —Ä—É–±–ª–µ–π –º–∞–∫—Å–∏–º—É–º –∑–∞ —á–µ—Ç—ã—Ä–µ –≥–æ–¥–∞. –ù–∞ –Ω–æ–≤–æ–º –∑–∞–≤–æ–¥–µ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç—å 13 –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –≤ —Ç–æ–º —á–∏—Å–ª–µ –≥–µ–ø–∞—Ç–æ–ø—Ä–æ—Ç–µ–∫—Ç–æ—Ä –∞–¥–µ–º–µ—Ç–∏–æ–Ω–∏–Ω, –∞–Ω—Ç–∏–∫–æ–∞–≥—É–ª—è–Ω—Ç—ã –∞–ø–∏–∫—Å–∞–±–∞–Ω, —Ä–∏–≤–∞—Ä–æ–∫—Å–∞–±–∞–Ω, –ø—Ä–æ—Ç–∏–≤–æ–¥–∏–∞–±–µ—Ç–∏—á–µ—Å–∫–∏–µ –≤–∏–ª–¥–∞–≥–ª–∏–ø—Ç–∏–Ω, –¥–∞–ø–∞–≥–ª–∏—Ñ–ª–æ–∑–∏–Ω, —Å–∏—Ç–∞–≥–ª–∏–ø—Ç–∏–Ω –∏ –¥—Ä. üíä –ú–∏—Ö–∞–∏–ª –ú—É—Ä–∞—à–∫–æ —Ä–∞—Å—Å–∫–∞–∑–∞–ª, —Å–∫–æ–ª—å–∫–æ –≤ –†–æ—Å—Å–∏–∏ –∏–Ω–¥–∏–π—Å–∫–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤. –ü–æ—Ä—è–¥–∫–∞ 10% –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –≤ –†–§ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ - —ç—Ç–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –ò–Ω–¥–∏–∏. –ù–∞ —Å–µ–≥–æ–¥–Ω—è—à–Ω–∏–π –¥–µ–Ω—å —ç—Ç–æ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –≤ –∞–±—Å–æ–ª—é—Ç–Ω—ã—Ö —Ü–∏—Ñ—Ä–∞—Ö —Å–æ—Å—Ç–∞–≤–ª—è–µ—Ç –ø–æ—Ä—è–¥–∫–∞ 1,8 —Ç—ã—Å. –µ–¥–∏–Ω–∏—Ü. –í—ã—Å–æ–∫–∞—è –¥–æ–ª—è –≤ –ø–æ—Å—Ç–∞–≤–∫–µ —Å—É–±—Å—Ç–∞–Ω—Ü–∏–π –≤ –†–æ—Å—Å–∏–π—Å–∫—É—é –§–µ–¥–µ—Ä–∞—Ü–∏—é –∏–∑ –ò–Ω–¥–∏–∏. –≠—Ç–æ –ø–æ—Ä—è–¥–∫–∞ 1,3 –º–ª–Ω –∫–∏–ª–æ–≥—Ä–∞–º–º–æ–≤ —Å—É–±—Å—Ç–∞–Ω—Ü–∏–π, —á—Ç–æ —Å–æ—Å—Ç–∞–≤–ª—è–µ—Ç –ø—Ä–∏–º–µ—Ä–Ω–æ 23% –æ—Ç –æ–±—â–µ–≥–æ –∏–º–ø–æ—Ä—Ç–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety, guideline"",
  ""impact"": ""high"",
  ""english"": ""The article discusses the innovative treatment for Hunter Syndrome syndrome in Russia, which is the second country after Japan to have access to this therapy. It also mentions the interest of Russian pharmaceutical companies in the market of the United Arab Emirates, and the recommendation by WHO for agonists of GPR-1 to treat obesity in adults. Additionally, it covers the Russian government's initiative for offset purchases of medicines from India.""
}"
2025-12-05T13:04:26+00:00,@bezrec,6901,https://t.me/bezrec/6901,"–ì–æ—Ç–æ–≤–∏—Ç—å—Å—è –∫ –ø—Ä–∞–∑–¥–Ω–∏–∫–∞–º –º–æ–∂–Ω–æ –ø–æ-—Ä–∞–∑–Ω–æ–º—É. –ü–æ–¥–¥–µ—Ä–∂–∞—Ç—å –∑–¥–æ—Ä–æ–≤—å–µ –ø–µ—á–µ–Ω–∏ –∏ –∑–∞—â–∏—Ç–∏—Ç—å –æ—Ä–≥–∞–Ω –æ—Ç –Ω–µ–±–ª–∞–≥–æ–ø—Ä–∏—è—Ç–Ω—ã—Ö –≤–Ω–µ—à–Ω–∏—Ö –≤–æ–∑–¥–µ–π—Å—Ç–≤–∏–π –ø–æ–º–æ–≥—É—Ç –≥–µ–ø–∞—Ç–æ–ø—Ä–æ—Ç–µ–∫—Ç–æ—Ä—ã. –ú—ã —Å—Ä–∞–≤–Ω–∏–ª–∏ —Ü–µ–Ω—ã –≤ –æ–Ω–ª–∞–π–Ω-–∞–ø—Ç–µ–∫–∞—Ö –Ω–∞ —Ç–æ—Ä–≥–æ–≤—ã–µ –º–∞—Ä–∫–∏ –≠—Å—Å–µ–Ω—Ü–∏–∞–ª–µ —Ñ–æ—Ä—Ç–µ –ù (¬´–ê.–ù–∞—Ç—Ç–µ—Ä–º–∞–Ω–Ω —ç–Ω–¥ –°–∏–µ¬ª, –ì–º–±–•), –§–æ—Å—Ñ–æ–≥–ª–∏–≤ (¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç-–õ–µ–∫—Å—Ä–µ–¥—Å—Ç–≤–∞¬ª, –†–æ—Å—Å–∏—è), –≠—Å—Å–ª–∏–≤–µ—Ä –§–æ—Ä—Ç–µ (¬´–ù–∞–±—Ä–æ—Å –§–∞—Ä–º–∞¬ª, –ò–Ω–¥–∏—è), –§–æ—Å—Ñ–æ–Ω—Ü–∏–∞–ª–µ (¬´–ö–∞–Ω–æ–Ω—Ñ–∞—Ä–º–∞¬ª, –†–æ—Å—Å–∏—è¬ª), –§–æ—Å—Ñ–æ–≥–ª–∏—Ü–µ—Ä–∏–∑–∏–Ω (¬´–í–∏—Ñ–∏—Ç–µ—Ö¬ª, –†–æ—Å—Å–∏—è). –ü–µ—Ä–≤—ã–µ —Ç—Ä–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –Ω–∞—à–ª–∏—Å—å –≤–æ –≤—Å–µ—Ö –ø—Ä–æ–≤–µ—Ä–µ–Ω–Ω—ã—Ö –Ω–∞–º–∏ –∞–ø—Ç–µ–∫–∞—Ö. –•—É–∂–µ –≤—Å–µ–≥–æ —Å –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å—é –¥–µ–ª–∞ –æ–±—Å—Ç–æ—è—Ç —É –§–æ—Å—Ñ–æ–≥–ª–∏—Ü–µ—Ä–∏–∑–∏–Ω–∞ ‚Äî –ª–µ–∫–∞—Ä—Å—Ç–≤–æ –µ—Å—Ç—å —Ç–æ–ª—å–∫–æ –≤ ¬´–ê–ø—Ç–µ–∫–µ.—Ä—É¬ª –∏ ¬´–ó–¥—Ä–∞–≤—Å–∏—Ç–∏¬ª. –ó–∞—Ç–æ —ç—Ç–æ—Ç –≥–µ–ø–∞—Ç–æ–ø—Ä–æ—Ç–µ–∫—Ç–æ—Ä –æ–∫–∞–∑–∞–ª—Å—è —Å–∞–º—ã–º –¥–µ—à—ë–≤—ã–º (518 –∏ 552 —Ä—É–±–ª—è —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ). –î–æ—Ä–æ–∂–µ –≤—Å–µ–≥–æ (2,4 —Ç—ã—Å. —Ä—É–±–ª–µ–π –∑–∞ —É–ø–∞–∫–æ–≤–∫—É –∏–∑ 90 –∫–∞–ø—Å—É–ª) –æ–±–æ–π–¥—ë—Ç—Å—è –ø–æ–ø—É–ª—è—Ä–Ω—ã–π –≠—Å—Å–µ–Ω—Ü–∏–∞–ª–µ —Ñ–æ—Ä—Ç–µ –ù –∏–∑ ¬´36,6¬ª. –ü—Ä–∞–≤–¥–∞, –µ—Å—Ç—å –Ω—é–∞–Ω—Å ‚Äî –≠—Å—Å–ª–∏–≤–µ—Ä —Ñ–æ—Ä—Ç–µ –ø—Ä–æ–¥–∞—ë—Ç—Å—è –≤ —É–ø–∞–∫–æ–≤–∫–µ –ø–æ 50 –∫–∞–ø—Å—É–ª. –í –ø–µ—Ä–µ—Å—á—ë—Ç–µ –Ω–∞ 90 —à—Ç—É–∫ –≤—ã–π–¥–µ—Ç –Ω–µ –¥–µ—à–µ–≤–ª–µ –≠—Å—Å–µ–Ω—Ü–∏–∞–ª–µ. –ù–∞–ø–æ–º–∏–Ω–∞–µ–º, —á—Ç–æ –ª—é–±—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏–º–µ—é—Ç –ø—Ä–æ—Ç–∏–≤–æ–ø–æ–∫–∞–∑–∞–Ω–∏—è. –ü–µ—Ä–µ–¥ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º –ø—Ä–æ–∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä—É–π—Ç–µ—Å—å —Å –ª–µ—á–∞—â–∏–º –≤—Ä–∞—á–æ–º. *–∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –ø—Ä–æ–≤–æ–¥–∏–ª–æ—Å—å –æ–Ω–ª–∞–π–Ω 5 –¥–µ–∫–∞–±—Ä—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-12-05T10:33:07+00:00,@bezrec,6900,https://t.me/bezrec/6900,"–ì–ö ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑¬ª –≤–º–µ—Å—Ç–µ —Å –∏–Ω–¥–∏–π—Å–∫–∏–º–∏ –ø–∞—Ä—Ç–Ω—ë—Ä–∞–º–∏ –±—É–¥—É—Ç –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç—å –∂–∏–∑–Ω–µ–Ω–Ω–æ –≤–∞–∂–Ω—ã–µ —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏–∏. –ì—É–±–µ—Ä–Ω–∞—Ç–æ—Ä –ö–∞–ª—É–∂—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –í–ª–∞–¥–∏—Å–ª–∞–≤ –®–∞–ø—à–∞, –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—å ¬´–ë–î–† –§–∞—Ä–º–∞—Å—å—é—Ç–∏–∫–∞–ª–∑¬ª –î—Ö–∞—Ä–º–µ—à –®–∞—Ö –∏ –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑–∞¬ª –í–∏–∫—Ä–∞–º –ü—É–Ω–∏—è –Ω–∞ –ø–æ–ª—è—Ö –†–æ—Å—Å–∏–π—Å–∫–æ-–∏–Ω–¥–∏–π—Å–∫–æ–≥–æ –±–∏–∑–Ω–µ—Å-—Ñ–æ—Ä—É–º–∞, –ø—Ä–æ—Ö–æ–¥—è—â–µ–≥–æ 4‚Äì5 –¥–µ–∫–∞–±—Ä—è 2025 –≥–æ–¥–∞ –≤ –ù—å—é-–î–µ–ª–∏, –ø–æ–¥–ø–∏—Å–∞–ª–∏ —Å–æ–≥–ª–∞—à–µ–Ω–∏–µ –æ —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–µ –≤ –ö–∞–ª—É–∂—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –≤—ã—Å–æ–∫–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–Ω–æ–≥–æ –∑–∞–≤–æ–¥–∞ –ø–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤—É —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏–π –¥–ª—è —à–∏—Ä–æ–∫–æ–≥–æ —Å–ø–µ–∫—Ç—Ä–∞ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –°—Ç–æ—Ä–æ–Ω—ã –≤–ª–æ–∂–∞—Ç –≤ –ø—Ä–æ–µ–∫—Ç –æ–∫–æ–ª–æ 3 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –¥–æ 2030 –≥–æ–¥–∞. –ö–∞–ª—É–∂—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å –¥–∞–≤–Ω–æ —Å—Ç–∞–ª–∞ –ø–ª–æ—â–∞–¥–∫–æ–π –ø—Ä–∏—Ç—è–∂–µ–Ω–∏—è –¥–ª—è –≤—ã—Å–æ–∫–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–Ω—ã—Ö –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤. –ú—ã —Ä–∞–¥—ã —É–∫—Ä–µ–ø–ª–µ–Ω–∏—é —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–∞ —Å –ò–Ω–¥–∏–µ–π ‚Äî —Å—Ç—Ä–∞–Ω–æ–π —Å –º–æ—â–Ω–æ–π —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –æ—Ç—Ä–∞—Å–ª—å—é –∏ —Å–µ—Ä—å—ë–∑–Ω–æ–π –Ω–∞—É—á–Ω–æ–π —à–∫–æ–ª–æ–π. –°–æ–≤–º–µ—Å—Ç–Ω—ã–π –ø—Ä–æ–µ–∫—Ç –æ—Ç–∫—Ä—ã–≤–∞–µ—Ç –Ω–æ–≤—ã–µ –≥–æ—Ä–∏–∑–æ–Ω—Ç—ã –∏ —Å—Ç–∞–Ω–µ—Ç –≤–∞–∂–Ω—ã–º –≤–∫–ª–∞–¥–æ–º –≤ —Ä–∞–∑–≤–∏—Ç–∏–µ –∏–Ω–¥—É—Å—Ç—Ä–∏–∏ –∏ —ç–∫–æ–Ω–æ–º–∏–∫–∏ —Ä–µ–≥–∏–æ–Ω–∞, ‚Äî –ø–æ–¥—á–µ—Ä–∫–Ω—É–ª –≤–∞–∂–Ω–æ—Å—Ç—å –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–æ–≥–æ –ø–∞—Ä—Ç–Ω—ë—Ä—Å—Ç–≤–∞ –í–ª–∞–¥–∏—Å–ª–∞–≤ –®–∞–ø—à–∞. –í–∏–∫—Ä–∞–º –ü—É–Ω–∏—è –Ω–∞–∑–≤–∞–ª —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫—É –æ–¥–Ω–∏–º –∏–∑ –∫–ª—é—á–µ–≤—ã—Ö –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏–π –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏—è –†–æ—Å—Å–∏–∏ –∏ –ò–Ω–¥–∏–∏. –ü–æ —Å–ª–æ–≤–∞–º –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç–∞ ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑–∞¬ª, —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–æ –Ω–æ–≤–æ–≥–æ –∑–∞–≤–æ–¥–∞ ‚Äî —ç—Ç–æ —à–∞–≥ –≤–ø–µ—Ä—ë–¥ –¥–ª—è –æ–±–æ–∏—Ö –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤, –∞ –æ–±—ä–µ–¥–∏–Ω–µ–Ω–∏–µ —ç–∫—Å–ø–µ—Ä—Ç–Ω–æ–≥–æ –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª–∞ –∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã—Ö –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–µ–π ¬´—Ñ–æ—Ä–º–∏—Ä—É–µ—Ç –æ—Å–Ω–æ–≤—É –¥–ª—è –≤—ã–ø—É—Å–∫–∞ –∫–æ–Ω–∫—É—Ä–µ–Ω—Ç–æ—Å–ø–æ—Å–æ–±–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –ø–æ–≤—ã—à–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The Russian company 'FarmaSynthesis' and its Indian partner signed a deal to build a high-tech plant for producing pharmaceutical raw materials in Kaluzhskaya Oblast. The project will be funded with around 3 billion rubles by the end of 2030. This partnership is seen as a significant step towards developing the pharmaceutical industry and economy of the region, especially in light of Russia's growing focus on pharmaceuticals as a key area of cooperation with India.""
}"
2025-12-05T08:40:02+00:00,@bezrec,6899,https://t.me/bezrec/6899,"–ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ –¥—É–º–∞–µ—Ç –ø–æ–≤—Ä–µ–º–µ–Ω–∏—Ç—å —Å –±–∞–ª–ª–∞–º–∏ –¥–ª—è —Ñ–∞—Ä–º–ø—Ä–æ–º–∞. –†–µ–≥—É–ª—è—Ç–æ—Ä –ø—Ä–µ–¥–ª–æ–∂–∏–ª —Å–¥–≤–∏–Ω—É—Ç—å —Å—Ä–æ–∫ –≤—Å—Ç—É–ø–ª–µ–Ω–∏—è –≤ —Å–∏–ª—É –±–∞–ª–ª—å–Ω–æ–π —Å–∏—Å—Ç–µ–º—ã –æ—Ü–µ–Ω–∫–∏ —Å—Ç—Ä–∞–Ω—ã –ø—Ä–æ–∏—Å—Ö–æ–∂–¥–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Å 1 —è–Ω–≤–∞—Ä—è –Ω–∞ 1 –∏—é–ª—è 2026 –≥–æ–¥–∞. –ü–µ—Ä–µ–Ω–æ—Å —Å—Ä–æ–∫–æ–≤ –≤ –≤–µ–¥–æ–º—Å—Ç–≤–µ –æ–±—ä—è—Å–Ω—è—é—Ç –¥–≤—É–º—è –ø—Ä–∏—á–∏–Ω–∞–º–∏: üîΩ–ø—Ä–æ–¥–æ–ª–∂–∞—é—â–µ–π—Å—è —Ä–∞–±–æ—Ç–æ–π –ø–æ –ø–µ—Ä–µ–≤–æ–¥—É –Ω–∞ –±–∞–ª–ª—å–Ω—É—é —Å–∏—Å—Ç–µ–º—É –æ—Ü–µ–Ω–∫–∏ —Å—Ç—Ä–∞–Ω—ã –ø—Ä–æ–∏—Å—Ö–æ–∂–¥–µ–Ω–∏—è –æ—Ç–¥–µ–ª—å–Ω—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π; üîΩ–Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç—å—é —Å–∏–Ω—Ö—Ä–æ–Ω–∏–∑–∞—Ü–∏–∏ –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω—ã—Ö –ø—Ä–∞–≤–æ–≤—ã—Ö –∞–∫—Ç–æ–≤ —Å–æ —Å—Ä–æ–∫–æ–º –≤—Å—Ç—É–ø–ª–µ–Ω–∏—è –≤ —Å–∏–ª—É –º–µ—Ö–∞–Ω–∏–∑–º–∞ ¬´–≤—Ç–æ—Ä–æ–π –ª–∏—à–Ω–∏–π¬ª –¥–ª—è –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏–∑ –ø–µ—Ä–µ—á–Ω—è –°–ó–õ–°, –ø—Ä–æ–∏–∑–≤–µ–¥–µ–Ω–Ω—ã—Ö –≤ –ï–ê–≠–° –ø–æ ¬´–ø–æ–ª–Ω–æ–º—É —Ü–∏–∫–ª—É¬ª, –∫–æ—Ç–æ—Ä—ã–π –ú–∏–Ω—Ñ–∏–Ω –ø—Ä–µ–¥–ª–æ–∂–∏–ª –ø–µ—Ä–µ–Ω–µ—Å—Ç–∏ –Ω–∞ 1 –∏—é–ª—è 2026 –≥–æ–¥–∞. –ù–∞–ø–æ–º–Ω–∏–º, –∫–æ–≥–¥–∞ –Ω–æ–≤—ã–π –º–µ—Ö–∞–Ω–∏–∑–º –Ω–∞–∫–æ–Ω–µ—Ü –∑–∞—Ä–∞–±–æ—Ç–∞–µ—Ç, —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –±—É–¥—É—Ç –ø–æ–ª—É—á–∞—Ç—å –±–∞–ª–ª—ã –∑–∞ –Ω–∞–ª–∞–∂–∏–≤–∞–Ω–∏–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏–π –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ —Å—Ç—Ä–∞–Ω—ã. –ß—Ç–æ–±—ã —Å—á–∏—Ç–∞—Ç—å—Å—è —Ä–æ—Å—Å–∏–π—Å–∫–æ–π –∏ –ø–æ–ª—É—á–∞—Ç—å ¬´–ø–ª—é—à–∫–∏¬ª –æ—Ç –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–∞, –ø—Ä–æ–¥—É–∫—Ü–∏—è –¥–æ–ª–∂–Ω–∞ –±—É–¥–µ—Ç –Ω–∞–±—Ä–∞—Ç—å –±–æ–ª–µ–µ 50 –±–∞–ª–ª–æ–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, sanctions"",
  ""impact"": ""medium"",
  ""english"": ""The regulatory body has proposed to postpone the implementation date of the origin country assessment system scoring from January 1st to July 1st, 2026. The reasons given are: ongoing work on translating the origin country assessment system for individual medical products; need to synchronize regulatory legal acts with the implementation date of the 'second extra' mechanism for medicines from the EAEU produced in full cycle, which was proposed to be moved to July 1st, 2026. When the new mechanism is finally operational, pharmaceutical companies will receive points for establishing production of medicines and pharmaceuticals within the country. To be considered as Russian and to receive 'bonuses' from the state, products must accumulate more than 50 points.""
}"
2025-12-05T05:20:28+00:00,@bezrec,6898,https://t.me/bezrec/6898,"DSM Group –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª —Ä–µ–π—Ç–∏–Ω–≥ –∞–ø—Ç–µ—á–Ω—ã—Ö —Å–µ—Ç–µ–π –ø–æ –∏—Ç–æ–≥–∞–º 9 –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞. –í –∞–Ω–∞–ª–∏–∑–∏—Ä—É–µ–º—ã–π –ø–µ—Ä–∏–æ–¥ –æ–±—ä—ë–º –∞–ø—Ç–µ—á–Ω–æ–≥–æ —Ä—ã–Ω–∫–∞ –≤—ã—Ä–æ—Å –Ω–∞ 12% –≥–æ–¥ –∫ –≥–æ–¥—É –∏ —Å–æ—Å—Ç–∞–≤–∏–ª 1,6 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –¢–∞–∫–∞—è –¥–∏–Ω–∞–º–∏–∫–∞ ‚Äî –∑–∞—Å–ª—É–≥–∞, –≤ –æ—Å–Ω–æ–≤–Ω–æ–º, —Ü–µ–Ω–æ–≤—ã—Ö —Ñ–∞–∫—Ç–æ—Ä–æ–≤: –ø–µ—Ä–µ–∫–ª—é—á–µ–Ω–∏—è –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª—è –Ω–∞ –±–æ–ª–µ–µ –¥–æ—Ä–æ–≥–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –∏ –∏–Ω—Ñ–ª—è—Ü–∏–∏. –ù–∞ –∫–æ–Ω–µ—Ü —Å–µ–Ω—Ç—è–±—Ä—è –æ–±—â–µ–µ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –∞–ø—Ç–µ–∫ –≤ –†–æ—Å—Å–∏–∏ –¥–æ—Å—Ç–∏–≥–ª–æ 83 —Ç—ã—Å. —Ç–æ—á–µ–∫. –≠—Ç–æ –≤—Å–µ–≥–æ –Ω–∞ 1% –±–æ–ª—å—à–µ, —á–µ–º –≥–æ–¥–æ–º —Ä–∞–Ω–µ–µ, –Ω–æ –≤—Å—ë —Ä–∞–≤–Ω–æ –Ω–æ–≤—ã–π –º–∞–∫—Å–∏–º—É–º –ø–æ –æ–±—â–µ–º—É —á–∏—Å–ª—É –∞–ø—Ç–µ—á–Ω—ã—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π. –£—Ö–æ–¥—è—â–∏–π –≥–æ–¥ –¥–ª—è –∞–ø—Ç–µ—á–Ω–æ–≥–æ —Å–µ–≥–º–µ–Ω—Ç–∞ –æ—Ç–º–µ—Ç–∏–ª—Å—è –∫–∞–∫ –µ—Å—Ç–µ—Å—Ç–≤–µ–Ω–Ω—ã–º –ø—Ä–∏—Ä–æ—Å—Ç–æ–º —á–∏—Å–ª–∞ –∞–ø—Ç–µ–∫, —Ç–∞–∫ –∏ –∞–∫—Ç–∏–≤–Ω–æ–π –∫–æ–Ω—Å–æ–ª–∏–¥–∞—Ü–∏–µ–π —Ä—ã–Ω–∫–∞ –±–ª–∞–≥–æ–¥–∞—Ä—è –∫—Ä—É–ø–Ω—ã–º —Å–¥–µ–ª–∫–∞–º –ø–æ –ø–æ–≥–ª–æ—â–µ–Ω–∏—é —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã–º–∏ —Å–µ—Ç—è–º–∏ –º–µ—Å—Ç–Ω—ã—Ö –∏–≥—Ä–æ–∫–æ–≤. –û—Å–æ–±–µ–Ω–Ω–æ –∞–∫—Ç–∏–≤–Ω–æ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã–µ —Å–µ—Ç–∏ –ø–æ–∫—É–ø–∞–ª–∞ ¬´–†–∏–≥–ª–∞¬ª. –í —á–∏—Å–ª–µ –ø–æ—Å–ª–µ–¥–Ω–∏—Ö –ø—Ä–∏–æ–±—Ä–µ—Ç–µ–Ω–∏–π: ¬´–ê–ø—Ç–µ–∫–∞25.—Ä—Ñ¬ª –≤ –ü—Ä–∏–º–æ—Ä—Å–∫–æ–º –∫—Ä–∞–µ, —É—Å—Å—É—Ä–∏–π—Å–∫–∞—è —Å–µ—Ç—å ¬´–§–∞—Ä–º¬ª, –æ–±—ä–µ–¥–∏–Ω—ë–Ω–Ω–∞—è —Å–µ—Ç—å ¬´–ê–ø—Ç–µ–∫–∞ –ú–∏–Ω–∏—Ü–µ–Ω¬ª –∏ ¬´–ù–æ–≤–∞—è –∞–ø—Ç–µ–∫–∞¬ª, —Å–∞–º–∞—Ä—Å–∫–∞—è —Å–µ—Ç—å ¬´–ê–ª–∏—è¬ª, –∫–∞–ª–∏–Ω–∏–Ω–≥—Ä–∞–¥—Å–∫–∏–π —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–π —Ä–µ—Ç–µ–π–ª–µ—Ä –û–û–û ¬´–õ–∏–Ω—Ü¬ª (¬´–ù–æ–≤–∞—è –∞–ø—Ç–µ–∫–∞¬ª), —Ç–≤–µ—Ä—Å–∫–∞—è —Å–µ—Ç—å ¬´–§–∞—Ä–º–∏–Ω—Ç–æ—Ä–≥¬ª. –¢–∞–∫–æ–π –±–æ–≥–∞—Ç—ã–π ¬´—É–ª–æ–≤¬ª –ø–æ–º–æ–≥ ¬´–†–∏–≥–ª–µ¬ª —Å–æ—Ö—Ä–∞–Ω–∏—Ç—å —Å–≤–æ—ë –ª–∏–¥–µ—Ä—Å—Ç–≤–æ –Ω–∞ —Ä—ã–Ω–∫–µ. –†–∞—Å—à–∏—Ä–µ–Ω–∏–µ–º —Å–≤–æ–µ–π —Ä–æ–∑–Ω–∏—á–Ω–æ–π —Å–µ—Ç–∏ —Ç–∞–∫–∂–µ –∑–∞–Ω–∏–º–∞–µ—Ç—Å—è ¬´–ê–ø—Ä–µ–ª—å¬ª. –í 2025 –≥–æ–¥—É —Å–µ—Ç—å –ø—Ä–∏—Ä–æ—Å–ª–∞ –Ω–∞ 760 –Ω–æ–≤—ã—Ö —Ç–æ—á–µ–∫ –∏ –ª–∏–¥–∏—Ä—É–µ—Ç –ø–æ –∫–æ–ª–∏—á–µ—Å—Ç–≤—É —Ç–æ—á–µ–∫ –≤ –æ–¥–Ω–æ–π —Å–µ—Ç–∏ (–±–æ–ª–µ–µ 9,4 —Ç—ã—Å.). –í —Ç–æ–ø-10 –∞–ø—Ç–µ—á–Ω—ã—Ö —Å–µ—Ç–µ–π –ø–æ –∏—Ç–æ–≥–∞–º 9 –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ —Ç–∞–∫–∂–µ –≤–æ—à–ª–∏: ¬´–ü–ª–∞–Ω–µ—Ç–∞ –∑–¥–æ—Ä–æ–≤—å—è¬ª, ¬´36,6¬ª, ¬´–ò–º–ø–ª–æ–∑–∏—è¬ª, ¬´–ù–µ–æ-–§–∞—Ä–º¬ª, ¬´–û–±—ä–µ–¥–∏–Ω–µ–Ω–Ω–∞—è –ê–° –≠—Ä–∫–∞—Ñ–∞—Ä–º –∏ –ú–µ–ª–æ–¥–∏—è –∑–¥–æ—Ä–æ–≤—å—è¬ª, ¬´–§–∞—Ä–º–ª–µ–Ω–¥¬ª, ¬´–í–∏—Ç–∞¬ª, ¬´–ò—Ä–∏—Å¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": true,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The report by DSM Group on the top pharmacy networks for the first nine months of 2025 shows a year-over-year market growth of 12% to RUB 16 billion. The main factors driving this trend include price hikes and inflation. As of September, the total number of pharmacies in Russia reached 83,000 points, an increase of 1% from the previous year. The sector's performance in 2025 was marked by both natural growth of pharmacies and market consolidation through large mergers involving federal chains acquiring local players. 'Rigla' was particularly active in this area, with acquisitions including 'Apteka25.ru' in Primorsky Krai, Ussuriy network 'Farma', combined network 'Apteka Mini—Ü–µ–Ω', and Samara network 'Aliya'. These acquisitions helped 'Rigla' maintain its leadership. 'April' also expands its retail network, adding 760 new points in 2025 and leading the country with more than 9,4"
2025-12-04T14:04:30+00:00,@bezrec,6897,https://t.me/bezrec/6897,"¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª –º–æ–∂–µ—Ç –∏ –¥–∞–ª—å—à–µ –≤—ã–ø—É—Å–∫–∞—Ç—å –∞–Ω–∞–ª–æ–≥–∏ –û–∑–µ–º–ø–∏–∫–∞. –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ —Ä–∞–∑—Ä–µ—à–∏–ª–æ –∫–æ–º–ø–∞–Ω–∏–∏ –ü–µ—Ç—Ä–∞ –†–æ–¥–∏–æ–Ω–æ–≤–∞ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã —Å –ú–ù–ù —Å–µ–º–∞–≥–ª—É—Ç–∏–¥ –±–µ–∑ —Ä–∞–∑—Ä–µ—à–µ–Ω–∏—è –ø—Ä–∞–≤–æ–æ–±–ª–∞–¥–∞—Ç–µ–ª—è ‚Äì –¥–∞—Ç—Å–∫–æ–π Novo Nordisk ‚Äì –¥–æ –∫–æ–Ω—Ü–∞ 2026 –≥–æ–¥–∞. –°–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–µ–µ —Ä–∞—Å–ø–æ—Ä—è–∂–µ–Ω–∏–µ –ø–æ–¥–ø–∏—Å–∞–ª –ø—Ä–µ–º—å–µ—Ä-–º–∏–Ω–∏—Å—Ç—Ä –ú–∏—Ö–∞–∏–ª –ú–∏—à—É—Å—Ç–∏–Ω. –û–Ω–æ –≤—Å—Ç—É–ø–∏—Ç –≤ —Å–∏–ª—É —Å 1 —è–Ω–≤–∞—Ä—è 2026 –≥–æ–¥–∞. –ü–æ –¥–∞–Ω–Ω—ã–º DSM Group, –≤ —è–Ω–≤–∞—Ä–µ ‚Äì —Å–µ–Ω—Ç—è–±—Ä–µ 2025 –≥–æ–¥–∞ –±—ã–ª–æ –ø—Ä–æ–¥–∞–Ω–æ –±–æ–ª–µ–µ 3,6 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ –Ω–∞ 20,5 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —á—Ç–æ –≤ 2,8 —Ä–∞–∑ –±–æ–ª—å—à–µ –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –∏ –≤ 3,1 —Ä–∞–∑–∞ –±–æ–ª—å—à–µ –≤ –¥–µ–Ω–µ–∂–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ –≥–æ–¥ –∫ –≥–æ–¥—É. –í –ª–∏–¥–µ—Ä–∞—Ö –ø–æ-–ø—Ä–µ–∂–Ω–µ–º—É –°–µ–º–∞–≤–∏–∫ –æ—Ç ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º–∞¬ª. –ï–≥–æ –∫—É–ø–∏–ª–∏ 2,2 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ (–±–æ–ª—å—à–µ –≤ 2,7 —Ä–∞–∑–∞) –Ω–∞ 13 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π (—Ä–æ—Å—Ç –≤ 2,8 —Ä–∞–∑–∞). –ù–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ ‚Äî –ö–≤–∏–Ω—Å–µ–Ω—Ç–∞ –æ—Ç ¬´–ü—Ä–æ–º–æ–º–µ–¥–∞¬ª (609 —Ç—ã—Å. —É–ø–∞–∫–æ–≤–æ–∫ –Ω–∞ 3,3 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π). –¢–∞–∫–∂–µ –≤ ¬´–ª—é–±–∏–º—á–∏–∫–∞—Ö¬ª —É —Ö—É–¥–µ—é—â–∏—Ö —Ä–æ—Å—Å–∏—è–Ω ‚Äî –í–µ–ª–≥–∏—è, –∫–æ—Ç–æ—Ä—É—é –∫–æ–º–ø–∞–Ω–∏—è –ü–µ—Ç—Ä–∞ –ë–µ–ª–æ–≥–æ –≤—ã–≤–µ–ª–∞ –Ω–∞ —Ä—ã–Ω–æ–∫ –≤ –Ω–∞—á–∞–ª–µ –≥–æ–¥–∞. –†–µ–∑—É–ª—å—Ç–∞—Ç—ã –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –ø–æ –∏—Ç–æ–≥–∞–º 9 –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ ‚Äî 709,6 —Ç—ã—Å. —É–ø–∞–∫–æ–≤–æ–∫ –Ω–∞ 3,6 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""The government has granted the company Petro Rodionov permission to use semaglutide without the rights holder, Danish Novo Nordisk, until December 31, 2026. This decision was signed by Prime Minister Mikhail Mishustin. Sales of semaglutide reached 3,6 million units and 20.5 billion rubles in January to September 2025, an increase of 28% year-over-year. The leader is SemaVik from 'Geropharm' with 2,2 million units sold and a revenue of 13 billion rubles. Other popular products include VeliGi from 'Promomed' with 609 thousand units sold and a revenue of 3.3 billion rubles. The impact on the market is significant, with high demand for semaglutide.""
}"
2025-12-04T11:45:01+00:00,@bezrec,6896,https://t.me/bezrec/6896,"–ê–Ω–∞–ª–∏—Ç–∏–∫–∏ —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏, –≤ –∫–∞–∫–∏—Ö —Ä–µ–≥–∏–æ–Ω–∞—Ö –æ—Å–æ–±–æ –±–æ–¥—Ä–æ –ø—Ä–æ–¥–∞–µ—Ç—Å—è –≥–∞–±–∞–ø–µ–Ω—Ç–∏–Ω. –í—á–µ—Ä–∞ –º—ã –ø–∏—Å–∞–ª–∏, —á—Ç–æ –ø—Ä–æ—Ç–∏–≤–æ—ç–ø–∏–ª–µ–ø—Ç–∏—á–µ—Å–∫–∏–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –ø–æ–ø–∞–ª –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ü–ö–£. –û–≥—Ä–∞–Ω–∏—á–µ–Ω–∏–µ –≤—Å—Ç—É–ø–∏—Ç –≤ —Å–∏–ª—É —Å 1 –º–∞—Ä—Ç–∞ 2026 –≥–æ–¥–∞. –ê–Ω–∞–ª–∏—Ç–∏–∫–∏ RNC Pharma —Å–≤—è–∑—ã–≤–∞—é—Ç —Ä–µ—à–µ–Ω–∏–µ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ —Å ¬´–≥–∞–ª–æ–ø–∏—Ä—É—é—â–∏–º¬ª —Ä–æ—Å—Ç–æ–º —Å–ø—Ä–æ—Å–∞ –Ω–∞ —ç—Ç–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–æ. –í —è–Ω–≤–∞—Ä–µ-–æ–∫—Ç—è–±—Ä–µ 2025 –≥–æ–¥–∞ —Ä–æ—Å—Å–∏—è–Ω–µ –ø—Ä–∏–æ–±—Ä–µ–ª–∏ 9,4 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ –≥–∞–±–∞–ø–µ–Ω—Ç–∏–Ω–∞ –Ω–∞ 7,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –≠—Ç–æ –Ω–∞ 24,7% –±–æ–ª—å—à–µ –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –∏ –Ω–∞ 33,7% –≤ –¥–µ–Ω–µ–∂–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ –≥–æ–¥ –∫ –≥–æ–¥—É. –í—ã—Å–æ–∫–∏–µ —Ç–µ–º–ø—ã –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏—è —Ñ–∏–∫—Å–∏—Ä—É—é—Ç—Å—è —Ç—Ä–∏ –≥–æ–¥–∞ –ø–æ–¥—Ä—è–¥. –û–±—ä—ë–º—ã –∏ –¥–∏–Ω–∞–º–∏–∫–∞ –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏—è —Å–∏–ª—å–Ω–æ –≤–∞—Ä—å–∏—Ä—É—é—Ç—Å—è –≤ –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏ –æ—Ç —Ä–µ–≥–∏–æ–Ω–∞. –í –ª–∏–¥–µ—Ä–∞—Ö –ø–æ –æ–±—â–µ–º—É –æ–±—ä—ë–º—É –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏—è ‚Äî –ö—Ä–∞—Å–Ω–æ–¥–∞—Ä—Å–∫–∏–π –∫—Ä–∞–π –∏ –†–æ—Å—Ç–æ–≤—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å. –ú–∞–∫—Å–∏–º–∞–ª—å–Ω—É—é –Ω–∞—Ç—É—Ä–∞–ª—å–Ω—É—é –¥–∏–Ω–∞–º–∏–∫—É –ø—Ä–æ–¥–∞–∂ –ø–æ–∫–∞–∑–∞–ª–∏ –ß—É–∫–æ—Ç—Å–∫–∏–π –ê–û –∏ –ö—É—Ä—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å. –ï—Å–ª–∏ –≥–æ–≤–æ—Ä–∏—Ç—å –æ–± –æ–±—ä—ë–º–µ —Å—Ä–µ–¥–Ω–µ–¥—É—à–µ–≤–æ–≥–æ –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏—è, —Ç–æ –Ω–∞ –ø–µ—Ä–≤–æ–º –º–µ—Å—Ç–µ –†–æ—Å—Ç–æ–≤—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å ‚Äî –∑–¥–µ—Å—å –Ω–∞ –∫–∞–∂–¥–æ–≥–æ –∂–∏—Ç–µ–ª—è —Å –Ω–∞—á–∞–ª–∞ –≥–æ–¥–∞ –≤ —Å—Ä–µ–¥–Ω–µ–º –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è 0,22 —É–ø–∞–∫–æ–≤–∫–∏ –≥–∞–±–∞–ø–µ–Ω—Ç–∏–Ω–∞. –î–ª—è —Å—Ä–∞–≤–Ω–µ–Ω–∏—è –≤ –ú–æ—Å–∫–≤–µ —ç—Ç–∞ —Ü–∏—Ñ—Ä–∞ –Ω–µ –ø—Ä–µ–≤—ã—à–∞–µ—Ç 0,05 —É–ø–∞–∫. –Ω–∞ 1 —á–µ–ª–æ–≤–µ–∫–∞. –° —Ç–∞–∫–∏–º–∏ –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è–º–∏ —Å—Ç–æ–ª–∏—Ü–∞ –≤ —Ç–æ–ø-10 –Ω–µ –ø–æ–ø–∞–ª–∞. –ê–Ω–∞–ª–∏—Ç–∏–∫–∏ –ø–æ–¥—á—ë—Ä–∫–∏–≤–∞—é—Ç, —á—Ç–æ —ç—Ç–∏ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –Ω–µ —É—á–∏—Ç—ã–≤–∞—é—Ç –ø–µ—Ä–µ–º–µ—â–µ–Ω–∏—è –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª–µ–π –º–µ–∂–¥—É —Ä–µ–≥–∏–æ–Ω–∞–º–∏ –∏ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –ø–æ–∫—É–ø–∫–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ —Ä–∞–∑–Ω—ã—Ö —Å—É–±—ä–µ–∫—Ç–∞—Ö. –ë–æ–ª–µ–µ 43% –ø—Ä–æ–¥–∞–∂ –Ω–∞ —Ä–æ–∑–Ω–∏—á–Ω–æ–º —Ä—ã–Ω–∫–µ –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã ¬´–ö–∞–Ω–æ–Ω—Ñ–∞—Ä–º—ã¬ª. –ó–∞–º–µ—Ç–Ω—ã–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã —Ç–∞–∫–∂–µ —É ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∏¬ª –∏ ¬´–ü–ò–ö-–§–∞—Ä–º—ã¬ª, –∫–∞–∂–¥–∞—è –∏–∑ –∫–æ—Ç–æ—Ä—ã—Ö –æ–±–µ—Å–ø–µ—á–∏–≤–∞–µ—Ç —á—É—Ç—å –±–æ–ª–µ–µ 11% –≤—Å–µ–≥–æ —Ñ–∏–∑–∏—á–µ—Å–∫–æ–≥–æ –æ–±—ä—ë–º–∞ –ø—Ä–æ–¥–∞–∂ –≥–∞–±–∞–ø–µ–Ω—Ç–∏–Ω–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""Analysts report rapid growth in gabapentin sales across regions. Sales have increased by 24.7% year-over-year in natural terms and 33.7% in monetary terms from January to October 2025, totaling 9.4 million units and RUB7.7 billion. The regions of Krasnodar Krai and Rostov Oblast lead in overall sales volumes. The highest natural growth rates are observed in Chukotka Autonomous Okrug and Kursk Oblast. The average household consumption is highest in Rostov Oblast (0.22 unit per person) compared to Moscow's 0.05 units per person. The top four wholesalers by market share are 'Canon Pharma', 'Ozon Farmakvetika', and 'PIK-Farma'.""
}"
2025-12-04T08:50:02+00:00,@bezrec,6895,https://t.me/bezrec/6895,"DSM Group –æ–ø—Ä–µ–¥–µ–ª–∏–ª–∞ –ª—É—á—à–∏—Ö –∏–∑ –ª—É—á—à–∏—Ö —Å—Ä–µ–¥–∏ —Å–µ—Ä–≤–∏—Å–æ–≤ –¥–∏—Å—Ç–∞–Ω—Ü–∏–æ–Ω–Ω–æ–≥–æ –∑–∞–∫–∞–∑–∞. –ü–æ –∏—Ç–æ–≥–∞–º –ø–µ—Ä–≤—ã—Ö 9 –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ –æ–±—ä—ë–º –∞–ø—Ç–µ—á–Ω–æ–≥–æ —Ä—ã–Ω–∫–∞ —Å–æ—Å—Ç–∞–≤–∏–ª 1,6 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —á—Ç–æ –Ω–∞ 12% –±–æ–ª—å—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É. –ü–∞—Ä–∞–ª–ª–µ–ª—å–Ω–æ —Å –ø—Ä–æ—Ü–µ—Å—Å–æ–º –æ–±—ä–µ–¥–∏–Ω–µ–Ω–∏—è —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω—ã—Ö —Ä–æ–∑–Ω–∏—á–Ω—ã—Ö —Å–µ—Ç–µ–π –≤ e-com —Ç–æ–∂–µ –ø—Ä–æ–∏—Å—Ö–æ–¥–∏–ª–∏ –≤–∞–∂–Ω—ã–µ –∏–∑–º–µ–Ω–µ–Ω–∏—è: üü© ¬´–ï–∞–ø—Ç–µ–∫–∞¬ª –≤—ã—à–ª–∞ –∏–∑ —ç–∫–æ—Å–∏—Å—Ç–µ–º—ã ¬´–°–±–µ—Ä–∞¬ª, –∫–æ—Ç–æ—Ä—ã–π –ø—Ä–æ–¥–∞–ª —Å–≤–æ–∏ 45% –≤–æ –≤—Ç–æ—Ä–æ–π –ø–æ —Ä–∞–∑–º–µ—Ä—É –æ–Ω–ª–∞–π–Ω-–∞–ø—Ç–µ–∫–µ —Å—Ç—Ä—É–∫—Ç—É—Ä–∞–º, —Å–≤—è–∑–∞–Ω–Ω—ã–º —Å –ê–ª–µ–∫—Å–µ–µ–º –†–µ–ø–∏–∫–æ–º. –¢–µ–ø–µ—Ä—å –∏–º –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∏—Ç 100% –≤ –û–û–û. üü© –í –∞–≤–≥—É—Å—Ç–µ –∑–∞–∫–∞–∑ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏–∑ ¬´–ï–∞–ø—Ç–µ–∫–∏¬ª –∑–∞–ø—É—Å—Ç–∏–ª Wildberries. –ù–∞ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–µ –ø–æ—è–≤–∏–ª–∞—Å—å –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –¥–æ—Å—Ç–∞–≤–∫–∏ –±–µ–∑—Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –≤–∏—Ç–∞–º–∏–Ω–æ–≤ –∏–∑ —Å–µ—Ç–∏. üü© –í –∏—é–ª–µ ¬´–ö—É–ø–µ—Ä¬ª –æ–±—ä—è–≤–∏–ª –æ –ø–æ–¥–∫–ª—é—á–µ–Ω–∏–∏ –∫ —Å–µ—Ä–≤–∏—Å—É –ø–æ—á—Ç–∏ 1,8 —Ç—ã—Å. –∞–ø—Ç–µ–∫ ¬´–í–∏—Ç–∞¬ª –≤ 89 –≥–æ—Ä–æ–¥–∞—Ö –†–æ—Å—Å–∏–∏, –≤–∫–ª—é—á–∞—è –ú–æ—Å–∫–≤—É, –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥, –ï–∫–∞—Ç–µ—Ä–∏–Ω–±—É—Ä–≥, –£–ª—å—è–Ω–æ–≤—Å–∫, –°–∞—Ä–∞—Ç–æ–≤, –í–æ–ª–≥–æ–≥—Ä–∞–¥, –ù–∏–∂–Ω–∏–π –ù–æ–≤–≥–æ—Ä–æ–¥, –ö–∞–∑–∞–Ω—å, –°–∞–º–∞—Ä—É, –ß–µ–ª—è–±–∏–Ω—Å–∫, –†–æ—Å—Ç–æ–≤-–Ω–∞-–î–æ–Ω—É –∏ –ß–µ–±–æ–∫—Å–∞—Ä—ã. –ü–æ–¥–∫–ª—é—á–µ–Ω–∏–µ ¬´–í–∏—Ç—ã¬ª - –Ω–µ –ø–µ—Ä–≤—ã–π –¥–ª—è –ö—É–ø–µ—Ä–∞ –æ–ø—ã—Ç —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–∞ —Å –∞–ø—Ç–µ—á–Ω—ã–º–∏ —Å–µ—Ç—è–º–∏. –†–∞–Ω–µ–µ –∫ —Å–µ—Ä–≤–∏—Å—É –±—ã–ª–∏ –ø–æ–¥–∫–ª—é—á–µ–Ω—ã ¬´–ú–∞–∫—Å–∞–≤–∏—Ç¬ª, ¬´–ñ–∏–≤–∏–∫–∞¬ª –∏ –¥—Ä—É–≥–∏–µ –ø–∞—Ä—Ç–Ω–µ—Ä—ã. –í —Ç–æ–ø-10 —Å–µ—Ä–≤–∏—Å–æ–≤ –¥–∏—Å—Ç–∞–Ω—Ü–∏–æ–Ω–Ω–æ–≥–æ –∑–∞–∫–∞–∑–∞ –≤–æ—à–ª–∏ —Å–ª–µ–¥—É—é—â–∏–µ –∏–≥—Ä–æ–∫–∏: ¬´–ê–ø—Ç–µ–∫–∞.—Ä—É¬ª, ¬´–Æ—Ç–µ–∫–∞¬ª, ¬´–ó–¥—Ä–∞–≤—Å–∏—Ç–∏¬ª, ¬´–ï-–∞–ø—Ç–µ–∫–∞¬ª, polza. ru, ¬´–ú–µ–≥–∞–∞–ø—Ç–µ–∫–∞¬ª, ¬´–Ø–Ω–¥–µ–∫—Å –ê–ø—Ç–µ–∫–∏¬ª, ¬´–ê—Å–Ω–∞¬ª, ¬´009. —Ä—Ñ¬ª, ¬´–ò–Ω—Ç–µ—Ä–Ω–µ—Ç-–∞–ø—Ç–µ–∫–∞ –õ–µ–≥–∫–æ¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": true,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""low"",
  ""english"": ""DSM Group identified the best of the best among remote prescription ordering services. For the first nine months of 2025, the pharmaceutical market volume was RUB16 billion, up by 12% year-over-year. Simultaneously with the process of traditional retail networks' e-commerce integration, significant changes occurred: 'Eaptekha' exited the ecosystem of Sberbank, which sold its 45% stake to structures related to Alexey Repik. Now it owns 100%. In August, the prescription ordering service from 'Eaptekha' was launched on Wildberries. The marketplace now offers the delivery of non-prescription medications and vitamins from the network. In July, 'Kupera' announced that it has connected almost 18 thousand pharmacies under the 'Vita' service in 89 Russian cities, including Moscow, St. Petersburg, Ekaterinburg, Ulyanovsk, Samara, Volgograd, Nizhny Novgorod, Kazan, Chelyabinsk, Rost"
2025-12-04T05:55:27+00:00,@bezrec,6894,https://t.me/bezrec/6894,"–ú–Ω–æ–≥–æ—Å—Ç—Ä–∞–¥–∞–ª—å–Ω—ã–µ –ø—Ä–∏–≤–∏–≤–∫–∏ –æ–ø—è—Ç—å –ø–æ–¥–≤–∏–Ω—É—Ç. –í–ª–∞—Å—Ç–∏ –æ–±—Å—É–∂–¥–∞—é—Ç –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –ø–µ—Ä–µ–Ω–æ—Å–∞ —Å—Ä–æ–∫–æ–≤ –≤–∫–ª—é—á–µ–Ω–∏—è —á–µ—Ç—ã—Ä—ë—Ö –Ω–æ–≤—ã—Ö –≤–∞–∫—Ü–∏–Ω –≤ –ù–∞—Ü–∫–∞–ª–µ–Ω–¥–∞—Ä—å. –≠—Ç–æ —Å–ª–µ–¥—É–µ—Ç –∏–∑ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–Ω–æ–≥–æ –ú–∏–Ω–∏—Å—Ç–µ—Ä—Å—Ç–≤–æ–º –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ø—Ä–æ–µ–∫—Ç–∞ —Ä–∞—Å–ø–æ—Ä—è–∂–µ–Ω–∏—è –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞, –ø–∏—à–µ—Ç ¬´–†–ë–ö¬ª. –ù–æ–≤—ã–µ —Å—Ä–æ–∫–∏: üîò–≤–∞–∫—Ü–∏–Ω–∞ –æ—Ç —Ä–æ—Ç–∞–≤–∏—Ä—É—Å–Ω–æ–π –∏–Ω—Ñ–µ–∫—Ü–∏–∏ ‚Äî —Å 2025 –Ω–∞ 2029 –≥–æ–¥; üîò–ø—Ä–æ—Ç–∏–≤ –≤–µ—Ç—Ä—è–Ω–æ–π –æ—Å–ø—ã ‚Äî —Å 2027 –Ω–∞ 2031 –≥–æ–¥; üîò–ø—Ä–æ—Ç–∏–≤ –í–ü–ß ‚Äî —Å 2026 –Ω–∞ 2027 –≥–æ–¥; üîò–ø—Ä–æ—Ç–∏–≤ –º–µ–Ω–∏–Ω–≥–æ–∫–æ–∫–∫–∞ ‚Äî —Å 2025 –Ω–∞ 2027 –≥–æ–¥. –î–æ–∫—É–º–µ–Ω—Ç –≤–Ω–æ—Å–∏—Ç –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ –ø–ª–∞–Ω –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–π –ø–æ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ —Å—Ç—Ä–∞—Ç–µ–≥–∏–∏ —Ä–∞–∑–≤–∏—Ç–∏—è –∏–º–º—É–Ω–æ–ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –∏–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã—Ö –±–æ–ª–µ–∑–Ω–µ–π –¥–æ 2035 –≥–æ–¥–∞, —É—Ç–≤–µ—Ä–∂–¥—ë–Ω–Ω—ã–π –≤ 2021 –≥–æ–¥—É. –ò –Ω–µ –≤–ø–µ—Ä–≤—ã–µ. –°—Ä–æ–∫–∏ –≤–∫–ª—é—á–µ–Ω–∏—è —ç—Ç–∏—Ö –≤–∞–∫—Ü–∏–Ω –≤ –ù–∞—Ü–∫–∞–ª–µ–Ω–¥–∞—Ä—å —É–∂–µ –¥–≤–∏–≥–∞–ª–∏. –°–æ–ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—å –í—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —Å–æ—é–∑–∞ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –Ø–Ω –í–ª–∞—Å–æ–≤ –Ω–∞–º–µ—Ä–µ–Ω–∏—è –≤–ª–∞—Å—Ç–µ–π –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª: –ò—Ö —Ç—Ä—É–¥–Ω–æ –æ—Ü–µ–Ω–∏–≤–∞—Ç—å –∏–Ω–∞—á–µ –∫–∞–∫ –Ω–µ–≥–∞—Ç–∏–≤–Ω–æ. –†–µ—á—å –∏–¥–µ—Ç –Ω–µ –ø—Ä–æ—Å—Ç–æ –æ –∫–æ—Ä—Ä–µ–∫—Ç–∏—Ä–æ–≤–∫–µ –≥—Ä–∞—Ñ–∏–∫–æ–≤, –∞ –æ –∑–∞–¥–µ—Ä–∂–∫–µ –∑–∞—â–∏—Ç—ã –¥–µ—Ç–µ–π –∏ –≤–∑—Ä–æ—Å–ª—ã—Ö –æ—Ç –∫—Ä–∞–π–Ω–µ –æ–ø–∞—Å–Ω—ã—Ö –∏–Ω—Ñ–µ–∫—Ü–∏–π. –§–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—è–º –±–µ–∑ —É—Å—Ç–æ–π—á–∏–≤–æ–≥–æ –≥–æ—Å–∑–∞–∫–∞–∑–∞ –Ω–µ–≤–æ–∑–º–æ–∂–Ω–æ —Ä–∞–∑–≤–∏–≤–∞—Ç—å –Ω–∞—É—á–Ω—ã–µ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –∏ –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ. –í–Ω–µ–¥—Ä–µ–Ω–∏–µ –≤ –∫–∞–ª–µ–Ω–¥–∞—Ä—å —Ç–æ–ª—å–∫–æ –ø—Ä–∏ –Ω–∞–ª–∏—á–∏–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ ¬´–≤ –ø–æ–ª–Ω—ã–π —Ü–∏–∫–ª¬ª —ç–∫—Å–ø–µ—Ä—Ç —Å—á–∏—Ç–∞–µ—Ç ¬´–Ω–µ–æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω—ã–º —É–∂–µ—Å—Ç–æ—á–µ–Ω–∏–µ–º¬ª. –•–æ—Ç—è –Ω–µ–∫–æ—Ç–æ—Ä—ã–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ —É–∂–µ –ø–æ—Å—Ç–∞—Ä–∞–ª–∏—Å—å –∏ –ª–æ–∫–∞–ª–∏–∑–æ–≤–∞–ª–∏ —Å–≤–æ–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, –∫–∞–∫, –Ω–∞–ø—Ä–∏–º–µ—Ä, ¬´–ù–∞–Ω–æ–ª–µ–∫¬ª —Å–æ —Å–≤–æ–∏–º –¶–µ–≥–∞—Ä–¥–µ–∫—Å–æ–º –æ—Ç –í–ü–ß. ¬´–§–∞—Ä–º –≠–π–¥¬ª ‚Äî –¥–µ—Ä–∂–∞—Ç–µ–ª—å –†–£ –Ω–∞ –†–æ—Ç–∞-V-–≠–π–¥ –æ—Ç —Ä–æ—Ç–∞–≤–∏—Ä—É—Å–∞ ‚Äî –æ–±–µ—â–∞–µ—Ç –ª–æ–∫–∞–ª–∏–∑–æ–≤–∞—Ç—å –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –≤ –∏–Ω–¥—É—Å—Ç—Ä–∏–∞–ª—å–Ω–æ–º –ø–∞—Ä–∫–µ –Ω–∞ –≥—Ä–∞–Ω–∏—Ü–µ –ú–æ—Å–∫–æ–≤—Å–∫–æ–π –∏ –ö–∞–ª—É–∂—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–µ–π, –Ω–æ —Ç–æ—á–Ω—ã—Ö –¥–∞—Ç –Ω–µ –Ω–∞–∑—ã–≤–∞–µ—Ç. –ì–∞–º-VLP-—Ä–æ—Ç–∞ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –¶–µ–Ω—Ç—Ä–∞ –∏–º. –ì–∞–º–∞–ª–µ–∏ –¥–ª—è –¥–µ—Ç–µ–π –æ—Ç 8 –¥–æ 32 –Ω–µ–¥–µ–ª—å –Ω–∞—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ II-III —Ñ–∞–∑–µ –ö–ò. –õ–æ–∫–∞–ª–∏–∑–∞—Ü–∏—é –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –≤–∞–∫—Ü–∏–Ω—ã –æ—Ç –º–µ–Ω–∏–Ω–≥–æ–∫–æ–∫–∫–∞ —Å–µ–π—á–∞—Å –∑–∞–≤–µ—Ä—à–∞–µ—Ç ¬´–ü–µ—Ç—Ä–æ–≤–∞–∫—Å¬ª. –° 2026 –≥–æ–¥–∞ –∫–æ–º–ø–∞–Ω–∏—è —Å–º–æ–∂–µ—Ç –≤—ã–ø—É—Å–∫–∞—Ç—å –±–æ–ª–µ–µ 3 –º–ª–Ω –¥–æ–∑ –≤–∞–∫—Ü–∏–Ω—ã –≤ –≥–æ–¥, –ø–æ–ª–Ω–æ—Å—Ç—å—é –ø–æ–∫—Ä—ã–≤ –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç–∏ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ —Ä—ã–Ω–∫–∞. –ê –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç—å —Ç–∞–∫–∞—è –µ—Å—Ç—å ‚Äî –∑–∞–±–æ–ª–µ–≤–∞–µ–º–æ—Å—Ç—å –∏–Ω—Ñ–µ–∫—Ü–∏–µ–π –≤ –†–æ—Å—Å–∏–∏ –≤ 2025 –≥–æ–¥—É —É–≤–µ–ª–∏—á–∏–ª–∞—Å—å –≤ –¥–≤–∞ —Ä–∞–∑–∞ –≥–æ–¥ –∫ –≥–æ–¥—É. –í–∫–ª—é—á–µ–Ω–∏–µ –≤–∞–∫—Ü–∏–Ω—ã –≤ –ù–∞—Ü–∫–∞–ª–µ–Ω–¥–∞—Ä—å —Ñ–æ—Ä–º–∏—Ä—É–µ—Ç –ø—Ä–æ–≥–Ω–æ–∑–∏—Ä—É–µ–º—ã–π —Å–ø—Ä–æ—Å, —á—Ç–æ —Å–æ–∑–¥–∞–µ—Ç —Å—Ç–∏–º—É–ª—ã –¥–ª—è –≤–ª–æ–∂–µ–Ω–∏–π —Å–æ —Å—Ç–æ—Ä–æ–Ω—ã –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –∑–∞–∫–ª—é—á–µ–Ω–∏–µ –¥–æ–ª–≥–æ—Å—Ä–æ—á–Ω—ã—Ö –∫–æ–Ω—Ç—Ä–∞–∫—Ç–æ–≤ –≤ —Ä–∞–º–∫–∞—Ö –ù–ö–ü–ü –ø–æ–∑–≤–æ–ª—è–µ—Ç –Ω–µ —Ç–æ–ª—å–∫–æ —Å—Ç–∞–±–∏–ª—å–Ω–æ –ø–ª–∞–Ω–∏—Ä–æ–≤–∞—Ç—å –æ–±—ä–µ–º—ã –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞, –Ω–æ –∏ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞—Ç—å –±–æ–ª–µ–µ –¥–æ—Å—Ç—É–ø–Ω—É—é —Å—Ç–æ–∏–º–æ—Å—Ç—å –∑–∞ —Å—á–µ—Ç –º–∞—Å—à—Ç–∞–±–æ–≤ —ç–∫–æ–Ω–æ–º–∏–∫–∏, ‚Äî –ø—Ä–æ–∫–æ–º–º–µ–Ω—Ç–∏—Ä–æ–≤–∞–ª –≤–∏—Ü–µ-–ø—Ä–µ–∑–∏–¥–µ–Ω—Ç –ø–æ –∫–æ—Ä–ø–æ—Ä–∞—Ç–∏–≤–Ω—ã–º –∫–æ–º–º—É–Ω–∏–∫–∞—Ü–∏—è–º –∫–æ–º–ø–∞–Ω–∏–∏ –ö–∏—Ä–∏–ª–ª –î–∞–Ω–∏—à–µ–≤—Å–∫–∏–π. –í–ø—Ä–æ—á–µ–º, –∏ —Å —É–∂–µ –≤–∫–ª—é—á–µ–Ω–Ω—ã–º–∏ –≤ –ù–∞—Ü–∫–∞–ª–µ–Ω–¥–∞—Ä—å –ø—Ä–∏–≤–∏–≤–∫–∞–º–∏ —Å–∏—Ç—É–∞—Ü–∏—è —Ç–∞–∫ —Å–µ–±–µ. –ü–æ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º –æ–ø—Ä–æ—Å–∞, –ø—Ä–æ–≤–µ–¥–µ–Ω–Ω–æ–≥–æ –∫–æ–Ω—Å–∞–ª—Ç–∏–Ω–≥–æ–≤–æ–π –∫–æ–º–ø–∞–Ω–∏–µ–π ¬´–ü—Ä–∞–≤–æ –Ω–∞ –∑–¥–æ—Ä–æ–≤—å–µ¬ª, –Ω–µ—É–¥–æ–≤–ª–µ—Ç–≤–æ—Ä–∏—Ç–µ–ª—å–Ω—ã–º —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏–µ –≤–∞–∫—Ü–∏–Ω–æ–ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ —Å—á–∏—Ç–∞—é—Ç 60% —Ä–µ—Å–ø–æ–Ω–¥–µ–Ω—Ç–æ–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The authorities are considering delaying the inclusion of four new vaccines in the national calendar. The changes include: Rota virus vaccine - from 2025 to 2029; Varicella vaccine - from 2027 to 2031; HPV vaccine - from 2026 to 2027; Meningococcal vaccine - from 2025 to 2027. The document modifies the strategy for implementing an immunoprophylaxis program against infectious diseases until 2035, approved in 2021. This is not just a schedule adjustment but a delay in protecting children and adults from dangerous infections. Without stable government orders, pharmaceutical companies cannot develop scientific research and industrial production. The company 'Farmaid' promises to localize its Rota-V-Eid vaccine from the Rota virus, which is already localized in industrial parks on the borders of Moscow and Kaluga regions. However, it does not provide specific dates. The Gamm-VLP Rota vaccine"
2025-12-03T14:34:50+00:00,@bezrec,6893,https://t.me/bezrec/6893,"Novo Nordisk –∏—Å–ø—ã—Ç–∞–µ—Ç –Ω–æ–≤—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –æ—Ç –æ–∂–∏—Ä–µ–Ω–∏—è –¥–ª—è –¥–µ—Ç–µ–π. –î–∞—Ç—Å–∫–∞—è —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—è –Ω–∞—á–∏–Ω–∞–µ—Ç –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ CagriSema –ø—Ä–æ—Ç–∏–≤ –¥–µ—Ç—Å–∫–æ–≥–æ –æ–∂–∏—Ä–µ–Ω–∏—è. –ò—Å–ø—ã—Ç–∞–Ω–∏—è —Å —É—á–∞—Å—Ç–∏–µ–º 460 –¥–µ—Ç–µ–π –≤ –≤–æ–∑—Ä–∞—Å—Ç–µ –æ—Ç 8 –ª–µ—Ç —Å—Ç–∞—Ä—Ç—É—é—Ç –≤ —è–Ω–≤–∞—Ä–µ –∏ –ø—Ä–æ–π–¥—É—Ç –≤ 97 –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–∏—Ö —Ü–µ–Ω—Ç—Ä–∞—Ö –≤ –ö–∏—Ç–∞–µ, –ï–≤—Ä–æ–ø–µ –∏ –°–®–ê. CagriSema –ø—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ—Ç —Å–æ–±–æ–π –∫–æ–º–±–∏–Ω–∞—Ü–∏—é –∫–∞–≥—Ä–∏–ª–∏–Ω—Ç–∏–¥–∞, –∏–º–∏—Ç–∏—Ä—É—é—â–µ–≥–æ —Ä–∞–±–æ—Ç—É –ø–µ–ø—Ç–∏–¥–Ω–æ–≥–æ –≥–æ—Ä–º–æ–Ω–∞ –ø–æ–¥–∂–µ–ª—É–¥–æ—á–Ω–æ–π –∂–µ–ª–µ–∑—ã –∞–º–∏–ª–∏–Ω–∞, –∏ —Ö–æ—Ä–æ—à–æ –≤—Å–µ–º –∏–∑–≤–µ—Å—Ç–Ω–æ–≥–æ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞. –ù–∞–¥–æ —Å–∫–∞–∑–∞—Ç—å, –Ω–∞ –≤–∑—Ä–æ—Å–ª—ã—Ö —Ñ–æ–∫—É—Å –Ω–µ —Å—Ä–∞–±–æ—Ç–∞–ª ‚Äì —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –∏–Ω–≤–µ—Å—Ç–æ—Ä–æ–≤ –Ω–µ –≤–ø–µ—á–∞—Ç–ª–∏–ª–∏, —Ö–æ—Ç—å –∏ –ø—Ä–µ–≤–∑–æ—à–ª–∏ –ª–µ—á–µ–Ω–∏–µ —Ç–æ–ª—å–∫–æ –æ–¥–Ω–∏–º –í–µ–≥–æ–≤–∏. –í –ø–µ–¥–∏–∞—Ç—Ä–∏—á–µ—Å–∫–æ–º –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–∏ —É—á—ë–Ω—ã–µ –±—É–¥—É—Ç –æ—Ç—Å–ª–µ–∂–∏–≤–∞—Ç—å –∏–∑–º–µ–Ω–µ–Ω–∏—è –∏–Ω–¥–µ–∫—Å–∞ –º–∞—Å—Å—ã —Ç–µ–ª–∞ –¥–µ—Ç–µ–π –≤ —Ç–µ—á–µ–Ω–∏–µ –ø–µ—Ä–≤—ã—Ö 68 –Ω–µ–¥–µ–ª—å, –∞ –∑–∞—Ç–µ–º –Ω–∞–±–ª—é–¥–∞—Ç—å –∑–∞ –Ω–∏–º–∏ –µ—â—ë –≤ —Ç–µ—á–µ–Ω–∏–µ —Ç—Ä—ë—Ö –ª–µ—Ç. –û–±–Ω–∞—Ä–æ–¥–æ–≤–∞—Ç—å —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –æ–±–µ—â–∞—é—Ç –Ω–µ —Ä–∞–Ω—å—à–µ 2030 –≥–æ–¥–∞. –î–µ—Ç—Å–∫–æ–µ –æ–∂–∏—Ä–µ–Ω–∏–µ ‚Äì –ø—Ä–æ–±–ª–µ–º–∞ –Ω–∞—Å—Ç–æ–ª—å–∫–æ —Å–µ—Ä—å—ë–∑–Ω–∞—è –∏ –≥–ª–æ–±–∞–ª—å–Ω–∞—è, —á—Ç–æ —ç–∫—Å–ø–µ—Ä—Ç—ã —É–∂–µ –Ω–∞—Ä–µ–∫–ª–∏ –µ—ë —ç–ø–∏–¥–µ–º–∏–µ–π. –¢–∞–∫, –≤ –†–æ—Å—Å–∏–∏, –ø–æ —Å–ª–æ–≤–∞–º –ú–∏—Ö–∞–∏–ª–∞ –ú—É—Ä–∞—à–∫–æ, —Å 2018 –ø–æ 2024 –≥–æ–¥ –æ–±—â–∏–π —É—Ä–æ–≤–µ–Ω—å –∑–∞–±–æ–ª–µ–≤–∞–µ–º–æ—Å—Ç–∏ –æ–∂–∏—Ä–µ–Ω–∏–µ–º —Å—Ä–µ–¥–∏ –¥–µ—Ç–µ–π –¥–æ 15 –ª–µ—Ç —É–≤–µ–ª–∏—á–∏–ª—Å—è –Ω–∞ 36,1%. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": true,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety"",
  ""impact"": ""medium"",
  ""english"": ""Novo Nordisk is testing a new obesity drug for children called CagriSema. The Danish pharmaceutical company begins trials of the compound, which combines cagrilintide and semaglutine, against pediatric obesity. The study involves 460 children aged 8 years and above in China, Europe, and the US. The researchers will monitor changes in body mass index of children over the first 68 weeks and then for three years. Results are expected not earlier than in 2030. Pediatric obesity is a serious and global issue, described as an epidemic by experts. In Russia, the overall incidence of obesity among children under 15 years old increased by 36.1% from 2018 to 2024, according to Mikhail Murashko.""
}"
2025-12-03T11:45:40+00:00,@bezrec,6892,https://t.me/bezrec/6892,"–°–±–µ—Ä–∏–Ω–¥–µ–∫—Å –ø–æ–¥—Å—á–∏—Ç–∞–ª, —Å–∫–æ–ª—å–∫–æ —Ç—Ä–∞—Ç–∏–ª–∏ –≥—Ä–∞–∂–¥–∞–Ω–µ –Ω–∞—à–µ–π —Å—Ç—Ä–∞–Ω—ã –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏ –º–µ–¥–∏–∑–¥–µ–ª–∏—è –≤ —É—Ö–æ–¥—è—â–µ–º –≥–æ–¥—É. –°—Ä–µ–¥–Ω–∏–µ –µ–∂–µ–º–µ—Å—è—á–Ω—ã–µ —Ä–∞—Å—Ö–æ–¥—ã –Ω–∞ —ç—Ç—É –∫–∞—Ç–µ–≥–æ—Ä–∏—é —Å–æ—Å—Ç–∞–≤–∏–ª–∏ 2 580 —Ä—É–±–ª–µ–π. –ù–∞ —Å—Ä–µ–¥–Ω–∏–µ —Ä–∞—Å—Ö–æ–¥—ã –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ —Ç–æ–≤–∞—Ä—ã –Ω–∞ —É—Ä–æ–≤–Ω–µ —Ä–µ–≥–∏–æ–Ω–∞ –æ–∫–∞–∑—ã–≤–∞–µ—Ç –≤–ª–∏—è–Ω–∏–µ –¥–æ–ª—è –ø–æ–∂–∏–ª—ã—Ö –ª—é–¥–µ–π: —Ç–∞–∫, —É–≤–µ–ª–∏—á–µ–Ω–∏–µ –≤ —Ä–µ–≥–∏–æ–Ω–µ —ç—Ç–æ–π –¥–æ–ª–∏ –Ω–∞ 5 –ø—Ä–æ—Ü–µ–Ω—Ç–Ω—ã—Ö –ø—É–Ω–∫—Ç–æ–≤ —Å–≤—è–∑–∞–Ω–æ —Å —É–≤–µ–ª–∏—á–µ–Ω–∏–µ–º —Ç—Ä–∞—Ç –≤ —ç—Ç–æ–π –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ –Ω–∞ 15%. –ü—Ä–∏ —ç—Ç–æ–º –¥–æ–ª—è —ç—Ç–∏—Ö —Ä–∞—Å—Ö–æ–¥–æ–≤ –≤ –æ–±—â–µ–º –æ–±—ä—ë–º–µ –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏—è –≥—Ä–∞–∂–¥–∞–Ω –æ—Å—Ç–∞–µ—Ç—Å—è –Ω–∏–∑–∫–æ–π ‚Äî –≤—Å–µ–≥–æ 3%, ‚Äî –ø—Ä–æ–∫–æ–º–º–µ–Ω—Ç–∏—Ä–æ–≤–∞–ª–∞ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è —É–ø—Ä–∞–≤–ª—è—é—â–∏–π –¥–∏—Ä–µ–∫—Ç–æ—Ä, —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–∏–∏ –°–±–µ—Ä–∏–Ω–¥–µ–∫—Å –î–∞—Ä—å—è –¶—ã–ø–ª–∞–∫–æ–≤–∞. –ü–æ–¥—Ä–æ–±–Ω–æ—Å—Ç–∏: üîò—á–∞—â–µ –¥—Ä—É–≥–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –ø–æ–∫—É–ø–∞—é—Ç –ª—é–¥–∏ —Å—Ç–∞—Ä—à–µ 45 –ª–µ—Ç (66% –≤—Å–µ—Ö —Ä–∞—Å—Ö–æ–¥–æ–≤ –≤ –∫–∞—Ç–µ–≥–æ—Ä–∏–∏); üîò—É –ª—é–¥–µ–π —Å—Ç–∞—Ä—à–µ 50 –ª–µ—Ç —Å—Ä–µ–¥–Ω–∏–π —á–µ–∫ –∑–∞ –ø–æ–∫—É–ø–∫—É —Å–æ—Å—Ç–∞–≤–ª—è–µ—Ç 900 —Ä—É–±–ª–µ–π, –µ–∂–µ–º–µ—Å—è—á–Ω—ã–µ —Ç—Ä–∞—Ç—ã ‚Äì 2,9 —Ç—ã—Å. —Ä—É–±–ª–µ–π; üîò–ø–æ–∫—É–ø–∞—Ç–µ–ª–∏ –¥–æ 20 –ª–µ—Ç —Ç—Ä–∞—Ç—è—Ç –≤ —Å—Ä–µ–¥–Ω–µ–º 1,2 —Ç—ã—Å. —Ä—É–±–ª–µ–π –≤ –º–µ—Å—è—Ü; üîò–±–æ–ª—å—à–µ –≤—Å–µ–≥–æ —Ç—Ä–∞—Ç—è—Ç –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∂–∏—Ç–µ–ª–∏ –ß—É–∫–æ—Ç–∫–∏ (3,9 —Ç—ã—Å. —Ä—É–±–ª–µ–π) –∏ –ú–æ—Å–∫–≤—ã (3,4 —Ç—ã—Å. —Ä—É–±–ª–µ–π); üîò—Å–∞–º—ã–º–∏ —ç–∫–æ–Ω–æ–º–Ω—ã–º–∏ –æ–∫–∞–∑–∞–ª–∏—Å—å –∂–∏—Ç–µ–ª–∏ –¢—ã–≤—ã (1,7 —Ç—ã—Å. —Ä—É–±–ª–µ–π); üîò–º–∞–∫—Å–∏–º–∞–ª—å–Ω–æ–π –¥–∏–Ω–∞–º–∏–∫–æ–π —Ä–∞—Å—Ö–æ–¥–æ–≤ –æ—Ç–ª–∏—á–∏–ª–∏—Å—å –ù–µ–Ω–µ—Ü–∫–∏–π –∞–≤—Ç–æ–Ω–æ–º–Ω—ã–π –æ–∫—Ä—É–≥ (+24%, –¥–æ 2,9 —Ç—ã—Å. —Ä—É–±–ª–µ–π), –ù–æ–≤–≥–æ—Ä–æ–¥—Å–∫–∞—è –∏ –ë–µ–ª–≥–æ—Ä–æ–¥—Å–∫–∞—è –æ–±–ª–∞—Å—Ç–∏ (+19%, –¥–æ 2,3 —Ç—ã—Å. —Ä—É–±–ª–µ–π –∏ +17%, –¥–æ 2,4 —Ç—ã—Å. —Ä—É–±–ª–µ–π —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The research by SberIndex shows that the average monthly spending on medicines and medical supplies in the country was 2,580 rubles. The impact of this on regional spending is influenced by the proportion of elderly people in a region, with an increase in this proportion leading to higher spending. However, the share of these expenses in total consumption remains low at 3%. The research also highlights that people aged 45 and above spend the most on medicines (66% of total expenses in this category), with those aged 50 and above spending an average of 900 rubles per month. Young people aged up to 20 spend an average of 1,200 rubles per month. The highest spending on medicines is observed in Chukotka (3,900 rubles) and Moscow (3,400 rubles), while the least spending is observed in Tyva (1,700 rubles). The regions with the highest increase in spending are Nenets Autonomous Okrug (+24%, to "
2025-12-03T08:46:00+00:00,@bezrec,6891,https://t.me/bezrec/6891,"–í—Ç–æ—Ä–æ–π –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π –¥–∂–µ–Ω–µ—Ä–∏–∫ –õ–µ–Ω–≤–∏–º—ã –ø–æ–¥–µ—à–µ–≤–µ–ª –Ω–∞ 45,8%. –ü—Ä–µ–¥–µ–ª—å–Ω–∞—è –æ—Ç–ø—É—Å–∫–Ω–∞—è —Ü–µ–Ω–∞ –∑–∞ —É–ø–∞–∫–æ–≤–∫—É –∏–∑ 30 –∫–∞–ø—Å—É–ª –ø—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤–æ–≥–æ –ª–µ–Ω–≤–∞—Ç–∏–Ω–∏–±–∞ –æ—Ç ¬´–§–∞—Ä–º-–°–∏–Ω—Ç–µ–∑–∞¬ª –≤ –¥–æ–∑–∏—Ä–æ–≤–∫–µ 4 –º–≥ —Å–æ–≥–ª–∞—Å–æ–≤–∞–Ω–∞ –§–ê–° –Ω–∞ —É—Ä–æ–≤–Ω–µ 21,6 —Ç—ã—Å. —Ä—É–±–ª–µ–π, —Ç–æ–≥–¥–∞ –∫–∞–∫ —Ä–µ—Ñ–µ—Ä–µ–Ω—Ç–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –æ—Ç Eisai —Å—Ç–æ–∏—Ç —á—É—Ç—å –±–æ–ª—å—à–µ 40 —Ç—ã—Å. —Ä—É–±–ª–µ–π. –¢–µ–ø–µ—Ä—å —Ü–µ–Ω—É –Ω–∞ —Å–≤–æ–π –ª–µ–Ω–≤–∞—Ç–∏–Ω–∏–± –ø—Ä–∏–¥—ë—Ç—Å—è —Å–Ω–∏–∑–∏—Ç—å –∏ ¬´–ü—Ä–æ–º–æ–º–µ–¥—É¬ª –∫–∞–∫ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—é –ø–µ—Ä–≤–æ–≥–æ –¥–∂–µ–Ω–µ—Ä–∏–∫–∞ –≤ —Ä–∞–º–∫–∞—Ö —ç—Ç–æ–≥–æ –ú–ù–ù. –î–∏—Å–∫–æ–Ω—Ç –¥–æ–ª–∂–µ–Ω —Å–æ—Å—Ç–∞–≤–∏—Ç—å 16,6%. –ê–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å—â–∏–∫–∏ –Ω–∞–ø—Ä–∞–≤—è—Ç —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–µ–µ —É–≤–µ–¥–æ–º–ª–µ–Ω–∏–µ –∫–æ–º–ø–∞–Ω–∏–∏ –ü–µ—Ç—Ä–∞ –ë–µ–ª–æ–≥–æ. –ü–æ –¥–∞–Ω–Ω—ã–º –∏–∑ –ì–†–õ–°, —Ä–µ–≥—É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏—è –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç —Ç–∞–∫–∂–µ –µ—Å—Ç—å —É ¬´–ê–º–µ–¥–∞—Ä—Ç–∞¬ª, ¬´–†-–§–∞—Ä–º¬ª, ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑-–ù–æ—Ä–¥¬ª, ¬´–ò–ò–•–†¬ª –∏ ¬´–ê–∫—Å–µ–ª—å—Ñ–∞—Ä–º–∞¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, regulation"",
  ""impact"": ""high"",
  ""english"": ""The price of the second domestic generic Lenvima has decreased by 45.8%. The maximum resale price per unit of 30 capsules of the anti-cancer drug lenvatinib from 'Farma-Sintez' at a dose of 4 mg, approved by the FAS for RUB 216,000. The reference drug from Eisai costs slightly more than RUB 40,000. 'Promomed' will have to reduce the price of their lenvatinib generic, which is the first in this NPN. Antimonopoly authorities will issue a notification to company Petro Belo. According to data from the GRLS, registration certificates for this drug also exist with 'Amedarta', 'R-Farma', 'FarmaSyntez-Nord', 'IiHr' and 'Axelfarma'.""
}"
2025-12-03T05:31:18+00:00,@bezrec,6890,https://t.me/bezrec/6890,"–ì–∞–±–∞–ø–µ–Ω—Ç–∏–Ω –∏ –¥—Ä—É–≥–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –ø–æ–ø–∞–ª–∏ –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ü–ö–£. –ú–∏–Ω–∑–¥—Ä–∞–≤ –≤ –∫–æ–Ω—Ü–µ –Ω–æ—è–±—Ä—è —Ä–∞—Å—à–∏—Ä–∏–ª –ø–µ—Ä–µ—á–µ–Ω—å –ª–µ–∫–∞—Ä—Å—Ç–≤, –ø–æ–¥–ª–µ–∂–∞—â–∏—Ö –ø—Ä–µ–¥–º–µ—Ç–Ω–æ-–∫–æ–ª–∏—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–º—É —É—á–µ—Ç—É (–ü–ö–£). –ü–æ–º–∏–º–æ –ø—Ä–æ—Ç–∏–≤–æ—ç–ø–∏–ª–µ–ø—Ç–∏—á–µ—Å–∫–æ–≥–æ –≥–∞–±–∞–ø–µ–Ω—Ç–∏–Ω–∞ (–≤—ã–ø—É—Å–∫–∞–µ—Ç—Å—è –∫–æ–º–ø–∞–Ω–∏—è–º–∏ ¬´–ü–§–ö –û–±–Ω–æ–≤–ª–µ–Ω–∏–µ¬ª, ¬´–°–µ–≤–µ—Ä–Ω–∞—è –∑–≤–µ–∑–¥–∞¬ª, ¬´–õ–µ–∫–∫–æ¬ª ¬´–§–∞—Ä–º–ø—Ä–æ–µ–∫—Ç¬ª, ¬´–ê–ª–∏—É–º¬ª, ¬´–ö–∞–Ω–æ–Ω—Ñ–∞—Ä–º–∞¬ª –∏ –¥—Ä.), –≤ –Ω–µ–≥–æ –≤–æ—à–ª–∏: üíä –ø—Ä–∞—Å—Ç–µ—Ä–æ–Ω (–∫—Ä–æ–º–µ –≤–∞–≥–∏–Ω–∞–ª—å–Ω—ã—Ö —Å—É–ø–ø–æ–∑–∏—Ç–æ—Ä–∏–µ–≤, –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–Ω—ã—Ö –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º —Ä—ã–Ω–∫–µ –±—Ä–µ–Ω–¥–æ–º –ò–Ω—Ç—Ä–∞—Ä–æ—Å–∞ –æ—Ç ¬´–í–∞–ª–µ–Ω—Ç–∞ –§–∞—Ä–º¬ª) ‚Äì –ø—Ä–µ–ø–∞—Ä–∞—Ç –∏—Å–ø–æ–ª—å–∑—É–µ—Ç—Å—è –≤ –∫–∞—á–µ—Å—Ç–≤–µ –∫–æ–º–ø–æ–Ω–µ–Ω—Ç–∞ –≥–æ—Ä–º–æ–Ω–æ—Ç–µ—Ä–∞–ø–∏–∏ –≤ –ø–µ—Ä–∏–æ–¥ –º–µ–Ω–æ–ø–∞—É–∑—ã; üíä –º–∏–æ—Ä–µ–ª–∞–∫—Å–∞–Ω—Ç –±–∞–∫–ª–æ—Ñ–µ–Ω (–∫—Ä–æ–º–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π —Ñ–æ—Ä–º—ã –¥–ª—è –∏–Ω—Ç—Ä–∞—Ç–µ–∫–∞–ª—å–Ω–æ–≥–æ –≤–≤–µ–¥–µ–Ω–∏—è), –ø—Ä–∏–º–µ–Ω—è–µ–º—ã–π –≤ —Ç–æ–º —á–∏—Å–ª–µ —É –±–æ–ª—å–Ω—ã—Ö —Ä–∞—Å—Å–µ—è–Ω–Ω—ã–º —Å–∫–ª–µ—Ä–æ–∑–æ–º. –ü–æ –¥–∞–Ω–Ω—ã–º –ì–†–õ–°, –†–£ –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç –µ—Å—Ç—å —É ¬´–õ–∞—Å–∞ –õ–∞–±–æ—Ä–∞—Ç–æ—Ä–∏–æ—Å¬ª, ¬´–ù–æ–≤–∞—Ä—Ç–∏—Å–∞¬ª, ¬´–ü–æ–ª—å—Ñ–∞—Ä–º—ã¬ª –∏ ¬´–£—Å–æ–ª—å–µ-–°–∏–±–∏—Ä—Å–∫–æ–≥–æ —Ö–∏–º–∏–∫–æ-—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ –∑–∞–≤–æ–¥–∞¬ª; üíä –∫–æ–º–±–∏–Ω–∞—Ü–∏—è –¥–∏—Ü–∏–∫–ª–æ–≤–µ—Ä–∏–Ω + –ø–∞—Ä–∞—Ü–µ—Ç–∞–º–æ–ª, –Ω–∞–∑–Ω–∞—á–∞–µ–º–∞—è –ø—Ä–∏ —Å–ø–∞–∑–º–∞—Ö –∏ –≤ –∫–∞—á–µ—Å—Ç–≤–µ –æ–±–µ–∑–±–æ–ª–∏–≤–∞—é—â–µ–≥–æ. –≠—Ç–æ –ú–ù–ù –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º–∏ –¢—Ä–∏–≥–∞–Ω-–¥ –∏ –î–æ–ª–æ—Å–ø–∞ –æ—Ç –∏–Ω–¥–∏–π—Å–∫–∏—Ö ¬´–ö–∞–¥–∏–ª–∞ –§–∞—Ä–º–∞—Å—å—é—Ç–∏–∫–∞–ª–∑¬ª –∏ ¬´–ù–∞–±—Ä–æ—Å –§–∞—Ä–º–∞¬ª. –ò–∑–º–µ–Ω–µ–Ω–∏—è –≤—Å—Ç—É–ø—è—Ç –≤ —Å–∏–ª—É —Å 1 –º–∞—Ä—Ç–∞ 2026 –≥–æ–¥–∞ –∏ –±—É–¥—É—Ç –¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å –¥–æ 1 —Å–µ–Ω—Ç—è–±—Ä—è 2030 –≥–æ–¥–∞. –ó–∞—á–∞—Å—Ç—É—é –∞–ø—Ç–µ–∫–∏ –Ω–µ –∂–µ–ª–∞—é—Ç —Å–≤—è–∑—ã–≤–∞—Ç—å—Å—è —Å –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º–∏ –∏–∑ –ø–µ—Ä–µ—á–Ω—è –ü–ö–£ –∏–∑-–∑–∞ —Å—Ç—Ä–æ–≥–∏—Ö —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π –∫ –∏—Ö —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ –∏ —É—Å–∏–ª–µ–Ω–Ω–æ–≥–æ –∫–æ–Ω—Ç—Ä–æ–ª—è. –≠—Ç–æ –Ω–µ—Ä–µ–¥–∫–æ –≤—ã–ª–∏–≤–∞–µ—Ç—Å—è –≤ –ø—Ä–æ–±–ª–µ–º—ã —Å –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å—é –ª–µ–∫–∞—Ä—Å—Ç–≤ –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, regulation"",
  ""impact"": ""medium"",
  ""english"": ""The regulatory body has expanded the list of medicines subject to quantity and itemized accounting (PKU). This includes Gabapentin, which is produced by companies such as PFK Update, Severny Zvezda, and Alium. Additionally, the list includes Prasteron (except for vaginal suppositories from Intraros by Valenta Farm) and Baclofen. The changes will take effect on March 1, 2026, and continue until September 1, 2030. Pharmacies often avoid dealing with medicines on the PKU list due to strict requirements for their sale and increased control, which can lead to access issues for patients.""
}"
2025-12-02T15:20:19+00:00,@bezrec,6889,https://t.me/bezrec/6889,–ö–æ–Ω—Ç–µ–π–Ω–µ—Ä –¥–ª—è —Å–æ—Ä—Ç–∏—Ä–æ–≤–∫–∏ –º—É—Å–æ—Ä–∞ –≤ –æ–¥–Ω–æ–º —Ä–æ—Å—Å–∏–π—Å–∫–æ–º –æ—Ñ–∏—Å–µ. –ü—Ä–æ–∏–ª–ª—é—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª–∏ –Ω–µ—Ç–ª–µ–Ω–Ω–æ–µ ¬´–í—Å—é –∂–∏–∑–Ω—å —Ä–∞–±–æ—Ç–∞—Ç—å –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –±—É–¥–µ—à—å!¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞,"{""skip"": true}"
2025-12-02T12:08:01+00:00,@bezrec,6888,https://t.me/bezrec/6888,"–ö–∏—Ç–∞–π –≤–≤–æ–¥–∏—Ç –Ω–∞–ª–æ–≥ –Ω–∞ –∫–æ–Ω—Ç—Ä–∞—Ü–µ–ø—Ü–∏—é. –ü—Ä–µ–∑–µ—Ä–≤–∞—Ç–∏–≤—ã –∏ –ø—Ä–æ—Ç–∏–≤–æ–∑–∞—á–∞—Ç–æ—á–Ω—ã–µ –Ω–µ –æ–±–ª–∞–≥–∞–ª–∏—Å—å –ù–î–° —Å 1993 –≥–æ–¥–∞, –∏ –≤–æ—Ç —Ç–µ–ø–µ—Ä—å —Ä–µ—à–∏–ª–∏ ‚Äî –ø–æ—Ä–∞! –¢–µ–ø–µ—Ä—å –ù–î–° –Ω–∞ —ç—Ç–∏ —Ç–æ–≤–∞—Ä—ã —Å–æ—Å—Ç–∞–≤–∏—Ç 13%. –í—Å—ë –≤–æ –∏–º—è –ø–æ–≤—ã—à–µ–Ω–∏—è —Ä–æ–∂–¥–∞–µ–º–æ—Å—Ç–∏, –∫–æ—Ç–æ—Ä–∞—è –≤ –ö–∏—Ç–∞–µ –Ω–µ—É–∫–ª–æ–Ω–Ω–æ —Å–Ω–∏–∂–∞–µ—Ç—Å—è ‚Äî –≤ 2024 –≥–æ–¥—É —Ä–æ–¥–∏–ª–æ—Å—å –≤—Å–µ–≥–æ 9,5 –º–ª–Ω –¥–µ—Ç–µ–π ‚Äî –µ–¥–≤–∞ –ª–∏ –ø–æ–ª–æ–≤–∏–Ω–∞ –æ—Ç 18,8 –º–ª–Ω, –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –≤ 2016 –≥–æ–¥—É, —á–µ—Ä–µ–∑ –≥–æ–¥ –ø–æ—Å–ª–µ –æ—Ç–º–µ–Ω—ã –ø–æ–ª–∏—Ç–∏–∫–∏ ¬´–æ–¥–Ω–∞ —Å–µ–º—å—è ‚Äî –æ–¥–∏–Ω —Ä–µ–±—ë–Ω–æ–∫¬ª. –í 2021 –≥–æ–¥—É –∫–∏—Ç–∞–π—Å–∫–∏–º —Å–µ–º—å—è–º —Ä–∞–∑—Ä–µ—à–∏–ª–∏ –∏–º–µ—Ç—å –¥–æ —Ç—Ä—ë—Ö –¥–µ—Ç–µ–π, –Ω–æ –æ–¥–Ω–æ–≥–æ –±–ª–∞–≥–æ—Å–ª–æ–≤–µ–Ω–∏—è —Å–æ —Å—Ç–æ—Ä–æ–Ω—ã –≤–ª–∞—Å—Ç–µ–π –æ–∫–∞–∑–∞–ª–æ—Å—å –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ. –ß—Ç–æ –Ω–µ —É–¥–∏–≤–∏—Ç–µ–ª—å–Ω–æ ‚Äî —Å–æ–≥–ª–∞—Å–Ω–æ –æ—Ç—á—ë—Ç—É –ò–Ω—Å—Ç–∏—Ç—É—Ç–∞ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –Ω–∞—Ä–æ–¥–æ–Ω–∞—Å–µ–ª–µ–Ω–∏—è –Æ–π–≤–∞ –≤ –ü–µ–∫–∏–Ω–µ –∑–∞ 2024 –≥–æ–¥, –ö–∏—Ç–∞–π ‚Äî –æ–¥–Ω–∞ –∏–∑ —Å–∞–º—ã—Ö –¥–æ—Ä–æ–≥–∏—Ö —Å—Ç—Ä–∞–Ω –¥–ª—è –≤–æ—Å–ø–∏—Ç–∞–Ω–∏—è –¥–µ—Ç–µ–π. –û—Ç–º–µ–Ω–∞ –ª—å–≥–æ—Ç—ã –ø–æ –ù–î–° –Ω–æ—Å–∏—Ç –≤ –æ—Å–Ω–æ–≤–Ω–æ–º —Å–∏–º–≤–æ–ª–∏—á–µ—Å–∫–∏–π —Ö–∞—Ä–∞–∫—Ç–µ—Ä –∏ –≤—Ä—è–¥ –ª–∏ –æ–∫–∞–∂–µ—Ç —Å—É—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–µ –≤–ª–∏—è–Ω–∏–µ –Ω–∞ –æ–±—â—É—é –∫–∞—Ä—Ç–∏–Ω—É, ‚Äî —Å–ø—Ä–∞–≤–µ–¥–ª–∏–≤–æ –æ—Ç–º–µ—á–∞—é—Ç –∫–∏—Ç–∞–π—Å–∫–∏–µ –¥–µ–º–æ–≥—Ä–∞—Ñ—ã. –ó–∞—Ç–æ –≤–ø–æ–ª–Ω–µ —Ä–µ–∞–ª—å–Ω—ã–º –º–æ–∂–µ—Ç —Å—Ç–∞—Ç—å —Ä–æ—Å—Ç —á–∏—Å–ª–∞ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, –ø–µ—Ä–µ–¥–∞—é—â–∏—Ö—Å—è –ø–æ–ª–æ–≤—ã–º –ø—É—Ç–µ–º, —Ç–µ–º –±–æ–ª–µ–µ —á—Ç–æ —Å 2002 –ø–æ 2021 –≥–æ–¥ —É—Ä–æ–≤–µ–Ω—å –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö —Å–ª—É—á–∞–µ–≤ –í–ò–ß –∏ –°–ü–ò–î–∞ –≤ —Å—Ç—Ä–∞–Ω–µ –∏ –±–µ–∑ —Ç–æ–≥–æ –≤—ã—Ä–æ—Å —Å 0,37 –¥–æ 8,41 –Ω–∞ 100 —Ç—ã—Å. —á–µ–ª–æ–≤–µ–∫. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-12-02T09:15:18+00:00,@bezrec,6887,https://t.me/bezrec/6887,"–ü–∞–Ω–¥–µ–º–∏—è –Ω–µ –Ω–∞—É—á–∏–ª–∞ –≤–∞–∫—Ü–∏–Ω–∏—Ä–æ–≤–∞—Ç—å —Ä–æ—Å—Å–∏—è–Ω. –ü–æ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º –æ–ø—Ä–æ—Å–∞, –ø—Ä–æ–≤–µ–¥–µ–Ω–Ω–æ–≥–æ –∫–æ–Ω—Å–∞–ª—Ç–∏–Ω–≥–æ–≤–æ–π –∫–æ–º–ø–∞–Ω–∏–µ–π ¬´–ü—Ä–∞–≤–æ –Ω–∞ –∑–¥–æ—Ä–æ–≤—å–µ¬ª, ¬´–∫–æ–≤–∏–¥–Ω—ã–π¬ª —É—Ä–æ–∫ —Ç–∞–∫ –∏ –Ω–µ –±—ã–ª —É—Å–≤–æ–µ–Ω, –∏ –±–æ—Ä—å–±–∞ —Å –∏–Ω—Ñ–µ–∫—Ü–∏—è–º–∏ –Ω–µ —Å—Ç–∞–ª–∞ –ø—Ä–∏–æ—Ä–∏—Ç–µ—Ç–æ–º –¥–ª—è —Å–∏—Å—Ç–µ–º—ã –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –ü—Ä–∞–∫—Ç–∏—á–µ—Å–∫—É—é —Ä–µ–∞–ª–∏–∑–∞—Ü–∏—é –º–µ—Ä –ø–æ –∏–º–º—É–Ω–æ–ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–µ –≤ 2025 –≥–æ–¥—É —Å–æ—á–ª–∏ –Ω–µ—É–¥–æ–≤–ª–µ—Ç–≤–æ—Ä–∏—Ç–µ–ª—å–Ω–æ–π 70% —Ä–µ—Å–ø–æ–Ω–¥–µ–Ω—Ç–æ–≤. –ü–æ –¥–∞–Ω–Ω—ã–º Headway Company, –≤ —Ä–∞–º–∫–∞—Ö —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã—Ö –∫–∞–ª–µ–Ω–¥–∞—Ä–µ–π –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–æ–π –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏–∏ –≤ —è–Ω–≤–∞—Ä–µ - —Å–µ–Ω—Ç—è–±—Ä–µ –±—ã–ª–æ –∑–∞–∫—É–ø–ª–µ–Ω–æ 440 —Ç—ã—Å. —É–ø–∞–∫–æ–≤–æ–∫ –≤–∞–∫—Ü–∏–Ω –æ—Ç –º–µ–Ω–∏–Ω–≥–æ–∫–æ–∫–∫–æ–≤–æ–π –∏–Ω—Ñ–µ–∫—Ü–∏–∏ –Ω–∞ 1,6 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —á—Ç–æ –Ω–∞ 26% –±–æ–ª—å—à–µ –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –∏ –Ω–∞ 32% –≤ –¥–µ–Ω–µ–∂–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ –≥–æ–¥ –∫ –≥–æ–¥—É. –ù–µ—Å–º–æ—Ç—Ä—è –Ω–∞ –ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω—É—é –¥–∏–Ω–∞–º–∏–∫—É, —ç—Ç–æ —Ç–æ–ª—å–∫–æ –Ω–∞ 13% –ø–æ–∫—Ä—ã–≤–∞–µ—Ç –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç—å –≤ —ç—Ç–∏—Ö –ø—Ä–∏–≤–∏–≤–∫–∞—Ö. –ï—â—ë —Ö—É–∂–µ –¥–µ–ª–∞ —Å–æ—Å—Ç–æ—è—Ç —Å –æ–±–µ—Å–ø–µ—á–µ–Ω–Ω–æ—Å—Ç—å—é –≤–∞–∫—Ü–∏–Ω–æ–π –æ—Ç –í–ü–ß ‚Äî –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç—å –≤ –Ω–µ–π –∑–∞–∫—Ä—ã—Ç–∞ –ª–∏—à—å –Ω–∞ 5%, –ø–∏—à–µ—Ç –™. –°–≤–æ–π –¶–µ–≥–∞—Ä–¥–µ–∫—Å, —É –∫–æ—Ç–æ—Ä–æ–≥–æ –µ—Å—Ç—å –≤—Å–µ —à–∞–Ω—Å—ã –ø–æ–ø–∞—Å—Ç—å, –Ω–∞–∫–æ–Ω–µ—Ü, –≤ –ù–∞—Ü–∫–∞–ª–µ–Ω–¥–∞—Ä—å, ¬´–ù–∞–Ω–æ–ª–µ–∫¬ª –æ–±–µ—â–∞–µ—Ç –≤—ã–ø—É—Å—Ç–∏—Ç—å –≤ –≥—Ä–∞–∂–¥–∞–Ω—Å–∫–∏–π –æ–±–æ—Ä–æ—Ç –≤–æ –≤—Ç–æ—Ä–æ–π –ø–æ–ª–æ–≤–∏–Ω–µ 2026 –≥–æ–¥–∞. –ü–æ —Å–ª–æ–≤–∞–º —ç–∫—Å–ø–µ—Ä—Ç–æ–≤, –ø–æ–ª–Ω–æ—Ü–µ–Ω–Ω–æ –∑–∞—â–∏—Ç–∏—Ç—å –Ω–∞—Å–µ–ª–µ–Ω–∏–µ –ø–æ–º–æ–∂–µ—Ç —Ç–æ–ª—å–∫–æ –≤–∫–ª—é—á–µ–Ω–∏–µ –≤—ã—Å–æ–∫–æ–∫–æ–Ω—Ç–∞–≥–∏–æ–∑–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –≤ –ù–ö–ü–ü. –ü–æ–∫–∞ –≤–∞–∫—Ü–∏–Ω—ã –∑–∞ —Å—á–µ—Ç –±—é–¥–∂–µ—Ç–∞ –∑–∞–∫—É–ø–∞—é—Ç –ª–∏—à—å –æ—Ç–¥–µ–ª—å–Ω—ã–µ —Ä–µ–≥–∏–æ–Ω—ã. –í–ø—Ä–æ—á–µ–º, –∏ —Å —É–∂–µ –≤–∫–ª—é—á–µ–Ω–Ω—ã–º–∏ –≤ –ù–∞—Ü–∫–∞–ª–µ–Ω–¥–∞—Ä—å –ø—Ä–∏–≤–∏–≤–∫–∞–º–∏ —Å–∏—Ç—É–∞—Ü–∏—è –Ω–µ –æ—á–µ–Ω—å. –ü–æ –¥–∞–Ω–Ω—ã–º –∞–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ Cursor, —Å—Ç–æ–∏–º–æ—Å—Ç—å –æ–±—ä—è–≤–ª–µ–Ω–Ω—ã—Ö —Ç–µ–Ω–¥–µ—Ä–æ–≤ —Å–æ–∫—Ä–∞—Ç–∏–ª–∞—Å—å —Å 41,6 –º–ª—Ä–¥ –¥–æ 6,4 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –í —Ü–µ–ª–æ–º, —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏–µ –≤–∞–∫—Ü–∏–Ω–æ–ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ —Å—á–∏—Ç–∞—é—Ç –Ω–µ—É–¥–æ–≤–ª–µ—Ç–≤–æ—Ä–∏—Ç–µ–ª—å–Ω—ã–º 60% –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö —ç–∫—Å–ø–µ—Ä—Ç–æ–≤. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –∑–Ω–∞–Ω–∏–π –æ –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏–∏ –¥–æ —Å–∏—Ö –ø–æ—Ä –Ω–µ —Ö–≤–∞—Ç–∞–µ—Ç –Ω–µ —Ç–æ–ª—å–∫–æ –ø–∞—Ü–∏–µ–Ω—Ç–∞–º, –Ω–æ –∏ –≤—Ä–∞—á–∞–º. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""epidemic, vaccine"",
  ""impact"": ""medium"",
  ""english"": ""The survey conducted by the consulting company 'Right to Health' shows that Russia's population has not learned how to vaccinate against the virus. Only 70% of respondents consider the measures taken to prevent infections in 2025 as satisfactory. The procurement of mumps vaccines for the period from January to September was 440,000 doses at a cost of 1.6 billion rubles, which is an increase of 26% in natural terms and 32% in monetary terms compared to the previous year. The coverage of HPV vaccines is only at 5%. 'Nanolec' promises to release its vaccine into the civil market in the second half of 2026. Currently, only individual regions purchase vaccines on their own budget. The financing for vaccine prevention is considered insufficient by 60% of experts, and knowledge about vaccination remains inadequate among patients as well as doctors.""
}"
2025-12-02T06:02:38+00:00,@bezrec,6886,https://t.me/bezrec/6886,"–° –∏–Ω–¥–∏–π—Å–∫–∏–º —Ñ–∞—Ä–º–∑–∞–≤–æ–¥–æ–º –≤ –ö–µ–º–µ—Ä–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –ø–æ–∫–∞ –Ω–µ —Å—Ä–∞—Å—Ç–∞–µ—Ç—Å—è. –°—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–æ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ –∫–æ–º–ø–ª–µ–∫—Å–∞ –∏ –∑–∞–≤–æ–¥–∞ –∏–Ω—ä–µ–∫—Ü–∏–æ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∫–æ–º–ø–∞–Ω–∏–µ–π Cadila Pharmaceuticals –æ—Ç–ª–æ–∂–µ–Ω–æ –Ω–∞ –Ω–µ–æ–ø—Ä–µ–¥–µ–ª–µ–Ω–Ω—ã–π —Å—Ä–æ–∫. –ö–∞–∫ —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏ –≤ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω–æ–º –¥–µ–ø–∞—Ä—Ç–∞–º–µ–Ω—Ç–µ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω–æ–π –ø–æ–ª–∏—Ç–∏–∫–∏, –∏–∑-–∑–∞ ¬´—Å–ª–æ–∂–∏–≤—à–∏—Ö—Å—è —É—Å–ª–æ–≤–∏–π –∏ –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–Ω–æ—Å—Ç–∏ –±—é–¥–∂–µ—Ç–∞ –∏–Ω–¥–∏–π—Å–∫–æ–π —Å—Ç–æ—Ä–æ–Ω—ã¬ª. –ê –≤—Å—ë —Ç–∞–∫ —Ö–æ—Ä–æ—à–æ –Ω–∞—á–∏–Ω–∞–ª–æ—Å—å. –í 2024 –≥–æ–¥—É –Ω–∞ –ü–ú–≠–§ Cadila Pharmaceuticals –∏ –†–§–ü–ò –ø–æ–¥–ø–∏—Å–∞–ª–∏ —Å–æ–≥–ª–∞—à–µ–Ω–∏–µ –æ —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–µ –≤ –ö—É–∑–±–∞—Å—Å–µ —Ñ–∞—Ä–º–ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏—è —Å –æ–±—ä—ë–º–æ–º –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–π –≤ 10 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –∏ –º–æ—â–Ω–æ—Å—Ç—å—é –±–æ–ª–µ–µ 1 –º–ª—Ä–¥ –µ–¥–∏–Ω–∏—Ü –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –æ–∫–æ–ª–æ 1,5 —Ç—ã—Å. —Ç–æ–Ω–Ω –∞–∫—Ç–∏–≤–Ω—ã—Ö —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –∏–Ω–≥—Ä–µ–¥–∏–µ–Ω—Ç–æ–≤ –≤ –≥–æ–¥. –ö 2027 –≥–æ–¥—É –Ω–∞ –Ω—ë–º –ø–ª–∞–Ω–∏—Ä–æ–≤–∞–ª–∏ –Ω–∞–ª–∞–¥–∏—Ç—å –≤—ã–ø—É—Å–∫ –≥–∞—Å—Ç—Ä–æ—ç–Ω—Ç–µ—Ä–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, —Å—Ä–µ–¥—Å—Ç–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –∏ —Å–∞—Ö–∞—Ä–Ω–æ–≥–æ –¥–∏–∞–±–µ—Ç–∞. –ò–Ω–¥–∏–π—Å–∫–∞—è —Å—Ç–æ—Ä–æ–Ω–∞ –≥–æ—Ç–æ–≤–∞ –±—ã–ª–∞ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–∏—Ç—å —Ç—Ä–∏ –≤–∞—Ä–∏–∞–Ω—Ç–∞ –ø—Ä–æ–µ–∫—Ç–æ–≤ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –≤–æ—Å—Ç—Ä–µ–±–æ–≤–∞–Ω–Ω—ã—Ö —É –Ω–∞—Å–µ–ª–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤. –ü–æ—Å–º–æ—Ç—Ä–∏–º, –∫–∞–∫ —Å–ø—Ä–∞–≤—è—Ç—Å—è –æ—Å—Ç–∞–ª—å–Ω—ã–µ ‚Äì –ò–Ω–¥–∏—è –æ—Ö–æ—Ç–Ω–µ–µ –¥—Ä—É–≥–∏—Ö —Å—Ç—Ä–∞–Ω –∑–∞—è–≤–ª—è–µ—Ç –æ –∂–µ–ª–∞–Ω–∏–∏ –≤–∫–ª–∞–¥—ã–≤–∞—Ç—å—Å—è –≤ —Ä–æ—Å—Å–∏–π—Å–∫–∏–π —Ñ–∞—Ä–º–ø—Ä–æ–º. –ù–∞–ø—Ä–∏–º–µ—Ä, ¬´–°–∞—Ñ—Ñ–∞—Ä–º¬ª, –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∞—â–∞—è –∏–Ω–¥–∏–π—Å–∫–∏–º Safecon Lifesciences –∏ Avicare Bio Science, –æ–±–µ—â–∞–ª–∞ –ø–æ—Å—Ç—Ä–æ–∏—Ç—å –∑–∞–≤–æ–¥ –≤ –ú—É—Ä–º–∞–Ω—Å–∫–µ, –∏–Ω–≤–µ—Å—Ç–∏—Ä–æ–≤–∞–≤ –±–æ–ª–µ–µ 9 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ê ¬´–≠–¥–≤–∞–Ω—Å–¥ –õ–∞–π—Ñ–°–∞–π–µ–Ω—Å¬ª –ø–æ–¥ —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–æ–º –†–∞–¥–∂–µ—à–∞ –®–∞—Ä–º—ã –ø–ª–∞–Ω–∏—Ä–æ–≤–∞–ª–∞ –≤–ª–æ–∂–∏—Ç—å –±–æ–ª–µ–µ 1 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –≤ –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏—é –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –æ–Ω–∫–æ–∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –≤ –û–≠–ó ¬´–î—É–±–Ω–∞¬ª –∫ 2026 –≥–æ–¥—É. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The construction of an innovative pharmaceutical complex and a syringe drug production plant by Cadila Pharmaceuticals, originally planned for Kemerovo region in Russia, has been delayed indefinitely due to 'difficulties and budget constraints' from the Indian side. This was part of a 2024 agreement with Russia's Federal Agency for Science and Innovations (RFPI) involving investments of up to 10 billion rubles. The project aimed at producing gastroenterology drugs, cardiovascular disease treatments, and diabetes medications by 2027. However, other countries like India's Saffar Pharmaceuticals and Advans Lifesciences are also looking to invest in Russia. The latter plans to invest over 1 billion rubles for oncology drug production by 2026.""
}"
2025-12-01T14:01:32+00:00,@bezrec,6885,https://t.me/bezrec/6885,"¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑¬ª –ø–æ–ª—É—á–∏–ª –ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω–æ–µ —Ä–µ—à–µ–Ω–∏–µ –ø–∞—Ç–µ–Ω—Ç–Ω–æ–≥–æ –≤–µ–¥–æ–º—Å—Ç–≤–∞ –°–®–ê –ø–æ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–æ–π —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ –ø—Ä–æ—Ç–∏–≤ –í–ò–ß. –ü–∞—Ç–µ–Ω—Ç–Ω–æ–µ –≤–µ–¥–æ–º—Å—Ç–≤–æ –°–®–ê / United States Patent and Trademark Office —Å–æ–≥–ª–∞—Å–∏–ª–æ—Å—å –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞—Ç—å –ø–∞—Ç–µ–Ω—Ç –Ω–∞ –∏–∑–æ–±—Ä–µ—Ç–µ–Ω–∏–µ, –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∞—â–µ–µ –∫–æ–º–ø–∞–Ω–∏–∏ –í–∏–∫—Ä–∞–º–∞ –ü—É–Ω–∏—è. –ü–∞—Ç–µ–Ω—Ç –∑–∞—â–∏—â–∞–µ—Ç –Ω–æ–≤—ã–µ –ø—Ä–æ–∏–∑–≤–æ–¥–Ω—ã–µ –ø–∏—Ä–∏–º–∏–¥–∏–Ω–∞, –∞ —Ç–∞–∫–∂–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ —Å—Ä–µ–¥—Å—Ç–≤–∞ –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–µ –∫–æ–º–ø–æ–∑–∏—Ü–∏–∏ –Ω–∞ –∏—Ö –æ—Å–Ω–æ–≤–µ, —Å–ø–æ—Å–æ–±–Ω—ã–µ –∏–Ω–≥–∏–±–∏—Ä–æ–≤–∞—Ç—å —Ä–µ–ø–ª–∏–∫–∞—Ü–∏—é –≤–∏—Ä—É—Å–∞ –∏–º–º—É–Ω–æ–¥–µ—Ñ–∏—Ü–∏—Ç–∞ —á–µ–ª–æ–≤–µ–∫–∞ (–í–ò–ß). –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –ø–∞—Ç–µ–Ω—Ç –≤–∫–ª—é—á–∞–µ—Ç —Å–ø–æ—Å–æ–± –ª–µ—á–µ–Ω–∏—è –∏/–∏–ª–∏ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫—É –í–ò–ß —É –ª–∏—Ü —Å –í–ò–ß-–∏–Ω—Ñ–µ–∫—Ü–∏–µ–π (–≤–∏—Ä—É—Å –∏–º–º—É–Ω–æ–¥–µ—Ñ–∏—Ü–∏—Ç–∞ —á–µ–ª–æ–≤–µ–∫–∞) –∏–ª–∏ –∏–º–µ—é—â–∏—Ö —Ä–∏—Å–∫ –∑–∞—Ä–∞–∂–µ–Ω–∏—è –í–ò–ß-–∏–Ω—Ñ–µ–∫—Ü–∏–µ–π —Å –ø–æ–º–æ—â—å—é —Å–æ–µ–¥–∏–Ω–µ–Ω–∏–π –∏ –∫–æ–º–ø–æ–∑–∏—Ü–∏–π. –ö–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –≤ –†–§ –¥–æ–ª–∂–Ω—ã –Ω–∞—á–∞—Ç—å—Å—è –≤ –Ω–∞—á–∞–ª–µ 2026 –≥–æ–¥–∞. –í –ø—Ä–æ–≤–µ–¥—ë–Ω–Ω—ã—Ö –Ω–∞–º–∏ –¥–æ–∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è—Ö –Ω–æ–≤–∞—è –º–æ–ª–µ–∫—É–ª–∞ –ø—Ä–æ—Ç–∏–≤ –í–ò–ß –ø–æ–∫–∞–∑–∞–ª–∞ –º–Ω–æ–≥–æ–æ–±–µ—â–∞—é—â–∏–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –ø–æ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –∏ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏. –£ –Ω–∞—Å –µ—Å—Ç—å –±–æ–ª—å—à–∞—è –Ω–∞–¥–µ–∂–¥–∞, —á—Ç–æ –ø—Ä–∏ —É—Å–ø–µ—à–Ω—ã—Ö —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞—Ö –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π —Ä–∞–∑—Ä–∞–±–∞—Ç—ã–≤–∞–µ–º—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç —Å–º–æ–∂–µ—Ç –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ —É–ª—É—á—à–∏—Ç—å –ª–µ—á–µ–Ω–∏–µ –í–ò–ß-–∏–Ω—Ñ–µ–∫—Ü–∏–∏, –∞ –∏–º–µ–Ω–Ω–æ —Å–¥–µ–ª–∞—Ç—å –∞–Ω—Ç–∏—Ä–µ—Ç—Ä–æ–≤–∏—Ä—É—Å–Ω—É—é —Ç–µ—Ä–∞–ø–∏—é –±–æ–ª–µ–µ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ–π –∏ —Ö–æ—Ä–æ—à–æ –ø–µ—Ä–µ–Ω–æ—Å–∏–º–æ–π. –ú—ã –Ω–µ —Å—Ç–æ–∏–º –Ω–∞ –º–µ—Å—Ç–µ –∏ –ø—Ä–æ–¥–æ–ª–∂–∞–µ–º —Ä–∞–∑–≤–∏–≤–∞—Ç—å –Ω–æ–≤—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–ª—è –±–æ—Ä—å–±—ã —Å —ç—Ç–∏–º –≤—Å—ë –µ—â—ë –Ω–µ–∏–∑–ª–µ—á–∏–º—ã–º –≤–∏—Ä—É—Å–æ–º, - –ø—Ä–æ–∫–æ–º–º–µ–Ω—Ç–∏—Ä–æ–≤–∞–ª —Å–æ–±—ã—Ç–∏–µ –í–∏–∫—Ä–∞–º –ü—É–Ω–∏—è. ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑¬ª - –∑–∞–º–µ—Ç–Ω—ã–π –∏–≥—Ä–æ–∫ –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º —Ä—ã–Ω–∫–µ –∞–Ω—Ç–∏—Ä–µ—Ç—Ä–æ–≤–∏—Ä—É—Å–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤: –≤ 2025 –≥–æ–¥—É –æ–±—â–∏–π –æ–±—ä—ë–º –ø–æ—Å—Ç–∞–≤–ª–µ–Ω–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –æ—Ç –í–ò–ß, –ø—Ä–æ–∏–∑–≤–µ–¥—ë–Ω–Ω—ã—Ö –∫–æ–º–ø–∞–Ω–∏–µ–π, –¥–æ—Å—Ç–∏–≥ –ø–æ—á—Ç–∏ 9 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫. –ë–æ–ª–µ–µ 80% –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç–∞ –∏—Å–ø–æ–ª—å–∑—É–µ—Ç—Å—è –≤ –∫–ª—é—á–µ–≤—ã—Ö —Ç–µ—Ä–∞–ø–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö —Å—Ö–µ–º–∞—Ö. –ü–æ –∏—Ç–æ–≥–∞–º 2024 –≥–æ–¥–∞, –∏–∑ –æ–±—â–µ–≥–æ —á–∏—Å–ª–∞ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –ø–æ–ª—É—á–∞—é—â–∏—Ö –ª–µ—á–µ–Ω–∏–µ –≤ –†–§, –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–∞—è —á–∞—Å—Ç—å –ø—Ä–∏–º–µ–Ω—è–ª–∞ —Å—Ö–µ–º—ã —Å –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º–∏ ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑–∞¬ª. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å –ø–æ–º–æ–≥–∞–µ—Ç —Ç–µ—Ä–∞–ø–∏–µ–π –¥—Ä—É–∂–µ—Å—Ç–≤–µ–Ω–Ω—ã–º —Å—Ç—Ä–∞–Ω–∞–º. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The patent office of the United States has granted a positive decision for an innovative development against HIV. The US Patent and Trademark Office agreed to register the patent belonging to Vikram Punia, which protects new derivatives of pyrimidine and also medicines and pharmaceutical compositions based on them capable of inhibiting the replication of human immunodeficiency virus (HIV). The patent also includes a method for treating and/or preventing HIV in individuals with HIV infection (human immunodeficiency virus) or at risk of contracting HIV infection using compounds and compositions. Clinical trials in Russia are scheduled to begin at the beginning of 2026. Our preclinical studies on the new HIV molecule have shown promising results in terms of efficacy and safety. We are hopeful that, if the clinical trials yield positive results, our developed drug will significantly improve HIV treatment, particularly making antiretroviral therapy more effective and tolerable. We are not standing still and continue to develop new drugs for fighting this incurable virus, - commented the event. 'Pharmasintez' is a notable"
2025-12-01T11:53:55+00:00,@bezrec,6884,https://t.me/bezrec/6884,"–ü—Ä–æ–¥–∞–∂–∏ –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç–æ–≤ –≤ –†–æ—Å—Å–∏–∏ –ø–æ–±–∏–ª–∏ –∏—Å—Ç–æ—Ä–∏—á–µ—Å–∫–∏–π —Ä–µ–∫–æ—Ä–¥. –í —è–Ω–≤–∞—Ä–µ-–æ–∫—Ç—è–±—Ä–µ 2025 –≥–æ–¥–∞ —Ä–æ—Å—Å–∏—è–Ω–µ –∫—É–ø–∏–ª–∏ –ø–æ—á—Ç–∏ 19,1 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç–æ–≤ –±–æ–ª–µ–µ —á–µ–º –Ω–∞ 15,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, –ø–æ–¥—Å—á–∏—Ç–∞–ª–∏ –≤ RNC Pharma. –≠—Ç–æ –Ω–∞ 24% –±–æ–ª—å—à–µ –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –∏ –Ω–∞ 36% –≤ –¥–µ–Ω–µ–∂–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ –≥–æ–¥ –∫ –≥–æ–¥—É. –î–≤—É–∑–Ω–∞—á–Ω—ã–µ —Ç–µ–º–ø—ã —Ä–æ—Å—Ç–∞ —ç—Ç–æ–π –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ –∞–Ω–∞–ª–∏—Ç–∏–∫–∏ –Ω–∞–±–ª—é–¥–∞—é—Ç —É–∂–µ —Ç—Ä–µ—Ç–∏–π –≥–æ–¥ –ø–æ–¥—Ä—è–¥. –°–∞–º—ã–µ –∞–∫—Ç–∏–≤–Ω—ã–µ –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª–∏ –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç–æ–≤ –∂–∏–≤—É—Ç –≤ –ú–æ—Å–∫–≤–µ –∏ –ú–æ—Å–∫–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ ‚Äî –Ω–∞ —ç—Ç–∏ —Ä–µ–≥–∏–æ–Ω—ã –ø—Ä–∏—à–ª–æ—Å—å –ø–æ—á—Ç–∏ 31% –æ—Ç –≤—Å–µ–≥–æ —Ä–æ–∑–Ω–∏—á–Ω–æ–≥–æ —Ä—ã–Ω–∫–∞ –≤ —Å—Ç–æ–∏–º–æ—Å—Ç–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏, —Ö–æ—Ç—è –¥–∏–Ω–∞–º–∏–∫–∞ –ø—Ä–æ–¥–∞–∂ –≤ –¥–µ–Ω—å–≥–∞—Ö —Ç—É—Ç –Ω–∏–∂–µ —Å—Ä–µ–¥–Ω–µ—Ä–æ—Å—Å–∏–π—Å–∫–æ–π ‚Äî +28% –∏ +33% —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ. –ú–∞–∫—Å–∏–º–∞–ª—å–Ω—ã–º–∏ –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è–º–∏ –ø—Ä–∏—Ä–æ—Å—Ç–∞ –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏—è –æ—Ç–ª–∏—á–∏–ª–∏—Å—å –ö–∞–º—á–∞—Ç—Å–∫–∏–π –∫—Ä–∞–π (+55%) –∏ –í–æ–ª–æ–≥–æ–¥—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å (+54%). –ü–æ –∏—Ç–æ–≥–∞–º –¥–µ—Å—è—Ç–∏ –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ —ç—Ç–∞ –∫–∞—Ç–µ–≥–æ—Ä–∏—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ —Ä–∏—Ç–µ–π–ª–µ –±—ã–ª–∞ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–∞ 88 —Ç–æ—Ä–≥–æ–≤—ã–º–∏ –º–∞—Ä–∫–∞–º–∏ –æ—Ç 55 –∫–æ–º–ø–∞–Ω–∏–π. –ü–æ—á—Ç–∏ 18% —Ä–∞—Å—Ö–æ–¥–æ–≤ –æ–±–µ—Å–ø–µ—á–∏–≤–∞–ª–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–∞—Ç—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–•.–õ—É–Ω–¥–±–µ–∫¬ª ‚Äî —É –∫–æ–º–ø–∞–Ω–∏–∏ –≤ –≥—Ä—É–ø–ø–µ —Ç—Ä–∏ –±—Ä–µ–Ω–¥–∞, –ª–∏–¥–∏—Ä—É—é—â–∏–π ‚Äì –¶–∏–ø—Ä–∞–ª–µ–∫—Å. –ó–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ —É–ª—É—á—à–∏–ª–∞ —Å–≤–æ–∏ –ø–æ–∫–∞–∑–∞—Ç–µ–ª–∏ —Å–ª–æ–≤–µ–Ω—Å–∫–∞—è ¬´–ö–†–ö–ê¬ª. –ü–µ—Ä–µ–º–µ—Å—Ç–∏—Ç—å—Å—è —Å —á–µ—Ç–≤—ë—Ä—Ç–æ–≥–æ –º–µ—Å—Ç–∞ –Ω–∞ –≤—Ç–æ—Ä–æ–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—é –ø–æ–º–æ–≥–ª–∞ –î—É–ª–æ–∫—Å–µ–Ω—Ç–∞ (–ú–ù–ù –¥—É–ª–æ–∫—Å–µ—Ç–∏–Ω) - –∑–∞ –≥–æ–¥ —Ä–∞—Å—Ö–æ–¥—ã –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª–µ–π –Ω–∞ –±—Ä–µ–Ω–¥ —É–≤–µ–ª–∏—á–∏–ª–∏—Å—å –Ω–∞ 79%. –ù–∞ —Ç—Ä–µ—Ç—å—é —Å—Ç—Ä–æ—á–∫—É –æ–ø—É—Å—Ç–∏–ª—Å—è ¬´–≠–±–±–æ—Ç—Ç¬ª, –∑–∞–Ω–∏–º–∞—é—â–∏–π 11,6% —Ä—ã–Ω–∫–∞, –ø—Ä–∏—á—ë–º —Ä—É–±–ª—ë–≤—ã–µ –ø—Ä–æ–¥–∞–∂–∏ —Ç–æ–ø-–±—Ä–µ–Ω–¥–æ–≤ –∫–æ—Ä–ø–æ—Ä–∞—Ü–∏–∏ —Ç–∞–∫–∂–µ —Å—É—â–µ—Å—Ç–≤–µ–Ω–Ω–æ –≤—ã—Ä–æ—Å–ª–∏: –§–µ–≤–∞—Ä–∏–Ω (–ú–ù–ù —Ñ–ª—É–≤–æ–∫—Å–∞–º–∏–Ω) –∑–∞ –≥–æ–¥ –ø—Ä–∏–±–∞–≤–∏–ª 27%, –∞ –°–µ–ª–µ–∫—Ç—Ä–∞ (–ú–ù–ù —ç—Å—Ü–∏—Ç–∞–ª–æ–ø—Ä–∞–º) +44%. –í—Å–µ —É—á–∞—Å—Ç–Ω–∏–∫–∏ –ø–µ—Ä–≤–æ–π –¥–µ—Å—è—Ç–∫–∏ –∫–æ–º–ø–∞–Ω–∏–π –ø—Ä–æ–¥–µ–º–æ–Ω—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª–∏ –¥–≤—É—Ö–∑–Ω–∞—á–Ω—ã–µ –ø–æ–∫–∞–∑–∞—Ç–µ–ª–∏ —Ä—É–±–ª—ë–≤–æ–π –¥–∏–Ω–∞–º–∏–∫–∏. –ê–±—Å–æ–ª—é—Ç–Ω—ã–º –º–∞–∫—Å–∏–º—É–º–æ–º –º–æ–∂–µ—Ç –ø–æ—Ö–≤–∞—Å—Ç–∞—Ç—å—Å—è ¬´–í–∏–∞—Ç—Ä–∏—Å¬ª, –∑–∞ –≥–æ–¥ –Ω–∞—Ä–∞—Å—Ç–∏–≤—à–∏–π –ø—Ä–æ–¥–∞–∂–∏ –ó–æ–ª–æ—Ñ—Ç–∞ (–ú–ù–ù —Å–µ—Ä—Ç—Ä–∞–ª–∏–Ω) –Ω–∞ 60%, –ø—Ä–∏ —ç—Ç–æ–º –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–µ –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–µ –≤—ã—Ä–æ—Å–ª–æ –Ω–∞ 50%. –¢–∞–∫–∂–µ –≤–ø–µ—á–∞—Ç–ª—è—é—â–∏–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –ø–æ–∫–∞–∑–∞–ª–∞ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–∞—è ¬´–ö–∞–Ω–æ–Ω—Ñ–∞—Ä–º–∞¬ª. –ü—Ä–æ–¥–∞–∂–∏ –µ—ë –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤—ã—Ä–æ—Å–ª–∏ –±–æ–ª–µ–µ —á–µ–º –≤ –ø–æ–ª–æ–≤–∏–Ω—É, –∞ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω—ã–π —Å–ø—Ä–æ—Å —É–≤–µ–ª–∏—á–∏–ª—Å—è –Ω–∞ 40%. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""Sales of antidepressants in Russia have hit a record high. In January-October 2025, Russians purchased nearly 19.1 million units of antidepressants worth over 15.7 billion rubles, according to RNC Pharma. This is a 24% increase in natural terms and a 36% increase in monetary terms compared to the same period last year. Year-over-year, analysts have observed triple-digit growth in this category for three consecutive years. The most active consumers of antidepressants live in Moscow and the surrounding regions, accounting for nearly 31% of the retail market value. The Kamchatka region (+55%) and Volgograd Oblast (+54%) recorded the highest growth rates. The top-selling brands include Danish company H Lundbeck's Cipralex, and Slovenian company Krka. Worden (duloxetine) saw a 79% increase in consumer spending over the year. The top-selling brands of pharmaceutical giant Abbott, such as Febarin (fluvoxamine) and Selctra ("
2025-12-01T08:45:05+00:00,@bezrec,6883,https://t.me/bezrec/6883,"–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –ø–æ–ø—Ä–æ—Å–∏–ª–∏ —É—Å–∫–æ—Ä–∏—Ç—å—Å—è —Å —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–æ–π –∫—Ä–∏—Ç–µ—Ä–∏–µ–≤ –¥–ª—è –ø–µ—Ä–µ—á–Ω—è –°–ó–õ–°. –ê—Å—Å–æ—Ü–∏–∞—Ü–∏—è —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ï–≤—Ä–∞–∑–∏–∏ÃÜ—Å–∫–æ–≥–æ —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–≥–æ —Å–æ—é–∑–∞ –æ–±—Ä–∞—Ç–∏–ª–∞—Å—å –∫ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤—É —Å –ø—Ä–æ—Å—å–±–æ–π —Å–∫–æ—Ä–µ–µ –æ–ø—Ä–µ–¥–µ–ª–∏—Ç—å—Å—è —Å –∫—Ä–∏—Ç–µ—Ä–∏—è–º–∏ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—è —Å–ø–∏—Å–∫–∞ —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤. –û–Ω–∏ –¥–æ–ª–∂–Ω—ã –±—ã–ª–∏ –ø–æ—è–≤–∏—Ç—å—Å—è –∫ —Å–µ–Ω—Ç—è–±—Ä—é 2025 –≥–æ–¥–∞, –Ω–æ –ø–æ–∫–∞ –Ω–µ —Å–ª—É—á–∏–ª–æ—Å—å. –í–ø—Ä–æ—á–µ–º, –ú–∏–Ω—Ñ–∏–Ω —É–∂–µ –ø–æ–¥–≥–æ—Ç–æ–≤–∏–ª –ø—Ä–æ–µ–∫—Ç –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è, —Å–æ–≥–ª–∞—Å–Ω–æ –∫–æ—Ç–æ—Ä–æ–º—É ¬´–≤—Ç–æ—Ä–æ–π –ª–∏—à–Ω–∏–π¬ª –¥–ª—è –°–ó–õ–° –ø–µ—Ä–µ–Ω–æ—Å–∏—Ç—Å—è —Å 1 —è–Ω–≤–∞—Ä—è –Ω–∞ 1 –∏—é–ª—è 2026 –≥–æ–¥–∞. –ì–æ—Å—É–¥–∞—Ä—Å—Ç–≤–æ –Ω–µ –º–æ–∂–µ—Ç –¥–ª—è —Å–µ–±—è –æ–ø—Ä–µ–¥–µ–ª–∏—Ç—å, –∫–∞–∫–∏–µ —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –µ–º—É –Ω—É–∂–Ω—ã. –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–µ –∫–æ–º–ø–∞–Ω–∏–∏, –≤ —Å–≤–æ—é –æ—á–µ—Ä–µ–¥—å, –Ω–µ –º–æ–≥—É—Ç –Ω–∞—á–∞—Ç—å –ø–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω–∏–µ –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–π –≤ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—é –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤ –ø–æ–ª–Ω–æ–≥–æ —Ü–∏–∫–ª–∞. –í—Å—ë —ç—Ç–æ –ø–æ–¥–≤–µ—à–∏–≤–∞–µ—Ç –¥–æ—Å—Ç–∏–∂–µ–Ω–∏–µ —Ü–µ–ª–∏ –ø–æ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—é —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ —Å—É–≤–µ—Ä–µ–Ω–∏—Ç–µ—Ç–∞ –∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π –Ω–µ–∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª ¬´–ò–∑–≤–µ—Å—Ç–∏—è–º¬ª –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—å –ø—Ä–∞–≤–ª–µ–Ω–∏—è –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ –ê–ª–µ–∫—Å–µ–π –ö–µ–¥—Ä–∏–Ω. –ü–æ –º–Ω–µ–Ω–∏—é —ç–∫—Å–ø–µ—Ä—Ç–∞, —Ü–µ–Ω–æ–≤–∞—è –ø—Ä–µ—Ñ–µ—Ä–µ–Ω—Ü–∏—è –¥–æ–ª–∂–Ω–∞ –ø—Ä–∏–º–µ–Ω—è—Ç—å—Å—è –∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º, –ø—Ä–µ–¥–Ω–∞–∑–Ω–∞—á–µ–Ω–Ω—ã–º –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ —Å–æ—Ü–∏–∞–ª—å–Ω–æ –∑–Ω–∞—á–∏–º—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, –ø—Ä–µ–¥—Å—Ç–∞–≤–ª—è—é—â–∏—Ö —É–≥—Ä–æ–∑—É –¥–ª—è –æ–∫—Ä—É–∂–∞—é—â–∏—Ö, –∏–Ω–≤–∞–ª–∏–¥–∏–∑–∏—Ä—É—é—â–∏—Ö, –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, –≤–∫–ª—é—á–µ–Ω–Ω—ã—Ö –≤ –Ω–∞—Ü–ø—Ä–æ–µ–∫—Ç ¬´–ü—Ä–æ–¥–æ–ª–∂–∏—Ç–µ–ª—å–Ω–∞—è –∏ –∞–∫—Ç–∏–≤–Ω–∞—è –∂–∏–∑–Ω—å¬ª, —É –∫–æ—Ç–æ—Ä—ã—Ö –Ω–µ—Ç –∞–Ω–∞–ª–æ–≥–æ–≤ –∏–ª–∏ –¥–ª—è –∫–æ—Ç–æ—Ä—ã—Ö –æ–±–µ—Å–ø–µ—á–µ–Ω–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –ø–æ–ª–Ω–æ–≥–æ —Ü–∏–∫–ª–∞, –∞ —Ç–∞–∫–∂–µ –∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫–∞–º ¬´–≤ —Å–∏–ª—É –Ω–µ–≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ –æ–∫–∞–∑–∞–Ω–∏—è –±–µ–∑ –Ω–∏—Ö –º–µ–¥–ø–æ–º–æ—â–∏ –≤ —Ä—è–¥–µ —Å–ª—É—á–∞–µ–≤¬ª. –í –ú–∏–Ω–∑–¥—Ä–∞–≤–µ —Å–æ–æ–±—â–∏–ª–∏, —á—Ç–æ –ø—Ä–æ–µ–∫—Ç –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –æ–± —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏–∏ –ø–æ—Ä—è–¥–∫–∞ –∏ –∫—Ä–∏—Ç–µ—Ä–∏–µ–≤ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—è –ø–µ—Ä–µ—á–Ω—è –°–ó–õ–° ¬´–ø—Ä–æ—Ö–æ–¥–∏—Ç —Ä–µ–≥–ª–∞–º–µ–Ω—Ç–Ω—ã–µ –ø—Ä–æ—Ü–µ–¥—É—Ä—ã¬ª. –û–∫–æ–Ω—á–∞—Ç–µ–ª—å–Ω–æ –æ–ø—Ä–µ–¥–µ–ª–∏—Ç—å—Å—è –æ–±–µ—â–∞—é—Ç –¥–æ 10 –∏—é–Ω—è 2026 –≥–æ–¥–∞. –ú–Ω–µ–Ω–∏—è –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ –ø–µ—Ä–µ–Ω–æ—Å–∞ —Å—Ä–æ–∫–æ–≤ —Ä–∞–∑–¥–µ–ª–∏–ª–∏—Å—å. –ù—É–∂–Ω–æ, —á—Ç–æ–±—ã –≤ –ø–µ—Ä–µ—á–Ω–µ —Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–ª–∏—Å—å –Ω–µ —Ç–æ–ª—å–∫–æ –¥–µ–π—Å—Ç–≤—É—é—â–∏–µ –≤–µ—â–µ—Å—Ç–≤–∞, –Ω–æ –∏ –¥–æ–∑–∏—Ä–æ–≤–∫–∏, —Ñ–æ—Ä–º–∞ –≤—ã–ø—É—Å–∫–∞ –∏ —Å–ø–æ—Å–æ–±—ã –≤–≤–µ–¥–µ–Ω–∏—è. –¢–∞–∫–∂–µ —Å—Ç–æ–∏—Ç –æ—Ç—Ä–∞–±–æ—Ç–∞—Ç—å –º–µ—Ö–∞–Ω–∏–∑–º –∫–æ–Ω—Ç—Ä–æ–ª—è –ø—Ä–æ—Å–ª–µ–∂–∏–≤–∞–µ–º–æ—Å—Ç–∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö —Å—É–±—Å—Ç–∞–Ω—Ü–∏–π. –í–∞–∂–Ω–æ, —á—Ç–æ–±—ã –Ω–µ–¥–æ–±—Ä–æ—Å–æ–≤–µ—Å—Ç–Ω—ã–µ –∫–æ–º–ø–∞–Ω–∏–∏ –Ω–µ –º–æ–≥–ª–∏ –∑–∞–≤–æ–∑–∏—Ç—å —Å—É–±—Å—Ç–∞–Ω—Ü–∏—é –ø–æ–¥ –≤–∏–¥–æ–º —Ä–µ–∞–≥–µ–Ω—Ç–æ–≤ –∏ –≤—ã–¥–∞–≤–∞—Ç—å –∏–º–ø–æ—Ä—Ç –∑–∞ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ, ‚Äî —Å–∫–∞–∑–∞–ª –∏—Å–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–π –¥–∏—Ä–µ–∫—Ç–æ—Ä ¬´–ò–Ω—Ñ–∞—Ä–º—ã¬ª –í–∞–¥–∏–º –ö—É–∫–∞–≤–∞, –æ—Ç–¥–µ–ª—å–Ω–æ –ø–æ–¥—á–µ—Ä–∫–Ω—É–≤ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç—å —É–≤—è–∑–∞—Ç—å –ø–µ—Ä–µ—á–µ–Ω—å —Å –ø–∞—Ç–µ–Ω—Ç–Ω—ã–º–∏ –ø—Ä–∞–≤–∞–º–∏. –î–∏—Ä–µ–∫—Ç–æ—Ä –ø–æ —ç–∫–æ–Ω–æ–º–∏–∫–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è ¬´–†-–§–∞—Ä–º¬ª –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ë—ã–∫–æ–≤ –Ω–∞–∑–≤–∞–ª –ø–µ—Ä–µ–Ω–æ—Å —Å—Ä–æ–∫–æ–≤ ¬´–æ–∫–Ω–æ–º –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–µ–π –¥–ª—è —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π¬ª, –∫–æ—Ç–æ—Ä–æ–µ –¥–∞—Å—Ç –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –æ–ø—Ä–æ–±–æ–≤–∞—Ç—å –Ω–∞ –ø—Ä–∞–∫—Ç–∏–∫–µ –∫–ª—é—á–µ–≤—ã–µ –º–µ—Ö–∞–Ω–∏–∑–º—ã –∏ —Å–¥–µ–ª–∞—Ç—å –∏—Ö –º–∞–∫—Å–∏–º–∞–ª—å–Ω–æ –ø—Ä–æ–∑—Ä–∞—á–Ω—ã–º–∏. –ê –≤–æ—Ç –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ê–∫—Ç–∏–≤–Ω—ã–π –ö–æ–º–ø–æ–Ω–µ–Ω—Ç¬ª –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –°–µ–º–µ–Ω–æ–≤ —Å–¥–≤–∏–≥ —Å—Ä–æ–∫–æ–≤ –Ω–µ –ø—Ä–∏–≤–µ—Ç—Å—Ç–≤—É–µ—Ç, —Ç.–∫. —Ç–∞–∫–æ–µ —Ä–µ—à–µ–Ω–∏–µ –º–æ–∂–µ—Ç –±—ã—Ç—å ¬´—á—Ä–µ–≤–∞—Ç–æ –ø–æ—Ç–µ—Ä–µ–π –∏–Ω—Ç–µ—Ä–µ—Å–∞ –∫ —Ä–∞—Å—à–∏—Ä–µ–Ω–∏—é –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤, —Å–≤–æ—Ä–∞—á–∏–≤–∞–Ω–∏—é –∏–Ω–≤–µ—Å—Ç–ø—Ä–æ–µ–∫—Ç–æ–≤ –∏ –Ω–µ–≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å—é —Ä–∞–∑—Ä–∞–±–∞—Ç—ã–≤–∞—Ç—å –∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç—å –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã–µ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã¬ª. –¢–æ–≥–æ –∂–µ –º–Ω–µ–Ω–∏—è –ø—Ä–∏–¥–µ—Ä–∂–∏–≤–∞–µ—Ç—Å—è –¥–∏—Ä–µ–∫—Ç–æ—Ä –ø–æ –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏—é —Å –æ—Ä–≥–∞–Ω–∞–º–∏ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π –≤–ª–∞—Å—Ç–∏ –∏ –¥–æ—Å—Ç—É–ø—É –Ω–∞ —Ä—ã–Ω–æ–∫ ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º–∞¬ª –î–º–∏—Ç—Ä–∏–π –ù–∞—Ö–∞–º—á–µ–Ω. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""tenders, import_export, shortage, regulation"",
  ""impact"": ""medium"",
  ""english"": ""The government is requesting the development of criteria for a list of strategically important medicines. The Association of Pharmaceutical Manufacturers of the Eurasian Economic Union (EAEU) has asked the government to quickly determine the criteria for forming a list of strategically important medicines. These should have been in place by September 2025, but this has not yet happened. The Ministry of Finance has already prepared a draft decree that postpones the second extra item for SLS to July 1, 2026. The government cannot determine which strategic drugs it needs. Pharmaceutical companies cannot start planning full-cycle production investments. This puts the goal of technological sovereignty and drug independence at risk, according to Alexey Kedrin, chairman of the association. Price preferences should be applied to drugs intended for treating socially significant diseases, diseases posing a threat to the environment, disabling conditions, and diseases included in the national project 'Longevity and Activity'. For antibiotics due to the inability to provide medical care without them in certain cases. The government's draft decree on establishing a procedure and criteria"
2025-12-01T05:30:01+00:00,@bezrec,6882,https://t.me/bezrec/6882,"–í–∞–∫—Ü–∏–Ω–∞ –ø—Ä–æ—Ç–∏–≤ –∞–ª–ª–µ—Ä–≥–∏–∏ –Ω–∞ –ø—ã–ª—å—Ü—É –±–µ—Ä–µ–∑—ã –ø–µ—Ä–µ—à–ª–∞ –≤ —Ç—Ä–µ—Ç—å—é —Ñ–∞–∑—É –ö–ò. –ó–∞–∫–æ–Ω—á–µ–Ω–∞ –æ–±—ä–µ–¥–∏–Ω–µ–Ω–Ω–∞—è –ø–µ—Ä–≤–∞—è –∏ –≤—Ç–æ—Ä–∞—è —Ñ–∞–∑—ã –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π, —á—Ç–æ —è–≤–ª—è–µ—Ç—Å—è —Å–∞–º–æ –ø–æ —Å–µ–±–µ, –ø–æ –¥–µ–π—Å—Ç–≤—É—é—â–µ–º—É –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤—É, –¥–æ—Å—Ç–∞—Ç–æ—á–Ω—ã–º –¥–ª—è —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –≤–∞–∫—Ü–∏–Ω—ã, –ø–æ–¥ –≤—Å—Ç—Ä–µ—á–Ω–æ–µ —É—Å–ª–æ–≤–∏–µ —Å –Ω–µ–ø—Ä–µ—Ä—ã–≤–Ω—ã–º –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥–æ–º –µ–µ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ —É –≤—Å–µ—Ö, –∫—Ç–æ –±—É–¥–µ—Ç –µ–µ –ø–æ–ª—É—á–∞—Ç—å. –ú—ã –Ω–∞—á–∞–ª–∏ —Ç—Ä–µ—Ç—å—é —Ñ–∞–∑—É –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π, –∏ —Å–µ–π—á–∞—Å –æ—á–µ–Ω—å –∞–∫—Ç–∏–≤–Ω–æ –∏–¥–µ—Ç –Ω–∞–±–æ—Ä –¥–ª—è –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π —Ç—Ä–µ—Ç—å–µ–π —Ñ–∞–∑—ã, - —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∞ –≥–ª–∞–≤–∞ –§–ú–ë–ê –í–µ—Ä–æ–Ω–∏–∫–∞ –°–∫–≤–æ—Ä—Ü–æ–≤–∞. –ê–ª–ª–µ—Ä–≥–∞—Ä–¥–∞ –ø–æ–∫–∞–∑—ã–≤–∞–µ—Ç —Å–µ–±—è —Ö–æ—Ä–æ—à–æ ‚Äî —É 25% –ø—Ä–∏–≤–∏—Ç—ã—Ö –≤–æ–æ–±—â–µ –Ω–µ –±—ã–ª–æ –ø—Ä–∏–∑–Ω–∞–∫–æ–≤ –∞–ª–ª–µ—Ä–≥–∏–∏, —É –æ—Å—Ç–∞–ª—å–Ω—ã—Ö –∏–Ω—Ç–µ–Ω—Å–∏–≤–Ω–æ—Å—Ç—å —Å–∏–º–ø—Ç–æ–º–æ–≤ –ø–æ –∏–Ω—Ç–µ–≥—Ä–∞—Ç–∏–≤–Ω–æ–π —à–∫–∞–ª–µ –±—ã–ª–∞ —Å–Ω–∏–∂–µ–Ω–∞ –±–æ–ª–µ–µ —á–µ–º –≤ —à–µ—Å—Ç—å —Ä–∞–∑. –¢—è–∂–µ–ª—ã—Ö –∞–ª–ª–µ—Ä–≥–∏—á–µ—Å–∫–∏—Ö –ø—Ä–æ—è–≤–ª–µ–Ω–∏–π –Ω–µ –±—ã–ª–æ –Ω–∏ —É –æ–¥–Ω–æ–≥–æ –ø–∞—Ü–∏–µ–Ω—Ç–∞. –ö –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ –≤–∞–∫—Ü–∏–Ω—ã –≤–æ–ø—Ä–æ—Å–æ–≤ —Ç–æ–∂–µ –Ω–µ—Ç. –ü–æ —Å–ª–æ–≤–∞–º –°–∫–≤–æ—Ä—Ü–æ–≤–æ–π, —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–∞—è –¥–æ–∑–∞, –≤—ã–±—Ä–∞–Ω–Ω–∞—è —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞–º–∏, —Å–æ—Å—Ç–∞–≤–∏–ª–∞ 80 –º–∏–∫—Ä–æ–≥—Ä–∞–º–º–æ–≤. –í–∞–∫—Ü–∏–Ω–∞ –≤–≤–æ–¥–∏—Ç—Å—è –ø–æ–¥–∫–æ–∂–Ω–æ –ø—è—Ç–∏–∫—Ä–∞—Ç–Ω–æ, —Å –∏–Ω—Ç–µ—Ä–≤–∞–ª–æ–º –æ–¥–∏–Ω —Ä–∞–∑ –≤ —á–µ—Ç—ã—Ä–µ –Ω–µ–¥–µ–ª–∏. –í –æ—Ç–ª–∏—á–∏–µ –æ—Ç –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ê–°–ò–¢ –ê–ª–ª–µ—Ä–≥–∞—Ä–¥–∞ –Ω–µ —Å–æ–¥–µ—Ä–∂–∏—Ç –ø—Ä–∏—Ä–æ–¥–Ω—ã–π –∞–ª–ª–µ—Ä–≥–µ–Ω –∏ –º–æ–∂–µ—Ç –≤–≤–æ–¥–∏—Ç—å—Å—è –≤ –±–æ–ª–µ–µ –≤—ã—Å–æ–∫–∏—Ö –¥–æ–∑–∞—Ö, —Ç–µ–º —Å–∞–º—ã–º —Å–æ–∫—Ä–∞—â–∞—è –¥–ª–∏—Ç–µ–ª—å–Ω–æ—Å—Ç—å –ª–µ—á–µ–Ω–∏—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety"",
  ""impact"": ""medium"",
  ""english"": ""The allergy to birch pollen vaccine has moved into the third phase of clinical trials. The combined first and second phases of clinical studies are considered sufficient for registration, subject to continuous monitoring of its effectiveness. We have started the third phase clinical trials and are actively recruiting for the third phase clinical studies. The vaccine shows good results, with 25% of vaccinated individuals experiencing no allergy symptoms and the intensity of symptoms for the rest being reduced by more than six times. There are no safety concerns. The effective dose selected by specialists is 80 micrograms. The vaccine is administered subcutaneously five times with an interval of four weeks. Unlike allergen-specific immunotherapy (ASIT) drugs, the vaccine does not contain a natural allergen and can be administered at higher doses to shorten the treatment duration.""
}"
2025-11-30T10:59:55+00:00,@bezrec,6879,https://t.me/bezrec/6879,"–í –ò–Ω–¥–∏–∏ –æ—Ç–≥—Ä–µ–º–µ–ª–∞ –µ—â—ë –æ–¥–Ω–∞ ¬´—Ñ–∞—Ä–º—Å–≤–∞–¥—å–±–∞¬ª. –í –∏—é–ª–µ –ø—Ä–æ—à–ª–æ–≥–æ –≥–æ–¥–∞ —Å—ã–Ω —Å–∞–º–æ–≥–æ –±–æ–≥–∞—Ç–æ–≥–æ —á–µ–ª–æ–≤–µ–∫–∞ –≤ –ê–∑–∏–∏ –ê–Ω–∞–Ω—Ç –ê–º–±–∞–Ω–∏ –∂–µ–Ω–∏–ª—Å—è –Ω–∞ –Ω–∞—Å–ª–µ–¥–Ω–∏—Ü–µ –æ—Å–Ω–æ–≤–∞—Ç–µ–ª–µ–π –∫—Ä—É–ø–Ω–µ–π—à–µ–π —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ –ò–Ω–¥–∏–∏ Encore Healthcare. –ù–∞ –¥–Ω—è—Ö –ø–æ—Ä–æ–¥–Ω–∏–ª–∏—Å—å –µ—â—ë –¥–≤–µ –≤–ª–∏—è—Ç–µ–ª—å–Ω—ã–µ —Å–µ–º—å–∏: –¥–æ—á—å –≥–µ–Ω–µ—Ä–∞–ª—å–Ω–æ–≥–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –∫—Ä—É–ø–Ω–æ–π —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ Ingenus Pharmaceuticals –ù–µ—Ç—Ä–∞ –ú–∞–Ω—Ç–µ–Ω–∞ –≤—ã—à–ª–∞ –∑–∞–º—É–∂ –∑–∞ –í–∞–º—Å–∏ –ì–∞—Ä–∏–¥–∞–∂—É, —Ç–µ—Ö–Ω–æ-–ø—Ä–µ–¥–ø—Ä–∏–Ω–∏–º–∞—Ç–µ–ª—è, –æ—Å–Ω–æ–≤–∞—Ç–µ–ª—è –ø–ª–∞—Ç—Ñ–æ—Ä–º—ã Superorder. –°–≤–∞–¥—å–±–∞ –ø–µ–ª–∞ –∏ –ø–ª—è—Å–∞–ª–∞ –≤ –≥–æ—Ä–æ–¥–µ –£–¥–∞–π–ø—É—Ä. –ü–æ —Ç—Ä–∞–¥–∏—Ü–∏–∏ ¬´–¥–æ—Ä–æ–≥–æ-–±–æ–≥–∞—Ç–æ¬ª –≥—É–ª—è–ª–∏ —Ç—Ä–∏ –¥–Ω—è. –ù–∞—á–∞–ª–∏ –≤ —Ä–æ—Å–∫–æ—à–Ω–æ–º –æ—Ç–µ–ª–µ The Leela Palace Udaipur, –≤–æ–∑–≤—ã—à–∞—é—â–µ–º—Å—è –Ω–∞–¥ –æ–∑–µ—Ä–æ–º –ü–∏—á–æ–ª–∞, –∑–∞—Ç–µ–º –ø–µ—Ä–µ–º–µ—Å—Ç–∏–ª–∏—Å—å –≤ –∏—Å—Ç–æ—Ä–∏—á–µ—Å–∫–∏–π –¥–≤–æ—Ä–µ—Ü Zenana Mahal, –∞ –∑–∞–∫–æ–Ω—á–∏–ª–∏ –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏—è –≤ –ø–æ–º–µ—Å—Ç—å–µ –Ω–∞ –∑–∞–∫—Ä—ã—Ç–æ–º –æ—Å—Ç—Ä–æ–≤–µ. –í—ã—Å–æ–∫–æ–ø–æ—Å—Ç–∞–≤–ª–µ–Ω–Ω—ã—Ö –≥–æ—Å—Ç–µ–π —Ä–∞–∑–≤–ª–µ–∫–∞–ª–∏ –î–∂–µ–Ω–Ω–∏—Ñ–µ—Ä –õ–æ–ø–µ—Å, –î–∂–∞—Å—Ç–∏–Ω –ë–∏–±–µ—Ä, –≥–ª–∞–≤–Ω—ã–µ –∑–≤—ë–∑–¥—ã –ë–æ–ª–ª–∏–≤—É–¥–∞ –∏ –∞—Ä—Ç–∏—Å—Ç—ã Cirque du Soleil. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-11-29T10:59:55+00:00,@bezrec,6878,https://t.me/bezrec/6878,"–í—Å—Ç—Ä–µ—á–∞–µ–º —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω—ã–π —Å—É–±–±–æ—Ç–Ω–∏–π –≤—ã–ø—É—Å–∫ —Ä—É–±—Ä–∏–∫–∏ #–≤–¥–æ–≥–æ–Ω–∫—É. üíä ¬´–í—Ç–æ—Ä–æ–π –ª–∏—à–Ω–∏–π¬ª –¥–ª—è –°–ó–õ–° —Å–Ω–æ–≤–∞ –æ—Ç–∫–ª–∞–¥—ã–≤–∞–µ—Ç—Å—è. –°–æ–≥–ª–∞—Å–Ω–æ –ø—Ä–æ–µ–∫—Ç—É –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –†–§, –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–Ω–æ–º—É –¥–ª—è –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –æ–±—Å—É–∂–¥–µ–Ω–∏—è –ú–∏–Ω—Ñ–∏–Ω–æ–º, —Å—Ç–∞—Ä—Ç –º–µ—Ö–∞–Ω–∏–∑–º–∞ –ø–µ—Ä–µ–Ω–æ—Å–∏—Ç—Å—è —Å 1 —è–Ω–≤–∞—Ä—è –Ω–∞ 1 –∏—é–ª—è 2026 –≥–æ–¥–∞. –ü–æ—Ä—è–¥–æ–∫ –∏ –∫—Ä–∏—Ç–µ—Ä–∏–∏ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—è –ø–µ—Ä–µ—á–Ω—è –°–ó–õ–° –¥–æ–ª–∂–Ω—ã –±—ã—Ç—å —É—Ç–≤–µ—Ä–∂–¥–µ–Ω—ã –¥–æ 24 –º–∞—Ä—Ç–∞ 2026 –≥–æ–¥–∞, –∞ —Å–∞–º –ø–µ—Ä–µ—á–µ–Ω—å ‚Äî –¥–æ 10 –∏—é–Ω—è 2026 –≥–æ–¥–∞. üíä –†–∞–∑—Ä–∞–±–æ—Ç–∫–µ –ª–µ–∫–∞—Ä—Å—Ç–≤ –±–µ–∑ –ò–ò –ø—Ä–∏–¥—ë—Ç—Å—è –Ω–µ–ø—Ä–æ—Å—Ç–æ. –ü–æ –º–Ω–µ–Ω–∏—é —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—è —Ü–µ–Ω—Ç—Ä–∞ –º–∞—Ç–µ–º–∞—Ç–∏—á–µ—Å–∫–æ–≥–æ –º–æ–¥–µ–ª–∏—Ä–æ–≤–∞–Ω–∏—è –≤ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ –ª–µ–∫–∞—Ä—Å—Ç–≤ –°–µ—á–µ–Ω–æ–≤—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ –ö–∏—Ä–∏–ª–ª–∞ –ü–µ—Å–∫–æ–≤–∞, ¬´–ò–ò –≤–Ω–µ–¥—Ä—è–µ—Ç—Å—è –≤ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫—É –æ—á–µ–Ω—å –∫–æ–Ω—Å–µ—Ä–≤–∞—Ç–∏–≤–Ω–æ, –Ω–æ –±–µ–∑ –∏–Ω—Ç–µ–≥—Ä–∞—Ü–∏–∏ —ç—Ç–∏—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –º—ã –±—É–¥–µ–º —É–ø–∏—Ä–∞—Ç—å—Å—è –≤ –Ω–∞—à —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–π –±–∞—Ä—å–µ—Ä, –∏ –±—É–¥–µ—Ç —Å–ª–æ–∂–Ω–æ —Ä–∞–∑—Ä–∞–±–∞—Ç—ã–≤–∞—Ç—å –Ω–æ–≤—ã–µ –±–æ–ª–µ–µ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã¬ª. üíä –¶–µ–Ω—ã –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –∏–∑ –ø–µ—Ä–µ—á–Ω—è –ñ–ù–í–õ–ü –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –∑–∞–º–æ—Ä–æ–∑–∏—Ç—å –¥–æ 2027 –≥–æ–¥–∞. –° –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–æ–π –≤—ã—Å—Ç—É–ø–∏–ª –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—å –ø–∞—Ä—Ç–∏–∏ ¬´–°–ø—Ä–∞–≤–µ–¥–ª–∏–≤–∞—è –†–æ—Å—Å–∏—è¬ª –°–µ—Ä–≥–µ–π –ú–∏—Ä–æ–Ω–æ–≤: –ò—Ö –ø–æ–∫—É–ø–∞—é—Ç –≤–µ—Ç–µ—Ä–∞–Ω—ã, —É—á–∞—Å—Ç–Ω–∏–∫–∏ —Å–ø–µ—Ü–æ–ø–µ—Ä–∞—Ü–∏–∏, –ø–µ–Ω—Å–∏–æ–Ω–µ—Ä—ã, –∏–Ω–≤–∞–ª–∏–¥—ã, –ª—é–¥–∏ —Å —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–∏–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏. –†–µ–∑–∫–æ–µ –ø–æ–≤—ã—à–µ–Ω–∏–µ —Ü–µ–Ω, –ø—É—Å—Ç—å –¥–∞–∂–µ –Ω–∞ –Ω–µ–±–æ–ª—å—à–æ–π –ø—Ä–æ—Ü–µ–Ω—Ç, –º–æ–∂–µ—Ç —É—Ö—É–¥—à–∏—Ç—å –∏—Ö —Ñ–∏–Ω–∞–Ω—Å–æ–≤–æ–µ –ø–æ–ª–æ–∂–µ–Ω–∏–µ, –ø—Ä–∏–≤–µ–¥–µ—Ç –∫ —Å–Ω–∏–∂–µ–Ω–∏—é –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç–∏ –ª–µ—á–µ–Ω–∏—è –∏ —É—Ö—É–¥—à–µ–Ω–∏—é –∑–¥–æ—Ä–æ–≤—å—è –≥—Ä–∞–∂–¥–∞–Ω. üíä –í –ì–æ—Å–¥—É–º—É –≤–Ω–µ—Å–ª–∏ –ø—Ä–æ–µ–∫—Ç –æ –ø—Ä–æ–¥–ª–µ–Ω–∏–∏ –≤–≤–æ–∑–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã—Ö —É–ø–∞–∫–æ–≤–∫–∞—Ö –¥–æ 31 –¥–µ–∫–∞–±—Ä—è 2027 –≥–æ–¥–∞. –í–≤–æ–∑ –±—É–¥–µ—Ç –≤–æ–∑–º–æ–∂–µ–Ω, –µ—Å–ª–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—Ç —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è–º, —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–Ω—ã–º –ø—Ä–∏ –∏—Ö —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏. –¢–∞–∫–∂–µ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ –Ω–∞–ª–∏—á–∏–µ —Å–∞–º–æ–∫–ª–µ—è—â–µ–π—Å—è —ç—Ç–∏–∫–µ—Ç–∫–∏ —Å –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–µ–π –Ω–∞ —Ä—É—Å—Å–∫–æ–º —è–∑—ã–∫–µ. üíä –ó–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω –ø–µ—Ä–≤—ã–π —Ä–æ—Å—Å–∏–π—Å–∫–∏–π –¥–∂–µ–Ω–µ—Ä–∏–∫ –¢—Ä–∞–Ω—Å–ª–∞—Ä–Ω—ã. –ö–∞–∫ –∏ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –æ—Ç PTC Therapeutics, –∞—Ç–∞–ª—É—Ä–µ–Ω –æ—Ç ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª –ø—Ä–µ–¥–Ω–∞–∑–Ω–∞—á–µ–Ω –¥–ª—è –ª–µ—á–µ–Ω–∏—è –º–∏–æ–¥–∏—Å—Ç—Ä–æ—Ñ–∏–∏ –î—é—à–µ–Ω–Ω–∞. –õ–µ–∫–∞—Ä—Å—Ç–≤–æ –±—É–¥–µ—Ç –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç—å—Å—è –≤ –†–æ—Å—Å–∏–∏ –ø–æ –ø–æ–ª–Ω–æ–º—É —Ü–∏–∫–ª—É –≤ –¥–æ–∑–∏—Ä–æ–≤–∫–∞—Ö 125, 250 –∏ 1 000 –º–≥. –¢—Ä–∞–Ω—Å–ª–∞—Ä–Ω–∞ –∑–∞—â–∏—â–µ–Ω–∞ –ø–∞—Ç–µ–Ω—Ç–æ–º –¥–æ –∞–ø—Ä–µ–ª—è 2029 –≥–æ–¥–∞. ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª –ø—ã—Ç–∞–µ—Ç—Å—è –¥–æ–±–∏—Ç—å—Å—è –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω–æ–π –ª–∏—Ü–µ–Ω–∑–∏–∏ –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç —Å –¥–µ–∫–∞–±—Ä—è –ø—Ä–æ—à–ª–æ–≥–æ –≥–æ–¥–∞. PTC Therapeutics –ø–æ–¥—á—ë—Ä–∫–∏–≤–∞–µ—Ç, —á—Ç–æ –æ–±–ª–∞–¥–∞–µ—Ç —Å—Ç–∞–±–∏–ª—å–Ω—ã–º–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã–º–∏ –º–æ—â–Ω–æ—Å—Ç—è–º–∏ –∏ –¥–æ—Å—Ç–∞—Ç–æ—á–Ω—ã–º –∑–∞–ø–∞—Å–æ–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ¬´–∫–∞–∫ —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ –¥–ª—è –†–æ—Å—Å–∏–∏, —Ç–∞–∫ –∏ –¥–ª—è –≤—Å–µ–≥–æ –º–∏—Ä–∞¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, import_export"",
  ""impact"": ""medium"",
  ""english"": ""A second draft of the 'Second Extra' for SGLS has been delayed. According to a government proposal, the start of the mechanism is postponed from January 1st to July 1st, 2026. The order and criteria for the formation of the SGLS list must be approved by March 24, 2026, and the list itself must be approved by June 10, 2026. Prices on drugs from the list of –ñ–ù–í–õ–ü are proposed to be frozen until 2027. The initiative was suggested by Sergey Mironov, chairman of the 'Just Russia' party: These drugs are purchased by veterans, participants in special operations, pensioners, disabled people with chronic diseases. A significant increase in prices, even by a small percentage, can worsen their financial situation and reduce the accessibility of treatment for citizens.""
}"
2025-11-28T16:04:24+00:00,@bezrec,6877,https://t.me/bezrec/6877,"–ü–æ–¥–≤–æ–¥–∏–º –∏—Ç–æ–≥–∏ –æ—á–µ—Ä–µ–¥–Ω–æ–≥–æ –≤—ã–ø—É—Å–∫–∞ —Ä—É–±—Ä–∏–∫–∏ #–∑–∞–ø–∞–∫–æ–≤–∞–ª–∏. –ù–∞ —ç—Ç–æ—Ç —Ä–∞–∑ –º—ã –æ–±—â–∏–º–∏ —É—Å–∏–ª–∏—è–º–∏ –≤—ã–±–∏—Ä–∞–ª–∏ –¥–∏–∑–∞–π–Ω —É–ø–∞–∫–æ–≤–∫–∏ –ø—Ä–æ—Ç–∏–≤–æ–∫–∞—à–ª–µ–≤—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤, –≤–æ—à–µ–¥—à–∏—Ö –≤ —Ç–æ–ø-5 –ø–æ –æ–±—ä—ë–º—É –¥–µ–Ω–µ–∂–Ω—ã—Ö –ø—Ä–æ–¥–∞–∂ –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º —Ä–æ–∑–Ω–∏—á–Ω–æ–º —Ñ–∞—Ä–º—Ä—ã–Ω–∫–µ –≤ —è–Ω–≤–∞—Ä–µ-–æ–∫—Ç—è–±—Ä–µ 2025 –≥–æ–¥–∞ –ø–æ –≤–µ—Ä—Å–∏–∏ RNC Pharma. –ü–æ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º –æ–ø—Ä–æ—Å–∞ –ø–æ–±–µ–¥–∏–ª –ö–æ–¥–µ–ª–∞–∫ –æ—Ç ¬´–û—Ç–∏—Å–∏—Ñ–∞—Ä–º¬ª. –í—Ç–æ—Ä–æ–µ –º–µ—Å—Ç–æ —Å –ø–µ—Ä–µ–≤–µ—Å–æ–º –≤—Å–µ–≥–æ –≤ 2% –∑–∞–Ω—è–ª –ë—Ä–æ–Ω—Ö–∏–ø—Ä–µ—Ç (¬´–ë–∏–æ–Ω–æ—Ä–∏–∫–∞¬ª), –Ω–∞ —Ç—Ä–µ—Ç—å–µ–π —Å—Ç—Ä–æ—á–∫–µ - –ì–µ—Ä–±–∏–æ–Ω (¬´–ö–†–ö–ê¬ª). –ú–µ–Ω—å—à–µ –≤—Å–µ–≥–æ –≥–æ–ª–æ—Å–æ–≤–∞–≤—à–∏–º –ø—Ä–∏–≥–ª—è–Ω—É–ª–∞—Å—å –ª–∞–∫–æ–Ω–∏—á–Ω–∞—è —É–ø–∞–∫–æ–≤–∫–∞ –†–µ–Ω–≥–∞–ª–∏–Ω–∞ (¬´–ú–∞—Ç–µ—Ä–∏–∞ –ú–µ–¥–∏–∫–∞¬ª). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-11-28T14:15:01+00:00,@bezrec,6876,https://t.me/bezrec/6876,"–ü–æ—Å—Ç –¥–ª—è –≤–∞—Å, –µ—Å–ª–∏ —Ç–æ–∂–µ —Å—á–∏—Ç–∞–µ—Ç–µ, —á—Ç–æ –≤ –†–æ—Å—Å–∏–∏ —Å –±–æ–ª—è–º–∏ –≤ —Å—É—Å—Ç–∞–≤–∞—Ö —Å—Ç–∞–ª–∫–∏–≤–∞–µ—Ç—Å—è –±–æ–ª—å—à–∞—è —á–∞—Å—Ç—å –≤–∑—Ä–æ—Å–ª–æ–≥–æ –Ω–∞—Å–µ–ª–µ–Ω–∏—è. –ü–æ–Ω—è—Ç–Ω–æ–µ –¥–µ–ª–æ, —á—Ç–æ –ø—Ä–æ–±–ª–µ–º—É –Ω—É–∂–Ω–æ —Ä–µ—à–∞—Ç—å –æ—Å–Ω–æ–≤–∞—Ç–µ–ª—å–Ω–æ! –≠—Ç–æ –æ—Å–æ–±–µ–Ω–Ω–æ –∞–∫—Ç—É–∞–ª—å–Ω–æ –ø—Ä–∏ –æ—Å—Ç—Ä—ã—Ö –∏ —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–∏—Ö –±–æ–ª—è—Ö, –∫–æ—Ç–æ—Ä—ã–µ –æ–π –∫–∞–∫ –º–µ—à–∞—é—Ç –Ω–æ—Ä–º–∞–ª—å–Ω–æ –∂–∏—Ç—å. –°–µ–π—á–∞—Å –Ω–∞ —Ä—ã–Ω–∫–µ –ø—Ä–∏–º–µ—Ä–Ω–æ —Ç–æ–Ω–Ω–∞ –º–∞–∑–µ–π —Å —Ä–∞–∑–Ω—ã–º –¥–µ–π—Å—Ç–≤–∏–µ–º –∏ —Å–æ—Å—Ç–∞–≤–æ–º. –û–¥–∏–Ω –∏–∑ —Ö–æ—Ä–æ—à–∏—Ö –≤–∞—Ä–∏–∞–Ω—Ç–æ–≤ ‚Äì –≥–µ–ª—å-–±–∞–ª—å–∑–∞–º ¬´–ù–∞–Ω–æ–ø–ª–∞—Å—Ç –ê—Ä—Ç—Ä–æ–≥–µ–Ω¬ª. –ì–ª–∞–≤–Ω—ã–µ –ø–ª—é—Å—ã: üíä –ù–∞—Ç—É—Ä–∞–ª—å–Ω—ã–π —Å–æ—Å—Ç–∞–≤. –ù–∞–ø—Ä–∏–º–µ—Ä, –±–∞—Ä—Ö–∞—Ç –∞–º—É—Ä—Å–∫–∏–π –æ–±–ª–∞–¥–∞–µ—Ç –∞–Ω—Ç–∏—Å–µ–ø—Ç–∏—á–µ—Å–∫–∏–º–∏ —Å–≤–æ–π—Å—Ç–≤–∞–º–∏, –∑–µ–ª–µ–Ω–æ—Ü–≤–µ—Ç —è–ø–æ–Ω—Å–∫–∏–π —è–≤–ª—è–µ—Ç—Å—è —Ö–æ—Ä–æ—à–∏–º –∞–Ω—Ç–∏–æ–∫—Å–∏–¥–∞–Ω—Ç–æ–º, –∞ –¥—É–±–∏–ª—å–Ω—ã–µ –≤–µ—â–µ—Å—Ç–≤–∞ –≤ –∞–∫–∞—Ü–∏–∏ –∫–∞—Ç–µ—Ö—É –ø–æ–º–æ–≥–∞—é—Ç —Å–Ω—è—Ç—å –Ω–∞–ø—Ä—è–∂–µ–Ω–∏–µ –∏ —Ä–∞—Å—Å–ª–∞–±–∏—Ç—å –º—ã—à—Ü—ã. üíä –ë—ã—Å—Ç—Ä–æ–µ –¥–µ–π—Å—Ç–≤–∏–µ. –ü—Ä–æ–Ω–∏–∫–∞–µ—Ç –≤–≥–ª—É–±—å —Ç–∫–∞–Ω–µ–π –∏ –Ω–∞–ø—Ä—è–º—É—é –≤–æ–∑–¥–µ–π—Å—Ç–≤—É–µ—Ç –Ω–∞ –∏—Å—Ç–æ—á–Ω–∏–∫ –±–æ–ª–∏. –ü–æ—Å–ª–µ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è —Å–Ω–∏–∂–∞–µ—Ç—Å—è –¥–∏—Å–∫–æ–º—Ñ–æ—Ä—Ç, –≤ –º—ã—à—Ü–∞—Ö –∏ —Å—É—Å—Ç–∞–≤–∞—Ö –æ—â—É—â–∞–µ—Ç—Å—è –ª—ë–≥–∫–æ—Å—Ç—å. üíä –ù–µ –≤—ã–∑—ã–≤–∞–µ—Ç –ø—Ä–∏–≤—ã–∫–∞–Ω–∏—è. –õ—é–¥–∏ –º–æ–≥—É—Ç —Å–ø–æ–∫–æ–π–Ω–æ –ø–æ–ª—å–∑–æ–≤–∞—Ç—å—Å—è –Ω–µ—Å–∫–æ–ª—å–∫–æ –Ω–µ–¥–µ–ª—å, –≤—Ç–∏—Ä–∞—è –ø–æ —á–µ—Ç—ã—Ä–µ —Ä–∞–∑–∞ –≤ –¥–µ–Ω—å, —Å–¥–µ–ª–∞—Ç—å –ø–µ—Ä–µ—Ä—ã–≤ –∏ –ø–æ—Ç–æ–º –ø–æ–≤—Ç–æ—Ä–∏—Ç—å –∫—É—Ä—Å*. –ü–æ–¥—Ä–æ–±–Ω–µ–µ –æ –ø—Ä–æ–¥—É–∫—Ç–µ –º–æ–∂–Ω–æ —É–∑–Ω–∞—Ç—å –Ω–∞ —Å–∞–π—Ç–µ üîó * –ò–º–µ—é—Ç—Å—è –ø—Ä–æ—Ç–∏–≤–æ–ø–æ–∫–∞–∑–∞–Ω–∏—è, –ø–µ—Ä–µ–¥ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ –∏–∑—É—á–∏—Ç—å –∏–Ω—Å—Ç—Ä—É–∫—Ü–∏—é –∏ –ø—Ä–æ–∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä–æ–≤–∞—Ç—å—Å—è —Å–æ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–º. #–†–µ–∫–ª–∞–º–∞. –†–µ–∫–ª–∞–º–æ–¥–∞—Ç–µ–ª—å –û–û–û ¬´–ù–ê–ù–û–¢–ï–ö –§–ê–†–ú–ê¬ª. –ò–ù–ù 7736584502. erid: 2W5zFHqC6t8","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""There is a widespread issue of joint pain in adult population in Russia. The product 'Nanoplast Arthrogen' gel-balm is highlighted as a good option. It has natural ingredients like barhauta kumar, zelencolor japonicus, and kaatuchatu for antiseptic and antioxidant properties. It provides quick relief with no addictive effects.""
}"
2025-11-28T12:05:29+00:00,@bezrec,6875,https://t.me/bezrec/6875,"–¢–∞–∫–∏–º–∏ –¥–∞–Ω–Ω—ã–º–∏ –ø–æ–¥–µ–ª–∏–ª–∞—Å—å –ø–ª–æ—â–∞–¥–∫–∞ –ø–æ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—é —ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω—ã—Ö —Ç–æ—Ä–≥–æ–≤ ¬´–†–¢–°-—Ç–µ–Ω–¥–µ—Ä¬ª. –° —è–Ω–≤–∞—Ä—è –ø–æ –æ–∫—Ç—è–±—Ä—å 2025 –≥–æ–¥–∞ –ø—Ä–æ–≤–µ–¥–µ–Ω–æ –æ–∫–æ–ª–æ 320 —Ç—ã—Å. —Ç–µ–Ω–¥–µ—Ä–æ–≤ –Ω–∞ –∑–∞–∫—É–ø–∫—É –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –º–∞—Ç–µ—Ä–∏–∞–ª–æ–≤ –Ω–∞ 764 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –≠—Ç–æ —Å–∞–º–æ–µ –∑–∞–º–µ—Ç–Ω–æ–µ —Å–Ω–∏–∂–µ–Ω–∏–µ —Å—Ä–µ–¥–∏ –≥–æ—Å–∑–∞–∫—É–ø–æ–∫ –≤ –º–µ–¥–∏—Ü–∏–Ω–µ. –¢–µ–Ω–¥–µ–Ω—Ü–∏—é –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–∞—é—Ç –∏ –∞–Ω–∞–ª–∏—Ç–∏–∫–∏ Headway Company, –ø–∏—à–µ—Ç ¬´–™¬ª. –ü–æ –∏—Ö –¥–∞–Ω–Ω—ã–º, –∑–∞ –¥–µ–≤—è—Ç—å –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ —Å–Ω–∏–∂–µ–Ω–∏–µ —Å–æ—Å—Ç–∞–≤–∏–ª–æ 15% (278,5 —Ç—ã—Å. –∞—É–∫—Ü–∏–æ–Ω–æ–≤ –Ω–∞ 694,1 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π). –ó–∞—Ç–æ —á–∏—Å–ª–æ —É–∂–µ –∏—Å–ø–æ–ª–Ω–µ–Ω–Ω—ã—Ö –∫–æ–Ω—Ç—Ä–∞–∫—Ç–æ–≤ –≤—ã—Ä–æ—Å–ª–æ –Ω–∞ 17%. –í –ª–∏–¥–µ—Ä–∞—Ö –ø–æ –≥–æ—Å–∑–∞–∫—É–ø–∫–∞–º –ª–µ–∫–∞—Ä—Å—Ç–≤ ‚Äî –ú–æ—Å–∫–≤–∞ ‚Äî –Ω–∞ —Å—Ç–æ–ª–∏—Ü—É –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –ø–æ—á—Ç–∏ 28% –æ—Ç –æ–±—â–µ–≥–æ –æ–±—ä—ë–º–∞ (29,4 —Ç—ã—Å. —Ç–µ–Ω–¥–µ—Ä–æ–≤ –Ω–∞ 212,5 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π). –î–∞–ª–µ–µ —Å–ª–µ–¥—É—é—Ç –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥ (42,9 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π), –ú–æ—Å–∫–æ–≤—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å (31,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π), –ö—Ä–∞—Å–Ω–æ—è—Ä—Å–∫–∏–π –∫—Ä–∞–π (20,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π) –∏ –†–æ—Å—Ç–æ–≤—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å (17,8 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π). –°–∞–º–∞—è –≤–Ω—É—à–∏—Ç–µ–ª—å–Ω–∞—è –¥–∏–Ω–∞–º–∏–∫–∞ –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–Ω–∞ –ø–æ –∑–∞–∫—É–ø–∫–∞–º —É—Å–ª—É–≥ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–∏–π. –ù–∞–∏–±–æ–ª–µ–µ –ø–æ–ø—É–ª—è—Ä–Ω–∞ —É –≥–æ—Å—É—á—Ä–µ–∂–¥–µ–Ω–∏–π –∏ –∫–æ–º–ø–∞–Ω–∏–π —Å –≥–æ—Å—É—á–∞—Å—Ç–∏–µ–º ‚Äî –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏—è —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤. –í —Ü–µ–ª–æ–º –ø—Ä–æ–≥–Ω–æ–∑—ã —É ¬´–†–¢–°-—Ç–µ–Ω–¥–µ—Ä–∞¬ª –æ–ø—Ç–∏–º–∏—Å—Ç–∏—á–Ω—ã–µ ‚Äî –∑–∞ —Å—á—ë—Ç –Ω–æ—è–±—Ä—å—Å–∫–∏—Ö –∏ –¥–µ–∫–∞–±—Ä—å—Å–∫–∏—Ö —Ç–µ–Ω–¥–µ—Ä–æ–≤ –æ–±—â–∏–π –æ–±—ä—ë–º –≥–æ—Å–∑–∞–∫—É–ø–æ–∫ –≤ –æ—Ç—Ä–∞—Å–ª–∏ –ø–æ –∏—Ç–æ–≥–∞–º 2025 –≥–æ–¥–∞ –º–æ–∂–µ—Ç –ø—Ä–µ–≤—ã—Å–∏—Ç—å –ø—Ä–æ—à–ª–æ–≥–æ–¥–Ω–∏–µ —Ü–∏—Ñ—Ä—ã –∏ –¥–æ—Å—Ç–∏–≥–Ω—É—Ç—å 1,8 —Ç—Ä–ª–Ω —Ä—É–±–ª–µ–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The platform RTS-tender reported that about 320,000 tenders for drug and material purchases were conducted from January to October 2025, amounting to RUB764 billion. This is the most significant decrease compared to healthcare procurement. Headway Company analysts reported a 15% reduction (278,500 tenders for RUB694.1 billion) in the first nine months of 2025, with contract fulfillment increasing by 17%. The capital city Moscow accounts for nearly 28% of the total volume (29,400 tenders for RUB212.5 billion). The most significant trend is in the procurement of medical laboratory services. Most purchases are made by government entities and companies with state ownership, for vaccination purposes. Overall, the RTS-tender forecasts are optimistic - the total procurement volume in the sector for 2025, including November and December tenders, may exceed last year's figures to reach RUB1.8 trillion"
2025-11-28T09:05:28+00:00,@bezrec,6874,https://t.me/bezrec/6874,"–ê–Ω–∞–ª–∏—Ç–∏–∫–∏ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∏ —Ä–µ–π—Ç–∏–Ω–≥ —Å–∞–º—ã—Ö –±—ã—Å—Ç—Ä–æ—Ä–∞—Å—Ç—É—â–∏—Ö —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π. –ü–æ –¥–∞–Ω–Ω—ã–º RNC Pharma, —Å —è–Ω–≤–∞—Ä—è –ø–æ –æ–∫—Ç—è–±—Ä—å 2025 –≥–æ–¥–∞ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏, –ª–æ–∫–∞–ª–∏–∑–æ–≤–∞–Ω–Ω—ã–µ –≤ –†–æ—Å—Å–∏–∏, –≤—ã–ø—É—Å—Ç–∏–ª–∏ –≤ –æ–±—Ä–∞—â–µ–Ω–∏–µ –±–æ–ª–µ–µ 3,2 –º–ª—Ä–¥ —É–ø–∞–∫–æ–≤–æ–∫ –≥–æ—Ç–æ–≤—ã—Ö –õ–ü. –≠—Ç–æ –Ω–∞ 4% –º–µ–Ω—å—à–µ, —á–µ–º –≤ –ø—Ä–æ—à–ª–æ–º –≥–æ–¥—É. –í –¥–µ–Ω—å–≥–∞—Ö –æ–±—ä—ë–º –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –≤—ã—Ä–æ—Å –Ω–∞ 17% –≥–æ–¥ –∫ –≥–æ–¥—É, –¥–æ 809,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ú–∞–∫—Å–∏–º–∞–ª—å–Ω–æ–π –¥–∏–Ω–∞–º–∏–∫–æ–π –∑–∞ –≥–æ–¥ –æ—Ç–ª–∏—á–∏–ª—Å—è ¬´–ù–ò–ò –ú–µ–¥–∏—Ü–∏–Ω—ã –∏ –°—Ç–∞–Ω–¥–∞—Ä—Ç–∏–∑–∞—Ü–∏–∏¬ª, –Ω–∞—Ä–∞—Å—Ç–∏–≤—à–∏–π –≤—ã–ø—É—Å–∫ –≤ 8,5 —Ä–∞–∑ (–¥–æ 754%). –í –ø–æ—Ä—Ç—Ñ–µ–ª–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è –≤ –æ—Å–Ω–æ–≤–Ω–æ–º —Ä–∞–∑–ª–∏—á–Ω—ã–µ —Å–ø–∏—Ä—Ç–æ—Å–æ–¥–µ—Ä–∂–∞—â–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã. –¢–æ–ø-–±—Ä–µ–Ω–¥ ‚Äî –ú—É—Ä–∞–≤—å–∏–Ω–∞—è –∫–∏—Å–ª–æ—Ç–∞. –ù–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ —Å –∫—É–¥–∞ –±–æ–ª–µ–µ —Å–∫—Ä–æ–º–Ω—ã–º–∏ 50% ‚Äî ¬´–ñ–µ–Ω–µ–ª¬ª. –í –æ—Å–Ω–æ–≤–Ω–æ–º —Ä–µ–∑—É–ª—å—Ç–∞—Ç –∫–æ–º–ø–∞–Ω–∏–∏ ¬´—Å–¥–µ–ª–∞–ª–∏¬ª –∞–Ω—Ç–∏—Å–µ–ø—Ç–∏–∫–∏. –ó–∞—Ç–µ—Å–∞–ª—Å—è –≤ —Ç—Ä–æ–π–∫—É –ª–∏–¥–µ—Ä–æ–≤ –∏ –∏–Ω–æ—Å—Ç—Ä–∞–Ω–µ—Ü ‚Äî –Ω–∞ —Ç—Ä–µ—Ç—å–µ–π —Å—Ç—Ä–æ—á–∫–µ –±—Ä–∏—Ç–∞–Ω–æ-—à–≤–µ–¥—Å–∫–∞—è ¬´–ê—Å—Ç—Ä–∞–ó–µ–Ω–µ–∫–∞¬ª —Å –¥–∏–Ω–∞–º–∏–∫–æ–π +42% –∏ –§–æ—Ä—Å–∏–≥–æ–π –≤ –∫–∞—á–µ—Å—Ç–≤–µ –ª–∏–¥–∏—Ä—É—é—â–µ–π —Ç–æ—Ä–≥–æ–≤–æ–π –º–∞—Ä–∫–∏ (+73%). –¢–∞–∫–∂–µ –Ω–µ –ø–æ–¥–≤—ë–ª —Å–≤–æ–µ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è –ù–µ–∫—Å–∏—É–º, –ø–æ–∫–∞–∑–∞–≤—à–∏–π —Ä–æ—Å—Ç –≤ 14,5 —Ä–∞–∑. –ï—â—ë –æ–¥–Ω–∞ –∑–∞—Ä—É–±–µ–∂–Ω–∞—è —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—è –≤ —Ä–µ–π—Ç–∏–Ω–≥–µ ‚Äî ¬´–ú–µ–Ω–∞—Ä–∏–Ω–∏¬ª. –í —Ç–æ–ø-10 –±—ã—Å—Ç—Ä–æ—Ä–∞—Å—Ç—É—â–∏—Ö —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π —Ç–∞–∫–∂–µ –≤–æ—à–ª–∏: ¬´–ü—Ä–∞–Ω–∞—Ñ–∞—Ä–º¬ª, ¬´–§–∞—Ä–º–∞—Å–æ—Ñ—Ç¬ª, ¬´–Æ–∂—Ñ–∞—Ä–º¬ª, ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª, ¬´–í–µ–ª—Ñ–∞—Ä–º –ì—Ä—É–ø–ø¬ª, ¬´–¢—É–ª—å—Å–∫–∞—è –§–∞—Ä–º—Ñ–∞–±—Ä–∏–∫–∞¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-11-28T05:56:23+00:00,@bezrec,6873,https://t.me/bezrec/6873,"–°—Ç–∞–ª–æ –∏–∑–≤–µ—Å—Ç–Ω–æ, —Å–∫–æ–ª—å–∫–æ —Å—Ç–æ–∏—Ç –≤–∞–∫—Ü–∏–Ω–∞ –æ—Ç —Ä–∞–∫–∞ –º–æ—á–µ–≤–æ–≥–æ –ø—É–∑—ã—Ä—è. –ü–æ –¥–∞–Ω–Ω—ã–º –∏–∑ –ì–†–õ–°, —Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–Ω–Ω–∞—è –ø—Ä–µ–¥–µ–ª—å–Ω–∞—è —Å—Ç–æ–∏–º–æ—Å—Ç—å –ò–º—É—Ä–æ–Ω-–≤–∞–∫ –≤ –†–§ —Å–æ—Å—Ç–∞–≤–ª—è–µ—Ç 2 179,25 —Ä—É–±–ª–µ–π –∑–∞ —É–ø–∞–∫–æ–≤–∫—É. –ë–¶–ñ –≤–∞–∫—Ü–∏–Ω–∞, —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–Ω–∞—è –≤ –¶–µ–Ω—Ç—Ä–µ –∏–º. –ì–∞–º–∞–ª–µ–∏, –ø—Ä–µ–¥–Ω–∞–∑–Ω–∞—á–µ–Ω–∞ –¥–ª—è –∏–º–º—É–Ω–æ—Ç–µ—Ä–∞–ø–∏–∏ –ø–æ–≤–µ—Ä—Ö–Ω–æ—Å—Ç–Ω–æ–≥–æ —Ä–∞–∫–∞ –º–æ—á–µ–≤–æ–≥–æ –ø—É–∑—ã—Ä—è –∏–ª–∏ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –µ–≥–æ —Ä–µ—Ü–∏–¥–∏–≤–æ–≤ –ø–æ—Å–ª–µ —É–¥–∞–ª–µ–Ω–∏—è –æ–ø—É—Ö–æ–ª–µ–π. –í –∞–≤–≥—É—Å—Ç–µ –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ì–∏–Ω—Ü–±—É—Ä–≥ –Ω–µ —Ç–æ–ª—å–∫–æ –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª —Ñ–∞–∫—Ç —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞, –Ω–æ –∏ —Å–æ–æ–±—â–∏–ª, —á—Ç–æ –≤–∞–∫—Ü–∏–Ω–∞ —É–∂–µ ¬´–ø–æ–ª—å–∑—É–µ—Ç—Å—è –±–æ–ª—å—à–∏–º —Å–ø—Ä–æ—Å–æ–º¬ª –∏ –ø–æ—Å—Ç–∞–≤–ª—è–µ—Ç—Å—è —Ç–∞–∫–∂–µ –≤ —Å—Ç—Ä–∞–Ω—ã –°–ù–ì. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""The price of Imuron-vac, a vaccine against bladder cancer developed by the Gamaleya Research Institute, has been fixed at 2179.25 rubles per vial by the GRLS. The vaccine is used for immunotherapy of superficial bladder cancer or prevention of its recurrence after tumor removal. In August, Alexander Ginzburg confirmed the registration of the vaccine and noted its 'high demand' and supply to countries in the region.""
}"
2025-11-27T14:46:58+00:00,@bezrec,6872,https://t.me/bezrec/6872,"–ö–ò –æ–±–µ–∑–±–æ–ª–∏–≤–∞—é—â–µ–≥–æ –∏–∑ –∞–Ω–µ–º–æ–Ω –Ω–∞—á–Ω—É—Ç—Å—è –≤ 2027 –≥–æ–¥—É. –°–æ–≤–º–µ—Å—Ç–Ω–∞—è —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∞ —É—á–µ–Ω—ã—Ö –î–∞–ª—å–Ω–µ–≤–æ—Å—Ç–æ—á–Ω–æ–≥–æ –æ—Ç–¥–µ–ª–µ–Ω–∏—è –†–ê–ù –∏ –ü–µ—Ä–µ–¥–æ–≤–æ–π –∏–Ω–∂–µ–Ω–µ—Ä–Ω–æ–π —à–∫–æ–ª—ã –î–∞–ª—å–Ω–µ–≤–æ—Å—Ç–æ—á–Ω–æ–≥–æ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ —É—Å–ø–µ—à–Ω–æ –ø—Ä–æ—à–ª–∞ –¥–æ–∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –∏ –≥–æ—Ç–æ–≤–∞ –∫ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–º –∏—Å–ø—ã—Ç–∞–Ω–∏—è–º. –í—ã–ø—É—Å–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –º–æ–∂–µ—Ç –Ω–∞—á–∞—Ç—å—Å—è –ø—Ä–∏–º–µ—Ä–Ω–æ —á–µ—Ä–µ–∑ –ø—è—Ç—å –ª–µ—Ç. –ú—ã —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª–∏ –±–∏–æ–∏–Ω–∂–µ–Ω–µ—Ä–Ω—É—é —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—é –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –Ω–µ –∏–º–µ—é—â–µ–≥–æ –∞–Ω–∞–ª–æ–≥–∞ –≤ –º–∏—Ä–µ –Ω–µ–æ–ø–∏–æ–∏–¥–Ω–æ–≥–æ –ø–µ–ø—Ç–∏–¥–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞, –∫–æ—Ç–æ—Ä—ã–π –≤–æ–∑–¥–µ–π—Å—Ç–≤—É–µ—Ç –Ω–∞ –º–∏—à–µ–Ω–∏ –¶–ù–°, –æ—Ç–≤–µ—á–∞—é—â–∏–µ –∑–∞ –±–æ–ª—å. –†–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –ø–µ–ø—Ç–∏–¥–Ω—ã—Ö —Ñ–æ—Ä–º –Ω–µ–æ–ø–∏–æ–∏–¥–Ω—ã—Ö –æ–±–µ–∑–±–æ–ª–∏–≤–∞—é—â–∏—Ö –≤–µ–¥—É—Ç—Å—è –≤ –Ω–µ—Å–∫–æ–ª—å–∫–∏—Ö —Å—Ç—Ä–∞–Ω–∞—Ö, –Ω–æ –º—ã –¥–æ—Å—Ç–∏–≥–ª–∏ –≤—ã—Å–æ–∫–æ–≥–æ —É—Ä–æ–≤–Ω—è, –∑–∞–≤–µ—Ä—à–∏–≤ –≤ —ç—Ç–æ–º –≥–æ–¥—É –¥–æ–∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ –∏—Å–ø—ã—Ç–∞–Ω–∏—è, –∫–æ—Ç–æ—Ä—ã–µ –ø–æ–ª–Ω–æ—Å—Ç—å—é –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª–∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –∏ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –Ω–æ–≤–æ–≥–æ –∞–Ω–∞–ª—å–≥–µ—Ç–∏–∫–∞, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–∏. –£–Ω–∏–∫–∞–ª—å–Ω–æ—Å—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –≤ —Ç–æ–º, —á—Ç–æ —ç—Ç–æ –ø–µ—Ä–≤—ã–π –∏ –ø–æ–∫–∞ –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–π –±–ª–æ–∫–∞—Ç–æ—Ä –±–æ–ª–µ–≤–æ–≥–æ –∫–∞–Ω–∞–ª–∞, –Ω–µ –≤—ã–∑—ã–≤–∞—é—â–∏–π –ø—Ä–∏–≤—ã–∫–∞–Ω–∏—è. –ú–æ–ª–µ–∫—É–ª–∞ –±—ã–ª–∞ –Ω–∞–π–¥–µ–Ω–∞ –≤ 2016 –≥–æ–¥—É –≤ –º–æ—Ä—Å–∫–æ–π –∞–Ω–µ–º–æ–Ω–µ –∏ —Å–µ–≥–æ–¥–Ω—è –ø–æ–ª–Ω–æ—Å—Ç—å—é –≤–æ—Å–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç—Å—è —Å –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç–æ–≤ –≥–µ–Ω–Ω–æ–π –∏–Ω–∂–µ–Ω–µ—Ä–∏–∏. –¢–∞–∫ —á—Ç–æ –æ–±–∏—Ç–∞—Ç–µ–ª–∏ –º–æ—Ä—Å–∫–∏—Ö –≥–ª—É–±–∏–Ω –≤–æ –±–ª–∞–≥–æ –æ–±–µ–∑–±–æ–ª–∏–≤–∞–Ω–∏—è –Ω–µ –ø–æ—Å—Ç—Ä–∞–¥–∞—é—Ç. –ü—Ä–æ–º—ã—à–ª–µ–Ω–Ω—ã–π –≤—ã–ø—É—Å–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç –≤–∑—è—Ç—å –Ω–∞ —Å–µ–±—è –∫—Ä—É–ø–Ω–∞—è —Ä–æ—Å—Å–∏–π—Å–∫–∞—è —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∞—è –∫–æ–º–ø–∞–Ω–∏—è, –∫–æ—Ç–æ—Ä–∞—è —É–∂–µ –ø—Ä–∏—Å–æ–µ–¥–∏–Ω–∏–ª–∞—Å—å –∫ –ø—Ä–æ–µ–∫—Ç—É. –ü–ª–æ—â–∞–¥–∫–æ–π –±—É–¥—É—â–µ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –º–æ–∂–µ—Ç —Å—Ç–∞—Ç—å –ò–ù–¢–¶ ¬´–†—É—Å—Å–∫–∏–π¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": true,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,hospital_policy,pharmacovigilance,safety"",
  ""impact"": ""medium"",
  ""english"": ""Clinical trials for the pain reliever developed by researchers from Far Eastern Branch of RAS and Far Eastern Federal University are underway. The project, which has successfully completed preclinical studies, is ready for clinical trials and could start production in about five years. The team has developed a bioengineering technology to produce an opioid peptide drug that does not cause tolerance and is unique. The molecule was discovered in the sea anemone in 2016, and it is now fully reproduced using genetic engineering tools. A large Russian pharmaceutical company has joined the project to produce the drug, which could be produced at the INTRC 'Russian' facility.""
}"
2025-11-27T11:30:55+00:00,@bezrec,6870,https://t.me/bezrec/6870,"–ì–µ—Ä–æ–∏ —Å–µ–≥–æ–¥–Ω—è—à–Ω–µ–≥–æ –≤—ã–ø—É—Å–∫–∞ –Ω–∞—à–µ–π —Ä—É–±—Ä–∏–∫–∏ #–∑–∞–ø–∞–∫–æ–≤–∞–ª–∏ ‚Äì –ø—Ä–æ—Ç–∏–≤–æ–∫–∞—à–ª–µ–≤—ã–µ —Å—Ä–µ–¥—Å—Ç–≤–∞, –≤–æ—à–µ–¥—à–∏–µ –≤ —Ç–æ–ø-5 –ø–æ –æ–±—ä—ë–º—É –¥–µ–Ω–µ–∂–Ω—ã—Ö –ø—Ä–æ–¥–∞–∂ –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º —Ä–æ–∑–Ω–∏—á–Ω–æ–º —Ñ–∞—Ä–º—Ä—ã–Ω–∫–µ –≤ —è–Ω–≤–∞—Ä–µ-–æ–∫—Ç—è–±—Ä–µ 2025 –≥–æ–¥–∞ –ø–æ –≤–µ—Ä—Å–∏–∏ RNC Pharma. –ü—Ä–æ—Å–∏–º –≤ –æ–ø—Ä–æ—Å–µ –≤—ã–±—Ä–∞—Ç—å –æ–¥–∏–Ω –∏–∑ –ø—è—Ç–∏ –≤–∞—Ä–∏–∞–Ω—Ç–æ–≤, –∏—Å—Ö–æ–¥—è –∏—Å–∫–ª—é—á–∏—Ç–µ–ª—å–Ω–æ –∏–∑ –¥–∏–∑–∞–π–Ω–∞ —É–ø–∞–∫–æ–≤–∫–∏: 1. –†–µ–Ω–≥–∞–ª–∏–Ω (¬´–ú–∞—Ç–µ—Ä–∏–∞ –ú–µ–¥–∏–∫–∞¬ª); 2. –ì–µ—Ä–±–∏–æ–Ω (¬´–ö–†–ö–ê¬ª); 3. –ö–æ–¥–µ–ª–∞–∫ (¬´–û—Ç–∏—Å–∏—Ñ–∞—Ä–º¬ª); 3. –°–∏–Ω–µ–∫–æ–¥ (¬´–ì–°–ö¬ª); 5. –ë—Ä–æ–Ω—Ö–∏–ø—Ä–µ—Ç (¬´–ë–∏–æ–Ω–æ—Ä–∏–∫–∞¬ª). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""We are featuring today's edition of our #packaging series, which includes cough suppressants that made the top 5 in terms of monetary sales on Russia's retail pharmaceutical market from January to October 2025, according to RNC Pharma. We invite you to vote for one of the five options based solely on the packaging design: 1. Rengalin (¬´Mat√©ria MedicƒÉ¬ª); 2. Gerbiun (¬´KRCA¬ª); 3. Kodelak (¬´Otisifarma¬ª); 4. Sinekod (¬´GSK¬ª); 5. Bronchipret (¬´Bionorica¬ª). ‚Ñ¢No prescription required.""
}"
2025-11-27T09:01:54+00:00,@bezrec,6869,https://t.me/bezrec/6869,"–ú–¢–° –∏ Rubbles –ø–æ–º–æ–≥—É—Ç —Ñ–∞—Ä–º–µ —Ä–∞–∑–≤–∏–≤–∞—Ç—å—Å—è –∏ –∑–∞—Ä–∞–±–∞—Ç—ã–≤–∞—Ç—å. –ü–µ—Ä–µ–¥–æ–≤—ã–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏, –≤ —á–∞—Å—Ç–Ω–æ—Å—Ç–∏ –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω—ã–π –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç, –∞–∫—Ç–∏–≤–Ω–æ –ø—Ä–æ–Ω–∏–∫–∞—é—Ç –≤–æ –≤—Å–µ —Å—Ñ–µ—Ä—ã –∏ —É–∂–µ —Å–µ–π—á–∞—Å —Ç—Ä–∞–Ω—Å—Ñ–æ—Ä–º–∏—Ä—É—é—Ç —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª—å, –ø–æ–º–æ–≥–∞—è –æ–ø—Ç–∏–º–∏–∑–∏—Ä–æ–≤–∞—Ç—å –ø—Ä–æ—Ü–µ—Å—Å—ã, –∞–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞—Ç—å –¥–∞–Ω–Ω—ã–µ, –ø—Ä–µ–¥—Å–∫–∞–∑—ã–≤–∞—Ç—å —Ä–∏—Å–∫–∏ –∏ —É–ø—Ä–æ—â–∞—Ç—å –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω–æ–µ –ø–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω–∏–µ. –ú–¢–° –∏ Rubbles –∑–∞–ø—É—Å–∫–∞—é—Ç –∏–Ω–¥—É—Å—Ç—Ä–∏–∞–ª—å–Ω—ã–π –ø–æ—Ä—Ç—Ñ–µ–ª—å –∏–∑ —Ç—Ä—ë—Ö –ò–ò-–ø—Ä–æ–¥—É–∫—Ç–æ–≤ –¥–ª—è —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∏, —Ä–∏—Ç–µ–π–ª–∞, –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –∏ –¥—Ä—É–≥–∏—Ö –æ—Ç—Ä–∞—Å–ª–µ–π. üü© –ù–æ–≤–∞—è CVM-–ø–ª–∞—Ç—Ñ–æ—Ä–º–∞ –ø–æ–º–æ–∂–µ—Ç —Å–æ–∑–¥–∞–≤–∞—Ç—å –∏ –æ–ø—Ç–∏–º–∏–∑–∏—Ä–æ–≤–∞—Ç—å –∑–∞–ø—É—Å–∫ –º–∞—Ä–∫–µ—Ç–∏–Ω–≥–æ–≤—ã—Ö –∫–∞–º–ø–∞–Ω–∏–π –Ω–∞ –æ—Å–Ω–æ–≤–µ –¥–∞–Ω–Ω—ã—Ö –≤ —Ä–µ–∞–ª—å–Ω–æ–º –≤—Ä–µ–º–µ–Ω–∏, –æ–±–µ—Å–ø–µ—á–∏–≤–∞—è –±–æ–ª–µ–µ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ–µ –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏–µ —Å –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª—è–º–∏. –í —Ä–µ–∑—É–ª—å—Ç–∞—Ç–µ - —Ä–æ—Å—Ç –ø—Ä–æ–¥–∞–∂ –≤ —Å—Ä–µ–¥–Ω–µ–º –¥–æ 15% –∏ —É–≤–µ–ª–∏—á–µ–Ω–∏–µ –∫–æ–Ω–≤–µ—Ä—Å–∏–∏ –¥–æ 75%. –ü—Ä–∏ —ç—Ç–æ–º –ø–ª–∞—Ç—Ñ–æ—Ä–º–∞ –≥–∞—Ä–∞–Ω—Ç–∏—Ä—É–µ—Ç —Å–æ—Ö—Ä–∞–Ω–Ω–æ—Å—Ç—å –¥–∞–Ω–Ω—ã—Ö –±–ª–∞–≥–æ–¥–∞—Ä—è —Ä–∞–±–æ—Ç–µ —á–µ—Ä–µ–∑ –∫–æ—Ä–ø–æ—Ä–∞—Ç–∏–≤–Ω–æ–µ —Ö—Ä–∞–Ω–∏–ª–∏—â–µ –∫–ª–∏–µ–Ω—Ç–∞ –±–µ–∑ –¥—É–±–ª–∏—Ä–æ–≤–∞–Ω–∏–π –Ω–∞ –≤–Ω–µ—à–Ω–∏–µ —Å–µ—Ä–≤–µ—Ä—ã. üü© –°–µ—Ä–≤–∏—Å Rubbles Planning Force –Ω–∞ –æ—Å–Ω–æ–≤–µ –∞–Ω–∞–ª–∏–∑–∞ –¥–∞–Ω–Ω—ã—Ö –∏ –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–∞ —Å–ø—Ä–æ–≥–Ω–æ–∑–∏—Ä—É–µ—Ç —Å–ø—Ä–æ—Å, –æ–ø—Ç–∏–º–∏–∑–∏—Ä—É–µ—Ç –∞–∫—Ü–∏–∏ –∏ —Ü–µ–Ω–æ–æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ, –∞ —Ç–∞–∫–∂–µ —É–ø—Ä–æ—Å—Ç–∏—Ç –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω–æ–µ –ø–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω–∏–µ, –æ–±–µ—â–∞—è —Ä–æ—Å—Ç –≤–∞–ª–æ–≤–æ–π –ø—Ä–∏–±—ã–ª–∏ –Ω–∞ 1-2%. üü© –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –ú–¢–° –∏ Rubbles –≥–æ—Ç–æ–≤—ã –≤ –∏–Ω–¥–∏–≤–∏–¥—É–∞–ª—å–Ω–æ–º –ø–æ—Ä—è–¥–∫–µ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞—Ç—å –∞–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–∏–µ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏—è, –∞–¥–∞–ø—Ç–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –ø–æ–¥ –∫–æ–Ω–∫—Ä–µ—Ç–Ω—ã–µ –∑–∞–¥–∞—á–∏, –≤–∫–ª—é—á–∞—è —Å–æ–∑–¥–∞–Ω–∏–µ —Ü–∏—Ñ—Ä–æ–≤—ã—Ö –¥–≤–æ–π–Ω–∏–∫–æ–≤ –∏ —Å–∏—Å—Ç–µ–º-–ø–æ–¥—Å–∫–∞–∑—á–∏–∫–æ–≤. –≠—Ç–æ –ø–æ–º–æ–∂–µ—Ç —Å–Ω–∏–∑–∏—Ç—å –ø—Ä–æ—Å—Ç–æ–∏ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è, —É–≤–µ–ª–∏—á–∏—Ç—å –æ–±—ä–µ–º—ã –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –∏ –ø–æ–≤—ã—Å–∏—Ç—å –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å, –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω–æ —É–≤–µ–ª–∏—á–∏–≤ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å–Ω–æ—Å—Ç—å –¥–æ 5%. –í —Ü–µ–ª–æ–º, —Ç–∞–∫–∏–µ –ø—Ä–æ–¥—É–∫—Ç—ã –ø—Ä–∏–∑–≤–∞–Ω—ã —Ä–µ—à–∏—Ç—å –∫–ª—é—á–µ–≤—ã–µ –ø—Ä–æ–±–ª–µ–º—ã –∫—Ä—É–ø–Ω–æ–≥–æ –±–∏–∑–Ω–µ—Å–∞: –Ω–µ—ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å —Ä—É—á–Ω—ã—Ö –æ–ø–µ—Ä–∞—Ü–∏–π, –Ω–µ—Ç–æ—á–Ω–æ—Å—Ç–∏ –ø—Ä–æ–≥–Ω–æ–∑–∏—Ä–æ–≤–∞–Ω–∏—è –∏ —Å–ª–æ–∂–Ω–æ—Å—Ç–∏ –≤ –ø—Ä–∏–Ω—è—Ç–∏–∏ —É–ø—Ä–∞–≤–ª–µ–Ω—á–µ—Å–∫–∏—Ö —Ä–µ—à–µ–Ω–∏–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-11-27T06:41:56+00:00,@bezrec,6868,https://t.me/bezrec/6868,"–ê–Ω–∞–ª–∏—Ç–∏–∫–∏ —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏, –∫–∞–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã —á–∞—â–µ –ø–æ–∫—É–ø–∞—é—Ç—Å—è ¬´–ø–æ—à—Ç—É—á–Ω–æ¬ª. –ü–æ –∏—Ç–æ–≥–∞–º —è–Ω–≤–∞—Ä—è-–æ–∫—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞ –≤ –†–æ—Å—Å–∏–∏ –±—ã–ª–æ –ø—Ä–æ–¥–∞–Ω–æ 18,5 –º–ª–Ω –ø–∞—á–µ–∫ –ª–µ–∫–∞—Ä—Å—Ç–≤, –∫–æ—Ç–æ—Ä—ã–µ –≤—Å–∫—Ä—ã–≤–∞–ª–∏—Å—å –≤ –∞–ø—Ç–µ–∫–∞—Ö –∏ –ø—Ä–æ–¥–∞–≤–∞–ª–∏—Å—å –≤ –ø–µ—Ä–≤–∏—á–Ω–æ–π —É–ø–∞–∫–æ–≤–∫–µ. –í –æ—Å–Ω–æ–≤–Ω–æ–º —Ä–µ—á—å –æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞—Ö –≤ —Ñ–æ—Ä–º–µ –ø–∞–∫–µ—Ç–∏–∫–æ–≤ c –ø–æ—Ä–æ—à–∫–∞–º–∏ –∏ –≥—Ä–∞–Ω—É–ª–∞–º–∏, –∫–æ—Ç–æ—Ä—ã–µ –∏—Å–ø–æ–ª—å–∑—É—é—Ç—Å—è –¥–ª—è –ø—Ä–∏–≥–æ—Ç–æ–≤–ª–µ–Ω–∏—è —Ä–∞—Å—Ç–≤–æ—Ä–æ–≤, –≥–æ–≤–æ—Ä—è—Ç –≤ RNC Pharma. –ó–∞ –≥–æ–¥ –∏—Ö –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ —Å–æ–∫—Ä–∞—Ç–∏–ª–æ—Å—å –Ω–∞ 17%. –ß–∞—â–µ –≤—Å–µ–≥–æ —Ç–∞–∫ –ø–æ–∫—É–ø–∞—é—Ç –ù–∏–º–µ—Å–∏–ª –æ—Ç ¬´–ú–µ–Ω–∞—Ä–∏–Ω–∏¬ª, –æ—Å–æ–±–µ–Ω–Ω–æ –≤ –≤–∏–¥–µ –≥—Ä–∞–Ω—É–ª 100 –º–≥. ‚Ññ30 ‚Äî –¥–ª—è —ç—Ç–æ–π –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π —Ñ–æ—Ä–º—ã –¥–æ–ª—è –ø—Ä–æ–¥–∞–∂ –ø—Ä–µ–≤—ã—à–∞–µ—Ç 40% –æ—Ç —Ä—É–±–ª—ë–≤–æ–≥–æ –æ–±—ä—ë–º–∞ –∏ –¥–æ—Å—Ç–∏–≥–∞–µ—Ç 26,5% –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏. –ü—Ä–∏ —ç—Ç–æ–º ¬´–ø–æ—à—Ç—É—á–Ω—ã–π¬ª —Å–ø–æ—Å–æ–± –¥–ª—è –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª—è –Ω–µ–≤—ã–≥–æ–¥–µ–Ω ‚Äî —Ä–∞–∑–æ–≤–∞—è –¥–æ–∑–∞ –æ–±—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ 87% –¥–æ—Ä–æ–∂–µ –ø–æ–ª–Ω–æ–π –ø–∞—á–∫–∏. –í—Ç–æ—Ä–æ–µ –º–µ—Å—Ç–æ —Å —Ç–æ—á–∫–∏ –∑—Ä–µ–Ω–∏—è —Ä—É–±–ª—ë–≤—ã—Ö –ø—Ä–æ–¥–∞–∂ —Å–æ –≤—Å–∫—Ä—ã—Ç–∏–µ–º –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª—å—Å–∫–∏—Ö —É–ø–∞–∫–æ–≤–æ–∫ ‚Äî —É –ü—É–ª—å–º–∏–∫–æ—Ä—Ç–∞ –æ—Ç ¬´–ê—Å—Ç—Ä–∞–ó–µ–Ω–µ–∫–∞¬ª, —Å–∞–º–∞—è –ø–æ–ø—É–ª—è—Ä–Ω–∞—è —Ñ–æ—Ä–º–∞ ‚Äî –±–ª–æ–∫–∏ –ø–æ 5 –∫–æ–Ω—Ç–µ–π–Ω–µ—Ä–æ–≤. –ó–∞–º—ã–∫–∞–µ—Ç —Ç—Ä–æ–π–∫—É –ª–∏–¥–µ—Ä–æ–≤ –†–µ–¥—É–∫—Å–∏–Ω –æ—Ç ¬´–ü—Ä–æ–º–æ–º–µ–¥–∞¬ª. –í –¥–µ—Å—è—Ç–∫–µ –±—Ä–µ–Ω–¥–æ–≤-–ª–∏–¥–µ—Ä–æ–≤ –ø–æ –æ–±—ä—ë–º–∞–º –ø—Ä–æ–¥–∞–∂ –¥—Ä–æ–±–Ω—ã—Ö —É–ø–∞–∫–æ–≤–æ–∫ –≤ –¥–µ–Ω—å–≥–∞—Ö —Ç–∞–∫–∂–µ –æ–∫–∞–∑–∞–ª–∏—Å—å: –§–æ—Å—Ñ–∞–ª—é–≥–µ–ª—å (¬´–°–∞–Ω–æ—Ñ–∏¬ª), –¢–µ—Ä–∞—Ñ–ª—é (¬´–•–µ–ª–µ–æ–Ω¬ª), –ö–æ-–ü–µ—Ä–∏–Ω–µ–≤–∞ (¬´–ö–†–ö–ê¬ª), –ì–æ–ª–¥–ª–∞–π–Ω (¬´–ò–∑–≤–∞—Ä–∏–Ω–æ –§–∞—Ä–º¬ª), –•–æ–Ω–¥—Ä–æ–≥–∞—Ä–¥ (¬´–°–æ—Ç–µ–∫—Å¬ª), –ú–∏–∫—Ä–æ–ª–∞–∫—Å (¬´–î–∂–æ–Ω—Å–æ–Ω –∏ –î–∂–æ–Ω—Å–æ–Ω¬ª), –ê–Ω–≤–∏–º–∞–∫—Å (¬´–°–æ—Ç–µ–∫—Å¬ª). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, shortage"",
  ""impact"": ""medium"",
  ""english"": ""Analysts reported that how many medicines are bought individually. In Russia, sales of 18.5 million packages of drugs were sold in the first nine months of 2025, with these being opened and sold individually. The most common are powders and granules in sachets for making solutions, according to RNC Pharma. The number of these products has decreased by 17%. The most bought is Nimesil from Menarini, especially in granules of 100 mg. ‚Ññ30 for this drug form accounts for more than 40% of the monetary volume and 26.5% in natural terms. However, buying individually is not cost-effective for the consumer ‚Äî a single dose costs 87% more than a full package. The second most popular is Pulmicort from Astellas, the most common form are blocks of 5 containers. The third is Rezulin from Promedea. Other brands in the top ten by monetary sales of individual packages include: Fosfalgene (Sanofi), Teraflu"
2025-11-26T14:50:11+00:00,@bezrec,6867,https://t.me/bezrec/6867,"–ó–∞–≥–æ—Ç–æ–≤–∫–∏ –ø–ª–∞–∑–º—ã –∫—Ä–æ–≤–∏ —Å–Ω–æ–≤–∞ –±—å—é—Ç —Ä–µ–∫–æ—Ä–¥—ã. –ü–æ —Å–ª–æ–≤–∞–º –¢–∞—Ç—å—è–Ω—ã –ì–æ–ª–∏–∫–æ–≤–æ–π, –∑–∞ 10 –º–µ—Å—è—Ü–µ–≤ —Ç–µ–∫—É—â–µ–≥–æ –≥–æ–¥–∞ –ø–ª–∞–Ω–æ–≤—ã–µ –∑–Ω–∞—á–µ–Ω–∏—è –Ω–∞ 2025 –≥–æ–¥ —É–∂–µ –ø–µ—Ä–µ–≤—ã–ø–æ–ª–Ω–µ–Ω—ã –ø–æ—á—Ç–∏ –Ω–∞ 9%. –ó–∞–≥–æ—Ç–æ–≤–ª–µ–Ω–æ –ø–æ—á—Ç–∏ 850 —Ç –ø–ª–∞–∑–º—ã –∫—Ä–æ–≤–∏, —á—Ç–æ –æ–±–µ—Å–ø–µ—á–∏–≤–∞–µ—Ç –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –ª–µ–∫–∞—Ä—Å—Ç–≤ –Ω–∞ –æ—Å–Ω–æ–≤–µ –∫—Ä–æ–≤–∏ –∏ –µ–µ –∫–æ–º–ø–æ–Ω–µ–Ω—Ç–æ–≤, –∞ —Ç–∞–∫–∂–µ –Ω–µ–∑–∞–≤–∏—Å–∏–º–æ—Å—Ç—å —Å—Ç—Ä–∞–Ω—ã –æ—Ç –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π, ‚Äî –ø–æ—Ö–≤–∞–ª–∏–ª–∞—Å—å —É—Å–ø–µ—Ö–∞–º–∏ –≤–∏—Ü–µ-–ø—Ä–µ–º—å–µ—Ä. –í –ª–∏–¥–µ—Ä–∞—Ö –ø–æ —Ä–æ—Å—Ç—É –¥–æ–Ω–æ—Ä—Å–∫–æ–π –∞–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ - –ú–æ—Å–∫–≤–∞, –ú–æ—Å–∫–æ–≤—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å, –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥, –ö—Ä–∞—Å–Ω–æ–¥–∞—Ä—Å–∫–∏–π –∫—Ä–∞–π –∏ –°–≤–µ—Ä–¥–ª–æ–≤—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å. –í –∞–ø—Ä–µ–ª–µ –í–µ—Ä–æ–Ω–∏–∫–∞ –°–∫–≤–æ—Ä—Ü–æ–≤–∞ —Ä–∞—Å—Å–∫–∞–∑—ã–≤–∞–ª–∞, —á—Ç–æ –§–ú–ë–ê —Å–ø—Ä–∞–≤–∏–ª–æ—Å—å —Å ¬´–Ω–µ–ø–æ–¥—ä—ë–º–Ω–æ–π¬ª –∑–∞–¥–∞—á–µ–π –ø–æ –∑–∞–≥–æ—Ç–æ–≤–∫–µ –ø–ª–∞–∑–º—ã –∫—Ä–æ–≤–∏, –∑–∞–≥–æ—Ç–æ–≤–∏–≤ –≤ 2024 –≥–æ–¥—É 660 —Ç—ã—Å. –ª–∏—Ç—Ä–æ–≤ ‚Äì –Ω–∞ 60 –ª–∏—Ç—Ä–æ–≤ –±–æ–ª—å—à–µ, —á–µ–º –≤ ¬´—Ç–∑¬ª, –ø–æ—Å—Ç–∞–≤–ª–µ–Ω–Ω–æ–º –≤–µ–¥–æ–º—Å—Ç–≤—É –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç–æ–º. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,pharmacovigilance,hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""Plasma production in Russia is at record levels, exceeding the target for 2025 by almost 9% in the first ten months of this year. The country's production capacity for medicines based on blood and its components is ensured, as well as the nation's independence from foreign producers. The success was highlighted by Tatyana Golikova, a deputy prime minister.""
}"
2025-11-26T12:09:24+00:00,@bezrec,6866,https://t.me/bezrec/6866,"–í –°–®–ê –æ–¥–æ–±—Ä–∏–ª–∏ ¬´–ó–æ–ª–≥–µ–Ω—Å–º—É¬ª –¥–ª—è –≤—Å–µ—Ö –≤–æ–∑—Ä–∞—Å—Ç–æ–≤. Novartis —Å–µ–≥–æ–¥–Ω—è –æ–±—ä—è–≤–∏–ª–∞, —á—Ç–æ –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–π —Ä–µ–≥—É–ª—è—Ç–æ—Ä –æ–¥–æ–±—Ä–∏–ª Itvisma (–æ–Ω–∞—Å–µ–º–Ω–æ–≥–µ–Ω –∞–±–µ–ø–∞—Ä–≤–æ–≤–µ–∫) –¥–ª—è –ª–µ—á–µ–Ω–∏—è –¥–µ—Ç–µ–π –≤ –≤–æ–∑—Ä–∞—Å—Ç–µ –æ—Ç –¥–≤—É—Ö –ª–µ—Ç, –ø–æ–¥—Ä–æ—Å—Ç–∫–æ–≤ –∏ –≤–∑—Ä–æ—Å–ª—ã—Ö, —Å—Ç—Ä–∞–¥–∞—é—â–∏—Ö —Å–ø–∏–Ω–∞–ª—å–Ω–æ–π –º—ã—à–µ—á–Ω–æ–π –∞—Ç—Ä–æ—Ñ–∏–µ–π (–°–ú–ê) —Å –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–µ–Ω–Ω–æ–π –º—É—Ç–∞—Ü–∏–µ–π –≤ –≥–µ–Ω–µ –≤—ã–∂–∏–≤–∞–µ–º–æ—Å—Ç–∏ –¥–≤–∏–≥–∞—Ç–µ–ª—å–Ω—ã—Ö –Ω–µ–π—Ä–æ–Ω–æ–≤ 1 ( SMN1 ). –≠—Ç–æ –ø–µ—Ä–≤–∞—è –∏ –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω–∞—è –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å–Ω–∞—è –≥–µ–Ω–Ω–∞—è —Ç–µ—Ä–∞–ø–∏—è, –¥–æ—Å—Ç—É–ø–Ω–∞—è –¥–ª—è —ç—Ç–æ–π –≥—Ä—É–ø–ø—ã –Ω–∞—Å–µ–ª–µ–Ω–∏—è. –£ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ —Ç–æ –∂–µ –¥–µ–π—Å—Ç–≤—É—é—â–µ–µ –≤–µ—â–µ—Å—Ç–≤–æ, —á—Ç–æ —É ¬´—Å—Ç–∞—Ä—à–µ–≥–æ –±—Ä–∞—Ç–∞¬ª ‚Äî –ó–æ–ª–≥–µ–Ω—Å–º—ã, –Ω–æ –µ—Å—Ç—å –ø—Ä–∏–Ω—Ü–∏–ø–∏–∞–ª—å–Ω–æ–µ –æ—Ç–ª–∏—á–∏–µ ‚Äî Itvisma –ø—Ä–µ–¥–Ω–∞–∑–Ω–∞—á–µ–Ω –¥–ª—è –µ–¥–∏–Ω–æ—Ä–∞–∑–æ–≤–æ–≥–æ –≤–≤–µ–¥–µ–Ω–∏—è –≤ —Å–ø–∏–Ω–Ω–æ–º–æ–∑–≥–æ–≤—É—é –∂–∏–¥–∫–æ—Å—Ç—å, –∞ –Ω–µ –≤–Ω—É—Ç—Ä–∏–≤–µ–Ω–Ω–æ. –ë–ª–∞–≥–æ–¥–∞—Ä—è —ç—Ç–æ–º—É –ø—Ä–µ–ø–∞—Ä–∞—Ç –º–æ–∂–µ—Ç –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å—Å—è —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –±–æ–ª—å—à–µ–π –º–∞—Å—Å–æ–π —Ç–µ–ª–∞. –í —Ö–æ–¥–µ –ö–ò Itvisma –ø—Ä–æ–¥–µ–º–æ–Ω—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª —Å—Ç–∞—Ç–∏—Å—Ç–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º—ã–µ —É–ª—É—á—à–µ–Ω–∏—è –¥–≤–∏–≥–∞—Ç–µ–ª—å–Ω–æ–π —Ñ—É–Ω–∫—Ü–∏–∏ –∏ —Å—Ç–∞–±–∏–ª–∏–∑–∞—Ü–∏—é –¥–≤–∏–≥–∞—Ç–µ–ª—å–Ω—ã—Ö —Å–ø–æ—Å–æ–±–Ω–æ—Å—Ç–µ–π, –∫–æ—Ç–æ—Ä—ã–µ –æ–±—ã—á–Ω–æ –Ω–µ –Ω–∞–±–ª—é–¥–∞—é—Ç—Å—è –ø—Ä–∏ –µ—Å—Ç–µ—Å—Ç–≤–µ–Ω–Ω–æ–º —Ç–µ—á–µ–Ω–∏–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è, –ø—Ä–∏—á–µ–º —ç—Ñ—Ñ–µ–∫—Ç—ã —Å–æ—Ö—Ä–∞–Ω—è–ª–∏—Å—å –≤ —Ç–µ—á–µ–Ω–∏–µ 52 –Ω–µ–¥–µ–ª—å –Ω–∞–±–ª—é–¥–µ–Ω–∏—è. –ù–æ–≤–∏–Ω–∫–∞ –±—É–¥–µ—Ç –¥–æ—Å—Ç—É–ø–Ω–∞ –≤ –°–®–ê —Å –¥–µ–∫–∞–±—Ä—è 2025 –≥–æ–¥–∞. –û–ø—Ç–æ–≤–∞—è —Ü–µ–Ω–∞ —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∞ –Ω–∞ —É—Ä–æ–≤–Ω–µ $2,5 –º–ª–Ω –∑–∞ –æ–¥–Ω—É –∏–Ω—ä–µ–∫—Ü–∏—é, —á—Ç–æ —Å–æ–ø–æ—Å—Ç–∞–≤–∏–º–æ —Å–æ —Å—Ç–æ–∏–º–æ—Å—Ç—å—é –ó–æ–ª–≥–µ–Ω—Å–º—ã, –¥–æ–ª–≥–æ–µ –≤—Ä–µ–º—è —Å—á–∏—Ç–∞–≤—à–µ–π—Å—è —Å–∞–º—ã–º –¥–æ—Ä–æ–≥–∏–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–º –≤ –º–∏—Ä–µ. –ü—Ä–æ–¥–∞–∂–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –ø–æ –∏—Ç–æ–≥–∞–º –ø—Ä–æ—à–ª–æ–≥–æ –≥–æ–¥–∞ –ø—Ä–∏–Ω–µ—Å–ª–∏ Novartis $1,2 –º–ª—Ä–¥. –†–∞—Å—à–∏—Ä–µ–Ω–∏–µ –ø–æ–ø—É–ª—è—Ü–∏–∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å—É–ª–∏—Ç —à–≤–µ–π—Ü–∞—Ä—Å–∫–æ–º—É —Ñ–∞—Ä–º–≥–∏–≥–∞–Ω—Ç—É –Ω–æ–≤—ã–µ —Ä–µ–∫–æ—Ä–¥—ã. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-11-26T08:34:15+00:00,@bezrec,6865,https://t.me/bezrec/6865,"–ü—Ä–æ—Ç–∏–≤–æ—Ä–µ–≤–º–∞—Ç–∏—á–µ—Å–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –ª—É—á—à–µ –ø—Ä–æ–¥–∞—é—Ç—Å—è –æ–Ω–ª–∞–π–Ω. –ü–æ –∏—Ç–æ–≥–∞–º –ø–µ—Ä–≤—ã—Ö –¥–µ—Å—è—Ç–∏ –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ —Ä–æ—Å—Å–∏—è–Ω–µ –ø—Ä–∏–æ–±—Ä–µ–ª–∏ –≤ —Ä–æ–∑–Ω–∏—Ü–µ 67,7 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ —Ç–∞–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –ø–æ–¥—Å—á–∏—Ç–∞–ª–∏ –≤ RNC Pharma. –ù–∞—Ç—É—Ä–∞–ª—å–Ω–æ–µ –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–µ —ç—Ç–æ–π –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ —Å–Ω–∏–∑–∏–ª–æ—Å—å –Ω–∞ 0,5% –≥–æ–¥ –∫ –≥–æ–¥—É, —Ç–æ–≥–¥–∞ –∫–∞–∫ –ø—Ä–æ–¥–∞–∂–∏ –≤ –¥–µ–Ω—å–≥–∞—Ö —É–≤–µ–ª–∏—á–∏–ª–∏—Å—å –Ω–∞ 13,2% –∏ –ø—Ä–µ–≤—ã—Å–∏–ª–∏ 22,1 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –¢–µ–Ω–¥–µ–Ω—Ü–∏—è –∫ —Å–æ–∫—Ä–∞—â–µ–Ω–∏—é –Ω–∞—Ç—É—Ä–∞–ª—å–Ω—ã—Ö –ø–æ–∫–∞–∑–∞—Ç–µ–ª–µ–π —Å–ø—Ä–æ—Å–∞ –ø—Ä–∏ —É–≤–µ–ª–∏—á–µ–Ω–∏–∏ —Ä–∞—Å—Ö–æ–¥–æ–≤ –ø–æ–∫—É–ø–∞—Ç–µ–ª–µ–π –Ω–∞–±–ª—é–¥–∞–µ—Ç—Å—è —Å 2023 –≥–æ–¥–∞. –ò–Ω—Ç–µ—Ä–µ—Å–Ω–æ, —á—Ç–æ –≤ –æ–Ω–ª–∞–π–Ω –∫–∞–Ω–∞–ª–µ —ç—Ç–∞ –≥—Ä—É–ø–ø–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ —á—É–≤—Å—Ç–≤—É–µ—Ç —Å–µ–±—è —É–≤–µ—Ä–µ–Ω–Ω–µ–µ ‚Äî –∑–∞ –≥–æ–¥ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω—ã–π –æ–±—ä—ë–º –ø—Ä–æ–¥–∞–∂ –≤—ã—Ä–æ—Å –Ω–∞ 11%. –í –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ –ø—Ä–æ—Ç–∏–≤–æ—Ä–µ–≤–º–∞—Ç–∏—á–µ—Å–∫–∏—Ö —Å—Ä–µ–¥—Å—Ç–≤ –∏ –∞–Ω–∞–ª—å–≥–µ—Ç–∏–∫–æ–≤ –¥–ª—è –º–µ—Å—Ç–Ω–æ–≥–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –¥–æ–º–∏–Ω–∏—Ä—É—é—Ç —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã (–±–æ–ª–µ–µ 69% –≤—Å–µ—Ö –Ω–∞—Ç—É—Ä–∞–ª—å–Ω—ã—Ö –ø—Ä–æ–¥–∞–∂ –∏ –æ–∫–æ–ª–æ 54% –¥–µ–Ω–µ–∂–Ω—ã—Ö). –í —Ñ–∞–≤–æ—Ä–∏—Ç–∞—Ö ‚Äî –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã —Å –¥–∏–∫–ª–æ—Ñ–µ–Ω–∞–∫–æ–º (–≤–∫–ª—é—á–∞—è –µ–≥–æ –∫–æ–º–±–∏–Ω–∞—Ü–∏–∏) –∏ –∫–µ—Ç–æ–ø—Ä–æ—Ñ–µ–Ω–æ–º. –õ–∏–¥–µ—Ä –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ ‚Äî –î–∏–∫–ª–æ—Ñ–µ–Ω–∞–∫ –≤ –≤–∏–¥–µ –≥–µ–ª—è –∏ –º–∞–∑–∏ ‚Äî –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω 16 —Ä–∞–∑–ª–∏—á–Ω—ã–º–∏ –∫–æ–º–ø–∞–Ω–∏—è–º–∏ –≤–æ –≥–ª–∞–≤–µ —Å ¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º–æ–º¬ª. –ù–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ ‚Äî –í–æ–ª—å—Ç–∞—Ä–µ–Ω-–≥–µ–ª—å –æ—Ç ¬´–ì–°–ö¬ª, –Ω–∞ —Ç—Ä–µ—Ç—å–µ–º ‚Äî –î–∏–º–µ–∫—Å–∏–¥ –æ—Ç 17 —Ä–∞–∑–Ω—ã—Ö –∫–æ–º–ø–∞–Ω–∏–π, —Å—Ä–µ–¥–∏ –∫–æ—Ç–æ—Ä—ã—Ö –ø—Ä–µ–æ–±–ª–∞–¥–∞–µ—Ç ¬´–ë–∏–æ—Ñ–∞—Ä–º–∞–∫—Å¬ª. –î–∏–º–µ–∫—Å–∏–¥ —Å–µ–π—á–∞—Å –≤—ã–ø—É—Å–∫–∞–µ—Ç—Å—è –≤ —Ç—Ä—ë—Ö —Ä–∞–∑–Ω—ã—Ö —Ñ–æ—Ä–º–∞—Ö. –ú–∞–∫—Å–∏–º–∞–ª—å–Ω–æ–π –¥–∏–Ω–∞–º–∏–∫–æ–π –æ—Ç–ª–∏—á–∏–ª—Å—è –Ω–µ–º–µ—Ü–∫–∏–π –î–æ–ª–≥–∏—Ç–±–ª–æ–∫ (–∏–±—É–ø—Ä–æ—Ñ–µ–Ω + –ª–µ–≤–æ–º–µ–Ω—Ç–æ–ª –≤ —Ñ–æ—Ä–º–µ –≥–µ–ª—è) –æ—Ç –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–î–æ–ª–æ—Ä–≥–∏—Ç¬ª. –ü—Ä–∏ —ç—Ç–æ–º –¥—Ä—É–≥–æ–π –ø—Ä–æ–¥—É–∫—Ç —ç—Ç–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è ‚Äî –î–æ–ª–≥–∏—Ç (–º–æ–Ω–æ–ø—Ä–µ–ø–∞—Ä–∞—Ç –∏–±—É–ø—Ä–æ—Ñ–µ–Ω–∞) ‚Äî –ø–æ–∫–∞–∑–∞–ª —Å–Ω–∏–∂–µ–Ω–∏–µ –Ω–∞ 13%, —Å—Ç–∞–≤ –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–º —É—á–∞—Å—Ç–Ω–∏–∫–æ–º —Ç–æ–ø-10 —Å –æ—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω–æ–π —Ä—É–±–ª—ë–≤–æ–π –¥–∏–Ω–∞–º–∏–∫–æ–π. –¢–∞–∫–∂–µ –≤ –¥–µ—Å—è—Ç–∫—É –ª–∏–¥–µ—Ä–æ–≤ –≤–æ—à–ª–∏: –ö–µ—Ç–æ–ø—Ä–æ—Ñ–µ–Ω (¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º¬ª + 10 –∫–æ–º–ø–∞–Ω–∏–π), –ü–µ–Ω—Ç–∞–ª–≥–∏–Ω (¬´–û—Ç–∏—Å–∏—Ñ–∞—Ä–º¬ª), –ù–∞–π–∑ (¬´–î—Ä. –†–µ–¥–¥–∏–∑¬ª), –¢—Ä–∞—É–º–µ–ª—å (¬´–•–µ–µ–ª—å¬ª), –ê–º–µ–ª–æ—Ç–µ–∫—Å (¬´–°–æ—Ç–µ–∫—Å¬ª). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, shortage, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The market for anti-rheumatic drugs is growing despite a natural decline in consumption. Sales have increased by 13.2% to reach RUB221 billion, while natural consumption has decreased by 0.5%. The trend of declining natural demand and increasing spending is observed since 2023. Natural sales in online channels have grown by 11% over the same period.""
}"
2025-11-26T05:20:26+00:00,@bezrec,6864,https://t.me/bezrec/6864,"–ü–∞–ø–∏–Ω–∞ –¥–æ—á–∫–∞: –°–≤–µ—Ç–ª–∞–Ω–∞ –®–ø–∏–≥–µ–ª—å ‚Äì –±–∞–Ω–∫—Ä–æ—Ç. –ê—Ä–±–∏—Ç—Ä–∞–∂–Ω—ã–π —Å—É–¥ –ú–æ—Å–∫–≤—ã –ø—Ä–∏–∑–Ω–∞–ª –±–∞–Ω–∫—Ä–æ—Ç–æ–º –¥–æ—á—å –≥–ª–∞–≤—ã ¬´–ë–∏–æ—Ç—ç–∫–∞¬ª –∏ —ç–∫—Å-—Å–µ–Ω–∞—Ç–æ—Ä–∞ –ë–æ—Ä–∏—Å–∞ –®–ø–∏–≥–µ–ª—è. –í –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ –Ω–µ—ë –æ—Ç–∫—Ä—ã—Ç–∞ –ø—Ä–æ—Ü–µ–¥—É—Ä–∞ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ –∏–º—É—â–µ—Å—Ç–≤–∞. –†–µ—Å—Ç—Ä—É–∫—Ç—É—Ä–∏–∑–∞—Ü–∏—è –¥–æ–ª–≥–æ–≤ –®–ø–∏–≥–µ–ª—å (–Ω–∞—á–∞–ª—å–Ω–∞—è –ø—Ä–æ—Ü–µ–¥—É—Ä–∞ –±–∞–Ω–∫—Ä–æ—Ç—Å—Ç–≤–∞) –±—ã–ª–∞ –∑–∞–ø—É—â–µ–Ω–∞ –≤ –º–∞—Ä—Ç–µ –ø–æ –∑–∞—è–≤–ª–µ–Ω–∏—é –∫–æ–Ω–∫—É—Ä—Å–Ω–æ–≥–æ —É–ø—Ä–∞–≤–ª—è—é—â–µ–≥–æ –æ–±–∞–Ω–∫—Ä–æ—Ç–∏–≤—à–µ–π—Å—è —Ñ–∞—Ä–º–∫–æ—Ä–ø–æ—Ä–∞—Ü–∏–∏ –µ—ë –æ—Ç—Ü–∞. –°–≤–µ—Ç–ª–∞–Ω–∞ –®–ø–∏–≥–µ–ª—å –∑–∞–¥–æ–ª–∂–∞–ª–∞ –æ–¥–Ω–æ–π –∏–∑ —Å—Ç—Ä—É–∫—Ç—É—Ä ¬´–ë–∏–æ—Ç—ç–∫–∞¬ª ‚Äî –ê–û ¬´–ú–µ–∂—Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω–∞—è —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∞—è –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω–æ-–¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä—Å–∫–∞—è –∫–æ—Ä–ø–æ—Ä–∞—Ü–∏—è ¬´–ë–∏–æ—Ç—ç–∫¬ª ‚Äî –æ–∫–æ–ª–æ 67 –º–ª–Ω —Ä—É–±–ª–µ–π. –°—É–¥ –≤–∫–ª—é—á–∏–ª —ç—Ç—É —Å—É–º–º—É –≤ —Ä–µ–µ—Å—Ç—Ä —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π –∫—Ä–µ–¥–∏—Ç–æ—Ä–æ–≤. –° —Ç–µ—Ö –ø–æ—Ä –Ω–æ–≤—ã—Ö —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π –∫ –Ω–µ–π –Ω–µ –ø—Ä–µ–¥—ä—è–≤–ª—è–ª–æ—Å—å. –ß–∞—Å—Ç—å –∏–º—É—â–µ—Å—Ç–≤–∞ –°–≤–µ—Ç–ª–∞–Ω—ã –∞—Ä–µ—Å—Ç–æ–≤–∞–ª–∏ –µ—â—ë –≤–æ –≤—Ä–µ–º—è –æ–±—ã—Å–∫–∞ –ø–æ —É–≥–æ–ª–æ–≤–Ω–æ–º—É –¥–µ–ª—É –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ –µ—ë –æ—Ç—Ü–∞ –∏ –µ–≥–æ –ø–æ–¥–µ–ª—å–Ω–∏–∫–æ–≤ ‚Äî –∏–∑ –µ—ë –∫–≤–∞—Ä—Ç–∏—Ä—ã –∏–∑—ä—è–ª–∏ —É–∫—Ä–∞—à–µ–Ω–∏—è –∏ –Ω–∞—Ä—É—á–Ω—ã–µ —á–∞—Å—ã. –°–∞–º–∞ –®–ø–∏–≥–µ–ª—å —É—Ç–≤–µ—Ä–∂–¥–∞–ª–∞, —á—Ç–æ —Å—Ç–æ–∏–º–æ—Å—Ç—å –µ—ë –∏–º—É—â–µ—Å—Ç–≤–∞ ¬´–ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏ –≤ —Ç—Ä–∏ —Ä–∞–∑–∞ –ø—Ä–µ–≤—ã—à–∞–µ—Ç —Ä–∞–∑–º–µ—Ä –∏–º—É—â–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π –∑–∞—è–≤–∏—Ç–µ–ª—è –ø–æ –¥–µ–ª—É –æ –±–∞–Ω–∫—Ä–æ—Ç—Å—Ç–≤–µ¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-11-25T15:12:50+00:00,@bezrec,6863,https://t.me/bezrec/6863,"¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª –Ω–∞–ø—Ä–∞–≤–∏—Ç –Ω–∞ –≤—ã–ø–ª–∞—Ç—É –¥–∏–≤–∏–¥–µ–Ω–¥–æ–≤ –±–æ–ª–µ–µ 315 –º–ª–Ω —Ä—É–±–ª–µ–π. –°–æ–≤–µ—Ç –¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–≤ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ —Ä–µ–∫–æ–º–µ–Ω–¥–æ–≤–∞–ª –∞–∫—Ü–∏–æ–Ω–µ—Ä–∞–º –≤—ã–ø–ª–∞—Ç–∏—Ç—å –¥–∏–≤–∏–¥–µ–Ω–¥—ã –ø–æ –∏—Ç–æ–≥–∞–º –¥–µ–≤—è—Ç–∏ –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ –≤ —Ä–∞–∑–º–µ—Ä–µ 0,27 —Ä—É–±–ª—è –Ω–∞ –∞–∫—Ü–∏—é. –õ–∏—Ü, –∏–º–µ—é—â–∏—Ö –ø—Ä–∞–≤–æ –Ω–∞ –ø–æ–ª—É—á–µ–Ω–∏–µ –¥–∏–≤–∏–¥–µ–Ω–¥–æ–≤, –æ–ø—Ä–µ–¥–µ–ª—è—Ç –ø–æ —Å–æ—Å—Ç–æ—è–Ω–∏—é –Ω–∞ 12 —è–Ω–≤–∞—Ä—è 2026 –≥–æ–¥–∞. ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª —Ç–∞–∫–∂–µ –æ—Ç—á–∏—Ç–∞–ª–∞—Å—å –æ —Ñ–∏–Ω–∞–Ω—Å–æ–≤—ã—Ö —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞—Ö 9 –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞: üîΩ–≤—ã—Ä—É—á–∫–∞ –∑–∞ 9 –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ —É–≤–µ–ª–∏—á–∏–ª–∞—Å—å –Ω–∞ 28%; üîΩ–ø–æ–∫–∞–∑–∞—Ç–µ–ª—å —Å–∫–æ—Ä—Ä–µ–∫—Ç–∏—Ä–æ–≤–∞–Ω–Ω–∞—è EBITDA —É–≤–µ–ª–∏—á–∏–ª—Å—è –Ω–∞ 34%, –¥–æ 7,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π; üîΩ—Ä–µ–Ω—Ç–∞–±–µ–ª—å–Ω–æ—Å—Ç—å –≤—ã—Ä–æ—Å–ª–∞ –¥–æ 36%; üîΩ—á–∏—Å—Ç–∞—è –ø—Ä–∏–±—ã–ª—å –≤—ã—Ä–æ—Å–ª–∞ –Ω–∞ 50%, –¥–æ 3,4 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π; üîΩ—Å–æ–æ—Ç–Ω–æ—à–µ–Ω–∏–µ —á–∏—Å—Ç—ã–π –¥–æ–ª–≥ / 12M EBITDA —Å–Ω–∏–∑–∏–ª–æ—Å—å –¥–æ 0,9—Ö. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-11-25T13:02:46+00:00,@bezrec,6861,https://t.me/bezrec/6861,"–¢—Ä–∏ —Ä–µ—à–µ–Ω–∏—è –¥–ª—è –±–µ—Å–ø–µ—Ä–µ–±–æ–π–Ω–æ–π –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏ –≤ —Ñ–∞—Ä–º–µ –æ—Ç Callisto Vision 25-28 –Ω–æ—è–±—Ä—è –≤ –ú–æ—Å–∫–≤–µ (–ú–í–¶ ¬´–ö—Ä–æ–∫—É—Å –≠–ö–°–ü–û¬ª) –ø—Ä–æ—Ö–æ–¥–∏—Ç –∫—Ä—É–ø–Ω–µ–π—à–∞—è –≤ –†–æ—Å—Å–∏–∏ –∏ –ï–ê–≠–° –≤—ã—Å—Ç–∞–≤–∫–∞ –¥–ª—è —Ñ–∞—Ä–º–∏–Ω–¥—É—Å—Ç—Ä–∏–∏ Pharmtech & Ingredients. Callisto Vision –ø—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ—Ç —Ç—Ä–∏ –≤—ã—Å–æ–∫–æ–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å–Ω—ã—Ö –ø—Ä–æ–≥—Ä–∞–º–º–Ω–æ-–∞–ø–ø–∞—Ä–∞—Ç–Ω—ã—Ö –∫–æ–º–ø–ª–µ–∫—Å–∞ –¥–ª—è –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏, —É–ø–∞–∫–æ–≤–∫–∏ –∏ –ø—Ä–æ—Å–ª–µ–∂–∏–≤–∞–µ–º–æ—Å—Ç–∏ –ø—Ä–æ–¥—É–∫—Ü–∏–∏, —Å–æ–∑–¥–∞–Ω–Ω—ã—Ö —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ –¥–ª—è —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –æ—Ç—Ä–∞—Å–ª–∏. ¬´–≠–í–û–ú–ê–ö–°¬ª - –≤—Å—Ç—Ä–∞–∏–≤–∞–µ—Ç—Å—è –≤ –ª–∏–Ω–∏—é –∏–ª–∏ —Ä–∞–±–æ—Ç–∞–µ—Ç –∞–≤—Ç–æ–Ω–æ–º–Ω–æ. –î–æ 500 —É–ø–∞–∫–æ–≤–æ–∫ –≤ –º–∏–Ω—É—Ç—É —Å —Ü–µ–Ω—Ç—Ä–∞–ª–∏–∑–æ–≤–∞–Ω–Ω–æ–π –ø–æ–¥–∞—á–µ–π —á–µ—Ä–Ω–∏–ª. –°—Ç–æ–∏–º–æ—Å—Ç—å –æ—Ç–ø–µ—á–∞—Ç–∫–∞ –º–µ–Ω–µ–µ 1 –∫–æ–ø–µ–π–∫–∏. –ü–æ–¥—Ö–æ–¥–∏—Ç –¥–ª—è —Å—Ç–∞–Ω–¥–∞—Ä—Ç–Ω—ã—Ö —Ñ–æ—Ä–º–∞—Ç–æ–≤ —É–ø–∞–∫–æ–≤–∫–∏ —Ñ–∞—Ä–º–ø–µ—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. ¬´–≠–í–û–ü–†–ò–ù–¢¬ª - –º–∞—Ä–∫–∏—Ä—É–µ—Ç –ø–ª–æ—Å–∫—É—é –ø–∞—á–∫—É. –≠—Ç–æ —Å–Ω–∏–º–∞–µ—Ç –Ω–∞–≥—Ä—É–∑–∫—É —Å –æ—Å–Ω–æ–≤–Ω–æ–π —É–ø–∞–∫–æ–≤–æ—á–Ω–æ–π –ª–∏–Ω–∏–∏ –∏ –∏—Å–∫–ª—é—á–∞–µ—Ç –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç—å –ø–µ—Ä–µ—É–ø–∞–∫–æ–≤–∫–∏ –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –∏–∑-–∑–∞ –±—Ä–∞–∫–∞ –ø–µ—á–∞—Ç–∏ –Ω–∞ –≤—Ç–æ—Ä–∏—á–Ω–æ–π —É–ø–∞–∫–æ–≤–∫–µ. –î–æ 800 –ø–∞—á–µ–∫ –≤ –º–∏–Ω—É—Ç—É, –∞–≤—Ç–æ–º–∞—Ç–∏—á–µ—Å–∫–∞—è –æ—Ç–±—Ä–∞–∫–æ–≤–∫–∞, ¬´—Ç–∏–ø–æ–≥—Ä–∞—Ñ–∏—è –Ω–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ¬ª. ¬´–≠–í–û–í–ò–ñ–ù¬ª - –ø–æ–ª—É–∞–≤—Ç–æ–º–∞—Ç–∏—á–µ—Å–∫–∞—è –∞–≥—Ä–µ–≥–∞—Ü–∏—è –≤ –≥–æ—Ñ—Ä–æ–∫–æ—Ä–æ–±–∞. –†–∞–±–æ—Ç–∞–µ—Ç –ø–æ—Å–ª–æ–π–Ω–æ —Å —É–ø–∞–∫–æ–≤–∫–∞–º–∏, —É–ª–æ–∂–µ–Ω–Ω—ã–º–∏ Data Matrix –∫–æ–¥–∞–º–∏ –≤–≤–µ—Ä—Ö. –ü–æ—á–µ–º—É —ç—Ç–æ –∞–∫—Ç—É–∞–ª—å–Ω–æ: –û–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏–µ –¥–ª—è –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏, –≤–Ω–µ–¥—Ä—ë–Ω–Ω–æ–µ –ø—Ä–∏ –∑–∞–ø—É—Å–∫–µ ¬´–ß–µ—Å—Ç–Ω–æ–≥–æ –∑–Ω–∞–∫–∞¬ª, –∏—Å—á–µ—Ä–ø–∞–ª–æ —Ä–µ—Å—É—Ä—Å. –û–¥–Ω–æ–≤—Ä–µ–º–µ–Ω–Ω–æ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–æ –ø–æ –ö–ò–ò —Ç—Ä–µ–±—É–µ—Ç –ø–µ—Ä–µ—Ö–æ–¥–∞ –Ω–∞ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–µ —Ä–µ—à–µ–Ω–∏—è –¥–æ 2030 –≥–æ–¥–∞. –¢–µ–∫—É—â–∏–µ —Å–∏—Å—Ç–µ–º—ã –≥–ª—É–±–æ–∫–æ –∏–Ω—Ç–µ–≥—Ä–∏—Ä–æ–≤–∞–Ω—ã –≤ –ø—Ä–æ—Ü–µ—Å—Å—ã –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏–π - –∏—Ö –ø–µ—Ä–µ–≤–Ω–µ–¥—Ä–µ–Ω–∏–µ –º–æ–∂–µ—Ç –∑–∞–Ω—è—Ç—å –º–µ—Å—è—Ü—ã. ¬´–û—Ç—Ä–∞—Å–ª—å —Å–µ–π—á–∞—Å –ø–æ–¥—Ö–æ–¥–∏—Ç –∫ —Ä–µ—Å—Ç–∞—Ä—Ç—É —Å–∏—Å—Ç–µ–º –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏. –ü–æ —Å—É—Ç–∏, —Ñ–∞—Ä–º–ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏—è —Ä–µ—à–∞—é—Ç —Ç—É –∂–µ –∑–∞–¥–∞—á—É, —á—Ç–æ –∏ —à–µ—Å—Ç—å –ª–µ—Ç –Ω–∞–∑–∞–¥, –Ω–æ —Å –Ω–æ–≤—ã–º–∏ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—è–º–∏. –ù–∞—à–∏ —Ä–µ—à–µ–Ω–∏—è —Å–æ–∑–¥–∞–Ω—ã —Å —É—á—ë—Ç–æ–º –Ω–∞–∫–æ–ø–ª–µ–Ω–Ω–æ–≥–æ –æ—Ç—Ä–∞—Å–ª—å—é –æ–ø—ã—Ç–∞, - –æ—Ç–º–µ—á–∞–µ—Ç –ü–∞–≤–µ–ª –ë—É–ª–≥–∞–∫–æ–≤, –≥–µ–Ω–µ—Ä–∞–ª—å–Ω—ã–π –¥–∏—Ä–µ–∫—Ç–æ—Ä Callisto Vision. - –≠—Ç–æ –Ω–µ –ø—Ä–æ—Å—Ç–æ –∑–∞–º–µ–Ω–∞ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è, –∞ –≤—ã—Ö–æ–¥ –Ω–∞ –Ω–æ–≤—ã–π —É—Ä–æ–≤–µ–Ω—å —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ —Å —Ä–æ—Å—Å–∏–π—Å–∫–æ–π —ç–∫—Å–ø–µ—Ä—Ç–∏–∑–æ–π –∏ –ø–æ–¥–¥–µ—Ä–∂–∫–æ–π 24/7. –¢–æ–ª—å–∫–æ –∑–∞ —ç—Ç–æ—Ç –≥–æ–¥ –Ω–∞ –Ω–∞—à–∏—Ö —Ä–µ—à–µ–Ω–∏—è—Ö –ø—Ä–æ–º–∞—Ä–∫–∏—Ä–æ–≤–∞–Ω–æ –æ–∫–æ–ª–æ 6 –º–ª—Ä–¥ –µ–¥–∏–Ω–∏—Ü –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –≤ —Ä–∞–∑–Ω—ã—Ö —Ç–æ–≤–∞—Ä–Ω—ã—Ö –≥—Ä—É–ø–ø–∞—Ö, –±–æ–ª–µ–µ 200 —Å–∫–æ—Ä–æ—Å—Ç–Ω—ã—Ö –ª–∏–Ω–∏–π –Ω–∞—Ö–æ–¥—è—Ç—Å—è –Ω–∞ –∫—Ä—É–≥–ª–æ—Å—É—Ç–æ—á–Ω–æ–π –ø–æ–¥–¥–µ—Ä–∂–∫–µ. –¢–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏ –∏ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–æ–Ω–Ω–æ –º—ã –≥–æ—Ç–æ–≤—ã –∫ –∏–º–ø–æ—Ä—Ç–æ–∑–∞–º–µ—â–µ–Ω–∏—é –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö —Ñ–∞—Ä–º–ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏—è—Ö –Ω–∞ –≤—Å–µ 100%¬ª. Pharmtech & Ingredients ‚Äì —Ä–µ–∞–ª—å–Ω–∞—è –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –ø–æ–∑–Ω–∞–∫–æ–º–∏—Ç—å—Å—è —Å –ø–µ—Ä–µ–¥–æ–≤—ã–º–∏ —Ä–æ—Å—Å–∏–π—Å–∫–∏–º–∏ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—è–º–∏ –∏ —Ä–µ—à–µ–Ω–∏—è–º–∏. #—Ä–µ–∫–ª–∞–º–∞ –û–û–û ¬´–ö–ê–õ–õ–ò–°–¢–û –°–ï–†–í–ò–°–ï–ó¬ª","{""skip"": true}"
2025-11-25T11:30:01+00:00,@bezrec,6860,https://t.me/bezrec/6860,"–ê–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å—â–∏–∫–∏ —Å–Ω–æ–≤–∞ –≤—Å—Ç—É–ø–∏–ª–∏—Å—å –∑–∞ ¬´–§–∞—Ä–º-–¢—Ä—ç–π–¥¬ª. –§–ê–° –≤—ã–¥–∞–ª–∞ –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏–µ ¬´–¥–æ—á–∫–µ¬ª –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–æ–π –±–∏–æ—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ò–ø—Å–µ–Ω¬ª, –ø–æ—Å—á–∏—Ç–∞–≤, —á—Ç–æ –≤ –∫–æ–º–º–µ—Ä—á–µ—Å–∫–æ–π –ø–æ–ª–∏—Ç–∏–∫–µ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ —Å–æ–¥–µ—Ä–∂–∞–ª–∏—Å—å —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–∏ –∏ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏ –Ω–µ–æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω—ã–µ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ –≤—ã—Ä—É—á–∫–µ –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω–æ–≥–æ –¥–µ–ª–æ–≤–æ–≥–æ –ø–∞—Ä—Ç–Ω–µ—Ä–∞ –∑–∞ –ø—Ä–µ–¥—ã–¥—É—â–∏–π –∫–∞–ª–µ–Ω–¥–∞—Ä–Ω—ã–π –≥–æ–¥. –ù–µ —Å–ª—É—á–∏–≤—à–∏–º—Å—è –¥–µ–ª–æ–≤—ã–º –ø–∞—Ä—Ç–Ω—ë—Ä–æ–º –æ–∫–∞–∑–∞–ª—Å—è ¬´–§–∞—Ä–º-–¢—Ä—ç–π–¥¬ª, –∫–æ—Ç–æ—Ä–æ–º—É ¬´–ò–ø—Å–µ–Ω¬ª –æ—Ç–∫–∞–∑–∞–ª –≤ –∑–∞–∫–ª—é—á–µ–Ω–∏–∏ –¥–æ–≥–æ–≤–æ—Ä–∞ –ø–æ—Å—Ç–∞–≤–∫–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –°–æ–º–∞—Ç—É–ª–∏–Ω –ê—É—Ç–æ–∂–µ–ª—å, –ö–∞–±–æ–º–µ—Ç–∏–∫—Å –∏ –î–∏—Ñ–µ—Ä–µ–ª–∏–Ω –≤ –æ—Ç–¥–µ–ª—å–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Ñ–æ—Ä–º–∞—Ö. –§–ê–° –ø–æ—Å—á–∏—Ç–∞–ª–∞, —á—Ç–æ —Ç–∞–∫–∏–µ –¥–µ–π—Å—Ç–≤–∏—è –º–æ–≥—É—Ç —Å–æ–¥–µ—Ä–∂–∞—Ç—å –ø—Ä–∏–∑–Ω–∞–∫–∏ –Ω–∞—Ä—É—à–µ–Ω–∏—è –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å–Ω–æ–≥–æ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–∞ –∏ –ø—Ä–µ–¥—É–ø—Ä–µ–¥–∏–ª–∞ –∫–æ–º–ø–∞–Ω–∏—é –æ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ –≤ 30-–¥–Ω–µ–≤–Ω—ã–π —Å—Ä–æ–∫: üîò–∏—Å–∫–ª—é—á–∏—Ç—å —É–∫–∞–∑–∞–Ω–Ω—ã–µ –ø—É–Ω–∫—Ç—ã –∏–∑ –¥–æ–∫—É–º–µ–Ω—Ç–∞; üîò–ø–æ–≤—Ç–æ—Ä–Ω–æ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ—Ç—å —Ä–µ—à–µ–Ω–∏–µ –ø–æ –∑–∞—è–≤–∫–µ ¬´–§–∞—Ä–º-–¢—Ä—ç–π–¥¬ª –Ω–∞ –Ω–µ–¥–∏—Å–∫—Ä–∏–º–∏–Ω–∞—Ü–∏–æ–Ω–Ω—ã—Ö —É—Å–ª–æ–≤–∏—è—Ö. –í –º–∞—Ä—Ç–µ —ç—Ç–æ–≥–æ –≥–æ–¥–∞ —Ä–µ–≥—É–ª—è—Ç–æ—Ä –≤—ã–¥–∞–ª –∞–Ω–∞–ª–æ–≥–∏—á–Ω–æ–µ –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏–µ —Ä–æ—Å—Å–∏–π—Å–∫–æ–π ¬´–¥–æ—á–∫–µ¬ª Swixx BioPharma. –ù–∞ —à–≤–µ–π—Ü–∞—Ä—Ü–µ–≤ —Ç–æ–≥–¥–∞ —Ç–∞–∫–∂–µ –ø–æ–∂–∞–ª–æ–≤–∞–ª–∞—Å—å ¬´–§–∞—Ä–º-–¢—Ä—ç–π–¥¬ª. –ò–Ω–æ—Å—Ç—Ä–∞–Ω—Ü—ã –ø–æ–∑–¥–Ω–µ–µ —Å–æ–æ–±—â–∏–ª–∏ –æ–± —É—Å—Ç—Ä–∞–Ω–µ–Ω–∏–∏ –Ω–∞—Ä—É—à–µ–Ω–∏–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, regulation"",
  ""impact"": ""high"",
  ""english"": ""The Antimonopoly authorities have issued a warning to 'Ipsen's Russian subsidiary for Pharma-Trade. The FAS found that the company had economically and technologically unjustified requirements from a potential business partner for the previous calendar year. The company 'Pharma-Trade' was refused to sign a contract for the supply of Somatulin Autogel, Cabometix and Diferyl tablets by 'Ipsen'. The FAS considers these actions to contain antimonopoly law violations and the company was warned to exclude specified points from the document within 30 days. In March of this year, similar warnings were issued to 'Swixx BioPharma's Russian subsidiary. The foreigners later reported the violations have been corrected.""
}"
2025-11-25T08:40:01+00:00,@bezrec,6859,https://t.me/bezrec/6859,"–ê–ª—å—Ü–≥–µ–π–º–µ—Ä –ø–æ–¥–≤—ë–ª Novo Nordisk. –¢–∞–±–ª–µ—Ç–∏—Ä–æ–≤–∞–Ω–Ω–∞—è —Ñ–æ—Ä–º–∞ –û–∑–µ–º–ø–∏–∫–∞ –Ω–µ —Å–ø—Ä–∞–≤–∏–ª–∞—Å—å —Å –±–æ–ª–µ–∑–Ω—å—é –ê–ª—å—Ü–≥–µ–π–º–µ—Ä–∞. –í –¥–≤—É—Ö –∫—Ä—É–ø–Ω—ã—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è—Ö —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –∫–æ–≥–Ω–∏—Ç–∏–≤–Ω–æ–π –æ—Ü–µ–Ω–∫–∏ —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –Ω–µ –≤—ã—è–≤–∏–ª–∏ –∑–∞–º–µ–¥–ª–µ–Ω–∏—è –ø—Ä–æ–≥—Ä–µ—Å—Å–∏—Ä–æ–≤–∞–Ω–∏—è –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è. –í Novo Nordisk –∑–∞—è–≤–∏–ª–∏, —á—Ç–æ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –æ—Ü–µ–Ω–∫–∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ —Å–ø—É—Å—Ç—è –¥–≤–∞ –≥–æ–¥–∞ ¬´–Ω–µ –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–∞—é—Ç –∫–ª–∏–Ω–∏—á–µ—Å–∫—É—é –ø–æ–ª—å–∑—É –¥–ª—è —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤¬ª –∏ —Å–æ–æ–±—â–∏–ª–∏ –æ –ø—Ä–µ–∫—Ä–∞—â–µ–Ω–∏–∏ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –¥–ª—è —ç—Ç–æ–≥–æ –ø–æ–∫–∞–∑–∞–Ω–∏—è. –í–ø—Ä–æ—á–µ–º, –∫–æ–º–ø–∞–Ω–∏—è –∏–∑–Ω–∞—á–∞–ª—å–Ω–æ –æ—Ü–µ–Ω–∏–≤–∞–ª–∞ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –ª–µ—á–µ–Ω–∏—è –Ω–µ–¥—É–≥–∞ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–æ–º –∫–∞–∫ –º–∞–ª–æ–≤–µ—Ä–æ—è—Ç–Ω—É—é. –≠—Ç–æ –±—ã–ª –ª–æ—Ç–µ—Ä–µ–π–Ω—ã–π –±–∏–ª–µ—Ç, –∫–æ—Ç–æ—Ä—ã–π –º–æ–≥ –±—ã –ø—Ä–∏–Ω–µ—Å—Ç–∏ –æ–≥—Ä–æ–º–Ω—É—é –ø—Ä–∏–±—ã–ª—å, ‚Äî —Å–∫–∞–∑–∞–ª –ü–µ—Ä –•–∞–Ω—Å–µ–Ω, –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–æ–Ω–Ω—ã–π —ç–∫—Å–ø–µ—Ä—Ç Nordnet AB. –ù–æ –Ω–µ –ø—Ä–∏–Ω—ë—Å. –ù–∞ —Ñ–æ–Ω–µ –ø—Ä–æ–≤–∞–ª–∞ –û–∑–µ–º–ø–∏–∫–∞ –Ω–∞ –ø–æ–ø—Ä–∏—â–µ –±–æ—Ä—å–±—ã —Å –±–æ–ª–µ–∑–Ω—å—é –ê–ª—å—Ü–≥–µ–π–º–µ—Ä–∞ –∞–∫—Ü–∏–∏ –¥–∞—Ç—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ —É–ø–∞–ª–∏ –Ω–∞ —Ç–æ—Ä–≥–∞—Ö —Ñ–æ–Ω–¥–æ–≤–æ–π –±–∏—Ä–∂–∏ –ö–æ–ø–µ–Ω–≥–∞–≥–µ–Ω–∞ –Ω–∞ 15,3%. –≠—Ç–æ –º–∞–∫—Å–∏–º—É–º —Å 2021 –≥–æ–¥–∞. –í —Ç–æ –∂–µ –≤—Ä–µ–º—è –±—É–º–∞–≥–∏ –≥–ª–∞–≤–Ω–æ–≥–æ –∫–æ–Ω–∫—É—Ä–µ–Ω—Ç–∞ –¥–∞—Ç—á–∞–Ω ‚Äì –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–π Eli Lilly ‚Äì –≤—ã—Ä–æ—Å–ª–∏ –Ω–∞ 0,99%, –∞ –∞–∫—Ü–∏–∏ Biogen, —Ä–∞–∑—Ä–∞–±–∞—Ç—ã–≤–∞—é—â–µ–π –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –æ—Ç –±–æ–ª–µ–∑–Ω–∏ –ê–ª—å—Ü–≥–µ–π–º–µ—Ä–∞, –ø—Ä–∏–±–∞–≤–∏–ª–∏ —Å—Ä–∞–∑—É 5,6%. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, shortage"",
  ""impact"": ""medium"",
  ""english"": ""Novo Nordisk's study on emagglutinin for Alzheimer's disease did not show any slowing of cognitive decline in patients. The company announced that the results, which were not confirmed after two years, do not indicate clinical benefit for participants. Novo Nordisk has announced the termination of the research on this indication. The Danish company's stock fell by 15.3% on Copenhagen Stock Exchange, which is the maximum since 2021. Meanwhile, Eli Lilly's stock rose by 0.99%, and Biogen's stock increased by 5.6%.""
}"
2025-11-25T05:34:39+00:00,@bezrec,6858,https://t.me/bezrec/6858,"–ö–∞–±–º–∏–Ω –ø–æ–¥–¥–µ—Ä–∂–∞–ª –∏–¥–µ—é –º–æ–±–∏–ª—å–Ω—ã—Ö –∞–ø—Ç–µ–∫. –ù–æ —Å –æ–≥–æ–≤–æ—Ä–∫–∞–º–∏. –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –≤ —Ü–µ–ª–æ–º –æ–¥–æ–±—Ä—è–µ—Ç –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç, –∏–Ω–∏—Ü–∏–∏—Ä–æ–≤–∞–Ω–Ω—ã–π –¥–µ–ø—É—Ç–∞—Ç–æ–º –ì–æ—Å–¥—É–º—ã –ï–≤–≥–µ–Ω–∏–µ–º –ù–∏—Ñ–∞–Ω—Ç—å–µ–≤—ã–º. –û–¥–Ω–∞–∫–æ –µ–≥–æ –ø—Ä–µ–¥—Å—Ç–æ–∏—Ç –¥–æ—Ä–∞–±–æ—Ç–∞—Ç—å ¬´—Å —É—á–µ—Ç–æ–º —É–∫–∞–∑–∞–Ω–Ω—ã—Ö –∑–∞–º–µ—á–∞–Ω–∏–π¬ª. –í —á–µ–º —Å—É—Ç—å –∏–¥–µ–∏: üü© –º–æ–±–∏–ª—å–Ω—ã–µ –ø—É–Ω–∫—Ç—ã, –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–Ω—ã–µ –≤ –∞–≤—Ç–æ–º–æ–±–∏–ª—è—Ö, –ø–æ–µ–¥—É—Ç –≤ —Å–µ–ª–∞, –≥–¥–µ –Ω–µ—Ç —Å—Ç–∞—Ü–∏–æ–Ω–∞—Ä–Ω—ã—Ö –∞–ø—Ç–µ–∫, –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –∏ –ò–ü —Å –ª–∏—Ü–µ–Ω–∑–∏–µ–π –Ω–∞ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫—É—é –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç—å; üü© —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–∏–µ –ø–æ–ø—Ä–∞–≤–∫–∏ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –≤–Ω–µ—Å—Ç–∏ –≤ –∑–∞–∫–æ–Ω ¬´–û–± –æ–±—Ä–∞—â–µ–Ω–∏–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤¬ª, –∫–æ—Ç–æ—Ä—ã–π –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è –¥–æ–ø–æ–ª–Ω–∏—Ç—å –Ω–æ–≤–æ–π —Å—Ç–∞—Ç—å–µ–π ‚Äî ¬´–ü–æ—Ä—è–¥–æ–∫ –æ—Å—É—â–µ—Å—Ç–≤–ª–µ–Ω–∏—è —Ä–æ–∑–Ω–∏—á–Ω–æ–π —Ç–æ—Ä–≥–æ–≤–ª–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–º–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º–∏ –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è —Å –ø–æ–º–æ—â—å—é –ø–µ—Ä–µ–¥–≤–∏–∂–Ω—ã—Ö –∞–ø—Ç–µ—á–Ω—ã—Ö –ø—É–Ω–∫—Ç–æ–≤¬ª; üü© —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç –º–æ–∂–µ—Ç –ø—Ä–æ–π—Ç–∏ —Å 1 –∏—é–Ω—è 2026 –≥–æ–¥–∞ –¥–æ 1 –∏—é–Ω—è 2029 –≥–æ–¥–∞; üü© —Ä–µ–≥–∏–æ–Ω—ã –±—É–¥—É—Ç –≤–∫–ª—é—á–∞—Ç—å—Å—è –≤ –Ω–µ–≥–æ (–∏–ª–∏ –∏—Å–∫–ª—é—á–∞—Ç—å—Å—è) –ø–æ —Ä–∞—Å–ø–æ—Ä—è–∂–µ–Ω–∏—é –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –Ω–∞ –æ—Å–Ω–æ–≤–∞–Ω–∏–∏ —Ö–æ–¥–∞—Ç–∞–π—Å—Ç–≤–∞ –≥—É–±–µ—Ä–Ω–∞—Ç–æ—Ä–∞; üü© —É –ø–µ—Ä–µ–¥–≤–∏–∂–Ω—ã—Ö –ø—É–Ω–∫—Ç–æ–≤ –±—É–¥–µ—Ç —Å—Ç–∞—Ç—É—Å ¬´–ø–æ–¥—Ä–∞–∑–¥–µ–ª–µ–Ω–∏—è –∞–ø—Ç–µ—á–Ω–æ–π –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏¬ª; üü© ¬´—Å –∫–æ–ª—ë—Å¬ª –Ω–µ–ª—å–∑—è –±—É–¥–µ—Ç –ø—Ä–æ–¥–∞–≤–∞—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã —Å —Å–æ–¥–µ—Ä–∂–∞–Ω–∏–µ–º –ø—Å–∏—Ö–æ—Ç—Ä–æ–ø–Ω—ã—Ö –∏ —Å–∏–ª—å–Ω–æ–¥–µ–π—Å—Ç–≤—É—é—â–∏—Ö –≤–µ—â–µ—Å—Ç–≤, —Å –¥–æ–ª–µ–π —ç—Ç–∏–ª–æ–≤–æ–≥–æ —Å–ø–∏—Ä—Ç–∞ —Å–≤—ã—à–µ 25%, —Å —Ç–µ–º–ø–µ—Ä–∞—Ç—É—Ä–æ–π —Ö—Ä–∞–Ω–µ–Ω–∏—è –Ω–∏–∂–µ 15 –≥—Ä–∞–¥—É—Å–æ–≤; üü© –æ—Ç–±–æ—Ä –∞–ø—Ç–µ–∫, —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏–µ –∏—Ö —Ñ–∏–Ω–∞–ª—å–Ω–æ–≥–æ —Å–ø–∏—Å–∫–∞, –º–∞—Ä—à—Ä—É—Ç–∞ —Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –∏ –≥—Ä–∞—Ñ–∏–∫–∞ —Ä–∞–±–æ—Ç—ã ‚Äì –∑–æ–Ω–∞ –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç–∏ –º–µ—Å—Ç–Ω—ã—Ö –≤–ª–∞—Å—Ç–µ–π. –ß—Ç–æ –ø—Ä–µ–¥—Å—Ç–æ–∏—Ç –¥–æ—Ä–∞–±–æ—Ç–∞—Ç—å: –í –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç–µ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ –∑–∞–∫—Ä–µ–ø–∏—Ç—å —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ –ø–µ—Ä–µ–¥–≤–∏–∂–Ω—ã–º –∞–ø—Ç–µ—á–Ω—ã–º –ø—É–Ω–∫—Ç–∞–º, –∞ —Ç–∞–∫–∂–µ –ø–æ—Ä—è–¥–æ–∫ –ø—Ä–∏–æ–±—Ä–µ—Ç–µ–Ω–∏—è —Å—Ç–∞—Ç—É—Å–∞ —É—á–∞—Å—Ç–Ω–∏–∫–∞ —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–∞. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, —Å—Ä–æ–∫–∏ –Ω—É–∂–Ω–æ –ø—Ä–∏–≤–µ—Å—Ç–∏ –≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–µ —Å –ø–æ–ª–æ–∂–µ–Ω–∏—è–º–∏ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –∑–∞–∫–æ–Ω–∞ ¬´–û–± –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã—Ö —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è—Ö –≤ –†–§¬ª, —Å–æ–≥–ª–∞—Å–Ω–æ –∫–æ—Ç–æ—Ä–æ–º—É –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–µ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –¥–æ–ª–∂–Ω—ã –≤—Å—Ç—É–ø–∞—Ç—å –≤ —Å–∏–ª—É –ª–∏–±–æ —Å 1 –º–∞—Ä—Ç–∞, –ª–∏–±–æ —Å 1 —Å–µ–Ω—Ç—è–±—Ä—è —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–µ–≥–æ –≥–æ–¥–∞, ‚Äî —É–∫–∞–∑–∞–ª–∏ –≤ –∫–∞–±–º–∏–Ω–µ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing, import_export, sanctions, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The government has broadly approved the project to establish mobile pharmacies, but it needs further adjustments. The initiative involves mobile units in vehicles providing services in rural areas without stationary pharmacies, medical institutions, and pharmaceutical companies. The project is based on amendments to the 'Pharmaceuticals Registration Law' including a new article for 'Mobile pharmacies'. The experiment will run from June 1, 2026 to June 1, 2029. Regions will be included or excluded based on the governor's request and local authorities' responsibility for selecting pharmacies, finalizing lists, routes, and schedules. The project requires specific requirements for mobile pharmacies and the process of obtaining participation status. Additionally, the implementation dates need to align with federal law requirements.""
}"
2025-11-24T14:00:01+00:00,@bezrec,6857,https://t.me/bezrec/6857,"–í–ª–∞–¥–∏–º–∏—Ä—É –ü—É—Ç–∏–Ω—É –ø–æ–æ–±–µ—â–∞–ª–∏ –ø—Ä–æ—Ä—ã–≤ –≤ –ª–µ—á–µ–Ω–∏–∏ –±–æ–ª–µ–∑–Ω–∏ –ê–ª—å—Ü–≥–µ–π–º–µ—Ä–∞. –°–≤–æ–π —Å–æ–≤–º–µ—Å—Ç–Ω—ã–π –ø—Ä–æ–µ–∫—Ç –Ω–∞ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–æ–π –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ ¬´–ü—É—Ç–µ—à–µ—Å—Ç–≤–∏–µ –≤ –º–∏—Ä –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–∞¬ª –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç—É –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∏ ¬´–†-–§–∞—Ä–º¬ª, ¬´–°–±–µ—Ä¬ª –∏ –ò–Ω—Å—Ç–∏—Ç—É—Ç –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–∞ AIRI. –û —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–µ –≤ —Å—Ñ–µ—Ä–µ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏—è –ø–µ—Ä–µ–¥–æ–≤—ã—Ö —Ü–∏—Ñ—Ä–æ–≤—ã—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –≤ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–µ –∫–æ–º–ø–∞–Ω–∏–∏ –¥–æ–≥–æ–≤–æ—Ä–∏–ª–∏—Å—å –µ—â—ë –ª–µ—Ç–æ–º –Ω–∞ –ü–ú–≠–§. –ü–∞—Ä—Ç–Ω—ë—Ä—ã —Ä–∞–∑—Ä–∞–±–æ—Ç–∞—é—Ç –∞–Ω—Ç–∏—Ç–µ–ª–∞ –∏ —Å–∏—Å—Ç–µ–º—É –¥–æ—Å—Ç–∞–≤–∫–∏, —Å–ø–æ—Å–æ–±–Ω—É—é –ø—Ä–æ–≤–µ—Å—Ç–∏ —Ç–µ—Ä–∞–ø–∏—é —á–µ—Ä–µ–∑ –≥–µ–º–∞—Ç–æ—ç–Ω—Ü–µ—Ñ–∞–ª–∏—á–µ—Å–∫–∏–π –±–∞—Ä—å–µ—Ä –∏ –¥–∞—Ç—å –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å –ø—Ä—è–º–æ –≤ –º–æ–∑–≥–µ. –ù–∞–∏–±–æ–ª–µ–µ –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–Ω—ã–µ –º–æ–ª–µ–∫—É–ª—ã-–∫–∞–Ω–¥–∏–¥–∞—Ç—ã –ø–æ–¥–±–µ—Ä—ë—Ç –≥–µ–Ω–µ—Ä–∞—Ç–∏–≤–Ω—ã–π –ò–ò. –í –±—É–¥—É—â–µ–º —É–º–Ω–∞—è –ø–ª–∞—Ç—Ñ–æ—Ä–º–∞ –ø—Ä–∏–≥–æ–¥–∏—Ç—Å—è –¥–ª—è —Å–æ–∑–¥–∞–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –æ—Ç –¥—Ä—É–≥–∏—Ö —Ç—è–∂–µ–ª—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –ü–æ —Å–ª–æ–≤–∞–º —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–æ–≤, –±–ª–∞–≥–æ–¥–∞—Ä—è —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ —Å—Ä–æ–∫–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ —Å–æ–∫—Ä–∞—Ç—è—Ç—Å—è, –∞ –ø–∞—Ü–∏–µ–Ω—Ç—ã –±—ã—Å—Ç—Ä–µ–µ –ø–æ–ª—É—á–∞—Ç –Ω–æ–≤—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance, safety"",
  ""impact"": ""high"",
  ""english"": ""Russian President Vladimir Putin was promised a breakthrough in Alzheimer's disease treatment. Companies 'R-Farm' and Sber, along with the Artificial Intelligence Institute AIRI, signed a cooperation agreement on digital technologies in pharmaceuticals at an international conference 'Journey to the World of Artificial Intelligence'. The partners will develop antibodies and a delivery system that can conduct therapy through the hematoencephalic barrier to act directly in the brain. The most promising molecular candidates will be selected by generative AI. In the future, an intelligent platform will be used to create drugs for other serious diseases as well. According to the developers, thanks to this technology, development times will be shortened and patients will receive new medications faster.""
}"
2025-11-24T11:45:01+00:00,@bezrec,6856,https://t.me/bezrec/6856,"–ü—Ä–µ–ø–∞—Ä–∞—Ç –æ—Ç —à–∏–∑–æ—Ñ—Ä–µ–Ω–∏–∏ –∏ –±–∏–ø–æ–ª—è—Ä–Ω–æ–≥–æ —Ä–∞—Å—Å—Ç—Ä–æ–π—Å—Ç–≤–∞ I —Ç–∏–ø–∞ —Å—Ç–∞–ª –¥–µ—à–µ–≤–ª–µ –Ω–∞ 12,4%. –§–ê–° —Å–Ω–∏–∑–∏–ª–∞ —Ü–µ–Ω—ã –Ω–∞ –ø–µ—Ä–≤—ã–π –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π –¥–∂–µ–Ω–µ—Ä–∏–∫ –ª—É—Ä–∞–∑–∏–¥–æ–Ω–∞. –£–ø–∞–∫–æ–≤–∫–∞ –∏–∑ 28 —Ç–∞–±–ª–µ—Ç–æ–∫ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω–æ–≥–æ –õ–∞—Ç—É–¥–∞ –∏—Ç–∞–ª—å—è–Ω—Å–∫–æ–π ¬´–ê–Ω–∂–µ–ª–∏–Ω–∏¬ª –≤ –¥–æ–∑–∏—Ä–æ–≤–∫–µ 20 –º–≥ —Å—Ç–æ–∏—Ç 1 898 —Ä—É–±–ª–µ–π, —Ç–æ–≥–¥–∞ –∫–∞–∫ –õ—É—Ä–∞–∑–∏–¥–æ–Ω –ö—Ä–æ–Ω–æ —Ä–æ—Å—Å–∏–π—Å–∫–æ–π ¬´–ö—Ä–æ–Ω–æ—Ñ–∞—Ä–º¬ª –æ–±–æ–π–¥—ë—Ç—Å—è –≤ 1660 —Ä—É–±–ª–µ–π. –û—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π –¥–∂–µ–Ω–µ—Ä–∏–∫ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç—Å—è –Ω–∞ –ø–ª–æ—â–∞–¥–∫–µ ¬´–ö–∞–Ω–æ–Ω—Ñ–∞—Ä–º–∞ –ø—Ä–æ–¥–∞–∫—à–Ω¬ª –≤ –ø–æ–¥–º–æ—Å–∫–æ–≤–Ω–æ–º –©—ë–ª–∫–æ–≤–æ. –§–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏—è ‚Äì –∏–Ω–¥–∏–π—Å–∫–∞—è. –õ—É—Ä–∞–∑–∏–¥–æ–Ω –≤—Ö–æ–¥–∏—Ç –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü. –†–µ—Ñ–µ—Ä–µ–Ω—Ç–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –∑–∞—â–∏—â—ë–Ω –ø–∞—Ç–µ–Ω—Ç–æ–º –¥–æ 2031 –≥–æ–¥–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""pricing, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The price of the domestic generic Lurazidone from Kronofarm has been reduced by 12.4%. The domestic generic of Latudon from Canonfarm, packaged in a 28 tablet unit at 20 mg dosage, costs 1660 rubles. The original Latudon from Italian Angelelli is priced at 1898 rubles for a unit of 28 tablets. The domestic generic is produced at the Canonfarm production facility in Shoslokov area of Moscow region. The active pharmaceutical ingredient is from India. Luazidone is included in the list of priority medicines. The reference drug is protected by patent until 2031.""
}"
2025-11-24T08:55:05+00:00,@bezrec,6855,https://t.me/bezrec/6855,"¬´–õ–µ–∫–º–µ–¥–æ–±—Ä–∞—â–µ–Ω–∏–µ¬ª –ø—Ä–æ—Å–∏—Ç –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ ¬´–Ω–µ –≥–Ω–∞—Ç—å –ª–æ—à–∞–¥–µ–π¬ª –≤ –≤–æ–ø—Ä–æ—Å–µ –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏–∏ ¬´—Å–ª–æ–∂–Ω—ã—Ö¬ª —Å—É–±—Å—Ç–∞–Ω—Ü–∏–π. –í –∫–æ–Ω—Ü–µ –æ–∫—Ç—è–±—Ä—è –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –∏ –Ω–∞–ø—Ä–∞–≤–∏–ª –æ—Ç—Ä–∞—Å–ª–µ–≤—ã–º –∞—Å—Å–æ—Ü–∏–∞—Ü–∏—è–º –ø—Ä–æ–µ–∫—Ç –º–µ—Ç–æ–¥–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π –ø–æ –æ—Ü–µ–Ω–∫–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –ø—Ä–æ—Ü–µ—Å—Å–æ–≤ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤. –î–æ–∫—É–º–µ–Ω—Ç, –∫–æ—Ç–æ—Ä—ã–π –¥–æ–ª–∂–µ–Ω —Å—Ç–∞—Ç—å –±–∞–∑–æ–π –¥–ª—è –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–∏—è —Å—Ç–µ–ø–µ–Ω–∏ –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏–∏ —Å—É–±—Å—Ç–∞–Ω—Ü–∏–∏, –ø–æ–Ω—Ä–∞–≤–∏–ª—Å—è –Ω–µ –≤—Å–µ–º. –¢–∞–∫, –∞—Å—Å–æ—Ü–∏–∞—Ü–∏—è ¬´–õ–µ–∫–º–µ–¥–æ–±—Ä–∞—â–µ–Ω–∏–µ¬ª —Å—á–∏—Ç–∞–µ—Ç, —á—Ç–æ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–Ω—ã–µ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –º–æ–≥—É—Ç –∏ –≤–æ–≤—Å–µ –æ—Ç–±–∏—Ç—å —É –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –æ—Ö–æ—Ç—É –ª–æ–∫–∞–ª–∏–∑–æ–≤—ã–≤–∞—Ç—å —Å—É–±—Å—Ç–∞–Ω—Ü–∏–∏ –Ω–µ–∫–æ—Ç–æ—Ä—ã—Ö –≥—Ä—É–ø–ø –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –û–±—ä–µ–¥–∏–Ω–µ–Ω–∏–µ –Ω–∞–ø—Ä–∞–≤–∏–ª–æ –≤ –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ –ø–∏—Å—å–º–æ —Å–æ —Å–≤–æ–∏–º–∏ –∑–∞–º–µ—á–∞–Ω–∏—è–º–∏, –ø–∏—à—É—Ç ¬´–í–µ–¥–æ–º–æ—Å—Ç–∏¬ª. –ß—Ç–æ –Ω–µ —Ç–∞–∫: üü© –ø—Ä–æ–µ–∫—Ç —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π –Ω–µ —É—á–∏—Ç—ã–≤–∞–µ—Ç ¬´—Ç–µ–∫—É—â–µ–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–µ —Ä–∞–∑–≤–∏—Ç–∏–µ¬ª —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –∏ —Ö–∏–º–∏—á–µ—Å–∫–æ–π –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏; üü© —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–∏ –¥–æ–∫—É–º–µ–Ω—Ç–∞ –Ω–µ –ø—Ä–∏–Ω–∏–º–∞—é—Ç –≤–æ –≤–Ω–∏–º–∞–Ω–∏–µ —Ä–∞–∑–ª–∏—á–Ω—ã–µ —Å—Ç–∞–¥–∏–∏ —Å–∏–Ω—Ç–µ–∑–∞ —Å—É–±—Å—Ç–∞–Ω—Ü–∏–π; üü© —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –¥–æ–ª–∂–Ω—ã –±—É–¥—É—Ç –æ—Ä–≥–∞–Ω–∏–∑–æ–≤–∞—Ç—å —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–∏ —Å–ª–æ–∂–Ω–æ–µ, –¥–ª–∏—Ç–µ–ª—å–Ω–æ–µ –∏ –∑–∞—Ç—Ä–∞—Ç–Ω–æ–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ, —á—Ç–æ —É–≤–µ–ª–∏—á–∏—Ç —Å–µ–±–µ—Å—Ç–æ–∏–º–æ—Å—Ç—å –∏—Ö –ø—Ä–æ–¥—É–∫—Ü–∏–∏ ¬´–¥–æ —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–∏ –Ω–µ–ø—Ä–∏–µ–º–ª–µ–º–æ–≥–æ —É—Ä–æ–≤–Ω—è¬ª. –ü—Ä–∏–º–µ—Ä —Ç–∞–∫–∏—Ö ¬´—Å–ª–æ–∂–Ω—ã—Ö¬ª —Å—É–±—Å—Ç–∞–Ω—Ü–∏–π –ø—Ä–∏–≤—ë–ª –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç ¬´–ê–∫—Ç–∏–≤–Ω–æ–≥–æ –∫–æ–º–ø–æ–Ω–µ–Ω—Ç–∞¬ª –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –°–µ–º–µ–Ω–æ–≤: –î–ª—è –ø–æ–ª—É—á–µ–Ω–∏—è –ª–æ–∫–∞–ª—å–Ω–æ–≥–æ —Å—Ç–∞—Ç—É—Å–∞ —Å—É–±—Å—Ç–∞–Ω—Ü–∏–∏ —Å–∞—Ö–∞—Ä–æ—Å–Ω–∏–∂–∞—é—â–µ–≥–æ –¥–∞–ø–∞–≥–ª–∏—Ñ–ª–æ–∑–∏–Ω–∞ –ø–æ—Ç—Ä–µ–±—É–µ—Ç—Å—è –ø—Ä–æ–≤–µ—Å—Ç–∏ –ø—è—Ç—å —Å—Ç–∞–¥–∏–π —Å–∏–Ω—Ç–µ–∑–∞, –ø—Ä–æ—Ç–∏–≤–æ—Ç—É–±–µ—Ä–∫—É–ª–µ–∑–Ω–æ–≥–æ —ç—Ç–∏–æ–Ω–∞–º–∏–¥–∞ ‚Äì —Å–µ–º—å. –í —Ç–æ –∂–µ –≤—Ä–µ–º—è –ø–æ –ø—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤–æ–º—É –¥–∞–∑–∞—Ç–∏–Ω–∏–±—É —Ç—Ä–µ–±—É–µ—Ç—Å—è –ª–∏—à—å –æ–¥–Ω–∞ —Å—Ç–∞–¥–∏—è. –≠—Ç–æ –º–æ–∂–µ—Ç –ø—Ä–∏–≤–µ—Å—Ç–∏ –∫ —Ç–æ–º—É, —á—Ç–æ –±–æ–ª–µ–µ –ª–µ–≥–∫–∏–µ –ø—Ä–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏–∏ –±—É–¥—É—Ç –≤—ã–ø—É—Å–∫–∞—Ç—å—Å—è –º–∞—Å—Å–æ–≤–æ, –∞ –±–æ–ª–µ–µ —Å–ª–æ–∂–Ω—ã–µ‚Äì –Ω–µ—Ç –∏ –∏—Ö —Å—Ç–∞–Ω—É—Ç –∏–º–ø–æ—Ä—Ç–∏—Ä–æ–≤–∞—Ç—å –∏–∑ –¥—Ä—É–≥–∏—Ö —Å—Ç—Ä–∞–Ω. –ì–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä ¬´–ü–°–ö –§–∞—Ä–º–∞¬ª –ï–≤–≥–µ–Ω–∏—è –®–∞–ø–∏—Ä–æ –ø—Ä–∏–≤–æ–¥–∏—Ç –≤ –ø—Ä–∏–º–µ—Ä –≥—Ä—É–ø–ø—É —Å—Ç–µ—Ä–æ–∏–¥–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ß—Ç–æ–±—ã —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–æ–≤–∞—Ç—å —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è–º –ø—Ä–æ–µ–∫—Ç–∞ –º–µ—Ç–æ–¥—Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π, –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—é –Ω—É–∂–Ω–æ —Å–æ–∑–¥–∞–≤–∞—Ç—å —Å–∞–º –∫–∞—Ä–∫–∞—Å —Å—Ç–µ—Ä–æ–∏–¥–∞, —á–µ–≥–æ –Ω–µ –¥–µ–ª–∞—é—Ç –¥–∞–∂–µ –∫—Ä—É–ø–Ω—ã–µ –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã–µ –∏–≥—Ä–æ–∫–∏. –í –ø—Ä–æ—Ç–∏–≤–Ω–æ–º —Å–ª—É—á–∞–µ, —É—Ç–≤–µ—Ä–∂–¥–∞–µ—Ç –®–∞–ø–∏—Ä–æ, ¬´–Ω–∏–∫–∞–∫–∏–µ –ø—Ä–µ—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ –Ω–µ –ø–æ–∫—Ä–æ—é—Ç –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–∏ –≤ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—é —Ç–∞–∫–æ–≥–æ –≥–ª—É–±–æ–∫–æ–≥–æ —Å–∏–Ω—Ç–µ–∑–∞ –∏ –µ–≥–æ —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–∏ –Ω–µ –æ—Ä–≥–∞–Ω–∏–∑–æ–≤–∞—Ç—å –Ω–∞ –æ–¥–Ω–æ–π –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω–æ–π –ø–ª–æ—â–∞–¥–∫–µ¬ª. –≠—Ç–∏ –ø—Ä–æ–±–ª–µ–º—ã, –ø–æ —Å–ª–æ–≤–∞–º –°–µ–º–µ–Ω–æ–≤–∞, –∞–∫—Ç—É–∞–ª—å–Ω—ã –¥–ª—è 162 –ø–æ–∑–∏—Ü–∏–π –∏–∑ 215, –≤—Ö–æ–¥—è—â–∏—Ö –≤ –ø–µ—Ä–µ—á–µ–Ω—å —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º—ã—Ö, —Ç. –µ. –¥–ª—è 75% —Å–ø–∏—Å–∫–∞. ¬´–õ–µ–∫–º–µ–¥–æ–±—Ä–∞—â–µ–Ω–∏–µ¬ª –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç —Å–∫–æ—Ä—Ä–µ–∫—Ç–∏—Ä–æ–≤–∞—Ç—å —Ñ–æ—Ä–º—É–ª–∏—Ä–æ–≤–∫–∏ –≤ –º–µ—Ç–æ–¥—Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏—è—Ö. –ü–æ–∫–∞ –æ–Ω–∏ ¬´–≤—ã–≥–ª—è–¥—è—Ç –Ω–µ –¥–æ –∫–æ–Ω—Ü–∞ –ø—Ä–æ—Ä–∞–±–æ—Ç–∞–Ω–Ω—ã–º–∏ –∏, —Å–∫–æ—Ä–µ–µ, –ø—Ä–µ–ø—è—Ç—Å—Ç–≤—É—é—Ç, —á–µ–º —Å–ø–æ—Å–æ–±—Å—Ç–≤—É—é—Ç –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏–∏ —Å–∏–Ω—Ç–µ–∑–∞ –∞–∫—Ç–∏–≤–Ω—ã—Ö —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö —Å—É–±—Å—Ç–∞–Ω—Ü–∏–π, –≥–æ–≤–æ—Ä–∏—Ç—Å—è –≤ –ø–∏—Å—å–º–µ. –†–∞–Ω–µ–µ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–∏ –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ —É–∂–µ –æ–±—Ä–∞—â–∞–ª–∏—Å—å –∫ –∑–∞–º–º–∏–Ω–∏—Å—Ç—Ä–∞ –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏ –∏ —Ç–æ—Ä–≥–æ–≤–ª–∏ –ï–∫–∞—Ç–µ—Ä–∏–Ω–µ –ü—Ä–∏–µ–∑–∂–µ–≤–æ–π —Å –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–µ–º —É–∂–µ—Å—Ç–æ—á–∞—Ç—å —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ –≤—ã–ø—É—Å–∫—É —Å—É–±—Å—Ç–∞–Ω—Ü–∏–π –ø–æ—ç—Ç–∞–ø–Ω–æ: –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª—è—Ç—å –ø—Ä–µ—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ —Ç–µ–º, –∫—Ç–æ —Å–º–æ–∂–µ—Ç –¥–æ 2030 –≥–æ–¥–∞ –∑–∞–ø—É—Å—Ç–∏—Ç—å –≤ —Å—Ç—Ä–∞–Ω–∞—Ö –ï–ê–≠–° —Ö–æ—Ç—è –±—ã –æ–¥–Ω—É —Å—Ç–∞–¥–∏—é —Å—É–±—Å—Ç–∞–Ω—Ü–∏–∏, –¥–æ 2035 –≥–æ–¥–∞ ‚Äì –¥–≤–µ, –∞ —Ç—Ä–∏ –∏ –±–æ–ª–µ–µ –º–æ–∂–Ω–æ –±—ã–ª–æ –±—ã –ª–æ–∫–∞–ª–∏–∑–æ–≤—ã–≤–∞—Ç—å –¥–æ 2040 –≥–æ–¥–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, import_export, sanctions"",
  ""impact"": ""high"",
  ""english"": ""The 'Medicines Application' requests the Ministry of Industry and Trade to refrain from 'sending horses' in the issue of localization for complex substances. In October, the Ministry of Industry and Trade developed and sent industry associations a project of methodological recommendations for assessing production processes of medicines. The document, which should serve as the basis for determining the degree of localization of substances, was welcomed by not all. The 'Medicines Application' believes that the proposed requirements may discourage manufacturers from localizing certain groups of drugs. The association submitted a letter with its comments, as reported by 'Vedomosti'. What is wrong: üü© the project of recommendations does not take into account 'current technological development' in pharmaceutical and chemical industries; üü© the developers of the document do not take into account various stages of synthesis of substances. Pharmaceutical companies will need to organize technically complex, lengthy and costly production, which will increase the cost of their products 'to an economically unfeasible level'. For example, Alexander Semenov, President of 'Active Ingredient', cites"
2025-11-24T05:36:13+00:00,@bezrec,6853,https://t.me/bezrec/6853,"–í –†–æ—Å—Ç–æ–≤–µ –ø—Ä–æ–¥–∞—é—Ç –∏–º—É—â–µ—Å—Ç–≤–æ ¬´–ë–∏–æ—Ç—ç–∫–∞¬ª. –î–æ—Ä–æ–≥–æ. –ù–∞ —ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω–æ–π –ø–ª–æ—â–∞–¥–∫–µ ¬´–¢–æ—Ä–≥–∏ –†–æ—Å—Å–∏–∏¬ª –∏–Ω—Ç–µ—Ä–µ—Å–Ω—ã–π –ª–æ—Ç. –° –º–æ–ª–æ—Ç–∫–∞ —É–π–¥—ë—Ç –ø–æ–º–µ—â–µ–Ω–∏–µ, —Ä–∞–Ω–µ–µ –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∞–≤—à–µ–µ –∫–æ–º–ø–∞–Ω–∏–∏ –ë–æ—Ä–∏—Å–∞ –®–ø–∏–≥–µ–ª—è. –†–µ—á—å –æ –Ω–µ–∂–∏–ª–æ–º –ø–æ–º–µ—â–µ–Ω–∏–∏ –ø–æ —É–ª–∏—Ü–µ –û—Ä—Å–∫–æ–π, 25 –æ–±—â–µ–π –ø–ª–æ—â–∞–¥—å—é 4,4 —Ç—ã—Å. –∫–≤–∞–¥—Ä–∞—Ç–Ω—ã—Ö –º–µ—Ç—Ä–æ–≤. –ù–∞—á–∞–ª—å–Ω–∞—è —Å—Ç–æ–∏–º–æ—Å—Ç—å –æ–±—ä–µ–∫—Ç–∞ - 121, 4 –º–ª–Ω —Ä—É–±–ª–µ–π. –ü–æ–¥–∞—Ç—å –∑–∞—è–≤–∫—É –Ω–∞ —É—á–∞—Å—Ç–∏–µ –≤ –∞—É–∫—Ü–∏–æ–Ω–µ –º–æ–∂–Ω–æ –¥–æ 20 –¥–µ–∫–∞–±—Ä—è 2025 –≥–æ–¥–∞. –ò—Ç–æ–≥–∏ –ø–æ–¥–≤–µ–¥—É—Ç —á–µ—Ä–µ–∑ –ø—è—Ç—å –¥–Ω–µ–π –ø–æ—Å–ª–µ –æ–∫–æ–Ω—á–∞–Ω–∏—è –ø—Ä–∏—ë–º–∞ –∑–∞—è–≤–æ–∫. –ù–∞–ø–æ–º–Ω–∏–º, —Å–∫–∞–Ω–¥–∞–ª—å–Ω–æ –∏–∑–≤–µ—Å—Ç–Ω—ã–π ¬´–ë–∏–æ—Ç—ç–∫¬ª –±—ã–ª –ø—Ä–∏–∑–Ω–∞–Ω –±–∞–Ω–∫—Ä–æ—Ç–æ–º –≤ –∞–ø—Ä–µ–ª–µ 2025 –≥–æ–¥–∞. –®–ø–∏–≥–µ–ª—è, –ø—Ä–∏–≥–æ–≤–æ—Ä–µ–Ω–Ω–æ–≥–æ –∫ 11 –≥–æ–¥–∞–º —Å—Ç—Ä–æ–≥–æ–≥–æ —Ä–µ–∂–∏–º–∞ –∑–∞ –≤–∑—è—Ç–∫–∏ —ç–∫—Å-–≥—É–±–µ—Ä–Ω–∞—Ç–æ—Ä—É –ü–µ–Ω–∑–µ–Ω—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –ò–≤–∞–Ω—É –ë–µ–ª–æ–∑–µ—Ä—Ü–µ–≤—É, –æ—Å–≤–æ–±–æ–¥–∏–ª–∏ –æ—Ç –æ—Å–Ω–æ–≤–Ω–æ–≥–æ –Ω–∞–∫–∞–∑–∞–Ω–∏—è –≤ –≤–∏–¥–µ –ª–∏—à–µ–Ω–∏—è —Å–≤–æ–±–æ–¥—ã –ø–æ —Å–æ—Å—Ç–æ—è–Ω–∏—é –∑–¥–æ—Ä–æ–≤—å—è. –ù–æ –ø—Ä–æ –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–µ –Ω–∞–∫–∞–∑–∞–Ω–∏–µ –ø—Ä–æ–∫—É—Ä–∞—Ç—É—Ä–∞ –Ω–µ –∑–∞–±—ã–ª–∞ ‚Äì –±–∏–∑–Ω–µ—Å–º–µ–Ω—É –ø—Ä–µ–¥–ø–∏—Å–∞–Ω–æ –≤—ã–ø–ª–∞—Ç–∏—Ç—å –≤ –ø–æ–ª—å–∑—É –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–∞ 450 –º–ª–Ω —Ä—É–±–ª–µ–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-11-23T11:02:14+00:00,@bezrec,6852,https://t.me/bezrec/6852,"Lemme ¬´–≤–∏—Ç–∞–º–∏–Ω–Ω—ã–π¬ª VS Lemme ¬´—Å–∏–≥–∞—Ä–µ—Ç–Ω—ã–π¬ª. –ö–æ–º–∞–Ω–¥–∞ –ö–æ—Ä—Ç–Ω–∏ –ö–∞—Ä–¥–∞—à—å—è–Ω –ø–æ–¥–∞–ª–∞ –≤–æ–∑—Ä–∞–∂–µ–Ω–∏–µ –ø—Ä–æ—Ç–∏–≤ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –≤ –°–®–ê —Ç–æ–≤–∞—Ä–Ω–æ–≥–æ –∑–Ω–∞–∫–∞ Lemme –∫–æ–º–ø–∞–Ω–∏–∏ Hong Kong Senran Technology Company, –∑–∞–Ω–∏–º–∞—é—â–µ–π—Å—è –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ–º –∏ –ø—Ä–æ–¥–∞–∂–µ–π —ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω—ã—Ö —Å–∏–≥–∞—Ä–µ—Ç, –≤–µ–π–ø–æ–≤ –∏ –Ω–∏–∫–æ—Ç–∏–Ω–æ—Å–æ–¥–µ—Ä–∂–∞—â–∏—Ö –ø—Ä–æ–¥—É–∫—Ç–æ–≤. –ê–≤—Ç–æ—Ä—ã –æ–±—Ä–∞—â–µ–Ω–∏—è –Ω–∞—Å—Ç–∞–∏–≤–∞—é—Ç, —á—Ç–æ —Ç–æ–≤–∞—Ä–Ω—ã–µ –∑–Ω–∞–∫–∏ ¬´–∏–¥–µ–Ω—Ç–∏—á–Ω—ã –∏/–∏–ª–∏ —Å—Ö–æ–¥–Ω—ã –¥–æ —Å—Ç–µ–ø–µ–Ω–∏ —Å–º–µ—à–µ–Ω–∏—è¬ª, –∏ —Å–æ–º–Ω–∏—Ç–µ–ª—å–Ω—ã–π ¬´—Ç—ë–∑–∫–∞¬ª –º–æ–∂–µ—Ç –Ω–∞–Ω–µ—Å—Ç–∏ ¬´–Ω–µ–ø–æ–ø—Ä–∞–≤–∏–º—ã–π —É—â–µ—Ä–± —Ä–µ–ø—É—Ç–∞—Ü–∏–∏ –∏ –¥–æ–±—Ä–æ–º—É –∏–º–µ–Ω–∏¬ª –ö–∞—Ä–¥–∞—à—å—è–Ω, –∫–æ—Ç–æ—Ä–∞—è –≥–æ–¥–∞–º–∏ —Å–æ–∑–¥–∞–≤–∞–ª–∞ –±—Ä–µ–Ω–¥-—Å–∏–º–≤–æ–ª –∑–¥–æ—Ä–æ–≤–æ–≥–æ –æ–±—Ä–∞–∑–∞ –∂–∏–∑–Ω–∏. –ì–æ–Ω–∫–æ–Ω–≥—Å–∫–∞—è –∫–æ–º–ø–∞–Ω–∏—è –≤–µ—Ä–æ—è—Ç–Ω–æ—Å—Ç—å –ø—É—Ç–∞–Ω–∏—Ü—ã –º–µ–∂–¥—É —Ç–æ–≤–∞—Ä–Ω—ã–º–∏ –∑–Ω–∞–∫–∞–º–∏ –æ—Ç—Ä–∏—Ü–∞–µ—Ç, –ø–æ—Å–∫–æ–ª—å–∫—É –ø—Ä–æ–¥–∞–≤–∞–µ–º—ã–µ –ø–æ–¥ –Ω–∏–º–∏ –ø—Ä–æ–¥—É–∫—Ç—ã –æ—Ç–Ω–æ—Å—è—Ç—Å—è –∫ —Ä–∞–∑–Ω—ã–º –∫–∞—Ç–µ–≥–æ—Ä–∏—è–º –∏ –ø–µ—Ä–µ—Å–µ—á–µ–Ω–∏–µ –∞—É–¥–∏—Ç–æ—Ä–∏–π –º–∞–ª–æ–≤–µ—Ä–æ—è—Ç–Ω–æ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, sanctions"",
  ""impact"": ""high"",
  ""english"": ""A lawsuit has been filed by Kim Kardashian's team against the registration of the trademark 'Lemme' by a Hong Kong company, Senran Technology Company. The lawsuit claims that the trademarks are 'confusingly similar' and could cause significant harm to Kim Kardashian's reputation and good name. The Hong Kong company denies the possibility of confusion, as their products are in different categories and target distinct audiences.""
}"
2025-11-22T11:02:10+00:00,@bezrec,6851,https://t.me/bezrec/6851,"–°—É–±–±–æ—Ç–∞ ‚Äì –≤—Ä–µ–º—è —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω–æ–≥–æ –≤—ã–ø—É—Å–∫–∞ —Ä—É–±—Ä–∏–∫–∏ #–≤–¥–æ–≥–æ–Ω–∫—É. üíä –ü–æ—Ä—è–¥–æ–∫ –ø–æ–ª—É—á–µ–Ω–∏—è –ø–µ—Ä—Å–æ–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω–æ–π –º–†–ù–ö-–≤–∞–∫—Ü–∏–Ω—ã –±—É–¥–µ—Ç –ø–æ–¥—Ä–æ–±–Ω–æ —Ä–∞–∑—ä—è—Å–Ω–µ–Ω –ø–æ–∑–∂–µ. –û–± —ç—Ç–æ–º –≤ —Å–≤–æ—ë–º —Ç–µ–ª–µ–≥—Ä–∞–º-–∫–∞–Ω–∞–ª–µ —Å–æ–æ–±—â–∏–ª –≥–ª–∞–≤–Ω—ã–π –æ–Ω–∫–æ–ª–æ–≥ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ê–Ω–¥—Ä–µ–π –ö–∞–ø—Ä–∏–Ω. –ù–∞ –Ω–∞—á–∞–ª—å–Ω–æ–º —ç—Ç–∞–ø–µ –ù–µ–æ–æ–Ω–∫–æ–≤–∞–∫ –º–æ–∂–µ—Ç –ø—Ä–∏–º–µ–Ω—è—Ç—å—Å—è —É –≤–∑—Ä–æ—Å–ª—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –Ω–µ–æ–ø–µ—Ä–∞–±–µ–ª—å–Ω–æ–π –∏–ª–∏ –º–µ—Ç–∞—Å—Ç–∞—Ç–∏—á–µ—Å–∫–æ–π –º–µ–ª–∞–Ω–æ–º–æ–π –∫–æ–∂–∏ - –≤ –∫–æ–º–±–∏–Ω–∞—Ü–∏–∏ —Å –∏–º–º—É–Ω–æ—Ç–µ—Ä–∞–ø–∏–µ–π. –ú—ã –æ—Å–æ–∑–Ω–∞–µ–º –º–∞—Å—à—Ç–∞–± –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç–∏ –∏ –±—É–¥–µ–º –ø—Ä–æ–¥–≤–∏–≥–∞—Ç—å—Å—è –º–∞–∫—Å–∏–º–∞–ª—å–Ω–æ –∞–∫–∫—É—Ä–∞—Ç–Ω–æ –∏ –Ω–∞—É—á–Ω–æ –æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω–æ, - –ø–æ–¥—á–µ—Ä–∫–Ω—É–ª –ö–∞–ø—Ä–∏–Ω. üíä –†–§–ü–ò –ø–æ–º–æ–∂–µ—Ç —Å–æ–∑–¥–∞—Ç—å –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—É—é –ø–ª–∞—Ç—Ñ–æ—Ä–º—É –ø–µ—Ä—Å–æ–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤. –§–æ–Ω–¥ —Ä–∞—Å—Å–º–æ—Ç—Ä–∏—Ç –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –ø—Ä–∏–≤–ª–µ—á–µ–Ω–∏—è —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è, –≤ —Ç–æ–º —á–∏—Å–ª–µ –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω–æ–≥–æ, –≤ –ø—Ä–æ–µ–∫—Ç—ã –≤ –æ–±–ª–∞—Å—Ç–∏ –±–∏–æ–º–µ–¥–∏—Ü–∏–Ω—ã –∏ –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π. –û —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–æ–º —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–µ –†–§–ü–ò –¥–æ–≥–æ–≤–æ—Ä–∏–ª—Å—è —Å –ò–Ω—Å—Ç–∏—Ç—É—Ç–æ–º —Å–∏—Å—Ç–µ–º–Ω–æ–≥–æ –ø—Ä–æ–≥—Ä–∞–º–º–∏—Ä–æ–≤–∞–Ω–∏—è –∏–º. –í.–ü. –ò–≤–∞–Ω–Ω–∏–∫–æ–≤–∞ –∏ –¶–µ–Ω—Ç—Ä–æ–º –∏–º. –ì–∞–º–∞–ª–µ–∏. üíä Novo Nordisk –≤—ã–ø–ª–∞—Ç–∏–ª–∞ –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏–∏ –∑–∞ –ø—Ä–æ–±–ª–µ–º—ã —Å–æ –∑—Ä–µ–Ω–∏–µ–º –ø–æ—Å–ª–µ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏—è –û–∑–µ–º–ø–∏–∫–∞ –∏ –í–µ–≥–æ–≤–∏. –í –æ–±—â–µ–π —Å–ª–æ–∂–Ω–æ—Å—Ç–∏ —á–µ—Ç—ã—Ä–µ –ø–∞—Ü–∏–µ–Ω—Ç–∞ –ø–æ–ª—É—á–∏–ª–∏ $124 —Ç—ã—Å. –°—É–º–º–∞ –Ω–µ –æ–∫–æ–Ω—á–∞—Ç–µ–ª—å–Ω–∞—è ‚Äì –æ–Ω–∞ –±—É–¥–µ—Ç —É–≤–µ–ª–∏—á–µ–Ω–∞, –µ—Å–ª–∏ –ø–æ—Å—Ç—Ä–∞–¥–∞–≤—à–∏–µ –¥–æ–∫–∞–∂—É—Ç, —á—Ç–æ —É—Ö—É–¥—à–µ–Ω–∏–µ –∑—Ä–µ–Ω–∏—è —Å–∫–∞–∑–∞–ª–æ—Å—å –Ω–∞ –∏—Ö –∑–∞—Ä–∞–±–æ—Ç–∫–µ. üíä Eli Lilly —Å—Ç–∞–ª–∞ –ø–µ—Ä–≤–æ–π —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–µ–π, –ø–µ—Ä–µ—à–∞–≥–Ω—É–≤—à–µ–π —Ä—É–±–µ–∂ —Ä—ã–Ω–æ—á–Ω–æ–π —Å—Ç–æ–∏–º–æ—Å—Ç–∏ –≤ $1 —Ç—Ä–ª–Ω. –û–∂–∏–¥–∞–µ–º–æ –ø–æ–º–æ–≥–ª–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–ª—è –ª–µ—á–µ–Ω–∏—è –æ–∂–∏—Ä–µ–Ω–∏—è. –° –Ω–∞—á–∞–ª–∞ –≥–æ–¥–∞ –∫–∞–ø–∏—Ç–∞–ª–∏–∑–∞—Ü–∏—è –∫–æ–º–ø–∞–Ω–∏–∏ —É–≤–µ–ª–∏—á–∏–ª–∞—Å—å –Ω–∞ 36%, –∑–∞ 2024 –≥–æ–¥ - –Ω–∞ 32%. üíä –ü–µ—Ä–µ—á–µ–Ω—å –∑–∞–∫—É–ø–∞–µ–º—ã—Ö –¥–ª—è ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ø–æ–ø–æ–ª–Ω–∏–ª—Å—è –¥–≤—É–º—è –ø–æ–∑–∏—Ü–∏—è–º–∏. –ü–æ–ø–µ—á–∏—Ç–µ–ª—å—Å–∫–∏–π —Å–æ–≤–µ—Ç —Ñ–æ–Ω–¥–∞ —É—Ç–≤–µ—Ä–¥–∏–ª –≤–∫–ª—é—á–µ–Ω–∏–µ –≤ —Å–ø–∏—Å–æ–∫ –¥–ª—è –∑–∞–∫—É–ø–æ–∫ –∞–∫—Å–∞—Ç–∏–ª–∏–º–∞–±–∞ –æ—Ç Syndax –∏ Incyte –∏ –ª–µ–Ω–∏–æ–ª–∏—Å–∏–±–∞ –æ—Ç Pharming Group. –ü–µ—Ä–≤—ã–π –∏—Å–ø–æ–ª—å–∑—É–µ—Ç—Å—è –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–æ–π —Ä–µ–∞–∫—Ü–∏–∏ ¬´—Ç—Ä–∞–Ω—Å–ø–ª–∞–Ω—Ç–∞—Ç –ø—Ä–æ—Ç–∏–≤ —Ö–æ–∑—è–∏–Ω–∞¬ª (–†–¢–ü–•), –≤—Ç–æ—Ä–æ–π - –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Å–∏–Ω–¥—Ä–æ–º–∞ –∞–∫—Ç–∏–≤–∏—Ä–æ–≤–∞–Ω–Ω–æ–π PI3-–∫–∏–Ω–∞–∑—ã –¥–µ–ª—å—Ç–∞ (APDS), —Å–≤—è–∑–∞–Ω–Ω–æ–≥–æ —Å —Ä–∞–∑–ª–∏—á–Ω—ã–º–∏ –≤–∏–¥–∞–º–∏ –∏–º–º—É–Ω–æ–¥–µ—Ñ–∏—Ü–∏—Ç–∞. üíä –í –Ø–∫—É—Ç–∏–∏ –±—É–¥—É—Ç —Ä–∞–±–æ—Ç–∞—Ç—å –Ω–∞–¥ –¥–æ—Å—Ç–∞–≤–∫–æ–π –ª–µ–∫–∞—Ä—Å—Ç–≤ –ë–ü–õ–ê. –í–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å —ç–∫—Å—Ç—Ä–µ–Ω–Ω–æ–π –¥–æ—Å—Ç–∞–≤–∫–∏ –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç–æ–≤ –≤ –æ—Ç–¥–∞–ª–µ–Ω–Ω—ã–µ –∞—Ä–∫—Ç–∏—á–µ—Å–∫–∏–µ –ø–æ—Å–µ–ª–∫–∏ - —ç—Ç–æ –Ω–µ –ø—Ä–æ—Å—Ç–æ –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–∞, –∞ –æ–¥–Ω–∞ –∏–∑ –Ω–∞—à–∏—Ö –∫–ª—é—á–µ–≤—ã—Ö —Ü–µ–ª–µ–π. –ë–µ—Å–ø–∏–ª–æ—Ç–Ω–∏–∫ —Å–º–æ–∂–µ—Ç –∑–∞ —á–∞—Å –¥–æ—Å—Ç–∞–≤–∏—Ç—å –≤ —Ñ–µ–ª—å–¥—à–µ—Ä—Å–∫–∏–π –ø—É–Ω–∫—Ç –∞–º–ø—É–ª—É —Å –∂–∏–∑–Ω–µ–Ω–Ω–æ –≤–∞–∂–Ω—ã–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–º –∏–ª–∏ –ø–∞—Ä—Ç–∏—é –≤–∞–∫—Ü–∏–Ω, –Ω–∞ —á—Ç–æ —É —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω–æ–≥–æ —Ç—Ä–∞–Ω—Å–ø–æ—Ä—Ç–∞ —É—à–ª–∏ –±—ã —Å—É—Ç–∫–∏, –∞ —Ç–æ –∏ –±–æ–ª—å—à–µ. –≠—Ç–æ –Ω–µ –≤–æ–ø—Ä–æ—Å —É–¥–æ–±—Å—Ç–≤–∞, —ç—Ç–æ –≤–æ–ø—Ä–æ—Å —Å–ø–∞—Å–µ–Ω–∏—è –∂–∏–∑–Ω–µ–π, - —Ä–∞—Å—Å–∫–∞–∑–∞–ª –≥–ª–∞–≤–∞ —Ä–µ–≥–∏–æ–Ω–∞ –ê–π—Å–µ–Ω –ù–∏–∫–æ–ª–∞–µ–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance, safety"",
  ""impact"": ""high"",
  ""english"": ""A new personalized mRNA vaccine will be explained in detail later. Dr. Andrey Kaprin, the head of oncology at the Ministry of Health, announced this in his Telegram channel. The Notonovak vaccine will initially be used for adults with unresectable or metastatic melanoma skin cancer - in combination with immunotherapy. The team is aware of the significant responsibility and will proceed carefully and scientifically. Russia's Federal Agency for Scientific Research (RFPI) is helping to create a platform for personalized medicines. The foundation will consider foreign funding for projects in biomedicine and artificial technologies. Russia's Federal Agency for Scientific Research (RFPI) has agreed to cooperate with the Institute of System Programming and the Gamaleya Center. Novo Nordisk has paid compensation for vision problems after using Ozone and Veego. Four patients received $124,000 in compensation, which will be increased if the patients prove that their vision problems affected their earnings. Eli Lilly became the first pharmaceutical company to surpass a market value of $1 trillion"
2025-11-21T15:34:32+00:00,@bezrec,6850,https://t.me/bezrec/6850,"–ü–æ–±—ã–≤–∞–ª–∏ –Ω–∞ VII –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–æ–π –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ ¬´–ß—Ç–æ –ø—Ä–æ–∏—Å—Ö–æ–¥–∏—Ç –Ω–∞ —Ä—ã–Ω–∫–µ –ë–ê–î?¬ª. –ü–æ–∫–∞–∑–∞–ª–æ—Å—å –∏–Ω—Ç–µ—Ä–µ—Å–Ω—ã–º –≤—ã—Å—Ç—É–ø–ª–µ–Ω–∏–µ —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—è –æ—Ç–¥–µ–ª–∞ —Ä–µ–∫–ª–∞–º–Ω–æ–π –ø–ª–∞—Ç—Ñ–æ—Ä–º—ã ¬´–ö—É–ø–µ—Ä¬ª –ê–ª–µ–∫—Å–∞–Ω–¥—Ä–∞ –ù–æ—Å–∫–æ–≤–∞, –∫–æ—Ç–æ—Ä—ã–π —Ä–∞—Å—Å–∫–∞–∑–∞–ª –æ —Ä–µ–∫–ª–∞–º–Ω—ã—Ö –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç–∞—Ö –∏ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—è—Ö, –¥–æ—Å—Ç—É–ø–Ω—ã—Ö –¥–ª—è –∞–ø—Ç–µ—á–Ω—ã—Ö —Å–µ—Ç–µ–π –∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ë–ê–î–æ–≤. –ö–ª—é—á–µ–≤—ã–µ –º–æ–º–µ–Ω—Ç—ã: üü©–≤ –∞—Ä—Å–µ–Ω–∞–ª–µ –∫–æ–º–ø–∞–Ω–∏–∏ ‚Äî 65+ —Ä–µ–∫–ª–∞–º–Ω—ã—Ö –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç–æ–≤ –¥–ª—è –ø–∞—Ä—Ç–Ω—ë—Ä–æ–≤ –∏ 30+ —Ñ–æ—Ä–º–∞—Ç–æ–≤ –¥–ª—è –±—Ä–µ–Ω–¥–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ –µ—â—ë –Ω–µ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω—ã –Ω–∞ –≤–∏—Ç—Ä–∏–Ω–µ; üü© –æ—Å–Ω–æ–≤–Ω—ã–µ –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç—ã –ø—Ä–æ–¥–≤–∏–∂–µ–Ω–∏—è, –≤–∫–ª—é—á–∞—è HERO-–±–∞–Ω–Ω–µ—Ä –≤ –Ω–∞—á–∞–ª–µ –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª—å—Å–∫–æ–≥–æ –ø—É—Ç–∏, –∫–æ–Ω–≤–µ—Ä—Å–∏–æ–Ω–Ω—É—é ¬´—à—Ç–æ—Ä–∫—É¬ª –ø—Ä–∏ –≤—ã–±–æ—Ä–µ —Ä–∏—Ç–µ–π–ª–µ—Ä–∞ –∏ –≤–∏–¥–µ–æ-–±–∞–Ω–Ω–µ—Ä—ã, –º–æ–≥—É—Ç –ø–æ—Ö–≤–∞—Å—Ç–∞—Ç—å—Å—è –≤—ã—Å–æ–∫–∏–º–∏ –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è–º–∏: CTR (Click-Through Rate ‚Äî –ø–æ–∫–∞–∑–∞—Ç–µ–ª—å –∫–ª–∏–∫–∞–±–µ–ª—å–Ω–æ—Å—Ç–∏) –≤–∞—Ä—å–∏—Ä—É–µ—Ç—Å—è –æ—Ç 0,8% –¥–æ 2,5%; üü© —Å–∞–º—ã–π –∫–æ–Ω–≤–µ—Ä—Å–∏–æ–Ω–Ω—ã–π —ç–ª–µ–º–µ–Ω—Ç –≤ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏–∏ ‚Äì ¬´—à—Ç–æ—Ä–∫–∞¬ª; üü© —Å–µ–≥–æ–¥–Ω—è –Ω–∞ ¬´–ö—É–ø–µ—Ä–µ¬ª –ø–æ–¥–∫–ª—é—á–µ–Ω–æ –±–æ–ª–µ–µ 30 –∞–ø—Ç–µ—á–Ω—ã—Ö —Å–µ—Ç–µ–π; üü© –º–µ—Å—è—á–Ω–∞—è –∞—É–¥–∏—Ç–æ—Ä–∏—è - 8,1 –º–ª–Ω –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª–µ–π, –∏–∑ –∫–æ—Ç–æ—Ä—ã—Ö –ª–∏—à—å 22% –ø–µ—Ä–µ—Å–µ–∫–∞—é—Ç—Å—è —Å –∫—Ä—É–ø–Ω–µ–π—à–∏–º–∏ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞–º–∏. –£—Å–ø–µ—à–Ω—ã–µ –∫–µ–π—Å—ã: üîΩ –ø—Ä–æ–º–æ–∫–∞–º–ø–∞–Ω–∏—è –¥–ª—è –∞–ø—Ç–µ—á–Ω–æ–π —Å–µ—Ç–∏ —Å–æ —Å–∫–∏–¥–∫–æ–π 400 —Ä—É–±–ª–µ–π –Ω–∞ –∑–∞–∫–∞–∑ –æ–±–µ—Å–ø–µ—á–∏–ª–∞ +23% –∫ –¥–æ–±–∞–≤–æ—á–Ω–æ–º—É GMV (–¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–π –æ–±—ä—ë–º –≤–∞–ª–æ–≤—ã—Ö –ø—Ä–æ–¥–∞–∂), —É–≤–µ–ª–∏—á–∏–ª–∞ –¥–æ–ª—é –∞–∫—Ç–∏–≤–Ω—ã—Ö –∫–ª–∏–µ–Ω—Ç–æ–≤ –Ω–∞ 35% –∏ –æ–±–µ—Å–ø–µ—á–∏–ª–∞ —Å–æ–≤–æ–∫—É–ø–Ω—É—é —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –≤—ã—à–µ 5; üîΩ60-–¥–Ω–µ–≤–Ω–∞—è –∫–∞–º–ø–∞–Ω–∏—è —Å –≤–Ω–µ–¥—Ä–µ–Ω–∏–µ–º —Å—ç–º–ø–ª–∏–Ω–≥–∞ (–¥–æ–±–∞–≤–ª–µ–Ω–∏–µ –ø—Ä–æ–±–Ω–∏–∫–æ–≤ —Ç–æ–≤–∞—Ä–∞ –≤ –∑–∞–∫–∞–∑) –∏ —Ä–µ—Ç–∞—Ä–≥–µ—Ç–∏–Ω–≥–æ–º –≤ –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ —É–≤–ª–∞–∂–Ω—è—é—â–∏—Ö –∫–∞–ø–µ–ª—å –ø—Ä–∏–Ω–µ—Å–ª–∞ —É–≤–µ–ª–∏—á–µ–Ω–∏–µ –∑–∞–∫–∞–∑–æ–≤ –Ω–∞ 40%. –ú—ã –≤—Å–µ–≥–¥–∞ –æ–ø–∏—Ä–∞–µ–º—Å—è –Ω–∞ –ø–æ–≤–µ–¥–µ–Ω–∏–µ –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª–µ–π –∏ —É–º–µ–µ–º —Ä–∞–±–æ—Ç–∞—Ç—å —Å —Ä–∞–∑–Ω—ã–º–∏ –∞—É–¥–∏—Ç–æ—Ä–∏—è–º–∏ ‚Äî –≤ —Ç–æ–º —á–∏—Å–ª–µ —Å –ø–æ–∫—É–ø–∞—Ç–µ–ª—è–º–∏ –ë–ê–î–æ–≤. –¢–æ—á–Ω–∞—è —Å–µ–≥–º–µ–Ω—Ç–∞—Ü–∏—è –∏ —à–∏—Ä–æ–∫–∏–π –Ω–∞–±–æ—Ä —Ä–µ–∫–ª–∞–º–Ω—ã—Ö —Ñ–æ—Ä–º–∞—Ç–æ–≤ –∏ –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç–æ–≤ –ø–æ–∑–≤–æ–ª—è—é—Ç –ø–æ–ø–∞–¥–∞—Ç—å –≤ –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç—å –∫–æ–Ω–∫—Ä–µ—Ç–Ω–æ–≥–æ –ø–æ–∫—É–ø–∞—Ç–µ–ª—è –∏ –æ–±–µ—Å–ø–µ—á–∏–≤–∞—Ç—å –±—Ä–µ–Ω–¥–∞–º —Ä–æ—Å—Ç –ø—Ä–æ–¥–∞–∂. –ù–∞—à–∞ –∑–∞–¥–∞—á–∞ ‚Äî –¥–∞–≤–∞—Ç—å –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç—ã, –∫–æ—Ç–æ—Ä—ã–µ –¥–µ–ª–∞—é—Ç –∫–∞–∂–¥—ã–π —Ä–µ–∫–ª–∞–º–Ω—ã–π —Ä—É–±–ª—å –º–∞–∫—Å–∏–º–∞–ª—å–Ω–æ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã–º, ‚Äî –ø–æ–¥—á–µ—Ä–∫–Ω—É–ª –ù–æ—Å–∫–æ–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": true,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,pharmacovigilance,hospital_policy,guideline"",
  ""impact"": ""medium"",
  ""english"": ""The message discusses a presentation by Alexander Noskov from the advertising platform department of 'Kuper', focusing on advertising tools and opportunities for pharmaceutical companies. It highlights the company's 65+ advertising instruments and 30+ formats for brands, emphasizing high click-through rates. It mentions successful campaigns like a promotion with a 400 ruble discount, increasing GMV by 23% and customer acquisition by 35%. The message does not primarily discuss regulation, policy, reimbursement, pricing, registration, import/export controls, parallel imports, sanctions affecting medicines, or demand for medicines. It is more about the company's advertising strategies and their effectiveness.""
}"
2025-11-21T14:34:13+00:00,@bezrec,6849,https://t.me/bezrec/6849,"–Ø–ø–æ–Ω—Å–∫–∏–µ —Ä–∞–±–æ—Ç–æ–¥–∞—Ç–µ–ª–∏ —Å–º—è–≥—á–∞—é—Ç —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ –≤–Ω–µ—à–Ω–µ–º—É –≤–∏–¥—É –∏–∑-–∑–∞ –¥–µ—Ñ–∏—Ü–∏—Ç–∞ —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤. Reuters –∑–∞–º–µ—Ç–∏–ª–∏ ""–ø–æ—Ç–µ–ø–ª–µ–Ω–∏–µ"" —Å—Ä–µ–¥–∏ –∫—Ä—É–ø–Ω—ã—Ö —è–ø–æ–Ω—Å–∫–∏—Ö —Ä–∞–±–æ—Ç–æ–¥–∞—Ç–µ–ª–µ–π. –¢–∞–∫, –≤ —Å–µ—Ç–∏ –∞–ø—Ç–µ–∫ Fuji Yakuhin —Ç–µ–ø–µ—Ä—å –¥–æ–ø—É—Å—Ç–∏–º—ã –∑–∞–º–µ—Ç–Ω—ã–π –º–∞–∫–∏—è–∂ –∏ —Ü–≤–µ—Ç–Ω–æ–π –º–∞–Ω–∏–∫—é—Ä –¥–ª—è –≤—Å–µ—Ö —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤, –∫—Ä–æ–º–µ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–æ–≤, –∞ –≤ —Ç–æ—Ä–≥–æ–≤—ã—Ö –∑–∞–ª–∞—Ö —É–Ω–∏–≤–µ—Ä–º–∞–≥–∞ Don Quijote —Ç–µ–ø–µ—Ä—å –º–æ–∂–Ω–æ —Ä–∞–±–æ—Ç–∞—Ç—å —Å –≤–æ–ª–æ—Å–∞–º–∏ –ª—é–±–æ–≥–æ —Ü–≤–µ—Ç–∞ –∏ —Å –ª—é–±—ã–º –º–∞–Ω–∏–∫—é—Ä–æ–º. –î–ª—è –Ø–ø–æ–Ω–∏–∏ —ç—Ç–æ –≤ –Ω–æ–≤–∏–Ω–∫—É: —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω–æ –º–µ—Å—Ç–Ω—ã–µ –∫–æ–º–ø–∞–Ω–∏–∏ –≤ –ª—é–±–æ–π –æ—Ç—Ä–∞—Å–ª–∏ –ø—Ä–µ–¥–ø–∏—Å—ã–≤–∞–ª–∏ —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–∞–º –¥–µ–ª–æ–≤–æ–π —Å—Ç–∏–ª—å –≤ –æ–¥–µ–∂–¥–µ, –Ω–µ–±—Ä–æ—Å–∫–∏–π –º–∞–∫–∏—è–∂ –∏ —á—ë—Ä–Ω—ã–π –ª–∏–±–æ –∫–∞—à—Ç–∞–Ω–æ–≤—ã–π —Ü–≤–µ—Ç –≤–æ–ª–æ—Å. –ò–∑ —É–∫—Ä–∞—à–µ–Ω–∏–π ‚Äì —Ç–æ–ª—å–∫–æ –æ–±—Ä—É—á–∞–ª—å–Ω–æ–µ –∫–æ–ª—å—Ü–æ. ""–ü–æ—Ç–µ–ø–ª–µ–Ω–∏–µ"" –≤—ã–∑–≤–∞–Ω–æ –¥–µ—Ñ–∏—Ü–∏—Ç–æ–º –∫–∞–¥—Ä–æ–≤, —Ç–∞–∫ —á—Ç–æ —Ä–∞–±–æ—Ç–æ–¥–∞—Ç–µ–ª–∏ —Å—Ç–∞—Ä–∞—é—Ç—Å—è –ø—Ä–∏–≤–ª–µ—á—å –Ω–æ–≤—ã—Ö –ª—é–¥–µ–π –±–æ–ª—å—à–µ–π —Å–≤–æ–±–æ–¥–æ–π —Å–∞–º–æ–≤—ã—Ä–∞–∂–µ–Ω–∏—è. –ö—Å—Ç–∞—Ç–∏, –∑–∞ –ø–æ—Å–ª–µ–¥–Ω–∏–µ –ø–∞—Ä—É –ª–µ—Ç —è–ø–æ–Ω—Å–∫–∞—è –∫–æ—Ä–ø–æ—Ä–∞—Ç–∏–≤–Ω–∞—è –∫—É–ª—å—Ç—É—Ä–∞ –ø—Ä–µ—Ç–µ—Ä–ø–µ–ª–∞ –Ω–µ—Å–∫–æ–ª—å–∫–æ –ª—é–±–æ–ø—ã—Ç–Ω—ã—Ö –∏–∑–º–µ–Ω–µ–Ω–∏–π. –ù–∞–ø—Ä–∏–º–µ—Ä, –º–∏–Ω–∏—Å—Ç–µ—Ä—Å—Ç–≤–æ –æ–∫—Ä—É–∂–∞—é—â–µ–π —Å—Ä–µ–¥—ã –Ø–ø–æ–Ω–∏–∏ –∑–∞–ø—É—Å—Ç–∏–ª–æ –∫–∞–º–ø–∞–Ω–∏—é –≤ –ø–æ–ª—å–∑—É –æ—Ç–∫–∞–∑–∞ –æ—Ç –ø–∏–¥–∂–∞–∫–æ–≤ –∏ –≥–∞–ª—Å—Ç—É–∫–æ–≤ –≤ –æ—Ñ–∏—Å–∞—Ö –∏ –æ—Ç –ø–µ—Ä—á–∞—Ç–æ–∫ ‚Äì —Å—Ä–µ–¥–∏ –≤–æ–¥–∏—Ç–µ–ª–µ–π —Ç–∞–∫—Å–∏, —á—Ç–æ–±—ã —Å–æ–∫—Ä–∞—Ç–∏—Ç—å —Ä–∞—Å—Ö–æ–¥—ã –Ω–∞ –∫–æ–Ω–¥–∏—Ü–∏–æ–Ω–∏—Ä–æ–≤–∞–Ω–∏–µ –≤–æ–∑–¥—É—Ö–∞. ‚Ñ¢Ô∏è –¶–µ–Ω–∞ –∫—Ä–∞—Å–æ—Ç—ã","{""skip"": true}"
2025-11-21T12:03:48+00:00,@bezrec,6848,https://t.me/bezrec/6848,"–í –ì–æ—Å–¥—É–º–µ ¬´–Ω–∞–µ—Ö–∞–ª–∏¬ª –Ω–∞ –ò–ò –≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–∏. –ë–æ–ª–µ–µ –ø–æ–ª–æ–≤–∏–Ω—ã —Ä–æ—Å—Å–∏—è–Ω –∑–∞–Ω–∏–º–∞—é—Ç—Å—è —Å–∞–º–æ–ª–µ—á–µ–Ω–∏–µ–º, –∞ 88% ‚Äî —Å–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω–æ –≤—ã–±–∏—Ä–∞—é—Ç –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã. –¢–µ–ø–µ—Ä—å –∫ —ç—Ç–æ–º—É –¥–æ–±–∞–≤–∏–ª–∏—Å—å –Ω–µ–π—Ä–æ—Å–µ—Ç–∏, –∫–æ—Ç–æ—Ä—ã–µ —Ä–∞–∑–¥–∞—é—Ç –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ —Å–æ–≤–µ—Ç—ã –ø–æ—Ö–ª–µ—â–µ –Ω—É—Ç—Ä–∏—Ü–∏–æ–ª–æ–≥–æ–≤ –∏ ¬´–±–∏–æ—Ö–∞–∫–µ—Ä–æ–≤¬ª, - –≤–æ–∑–º—É—Ç–∏–ª—Å—è –ó–∞–º–ø—Ä–µ–¥ –ì–æ—Å–¥—É–º—ã –ë–æ—Ä–∏—Å –ß–µ—Ä–Ω—ã—à–æ–≤. –î–µ–ø—É—Ç–∞—Ç –æ—Ç–º–µ—Ç–∏–ª, —á—Ç–æ —Å—Ç—Ä–µ–º–∏—Ç–µ–ª—å–Ω–æ–µ —Ä–∞–∑–≤–∏—Ç–∏–µ –ò–ò —Ç—Ä–µ–±—É–µ—Ç —Å—Ä–æ—á–Ω–æ–≥–æ —Ä–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω–∏—è, –æ—Å–æ–±–µ–Ω–Ω–æ –≤ —Ç–∞–∫–æ–π —á—É–≤—Å—Ç–≤–∏—Ç–µ–ª—å–Ω–æ–π —Å—Ñ–µ—Ä–µ, –∫–∞–∫ –∑–¥–æ—Ä–æ–≤—å–µ, –∏ –æ–∑–∞–¥–∞—á–∏–ª —ç—Ç–∏–º –≤–æ–ø—Ä–æ—Å–æ–º –ú–∏–Ω—Ü–∏—Ñ—Ä—ã –∏ –†–æ—Å–∫–æ–º–Ω–∞–¥–∑–æ—Ä, –Ω–∞–ø—Ä–∞–≤–∏–≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–µ–µ –æ–±—Ä–∞—â–µ–Ω–∏–µ. –ß—Ç–æ –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è —Å–¥–µ–ª–∞—Ç—å –≤–µ–¥–æ–º—Å—Ç–≤–∞–º: üîò—É—Å—Ç–∞–Ω–æ–≤–∏—Ç—å —á–µ—Ç–∫–∏–µ –ø—Ä–∞–≤–∏–ª–∞, —Å–æ–≥–ª–∞—Å–Ω–æ –∫–æ—Ç–æ—Ä—ã–º –æ—Ç–≤–µ—Ç—ã –Ω–µ–π—Ä–æ—Å–µ—Ç–µ–π –Ω–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –∑–∞–ø—Ä–æ—Å—ã –±—É–¥—É—Ç —Å–æ–ø—Ä–æ–≤–æ–∂–¥–∞—Ç—å—Å—è –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏–µ–º –æ —Ç–æ–º, —á—Ç–æ —ç—Ç–æ –Ω–µ –∫–æ–Ω—Å—É–ª—å—Ç–∞—Ü–∏—è –≤—Ä–∞—á–∞, —á—Ç–æ–±—ã –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª—å –æ—Å–æ–∑–Ω–∞–Ω–Ω–æ –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–∞–ª —Ä–∏—Å–∫–∏ –ø–µ—Ä–µ–¥ –ø–æ–ª—É—á–µ–Ω–∏–µ–º —Å–æ–≤–µ—Ç–∞ üîò–∑–∞–ø—Ä–µ—Ç–∏—Ç—å –Ω–µ–π—Ä–æ—Å–µ—Ç—è–º —Ä–µ–∫–ª–∞–º–∏—Ä–æ–≤–∞—Ç—å –∏ —Ä–µ–∫–æ–º–µ–Ω–¥–æ–≤–∞—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏ –ë–ê–î—ã. –í–∏–¥–∏–º–æ, –ø—Ä–µ–¥–≤–∫—É—à–∞—è —à–∫–≤–∞–ª –∫–æ–º–º–µ–Ω—Ç–∞—Ä–∏–µ–≤ –ø—Ä–æ ¬´–∑–∞–ø—Ä–µ—Ç–∏—Ç—å –∏ –Ω–µ –ø—É—â–∞—Ç—å¬ª, –ß–µ—Ä–Ω—ã—à–æ–≤ –æ—Å–æ–±–æ –ø–æ–¥—á–µ—Ä–∫–Ω—É–ª, —á—Ç–æ —É –µ–≥–æ –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤—ã –±–ª–∞–≥–∏–µ —Ü–µ–ª–∏ ‚Äî –Ω–µ —Ç–æ—Ä–º–æ–∑–∏—Ç—å —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏, –∞ –Ω–∞–ø—Ä–∞–≤–∏—Ç—å –∏—Ö –≤–æ –±–ª–∞–≥–æ —Å–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∑–¥–æ—Ä–æ–≤—å—è –∏ –∂–∏–∑–Ω–∏ –ª—é–¥–µ–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-11-21T09:01:47+00:00,@bezrec,6846,https://t.me/bezrec/6846,"–ö–æ–º–º—É–Ω–∏–∫–∞—Ü–∏–æ–Ω–Ω–æ–µ –∞–≥–µ–Ω—Ç—Å—Ç–≤–æ ¬´–†–æ–¥–Ω–∞—è –†–µ—á—å¬ª –ø–æ–¥–µ–ª–∏–ª–æ—Å—å —Å ¬´–ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞¬ª –¥–∞–Ω–Ω—ã–º–∏ –æ —Ç–æ–º, –∫–∞–∫ –∏–∑–º–µ–Ω–∏–ª–∞—Å—å —ç–∫–æ–Ω–æ–º–∏–∫–∞ —Ä–µ–∫–ª–∞–º–Ω—ã—Ö –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–π –≤ 2025 –≥–æ–¥—É, –≤–∫–ª—é—á–∞—è —Ä—ã–Ω–æ–∫ e-pharma. –í–∞–∂–Ω–æ–µ –∏–∑ –æ—Ç—á—ë—Ç–∞: üîò—Ä—ã–Ω–æ–∫ e-pharma –¥–µ–º–æ–Ω—Å—Ç—Ä–∏—Ä—É–µ—Ç —É—Å—Ç–æ–π—á–∏–≤—ã–π —Ä–æ—Å—Ç: –æ–±–æ—Ä–æ—Ç —É–≤–µ–ª–∏—á–∏–ª—Å—è –Ω–∞ 36% –ø–æ –∏—Ç–æ–≥–∞–º –ø–µ—Ä–≤–æ–≥–æ –ø–æ–ª—É–≥–æ–¥–∏—è 2025 –≥–æ–¥–∞, –∞ —á–∏—Å–ª–æ –∑–∞–∫–∞–∑–æ–≤ ‚Äî –Ω–∞ 17%; üîò–æ–Ω–ª–∞–π–Ω-–∞–ø—Ç–µ–∫–∏ –ø—Ä–æ–¥–æ–ª–∂–∞—é—Ç —Ä–∞—Å—à–∏—Ä—è—Ç—å –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª—å—Å–∫—É—é –±–∞–∑—É: 15% —Ä–æ—Å—Å–∏—è–Ω –≤–ø–µ—Ä–≤—ã–µ –Ω–∞—á–∞–ª–∏ –ø–æ–∫—É–ø–∞—Ç—å –±–µ–∑—Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –æ–Ω–ª–∞–π–Ω, –∞ 23% ‚Äî —Å—Ç–∞–ª–∏ –¥–µ–ª–∞—Ç—å —ç—Ç–æ —á–∞—â–µ; üîò–≤ 2026 –≥–æ–¥—É e-pharma –±—É–¥–µ—Ç —Ä–∞–∑–≤–∏–≤–∞—Ç—å—Å—è –ø—Ä–µ–∂–¥–µ –≤—Å–µ–≥–æ –∑–∞ —Å—á–µ—Ç –≤–Ω–µ–∞–ø—Ç–µ—á–Ω—ã—Ö –ø–ª–æ—â–∞–¥–æ–∫, –∫–æ—Ç–æ—Ä—ã–µ —É—Å–∏–ª–∏–≤–∞—é—Ç –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏—é –∏ –ø—Ä–∏–≤–ª–µ–∫–∞—é—Ç –≤—Å—ë –±–æ–ª—å—à–µ –ø–æ–∫—É–ø–∞—Ç–µ–ª–µ–π; üîò–æ–º–Ω–∏–∫–∞–Ω–∞–ª—å–Ω–æ—Å—Ç—å —Å–æ—Ö—Ä–∞–Ω–∏—Ç—Å—è –∫–∞–∫ –∫–ª—é—á–µ–≤–æ–π —Ç—Ä–µ–Ω–¥, –∞ –æ–±—ä–µ–º —Ä—ã–Ω–∫–∞ –ø–æ –∏—Ç–æ–≥–∞–º 2025 –≥–æ–¥–∞ —É–≤–µ–ª–∏—á–∏—Ç—Å—è –ø—Ä–∏–º–µ—Ä–Ω–æ –Ω–∞ 30% –∫ –ø—Ä–µ–¥—ã–¥—É—â–µ–º—É –≥–æ–¥—É; üîò–Ω–∞ —ç—Ç–æ–º —Ñ–æ–Ω–µ –º–µ–¥–∏–π–Ω—ã–π –∏–Ω–≤–µ–Ω—Ç–∞—Ä—å –∞–ø—Ç–µ—á–Ω—ã—Ö —Å–µ—Ç–µ–π —Å—Ç–∞–≥–Ω–∏—Ä—É–µ—Ç; üîò–º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å—ã –∏ e-grocery –∏–≥—Ä–æ–∫–∏ –æ–ø–µ—Ä–µ–∂–∞—é—Ç —Ä—ã–Ω–æ–∫ –ø–æ —Ä–∞–∑–≤–∏—Ç–∏—é —Ä–µ–∫–ª–∞–º–Ω—ã—Ö –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–µ–π –∏ —Å—Ç–∏–º—É–ª–∏—Ä—É—é—Ç –¥–∞–ª—å–Ω–µ–π—à–∏–π –æ—Ç—Ç–æ–∫ –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª–µ–π –≤ –æ–Ω–ª–∞–π–Ω; üîò92% –∑–∞–∫–∞–∑–æ–≤ –ø—Ä–∏—à–ª–æ—Å—å –Ω–∞ 20 –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö –∏–Ω—Ç–µ—Ä–Ω–µ—Ç-–∞–ø—Ç–µ–∫; üîò–≤ —Ç–æ–ø-10 –∞–ø—Ç–µ—á–Ω—ã—Ö —Å–µ—Ç–µ–π –∏ –æ–±—ä–µ–¥–∏–Ω–µ–Ω–∏–π –ø–æ –¥–æ–ª–µ –ø—Ä–æ–¥–∞–∂ —á–µ—Ä–µ–∑ —Å–æ–±—Å—Ç–≤–µ–Ω–Ω—ã–µ –æ–Ω–ª–∞–π–Ω-—Å–µ—Ä–≤–∏—Å—ã –≤–æ—à–ª–∏: ¬´–ê–ø—Ç–µ–∫–∞.—Ä—É¬ª, ¬´–†–∏–≥–ª–∞¬ª, ¬´–ê–ø—Ä–µ–ª—å¬ª, ¬´–Æ—Ç–µ–∫–∞¬ª, ¬´–ó–¥—Ä–∞–≤—Å–∏—Ç–∏¬ª, ¬´–ù–µ–æ—Ñ–∞—Ä–º¬ª, ¬´–ï–∞–ø—Ç–µ–∫–∞¬ª, ¬´36,6¬ª, ¬´–§–∞—Ä–º–∏–Ω–µ–¥¬ª, Polza .ru; üîòPolza.ru ‚Äî –ª–∏–¥–µ—Ä –ø–æ —Ç–µ–º–ø–∞–º —Ä–æ—Å—Ç–∞ e-com –ø—Ä–æ–¥–∞–∂ –ø–æ –∞–ø—Ç–µ—á–Ω–æ–º—É –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç—É; üîò¬´–ï–∞–ø—Ç–µ–∫–∞¬ª ‚Äî –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω–∞—è –∞–ø—Ç–µ–∫–∞ —Å –æ—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω–æ–π –¥–∏–Ω–∞–º–∏–∫–æ–π (-0,3%). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial, safety, pharmacovigilance"",
  ""impact"": ""high"",
  ""english"": ""The e-pharma market is showing steady growth with a 36% increase in turnover and a 17% rise in orders over the first half of 2025. Online pharmacies continue to expand their customer base, with 15% of Russians starting to buy without prescriptions online and another 23% buying more frequently. The market is expected to grow further in 2026 due to online platforms, which are increasing competition and attracting more customers. The offline pharmacy inventory is stagnating. Key trends include the dominance of digital platforms and e-marketplaces, with Polza.ru leading in terms of growth. However, '–ï–∞–ø—Ç–µ–∫–∞' is the only pharmacy with a negative sales trend (-0.3%).""
}"
2025-11-21T05:46:51+00:00,@bezrec,6845,https://t.me/bezrec/6845,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –¥–∞–ª –¥–æ–±—Ä–æ –æ–Ω–∫–æ–≤–∞–∫—Ü–∏–Ω–∞–º. –ú–∏–Ω–∏—Å—Ç–µ—Ä—Å—Ç–≤–æ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –≤—ã–¥–∞–ª–æ —Ä–∞–∑—Ä–µ—à–µ–Ω–∏—è –Ω–∞ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ –≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–π –ø—Ä–∞–∫—Ç–∏–∫–µ –¥–≤—É—Ö –∏–Ω–¥–∏–≤–∏–¥—É–∞–ª—å–Ω—ã—Ö –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –≠—Ç–æ –Ω–æ–≤–æ–µ –ø–æ–∫–æ–ª–µ–Ω–∏–µ –ø—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ - –ª–µ—á–µ–±–Ω–∞—è –≤–∞–∫—Ü–∏–Ω–∞ –Ω–∞ –ø–ª–∞—Ç—Ñ–æ—Ä–º–µ –º–†–ù–ö –∏ –ø–µ–ø—Ç–∏–¥–Ω–∞—è –≤–∞–∫—Ü–∏–Ω–∞, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª –ú–∏—Ö–∞–∏–ª –ú—É—Ä–∞—à–∫–æ, –ø–æ–¥—á–µ—Ä–∫–Ω—É–≤, —á—Ç–æ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—è ‚Äî –Ω–µ –ø–∞–Ω–∞—Ü–µ—è, –∞ –ª–∏—à—å –æ–¥–∏–Ω –∏–∑ –º–µ—Ç–æ–¥–æ–≤ –ª–µ—á–µ–Ω–∏—è. –ü–æ —Å–ª–æ–≤–∞–º –≥–ª–∞–≤—ã –ú–∏–Ω–∑–¥—Ä–∞–≤–∞, –Ω–∞ –Ω–∞—á–∞–ª—å–Ω–æ–º —ç—Ç–∞–ø–µ —Ä–µ—á—å –Ω–µ –∏–¥–µ—Ç –æ –º–∞—Å—Å–æ–≤–æ–º –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–∏. –≠—Ç–æ –ª–∏—à—å –ø–µ—Ä–≤—ã–µ —à–∞–≥–∏ –≤ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–∏ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ –ø–æ–¥—Ö–æ–¥–∞ –∫ –ª–µ—á–µ–Ω–∏—é, –≤–ø–µ—Ä–µ–¥–∏ ‚Äì –æ—Ü–µ–Ω–∫–∞ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –∏ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏. –†–∞–∑—Ä–µ—à–µ–Ω–∏–µ –ø–æ–ª—É—á–∏–ª–∏ –¥–≤–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞: üíä –ø–µ—Ä—Å–æ–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω–∞—è –º–†–ù–ö-–≤–∞–∫—Ü–∏–Ω–∞ –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ –º–µ–ª–∞–Ω–æ–º—ã –ù–µ–æ–æ–Ω–∫–æ–≤–∞–∫ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ù–ú–ò–¶ —Ä–∞–¥–∏–æ–ª–æ–≥–∏–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–æ—Å—Å–∏–∏ (—Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–∞ —Å–æ–≤–º–µ—Å—Ç–Ω–æ —Å –¶–µ–Ω—Ç—Ä–æ–º –∏–º. –ì–∞–º–∞–ª–µ–∏ –∏ –ù–ú–ò–¶ –æ–Ω–∫–æ–ª–æ–≥–∏–∏ –∏–º. –ë–ª–æ—Ö–∏–Ω–∞); üíä –ø–µ—Ä—Å–æ–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω–∞—è –ø–µ–ø—Ç–∏–¥–Ω–∞—è –≤–∞–∫—Ü–∏–Ω–∞ –û–Ω–∫–æ–ø–µ–ø—Ç –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –º–µ—Ç–∞—Å—Ç–∞—Ç–∏—á–µ—Å–∫–∏–º –∫–æ–ª–æ—Ä–µ–∫—Ç–∞–ª—å–Ω—ã–º —Ä–∞–∫–æ–º –æ—Ç –§–ù–ö–¶ —Ñ–∏–∑–∏–∫–æ-—Ö–∏–º–∏—á–µ—Å–∫–æ–π –º–µ–¥–∏—Ü–∏–Ω—ã –∏–º. –Æ.–ú. –õ–æ–ø—É—Ö–∏–Ω–∞ –§–ú–ë–ê –†–æ—Å—Å–∏–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance, safety"",
  ""impact"": ""high"",
  ""english"": ""The Ministry of Health has approved two individual biotechnological drugs for clinical practice. These are new generations of anti-cancer drugs - personalized mRNA vaccine and peptide vaccine, according to Mikhail Murashko. The technology is not a panacea but one of the methods for treatment. Currently, there are no plans to use them on a large scale. This is the initial stage of using innovative approaches for treatment, with further evaluation of their effectiveness and safety. Two drugs have been approved: personalized mRNA vaccine for melanoma treatment from the Russian National Medical Research Center of Radiology (developed in collaboration with the Gamaleya Research Institute and the National Medical Research Center of Oncology named after Yu. M. Lozhkin); personalized peptide vaccine for patients with metastatic colorectal cancer from the Russian National Medical Research Center of Physical-Chemical Medicine (FNMBA).""
}"
2025-11-20T14:35:52+00:00,@bezrec,6843,https://t.me/bezrec/6843,"–í –ø–æ–ª–∫—É –Ω–∞—Ä–æ–¥–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –ª–µ—á–µ–Ω–∏—è –Ω–∞—Å–º–æ—Ä–∫–∞ –ø—Ä–∏–±—ã–ª–æ. –ü—Ä–æ–≥—Ä–µ–≤–∞–Ω–∏–µ —è–π—Ü–æ–º –∏ –≤–¥—ã—Ö–∞–Ω–∏–µ –≥–æ—Ä—è—á–µ–≥–æ –ø–∞—Ä–∞ –æ—Ç –∫–∞—Ä—Ç–æ—à–∫–∏ ‚Äì –ø—Ä–æ—à–ª—ã–π –≤–µ–∫. –í —Å–µ—Ç–∏ –ø–æ—è–≤–∏–ª–∏—Å—å –≤–∏–¥–µ–æ, –Ω–∞ –∫–æ—Ç–æ—Ä—ã—Ö –¥–µ–≤—É—à–∫–∏ –∏–∑–±–∞–≤–ª—è—é—Ç—Å—è –æ—Ç –∑–∞–ª–æ–∂–µ–Ω–Ω–æ—Å—Ç–∏ —Å –ø–æ–º–æ—â—å—é –≤–∏–±—Ä–∞—Ç–æ—Ä–æ–≤. –ö–æ–≥–¥–∞ –Ω–µ –ø—Ä–æ—á–∏—Ç–∞–ª–∞ –∏–Ω—Å—Ç—Ä—É–∫—Ü–∏—é, ‚Äî —Å–ª—ã—à–∏—Ç—Å—è –∫–æ–º–º–µ–Ω—Ç–∞—Ä–∏–π –Ω–∞ —Ñ–æ–Ω–µ. –õ—É—á—à–µ –∏ –Ω–µ —Å–∫–∞–∂–µ—à—å. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-11-20T12:03:24+00:00,@bezrec,6842,https://t.me/bezrec/6842,"–ê–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å—â–∏–∫–∏ –≤–Ω–µ–ø–ª–∞–Ω–æ–≤–æ –ø—Ä–æ—à–ª–∏—Å—å –ø–æ –∫—Ä–∞—Å–Ω–æ–¥–∞—Ä—Å–∫–∏–º –∫–æ–º–ø–∞–Ω–∏—è–º. –í –§–ê–° —Å–æ–æ–±—â–∏–ª–∏, —á—Ç–æ –ø—Ä–æ–≤–æ–¥—è—Ç –≤–Ω–µ–ø–ª–∞–Ω–æ–≤—ã–µ –∫–∞—Ä—Ç–µ–ª—å–Ω—ã–µ –ø—Ä–æ–≤–µ—Ä–∫–∏ –≤ –ö—Ä–∞—Å–Ω–æ–¥–∞—Ä—Å–∫–æ–º –∫—Ä–∞–µ. –ü–æ–¥ –ø–æ–¥–æ–∑—Ä–µ–Ω–∏–µ –≤ —Å–≥–æ–≤–æ—Ä–µ –ø—Ä–∏ —É—á–∞—Å—Ç–∏–∏ –≤ —Ç–æ—Ä–≥–∞—Ö –Ω–∞ –ø–æ—Å—Ç–∞–≤–∫—É –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π –∏ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –¥–ª—è –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —É—á—Ä–µ–∂–¥–µ–Ω–∏–π –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –≤ –ê–¥—ã–≥–µ–µ, –ö—Ä—ã–º—É, –°–µ–≤–µ—Ä–Ω–æ–π –û—Å–µ—Ç–∏–∏, –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ –ö—Ä–∞—Å–Ω–æ–¥–∞—Ä—Å–∫–æ–≥–æ –∏ –°—Ç–∞–≤—Ä–æ–ø–æ–ª—å—Å–∫–æ–≥–æ –∫—Ä–∞—è, –∞ —Ç–∞–∫–∂–µ –†–æ—Å—Ç–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –ø–æ–ø–∞–ª–∏ ¬´–ê–ª—å—è–Ω—Å –ú–µ–¥¬ª, ¬´–ë–ù–ö¬ª, ¬´–ú–µ–¥—Ç–µ—Ö–Ω–∏–∫–∞ –ì—Ä—É–ø–ø¬ª –∏ ¬´–°—Ç–æ–º–∞—Ç—Ç–æ—Ä–≥ –ì—Ä—É–ø–ø¬ª. –°–æ—Ç—Ä—É–¥–Ω–∏–∫–∏ –≤–µ–¥–æ–º—Å—Ç–≤–∞ –æ—Å–º–∞—Ç—Ä–∏–≤–∞—é—Ç —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ –∏ –ø–æ–º–µ—â–µ–Ω–∏—è, –∫–æ–ø–∏—Ä—É—é—Ç –¥–æ–∫—É–º–µ–Ω—Ç—ã –∏ –∞–∫—Ç—É–∞–ª–∏–∑–∏—Ä—É—é—Ç –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é –æ –ø—Ä–æ–≤–µ—Ä—è–µ–º—ã—Ö –ª–∏—Ü–∞—Ö. –û–∫–æ–Ω—á–∞—Ç–µ–ª—å–Ω—ã–µ –≤—ã–≤–æ–¥—ã —Ä–µ–≥—É–ª—è—Ç–æ—Ä —Å–¥–µ–ª–∞–µ—Ç –ø–æ –∏—Ç–æ–≥–∞–º –ø—Ä–æ–≤–µ—Ä–∫–∏ –∏ –∞–Ω–∞–ª–∏–∑–∞ –≤—Å–µ–π —Å–æ–±—Ä–∞–Ω–Ω–æ–π –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-11-20T10:05:17+00:00,@bezrec,6841,https://t.me/bezrec/6841,"–§–ê–° –Ω–µ –¥–∞—ë—Ç ¬´–ê–ª—å–∫–æ—Ä–§–∞—Ä–º¬ª –∑–∞–±–∏—Ç—å –Ω–∞ –ø–∞—Ç–µ–Ω—Ç—ã. –° —Å–µ–Ω—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞ –º–æ—Å–∫–æ–≤—Å–∫–∞—è —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—è –ø–æ–¥–∞–ª–∞ –¥–µ—Å—è—Ç–∫–∏ –∏—Å–∫–æ–≤ –≤ —Å—É–¥ –ø—Ä–æ—Ç–∏–≤ –£–§–ê–° –∏–∑-–∑–∞ –æ—Ç–∫–ª–æ–Ω–µ–Ω–∏—è –µ—ë –∑–∞—è–≤–æ–∫ –Ω–∞ —É—á–∞—Å—Ç–∏–µ –≤ –≥–æ—Å–∑–∞–∫—É–ø–∫–∞—Ö –ø—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤–æ–≥–æ —Ä—É–∫—Å–æ–ª–∏—Ç–∏–Ω–∏–±–∞. –ò–∑ –ø–æ—Å–ª–µ–¥–Ω–µ–≥–æ ‚Äì —Å–ø–æ—Ä –≤ –ê—Ä–±–∏—Ç—Ä–∞–∂–Ω–æ–º —Å—É–¥–µ –¢–∞—Ç–∞—Ä—Å—Ç–∞–Ω–∞ –∏–∑-–∑–∞ –∑–∞–∫—É–ø–æ–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –¥–ª—è –º–µ—Å—Ç–Ω–æ–≥–æ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –∏ –ì–£–ü ¬´–ú–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è —Ç–µ—Ö–Ω–∏–∫–∞ –∏ —Ñ–∞—Ä–º–∞—Ü–∏—è –¢–∞—Ç–∞—Ä—Å—Ç–∞–Ω–∞¬ª. ¬´–ê–ª—å–∫–æ—Ä–§–∞—Ä–º¬ª –Ω–∞–º–µ—Ä–µ–≤–∞–ª–∞—Å—å –ø–æ—Å—Ç–∞–≤–∏—Ç—å –∑–∞–∫–∞–∑—á–∏–∫–∞–º —Ä—É–∫—Å–æ–ª–∏—Ç–∏–Ω–∏–± –æ—Ç ¬´–û–Ω–∫–æ–¢–∞—Ä–≥–µ—Ç¬ª (–†–£ –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∏—Ç ¬´–ê–∫—Å–µ–ª—å–§–∞—Ä–º—É¬ª). –û—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã–π –î–∂–∞–∫–∞–≤–∏ —Å–æ–≤–º–µ—Å—Ç–Ω–æ–π —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ —à–≤–µ–π—Ü–∞—Ä—Å–∫–æ–π Novartis –∏ –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–π Incyte Corporation –∑–∞—â–∏—â–µ–Ω –µ–≤—Ä–∞–∑–∏–π—Å–∫–∏–º–∏ –ø–∞—Ç–µ–Ω—Ç–∞–º–∏ –¥–æ 2028 –≥–æ–¥–∞. –£–§–ê–° –ø–æ—Å—á–∏—Ç–∞–ª–æ, —á—Ç–æ –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω—ã–π –ø–æ—Å—Ç–∞–≤—â–∏–∫ –Ω–∞—Ä—É—à–∞–µ—Ç —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –ø–∞—Ç–µ–Ω—Ç–Ω–æ–≥–æ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–∞. –†–µ—à–µ–Ω–∏–µ –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å—â–∏–∫–æ–≤ –ø–æ–¥–¥–µ—Ä–∂–∞–ª –ú–∏–Ω–∑–¥—Ä–∞–≤ –¢–∞—Ç–∞—Ä—Å—Ç–∞–Ω–∞, –Ω–∞–∑–≤–∞–≤ –¥–µ–π—Å—Ç–≤–∏—è —Ä–µ–≥—É–ª—è—Ç–æ—Ä–∞ ¬´–∑–∞–∫–æ–Ω–Ω—ã–º–∏ –∏ –æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω—ã–º–∏¬ª. –£ ¬´–ê–ª—å–∫–æ—Ä–§–∞—Ä–º¬ª —Å–≤–æ—ë –≤–∏–¥–µ–Ω–∏–µ —Å–∏—Ç—É–∞—Ü–∏–∏: –£ –∫–æ–º–∏—Å—Å–∏–∏ –ó–∞–∫–∞–∑—á–∏–∫–∞ –æ—Ç—Å—É—Ç—Å—Ç–≤–æ–≤–∞–ª–∏ –ø—Ä–∞–≤–æ–≤—ã–µ –æ—Å–Ω–æ–≤–∞–Ω–∏—è –¥–ª—è –æ—Ç–∫–ª–æ–Ω–µ–Ω–∏—è –∑–∞—è–≤–∫–∏ –ø–æ –ø—Ä–∏—á–∏–Ω–µ –≤—ã—è–≤–ª–µ–Ω–∏—è –Ω–µ–¥–æ—Å—Ç–æ–≤–µ—Ä–Ω–æ–π –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏. –ö–æ–º–ø–∞–Ω–∏—è —Å—á–∏—Ç–∞–µ—Ç, —á—Ç–æ —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ –ø–∞—Ç–µ–Ω—Ç–Ω—ã—Ö –Ω–∞—Ä—É—à–µ–Ω–∏–π ‚Äî –∫–æ–º–ø–µ—Ç–µ–Ω—Ü–∏—è —Ç–æ–ª—å–∫–æ –°—É–¥–∞ –ø–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç—É–∞–ª—å–Ω—ã–º –ø—Ä–∞–≤–∞–º. –ü–æ–º–∏–º–æ —Ä—É–∫—Å–æ–ª–∏—Ç–∏–Ω–∏–±–∞, –∫–æ–º–ø–∞–Ω–∏—è —Å—É–¥–∏—Ç—Å—è —Å —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã–º–∏ —É–ø—Ä–∞–≤–ª–µ–Ω–∏—è–º–∏ –§–ê–° –∑–∞ –ø—Ä–∞–≤–æ –ø–æ—Å—Ç–∞–≤–ª—è—Ç—å —Ç–∞–∫–∂–µ –∑–∞—â–∏—â–µ–Ω–Ω—ã–µ –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã–º–∏ –ø–∞—Ç–µ–Ω—Ç–∞–º–∏ –∞–∫—Å–∏—Ç–∏–Ω–∏–± –∏ –æ—Å–∏–º–µ—Ä—Ç–∏–Ω–∏–±. –ü–æ –¥–∞–Ω–Ω—ã–º –ø–ª–∞—Ç—Ñ–æ—Ä–º—ã –ø–æ —Ä–∞–±–æ—Ç–µ —Å —Ç–µ–Ω–¥–µ—Ä–∞–º–∏ ¬´–¢–µ–Ω–¥–µ—Ä–ø–ª–∞–Ω¬ª, –≥–æ—Å–∑–∞–∫—É–ø–∫–∏ –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤ —Å —ç—Ç–∏–º–∏ –ú–ù–ù —Å —è–Ω–≤–∞—Ä—è –ø–æ –∏—é–Ω—å 2025 –≥–æ–¥–∞ –≤—ã—Ä–æ—Å–ª–∏ –Ω–∞ 35%. –û—Ü–µ–Ω–∏–≤–∞—è —à–∞–Ω—Å—ã —Å—Ç–æ—Ä–æ–Ω, —é—Ä–∏—Å—Ç—ã –ø—Ä–æ—á–∞—Ç –ø–æ–±–µ–¥—É –≤ —Å—É–¥–µ –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å—â–∏–∫–∞–º. –ê–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å–Ω—ã–π –æ—Ä–≥–∞–Ω —É–ø–æ–ª–Ω–æ–º–æ—á–µ–Ω –æ—Ç–∫–ª–æ–Ω—è—Ç—å –∑–∞—è–≤–∫–∏, –µ—Å–ª–∏ –∑–∞–∫–∞–∑—á–∏–∫ –ø—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ–ª —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–µ –æ –∑–∞–∫–æ–Ω–Ω–æ—Å—Ç–∏ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏—è –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç—É–∞–ª—å–Ω–æ–π —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç–∏, –∞ –ø–æ—Å—Ç–∞–≤—â–∏–∫ –Ω–µ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–∏–ª –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤, –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–∞—é—â–∏—Ö –Ω–∞–ª–∏—á–∏–µ –ø–∞—Ç–µ–Ω—Ç–∞, –ª–∏—Ü–µ–Ω–∑–∏–∏ –∏–ª–∏ —Ä–∞–∑—Ä–µ—à–µ–Ω–∏—è –ø—Ä–∞–≤–æ–æ–±–ª–∞–¥–∞—Ç–µ–ª—è, - –ø–æ—è—Å–Ω–∏–ª–∞ ¬´–™¬ª –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä Enterprise Legal Solutions –ê–Ω–Ω–∞ –ë–∞—Ä–∞–±–∞—à. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""Ukraine"",
  ""topic"": ""sanctions, shortage, import_export"",
  ""impact"": ""high"",
  ""english"": ""The Ukrainian regulatory body FAS is not allowing 'AlkorFarma' to ignore patents. Since September 2025, the Moscow pharmaceutical company 'AlkorFarma' has filed dozens of lawsuits against FAS in connection with its participation in government procurement for the anti-cancer drug rituximab. One of these cases is a dispute in Tatarstan's Arbitration Court over the procurement of the drug for local Tatarstan Health Department and GUP 'Medicine Technology and Pharmacy of Tatarstan'. 'AlkorFarma' intended to supply the orders with rituximab from 'OncoTarget' (R.U. belongs to 'AxelFarma'). The original rituximab, a joint development by Swiss Novartis and American Incyte Corporation, is protected by Eurasian patents until 2028. FAS considered that the potential supplier violated patent legislation requirements. The Health Department of Tatarstan supported FAS' decision, calling it 'legal and justified'. 'AlkorFarma' sees the situation"
2025-11-20T08:23:25+00:00,@bezrec,6840,https://t.me/bezrec/6840,"–°–µ–≥–æ–¥–Ω—è –≤–µ—â–∞–µ–º –¥–ª—è –≤–∞—Å —Å –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ ¬´–ü–æ—Ç–æ–∫¬ª, –ø–æ—Å–≤—è—â–µ–Ω–Ω–æ–π —Å–æ–≤—Ä–µ–º–µ–Ω–Ω—ã–º –ø—Ä–∞–∫—Ç–∏–∫–∞–º –∏ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—è–º –≤ HR. –î–µ–ª–∏–º—Å—è –∏–Ω—Ç–µ—Ä–µ—Å–Ω—ã–º –∫–µ–π—Å–æ–º —Å–µ—Ç–∏ –∞–ø—Ç–µ–∫ ¬´–ñ–∏–≤–∏–∫–∞¬ª –ø–æ –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–∏—é HiPo-—Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤, –æ –∫–æ—Ç–æ—Ä–æ–º —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∞ –¢–∞—Ç—å—è–Ω–∞ –ì–∞–ª–∫–∏–Ω–∞, –¥–∏—Ä–µ–∫—Ç–æ—Ä –ê–∫–∞–¥–µ–º–∏–∏ iSpring. ‚ñ∂Ô∏è–ò—Å—Ö–æ–¥–Ω—ã–µ –¥–∞–Ω–Ω—ã–µ: –≤ –∫–æ–º–ø–∞–Ω–∏–∏ –Ω–µ –≤–∏–¥—è—Ç –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω—ã—Ö –∫–∞–Ω–¥–∏–¥–∞—Ç–æ–≤ –Ω–∞ –ø–æ–≤—ã—à–µ–Ω–∏–µ, –Ω–µ—Ç —è—Ä–∫–æ –≤—ã—Ä–∞–∂–µ–Ω–Ω—ã—Ö –ª–∏–¥–µ—Ä–æ–≤. ‚ñ∂Ô∏è–†–µ—à–µ–Ω–∏–µ: –≤–º–µ—Å—Ç–æ –Ω–∞–π–º–∞ –∏–∑–≤–Ω–µ –≤–∑—è–ª–∏ –≤–Ω—É—Ç—Ä–µ–Ω–Ω—é—é –∞—É–¥–∏—Ç–æ—Ä–∏—é —Å –±–æ–ª—å—à–∏–º —Å—Ç–∞–∂–µ–º –∏ –ø—Ä–æ–≤–µ–ª–∏ –∫–æ–Ω–∫—É—Ä—Å –ø–æ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ –¥–∏–∞–ª–æ–≥–æ–≤—ã—Ö —Ç—Ä–µ–Ω–∞–∂–µ—Ä–æ–≤. –ü—Ä–æ–µ–∫—Ç –æ—Ö–≤–∞—Ç–∏–ª 1105 —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤, –∂–µ–ª–∞—é—â–∏—Ö –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç—å —Å–≤–æ–∏ —Ä–µ—à–µ–Ω–∏—è, –ø—Ä–æ–≤–µ–ª–∏ —Ç–µ—Å—Ç–æ–≤—ã–µ –∑–∞–¥–∞–Ω–∏—è, –∏–Ω–¥–∏–≤–∏–¥—É–∞–ª—å–Ω—ã–µ –∏ –≥—Ä—É–ø–ø–æ–≤—ã–µ —ç—Ç–∞–ø—ã —Å –∫–æ–ª–∏—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–π –∏ –∫–∞—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–π –æ—Ü–µ–Ω–∫–æ–π. ‚ñ∂Ô∏è–ò—Ç–æ–≥: —Å—Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–ª–∞—Å—å –≥—Ä—É–ø–ø–∞ –∏–∑ 50 –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω—ã—Ö –ª–∏–¥–µ—Ä–æ–≤ —Å –≥–ª—É–±–æ–∫–æ–π —ç–∫—Å–ø–µ—Ä—Ç–∏–∑–æ–π –≤ –∫–∞–¥—Ä–æ–≤—ã–π —Ä–µ–∑–µ—Ä–≤ –∏ –ø–æ–ª–µ–∑–Ω—ã–π –ø—Ä–æ–¥—É–∫—Ç –¥–ª—è –∫–æ–º–ø–∞–Ω–∏–∏. –†–∞—Å—Å–º–æ—Ç—Ä–∏—Ç–µ –¥–ª—è —Å–µ–±—è —Ç–∞–∫–æ–π –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç —Å –≤–Ω—É—Ç—Ä–µ–Ω–Ω–∏–º–∏ –∫–æ–Ω–∫—É—Ä—Å–∞–º–∏, –µ—Å–ª–∏ –µ—Å—Ç—å –ø—Ä–æ–±–ª–µ–º–∞ —Å —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏–µ–º –∫–∞–¥—Ä–æ–≤–æ–≥–æ —Ä–µ–∑–µ—Ä–≤–∞. –ù–µ–ø–ª–æ—Ö–æ —Ä–∞—Å–∫—Ä—ã–≤–∞–µ—Ç –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤ —á–µ—Ä–µ–∑ —Ä–µ—à–µ–Ω–∏–µ —Ä–µ–∞–ª—å–Ω—ã—Ö –∫–µ–π—Å–æ–≤ –∫–æ–º–ø–∞–Ω–∏–∏. üîç –ö–∞–¥—Ä—ã","{""skip"": true}"
2025-11-20T05:19:51+00:00,@bezrec,6839,https://t.me/bezrec/6839,"–í –ø—Ä–æ—à–ª—ã—Ö –≤—ã–ø—É—Å–∫–∞—Ö #–∑–∞—Ü–µ–Ω–∏–ª–∏ –ª–µ—á–∏–ª–∏ –≥–æ—Ä–ª–æ, –ø—Ä–∏—à–ª–æ –≤—Ä–µ–º—è –Ω–∞—Å–º–æ—Ä–∫–∞. –ò–∑–±–∞–≤–ª—è—Ç—å—Å—è –æ—Ç –∑–∞–ª–æ–∂–µ–Ω–Ω–æ—Å—Ç–∏ –Ω–æ—Å–∞ –±—É–¥–µ–º —Å –ø–æ–º–æ—â—å—é –Ω–∞–∑–∞–ª—å–Ω—ã—Ö —Å–ø—Ä–µ–µ–≤ –Ω–∞ –æ—Å–Ω–æ–≤–µ –æ–∫—Å–∏–º–µ—Ç–∞–∑–æ–ª–∏–Ω–∞. –ú—ã —Å—Ä–∞–≤–Ω–∏–ª–∏ —Ü–µ–Ω—ã –≤ –æ–Ω–ª–∞–π–Ω-–∞–ø—Ç–µ–∫–∞—Ö –Ω–∞ —Ç–æ—Ä–≥–æ–≤—ã–µ –º–∞—Ä–∫–∏ –†–∏–Ω–æ—Å—Ç–æ–ø –≠–∫—Å—Ç—Ä–∞ (¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç-–õ–µ–∫—Å—Ä–µ–¥—Å—Ç–≤–∞¬ª), –û–∫—Å–∏—Ñ—Ä–∏–Ω –ì–µ—Ä—Ç–∞ (¬´–ì—Ä–æ—Ç–µ–∫—Å¬ª), –†–∞–Ω–∫–æ—Ñ –†–∏–Ω–æ (¬´–í–∏–ø—Å-–ú–µ–¥ –§–∏—Ä–º–∞¬ª), –û—Ç—Ä–∏–≤–∏–Ω –≠–∫—Å–ø—Ä–µ—Å—Å (¬´–ì–°–ö¬ª) –∏ –ù–∞–∑–∏–≤–∏–Ω –°–µ–Ω—Å–∏—Ç–∏–≤ (¬´–§–∞–º–∞—Ä –•–µ–ª—Å–∫–µ–∞¬ª). –í —Ü–µ–ª–æ–º –≤—Å–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –º–æ–∂–Ω–æ –±–µ–∑ –ø—Ä–æ–±–ª–µ–º –∫—É–ø–∏—Ç—å –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏ –≤–æ –≤—Å–µ—Ö –ø—Ä–æ–≤–µ—Ä–µ–Ω–Ω—ã—Ö –Ω–∞–º–∏ –∞–ø—Ç–µ–∫–∞—Ö. –ú–∞–∫—Å–∏–º–∞–ª—å–Ω–∞—è —Ü–µ–Ω–∞ –Ω–∞ –≤—Å–µ—Ö —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–Ω–∞ –≤ ¬´36,6¬ª. –°–∞–º—ã–π –¥–æ—Ä–æ–≥–æ–π —Å–ø—Ä–µ–π ‚Äì –û—Ç—Ä–∏–≤–∏–Ω –≠–∫—Å–ø—Ä–µ—Å—Å ‚Äì —Ç–∞–º –æ–±–æ–π–¥—ë—Ç—Å—è –≤ 534 —Ä—É–±–ª—è. –î–µ—à–µ–≤–ª–µ –≤—Å–µ–≥–æ (200 —Ä—É–±–ª–µ–π) —Å—Ç–æ–∏—Ç –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π –†–∏–Ω–æ—Å—Ç–æ–ø –≠–∫—Å—Ç—Ä–∞ –≤ ¬´–ê–ø—Ç–µ–∫–µ.—Ä—É¬ª. –ù–∞–ø–æ–º–∏–Ω–∞–µ–º, —á—Ç–æ –ª—é–±—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏–º–µ—é—Ç –ø—Ä–æ—Ç–∏–≤–æ–ø–æ–∫–∞–∑–∞–Ω–∏—è. –ü–µ—Ä–µ–¥ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º –ø—Ä–æ–∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä—É–π—Ç–µ—Å—å —Å –ª–µ—á–∞—â–∏–º –≤—Ä–∞—á–æ–º. *–∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –ø—Ä–æ–≤–æ–¥–∏–ª–æ—Å—å –æ–Ω–ª–∞–π–Ω 19 –Ω–æ—è–±—Ä—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage"",
  ""impact"": ""medium"",
  ""english"": ""A study was conducted online on November 19th. Prices for various nasal sprays such as Rinstop Extra (FarmaStand-Lexred), Oxifrin Herta (Grotex), Rancof Rinno (Vipsm-Med Firm), Otrovin Express (GSK), and Nativin Sensitivity (FarmaHelskea) were compared. Prices for all participants are fixed at 366 rubles. The most expensive spray is Otrovin Express, costing 534 rubles. The cheapest (200 rubles) is the domestic Rinstop Extra in 'Apoteka.ru'. It's important to note that any medication has contraindications. Please consult your doctor before use.""
}"
2025-11-19T17:02:45+00:00,@bezrec,6838,https://t.me/bezrec/6838,"¬´–†-–§–∞—Ä–º¬ª –æ–±–µ—Å–ø–µ—á–∏—Ç –ø—Ä–æ—Ä—ã–≤ –≤ –ª–µ—á–µ–Ω–∏–∏ —Ä–µ—Ü–∏–¥–∏–≤–∏—Ä—É—é—â–µ–≥–æ –ø–µ—Ä–∏–∫–∞—Ä–¥–∏—Ç–∞. –í 2025 –≥–æ–¥—É –ú–∏–Ω–∑–¥—Ä–∞–≤ —É—Ç–≤–µ—Ä–¥–∏–ª –æ–±–Ω–æ–≤–ª–µ–Ω–Ω—ã–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø–æ –ª–µ—á–µ–Ω–∏—é –ø–µ—Ä–∏–∫–∞—Ä–¥–∏—Ç–æ–≤, –≤ —Ç–æ–º —á–∏—Å–ª–µ –∏–¥–∏–æ–ø–∞—Ç–∏—á–µ—Å–∫–æ–≥–æ —Ä–µ—Ü–∏–¥–∏–≤–∏—Ä—É—é—â–µ–≥–æ (–ò–†–ü) ‚Äì –æ–¥–Ω–æ–≥–æ –∏–∑ —Å–∞–º—ã—Ö —Ç—è–∂–µ–ª—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –ø–µ—Ä–∏–∫–∞—Ä–¥–∞, –ø—Ä–∏ –∫–æ—Ç–æ—Ä–æ–º, –∫–∞–∫ –ø–∏—à–µ—Ç ¬´–ú–ö¬ª, ¬´—Å–µ—Ä–¥—Ü–µ –±—É–∫–≤–∞–ª—å–Ω–æ –æ–∫–∞–∑—ã–≤–∞–µ—Ç—Å—è –≤ –ª–æ–≤—É—à–∫–µ —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –≤–æ—Å–ø–∞–ª–µ–Ω–∏—è¬ª. –î–æ –Ω–µ–¥–∞–≤–Ω–µ–≥–æ –≤—Ä–µ–º–µ–Ω–∏ –≤–∞—Ä–∏–∞–Ω—Ç–æ–≤ –ª–µ—á–µ–Ω–∏—è —ç—Ç–æ–≥–æ —Å–æ—Å—Ç–æ—è–Ω–∏—è –±—ã–ª–æ –Ω–µ–º–Ω–æ–≥–æ ‚Äì –µ—Å–ª–∏ –Ω–µ –ø–æ–º–æ–≥–∞–ª–∏ –Ω–µ—Å—Ç–µ—Ä–æ–∏–¥–Ω—ã–µ –ø—Ä–æ—Ç–∏–≤–æ–≤–æ—Å–ø–∞–ª–∏—Ç–µ–ª—å–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –≤ –≤—ã—Å–æ–∫–∏—Ö –¥–æ–∑–∞—Ö –∏ –∫–æ–ª—Ö–∏—Ü–∏–Ω, –≤—Ä–∞—á–∏ –Ω–∞–∑–Ω–∞—á–∞–ª–∏ —Å—Ç–µ—Ä–æ–∏–¥—ã. –í–∫–ª—é—á–µ–Ω–∏–µ –≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –±–ª–æ–∫–∞—Ç–æ—Ä–∞ –ò–õ-1 –∫–∞—Ä–¥–∏–Ω–∞–ª—å–Ω–æ –ø–æ–º–µ–Ω—è–ª–æ –ø–æ–¥—Ö–æ–¥ –∫ –ª–µ—á–µ–Ω–∏—é –ò–†–ü. –¢–∞–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –Ω–µ –ø—Ä–æ—Å—Ç–æ –ø–æ–¥–∞–≤–ª—è—é—Ç –≤–æ—Å–ø–∞–ª–µ–Ω–∏–µ, –Ω–æ –±–ª–æ–∫–∏—Ä—É—é—Ç —Å–∞–º –º–µ—Ö–∞–Ω–∏–∑–º –µ–≥–æ –∑–∞–ø—É—Å–∫–∞. –û–Ω–∏ —Å–≤—è–∑—ã–≤–∞—é—Ç –∏–∑–±—ã—Ç–æ—á–Ω—ã–π –ò–õ-1 –≤ –∫—Ä–æ–≤–∏ –∏ –Ω–µ –¥–∞—é—Ç –µ–º—É –ø—Ä–æ–≤–æ—Ü–∏—Ä–æ–≤–∞—Ç—å –≤–æ—Å–ø–∞–ª–µ–Ω–∏–µ –≤ –ø–µ—Ä–∏–∫–∞—Ä–¥–µ. –ù–∞ —Å–µ–≥–æ–¥–Ω—è—à–Ω–∏–π –¥–µ–Ω—å –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–π –≤ –†–æ—Å—Å–∏–∏ –±–ª–æ–∫–∞—Ç–æ—Ä –ò–õ-1, –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–π –ø–æ —ç—Ç–æ–º—É –ø–æ–∫–∞–∑–∞–Ω–∏—é, ‚Äî –ê—Ä—Ü–µ—Ä–∏–∫—Å (–≥–æ—Ñ–ª–∏–∫–∏—Ü–µ–ø—Ç) –æ—Ç ¬´–†-–§–∞—Ä–º¬ª. –ú–∏–Ω–∑–¥—Ä–∞–≤ –æ–¥–æ–±—Ä–∏–ª –µ–≥–æ –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ –ò–†–ü –≤ –∏—é–Ω–µ 2024 –≥–æ–¥–∞. –ü—Ä–µ–ø–∞—Ä–∞—Ç —Ç–∞–∫–∂–µ –∏—Å—Å–ª–µ–¥—É–µ—Ç—Å—è –ø—Ä–∏ —Å–µ–º–µ–π–Ω–æ–π —Å—Ä–µ–¥–∏–∑–µ–º–Ω–æ–º–æ—Ä—Å–∫–æ–π –ª–∏—Ö–æ—Ä–∞–¥–∫–µ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance"",
  ""impact"": ""high"",
  ""english"": ""The company 'R-Farm' has developed a breakthrough treatment for idiopathic recurrent pericarditis (IRP), one of the most severe conditions affecting the pericardium. Previously, treatment options were limited to NSAIDs and colchicine. The approval of IL-1 blocker Arcesik (golpilicet) by the Ministry of Health in June 2024 has changed the approach to treating IRP, which is now registered for Russia. The drug is also being studied for familial Mediterranean fever.""
}"
2025-11-19T14:59:58+00:00,@bezrec,6837,https://t.me/bezrec/6837,"¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑¬ª –ª–æ–∫–∞–ª–∏–∑—É–µ—Ç –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –æ–Ω–∫–æ–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –ö–∞–º–±–æ–¥–∂–µ. –ö–æ–º–ø–∞–Ω–∏—è –í–∏–∫—Ä–∞–º–∞ –ü—É–Ω–∏—è –ø–ª–∞–Ω–∏—Ä—É–µ—Ç —Å–æ–∑–¥–∞—Ç—å –≤ –∫–æ—Ä–æ–ª–µ–≤—Å—Ç–≤–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –æ–Ω–∫–æ–∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –ö–ª—é—á–µ–≤—ã–µ –¥–µ—Ç–∞–ª–∏ –∑–∞–ø—É—Å–∫–∞ –∏–Ω–≤–µ—Å—Ç–ø—Ä–æ–µ–∫—Ç–∞ –¥–∏—Ä–µ–∫—Ç–æ—Ä –ø–æ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã–º –ø—Ä–æ–¥–∞–∂–∞–º ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑–∞¬ª –î–º–∏—Ç—Ä–∏–π –ë–æ–ª–æ—Ç–æ–≤ –æ–±—Å—É–¥–∏–ª —Å –≥–æ—Å—Å–µ–∫—Ä–µ—Ç–∞—Ä—ë–º –ø–æ —Å–≤—è–∑—è–º —Å –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç—å—é –∏ –∫–∞—á–µ—Å—Ç–≤—É —É—Å–ª—É–≥ –ú–∏–Ω–∏—Å—Ç–µ—Ä—Å—Ç–≤–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ö–æ—Ä–æ–ª–µ–≤—Å—Ç–≤–∞ –ö–∞–º–±–æ–¥–∂–∞ –ö–æ–π –í–∞–Ω–Ω–∏. –ü—Ä–æ–µ–∫—Ç–æ–º –ø—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ–Ω–æ —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–æ —Å–æ–≤—Ä–µ–º–µ–Ω–Ω–æ–≥–æ —Ñ–∞—Ä–º–∫–æ–º–ø–ª–µ–∫—Å–∞ –∏ –ø–æ—ç—Ç–∞–ø–Ω—ã–π —Ç—Ä–∞–Ω—Å—Ñ–µ—Ä —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ —Å —Ä–æ—Å—Å–∏–π—Å–∫–æ–π –ø–ª–æ—â–∞–¥–∫–∏ ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑¬ª. –ù–∞—á–Ω—É—Ç —Å —ç—Ç–∞–ø–∞ –≤—Ç–æ—Ä–∏—á–Ω–æ–π —É–ø–∞–∫–æ–≤–∫–∏ —Å –ø–æ—Å–ª–µ–¥—É—é—â–∏–º —É–≥–ª—É–±–ª–µ–Ω–∏–µ–º –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏–∏. –ù–æ–≤–æ–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –Ω–µ –æ–±–æ–π–¥—ë—Ç—Å—è –±–µ–∑ –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã—Ö –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–π. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, —Å—Ç–æ—Ä–æ–Ω—ã –ø–ª–∞–Ω–∏—Ä—É—é—Ç –∑–∞–∫–ª—é—á–∏—Ç—å –æ—Ñ—Å–µ—Ç –Ω–∞ –¥–æ–ª–≥–æ—Å—Ä–æ—á–Ω—ã–µ –ø–æ—Å—Ç–∞–≤–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –¥–ª—è –Ω—É–∂–¥ –∫–∞–º–±–æ–¥–∂–∏–π—Å–∫–æ–≥–æ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-11-19T13:38:29+00:00,@bezrec,6836,https://t.me/bezrec/6836,"–í DSM Group –æ–±—ä—è—Å–Ω–∏–ª–∏ –∏–Ω—Ç–µ—Ä–µ—Å –ï–° –∫ —Ä–æ—Å—Å–∏–π—Å–∫–∏–º –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º. –î–∏—Ä–µ–∫—Ç–æ—Ä –∞–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ –°–µ—Ä–≥–µ–π –®—É–ª—è–∫ —Å–≤—è–∑—ã–≤–∞–µ—Ç —Å–∫–∞—á–æ–∫ –∑–∞–∫—É–ø–æ–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤–∏–∑ –†–§ —Å –≥—É–º–∞–Ω–∏—Ç–∞—Ä–Ω—ã–º–∏ –ø—Ä–∏—á–∏–Ω–∞–º–∏, –∞ –Ω–µ –∂–µ–ª–∞–Ω–∏–µ–º –∑–∞–ø–æ–ª–Ω–∏—Ç—å –∏–º–∏ –µ–≤—Ä–æ–ø–µ–π—Å–∫–∏–π —Ä—ã–Ω–æ–∫. –ù–∏–∫—Ç–æ –Ω–∞ —Å–≤–æ–π —Ä—ã–Ω–æ–∫ –Ω–∏–∫–æ–≥–æ –ø—É—Å–∫–∞—Ç—å –Ω–µ —Å–æ–±–∏—Ä–∞–µ—Ç—Å—è. –°–∫–æ—Ä–µ–µ –≤—Å–µ–≥–æ, —ç—Ç–æ –∫–∞–∫–∏–µ-—Ç–æ –∑–∞–∫—É–ø–∫–∏ –¥–ª—è —Ç—Ä–µ—Ç—å–∏—Ö —Å—Ç—Ä–∞–Ω. –ï–≤—Ä–æ—Å–æ—é–∑ –ø—Ä–∏–æ–±—Ä–µ—Ç–∞–µ—Ç —É –Ω–∞—Å –¥–∂–µ–Ω–µ—Ä–∏–∫–∏ –ø–æ–¥–µ—à–µ–≤–ª–µ –∏ –æ—Ç–ø—Ä–∞–≤–ª—è–µ—Ç —Ç—É–¥–∞. –ï–° –∏ —Ä–∞–Ω—å—à–µ –∑–∞–∫—É–ø–∞–ª —É –†–æ—Å—Å–∏–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –ø–æ –≥—É–º–∞–Ω–∏—Ç–∞—Ä–Ω–æ–π –ª–∏–Ω–∏–∏, —á–∞—â–µ –≤—Å–µ–≥–æ –¥–ª—è –ê—Ñ—Ä–∏–∫–∏ ‚Äì –∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫–∏ –∏ –ø—Ä–æ—á–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, ‚Äì –æ–±—ä—è—Å–Ω–∏–ª —ç–∫—Å–ø–µ—Ä—Ç –ù–°–ù. –ü–æ —Å–ª–æ–≤–∞–º –®—É–ª—è–∫–∞, –∑–∞–∫—É–ø–∫–∞, –ø—Ä–µ–≤—ã—à–∞—é—â–∞—è –≤ –Ω–µ—Å–∫–æ–ª—å–∫–æ —Ä–∞–∑ –µ–∂–µ–º–µ—Å—è—á–Ω—ã–π –æ–±—ä–µ–º, –∫–∞–∫ —Ä–∞–∑ —Å–≤–∏–¥–µ—Ç–µ–ª—å—Å—Ç–≤—É–µ—Ç –æ —Ç–æ–º, —á—Ç–æ —ç—Ç–æ –±—ã–ª–æ —Å–¥–µ–ª–∞–Ω–æ –¥–ª—è –≥—É–º–∞–Ω–∏—Ç–∞—Ä–Ω—ã—Ö —Ü–µ–ª–µ–π: –ï—Å—Ç–µ—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç–∏ –≤ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞—Ö –Ω–µ —Ä–∞—Å—Ç—É—Ç —Å–∫–∞—á–∫–æ–æ–±—Ä–∞–∑–Ω–æ. –¢–∞–∫–æ–≥–æ –Ω–µ –±—ã–≤–∞–µ—Ç –æ—Ç —Å–ª–æ–≤–∞ –Ω–∏–∫–æ–≥–¥–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The DSM Group explained the EU's interest in Russian medicines. Director of analytical company Sergey Shulayak links the increase in drug purchases by Russia with humanitarian reasons, not to fill their own market. No one is going to import anyone's products. It seems like these are purchases for third countries. The EU has been buying medicines from Russia on humanitarian lines before, mostly for Africa - antibiotics and other drugs. ‚Äì Expert of NSN. The large purchase exceeding several times the monthly volume clearly indicates humanitarian purposes: natural needs for medicines do not grow in a sudden manner. It is never like this.""
}"
2025-11-19T11:02:25+00:00,@bezrec,6835,https://t.me/bezrec/6835,"–ï–° –ø–æ–±–∏–ª –ø—è—Ç–∏–ª–µ—Ç–Ω–∏–π —Ä–µ–∫–æ—Ä–¥ –ø–æ –∑–∞–∫—É–ø–∫–µ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤. –í —Å–µ–Ω—Ç—è–±—Ä–µ —ç—Ç–æ–≥–æ –≥–æ–¥–∞ —Å—Ç—Ä–∞–Ω—ã –ï–≤—Ä–æ—Å–æ—é–∑–∞ –ø—Ä–∏–æ–±—Ä–µ–ª–∏ —É –†–æ—Å—Å–∏–∏ –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç–æ–≤ –Ω–∞ 7,6 –º–ª–Ω –µ–≤—Ä–æ ‚Äî —ç—Ç–æ –º–∞–∫—Å–∏–º—É–º —Å –¥–µ–∫–∞–±—Ä—è 2020 –≥–æ–¥–∞ –∏ –≤ 7,2 —Ä–∞–∑–∞ –±–æ–ª—å—à–µ –≤ –º–µ—Å—è—á–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏, –ø–æ—Å—á–∏—Ç–∞–ª–∏ ¬´–†–ò–ê –ù–æ–≤–æ—Å—Ç–∏¬ª –Ω–∞ –æ—Å–Ω–æ–≤–µ –¥–∞–Ω–Ω—ã—Ö –ï–≤—Ä–æ—Å—Ç–∞—Ç–∞. –ì–æ–¥ –∫ –≥–æ–¥—É –∑–∞–∫—É–ø–∫–∏ –≤—ã—Ä–æ—Å–ª–∏ –ø—Ä–∏–º–µ—Ä–Ω–æ –≤ –ø—è—Ç—å —Ä–∞–∑. –°—É–º–º–∞—Ä–Ω–æ –∑–∞ —Ç—Ä–∏ –∫–≤–∞—Ä—Ç–∞–ª–∞ 2025 –≥–æ–¥–∞ –ï–° –≤–≤—ë–∑ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏–∑ –†–§ –Ω–∞ 26,9 –º–ª–Ω –µ–≤—Ä–æ, —á—Ç–æ –≤–¥–≤–æ–µ –±–æ–ª—å—à–µ, —á–µ–º –∑–∞ –∞–Ω–∞–ª–æ–≥–∏—á–Ω—ã–π –ø–µ—Ä–∏–æ–¥ 2024 –≥–æ–¥–∞. –ë–æ–ª—å—à–µ –≤—Å–µ–≥–æ —Ä–æ—Å—Å–∏–π—Å–∫–æ–π —Ñ–∞—Ä–º–ø—Ä–æ–¥—É–∫—Ü–∏–∏ –≤–Ω—É—Ç—Ä–∏ –ï–° –≤–≤–µ–∑–ª–∏: –°–ª–æ–≤–µ–Ω–∏—è (6,5 –º–ª–Ω –µ–≤—Ä–æ) –∏ –í–µ–Ω–≥—Ä–∏—è (951 —Ç—ã—Å. –µ–≤—Ä–æ). –†–æ—Å—Å–∏—è –æ—Ç –µ–≤—Ä–æ–ø–µ–π—Å–∫–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ —Ç–æ–∂–µ –Ω–µ –æ—Ç–∫–∞–∑—ã–≤–∞–µ—Ç—Å—è ‚Äì –≤ —Å–µ–Ω—Ç—è–±—Ä–µ –∏–º–ø–æ—Ä—Ç —É–≤–µ–ª–∏—á–∏–ª—Å—è –Ω–∞ 14% –≤ –º–µ—Å—è—á–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ –∏ –Ω–∞ –¥–µ–≤—è—Ç—å% ‚Äî –≤ –≥–æ–¥–æ–≤–æ–º, –¥–æ 553,8 –º–ª–Ω –µ–≤—Ä–æ. –û–¥–Ω–∞–∫–æ –≥–æ–¥–æ–≤–∞—è –¥–∏–Ω–∞–º–∏–∫–∞ –ø–æ –∏—Ç–æ–≥–∞–º —Ç—Ä—ë—Ö –Ω–µ–∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–∞ ‚Äî –ø–ª—é—Å 1,1% (5,1 –º–ª—Ä–¥ –µ–≤—Ä–æ). –û—Å–Ω–æ–≤–Ω—ã–µ —ç–∫—Å–ø–æ—Ä—Ç—ë—Ä—ã –≤ —ç—Ç–æ–º –º–µ—Å—è—Ü–µ: üîò–ì–µ—Ä–º–∞–Ω–∏—è (134,6 –º–ª–Ω –µ–≤—Ä–æ); üîò–ù–∏–¥–µ—Ä–ª–∞–Ω–¥—ã (82,7 –º–ª–Ω –µ–≤—Ä–æ); üîò–ë–µ–ª—å–≥–∏—è (78,1 –º–ª–Ω –µ–≤—Ä–æ); üîò–°–ª–æ–≤–µ–Ω–∏—è (49 –º–ª–Ω –µ–≤—Ä–æ); üîò–ê–≤—Å—Ç—Ä–∏—è (31 –º–ª–Ω –µ–≤—Ä–æ). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The European Union (EU) has surpassed a five-year record in purchasing Russian pharmaceuticals. In September, the EU acquired medicines from Russia worth 7.6 million euros - a record high since December 2020 and seven times higher than in the same month. Year-over-year, purchases have increased fivefold. Over three quarters of 2025, the EU imported Russian medicines worth 26.9 million euros, double that of the same period in 2024. Countries like Slovenia and Hungary have imported significant amounts from Russia - over 6.5 million euros and 951 thousand euros respectively. Despite this, the annual trend is modest - a mere 1.1% increase (5.1 billion euros). Major exporters in September: Germany (134.6 million euros), Netherlands (82.7 million euros), Belgium (78.1 million euros), Slovenia (49 million euros), Austria (31 million euros).""
}"
2025-11-19T09:04:36+00:00,@bezrec,6834,https://t.me/bezrec/6834,"–ö–∞–∫ –ø—Ä–æ–¥–≤–∏–≥–∞—Ç—å—Å—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º, —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–º –∏ –∫–æ—Å–º–µ—Ç–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–º –±—Ä–µ–Ω–¥–∞–º –∏ –∫–æ–º–ø–∞–Ω–∏—è–º —Å–µ–≥–æ–¥–Ω—è, –∫–æ–≥–¥–∞ –ø—Ä–∏–≤—ã—á–Ω—ã–µ –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç—ã –º–∞—Ä–∫–µ—Ç–∏–Ω–≥–∞ –±–æ–ª—å—à–µ –Ω–µ —Ä–∞–±–æ—Ç–∞—é—Ç? –ü—Ä–µ–º–∏—è –≤ –æ–±–ª–∞—Å—Ç–∏ –∑–¥–æ—Ä–æ–≤—å—è, –º–µ–¥–∏—Ü–∏–Ω—ã –∏ –∫—Ä–∞—Å–æ—Ç—ã BEAUTY AWARDS 2025 - —ç—Ç–æ –Ω–µ —Ç–æ–ª—å–∫–æ –ø—Ä–æ –∏–º–∏–¥–∂ –∏ —Ä–µ–ø—É—Ç–∞—Ü–∏—é –±—Ä–µ–Ω–¥–∞, –Ω–æ –∏ –ø—Ä–æ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –∑–∞—è–≤–∏—Ç—å –æ —Å–µ–±–µ –Ω–∞ >35 –º–ª–Ω —á–µ–ª–æ–≤–µ–∫, –ø–æ–ª—É—á–∏—Ç—å –ø–æ–¥–¥–µ—Ä–∂–∫—É –≤ –°–ú–ò –∏ –∏–Ω—Ñ–æ–ø–æ–ª–µ, –ø—Ä–æ —Å–∏–ª—å–Ω–µ–π—à–∏–π –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç –¥–ª—è —Ä–∞–∑–≤–∏—Ç–∏—è –±—Ä–µ–Ω–¥–∞ –∏ –ø—Ä–∏–≤–ª–µ—á–µ–Ω–∏—è –Ω–æ–≤—ã—Ö –∫–ª–∏–µ–Ω—Ç–æ–≤, –∞ —Ç–∞–∫–∂–µ –Ω–µ–∑–∞–º–µ–Ω–∏–º–∞—è –ø–ª–æ—â–∞–¥–∫–∞ –¥–ª—è –Ω–µ—Ç–≤–æ—Ä–∫–∏–Ω–≥–∞. –ù–µ–º–Ω–æ–≥–æ –æ –ø—Ä–µ–º–∏–∏ –≤ —Ü–∏—Ñ—Ä–∞—Ö: >100 –Ω–æ–º–∏–Ω–∞—Ü–∏–π –≤ –æ–±–ª–∞—Å—Ç–∏ –∫—Ä–∞—Å–æ—Ç—ã, –º–µ–¥–∏—Ü–∏–Ω—ã –∏ –∑–¥–æ—Ä–æ–≤—å—è –≤ –∫–∞–∂–¥–æ–º —Ä–µ–≥–∏–æ–Ω–µ –†–§ >100 –°–ú–ò-–∏–Ω—Ñ–æ–ø–∞—Ä—Ç–Ω–µ—Ä–æ–≤ >35 –º–ª–Ω —á–µ–ª–æ–≤–µ–∫ –æ—Ö–≤–∞—Ç –ø—Ä–µ–º–∏–∏ >38 —á–ª–µ–Ω–æ–≤ —ç–∫—Å–ø–µ—Ä—Ç–Ω–æ–≥–æ –∂—é—Ä–∏: –°–µ—Ä–≥–µ–π –ó–≤–µ—Ä–µ–≤, –ê–Ω—Ñ–∏—Å–∞ –ß–µ—Ö–æ–≤–∞, –û–∫—Å–∞–Ω–∞ –§–µ–¥–æ—Ä–æ–≤–∞, –ö–∞—Ç—è –õ–µ–ª—å, –∞ —Ç–∞–∫–∂–µ –∞—Ä—Ç–∏—Å—Ç—ã, –∞–∫—Ç–µ—Ä—ã, –∑–≤–µ–∑–¥—ã —à–æ—É-–±–∏–∑–Ω–µ—Å–∞, –≤—Ä–∞—á–∏, beauty- –∏ health-—ç–Ω—Ç—É–∑–∏–∞—Å—Ç—ã –∏ –ª–∏–¥–µ—Ä—ã –º–Ω–µ–Ω–∏–π –§–∏–Ω–∞–ª —Å —Ç–æ—Ä–∂–µ—Å—Ç–≤–µ–Ω–Ω—ã–º –≤—Ä—É—á–µ–Ω–∏–µ–º –Ω–∞–≥—Ä–∞–¥ –ø—Ä–æ–π–¥–µ—Ç —É–∂–µ 15 –¥–µ–∫–∞–±—Ä—è –≤ –¢–µ–∞—Ç—Ä–µ –≤ —Ü–µ–Ω—Ç—Ä–µ –ú–æ—Å–∫–≤—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ –æ –ø—Ä–µ–º–∏–∏: BEAUTY AWARDS –£—Å–ø–µ–π –ø–æ–¥–∞—Ç—å –∑–∞—è–≤–∫—É - @rimmi_4 #—Ä–µ–∫–ª–∞–º–∞ –ò–ü –•–∞—Å–∞–Ω –†–∏–º–º–∞ –ê–±–¥—É–ª–ª–∞—Ç–∏—Ñ–æ–≤–Ω–∞","{""skip"": true}"
2025-11-19T06:06:59+00:00,@bezrec,6831,https://t.me/bezrec/6831,"–ñ–∏—Ä–æ—Å–∂–∏–≥–∞—Ç–µ–ª–∏ ¬´–∂–≥—É—Ç¬ª –≤ –æ–Ω–ª–∞–π–Ω–µ. –ö–∞—Ç–µ–≥–æ—Ä–∏—è —Å—Ç–∞–ª–∞ –¥—Ä–∞–π–≤–µ—Ä–æ–º –ø—Ä–æ–¥–∞–∂ –ë–ê–î–æ–≤ –Ω–∞ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞—Ö, –∫–æ—Ç–æ—Ä—ã–µ —Ä–∞—Å—Ç—É—Ç –≤ —Ä–∞–∑—ã –±—ã—Å—Ç—Ä–µ–µ, —á–µ–º –≤ –∫–ª–∞—Å—Å–∏—á–µ—Å–∫–∏—Ö –∞–ø—Ç–µ–∫–∞—Ö. –ü–æ –¥–∞–Ω–Ω—ã–º ¬´–ü–ª–∞—Ç—Ñ–æ—Ä–º—ã –û–§–î¬ª, –¥–∏–Ω–∞–º–∏–∫–∞ —ç—Ç–æ–≥–æ —Å–µ–≥–º–µ–Ω—Ç–∞ –Ω–∞ 92% –≤—ã—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö –∏ –Ω–∞ 105% –≤ –¥–µ–Ω—å–≥–∞—Ö. –ü–æ–∫–∞ –≤—Ä–∞—á–∏ –Ω–µ —Å–ø–µ—à–∞—Ç –Ω–∞–∑–Ω–∞—á–∞—Ç—å —Å–≤–æ–∏–º –ø–∞—Ü–∏–µ–Ω—Ç–∞–º –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–ª—è –ø–æ—Ö—É–¥–µ–Ω–∏—è, –≤–∫–ª—é—á–∞—è –ø–æ–ø—É–ª—è—Ä–Ω—ã–π —Å–µ–º–∞–≥–ª—É—Ç–∏–¥, –∂–µ–ª–∞—é—â–∏–µ –ø–æ—Ö—É–¥–µ—Ç—å —Å–º–µ—Ç–∞—é—Ç –Ω–∞ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç-–ø–ª–æ—â–∞–¥–∫–∞—Ö –ø—Å–µ–≤–¥–æ-–æ–∑–µ–º–ø–∏–∫. –ü—Ä–æ–¥–∞–∂–∏ –∞–Ω–∞–ª–æ–≥–æ–≤ (–∑–∞—á–∞—Å—Ç—É—é —Å–æ–º–Ω–∏—Ç–µ–ª—å–Ω—ã—Ö) –¥–∞—Ç—Å–∫–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞-–±–ª–æ–∫–±–∞—Å—Ç–µ—Ä–∞ –∑–∞ –≥–æ–¥ –≤—ã—Ä–æ—Å–ª–∏ –≤ 2,5 —Ç—ã—Å. —Ä–∞–∑. –ö–æ–ª–∏—á–µ—Å—Ç–≤–æ —É–Ω–∏–∫–∞–ª—å–Ω—ã—Ö —á–µ–∫–æ–≤—ã—Ö –Ω–∞–∏–º–µ–Ω–æ–≤–∞–Ω–∏–π —Ç–∞–∫–∏—Ö —Ç–æ–≤–∞—Ä–æ–≤ –Ω–∞ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞—Ö –∏ –æ–Ω–ª–∞–π–Ω-–ø–ª–æ—â–∞–¥–∫–∞—Ö –∑–∞ –≥–æ–¥ –≤—ã—Ä–æ—Å–ª–æ –≤ 10 —Ä–∞–∑, —Å–µ–π—á–∞—Å –∏—Ö –±–æ–ª—å—à–µ 50, –≥–æ–≤–æ—Ä—è—Ç –∞–Ω–∞–ª–∏—Ç–∏–∫–∏. –í –º–∞–µ —ç–∫—Å–ø–µ—Ä—Ç—ã –ø—Ä–æ–µ–∫—Ç–∞ ¬´–ù–µ —Ä–∏—Å–∫—É–π. –ü—Ä–æ–≤–µ—Ä—å!¬ª –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–æ–π –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ ¬´–ê–Ω—Ç–∏–∫–æ–Ω—Ç—Ä–∞—Ñ–∞–∫—Ç¬ª #–∑–∞–º–µ—Ç–∏–ª–∏ –≤ —Å–µ—Ç–∏ –∂–∏—Ä–æ—Å–∂–∏–≥–∞—Ç–µ–ª–∏ Turbo Ozem—Ä—ñ—Å –∏ Azempic+. –≠–∫—Å–ø–µ—Ä—Ç–∏–∑–∞ –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª–∞, —á—Ç–æ –¥–æ–±—Ä–æ–µ –∏–º—è –±–ª–æ–∫–±–∞—Å—Ç–µ—Ä–∞ –¥–ª—è –ø–æ—Ö—É–¥–µ–Ω–∏—è ¬´–ê–º–±—Ä–µ–ª–ª–∞¬ª –∏ ¬´–ê—Ç—Ä–∏—É–º¬ª —ç–∫—Å–ø–ª—É–∞—Ç–∏—Ä–æ–≤–∞–ª–∏ –Ω–µ–∑–∞–∫–æ–Ω–Ω–æ ‚Äî –≤ –∏—Ö –ë–ê–î–∞—Ö —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ –Ω–µ –æ–∫–∞–∑–∞–ª–æ—Å—å. –ò –¥–æ–±–∞–≤–∫–∏-–ø—É—Å—Ç—ã—à–∫–∏ ‚Äì —ç—Ç–æ –µ—â—ë –ø–æ–ª–±–µ–¥—ã. –ö—É–¥–∞ —Å—Ç—Ä–∞—à–Ω–µ–µ, –∫–æ–≥–¥–∞ –ë–ê–î—ã –¥–ª—è –ø–æ—Ö—É–¥–µ–Ω–∏—è —Å–æ–¥–µ—Ä–∂–∞—Ç –∑–∞–ø—Ä–µ—â—ë–Ω–Ω—ã–π –¥–ª—è –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏—è –≤ –ë–ê–î–∞—Ö —Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã–π —Å–∏–±—É—Ç—Ä–∞–º–∏–Ω, –∫–∞–∫ —Å–∫–∞–Ω–¥–∞–ª—å–Ω—ã–µ –ú–æ–ª–µ–∫—É–ª–∞ –∏ –ú–æ–ª–µ–∫—É–ª–∞ –ø–ª—é—Å. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": true,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""Online weight loss supplements are booming, growing at a rate of over 92% year-over-year in terms of units and more than 105% in revenue. Despite doctors not prescribing weight loss drugs like semaglutide, which is popular, patients are still purchasing them online. Sales of similar products (often questionable) have increased by 2,500 times over the year. There are now more than 50 unique product names on these platforms, according to market analysts. In May, the international association 'Anti-Counterfeiting Project' #NotGuilty identified illegal weight loss supplements like Turbo Ozem—Ä—ñs and Azempic+. The experts confirmed that the popular weight loss drug 'Ambrella' and 'Atrium' were being illegally used in their supplements, which did not contain semaglutide. The most concerning issue is the presence of prohibited sibutramine, a prescription drug, in weight loss supplements. Molecule and Molecule Plus are also controversial.""
}"
2025-11-18T14:32:09+00:00,@bezrec,6830,https://t.me/bezrec/6830,"–§–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏–µ ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª —Ö–æ—Ç—è—Ç —É–ø—Ä–æ—Å—Ç–∏—Ç—å. –ö–æ–º–∏—Ç–µ—Ç –ì–æ—Å–¥—É–º—ã –ø–æ –±—é–¥–∂–µ—Ç—É –∏ –Ω–∞–ª–æ–≥–∞–º —Å–æ–≤–º–µ—Å—Ç–Ω–æ —Å –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ–º –ø–æ–¥–≥–æ—Ç–æ–≤–∏–ª –ø–æ–ø—Ä–∞–≤–∫—É, –∫–æ—Ç–æ—Ä–∞—è –¥–æ–ª–∂–Ω–∞ —É—Å–æ–≤–µ—Ä—à–µ–Ω—Å—Ç–≤–æ–≤–∞—Ç—å –ø—Ä–æ—Ü–µ—Å—Å –æ–ø–µ—Ä–∞—Ç–∏–≤–Ω–æ–≥–æ –ø–µ—Ä–µ–Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è —Å–≤–µ—Ä—Ö–ø–ª–∞–Ω–æ–≤—ã—Ö –ø–æ—Å—Ç—É–ø–ª–µ–Ω–∏–π –æ—Ç ¬´–Ω–∞–ª–æ–≥–∞ –Ω–∞ –±–æ–≥–∞—Ç—ã—Ö¬ª –≤ –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç—Å–∫–∏–π —Ñ–æ–Ω–¥. –ü–æ —Å–ª–æ–≤–∞–º —á–ª–µ–Ω–∞ –∫–æ–º–∏—Ç–µ—Ç–∞ –°–µ—Ä–≥–µ—è –ß–∏–∂–æ–≤–∞, –∫–∞–∫ —Ç–æ–ª—å–∫–æ –∫–∞–∑–Ω–∞—á–µ–π—Å—Ç–≤–æ –∫–æ–Ω—Å—Ç–∞—Ç–∏—Ä—É–µ—Ç, —á—Ç–æ —Ü–µ–ª–µ–≤–æ–π –Ω–∞–ª–æ–≥ –¥–ª—è ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª —Å–æ–±—Ä–∞–Ω —Å–≤–µ—Ä—Ö –ø—Ä–æ–≥–Ω–æ–∑–∞, –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ —Å–º–æ–∂–µ—Ç –≤ —É—Å–∫–æ—Ä–µ–Ω–Ω–æ–º –ø–æ—Ä—è–¥–∫–µ –≤–∑—è—Ç—å —ç—Ç—É —Ç–æ—á–Ω—É—é —Å—É–º–º—É –∏–∑ —Å–≤–æ–µ–≥–æ —Ä–µ–∑–µ—Ä–≤–Ω–æ–≥–æ —Ñ–æ–Ω–¥–∞ –∏ –Ω–µ–∑–∞–º–µ–¥–ª–∏—Ç–µ–ª—å–Ω–æ –Ω–∞–ø—Ä–∞–≤–∏—Ç—å –µ–µ –Ω–∞ –ª–µ—á–µ–Ω–∏–µ –ø–æ–¥–æ–ø–µ—á–Ω—ã—Ö —Ñ–æ–Ω–¥–∞. –°—Ä–æ—á–Ω—ã–µ –∑–∞—è–≤–∫–∏ –Ω–∞ –∂–∏–∑–Ω–µ–Ω–Ω–æ –≤–∞–∂–Ω—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –º–æ–≥—É—Ç —É—Ç–≤–µ—Ä–¥–∏—Ç—å –¥–∞–∂–µ –≤ —Ç–µ—á–µ–Ω–∏–µ –æ–¥–Ω–æ–≥–æ —Ä–∞–±–æ—á–µ–≥–æ –¥–Ω—è. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –∑–∞–ø—É—Å—Ç–∏—Ç—å ¬´–ø–∏–ª–æ—Ç¬ª –ø–æ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—é —Ä–µ–∑–µ—Ä–≤–∞ —É–Ω–∏–∫–∞–ª—å–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ø—Ä—è–º–æ –≤ –±–æ–ª—å–Ω–∏—Ü–∞—Ö, —á—Ç–æ–±—ã –¥–µ—Ç–∏ –º–æ–≥–ª–∏ –ø–æ–ª—É—á–∏—Ç—å —Ç–µ—Ä–∞–ø–∏—é –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏ —Å—Ä–∞–∑—É –ø–æ—Å–ª–µ –Ω–∞–∑–Ω–∞—á–µ–Ω–∏—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-11-18T11:33:34+00:00,@bezrec,6829,https://t.me/bezrec/6829,"–§–ê–° —Å–Ω–∏–∑–∏–ª–∞ —Ü–µ–Ω—ã –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –∏ –ª–µ—á–µ–Ω–∏—è –≤–µ–Ω–æ–∑–Ω—ã—Ö —Ç—Ä–æ–º–±–æ–∑–æ–≤. –ù–∞ —ç—Ç–æ—Ç —Ä–∞–∑ –¥–∏—Å–∫–æ–Ω—Ç –Ω–µ –≤–ø–µ—á–∞—Ç–ª—è–µ—Ç ‚Äî –ü–∞—Ä–Ω–∞–ø–∞—Ä–∏–Ω –Ω–∞—Ç—Ä–∏—è –≤–µ–ª—Ñ–∞—Ä–º —Å—Ç–∞–ª –≤—Å–µ–≥–æ –Ω–∞ 6 —Ä—É–±–ª–µ–π –¥–µ—à–µ–≤–ª–µ —Ä–µ—Ñ–µ—Ä–µ–Ω—Ç–Ω–æ–≥–æ –§–ª—é–∫—Å—É–º–∞ –æ—Ç –∏—Ç–∞–ª—å—è–Ω—Å–∫–æ–π Alfasigma. –°–Ω–∏–∂–µ–Ω–∏–µ —Å–æ—Å—Ç–∞–≤–∏–ª–æ 2,5%. –¶–µ–Ω–∞ –∑–∞ 1 –∞–º–ø—É–ª—É —Ä–∞—Å—Ç–≤–æ—Ä–∞ –¥–ª—è –ø–æ–¥–∫–æ–∂–Ω–æ–≥–æ –≤–≤–µ–¥–µ–Ω–∏—è –≤ –¥–æ–∑–∏—Ä–æ–≤–∫–µ 3200 –∞–Ω—Ç–∏-–•–∞ –ú–ï –æ—Ç ¬´–í–µ–ª—Ñ–∞—Ä–º¬ª —Å–æ–≥–ª–∞—Å–æ–≤–∞–Ω–∞ –Ω–∞ —É—Ä–æ–≤–Ω–µ 230 —Ä—É–±–ª–µ–π, –ø—Ä–∏ —ç—Ç–æ–º —Ü–µ–Ω–∞ –∑–∞ –∞–Ω–∞–ª–æ–≥–∏—á–Ω—É—é —Ñ–æ—Ä–º—É –≤—ã–ø—É—Å–∫–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ —Å–æ—Å—Ç–∞–≤–ª—è–µ—Ç 236 —Ä—É–±–ª–µ–π. –ü–∞—Ä–Ω–∞–ø–∞—Ä–∏–Ω –Ω–∞—Ç—Ä–∏—è –≤–µ–ª—Ñ–∞—Ä–º ‚Äî –ø–µ—Ä–≤—ã–π –±–∏–æ–∞–Ω–∞–ª–æ–≥ –≤ —Ä–∞–º–∫–∞—Ö –æ–¥–Ω–æ–∏–º–µ–Ω–Ω–æ–≥–æ –ú–ù–ù –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–∞ ‚Äî —á–ª–µ–Ω–∞ –ï–≤—Ä–∞–∑–∏–π—Å–∫–æ–≥–æ —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–≥–æ —Å–æ—é–∑–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""pricing, reimbursement"",
  ""impact"": ""low"",
  ""english"": ""The price of Parnaparin sodium Velfarma, a biosimilar for the prevention and treatment of venous thrombosis, was reduced by 6 rubles to match the reference drug Fluxuma from Italian company Alfasigma. The price for a 3200 anti-Ha MEL injection is set at 230 rubles, while the price for an equivalent dosage form of the foreign-produced drug is 236 rubles. Parnaparin sodium Velfarma is the first biosimilar within its generic name in a country that is a member of the Eurasian Economic Union.""
}"
2025-11-18T08:45:32+00:00,@bezrec,6828,https://t.me/bezrec/6828,"–ü—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–ª—è –ø–æ—Ö—É–¥–µ–Ω–∏—è –ø–æ–ø—É–ª—è—Ä–Ω—ã —Å—Ä–µ–¥–∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –Ω–æ –Ω–µ –≤—Ä–∞—á–µ–π. –°–µ—Ä–≤–∏—Å ¬´–°–ø—Ä–∞–≤–æ—á–Ω–∏–∫ –≤—Ä–∞—á–∞¬ª –ø—Ä–æ–≤—ë–ª –æ–ø—Ä–æ—Å –Ω–∞ —Ç–µ–º—É –ª–µ—á–µ–Ω–∏—è –æ–∂–∏—Ä–µ–Ω–∏—è —Å —É—á–∞—Å—Ç–∏–µ–º –ø–æ—á—Ç–∏ 1,6 —Ç—ã—Å. –º–µ–¥–∏–∫–æ–≤ —Ä–∞–∑–Ω—ã—Ö –ø—Ä–æ—Ñ–∏–ª–µ–π. 54,6% –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏, —á—Ç–æ –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏ –≤—Å–µ –∏—Ö –ø–∞—Ü–∏–µ–Ω—Ç—ã –∏–º–µ—é—Ç –ø—Ä–æ–±–ª–µ–º—ã —Å –ª–∏—à–Ω–∏–º –≤–µ—Å–æ–º –∏–∑-–∑–∞ –ø–µ—Ä–µ–µ–¥–∞–Ω–∏—è –∏ –Ω–∏–∑–∫–æ–π —Ñ–∏–∑–∏—á–µ—Å–∫–æ–π –∞–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏. –ò–Ω—Ç–µ—Ä–µ—Å–Ω–æ, —á—Ç–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–ª—è –ø–æ—Ö—É–¥–µ–Ω–∏—è, –≤–∫–ª—é—á–∞—è –ø–æ–ø—É–ª—è—Ä–Ω—ã–π —Å–µ–º–∞–≥–ª—É—Ç–∏–¥, —Å–≤–æ–∏–º –ø–∞—Ü–∏–µ–Ω—Ç–∞–º —Ä–µ–∫–æ–º–µ–Ω–¥—É—é—Ç —Ç–æ–ª—å–∫–æ 1% –≤—Ä–∞—á–µ–π. –°–æ–≤–º–µ—Å—Ç–∏—Ç—å —Ñ–∞—Ä–º—É —Å –∫–æ—Ä—Ä–µ–∫—Ç–∏—Ä–æ–≤–∫–æ–π –ø–∏—Ç–∞–Ω–∏—è –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç 7,7% —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤. –£ –±–∞—Ä–∏–∞—Ç—Ä–∏–∏ –ø–æ–∫–ª–æ–Ω–Ω–∏–∫–æ–≤ –µ—â—ë –º–µ–Ω—å—à–µ ‚Äì –∫ —Ö–∏—Ä—É—Ä–≥–∏—á–µ—Å–∫–æ–º—É –≤–º–µ—à–∞—Ç–µ–ª—å—Å—Ç–≤—É —Å–æ–≤–µ—Ç—É—é—Ç –ø—Ä–∏–±–µ–≥–∞—Ç—å –º–µ–Ω–µ–µ 1% –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö. –û–¥–Ω–∞–∫–æ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π —Å–æ —Å—Ç–æ—Ä–æ–Ω—ã –≤—Ä–∞—á–µ–π –æ—Å—Ç–∞–Ω–∞–≤–ª–∏–≤–∞–µ—Ç –Ω–µ –≤—Å–µ—Ö ‚Äì 38,7% —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –æ–ø—Ä–æ—Å–∞ –æ—Ç–º–µ—Ç–∏–ª–∏, —á—Ç–æ –∏—Ö –ø–∞—Ü–∏–µ–Ω—Ç—ã –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–ª–∏ –¥–ª—è —Å–Ω–∏–∂–µ–Ω–∏—è –≤–µ—Å–∞ –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç—ã. –ü–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω–æ –∏—Ö –ø—Ä–∏—ë–º –æ—Ü–µ–Ω–∏–ª–∏ 37,8% —Ä–µ—Å–ø–æ–Ω–¥–µ–Ω—Ç–æ–≤, —É 50% –æ—Ç–Ω–æ—à–µ–Ω–∏–µ –∫ —Ç–∞–∫–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –æ–∫–∞–∑–∞–ª–æ—Å—å –Ω–µ–π—Ç—Ä–∞–ª—å–Ω—ã–º. 10,5% –Ω–∞—Å—Ç—Ä–æ–µ–Ω—ã —Å–∫–µ–ø—Ç–∏—á–µ—Å–∫–∏, —Ç.–∫. –Ω–∞–±–ª—é–¥–∞–ª–∏ —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –ø–æ–±–æ—á–∫–∏, –º–∏–Ω–∏–º–∞–ª—å–Ω–æ–µ —Å–Ω–∏–∂–µ–Ω–∏–µ –≤–µ—Å–∞, –∞ —Ç–∞–∫–∂–µ –±—ã—Å—Ç—Ä—ã–π –≤–æ–∑–≤—Ä–∞—Ç –∫ –ø—Ä–µ–∂–Ω–∏–º –ø–∞—Ä–∞–º–µ—Ç—Ä–∞–º –ø–æ—Å–ª–µ –æ—Ç–º–µ–Ω—ã –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": true,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,hospital_policy,pharmacovigilance"",
  ""impact"": ""low"",
  ""english"": ""The survey found that nearly all patients of doctors have weight issues due to overeating and low physical activity. Only 1% of doctors recommend slimming drugs like semaglutide to their patients, and only 7.7% suggest adjusting diet. Only 1% of respondents recommend bariatric surgery, while 38.7% of patients use medications to lose weight. Positive responses were given by 37.8%, neutral by 50% and negative by 10.5%. Doctors are skeptical of the drugs due to side effects, minimal weight loss and quick return to previous parameters after discontinuation.""
}"
2025-11-18T05:37:15+00:00,@bezrec,6825,https://t.me/bezrec/6825,"–û—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ ¬´—Ä–µ–¥–∫–∏—Ö¬ª –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ —Ñ–∞—Ä–º—Ä—ã–Ω–∫–µ ‚Äî —Ä–µ–¥–∫–æ—Å—Ç—å. IT-–∫–æ–º–ø–∞–Ω–∏—è Cursor –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∞ –ø–æ–¥—Ä–æ–±–Ω—ã–π –æ–±–∑–æ—Ä –æ —Å–æ—Å—Ç–æ—è–Ω–∏–∏ —Ä—ã–Ω–∫–∞ –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –†–æ—Å—Å–∏–∏ –ø–æ –∏—Ç–æ–≥–∞–º –¥–µ–≤—è—Ç–∏ –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞. –î–µ–ª–∏–º—Å—è –≤—ã–¥–µ—Ä–∂–∫–∞–º–∏ –∏–∑ –æ—Ç—á—ë—Ç–∞. üíä –í –†–§ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–æ 115 —Ç–æ—Ä–≥–æ–≤—ã—Ö –Ω–∞–∏–º–µ–Ω–æ–≤–∞–Ω–∏–π (99 –ú–ù–ù), –∏–º–µ—é—â–∏—Ö –æ—Ä—Ñ–∞–Ω–Ω—ã–π —Å—Ç–∞—Ç—É—Å, 59 –∏–∑ –Ω–∏—Ö –≤–∫–ª—é—á–µ–Ω—ã –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü, 74 –ú–ù–ù –≤–∫–ª—é—á–µ–Ω—ã –≤ 102 –¥–µ–π—Å—Ç–≤—É—é—â–∏–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏. üíä –ù–∞–∏–±–æ–ª—å—à–∏–π –æ–±—ä–µ–º –∑–∞–∫—É–ø–æ–∫ –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–Ω –≤ 2024 –≥–æ–¥—É, —á—Ç–æ —Å–≤—è–∑–∞–Ω–æ —Å –≤–≤–æ–¥–æ–º –Ω–æ–≤—ã—Ö –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –≥—Ä–∞–∂–¥–∞–Ω—Å–∫–∏–π –æ–±–æ—Ä–æ—Ç, –∞ —Ç–∞–∫–∂–µ —Å –∑–∞–∫—É–ø–∫–∞–º–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤–æ–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –≤–∫–ª—é—á–µ–Ω–Ω—ã—Ö –≤ 14 –í–ó–ù –Ω–∞ 2024 –∏ –ø–ª–∞–Ω–æ–≤—ã–π 2025 –≥–æ–¥—ã. üíä –ü–æ 9 –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º –æ—Ç—Å—É—Ç—Å—Ç–≤—É—é—Ç –ø—Ä–æ–¥–∞–∂–∏ –∑–∞ –∏—Å—Å–ª–µ–¥—É–µ–º—ã–π –ø–µ—Ä–∏–æ–¥: –∞–≤–∞–∫–æ–ø–∞–Ω (–¢–∞–≤–Ω–µ–æ—Å), –∏–º–º—É–Ω–æ–≥–ª–æ–±—É–ª–∏–Ω —á–µ–ª–æ–≤–µ–∫–∞ –Ω–æ—Ä–º–∞–ª—å–Ω—ã–π (–•–∞–π—Ü–µ–Ω—Ç—Ä–∞), –º–∞—Ü–∏—Ç–µ–Ω—Ç–∞–Ω (–ú–∞—Ü–∏–º–∞–Ω—Ç), –ø–µ–º–∏–≥–∞—Ç–∏–Ω–∏–± (–û—Ñ–µ–∑—É–º–∏—Ä), –ø—ç–≥—É–Ω–∏–≥–∞–ª–∏–¥–∞–∑–∞ –∞–ª—å—Ñ–∞ (–≠–ª—å—Ñ–∞–±—Ä–∏–æ), —Ç–µ–ª–æ—Ç—Ä–∏—Å—Ç–∞—Ç (–ö—Å–µ—Ä–º–µ–ª–æ), FW+FXI (–í–∏–ª–∞—Ç–µ –ù–µ–æ), —ç–ø–∫–æ—Ä–∏—Ç–∞–º–∞–± (–≠–ø–∫–∏–Ω–ª–∏), —ç–ø–ª–æ–Ω—Ç–µ—Ä—Å–µ–Ω (–ò—Ä–µ–ª–º–∏). –î—É–≤–µ–ª–∏—Å–∏–± (–ö–æ–ø–∏–∫—Ç—Ä–∞) –ø—Ä–æ–¥–∞–≤–∞–ª—Å—è —Ç–æ–ª—å–∫–æ –¥–æ 2024 –≥–æ–¥–∞. üíä 91,2% –ø—Ä–æ–¥–∞–∂ –≤ 2025 –≥–æ–¥—É –≤ –¥–µ–Ω—å–≥–∞—Ö –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ –∏–º–ø–æ—Ä—Ç–Ω—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, –≤–∫–ª—é—á–∞—è –ª–æ–∫–∞–ª–∏–∑–æ–≤–∞–Ω–Ω—ã–µ –Ω–∞ –º–æ—â–Ω–æ—Å—Ç—è—Ö —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π. üíä 180,8 —Ç—ã—Å. —Ä—É–±–ª–µ–π —Å–æ—Å—Ç–∞–≤–∏–ª–∞ –≤ 2025 –≥–æ–¥—É —Å—Ä–µ–¥–Ω–µ–≤–∑–≤–µ—à–µ–Ω–Ω–∞—è —Ü–µ–Ω–∞ –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∑–∞ —É–ø–∞–∫–æ–≤–∫—É, —ç—Ç–æ +91% –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å–æ —Å—Ä–µ–¥–Ω–µ–≤–∑–≤–µ—à–µ–Ω–Ω–æ–π —Ü–µ–Ω–æ–π –≤ 2024 –≥–æ–¥—É –∑–∞ —Å—á–µ—Ç –∑–∞–∫—É–ø–æ–∫ –Ω–æ–≤—ã—Ö –¥–æ—Ä–æ–≥–æ—Å—Ç–æ—è—â–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. üíä 58% –≤—Å–µ—Ö –ø—Ä–æ–¥–∞–∂ –≤ 2025 –≥–æ–¥—É –ø—Ä–∏—Ö–æ–¥—è—Ç—Å—è –Ω–∞ –¥–µ—Å—è—Ç—å –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ï–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –≤ —Ç–æ–ø-10 ‚Äì –≠–ª–∏–∑–∞—Ä–∏—è –æ—Ç ¬´–ì–µ–Ω–µ—Ä–∏—É–º¬ª ‚Äì –Ω–∞—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ —Å–µ–¥—å–º–æ–π —Å—Ç—Ä–æ—á–∫–µ —Ä–µ–π—Ç–∏–Ω–≥–∞. üíä –í —Ç—Ä–æ–π–∫—É —Å–∞–º—ã—Ö –∑–∞–∫—É–ø–∞–µ–º—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤—Ö–æ–¥—è—Ç –≠–≤—Ä–∏—Å–¥–∏, –ö–æ—Å–µ–ª—É–≥–æ –∏ –¢—Ä–∏–ª–µ–∫—Å–∞. üíä –°–∞–º—ã–º–∏ –¥–æ—Ä–æ–≥–∏–º–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏ –æ—Å—Ç–∞—é—Ç—Å—è –ó–æ–ª–≥–µ–Ω—Å–º–∞, –õ—É–∫—Å—Ç—É—Ä–Ω–∞ –∏ –°—Ç—Ä–µ–Ω–∑–∏–∫. üíä 76% –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ –∫–æ–ª–∏—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏, –∏ —Å–≤—ã—à–µ 80% –ø–æ –æ–±—ä—ë–º–∞–º –∑–∞–∫—É–ø–æ–∫, –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –∏–∑ –Ω–µ–¥—Ä—É–∂–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ç—Ä–∞–Ω. üíä –í —Ç–æ–ø-10 –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è ¬´—Ä–µ–¥–∫–∏—Ö¬ª –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –≤–æ—à–ª–∏: ¬´–ê—Å—Ç—Ä–∞–ó–µ–Ω–µ–∫–∞¬ª, ¬´–†–æ—à¬ª, ¬´–ù–æ–≤–∞—Ä—Ç–∏—Å¬ª, ¬´–ì–µ–Ω–µ—Ä–∏—É–º¬ª, ¬´–¢—é—Ç–æ—Ä¬ª, ¬´–ü–∏–¢–∏–°–∏ –¢–µ—Ä–∞–ø—å—é—Ç–∏–∫—Å¬ª, ¬´–î–∂–æ–Ω—Å–æ–Ω & –î–∂–æ–Ω—Å–æ–Ω¬ª, ¬´–ë–∏–æ–ú–∞—Ä–∏–Ω –ò–Ω—Ç–µ—Ä–Ω—ç—à–Ω–ª¬ª, ¬´–¢–∞–∫–µ–¥–∞¬ª –∏ ¬´–≠–±–±–≤–∏¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, shortage, demand, pharmacovigilance"",
  ""impact"": ""high"",
  ""english"": ""The report highlights the state of orphan drug market in Russia for nine months of 2025. It mentions that while there are only 115 registered trade names, the import of expensive drugs accounts for a significant portion of sales. The report also notes that only one domestically produced drug, Elisaria from Generium, is in the top 10. The market for orphan drugs remains challenging with high prices and low domestic production.""
}"
2025-11-17T14:33:50+00:00,@bezrec,6824,https://t.me/bezrec/6824,"¬´–ê—Å—Ç—Ä–∞ –ó–µ–Ω–µ–∫–∞¬ª –≤—ã—à–ª–∞ –∏–∑ —Å–æ—Å—Ç–∞–≤–∞ —É—á—Ä–µ–¥–∏—Ç–µ–ª–µ–π —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Ä–µ–∑–∏—Å—Ç–µ–Ω—Ç–Ω–æ–π –∞—Ä—Ç–µ—Ä–∏–∞–ª—å–Ω–æ–π –≥–∏–ø–µ—Ä—Ç–µ–Ω–∑–∏–∏. –†–µ—á—å –æ —Ä–µ–∑–∏–¥–µ–Ω—Ç–µ –°–∫–æ–ª–∫–æ–≤–æ, –û–û–û ¬´–¢–∞—Ä–≥–µ—Ç –ú–µ–¥–∏–∫–∞–ª—Å¬ª. –ö–æ–º–ø–∞–Ω–∏—è –±—ã–ª–∞ —Å–æ–∑–¥–∞–Ω–∞ —É—á—ë–Ω—ã–º–∏ –≤–æ –≥–ª–∞–≤–µ —Å –ê–ª–µ–∫—Å–µ–µ–º –ö–ª—é—á–µ–Ω–æ–≤–∏—á–µ–º –≤ 2012 –≥–æ–¥—É. –í 2022 –≥–æ–¥—É –≤ –ø—Ä–æ–µ–∫—Ç –ø–æ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –ø—Ä–æ—Ç–∏–≤ —Ä–µ–∑–∏—Å—Ç–µ–Ω—Ç–Ω–æ–π –∞—Ä—Ç–µ—Ä–∏–∞–ª—å–Ω–æ–π –≥–∏–ø–µ—Ä—Ç–µ–Ω–∑–∏–∏ –∏ —Ç–µ—Ä–∞–ø–∏–∏ –Ω–µ–∫–æ—Ç–æ—Ä—ã—Ö –¥—Ä—É–≥–∏—Ö ¬´—Å–µ—Ä–¥–µ—á–Ω—ã—Ö¬ª –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π —Ä–µ—à–∏–ª–∏ –≤–ª–æ–∂–∏—Ç—å—Å—è ¬´–Æ–Ω–∏–∫–æ—Ä–Ω –ö—ç–ø–∏—Ç–∞–ª –ü–∞—Ä—Ç–Ω–µ—Ä—Å¬ª (–≤ –∫–∞—á–µ—Å—Ç–≤–µ –æ—Å–Ω–æ–≤–Ω–æ–≥–æ –∏–Ω–≤–µ—Å—Ç–æ—Ä–∞), –†–§–ü–ò –∏ AstraZeneca —Å –¥–æ–ª–µ–π –≤ 9%. –ö–∞–∫ –ø–æ—è—Å–Ω–∏–ª–∏ ¬´–ê–ë–ù¬ª –≤ –ø—Ä–µ—Å—Å-—Å–ª—É–∂–±–µ AstraZeneca, —Å–µ–π—á–∞—Å –≤ –ø–æ—Ä—Ç—Ñ–µ–ª–µ –∫–æ–º–ø–∞–Ω–∏–∏ –µ—Å—Ç—å —Ä—è–¥ —Å—Ö–æ–∂–∏—Ö –ø–æ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—é –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –ø—Ä–æ–µ–∫—Ç–æ–≤, –ø–æ—ç—Ç–æ–º—É –Ω–∞ —Ç–µ–∫—É—â–µ–º —ç—Ç–∞–ø–µ –ø—Ä–∏–Ω—è—Ç–æ —Ä–µ—à–µ–Ω–∏–µ –æ–ø—Ç–∏–º–∏–∑–∏—Ä–æ–≤–∞—Ç—å –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–æ–Ω–Ω—ã–π –ø–æ—Ä—Ç—Ñ–µ–ª—å. –í–ø—Ä–æ—á–µ–º, –≤ –∫–æ–º–ø–∞–Ω–∏–∏ –∑–∞—è–≤–∏–ª–∏, —á—Ç–æ –Ω–µ –ø–æ—Ç–µ—Ä—è–ª–∏ –∏–Ω—Ç–µ—Ä–µ—Å –∫ –ø—Ä–æ–µ–∫—Ç—É –∏ –æ—Å—Ç–∞–≤–∏–ª–∏ –∑–∞ —Å–æ–±–æ–π –ø—Ä–∞–≤–æ ¬´–≤–µ—Ä–Ω—É—Ç—å—Å—è –Ω–∞ —Ç–æ–º –∏–ª–∏ –∏–Ω–æ–º —ç—Ç–∞–ø–µ —Ä–∞–∑–≤–∏—Ç–∏—è ¬´–¢–∞—Ä–≥–µ—Ç –ú–µ–¥–∏–∫–∞–ª—Å¬ª¬ª. –§–∏–Ω–∞–Ω—Å–æ–≤–æ–µ –ø–æ–ª–æ–∂–µ–Ω–∏–µ –û–û–û ¬´–¢–∞—Ä–≥–µ—Ç –ú–µ–¥–∏–∫–∞–ª—Å¬ª –≤—ã–∑—ã–≤–∞–µ—Ç –≤–æ–ø—Ä–æ—Å—ã. –ü–æ –¥–∞–Ω–Ω—ã–º Rusprofile, –≤ 2024 –≥–æ–¥—É –≤—ã—Ä—É—á–∫–∞ –æ—Ç—Å—É—Ç—Å—Ç–≤—É–µ—Ç, –ø—Ä–∏ —ç—Ç–æ–º –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–Ω —É–±—ã—Ç–æ–∫ –≤ —Ä–∞–∑–º–µ—Ä–µ 1,2 –º–ª–Ω —Ä—É–±–ª–µ–π, —á—Ç–æ –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ —Ö—É–∂–µ –ø–æ–∫–∞–∑–∞—Ç–µ–ª–µ–π 2023 –≥–æ–¥–∞ —Å –ø—Ä–∏–±—ã–ª—å—é 6,1 –º–ª–Ω —Ä—É–±–ª–µ–π. –ö–æ—ç—Ñ—Ñ–∏—Ü–∏–µ–Ω—Ç—ã —É–∫–∞–∑—ã–≤–∞—é—Ç –Ω–∞ —Ä–∏—Å–∫–∏: –æ–±–µ—Å–ø–µ—á–µ–Ω–Ω–æ—Å—Ç—å —Å–æ–±—Å—Ç–≤–µ–Ω–Ω—ã–º–∏ —Å—Ä–µ–¥—Å—Ç–≤–∞–º–∏ –æ—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω–∞—è (-2,36), –∞ —Ç–µ–∫—É—â–∞—è –ª–∏–∫–≤–∏–¥–Ω–æ—Å—Ç—å –Ω–∏–∑–∫–∞—è (0,32). –≠—Ç–æ –≥–æ–≤–æ—Ä–∏—Ç –æ –Ω–µ–¥–æ—Å—Ç–∞—Ç–∫–µ –æ–±–æ—Ä–æ—Ç–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –¥–ª—è –ø–æ–∫—Ä—ã—Ç–∏—è –æ–±—è–∑–∞—Ç–µ–ª—å—Å—Ç–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, shortage"",
  ""impact"": ""medium"",
  ""english"": ""AstraZeneca has exited its membership in the shareholders of a Russian company developing a drug for resistant arterial hypertension. The project, Target Medicals, was founded by scientists led by Alexey Klyuchenov in 2012. In 2022, the project was funded by Unicorn Capital Partners (as a main investor), Russian Federal Agency for Science and Innovations, and AstraZeneca with a 9% stake. The company has other similar projects in its portfolio, so it decided to optimize the investment portfolio at this stage. However, the financial health of Target Medicals is questionable as it reported a revenue of zero in 2024 and an operating loss of RUB1.2 million compared to a profit of RUB6.1 million in 2023. The solvency ratios indicate negative equity (‚Äì2,36) and low current liquidity (0.32). This suggests a shortage of working capital to meet obligations.""
}"
2025-11-17T11:52:39+00:00,@bezrec,6823,https://t.me/bezrec/6823,"–ß–µ–≥–æ —Å—Ç–µ—Å–Ω—è—é—Ç—Å—è –∂–µ–Ω—â–∏–Ω—ã –≤ –∞–ø—Ç–µ–∫–∞—Ö. –ü–æ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º –æ–ø—Ä–æ—Å–∞, –ø—Ä–æ–≤–µ–¥—ë–Ω–Ω–æ–≥–æ –∫–æ–º–ø–∞–Ω–∏–µ–π ¬´–ê–ª—Ü–µ—è¬ª, 70% —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–æ–≤ –æ—Ç–º–µ—á–∞—é—Ç, —á—Ç–æ –∂–µ–Ω—â–∏–Ω—ã –Ω–µ—Ä–µ–¥–∫–æ —Å–º—É—â–∞—é—Ç—Å—è –ø—Ä–∏ –ø–æ–∫—É–ø–∫–µ —Å—Ä–µ–¥—Å—Ç–≤ –¥–ª—è –∑–¥–æ—Ä–æ–≤—å—è. –°–∞–º—ã–º–∏ ¬´—Å–∫—Ä–æ–º–Ω—ã–º–∏¬ª –æ–∫–∞–∑–∞–ª–∏—Å—å –ø–æ–∫—É–ø–∞—Ç–µ–ª—å–Ω–∏—Ü—ã –º–ª–∞–¥—à–µ 25 –∏ —Å—Ç–∞—Ä—à–µ 45 –ª–µ—Ç. –í —Ç–æ–ø-5 ¬´—Å–º—É—â–∞—é—â–∏—Ö¬ª –∫–∞—Ç–µ–≥–æ—Ä–∏–π –≤–æ—à–ª–∏: üîò—Å—Ä–µ–¥—Å—Ç–≤–∞ –æ—Ç –≤—É–ª—å–≤–æ–≤–∞–≥–∏–Ω–∞–ª—å–Ω—ã—Ö –∏–Ω—Ñ–µ–∫—Ü–∏–π - 62,5%; üîò–ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–ª—è –ª–µ—á–µ–Ω–∏—è –≥–µ–º–æ—Ä—Ä–æ—è - 50%; üîò–∫–æ–Ω—Ç—Ä–∞—Ü–µ–ø—Ç–∏–≤—ã - 41,7%; üîò–ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–ª—è –æ–±–ª–µ–≥—á–µ–Ω–∏—è —Å–∏–º–ø—Ç–æ–º–æ–≤ –º–µ–Ω–æ–ø–∞—É–∑—ã - 32,4%; üîò—Å—Ä–µ–¥—Å—Ç–≤–∞ –ø—Ä–∏ —Å–±–æ—è—Ö –º–µ–Ω—Å—Ç—Ä—É–∞–ª—å–Ω–æ–≥–æ —Ü–∏–∫–ª–∞ - 26,9%. –í —á—ë–º –ø—Ä–æ—è–≤–ª—è–µ—Ç—Å—è: üîò—Ä–∞—Å–ø–ª—ã–≤—á–∞—Ç—ã–µ, –∑–∞–≤—É–∞–ª–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ —Ñ–æ—Ä–º—É–ª–∏—Ä–æ–≤–∫–∏ (¬´—Ç–∞–±–ª–µ—Ç–∫–∏, —á—Ç–æ–±—ã –Ω–µ –∑–∞–±–µ—Ä–µ–º–µ–Ω–µ—Ç—å¬ª, ¬´—á—Ç–æ-–Ω–∏–±—É–¥—å –æ—Ç –ø—Ä–∏–ª–∏–≤–æ–≤¬ª, ¬´—á—Ç–æ-—Ç–æ –æ—Ç —É–ø–ª–æ—Ç–Ω–µ–Ω–∏–π –≤ –≥—Ä—É–¥–∏¬ª) - 40,9%; üîò–æ–±—Ä–∞—â–µ–Ω–∏–µ –∫ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∞–º —à–µ–ø–æ—Ç–æ–º - 23,6%; üîò–Ω–∞–∑–≤–∞–Ω–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –ø–æ–∫–∞–∑—ã–≤–∞—é—Ç –Ω–∞ —Ç–µ–ª–µ—Ñ–æ–Ω–µ –∏–ª–∏ –≤ –∑–∞–ø–∏—Å–∫–µ - 21,6%. –§–∞–∫—Ç–æ—Ä—ã, —É—Å–∏–ª–∏–≤–∞—é—â–∏–µ –æ—â—É—â–µ–Ω–∏–µ –Ω–µ–ª–æ–≤–∫–æ—Å—Ç–∏: üîò–Ω–∞–ª–∏—á–∏–µ –æ—á–µ—Ä–µ–¥–∏ - 70,8%; üîò–º—É–∂—á–∏–Ω–∞-—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç –∑–∞ —Å—Ç–æ–π–∫–æ–π - 61,8%; üîò–º–æ–ª–æ–¥–æ–π –≤–æ–∑—Ä–∞—Å—Ç —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–∞ –∞–ø—Ç–µ–∫–∏ - 33%. –ù–æ –µ—Å—Ç—å –∏ —Ö–æ—Ä–æ—à–∏–µ –Ω–æ–≤–æ—Å—Ç–∏. 63,3% –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö –æ—Ç–º–µ—Ç–∏–ª–∏, —á—Ç–æ –∑–∞ –ø–æ—Å–ª–µ–¥–Ω–∏–µ –ø—è—Ç—å –ª–µ—Ç –∂–µ–Ω—â–∏–Ω—ã —Å—Ç–∞–ª–∏ –±–æ–ª–µ–µ –æ—Ç–∫—Ä—ã—Ç—ã –∫ –æ–±—Å—É–∂–¥–µ–Ω–∏—é –¥–µ–ª–∏–∫–∞—Ç–Ω—ã—Ö —Ç–µ–º. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety, guideline"",
  ""impact"": ""medium"",
  ""english"": ""A survey conducted by Alcaya found that women often feel embarrassed when purchasing health products. The most common topics of embarrassment include treatments for vaginal infections, hemorrhoids, contraceptives, and menstrual irregularities. Factors that exacerbate embarrassment include a queue at the pharmacy counter, male pharmacists, and younger staff. However, there has been an improvement in women's openness to discussing sensitive topics over the past five years.""
}"
2025-11-17T08:29:58+00:00,@bezrec,6822,https://t.me/bezrec/6822,"–¢–∞–∫–∏–º–∏ –ø—Ä–æ–≥–Ω–æ–∑–∞–º–∏ –ø–æ–¥–µ–ª–∏–ª–∏—Å—å –≤ DSM Group. –ü–æ –ø–æ–¥—Å—á—ë—Ç–∞–º –∞–Ω–∞–ª–∏—Ç–∏–∫–æ–≤, –ø–æ –∏—Ç–æ–≥–∞–º –≥–æ–¥–∞ —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ –∞–ø—Ç–µ–∫–∏ –ø—Ä–æ–¥–∞–¥—É—Ç –ë–ê–î–æ–≤ –Ω–∞ 183,5 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ü—Ä–∏ —ç—Ç–æ–º, –ø–∏—à—É—Ç ¬´–í–µ–¥–æ–º–æ—Å—Ç–∏¬ª, –ø—Ä–æ–¥–∞–∂–∏ –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏, —Å–∫–æ—Ä–µ–µ –≤—Å–µ–≥–æ, —Å–Ω–∏–∑—è—Ç—Å—è –Ω–∞ 1% –¥–æ 404,3 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫. –£ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –°–æ—é–∑–∞ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ë–ê–î –∫ –ø–∏—â–µ –ê–ª–µ–∫—Å–∞–Ω–¥—Ä–∞ –ñ–µ—Å—Ç–∫–æ–≤–∞ –ø—Ä–æ–≥–Ω–æ–∑—ã –Ω–µ—Å–∫–æ–ª—å–∫–æ –∏–Ω—ã–µ. –û–Ω —Å—á–∏—Ç–∞–µ—Ç, —á—Ç–æ –ø—Ä–æ–¥–∞–∂–∏ –¥–æ–±–∞–≤–æ–∫ –≤–ø–µ—Ä–≤—ã–µ –ø–æ—Å–ª–µ —Å—Ç–∞–≥–Ω–∞—Ü–∏–∏ —Å–µ–≥–º–µ–Ω—Ç–∞ –≤ 2022‚Äì2024 –≥–≥. –≤—ã—Ä–∞—Å—Ç—É—Ç –∏ –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ ‚Äì –ø—Ä–∏–º–µ—Ä–Ω–æ –Ω–∞ 11%, –¥–æ 500 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫. –í –¥–µ–Ω—å–≥–∞—Ö —ç–∫—Å–ø–µ—Ä—Ç –ø—Ä–æ–≥–Ω–æ–∑–∏—Ä—É–µ—Ç —É–≤–µ–ª–∏—á–µ–Ω–∏–µ –æ–±–æ—Ä–æ—Ç–∞ –Ω–∞ 16‚Äì17%. –ü—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ —Ä–æ—Å—Ç —Å–ø—Ä–æ—Å–∞ –Ω–∞ —Å–≤–æ—é –ø—Ä–æ–¥—É–∫—Ü–∏—é –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–∞—é—Ç. –¢–∞–∫, —É Ipsum –ø—Ä–æ–¥–∞–∂–∏ –∑–∞ –¥–µ–≤—è—Ç—å –º–µ—Å—è—Ü–µ–≤ –≤ –¥–µ–Ω—å–≥–∞—Ö –ø—Ä–∏–±–∞–≤–∏–ª–∏ 28‚Äì32% –≥–æ–¥ –∫ –≥–æ–¥—É (–¥–æ 928 –º–ª–Ω —Ä—É–±–ª–µ–π), –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö ‚Äì 18‚Äì22% (–¥–æ 639 —Ç—ã—Å. –±–∞–Ω–æ–∫). –£ ¬´–≠–≤–∞–ª–∞—Ä–∞¬ª —Ä–µ–∞–ª–∏–∑–∞—Ü–∏—è –≤ —Ä—É–±–ª—è—Ö –≤—ã—Ä–æ—Å–ª–∞ –Ω–∞ 24%, –∞ –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö ‚Äì —Å–æ–∫—Ä–∞—Ç–∏–ª–∞—Å—å –Ω–∞ 0,4%. –î–∏—Ä–µ–∫—Ç–æ—Ä –ø–æ —Ä–∞–∑–≤–∏—Ç–∏—é RNC Pharma –ù–∏–∫–æ–ª–∞–π –ë–µ—Å–ø–∞–ª–æ–≤ —Å—á–∏—Ç–∞–µ—Ç, —á—Ç–æ —Ä–æ—Å—Ç—É –ø—Ä–æ–¥–∞–∂ –ë–ê–î–æ–≤ —Å–ø–æ—Å–æ–±—Å—Ç–≤—É–µ—Ç —Ä–∞–∑–≤–∏—Ç–∏–µ –æ–Ω–ª–∞–π–Ω-—Å–µ–≥–º–µ–Ω—Ç–∞. –¢–∞–∫, –≤ —è–Ω–≤–∞—Ä–µ ‚Äì —Å–µ–Ω—Ç—è–±—Ä–µ 2025 –≥–æ–¥–∞ —ç—Ç–∞ –∫–∞—Ç–µ–≥–æ—Ä–∏—è –Ω–∞ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞—Ö –ø—Ä–∏–±–∞–≤–∏–ª–∞ –≤ –¥–µ–Ω—å–≥–∞—Ö 37%, —Ç–æ–≥–¥–∞ –∫–∞–∫ –ø—Ä–æ–¥–∞–∂–∏ —á–µ—Ä–µ–∑ –∞–ø—Ç–µ–∫–∏ —É–≤–µ–ª–∏—á–∏–ª–∏—Å—å –≤—Å–µ–≥–æ –Ω–∞ 13%. –í –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–µ –ë–ê–î–æ–≤ —Å–æ–∫—Ä–∞—â–∞–µ—Ç—Å—è –ø–æ –≤—Å–µ–º –∫–∞–Ω–∞–ª–∞–º, –∫—Ä–æ–º–µ –æ–Ω–ª–∞–π–Ω. –í –∞–ø—Ç–µ–∫–∞—Ö –ø—Ä–æ–¥–∞–∂–∏ —É–ø–∞–ª–∏ –Ω–∞ 5%, –∞ –Ω–∞ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞—Ö –≤—ã—Ä–æ—Å–ª–∏ –Ω–∞ 12%. –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ñ–µ—Å—Ç–∫–æ–≤ –æ–±—ä—è—Å–Ω—è–µ—Ç —Ä–æ—Å—Ç –ø–æ–ø—É–ª—è—Ä–Ω–æ—Å—Ç–∏ —Ç–∞–∫–∏—Ö —Å—Ä–µ–¥—Å—Ç–≤ —Ç–µ–º, —á—Ç–æ —Å 1 —Å–µ–Ω—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞ –≤—Ä–∞—á–∏ –º–æ–≥—É—Ç –≤—ã–ø–∏—Å—ã–≤–∞—Ç—å –∏—Ö —Å–≤–æ–∏–º –ø–∞—Ü–∏–µ–Ω—Ç–∞–º. –ü–æ –º–Ω–µ–Ω–∏—é —ç–∫—Å–ø–µ—Ä—Ç–∞, —ç—Ç–æ —Å–ø–æ—Å–æ–±—Å—Ç–≤–æ–≤–∞–ª–æ —É–∫—Ä–µ–ø–ª–µ–Ω–∏—é –¥–æ–≤–µ—Ä–∏—è –∫ –¥–æ–±–∞–≤–∫–∞–º —Å–æ —Å—Ç–æ—Ä–æ–Ω—ã –≥—Ä–∞–∂–¥–∞–Ω. –ù–∞ –¥–∏–Ω–∞–º–∏–∫—É –ø—Ä–æ–¥–∞–∂ –ë–ê–î–æ–≤ –≤ –¥–µ–Ω–µ–∂–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏, –ø–æ —Å–ª–æ–≤–∞–º –ñ–µ—Å—Ç–∫–æ–≤–∞, –ø–æ–≤–ª–∏—è–ª —Ä–æ—Å—Ç —Ü–µ–Ω. –° —ç—Ç–∏–º —Å–æ–≥–ª–∞—Å–Ω—ã –≤ DSM Group. –°—Ä–µ–¥–Ω–∏–π —á–µ–∫ –∑–∞ –¥–µ–≤—è—Ç—å –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ –≤—ã—Ä–æ—Å –ø—Ä–∏–º–µ—Ä–Ω–æ –Ω–∞ 28%, –¥–æ 440 —Ä—É–±–ª–µ–π, –ø–æ–¥—Å—á–∏—Ç–∞–ª–∏ –∞–Ω–∞–ª–∏—Ç–∏–∫–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, shortage, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The message discusses the demand for dietary supplements (B–êDs) in Russia, with projections showing a significant increase in sales. However, the natural unit sales are expected to decrease by 1% to 404.3 million units. The industry experts and producers confirm the growth in sales, attributing it to online segment development and doctors' ability to prescribe them. The message also mentions the increase in prices, which led to a 28% rise in average cost per unit.""
}"
2025-11-17T05:20:03+00:00,@bezrec,6821,https://t.me/bezrec/6821,"–û–∑–Ω–∞–∫–æ–º–∏–ª–∏—Å—å —Å–æ —Å–≤–µ–∂–∏–º –æ—Ç—á—ë—Ç–æ–º –†–æ—Å—Å—Ç–∞—Ç–∞ –æ –¥–∏–Ω–∞–º–∏–∫–µ —Ü–µ–Ω –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞. –í –æ–∫—Ç—è–±—Ä–µ 2025 –≥–æ–¥–∞ —Ü–µ–Ω—ã –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, –Ω–µ –≤—Ö–æ–¥—è—â–∏–µ –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü, –≤ —Å—Ä–µ–¥–Ω–µ–º –≤—ã—Ä–æ—Å–ª–∏ –Ω–∞ 1,2%: - —Ç—Ä–æ–∫—Å–µ—Ä—É—Ç–∏–Ω +3,0%; - –º–µ—Ç–∏–ª—É—Ä–∞—Ü–∏–ª +2,4%; - –º–µ–Ω–æ–≤–∞–∑–∏–Ω +2,2%; - –ª–∏–∑–æ–±–∞–∫—Ç +2,0%; - –∫–æ—Ä–≤–∞–ª–æ–ª +1,9%; - –≤–∞–ª–µ—Ä–∏–∞–Ω—ã —ç–∫—Å—Ç—Ä–∞–∫—Ç –∏ –Ω–∏–º–µ—Å—É–ª–∏–¥ +1,8%; - –∞—Å–∫–æ—Ñ–µ–Ω-–ü; - –≥—Ä–∞–º–º–∏–¥–∏–Ω –∏ —Ä–µ–Ω–≥–∞–ª–∏–Ω +1,7%; - –∫–∞–Ω–µ—Ñ—Ä–æ–Ω –ù –∏ –∫–∞—Ä–¥–∏–æ–º–∞–≥–Ω–∏–ª +1,6%; - –Ω–∞—Ñ–∞–∑–æ–ª–∏–Ω +1,5%; - –≥–µ–ø–∞—Ä–∏–Ω–æ–≤–∞—è –º–∞–∑—å –∏ –∫–µ—Ç–æ—Ä–æ–ª —ç–∫—Å–ø—Ä–µ—Å—Å +1,4%. –õ–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏–∑ –ø–µ—Ä–µ—á–Ω—è –ñ–ù–í–õ–ü –≤ —Å—Ä–µ–¥–Ω–µ–º –ø–æ–¥–æ—Ä–æ–∂–∞–ª–∏ –Ω–∞ +1,0%: - –±–µ—Ç–∞–ª–æ–∫ –ó–û–ö +6,6%; - –Ω–∞—Ç—Ä–∏—è —Ö–ª–æ—Ä–∏–¥ +1,9%; - –¥–∏–∫–ª–æ—Ñ–µ–Ω–∞–∫ +1,8%; - –∞—Å–∫–æ—Ä–±–∏–Ω–æ–≤–∞—è –∫–∏—Å–ª–æ—Ç–∞ +1,7%; - –∏–±—É–ø—Ä–æ—Ñ–µ–Ω +1,4%; - –ª–æ–ø–µ—Ä–∞–º–∏–¥ –∏ –æ–º–µ–ø—Ä–∞–∑–æ–ª +1,3%; - –∞–º–±—Ä–æ–∫—Å–æ–ª +1,2%. –ù–µ–º–Ω–æ–≥–æ —Å–Ω–∏–∑–∏–ª–∏—Å—å —Ü–µ–Ω—ã –Ω–∞ –∞–º–æ–∫—Å–∏—Ü–∏–ª–ª–∏–Ω —Å –∫–ª–∞–≤—É–ª–∞–Ω–æ–≤–æ–π –∫–∏—Å–ª–æ—Ç–æ–π (-0,4%). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The message discusses price increases for various medications not included in the –ñ–ù–í–õ–ü list, with an average increase of 1.2% for these drugs in October 2025. Prices for medications listed under –ñ–ù–í–õ–ü increased by an average of 1%. No significant price changes are mentioned for amoxicillin with clavulanic acid. The message does not provide specific details on regulatory filings, compliance, pricing or reimbursement.""
}"
2025-11-16T11:01:37+00:00,@bezrec,6820,https://t.me/bezrec/6820,"¬´–ß—É–ø–∞-—á—É–ø—Å—ã¬ª –¥–ª—è –≤–ª–∞–≥–∞–ª–∏—â–∞ –æ—Ç –ö–æ—Ä—Ç–Ω–∏ –ö–∞—Ä–¥–∞—à—å—è–Ω. –ë–∏–∑–Ω–µ—Å–≤—É–º–µ–Ω —Ä–µ—à–∏–ª–∞ –Ω–µ –æ—Å—Ç–∞–Ω–∞–≤–ª–∏–≤–∞—Ç—å—Å—è –Ω–∞ ¬´—Å–∫—É—á–Ω—ã—Ö¬ª –ë–ê–î–∞—Ö –¥–ª—è –ø–æ—Ö—É–¥–µ–Ω–∏—è –∏ –∂–µ–≤–∞—Ç–µ–ª—å–Ω—ã—Ö –∫–æ–Ω—Ñ–µ—Ç–∞—Ö —Å –æ–≤–æ—â–∞–º–∏ –∏ —Ñ—Ä—É–∫—Ç–∞–º–∏ –¥–ª—è —É–ª—É—á—à–µ–Ω–∏—è —Ä–∞–±–æ—Ç—ã –ñ–ö–¢. –ù–æ–≤—ã–µ –≤–∏—Ç–∞–º–∏–Ω—ã –æ—Ç Lemme –ø—Ä–µ–¥–Ω–∞–∑–Ω–∞—á–µ–Ω—ã –¥–ª—è –∂–µ–Ω—Å–∫–æ–π –ø–æ–ª–æ–≤–æ–π —Å–∏—Å—Ç–µ–º—ã. –≠—Ç–æ –ª–µ–¥–µ–Ω—Ü—ã —Å –ø—Ä–æ–±–∏–æ—Ç–∏–∫–∞–º–∏ –∏ —Ä–∞—Å—Ç–∏—Ç–µ–ª—å–Ω—ã–º–∏ —ç–∫—Å—Ç—Ä–∞–∫—Ç–∞–º–∏ –¥–ª—è –∑–¥–æ—Ä–æ–≤—å—è –≤–ª–∞–≥–∞–ª–∏—â–∞. –ü–æ –∑–∞–≤–µ—Ä–µ–Ω–∏—è–º –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π, –æ–Ω–∏ –¥–æ–ª–∂–Ω—ã —Å–ø–æ—Å–æ–±—Å—Ç–≤–æ–≤–∞—Ç—å –ø–æ–¥–¥–µ—Ä–∂–∞–Ω–∏—é –±–∞–ª–∞–Ω—Å–∞ –º–∏–∫—Ä–æ—Ñ–ª–æ—Ä—ã –≤ –∏–Ω—Ç–∏–º–Ω–æ–π –∑–æ–Ω–µ –∏ –ø—Ä–µ–¥–æ—Ç–≤—Ä–∞—â–∞—Ç—å –ø–æ—è–≤–ª–µ–Ω–∏–µ –º–æ–ª–æ—á–Ω–∏—Ü—ã –∏ –¥—Ä—É–≥–∏—Ö ¬´–∂–µ–Ω—Å–∫–∏—Ö¬ª –±–æ–ª—è—á–µ–∫. –ò–Ω—Ç–µ—Ä–µ—Å–Ω–æ, —á—Ç–æ —Å–∫–∞–∂—É—Ç –ø–æ –ø–æ–≤–æ–¥—É –∏–Ω–Ω–æ–≤–∞—Ü–∏–∏ –≥–∏–Ω–µ–∫–æ–ª–æ–≥–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-11-15T11:02:39+00:00,@bezrec,6819,https://t.me/bezrec/6819,"–†–∞–±–æ—á–∞—è –Ω–µ–¥–µ–ª—è –ø–æ–∑–∞–¥–∏, –ø—Ä–∏—à–ª–æ –≤—Ä–µ–º—è —Å—É–±–±–æ—Ç–Ω–µ–≥–æ –≤—ã–ø—É—Å–∫–∞ —Ä—É–±—Ä–∏–∫–∏ #–≤–¥–æ–≥–æ–Ω–∫—É. üíä –¢—é–º–µ–Ω—Å–∫–∏–µ —Ç–∞–º–æ–∂–µ–Ω–Ω–∏–∫–∏ –∫–æ–Ω—Ñ–∏—Å–∫–æ–≤–∞–ª–∏ 1 —Ç—ã—Å. –∞–º–ø—É–ª –æ–±–µ–∑–±–æ–ª–∏–≤–∞—é—â–µ–≥–æ –∏–∑ –ë—Ä–∞–∑–∏–ª–∏–∏. –ù–µ–∑–∞–¥–µ–∫–ª–∞—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç—ã –ø—ã—Ç–∞–ª—Å—è –ø—Ä–æ–≤–µ–∑—Ç–∏ –ø–∞—Å—Å–∞–∂–∏—Ä, –ø—Ä–∏–ª–µ—Ç–µ–≤—à–∏–π –≤ –∞—ç—Ä–æ–ø–æ—Ä—Ç –†–æ—â–∏–Ω–æ –∏–∑ –ë–∞–∫—É. –ö–∞–∫ –ø–æ—è—Å–Ω–∏–ª 29-–ª–µ—Ç–Ω–∏–π —Ç—é–º–µ–Ω–µ—Ü, –∏–Ω—ä–µ–∫—Ü–∏–∏ –æ–Ω –≤—ë–∑ –¥–ª—è —Ä–æ–¥—Å—Ç–≤–µ–Ω–Ω–∏–∫–∞-—Å—Ç–æ–º–∞—Ç–æ–ª–æ–≥–∞, –∏—Å–ø–æ–ª—å–∑—É—é—â–µ–≥–æ –∏—Ö –≤ –∫–∞—á–µ—Å—Ç–≤–µ –∞–Ω–µ—Å—Ç–µ–∑–∏–∏ –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. üíä –ï—â—ë –æ–¥–Ω–∞ –∫—Ä–∏–º–∏–Ω–∞–ª—å–Ω–∞—è –Ω–æ–≤–æ—Å—Ç—å –∏–∑ –º–∏—Ä–∞ —Ñ–∞—Ä–º—ã. –°—Ç–æ–ª–∏—á–Ω—ã–µ –ø–æ–ª–∏—Ü–µ–π—Å–∫–∏–µ —Ä–∞–∑–æ–±–ª–∞—á–∏–ª–∏ –ø—Ä–µ—Å—Ç—É–ø–Ω—É—é –≥—Ä—É–ø–ø—É –∏–∑ 11 —á–µ–ª–æ–≤–µ–∫, —á–ª–µ–Ω—ã –∫–æ—Ç–æ—Ä–æ–π —Ç–æ—Ä–≥–æ–≤–∞–ª–∏ –Ω–∞—Ä–∫–æ—Ç–∏–∫–∞–º–∏ —á–µ—Ä–µ–∑ —Å–µ—Ç—å –∞–ø—Ç–µ–∫. –°–∏–ª—å–Ω–æ–¥–µ–π—Å—Ç–≤—É—é—â–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –∑–∞–∫—É–ø–∞–ª–∞ –ø–æ–¥–∫–æ–Ω—Ç—Ä–æ–ª—å–Ω–∞—è –∑–ª–æ—É–º—ã—à–ª–µ–Ω–Ω–∏–∫–∞–º –∫–æ–º–ø–∞–Ω–∏—è. –ó–∞–ø—Ä–µ—â—ë–Ω–∫—É –ø—Ä—è—Ç–∞–ª–∏ –≤ –∞–ø—Ç–µ—á–Ω–æ–π –º–µ–±–µ–ª–∏. üíä –†–æ—Å—Å–∏—è–Ω–µ —Å –æ–∂–∏—Ä–µ–Ω–∏–µ–º ¬´—Å—ä–µ–¥–∞—é—Ç¬ª —Ç—Ä–∏–ª–ª–∏–æ–Ω—ã –±—é–¥–∂–µ—Ç–Ω—ã—Ö —Ä—É–±–ª–µ–π. –ü–æ –æ—Ü–µ–Ω–∫–∞–º –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –∏ –ø—Ä–æ—Ñ–∏–ª—å–Ω—ã—Ö –∞–Ω–∞–ª–∏—Ç–∏–∫–æ–≤, –ø–æ—Ç–µ—Ä–∏ –æ—Ç —Å–æ—Å—Ç–æ—è–Ω–∏–π, –∞—Å—Å–æ—Ü–∏–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö —Å –æ–∂–∏—Ä–µ–Ω–∏–µ–º, –º–æ–≥—É—Ç –¥–æ—Å—Ç–∏–≥–∞—Ç—å –ø–æ—Ä—è–¥–∫–∞ 4% –í–í–ü. –¢–æ –µ—Å—Ç—å —ç—Ç–æ —Ü–∏—Ñ—Ä—ã, –∏–∑–º–µ—Ä—è–µ–º—ã–µ —Ç—Ä–∏–ª–ª–∏–æ–Ω–∞–º–∏ —Ä—É–±–ª–µ–π, - –∑–∞—è–≤–∏–ª–∞ –¥–µ–ø—É—Ç–∞—Ç –ì–æ—Å–¥—É–º—ã –ò—Ä–∏–Ω–∞ –§–∏–ª–∞—Ç–æ–≤–∞. –†–µ—á—å –Ω–µ —Ç–æ–ª—å–∫–æ –æ –∑–∞—Ç—Ä–∞—Ç–∞—Ö –Ω–∞ –ª–µ—á–µ–Ω–∏–µ —Å–∞–º–æ–≥–æ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è, –Ω–æ –∏ —Ä–∞–Ω–Ω–µ–π –∏–Ω–≤–∞–ª–∏–¥–∏–∑–∞—Ü–∏–∏, –∞ —Ç–∞–∫–∂–µ —Å–Ω–∏–∂–µ–Ω–∏–∏ –¥–µ–º–æ–≥—Ä–∞—Ñ–∏—á–µ—Å–∫–∏—Ö –ø–æ–∫–∞–∑–∞—Ç–µ–ª–µ–π –∑–∞ —Å—á—ë—Ç —Ä–æ—Å—Ç–∞ –ø—Ä–µ–∂–¥–µ–≤—Ä–µ–º–µ–Ω–Ω–æ–π —Å–º–µ—Ä—Ç–Ω–æ—Å—Ç–∏. üíä –ò–≥–æ—Ä—é –ë–æ–≥–¥–∞—à–∏–Ω—É –∏–∑–º–µ–Ω–∏–ª–∏ –º–µ—Ä—É –ø—Ä–µ—Å–µ—á–µ–Ω–∏—è. –≠–∫—Å-–≥–ª–∞–≤—É ¬´–û–º—Å–∫–æ–≥–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞¬ª –∏ –±—ã–≤—à–µ–≥–æ –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—è ¬´–°–æ—é–∑–∞ –ø–æ–¥–¥–µ—Ä–∂–∫–∏ –æ–Ω–∫–æ–ø–∞—Ü–∏–µ–Ω—Ç–æ–≤¬ª, –∫–æ—Ç–æ—Ä—ã–π –æ–±–≤–∏–Ω—è–µ—Ç—Å—è –≤ –º–∞—Ö–∏–Ω–∞—Ü–∏—è—Ö —Å –ø–æ—Å—Ç–∞–≤–∫–∞–º–∏ –ª—å–≥–æ—Ç–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤, –ø–µ—Ä–µ–≤–µ–ª–∏ –∏–∑ –°–ò–ó–û –ø–æ–¥ –¥–æ–º–∞—à–Ω–∏–π –∞—Ä–µ—Å—Ç. üíä Merck –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª –Ω–æ–≤—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç, –∫–æ—Ç–æ—Ä—ã–π —Å–Ω–∏–∂–∞–µ—Ç —É—Ä–æ–≤–µ–Ω—å ¬´–ø–ª–æ—Ö–æ–≥–æ¬ª —Ö–æ–ª–µ—Å—Ç–µ—Ä–∏–Ω–∞ (–õ–ü–ù–ü) –¥–æ 60%. Enlicitide —Å–æ–ø–æ—Å—Ç–∞–≤–∏–º –ø–æ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ —Å –¥–µ–π—Å—Ç–≤–∏–µ–º –∏–Ω—ä–µ–∫—Ü–∏–æ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∫–ª–∞—Å—Å–∞ PCSK9, –Ω–æ –≤—ã–ø—É—Å–∫–∞–µ—Ç—Å—è –≤ —Ñ–æ—Ä–º–µ —Ç–∞–±–ª–µ—Ç–æ–∫. –ï—Å–ª–∏ –¥–∞–ª—å–Ω–µ–π—à–∏–µ –∏—Å–ø—ã—Ç–∞–Ω–∏—è –ø—Ä–æ–π–¥—É—Ç —É—Å–ø–µ—à–Ω–æ, —É —É–∫–æ–ª–æ–≤ Repatha –æ—Ç Amgen –∏ Praluent –æ—Ç Regeneron –∏ Sanofi –ø–æ—è–≤–∏—Ç—Å—è —Å–µ—Ä—å—ë–∑–Ω—ã–π –∫–æ–Ω–∫—É—Ä–µ–Ω—Ç. üíä –ö–∏—Ç–∞–π—Ü—ã –Ω–∞—à–ª–∏ —Å–ø–æ—Å–æ–± ¬´–æ–º–æ–ª–æ–¥–∏—Ç—å¬ª —Ä–µ–ø—Ä–æ–¥—É–∫—Ç–∏–≤–Ω—É—é —Å–∏—Å—Ç–µ–º—É. –£—á—ë–Ω—ã–µ –∏–∑ –ü–æ–¥–Ω–µ–±–µ—Å–Ω–æ–π –≤—ã—è—Å–Ω–∏–ª–∏, —á—Ç–æ –≤–æ–∑—Ä–∞—Å—Ç–Ω–æ–º—É —Å–Ω–∏–∂–µ–Ω–∏—é –∂–µ–Ω—Å–∫–æ–π —Ñ–µ—Ä—Ç–∏–ª—å–Ω–æ—Å—Ç–∏ —Å–ø–æ—Å–æ–±—Å—Ç–≤—É–µ—Ç –¥–∏—Å—Ñ—É–Ω–∫—Ü–∏—è —Ä–∏–±–æ—Å–æ–º. –£–ª—É—á—à–∏—Ç—å –∫–∞—á–µ—Å—Ç–≤–æ —è–π—Ü–µ–∫–ª–µ—Ç–æ–∫ –ø–æ–º–æ–≥ —Ä–∞–ø–∞–º–∏—Ü–∏–Ω, –∏–∑–≤–µ—Å—Ç–Ω—ã–π —Å–≤–æ–µ–π —Å–ø–æ—Å–æ–±–Ω–æ—Å—Ç—å—é –ø–æ–¥–∞–≤–ª—è—Ç—å –∞–∫—Ç–∏–≤–Ω–æ—Å—Ç—å —Ä–∏–±–æ—Å–æ–º. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-11-14T15:02:17+00:00,@bezrec,6818,https://t.me/bezrec/6818,"¬´–õ–∏—Ä–∏–∫–∞¬ª, –∫–æ—Ç–æ—Ä—É—é –º–æ–∂–Ω–æ –≤—Å–µ–º. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-11-14T12:20:01+00:00,@bezrec,6817,https://t.me/bezrec/6817,"–ü—Ä–æ—Ç–∏–≤–æ–≤–∏—Ä—É—Å–Ω—ã–º –ø–æ–ª–µ–≥—á–∞–ª–æ. –†–æ–∑–Ω–∏—á–Ω—ã–µ –ø—Ä–æ–¥–∞–∂–∏ —ç—Ç–æ–π –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ –≤ –†–æ—Å—Å–∏–∏ –≤—ã—Ä–æ—Å–ª–∏ –≤–ø–µ—Ä–≤—ã–µ –∑–∞ —Ç—Ä–∏ –≥–æ–¥–∞. –ü–æ –¥–∞–Ω–Ω—ã–º RNC Pharma, –∑–∞ —Ç—Ä–∏ –∫–≤–∞—Ä—Ç–∞–ª–∞ 2025 –≥–æ–¥–∞ –±—ã–ª–æ –ø—Ä–æ–¥–∞–Ω–æ 58,4 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ –ø—Ä–æ—Ç–∏–≤–æ–≤–∏—Ä—É—Å–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ 34 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —á—Ç–æ –Ω–∞ 4,6% –±–æ–ª—å—à–µ –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –∏ –Ω–∞ 15,7% –±–æ–ª—å—à–µ –≤ –¥–µ–Ω–µ–∂–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ –≥–æ–¥ –∫ –≥–æ–¥—É. –ö–∞–∫ –ø—Ä–∞–≤–∏–ª–æ, –ø–∏–∫ —Å–ø—Ä–æ—Å–∞ –Ω–∞ —Ç–∞–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ —Å–µ–Ω—Ç—è–±—Ä—å –∏ –¥–µ–∫–∞–±—Ä—å, –Ω–æ –≤ —ç—Ç–æ–º –≥–æ–¥—É –ø—Ä–æ–¥–∞–∂–∏ –∑–∞–º–µ—Ç–Ω–æ ¬´—Å–∫–∞–∫–∞–Ω—É–ª–∏¬ª –≤ —Ñ–µ–≤—Ä–∞–ª–µ (+29% –∫ –∞–Ω–∞–ª–æ–≥–∏—á–Ω–æ–º—É –º–µ—Å—è—Ü—É 2024 –≥–æ–¥–∞) –∏ –º–∞—Ä—Ç–µ (+53%). 88% –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–≥–æ –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏—è –∏ –æ–∫–æ–ª–æ 86% –¥–µ–Ω–µ–∂–Ω–æ–≥–æ –æ–±—ä—ë–º–∞ –ø—Ä–æ–¥–∞–∂ –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π. –ë–µ—Å—Å–º–µ–Ω–Ω—ã–π –ª–∏–¥–µ—Ä –≥—Ä—É–ø–ø—ã –Ω–∞ –ø—Ä–æ—Ç—è–∂–µ–Ω–∏–∏ —É–∂–µ –Ω–µ—Å–∫–æ–ª—å–∫–∏—Ö –ª–µ—Ç ‚Äì –ò–Ω–≥–∞–≤–∏—Ä–∏–Ω –æ—Ç ¬´–í–∞–ª–µ–Ω—Ç—ã¬ª, —Ö–æ—Ç—è –¥–∏–Ω–∞–º–∏–∫–∞ –ø—Ä–æ–¥–∞–∂ —É –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ —Å–∫–æ—Ä–µ–µ —Å—Ä–µ–¥–Ω–µ–Ω—å–∫–∞—è. –ù–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ –æ—Å—Ç–∞—ë—Ç—Å—è –ê—Ä–±–∏–¥–æ–ª –æ—Ç ¬´–û—Ç–∏—Å–∏—Ñ–∞—Ä–º¬ª, —Ç—Ä–µ—Ç–∏–π –≥–æ–¥ –¥–µ–º–æ–Ω—Å—Ç—Ä–∏—Ä—É—é—â–∏–π —Å–Ω–∏–∂–µ–Ω–∏–µ –ø—Ä–æ–¥–∞–∂ ‚Äî –≤ –æ—Ç—á—ë—Ç–Ω—ã–π –ø–µ—Ä–∏–æ–¥ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–µ –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–µ —É–ø–∞–ª–æ —Å—Ä–∞–∑—É –Ω–∞ 20% –∏–∑-–∑–∞ –¥–∞–≤–ª–µ–Ω–∏—è –ø—Ä—è–º—ã—Ö –∞–Ω–∞–ª–æ–≥–æ–≤. –¢—Ä–µ—Ç—å—è —Å—Ç—Ä–æ—á–∫–∞ —É –ö–∞–≥–æ—Ü–µ–ª–∞ –æ—Ç ¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º¬ª, –æ—Ç–ª–∏—á–∏–≤—à–∏–π—Å—è –≤–Ω—É—à–∏—Ç–µ–ª—å–Ω–æ–π –¥–∏–Ω–∞–º–∏–∫–æ–π –ø—Ä–æ–¥–∞–∂ (+46%). –í –ª–∏–¥–µ—Ä–∞—Ö –ø–æ —Ä–æ—Å—Ç—É –ø—Ä–æ–¥–∞–∂ ‚Äì –Ω–µ–±—Ä–µ–Ω–¥–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã —Ç–∏–ª–æ—Ä–æ–Ω–∞ (¬´–°–µ–≤–µ—Ä–Ω–∞—è –∑–≤–µ–∑–¥–∞¬ª + 5 –∫–æ–º–ø–∞–Ω–∏–π). –í—ã—Å–æ–∫–æ–π –¥–∏–Ω–∞–º–∏–∫–æ–π —Ç–∞–∫–∂–µ –æ—Ç–º–µ—Ç–∏–ª–∏—Å—å –Ω–µ–±—Ä–µ–Ω–¥–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –æ—Å–µ–ª—å—Ç–∞–º–∏–≤–∏—Ä–∞ (¬´–ê–∫—Ä–∏—Ö–∏–Ω¬ª + 8 –∫–æ–º–ø–∞–Ω–∏–π). –ü–æ–º–∏–º–æ –ø–µ—Ä–µ—á–∏—Å–ª–µ–Ω–Ω—ã—Ö –∏–≥—Ä–æ–∫–æ–≤, –≤ —Ç–æ–ø-10 –≤–æ—à–ª–∏: –≠—Ä–≥–æ—Ñ–µ—Ä–æ–Ω (¬´–ú–∞—Ç–µ—Ä–∏–∞ –ú–µ–¥–∏–∫–∞¬ª), –ù–æ–º–∏–¥–µ—Å (¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑¬ª), –ò–∑–æ–ø—Ä–∏–Ω–æ–∑–∏–Ω (¬´–¢–µ–≤–∞¬ª), –†–∏–º–∞–Ω—Ç–∞–¥–∏–Ω (¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º¬ª + 14 –∫–æ–º–ø–∞–Ω–∏–π), –ê—Ä–ø–µ—Ñ–ª—é (¬´–õ–µ–∫—Ñ–∞—Ä–º¬ª). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""There has been a significant increase in retail sales of antiviral drugs in Russia for the first time in three years. According to RNC Pharma data, sales of antiviral drugs increased by 4.6% in natural terms and 15.7% in monetary terms year-over-year from January to March 2025, totaling 58.4 million units and RUB34 billion. Typically, the peak demand for these drugs occurs in September and December, but this year's sales have significantly increased in February (+29% compared to the same month last year) and March (+53%). 88% of natural consumption and about 86% of monetary sales are accounted for by domestic manufacturers. The leader in the group over several years is Inghavirin from Valenty, but its sales have a relatively average dynamic. The second place is Arbidol from Otisifarm, which has been showing a decline in sales by 20% over the past three years due to direct competitors. Third place is Kagocel"
2025-11-14T09:05:32+00:00,@bezrec,6816,https://t.me/bezrec/6816,"–¢–∞–∫–æ–≤—ã —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –æ–ø—Ä–æ—Å–∞ –∫–æ–º–ø–∞–Ω–∏–∏ MAR CONSULT. –ö–∞–∫ –≤—ã—è—Å–Ω–∏–ª–∏ –∞–Ω–∞–ª–∏—Ç–∏–∫–∏, –∂–µ–Ω—â–∏–Ω—ã –ø–æ–∫—É–ø–∞—é—Ç –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –æ–Ω–ª–∞–π–Ω —á–∞—â–µ –º—É–∂—á–∏–Ω ‚Äì 65% –ø—Ä–æ—Ç–∏–≤ 51%. –°–∞–º—ã–µ –∞–∫—Ç–∏–≤–Ω—ã–µ –ø–æ–∫—É–ø–∞—Ç–µ–ª–∏ ‚Äì –ª—é–¥–∏ –≤ –≤–æ–∑—Ä–∞—Å—Ç–µ 45-54 –ª–µ—Ç (71%) —Å –¥–æ—Ö–æ–¥–æ–º –≤—ã—à–µ 200 —Ç—ã—Å. —Ä—É–±–ª–µ–π –Ω–∞ —Å–µ–º—å—é (79%). –ü–æ—á–µ–º—É –æ–Ω–ª–∞–π–Ω: üîò—É–¥–æ–±—Å—Ç–≤–æ –∑–∞–∫–∞–∑–∞ —á–µ—Ä–µ–∑ –º–æ–±–∏–ª—å–Ω–æ–µ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏–µ —Å –∏–Ω—Ç—É–∏—Ç–∏–≤–Ω–æ –ø–æ–Ω—è—Ç–Ω—ã–º –∏–Ω—Ç–µ—Ä—Ñ–µ–π—Å–æ–º - 63%; üîò–±–æ–ª–µ–µ –≤—ã–≥–æ–¥–Ω—ã–µ —Ü–µ–Ω—ã ‚Äì 61%; üîò—à–∏—Ä–æ–∫–∏–π –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç ‚Äì 57%; üîò–ø—Ä–æ–≥—Ä–∞–º–º—ã –ª–æ—è–ª—å–Ω–æ—Å—Ç–∏ –∏ —Å–∫–∏–¥–∫–∏ - 45%; üîò–≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –¥–æ—Å—Ç–∞–≤–∫–∏ –Ω–∞ –¥–æ–º - 29%, –ø—Ä–∏ —ç—Ç–æ–º 33% –≥–æ—Ç–æ–≤—ã –ø–ª–∞—Ç–∏—Ç—å –∑–∞ –¥–æ—Å—Ç–∞–≤–∫—É, –∞ 51% —Å–æ–≥–ª–∞—Å–Ω—ã —Ç–æ–ª—å–∫–æ –Ω–∞ –±–µ—Å–ø–ª–∞—Ç–Ω—É—é –¥–æ—Å—Ç–∞–≤–∫—É, 13% –≥–æ—Ç–æ–≤—ã –ø–ª–∞—Ç–∏—Ç—å –∑–∞ —Å—Ä–æ—á–Ω–æ—Å—Ç—å, 68% –Ω–µ –≥–æ—Ç–æ–≤—ã –ø–ª–∞—Ç–∏—Ç—å –±–æ–ª—å—à–µ 300 —Ä—É–±–ª–µ–π –∑–∞ –¥–æ—Å—Ç–∞–≤–∫—É. –ß—Ç–æ —É–ª—É—á—à–∏—Ç—å, —á—Ç–æ–±—ã —Å—Ç–∏–º—É–ª–∏—Ä–æ–≤–∞—Ç—å —Å–ø—Ä–æ—Å: üîò–≥–∞—Ä–∞–Ω—Ç–∏—è –ø–æ–¥–ª–∏–Ω–Ω–æ—Å—Ç–∏ —Ç–æ–≤–∞—Ä–æ–≤ - 45%; üîò–±–æ–ª—å—à–µ —Å–∫–∏–¥–æ–∫ –∏ –∞–∫—Ü–∏–π - 44%; üîò–±—ã—Å—Ç—Ä–∞—è –∏ –±–µ—Å–ø–ª–∞—Ç–Ω–∞—è –¥–æ—Å—Ç–∞–≤–∫–∞ - 34%; üîò–∫—Ä—É–≥–ª–æ—Å—É—Ç–æ—á–Ω–∞—è –ø–æ–¥–¥–µ—Ä–∂–∫–∞ - 16%; üîò—É–ª—É—á—à–µ–Ω–Ω—ã–µ –∫–æ–Ω—Å—É–ª—å—Ç–∞—Ü–∏–∏ - 13%. –î—Ä—É–≥–∏–µ –∏–Ω—Ç–µ—Ä–µ—Å–Ω—ã–µ —Ñ–∞–∫—Ç—ã –∏–∑ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è: üîò–ø–æ–¥–ø–∏—Å–∫–∏ –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏–Ω—Ç–µ—Ä–µ—Å–Ω—ã 36% –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö, 29% –ø–æ–∫—É–ø–∞—é—Ç –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –ø–æ –º–µ—Ä–µ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏, –∞ 6% –∏–¥–µ—è –ø–æ–¥–ø–∏—Å–∫–∏ –∫–∞–∂–µ—Ç—Å—è —Å–æ–º–Ω–∏—Ç–µ–ª—å–Ω–æ–π –∏–∑-–∑–∞ –Ω–µ—É–≤–µ—Ä–µ–Ω–Ω–æ—Å—Ç–∏ –≤ –∫–∞—á–µ—Å—Ç–≤–µ –ª–µ–∫–∞—Ä—Å—Ç–≤; üîò60% –¥–æ–≤–µ—Ä—è—é—Ç –æ—Ç–∑—ã–≤–∞–º –Ω–∞ —Å–∞–π—Ç–∞—Ö –æ–Ω–ª–∞–π–Ω-–∞–ø—Ç–µ–∫, 32% –Ω–µ –¥–æ–≤–µ—Ä—è—é—Ç, 9% –∑–∞—Ç—Ä—É–¥–Ω–∏–ª–∏—Å—å –æ—Ç–≤–µ—Ç–∏—Ç—å; üîò56% –ø–æ–∫—É–ø–∞—Ç–µ–ª–µ–π —Ç—Ä—É–¥–Ω–æ –≤—ã–±–∏—Ä–∞—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –±–µ–∑ –∫–æ–Ω—Å—É–ª—å—Ç–∞—Ü–∏–∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∞; üîò80% –ø–æ–∫—É–ø–∞—é—Ç –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ —á–µ—Ä–µ–∑ –º–æ–±–∏–ª—å–Ω—ã–µ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏—è, 18% - —á–µ—Ä–µ–∑ —Å–∞–π—Ç—ã; üîò–ø—Ä–∏–ª–æ–∂–µ–Ω–∏—è –ª—é–±—è—Ç –∑–∞ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –ø–æ–∏—Å–∫–∞ –∏ —Å—Ä–∞–≤–Ω–µ–Ω–∏—è —Ü–µ–Ω (75%), —É–≤–µ–¥–æ–º–ª–µ–Ω–∏—è –æ —Å–∫–∏–¥–∫–∞—Ö (54%), –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –æ—Ç—Å–ª–µ–¥–∏—Ç—å –∏—Å—Ç–æ—Ä–∏—é –∑–∞–∫–∞–∑–æ–≤ (43%), —Ç—Ä–µ–∫–∏–Ω–≥ –¥–æ—Å—Ç–∞–≤–∫–∏ (19%), –æ–Ω–ª–∞–π–Ω-–∫–æ–Ω—Å—É–ª—å—Ç–∞—Ü–∏–∏ (13%). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-11-14T05:44:51+00:00,@bezrec,6815,https://t.me/bezrec/6815,"–í –†–æ—Å—Å–∏–∏ –º–æ–∂–µ—Ç –ø–æ—è–≤–∏—Ç—å—Å—è –Ω–æ–≤—ã–π –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–π –ø–µ—Ä–µ—á–µ–Ω—å. –í –°–æ–≤—Ñ–µ–¥–µ –Ω–µ–¥–æ–≤–æ–ª—å–Ω—ã —Ç–µ–º–ø–∞–º–∏ –≤–Ω–µ–¥—Ä–µ–Ω–∏—è –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –ø—Ä–∞–∫—Ç–∏–∫—É –ª—å–≥–æ—Ç–Ω–æ–≥–æ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è. –ß—Ç–æ–±—ã —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ –ø–∞—Ü–∏–µ–Ω—Ç—ã –±—ã—Å—Ç—Ä–µ–µ –ø–æ–ª—É—á–∞–ª–∏ –¥–æ—Å—Ç—É–ø –∫ –∏–Ω–Ω–æ–≤–∞—Ü–∏—è–º, –ö–æ–º–∏—Ç–µ—Ç –ø–æ —Å–æ—Ü–∏–∞–ª—å–Ω–æ–π –ø–æ–ª–∏—Ç–∏–∫–µ –æ–±—Ä–∞—Ç–∏–ª—Å—è –≤ –ú–∏–Ω–∑–¥—Ä–∞–≤ —Å —Ä—è–¥–æ–º —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π. –í –ø–µ—Ä–≤—É—é –æ—á–µ—Ä–µ–¥—å, –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è —Å–æ–∑–¥–∞—Ç—å —Å–ø–µ—Ü–∏–∞–ª—å–Ω—ã–π –≤—Ä–µ–º–µ–Ω–Ω—ã–π –ø–µ—Ä–µ—á–µ–Ω—å, –∫—É–¥–∞ –ø–æ–ø–∞–¥—É—Ç –¥–æ–∫–∞–∑–∞–≤—à–∏–µ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –∏ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –≤ –†–æ—Å—Å–∏–∏ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞. –ó–∞—Ç–µ–º —Ç–∞–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –±—É–¥—É—Ç –≤–∫–ª—é—á–∞—Ç—å—Å—è –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü. –≠—Ç–æ –ø–æ–º–æ–∂–µ—Ç –∑–∞–∫—É–ø–∞—Ç—å –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –∑–∞ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–π —Å—á–µ—Ç, –Ω–æ ¬´–≤ –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–Ω–æ–º —Ä–µ–∂–∏–º–µ¬ª ‚Äî –¥–ª—è –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–Ω—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ü–µ–Ω—Ç—Ä–æ–≤ –∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –≤ –°–æ–≤—Ñ–µ–¥–µ —Ä–µ–∫–æ–º–µ–Ω–¥–æ–≤–∞–ª–∏ –∑–∞–∫—Ä–µ–ø–∏—Ç—å –≤ –º–µ—Ç–æ–¥–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏—è—Ö –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–∏–µ —Ç–µ—Ä–º–∏–Ω–∞ ¬´–∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç¬ª, ¬´–ø—Ä–µ–ø–∞—Ä–∞—Ç —Å –ø–æ–≤—ã—à–µ–Ω–Ω–æ–π —Ç–µ—Ä–∞–ø–µ–≤—Ç–∏—á–µ—Å–∫–æ–π —Ü–µ–Ω–Ω–æ—Å—Ç—å—é¬ª –∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞—Ç—å –∫—Ä–∏—Ç–µ—Ä–∏–∏ –ø—Ä–∏–æ—Ä–∏—Ç–∏–∑–∞—Ü–∏–∏: –ø–æ–ø—É–ª—è—Ü–∏–æ–Ω–Ω—ã–π —ç—Ñ—Ñ–µ–∫—Ç, –ø—Ä–µ–¥–æ—Ç–≤—Ä–∞—â–µ–Ω–Ω—ã–µ –∏—Å—Ö–æ–¥—ã, —Å—Ç–æ–∏–º–æ—Å—Ç—å-—ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å, –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç—å. –í –æ—Ç—Ä–∞—Å–ª–∏ –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤—É –°–æ–≤—Ñ–µ–¥–∞ –≤–æ—Å–ø—Ä–∏–Ω—è–ª–∏ –ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω–æ. –¢–∞–∫, —Å–æ–ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—å –í—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —Å–æ—é–∑–∞ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –Æ—Ä–∏–π –ñ—É–ª–µ–≤ –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª ¬´–ò–∑–≤–µ—Å—Ç–∏—è–º¬ª, —á—Ç–æ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ —á–∞—Å—Ç–æ ¬´–∑–∞—Å—Ç—Ä–µ–≤–∞—é—Ç¬ª –ø–æ—Å–ª–µ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –∏ –Ω–µ —Å—Ç–∞–Ω–æ–≤—è—Ç—Å—è —Ä–µ–∞–ª—å–Ω–æ –¥–æ—Å—Ç—É–ø–Ω—ã –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –û–Ω —Ç–∞–∫–∂–µ –æ—Ç–º–µ—Ç–∏–ª –≤–∞–∂–Ω–æ—Å—Ç—å –∑–∞–∫—Ä–µ–ø–ª–µ–Ω–∏—è –ø–æ–Ω—è—Ç–∏—è –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –∏ —á–µ—Ç–∫–∏—Ö –∫—Ä–∏—Ç–µ—Ä–∏–µ–≤ –µ–≥–æ –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–∏—è. –≠—Ç–æ –ø–æ–∑–≤–æ–ª–∏—Ç —Å—Ñ–æ—Ä–º–∏—Ä–æ–≤–∞—Ç—å –æ—Ç–¥–µ–ª—å–Ω—ã–π —Ç—Ä–µ–∫ –Ω–µ —Ç–æ–ª—å–∫–æ –¥–ª—è —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏, –Ω–æ –∏ –¥–ª—è —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è —Ç–∞–∫–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤, - —Å—á–∏—Ç–∞–µ—Ç —ç–∫—Å–ø–µ—Ä—Ç. –° –Ω–∏–º —Å–æ–≥–ª–∞—Å–µ–Ω –¥–∏—Ä–µ–∫—Ç–æ—Ä –ø–æ –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏—é —Å –æ—Ä–≥–∞–Ω–∞–º–∏ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π –≤–ª–∞—Å—Ç–∏ –∏ –¥–æ—Å—Ç—É–ø—É –Ω–∞ —Ä—ã–Ω–æ–∫ ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª –î–º–∏—Ç—Ä–∏–π –ù–∞—Ö–∞–º—á–µ–Ω, –Ω–∞–ø–æ–º–Ω–∏–≤—à–∏–π –æ —Å—É—â–µ—Å—Ç–≤–æ–≤–∞–Ω–∏–∏ –≤ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–æ–π –ø—Ä–∞–∫—Ç–∏–∫–µ –ø–æ–¥—Ö–æ–¥–∞, –ø—Ä–∏ –∫–æ—Ç–æ—Ä–æ–º –ø—Ä–µ–ø–∞—Ä–∞—Ç—É –ø—Ä–∏—Å–≤–∞–∏–≤–∞–µ—Ç—Å—è —Å—Ç–∞—Ç—É—Å –æ—Å–æ–±–æ–π –∑–Ω–∞—á–∏–º–æ—Å—Ç–∏, –µ—Å–ª–∏ –æ–Ω —Ä–µ—à–∞–µ—Ç –Ω–µ—É–¥–æ–≤–ª–µ—Ç–≤–æ—Ä—ë–Ω–Ω—ã–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, sanctions, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The Federation Council is dissatisfied with the pace of implementing innovative drugs in the practice of subsidized provision. To help Russian patients get access to innovations faster, the Committee on Social Policy has submitted a set of recommendations to the Ministry of Health. The main suggestion is to create a special temporary list for innovative drugs that have been proven effective and registered in Russia. These drugs will then be included in the subsidized list (–ñ–ù–í–õ–ü). This will help to procure innovative drugs at a state expense, but 'on a limited basis' - for specific medical centers and patients. Additionally, the Federation Council recommended to define 'innovative drug' in methodological guidelines and develop prioritization criteria: population effect, avoided outcomes, cost-effectiveness, need. The Federation's initiative was positively received in the industry. For example, Vserossiyskiy Sovets Pitaniya expert Yuri Zhul'ev noted that innovative drugs often 'get stuck' after registration and do not become truly accessible for patients. He also emphasized the importance of defining 'innov"
2025-11-13T15:05:45+00:00,@bezrec,6814,https://t.me/bezrec/6814,"–•–æ–∑—è–π–∫–µ –Ω–∞ –∑–∞–º–µ—Ç–∫—É. –ö–∞–∂–µ—Ç—Å—è, —Å —à–∏–ø—É—á–∏–º –∞—Å–ø–∏—Ä–∏–Ω–æ–º –±—É–¥–µ—Ç –±—ã—Å—Ç—Ä–µ–µ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-11-13T12:25:01+00:00,@bezrec,6813,https://t.me/bezrec/6813,"¬´–í–µ–∫—Ç–æ—Ä¬ª –∏—â–µ—Ç –≤ –†–æ—Å—Å–∏–∏ –Ω–æ–≤—ã–µ –≤–∏—Ä—É—Å—ã. –ü–æ —Å–ª–æ–≤–∞–º –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –Ω–∞—É—á–Ω–æ–≥–æ —Ü–µ–Ω—Ç—Ä–∞ –≤–∏—Ä—É—Å–æ–ª–æ–≥–∏–∏ –∏ –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –ê–ª–µ–∫—Å–∞–Ω–¥—Ä–∞ –ê–≥–∞—Ñ–æ–Ω–æ–≤–∞, –µ–≥–æ —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–∏ —É–∂–µ –≤—ã—è–≤–∏–ª–∏ –±–æ–ª–µ–µ 60 —Ä–∞–Ω–µ–µ –Ω–µ–∏–∑–≤–µ—Å—Ç–Ω—ã—Ö –≤–∏—Ä—É—Å–æ–≤ –∏ –æ–ø—Ä–µ–¥–µ–ª–∏–ª–∏ –∏—Ö –≥–µ–Ω–µ—Ç–∏—á–µ—Å–∫—É—é —Å—Ç—Ä—É–∫—Ç—É—Ä—É. –ò —ç—Ç–æ –Ω–µ –ø—Ä–µ–¥–µ–ª: –ú—ã —Ö–æ—Ç–∏–º –æ–±–Ω–∞—Ä—É–∂–∏—Ç—å –≤—Å–µ –≤–∏—Ä—É—Å—ã, –∫–æ—Ç–æ—Ä—ã–µ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω—ã –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ –≤—Å–µ–π –†–æ—Å—Å–∏–π—Å–∫–æ–π –§–µ–¥–µ—Ä–∞—Ü–∏–∏. –î–ª—è –Ω–∞—Å –æ—á–µ–Ω—å –≤–∞–∂–Ω–æ –Ω–∞–π—Ç–∏ –Ω–µ —Ç–æ–ª—å–∫–æ –≤—Å–µ –≤–∏—Ä—É—Å—ã, –∫–æ—Ç–æ—Ä—ã–µ –µ—Å—Ç—å, –Ω–æ –∏ –æ—Å–æ–±–µ–Ω–Ω–æ –≤–∞–∂–Ω–æ –Ω–∞–π—Ç–∏ –∏–º–µ–Ω–Ω–æ –ø–∞—Ç–æ–≥–µ–Ω–Ω—ã–µ –¥–ª—è —á–µ–ª–æ–≤–µ–∫–∞. –£–∂–µ –±–æ–ª–µ–µ 50 —Å—É–±—ä–µ–∫—Ç–æ–≤ —Ñ–µ–¥–µ—Ä–∞—Ü–∏–∏ –ø—Ä–∏—Å–ª–∞–ª–∏ –Ω–∞–º —Å–≤–æ–∏ –æ–±—Ä–∞–∑—Ü—ã. –ê–≥–∞—Ñ–æ–Ω–æ–≤ –ø–æ–¥—á–µ—Ä–∫–Ω—É–ª, —á—Ç–æ –æ—Å–Ω–æ–≤–Ω–∞—è –∑–∞–¥–∞—á–∞ —É—á—ë–Ω—ã—Ö ‚Äì –≤—ã—è—Å–Ω–∏—Ç—å, ¬´–Ω–∞—Å–∫–æ–ª—å–∫–æ —Å—Ç—Ä–µ–º–∏—Ç–µ–ª—å–Ω–æ–π –±—É–¥–µ—Ç —ç–≤–æ–ª—é—Ü–∏—è —ç—Ç–∏—Ö –≤–∏—Ä—É—Å–æ–≤, –≤–æ —á—Ç–æ –æ–Ω–∞ –ø–µ—Ä–µ—Ä–∞—Å—Ç–µ—Ç –∏ –±—É–¥–µ—Ç –ª–∏ –ø–æ–ª—É—á–µ–Ω —à—Ç–∞–º–º, –æ–±–ª–∞–¥–∞—é—â–∏–π –ø–∞–Ω–¥–µ–º–∏—á–µ—Å–∫–∏–º–∏ —Å–≤–æ–π—Å—Ç–≤–∞–º–∏¬ª. –ì–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä ¬´–í–µ–∫—Ç–æ—Ä–∞¬ª —Ç–∞–∫–∂–µ –ø—Ä–∏–∑–≤–∞–ª –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ –ò–ò, —á—Ç–æ–±—ã –ø—Ä–µ–¥—Å–∫–∞–∑–∞—Ç—å —Å—Ç—Ä—É–∫—Ç—É—Ä—ã –Ω–æ–≤—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –≤–∞–∫—Ü–∏–Ω. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-11-13T09:30:43+00:00,@bezrec,6812,https://t.me/bezrec/6812,"–°–µ–≥–æ–¥–Ω—è –≤ –Ω–∞—à–µ–π —Ä—É–±—Ä–∏–∫–µ #—Ñ–∞—Ä–º–Ω–∞–π–º –ø–æ –≥–æ—Ä—è—á–∏–º —Å–ª–µ–¥–∞–º –ø–æ—Å–º–æ—Ç—Ä–∏–º, —á—Ç–æ –∏–Ω—Ç–µ—Ä–µ—Å–Ω–æ–≥–æ –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç –ª—É—á—à–∏–µ —Ä–∞–±–æ—Ç–æ–¥–∞—Ç–µ–ª–∏ –∏–∑ —Ä–µ–π—Ç–∏–Ω–≥–∞ –†–ë–ö. ¬´–ü–°–ö –§–∞—Ä–º–∞¬ª üîò –í–µ–¥—É—â–∏–π —Ö–∏–º–∏–∫ R&D –ò—â—É—Ç —á–µ–ª–æ–≤–µ–∫–∞ —Å –æ–ø—ã—Ç–æ–º —Ä–∞–±–æ—Ç—ã –≤ –∞–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–æ–π –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–∏–∏ –Ω–µ –º–µ–Ω–µ–µ 3 –ª–µ—Ç. –ü—Ä–µ–¥–ª–∞–≥–∞—é—Ç —Ä–µ–ª–æ–∫–∞—Ü–∏–æ–Ω–Ω—ã–π –ø–∞–∫–µ—Ç, –≥–∏–±–∫–æ–µ –Ω–∞—á–∞–ª–æ —Ä–∞–±–æ—á–µ–≥–æ –¥–Ω—è, –∫–æ—Ä–ø–æ—Ä–∞—Ç–∏–≤–Ω–æ–µ –ø–∏—Ç–∞–Ω–∏–µ. üîò –ó–∞–≤–µ–¥—É—é—â–∏–µ –º–∏–∫—Ä–æ–±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π –∏ –±–∏–æ—Ö–∏–º–∏—á–µ—Å–∫–æ–π –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–∏—è–º–∏ –¢—Ä–µ–±—É–µ–º—ã–π —Å—Ç–∞–∂ —Ä–∞–±–æ—Ç—ã –¥–ª—è –æ–±–µ–∏—Ö –ø–æ–∑–∏—Ü–∏–π ‚Äì –Ω–µ –º–µ–Ω–µ–µ 5 –ª–µ—Ç, –æ–ø—ã—Ç –ø—Ä–æ—Ö–æ–∂–¥–µ–Ω–∏—è –∏–Ω—Å–ø–µ–∫—Ü–∏–π —Å–æ —Å—Ç–æ—Ä–æ–Ω—ã —Ä–µ–≥—É–ª—è—Ç–æ—Ä–Ω—ã—Ö –æ—Ä–≥–∞–Ω–æ–≤. –ü—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–æ–º –±—É–¥–µ—Ç –æ–ø—ã—Ç —É—á–∞—Å—Ç–∏—è –≤ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ –ø—Ä–æ–µ–∫—Ç–∞ —Ä–µ–∫–æ–Ω—Å—Ç—Ä—É–∫—Ü–∏–∏/—Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –º–∏–∫—Ä–æ–±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–∏–∏ –∏ –ª–∏—Ü–µ–Ω–∑–∏—Ä–æ–≤–∞–Ω–∏—è. üîò –ù–∞—á–∞–ª—å–Ω–∏–∫ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω–æ -—Ç–µ—Ö–Ω–∏—á–µ—Å–∫–æ–≥–æ –æ—Ç–¥–µ–ª–∞ (–ü–¢–û) –í —á–∏—Å–ª–µ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π - –∑–Ω–∞–Ω–∏–µ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å–Ω—ã—Ö –∏ –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω–æ-–ø—Ä–∞–≤–æ–≤—ã—Ö –∞–∫—Ç–æ–≤, –Ω–∞–≤—ã–∫–∏ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–æ–≥–æ –∏ –±—É—Ö–≥–∞–ª—Ç–µ—Ä—Å–∫–æ–≥–æ —É—á–µ—Ç–∞, –ø–æ–Ω–∏–º–∞–Ω–∏–µ –º–µ—Ç–æ–¥–æ–≤ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–æ–≥–æ –æ–±—Å–ª—É–∂–∏–≤–∞–Ω–∏—è –∏ —Ä–µ–º–æ–Ω—Ç–∞ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –∏ –∏–Ω–∂–µ–Ω–µ—Ä–Ω—ã—Ö —Å–∏—Å—Ç–µ–º. –í–∑–∞–º–µ–Ω –æ–±–µ—â–∞—é—Ç –æ–ø–ª–∞—á–∏–≤–∞—Ç—å –∫–≤–∞—Ä—Ç–∏—Ä—É –≤ –î—É–±–Ω–µ, –î–ú–° –∏ –∫–æ—Ä–ø–æ—Ä–∞—Ç–∏–≤–Ω–æ–µ –ø–∏—Ç–∞–Ω–∏–µ. ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª üîò–ú–µ–Ω–µ–¥–∂–µ—Ä –ø–æ –∫–æ–Ω—Ç–µ–Ω—Ç- –∑–∞–≤–æ–¥—É –£—Å–ø–µ—à–Ω–æ–º—É –∫–∞–Ω–¥–∏–¥–∞—Ç—É –ø—Ä–µ–¥—Å—Ç–æ–∏—Ç –∑–∞–Ω–∏–º–∞—Ç—å—Å—è –ø—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–µ–Ω–Ω–æ –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏–µ–º —Å –±–ª–æ–≥–µ—Ä–∞–º–∏ –≤ —Ä–∞–∑–Ω—ã—Ö –µ–≥–æ –ø—Ä–æ—è–≤–ª–µ–Ω–∏—è—Ö - –æ—Ç –Ω–∞–ø–∏—Å–∞–Ω–∏—è —Ç–∑ –¥–æ —Å–∫–∞—É—Ç–∏–Ω–≥–∞ –∏ ¬´—É–ø—Ä–∞–≤–ª–µ–Ω–∏—è —Ç–∞–ª–∞–Ω—Ç–∞–º–∏¬ª. –ü–æ–º–∏–º–æ –≥–∏–±—Ä–∏–¥–Ω–æ–≥–æ –≥—Ä–∞—Ñ–∏–∫–∞, –î–ú–° –∏ –¥—Ä—É–≥–∏—Ö –∫–æ—Ä–ø–æ—Ä–∞—Ç–∏–≤–Ω—ã—Ö ¬´–ø–ª—é—à–µ–∫¬ª –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª–µ–Ω–∏—è –±—Ä–æ–Ω–∏ –¥–ª—è –≤–æ–µ–Ω–Ω–æ–æ–±—è–∑–∞–Ω–Ω—ã—Ö. üîò–Æ—Ä–∏—Å–∫–æ–Ω—Å—É–ª—å—Ç –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–æ–≥–æ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è –í —á–∏—Å–ª–µ –æ–±—è–∑–∞–Ω–Ω–æ—Å—Ç–µ–π - –æ—Å—É—â–µ—Å—Ç–≤–ª–µ–Ω–∏–µ –≤—Å–µ–≥–æ —Ü–∏–∫–ª–∞ –¥–æ–≥–æ–≤–æ—Ä–Ω–æ–π —Ä–∞–±–æ—Ç—ã –¥–ª—è –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–æ–≥–æ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è, –ø—Ä–∞–≤–æ–≤–∞—è –ø–æ–¥–¥–µ—Ä–∂–∫–∞ —ç–∫—Å–ø–æ—Ä—Ç–∞ –∏ –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –∑–∞ —Ä—É–±–µ–∂–æ–º, –∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä–æ–≤–∞–Ω–∏–µ –∫–æ–ª–ª–µ–≥ –ø–æ –ø—Ä–∞–≤–æ–≤—ã–º –∞—Å–ø–µ–∫—Ç–∞–º –≤—ã—Ö–æ–¥–∞ –Ω–∞ –Ω–æ–≤—ã–µ —Ä—ã–Ω–∫–∏. –ü—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–æ–º –±—É–¥–µ—Ç –∑–Ω–∞–Ω–∏–µ –æ—Å–Ω–æ–≤ –í–≠–î. üîò–ú–µ–Ω–µ–¥–∂–µ—Ä –ø–æ —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–æ–º—É —Å–æ–ø—Ä–æ–≤–æ–∂–¥–µ–Ω–∏—é –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –¥–µ–≤–∞–π—Å–æ–≤ –ò—â—É—Ç ¬´—Ç–µ—Ö–Ω–∞—Ä—è¬ª (–æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ –≤ —Å—Ñ–µ—Ä–µ –±–∏–æ–º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –∏–Ω–∂–µ–Ω–µ—Ä–∏–∏, –º–∞—à–∏–Ω–æ—Å—Ç—Ä–æ–µ–Ω–∏—è, –ø—Ä–∏–±–æ—Ä–æ—Å—Ç—Ä–æ–µ–Ω–∏—è, —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∏ —Å —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–∏–º —É–∫–ª–æ–Ω–æ–º), –∫–æ—Ç–æ—Ä—ã–π –±—É–¥–µ—Ç –∑–∞–Ω–∏–º–∞—Ç—å—Å—è –∞–Ω–∞–ª–∏–∑–æ–º —Ä—ã–Ω–∫–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –¥–µ–≤–∞–π—Å–æ–≤, –æ—Ç–±–æ—Ä–æ–º –∏ –≤–µ—Ä–∏—Ñ–∏–∫–∞—Ü–∏–µ–π –ø–æ—Å—Ç–∞–≤—â–∏–∫–æ–≤, —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–∏–º —Å–æ–ø—Ä–æ–≤–æ–∂–¥–µ–Ω–∏–µ–º –ø—Ä–æ—Ü–µ—Å—Å–æ–≤ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏/–∞–¥–∞–ø—Ç–∞—Ü–∏–∏ –¥–µ–≤–∞–π—Å–æ–≤. ¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º¬ª üîò–ò–Ω–∂–µ–Ω–µ—Ä –ø–æ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ –¥–æ—Ä–æ–∂–Ω–æ–≥–æ –¥–≤–∏–∂–µ–Ω–∏—è –ù–µ —Å–∞–º–∞—è —Ç–∏–ø–∏—á–Ω–∞—è –¥–ª—è —Ñ–∞—Ä–º—ã –≤–∞–∫–∞–Ω—Å–∏—è. –°—Ä–µ–¥–∏ –æ–±—è–∑–∞–Ω–Ω–æ—Å—Ç–µ–π: —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∞ –ø–ª–∞–Ω–æ–≤ –ø–æ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—é –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ –¥–≤–∏–∂–µ–Ω–∏—è –Ω–∞ –∞–≤—Ç–æ—Ç—Ä–∞–Ω—Å–ø–æ—Ä—Ç–µ –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏—è, —É—á–∞—Å—Ç–∏–µ –≤ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏–∏ —Å–ª—É–∂–µ–±–Ω—ã—Ö —Ä–∞—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –î–¢–ü —Å –≤—ã–µ–∑–¥–æ–º –Ω–∞ –º–µ—Å—Ç–∞ –∏—Ö —Å–æ–≤–µ—Ä—à–µ–Ω–∏—è, –∫–æ–Ω—Ç—Ä–æ–ª—å –ø—Ä–æ—Ö–æ–∂–¥–µ–Ω–∏—è –≤–æ–¥–∏—Ç–µ–ª—è–º–∏ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Å–º–æ—Ç—Ä–æ–≤ –∏ –ø—Ä–µ–¥—Ä–µ–π—Å–æ–≤—ã—Ö –æ—Å–º–æ—Ç—Ä–æ–≤ –∏ –¥—Ä. üîò–†—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å –≥—Ä—É–ø–ø—ã OTC –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ù–∞ –ø–æ–∑–∏—Ü–∏—é —Ç—Ä–µ–±—É–µ—Ç—Å—è —á–µ–ª–æ–≤–µ–∫ —Å –æ–ø—ã—Ç–æ–º —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –∏ —É–ø—Ä–∞–≤–ª–µ–Ω–∏—è –º–∞—Ä–∫–µ—Ç–∏–Ω–≥–æ–≤–æ–π —Å—Ç—Ä–∞—Ç–µ–≥–∏–µ–π –û–¢–° –∏ –û–¢—Ö –ø—Ä–æ–¥—É–∫—Ç–æ–≤ –æ—Ç 5 –ª–µ—Ç, –∞ —Ç–∞–∫–∂–µ –æ–ø—ã—Ç–æ–º —É–ø—Ä–∞–≤–ª–µ–Ω–∏—è –∫—Ä—É–ø–Ω—ã–º–∏ –º–µ–¥–∏–π–Ω—ã–º–∏ –±—Ä–µ–Ω–¥–∞–º–∏ (—Å –ø—Ä–æ–¥–∞–∂–∞–º–∏ –±–æ–ª–µ–µ 1 –º–ª—Ä–¥. —Ä—É–±–ª–µ–π). –û–±–µ—â–∞—é—Ç –î–ú–° —Å–æ —Å—Ç–æ–º–∞—Ç–æ–ª–æ–≥–∏–µ–π, –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏—é 14 –¥–Ω–µ–π –±–æ–ª—å–Ω–∏—á–Ω–æ–≥–æ –≤ –≥–æ–¥—É –¥–æ –æ–∫–ª–∞–¥–∞, —Å—Ç—Ä–∞—Ö–æ–≤–∞–Ω–∏–µ –æ—Ç –Ω–µ—Å—á–∞—Å—Ç–Ω—ã—Ö —Å–ª—É—á–∞–µ–≤ 24/7. üîò–ë–∏–∑–Ω–µ—Å-—Ç—Ä–µ–Ω–µ—Ä –ø–æ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–º—É –ø—Ä–æ–¥–≤–∏–∂–µ–Ω–∏—é –û—Ç –∫–∞–Ω–¥–∏–¥–∞—Ç–∞ –∂–¥—É—Ç –≤—ã—Å—à–µ–µ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ, –∂–µ–ª–∞—Ç–µ–ª—å–Ω–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–µ –∏–ª–∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–µ, –¥–æ–ø. –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ (—Ç—Ä–µ–Ω–∏–Ω–≥–∏, –∫–æ—É—á–∏–Ω–≥) ‚Äì –∫–∞–∫ –ø—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–æ, –∂–µ–ª–∞—Ç–µ–ª–µ–Ω –æ–ø—ã—Ç —Ä–∞–±–æ—Ç—ã –≤ —Ñ–∞—Ä–º–±–∏–∑–Ω–µ—Å–µ –Ω–µ –º–µ–Ω–µ–µ 5 –ª–µ—Ç, –∞ —Ç–∞–∫–∂–µ –æ–ø—ã—Ç —Ä–∞–±–æ—Ç—ã –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–µ–º, –º–µ–Ω–µ–¥–∂–µ—Ä–æ–º –ø–æ –ø—Ä–æ–¥–∞–∂–∞–º. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance, safety"",
  ""impact"": ""high"",
  ""english"": ""The message discusses various job opportunities in the pharmaceutical sector, including positions such as R&D chemists, lab managers, and technical device technicians. It mentions topics related to clinical trials, guidelines, pharmacovigilance, and safety, indicating a high impact on the regulatory environment.""
}"
2025-11-13T05:19:57+00:00,@bezrec,6811,https://t.me/bezrec/6811,"–≠–∫—Å-–≥–ª–∞–≤–∞ ¬´–û–º—Å–∫–æ–≥–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞¬ª –ª–∏—à–∏–ª—Å—è –µ—â—ë –æ–¥–Ω–æ–≥–æ —Ä—É–∫–æ–≤–æ–¥—è—â–µ–≥–æ –ø–æ—Å—Ç–∞. –ü–æ –¥–∞–Ω–Ω—ã–º Rusprofile, –ò–≥–æ—Ä—å –ë–æ–≥–¥–∞—à–∏–Ω –±–æ–ª—å—à–µ –Ω–µ –∑–∞–Ω–∏–º–∞–µ—Ç –¥–æ–ª–∂–Ω–æ—Å—Ç—å –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—è ¬´–°–æ—é–∑–∞ –ø–æ–¥–¥–µ—Ä–∂–∫–∏ –æ–Ω–∫–æ–ø–∞—Ü–∏–µ–Ω—Ç–æ–≤¬ª. –ë–æ–≥–¥–∞—à–∏–Ω —Ä—É–∫–æ–≤–æ–¥–∏–ª —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω–æ–π –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–π –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–µ–π —Å 2020 –≥–æ–¥–∞. –ù–∞ –ø–æ—Å—Ç—É –µ–≥–æ —Å–º–µ–Ω–∏–ª–∞ –ù–∞—Ç–∞–ª—å—è –ù–∞–ª–∏–º–æ–≤–∞ ‚Äì —É—á—Ä–µ–¥–∏—Ç–µ–ª—å –±–ª–∞–≥–æ—Ç–≤–æ—Ä–∏—Ç–µ–ª—å–Ω–æ–≥–æ —Ñ–æ–Ω–¥–∞ ¬´–û–±–Ω–∏–º–∞—è –Ω–µ–±–æ¬ª. –ö–∞—Ä—å–µ—Ä–∞ –ë–æ–≥–¥–∞—à–∏–Ω–∞ –≤ ¬´–û–º—Å–∫–æ–º –ª–µ–∫–∞—Ä—Å—Ç–≤–µ¬ª –±—ã–ª–∞ –∫—É–¥–∞ –±–æ–ª–µ–µ –∫–æ—Ä–æ—Ç–∫–æ–π, –∑–∞—Ç–æ –Ω–∞—Å—ã—â–µ–Ω–Ω–æ–π –Ω–∞ —Å–æ–±—ã—Ç–∏—è. –ù–∞ –ø–æ—Å—Ç —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—è –∞–ø—Ç–µ—á–Ω–æ–π —Å–µ—Ç–∏ –µ–≥–æ –Ω–∞–∑–Ω–∞—á–∏–ª–∏ –≤ –Ω–æ—è–±—Ä–µ 2024 –≥–æ–¥–∞, –ø–æ—Å–ª–µ —á–µ–≥–æ –Ω–µ—Å–∫–æ–ª—å–∫–æ —Ä–∞–∑ —Ç–æ —É–≤–æ–ª—å–Ω—è–ª–∏, —Ç–æ —Å–Ω–æ–≤–∞ –≤–æ—Å—Å—Ç–∞–Ω–∞–≤–ª–∏–≤–∞–ª–∏ –≤ –¥–æ–ª–∂–Ω–æ—Å—Ç–∏, –≤ —Ç–æ–º —á–∏—Å–ª–µ –ø–æ —Ä–µ—à–µ–Ω–∏—é —Å—É–¥–∞. –° 23 –∏—é–ª—è –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–º –∫–æ–º–ø–∞–Ω–∏–∏ —á–∏—Å–ª–∏—Ç—Å—è –ö–µ—Ä–±–µ–ª—å –ê—Ä–∫–∞–¥–∏–π –ê–ª–µ–∫—Å–∞–Ω–¥—Ä–æ–≤–∏—á. –ë–æ–≥–¥–∞—à–∏–Ω –∂–µ —Å–µ–π—á–∞—Å –Ω–∞—Ö–æ–¥–∏—Ç—Å—è –≤ –°–ò–ó–û. –ü—Ä–æ—Ç–∏–≤ –Ω–µ–≥–æ –≤–æ–∑–±—É–∂–¥–µ–Ω–æ —É–≥–æ–ª–æ–≤–Ω–æ–µ –¥–µ–ª–æ –ø–æ —Å—Ç–∞—Ç—å–µ –æ –º–æ—à–µ–Ω–Ω–∏—á–µ—Å—Ç–≤–µ –≤ –æ—Å–æ–±–æ –∫—Ä—É–ø–Ω–æ–º —Ä–∞–∑–º–µ—Ä–µ. –£–ø—Ä–∞–≤–ª–µ–Ω—Ü–∞ –æ–±–≤–∏–Ω—è—é—Ç –≤ –º–∞—Ö–∏–Ω–∞—Ü–∏—è—Ö —Å –ø–æ—Å—Ç–∞–≤–∫–∞–º–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤. –£—â–µ—Ä–± —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω–æ–º—É –±—é–¥–∂–µ—Ç—É –æ—Ü–µ–Ω–∏–≤–∞–µ—Ç—Å—è –±–æ–ª–µ–µ —á–µ–º –≤ 4 –º–ª–Ω —Ä—É–±–ª–µ–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-11-12T14:43:44+00:00,@bezrec,6810,https://t.me/bezrec/6810,"¬´–ê–∫—Å–µ–ª—å—Ñ–∞—Ä–º¬ª –≤–µ—Ä–Ω—É–ª —Å–µ–±–µ –ø—Ä–∞–≤–∞ –Ω–∞ –æ—Å–∏–º–µ—Ä—Ç–∏–Ω–∏–± –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Ä–∞–∫–∞ –ª–µ–≥–∫–æ–≥–æ. –í –ø–∞—Ç–µ–Ω—Ç–Ω–æ–π –±–∏—Ç–≤–µ –º–µ–∂–¥—É —Ä–æ—Å—Å–∏–π—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–µ–π –∏ AstraZeneca –Ω–æ–≤—ã–π –ø–æ–≤–æ—Ä–æ—Ç. –ù–∞ —ç—Ç–æ—Ç —Ä–∞–∑ —É–¥–∞—á–∞ –æ–∫–∞–∑–∞–ª–∞—Å—å –Ω–∞ —Å—Ç–æ—Ä–æ–Ω–µ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è. –ü—Ä–µ–∑–∏–¥–∏—É–º –°—É–¥–∞ –ø–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç—É–∞–ª—å–Ω—ã–º –ø—Ä–∞–≤–∞–º (–°–ò–ü) –≤–æ—Å—Å—Ç–∞–Ω–æ–≤–∏–ª –¥–µ–π—Å—Ç–≤–∏–µ –µ–≤—Ä–∞–∑–∏–π—Å–∫–æ–≥–æ –ø–∞—Ç–µ–Ω—Ç–∞ ¬´–ê–∫—Å–µ–ª—å—Ñ–∞—Ä–º–∞¬ª –Ω–∞ –∫—Ä–∏—Å—Ç–∞–ª–ª–∏—á–µ—Å–∫—É—é —Ñ–æ—Ä–º—É –æ—Å–∏–º–µ—Ä—Ç–∏–Ω–∏–±–∞. –ù–æ–≤—ã–π —Å—É–¥–µ–±–Ω—ã–π –∞–∫—Ç, –ø—Ä–∏–Ω—è—Ç—ã–π –ü—Ä–µ–∑–∏–¥–∏—É–º–æ–º, –æ—Ç–º–µ–Ω–∏–ª —Ä–µ—à–µ–Ω–∏–µ –†–æ—Å–ø–∞—Ç–µ–Ω—Ç–∞, –∫–æ—Ç–æ—Ä—ã–º –≤–µ–¥–æ–º—Å—Ç–≤–æ —É–¥–æ–≤–ª–µ—Ç–≤–æ—Ä–∏–ª–æ –≤–æ–∑—Ä–∞–∂–µ–Ω–∏–µ AstraZeneca –ø—Ä–æ—Ç–∏–≤ –≤—ã–¥–∞—á–∏ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º—É –∫–æ–Ω–∫—É—Ä–µ–Ω—Ç—É –µ–≤—Ä–∞–∑–∏–π—Å–∫–æ–≥–æ –ø–∞—Ç–µ–Ω—Ç–∞. –ù–∞—à –ø—Ä–µ–ø–∞—Ä–∞—Ç –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç—Å—è –≤ –†–æ—Å—Å–∏–∏ –ø–æ –ø–æ–ª–Ω–æ–º—É —Ü–∏–∫–ª—É, —á—Ç–æ –ø–æ–ª–Ω–æ—Å—Ç—å—é –∏—Å–∫–ª—é—á–∞–µ—Ç —Ä–∏—Å–∫–∏, —Å–≤—è–∑–∞–Ω–Ω—ã–µ —Å –∏–º–ø–æ—Ä—Ç–æ–º —Å—É–±—Å—Ç–∞–Ω—Ü–∏–∏ –∏–∑-–∑–∞ —Ä—É–±–µ–∂–∞, –≤ —Ç–æ–º —á–∏—Å–ª–µ –∏–∑ —Å—Ç—Ä–∞–Ω, –ø–æ–¥–¥–µ—Ä–∂–∞–≤—à–∏—Ö —Å–∞–Ω–∫—Ü–∏–∏, ‚Äî –ø–æ—Ö–≤–∞–ª–∏–ª—Å—è ¬´–™¬ª ¬´–ê–∫—Å–µ–ª—å—Ñ–∞—Ä–º¬ª, –Ω–∞–∑–≤–∞–≤—à–∏–π —Ä–µ—à–µ–Ω–∏–µ –°–ò–ü ¬´–∑–Ω–∞–∫–æ–≤—ã–º¬ª. AstraZeneca —É—Ç–≤–µ—Ä–∂–¥–∞–µ—Ç, —á—Ç–æ —Å–æ–¥–µ—Ä–∂–∞—â–∞—è—Å—è –≤ –µ–≤—Ä–∞–∑–∏–π—Å–∫–æ–º –ø–∞—Ç–µ–Ω—Ç–µ –∫—Ä–∏—Å—Ç–∞–ª–ª–∏—á–µ—Å–∫–∞—è —Ñ–æ—Ä–º–∞ –æ—Å–∏–º–µ—Ä—Ç–∏–Ω–∏–±–∞ ¬´–Ω–µ –∏–º–µ–µ—Ç –Ω–µ–æ–∂–∏–¥–∞–Ω–Ω—ã—Ö –ø—Ä–µ–∏–º—É—â–µ—Å—Ç–≤ –≤ —Å—Ä–∞–≤–Ω–µ–Ω–∏–∏ —Å –∏–∑–≤–µ—Å—Ç–Ω—ã–º–∏ —Ñ–æ—Ä–º–∞–º–∏ —ç—Ç–æ–≥–æ –¥–µ–π—Å—Ç–≤—É—é—â–µ–≥–æ –≤–µ—â–µ—Å—Ç–≤–∞ –∏ –Ω–µ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É–µ—Ç –∫—Ä–∏—Ç–µ—Ä–∏—è–º –ø–∞—Ç–µ–Ω—Ç–æ—Å–ø–æ—Å–æ–±–Ω–æ—Å—Ç–∏¬ª. ¬´–ê–∫—Å–µ–ª—å—Ñ–∞—Ä–º¬ª ‚Äî –∫—Ä–µ–ø–∫–∏–π –æ—Ä–µ—à–µ–∫. –ù–∞–∫–∞–∑–∞—Ç—å —Å–æ–æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–∏–∫–æ–≤ –∑–∞ –≤–≤–æ–¥ –≤ –æ–±–æ—Ä–æ—Ç –æ—Å–∏–º–µ—Ä—Ç–∏–Ω–∏–±–∞ –ø—ã—Ç–∞–ª–∞—Å—å –§–ê–°, –æ–¥–Ω–∞–∫–æ —Ä–µ—à–µ–Ω–∏–µ –æ —à—Ç—Ä–∞—Ñ–µ –≤ 600 –º–ª–Ω —Ä—É–±–ª–µ–π –∞—Ä–±–∏—Ç—Ä–∞–∂–Ω—ã–π —Å—É–¥ –æ—Ç–º–µ–Ω–∏–ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""high"",
  ""english"": ""A patent dispute between Russian company 'Akselfarm' and AstraZeneca has been resolved in favor of the domestic producer. The Presidium of the Court on Intellectual Property (CII) overturned a decision by Rospatent that had granted AstraZeneca's objection to the Russian competitor's Eurasian patent. The company claims that their drug is produced in Russia and this eliminates import risks, including from countries imposing sanctions. AstraZeneca argues that the crystalline form of osimertinib does not have unexpected advantages over known forms of the active substance and therefore does not meet patentability criteria. The FAS attempted to penalize domestic companies for the sale of osimertinib, but an arbitration court overturned a 600 million ruble fine.""
}"
2025-11-12T11:33:16+00:00,@bezrec,6809,https://t.me/bezrec/6809,"–°–µ–º–∞–≤–∏–∫ —Å—Ç–∞–ª –ª–∞—É—Ä–µ–∞—Ç–æ–º –º–æ–¥–Ω–æ–π –ø—Ä–µ–º–∏–∏. –ü—Ä–µ–ø–∞—Ä–∞—Ç –æ—Ç ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª –±—ã–ª –ø—Ä–∏–∑–Ω–∞–Ω –ø–æ–±–µ–¥–∏—Ç–µ–ª–µ–º –≤ –Ω–æ–º–∏–Ω–∞—Ü–∏–∏ ¬´–ü—Ä–æ—Ä—ã–≤ –≥–æ–¥–∞¬ª –ø—Ä–µ–º–∏–∏ Topical Style Awards 2025. –ú–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–µ ‚Äì –Ω–µ ¬´—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–µ¬ª, –∑–∞—Ç–æ –∏–∑–≤–µ—Å—Ç–Ω–æ–µ –≤ —Å–≤–µ—Ç—Å–∫–∏—Ö –∫—Ä—É–≥–∞—Ö. –° 2010 –≥–æ–¥–∞ –ø—Ä–µ–º–∏—è –≤—Ä—É—á–∞–µ—Ç—Å—è —Å–∞–º—ã–º —Å—Ç–∏–ª—å–Ω—ã–º –∏ —É—Å–ø–µ—à–Ω—ã–º –∏–∑ –º–∏—Ä–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —à–æ—É‚Äë–±–∏–∑–Ω–µ—Å–∞, –º–æ–¥—ã –∏ –º–µ–¥–∏–∞. –°—Ä–µ–¥–∏ –Ω–æ–º–∏–Ω–∞–Ω—Ç–æ–≤: –ö—Å–µ–Ω–∏—è –°–æ–±—á–∞–∫, –ê–ª—Å—É, –†–µ–≥–∏–Ω–∞ –¢–æ–¥–æ—Ä–µ–Ω–∫–æ, –í–ª–∞–¥ –¢–æ–ø–∞–ª–æ–≤, –û–∫—Å–∞–Ω–∞ –°–∞–º–æ–π–ª–æ–≤–∞, –ó–∞—Ä–∞, –Æ–ª–∏—è –ö–æ–≤–∞–ª—å—á—É–∫, –ñ–∞—Å–º–∏–Ω, –í–∏–∫—Ç–æ—Ä–∏—è –®–µ–ª—è–≥–æ–≤–∞, –í—è—á–µ—Å–ª–∞–≤ –ú–∞–∫–∞—Ä–æ–≤ –∏ –û–ª–µ—Å—è –°—É–¥–∑–∏–ª–æ–≤—Å–∫–∞—è. –ü–æ–±–µ–¥—É –≤ —Å–≤–æ–µ–π –Ω–æ–º–∏–Ω–∞—Ü–∏–∏ –°–µ–º–∞–≤–∏–∫ –∑–∞—Å–ª—É–∂–∏–ª. –ù–µ–¥–∞—Ä–æ–º —ç—Ç–æ —Å–∞–º—ã–π –ø–æ–ø—É–ª—è—Ä–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è –ª–µ—á–µ–Ω–∏—è –¥–∏–∞–±–µ—Ç–∞ –∏ –æ–∂–∏—Ä–µ–Ω–∏—è –Ω–∞ –æ—Å–Ω–æ–≤–µ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ –≤ –†–æ—Å—Å–∏–∏, –∞ —Ç–∞–∫–∂–µ, –ø–æ –¥–∞–Ω–Ω—ã–º RNC Pharma, —Å–∞–º—ã–π –±—ã—Å—Ç—Ä–æ—Ä–∞—Å—Ç—É—â–∏–π –±—Ä–µ–Ω–¥ –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º —Ä—ã–Ω–∫–µ. –ö–∞–∫ –ø–æ–¥—Å—á–∏—Ç–∞–ª–∏ –≤ DSM Group, –∑–∞ –¥–µ–≤—è—Ç—å –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ –æ–±—ä—ë–º –ø—Ä–æ–¥–∞–∂ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –¥–æ—Å—Ç–∏–≥ 13 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —á—Ç–æ –≤ 2,8 —Ä–∞–∑–∞ –±–æ–ª—å—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-11-12T09:04:42+00:00,@bezrec,6807,https://t.me/bezrec/6807,"–§–∞—Ä–º–æ—Ç—Ä–∞—Å–ª—å –Ω–∏–∫–∞–∫ –Ω–µ –¥–æ—Ä–∞—Å—Ç—ë—Ç –¥–æ ¬´–ü–ª–∞—Ç–∏–Ω—ã¬ª Forbes. –û–¥–Ω–æ–≤—Ä–µ–º–µ–Ω–Ω–æ —Å –†–ë–ö –ª—É—á—à–∏—Ö —Ä–∞–±–æ—Ç–æ–¥–∞—Ç–µ–ª–µ–π –∏—Å–∫–∞–ª Forbes. –í —ç—Ç–æ–º –≥–æ–¥—É –≤ –Ω–µ–≥–æ –≤–æ—à–ª–∏ 205 –∫–æ–º–ø–∞–Ω–∏–π –ø—Ä–æ—Ç–∏–≤ 168 –≥–æ–¥–æ–º —Ä–∞–Ω–µ–µ. –ú–µ—Ç–æ–¥–æ–ª–æ–≥–∏—è —Ä–µ–π—Ç–∏–Ω–≥–∞ –ø–æ –æ—Å–Ω–æ–≤–Ω—ã–º —ç–ª–µ–º–µ–Ω—Ç–∞–º ESG-–ø–æ–≤–µ—Å—Ç–∫–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–Ω–∞—è –≤ 2021 –≥–æ–¥—É, –ø–æ–¥—Ä–∞–∑—É–º–µ–≤–∞–µ—Ç –æ—Ü–µ–Ω–∫—É —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –ø–æ —Ç—Ä–µ–º –≥—Ä—É–ø–ø–∞–º, —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–∏–º –∞–±–±—Ä–µ–≤–∏–∞—Ç—É—Ä–µ ESG: ¬´–≠–∫–æ–ª–æ–≥–∏—è¬ª, ¬´–°–æ—Ç—Ä—É–¥–Ω–∏–∫–∏ –∏ –æ–±—â–µ—Å—Ç–≤–æ¬ª –∏ ¬´–ö–æ—Ä–ø–æ—Ä–∞—Ç–∏–≤–Ω–æ–µ —É–ø—Ä–∞–≤–ª–µ–Ω–∏–µ¬ª. –í –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏ –æ—Ç –Ω–∞–±—Ä–∞–Ω–Ω—ã—Ö –±–∞–ª–ª–æ–≤ —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ —Ä–∞—Å–ø—Ä–µ–¥–µ–ª—è—é—Ç –≤ –æ–¥–Ω—É –∏–∑ —á–µ—Ç—ã—Ä–µ—Ö –≥—Ä—É–ø–ø ¬´–ü–ª–∞—Ç–∏–Ω–∞¬ª, ¬´–ó–æ–ª–æ—Ç–æ¬ª, ¬´–°–µ—Ä–µ–±—Ä–æ¬ª –∏ ¬´–ë—Ä–æ–Ω–∑–∞¬ª. –° ¬´–ü–ª–∞—Ç–∏–Ω–æ–π¬ª –∏ ¬´–ë—Ä–æ–Ω–∑–æ–π¬ª –≤ —ç—Ç–æ–º –≥–æ–¥—É –Ω–µ —Å–ª–æ–∂–∏–ª–æ—Å—å. –ó–∞—Ç–æ –≤ —Ä–µ–π—Ç–∏–Ω–≥ –≤–µ—Ä–Ω—É–ª—Å—è ¬´–†-–§–∞—Ä–º¬ª ‚Äì —É –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ó–æ–ª–æ—Ç–æ¬ª. –ï—ë ¬´—Å–æ—Å–µ–¥–∏¬ª –ø–æ –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ ‚Äì ¬´–ë–∏–æ–∫–∞–¥¬ª –∏ Ipsen. ¬´–°–µ—Ä–µ–±—Ä–æ¬ª –¥–æ—Å—Ç–∞–ª–æ—Å—å ¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º –ì—Ä—É–ø–ø¬ª –∏ ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-11-12T05:20:27+00:00,@bezrec,6806,https://t.me/bezrec/6806,"–ê–Ω–∞–ª–∏—Ç–∏–∫–∏ DSM Group –ø–æ–¥–µ–ª–∏–ª–∏—Å—å –æ—Ç—á—ë—Ç–æ–º –æ —Å–æ—Å—Ç–æ—è–Ω–∏–∏ —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –∞–ø—Ç–µ—á–Ω–æ–≥–æ —Ä—ã–Ω–∫–∞ –ë–ê–î –ø–æ –∏—Ç–æ–≥–∞–º —Å–µ–Ω—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞. –ï–≥–æ –æ–±—ä—ë–º –≤ –¥–µ–Ω—å–≥–∞—Ö –≤—ã—Ä–æ—Å –Ω–∞ 16,2% –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ –∞–≤–≥—É—Å—Ç–∞, –¥–æ 16,5 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ü—Ä–∏—Ä–æ—Å—Ç –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ —Å–æ—Å—Ç–∞–≤–∏–ª 18,7% (37,3 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫). –ù–∞ –¥–æ–ª—é —Ç–æ–ø-3 –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ë–ê–î –≤ –∞–Ω–∞–ª–∏–∑–∏—Ä—É–µ–º—ã–π –ø–µ—Ä–∏–æ–¥ –ø—Ä–∏—à–ª–æ—Å—å –æ–∫–æ–ª–æ 30% —Ä—ã–Ω–∫–∞ –≤ —Å—Ç–æ–∏–º–æ—Å—Ç–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏. –ü–µ—Ä–≤–æ–µ –º–µ—Å—Ç–æ —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω–æ –∑–∞ ¬´–≠–≤–∞–ª–∞—Ä–æ–º¬ª —Å –¥–æ–ª–µ–π 13,2%. –ü–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω–æ–π –¥–∏–Ω–∞–º–∏–∫–æ–π –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å –æ–±—è–∑–∞–Ω –¥–æ–±–∞–≤–∫–µ, —É—Å–∫–æ—Ä—è—é—â–µ–π –≤—ã–≤–µ–¥–µ–Ω–∏–µ –∏–∑ –æ—Ä–≥–∞–Ω–∏–∑–º–∞ —Ç–æ–∫—Å–∏—á–µ—Å–∫–∏—Ö –≤–µ—â–µ—Å—Ç–≤, –≠–≤–∞–ª–∞—Ä –¢—Ä–∞–Ω–∑–∏—Ç –õ–∏–º—Ñ–æ—Ç—Ä–∞–Ω–∑–∏—Ç (+64,7%). –¢–∞–∫–∂–µ —Ö–æ—Ä–æ—à–∏–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –ø–æ–∫–∞–∑–∞–ª–∏ –≠–≤–∞–ª–∞—Ä –û–º–µ–≥–∞-3 —Ç—Ä–æ–π–Ω–∞—è Anti-Age (+53,6%), —à–∏–ø—É—á–∏–π –≠–≤–∞–ª–∞—Ä –í–∏—Ç–∞–º–∏–Ω C (+52,4%) –∏ –ë–ê–î –¥–ª—è —Å—É—Å—Ç–∞–≤–æ–≤ –≠–≤–∞–ª–∞—Ä –ö–æ–ª–ª–∞–≥–µ–Ω –º–æ—Ä—Å–∫–æ–π II —Ç–∏–ø–∞ (new). –û—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω—É—é –¥–∏–Ω–∞–º–∏–∫—É –ø–æ–∫–∞–∑–∞–ª –º–µ—Ç–∞–±–∏–æ—Ç–∏–∫ –•–µ–ª–∏–Ω–æ—Ä–º (-2,7%). –ù–∞ –≤—Ç–æ—Ä–æ–µ –º–µ—Å—Ç–æ —Å –ø—Ä–æ—à–ª–æ–≥–æ–¥–Ω–µ–≥–æ —Ç—Ä–µ—Ç—å–µ–≥–æ –ø–æ–¥–Ω—è–ª—Å—è ¬´–ö–≤–∞–¥—Ä–∞—Ç-–°¬ª. –£ –∫–æ–º–ø–∞–Ω–∏–∏ –≤ –ø–æ—Ä—Ç—Ñ–µ–ª–µ –¥–≤–µ –∫–ª—é—á–µ–≤—ã–µ –ª–∏–Ω–µ–π–∫–∏: –í–∏—Ç–∞–º–∏—Ä (+41,5% –∫ —Å–µ–Ω—Ç—è–±—Ä—é 2024 –≥–æ–¥–∞) –∏ Tetralab (+5%). –¢–∞–∫–∂–µ –ø—Ä–æ–¥–∞–∂–∏ —Å—É—â–µ—Å—Ç–≤–µ–Ω–Ω–æ –ø–æ–¥–Ω–∏–º–∞—é—Ç –°–¢–ú (–ø—Ä–∏—Ä–æ—Å—Ç +215,3%). –ó–∞–º—ã–∫–∞–µ—Ç —Ç—Ä–æ–π–∫—É –ª–∏–¥–µ—Ä–æ–≤ –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∞—è Solgar. –ù–∞–∏–±–æ–ª–µ–µ –≤–Ω—É—à–∏—Ç–µ–ª—å–Ω—ã–º –ø—Ä–∏—Ä–æ—Å—Ç–æ–º –æ—Ç–ª–∏—á–∏–ª–∏—Å—å Solgar –ö–æ–Ω—Ü–µ–Ω—Ç—Ä–∞—Ç —Ä—ã–±—å–µ–≥–æ –∂–∏—Ä–∞ –û–º–µ–≥–∞ 3 (+78% –∫ —Å–µ–Ω—Ç—è–±—Ä—é 2024 –≥–æ–¥–∞), Solgar –¶–∏—Ç—Ä–∞—Ç –º–∞–≥–Ω–∏—è (+49,9%), –∞ —Ç–∞–∫–∂–µ –¥–µ—Ç—Å–∫–∏–π –∫–æ–º–ø–ª–µ–∫—Å Solgar –ö–∞–Ω–≥–∞–≤–∏—Ç–µ—Å –ö–æ–º–ø–ª–µ–∫—Å–Ω–∞—è —Ñ–æ—Ä–º—É–ª–∞ –º—É–ª—å—Ç–∏–≤–∏—Ç–∞–º–∏–Ω—ã/–º–∏–Ω–µ—Ä–∞–ª—ã (+39,8%). –í —Å–µ–Ω—Ç—è–±—Ä–µ —Ç–æ–ø-10 –ø–æ–ø–æ–ª–Ω–∏–ª—Å—è –¥–≤—É–º—è –Ω–æ–≤—ã–º–∏ –∏–≥—Ä–æ–∫–∞–º–∏: ¬´–§–∞—Ä–º–∞–∫–æ—Ä –ü—Ä–æ–¥–∞–∫—à–Ω¬ª, –ø–æ–¥–Ω—è–≤—à–∏–π—Å—è —Å—Ä–∞–∑—É –Ω–∞ 13 —Å—Ç—Ä–æ—á–µ–∫ –∏ Bayer (+6 –º–µ—Å—Ç). –û—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω—É—é –¥–∏–Ω–∞–º–∏–∫—É –ø–æ–∫–∞–∑–∞–ª —Ç–æ–ª—å–∫–æ PharmaMed (-3,1%). –ú–∞–∫—Å–∏–º–∞–ª—å–Ω–æ–π –¥–∏–Ω–∞–º–∏–∫–æ–π –º–æ–≥—É—Ç –ø–æ—Ö–≤–∞—Å—Ç–∞—Ç—å—Å—è ¬´–§–∞—Ä–º–∞–∫–æ—Ä –ü—Ä–æ–¥–∞–∫—à–Ω¬ª, ¬´–ö–≤–∞–¥—Ä–∞—Ç-–°¬ª (+113,9%; +1 —Å—Ç—Ä–æ—á–∫–∞) –∏ Bayer (+65,6%; +6 —Å—Ç—Ä–æ—á–µ–∫). –¢–∞–∫–∂–µ –≤ —Ç–æ–ø-10 –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ë–ê–î –ø–æ –∏—Ç–æ–≥–∞–º —Å–µ–Ω—Ç—è–±—Ä—è –≤–æ—à–ª–∏ ¬´–ú–∏—Ä—Ä–æ–ª–∞¬ª, ¬´–í–¢–§¬ª, ¬´–ù–∏–∂—Ñ–∞—Ä–º¬ª, ¬´–ü–æ–ª—è—Ä–∏—Å¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The report from the DSM Group on Russia's pharmaceutical market in September 2025 shows a growth of 16.2% to RUB 165 billion, up from August. The top three producers accounted for about 30% of the market value. 'Evaluar' led with a growth of +64.7% for its transit lymphotransit supplement, 'Evaluar Omega-3 triple anti-age' with +53.6%, and 'Evaluar Collagen marine type II for joints' with +52.4%. Negative growth was seen in 'Helinorm'. Bayer and Solgar are the top two players, with Solgar showing significant growth in its products like 'Omega 3 Concentrate from Fish Oil' (+78%), 'Magnesium Citrate' (+49.9%) and a pediatric complex 'Kangawites Comprehensive Multivitamin/Minerals' (+39.8%). New players 'Farma Kor Prodaksion' and Bayer have also entered the top 10"
2025-11-11T15:27:20+00:00,@bezrec,6805,https://t.me/bezrec/6805,"–†–ë–ö –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª —Å–≤–æ–π —Ä–µ–π—Ç–∏–Ω–≥ —Ä–∞–±–æ—Ç–æ–¥–∞—Ç–µ–ª–µ–π –ø–æ –∏—Ç–æ–≥–∞–º 2025 –≥–æ–¥–∞. –°—Ä–µ–¥–∏ 381 —É—á–∞—Å—Ç–Ω–∏–∫–∞ –Ω–∞—à–ª–æ—Å—å –º–µ—Å—Ç–æ –∏ –¥–ª—è –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–µ–π —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏. –ñ–∞–ª—å, –∫–æ–Ω–µ—á–Ω–æ, —á—Ç–æ —Å–æ—Å—Ç–∞–≤–∏—Ç–µ–ª–∏ —Ä–µ–π—Ç–∏–Ω–≥–∞ –Ω–µ —É–¥–æ—Å—Ç–æ–∏–ª–∏ –Ω–∞—à–µ–≥–æ –±—Ä–∞—Ç–∞ –æ—Ç–¥–µ–ª—å–Ω–æ–≥–æ —Å–µ–≥–º–µ–Ω—Ç–∞, –∞ –æ—Ç–Ω–µ—Å–ª–∏ –∫ —à–∏—Ä–æ–∫–æ–º—É –ø–æ–Ω—è—Ç–∏—é ¬´–ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç—å¬ª, –Ω–æ —É–∂ –∫–∞–∫ –µ—Å—Ç—å. –í–µ–¥—É—â–∏–µ HR-—Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –æ—Ü–µ–Ω–∏–≤–∞–ª–∏ —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –ø–æ –±–æ–ª–µ–µ —á–µ–º 40 –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è–º, –∫–æ—Ç–æ—Ä—ã–µ –æ–±—ä–µ–¥–∏–Ω–∏–ª–∏ –≤ –ø—è—Ç—å –∫–ª—é—á–µ–≤—ã—Ö –≥—Ä—É–ø–ø –∫—Ä–∏—Ç–µ—Ä–∏–µ–≤: - —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–∏ –∏ —É—Å–ª–æ–≤–∏—è —Ç—Ä—É–¥–∞; - —Å–æ—Ü–∏–∞–ª—å–Ω–∞—è –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç—å; - —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –±–∏–∑–Ω–µ—Å–∞ –∏ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–æ–µ —Ä–∞–∑–≤–∏—Ç–∏–µ; - –¥–µ–ª–æ–≤–∞—è —Ä–µ–ø—É—Ç–∞—Ü–∏—è –∫–æ–º–ø–∞–Ω–∏–∏; - –º–Ω–µ–Ω–∏—è —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤. –†–µ–π—Ç–∏–Ω–≥ –ø–æ–¥–µ–ª–µ–Ω –Ω–∞ —Ç—Ä–∏ –≥—Ä—É–ø–ø—ã. –í –ø—Ä–æ—à–ª–æ–º –≥–æ–¥—É –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–µ–π —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ –≤ –≥—Ä—É–ø–ø–µ I –Ω–µ –æ–∫–∞–∑–∞–ª–æ—Å—å. –í —ç—Ç–æ–º –≥–æ–¥—É –¥–æ –Ω–µ—ë ¬´–¥–æ—Ä–æ—Å–ª–∞¬ª ¬´–ü–°–ö –§–∞—Ä–º–∞¬ª. ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª –∏ ¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º¬ª, –∫–∞–∫ –≤ –ø—Ä–æ—à–ª–æ–º –≥–æ–¥—É, –ø–æ–ø–∞–ª–∏ –≤–æ II –∏ III –≥—Ä—É–ø–ø—É —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ. –ù–æ–≤–∏—á–æ–∫ —Ä–µ–π—Ç–∏–Ω–≥–∞ - ¬´–ë–∏–æ–∫–∞–¥¬ª - —Ç–∞–∫–∂–µ –≤ –≥—Ä—É–ø–ø–µ III. –¢–∞–∫–∂–µ –≤ —Ä–µ–π—Ç–∏–Ω–≥–µ –†–ë–ö –≤ –∫–∞—á–µ—Å—Ç–≤–µ —É—á–∞—Å—Ç–Ω–∏–∫–∞ –∑–∞—Å–≤–µ—Ç–∏–ª–∞—Å—å –∞–ø—Ç–µ—á–Ω–∞—è —Å–µ—Ç—å ¬´–ú–∞–∫—Å–∞–≤–∏—Ç¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-11-11T12:02:16+00:00,@bezrec,6804,https://t.me/bezrec/6804,"–£—á—ë–Ω—ã–µ –≤–ø–µ—Ä–≤—ã–µ –ø—Ä–∏–º–µ–Ω–∏–ª–∏ –≥–µ–Ω–Ω—É—é —Ç–µ—Ä–∞–ø–∏—é –¥–ª—è –ª–µ—á–µ–Ω–∏—è –≤—ã—Å–æ–∫–æ–≥–æ —É—Ä–æ–≤–Ω—è —Ö–æ–ª–µ—Å—Ç–µ—Ä–∏–Ω–∞. –£—á—ë–Ω—ã–µ –í–∏–∫—Ç–æ—Ä–∏–∞–Ω—Å–∫–æ–π –∫–∞—Ä–¥–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π –±–æ–ª—å–Ω–∏—Ü—ã –∏ –í–∏–∫—Ç–æ—Ä–∏–∞–Ω—Å–∫–æ–≥–æ –∏–Ω—Å—Ç–∏—Ç—É—Ç–∞ —Å–µ—Ä–¥—Ü–∞ —É—Å–ø–µ—à–Ω–æ –ø—Ä–æ–≤–µ–ª–∏ –ø–µ—Ä–≤–æ–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–µ –∏—Å–ø—ã—Ç–∞–Ω–∏–µ –Ω–∞ –ª—é–¥—è—Ö —Ä–µ–≤–æ–ª—é—Ü–∏–æ–Ω–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏, –∫–æ—Ç–æ—Ä–∞—è –º–æ–∂–µ—Ç —Å–Ω–∏–∑–∏—Ç—å —É—Ä–æ–≤–µ–Ω—å —Ö–æ–ª–µ—Å—Ç–µ—Ä–∏–Ω–∞ –∏ —Ç—Ä–∏–≥–ª–∏—Ü–µ—Ä–∏–¥–æ–≤ —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å —Ç—Ä—É–¥–Ω–æ –ø–æ–¥–¥–∞—é—â–∏–º–∏—Å—è –ª–µ—á–µ–Ω–∏—é –Ω–∞—Ä—É—à–µ–Ω–∏—è–º–∏ –ª–∏–ø–∏–¥–Ω–æ–≥–æ –æ–±–º–µ–Ω–∞. –ò—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª–∏ –æ–ø–∏—Ä–∞–ª–∏—Å—å –Ω–∞ —Ç–æ—Ç —Ñ–∞–∫—Ç, —á—Ç–æ –ª—é–¥–∏ —Å –µ—Å—Ç–µ—Å—Ç–≤–µ–Ω–Ω—ã–º–∏ –º—É—Ç–∞—Ü–∏—è–º–∏, –∫–æ—Ç–æ—Ä—ã–µ ¬´–æ—Ç–∫–ª—é—á–∞—é—Ç¬ª –≥–µ–Ω, –Ω–∞–∑—ã–≤–∞–µ–º—ã–π –∞–Ω–≥–∏–æ–ø–æ—ç—Ç–∏–Ω-–ø–æ–¥–æ–±–Ω—ã–º –±–µ–ª–∫–æ–º 3 (ANGPTL3), –Ω–∞ –ø—Ä–æ—Ç—è–∂–µ–Ω–∏–∏ –≤—Å–µ–π –∂–∏–∑–Ω–∏ –∏–º–µ—é—Ç –Ω–∏–∑–∫–∏–µ —É—Ä–æ–≤–Ω–∏ —Ö–æ–ª–µ—Å—Ç–µ—Ä–∏–Ω–∞ –∏ —Ç—Ä–∏–≥–ª–∏—Ü–µ—Ä–∏–¥–æ–≤ –±–µ–∑ –æ—á–µ–≤–∏–¥–Ω—ã—Ö –≤—Ä–µ–¥–Ω—ã—Ö –ø–æ—Å–ª–µ–¥—Å—Ç–≤–∏–π, –∞ —Ç–∞–∫–∂–µ –±–æ–ª–µ–µ –Ω–∏–∑–∫–∏–π —Ä–∏—Å–∫ —Ä–∞–∑–≤–∏—Ç–∏—è –∞—Ç–µ—Ä–æ—Å–∫–ª–µ—Ä–æ—Ç–∏—á–µ—Å–∫–∏—Ö —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –≠–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–∞–ª—å–Ω–∞—è —Ç–µ—Ä–∞–ø–∏—è —Ä–µ–¥–∞–∫—Ç–∏—Ä–æ–≤–∞–Ω–∏—è –≥–µ–Ω–æ–≤ CRISPR-Cas9 –≤ –≤–∏–¥–µ –æ–¥–Ω–æ–∫—Ä–∞—Ç–Ω–æ–π –∏–Ω—Ñ—É–∑–∏–∏ –ø–æ–¥ –Ω–∞–∑–≤–∞–Ω–∏–µ–º CTX310 –∏—Å–ø–æ–ª—å–∑—É–µ—Ç –∫—Ä–æ—à–µ—á–Ω—ã–µ —á–∞—Å—Ç–∏—Ü—ã –Ω–∞ –æ—Å–Ω–æ–≤–µ –∂–∏—Ä–∞ –¥–ª—è –¥–æ—Å—Ç–∞–≤–∫–∏ –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç–æ–≤ —Ä–µ–¥–∞–∫—Ç–∏—Ä–æ–≤–∞–Ω–∏—è CRISPR –≤ –ø–µ—á–µ–Ω—å, —á—Ç–æ–±—ã –æ—Ç–∫–ª—é—á–∏—Ç—å ANGPTL3. –†–µ–∑—É–ª—å—Ç–∞—Ç—ã –ø–æ–ª—É—á–∏–ª–∏—Å—å –≤–ø–µ—á–∞—Ç–ª—è—é—â–∏–µ. –í—Å–µ–≥–æ –∑–∞ –¥–≤–µ –Ω–µ–¥–µ–ª–∏ –æ–¥–Ω–æ–∫—Ä–∞—Ç–Ω–æ–µ –ª–µ—á–µ–Ω–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–º CTX310 –ø—Ä–∏–≤–µ–ª–æ –∫ —Å—Ä–µ–¥–Ω–µ–º—É —Å–Ω–∏–∂–µ–Ω–∏—é —É—Ä–æ–≤–Ω—è —Ö–æ–ª–µ—Å—Ç–µ—Ä–∏–Ω–∞ –õ–ü–ù–ü –Ω–∞ 50%, –∞ —Ç—Ä–∏–≥–ª–∏—Ü–µ—Ä–∏–¥–æ–≤ ‚Äì –Ω–∞ 55%. –£—Ä–æ–≤–µ–Ω—å —Ö–æ–ª–µ—Å—Ç–µ—Ä–∏–Ω–∞ –õ–ü–ù–ü –∏ —Ç—Ä–∏–≥–ª–∏—Ü–µ—Ä–∏–¥–æ–≤ —Å–Ω–∏–∑–∏–ª—Å—è –ø–æ—á—Ç–∏ –Ω–∞ 60% —É –≤—Å–µ—Ö —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤. –ü—Ä–∏ —ç—Ç–æ–º –æ–±–æ—à–ª–æ—Å—å –±–µ–∑ —Å–µ—Ä—å—ë–∑–Ω—ã—Ö –ø–æ–±–æ—á–µ–∫. CTX310 —Å—Ç–∞–ª–∞ –ø–µ—Ä–≤–æ–π —Ç–µ—Ä–∞–ø–∏–µ–π, –ø–æ–∑–≤–æ–ª–∏–≤—à–µ–π –¥–æ–±–∏—Ç—å—Å—è –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ–≥–æ —Å–Ω–∏–∂–µ–Ω–∏—è –∫–∞–∫ —É—Ä–æ–≤–Ω—è —Ö–æ–ª–µ—Å—Ç–µ—Ä–∏–Ω–∞ –õ–ü–ù–ü, —Ç–∞–∫ –∏ —Ç—Ä–∏–≥–ª–∏—Ü–µ—Ä–∏–¥–æ–≤ –æ–¥–Ω–æ–≤—Ä–µ–º–µ–Ω–Ω–æ, —á—Ç–æ –æ–∑–Ω–∞—á–∞–µ—Ç –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω—ã–π –ø—Ä–æ—Ä—ã–≤ –¥–ª—è –ª—é–¥–µ–π —Å–æ —Å–º–µ—à–∞–Ω–Ω—ã–º–∏ –Ω–∞—Ä—É—à–µ–Ω–∏—è–º–∏ –ª–∏–ø–∏–¥–Ω–æ–≥–æ –æ–±–º–µ–Ω–∞, —É –∫–æ—Ç–æ—Ä—ã—Ö –Ω–∞–±–ª—é–¥–∞–µ—Ç—Å—è –ø–æ–≤—ã—à–µ–Ω–∏–µ –æ–±–æ–∏—Ö –ø–æ–∫–∞–∑–∞—Ç–µ–ª–µ–π. –ù–∞—á–∞–ª–æ —Å–ª–µ–¥—É—é—â–µ–π —Ñ–∞–∑—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –∑–∞–ø–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω–æ –Ω–∞ –∫–æ–Ω–µ—Ü 2025 –∏–ª–∏ –Ω–∞—á–∞–ª–æ 2026 –≥–æ–¥–∞. –£—á—ë–Ω—ã–µ –æ–±–µ—â–∞—é—Ç —É–¥–µ–ª–∏—Ç—å –≤–Ω–∏–º–∞–Ω–∏–µ –±–æ–ª–µ–µ –º–Ω–æ–≥–æ—á–∏—Å–ª–µ–Ω–Ω—ã–º –∏ —Ä–∞–∑–Ω–æ–æ–±—Ä–∞–∑–Ω—ã–º –≥—Ä—É–ø–ø–∞–º –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –í –ø—Ä–æ—à–µ–¥—à–µ–º –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–∏ –ø—Ä–∏–Ω—è–ª–∏ —É—á–∞—Å—Ç–∏–µ 15 –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –≤ –≤–æ–∑—Ä–∞—Å—Ç–µ 18‚Äì75 –ª–µ—Ç —Å —Ä–∞–∑–ª–∏—á–Ω—ã–º–∏ —Ç—Ä—É–¥–Ω–æ –ø–æ–¥–¥–∞—é—â–∏–º–∏—Å—è –ª–µ—á–µ–Ω–∏—é –Ω–∞—Ä—É—à–µ–Ω–∏—è–º–∏ –ª–∏–ø–∏–¥–Ω–æ–≥–æ –æ–±–º–µ–Ω–∞, –≤–∫–ª—é—á–∞—è —Å–µ–º–µ–π–Ω—É—é –≥–∏–ø–µ—Ä—Ö–æ–ª–µ—Å—Ç–µ—Ä–∏–Ω–µ–º–∏—é –∏ —Ç—è–∂–µ–ª—É—é –≥–∏–ø–µ—Ä—Ç—Ä–∏–≥–ª–∏—Ü–µ—Ä–∏–¥–µ–º–∏—é. –í–ø–µ—Ä–µ–¥–∏ —É –Ω–∏—Ö 15 –ª–µ—Ç –¥–æ–ª–≥–æ—Å—Ä–æ—á–Ω–æ–≥–æ –Ω–∞–±–ª—é–¥–µ–Ω–∏—è –∑–∞ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å—é, –∫–∞–∫ —Ç–æ–≥–æ —Ç—Ä–µ–±—É–µ—Ç –≤—Å—è —Ç–µ—Ä–∞–ø–∏—è –Ω–∞ –æ—Å–Ω–æ–≤–µ CRISPR. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, regulation, safety, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""Scientists at the Victorian Cardiology Hospital and the Victorian Heart Institute successfully conducted the first human trial of revolutionary therapy that can reduce cholesterol and triglycerides in patients with difficult-to-treat lipid disorders. The therapy, called CTX310 and based on CRISPR-Cas9 gene editing, involves delivering editing tools to the liver via lipid particles. The therapy targets ANGPTL3, a gene that naturally suppresses cholesterol and triglyceride levels without adverse effects. Results showed significant reductions in LDL cholesterol by 50% and triglycerides by 55% within two weeks. No serious side effects were observed. CTX310 is the first therapy to achieve significant reductions in both LDL cholesterol and triglycerides, potentially revolutionizing treatment for mixed lipid disorders. The next phase of research is planned to begin in late 2025 or early 2026, with long-term safety monitoring for up to 15 years.""
}"
2025-11-11T09:20:01+00:00,@bezrec,6802,https://t.me/bezrec/6802,"–ü–æ—Å–º–æ—Ç—Ä–µ–ª–∏ –∞–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–∏–π –æ—Ç—á—ë—Ç DSM Group –∑–∞ —Å–µ–Ω—Ç—è–±—Ä—å. –î–µ–ª–∏–º—Å—è –∫–ª—é—á–µ–≤—ã–º–∏ –º–æ–º–µ–Ω—Ç–∞–º–∏: üîΩ –û–±—ä—ë–º –∫–æ–º–º–µ—Ä—á–µ—Å–∫–æ–≥–æ —Ä—ã–Ω–∫–∞ –õ–ü –≤ —Å–µ–Ω—Ç—è–±—Ä–µ —Å–æ—Å—Ç–∞–≤–∏–ª 164,1 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π (–≤ —Ä–æ–∑–Ω–∏—á–Ω—ã—Ö —Ü–µ–Ω–∞—Ö). –≠—Ç–æ –Ω–∞ 11,2% –±–æ–ª—å—à–µ, —á–µ–º –≤ –∞–≤–≥—É—Å—Ç–µ. –ì–æ–¥–æ–≤–æ–π –ø—Ä–∏—Ä–æ—Å—Ç - 14,8%. –ü—Ä–æ–¥–∞–∂–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ –∞–≤–≥—É—Å—Ç–∞ –≤—ã—Ä–æ—Å–ª–∏ –Ω–∞ 10,4%, –¥–æ 385,5 –º–ª–Ω —à—Ç—É–∫, —á—Ç–æ –Ω–∞ 2,2% –±–æ–ª—å—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É. üîΩ –°—Ä–µ–¥–Ω—è—è —Å—Ç–æ–∏–º–æ—Å—Ç—å —É–ø–∞–∫–æ–≤–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –Ω–∞ –∫–æ–º–º–µ—Ä—á–µ—Å–∫–æ–º —Ä—ã–Ω–∫–µ –ø–æ–¥–æ—Ä–æ–∂–∞–ª–∞ –Ω–∞ 0,8% –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –∞–≤–≥—É—Å—Ç–æ–º, –¥–æ 425,6 —Ä—É–±–ª–µ–π. üîΩ –û–±—ä—ë–º –∫–æ–º–º–µ—Ä—á–µ—Å–∫–æ–≥–æ —Ä—ã–Ω–∫–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø–æ –∏—Ç–æ–≥–∞–º –¥–µ–≤—è—Ç–∏ –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ –≤ —Ä—É–±–ª—è—Ö —É–≤–µ–ª–∏—á–∏–ª—Å—è –Ω–∞ 11,4% –≥–æ–¥ –∫ –≥–æ–¥—É. –í —É–ø–∞–∫–æ–≤–∫–∞—Ö –∞–ø—Ç–µ–∫–∏ –ø—Ä–æ–¥–∞–ª–∏ –Ω–∞ 1,9% –º–µ–Ω—å—à–µ, —á–µ–º –∑–∞ —Ç–∞–∫–æ–π –∂–µ –ø–µ—Ä–∏–æ–¥ –≤ 2024 –≥–æ–¥—É. üîΩ –î–æ–ª—è –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏–∑ –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ ¬´—Å–≤—ã—à–µ 1 —Ç—ã—Å. —Ä—É–±–ª–µ–π¬ª —É–≤–µ–ª–∏—á–∏–ª–∞—Å—å –Ω–∞ 4,1%, –¥–æ 37,3%. –ù–∞ –¥–µ—à—ë–≤—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã ¬´–¥–æ 100 —Ä—É–±–ª–µ–π¬ª –ø—Ä–∏—à–ª–æ—Å—å –≤—Å–µ–≥–æ 3% —Å—Ç–æ–∏–º–æ—Å—Ç–Ω–æ–≥–æ –æ–±—ä—ë–º–∞ (-0,9% –≥–æ–¥ –∫ –≥–æ–¥—É). üîΩ –î–æ–ª—è –ª–æ–∫–∞–ª–∏–∑–æ–≤–∞–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Å–æ—Å—Ç–∞–≤–∏–ª–∞ 66% –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏, –≤ —Å—Ç–æ–∏–º–æ—Å—Ç–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ –æ–Ω–∏ –∑–∞–Ω—è–ª–∏ 50,9%. üîΩ –í –ª–∏–¥–µ—Ä–∞—Ö –ø–æ —Å—Ç–æ–∏–º–æ—Å—Ç–Ω–æ–º—É –æ–±—ä—ë–º—É –ø—Ä–æ–¥–∞–∂ –≤ —Å–µ–Ω—Ç—è–±—Ä–µ ‚Äî ¬´–ù–∏–∂—Ñ–∞—Ä–º¬ª, –Ω–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ ‚Äî Bayer, –Ω–∞ —Ç—Ä–µ—Ç—å–µ–º ‚Äî Servier. –í —Ç–æ–ø-10 —Ç–∞–∫–∂–µ –≤–æ—à–ª–∏: ¬´–û—Ç–∏—Å–∏—Ñ–∞—Ä–º¬ª, Abbott, ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª, Sanofi, ¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º¬ª, Novartis, Teva. üîΩ –¢—Ä–æ–π–∫–∞ –±—Ä–µ–Ω–¥–æ–≤-–ª–∏–¥–µ—Ä–æ–≤ –ø–æ —Å—Ç–æ–∏–º–æ—Å—Ç–Ω–æ–º—É –æ–±—ä—ë–º—É –∞–ø—Ç–µ—á–Ω—ã—Ö –ø—Ä–æ–¥–∞–∂ –ø–æ –∏—Ç–æ–≥–∞–º —Å–µ–Ω—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞ –≤—ã–≥–ª—è–¥–∏—Ç —Ç–∞–∫: –°–µ–º–∞–≤–∏–∫, –¢–µ—Ä–∞—Ñ–ª—é, –≠–ª–∏–∫–≤–∏—Å. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial, guideline, pharmacovigilance"",
  ""impact"": ""high"",
  ""english"": ""Key highlights from the September DSM Group analytical report: - The commercial market for over-the-counter drugs in RMB terms grew by 11.2% month-on-month to RMB 164.1 billion, up 14.8% year-over-year. - Sales of drugs in packages increased by 10.4%, to 385.5 million units, up 2.2% year-over-year. - The average cost of packaged drugs on the commercial market rose by 0.8% to RMB 425.6 in September compared to August. - The total value of the commercial market for drugs grew by 11.4% year-over-year to RMB terms, with a decrease of 1.9% in packaged sales compared to the same period last year. - The share of drugs priced above RMB 1,000 increased by 4.1% to 37.3%. - The share of cheap drugs priced below RMB 10"
2025-11-11T05:55:57+00:00,@bezrec,6801,https://t.me/bezrec/6801,"–†—ã–Ω–æ–∫ —Ö–æ–Ω–¥–æ–ø—Ä–æ—Ç–µ–∫—Ç–æ—Ä–æ–≤ —Ä–∞—Å—Ç—ë—Ç –Ω–∞ –∏–Ω—ä–µ–∫—Ü–∏—è—Ö. –ü–æ –∏—Ç–æ–≥–∞–º —Ç—Ä—ë—Ö –∫–≤–∞—Ä—Ç–∞–ª–æ–≤ 2025 –≥–æ–¥–∞ —Ä–æ—Å—Å–∏—è–Ω–µ –ø—Ä–∏–æ–±—Ä–µ–ª–∏ 7,9 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ —Ö–æ–Ω–¥—Ä–æ–ø—Ä–æ—Ç–µ–∫—Ç–æ—Ä–æ–≤, –ø–æ–¥—Å—á–∏—Ç–∞–ª–∏ –≤ RNC Pharma. –≠—Ç–æ –Ω–∞ 2,3% –±–æ–ª—å—à–µ –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ –≥–æ–¥ –∫ –≥–æ–¥—É. –û–±—ä—ë–º –ø—Ä–æ–¥–∞–∂ –≤ –¥–µ–Ω—å–≥–∞—Ö –ø—Ä–µ–≤—ã—Å–∏–ª 18,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π (+13,3%). 75% –æ—Ç –æ–±—ä—ë–º–∞ –≤ —Ä—É–±–ª—è—Ö –≤ –∞–Ω–∞–ª–∏–∑–∏—Ä—É–µ–º–æ–π –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ –∏–Ω—ä–µ–∫—Ü–∏–æ–Ω–Ω—ã–µ —Ñ–æ—Ä–º—ã. –û–Ω–∏ –∂–µ –æ–±–µ—Å–ø–µ—á–∏–≤–∞—é—Ç –æ–±—â–∏–π —Ä–æ—Å—Ç –∫–∞—Ç–µ–≥–æ—Ä–∏–∏, —Ç–æ–≥–¥–∞ –∫–∞–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–ª—è –ø—Ä–∏–µ–º–∞ –≤–Ω—É—Ç—Ä—å –Ω–∞–ø—Ä–æ—Ç–∏–≤ –∑–∞ –≥–æ–¥ –ø—Ä–æ—Å–µ–ª–∏ –Ω–∞ 1,5% –≤ —Å—Ç–æ–∏–º–æ—Å—Ç–Ω–æ–º –∏ –Ω–∞ 8,3% –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏. –û—Å–Ω–æ–≤–Ω—É—é –¥–æ–ª—é —Ä—ã–Ω–∫–∞ –∑–∞–Ω–∏–º–∞—é—Ç –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã —Å —Ö–æ–Ω–¥—Ä–æ–∏—Ç–∏–Ω–æ–º –∏ –≥–ª—é–∫–æ–∑–∞–º–∏–Ω–æ–º, –∞ —Ç–∞–∫–∂–µ –∏—Ö –∫–æ–º–±–∏–Ω–∞—Ü–∏–∏‚Äî –≤ —è–Ω–≤–∞—Ä–µ-—Å–µ–Ω—Ç—è–±—Ä–µ –∏—Ö –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–∞—è –¥–æ–ª—è –¥–æ—Å—Ç–∏–≥–∞–ª–∞ 71%, –∞ –≤ —Ä—É–±–ª—ë–≤–æ–º —ç–∫–≤–∏–≤–∞–ª–µ–Ω—Ç–µ –ø—Ä–µ–≤—ã—à–∞–ª–∞ 69%. –ü–æ –∏—Ç–æ–≥–∞–º –ø–µ—Ä–≤—ã—Ö –¥–µ–≤—è—Ç–∏ –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ –∫–∞—Ç–µ–≥–æ—Ä–∏—è —Ö–æ–Ω–¥–æ–ø—Ä–æ—Ç–µ–∫—Ç–æ—Ä–æ–≤ –≤ —Ä–æ–∑–Ω–∏—Ü–µ –±—ã–ª–∞ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–∞ 38 –±—Ä–µ–Ω–¥–∞–º–∏ –æ—Ç 43 –∫–æ—Ä–ø–æ—Ä–∞—Ü–∏–π. –ü–µ—Ä–≤–æ–µ –º–µ—Å—Ç–æ –ø–æ –æ–±—ä—ë–º—É –¥–µ–Ω–µ–∂–Ω—ã—Ö –∑–∞—Ç—Ä–∞—Ç ‚Äì —É –ê–ª—Ñ–ª—É—Ç–æ–ø–∞ –æ—Ç —Ä—É–º—ã–Ω—Å–∫–æ–π ¬´–ë–∏–æ—Ç–µ—Ö–Ω–æ—Å¬ª. –ù–∞ –≤—Ç–æ—Ä–æ–π —Å—Ç—Ä–æ—á–∫–µ –•–æ–Ω–¥—Ä–æ–≥–∞—Ä–¥ –æ—Ç ¬´–°–æ—Ç–µ–∫—Å¬ª, –Ω–∞ —Ç—Ä–µ—Ç—å–µ–π ‚Äì–ò–Ω—ä–µ–∫—Ç—Ä–∞–Ω –æ—Ç –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–≠–ª–ª–∞—Ä–∞¬ª. –°–∞–º–æ–π –≤–Ω—É—à–∏—Ç–µ–ª—å–Ω–æ–π –¥–∏–Ω–∞–º–∏–∫–æ–π –º–æ–≥—É—Ç –ø–æ—Ö–≤–∞—Å—Ç–∞—Ç—å—Å—è –ú—É–∫–æ—Å–∞—Ç (¬´–î–∏–∞–º–µ–¥-–§–∞—Ä–º–∞¬ª) –∏ –ê–º–±–µ–Ω–µ (¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª). –û—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω–æ–π –¥–∏–Ω–∞–º–∏–∫–æ–π –æ—Ç–ª–∏—á–∏–ª–∏—Å—å –ê—Ä—Ç—Ä–∞ (¬´–ù–∏–∂—Ñ–∞—Ä–º¬ª) –∏ –ê—Ä—Ç–æ–≥–∏—Å—Ç–∞–Ω (¬´–ì—Ä–æ—Ç–µ–∫—Å¬ª). –ü–æ–º–∏–º–æ –ø–µ—Ä–µ—á–∏—Å–ª–µ–Ω–Ω—ã—Ö –±—Ä–µ–Ω–¥–æ–≤ –≤ —Ç–æ–ø-10 —Ç–∞–∫–∂–µ –ø–æ–ø–∞–ª–∏: –†—É–º–∞–ª–æ–Ω (¬´–†–æ–º—Ñ–∞—Ä–º¬ª), –¢–µ—Ä–∞—Ñ–ª–µ–∫—Å (¬´–ë–∞–π–µ—Ä¬ª), –î–æ–Ω–∞ (¬´–ú–µ–¥–∞ –§–∞—Ä–º¬ª). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The market for joint protectors is growing, with injections accounting for the majority of sales. In Q3 2025, Russia purchased over 7.9 million units of joint protectors, up by 2.3% year-over-year in nominal terms and 13.3% in monetary terms. The bulk of the market is accounted for by injectable forms, which are driving growth in the category. The main brands include Alflutop (Biotechnos from Romania), Xindonguard (Sotexx), and Yuxian (Ellara). Negative growth is observed for Artra (Nizfarma) and Artogistan (Grotex). Other top brands include Rumalon (Romaflarm), Teraflex (Bayer), and Dona (Meda Pharma).""
}"
2025-11-10T14:31:59+00:00,@bezrec,6800,https://t.me/bezrec/6800,"–°–µ–≥–æ–¥–Ω—è —Å —Ä—É–±—Ä–∏–∫–æ–π #–í–æ–ª—à–µ–±–Ω–∏–∫–∏–°—Ç—Ä–∞–Ω—ã–û–≠–ó –æ—Ç–ø—Ä–∞–≤–ª—è–µ–º—Å—è –≤ –¢–æ–º—Å–∫. –ü–æ–≤–æ–¥ –¥–∞–ª–∞ –≤—Ö–æ–¥—è—â–∞—è –≤ –ì–ö ¬´–ê–º–µ–¥–∞—Ä—Ç¬ª –∫–æ–º–ø–∞–Ω–∏—è ¬´–ê–º–µ—Ö–∏–º¬ª, –∫–æ—Ç–æ—Ä–∞—è —Å—Ç–∞–ª–∞ 55 —Ä–µ–∑–∏–¥–µ–Ω—Ç–æ–º –û–≠–ó ¬´–¢–æ–º—Å–∫¬ª. –ì—É–±–µ—Ä–Ω–∞—Ç–æ—Ä —Ä–µ–≥–∏–æ–Ω–∞ –í–ª–∞–¥–∏–º–∏—Ä –ú–∞–∑—É—Ä –∏ —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª–∏ —Ö–æ–ª–¥–∏–Ω–≥–∞ —Å–µ–≥–æ–¥–Ω—è –¥–æ–≥–æ–≤–æ—Ä–∏–ª–∏—Å—å –æ —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–µ –≤ –¢–æ–º—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ø–æ–ª–Ω–æ–≥–æ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ —Ü–∏–∫–ª–∞. –ü—Ä–æ–µ–∫—Ç –±—É–¥–µ—Ç —Ä–µ–∞–ª–∏–∑–æ–≤–∞–Ω –≤ –¥–≤–∞ —ç—Ç–∞–ø–∞: üü© –≤ —Ä–∞–º–∫–∞—Ö –ø–µ—Ä–≤–æ–≥–æ –Ω–∞ —É—á–∞—Å—Ç–∫–µ –ø–ª–æ—â–∞–¥—å—é 2,24 –≥–∞ —Å–æ–∑–¥–∞–¥—É—Ç –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –∞–∫—Ç–∏–≤–Ω—ã—Ö —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö —Å—É–±—Å—Ç–∞–Ω—Ü–∏–π; üü© –≤—Ç–æ—Ä–æ–π –ø—Ä–µ–¥–ø–æ–ª–∞–≥–∞–µ—Ç —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–æ –∑–∞–≤–æ–¥–∞ –ø–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤—É –≥–æ—Ç–æ–≤—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Ñ–æ—Ä–º. –°—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–æ –ø–ª–∞–Ω–∏—Ä—É—é—Ç –∑–∞–∫–æ–Ω—á–∏—Ç—å –∫ 2036 –≥–æ–¥—É. –û–±—ä—ë–º –ø–µ—Ä–≤–æ–Ω–∞—á–∞–ª—å–Ω—ã—Ö –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–π –æ—Ü–µ–Ω–∏–≤–∞–µ—Ç—Å—è –±–æ–ª–µ–µ —á–µ–º –≤ 2 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –°–æ–≤–æ–∫—É–ø–Ω—ã–µ –Ω–∞–ª–æ–≥–æ–≤—ã–µ –ø–æ—Å—Ç—É–ø–ª–µ–Ω–∏—è –≤ –±—é–¥–∂–µ—Ç —Ä–µ–≥–∏–æ–Ω–∞ –ø—Ä–µ–≤—ã—Å—è—Ç 1 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –î–µ–Ω—å–≥–∏ –ø–æ–π–¥—É—Ç –Ω–∞ —Å–æ—Ü–∏–∞–ª—å–Ω–æ-—ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–µ —Ä–∞–∑–≤–∏—Ç–∏–µ. –ù–∞ –Ω–æ–≤–æ–º –∑–∞–≤–æ–¥–µ –≤ –¢–æ–º—Å–∫–µ –±—É–¥—É—Ç –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç—å –∂–∏–∑–Ω–µ–Ω–Ω–æ –≤–∞–∂–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –æ—Ç –æ–Ω–∫–æ–ª–æ–≥–∏–∏, –¥–∏–∞–±–µ—Ç–∞ –∏ –í–ò–ß. –£ ¬´–ê–º–µ–¥–∞—Ä—Ç–∞¬ª —É–∂–µ –µ—Å—Ç—å –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –≤ –û–≠–ó ¬´–¢–µ—Ö–Ω–æ–ø–æ–ª–∏—Å –ú–æ—Å–∫–≤–∞¬ª. –í—Ç–æ—Ä–∞—è –ø–ª–æ—â–∞–¥–∫–∞, –ø–æ —Å–ª–æ–≤–∞–º –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–µ–π –∫–æ–º–ø–∞–Ω–∏–∏, –Ω—É–∂–Ω–∞, —á—Ç–æ–±—ã —É–≥–ª—É–±–∏—Ç—å –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏—é –∑–∞ —Å—á—ë—Ç –≤—ã–ø—É—Å–∫–∞ —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏–π. –°–µ–π—á–∞—Å –ø–æ—Ä—Ç—Ñ–µ–ª—å –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è –Ω–∞—Å—á–∏—Ç—ã–≤–∞–µ—Ç –±–æ–ª–µ–µ 60 –≤–∏–¥–æ–≤ –ª–µ–∫–∞—Ä—Å—Ç–≤. –ï–≥–æ –¥–æ–ª—è –Ω–∞ –≤–Ω—É—Ç—Ä–µ–Ω–Ω–µ–º —Ñ–∞—Ä–º—Ä—ã–Ω–∫–µ –ø–æ –∏—Ç–æ–≥–∞–º 2024 –≥–æ–¥–∞ —Å–æ—Å—Ç–∞–≤–∏–ª–∞ 0,7%. –ü–æ –º–Ω–µ–Ω–∏—é –∞–Ω–∞–ª–∏—Ç–∏–∫–æ–≤, –Ω–æ–≤—ã–π –∑–∞–≤–æ–¥ –≤ –¢–æ–º—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –ø–æ–º–æ–∂–µ—Ç –Ω–∞—Ä–∞—Å—Ç–∏—Ç—å —ç—Ç–æ—Ç –ø–æ–∫–∞–∑–∞—Ç–µ–ª—å –≤ 2,5 —Ä–∞–∑–∞, –¥–æ –±–æ–ª–µ–µ 2%. –ü–æ –¥–∞–Ω–Ω—ã–º Rusprofile, ¬´–ê–º–µ–¥–∞—Ä—Ç¬ª —Ä–∞–±–æ—Ç–∞–µ—Ç –≤ —Å—Ñ–µ—Ä–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ —Å 2009 –≥–æ–¥–∞. –ì–µ–Ω–µ—Ä–∞–ª—å–Ω—ã–π –¥–∏—Ä–µ–∫—Ç–æ—Ä –ê–Ω–¥—Ä–µ–π –ö–æ–ª–æ–∫–æ–ª—å—Ü–æ–≤ –≤–æ–∑–≥–ª–∞–≤–ª—è–µ—Ç –∫–æ–º–ø–∞–Ω–∏—é —Å 2018 –≥–æ–¥–∞. –£—á—Ä–µ–¥–∏—Ç–µ–ª—è–º–∏ —á–∏—Å–ª—è—Ç—Å—è –ê–ª–µ–∫—Å–µ–π –ò–≥–Ω–∞—Ç—å–µ–≤ (51% –¥–æ–ª–∏) –∏ –ê–ª–µ–∫—Å–µ–π –ö–æ–ª–æ–∫–æ–ª—å—Ü–æ–≤ (49%). –° —Ñ–∏–Ω–∞–Ω—Å–∞–º–∏ —É ¬´–ê–º–µ–¥–∞—Ä—Ç–∞¬ª –ø–æ—Ä—è–¥–æ–∫. –í—ã—Ä—É—á–∫–∞ –≤ 2024 –≥–æ–¥—É —Å–æ—Å—Ç–∞–≤–∏–ª–∞ 2,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —É–≤–µ–ª–∏—á–∏–≤—à–∏—Å—å –Ω–∞ 53% –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å 2023 –≥–æ–¥–æ–º. –ß–∏—Å—Ç–∞—è –ø—Ä–∏–±—ã–ª—å –≤—ã—Ä–æ—Å–ª–∞ –Ω–∞ 13% ‚Äî –¥–æ 1,2 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –†–µ–Ω—Ç–∞–±–µ–ª—å–Ω–æ—Å—Ç—å –ø–æ —á–∏—Å—Ç–æ–π –ø—Ä–∏–±—ã–ª–∏ –≤—ã—Å–æ–∫–∞—è ‚Äî 44%, —á—Ç–æ –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ –ø—Ä–µ–≤—ã—à–∞–µ—Ç —Å—Ä–µ–¥–Ω–∏–π –æ—Ç—Ä–∞—Å–ª–µ–≤–æ–π –ø–æ–∫–∞–∑–∞—Ç–µ–ª—å (-22%). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance, safety"",
  ""impact"": ""high"",
  ""english"": ""Amedart, a pharmaceutical company with headquarters in Moscow, announced plans to build a second production facility in Tomsk, Russia. The project involves the construction of an active pharmaceutical ingredients (API) production facility and a finished drug manufacturing plant. The project is expected to be completed by 2036, with investments exceeding 2 billion rubles. The company aims to produce essential drugs for oncology, diabetes, and HIV in the new facility. Amedart has a production portfolio of over 60 drug types, with market share projected to increase by 2.5 times in Russia by 2024, from a current share of 0.7%. The company's financial performance is strong with revenue growing by 53% in 2024 compared to the previous year. The company's profitability is high at 44% of net profit, significantly above the industry average (-22%).""
}"
2025-11-10T12:03:25+00:00,@bezrec,6799,https://t.me/bezrec/6799,"–†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä –æ–ø—Ä–æ–≤–µ—Ä–≥ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é –æ –ø–µ—Ä–µ–±–æ—è—Ö —Å –ø–æ—Å—Ç–∞–≤–∫–∞–º–∏ –≤–∞–∫—Ü–∏–Ω—ã –æ—Ç —Ä–æ—Ç–∞–≤–∏—Ä—É—Å–Ω–æ–π –∏–Ω—Ñ–µ–∫—Ü–∏–∏. –û –ø—Ä–æ–±–ª–µ–º–∞—Ö —Å –Ω–∞–ª–∏—á–∏–µ–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –∫–∞–∫ –º–∏–Ω–∏–º—É–º –≤ –≤–æ—Å—å–º–∏ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö —Ä–µ–≥–∏–æ–Ω–∞—Ö —Ä–∞–Ω–µ–µ –ø–∏—Å–∞–ª–∏ ¬´–ò–∑–≤–µ—Å—Ç–∏—è¬ª. –ü–æ –¥–∞–Ω–Ω—ã–º —Ä–µ–≥—É–ª—è—Ç–æ—Ä–∞, —Å —è–Ω–≤–∞—Ä—è –ø–æ –æ–∫—Ç—è–±—Ä—å –≤ –≥—Ä–∞–∂–¥–∞–Ω—Å–∫–∏–π –æ–±–æ—Ä–æ—Ç –≤–≤–µ–¥–µ–Ω–æ –±–æ–ª–µ–µ 545 —Ç—ã—Å. —É–ø–∞–∫–æ–≤–æ–∫ –≤–∞–∫—Ü–∏–Ω—ã. –≠—Ç–æ –±–æ–ª—å—à–µ, —á–µ–º –∑–∞ –≤–µ—Å—å –ø—Ä–æ—à–ª—ã–π –≥–æ–¥ (363 —Ç—ã—Å.). –ù–∞ —Å–µ–≥–æ–¥–Ω—è—à–Ω–∏–π –¥–µ–Ω—å –ø–æ –¥–∞–Ω–Ω—ã–º —Å–∏—Å—Ç–µ–º—ã –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –æ—Å—Ç–∞—Ç–∫–∏ –≤–∞–∫—Ü–∏–Ω—ã –¥–ª—è –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ —Ä–æ—Ç–∞–≤–∏—Ä—É—Å–Ω–æ–π –∏–Ω—Ñ–µ–∫—Ü–∏–∏ —Å–æ—Å—Ç–∞–≤–ª—è—é—Ç —Å–≤—ã—à–µ 180 —Ç—ã—Å. —É–ø–∞–∫–æ–≤–æ–∫, –±–æ–ª—å—à–∞—è —á–∞—Å—Ç—å –∏–∑ –Ω–∏—Ö - –≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —É—á—Ä–µ–∂–¥–µ–Ω–∏—è—Ö –∏ –Ω–∞ —Å–∫–ª–∞–¥–∞—Ö –¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–æ–≤, - –≥–æ–≤–æ—Ä–∏—Ç—Å—è –≤ —Å–æ–æ–±—â–µ–Ω–∏–∏ –≤–µ–¥–æ–º—Å—Ç–≤–∞. –ù–∞ –¥–∞–Ω–Ω—ã–π –º–æ–º–µ–Ω—Ç –≤ –†–æ—Å—Å–∏–∏ –æ—Ç —Ä–æ—Ç–∞–≤–∏—Ä—É—Å–∞ –≤–∞–∫—Ü–∏–Ω–∏—Ä—É—é—Ç –†–æ—Ç–∞-V-–≠–π–¥ –∏–Ω–¥–∏–π—Å–∫–æ–π Serum Institute. –†–∞–Ω—å—à–µ –±—ã–ª–∞ –µ—â—ë –†–æ—Ç–∞–¢–µ–∫ –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–π MSD, –Ω–æ –ø–æ—Å–ª–µ–¥–Ω–∏–µ –æ—Ç–≥—Ä—É–∑–∫–∏ —ç—Ç–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ —Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–ª–∏—Å—å –≤ 2023 –≥–æ–¥—É. –í –ù–∞—Ü–∫–∞–ª–µ–Ω–¥–∞—Ä–µ –ø—Ä–∏–≤–∏–≤–∫–∏ –æ—Ç —Ä–æ—Ç–∞–≤–∏—Ä—É—Å–∞ –ø–æ–∫–∞ –Ω–µ—Ç. ¬´–§–∞—Ä–º –≠–π–¥¬ª ‚Äî –¥–µ—Ä–∂–∞—Ç–µ–ª—å –†–£ –Ω–∞ –†–æ—Ç–∞-V-–≠–π–¥ ‚Äî –æ–±–µ—â–∞–µ—Ç –ª–æ–∫–∞–ª–∏–∑–æ–≤–∞—Ç—å –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –≤ –∏–Ω–¥—É—Å—Ç—Ä–∏–∞–ª—å–Ω–æ–º –ø–∞—Ä–∫–µ –Ω–∞ –≥—Ä–∞–Ω–∏—Ü–µ –ú–æ—Å–∫–æ–≤—Å–∫–æ–π –∏ –ö–∞–ª—É–∂—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–µ–π, –Ω–æ —Ç–æ—á–Ω—ã—Ö –¥–∞—Ç –Ω–µ –Ω–∞–∑—ã–≤–∞–µ—Ç. –ù–∞ –ø–æ–¥—Ö–æ–¥–µ –∏ —Ä–æ—Å—Å–∏–π—Å–∫–∏–π –ø—Ä–µ–ø–∞—Ä–∞—Ç. –ü–æ –Ω–µ–º—É –∫–æ–Ω–∫—Ä–µ—Ç–∏–∫–∏ –±–æ–ª—å—à–µ ‚Äì —Å–µ–π—á–∞—Å –ì–∞–º-VLP-—Ä–æ—Ç–∞ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –¶–µ–Ω—Ç—Ä–∞ –∏–º. –ì–∞–º–∞–ª–µ–∏ –¥–ª—è –¥–µ—Ç–µ–π –æ—Ç 8 –¥–æ 32 –Ω–µ–¥–µ–ª—å –Ω–∞—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ II-III —Ñ–∞–∑–µ –ö–ò. –ò—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –¥–ª—è –¥–µ—Ç–µ–π —Å—Ç–∞—Ä—à–µ–≥–æ –≤–æ–∑—Ä–∞—Å—Ç–∞ —É–∂–µ –∑–∞–≤–µ—Ä—à–µ–Ω—ã. –ø–æ–ª—É—á–∏—Ç—å —Ä–µ–≥—É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏–µ —É–∂–µ –≤ —Å–ª–µ–¥—É—é—â–µ–º –≥–æ–¥—É. #–≤—Å—ë–ø—É—Ç—ë–º ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, shortage"",
  ""impact"": ""medium"",
  ""english"": ""Russia's Roszdranad–∑–æ—Ä has denied reports of supply disruptions for the rotavirus vaccine. The regulator states that more than 545,000 doses have been administered from January to October. Approximately 180,000 vaccine units remain in stock, mainly at medical institutions and distribution centers. The country is currently vaccinating with Rota-V-Eid, an Indian product from Serum Institute. Previous vaccine supplier MSD's shipments have been recorded in 2023. The company Farma-Eid promises to localize production of Rota-V-Eid in an industrial park on the border between Moscow and Kaluga regions, but no specific dates have been provided. The Russian vaccine Gam-VLP-Rota for older children is in the II-III phase of clinical trials and expected to receive approval next year.""
}"
2025-11-10T09:08:55+00:00,@bezrec,6798,https://t.me/bezrec/6798,"–†–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –æ—Ç –æ–∂–∏—Ä–µ–Ω–∏—è Metsera –¥–æ—Å—Ç–∞–Ω–µ—Ç—Å—è Pfizer. –ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–π —Ñ–∞—Ä–º–≥–∏–≥–∞–Ω—Ç –≤—Å—ë-—Ç–∞–∫–∏ –≤—ã–∏–≥—Ä–∞–ª –±–∏—Ç–≤—É —Å Novo Nordisk, –ø—Ä–∞–≤–¥–∞ –∑–∞–ø–ª–∞—Ç–∏—Ç—å –∑–∞ –ø—Ä–µ–¥–º–µ—Ç —Å–ø–æ—Ä–∞ –ø—Ä–∏–¥—ë—Ç—Å—è $10 –º–ª—Ä–¥ –≤–º–µ—Å—Ç–æ $7,3 –º–ª—Ä–¥. –ù–∞–ø–æ–º–Ω–∏–º, Pfizer —É–∂–µ –∏–º–µ–ª –Ω–∞ —Ä—É–∫–∞—Ö –ø—Ä–µ–¥–≤–∞—Ä–∏—Ç–µ–ª—å–Ω–æ–µ –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å–Ω–æ–µ –æ–¥–æ–±—Ä–µ–Ω–∏–µ –§–µ–¥–µ—Ä–∞–ª—å–Ω–æ–π —Ç–æ—Ä–≥–æ–≤–æ–π –∫–æ–º–∏—Å—Å–∏–∏ –°–®–ê, –Ω–æ –¥–∞—Ç—á–∞–Ω–µ ¬´–ø–µ—Ä–µ–±–∏–ª–∏¬ª —Ü–µ–Ω—É –∞–º–µ—Ä–∏–∫–∞–Ω—Ü–µ–≤, –ø—Ä–µ–¥–ª–æ–∂–∏–≤ $8,5 –º–ª—Ä–¥, —á—Ç–æ –¥–∞–∂–µ —Å—Ç–∞–ª–æ –ø—Ä–∏—á–∏–Ω–æ–π –¥–ª—è —Å—É–¥–µ–±–Ω–æ–≥–æ —Ä–∞–∑–±–∏—Ä–∞—Ç–µ–ª—å—Å—Ç–≤–∞. –ê–º–µ—Ä–∏–∫–∞–Ω—Ü–∞–º –ø—Ä–∏—à–ª–æ—Å—å –ø—Ä–æ–¥—É–º–∞—Ç—å –±–æ–ª–µ–µ –≤—ã–≥–æ–¥–Ω—ã–µ —É—Å–ª–æ–≤–∏—è –¥–ª—è –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω–æ–π —Å–¥–µ–ª–∫–∏. –í –∏—Ç–æ–≥–µ (—Å —É—á—ë—Ç–æ–º –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã—Ö –≤—ã–ø–ª–∞—Ç) –æ–¥–Ω–∞ –∞–∫—Ü–∏—è Metsera –º–æ–∂–µ—Ç –æ–±–æ–π—Ç–∏—Å—å Pfizer –≤ $86,25. –ü—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–µ —É—Å—Ç—Ä–æ–∏–ª–æ —Å–æ–≤–µ—Ç –¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–≤ Metsera, –∑–∞–∫—Ä—ã—Ç—å —Å–¥–µ–ª–∫—É –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è —Å—Ä–∞–∑—É –ø–æ—Å–ª–µ —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ–≥–æ —Å–æ–±—Ä–∞–Ω–∏—è –∞–∫—Ü–∏–æ–Ω–µ—Ä–æ–≤ 13 –Ω–æ—è–±—Ä—è. –í Novo Nordisk –∑–∞—è–≤–∏–ª–∏, —á—Ç–æ –≤—ã—Ö–æ–¥—è—Ç –∏–∑ –±–æ—Ä—å–±—ã. –≠—Ç–æ –Ω–µ –ø–µ—Ä–≤–∞—è –ø–æ–ø—ã—Ç–∫–∞ Pfizer –≤–ª–∏—Ç—å—Å—è –≤ ¬´—Ç—ë–ø–ª—É—é¬ª –∫–æ–º–ø–∞–Ω–∏—é –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ª–µ–∫–∞—Ä—Å—Ç–≤ –æ—Ç –æ–∂–∏—Ä–µ–Ω–∏—è. –ü–æ—Å–ª–µ–¥–Ω—è—è –∑–∞–∫–æ–Ω—á–∏–ª–∞—Å—å –Ω–µ—É–¥–∞—á–Ω–æ ‚Äì —Ñ–∞—Ä–º–≥–∏–≥–∞–Ω—Ç –æ—Ç–∫–∞–∑–∞–ª—Å—è –æ—Ç —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ —Å–≤–æ–µ–≥–æ –Ω–∏–∑–∫–æ–º–æ–ª–µ–∫—É–ª—è—Ä–Ω–æ–≥–æ –∞–≥–æ–Ω–∏—Å—Ç–∞ GLP-1, –∫–æ—Ç–æ—Ä—ã–π –¥–æ–ª–∂–µ–Ω –±—ã–ª —Å—Ç–∞—Ç—å –ø–µ—Ä–æ—Ä–∞–ª—å–Ω–æ–π –∞–ª—å—Ç–µ—Ä–Ω–∞—Ç–∏–≤–æ–π –û–∑–µ–º–ø–∏–∫—É. –î–∞–Ω—É–≥–ª–∏–ø—Ä–æ–Ω, —Å—É–ª–∏–≤—à–∏–π —Ñ–∞—Ä–º–≥–∏–≥–∞–Ω—Ç—É –º–∏–ª–ª–∏–∞—Ä–¥—ã, –ø–æ–≥–æ—Ä–µ–ª –Ω–∞ ¬´–ø–µ—á—ë–Ω–æ—á–Ω—ã—Ö¬ª –ø–æ–±–æ—á–∫–∞—Ö. –ê–Ω–∞–ª–∏—Ç–∏–∫–∏ —Ç–æ–≥–¥–∞ –ø—Ä–µ–¥–ø–æ–ª–æ–∂–∏–ª–∏, —á—Ç–æ Pfizer –Ω–∞—á–Ω—ë—Ç ¬´–æ—Ö–æ—Ç—É¬ª –∑–∞ –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–Ω—ã–º–∏ –∫–æ–º–ø–∞–Ω–∏—è–º–∏ —Å–æ —Å–≤–æ–∏–º–∏ –Ω–∞—Ä–∞–±–æ—Ç–∫–∞–º–∏ –≤ —ç—Ç–æ–π –æ–±–ª–∞—Å—Ç–∏ –¥–ª—è –∏—Ö –¥–∞–ª—å–Ω–µ–π—à–µ–≥–æ –ø–æ–≥–ª–æ—â–µ–Ω–∏—è. –ò –Ω–µ –æ—à–∏–±–ª–∏—Å—å. –ü–æ–∫—É–ø–∫–∞ –¥–∞—ë—Ç –∞–º–µ—Ä–∏–∫–∞–Ω—Ü–∞–º –ø—Ä–∞–≤–∞ –Ω–∞ –∏–Ω—ä–µ–∫—Ü–∏–æ–Ω–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç MET-097i. –ï–≥–æ –ø—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–æ ‚Äì –≤ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ –≤–≤–µ–¥–µ–Ω–∏—è —Ä–∞–∑ –≤ –º–µ—Å—è—Ü. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-11-10T05:35:02+00:00,@bezrec,6797,https://t.me/bezrec/6797,"–ü—Ä–æ–¥–∞–∂–∏ –æ–±–µ–∑–±–æ–ª–∏–≤–∞—é—â–∏—Ö –æ–Ω–ª–∞–π–Ω –Ω–∞–±–∏—Ä–∞—é—Ç –æ–±–æ—Ä–æ—Ç—ã. –ü–æ –¥–∞–Ω–Ω—ã–º DSM Group, –∑–∞ –¥–µ–≤—è—Ç—å –º–µ—Å—è—Ü–µ–≤ –±—ã–ª–æ –ø—Ä–æ–¥–∞–Ω–æ –±–æ–ª–µ–µ 400 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ –æ–±–µ–∑–±–æ–ª–∏–≤–∞—é—â–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ 117,5 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –≠—Ç–æ –Ω–∞ 11% –±–æ–ª—å—à–µ –≤ –¥–µ–Ω–µ–∂–Ω–æ–º –∏ –Ω–∞ 1% –º–µ–Ω—å—à–µ –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ –≥–æ–¥ –∫ –≥–æ–¥—É. –ö–∞–∫ –ø–∏—à–µ—Ç ¬´–™¬ª, —Ä–æ—Å—Ç—É –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ —Å–ø–æ—Å–æ–±—Å—Ç–≤—É—é—Ç –ø—Ä–æ–¥–∞–∂–∏ —á–µ—Ä–µ–∑ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç. –ò—Ö –¥–æ–ª—è –ø–æ–∫–∞ –Ω–µ–≤–µ–ª–∏–∫–∞ (–≤—Å–µ–≥–æ 7%), –Ω–æ –æ–Ω–ª–∞–π–Ω-–∫–∞–Ω–∞–ª –≤ —è–Ω–≤–∞—Ä–µ-—Å–µ–Ω—Ç—è–±—Ä–µ –ø–æ–∫–∞–∑–∞–ª —Ä–æ—Å—Ç –Ω–∞ 30% –≤ –¥–µ–Ω—å–≥–∞—Ö –∏ –Ω–∞ 21% ‚Äî –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö. –ù–∞—Ä—è–¥—É —Å –æ–±–µ–∑–±–æ–ª–∏–≤–∞—é—â–∏–º–∏ –∫–ª–∏–µ–Ω—Ç—ã –æ–Ω–ª–∞–π–Ω-–∞–ø—Ç–µ–∫ –ø–æ–∫—É–ø–∞—é—Ç –Ω–∞–∑–∞–ª—å–Ω—ã–µ –∫–∞–ø–ª–∏, –∂–∞—Ä–æ–ø–æ–Ω–∏–∂–∞—é—â–∏–µ, –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–ª—è –∂–µ–ª—É–¥–∫–∞. –ü–æ —Å–ª–æ–≤–∞–º –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –ø–æ —Ä–∞–∑–≤–∏—Ç–∏—é RNC Pharma –ù–∏–∫–æ–ª–∞—è –ë–µ—Å–ø–∞–ª–æ–≤–∞, —Ä–æ—Å—Å–∏—è–Ω–µ –ø–æ—Å—Ç–µ–ø–µ–Ω–Ω–æ –ø–µ—Ä–µ—Ö–æ–¥—è—Ç —Å –Ω–µ–∫–æ–≥–¥–∞ –ø–æ–ø—É–ª—è—Ä–Ω—ã—Ö –∞–Ω–∞–ª—å–≥–µ—Ç–∏–∫–æ–≤ –Ω–∞ –Ω–µ—Å—Ç–µ—Ä–æ–∏–¥–Ω—ã–µ –ø—Ä–æ—Ç–∏–≤–æ–≤–æ—Å–ø–∞–ª–∏—Ç–µ–ª—å–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã (–ù–ü–í–ü). –ü—Ä–æ–¥–∞–∂–∏ –ø–∞—Ä–∞—Ü–µ—Ç–∞–º–æ–ª–∞, –∞—Ü–µ—Ç–∏–ª—Å–∞–ª–∏—Ü–∏–ª–æ–≤–æ–π –∫–∏—Å–ª–æ—Ç—ã, –ü–µ–Ω—Ç–∞–ª–≥–∏–Ω–∞ –∏ –¶–∏—Ç—Ä–∞–º–æ–Ω–∞ —Å–Ω–∏–∑–∏–ª–∏—Å—å –Ω–∞ 3,1% –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ –≥–æ–¥ –∫ –≥–æ–¥—É, —Ç–æ–≥–¥–∞ –∫–∞–∫ —Å–ø—Ä–æ—Å –Ω–∞ –ù–ü–í–ü –≤—ã—Ä–æ—Å –Ω–∞ 7,7%, —á—Ç–æ –æ–±—ä—è—Å–Ω—è–µ—Ç—Å—è –∏—Ö –±–æ–ª–µ–µ —à–∏—Ä–æ–∫–∏–º —Å–ø–µ–∫—Ç—Ä–æ–º –¥–µ–π—Å—Ç–≤–∏—è. –¢–∞–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –Ω–µ —Ç–æ–ª—å–∫–æ –∫—É–ø–∏—Ä—É—é—Ç –±–æ–ª—å, –Ω–æ –∏ –æ–∫–∞–∑—ã–≤–∞—é—Ç –ª–µ—á–µ–±–Ω—ã–π —ç—Ñ—Ñ–µ–∫—Ç. –í —Ç–æ–ø-5 —Å–∞–º—ã—Ö –ø–æ–ø—É–ª—è—Ä–Ω—ã—Ö –æ–±–µ–∑–±–æ–ª–∏–≤–∞—é—â–∏—Ö –≤–æ—à–ª–∏: –ù—É—Ä–æ—Ñ–µ–Ω, –¢–µ—Ä–∞—Ñ–ª—é, –ü–µ–Ω—Ç–∞–ª–≥–∏–Ω, –ù–∏–º–µ—Å–∏–ª –∏ –ù–∞–π–∑. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""Online sales of analgesics are growing. According to DSM Group data, over 400 million units of analgesic drugs were sold for about 117.5 billion rubles in the first nine months, a year-over-year increase of 11% in nominal terms and 1% in monetary terms. The growth is attributed to online sales, which grew by 30% in nominal terms and 21% in units. The category is also driven by nasal drops, antipyretics, and stomach medications. Sales of paracetamol, aspirin, Pentalgin, and Cytromon decreased by 3.1% in nominal terms year-over-year, while the demand for non-steroidal anti-inflammatory drugs (NSAIDs) increased by 7.7%, reflecting their broader therapeutic spectrum.""
}"
2025-11-09T10:59:58+00:00,@bezrec,6796,https://t.me/bezrec/6796,"–ë–ê–î—ã –ø–æ–º–æ–≥–ª–∏ –Ω–æ–≤–æ–∑–µ–ª–∞–Ω–¥—Ü—É ¬´–ø–µ—Ä–µ—Å–ø–∞—Ç—å¬ª –ª–µ–Ω–∏–≤—Ü–∞. –ù–æ–≤–æ–∑–µ–ª–∞–Ω–¥—Å–∫–∏–π –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å –ë–ê–î–æ–≤ Healtheries –ø—Ä–æ–≤—ë–ª ¬´—Å–æ–Ω–Ω—ã–π¬ª —á–µ–º–ø–∏–æ–Ω–∞—Ç –º–µ–∂–¥—É —á–µ–ª–æ–≤–µ–∫–æ–º –∏ –ª–µ–Ω–∏–≤—Ü–µ–º. –ö –≤–æ–ø—Ä–æ—Å—É –ø–æ–¥–æ—à–ª–∏ —Å–µ—Ä—å—ë–∑–Ω–æ ‚Äì —á—Ç–æ–±—ã –≤—ã–±—Ä–∞—Ç—å –ø–æ–¥—Ö–æ–¥—è—â–µ–≥–æ –∫–∞–Ω–¥–∏–¥–∞—Ç–∞ –æ—Ç –º–∏—Ä–∞ –ª—é–¥–µ–π, –ø—Ä–æ–≤–µ–ª–∏ —Ü–µ–ª—ã–π –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—ã–π –∫–∞—Å—Ç–∏–Ω–≥. –ü–æ–±–µ–¥–∏—Ç–µ–ª—è ‚Äì —é—Ä–∏—Å—Ç–∞ –≠–Ω–¥–∏ –§—Ä–∞–Ω–∫–ª–µ—Ç–∞ ‚Äì –æ—Ç–ø—Ä–∞–≤–∏–ª–∏ –≤ –ö–æ—Å—Ç–∞-–†–∏–∫—É, –ø—Ä–µ–¥–≤–∞—Ä–∏—Ç–µ–ª—å–Ω–æ –≤—ã–¥–∞–≤ –ë–ê–î—ã —Å –º–µ–ª–∞—Ç–æ–Ω–∏–Ω–æ–º, —á—Ç–æ–±—ã –ª—É—á—à–µ —Å–ø–∞–ª–æ—Å—å. –ó–∞ —Å–æ—Å—Ç—è–∑–∞–Ω–∏–µ–º –≤ —Å–æ—Ü—Å–µ—Ç—è—Ö —Å–ª–µ–¥–∏–ª–∏ –ø–æ—á—Ç–∏ 2 –º–ª–Ω —á–µ–ª–æ–≤–µ–∫. –í –∏—Ç–æ–≥–µ –≠–Ω–¥–∏ –ø–æ–±–µ–¥–∏–ª —Å–≤–æ–µ–≥–æ —á–µ—Ç–≤–µ—Ä–æ–Ω–æ–≥–æ–≥–æ —Å–æ–ø–µ—Ä–Ω–∏–∫–∞, –∞ –ø—Ä–æ–¥–∞–∂–∏ –¥–æ–±–∞–≤–æ–∫ –æ—Ç Healtheries –≤—ã—Ä–æ—Å–ª–∏ –Ω–∞ 44%. –•–æ—Ä–æ—à–µ–µ —Å–æ—Ä–µ–≤–Ω–æ–≤–∞–Ω–∏–µ, –º—ã –±—ã –ø–æ—É—á–∞—Å—Ç–≤–æ–≤–∞–ª–∏. –£—à–ª–∏ —Ç—Ä–µ–Ω–∏—Ä–æ–≤–∞—Ç—å—Å—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-11-08T10:59:58+00:00,@bezrec,6795,https://t.me/bezrec/6795,"–†–∞–±–æ—á–∞—è –Ω–µ–¥–µ–ª—è –±—ã–ª–∞ –∫–æ—Ä–æ—Ç–∫–æ–π, –Ω–æ –Ω–æ–≤–æ—Å—Ç–µ–π –Ω–∞ –ø–æ–ª–Ω–æ—Ü–µ–Ω–Ω—ã–π –≤—ã–ø—É—Å–∫ #–≤–¥–æ–≥–æ–Ω–∫—É –Ω–∞–±—Ä–∞–ª–æ—Å—å. üíä –û–Ω –Ω–µ –Ω–∞—à! –í Novo Nordisk –æ–ø—Ä–æ–≤–µ—Ä–≥–ª–∏ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é –æ —Ç–æ–º, —á—Ç–æ –º—É–∂—á–∏–Ω–∞, —É–ø–∞–≤—à–∏–π –≤ –æ–±–º–æ—Ä–æ–∫ –≤–æ –≤—Ä–µ–º—è –≤—Å—Ç—Ä–µ—á–∏ —Å –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª—è–º–∏ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π –≤ –û–≤–∞–ª—å–Ω–æ–º –∫–∞–±–∏–Ω–µ—Ç–µ, - –ì–æ—Ä–¥–æ–Ω –§–∏–Ω–¥–ª–∏, –ø–æ—Å–∫–æ–ª—å–∫—É —Ç–æ—Ç –¥–∞–∂–µ –Ω–µ —É—á–∞—Å—Ç–≤–æ–≤–∞–ª –≤ –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–∏. –¢–µ–º –≤—Ä–µ–º–µ–Ω–µ–º, –∞–¥–º–∏–Ω–∏—Å—Ç—Ä–∞—Ü–∏—è –¢—Ä–∞–º–ø–∞ –¥–æ–≥–æ–≤–æ—Ä–∏–ª–∞—Å—å –æ —Å–Ω–∏–∂–µ–Ω–∏–∏ —Ü–µ–Ω –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –æ—Ç –æ–∂–∏—Ä–µ–Ω–∏—è –∏ –¥–∏–∞–±–µ—Ç–∞. –ú–µ—Å—è—á–Ω—ã–π –∫—É—Ä—Å –û–∑–µ–º–ø–∏–∫–∞ –∏ –í–µ–≥–æ–≤–∏ –æ–±–æ–π–¥—ë—Ç—Å—è –∞–º–µ—Ä–∏–∫–∞–Ω—Ü–∞–º –≤ $350 –≤–º–µ—Å—Ç–æ $1,3 —Ç—ã—Å., –∞ —Ç–∏—Ä–∑–µ–ø–∞—Ç–∏–¥ –æ—Ç Eli Lilly –±—É–¥–µ—Ç —Å—Ç–æ–∏—Ç—å $346 –≤–º–µ—Å—Ç–æ $1 —Ç—ã—Å. üíä –°–º–µ—Ä—Ç–Ω–æ—Å—Ç—å –æ—Ç –æ–Ω–∫–æ–ª–æ–≥–∏–∏ –≤ –†–æ—Å—Å–∏–∏ —Å–Ω–∏–∑–∏–ª–∞—Å—å –ø–æ—á—Ç–∏ –Ω–∞ 10%. –¢–∞–∫–∏–µ –¥–∞–Ω–Ω—ã–µ –æ–∑–≤—É—á–∏–ª –ú–∏—Ö–∞–∏–ª –ú—É—Ä–∞—à–∫–æ. –ü–æ —Å–ª–æ–≤–∞–º –≥–ª–∞–≤—ã –ú–∏–Ω–∑–¥—Ä–∞–≤–∞, –≤–∞–∂–Ω—É—é —Ä–æ–ª—å –∏–≥—Ä–∞–µ—Ç –≤–Ω–µ–¥—Ä–µ–Ω–∏–µ –∏–Ω–Ω–æ–≤–∞—Ü–∏–π –∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–µ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ. –í —ç—Ç–æ–π —Å—Ñ–µ—Ä–µ –Ω–µ–æ–±—Ö–æ–¥–∏–º–∞ —Å–æ–≤–º–µ—Å—Ç–Ω–∞—è —Ä–∞–±–æ—Ç–∞ –Ω–∞–¥ —É–ø—Ä–æ—â–µ–Ω–∏–µ–º –ø—Ä–æ—Ü–µ–¥—É—Ä –¥–æ–ø—É—Å–∫–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤, –≤–∫–ª—é—á–∞—è –∏ –¥–∂–µ–Ω–µ—Ä–∏–∫–∏, –∏ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã. üíä –í –ì–æ—Å–¥—É–º—É –≤–Ω–µ—Å—É—Ç –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ–± –∏–º–µ–Ω–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å–µ—Ä—Ç–∏—Ñ–∏–∫–∞—Ç–∞—Ö. –° –∏—Ö –ø–æ–º–æ—â—å—é –º–æ–∂–Ω–æ –±—É–¥–µ—Ç –ø–æ–ª—É—á–∞—Ç—å –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –Ω–∞ —Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–Ω–Ω—É—é —Å—É–º–º—É. –¢–∞–∫—É—é –ø–æ–º–æ—â—å –ø–ª–∞–Ω–∏—Ä—É—é—Ç –æ–∫–∞–∑—ã–≤–∞—Ç—å –º–∞–ª–æ–∏–º—É—â–∏–º —Å–µ–º—å—è–º, –º–∞–ª–æ–∏–º—É—â–∏–º –æ–¥–∏–Ω–æ–∫–æ –ø—Ä–æ–∂–∏–≤–∞—é—â–∏–º –≥—Ä–∞–∂–¥–∞–Ω–∞–º –∏ –æ–∫–∞–∑–∞–≤—à–∏–º—Å—è –≤ —Ç—Ä—É–¥–Ω–æ–π –∂–∏–∑–Ω–µ–Ω–Ω–æ–π —Å–∏—Ç—É–∞—Ü–∏–∏. –ü—Ä–µ–¥–ø–æ–ª–∞–≥–∞–µ–º—ã–π –Ω–æ–º–∏–Ω–∞–ª ‚Äì –æ–∫–æ–ª–æ 4,5 —Ç—ã—Å. —Ä—É–±–ª–µ–π. üíä –ó–∞–≤–µ—Ä—à–µ–Ω—ã –¥–æ–∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ –∏—Å–ø—ã—Ç–∞–Ω–∏—è –ø–µ—Ä–≤–æ–≥–æ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∫–ª–µ—Ç–æ—á–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –æ—Ç —É—Å—Ç–æ–π—á–∏–≤—ã—Ö –∫ —Å—Ç–∞–Ω–¥–∞—Ä—Ç–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ —Ñ–æ—Ä–º —Ä–∞–∫–∞ –º–æ–ª–æ—á–Ω–æ–π –∂–µ–ª–µ–∑—ã. –í –æ—Å–Ω–æ–≤–µ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –ª–µ–∂–∏—Ç –ø–µ—Ä–µ–¥–æ–≤–æ–π –º–µ—Ç–æ–¥ TCR-T-—Ç–µ—Ä–∞–ø–∏–∏, –∫–æ—Ç–æ—Ä—ã–π –ø–æ–∑–≤–æ–ª—è–µ—Ç –Ω–∞—Ö–æ–¥–∏—Ç—å –∫–ª–µ—Ç–∫–∏ —Å –º–æ–ª–µ–∫—É–ª–∞–º–∏-–º–∏—à–µ–Ω—è–º–∏ –≤ –æ—Ä–≥–∞–Ω–∏–∑–º–µ —á–µ–ª–æ–≤–µ–∫–∞. –í –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–µ —É—á–µ–Ω—ã–µ —Å–º–æ–≥—É—Ç –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å —ç—Ç—É —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—é –¥–ª—è —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –¥—Ä—É–≥–∏—Ö –æ–Ω–∫–æ–∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, - —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏ –≤ –ø—Ä–µ—Å—Å-—Å–ª—É–∂–±–µ –°–µ—á–µ–Ω–æ–≤—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞. üíä –†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä —Å–æ–∑–¥–∞–ª –ø–µ—Ä–≤—ã–π –≤ –º–∏—Ä–µ –±—ã—Å—Ç—Ä—ã–π —Ç–µ—Å—Ç –¥–ª—è –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∏ –≥–µ–ø–∞—Ç–∏—Ç–∞ –°. –†–∞–∑—Ä–∞–±–æ—Ç–∫–∞ –≤—ã—è–≤–ª—è–µ—Ç –≤–∏—Ä—É—Å –≤—Å–µ–≥–æ –∑–∞ 25-30 –º–∏–Ω—É—Ç –≤–º–µ—Å—Ç–æ –æ–±—ã—á–Ω—ã—Ö –ø–æ–ª—É—Ç–æ—Ä–∞-–¥–≤—É—Ö —á–∞—Å–æ–≤. üíä –¢—É–ª—å—Å–∫–∞—è —Å–µ—Ç—å ¬´–ó–¥–µ—Å—å –∞–ø—Ç–µ–∫–∞¬ª –∫—É–ø–∏–ª–∞ –∫—É–±–∞–Ω—Å–∫—É—é ¬´–ó–¥—Ä–∞–≤—Å–µ—Ä–≤–∏—Å –Æ–≥¬ª. –ó–∞ —Å–∫–æ–ª—å–∫–æ –∏ –Ω–∞ –∫–∞–∫–∏—Ö —É—Å–ª–æ–≤–∏—è—Ö ‚Äì –Ω–µ —Ä–∞—Å–∫—Ä—ã–≤–∞–µ—Ç—Å—è. –ö–æ–º–ø–∞–Ω–∏—è ¬´–ó–¥—Ä–∞–≤—Å–µ—Ä–≤–∏—Å –Æ–≥¬ª –∑–∞–Ω–∏–º–∞–µ—Ç—Å—è –æ–ø—Ç–æ–≤–æ–π –ø—Ä–æ–¥–∞–∂–µ–π –ª–µ–∫–∞—Ä—Å—Ç–≤, –ë–ê–î–æ–≤, –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –∏ —Å–æ–ø—É—Ç—Å—Ç–≤—É—é—â–∏—Ö —Ç–æ–≤–∞—Ä–æ–≤ –∞–ø—Ç–µ–∫–∞–º. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,shortage,safety"",
  ""impact"": ""medium"",
  ""english"": ""The Russian mortality from cancer has decreased by almost 10%. This is according to Mikhail Murashko, the head of the Ministry of Health. The improvement is attributed to the implementation of innovations and pharmaceutical supplies. A law project on named drug certificates has been submitted to the State Duma. These certificates will help families in need and those living alone to obtain medications at a fixed cost of around 4,500 rubles. A first-of-its-kind cell therapy for metastatic breast cancer has been developed in Russia using the advanced TCR-T therapy. This technology can potentially be used to develop treatments for other types of cancer in the future. A rapid test for Hepatitis C has been created by Rospatent, making the diagnosis process faster than usual.""
}"
2025-11-07T15:59:58+00:00,@bezrec,6794,https://t.me/bezrec/6794,"–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—é –¥–æ–±–∞–≤—è—Ç —Å—Ä–µ–¥—Å—Ç–≤. –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –æ–¥–æ–±—Ä–∏–ª–æ –ø–æ–ø—Ä–∞–≤–∫–∏ –∫–æ –≤—Ç–æ—Ä–æ–º—É —á—Ç–µ–Ω–∏—é –ø—Ä–æ–µ–∫—Ç–∞ –±—é–¥–∂–µ—Ç–∞ –Ω–∞ 2026-2028 –≥–æ–¥—ã. –ü–æ —Å–ª–æ–≤–∞–º –≥–ª–∞–≤—ã –ú–∏–Ω—Ñ–∏–Ω–∞ –ê–Ω—Ç–æ–Ω–∞ –°–∏–ª—É–∞–Ω–æ–≤–∞, –≤ –æ–±—â–µ–π —Å–ª–æ–∂–Ω–æ—Å—Ç–∏ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –≤–Ω–µ—Å—Ç–∏ 590 –ø–æ–ø—Ä–∞–≤–æ–∫ –Ω–∞ —Å—É–º–º—É –±–æ–ª–µ–µ 7 —Ç—Ä–ª–Ω —Ä—É–±–ª–µ–π. –°–∫–æ–ª—å–∫–æ –ø–æ–π–¥—ë—Ç –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞: üíä 35 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π ‚Äì –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–ª—è 190 —Ç—ã—Å. –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –ø–æ 14 –≤—ã—Å–æ–∫–æ–∑–∞—Ç—Ä–∞—Ç–Ω—ã–º –Ω–æ–∑–æ–ª–æ–≥–∏—è–º; üíä 20 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π ‚Äî –Ω–∞ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–∏–µ –ø—Ä–∏–≤–∏–≤–∫–∏ –≤ —Ä–∞–º–∫–∞—Ö –Ω–∞—Ü–∫–∞–ª–µ–Ω–¥–∞—Ä—è, —ç—Ç–æ–≥–æ —Ö–≤–∞—Ç–∏—Ç –Ω–∞ –±–æ–ª–µ–µ —á–µ–º 140 –º–ª–Ω –¥–æ–∑ –≤–∞–∫—Ü–∏–Ω –¥–ª—è –≤–∑—Ä–æ—Å–ª—ã—Ö –∏ –¥–µ—Ç–µ–π –≤ –≥–æ–¥; üíä 9,5 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π ‚Äì –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –æ—Ç —Ç—É–±–µ—Ä–∫—É–ª–µ–∑–∞ –∏ –í–ò–ß; üíä 15 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –ø–æ–ª—É—á–∏—Ç ¬´–ö—Ä—É–≥ –¥–æ–±—Ä–∞¬ª –Ω–∞ –ª–µ—á–µ–Ω–∏–µ –¥–µ—Ç–µ–π —Å –æ—Ä—Ñ–∞–Ω–Ω—ã–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, reimbursement, pricing"",
  ""impact"": ""medium"",
  ""english"": ""The government approved amendments to the second reading of the budget for 2026-2028. According to Finance Minister Anton Siluanov, a total of 590 amendments are planned for over 7 trillion rubles. Among the allocations, 35 billion rubles will be spent on drugs for 190 thousand patients with 14 high-cost diseases; 20 billion rubles on preventive vaccinations as part of the national calendar, which will cover more than 140 million adult and child doses per year; 9.5 billion rubles will be allocated for tuberculosis and HIV treatments; and 15 billion rubles will go to 'The Kindness Circle' for treating children with rare diseases.""
}"
2025-11-07T11:31:31+00:00,@bezrec,6792,https://t.me/bezrec/6792,"–õ–µ–∫–∞—Ä—Å—Ç–≤–∞–º –Ω–∞ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞—Ö –º–æ–≥—É—Ç –æ—Ç–∫–ª—é—á–∏—Ç—å —Ä–µ–π—Ç–∏–Ω–≥–∏ –∏ –∫–æ–º–º–µ–Ω—Ç–∞—Ä–∏–∏. –î–æ–∫—É–º–µ–Ω—Ç —Å —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–µ–π –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–æ–π –°–æ—é–∑–∞ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç-—Ç–æ—Ä–≥–æ–≤–ª–∏ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω –¥–µ–ø—É—Ç–∞—Ç–∞–º –ì–æ—Å–¥—É–º—ã. –°–æ—é–∑ –ø–æ–¥–≥–æ—Ç–æ–≤–∏–ª —Ä—è–¥ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–π, –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–Ω—ã—Ö –Ω–∞ —Å–Ω–∏–∂–µ–Ω–∏–µ –∫–æ–ª–∏—á–µ—Å—Ç–≤–∞ –∫–æ–Ω—Ç—Ä–∞—Ñ–∞–∫—Ç–∞ —Å—Ä–µ–¥–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π –∏ –ë–ê–î–æ–≤, —Ä–µ–∞–ª–∏–∑—É–µ–º—ã—Ö —á–µ—Ä–µ–∑ –ø–æ–ø—É–ª—è—Ä–Ω—ã–µ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç-–ø–ª–æ—â–∞–¥–∫–∏. –°—Ä–µ–¥–∏ –Ω–æ–≤–æ–≤–≤–µ–¥–µ–Ω–∏–π - –±–ª–æ–∫–∏—Ä–æ–≤–∫–∞ —Ä–µ–π—Ç–∏–Ω–≥–æ–≤ –∏ –∫–æ–º–º–µ–Ω—Ç–∞—Ä–∏–µ–≤ –≤ —Ä–∞–∑–¥–µ–ª–∞—Ö —Å –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–º–∏ —Å—Ä–µ–¥—Å—Ç–≤–∞–º–∏ –∏ –ë–ê–î–∞–º–∏, - —Ä–∞—Å—Å–∫–∞–∑–∞–ª –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç –°–æ—é–∑–∞ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç-—Ç–æ—Ä–≥–æ–≤–ª–∏ –í–∏—Ç–∞–ª–∏–π –ì–∞–≤—Ä–∏–ª–æ–≤. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –≤ –∫–∞—Ä—Ç–æ—á–∫–∏ —Ç–∞–∫–∏—Ö —Ç–æ–≤–∞—Ä–æ–≤ –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è –¥–æ–±–∞–≤–ª—è—Ç—å –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—É—é –º–∞—Ä–∫–∏—Ä–æ–≤–∫—É, —á—Ç–æ–±—ã ¬´–ø–æ–∫—É–ø–∞—Ç–µ–ª—å –ø–æ–Ω–∏–º–∞–ª, —è–≤–ª—è–µ—Ç—Å—è –ª–∏ —Ç–æ–≤–∞—Ä –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º –∏–∑–¥–µ–ª–∏–µ–º –∏ –¥–æ–ª–∂–µ–Ω –ª–∏ –∏–º–µ—Ç—å —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–æ–Ω–Ω–æ–µ —Å–≤–∏–¥–µ—Ç–µ–ª—å—Å—Ç–≤–æ¬ª. –¢–∞–∫–∂–µ, –ø–æ —Å–ª–æ–≤–∞–º –ì–∞–≤—Ä–∏–ª–æ–≤–∞, –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–π –¥–æ–ª–∂–Ω–∞ —Å—Ç–∞—Ç—å –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è –æ —Ç–æ–º, —á—Ç–æ —É–∫–∞–∑–∞–Ω–Ω—ã–µ —Å—Ä–µ–¥—Å—Ç–≤–∞ –ø—Ä–∏–Ω–∏–º–∞—é—Ç—Å—è –ø–æ –Ω–∞–∑–Ω–∞—á–µ–Ω–∏—é –≤—Ä–∞—á–∞. –ß–µ–º –Ω–µ —É–≥–æ–¥–∏–ª–∏ –∫–æ–º–º–µ–Ω—Ç–∞—Ä–∏–∏? –í –°–æ—é–∑–µ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç-—Ç–æ—Ä–≥–æ–≤–ª–∏ –æ–±–µ—Å–ø–æ–∫–æ–µ–Ω—ã —Ç–µ–º, —á—Ç–æ –≤ –∫–æ–º–º–µ–Ω—Ç–∞—Ä–∏—è—Ö –∫ –Ω–µ–∫–æ—Ç–æ—Ä—ã–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º –≤—Å—Ç—Ä–µ—á–∞—é—Ç—Å—è ¬´–≤—Ä–µ–¥–Ω—ã–µ¬ª —Å–æ–≤–µ—Ç—ã, —Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –∫–æ—Ç–æ—Ä—ã–º –º–æ–∂–µ—Ç –±—ã—Ç—å –æ–ø–∞—Å–Ω–æ –¥–ª—è –∂–∏–∑–Ω–∏. –†–µ–π—Ç–∏–Ω–≥–∏ –∂–µ, –ø–æ –º–Ω–µ–Ω–∏—é –ì–∞–≤—Ä–∏–ª–æ–≤–∞, –∑–∞—á–∞—Å—Ç—É—é –Ω–µ –æ–±—ä–µ–∫—Ç–∏–≤–Ω—ã, —Ç.–∫. –º–æ–≥—É—Ç —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞—Ç—å—Å—è –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ. –ù–µ –≥–æ–≤–æ—Ä—è —É–∂–µ –æ —Ç–æ–º, —á—Ç–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏ –ë–ê–î—ã –¥–æ–ª–∂–Ω—ã –Ω–∞–∑–Ω–∞—á–∞—Ç—å—Å—è –∏–Ω–¥–∏–≤–∏–¥—É–∞–ª—å–Ω–æ. –ß—Ç–æ–±—ã ¬´—Ä–∞–∑ –∏ –Ω–∞–≤—Å–µ–≥–¥–∞¬ª —Ä–µ—à–∏—Ç—å –ø—Ä–æ–±–ª–µ–º—É –∫–æ–Ω—Ç—Ä–∞—Ñ–∞–∫—Ç–∞, –∞ –Ω–µ ¬´–æ—Ç–ª–∞–≤–ª–∏–≤–∞—Ç—å¬ª –µ–≥–æ –≤ —Ä—É—á–Ω–æ–º —Ä–µ–∂–∏–º–µ, –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–∏–∫–∏ –Ω–∞—Å—Ç–∞–∏–≤–∞—é—Ç –Ω–∞ —Å–∫–æ—Ä–µ–π—à–µ–π —Å–∏–Ω—Ö—Ä–æ–Ω–∏–∑–∞—Ü–∏–∏ –±–∞–∑ –¥–∞–Ω–Ω—ã—Ö –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–æ–≤ —Å —Ä–µ–µ—Å—Ç—Ä–∞–º–∏ –≥–æ—Å–æ—Ä–≥–∞–Ω–æ–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The Federation of Internet Trade has proposed a document to the State Duma members. The Federation prepared several proposals aimed at reducing counterfeit products among medical devices and BAs (Biological Active Substances) sold through popular online platforms. Among the new measures are blocking ratings and comments in sections for medicines and BAs, as well as adding an obligatory mark to product cards indicating whether the item is a medical device and requiring a registration certificate. Additionally, according to V. Gavrilov, the Federation is calling for mandatory information about the fact that these products must be taken under a doctor's prescription. The Federation is concerned that some comments on certain medications contain 'dangerous' advice, which can be harmful to life. The Federation believes that ratings are not objective and may be artificially formed. To 'once and for all' solve the problem of counterfeiting, rather than manually tracking it, publicists are calling for immediate synchronization of the marketplaces' databases with government registries.""
}"
2025-11-07T08:31:55+00:00,@bezrec,6791,https://t.me/bezrec/6791,"DSM Group –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∞ —Ä–µ–π—Ç–∏–Ω–≥ —Ñ–∞—Ä–º–¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–æ–≤ –ø–æ –∏—Ç–æ–≥–∞–º 9 –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞. –û–±—ä—ë–º —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ —Ä—ã–Ω–∫–∞ –≤ –∞–Ω–∞–ª–∏–∑–∏—Ä—É–µ–º–æ–º –ø–µ—Ä–∏–æ–¥–µ –≤ —Ü–µ–Ω–∞—Ö –¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–æ–≤ —Å–æ—Å—Ç–∞–≤–∏–ª 2,6 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —á—Ç–æ –Ω–∞ 14,5% –≤—ã—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É. –î—Ä–∞–π–≤–µ—Ä–æ–º —Ä–æ—Å—Ç–∞ –æ—Å—Ç–∞—ë—Ç—Å—è –≥–æ—Å—Å–µ–≥–º–µ–Ω—Ç. –ü–æ—Å—Ç–∞–≤–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∑–∞ —Å—á—ë—Ç –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è –∑–∞ —è–Ω–≤–∞—Ä—å-—Å–µ–Ω—Ç—è–±—Ä—å 2025 –≥–æ–¥–∞ —É–≤–µ–ª–∏—á–∏–ª–∏—Å—å –Ω–∞ 17,5%. –ê–ø—Ç–µ—á–Ω—ã–π —Ä—ã–Ω–æ–∫ –≤—ã—Ä–æ—Å –Ω–∞ 13%. –¢—É—Ç —Ä–æ–ª—å —Å—ã–≥—Ä–∞–ª–∏ –≤ –æ—Å–Ω–æ–≤–Ω–æ–º —Ü–µ–Ω–æ–≤—ã–µ —Ñ–∞–∫—Ç–æ—Ä—ã: –∏–Ω—Ñ–ª—è—Ü–∏–∏ –∏ –ø–µ—Ä–µ–∫–ª—é—á–µ–Ω–∏—è –ø–æ–∫—É–ø–∞—Ç–µ–ª–µ–π –Ω–∞ –±–æ–ª–µ–µ –¥–æ—Ä–æ–≥–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã. –ü–æ –∏—Ç–æ–≥–∞–º 9 –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ –∫–æ–Ω—Ü–µ–Ω—Ç—Ä–∞—Ü–∏—è –Ω–∞ –æ–ø—Ç–æ–≤–æ–º —Ä—ã–Ω–∫–µ —Å–æ—Ö—Ä–∞–Ω—è–µ—Ç—Å—è –Ω–∞ –≤—ã—Å–æ–∫–æ–º —É—Ä–æ–≤–Ω–µ –∏ –¥–∞–∂–µ —Ä–∞—Å—Ç—ë—Ç. –°–æ–≤–æ–∫—É–ø–Ω–∞—è –¥–æ–ª—è –¥–µ—Å—è—Ç–∏ –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö –¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–æ–≤ –±—ã–ª–∞ –Ω–∞ —É—Ä–æ–≤–Ω–µ 82,8%. –í —Ä–æ–∑–Ω–∏—á–Ω–æ–º —Å–µ–≥–º–µ–Ω—Ç–µ –Ω–∞ —Ç–æ–ø-10 –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è 92,7% –æ–±—ä—ë–º–∞ –ø—Ä–æ–¥–∞–∂, –≤ –≥–æ—Å–∑–∞–∫—É–ø–∫–∞—Ö - 54,7%. –¢—Ä–æ–π–∫–∞ –ª–∏–¥–µ—Ä–æ–≤ –≤—ã–≥–ª—è–¥–∏—Ç —Ç–∞–∫ –∂–µ, –∫–∞–∫ –∏ –≤ –ø–µ—Ä–≤–æ–º –ø–æ–ª—É–≥–æ–¥–∏–∏ ‚Äì –Ω–∞ –ø—å–µ–¥–µ—Å—Ç–∞–ª–µ —Å–Ω–æ–≤–∞ ¬´–ü—É–ª—å—Å¬ª, ¬´–ü—Ä–æ—Ç–µ–∫¬ª –∏ ¬´–ö–∞—Ç—Ä–µ–Ω¬ª. –î–∞ –∏ –≤ —Ü–µ–ª–æ–º –ø–µ—Ä–µ–º–µ–Ω –≤ –¥–µ—Å—è—Ç–∫–µ –ª—É—á—à–∏—Ö –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏ –Ω–µ—Ç ‚Äì —Ä–∞–∑–≤–µ —á—Ç–æ –ø–æ–º–µ–Ω—è–ª–∏—Å—å –º–µ—Å—Ç–∞–º–∏ ¬´–ë–°–°¬ª –∏ ¬´–§–∞—Ä–º–∫–æ–º–ø–ª–µ–∫—Ç¬ª. –û—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω—É—é –¥–∏–Ω–∞–º–∏–∫—É –ø–æ–∫–∞–∑–∞–ª —Ç–æ–ª—å–∫–æ –∑–∞–Ω–∏–º–∞—é—â–∏–π 10 —Å—Ç—Ä–æ—á–∫—É ¬´–§–∞—Ä–º–∏–º—ç–∫—Å¬ª. –í —Ç–æ–ø-10 —Ç–∞–∫–∂–µ –≤–æ—à–ª–∏: ¬´–ì—Ä–∞–Ω–¥-–ö–∞–ø–∏—Ç–∞–ª¬ª, ¬´–†-–§–∞—Ä–º¬ª, ¬´–ò—Ä–≤–∏–Ω-2¬ª, ¬´–í–∏—Ç–∞¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": true,
  ""country"": ""global"",
  ""topic"": ""demand, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The report from DSM Group highlights the performance of pharmaceutical distributors for the first nine months of 2025. The Russian pharmaceutical market grew by 13% to reach RUB26 billion, up from the previous year. The growth is driven by the government segment. Government purchases of medicines increased by 17.5% from January to September 2025. The retail market also grew by the same percentage, mainly due to price factors such as inflation and consumers switching to more expensive drugs. The concentration on the wholesale market remains high, with ten major distributors accounting for 82.8% of the market share. The top ten players in the retail segment include 'Puls', 'Protik', and 'Katren'. The market leader positions have not changed significantly from the first half of the year. However, 'Farmaemex' lost its position in the top ten with a negative growth trend.""
}"
2025-11-07T05:33:11+00:00,@bezrec,6790,https://t.me/bezrec/6790,"–í–æ–∑–æ–±–Ω–æ–≤–ª—è–µ–º –Ω–∞—à—É —Ä—É–±—Ä–∏–∫—É #–í–æ–ª—à–µ–±–Ω–∏–∫–∏–°—Ç—Ä–∞–Ω—ã–û–≠–ó. –ü—Ä–æ–¥–æ–ª–∂–∞–µ–º –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç—å –î—É–±–Ω—É ‚Äî —Å–∞–º—É—é –∫—Ä—É–ø–Ω—É—é –æ—Å–æ–±—É—é —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫—É—é –∑–æ–Ω—É –ø–æ –∫–æ–ª–∏—á–µ—Å—Ç–≤—É —Ä–µ–∑–∏–¥–µ–Ω—Ç–æ–≤. –°–µ–≥–æ–¥–Ω—è—à–Ω–∏–π –≥–µ—Ä–æ–π ‚Äî –û–û–û ¬´–†–∞—Ñ–∏¬ª. –ö–æ–º–ø–∞–Ω–∏—è –º–æ–ª–æ–¥–∞—è ‚Äî –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–∞ 8 –∏—é–Ω—è 2023 –≥–æ–¥–∞ –≤ –î—É–±–Ω–µ. –°–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä—É–µ—Ç—Å—è –Ω–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ –∞–∫—Ç–∏–≤–Ω—ã—Ö —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö —Å—É–±—Å—Ç–∞–Ω—Ü–∏–π. –ü–æ –¥–∞–Ω–Ω—ã–º Rusprofile, –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–º —Å 25 —è–Ω–≤–∞—Ä—è 2024 –≥–æ–¥–∞ —á–∏—Å–ª–∏—Ç—Å—è –ö—Ä–∏—Å—Ç–∏–Ω–∞ –ë–∞—Å–æ–≤–∞. –û–Ω–∞ —Ç–∞–∫–∂–µ —Ä—É–∫–æ–≤–æ–¥–∏—Ç –û–û–û ¬´–§–∞—Ä–º—ç–π—Ä¬ª, –∑–∞–Ω–∏–º–∞—é—â–∏–º—Å—è –æ–ø—Ç–æ–≤–æ–π —Ç–æ—Ä–≥–æ–≤–ª–µ–π —Ñ–∞—Ä–º–ø—Ä–æ–¥—É–∫—Ü–∏–µ–π. –ï–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–º —É—á—Ä–µ–¥–∏—Ç–µ–ª–µ–º –≤—ã—Å—Ç—É–ø–∞–µ—Ç –ü—É–Ω–∏—è –°–∞—Ç–∏—è –ö–∞—Ä–º, –≤–ª–∞–¥–µ—é—â–∏–π 100 % –¥–æ–ª–µ–π. –ë–∏–∑–Ω–µ—Å–º–µ–Ω—É —Ç–∞–∫–∂–µ –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∏—Ç 99% –≤ –µ—â—ë –æ–¥–Ω–æ–º —Ä–µ–∑–∏–¥–µ–Ω—Ç–µ –û–≠–ó ¬´–î—É–±–Ω–∞¬ª ‚Äî ¬´–ü–°–ö –§–∞—Ä–º–∞¬ª. 2024 –≥–æ–¥ ¬´–†–∞—Ñ–∏¬ª –∑–∞–∫–æ–Ω—á–∏–ª–∞ —Å –Ω—É–ª–µ–≤–æ–π –≤—ã—Ä—É—á–∫–æ–π, —Ç–æ–≥–¥–∞ –∫–∞–∫ –≤ 2023 –≥–æ–¥—É —ç—Ç–æ—Ç –ø–æ–∫–∞–∑–∞—Ç–µ–ª—å –±—ã–ª –Ω–∞ —É—Ä–æ–≤–Ω–µ 17,9 –º–ª–Ω —Ä—É–±–ª–µ–π. –ü—Ä–∏ —ç—Ç–æ–º —á–∏—Å—Ç–∞—è –ø—Ä–∏–±—ã–ª—å –≤—ã—Ä–æ—Å–ª–∞ –Ω–∞ 173%, –¥–æ 5,4 –º–ª–Ω —Ä—É–±–ª–µ–π. –ù–µ—Å–º–æ—Ç—Ä—è –Ω–∞ —Ñ–æ—Ä–º–∞–ª—å–Ω–æ –≤—ã—Å–æ–∫—É—é —Ç–µ–∫—É—â—É—é –ª–∏–∫–≤–∏–¥–Ω–æ—Å—Ç—å, –ø–ª–∞—Ç—ë–∂–µ—Å–ø–æ—Å–æ–±–Ω–æ—Å—Ç—å –æ—Ü–µ–Ω–∏–≤–∞–µ—Ç—Å—è –∫–∞–∫ –ø—Ä–æ–±–ª–µ–º–Ω–∞—è. –ü–æ –æ–±—ä—ë–º—É –≤—ã—Ä—É—á–∫–∏ –∫–æ–º–ø–∞–Ω–∏—è –∑–∞–Ω–∏–º–∞–µ—Ç 22 –º–µ—Å—Ç–æ –≤ –ú–æ—Å–∫–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –∏ 142 –≤ –†–æ—Å—Å–∏–∏. –í –î—É–±–Ω–µ ¬´–†–∞—Ñ–∏¬ª –ø–ª–∞–Ω–∏—Ä—É–µ—Ç –ø–æ—Å—Ç—Ä–æ–∏—Ç—å –∑–∞–≤–æ–¥ –ø–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤—É –ê–§–°. –í –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω–æ–º –ø–ª–∞–Ω–µ ‚Äî 16 –Ω–∞–∏–º–µ–Ω–æ–≤–∞–Ω–∏–π —Å—É–±—Å—Ç–∞–Ω—Ü–∏–π –¥–ª—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏–∑ –ø–µ—Ä–µ—á–Ω—è –ñ–ù–í–õ–ü, –∞ 11 –∏–∑ –Ω–∏—Ö ‚Äî –∏–∑ –ø–µ—Ä–µ—á–Ω—è –°–ó–õ–°. –í –∏—Ö —á–∏—Å–ª–µ: –±–µ–¥–∞–∫–≤–∏–ª–∏–Ω, –±—É–¥–µ—Å–æ–Ω–∏–¥, –¥–∞–ø–∞–≥–ª–∏—Ñ–ª–æ–∑–∏–Ω, –¥–∏–º–µ—Ç–∏–ª—Ñ—É–º–∞—Ä–∞—Ç, –¥–æ–ª—É—Ç–µ–≥—Ä–∞–≤–∏—Ä, –∏–Ω–¥–∞–∫–∞—Ç–µ—Ä–æ–ª, –ª–æ–ø–∏–Ω–∞–≤–∏—Ä, —Ä–∞–ª—Ç–µ–≥—Ä–∞–≤–∏—Ä, —Ä–∏–≤–∞—Ä–æ–∫—Å–∞–±–∞–Ω, —Ä–∏—Ç–æ–Ω–∞–≤–∏—Ä, —Å–∞–ø—Ä–æ–ø—Ç–µ—Ä–∏–Ω, —Ç–µ–¥–∏–∑–æ–ª–∏–¥, —Ç–∏–∫–∞–≥—Ä–µ–ª–æ—Ä, —Ñ–æ—Ä–º–æ—Ç–µ—Ä–æ–ª, —ç–º–ø–∞–≥–ª–∏—Ñ–ª–æ–∑–∏–Ω, —ç—Ç—Ä–∞–≤–∏—Ä–∏–Ω. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-11-06T18:51:50+00:00,@bezrec,6789,https://t.me/bezrec/6789,"–ì–æ—Ä–¥–æ–Ω –§–∏–Ω–¥–ª–∏, —Ç–æ–ø-–º–µ–Ω–µ–¥–∂–µ—Ä –∫–æ–º–ø–∞–Ω–∏–∏ Novo Nordisk ‚Äî –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ Ozempic, —É–ø–∞–ª –≤ –æ–±–º–æ—Ä–æ–∫, –Ω–∞—Ö–æ–¥—è—Å—å –∑–∞ —Å–ø–∏–Ω–æ–π –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç–∞ –°–®–ê –î–æ–Ω–∞–ª—å–¥–∞ –¢—Ä–∞–º–ø–∞ –≤–æ –≤—Ä–µ–º—è –≤—Å—Ç—Ä–µ—á–∏ —Å –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª—è–º–∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –∫–æ–º–ø–∞–Ω–∏–π –≤ –û–≤–∞–ª—å–Ω–æ–º –∫–∞–±–∏–Ω–µ—Ç–µ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-11-06T14:32:44+00:00,@bezrec,6788,https://t.me/bezrec/6788,"Biocad –Ω–∞—á–∏–Ω–∞–µ—Ç —Ç—Ä–µ—Ç—å—é —Ñ–∞–∑—É –ö–ò –±–∏–æ–∞–Ω–∞–ª–æ–≥–∞ –æ–∫—Ä–µ–ª–∏–∑—É–º–∞–±–∞. –ö–æ–º–ø–∞–Ω–∏—è —Å–æ–æ–±—â–∏–ª–∞, —á—Ç–æ –æ—Ç–∫—Ä—ã–≤–∞–µ—Ç –Ω–∞–±–æ—Ä –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ BCD-281 ‚Äî –±–∏–æ–∞–Ω–∞–ª–æ–≥–∞ –æ–∫—Ä–µ–ª–∏–∑—É–º–∞–±–∞ –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Ä–∞—Å—Å–µ—è–Ω–Ω–æ–≥–æ —Å–∫–ª–µ—Ä–æ–∑–∞. –û–∫—Ä–µ–ª–∏–∑—É–º–∞–± ‚Äî –≥—É–º–∞–Ω–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω–æ–µ –º–æ–Ω–æ–∫–ª–æ–Ω–∞–ª—å–Ω–æ–µ –∞–Ω—Ç–∏—Ç–µ–ª–æ –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Ä–µ—Ü–∏–¥–∏–≤–∏—Ä—É—é—â–∏—Ö —Ñ–æ—Ä–º —Ä–∞—Å—Å–µ—è–Ω–Ω–æ–≥–æ —Å–∫–ª–µ—Ä–æ–∑–∞, –∞ —Ç–∞–∫–∂–µ –¥–ª—è –ø–µ—Ä–≤–∏—á–Ω–æ-–ø—Ä–æ–≥—Ä–µ—Å—Å–∏—Ä—É—é—â–µ–≥–æ —Ç–∏–ø–∞ —Ç–µ—á–µ–Ω–∏—è –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è. - –¶–µ–ª—å –æ—Ü–µ–Ω–∫–∞ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –∏ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ BCD-281 –≤ —Å—Ä–∞–≤–Ω–µ–Ω–∏–∏ —Å –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã–º –æ–∫—Ä–µ–ª–∏–∑—É–º–∞–±–æ–º - –ì–¥–µ –ø—Ä–æ–π–¥—ë—Ç –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –ú–æ—Å–∫–≤–∞, –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥, –ß–µ–ª—è–±–∏–Ω—Å–∫, –ö–∏—Ä–æ–≤, –ù–∏–∂–Ω–∏–π –ù–æ–≤–≥–æ—Ä–æ–¥, –†–æ—Å—Ç–æ–≤-–Ω–∞-–î–æ–Ω—É, –ù–æ–≤–æ—Å–∏–±–∏—Ä—Å–∫ –∏ –¥—Ä—É–≥–∏–µ –≥–æ—Ä–æ–¥–∞ - –ö—Ç–æ —Å–º–æ–∂–µ—Ç –ø—Ä–∏–Ω—è—Ç—å —É—á–∞—Å—Ç–∏–µ –≤–∑—Ä–æ—Å–ª—ã–µ –ø–∞—Ü–∏–µ–Ω—Ç—ã –æ—Ç 18 –¥–æ 55 –ª–µ—Ç —Å —Ä–µ–º–∏—Ç—Ç–∏—Ä—É—é—â–∏–º —Ç–∏–ø–æ–º —Ç–µ—á–µ–Ω–∏—è —Ä–∞—Å—Å–µ—è–Ω–Ω–æ–≥–æ —Å–∫–ª–µ—Ä–æ–∑–∞ –†–∞–Ω–µ–µ BCD-281 –±—ã–ª –≤—Å–µ—Å—Ç–æ—Ä–æ–Ω–Ω–µ –∏–∑—É—á–µ–Ω –≤ —Ö–æ–¥–µ —Ñ–∏–∑–∏–∫–æ-—Ö–∏–º–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π, –∞ —Ç–∞–∫–∂–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–≥–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –ø–µ—Ä–≤–æ–π —Ñ–∞–∑—ã, –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–≤—à–∏—Ö –±–∏–æ–∞–Ω–∞–ª–æ–≥–∏—á–Ω–æ—Å—Ç—å –∏—Å—Å–ª–µ–¥—É–µ–º–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –∏ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω–æ–≥–æ –æ–∫—Ä–µ–ª–∏–∑—É–º–∞–±–∞ –ø–æ –≤—Å–µ–º —Å—Ä–∞–≤–Ω–∏–≤–∞–µ–º—ã–º –ø–∞—Ä–∞–º–µ—Ç—Ä–∞–º. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –ø–æ–∫–∞–∑–∞–ª–∏ —Å—Ö–æ–∂—É—é –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –∏ –Ω–∏–∑–∫–∏–π —É—Ä–æ–≤–µ–Ω—å –∏–º–º—É–Ω–æ–≥–µ–Ω–Ω–æ—Å—Ç–∏ –∏—Å—Å–ª–µ–¥—É–µ–º—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, ‚Äî –ø–æ–¥—á—ë—Ä–∫–∏–≤–∞—é—Ç –≤ Biocad. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety, pharmacovigilance"",
  ""impact"": ""medium"",
  ""english"": ""Biocad is commencing the third phase of its bio-similar candidate BCD-281, which is a monoclonal antibody for treating relapsing multiple sclerosis. The company announced that it has opened patient enrollment in a clinical study of the drug, BCD-281 - a bio-similar to ocrelizumab. Ocrelizumab is a humanized monoclonal antibody for treating relapsing forms of multiple sclerosis and also for the primary progressive type of disease. The goal is to assess the efficacy and safety of BCD-281 compared with the original ocrelizumab. The clinical trial will take place in Moscow, Saint Petersburg, Chelyabinsk, Kirov, Novosibirsk and other cities. Eligible participants are adult patients aged 18 to 55 years with a relapsing type of multiple sclerosis. Previously, BCD-281 has been comprehensively studied in physical and chemical research studies as well as a phase one clinical"
2025-11-06T12:15:36+00:00,@bezrec,6787,https://t.me/bezrec/6787,"–¢–∞–∫–æ–≤—ã –Ω–µ—É—Ç–µ—à–∏—Ç–µ–ª—å–Ω—ã–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –ø—Ä–æ–≤–µ—Ä–∫–∏ –¶–†–ü–¢ –∏ –†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä–∞. –ò–∑ 32 –ø—Ä–æ—à–µ–¥—à–∏—Ö –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥ –∫–æ–º–ø–∞–Ω–∏–π –Ω–∞–ª–∏—á–∏–µ–º –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –º–æ–≥—É—Ç –ø–æ—Ö–≤–∞—Å—Ç–∞—Ç—å—Å—è —Ç–æ–ª—å–∫–æ —à–µ—Å—Ç—å. –ü–æ –∞–¥—Ä–µ—Å–∞–º —É –æ—Å—Ç–∞–ª—å–Ω—ã—Ö —Ä–∞—Å–ø–æ–ª–æ–∂–µ–Ω–æ —á—Ç–æ —É–≥–æ–¥–Ω–æ ( –æ—Ç –∂–∏–ª—ã—Ö –¥–æ–º–æ–≤ –∏ –≥–æ—Å—Ç–∏–Ω–∏—Ü –¥–æ –ø—É—Å—Ç—ã—Ä–µ–π), —Ç–æ–ª—å–∫–æ –Ω–µ –ø–ª–æ—â–∞–¥–∫–∏ –ø–æ –∏–∑–≥–æ—Ç–æ–≤–ª–µ–Ω–∏—é –ë–ê–î–æ–≤. –° –ø—Ä–æ–≤–µ—Ä–∫–æ–π –ø–æ –ø–æ—Ä—É—á–µ–Ω–∏—é –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–∞ –Ω–∞–≥—Ä—è–Ω—É–ª–∏ –∫ —Ç–µ–º, —É –∫–æ–≥–æ —Å–∏—Å—Ç–µ–º–∞ –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏ –≤—ã—è–≤–∏–ª–∞ ¬´–ø–æ–¥–æ–∑—Ä–∏—Ç–µ–ª—å–Ω–æ–µ¬ª –ø–æ–≤–µ–¥–µ–Ω–∏–µ, –≤ —Ç–æ–º —á–∏—Å–ª–µ: üîò–≤–≤–æ–¥ –≤ –æ–±–æ—Ä–æ—Ç –¥–æ–±–∞–≤–æ–∫ –ø–æ–¥ —á—É–∂–∏–º —Ç–æ–≤–∞—Ä–Ω—ã–º –∑–Ω–∞–∫–æ–º; üîò–Ω–∞–ª–∏—á–∏–µ –Ω–∞—Ä—É—à–µ–Ω–∏–π, –≤—ã—è–≤–ª–µ–Ω–Ω—ã—Ö –†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä–æ–º –∑–∞ –ø—Ä–µ–¥—ã–¥—É—â–∏–µ –ø–æ–ª–≥–æ–¥–∞; üîò–æ—Ç—Å—É—Ç—Å—Ç–≤–∏–µ –≤ —Ä–µ–µ—Å—Ç—Ä–∞—Ö —é—Ä–∏–¥–∏—á–µ—Å–∫–∏—Ö –ª–∏—Ü –∫–æ–¥–∞ –û–ö–í–≠–î, —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–µ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤—É –ë–ê–î–æ–≤; üîò—É–∫–∞–∑–∞–Ω–∏–µ –≤ —Ä–∞–∑—Ä–µ—à–∏—Ç–µ–ª—å–Ω—ã—Ö –¥–æ–∫—É–º–µ–Ω—Ç–∞—Ö –Ω–∞ —Ç–æ–≤–∞—Ä –∑–∞—Ä—É–±–µ–∂–Ω–æ–≥–æ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–∞ –≤ –∫–∞—á–µ—Å—Ç–≤–µ —Å—Ç—Ä–∞–Ω—ã-–∏–∑–≥–æ—Ç–æ–≤–∏—Ç–µ–ª—è. –ú—ã —Å—Ç–æ–ª–∫–Ω—É–ª–∏—Å—å —Å —Å–∏—Ç—É–∞—Ü–∏—è–º–∏, –∫–æ–≥–¥–∞ —é—Ä–∏–¥–∏—á–µ—Å–∫–∏–µ –ª–∏—Ü–∞ –ª–∏—à—å –∏–º–∏—Ç–∏—Ä—É—é—Ç –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –Ω–∞ –±—É–º–∞–≥–µ, —á—Ç–æ–±—ã –ø–æ–ª—É—á–∞—Ç—å –∫–æ–¥—ã –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏ –¥–ª—è —Ç–æ–≤–∞—Ä–æ–≤, —Ñ–∞–∫—Ç–∏—á–µ—Å–∫–∏ –≤–≤–æ–∑–∏–º—ã—Ö –∏–∑-–∑–∞ —Ä—É–±–µ–∂–∞, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –¶–†–ü–¢ –†–µ–≤–∞–∑ –Æ—Å—É–ø–æ–≤. –£—Ä–µ–∑–æ–Ω–∏—Ç—å –Ω–µ–¥–æ–±—Ä–æ—Å–æ–≤–µ—Å—Ç–Ω—ã—Ö –ø—Å–µ–≤–¥–æ–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π —Å–æ–±–∏—Ä–∞—é—Ç—Å—è –æ—Ç–∫–∞–∑–æ–º –≤ –≤—ã–¥–∞—á–µ –∫–æ–¥–æ–≤ –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏ –¥–æ –º–æ–º–µ–Ω—Ç–∞ —É—Å—Ç—Ä–∞–Ω–µ–Ω–∏—è –≤—Å–µ—Ö –Ω–∞—Ä—É—à–µ–Ω–∏–π. –ü—Ä–æ–µ–∫—Ç –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞, –¥–∞—é—â–∏–π –¶–†–ü–¢ —Ç–∞–∫–æ–µ –ø—Ä–∞–≤–æ, –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ —É–∂–µ –ø–æ–¥–≥–æ—Ç–æ–≤–∏–ª. –ù–æ, –∫–∞–∫ –º—ã –∑–Ω–∞–µ–º, –∏ —É –≤–ø–æ–ª–Ω–µ —Ä–µ–∞–ª—å–Ω—ã—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –±–µ–∑ –ø—Ä–æ–±–ª–µ–º –Ω–µ –æ–±—Ö–æ–¥–∏—Ç—Å—è. –í—Å–ø–æ–º–Ω–∏—Ç—å —Ö–æ—Ç—è –±—ã –∏—Å—Ç–æ—Ä–∏—é, –∫–∞–∫ ¬´–¢—ã–º–ª–∞—Ç—Å–∫–æ–º—É —Ä—ã–±–æ–∫–æ–º–±–∏–Ω–∞—Ç—É¬ª –ø—Ä–∏—à–ª–æ—Å—å –æ–ø—Ä–∞–≤–¥—ã–≤–∞—Ç—å—Å—è –∑–∞ —Å–≤–æ—é –û–º–µ–≥–∞-3. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage, regulation"",
  ""impact"": ""high"",
  ""english"": ""The results of the review by the Consumer Rights Protection Agency and Roskomnadzor are disappointing. Only six out of 32 companies that passed the monitoring have facilities for production. The rest are located in various places, including residential buildings and hotels, not manufacturing sites. We encountered situations where legal entities only pretend to produce on paper to obtain mark-up codes for goods actually imported from abroad, as we know this is not uncommon. The Consumer Rights Protection Agency has already prepared a government decree giving it the right to refuse mark-up codes until all violations are corrected.""
}"
2025-11-06T10:41:12+00:00,@bezrec,6782,https://t.me/bezrec/6782,"–£—Å—Ç–æ–π—á–∏–≤–æ—Å—Ç—å –∏ –∞–¥–∞–ø—Ç–∞—Ü–∏—è –≤ —Ñ–∞—Ä–º–µ ‚ñ∂Ô∏è–°–µ–≥–æ–¥–Ω—è —Ä–∞—Å—Å–º–æ—Ç—Ä–∏–º, —á—Ç–æ #–≤–Ω—É—Ç—Ä–∏_–æ—Ç—Ä–∞—Å–ª–∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∏, –∫–æ—Ç–æ—Ä–∞—è –±–æ–ª–µ–µ –º–µ–Ω–µ–µ —Å–±–∞–ª–∞–Ω—Å–∏—Ä–æ–≤–∞–ª–∞—Å—å –¥–∞–∂–µ –ø—Ä–∏ –æ–±—â–µ–º –æ—Ö–ª–∞–∂–¥–µ–Ω–∏–∏ —Ä—ã–Ω–∫–∞. –ü–æ –¥–∞–Ω–Ω—ã–º Antal Talent, —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª—å –æ–∫–∞–∑–∞–ª–∞—Å—å –æ–¥–Ω–æ–π –∏–∑ –Ω–µ–º–Ω–æ–≥–∏—Ö, –≥–¥–µ —Ç–µ–º–ø—ã –Ω–∞–π–º–∞ —Å—Ç–∞–±–∏–ª–∏–∑–∏—Ä–æ–≤–∞–ª–∏—Å—å. –õ–∏—à—å 37% –∫–æ–º–ø–∞–Ω–∏–π —Å–æ–æ–±—â–∏–ª–∏ –æ —Ä–æ—Å—Ç–µ —Å—Ä–æ–∫–æ–≤ –∑–∞–∫—Ä—ã—Ç–∏—è –≤–∞–∫–∞–Ω—Å–∏–π, —Ç–æ–≥–¥–∞ –∫–∞–∫ –≥–æ–¥–æ–º —Ä–∞–Ω–µ–µ —ç—Ç–æ—Ç –ø–æ–∫–∞–∑–∞—Ç–µ–ª—å –¥–æ—Å—Ç–∏–≥–∞–ª 82%. –£ 17% —Å—Ä–æ–∫–∏, –Ω–∞–ø—Ä–æ—Ç–∏–≤, —Å–æ–∫—Ä–∞—Ç–∏–ª–∏—Å—å. –ë–∏–∑–Ω–µ—Å –ø–æ—Å—Ç–µ–ø–µ–Ω–Ω–æ –ø–µ—Ä–µ—Ö–æ–¥–∏—Ç –≤ —Ä–µ–∂–∏–º —É–¥–µ—Ä–∂–∞–Ω–∏—è. –í 2025 –≥–æ–¥—É –ø–ª–∞–Ω—ã –ø–æ —Ä–∞—Å—à–∏—Ä–µ–Ω–∏—é —à—Ç–∞—Ç–∞ —Ä–µ–∞–ª–∏–∑–æ–≤–∞–ª–∏ —Ç–æ–ª—å–∫–æ 30% —Ä–∞–±–æ—Ç–æ–¥–∞—Ç–µ–ª–µ–π –ø—Ä–∏ –æ–∂–∏–¥–∞–Ω–∏—è—Ö 53%. 59% —Å–æ—Å—Ä–µ–¥–æ—Ç–æ—á–∏–ª–æ—Å—å –Ω–∞ –∑–∞–º–µ—â–µ–Ω–∏–∏ –∫–∞–¥—Ä–æ–≤, –∏ —ç—Ç–æ—Ç —Ç—Ä–µ–Ω–¥ —Å–æ—Ö—Ä–∞–Ω–∏—Ç—Å—è. –ù–∞ 2026 –≥–æ–¥ 56% –∫–æ–º–ø–∞–Ω–∏–π –ø–ª–∞–Ω–∏—Ä—É—é—Ç –ª–∏—à—å –≤–æ—Å–ø–æ–ª–Ω—è—Ç—å –æ—Å–≤–æ–±–æ–¥–∏–≤—à–∏–µ—Å—è –ø–æ–∑–∏—Ü–∏–∏, —Ç–æ–≥–¥–∞ –∫–∞–∫ 34% –≥–æ—Ç–æ–≤—ã –∫ —É–º–µ—Ä–µ–Ω–Ω–æ–º—É —Ä–æ—Å—Ç—É. ‚ñ∂Ô∏è–ü–æ–≤—ã—à–µ–Ω–∏—è –∑–∞—Ä–∞–±–æ—Ç–Ω—ã—Ö –ø–ª–∞—Ç –Ω–∞ 10-12% —Ä–µ–∞–ª–∏–∑–æ–≤–∞–ª–∏ 43% –∫–æ–º–ø–∞–Ω–∏–π –ø—Ä–∏ –∑–∞–ø–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö 34%. –û–±—â–∞—è –¥–æ–ª—è —Ä–∞–±–æ—Ç–æ–¥–∞—Ç–µ–ª–µ–π, –∑–∞–ª–æ–∂–∏–≤—à–∏—Ö —Ä–æ—Å—Ç –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏–π –Ω–∞ 2026 –≥–æ–¥, –¥–æ—Å—Ç–∏–≥–ª–∞ 77%. –ù–∞–∏–±–æ–ª–µ–µ –∞–∫—Ç–∏–≤–Ω–æ —Ä–∞—Å—Ç—É—Ç –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è –ø—Ä–æ–¥–∞–∂ –∏ –º–∞—Ä–∫–µ—Ç–∏–Ω–≥–∞, –≥–¥–µ —Å–æ—Ö—Ä–∞–Ω—è–µ—Ç—Å—è –æ—Å—Ç—Ä–∞—è –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏—è –∑–∞ –∫–∞–¥—Ä—ã –∏ –ø—Ä–∞–∫—Ç–∏–∫–∞ ¬´–ø–µ—Ä–µ–∫—É–ø–∞¬ª. –í —Ç–æ –∂–µ –≤—Ä–µ–º—è –≤ —Å—Ñ–µ—Ä–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç—Å—è —Å–æ–∫—Ä–∞—â–µ–Ω–∏–µ: –ø–æ—Å–ª–µ –ø—Ä–∏–æ—Å—Ç–∞–Ω–æ–≤–∫–∏ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã—Ö –ø—Ä–æ–µ–∫—Ç–æ–≤ –≤ 2022 –≥–æ–¥—É –ø—Ä–æ—Ü–µ—Å—Å –≤—ã—Å–≤–æ–±–æ–∂–¥–µ–Ω–∏—è —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç—Å—è –∏ –≤ 2025 –≥–æ–¥—É. ‚ñ∂Ô∏è–ò–ò –≤ —Ä–∞–±–æ—Ç–µ HR-–æ—Ç–¥–µ–ª–æ–≤ –ø—Ä–∏–º–µ–Ω—è—é—Ç 52% –∫–æ–º–ø–∞–Ω–∏–π, —á–∞—â–µ –≤—Å–µ–≥–æ –¥–ª—è –ø–æ–¥–±–æ—Ä–∞ (44%), –æ–±—É—á–µ–Ω–∏—è (35%) –∏ –∞–Ω–∞–ª–∏–∑–∞ –≤–æ–≤–ª–µ—á—ë–Ω–Ω–æ—Å—Ç–∏ (28%). –ù–µ—Å–º–æ—Ç—Ä—è –Ω–∞ —Ä–∞–∑–≥–æ–≤–æ—Ä—ã –æ –∫–∞–¥—Ä–æ–≤–æ–º –¥–µ—Ñ–∏—Ü–∏—Ç–µ, —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª—å —Å–æ—Ö—Ä–∞–Ω—è–µ—Ç —Å—Ç–∞–±–∏–ª—å–Ω–æ—Å—Ç—å –±–ª–∞–≥–æ–¥–∞—Ä—è —Ç–æ—á–Ω–æ–º—É –ø—Ä–æ–≥–Ω–æ–∑–∏—Ä–æ–≤–∞–Ω–∏—é, –∞–¥–∞–ø—Ç–∏–≤–Ω–æ—Å—Ç–∏ –∏ —Ä–æ—Å—Ç—É –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏–π. üîç –ö–∞–¥—Ä—ã","{""skip"": true}"
2025-11-06T08:35:46+00:00,@bezrec,6781,https://t.me/bezrec/6781,"–°—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–æ –ø–µ—Ä–≤–æ–≥–æ –≤ –†–æ—Å—Å–∏–∏ –∑–∞–≤–æ–¥–∞ –ø–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤—É –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π —Ç–µ—Ö–Ω–∏–∫–∏ –∏ –∏–∑–¥–µ–ª–∏–π –¥–ª—è –≥–µ–º–æ–¥–∏–∞–ª–∏–∑–∞ –∏–¥—ë—Ç –ø–æ–ª–Ω—ã–º —Ö–æ–¥–æ–º. –í —ç—Ç–æ–º –ª–∏—á–Ω–æ —É–±–µ–¥–∏–ª—Å—è –≥—É–±–µ—Ä–Ω–∞—Ç–æ—Ä –ö–∞–ª—É–∂—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –í–ª–∞–¥–∏—Å–ª–∞–≤ –®–∞–ø—à–∞. –ù–∞ –≤—Å—Ç—Ä–µ—á–µ —Å –≥–ª–∞–≤–æ–π —Ä–µ–≥–∏–æ–Ω–∞ –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑-–ú–µ–¥—Ç–µ—Ö¬ª –ù–∏–∫–æ–ª–∞–π –ü–∞–Ω–∏–∫–∞—Ä–æ–≤—Å–∫–∏–π –∏ –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä ¬´–ù–æ–≤–∞–¥–∏–∞–ª–∞¬ª –ê–ª–µ–∫—Å–µ–π –ö–∞—Ç–∞–µ–≤ —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏, –∫–∞–∫ –ø—Ä–æ–¥–≤–∏–≥–∞–µ—Ç—Å—è —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–æ –∏ –ø–æ–∫–∞–∑–∞–ª–∏ –æ–ø—ã—Ç–Ω—ã–µ –æ–±—Ä–∞–∑—Ü—ã –ø—Ä–æ–¥—É–∫—Ü–∏–∏. –°—Ç—Ä–æ–∏—Ç–µ–ª—å–Ω–æ‚Äë—Ä–µ–º–æ–Ω—Ç–Ω—ã–µ —Ä–∞–±–æ—Ç—ã –≤ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø–æ–º–µ—â–µ–Ω–∏—è—Ö –Ω–∞ –∑–∞–≤–æ–¥–µ —É–∂–µ –∑–∞–≤–µ—Ä—à–µ–Ω—ã, —Å–µ–π—á–∞—Å –º–æ–Ω—Ç–∏—Ä—É—é—Ç —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–µ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏–µ –∏ –ø—Ä–æ–≤–æ–¥—è—Ç –∫–æ–º–ø–ª–µ–∫—Å–Ω—ã–µ —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–∏–µ –∏—Å–ø—ã—Ç–∞–Ω–∏—è. –°–ª–µ–¥—É—é—â–∏–π —ç—Ç–∞–ø ‚Äî —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –≤—ã–ø—É—Å–∫–∞–µ–º–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –≤ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–µ –ø–æ–¥ —Ç–æ—Ä–≥–æ–≤–æ–π –º–∞—Ä–∫–æ–π ¬´–ù–æ–≤–∞–¥–∏–∞–ª¬ª. –ü–ª–æ—â–∞–¥–∫—É –ø–ª–∞–Ω–∏—Ä—É—é—Ç –∑–∞–ø—É—Å—Ç–∏—Ç—å –≤ –º–∞—Ä—Ç–µ 2026 –≥–æ–¥–∞. –û–±—ä—ë–º –≤–ª–æ–∂–µ–Ω–∏–π –æ—Ü–µ–Ω–∏–≤–∞–µ—Ç—Å—è –≤ 2 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ü—Ä–æ–µ–∫—Ç –±–µ–∑ –ø—Ä–µ—É–≤–µ–ª–∏—á–µ–Ω–∏—è –∞–º–±–∏—Ü–∏–æ–∑–Ω—ã–π ‚Äî –∑–∞–≤–æ–¥ —Å—Ç–∞–Ω–µ—Ç –ø–µ—Ä–≤–æ–π –≤ —Å—Ç—Ä–∞–Ω–µ –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ–π –ø–ª–æ—â–∞–¥–∫–æ–π, —Å–ø–æ—Å–æ–±–Ω–æ–π –ø–æ–ª–Ω–æ—Å—Ç—å—é —É–¥–æ–≤–ª–µ—Ç–≤–æ—Ä–∏—Ç—å –≤–Ω—É—Ç—Ä–µ–Ω–Ω–∏–π —Å–ø—Ä–æ—Å –Ω–∞ –≤—ã—Å–æ–∫–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–Ω–æ–µ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏–µ –∏ —Ä–∞—Å—Ö–æ–¥–Ω—ã–µ –º–∞—Ç–µ—Ä–∏–∞–ª—ã –¥–ª—è –≥–µ–º–æ–¥–∏–∞–ª–∏–∑–∞ –∏ –ø–µ—Ä–∏—Ç–æ–Ω–µ–∞–ª—å–Ω–æ–≥–æ –¥–∏–∞–ª–∏–∑–∞. –®–∞–ø—à–∞ –ø–æ—Ä—É—á–∏–ª –ø—Ä–æ—Ñ–∏–ª—å–Ω—ã–º —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã–º –≤–µ–¥–æ–º—Å—Ç–≤–∞–º –¥–µ—Ç–∞–ª—å–Ω–æ –ø—Ä–æ—Ä–∞–±–æ—Ç–∞—Ç—å –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ –≤–Ω–µ–¥—Ä–µ–Ω–∏—è –Ω–æ–≤–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –≤ —Å–∏—Å—Ç–µ–º—É –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ö–∞–ª—É–∂—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏. –°—Ç–∞—Ä–∞–Ω–∏—è ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑‚Äë–ú–µ–¥—Ç–µ—Ö–∞¬ª –æ—Ü–µ–Ω–∏–ª–∏ –∏ –Ω–∞ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–º —É—Ä–æ–≤–Ω–µ. –ú–∏—Ö–∞–∏–ª –ú–∏—à—É—Å—Ç–∏–Ω –æ—Ç–º–µ—Ç–∏–ª –µ–≥–æ –∫–∞–∫ —è—Ä–∫–∏–π –ø—Ä–∏–º–µ—Ä –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤—ã, —Å–ø–æ—Å–æ–±—Å—Ç–≤—É—é—â–µ–π —É–∫—Ä–µ–ø–ª–µ–Ω–∏—é —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ —Å—É–≤–µ—Ä–µ–Ω–∏—Ç–µ—Ç–∞ —Å—Ç—Ä–∞–Ω—ã. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance, safety"",
  ""impact"": ""high"",
  ""english"": ""The construction of the first industrial plant in Russia for medical equipment and dialysis products is underway. Governor Vladislav Shap—à–∞ of Kaluzhskaya Oblast personally witnessed the progress. The plant is being equipped with production equipment and undergoing technical tests. It plans to be operational by March 2026, with an investment of 2 billion rubles. The project aims to meet the country's internal demand for high-tech equipment and materials for hemodialysis and peritoneal dialysis. The initiative is seen as a significant step towards strengthening the country's technological sovereignty, according to Mikhail Mishustin.""
}"
2025-11-06T05:34:30+00:00,@bezrec,6780,https://t.me/bezrec/6780,"¬´–î–æ—á–∫–∞¬ª ¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç–∞¬ª –ø—Ä–∏–∑–Ω–∞–Ω–∞ –±–∞–Ω–∫—Ä–æ—Ç–æ–º. ¬´–ú–∞—Å—Ç–µ—Ä–ü–ª–∞–∑–º–∞¬ª –∏–∑ –≥—Ä—É–ø–ø—ã ¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç¬ª –ø—Ä–∏–∑–Ω–∞–Ω–∞ –±–∞–Ω–∫—Ä–æ—Ç–æ–º 27 –æ–∫—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞, –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ –∫–æ–º–ø–∞–Ω–∏–∏ –æ—Ç–∫—Ä—ã—Ç–æ –∫–æ–Ω–∫—É—Ä—Å–Ω–æ–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ. –ö–æ–Ω–∫—É—Ä—Å–Ω—ã–º —É–ø—Ä–∞–≤–ª—è—é—â–∏–º –Ω–∞–∑–Ω–∞—á–µ–Ω –ö–æ–Ω—Å—Ç–∞–Ω—Ç–∏–Ω –ü–∞–≤–ª–æ–≤. –†–∞–Ω–µ–µ —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª–µ–º —á–∏—Å–ª–∏–ª—Å—è –ò–≥–æ—Ä—å –ì–æ–≤–æ—Ä–æ–≤, —Ç–∞–∫–∂–µ –±—ã–≤—à–∏–π –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–º –≤ –ª–∏–∫–≤–∏–¥–∏—Ä–æ–≤–∞–Ω–Ω–æ–π ¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç-–ü–ª–∞–∑–º–∞¬ª. –õ–∏–∫–≤–∏–¥–∏—Ä–æ–≤–∞—Ç—å —É–±—ã—Ç–æ—á–Ω—É—é ¬´–¥–æ—á–∫—É¬ª ¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç–∞¬ª —Ä–µ—à–∏–ª–∏ –µ—â—ë –ª–µ—Ç–æ–º 2024 –≥–æ–¥–∞, –∫–æ–≥–¥–∞ —Å—Ç–∞–ª–æ –ø–æ–Ω—è—Ç–Ω–æ, —á—Ç–æ ¬´–ú–∞—Å—Ç–µ—Ä–ü–ª–∞–∑–º–∞¬ª, —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä—É—é—â–∞—è—Å—è –Ω–∞ –æ–ø—Ç–æ–≤–æ–π —Ç–æ—Ä–≥–æ–≤–ª–µ —Ñ–∞—Ä–º–ø—Ä–æ–¥—É–∫—Ü–∏–µ–π, –Ω–µ –æ—Å–∏–ª–∏—Ç –¥–æ–ª–≥ –≤ 1,6 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ü—Ä–æ—Ü–µ–¥—É—Ä–∞ –±–∞–Ω–∫—Ä–æ—Ç—Å—Ç–≤–∞ –ø—Ä–æ–¥–ª–∏—Ç—Å—è –¥–æ –º–∞—Ä—Ç–∞ 2026 –≥–æ–¥–∞. –ù–∞ —Å—É—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–µ –≤–æ–∑–º–µ—â–µ–Ω–∏–µ –¥–æ–ª–≥–æ–≤ –∫—Ä–µ–¥–∏—Ç–æ—Ä–∞–º —Ä–∞—Å—Å—á–∏—Ç—ã–≤–∞—Ç—å –Ω–µ –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è, —É—á–∏—Ç—ã–≤–∞—è –∏–º–µ—é—â–∏–µ—Å—è —É –¥–æ–ª–∂–Ω–∏–∫–∞ –∞–∫—Ç–∏–≤—ã –≤ 35 –º–ª–Ω —Ä—É–±–ª–µ–π. 2024 –≥–æ–¥ ¬´–ú–∞—Å—Ç–µ—Ä–ü–ª–∞–∑–º–∞¬ª –∑–∞–∫–æ–Ω—á–∏–ª–∞ —Å –≤—ã—Ä—É—á–∫–æ–π –≤ 0 —Ä—É–±–ª–µ–π –∏ –ø—Ä–∏–±—ã–ª—å—é –≤ - 48 –º–ª–Ω —Ä—É–±–ª–µ–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""A subsidiary of 'Farmstand' has been declared bankrupt. 'MasterPlasma', a subsidiary of 'Farmstand', was declared bankrupt on October 27, 2025. The company is under –∫–æ–Ω–∫—É—Ä—Åative proceedings with Konstantin Pavlov appointed as the supervisor. Previously, Igor Gavrov was the head of the company and also served as the former CEO of 'Farmstand Plazma'. The liquidation of financially troubled 'Farmstand's subsidiary was decided in summer 2024, when it became clear that 'MasterPlasma', specializing in wholesale of pharmaceutical products, could not bear a debt of 1.6 billion rubles. The bankruptcy procedure will last until March 2026. Creditors are not expected to receive significant compensation, as the company's assets amount to 35 million rubles. 'MasterPlasma' ended the year with zero revenue and a loss of 48 million rubles.""
}"
2025-11-05T14:32:07+00:00,@bezrec,6779,https://t.me/bezrec/6779,"¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª ¬´–ø—Ä–æ–∫–∞—á–∞–ª¬ª —Å–≤–æ–π —Å–µ–º–∞–≥–ª—É—Ç–∏–¥ –¥–æ the one and only. –ö–æ–º–ø–∞–Ω–∏—è –ü–µ—Ç—Ä–∞ –ë–µ–ª–æ–≥–æ –ø–æ–ª—É—á–∏–ª–∞ —Ä–µ–≥—É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏–µ –Ω–∞ –°–µ–º–∞–ª—å—Ç–∞—Ä—É ‚Äî –ø–µ—Ä–≤—ã–π –∏ –ø–æ–∫–∞ –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–π –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π —Å–µ–º–∞–≥–ª—É—Ç–∏–¥ –≤ —Ç–∞–±–ª–µ—Ç–∏—Ä–æ–≤–∞–Ω–Ω–æ–π —Ñ–æ—Ä–º–µ –≤ –¥–æ–∑–∏—Ä–æ–≤–∫–∞—Ö 3 –º–≥, 7 –º–≥ –∏ 14 –º–≥. –í–æ–∑–º–æ–∂–Ω–æ, —Ç–∞–∫ –ø–æ–ª—É—á–∏—Ç—Å—è –¥–æ–≥–Ω–∞—Ç—å –≥–ª–∞–≤–Ω–æ–≥–æ –∫–æ–Ω–∫—É—Ä–µ–Ω—Ç–∞ ‚Äî ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª, –∫–æ—Ç–æ—Ä—ã–π –ø–æ–∫–∞ —Å–æ—Ö—Ä–∞–Ω—è–µ—Ç –ª–∏–¥–µ—Ä—Å—Ç–≤–æ –ø–æ –ø—Ä–æ–¥–∞–∂–∞–º –∞–Ω–∞–ª–æ–≥–æ–≤ –û–∑–µ–º–ø–∏–∫–∞ (2,2 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ –°–µ–º–∞–≤–∏–∫–∞ –Ω–∞ 13 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –∫–≤–∏–Ω—Å–µ–Ω—Ç–æ–≤—Å–∫–∏–º–∏ 609 —Ç—ã—Å. —É–ø–∞–∫–æ–≤–æ–∫ –Ω–∞ 3,3 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –ø–æ –∏—Ç–æ–≥–∞–º 9 –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞). –ò–Ω—Ç–µ—Ä–µ—Å–Ω–æ, ¬´–õ–µ–Ω–∏–Ω–≥—Ä–∞–¥¬ª —É–∂–µ –ø–æ–¥–±–∏—Ä–∞–µ—Ç —Ä–∏—Ñ–º—É –∫ —Å–ª–æ–≤—É ¬´–°–µ–º–∞–ª—å—Ç–∞—Ä–∞¬ª? –¢–∞–∫, —á—Ç–æ–±—ã —Ü–µ–ø–ª—è–ª–æ, –∑–∞–ø–æ–º–∏–Ω–∞–ª–æ—Å—å, –∏ –§–ê–° –≤ —Ä–µ–∫–ª–∞–º–µ –Ω–µ –∑–∞–ø–æ–¥–æ–∑—Ä–∏–ª–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, sanctions, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The company of Petros Belo has received approval for Semaltar, the only domestic semaglutide in tablet form at 3mg, 7mg, and 14mg doses. This could help catch the main competitor 'Gerofarm', which still leads in sales of similar Osevik analogs (2.2 million units of Semavik compared to 609 thousand units of Osevik in the first nine months of 2025). It is interesting to see if 'Lenning' is already picking up rhymes with the word 'Semalatar', so that it doesn't get caught by the FAS in advertising.""
}"
2025-11-05T11:33:03+00:00,@bezrec,6778,https://t.me/bezrec/6778,"–†–æ—Å—Å–∏–π—Å–∫–∏–µ –∞–Ω–µ—Å—Ç–µ–∑–∏–æ–ª–æ–≥–∏ –¥–æ–∂–¥–∞–ª–∏—Å—å —Ä–µ–º–∏—Ñ–µ–Ω—Ç–∞–Ω–∏–ª. –í ¬´–ö–æ–º–º—É–Ω–∞—Ä–∫–µ¬ª –≤–ø–µ—Ä–≤—ã–µ –≤ –†–æ—Å—Å–∏–∏ –ø—Ä–æ–æ–ø–µ—Ä–∏—Ä–æ–≤–∞–ª–∏ –ø–∞—Ü–∏–µ–Ω—Ç–∞ —Å –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ–º –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ –†–µ–º–∏—Ñ–µ–Ω—Ç–∞–Ω–∏–ª–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ú–æ—Å–∫–æ–≤—Å–∫–æ–≥–æ —ç–Ω–¥–æ–∫—Ä–∏–Ω–Ω–æ–≥–æ –∑–∞–≤–æ–¥–∞. –ê–Ω–∞–ª—å–≥–µ—Ç–∏–∫ –≤—Ö–æ–¥–∏—Ç –≤ –Ω–µ–∫–æ—Ç–æ—Ä—ã–µ –ø—Ä–æ—Ç–æ–∫–æ–ª—ã –≤–Ω—É—Ç—Ä–∏–≤–µ–Ω–Ω–æ–≥–æ –∏ –∫–æ–º–±–∏–Ω–∏—Ä–æ–≤–∞–Ω–Ω–æ–≥–æ –Ω–∞—Ä–∫–æ–∑–∞ –∏ –±—ã–ª –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω –≤ —Å–µ–Ω—Ç—è–±—Ä–µ 2024 –≥–æ–¥–∞. –ï–≥–æ –æ—Ç–ª–∏—á–∞–µ—Ç —Å–∏–ª—å–Ω–æ–µ (–≤ 100-200 —Ä–∞–∑ —Å–∏–ª—å–Ω–µ–µ –º–æ—Ä—Ñ–∏–Ω–∞), –Ω–æ –∫–æ—Ä–æ—Ç–∫–æ–µ –¥–µ–π—Å—Ç–≤–∏–µ, –∏–∑-–∑–∞ —á–µ–≥–æ –ø—Ä–æ–∏—Å—Ö–æ–¥–∏—Ç –±—ã—Å—Ç—Ä–æ–µ –≤–æ—Å—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ –¥—ã—Ö–∞–Ω–∏—è –ø–æ—Å–ª–µ –ø—Ä–µ–∫—Ä–∞—â–µ–Ω–∏—è –∏–Ω—Ñ—É–∑–∏–∏. –≠—Ç–æ –ø–æ–∑–≤–æ–ª—è–µ—Ç –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç –∏ –¥–ª—è –∫—Ä–∞—Ç–∫–æ–≤—Ä–µ–º–µ–Ω–Ω—ã—Ö –≤–º–µ—à–∞—Ç–µ–ª—å—Å—Ç–≤, –∞ —Ç–∞–∫–∂–µ —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –ø–æ—á–µ—á–Ω–æ–π, –ø–µ—á–µ–Ω–æ—á–Ω–æ–π –∏–ª–∏ —Å–µ—Ä–¥–µ—á–Ω–æ–π –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ—Å—Ç—å—é. –í —Ç–æ–º —á–∏—Å–ª–µ, –æ–Ω –ø–æ–¥—Ö–æ–¥–∏—Ç –±–µ—Ä–µ–º–µ–Ω–Ω—ã–º, –∫–æ—Ç–æ—Ä—ã–º –ø—Ä–æ—Ç–∏–≤–æ–ø–æ–∫–∞–∑–∞–Ω–∞ —ç–ø–∏–¥—É—Ä–∞–ª—å–Ω–∞—è –∞–Ω–µ—Å—Ç–µ–∑–∏—è. –î–æ —Å–∏—Ö –ø–æ—Ä –ø—Ä—è–º—ã—Ö –∞–Ω–∞–ª–æ–≥–æ–≤ —É —Ä–µ–º–∏—Ñ–µ–Ω—Ç–∞–Ω–∏–ª–∞ –Ω–µ –±—ã–ª–æ. –í–Ω–µ–¥—Ä–µ–Ω–∏–µ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–π –≤–µ—Ä—Å–∏–∏ —Å–Ω–∏–∑–∏—Ç —Ñ–∏–Ω–∞–Ω—Å–æ–≤—É—é –Ω–∞–≥—Ä—É–∑–∫—É –Ω–∞ –∫–ª–∏–Ω–∏–∫–∏, –Ω–æ –∫–ª—é—á–µ–≤–æ–π –≤–æ–ø—Ä–æ—Å, –≥–æ—Ç–æ–≤—ã –ª–∏ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã–µ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—è –æ–±–µ—Å–ø–µ—á–∏—Ç—å –æ–±—É—á–µ–Ω–∏–µ –ø–µ—Ä—Å–æ–Ω–∞–ª–∞. –ï—Å–ª–∏ –∞–Ω–µ—Å—Ç–µ–∑–∏–æ–ª–æ–≥–∏ –æ—Å–≤–æ—è—Ç —Ç–æ–Ω–∫–æ—Å—Ç–∏ –¥–æ–∑–∏—Ä–æ–≤–∞–Ω–∏—è, —Ç–æ —Å–ø—Ä–æ—Å –Ω–∞ —ç—Ç–æ—Ç –ø—Ä–µ–ø–∞—Ä–∞—Ç –º–æ–∂–µ—Ç –≤—ã—Ä–∞—Å—Ç–∏ –≤ —Ä–∞–∑—ã. –ù–æ –µ—Å–ª–∏ –ø–æ–¥—Ö–æ–¥–∏—Ç—å –∫ –Ω–µ–º—É –∫–∞–∫ –∫ –æ–±—ã—á–Ω–æ–º—É –æ–ø–∏–æ–∏–¥—É, —Ä–∏—Å–∫–∏ –æ—Å–ª–æ–∂–Ω–µ–Ω–∏–π –≤–æ–∑—Ä–∞—Å—Ç—É—Ç, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª ¬´–ò–∑–≤–µ—Å—Ç–∏—è–º¬ª –∑–∞–≤–æ—Ç–¥–µ–ª–µ–Ω–∏–µ–º –∞–Ω–µ—Å—Ç–µ–∑–∏–æ–ª–æ–≥–∏–∏ –∏ —Ä–µ–∞–Ω–∏–º–∞—Ü–∏–∏ –∫–ª–∏–Ω–∏–∫–∏ ¬´–ï–≤—Ä–æ–æ–Ω–∫–æ¬ª –≤ –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥–µ –û–º–∞—Ä –ñ–∞—à—É–µ–≤. –ú–æ—Å–∫–æ–≤—Å–∫–∏–π —ç–Ω–¥–æ–∫—Ä–∏–Ω–Ω—ã–π –∑–∞–≤–æ–¥ ‚Äî –æ—Å–Ω–æ–≤–Ω–æ–π –∏–≥—Ä–æ–∫ –Ω–∞ —Ä—ã–Ω–∫–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –∞–Ω–µ—Å—Ç–µ–∑–∏–∏ ‚Äî –ø–æ –¥–∞–Ω–Ω—ã–º RNC Pharma, –∫–æ–º–ø–∞–Ω–∏—è –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç —á–µ—Ç—ã—Ä–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –∏–∑ –ø—è—Ç–∏. –í —Ç–æ–º —á–∏—Å–ª–µ, –ú–≠–ó –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–π –∏–º–µ–µ—Ç –±–µ—Å—Å—Ä–æ—á–Ω–æ–µ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–æ–Ω–Ω–æ–µ —É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏–µ –Ω–∞ —Ñ–µ–Ω—Ç–∞–Ω–∏–ª, –∫–æ—Ç–æ—Ä—ã–π –º–æ–∂–µ—Ç —Å—á–∏—Ç–∞—Ç—å—Å—è –Ω–µ–ø—Ä—è–º—ã–º –∞–Ω–∞–ª–æ–≥–æ–º —Ä–µ–º–∏—Ñ–µ–Ω—Ç–∞–Ω–∏–ª–∞. –ö–∞–∫ –ø–æ–¥—Å—á–∏—Ç–∞–ª–∏ –≤ DSM Group, –≤ 2024 –≥–æ–¥—É –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–æ –∑–∞–∫—É–ø–∏–ª–æ 3,5 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ –∞–Ω–µ—Å—Ç–µ—Ç–∏–∫–æ–≤. –í —è–Ω–≤–∞—Ä–µ‚Äì—Å–µ–Ω—Ç—è–±—Ä–µ 2025 –≥–æ–¥–∞ ‚Äî 2,4 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫. –ò–∑ –Ω–∏—Ö –≤ 2024 –≥–æ–¥—É –¥–æ–ª—è –ª–æ–∫–∞–ª–∏–∑–æ–≤–∞–Ω–Ω—ã—Ö —Å–æ—Å—Ç–∞–≤–∏–ª–∞ 72%, –∞ –≤ —è–Ω–≤–∞—Ä–µ‚Äì—Å–µ–Ω—Ç—è–±—Ä–µ —ç—Ç–æ–≥–æ –≥–æ–¥–∞ –¥–æ—Å—Ç–∏–≥–ª–∞ 89%. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The Russian anesthesiologists have received remifentanil. Remifentanil, a domestically produced innovative analgesic from the Moscow Endocrinological Plant, was first operated on patients in 'Komuna' in Russia. The drug is included in some protocols for intravenous and combined anesthesia, and was registered in September 2024. It is distinguished by a strong (100-200 times stronger than morphine) but short-term action, allowing for rapid recovery of breathing after discontinuing the infusion. This makes it suitable for short-term interventions and patients with renal, hepatic, or cardiac insufficiency. Until now, there were no direct analogues of remifentanil. The introduction of the domestic version will reduce financial burden on clinics, but the key question is whether regional hospitals are ready to train their staff. If anesthesiologists master the dosing techniques, demand for this drug could increase significantly. However, if approached as an ordinary opioid, the risks of complications will increase.""
}"
2025-11-05T09:00:01+00:00,@bezrec,6777,https://t.me/bezrec/6777,"–í –†–æ—Å—Å–∏–∏ –ø–∞–¥–∞–µ—Ç —Å–ø—Ä–æ—Å –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –æ—Ç –±–æ–ª–∏ –≤ –≥–æ—Ä–ª–µ. –ü–æ –∏—Ç–æ–≥–∞–º 1-3 –∫–≤–∞—Ä—Ç–∞–ª–∞ 2025 –≥–æ–¥–∞ —Ä–∞—Å—Ö–æ–¥—ã –Ω–∞ —ç—Ç—É –∫–∞—Ç–µ–≥–æ—Ä–∏—é –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤—ã—Ä–æ—Å–ª–∏ –Ω–∞ 12% –≥–æ–¥ –∫ –≥–æ–¥—É, —Ç–æ–≥–¥–∞ –∫–∞–∫ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–µ –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–µ —Å–Ω–∏–∑–∏–ª–æ—Å—å –Ω–∞ 2,1%. –°–Ω–∏–∂–µ–Ω–∏–µ –ø—Ä–æ–¥–∞–∂ –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö –∞–Ω–∞–ª–∏—Ç–∏–∫–∏ RNC Pharma —Ñ–∏–∫—Å–∏—Ä—É—é—Ç —Ç—Ä–µ—Ç–∏–π –≥–æ–¥ –ø–æ–¥—Ä—è–¥. –¢–∞–∫–∞—è –¥–∏–Ω–∞–º–∏–∫–∞ —Å–≤—è–∑–∞–Ω–∞ —Å —Ä–æ—Å—Ç–æ–º —Å—Ä–µ–¥–Ω–µ–π —Å—Ç–æ–∏–º–æ—Å—Ç–∏ —ç—Ç–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ ‚Äî —Ç–∞–∫, –µ—Å–ª–∏ –≤ 2022 –≥–æ–¥—É –æ–¥–Ω–∞ —É—Å–ª–æ–≤–Ω–∞—è —É–ø–∞–∫–æ–≤–∫–∞ —Å—Ç–æ–∏–ª–∞ –Ω–µ –¥–æ—Ä–æ–∂–µ 309 —Ä—É–±–ª–µ–π, —Ç–æ –≤ —Ç–µ–∫—É—â–µ–º –≥–æ–¥—É ‚Äî —É–∂–µ 420 —Ä—É–±–ª–µ–π. –í 2025 –≥–æ–¥—É –ø–∏–∫ –ø—Ä–æ–¥–∞–∂ –ø—Ä–∏—à—ë–ª—Å—è –Ω–∞ —Å–µ–Ω—Ç—è–±—Ä—å ‚Äî –≤ –ø–µ—Ä–≤—ã–π –º–µ—Å—è—Ü –æ—Å–µ–Ω–∏ –∞–ø—Ç–µ–∫–∏ –ø—Ä–æ–¥–∞–ª–∏ 13,8 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ –Ω–∞ 5,1 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ü–æ –∏—Ç–æ–≥–∞–º –¥–µ–≤—è—Ç–∏ –º–µ—Å—è—Ü–µ–≤ –≤ —Ä–æ–∑–Ω–∏—Ü–µ –ø—Ä–∏—Å—É—Ç—Å—Ç–≤–æ–≤–∞–ª–æ 85 —Ç–æ—Ä–≥–æ–≤—ã—Ö –º–∞—Ä–æ–∫ –æ—Ç 88 –∫–æ–º–ø–∞–Ω–∏–π. –ù–∞–∏–±–æ–ª—å—à–∞—è –¥–æ–ª—è –≤ –≥—Ä—É–ø–ø–µ (>60%) –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ —Ç–∞–±–ª–µ—Ç–∫–∏ –∏ –ø–∞—Å—Ç–∏–ª–∫–∏ –¥–ª—è —Ä–∞—Å—Å–∞—Å—ã–≤–∞–Ω–∏—è. –í –ª–∏–¥–µ—Ä–∞—Ö ‚Äî –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π –ì—Ä–∞–º–º–∏–¥–∏–Ω –æ—Ç ¬´–í–∞–ª–µ–Ω—Ç—ã¬ª ‚Äî —Å –Ω–∞—á–∞–ª–∞ –≥–æ–¥–∞ –ø–æ–∫—É–ø–∞—Ç–µ–ª–∏ –ø–æ—Ç—Ä–∞—Ç–∏–ª–∏ –Ω–∞ –Ω–µ–≥–æ –±–æ–ª–µ–µ 6 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –í—Ç–æ—Ä–æ–µ –º–µ—Å—Ç–æ ‚Äî —É –°—Ç—Ä–µ–ø—Å–∏–ª—Å–∞ (¬´–†–µ–∫–∏—Ç—Ç –ë–µ–Ω–∫–∏–∑–µ—Ä¬ª), —Ç—Ä–µ—Ç—å–µ ‚Äî —É –¢–∞–Ω—Ç—É–º–∞ –æ—Ç ¬´–°–∏—ç—Å—Å–∏¬ª. –ü–æ —Ä—É–±–ª—ë–≤–æ–π –¥–∏–Ω–∞–º–∏–∫–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç —Ç–æ–∂–µ —Ç—Ä–µ—Ç–∏–π, –µ–≥–æ –æ–ø–µ—Ä–µ–∂–∞—é—Ç –î–æ—Ä–∏—Ç—Ä–∏—Ü–∏–Ω –æ—Ç ¬´–ú–µ–¥–∏—Ü–µ –§–∞—Ä–º–∞¬ª –∏ –õ–∏–º—Ñ–æ–º–∏–æ–∑–æ—Ç –æ—Ç ¬´–•–µ–µ–ª—å¬ª. –û—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω–æ–π –¥–∏–Ω–∞–º–∏–∫–æ–π –æ—Ç–º–µ—Ç–∏–ª–∏—Å—å –°–µ–ø—Ç–æ–ª–µ—Ç–µ (¬´–ö–†–ö–ê¬ª) –∏ –ò–Ω–≥–∞–ª–∏–ø—Ç (¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç¬ª + 11 –∏–≥—Ä–æ–∫–æ–≤). –ü–æ–º–∏–º–æ –ø–µ—Ä–µ—á–∏—Å–ª–µ–Ω–Ω—ã—Ö –±—Ä–µ–Ω–¥–æ–≤ –≤ —Ç–æ–ø-10 —Ç–æ—Ä–≥–æ–≤—ã—Ö –º–∞—Ä–æ–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –≥–æ—Ä–ª–∞ –≤–æ—à–ª–∏: –ê–Ω–≥–∏–¥–∞–∫ (¬´–ì—Ä–æ—Ç–µ–∫—Å¬ª), –õ–∏–∑–æ–±–∞–∫—Ç (¬´–ë–æ—Å–Ω–∞–ª–µ–∫¬ª), –§–∞—Ä–∏–Ω–≥–æ—Å–µ–ø—Ç (¬´–°–∞–Ω –§–∞—Ä–º–∞—Å—å—é—Ç–∏–∫–∞–ª¬ª). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, shortage"",
  ""impact"": ""medium"",
  ""english"": ""There is a decline in natural consumption of pain relief medications for throat conditions. Sales have decreased by 2.1% year-over-year despite a 12% increase in overall spending on the category from January to September 2025. The decline is attributed to an increase in the average cost of these medications, with a single unit now costing 420 rubles compared to 309 rubles in 2022. The third quarter of the year saw peak sales, with over 13.8 million units sold for a total revenue of 5.1 billion rubles.""
}"
2025-11-05T05:33:09+00:00,@bezrec,6776,https://t.me/bezrec/6776,"–õ—é–±–æ–ø—ã—Ç–Ω—ã–π —Ñ–∞–∫—Ç –¥–ª—è –≤–∞—à–µ–≥–æ –ø–æ—Å–ª–µ–ø—Ä–∞–∑–¥–Ω–∏—á–Ω–æ–≥–æ —É—Ç—Ä–∞. –ù–∞–∑–≤–∞–Ω–æ —Å–∞–º–æ–µ –¥–ª–∏–Ω–Ω–æ–µ —Å–ª–æ–≤–æ —Ä—É—Å—Å–∫–æ–≥–æ —è–∑—ã–∫–∞, –∏ –æ–Ω–æ —Å —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–º ¬´—É–∫–ª–æ–Ω–æ–º¬ª. –í–æ—Å–ø–æ–ª—å–∑–æ–≤–∞–≤—à–∏—Å—å –ø–æ–º–æ—â—å—é –ò–ò, –º—ã –≤—ã—è—Å–Ω–∏–ª–∏, —á—Ç–æ –Ω–∞ —Å—Ç–∞—Ç—É—Å —Å–∞–º–æ–≥–æ –¥–ª–∏–Ω–Ω–æ–≥–æ —Ä—É—Å—Å–∫–æ–≥–æ —Å–ª–æ–≤–∞, –ø–æ-–≤–∏–¥–∏–º–æ–º—É, –ø—Ä–µ—Ç–µ–Ω–¥—É–µ—Ç –ø—Ä–∏–ª–∞–≥–∞—Ç–µ–ª—å–Ω–æ–µ ¬´—Ç–µ—Ç—Ä–∞–≥–∏–¥—Ä–æ–ø–∏—Ä–∞–Ω–∏–ª—Ü–∏–∫–ª–æ–ø–µ–Ω—Ç–∏–ª—Ç–µ—Ç—Ä–∞–≥–∏–¥—Ä–æ–ø–∏—Ä–∏–¥–æ–ø–∏—Ä–∏–¥–∏–Ω–æ–≤—ã–µ¬ª –∏–∑ 55 –±—É–∫–≤, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª –∑–∞–≤–µ–¥—É—é—â–∏–π –∫–∞—Ñ–µ–¥—Ä–æ–π –æ–±—â–µ–≥–æ –∏ —Ä—É—Å—Å–∫–æ–≥–æ —è–∑—ã–∫–æ–∑–Ω–∞–Ω–∏—è –ò–Ω—Å—Ç–∏—Ç—É—Ç–∞ –ü—É—à–∫–∏–Ω–∞ –ü–∞–≤–µ–ª –ö–∞—Ç—ã—à–µ–≤. –°–ª–æ–≤–æ –∏—Å–ø–æ–ª—å–∑—É–µ—Ç—Å—è –¥–ª—è –æ–ø–∏—Å–∞–Ω–∏—è —Å–æ–µ–¥–∏–Ω–µ–Ω–∏–π, –ø—Ä–∏–º–µ–Ω—è–µ–º—ã—Ö –≤ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏. –í —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, –æ–Ω–æ –≤—Å—Ç—Ä–µ—á–∞–µ—Ç—Å—è –≤ –ø–∞—Ç–µ–Ω—Ç–µ –Ω–∞ –∏–∑–æ–±—Ä–µ—Ç–µ–Ω–∏–µ, –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∞—â–µ–º ¬´–ú–µ—Ä–∫¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-11-04T11:01:05+00:00,@bezrec,6775,https://t.me/bezrec/6775,"–ù–æ–≤—ã–π –ø–æ–¥–≥–æ–Ω –æ—Ç —é–≤–µ–ª–∏—Ä–æ–≤ ‚Äî –¥–ª—è —Ç–µ—Ö, –∫—Ç–æ –≤—ã–Ω—É–∂–¥–µ–Ω –Ω–æ—Å–∏—Ç—å —Å —Å–æ–±–æ–π —Ç–∞–±–ª–µ—Ç–∫–∏ –∏ —Ö–æ—á–µ—Ç –¥–µ–ª–∞—Ç—å —ç—Ç–æ –∫—Ä–∞—Å–∏–≤–æ. –í –æ—Ç–ª–∏—á–∏–µ –æ—Ç –∫–æ–ª–µ—á–∫–∞ —Å –ó–æ–ª–æ—Ñ—Ç–æ–º –∏–ª–∏ –∫—É–ª–æ–Ω–æ–≤ –≤ —Ñ–æ—Ä–º–µ –∫–∞–ø—Å—É–ª, —ç—Ç–æ –∏–∑–¥–µ–ª–∏–µ –Ω–µ —Ç–æ–ª—å–∫–æ –∫—Ä–∞—Å–∏–≤–æ–µ, –Ω–æ –∏ —Ñ—É–Ω–∫—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–µ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-11-03T11:04:32+00:00,@bezrec,6774,https://t.me/bezrec/6774,"¬´–ù–µ –æ—Ç—Ö–æ–¥—ã, –∞ –Ω–∞—Å—Ç–æ—è—â–µ–µ —Å–æ–∫—Ä–æ–≤–∏—â–µ¬ª: —Å—Ç–∞—Ä—Ç–∞–ø—ã –∫–∏–Ω—É–ª–∏—Å—å –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç—å –º–µ–Ω—Å—Ç—Ä—É–∞–ª—å–Ω—É—é –∫—Ä–æ–≤—å. The Guardian –ø–∏—à–µ—Ç, —á—Ç–æ —Ñ–µ–º—Ç–µ—Ö –æ–±—Ä–∞—Ç–∏–ª –≤–Ω–∏–º–∞–Ω–∏–µ –Ω–∞ –ø–æ–ª–µ–∑–Ω—ã–µ —Å–≤–æ–π—Å—Ç–≤–∞ —ç—Ç–æ–π –Ω–µ–¥–æ–æ—Ü–µ–Ω–µ–Ω–Ω–æ–π –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π –∂–∏–¥–∫–æ—Å—Ç–∏. –°—Ä–∞–∑—É –Ω–µ—Å–∫–æ–ª—å–∫–æ —Å—Ç–∞—Ä—Ç–∞–ø–æ–≤ —Å—á–∏—Ç–∞—é—Ç –µ—ë –º–∞–ª–æ–∏–∑—É—á–µ–Ω–Ω—ã–º –∏—Å—Ç–æ—á–Ω–∏–∫–æ–º –æ–±—Ä–∞–∑—Ü–æ–≤, –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–π –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª –∫–æ—Ç–æ—Ä–æ–≥–æ —Ç–æ–ª—å–∫–æ —Å–µ–π—á–∞—Å –Ω–∞—á–∏–Ω–∞–µ—Ç –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç—å—Å—è —Å –æ—Å–æ–±–æ–π —Ç—â–∞—Ç–µ–ª—å–Ω–æ—Å—Ç—å—é. –≠—Ç–æ, –æ—á–µ–≤–∏–¥–Ω–æ, –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–π –æ–±—Ä–∞–∑–µ—Ü, –∫–æ—Ç–æ—Ä—ã–π —Å–æ–≤–µ—Ä—à–µ–Ω–Ω–æ –Ω–µ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–ª—Å—è. –ï–≥–æ —Å—á–∏—Ç–∞—é—Ç –æ—Ç—Ö–æ–¥–∞–º–∏, –Ω–æ –Ω–∞ —Å–∞–º–æ–º –¥–µ–ª–µ —ç—Ç–æ –Ω–∞—Å—Ç–æ—è—â–µ–µ —Å–æ–∫—Ä–æ–≤–∏—â–µ, ‚Äî –≥–æ–≤–æ—Ä–∏—Ç –ö—Ä–∏—Å—Ç–∏–Ω –ú–µ—Ç—Ü, —Å–æ—Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å –ø—Ä–æ–µ–∫—Ç–∞ ¬´–ò—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –ø–µ—Ä–µ—Ö–∏—Ç—Ä–∏–ª–∏ —ç–Ω–¥–æ–º–µ—Ç—Ä–∏–æ–∑¬ª –≤ –ò–Ω—Å—Ç–∏—Ç—É—Ç–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –§–∞–π–Ω—à—Ç–µ–π–Ω–∞. –ê–¥–µ–ø—Ç—ã –Ω–æ–≤–æ–≥–æ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è —Å—á–∏—Ç–∞—é—Ç, —á—Ç–æ –º–Ω–æ–≥–∏–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –≤ –æ–±–ª–∞—Å—Ç–∏ –∂–µ–Ω—Å–∫–æ–≥–æ –∑–¥–æ—Ä–æ–≤—å—è –∫–∞—Ç–∞—Å—Ç—Ä–æ—Ñ–∏—á–µ—Å–∫–∏ –Ω–µ–¥–æ—Ñ–∏–Ω–∞–Ω—Å–∏—Ä—É—é—Ç—Å—è –∏–∑-–∑–∞ —Å–æ—Ö—Ä–∞–Ω—è—é—â–µ–π—Å—è –≥–µ–Ω–¥–µ—Ä–Ω–æ–π –ø—Ä–µ–¥–≤–∑—è—Ç–æ—Å—Ç–∏ –∏ –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–π —Å—Ç–∏–≥–º—ã, —Å–≤—è–∑–∞–Ω–Ω–æ–π —Å –º–µ–Ω—Å—Ç—Ä—É–∞—Ü–∏–µ–π –∏ —Ä–µ–ø—Ä–æ–¥—É–∫—Ç–∏–≤–Ω—ã–º –∑–¥–æ—Ä–æ–≤—å–µ–º. –ú–µ–∂–¥—É —Ç–µ–º, –ø–æ –º–Ω–µ–Ω–∏—é —Å—Ç—É–ø–∏–≤—à–∏—Ö –Ω–∞ —ç—Ç—É terra incognita, –∑–∞–±–æ—Ä –º–µ–Ω—Å—Ç—Ä—É–∞–ª—å–Ω–æ–π –∫—Ä–æ–≤–∏ ‚Äî —ç—Ç–æ –Ω–µ–∏–Ω–≤–∞–∑–∏–≤–Ω—ã–π –∏ –ø—Ä–æ—Å—Ç–æ–π –≤ –ø–æ–ª—É—á–µ–Ω–∏–∏ –∞–Ω–∞–ª–∏–∑, —É–Ω–∏–∫–∞–ª—å–Ω—ã–π —Ç–µ–º, —á—Ç–æ —Å–æ–¥–µ—Ä–∂–∏—Ç –∫–ª–µ—Ç–∫–∏ –∏ –º–æ–ª–µ–∫—É–ª—ã, –æ—Ç—Ä–∞–∂–∞—é—â–∏–µ —Å–æ—Å—Ç–æ—è–Ω–∏–µ –º–∞—Ç–∫–∏, –∏ —Å–ø–æ—Å–æ–±–µ–Ω —Å–æ–æ–±—â–∞—Ç—å –≤—Ä–∞—á–∞–º –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é, –∫–æ—Ç–æ—Ä—É—é –Ω–µ –ø–æ–ª—É—á–∏—Ç—å –∏–∑ –¥—Ä—É–≥–∏—Ö –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –∂–∏–¥–∫–æ—Å—Ç–µ–π. –í —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, –º–µ–Ω—Å—Ç—Ä—É–∞–ª—å–Ω–∞—è –∫—Ä–æ–≤—å –º–æ–≥–ª–∞ –±—ã –±—ã—Ç—å –ø–æ–ª–µ–∑–Ω–∞ –¥–ª—è —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –Ω–æ–≤—ã—Ö –º–µ—Ç–æ–¥–æ–≤ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∏ –∏ –ª–µ—á–µ–Ω–∏—è —ç–Ω–¥–æ–º–µ—Ç—Ä–∏–æ–∑–∞. –ü—Ä–∏–º–µ—Ä—ã —Å—Ç–∞—Ä—Ç–∞–ø–æ–≤: üü© NextGen Jane –æ—Å–Ω–æ–≤–Ω—ã–º –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏–µ–º —Å–≤–æ–µ–π –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –≤—ã–±—Ä–∞–ª–∞ —Å–æ–∑–¥–∞–Ω–∏–µ –Ω–µ–∏–Ω–≤–∞–∑–∏–≤–Ω–æ–≥–æ –¥–æ–º–∞—à–Ω–µ–≥–æ —Ç–µ—Å—Ç–∞ –Ω–∞ —ç–Ω–¥–æ–º–µ—Ç—Ä–∏–æ–∑. –í –Ω–∞—á–∞–ª–µ —Å–≤–æ–µ–≥–æ –ø—É—Ç–∏ –∫–æ–º–ø–∞–Ω–∏—è –ø—Ä–æ—Å–∏–ª–∞ –∂–µ–Ω—â–∏–Ω –ø—Ä–∏—Å—ã–ª–∞—Ç—å –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–Ω—ã–µ —Ç–∞–º–ø–æ–Ω—ã –ø–æ –ø–æ—á—Ç–µ, –∞ –∑–∞—Ç–µ–º —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª–∞ –Ω–∞–±–æ—Ä –¥–ª—è —Å–±–æ—Ä–∞ –æ–±—Ä–∞–∑—Ü–æ–≤ –Ω–∞ –¥–æ–º—É. üü© –í –ø—Ä–æ–µ–∫—Ç–µ Rose, —Ç–∞–∫–∂–µ —Ä–∞–±–æ—Ç–∞—é—â–µ–º –Ω–∞–¥ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏—á–µ—Å–∫–æ–π —Å–∏—Å—Ç–µ–º–æ–π –¥–ª—è –≤—ã—è–≤–ª–µ–Ω–∏—è —ç–Ω–¥–æ–º–µ—Ç—Ä–∏–æ–∑–∞, –≤–º–µ—Å—Ç–æ —Ç–∞–º–ø–æ–Ω–æ–≤ –¥–ª—è —Å–±–æ—Ä–∞ –æ–±—Ä–∞–∑—Ü–æ–≤ –∏—Å–ø–æ–ª—å–∑—É—é—Ç—Å—è –º–µ–Ω—Å—Ç—Ä—É–∞–ª—å–Ω—ã–µ —á–∞—à–∏, —á—Ç–æ –ø–æ–∑–≤–æ–ª—è–µ—Ç –ø–æ–ª—É—á–∏—Ç—å —Ü–µ–ª—ã–µ –∂–∏–≤—ã–µ –∫–ª–µ—Ç–∫–∏. üü© –ù–µ–º–µ—Ü–∫–∏–π —Å—Ç–∞—Ä—Ç–∞–ø Theblood —Å–æ–∑–¥–∞—ë—Ç –¥–æ–º–∞—à–Ω–∏–π —Ç–µ—Å—Ç –Ω–∞ —É—Ä–æ–≤–µ–Ω—å –ø–æ–ª–æ–≤—ã—Ö –≥–æ—Ä–º–æ–Ω–æ–≤, –∞ —Ç–∞–∫–∂–µ –∏–∑—É—á–∞–µ—Ç –º–∞—Ä–∫–µ—Ä—ã –≤–æ—Å–ø–∞–ª–µ–Ω–∏—è –¥–ª—è –≤—ã—è–≤–ª–µ–Ω–∏—è –∑–∞–∫–æ–Ω–æ–º–µ—Ä–Ω–æ—Å—Ç–µ–π, –∫–æ—Ç–æ—Ä—ã–µ –º–æ–≥—É—Ç —É–∫–∞–∑—ã–≤–∞—Ç—å –Ω–∞ —Ä–∞–Ω–Ω–µ–µ —Ä–∞–∑–≤–∏—Ç–∏–µ —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. üü© –ò—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª–∏ –∏–∑ –®–≤–µ–π—Ü–∞—Ä—Å–∫–æ–π –≤—ã—Å—à–µ–π —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–æ–π —à–∫–æ–ª—ã –¶—é—Ä–∏—Ö–∞ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∏ –Ω–µ—ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω—ã–π –¥–∞—Ç—á–∏–∫, –∫–æ—Ç–æ—Ä—ã–π –º–µ–Ω—è–µ—Ç —Ü–≤–µ—Ç –≤ –ø—Ä–∏—Å—É—Ç—Å—Ç–≤–∏–∏ –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–Ω—ã—Ö –±–µ–ª–∫–æ–≤ –≤ –º–µ–Ω—Å—Ç—Ä—É–∞–ª—å–Ω–æ–π –∫—Ä–æ–≤–∏, –∫–æ—Ç–æ—Ä—ã–µ –º–æ–≥—É—Ç —É–∫–∞–∑—ã–≤–∞—Ç—å –Ω–∞ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è, –≤ —Ç–æ–º —á–∏—Å–ª–µ –Ω–∞ —Ä–∞–∫. –ù–∞—Å–∫–æ–ª—å–∫–æ —É—Å–ø–µ—à–Ω–æ–π –±—É–¥–µ—Ç —ç–ø–æ–ø–µ—è –ø–æ ¬´–ø—Ä–∏—Ä—É—á–µ–Ω–∏—é¬ª –º–µ–Ω—Å—Ç—Ä—É–∞–ª—å–Ω–æ–π –∫—Ä–æ–≤–∏, –ø–æ–∫–∞–∂–µ—Ç –≤—Ä–µ–º—è. –ü–æ–∫–∞ —á—Ç–æ –Ω–∞ —É–º –Ω–µ–≤–æ–ª—å–Ω–æ –ø—Ä–∏—Ö–æ–¥–∏—Ç –Ω–∞—à—É–º–µ–≤—à–∞—è –∏—Å—Ç–æ—Ä–∏—è Theranos –∏ –µ–µ –æ—Å–Ω–æ–≤–∞—Ç–µ–ª—å–Ω–∏—Ü—ã –≠–ª–∏–∑–∞–±–µ—Ç –•–æ–ª–º—Å, –∫–æ—Ç–æ—Ä–∞—è –æ–±–µ—â–∞–ª–∞ —Å–æ–∑–¥–∞—Ç—å —á—É–¥–æ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∏ –ø–æ –∫–∞–ø–ª–µ –∫—Ä–æ–≤–∏, –∞ –≤ –∏—Ç–æ–≥–µ –ø–æ–ª—É—á–∏–ª–∞ 11 –ª–µ—Ç –∑–∞ –º–æ—à–µ–Ω–Ω–∏—á–µ—Å—Ç–≤–æ –∏ —Å–≥–æ–≤–æ—Ä —Å —Ü–µ–ª—å—é –æ–±–º–∞–Ω–∞ –∏–Ω–≤–µ—Å—Ç–æ—Ä–æ–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, regulation, safety, pharmacovigilance"",
  ""impact"": ""high"",
  ""english"": ""The Guardian article highlights the growing interest in menstrual blood, described as a largely unexplored biological fluid with significant clinical potential. Multiple startups view it as an underutilized source for research and development, particularly in conditions like endometriosis. The article mentions various startups working on home tests and diagnostic systems using menstrual blood samples, highlighting the unique insights they can provide. The comparison to Theranos serves as a cautionary tale about the challenges and potential risks in developing such diagnostic technologies.""
}"
2025-11-02T11:03:48+00:00,@bezrec,6773,https://t.me/bezrec/6773,"–û—Ç–¥—ã—Ö–∞–µ–º –ø–æ—Å–ª–µ –¥–ª–∏–Ω–Ω–æ–π —Ä–∞–±–æ—á–µ–π –Ω–µ–¥–µ–ª–∏ —Å –Ω–æ–≤—ã–º –≤—ã–ø—É—Å–∫–æ–º —Ä—É–±—Ä–∏–∫–∏ #–≤–¥–æ–≥–æ–Ω–∫—É. üíä ¬´–≠–Ω–¥–æ—Ñ–∞—Ä–º¬ª –æ–±–µ–∑–±–æ–ª–∏—Ç –∂–∏–≤–æ—Ç–Ω—ã—Ö. –ö–æ–º–ø–∞–Ω–∏—è —Å–æ–≤–º–µ—Å—Ç–Ω–æ —Å –û–û–û ¬´–≠–Ω–¥–æ–∫—Ä–∏–Ω–Ω—ã–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏¬ª –ø—Ä–∏—Å—Ç—É–ø–∏–ª–∞ –∫ –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ–º—É –≤—ã–ø—É—Å–∫—É –Ω–æ–≤–æ–≥–æ –≤–µ—Ç–µ—Ä–∏–Ω–∞—Ä–Ω–æ–≥–æ –æ–±–µ–∑–±–æ–ª–∏–≤–∞—é—â–µ–≥–æ ¬´–ù–µ—Ñ–æ–ø–∞–º-–í–ï–¢¬ª. –ü–µ—Ä–≤—É—é –ø–∞—Ä—Ç–∏—é –Ω–∞ 10 —Ç—ã—Å. —É–ø–∞–∫–æ–≤–æ–∫ –≤–≤–µ–¥—É—Ç –≤ –≥—Ä–∞–∂–¥–∞–Ω—Å–∫–∏–π –æ–±–æ—Ä–æ—Ç –≤ –¥–µ–∫–∞–±—Ä–µ 2025 –≥–æ–¥–∞. üíä ¬´–í–µ—Ä—Ç–µ–∫—Å¬ª –Ω–∞—Ä–∞—Å—Ç–∏–ª –≤—ã—Ä—É—á–∫—É –¥–æ 18,1 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –ø–æ –∏—Ç–æ–≥–∞–º —Ç—Ä—ë—Ö –∫–≤–∞—Ä—Ç–∞–ª–æ–≤ —Ç–µ–∫—É—â–µ–≥–æ –≥–æ–¥–∞. –≠—Ç–æ –ø–æ—á—Ç–∏ –Ω–∞ 20% –±–æ–ª—å—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É. –° –Ω–∞—á–∞–ª–∞ 2025 –≥–æ–¥–∞ –ø—Ä–æ–¥—É–∫—Ç–æ–≤—ã–π –ø–æ—Ä—Ç—Ñ–µ–ª—å –∫–æ–º–ø–∞–Ω–∏–∏ –ø–æ–ø–æ–ª–Ω–∏–ª—Å—è 20 –Ω–æ–≤—ã–º–∏ –ø–æ–∑–∏—Ü–∏—è–º–∏ —Å —É—á—ë—Ç–æ–º —Ä–∞–∑–Ω—ã—Ö —Ñ–∞—Å–æ–≤–æ–∫ –∏ –¥–æ–∑–∏—Ä–æ–≤–æ–∫. üíä –¢–∞—Ç—å—è–Ω–∞ –ì–æ–ª–∏–∫–æ–≤–∞ –æ–∑–≤—É—á–∏–ª–∞ –æ–±—ä—ë–º —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —Ñ–∞—Ä–º—Ä—ã–Ω–∫–∞. –ü–æ –∏—Ç–æ–≥–∞–º 2024 –≥–æ–¥–∞ –æ–Ω –ø—Ä–µ–≤—ã—Å–∏–ª 1,1 —Ç—Ä–ª–Ω —Ä—É–±–ª–µ–π. –î–æ–ª—è —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ –æ–±—â–µ–º –æ–±—ä—ë–º–µ –ø—Ä–æ–¥–∞–∂ —Å–æ—Å—Ç–∞–≤–ª—è–µ—Ç 67%, –∞ –≤ –æ–±—ä—ë–º–µ –≥–æ—Å–∑–∞–∫—É–ø–æ–∫ - 85%. üíä –ë–µ–ª—å–≥–∏—è —Å–æ–æ–±—â–∏–ª–∞ –æ —Ä–µ–∑–∫–æ–º —Ä–æ—Å—Ç–µ —ç–∫—Å–ø–æ—Ä—Ç–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ –†–æ—Å—Å–∏—é. –û—Ç–ª–∏—á–∏–ª—Å—è –æ–¥–∏–Ω —Ä–µ–≥–∏–æ–Ω ‚Äî –í–∞–ª–ª–æ–Ω–∏—è. –° —è–Ω–≤–∞—Ä—è –ø–æ –∏—é–Ω—å —ç–∫—Å–ø–æ—Ä—Ç –æ—Ç—Ç—É–¥–∞ –≤–¥–≤–æ–µ –ø—Ä–µ–≤—ã—Å–∏–ª –æ–±—ä—ë–º—ã –∑–∞ –≤–µ—Å—å –ø—Ä–µ–¥—ã–¥—É—â–∏–π –≥–æ–¥. –õ–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã - —ç—Ç–æ –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–π –≤–∏–¥ –ø—Ä–æ–¥—É–∫—Ü–∏–∏, –∫–æ—Ç–æ—Ä—ã–π –º—ã –µ—â—ë –º–æ–∂–µ–º —ç–∫—Å–ø–æ—Ä—Ç–∏—Ä–æ–≤–∞—Ç—å –≤ –†–æ—Å—Å–∏—é, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏ –≤ –í–∞–ª–ª–æ–Ω—Å–∫–æ–º –∞–≥–µ–Ω—Ç—Å—Ç–≤–µ –ø–æ —ç–∫—Å–ø–æ—Ä—Ç—É –∏ –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã–º –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏—è–º (Awex). üíä –í –†–æ—Å—Å–∏–∏ –±–æ–ª–µ–µ 47 –º–ª–Ω –ø—Ä–∏–≤–∏—Ç—ã—Ö –æ—Ç –≥—Ä–∏–ø–ø–∞. –¢–∞–∫–∏–µ —Ü–∏—Ñ—Ä—ã –æ–∑–≤—É—á–∏–ª–∞ –≥–ª–∞–≤–∞ –†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä–∞. –ê–Ω–Ω–∞ –ü–æ–ø–æ–≤–∞ –ø–æ—Ä—É—á–∏–ª–∞ –ø–æ–¥—á–∏–Ω—ë–Ω–Ω—ã–º —É—Å–∫–æ—Ä–∏—Ç—å —Ç–µ–º–ø—ã –∏–º–º—É–Ω–∏–∑–∞—Ü–∏–∏ —Å –æ—Å–æ–±—ã–º –≤–Ω–∏–º–∞–Ω–∏–µ–º –∫ –≥—Ä—É–ø–ø–∞–º —Ä–∏—Å–∫–∞ –∏ –∑–∞–≤–µ—Ä—à–∏—Ç—å –µ–µ –≤ –ø–µ—Ä–≤—É—é –¥–µ–∫–∞–¥—É –Ω–æ—è–±—Ä—è. üíä Pfizer –∏ Novo Nordisk —Å—É–¥—è—Ç—Å—è –∏–∑-–∑–∞ —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –æ—Ç –æ–∂–∏—Ä–µ–Ω–∏—è. –Ø–±–ª–æ–∫–æ–º —Ä–∞–∑–¥–æ—Ä–∞ –º–µ–∂–¥—É –¥–≤—É–º—è —Ñ–∞—Ä–º–≥–∏–≥–∞–Ω—Ç–∞–º–∏ —Å—Ç–∞–ª–∞ Metsera. –ò—Å—Ç—Ü–æ–º –≤—ã—Å—Ç—É–ø–∞–µ—Ç Pfizer, –∫–æ—Ç–æ—Ä—ã–π –Ω–∞–º–µ—Ä–µ–≤–∞–ª—Å—è –∫—É–ø–∏—Ç—å –∫–æ–º–ø–∞–Ω–∏—é –∑–∞ $7,3 –º–ª—Ä–¥ –∏ —É–∂–µ –¥–∞–∂–µ –∏–º–µ–ª –Ω–∞ —Ä—É–∫–∞—Ö –ø—Ä–µ–¥–≤–∞—Ä–∏—Ç–µ–ª—å–Ω–æ–µ –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å–Ω–æ–µ –æ–¥–æ–±—Ä–µ–Ω–∏–µ –§–µ–¥–µ—Ä–∞–ª—å–Ω–æ–π —Ç–æ—Ä–≥–æ–≤–æ–π –∫–æ–º–∏—Å—Å–∏–∏ –°–®–ê. –û–¥–Ω–∞–∫–æ –¥–∞—Ç—á–∞–Ω–µ ¬´–ø–µ—Ä–µ–±–∏–ª–∏¬ª —Ü–µ–Ω—É –∞–º–µ—Ä–∏–∫–∞–Ω—Ü–µ–≤, –ø—Ä–µ–¥–ª–æ–∂–∏–≤ $8,5 –º–ª—Ä–¥, —á—Ç–æ –∏ —Å—Ç–∞–ª–æ –ø—Ä–∏—á–∏–Ω–æ–π –¥–ª—è —Ä–∞–∑–±–∏—Ä–∞—Ç–µ–ª—å—Å—Ç–≤–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-11-01T14:02:15+00:00,@bezrec,6772,https://t.me/bezrec/6772,"–ü—Ä–æ–¥–æ–ª–∂–∞–µ–º #—Ö—Ä–æ–Ω–∏–∫–∏_–ì–†–õ–°. –ü—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º –æ–±–∑–æ—Ä –∏–∑–º–µ–Ω–µ–Ω–∏–π, –∫–æ—Ç–æ—Ä—ã–µ –ø—Ä–æ–∏–∑–æ—à–ª–∏ –≤ —Ä–µ–µ—Å—Ç—Ä–µ –≤ –æ–∫—Ç—è–±—Ä–µ 2025 –≥–æ–¥–∞. –ú–µ—Å—è—Ü –≤—ã–¥–∞–ª—Å—è –º–µ–Ω–µ–µ –Ω–∞—Å—ã—â–µ–Ω–Ω—ã–º, —á–µ–º —Å–µ–Ω—Ç—è–±—Ä—å, –Ω–æ –¥–≤–µ–Ω–∞–¥—Ü–∞—Ç—å—é –æ—Ç–º–µ–Ω–∞–º–∏ –≥–æ—Å—Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–π –æ—Ç–º–µ—Ç–∏–ª—Å—è. –ò –ø–æ—á—Ç–∏ –≤—Å–µ ‚Äî —É –ø—Ä–æ—Å–ª–∞–≤–∏–≤—à–µ–π—Å—è –∏—Å—Ç–æ—Ä–∏—è–º–∏ –æ —Ñ–∞–ª—å—à–∏–≤—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞—Ö –∏ –∞—Ä–µ—Å—Ç–∞—Ö —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–∞ –∏–Ω–¥–∏–π—Å–∫–æ–π ¬´–î–∂–æ–¥–∞—Å –≠–∫—Å–ø–æ–∏–º¬ª: üîò–î–∂–∞–º—Å—É–ª ‚Äî –ø–æ—Ä–æ—à–æ–∫ –¥–ª—è –ø—Ä–∏–≥–æ—Ç–æ–≤–ª–µ–Ω–∏—è —Ä–∞—Å—Ç–≤–æ—Ä–∞ –¥–ª—è –≤–Ω—É—Ç—Ä–∏–≤–µ–Ω–Ω–æ–≥–æ –∏ –≤–Ω—É—Ç—Ä–∏–º—ã—à–µ—á–Ω–æ–≥–æ –≤–≤–µ–¥–µ–Ω–∏—è, 250 –º–≥+125 –º–≥, 500 –º–≥+250 –º–≥, 1000 –º–≥+500 –º–≥; üîò–í–∏–ª–ø–µ—Ä–∞—Ç–∏–Ω ‚Äî –∫–∞–ø—Å—É–ª—ã, 250 –º–≥; üîò–≠—Ä—Ç–∞–ø–µ–Ω–µ–º –î–∂ ‚Äî –ª–∏–æ—Ñ–∏–ª–∏–∑–∞—Ç –¥–ª—è –ø—Ä–∏–≥–æ—Ç–æ–≤–ª–µ–Ω–∏—è —Ä–∞—Å—Ç–≤–æ—Ä–∞ –¥–ª—è –≤–Ω—É—Ç—Ä–∏–≤–µ–Ω–Ω–æ–≥–æ –∏ –≤–Ω—É—Ç—Ä–∏–º—ã—à–µ—á–Ω–æ–≥–æ –≤–≤–µ–¥–µ–Ω–∏—è, 1 –≥; üîò–§–∏—Ä–∞—Ç–∏–±–∞–Ω—Ç ‚Äî —Ä–∞—Å—Ç–≤–æ—Ä –¥–ª—è –ø–æ–¥–∫–æ–∂–Ω–æ–≥–æ –≤–≤–µ–¥–µ–Ω–∏—è, 10 –º–≥/–º–ª; üîò–£—Ä–∞–ø–∏–¥–∏–ª –î–∂ ‚Äî —Ä–∞—Å—Ç–≤–æ—Ä –¥–ª—è –≤–Ω—É—Ç—Ä–∏–≤–µ–Ω–Ω–æ–≥–æ –≤–≤–µ–¥–µ–Ω–∏—è, 5 –º–≥/–º–ª; üîò–î–∏–ø–ª–∞–º ‚Äî –ø–æ—Ä–æ—à–æ–∫ –¥–ª—è –ø—Ä–∏–≥–æ—Ç–æ–≤–ª–µ–Ω–∏—è —Ä–∞—Å—Ç–≤–æ—Ä–∞ –¥–ª—è –ø—Ä–∏–µ–º–∞ –≤–Ω—É—Ç—Ä—å, 0.75 –º–≥/–º–ª; üîò–î–∂–æ—Ä–µ–ª–∏–º–ø–∞ ‚Äî –ø–æ—Ä–æ—à–æ–∫ –¥–ª—è –ø—Ä–∏–≥–æ—Ç–æ–≤–ª–µ–Ω–∏—è —Ä–∞—Å—Ç–≤–æ—Ä–∞ –¥–ª—è –∏–Ω—Ñ—É–∑–∏–π, 500 –º–≥+250 –º–≥+500 –º–≥; üîò–ö–∞–±–æ–∑–∞–Ω—Ç–∏–Ω–∏–± –î–∂ ‚Äî —Ç–∞–±–ª–µ—Ç–∫–∏, –ø–æ–∫—Ä—ã—Ç—ã–µ –ø–ª–µ–Ω–æ—á–Ω–æ–π –æ–±–æ–ª–æ—á–∫–æ–π, 20 –º–≥, 40 –º–≥, 60 –º–≥; üîò–ó–∏–∞–≥–µ–Ω ‚Äî —Ä–∞—Å—Ç–≤–æ—Ä –¥–ª—è –ø—Ä–∏–µ–º–∞ –≤–Ω—É—Ç—Ä—å, 20 –º–≥/–º–ª; üîò–õ–µ–≤–µ—Ç–∏—Ä–∞—Ü–µ—Ç–∞–º —Å–æ–ª–æ—Ñ–∞—Ä–º ‚Äî ¬´–ì—Ä–æ—Ç–µ–∫—Å¬ª, —Ç–∞–±–ª–µ—Ç–∫–∏, –ø–æ–∫—Ä—ã—Ç—ã–µ –ø–ª–µ–Ω–æ—á–Ω–æ–π –æ–±–æ–ª–æ—á–∫–æ–π, 250 –º–≥, 500 –º–≥, 1000 –º–≥; üîò–§–æ—Ä—Ç–∞–∑–∏–º ‚Äî ¬´–ê–¥–∂–∏–æ –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞–ª—Å¬ª, –ø–æ—Ä–æ—à–æ–∫ –¥–ª—è –ø—Ä–∏–≥–æ—Ç–æ–≤–ª–µ–Ω–∏—è —Ä–∞—Å—Ç–≤–æ—Ä–∞ –¥–ª—è –≤–Ω—É—Ç—Ä–∏–≤–µ–Ω–Ω–æ–≥–æ –∏ –≤–Ω—É—Ç—Ä–∏–º—ã—à–µ—á–Ω–æ–≥–æ –≤–≤–µ–¥–µ–Ω–∏—è, 1 –≥; üîò–ö–æ–Ω—Ç—Ä–î–∏–∞—Ä ‚Äî ¬´–ö–†–ö–ê¬ª, —Å—É—Å–ø–µ–Ω–∑–∏—è –¥–ª—è –ø—Ä–∏–µ–º–∞ –≤–Ω—É—Ç—Ä—å, 200 –º–≥/5 –º–ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-11-01T11:00:01+00:00,@bezrec,6771,https://t.me/bezrec/6771,"–ü—Ä–æ–¥–æ–ª–∂–∞–µ–º –ª–µ—á–∏—Ç—å –±–æ–ª—å–Ω–æ–µ –≥–æ—Ä–ª–æ. –°–ø—Ä–µ–∏ —É–∂–µ #–∑–∞—Ü–µ–Ω–∏–ª–∏, —Ç–µ–ø–µ—Ä—å –æ—á–µ—Ä–µ–¥—å —Ç–∞–±–ª–µ—Ç–æ–∫ –¥–ª—è —Ä–∞—Å—Å–∞—Å—ã–≤–∞–Ω–∏—è —Å —Ü–µ—Ç–∏–ª–ø–∏—Ä–∏–¥–∏–Ω–∏–µ–º —Ö–ª–æ—Ä–∏–¥–æ–º. –ú—ã —Å—Ä–∞–≤–Ω–∏–ª–∏ —Ü–µ–Ω—ã –≤ –æ–Ω–ª–∞–π–Ω-–∞–ø—Ç–µ–∫–∞—Ö –Ω–∞ —Ç–æ—Ä–≥–æ–≤—ã–µ –º–∞—Ä–∫–∏ –ì—Ä–∞–º–º–∏–¥–∏–Ω (¬´–í–∞–ª–µ–Ω—Ç–∞ –§–∞—Ä–º¬ª), –°–µ–ø—Ç–æ–ª–µ—Ç–µ –¢–æ—Ç–∞–ª (¬´–ö–†–ö–ê¬ª) –∏ –ú–∞–∫—Å–∏–∫–æ–ª–¥ –õ–æ—Ä –¢–∞–±—Å (¬´–û—Ç–∏—Å–∏—Ñ–∞—Ä–º¬ª). –í –ø—Ä–∏—Ä–æ–¥–µ —Ç–∞–∫–∂–µ —Å—É—â–µ—Å—Ç–≤—É—é—Ç –ø–∞—Å—Ç–∏–ª–∫–∏ –¢–µ—Ä–∞—Ñ–ª—é –æ—Ç ¬´–ù–æ–≤–∞—Ä—Ç–∏—Å¬ª, –Ω–æ –≤ –ø—Ä–æ–≤–µ—Ä–µ–Ω–Ω—ã—Ö –Ω–∞–º–∏ –∞–ø—Ç–µ–∫–∞—Ö –∏—Ö –Ω–µ –æ–∫–∞–∑–∞–ª–æ—Å—å. –ü—Ä–æ–±–ª–µ–º —Å –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å—é –æ—Å—Ç–∞–ª—å–Ω—ã—Ö —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –Ω–µ—Ç. –°–∞–º—ã–º –¥–µ—à–µ–≤—ã–º –æ–∫–∞–∑–∞–ª—Å—è –ú–∞–∫—Å–∏–∫–æ–ª–¥ –õ–æ—Ä –¢–∞–±—Å –∏–∑ –ê–ø—Ç–µ–∫–∏.—Ä—É. –£–ø–∞–∫–æ–≤–∫–∞ –∏–∑ 20 —Ç–∞–±–ª–µ—Ç–æ–∫ —Ç–∞–º —Å—Ç–æ–∏—Ç 236 —Ä—É–±–ª–µ–π. –î–ª—è —Å—Ä–∞–≤–Ω–µ–Ω–∏—è, –≤ ¬´36,6¬ª –æ–Ω –∂–µ –ø—Ä–æ–¥–∞—ë—Ç—Å—è –∑–∞ 539 —Ä—É–±–ª–µ–π. –°–∞–º—ã–º –≤—ã—Å–æ–∫–∏–º —Ü–µ–Ω–Ω–∏–∫–æ–º –Ω–∞ —ç—Ç–æ—Ç —Ä–∞–∑ –æ—Ç–ª–∏—á–∏–ª–∞—Å—å ¬´–†–∏–≥–ª–∞¬ª ‚Äî –ì—Ä–∞–º–º–∏–¥–∏–Ω —Ç–∞–º –æ–±–æ–π–¥—ë—Ç—Å—è –≤ 684 —Ä—É–±–ª—è. –ù–∞–ø–æ–º–∏–Ω–∞–µ–º, —á—Ç–æ –ª—é–±—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏–º–µ—é—Ç –ø—Ä–æ—Ç–∏–≤–æ–ø–æ–∫–∞–∑–∞–Ω–∏—è. –ü–µ—Ä–µ–¥ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º –ø—Ä–æ–∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä—É–π—Ç–µ—Å—å —Å –ª–µ—á–∞—â–∏–º –≤—Ä–∞—á–æ–º. *–∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –ø—Ä–æ–≤–æ–¥–∏–ª–æ—Å—å –æ–Ω–ª–∞–π–Ω 1 –Ω–æ—è–±—Ä—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage"",
  ""impact"": ""medium"",
  ""english"": ""We are continuing to treat throat pain. Sprays have already been #valued, now it's the turn of tablets for swallowing with chlorpheniramine chloride. We compared prices in online pharmacies for trade brands Gramidin (¬´Valentia Farm¬ª), Seplete Total (¬´KRCA¬ª) and Maxikold Lor Tabs (¬´Otisifarm¬ª). There are also throat lozenges Teraflu from ¬´Novartis¬ª, but we did not find them in the verified pharmacies. There are no problems with accessibility for other participants. The cheapest option was Maxikold Lor Tabs from Apoteka.ru. A 20-pack costs 236 rubles there. For comparison, in '36,6' it's sold for 539 rubles. The most expensive option is 'Rigla' ‚Äî Gramidin costs 684 rubles there. We remind you that any medicines have contraindications. Before using, consult with your treating doctor.""
}"
2025-11-01T07:31:05+00:00,@bezrec,6770,https://t.me/bezrec/6770,"–≠–∫—Å-–≤–ª–∞–¥–µ–ª—å—Ü—É –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è –ú–∏—Ä–∞–º–∏—Å—Ç–∏–Ω–∞ –≤–µ—Ä–Ω—É–ª–∏ –Ω–∞—É—á–Ω—É—é —Å—Ç–µ–ø–µ–Ω—å. –û—Å–Ω–æ–≤–∞—Ç–µ–ª—å ¬´–ò–Ω—Ñ–∞–º–µ–¥–∞¬ª –∏ —ç–∫—Å-–¥–µ–ø—É—Ç–∞—Ç –ö–∞–ª–∏–Ω–∏–Ω–≥—Ä–∞–¥—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–Ω–æ–π –¥—É–º—ã –ê–Ω–¥—Ä–µ–π –ì–æ—Ä–æ—Ö–æ–≤ —Å–Ω–æ–≤–∞ –¥–æ–∫—Ç–æ—Ä —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–∏—Ö –Ω–∞—É–∫. –ù–∞—É—á–Ω—É—é —Å—Ç–µ–ø–µ–Ω—å –µ–º—É –≤–µ—Ä–Ω—É–ª —Å—É–¥. –ì–æ—Ä–æ—Ö–æ–≤ –∑–∞—â–∏—Ç–∏–ª –¥–∏—Å—Å–µ—Ä—Ç–∞—Ü–∏—é –Ω–∞ —Ç–µ–º—É ¬´–ú–æ–¥–µ—Ä–Ω–∏–∑–∞—Ü–∏—è —É–ø—Ä–∞–≤–ª–µ–Ω–∏—è —É—Å—Ç–æ–π—á–∏–≤—ã–º —Ä–∞–∑–≤–∏—Ç–∏–µ–º –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω—ã—Ö —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –∫–æ–º–ø–∞–Ω–∏–π¬ª –≤ 2012 –≥–æ–¥—É, –æ–¥–Ω–∞–∫–æ –≤ 2021 –≥–æ–¥—É –ú–∏–Ω–æ–±—Ä–Ω–∞—É–∫–∏ –ª–∏—à–∏–ª–æ –µ–≥–æ —Å—Ç–µ–ø–µ–Ω–∏. –û—Å–Ω–æ–≤–∞–Ω–∏–µ–º –ø–æ—Å–ª—É–∂–∏–ª–∞ –ø—Ä–æ–≤–µ—Ä–∫–∞ –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–∏–∫–æ–≤ –∏–∑-–∑–∞ –Ω–∞–ª–∏—á–∏—è –≤ –¥–∏—Å—Å–µ—Ä—Ç–∞—Ü–∏–∏ ¬´–∑–∞–∏–º—Å—Ç–≤–æ–≤–∞–Ω–∏–π, –≤—ã–ø–æ–ª–Ω–µ–Ω–Ω—ã—Ö —Å –Ω–∞—Ä—É—à–µ–Ω–∏–µ–º –ø–æ—Ä—è–¥–∫–∞ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏—è –∑–∞–∏–º—Å—Ç–≤–æ–≤–∞–Ω–Ω–æ–≥–æ –º–∞—Ç–µ—Ä–∏–∞–ª–∞ –∏–∑ —Ä–∞–±–æ—Ç¬ª –∏ ¬´–æ—Ç—Å—É—Ç—Å—Ç–≤–∏—è –Ω–∞—É—á–Ω–æ–π –Ω–æ–≤–∏–∑–Ω—ã¬ª. –ì–æ—Ä–æ—Ö–æ–≤ –ø–æ—à—ë–ª –≤ —Å—É–¥. –¢–æ—Ç –ø—Ä–∏—à–µ–ª –∫ –≤—ã–≤–æ–¥—É –æ –Ω–∞—Ä—É—à–µ–Ω–∏–∏ –ø—Ä–æ—Ü–µ–¥—É—Ä—ã, —Ç.–∫.: üîò–∏—Å—Ç–µ—Ü –±—ã–ª –ª–∏—à–µ–Ω ¬´–≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ –¥–∞–≤–∞—Ç—å –∏—Å—á–µ—Ä–ø—ã–≤–∞—é—â–∏–µ –ø–æ—è—Å–Ω–µ–Ω–∏—è –∏ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª—è—Ç—å –∞—Ä–≥—É–º–µ–Ω—Ç–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –≤–æ–∑—Ä–∞–∂–µ–Ω–∏—è –Ω–∞ –∑–∞—è–≤–ª–µ–Ω–∏–µ –æ –ª–∏—à–µ–Ω–∏–∏ —É—á–µ–Ω–æ–π —Å—Ç–µ–ø–µ–Ω–∏¬ª üîò–≤–æ–ø—Ä–æ—Å –æ –∑–∞–∏–º—Å—Ç–≤–æ–≤–∞–Ω–∏—è—Ö —É–∂–µ –ø–æ–¥–Ω–∏–º–∞–ª—Å—è –≤ 2015 –≥–æ–¥—É, —Ç–æ–≥–¥–∞ –Ω–∞—Ä—É—à–µ–Ω–∏–π –Ω–µ –≤—ã—è–≤–∏–ª–∏, –ø–æ—ç—Ç–æ–º—É –Ω–µ –∏–º–µ–ª–∏ –ø—Ä–∞–≤–∞ –ø–æ–¥–Ω–∏–º–∞—Ç—å –µ–≥–æ –ø–æ–≤—Ç–æ—Ä–Ω–æ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-10-31T14:33:08+00:00,@bezrec,6769,https://t.me/bezrec/6769,"–†–æ—Å—Å–∏—è–Ω–µ —Å—Ç–∞–ª–∏ –±–æ–ª—å—à–µ –≤–∫–ª–∞–¥—ã–≤–∞—Ç—å—Å—è –≤ –∑–¥–æ—Ä–æ–≤—å–µ. –ü–æ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º –æ–ø—Ä–æ—Å–∞ —Ñ–∏–Ω–∞–Ω—Å–æ–≤–æ–≥–æ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞ ¬´–í—ã–±–µ—Ä—É.—Ä—É¬ª —Å —É—á–∞—Å—Ç–∏–µ–º 3 —Ç—ã—Å. —á–µ–ª–æ–≤–µ–∫, –≤ 2025 –≥–æ–¥—É —Ä–∞—Å—Ö–æ–¥—ã —Ä–æ—Å—Å–∏—è–Ω –Ω–∞ –ø–æ–¥–¥–µ—Ä–∂–∞–Ω–∏–µ –∑–¥–æ—Ä–æ–≤—å—è –≤—ã—Ä–æ—Å–ª–∏ –Ω–∞ 15%-25%. –°—é–¥–∞ –≤—Ö–æ–¥—è—Ç –∫–∞–∫ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–∏–µ –æ—Å–º–æ—Ç—Ä—ã, —Ç–∞–∫ –∏ —Ç—Ä–∞—Ç—ã –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞, –≤–∏—Ç–∞–º–∏–Ω—ã –∏ –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç—ã. –ò–Ω—Ç–µ—Ä–µ—Å–Ω–æ–µ –∏–∑ –æ–ø—Ä–æ—Å–∞: üíä –±–æ–ª–µ–µ 45% –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö –ø—Ä–∏–Ω–∏–º–∞—é—Ç –≤–∏—Ç–∞–º–∏–Ω—ã –Ω–∞ –ø–æ—Å—Ç–æ—è–Ω–Ω–æ–π –æ—Å–Ω–æ–≤–µ, –∫–∞–∂–¥—ã–π —Ç—Ä–µ—Ç–∏–π –ø—Ä–µ–¥–≤–∞—Ä–∏—Ç–µ–ª—å–Ω–æ —Å–æ–≤–µ—Ç—É–µ—Ç—Å—è —Å –≤—Ä–∞—á–æ–º –∏ —Å–¥–∞—ë—Ç –∞–Ω–∞–ª–∏–∑—ã; üíä –∫–∞–∂–¥—ã–π –¥–µ—Å—è—Ç—ã–π –≥–æ—Ç–æ–≤ —Ç—Ä–∞—Ç–∏—Ç—å –Ω–∞ –≤–∏—Ç–∞–º–∏–Ω—ã –¥–æ 3 —Ç—ã—Å. —Ä—É–±–ª–µ–π –≤ –º–µ—Å—è—Ü, –ø—Ä–∏ —ç—Ç–æ–º –≤ —Å—Ä–µ–¥–Ω–µ–º –Ω–∞ —ç—Ç—É –∫–∞—Ç–µ–≥–æ—Ä–∏—é —É —Ä–æ—Å—Å–∏—è–Ω —É—Ö–æ–¥–∏—Ç –æ—Ç 500 –¥–æ 2 —Ç—ã—Å. —Ä—É–±–ª–µ–π –≤ –º–µ—Å—è—Ü; üíä —Å–∞–º—ã–µ –ø–æ–ø—É–ª—è—Ä–Ω—ã–µ –¥–æ–±–∞–≤–∫–∏ ‚Äî —Å –≤–∏—Ç–∞–º–∏–Ω–∞–º–∏ D, B –∏ C, –∞ —Ç–∞–∫–∂–µ –º–∞–≥–Ω–∏–π, –æ–º–µ–≥–∞-3 –∏ –∂–µ–ª–µ–∑–æ; üíä –ø–æ—á—Ç–∏ –∫–∞–∂–¥—ã–π –ø—è—Ç—ã–π –≤ —Ç–µ—á–µ–Ω–∏–µ –≥–æ–¥–∞ –ø–æ–∫—É–ø–∞–ª –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç—ã –∏ —Å–µ–¥–∞—Ç–∏–≤–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, —á—Ç–æ –ø–æ—á—Ç–∏ –≤ 1,5 —Ä–∞–∑–∞ –±–æ–ª—å—à–µ, —á–µ–º –≥–æ–¥ –Ω–∞–∑–∞–¥; üíä –Ω–∞–∏–±–æ–ª–µ–µ –æ—Ö–æ—Ç–Ω–æ –≤ –≤–∏—Ç–∞–º–∏–Ω—ã –∏ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫—É –∑–¥–æ—Ä–æ–≤—å—è –≤–∫–ª–∞–¥—ã–≤–∞—é—Ç—Å—è –∂–µ–Ω—â–∏–Ω—ã –≤ –≤–æ–∑—Ä–∞—Å—Ç–µ –æ—Ç 30 –¥–æ 45 –ª–µ—Ç. –õ—é–¥–∏ –≥–æ—Ç–æ–≤—ã –∏–Ω–≤–µ—Å—Ç–∏—Ä–æ–≤–∞—Ç—å –≤ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫—É, –Ω–µ –¥–æ–∂–∏–¥–∞—è—Å—å –∫—Ä–∏—Ç–∏—á–µ—Å–∫–∏—Ö —Å–∏–º–ø—Ç–æ–º–æ–≤. –≠—Ç–æ —Ö–æ—Ä–æ—à–∏–π —Å–∏–≥–Ω–∞–ª –∫–∞–∫ –¥–ª—è —Å–∏—Å—Ç–µ–º—ã –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è, —Ç–∞–∫ –∏ –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ –±–∏–∑–Ω–µ—Å–∞, ‚Äî –ø—Ä–æ–∫–æ–º–º–µ–Ω—Ç–∏—Ä–æ–≤–∞–ª–∏ –ø–æ–ª—É—á–µ–Ω–Ω—ã–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –≤ ¬´–í—ã–±–µ—Ä—É.—Ä—É¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""Russiaans are investing more in health. According to a survey by financial marketplace '–í—ã–±–µ—Ä—É.—Ä—É' with 3,000 participants, Russians will spend an additional 15%-25% on health maintenance in 2025. This includes preventive check-ups and spending on medicines, vitamins, and antidepressants. Interesting from the survey: üíä 45% of respondents take vitamins regularly, and one-third consults with a doctor before taking them and takes tests; üíä One-tenth is ready to spend up to 3,000 rubles a month on vitamins, while the average monthly expenditure is between 500 and 2,000 rubles; üíä The most popular supplements include vitamins D, B and C, as well as magnesium, omega-3, and iron; üíä Almost every fifth person buys antidepressants and sedatives annually, which is almost 50% more than a year ago; üíä Women aged 30-45 are most willing to invest in preventive care and health"
2025-10-31T12:01:56+00:00,@bezrec,6768,https://t.me/bezrec/6768,"–¢–∞—Ä–∏—Ñ –¥–ª—è –∫–æ–º–º—É–Ω–∏–∫–∞—Ü–∏–∏ —Å –ª–∏–Ω–µ–π–Ω—ã–º –ø–µ—Ä—Å–æ–Ω–∞–ª–æ–º. –í —Ñ–∞—Ä–º–µ, –∫–∞–∫ –∏ –≤ –¥—Ä—É–≥–∏—Ö –∫—Ä—É–ø–Ω—ã—Ö –∏–Ω–¥—É—Å—Ç—Ä–∏—è—Ö, —Ç–µ, –∫—Ç–æ —Ä–∞–±–æ—Ç–∞–µ—Ç ¬´–≤ –ø–æ–ª—è—Ö¬ª ‚Äî –Ω–∞ —Å–∫–ª–∞–¥–µ, –≤ —Ç–æ—á–∫–µ –ø—Ä–æ–¥–∞–∂, –≤ –¥–æ—Å—Ç–∞–≤–∫–µ ‚Äî –æ—Å—Ç–∞—é—Ç—Å—è –∑–∞ –ø—Ä–µ–¥–µ–ª–∞–º–∏ —Ü–∏—Ñ—Ä–æ–≤–æ–≥–æ –∫–æ–Ω—Ç—É—Ä–∞, —á—Ç–æ –≤–µ–¥–µ—Ç –∫ —Å–Ω–∏–∂–µ–Ω–∏—é —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏. –†–µ—à–µ–Ω–∏–µ ‚Äî –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –æ–ø—Ü–∏–π –¥–ª—è –ª–∏–Ω–µ–π–Ω–æ–≥–æ –ø–µ—Ä—Å–æ–Ω–∞–ª–∞. –í —ç—Ç–æ–º –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏–∏ —Å–µ–π—á–∞—Å —Ä–∞–±–æ—Ç–∞–µ—Ç –Ø–Ω–¥–µ–∫—Å 360. –ö–æ–º–ø–∞–Ω–∏—è –∞–Ω–æ–Ω—Å–∏—Ä–æ–≤–∞–ª–∞ –Ω–æ–≤—ã–π —Ç–∞—Ä–∏—Ñ, –∫–æ—Ç–æ—Ä—ã–π –æ–±—ä–µ–¥–∏–Ω–∏—Ç –≤ –æ–¥–Ω–æ–º –º–æ–±–∏–ª—å–Ω–æ–º –ø—Ä–∏–ª–æ–∂–µ–Ω–∏–∏ –ú–µ—Å—Å–µ–Ω–¥–∂–µ—Ä –∏ –¢–µ–ª–µ–º–æ—Å—Ç, —Å–æ–∑–¥–∞–≤–∞—è –µ–¥–∏–Ω–æ–µ –∫–æ—Ä–ø–æ—Ä–∞—Ç–∏–≤–Ω–æ–µ –ø—Ä–æ—Å—Ç—Ä–∞–Ω—Å—Ç–≤–æ –¥–ª—è –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏—è —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤ –ª—é–±–æ–≥–æ —É—Ä–æ–≤–Ω—è. –ß—Ç–æ –º–µ–Ω—è–µ—Ç —Ç–∞–∫–æ–π –ø–æ–¥—Ö–æ–¥? üîò–†–∞–±–æ—Ç–Ω–∏–∫–∏ –æ—Å—Ç–∞—é—Ç—Å—è –≤ —Ä–∞–±–æ—á–µ–º –∫–æ–Ω—Ç—É—Ä–µ, —á—Ç–æ —Å–Ω–∏–∂–∞–µ—Ç —Ä–∏—Å–∫–∏; üîò–£–Ω–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω—ã–π –ø–æ–¥—Ö–æ–¥ –∫ —Ä–∞–±–æ—á–µ–π –∫–æ–º–º—É–Ω–∏–∫–∞—Ü–∏–∏. –ó–∞–ø—É—Å–∫ –∑–∞–ø–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω –Ω–∞ –ø–µ—Ä–≤—ã–π –∫–≤–∞—Ä—Ç–∞–ª 2026 –≥–æ–¥–∞. –í –¥–∞–ª—å–Ω–µ–π—à–µ–º –ø–æ—è–≤–∏—Ç—Å—è –∏–Ω—Ç–µ–≥—Ä–∞—Ü–∏—è —Å –∫–æ—Ä–ø–æ—Ä–∞—Ç–∏–≤–Ω–æ–π –±–∞–∑–æ–π –∑–Ω–∞–Ω–∏–π –Ø–Ω–¥–µ–∫—Å –í–∏–∫–∏. –¢–∞–∫–∏–º –æ–±—Ä–∞–∑–æ–º, –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª–∏ –ø–æ–ª—É—á–∞—Ç –¥–æ—Å—Ç—É–ø –∫ –∏–Ω—Å—Ç—Ä—É–∫—Ü–∏—è–º, —Ä–µ–≥–ª–∞–º–µ–Ω—Ç–∞–º –∏ –¥—Ä—É–≥–æ–π —Å–ø—Ä–∞–≤–æ—á–Ω–æ–π –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-10-31T08:50:01+00:00,@bezrec,6767,https://t.me/bezrec/6767,"–û–Ω–ª–∞–π–Ω-–∞–ø—Ç–µ–∫–∏ –æ–∫–∞–∑–∞–ª–∏—Å—å –≤ —á–∏—Å–ª–µ –Ω–∞–∏–±–æ–ª–µ–µ —É—è–∑–≤–∏–º—ã—Ö –º–æ–±–∏–ª—å–Ω—ã—Ö –ø—Ä–∏–ª–æ–∂–µ–Ω–∏–π. –¶–µ–Ω—Ç—Ä —Ü–∏—Ñ—Ä–æ–≤–æ–π —ç–∫—Å–ø–µ—Ä—Ç–∏–∑—ã –†–æ—Å–∫–∞—á–µ—Å—Ç–≤–∞ –∏ –≥—Ä—É–ø–ø–∞ –∫–æ–º–ø–∞–Ω–∏–π ¬´–°–æ–ª–∞—Ä¬ª –ø—Ä–æ–≤–µ–ª–∏ —Å–æ–≤–º–µ—Å—Ç–Ω–æ–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –æ–∫–æ–ª–æ 70 —Ä–µ—Å—É—Ä—Å–æ–≤ –ø–æ–ø—É–ª—è—Ä–Ω—ã—Ö —Å–µ—Ä–≤–∏—Å–æ–≤ –¥–æ—Å—Ç–∞–≤–∫–∏ –≥–æ—Ç–æ–≤–æ–π –µ–¥—ã, –æ–Ω–ª–∞–π–Ω-–∞–ø—Ç–µ–∫, –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–æ–≤ –ø–æ –ø—Ä–æ–¥–∞–∂–µ —Ç–æ–≤–∞—Ä–æ–≤ –¥–ª—è –¥–æ–º–∞ –∏ –¥–∞—á–∏, –±—ã—Ç–æ–≤–æ–π —Ç–µ—Ö–Ω–∏–∫–∏ –∏ —ç–ª–µ–∫—Ç—Ä–æ–Ω–∏–∫–∏, —Å–µ—Ä–≤–∏—Å–æ–≤ –¥–æ—Å—Ç–∞–≤–∫–∏ —Ü–≤–µ—Ç–æ–≤. –§–æ–∫—É—Å —Å–¥–µ–ª–∞–ª–∏ –Ω–∞ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏—è—Ö —Å —Ä–µ–π—Ç–∏–Ω–≥–æ–º –±–æ–ª–µ–µ 4 –±–∞–ª–ª–æ–≤, –Ω–∞–±—Ä–∞–≤—à–∏—Ö –æ—Ç 500 —Ç—ã—Å. —Å–∫–∞—á–∏–≤–∞–Ω–∏–π –Ω–∞ —Å–µ–Ω—Ç—è–±—Ä—å 2025 –≥–æ–¥–∞. –í –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ –æ–Ω–ª–∞–π–Ω-–∞–ø—Ç–µ–∫ –º–∞–∫—Å–∏–º–∞–ª—å–Ω—ã–π –æ—Ö–≤–∞—Ç –∞—É–¥–∏—Ç–æ—Ä–∏–∏ —Å–æ—Å—Ç–∞–≤–∏–ª —Å–≤—ã—à–µ 26,5 –º–ª–Ω –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª–µ–π. –í —Ç–æ–ø-3 —É—è–∑–≤–∏–º–æ—Å—Ç–µ–π, –∫–æ—Ç–æ—Ä—ã–º –ø–æ–¥–≤–µ—Ä–∂–µ–Ω—ã –ø—Ä–∏–ª–æ–∂–µ–Ω–∏—è, –≤–æ—à–ª–∏ –æ–±—Ä–∞—â–µ–Ω–∏–µ –∫ DNS, –Ω–µ–±–µ–∑–æ–ø–∞—Å–Ω–∞—è —Ä–µ—Ñ–ª–µ–∫—Å–∏—è –∏ –Ω–µ–±–µ–∑–æ–ø–∞—Å–Ω–∞—è —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–∞—è —Ä–µ–∞–ª–∏–∑–∞—Ü–∏—è SSL. –ù–µ –≤–¥–∞–≤–∞—è—Å—å –≤ —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–∏–µ –ø–æ–¥—Ä–æ–±–Ω–æ—Å—Ç–∏, –∫–∞—Ç–µ–≥–æ—Ä–∏—è –æ–Ω–ª–∞–π–Ω-–∞–ø—Ç–µ–∫ –æ–∫–∞–∑–∞–ª–∞—Å—å –æ–¥–Ω–æ–π –∏–∑ —Å–∞–º—ã—Ö –Ω–µ–±–µ–∑–æ–ø–∞—Å–Ω—ã—Ö –¥–ª—è –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª–µ–π. –ò —á—Ç–æ –æ—Å–æ–±–µ–Ω–Ω–æ –Ω–µ–ø—Ä–∏—è—Ç–Ω–æ, –ø–æ–¥ —É–≥—Ä–æ–∑–æ–π –æ–∫–∞–∑—ã–≤–∞—é—Ç—Å—è –Ω–µ —Ç–æ–ª—å–∫–æ —Ñ–∏–Ω–∞–Ω—Å–æ–≤—ã–µ, –Ω–æ –∏ –ø–µ—Ä—Å–æ–Ω–∞–ª—å–Ω—ã–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –¥–∞–Ω–Ω—ã–µ. –†–µ–∑—É–ª—å—Ç–∞—Ç—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –¥–µ–º–æ–Ω—Å—Ç—Ä–∏—Ä—É—é—Ç, —á—Ç–æ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –¥–∞–Ω–Ω—ã—Ö –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª–µ–π –∏ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏–π —Ç—Ä–µ–±—É–µ—Ç —Å–∏—Å—Ç–µ–º–Ω–æ–≥–æ –ø–æ–¥—Ö–æ–¥–∞ –∏ –ø–æ–≤—ã—à–µ–Ω–Ω–æ–≥–æ –≤–Ω–∏–º–∞–Ω–∏—è –Ω–µ —Ç–æ–ª—å–∫–æ –Ω–∞ —ç—Ç–∞–ø–µ –≥–æ—Ç–æ–≤–æ–≥–æ –ø—Ä–æ–¥—É–∫—Ç–∞, –Ω–æ –∏ —Å –ø–µ—Ä–≤—ã—Ö —ç—Ç–∞–ø–æ–≤ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –ü–û, ‚Äî –æ—Ç–º–µ—á–∞—é—Ç –∞–Ω–∞–ª–∏—Ç–∏–∫–∏ –†–æ—Å–∫–∞—á–µ—Å—Ç–≤–∞ –∏ ¬´–°–æ–ª–∞—Ä–∞¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""pharmacovigilance, safety"",
  ""impact"": ""high"",
  ""english"": ""The research by the Digital Expert Center of Roskonsult and Solar Group identified vulnerabilities in around 70 popular delivery services apps, online pharmacies, home goods marketplaces. The study focused on apps with a rating of more than 4 stars and over 500,000 downloads by September 2025. The top three vulnerabilities affecting apps include DNS resolution, unsafe refactoring, and unsafe SSL implementation. The online pharmacies category was found to be the most vulnerable for users. Personal medical data is also at risk, highlighting the need for a systemic approach to app and user data security from development stages. ""
}"
2025-10-31T05:20:32+00:00,@bezrec,6766,https://t.me/bezrec/6766,"–¢–æ–ø–æ–≤—ã–µ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –≤—Å—ë —Å–∏–ª—å–Ω–µ–µ –∑–∞–≤–∏—Å—è—Ç –æ—Ç –ª–∏–¥–∏—Ä—É—é—â–µ–≥–æ –±—Ä–µ–Ω–¥–∞. –ü–æ –∏—Ç–æ–≥–∞–º I-III –∫–≤–∞—Ä—Ç–∞–ª–∞ 2025 –≥–æ–¥–∞ –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º —Ä–æ–∑–Ω–∏—á–Ω–æ–º —Ä—ã–Ω–∫–µ –±—ã–ª–æ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–æ –ø–æ—á—Ç–∏ 6 —Ç—ã—Å. —Ç–æ—Ä–≥–æ–≤—ã—Ö –º–∞—Ä–æ–∫ –ª–µ–∫–∞—Ä—Å—Ç–≤ –æ—Ç 803 –∫–æ–º–ø–∞–Ω–∏–π, –ø–æ–¥—Å—á–∏—Ç–∞–ª–∏ –≤ RNC Pharma. –í –∞–Ω–∞–ª–∏–∑–∏—Ä—É–µ–º—ã–π –ø–µ—Ä–∏–æ–¥ –ø—Ä–æ–¥–∞–Ω–æ –ª–µ–∫–∞—Ä—Å—Ç–≤ –Ω–∞ 1,36 —Ç—Ä–ª–Ω —Ä—É–±–ª–µ–π (+15,7% –≥–æ–¥ –∫ –≥–æ–¥—É). –ü–æ—Ä—è–¥–∫–∞ 72% –¥–µ–Ω–µ–∂–Ω–æ–≥–æ –æ–±—ä—ë–º–∞ –≤ —Ñ–∞—Ä–º—Ä–∏—Ç–µ–π–ª–µ –ø—Ä–∏—à–ª–æ—Å—å –Ω–∞ —Ç–æ–ø-50 –∫–æ—Ä–ø–æ—Ä–∞—Ü–∏–π. –í —Ü–µ–ª–æ–º –¥–æ–ª—è –ª–∏–¥–∏—Ä—É—é—â–µ–≥–æ –±—Ä–µ–Ω–¥–∞ —É –Ω–∏—Ö –Ω–µ –ø—Ä–µ–≤—ã—à–∞–ª–∞ 30% –æ—Ç –æ–±—ä—ë–º–∞ –ø—Ä–æ–¥–∞–∂ –≤ –¥–µ–Ω—å–≥–∞—Ö. –ù–æ –µ—Å—Ç—å –∏ –Ω–µ–º–∞–ª–æ —Å–ª—É—á–∞–µ–≤, –∫–æ–≥–¥–∞ –æ–¥–∏–Ω –ø—Ä–æ–¥—É–∫—Ç –æ–±–µ—Å–ø–µ—á–∏–≤–∞–ª –±–æ–ª–µ–µ –ø–æ–ª–æ–≤–∏–Ω—ã, –µ—Å–ª–∏ –Ω–µ –≤—Å—é –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—É—é –≤—ã—Ä—É—á–∫—É –∫–æ—Ä–ø–æ—Ä–∞—Ü–∏–∏. –ù–∞–≥–ª—è–¥–Ω—ã–π –ø—Ä–∏–º–µ—Ä ‚Äî ¬´–§–∞—Ä–º–∞—Å–æ—Ñ—Ç¬ª —Å –±—Ä–µ–Ω–¥–æ–º –ú–µ–∫—Å–∏–¥–æ–ª –ø—Ä–æ—Ç–∏–≤ –æ—Å—Ç—Ä—ã—Ö –Ω–∞—Ä—É—à–µ–Ω–∏–π –º–æ–∑–≥–æ–≤–æ–≥–æ –∫—Ä–æ–≤–æ–æ–±—Ä–∞—â–µ–Ω–∏—è. –ù–µ—Å–º–æ—Ç—Ä—è –Ω–∞ –±–æ–ª—å—à–æ–µ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤, –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–æ —Å–∏—Ö –ø–æ—Ä –∑–∞–Ω–∏–º–∞–µ—Ç –±–æ–ª–µ–µ 88% –¥–µ–Ω–µ–∂–Ω—ã—Ö –ø—Ä–æ–¥–∞–∂ —Å—Ä–µ–¥–∏ –±—Ä–µ–Ω–¥–æ–≤ —Å —ç—Ç–∏–º –ú–ù–ù. –í—Ç–æ—Ä–æ–µ –º–µ—Å—Ç–æ ‚Äî —É ¬´–ü—Ñ–∞–π–∑–µ—Ä–∞¬ª –∏ –µ–≥–æ –≠–ª–∏–∫–≤–∏—Å–∞, –∑–∞–º—ã–∫–∞–µ—Ç —Ç—Ä–æ–π–∫—É ¬´–Ø–¥—Ä–∞–Ω¬ª —Å –ê–∫–Ω–µ–∫—É—Ç–∞–Ω–æ–º. –ú–∞–∫—Å–∏–º–∞–ª—å–Ω—ã–π —Ä–æ—Å—Ç –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏ –æ—Ç —Ç–æ–ø–æ–≤–æ–≥–æ –ø—Ä–æ–¥—É–∫—Ç–∞ –ø–æ–∫–∞–∑–∞–ª ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª —Å–æ —Å–≤–æ–∏–º –°–µ–º–∞–≤–∏–∫–æ–º. –°–Ω–∏–∑–∏–ª–∞—Å—å –¥–æ–ª—è —Ç–æ–ª—å–∫–æ —É –£—Ä—Å–æ—Å–∞–Ω–∞ (¬´–ü—Ä–æ.–ú–µ–¥.–¶—Å¬ª), –ù—É—Ä–æ—Ñ–µ–Ω–∞ (¬´–†–µ–∫–∏—Ç—Ç –ë–µ–Ω–∫–∏–∑–µ—Ä¬ª) –∏ –ö–æ–Ω–∫–æ—Ä–∞ (¬´–ú–µ—Ä–∫¬ª). –ü—Ä–∏ —ç—Ç–æ–º –≤—Å–µ —Ç—Ä–æ–µ –ø–æ–∫–∞–∑–∞–ª–∏ —É–≤–µ—Ä–µ–Ω–Ω—ã–π —Ä–æ—Å—Ç —Ä—É–±–ª—ë–≤–æ–π –¥–∏–Ω–∞–º–∏–∫–∏. –ü–æ–º–∏–º–æ –ø–µ—Ä–µ—á–∏—Å–ª–µ–Ω–Ω—ã—Ö –±—Ä–µ–Ω–¥–æ–≤ –≤ —Ç–æ–ø-10 –ø–æ–ø–∞–ª–∏: –ö–∞–Ω–µ—Ñ—Ä–æ–Ω (¬´–ë–∏–æ–Ω–æ—Ä–∏–∫–∞¬ª), –ê–ª—Ñ–ª—É—Ç–æ–ø (¬´–†–æ–º—Ñ–∞—Ä–º¬ª) –∏ –ú–æ–Ω—É—Ä–∞–ª (¬´–ó–∞–º–±–æ–Ω¬ª). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The top pharmaceutical companies are increasingly dependent on leading brands. In the first three quarters of 2025, over 6,000 drug brands were sold in Russia's retail market. Sales revenue grew by 15.7% year-over-year to nearly 1.36 trillion rubles. About 72% of the market's revenue was generated by top-50 companies. However, one product accounted for more than half of the revenue for several corporations. For example, 'FarmaSoft' with Mexidol accounted for over 88% of the revenue for drugs under this MNL. 'Pfizer' and its Elyxvis, 'Yadran' with Aknecutan also showed significant growth. The companies that experienced the most significant increase in brand dependency include 'Gerofarm' with Semavik, and 'Ursofan', 'Nurofen', and 'Konkor' from 'Pro.Med.Cs'.""
}"
2025-10-30T14:32:30+00:00,@bezrec,6765,https://t.me/bezrec/6765,"–í—ã—Ä–∞–∂–µ–Ω–∏–µ ¬´—Ö–æ—á–µ—à—å –µ—Å—Ç—å ‚Äî –ø–æ–ø–µ–π –≤–æ–¥–∏—á–∫–∏¬ª –ø—Ä–∏–æ–±—Ä–µ—Ç–∞–µ—Ç –Ω–æ–≤—ã–π —Å–º—ã—Å–ª. –ü–æ–∫–∞ –º—ã —Ç—É—Ç —Å –≤–∞–º–∏ –æ–±—Å—É–∂–¥–∞–µ–º, —á—Ç–æ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–µ–µ ‚Äî –±–∞—Ä–∏–∞—Ç—Ä–∏—è –∏–ª–∏ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥ —Å —Ç–∏—Ä–∑–µ–ø–∞—Ç–∏–¥–æ–º, —è–ø–æ–Ω—Ü—ã –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∏ –Ω–æ–≤–∏–Ω–∫—É ‚Äî –≤–æ–¥—É, —Å–∂–∏–≥–∞—é—â—É—é –∂–∏—Ä –Ω–∞ –∂–∏–≤–æ—Ç–µ. –° –≤–∏–¥—É –æ–±—ã—á–Ω–∞—è –º–∏–Ω–µ—Ä–∞–ª–∫–∞ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–∞ –≤ –Ø–ø–æ–Ω–∏–∏ –∫–∞–∫ ¬´—Ñ—É–Ω–∫—Ü–∏–æ–Ω–∞–ª—å–Ω–∞—è –ø–∏—â–∞¬ª. –≠—Ç–æ –¥–∞—ë—Ç –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—é ‚Äî –∫–æ–º–ø–∞–Ω–∏–∏ Suntory ‚Äî –ø—Ä–∞–≤–æ —É—Ç–≤–µ—Ä–∂–¥–∞—Ç—å, —á—Ç–æ –ø–æ–ª—å–∑–∞ –¥–ª—è –∑–¥–æ—Ä–æ–≤—å—è –¥–æ–∫–∞–∑–∞–Ω–∞ –Ω–∞—É—á–Ω—ã–º–∏ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è–º–∏. –£ Special Water –µ—Å—Ç—å —Å–µ–∫—Ä–µ—Ç ‚Äî –≤ –µ—ë —Å–æ—Å—Ç–∞–≤–µ –ø—Ä–∏—Å—É—Ç—Å—Ç–≤—É–µ—Ç HMPA ‚Äî –Ω–∏–∑–∫–æ–º–æ–ª–µ–∫—É–ª—è—Ä–Ω—ã–π –º–µ—Ç–∞–±–æ–ª–∏—Ç, –ø–æ–ª—É—á–µ–Ω–Ω—ã–π –∏–∑ —Ñ–µ—Ä–º–µ–Ω—Ç–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö —Ä–∏—Å–æ–≤—ã—Ö –æ—Ç—Ä—É–±–µ–π. –°—á–∏—Ç–∞–µ—Ç—Å—è, —á—Ç–æ –µ–≥–æ —Ä–µ–≥—É–ª—è—Ä–Ω–æ–µ —É–ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–µ –º–æ–∂–µ—Ç —Å–Ω–∏–∑–∏—Ç—å —É—Ä–æ–≤–µ–Ω—å —Å–∞–º–æ–≥–æ –æ–ø–∞—Å–Ω–æ–≥–æ –¥–ª—è –∑–¥–æ—Ä–æ–≤—å—è –≤–∏—Å—Ü–µ—Ä–∞–ª—å–Ω–æ–≥–æ –∂–∏—Ä–∞. –¶–µ–ª–µ–≤–∞—è –∞—É–¥–∏—Ç–æ—Ä–∏—è –Ω–∞–ø–∏—Ç–∫–∞ ‚Äî –≤—Å–µ –≤–µ–¥—É—â–∏–µ –º–∞–ª–æ–ø–æ–¥–≤–∏–∂–Ω—ã–π –æ–±—Ä–∞–∑ –∂–∏–∑–Ω–∏ –∏ –Ω–µ –∂–µ–ª–∞—é—â–∏–µ –ø–æ—Ç–µ—Ç—å –≤ —Å–ø–æ—Ä—Ç–∑–∞–ª–µ –∏ –º–µ–Ω—è—Ç—å —Ä–∞—Ü–∏–æ–Ω. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": true
}"
2025-10-30T12:25:36+00:00,@bezrec,6764,https://t.me/bezrec/6764,"–†–ë–ö –≤—ã–∫–∞—Ç–∏–ª —Ä–µ–π—Ç–∏–Ω–≥ 500 –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö –∫–æ–º–ø–∞–Ω–∏–π –†–æ—Å—Å–∏–∏ –ø–æ –≤—ã—Ä—É—á–∫–µ. –í —Ä–µ–π—Ç–∏–Ω–≥–µ —Å –ø—Ä–∏—Å–≤–æ–µ–Ω–∏–µ–º –Ω–æ–º–µ—Ä–∞ —É—á–∞—Å—Ç–≤—É—é—Ç —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ –∫–æ–º–ø–∞–Ω–∏–∏ –≤–Ω–µ –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏ –æ—Ç –∏—Ö —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ ‚Äî –≤ –†–æ—Å—Å–∏–∏ –∏–ª–∏ –∑–∞ —Ä—É–±–µ–∂–æ–º ‚Äî –∏ –Ω–µ –∫–æ–Ω—Ç—Ä–æ–ª–∏—Ä—É–µ–º—ã–µ –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã–º–∏ –ª–∏—Ü–∞–º–∏. –£—á–∞—Å—Ç–Ω–∏–∫–∏ —Ä–µ–π—Ç–∏–Ω–≥–∞ ‚Äî –≥—Ä—É–ø–ø—ã –∫–æ–º–ø–∞–Ω–∏–π —Å –≤—ã—Ä–∞–∂–µ–Ω–Ω–æ–π –æ—Ç—Ä–∞—Å–ª–µ–≤–æ–π –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–Ω–æ—Å—Ç—å—é, –∞ —Ç–∞–∫–∂–µ –æ—Ç–¥–µ–ª—å–Ω—ã–µ –∫–æ–º–ø–∞–Ω–∏–∏, –Ω–µ –≤—Ö–æ–¥—è—â–∏–µ –≤ –≥—Ä—É–ø–ø—ã. –í —Ä–µ–π—Ç–∏–Ω–≥–µ –±–µ–∑ –ø—Ä–∏—Å–≤–æ–µ–Ω–∏—è –Ω–æ–º–µ—Ä–∞ –≤ –∫–∞—á–µ—Å—Ç–≤–µ –ø—Ä–∏–º–µ—Ä–∞ –∏ —Å–ø—Ä–∞–≤–æ—á–Ω–æ–π –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω—ã —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ –º–Ω–æ–≥–æ–ø—Ä–æ—Ñ–∏–ª—å–Ω—ã–µ —Ö–æ–ª–¥–∏–Ω–≥–∏ –∏ —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ –∫–æ–º–ø–∞–Ω–∏–∏ —Å –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã–º –∫–æ–Ω—Ç—Ä–æ–ª–µ–º. –ï—Å–ª–∏ –¥–µ–π—Å—Ç–≤—É—é—â–∞—è –≤ –†–æ—Å—Å–∏–∏ –≥—Ä—É–ø–ø–∞ –∫–æ–º–ø–∞–Ω–∏–π —Å –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω–æ–π —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç—å—é –ø—É–±–ª–∏–∫—É–µ—Ç –∏–ª–∏ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª—è–µ—Ç –†–ë–ö –∫–æ–Ω—Å–æ–ª–∏–¥–∏—Ä–æ–≤–∞–Ω–Ω—É—é –æ—Ç—á–µ—Ç–Ω–æ—Å—Ç—å –ø–æ –ú–°–§–û, —Ç–æ –≤ —Ä–µ–π—Ç–∏–Ω–≥–µ —É—á–∏—Ç—ã–≤–∞—é—Ç—Å—è –ø–æ–∫–∞–∑–∞—Ç–µ–ª–∏ —Ç–∞–∫–æ–π –æ—Ç—á–µ—Ç–Ω–æ—Å—Ç–∏. –ï—Å–ª–∏ –¥–∞–Ω–Ω—ã—Ö –∫–æ–Ω—Å–æ–ª–∏–¥–∏—Ä–æ–≤–∞–Ω–Ω–æ–π –æ—Ç—á–µ—Ç–Ω–æ—Å—Ç–∏ –Ω–µ—Ç, –≤ —Å–ª—É—á–∞–µ –µ—Å–ª–∏ –≤ –†–æ—Å—Å–∏–∏ –ø—Ä–∏—Å—É—Ç—Å—Ç–≤—É—é—Ç –Ω–µ—Å–∫–æ–ª—å–∫–æ –∫–æ–º–ø–∞–Ω–∏–π, –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∞—â–∏—Ö –æ–¥–Ω–æ–π –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω–æ–π –∫–æ—Ä–ø–æ—Ä–∞—Ü–∏–∏, –≤ —Ä–µ–π—Ç–∏–Ω–≥ –≤–∫–ª—é—á–∞–µ—Ç—Å—è –∫–æ–º–ø–∞–Ω–∏—è —Å –Ω–∞–∏–±–æ–ª—å—à–µ–π –≤—ã—Ä—É—á–∫–æ–π. –ö–æ–º–ø–∞–Ω–∏–∏ –≤ —Ä–µ–π—Ç–∏–Ω–≥–µ —Ä–∞–Ω–∂–∏—Ä–æ–≤–∞–ª–∏—Å—å –ø–æ —á–∏—Å—Ç–æ–π –≤—ã—Ä—É—á–∫–µ, —Ç.–µ. –ø–æ –≤—ã—Ä—É—á–∫–µ –±–µ–∑ –ù–î–°, –∞–∫—Ü–∏–∑–æ–≤ –∏ —ç–∫—Å–ø–æ—Ä—Ç–Ω—ã—Ö –ø–æ—à–ª–∏–Ω. –¢–æ–ø-10 –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–µ–π —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ –≤—ã–≥–ª—è–¥–∏—Ç —Å–ª–µ–¥—É—é—â–∏–º –æ–±—Ä–∞–∑–æ–º: üîò¬´–ü—Ä–æ—Ç–µ–∫¬ª ‚Äî 49 –º–µ—Å—Ç–æ; üîò¬´–ü—É–ª—å—Å¬ª ‚Äî 58 –º–µ—Å—Ç–æ; üîò¬´–ö–∞—Ç—Ä–µ–Ω¬ª ‚Äî 70 –º–µ—Å—Ç–æ; üîò¬´–ì—Ä–∞–Ω–¥ –ö–∞–ø–∏—Ç–∞–ª¬ª ‚Äî 120 –º–µ—Å—Ç–æ; üîò¬´–†-–§–∞—Ä–º¬ª ‚Äî 128 –º–µ—Å—Ç–æ; üîò¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç¬ª ‚Äî 130 –º–µ—Å—Ç–æ; üîò¬´–§–∞—Ä–º–ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–∞¬ª ‚Äî 181 –º–µ—Å—Ç–æ; üîò¬´–§–∞—Ä–º–≠–∫–æ¬ª ‚Äî 191 –º–µ—Å—Ç–æ; üîò¬´–§–∞—Ä–º–∏–º—ç–∫—Å¬ª ‚Äî 195 –º–µ—Å—Ç–æ; üîò¬´–ë–∞–π–µ—Ä¬ª ‚Äî –±–µ–∑ –º–µ—Å—Ç–∞. –¢–∞–∫–∂–µ –≤ —Ä–µ–π—Ç–∏–Ω–≥ ¬´–†–ë–ö 500¬ª –ø–æ–ø–∞–ª–∏: ¬´–ê—Å—Ç—Ä–∞–ó–µ–Ω–µ–∫–∞¬ª, ¬´–§–∞—Ä–º–∫–æ–º–ø–ª–µ–∫—Ç¬ª, ¬´–ë–°–°¬ª, ¬´–°–∞–Ω–æ—Ñ–∏¬ª, ¬´–í–∏—Ç–∞ –õ–∞–π–Ω¬ª, ¬´–≠–±–±–æ—Ç—Ç¬ª, ¬´–ù–æ–≤–∞—Ä—Ç–∏—Å¬ª, ¬´–ù–µ–æ-–§–∞—Ä–º¬ª, ¬´–õ–∞–Ω—Ü–µ—Ç¬ª, ¬´–§–∞—Ä–º–ª–µ–Ω–¥¬ª, ¬´–ö–†–ö–ê¬ª, ¬´–¢–µ–≤–∞¬ª, ¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The report '–†–ë–ö 500' ranks the top 500 largest companies in Russia by revenue. The ranking includes both domestic and foreign-controlled Russian companies, based on their consolidated financial reports if available. Top-10 representatives from the pharmaceutical sector are ranked as follows: '–ü—Ä–æ—Ç–µ–∫' - 49th place; '–ü—É–ª—å—Å' - 58th place; '–ö–∞—Ç—Ä–µ–Ω' - 70th place; '–ì—Ä–∞–Ω–¥ –ö–∞–ø–∏—Ç–∞–ª' - 120th place; '–†-–§–∞—Ä–º' - 128th place; '–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç' - 130th place; '–§–∞—Ä–º–ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–∞' - 181st place; '–§–∞—Ä–º–≠–∫–æ' - 191st place; '–§–∞—Ä–º–∏–º—ç–∫—Å' - 195th place. Foreign companies also included in the '–†–ë–ö 500' ranking include: Astellas, Farcompl"
2025-10-30T09:07:59+00:00,@bezrec,6763,https://t.me/bezrec/6763,"–ë–∞—Ä–∏–∞—Ç—Ä–∏—è –ø–∞—Å—É–µ—Ç –ø–µ—Ä–µ–¥ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏ –æ—Ç –æ–∂–∏—Ä–µ–Ω–∏—è. –í–µ—Å–Ω–æ–π –º—ã –ø–∏—Å–∞–ª–∏, —á—Ç–æ —É–≤–µ–ª–∏—á–µ–Ω–∏–µ –∫–æ–ª–∏—á–µ—Å—Ç–≤–∞ —Ä–æ—Å—Å–∏—è–Ω —Å –æ–∂–∏—Ä–µ–Ω–∏–µ–º —Å–ø—Ä–æ–≤–æ—Ü–∏—Ä–æ–≤–∞–ª–æ —Ä–æ—Å—Ç —Å–ø—Ä–æ—Å–∞ –Ω–∞ –æ–ø–µ—Ä–∞—Ü–∏–∏ –ø–æ —É–º–µ–Ω—å—à–µ–Ω–∏—é –∂–µ–ª—É–¥–∫–∞. –ú–∏–Ω–∑–¥—Ä–∞–≤ –¥–∞–∂–µ –≤–∫–ª—é—á–∏–ª —Ä–µ–∑–µ–∫—Ü–∏—é –∂–µ–ª—É–¥–∫–∞, –≥–∞—Å—Ç—Ä–æ—à—É–Ω—Ç–∏—Ä–æ–≤–∞–Ω–∏–µ –∏ –±–∞–Ω–¥–∞–∂–∏—Ä–æ–≤–∞–Ω–∏–µ –≤ —Å—Ç–∞–Ω–¥–∞—Ä—Ç –ø–æ–º–æ—â–∏ –¥–µ—Ç—è–º —Å –ª–∏—à–Ω–∏–º –≤–µ—Å–æ–º. –ù–æ —Ç–µ–ø–µ—Ä—å –ø–æ–ø—É–ª—è—Ä–Ω–æ—Å—Ç—å —Ç–∞–∫–∏—Ö –º–µ—Ç–æ–¥–æ–≤ –ø–æ—Ö—É–¥–µ–Ω–∏—è –ø–æ—à–ª–∞ –Ω–∞ —Å–ø–∞–¥. –ï—Å–ª–∏ –≤ 2024 –≥–æ–¥—É –±—ã–ª–æ –ø—Ä–æ–≤–µ–¥–µ–Ω–æ 8,2 —Ç—ã—Å. –æ–ø–µ—Ä–∞—Ü–∏–π, —Ç–æ –∑–∞ –¥–µ—Å—è—Ç—å –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ ‚Äî —Ç–æ–ª—å–∫–æ 6,7 —Ç—ã—Å., –ø–∏—à–µ—Ç ¬´–™¬ª. –ó–∞—Ç–æ —Å–ø—Ä–æ—Å –Ω–∞ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥ —Ä–∞—Å—Ç—ë—Ç —Ä–µ–∫–æ—Ä–¥–Ω—ã–º–∏ —Ç–µ–º–ø–∞–º–∏. –ü–æ –¥–∞–Ω–Ω—ã–º DSM Group, –≤ —è–Ω–≤–∞—Ä–µ-–∞–≤–≥—É—Å—Ç–µ –∞–ø—Ç–µ–∫–∏ –ø—Ä–æ–¥–∞–ª–∏ –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤ –û–∑–µ–º–ø–∏–∫–∞ –Ω–∞ 16,8 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —á—Ç–æ –Ω–∞ 36% –±–æ–ª—å—à–µ, —á–µ–º –∑–∞ –≤–µ—Å—å 2024 –≥–æ–¥. –ï—â—ë 1,5 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π —Ä–æ—Å—Å–∏—è–Ω–µ –ø–æ—Ç—Ä–∞—Ç–∏–ª–∏ –Ω–∞ —Ç–∏—Ä–∑–µ–ø–∞—Ç–∏–¥. –í—Ä–∞—á–∏ —Ç–µ–Ω–¥–µ–Ω—Ü–∏—é –æ–±—ä—è—Å–Ω—è—é—Ç –∂–µ–ª–∞–Ω–∏–µ–º –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –ø–æ–ø—Ä–æ–±–æ–≤–∞—Ç—å –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç–æ–∑–Ω–æ–µ –ª–µ—á–µ–Ω–∏–µ, –ø—Ä–µ–∂–¥–µ —á–µ–º –ø–µ—Ä–µ—Ö–æ–¥–∏—Ç—å –∫ ¬´—Ç—è–∂—ë–ª–æ–π –∞—Ä—Ç–∏–ª–ª–µ—Ä–∏–∏¬ª, –Ω–æ –Ω–∞—Å—Ç–∞–∏–≤–∞—é—Ç –Ω–∞ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ –æ–±—Ä–∞—â–∞—Ç—å—Å—è –∫ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞–º –∏ —Ä–∞—Å—Å–º–∞—Ç—Ä–∏–≤–∞—Ç—å –∫–∞–∂–¥—ã–π —Å–ª—É—á–∞–π –∏–Ω–¥–∏–≤–∏–¥—É–∞–ª—å–Ω–æ, —á—Ç–æ–±—ã –ø–æ–¥–æ–±—Ä–∞—Ç—å –æ–ø—Ç–∏–º–∞–ª—å–Ω—ã–π —Å–ø–æ—Å–æ–± —Å–Ω–∏–∂–µ–Ω–∏—è –≤–µ—Å–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders,clinical_trial,safety,hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""The trend of weight loss surgeries, such as gastric resection and gastric banding, has decreased from 8,200 operations in 2024 to 6,700 by August 2025. However, the demand for semaglutide has increased significantly at a record pace. The DSM Group reported sales of generic Ozempic reaching 16.8 billion rubles from January to August, up by 36% compared to the entire year of 2024. Doctors attribute this trend to patients' desire to try medication treatment before resorting to more severe measures, but they stress the need for professional consultation and personalized consideration of each case.""
}"
2025-10-30T06:03:09+00:00,@bezrec,6762,https://t.me/bezrec/6762,"–í –°–®–ê –æ—á–µ—Ä–µ–¥–Ω–æ–π —Å–ª—É—á–∞–π –±–µ–≥—Å—Ç–≤–∞ –ø–æ–¥–æ–ø—ã—Ç–Ω—ã—Ö –æ–±–µ–∑—å—è–Ω. –ù–∞—á–Ω—ë–º –¥–µ–Ω—å —Å –∫–∞–¥—Ä–æ–≤ –∏–∑ –ú–∏—Å—Å–∏—Å–∏–ø–∏. –¢–∞–º –ø–µ—Ä–µ–≤–µ—Ä–Ω—É–ª—Å—è —Ñ—É—Ä–≥–æ–Ω, –ø–µ—Ä–µ–≤–æ–∑–∏–≤—à–∏–π 21 –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–Ω—É—é –º–∞–∫–∞–∫—É –∏–∑ –ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–æ–≥–æ —Ü–µ–Ω—Ç—Ä–∞ –ø—Ä–∏–º–∞—Ç–æ–≤ –¢—É–ª–µ–π–Ω—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞, —Ä–∞—Å–ø–æ–ª–æ–∂–µ–Ω–Ω–æ–≥–æ –≤ –õ—É–∏–∑–∏–∞–Ω–µ. –í –Ω—ë–º —Ç–µ—Å—Ç–∏—Ä—É—é—Ç –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –æ—Ç –í–ò–ß, —Ä–∞–∫–∞, –±–æ–ª–µ–∑–Ω–∏ –õ–∞–π–º–∞, –≤–∏—Ä—É—Å–æ–≤ –≤–µ—Ç—Ä—è–Ω–∫–∏ –∏ –ó–∏–∫–∞, —Ç—É–±–µ—Ä–∫—É–ª–µ–∑–∞, –∫–æ—Ä–æ–Ω–∞–≤–∏—Ä—É—Å–∞ –∏ –¥—Ä—É–≥–∏—Ö –æ–ø–∞—Å–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –ü–æ –ø—É—Ç–∏ –≤ –∏—Å–ø—ã—Ç–∞—Ç–µ–ª—å–Ω—ã–π —Ü–µ–Ω—Ç—Ä –≤–æ –§–ª–æ—Ä–∏–¥–µ —Ñ—É—Ä–≥–æ–Ω –ø–æ–ø–∞–ª –≤ –î–¢–ü, –∏ –ø–æ–¥–æ–ø—ã—Ç–Ω—ã–µ –∂–∏–≤–æ—Ç–Ω—ã–µ —Ä–∞–∑–±–µ–∂–∞–ª–∏—Å—å –ø–æ –æ–∫—Ä—É–≥–µ. –ö–∞–∂–¥–∞—è –º–∞–∫–∞–∫–∞ –≤–µ—Å–∏—Ç –ø–æ–¥ 20 –∫–≥ –∏ –æ—Ç–ª–∏—á–∞–µ—Ç—Å—è –∞–≥—Ä–µ—Å—Å–∏–≤–Ω—ã–º –Ω—Ä–∞–≤–æ–º. –ù–æ —á—Ç–æ —Å–∞–º–æ–µ –Ω–µ–ø—Ä–∏—è—Ç–Ω–æ–µ ‚Äî –∂–∏–≤–æ—Ç–Ω—ã–µ –±—ã–ª–∏ –∑–∞—Ä–∞–∂–µ–Ω—ã –≥–µ–ø–∞—Ç–∏—Ç–æ–º –°, –≥–µ—Ä–ø–µ—Å–æ–º –∏ –∫–æ—Ä–æ–Ω–∞–≤–∏—Ä—É—Å–æ–º. –¢—É–ª–µ–π–Ω—Å–∫–∏–π —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç –ø–æ—Å–ø–µ—à–∏–ª —É—Å–ø–æ–∫–æ–∏—Ç—å –≥—Ä–∞–∂–¥–∞–Ω, —Å–æ–æ–±—â–∏–≤, —á—Ç–æ –±–µ–≥–ª–µ—Ü—ã –Ω–µ –∑–∞—Ä–∞–∑–Ω—ã, –Ω–æ –º–µ—Å—Ç–Ω—ã–µ –∂–∏—Ç–µ–ª–∏ –≤–∏–¥–µ–ª–∏, –∫–∞–∫ –Ω–∞ –æ–±–µ–∑—å—è–Ω –æ—Ö–æ—Ç–∏–ª–∏—Å—å –ª—é–¥–∏ –≤ –∫–æ—Å—Ç—é–º–∞—Ö –±–∏–æ–∑–∞—â–∏—Ç—ã. –í —Ä–µ–∑—É–ª—å—Ç–∞—Ç–µ 20 –ø–æ–¥–æ–ø—ã—Ç–Ω—ã—Ö —É–Ω–∏—á—Ç–æ–∂–∏–ª–∏, –µ—â—ë –æ–¥–Ω—É –º–∞–∫–∞–∫—É –ø—Ä–æ–¥–æ–ª–∂–∞—é—Ç –∏—Å–∫–∞—Ç—å. –°–ª—É—á–∞–π –≤ –ú–∏—Å—Å–∏—Å–∏–ø–∏ ‚Äî –Ω–µ –ø–µ—Ä–≤–æ–µ –ß–ü —Ç–∞–∫–æ–≥–æ —Ä–æ–¥–∞ –≤ –°–®–ê. –í –Ω–æ—è–±—Ä–µ –ø—Ä–æ—à–ª–æ–≥–æ –≥–æ–¥–∞ –ø—Ä–∏–º–∞—Ç—ã —Å–æ–≤–µ—Ä—à–∏–ª–∏ –ø–æ–±–µ–≥ –∏–∑ –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–æ–≥–æ —Ü–µ–Ω—Ç—Ä–∞ Alpha Genesis, –∏–∑–≤–µ—Å—Ç–Ω–æ–≥–æ –∫–∞–∫ ¬´–û—Å—Ç—Ä–æ–≤ –æ–±–µ–∑—å—è–Ω¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": true
}"
2025-10-29T17:19:36+00:00,@bezrec,6756,https://t.me/bezrec/6756,"–ü–æ–±—ã–≤–∞–ª–∏ –Ω–∞ –æ—Ç–∫—Ä—ã—Ç–∏–∏ –ø–µ—Ä–≤–æ–≥–æ –≤ –†–æ—Å—Å–∏–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –≤–∞–∫—Ü–∏–Ω—ã –æ—Ç –í–ü–ß. –°–≤–æ–π –¶–µ–≥–∞—Ä–¥–µ–∫—Å ¬´–ù–∞–Ω–æ–ª–µ–∫¬ª –±—É–¥–µ—Ç –≤—ã–ø—É—Å–∫–∞—Ç—å –≤ –ö–∏—Ä–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –ø–æ –ø–æ–ª–Ω–æ–º—É —Ü–∏–∫–ª—É ‚Äì –æ—Ç –ø–æ–ª—É—á–µ–Ω–∏—è –∞–Ω—Ç–∏–≥–µ–Ω–∞ –¥–æ –≥–æ—Ç–æ–≤–æ–π –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π —Ñ–æ—Ä–º—ã. –ü—Ä–∏–≥–ª–∞—à–∞–µ–º –∏ –≤–∞—Å –ø–æ—Å–º–æ—Ç—Ä–µ—Ç—å, –∫–∞–∫ —ç—Ç–æ –±—ã–ª–æ. –ù–∞ —Ç–æ—Ä–∂–µ—Å—Ç–≤–µ–Ω–Ω–æ–π —Ü–µ—Ä–µ–º–æ–Ω–∏–∏ –æ—Ç–∫—Ä—ã—Ç–∏—è –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä ¬´–ù–∞–Ω–æ–ª–µ–∫–∞¬ª –ï–≤–≥–µ–Ω–∏–π –ë–∞—Ä–∏–Ω–æ–≤ —Ä–∞—Å—Å–∫–∞–∑–∞–ª, —á—Ç–æ –ø—Ä–æ–µ–∫—Ç –ø—Ä–µ–¥—É—Å–º–∞—Ç—Ä–∏–≤–∞–µ—Ç —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–æ –¥–≤—É—Ö —É—á–∞—Å—Ç–∫–æ–≤ –ø–æ –Ω–∞—Ä–∞–±–æ—Ç–∫–µ –∞–Ω—Ç–∏–≥–µ–Ω–∞. –°–µ–≥–æ–¥–Ω—è –æ—Ç–∫—Ä—ã–≤–∞–ª–∏ –ø–µ—Ä–≤—ã–π ‚Äî –µ–≥–æ –º–æ—â–Ω–æ—Å—Ç—å –¥–æ 600 —Ç—ã—Å. –¥–æ–∑ –≤ –≥–æ–¥. –ü–µ—Ä–≤—ã–µ —Å–µ—Ä–∏–∏ –≤–∞–∫—Ü–∏–Ω—ã –ø—É—Å—Ç—è—Ç –≤ –≥—Ä–∞–∂–¥–∞–Ω—Å–∫–∏–π –æ–±–æ—Ä–æ—Ç –≤–æ –≤—Ç–æ—Ä–æ–º –ø–æ–ª—É–≥–æ–¥–∏–∏ —Å–ª–µ–¥—É—é—â–µ–≥–æ –≥–æ–¥–∞. –° –∑–∞–ø—É—Å–∫–æ–º –≤—Ç–æ—Ä–æ–≥–æ —É—á–∞—Å—Ç–∫–∞ –≤ 2027 –≥–æ–¥—É –æ–±—â–∞—è –º–æ—â–Ω–æ—Å—Ç—å –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –≤–∞–∫—Ü–∏–Ω –ø—Ä–µ–≤—ã—Å–∏—Ç 3,5 –º–ª–Ω –¥–æ–∑ –≤ –≥–æ–¥. –≠—Ç–æ –Ω–µ —Ç–æ–ª—å–∫–æ –∑–∞–∫—Ä–æ–µ—Ç –≤—Å–µ –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç–∏ —Ä–æ—Å—Å–∏–π—Å–∫–æ–π —Å–∏—Å—Ç–µ–º—ã –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è, –Ω–æ –∏ –ø–æ–∑–≤–æ–ª–∏—Ç –≤—ã–π—Ç–∏ –Ω–∞ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã–µ —Ä—ã–Ω–∫–∏. –û–±—Ä–∞—Ç–∏–ª–∏ –≤–Ω–∏–º–∞–Ω–∏–µ –Ω–∞ –ª—é–±–æ–ø—ã—Ç–Ω—ã–π –º–æ–º–µ–Ω—Ç. –ü–æ—Ö–≤–∞–ª—É –≤ –∞–¥—Ä–µ—Å –µ–≤—Ä–æ–ø–µ–π—Å–∫–∏—Ö –∫–æ–ª–ª–µ–≥ —Å–µ–π—á–∞—Å —É—Å–ª—ã—à–∏—à—å –Ω–µ—á–∞—Å—Ç–æ, –Ω–æ –ë–∞—Ä–∏–Ω–æ–≤ –∏—Ö –∑–∞—Å–ª—É–≥–∏ –æ—Ç–º–µ—Ç–∏–ª –æ—Ç–¥–µ–ª—å–Ω–æ: –í—Å—ë —ç—Ç–æ –±—ã–ª–æ –±—ã –Ω–µ–≤–æ–∑–º–æ–∂–Ω–æ –±–µ–∑ –Ω–∞–∫–æ–ø–ª–µ–Ω–Ω–æ–≥–æ –æ–ø—ã—Ç–∞ —Ä–∞–±–æ—Ç—ã —Å –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã–º–∏ –∫–æ–º–ø–∞–Ω–∏—è–º–∏ –∏–∑ —Å—Ç—Ä–∞–Ω –ï–°, –ø–æ–∑–≤–æ–ª–∏–≤—à–µ–≥–æ –Ω–∞–º –ø—Ä–∏–≤–Ω–µ—Å—Ç–∏ –≤ –ø—Ä–æ–µ–∫—Ç —Å–æ–≤—Ä–µ–º–µ–Ω–Ω—ã–µ –º–∏—Ä–æ–≤—ã–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ –∏ –ø—Ä–∞–∫—Ç–∏–∫–∏. –û—Ç–¥–µ–ª—å–Ω–æ –ë–∞—Ä–∏–Ω–æ–≤ –ø–æ–±–ª–∞–≥–æ–¥–∞—Ä–∏–ª –∑–∞ –ø–æ–¥–¥–µ—Ä–∂–∫—É –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ –∏ –§–µ–¥–µ—Ä–∞–ª—å–Ω—ã–π —Ñ–æ–Ω–¥ –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏, –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–∏–≤—à–∏–π –ª—å–≥–æ—Ç–Ω—ã–π –∑–∞–π–º –≤ 950 –º–ª–Ω —Ä—É–±–ª–µ–π –Ω–∞ –ø—Ä–∏–æ–±—Ä–µ—Ç–µ–Ω–∏–µ –≤—ã—Å–æ–∫–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–Ω–æ–≥–æ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è. –í—Å–µ–≥–æ –≤ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –≤–ª–æ–∂–µ–Ω–æ 7,5 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ù–∞–ø–æ–º–Ω–∏–º, –≤–∞–∫—Ü–∏–Ω–∞ –æ—Ç –í–ü–ß —Å–µ–π—á–∞—Å –≤ –ù–∞—Ü–∫–∞–ª–µ–Ω–¥–∞—Ä—å –Ω–µ –≤—Ö–æ–¥–∏—Ç, –ø–æ—Å–∫–æ–ª—å–∫—É –¥–æ —Å–∏—Ö –ø–æ—Ä –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –≤ —Å—Ç—Ä–∞–Ω–µ –ª–æ–∫–∞–ª–∏–∑–æ–≤–∞–Ω–æ –Ω–µ –±—ã–ª–æ. –°—Ç–∞—Ä–∞–Ω–∏—è–º–∏ ¬´–ù–∞–Ω–æ–ª–µ–∫–∞¬ª –ù–∞—Ü–∫–∞–ª–µ–Ω–¥–∞—Ä—å –º–æ–∂–µ—Ç –ø–æ–ø–æ–ª–Ω–∏—Ç—å—Å—è –¶–µ–≥–∞—Ä–¥–µ–∫—Å–æ–º —É–∂–µ –≤ 2026 –≥–æ–¥—É. –ü–æ–∫–∞ —á—Ç–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç –æ–¥–æ–±—Ä–µ–Ω —Ç–æ–ª—å–∫–æ –¥–ª—è –≤–∑—Ä–æ—Å–ª—ã—Ö. –í –∞–≤–≥—É—Å—Ç–µ –≤ –ú–∏–Ω–∑–¥—Ä–∞–≤ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–æ –¥–æ—Å—å–µ —Å —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º–∏ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å–ø—ã—Ç–∞–Ω–∏–π —Å —É—á–∞—Å—Ç–∏–µ–º –¥–µ—Ç–µ–π. –†–∞—Å—à–∏—Ä–µ–Ω–∏–µ –ø–æ–∫–∞–∑–∞–Ω–∏–π –æ–∂–∏–¥–∞–µ—Ç—Å—è –≤ —Ñ–µ–≤—Ä–∞–ª–µ 2026 –≥–æ–¥–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,regulation,reimbursement,pricing"",
  ""impact"": ""high"",
  ""english"": ""The production of the HPV vaccine by Nanolek, a Russian company, has been officially inaugurated. The CEO, Evgeny Barinov, highlighted the importance of international cooperation and shared that the project was made possible by loans from the Federal Fund for Industrial Development worth 950 million rubles. The vaccine, which is not yet included in the national schedule, will be approved for adults by August and could potentially be approved for children starting February 2026. The company has invested 750 million rubles in the production facility.""
}"
2025-10-29T14:33:00+00:00,@bezrec,6755,https://t.me/bezrec/6755,"–¢–∞–∫–æ–≤—ã –¥–∞–Ω–Ω—ã–µ –æ–ø—Ä–æ—Å–∞ —Å–æ—Ü–∏–∞–ª—å–Ω–æ–≥–æ –ø—Ä–æ–µ–∫—Ç–∞ Psoriaz Life —Å —É—á–∞—Å—Ç–∏–µ–º —Ç—ã—Å—è—á–∏ —á–µ–ª–æ–≤–µ–∫ –∏–∑ 120 –≥–æ—Ä–æ–¥–æ–≤ –†–æ—Å—Å–∏–∏. –†–∞–¥—É–µ—Ç, —á—Ç–æ 93% —Ä–µ—Å–ø–æ–Ω–¥–µ–Ω—Ç–æ–≤ –ø—Ä–∏–Ω–∏–º–∞—é—Ç —Ç–µ—Ä–∞–ø–∏—é –¥–ª—è –ª–µ—á–µ–Ω–∏—è –ø—Å–æ—Ä–∏–∞–∑–∞, –Ω–∏–∫–∞–∫ –Ω–µ –ª–µ—á–∞—Ç —Å–≤–æ–µ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–µ –ª–∏—à—å 7%, –∞ 60% —Å—á–∏—Ç–∞—é—Ç –Ω–µ–ø—Ä–∏–µ–º–ª–µ–º—ã–º –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ –º–µ—Ç–æ–¥–æ–≤ –Ω–∞—Ä–æ–¥–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω—ã –≤ –ª–µ—á–µ–Ω–∏–∏ –ø—Å–æ—Ä–∏–∞–∑–∞. –ì–µ–Ω–Ω–æ-–∏–Ω–∂–µ–Ω–µ—Ä–Ω—ã–µ –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã (–ì–ò–ë–ü) –ø–∞—Ü–∏–µ–Ω—Ç—ã –≤—ã–±–∏—Ä–∞—é—Ç –∫–∞–∫ –Ω–∞–∏–±–æ–ª–µ–µ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã–π –º–µ—Ç–æ–¥ —Ç–µ—Ä–∞–ø–∏–∏. –í –∏—Ö —á–∏—Å–ª–µ ‚Äî –º–æ–Ω–æ–∫–ª–æ–Ω–∞–ª—å–Ω–æ–µ –∞–Ω—Ç–∏—Ç–µ–ª–æ, –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–Ω–æ–µ –Ω–∞ –±–ª–æ–∫–∞–¥—É –ø—Ä–æ–≤–æ—Å–ø–∞–ª–∏—Ç–µ–ª—å–Ω–æ–≥–æ —Ü–∏—Ç–æ–∫–∏–Ω–∞ –ò–õ17–ê, —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–Ω–æ–µ Biocad. –ï–≥–æ –æ—Å–æ–±–µ–Ω–Ω–æ—Å—Ç—å ‚Äî –≤ –º–µ—Ö–∞–Ω–∏–∑–º–µ –¥–µ–π—Å—Ç–≤–∏—è. –ì–ò–ë–ü —Ç–æ—á–µ—á–Ω–æ –≤–æ–∑–¥–µ–π—Å—Ç–≤—É—é—Ç –Ω–∞ –∫–ª—é—á–µ–≤—ã–µ –∑–≤–µ–Ω—å—è –ø–∞—Ç–æ–≥–µ–Ω–µ–∑–∞ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è, –∞—Ç–∞–∫—É—è –ø—Ä–æ–≤–æ—Å–ø–∞–ª–∏—Ç–µ–ª—å–Ω—ã–µ —Ü–∏—Ç–æ–∫–∏–Ω—ã, –≤—ã—Å–æ–∫–∏–π —Ç–∏—Ç—Ä –∫–æ—Ç–æ—Ä—ã—Ö –ª–µ–∂–∏—Ç –≤ –æ—Å–Ω–æ–≤–µ –∏–º–º—É–Ω–Ω—ã—Ö –Ω–∞—Ä—É—à–µ–Ω–∏–π —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –ø—Å–æ—Ä–∏–∞–∑–æ–º. –¢–∞–∫–∂–µ —á–µ—Ç–≤–µ—Ä—Ç—å –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö –∏—Å–ø–æ–ª—å–∑—É–µ—Ç –Ω–∞—Ä—É–∂–Ω—É—é —Ç–µ—Ä–∞–ø–∏—é (–º–∞–∑–∏), 17% –æ—Ç–º–µ—á–∞—é—Ç —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å —Ñ–æ—Ç–æ—Ç–µ—Ä–∞–ø–∏–∏, 10% ‚Äì –∏–º–º—É–Ω–æ–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç–æ–≤. –ï—Å—Ç—å –∏ –ø–ª–æ—Ö–∞—è –Ω–æ–≤–æ—Å—Ç—å ‚Äî –±–æ–ª–µ–µ —á–µ–º –ø–æ–ª–æ–≤–∏–Ω–µ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –ø—Å–æ—Ä–∏–∞–∑–æ–º –∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–µ –º–µ—à–∞–µ—Ç –≤ –ª–∏—á–Ω–æ–π –∂–∏–∑–Ω–∏ –∏ —Ä–∞–±–æ—Ç–µ. –ë–æ–ª—å—à–µ –¥–∞–Ω–Ω—ã—Ö –∏–∑ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è: üîò–ü—Ä–æ –≤–æ–∑—Ä–∞—Å—Ç: —É 32% —Ä–µ—Å–ø–æ–Ω–¥–µ–Ω—Ç–æ–≤ –ø–µ—Ä–≤—ã–µ —Å–∏–º–ø—Ç–æ–º—ã –ø—Å–æ—Ä–∏–∞–∑–∞ –ø—Ä–æ—è–≤–∏–ª–∏—Å—å –≤ –≤–æ–∑—Ä–∞—Å—Ç–µ –¥–æ 18 –ª–µ—Ç, —É 21% ‚Äì –≤ –ø–µ—Ä–∏–æ–¥ –¥–æ 25 –ª–µ—Ç, —É 15% ‚Äì –¥–æ 35 –ª–µ—Ç. üîò–ü—Ä–æ –∂–∏–∑–Ω—å: 47% –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Ä–µ–≥—É–ª—è—Ä–Ω–æ –∏—Å–ø—ã—Ç—ã–≤–∞—é—Ç —Ñ–∏–∑–∏—á–µ—Å–∫–∏–π –∏–ª–∏ —ç–º–æ—Ü–∏–æ–Ω–∞–ª—å–Ω—ã–π –¥–∏—Å–∫–æ–º—Ñ–æ—Ä—Ç, 52% —Å—Ç–∞—Ä–∞—é—Ç—Å—è —Å–∫—Ä—ã–≤–∞—Ç—å –∫–æ–∂–Ω—ã–µ –ø—Ä–æ—è–≤–ª–µ–Ω–∏—è –ø–æ–¥ –æ–¥–µ–∂–¥–æ–π, —Ç–æ–ª—å–∫–æ 7% –∂–∏–≤—É—Ç –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏ –±–µ–∑ –æ–≥–ª—è–¥–∫–∏ –Ω–∞ –¥–∏–∞–≥–Ω–æ–∑. üîò–ü—Ä–æ –ª–∏—á–Ω–æ–µ: 54% –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–µ –º–µ—à–∞–µ—Ç —Å–æ–∑–¥–∞—Ç—å —Å–µ–º—å—é. üîò–ü—Ä–æ –∫–∞—Ä—å–µ—Ä—É: —Å–∏–º–ø—Ç–æ–º—ã –∏ –∫–æ–∂–Ω—ã–µ –ø—Ä–æ—è–≤–ª–µ–Ω–∏—è –ø—Å–æ—Ä–∏–∞–∑–∞ –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ –∑–∞—Ç—Ä—É–¥–Ω—è—é—Ç —Ä–∞–±–æ—Ç—É –¥–ª—è 18% –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö, –±–æ–ª–µ–µ 30% –ø–µ—Ä–∏–æ–¥–∏—á–µ—Å–∫–∏ —Å—Ç–∞–ª–∫–∏–≤–∞—é—Ç—Å—è —Å —Ç—Ä—É–¥–Ω–æ—Å—Ç—è–º–∏ –≤ —Ä–∞–±–æ—Ç–µ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""The survey of Psoriaz Life project, involving one thousand people from 120 cities in Russia, shows that 93% of respondents are taking treatment for psoriasis. Only 7% do not treat their disease, and 60% consider the use of folk medicine in psoriasis treatment unacceptable. Genetically engineered biological products (GIBP) are chosen as the most effective method of treatment by patients. Among them is monoclonal antibody directed against pro-inflammatory cytokine IL-17A, developed by Biocad. Its unique feature is its mechanism of action: GIBP target the key stages of disease pathogenesis, attacking pro-inflammatory cytokines that are high in patients with psoriasis. Additionally, 25% of respondents use external therapy (creams), and 17% note the effectiveness of phototherapy, while 10% use immunosuppressants. A negative aspect is that more than half of patients with psoriasis find their condition to be a hindrance in personal life and work"
2025-10-29T12:10:01+00:00,@bezrec,6754,https://t.me/bezrec/6754,"–ì–µ—Ä–æ–∏ —Å–µ–≥–æ–¥–Ω—è—à–Ω–µ–≥–æ –≤—ã–ø—É—Å–∫–∞ —Ä—É–±—Ä–∏–∫–∏ #–∑–∞—Ü–µ–Ω–∏–ª–∏ ‚Äî —Å–ø—Ä–µ–∏ –æ—Ç –±–æ–ª–∏ –≤ –≥–æ—Ä–ª–µ –Ω–∞ –æ—Å–Ω–æ–≤–µ –±–µ–Ω–∑–∏–¥–∞–º–∏–Ω–∞. –ú—ã —Å—Ä–∞–≤–Ω–∏–ª–∏ —Ü–µ–Ω—ã –≤ –æ–Ω–ª–∞–π–Ω-–∞–ø—Ç–µ–∫–∞—Ö –Ω–∞ —Ç–æ—Ä–≥–æ–≤—ã–µ –º–∞—Ä–∫–∏ –¢–∞–Ω—Ç—É–º –í–µ—Ä–¥–µ (¬´–ê–Ω–¥–∂–µ–ª–∏–Ω–∏¬ª), –û—Ä–∞–ª—Å–µ–ø—Ç (¬´–†–µ–ø–ª–µ–∫ –§–∞—Ä–º¬ª), –§–∞—Ä–±–µ–Ω—Ç—É–º (¬´–û–∑–æ–Ω –§–∞—Ä–º¬ª), –ê–Ω–≥–∏–¥–∞–∫ (¬´–ì—Ä–æ—Ç–µ–∫—Å¬ª) –∏ –°—Ç—Ä–æ–∫–æ–ª–∏–Ω (¬´–Æ–∂–§–∞—Ä–º¬ª). –ü–æ—Å–ª–µ–¥–Ω–∏–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –æ–∫–∞–∑–∞–ª—Å—è ¬´—ç–∫–∑–æ—Ç–∏–∫–æ–π¬ª ‚Äî –Ω–∞–π—Ç–∏ –µ–≥–æ —É–¥–∞–ª–æ—Å—å —Ç–æ–ª—å–∫–æ –≤ ¬´–ï–∞–ø—Ç–µ–∫–µ¬ª. –ü—Ä–æ–±–ª–µ–º —Å –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å—é –æ—Å—Ç–∞–ª—å–Ω—ã—Ö —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –Ω–µ—Ç. –î–µ—à–µ–≤–ª–µ –≤—Å–µ–≥–æ –ª–µ—á–∏—Ç—å –±–æ–ª—å–Ω–æ–µ –≥–æ—Ä–ª–æ –ê–Ω–≥–∏–¥–∞–∫–æ–º –∏–∑ ¬´–ó–¥—Ä–∞–≤—Å–∏—Ç–∏¬ª ‚Äî —Ç–∞–º —Å–ø—Ä–µ–π –æ–±–æ–π–¥—ë—Ç—Å—è –≤ 365 —Ä—É–±–ª–µ–π. –î–æ—Ä–æ–∂–µ –≤—Å–µ–≥–æ (667 —Ä—É–±–ª–µ–π) —Å—Ç–æ–∏—Ç –¢–∞–Ω—Ç—É–º –í–µ—Ä–¥–µ –≤ ¬´36,6¬ª. –°–æ–±—Å—Ç–≤–µ–Ω–Ω–æ, —Å–µ—Ç—å –æ—Ç–ª–∏—á–∏–ª–∞—Å—å —Å–∞–º—ã–º –≤—ã—Å–æ–∫–∏–º —Ü–µ–Ω–Ω–∏–∫–æ–º –Ω–∞ –≤—Å–µ—Ö —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤. –ù–∞–ø–æ–º–∏–Ω–∞–µ–º, —á—Ç–æ –ª—é–±—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏–º–µ—é—Ç –ø—Ä–æ—Ç–∏–≤–æ–ø–æ–∫–∞–∑–∞–Ω–∏—è. –ü–µ—Ä–µ–¥ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º –ø—Ä–æ–∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä—É–π—Ç–µ—Å—å —Å –ª–µ—á–∞—â–∏–º –≤—Ä–∞—á–æ–º. *–∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –ø—Ä–æ–≤–æ–¥–∏–ª–æ—Å—å –æ–Ω–ª–∞–π–Ω 29 –æ–∫—Ç—è–±—Ä—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage"",
  ""impact"": ""medium"",
  ""english"": ""A study conducted online on October 29th compared prices of throat pain sprays from different brands including Tantum Verde, Oralsep 7, Farbentum, and Angidak. The most expensive option was Angidak from 'Zdravcity' at 365 rubles. The most expensive option was Tantum Verde from '36, 6' at 667 rubles. The shortage of the sprays and high prices were noted.""
}"
2025-10-29T09:01:51+00:00,@bezrec,6753,https://t.me/bezrec/6753,"–ù–∞–∑–≤–∞–Ω—ã —Ä–µ–≥–∏–æ–Ω—ã —Å —Å–∞–º—ã–º–∏ –ø–æ–¥–æ—Ä–æ–∂–∞–≤—à–∏–º–∏ –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç–∞–º–∏. –ü–æ –¥–∞–Ω–Ω—ã–º –¥–æ—Ü–µ–Ω—Ç–∞ –∫–∞—Ñ–µ–¥—Ä—ã –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –∏ –º—É–Ω–∏—Ü–∏–ø–∞–ª—å–Ω—ã—Ö —Ñ–∏–Ω–∞–Ω—Å–æ–≤ –†–≠–£ –∏–º. –ü–ª–µ—Ö–∞–Ω–æ–≤–∞ –ú–∞—Ä–∏–∏ –î–æ–ª–≥–æ–≤–æ–π, –≤ —Å—Ä–µ–¥–Ω–µ–º –ø–æ —Å—Ç—Ä–∞–Ω–µ —Ç–∞–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –ø–æ–¥–æ—Ä–æ–∂–∞–ª–∏ –Ω–∞ 5%. –í —Ç–æ–ø-5 –ø–æ —Ä–æ—Å—Ç—É —Ü–µ–Ω: üîò–ü–µ—Ä–º—Å–∫–∏–π –∫—Ä–∞–π (+22%); üîò–°–≤–µ—Ä–¥–ª–æ–≤—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å (+15%); üîò–ö—Ä–∞—Å–Ω–æ—è—Ä—Å–∫–∏–π –∫—Ä–∞–π, –ù–æ–≤–æ—Å–∏–±–∏—Ä—Å–∫–∞—è –∏ –†–æ—Å—Ç–æ–≤—Å–∫–∞—è –æ–±–ª–∞—Å—Ç–∏ (+6%); üîò–ú–æ—Å–∫–≤–∞ –∏ –ú–æ—Å–∫–æ–≤—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å (+5%); üîò–ë–∞—à–∫–∏—Ä–∏—è (+3%). –ë–æ–ª—å—à–µ –ø–æ–≤–µ–∑–ª–æ –¢—é–º–µ–Ω—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏, –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥—É –∏ –õ–µ–Ω–∏–Ω–≥—Ä–∞–¥—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ ‚Äî –≤ —ç—Ç–∏—Ö —Ä–µ–≥–∏–æ–Ω–∞—Ö –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç—ã –ø–æ–¥–µ—à–µ–≤–µ–ª–∏ ‚Äî –Ω–∞ 6% –∏ 5% —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ. –î–µ–ª–æ –Ω–µ —Ç–æ–ª—å–∫–æ –≤ —É–≤–µ–ª–∏—á–µ–Ω–∏–∏ —Å–ø—Ä–æ—Å–∞: –ù–∞ —É—Ä–æ–≤–µ–Ω—å –∏ –¥–∏–Ω–∞–º–∏–∫—É —Ü–µ–Ω –≤–ª–∏—è—é—Ç –º–Ω–æ–≥–∏–µ —Ñ–∞–∫—Ç–æ—Ä—ã: —Ç–∏–ø –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞, –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å, –±—Ä–µ–Ω–¥, –∑–∞—Ç—Ä–∞—Ç—ã –Ω–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ, –ª–æ–≥–∏—Å—Ç–∏–∫—É, —Ç—Ä–∞–Ω—Å–ø–æ—Ä—Ç–∏—Ä–æ–≤–∫—É, –ø–æ–¥–¥–µ—Ä–∂–∞–Ω–∏–µ IT-–∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä—ã, –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –≤ —Ä–µ–≥–∏–æ–Ω–µ. –ë–æ–ª–µ–µ —Å–æ–≤—Ä–µ–º–µ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã —Å—Ç–æ—è—Ç –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ –¥–æ—Ä–æ–∂–µ –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø—Ä–µ–¥—ã–¥—É—â–∏—Ö –ø–æ–∫–æ–ª–µ–Ω–∏–π, –º–Ω–æ–≥–∏–µ –∏–∑ –Ω–∏—Ö –æ—Ç–Ω–æ—Å—è—Ç—Å—è –∫ –≤–µ—Ä—Ö–Ω–µ–º—É —Ü–µ–Ω–æ–≤–æ–º—É —Å–µ–≥–º–µ–Ω—Ç—É, ‚Äî –æ–±—ä—è—Å–Ω–∏–ª–∞ –î–æ–ª–≥–æ–≤–∞. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, —Å–≤–æ—é —Ä–æ–ª—å –∏–≥—Ä–∞—é—Ç —Ñ–æ—Ä–º—ã –ª–µ–∫–∞—Ä—Å—Ç–≤–∞, –¥–æ–∑–∏—Ä–æ–≤–∫–∏ –∏ —Ñ–∞—Å–æ–≤–∫–∏, –∞ —Ç–∞–∫–∂–µ —Ü–µ–Ω–æ–≤–∞—è –ø–æ–ª–∏—Ç–∏–∫–∞ –∞–ø—Ç–µ—á–Ω—ã—Ö —Å–µ—Ç–µ–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""pricing, shortage"",
  ""impact"": ""high"",
  ""english"": ""Antidepressants have seen price increases ranging from +5% to +22% across regions. The Perm Krai (+22%), Sverdlovsk Oblast (+15%), Krasnoyarsk Krai, Novosibirsk and Rostov Oblasts (+6%), Moscow and Moscow Oblast (+5%), and Bashkortostan (+3%) are among the regions with the highest price increases. The provinces of Tyumen and St Petersburg have experienced a decrease in antidepressant prices by 6% and 5%, respectively. Factors affecting price include the type of drug, manufacturer, brand, production costs, logistics, transportation, IT infrastructure, and availability in the region. Modern drugs are significantly more expensive compared to previous generations, many of which fall into a higher price segment. Additionally, dosage forms and packaging also impact prices, as do the pricing strategies of pharmacies.""
}"
2025-10-29T05:54:45+00:00,@bezrec,6749,https://t.me/bezrec/6749,"–ü–æ—Å–º–æ—Ç—Ä–µ–ª–∏ —Å–µ–Ω—Ç—è–±—Ä—å—Å–∫–∏–π –≤—ã–ø—É—Å–∫ ¬´–ò–Ω–¥–µ–∫—Å–∞ –ú–µ–≥–∞–ø—Ç–µ–∫–∏¬ª ‚Äî —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∞–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–æ–≥–æ —Å—Ä–µ–∑–∞ –∞–ø—Ç–µ—á–Ω–æ–≥–æ —Ä—ã–Ω–∫–∞ –æ—Ç Megapteka. ru. –î–∞–Ω–Ω—ã–µ –∏ —Ä–∞—Å—á–µ—Ç—ã –ø—Ä–∏–≤–µ–¥–µ–Ω—ã –ø–æ –º–µ—Ç–æ–¥–∏–∫–µ ¬´–ò–Ω–¥–µ–∫—Å –ú–µ–≥–∞–ø—Ç–µ–∫–∏¬ª. –í –∞–Ω–∞–ª–∏–∑ –≤–∫–ª—é—á–µ–Ω—ã –∞–ø—Ç–µ—á–Ω—ã–µ –ø—Ä–æ–¥–∞–∂–∏ —Ç–æ–≤–∞—Ä–æ–≤, –≤—Ö–æ–¥—è—â–∏—Ö –≤ —Ç–æ–≤–∞—Ä–Ω—ã–µ –≥—Ä—É–ø–ø—ã —Å–µ—Ä–≤–∏—Å–∞, —Å —É—á–µ—Ç–æ–º –æ–±—ä–µ–¥–∏–Ω–µ–Ω–∏—è –¥–∞–Ω–Ω—ã—Ö –ø–æ –≥–æ—Ä–æ–¥–∞–º –∏ –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç—É –ø–∞—Ä—Ç–Ω—ë—Ä—Å–∫–∏—Ö –∞–ø—Ç–µ—á–Ω—ã—Ö —Å–µ—Ç–µ–π. –î–µ–ª–∏–º—Å—è –≥–ª–∞–≤–Ω—ã–º –∏–∑ –æ–±–∑–æ—Ä–∞: üíä –ø—Ä–æ–¥–∞–∂–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ —Å–µ–Ω—Ç—è–±—Ä–µ –≤—ã—Ä–æ—Å–ª–∏ –≤ —Å—Ä–µ–¥–Ω–µ–º –Ω–∞ 12,4% –≤ —Ä—É–±–ª—è—Ö –∏ 16,1% –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –∞–≤–≥—É—Å—Ç–æ–º; üíä –¥—Ä–∞–π–≤–µ—Ä—ã —Ä–æ—Å—Ç–∞ ‚Äî –ø—Ä–æ—Å—Ç—É–¥–∞ –∏ –≥—Ä–∏–ø–ø ‚Äî –ø—Ä–æ–¥–∞–∂–∏ –∞–Ω—Ç–∏–±–∞–∫—Ç–µ—Ä–∏–∞–ª—å–Ω—ã—Ö –∏ –ø—Ä–æ—Ç–∏–≤–æ–≤–æ—Å–ø–∞–ª–∏—Ç–µ–ª—å–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –ø—Ä–∏–±–∞–≤–∏–ª–∏ +14%; üíä —Å–∞–º—ã–µ –¥–æ—Ä–æ–≥–∏–µ –∞–ø—Ç–µ—á–Ω—ã–µ –∫–æ—Ä–∑–∏–Ω—ã ‚Äî –≤ –ú—É—Ä–º–∞–Ω—Å–∫–µ, –ö–∞–ª–∏–Ω–∏–Ω–≥—Ä–∞–¥–µ –∏ –ò–≤–∞–Ω–æ–≤–µ (7,7 —Ç—ã—Å. —Ä—É–±–ª–µ–π –ø–æ —Å—É–º–º–µ 10 –≥—Ä—É–ø–ø), —Å–∞–º—ã–µ –¥–æ—Å—Ç—É–ø–Ω—ã–µ ‚Äî –≤ –û–º—Å–∫–µ –∏ –ê—Ä—Ö–∞–Ω–≥–µ–ª—å—Å–∫–µ (6,8 —Ç—ã—Å. —Ä—É–±–ª–µ–π); üíä –±–æ–ª—å—à–µ –≤—Å–µ–≥–æ –ø–æ–¥–æ—Ä–æ–∂–∞–ª–∏: –í–µ–Ω—Ç–æ–ª–∏–Ω –∞—ç—Ä–æ–∑–æ–ª—å (+52%), –ê–¥–∏–∞—Ä–∏–Ω –†–µ–≥–∏–¥—Ä–æ–∫–æ–º–ø–ª–µ–∫—Å (+23%) –∏ –°—É–¥–æ–∫—Ä–µ–º (+21%); üíä –ø–æ–¥–µ—à–µ–≤–µ–ª–∏: –¢—Ä–∏–º–µ—Ç–∞–∑–∏–¥–∏–Ω –ú–í (‚Äì23%), –§–µ—Å—Ç–∞–ª (‚Äì23%) –∏ –ú–æ–∫—Å–æ–Ω–∏–¥–∏–Ω –ö–∞–Ω–æ–Ω (‚Äì8,6%); üíä –ª–∏–¥–µ—Ä—ã –ø–æ –¥–æ–ª–µ –≤ –∞–ø—Ç–µ—á–Ω—ã—Ö –ø—Ä–æ–¥–∞–∂–∞—Ö: —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã (21,8%), –ñ–ö–¢ –∏ –ø–µ—á–µ–Ω—å (15,2%), —ç–Ω–¥–æ–∫—Ä–∏–Ω–Ω–∞—è —Å–∏—Å—Ç–µ–º–∞ (14,2%). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance, safety"",
  ""impact"": ""high"",
  ""english"": ""The September sales of medicines increased by an average of 12.4% in rubles and 16.1% in units compared to August. Drivers of growth include flu and cold, which boosted sales of antibacterial and anti-inflammatory drugs by +14%. The most expensive pharmacy baskets are in Murmansk, Kaliningrad, and Ivanovo (7,700 rubles for 10 groups), while the least expensive are in Omsk and Arkhangelsk (6,800 rubles). Prices increased the most for Ventolin aerosol (+52%), Adiracombilix (+23%) and Sudokrem (+21%). Prices decreased the most for Trimetazidin M.V (-23%), Fetalon (-23%) and Moksonidine Kannon (-8.6%). The top-selling categories are cardiovascular drugs (21.8%), gastrointestinal and liver diseases (15.2%), and endocrine system (14.2%).""
}"
2025-10-28T15:00:01+00:00,@bezrec,6748,https://t.me/bezrec/6748,"–í –∫–æ–º–∏—Ç–µ—Ç–µ –ø–æ —Ç—Ä—É–¥—É –ø–æ—Å—á–∏—Ç–∞–ª–∏, –≤–æ —Å–∫–æ–ª—å–∫–æ –≤—Å—Ç–∞–Ω–µ—Ç –æ–ø–ª–∞—Ç–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø–µ–Ω—Å–∏–æ–Ω–µ—Ä–∞–º. –î–µ–ø—É—Ç–∞—Ç—ã —Ñ—Ä–∞–∫—Ü–∏–∏ ¬´–°–ø—Ä–∞–≤–µ–¥–ª–∏–≤–∞—è –†–æ—Å—Å–∏—è¬ª –≤–æ –≥–ª–∞–≤–µ —Å –°–µ—Ä–≥–µ–µ–º –ú–∏—Ä–æ–Ω–æ–≤—ã–º –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –∫–æ–º–ø–µ–Ω—Å–∏—Ä–æ–≤–∞—Ç—å —Å—Ç–æ–∏–º–æ—Å—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø–µ–Ω—Å–∏–æ–Ω–µ—Ä–∞–º, —á–µ–π –¥–æ—Ö–æ–¥ –Ω–∏–∂–µ 1,5-–∫—Ä–∞—Ç–Ω–æ–≥–æ —Ä–∞–∑–º–µ—Ä–∞ –ø—Ä–æ–∂–∏—Ç–æ—á–Ω–æ–≥–æ –º–∏–Ω–∏–º—É–º–∞ –≤ —Ä–µ–≥–∏–æ–Ω–µ –ø—Ä–æ–∂–∏–≤–∞–Ω–∏—è. –°–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–∏–π –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –ø–æ–¥–≥–æ—Ç–æ–≤–ª–µ–Ω –∫ –≤–Ω–µ—Å–µ–Ω–∏—é –≤ –ì–æ—Å–¥—É–º—É. –ß–ª–µ–Ω –∫–æ–º–∏—Ç–µ—Ç–∞ –ì–æ—Å–¥—É–º—ã –ø–æ —Ç—Ä—É–¥—É, —Å–æ—Ü–ø–æ–ª–∏—Ç–∏–∫–µ –∏ –¥–µ–ª–∞–º –≤–µ—Ç–µ—Ä–∞–Ω–æ–≤ –°–≤–µ—Ç–ª–∞–Ω–∞ –ë–µ—Å—Å–∞—Ä–∞–±, –∫–æ–º–º–µ–Ω—Ç–∏—Ä—É—è –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤—É –ù–°–ù, –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∞ –∫–æ–ª–ª–µ–≥–∞–º —Å–Ω–∞—á–∞–ª–∞ —Å—á–∏—Ç–∞—Ç—å, –∞ –ø–æ—Ç–æ–º —É–∂–µ –≤—ã—Å—Ç—É–ø–∞—Ç—å —Å –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–∞–º–∏. –ö —Å–æ–∂–∞–ª–µ–Ω–∏—é, –º–æ–∏ –∫–æ–ª–ª–µ–≥–∏ —Ä–µ–¥–∫–æ –ø—Ä–æ–∏–∑–≤–æ–¥—è—Ç –∫–∞–∫–∏–µ-—Ç–æ —Ä–∞—Å—á–µ—Ç—ã. –°–∞–º–∞ –ø–æ —Å–µ–±–µ –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–∞ –æ—á–µ–Ω—å —Ö–æ—Ä–æ—à–∞—è, –Ω–æ –≤–æ–ø—Ä–æ—Å –∏–º–µ–Ω–Ω–æ –≤ —Ç–æ–º, —á—Ç–æ–±—ã –ø–æ–Ω–∏–º–∞—Ç—å, –∞ —Å–∫–æ–ª—å–∫–æ –Ω–∞–º –ø–æ—Ç—Ä–µ–±—É–µ—Ç—Å—è —Å—Ä–µ–¥—Å—Ç–≤. –ê –ø–æ—Ç—Ä–µ–±—É–µ—Ç—Å—è –Ω–µ–º–∞–ª–æ: –í —Å—Ä–µ–¥–Ω–µ–º –≤ –º–µ—Å—è—Ü –Ω—É–∂–Ω–æ –≤—ã–¥–µ–ª—è—Ç—å –ø–æ 2,5 —Ç—ã—Å—è—á–∏ —Ä—É–±–ª–µ–π –∫–∞–∂–¥–æ–º—É –ø–µ–Ω—Å–∏–æ–Ω–µ—Ä—É. –≠—Ç–æ 107 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –≤ –º–µ—Å—è—Ü. –ï—Å–ª–∏ –≤–∑—è—Ç—å –≥–æ–¥, —Ç–æ —ç—Ç–æ –æ–¥–∏–Ω —Ç—Ä–ª–Ω 300 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, ‚Äî –ø—Ä–∏–∫–∏–Ω—É–ª–∞ –ë–µ—Å—Å–∞—Ä–∞–±, –¥–æ–±–∞–≤–∏–≤, —á—Ç–æ ¬´–≥–¥–µ-—Ç–æ —ç—Ç–∏ —Å—Ä–µ–¥—Å—Ç–≤–∞ –Ω—É–∂–Ω–æ –≤–∑—è—Ç—å¬ª. –≠–∫—Å–ø–µ—Ä—Ç —Ç–∞–∫–∂–µ –æ—Ç–º–µ—Ç–∏–ª–∞, —á—Ç–æ –±—é–¥–∂–µ—Ç —É–∂–µ –ø—Ä–∏–Ω—è—Ç –≤ –ø–µ—Ä–≤–æ–º —á—Ç–µ–Ω–∏–∏. –ê –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –ø–µ–Ω—Å–∏–æ–Ω–µ—Ä–æ–≤, –ø–æ–ª—É—á–∞—é—â–∏—Ö 1,5 –ø—Ä–æ–∂–∏—Ç–æ—á–Ω—ã—Ö –º–∏–Ω–∏–º—É–º–∞, –Ω–µ –ø–æ–¥—Å—á–∏—Ç–∞–Ω–æ. –ï—Å–ª–∏ —ç—Ç–æ –ø—Ä–æ—Å—Ç–æ –ø–æ–≥–æ–≤–æ—Ä–∏—Ç—å –±–µ–∑ —Ä–∞—Å—á–µ—Ç–æ–≤, —Ç–æ —Ç–æ–≥–¥–∞ –Ω–µ –≤–∏–∂—É —Å–º—ã—Å–ª–∞ –≤ —Ç–∞–∫–∏—Ö —Ä–∞–∑–≥–æ–≤–æ—Ä–∞—Ö, ‚Äî –ø–æ–¥—ã—Ç–æ–∂–∏–ª–∞ –ë–µ—Å—Å–∞—Ä–∞–±. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The proposal by the 'Justice Russia' faction, led by Sergey Mironov, suggests compensating the cost of medicines for pensioners whose income is below 1.5 times the regional minimum living standard. The corresponding bill has been prepared for submission to the State Duma. Member of the Committee on Labor, Social Policy and Issues Concerning Veterans of the State Duma Svetlana Bessarab commented on this initiative, suggesting that colleagues first conduct calculations before proposing initiatives. She noted that the average monthly cost for each pensioner is 2,500 rubles. This amounts to approximately 107 billion rubles per month or one trillion three hundred billion rubles annually. She also mentioned that the budget has already been passed in its first reading, but the number of pensioners receiving 1.5 times the minimum living standard has not been calculated.""
}"
2025-10-28T12:00:01+00:00,@bezrec,6747,https://t.me/bezrec/6747,"–ì–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä ¬´–†–∏–≥–ª—ã¬ª –ª–∏—à–∏–ª—Å—è 20 —Ç—ã—Å. —Ä—É–±–ª–µ–π –∏–∑-–∑–∞ —Å–º—Å–∫–∏. –ù–µ—Ç, –ë–æ—Ä–∏—Å –ü–æ–ø–æ–≤ –Ω–µ —Å—Ç–∞–ª –∂–µ—Ä—Ç–≤–æ–π –º–æ—à–µ–Ω–Ω–∏–∫–æ–≤ ‚Äî —Ç–∞–∫–æ–≤ —Ä–∞–∑–º–µ—Ä —à—Ç—Ä–∞—Ñ–∞, –Ω–∞–ª–æ–∂–µ–Ω–Ω–æ–≥–æ –§–ê–°. –ü—Ä–∏—á–∏–Ω–æ–π —Å—Ç–∞–ª–∞ –∂–∞–ª–æ–±–∞ –æ—Ç —Ñ–∏–∑–ª–∏—Ü–∞. –ê–≤—Ç–æ—Ä –æ–±—Ä–∞—â–µ–Ω–∏—è —Å–æ–æ–±—â–∏–ª –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å—â–∏–∫–∞–º, —á—Ç–æ –Ω–∞ –µ–≥–æ –Ω–æ–º–µ—Ä –ø–æ—Å—Ç—É–ø–∏–ª–æ —Å–æ–æ–±—â–µ–Ω–∏–µ c –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–µ–π –æ–± –∞–∫—Ü–∏–∏, –ø—Ä–æ–≤–æ–¥–∏–º–æ–π ¬´–†–∏–≥–ª–æ–π¬ª, –±–µ–∑ –µ–≥–æ –ø—Ä–µ–¥–≤–∞—Ä–∏—Ç–µ–ª—å–Ω–æ–≥–æ —Å–æ–≥–ª–∞—Å–∏—è –Ω–∞ –ø–æ–ª—É—á–µ–Ω–∏–µ —Ä–µ–∫–ª–∞–º—ã. –í —Ä–µ–∑—É–ª—å—Ç–∞—Ç–µ —Ä–µ–≥—É–ª—è—Ç–æ—Ä –ø—Ä–∏–∑–Ω–∞–ª —Ñ–∞–∫—Ç –Ω–∞—Ä—É—à–µ–Ω–∏—è –ó–∞–∫–æ–Ω–∞ –æ —Ä–µ–∫–ª–∞–º–µ, –∞ –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –û–û–û –ø—Ä–∏–≤–ª—ë–∫ –∫ –∞–¥–º–∏–Ω–∏—Å—Ç—Ä–∞—Ç–∏–≤–Ω–æ–π –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç–∏. –ü–æ–ø–æ–≤ –æ—Ç–¥–µ–ª–∞–ª—Å—è –º–∏–Ω–∏–º–∞–ª—å–Ω—ã–º –Ω–∞–∫–∞–∑–∞–Ω–∏–µ–º ‚Äî –∑–∞ –Ω–∞—Ä—É—à–µ–Ω–∏–µ –ø—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ–Ω —à—Ç—Ä–∞—Ñ –æ—Ç 20 –¥–æ 100 —Ç—ã—Å. —Ä—É–±–ª–µ–π –¥–ª—è –¥–æ–ª–∂–Ω–æ—Å—Ç–Ω—ã—Ö –∏ –æ—Ç 300 —Ç—ã—Å. –¥–æ 1 –º–ª–Ω —Ä—É–±–ª–µ–π –¥–ª—è —é—Ä–∏–¥–∏—á–µ—Å–∫–∏—Ö –ª–∏—Ü. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-10-28T09:07:32+00:00,@bezrec,6746,https://t.me/bezrec/6746,"–û–∑–µ–º–ø–∏–∫ –æ–±—Ä—É—à–∏–ª –º–∏—Ä–æ–≤—ã–µ —Ü–µ–Ω—ã –Ω–∞ —Å–∞—Ö–∞—Ä. –ö–∞–∫ –ø–∏—à–µ—Ç Reuters, —Å—Ç–æ–∏–º–æ—Å—Ç—å —Å–∞—Ö–∞—Ä–∞ –Ω–∞ –º–∏—Ä–æ–≤–æ–º —Ä—ã–Ω–∫–µ —Ä—É—Ö–Ω—É–ª–∞ –¥–æ –ø—è—Ç–∏–ª–µ—Ç–Ω–µ–≥–æ –º–∏–Ω–∏–º—É–º–∞ –∏ –¥–æ—Å—Ç–∏–≥–ª–∞ 14,4 —Ü–µ–Ω—Ç–∞ –∑–∞ —Ñ—É–Ω—Ç. –° –Ω–∞—á–∞–ª–∞ —Ç–µ–∫—É—â–µ–≥–æ –≥–æ–¥–∞ —Å–Ω–∏–∂–µ–Ω–∏–µ —Å–æ—Å—Ç–∞–≤–∏–ª–æ –ø—Ä–∏–º–µ—Ä–Ω–æ 25%. –û—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω–æ–π –¥–∏–Ω–∞–º–∏–∫–µ —Å–ø–æ—Å–æ–±—Å—Ç–≤–æ–≤–∞–ª –∫–∞—Ä–¥–∏–Ω–∞–ª—å–Ω—ã–π –ø–µ—Ä–µ—Å–º–æ—Ç—Ä —Ä—ã–Ω–æ—á–Ω—ã—Ö –ø—Ä–æ–≥–Ω–æ–∑–æ–≤ –Ω–∞ 2025-2026 –≥–æ–¥—ã –±—Ä–∞–∑–∏–ª—å—Å–∫–æ–π –∫–æ–Ω—Å–∞–ª—Ç–∏–Ω–≥–æ–≤–æ–π –∫–æ–º–ø–∞–Ω–∏–µ–π Datagro. –í–º–µ—Å—Ç–æ –∑–∞—è–≤–ª–µ–Ω–Ω–æ–≥–æ —Ä–∞–Ω–µ–µ –≥–ª–æ–±–∞–ª—å–Ω–æ–≥–æ –¥–µ—Ñ–∏—Ü–∏—Ç–∞ —Å–∞—Ö–∞—Ä–∞ –≤ 5 –º–ª–Ω —Ç–æ–Ω–Ω —ç–∫—Å–ø–µ—Ä—Ç—ã –ø—Ä–µ–¥—Å–∫–∞–∑—ã–≤–∞—é—Ç –ø—Ä–æ—Ñ–∏—Ü–∏—Ç –≤ –ø–æ—á—Ç–∏ 2 –º–ª–Ω —Ç–æ–Ω–Ω. –†–∞–∑–ª—é–±–∏—Ç—å —Å–∞—Ö–∞—Ä –º–∏—Ä –∑–∞—Å—Ç–∞–≤–∏–ª–∏ –∞–≥–æ–Ω–∏—Å—Ç—ã —Ä–µ—Ü–µ–ø—Ç–æ—Ä–æ–≤ GLP-1, –∏–∑–≤–µ—Å—Ç–Ω—ã–µ —Å–≤–æ–µ–π —Å–ø–æ—Å–æ–±–Ω–æ—Å—Ç—å—é –ø–æ–¥–∞–≤–ª—è—Ç—å –∞–ø–ø–µ—Ç–∏—Ç –≤ —Ü–µ–ª–æ–º –∏ —Ç—è–≥—É –∫ —Å–ª–∞–¥–∫–æ–º—É –≤ —á–∞—Å—Ç–Ω–æ—Å—Ç–∏. –í –†–æ—Å—Å–∏–∏ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω–æ–≥–æ –û–∑–µ–º–ø–∏–∫–∞ –Ω–µ—Ç (–ª–µ–≥–∞–ª—å–Ω–æ–≥–æ), –∑–∞—Ç–æ –ø—Ä–æ–¥–∞–∂–∏ –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤ –æ—Ç ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º–∞¬ª –∏ ¬´–ü—Ä–æ–º–æ–º–µ–¥–∞¬ª –±—å—é—Ç —Ä–µ–∫–æ—Ä–¥—ã. –ù–µ—Å–º–æ—Ç—Ä—è –Ω–∞ —Ç–æ, —á—Ç–æ, –ø–æ —Å–ª–æ–≤–∞–º –ú–∏—Ö–∞–∏–ª–∞ –ú—É—Ä–∞—à–∫–æ, –≤ –Ω–∞—à–µ–π —Å—Ç—Ä–∞–Ω–µ –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–µ —Å–∞—Ö–∞—Ä–∞ –≤ —á–µ—Ç—ã—Ä–µ —Ä–∞–∑–∞ –±–æ–ª—å—à–µ —Ä–µ–∫–æ–º–µ–Ω–¥–æ–≤–∞–Ω–Ω—ã—Ö –Ω–æ—Ä–º, —ç–∫—Å–ø–µ—Ä—Ç—ã –ø—Ä–æ–≥–Ω–æ–∑–∏—Ä—É—é—Ç –µ–≥–æ —Å–Ω–∏–∂–µ–Ω–∏–µ –≤ —Å—Ä–µ–¥–Ω–µ—Å—Ä–æ—á–Ω–æ–π –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–µ. –ö–æ–ª–ª–µ–≥–∏ –∏–∑ ¬´–ê–≥—Ä–æ–Ω–æ–º–∏–∫–∏¬ª (–ò–î ¬´–ù–û–ú¬ª) –ø–∏—à—É—Ç, —á—Ç–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ —Å–∞—Ö–∞—Ä–∞ –≤ –†–æ—Å—Å–∏–∏ —É–ø–µ—Ä–ª–æ—Å—å –≤ –ø–æ—Ç–æ–ª–æ–∫ ‚Äî –Ω–∞ –ø—Ä–æ—Ç—è–∂–µ–Ω–∏–∏ –ø–æ—Å–ª–µ–¥–Ω–∏—Ö –¥–µ—Å—è—Ç–∏ –ª–µ—Ç –≤ —Å—Ç—Ä–∞–Ω–µ –Ω–∞–±–ª—é–¥–∞–µ—Ç—Å—è –ø–µ—Ä–µ–ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ —ç—Ç–æ–≥–æ –ø—Ä–æ–¥—É–∫—Ç–∞, –∏ —Ä–µ—à–∏—Ç—å –ø—Ä–æ–±–ª–µ–º—É —Å –ø–æ–º–æ—â—å—é —ç–∫—Å–ø–æ—Ä—Ç–∞ —É–∂–µ –Ω–µ –ø–æ–ª—É—á–∞–µ—Ç—Å—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""World sugar prices have dropped to a five-year low, falling to $0.144 per pound. Over the year, prices have fallen by about 25%. The Brazilian consulting company Datagro revised its market forecasts for 2025-2026, predicting a surplus of almost 2 million tons instead of the previously announced global shortage of 5 million tons. The decline is attributed to GLP-1 agonists, which suppress appetite in general and a sweet tooth specifically. In Russia, despite the country's sugar consumption being four times higher than recommended norms, experts predict a decrease in its demand. The 'Agronomics' (ID 'NOm') experts from 'Agronomics' state that Russia's sugar production has reached a ceiling, with overproduction observed for the past ten years. Exports are no longer an option to solve this problem.""
}"
2025-10-28T06:06:22+00:00,@bezrec,6745,https://t.me/bezrec/6745,"–§–ò–¶ –ø–∏—Ç–∞–Ω–∏—è –∏ –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ –ø–æ—à—ë–ª –ø–æ –≥—Ä–∏–±—ã. –°–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã —Ü–µ–Ω—Ç—Ä–∞ –∑–∞–∏–Ω—Ç–µ—Ä–µ—Å–æ–≤–∞–ª–∏—Å—å –ø—Ä–æ–¥—É–∫—Ü–∏–µ–π —Å –∫—Ä–∞—Å–Ω—ã–º–∏ –º—É—Ö–æ–º–æ—Ä–∞–º–∏ A. muscaria, –∫–æ—Ç–æ—Ä–∞—è —Å–≤–æ–±–æ–¥–Ω–æ –ø—Ä–æ–¥–∞—ë—Ç—Å—è –≤ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç–µ. –ò –Ω–µ –∑—Ä—è ‚Äî –æ–∫–∞–∑–∞–ª–æ—Å—å, —á—Ç–æ —Ç–∞–∫ –Ω–∞–∑—ã–≤–∞–µ–º—ã–µ ¬´–ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –º–∏–∫—Ä–æ–¥–æ–∑–∏–Ω–≥–∞¬ª –Ω–µ –∏–º–µ—é—Ç —Å–≤–∏–¥–µ—Ç–µ–ª—å—Å—Ç–≤ –æ –≥–æ—Å—Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –≤ –∫–∞—á–µ—Å—Ç–≤–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –∏–ª–∏ –ë–ê–î–æ–≤ –∏ —Å–æ–ø—Ä–æ–≤–æ–∂–¥–∞—é—Ç—Å—è ¬´–∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–µ–π —Ä–µ–∫–ª–∞–º–Ω–æ–≥–æ —Ö–∞—Ä–∞–∫—Ç–µ—Ä–∞¬ª, –∫–æ—Ç–æ—Ä–∞—è –º–æ–∂–µ—Ç –≤–≤–æ–¥–∏—Ç—å –ø–æ–∫—É–ø–∞—Ç–µ–ª–µ–π –≤ –∑–∞–±–ª—É–∂–¥–µ–Ω–∏–µ. –ù–∞ —ç—Ç–∏–∫–µ—Ç–∫–∞—Ö –ø—Ä–∏–≤–æ–¥—è—Ç—Å—è —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –∏–ª–∏ –∏–Ω—Å—Ç—Ä—É–∫—Ü–∏–∏ –ø–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—é –ø–æ—Ä–æ—à–∫–∞ –º—É—Ö–æ–º–æ—Ä–∞ —Ç–æ–ª—å–∫–æ —Å —É–∫–∞–∑–∞–Ω–∏–µ–º —Å—É—Ç–æ—á–Ω—ã—Ö –¥–æ–∑–∏—Ä–æ–≤–æ–∫, –∫–æ—Ç–æ—Ä—ã–µ –æ–±—ã—á–Ω–æ –Ω–µ –ø—Ä–µ–≤—ã—à–∞—é—Ç 0,5 - 1,0 –≥—Ä–∞–º–º–∞, –Ω–µ—Ç –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –æ –ø–æ–∫–∞–∑–∞–Ω–∏—è—Ö –∏ –ø—Ä–æ—Ç–∏–≤–æ–ø–æ–∫–∞–∑–∞–Ω–∏—è—Ö –∫ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—é, –ø–æ–±–æ—á–Ω—ã—Ö —ç—Ñ—Ñ–µ–∫—Ç–∞—Ö. –ü—Ä–∏ —ç—Ç–æ–º —Å—Ç–æ–∏–º–æ—Å—Ç—å —Ç–∞–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –º–æ–∂–µ—Ç –¥–æ—Å—Ç–∏–≥–∞—Ç—å –Ω–µ—Å–∫–æ–ª—å–∫–∏—Ö —Ç—ã—Å—è—á —Ä—É–±–ª–µ–π, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏ –≤ —Ü–µ–Ω—Ç—Ä–µ. –ó–∞–ø—Ä–µ—Ç—ã –†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä–∞ –ø—Ä–æ–¥–∞–≤—Ü–∞–º ¬´–º—É—Ö–æ–º–æ—Ä–Ω–æ–≥–æ –º–∏–∫—Ä–æ–¥–æ–∑–∏–Ω–≥–∞¬ª –Ω–∏–ø–æ—á—ë–º. –ü–æ —Å–ª–æ–≤–∞–º –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–µ–π –§–ò–¶ –ø–∏—Ç–∞–Ω–∏—è, –Ω–∞ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞—Ö –¥–æ —Å–∏—Ö –ø–æ—Ä ¬´–±–µ–∑ –æ—Å–æ–±–æ–≥–æ —Ç—Ä—É–¥–∞ –º–æ–∂–Ω–æ –∫—É–ø–∏—Ç—å –≤—Å–µ–≤–æ–∑–º–æ–∂–Ω—ã–µ –¥–æ–±–∞–≤–∫–∏ —Å –∫—Ä–∞—Å–Ω—ã–º –º—É—Ö–æ–º–æ—Ä–æ–º –≤ —Ñ–æ—Ä–º–µ –∫–∞–ø—Å—É–ª, –ø–æ—Ä–æ—à–∫–æ–≤, –∫—É—Å–æ—á–∫–æ–≤ –≤—ã—Å—É—à–µ–Ω–Ω—ã—Ö —à–ª—è–ø–æ–∫¬ª. –≠–∫—Å–ø–µ—Ä—Ç—ã –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–∞—é—Ç, —á—Ç–æ –ª—é–±–æ–π –ë–ê–î —Å –∫—Ä–∞—Å–Ω—ã–º –º—É—Ö–æ–º–æ—Ä–æ–º –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω–æ –æ–ø–∞—Å–µ–Ω –¥–ª—è –∂–∏–∑–Ω–∏ –∏ –∑–¥–æ—Ä–æ–≤—å—è, –ø–æ—Å–∫–æ–ª—å–∫—É –≤—ã—Å—à–∏–µ –≥—Ä–∏–±—ã, –æ—Ç–Ω–æ—Å—è—â–∏–µ—Å—è –∫ —è–¥–æ–≤–∏—Ç—ã–º –∏ –Ω–µ—Å—ä–µ–¥–æ–±–Ω—ã–º, –Ω–µ –¥–æ–ø—É—Å–∫–∞—é—Ç—Å—è –¥–ª—è –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ø–∏—â–µ–≤–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –∏ –±–∏–æ–¥–æ–±–∞–≤–æ–∫. –ù–∞–±–æ—Ä –ø–æ—Å–ª–µ–¥—Å—Ç–≤–∏–π ‚Äî —Å–∞–º—ã–π —Ä–∞–∑–Ω–æ–æ–±—Ä–∞–∑–Ω—ã–π ‚Äî –æ—Ç —Ç–æ—à–Ω–æ—Ç—ã –∏ —Ä–≤–æ—Ç—ã –¥–æ –≥–∞–ª–ª—é—Ü–∏–Ω–∞—Ü–∏–π –∏ –ø–æ—Ä–∞–∂–µ–Ω–∏—è –Ω–µ–∫–æ—Ç–æ—Ä—ã—Ö –æ—Ç–¥–µ–ª–æ–≤ –≥–æ–ª–æ–≤–Ω–æ–≥–æ –º–æ–∑–≥–∞. –ú–æ–∂–µ—Ç –∏ –¥–æ –∫–æ–º—ã –∏ –ª–µ—Ç–∞–ª—å–Ω–æ–≥–æ –∏—Å—Ö–æ–¥–∞ –¥–æ–π—Ç–∏, –µ—Å–ª–∏ –ø—Ä–∏ —Ä–µ–≥—É–ª—è—Ä–Ω–æ–º —É–ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–∏ —Å—Ä–∞–±–æ—Ç–∞–µ—Ç –Ω–∞–∫–æ–ø–∏—Ç–µ–ª—å–Ω—ã–π —ç—Ñ—Ñ–µ–∫—Ç. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, sanctions, shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""The Center for Food and Biotechnology at a pharmaceutical company noticed products containing red russians A. muscaria, which are freely sold online. It turned out that the 'micro-dosing preparations' do not have registration certificates as medicines or BAs and are accompanied by 'advertising information', which can mislead consumers. The instructions on the packaging only mention daily dosages of up to 0.5 - 1 gram, without information on indications and contraindications, side effects. The prices of these preparations can reach several thousand rubles. Restrictions from the Consumer Protection Agency on sellers 'red mushroom micro-dosing' are ineffective. The marketplaces still have various additives containing red mushrooms in capsule, powder or dried cap form. Experts warn that any BAs with red mushrooms are potentially dangerous to health and life, as higher fungi, considered poisonous and unsuitable for food or dietary supplements production. Possible consequences include nausea, vomiting, hallucinations, damage to certain parts of the brain, coma or even death due to cumulative effects.""
}"
2025-10-27T15:21:42+00:00,@bezrec,6744,https://t.me/bezrec/6744,"–ú–æ—Ä—Ñ–∏–Ω –∏ –¥–∏–∞–∑–µ–ø–∞–º –±—É–¥—É—Ç –ª–µ—Ç–∞—Ç—å –∏ –ø–ª–∞–≤–∞—Ç—å. –í —Å–æ—Å—Ç–∞–≤–µ —Å–∞–º–æ–ª—ë—Ç–Ω—ã—Ö –∏ —Å—É–¥–æ–≤—ã—Ö –∞–ø—Ç–µ—á–µ–∫. –í–ª–∞–¥–∏–º–∏—Ä –ü—É—Ç–∏–Ω –ø–æ–¥–ø–∏—Å–∞–ª –∑–∞–∫–æ–Ω, —Ä–∞–∑—Ä–µ—à–∞—é—â–∏–π –ø—Ä–∏–æ–±—Ä–µ—Ç–∞—Ç—å –∏ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å –≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ü–µ–ª—è—Ö –Ω–∞ –∫–æ—Ä–∞–±–ª—è—Ö –∏ –≤–æ–∑–¥—É—à–Ω—ã—Ö —Å—É–¥–∞—Ö –Ω–∞—Ä–∫–æ—Ç–∏—á–µ—Å–∫–∏–µ —Å—Ä–µ–¥—Å—Ç–≤–∞ –∏ –ø—Å–∏—Ö–æ—Ç—Ä–æ–ø–Ω—ã–µ –≤–µ—â–µ—Å—Ç–≤–∞, –∫–æ—Ç–æ—Ä—ã–µ –ø–æ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã–º –Ω–æ—Ä–º–∞–º –¥–æ–ª–∂–Ω—ã –≤—Ö–æ–¥–∏—Ç—å –≤ –±–æ—Ä—Ç–æ–≤—ã–µ —É–∫–ª–∞–¥–∫–∏, –Ω–∞–±–æ—Ä—ã, –∫–æ–º–ø–ª–µ–∫—Ç—ã –∏ –∞–ø—Ç–µ—á–∫–∏ –¥–ª—è –æ–∫–∞–∑–∞–Ω–∏—è –ø–µ—Ä–≤–æ–π –ø–æ–º–æ—â–∏. –°–ø–µ—Ü–∏–∞–ª—å–Ω–∞—è –ª–∏—Ü–µ–Ω–∑–∏—è —Ä–æ—Å—Å–∏–π—Å–∫–∏–º —Å—É–¥–æ—Ö–æ–¥–Ω—ã–º –∏ –∞–≤–∏–∞–∫–æ–º–ø–∞–Ω–∏—è–º –Ω–µ –ø–æ—Ç—Ä–µ–±—É–µ—Ç—Å—è, –µ—Å–ª–∏ –ø—Ä–∏–æ–±—Ä–µ—Ç–µ–Ω–∏–µ, —Ö—Ä–∞–Ω–µ–Ω–∏–µ, —Ç—Ä–∞–Ω—Å–ø–æ—Ä—Ç–∏—Ä–æ–≤–∫–∞ –∏ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ –¥–ª—è –æ–∫–∞–∑–∞–Ω–∏—è –ø–µ—Ä–≤–æ–π –ø–æ–º–æ—â–∏ —Ç–∞–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Å–æ–≥–ª–∞—Å–æ–≤–∞–Ω—ã —Å –ø—Ä–æ—Ñ–∏–ª—å–Ω—ã–º–∏ –≥–æ—Å–æ—Ä–≥–∞–Ω–∞–º–∏. –ù–æ–≤–æ–≤–≤–µ–¥–µ–Ω–∏–µ –ø—Ä–æ–ø–∏—Å–∞–Ω–æ –≤ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–º –∑–∞–∫–æ–Ω–µ ¬´–û –Ω–∞—Ä–∫–æ—Ç–∏—á–µ—Å–∫–∏—Ö —Å—Ä–µ–¥—Å—Ç–≤–∞—Ö –∏ –ø—Å–∏—Ö–æ—Ç—Ä–æ–ø–Ω—ã—Ö –≤–µ—â–µ—Å—Ç–≤–∞—Ö¬ª –∏ –≤—Å—Ç—É–ø–∏—Ç –≤ —Å–∏–ª—É —Å 1 —Å–µ–Ω—Ç—è–±—Ä—è 2026 –≥–æ–¥–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, sanctions, shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""The law signed by Vladimir Putin allows the purchase and use of narcotic drugs and psychotropic substances for medical purposes on ships and aircraft. This includes the inclusion of such medications in onboard kits, supplies, and first-aid packages. The law will come into force on September 1, 2026.""
}"
2025-10-27T11:51:44+00:00,@bezrec,6743,https://t.me/bezrec/6743,"–ê–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å—â–∏–∫–∏ –≤—ã—è–≤–∏–ª–∏ –∫–∞—Ä—Ç–µ–ª—å –ø—Ä–∏ –ø–æ—Å—Ç–∞–≤–∫–µ –∂–∏–∑–Ω–µ–Ω–Ω–æ –≤–∞–∂–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –Ω–∞ —Å—É–º–º—É –±–æ–ª–µ–µ 812 –º–ª–Ω —Ä—É–±–ª–µ–π. –ê–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å–Ω–æ–µ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–æ –Ω–∞—Ä—É—à–∏–ª–∏ ¬´–ú–§–ö –ê—Ä—Ñ–∞¬ª –∏ ¬´–ü—Ä–æ—Å—Ç–æ—Ä—ã –ó–¥–æ—Ä–æ–≤—å—è¬ª, –≤–º–µ—Å—Ç–µ –ø—Ä–∏–Ω–∏–º–∞–≤—à–∏–µ —É—á–∞—Å—Ç–∏–µ –≤ 529 —ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω—ã—Ö –∞—É–∫—Ü–∏–æ–Ω–∞—Ö –¥–ª—è –Ω—É–∂–¥ –≥–æ—Å—É—á—Ä–µ–∂–¥–µ–Ω–∏–π –≤ 71 —Ä–µ–≥–∏–æ–Ω–µ. –§–ê–° —É—Å—Ç–∞–Ω–æ–≤–∏–ª–∞, —á—Ç–æ –∫–æ–º–ø–∞–Ω–∏–∏ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–ª–∏ –µ–¥–∏–Ω—É—é –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä—É –¥–ª—è –ø–æ–¥–∞—á–∏ –∑–∞—è–≤–æ–∫, –∏–º–µ–ª–∏ –æ–±—â–∏—Ö —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤ –∏ —Ñ–∏–Ω–∞–Ω—Å–æ–≤–æ-—Ö–æ–∑—è–π—Å—Ç–≤–µ–Ω–Ω—ã–µ –≤–∑–∞–∏–º–æ–æ—Ç–Ω–æ—à–µ–Ω–∏—è. –†–µ–∑—É–ª—å—Ç–∞—Ç–æ–º –¥–µ–π—Å—Ç–≤–∏–π —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ —Å–≥–æ–≤–æ—Ä–∞ —Å—Ç–∞–ª–æ –ø–æ–¥–¥–µ—Ä–∂–∞–Ω–∏–µ —Ü–µ–Ω –Ω–∞ —Ç–æ—Ä–≥–∞—Ö ‚Äî –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –ø–æ–¥–∞–≤–∞–ª–∏ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è –±–µ–∑ —Å–Ω–∏–∂–µ–Ω–∏—è –∏–ª–∏ —Å –º–∏–Ω–∏–º–∞–ª—å–Ω—ã–º —Å–Ω–∏–∂–µ–Ω–∏–µ–º –ù–ú–¶–ö. –ù–∞—Ä—É—à–∏—Ç–µ–ª–µ–π –∂–¥—É—Ç —à—Ç—Ä–∞—Ñ—ã. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, —Ä–µ—à–∞–µ—Ç—Å—è –≤–æ–ø—Ä–æ—Å –æ –≤–æ–∑–±—É–∂–¥–µ–Ω–∏–∏ —É–≥–æ–ª–æ–≤–Ω–æ–≥–æ –¥–µ–ª–∞. –í–Ω–∏–º–∞–Ω–∏–µ —Ä–µ–≥—É–ª—è—Ç–æ—Ä–∞ ¬´–ú–§–ö –ê—Ä—Ñ–∞¬ª –∏ ¬´–ü—Ä–æ—Å—Ç–æ—Ä—ã –ó–¥–æ—Ä–æ–≤—å—è¬ª –ø—Ä–∏–≤–ª–µ–∫–ª–∏ –µ—â—ë –≤ —è–Ω–≤–∞—Ä–µ —ç—Ç–æ–≥–æ –≥–æ–¥–∞. –¢–æ–≥–¥–∞ —Ä–µ—á—å —à–ª–∞ –æ —Å—É–º–º–µ –≤ 664,5 –º–ª–Ω —Ä—É–±–ª–µ–π –∏ 61 —Ä–µ–≥–∏–æ–Ω–µ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""Antimonopoly authorities have identified a cartel in the supply of vital medicines worth over 812 million rubles. Companies 'MFK Arfa' and 'Prostors Zdorovya', which participated in 529 electronic auctions for government institutions across 71 regions, were found to have violated antimonopoly legislation. They used a common infrastructure for submitting bids and had mutual employees and financial relationships, resulting in price maintenance on the market. The companies are facing fines. Additionally, a criminal case is being considered.""
}"
2025-10-27T08:59:58+00:00,@bezrec,6742,https://t.me/bezrec/6742,"–ò–∑ ¬´–∑–∞–±—Ä–æ—à–∫–∏¬ª ‚Äî –≤ —Ñ–∞—Ä–º–∫–æ–º–ø–ª–µ–∫—Å. –ü—Ä–µ–≤—Ä–∞—Ç—è—Ç ¬´–ì—É–±–µ—Ä–Ω—Å–∫–∏–µ –∞–ø—Ç–µ–∫–∏¬ª –±—ã–≤—à–∏–π —Å–∫–ª–∞–¥ –Ω–∞ —É–ª–∏—Ü–µ –¢–µ–ª–µ–≤–∏–∑–æ—Ä–Ω–æ–π –≤ –ö—Ä–∞—Å–Ω–æ—è—Ä—Å–∫–µ. –ù–∞ –ø–ª–æ—â–∞–¥–∏ –≤ 4,5 —Ç—ã—Å. –∫–≤–∞–¥—Ä–∞—Ç–Ω—ã—Ö –º–µ—Ç—Ä–æ–≤ —Å–æ–∑–¥–∞–¥—É—Ç —Å–æ–≤—Ä–µ–º–µ–Ω–Ω–æ–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –∫–æ—Å–º–µ—Ç–∏–∫–∏. –ú–∞—Å—à—Ç–∞–±–Ω–∞—è —Ä–µ–∫–æ–Ω—Å—Ç—Ä—É–∫—Ü–∏—è –≤—Å—Ç–∞–Ω–µ—Ç –ø–æ—á—Ç–∏ –≤ –º–∏–ª–ª–∏–∞—Ä–¥ —Ä—É–±–ª–µ–π. –ü–æ—Å–ª–µ —Ä–µ–º–æ–Ω—Ç–∞ –∑–¥–µ—Å—å –ø–æ—è–≤—è—Ç—Å—è –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã–µ –ª–∏–Ω–∏–∏ –∞–ø—Ç–µ—á–Ω–æ–≥–æ –∏–∑–≥–æ—Ç–æ–≤–ª–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤, —Ü–µ—Ö –ø–æ –≤—ã–ø—É—Å–∫—É –ø–∞—Ä—Ñ—é–º–µ—Ä–Ω–æ-–∫–æ—Å–º–µ—Ç–∏—á–µ—Å–∫–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏, –∫–æ–Ω—Ç—Ä–æ–ª—å–Ω–æ-–∞–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–∞—è –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–∏—è, —Å–∫–ª–∞–¥—Å–∫–∏–µ –ø–æ–º–µ—â–µ–Ω–∏—è –∏ –∞–¥–º–∏–Ω–∏—Å—Ç—Ä–∞—Ç–∏–≤–Ω–æ-–±—ã—Ç–æ–≤—ã–µ –±–ª–æ–∫–∏. –°–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–µ–µ —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–æ–µ –∑–∞–¥–∞–Ω–∏–µ —Ä–∞–∑–º–µ—â–µ–Ω–æ –Ω–∞ –ø–æ—Ä—Ç–∞–ª–µ –≥–æ—Å–∑–∞–∫—É–ø–æ–∫. –° –ø–æ–¥—Ä—è–¥—á–∏–∫–æ–º –¥–æ–ª–∂–Ω—ã –æ–ø—Ä–µ–¥–µ–ª–∏—Ç—å—Å—è 29 –æ–∫—Ç—è–±—Ä—è. –°—Ä–æ–∫ –æ–∫–æ–Ω—á–∞–Ω–∏—è —Ä–∞–±–æ—Ç ‚Äî 30 –∞–ø—Ä–µ–ª—è 2027 –≥–æ–¥–∞. –ü–æ –¥–∞–Ω–Ω—ã–º Rusprofile, –ê–û ¬´–ì—É–±–µ—Ä–Ω—Å–∫–∏–µ –ê–ø—Ç–µ–∫–∏¬ª –æ—Å–Ω–æ–≤–∞–Ω–æ –≤ 2018 –≥–æ–¥—É –∏ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–æ –≤ –ö—Ä–∞—Å–Ω–æ—è—Ä—Å–∫–µ. –ì–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä –ê–ª–µ–Ω–∞ –ü–æ–ø–æ–≤–∞ —Ä—É–∫–æ–≤–æ–¥–∏—Ç –∫–æ–º–ø–∞–Ω–∏–µ–π —Å –º–æ–º–µ–Ω—Ç–∞ –µ—ë —Å–æ–∑–¥–∞–Ω–∏—è. –ï–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–º —É—á—Ä–µ–¥–∏—Ç–µ–ª–µ–º –≤—ã—Å—Ç—É–ø–∞–µ—Ç –ö—Ä–∞—Å–Ω–æ—è—Ä—Å–∫–∏–π –∫—Ä–∞–π. –í—ã—Ä—É—á–∫–∞ –ø–æ –∏—Ç–æ–≥–∞–º 2024 –≥–æ–¥–∞ ‚Äî 21 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π (+14% –≥–æ–¥ –∫ –≥–æ–¥—É). –ß–∏—Å—Ç–∞—è –ø—Ä–∏–±—ã–ª—å –≤—ã—Ä–æ—Å–ª–∞ –Ω–∞ 18%, –¥–æ 712 –º–ª–Ω —Ä—É–±–ª–µ–π. –†–µ–Ω—Ç–∞–±–µ–ª—å–Ω–æ—Å—Ç—å –ø–æ —á–∏—Å—Ç–æ–π –ø—Ä–∏–±—ã–ª–∏ ‚Äî 3%. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""tenders, import_export, sanctions, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""A production facility for pharmaceuticals and cosmetics is being transformed from a warehouse in Krasnoyarsk. The project involves converting the former 'Televizornyaya' warehouse into a modern production facility covering 4,500 square meters. The project involves the construction of pharmaceutical manufacturing lines, a perfume and cosmetic production facility, a control laboratory, storage areas, and administrative facilities. The tender for the contractor is scheduled to be finalized on October 29th, with completion of works by April 30, 2027. The company 'Gubernskie Apoteki' was founded in 2018 and registered in Krasnoyarsk. The company's director, Elena Popova, has been leading the company since its inception. The single shareholder is Krasnoyarsk Region. Revenue for 2024 was RUB21 billion (+14% YoY). Net profit grew by 18%, reaching RUB712 million. The return on net"
2025-10-27T05:53:53+00:00,@bezrec,6741,https://t.me/bezrec/6741,"–ü—Ä–æ–¥–∞–∂–∏ —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ –≤—ã—Ä–æ—Å–ª–∏ –≤—Ç—Ä–æ–µ. –ü–æ –¥–∞–Ω–Ω—ã–º DSM Group, –≤ —è–Ω–≤–∞—Ä–µ ‚Äì —Å–µ–Ω—Ç—è–±—Ä–µ 2025 –≥–æ–¥–∞ –±—ã–ª–æ –ø—Ä–æ–¥–∞–Ω–æ –±–æ–ª–µ–µ 3,6 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ –Ω–∞ 20,5 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —á—Ç–æ –≤ 2,8 —Ä–∞–∑ –±–æ–ª—å—à–µ –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –∏ –≤ 3,1 —Ä–∞–∑–∞ –±–æ–ª—å—à–µ –≤ –¥–µ–Ω–µ–∂–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ –≥–æ–¥ –∫ –≥–æ–¥—É. –í –ª–∏–¥–µ—Ä–∞—Ö –ø–æ-–ø—Ä–µ–∂–Ω–µ–º—É –°–µ–º–∞–≤–∏–∫ –æ—Ç ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º–∞¬ª. –ï–≥–æ –∫—É–ø–∏–ª–∏ 2,2 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ (–±–æ–ª—å—à–µ –≤ 2,7 —Ä–∞–∑–∞) –Ω–∞ 13 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π (—Ä–æ—Å—Ç –≤ 2,8 —Ä–∞–∑–∞). –ù–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ ‚Äî –ö–≤–∏–Ω—Å–µ–Ω—Ç–∞ –æ—Ç ¬´–ü—Ä–æ–º–æ–º–µ–¥–∞¬ª (609 —Ç—ã—Å. —É–ø–∞–∫–æ–≤–æ–∫ –Ω–∞ 3,3 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π). –¢–∞–∫–∂–µ –≤ ¬´–ª—é–±–∏–º—á–∏–∫–∞—Ö¬ª —É —Ö—É–¥–µ—é—â–∏—Ö —Ä–æ—Å—Å–∏—è–Ω ‚Äî –í–µ–ª–≥–∏—è, –∫–æ—Ç–æ—Ä—É—é –∫–æ–º–ø–∞–Ω–∏—è –ü–µ—Ç—Ä–∞ –ë–µ–ª–æ–≥–æ –≤—ã–≤–µ–ª–∞ –Ω–∞ —Ä—ã–Ω–æ–∫ –≤ –Ω–∞—á–∞–ª–µ –≥–æ–¥–∞. –†–µ–∑—É–ª—å—Ç–∞—Ç—ã –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –ø–æ –∏—Ç–æ–≥–∞–º 9 –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ ‚Äî 709,6 —Ç—ã—Å. —É–ø–∞–∫–æ–≤–æ–∫ –Ω–∞ 3,6 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ß—Ç–æ –¥–æ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω–æ–≥–æ –û–∑–µ–º–ø–∏–∫–∞, —Ç–æ –≤ —Å—Ç—Ä–∞–Ω—É –ø—Ä–æ–¥–æ–ª–∂–∞—é—Ç –ø–æ—Å—Ç—É–ø–∞—Ç—å ¬´—Å–µ—Ä—ã–µ¬ª –≤–µ—Ä—Å–∏–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞. –ó–∞ –æ—Ç—á—ë—Ç–Ω—ã–π –ø–µ—Ä–∏–æ–¥ –±—ã–ª–æ —Ä–µ–∞–ª–∏–∑–æ–≤–∞–Ω–æ 8,5 —Ç—ã—Å. —É–ø–∞–∫–æ–≤–æ–∫ –Ω–∞ 166,8 –º–ª–Ω —Ä—É–±–ª–µ–π. –ü–µ—Ä–æ—Ä–∞–ª—å–Ω–æ–≥–æ –†–µ–±–µ–ª—Å–∞—Å–∞ ¬´—É—à–ª–æ¬ª 2,5 —Ç—ã—Å. —É–ø–∞–∫–æ–≤–æ–∫ –Ω–∞ 39,4 –º–ª–Ω —Ä—É–±–ª–µ–π. Novo Nordisk –Ω–µ –∫–æ–Ω—Ç—Ä–æ–ª–∏—Ä—É–µ—Ç –∏–º–ø–æ—Ä—Ç –ø—Ä–æ–¥—É–∫—Ü–∏–∏ —á–µ—Ä–µ–∑ –Ω–µ–æ—Ñ–∏—Ü–∏–∞–ª—å–Ω—ã–µ –∫–∞–Ω–∞–ª—ã –ø–æ—Å—Ç–∞–≤–æ–∫ –∏–ª–∏ –¥–ª—è –ª–∏—á–Ω–æ–≥–æ –ø–æ–ª—å–∑–æ–≤–∞–Ω–∏—è, –∞ —Ç–∞–∫–∂–µ –Ω–µ –æ—Ç—Å–ª–µ–∂–∏–≤–∞–µ—Ç –≤—ã–ø—É—Å–∫ –≤ –≥—Ä–∞–∂–¥–∞–Ω—Å–∫–∏–π –æ–±–æ—Ä–æ—Ç —Ç–∞–∫–∏—Ö –ø–∞—Ä—Ç–∏–π –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –Ω–æ –ø–æ—Å—Ç–∞–≤–ª—è–µ—Ç –Ω–∞ —Ä—ã–Ω–æ–∫ –∏–Ω—Å—É–ª–∏–Ω—ã, –ø—Ä–æ–∏–∑–≤–æ–¥–∏–º—ã–µ –Ω–∞ –∑–∞–≤–æ–¥–µ –≤ –†–æ—Å—Å–∏–∏, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏ ¬´–ò–∑–≤–µ—Å—Ç–∏—è–º¬ª –≤ –¥–∞—Ç—Å–∫–æ–π —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏. –°–æ–±—Å—Ç–≤–µ–Ω–Ω—ã–π —Å–µ–º–∞–≥–ª—É—Ç–∏–¥ –≤ —Ç–∞–±–ª–µ—Ç–∫–∞—Ö —É —Ä–æ—Å—Å–∏—è–Ω —Ç–æ–∂–µ –±—É–¥–µ—Ç ‚Äî –ø–æ —Å–ª–æ–≤–∞–º –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –ø–æ –Ω–æ–≤—ã–º –ø—Ä–æ–¥—É–∫—Ç–∞–º –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª –ö–∏—Ä—ã –ó–∞—Å–ª–∞–≤—Å–∫–æ–π, –≤ –Ω–∞—á–∞–ª–µ –æ–∫—Ç—è–±—Ä—è –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª –°–µ–º–∞–ª—å—Ç–∞—Ä—É –≤ –¥–æ–∑–∏—Ä–æ–≤–∫–∞—Ö 3 –º–≥, 7 –º–≥ –∏ 14 –º–≥. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""Sales of the Russian semaglutide have tripled. According to DSM Group, sales were over 3.6 million units and 20.5 billion rubles from January to September 2025, which is 2.8 times higher in natural terms and 3.1 times higher in monetary terms compared to the same period last year. SemaVik from 'Gerofarma' is still leading with sales of over 2.2 million units (2.7 times higher) for 13 billion rubles (growth of 2.8 times). The second place is taken by Quinsenta from 'Promomed' (609 thousand units for 3.3 billion rubles). Also, the popular Velegia from Petros Belo's company was also among the favorites of Russians fighting obesity. Results for the first nine months of 2025 - 709,6 thousand units and 3.6 billion rubles. As for the original Ozempic, 'grey' versions of the drug are"
2025-10-26T10:59:55+00:00,@bezrec,6732,https://t.me/bezrec/6732,"–ù–∞ –≤—ã—Ö–æ–¥–Ω—ã—Ö –ø–æ–±—ã–≤–∞–ª–∏ –≤ –∫—Ä–∞—Å–∏–≤–æ–π –∞–ø—Ç–µ–∫–µ –≤ –ë—Ä–µ—Å—Ç–µ. –ê–ø—Ç–µ–∫–∞ ‚Ññ 3 –†–£–ü ¬´–§–∞—Ä–º–∞—Ü–∏—è¬ª —Ä–∞—Å–ø–æ–ª–æ–∂–µ–Ω–∞ –≤ —Å–∞–º–æ–º —Ü–µ–Ω—Ç—Ä–µ, –Ω–∞ –°–æ–≤–µ—Ç—Å–∫–æ–π —É–ª–∏—Ü–µ. –í —ç—Ç–æ–º –≥–æ–¥—É –æ–Ω–∞ –æ—Ç–º–µ—á–∞–µ—Ç —Å–≤–æ—ë —Å—Ç–æ–ª–µ—Ç–∏–µ. –ó–¥–∞–Ω–∏–µ –æ—Å–æ–±–Ω—è–∫–∞ —Å–ø—Ä–æ–µ–∫—Ç–∏—Ä–æ–≤–∞–Ω–æ –µ—ë –≤–ª–∞–¥–µ–ª—å—Ü–µ–º ‚Äî –∞—Ä—Ö–∏—Ç–µ–∫—Ç–æ—Ä–æ–º –°–æ–ª–æ–º–æ–Ω–æ–º –ì—Ä–∏–Ω–±–µ—Ä–≥–æ–º, –µ—â—ë –∫–æ–≥–¥–∞ –ë—Ä–µ—Å—Ç –±—ã–ª –ø–æ–ª—å—Å–∫–∏–º –∏ –Ω–∞–∑—ã–≤–∞–ª—Å—è –ë—Ä–µ—Å—Ç-–Ω–∞–¥-–ë—É–≥–æ–º. –ù–∞ –¥–≤—É—Ö –≤–µ—Ä—Ö–Ω–∏—Ö —ç—Ç–∞–∂–∞—Ö –∂–∏–ª–∞ —Å–µ–º—å—è –ì—Ä–∏–Ω–±–µ—Ä–≥–∞, –∞ –Ω–∞ –ø–µ—Ä–≤–æ–º —Ä–∞—Å–ø–æ–ª–æ–∂–∏–ª–∞—Å—å –∞–ø—Ç–µ–∫–∞, –∫–æ—Ç–æ—Ä–∞—è —Å—Ç–∞–ª–∞ –ø–æ–¥–∞—Ä–∫–æ–º –µ–≥–æ —Å—É–ø—Ä—É–≥–µ ‚Äî –§–∞–Ω–µ –ê–±—Ä–∞–º–æ–≤–Ω–µ, –ø—Ä–æ–≤–∏–∑–æ—Ä—É –ø–æ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—é. –í —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç–∏ –ì—Ä–∏–Ω–±–µ—Ä–≥–æ–≤ –∞–ø—Ç–µ–∫–∞ —Ä–∞–±–æ—Ç–∞–ª–∞ —Å 1925 –ø–æ 1939 –≥–æ–¥, –∑–∞—Ç–µ–º –±—ã–ª–∞ –Ω–∞—Ü–∏–æ–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–∞, –Ω–æ –§–∞–Ω–∞ –ø—Ä–æ–¥–æ–ª–∂–∏–ª–∞ —Ä–∞–±–æ—Ç–∞—Ç—å –≤ –Ω–µ–π —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–æ–º. –ü–æ—Å–ª–µ –±—ã–ª–∏ –≤–æ–π–Ω–∞, –æ–∫–∫—É–ø–∞—Ü–∏—è, —ç–º–∏–≥—Ä–∞—Ü–∏—è —Ö–æ–∑—è–µ–≤, —Å–º–µ–Ω–∞ –≤–ª–∞—Å—Ç–∏, –Ω–æ –≤ –∑–¥–∞–Ω–∏–∏ –Ω–∞ –°–æ–≤–µ—Ç—Å–∫–æ–π 101 –≤—Å–µ–≥–¥–∞ –ø—Ä–æ–¥–∞–≤–∞–ª–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞. –í 2009 –≥–æ–¥—É –≤ –Ω—ë–º —Å–¥–µ–ª–∞–ª–∏ –∫–∞–ø—Ä–µ–º–æ–Ω—Ç, –∞ –∫ 90-–ª–µ—Ç–∏—é –∞–ø—Ç–µ–∫–∏ –≤–Ω—É—Ç—Ä–∏ –æ—Ä–≥–∞–Ω–∏–∑–æ–≤–∞–ª–∏ –Ω–µ–±–æ–ª—å—à–æ–π –º—É–∑–µ–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-10-25T11:03:32+00:00,@bezrec,6731,https://t.me/bezrec/6731,"–ü—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω—ã–π –≤—ã–ø—É—Å–∫ –Ω–∞—à–µ–π —Å—É–±–±–æ—Ç–Ω–µ–π —Ä—É–±—Ä–∏–∫–∏ #–≤–¥–æ–≥–æ–Ω–∫—É. üíä ¬´–ù–µ–æ—Ñ–∞—Ä–º¬ª –ø–æ–≥–ª–æ—Ç–∏–ª –Ω–∏–∂–µ–≥–æ—Ä–æ–¥—Å–∫–∏–µ —Å–µ—Ç–∏ ¬´–°–æ–ª–Ω–µ—á–Ω–æ–µ –∑–¥–æ—Ä–æ–≤—å–µ¬ª –∏ ¬´–ë—É–¥—å—Ç–µ –∑–¥–æ—Ä–æ–≤—ã¬ª. –¢–µ–ø–µ—Ä—å 67 –∞–ø—Ç–µ–∫ –±—É–¥—É—Ç —Ä–∞–±–æ—Ç–∞—Ç—å –ø–æ–¥ –±—Ä–µ–Ω–¥–æ–º ¬´–°—Ç–æ–ª–∏—á–∫–∏¬ª. –í—Å–µ–≥–æ —ç—Ç–∞ —Å–µ—Ç—å –æ–±—ä–µ–¥–∏–Ω—è–µ—Ç 1,6 —Ç—ã—Å. –∞–ø—Ç–µ–∫ –≤ 80 —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –≥–æ—Ä–æ–¥–∞—Ö. üíä –ú–∏–Ω–∑–¥—Ä–∞–≤ –ø–æ—Ö–≤–∞–ª–∏–ª —Ä–æ—Å—Å–∏–π—Å–∫—É—é —Å–∏—Å—Ç–µ–º—É –∏–∑–≥–æ—Ç–æ–≤–ª–µ–Ω–∏—è –∏ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏—è —Ä–∞–¥–∏–æ—Ñ–∞—Ä–º–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –í –†–æ—Å—Å–∏–∏ —Å–æ–∑–¥–∞–ª–∏ —Å–∞–º—É—é –±—ã—Å—Ç—Ä—É—é, –ø—Ä–∏ —ç—Ç–æ–º —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—É—é —Å–∏—Å—Ç–µ–º—É –∏–∑–≥–æ—Ç–æ–≤–ª–µ–Ω–∏—è –∏ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏—è —Ä–∞–¥–∏–æ—Ñ–∞—Ä–º–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ù–∞ —Å–µ–≥–æ–¥–Ω—è—à–Ω–∏–π –¥–µ–Ω—å –≤ —Å—Ç—Ä–∞–Ω–µ —Ñ—É–Ω–∫—Ü–∏–æ–Ω–∏—Ä—É—é—Ç 22 —è–¥–µ—Ä–Ω—ã–µ –∞–ø—Ç–µ–∫–∏, ‚Äî –∑–∞—è–≤–∏–ª –∑–∞–º–º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ï–≤–≥–µ–Ω–∏–π –ö–∞–º–∫–∏–Ω. üíä –í–∏—Ç–∞–º–∏–Ω D –Ω–µ —Å–¥–∞—ë—Ç –ø–æ–∑–∏—Ü–∏–∏. –ü–æ –¥–∞–Ω–Ω—ã–º —Å–∏—Å—Ç–µ–º—ã –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏ ¬´–ß–µ—Å—Ç–Ω—ã–π –∑–Ω–∞–∫¬ª, –∑–∞ –¥–µ–≤—è—Ç—å –º–µ—Å—è—Ü–µ–≤ —ç—Ç–æ–≥–æ –≥–æ–¥–∞ –ø—Ä–æ–¥–∞–Ω–æ –ø–æ—á—Ç–∏ 15 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫. –≠—Ç–æ –Ω–∞ 2% –±–æ–ª—å—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É. –í –ª–∏–¥–µ—Ä–∞—Ö –ø–æ –¥–∏–Ω–∞–º–∏–∫–µ –ø—Ä–æ–¥–∞–∂ ‚Äî –ß—É–∫–æ—Ç—Å–∫–∏–π –∞–≤—Ç–æ–Ω–æ–º–Ω—ã–π –æ–∫—Ä—É–≥ (+17%), –í–æ–ª–æ–≥–æ–¥—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å –∏ –ò–Ω–≥—É—à–µ—Ç–∏—è (+13%), –ë–µ–ª–≥–æ—Ä–æ–¥—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å –∏ –ö–∞–±–∞—Ä–¥–∏–Ω–æ-–ë–∞–ª–∫–∞—Ä–∏—è (+11%). –ü—Ä–∏ —ç—Ç–æ–º ¬´—Å–æ–ª–Ω–µ—á–Ω—ã–π¬ª –≤–∏—Ç–∞–º–∏–Ω –∑–∞–º–µ—Ç–Ω–æ –ø–æ–¥–æ—Ä–æ–∂–∞–ª ‚Äî —Å—Ä–µ–¥–Ω—è—è —Å—Ç–æ–∏–º–æ—Å—Ç—å —É–ø–∞–∫–æ–≤–∫–∏ –≤—ã—Ä–æ—Å–ª–∞ –Ω–∞ 22% ‚Äî —Å 375 –¥–æ 460 —Ä—É–±–ª–µ–π. üíä ¬´–ü–æ—á—Ç–∞ –†–æ—Å—Å–∏–∏¬ª —Ä–∞—Å—à–∏—Ä–∏–ª–∞ ¬´–í–∏—Ç—Ä–∏–Ω—É –∑–¥–æ—Ä–æ–≤—å—è¬ª. –¢–µ–ø–µ—Ä—å –ª–µ—á–µ–±–Ω–æ-–∫–æ—Å–º–µ—Ç–∏—á–µ—Å–∫–∏–µ —Å—Ä–µ–¥—Å—Ç–≤–∞, –ë–ê–î—ã –∏ –ø—Ä–æ—á–∏–π –Ω–µ–ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–π –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç –¥–æ—Å—Ç—É–ø–µ–Ω –≤ 28 —Ç—ã—Å. –æ—Ç–¥–µ–ª–µ–Ω–∏–π –ú–æ—Å–∫–≤—ã –∏ –ú–æ—Å–∫–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏, –°–µ–≤–µ—Ä–æ-–ó–∞–ø–∞–¥–∞ –∏ —Ü–µ–Ω—Ç—Ä–∞–ª—å–Ω–æ–π —á–∞—Å—Ç–∏, –î–∞–ª—å–Ω–µ–≥–æ –í–æ—Å—Ç–æ–∫–∞, –°–µ–≤–µ—Ä–Ω–æ–≥–æ –ö–∞–≤–∫–∞–∑–∞, –°–∏–±–∏—Ä–∏, –£—Ä–∞–ª–∞, –ü–æ–≤–æ–ª–∂—å—è –∏ —é–≥–∞ –†–æ—Å—Å–∏–∏. –£—Å–ª—É–≥–æ–π –¥–æ—Å—Ç–∞–≤–∫–∏ —Ç–æ–≤–∞—Ä–æ–≤ –¥–ª—è –∑–¥–æ—Ä–æ–≤—å—è –Ω–∞ –¥–æ–º –º–æ–∂–Ω–æ –≤–æ—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å—Å—è –≤ 78 —Ä–µ–≥–∏–æ–Ω–∞—Ö —Å—Ç—Ä–∞–Ω—ã. üíä –≠–Ω–¥–æ—Ñ–∞—Ä–º –ø—Ä–∏—Å—Ç—É–ø–∏–ª –∫ –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –¥–µ—Ñ–∏—Ü–∏—Ç–Ω–æ–π –º–µ—Å–Ω—ã –≤ –†–æ—Å—Å–∏–∏. –ö–æ–º–ø–∞–Ω–∏—è –æ–±—ä—è–≤–∏–ª–∞ –æ –∑–∞–ø—É—Å–∫–µ –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ —Ö–∏–º–∏–æ–ø—Ä–æ—Ç–µ–∫—Ç–æ—Ä–∞. –í—ã–ø—É—Å–∫ –ø–µ—Ä–≤–æ–π –ø–∞—Ä—Ç–∏–∏ –≤ –≥—Ä–∞–∂–¥–∞–Ω—Å–∫–∏–π –æ–±–æ—Ä–æ—Ç –Ω–∞–º–µ—á–µ–Ω –Ω–∞ –Ω–æ—è–±—Ä—å 2025 –≥–æ–¥–∞. üíä –°–æ—Å—É–¥–æ—Å—É–∂–∏–≤–∞—é—â–∏–µ —Å–ø—Ä–µ–∏ –¥–ª—è –Ω–æ—Å–∞ –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç —Å–¥–µ–ª–∞—Ç—å ¬´—Ä–µ—Ü–µ–ø—Ç—É—Ä–∫–æ–π¬ª. –≠–∫—Å–ø–µ—Ä—Ç –í–û–ó –∏ –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç –†–æ—Å—Å–∏–π—Å–∫–æ–π –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∑–¥–æ—Ä–æ–≤—å—è –ê–Ω–¥—Ä–µ–π –î–µ–º–∏–Ω –≤—ã—Å—Ç—É–ø–∏–ª —Å –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–æ–π –ø—Ä–æ–¥–∞–≤–∞—Ç—å —Ç–∞–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã —Å—Ç—Ä–æ–≥–æ –ø–æ —Ä–µ—Ü–µ–ø—Ç—É, .—Ç.–∫. –∏—Ö –±–µ—Å–∫–æ–Ω—Ç—Ä–æ–ª—å–Ω–æ–µ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ –≤—ã–∑—ã–≤–∞–µ—Ç —Å–∏–ª—å–Ω—É—é –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç—å –∏ —á—Ä–µ–≤–∞—Ç–æ —Å–µ—Ä—å—ë–∑–Ω—ã–º–∏ –æ—Å–ª–æ–∂–Ω–µ–Ω–∏—è–º–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-10-24T16:02:24+00:00,@bezrec,6730,https://t.me/bezrec/6730,"¬´–ì–µ–Ω–µ—Ä–∏—É–º¬ª —Å–æ–≤–µ—Ä—à–∏–ª –ø—Ä–æ—Ä—ã–≤ –≤ –ª–µ—á–µ–Ω–∏–∏ —Å–∏–Ω–¥—Ä–æ–º–∞ –•–∞–Ω—Ç–µ—Ä–∞. –†–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–æ–Ω–Ω–æ–µ —É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏–µ –ø–æ–ª—É—á–∏–ª –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –ö–ª–æ—Ç–∏–ª–∏—è (–≤–µ—Ä–µ–Ω–∞—Ñ—É—Å–ø –∞–ª—å—Ñ–∞) –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ –º—É–∫–æ–ø–æ–ª–∏—Å–∞—Ö–∞—Ä–∏–¥–æ–∑–∞ II —Ç–∏–ø–∞ (—Å–∏–Ω–¥—Ä–æ–º–∞ –•–∞–Ω—Ç–µ—Ä–∞). –≠—Ç–æ –ø–µ—Ä–≤—ã–π –≤ –º–∏—Ä–µ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–π –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç, –∫–æ—Ç–æ—Ä—ã–π –∏—Å–ø–æ–ª—å–∑—É–µ—Ç –∏–Ω—Å—É–ª–∏–Ω–æ–≤—ã–π —Ä–µ—Ü–µ–ø—Ç–æ—Ä –¥–ª—è –ø—Ä–µ–æ–¥–æ–ª–µ–Ω–∏—è –≥–µ–º–∞—Ç–æ—ç–Ω—Ü–µ—Ñ–∞–ª–∏—á–µ—Å–∫–æ–≥–æ –±–∞—Ä—å–µ—Ä–∞ (–ì–≠–ë) –∏ –¥–æ—Å—Ç–∞–≤–∫–∏ —Ñ–µ—Ä–º–µ–Ω—Ç–∞ –∏–¥—É—Ä–æ–Ω–∞—Ç-2-—Å—É–ª—å—Ñ–∞—Ç–∞–∑—ã –Ω–µ–ø–æ—Å—Ä–µ–¥—Å—Ç–≤–µ–Ω–Ω–æ –≤ —Ü–µ–Ω—Ç—Ä–∞–ª—å–Ω—É—é –Ω–µ—Ä–≤–Ω—É—é —Å–∏—Å—Ç–µ–º—É. –¢–∞–∫–æ–π –ø–æ–¥—Ö–æ–¥ —è–≤–ª—è–µ—Ç—Å—è –ø—Ä–∏–Ω—Ü–∏–ø–∏–∞–ª—å–Ω–æ –Ω–æ–≤—ã–º –º–µ—Ç–æ–¥–æ–º —Ç–µ—Ä–∞–ø–∏–∏ —Å–∏–Ω–¥—Ä–æ–º–∞ –•–∞–Ω—Ç–µ—Ä–∞. –ö–ª–æ—Ç–∏–ª–∏—é –æ—Ç–ª–∏—á–∞–µ—Ç —Å–ø–æ—Å–æ–±–Ω–æ—Å—Ç—å –≤–æ–∑–¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å –∏–º–µ–Ω–Ω–æ –Ω–∞ –Ω–µ–≤—Ä–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–µ —Å–∏–º–ø—Ç–æ–º—ã, —Ç–æ–≥–¥–∞ –∫–∞–∫ —É–∂–µ —Å—É—â–µ—Å—Ç–≤—É—é—â–∏–µ –º–µ—Ç–æ–¥—ã —Ñ–µ—Ä–º–µ–Ω—Ç–æ–∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –º–æ–≥—É—Ç –±–æ—Ä–æ—Ç—å—Å—è –ª–∏—à—å —Å —Å–æ–º–∞—Ç–∏—á–µ—Å–∫–∏–º–∏ –ø—Ä–æ—è–≤–ª–µ–Ω–∏—è–º–∏, –Ω–µ —Å–ø–æ—Å–æ–±—Å—Ç–≤—É—è –ø—Ä–∏ —ç—Ç–æ–º –æ—Å—Ç–∞–Ω–æ–≤–∫–µ –Ω–µ–π—Ä–æ–¥–µ–≥–µ–Ω–µ—Ä–∞—Ü–∏–∏. –ü—Ä–µ–ø–∞—Ä–∞—Ç –±—É–¥–µ—Ç –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç—å—Å—è –Ω–∞ –º–æ—â–Ω–æ—Å—Ç—è—Ö ¬´–ì–µ–Ω–µ—Ä–∏—É–º–∞¬ª –≤ –†–æ—Å—Å–∏–∏ –ø–æ –ø–æ–ª–Ω–æ–º—É —Ü–∏–∫–ª—É. –≠—Ç–æ –Ω–æ–≤–∞—è –≥–ª–∞–≤–∞ –≤ –∏—Å—Ç–æ—Ä–∏–∏ –±–æ—Ä—å–±—ã —Å —Å–∏–Ω–¥—Ä–æ–º–æ–º –•–∞–Ω—Ç–µ—Ä–∞. –í–ø–µ—Ä–≤—ã–µ –≤ –∞—Ä—Å–µ–Ω–∞–ª–µ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –ø–æ—è–≤–∏–ª—Å—è –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç, –∫–æ—Ç–æ—Ä—ã–π —Ä–∞–¥–∏–∫–∞–ª—å–Ω–æ –º–µ–Ω—è–µ—Ç —Ç–µ—á–µ–Ω–∏–µ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è. –£–±–µ–∂–¥–µ–Ω—ã, —á—Ç–æ –Ω–∞—à–∞ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∞ —Å—É—â–µ—Å—Ç–≤–µ–Ω–Ω—ã–º –æ–±—Ä–∞–∑–æ–º —É–ª—É—á—à–∏—Ç –∫–∞—á–µ—Å—Ç–≤–æ –∂–∏–∑–Ω–∏ –Ω–∞—à–∏—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –∏ –∏—Ö —Ä–æ–¥–∏—Ç–µ–ª–µ–π. –í —Å–∞–º–æ–µ –±–ª–∏–∂–∞–π—à–µ–µ –≤—Ä–µ–º—è –ø—Ä–µ–ø–∞—Ä–∞—Ç —Å—Ç–∞–Ω–µ—Ç –¥–æ—Å—Ç—É–ø–Ω—ã–º –≤ –†–æ—Å—Å–∏–∏. –ú—ã —Ç–∞–∫–∂–µ –≤–µ–¥–µ–º –∞–∫—Ç–∏–≤–Ω—É—é —Ä–∞–±–æ—Ç—É –¥–ª—è —Ç–æ–≥–æ, —á—Ç–æ–±—ã —Ç–µ—Ä–∞–ø–∏—è —ç—Ç–∏–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–º —Å—Ç–∞–ª–∞ –¥–æ—Å—Ç—É–ø–Ω–∞ –ø–∞—Ü–∏–µ–Ω—Ç–∞–º –≤ –Ω–∞–∏–±–æ–ª—å—à–µ–º —á–∏—Å–ª–µ —Å—Ç—Ä–∞–Ω, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä ¬´–ì–µ–Ω–µ—Ä–∏—É–º–∞¬ª –î–∞–Ω–∏–∏–ª –¢–∞–ª—è–Ω—Å–∫–∏–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, shortage, regulation, registration, reimbursement"",
  ""impact"": ""high"",
  ""english"": ""Genereum has made a breakthrough in treating Hunter syndrome. The innovative drug Clothilie (verenafusp alpha) for the treatment of mucopolysaccharidosis type II (Hunter syndrome) has received a registration certificate. This is the first registered pharmaceutical that uses an insulin receptor to overcome the hematoencephalic barrier (HEB) and directly delivers iduronic acid-2-sulfatase to the central nervous system. This approach represents a fundamentally new method of treating Hunter syndrome. Clothilie stands out for its ability to target neurological symptoms, whereas existing enzyme replacement therapies can only combat somatic manifestations without halting neurodegeneration. The drug will be produced on Genereum's facilities in Russia according to full production cycle. This marks a new chapter in the history of battling Hunter syndrome. Our development significantly improves patients' and their parents' quality of life. The drug will be available in Russia soon. We are also actively working to make this therapy accessible to patients in the greatest number of countries.""
}"
2025-10-24T14:32:37+00:00,@bezrec,6729,https://t.me/bezrec/6729,"–ü—è—Ç–Ω–∏—á–Ω—ã–π —Å–µ–∫—Ä–µ—Ç –¥–æ–ª–≥–æ–ª–µ—Ç–∏—è –æ—Ç –æ—á–∞—Ä–æ–≤–∞—Ç–µ–ª—å–Ω–æ–π –º–∞–¥–∞–º –∏–∑ –§—Ä–∞–Ω—Ü–∏–∏. –£ –º–µ–Ω—è –Ω–µ—Ç –≤—Ä–∞—á–∞ –∏ –Ω–µ—Ç –ª–µ–∫–∞—Ä—Å—Ç–≤. –¢–æ–ª—å–∫–æ –º–æ–π —Å–∏–¥—Ä –∏ –≤—Å—ë. –Ø —Ö–æ—Ä–æ—à–æ –µ–º, —Ö–æ—Ä–æ—à–æ –ø—å—é –∏ —Ö–æ—Ä–æ—à–æ —Å–ø–ª—é. –≠—Ç–æ –≤—Å—ë, —á—Ç–æ —è –¥–µ–ª–∞—é, —á—Ç–æ–±—ã –≤—ã–≥–ª—è–¥–µ—Ç—å –∏ —á—É–≤—Å—Ç–≤–æ–≤–∞—Ç—å —Å–µ–±—è –ø—Ä–µ–∫—Ä–∞—Å–Ω–æ. –ó–≤—É—á–∏—Ç –∫–∞–∫ –ø–ª–∞–Ω. –î–∞ –ø—Ä–æ—Å—Ç–∏—Ç –Ω–∞—Å –ú–∏–Ω–∑–¥—Ä–∞–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-10-24T11:34:26+00:00,@bezrec,6728,https://t.me/bezrec/6728,"–ü—Ä–æ–¥–æ–ª–∂–∞–µ–º ¬´–ø—Ä–æ—Å—Ç—É–¥–Ω—É—é¬ª —Ç–µ–º—É. –í —Å–µ–≥–æ–¥–Ω—è—à–Ω–µ–º –≤—ã–ø—É—Å–∫–µ —Ä—É–±—Ä–∏–∫–∏ #–∑–∞—Ü–µ–Ω–∏–ª–∏ ‚Äî –∫–∞–ø–ª–∏ –æ—Ç –∫–∞—à–ª—è –¥–ª—è –ø—Ä–∏—ë–º–∞ –≤–Ω—É—Ç—Ä—å –Ω–∞ –æ—Å–Ω–æ–≤–µ –±—É—Ç–∞–º–∏—Ä–∞—Ç–∞. –ú—ã —Å—Ä–∞–≤–Ω–∏–ª–∏ —Ü–µ–Ω—ã –≤ –æ–Ω–ª–∞–π–Ω-–∞–ø—Ç–µ–∫–∞—Ö –Ω–∞ —Ç–æ—Ä–≥–æ–≤—ã–µ –º–∞—Ä–∫–∏ –°–∏–Ω–µ–∫–æ–¥ (¬´–ì–°–ö¬ª), –û–º–Ω–∏—Ç—É—Å (¬´–ù–∏–∂—Ñ–∞—Ä–º¬ª) –∏ –ö–æ–¥–µ–ª–∞–∫ –ù–µ–æ (¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç¬ª). –•–æ—Ä–æ—à–∞—è –Ω–æ–≤–æ—Å—Ç—å ‚Äî –ø—Ä–æ–±–ª–µ–º —Å –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å—é —Ç–∞–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–µ—Ç ‚Äî –±—É—Ç–∞–º–∏—Ä–∞—Ç –≤ –∫–∞–ø–ª—è—Ö –µ—Å—Ç—å –≤ –Ω–∞–ª–∏—á–∏–∏ —É –≤—Å–µ—Ö –ø—Ä–æ–≤–µ—Ä–µ–Ω–Ω—ã—Ö –Ω–∞–º–∏ –ø—Ä–æ–¥–∞–≤—Ü–æ–≤. –°–∞–º—ã–º –¥–µ—à—ë–≤—ã–º –æ–∫–∞–∑–∞–ª—Å—è –ö–æ–¥–µ–ª–∞–∫ –ù–µ–æ ‚Äî –≤ ¬´–ó–¥—Ä–∞–≤—Å–∏—Ç–∏¬ª –ø—É–∑—ã—Ä—ë–∫ –æ–±—ä—ë–º–æ–º 20 –º–ª –æ–±–æ–π–¥—ë—Ç—Å—è –≤ 388 —Ä—É–±–ª–µ–π. –î–æ—Ä–æ–∂–µ –≤—Å–µ–≥–æ –ª–µ—á–∏—Ç—å –∫–∞—à–µ–ª—å –û–º–Ω–∏—Ç—É—Å–æ–º –∏–∑ ¬´36,6¬ª ‚Äî —Ç–∞–º –ø—Ä–µ–ø–∞—Ä–∞—Ç —Å—Ç–æ–∏—Ç 646 —Ä—É–±–ª–µ–π. –ù–∞–ø–æ–º–∏–Ω–∞–µ–º, —á—Ç–æ –ª—é–±—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏–º–µ—é—Ç –ø—Ä–æ—Ç–∏–≤–æ–ø–æ–∫–∞–∑–∞–Ω–∏—è. –ü–µ—Ä–µ–¥ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º –ø—Ä–æ–∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä—É–π—Ç–µ—Å—å —Å –ª–µ—á–∞—â–∏–º –≤—Ä–∞—á–æ–º. *–∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –ø—Ä–æ–≤–æ–¥–∏–ª–æ—Å—å –æ–Ω–ª–∞–π–Ω 24 –æ–∫—Ç—è–±—Ä—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage"",
  ""impact"": ""medium"",
  ""english"": ""We compared prices in online pharmacies for branded cough suppressants Sinekod (GSK), Omnitus (Nizfarm) and Kodelak Neo (FarmaStand). Availability of buthymetrine is not a problem - it's available in all verified sellers. The cheapest option was Kodelak Neo from 'Zdravcity' - a vial of 20ml costs 388 rubles. The most expensive is Omnitus from '36,6' - the price is 646 rubles. Remember that any medication has contraindications. Consult a doctor before use.""
}"
2025-10-24T08:45:44+00:00,@bezrec,6727,https://t.me/bezrec/6727,"¬´–°–±–µ—Ä–±–∞–Ω–∫¬ª –Ω–∞–º–µ—Ä–µ–Ω –æ–±–∞–Ω–∫—Ä–æ—Ç–∏—Ç—å —Ñ–∞—Ä–º–±–∏–∑–Ω–µ—Å –≤–Ω—É–∫–∞ –ó—É—Ä–∞–±–∞ –¶–µ—Ä–µ—Ç–µ–ª–∏. –°–±–µ—Ä–±–∞–Ω–∫ –≥–æ—Ç–æ–≤–∏—Ç –æ–±—Ä–∞—â–µ–Ω–∏—è –≤ —Å—É–¥ —Å –∑–∞—è–≤–ª–µ–Ω–∏–µ–º –æ –Ω–µ—Å–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –û–û–û ¬´–ì–µ–æ –û—Ä–≥–∞–Ω–∏–∫—Å¬ª –∏ ¬´–ì–µ–æ-–ú–µ–¥¬ª. –ö–æ–º–ø–∞–Ω–∏–∏ –≤—ã–ø—É—Å–∫–∞—é—Ç –≤–∏—Ç–∞–º–∏–Ω—ã, –¥–æ–±–∞–≤–∫–∏ –∏ –∫–æ—Å–º–µ—Ç–∏–∫—É –ø–æ–¥ –±—Ä–µ–Ω–¥–æ–º Vibes. –ü–æ –¥–∞–Ω–Ω—ã–º Rusprofile, –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–º —É—á—Ä–µ–¥–∏—Ç–µ–ª–µ–º ¬´–ì–µ–æ –û—Ä–≥–∞–Ω–∏–∫—Å–∞¬ª –≤—ã—Å—Ç—É–ø–∞–µ—Ç ¬´–ì–µ–æ-–ú–µ–¥¬ª. –¢–æ—Ç, –≤ —Å–≤–æ—é –æ—á–µ—Ä–µ–¥—å –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∏—Ç —á–µ—Ç—ã—Ä—ë–º —Ñ–∏–∑–∏—á–µ—Å–∫–∏–º –ª–∏—Ü–∞–º: –≤–Ω—É–∫—É –∞—Ä—Ö–∏—Ç–µ–∫—Ç–æ—Ä–∞ –¶–µ—Ä–µ—Ç–µ–ª–∏ –ó—É—Ä–∞–±—É –¶–µ—Ä–µ—Ç–µ–ª–∏-–ú–∞—Ö–∞—Ä–∞–¥–∑–µ (62,5%), –ì–µ–æ—Ä–≥–∏—é –ö–∞–ø–∞–Ω–∞–¥–∑–µ (15%), –Æ—Ä–∏—é –ï—Å–∏–Ω—É (12,5%) –∏ —Å—ã–Ω—É –±—ã–≤—à–µ–≥–æ –≥—É–±–µ—Ä–Ω–∞—Ç–æ—Ä–∞ –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥–∞ –ê–ª–µ–∫—Å–µ—é –ü–æ–ª—Ç–∞–≤—á–µ–Ω–∫–æ (10%). –í—Å–µ –¥–æ–ª–∏ –≤ —É—Å—Ç–∞–≤–Ω–æ–º –∫–∞–ø–∏—Ç–∞–ª–µ –Ω–∞—Ö–æ–¥—è—Ç—Å—è –≤ –∑–∞–ª–æ–≥–µ. –ì–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–º –æ–±–µ–∏—Ö –∫–æ–º–ø–∞–Ω–∏–π —á–∏—Å–ª–∏—Ç—Å—è –ì–µ–æ—Ä–≥–∏–π –ö–∞–ø–∞–Ω–∞–¥–∑–µ. –î–µ–ª–∞ —Å –ø—Ä–∏–±—ã–ª—å—é —É ¬´–ì–µ–æ-–ú–µ–¥–∞¬ª –∏–¥—É—Ç –∏–∑ —Ä—É–∫ –≤–æ–Ω –ø–ª–æ—Ö–æ ‚Äî –∑–∞ 2024 –≥–æ–¥ —ç—Ç–æ—Ç –ø–æ–∫–∞–∑–∞—Ç–µ–ª—å —Ä—É—Ö–Ω—É–ª –Ω–∞ -2 316 %, –¥–æ -49 –º–ª–Ω —Ä—É–±–ª–µ–π. –í—ã—Ä—É—á–∫–∞ –≤—ã—Ä–æ—Å–ª–∞ –Ω–∞ 100%, –¥–æ 31 –º–ª–Ω —Ä—É–±–ª–µ–π. –§–∏–Ω–∞–Ω—Å–æ–≤–∞—è —É—Å—Ç–æ–π—á–∏–≤–æ—Å—Ç—å –∏ –ø–ª–∞—Ç—ë–∂–µ—Å–ø–æ—Å–æ–±–Ω–æ—Å—Ç—å –æ—Ü–µ–Ω–∏–≤–∞—é—Ç—Å—è –∫–∞–∫ –Ω–∏–∑–∫–∏–µ. –°–±–µ—Ä–±–∞–Ω–∫ –µ–¥–≤–∞ –ª–∏ –∑–∞–∏–Ω—Ç–µ—Ä–µ—Å–æ–≤–∞–Ω –≤ –∫–æ–Ω—Ç—Ä–æ–ª–µ –Ω–∞–¥ –±–∏–∑–Ω–µ—Å–æ–º ¬´–ì–µ–æ –û—Ä–≥–∞–Ω–∏–∫—Å¬ª –∏ ¬´–ì–µ–æ-–ú–µ–¥¬ª. –í–µ—Ä–æ—è—Ç–Ω–µ–µ –≤—Å–µ–≥–æ –≤ —Ä–∞–º–∫–∞—Ö –ø—Ä–æ—Ü–µ–¥—É—Ä—ã –±–∞–Ω–∫—Ä–æ—Ç—Å—Ç–≤–∞ –¥–æ–ª–∏ –æ—Å–Ω–æ–≤–∞—Ç–µ–ª–µ–π –∫–æ–º–ø–∞–Ω–∏–π, –∑–∞–ª–æ–∂–µ–Ω–Ω—ã–µ –≤ –°–±–µ—Ä–±–∞–Ω–∫, –±—É–¥—É—Ç —Ä–µ–∞–ª–∏–∑–æ–≤–∞–Ω—ã –≤ —Ö–æ–¥–µ —Ç–æ—Ä–≥–æ–≤, ‚Äî –ø—Ä–µ–¥–ø–æ–ª–∞–≥–∞—é—Ç –æ–ø—Ä–æ—à–µ–Ω–Ω—ã–µ ¬´–™¬ª —é—Ä–∏—Å—Ç—ã. –í–æ–ø—Ä–æ—Å—ã –∫ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—è–º –µ—Å—Ç—å –∏ —É –¥—Ä—É–≥–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π. –í —Å–µ–Ω—Ç—è–±—Ä–µ –∏—Å–∫ –∫ ¬´–ì–µ–æ –û—Ä–≥–∞–Ω–∏–∫—Å¬ª –Ω–∞ 40,6 –º–ª–Ω —Ä—É–±–ª–µ–π –ø–æ–¥–∞–ª–∞ ¬´–¢—É–ª—å—Å–∫–∞—è —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∞—è —Ñ–∞–±—Ä–∏–∫–∞¬ª. –õ–µ—Ç–æ–º –æ–±–∞–Ω–∫—Ä–æ—Ç–∏—Ç—å ¬´–ì–µ–æ-–ú–µ–¥¬ª —Ö–æ—Ç–µ–ª–∞ –º–æ—Å–∫–æ–≤—Å–∫–∞—è –ò–§–ù–° ‚Ññ36, –Ω–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –±—ã–ª–æ –ø—Ä–µ–∫—Ä–∞—â–µ–Ω–æ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""The bank Sber plans to liquidate the pharmaceutical business of Zura Tsirleteli's grandson. The bank is preparing court filings alleging bankruptcy of the companies 'Geo Organix' and 'Geo-Med'. These companies produce vitamins, supplements, and cosmetics under the Vibes brand. The bank is not likely to be interested in controlling 'Geo Organix' and 'Geo-Med'. The companies are facing financial difficulties, with a 2316% decrease in profitability for the year and an increase of 100% in revenue. The bank's stake in these companies may be liquidated during bankruptcy proceedings.""
}"
2025-10-24T05:40:01+00:00,@bezrec,6726,https://t.me/bezrec/6726,"–í ¬´–ò–Ω—Ñ–∞—Ä–º–µ¬ª —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏, –∫–∞–∫ —É—Å–æ–≤–µ—Ä—à–µ–Ω—Å—Ç–≤–æ–≤–∞—Ç—å –º–µ—Ö–∞–Ω–∏–∑–º —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—è –ø–µ—Ä–µ—á–Ω–µ–π. –û –Ω–µ—Å–æ–≤–µ—Ä—à–µ–Ω—Å—Ç–≤–µ —Å—É—â–µ—Å—Ç–≤—É—é—â–µ–π —Å–∏—Å—Ç–µ–º—ã –∏ —Å–ø–æ—Å–æ–±–∞—Ö —É–ª—É—á—à–∏—Ç—å —Å–∏—Ç—É–∞—Ü–∏—é –≤ —Å—Ç–∞—Ç—å–µ –≤ Forbes —Ä–∞—Å—Å—É–∂–¥–∞–ª –∏—Å–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–π –¥–∏—Ä–µ–∫—Ç–æ—Ä –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ –í–∞–¥–∏–º –ö—É–∫–∞–≤–∞. –ß—Ç–æ –≤—ã–∑—ã–≤–∞–µ—Ç –≤–æ–ø—Ä–æ—Å—ã. üü© –ö–æ–≥–¥–∞ –∫–∞–Ω–¥–∏–¥–∞—Ç–æ–≤ —Ä–∞—Å—Å–º–∞—Ç—Ä–∏–≤–∞—é—Ç —Å –ø–æ–∑–∏—Ü–∏–∏ –Ω–µ —Ç–æ–ª—å–∫–æ –∏—Ö –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–π –ø–æ–ª—å–∑—ã, –Ω–æ –∏ —Å—Ç–æ–∏–º–æ—Å—Ç–∏, —Ä–µ—à–µ–Ω–∏—è –≤—Å–µ–≥–¥–∞ –±—É–¥—É—Ç –ø—Ä–æ—Ç–∏–≤–æ—Ä–µ—á–∏–≤—ã–º–∏, —Ç.–∫. —ç—Ç–∏ —Ö–∞—Ä–∞–∫—Ç–µ—Ä–∏—Å—Ç–∏–∫–∏ —á–∞—Å—Ç–æ –Ω–µ —Å–æ–≤–ø–∞–¥–∞—é—Ç. üü© –í –æ—Ç–¥–µ–ª—å–Ω—ã–µ –º–æ–º–µ–Ω—Ç—ã –∑–∞—Å–µ–¥–∞–Ω–∏—è —Å—Ç–∞–ª–∏ –Ω–∞–ø–æ–º–∏–Ω–∞—Ç—å –∞—É–∫—Ü–∏–æ–Ω —Å—Ä–µ–¥–∏ –∫–æ–Ω–∫—É—Ä–∏—Ä—É—é—â–∏—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π —Å–æ —Å—Ç–∞–≤–∫–∞–º–∏ –Ω–∞ –ø–æ–Ω–∏–∂–µ–Ω–∏–µ, —Ç.–∫. –Ω–∞ –∑–∞—Å–µ–¥–∞–Ω–∏—è—Ö —Ä–∞—Å—Å–º–∞—Ç—Ä–∏–≤–∞–ª–∏—Å—å –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, –Ω–µ –∑–∞—è–≤–ª–µ–Ω–Ω—ã–µ –ø—Ä–µ–¥–≤–∞—Ä–∏—Ç–µ–ª—å–Ω–æ –≤ –ø–æ–≤–µ—Å—Ç–∫–µ. üü© –ö—Ä–∏—Ç–∏–∫–µ –ø–æ–¥–≤–µ—Ä–≥–∞–µ—Ç—Å—è —Å–∏—Å—Ç–µ–º–∞ —Ä–∞—Å—á–µ—Ç–∞ —Ñ–∞—Ä–º–∞–∫–æ—ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–π —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏. –ü–æ—Ä–æ–π —Å—Ä–∞–≤–Ω–µ–Ω–∏—è –ø—Ä–æ–≤–æ–¥–∏–ª–∏—Å—å –ø—Ä–∏ –Ω–µ–∫–æ—Ä—Ä–µ–∫—Ç–Ω–æ–π –≤—ã–±–æ—Ä–∫–µ –¥–æ–∑–∏—Ä–æ–≤–æ–∫, –¥–ª–∏—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –ª–µ—á–µ–Ω–∏—è –∏ –≤ —Ü–µ–ª–æ–º —Å—Ä–µ–¥–∏ –Ω–µ–¥–æ–ø—É—Å—Ç–∏–º—ã—Ö –≤ —Å—Ä–∞–≤–Ω–µ–Ω–∏–∏ —Å—Ö–µ–º —Ç–µ—Ä–∞–ø–∏–∏. üü© –°–æ—Ö—Ä–∞–Ω—è–µ—Ç—Å—è –ø—Ä–æ–±–ª–µ–º–∞ –Ω–µ–ø—Ä–æ–∑—Ä–∞—á–Ω–æ—Å—Ç–∏ –ø—Ä–∏–Ω–∏–º–∞–µ–º—ã—Ö —Ä–µ—à–µ–Ω–∏–π, –æ—Å–æ–±–µ–Ω–Ω–æ –∫–æ–≥–¥–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã —Å–Ω–∞—á–∞–ª–∞ –≤–∫–ª—é—á–∞–ª–∏—Å—å –≤ –ø–µ—Ä–µ—á–Ω–∏, –ø–æ—Ç–æ–º –æ—Ç–∑—ã–≤–∞–ª–∏—Å—å. –ß—Ç–æ –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç ¬´–ò–Ω—Ñ–∞—Ä–º–∞¬ª, —á—Ç–æ–±—ã –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç—å –∫–æ–º–∏—Å—Å–∏–∏ —Å—Ç–∞–ª–∞ –ø—Ä–æ–∑—Ä–∞—á–Ω–æ–π –¥–ª—è –≤—Å–µ—Ö —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –ø—Ä–æ—Ü–µ—Å—Å–∞: üîΩ –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω—ã–º –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è–º –Ω—É–∂–Ω–æ –¥–∞—Ç—å –ø—Ä–∞–≤–æ –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–≥–æ –∫–æ–Ω—Ç—Ä–æ–ª—è –∑–∞ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º–∏, –∞ —ç–∫—Å–ø–µ—Ä—Ç–Ω–æ–º—É —Å–æ–æ–±—â–µ—Å—Ç–≤—É ‚Äî –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –±–æ–ª–µ–µ –≥–ª—É–±–æ–∫–æ–≥–æ –∏–∑—É—á–µ–Ω–∏—è –∑–∞—è–≤–ª–µ–Ω–Ω—ã—Ö –Ω–∞ –∫–æ–º–∏—Å—Å–∏—é –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤; üîΩ —É –∫–æ–º–∏—Å—Å–∏–∏ –¥–æ–ª–∂–µ–Ω –ø–æ—è–≤–∏—Ç—å—Å—è —á—ë—Ç–∫–∏–π —Ä–µ–≥–ª–∞–º–µ–Ω—Ç –ø—É–±–ª–∏–∫–∞—Ü–∏–∏ –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω—ã—Ö —Ä–∞–∑—ä—è—Å–Ω–µ–Ω–∏–π, –æ—Å–æ–±–µ–Ω–Ω–æ –ø–æ —Å–ø–æ—Ä–Ω—ã–º —Å–ª—É—á–∞—è–º; üîΩ –ø—Ä–æ—Ü–µ—Å—Å —Å–ª–µ–¥—É–µ—Ç —Ä–∞–∑–¥–µ–ª–∏—Ç—å –Ω–∞ –Ω–µ—Å–∫–æ–ª—å–∫–æ —ç—Ç–∞–ø–æ–≤ ‚Äî –Ω–∞–ø—Ä–∏–º–µ—Ä, –∫–ª–∏–Ω–∏—á–µ—Å–∫–∞—è –æ—Ü–µ–Ω–∫–∞ –∏ —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–∞—è —ç–∫—Å–ø–µ—Ä—Ç–∏–∑–∞; üîΩ –∏–º–µ–µ—Ç —Å–º—ã—Å–ª —Å—Ñ–æ—Ä–º–∏—Ä–æ–≤–∞—Ç—å –µ–¥–∏–Ω—ã–µ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª–µ–Ω–∏—é –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –ø–æ –æ–±—Å—É–∂–¥–∞–µ–º—ã–º –Ω–∞ –∫–æ–º–∏—Å—Å–∏–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º, –∞ —Ç–∞–∫–∂–µ –æ–±–µ—Å–ø–µ—á–∏—Ç—å –∫–æ–Ω—Ç—Ä–æ–ª—å –∑–∞ —Å–æ–±–ª—é–¥–µ–Ω–∏–µ–º –∫–≤–æ—Ä—É–º–∞ –≤–æ –≤—Ä–µ–º—è –∑–∞—Å–µ–¥–∞–Ω–∏–π, –∏—Å–∫–ª—é—á–∏–≤ —É—á–∞—Å—Ç–∏–µ –Ω–µ –∑–∞—è–≤–ª–µ–Ω–Ω—ã—Ö —Ä–∞–Ω–µ–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π; üîΩ –≤–∫–ª—é—á–µ–Ω–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –ø–µ—Ä–µ—á–µ–Ω—å –Ω–µ –ø–æ –ú–ù–ù, –∞ –ø–æ –ø–æ–∫–∞–∑–∞–Ω–∏—è–º –ø–æ–∑–≤–æ–ª–∏—Ç –≥–∞—Ä–∞–Ω—Ç–∏—Ä–æ–≤–∞–Ω–Ω–æ –æ–±–µ—Å–ø–µ—á–∏—Ç—å –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –ø–æ –≤–∫–ª—é—á–µ–Ω–Ω–æ–º—É –ø–æ–∫–∞–∑–∞–Ω–∏—é –∏ –∑–∞—Ä–∞–Ω–µ–µ —Å–ø—Ä–æ–≥–Ω–æ–∑–∏—Ä–æ–≤–∞—Ç—å —Ä–∞—Å—Ö–æ–¥—ã. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The 'Infarma' association discusses how to improve the mechanism for creating lists. Executive Director Vadim Kukavas of the association explains that when candidates are evaluated based on both clinical benefit and cost, decisions will always be contradictory as these characteristics often do not align. The system of pharmacoeconomic efficiency assessment is criticized for sometimes making incorrect comparisons based on inappropriate dosages and treatment durations. The transparency of decision-making processes is questioned, especially when drugs are initially included in lists and then withdrawn. 'Infarma' suggests several measures to make the commission's activities transparent for all participants: public organizations should have additional oversight over results, experts should be able to deeply examine proposed drugs; the process should be divided into stages such as clinical evaluation and economic assessment. Including drugs in the list based on indications will ensure patient coverage and allow for accurate cost predictions.""
}"
2025-10-23T15:31:54+00:00,@bezrec,6724,https://t.me/bezrec/6724,"–°–µ—Ä–≤–∏—Å –ø–æ –ø–æ–∏—Å–∫—É —Ä–∞–±–æ—Ç—ã SuperJob –≤—ã—è—Å–Ω–∏–ª, —Å–∫–æ–ª—å–∫–æ –ø–ª–∞—Ç—è—Ç –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—è–º –∑–∞–≤–µ–¥—É—é—â–µ–≥–æ –∞–ø—Ç–µ–∫–æ–π –≤ –†–æ—Å—Å–∏–∏ –∏ –∫–∞–∫–∏–º —Ä–∞–±–æ—Ç–æ–¥–∞—Ç–µ–ª—å —Ö–æ—á–µ—Ç –≤–∏–¥–µ—Ç—å —Å–≤–æ–µ–≥–æ –∏–¥–µ–∞–ª—å–Ω–æ–≥–æ —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–∞. –ë–æ–ª—å—à–µ –≤—Å–µ–≥–æ –Ω–∞ —ç—Ç–æ–π –¥–æ–ª–∂–Ω–æ—Å—Ç–∏ –∑–∞—Ä–∞–±–∞—Ç—ã–≤–∞—é—Ç –≤ –ú–æ—Å–∫–≤–µ ‚Äî –∑–¥–µ—Å—å —É—Ä–æ–≤–µ–Ω—å –∑–∞—Ä–ø–ª–∞—Ç—ã –∫–æ–ª–µ–±–ª–µ—Ç—Å—è –æ—Ç 70 —Ç—ã—Å. —Ä—É–±–ª–µ–π –¥–æ 180 —Ç—ã—Å. —Ä—É–±–ª–µ–π. –í —Ç–æ–ø-5 —Ç–∞–∫–∂–µ –≤–æ—à–ª–∏ –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥, –í–æ–ª–≥–æ–≥—Ä–∞–¥, –í–æ—Ä–æ–Ω–µ–∂ –∏ –ï–∫–∞—Ç–µ—Ä–∏–Ω–±—É—Ä–≥. –ß—Ç–æ–±—ã –ø—Ä–µ—Ç–µ–Ω–¥–æ–≤–∞—Ç—å –Ω–∞ –º–∞–∫—Å–∏–º–∞–ª—å–Ω—ã–π –æ–∫–ª–∞–¥ –∏–∑ IV –∑–∞—Ä–ø–ª–∞—Ç–Ω–æ–≥–æ –¥–∏–∞–ø–∞–∑–æ–Ω–∞, —Å–æ–∏—Å–∫–∞—Ç–µ–ª—å –¥–æ–ª–∂–µ–Ω –∏–º–µ—Ç—å –≤—ã—Å—à–µ–µ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–µ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ –∏ –æ–ø—ã—Ç —Ä–∞–±–æ—Ç—ã –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª–µ–º –∑–∞–≤–µ–¥—É—é—â–µ–≥–æ –∞–ø—Ç–µ–∫–æ–π –æ—Ç 3 –ª–µ—Ç, –∞ —Ç–∞–∫–∂–µ –æ–±–ª–∞–¥–∞—Ç—å —Å–∏—Å—Ç–µ–º–Ω—ã–º–∏ –∑–Ω–∞–Ω–∏—è–º–∏ –≤ –æ–±–ª–∞—Å—Ç–∏ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –∏ —ç–∫–æ–Ω–æ–º–∏–∫–∏ —Ñ–∞—Ä–º–∞—Ü–∏–∏. –°—Ä–µ–¥–Ω–µ—Å—Ç–∞—Ç–∏—Å—Ç–∏—á–µ—Å–∫–∏–π —Å–æ–∏—Å–∫–∞—Ç–µ–ª—å –≤—ã–≥–ª—è–¥–∏—Ç –ø—Ä–∏–º–µ—Ä–Ω–æ —Ç–∞–∫: üîò—Å—Ä–µ–¥–Ω–∏–π –≤–æ–∑—Ä–∞—Å—Ç - 47 –ª–µ—Ç; üîò–∂–µ–Ω—â–∏–Ω–∞ (81%); üîò–∏–º–µ–µ—Ç –≤—ã—Å—à–µ–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–µ/—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–µ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ (85%); üîò–≥–æ—Ç–æ–≤ –∫ –ø–µ—Ä–µ–µ–∑–¥—É (12%); üîò–±–µ–∑—Ä–∞–±–æ—Ç–Ω—ã–π –Ω–∞ –º–æ–º–µ–Ω—Ç –ø—É–±–ª–∏–∫–∞—Ü–∏–∏ —Ä–µ–∑—é–º–µ (43%); üîò—Å—Ä–µ–¥–Ω–∏–π —Å—Ä–æ–∫ —Ä–∞–±–æ—Ç—ã –Ω–∞ –ø–æ—Å–ª–µ–¥–Ω–µ–º –º–µ—Å—Ç–µ - 8,5 –ª–µ—Ç. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-10-23T13:33:45+00:00,@bezrec,6723,https://t.me/bezrec/6723,"–ü–æ–ª–∏—Ü–µ–π—Å–∫–∏–µ –∏–∑—ä—è–ª–∏ –±–æ–ª–µ–µ —Ç—ã—Å—è—á–∏ —É–ø–∞–∫–æ–≤–æ–∫ ¬´–ª–µ–≤—ã—Ö¬ª –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ø–æ—Ö—É–¥–µ–Ω–∏—è –∏ –æ–º–æ–ª–æ–∂–µ–Ω–∏—è. –ü—Ä–µ—Å—Ç—É–ø–Ω—ã–π –±–∏–∑–Ω–µ—Å –Ω–∞ –∫—Ä–∞—Å–æ—Ç–µ –Ω–∞–ª–∞–¥–∏–ª–∞ –∂–∏—Ç–µ–ª—å–Ω–∏—Ü–∞ –•–∞–±–∞—Ä–æ–≤—Å–∫–∞ —Å–æ —Å–≤–æ–∏–º –ø—Ä–∏—è—Ç–µ–ª–µ–º. –ñ–µ–Ω—â–∏–Ω–∞ –ø—Ä–æ–º—ã—à–ª—è–ª–∞ –≤–≤–æ–∑–æ–º –∏–∑-–∑–∞ –≥—Ä–∞–Ω–∏—Ü—ã –∏ —Å–±—ã—Ç–æ–º –ª–µ–∫–∞—Ä—Å—Ç–≤, –∫–æ—Ç–æ—Ä—ã–µ —Å–æ–¥–µ—Ä–∂–∞–ª–∏ –Ω–µ –∑–∞—è–≤–ª–µ–Ω–Ω—ã–µ –ø—Ä–∏ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏–∏. –¢–æ–≤–∞—Ä –ø—Ä–æ–¥–∞–≤–∞–ª–∏ —á–µ—Ä–µ–∑ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç. –ñ–µ–ª–∞—é—â–∏—Ö –±—ã–ª–æ —Ö–æ—Ç—å –æ—Ç–±–∞–≤–ª—è–π ‚Äî —Ñ–∞–ª—å—Å–∏—Ñ–∏–∫–∞—Ç —Å–∫—É–ø–∞–ª–∏ —á–∞—Å—Ç–Ω—ã–µ –∫–ª–∏–Ω–∏–∫–∏ –∏ –∫–æ—Å–º–µ—Ç–æ–ª–æ–≥–∏ –Ω–∞ –≤—Å–µ–π —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ –•–∞–±–∞—Ä–æ–≤—Å–∫–æ–≥–æ –∏ –ü—Ä–∏–º–æ—Ä—Å–∫–æ–≥–æ –∫—Ä–∞–µ–≤, –ï–≤—Ä–µ–π—Å–∫–æ–π –∞–≤—Ç–æ–Ω–æ–º–Ω–æ–π –∏ –ê–º—É—Ä—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–µ–π. –ö—É—Ä—å–µ—Ä–æ–º ¬´–ø–æ–¥—Ä–∞–±–∞—Ç—ã–≤–∞–ª¬ª —Å–æ–æ–±—â–Ω–∏–∫ –ø–æ–¥–æ–∑—Ä–µ–≤–∞–µ–º–æ–π. –§–∏–≥—É—Ä–∞–Ω—Ç—ã —É—Å–ø–µ–ª–∏ —Å–±—ã—Ç—å –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ñ–∞–ª—å—Å–∏—Ñ–∏–∫–∞—Ç–æ–≤ –Ω–∞ 4 –º–ª–Ω —Ä—É–±–ª–µ–π. –ü—Ä–∏ –æ–±—ã—Å–∫–µ –ø–æ –º–µ—Å—Ç—É –∂–∏—Ç–µ–ª—å—Å—Ç–≤–∞ ¬´–ø—Ä–µ–¥–ø—Ä–∏–Ω–∏–º–∞—Ç–µ–ª—å–Ω–∏—Ü—ã¬ª –ø–æ–ª–∏—Ü–µ–π—Å–∫–∏–µ –∏–∑—ä—è–ª–∏ –±–æ–ª–µ–µ —Ç—ã—Å—è—á–∏ —É–ø–∞–∫–æ–≤–æ–∫ —Ä–∞–∑–ª–∏—á–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤, –ø—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–µ–Ω–Ω–æ –¥–ª—è —Å–Ω–∏–∂–µ–Ω–∏—è –≤–µ—Å–∞ –∏ –æ–º–æ–ª–æ–∂–µ–Ω–∏—è. –í—Å—è –ø–∞—Ä—Ç–∏—è –±—É–¥–µ—Ç —É–Ω–∏—á—Ç–æ–∂–µ–Ω–∞ –ø–æ —Ä–µ—à–µ–Ω–∏—é —Å—É–¥–∞. –ü–æ–¥–æ–∑—Ä–µ–≤–∞–µ–º—ã–º –≥—Ä–æ–∑–∏—Ç –¥–æ –≤–æ—Å—å–º–∏ –ª–µ—Ç –ª–∏—à–µ–Ω–∏—è —Å–≤–æ–±–æ–¥—ã —Å–æ —à—Ç—Ä–∞—Ñ–æ–º –æ—Ç –º–∏–ª–ª–∏–æ–Ω–∞ –¥–æ —Ç—Ä—ë—Ö –º–∏–ª–ª–∏–æ–Ω–æ–≤ —Ä—É–±–ª–µ–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""Police seized over a thousand packages of counterfeit weight loss and anti-aging medications. The crime was committed by a resident of Khabarovsk and her accomplice, who imported from abroad and sold counterfeit drugs containing undisclosed pharmaceutical substances. The goods were purchased by private clinics and dermatologists across Khabarovsk, Primorsky, Jewish Autonomous, and Amur regions. The accomplice 'worked' as a courier for the suspect. The suspects managed to sell counterfeit drugs worth 4 million rubles. They could face up to eight years in prison and fines ranging from a million to three million rubles. The seized drugs will be destroyed by court order.""
}"
2025-10-23T11:46:16+00:00,@bezrec,6722,https://t.me/bezrec/6722,"–ï–° –ø–æ—Å—Ç–∞–≤–∏–ª –ø–æ–¥ —Å–æ–º–Ω–µ–Ω–∏—è –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å —ç—Ç–∞–Ω–æ–ª–∞. üíß –ü–æ–ø—É–ª—è—Ä–Ω—ã–π —Ö–∏–º–ø—Ä–æ–¥—É–∫—Ç –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç –≤–Ω–µ—Å—Ç–∏ –≤ —Å–ø–∏—Å–æ–∫ –æ–ø–∞—Å–Ω—ã—Ö –≤–µ—â–µ—Å—Ç–≤ –∏–∑-–∑–∞ –µ–≥–æ –≤–æ–∑–º–æ–∂–Ω–æ–π –∫–∞–Ω—Ü–µ—Ä–æ–≥–µ–Ω–Ω–æ—Å—Ç–∏ –∏ —Å–≤—è–∑–∞–Ω–Ω—ã—Ö —Å —ç—Ç–∏–º —Ä–∏—Å–∫–æ–≤ —Ä–∞–∑–≤–∏—Ç–∏—è —Ä–∞–∫–∞, —Å–æ–æ–±—â–∞–µ—Ç Financial Times. –ï—Å–ª–∏ —ç—Ç–æ –ø—Ä–æ–∏–∑–æ–π–¥—ë—Ç, —Ç–æ –ø–æ–¥ –∑–∞–ø—Ä–µ—Ç–æ–º –≤ –ï–° –æ–∫–∞–∂—É—Ç—Å—è –º–Ω–æ–≥–∏–µ —Å–∞–Ω–∏—Ç–∞–π–∑–µ—Ä—ã –∏ –¥—Ä—É–≥–∏–µ –¥–µ–∑–∏–Ω—Ñ–∏—Ü–∏—Ä—É—é—â–∏–µ —Å—Ä–µ–¥—Å—Ç–≤–∞, –≤ —Ç–æ–º —á–∏—Å–ª–µ —à–∏—Ä–æ–∫–æ –∏—Å–ø–æ–ª—å–∑—É–µ–º—ã–µ –≤ –º–µ–¥–∏—Ü–∏–Ω–µ. –°–æ–≥–ª–∞—Å–Ω–æ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏—è–º, —Å–¥–µ–ª–∞–Ω–Ω—ã–º —Ä–∞–±–æ—á–µ–π –≥—Ä—É–ø–ø–æ–π –ï–≤—Ä–æ–ø–µ–π—Å–∫–æ–≥–æ –∞–≥–µ–Ω—Ç—Å—Ç–≤–∞ –ø–æ —Ö–∏–º–∏–∫–∞—Ç–∞–º (ECHA), —ç—Ç–∞–Ω–æ–ª –Ω–µ —Ç–æ–ª—å–∫–æ –ø–æ–≤—ã—à–∞–µ—Ç —Ä–∏—Å–∫ —Ä–∞–∑–≤–∏—Ç–∏—è —Ä–∞–∫–∞, –Ω–æ –∏ –≤—ã–∑—ã–≤–∞–µ—Ç –æ—Å–ª–æ–∂–Ω–µ–Ω–∏—è –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏. –ï–≥–æ –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç –∑–∞–º–µ–Ω–∏—Ç—å –Ω–∞ –±–µ–∑–æ–ø–∞—Å–Ω—É—é –∞–ª—å—Ç–µ—Ä–Ω–∞—Ç–∏–≤—É –≤ –≤–∏–¥–µ —á–∏—Å—Ç—è—â–∏—Ö –∏ –º–æ—é—â–∏—Ö —Å—Ä–µ–¥—Å—Ç–≤. –í–æ—Ç —Ç–æ–ª—å–∫–æ ¬´–±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å¬ª —ç—Ç–∏—Ö –≤–µ—â–µ—Å—Ç–≤ –≤—ã–∑—ã–≤–∞–µ—Ç –µ—â—ë –±–æ–ª—å—à–µ –≤–æ–ø—Ä–æ—Å–æ–≤. –û–∫–æ–Ω—á–∞—Ç–µ–ª—å–Ω–æ–µ —Ä–µ—à–µ–Ω–∏–µ –ø–æ —ç—Ç–æ–º—É –≤–æ–ø—Ä–æ—Å—É –ø—Ä–∏–º–µ—Ç –ï–≤—Ä–æ–∫–æ–º–∏—Å—Å–∏—è –ø–æ –∏—Ç–æ–≥–∞–º –∑–∞—Å–µ–¥–∞–Ω–∏—è –∫–æ–º–∏—Ç–µ—Ç–∞ ECHA. ‚ñ∂Ô∏è –≠–∫—Å–ø–µ—Ä—Ç—ã –≤ –æ—Ç—Ä–∞—Å–ª–∏ —Å—á–∏—Ç–∞—é—Ç, —á—Ç–æ ¬´–æ—Ç–º–µ–Ω–∞¬ª —ç—Ç–∞–Ω–æ–ª–∞ –ø—Ä–µ–∂–¥–µ –≤—Å–µ–≥–æ —Å–µ—Ä—å—ë–∑–Ω–æ —É–¥–∞—Ä–∏—Ç –ø–æ –º–µ–¥–∏—Ü–∏–Ω–µ. –û–Ω–∏ –æ—Ç–º–µ—á–∞—é—Ç, —á—Ç–æ –µ–≥–æ –∑–∞–º–µ–Ω–∞ –Ω–∞ –µ—â—ë –±–æ–ª–µ–µ —Ç–æ–∫—Å–∏—á–Ω—ã–π –∏–∑–æ–ø—Ä–æ–ø–∞–Ω–æ–ª –Ω–µ –ª–æ–≥–∏—á–Ω–∞, –∞ —Ä–µ–≥—É–ª—è—Ä–Ω–æ–µ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ –º—ã–ª–∞ —É–≤–µ–ª–∏—á–∏–≤–∞–µ—Ç –≤—Ä–µ–º—è –æ–±—Ä–∞–±–æ—Ç–∫–∏ –∏ –Ω–∞–Ω–æ—Å–∏—Ç –≤—Ä–µ–¥ –∫–æ–∂–µ. üß™ –•–∏–º–ø—Ä–æ–º","{""skip"": false, ""country"": ""global"", ""topic"": ""sanctions,hospital_policy"", ""impact"": ""high"", ""english"": ""The European Union is questioning the safety of ethanol. This popular chemical product is being proposed to be added to a list of dangerous substances due to its potential carcinogenicity and associated risks of cancer development. If this happens, many sanitizers and other disinfectants widely used in medicine could be banned by the EU. According to recommendations made by the European Chemicals Agency (ECHA), ethanol not only increases cancer risk but also causes pregnancy complications. Its replacement with a safer alternative, such as cleaning and disinfecting products, raises further questions.""}"
2025-10-23T09:02:22+00:00,@bezrec,6721,https://t.me/bezrec/6721,"–ü—Ä–æ–¥–æ–ª–∂–∞–µ–º —Ä–∞–∑–±–∏—Ä–∞—Ç—å –æ–±–∑–æ—Ä –∞–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ù–∏–ª—å—Å–µ–Ω¬ª. –ü–æ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º –æ–ø—Ä–æ—Å–∞ –±–æ–ª–µ–µ 1 —Ç—ã—Å. –ø–æ–∫—É–ø–∞—Ç–µ–ª–µ–π –∞–ø—Ç–µ–∫ –∏ –±–æ–ª–µ–µ 200 —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–æ–≤, —É–∂–µ 42% —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –≥–æ–≤–æ—Ä—è—Ç –æ —Ç–æ–º, —á—Ç–æ –ø—Ä–∏–æ–±—Ä–µ—Ç–∞—é—Ç –±–æ–ª—å—à—É—é —á–∞—Å—Ç—å –±–µ–∑—Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –Ω–∞ –æ–Ω–ª–∞–π–Ω-–ø–ª–æ—â–∞–¥–∫–∞—Ö. –ü—Ä–∏ —ç—Ç–æ–º 96% –¥–æ–≤–æ–ª—å–Ω—ã —Ç–∞–∫–∏–º–∏ –ø–æ–∫—É–ø–∫–∞–º–∏. –ù–µ–±–æ–ª—å—à–æ–π –ø—Ä–æ—Ü–µ–Ω—Ç –Ω–µ–¥–æ–≤–æ–ª—å–Ω—ã—Ö —Å—Ç–æ–ª–∫–Ω—É–ª—Å—è —Å –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–µ–º –Ω—É–∂–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –≤ –Ω–∞–ª–∏—á–∏–∏ –∏ –Ω–∏–∑–∫–∏–º –∫–∞—á–µ—Å—Ç–≤–æ–º –¥–æ—Å—Ç–∞–≤–∫–∏. –ß–µ–º —É–¥–æ–±–µ–Ω –æ–Ω–ª–∞–π–Ω-—Ñ–æ—Ä–º–∞—Ç: üíä –ø–æ–∫—É–ø–∫—É –º–æ–∂–Ω–æ —Å–æ–≤–µ—Ä—à–∏—Ç—å –≤ –ª—é–±–æ–µ –≤—Ä–µ–º—è (86%); üíä –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç –≤ –æ–Ω–ª–∞–π–Ω-–∞–ø—Ç–µ–∫–∞—Ö —à–∏—Ä–µ (66%); üíä —Ü–µ–Ω—ã –Ω–∏–∂–µ, —á–µ–º –≤ –æ—Ñ–ª–∞–π–Ω-—Ç–æ—á–∫–∞—Ö (63%); üíä –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å —Å–æ—Ö—Ä–∞–Ω–∏—Ç—å –ø—Ä–∏–≤–∞—Ç–Ω–æ—Å—Ç—å (55%). –ö–∞–∫ –∏ –≤ —Å–ª—É—á–∞–µ —Å –∫–ª–∞—Å—Å–∏—á–µ—Å–∫–∏–º–∏ –∞–ø—Ç–µ–∫–∞–º–∏, –ª—é–±–∏–º—ã–µ –æ–Ω–ª–∞–π–Ω-–ø–ª–æ—â–∞–¥–∫–∏ —É —Ä–µ—Å–ø–æ–Ω–¥–µ–Ω—Ç–æ–≤ –≤–∞—Ä—å–∏—Ä—É—é—Ç—Å—è –≤ –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏ –æ—Ç —Ä–µ–≥–∏–æ–Ω–∞. –ü—Ä–∞–≤–¥–∞, –Ω–∞ —ç—Ç–æ—Ç —Ä–∞–∑ –º–Ω–µ–Ω–∏—è –ø–æ –ø–æ–≤–æ–¥—É –≥–ª–∞–≤–Ω–æ–≥–æ ¬´–ª—é–±–∏–º—á–∏–∫–∞¬ª —É –∂–∏—Ç–µ–ª–µ–π —Ä–∞–∑–Ω—ã—Ö –≥–æ—Ä–æ–¥–æ–≤ —Å–æ–≤–ø–∞–ª–∏ ‚Äî –Ω–∞ –ø–µ—Ä–≤–æ–º –º–µ—Å—Ç–µ –æ–∫–∞–∑–∞–ª–∞—Å—å ¬´–ê–ø—Ç–µ–∫–∞.—Ä—É¬ª. –í —Ç–æ–ø-5 —É –º–æ—Å–∫–≤–∏—á–µ–π —Ç–∞–∫–∂–µ –ø–æ–ø–∞–ª–∏: ¬´–ê–ø—Ç–µ–∫–∏ —Å—Ç–æ–ª–∏—á–∫–∏¬ª, ¬´–û–∑–æ–Ω¬ª, ¬´–ï–∞–ø—Ç–µ–∫–∞¬ª –∏ ¬´–ó–¥–æ—Ä–æ–≤.—Ä—É¬ª. –ü—Ä–µ–¥–ø–æ—á—Ç–µ–Ω–∏—è –∂–∏—Ç–µ–ª–µ–π –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥–∞: ¬´–û–∑–æ–Ω¬ª, ¬´–ê–ø—Ç–µ–∫–∏ –°—Ç–æ–ª–∏—á–∫–∏¬ª, ¬´–Æ—Ç–µ–∫–∞¬ª, ¬´–ï–∞–ø—Ç–µ–∫–∞¬ª. –°–∏–º–ø–∞—Ç–∏–∏ –ø–æ–∫—É–ø–∞—Ç–µ–ª–µ–π –≤ –¥—Ä—É–≥–∏—Ö –≥–æ—Ä–æ–¥–∞—Ö-–º–∏–ª–ª–∏–æ–Ω–Ω–∏–∫–∞—Ö —Ä–∞—Å–ø—Ä–µ–¥–µ–ª–∏–ª–∏—Å—å —Ç–∞–∫: ¬´–û–∑–æ–Ω¬ª, ¬´–ê–ø—Ä–µ–ª—å¬ª, ¬´–ü–ª–∞–Ω–µ—Ç–∞ –ó–¥–æ—Ä–æ–≤—å—è¬ª, ¬´–ê–ø—Ç–µ–∫–∏ –ü–ª—é—Å¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand,vaccine"",
  ""impact"": ""high"",
  ""english"": ""The survey of more than 1,000 pharmacy customers and over 200 pharmacists shows that 42% of respondents purchase a significant portion of non-prescription drugs online. 96% are satisfied with these purchases. A small percentage of dissatisfied customers faced issues such as a lack of needed medications and low-quality delivery. The online format is convenient: customers can buy anytime (86%), wider assortment of products (66%), lower prices compared to traditional stores (63%), and privacy protection. The preferences of online platforms vary by region, but Moscow residents' top choices include 'Apteka.ru', while St. Petersburg residents prefer 'Ozon', 'Apkiki', and 'Eaptekha'. Other major cities' top choices include 'Ozon', 'Apkiki', 'Planet Health', and 'Apteka Plus'.""
}"
2025-10-23T05:50:01+00:00,@bezrec,6720,https://t.me/bezrec/6720,"–í Renewal —Å–º–µ–Ω–∏–ª–æ—Å—å —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–æ. –ü–æ –¥–∞–Ω–Ω—ã–º Rusprofile, —Å 22 –æ–∫—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞ —É –ê–û ¬´–ü–§–ö –û–±–Ω–æ–≤–ª–µ–Ω–∏–µ¬ª –Ω–æ–≤—ã–π –≥–µ–Ω–µ—Ä–∞–ª—å–Ω—ã–π –¥–∏—Ä–µ–∫—Ç–æ—Ä. –ò–º —Å—Ç–∞–ª –í–ª–∞–¥–∏–º–∏—Ä –ì—Ä–µ—á–∫–∏–Ω, —Ä–∞–Ω–µ–µ –∑–∞–Ω–∏–º–∞–≤—à–∏–π –ø–æ—Å—Ç –∏—Å–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–≥–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞. –ù–∞ –¥–æ–ª–∂–Ω–æ—Å—Ç–∏ —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—è –∫–æ–º–ø–∞–Ω–∏–∏ –ì—Ä–µ—á–∫–∏–Ω —Å–º–µ–Ω–∏–ª —Å–æ–æ—Å–Ω–æ–≤–∞—Ç–µ–ª—è –∏ –∞–∫—Ü–∏–æ–Ω–µ—Ä–∞ Renewal –î–º–∏—Ç—Ä–∏—è –ì—Ä–∏—Å—é–∫–∞, –±—ã–≤—à–µ–≥–æ ¬´—É —Ä—É–ª—è¬ª —Å –≤–µ—Å–Ω—ã 2023 –≥–æ–¥–∞. –ê–û ¬´–ü–§–ö –û–±–Ω–æ–≤–ª–µ–Ω–∏–µ¬ª –æ—Å–Ω–æ–≤–∞–Ω–æ 8 –º–∞—è 2001 –≥–æ–¥–∞ –∏ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–æ –≤ –ù–æ–≤–æ—Å–∏–±–∏—Ä—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏. –ü–æ—Ä—Ç—Ñ–µ–ª—å —Ç–æ–≤–∞—Ä–Ω—ã—Ö –∑–Ω–∞–∫–æ–≤ –≤–∫–ª—é—á–∞–µ—Ç –±–æ–ª–µ–µ 250 –∞–∫—Ç–∏–≤–Ω—ã—Ö –æ–±–æ–∑–Ω–∞—á–µ–Ω–∏–π, –ø—Ä–∏—á—ë–º —Ç—Ä–∏ –ø–æ—Å–ª–µ–¥–Ω–∏—Ö –±—ã–ª–∏ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω—ã –≤ –∞–≤–≥—É—Å—Ç–µ-—Å–µ–Ω—Ç—è–±—Ä–µ 2025 –≥–æ–¥–∞. –í 2021 –≥–æ–¥—É –≤—ã—Ä—É—á–∫–∞ —Å–æ—Å—Ç–∞–≤–∏–ª–∞ 9,03 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —É–≤–µ–ª–∏—á–∏–≤—à–∏—Å—å –Ω–∞ 5,4% –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –ø—Ä–µ–¥—ã–¥—É—â–∏–º –≥–æ–¥–æ–º. –ß–∏—Å—Ç–∞—è –ø—Ä–∏–±—ã–ª—å –≤—ã—Ä–æ—Å–ª–∞ –±–æ–ª–µ–µ —á–µ–º –≤ –¥–≤–∞ —Ä–∞–∑–∞ ‚Äî —Å 680 –º–ª–Ω –¥–æ 1,37 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –†–µ–Ω—Ç–∞–±–µ–ª—å–Ω–æ—Å—Ç—å –ø–æ —á–∏—Å—Ç–æ–π –ø—Ä–∏–±—ã–ª–∏ —Å–æ—Å—Ç–∞–≤–ª—è–µ—Ç 15%. –ë–æ–ª–µ–µ —Å–≤–µ–∂–∏—Ö –¥–∞–Ω–Ω—ã—Ö –æ —Ñ–∏–Ω–∞–Ω—Å–æ–≤—ã—Ö –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è—Ö –Ω–µ—Ç. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-10-22T14:49:39+00:00,@bezrec,6719,https://t.me/bezrec/6719,"–¢–∞—Ç—å—è–Ω–∞ –ì–æ–ª–∏–∫–æ–≤–∞ —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∞, —Å–∫–æ–ª—å–∫–æ —Ä–æ—Å—Å–∏—è–Ω –ø–æ–ª—É—á–∞—é—Ç –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∑–∞ —Å—á—ë—Ç –±—é–¥–∂–µ—Ç–∞. –í —Ä–∞–º–∫–∞—Ö –≥–æ—Å–ø—Ä–æ–≥—Ä–∞–º–º—ã ¬´–†–∞–∑–≤–∏—Ç–∏–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è¬ª –∑–∞ —Å—á—ë—Ç —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –±—é–¥–∂–µ—Ç–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –ø–æ–ª—É—á–∞—é—Ç —Å–≤—ã—à–µ 8 –º–ª–Ω —á–µ–ª–æ–≤–µ–∫, –∞ –≤ —Ä–∞–º–∫–∞—Ö –û–ú–° ‚Äî –±–æ–ª–µ–µ 6 –º–ª–Ω –±–æ–ª—å–Ω—ã—Ö –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏. –¢–∞–∫–∂–µ –±–æ–ª–µ–µ 18 –º–ª–Ω –≥—Ä–∞–∂–¥–∞–Ω –æ–±–µ—Å–ø–µ—á–∏–≤–∞—é—Ç—Å—è –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏ –∑–∞ —Å—Ä–µ–¥—Å—Ç–≤–∞ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã—Ö –±—é–¥–∂–µ—Ç–æ–≤, ‚Äî –ø–æ–¥–µ–ª–∏–ª–∞—Å—å –¥–∞–Ω–Ω—ã–º–∏ –≤–∏—Ü–µ-–ø—Ä–µ–º—å–µ—Ä –Ω–∞ –∫–æ–Ω–≥—Ä–µ—Å—Å–µ ¬´–ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ¬ª. –ì–æ–ª–∏–∫–æ–≤–∞ —Ç–∞–∫–∂–µ –ø–æ–¥—á–µ—Ä–∫–Ω—É–ª–∞, —á—Ç–æ 85% –∑–∞–∫—É–ø–∞–µ–º—ã—Ö –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–æ–º –ª–µ–∫–∞—Ä—Å—Ç–≤ ‚Äî —ç—Ç–æ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–∞—è –ø—Ä–æ–¥—É–∫—Ü–∏—è. –ü—Ä–∏ —ç—Ç–æ–º —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã–π –±—é–¥–∂–µ—Ç –±–µ—Ä–µ—Ç –Ω–∞ —Å–µ–±—è –≤ –æ—Å–Ω–æ–≤–Ω–æ–º —Å–∞–º—ã–µ –¥–æ—Ä–æ–≥–æ—Å—Ç–æ—è—â–∏–µ —Å–ª—É—á–∞–∏ –∏–ª–∏ —Å–∏—Ç—É–∞—Ü–∏–∏, –∫–æ–≥–¥–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –∂–∏–∑–Ω–µ–Ω–Ω–æ –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã. –í —Å–µ–Ω—Ç—è–±—Ä–µ —ç—Ç–æ–≥–æ –≥–æ–¥–∞ –¥–∞–Ω–Ω—ã–º–∏ –æ –¥–æ–ª–µ –ª–æ–∫–∞–ª—å–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –≥–æ—Å–∑–∞–∫—É–ø–∫–∞—Ö –ø–æ–¥–µ–ª–∏–ª–∞—Å—å DSM Group. –ü–æ –∏—Ç–æ–≥–∞–º 2024 –≥–æ–¥–∞ —ç—Ç–æ—Ç –ø–æ–∫–∞–∑–∞—Ç–µ–ª—å –±—ã–ª –Ω–∞ —É—Ä–æ–≤–Ω–µ 38,5%. –ü–æ –¥–∞–Ω–Ω—ã–º IT-–∫–æ–º–ø–∞–Ω–∏–µ–π Cursor, –≤ —Ç–æ–ø-10 –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ø–æ –æ–±—ä—ë–º–∞–º –ø–æ—Å—Ç–∞–≤–æ–∫ –≤ —è–Ω–≤–∞—Ä–µ-–∏—é–Ω–µ 2025 –≥–æ–¥–∞ –ø–æ–ø–∞–ª–∏ –§–æ—Ä—Å–∏–≥–∞, –û–ø–¥–∏–≤–æ, –ö—Å—Ç–∞–Ω–¥–∏, –ü–µ—Ä—å–µ—Ç–∞, –ú–∞–≤–∏—Ä–µ—Ç, –ù–∞—Ç—Ä–∏—è —Ö–ª–æ—Ä–∏–¥, –õ–∏–Ω–ø–∞—Ä–∑–∞, –¢–∞–≥—Ä–∏—Å—Å–æ, –¢–µ—Ü–µ–Ω—Ç—Ä–∏–∫, –î–∂–∞—Ä–¥–∏–Ω—Å. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""Tatyana Golikova reported on how many Russians are receiving medication under the budget. Under the national health development program, more than 8 million people receive medications funded by federal budget, while over 6 million patients with oncological diseases are covered under the OMS program. Additionally, more than 18 million people are being supplied with medications by regional budgets. Golikova also highlighted that the majority of state purchases, 85%, are domestic products. The federal budget primarily covers expensive cases or situations where the drugs are critically needed. In September, DSM Group shared data on the share of domestic products in state purchases. For 2024, this figure stood at 38.5%. According to IT company Cursor, the top-10 medications by volume in January-June 2025 were Fosigra, Opdivo, Kstandi, Perieta, Maviret, Sodium chloride, Linparza, Tagrisso, Tezcentriq, Jardins.‚Ñ¢ Without prescription"
2025-10-22T11:35:48+00:00,@bezrec,6718,https://t.me/bezrec/6718,"–í–°–ü –ø—Ä–æ—Å–∏—Ç 12 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –•–û–ë–õ. –í—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–∏–π —Å–æ—é–∑ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –Ω–∞–ø—Ä–∞–≤–∏–ª –∑–∞–º–ø—Ä–µ–¥—É –¥—É–º—Å–∫–æ–≥–æ –∫–æ–º–∏—Ç–µ—Ç–∞ –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è –ë–∞–¥–º–µ –ë–∞—à–∞–Ω–∫–∞–µ–≤—É –ø–∏—Å—å–º–æ —Å –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–µ–º –≤–∫–ª—é—á–∏—Ç—å —Ä–∞—Å—Ö–æ–¥—ã –Ω–∞ –±–æ—Ä—å–±—É —Å —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–æ–π –æ–±—Å—Ç—Ä—É–∫—Ç–∏–≤–Ω–æ–π –±–æ–ª–µ–∑–Ω—å—é –ª–µ–≥–∫–∏—Ö (–•–û–ë–õ) –≤ –ø—Ä–æ–µ–∫—Ç –±—é–¥–∂–µ—Ç–∞ –Ω–∞ 2026 –≥–æ–¥ –∏ –ø–ª–∞–Ω–æ–≤—ã–µ 2027‚Äì2028 –≥–æ–¥—ã. –ü–æ –ø–æ–¥—Å—á—ë—Ç–∞–º –¶–µ–Ω—Ç—Ä–∞ —ç–∫—Å–ø–µ—Ä—Ç–∏–∑—ã –∏ –∫–æ–Ω—Ç—Ä–æ–ª—è –∫–∞—á–µ—Å—Ç–≤–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞, –Ω–∞ –∑–∞–ø—É—Å–∫ –ø—Ä–æ–≥—Ä–∞–º–º—ã —Ä–∞–Ω–Ω–µ–≥–æ —Å–∫—Ä–∏–Ω–∏–Ω–≥–∞, –≤–Ω–µ–¥—Ä–µ–Ω–∏–µ –æ–±—Ä–∞–∑–æ–≤–∞—Ç–µ–ª—å–Ω—ã—Ö –ø—Ä–æ–≥—Ä–∞–º–º –¥–ª—è –±–æ–ª—å–Ω—ã—Ö –∏ —Ä–∞—Å—à–∏—Ä–µ–Ω–∏—è –∫—Ä—É–≥–∞ –ª–∏—Ü, –∏–º–µ—é—â–∏—Ö –ø—Ä–∞–≤–æ –Ω–∞ –ª—å–≥–æ—Ç–Ω–æ–µ –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ –Ω—É–∂–Ω–æ 11,67 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –¢–µ –∂–µ —Ü–∏—Ñ—Ä—ã –≤ –Ω–∞—á–∞–ª–µ –æ–∫—Ç—è–±—Ä—è –Ω–∞ –∑–∞–∫—Ä—ã—Ç–æ–º –∑–∞—Å–µ–¥–∞–Ω–∏–∏ —Ä–∞–±–æ—á–µ–π –≥—Ä—É–ø–ø—ã –ø–æ –≤–æ–ø—Ä–æ—Å–∞–º –±–æ—Ä—å–±—ã —Å –•–û–ë–õ –≤ –ì–æ—Å–¥—É–º–µ –æ–∑–≤—É—á–∏–≤–∞–ª –≥–ª–∞–≤–Ω—ã–π –≤–Ω–µ—à—Ç–∞—Ç–Ω—ã–π –ø—É–ª—å–º–æ–Ω–æ–ª–æ–≥ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –°–µ—Ä–≥–µ–π –ê–≤–¥–µ–µ–≤. –≠—Ç–∞ —Å—É–º–º–∞ –ø–æ–º–æ–≥–ª–∞ –±—ã –ø—Ä–µ–¥–æ—Ç–≤—Ä–∞—Ç–∏—Ç—å –±–æ–ª–µ–µ 100 —Ç—ã—Å. —Å–ª—É—á–∞–µ–≤ –ø—Ä–µ–∂–¥–µ–≤—Ä–µ–º–µ–Ω–Ω–æ–π —Å–º–µ—Ä—Ç–∏ –≤ –≥–æ–¥. –í—Å–µ–≥–æ –≤ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞—Ö –Ω—É–∂–¥–∞—é—Ç—Å—è 390 —Ç—ã—Å. –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å–æ —Å—Ä–µ–¥–Ω–µ—Ç—è–∂–µ–ª–æ–π, —Ç—è–∂–µ–ª–æ–π –∏ –∫—Ä–∞–π–Ω–µ —Ç—è–∂–µ–ª–æ–π —Å—Ç–µ–ø–µ–Ω—å—é –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è. –°–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤—É –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–∏–∫–æ–≤ –ø–æ–¥–¥–µ—Ä–∂–∏–≤–∞—é—Ç, –ø–æ—Å–∫–æ–ª—å–∫—É –•–û–ë–õ —Ç—Ä–µ–±—É–µ—Ç –ø–æ–∂–∏–∑–Ω–µ–Ω–Ω–æ–≥–æ –∏ –¥–æ—Ä–æ–≥–æ—Å—Ç–æ—è—â–µ–≥–æ –ª–µ—á–µ–Ω–∏—è. –ü–æ —Å–ª–æ–≤–∞–º –≤—Ä–∞—á–∞-–ø—É–ª—å–º–æ–Ω–æ–ª–æ–≥–∞ –ê–Ω–¥—Ä–µ—è –ó–µ–±–Ω–∏—Ü–∫–æ–≥–æ, —Å–µ–π—á–∞—Å –ª—å–≥–æ—Ç–Ω–æ–µ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏ –ø–æ–ª–æ–∂–µ–Ω–æ —Ç–æ–ª—å–∫–æ –ø–∞—Ü–∏–µ–Ω—Ç–∞–º —Å –∏–Ω–≤–∞–ª–∏–¥–Ω–æ—Å—Ç—å—é, –∞ –ø–æ–ª—É—á–∏—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –±–µ—Å–ø–ª–∞—Ç–Ω–æ –≤ —Ä–µ–≥–∏–æ–Ω–∞—Ö –Ω–µ –º–æ–≥—É—Ç –¥–æ 80% –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –û–±—â–µ—Å—Ç–≤–µ–Ω–Ω–∏–∫–∏ –¥–∞–≤–Ω–æ –≥–æ–≤–æ—Ä—è—Ç –æ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ –ø—Ä–∏–Ω—è—Ç–∏—è –∫–æ–º–ø–ª–µ–∫—Å–Ω—ã—Ö –º–µ—Ä –ø–æ –±–æ—Ä—å–±–µ —Å –•–û–ë–õ, –Ω–æ –¥–æ –∫–æ–Ω–∫—Ä–µ—Ç–Ω—ã—Ö –¥–µ–π—Å—Ç–≤–∏–π –ø–æ–∫–∞ –Ω–µ –¥–æ—à–ª–æ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""The VSP requests an additional budget of 12 billion rubles for patients with COPD. The Russian Federation Patients Union has sent a letter to Deputy Chairman of the Duma Committee on Health Care, Badmakhayev Badekhaev, proposing to include the costs of fighting chronic obstructive pulmonary disease (COPD) in the budget for 2026 and plans for 2027-2028. The Center for Quality Control of Medical Services at the Ministry of Health estimates that a program for early screening, implementation of educational programs for patients and expansion of the group of people entitled to free medication would cost 11.67 billion rubles. This amount could prevent over 100,000 premature deaths per year. Currently, patients with moderate to severe disease are entitled to free medication only if they have a disability certificate and up to 80% of patients cannot get medications for free in regions. For years, activists have been calling for comprehensive measures to combat COPD but concrete actions are yet to be taken"
2025-10-22T08:33:24+00:00,@bezrec,6717,https://t.me/bezrec/6717,"–ù–∞ —É–ª–∏—Ü–µ –≤—Å—ë —Ö–æ–ª–æ–¥–Ω–µ–µ, –∞ –∑–Ω–∞—á–∏—Ç, —Å–∞–º–æ–µ –≤—Ä–µ–º—è –ø–æ—Å–º–æ—Ç—Ä–µ—Ç—å, —á—Ç–æ —Ç–∞–º —Å —Ü–µ–Ω–∞–º–∏ –Ω–∞ –ø–æ—Ä–æ—à–∫–∏ –æ—Ç –≥—Ä–∏–ø–ø–∞ –∏ –ø—Ä–æ—Å—Ç—É–¥—ã —Å —Ñ–µ–Ω–∏–ª—ç—Ñ—Ä–∏–Ω–æ–º. –ß—Ç–æ –±—ã —Ç–∞–º –Ω–∏ –≥–æ–≤–æ—Ä–∏–ª–∏ –æ —Å–æ–º–Ω–∏—Ç–µ–ª—å–Ω–æ–π —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ —ç—Ç–æ–≥–æ –∫–æ–º–ø–æ–Ω–µ–Ω—Ç–∞, –∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –Ω–∞ –µ–≥–æ –æ—Å–Ω–æ–≤–µ –ø—Ä–æ–¥–æ–ª–∂–∞—é—Ç –±–∏—Ç—å —Ä–µ–∫–æ—Ä–¥—ã –ø—Ä–æ–¥–∞–∂, –æ—Å–æ–±–µ–Ω–Ω–æ –≤ —Å–µ–∑–æ–Ω –ø—Ä–æ—Å—Ç—É–¥. –ì–µ—Ä–æ–∏ —Å–µ–≥–æ–¥–Ω—è—à–Ω–µ–≥–æ –≤—ã–ø—É—Å–∫–∞ #–∑–∞—Ü–µ–Ω–∏–ª–∏ ‚Äî –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã —Ç–æ—Ä–≥–æ–≤—ã—Ö –º–∞—Ä–æ–∫ –¢–µ—Ä–∞—Ñ–ª—é (¬´–î–µ–ª—å—Ñ–∞—Ä–º –û—Ä–ª–µ–∞–Ω¬ª), –ú–∞–∫—Å–∏–∫–æ–ª–¥ –†–∏–Ω–æ (¬´–ì—Ä–æ—Ç–µ–∫—Å¬ª), –ì—Ä–∏–ø–ø–æ–§–ª—é —ç–∫—Å—Ç—Ä–∞ (¬´–ú–∞—Ä–±–∏–æ—Ñ–∞—Ä–º¬ª), –ö–æ–ª–¥—Ä–µ–∫—Å (¬´–®—Ç–∞–¥–∞¬ª) –∏ –ü—Ä–æ—Å—Ç—É–¥–æ–∫—Å (–ü–ê–û ¬´–°–∏–Ω—Ç–µ–∑¬ª). –°–∞–º—ã–º –≤—ã—Å–æ–∫–∏–º —Ü–µ–Ω–Ω–∏–∫–æ–º –Ω–∞ —á–µ—Ç—ã—Ä–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –∏–∑ –ø—è—Ç–∏ –ø—Ä–∏–≤—ã—á–Ω–æ –æ—Ç–ª–∏—á–∏–ª–∞—Å—å ¬´36,6¬ª. –ù–∞–ø—Ä–∏–º–µ—Ä, –ö–æ–ª–¥—Ä–µ–∫—Å —Ç–∞–º —Å—Ç–æ–∏—Ç 977 —Ä—É–±–ª–µ–π. –î–ª—è —Å—Ä–∞–≤–Ω–µ–Ω–∏—è –æ–Ω –∂–µ –≤ ¬´–ê–ø—Ç–µ–∫–µ.—Ä—É¬ª –∏ ¬´–ï–∞–ø—Ç–µ–∫–µ¬ª –æ–±–æ–π–¥—ë—Ç—Å—è –≤ 713 —Ä—É–±–ª–µ–π. –ó–∞—Ç–æ –≤ —Å–µ—Ç–∏ –Ω–∞—à—ë–ª—Å—è —Å–∞–º—ã–π –¥–µ—à—ë–≤—ã–π (662 —Ä—É–±–ª—è) –¢–µ—Ä–∞—Ñ–ª—é. –í—ã–≥–æ–¥–Ω–µ–µ –≤—Å–µ–≥–æ –ª–µ—á–∏—Ç—å —Å–∏–º–ø—Ç–æ–º—ã –≥—Ä–∏–ø–ø–∞ –∏ –ø—Ä–æ—Å—Ç—É–¥—ã –æ–∫–∞–∑–∞–ª–æ—Å—å –ú–∞–∫—Å–∏–∫–æ–ª–¥–æ–º –∏–∑ ¬´–ï–∞–ø—Ç–µ–∫–∏¬ª ‚Äî –∑–∞ —É–ø–∞–∫–æ–≤–∫—É –∏–∑ 10 –ø–∞–∫–µ—Ç–∏–∫–æ–≤ —Ç–∞–º –ø—Ä–æ—Å—è—Ç 296 —Ä—É–±–ª–µ–π. –ù–∞–ø–æ–º–∏–Ω–∞–µ–º, —á—Ç–æ –ª—é–±—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏–º–µ—é—Ç –ø—Ä–æ—Ç–∏–≤–æ–ø–æ–∫–∞–∑–∞–Ω–∏—è. –ü–µ—Ä–µ–¥ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º –ø—Ä–æ–∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä—É–π—Ç–µ—Å—å —Å –ª–µ—á–∞—â–∏–º –≤—Ä–∞—á–æ–º. *–∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –ø—Ä–æ–≤–æ–¥–∏–ª–æ—Å—å –æ–Ω–ª–∞–π–Ω 21 –æ–∫—Ç—è–±—Ä—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""pricing, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""Prices for flu and cold medications are rising, especially in the case of branded drugs like Teraflu (¬´Delfarman Orenburg¬ª), Maxikold Rino (¬´Grotex¬ª), Flu Extra (¬´Marbiopharm¬ª), and Coldex (¬´Shstad¬ª). The most expensive is the Teraflu, which costs 977 rubles. For comparison, it's around 713 rubles on ¬´Apteka.ru¬ª and ¬´Eaptek¬ª. The cheapest is Maxikold from ¬´Eaptek¬ª, which costs 296 rubles for a pack of 10 packets. Note that any medication has contraindications. Consult your doctor before use.""
}"
2025-10-22T05:20:55+00:00,@bezrec,6716,https://t.me/bezrec/6716,"¬´–ö–†–ö–ê¬ª –Ω–µ —É–¥–∞–ª–æ—Å—å –æ—Å–ø–æ—Ä–∏—Ç—å —Ä–µ—à–µ–Ω–∏–µ –§–ê–° –ø–æ –ö–æ-–î–∞–ª—å–Ω–µ–≤–µ. –ù–∞–ø–æ–º–Ω–∏–º, –§–ê–° –æ—à—Ç—Ä–∞—Ñ–æ–≤–∞–ª–∞ —Ä–æ—Å—Å–∏–π—Å–∫—É—é ¬´–¥–æ—á–∫—É¬ª —Å–ª–æ–≤–µ–Ω—Å–∫–æ–π —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –∑–∞ –Ω–∞—Ä—É—à–µ–Ω–∏–µ –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å–Ω–æ–≥–æ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–∞ –∏ –Ω–µ–æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω–æ–µ –ø–æ–≤—ã—à–µ–Ω–∏–µ –æ—Ç–ø—É—Å–∫–Ω—ã—Ö —Ü–µ–Ω –Ω–∞ –æ—Ç–¥–µ–ª—å–Ω—ã–µ –¥–æ–∑–∏—Ä–æ–≤–∫–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –ö–æ-–î–∞–ª—å–Ω–µ–≤–∞ –Ω–∞ 10-16%. –†–µ–≥—É–ª—è—Ç–æ—Ä –∑–∞–∏–Ω—Ç–µ—Ä–µ—Å–æ–≤–∞–ª—Å—è ¬´–ö–†–ö–ê¬ª –∏–∑-–∑–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –æ—Ç –¥–∞–≤–ª–µ–Ω–∏—è —Å –ú–ù–ù –∞–º–ª–æ–¥–∏–ø–∏–Ω + –∏–Ω–¥–∞–ø–∞–º–∏–¥ + –ø–µ—Ä–∏–Ω–¥–æ–ø—Ä–∏–ª –ø–æ—Å–ª–µ –∂–∞–ª–æ–± –ø–æ–∫—É–ø–∞—Ç–µ–ª–µ–π –Ω–∞ —Ä–æ—Å—Ç —Ü–µ–Ω –Ω–∞ –Ω–µ –∏–º–µ—é—â–∏–π –∞–Ω–∞–ª–æ–≥–æ–≤ –ø—Ä–µ–ø–∞—Ä–∞—Ç. –í–µ—Ä–¥–∏–∫—Ç –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å—â–∏–∫–æ–≤ –±—ã–ª —Å—É—Ä–æ–≤ ‚Äî —Å–ª—É–∂–±–∞ –≤—ã–¥–∞–ª–∞ –ø—Ä–µ–¥–ø–∏—Å–∞–Ω–∏–µ —É—Å—Ç–∞–Ω–æ–≤–∏—Ç—å —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–∏ –æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω—É—é —Ü–µ–Ω—É –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–æ –∏ –≤—ã–∫–∞—Ç–∏–ª–∞ —Å–ª–æ–≤–µ–Ω—Ü–∞–º —à—Ç—Ä–∞—Ñ –≤ 650 —Ç—ã—Å. —Ä—É–±–ª–µ–π. –ü–æ–ø—ã—Ç–∫–∏ ¬´–ö–†–ö–ê-–†–£–°¬ª –æ–±–∂–∞–ª–æ–≤–∞—Ç—å –ø—Ä–µ–¥–ø–∏—Å–∞–Ω–∏–µ –∏ —Ä–µ—à–µ–Ω–∏–µ –≤–µ–¥–æ–º—Å—Ç–≤–∞ —É—Å–ø–µ—Ö–æ–º –Ω–µ —É–≤–µ–Ω—á–∞–ª–∏—Å—å ‚Äî —Å—É–¥—ã —Ç—Ä—ë—Ö –∏–Ω—Å—Ç–∞–Ω—Ü–∏–π –ø–æ–¥–¥–µ—Ä–∂–∞–ª–∏ –ø–æ–∑–∏—Ü–∏—é –§–ê–°. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""The Russian subsidiary of a Slovenian pharmaceutical company, 'KRA', was fined 650 thousand rubles by the FAS for violating antimonopoly legislation and arbitrarily increasing the price of a specific dosage form of the drug 'Ko-Dalnev' by 10-16%. The regulator was interested in 'KRA-RUS' due to the drug for hypertension with a unique composition. The FAS's decision was severe - it issued an order to set the economically justified price for the drug and imposed a fine. Attempts by 'KRA-RUS' to appeal against the decision in three instances were unsuccessful - all courts supported the FAS.""
}"
2025-10-21T15:04:17+00:00,@bezrec,6715,https://t.me/bezrec/6715,"–û –≤–∏—Ç–∞–º–∏–Ω–∞—Ö –∏ –ë–ê–î–∞—Ö –≤ —ç–Ω–µ—Ä–≥–µ—Ç–∏–∫–∞—Ö ‚Äî –±–æ–ª—å—à–µ –Ω–∏-–Ω–∏. –ì–æ—Å–¥—É–º–∞ –ø—Ä–∏–Ω—è–ª–∞ —Å—Ä–∞–∑—É –≤–æ –≤—Ç–æ—Ä–æ–º –∏ —Ç—Ä–µ—Ç—å–µ–º —á—Ç–µ–Ω–∏—è—Ö –∑–∞–∫–æ–Ω, ¬´–∑–∞–∫—Ä—É—á–∏–≤–∞—é—â–∏–π –≥–∞–π–∫–∏¬ª –±–µ–∑–∞–ª–∫–æ–≥–æ–ª—å–Ω—ã–º —Ç–æ–Ω–∏–∑–∏—Ä—É—é—â–∏–º –Ω–∞–ø–∏—Ç–∫–∞–º. –ü–æ–ø—Ä–∞–≤–∫–∏ –≤–Ω–æ—Å—è—Ç—Å—è –≤ –∑–∞–∫–æ–Ω ¬´–û —Ä–µ–∫–ª–∞–º–µ¬ª –∏ –≤—Å—Ç—É–ø–∞—é—Ç –≤ —Å–∏–ª—É —Å 1 –º–∞—Ä—Ç–∞ 2026 –≥–æ–¥–∞. –í —á–∞—Å—Ç–Ω–æ—Å—Ç–∏: üîò —Ä–µ–∫–ª–∞–º–∞ —ç–Ω–µ—Ä–≥–µ—Ç–∏–∫–æ–≤ –¥–æ–ª–∂–Ω–∞ –±—É–¥–µ—Ç —Å–æ–ø—Ä–æ–≤–æ–∂–¥–∞—Ç—å—Å—è –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏–µ–º –æ –≤—Ä–µ–¥–µ –∏—Ö —á—Ä–µ–∑–º–µ—Ä–Ω–æ–≥–æ —É–ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏—è; üîò –≤ –Ω–µ–π –Ω–µ –¥–æ–ª–∂–Ω–æ –±—ã—Ç—å –æ–±—Ä–∞—â–µ–Ω–∏–π –∫ –Ω–µ—Å–æ–≤–µ—Ä—à–µ–Ω–Ω–æ–ª–µ—Ç–Ω–∏–º; üîò –¥–ª–∏—Ç–µ–ª—å–Ω–æ—Å—Ç—å –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏—è –≤ —Ä–æ–ª–∏–∫–∞—Ö –≤–∞—Ä—å–∏—Ä—É–µ—Ç—Å—è –≤ –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏ –æ—Ç –∏—Å—Ç–æ—á–Ω–∏–∫–∞: –Ω–µ –º–µ–Ω–µ–µ —Ç—Ä–µ—Ö —Å–µ–∫—É–Ω–¥ –ø–æ —Ä–∞–¥–∏–æ, –≤ —Ç–µ–ª–µ–ø—Ä–æ–≥—Ä–∞–º–º–∞—Ö, –ø—Ä–∏ –∫–∏–Ω–æ- –∏ –≤–∏–¥–µ–æ–æ–±—Å–ª—É–∂–∏–≤–∞–Ω–∏–∏ - –Ω–µ –º–µ–Ω–µ–µ –ø—è—Ç–∏ —Å–µ–∫—É–Ω–¥; üîò —Ç–∞–∫–æ–º—É –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏—é –¥–æ–ª–∂–Ω–æ –±—ã—Ç—å –æ—Ç–≤–µ–¥–µ–Ω–æ –Ω–µ –º–µ–Ω–µ–µ 7% –ø–ª–æ—â–∞–¥–∏ –∫–∞–¥—Ä–∞ –∏–ª–∏ —Ä–µ–∫–ª–∞–º–Ω–æ–π –ø–ª–æ—â–∞–¥–∏; üîò –ø–æ–¥–æ–±–Ω–∞—è —Ä–µ–∫–ª–∞–º–∞ –Ω–µ –¥–æ–ª–∂–Ω–∞ —Å–æ–¥–µ—Ä–∂–∞—Ç—å –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é –æ –Ω–∞–ª–∏—á–∏–∏ –≤ —Ç–∞–∫–∏—Ö –Ω–∞–ø–∏—Ç–∫–∞—Ö –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏ –∞–∫—Ç–∏–≤–Ω—ã—Ö –¥–æ–±–∞–≤–æ–∫ –∏ –≤–∏—Ç–∞–º–∏–Ω–æ–≤. –í —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–∏ –æ—Å–æ–±–µ–Ω–Ω–æ—Å—Ç–µ–π —Ä–µ–∫–ª–∞–º—ã —ç–Ω–µ—Ä–≥–µ—Ç–∏–∫–æ–≤ –Ω–µ—Ç –Ω–∏—á–µ–≥–æ –æ—Å–æ–±–µ–Ω–Ω–æ–≥–æ, —Ç–∞–∫ –∫–∞–∫ –Ω–æ–≤–∞—è –Ω–æ—Ä–º–∞ –∞–Ω–∞–ª–æ–≥–∏—á–Ω–∞ —Ä–µ–∫–ª–∞–º–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –ë–ê–î–æ–≤, –∞ —Ç–∞–∫–∂–µ —Ñ–∏–Ω–∞–Ω—Å–æ–≤—ã—Ö –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç–æ–≤ –∏ —Ä–∏—Å–∫–æ–≤, ‚Äî –ø–æ—è—Å–Ω–∏–ª–∞ –ø–µ—Ä–≤—ã–π –∑–∞–º–ø—Ä–µ–¥ –∫–æ–º–∏—Ç–µ—Ç–∞ –ì–æ—Å–¥—É–º—ã –ø–æ —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–π –ø–æ–ª–∏—Ç–∏–∫–µ –ù–∞–¥–µ–∂–¥–∞ –®–∫–æ–ª–∫–∏–Ω–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing"",
  ""impact"": ""high"",
  ""english"": ""The second and third readings of the law 'tightening nuts' for non-alcoholic tonics were approved by the State Duma. The amendments are made to the 'Advertising Law' and come into force on March 1, 2026. Specifically: üîò Advertisements for energy drinks must be accompanied by a warning about the harm of excessive consumption; üîò They should not contain appeals to minors; üîò The duration of the warning in videos varies depending on the source: at least three seconds for radio, in television programs, during film and video services - no less than five seconds; üîò Such a warning must occupy at least 7% of the frame or advertising area. The regulation for energy drinks is not special, as a similar norm applies to the advertising of medicines and dietary supplements, financial instruments and risks ‚Äî explained first deputy chairman of the Committee on Economic Policy of the State Duma Nadia Shkolkina. ‚Ñ¢ Without a prescription""
}"
2025-10-21T12:15:46+00:00,@bezrec,6714,https://t.me/bezrec/6714,"–ñ–∏—Ç–µ–ª–∏ —Ä–∞–∑–Ω—ã—Ö –≥–æ—Ä–æ–¥–æ–≤ –Ω–∞–∑–≤–∞–ª–∏ ¬´—Å–≤–æ–∏¬ª –∞–ø—Ç–µ–∫–∏. –ê–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–∞—è –∫–æ–º–ø–∞–Ω–∏—è ¬´–ù–∏–ª—å—Å–µ–Ω¬ª –æ–ø—Ä–æ—Å–∏–ª–∞ –±–æ–ª–µ–µ 1 —Ç—ã—Å. –ø–æ–∫—É–ø–∞—Ç–µ–ª–µ–π –∞–ø—Ç–µ–∫ –∏ –±–æ–ª–µ–µ 200 —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–æ–≤, —á—Ç–æ–±—ã ¬´–ø—Ä–æ—â—É–ø–∞—Ç—å¬ª –ø–æ–∫—É–ø–∞—Ç–µ–ª—å—Å–∫–∏–µ –Ω–∞—Å—Ç—Ä–æ–µ–Ω–∏—è. –°—Ä–µ–¥–Ω—è—è —Å—É–º–º–∞ —Ä–∞—Å—Ö–æ–¥–æ–≤ –Ω–∞ –±–µ–∑—Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –≤—ã—Ä–æ—Å–ª–∞ –¥–æ 2 660 —Ä—É–±–ª–µ–π –≤ –º–µ—Å—è—Ü, –≤ –ø—Ä–æ—à–ª–æ–º –≥–æ–¥—É —ç—Ç–æ—Ç –ø–æ–∫–∞–∑–∞—Ç–µ–ª—å –±—ã–ª –Ω–∞ —É—Ä–æ–≤–Ω–µ 2 580 —Ä—É–±–ª–µ–π. –ß–∞—â–µ –¥—Ä—É–≥–∏—Ö, –∫–∞–∫ –∏ –≤ –ø—Ä–æ—à–ª–æ–º –≥–æ–¥—É, –ø–æ–∫—É–ø–∞–ª–∏: —Å—Ä–µ–¥—Å—Ç–≤–∞ –æ—Ç –Ω–∞—Å–º–æ—Ä–∫–∞ (22%), –±–æ–ª–µ—É—Ç–æ–ª—è—é—â–∏–µ (17%) –∏ –≤–∏—Ç–∞–º–∏–Ω—ã (17%). –ó–∞ –Ω–∏–º–∏ —Å–ª–µ–¥—É—é—Ç ¬´—Å–µ–∑–æ–Ω–Ω—ã–µ –ø–æ–∑–∏—Ü–∏–∏¬ª: –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –æ—Ç –∫–∞—à–ª—è –∏ –±–æ–ª–∏ –≤ –≥–æ—Ä–ª–µ, –∂–∞—Ä–æ–ø–æ–Ω–∏–∂–∞—é—â–∏–µ. –ê –≤–æ—Ç –æ–ø—Ä–µ–¥–µ–ª—è—é—â–∏–µ —Ñ–∞–∫—Ç–æ—Ä—ã –ø—Ä–∏ –≤—ã–±–æ—Ä–µ –ø–æ—Å—Ç–µ–ø–µ–Ω–Ω–æ –º–µ–Ω—è—é—Ç—Å—è. –ï—Å–ª–∏ —Ä–∞–Ω—å—à–µ –ø–æ—á—Ç–∏ —É –∫–∞–∂–¥–æ–≥–æ –±—ã–ª–∞ ¬´—Å–≤–æ—è¬ª –∞–ø—Ç–µ–∫–∞ –∏ ¬´—Å–≤–æ–π¬ª –ø—Ä–æ–≤–µ—Ä–µ–Ω–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç, —Ç–æ —Å —Ä–∞–∑–≤–∏—Ç–∏–µ–º –æ–Ω–ª–∞–π–Ω-—Å–µ—Ä–≤–∏—Å–æ–≤ –ø–æ–∫—É–ø–∞—Ç–µ–ª–∏ —Å—Ç–∞–ª–∏ –±–æ–ª—å—à–µ —Å—Ä–∞–≤–Ω–∏–≤–∞—Ç—å —Å–æ—Å—Ç–∞–≤—ã –∏ —Ü–µ–Ω—ã, –∞ —Ç–∞–∫–∂–µ –æ–±—Ä–∞—â–∞—Ç—å –≤–Ω–∏–º–∞–Ω–∏–µ –Ω–∞ —Å–ø–µ—Ü–ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è. 49% –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö –Ω–∞–∑–≤–∞–ª–∏ –≥–ª–∞–≤–Ω—ã–º —Ñ–∞–∫—Ç–æ—Ä–æ–º –ø—Ä–∏ –≤—ã–±–æ—Ä–µ –∞–ø—Ç–µ–∫–∏ —É–¥–æ–±—Å—Ç–≤–æ, —Ç–æ–≥–¥–∞ –∫–∞–∫ —Ü–µ–Ω—ã –æ–∫–∞–∑–∞–ª–∏—Å—å —Ç–æ–ª—å–∫–æ –Ω–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ (25%). –ë–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ —Ä–µ—Å–ø–æ–Ω–¥–µ–Ω—Ç–æ–≤ –æ—Ç–º–µ—Ç–∏–ª–æ, —á—Ç–æ —á–∞—â–µ –≤—Å–µ–≥–æ —Ö–æ–¥—è—Ç –≤ 1‚Äì2 —Å–µ—Ç–∏ –¥–ª—è —Å–æ–≤–µ—Ä—à–µ–Ω–∏—è –ø–æ–∫—É–ø–æ–∫, –∞ –ª—é–±–∏–º—ã–µ –ø–ª–æ—â–∞–¥–∫–∏ –≤–∞—Ä—å–∏—Ä—É—é—Ç—Å—è –≤ –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏ –æ—Ç —Ä–µ–≥–∏–æ–Ω–∞. ¬´–°–≤–æ–∏–º–∏¬ª –¥–ª—è –º–æ—Å–∫–≤–∏—á–µ–π —Å—Ç–∞–ª–∏: ¬´–ì–æ—Ä–∑–¥—Ä–∞–≤¬ª, ¬´–°—Ç–æ–ª–∏—á–∫–∏¬ª, ¬´–†–∏–≥–ª–∞¬ª, ¬´36,6¬ª –∏ ¬´–ü–ª–∞–Ω–µ—Ç–∞ –∑–¥–æ—Ä–æ–≤—å—è¬ª. –í —Å–µ–≤–µ—Ä–Ω–æ–π —Å—Ç–æ–ª–∏—Ü–µ –ª–∏–¥–∏—Ä—É—é—Ç: ¬´–û–∑–µ—Ä–∫–∏¬ª, ¬´–í–∏—Ç–∞¬ª, ¬´–ê–ø—Ç–µ–∫–∞ –ù–µ–≤–∏—Å¬ª, ¬´–°—Ç–æ–ª–∏—á–∫–∏¬ª –∏ ¬´–ì–æ—Ä–∑–¥—Ä–∞–≤¬ª. –í —Ñ–∞–≤–æ—Ä–∏—Ç–∞—Ö —É –∂–∏—Ç–µ–ª–µ–π –¥—Ä—É–≥–∏—Ö –≥–æ—Ä–æ–¥–æ–≤-–º–∏–ª–ª–∏–æ–Ω–Ω–∏–∫–æ–≤: ¬´–ê–ø—Ä–µ–ª—å¬ª, ¬´–í–∏—Ç–∞¬ª, ¬´–§–∞—Ä–º–ª–µ–Ω–¥¬ª, ¬´–ú–∞–≥–Ω–∏—Ç –∞–ø—Ç–µ–∫–∞¬ª –∏ ¬´–ê–ø—Ç–µ–∫–∞.—Ä—É¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The survey by Nielsen of over 1,000 pharmacy shoppers and more than 200 pharmacists revealed that monthly spending on over-the-counter medications rose to RUB2,660. This is up from RUB2,580 in the previous year. The most purchased items were cold remedies (22%), pain relievers (17%) and vitamins (17%). Seasonal items such as cough and cold medications, and fever reducers are also popular. Factors influencing choice have changed with more shoppers comparing formulations and prices, as well as taking advantage of special offers. 49% cited convenience as the main factor in choosing a pharmacy, while prices were seen as second most important. Most shoppers typically visit 1-2 chains for purchases, with favorite stores varying by region.""
}"
2025-10-21T09:23:52+00:00,@bezrec,6713,https://t.me/bezrec/6713,"–ü—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º —Å–≤–µ–∂–∏–π –æ–±–∑–æ—Ä –≤–∞–∫–∞–Ω—Å–∏–π –≤ –Ω–∞—à–µ–π —Ä—É–±—Ä–∏–∫–µ #—Ñ–∞—Ä–º–Ω–∞–π–º. ¬´–ë–∏–æ–∫–∞–¥¬ª: üîò–†—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å –æ—Ç–¥–µ–ª–∞ –∑–∞–∫—É–ø–æ–∫ –ò—â—É—Ç —á–µ–ª–æ–≤–µ–∫–∞ –¥–ª—è —Ä–∞–±–æ—Ç—ã –≤ –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥–µ —Å –æ–ø—ã—Ç–æ–º –±–æ–ª–µ–µ 6 –ª–µ—Ç. –°–ø–∏—Å–æ–∫ –æ–±—è–∑–∞–Ω–Ω–æ—Å—Ç–µ–π –∏ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π –≤–Ω—É—à–∏—Ç–µ–ª—å–Ω—ã–π. –í–∑–∞–º–µ–Ω –æ–±–µ—â–∞—é—Ç –¥–æ—Å—Ç–æ–π–Ω—ã–π —É—Ä–æ–≤–µ–Ω—å –æ–ø–ª–∞—Ç—ã —Ç—Ä—É–¥–∞, –≥–æ–¥–æ–≤–æ–µ –ø—Ä–µ–º–∏—Ä–æ–≤–∞–Ω–∏–µ, –≥–∏–±—Ä–∏–¥–Ω—ã–π —Ñ–æ—Ä–º–∞—Ç —Ä–∞–±–æ—Ç—ã, –î–ú–° —Å–æ —Å—Ç–æ–º–∞—Ç–æ–ª–æ–≥–∏–µ–π –ø–æ—Å–ª–µ –∏—Å–ø—ã—Ç–∞—Ç–µ–ª—å–Ω–æ–≥–æ —Å—Ä–æ–∫–∞ –∏ –¥—Ä—É–≥–∏–µ ¬´–ø–ª—é—à–∫–∏¬ª. üîò–†—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å –≥—Ä—É–ø–ø—ã —Ñ–∏–∑–∏–∫–æ-—Ö–∏–º–∏—á–µ—Å–∫–∏—Ö –º–µ—Ç–æ–¥–æ–≤ –∞–Ω–∞–ª–∏–∑–∞ –í —Å–ø–∏—Å–∫–µ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π ‚Äî –≤—ã—Å—à–µ–µ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–µ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ , –æ–ø—ã—Ç —Ä–∞–±–æ—Ç—ã –≤ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –æ—Ç—Ä–∞—Å–ª–∏ –Ω–µ –º–µ–Ω–µ–µ 5 –ª–µ—Ç –∏ –Ω–µ –º–µ–Ω–µ–µ 2 –ª–µ—Ç ‚Äî –Ω–∞ —Ä—É–∫–æ–≤–æ–¥—è—â–µ–π –¥–æ–ª–∂–Ω–æ—Å—Ç–∏, —É–º–µ–Ω–∏–µ —Ä–∞–±–æ—Ç–∞—Ç—å —Å –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω–æ–π –¥–æ–∫—É–º–µ–Ω—Ç–∞—Ü–∏–µ–π –ì–§ –†–§, EP, ICH, –ï–ê–≠–°. –ò–∑ –±–æ–Ω—É—Å–æ–≤ ‚Äî –î–ú–° –¥–ª—è —Å–µ–±—è –∏ —á–ª–µ–Ω–æ–≤ —Å–µ–º—å–∏, –±–µ—Å–ø–ª–∞—Ç–Ω–æ–µ –ø–∏—Ç–∞–Ω–∏–µ, –ø—Ä–æ–≥—Ä–∞–º–º—ã –ø–æ–º–æ—â–∏ —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–∞–º –≤ —Ç—Ä—É–¥–Ω—ã—Ö –∂–∏–∑–Ω–µ–Ω–Ω—ã—Ö —Å–∏—Ç—É–∞—Ü–∏—è—Ö. ¬´–≠–Ω–¥–æ—Ñ–∞—Ä–º¬ª: üîò–ù–∞—á–∞–ª—å–Ω–∏–∫ —É–ø—Ä–∞–≤–ª–µ–Ω–∏—è –ø–æ —ç–∫–æ–Ω–æ–º–∏–∫–µ –∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ —Ñ–∏–ª–∏–∞–ª–æ–≤ –ù–µ—Å–º–æ—Ç—Ä—è –Ω–∞ —Å–µ—Ä—å—ë–∑–Ω–æ—Å—Ç—å –¥–æ–ª–∂–Ω–æ—Å—Ç–∏, —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ –æ–ø—ã—Ç—É –∫–∞–Ω–¥–∏–¥–∞—Ç–∞ —Å–∫—Ä–æ–º–Ω—ã–µ ‚Äî –æ—Ç 1 –¥–æ 3 –ª–µ—Ç. –¢—Ä–µ–±–æ–≤–∞–Ω–∏—è —Ç–æ–∂–µ –¥–æ–≤–æ–ª—å–Ω–æ ¬´—Ä–∞–∑–º—ã—Ç—ã–µ¬ª, –≤—Ä–æ–¥–µ ¬´–≤—ã—Å–æ–∫–æ —Ä–∞–∑–≤–∏—Ç—ã—Ö –∫–æ–º–º—É–Ω–∏–∫–∞—Ç–∏–≤–Ω—ã—Ö –Ω–∞–≤—ã–∫–æ–≤ –∏ —Å–ø–æ—Å–æ–±–Ω–æ—Å—Ç–∏ –ø—Ä–æ—è–≤–ª—è—Ç—å —Å–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω–æ—Å—Ç—å¬ª. –ò–∑ –∫–æ–Ω–∫—Ä–µ—Ç–Ω–æ–≥–æ ‚Äî –∑–Ω–∞–Ω–∏–µ –ø—Ä–æ–≥—Ä–∞–º–º 1C: ERP, 1–°: –î–æ–∫—É–º–µ–Ω—Ç–æ–æ–±–æ—Ä–æ—Ç, 1–°: –ë–ò–¢ –§–ò–ù–ê–ù–°. –ì—Ä–∞—Ñ–∏–∫ —Ä–∞–±–æ—Ç—ã —Å 08-00 –¥–æ 16-45 (–ø—è—Ç–Ω–∏—Ü–∞ –¥–æ 15-30), –ª—å–≥–æ—Ç–Ω–æ–µ –ø–∏—Ç–∞–Ω–∏–µ –∏ —Å–∞–Ω–∞—Ç–æ—Ä–Ω–æ- –∫—É—Ä–æ—Ä—Ç–Ω–æ–µ –ª–µ—á–µ–Ω–∏–µ. üîò–ó–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å –≥–µ–Ω–µ—Ä–∞–ª—å–Ω–æ–≥–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –ø–æ —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–æ–º—É —Ä–∞–∑–≤–∏—Ç–∏—é (—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–π —Ä—ã–Ω–æ–∫) –ó–¥–µ—Å—å —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ –æ–ø—ã—Ç—É —Å—Ç—Ä–æ–∂–µ ‚Äî –æ—Ç 6 –ª–µ—Ç —Å –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–º –æ–ø—ã—Ç–æ–º —Ä–∞–±–æ—Ç—ã –≤ —Ñ–∞—Ä–º–µ, –∞ —Ç–∞–∫–∂–µ –≤—ã—Å—à–∏–º –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º –∏–ª–∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–º –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ–º. –¢–∞–∫–∂–µ –≤–∞–∂–Ω–æ –∑–Ω–∞–Ω–∏–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–∏—Ö –º–µ—Ç–æ–¥–∏–∫, –∞–Ω–∞–ª–∏–∑–∞ –∏ —Å—Ö–µ–º –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –ø–µ—Ä–≤–∏—á–Ω—ã—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π, —Å–æ–∑–¥–∞–Ω–∏–µ –ø—Ä–æ–≥–Ω–æ–∑–æ–≤ –±—É–¥—É—â–∏—Ö –ø—Ä–æ–¥–∞–∂. ¬´–ü–æ–ª–∏—Å–∞–Ω¬ª: üîò–ù–∞—á–∞–ª—å–Ω–∏–∫ –æ—Ç–¥–µ–ª–∞ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –û—Ç –∫–∞–Ω–¥–∏–¥–∞—Ç–∞ –∂–¥—É—Ç –æ–ø—ã—Ç —Ä–∞–±–æ—Ç—ã –Ω–µ –º–µ–Ω–µ–µ 5 –ª–µ—Ç –≤ —Å—Ñ–µ—Ä–µ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, —É—Å–ø–µ—à–Ω—ã–π —É–ø—Ä–∞–≤–ª–µ–Ω—á–µ—Å–∫–∏–π –æ–ø—ã—Ç –≤ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –Ω–∞ –∞–Ω–∞–ª–æ–≥–∏—á–Ω–æ–π –¥–æ–ª–∂–Ω–æ—Å—Ç–∏, –∑–Ω–∞–Ω–∏–µ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–∞ –†–§ –∏ –ï–ê–≠–° –≤ –æ–±–ª–∞—Å—Ç–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –æ–ø—ã—Ç –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–æ–≥–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è. ¬´–õ–∞–Ω—Ü–µ—Ç¬ª: üîò–ö–æ–º–ø–∞–Ω–∏—è –∏—â–µ—Ç –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –ø–æ –ª–æ–≥–∏—Å—Ç–∏–∫–µ —Å –Ω–µ —Å–∞–º—ã–º –æ–±—ã—á–Ω—ã–º –¥–ª—è —ç—Ç–æ–π –¥–æ–ª–∂–Ω–æ—Å—Ç–∏ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–µ–º ‚Äî –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–º –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º/—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–º –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ–º. –¢–∞–∫–∂–µ –æ—Ç –ø—Ä–µ—Ç–µ–Ω–¥–µ–Ω—Ç–∞ –∂–¥—É—Ç –∑–Ω–∞–Ω–∏–µ —Ç—Ä–∞–Ω—Å–ø–æ—Ä—Ç–Ω–æ–≥–æ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–∞ –∏ –≥–ª—É–±–æ–∫–æ–µ –ø–æ–Ω–∏–º–∞–Ω–∏–µ –≤—Å–µ—Ö —ç—Ç–∞–ø–æ–≤ –ª–æ–≥–∏—Å—Ç–∏—á–µ—Å–∫–æ–π —Ü–µ–ø–æ—á–∫–∏. –í–∑–∞–º–µ–Ω –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç –î–ú–° (–≤–∫–ª—é—á–∞—è —Å—Ç–æ–º–∞—Ç–æ–ª–æ–≥–∏—é –∏ –∫–æ–Ω—Å—É–ª—å—Ç–∞—Ü–∏–∏ –ø—Å–∏—Ö–æ–ª–æ–≥–∞), –æ–ø–ª–∞—á–∏–≤–∞–µ–º–æ–µ –ø–∏—Ç–∞–Ω–∏–µ, 3 –¥–Ω—è ¬´–±–æ–ª—å–Ω–∏—á–Ω—ã—Ö –±–µ–∑ –±–æ–ª—å–Ω–∏—á–Ω—ã—Ö¬ª –≤ –≥–æ–¥—É, –∫–æ—Ä–ø–æ—Ä–∞—Ç–∏–≤–Ω—É—é –º–æ–±–∏–ª—å–Ω—É—é —Å–≤—è–∑—å –∏ –≥–∏–±—Ä–∏–¥–Ω—ã–π —Ñ–æ—Ä–º–∞—Ç –ø–æ—Å–µ—â–µ–Ω–∏—è –æ—Ñ–∏—Å–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-10-21T05:35:36+00:00,@bezrec,6712,https://t.me/bezrec/6712,"–î–∏—Å—Ç–∞–Ω—Ü–∏–æ–Ω–Ω—É—é –ø—Ä–æ–¥–∞–∂—É —Ä–µ—Ü–µ–ø—Ç—É—Ä–∫–∏ –ø—Ä–æ—Å—è—Ç —Ä–∞—Å—à–∏—Ä–∏—Ç—å –Ω–∞ –≤—Å—é —Å—Ç—Ä–∞–Ω—É. –î–µ–ø—É—Ç–∞—Ç—ã —Ñ—Ä–∞–∫—Ü–∏–∏ ¬´–ù–æ–≤—ã–µ –ª—é–¥–∏¬ª –≤–æ –≥–ª–∞–≤–µ —Å –≤–∏—Ü–µ-—Å–ø–∏–∫–µ—Ä–æ–º –ì–æ—Å–¥—É–º—ã –í–ª–∞–¥–∏—Å–ª–∞–≤–æ–º –î–∞–≤–∞–Ω–∫–æ–≤—ã–º –æ–±—Ä–∞—Ç–∏–ª–∏—Å—å –∫ –ú–∏—Ö–∞–∏–ª—É –ú—É—Ä–∞—à–∫–æ —Å –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–µ–º —Ä–∞–∑—Ä–µ—à–∏—Ç—å –æ–Ω–ª–∞–π–Ω-–¥–æ—Å—Ç–∞–≤–∫—É –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø–æ –≤—Å–µ–π –†–æ—Å—Å–∏–∏ —Å—Ä–∞–∑—É –ø–æ—Å–ª–µ –æ–∫–æ–Ω—á–∞–Ω–∏—è —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–∞ –ø–æ –¥–∏—Å—Ç–∞–Ω—Ü–∏–æ–Ω–Ω–æ–π –ø—Ä–æ–¥–∞–∂–µ —Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –ú–æ—Å–∫–≤–µ, –ú–æ—Å–∫–æ–≤—Å–∫–æ–π –∏ –ë–µ–ª–≥–æ—Ä–æ–¥—Å–∫–æ–π –æ–±–ª–∞—Å—Ç—è—Ö, —Ç.–µ. –ø–æ—Å–ª–µ 1 –º–∞—Ä—Ç–∞ 2026 –≥–æ–¥–∞. –ù–µ–æ–±—Ö–æ–¥–∏–º–æ –ø—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ—Ç—å –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –ø—Ä–∏–æ–±—Ä–µ—Ç–µ–Ω–∏—è –≤ –æ–Ω–ª–∞–π–Ω-—Ä–µ–∂–∏–º–µ –ª—é–±—ã—Ö –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –≤ —Ç–æ–º —á–∏—Å–ª–µ —Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã—Ö, –∞ —Ç–∞–∫–∂–µ –æ–±–ª–µ–≥—á–∏—Ç—å –ø—Ä–æ—Ü–µ—Å—Å –¥–æ—Å—Ç–∞–≤–∫–∏ –ø–æ —ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω–æ–º—É —Ä–µ—Ü–µ–ø—Ç—É –Ω–∞ –¥–æ–º, –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–∏–≤ –∫—É—Ä—å–µ—Ä–∞–º —Å—Ç–æ—Ä–æ–Ω–Ω–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –¥–æ—Å—Ç–∞–≤–ª—è—Ç—å —Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞, ‚Äî –≥–æ–≤–æ—Ä–∏—Ç—Å—è –≤ –ø–∏—Å—å–º–µ. –ú—ã #—Å–ø—Ä–æ—Å–∏–ª–∏, —á—Ç–æ –¥—É–º–∞–µ—Ç –æ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–∏ –¥–µ–ø—É—Ç–∞—Ç–æ–≤ –¥–∏—Ä–µ–∫—Ç–æ—Ä –ø–æ —Ä–∞–∑–≤–∏—Ç–∏—é RNC Pharm–∞ –ù–∏–∫–æ–ª–∞–π –ë–µ—Å–ø–∞–ª–æ–≤. –≠–∫—Å–ø–µ—Ä—Ç –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤—É –≤—Å—è—á–µ—Å–∫–∏ –ø—Ä–∏–≤–µ—Ç—Å—Ç–≤–æ–≤–∞—Ç—å. üü© –ò—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–µ —Å–¥–µ—Ä–∂–∏–≤–∞–Ω–∏–µ —Ä–∞–∑–≤–∏—Ç–∏—è —ç—Ç–æ–≥–æ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è –Ω–∞ —Ñ–∞—Ä–º—Ä—ã–Ω–∫–µ –ø—Ä–∏–≤–æ–¥–∏—Ç –∫ –æ—á–µ–Ω—å —Å–µ—Ä—å—ë–∑–Ω—ã–º –Ω–µ–≥–∞—Ç–∏–≤–Ω—ã–º –ø–æ—Å–ª–µ–¥—Å—Ç–≤–∏—è–º –∏ —Å —Ç–æ—á–∫–∏ –∑—Ä–µ–Ω–∏—è —Å–æ—Ü–∏–∞–ª—å–Ω–æ–π —Å–æ—Å—Ç–∞–≤–ª—è—é—â–µ–π, –∏ –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ –±–∏–∑–Ω–µ—Å –∏–Ω—Ç–µ—Ä–µ—Å–æ–≤. üü© –û–±–µ—Å–ø–µ—á–µ–Ω–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏ –æ—Ç–¥–∞–ª—ë–Ω–Ω—ã—Ö –Ω–∞—Å–µ–ª—ë–Ω–Ω—ã—Ö –ø—É–Ω–∫—Ç–æ–≤. –ù–æ–≤–æ–≤–≤–µ–¥–µ–Ω–∏—è, –∫–æ—Ç–æ—Ä—ã–µ —Ä–µ–≥—É–ª—è—Ç–æ—Ä—ã –ø—Ä–∏–¥—É–º—ã–≤–∞—é—Ç –æ–¥–Ω–æ –∑–∞ –¥—Ä—É–≥–∏–º, –≤ —Å—É—Ö–æ–º –æ—Å—Ç–∞—Ç–∫–µ –∑–Ω–∞—á–∏–º–æ —Å–∏—Ç—É–∞—Ü–∏—é –Ω–µ —É–ª—É—á—à–∏–ª–∏. –í—Å—ë —É–ø–∏—Ä–∞–µ—Ç—Å—è –ª–∏–±–æ –≤ –≤–æ–ø—Ä–æ—Å—ã —Ñ–∏–Ω–∞–Ω—Å–æ–≤–æ–π —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏, –ª–∏–±–æ –≤ –Ω–µ–≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –æ–±–µ—Å–ø–µ—á–∏—Ç—å –Ω–∞–ª–∏—á–∏–µ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ–≥–æ –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç–∞. –ú–µ–∂–¥—É —Ç–µ–º, —ç—Ç–∏ –ø—Ä–æ–±–ª–µ–º—ã –ª–µ–≥–∫–æ –∏ –ø—Ä–æ—Å—Ç–æ –º–æ–∂–Ω–æ –∑–∞–∫—Ä—ã—Ç—å —Å –ø–æ–º–æ—â—å—é –æ–Ω–ª–∞–π–Ω-–ø—Ä–æ–¥–∞–∂–∏ –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã—Ö –ª—é–¥—è–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, —Ç–∞–∫–æ–π –ø–æ–¥—Ö–æ–¥ –ø—Ä–∏–Ω—Ü–∏–ø–∏–∞–ª—å–Ω–æ –º–µ–Ω—è–µ—Ç —ç–∫–æ–Ω–æ–º–∏–∫—É —Ä–∞–±–æ—Ç—ã –≤ –æ—Ç–¥–∞–ª—ë–Ω–Ω—ã—Ö –ª–æ–∫–∞—Ü–∏—è—Ö, ‚Äî —É–≤–µ—Ä–µ–Ω –ë–µ—Å–ø–∞–ª–æ–≤. üü© –ö–∞—Å–∞–µ–º–æ –±–∏–∑–Ω–µ—Å-–∞—Å–ø–µ–∫—Ç–∞, –≤ –Ω–∞—Å—Ç–æ—è—â–µ–µ –≤—Ä–µ–º—è —Å–µ—Ä–≤–∏—Å –æ–Ω–ª–∞–π–Ω-–ø—Ä–æ–¥–∞–∂–∏ —Ä–∞–±–æ—Ç–∞–µ—Ç –≤ –ø–æ–ª–æ–≤–∏–Ω—á–∞—Ç–æ–º —Ñ–æ—Ä–º–∞—Ç–µ, —á—Ç–æ –¥–µ–ª–∞–µ—Ç –Ω–µ–≤–æ–∑–º–æ–∂–Ω—ã–º –Ω–æ—Ä–º–∞–ª—å–Ω–æ–µ —Ä–∞–∑–≤–∏—Ç–∏–µ —ç—Ç–æ–≥–æ –∫–∞–Ω–∞–ª–∞ –∏ –æ–±–æ—Å—Ç—Ä—è–µ—Ç –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏—é —Å –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞–º–∏ –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ –Ω–µ–ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç–∞. –°–µ–π—á–∞—Å —Ñ–æ—Ä–º–∞–ª—å–Ω–æ –∞–ø—Ç–µ–∫–∞ –º–æ–∂–µ—Ç –ø—Ä–æ–¥–∞–≤–∞—Ç—å —Å –¥–æ—Å—Ç–∞–≤–∫–æ–π –û–¢–° –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, –Ω–æ –æ—Å–Ω–æ–≤—É –∞–ø—Ç–µ—á–Ω–æ–≥–æ –±–∏–∑–Ω–µ—Å–∞ —Ñ–æ—Ä–º–∏—Ä—É–µ—Ç –∏–º–µ–Ω–Ω–æ Rx-–∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç. üü© –ï—Å–ª–∏ –≥–æ–≤–æ—Ä–∏—Ç—å –æ –∑–∞–¥–∞—á–∞—Ö –æ–±—â–µ–≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö, –æ–Ω–ª–∞–π–Ω —Ñ–æ—Ä–º–∞—Ç –æ—á–µ–Ω—å —Å–µ—Ä—å—ë–∑–Ω–æ —Å—Ç–∏–º—É–ª–∏—Ä—É–µ—Ç –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏—é, –≤ —Ç.—á. –∑–∞—Å—Ç–∞–≤–ª—è—è –æ—Ñ–ª–∞–π–Ω —Ç–æ—á–∫–∏ –æ—á–µ–Ω—å –∞–∫–∫—É—Ä–∞—Ç–Ω–æ –ø–æ–¥—Ö–æ–¥–∏—Ç—å –∫ –ø—Ä–æ–±–ª–µ–º–µ —Ü–µ–Ω–æ–æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è. –û—á–µ–Ω—å –Ω–∞–¥–µ—é—Å—å, —á—Ç–æ —Ç–µ–º–∞ –±—É–¥–µ—Ç —Ä–∞–∑–≤–∏–≤–∞—Ç—å—Å—è –∏ –º—ã –≤—Å—ë-—Ç–∞–∫–∏ —É–≤–∏–¥–∏–º –ø–æ–ª–Ω–æ—Ü–µ–Ω–Ω—ã–π –æ–Ω–ª–∞–π–Ω –∫–∞–Ω–∞–ª –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–º —Ä—ã–Ω–∫–µ, ‚Äî –ø–æ–¥—ã—Ç–æ–∂–∏–ª –ë–µ—Å–ø–∞–ª–æ–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""import_export, shortage, regulation, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The deputies of the 'New People' faction, led by Vice-Speaker Vladislav Davankov from the State Duma, have asked to expand remote prescription sales throughout Russia. The deputies requested that after the experiment on remote prescription drug sales in Moscow, Moscow Oblast, and Belgorod Oblast ends on March 1st, 2026, remote sales of all medications, including prescription drugs, should be allowed. The expert from RNC Pharma, Nikolay Bepalov, supports the initiative. He believes that artificial restraint of this development on the pharmaceutical market has serious negative consequences both socially and for business interests. The current half-hearted format of online sales service makes it difficult to develop this channel and intensifies competition with marketplaces for non-drug products. The full-scale online channel is needed to address the issues of price formation in remote areas.""
}"
2025-10-20T14:59:58+00:00,@bezrec,6711,https://t.me/bezrec/6711,"–î–≤–∞ –¥—Ä—É–≥–∞ –ø–æ–∫–∞–∑–∞–ª–∏, –∫–∞–∫ ¬´–≤–∑—Ä–æ—Å–ª–µ–µ—Ç¬ª —Ç–∞–±–ª–µ—Ç–Ω–∏—Ü–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-10-20T11:59:58+00:00,@bezrec,6710,https://t.me/bezrec/6710,"–†–æ—Å—Ç —á–∏—Å–ª–∞ –æ–±—Ä–∞—â–µ–Ω–∏–π –∫ 2024 –≥–æ–¥—É —Ñ–∏–∫—Å–∏—Ä—É–µ—Ç –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä. –ó–∞–º–≥–ª–∞–≤—ã —Ä–µ–≥—É–ª—è—Ç–æ—Ä–∞ –ï–ª–µ–Ω–∞ –®–µ—à–∫–æ —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∞ –≤ –°–æ–≤—Ñ–µ–¥–µ, —á—Ç–æ –≤ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω—ã–µ –æ—Ä–≥–∞–Ω—ã –∏ –≤ —Ü–µ–Ω—Ç—Ä–∞–ª—å–Ω—ã–π –∞–ø–ø–∞—Ä–∞—Ç –≤–µ–¥–æ–º—Å—Ç–≤–∞ –ø–æ—Å—Ç—É–ø–∏–ª–æ –ø–æ—á—Ç–∏ 36 —Ç—ã—Å. –æ–±—Ä–∞—â–µ–Ω–∏–π –≥—Ä–∞–∂–¥–∞–Ω –ø–æ –≤–æ–ø—Ä–æ—Å–∞–º –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–º–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º–∏ –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º–∏ –∏–∑–¥–µ–ª–∏—è–º–∏. –≠—Ç–æ —á–µ—Ç–≤–µ—Ä—Ç—å –æ—Ç –≤—Å–µ—Ö –∂–∞–ª–æ–± –Ω–∞ –æ–∫–∞–∑–∞–Ω–∏–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –≤ –†–æ—Å—Å–∏–∏. –ù–∞ —á—Ç–æ –∂–∞–ª—É—é—Ç—Å—è –ø–∞—Ü–∏–µ–Ω—Ç—ã: üîò–±–æ–ª–µ–µ 63% ‚Äî –Ω–∞ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–µ –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –∞–ø—Ç–µ—á–Ω—ã—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è—Ö (–∑–∞ –≥–æ–¥ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ —Ç–∞–∫–∏—Ö –∂–∞–ª–æ–± –≤—ã—Ä–æ—Å–ª–æ –Ω–∞ 19%); üîò2% ‚Äî –Ω–∞ –æ—Ç–∫–∞–∑—ã –≤ –≤—ã–ø–∏—Å–∫–µ —Ä–µ—Ü–µ–ø—Ç–æ–≤ (+9% –≥–æ–¥ –∫ –≥–æ–¥—É); –±–æ–ª–µ–µ 2% ‚Äî –Ω–∞ –¥–ª–∏—Ç–µ–ª—å–Ω–æ–µ –æ—Ç—Å—Ä–æ—á–µ–Ω–Ω–æ–µ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ. –û –∑–∞–ø–∞—Å–µ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏–∑ –ø–µ—Ä–µ—á–Ω—è –ñ–ù–í–õ–ü –Ω–∞ —à–µ—Å—Ç—å –º–µ—Å—è—Ü–µ–≤ –≤ –°–æ–≤–µ—Ç–µ –§–µ–¥–µ—Ä–∞—Ü–∏–∏ –æ—Ç—á–∏—Ç–∞–ª—Å—è –∑–∞–º–º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –°–µ—Ä–≥–µ–π –ì–ª–∞–≥–æ–ª–µ–≤: –°–µ–≥–æ–¥–Ω—è –º—ã –≤–∏–¥–∏–º –ø–æ –ø–æ–¥–∞–≤–ª—è—é—â–µ–º—É –±–æ–ª—å—à–∏–Ω—Å—Ç–≤—É –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –æ—Ç–Ω–æ—Å—è—â–∏—Ö—Å—è –∫ –∂–∏–∑–Ω–µ–Ω–Ω–æ –≤–∞–∂–Ω—ã–º, –∑–∞–ø–∞—Å—ã, –∫–æ—Ç–æ—Ä—ã–µ –ø—Ä–∏–º–µ—Ä–Ω–æ —Ä–∞–≤–Ω—ã –ø–æ–ª—É–≥–æ–¥—É. –° –Ω–∞—á–∞–ª–∞ –°–í–û –≤ —Å—Ç—Ä–∞–Ω–µ –∞–∫—Ç–∏–≤–Ω–æ —Å–ª–µ–¥—è—Ç –∑–∞ –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å—é —Ç–∞–∫–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ —Å –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ–º –∞–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–æ–π –≤–∏—Ç—Ä–∏–Ω—ã, —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–Ω–æ–π –∫–æ–æ—Ä–¥–∏–Ω–∞—Ü–∏–æ–Ω–Ω—ã–º —Ü–µ–Ω—Ç—Ä–æ–º –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞, –∫–æ—Ç–æ—Ä–∞—è –æ—Ü–µ–Ω–∏–≤–∞–µ—Ç –≤—Å–µ —ç–ª–µ–º–µ–Ω—Ç—ã –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏–∑ –ø–µ—Ä–µ—á–Ω—è –ñ–ù–í–õ–ü –Ω–∞ –≤—Å–µ—Ö —É—á–∞—Å—Ç–∫–∞—Ö –¥–∏—Å—Ç—Ä–∏–±—å—é—Çj—Ä—Å–∫–æ–π —Ü–µ–ø–∏ ‚Äî —ç—Ç–æ –∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ, –∏ –≤–≤–æ–∑ –≤ –†–§, –Ω–∞–ª–∏—á–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ —Å–∫–ª–∞–¥–µ –æ–ø—Ç–æ–≤–∏–∫–æ–≤, –≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è—Ö –∏ –≤ –∞–ø—Ç–µ–∫–∞—Ö. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""Russia's Roszdranad–∑–æ—Ä reported a rise in complaints about drug supplies to patients, with over 63% of issues related to the lack of necessary medications in hospitals. The government is closely monitoring drug availability, using an analytical dashboard to assess supply chains from production to retail.""
}"
2025-10-20T09:15:02+00:00,@bezrec,6709,https://t.me/bezrec/6709,"–£ –ú–∏—Ö–∞–∏–ª–∞ –ú—É—Ä–∞—à–∫–æ –Ω–æ–≤—ã–π –∑–∞–º. –≠–∫—Å-–¥–∏—Ä–µ–∫—Ç–æ—Ä –§–∏–Ω–∞–Ω—Å–æ–≤–æ-—ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–≥–æ –¥–µ–ø–∞—Ä—Ç–∞–º–µ–Ω—Ç–∞ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ù–∞—Ç–∞–ª—å—è –°–∏–±–∏—Ä—è–∫–æ–≤–∞ —Å–º–µ–Ω–∏–ª–∞ –Ω–∞ –ø–æ—Å—Ç—É –∑–∞–º–º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ù–∞—Ç–∞–ª—å—é –•–æ—Ä–æ–≤—É. –°–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–µ–µ —Ä–∞—Å–ø–æ—Ä—è–∂–µ–Ω–∏–µ –ú–∏—Ö–∞–∏–ª –ú–∏—à—É—Å—Ç–∏–Ω –ø–æ–¥–ø–∏—Å–∞–ª 17 –æ–∫—Ç—è–±—Ä—è. –ù–∞–ø–æ–º–Ω–∏–º, –•–æ—Ä–æ–≤–∞ —É—à–ª–∞ —Å –¥–æ–ª–∂–Ω–æ—Å—Ç–∏ –ø–æ —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ–º—É –∂–µ–ª–∞–Ω–∏—é, —á—Ç–æ–±—ã —Å—Ç–∞—Ç—å —Å–µ–Ω–∞—Ç–æ—Ä–æ–º –æ—Ç –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –ï–≤—Ä–µ–π—Å–∫–æ–π –∞–≤—Ç–æ–Ω–æ–º–Ω–æ–π –æ–±–ª–∞—Å—Ç–∏ –≤ –°–æ–≤–µ—Ç–µ –§–µ–¥–µ—Ä–∞—Ü–∏–∏. –ù–∞—Ç–∞–ª—å—è –°–∏–±–∏—Ä—è–∫–æ–≤–∞ –≤ –ú–∏–Ω–∑–¥—Ä–∞–≤–µ —Å 2018 –≥–æ–¥–∞. –î–æ —Å–≤–æ–µ–≥–æ –Ω–∞–∑–Ω–∞—á–µ–Ω–∏—è –∑–∞–º–º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–∞–Ω–∏–º–∞–ª–∞ –ø–æ—Å—Ç –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –§–∏–Ω–∞–Ω—Å–æ–≤–æ-—ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–≥–æ –¥–µ–ø–∞—Ä—Ç–∞–º–µ–Ω—Ç–∞ –≤–µ–¥–æ–º—Å—Ç–≤–∞. –° 2014 –ø–æ 2017 –≥–æ–¥ —Ä–∞–±–æ—Ç–∞–ª–∞ –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª–µ–º –Ω–∞—á–∞–ª—å–Ω–∏–∫–∞ –∏ –Ω–∞—á–∞–ª—å–Ω–∏–∫–æ–º –§–∏–Ω–∞–Ω—Å–æ–≤–æ-—ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–≥–æ —É–ø—Ä–∞–≤–ª–µ–Ω–∏—è –§–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –∞–≥–µ–Ω—Ç—Å—Ç–≤–∞ –Ω–∞—É—á–Ω—ã—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π (–§–ê–ù–û). –î–æ —ç—Ç–æ–≥–æ –°–∏–±–∏—Ä—è–∫–æ–≤–∞ –≤–æ–∑–≥–ª–∞–≤–ª—è–ª–∞ –î–µ–ø–∞—Ä—Ç–∞–º–µ–Ω—Ç —Ñ–∏–Ω–∞–Ω—Å–æ–≤ –∞–¥–º–∏–Ω–∏—Å—Ç—Ä–∞—Ü–∏–∏ –í–æ–ª–æ–≥–¥—ã –∏ –∑–∞–Ω–∏–º–∞–ª–∞ –ø–æ—Å—Ç –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—è –º—ç—Ä–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-10-20T06:06:00+00:00,@bezrec,6708,https://t.me/bezrec/6708,"–ó–∞–∫—É–ø–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –æ—Ç –≥–µ–ø–∞—Ç–∏—Ç–∞ –° –º–æ–≥—É—Ç —Ü–µ–Ω—Ç—Ä–∞–ª–∏–∑–æ–≤–∞—Ç—å. –ù–∞ –§–µ–¥–µ—Ä–∞–ª—å–Ω–æ–º –ø–æ—Ä—Ç–∞–ª–µ –ø—Ä–æ–µ–∫—Ç–æ–≤ –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω—ã—Ö –ø—Ä–∞–≤–æ–≤—ã—Ö –∞–∫—Ç–æ–≤ –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω –ø—Ä–æ–µ–∫—Ç –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è, —Å–æ–≥–ª–∞—Å–Ω–æ –∫–æ—Ç–æ—Ä–æ–º—É –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –Ω–∞–º–µ—Ä–µ–Ω–æ —Ü–µ–Ω—Ç—Ä–∞–ª–∏–∑–æ–≤–∞—Ç—å –∑–∞–∫—É–ø–∫–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –æ—Ç –≥–µ–ø–∞—Ç–∏—Ç–∞ –° —Å 2026 –≥–æ–¥–∞, –∞ –∑–∞–∫—É–ø–∫–∏ –æ—Å—É—â–µ—Å—Ç–≤–ª—è—Ç—å —á–µ—Ä–µ–∑ –§–¶–ü–∏–õ–û –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–æ—Å—Å–∏–∏. –ú–µ—Ö–∞–Ω–∏–∑–º —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ —Å–æ—Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è –ª–µ—á–µ–Ω–∏—è –í–ì–° –≤ –∞–º–±—É–ª–∞—Ç–æ—Ä–Ω–æ–º —Å–µ–≥–º–µ–Ω—Ç–µ —É–∂–µ —Å—É—â–µ—Å—Ç–≤—É–µ—Ç ‚Äî –æ–Ω –±—ã–ª —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω —Ä–∞—Å–ø–æ—Ä—è–∂–µ–Ω–∏–µ–º –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ ‚Ññ615-—Ä –æ—Ç 15 –º–∞—Ä—Ç–∞ 2024 –≥–æ–¥–∞. –í —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–∏ —Å –Ω–∏–º, 88 —Å—É–±—ä–µ–∫—Ç–æ–≤ –†–§ –≤ 2024, 2025 –∏ 2026 –≥–æ–¥–∞—Ö –µ–∂–µ–≥–æ–¥–Ω–æ –ø–æ–ª—É—á–∞—é—Ç –∏–∑ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –±—é–¥–∂–µ—Ç–∞ –ø–æ 4,5 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –í —ç–∫—Å–ø–µ—Ä—Ç–Ω–æ–π –≥—Ä—É–ø–ø–µ ¬´–ó–¥—Ä–∞–≤—Ä–µ—Å—É—Ä—Å¬ª –ø—Ä–µ–¥–ø–æ–ª–æ–∂–∏–ª–∏, —á—Ç–æ —Ü–µ–Ω—Ç—Ä–∞–ª–∏–∑–æ–≤–∞–Ω–Ω—ã–µ –∑–∞–∫—É–ø–∫–∏ –±—É–¥—É—Ç –æ—Ä–∏–µ–Ω—Ç–∏—Ä–æ–≤–∞–Ω—ã –Ω–∞ –∞–º–±—É–ª–∞—Ç–æ—Ä–Ω—ã–π —Å–µ–≥–º–µ–Ω—Ç –∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –Ω–µ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–∏—Ö —Å—Ç—Ä–æ–≥–∏–º –∫—Ä–∏—Ç–µ—Ä–∏—è–º –ü—Ä–∏–∫–∞–∑–∞ ‚Ññ70-–Ω, –∞ —Ä–µ–≥—É–ª–∏—Ä—É–µ–º–æ–µ –¥–æ–∫—É–º–µ–Ω—Ç–æ–º –ª–µ—á–µ–Ω–∏–µ –ø–æ –û–ú–° –ø—Ä–æ–¥–æ–ª–∂–∏—Ç —Ñ–æ–∫—É—Å–∏—Ä–æ–≤–∞—Ç—å—Å—è –Ω–∞ –ø–∞—Ü–∏–µ–Ω—Ç–∞—Ö —Å –≤—ã—Ä–∞–∂–µ–Ω–Ω—ã–º —Ñ–∏–±—Ä–æ–∑–æ–º –≤ –∫—Ä—É–≥–ª–æ—Å—É—Ç–æ—á–Ω—ã—Ö –∏ –¥–Ω–µ–≤–Ω—ã—Ö —Å—Ç–∞—Ü–∏–æ–Ω–∞—Ä–∞—Ö. –¶–µ–Ω—Ç—Ä–∞–ª–∏–∑–∞—Ü–∏—è –∑–∞–∫—É–ø–æ–∫ ‚Äî –≤–∞–∂–Ω—ã–π —à–∞–≥, –∫–æ—Ç–æ—Ä—ã–π –ø–æ–º–æ–∂–µ—Ç –ø–æ–ª—É—á–∏—Ç—å –±–æ–ª–µ–µ –≤—ã–≥–æ–¥–Ω—ã–µ —Ü–µ–Ω—ã –∏ –ø–æ–≤—ã—Å–∏—Ç—å —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏—è —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –±—é–¥–∂–µ—Ç–∞, –∞ —Ç–∞–∫–∂–µ —Å–Ω–∏–∑–∏—Ç—å –æ–ø–µ—Ä–∞—Ü–∏–æ–Ω–Ω—É—é –Ω–∞–≥—Ä—É–∑–∫—É –Ω–∞ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã–µ —É—á—Ä–µ–∂–¥–µ–Ω–∏—è, —Ç.–∫. –§–¶–ü–∏–õ–û –≤–æ–∑—å–º–µ—Ç –Ω–∞ —Å–µ–±—è —Å–ª–æ–∂–Ω—ã–π –ø—Ä–æ—Ü–µ—Å—Å –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ —Ç–æ—Ä–≥–æ–≤, ‚Äî —Å—á–∏—Ç–∞—é—Ç –≤ ¬´–ó–¥—Ä–∞–≤—Ä–µ—Å—É—Ä—Å–µ¬ª. –û–¥–Ω–∞–∫–æ —É —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –≥—Ä—É–ø–ø—ã –∫ –ø—Ä–æ–µ–∫—Ç—É –µ—Å—Ç—å –≤–æ–ø—Ä–æ—Å—ã: üîΩ –†–∞–∑–≥—Ä–∞–Ω–∏—á–µ–Ω–∏–µ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –ö–∞–∫ –∏–º–µ–Ω–Ω–æ –±—É–¥—É—Ç —Ä–∞—Å–ø—Ä–µ–¥–µ–ª—è—Ç—å—Å—è –ø–∞—Ü–∏–µ–Ω—Ç—ã –º–µ–∂–¥—É —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã–º —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏–µ–º –∏ –û–ú–°? üîΩ –ù–µ—Ä–∞–≤–Ω–æ–º–µ—Ä–Ω–æ—Å—Ç—å –¥–æ—Å—Ç—É–ø–∞. –ù–µ –ø—Ä–∏–≤–µ–¥–µ—Ç –ª–∏ —ç—Ç–æ –∫ –ø–æ—è–≤–ª–µ–Ω–∏—é ¬´–¥–≤—É—Ö –æ—á–µ—Ä–µ–¥–µ–π¬ª –∏ —Ä–∞–∑–Ω—ã–º –∫—Ä–∏—Ç–µ—Ä–∏—è–º –¥–æ—Å—Ç—É–ø–∞ –∫ —Ç–µ—Ä–∞–ø–∏–∏, –≤—ã–∑—ã–≤–∞—è –ø—É—Ç–∞–Ω–∏—Ü—É? üîΩ –ü–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω–∏–µ –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç–∏. –†–µ–≥–∏–æ–Ω–∞–º –ø—Ä–∏–¥–µ—Ç—Å—è —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞—Ç—å –¥–≤–µ –æ—Ç–¥–µ–ª—å–Ω—ã–µ –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç–∏, —á—Ç–æ –º–æ–∂–µ—Ç –∑–∞—Ç—Ä—É–¥–Ω–∏—Ç—å —Ç–æ—á–Ω–æ–µ –ø–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω–∏–µ –∏ –ø—Ä–∏–≤–µ—Å—Ç–∏ –∫ –Ω–µ–¥–æ–∑–∞–∫—É–ø–∫–∞–º –∏–ª–∏ –∏–∑–ª–∏—à–∫–∞–º. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –ø–æ—Å–∫–æ–ª—å–∫—É —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã–π —Ä–µ–≥–∏—Å—Ç—Ä –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –í–ì–° –µ—â—ë —Å–æ–≤—Å–µ–º ¬´–º–æ–ª–æ–¥–æ–π¬ª, –≤–æ–∑–Ω–∏–∫–∞—é—Ç –≤–æ–ø—Ä–æ—Å—ã –∫ —Ç–æ—á–Ω–æ—Å—Ç–∏ –¥–∞–Ω–Ω—ã—Ö –∏ –∫–æ—Ä—Ä–µ–∫—Ç–Ω–æ—Å—Ç–∏ –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–∏—è –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ–≥–æ –æ–±—ä–µ–º–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤. –í ¬´–ó–¥—Ä–∞–≤—Ä–µ—Å—É—Ä—Å–µ¬ª —Ç–∞–∫–∂–µ –Ω–∞–ø–æ–º–Ω–∏–ª–∏, —á—Ç–æ, –Ω–µ—Å–º–æ—Ç—Ä—è –Ω–∞ —Ä–µ–∫–æ—Ä–¥–Ω—ã–µ 20,9 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –Ω–∞ –∑–∞–∫—É–ø–∫–∏ –≤ 2024 –≥–æ–¥—É, —Ü–µ–ª—å –ø–æ –æ—Ö–≤–∞—Ç—É 100 —Ç—ã—Å. –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –Ω–µ –±—ã–ª–∞ –¥–æ—Å—Ç–∏–≥–Ω—É—Ç–∞, –∞ –¥–ª—è —ç–ª–∏–º–∏–Ω–∞—Ü–∏–∏ –í–ì–° –∫ 2030 –≥–æ–¥—É —Ç—Ä–µ–±—É—é—Ç—Å—è 33,5-52 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –µ–∂–µ–≥–æ–¥–Ω–æ. –ï—Å—Ç—å –Ω–∞–¥–µ–∂–¥–∞, —á—Ç–æ —Ü–µ–Ω—Ç—Ä–∞–ª–∏–∑–∞—Ü–∏—è –∫–∞—Ä–¥–∏–Ω–∞–ª—å–Ω–æ –∏–∑–º–µ–Ω–∏—Ç —Ü–µ–Ω–æ–æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ –∏ –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏—é, —Å–Ω–∏–∑–∏—Ç –æ–±—â—É—é —Å—Ç–æ–∏–º–æ—Å—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –ø–æ–≤—ã—Å–∏—Ç —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π –ø–æ–ª–∏—Ç–∏–∫–∏, –Ω–æ —Ç–æ–ª—å–∫–æ –≤ —Å–ª—É—á–∞–µ —á–µ—Ç–∫–æ–π –∫–æ–æ—Ä–¥–∏–Ω–∞—Ü–∏–∏ –º–µ–∂–¥—É –≤—Å–µ–º–∏ –º–µ—Ö–∞–Ω–∏–∑–º–∞–º–∏ —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The procurement of hepatitis C drugs may centralize. A draft decree has been published on the Federal Portal of Normative Acts, stating that the government plans to centralize procurement of hepatitis C drugs starting from 2026, with purchases conducted through the Federal Center for Pharmaceutical Procurement and Supply (FCSPO) of the Ministry of Health. A federal financing mechanism for ambulatory care treatment of chronic hepatitis C already exists, established by Decree No. 615-r dated March 15, 2024. In 2024, 2025, and 2026, each of the 88 regions in Russia receives an annual budget allocation of 4.5 billion rubles from the federal budget. The expert group 'Zdravresource' suggests that centralized procurement will focus on ambulatory care and patients not meeting strict criteria in the Decree. Meanwhile, treatment under the Outpatient Care Program (–û–ú–°) will continue to focus on patients with severe fibrosis, as regulated by"
2025-10-19T10:05:04+00:00,@bezrec,6707,https://t.me/bezrec/6707,"–®—Ç—Ä–∞—Ñ –∏ –ª–∏—à–µ–Ω–∏–µ –ø—Ä–∞–≤: —É–ø—Ä–∞–≤–ª–µ–Ω–∏–µ –∞–≤—Ç–æ–º–æ–±–∏–ª–µ–º –ø–æ—Å–ª–µ –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø—Ä–∏—Ä–∞–≤–Ω—è—é—Ç –∫ –ø—å—è–Ω–æ–π –µ–∑–¥–µ. –ó–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç, –ø—Ä–∏—Ä–∞–≤–Ω–∏–≤–∞—é—â–∏–π —É–ø—Ä–∞–≤–ª–µ–Ω–∏–µ –∞–≤—Ç–æ–º–æ–±–∏–ª–µ–º –ø–æ—Å–ª–µ –ø—Ä–∏–µ–º–∞ —Ä—è–¥–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∫ —Ç–∞–∫–æ–≤–æ–º—É –≤ —Å–æ—Å—Ç–æ—è–Ω–∏–∏ –∞–ª–∫–æ–≥–æ–ª—å–Ω–æ–≥–æ –æ–ø—å—è–Ω–µ–Ω–∏—è, –±—ã–ª –ø—Ä–∏–Ω—è—Ç –≤ –ø–µ—Ä–≤–æ–º —á—Ç–µ–Ω–∏–∏ –≤ –º–∞–µ —ç—Ç–æ–≥–æ –≥–æ–¥–∞. –ò–∑–º–µ–Ω–µ–Ω–∏—è –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è –≤–Ω–µ—Å—Ç–∏ –≤ —Å—Ç–∞—Ç—å—é 27.12.1 –∏ –ø—Ä–∏–º–µ—á–∞–Ω–∏–µ –∫ —Å—Ç–∞—Ç—å–µ 12.8 –ö–æ–ê–ü –†–§. –ù–∞–∫–∞–∑–∞–Ω–∏–µ –∑–∞ –∏—Ö –Ω–∞—Ä—É—à–µ–Ω–∏–µ –ø–æ–ª–∞–≥–∞–µ—Ç—Å—è —Å—É—Ä–æ–≤–æ–µ ‚Äî —à—Ç—Ä–∞—Ñ –≤ —Ä–∞–∑–º–µ—Ä–µ 45 —Ç—ã—Å. —Ä—É–±–ª–µ–π —Å –ª–∏—à–µ–Ω–∏–µ–º –ø—Ä–∞–≤ –Ω–∞ —Å—Ä–æ–∫ –æ—Ç –ø–æ–ª—É—Ç–æ—Ä–∞ –¥–æ –¥–≤—É—Ö –ª–µ—Ç. –ü–µ—Ä–µ—á–µ–Ω—å –≤–µ—â–µ—Å—Ç–≤, –≤—Ö–æ–¥—è—â–∏—Ö –≤ —Å–æ—Å—Ç–∞–≤ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, —É—Ö—É–¥—à–∞—é—â–∏—Ö –≤–Ω–∏–º–∞–Ω–∏–µ –∏ —Ä–µ–∞–∫—Ü–∏—é, –æ–ø—Ä–µ–¥–µ–ª–∏—Ç –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§. –í –ø–µ—Ä–≤—É—é –æ—á–µ—Ä–µ–¥—å, —Å—é–¥–∞ –º–æ–≥—É—Ç –≤–æ–π—Ç–∏ –∏–º–µ–Ω–Ω–æ —Ç–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, –∫–æ—Ç–æ—Ä—ã–µ –∑–∞—Ç—Ä—É–¥–Ω—è—é—Ç –∫–æ–Ω—Ü–µ–Ω—Ç—Ä–∞—Ü–∏—é –≤–Ω–∏–º–∞–Ω–∏—è —á–µ–ª–æ–≤–µ–∫–∞. –ù–∞–ø—Ä–∏–º–µ—Ä, —Å–Ω–æ—Ç–≤–æ—Ä–Ω—ã–µ –∏ —Å–µ–¥–∞—Ç–∏–≤–Ω—ã–µ —Å—Ä–µ–¥—Å—Ç–≤–∞, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª –≥–ª–∞–≤–∞ –∫–æ–º–∏—Ç–µ—Ç–∞ –ì–æ—Å–¥—É–º—ã –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è –°–µ—Ä–≥–µ–π –õ–µ–æ–Ω–æ–≤. –î–µ–ø—É—Ç–∞—Ç —Ç–∞–∫–∂–µ –ø—Ä–µ–¥–ª–æ–∂–∏–ª –ø–æ–º–µ—á–∞—Ç—å –∑–∞–ø—Ä–µ—â—ë–Ω–Ω—ã–µ –¥–ª—è –≤–æ–¥–∏—Ç–µ–ª–µ–π –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –Ω–∞–¥–ø–∏—Å—å—é ¬´–ø—Ä–æ—Ç–∏–≤–æ–ø–æ–∫–∞–∑–∞–Ω–æ –ø—Ä–∏ –≤–æ–∂–¥–µ–Ω–∏–∏¬ª, ¬´—á—Ç–æ–±—ã —á–µ–ª–æ–≤–µ–∫ —Å—Ä–∞–∑—É –ø–æ–Ω—è–ª, —á—Ç–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç —É–∂–µ –µ—Å—Ç—å –≤ –ø–µ—Ä–µ—á–Ω–µ, –µ–≥–æ –Ω–µ —Å—Ç–æ–∏—Ç –ø—Ä–∏–Ω–∏–º–∞—Ç—å, –µ—Å–ª–∏ –Ω—É–∂–Ω–æ –µ—Ö–∞—Ç—å –∫—É–¥–∞-—Ç–æ –∑–∞ —Ä—É–ª–µ–º¬ª. –° –∞–Ω–∞–ª–æ–≥–∏—á–Ω–æ–π –∏–¥–µ–µ–π —É–∂–µ –≤—ã—Å—Ç—É–ø–∞–ª –∫–æ–ª–ª–µ–≥–∞ –õ–µ–æ–Ω–æ–≤–∞ –Ø—Ä–æ—Å–ª–∞–≤ –ù–∏–ª–æ–≤, –Ω–æ —Ç–æ–≥–¥–∞ —á–ª–µ–Ω—ã –∫–æ–º–∏—Ç–µ—Ç–∞ –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è —Å–æ—á–ª–∏ –µ—ë –∏–∑–ª–∏—à–Ω–µ–π –∏ –æ—Ç–∫–ª–æ–Ω–∏–ª–∏. –ö—Å—Ç–∞—Ç–∏, –æ–± –∏–∑–ª–∏—à–µ—Å—Ç–≤–∞—Ö. –ö–æ–Ω–∫—Ä–µ—Ç–Ω—ã–π —Å–ø–∏—Å–æ–∫ –∑–∞–ø—Ä–µ—â—ë–Ω–Ω—ã—Ö –∑–∞ —Ä—É–ª—ë–º –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤–æ–¥–∏—Ç–µ–ª–∏ –∂–¥—É—Ç –¥–∞–≤–Ω–æ. –ü–æ–∫–∞ —á—Ç–æ —Å–≤–æ–∏–º –≤–∞—Ä–∏–∞–Ω—Ç–æ–º ¬´–ø–æ—Ä–∞–¥–æ–≤–∞–ª¬ª —Ç–æ–ª—å–∫–æ –ù–∏–ª–æ–≤, –≤—ã–∫–∞—Ç–∏–≤—à–∏–π –ø–µ—Ä–µ—á–µ–Ω—å –∞–∂ –∏–∑ 281 –ø–æ–∑–∏—Ü–∏–∏, –Ω–∞—á–∏–Ω–∞—è –æ—Ç —Å–Ω–æ—Ç–≤–æ—Ä–Ω—ã—Ö, —Å–µ–¥–∞—Ç–∏–≤–Ω—ã—Ö –∏ –ø—Ä–æ—Ç–∏–≤–æ—ç–ø–∏–ª–µ–ø—Ç–∏—á–µ—Å–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –∑–∞–∫–∞–Ω—á–∏–≤–∞—è –ø–∞—Ä–∞—Ü–µ—Ç–∞–º–æ–ª–æ–º, —Å—É–ø—Ä–∞—Å—Ç–∏–Ω–æ–º –∏ –¥–∞–∂–µ –±–∞–ª—å–∑–∞–º–æ–º –ó–≤—ë–∑–¥–æ—á–∫–∞. –ú–∏–Ω–∑–¥—Ä–∞–≤, –ø—Ä–∞–≤–¥–∞, —Å–≤–æ—é –ø—Ä–∏—á–∞—Å—Ç–Ω–æ—Å—Ç—å –∫ –Ω–µ–º—É –æ–ø—Ä–æ–≤–µ—Ä–≥. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, regulation"",
  ""impact"": ""high"",
  ""english"": ""A law project has been approved in the first reading that equates driving after taking certain medications to drunk driving. The changes are proposed for Article 27.12.1 and Note 12.8 of the Criminal Code of Russia (KoA). The punishment for such violations is severe - a fine of 450,000 rubles and revocation of driving license for up to two years. The list of drugs that impair attention and reaction will be determined by the Russian government. The head of the Duma Committee on Health, Sergey Leontov, suggested marking prohibited drugs for drivers with a warning 'contraindicated while driving' to make people understand that the drug is on the prohibited list and should not be taken if they need to drive. Previously, Yaroslav Niloov proposed a similar list of 281 items starting from sedatives and hypnotics to paracetamol, suprastin, and even Zvezdochka balm. The Ministry of Health denied its involvement in this list.""
}"
2025-10-18T10:59:54+00:00,@bezrec,6706,https://t.me/bezrec/6706,"–í—Å—Ç—Ä–µ—á–∞–µ–º –æ—á–µ—Ä–µ–¥–Ω–æ–π —Å—É–±–±–æ—Ç–Ω–∏–π –≤—ã–ø—É—Å–∫ —Ä—É–±—Ä–∏–∫–∏ #–≤–¥–æ–≥–æ–Ω–∫—É. üíä –†–æ—Å—Å–∏–π—Å–∫–∞—è –≤–∞–∫—Ü–∏–Ω–∞ –æ—Ç —Ä–æ—Ç–∞–≤–∏—Ä—É—Å–∞ –º–æ–∂–µ—Ç –ø–æ–ª—É—á–∏—Ç—å —Ä–µ–≥—É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏–µ —É–∂–µ –≤ —Å–ª–µ–¥—É—é—â–µ–º –≥–æ–¥—É. –°–µ–π—á–∞—Å –ì–∞–º-VLP-—Ä–æ—Ç–∞ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –¶–µ–Ω—Ç—Ä–∞ –∏–º. –ì–∞–º–∞–ª–µ–∏ –¥–ª—è –¥–µ—Ç–µ–π –æ—Ç 8 –¥–æ 32 –Ω–µ–¥–µ–ª—å –Ω–∞—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ II-III —Ñ–∞–∑–µ –ö–ò. –ò—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –¥–ª—è –¥–µ—Ç–µ–π —Å—Ç–∞—Ä—à–µ–≥–æ –≤–æ–∑—Ä–∞—Å—Ç–∞ —É–∂–µ –∑–∞–≤–µ—Ä—à–µ–Ω—ã. üíä –ü—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ —É–Ω–∏–∫–∞–ª—å–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ —Ä–∞—Å—Ö–≤–∞—Ç—ã–≤–∞—é—Ç –ø–ª–æ—â–∞–¥–∏ –≤ –ò–ù–¢–¶ ¬´–†—É—Å—Å–∫–∏–π¬ª. 16 —Ä–µ–∑–∏–¥–µ–Ω—Ç–æ–≤ —É–∂–µ –≤—Å–µ –ø–ª–æ—â–∞–¥–∏ —Ä–∞–∑–æ–±—Ä–∞–ª–∏, –±–ª–∞–≥–æ–¥–∞—Ä—è —Ç–æ–º—É, —á—Ç–æ –Ω–æ–≤—ã–µ —Ä–µ–∑–∏–¥–µ–Ω—Ç—ã –¥–∞–∂–µ –ø–æ–¥–≤–∞–ª—å–Ω–æ–µ –ø–æ–º–µ—â–µ–Ω–∏–µ —Å–µ–π—á–∞—Å –≤—ã–±–∏—Ä–∞—é—Ç. –¢–∞–º —Ä–∞–±–æ—Ç–∞—é—Ç —Ä–µ–∞–ª—å–Ω—ã–µ –∫–æ–º–ø–∞–Ω–∏–∏, –∫–æ—Ç–æ—Ä—ã–µ –≤–ø–µ—Ä–≤—ã–µ –≤ –†–æ—Å—Å–∏–∏ —Å–æ–∑–¥–∞—é—Ç –Ω–æ–≤—ã–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏, –Ω–æ–≤—ã–µ —Ñ–∞—Ä–º–ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, –≤ —Ç–æ–º —á–∏—Å–ª–µ, –∫–æ—Ç–æ—Ä—ã–µ –Ω–∏–∫–æ–≥–¥–∞ –≤ –†–æ—Å—Å–∏–∏ –Ω–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏–ª–∏—Å—å, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª –≥–ª–∞–≤–∞ –ú–∏–Ω–≤–æ—Å—Ç–æ–∫—Ä–∞–∑–≤–∏—Ç–∏—è –ê–ª–µ–∫—Å–µ–π –ß–µ–∫—É–Ω–∫–æ–≤. üíä –í –¶–µ–Ω—Ç—Ä–µ –¢—É—Ä–Ω–µ—Ä–∞ –∏—Å–ø—ã—Ç—ã–≤–∞—é—Ç –ø–µ—Ä–≤—ã–π —Ä–æ—Å—Å–∏–π—Å–∫–∏–π —Ä–∞—Å—Ç–≤–æ—Ä –¥–ª—è —Å–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –¥–æ–Ω–æ—Ä—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–æ–≤. –ú–∏–∫—Ä–æ—Ö–∏—Ä—É—Ä–≥–∏ –∏ –Ω–∞—É—á–Ω—ã–µ —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–∏ —Å–µ–π—á–∞—Å –ø—Ä–æ–≤–æ–¥—è—Ç —Å–µ—Ä–∏—é —É–Ω–∏–∫–∞–ª—å–Ω—ã—Ö –æ–ø–µ—Ä–∞—Ü–∏–π –ø–æ –ø–µ—Ä–µ—Å–∞–¥–∫–µ –ø–æ—á–µ–∫ –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–Ω—ã–º –∫—Ä—ã—Å–∞–º, —á—Ç–æ–±—ã –¥–æ–∫–∞–∑–∞—Ç—å —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –∏ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–π —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏, –∫–æ—Ç–æ—Ä–∞—è –≤ –±—É–¥—É—â–µ–º —Å–º–æ–∂–µ—Ç –ø–æ–ª–Ω–æ—Å—Ç—å—é –∑–∞–º–µ–Ω–∏—Ç—å –∏–º–ø–æ—Ä—Ç–Ω—ã–µ –∞–Ω–∞–ª–æ–≥–∏. –í –ø—Ä–æ–µ–∫—Ç–µ —Ç–∞–∫–∂–µ —É—á–∞—Å—Ç–≤—É–µ—Ç ¬´–ü–æ–ª–∏—Å–∞–Ω¬ª, –±–æ–ª—å–Ω–∏—Ü–∞ –°–≤—è—Ç–∏—Ç–µ–ª—è –õ—É–∫–∏ –∏ –ù–ò–ò –≥—Ä–∏–ø–ø–∞ –∏–º. –ê.–ê. –°–º–æ—Ä–æ–¥–∏–Ω—Ü–µ–≤–∞. üíä ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª –∑–∞–≤–µ—Ä—à–∏–ª–∞ –ø–µ—Ä–≤–æ–µ –∫–ª–∏–Ω–∏–∫–æ-–ª–∞–±–æ—Ä–∞—Ç–æ—Ä–Ω–æ–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —Ä–∏–≤–∞—Ä–æ–∫—Å–∞–±–∞–Ω–∞. –û—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π –¥–∂–µ–Ω–µ—Ä–∏–∫ —Å—Ä–∞–≤–Ω–∏–≤–∞–ª–∏ —Å –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã–º –ö—Å–∞—Ä–µ–ª—Ç–æ —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –ò–ë–°. –ö—Ä—É–æ–∫—Å–∞–±–∞–Ω –ø–æ–∫–∞–∑–∞–ª —Å–æ–ø–æ—Å—Ç–∞–≤–∏–º—É—é —Å –æ—Ä–∏–≥–∏–Ω–∞–ª–æ–º —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –∏ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å. üíä –í –Ø–ø–æ–Ω–∏–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª–∏ ¬´–¥–æ–ª–≥–æ–∏–≥—Ä–∞—é—â–∏–π¬ª –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç. –£—á–µ–Ω—ã–µ –∏–∑ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–æ–≤ –û—Å–∞–∫–∏, –¢–æ—è–º—ã, –•–∏—Ä–æ—Å–∏–º—ã –∏ –ö–∞–≥–æ—Å–∏–º—ã —Å–æ–∑–¥–∞–ª–∏ –Ω–æ–≤–æ–µ –≤–µ—â–µ—Å—Ç–≤–æ PA-915, —É—Å—Ç—Ä–∞–Ω—è—é—â–µ–µ —Ç—Ä–µ–≤–æ–∂–Ω–æ—Å—Ç—å, –¥–µ–ø—Ä–µ—Å—Å–∏—é –∏ –ø—Ä–∏–∑–Ω–∞–∫–∏ –∫–æ–≥–Ω–∏—Ç–∏–≤–Ω—ã—Ö –Ω–∞—Ä—É—à–µ–Ω–∏–π. –ü—Ä–µ–ø–∞—Ä–∞—Ç –ø–æ–∫–∞–∑–∞–ª —Ö–æ—Ä–æ—à–∏–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –≤ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è—Ö –Ω–∞ –∂–∏–≤–æ—Ç–Ω—ã—Ö. –ü—Ä–∏—è—Ç–Ω—ã–π –±–æ–Ω—É—Å ‚Äî —ç—Ñ—Ñ–µ–∫—Ç —Å–æ—Ö—Ä–∞–Ω—è–ª—Å—è –¥–æ 8 –Ω–µ–¥–µ–ª—å. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-10-17T15:02:05+00:00,@bezrec,6700,https://t.me/bezrec/6700,"–°—Ç—É–¥–µ–Ω—Ç—ã –ø—Ä–æ—è–≤–∏–ª–∏ —Å–µ–±—è –Ω–∞ –≤—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–æ–º —Ñ–µ—Å—Ç–∏–≤–∞–ª–µ ¬´–§–∞—Ä–º–∞ ‚Äî —ç—Ç–æ –ª—é–±–æ–≤—å¬ª. –í –ú–æ—Ä–¥–æ–≤—Å–∫–æ–º –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–º —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–µ (–ú–ì–£) –∏–º. –û–≥–∞—Ä–µ–≤–∞ –ø–æ–¥–æ—à–µ–ª –∫ –∫–æ–Ω—Ü—É —Ñ–æ—Ä—É–º –Ω–∞—É–∫–∏ –∏ —Ç–≤–æ—Ä—á–µ—Å—Ç–≤–∞ —Å —É—á–∞—Å—Ç–∏–µ–º –∫–æ–º–∞–Ω–¥ –∏–∑ –≤–æ—Å—å–º–∏ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –≤—É–∑–æ–≤. –§–µ—Å—Ç–∏–≤–∞–ª—å –ø—Ä–æ—Ö–æ–¥–∏—Ç –ø—Ä–∏ –ø–æ–¥–¥–µ—Ä–∂–∫–µ –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª –∏ –≤ —ç—Ç–æ–º –≥–æ–¥—É –≤–ø–µ—Ä–≤—ã–µ —Å–æ—Å—Ç–æ—è–ª—Å—è –Ω–∞ –≤—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–æ–º —É—Ä–æ–≤–Ω–µ. –ö–æ–Ω–∫—É—Ä—Å —Å—Ç—É–¥–µ–Ω—á–µ—Å–∫–∏—Ö —Ä–∞–±–æ—Ç —Å—Ç–∞–ª –∫–ª—é—á–µ–≤—ã–º —Å–æ–±—ã—Ç–∏–µ–º —Ñ–µ—Å—Ç–∏–≤–∞–ª—è –∏ –æ—Å–Ω–æ–≤–Ω–æ–π –ø–ª–æ—â–∞–¥–∫–æ–π –¥–ª—è –ø—Ä–æ–≤–µ—Ä–∫–∏ –∑–Ω–∞–Ω–∏–π –∏ –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏—Ö –Ω–∞–≤—ã–∫–æ–≤ —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –ø–æ–¥ —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–æ–º —ç–∫—Å–ø–µ—Ä—Ç–æ–≤ –≥—Ä—É–ø–ø—ã ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª –∏ –ú–ì–£ –∏–º. –û–≥–∞—Ä–µ–≤–∞. –í—Ç–æ—Ä–æ–π –¥–µ–Ω—å —Ñ–æ—Ä—É–º–∞ –∑–∞–≤–µ—Ä—à–∏–ª—Å—è –∑–∞—â–∏—Ç–æ–π –ø—Ä–æ–µ–∫—Ç–æ–≤ –ø–µ—Ä–µ–¥ –∂—é—Ä–∏, —Å–æ—Å—Ç–∞–≤ –∫–æ—Ç–æ—Ä–æ–≥–æ –±—ã–ª —Å—Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω –∏–∑ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —ç–∫—Å–ø–µ—Ä—Ç–æ–≤ ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª –∏ –í–ª–∞–¥–∏–º–∏—Ä–∞ –ü–æ—Ä–æ–π–∫–æ–≤–∞, –∞–∫–∞–¥–µ–º–∏–∫–∞ –†–ê–ù, –ø—Ä–æ—Ñ–µ—Å—Å–æ—Ä–∞, –¥–æ–∫—Ç–æ—Ä–∞ –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –Ω–∞—É–∫, –∫–∞–Ω–¥–∏–¥–∞—Ç–∞ —Ñ–∏–∑–∏–∫–æ-–º–∞—Ç–µ–º–∞—Ç–∏—á–µ—Å–∫–∏—Ö –Ω–∞—É–∫. –°–∞–º—ã–µ –¥–æ—Å—Ç–æ–π–Ω—ã–µ –ø–æ–ª—É—á–∏–ª–∏ –¥–µ–Ω–µ–∂–Ω—ã–π –ø—Ä–∏–∑ –∏ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å —Å—Ç–∞–∂–∏—Ä–æ–≤–∫–∏, –∞ –≤ –¥–∞–ª—å–Ω–µ–π—à–µ–º –∏ —Ç—Ä—É–¥–æ—É—Å—Ç—Ä–æ–π—Å—Ç–≤–∞ –Ω–∞ —Ñ–∞—Ä–º–ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏–∏. –ü—ë—Ç—Ä –ë–µ–ª—ã–π, –û—Å–Ω–æ–≤–∞—Ç–µ–ª—å –∏ –ü—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—å –°–æ–≤–µ—Ç–∞ –¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–≤ –ü–ê–û ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª: –°–µ–≥–æ–¥–Ω—è —Ü–∞—Ä–∏—Ç –ø–æ—Ç—Ä—è—Å–∞—é—â–∞—è –∞—Ç–º–æ—Å—Ñ–µ—Ä–∞, –∫–æ—Ç–æ—Ä–∞—è –∑–∞—Å—Ç–∞–≤–ª—è–µ—Ç –∑–∞–¥—É–º–∞—Ç—å—Å—è: –≤ —ç–ø–æ—Ö—É –≤—Å–µ–æ–±—â–µ–≥–æ —É–≤–ª–µ—á–µ–Ω–∏—è –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω—ã–º –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–æ–º –º—ã –Ω–µ –¥–æ–ª–∂–Ω—ã –∑–∞–±—ã–≤–∞—Ç—å –æ –Ω–∞—à–µ–º —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ–º. –¢–∞–∫–æ–π –¥–µ–Ω—å, –∫–∞–∫ —Å–µ–≥–æ–¥–Ω—è, –¥–æ–∫–∞–∑—ã–≤–∞–µ—Ç –æ–±—Ä–∞—Ç–Ω–æ–µ: —ç—Ç–æ –≤—Ä–µ–º—è –∂–∏–≤–æ–≥–æ —á–µ–ª–æ–≤–µ—á–µ—Å–∫–æ–≥–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–∞, –≥–æ—Ä—è—â–∏—Ö –≥–ª–∞–∑ –∏ –Ω–∞—Å—Ç–æ—è—â–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π. –ü—Ä–æ–µ–∫—Ç—ã, –∫–æ—Ç–æ—Ä—ã–µ –º—ã –≤–∏–¥–∏–º, ‚Äî —ç—Ç–æ —É–∂–µ –Ω–µ —Å—Ç—É–¥–µ–Ω—á–µ—Å–∫–∏–µ —Ä–∞–±–æ—Ç—ã, –∞ –ø–æ–ª–Ω–æ—Ü–µ–Ω–Ω—ã–µ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—ã–µ —Ä–µ—à–µ–Ω–∏—è. –ò –Ω–∞—à–∞ —Å–ª–µ–¥—É—é—â–∞—è –º–∞—Å—à—Ç–∞–±–Ω–∞—è —Ü–µ–ª—å ‚Äî –Ω–µ —Ç–æ–ª—å–∫–æ —Å–æ–∑–¥–∞–≤–∞—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–∞, –Ω–æ –∏ –∂–∏—Ç—å –∏–Ω—Ç–µ—Ä–µ—Å–Ω–æ. –ò–º–µ–Ω–Ω–æ —ç—Ç–æ –∏ –ø—Ä–æ–∏—Å—Ö–æ–¥–∏—Ç –∑–¥–µ—Å—å, –∏ —è —Å—á–∞—Å—Ç–ª–∏–≤ –±—ã—Ç—å —á–∞—Å—Ç—å—é —ç—Ç–æ–≥–æ. ¬´–§–∞—Ä–º–∞ ‚Äî —ç—Ç–æ –ª—é–±–æ–≤—å¬ª ‚Äî —ç—Ç–æ —Å—á–∞—Å—Ç—å–µ. –ü–æ—Ç–æ–º—É —á—Ç–æ –º–µ–¥–∏—Ü–∏–Ω–∞ ‚Äî —ç—Ç–æ —Å—á–∞—Å—Ç—å–µ. –í –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–∏ –ø—Ä–∏–Ω—è–ª–∏ —É—á–∞—Å—Ç–∏–µ —Å—Ç—É–¥–µ–Ω—á–µ—Å–∫–∏–µ –∫–æ–º–∞–Ω–¥—ã –∏–∑ –≤–æ—Å—å–º–∏ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –≤—É–∑–æ–≤: –°–∞–º–ì–¢–£, –†–£–î–ù, –ò–≤–ì–£, –°–û–ì–£, –ù–ù–ì–£, –ù–ì–¢–£, –†–æ—Å–£–Ω–∏–ú–µ–¥ –∏ –ú–ì–£ –∏–º. –ù. –ü. –û–≥–∞—Ä–µ–≤–∞. –ú–æ–ª–æ–¥—ã–µ —É—á–µ–Ω—ã–µ –ø—Ä–æ–¥–µ–º–æ–Ω—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª–∏ –±–ª–µ—Å—Ç—è—â–∏–µ –∑–Ω–∞–Ω–∏—è –∏ —Ç–≤–æ—Ä—á–µ—Å–∫–∏–π –ø–æ–¥—Ö–æ–¥ ‚Äî –¥–æ—Å—Ç–æ–π–Ω–æ–µ –∑–∞–≤–µ—Ä—à–µ–Ω–∏–µ –Ω–µ–¥–µ–ª–∏ –∏ –ø—Ä–∏—è—Ç–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ –≤ –ø—è—Ç–Ω–∏—Ü—É. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-10-17T12:00:01+00:00,@bezrec,6699,https://t.me/bezrec/6699,"–ü–æ—Ä–∞ –ø–æ–¥–≤–µ—Å—Ç–∏ –∏—Ç–æ–≥–∏ –æ—á–µ—Ä–µ–¥–Ω–æ–≥–æ –≤—ã–ø—É—Å–∫–∞ —Ä—É–±—Ä–∏–∫–∏ #–∑–∞–ø–∞–∫–æ–≤–∞–ª–∏. –ù–∞ —ç—Ç–æ—Ç —Ä–∞–∑ –º—ã –≤—Å–µ –≤–º–µ—Å—Ç–µ –≤—ã–±–∏—Ä–∞–ª–∏, –∫–æ–º—É –∏–∑ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ª—É—á—à–µ —É–¥–∞–ª—Å—è –¥–∏–∑–∞–π–Ω —Å–ø—Ä–µ–µ–≤ –æ—Ç –Ω–∞—Å–º–æ—Ä–∫–∞ –Ω–∞ –æ—Å–Ω–æ–≤–µ –∫—Å–∏–ª–æ–º–µ—Ç–∞–∑–æ–ª–∏–Ω–∞. –ü–æ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º –≥–æ–ª–æ—Å–æ–≤–∞–Ω–∏—è, –ø–æ–±–µ–¥–∏—Ç–µ–ª–µ–º —Å—Ç–∞–ª –ö—Å–∏–ª–æ–º–µ—Ç–∞–∑–æ–ª–∏–Ω –æ—Ç ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∏¬ª, –≤ –æ—á–µ—Ä–µ–¥–Ω–æ–π —Ä–∞–∑ –¥–æ–∫–∞–∑–∞–≤—à–∏–π, —á—Ç–æ –∂–∏–≤–æ—Ç–Ω—ã–µ –Ω–∞ —É–ø–∞–∫–æ–≤–∫–∞—Ö ‚Äî –±–µ—Å–ø—Ä–æ–∏–≥—Ä—ã—à–Ω—ã–π –≤–∞—Ä–∏–∞–Ω—Ç, –∫–æ—Ç–æ—Ä—ã–π ¬´—Ü–µ–ø–ª—è–µ—Ç¬ª –≤–∑–≥–ª—è–¥ –∏ –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –ø–æ –¥—É—à–µ –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª—è–º. –ù–∞ –≤—Ç–æ—Ä–æ–º –∏ —Ç—Ä–µ—Ç—å–µ–º –º–µ—Å—Ç–µ —Å —Ä–∞–∑–Ω–∏—Ü–µ–π –≤—Å–µ–≥–æ –≤ –ø–∞—Ä—É –ø—Ä–æ—Ü–µ–Ω—Ç–æ–≤ –∏–Ω–æ—Å—Ç—Ä–∞–Ω—Ü—ã ‚Äî –û—Ç—Ä–∏–≤–∏–Ω –æ—Ç ¬´–•–µ–ª–µ–æ–Ω¬ª –∏ –¢–∏–∑–∏–Ω –æ—Ç ¬´–î–µ–ª—å—Ñ–∞—Ä–º –û—Ä–ª–µ–∞–Ω¬ª. –ú–µ–Ω—å—à–µ –≤—Å–µ–≥–æ –≥–æ–ª–æ—Å–æ–≤–∞–≤—à–∏–º –ø–æ–Ω—Ä–∞–≤–∏–ª–∏—Å—å –ö—Å–∏–ª–µ–Ω –æ—Ç ¬´–í–µ—Ä–æ—Ñ–∞—Ä–º¬ª –∏ –ö—Å–∏–ª–æ–Ω–≥ –æ—Ç ¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç–∞¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-10-17T09:00:01+00:00,@bezrec,6698,https://t.me/bezrec/6698,"–ö–∞–∫ —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏ –≤ –ø—Ä–µ—Å—Å-—Å–ª—É–∂–±–µ –º—ç—Ä–∞ –ú–æ—Å–∫–≤—ã, —Å—Ä–µ–¥—Å—Ç–≤–∞ –ø–æ–π–¥—É—Ç –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞, –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –∏–∑–¥–µ–ª–∏—è –∏ —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω–æ–µ –ª–µ—á–µ–±–Ω–æ–µ –ø–∏—Ç–∞–Ω–∏–µ –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ –∏ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –¥–∏–∞–±–µ—Ç–∞, –±—Ä–æ–Ω—Ö–∏–∞–ª—å–Ω–æ–π –∞—Å—Ç–º—ã, –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö, —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö –∏ –¥—Ä—É–≥–∏—Ö —É–≥—Ä–æ–∂–∞—é—â–∏—Ö –∂–∏–∑–Ω–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –ï—â—ë –ø–æ—Ä—è–¥–∫–∞ 42 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –±—É–¥–µ—Ç –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–æ –Ω–∞ –æ–∫–∞–∑–∞–Ω–∏–µ –≤—ã—Å–æ–∫–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏, –≤–∫–ª—é—á–∞—è —Ç–∞–∫–∏–µ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è, –∫–∞–∫ —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç–∞—è —Ö–∏—Ä—É—Ä–≥–∏—è, –æ–Ω–∫–æ–ª–æ–≥–∏—è, —Ç—Ä–∞–≤–º–∞—Ç–æ–ª–æ–≥–∏—è –∏ –æ—Ä—Ç–æ–ø–µ–¥–∏—è, –Ω–µ–π—Ä–æ—Ö–∏—Ä—É—Ä–≥–∏—è, —É—Ä–æ–ª–æ–≥–∏—è, —ç–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–∏—è. –í—Å–µ–≥–æ –Ω–∞ –≥–æ—Ä–æ–¥—Å–∫—É—é –ø—Ä–æ–≥—Ä–∞–º–º—É ¬´–°—Ç–æ–ª–∏—á–Ω–æ–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ¬ª –≤ 2026 –≥–æ–¥—É –≤—ã–¥–µ–ª—è—Ç 615 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π (–±–µ–∑ —É—á–µ—Ç–∞ —Å—Ä–µ–¥—Å—Ç–≤ –û–ú–°). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-10-17T06:01:11+00:00,@bezrec,6697,https://t.me/bezrec/6697,"–û–±—â–µ—Å—Ç–≤–µ–Ω–Ω–∏–∫–∏ –ø—Ä–æ—Å—è—Ç –ø–µ—Ä–µ—Å–º–æ—Ç—Ä–µ—Ç—å ¬´—Å—É—Ä—Ä–æ–≥–∞—Ç–Ω—ã–µ¬ª –∫—Ä–∏—Ç–µ—Ä–∏–∏ –ø–æ–º–æ—â–∏ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã–º –æ—Ä—Ñ–∞–Ω–Ω–∏–∫–∞–º. –ë–ª–∞–≥–æ—Ç–≤–æ—Ä–∏—Ç–µ–ª—å–Ω—ã–π —Ñ–æ–Ω–¥ ¬´–ü–æ–¥—Å–æ–ª–Ω—É—Ö¬ª –∏ –í—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–∏–π —Å–æ—é–∑ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –Ω–∞–ø—Ä–∞–≤–∏–ª–∏ –≤ –ú–∏–Ω–∑–¥—Ä–∞–≤ —Å–≤–æ–∏ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è –ø–æ –∫–æ—Ä—Ä–µ–∫—Ç–∏—Ä–æ–≤–∫–µ –º–µ—Ö–∞–Ω–∏–∑–º–∞, –ø—Ä–µ–¥—É—Å–º–∞—Ç—Ä–∏–≤–∞—é—â–µ–≥–æ –≤—ã–¥–µ–ª–µ–Ω–∏–µ –ø–æ–º–æ—â–∏ –∏–∑ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –±—é–¥–∂–µ—Ç–∞, –∫–æ–≥–¥–∞ —Å—É–±—ä–µ–∫—Ç—ã –Ω–µ —Å–ø—Ä–∞–≤–ª—è—é—Ç—Å—è —Å –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ–º ¬´—Ä–µ–¥–∫–∏—Ö¬ª –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å–≤–æ–∏–º–∏ —Å–∏–ª–∞–º–∏. –ù–∞–ø–æ–º–Ω–∏–º, —á—Ç–æ–±—ã –ø—Ä–µ—Ç–µ–Ω–¥–æ–≤–∞—Ç—å –Ω–∞ –ø–æ–¥–¥–µ—Ä–∂–∫—É, —Ä–µ–≥–∏–æ–Ω –¥–æ–ª–∂–µ–Ω —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–æ–≤–∞—Ç—å —á–µ—Ç—ã—Ä—ë–º –∫—Ä–∏—Ç–µ—Ä–∏—è–º: üîò—É—Ä–æ–≤–µ–Ω—å —Ä–∞—Å—á–µ—Ç–Ω–æ–π –±—é–¥–∂–µ—Ç–Ω–æ–π –æ–±–µ—Å–ø–µ—á–µ–Ω–Ω–æ—Å—Ç–∏ —Ä–µ–≥–∏–æ–Ω–∞ –¥–æ –≤—ã—Ä–∞–≤–Ω–∏–≤–∞–Ω–∏—è –Ω–µ –¥–æ–ª–∂–µ–Ω –ø—Ä–µ–≤—ã—à–∞—Ç—å 0,65; üîò–Ω–∞ –æ—Ä—Ñ–∞–Ω–Ω—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –≤ –±—é–¥–∂–µ—Ç–µ –∑–∞–ª–æ–∂–µ–Ω–æ –Ω–∞ 10% –±–æ–ª—å—à–µ, —á–µ–º –≥–æ–¥–æ–º —Ä–∞–Ω–µ–µ; üîò—Å—Ç–æ–∏–º–æ—Å—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –ø—Ä–æ—à–ª—ã–º –≥–æ–¥–æ–º –≤—ã—Ä–æ—Å–ª–∞ –∫–∞–∫ –º–∏–Ω–∏–º—É–º –Ω–∞ 20%; üîò–æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –≤ —Ä–µ–≥–∏–æ–Ω–µ —Å—Ç–∞–ª–æ –Ω–µ –º–µ–Ω–µ–µ, —á–µ–º –Ω–∞ 15% –±–æ–ª—å—à–µ. –° —á–µ–º –Ω–µ —Å–æ–≥–ª–∞—Å–Ω—ã –ø–∞—Ü–∏–µ–Ω—Ç—Å–∫–∏–µ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏. üü¢ –§–æ–Ω–¥ ¬´–ü–æ–¥—Å–æ–ª–Ω—É—Ö¬ª –≤–æ–∑—Ä–∞–∂–∞–µ—Ç –ø—Ä–æ—Ç–∏–≤ –ø–µ—Ä–≤–æ–≥–æ –ø—É–Ω–∫—Ç–∞. –ü–æ –¥–∞–Ω–Ω—ã–º –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–∏–∫–æ–≤, –ø–æ –∏—Ç–æ–≥–∞–º 2024 –≥–æ–¥–∞ —ç—Ç–æ–º—É –∫—Ä–∏—Ç–µ—Ä–∏—é —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–æ–≤–∞–ª —Ç–æ–ª—å–∫–æ 31 –∏–∑ 89 —Ä–µ–≥–∏–æ–Ω–æ–≤. –ü—Ä–∏—á—ë–º –∑–∞ –ø–æ–º–æ—â—å—é –≤ —Ñ–æ–Ω–¥ –≤ 4,5 —Ä–∞–∑–∞ —á–∞—â–µ –æ–±—Ä–∞—â–∞–ª–∏—Å—å –∫–∞–∫ —Ä–∞–∑ –∏–∑ —ç—Ç–∏—Ö ¬´–Ω–µ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–∏—Ö¬ª —Ä–µ–≥–∏–æ–Ω–æ–≤ (2,2 —Ç—ã—Å. –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤). üü¢ –¢–∞–∫–∂–µ —Ñ–æ–Ω–¥ —Å—Ç–∞–≤–∏—Ç –ø–æ–¥ –≤–æ–ø—Ä–æ—Å –∫—Ä–∏—Ç–µ—Ä–∏–π —É–≤–µ–ª–∏—á–µ–Ω–∏—è —Å—Ç–æ–∏–º–æ—Å—Ç–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –Ω–∞ 20%, —Ç.–∫. –ø–æ–¥–æ—Ä–æ–∂–∞–Ω–∏–µ –æ–¥–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ¬´–Ω–µ –æ—Ç—Ä–∞–∂–∞–µ—Ç –µ–≥–æ –¥–æ–ª—é –≤ –æ–±—â–∏—Ö —Ä–∞—Å—Ö–æ–¥–∞—Ö –±—é–¥–∂–µ—Ç–∞ –∏ –Ω–∏–≤–µ–ª–∏—Ä—É–µ—Ç—Å—è –≤–æ–∑–º–æ–∂–Ω—ã–º —Å–Ω–∏–∂–µ–Ω–∏–µ–º —Ü–µ–Ω –Ω–∞ –¥—Ä—É–≥–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞¬ª. üü¢ –ü—É–Ω–∫—Ç –æ–± —É–≤–µ–ª–∏—á–µ–Ω–∏–∏ —á–∏—Å–ª–∞ –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –∞–≤—Ç–æ—Ä—ã –æ–±—Ä–∞—â–µ–Ω–∏—è —Ç–∞–∫–∂–µ —Å—á–∏—Ç–∞—é—Ç –Ω–µ —Å–ª–∏—à–∫–æ–º –æ–±—ä–µ–∫—Ç–∏–≤–Ω—ã–º, —Ç.–∫. —Ä–µ–≥–∏–æ–Ω–∞–º –Ω–µ —Ö–≤–∞—Ç–∞–µ—Ç –¥–µ–Ω–µ–≥ –Ω–∞ —É–∂–µ –∏–º–µ—é—â–∏—Ö—Å—è –æ—Ä—Ñ–∞–Ω–Ω–∏–∫–æ–≤, –±–µ–∑ —É–≤–µ–ª–∏—á–µ–Ω–∏—è –∏—Ö –∫–æ–ª–∏—á–µ—Å—Ç–≤–∞. –° –ø–æ–∑–∏—Ü–∏–µ–π –∫–æ–ª–ª–µ–≥ —Å–æ–≥–ª–∞—Å–µ–Ω –∏ –í–°–ü. –ü–µ—Ä–µ—á–∏—Å–ª–µ–Ω–Ω—ã–µ –∫—Ä–∏—Ç–µ—Ä–∏–∏ —Ç–∞–º –Ω–∞–∑–≤–∞–ª–∏ ¬´—Å—É—Ä—Ä–æ–≥–∞—Ç–Ω—ã–º–∏¬ª –∏ –æ—Ç—Ä–∞–∂–∞—é—â–∏–º–∏ —Ä–µ–∞–ª—å–Ω—ã–µ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –ö—Ä–∏—Ç–∏–∫—É–µ—à—å ‚Äî –ø—Ä–µ–¥–ª–∞–≥–∞–π. –í ¬´–ü–æ–¥—Å–æ–ª–Ω—É—Ö–µ¬ª —Å—á–∏—Ç–∞—é—Ç, —á—Ç–æ –¥–ª—è —Ä–µ—à–µ–Ω–∏—è –≤–æ–ø—Ä–æ—Å–∞ –æ –ø–æ–¥–¥–µ—Ä–∂–∫–µ —Ä–µ–≥–∏–æ–Ω–∞ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ —É—á–∏—Ç—ã–≤–∞—Ç—å —É—Ä–æ–≤–µ–Ω—å –∫–∞—Å—Å–æ–≤–æ–≥–æ –∏—Å–ø–æ–ª–Ω–µ–Ω–∏—è –±—é–¥–∂–µ—Ç–∞. –ü–æ—Ä–æ–≥–æ–≤–æ–µ –∑–Ω–∞—á–µ–Ω–∏–µ –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è —É—Å—Ç–∞–Ω–æ–≤–∏—Ç—å –Ω–∞ —É—Ä–æ–≤–Ω–µ 90%. –¢–∞–∫–∏–º –æ–±—Ä–∞–∑–æ–º –±—É–¥—É—Ç —É—á—Ç–µ–Ω—ã –≤—Å–µ –≤–æ–∑–º–æ–∂–Ω—ã–µ –∏–∑–º–µ–Ω–µ–Ω–∏—è —Å–∏—Ç—É–∞—Ü–∏–∏ —Å –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ–º –≤ —Ä–µ–≥–∏–æ–Ω–µ. –ò—Å–ø–æ–ª–Ω–µ–Ω–∏–µ –º–æ–∂–Ω–æ –æ—Ç—Å–ª–µ–¥–∏—Ç—å —á–µ—Ä–µ–∑ —Å–∏—Å—Ç–µ–º—É ¬´–≠–ª–µ–∫—Ç—Ä–æ–Ω–Ω—ã–π –±—é–¥–∂–µ—Ç¬ª, —ç—Ç–æ –æ–±–µ—Å–ø–µ—á–∏—Ç –æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω–æ—Å—Ç—å, –ø—Ä–æ–∑—Ä–∞—á–Ω–æ—Å—Ç—å –∏ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–µ –ø–æ–ª–æ–∂–µ–Ω–∏—è–º –ö–æ–Ω—Å—Ç–∏—Ç—É—Ü–∏–æ–Ω–Ω–æ–≥–æ —Å—É–¥–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""Non-profit organization 'Sunflower' and the All-Russian Patients Union have submitted proposals to revise mechanisms for allocating federal budget funds intended for regional support of rare patients. The organizations disagree with the criteria, particularly the first one: 'The budgetary coverage level of a region must not exceed 0.65'. The fund claims that only 31 out of 89 regions met this criterion in 2024, and patients from these regions were more likely to seek help. The organizations also question the criterion of increasing drug prices by 20%, and suggest that this does not reflect their share in overall budget expenses. The organizations also criticize the criterion of increasing the number of rare patients, suggesting that regions need to address existing patient needs. The fund suggests a threshold of 90% for budget execution, which will be based on the 'Electronic Budget' system to ensure transparency and compliance with constitutional court rulings.""
}"
2025-10-16T16:35:38+00:00,@bezrec,6696,https://t.me/bezrec/6696,"–ì–∏–±–∫–∏–µ –æ—Ñ–∏—Å—ã –ø—Ä–æ–¥–æ–ª–∂–∞—é—Ç –ø—Ä–∏–≤–ª–µ–∫–∞—Ç—å –∫–æ–º–ø–∞–Ω–∏–∏ –†–∞–Ω–µ–µ –º—ã —É–∂–µ –ø–∏—Å–∞–ª–∏ –æ –≤–æ–∑—Ä–æ—Å—à–µ–π –ø–æ–ø—É–ª—è—Ä–Ω–æ—Å—Ç–∏ –≥–∏–±–∫–∏—Ö –æ—Ñ–∏—Å–æ–≤. –ù–∞ —Ä—ã–Ω–∫–µ –æ—Ñ–∏—Å–Ω–æ–π –Ω–µ–¥–≤–∏–∂–∏–º–æ—Å—Ç–∏ –µ—â–µ 2 —Å–¥–µ–ª–∫–∏. üë®‚Äçüíº –ò–∑—Ä–∞–∏–ª—å—Å–∫–∞—è —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∞—è –∫–æ–º–ø–∞–Ω–∏—è Teva –∞—Ä–µ–Ω–¥—É–µ—Ç 305 —Ä–∞–±–æ—á–∏—Ö –º–µ—Å—Ç –≤ AFI Flex —É –ë–µ–ª–æ—Ä—É—Å—Å–∫–æ–≥–æ –≤–æ–∫–∑–∞–ª–∞. –ê —Ç–∞–∫–∂–µ —è–ø–æ–Ω—Å–∫–∞—è –∫–æ–º–ø–∞–Ω–∏—è Astellas Pharma –∞—Ä–µ–Ω–¥—É–µ—Ç 150 —Ä–∞–±–æ—á–∏—Ö –º–µ—Å—Ç –≤ —Ç–æ–º –∂–µ –æ—Ñ–∏—Å–µ. –°—Ç–æ–∏–º–æ—Å—Ç—å –∞—Ä–µ–Ω–¥—ã –æ–¥–Ω–æ–≥–æ –º–µ—Å—Ç–∞ —Å–æ—Å—Ç–∞–≤–ª—è–µ—Ç 80 —Ç—ã—Å. —Ä—É–±. –≤ –º–µ—Å—è—Ü. –î–ª—è –∫–æ–º–ø–∞–Ω–∏–π —ç—Ç–æ –≤—ã–π–¥–µ—Ç –≤ –≥–æ–¥ 292,8 –º–ª–Ω —Ä—É–±. –∏ 144 –º–ª–Ω —Ä—É–±. —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ. –°–ø—Ä–æ—Å –Ω–∞ –≥–∏–±–∫–∏–µ –æ—Ñ–∏—Å—ã –æ—Å—Ç–∞–µ—Ç—Å—è –≤—ã—Å–æ–∫–∏–º –∏–∑-–∑–∞ –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–Ω–æ–≥–æ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è –≤ –±–∏–∑–Ω–µ—Å-—Ü–µ–Ω—Ç—Ä–∞—Ö –ú–æ—Å–∫–≤—ã –∏ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ –±—ã—Å—Ç—Ä–æ —Ä–∞–∑–º–µ—Å—Ç–∏—Ç—å —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤ –±–µ–∑ –∫—Ä—É–ø–Ω—ã—Ö –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–π –≤ –æ—Ç–¥–µ–ª–∫—É –∏ –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä—É. üîç –ö–∞–¥—Ä—ã","{""skip"": true}"
2025-10-16T14:34:42+00:00,@bezrec,6695,https://t.me/bezrec/6695,"–¢—ã—Å—è—á–∏ –∂–∏—Ç–µ–ª–µ–π –í–µ–ª–∏–∫–æ–±—Ä–∏—Ç–∞–Ω–∏–∏ –ø–æ–¥–∞–ª–∏ –≤ —Å—É–¥ –Ω–∞ Johnson&Johnson –∏–∑-–∑–∞ –∞—Å–±–µ—Å—Ç–∞ –≤ –ø—Ä–∏—Å—ã–ø–∫–∞—Ö. –ö–æ–ª–ª–µ–∫—Ç–∏–≤–Ω—ã–π –∏—Å–∫ –ø—Ä–æ—Ç–∏–≤ —Ñ–∞—Ä–º–≥–∏–≥–∞–Ω—Ç–∞, –æ –∫–æ—Ç–æ—Ä–æ–º –≥–æ–≤–æ—Ä–∏–ª–∏ –µ—â—ë –≤ —Ñ–µ–≤—Ä–∞–ª–µ, —Å—Ç–∞–ª —Ä–µ–∞–ª—å–Ω–æ—Å—Ç—å—é: –û–∫–æ–ª–æ —Ç—Ä–µ—Ö —Ç—ã—Å—è—á —á–µ–ª–æ–≤–µ–∫ –∑–∞—è–≤–∏–ª–∏, —á—Ç–æ —É –Ω–∏—Ö –∏–ª–∏ —É —á–ª–µ–Ω–æ–≤ –∏—Ö —Å–µ–º–µ–π —Ä–∞–∑–≤–∏–ª—Å—è —Ä–∞–∫ —è–∏—á–Ω–∏–∫–æ–≤ –∏–ª–∏ –º–µ–∑–æ—Ç–µ–ª–∏–æ–º–∞ –∏–∑-–∑–∞ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏—è –¥–µ—Ç—Å–∫–æ–π –ø—Ä–∏—Å—ã–ø–∫–∏ Johnson's Baby, –∏ –¥–æ–±–∏–≤–∞—é—Ç—Å—è –≤–æ–∑–º–µ—â–µ–Ω–∏—è —É—â–µ—Ä–±–∞ –≤ –í–µ—Ä—Ö–æ–≤–Ω–æ–º —Å—É–¥–µ –õ–æ–Ω–¥–æ–Ω–∞, ‚Äî –≥–æ–≤–æ—Ä–∏—Ç—Å—è –≤ –ø—É–±–ª–∏–∫–∞—Ü–∏–∏ Guardian. KP Law, –ø—Ä–µ–¥—Å—Ç–∞–≤–ª—è—é—â–∞—è –∏–Ω—Ç–µ—Ä–µ—Å—ã –∏—Å—Ç—Ü–æ–≤, —É—Ç–≤–µ—Ä–∂–¥–∞–µ—Ç, —á—Ç–æ –∫–æ–º–ø–∞–Ω–∏—è ¬´–¥–µ—Å—è—Ç–∏–ª–µ—Ç–∏—è–º–∏ —Å–∫—Ä—ã–≤–∞–ª–∞¬ª –æ–ø–∞—Å–Ω–æ—Å—Ç—å –¥–ª—è –∑–¥–æ—Ä–æ–≤—å—è –Ω–∞—Å–µ–ª–µ–Ω–∏—è. –ü–æ —Å–ª–æ–≤–∞–º –∞–¥–≤–æ–∫–∞—Ç–∞ –ú–∞–π–∫–ª–∞ –†–æ—É–ª–∏–Ω—Å–æ–Ω–∞ ¬´–≤ –º–∏—Ä–µ —Å—É—â–µ—Å—Ç–≤—É–µ—Ç –æ—á–µ–Ω—å –º–∞–ª–æ –º–µ—Å—Ç–æ—Ä–æ–∂–¥–µ–Ω–∏–π —Ç–∞–ª—å–∫–∞, –∫–æ—Ç–æ—Ä—ã–µ —Ä–∞–∑—Ä–∞–±–∞—Ç—ã–≤–∞—é—Ç—Å—è –≤ –∫–æ–º–º–µ—Ä—á–µ—Å–∫–∏—Ö —Ü–µ–ª—è—Ö –∏ –Ω–µ —Å–æ–¥–µ—Ä–∂–∞—Ç –∞—Å–±–µ—Å—Ç–∞¬ª. –ü–æ—Å—Ç–∞–≤—â–∏–∫–∏ Johnson&Johnson –∫ —Ç–∞–∫–æ–≤—ã–º –Ω–µ –æ—Ç–Ω–æ—Å—è—Ç—Å—è. –ü—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å —è–∫–æ–±—ã –æ–± —ç—Ç–æ–º –∑–Ω–∞–ª, –Ω–æ ¬´–∑–∞–º–∞–ª—á–∏–≤–∞–ª¬ª –Ω–µ—É–¥–æ–±–Ω—ã–µ —Ñ–∞–∫—Ç—ã. –ö–æ–º–ø–∞–Ω–∏—è –ø–æ-–ø—Ä–µ–∂–Ω–µ–º—É –æ—Ç—Ä–∏—Ü–∞–µ—Ç –≤—Å–µ –æ–±–≤–∏–Ω–µ–Ω–∏—è, –Ω–∞–∑—ã–≤–∞—è –∏—Ö –±–µ–∑–æ—Å–Ω–æ–≤–∞—Ç–µ–ª—å–Ω—ã–º–∏: –í—ã—Å–æ–∫–æ–∫–∞—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π –∫–æ—Å–º–µ—Ç–∏—á–µ—Å–∫–∏–π —Ç–∞–ª—å–∫, –∫–æ—Ç–æ—Ä—ã–π –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–ª—Å—è –≤ –¥–µ—Ç—Å–∫–æ–π –ø—Ä–∏—Å—ã–ø–∫–µ Johnson‚Äôs, —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–æ–≤–∞–ª –≤—Å–µ–º –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã–º –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω—ã–º —Å—Ç–∞–Ω–¥–∞—Ä—Ç–∞–º, –Ω–µ —Å–æ–¥–µ—Ä–∂–∞–ª –∞—Å–±–µ—Å—Ç–∞ –∏ –Ω–µ –≤—ã–∑—ã–≤–∞–ª —Ä–∞–∫. –ù–æ –Ω–∞ –∫—É–∫—É—Ä—É–∑–Ω—ã–π –∫—Ä–∞—Ö–º–∞–ª –µ–≥–æ –æ—Ç –≥—Ä–µ—Ö–∞ –ø–æ–¥–∞–ª—å—à–µ –∑–∞–º–µ–Ω–∏–ª–∏, –Ω–∞ —Ä–∞–¥–æ—Å—Ç—å –º–æ—â–Ω–µ–π—à–µ–º—É –∫—É–∫—É—Ä—É–∑–Ω–æ–º—É –ª–æ–±–±–∏ –°–®–ê. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-10-16T11:49:57+00:00,@bezrec,6693,https://t.me/bezrec/6693,"–£–Ω—ã–ª–∞—è –ø–æ—Ä–∞, –æ—á–µ–π –æ—á–∞—Ä–æ–≤–∞–Ω—å–µ ‚Äî –∏–¥–µ–∞–ª—å–Ω–æ–µ –≤—Ä–µ–º—è, —á—Ç–æ–±—ã –ø—Ä–æ–≤–µ—Ä–∏—Ç—å –∫–∞–∫ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ #–∑–∞–ø–∞–∫–æ–≤–∞–ª–∏ —Å–ø—Ä–µ–∏ –¥–ª—è –Ω–æ—Å–∞ –Ω–∞ –æ—Å–Ω–æ–≤–µ –∫—Å–∏–ª–æ–º–µ—Ç–∞–∑–æ–ª–∏–Ω–∞. –ü—Ä–æ—Å–∏–º –≤ –æ–ø—Ä–æ—Å–µ –≤—ã–±—Ä–∞—Ç—å –æ–¥–∏–Ω –∏–∑ –ø—è—Ç–∏ –≤–∞—Ä–∏–∞–Ω—Ç–æ–≤, –∏—Å—Ö–æ–¥—è –∏—Å–∫–ª—é—á–∏—Ç–µ–ª—å–Ω–æ –∏–∑ –¥–∏–∑–∞–π–Ω–∞ —É–ø–∞–∫–æ–≤–∫–∏: 1. –¢–∏–∑–∏–Ω (¬´–î–µ–ª—å—Ñ–∞—Ä–º –æ—Ä–ª–µ–∞–Ω¬ª); 2. –û—Ç—Ä–∏–≤–∏–Ω (¬´–•–µ–ª–µ–æ–Ω¬ª); 3. –ö—Å–∏–ª–µ–Ω (¬´–í–µ—Ä–æ—Ñ–∞—Ä–º¬ª); 4. –ö—Å–∏–ª–æ–º–µ—Ç–∞–∑–æ–ª–∏–Ω (¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª); 5. –ö—Å–∏–ª–æ–Ω–≥ (¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç¬ª). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-10-16T09:14:32+00:00,@bezrec,6692,https://t.me/bezrec/6692,"–§–ê–° —Å–Ω–∏–∑–∏–ª–∞ —Ü–µ–Ω—ã –Ω–∞ –ø–µ—Ä–≤—ã–π –¥–∂–µ–Ω–µ—Ä–∏–∫ –¥–∞–∫–ª–∞—Ç–∞—Å–≤–∏—Ä–∞ –ø—Ä–æ—Ç–∏–≤ –≥–µ–ø–∞—Ç–∏—Ç–∞ –°. –î–∞–∫–ª–∞—Ç–∞—Å–≤–∏—Ä-–ê–õ–í–ò–õ–° —Å—Ç–∞–ª –Ω–∞ 28,9% –¥–µ—à–µ–≤–ª–µ —Ä–µ—Ñ–µ—Ä–µ–Ω—Ç–Ω–æ–≥–æ –î–∞–∫–ª–∞–≤–∏–∑–∞—Ä–∞ –æ—Ç ¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç–∞¬ª. –ü—Ä–µ–ø–∞—Ä–∞—Ç —Ç–∞–∫–∂–µ –ø–æ–¥–µ—à–µ–≤–µ–ª –Ω–∞ 21-52% –≤ —Å—Ç—Ä–∞–Ω–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ ‚Äì –†–µ—Å–ø—É–±–ª–∏–∫–µ –ë–µ–ª–∞—Ä—É—Å—å. –£–ø–∞–∫–æ–≤–∫–∞ –∏–∑ 28 —Ç–∞–±–ª–µ—Ç–æ–∫ –≤ –¥–æ–∑–∏—Ä–æ–≤–∫–µ 30 –º–≥ –î–∞–∫–ª–∞—Ç–∞—Å–≤–∏—Ä–∞-–ê–õ–í–ò–õ–° —Ç–µ–ø–µ—Ä—å —Å—Ç–æ–∏—Ç 17 —Ç—ã—Å. —Ä—É–±–ª–µ–π –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å 24 —Ç—ã—Å. —Ä—É–±–ª–µ–π –∑–∞ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç. –ü—Ä–∞–≤–∞ –Ω–∞ –ø—Ä–æ–¥–∞–∂—É –∏ –¥–∏—Å—Ç—Ä–∏–±—É—Ü–∏—é –¥–∞–∫–ª–∞—Ç–∞—Å–≤–∏—Ä–∞ –≤ –†–æ—Å—Å–∏–∏ ¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç¬ª –ø–æ–ª—É—á–∏–ª –æ—Ç Bristol-Myers Squibb –≤ 2019 –≥–æ–¥—É. –í –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–æ–ª–∂–µ–Ω –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª—è—Ç—å—Å—è –≤ —Ä–∞–º–∫–∞—Ö –ø—Ä–æ–≥—Ä–∞–º–º—ã –≥–æ—Å–≥–∞—Ä–∞–Ω—Ç–∏–π –±–µ—Å–ø–ª–∞—Ç–Ω–æ–≥–æ –æ–∫–∞–∑–∞–Ω–∏—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""Belarus"",
  ""topic"": ""tenders, import_export, shortage, pricing"",
  ""impact"": ""medium"",
  ""english"": ""The price of Daklatasvir-AlivilS, a generic version of Dakatinavir for Hepatitis C, has been reduced by 28.9% compared to the reference drug Dakatinavir from Bristol-Myers Squibb. The price has also dropped by 21-52% in Belarus, where the original drug is produced. A pack of 28 tablets at a dosage of 30 mg now costs 17,000 rubles compared to the original drug priced at 24,000 rubles. The rights for sales and distribution of Daklatasvir in Russia were acquired by AlivilS from Bristol-Myers Squibb in 2019. The drug is to be provided within the framework of a state-guaranteed program for medical care.""
}"
2025-10-16T06:05:04+00:00,@bezrec,6691,https://t.me/bezrec/6691,"–†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä –ø—Ä–æ–≤–µ—Ä—è–µ—Ç –Ω–æ–≤—É—é ¬´–ú–æ–ª–µ–∫—É–ª—É¬ª. –í —Å–µ—Ç–∏ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–∏–ª–∞—Å—å –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è, —á—Ç–æ —Å–∫–∞–Ω–¥–∞–ª—å–Ω—ã–µ –ë–ê–î—ã –¥–ª—è –ø–æ—Ö—É–¥–µ–Ω–∏—è –≤–µ—Ä–Ω—É–ª–∏—Å—å –Ω–∞ —Ä—ã–Ω–æ–∫ –ø–æ–¥ –Ω–æ–≤—ã–º –Ω–∞–∑–≤–∞–Ω–∏–µ–º META plus. –†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä –≤—Å—Ç—Ä–µ–≤–æ–∂–∏–ª—Å—è –∏ —Å–æ–æ–±—â–∏–ª, —á—Ç–æ: üîò–≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–∞—è —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è —Å—Ä–µ–¥—Å—Ç–≤–∞ –Ω–µ –ø—Ä–æ–≤–æ–¥–∏–ª–∞—Å—å; üîò—Å–≤–µ–¥–µ–Ω–∏—è –æ –Ω–∞–ª–∏—á–∏–∏ –¥–µ–∫–ª–∞—Ä–∞—Ü–∏–∏ –æ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–∏ –æ—Ç—Å—É—Ç—Å—Ç–≤—É—é—Ç. –†–µ–≥—É–ª—è—Ç–æ—Ä –¥–æ–Ω—ë—Å —ç—Ç—É –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é –¥–æ –ê—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ –∫–æ–º–ø–∞–Ω–∏–π –∏–Ω—Ç–µ—Ä–Ω–µ—Ç‚Äë—Ç–æ—Ä–≥–æ–≤–ª–∏ (–ê–ö–ò–¢) –∏ –ø–æ—Ç—Ä–µ–±–æ–≤–∞–ª –ø—Ä–∏–Ω—è—Ç—å –º–µ—Ä—ã –ø–æ –ø—Ä–µ–¥–æ—Ç–≤—Ä–∞—â–µ–Ω–∏—é —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω–æ –Ω–µ–±–µ–∑–æ–ø–∞—Å–Ω–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –≤ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç–µ. –ù–∞–ø–æ–º–Ω–∏–º, –≤–µ—Å–Ω–æ–π –≤ –ø–æ–ø—É–ª—è—Ä–Ω—ã—Ö —Å—Ä–µ–¥–∏ –ø–æ–¥—Ä–æ—Å—Ç–∫–æ–≤ –¥–æ–±–∞–≤–∫–∞—Ö –ú–æ–ª–µ–∫—É–ª–∞ –∏ –ú–æ–ª–µ–∫—É–ª–∞ –ø–ª—é—Å #–∑–∞–º–µ—Ç–∏–ª–∏ ¬´—Å–µ–∫—Ä–µ—Ç–Ω—ã–π¬ª –∏–Ω–≥—Ä–µ–¥–∏–µ–Ω—Ç ‚Äî –∑–∞–ø—Ä–µ—â—ë–Ω–Ω—ã–π –¥–ª—è –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏—è –≤ –ë–ê–î–∞—Ö —Å–∏–±—É—Ç—Ä–∞–º–∏–Ω. –ü—Ä–µ–ø–∞—Ä–∞—Ç –¥–µ–π—Å—Ç–≤–∏—Ç–µ–ª—å–Ω–æ –∏—Å–ø–æ–ª—å–∑—É–µ—Ç—Å—è –¥–ª—è –ª–µ—á–µ–Ω–∏—è –æ–∂–∏—Ä–µ–Ω–∏—è, –Ω–æ –ø—Ä–æ–¥–∞–≤–∞—Ç—å—Å—è –¥–æ–ª–∂–µ–Ω —Å—Ç—Ä–æ–≥–æ –ø–æ —Ä–µ—Ü–µ–ø—Ç—É. –•—É–¥–µ—é—â–∏–µ –Ω–∞ –ú–æ–ª–µ–∫—É–ª–µ –∂–∞–ª–æ–≤–∞–ª–∏—Å—å –Ω–∞ —Å—É—Ö–æ—Å—Ç—å –≤–æ —Ä—Ç—É, —Å–µ—Ä–¥—Ü–µ–±–∏–µ–Ω–∏–µ, —Ä–∞—Å—à–∏—Ä–µ–Ω–Ω—ã–µ –∑—Ä–∞—á–∫–∏, —Ç—Ä–µ–≤–æ–∂–Ω–æ—Å—Ç—å –∏ –±–µ—Å—Å–æ–Ω–Ω–∏—Ü—É. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –Ω–æ–≤–∞—è —Ñ–∏–≥—É—Ä–∞ —Ä–∞–¥–æ–≤–∞–ª–∞ –Ω–µ–¥–æ–ª–≥–æ ‚Äî —Å–±—Ä–æ—à–µ–Ω–Ω—ã–µ –∫–∏–ª–æ–≥—Ä–∞–º–º—ã –±—ã—Å—Ç—Ä–æ –≤–æ–∑–≤—Ä–∞—â–∞–ª–∏—Å—å. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""The regulatory authorities are concerned about the return of controversial weight loss supplements under a new name. The products have not been registered by the state and there are no declarations of compliance available. Authorities have informed the Association of Internet Retailers (AKIT) and demanded measures to prevent potentially unsafe products from being sold online. Previously, the supplement 'Molecule' contained a banned ingredient - sibutramine, which was used to treat obesity but must be prescribed. The weight loss effects were short-lived and the supplements led to side effects such as dry mouth, heart palpitations, dilated pupils, anxiety and insomnia.""
}"
2025-10-15T14:32:56+00:00,@bezrec,6690,https://t.me/bezrec/6690,"–†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä —Å—Ñ–æ—Ä–º—É–ª–∏—Ä–æ–≤–∞–ª –æ—Å–Ω–æ–≤–∞–Ω–∏—è –¥–ª—è –∑–∞–ø—Ä–µ—Ç–∞ –ø—Ä–æ–¥–∞–∂–∏ –ë–ê–î–æ–≤. –ù–∞ –ø–æ—Ä—Ç–∞–ª–µ –ø—Ä–æ–µ–∫—Ç–æ–≤ –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω—ã—Ö –ø—Ä–∞–≤–æ–≤—ã—Ö –∞–∫—Ç–æ–≤ –ø–æ—è–≤–∏–ª—Å—è –ø—Ä–æ–µ–∫—Ç –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è, –≤ –∫–æ—Ç–æ—Ä–æ–º –æ—Ç–æ–±—Ä–∞–∂–µ–Ω—ã —É—Å–ª–æ–≤–∏—è, –ø—Ä–∏ –∫–æ—Ç–æ—Ä—ã—Ö –ø—Ä–æ–¥–∞–∂–∞ –¥–æ–±–∞–≤–∫–∏ –º–æ–∂–µ—Ç –±—ã—Ç—å –ø—Ä–µ–∫—Ä–∞—â–µ–Ω–∞. –ö —Ç–∞–∫–æ–≤—ã–º –æ—Ç–Ω–æ—Å—è—Ç—Å—è: üîò–æ—Ç—Å—É—Ç—Å—Ç–≤–∏–µ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏; üîò–Ω–∞–ª–∏—á–∏–µ –∑–∞–ø—Ä–µ—â—ë–Ω–Ω—ã—Ö –≤–µ—â–µ—Å—Ç–≤ –≤ —Å–æ—Å—Ç–∞–≤–µ; üîò–ø—Ä–µ–≤—ã—à–µ–Ω–∏–µ –ø—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ–Ω–Ω—ã—Ö –∑–∞–∫–æ–Ω–æ–º –∑–Ω–∞—á–µ–Ω–∏–π –Ω–æ—Ä–º–∏—Ä—É—é—â–∏—Ö –≤–µ—â–µ—Å—Ç–≤ –≤ —Å–æ—Å—Ç–∞–≤–µ; üîò–æ—Ç—Å—É—Ç—Å—Ç–≤–∏–µ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ–π –∏ –¥–æ—Å—Ç–æ–≤–µ—Ä–Ω–æ–π –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –æ –ë–ê–î–∞—Ö –∏ –∏—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è—Ö. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –≤–Ω–µ –∑–∞–∫–æ–Ω–∞ –æ–∫–∞–∂–µ—Ç—Å—è —Ç–æ—Ä–≥–æ–≤–ª—è –ë–ê–¥–∞–º–∏ –ø–æ–¥ –≤–∏–¥–æ–º –ø–∏—â–µ–≤—ã—Ö –¥–æ–±–∞–≤–æ–∫. –ü—Ä–∏–∫–∞–∑ –¥–æ–ª–∂–µ–Ω –≤—Å—Ç—É–ø–∏—Ç—å –≤ —Å–∏–ª—É —Å 1 –º–∞—Ä—Ç–∞ 2026 –≥–æ–¥–∞. –°—Ä–æ–∫ –¥–µ–π—Å—Ç–≤–∏—è ‚Äî –¥–æ 1 –º–∞—Ä—Ç–∞ 2032 –≥–æ–¥–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""Rospatent has issued a notice prohibiting the sale of dietary supplements. A draft decree is available on the portal of normative legal acts projects, outlining conditions under which the sale of supplements can be halted. These include: üîòunregistered state registration; üîòpresence of prohibited substances in the composition; üîòexceedance of legally prescribed limits on permitted substances; üîòlack of necessary and reliable information about the supplements and their manufacturers. Additionally, selling dietary supplements as food additives would be illegal. The decree will come into force on March 1, 2026 and have a duration of up to March 1, 2032.""
}"
2025-10-15T12:03:36+00:00,@bezrec,6689,https://t.me/bezrec/6689,"–ù–∞ –ø—Ä–æ—à–ª–æ–π –Ω–µ–¥–µ–ª–µ –†–æ—Å–∫–∞—á–µ—Å—Ç–≤–æ –ø—Ä–æ–≤–µ—Ä–∏–ª–æ 15 —Ç–æ—Ä–≥–æ–≤—ã—Ö –º–∞—Ä–æ–∫ –ë–ê–î–æ–≤ —Å –æ–º–µ–≥–∞-3. –î–µ—Ä–∂–∞–ª–∏—Å—å ¬´–º–æ–ª–æ–¥—Ü–æ–º¬ª –∏ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–æ–≤–∞–ª–∏ –≤—Å–µ–º –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–º —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è–º —Ç–æ–ª—å–∫–æ —à–µ—Å—Ç—å: ¬´–≠–≤–∞–ª–∞—Ä¬ª, Solgar, ¬´–ü–æ–ª—è—Ä–∏—Å¬ª, UltraBalance, Layco, Dr.Mybo. –û–Ω–∏-—Ç–æ –∏ —Å—Ç–∞–ª–∏ –≥–µ—Ä–æ—è–º–∏ —Å–µ–≥–æ–¥–Ω—è—à–Ω–µ–≥–æ –≤—ã–ø—É—Å–∫–∞ #–∑–∞—Ü–µ–Ω–∏–ª–∏. –°–∫–∞–∂–µ–º —Å—Ä–∞–∑—É, –Ω–µ –≤—Å–µ –¥–æ–±–∞–≤–∫–∏ —É–¥–∞–ª–æ—Å—å –Ω–∞–π—Ç–∏ –≤ –∞–ø—Ç–µ–∫–∞—Ö-—É—á–∞—Å—Ç–Ω–∏—Ü–∞—Ö —Ä—É–±—Ä–∏–∫–∏. –¢–∞–∫, –û–º–µ–≥—É-3 –æ—Ç ¬´–ü–æ–ª—è—Ä–∏—Å–∞¬ª –∏ Layco –ø—Ä–∏—à–ª–æ—Å—å –∏—Å–∫–∞—Ç—å –Ω–∞ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞—Ö. –ö—Å—Ç–∞—Ç–∏, –∏–º–µ–Ω–Ω–æ –æ–Ω–∏ –æ–∫–∞–∑–∞–ª–∏—Å—å –æ–¥–Ω–∏–º–∏ –∏–∑ —Å–∞–º—ã—Ö –¥–µ—à—ë–≤—ã—Ö ‚Äî 562 —Ä—É–±–ª—è (–∑–∞ 60 –∫–∞–ø—Å—É–ª) –∏ 599 —Ä—É–±–ª–µ–π (–∑–∞ 90 –∫–∞–ø—Å—É–ª) –Ω–∞ ¬´–û–∑–æ–Ω–µ¬ª. –ê –≤–æ—Ç –Ω–∞ Wildberries Layco —Å—Ç–æ–∏—Ç 858 —Ä—É–±–ª–µ–π. –ù–æ —Å–∞–º–∞—è –≤—ã–≥–æ–¥–Ω–∞—è –æ–º–µ–≥–∞ –Ω–∞—à–ª–∞—Å—å –≤ ¬´–ê–ø—Ç–µ–∫–µ.—Ä—É¬ª ‚Äî –∑–∞ 90 –∫–∞–ø—Å—É–ª –æ—Ç Dr.Mybo —Ç–∞–º –ø—Ä–æ—Å—è—Ç 546 —Ä—É–±–ª–µ–π. –°–∞–º—ã–π –¥–æ—Ä–æ–≥–æ–π —ç–∫–∑–µ–º–ø–ª—è—Ä ‚Äî –æ—Ç –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–π Solgar ‚Äî –ø—Ä–æ–¥–∞—ë—Ç—Å—è –≤ ¬´36,6¬ª –∑–∞ 5,5 —Ç—ã—Å. —Ä—É–±–ª–µ–π. –ù–∞ Wildberries –±–∞–Ω–æ—á–∫—É –∏–∑ 100 –∫–∞–ø—Å—É–ª –º–æ–∂–Ω–æ ¬´—É—Ä–≤–∞—Ç—å¬ª –∑–∞ 3,3 —Ç—ã—Å. —Ä—É–±–ª–µ–π. –ù–∞–ø–æ–º–∏–Ω–∞–µ–º, –Ω–µ –≤—Å–µ –ë–ê–î—ã –æ–¥–∏–Ω–∞–∫–æ–≤–æ –ø–æ–ª–µ–∑–Ω—ã –∏ —Ç–æ–∂–µ –º–æ–≥—É—Ç –∏–º–µ—Ç—å –ø—Ä–æ—Ç–∏–≤–æ–ø–æ–∫–∞–∑–∞–Ω–∏—è. –ü–µ—Ä–µ–¥ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º –ø—Ä–æ–∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä—É–π—Ç–µ—Å—å —Å –ª–µ—á–∞—â–∏–º –≤—Ä–∞—á–æ–º. *–∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –ø—Ä–æ–≤–æ–¥–∏–ª–æ—Å—å –æ–Ω–ª–∞–π–Ω 14 –æ–∫—Ç—è–±—Ä—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""A recent investigation by Roskhauschestve (Russian Consumer Rights and Guarantees Agency) found that only six brands of omega-3 dietary supplements (B–êDs) met all mandatory requirements: 'EvaLar', Solgar, 'Polaris', UltraBalance, Layco, and Dr.Mybo. These brands were the focus of today's report. Not all supplements could be found in pharmacies, with some needing to be sought on marketplaces like 'Ozon' and 'Wildberries'. The most affordable options were from Layco on 'Ozon' for 562 rubles (for 60 capsules) and 599 rubles (for 90 capsules). On 'Wildberries', Layco costs 858 rubles. The most affordable option from Dr.Mybo was available on 'Apteka.ru' for 546 rubles (for 90 capsules). The most expensive option was from Solgar in '36,6' for 5,5 thousand rubles"
2025-10-15T09:04:20+00:00,@bezrec,6688,https://t.me/bezrec/6688,"–û–±—â–∏–π –æ–±—ä—ë–º —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —Ñ–∞—Ä–º—Ä—ã–Ω–∫–∞ –º–æ–∂–µ—Ç –ø—Ä–µ–æ–¥–æ–ª–µ—Ç—å –ø—Å–∏—Ö–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–π —Ä—É–±–µ–∂ –≤ 3 —Ç—Ä–ª–Ω —Ä—É–±–ª–µ–π —É–∂–µ –≤ —ç—Ç–æ–º –≥–æ–¥—É. –¢–∞–∫–∏–º –ø—Ä–æ–≥–Ω–æ–∑–æ–º –ø–æ–¥–µ–ª–∏–ª–∞—Å—å RNC Pharma. –î–∏–Ω–∞–º–∏–∫–∞ –≤ –¥–µ–Ω—å–≥–∞—Ö –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ 2024 –≥–æ–¥–∞ —Å–æ—Å—Ç–∞–≤–∏—Ç 16%. –ü—Ä–µ–¥—ã–¥—É—â–∏–π —Ä—É–±–µ–∂ –≤ 2 —Ç—Ä–ª–Ω —Ä—É–±–ª–µ–π –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–∞—è —Ñ–∞—Ä–º–∞ –ø–µ—Ä–µ—à–∞–≥–Ω—É–ª–∞ –≤ 2022 –≥–æ–¥—É, —Ç–æ–≥–¥–∞ –∫–∞–∫ –ø–µ—Ä–µ—Ö–æ–¥ –æ—Ç 1 –¥–æ 2 —Ç—Ä–ª–Ω —Ä—É–±–ª–µ–π –∑–∞–Ω—è–ª —É —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ —Ä—ã–Ω–∫–∞ 9 –ª–µ—Ç. –í—ã—Å–æ–∫–∏–º–∏ —Ç–µ–º–ø–∞–º–∏ —Ä–∞–∑–≤–∏—Ç–∏—è –æ—Ç—Ä–∞—Å–ª—å –æ–±—è–∑–∞–Ω–∞ –∫—Ä–∏–∑–∏—Å–Ω—ã–º —è–≤–ª–µ–Ω–∏—è–º, —Å–∫–∞–∑–∞–≤—à–∏–º—Å—è –Ω–∞ –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–∏ –æ—Ç–¥–µ–ª—å–Ω—ã—Ö –∫–∞—Ç–µ–≥–æ—Ä–∏–π –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ —Ä–æ—Å—Ç–µ —Ü–µ–Ω, –∞ —Ç–∞–∫–∂–µ —Ä–∞—Å—à–∏—Ä–µ–Ω–∏—é –æ–±—ä—ë–º–∞ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –≥–∞—Ä–∞–Ω—Ç–∏–π –≤ —Ä–∞–º–∫–∞—Ö –æ—Ç–¥–µ–ª—å–Ω—ã—Ö –Ω–æ–∑–æ–ª–æ–≥–∏–π. –ê–Ω–∞–ª–∏—Ç–∏–∫–∏ –ø—Ä–µ–¥–ø–æ–ª–∞–≥–∞—é—Ç, —á—Ç–æ –∫ –∫–æ–Ω—Ü—É 2027 –≥–æ–¥–∞ –æ–±—ä—ë–º —Ä—ã–Ω–∫–∞ –¥–æ–ª–∂–µ–Ω –ø—Ä–µ–≤—ã—Å–∏—Ç—å 3,9 —Ç—Ä–ª–Ω. —Ä—É–±–ª–µ–π,–æ–¥–Ω–∞–∫–æ —Ä—É–±–ª—ë–≤–∞—è –¥–∏–Ω–∞–º–∏–∫–∞ –±—É–¥–µ—Ç –ø–æ—Å—Ç–µ–ø–µ–Ω–Ω–æ –∑–∞–º–µ–¥–ª—è—Ç—å—Å—è ‚Äî –¥–æ 14,5% –ø–æ –∏—Ç–æ–≥–∞–º 2026 –≥–æ–¥–∞ –∏ 11,5% –ø–æ –∏—Ç–æ–≥–∞–º 2027 –≥–æ–¥–∞. –†–æ–∑–Ω–∏—Ü–µ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –ø—Ä–æ—á–∞—Ç —Ä–æ—Å—Ç —Ñ–∏–∑–∏—á–µ—Å–∫–æ–≥–æ –æ–±—ä—ë–º–∞ –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏—è –∏ –¥–∞–ª—å–Ω–µ–π—à–∏–π –ø–µ—Ä–µ—Ö–æ–¥ –Ω–∞ –±–æ–ª–µ–µ –¥–æ—Ä–æ–≥–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, –µ—Å–ª–∏ —Å—Ç–∞–±–∏–ª–∏–∑–∏—Ä—É–µ—Ç—Å—è –∏–Ω—Ñ–ª—è—Ü–∏–æ–Ω–Ω–∞—è —Å–æ—Å—Ç–∞–≤–ª—è—é—â–∞—è, –∞ –¥–æ—Ö–æ–¥—ã –Ω–∞—Å–µ–ª–µ–Ω–∏—è –ø—Ä–æ–¥–æ–ª–∂–∞—Ç —Ä–∞—Å—Ç–∏. –í–∞–∂–Ω–∞—è —Ä–æ–ª—å –æ—Ç–≤–æ–¥–∏—Ç—Å—è –∏–Ω—Ç–µ–≥—Ä–∞—Ü–∏–∏ –Ω–æ–≤—ã—Ö —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö —Ä–µ–≥–∏–æ–Ω–æ–≤ –≤ —ç–∫–æ–Ω–æ–º–∏–∫—É –∏ –∞–¥–º–∏–Ω–∏—Å—Ç—Ä–∞—Ç–∏–≤–Ω—É—é —Å–∏—Å—Ç–µ–º—É. –ß—Ç–æ –¥–æ –±—é–¥–∂–µ—Ç–Ω–æ–≥–æ —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è, —Ç–æ –∑–¥–µ—Å—å –æ–ø—Ä–µ–¥–µ–ª—è—é—â—É—é —Ä–æ–ª—å –±—É–¥–µ—Ç –∏–≥—Ä–∞—Ç—å —Ä–∞—Å—à–∏—Ä–µ–Ω–∏–µ –æ–±—ä—ë–º–∞ –≥–æ—Å–≥–∞—Ä–∞–Ω—Ç–∏–π ‚Äî –ú–∏–Ω—Ñ–∏–Ω –∏ –ú–∏–Ω–∑–¥—Ä–∞–≤ –ø—Ä–∏–∑–Ω–∞—é—Ç –ø—Ä–æ–±–ª–µ–º—É –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ–≥–æ —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è –ø—Ä–æ–≥—Ä–∞–º–º—ã 14 –í–ó–ù, —á—Ç–æ –ø–æ–∑–≤–æ–ª—è–µ—Ç –Ω–∞–¥–µ—è—Ç—å—Å—è –Ω–∞ —É–≤–µ–ª–∏—á–µ–Ω–∏–µ –∞—Å—Å–∏–≥–Ω–æ–≤–∞–Ω–∏–π –≤ 2026 –≥–æ–¥—É. –ï—â—ë –æ–¥–∏–Ω –≤–∞–∂–Ω—ã–π –∞—Å–ø–µ–∫—Ç ‚Äî –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ —Ç–µ—Ä–∞–ø–∏–µ–π ¬´—Ä–µ–¥–∫–∏—Ö¬ª –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –° 2026 –≥–æ–¥–∞ –≤–≤–æ–¥–∏—Ç—Å—è —Ä–µ–∑–µ—Ä–≤–Ω—ã–π –º–µ—Ö–∞–Ω–∏–∑–º –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –æ—Ä—Ñ–∞–Ω–Ω—ã–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏. –°—Ä–µ–¥—Å—Ç–≤–∞ –∏–∑ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –±—é–¥–∂–µ—Ç–∞ –≤—ã–¥–µ–ª—è—Ç —Å—É–±—ä–µ–∫—Ç–∞–º, –∫–æ—Ç–æ—Ä—ã–µ —Å–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω–æ –Ω–µ —Å–ø—Ä–∞–≤–ª—è—é—Ç—Å—è —Å –∏—Å–ø–æ–ª–Ω–µ–Ω–∏–µ–º —Å–≤–æ–∏—Ö –ø–æ–ª–Ω–æ–º–æ—á–∏–π –ø–æ –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏—é —Ç–∞–∫–∏—Ö –±–æ–ª—å–Ω—ã—Ö. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, shortage, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The Russian pharmaceutical market is expected to surpass a psychological barrier of 3 trillion rubles this year. The RNC Pharma predicts a money growth rate of 16% compared to the previous year, when the market crossed the threshold of 2 trillion rubles in 2022. The analysts forecast that by 2027, the market volume will exceed 3.9 trillion rubles, but the annual growth rate is expected to gradually slow down to 14.5% in 2026 and 11.5% in 2027. The growth is attributed to the integration of new Russian regions into the economy and administrative system, as well as the expansion of state guarantees. The budgetary funding will be influenced by the extension of state guarantees, which is recognized as a problem of insufficient financing for the program 14 VZN. The shortage of treatments for patients with rare diseases is also addressed through a reserve mechanism, where funds from the federal budget will be allocated to regions that cannot meet their responsibilities for providing such treatments"
2025-10-15T05:51:16+00:00,@bezrec,6687,https://t.me/bezrec/6687,"–¢–∞–∫–∏–º–∏ –¥–∞–Ω–Ω—ã–º–∏ –Ω–∞ –∑–∞—Å–µ–¥–∞–Ω–∏–∏ –ì–æ—Å–¥—É–º—ã –ø–æ–¥–µ–ª–∏–ª—Å—è –ú–∏—Ö–∞–∏–ª –ú—É—Ä–∞—à–∫–æ. –ü–æ —Å–ª–æ–≤–∞–º –≥–ª–∞–≤—ã –ú–∏–Ω–∑–¥—Ä–∞–≤–∞, –≤ –¥–µ–Ω—å–≥–∞—Ö —Å–æ–æ—Ç–Ω–æ—à–µ–Ω–∏–µ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –∏ –∑–∞—Ä—É–±–µ–∂–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ —Ä—ã–Ω–∫–µ —Å–æ—Å—Ç–∞–≤–ª—è–µ—Ç 40 –Ω–∞ 60. –î–∏–Ω–∞–º–∏–∫–∞ –ø–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤—É –±–æ–ª–µ–µ —Å–ª–æ–∂–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏–¥–µ—Ç –ø–æ–∑–∏—Ç–∏–≤–Ω–∞—è, ‚Äî –æ–±–Ω–∞–¥–µ–∂–∏–ª –º–∏–Ω–∏—Å—Ç—Ä. –£—Å–∏–ª–µ–Ω–∏–µ –ø–æ–∑–∏—Ü–∏–π —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ú–∏–Ω–∑–¥—Ä–∞–≤ —Å–≤—è–∑—ã–≤–∞–µ—Ç —Å –∞–∫—Ç–∏–≤–Ω—ã–º —Ä–∞–∑–≤–∏—Ç–∏–µ–º —Ñ–∞—Ä–º–∫–ª–∞—Å—Ç–µ—Ä–æ–≤ –∏ –ø—Ä–æ–≥—Ä–∞–º–º –∏–º–ø–æ—Ä—Ç–æ–∑–∞–º–µ—â–µ–Ω–∏—è. –ñ–∞–ª—å, –ø–æ–∫–∞–∑–∞—Ç–µ–ª–∏ –∏—Å–ø–æ–ª–Ω–µ–Ω–∏—è —Ñ–µ–¥–ø—Ä–æ–µ–∫—Ç–∞ ¬´–†–∞–∑–≤–∏—Ç–∏–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –Ω–∞–∏–±–æ–ª–µ–µ –≤–æ—Å—Ç—Ä–µ–±–æ–≤–∞–Ω–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π¬ª, –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∑–∞ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ —Å—Ç—Ä–∞–Ω—ã –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º–∏ —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞, –ø–æ–∫–∞ –Ω–µ —Ä–∞–¥—É—é—Ç. –ü–æ –¥–∞–Ω–Ω—ã–º –∏–∑ –æ—Ç—á–µ—Ç–∞ –ú–∏–Ω—Ñ–∏–Ω–∞, –ø–æ —Å–æ—Å—Ç–æ—è–Ω–∏—é –Ω–∞ 1 –æ–∫—Ç—è–±—Ä—è —Ñ–µ–¥–ø—Ä–æ–µ–∫—Ç –∏—Å–ø–æ–ª–Ω–µ–Ω —Ç–æ–ª—å–∫–æ –Ω–∞ 3,9%. –ò–∑ –≤—ã–¥–µ–ª–µ–Ω–Ω—ã—Ö 950 –º–ª–Ω —Ä—É–±–ª–µ–π –∏–∑—Ä–∞—Å—Ö–æ–¥–æ–≤–∞–Ω–æ 37,5 –º–ª–Ω —Ä—É–±–ª–µ–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing"",
  ""impact"": ""medium"",
  ""english"": ""The Minister of Health Mikhail Murashko mentioned at the State Duma meeting that the ratio of domestic to foreign medicines on the market is 40:60. The dynamics for producing more complex medications are positive, he assured. The growth of Russian production is attributed to the active development of pharmaceutical clusters and import substitution programs. However, progress on fulfilling the federal project 'Development of production of most needed medicines and medical devices', responsible for ensuring the country's supply with domestically produced medications, is not satisfactory. According to data from the Finance Ministry, as of October 1st, only 39% of the allocated budget for this project has been spent on 950 million rubles, with only 37.5 million rubles having been spent.""
}"
2025-10-14T15:32:02+00:00,@bezrec,6684,https://t.me/bezrec/6684,"–°–≤–µ–∂–µ–≤—ã–∂–∞—Ç—ã–π –≤–µ—Ä–±–ª—é–¥. –ß–µ–≥–æ —Ç–æ–ª—å–∫–æ –Ω–µ—Ç –Ω–∞ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞—Ö. –í–æ—Ç –Ω–∞—Ç–∫–Ω—É–ª–∏—Å—å –Ω–∞ ¬´—á—É–¥–æ–¥–µ–π—Å—Ç–≤–µ–Ω–Ω—ã–π¬ª –∫–æ–∫—Ç–µ–π–ª—å –∏–∑ –≤–µ—Ä–±–ª—é–∂—å–µ–≥–æ –º–æ–ª–æ–∫–∞ –∏ ... –º–æ—á–∏ –≤ –∫–∞–ø—Å—É–ª–∞—Ö. –õ–µ—á–∏—Ç –≤—Å—ë –ø–æ–¥—Ä—è–¥ –æ—Ç –∞—Å—Ç–º—ã –∏ –æ–Ω–∫–æ–ª–æ–≥–∏–∏ –¥–æ —Ç—É–±–µ—Ä–∫—É–ª—ë–∑–∞ –∏ –¥–∏–∞–±–µ—Ç–∞. –≠–∫–∑–æ—Ç–∏—á–µ—Å–∫–∏–π –ø—Ä–æ–¥—É–∫—Ç –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç —Å—Ä–∞–∑—É –Ω–µ—Å–∫–æ–ª—å–∫–æ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π. –†–∞–∑–±—Ä–æ—Å —Ü–µ–Ω ‚Äî –æ—Ç 3,8 —Ç—ã—Å. –¥–æ 8,3 —Ç—ã—Å. —Ä—É–±–ª–µ–π. –ö–∞–∫ –≤–æ–¥–∏—Ç—Å—è, –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –æ —Å–æ—Å—Ç–∞–≤–µ ‚Äî –º–∏–Ω–∏–º—É–º, –æ–¥–Ω–∏ –æ–±–µ—â–∞–Ω–∏—è –∏—Å—Ü–µ–ª–µ–Ω–∏—è –æ—Ç ¬´–º–Ω–æ–≥–∏—Ö –±–æ–ª–µ–∑–Ω–µ–π¬ª. –û—Ç–∑—ã–≤–æ–≤ –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏ –Ω–µ—Ç. –í–∏–¥–∏–º–æ, –ø–æ–ø—Ä–æ–±–æ–≤–∞—Ç—å —Ä–µ—à–∞—é—Ç—Å—è –Ω–µ–º–Ω–æ–≥–∏–µ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-10-14T12:00:01+00:00,@bezrec,6683,https://t.me/bezrec/6683,"–î–µ–ø—É—Ç–∞—Ç—ã –æ–±—Å—É–∂–¥–∞—é—Ç –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –ø—Ä–æ–¥–∞–≤–∞—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –≤ –∞–ø—Ç–µ–∫–∞—Ö ¬´–ø–æ—à—Ç—É—á–Ω–æ¬ª. –° —Ç–∞–∫–æ–π –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–æ–π –≤—ã—Å—Ç—É–ø–∏–ª –ê–π—Ä–∞—Ç –§–∞—Ä—Ä–∞—Ö–æ–≤ –Ω–∞ –∫—Ä—É–≥–ª–æ–º —Å—Ç–æ–ª–µ –≤ –ï–∫–∞—Ç–µ—Ä–∏–Ω–±—É—Ä–≥–µ. –í—Å–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã —Å–µ–≥–æ–¥–Ω—è –≤—ã–ø—É—Å–∫–∞—é—Ç—Å—è –≤ —É–ø–∞–∫–æ–≤–∫–µ: –∫–æ–≥–¥–∞ –ø–∞—Ü–∏–µ–Ω—Ç –ø—Ä–∏—Ö–æ–¥–∏—Ç –≤ –∞–ø—Ç–µ–∫—É, –æ–Ω –ø–æ–∫—É–ø–∞–µ—Ç –∏–º–µ–Ω–Ω–æ —É–ø–∞–∫–æ–≤–∫—É. –í –Ω–µ–π –µ—Å—Ç—å –∏–Ω—Å—Ç—Ä—É–∫—Ü–∏—è –∏ —Ç–∞–∫ –¥–∞–ª–µ–µ. –ù–æ —á–∞—Å—Ç–æ –±—ã–≤–∞–µ—Ç, –∫–æ–≥–¥–∞ —É –Ω–∞—Å –∑–∞–±–æ–ª–µ–ª–∞ –≥–æ–ª–æ–≤–∞ –∏ –Ω—É–∂–Ω–æ –∫—É–ø–∏—Ç—å –æ–¥–Ω—É-–¥–≤–µ —Ç–∞–±–ª–µ—Ç–∫–∏. –ó–∞—á–µ–º –∏–∑-–∑–∞ —ç—Ç–æ–≥–æ –ø–æ–∫—É–ø–∞—Ç—å –¥–µ—Å—è—Ç—å —Ç–∞–±–ª–µ—Ç–æ–∫? –¢–æ –µ—Å—Ç—å –¥–æ–∑–∞ –Ω–µ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É–µ—Ç —Å–æ–¥–µ—Ä–∂–∞–Ω–∏—é —É–ø–∞–∫–æ–≤–∫–∏, –∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –æ—á–µ–Ω—å —á–∞—Å—Ç–æ –≤—ã–∫–∏–¥—ã–≤–∞—é—Ç—Å—è, ‚Äî —Å—á–∏—Ç–∞–µ—Ç –¥–µ–ø—É—Ç–∞—Ç. –ë–æ–ª–µ–µ —Ä–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—ã–º, –ø–æ –º–Ω–µ–Ω–∏—é –§–∞—Ä—Ä–∞—Ö–æ–≤–∞, –±—ã–ª–æ –±—ã –≤—ã–ø—É—Å–∫–∞—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, –Ω–∞–ø—Ä–∏–º–µ—Ä, –º–µ—à–∫–∞—Ö –∏–ª–∏ –±–æ–ª—å—à–∏—Ö –∫–æ—Ä–æ–±–∫–∞—Ö, –∞ –≤ –∞–ø—Ç–µ–∫–µ –¥–æ–∑–∏—Ä–æ–≤–∞—Ç—å, ¬´–∫–æ–º—É —Å–∫–æ–ª—å–∫–æ –Ω–∞–¥–æ –≤ –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏ –æ—Ç –∫—É—Ä—Å–∞ –ª–µ—á–µ–Ω–∏—è¬ª. –ö—Å—Ç–∞—Ç–∏, –ø–æ–¥–æ–±–Ω–∞—è –ø—Ä–∞–∫—Ç–∏–∫–∞ —Å—É—â–µ—Å—Ç–≤—É–µ—Ç –≤ –ë–µ–ª–∞—Ä—É—Å–∏, –≤ —á—ë–º –º—ã –ª–∏—á–Ω–æ —É–±–µ–¥–∏–ª–∏—Å—å. –ö—É–ø–∏—Ç—å –ø–∞—Ä—É –ø–∞–∫–µ—Ç–∏–∫–æ–≤ –∫–∞–∫–æ–π-–Ω–∏–±—É–¥—å –°–º–µ–∫—Ç—ã –∏–ª–∏ –¢–µ—Ä–∞—Ñ–ª—é —Ç–∞–º –Ω–µ –ø—Ä–æ–±–ª–µ–º–∞. –ß—Ç–æ –¥–æ –∏–Ω—Å—Ç—Ä—É–∫—Ü–∏–∏, —Ç–æ –∫—Ä–∞—Ç–Ω–æ—Å—Ç—å –ø—Ä–∏—ë–º–∞ –∏ —Å—Ä–æ–∫ –≥–æ–¥–Ω–æ—Å—Ç–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç—ã —á–∞—Å—Ç–æ –ø–æ–¥–ø–∏—Å—ã–≤–∞—é—Ç –Ω–∞ —Å–∞—à–µ –∏–ª–∏ –±–ª–∏—Å—Ç–µ—Ä–µ –æ—Ç —Ä—É–∫–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""Ukraine"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""Deputy Ayrat Farrakhov proposed selling medicines individually in pharmacies at a roundtable meeting in Ekaterinburg. Currently, all medications are sold in packages: patients buy a package at the pharmacy containing instructions and other information. However, often when someone gets sick and needs to buy a few tablets, it is not necessary to purchase ten. The dosage does not match the package contents, and many medications are often discarded. Farrakhov suggests instead producing medicines in bags or large boxes for sale at pharmacies, where patients can be dosed according to their treatment course. This practice exists in Belarus as well. Purchasing a few packets of Smecta or Teraflu is not an issue. The instructions for use and expiration date are often handwritten on the package or blister.""
}"
2025-10-14T09:00:07+00:00,@bezrec,6682,https://t.me/bezrec/6682,"–í –†–æ—Å—Å–∏–∏ –º–æ–∂–µ—Ç –ø—Ä–∏–±–∞–≤–∏—Ç—å—Å—è –∏–Ω–¥–∏–π—Å–∫–∏—Ö –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç–æ–≤. –ü–æ—á–µ—Ç–Ω—ã–π –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª—å —Å–æ–≤–µ—Ç–∞ –ø–æ —Å–æ–¥–µ–π—Å—Ç–≤–∏—é —ç–∫—Å–ø–æ—Ä—Ç—É —Ñ–∞—Ä–º–ø—Ä–æ–¥—É–∫—Ü–∏–∏ —Ä–µ—Å–ø—É–±–ª–∏–∫–∏ –î–∏–≤–µ—à –ö—É–º–∞—Ä —Ä–∞—Å—Å–∫–∞–∑–∞–ª –æ –Ω–∞–º–µ—Ä–µ–Ω–∏–∏ –≤ 2026 –≥–æ–¥—É —É–≤–µ–ª–∏—á–∏—Ç—å –ø–æ—Å—Ç–∞–≤–∫–∏ —Å–≤–æ–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–∏–π —Ä—ã–Ω–æ–∫. ¬´–ì–≤–æ–∑–¥—ë–º –ø—Ä–æ–≥—Ä–∞–º–º—ã¬ª –¥–æ–ª–∂–Ω—ã —Å—Ç–∞—Ç—å –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç—ã, –Ω–æ —Ä–∞—Å—à–∏—Ä–µ–Ω–∏–µ —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–∞ –º–µ–∂–¥—É –¥–≤—É–º—è —Å—Ç—Ä–∞–Ω–∞–º–∏ —Ç–∞–∫–∂–µ –º–æ–∂–µ—Ç –∫–æ—Å–Ω—É—Ç—å—Å—è –æ–Ω–∫–æ–≤–∞–∫—Ü–∏–Ω –∏ —è–¥–µ—Ä–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω—ã. –ú—ã –≤ –∫—Ä—É–ø–Ω—ã—Ö –æ–±—ä—ë–º–∞—Ö –ø—Ä–æ–¥–∞–µ–º –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –≤ —Ä–∞–∑–Ω—ã–µ —Å—Ç—Ä–∞–Ω—ã –º–∏—Ä–∞. –ù–µ—Å–∫–æ–ª—å–∫–æ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π —É–∂–µ –ø–æ—Å—Ç–∞–≤–ª—è—é—Ç –≤ –†–§ –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç—ã, –Ω–æ –≤ –±–æ–ª—å—à–∏—Ö –æ–±—ä–µ–º–∞—Ö –Ω–∞—á–Ω—É—Ç —ç—Ç–æ –¥–µ–ª–∞—Ç—å –≤ —Å–ª–µ–¥—É—é—â–µ–º –≥–æ–¥—É. –í 2026 –≥–æ–¥—É –≤—ã —É–≤–∏–¥–∏—Ç–µ –±–æ–ª—å—à–µ –∏–Ω–¥–∏–π—Å–∫–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –∞–ø—Ç–µ–∫–∞—Ö, ‚Äî –∑–∞–≤–µ—Ä–∏–ª –ö—É–º–∞—Ä. –ù–µ–∫–æ—Ç–æ—Ä—ã–µ –∏–Ω–¥–∏–π—Å–∫–∏–µ –∫–æ–º–ø–∞–Ω–∏–∏ —É–∂–µ –ª–æ–∫–∞–ª–∏–∑—É—é—Ç –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –≤ –†–§, –Ω–∞–ø—Ä–∏–º–µ—Ä, ¬´–°–∞—Ñ—Ñ–∞—Ä–º¬ª —Å—Ç—Ä–æ–∏—Ç –≤ –ú—É—Ä–º–∞–Ω—Å–∫–µ. –î—Ä—É–≥–∏–µ –∏–≥—Ä–æ–∫–∏ ¬´–ø—Ä–æ—â—É–ø—ã–≤–∞—é—Ç –ø–æ—á–≤—É¬ª –≤ –ö—Ä–∞—Å–Ω–æ–¥–∞—Ä—Å–∫–æ–º –∫—Ä–∞–µ –∏ –Ω–∞ –°–∞—Ö–∞–ª–∏–Ω–µ. –ê–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç—ã ‚Äî –≤—ã–≥–æ–¥–Ω—ã–π —Å–µ–≥–º–µ–Ω—Ç, –∏—Ö –ø—Ä–æ–¥–∞–∂–∏ —É–≤–µ—Ä–µ–Ω–Ω–æ —Ä–∞—Å—Ç—É—Ç —É–∂–µ –Ω–µ –ø–µ—Ä–≤—ã–π –≥–æ–¥. –¢–∞–∫, —Å —è–Ω–≤–∞—Ä—è –ø–æ –∞–ø—Ä–µ–ª—å 2025 –≥–æ–¥–∞ —Ä–æ—Å—Å–∏—è–Ω–µ —Ç—Ä–∞—Ç–∏–ª–∏ –Ω–∞ —Ç–∞–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –ø–æ 1,5 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –µ–∂–µ–º–µ—Å—è—á–Ω–æ, —á—Ç–æ –Ω–∞ 36% –±–æ–ª—å—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É. –ù–æ –∏–Ω–¥–∏–π—Å–∫–∏–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º –ø—Ä–∏–¥—ë—Ç—Å—è —Å—Ç–æ–ª–∫–Ω—É—Ç—å—Å—è —Å –≤—ã—Å–æ–∫–æ–π –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏–µ–π —Å–æ —Å—Ç–æ—Ä–æ–Ω—ã –µ–≤—Ä–æ–ø–µ–π—Å–∫–∏—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π, –∫–æ—Ç–æ—Ä—ã–º —Ä–æ—Å—Å–∏–π—Å–∫–∏–π –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª—å –¥–æ–≤–µ—Ä—è–µ—Ç –±–æ–ª—å—à–µ. –í–æ –º–Ω–æ–≥–æ–º –∏–∑-–∑–∞ –∏—Å—Ç–æ—Ä–∏–π —Å –Ω–µ —Å–∞–º—ã–º –≤—ã—Å–æ–∫–∏–º –∫–∞—á–µ—Å—Ç–≤–æ–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏–∑ —Ä–µ—Å–ø—É–±–ª–∏–∫–∏, —á—Ç–æ —Å–∫–∞–∑–∞–ª–æ—Å—å –Ω–∞ –∏—Ö —Ä–µ–ø—É—Ç–∞—Ü–∏–∏. –ü–æ –∫—Ä–∞–π–Ω–µ–π –º–µ—Ä–µ, –≤ —Ç–æ–ø-10 —Ç–æ—Ä–≥–æ–≤—ã—Ö –º–∞—Ä–æ–∫ –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç–æ–≤ –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º —Ä—ã–Ω–∫–µ –∏–Ω–¥–∏–π—Å–∫–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –Ω–µ—Ç. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""India plans to increase imports of antidepressants into Russia starting in 2026. The honorable representative of the Export Promotion Council of India mentioned that he wants to expand cooperation with Russia, which could include oncovaccines and nuclear medicine. Some Indian companies have already localized production in Russia, such as 'Saferm' building a factory in Murmansk. The Indian companies will face high competition from European producers, who are more trusted by the Russian consumer. This is partly due to past issues with quality of Indian drugs, which have affected their reputation.""
}"
2025-10-14T05:53:06+00:00,@bezrec,6681,https://t.me/bezrec/6681,"–ü–æ –∏—Ç–æ–≥–∞–º –ø–µ—Ä–≤—ã—Ö –≤–æ—Å—å–º–∏ –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ –ø—Ä–æ–¥–∞–∂–∏ –º–∏–æ—Ä–µ–ª–∞–∫—Å–∞–Ω—Ç–æ–≤ —Ü–µ–Ω—Ç—Ä–∞–ª—å–Ω–æ–≥–æ –¥–µ–π—Å—Ç–≤–∏—è –≤—ã—Ä–æ—Å–ª–∏ –Ω–∞ 16,8% –≤ –¥–µ–Ω—å–≥–∞—Ö –∏ –Ω–∞ 9,2% –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö –≥–æ–¥ –∫ –≥–æ–¥—É (14,2 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ –Ω–∞ 6,9 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π). –°–ø—Ä–æ—Å –Ω–∞ —ç—Ç—É –∫–∞—Ç–µ–≥–æ—Ä–∏—é –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ —Ä–∞—Å—Ç—ë—Ç –Ω–µ—Å–∫–æ–ª—å–∫–æ –ª–µ—Ç, –≥–æ–≤–æ—Ä—è—Ç –≤ RNC Pharma, –ø—Ä–∏—á—ë–º –≤ –æ—Å–Ω–æ–≤–Ω–æ–º –∑–∞ —Å—á—ë—Ç –Ω–æ–≤–∏–Ω–æ–∫. –†–æ–∑–Ω–∏—á–Ω—ã–π —Å–µ–≥–º–µ–Ω—Ç —Ä—ã–Ω–∫–∞ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω 23 –±—Ä–µ–Ω–¥–∞–º–∏ –æ—Ç 28 –∫–æ–º–ø–∞–Ω–∏–π, –∫–æ—Ç–æ—Ä—ã–µ –≤–∫–ª—é—á–∞—é—Ç –¥–µ–≤—è—Ç—å –ú–ù–ù. –ë–æ–ª–µ–µ 62% —Ä—É–±–ª—ë–≤–æ–≥–æ —Ä—ã–Ω–∫–∞ –æ–±–µ—Å–ø–µ—á–∏–≤–∞–µ—Ç –≤–µ–Ω–≥–µ—Ä—Å–∫–∞—è ¬´–ì–µ–¥–µ–æ–Ω –†–∏—Ö—Ç–µ—Ä¬ª —Å–æ —Å–≤–æ–∏–º –∫–ª—é—á–µ–≤—ã–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–º ‚Äî –ú–∏–¥–æ–∫–∞–ª–º–æ–º (–ú–ù–ù —Ç–æ–ª–ø–µ—Ä–∏–∑–æ–Ω), —Å–µ—Ä—å—ë–∑–Ω–æ –æ–±–æ–≥–Ω–∞–≤—à–∏–º –æ—Å—Ç–∞–ª—å–Ω—ã–µ —Ç–æ—Ä–≥–æ–≤—ã–µ –º–∞—Ä–∫–∏ –ø–æ –æ–±—ä—ë–º—É –¥–µ–Ω–µ–∂–Ω—ã—Ö –ø—Ä–æ–¥–∞–∂. –ù–∞ –≤—Ç–æ—Ä–æ–π —Å—Ç—Ä–æ—á–∫–µ –ø–æ –ø–æ–ø—É–ª—è—Ä–Ω–æ—Å—Ç–∏ —É —Ä–æ—Å—Å–∏—è–Ω ‚Äî –°–∏—Ä–¥–∞–ª—É–¥ (–ú–ù–ù —Ç–∏–∑–∞–Ω–∏–¥–∏–Ω) –æ—Ç ¬´–°–∞–Ω–¥–æ–∑¬ª, –Ω–∞ —Ç—Ä–µ—Ç—å–µ–π ‚Äî –Ω–µ–±—Ä–µ–Ω–¥–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã —Ç–æ–ª–ø–µ—Ä–∏–∑–æ–Ω–∞ –æ—Ç –¥–µ–≤—è—Ç–∏ —Ä–∞–∑–Ω—ã—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –≤–æ –≥–ª–∞–≤–µ —Å ¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º–æ–º¬ª. –û—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω—É—é –¥–∏–Ω–∞–º–∏–∫—É –≤ –æ—Ç—á—ë—Ç–Ω—ã–π –ø–µ—Ä–∏–æ–¥ –ø–æ–∫–∞–∑–∞–ª —Ç–æ–ª—å–∫–æ –¢–æ–ª–∏–∑–æ—Ä (–ú–ù–ù —Ç–æ–ª–ø–µ—Ä–∏–∑–æ–Ω) –æ—Ç ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∏¬ª, –ø–æ—Ç–µ—Ä—è–≤—à–∏–π 7% –≤ –¥–µ–Ω—å–≥–∞—Ö. –ú–∞–∫—Å–∏–º–∞–ª—å–Ω—ã–º–∏ —Ç–µ–º–ø–∞–º–∏ —Ä–æ—Å—Ç–∞ –º–æ–∂–µ—Ç –ø–æ—Ö–≤–∞—Å—Ç–∞—Ç—å—Å—è —Ä–∞—Å—Ç–≤–æ—Ä –¥–ª—è –≤–Ω—É—Ç—Ä–∏–º—ã—à–µ—á–Ω–æ–≥–æ –≤–≤–µ–¥–µ–Ω–∏—è –¢–æ–ª–ø–µ—Ä–∏–∑–æ–Ω+–ª–∏–¥–æ–∫–∞–∏–Ω –æ—Ç —á–µ—Ç—ã—Ä—ë—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π (–≤ –ª–∏–¥–µ—Ä–∞—Ö ‚Äî ¬´–•–∏–º—Ñ–∞—Ä–º¬ª). –í —Ç–æ–ø-10 —Ç–æ—Ä–≥–æ–≤—ã—Ö –º–∞—Ä–æ–∫ –º–∏–æ—Ä–µ–ª–∞–∫—Å–∞–Ω—Ç–æ–≤ —Ü–µ–Ω—Ç—Ä–∞–ª—å–Ω–æ–≥–æ –¥–µ–π—Å—Ç–≤–∏—è —Ç–∞–∫–∂–µ –≤–æ—à–ª–∏: –ë–∞–∫–ª–æ—Å–∞–Ω (¬´–ê–∫—Ä–∏—Ö–∏–Ω¬ª), –ö–∞–ª–º–∏—Ä–µ–∫—Å (¬´–°–æ—Ç–µ–∫—Å¬ª), –õ–∏–¥–∞–º–∏—Ç–æ–ª (¬´–ì—Ä–æ—Ç–µ–∫—Å¬ª), –¢–∏–∑–∞–Ω–∏–¥–∏–Ω (¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª + 3 –∫–æ–º–ø–∞–Ω–∏–∏), –†–µ–ª–æ–ø—Ä–∏–º (¬´–ê–∫—Ä–∏—Ö–∏–Ω¬ª). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""Sales of central muscle relaxants grew by 16.8% in RUB and 9.2% in units year-over-year (from 14.2 million units to RUB6.9 billion) in the first eight months of 2025. The market for this category of drugs has been growing steadily over the past few years, according to RNC Pharma. The retail segment of the market is represented by 23 brands from 28 companies, including nine active substances. More than 62% of the RUB market is covered by Hungarian 'Gedeon Richter' with its key product Midokalm (active substance tolperizone), significantly outperforming other branded products in terms of sales volume. The second most popular brand among Russians is Sidalud (active substance tilidine) from 'Sandoz', followed by generic versions of tolperizone from nine different manufacturers led by 'Binofarma'. Only Tolic (active substance tolperizone) from 'Ozon Farmakvetika' lost "
2025-10-13T15:59:54+00:00,@bezrec,6680,https://t.me/bezrec/6680,"–ó–∞ –¥–∏–∞–≥–Ω–æ–∑–æ–º –∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–æ–º ‚Äî –≤ –ò–ò-–∫–∏–æ—Å–∫. –í –ö–∏—Ç–∞–µ –Ω–∞—á–∞–ª–∏ —É—Å—Ç–∞–Ω–∞–≤–ª–∏–≤–∞—Ç—å –∞–ø–ø–∞—Ä–∞—Ç—ã —Å –ò–ò, –∫–æ—Ç–æ—Ä—ã–µ –º–æ–≥—É—Ç –≤ –Ω–µ—Å–ª–æ–∂–Ω—ã—Ö —Å–ª—É—á–∞—è—Ö –∑–∞–º–µ–Ω–∏—Ç—å –≤—Ä–∞—á–∞. –ß—É–¥–æ-–∞–ø–ø–∞—Ä–∞—Ç –∑–∞ —Å—á–∏—Ç–∞–Ω–Ω—ã–µ –º–∏–Ω—É—Ç—ã –∏–∑–º–µ—Ä–∏—Ç –¥–∞–≤–ª–µ–Ω–∏–µ, —Ç–µ–º–ø–µ—Ä–∞—Ç—É—Ä—É, –ø—É–ª—å—Å –∏ –¥—Ä—É–≥–∏–µ –ø–∞—Ä–∞–º–µ—Ç—Ä—ã –∏ –Ω–∞ –æ—Å–Ω–æ–≤–∞–Ω–∏–∏ —Ç–∞–∫–æ–≥–æ ¬´–æ—Å–º–æ—Ç—Ä–∞¬ª –ø–æ—Å—Ç–∞–≤–∏—Ç –¥–∏–∞–≥–Ω–æ–∑, –∞ —Ç–∞–∫–∂–µ –≤—ã–¥–∞—Å—Ç –Ω—É–∂–Ω–æ–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–æ. –î–∞–∂–µ –≤ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏–µ –∏–¥—Ç–∏ –Ω–µ –Ω–∞–¥–æ ‚Äî ¬´—É–º–Ω—ã–µ¬ª –∫–∏–æ—Å–∫–∏ –ø–æ—è–≤–ª—è—é—Ç—Å—è –≤ —Ç–æ—Ä–≥–æ–≤—ã—Ö —Ü–µ–Ω—Ç—Ä–∞—Ö, –≤–æ–∫–∑–∞–ª–∞—Ö –∏ –¥—Ä—É–≥–∏—Ö –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –º–µ—Å—Ç–∞—Ö. –ü—Ä–µ–¥–ø–æ–ª–∞–≥–∞–µ—Ç—Å—è, —á—Ç–æ –Ω–æ–≤–æ–≤–≤–µ–¥–µ–Ω–∏–µ —Ä–∞–∑–≥—Ä—É–∑–∏—Ç –º–µ–¥–∏–∫–æ–≤. –ù–æ –∫–∞–∫ –±—ã –Ω–µ –≤—ã—à–ª–æ –Ω–∞–æ–±–æ—Ä–æ—Ç, –∏ –≤—Ä–∞—á–∞–º –Ω–µ –ø—Ä–∏—à–ª–æ—Å—å –ø–µ—Ä–µ–ª–µ—á–∏–≤–∞—Ç—å —Ç–∞–∫–∏—Ö ¬´—Å–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω—ã—Ö¬ª –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –∏ —Ä–∞–∑–±–∏—Ä–∞—Ç—å—Å—è –≤ –æ—Å–ª–æ–∂–Ω–µ–Ω–∏—è—Ö –∑–∞–ø—É—â–µ–Ω–Ω—ã—Ö –±–æ–ª–µ–∑–Ω–µ–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-10-13T13:59:54+00:00,@bezrec,6679,https://t.me/bezrec/6679,"–í –ú–∏–Ω–∑–¥—Ä–∞–≤–µ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –∏–∑–º–µ–Ω–∏—Ç—å –æ–ø–ª–∞—Ç—É –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π ‚ô¶Ô∏è–§–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –ø–æ—Ç–µ—Ä—è—é—Ç –ø—Ä–∞–≤–æ –ø–ª–∞—Ç–∏—Ç—å –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—è–º –Ω–∞–ø—Ä—è–º—É—é, –≤—ã–ø–ª–∞—Ç—ã –ø–æ—Å—Ç—É–ø—è—Ç –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏, –∫–æ—Ç–æ—Ä–∞—è –∑–∞—Ç–µ–º –∏—Ö —Ä–∞—Å–ø—Ä–µ–¥–µ–ª–∏—Ç. –í–µ–¥–æ–º—Å—Ç–≤–æ –æ–±–æ—Å–Ω–æ–≤—ã–≤–∞–µ—Ç –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤—É –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç—å—é —Å–Ω–∏–∑–∏—Ç—å —Ä–∏—Å–∫ –∫–æ–Ω—Ñ–ª–∏–∫—Ç–∞ –∏–Ω—Ç–µ—Ä–µ—Å–æ–≤ –∏ –ø–æ–≤—ã—Å–∏—Ç—å –Ω–µ–∑–∞–≤–∏—Å–∏–º–æ—Å—Ç—å –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª–µ–π. –≠–∫—Å–ø–µ—Ä—Ç—ã —Å—á–∏—Ç–∞—é—Ç, —á—Ç–æ –ø—Ä–µ–¥–ª–∞–≥–∞–µ–º–∞—è —Å—Ö–µ–º–∞ —É–≥—Ä–æ–∂–∞–µ—Ç —Å–∫–æ—Ä–æ—Å—Ç–∏ –∏ –∫–∞—á–µ—Å—Ç–≤–∞ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π. –î–ª—è —Å–Ω–∏–∂–µ–Ω–∏—è —Ä–∏—Å–∫–æ–≤ –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç—Å—è —Å–ª–µ–¥—É—é—â–∏–µ –º–µ—Ä—ã: üîµ–†–∞–∑—Ä–∞–±–æ—Ç–∫–∞ —Å—Ç–∞–Ω–¥–∞—Ä—Ç–æ–≤ –ø—Ä–æ–∑—Ä–∞—á–Ω–æ–≥–æ —Ä–∞—Å–ø—Ä–µ–¥–µ–ª–µ–Ω–∏—è —Å—Ä–µ–¥—Å—Ç–≤. üîµ–£–ø—Ä–æ—â—ë–Ω–Ω—ã–µ –ø—Ä–æ—Ü–µ–¥—É—Ä—ã –≤–Ω–µ—Å–µ–Ω–∏—è –∏–∑–º–µ–Ω–µ–Ω–∏–π –≤ —Å–æ—Å—Ç–∞–≤ –∫–æ–º–∞–Ω–¥—ã. üîµ–û–ø–µ—Ä–∞—Ç–∏–≤–Ω—ã–µ –º–µ—Ö–∞–Ω–∏–∑–º—ã –≤—ã–ø–ª–∞—Ç—ã –≤–æ–∑–Ω–∞–≥—Ä–∞–∂–¥–µ–Ω–∏–π. –û–¥–Ω–∞–∫–æ —Å–º—è–≥—á—ë–Ω–Ω—ã–µ —Ñ–æ—Ä–º—É–ª–∏—Ä–æ–≤–∫–∏ –æ—Ç—Ä–∞—Å–ª–µ–≤—ã—Ö –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–π –≤ —Ä–∞–º–∫–∞—Ö —Ä–∞–±–æ—á–µ–π –≥—Ä—É–ø–ø—ã –ø–æ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ –º–µ—Ö–∞–Ω–∏–∑–º–∞ ¬´—Ä–µ–≥—É–ª—è—Ç–æ—Ä–Ω–æ–π –≥–∏–ª—å–æ—Ç–∏–Ω—ã¬ª –≤ —Å—Ñ–µ—Ä–µ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∏ –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π —É–∂–µ –±—ã–ª–∏ –æ—Ç–≤–µ—Ä–≥–Ω—É—Ç—ã –ú–∏–Ω–∑–¥—Ä–∞–≤–æ–º –∏ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–æ–º ‚Äî –Ω–µ–∏–∑–≤–µ—Å—Ç–Ω–æ, –ø—Ä–∏—Å–ª—É—à–∞—é—Ç—Å—è –ª–∏ –æ–Ω–∏ —Ç–µ–ø–µ—Ä—å. ‚Ñ¢Ô∏è –ú–µ–¥–∫–∞—Ä—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health proposed changing the payment for clinical trials. Pharmaceutical companies will lose the right to pay researchers directly, and payments will be made by medical organizations which then distribute them. The ministry justifies the initiative to reduce conflict of interest risks and increase researchers' independence. Experts argue that the proposed scheme threatens the speed and quality of trials. Mitigation measures include developing transparent payment standards, simplifying team change procedures, and implementing prompt compensation mechanisms. However, softened industry association proposals within a working group on 'regulatory guillotine' in the pharmaceutical and medical device sectors have been rejected by the Ministry of Health and Roszdravnadzor, whose future acceptance is uncertain.""
}"
2025-10-13T11:54:54+00:00,@bezrec,6678,https://t.me/bezrec/6678,"¬´–ü—Ä–∏–≤–∏–≤–∫–∞ –¥–æ—Å—Ç–∞–µ—Ç—Å—è —Ç–æ–ª—å–∫–æ —Å–∞–º—ã–º —É–ø–æ—Ä–Ω—ã–º¬ª: –≤ –†–æ—Å—Å–∏–∏ –≤–æ–∑–Ω–∏–∫ –¥–µ—Ñ–∏—Ü–∏—Ç –≤–∞–∫—Ü–∏–Ω –æ—Ç –≤–µ—Ç—Ä—è–Ω–∫–∏. –í —Ä—è–¥–µ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö —Ä–µ–≥–∏–æ–Ω–æ–≤ –≤—Ä–∞—á–∏ —Ñ–∏–∫—Å–∏—Ä—É—é—Ç –≤—Å–ø–ª–µ—Å–∫ –∑–∞–±–æ–ª–µ–≤–∞–µ–º–æ—Å—Ç–∏ –≤–µ—Ç—Ä—è–Ω–∫–æ–π –∫–∞–∫ —Å—Ä–µ–¥–∏ –¥–µ—Ç–µ–π, —Ç–∞–∫ –∏ —Å—Ä–µ–¥–∏ –≤–∑—Ä–æ—Å–ª—ã—Ö. –ù–∞–ø—Ä–∏–º–µ—Ä, ¬´–ò–∑–≤–µ—Å—Ç–∏—è¬ª –ø–∏—à—É—Ç, —á—Ç–æ –Ω–∞ –Ø–º–∞–ª–µ –ø–æ–∫–∞–∑–∞—Ç–µ–ª—å —É–≤–µ–ª–∏—á–∏–ª—Å—è –Ω–∞ 67%, –≤ –ë–∞—à–∫–∏—Ä–∏–∏ ‚Äî –±–æ–ª–µ–µ, —á–µ–º –≤–¥–≤–æ–µ. –ï–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –≤–µ—Ç—Ä—è–Ω–æ–π –æ—Å–ø—ã –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º —Ä—ã–Ω–∫–µ ‚Äî –í–∞—Ä–∏–ª—Ä–∏–∫—Å –æ—Ç GSK. –ü–æ –¥–∞–Ω–Ω—ã–º RNC Pharm–∞, –≤ —è–Ω–≤–∞—Ä–µ‚Äì–∞–≤–≥—É—Å—Ç–µ 2025 –≥–æ–¥–∞ –≤ –†–§ –ø—Ä–∏–≤–µ–∑–ª–∏ –ø–æ—á—Ç–∏ 400 —Ç—ã—Å. –¥–æ–∑ –≤–∞–∫—Ü–∏–Ω—ã. –î–ª—è —Å—Ä–∞–≤–Ω–µ–Ω–∏—è –∑–∞ –≤–µ—Å—å 2024 –≥–æ–¥ —Ä—ã–Ω–æ–∫ –ø–æ–ª—É—á–∏–ª 281,3 —Ç—ã—Å. –¥–æ–∑. –ü–æ —Å–ª–æ–≤–∞–º –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –ø–æ —Ä–∞–∑–≤–∏—Ç–∏—é –∞–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ –ù–∏–∫–æ–ª–∞—è –ë–µ—Å–ø–∞–ª–æ–≤–∞, –≤ —ç—Ç–æ–º –≥–æ–¥—É –ø–æ—Å—Ç–∞–≤–∫–∏ —Ä–µ–≥—É–ª—è—Ä–Ω—ã–µ, –ø–æ—Å–ª–µ–¥–Ω—è—è –∏–∑ 33 —Ç—ã—Å. –¥–æ–∑ –ø—Ä–æ—à–ª–∞ –≤ –∞–≤–≥—É—Å—Ç–µ. –¢–µ–º –Ω–µ –º–µ–Ω–µ–µ, –æ–± –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–∏ –≤–∞–∫—Ü–∏–Ω—ã –¥–∞–∂–µ –≤ —á–∞—Å—Ç–Ω—ã—Ö –∫–ª–∏–Ω–∏–∫–∞—Ö —Å–æ–æ–±—â–∞—é—Ç –∂–∏—Ç–µ–ª–∏ –ë–∞—à–∫–∏—Ä–∏–∏, –¢–∞—Ç–∞—Ä—Å—Ç–∞–Ω–∞, –ö—Ä–∞—Å–Ω–æ–¥–∞—Ä—Å–∫–æ–≥–æ –∫—Ä–∞—è, –°–≤–µ—Ä–¥–ª–æ–≤—Å–∫–æ–π, –í–æ—Ä–æ–Ω–µ–∂—Å–∫–æ–π, –°–∞–º–∞—Ä—Å–∫–æ–π, –ö–∏—Ä–æ–≤—Å–∫–æ–π, –†–æ—Å—Ç–æ–≤—Å–∫–æ–π –∏ –ß–µ–ª—è–±–∏–Ω—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–µ–π. –û—Ç–¥–µ–ª—å–Ω—ã–µ –∂–∞–ª–æ–±—ã –ø—Ä–∏—Ö–æ–¥—è—Ç –∏ –∏–∑ –ú–æ—Å–∫–≤—ã. –ù–µ—Ö–≤–∞—Ç–∫–∞ –í–∞—Ä–∏–ª—Ä–∏–∫—Å–∞ –≤ —Ä–µ–≥–∏–æ–Ω–∞—Ö –º–æ–≥–ª–∞ –≤–æ–∑–Ω–∏–∫–Ω—É—Ç—å –∏–∑-–∑–∞ –ø—Ä–æ–±–ª–µ–º –≤ –ª–æ–≥–∏—Å—Ç–∏–∫–µ –∏–ª–∏ –Ω–µ–∫–æ—Ä—Ä–µ–∫—Ç–Ω–æ–≥–æ –ø–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω–∏—è –∑–∞–∫—É–ø–æ–∫, —Å—á–∏—Ç–∞–µ—Ç –ë–µ—Å–ø–∞–ª–æ–≤. –ú–Ω–µ —Å–æ–æ–±—â–∞—é—Ç –æ —Å–ª—É—á–∞—è—Ö, –∫–æ–≥–¥–∞ –∂–∏—Ç–µ–ª–∏ –ï–∫–∞—Ç–µ—Ä–∏–Ω–±—É—Ä–≥–∞ –ª–µ—Ç–∞–ª–∏ –≤ –ø–æ–∏—Å–∫–∞—Ö –≤–∞–∫—Ü–∏–Ω—ã –¥–ª—è —Ä–µ–±–µ–Ω–∫–∞ –≤ –ú–æ—Å–∫–≤—É. –¢–∞–º —Å –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å—é –Ω–µ–º–Ω–æ–≥–æ –ø—Ä–æ—â–µ ‚Äî –∫–∞–∫ –º–∏–Ω–∏–º—É–º –∏–∑-–∑–∞ –±–æ–ª—å—à–æ–≥–æ –∫–æ–ª–∏—á–µ—Å—Ç–≤–∞ —á–∞—Å—Ç–Ω—ã—Ö –∫–ª–∏–Ω–∏–∫, —É—Å–ø–µ–≤–∞—é—â–∏—Ö ¬´—É—Ä–≤–∞—Ç—å¬ª —Å–µ–±–µ –Ω–µ–∫–æ—Ç–æ—Ä–æ–µ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –¥–æ–∑. –Ø –æ—Ü–µ–Ω–∏–≤–∞—é —Å–∏—Ç—É–∞—Ü–∏—é –∫–∞–∫ –æ—Å—Ç—Ä—ã–π –¥–µ—Ñ–∏—Ü–∏—Ç ‚Äî —Å–ø—Ä–æ—Å –≤ —Ä–∞–∑—ã –≤—ã—à–µ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è. –ü—Ä–∏–≤–∏–≤–∫–∞ –¥–æ—Å—Ç–∞–µ—Ç—Å—è —Ç–æ–ª—å–∫–æ —Å–∞–º—ã–º —É–ø–æ—Ä–Ω—ã–º, ‚Äî –ø—Ä–æ–∫–æ–º–º–µ–Ω—Ç–∏—Ä–æ–≤–∞–ª–∞ —Å–∏—Ç—É–∞—Ü–∏—é –¥–∏—Ä–µ–∫—Ç–æ—Ä –∏ —Å–æ—É—á—Ä–µ–¥–∏—Ç–µ–ª—å –ê–ù–û ¬´–ö–æ–ª–ª–µ–∫—Ç–∏–≤–Ω—ã–π –∏–º–º—É–Ω–∏—Ç–µ—Ç¬ª –ê–Ω—Ç–æ–Ω–∏–Ω–∞ –û–±–ª–∞—Å–æ–≤–∞. –°–≤–æ—é –≤–∞–∫—Ü–∏–Ω—É –æ—Ç –≤–µ—Ç—Ä—è–Ω–∫–∏ –¥–ª—è –¥–µ—Ç–µ–π –≤ –≤–æ–∑—Ä–∞—Å—Ç–µ –æ—Ç 9 –º–µ—Å—è—Ü–µ–≤ –¥–æ 17 –ª–µ—Ç —Å–µ–π—á–∞—Å –∏—Å—Å–ª–µ–¥—É–µ—Ç ¬´–ù–∞–Ω–æ–ª–µ–∫¬ª. –ò—Å–ø—ã—Ç–∞–Ω–∏—è –æ–±–µ—â–∞—é—Ç –∑–∞–≤–µ—Ä—à–∏—Ç—å –≤–æ –≤—Ç–æ—Ä–æ–π –ø–æ–ª–æ–≤–∏–Ω–µ 2026 –≥–æ–¥–∞. –ü—Ä–µ–ø–∞—Ä–∞—Ç —Ä–∞–∑—Ä–∞–±–∞—Ç—ã–≤–∞–µ—Ç—Å—è —Å–æ–≤–º–µ—Å—Ç–Ω–æ —Å —é–∂–Ω–æ–∫–æ—Ä–µ–π—Å–∫–æ–π GC Biopharma, –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –±—É–¥–µ—Ç –ø–æ–ª–Ω–æ—Å—Ç—å—é –ª–æ–∫–∞–ª–∏–∑–æ–≤–∞–Ω–æ –≤ –ö–∏—Ä–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏. –¢–∞–º –∂–µ –±—É–¥—É—Ç –≤—ã–ø—É—Å–∫–∞—Ç—å –≤–∞–∫—Ü–∏–Ω—ã –ø—Ä–æ—Ç–∏–≤ –º–µ–Ω–∏–Ω–≥–æ–∫–æ–∫–∫–∞ –∏ –í–ü–ß. –í –ø—Ä–æ–µ–∫—Ç –≤–ª–æ–∂–∞—Ç –±–æ–ª–µ–µ 15 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –í –≤–∞–∂–Ω–æ–º –¥–µ–ª–µ –ø–æ—É—á–∞—Å—Ç–≤—É–µ—Ç –∏ ¬´–ì–∞–∑–ø—Ä–æ–º–±–∞–Ω–∫¬ª. –°—Ç–æ—Ä–æ–Ω—ã –Ω–∞—Ö–æ–¥—è—Ç—Å—è –≤ –ø—Ä–æ—Ü–µ—Å—Å–µ –ø—Ä–∏–≤–ª–µ—á–µ–Ω–∏—è –∑–∞–µ–º–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –≤ —Ä–∞–∑–º–µ—Ä–µ 10 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –≤ —Ä–∞–º–∫–∞—Ö –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ ¬´–û –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π –ø–æ–¥–¥–µ—Ä–∂–∫–µ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π, —Ä–µ–∞–ª–∏–∑—É—é—â–∏—Ö –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–æ–Ω–Ω—ã–µ –ø—Ä–æ–µ–∫—Ç—ã, –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–Ω—ã–µ –Ω–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –ø—Ä–∏–æ—Ä–∏—Ç–µ—Ç–Ω–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, demand, vaccine"",
  ""impact"": ""high"",
  ""english"": ""A shortage of the GSK vaccine Varilrix for rubella has been reported in Russia. The country is facing a significant increase in cases of rubella, both among children and adults. The shortage has led to patients traveling from various regions such as YAMAL, Bashkiriya, Krasnodar Krai, Sverdlovskaya Oblast, Voronezhskaya Oblast, Samarskaya Oblast, Kirovskaya Oblast, Rostovskaya Oblast, and Chelyabinskaya Oblast to find the vaccine. The situation is described as an acute shortage, with demand far exceeding supply.""
}"
2025-10-13T08:39:54+00:00,@bezrec,6677,https://t.me/bezrec/6677,"–ï—â—ë –æ–¥–∏–Ω –æ–Ω–∫–æ–ø—Ä–µ–ø–∞—Ä–∞—Ç –æ—Ç ¬´–ê–º–µ–¥–∞—Ä—Ç¬ª —Å—Ç–∞–ª –≤–¥–≤–æ–µ –¥–µ—à–µ–≤–ª–µ. –§–ê–° —Å–æ–≥–ª–∞—Å–æ–≤–∞–ª–∞ —Ü–µ–Ω—É –Ω–∞ –≤—Ç–æ—Ä–æ–π –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π –¥–∂–µ–Ω–µ—Ä–∏–∫ –≤ —Ä–∞–º–∫–∞—Ö –ú–ù–ù –ò–±—Ä—É—Ç–∏–Ω–∏–±. –ò–±—Ä—É—Ç–∏–Ω–∏–±-–ê–º–µ–¥–∞—Ä—Ç —Å—Ç–∞–ª –Ω–∞ 50% –¥–µ—à–µ–≤–ª–µ –ò–º–±—Ä—É–≤–∏–∫–∏ –æ—Ç ¬´–î–∂–æ–Ω—Å–æ–Ω & –î–∂–æ–Ω—Å–æ–Ω¬ª. –ü—Ä–µ–ø–∞—Ä–∞—Ç—ã —Å —ç—Ç–∏–º –¥–µ–π—Å—Ç–≤—É—é—â–∏–º –≤–µ—â–µ—Å—Ç–≤–æ–º –æ—Ç–Ω–æ—Å—è—Ç—Å—è –∫ –≥—Ä—É–ø–ø–µ –ø—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –∏ –∏—Å–ø–æ–ª—å–∑—É—é—Ç—Å—è –≤ –æ–Ω–∫–æ–≥–µ–º–∞—Ç–æ–ª–æ–≥–∏–∏. –ö–∞–ø—Å—É–ª–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –≤ –¥–æ–∑–∏—Ä–æ–≤–∫–µ 140 –º–≥ —Ç–µ–ø–µ—Ä—å —Å—Ç–æ–∏—Ç 2 141 —Ä—É–±–ª—å –ø—Ä–æ—Ç–∏–≤ 4 283 —Ä—É–±–ª—è –∑–∞ –∞–Ω–∞–ª–æ–≥–∏—á–Ω—É—é –¥–æ–∑–∏—Ä–æ–≤–∫—É —Ä–µ—Ñ–µ—Ä–µ–Ω—Ç–Ω–æ–≥–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞. –°–Ω–∏–∑–∏—Ç—å —Ü–µ–Ω—É –Ω–∞ 16,67% –Ω–∞ —Å–≤–æ–π –ò–±—Ä—É—Ç–∏–Ω–∏–± —Ç–µ–ø–µ—Ä—å –ø—Ä–∏–¥—ë—Ç—Å—è –∏ ¬´–ü—Ä–æ–º–æ–º–µ–¥—É¬ª. –†–µ–≥—É–ª—è—Ç–æ—Ä –Ω–∞–ø—Ä–∞–≤–∏—Ç —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–µ–µ —É–≤–µ–¥–æ–º–ª–µ–Ω–∏–µ –∫–æ–º–ø–∞–Ω–∏–∏ –ü–µ—Ç—Ä–∞ –ë–µ–ª–æ–≥–æ. –ù–∞ –ø—Ä–æ—à–ª–æ–π –Ω–µ–¥–µ–ª–µ —Å—Ç–∞—Ä–∞–Ω–∏—è–º–∏ –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å—â–∏–∫–æ–≤ –Ω–∞ 50% –ø–æ–¥–µ—à–µ–≤–µ–ª –ø—Ä–æ—Ç–∏–≤–æ–æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–π –†–µ–≥–æ—Ä–∞—Ñ–µ–Ω–∏–±-–ê–º–µ–¥–∞—Ä—Ç. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""pricing, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The price of the second domestically produced generic Ibrutinib from 'Amedart' has been reduced by 50% to RUB2,141 from RUB4,283. The regulator will issue a notification to 'Promomed' for reducing the price of their Ibrutinib by 16.67%. Last week, due to antimonopoly efforts, the price of another oncology drug Regorafenib from 'Amedart' was reduced by 50%.""
}"
2025-10-13T05:44:54+00:00,@bezrec,6676,https://t.me/bezrec/6676,"–†–æ—Å—Å—Ç–∞—Ç –æ—Ç—á–∏—Ç–∞–ª—Å—è –æ –¥–∏–Ω–∞–º–∏–∫–µ —Ü–µ–Ω –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –≤ —Å–µ–Ω—Ç—è–±—Ä–µ 2025 –≥–æ–¥–∞. –¶–µ–Ω—ã –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –Ω–µ –∏–∑ –ø–µ—Ä–µ—á–Ω—è –ñ–ù–í–õ–ü –≤ —Å—Ä–µ–¥–Ω–µ–º –∏–∑–º–µ–Ω–∏–ª–∏—Å—å –Ω–∞ +1,4%: - –ª–µ–≤–æ–º–µ–∫–æ–ª—å +5,8%; - –≥—Ä–∞–º–º–∏–¥–∏–Ω +3,1%; - –ª–∏–∑–æ–±–∞–∫—Ç +2,5%; - –∞—Å–∫–æ—Ñ–µ–Ω-–ü +2,3%; - –º–µ—Ç–∏–ª—É—Ä–∞—Ü–∏–ª +2,2%; - –Ω–∞—Ñ–∞–∑–æ–ª–∏–Ω +2,1%; - –≥–µ–ø–∞—Ä–∏–Ω–æ–≤–∞—è –º–∞–∑—å –∏ –∞–∫—Ç–∏–≤–∏—Ä–æ–≤–∞–Ω–Ω—ã–π —É–≥–æ–ª—å +1,9%; - –∫–µ—Ç–æ—Ä–æ–ª —ç–∫—Å–ø—Ä–µ—Å—Å +1,8%; - –Ω–∏–º–µ—Å—É–ª–∏–¥ –∏ –∫–∞—Ä–¥–∏–æ–º–∞–≥–Ω–∏–ª +1,6%. –¶–µ–Ω—ã –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, –æ—Ç–Ω–æ—Å—è—â–∏–µ—Å—è –∫ –ñ–ù–í–õ–ü, –≤ —Å—Ä–µ–¥–Ω–µ–º –∏–∑–º–µ–Ω–∏–ª–∏—Å—å –Ω–∞ +0,9%: - –∏–±—É–ø—Ä–æ—Ñ–µ–Ω +2,1%; - –Ω–∞—Ç—Ä–∏—è —Ö–ª–æ—Ä–∏–¥ +1,7%; - –æ–º–µ–ø—Ä–∞–∑–æ–ª –∏ —Ü–µ—Ñ—Ç—Ä–∏–∞–∫—Å–æ–Ω +1,6%; - –≤–µ—Ä–æ—à–ø–∏—Ä–æ–Ω –∏ –≥—Ä–∏–ø–ø—Ñ–µ—Ä–æ–Ω +1,1%; - –¥–∏–∫–ª–æ—Ñ–µ–Ω–∞–∫ –∏ —Å–∞–ª–∏—Ü–∏–ª–æ–≤–∞—è –∫–∏—Å–ª–æ—Ç–∞ +1,0%. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""pricing, shortage"",
  ""impact"": ""medium"",
  ""english"": ""Russia's Rosstat reported on the September 2025 price dynamics of medicines. Prices for non-listed drugs (levo-mecobalamin, gramidin, lysobac, ascofen-P, methyluracil, nefazolin, heparin ointment and activated charcoal) increased on average by +1.4%. Prices for drugs listed under the HEVLP (ibuprofen, sodium chloride, omeprazole and cephrithrixon, veroshpiron and gripferon, diclofenac and salicylic acid) increased on average by +0.9%. No prescription medicines were included in the list.""
}"
2025-10-12T11:04:01+00:00,@bezrec,6675,https://t.me/bezrec/6675,"–ü—Ä–æ–ø–∏—Å—ã–≤–∞—é –≤–∞–º ... –®–≤–µ—Ü–∏—é. –®–≤–µ—Ü–∏—è —Å–∞–º–∞ —Å–µ–±—è –ø—Ä–∏–∑–Ω–∞–ª–∞ ¬´–ª–µ—á–µ–±–Ω–æ–π¬ª —Å—Ç—Ä–∞–Ω–æ–π. –ù–µ–æ–±—ã—á–Ω—ã–π –ø—Ä–æ–µ–∫—Ç –∑–∞–ø—É—Å—Ç–∏–ª–∞ —Ç—É—Ä–∏—Å—Ç–∏—á–µ—Å–∫–∞—è –∫–æ–º–ø–∞–Ω–∏—è Visit Sweden. –ù–∞ –µ—ë —Å–∞–π—Ç–µ –º–æ–∂–Ω–æ —Å–∫–∞—á–∞—Ç—å –±–ª–∞–Ω–∫, –≤ –∫–æ—Ç–æ—Ä–æ–º –ø–µ—Ä–µ—á–∏—Å–ª–µ–Ω–æ, –∫–∞–∫ –º–æ–∂–Ω–æ –æ–∑–¥–æ—Ä–æ–≤–∏—Ç—å—Å—è, —Å—ä–µ–∑–¥–∏–≤ –≤ –®–≤–µ—Ü–∏—é. –ß—É–¥–æ —Å –æ—Ä–≥–∞–Ω–∏–∑–º–æ–º –¥–æ–ª–∂–Ω—ã —Å–æ—Ç–≤–æ—Ä–∏—Ç—å –∫—Ä–∞—Å–∏–≤–∞—è –ø—Ä–∏—Ä–æ–¥–∞, —Å–∞—É–Ω–∞ –∏ –∫—É–ª—å—Ç—É—Ä–Ω—ã–π –¥–æ—Å—É–≥. –í —Ç–µ–æ—Ä–∏–∏ –≤—Ä–∞—á –º–æ–∂–µ—Ç –ø—Ä–æ–ø–∏—Å–∞—Ç—å –ø–∞—Ü–∏–µ–Ω—Ç—É —Ç–∞–∫—É—é —Ü–µ–ª–∏—Ç–µ–ª—å–Ω—É—é –ø–æ–µ–∑–¥–∫—É. –ü—Ä–∞–≤–¥–∞, –ø–ª–∞—Ç–∏—Ç—å –∑–∞ –Ω–µ—ë –ø—Ä–∏–¥—ë—Ç—Å—è —Å–∞–º–æ–º—É. –ù–∞–º –ø–æ–¥–¥–µ—Ä–∂–∏–≤–∞—é—â–∏–π –∫–∞–º–ø–∞–Ω–∏—é —Ä–æ–ª–∏–∫ —Å —É—á–∞—Å—Ç–∏–µ–º –ø—Ä–æ—Ñ–µ—Å—Å–æ—Ä–∞ –ö–∞—Ä–æ–ª–∏–Ω—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ –ò–≤–æ–Ω–Ω –§–æ—Ä—Å–µ–ª–ª –ø–æ–Ω—Ä–∞–≤–∏–ª—Å—è. –ò, –ø–æ—Ö–æ–∂–µ, —Ü–µ–ª—å –¥–æ—Å—Ç–∏–≥–Ω—É—Ç–∞ ‚Äî –≤ –®–≤–µ—Ü–∏—é –∑–∞—Ö–æ—Ç–µ–ª–æ—Å—å. –ñ–∞–ª—å, –¥–æ–∫—É–º–µ–Ω—Ç —Å —Å–∞–π—Ç–∞ Visit Sweden –Ω–µ –ø–æ–º–æ–∂–µ—Ç –ø–æ–ª—É—á–∏—Ç—å –≤–∏–∑—É. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-10-11T14:42:39+00:00,@bezrec,6674,https://t.me/bezrec/6674,"–ò —á—Ç–æ–±—ã –∑–∞–∫—Ä—ã—Ç—å —Ç–µ–º—É –ü–æ –Ω–∞—à–∏–º –¥–∞–Ω–Ω—ã–º, –Ω–µ—Å–∫–æ–ª—å–∫–æ –¥–Ω–µ–π –Ω–∞–∑–∞–¥ ¬´–¢—ã–º–ª–∞—Ç—Å–∫–æ–º—É —Ä—ã–±–æ–∫–æ–º–±–∏–Ω–∞—Ç—É¬ª –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –ø—Ä–æ–π—Ç–∏ –ø–æ–≤—Ç–æ—Ä–Ω—ã–µ –∏—Å–ø—ã—Ç–∞–Ω–∏—è –ø—Ä–æ–¥—É–∫—Ü–∏–∏. –û–¥–Ω–∞–∫–æ –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏–µ –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω–æ –æ—Ç–∫–∞–∑–∞–ª–æ—Å—å. –ü–æ—á—Ç–∏ –æ–¥–Ω–æ–≤—Ä–µ–º–µ–Ω–Ω–æ —Å —ç—Ç–∏–º –≤ –ø—Ä–æ—Ü–µ—Å—Å –≤–º–µ—à–∞–ª—Å—è –∞–¥–º–∏–Ω–∏—Å—Ç—Ä–∞—Ç–∏–≤–Ω—ã–π —Ä–µ—Å—É—Ä—Å ‚Äî –ø–æ—è–≤–∏–ª–æ—Å—å –ø—É–±–ª–∏—á–Ω–æ–µ –ø–∏—Å—å–º–æ –≥—É–±–µ—Ä–Ω–∞—Ç–æ—Ä–∞ –ö–∞–º—á–∞—Ç–∫–∏ –í–ª–∞–¥–∏–º–∏—Ä–∞ –°–æ–ª–æ–¥–æ–≤–∞ —Å –ø—Ä–æ—Å—å–±–æ–π –ø—Ä–æ—è—Å–Ω–∏—Ç—å —Å–∏—Ç—É–∞—Ü–∏—é. –£—á–∞—Å—Ç–∏–µ –≤—ã—Å–æ–∫–æ–ø–æ—Å—Ç–∞–≤–ª–µ–Ω–Ω—ã—Ö —á–∏–Ω–æ–≤–Ω–∏–∫–æ–≤ –≤ –ø–æ–¥–æ–±–Ω—ã—Ö –∏—Å—Ç–æ—Ä–∏—è—Ö –≤—Å–µ–≥–¥–∞ –Ω–µ—Å—ë—Ç —Ä–µ–ø—É—Ç–∞—Ü–∏–æ–Ω–Ω—ã–µ —Ä–∏—Å–∫–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""A public letter from the Governor of Kamchatka, Vladimir Solodov, requests clarification on a situation involving Yumalta Fish Combine. The company has officially declined to undergo repeat product testing, raising concerns about reputational risks when high-ranking officials are involved in such issues.""
}"
2025-10-11T11:24:15+00:00,@bezrec,6672,https://t.me/bezrec/6672,"¬´–¢—ã–º–ª–∞—Ç—Å–∫–∏–π —Ä—ã–±–æ–∫–æ–º–±–∏–Ω–∞—Ç¬ª –æ–ø—Ä–∞–≤–¥—ã–≤–∞–µ—Ç—Å—è –∑–∞ –û–º–µ–≥–∞-3. –û–¥–∏–Ω –Ω–µ–±–æ–ª—å—à–æ–π —Ç–µ–ª–µ–≥—Ä–∞–º-–∫–∞–Ω–∞–ª –≤–∑—è–ª—Å—è ¬´—Ä–∞–∑–≤–µ—è—Ç—å –≤—Å–µ —Å–æ–º–Ω–µ–Ω–∏—è¬ª –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ –∫–∞—á–µ—Å—Ç–≤–∞ –û–º–µ–≥–∏-3 ¬´–¢—ã–º–ª–∞—Ç—Å–∫–æ–≥–æ —Ä—ã–±–æ–∫–æ–º–±–∏–Ω–∞—Ç–∞¬ª. (–ú—ã –ø–æ–¥–æ–∑—Ä–µ–≤–∞–µ–º, —á—Ç–æ —Å –ø–æ–¥–∞—á–∏ –ø—Ä–µ—Å—Å-—Å–ª—É–∂–±—ã —Å–∞–º–æ–≥–æ –∫–æ–º–±–∏–Ω–∞—Ç–∞, –Ω–æ –Ω–µ –º–æ–∂–µ–º —ç—Ç–æ–≥–æ —É—Ç–≤–µ—Ä–∂–¥–∞—Ç—å) –ê–≤—Ç–æ—Ä—ã —Ç–∞–∫ —Ä–∞–∑–æ—à–ª–∏—Å—å, —á—Ç–æ –≤ —Ä–∞–∑—Ä—è–¥ ¬´–Ω–µ–¥–æ–±—Ä–æ—Å–æ–≤–µ—Å—Ç–Ω—ã—Ö –∏—Å—Ç–æ—á–Ω–∏–∫–æ–≤¬ª –ø–æ—Å—Ç–∞–≤–∏–ª–∏ –Ω–∞—à –∫–∞–Ω–∞–ª, —É–∫–∞–∑–∞–≤—à–∏–π –Ω–∞ –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ–µ —Å–æ–¥–µ—Ä–∂–∞–Ω–∏–µ –∂–∏—Ä–Ω—ã—Ö –∫–∏—Å–ª–æ—Ç –≤ –ë–ê–î–∞—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è, –∏ –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω—ã–π —Ç–µ–ª–µ–≥—Ä–∞–º-–∫–∞–Ω–∞–ª –†–æ—Å–∫–∞—á–µ—Å—Ç–≤–∞ —Å —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–∏–º –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ–º. –û—á–µ–Ω—å —Å–º–µ–ª–æ —Å –∏—Ö —Å—Ç–æ—Ä–æ–Ω—ã. –ù–∞–¥–µ–µ–º—Å—è, —á—Ç–æ —Ç–∞–∫–æ–µ –Ω–µ–¥–∞–ª—å–Ω–æ–≤–∏–¥–Ω–æ–µ –∑–∞—è–≤–ª–µ–Ω–∏–µ –≤ –ø—É–±–ª–∏–∫–∞—Ü–∏–∏ ‚Äî —ç—Ç–æ —Å–∞–º–æ–¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç—å –∞–≤—Ç–æ—Ä–æ–≤ –∫–∞–Ω–∞–ª–∞ –∏–ª–∏ –≤–æ–∑–º–æ–∂–Ω–æ –ø—Ä–µ—Å—Å-—Å–ª—É–∂–±—ã, –∏ —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–æ –≤ –ª–∏—Ü–µ –ê–ª–µ–∫—Å–∞–Ω–¥—Ä–∞ –õ–∏—Ç–≤–∏–Ω–µ–Ω–∫–æ –Ω–µ –≤ –∫—É—Ä—Å–µ —ç—Ç–æ–≥–æ. –ß—Ç–æ –¥–æ —Å–∞–º–æ–≥–æ —Ä—ã–±–æ–∫–æ–º–±–∏–Ω–∞—Ç–∞, —Ç–æ ¬´–µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω–æ–º—É –≤ –†–æ—Å—Å–∏–∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—é –ë–ê–î ¬´–û–º–µ–≥–∞-3 –∏–∑ –¥–∏–∫–æ–≥–æ –ö–∞–º—á–∞—Ç—Å–∫–æ–≥–æ –ª–æ—Å–æ—Å—è¬ª¬ª –ø—Ä–∏—à–ª–æ—Å—å –¥–∞–∂–µ —Å–æ–∑—ã–≤–∞—Ç—å —Ü–µ–ª—É—é –∫–æ–º–∏—Å—Å–∏—é. –í—Å–µ –Ω–µ—Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏—è –∫–æ–º–ø–∞–Ω–∏—è —Å–ø–∏—Å–∞–ª–∞ –Ω–∞ –ø–æ–≥—Ä–µ—à–Ω–æ—Å—Ç–∏ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–æ–≤ –ø—Ä–∏ —Ä–∞–∑–Ω—ã—Ö –º–µ—Ç–æ–¥–∞—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è, –∞ —Ç–∞–∫–∂–µ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–µ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å–Ω–æ —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–Ω–æ–≥–æ –ì–û–°–¢–∞ –∏ –µ–¥–∏–Ω–æ–π –º–µ—Ç–æ–¥–∏–∫–∏ —Ä–∞—Å—á—ë—Ç–∞ –∂–∏—Ä–Ω–æ–∫–∏—Å–ª–æ—Ç–Ω–æ–≥–æ —Å–æ—Å—Ç–∞–≤–∞ –≤ —Ä—ã–±–Ω–æ–º –∂–∏—Ä–µ. –ò –¥–∞–∂–µ –ø–æ–¥–∫–ª—é—á–∏–ª–∏ –≥—É–±–µ—Ä–Ω–∞—Ç–æ—Ä–∞ –ö–∞–º—á–∞—Ç–∫–∏ –í–ª–∞–¥–∏–º–∏—Ä–∞ –°–æ–ª–æ–¥–æ–≤–∞, –ø–æ–ø—Ä–æ—Å–∏–≤—à–µ–≥–æ –ê–ù–û ¬´–†–æ—Å–∫–∞—á–µ—Å—Ç–≤–æ¬ª –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–∏—Ç—å –¥–µ—Ç–∞–ª—å–Ω—ã–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è, –∏ –æ–Ω–æ –µ–º—É –Ω–µ –ø–æ–Ω—Ä–∞–≤–∏—Ç—Å—è. –û—Ñ–∏—Ü–∏–∞–ª—å–Ω—ã–µ –∑–∞–∫–ª—é—á–µ–Ω–∏—è –†–æ—Å–∫–∞—á–µ—Å—Ç–≤–∞ —Å –≤—ã—è–≤–ª–µ–Ω–Ω—ã–º–∏ —Ñ–∞–∫—Ç–∞–º–∏ –Ω–∞—Ä—É—à–µ–Ω–∏–π –ø—Ä–∏–∫–ª–∞–¥—ã–≤–∞–µ–º. –ò –ø—Ä–µ–¥–æ—Å—Ç–µ—Ä–µ–∂–µ–Ω–∏–µ –æ –Ω–µ–¥–æ–ø—É—Å—Ç–∏–º–æ—Å—Ç–∏ –Ω–∞—Ä—É—à–µ–Ω–∏—è –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã—Ö —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π –≤ –∞–¥—Ä–µ—Å –û–û–û ¬´–¢—ã–º–ª–∞—Ç—Å–∫–∏–π —Ä—ã–±–æ–∫–æ–º–±–∏–Ω–∞—Ç¬ª –∫–∞–º—á–∞—Ç—Å–∫–∏–π –†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä –≤—Å—ë-—Ç–∞–∫–∏ –æ–±—ä—è–≤–∏–ª. –í –∫–∞—á–µ—Å—Ç–≤–µ —Å–ø—Ä–∞–≤–∫–∏: ""–¢—ã–º–ª–∞—Ç—Å–∫–∏–π —Ä—ã–±–æ–∫–æ–º–±–∏–Ω–∞—Ç"" –≤—Ö–æ–¥–∏—Ç –≤ –ì–ö Salmonica, –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∞—â—É—é —Å–µ–º—å–µ –≥—É–±–µ—Ä–Ω–∞—Ç–æ—Ä–∞ –ü—Ä–∏–º–æ—Ä—Å–∫–æ–≥–æ –∫—Ä–∞—è –û–ª–µ–≥–∞ –ö–æ–∂–µ–º—è–∫–æ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration, reimbursement, pricing, shortage"",
  ""impact"": ""high"",
  ""english"": ""A Telegram channel 'Yamalty Fish Combine' is defending itself against Omega-3 quality. The authors of the article disagree, and one channel has been labeled as 'unscrupulous source' for pointing out low content of fatty acids in the products. The official Telegram channel Roskachestvo has a corresponding research. We suspect this is self-declaration or the press service of the company, but we can't confirm it. The 'Yamalty Fish Combine', a single producer of Omega-3 from wild Kamchatka salmon in Russia, had to assemble a commission. The company listed all discrepancies as measurement errors and the lack of a legally approved GOST and uniform method for calculating fatty acid content in fish oil. The governor of Kamchatka, Vladimir Solodov, was also asked to request detailed results from Roskachestvo. If he doesn't like the results, they will be a warning to OOO 'Yamalty Fish Combine'. As background: 'Yamalty Fish Combine' is part of the Salmonica Group"
2025-10-11T10:34:10+00:00,@bezrec,6671,https://t.me/bezrec/6671,"–≠—Ç–∞ –Ω–µ–¥–µ–ª—è –ø—Ä–æ—à–ª–∞ –ø–æ–¥ –∑–Ω–∞–∫–æ–º ¬´–ë–∏–æ–ø—Ä–æ–º–∞¬ª, –Ω–æ –±—ã–ª–∏ –∏ —Å–æ–±—ã—Ç–∏—è –≤–Ω–µ —Ñ–æ—Ä—É–º–∞. –û –Ω–∏—Ö ‚Äî –≤ –Ω–æ–≤–æ–º —Å—É–±–±–æ—Ç–Ω–µ–º –≤—ã–ø—É—Å–∫–µ —Ä—É–±—Ä–∏–∫–∏ #–≤–¥–æ–≥–æ–Ω–∫—É. üíä –ú–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–∞—è –∞—Å—Å–æ—Ü–∏–∞—Ü–∏—è ¬´–ê–Ω—Ç–∏–∫–æ–Ω—Ç—Ä–∞—Ñ–∞–∫—Ç¬ª –∑–∞–ø—É—Å—Ç–∏–ª–∞ –ø—É–±–ª–∏—á–Ω—ã–π —Ä–µ–µ—Å—Ç—Ä –ø—Ä–æ–≤–µ—Ä–µ–Ω–Ω—ã—Ö –ë–ê–î. –ú—ã —Å–æ–∑–¥–∞–µ–º –±–∞—Ä–æ–º–µ—Ç—Ä –¥–æ–≤–µ—Ä–∏—è: —Ä–µ–µ—Å—Ç—Ä –ø—Ä–æ–≤–µ—Ä–µ–Ω–Ω—ã—Ö –ë–ê–î, —á–µ—Ä–Ω—ã–π —Å–ø–∏—Å–æ–∫ –Ω–∞—Ä—É—à–∏—Ç–µ–ª–µ–π –∏ –æ–ø–µ—Ä–∞—Ç–∏–≤–Ω—ã–π –º–µ—Ö–∞–Ω–∏–∑–º –∂–∞–ª–æ–±. –ù–∞—à–∞ —Ü–µ–ª—å - –ª–∏—à–∏—Ç—å –Ω–µ–¥–æ–±—Ä–æ—Å–æ–≤–µ—Å—Ç–Ω—ã—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –∞–Ω–æ–Ω–∏–º–Ω–æ—Å—Ç–∏ –∏ –≤–µ—Ä–Ω—É—Ç—å —Ä—ã–Ω–∫—É –¥–æ–≤–µ—Ä–∏–µ. –ù–∞ –¥–∞–Ω–Ω—ã–π –º–æ–º–µ–Ω—Ç –≤ —Ä–µ–µ—Å—Ç—Ä–µ –Ω–µ–±–µ–∑–æ–ø–∞—Å–Ω–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –Ω–∞—Å—á–∏—Ç—ã–≤–∞–µ—Ç—Å—è 866 –Ω–∞–∏–º–µ–Ω–æ–≤–∞–Ω–∏–π, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª –≥–ª–∞–≤–∞ –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ –í–ª–∞–¥–∏—Å–ª–∞–≤ –†–µ–∑–Ω–∏–∫. üíä –ú–∏–Ω–∑–¥—Ä–∞–≤ –æ—Ç–º–µ—Ç–∏–ª —Ä–æ–ª—å –ò–ò –≤ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ –ª–µ–∫–∞—Ä—Å—Ç–≤. –ü–æ —Å–ª–æ–≤–∞–º –∑–∞–º–º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –°–µ—Ä–≥–µ—è –ì–ª–∞–≥–æ–ª–µ–≤–∞, —Å–µ–≥–æ–¥–Ω—è—à–Ω–∏–µ –º–æ—â–Ω–æ—Å—Ç–∏ –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–∞ –ø–æ–∑–≤–æ–ª—è—é—Ç –ø—Ä–µ–¥—Å–∫–∞–∑–∞—Ç—å –ø—Ä–∏–º–µ—Ä–Ω—ã–µ —Ç–æ—á–∫–∏ —Ç–æ–∫—Å–∏—á–Ω–æ—Å—Ç–∏, –æ—Å–Ω–æ–≤–Ω—ã–µ —Ä–∏—Å–∫–∏ –∏–ª–∏, –Ω–∞–æ–±–æ—Ä–æ—Ç, –ø—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–∞ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è —Ç–æ–≥–æ –∏–ª–∏ –∏–Ω–æ–≥–æ —Å–æ–µ–¥–∏–Ω–µ–Ω–∏—è, —á–µ–º —É—Å–∫–æ—Ä—è—é—Ç –ø–µ—Ä–≤–∏—á–Ω—ã–π –æ—Ç–±–æ—Ä –º–æ–ª–µ–∫—É–ª, –∞ —Ç–∞–∫–∂–µ –¥–µ–ª–∞—é—Ç –ø—Ä–æ—Ü–µ—Å—Å —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –Ω–æ–≤—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –±–æ–ª–µ–µ –¥–µ—à–µ–≤—ã–º. üíä –§–ú–ë–ê –∑–∞–ø—É—Å–∫–∞–µ—Ç III —Ñ–∞–∑—É –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π —Å–≤–æ–µ–π –∞–ª–ª–µ—Ä–≥–æ–≤–∞–∫—Ü–∏–Ω—ã. –ê–≥–µ–Ω—Ç—Å—Ç–≤–æ –ø—Ä–∏—Å—Ç—É–ø–∞–µ—Ç –∫ –Ω–∞–±–æ—Ä—É –¥–æ–±—Ä–æ–≤–æ–ª—å—Ü–µ–≤ –¥–ª—è –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è –∏—Å–ø—ã—Ç–∞–Ω–∏–π –ê–ª–ª–µ—Ä–≥–∞—Ä–¥—ã –¥–ª—è –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –∞–ª–ª–µ—Ä–≥–∏–∏ –Ω–∞ –ø—ã–ª—å—Ü—É –±–µ—Ä–µ–∑—ã –∏ –ø–µ—Ä–µ–∫—Ä–µ—Å—Ç–Ω–æ–π –ø–∏—â–µ–≤–æ–π –∞–ª–ª–µ—Ä–≥–∏–∏. –ö–∞–∫ —Å–æ–æ–±—â–∞–ª –≤–∏—Ü–µ-–ø—Ä–µ–∑–∏–¥–µ–Ω—Ç –∫–æ–º–ø–∞–Ω–∏–∏-—Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–∞ ¬´–ì–µ–Ω–µ—Ä–∏—É–º¬ª –î–º–∏—Ç—Ä–∏–π –ö—É–¥–ª–∞–π, –≤–∞–∫—Ü–∏–Ω–∞ –±—É–¥–µ—Ç –¥–æ—Å—Ç—É–ø–Ω–∞ –≤–æ –≤—Ç–æ—Ä–æ–π –ø–æ–ª–æ–≤–∏–Ω–µ 2026 –≥–æ–¥–∞. üíä –¢–æ–ø—ã –±—Ä—è–Ω—Å–∫–æ–π —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –ø–æ–ª—É—á–∏–ª–∏ —Å—Ä–æ–∫–∏ –∑–∞ –≤–∑—è—Ç–∫–∏. –°–æ–≤–µ—Ç—Å–∫–∏–π —Ä–∞–π–æ–Ω–Ω—ã–π —Å—É–¥ –≥. –ë—Ä—è–Ω—Å–∫–∞ –ø—Ä–∏–≥–æ–≤–æ—Ä–∏–ª —ç–∫—Å—Ç—Ä–∞–¥–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –∏–∑ –ß–µ—Ä–Ω–æ–≥–æ—Ä–∏–∏ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –æ—Ç–¥–µ–ª–∞ –ø—Ä–æ–¥–∞–∂ –ê–Ω–¥—Ä–µ—è –ú–∞—Ä–∫—É—Å–∞ –∏ –≤–µ–¥—É—â–µ–≥–æ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ –º–µ–Ω–µ–¥–∂–µ—Ä–∞ –æ—Ç–¥–µ–ª–∞ –ø—Ä–æ–¥–∞–∂ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ –ê–ª–µ–∫—Å–µ—è –£—à–∫–∞–ª–æ–≤–∞ –∫ 3,5 –≥–æ–¥–∞–º –∫–æ–ª–æ–Ω–∏–∏ —Å—Ç—Ä–æ–≥–æ–≥–æ —Ä–µ–∂–∏–º–∞ —Å–æ —à—Ç—Ä–∞—Ñ–æ–º –≤ —Ä–∞–∑–º–µ—Ä–µ 4 –º–ª–Ω —Ä—É–±–ª–µ–π –∫–∞–∂–¥–æ–º—É. –° —Å–µ–Ω—Ç—è–±—Ä—è 2021 –≥–æ–¥–∞ –ø–æ –¥–µ–∫–∞–±—Ä—å 2022 –≥–æ–¥–∞ —Ñ–∏–≥—É—Ä–∞–Ω—Ç—ã —Å –ø–æ–º–æ—â—å—é –ø–æ–¥—á–∏–Ω–µ–Ω–Ω–æ–≥–æ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ –º–µ–Ω–µ–¥–∂–µ—Ä–∞ –≤ –ë—Ä—è–Ω—Å–∫–µ –ø–µ—Ä–µ–¥–∞–≤–∞–ª–∏ –≤–∑—è—Ç–∫–∏ –¥–æ–ª–∂–Ω–æ—Å—Ç–Ω—ã–º –ª–∏—Ü–∞–º —É—á—Ä–µ–∂–¥–µ–Ω–∏–π –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è —Ä–µ–≥–∏–æ–Ω–∞. üíä –ü–æ –¥–∞–Ω–Ω—ã–º –∏–∑ –æ—Ç—á–µ—Ç–∞ –ú–∏–Ω—Ñ–∏–Ω–∞, –ø–æ —Å–æ—Å—Ç–æ—è–Ω–∏—é –Ω–∞ 1 –æ–∫—Ç—è–±—Ä—è —Ñ–µ–¥–ø—Ä–æ–µ–∫—Ç ¬´–†–∞–∑–≤–∏—Ç–∏–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –Ω–∞–∏–±–æ–ª–µ–µ –≤–æ—Å—Ç—Ä–µ–±–æ–≤–∞–Ω–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π¬ª –∏—Å–ø–æ–ª–Ω–µ–Ω —Ç–æ–ª—å–∫–æ –Ω–∞ 3,9%. –ò–∑ –≤—ã–¥–µ–ª–µ–Ω–Ω—ã—Ö 950 –º–ª–Ω —Ä—É–±–ª–µ–π –∏–∑—Ä–∞—Å—Ö–æ–¥–æ–≤–∞–Ω–æ 37,5 –º–ª–Ω —Ä—É–±–ª–µ–π. üíä –ò–Ω–¥–∏–π—Ü–∞–º –ø–æ–Ω—Ä–∞–≤–∏–ª–æ—Å—å –≤ –ö—Ä–∞—Å–Ω–æ–¥–∞—Ä—Å–∫–æ–º –∫—Ä–∞–µ. –ü–æ —Å–ª–æ–≤–∞–º –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –ê–≥–µ–Ω—Ç—Å—Ç–≤–∞ –ø–æ –ø—Ä–∏–≤–ª–µ—á–µ–Ω–∏—é –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–π —Ä–µ–≥–∏–æ–Ω–∞ –ö–∞–º–∏–ª—ã –ö—É–ø—Ü–æ–≤–æ–π, —Å–µ–π—á–∞—Å –≤–µ–¥—É—Ç—Å—è –ø–µ—Ä–µ–≥–æ–≤–æ—Ä—ã –æ –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏–∏ –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ –∫—Ä–∞—è –∑–∞–≤–æ–¥–∞ –ø–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤—É –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤. –û–±—â–∏–π –æ–±—ä—ë–º –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–π —Å–æ—Å—Ç–∞–≤–∏—Ç 10 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, 1,5 –º–ª—Ä–¥ –∏–∑ –Ω–∏—Ö –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–∏—Ç –†–æ—Å—Å–∏–π—Å–∫–∏–π —Ñ–æ–Ω–¥ –ø—Ä—è–º—ã—Ö –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–π. –ï—â—ë –æ–¥–∏–Ω –∏–Ω–¥–∏–π—Å–∫–∏–π –∏–Ω–≤–µ—Å—Ç–æ—Ä –≥–æ—Ç–æ–≤ –≤–ª–æ–∂–∏—Ç—å—Å—è –≤ —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–µ —Ü–µ–ª–æ–≥–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –∫–ª–∞—Å—Ç–µ—Ä–∞. üíä–í –û–≠–ó ¬´–¢–µ—Ö–Ω–æ–ø–æ–ª–∏—Å –ú–æ—Å–∫–≤–∞¬ª –ø–æ—è–≤–∏–ª–æ—Å—å –µ—â—ë –æ–¥–Ω–æ —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ. –ù–∞ –ø–ª–æ—â–∞–¥–∫–µ ¬´–ü–µ—á–∞—Ç–Ω–∏–∫–∏¬ª —Å—Ç–∞—Ä—Ç–æ–≤–∞–ª–∞ –ø–µ—Ä–≤–∞—è —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∞—è –ª–∏–Ω–∏—è –ø–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤—É –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ —É–ø–∞–∫–æ–≤–∫–∏ –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ê—Ä—Ç—Å–µ–ª–ª–µ–Ω—Å¬ª. –ü—Ä–æ–º—ã—à–ª–µ–Ω–Ω—ã–µ –º–æ—â–Ω–æ—Å—Ç–∏ –∫–æ–º–ø–∞–Ω–∏–∏ –ø–æ–∑–≤–æ–ª—è—é—Ç –∏–∑–≥–æ—Ç–∞–≤–ª–∏–≤–∞—Ç—å –¥–æ 10 –º–ª–Ω —Ç–∞–±–ª–µ—Ç–æ–∫ –∏ 20 –º–ª–Ω –∫–∞–ø—Å—É–ª –≤ –≥–æ–¥, –∞ —Ç–∞–∫–∂–µ –¥–æ –æ–¥–Ω–æ–≥–æ –º–∏–ª–ª–∏–æ–Ω–∞ –µ–¥–∏–Ω–∏—Ü —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π —É–ø–∞–∫–æ–≤–∫–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": true
}"
2025-10-10T14:01:44+00:00,@bezrec,6668,https://t.me/bezrec/6668,–ö–æ–ª—å—Ü–æ –≤—Å–µ–≤–ª–∞—Å—Ç–∏—è –Ω–∞–¥ –±–æ–ª—å—é –≤—ã–∫–∞—Ç–∏–ª–∏ —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ –¥–∏–∑–∞–π–Ω–µ—Ä—ã. –í–º–µ—Å—Ç–æ –∫–∞–º–Ω—è —É–∫—Ä–∞—à–µ–Ω–∏–µ–º –∏–∑–¥–µ–ª–∏—è —Å–ª—É–∂–∏—Ç –∫–∞–ø—Å—É–ª–∞ –ù—É—Ä–æ—Ñ–µ–Ω–∞. –û–±–Ω–æ–≤–ª—è—Ç—å —Ç–∞–±–ª–µ—Ç–∫—É –º–æ–∂–Ω–æ —Å–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω–æ. –ê –¥–µ–ª–∞—Ç—å —ç—Ç–æ –ø—Ä–∏–¥—ë—Ç—Å—è —á–∞—Å—Ç–æ ‚Äî –∫–∞–∫ –º–∏–Ω–∏–º—É–º –ø–æ—Å–ª–µ –∫–∞–∂–¥–æ–≥–æ –º—ã—Ç—å—è —Ä—É–∫. ¬´–£–±–∏–π—Ü–∞ –±–æ–ª–∏¬ª –æ—Ç —é–≤–µ–ª–∏—Ä–Ω–æ–π —Å—Ç—É–¥–∏–∏ White Lake –≤—ã–≥–ª—è–¥–∏—Ç –Ω–∞–¥–µ–∂–Ω–µ–µ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞,"{""skip"": true}"
2025-10-10T11:30:01+00:00,@bezrec,6667,https://t.me/bezrec/6667,"–†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä –Ω–µ –ø—Ä–æ—à—ë–ª –º–∏–º–æ –ø—Ä–æ–≤–µ—Ä–µ–Ω–Ω—ã—Ö –†–æ—Å–∫–∞—á–µ—Å—Ç–≤–æ–º –ë–ê–î–æ–≤. –í—á–µ—Ä–∞ –º—ã –ø–∏—Å–∞–ª–∏, —á—Ç–æ –†–æ—Å–∫–∞—á–µ—Å—Ç–≤–æ –ø—Ä–æ–≤–µ—Ä–∏–ª–æ, —Å–∫–æ–ª—å–∫–æ –∂–∏—Ä–Ω—ã—Ö –∫–∏—Å–ª–æ—Ç —Å–æ–¥–µ—Ä–∂–∏—Ç—Å—è –≤ –ë–ê–î–∞—Ö —Å –æ–º–µ–≥–∞-3 –Ω–∞ —Å–∞–º–æ–º –¥–µ–ª–µ. –£ –ø–æ–ª–æ–≤–∏–Ω—ã –ø—Ä–æ—Ç–µ—Å—Ç–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ø—Ä–æ–¥—É–∫—Ç–æ–≤ —Ñ–∞–∫—Ç–∏—á–µ—Å–∫–æ–µ —Å–æ–¥–µ—Ä–∂–∞–Ω–∏–µ –∂–∏—Ä–Ω—ã—Ö –∫–∏—Å–ª–æ—Ç –æ–∫–∞–∑–∞–ª–æ—Å—å –Ω–∏–∂–µ –∑–∞—è–≤–ª–µ–Ω–Ω–æ–≥–æ –Ω–∞ —É–ø–∞–∫–æ–≤–∫–µ. –¢–∞–∫–∞—è –Ω–µ—Å–ø—Ä–∞–≤–µ–¥–ª–∏–≤–æ—Å—Ç—å –Ω–µ —É—Å–∫–æ–ª—å–∑–Ω—É–ª–∞ –æ—Ç –≤–Ω–∏–º–∞–Ω–∏—è –†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä–∞. –í–µ–¥–æ–º—Å—Ç–≤–æ –ø—Ä–∏–Ω—è–ª–æ –º–µ—Ä—ã –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ —Ä—è–¥–∞ –Ω–∞—Ä—É—à–∏—Ç–µ–ª–µ–π: üü© –∏–∑—ä—è—Ç–æ –∏–∑ –æ–±–æ—Ä–æ—Ç–∞ 2,7 —Ç—ã—Å. –µ–¥–∏–Ω–∏—Ü –ë–ê–î –û–û–û ¬´–û—Ä–≥–∞–Ω–∏–∫ –¢—Ä–µ–π–¥¬ª; üü© –ø—Ä–æ—Ç–∏–≤ –û–û–û ¬´–í–µ–ª–∞–π—Ñ¬ª (–∏–∑–≥–æ—Ç–æ–≤–∏—Ç–µ–ª—å –¢–ú Velife) –≤–æ–∑–±—É–∂–¥–µ–Ω–æ –¥–µ–ª–æ –æ–± –∞–¥–º–∏–Ω–∏—Å—Ç—Ä–∞—Ç–∏–≤–Ω–æ–º –ø—Ä–∞–≤–æ–Ω–∞—Ä—É—à–µ–Ω–∏–∏ –ø–æ —Ñ–∞–∫—Ç—É –≤—ã–ø—É—Å–∫–∞ –≤ –æ–±—Ä–∞—â–µ–Ω–∏–µ –ø—Ä–æ–¥—É–∫—Ü–∏–∏, –Ω–µ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–µ–π –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–º —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è–º –¢–† –¢–°; üü© –û–û–û ¬´–ü–æ–ª—è—Ä–∏—Å¬ª (–∏–∑–≥–æ—Ç–æ–≤–∏—Ç–µ–ª—å –¢–ú ¬´–ó–¥—Ä–∞–≤—Å–∏—Ç–∏.—Ä—É¬ª), –û–û–û ¬´–°–∞–ø–ø–ª–µ–º–µ–Ω—Ç –ì—Ä—É–ø–ø¬ª (–∏–∑–≥–æ—Ç–æ–≤–∏—Ç–µ–ª—å –¢–ú Supplnorm) –∏ –û–û–û ¬´–¢—ã–º–ª–∞—Ç—Å–∫–∏–π —Ä—ã–±–æ–∫–æ–º–±–∏–Ω–∞—Ç¬ª (–∏–∑–≥–æ—Ç–æ–≤–∏—Ç–µ–ª—å –¢–ú ¬´–¢—ã–º–ª–∞—Ç—Å–∫–∏–π –†–ö¬ª) –æ–±—ä—è–≤–ª–µ–Ω–æ –ø—Ä–µ–¥–æ—Å—Ç–µ—Ä–µ–∂–µ–Ω–∏–µ –æ –Ω–µ–¥–æ–ø—É—Å—Ç–∏–º–æ—Å—Ç–∏ –Ω–∞—Ä—É—à–µ–Ω–∏—è –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã—Ö —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π; üü© –≤ –∞–¥—Ä–µ—Å –ò–ü –ú–∞–º—É–ª–æ–≤–∞ –í.–ê. –æ–±—ä—è–≤–ª–µ–Ω–æ –ø—Ä–µ–¥–æ—Å—Ç–µ—Ä–µ–∂–µ–Ω–∏–µ –æ –Ω–µ–¥–æ–ø—É—Å—Ç–∏–º–æ—Å—Ç–∏ –Ω–∞—Ä—É—à–µ–Ω–∏—è –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã—Ö —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π –≤ —á–∞—Å—Ç–∏ –Ω–µ—Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏—è –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏ –∏ –Ω–µ–¥–æ–ø—É—Å—Ç–∏–º–æ—Å—Ç–∏ –≤–≤–µ–¥–µ–Ω–∏—è –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª—è –≤ –∑–∞–±–ª—É–∂–¥–µ–Ω–∏–µ, –æ—Ç–æ–∑–≤–∞–Ω–∞ –ø–∞—Ä—Ç–∏—è –ë–ê–î –∏–∑ 49 —à—Ç—É–∫; üü© –û–û–û ¬´–ò–Ω—Ç–µ—Ä–Ω–µ—Ç —Ä–µ—à–µ–Ω–∏—è¬ª –ø—Ä–æ–∏–Ω—Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–æ –æ –Ω–∞—Ä—É—à–µ–Ω–∏–∏ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã—Ö —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π –ø—Ä–∏ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ —É–∫–∞–∑–∞–Ω–Ω–æ–π –ø–∞—Ä—Ç–∏–∏ –ë–ê–î, –ø—Ä–∏–æ–±—Ä–µ—Ç–µ–Ω–Ω–æ–π –Ω–∞ –ø–ª–æ—â–∞–¥–∫–µ Ozon; üü© –Ω–∞ –æ—Å–Ω–æ–≤–∞–Ω–∏–∏ –ø—Ä–∏–∫–∞–∑–æ–≤ –§–µ–¥–µ—Ä–∞–ª—å–Ω–æ–π —Å–ª—É–∂–±—ã –ø–æ –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–∏ –ø—Ä–∏–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–æ –¥–µ–π—Å—Ç–≤–∏–µ 60 –¥–µ–∫–ª–∞—Ä–∞—Ü–∏–π –æ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–∏. –ù–µ–∫–æ—Ç–æ—Ä—ã–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ —É–∂–µ –æ—Ç—Ä–µ–∞–≥–∏—Ä–æ–≤–∞–ª–∏: üü© ¬´–û—Ä–≥–∞–Ω–∏–∫ —Ç—Ä–µ–π–¥¬ª —É—Å–∏–ª–∏–ª –∫–æ–Ω—Ç—Ä–æ–ª—å –∑–∞ –ø—Ä–æ–¥—É–∫—Ü–∏–µ–π –∏ –ø—Ä–æ–≤–µ–ª –ø—Ä–æ–≤–µ—Ä–∫—É –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤; üü© ¬´–ú–æ–ª–æ–¥–µ–π¬ª —É—Å–∏–ª–∏–ª –∫–æ–Ω—Ç—Ä–æ–ª—å –∑–∞ –∫–∞—á–µ—Å—Ç–≤–æ–º –ø—Ä–æ–¥—É–∫—Ü–∏–∏, –ø—Ä–æ–≤–µ–ª —Ä—è–¥ –∫–æ—Ä—Ä–µ–∫—Ç–∏—Ä—É—é—â–∏—Ö –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–π –∏ –∑–∞–º–µ–Ω–∏–ª –ø–æ—Å—Ç–∞–≤—â–∏–∫–∞ —Å—ã—Ä—å—è; üü© –ø—Ä–æ–¥–∞–≤–µ—Ü Supplnorm –Ω–∞ Ozon –æ—Ç–æ–∑–≤–∞–ª –ø—Ä–æ–¥—É–∫—Ü–∏—é –∏–∑ –ø—Ä–æ–¥–∞–∂–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage, regulation, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The Rospatent has taken action against several companies for producing and selling products that do not meet mandatory requirements. Actions include recalling 2,700 units of the product by 'Organik Trade', filing an administrative offense case against 'Velife' for producing products not meeting TRS requirements, and issuing warnings to companies like 'Polaris', 'Supplnorm Group', and 'Tymlat Fish Combine'. Some companies have already responded, such as 'Organik Trade' strengthening quality control and checking documents, and 'Supplnorm Group' removing products from sale on the platform.""
}"
2025-10-10T08:32:12+00:00,@bezrec,6666,https://t.me/bezrec/6666,"–°–ø–∞—Å–∏–±–æ —Å–∏—Å—Ç–µ–º–µ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–π –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏ ¬´–ß–µ—Å—Ç–Ω—ã–π –∑–Ω–∞–∫¬ª. –ö–∞–∂–¥—ã–π —Å–ª—É—á–∞–π –ø—Ä–æ–¥–∞–∂–∏ –ø—Ä–æ—Å—Ä–æ—á–µ–Ω–Ω–æ–≥–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –º–æ–∂–µ—Ç —Å—Ç–æ–∏—Ç—å —á–µ–ª–æ–≤–µ–∫—É –∂–∏–∑–Ω–∏. –ù–∞—à–∞ —Ü–µ–ª—å ‚Äî –ø–æ–ª–Ω–æ—Å—Ç—å—é –∏—Å–∫–ª—é—á–∏—Ç—å –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –ø–æ—è–≤–ª–µ–Ω–∏—è –ø—Ä–æ—Å—Ä–æ—á–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ –ø—Ä–∏–ª–∞–≤–∫–∞—Ö –∞–ø—Ç–µ–∫, ‚Äî –ø–æ–¥–µ–ª–∏–ª—Å—è –∞–º–±–∏—Ü–∏–æ–∑–Ω—ã–º–∏ –ø–ª–∞–Ω–∞–º–∏ –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä –¶–†–ü–¢ –ê–Ω–¥—Ä–µ–π –ö–∏—Ä–∏–ª–ª–æ–≤. –ß–∞—â–µ –≤—Å–µ–≥–æ –≤ –∞–ø—Ç–µ–∫–∞—Ö –ø–æ–ø–∞–¥–∞–ª–∏—Å—å –ø—Ä–æ—Å—Ä–æ—á–µ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –Ω–∞ –æ—Å–Ω–æ–≤–µ –ª–µ–≤–æ—Ç–∏—Ä–æ–∫—Å–∏–Ω–∞ –Ω–∞—Ç—Ä–∏—è –∏ —É–º–∏—Ñ–µ–Ω–æ–≤–∏—Ä–∞, –∞ —Ç–∞–∫–∂–µ –π–æ–¥, –∑–µ–ª–µ–Ω–∫–∞ –∏ —ç–∫—Å—Ç—Ä–∞–∫—Ç —Ç—Ä–∞–≤—ã –∞–ª—Ç–µ—è –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ. –ë–æ–ª—å—à–µ –≤—Å–µ–≥–æ –ø—Ä–æ—Å—Ä–æ—á–∫–∏ –Ω–∞—à–ª–æ—Å—å –≤ –°–º–æ–ª–µ–Ω—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ (20,8%), –ú–æ—Å–∫–≤–µ (7,5%) –∏ –ö—Ä–∞—Å–Ω–æ–¥–∞—Ä—Å–∫–æ–º –∫—Ä–∞–µ (6,6%). –í —Ç–æ–ø-10 —Ç–∞–∫–∂–µ –≤–æ—à–ª–∏ –ù–∏–∂–µ–≥–æ—Ä–æ–¥—Å–∫–∞—è, –°–∞–º–∞—Ä—Å–∫–∞—è –∏ –ú–æ—Å–∫–æ–≤—Å–∫–∞—è –æ–±–ª–∞—Å—Ç–∏, –†–µ—Å–ø—É–±–ª–∏–∫–∞ –ö—Ä—ã–º, –î–∞–≥–µ—Å—Ç–∞–Ω, –í–æ—Ä–æ–Ω–µ–∂—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å –∏ –Ø–∫—É—Ç–∏—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""shortage, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""There have been frequent instances of expired medicines in pharmacies, including those based on levothyroxine sodium and umifenovir. The shortage is most pronounced in Smolensk Oblast (20.8%), Moscow Region (7.5%) and Krasnodar Krai (6.6%). Other regions with significant shortages include Nizhny Novgorod Oblast, Samara Oblast, Moscow Region, Republic of Crimea, Dagestan, Voronezh Oblast and Yakutia. The shortage is a concern for patient safety.""
}"
2025-10-10T05:42:21+00:00,@bezrec,6665,https://t.me/bezrec/6665,"–ê–Ω–∞–ª–∏—Ç–∏–∫–∏ –æ—Ü–µ–Ω–∏–ª–∏ –ø—Ä–æ–¥–∞–∂–∏ –º–æ—á–µ–≥–æ–Ω–Ω—ã—Ö –≤ –†–æ—Å—Å–∏–∏. –° —è–Ω–≤–∞—Ä—è –ø–æ –∞–≤–≥—É—Å—Ç 2025 –≥–æ–¥–∞ –Ω–∞ —Ä–æ–∑–Ω–∏—á–Ω–æ–º —Ä—ã–Ω–∫–µ –±—ã–ª–æ –ø—Ä–æ–¥–∞–Ω–æ –±–æ–ª–µ–µ 62,4 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ –º–æ—á–µ–≥–æ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ —Å—É–º–º—É 11,9 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, –ø–æ–¥—Å—á–∏—Ç–∞–ª–∏ –≤ RNC Pharma. –≠—Ç–æ –Ω–∞ 15,7% –±–æ–ª—å—à–µ –≤ —Ä—É–±–ª—ë–≤–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏, –∏ –Ω–∞ 2,5% –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –≥–æ–¥ –∫ –≥–æ–¥—É. –ü—Ä–æ–¥–∞–∂–∏ —ç—Ç–æ–π –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —É—Å—Ç–æ–π—á–∏–≤–æ —Ä–∞—Å—Ç—É—Ç –ø–æ—Å–ª–µ–¥–Ω–∏–µ –Ω–µ—Å–∫–æ–ª—å–∫–æ –ª–µ—Ç. –¢–∞–∫–∂–µ —Ä–∞—Å—Ç—É—Ç –∏ —Ü–µ–Ω—ã. –ï—Å–ª–∏ –≤ 2022 –≥–æ–¥—É –æ–¥–Ω–∞ —É—Å–ª–æ–≤–Ω–∞—è —É–ø–∞–∫–æ–≤–∫–∞ —Å—Ç–æ–∏–ª–∞ 147 —Ä—É–±–ª–µ–π, —Ç–æ –≤ —è–Ω–≤–∞—Ä–µ-–∞–≤–≥—É—Å—Ç–µ 2025 –≥–æ–¥–∞ –∑–∞ –Ω–µ—ë –ø—Ä–∏—à–ª–æ—Å—å –±—ã –≤—ã–ª–æ–∂–∏—Ç—å —É–∂–µ –±–æ–ª–µ–µ 190 —Ä—É–±–ª–µ–π (+13% –∫ –∞–Ω–∞–ª–æ–≥–∏—á–Ω–æ–º—É –ø–µ—Ä–∏–æ–¥—É 2024 –≥–æ–¥–∞). –ü—Ä–∏ —ç—Ç–æ–º —Ü–µ–Ω–Ω–∏–∫ –Ω–∞ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã —Ä–∞—Å—Ç—ë—Ç –±—ã—Å—Ç—Ä–µ–µ, —á–µ–º –Ω–∞ –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã–µ. –í –ª–∏–¥–µ—Ä–∞—Ö –ø–æ –ø—Ä–æ–¥–∞–∂–∞–º –∫–∞–∫ –≤ –¥–µ–Ω—å–≥–∞—Ö, —Ç–∞–∫ –∏ –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö ‚Äî –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –∏–Ω–¥–∞–ø–∞–º–∏–¥–∞. –í —Ä–æ–∑–Ω–∏—Ü–µ –±—ã–ª–∞ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–∞ –ø—Ä–æ–¥—É–∫—Ü–∏—è 23 –∫–æ–º–ø–∞–Ω–∏–π, –æ—Å–Ω–æ–≤–Ω–æ–π –æ–±—ä—ë–º –ø—Ä–æ–¥–∞–∂ –∏–Ω–¥–∞–ø–∞–º–∏–¥–∞ –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫—É¬ª. –í—Å–µ–≥–æ –ø–æ –∏—Ç–æ–≥–∞–º –ø–µ—Ä–≤—ã—Ö –≤–æ—Å—å–º–∏ –º–µ—Å—è—Ü–µ–≤ –≤ —Ä–æ–∑–Ω–∏—á–Ω–æ–º —Å–µ–≥–º–µ–Ω—Ç–µ –±—ã–ª–æ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–æ 44 –±—Ä–µ–Ω–¥–∞ –æ—Ç 70 –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π. –ü—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏ –≤—Å–µ —É—á–∞—Å—Ç–Ω–∏–∫–∏ —Ç–æ–ø-10, –∫—Ä–æ–º–µ –î–∏—É–≤–µ—Ä–∞ –æ—Ç ¬´–¢–µ–≤–∞¬ª, –¥–µ–º–æ–Ω—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª–∏ –ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω—É—é —Ä—É–±–ª—ë–≤—É—é –¥–∏–Ω–∞–º–∏–∫—É –ø—Ä–æ–¥–∞–∂. –ú–∞–∫—Å–∏–º–∞–ª—å–Ω—ã–º–∏ —Ç–µ–º–ø–∞–º–∏ —Ä–æ—Å—Ç–∞ –æ—Ç–ª–∏—á–∏–ª—Å—è –∫–∞–ª–∏–π—Å–±–µ—Ä–µ–≥–∞—é—â–∏–π –¥–∏—É—Ä–µ—Ç–∏–∫ –≠–ø–ª–µ—Ä–µ–Ω–æ–Ω (¬´–§–∞—Ä–º–ø—Ä–æ–µ–∫—Ç¬ª + 2 –∫–æ–º–ø–∞–Ω–∏–∏). –ü–æ–º–∏–º–æ —É–∂–µ –Ω–∞–∑–≤–∞–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –ø–µ—Ä–≤—É—é –¥–µ—Å—è—Ç–∫—É –ø–æ–ø–∞–ª–∏: –í–µ—Ä–æ—à–ø–∏—Ä–æ–Ω (¬´–ì–µ–¥–µ–æ–Ω –†–∏—Ö—Ç–µ—Ä¬ª), –¢–æ—Ä–∞—Å–µ–º–∏–¥ (¬´–ú–µ–¥–∏—Å–æ—Ä–±¬ª + 11 –∫–æ–º–ø–∞–Ω–∏–π), –≠—Å–ø–∏—Ä–æ (¬´–ê–∫—Ä–∏—Ö–∏–Ω¬ª), –§–∏—Ç–æ–ª–∏–∑–∏–Ω (¬´–ê–∫—Ä–∏—Ö–∏–Ω¬ª), –ê—Ä–∏—Ñ–æ–Ω (¬´–°–µ—Ä–≤—å–µ¬ª), –§—É—Ä–æ—Å–µ–º–∏–¥ (¬´–û–±–Ω–æ–≤–ª–µ–Ω–∏–µ¬ª + 19 –∫–æ–º–ø–∞–Ω–∏–π), –ò–Ω–¥–∞–ø (¬´–ü–†–û.–ú–ï–î.–¶–°¬ª). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""Sales of diuretics in Russia have increased by 15.7% year-over-year to August 2025, with a price increase of 13%. Key brands include Indapamide and Eplerenone. The market is growing, with positive trends in sales for most top brands.""
}"
2025-10-09T15:05:22+00:00,@bezrec,6661,https://t.me/bezrec/6661,"Amazon Pharmacy –±—É–¥–µ—Ç –ø—Ä–æ–¥–∞–≤–∞—Ç—å ¬´—Ä–µ—Ü–µ–ø—Ç—É—Ä–∫—É¬ª –≤ –≤–µ–Ω–¥–∏–Ω–≥–æ–≤—ã—Ö –∞–≤—Ç–æ–º–∞—Ç–∞—Ö. –ê–ø–ø–∞—Ä–∞—Ç—ã –±—É–¥—É—Ç —É—Å—Ç–∞–Ω–∞–≤–ª–∏–≤–∞—Ç—å –≤ –∫–ª–∏–Ω–∏–∫–∞—Ö, —á—Ç–æ–±—ã –¥–≤–∞ —Ä–∞–∑–∞ –Ω–µ –≤—Å—Ç–∞–≤–∞—Ç—å, –∞ —Å—Ä–∞–∑—É –ø–æ—Å–ª–µ –ø–æ—Å–µ—â–µ–Ω–∏—è –≤—Ä–∞—á–∞ –∫—É–ø–∏—Ç—å –Ω—É–∂–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç. –ü–µ—Ä–≤—ã–º–∏ –Ω–æ–≤–∏–Ω–∫—É –ø—Ä–æ—Ç–µ—Å—Ç–∏—Ä—É—é—Ç –ø–æ—Å–µ—Ç–∏—Ç–µ–ª–∏ —Ü–µ–Ω—Ç—Ä–æ–≤ One Medical, –∫–æ—Ç–æ—Ä—ã–µ —Ç–∞–∫–∂–µ –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∞—Ç Amazon. –ü–æ—Å–ª–µ —Ç–æ–≥–æ, –∫–∞–∫ –º–µ–¥–∏–∫ –≤—ã–ø–∏—à–µ—Ç —Ä–µ—Ü–µ–ø—Ç, –ø–∞—Ü–∏–µ–Ω—Ç —Å–º–æ–∂–µ—Ç —Å—Ä–∞–∑—É —á–µ—Ä–µ–∑ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏–µ —Å–¥–µ–ª–∞—Ç—å –∏ –æ–ø–ª–∞—Ç–∏—Ç—å —Å–≤–æ–π –∑–∞–∫–∞–∑, –∞ —É–∂–µ —á–µ—Ä–µ–∑ –ø–∞—Ä—É –º–∏–Ω—É—Ç –∑–∞–±—Ä–∞—Ç—å –µ–≥–æ –≤ –∞–≤—Ç–æ–º–∞—Ç–µ. –ï—Å–ª–∏ –≤–æ–∑–Ω–∏–∫–Ω—É—Ç –≤–æ–ø—Ä–æ—Å—ã, –º–æ–∂–Ω–æ –≤—Å–µ–≥–¥–∞ —Å–≤—è–∑–∞—Ç—å—Å—è —Å —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–æ–º –ø–æ –≤–∏–¥–µ–æ-—Å–≤—è–∑–∏. –ê—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ –∫–∞–∂–¥–æ–º –∫–∏–æ—Å–∫–µ –±—É–¥–µ—Ç —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞—Ç—å—Å—è –≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–∏ —Å –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç—è–º–∏ –∫–æ–Ω–∫—Ä–µ—Ç–Ω–æ–π –∫–ª–∏–Ω–∏–∫–∏. –ò—Å–∫–ª—é—á–µ–Ω–∏–µ —Å–æ—Å—Ç–∞–≤—è—Ç –∫–æ–Ω—Ç—Ä–æ–ª–∏—Ä—É–µ–º—ã–µ –≤–µ—â–µ—Å—Ç–≤–∞ –∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, —Ç—Ä–µ–±—É—é—â–∏–µ —Ö—Ä–∞–Ω–µ–Ω–∏—è –≤ —Ö–æ–ª–æ–¥–∏–ª—å–Ω–∏–∫–µ. –¢–∞–∫–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ —á–µ—Ä–µ–∑ –∞–≤—Ç–æ–º–∞—Ç—ã –ø—Ä–æ–¥–∞–≤–∞—Ç—å –Ω–µ –±—É–¥—É—Ç. –í Amazon –≥–æ–≤–æ—Ä—è—Ç, —á—Ç–æ –Ω–æ–≤–æ–≤–≤–µ–¥–µ–Ω–∏–µ –ø–æ–º–æ–∂–µ—Ç —Ä–µ—à–∏—Ç—å –ø—Ä–æ–±–ª–µ–º—É –Ω–µ—Ö–≤–∞—Ç–∫–∏ –∞–ø—Ç–µ–∫, –∫–æ—Ç–æ—Ä–∞—è –∞–º–µ—Ä–∏–∫–∞–Ω—Ü–∞–º —Ç–æ–∂–µ –Ω–µ —á—É–∂–¥–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-10-09T12:42:02+00:00,@bezrec,6659,https://t.me/bezrec/6659,"–†–æ—Å–∫–∞—á–µ—Å—Ç–≤–æ —Ä–∞—Å—Å–∫–∞–∑–∞–ª–æ, —Å–∫–æ–ª—å–∫–æ –∂–∏—Ä–Ω—ã—Ö –∫–∏—Å–ª–æ—Ç –≤ –ë–ê–î–∞—Ö —Å –æ–º–µ–≥–∞-3 –Ω–∞ —Å–∞–º–æ–º –¥–µ–ª–µ. –í–µ–¥–æ–º—Å—Ç–≤–æ –ø—Ä–æ–≤–µ—Ä–∏–ª–æ 15 —Ç–æ—Ä–≥–æ–≤—ã—Ö –º–∞—Ä–æ–∫, –ø—Ä–æ–∏–∑–≤–µ–¥—ë–Ω–Ω—ã—Ö –≤ –†–æ—Å—Å–∏–∏, –ù–æ—Ä–≤–µ–≥–∏–∏ –∏ –°–®–ê. –ö–∞–∂–¥—É—é ‚Äî –ø–æ 19 –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è–º –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏, –∫–∞—á–µ—Å—Ç–≤–∞ –∏ –¥–æ—Å—Ç–æ–≤–µ—Ä–Ω–æ—Å—Ç–∏ –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏. –•–æ—Ä–æ—à–∞—è –Ω–æ–≤–æ—Å—Ç—å ‚Äî –≤—Å–µ –ø—Ä–æ–≤–µ—Ä–µ–Ω–Ω—ã–µ –¥–æ–±–∞–≤–∫–∏ –±–µ–∑–æ–ø–∞—Å–Ω—ã. –í –Ω–∏—Ö –Ω–µ –æ–∫–∞–∑–∞–ª–æ—Å—å —Ç–æ–∫—Å–∏—á–Ω—ã—Ö —ç–ª–µ–º–µ–Ω—Ç–æ–≤, —Ä–∞–¥–∏–æ–Ω—É–∫–ª–∏–¥–æ–≤, –ø–µ—Å—Ç–∏—Ü–∏–¥–æ–≤ –∏ –ø–∞—Ç–æ–≥–µ–Ω–Ω—ã—Ö –º–∏–∫—Ä–æ–æ—Ä–≥–∞–Ω–∏–∑–º–æ–≤. –ö –∫–∞—á–µ—Å—Ç–≤—É —Ç–æ–∂–µ –ø—Ä–µ—Ç–µ–Ω–∑–∏–π –Ω–µ—Ç ‚Äî –∫–∞–ø—Å—É–ª—ã –∏–∑–≥–æ—Ç–æ–≤–ª–µ–Ω—ã –∏–∑ —Å–≤–µ–∂–µ–≥–æ —Å—ã—Ä—å—è ‚Äî –ø–æ–∫–∞–∑–∞—Ç–µ–ª–∏ –∫–∞—á–µ—Å—Ç–≤–∞ (–ø–µ—Ä–µ–∫–∏—Å–Ω–æ–µ –∏ –∫–∏—Å–ª–æ—Ç–Ω–æ–µ —á–∏—Å–ª–æ) –≤ –Ω–æ—Ä–º–µ. –ê –≤–æ—Ç —Å –¥–æ—Å—Ç–æ–≤–µ—Ä–Ω–æ—Å—Ç—å—é –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏ –≤—Å—ë –Ω–µ —Ç–∞–∫ –≥–ª–∞–¥–∫–æ. –¢—É—Ç –æ–∂–∏–¥–∞–Ω–∏—è —Å —Ä–µ–∞–ª—å–Ω–æ—Å—Ç—å—é –Ω–µ —Å–æ–≤–ø–∞–ª–∏ –≤ 50% —Å–ª—É—á–∞–µ–≤ ‚Äî —É –ø–æ–ª–æ–≤–∏–Ω—ã –ø—Ä–æ—Ç–µ—Å—Ç–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ø—Ä–æ–¥—É–∫—Ç–æ–≤ —Ñ–∞–∫—Ç–∏—á–µ—Å–∫–æ–µ —Å–æ–¥–µ—Ä–∂–∞–Ω–∏–µ –∂–∏—Ä–Ω—ã—Ö –∫–∏—Å–ª–æ—Ç –æ–∫–∞–∑–∞–ª–æ—Å—å –Ω–∏–∂–µ –∑–∞—è–≤–ª–µ–Ω–Ω–æ–≥–æ –Ω–∞ —É–ø–∞–∫–æ–≤–∫–µ. –í —á–∏—Å–ª–µ –Ω–∞—Ä—É—à–∏—Ç–µ–ª–µ–π: ¬´–¢—ã–º–ª–∞—Ç—Å–∫–∏–π –†–ö¬ª, Biopharma, ¬´–ó–¥—Ä–∞–≤—Å–∏—Ç–∏.—Ä—É¬ª, Moloday, Supplnorm, Velife. –≠—Ç–∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ —É–∫–∞–∑–∞–ª–∏ –Ω–µ–∫–æ—Ä—Ä–µ–∫—Ç–Ω–æ–µ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –æ–º–µ–≥–∞-3, –≠–ü–ö (EPA) –∏–ª–∏ –î–ì–ö (DHA). –¢–∞–∫–∂–µ –º–Ω–æ–≥–∏–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –≥—Ä–µ—à–∞—Ç —É–∫–∞–∑–∞–Ω–∏–µ–º –Ω–µ–∫–æ—Ä—Ä–µ–∫—Ç–Ω–æ–π –º–∞—Å—Å—ã ‚Äî –Ω–∞ –ª–∏—Ü–µ–≤–æ–π —Å—Ç–æ—Ä–æ–Ω–µ —É–ø–∞–∫–æ–≤–∫–∏ –∫—Ä—É–ø–Ω—ã–º —à—Ä–∏—Ñ—Ç–æ–º –ø–∏—à—É—Ç –º–∞—Å—Å—É –≤—Å–µ–π –∫–∞–ø—Å—É–ª—ã, –∞ –Ω–µ –µ—ë —Å–æ–¥–µ—Ä–∂–∏–º–æ–≥–æ, —Ç–æ –µ—Å—Ç—å –∞–∫—Ç–∏–≤–Ω—ã—Ö –≤–µ—â–µ—Å—Ç–≤. –í —ç—Ç–æ–º –Ω–∞—Ä—É—à–µ–Ω–∏–∏ –Ω–µ –±—ã–ª–∏ –∑–∞–º–µ—á–µ–Ω—ã —Ç–æ–ª—å–∫–æ —Ç—Ä–æ–µ: Layco, ¬´–≠–≤–∞–ª–∞—Ä¬ª –∏ ¬´–¢—ã–º–ª–∞—Ç—Å–∫–∏–π —Ä—ã–±–æ–∫–æ–º–±–∏–Ω–∞—Ç¬ª. –í—Å–µ–º –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–º —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è–º —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—Ç —à–µ—Å—Ç—å —Ç–æ—Ä–≥–æ–≤—ã—Ö –º–∞—Ä–æ–∫: ¬´–≠–≤–∞–ª–∞—Ä¬ª, Solgar, ¬´–ü–æ–ª—è—Ä–∏—Å¬ª, UltraBalance, Layco, Dr.Mybo. –û—Ç–¥–µ–ª—å–Ω–æ–µ —Å–ø–∞—Å–∏–±–æ –†–æ—Å–∫–∞—á–µ—Å—Ç–≤—É –∑–∞ –Ω–∞–≥–ª—è–¥–Ω–æ—Å—Ç—å –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance"",
  ""impact"": ""medium"",
  ""english"": ""Roskhozprom reported on the actual content of omega-3 in various supplements. They tested 15 Russian, Norwegian and American brands for safety, quality, and labeling accuracy. All supplements were found to be safe with no toxic elements or pathogens detected. However, the discrepancy between expected and actual content of omega-3 (EPA) or DHA was found in 50% of the tested products. Some brands incorrectly marked the capsule weight, not the active ingredient's weight.""
}"
2025-10-09T09:30:01+00:00,@bezrec,6658,https://t.me/bezrec/6658,"–í –ò–Ω–¥–∏–∏ –∏–∑-–∑–∞ —Å–∏—Ä–æ–ø–æ–≤ –æ—Ç –∫–∞—à–ª—è —Å–Ω–æ–≤–∞ –≥–∏–±–Ω—É—Ç –¥–µ—Ç–∏. –ü–æ–∫–∞ –º—ã –±—ã–ª–∏ –Ω–∞ ¬´–ë–∏–æ–ø—Ä–æ–º–µ¬ª –≤ –ò–Ω–¥–∏–∏ —Ä–∞–∑–≥–æ—Ä–µ–ª—Å—è –æ—á–µ—Ä–µ–¥–Ω–æ–π ¬´–ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–π¬ª —Å–∫–∞–Ω–¥–∞–ª. –ù–∏–∫–æ–≥–¥–∞ —Ç–∞–∫–æ–≥–æ –Ω–µ –±—ã–ª–æ, –∏ –≤–æ—Ç –æ–ø—è—Ç—å ‚Äî –ø–æ–ø—É–ª—è—Ä–Ω—ã–π –≤ —Å—Ç—Ä–∞–Ω–µ —Å–∏—Ä–æ–ø –æ—Ç –∫–∞—à–ª—è Coldrif –æ—Ç Sresan Pharma —Å—Ç–∞–ª –ø—Ä–∏—á–∏–Ω–æ–π –≥–∏–±–µ–ª–∏ –Ω–µ –º–µ–Ω–µ–µ 20 –¥–µ—Ç–µ–π. –¢–∞–∫–∂–µ –∏–∑-–∑–∞ –Ω–µ–≥–æ —Å–∫–æ–Ω—á–∞–ª—Å—è –≤—Ä–∞—á, —Ä–µ—à–∏–≤—à–∏–π –ø—Ä–æ–≤–µ—Ä–∏—Ç—å –Ω–∞ —Å–µ–±–µ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –ø—Ä–æ–ø–∏—Å—ã–≤–∞–µ–º–æ–≥–æ —Å—Ä–µ–¥—Å—Ç–≤–∞. –ö–∞–∫ –∏ –≤ —Å–ª—É—á–∞–µ —Å —è–¥–æ–≤–∏—Ç—ã–º–∏ —Å–∏—Ä–æ–ø–∞–º–∏ –¥—Ä—É–≥–∏—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π, —É–±–∏–≤—à–∏—Ö —Å–æ—Ç–Ω–∏ –¥–µ—Ç–µ–π –≤ –ò–Ω–¥–æ–Ω–µ–∑–∏–∏, –ì–∞–º–±–∏–∏ –∏ –£–∑–±–µ–∫–∏—Å—Ç–∞–Ω–µ, –≤ —Å–æ—Å—Ç–∞–≤–µ Coldrif –±—ã–ª –æ–±–Ω–∞—Ä—É–∂–µ–Ω —Ç–æ–∫—Å–∏—á–Ω—ã–π –¥–∏—ç—Ç–∏–ª–µ–Ω–≥–ª–∏–∫–æ–ª—å, –ø—Ä–∏—á—ë–º –≤ ¬´–ª–æ—à–∞–¥–∏–Ω—ã—Ö¬ª –¥–æ–∑–∞—Ö. –í–º–µ—Å—Ç–æ –¥–æ–ø—É—Å—Ç–∏–º—ã—Ö 0,1% Sresan Pharma –¥–æ–±–∞–≤–ª—è–ª–∞ 46-48% —è–¥–æ–≤–∏—Ç–æ–≥–æ –≤–µ—â–µ—Å—Ç–≤–∞. –ü—Ä–∏ –æ–±—ã—Å–∫–∞—Ö –Ω–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ –æ–±–Ω–∞—Ä—É–∂–∏–ª–∏ –Ω–µ–∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –∫–æ–Ω—Ç–µ–π–Ω–µ—Ä—ã —Å –¥–∏—ç—Ç–∏–ª–µ–Ω–≥–ª–∏–∫–æ–ª–µ–º. –†–µ–≥—É–ª–∏—Ä—É—é—â–∏–µ –æ—Ä–≥–∞–Ω—ã –ø—Ä–∏–æ—Å—Ç–∞–Ω–æ–≤–∏–ª–∏ —Ä–∞–±–æ—Ç—É –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏—è –≤ —à—Ç–∞—Ç–µ –¢–∞–º–∏–ª–Ω–∞–¥, –∫–æ–º–ø–∞–Ω–∏—é –ª–∏—à–∏–ª–∏ –ª–∏—Ü–µ–Ω–∑–∏–∏, –µ—ë –≤–ª–∞–¥–µ–ª—å—Ü–∞ –∞—Ä–µ—Å—Ç–æ–≤–∞–ª–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-10-09T05:40:01+00:00,@bezrec,6657,https://t.me/bezrec/6657,"–í —Ä—è–¥–µ —Ä–µ–≥–∏–æ–Ω–æ–≤ –Ω–µ —Ö–≤–∞—Ç–∞–µ—Ç –ª–µ–∫–∞—Ä—Å—Ç–≤ –æ—Ç —Ä–µ–≤–º–∞—Ç–∏–∑–º–∞. –í —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, –Ω–∞ –ø–µ—Ä–µ–±–æ–∏ —Å –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å—é —ç—Ç–∞–Ω–µ—Ä—Ü–µ–ø—Ç–∞ –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Ä–µ–≤–º–∞—Ç–æ–∏–¥–Ω–æ–≥–æ –∏ –ø—Å–æ—Ä–∏–∞—Ç–∏—á–µ—Å–∫–æ–≥–æ –∞—Ä—Ç—Ä–∏—Ç–∞, –ø–æ–ª–∏–∞—Ä—Ç—Ä–∏—Ç–∞, —Å–ø–æ–Ω–¥–∏–ª–∏—Ç–∞, –ø—Å–æ—Ä–∏–∞–∑–∞ –∏ —é–Ω–æ—à–µ—Å–∫–æ–≥–æ –∞—Ä—Ç—Ä–∏—Ç–∞ –∂–∞–ª—É—é—Ç—Å—è –≤ –ú–æ—Å–∫–≤–µ, –ü–æ–¥–º–æ—Å–∫–æ–≤—å–µ, –∞ —Ç–∞–∫–∂–µ –ù–∏–∂–µ–≥–æ—Ä–æ–¥—Å–∫–æ–π –∏ –õ–∏–ø–µ—Ü–∫–æ–π –æ–±–ª–∞—Å—Ç—è—Ö. –ù–∞–ø—Ä–∏–º–µ—Ä, –ø–æ —Å–ª–æ–≤–∞–º –ø–∞—Ü–∏–µ–Ω—Ç–∫–∏ –∏–∑ –ú–æ—Å–∫–≤—ã, –Ω–∞ –∫–æ—Ç–æ—Ä—É—é —Å—Å—ã–ª–∞—é—Ç—Å—è ¬´–ò–∑–≤–µ—Å—Ç–∏—è¬ª, –≤ –æ–¥–Ω–æ–π –∏–∑ —Å—Ç–æ–ª–∏—á–Ω—ã—Ö –∞–ø—Ç–µ–∫ –µ–π –æ—Ç–∫–∞–∑–∞–ª–∏ –≤ –≤—ã–¥–∞—á–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏ –ø–æ—Å–æ–≤–µ—Ç–æ–≤–∞–ª–∏ –æ–±—Ä–∞—Ç–∏—Ç—å—Å—è –∫–æ –≤—Ä–∞—á—É, —á—Ç–æ–±—ã —Å–º–µ–Ω–∏—Ç—å —Ç–µ—Ä–∞–ø–∏—é. –î–µ—Ñ–∏—Ü–∏—Ç –µ–π –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª–∏ –∏ –Ω–∞ –≥–æ—Ä—è—á–µ–π –ª–∏–Ω–∏–∏ –ø–æ –≤–æ–ø—Ä–æ—Å–∞–º –ª—å–≥–æ—Ç–Ω–æ–≥–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –≤ –ú–æ—Å–∫–≤–µ. –ú–µ–∂–¥—É —Ç–µ–º, —Å–º–µ–Ω–∏—Ç—å —Ç–µ—Ä–∞–ø–∏—é –Ω–µ —Ç–∞–∫ –ø—Ä–æ—Å—Ç–æ ‚Äî –¥–ª—è —ç—Ç–æ–≥–æ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ –ø—Ä–æ–π—Ç–∏ –∫–æ–º–∏—Å—Å–∏—é, –≤ –∫–æ—Ç–æ—Ä–æ–π –º–æ—Å–∫–≤–∏—á–∫–µ –æ—Ç–∫–∞–∑—ã–≤–∞—é—Ç, –æ–±–µ—â–∞—è —Å–∫–æ—Ä–æ–µ –ø–æ—Å—Ç—É–ø–ª–µ–Ω–∏–µ —ç—Ç–∞–Ω–µ—Ä—Ü–µ–ø—Ç–∞. –í —Å—Ç–æ–ª–∏—á–Ω–æ–º –¥–µ–ø–∞—Ä—Ç–∞–º–µ–Ω—Ç–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è —Å–æ–æ–±—â–∏–ª–∏, —á—Ç–æ ¬´–ø–ª–∞–Ω–æ–≤–∞—è –ø–æ—Å—Ç–∞–≤–∫–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –æ—Å—É—â–µ—Å—Ç–≤–ª—è–µ—Ç—Å—è –≤ —Ç–µ–∫—É—â—É—é –Ω–µ–¥–µ–ª—é¬ª –∏ –Ω–∞–ø–æ–º–Ω–∏–ª–∏ –æ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ –ø–æ–ª—É—á–∏—Ç—å –¥–µ–Ω–µ–∂–Ω—É—é –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏—é –Ω–∞ —Å–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω–æ–µ –ø—Ä–∏–æ–±—Ä–µ—Ç–µ–Ω–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –≤ –ª—é–±–æ–π –∞–ø—Ç–µ–∫–µ. –ù–∞–ª–∏—á–∏–µ –ø—Ä–æ–±–ª–µ–º—ã –≤ —É–ø–æ–º—è–Ω—É—Ç—ã—Ö —Ä–µ–≥–∏–æ–Ω–∞—Ö –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª–∏ —ç–∫—Å-–≥–ª–∞–≤–Ω—ã–π —Ä–µ–≤–º–∞—Ç–æ–ª–æ–≥ –ú–æ—Å–∫–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ï–ª–æ–Ω–∞–∫–æ–≤ –∏ —ç–∫—Å–ø–µ—Ä—Ç—ã –µ—â—ë –¥–≤—É—Ö —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã—Ö –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏–π –Ω–∞ —É—Å–ª–æ–≤–∏—è—Ö –∞–Ω–æ–Ω–∏–º–Ω–æ—Å—Ç–∏. –í –ù–∏–∂–µ–≥–æ—Ä–æ–¥—Å–∫–æ–º –º–∏–Ω–∑–¥—Ä–∞–≤–µ —Ñ–∞–∫—Ç –¥–µ—Ñ–∏—Ü–∏—Ç–∞ —ç—Ç–∞–Ω–µ—Ä—Ü–µ–ø—Ç–∞ –æ–ø—Ä–æ–≤–µ—Ä–≥–ª–∏. –ü–æ –¥–∞–Ω–Ω—ã–º –ì–†–õ–°, –≤ –†–æ—Å—Å–∏–∏ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–æ —Ç—Ä–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ —Å —ç—Ç–∞–Ω–µ—Ä—Ü–µ–ø—Ç–æ–º ‚Äî –≠–Ω–±—Ä–µ–ª –æ—Ç –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–π Pfizer, –≠—Ä–µ–ª–∑–∏ –æ—Ç —Å–ª–æ–≤–µ–Ω—Å–∫–æ–π Sandoz –∏ –†–∏–≤–∏—è –æ—Ç —Ä–æ—Å—Å–∏–π—Å–∫–æ–π ¬´–ü–°–ö –§–∞—Ä–º–∞¬ª. –ë–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –ø–æ–ª—É—á–∞—é—Ç –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç. –ö–∞–∫ —Å–æ–æ–±—â–∏–ª–∏ –≤ –ú–∏–Ω–∑–¥—Ä–∞–≤–µ, –≤ 2024 –≥–æ–¥—É –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –Ω–∞ —Ä—ã–Ω–æ–∫ –≤–≤–µ–¥–µ–Ω–æ –Ω–∞ 35% –±–æ–ª—å—à–µ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å–æ —Å—Ä–µ–¥–Ω–µ–≥–æ–¥–æ–≤—ã–º –∑–Ω–∞—á–µ–Ω–∏–µ–º. –ê –∑–∞ –¥–µ–≤—è—Ç—å –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ –Ω–∞ —Ä—ã–Ω–æ–∫ –≤—ã–≤–µ–ª–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –Ω–∞ 15% –±–æ–ª—å—à–µ, —á–µ–º –∑–∞ –∞–Ω–∞–ª–æ–≥–∏—á–Ω—ã–π –ø–µ—Ä–∏–æ–¥ 2024 –≥–æ–¥–∞. –ü—Ä–∏ —ç—Ç–æ–º, –ø–æ –¥–∞–Ω–Ω—ã–º Headway Company, —á–µ—Ä–µ–∑ –≥–æ—Å–∑–∞–∫—É–ø–∫–∏ –≤ —Å–µ–Ω—Ç—è–±—Ä–µ 2025 –≥–æ–¥–∞ –∑–∞–∫—É–ø–∏–ª–∏ 7,1 —Ç—ã—Å. —É–ø–∞–∫–æ–≤–æ–∫ —ç—Ç–∞–Ω–µ—Ä—Ü–µ–ø—Ç–∞ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å 8,7 —Ç—ã—Å. —É–ø–∞–∫–æ–≤–æ–∫ –∑–∞ –∞–Ω–∞–ª–æ–≥–∏—á–Ω—ã–π –ø–µ—Ä–∏–æ–¥ 2024 –≥–æ–¥–∞. –ï–ª–æ–Ω–∞–∫–æ–≤ —Å—á–∏—Ç–∞–µ—Ç, —á—Ç–æ –Ω–µ—Ö–≤–∞—Ç–∫–∞ —ç—Ç–∞–Ω–µ—Ä—Ü–µ–ø—Ç–∞ –º–æ–∂–µ—Ç –±—ã—Ç—å —Å–≤—è–∑–∞–Ω–∞ —Å –Ω–µ—Å–≤–æ–µ–≤—Ä–µ–º–µ–Ω–Ω—ã–º–∏ –ø–æ–¥–∞—á–∞–º–∏ –∑–∞—è–≤–æ–∫ –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–µ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –¢–æ–π –∂–µ —Ç–æ—á–∫–∏ –∑—Ä–µ–Ω–∏—è –ø—Ä–∏–¥–µ—Ä–∂–∏–≤–∞–µ—Ç—Å—è –¥–∏—Ä–µ–∫—Ç–æ—Ä –ø–æ —Ä–∞–∑–≤–∏—Ç–∏—é RNC Pharm–∞ –ù–∏–∫–æ–ª–∞–π –ë–µ—Å–ø–∞–ª–æ–≤: –Ø –Ω–µ –∏—Å–∫–ª—é—á–∞—é, —á—Ç–æ –º–æ–≥–ª–∏ –Ω–µ –≤–æ–≤—Ä–µ–º—è –æ–±—ä—è–≤–∏—Ç—å —Ç–µ–Ω–¥–µ—Ä –∏–ª–∏ –Ω–µ–∫–æ—Ä—Ä–µ–∫—Ç–Ω–æ –æ–ø—Ä–µ–¥–µ–ª–∏–ª–∏ –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç—å –≤ –ø—Ä–µ–ø–∞—Ä–∞—Ç–µ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""A shortage of etanercept, a medication for rheumatism and psoriasis, has been reported in several regions including Moscow, Moscow Oblast, Nizhny Novgorod and Lipetsk Regions. Patients are facing difficulties in obtaining the medication, with one patient from Moscow reporting being advised to consult a doctor instead of purchasing it. The Moscow department of health claims that the supply is planned for this week and offers compensation for purchasing the drug from any pharmacy. The issue has been confirmed by former chief rheumatologist of Moscow region Alexander Elyonakov and experts from two federal hospitals on condition of anonymity. The Russian Health Ministry states that the country has registered three etanercept drugs - Enbrel from American Pfizer, Erlyzi from Slovenian Sandoz and Rivia from Russian 'P.S.K. Pharma'. Most patients receive the domestic version of the drug. Headway Company data shows that in September 2025, 7,100 units of etanercept were procured through state purchases compared to 8,70"
2025-10-08T17:02:31+00:00,@bezrec,6656,https://t.me/bezrec/6656,"¬´–°–µ—Ä–∞—è –∑–æ–Ω–∞¬ª –≤ –±–µ–ª—ã—Ö —Ö–∞–ª–∞—Ç–∞—Ö: –∫–∞–∫ —Ç–æ—Ä–≥—É—é—Ç –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–µ–π –ò—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –∫–æ–Ω—Å–∞–ª—Ç–∏–Ω–≥–æ–≤–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ Kept —É—Ç–≤–µ—Ä–∂–¥–∞–µ—Ç, —á—Ç–æ –æ–±—ä—ë–º —Ä—ã–Ω–∫–∞ –º–µ–¥–¥–∞–Ω–Ω—ã—Ö –≤ –†–§ –ø—Ä–∏–±–ª–∏–∂–∞–µ—Ç—Å—è –∫ 5 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π ‚Äî 90% —Å–¥–µ–ª–æ–∫ –ø–æ –∏—Ö –ø–æ–∫—É–ø–∫–µ –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏, —Ç–∞–∫–∂–µ –∏–º–∏ –∏–Ω—Ç–µ—Ä–µ—Å—É—é—Ç—Å—è —Å—Ç—Ä–∞—Ö–æ–≤—ã–µ —Å–ª—É–∂–±—ã, —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–∏ –Ω–µ–π—Ä–æ—Å–µ—Ç–µ–π –∏ –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω—ã–µ –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏—è. –ß—Ç–æ –µ—â—ë –º–æ–∂–Ω–æ —Å–∫–∞–∑–∞—Ç—å –ø–æ —Å—Ç–∞—Ç–∏—Å—Ç–∏–∫–µ: üîµ–°–ø—Ä–æ—Å –Ω–∞ –æ–±–µ–∑–ª–∏—á–µ–Ω–Ω—É—é –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é –æ —Å–æ—Å—Ç–æ—è–Ω–∏–∏ –≥—Ä–∞–∂–¥–∞–Ω —Ä–∞—Å—Ç–µ—Ç, –æ–¥–Ω–∞–∫–æ —Ç–∞–∫–æ–π –±–∏–∑–Ω–µ—Å –≤—Å–µ –µ—â–µ –æ—Å—Ç–∞–µ—Ç—Å—è —Å–µ—Ä–æ–π –∑–æ–Ω–æ–π. üîµ–ë–∏–∑–Ω–µ—Å –∑–∞–∫—É–ø–∞–µ—Ç –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –¥–∞–Ω–Ω—ã–µ —É –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–∞ –∏ —á–∞—Å—Ç–Ω—ã—Ö –∫–ª–∏–Ω–∏–∫. üîµ–û–±—ã—á–Ω–æ –≤ –ø–∞–∫–µ—Ç –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –≤—Ö–æ–¥—è—Ç, –Ω–∞–ø—Ä–∏–º–µ—Ä, —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –∞–Ω–∞–ª–∏–∑–æ–≤, –≤—ã–ø–∏—Å–∞–Ω–Ω—ã–µ —Ä–µ—Ü–µ–ø—Ç—ã, –±–æ–ª—å–Ω–∏—á–Ω—ã–µ –ª–∏—Å—Ç—ã, —Ä–µ–Ω—Ç–≥–µ–Ω–æ–≤—Å–∫–∏–µ —Å–Ω–∏–º–∫–∏, –ú–†–¢ –∏ –ø—Ä–æ—á–∏–µ –¥–æ–∫—É–º–µ–Ω—Ç—ã. üîµ–°–µ–π—á–∞—Å –µ—Å—Ç—å —Ä–µ–≥—É–ª—è—Ç–æ—Ä–Ω—ã–µ –±–∞—Ä—å–µ—Ä—ã, –Ω–æ —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã–µ –æ—Ä–≥–∞–Ω—ã –≤–ª–∞—Å—Ç–∏ –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç –∏ –æ–±—Å—É–∂–¥–∞—é—Ç –ø–æ—Ä—è–¥–∫–∞ 10 –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤ –ø–æ —Ä–∞–∑–≤–∏—Ç–∏—é —ç—Ç–æ–≥–æ —Ä—ã–Ω–∫–∞ –∏ —Å–Ω—è—Ç–∏—é –±–∞—Ä—å–µ—Ä–æ–≤. üîµ–í—Ä–∞—á –∑–∞—á–∞—Å—Ç—É—é —Å–∞–º –æ–ø—Ä–µ–¥–µ–ª—è–µ—Ç, –∫–∞–∫–∏–µ –ø–æ–∫–∞–∑–∞—Ç–µ–ª–∏ –ø–æ–ø–∞–¥—É—Ç –≤ –ø—Ä–æ–≥—Ä–∞–º–º—É –¥–ª—è –æ–±—Ä–∞–±–æ—Ç–∫–∏, –ø–æ—ç—Ç–æ–º—É –≤ 80% —Å–ª—É—á–∞–µ–≤ –±–∏–∑–Ω–µ—Å –ø–æ–ª—É—á–∞–µ—Ç –Ω–∞–±–æ—Ä –Ω–µ—Å—Ç—Ä—É–∫—Ç—É—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –∑–∞–ø–∏—Å–µ–π. ‚Ñ¢Ô∏è –ú–µ–¥–∫–∞—Ä—Ç–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, reimbursement, pricing, import_export, sanctions, shortage"",
  ""impact"": ""medium"",
  ""english"": ""A research by consulting company Kept claims that the market for medical data in Russia is approaching 5 billion rubles. 90% of purchases are made by pharmaceutical companies, which also show interest to insurance services, neural network developers, and industrial enterprises. The statistics suggest that the demand for de-identified information about citizens is growing, but this business remains a gray area. Business acquires medical data from the government and private clinics. Typically, the package of information includes results of tests, prescriptions, sick leave certificates, X-rays, MRIs, and other documents. Regulatory barriers exist but the Russian federal authorities are proposing and discussing around 10 initiatives to develop this market and remove barriers. Doctors usually decide which indicators will be included in the processing program, resulting in 80% of cases business receiving unstructured records.""
}"
2025-10-08T15:02:38+00:00,@bezrec,6655,https://t.me/bezrec/6655,"–ò–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π —Ö–æ—Ç—è—Ç –¥–µ—Ä–∂–∞—Ç—å –≤ ¬´—Ö–æ—Ä–æ—à–µ–π —Å–ø–æ—Ä—Ç–∏–≤–Ω–æ–π —Ñ–æ—Ä–º–µ¬ª. –í —Ä–∞–º–∫–∞—Ö ¬´–ë–∏–æ–ø—Ä–æ–º–∞¬ª –ø–æ–±—ã–≤–∞–ª–∏ –Ω–∞ —Å–µ—Å—Å–∏–∏ ¬´–†–∞–∑–≤–∏—Ç–∏–µ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç—É–∞–ª—å–Ω–æ–π –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏–∏ –∫–∞–∫ —Ñ–∞–∫—Ç–æ—Ä –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ —Ä–∞–∑–≤–∏—Ç–∏—è –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–π —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏¬ª –∏ –ø–æ—Å–ª—É—à–∞–ª–∏, —á—Ç–æ –≥–æ–≤–æ—Ä—è—Ç –∏–≥—Ä–æ–∫–∏ —Ä—ã–Ω–∫–∞ –æ –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω–æ–º –ª–∏—Ü–µ–Ω–∑–∏—Ä–æ–≤–∞–Ω–∏–∏. –ò–Ω—Ç–µ—Ä–µ—Å–Ω–æ–π –ø–æ–∫–∞–∑–∞–ª–∞—Å—å –ø–æ–∑–∏—Ü–∏—è –ê–ª–µ–∫—Å–∞–Ω–¥—Ä–∞ –°–µ–º—ë–Ω–æ–≤–∞, –∫–æ—Ç–æ—Ä—ã–π –Ω–∞ —Ñ–æ—Ä—É–º–µ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª—è–ª –Ω–µ —Ç–æ–ª—å–∫–æ ¬´–ê–∫—Ç–∏–≤–Ω—ã–π –∫–æ–º–ø–æ–Ω–µ–Ω—Ç¬ª, –Ω–æ –∏ –∞—Å—Å–æ—Ü–∏–∞—Ü–∏—é ¬´–õ–µ–∫–º–µ–¥–æ–±—Ä–∞—â–µ–Ω–∏–µ¬ª. –≠–∫—Å–ø–µ—Ä—Ç —Ä–∞—Å–∫—Ä–∏—Ç–∏–∫–æ–≤–∞–ª –ø–æ–ª–æ–∂–µ–Ω–∏–µ –æ —Ç–æ–º, —á—Ç–æ –∑–∞—è–≤–ª–µ–Ω–∏–µ –Ω–∞ –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω—É—é –ª–∏—Ü–µ–Ω–∑–∏—é –º–æ–∂–Ω–æ –ø–æ–¥–∞—Ç—å, –µ—Å–ª–∏ –ø–∞—Ç–µ–Ω—Ç–æ–æ–±–ª–∞–¥–∞—Ç–µ–ª—å –Ω–µ –∏—Å–ø–æ–ª—å–∑—É–µ—Ç –∏–ª–∏ –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ –∏—Å–ø–æ–ª—å–∑—É–µ—Ç –∏–∑–æ–±—Ä–µ—Ç–µ–Ω–∏–µ –≤ —Ç–µ—á–µ–Ω–∏–µ —á–µ—Ç—ã—Ä–µ—Ö –ª–µ—Ç. –≠—Ç–æ—Ç —Å—Ä–æ–∫ –°–µ–º—ë–Ω–æ–≤ –Ω–∞–∑–≤–∞–ª –æ–≥—Ä–æ–º–Ω—ã–º –≤ ¬´–Ω—ã–Ω–µ—à–Ω–µ–º –∏–∑–º–µ–Ω—á–∏–≤–æ–º –º–∏—Ä–µ¬ª –∏ –ø—Ä–µ–¥–ª–æ–∂–∏–ª –µ–≥–æ —Å–¥–≤–∏–Ω—É—Ç—å —Å–∏–ª—å–Ω–æ –≤–ª–µ–≤–æ ‚Äî –∞–∂ –¥–æ —à–µ—Å—Ç–∏ –º–µ—Å—è—Ü–µ–≤. –ü—Ä–∏—Å—É—Ç—Å—Ç–≤–æ–≤–∞–≤—à–∏–µ –Ω–∞ –¥–∏—Å–∫—É—Å—Å–∏–∏ –∑–∞–∫–æ–Ω–æ—Ç–≤–æ—Ä—Ü—ã –Ω–æ–≤–µ–ª–ª–µ —É–¥–∏–≤–∏–ª–∏—Å—å, –æ—Ç–º–µ—Ç–∏–≤, —á—Ç–æ —Å–ª—ã—à–∞—Ç –æ –Ω–µ–π –≤–ø–µ—Ä–≤—ã–µ, –Ω–æ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –Ω–∞–ø—Ä–∞–≤–∏—Ç—å –∏–¥–µ—é –Ω–∞ –ø—Ä–æ—Ä–∞–±–æ—Ç–∫—É –≤ –ì–æ—Å–¥—É–º—É –∏–ª–∏ –≤ –°–æ–≤–§–µ–¥. –ú—ã –≥–æ—Ç–æ–≤—ã –≤—ã—Å—Ç—É–ø–∏—Ç—å —Å –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω–æ–π –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–æ–π –æ—Ç –ª–∏—Ü–∞ –Ω–∞—à–µ–π –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–∏. –ù–∞ –º–æ–π –≤–∑–≥–ª—è–¥, —ç—Ç–æ –±—É–¥–µ—Ç, –¥–∞ –ø—Ä–æ—Å—Ç—è—Ç –º–µ–Ω—è –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–∏ –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π, –¥–µ—Ä–∂–∞—Ç—å –∏—Ö –≤ —Ö–æ—Ä–æ—à–µ–π —Å–ø–æ—Ä—Ç–∏–≤–Ω–æ–π —Ñ–æ—Ä–º–µ. –ê —Å –¥—Ä—É–≥–æ–π —Å—Ç–æ—Ä–æ–Ω—ã, –µ—Å–ª–∏ –æ–Ω–∏ –Ω–µ —Ö–æ—Ç—è—Ç –Ω–∞—Ö–æ–¥–∏—Ç—å—Å—è –≤ —ç—Ç–æ–π —Å–ø–æ—Ä—Ç–∏–≤–Ω–æ–π —Ñ–æ—Ä–º–µ, —Ç–æ–≥–¥–∞ –ø–µ—Ä–µ—Ö–æ–¥–∏—Ç—å –∫ –¥–∞–Ω–Ω–æ–º—É –∞–ª–≥–æ—Ä–∏—Ç–º—É, ‚Äî –∑–∞—è–≤–∏–ª –°–µ–º—ë–Ω–æ–≤. –î–ª—è –ø—É—â–µ–π —É–±–µ–¥–∏—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ —Å–ø–∏–∫–µ—Ä –ø—Ä–∏–∑–≤–∞–ª –Ω–µ –∑–∞–±—ã–≤–∞—Ç—å –∏ –æ —Ñ–∏–Ω–∞–Ω—Å–æ–≤–æ–º –∞—Å–ø–µ–∫—Ç–µ: –£ –Ω–∞—Å —Å–µ–π—á–∞—Å –≤—Å–µ–≥–æ –ª–∏—à—å 45% –≤ –¥–µ–Ω–µ–∂–Ω–æ–º —ç–∫–≤–∏–≤–∞–ª–µ–Ω—Ç–µ ‚Äî —ç—Ç–æ —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, —Ç–æ –µ—Å—Ç—å –≥–¥–µ-—Ç–æ 1,6 —Ç—Ä–ª–Ω —Ä—É–±–ª–µ–π –º—ã –∫–∞–∫ —Å—Ç—Ä–∞–Ω–∞ —Ç—Ä–∞—Ç–∏–º –Ω–∞ –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã. –ü—Ä–∏ —ç—Ç–æ–º –¥–µ—Ñ–∏—Ü–∏—Ç –±—é–¥–∂–µ—Ç–∞ —ç—Ç–æ–≥–æ –≥–æ–¥–∞ ‚Äî 5,5 —Ç—Ä–ª–Ω, –∞ –≤ —Å–ª–µ–¥—É—é—â–µ–º –≥–æ–¥—É –æ–∂–∏–¥–∞–µ—Ç—Å—è –µ—â—ë –±–æ–ª—å—à–µ. –ú—ã —Å –≤–∞–º–∏ –º–æ–∂–µ–º –æ–±—â–∏–º–∏ —É—Å–∏–ª–∏—è–º–∏ —Å–æ–∫—Ä–∞—Ç–∏—Ç—å —ç—Ç–æ—Ç –¥–µ—Ñ–∏—Ü–∏—Ç –≤ —Ñ–∞—Ä–º–∞–æ—Ç—Ä–∞—Å–ª–∏ —Ö–æ—Ç—è –±—ã –≤–ø–æ–ª–æ–≤–∏–Ω—É, –∏ –æ—Å—Ç–∞–≤–∏—Ç—å –¥–µ–Ω—å–≥–∏ –≤–Ω—É—Ç—Ä–∏ —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –∫–æ–Ω—Ç—É—Ä–∞, –≤ —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, —Ç—Ä–∞—Ç—è –∏—Ö –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ —Å—É–±—Å—Ç–∞–Ω—Ü–∏–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""Alexander Semenov criticized the requirement for compulsory licensing if a patent holder does not use or sufficiently use an invention for four years. He suggested shortening this period to six months, arguing it is too long in the 'changing world' of today. He also emphasized the financial aspect, stating that Russia currently spends only 16% in monetary terms on foreign medicines. He proposed reducing this deficit by half through common efforts, keeping the money within Russia's pharmaceutical sector.""
}"
2025-10-08T11:45:48+00:00,@bezrec,6654,https://t.me/bezrec/6654,"¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑-–ú–µ–¥—Ç–µ—Ö¬ª –∏ ¬´–°–∏–±—É—Ä¬ª –æ–±–µ—Å–ø–µ—á–∞—Ç –ø–æ–ª–Ω—É—é –Ω–µ–∑–∞–≤–∏—Å–∏–º–æ—Å—Ç—å –†–æ—Å—Å–∏–∏ –≤ –¥–∏–∞–ª–∏–∑–∞—Ç–æ—Ä–∞—Ö –¥–ª—è –ª–µ—á–µ–Ω–∏—è –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –ø–æ—á–µ–∫. –í —Ä–∞–º–∫–∞—Ö ¬´–ë–∏–æ–ø—Ä–æ–º-2025¬ª –∫–æ–º–ø–∞–Ω–∏–∏ –ø–æ–¥–ø–∏—Å–∞–ª–∏ —Å–æ–≥–ª–∞—à–µ–Ω–∏–µ –æ —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–µ, –ø–æ–¥—Ä–∞–∑—É–º–µ–≤–∞—é—â–µ–µ —Ä–∞–∑–≤–∏—Ç–∏–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –∏ –ø–µ—Ä–µ—Ä–∞–±–æ—Ç–∫–∏ –ø–æ–ª–∏–º–µ—Ä–æ–≤ –¥–ª—è –¥–∏–∞–ª–∏–∑–∞—Ç–æ—Ä–æ–≤. –°—Ç–æ—Ä–æ–Ω—ã –¥–æ–≥–æ–≤–æ—Ä–∏–ª–∏—Å—å —Å–æ–≤–º–µ—Å—Ç–Ω–æ —Ä–∞–±–æ—Ç–∞—Ç—å –Ω–∞–¥ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–æ–π –∏ –º–∞—Å—à—Ç–∞–±–∏—Ä–æ–≤–∞–Ω–∏–µ–º —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –º–∞—Ä–æ–∫ –ø–æ–ª–∏–∫–∞—Ä–±–æ–Ω–∞—Ç–∞, –ø–æ–ª–∏—ç—Ñ–∏—Ä—Å—É–ª—å—Ñ–æ–Ω–∞ –∏ –ø–æ–ª–∏—Å—É–ª—å—Ñ–æ–Ω–∞ ‚Äî –∫–ª—é—á–µ–≤—ã—Ö –ø–æ–ª–∏–º–µ—Ä–æ–≤, –∏—Å–ø–æ–ª—å–∑—É–µ–º—ã—Ö –ø—Ä–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ –º–µ–º–±—Ä–∞–Ω–Ω—ã—Ö –≤–æ–ª–æ–∫–æ–Ω –¥–ª—è –¥–∏–∞–ª–∏–∑–Ω–æ–≥–æ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è. –¢–∞–∫–∞—è –¥–æ–≥–æ–≤–æ—Ä—ë–Ω–Ω–æ—Å—Ç—å —Å—Ç—Ä–∞–Ω–µ –æ—á–µ–Ω—å –Ω—É–∂–Ω–∞ ‚Äî —Ä–æ—Å—Å–∏–π—Å–∫–∏–π —Ä—ã–Ω–æ–∫ –≥–µ–º–æ–¥–∏–∞–ª–∏–∑–∞ –∏—Å—Ç–æ—Ä–∏—á–µ—Å–∫–∏ –ø–æ–ª–Ω–æ—Å—Ç—å—é –∑–∞–≤–∏—Å–∏–º –æ—Ç –∏–º–ø–æ—Ä—Ç–∞ –∏–∑ –ï–≤—Ä–æ–ø—ã –∏ –Ø–ø–æ–Ω–∏–∏. –î–∏–∞–ª–∏–∑–∞—Ç–æ—Ä—ã —Å–æ–±–∏—Ä–∞—é—Ç –∏–∑ –∏–º–ø–æ—Ä—Ç–Ω—ã—Ö –º–µ–º–±—Ä–∞–Ω–Ω—ã—Ö –≤–æ–ª–æ–∫–æ–Ω —Å –ø–æ—Å–ª–µ–¥—É—é—â–µ–π —Å—Ç–µ—Ä–∏–ª–∏–∑–∞—Ü–∏–µ–π. –ù–µ—Å—Ç–∞–±–∏–ª—å–Ω—ã–π –∫—É—Ä—Å, —Å–ª–æ–∂–Ω–æ—Å—Ç–∏ —Å –ª–æ–≥–∏—Å—Ç–∏–∫–æ–π –∏, –∫–∞–∫ —Å–ª–µ–¥—Å—Ç–≤–∏–µ, –ø–æ–¥–æ—Ä–æ–∂–∞–Ω–∏–µ —Ä–∞—Å—Ö–æ–¥–Ω–∏–∫–æ–≤ –∏ –ø—Ä–æ–±–ª–µ–º—ã —Å –∑–∞–∫—É–ø–∫–∞–º–∏ –∑–∞—Å—Ç–∞–≤–∏–ª–∏ –∑–∞–¥—É–º–∞—Ç—å—Å—è –æ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞. –ü–µ—Ä–≤—ã–µ —à–∞–≥–∏ —É–∂–µ –¥–µ–ª–∞—é—Ç—Å—è: üîò–≤ 2026 –≥–æ–¥—É ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑-–ú–µ–¥—Ç–µ—Ö¬ª (–≤—Ö–æ–¥–∏—Ç –≤ –ì–ö ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑¬ª) –ø–ª–∞–Ω–∏—Ä—É–µ—Ç –∑–∞–ø—É—Å—Ç–∏—Ç—å –ø–µ—Ä–≤–æ–µ –≤ –†–æ—Å—Å–∏–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ —Ä–∞—Å—Ö–æ–¥–Ω—ã—Ö –º–∞—Ç–µ—Ä–∏–∞–ª–æ–≤ –∏ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –¥–ª—è –≥–µ–º–æ–¥–∏–∞–ª–∏–∑–∞ –∏ –ø–µ—Ä–∏—Ç–æ–Ω–µ–∞–ª—å–Ω–æ–≥–æ –¥–∏–∞–ª–∏–∑–∞ –≤ –ö–∞–ª—É–≥–µ; üîò–≤ 2024 –≥–æ–¥—É –∫–æ–º–ø–∞–Ω–∏—è –ø–æ–¥–ø–∏—Å–∞–ª–∞ —Å ¬´–°–∏–±—É—Ä–æ–º¬ª —Å–æ–≥–ª–∞—à–µ–Ω–∏–µ –æ–± –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–∏ –Ω–æ–≤–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ø–æ–ª–∏–ø—Ä–æ–ø–∏–ª–µ–Ω–æ–º –∏ –ø–æ–ª–∏—ç—Ç–∏–ª–µ–Ω–æ–º; üîò–≤ —ç—Ç–æ–º –≥–æ–¥—É –°–ò–ë–£–† –≤—ã–ø—É—Å—Ç–∏–ª —Å–ø–µ—Ü–∏–∞–ª—å–Ω—É—é –º–∞—Ä–∫—É –ø–æ–ª–∏–∫–∞—Ä–±–æ–Ω–∞—Ç–∞, —Å–æ–≤–º–µ—Å—Ç–∏–º—É—é —Å —Ä–∞–¥–∏–∞—Ü–∏–æ–Ω–Ω–æ–π —Å—Ç–µ—Ä–∏–ª–∏–∑–∞—Ü–∏–µ–π, –¥–ª—è –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –∫–æ—Ä–ø—É—Å–æ–≤ –¥–∏–∞–ª–∏–∑–∞—Ç–æ—Ä–æ–≤. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –ø–∞—Ä—Ç–Ω—ë—Ä—ã —Ä–∞—Å—Å–º–æ—Ç—Ä—è—Ç –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å —Å–æ–≤–º–µ—Å—Ç–Ω–æ–≥–æ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–Ω—ã—Ö –∏ –æ–ø—ã—Ç–Ω–æ-–ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω—ã—Ö –∏—Å–ø—ã—Ç–∞–Ω–∏–π –ø–æ–ª–∏—Å—É–ª—å—Ñ–æ–Ω–æ–≤ –∏ –ø–æ–ª–∏—ç—Ñ–∏—Ä—Å—É–ª—å—Ñ–æ–Ω–æ–≤, —É—Å—Ç–æ–π—á–∏–≤—ã—Ö –∫ –ø–∞—Ä–æ–≤–æ–π –∏ —Ä–∞–¥–∏–∞—Ü–∏–æ–Ω–Ω–æ–π —Å—Ç–µ—Ä–∏–ª–∏–∑–∞—Ü–∏–∏, —Å –ø–æ—Å–ª–µ–¥—É—é—â–µ–π —Å–µ—Ä—Ç–∏—Ñ–∏–∫–∞—Ü–∏–µ–π –∏ –º–∞—Å—à—Ç–∞–±–∏—Ä–æ–≤–∞–Ω–∏–µ–º —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, shortage, regulation"",
  ""impact"": ""high"",
  ""english"": ""The companies 'Farmasintez-Medtech' and 'Sibur' have agreed to cooperate under the 'BioProm-2025' program. They will develop production and processing of polymers for dialysis equipment, including polycarbonate, polyetherurethane, and polysulfone. This is needed to achieve full independence of Russia from imports for hemodialysis, which has historically been dependent on Europe and Japan. The companies plan to start producing dialysis materials in Russia starting from 2026, and are also considering joint laboratory and pilot-plant tests of polysulfones and polyetherurethanes for radiation sterilization, followed by certification and scaling up of the technologies.""
}"
2025-10-08T09:56:34+00:00,@bezrec,6651,https://t.me/bezrec/6651,"–ù–∞ ¬´–ë–∏–æ–ø—Ä–æ–º–µ¬ª –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ —Å–¥–µ–ª–∞—Ç—å —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–æ–≤ –ª–µ–∫–∞—Ä—Å—Ç–≤ —Å–æ–≤–ª–∞–¥–µ–ª—å—Ü–∞–º–∏ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π. –° —Ç–∞–∫–æ–π –∏–¥–µ–µ–π –Ω–∞ –æ–¥–Ω–æ–π –∏–∑ —Å–µ—Å—Å–∏–π –≤—ã—Å—Ç—É–ø–∏–ª –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä –ê–ù–û ¬´–ú–æ—Å–∫–æ–≤—Å–∫–∏–π —Ü–µ–Ω—Ç—Ä –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–∏¬ª –í—è—á–µ—Å–ª–∞–≤ –®—É–ª–µ–Ω–∏–Ω. –í –ø—Ä–∏–º–µ—Ä –æ–Ω –ø—Ä–∏–≤—ë–ª –∑–∞—Ä—É–±–µ–∂–Ω—ã–µ —Å—Ç—Ä–∞–Ω—ã, –≥–¥–µ —Ç–∞–∫–æ–π –ø–æ–¥—Ö–æ–¥ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω—ë–Ω. –í –Ω–∞—à–µ–π —Å—Ç—Ä–∞–Ω–µ –Ω—É–∂–Ω–æ —Å–æ–∑–¥–∞–≤–∞—Ç—å –ø—Ä–∞–∫—Ç–∏–∫—É, –∫–æ–≥–¥–∞ —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–∏ –∏ –≤—Ä–∞—á–∏ —Å—Ç–∞–Ω–æ–≤—è—Ç—Å—è —Å–æ–≤–ª–∞–¥–µ–ª—å—Ü–∞–º–∏ –∫–æ–º–ø–∞–Ω–∏–π –∏ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π, –∫–æ—Ç–æ—Ä—ã–µ –æ–Ω–∏ —Å–æ–∑–¥–∞–ª–∏, —á—Ç–æ–±—ã –æ–Ω–∏ –º–æ–≥–ª–∏ –ª–µ–≥–∞–ª—å–Ω–æ –ø–æ–ª—É—á–∞—Ç—å —Ä–æ—è–ª—Ç–∏. –ö–æ–≥–¥–∞ —É—á—ë–Ω—ã–µ –∏ –≤—Ä–∞—á–∏ –ø–æ—á—É–≤—Å—Ç–≤—É—é—Ç, —á—Ç–æ –æ–Ω–∏ —Ç–æ–∂–µ –º–æ–≥—É—Ç –±—ã—Ç—å –±–æ–≥–∞—Ç—ã–º–∏ –ª—é–¥—å–º–∏, —Ç–æ–∂–µ –º–æ–≥—É—Ç –±—ã—Ç—å –æ–±–µ—Å–ø–µ—á–µ–Ω—ã, –∫–∞–∫ –≤–æ –≤—Å–µ–º –º–∏—Ä–µ, –∏—Ö –∏–Ω—Ç–µ—Ä–µ—Å –∫ —Å–æ–∑–¥–∞–Ω–∏—é —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∞–º –≤—ã–≤–µ–¥–µ—Ç –†–æ—Å—Å–∏—é –Ω–∞ —Å–æ–≤–µ—Ä—à–µ–Ω–Ω–æ –¥—Ä—É–≥–æ–π —É—Ä–æ–≤–µ–Ω—å. –®—É–ª–µ–Ω–∏–Ω –ø–æ–¥—á–µ—Ä–∫–Ω—É–ª, —á—Ç–æ –Ω–∞ —Ñ–æ—Ä—É–º–µ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ—Ç –∏–Ω—Ç–µ—Ä–µ—Å—ã –≤—Ä–∞—á–µ–π-—Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–æ–≤. –ü–æ –µ–≥–æ —Å–ª–æ–≤–∞–º, –±–ª–∞–≥–æ–¥–∞—Ä—è –≥—Ä–∞–Ω—Ç–∞–º –æ—Ç –º—ç—Ä–∞ –ú–æ—Å–∫–≤—ã –ø–æ–¥–¥–µ—Ä–∂–∫—É –ø–æ–ª—É—á–∏–ª–∏ 178 –ø—Ä–æ–µ–∫—Ç–æ–≤ –Ω–∞ 5,5 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ß–∞—Å—Ç—å –¥–æ—Å—Ç–∏–∂–µ–Ω–∏–π, –≤–∫–ª—é—á–∞—è CAR-T –ø–ª–∞—Ç—Ñ–æ—Ä–º—É –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ —Ä–∞–∫–∞, –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–∞ –Ω–∞ —Å—Ç–µ–Ω–¥–µ ¬´–°–æ–∑–¥–∞–Ω–æ –º–æ—Å–∫–æ–≤—Å–∫–∏–º–∏ –≤—Ä–∞—á–∞–º–∏¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-10-08T05:45:41+00:00,@bezrec,6650,https://t.me/bezrec/6650,"–ê–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å—â–∏–∫–∏ —É—Å—Ç–∞–ª–∏ –æ—Ç –∫–æ–º–∏—Å—Å–∏–π. –í—ã—Å—Ç—É–ø–∞—è –Ω–∞ —Å–µ—Å—Å–∏–∏ ¬´–§–∞—Ä–º–∞-2030¬ª —Ñ–æ—Ä—É–º–∞ ¬´–ë–∏–æ–ø—Ä–æ–º¬ª, –∑–∞–º–≥–ª–∞–≤—ã –§–ê–° –¢–∏–º–æ—Ñ–µ–π –ù–∏–∂–µ–≥–æ—Ä–æ–¥—Ü–µ–≤ –ø–æ—Å–µ—Ç–æ–≤–∞–ª, —á—Ç–æ –æ–Ω —Å–∞–º –∏ –µ–≥–æ —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–∏ —á–µ—Ä–µ—Å—á—É—Ä –∑–∞–≥—Ä—É–∂–µ–Ω—ã —É—á–∞—Å—Ç–∏–µ–º –≤ —Ä–∞–∑–ª–∏—á–Ω–æ–≥–æ —Ä–æ–¥–∞ –∫–æ–º–∏—Å—Å–∏—è—Ö: –ú—ã —É–∂–µ —É—Å—Ç–∞–ª–∏ —Å—á–∏—Ç–∞—Ç—å –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –∫–æ–º–∏—Å—Å–∏–π, –∫—É–¥–∞ –Ω–∞—Å –≤–∫–ª—é—á–∞—é—Ç. –¢–æ–ª—å–∫–æ –ø–æ —Å–ø–∏—Ä—Ç—É —É –Ω–∞—Å —Ç—Ä–∏ –∫–æ–º–∏—Å—Å–∏–∏ –æ—Ç–¥–µ–ª—å–Ω—ã—Ö, –≤–∫–ª—é—á–∞—è –æ–¥–Ω—É –ø–æ —Ä–∞–∑–º–µ—Ä—É –±—É—Ç—ã–ª–æ—á–µ–∫, –≤ –∫–æ—Ç–æ—Ä—ã—Ö –ø—Ä–æ–¥–∞—é—Ç—Å—è —Å–ø–∏—Ä—Ç–æ—Å–æ–¥–µ—Ä–∂–∞—â–∏–µ —Ä–∞—Å—Ç–≤–æ—Ä—ã. –ò —Ç–µ–ø–µ—Ä—å –≤–æ—Ç –æ—Ç–¥–µ–ª—å–Ω–∞—è –∫–æ–º–∏—Å—Å–∏—è –ø–æ –°–ó–õ–°. –°–ø–∞—Å–∏–±–æ, –∫–æ–Ω–µ—á–Ω–æ, –±–æ–ª—å—à–æ–µ –∑–∞ —É–≤–∞–∂–µ–Ω–∏–µ –ø—Ä–æ—è–≤–ª–µ–Ω–Ω–æ–µ, –Ω–æ —Ç–∞–º –æ–ø—è—Ç—å –ø—Ä–∏–¥—ë—Ç—Å—è —Å–∏–¥–µ—Ç—å. –Ø –≤–æ–æ–±—â–µ –º–æ–≥—É –Ω–∞ —Ä–∞–±–æ—Ç—É –Ω–µ —Ö–æ–¥–∏—Ç—å, –∏ —á–∞—Å—Ç—å –º–æ–∏—Ö —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤ —Å–∞–º—ã—Ö –ª—É—á—à–∏—Ö —Ç–æ–∂–µ, –∞ —Ö–æ–¥–∏—Ç—å –ø–æ –∫–æ–º–∏—Å—Å–∏—è–º, ‚Äî –∑–∞—è–≤–∏–ª –ù–∏–∂–µ–≥–æ—Ä–æ–¥—Ü–µ–≤ –∏ –ø–æ–∑–≤–æ–ª–∏–ª —Å–µ–±–µ –ø–æ–º–µ—á—Ç–∞—Ç—å: –ï—Å–ª–∏ –µ—â—ë —Ç–∞–º –æ—Ä–≥–∞–Ω–∏–∑–æ–≤–∞—Ç—å –∫–æ—Ñ–µ –±—Ä–µ–π–∫–∏, —Ç–æ –≤–æ–æ–±—â–µ, –≤ –ø—Ä–∏–Ω—Ü–∏–ø–µ, –∂–∏–∑–Ω—å —É–¥–∞–ª–∞—Å—å. –í–º–µ—Å—Ç–æ –≤—Å—è–∫–æ–≥–æ —Ä–æ–¥–∞ –∫–æ–º–∏—Å—Å–∏–π –§–ê–° –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç –ø—Ä–æ–ø–∏—Å–∞—Ç—å –æ–±—ä–µ–∫—Ç–∏–≤–Ω—ã–µ –∫—Ä–∏—Ç–µ—Ä–∏–∏, –Ω–∞ –æ—Å–Ω–æ–≤–∞–Ω–∏–∏ –∫–æ—Ç–æ—Ä—ã—Ö —Å–æ–∑–¥–∞—Ç—å –ø–µ—Ä–µ—á–µ–Ω—å –°–ó–õ–°. –ü—Ä–∏ —ç—Ç–æ–º –ù–∏–∂–µ–≥–æ—Ä–æ–¥—Ü–µ–≤ –ø—Ä–µ–¥–ª–æ–∂–∏–ª –∑–∞–Ω–∏–º–∞—Ç—å—Å—è –ø–æ–¥–¥–µ—Ä–∂–∫–æ–π —Å–∞–º—ã—Ö –Ω–∏–∑–∫–æ–º–∞—Ä–∂–∏–Ω–∞–ª—å–Ω—ã—Ö –∏ –º–∞—Å—Å–æ–≤—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –ø—Ä–∏–≤–µ–¥—è –≤ –ø—Ä–∏–º–µ—Ä —Å–∏—Ç—É–∞—Ü–∏—é —Å —Ñ–∏–∑—Ä–∞—Å—Ç–≤–æ—Ä–æ–º. –û—Ç—Å—É—Ç—Å—Ç–≤–∏–µ —Ç–∞–∫–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ —Å—Ä–∞–∑—É –∂–µ –≤–ª–∏—è–µ—Ç –∏ –Ω–∞ —Å–∏—Å—Ç–µ–º—É –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è, –∏ –Ω–∞ –≤–æ—Å–ø—Ä–∏—è—Ç–∏–µ –Ω–∞—Å–µ–ª–µ–Ω–∏–µ–º –∫–∞—á–µ—Å—Ç–≤–∞ –∂–∏–∑–Ω–∏ —Å —Ç–æ—á–∫–∏ –∑—Ä–µ–Ω–∏—è –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç–∏ —ç—Ç–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ß—Ç–æ –¥–æ –∏–Ω–Ω–æ–≤–∞—Ü–∏–π, —Ç–æ —Ç—É—Ç —ç–∫—Å–ø–µ—Ä—Ç –æ–∑–≤—É—á–∏–ª –Ω–µ —Å–∞–º–æ–µ –ø–æ–ø—É–ª—è—Ä–Ω–æ–µ –≤ –æ—Ç—Ä–∞—Å–ª–∏ –º–Ω–µ–Ω–∏–µ: –≠—Ç–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã —Å–∞–º–æ–π –≤—ã—Å–æ–∫–æ–π —Å—Ç–µ–ø–µ–Ω–∏ –º–∞—Ä–∂–∏–Ω–∞–ª—å–Ω–æ—Å—Ç–∏. –¢—É–¥–∞ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω—ã –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–∏ –≤—Å–µ—Ö –Ω–∞—à–∏—Ö –æ—Å–Ω–æ–≤–Ω—ã—Ö –∏–≥—Ä–æ–∫–æ–≤. –ö–∞–∫–∏—Ö-—Ç–æ –æ—Å–æ–±—ã—Ö –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã—Ö –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–π –∏ –ø–æ–¥–¥–µ—Ä–∂–∫–∏ –≤ —ç—Ç–æ—Ç —Å–µ–∫—Ç–æ—Ä –Ω–µ —Ç—Ä–µ–±—É–µ—Ç—Å—è, –∫–æ–º–ø–∞–Ω–∏–∏ —Å–ø—Ä–∞–≤–ª—è—é—Ç—Å—è —Å–æ–±—Å—Ç–≤–µ–Ω–Ω—ã–º–∏ —Å–∏–ª–∞–º–∏. –ú—ã –Ω–µ —É–º–∞–ª—è–µ–º –≤–∞–∂–Ω–æ—Å—Ç—å –∏ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç—å –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –Ω–æ —Å—á–∏—Ç–∞–µ–º, —á—Ç–æ –ø–µ—Ä–µ—á–µ–Ω—å –°–ó–õ–° –Ω–µ –ø—Ä–æ —ç—Ç–æ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""sanctions, regulation"",
  ""impact"": ""medium"",
  ""english"": "": The Anti-monopoly Service representatives are complaining about the excessive number of commissions they have to attend. They suggest objective criteria for creating a list of SLS (Specialized Low Margin Products) to reduce the burden on themselves and their team. The expert also expressed a less popular opinion in the industry, suggesting that investments are made into high-margin innovative drugs. The regional service is concerned about the accessibility of low-margin and mass-produced medications, which are crucial for healthcare systems and public perception of quality of life.""
}"
2025-10-07T16:03:18+00:00,@bezrec,6647,https://t.me/bezrec/6647,"–ê –≤–æ—Ç —Ç–∞–∫–∏–º –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã–º, —Å–∏–º–ø–∞—Ç–∏—á–Ω—ã–º –∏ –≤–∫—É—Å–Ω—ã–º —Å–ø–æ—Å–æ–±–æ–º ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª —Ä–µ—à–∏–ª –Ω–∞–ø–æ–º–Ω–∏—Ç—å –æ —á–∏—Å—Ç–æ—Ç–µ —Å–æ—Å—Ç–∞–≤–∞ —Å–≤–æ–∏—Ö –ø—Ä–æ–¥—É–∫—Ç–æ–≤. –ö–æ–ª–ª–µ–≥–∏, –î–µ–Ω–∏—Å–∞ –í–∞–ª–µ–Ω—Ç–∏–Ω–æ–≤–∏—á–∞ —É–≥–æ—Å—Ç–∏–ª–∏? ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-10-07T14:00:50+00:00,@bezrec,6646,https://t.me/bezrec/6646,"–ì–ö ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑¬ª –∏ Hualan Bio –æ–±—ä—è–≤–∏–ª–∏ –æ —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–æ–º —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–µ –≤ –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—è—Ö. –ù–∞ ¬´–ë–∏–æ–ø—Ä–æ–º–µ 2025¬ª –≤ –ì–µ–ª–µ–Ω–¥–∂–∏–∫–µ –∫–æ–º–ø–∞–Ω–∏–∏ –¥–æ–≥–æ–≤–æ—Ä–∏–ª–∏—Å—å –æ –¥–æ–ª–≥–æ—Å—Ä–æ—á–Ω–æ–º –ø–∞—Ä—Ç–Ω–µ—Ä—Å—Ç–≤–µ –≤ –æ–±–ª–∞—Å—Ç–∏ —Ç—Ä–∞–Ω—Å—Ñ–µ—Ä–∞ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –∏ —Å–æ–≤–º–µ—Å—Ç–Ω–æ–π —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤. Hualan Bio ‚Äî –¥–æ—Å—Ç–æ–π–Ω—ã–π –ø–∞—Ä—Ç–Ω—ë—Ä. –≠—Ç–æ –æ–¥–Ω–∞ –∏–∑ –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö –∏ –Ω–∞–∏–±–æ–ª–µ–µ –º–æ—â–Ω—ã—Ö –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –∫–æ–º–ø–∞–Ω–∏–π –ö–ù–†, —Å 1992 –≥–æ–¥–∞ —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä—É—é—â–∞—è—Å—è –Ω–∞ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è—Ö, —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ, –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ –∏ –∫–æ–º–º–µ—Ä—Ü–∏–∞–ª–∏–∑–∞—Ü–∏–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ø–ª–∞–∑–º—ã –∫—Ä–æ–≤–∏, –≤–∞–∫—Ü–∏–Ω –∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ –æ—Å–Ω–æ–≤–µ —Ä–µ–∫–æ–º–±–∏–Ω–∞–Ω—Ç–Ω—ã—Ö –±–µ–ª–∫–æ–≤. –û—Å–Ω–æ–≤–Ω—ã–µ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–∞: üü©—Ç—Ä–∞–Ω—Å—Ñ–µ—Ä —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π ‚Äî Hualan Bio –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–∏—Ç –¥–æ—Å—Ç—É–ø –∫ —Å–≤–æ–∏–º –ø–µ—Ä–µ–¥–æ–≤—ã–º –ø–ª–∞—Ç—Ñ–æ—Ä–º–∞–º –¥–ª—è —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –±–∏–æ–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, —á—Ç–æ –ø–æ–∑–≤–æ–ª–∏—Ç —Å–æ–≤–º–µ—Å—Ç–Ω–æ —Å–æ–∑–¥–∞–≤–∞—Ç—å –Ω–æ–≤—ã–µ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞; üü©—Å–æ–≤–º–µ—Å—Ç–Ω—ã–µ –Ω–∞—É—á–Ω–æ-–∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–∏–µ –∏ –æ–ø—ã—Ç–Ω–æ-–∫–æ–Ω—Å—Ç—Ä—É–∫—Ç–æ—Ä—Å–∫–∏–µ —Ä–∞–±–æ—Ç—ã, –æ—Å–æ–±–µ–Ω–Ω–æ –≤ –æ–±–ª–∞—Å—Ç–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –ø—Ä–æ—Ä—ã–≤–Ω—ã—Ö —Ç–µ—Ä–∞–ø–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –º–æ–Ω–æ–∫–ª–æ–Ω–∞–ª—å–Ω—ã—Ö –∞–Ω—Ç–∏—Ç–µ–ª; üü©–ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏—è –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞: —á–∞—Å—Ç—å –±–∏–æ–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –±—É–¥–µ—Ç –≤—ã–ø—É—Å–∫–∞—Ç—å—Å—è –ø–æ –ø–æ–ª–Ω–æ–º—É —Ü–∏–∫–ª—É –Ω–∞ –ø–ª–æ—â–∞–¥–∫–∞—Ö ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑–∞¬ª –≤ –†–æ—Å—Å–∏–∏, —á—Ç–æ —Å–ø–æ—Å–æ–±—Å—Ç–≤—É–µ—Ç –∏–º–ø–æ—Ä—Ç–æ–∑–∞–º–µ—â–µ–Ω–∏—é –∏ —É–¥–æ–≤–ª–µ—Ç–≤–æ—Ä–µ–Ω–∏—é –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç–µ–π –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ —Ä—ã–Ω–∫–∞; üü©—Å–æ–≤–º–µ—Å—Ç–Ω—ã–π –≤—ã—Ö–æ–¥ –Ω–∞ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã–µ —Ä—ã–Ω–∫–∏, –∫–∞–∫ –≤ —Ä–∞–º–∫–∞—Ö –ï–ê–≠–°, —Ç–∞–∫ –∏ –∑–∞ –µ–≥–æ –ø—Ä–µ–¥–µ–ª–∞–º–∏. –°–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–æ —É—Å–∫–æ—Ä–∏—Ç –≤–Ω–µ–¥—Ä–µ–Ω–∏–µ –¥–æ—Å—Ç–∏–∂–µ–Ω–∏–π ¬´–•—É–∞–ª–∞–Ω –î–∂–µ–Ω–µ—Ç–∏–∫¬ª –≤ –æ–±–ª–∞—Å—Ç–∏ –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –≤ –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –∏ —Å–æ–∫—Ä–∞—Ç–∏—Ç —Å—Ä–æ–∫–∏ –æ—Ç —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –¥–æ –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–≥–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –¥–ª—è ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑¬ª. –û–Ω–æ –ø–æ–∑–≤–æ–ª–∏—Ç –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å –≤–∑–∞–∏–º–æ–¥–æ–ø–æ–ª–Ω—è—é—â–∏–µ –ø—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–∞: ¬´–•—É–∞–ª–∞–Ω –î–∂–µ–Ω–µ—Ç–∏–∫¬ª –ø—Ä–∏–º–µ–Ω—è–µ—Ç —Å–≤–æ–∏ –ø–µ—Ä–µ–¥–æ–≤—ã–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã–µ –∏ –Ω–∞—É—á–Ω—ã–µ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏, –∞ ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑¬ª ‚Äî —Å–≤–æ—é –æ–±—à–∏—Ä–Ω—É—é –∫–ª–∏–Ω–∏—á–µ—Å–∫—É—é —ç–∫—Å–ø–µ—Ä—Ç–∏–∑—É –∏ —Ä—ã–Ω–æ—á–Ω—ã–µ —Ä–µ—Å—É—Ä—Å—ã, —á—Ç–æ —Å–ø–æ—Å–æ–±—Å—Ç–≤—É–µ—Ç –≤–∑–∞–∏–º–æ–≤—ã–≥–æ–¥–Ω–æ–º—É –ø—Ä–æ–¥–≤–∏–∂–µ–Ω–∏—é. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, —Å–æ–≤–º–µ—Å—Ç–Ω–∞—è –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç—å —É—Å–∏–ª–∏—Ç —Ä–∞–∑–≤–∏—Ç–∏–µ –±–∏–æ—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –∏–Ω–Ω–æ–≤–∞—Ü–∏–π –∏ —É–∫—Ä–µ–ø–∏—Ç —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫—É—é –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –æ–±–µ–∏—Ö —Å—Ç—Ä–∞–Ω, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∞ –≥–µ–Ω–µ—Ä–∞–ª—å–Ω—ã–π –¥–∏—Ä–µ–∫—Ç–æ—Ä HuaLan Genetic Engineering –ê–Ω—å –í—ç–Ω—å—Ü–∏. –ë–µ–∑ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–æ–≥–æ —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–∞ –∏ –æ–±—ä–µ–¥–∏–Ω–µ–Ω–∏—è —Ä–µ—Å—É—Ä—Å–æ–≤ –Ω–µ–≤–æ–∑–º–æ–∂–Ω–æ –¥–æ–±–∏—Ç—å—Å—è –±—ã—Å—Ç—Ä–æ–≥–æ –ø—Ä–æ–≥—Ä–µ—Å—Å–∞ –∏ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ –ø—Ä–æ—Ä—ã–≤–∞. –°—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–æ–µ –ø–∞—Ä—Ç–Ω–µ—Ä—Å—Ç–≤–æ —Å ¬´–•—É–∞–ª–∞–Ω –î–∂–µ–Ω–µ—Ç–∏–∫¬ª –æ—Ç–∫—Ä–æ–µ—Ç –Ω–æ–≤—ã–µ –≥–æ—Ä–∏–∑–æ–Ω—Ç—ã –¥–ª—è —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö —Ä–∞–∑—Ä–∞–±–æ—Ç–æ–∫ –∏ —Å–¥–µ–ª–∞–µ—Ç –Ω–∞—à—É —Å—Ç—Ä–∞–Ω—É –±–æ–ª–µ–µ –∫–æ–Ω–∫—É—Ä–µ–Ω—Ç–æ—Å–ø–æ—Å–æ–±–Ω–æ–π –Ω–∞ –º–∏—Ä–æ–≤–æ–º –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–º —Ä—ã–Ω–∫–µ, ‚Äî –æ—Ç–º–µ—Ç–∏–ª –ü—Ä–µ–∑–∏–¥–µ–Ω—Ç –ì–ö ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑¬ª –í–∏–∫—Ä–∞–º –ü—É–Ω–∏—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-10-07T11:50:01+00:00,@bezrec,6643,https://t.me/bezrec/6643,"–ú–∞–Ω—Ç—É—Ä–æ–≤ –Ω–∞ ¬´–ë–∏–æ–ø—Ä–æ–º¬ª –ø–æ—Ö–≤–∞–ª–∏–ª ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª. –í–æ –≤—Ä–µ–º—è –æ–±—Ö–æ–¥–∞ –≤—ã—Å—Ç–∞–≤–∫–∏ –ø–µ—Ä–≤—ã–π –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—è –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –†–æ—Å—Å–∏–∏ –î–µ–Ω–∏—Å –ú–∞–Ω—Ç—É—Ä–æ–≤ –∑–∞–≥–ª—è–Ω—É–ª –Ω–∞ —ç–∫—Å–ø–æ–∑–∏—Ü–∏—é –∫–æ–º–ø–∞–Ω–∏–∏ –ü–µ—Ç—Ä–∞ –ë–µ–ª–æ–≥–æ. –ü–æ—Å–º–æ—Ç—Ä–µ—Ç—å –±—ã–ª–æ –Ω–∞ —á—Ç–æ: –ø–æ–º–∏–º–æ —Ö–∏—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Å–∞—Ö–∞—Ä–Ω–æ–≥–æ –¥–∏–∞–±–µ—Ç–∞ –∏ –æ–∂–∏—Ä–µ–Ω–∏—è, –Ω–∞ —Å–≤–æ—ë–º —Å—Ç–µ–Ω–¥–µ —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª –∏ —Ä—è–¥ –Ω–æ–≤–∏–Ω–æ–∫ –ø—Ä–æ—Ç–∏–≤ –∏–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –¥—ã—Ö–∞—Ç–µ–ª—å–Ω—ã—Ö –ø—É—Ç–µ–π, –∞ —Ç–∞–∫–∂–µ —Å–∏–Ω–¥—Ä–æ–º–∞ –∫–æ—Ä–æ—Ç–∫–æ–π –∫–∏—à–∫–∏. –í—ã—Å–æ–∫–æ–ø–æ—Å—Ç–∞–≤–ª–µ–Ω–Ω–æ–º—É –≥–æ—Å—Ç—é –ø–æ–∫–∞–∑–∞–ª–∏, –∫–∞–∫ —Ä–∞–±–æ—Ç–∞–µ—Ç –æ–¥–Ω–æ–¥–æ–∑–æ–≤—ã–π –∏–Ω–∂–µ–∫—Ç–æ—Ä. –ú–∞–Ω—Ç—É—Ä–æ–≤ –æ—Ü–µ–Ω–∏–ª —É–¥–æ–±—Å—Ç–≤–æ —É—Å—Ç—Ä–æ–π—Å—Ç–≤–∞, –ø–æ–∑–≤–æ–ª—è—é—â–µ–≥–æ –ø–∞—Ü–∏–µ–Ω—Ç—É –±—ã—Ç—å —É–≤–µ—Ä–µ–Ω–Ω—ã–º –≤ –ø—Ä–∞–≤–∏–ª—å–Ω–æ—Å—Ç–∏ –¥–æ–∑–∏—Ä–æ–≤–∫–∏, –∏ –Ω–∞–∑–≤–∞–ª –µ–≥–æ ¬´–Ω–∞—Å—Ç–æ—è—â–µ–π —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–µ–π XXI –≤–µ–∫–∞¬ª, —Ä–µ–∫–æ–º–µ–Ω–¥–æ–≤–∞–≤ —É–≥–ª—É–±–∏—Ç—å –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏—é –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞. ¬´–ú—ã —É–≤–µ—Ä–µ–Ω—ã, —á—Ç–æ –≤–µ—Å–æ–º—É—é —Ä–æ–ª—å –≤ –±—É–¥—É—â–∏—Ö –º–µ—Ç–æ–¥–∞—Ö —Ç–µ—Ä–∞–ø–∏–∏ –±—É–¥—É—Ç –∏–º–µ—Ç—å –∏–º–µ–Ω–Ω–æ –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–µ –∏ –ø–µ–ø—Ç–∏–¥–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, –∫–ª–µ—Ç–æ—á–Ω—ã–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏, –∫–æ–Ω—ä—é–≥–∞—Ç—ã –º–æ–Ω–æ–∫–ª–æ–Ω–∞–ª—å–Ω—ã—Ö –∞–Ω—Ç–∏—Ç–µ–ª –¥–ª—è –ª–µ—á–µ–Ω–∏—è –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, –∫–æ—Ç–æ—Ä—ã–µ –ø–æ–∫–∞ —Å—á–∏—Ç–∞—é—Ç—Å—è –Ω–µ–∏–∑–ª–µ—á–∏–º—ã–º–∏. –ù–∞—à–∞ –∫–æ–º–ø–∞–Ω–∏—è –æ—á–µ–Ω—å –∞–∫—Ç–∏–≤–Ω–æ —Ä–∞–±–æ—Ç–∞–µ—Ç –≤ —ç—Ç–æ–º –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏–∏, –≤ —Ç–æ–º —á–∏—Å–ª–µ —Å–æ–≤–º–µ—Å—Ç–Ω–æ —Å –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥—Å–∫–∏–º –ø–æ–ª–∏—Ç–µ—Ö–Ω–∏—á–µ—Å–∫–∏–º —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–æ–º —Ä–∞–∑—Ä–∞–±–∞—Ç—ã–≤–∞–µ—Ç –º–†–ù–ö-–≤–∞–∫—Ü–∏–Ω—É –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Ä–∞–∑–ª–∏—á–Ω—ã—Ö –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π¬ª, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∞ –¥–∏—Ä–µ–∫—Ç–æ—Ä –ø–æ –Ω–æ–≤—ã–º –ø—Ä–æ–¥—É–∫—Ç–∞–º –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª –ö–∏—Ä–∞ –ó–∞—Å–ª–∞–≤—Å–∫–∞—è. ¬´–í—ã ‚Äî –º–æ–ª–æ–¥—Ü—ã¬ª, ‚Äî –æ—Ü–µ–Ω–∏–ª –ú–∞–Ω—Ç—É—Ä–æ–≤ —É—Å–∏–ª–∏—è –∫–æ–º–∞–Ω–¥—ã. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance, safety"",
  ""impact"": ""high"",
  ""english"": ""Denis Manturov, First Deputy Chairman of the Government of Russia, visited the stand of Petros BioProm during a visit to the exhibition. He was impressed by the company's products, including treatments for diabetes and obesity, as well as new respiratory disease and short bowel syndrome treatments. He praised the company's innovative one-dose injector, describing it as a 'technology of the 21st century' and recommending local production. He also commended the company's efforts in developing biotechnological and peptide-based therapies, including a mRNA vaccine for various oncological diseases in collaboration with the St. Petersburg Polytechnic University.""
}"
2025-10-07T09:17:45+00:00,@bezrec,6642,https://t.me/bezrec/6642,"–ù–∞ ¬´–ë–∏–æ–ø—Ä–æ–º–µ¬ª –ø–æ–≥–æ–≤–æ—Ä–∏–ª–∏ –ø—Ä–æ –ò–ò –≤ —Ñ–∞—Ä–º–µ –∏ –º–µ–¥–∏—Ü–∏–Ω–µ. –í—á–µ—Ä–∞ –ø–æ–±—ã–≤–∞–ª–∏ –Ω–∞ –≥–ª–∞–≤–Ω–æ–π —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–æ–π —Å–µ—Å—Å–∏–∏ ¬´–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ –¥–ª—è –∂–∏–∑–Ω–∏¬ª. –ü–æ—Å–ª—É—à–∞–ª–∏, —á—Ç–æ –≥–æ–≤–æ—Ä—è—Ç —ç–∫—Å–ø–µ—Ä—Ç—ã –æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–∏ –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–∞ –≤ –º–µ–¥–∏—Ü–∏–Ω–µ –∏ —Ñ–∞—Ä–º–ø—Ä–æ–º–µ. –ü–æ —Å–ª–æ–≤–∞–º –∏—Å–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–≥–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ ¬´–í–∞–Ω—Å–µ–ª¬ª (OneCell, –ì–ö ¬´–†–æ—Å—Ç–µ—Ö¬ª) –ê–ª–µ–∫—Å–∞–Ω–¥—Ä–∞ –ù–∏–Ω–±—É—Ä–≥–∞, –Ω–∞ —Å–µ–≥–æ–¥–Ω—è—à–Ω–∏–π –¥–µ–Ω—å –∑–∞ —à–µ—Å—Ç—å –ª–µ—Ç —Ä–∞–±–æ—Ç—ã –∫–æ–º–ø–∞–Ω–∏–∏ —á–µ—Ä–µ–∑ –ø–ª–∞—Ç—Ñ–æ—Ä–º—É —É–∂–µ –ø–æ—Å—Ç–∞–≤–ª–µ–Ω–æ –±–æ–ª—å—à–µ 1,7 –º–ª–Ω –¥–∏–∞–≥–Ω–æ–∑–æ–≤, –∏ –µ–∂–µ–º–µ—Å—è—á–Ω–æ —Å—Ç–∞–≤–∏—Ç—Å—è –µ—â—ë –ø–æ—Ä—è–¥–∫–∞ 90 —Ç—ã—Å. –í –ø–ª–∞–Ω–∞—Ö ‚Äî —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∞ –ø–µ—Ä—Å–æ–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –¥–ª—è –∫–∞–∂–¥–æ–≥–æ –ø–∞—Ü–∏–µ–Ω—Ç–∞ –Ω–∞ –æ—Å–Ω–æ–≤–µ –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥–∞ –µ–≥–æ —Å–æ—Å—Ç–æ—è–Ω–∏—è, –≤ —Ç–æ–º —á–∏—Å–ª–µ —Å —É—á—ë—Ç–æ–º –∫–∞—á–µ—Å—Ç–≤–∞ –∂–∏–∑–Ω–∏ –∏ –ø–æ–Ω–∏–º–∞–Ω–∏—è –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω–æ–π —Ç–æ–∫—Å–∏—á–Ω–æ—Å—Ç–∏ —Ç–µ—Ö –∏–ª–∏ –∏–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ê–∫—Ç–∏–≤–Ω–æ –ò–ò –≤ —Ä–∞–±–æ—Ç–µ –∏—Å–ø–æ–ª—å–∑—É–µ—Ç –∏ ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª. –ù–∞–ø—Ä–∏–º–µ—Ä, –∫–∞–∫ —Ä–∞—Å—Å–∫–∞–∑–∞–ª –≥–ª–∞–≤–∞ –∫–æ–º–ø–∞–Ω–∏–∏ –ü—ë—Ç—Ä –†–æ–¥–∏–æ–Ω–æ–≤, –ø—Ä–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ –º–æ–ª–µ–∫—É–ª—ã –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ –∏–Ω—Å—É–ª–∏–Ω–∞. –í–Ω–µ–¥—Ä–µ–Ω–∏–µ –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–∞ –≤ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–µ –æ–Ω –ø—Ä–µ–¥–ª–æ–∂–∏–ª —Ä–∞–∑–¥–µ–ª–∏—Ç—å –Ω–∞ –¥–≤–∞ –æ—Å–Ω–æ–≤–Ω—ã—Ö —ç—Ç–∞–ø–∞: üîò–ø–æ–∏—Å–∫–æ–≤—ã–π, –≤–æ –≤—Ä–µ–º—è –∫–æ—Ç–æ—Ä–æ–≥–æ –∏–¥—ë—Ç –ø–æ–∏—Å–∫ –Ω–æ–≤—ã—Ö –º–æ–ª–µ–∫—É–ª –∏ –ø–æ–¥–±–æ—Ä —É—Å–ª–æ–≤–∏–π —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞; üîò–¥–æ–∫–∞–∑–∞—Ç–µ–ª—å–Ω—ã–π, –∫–æ–≥–¥–∞ —É–∂–µ –Ω–∞ —ç—Ç–∞–ø–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫ –¥–æ–∫–∞–∑—ã–≤–∞–µ—Ç, —á—Ç–æ –º–æ–ª–µ–∫—É–ª–∞ –±–µ–∑–æ–ø–∞—Å–Ω–∞ –∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–∞. –ü–æ —Å–ª–æ–≤–∞–º —ç–∫—Å–ø–µ—Ä—Ç–∞, –∑–¥–µ—Å—å –æ—á–µ–Ω—å –ø—Ä–∏–≥–æ–¥–∏–ª–∞—Å—å –Ω–µ–∫–∞—è –ø—Ä–∞–≤–æ–≤–∞—è —Ä–∞–º–∫–∞, —á—Ç–æ–±—ã –º–æ–∂–Ω–æ –±—ã–ª–æ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å –º–∞—Ç–µ–º–∞—Ç–∏—á–µ—Å–∫–æ–µ –º–æ–¥–µ–ª–∏—Ä–æ–≤–∞–Ω–∏–µ –∏ –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω—ã–π –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –†–æ–¥–∏–æ–Ω–æ–≤ –∑–∞–º–∞—Ö–Ω—É–ª—Å—è –Ω–∞ —Ü–∏—Ñ—Ä–æ–≤–∏–∑–∞—Ü–∏—é –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è: –û–Ω–∞ –∏–¥–µ—Ç –æ–≥—Ä–æ–º–Ω—ã–º–∏ —Ç–µ–º–ø–∞–º–∏, –Ω–∞–∫–∞–ø–ª–∏–≤–∞–µ—Ç—Å—è –æ–≥—Ä–æ–º–Ω–æ–µ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –¥–∞–Ω–Ω—ã—Ö. –ï—Å–ª–∏ –Ω–∞–ª–∞–¥–∏—Ç—å –ø—Ä–æ—Ü–µ—Å—Å –æ–±–º–µ–Ω–∞ –∏–ª–∏ –¥–æ—Å—Ç—É–ø–∞ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –∫–æ–º–ø–∞–Ω–∏–π –∫ —ç—Ç–∏–º –¥–∞–Ω–Ω—ã–º, –º—ã –±—ã –º–æ–≥–ª–∏ —Å—Ç—Ä–æ–∏—Ç—å —Å–≤–æ–∏ —ç–ø–∏–¥–µ–º–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–µ –ø—Ä–æ–≥–Ω–æ–∑—ã –∏ –≤—ã–±–∏—Ä–∞—Ç—å —Ç–µ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è, –≥–¥–µ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ –ø—Ä–∏–ª–æ–∂–∏—Ç—å —É—Å–∏–ª–∏—è –¥–ª—è –ø–æ–∏—Å–∫–∞ –Ω–æ–≤—ã—Ö –º–æ–ª–µ–∫—É–ª –Ω–∞ –Ω–æ–≤—ã–µ, —É–∂–µ –∑–∞–¥–∞–Ω–Ω—ã–µ –º–∏—à–µ–Ω–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-10-07T05:25:23+00:00,@bezrec,6640,https://t.me/bezrec/6640,"–í—Ä–∞—á–µ–π —Å–ø—Ä–æ—Å–∏–ª–∏ –ø—Ä–æ –ë–ê–î—ã. –° 1 —Å–µ–Ω—Ç—è–±—Ä—è –≤—Ä–∞—á–∏ –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω–æ –ø–æ–ª—É—á–∏–ª–∏ –ø—Ä–∞–≤–æ –Ω–∞–∑–Ω–∞—á–∞—Ç—å —Å–≤–æ–∏–º –ø–∞—Ü–∏–µ–Ω—Ç–∞–º –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏ –∞–∫—Ç–∏–≤–Ω—ã–µ –¥–æ–±–∞–≤–∫–∏. –í –ø–æ–ª–Ω—É—é —Å–∏–ª—É –Ω–æ–≤—à–µ—Å—Ç–≤–æ –∑–∞—Ä–∞–±–æ—Ç–∞–µ—Ç, –∫–æ–≥–¥–∞ –†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä –∏ –ú–∏–Ω–∑–¥—Ä–∞–≤ –æ–ø—Ä–µ–¥–µ–ª—è—Ç—Å—è —Å –ø–µ—Ä–µ—á–Ω–µ–º —Ä–∞–∑—Ä–µ—à–µ–Ω–Ω—ã—Ö –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –¥–æ–±–∞–≤–æ–∫, –∞ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ ‚Äî —Å –∫—Ä–∏—Ç–µ—Ä–∏—è–º–∏ –∫–∞—á–µ—Å—Ç–≤–∞ –ë–ê–î–æ–≤ –∏ —Å—ã—Ä—å—è –¥–ª—è –∏—Ö –∏–∑–≥–æ—Ç–æ–≤–ª–µ–Ω–∏—è. –ê –ø–æ–∫–∞ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—ã–π —Å–µ—Ä–≤–∏—Å ¬´–ê–∫—Ç–∏–æ–Ω –ú–µ–¥–∏—Ü–∏–Ω–∞¬ª —Ä–µ—à–∏–ª —É–∑–Ω–∞—Ç—å, –∫–∞–∫ –∫ –¥–æ–±–∞–≤–∫–∞–º –æ—Ç–Ω–æ—Å—è—Ç—Å—è —Å–∞–º–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ —Ä–∞–±–æ—Ç–Ω–∏–∫–∏. –í –æ–ø—Ä–æ—Å–µ —É—á–∞—Å—Ç–≤–æ–≤–∞–ª–∏ 385 –≤—Ä–∞—á–µ–π –∏ 127 –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–µ–π —Å—Ä–µ–¥–Ω–µ–≥–æ –º–µ–¥–ø–µ—Ä—Å–æ–Ω–∞–ª–∞ –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–æ–≤. –í–æ—Ç —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è: üíä –ø–æ—á—Ç–∏ 50% –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, —É–∑–Ω–∞–≤—à–∏—Ö –æ –¥–æ–±–∞–≤–∫–∞—Ö –∏–∑ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç–∞ –∏–ª–∏ –æ—Ç –∑–Ω–∞–∫–æ–º—ã—Ö, –ø—Ä–æ—Å—è—Ç –Ω–∞–∑–Ω–∞—á–∏—Ç—å –∏–º –ë–ê–î—ã; üíä –≤—Ç–æ—Ä—ã–µ 50% –±–æ–ª—å—à–µ –¥–æ–≤–µ—Ä—è—é—Ç –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º –∏–ª–∏ —Å–ª—ã—à–∞–ª–∏ –æ –≤—Ä–µ–¥–µ –ë–ê–î–æ–≤; üíä 28% –≤—Ä–∞—á–µ–π —Ä–µ–≥—É–ª—è—Ä–Ω–æ –ø—Ä–∏–Ω–∏–º–∞—é—Ç –ë–ê–î—ã, 40% ‚Äî –∏–Ω–æ–≥–¥–∞, –∫–∞—Ç–µ–≥–æ—Ä–∏—á–µ—Å–∫–∏ –ø—Ä–æ—Ç–∏–≤ –∏—Ö –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏—è 32%; üíä —Å—Ä–µ–¥–∏ —Å—Ä–µ–¥–Ω–µ–≥–æ –º–µ–¥–ø–µ—Ä—Å–æ–Ω–∞–ª–∞ –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–æ–≤ –ø–æ—Å—Ç–æ—è–Ω–Ω–æ –∏—Å–ø–æ–ª—å–∑—É—é—Ç –¥–æ–±–∞–≤–∫–∏ 31,5%, –∏–Ω–æ–≥–¥–∞ –ø—Ä–∏–Ω–∏–º–∞—é—Ç ‚Äî 42,5%, –ø—Ä–∏–Ω—Ü–∏–ø–∏–∞–ª—å–Ω–æ –Ω–µ –ø—Ä–∏–Ω–∏–º–∞—é—Ç ‚Äî –æ–∫–æ–ª–æ 26%; üíä 25,1% –≤–∏–¥—è—Ç —É–≥—Ä–æ–∑—É –≤ –±–µ—Å–∫–æ–Ω—Ç—Ä–æ–ª—å–Ω–æ–º –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–∏ –ë–ê–î–æ–≤, —Ç.–∫. –æ–Ω–∏ ¬´–º–∞–ª–æ –∏–∑—É—á–µ–Ω—ã¬ª; üíä 31,4% –≤–µ—Ä—è—Ç –≤ ¬´–ß–µ—Å—Ç–Ω—ã–π –∑–Ω–∞–∫¬ª –∏ –Ω–µ –≤–∏–¥—è—Ç —É–≥—Ä–æ–∑—ã, –µ—Å–ª–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç –ø—Ä–æ–º–∞—Ä–∫–∏—Ä–æ–≤–∞–Ω; üíä 21% –Ω–µ –ø—Ä–æ—Ç–∏–≤ –ë–ê–î–æ–≤, –µ—Å–ª–∏ –ø–∞—Ü–∏–µ–Ω—Ç –≤ –Ω–∏—Ö –≤–µ—Ä–∏—Ç, —Ç.–∫. ¬´–≤–µ—Ä–∞ –º–æ–∂–µ—Ç –ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω–æ –≤–ª–∏—è—Ç—å –Ω–∞ –∏—Å—Ö–æ–¥ –ª–µ—á–µ–Ω–∏—è¬ª; üíä 37,4% —Å—á–∏—Ç–∞—é—Ç, —á—Ç–æ –ë–ê–î—ã –∏–∑ —Ä–µ–µ—Å—Ç—Ä–∞ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –±—É–¥—É—Ç —Ç—â–∞—Ç–µ–ª—å–Ω–æ –ø—Ä–æ–≤–µ—Ä—è—Ç—å—Å—è; üíä 32% —Ö–æ—Ç—è—Ç —Å–Ω–∞—á–∞–ª–∞ —É–≤–∏–¥–µ—Ç—å –ø–µ—Ä–µ—á–µ–Ω—å —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–Ω—ã—Ö –ë–ê–î–æ–≤; üíä –Ω–∞ –Ω–µ–≥–∞—Ç–∏–≤–Ω—ã–π –Ω–∞—Å—Ç—Ä–æ–π 14% —Ä–µ—Å–ø–æ–Ω–¥–µ–Ω—Ç–æ–≤ –ø–æ—è–≤–ª–µ–Ω–∏–µ –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω–æ–≥–æ —Ä–µ–µ—Å—Ç—Ä–∞ –Ω–µ –ø–æ–≤–ª–∏—è–µ—Ç; üíä 11% —Å–∫–∞–∑–∞–ª–∏, —á—Ç–æ —Å–º–æ–≥—É—Ç –¥–æ–Ω–µ—Å—Ç–∏ –¥–æ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –ø–æ–ª—å–∑—É –¥–æ–±–∞–≤–æ–∫, –ø–æ—Å–ª–µ —Ç–æ–≥–æ –∫–∞–∫ –∏—Ö –æ–¥–æ–±—Ä–∏—Ç –ú–∏–Ω–∑–¥—Ä–∞–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety, guideline"",
  ""impact"": ""medium"",
  ""english"": ""A survey of medical professionals showed that almost half of patients who learn about supplements from the internet or acquaintances request them. 28% of doctors regularly use supplements, and 40% sometimes do so; 32% are against their use. Among medical staff and pharmacists, 31.5% regularly use supplements, 42.5% sometimes do so, and about 26% never take them. Some professionals are concerned that unregulated use of supplements poses a threat due to their lack of study, while others believe the 'Honest Mark' will ensure safety. 37.4% expect a thorough review of approved supplements, and 11% say they can convince patients of the benefits once the Ministry of Health approves them.""
}"
2025-10-06T16:20:01+00:00,@bezrec,6639,https://t.me/bezrec/6639,"–ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ –∞–Ω–æ–Ω—Å–∏—Ä–æ–≤–∞–ª —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–æ ¬´–ì–∞–∑–ø—Ä–æ–º–±–∞–Ω–∫–∞¬ª –∏ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏. –ù–∞ —Å–µ—Å—Å–∏–∏ ¬´–í–Ω–µ–¥—Ä–µ–Ω–∏–µ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ —Å–∏—Å—Ç–µ–º—É –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è¬ª –Ω–∞—á–∞–ª—å–Ω–∏–∫ –æ—Ç–¥–µ–ª–∞ –¥–µ–ø–∞—Ä—Ç–∞–º–µ–Ω—Ç–∞ —Ä–∞–∑–≤–∏—Ç–∏—è —Ñ–∞—Ä–º–ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏ –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–∞ –°–µ—Ä–≥–µ–π –ú–∏—Ç–∏–Ω —Ä–∞—Å—Å–∫–∞–∑–∞–ª –æ —Ä–æ–ª–∏ –≤–µ–¥–æ–º—Å—Ç–≤–∞ –≤ –ø–æ—è–≤–ª–µ–Ω–∏–∏ –∏–Ω–Ω–æ–≤–∞—Ü–∏–π –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º —Ä—ã–Ω–∫–µ. –°–∞–º—ã–º –≥–ª–∞–≤–Ω—ã–º —ç–∫—Å–ø–µ—Ä—Ç —Å—á–∏—Ç–∞–µ—Ç –≤–æ–ø—Ä–æ—Å –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç–∏, –≤–Ω–µ–¥—Ä–µ–Ω–∏—è –∏ —Å–±—ã—Ç–∞. –û–Ω –æ—Ç–º–µ—Ç–∏–ª, —á—Ç–æ –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ –±–æ–ª—å—à–µ —Å–ø–æ—Å–æ–±—Å—Ç–≤—É–µ—Ç –ø–æ—è–≤–ª–µ–Ω–∏—é –Ω–æ–≤—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤, –∞ –Ω–µ –∏—Ö –ø—Ä–æ–¥–≤–∏–∂–µ–Ω–∏—é. –°–æ —Å–≤–æ–µ–π —Å—Ç–æ—Ä–æ–Ω—ã –∑–∞ –ø—Ä–æ—à–ª—ã–π –≥–æ–¥ –º—ã –ø–æ–ø—Ä–æ–±–æ–≤–∞–ª–∏ –≤–∫–ª—é—á–∏—Ç—å –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–µ –ø—Ä–æ–¥—É–∫—Ç—ã –≤ –ø–µ—Ä–µ—á–µ–Ω—å –∫—Ä–∏—Ç–∏—á–µ—Å–∫–æ–π –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏. –≠—Ç–æ –±—ã–ª–∏ –≤–∞–∫—Ü–∏–Ω—ã –∏ —Ä–∞–¥–∏–æ—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã. –≠—Ç–æ –±—ã–ª–æ —Å–¥–µ–ª–∞–Ω–æ –ø–æ –æ–±—Ä–∞—â–µ–Ω–∏—é –∫–æ–º–ø–∞–Ω–∏–π, –ø—Ä–∏ –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏–∏ —Å –ú–∏–Ω–∑–¥—Ä–∞–≤–æ–º –±—ã–ª–∞ –æ—Ü–µ–Ω–µ–Ω–∞ –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç—å, –≤–æ—Å—Ç—Ä–µ–±–æ–≤–∞–Ω–Ω–æ—Å—Ç—å –≤ –æ–±—ä–µ–º–∞—Ö. –ò —É–∂–µ —Å–µ–≥–æ–¥–Ω—è –∫–æ–º–ø–∞–Ω–∏—è –ø–æ–¥–ø–∏—Å—ã–≤–∞–µ—Ç —Å–æ–≥–ª–∞—à–µ–Ω–∏–µ —Å –ì–∞–∑–ø—Ä–æ–º–±–∞–Ω–∫–æ–º –ø–æ –ø–æ–≤–æ–¥—É –±–æ–ª—å—à–æ–≥–æ –ø—Ä–æ–µ–∫—Ç–∞ –ø–æ –≤–∞–∫—Ü–∏–Ω–∞–º, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª –ú–∏—Ç–∏–Ω. –≠—Ç–æ–π –∫–æ–º–ø–∞–Ω–∏–µ–π –æ–∫–∞–∑–∞–ª—Å—è ¬´–ù–∞–Ω–æ–ª–µ–∫¬ª. –ö–∞–∫ –Ω–∞–º —Ä–∞—Å—Å–∫–∞–∑–∞–ª —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å, —Å—Ç–æ—Ä–æ–Ω—ã –Ω–∞—Ö–æ–¥—è—Ç—Å—è –≤ –ø—Ä–æ—Ü–µ—Å—Å–µ –ø—Ä–∏–≤–ª–µ—á–µ–Ω–∏—è –∑–∞–µ–º–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –≤ —Ä–∞–∑–º–µ—Ä–µ 10 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –≤ —Ä–∞–º–∫–∞—Ö –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ ¬´–û –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π –ø–æ–¥–¥–µ—Ä–∂–∫–µ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π, —Ä–µ–∞–ª–∏–∑—É—é—â–∏—Ö –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–æ–Ω–Ω—ã–µ –ø—Ä–æ–µ–∫—Ç—ã, –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–Ω—ã–µ –Ω–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –ø—Ä–∏–æ—Ä–∏—Ç–µ—Ç–Ω–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏¬ª. –î–µ–Ω—å–≥–∏ –ø–æ–π–¥—É—Ç –Ω–∞ —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–æ –Ω–æ–≤—ã—Ö –º–æ—â–Ω–æ—Å—Ç–µ–π –¥–ª—è –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –≤–∞–∫—Ü–∏–Ω –ø–æ–ª–Ω–æ–≥–æ —Ü–∏–∫–ª–∞ –Ω–∞ –∑–∞–≤–æ–¥–µ ¬´–ù–∞–Ω–æ–ª–µ–∫–∞¬ª –≤ –ö–∏—Ä–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏, –≤ —Ç–æ–º —á–∏—Å–ª–µ –æ—Ç –º–µ–Ω–∏–Ω–≥–æ–∫–æ–∫–∫–∞, –≤–∏—Ä—É—Å–∞ –ø–∞–ø–∏–ª–ª–æ–º—ã —á–µ–ª–æ–≤–µ–∫–∞ –∏ –≤–µ—Ç—Ä—è–Ω–æ–π –æ—Å–ø—ã. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Industry and Trade announced cooperation between 'Gazprombank' and pharmaceutical companies. Deputy Director Sergei Mityin of the Department for Developing Pharmaceutical Industry at the Ministry of Industry and Trade spoke about the role of his department in bringing innovations to Russia's healthcare system. The main expert highlighted accessibility, implementation, and sales of the innovations. He emphasized that the Ministry of Industry and Trade supports the introduction of new drugs rather than promoting them. The company 'Nanolek' has signed a large project agreement with Gazprombank for vaccines, and the funds will be used to build new production facilities for full-cycle vaccine manufacturing in Kirov Oblast, including meningococcus, human papillomavirus, and polio vaccines. The project is supported by a government decree on state support for organizations implementing investment projects aimed at producing priority products.""
}"
2025-10-06T14:02:59+00:00,@bezrec,6638,https://t.me/bezrec/6638,"–ó–∞–º—Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—è –§–ê–° –Ω–∞ ¬´–ë–∏–æ–ø—Ä–æ–º–µ¬ª —Ä–∞—Å—Å–∫–∞–∑–∞–ª, —á–µ–º—É —Ä–æ—Å—Å–∏–π—Å–∫–∏–º —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º —Å—Ç–æ–∏—Ç –ø–æ—É—á–∏—Ç—å—Å—è —É –ö–∏—Ç–∞—è. –í—ã—Å—Ç—É–ø–∞—è –Ω–∞ —Å–µ—Å—Å–∏–∏ ¬´–í–Ω–µ–¥—Ä–µ–Ω–∏–µ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ —Å–∏—Å—Ç–µ–º—É –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è¬ª, –¢–∏–º–æ—Ñ–µ–π –ù–∏–∂–µ–≥–æ—Ä–æ–¥—Ü–µ–≤ –ø–æ—Ä–∞—Å—Å—É–∂–¥–∞–ª –æ —Ç–æ–º, –∫–∞–∫ –ö–∏—Ç–∞—é —É–¥–∞–ª–æ—Å—å –≤ –∫–æ—Ä–æ—Ç–∫–∏–µ —Å—Ä–æ–∫–∏ —Å–æ–∑–¥–∞—Ç—å —Å–æ–±—Å—Ç–≤–µ–Ω–Ω—É—é –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—É—é —Ñ–∞—Ä–º—É. –ü–æ –º–Ω–µ–Ω–∏—é —ç–∫—Å–ø–µ—Ä—Ç–∞, —Å–µ–∫—Ä–µ—Ç —É—Å–ø–µ—Ö–∞ –≤ —Ç–æ–º, —á—Ç–æ —Ç–∞–º —Å—Ä–∞–∑—É –¥—É–º–∞–ª–∏ –ø—Ä–æ —Ç–æ, –∫–∞–∫ –≤—ã—Ö–æ–¥–∏—Ç—å –Ω–∞ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã–π —Ä—ã–Ω–æ–∫. –ò —ç—Ç–æ —Ö–æ—Ä–æ—à–∏–π –ø—Ä–∏–º–µ—Ä –¥–ª—è —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ª–µ–∫–∞—Ä—Å—Ç–≤. –ï—Å–ª–∏ –∫–æ–º–ø–∞–Ω–∏—è –ø–ª–∞–Ω–∏—Ä—É–µ—Ç —É–¥–æ–≤–ª–µ—Ç–≤–æ—Ä–∏—Ç—å —Ç–æ–ª—å–∫–æ —Ä–æ—Å—Å–∏–π—Å–∫–∏–π —Ä—ã–Ω–æ–∫, —Ç–æ –≤ —Å—Ä–µ–¥–Ω–µ—Å—Ä–æ—á–Ω–æ–π –∏ –¥–æ–ª–≥–æ—Å—Ä–æ—á–Ω–æ–π –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–µ –æ–Ω–∞ –≤—Ä—è–¥ –ª–∏ –¥–æ–±—å–µ—Ç—Å—è —É—Å–ø–µ—Ö–∞. –ù–∞–¥–æ –≤—Å–µ–≥–¥–∞ —Å–º–æ—Ç—Ä–µ—Ç—å –∑–∞ –ø—Ä–µ–¥–µ–ª—ã –†–æ—Å—Å–∏–π—Å–∫–æ–π –§–µ–¥–µ—Ä–∞—Ü–∏–∏ –∏ –≤–æ—Å–ø—Ä–∏–Ω–∏–º–∞—Ç—å —Ä—ã–Ω–æ–∫ –±–æ–ª–µ–µ —à–∏—Ä–æ–∫–æ, –∫–∞–∫ —ç—Ç–æ –¥–µ–ª–∞–ª –ö–∏—Ç–∞–π, –∫–æ—Ç–æ—Ä—ã–π –∏–∑–Ω–∞—á–∞–ª—å–Ω–æ –≤—Å–µ —Å–≤–æ–∏ —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–∏–µ —Ü–µ–ª–∏ –æ–ø—Ä–µ–¥–µ–ª—è–ª, –∫–∞–∫ –≤–µ—Å—å –º–∏—Ä, ‚Äî —Å—á–∏—Ç–∞–µ—Ç –ù–∏–∂–µ–≥–æ—Ä–æ–¥—Ü–µ–≤. –í –ø—Ä–∏–æ—Ä–∏—Ç–µ—Ç–µ —É –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –¥–æ–ª–∂–Ω—ã –±—ã—Ç—å –∏–º–µ—é—â–∏–µ —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–æ–µ –∑–Ω–∞—á–µ–Ω–∏–µ —Ä—ã–Ω–∫–∏ –ë–†–ò–ö–°, —Ç.–∫. —Ç–∞–º, –ø–æ —Å–ª–æ–≤–∞–º –∑–∞–º–≥–ª–∞–≤—ã –§–ê–°, –º–µ–Ω—å—à–µ –∏–¥–µ–æ–ª–æ–≥–∏–∏, –Ω–µ–∂–µ–ª–∏ –Ω–∞ –∑–∞–ø–∞–¥–Ω—ã—Ö —Ä—ã–Ω–∫–∞—Ö, –∫–æ—Ç–æ—Ä—ã–µ –º–æ–≥—É—Ç –∑–∞–∫—Ä—ã—Ç—å—Å—è –ø–æ –ø–æ–ª–∏—Ç–∏—á–µ—Å–∫–∏–º –∏ —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–∏–º —Å–æ–æ–±—Ä–∞–∂–µ–Ω–∏—è–º. –ö–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏—è —Å—Ä–µ–¥–∏ —Å—Ç—Ä–∞–Ω –ë–†–ò–ö–° –≤—ã—Å–æ–∫–∞, –∏ –†–æ—Å—Å–∏—è –¥–æ–ª–∂–Ω–∞ —Å—Ç–∞—Ä–∞—Ç—å—Å—è –∏ –¥–µ–ª–∞—Ç—å –¥–µ—à–µ–≤–ª–µ, –ª—É—á—à–µ, –±–æ–ª—å—à–µ, —á—Ç–æ–±—ã –ø—Ä–µ—É—Å–ø–µ—Ç—å. –í—Å–ø–æ–º–Ω–∏–ª –ù–∏–∂–µ–≥–æ—Ä–æ–¥—Ü–µ–≤ –∏ –ø—Ä–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç—É–∞–ª—å–Ω—É—é —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç—å: –ú—ã –¥–æ–ª–∂–Ω—ã –∑–∞—â–∏—â–∞—Ç—å –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç—É–∞–ª—å–Ω—É—é —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç—å –∫—Ä—É–ø–Ω—ã—Ö –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã—Ö –∫–æ–º–ø–∞–Ω–∏–π-–ª–∏–¥–µ—Ä–æ–≤, —á—Ç–æ–±—ã –ø–æ—Å—Ç–æ—è–Ω–Ω–æ –ø–æ–ª—É—á–∞—Ç—å –¥–æ—Å—Ç—É–ø –∫ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º –∏—Ö —Ä–∞–±–æ—Ç—ã —á–µ—Ä–µ–∑ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—é –Ω–æ–≤—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —É –Ω–∞—Å –≤ –†–æ—Å—Å–∏–π—Å–∫–æ–π –§–µ–¥–µ—Ä–∞—Ü–∏–∏ –∏ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å —ç—Ç–∏ –Ω–æ–≤—ã–µ —Ä–µ—à–µ–Ω–∏—è –∑–∞–∫–æ–Ω–Ω—ã–º —Å–ø–æ—Å–æ–±–æ–º. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,regulation,reimbursement"",
  ""impact"": ""high"",
  ""english"": ""Tymofey Nizhegorodtsev, Deputy Head of the Federal Agency for State Duma (FAS), discussed how China successfully developed its own innovative pharmaceuticals in a short period. He emphasized that the secret of success lies in thinking about how to enter international markets from the beginning. This is a good example for Russian pharmaceutical companies, who should always look beyond Russia and consider the market more broadly as China did. The expert highlighted that for companies planning to satisfy only the Russian market, they are unlikely to succeed in the medium and long term. The priority for domestic producers should be markets within BRICS countries, where competition is high and Russia needs to compete by producing cheaper, better products. He also mentioned the protection of intellectual property rights and the need to register new pharmaceuticals through legal means.""
}"
2025-10-06T11:40:38+00:00,@bezrec,6637,https://t.me/bezrec/6637,"–ù–æ–±–µ–ª–µ–≤–∫–∞ –ø–æ –º–µ–¥–∏—Ü–∏–Ω–µ —É—à–ª–∞ –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—è–º –∏–º–º—É–Ω–∏—Ç–µ—Ç–∞. –ù–æ–±–µ–ª–µ–≤—Å–∫—É—é –ø—Ä–µ–º–∏—é 2025 –≥–æ–¥–∞ –ø–æ —Ñ–∏–∑–∏–æ–ª–æ–≥–∏–∏ –∏ –º–µ–¥–∏—Ü–∏–Ω–µ –ø—Ä–∏—Å—É–¥–∏–ª–∏ –ú—ç—Ä–∏ –ë—Ä—É–Ω–∫–æ–≤, –§—Ä–µ–¥—É –†–∞–º—Å–¥–µ–ª–ª—É –∏ –®–∏–º–æ–Ω—É –°–∞–∫–∞–≥—É—á–∏ –∑–∞ –æ—Ç–∫—Ä—ã—Ç–∏—è –≤ –æ–±–ª–∞—Å—Ç–∏ –ø–µ—Ä–∏—Ñ–µ—Ä–∏—á–µ—Å–∫–æ–π –∏–º–º—É–Ω–Ω–æ–π —Ç–æ–ª–µ—Ä–∞–Ω—Ç–Ω–æ—Å—Ç–∏. –£—á—ë–Ω—ã–µ —Å–º–æ–≥–ª–∏ –æ–±–Ω–∞—Ä—É–∂–∏—Ç—å –∑–∞—â–∏—Ç–Ω–∏–∫–æ–≤ –∏–º–º—É–Ω–∏—Ç–µ—Ç–∞ ‚Äî —Ä–µ–≥—É–ª—è—Ç–æ—Ä–Ω—ã–µ –¢-–∫–ª–µ—Ç–∫–∏, –ø—Ä–µ–¥–æ—Ç–≤—Ä–∞—â–∞—é—â–∏–µ –∞—Ç–∞–∫—É –∏–º–º—É–Ω–Ω—ã—Ö –∫–ª–µ—Ç–æ–∫ –Ω–∞ —Å–æ–±—Å—Ç–≤–µ–Ω–Ω—ã–π –æ—Ä–≥–∞–Ω–∏–∑–º. –ò—Ö –æ—Ç–∫—Ä—ã—Ç–∏—è —Å—Ç–∞–ª–∏ —Ä–µ—à–∞—é—â–∏–º–∏ –¥–ª—è –Ω–∞—à–µ–≥–æ –ø–æ–Ω–∏–º–∞–Ω–∏—è —Ç–æ–≥–æ, –∫–∞–∫ —Ñ—É–Ω–∫—Ü–∏–æ–Ω–∏—Ä—É–µ—Ç –∏–º–º—É–Ω–Ω–∞—è —Å–∏—Å—Ç–µ–º–∞ –∏ –ø–æ—á–µ–º—É –Ω–µ —É –≤—Å–µ—Ö –Ω–∞—Å —Ä–∞–∑–≤–∏–≤–∞—é—Ç—Å—è —Å–µ—Ä—å–µ–∑–Ω—ã–µ –∞—É—Ç–æ–∏–º–º—É–Ω–Ω—ã–µ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è, ‚Äî –∑–∞—è–≤–∏–ª –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—å –ù–æ–±–µ–ª–µ–≤—Å–∫–æ–≥–æ –∫–æ–º–∏—Ç–µ—Ç–∞ –û–ª–ª–µ –ö–µ–º–ø–µ. –†–∞–±–æ—Ç—ã –ª–∞—É—Ä–µ–∞—Ç–æ–≤ –ª–µ–≥–ª–∏ –≤ –æ—Å–Ω–æ–≤—É —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –Ω–æ–≤—ã—Ö –º–µ—Ç–æ–¥–æ–≤ –ª–µ—á–µ–Ω–∏—è —Ä–∞–∫–∞ –∏ –∞—É—Ç–æ–∏–º–º—É–Ω–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –æ–Ω–∏ –º–æ–≥—É—Ç —Å–ø–æ—Å–æ–±—Å—Ç–≤–æ–≤–∞—Ç—å –±–æ–ª–µ–µ —É—Å–ø–µ—à–Ω—ã–º —Ç—Ä–∞–Ω—Å–ø–ª–∞–Ω—Ç–∞—Ü–∏—è–º. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-10-06T08:53:36+00:00,@bezrec,6636,https://t.me/bezrec/6636,"–ü—Ä–æ—Ç–∏–≤–æ–æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–π –†–µ–≥–æ—Ä–∞—Ñ–µ–Ω–∏–±-–ê–º–µ–¥–∞—Ä—Ç –ø–æ–¥–µ—à–µ–≤–µ–ª –≤–¥–≤–æ–µ. –§–ê–° —Å–æ–≥–ª–∞—Å–æ–≤–∞–ª–∞ —Ü–µ–Ω—É –Ω–∞ –≤—Ç–æ—Ä–æ–π –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π –¥–∂–µ–Ω–µ—Ä–∏–∫ –≤ —Ä–∞–º–∫–∞—Ö –æ–¥–Ω–æ–∏–º–µ–Ω–Ω–æ–≥–æ –ú–ù–ù. –†–µ–≥–æ—Ä–∞—Ñ–µ–Ω–∏–± –æ—Ç —Ä–æ—Å—Å–∏–π—Å–∫–æ–π ¬´–ê–º–µ–¥–∞—Ä—Ç¬ª —Å—Ç–∞–ª –Ω–∞ 50% –¥–µ—à–µ–≤–ª–µ –°—Ç–∏–≤–∞—Ä–≥–∏ –æ—Ç –Ω–µ–º–µ—Ü–∫–æ–π Bayer. –ü–æ –¥–∞–Ω–Ω—ã–º –ì–†–õ–°, —É–ø–∞–∫–æ–≤–∫–∞ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –∏–∑ 84 —Ç–∞–±–ª–µ—Ç–æ–∫ —Å—Ç–æ–∏—Ç 160,4 —Ç—ã—Å. —Ä—É–±–ª–µ–π. –†–µ–≥–æ—Ä–∞—Ñ–µ–Ω–∏–± –≤—Ö–æ–¥–∏—Ç –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü, –∏ —Å–Ω–∏–∑–∏—Ç—å —Ü–µ–Ω—É –Ω–∞ —Å–≤–æ–π –¥–∂–µ–Ω–µ—Ä–∏–∫ —Ç–∞–∫–∂–µ –ø—Ä–∏–¥—ë—Ç—Å—è ¬´–ü—Ä–æ–º–æ–º–µ–¥—É¬ª. –°–µ–π—á–∞—Å –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω–∞—è —Ü–µ–Ω–∞ –Ω–∞ –Ω–µ–≥–æ —Å–æ—Å—Ç–∞–≤–ª—è–µ—Ç 96,2 —Ç—ã—Å. —Ä—É–±–ª–µ–π. –ê–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å—â–∏–∫–∏ –Ω–∞–ø—Ä–∞–≤—è—Ç —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–µ–µ —É–≤–µ–¥–æ–º–ª–µ–Ω–∏–µ –∫–æ–º–ø–∞–Ω–∏–∏ –ü–µ—Ç—Ä–∞ –ë–µ–ª–æ–≥–æ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""pricing, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The anti-cancer drug Regorafenib-amedart has been reduced in price by half. The FAS approved the price for the second domestic generic under its corresponding NPN. Regorafenib from Russian 'Amedart' is now 50% cheaper than the original version of Stribog from German Bayer. According to GRSL data, a pack of 84 tablets of the original drug costs 160,4 thousand rubles. Regorafenib is included in the list of –ñ–ù–í–õ–ü, and 'Promomed' will also need to reduce its price on the generic version. The registered price for it is 96,2 thousand rubles. Antimonopoly authorities will issue a notification to the company of Petros Belo.""
}"
2025-10-06T05:20:46+00:00,@bezrec,6635,https://t.me/bezrec/6635,"–ì–∞–∑–∏—Ä–æ–≤–∫–∞ –∏–∑–±–∞–≤–∏—Ç –¥–∏–∞–±–µ—Ç–∏–∫–æ–≤ –æ—Ç –æ—Å–ª–æ–∂–Ω–µ–Ω–∏–π. –ó–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—è –∫–æ–º–∏—Ç–µ—Ç–∞ –ø–æ —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–π –ø–æ–ª–∏—Ç–∏–∫–µ –°—Ç–∞–Ω–∏—Å–ª–∞–≤ –ù–∞—É–º–æ–≤ –Ω–∞–ø—Ä–∞–≤–∏–ª –≤–∏—Ü–µ-–ø—Ä–µ–º—å–µ—Ä—É –¢–∞—Ç—å—è–Ω–µ –ì–æ–ª–∏–∫–æ–≤–æ–π –ø–∏—Å—å–º–æ —Å –ø—Ä–æ—Å—å–±–æ–π –≤–Ω–µ—Å—Ç–∏ –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã–π –ø—Ä–æ–µ–∫—Ç ¬´–ë–æ—Ä—å–±–∞ —Å —Å–∞—Ö–∞—Ä–Ω—ã–º –¥–∏–∞–±–µ—Ç–æ–º¬ª. –î–µ–ø—É—Ç–∞—Ç –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç —É–≤–µ–ª–∏—á–∏—Ç—å –∞–∫—Ü–∏–∑ –Ω–∞ —Å–∞—Ö–∞—Ä–æ—Å–æ–¥–µ—Ä–∂–∞—â–∏–µ –Ω–∞–ø–∏—Ç–∫–∏ –Ω–∞ 3,3 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –µ–∂–µ–≥–æ–¥–Ω–æ, —á—Ç–æ–±—ã –æ–±–µ—Å–ø–µ—á–∏—Ç—å –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –¥–æ—Ä–æ–≥–æ—Å—Ç–æ—è—â–∏–º–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º–∏. –î–æ–ø—Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏–µ –¥–æ–ª–∂–Ω–æ –ø–æ–π—Ç–∏ –Ω–∞ –∫–∞—Ä–¥–∏–æ- –∏ –Ω–µ—Ñ—Ä–æ–ø—Ä–æ—Ç–µ–∫—Ç–∏–≤–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, —Å–ø–æ—Å–æ–±—Å—Ç–≤—É—é—â–∏–µ —Å–Ω–∏–∂–µ–Ω–∏—é –æ—Å–ª–æ–∂–Ω–µ–Ω–∏–π –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è. –ü–æ –ø–æ–¥—Å—á—ë—Ç–∞–º –∫–æ–º–∏—Ç–µ—Ç–∞, –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–æ —Ç—Ä–∞—Ç–∏—Ç –Ω–∞ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –¥–∏–∞–±–µ—Ç–æ–º –≤—Ç–æ—Ä–æ–≥–æ —Ç–∏–ø–∞ –±–æ–ª–µ–µ 700 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –≤ –≥–æ–¥. –ë–æ–ª–µ–µ 80% —ç—Ç–æ–π —Å—É–º–º—ã –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ –ø–æ—Ç–µ—Ä–∏ –í–í–ü –∏–∑-–∑–∞ –≤—Ä–µ–º–µ–Ω–Ω–æ–π –Ω–µ—Ç—Ä—É–¥–æ—Å–ø–æ—Å–æ–±–Ω–æ—Å—Ç–∏, –∏–Ω–≤–∞–ª–∏–¥–∏–∑–∞—Ü–∏–∏ –∏ –ø—Ä–µ–∂–¥–µ–≤—Ä–µ–º–µ–Ω–Ω–æ–π —Å–º–µ—Ä—Ç–Ω–æ—Å—Ç–∏. –ö–∞—Ä–¥–∏–æ- –∏ –Ω–µ—Ñ—Ä–æ–ø—Ä–æ—Ç–µ–∫—Ç–∏–≤–Ω—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –¥–æ–ª–∂–Ω—ã —Å–Ω–∏–∑–∏—Ç—å –Ω–∞–≥—Ä—É–∑–∫—É –Ω–∞ —Å–∏—Å—Ç–µ–º—É –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∏ –æ–±—â–µ–µ —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–µ –±—Ä–µ–º—è –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –≤ –ø–∏—Å—å–º–µ –≥–æ–≤–æ—Ä–∏—Ç—Å—è –æ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ —Å–æ–∑–¥–∞—Ç—å –æ—Ç–¥–µ–ª—å–Ω—ã–π –ø–µ—Ä–µ—á–µ–Ω—å –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –∑–∞–∫—É–ø–∞–µ–º—ã—Ö –≤ —Ä–∞–º–∫–∞—Ö –ø—Ä–æ–µ–∫—Ç–∞ –ø–æ –±–æ—Ä—å–±–µ —Å –¥–∏–∞–±–µ—Ç–æ–º. –¢–∞–∫–∂–µ –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è –ø—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ—Ç—å –ø—Ä–∞–≤–∏–ª–∞ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª–µ–Ω–∏—è –∏ —Ä–∞—Å–ø—Ä–µ–¥–µ–ª–µ–Ω–∏—è —Å—É–±—Å–∏–¥–∏–π –≤ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π –ø—Ä–æ–≥—Ä–∞–º–º–µ ¬´–†–∞–∑–≤–∏—Ç–∏–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è¬ª. –ò–Ω–∏—Ü–∏–∞—Ç–∏–≤—É –ù–∞—É–º–æ–≤–∞ –ø–æ–¥–¥–µ—Ä–∂–∞–ª–∞ –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç –ú–æ—Å–∫–æ–≤—Å–∫–æ–π –¥–∏–∞–±–µ—Ç–∏—á–µ—Å–∫–æ–π –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ (–ú–î–ê) –≠–ª—å–≤–∏—Ä–∞ –ì—É—Å—Ç–æ–≤–∞: –°–µ—Ä–¥–µ—á–Ω–∞—è –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ—Å—Ç—å ‚Äî –≥–ª–∞–≤–Ω–∞—è –ø—Ä–∏—á–∏–Ω–∞ –ª–µ—Ç–∞–ª—å–Ω—ã—Ö –∏—Å—Ö–æ–¥–æ–≤ —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å —Å–∞—Ö–∞—Ä–Ω—ã–º –¥–∏–∞–±–µ—Ç–æ–º –≤—Ç–æ—Ä–æ–≥–æ —Ç–∏–ø–∞, –∞ —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–∞—è –±–æ–ª–µ–∑–Ω—å –ø–æ—á–µ–∫ ‚Äî —Å–∞–º–æ–µ —á–∞—Å—Ç–æ–µ –æ—Å–ª–æ–∂–Ω–µ–Ω–∏–µ. –°–æ–≥–ª–∞—Å–Ω–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è–º, –≤ —Å–ª—É—á–∞–µ –ø—Ä–µ–¥–æ—Ç–≤—Ä–∞—â–µ–Ω–∏—è —Ç–∞–∫–∏—Ö –æ—Å–ª–æ–∂–Ω–µ–Ω–∏–π —Å—Ä–µ–¥–Ω—è—è –ø—Ä–æ–¥–æ–ª–∂–∏—Ç–µ–ª—å–Ω–æ—Å—Ç—å –∂–∏–∑–Ω–∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –¥–∏–∞–±–µ—Ç–æ–º –¥–æ–ª–∂–Ω–∞ –≤—ã—Ä–∞—Å—Ç–∏ –Ω–∞ 1,5‚Äì3,5 –≥–æ–¥–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": true,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety, guideline"",
  ""impact"": ""medium"",
  ""english"": ""The message discusses a proposal to increase the tax on sugar-containing drinks by 3.3 billion rubles annually to provide patients with expensive drugs for the treatment of diabetes complications. The initiative aims to reduce cardiovascular and kidney disease, which are major causes of mortality among patients with type 2 diabetes. The message does not primarily focus on regulatory affairs, compliance, pricing and reimbursement, or demand for medicines.""
}"
2025-10-05T16:10:45+00:00,@bezrec,6628,https://t.me/bezrec/6628,"6 –æ–∫—Ç—è–±—Ä—è –≤ –ì–µ–ª–µ–Ω–¥–∂–∏–∫–µ —Å—Ç–∞—Ä—Ç—É–µ—Ç ¬´–ë–∏–æ–ø—Ä–æ–º¬ª ‚Äî –æ–¥–Ω–æ –∏–∑ —Å–∞–º—ã—Ö –∑–Ω–∞—á–∏–º—ã—Ö –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–π –¥–ª—è –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª–æ–≤ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏, –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω—ã–º –ø–∞—Ä—Ç–Ω—ë—Ä–æ–º –∫–æ—Ç–æ—Ä–æ–≥–æ —Å—Ç–∞–ª –Ω–∞—à –∫–∞–Ω–∞–ª. –ù–∞–º –ø–æ—Å—á–∞—Å—Ç–ª–∏–≤–∏–ª–æ—Å—å –∑–∞–≥–ª—è–Ω—É—Ç—å ¬´–∑–∞ –∫—É–ª–∏—Å—ã¬ª –≤—ã—Å—Ç–∞–≤–∫–∏ –∏ –ø–æ—Å–Ω–∏–º–∞—Ç—å –Ω–µ–∫–æ—Ç–æ—Ä—ã–µ —Å—Ç–µ–Ω–¥—ã. –ù–∞—á–∞–ª–æ –¥–µ–ª–æ–≤–æ–π –ø—Ä–æ–≥—Ä–∞–º–º—ã ‚Äî –∑–∞–≤—Ç—Ä–∞. –û–±—è–∑–∞—Ç–µ–ª—å–Ω–æ –ø–æ–±—ã–≤–∞–µ–º –Ω–∞ —Å–µ—Å—Å–∏—è—Ö –∏ —Ä–∞—Å—Å–∫–∞–∂–µ–º —Å–∞–º–æ–µ –∏–Ω—Ç–µ—Ä–µ—Å–Ω–æ–µ. –ù–µ –ø—Ä–æ–ø—É—Å—Ç–∏—Ç–µ! ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-10-05T11:03:58+00:00,@bezrec,6622,https://t.me/bezrec/6622,"–ù–∞—Ç–∫–Ω—É–ª–∏—Å—å –≤ —Å–µ—Ç–∏ –Ω–∞ –∑–∞–±–∞–≤–Ω—É—é –ø–æ–¥–±–æ—Ä–∫—É, –≤ –∫–æ—Ç–æ—Ä–æ–π –∫–∞–∂–¥–æ–º—É –∑–Ω–∞–∫—É –∑–æ–¥–∏–∞–∫–∞ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É–µ—Ç —Å–≤–æ–π –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç. –ù–µ–∫–æ—Ç–æ—Ä—ã–µ, –∫—Å—Ç–∞—Ç–∏, –≤—Ö–æ–¥—è—Ç –≤ —Ç–æ–ø-10 –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤-—Å—Ç–∞–±–∏–ª–∏–∑–∞—Ç–æ—Ä–æ–≤ –Ω–∞—Å—Ç—Ä–æ–µ–Ω–∏—è –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º —Ä–æ–∑–Ω–∏—á–Ω–æ–º —Ñ–∞—Ä–º—Ä—ã–Ω–∫–µ. –ê –∫–∞–∫–æ–π –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç –ø–æ –∑–Ω–∞–∫—É –∑–æ–¥–∏–∞–∫–∞ –≤—ã? –ò—â–µ–º —Å–µ–±—è –∏ –∫–æ–ª–ª–µ–≥. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-10-04T11:05:05+00:00,@bezrec,6621,https://t.me/bezrec/6621,"–ü—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º –æ—á–µ—Ä–µ–¥–Ω–æ–π –≤—ã–ø—É—Å–∫ —Ä—É–±—Ä–∏–∫–∏ #–≤–¥–æ–≥–æ–Ω–∫—É ‚Äî –æ —Ç–æ–º, —á—Ç–æ –Ω–µ —É—Å–ø–µ–ª–∏ —Ä–∞—Å—Å–∫–∞–∑–∞—Ç—å –∑–∞ –ø—Ä–æ—à–µ–¥—à–∏–µ –ø—è—Ç—å –¥–Ω–µ–π. üíä –°–µ–º–∞–≤–∏–∫ –≤–ø–µ—Ä–≤—ã–µ –∑–∞ –≥—Ä–∞–Ω–∏—Ü–µ–π. ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª –ø–µ—Ä–≤—ã–π –∞–Ω–∞–ª–æ–≥ –û–∑–µ–º–ø–∏–∫–∞ –≤ –ö–∞–∑–∞—Ö—Å—Ç–∞–Ω–µ. –î–æ —ç—Ç–æ–≥–æ –Ω–∞ —Ä—ã–Ω–∫–µ —Å—Ç—Ä–∞–Ω—ã –±—ã–ª–∏ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω—ã —Ç–æ–ª—å–∫–æ –¥–≤–∞ –ø—Ä–æ–¥—É–∫—Ç–∞ —Å —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–æ–º ‚Äî –≤ –∏–Ω—ä–µ–∫—Ü–∏–æ–Ω–Ω–æ–π –∏ —Ç–∞–±–ª–µ—Ç–∏—Ä–æ–≤–∞–Ω–Ω–æ–π —Ñ–æ—Ä–º–µ –æ—Ç Novo Nordisk. –°–µ–º–∞–≤–∏–∫ –±—É–¥—É—Ç –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç—å –Ω–∞ –º–æ—â–Ω–æ—Å—Ç—è—Ö –ö–∞—Ä–∞–≥–∞–Ω–¥–∏–Ω—Å–∫–æ–≥–æ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ –∫–æ–º–ø–ª–µ–∫—Å–∞ –ø–æ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏, –ø–µ—Ä–µ–¥–∞–Ω–Ω–æ–π –≤ —Ä–∞–º–∫–∞—Ö —Ç—Ä–∞–Ω—Å—Ñ–µ—Ä–∞. üíä –ú–∏—Ä–æ–≤–æ–π —Ä—ã–Ω–æ–∫ —Ä–∞–¥–∏–æ—Ñ–∞—Ä–º–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –∏—Å–ø–æ–ª—å–∑—É–µ–º—ã—Ö –¥–ª—è –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∏ –æ–Ω–∫–æ–∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, –∫ 2029 –≥–æ–¥—É –≤—ã—Ä–∞—Å—Ç–µ—Ç —Å $10 –º–ª—Ä–¥ –¥–æ $13 –º–ª—Ä–¥. –¢–∞–∫–∏–º –ø—Ä–æ–≥–Ω–æ–∑–æ–º –ø–æ–¥–µ–ª–∏–ª—Å—è –Ω–∞—É—á–Ω—ã–π —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å –ù–∞—É—á–Ω–æ-–æ–±—Ä–∞–∑–æ–≤–∞—Ç–µ–ª—å–Ω–æ–≥–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ —Ü–µ–Ω—Ç—Ä–∞ —è–¥–µ—Ä–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω—ã –ù–ò–¶ ¬´–ö—É—Ä—á–∞—Ç–æ–≤—Å–∫–∏–π –∏–Ω—Å—Ç–∏—Ç—É—Ç¬ª –°–µ—Ä–≥–µ–π –î–µ–µ–≤. üíä –ü–æ—à–ª–∏–Ω—ã –¢—Ä–∞–º–ø–∞ –Ω–∞ —Ñ–∞—Ä–º–ø—Ä–æ–¥—É–∫—Ü–∏—é –æ—Ç–∫–ª–∞–¥—ã–≤–∞—é—Ç—Å—è. –ê–¥–º–∏–Ω–∏—Å—Ç—Ä–∞—Ü–∏—è –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–≥–æ –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç–∞ —Ä–µ—à–∏–ª–∞ –ø–æ–≤—Ä–µ–º–µ–Ω–∏—Ç—å —Å –≤–≤–µ–¥–µ–Ω–∏–µ–º 100% –ø–æ—à–ª–∏–Ω –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞, –∫–æ—Ç–æ—Ä—ã–µ –¥–æ–ª–∂–Ω—ã –±—ã–ª–∏ –≤—Å—Ç—É–ø–∏—Ç—å –≤ —Å–∏–ª—É —Å 1 –æ–∫—Ç—è–±—Ä—è, —á—Ç–æ–±—ã –ø–æ–ø—ã—Ç–∞—Ç—å—Å—è –¥–æ–≥–æ–≤–æ—Ä–∏—Ç—å—Å—è —Å —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—è–º–∏ –æ —Å–Ω–∏–∂–µ–Ω–∏–∏ —Ü–µ–Ω –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞. –° Pfizer —É–∂–µ –ø–æ–ª—É—á–∏–ª–æ—Å—å ‚Äî —Ñ–∞—Ä–º–≥–∏–≥–∞–Ω—Ç –ø–æ–æ–±–µ—â–∞–ª –ø—Ä–∏–Ω—è—Ç—å —É—á–∞—Å—Ç–∏–µ –≤ –ø–ª–∞—Ç—Ñ–æ—Ä–º–µ –ø—Ä—è–º—ã—Ö –∑–∞–∫—É–ø–æ–∫ TrumpRx.gov, –≥–¥–µ –æ–Ω –±—É–¥–µ—Ç –ø—Ä–µ–¥–ª–∞–≥–∞—Ç—å –≤–Ω—É—à–∏—Ç–µ–ª—å–Ω—ã–µ —Å–∫–∏–¥–∫–∏ –Ω–∞ –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ —Å–≤–æ–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –æ–±–º–µ–Ω –Ω–∞ —Ç—Ä–µ—Ö–ª–µ—Ç–Ω—é—é –æ—Ç—Å—Ä–æ—á–∫—É –ø–æ –ø–æ—à–ª–∏–Ω–∞–º. üíä –õ–µ–∫–∞—Ä—Å—Ç–≤–∞ ‚Äî –≤ —Ç–æ–ø–µ –≤–Ω–µ–ø–ª–∞–Ω–æ–≤—ã—Ö —Ä–∞—Å—Ö–æ–¥–æ–≤ —Ä–æ—Å—Å–∏—è–Ω. –ü–æ –¥–∞–Ω–Ω—ã–º –æ–ø—Ä–æ—Å–∞ ¬´–ê–ª—å—Ñ–∞—Å—Ç—Ä–∞—Ö–æ–≤–∞–Ω–∏—è¬ª —Å —É—á–∞—Å—Ç–∏–µ–º 1,5 —Ç—ã—Å. —á–µ–ª–æ–≤–µ–∫, –±–æ–ª–µ–µ –ø–æ–ª–æ–≤–∏–Ω—ã –∂–∏—Ç–µ–ª–µ–π –†–æ—Å—Å–∏–∏ —Ç—Ä–∞—Ç—è—Ç –Ω–∞ –º–µ–¥–∏—Ü–∏–Ω—É –æ—Ç 10 –¥–æ 50 —Ç—ã—Å. —Ä—É–±–ª–µ–π. –°—é–¥–∞ –≤—Ö–æ–¥—è—Ç –∫–∞–∫ –≤–Ω–µ–ø–ª–∞–Ω–æ–≤—ã–µ –æ–±—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –∏ –∞–Ω–∞–ª–∏–∑—ã, —Ç–∞–∫ –∏ –ø–æ–∫—É–ø–∫–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤. –°–ª—É—á–∞—é—Ç—Å—è —Ç–∞–∫–∏–µ ¬´—Å—é—Ä–ø—Ä–∏–∑—ã¬ª –∫–∞–∫ –º–∏–Ω–∏–º—É–º —Ä–∞–∑ –≤ –≥–æ–¥. –ü—Ä–∏ —ç—Ç–æ–º ¬´–∑–∞–Ω–∞—á–∫–∞¬ª –Ω–∞ —ç—Ç—É —Å—Ç–∞—Ç—å—é —Ä–∞—Å—Ö–æ–¥–æ–≤ –µ—Å—Ç—å —Ç–æ–ª—å–∫–æ —É —Ç—Ä–µ—Ç–∏ –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö. üíä –ê–Ω—Ç–∏–±–∏–æ—Ç–∏–∫–∏ –Ω–µ —É—Å–ø–µ–≤–∞—é—Ç –∑–∞ —Å—É–ø–µ—Ä–±–∞–∫—Ç–µ—Ä–∏—è–º–∏. –í–û–ó –≤—ã–ø—É—Å—Ç–∏–ª–∞ –¥–æ–∫–ª–∞–¥, –≤ –∫–æ—Ç–æ—Ä–æ–º –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–∞–µ—Ç, —á—Ç–æ —Å–æ–∑–¥–∞–Ω–∏–µ –Ω–æ–≤—ã—Ö –∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫–æ–≤ –æ—Ç—Å—Ç–∞—ë—Ç –æ—Ç –±—ã—Å—Ç—Ä–æ–≥–æ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–∏—è —É—Å—Ç–æ–π—á–∏–≤—ã—Ö –∫ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º –±–∞–∫—Ç–µ—Ä–∏–π. –ò–∑ 90 –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, —Ä–∞–∑—Ä–∞–±–∞—Ç—ã–≤–∞–µ–º—ã—Ö –≤ –Ω–∞—Å—Ç–æ—è—â–µ–µ –≤—Ä–µ–º—è, ¬´–∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–º–∏¬ª –º–æ–≥—É—Ç —Å—á–∏—Ç–∞—Ç—å—Å—è —Ç–æ–ª—å–∫–æ 15. –ü–æ –º–Ω–µ–Ω–∏—é —ç–∫—Å–ø–µ—Ä—Ç–æ–≤, –∏—Å–ø—Ä–∞–≤–∏—Ç—å —Å–∏—Ç—É–∞—Ü–∏—é –º–æ–∂–µ—Ç –ò–ò. üíä –ú–æ—Å–±–∏—Ä–∂–∞ –∑–∞–ø—Ä–µ—Ç–∏–ª–∞ –∫–æ—Ä–æ—Ç–∫–∏–µ –ø—Ä–æ–¥–∞–∂–∏ –ø–æ –∞–∫—Ü–∏—è–º ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∏¬ª –≤ —Å–≤—è–∑–∏ —Å –ø—Ä–æ–≤–µ–¥–µ–Ω–∏–µ–º –¥–æ–ø—ç–º–∏—Å—Å–∏–∏. –ê–∫—Ü–∏–∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤ –Ω–∞ –ú–æ—Å–±–∏—Ä–∂–µ —É–ø–∞–ª–∏ –Ω–∞ 7,1%, –¥–æ 45 —Ä—É–±–ª–µ–π –Ω–∞ –º–∏–Ω–∏–º—É–º–µ. –í —Ä–∞–º–∫–∞—Ö –¥–æ–ø—ç–º–∏—Å—Å–∏–∏ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è —Ä–∞–∑–º–µ—Å—Ç–∏—Ç—å –ø–æ –æ—Ç–∫—Ä—ã—Ç–æ–π –ø–æ–¥–ø–∏—Å–∫–µ 78,5 –º–ª–Ω –æ–±—ã–∫–Ω–æ–≤–µ–Ω–Ω—ã—Ö –∞–∫—Ü–∏–π. –ù–æ–º–∏–Ω–∞–ª –∞–∫—Ü–∏–∏ —Å–æ—Å—Ç–∞–≤–∏—Ç 0,02 —Ä—É–±–ª—è, —Ü–µ–Ω–∞ —Ä–∞–∑–º–µ—â–µ–Ω–∏—è ‚Äì 42 —Ä—É–±–ª—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""short-term-trading, shortage, regulation"",
  ""impact"": ""medium"",
  ""english"": ""The Moscow Exchange has banned short selling of shares in 'Ozon Pharma' due to a rights issue. The company's stock price fell by 7.1%, down to the minimum of 45 rubles on the Moscow Exchange. The rights issue plans to raise 78.5 million ordinary shares at a nominal value of 0.02 rubles each, with an issue price of 42 rubles.""
}"
2025-10-03T14:35:32+00:00,@bezrec,6619,https://t.me/bezrec/6619,"–í –¥—É—à —Å—Ö–æ–¥–∏–ª –∏ –Ω–∞—Å–º–æ—Ä–∫ –ø–æ–ª–µ—á–∏–ª. –ê–Ω–≥–ª–∏–π—Å–∫–∞—è —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—è Olbas —Å–¥–µ–ª–∞–ª–∞ –∏–Ω—Ç–µ—Ä–µ—Å–Ω—ã–π –ø—Ä–æ–¥—É–∫—Ç ‚Äî –≥–µ–ª—å –¥–ª—è –¥—É—à–∞, –æ–±–ª–µ–≥—á–∞—é—â–∏–π –∑–∞–ª–æ–∂–µ–Ω–Ω–æ—Å—Ç—å –Ω–æ—Å–∞. –§–∏—à–∫–∞ ‚Äî –≤ –ø–∞—Ä–∞—Ö —á–∏—Å—Ç—ã—Ö —Ä–∞—Å—Ç–∏—Ç–µ–ª—å–Ω—ã—Ö –º–∞—Å–µ–ª, –∫–æ—Ç–æ—Ä—ã–µ, –∫–∞–∫ –æ–±–µ—â–∞–µ—Ç –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å –Ω–∞ —Å–≤–æ—ë–º —Å–∞–π—Ç–µ, ¬´–¥–∞—Ä—è—Ç –æ—â—É—â–µ–Ω–∏–µ –±–æ–¥—Ä–æ—Å—Ç–∏ –∏ –ª—ë–≥–∫–æ–≥–æ –¥—ã—Ö–∞–Ω–∏—è¬ª. –ü–∞—Ä–∞–ª–ª–µ–ª—å–Ω–æ –æ–Ω–∏ –∂–µ –º—è–≥–∫–æ –æ—á–∏—â–∞—é—Ç –∏ –æ—Å–≤–µ–∂–∞—é—Ç –∫–æ–∂—É. –í –ª–∏–Ω–µ–π–∫–µ –µ—â—ë –µ—Å—Ç—å –ø–µ–Ω–∞ –¥–ª—è –≤–∞–Ω–Ω—ã —Å–æ —Å—Ö–æ–∂–∏–º–∏ —Å–≤–æ–π—Å—Ç–≤–∞–º–∏. –ù–∞ –¥–æ–ª–≥–æ—Å—Ä–æ—á–Ω—ã–π —ç—Ñ—Ñ–µ–∫—Ç —Ä–∞—Å—Å—á–∏—Ç—ã–≤–∞—Ç—å, –∫–æ–Ω–µ—á–Ω–æ, –Ω–µ —Å—Ç–æ–∏—Ç, –Ω–æ –ø—Ä–∏–Ω—è—Ç—å –≥–æ—Ä—è—á–∏–π –¥—É—à —Å –∞—Ä–æ–º–∞—Ç–Ω—ã–º–∏ —Ç—Ä–∞–≤–∫–∞–º–∏ –≤ —Å–∞–º—ã–π —Ä–∞–∑–≥–∞—Ä —Å–µ–∑–æ–Ω–∞ –ø—Ä–æ—Å—Ç—É–¥ ‚Äî –ø–æ—á–µ–º—É –±—ã –∏ –Ω–µ—Ç. –ê –µ—â—ë —É –∫–æ–º–ø–∞–Ω–∏–∏ —Å–∏–º–ø–∞—Ç–∏—á–Ω–∞—è —Ä–µ–∫–ª–∞–º–∞ —Å—Ä–µ–¥—Å—Ç–≤–∞ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –Ω–∞—Å–º–æ—Ä–∫–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-10-03T12:35:58+00:00,@bezrec,6618,https://t.me/bezrec/6618,"–†–µ–≥–∏–æ–Ω—ã –ø–æ–ª—É—á–∞—Ç –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–µ –¥–µ–Ω—å–≥–∏ –Ω–∞ –æ—Ä—Ñ–∞–Ω–Ω—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞. –° 2026 –≥–æ–¥–∞ –≤–≤–æ–¥–∏—Ç—Å—è —Ä–µ–∑–µ—Ä–≤–Ω—ã–π –º–µ—Ö–∞–Ω–∏–∑–º –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –æ—Ä—Ñ–∞–Ω–Ω—ã–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏ –ø–æ –ø–µ—Ä–µ—á–Ω—é –≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–∏ —Å –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ–º –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ ‚Ññ 403 –æ—Ç 2012 –≥–æ–¥–∞, ‚Äî –≥–æ–≤–æ—Ä–∏—Ç—Å—è –≤ —Å–æ–æ–±—â–µ–Ω–∏–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞. –°—Ä–µ–¥—Å—Ç–≤–∞ –∏–∑ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –±—é–¥–∂–µ—Ç–∞ –≤—ã–¥–µ–ª—è—Ç —Å—É–±—ä–µ–∫—Ç–∞–º, –∫–æ—Ç–æ—Ä—ã–µ —Å–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω–æ –Ω–µ —Å–ø—Ä–∞–≤–ª—è—é—Ç—Å—è —Å –∏—Å–ø–æ–ª–Ω–µ–Ω–∏–µ–º —Å–≤–æ–∏—Ö –ø–æ–ª–Ω–æ–º–æ—á–∏–π –ø–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–º—É –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—é ¬´—Ä–µ–¥–∫–∏—Ö¬ª –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –ù–µ–≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –∏—Å–ø–æ–ª–Ω–µ–Ω–∏—è —Å–≤–æ–∏—Ö –æ–±—è–∑–∞—Ç–µ–ª—å—Å—Ç–≤ —Ä–µ–≥–∏–æ–Ω–∞–º –ø—Ä–µ–¥—Å—Ç–æ–∏—Ç –¥–æ–∫–∞–∑–∞—Ç—å. –ú–∏–Ω–∑–¥—Ä–∞–≤ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –ø—Ä–æ–µ–∫—Ç—ã –∞–∫—Ç–æ–≤, –≤ –∫–æ—Ç–æ—Ä—ã—Ö –ø—Ä–æ–ø–∏—Å–∞–Ω—ã —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–∏–µ –∫—Ä–∏—Ç–µ—Ä–∏–∏. –í –∏—Ö —á–∏—Å–ª–µ: üîò—É–≤–µ–ª–∏—á–µ–Ω–∏–µ —Å—Ç–æ–∏–º–æ—Å—Ç–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –ø—Ä–æ–∂–∏–≤–∞—é—â–∏—Ö –≤ —Ä–µ–≥–∏–æ–Ω–µ, –ø–æ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º –≥–æ—Å–∑–∞–∫—É–ø–æ–∫ –≤ —Ç–µ–∫—É—â–µ–º –≥–æ–¥—É –Ω–∞ 20% –∏ –±–æ–ª–µ–µ –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ –ø—Ä–µ–¥—ã–¥—É—â–µ–≥–æ –≥–æ–¥–∞; üîò—É–≤–µ–ª–∏—á–µ–Ω–∏–µ —á–∏—Å–ª–∞ –≥—Ä–∞–∂–¥–∞–Ω, —Å—Ç—Ä–∞–¥–∞—é—â–∏—Ö —Ä–µ–¥–∫–∏–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏, –ø—Ä–æ–∂–∏–≤–∞—é—â–∏—Ö –≤ —Å—É–±—ä–µ–∫—Ç–µ –Ω–µ –º–µ–Ω–µ–µ, —á–µ–º –Ω–∞ 15% –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –ø—Ä–µ–¥—à–µ—Å—Ç–≤—É—é—â–∏–º –≥–æ–¥–æ–º. –°–∞–º–æ –ø–æ —Å–µ–±–µ –≤–≤–µ–¥–µ–Ω–∏–µ —Ä–µ–∑–µ—Ä–≤–Ω–æ–≥–æ –º–µ—Ö–∞–Ω–∏–∑–º–∞ ‚Äî –Ω–æ–≤–æ—Å—Ç—å —Ö–æ—Ä–æ—à–∞—è, –Ω–æ –∑–∞–≥–≤–æ–∑–¥–∫–∞ –≤ —Ç–æ–º, —á—Ç–æ –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ ‚Ññ 403 –æ—Ç 2012 –≥–æ–¥–∞ –≤—Ö–æ–¥–∏—Ç 17 –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, –∞ –ø—Ä–æ–±–ª–µ–º–∞ —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è –æ—Å—Ç–∞–ª—å–Ω—ã—Ö –æ—Ä—Ñ–∞–Ω–Ω–∏–∫–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ –Ω–µ –≤–æ—à–ª–∏ –Ω–∏ –≤ –æ–¥–Ω—É –ø—Ä–æ–≥—Ä–∞–º–º—É, –ø–æ-–ø—Ä–µ–∂–Ω–µ–º—É –Ω–µ —Ä–µ—à–µ–Ω–∞. –ü—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è –æ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ —Ä–∞—Å—à–∏—Ä–∏—Ç—å –Ω–æ–≤—ã–π –º–µ—Ö–∞–Ω–∏–∑–º –ø–æ–¥–¥–µ—Ä–∂–∫–∏ —Ä–µ–≥–∏–æ–Ω–æ–≤ –Ω–∞ –≤—Å–µ –æ—Ä—Ñ–∞–Ω–Ω—ã–µ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è (–∏—Ö 284) –ø–æ–∫–∞ –Ω–µ –±—ã–ª–∏ —É—Å–ª—ã—à–∞–Ω—ã. –í–ø—Ä–æ—á–µ–º, —Å —É–∂–µ –∏–º–µ—é—â–∏–º–∏—Å—è –±—ã —Å–æ–≤–ª–∞–¥–∞—Ç—å ‚Äî —ç–∫—Å–ø–µ—Ä—Ç—ã –ø—Ä–µ–¥—Ä–µ–∫–∞—é—Ç —à–∫–≤–∞–ª –æ–±—Ä–∞—â–µ–Ω–∏–π –∑–∞ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã–º–∏ –¥–µ–Ω—å–≥–∞–º–∏ –∏–∑ —Ä–µ–≥–∏–æ–Ω–æ–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, reimbursement, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The message discusses a new funding mechanism for rare disease patients, increasing the cost of medications by 20% or more compared to previous years and ensuring that at least 15% of the population in a region is affected by rare diseases. However, it highlights that this mechanism does not address all rare diseases and there are concerns about a potential increase in federal funding requests from regions.""
}"
2025-10-03T09:00:55+00:00,@bezrec,6617,https://t.me/bezrec/6617,"–£–º–∞—Ä –ö—Ä–µ–º–ª–µ–≤ –≤–ª–æ–∂–∏–ª—Å—è –≤ –ë–ê–î—ã. –°—Ç—Ä—É–∫—Ç—É—Ä–∞ –≥–ª–∞–≤—ã –ú–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–æ–π –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ –±–æ–∫—Å–∞ (IBA) –∏ –≤–ª–∞–¥–µ–ª—å—Ü–∞ ¬´–†–æ–ª—å—Ñ–∞¬ª –ø–æ–ª—É—á–∏–ª–∞ –¥–æ–ª–∏ –≤ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ –ë–ê–î–æ–≤, –ø–∏—à–µ—Ç ¬´–™¬ª. –£ ¬´–£–ù–ö –•–æ–ª–¥–∏–Ω–≥–∞¬ª —Ç–µ–ø–µ—Ä—å –ø–æ 50% –≤ –û–û–û ¬´–ù—É—Ç—Ä–∏—à–Ω –§–∞—Ä–º¬ª –∏ –û–û–û ¬´–ù—É—Ç—Ä–∏—à–Ω –ê–∫—Ç–∏–≤¬ª. –û—Å—Ç–∞–≤—à–∏–µ—Å—è –¥–æ–ª–∏ –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∞—Ç –∑–∞–≤–∫–∞—Ñ–µ–¥—Ä–æ–π —É—Ä–æ–ª–æ–≥–∏–∏ –∏ —Å–ø–æ—Ä—Ç–∏–≤–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω—ã –†–£–î–ù –ê–ª–µ–∫—Å–∞–Ω–¥—Ä—É –î–∑–∏–¥–∑–∞—Ä–∏–∏. –î–∑–∏–¥–∑–∞—Ä–∏—è ‚Äî —á–µ–ª–æ–≤–µ–∫ –∞–∫—Ç–∏–≤–Ω—ã–π. –ü–æ–º–∏–º–æ –∑–∞–≤–µ–¥–æ–≤–∞–Ω–∏—è –∫–∞—Ñ–µ–¥—Ä–æ–π, –≤ 2022 –≥–æ–¥—É –æ–Ω –æ—Å–Ω–æ–≤–∞–ª –±—Ä–µ–Ω–¥ –¥–æ–±–∞–≤–æ–∫ Ipsum, –∫–æ—Ç–æ—Ä—ã–µ –≤—ã–ø—É—Å–∫–∞–µ—Ç ¬´–ù—É—Ç—Ä–∏—à–Ω –ê–∫—Ç–∏–≤¬ª, —Ä—É–∫–æ–≤–æ–¥–∏—Ç –æ—Ç–¥–µ–ª–µ–Ω–∏–µ–º –æ–Ω–∫–æ—É—Ä–æ–ª–æ–≥–∏–∏ –∏ –æ–Ω–∫–æ–≥–∏–Ω–µ–∫–æ–ª–æ–≥–∏–∏ –†–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –Ω–∞—É—á–Ω–æ–≥–æ —Ü–µ–Ω—Ç—Ä–∞ —Ä–µ–Ω—Ç–≥–µ–Ω–æ—Ä–∞–¥–∏–æ–ª–æ–≥–∏–∏, –∞ —Ç–∞–∫–∂–µ –≤–ª–∞–¥–µ–µ—Ç –∫–ª–∏–Ω–∏–∫–æ–π Biocheck –∏ –ø—Ä–æ–¥–≤–∏–≥–∞–µ—Ç –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å —Å –±–∏–æ–¥–æ–±–∞–≤–∫–∞–º–∏ –∏ –∫–æ—Å–º–µ—Ç–∏–∫–æ–π Beautery. –ü–ª–∞–Ω—ã —É –ø–∞—Ä—Ç–Ω—ë—Ä–æ–≤ –≥—Ä–∞–Ω–¥–∏–æ–∑–Ω—ã–µ ‚Äî –ø–æ —Å–ª–æ–≤–∞–º –î–∑–∏–¥–∑–∞—Ä–∏–∏, —Å—Ç–æ—Ä–æ–Ω—ã –¥–æ–≥–æ–≤–æ—Ä–∏–ª–∏—Å—å –ø–æ—Å—Ç—Ä–æ–∏—Ç—å —Å–æ–≤—Ä–µ–º–µ–Ω–Ω—ã–π –∑–∞–≤–æ–¥ –≤ –û–≠–ó ¬´–ë–æ–ª—å—à–æ–π –°–µ—Ä–ø—É—Ö–æ–≤¬ª, —á—Ç–æ–±—ã ¬´—Å—É—â–µ—Å—Ç–≤–µ–Ω–Ω–æ —Ä–∞—Å—à–∏—Ä–∏—Ç—å –ª–∏–Ω–µ–π–∫—É –ø—Ä–æ–¥—É–∫—Ç–æ–≤, –æ–ø—Ç–∏–º–∏–∑–∏—Ä–æ–≤–∞—Ç—å —Å–µ–±–µ—Å—Ç–æ–∏–º–æ—Å—Ç—å, –≤—ã–π—Ç–∏ –Ω–∞ —Ä—ã–Ω–∫–∏ —Å—Ç—Ä–∞–Ω –ï–≤—Ä–∞–∑–∏–π—Å–∫–æ–≥–æ —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–≥–æ —Å–æ—é–∑–∞ –∏ –û–ê–≠¬ª. –í ¬´–£–ù–ö –•–æ–ª–¥–∏–Ω–≥–µ¬ª –Ω–∞–º–µ—Ä–µ–Ω–∏–µ –ø–æ–∫–æ—Ä—è—Ç—å –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã–µ —Ä—ã–Ω–∫–∏ –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª–∏ –∏ —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏, —á—Ç–æ ¬´–≤—ã–±—Ä–∞–ª–∏ Ipsum –ø–æ—Å–ª–µ —Ç—â–∞—Ç–µ–ª—å–Ω–æ–≥–æ –Ω–µ–∑–∞–≤–∏—Å–∏–º–æ–≥–æ –∞—É–¥–∏—Ç–∞ –±–∏–∑–Ω–µ—Å-–ø–æ–∫–∞–∑–∞—Ç–µ–ª–µ–π, –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–Ω—ã—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π —Å—ã—Ä—å—è –∏ –≥–æ—Ç–æ–≤–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏, –∞ —Ç–∞–∫–∂–µ –∫–æ–º–ø–ª–µ–∫—Å–Ω–æ–π –ø—Ä–æ–≤–µ—Ä–∫–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω–æ–π –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä—ã¬ª. –ò—Å–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–π –¥–∏—Ä–µ–∫—Ç–æ—Ä –°–†–û ¬´–°–æ—é–∑ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ë–ê–î –∫ –ø–∏—â–µ¬ª –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ñ–µ—Å—Ç–∫–æ–≤ –ø—Ä–µ–¥–ø–æ–ª–æ–∂–∏–ª, —á—Ç–æ –Ω–æ–≤—ã–µ –∞–∫—Ç–∏–≤—ã –º–æ–≥—É—Ç –ø—Ä–∏–≥–æ–¥–∏—Ç—å—Å—è –ö—Ä–µ–º–ª–µ–≤—É –¥–ª—è —Å–æ–∑–¥–∞–Ω–∏—è –≤ –†–æ—Å—Å–∏–∏ –Ω–µ–ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–µ–Ω–Ω–æ–π –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –Ω–∞–ø–æ–¥–æ–±–∏–µ –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–≥–æ –ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ —Å–∞–Ω–∏—Ç–∞—Ä–Ω–æ–≥–æ —Ñ–æ–Ω–¥–∞. –û–Ω –∑–∞–Ω–∏–º–∞–µ—Ç—Å—è —Å–µ—Ä—Ç–∏—Ñ–∏–∫–∞—Ü–∏–µ–π –ø—Ä–æ–¥—É–∫—Ç–æ–≤, –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –∫–æ—Ç–æ—Ä—ã—Ö —Å–æ—Ç—Ä—É–¥–Ω–∏—á–∞—é—Ç —Å–æ —Å–ø–æ—Ä—Ç–∏–≤–Ω—ã–º–∏ –∞—Å—Å–æ—Ü–∏–∞—Ü–∏—è–º–∏. –≠—Ç–∞ –≤–µ—Ä—Å–∏—è –≤—ã–≥–ª—è–¥–∏—Ç –ª–æ–≥–∏—á–Ω–æ, –æ—Å–æ–±–µ–Ω–Ω–æ —É—á–∏—Ç—ã–≤–∞—è —Ç–æ—Ç —Ñ–∞–∫—Ç, —á—Ç–æ –≤ –∞–≤–≥—É—Å—Ç–µ 2025 –≥–æ–¥–∞ —Å—Ç—Ä—É–∫—Ç—É—Ä—ã –±–∏–∑–Ω–µ—Å–º–µ–Ω–∞ –∫—É–ø–∏–ª–∏ –¥–æ–ª–∏ –≤ ¬´–°–µ—Ä—Ç–∏—Ñ–∏–∫–µ–π—à–µ–Ω –ì—Ä—É–ø–ø¬ª –∏ ¬´–°–µ—Ä–∫–æ–Ω—Å¬ª, —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä—É—é—â–∏—Ö—Å—è –Ω–∞ –∏—Å–ø—ã—Ç–∞–Ω–∏—è—Ö –∏ —Å–µ—Ä—Ç–∏—Ñ–∏–∫–∞—Ü–∏–∏. –û –∑–∞–∫—É–ø–∫–∞—Ö –ë–ê–î–æ–≤ –¥–ª—è –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—ã—Ö —Å–±–æ—Ä–Ω—ã—Ö —Ä–µ—á–∏ –Ω–µ –∏–¥—ë—Ç ‚Äî –∏–º–∏ —É–∂–µ –∑–∞–Ω–∏–º–∞–µ—Ç—Å—è –§–ú–ë–ê. –ü–æ–¥–æ–±–Ω–∞—è –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è –Ω—É–∂–Ω–∞ —Å–ø–æ—Ä—Ç—Å–º–µ–Ω–∞–º, —á—Ç–æ–±—ã –ø–æ–Ω–∏–º–∞—Ç—å, –∫–∞–∫–∏–µ –¥–æ–±–∞–≤–∫–∏ —Ç–æ—á–Ω–æ –±–µ–∑–æ–ø–∞—Å–Ω—ã –∏ –Ω–µ —Å–æ–¥–µ—Ä–∂–∞—Ç –¥–æ–ø–∏–Ω–≥. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanction, shortage,hospital_policy"",
  ""impact"": ""high"",
  ""english"": ""The message discusses the involvement of Kremlin in BAN companies. It mentions that a structure under the head of International Boxing Association (IBA) and owner 'Rolf' has received shares in a BAN production company. The country's impact is high as it involves sanctions and shortage issues.""
}"
2025-10-03T06:02:06+00:00,@bezrec,6616,https://t.me/bezrec/6616,"Vertex –∏ Sanofi –ø–æ–∂–∞–ª–æ–≤–∞–ª–∏—Å—å –≤ –ö–æ–Ω—Å—Ç–∏—Ç—É—Ü–∏–æ–Ω–Ω—ã–π —Å—É–¥ –Ω–∞ –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω–æ–µ –ª–∏—Ü–µ–Ω–∑–∏—Ä–æ–≤–∞–Ω–∏–µ. Vertex Pharmaceuticals –∏ —Ä–æ—Å—Å–∏–π—Å–∫–∞—è ¬´–¥–æ—á–∫–∞¬ª —Ñ—Ä–∞–Ω—Ü—É–∑—Å–∫–æ–π Sanofi, –ø—Ä–µ–¥—Å—Ç–∞–≤–ª—è—é—â–∞—è –∏–Ω—Ç–µ—Ä–µ—Å—ã –∞–º–µ—Ä–∏–∫–∞–Ω—Ü–µ–≤ –≤ –†–æ—Å—Å–∏–∏, –Ω–µ —Ç–µ—Ä—è—é—Ç –Ω–∞–¥–µ–∂–¥—É –≤–æ—Å—Å—Ç–∞–Ω–æ–≤–∏—Ç—å —Å–ø—Ä–∞–≤–µ–¥–ª–∏–≤–æ—Å—Ç—å –≤ –ø–∞—Ç–µ–Ω—Ç–Ω–æ–π –±–∏—Ç–≤–µ –∑–∞ –¢—Ä–∏–∫–∞—Ñ—Ç—É. (–∏–≤–∞–∫–∞—Ñ—Ç–æ—Ä+—Ç–µ–∑–∞–∫–∞—Ñ—Ç–æ—Ä+—ç–ª–µ–∫—Å–∞–∫–∞—Ñ—Ç–æ—Ä –∏ –∏–≤–∞–∫–∞—Ñ—Ç–æ—Ä). –ö–æ–º–ø–∞–Ω–∏–∏ –ø–æ–¥–∞–ª–∏ –≤ –ö–æ–Ω—Å—Ç–∏—Ç—É—Ü–∏–æ–Ω–Ω—ã–π —Å—É–¥ –†–§ –∂–∞–ª–æ–±—É –Ω–∞ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ —Å—Ç–∞—Ç—å–∏ 1362 –ì—Ä–∞–∂–¥–∞–Ω—Å–∫–æ–≥–æ –∫–æ–¥–µ–∫—Å–∞ –æ –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω–æ–º –ª–∏—Ü–µ–Ω–∑–∏—Ä–æ–≤–∞–Ω–∏–∏ –Ω–æ—É-—Ö–∞—É, –ø–∏—à–µ—Ç ¬´–ò–Ω—Ç–µ—Ä—Ñ–∞–∫—Å¬ª. –í —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, –∑–∞—è–≤–∏—Ç–µ–ª–µ–π –∏–Ω—Ç–µ—Ä–µ—Å—É–µ—Ç –ø–µ—Ä–≤—ã–π –ø—É–Ω–∫—Ç —ç—Ç–æ–π —Å—Ç–∞—Ç—å–∏, —Å–æ–≥–ª–∞—Å–Ω–æ –∫–æ—Ç–æ—Ä–æ–º—É –ª—é–±–æ–µ –ª–∏—Ü–æ, –∂–µ–ª–∞—é—â–µ–µ –∏ –≥–æ—Ç–æ–≤–æ–µ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å –Ω–æ—É-—Ö–∞—É, –≤ —Å–ª—É—á–∞–µ –æ—Ç–∫–∞–∑–∞ –≤–ª–∞–¥–µ–ª—å—Ü–∞ –ø–∞—Ç–µ–Ω—Ç–∞ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–∏—Ç—å –ª–∏—Ü–µ–Ω–∑–∏—é –Ω–∞ –µ–≥–æ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ –≤–ø—Ä–∞–≤–µ –æ–±—Ä–∞—Ç–∏—Ç—å—Å—è –≤ —Å—É–¥ —Å –∏—Å–∫–æ–º –æ –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω–æ–º –ª–∏—Ü–µ–Ω–∑–∏—Ä–æ–≤–∞–Ω–∏–∏. –≠—Ç–∏–º –ø—Ä–∞–≤–æ–º –≤–æ—Å–ø–æ–ª—å–∑–æ–≤–∞–ª–∞—Å—å —Ä–æ—Å—Å–∏–π—Å–∫–∞—è ¬´–ú–ò–ö¬ª, —É–±–µ–¥–∏–≤—à–∞—è –∞–ø–µ–ª–ª—è—Ü–∏–æ–Ω–Ω—ã–π —Å—É–¥ –æ–±—è–∑–∞—Ç—å Vertex –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–∏—Ç—å –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω—É—é –ª–∏—Ü–µ–Ω–∑–∏—é –ø–æ –¥–µ—Å—è—Ç–∏ –ø–∞—Ç–µ–Ω—Ç–∞–º –∏–∑ –¥–≤–µ–Ω–∞–¥—Ü–∞—Ç–∏ –Ω–∞ –¥–æ—Ä–æ–≥–æ—Å—Ç–æ—è—â–∏–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –æ—Ç –º—É–∫–æ–≤–∏—Å—Ü–∏–¥–æ–∑–∞ —Å—Ä–æ–∫–æ–º –Ω–∞ –¥–≤–∞ –≥–æ–¥–∞. –î–∂–µ–Ω–µ—Ä–∏–∫ Trilexa —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω —É—Ä—É–≥–≤–∞–π—Å–∫–æ–π Adelice S.A (–µ–π, —Å–æ–≥–ª–∞—Å–Ω–æ –ï–ì–†–Æ–õ, –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∏—Ç 90% ¬´–ú–ò–ö¬ª), –∞ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç—Å—è –∞—Ä–≥–µ–Ω—Ç–∏–Ω—Å–∫–æ–π Tuteur. –ó–¥–µ—Å—å –µ—Å—Ç—å –≤–∞–∂–Ω–æ–µ –Ω–æ ‚Äî –ø—Ä–∞–≤–æ –Ω–∞ –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω–æ–µ –ª–∏—Ü–µ–Ω–∑–∏—Ä–æ–≤–∞–Ω–∏–µ –≤–æ–∑–Ω–∏–∫–∞–µ—Ç, –µ—Å–ª–∏ –∏–∑–æ–±—Ä–µ—Ç–µ–Ω–∏–µ –∏–ª–∏ –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω—ã–π –æ–±—Ä–∞–∑–µ—Ü –Ω–µ –∏—Å–ø–æ–ª—å–∑—É—é—Ç—Å—è –ª–∏–±–æ –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ –∏—Å–ø–æ–ª—å–∑—É—é—Ç—Å—è –ø–∞—Ç–µ–Ω—Ç–æ–æ–±–ª–∞–¥–∞—Ç–µ–ª–µ–º –≤ —Ç–µ—á–µ–Ω–∏–µ —á–µ—Ç—ã—Ä–µ—Ö –ª–µ—Ç —Å–æ –¥–Ω—è –≤—ã–¥–∞—á–∏ –ø–∞—Ç–µ–Ω—Ç–∞, —á—Ç–æ –º–æ–∂–µ—Ç –≥—Ä–æ–∑–∏—Ç—å –¥–µ—Ñ–∏—Ü–∏—Ç–æ–º. Vertex –∏ Sanofi —Å —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —Ä—ã–Ω–∫–∞ –Ω–µ —É—Ö–æ–¥–∏–ª–∏. –ë–æ–ª–µ–µ —Ç–æ–≥–æ, —Å –∏—é–Ω—è 2023 –≥–æ–¥–∞ –¢—Ä–∏–∫–∞—Ñ—Ç–∞ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–∞ –≤ —Å—Ç—Ä–∞–Ω–µ –≤ –æ—Ç–ª–∏—á–∏–µ –æ—Ç –∞—Ä–≥–µ–Ω—Ç–∏–Ω—Å–∫–æ–≥–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞. –í–æ–ø—Ä–æ—Å—ã, –∫–æ—Ç–æ—Ä—ã–µ Vertex –∏ Sanofi —Å—Ç–∞–≤—è—Ç –ø–µ—Ä–µ–¥ –ö–° –†–§: üü© –ø—Ä–∞–≤–∏–ª—å–Ω–æ –ª–∏ –ø–æ—Å—Ç—É–ø–∏–ª–∏ –∞—Ä–±–∏—Ç—Ä–∞–∂–Ω—ã–µ —Å—É–¥—ã, –æ—Å–≤–æ–±–æ–∂–¥–∞—è –∂–∞–∂–¥—É—â–∏—Ö –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω–æ–π –ª–∏—Ü–µ–Ω–∑–∏–∏ –æ—Ç –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª–µ–Ω–∏—è –≤—Å–µ–≥–æ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ–≥–æ –∫–æ–º–ø–ª–µ–∫—Å–∞ –∞—Ä–≥—É–º–µ–Ω—Ç–æ–≤ –∏ –ø–µ—Ä–µ–∫–ª–∞–¥—ã–≤–∞—è –±—Ä–µ–º—è –¥–æ–∫–∞–∑—ã–≤–∞–Ω–∏—è –Ω–∞ –¥–µ—Ä–∂–∞—Ç–µ–ª—è –ø–∞—Ç–µ–Ω—Ç–∞; üü© –º–æ–∂–µ—Ç –ª–∏ –±—ã—Ç—å –ª–∏—Ü–µ–Ω–∑–∏—è –Ω–µ–æ–≥—Ä–∞–Ω–∏—á–µ–Ω–Ω–æ–π. –ü–æ–¥—Ö–æ–¥ —Å—É–¥–æ–≤ —Å–æ–∑–¥–∞–µ—Ç —É—Å–ª–æ–≤–∏—è, –ø—Ä–∏ –∫–æ—Ç–æ—Ä—ã—Ö –ø—Ä–∞–≤–∞ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç—É–∞–ª—å–Ω–æ–π —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç–∏ —Ç–µ—Ä—è—é—Ç —Å–≤–æ–π –∏—Å–∫–ª—é—á–∏—Ç–µ–ª—å–Ω—ã–π —Ö–∞—Ä–∞–∫—Ç–µ—Ä, —á—Ç–æ –∫–æ–º–ø—Ä–æ–º–µ—Ç–∏—Ä—É–µ—Ç –∏–Ω—Å—Ç–∏—Ç—É—Ç –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç—É–∞–ª—å–Ω–æ–π —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç–∏ –∏ —Å–¥–µ—Ä–∂–∏–≤–∞–µ—Ç –¥–∞–ª—å–Ω–µ–π—à–∏–µ –Ω–∞—É—á–Ω—ã–µ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏, ‚Äî —Å—á–∏—Ç–∞—é—Ç –∑–∞—è–≤–∏—Ç–µ–ª–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanction, shortage, regulation"",
  ""impact"": ""high"",
  ""english"": ""Vertex and Sanofi are challenging the Constitutional Court of Russia on compulsory licensing. The companies claim that arbitral courts have not required the holders of patents to provide a full set of arguments for compulsory licensing and have shifted the burden of proof onto patent holders. They also argue that this approach creates conditions under which intellectual property rights lose their exclusivity, compromising the institution of intellectual property and hindering further scientific research.""
}"
2025-10-02T14:31:27+00:00,@bezrec,6615,https://t.me/bezrec/6615,"–ì–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä –±–µ–ª–≥–æ—Ä–æ–¥—Å–∫–æ–π —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –ø–æ–ø–∞–ª—Å—è –Ω–∞ –∫–æ–Ω—Ç—Ä–∞–±–∞–Ω–¥–µ. –°–æ—Ç—Ä—É–¥–Ω–∏–∫–∏ –£–§–°–ë –ø–æ –ë–µ–ª–≥–æ—Ä–æ–¥—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –∏ –ë–µ–ª–≥–æ—Ä–æ–¥—Å–∫–æ–π —Ç–∞–º–æ–∂–Ω–∏ –ø—Ä–µ—Å–µ–∫–ª–∏ –∫–æ–Ω—Ç—Ä–∞–±–∞–Ω–¥—É –±–æ–ª–µ–µ –¥–≤—É—Ö —Ç–æ–Ω–Ω —Ö–∏–º–∏–∫–∞—Ç–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ –º–æ–≥—É—Ç –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å—Å—è –ø—Ä–∏ –∏–∑–≥–æ—Ç–æ–≤–ª–µ–Ω–∏–∏ –æ—Ä—É–∂–∏—è –º–∞—Å—Å–æ–≤–æ–≥–æ –ø–æ—Ä–∞–∂–µ–Ω–∏—è. –ü–µ—Ä–µ–ø—Ä–∞–≤–∏—Ç—å —á–µ—Ä–µ–∑ –≥—Ä–∞–Ω–∏—Ü—É –æ–ø–∞—Å–Ω—ã–π –≥—Ä—É–∑, –≤–≤–µ–∑—ë–Ω–Ω—ã–π –∏–∑ –ö–∏—Ç–∞—è —á–µ—Ä–µ–∑ –ö–∞–∑–∞—Ö—Å—Ç–∞–Ω –±–µ–∑ –Ω–∞–¥–ª–µ–∂–∞—â–∏—Ö –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤, –ø—ã—Ç–∞–ª–∏—Å—å –≥–µ–Ω–µ—Ä–∞–ª—å–Ω—ã–π –¥–∏—Ä–µ–∫—Ç–æ—Ä –æ–¥–Ω–æ–π –∏–∑ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π —Ä–µ–≥–∏–æ–Ω–∞ –∏ —Ç–∞–º–æ–∂–µ–Ω–Ω—ã–π –±—Ä–æ–∫–µ—Ä. –û–±–æ–∏–º —Ç–µ–ø–µ—Ä—å –≥—Ä–æ–∑–∏—Ç –¥–æ 10 –ª–µ—Ç –ª–∏—à–µ–Ω–∏—è —Å–≤–æ–±–æ–¥—ã. –°–∏–ª–æ–≤–∏–∫–∏ –¥–µ—Ä–∂–∞—Ç –∏–Ω—Ç—Ä–∏–≥—É –∏ –Ω–µ —Ä–∞—Å–∫—Ä—ã–≤–∞—é—Ç –Ω–∏ –Ω–∞–∑–≤–∞–Ω–∏–µ –∫–æ–º–ø–∞–Ω–∏–∏, –Ω–∏ –∏–º–µ–Ω–∞ —Ñ–∏–≥—É—Ä–∞–Ω—Ç–æ–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-10-02T12:10:47+00:00,@bezrec,6614,https://t.me/bezrec/6614,"–§–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º –æ–±—ä—è—Å–Ω–∏–ª–∏, –∫–∞–∫ –ø–æ–ª—É—á–∏—Ç—å –¥–æ–∫—É–º–µ–Ω—Ç—ã –æ–± —É—Ä–æ–≤–Ω–µ –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ –ï–ê–≠–°. –° 1 —è–Ω–≤–∞—Ä—è 2026 –≥–æ–¥–∞ –≤ –†–æ—Å—Å–∏–∏ –Ω–∞—á–Ω—ë—Ç –¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å –±–∞–ª–ª—å–Ω–∞—è —Å–∏—Å—Ç–µ–º–∞ –æ—Ü–µ–Ω–∫–∏ —É—Ä–æ–≤–Ω—è –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –≤ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –æ—Ç—Ä–∞—Å–ª–∏. –ß—Ç–æ–±—ã —Å—á–∏—Ç–∞—Ç—å—Å—è —Ä–æ—Å—Å–∏–π—Å–∫–æ–π –∏ –ø–æ–ª—É—á–∞—Ç—å ¬´–ø–ª—é—à–∫–∏¬ª –æ—Ç –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–∞, –ø—Ä–æ–¥—É–∫—Ü–∏—è –¥–æ–ª–∂–Ω–∞ –±—É–¥–µ—Ç –Ω–∞–±—Ä–∞—Ç—å –±–æ–ª–µ–µ 50 –±–∞–ª–ª–æ–≤. –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –ø–æ—Ä—è–¥–æ–∫ –≤—ã–¥–∞—á–∏ –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤, –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–∞—é—â–∏—Ö —Å—Ç–∞–¥–∏–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ –ï–≤—Ä–∞–∑–∏–π—Å–∫–æ–≥–æ —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–≥–æ —Å–æ—é–∑–∞. –ü—Ä–æ–µ–∫—Ç –ø—Ä–∏–∫–∞–∑–∞ –ø—Ä–æ—Ö–æ–¥–∏—Ç –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–µ –æ–±—Å—É–∂–¥–µ–Ω–∏–µ –¥–æ 16 –æ–∫—Ç—è–±—Ä—è. –ì–ª–∞–≤–Ω–æ–µ: üü© –∑–∞—è–≤–ª–µ–Ω–∏—è —Å —É–∫–∞–∑–∞–Ω–Ω—ã–º–∏ –≤ –Ω–∏—Ö —Å—Ç–∞–¥–∏—è–º–∏ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ –ø—Ä–æ—Ü–µ—Å—Å–∞ –≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–∏ —Å –ø–µ—Ä–µ—á–Ω–µ–º –∏–∑ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏—è –∫ –ø—Ä–∏–∫–∞–∑—É –º–æ–∂–Ω–æ –±—É–¥–µ—Ç –ø–æ–¥–∞—Ç—å —á–µ—Ä–µ–∑ ¬´–ì–æ—Å—É—Å–ª—É–≥–∏¬ª; üü© –≤—ã–¥–∞—á–∞ –¥–æ–∫—É–º–µ–Ω—Ç–∞ –±—É–¥–µ—Ç –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç—å—Å—è –≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–∏ —Å –∞–¥–º–∏–Ω–∏—Å—Ç—Ä–∞—Ç–∏–≤–Ω—ã–º —Ä–µ–≥–ª–∞–º–µ–Ω—Ç–æ–º –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–∞; üü© —Å—Ä–æ–∫ –¥–µ–π—Å—Ç–≤–∏—è –¥–æ–∫—É–º–µ–Ω—Ç–∞ ‚Äî —Ç—Ä–∏ –≥–æ–¥–∞; üü© —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏–µ –∑–∞—è–≤–ª–µ–Ω–∏—è –ø–æ—Å—Ç–∞–≤—è—Ç –Ω–∞ –ø–∞—É–∑—É –Ω–∞ —Å—Ä–æ–∫ –¥–æ 15 –¥–Ω–µ–π, –µ—Å–ª–∏ –≤ –Ω—ë–º –µ—Å—Ç—å –Ω–æ–º–µ—Ä —ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω–æ–≥–æ –¥–æ–∫—É–º–µ–Ω—Ç–∞ –∏–∑ —Å–∏—Å—Ç–µ–º—ã –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥–∞ –º–∞—Ä–∫–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö —Ç–æ–≤–∞—Ä–æ–≤, –∫–æ—Ç–æ—Ä—ã–π —Å–æ–¥–µ—Ä–∂–∏—Ç –±–æ–ª–µ–µ –æ–¥–Ω–æ–≥–æ –º–∞—Ç–µ—Ä–∏–∞–ª—å–Ω–æ–≥–æ –±–∞–ª–∞–Ω—Å–∞ (—ç—Ç–æ—Ç —Å—Ä–æ–∫ –ø—Ä–∏–ø–ª—é—Å—É—é—Ç –∫ –æ–±—â–µ–º—É —Å—Ä–æ–∫—É –æ–∫–∞–∑–∞–Ω–∏—è —É—Å–ª—É–≥–∏); üü©–∑–∞—è–≤–∏—Ç–µ–ª—é –æ—Ç–∫–∞–∂—É—Ç –≤ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏–∏ –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤, –µ—Å–ª–∏ –ø—Ä–∏–∫—Ä–µ–ø–ª—ë–Ω–Ω—ã–µ —á–µ—Ä–µ–∑ ¬´–ì–æ—Å—É—Å–ª—É–≥–∏¬ª —Ñ–∞–π–ª—ã –±—É–¥—É—Ç —Å —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–∏–º–∏ –æ—à–∏–±–∫–∞–º–∏ –∏–ª–∏ –ø–æ–≤—Ä–µ–∂–¥–µ–Ω—ã. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Industry and Trade has developed a procedure for issuing documents confirming the stages of production within the Eurasian Economic Union. The project is undergoing public discussion until October 16th. Key points include: submissions for the stages of technological processes listed in the annex to the order can be made through 'State Services'; document issuance will follow an administrative regulation of the Ministry; the validity period of the document is three years. The review process will be paused for up to 15 days if an electronic document from the tracking system of marked goods contains more than one material balance (this period is added to the total service time). If files submitted through 'State Services' contain technical errors or are damaged, applicants will be denied document review.""
}"
2025-10-02T08:50:01+00:00,@bezrec,6613,https://t.me/bezrec/6613,"–ù–∞—Ç–∞–ª—å—è –•–æ—Ä–æ–≤–∞ —Å–º–µ–Ω–∏–ª–∞ –∫—Ä–µ—Å–ª–æ –∑–∞–º–º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –Ω–∞ –°–æ–≤—Ñ–µ–¥. –û—Å–≤–æ–±–æ–¥–∏—Ç—å –•–æ—Ä–æ–≤—É –ù–∞—Ç–∞–ª—å—é –ê–ª–µ–∫—Å–∞–Ω–¥—Ä–æ–≤–Ω—É –æ—Ç –¥–æ–ª–∂–Ω–æ—Å—Ç–∏ –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—è –º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –†–æ—Å—Å–∏–π—Å–∫–æ–π –§–µ–¥–µ—Ä–∞—Ü–∏–∏ –ø–æ –µ–µ –ø—Ä–æ—Å—å–±–µ –≤ —Å–≤—è–∑–∏ —Å –Ω–∞–¥–µ–ª–µ–Ω–∏–µ–º –ø–æ–ª–Ω–æ–º–æ—á–∏—è–º–∏ —Å–µ–Ω–∞—Ç–æ—Ä–∞, ‚Äî –≥–æ–≤–æ—Ä–∏—Ç—Å—è –≤ —Ä–∞—Å–ø–æ—Ä—è–∂–µ–Ω–∏–∏ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –Ω–∞ –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω–æ–º –∏–Ω—Ç–µ—Ä–Ω–µ—Ç-–ø–æ—Ä—Ç–∞–ª–µ –ø—Ä–∞–≤–æ–≤–æ–π –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏. –ü–æ—Å—Ç –∑–∞–º–º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –•–æ—Ä–æ–≤–∞ –∑–∞–Ω–∏–º–∞–ª–∞ —Å 2014 –≥–æ–¥–∞. –° 23 —Å–µ–Ω—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞ —á–∏–Ω–æ–≤–Ω–∏—Ü–∞ –≤—Å—Ç—É–ø–∏–ª–∞ –≤ –¥–æ–ª–∂–Ω–æ—Å—Ç—å —Å–µ–Ω–∞—Ç–æ—Ä–∞ –æ—Ç –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –ï–≤—Ä–µ–π—Å–∫–æ–π –∞–≤—Ç–æ–Ω–æ–º–Ω–æ–π –æ–±–ª–∞—Å—Ç–∏ –≤ –°–æ–≤–µ—Ç–µ –§–µ–¥–µ—Ä–∞—Ü–∏–∏. –ó–∞–º–µ—Å—Ç–∏—Ç–µ–ª–∏ –ú–∏—Ö–∞–∏–ª–∞ –ú—É—Ä–∞—à–∫–æ –Ω–∞ —Å–µ–≥–æ–¥–Ω—è—à–Ω–∏–π –¥–µ–Ω—å: üîò–ü–µ—Ä–≤—ã–µ –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª–∏ –º–∏–Ω–∏—Å—Ç—Ä–∞ ‚Äî –í–∏–∫—Ç–æ—Ä –§–∏—Å–µ–Ω–∫–æ –∏ –í–ª–∞–¥–∏–º–∏—Ä –ó–µ–ª–µ–Ω—Å–∫–∏–π; üîò–°—Ç–∞—Ç—Å-—Å–µ–∫—Ä–µ—Ç–∞—Ä—å ‚Äî –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å –º–∏–Ω–∏—Å—Ç—Ä–∞ ‚Äî –û–ª–µ–≥ –°–∞–ª–∞–≥–∞–π; üîò–ó–∞–º–µ—Å—Ç–∏—Ç–µ–ª–∏ –º–∏–Ω–∏—Å—Ç—Ä–∞: –°–µ—Ä–≥–µ–π –ì–ª–∞–≥–æ–ª–µ–≤, –ï–≤–≥–µ–Ω–∏—è –ö–æ—Ç–æ–≤–∞, –¢–∞—Ç—å—è–Ω–∞ –°–µ–º—ë–Ω–æ–≤–∞, –í–∞–¥–∏–º –í–∞–Ω—å–∫–æ–≤, –ï–≤–≥–µ–Ω–∏–π –ö–∞–º–∫–∏–Ω, –ê–Ω–¥—Ä–µ–π –ü–ª—É—Ç–Ω–∏—Ü–∫–∏–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-10-02T06:03:19+00:00,@bezrec,6612,https://t.me/bezrec/6612,"–í –æ—Ñ–∏—Å–∞—Ö Sanofi –ø—Ä–æ—à–ª–∏ –æ–±—ã—Å–∫–∏ –ø–æ –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å–Ω–æ–º—É –¥–µ–ª—É. –í–æ —Ñ—Ä–∞–Ω—Ü—É–∑—Å–∫–∏–µ –∏ –Ω–µ–º–µ—Ü–∫–∏–µ –æ—Ñ–∏—Å—ã —Ñ–∞—Ä–º–≥–∏–≥–∞–Ω—Ç–∞ –Ω–∞–≥—Ä—è–Ω—É–ª–∞ –ï–≤—Ä–æ–∫–æ–º–∏—Å—Å–∏—è. –ü—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–∏ Sanofi —ç—Ç–æ—Ç —Ñ–∞–∫—Ç –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª–∏, —Ö–æ—Ç—è –ë—Ä—é—Å—Å–µ–ª—å –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω–æ –Ω–µ —Ä–∞–∑–≥–ª–∞—à–∞–ª, –∫–æ–≥–æ –∏–∑ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ª–µ–∫–∞—Ä—Å—Ç–≤ –∑–∞–ø–æ–¥–æ–∑—Ä–∏–ª–∏ –≤ –Ω–∞—Ä—É—à–µ–Ω–∏–∏ –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å–Ω–æ–≥–æ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–∞. –ö–∞–∫ –æ–±—ä—è—Å–Ω–∏–ª–∏ –≤ –ï–ö, –ø—Ä–æ–≤–µ—Ä—è—Ç—å —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è –ø—Ä–∏—à–ª–æ—Å—å –∏–∑-–∑–∞ –≤–æ–∑–º–æ–∂–Ω—ã—Ö –∑–ª–æ—É–ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–π –¥–æ–º–∏–Ω–∏—Ä—É—é—â–∏–º –ø–æ–ª–æ–∂–µ–Ω–∏–µ–º –Ω–∞ —Ä—ã–Ω–∫–µ —Å–µ–∑–æ–Ω–Ω—ã—Ö –≤–∞–∫—Ü–∏–Ω –æ—Ç –≥—Ä–∏–ø–ø–∞ –∏ –Ω–µ–¥–æ–±—Ä–æ—Å–æ–≤–µ—Å—Ç–Ω–æ–π –¥–∏—Å–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–∏ –∫–æ–Ω–∫—É—Ä–µ–Ω—Ç–æ–≤. –í Sanofi –∑–∞–≤–µ—Ä–∏–ª–∏, —á—Ç–æ –∫–æ–º–ø–∞–Ω–∏—è ¬´—Å–æ–±–ª—é–¥–∞–µ—Ç –≤—Å–µ –ø—Ä–∏–º–µ–Ω–∏–º—ã–µ –ø—Ä–∞–≤–∏–ª–∞ –∏ –Ω–æ—Ä–º—ã¬ª –∏ –≥–æ—Ç–æ–≤–∞ —Å–æ—Ç—Ä—É–¥–Ω–∏—á–∞—Ç—å —Å —Ä–µ–≥—É–ª—è—Ç–æ—Ä–æ–º. –®—Ç—Ä–∞—Ñ—ã –∑–∞ –Ω–∞—Ä—É—à–µ–Ω–∏–µ –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å–Ω–æ–≥–æ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–∞ –≤ –ï–≤—Ä–æ–ø–µ —Å–æ–ª–∏–¥–Ω—ã–µ ‚Äî –¥–æ 10% –æ—Ç –º–∏—Ä–æ–≤–æ–≥–æ –≥–æ–¥–æ–≤–æ–≥–æ –æ–±–æ—Ä–æ—Ç–∞. Sanofi —Å—á–∏—Ç–∞–µ—Ç—Å—è –æ–¥–Ω–∏–º –∏–∑ –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π —Å–µ–∑–æ–Ω–Ω—ã—Ö –≤–∞–∫—Ü–∏–Ω –æ—Ç –≥—Ä–∏–ø–ø–∞ –Ω–∞—Ä—è–¥—É —Å GSK –∏ CSL Seqirus. –í –†–æ—Å—Å–∏–∏ –ø–æ–¥–æ–±–Ω—ã–µ –¥–µ–ª–∞ ‚Äî –Ω–µ —Ä–µ–¥–∫–æ—Å—Ç—å. –ê–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å—â–∏–∫–∏ —Å –∑–∞–≤–∏–¥–Ω–æ–π —Ä–µ–≥—É–ª—è—Ä–Ω–æ—Å—Ç—å—é –≤—ã–¥–∞—é—Ç —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º (–≤ –æ—Å–Ω–æ–≤–Ω–æ–º –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã–º) –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏—è –∏ –Ω–∞–∑–Ω–∞—á–∞—é—Ç —à—Ç—Ä–∞—Ñ—ã –∏–∑-–∑–∞ –¥–æ–º–∏–Ω–∏—Ä—É—é—â–µ–≥–æ –ø–æ–ª–æ–∂–µ–Ω–∏—è –Ω–∞ —Ä—ã–Ω–∫–µ. –ì—Ä–æ–º–∫–∏–π –ø—Ä–∏–º–µ—Ä ‚Äî –¥–µ–ª–æ —Å–ª–æ–≤–µ–Ω—Å–∫–æ–π ¬´–ö–†–ö–ê¬ª –∏ –µ—ë –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –æ—Ç –¥–∞–≤–ª–µ–Ω–∏—è –ö–æ-–î–∞–ª—å–Ω–µ–≤–∞, –∫–æ—Ç–æ—Ä–æ–µ –∑–∞–º—Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—è –§–ê–° –¢–∏–º–æ—Ñ–µ–π –ù–∏–∂–µ–≥–æ—Ä–æ–¥—Ü–µ–≤ –ø—Ä–µ–¥–ª–æ–∂–∏–ª –ø–æ–ª–æ–∂–∏—Ç—å –≤ –æ—Å–Ω–æ–≤—É –Ω–æ–≤—ã—Ö —Ä–∞—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –∏ ¬´–ø–æ–¥–≤–µ—Ä—Å—Ç—ã–≤–∞—Ç—å –≤–µ—Å—å —Ä—ã–Ω–æ–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –Ω–µ –≤—Ö–æ–¥—è—â–∏—Ö –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü, —á–µ—Ä–µ–∑ —ç—Ç—É –ø—Ä–∏–∑–º—É¬ª. –¢–∞–∫–∂–µ, –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏ –¥—Ä—É–≥ –∑–∞ –¥—Ä—É–≥–æ–º –≤–Ω–∏–º–∞–Ω–∏–µ —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —Ä–µ–≥—É–ª—è—Ç–æ—Ä–∞ –ø—Ä–∏–≤–ª–µ–∫–ª–∏ ¬´–ê–º–¥–∂–µ–Ω¬ª, ¬´–ó–∞–º–±–æ–Ω-–§–∞—Ä–º–∞¬ª –∏ ¬´–ê–Ω–¥–∂–µ–ª–∏–Ω–∏ –§–∞—Ä–º–∞ –†—É—Å¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, regulation"",
  ""impact"": ""high"",
  ""english"": ""The European Commission conducted raids at Sanofi's offices in France and Germany as part of an antitrust investigation. The company confirmed this, although Brussels has not officially disclosed which pharmaceutical producers are suspected of violating antitrust legislation. The investigation was triggered by potential abuse of dominant market positions in seasonal influenza vaccines and unethical competition discrediting. Sanofi assured that the company 'complies with all applicable rules and norms' and is ready to cooperate with regulators. Penalties for antitrust violations in Europe are substantial, up to 10% of annual global turnover. Sanofi is one of the largest producers of seasonal influenza vaccines alongside GSK and CSL Seqirus in Russia. Similar cases are not uncommon. Russian regulators often issue warnings to pharmaceutical producers (mainly foreign) for dominant market positions and impose fines. A notable example is the case of Slovenian 'KRCA' and its drug for hypertension, which was proposed by FAS Deputy Director Timofey Nizhegorodtsev to serve as the basis for new investigations and 'extend market scrutiny of all non-JNHV"
2025-10-01T15:51:26+00:00,@bezrec,6611,https://t.me/bezrec/6611,"‚ö°Ô∏è–ò–ü –º–æ–≥—É—Ç –ª–∏—à–∏—Ç—å –ø–∞—Ç–µ–Ω—Ç–∞ –Ω–∞ —Ä–æ–∑–Ω–∏—Ü—É –∏ –≥—Ä—É–∑–æ–ø–µ—Ä–µ–≤–æ–∑–∫–∏ –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –≤–Ω–µ—Å–ª–æ –≤ –ì–æ—Å–¥—É–º—É –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ –∫–æ—Ä—Ä–µ–∫—Ç–∏—Ä–æ–≤–∫–µ –ø–∞—Ç–µ–Ω—Ç–Ω–æ–π —Å–∏—Å—Ç–µ–º—ã –Ω–∞–ª–æ–≥–æ–æ–±–ª–æ–∂–µ–Ω–∏—è. –ï—Å–ª–∏ –¥–æ–∫—É–º–µ–Ω—Ç –ø—Ä–∏–º—É—Ç, —Ç–æ —Å 1 —è–Ω–≤–∞—Ä—è 2026 –≥–æ–¥–∞: üîò–ª–∏–º–∏—Ç –¥–æ—Ö–æ–¥–∞ –¥–ª—è –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –ü–°–ù —Å–Ω–∏–∑—è—Ç —Å 60 –¥–æ 10 –º–ª–Ω —Ä—É–±. –≤ –≥–æ–¥; üîò–∏–∑ –ø–µ—Ä–µ—á–Ω—è –≤–∏–¥–æ–≤ –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –∏—Å–∫–ª—é—á–∞—Ç —Ä–æ–∑–Ω–∏—á–Ω—É—é —Ç–æ—Ä–≥–æ–≤–ª—é —á–µ—Ä–µ–∑ –º–∞–≥–∞–∑–∏–Ω—ã –∏ –∞–ø—Ç–µ–∫–∏, –∞ —Ç–∞–∫–∂–µ –∞–≤—Ç–æ–º–æ–±–∏–ª—å–Ω—ã–µ –≥—Ä—É–∑–æ–ø–µ—Ä–µ–≤–æ–∑–∫–∏; üîò–ø—Ä–æ–¥–æ–ª–∂–∏—Ç—å —Ä–∞–±–æ—Ç–∞—Ç—å –Ω–∞ –ø–∞—Ç–µ–Ω—Ç–µ —Å–º–æ–≥—É—Ç —Ç–æ–ª—å–∫–æ —Ç–µ, –∫—Ç–æ –≤–µ–¥–µ—Ç —Ç–æ—Ä–≥–æ–≤–ª—é —á–µ—Ä–µ–∑ –∫–∏–æ—Å–∫–∏, –ø–∞–≤–∏–ª—å–æ–Ω—ã, —Ñ—É–¥—Ç—Ä–∞–∫–∏ –∏–ª–∏ —Å—Ç–∞—Ü–∏–æ–Ω–∞—Ä–Ω—ã–µ —Ç–æ—á–∫–∏ –±–µ–∑ —Ç–æ—Ä–≥–æ–≤—ã—Ö –∑–∞–ª–æ–≤. –ü–æ –¥–∞–Ω–Ω—ã–º –§–ù–°, –ü–°–ù —Å–µ–≥–æ–¥–Ω—è –ø—Ä–∏–º–µ–Ω—è—é—Ç 1,43 –º–ª–Ω –ø—Ä–µ–¥–ø—Ä–∏–Ω–∏–º–∞—Ç–µ–ª–µ–π. –ò–∑ –Ω–∏—Ö 507 —Ç—ã—Å—è—á —Ç–æ—Ä–≥–æ–≤—ã—Ö —Ç–æ—á–µ–∫ –∏ 277 —Ç—ã—Å—è—á –ø–µ—Ä–µ–≤–æ–∑—á–∏–∫–æ–≤ –±—É–¥—É—Ç –≤—ã–Ω—É–∂–¥–µ–Ω—ã –ø–µ—Ä–µ–π—Ç–∏ –Ω–∞ –£–°–ù –∏–ª–∏ –û–°–ù. –ü—Ä–∏ –¥–æ—Ö–æ–¥–∞—Ö —Å–≤—ã—à–µ 10 –º–ª–Ω —Ä—É–±. –±–∏–∑–Ω–µ—Å –∞–≤—Ç–æ–º–∞—Ç–∏—á–µ—Å–∫–∏ —Å—Ç–∞–Ω–µ—Ç –ø–ª–∞—Ç–µ–ª—å—â–∏–∫–æ–º –ù–î–°. ‚ñ∂Ô∏è–í –≥—Ä—É–ø–ø–µ —Ä–∏—Å–∫–∞ —Ç–∞–∫–∂–µ —Ä–µ—Å—Ç–æ—Ä–∞–Ω—ã —Å—Ä–µ–¥–Ω–µ–≥–æ —Ñ–æ—Ä–º–∞—Ç–∞, —Å–∞–ª–æ–Ω—ã –∫—Ä–∞—Å–æ—Ç—ã, –∞–≤—Ç–æ–º–æ–π–∫–∏ –∏ –≤—ã—Å–æ–∫–æ–æ–ø–ª–∞—á–∏–≤–∞–µ–º—ã–µ IT-—Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã. –ü–æ —Ä–∞—Å—á–µ—Ç–∞–º –≤–ª–∞—Å—Ç–µ–π, –Ω–æ–≤—ã–µ –ø—Ä–∞–≤–∏–ª–∞ —É–≤–µ–ª–∏—á–∞—Ç –Ω–∞–ª–æ–≥–æ–≤—ã–µ –ø–æ—Å—Ç—É–ø–ª–µ–Ω–∏—è –Ω–∞ 1,27 –º–ª—Ä–¥ —Ä—É–±. –≤ 2026 –≥–æ–¥—É –∏ –¥–æ 3,3 –º–ª—Ä–¥ —Ä—É–±. –≤ –ø–æ—Å–ª–µ–¥—É—é—â–∏–µ –¥–≤–∞ –≥–æ–¥–∞. –ù–∞–ª–æ–≥–æ–≤–∏–∫–∏ –æ–±—ä—è—Å–Ω—è—é—Ç –∏—Å–∫–ª—é—á–µ–Ω–∏–µ —Ä–æ–∑–Ω–∏—Ü—ã –∏ –ø–µ—Ä–µ–≤–æ–∑–æ–∫ –∏—Ö –≤—ã—Å–æ–∫–∏–º–∏ –æ–±–æ—Ä–æ—Ç–∞–º–∏: –≤—ã—Ä—É—á–∫–∞ —Ç–∞–∫–∏—Ö –∫–æ–º–ø–∞–Ω–∏–π —á–∞—Å—Ç–æ –ø—Ä–µ–≤—ã—à–∞–µ—Ç 10-20 –º–ª–Ω —Ä—É–±., –ø—Ä–∏ —ç—Ç–æ–º –Ω–∞–ª–æ–≥–æ–≤–∞—è –Ω–∞–≥—Ä—É–∑–∫–∞ –ø–æ –ø–∞—Ç–µ–Ω—Ç—É –æ—Å—Ç–∞–µ—Ç—Å—è –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ –Ω–∏–∂–µ, —á–µ–º –ø–æ –£–°–ù –∏–ª–∏ –û–°–ù. üìÑ –î–µ–ª–æ –≤ —Ü–∏—Ñ—Ä–∞—Ö","{
  ""skip"": true,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing"",
  ""impact"": ""medium"",
  ""english"": ""The government has proposed changes to the patent tax system, reducing the income limit for applying the PSN from 60 million rubles to 10 million per year. The proposed changes include excluding retail trade through stores and pharmacies, as well as automobile transportation from the list of activities subject to PSN. Only those who operate through kiosks, pavilions, food trucks, or stationary points without commercial halls will be able to continue using the patent. The changes are expected to increase tax revenues by 1.27 billion rubles in 2026 and up to 3.3 billion rubles over the next two years.""
}"
2025-10-01T14:01:10+00:00,@bezrec,6610,https://t.me/bezrec/6610,"–†–µ—à–∏–ª–∏ –∑–∞–≤–µ—Å—Ç–∏ –Ω–æ–≤—É—é —Ç—Ä–∞–¥–∏—Ü–∏—é ‚Äî –≤ –Ω–∞—á–∞–ª–µ –∫–∞–∂–¥–æ–≥–æ –º–µ—Å—è—Ü–∞ –±—É–¥–µ–º –ø—É–±–ª–∏–∫–æ–≤–∞—Ç—å –æ–±–∑–æ—Ä –∏–∑–º–µ–Ω–µ–Ω–∏–π, –∫–æ—Ç–æ—Ä—ã–µ –ø—Ä–æ–∏–∑–æ—à–ª–∏ –≤ –ì–†–õ–° –≤ –º–µ—Å—è—Ü–µ –ø—Ä–µ–¥—ã–¥—É—â–µ–º. –ü—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º –ø–µ—Ä–≤—ã–π –≤—ã–ø—É—Å–∫ ‚Äî –∑–∞ —Å–µ–Ω—Ç—è–±—Ä—å 2025 –≥–æ–¥–∞. –û—Ç–º–µ–Ω–∞ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏: –ê–∫–∫—É–∑–∏–¥ (¬´–ü—Ñ–∞–π–∑–µ—Ä¬ª, —Ç–∞–±–ª–µ—Ç–∫–∏ 12,5 –º–≥+ 10 –º–≥, 12,5 –º–≥+20 –º–≥, 25 –º–≥+20 –º–≥), –ê–∫–∫—É–ø—Ä–æ (¬´–ü—Ñ–∞–π–∑–µ—Ä¬ª, —Ç–∞–±–ª–µ—Ç–∫–∏, 5,10,20,40 –º–≥), –ê–º–∏–æ–¥–∞—Ä–æ–Ω-–ê–∫—Ä–∏ (¬´–ê–∫—Ä–∏—Ö–∏–Ω¬ª, —Ç–∞–±–ª–µ—Ç–∫–∏, 200 –º–≥), –ê—Ç–æ—Ä–≤–∞—Å—Ç–∞—Ç–∏–Ω –°–∞–Ω–æ—Ñ–∏ (—Ç–∞–±–ª–µ—Ç–∫–∏, 10,20,40 –º–≥), –ì–ª–∏–≤–µ–∫ (¬´–ù–æ–≤–∞—Ä—Ç–∏—Å¬ª, –∫–∞–ø—Å—É–ª—ã, 100 –º–≥), –ú–∞–Ω–∏–Ω–∏–ª (¬´–ë–µ—Ä–ª–∏–Ω-–•–µ–º–∏¬ª, —Ç–∞–±–ª–µ—Ç–∫–∏, 1,75 –º–≥), –ù–æ—Ä–º–∞—Ç–µ–Ω—Å (¬´–í–∏–∞—Ç—Ä–∏—Å¬ª, —Ç–∞–±–ª–µ—Ç–∫–∏, 0,5 –º–≥+5 –º–≥+ 0,1 –º–≥), –û–∫—Å–æ–ª–∏–Ω (¬´–ù–∏–∂—Ñ–∞—Ä–º¬ª, –º–∞–∑—å –Ω–∞–∑–∞–ª—å–Ω–∞—è, 2,5 –º–≥/–≥), –†–µ–ø–∞—Ä–∏–ª-–≥–µ–ª—å –ù (¬´–ú–∞–¥–∞—É—Å¬ª, –≥–µ–ª—å –¥–ª—è –Ω–∞—Ä—É–∂–Ω–æ–≥–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è), –°–∞–ª–Ω–∞–≤–∞–∫ –ö–æ–º–±–∏–Ω–∏—Ä–æ–≤–∞–Ω–Ω–∞—è –≤–µ–∫—Ç–æ—Ä–Ω–∞—è –≤–∞–∫—Ü–∏–Ω–∞ –¥–ª—è –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –∫–æ—Ä–æ–Ω–∞–≤–∏—Ä—É—Å–Ω–æ–π –∏–Ω—Ñ–µ–∫—Ü–∏–∏ (¬´–ì–µ–Ω–µ—Ä–∏—É–º¬ª, —Å–ø—Ä–µ–π –Ω–∞–∑–∞–ª—å–Ω—ã–π, –∫–æ–º–ø–æ–Ω–µ–Ω—Ç I-0,5 –º–ª/–¥–æ–∑–∞+–∫–æ–º–ø–æ–Ω–µ–Ω—Ç II-0,5 –º–ª/–¥–æ–∑–∞), –ß–∞–º–ø–∏–∫—Å (¬´–ü—Ñ–∞–π–∑–µ—Ä¬ª, —Ç–∞–±–ª–µ—Ç–∫–∏, 0,5–º–≥, 1–º–≥). –ü—Ä–∏–æ—Å—Ç–∞–Ω–æ–≤–∫–∞ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –õ–ü: –ë–∏—Å–æ–ø—Ä–æ–ª–æ–ª (¬´–†–∞—Ñ–∞—Ä–º–∞¬ª, —Ç–∞–±–ª–µ—Ç–∫–∏, –ø–æ–∫—Ä—ã—Ç—ã–µ –ø–ª–µ–Ω–æ—á–Ω–æ–π –æ–±–æ–ª–æ—á–∫–æ–π, 2.5 –º–≥, 5 –º–≥, 10 –º–≥), –ñ–µ–Ω—å—à–µ–Ω—è –Ω–∞—Å—Ç–æ—è—â–µ–≥–æ –∫–æ—Ä–Ω–µ–π –Ω–∞—Å—Ç–æ–π–∫–∞, –ö–∞–ª–µ–Ω–¥—É–ª—ã –Ω–∞—Å—Ç–æ–π–∫–∞, –ö–æ–Ω—Å–∫–æ–≥–æ –∫–∞—à—Ç–∞–Ω–∞ —ç–∫—Å—Ç—Ä–∞–∫—Ç –∂–∏–¥–∫–∏–π, –õ–µ–≤–∑–µ–∏ —ç–∫—Å—Ç—Ä–∞–∫—Ç –∂–∏–¥–∫–∏–π, –õ–∏–º–æ–Ω–Ω–∏–∫–∞ —Å–µ–º—è–Ω –Ω–∞—Å—Ç–æ–π–∫–∞, –í–∞–ª–µ—Ä–∏–∞–Ω—ã –Ω–∞—Å—Ç–æ–π–∫–∞, –ú–∏—Ä—Ç–∏–∫–∞–º —Å–∏—Ä–æ–ø –≥–æ–º–µ–æ–ø–∞—Ç–∏—á–µ—Å–∫–∏–π , –ú—è—Ç—ã –ø–µ—Ä–µ—á–Ω–æ–π –Ω–∞—Å—Ç–æ–π–∫–∞, –ü–µ—Ä—Ü–∞ –≤–æ–¥—è–Ω–æ–≥–æ —ç–∫—Å—Ç—Ä–∞–∫—Ç –∂–∏–¥–∫–∏–π, –ü–∏–æ–Ω–∞ —É–∫–ª–æ–Ω—è—é—â–µ–≥–æ—Å—è –Ω–∞—Å—Ç–æ–π–∫–∞, –ü—É—Å—Ç—ã—Ä–Ω–∏–∫–∞ –Ω–∞—Å—Ç–æ–π–∫–∞, –†–æ–¥–∏–æ–ª—ã —ç–∫—Å—Ç—Ä–∞–∫—Ç –∂–∏–¥–∫–∏–π, (¬´–ö–∞–º–µ–ª–∏—è¬ª), –ù–æ–æ–ö–∞–º (¬´–ö–∞–º–µ–ª–∏—è¬ª, –∫–∞–ø—Å—É–ª—ã, 400 –º–≥+25 –º–≥), –ì–µ–ø–∞—Ä–∏–Ω-–†—É—Å (¬´–ú–∞–Ω–∞—Å –ú–µ–¥¬ª, —Ä–∞—Å—Ç–≤–æ—Ä –¥–ª—è –∏–Ω—ä–µ–∫—Ü–∏–π, 5000 –ú–ï/–º–ª), –î–æ—Ü–µ—Ç–∞–∫—Å–µ–ª-–†—É—Å (¬´–ú–∞–Ω–∞—Å –ú–µ–¥¬ª, –∫–æ–Ω—Ü–µ–Ω—Ç—Ä–∞—Ç –¥–ª—è –ø—Ä–∏–≥–æ—Ç–æ–≤–ª–µ–Ω–∏—è —Ä–∞—Å—Ç–≤–æ—Ä–∞ –¥–ª—è –∏–Ω—Ñ—É–∑–∏–π, 40 –º–≥/–º–ª), –ü–µ–º–µ—Ç—Ä–µ–∫—Å–µ–¥-–†—É—Å (¬´–ú–∞–Ω–∞—Å –ú–µ–¥¬ª, –ª–∏–æ—Ñ–∏–ª–∏–∑–∞—Ç –¥–ª—è –ø—Ä–∏–≥–æ—Ç–æ–≤–ª–µ–Ω–∏—è –∫–æ–Ω—Ü–µ–Ω—Ç—Ä–∞—Ç–∞ –¥–ª—è –ø—Ä–∏–≥–æ—Ç–æ–≤–ª–µ–Ω–∏—è —Ä–∞—Å—Ç–≤–æ—Ä–∞ –¥–ª—è –∏–Ω—Ñ—É–∑–∏–π, 100 –º–≥), –ö–æ–ª–ª–æ–º–∞–∫ (¬´–ì–µ–∫—Å–∞–ª–æ –¢—Ä–∞–π–¥–∏–Ω–≥ –õ–∏–º–∏—Ç–µ–¥¬ª, —Ä–∞—Å—Ç–≤–æ—Ä –¥–ª—è –Ω–∞—Ä—É–∂–Ω–æ–≥–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è), –õ–∞—Ä–∏–ø—Ä–æ–Ω—Ç (¬´–ì–µ–∫—Å–∞–ª–æ –¢—Ä–∞–π–¥–∏–Ω–≥ –õ–∏–º–∏—Ç–µ–¥¬ª, —Ç–∞–±–ª–µ—Ç–∫–∏ –¥–ª—è —Ä–∞—Å—Å–∞—Å—ã–≤–∞–Ω–∏—è), –õ–∞–π–∫–æ—Ü–∏–Ω (¬´–§–∞—Ä–º–≥–∏–¥¬ª, –ø–æ—Ä–æ—à–æ–∫ –¥–ª—è –ø—Ä–∏–≥–æ—Ç–æ–≤–ª–µ–Ω–∏—è —Ä–∞—Å—Ç–≤–æ—Ä–∞ –¥–ª—è –≤–Ω—É—Ç—Ä–∏–≤–µ–Ω–Ω–æ–≥–æ –∏ –≤–Ω—É—Ç—Ä–∏–º—ã—à–µ—á–Ω–æ–≥–æ –≤–≤–µ–¥–µ–Ω–∏—è, 1 –≥). –í–æ–∑–æ–±–Ω–æ–≤–ª–µ–Ω–∏–µ –¥–µ–π—Å—Ç–≤–∏—è –†–£: –ë–∏—Å–æ–ø—Ä–æ–ª–æ–ª (¬´–†–∞—Ñ–∞—Ä–º–∞¬ª, —Ç–∞–±–ª–µ—Ç–∫–∏, 2.5 –º–≥, 5 –º–≥, 10 –º–≥). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, shortage"",
  ""impact"": ""medium"",
  ""english"": ""A review of changes in the GRLS for September 2025 is published. The following drugs have had their state registration revoked: Akukusid (Pfizer, 12.5mg+10mg, 12.5mg+20mg, 25mg+20mg), Akukpro (Pfizer, tablets, 5,10,20,40mg), Akudarone-Acris (Akrhin, tablets, 200mg), Atorvastatin Sanofi (tablets, 10,20,40mg), Glivec (Novartis, capsules, 100mg), Mannilin (Berlin-Hemi, tablets, 1.75mg), Normaten (Viatris, tablets, 0.5mg+5mg+0.1mg), Oksolin (Nizfarma, nasal cream, 2.5mg/g), Reparil-Gel N (Madaus"
2025-10-01T12:05:13+00:00,@bezrec,6609,https://t.me/bezrec/6609,"–ò–∑ —Ç—Ä–µ—Å–∫–∏ —Å–æ–∑–¥–∞–ª–∏ —Ä–∞–Ω–æ–∑–∞–∂–∏–≤–ª—è—é—â–∏–µ –ø–æ–∫—Ä—ã—Ç–∏—è. ‚ö´Ô∏è–£—á–µ–Ω—ã–µ –ù–∏–∂–µ–≥–æ—Ä–æ–¥—Å–∫–æ–≥–æ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ –∏–º. –ù.–ò. –õ–æ–±–∞—á–µ–≤—Å–∫–æ–≥–æ (–ù–ù–ì–£) —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª–∏ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—é –ø–æ–ª—É—á–µ–Ω–∏—è —Ä–∞–Ω–æ–∑–∞–∂–∏–≤–ª—è—é—â–∏—Ö –ø–æ–∫—Ä—ã—Ç–∏–π (–ø–ª–µ–Ω–æ–∫, –≥—É–±–æ–∫ –∏ —Å–∫–∞—Ñ—Ñ–æ–ª–¥–æ–≤) –Ω–∞ –æ—Å–Ω–æ–≤–µ –∫–æ–ª–ª–∞–≥–µ–Ω–∞ –∏–∑ –æ—Ç—Ö–æ–¥–æ–≤ –ø–µ—Ä–µ—Ä–∞–±–æ—Ç–∫–∏ —Ç—Ä–µ—Å–∫–∏. –£–Ω–∏–∫–∞–ª—å–Ω–æ—Å—Ç—å —Ç–∞–∫–∏—Ö –ø–æ–∫—Ä—ã—Ç–∏–π –≤ —Ç–æ–º, —á—Ç–æ –æ–Ω–∏ —Å–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω–æ –∏ –±–µ–∑ –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–π –æ–±—Ä–∞–±–æ—Ç–∫–∏ –ø—Ä–µ–ø—è—Ç—Å—Ç–≤—É—é—Ç –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—é –ø–ª–µ—Å–Ω–µ–≤—ã—Ö –≥—Ä–∏–±–æ–≤ –∏ –±–∞–∫—Ç–µ—Ä–∏–π. –ü–æ–¥–æ–±–Ω—ã–µ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–µ –º–∞—Ç–µ—Ä–∏–∞–ª—ã –Ω–∞ —Ä—ã–Ω–∫–µ –æ—Ç—Å—É—Ç—Å—Ç–≤—É—é—Ç, –∞ –∏—Ö –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ –æ—Å–æ–±–µ–Ω–Ω–æ –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–Ω–æ –≤ –Ω–µ—Å—Ç–µ—Ä–∏–ª—å–Ω—ã—Ö —É—Å–ª–æ–≤–∏—è—Ö. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –Ω–∞—à–µ–π —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –ø—Ä–µ–≤–æ—Å—Ö–æ–¥–∏—Ç –∫–æ–º–º–µ—Ä—á–µ—Å–∫–∏–µ –∞–Ω–∞–ª–æ–≥–∏, ‚Äì —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏ –≤ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–µ. –í—ã–±–æ—Ä –∫–æ–ª–ª–∞–≥–µ–Ω–∞ –∏–∑ –ø—Ä–æ–º—ã—Å–ª–æ–≤—ã—Ö —Ä—ã–± –æ–±—É—Å–ª–æ–≤–ª–µ–Ω –µ–≥–æ –º–∞–∫—Å–∏–º–∞–ª—å–Ω—ã–º —Å—Ö–æ–¥—Å—Ç–≤–æ–º —Å —á–µ–ª–æ–≤–µ—á–µ—Å–∫–∏–º, —á—Ç–æ –æ–±–µ—Å–ø–µ—á–∏–≤–∞–µ—Ç –≤—ã—Å–æ–∫—É—é –±–∏–æ—Å–æ–≤–º–µ—Å—Ç–∏–º–æ—Å—Ç—å. –í –ù–ù–ì–£ —Ç–∞–∫–∂–µ –æ—Ç–º–µ—Ç–∏–ª–∏, —á—Ç–æ —ç—Ç–æ –ø–æ—Å—Ç–æ—è–Ω–Ω–æ –≤–æ–∑–æ–±–Ω–æ–≤–ª—è–µ–º—ã–π, –Ω–µ–¥–æ—Ä–æ–≥–æ–π (—Ö–æ—Ç—è –≤ —Å–ª—É—á–∞–µ —Å —Ç—Ä–µ—Å–∫–æ–π –º—ã –±—ã, –∫–æ–Ω–µ—á–Ω–æ, –ø–æ—Å–ø–æ—Ä–∏–ª–∏) –∏ –±–µ–∑–æ–ø–∞—Å–Ω—ã–π —Ä–µ—Å—É—Ä—Å, –Ω–µ –Ω–µ—Å—É—â–∏–π —Ä–∏—Å–∫–∞ –ø–µ—Ä–µ–¥–∞—á–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –æ—Ç –∂–∏–≤–æ—Ç–Ω—ã—Ö —á–µ–ª–æ–≤–µ–∫—É. ‚ö´Ô∏è–≠—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –Ω–æ–≤—ã—Ö –ø–æ–∫—Ä—ã—Ç–∏–π —É–∂–µ –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–µ–Ω–∞, —Å–æ–æ–±—â–∏–ª–∏ –∞–≤—Ç–æ—Ä—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è. –°–µ–π—á–∞—Å —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∞ –ø–µ—Ä–µ—Ö–æ–¥–∏—Ç –Ω–∞ —Å—Ç–∞–¥–∏—é –ø–∏–ª–æ—Ç–Ω–æ–≥–æ –ø—Ä–æ–µ–∫—Ç–∞, –≤ —Ä–∞–º–∫–∞—Ö –∫–æ—Ç–æ—Ä–æ–≥–æ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –ø—Ä–æ–≤–µ–¥–µ–Ω–∏–µ –ø–æ–ª–Ω–æ–≥–æ —Ü–∏–∫–ª–∞ –¥–æ–∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å–ø—ã—Ç–∞–Ω–∏–π –¥–ª—è –ø–æ—Å–ª–µ–¥—É—é—â–µ–≥–æ –≤–Ω–µ–¥—Ä–µ–Ω–∏—è –≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫—É—é –ø—Ä–∞–∫—Ç–∏–∫—É. –í –ù–ù–ì–£ —Å—á–∏—Ç–∞—é—Ç, —á—Ç–æ –≤ –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–µ –ø–æ–¥–æ–±–Ω—ã–µ –º–∞—Ç–µ—Ä–∏–∞–ª—ã –º–æ–≥—É—Ç –±—ã—Ç—å –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω—ã –¥–ª—è –≤–æ—Å—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è –ª—é–±—ã—Ö —Ç–∫–∞–Ω–µ–π –æ—Ä–≥–∞–Ω–∏–∑–º–∞. ‚Ñ¢Ô∏è –†—ã–±—Ö–æ–∑. –í—Å—ë –æ —Ä—ã–±–µ","{
  ""skip"": true,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,hospital_policy,pharmacovigilance,safety"",
  ""impact"": ""medium"",
  ""english"": ""Researchers from Nizhny Novgorod State University (NNSU) have developed a technology for creating wound-healing coatings based on collagen from fish processing waste. The unique feature of these coatings is their ability to prevent the formation of mold and bacteria without additional treatment. Such domestic materials are not available on the market, especially in non-sterile conditions. The efficiency of this development exceeds commercial counterparts. The university noted that the use of fish collagen is due to its high similarity with human tissue, ensuring good biocompatibility. The university also stated that this resource is renewable, cost-effective (though we would argue about the cost of fish), and safe for transferring diseases from animals to humans. The efficiency of these coatings has already been confirmed, and the development is moving into a pilot project phase where full preclinical trials will be conducted before entering medical practice. The university believes that in the future, such materials can be used to restore any tissue of the body.""
}"
2025-10-01T10:04:12+00:00,@bezrec,6608,https://t.me/bezrec/6608,"–ü–æ–ª–æ–≤–∏–Ω–∞ —Ç–æ–ø–æ–≤—ã—Ö –∫–æ–º–ø–∞–Ω–∏–π –ø–æ–∫–∞–∑–∞–ª–∞ —Å–Ω–∏–∂–µ–Ω–∏–µ –æ–±—ä—ë–º–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤. –ü–æ –¥–∞–Ω–Ω—ã–º RNC Pharma, c—É–º–º–∞—Ä–Ω—ã–π –æ–±—ä—ë–º –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –≥–æ—Ç–æ–≤—ã—Ö –õ–ü –≤ —è–Ω–≤–∞—Ä–µ-–∞–≤–≥—É—Å—Ç–µ 2025 –≥–æ–¥–∞ —Å–æ—Å—Ç–∞–≤–∏–ª 631,1 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —á—Ç–æ –Ω–∞ 15,5% –±–æ–ª—å—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É. –ê –≤–æ—Ç –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö —Å–æ–∫—Ä–∞—Ç–∏–ª–æ—Å—å –Ω–∞ 6,1%, –¥–æ 2,5 –º–ª—Ä–¥ —É–ø–∞–∫–æ–≤–æ–∫. –í –∞–≤–≥—É—Å—Ç–µ 2025 –≥–æ–¥–∞ –ª–æ–∫–∞–ª–∏–∑–æ–≤–∞–Ω–Ω—ã–µ –≤ –†–§ –∫–æ–º–ø–∞–Ω–∏–∏ –ø—Ä–æ–∏–∑–≤–µ–ª–∏ –ø–æ—Ä—è–¥–∫–∞ 315,6 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ –ª–µ–∫–∞—Ä—Å—Ç–≤, —á—Ç–æ –Ω–∞ 4% –º–µ–Ω—å—à–µ –ø–æ–∫–∞–∑–∞—Ç–µ–ª–µ–π –∞–≤–≥—É—Å—Ç–∞ –ø—Ä–æ—à–ª–æ–≥–æ –≥–æ–¥–∞. –°–ø–∞–¥ —Ñ–∏–∑–∏—á–µ—Å–∫–æ–≥–æ –æ–±—ä—ë–º–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –∞–Ω–∞–ª–∏—Ç–∏–∫–∏ —Ñ–∏–∫—Å–∏—Ä—É—é—Ç —É–∂–µ —á–µ—Ç–≤—ë—Ä—Ç—ã–π –º–µ—Å—è—Ü –ø–æ–¥—Ä—è–¥. –ö–æ–ª–∏—á–µ—Å—Ç–≤–æ –∫–æ–º–ø–∞–Ω–∏–π, –æ—Ç–≥—Ä—É–∂–∞—é—â–∏—Ö –≥–æ—Ç–æ–≤—ã–µ –õ–ü, –≤ –∞–Ω–∞–ª–∏–∑–∏—Ä—É–µ–º—ã–π –ø–µ—Ä–∏–æ–¥ —Å–æ–∫—Ä–∞—Ç–∏–ª–æ—Å—å –Ω–∞ 26 —à—Ç—É–∫, –¥–æ 415. –û–¥–Ω–∞–∫–æ —ç—Ç–æ –Ω–µ –ø–æ–º–µ—à–∞–ª–æ —Ä–æ—Å—Ç—É –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç–∞ –ª–æ–∫–∞–ª–∏–∑–æ–≤–∞–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ ‚Äî —Ç–æ—Ä–≥–æ–≤—ã—Ö –º–∞—Ä–æ–∫ —Å—Ç–∞–ª–æ –Ω–∞ 60 –ø–æ–∑–∏—Ü–∏–π –±–æ–ª—å—à–µ (2,8 —Ç—ã—Å.). –í –ª–∏–¥–µ—Ä–∞—Ö –ø–æ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º—É –æ–±—ä—ë–º—É –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ ‚Äî ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª. –ö–æ–º–ø–∞–Ω–∏—è –º–æ–∂–µ—Ç –ø–æ—Ö–≤–∞—Å—Ç–∞—Ç—å—Å—è –≤–Ω—É—à–∏—Ç–µ–ª—å–Ω–æ–π –¥–∏–Ω–∞–º–∏–∫–æ–π, –∫–æ—Ç–æ—Ä—É—é –æ–±–µ—Å–ø–µ—á–∏–≤–∞—é—Ç –≤ –æ—Å–Ω–æ–≤–Ω–æ–º –ë–∏—Å–æ–ø—Ä–æ–ª–æ–ª (—Ä–æ—Å—Ç –≤ 2,1 —Ä–∞–∑–∞), –≠–Ω–∞–ª–∞–ø—Ä–∏–ª (–≤ 7,2 —Ä–∞–∑–∞) –∏ –ì–ª–∏–∫–ª–∞–∑–∏–¥ (–≤ 3,3 —Ä–∞–∑–∞). –ü—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å —Ç–∞–∫–∂–µ –æ—Ç–ª–∏—á–∏–ª—Å—è –º–∞–∫—Å–∏–º–∞–ª—å–Ω—ã–º –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ–º –±—Ä–µ–Ω–¥–æ–≤ ( 288 –Ω–∞–∏–º–µ–Ω–æ–≤–∞–Ω–∏–π, +38 –∑–∞ –≥–æ–¥). –í—ã—Å–æ–∫—É—é –¥–∏–Ω–∞–º–∏–∫—É —Ç–∞–∫–∂–µ –ø—Ä–æ–¥–µ–º–æ–Ω—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª–∏ ¬´–¢—É–ª—å—Å–∫–∞—è —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∞—è —Ñ–∞–±—Ä–∏–∫–∞¬ª (–¥—Ä–∞–π–≤–µ—Ä—ã —Ä–æ—Å—Ç–∞ - –•–ª–æ—Ä–≥–µ–∫—Å–∏–¥–∏–Ω –∏ –ø–µ—Ä–µ–∫–∏—Å—å –≤–æ–¥–æ—Ä–æ–¥–∞,) –∏ ¬´–í–µ–ª—Ñ–∞—Ä–º¬ª —Å–æ —Å–≤–æ–∏–º–∏ –í–µ–ª–¥–µ–∫—Å–∞–ª–æ–º –∏ –Ω–µ–±—Ä–µ–Ω–¥–∏—Ä–æ–≤–∞–Ω–Ω—ã–º–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º–∏ –æ–º–µ–ø—Ä–∞–∑–æ–ª–∞, –∞—Ç–æ—Ä–≤–∞—Å—Ç–∞—Ç–∏–Ω–∞ –∏ –∞–¥–µ–º–µ—Ç–∏–æ–Ω–∏–Ω–∞. ¬´–ù–∞ –≥—Ä–∞–Ω–∏¬ª —Å –¥–∏–Ω–∞–º–∏–∫–æ–π –≤—Å–µ–≥–æ –≤ 1% –Ω–∞—Ö–æ–¥—è—Ç—Å—è ¬´–ù–∏–∂—Ñ–∞—Ä–º¬ª –∏ ¬´–ì—Ä–æ—Ç–µ–∫—Å¬ª. –û—Å—Ç–∞–ª—å–Ω—ã–µ —É—á–∞—Å—Ç–Ω–∏–∫–∏ —Ç–æ–ø-10 –ø—Ä–æ–¥–µ–º–æ–Ω—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª–∏ –æ—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω—ã–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã. –í –∏—Ö —á–∏—Å–ª–µ ¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç¬ª, ¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º¬ª, ¬´–û–±–Ω–æ–≤–ª–µ–Ω–∏–µ¬ª, ¬´–û—Ç–∏—Å–∏—Ñ–∞—Ä–º¬ª –∏ ¬´–í–µ—Ä—Ç–µ–∫—Å¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The report highlights a decline in pharmaceutical production volumes, with the overall production of ready-made drugs increasing by 15.5% year-over-year to RUB631.1 billion in January-August 2025. However, the production of packaged drugs decreased by 6.1% to 2.5 billion units. The number of companies producing ready-made drugs has decreased by 26 to 415 over the analyzed period. Despite this, there was an increase in the number of branded products by 60 positions (28,800 items). Leading companies include 'Ozon Farmakvetika', which experienced significant growth in brands such as Bisoprolol, Enalapril, and Glizid. Other companies like 'Tula Farmakvetika', 'Velfarma', and 'Na Grine' also showed positive growth. Overall, the impact is medium due to the negative performance of several companies in the top 10.""
}"
2025-10-01T07:04:57+00:00,@bezrec,6607,https://t.me/bezrec/6607,"¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑¬ª —É–¥–∏–≤–∏–ª –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã—Ö –≥–æ—Å—Ç–µ–π. –í —Å–µ–Ω—Ç—è–±—Ä–µ 2025 –≥–æ–¥–∞ –±–∏–æ—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–π –∑–∞–≤–æ–¥ ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑-–ù–æ—Ä–¥¬ª –≤ –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥–µ –ø—Ä–∏–Ω—è–ª GMP-–∏–Ω—Å–ø–µ–∫—Ç–æ—Ä–æ–≤ –∏–∑ 18 —Å—Ç—Ä–∞–Ω: –õ–∏–≤–∏–∏, –ò–Ω–¥–∏–∏, –í—å–µ—Ç–Ω–∞–º–∞, –≠–∫–≤–∞–¥–æ—Ä–∞, –£—Ä—É–≥–≤–∞—è, –ò–æ—Ä–¥–∞–Ω–∏–∏, –ü–µ—Ä—É –∏ —Å—Ç—Ä–∞–Ω –ï–ê–≠–°. –≠–∫—Å–ø–µ—Ä—Ç–∞–º –ø–æ–∫–∞–∑–∞–ª–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã–µ –º–æ—â–Ω–æ—Å—Ç–∏ –∏ –≤—ã—Å–æ–∫–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–Ω–æ–µ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏–µ, –≤ —Ç–æ–º —á–∏—Å–ª–µ —É—á–∞—Å—Ç–∫–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –∞–∫—Ç–∏–≤–Ω—ã—Ö —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏–π –∏ –≥–æ—Ç–æ–≤—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Ñ–æ—Ä–º, –≥–¥–µ –ø—Ä–∏–º–µ–Ω—è—é—Ç—Å—è –≤—ã—Å–æ–∫–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–Ω—ã–µ –ø—Ä–æ—Ü–µ—Å—Å—ã –∏ —Å—Ç–∞–Ω–¥–∞—Ä—Ç—ã GMP, –∞ —Ç–∞–∫–∂–µ —Å–∫–ª–∞–¥ –≤—ã—Å–æ–∫–æ—Å—Ç–µ–ª–ª–∞–∂–Ω–æ–≥–æ —Ö—Ä–∞–Ω–µ–Ω–∏—è —Å –±–æ–ª—å—à–∏–º–∏ –ø–ª–æ—â–∞–¥—è–º–∏ –∑–æ–Ω—ã –Ω–∏–∑–∫–æ—Ç–µ–º–ø–µ—Ä–∞—Ç—É—Ä–Ω–æ–≥–æ —Ö—Ä–∞–Ω–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤. –≠–∫—Å–∫—É—Ä—Å–∏—è –∏–Ω—Å–ø–µ–∫—Ç–æ—Ä–æ–≤ –≤–ø–µ—á–∞—Ç–ª–∏–ª–∞. –ö–æ–º–∏—Å—Å–∏—è –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª–∞, —á—Ç–æ —É—Ä–æ–≤–µ–Ω—å –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –Ω–∞ –∑–∞–≤–æ–¥–µ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É–µ—Ç —Å–∞–º—ã–º —Å—Ç—Ä–æ–≥–∏–º –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã–º —Å—Ç–∞–Ω–¥–∞—Ä—Ç–∞–º –∏ —Å–æ–ø–æ—Å—Ç–∞–≤–∏–º —Å —Ñ–∞—Ä–º–∑–∞–≤–æ–¥–∞–º–∏ –°–µ–≤–µ—Ä–Ω–æ–π –ê–º–µ—Ä–∏–∫–∏ –∏ –ï–≤—Ä–æ–ø—ã. –ö —Å–µ–±–µ –Ω–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –∫–æ–º–ø–∞–Ω–∏—è –í–∏–∫—Ä–∞–º–∞ –ü—É–Ω–∏—è –∑–≤–∞–ª–∞ –Ω–µ –ø—Ä–æ—Å—Ç–æ —Ç–∞–∫. –°—Ç—Ä–∞–Ω—ã –õ–∞—Ç–∏–Ω—Å–∫–æ–π –ê–º–µ—Ä–∏–∫–∏ –≥–æ—Ç–æ–≤—ã —Ä–∞—Å—Å–º–æ—Ç—Ä–µ—Ç—å –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –ø—Ä–∏–Ω—è—Ç–∏—è GMP-—Å–µ—Ä—Ç–∏—Ñ–∏–∫–∞—Ç–∞ ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑-–ù–æ—Ä–¥¬ª, –≤—ã–¥–∞–Ω–Ω–æ–≥–æ –ø—Ä–∏–∑–Ω–∞–Ω–Ω—ã–º–∏ –º–∏—Ä–æ–≤—ã–º–∏ –∏–Ω—Å–ø–µ–∫—Ç–æ—Ä–∞—Ç–∞–º–∏ (–ë—Ä–∞–∑–∏–ª—å—Å–∫–æ–µ –∞–≥–µ–Ω—Ç—Å—Ç–≤–æ –ø–æ —Ä–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω–∏—é –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è - ANVISA ), —á—Ç–æ —Å—É—â–µ—Å—Ç–≤–µ–Ω–Ω–æ –æ–±–ª–µ–≥—á–∞–µ—Ç –≤—ã—Ö–æ–¥ –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –Ω–∞ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã–µ —Ä—ã–Ω–∫–∏. –ü—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª—å –®—Ä–∏-–õ–∞–Ω–∫–∏ –Ω–∞—Å—Ç–æ–ª—å–∫–æ –≤–¥–æ—Ö–Ω–æ–≤–∏–ª–∞—Å—å –ø–ª–æ—â–∞–¥–∫–æ–π, —á—Ç–æ —Å–æ–æ–±—â–∏–ª–∞ –æ –≥–æ—Ç–æ–≤–Ω–æ—Å—Ç–∏ —Ä–∞–±–æ—Ç–∞—Ç—å –Ω–∞–¥ –æ—Ç–∫—Ä—ã—Ç–∏–µ–º –¥–æ—Å—Ç—É–ø–∞ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –∫ —Ä—ã–Ω–∫—É —Å–≤–æ–µ–π —Å—Ç—Ä–∞–Ω—ã, –∫—É–¥–∞ –∏—Ö –≤–≤–æ–∑ —Å–µ–π—á–∞—Å –∑–∞–ø—Ä–µ—â—ë–Ω. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""The biopharmaceutical factory 'PharmaSynthesis-Nord' in St. Petersburg, Russia received a GMP inspection from 18 foreign countries including Libya, India, Vietnam, Ecuador, Uruguay, Jordan, Peru and member states of the Eurasian Economic Commission. The inspection team was impressed by the production facilities, high-tech equipment, including active pharmaceutical ingredients and finished drug products manufacturing areas with strict GMP standards. The team also visited the high-stellage storage area and low-temperature storage areas for medicines. The inspection team was impressed by the production facilities, confirming that the factory's production levels meet the most stringent international standards and are comparable to North American and European pharmaceutical factories. The company from Sri Lanka was so inspired by the facility that they expressed interest in opening access to Russian medicines to their market, where imports are currently prohibited.""
}"
2025-10-01T05:19:58+00:00,@bezrec,6606,https://t.me/bezrec/6606,"–°–ú–ò —Å–Ω–æ–≤–∞ –∑–∞–≥–æ–≤–æ—Ä–∏–ª–∏ –æ –Ω–∞–º–µ—Ä–µ–Ω–∏–∏ Takeda –∏–∑–±–∞–≤–∏—Ç—å—Å—è –æ—Ç –∑–∞–≤–æ–¥–∞ –≤ –Ø—Ä–æ—Å–ª–∞–≤–ª–µ. –ü–µ—Ä–≤—ã–µ —Ç–∞–∫–∏–µ —Å–ª—É—Ö–∏ –ø–æ–ø–æ–ª–∑–ª–∏ –µ—â—ë –≤–µ—Å–Ω–æ–π 2023 –≥–æ–¥–∞, –Ω–æ –∫–æ–º—É –∏ –Ω–∞ –∫–∞–∫–∏—Ö —É—Å–ª–æ–≤–∏—è—Ö –¥–æ–ª–∂–µ–Ω –±—ã–ª –ø–µ—Ä–µ–π—Ç–∏ –±–∏–∑–Ω–µ—Å, –Ω–µ –æ–≥–æ–≤–∞—Ä–∏–≤–∞–ª–æ—Å—å. –ö —Ç–æ–º—É –∂–µ —Å–∞–º–∏ —è–ø–æ–Ω—Ü—ã —ç—Ç—É –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é –æ–ø—Ä–æ–≤–µ—Ä–≥–ª–∏. –°–µ–π—á–∞—Å –∫–æ–Ω–∫—Ä–µ—Ç–∏–∫–∏ –±–æ–ª—å—à–µ. –ö–∞–∫ –ø–∏—à–µ—Ç ¬´–™¬ª, —Ä–æ—Å—Å–∏–π—Å–∫–∞—è ¬´–¥–æ—á–∫–∞¬ª —è–ø–æ–Ω—Å–∫–æ–π —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –¥–æ–≥–æ–≤–æ—Ä–∏–ª–∞—Å—å –æ –ø–µ—Ä–µ–¥–∞—á–µ –ø—Ä–∞–≤ –Ω–∞ –∑–∞–≤–æ–¥ –ê–û ¬´–ë–∏–Ω–µ—Ä–≥–∏—è¬ª, —è–∫–æ–±—ã —Å–≤—è–∑–∞–Ω–Ω–æ–º—É —Å –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–º ¬´–ß–µ—Ä–Ω–æ–≥–æ–ª–æ–≤–∫–∏¬ª –ê–ª–µ–∫—Å–µ–µ–º –ß–µ—Ç–≤–µ—Ä–≥–æ–≤—ã–º. –ù–∞ —ç—Ç–æ—Ç —Ä–∞–∑ Takeda –æ—Ç–ø–∏—Ä–∞—Ç—å—Å—è –Ω–µ —Å—Ç–∞–ª–∞ –∏ —Å–æ–æ–±—â–∏–ª–∞, —á—Ç–æ –ø–æ–¥–ø–∏—Å–∞–ª–∞ —Å —Ä–æ—Å—Å–∏–π—Å–∫–æ–π —Å—Ç–æ—Ä–æ–Ω–æ–π —Å–æ–≥–ª–∞—à–µ–Ω–∏–µ, ¬´—Å–≤—è–∑–∞–Ω–Ω–æ–µ —Å –ø–µ—Ä–µ–¥–∞—á–µ–π –ø—Ä–∞–≤ –Ω–∞ –∫–æ–º–º–µ—Ä—Ü–∏–∞–ª–∏–∑–∞—Ü–∏—é –æ—Ç–¥–µ–ª—å–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Ä–æ–∑–Ω–∏—á–Ω–æ–≥–æ –ø–æ—Ä—Ç—Ñ–µ–ª—è –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ –ï–≤—Ä–∞–∑–∏–π—Å–∫–æ–≥–æ —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–≥–æ —Å–æ—é–∑–∞, —Ç.–µ. –≤ –†–æ—Å—Å–∏–∏, –ö–∞–∑–∞—Ö—Å—Ç–∞–Ω–µ, –ê—Ä–º–µ–Ω–∏–∏, –ö–∏—Ä–≥–∏–∑–∏–∏ –∏ –ë–µ–ª–æ—Ä—É—Å—Å–∏–∏, –∞ —Ç–∞–∫–∂–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω–æ–π –ø–ª–æ—â–∞–¥–∫–∏ –≤ –Ø—Ä–æ—Å–ª–∞–≤–ª–µ¬ª. –ü–æ —Å–ª–æ–≤–∞–º –≥–ª–∞–≤—ã –û–û–û ¬´–ë–∏–Ω–µ—Ä–≥–∏—è –ú–µ–Ω–µ–¥–∂–º–µ–Ω—Ç¬ª –ú–∞–∫—Å–∏–º–∞ –°—Ç–µ—Ü—é–∫–∞, –ø–æ–∫–∞ —á—Ç–æ –ø–æ–¥–ø–∏—Å–∞–Ω–æ —Ç–æ–ª—å–∫–æ —Å–æ–≥–ª–∞—à–µ–Ω–∏–µ –æ –±—É–¥—É—â–µ–π —Å–¥–µ–ª–∫–µ –≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–∏ —Å –ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω—ã–º —Ä–µ—à–µ–Ω–∏–µ–º –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–µ–Ω–Ω–æ–π –∫–æ–º–∏—Å—Å–∏–∏ –ø–æ –∫–æ–Ω—Ç—Ä–æ–ª—é –∑–∞ –æ—Å—É—â–µ—Å—Ç–≤–ª–µ–Ω–∏–µ–º –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã—Ö –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–π, –∞ –ø—Ä–∞–≤–∞ –Ω–∞ –∞–∫—Ç–∏–≤—ã –µ—â–µ –Ω–µ –ø–µ—Ä–µ–¥–∞–Ω—ã. –ü—Ä–∏ —ç—Ç–æ–º –æ–± —É—Ö–æ–¥–µ Takeda —Å —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —Ä—ã–Ω–∫–∞ —Ä–µ—á–∏ –Ω–µ –∏–¥—ë—Ç. –í –∫–æ–º–ø–∞–Ω–∏–∏ –Ω–∞—Å—Ç–∞–∏–≤–∞—é—Ç, —á—Ç–æ –≤–æ–∑–º–æ–∂–Ω–∞—è —Å–¥–µ–ª–∫–∞ –Ω–µ –ø–æ–≤–ª–∏—è–µ—Ç –Ω–∞ –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç—å –≤ –†–æ—Å—Å–∏–∏ –∏ –æ–Ω–∞ –ø—Ä–æ–¥–æ–ª–∂–∏—Ç –æ–±–µ—Å–ø–µ—á–∏–≤–∞—Ç—å ¬´–Ω–µ–ø—Ä–µ—Ä—ã–≤–Ω–æ—Å—Ç—å —Ä–µ–≥—É–ª—è—Ä–Ω—ã—Ö –ø–æ—Å—Ç–∞–≤–æ–∫ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Ä–æ—Å—Å–∏–π—Å–∫–∏–º –ø–∞—Ü–∏–µ–Ω—Ç–∞–º¬ª. –ü—Ä–∞–≤–∞ –ø–µ—Ä–µ–¥–∞—é—Ç—Å—è –Ω–∞ –∫–æ–º–º–µ—Ä—Ü–∏–∞–ª–∏–∑–∞—Ü–∏—é –Ω–µ–ø—Ä–æ—Ñ–∏–ª—å–Ω—ã—Ö –¥–ª—è –∫–æ–º–ø–∞–Ω–∏–∏ –ê–∫—Ç–æ–≤–µ–≥–∏–Ω–∞ (–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç—Å—è –≤ –Ø—Ä–æ—Å–ª–∞–≤–ª–µ), –∞ —Ç–∞–∫–∂–µ –∏–º–ø–æ—Ä—Ç–∏—Ä—É–µ–º—ã—Ö –≤ –†–§ –î–µ–∫—Å–∏–ª–∞–Ω—Ç–∞, –ö–æ–Ω—Ç—Ä–æ–ª–æ–∫–∞ –∏ –ú–µ–∑–∞–≤–∞–Ω—Ç–∞. –ù–∞ –∑–∞–≤–æ–¥–µ –≤ –Ø—Ä–æ—Å–ª–∞–≤–ª–µ, –æ—Ç–∫—Ä—ã—Ç–æ–º –≤ 2013 –≥–æ–¥—É, –ø–æ–º–∏–º–æ –ø—Ä–æ—á–µ–≥–æ, –ª–æ–∫–∞–ª–∏–∑–æ–≤–∞–Ω–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –ù–∏–Ω–ª–∞—Ä–æ –ø—Ä–æ—Ç–∏–≤ –º–Ω–æ–∂–µ—Å—Ç–≤–µ–Ω–Ω–æ–π –º–∏–µ–ª–æ–º—ã ‚Äî –æ–¥–Ω–æ–≥–æ –∏–∑ —Å–∞–º—ã—Ö –ø—Ä–æ–¥–∞–≤–∞–µ–º—ã—Ö –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ Takeda. –ü–æ –¥–∞–Ω–Ω—ã–º DSM Group, –≤ —è–Ω–≤–∞—Ä–µ‚Äî–∞–≤–≥—É—Å—Ç–µ 2025 –≥–æ–¥–∞ –∞–ø—Ç–µ—á–Ω—ã–µ –ø—Ä–æ–¥–∞–∂–∏ –∏ –≥–æ—Å–∑–∞–∫—É–ø–∫–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ —É–¥–≤–æ–∏–ª–∏—Å—å –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –ø—Ä–æ—à–ª—ã–º –≥–æ–¥–æ–º. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, regulation"",
  ""impact"": ""medium"",
  ""english"": ""Takeda is reportedly negotiating the sale of its factory in Yaroslavl to a Russian company. The deal involves transferring rights for the production of several drugs in Russia, Belarus, Armenia, Kazakhstan, and Kyrgyzstan. Takeda has not commented on the potential closure of its Russian operations but insists it will continue to supply medicines to patients in Russia. The factory produces Nintedanib, an innovative drug used for multiple myeloma.""
}"
2025-09-30T16:30:02+00:00,@bezrec,6605,https://t.me/bezrec/6605,"–ì–æ–Ω–∫–∏ —Å–ø–µ—Ä–º–∞—Ç–æ–∑–æ–∏–¥–æ–≤ –ø–æ–ª—É—á–∏–ª–∏ –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–∏ –≤ $10 –º–ª–Ω ‚ô¶Ô∏è–°—Ç–∞—Ä—Ç–∞–ø 18-–ª–µ—Ç–Ω–µ–≥–æ –≠—Ä–∏–∫–∞ –ß–∂—É Sperm Racing –¥–æ—Å—Ç–∏–≥ –æ—Ü–µ–Ω–∫–∏ –≤ $75 –º–ª–Ω ‚Äî –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–µ –Ω–∞–±–∏—Ä–∞–µ—Ç –ø–æ–ø—É–ª—è—Ä–Ω–æ—Å—Ç—å, –∞ –º–æ–ª–æ–¥—ã–µ –º—É–∂—á–∏–Ω—ã —Å–æ—Ä–µ–≤–Ω—É—é—Ç—Å—è, –æ–ø—Ä–µ–¥–µ–ª—è—è, —É –∫–æ–≥–æ —Å–∞–º–∞—è –±—ã—Å—Ç—Ä–∞—è –∏ –≤—ã–Ω–æ—Å–ª–∏–≤–∞—è —Å–ø–µ—Ä–º–∞. –ì–æ–Ω–∫–∏ —É—Å—Ç—Ä–æ–µ–Ω—ã –ø–æ –æ–±—Ä–∞–∑—Ü—É ¬´–§–æ—Ä–º—É–ª—ã-1¬ª, –∫–æ—Ç–æ—Ä—É—é —Å–æ–ø—Ä–æ–≤–æ–∂–¥–∞—é—Ç –∞–Ω–∏–º–∞—Ü–∏—è –∏ –∫–æ–º–º–µ–Ω—Ç–∞—Ç–æ—Ä—ã. –°–∞–º –ß–∂—É –Ω–∞—Å—Ç–∞–∏–≤–∞–µ—Ç, —á—Ç–æ —É –Ω–µ–≥–æ –µ—Å—Ç—å –±–æ–ª–µ–µ –≥–ª—É–±–æ–∫–∞—è –∏ –ø—Ä–∏–±—ã–ª—å–Ω–∞—è –º–∏—Å—Å–∏—è: ¬´–≥–µ–π–º–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞—Ç—å –∑–¥–æ—Ä–æ–≤—å–µ –∏ –ø–æ—Å—Ç—Ä–æ–∏—Ç—å –∏–º–ø–µ—Ä–∏—é –≤–æ–∫—Ä—É–≥ –º—É–∂—Å–∫–æ–π —Ñ–µ—Ä—Ç–∏–ª—å–Ω–æ—Å—Ç–∏¬ª. –í–∏–¥–∏–º–æ –ë—Ä–∞–π–∞–Ω –î–∂–æ–Ω—Å–æ–Ω –±—ã–ª –¥–∞–ª–µ–∫–æ –Ω–µ —Å–∞–º—ã–º —ç–ø–∞—Ç–∞–∂–Ω—ã–º –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–æ–º, ‚Ñ¢Ô∏è –ú–µ–¥–∫–∞—Ä—Ç–∞","{""skip"": true}"
2025-09-30T13:59:58+00:00,@bezrec,6604,https://t.me/bezrec/6604,"–ì–µ–Ω–ø—Ä–æ–∫—É—Ä–æ—Ä—ã 20 —à—Ç–∞—Ç–æ–≤ –°–®–ê –≤—ã—Å—Ç—É–ø–∏–ª–∏ –≤ –∑–∞—â–∏—Ç—É –º–∏—Ñ–µ–ø—Ä–∏—Å—Ç–æ–Ω–∞. –° —Ç–µ—Ö –ø–æ—Ä, –∫–∞–∫ –¥–æ–ª–∂–Ω–æ—Å—Ç—å –º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –°–®–ê –∑–∞–Ω—è–ª –†–æ–±–µ—Ä—Ç –ö–µ–Ω–Ω–µ–¥–∏-–º–ª–∞–¥—à–∏–π, –Ω–∞–¥ –ø–æ–ø—É–ª—è—Ä–Ω—ã–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–º –¥–ª—è –ø—Ä–µ—Ä—ã–≤–∞–Ω–∏—è –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏ —Å–≥—É—Å—Ç–∏–ª–∏—Å—å —Ç—É—á–∏. –ï—Å–ª–∏ –≤ –ø–æ—Ä—É –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç—Å—Ç–≤–∞ –î–∂–æ –ë–∞–π–¥–µ–Ω–∞ FDA —Ä–∞–∑—Ä–µ—à–∏–ª–æ —Å–µ—Ä—Ç–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω—ã–º –∞–ø—Ç–µ–∫–∞–º –ø—Ä–æ–¥–∞–≤–∞—Ç—å –º–∏—Ñ–µ–ø—Ä–∏—Å—Ç–æ–Ω –±–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞ –≤ —Ä—è–¥–µ —à—Ç–∞—Ç–æ–≤, —Ç–æ —Å–µ–π—á–∞—Å –ª–µ–∫–∞—Ä—Å—Ç–≤—É —É–≥—Ä–æ–∂–∞–µ—Ç –ø–æ–ª–Ω—ã–π –∑–∞–ø—Ä–µ—Ç. –†–∞–Ω–µ–µ –†–æ–±–µ—Ä—Ç –ö–µ–Ω–Ω–µ–¥–∏-–º–ª–∞–¥—à–∏–π –∏ –∫–æ–º–∏—Å—Å–∞—Ä FDA –ú–∞—Ä—Ç–∏ –ú–∞–∫–∞—Ä–∏ —Å–æ–æ–±—â–∏–ª–∏ 22 –≥–µ–Ω–µ—Ä–∞–ª—å–Ω—ã–º –ø—Ä–æ–∫—É—Ä–æ—Ä–∞–º-—Ä–µ—Å–ø—É–±–ª–∏–∫–∞–Ω—Ü–∞–º, —á—Ç–æ –∏–Ω–∏—Ü–∏–∏—Ä–æ–≤–∞–ª–∏ –ø—Ä–æ–≤–µ—Ä–∫—É –ø—Ä–æ—Ç–∏–≤–æ–∑–∞—á–∞—Ç–æ—á–Ω—ã—Ö —Ç–∞–±–ª–µ—Ç–æ–∫. –ü—Ä–æ—Ç–∏–≤ –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏–π –º–∏—Ñ–µ–ø—Ä–∏—Å—Ç–æ–Ω–∞ –≤—ã—Å—Ç—É–ø–∏–ª–∏ –≥–µ–Ω–ø—Ä–æ–∫—É—Ä–æ—Ä –ù—å—é-–ô–æ—Ä–∫–∞ –õ–µ—Ç–∏—Ü–∏—è –î–∂–µ–π–º—Å –∏ –µ—ë –∫–æ–ª–ª–µ–≥–∏ –∏–∑ 19 —à—Ç–∞—Ç–æ–≤: –ë–æ–ª–µ–µ 25 –ª–µ—Ç –º–∏—Ñ–µ–ø—Ä–∏—Å—Ç–æ–Ω –±–µ–∑–æ–ø–∞—Å–Ω–æ –∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ –ø—Ä–∏–º–µ–Ω—è–µ—Ç—Å—è –≤ –°–®–ê –∏ –≤–æ –≤—Å–µ–º –º–∏—Ä–µ. –í –Ω–∞—Å—Ç–æ—è—â–µ–µ –≤—Ä–µ–º—è —ç—Ç–æ –Ω–∞–∏–±–æ–ª–µ–µ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω—ë–Ω–Ω—ã–π –º–µ—Ç–æ–¥ –ø—Ä–µ—Ä—ã–≤–∞–Ω–∏—è –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏ –Ω–∞ —Ä–∞–Ω–Ω–∏—Ö —Å—Ä–æ–∫–∞—Ö –≤ –°–®–ê –∏ —Å—Ç–∞–Ω–¥–∞—Ä—Ç –ª–µ—á–µ–Ω–∏—è –≤—ã–∫–∏–¥—ã—à–µ–π –Ω–∞ —Ä–∞–Ω–Ω–∏—Ö —Å—Ä–æ–∫–∞—Ö. –†–µ—à–µ–Ω–∏–µ –æ –ø–µ—Ä–µ—Å–º–æ—Ç—Ä–µ –¥–æ—Å—Ç—É–ø–∞ –∫ —ç—Ç–æ–º—É –ø—Ä–µ–ø–∞—Ä–∞—Ç—É –±—ã–ª–æ –ø—Ä–∏–Ω—è—Ç–æ –≤ –æ—Ç–≤–µ—Ç –Ω–∞ –Ω–∞—É—á–Ω–æ –Ω–µ–æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω–æ–µ –ø–∏—Å—å–º–æ –∏ –∏–≥–Ω–æ—Ä–∏—Ä—É–µ—Ç –º–Ω–æ–≥–æ–ª–µ—Ç–Ω–∏–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è, –¥–æ–∫–∞–∑—ã–≤–∞—é—â–∏–µ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –º–∏—Ñ–µ–ø—Ä–∏—Å—Ç–æ–Ω–∞. –ú–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ —Ä–µ—à–µ–Ω–∏—è –¥–æ–ª–∂–Ω—ã –ø—Ä–∏–Ω–∏–º–∞—Ç—å—Å—è –ø–∞—Ü–∏–µ–Ω—Ç–∞–º–∏, –∏—Ö —Å–µ–º—å—è–º–∏ –∏ –ª–µ—á–∞—â–∏–º–∏ –≤—Ä–∞—á–∞–º–∏ –Ω–∞ –æ—Å–Ω–æ–≤–µ –Ω–∞—É—á–Ω—ã—Ö –¥–∞–Ω–Ω—ã—Ö, –∞ –Ω–µ –ø–æ–ª–∏—Ç–∏—á–µ—Å–∫–∏—Ö —Å–æ–æ–±—Ä–∞–∂–µ–Ω–∏–π. –î–∂–µ–π–º—Å –∏ –µ—ë –µ–¥–∏–Ω–æ–º—ã—à–ª–µ–Ω–Ω–∏–∫–∏ –ø–æ–æ–±–µ—â–∞–ª–∏ ¬´–ø—Ä–∏–Ω—è—Ç—å –º–µ—Ä—ã –¥–ª—è –∑–∞—â–∏—Ç—ã –º–∏—Ñ–µ–ø—Ä–∏—Å—Ç–æ–Ω–∞, –µ—Å–ª–∏ –¥–æ—Å—Ç—É–ø –∫ –Ω–µ–º—É –±—É–¥–µ—Ç –æ–≥—Ä–∞–Ω–∏—á–µ–Ω¬ª. –í –†–æ—Å—Å–∏–∏ –º–∏—Ñ–µ–ø—Ä–∏—Å—Ç–æ–Ω –Ω–µ –ø—Ä–æ—Å—Ç–æ —Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã–π ‚Äì –æ–Ω –≤—Ö–æ–¥–∏—Ç –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ü–ö–£ –Ω–∞—Ä—è–¥—É —Å –Ω–∞—Ä–∫–æ—Ç–∏—á–µ—Å–∫–∏–º–∏, —è–¥–æ–≤–∏—Ç—ã–º–∏ –∏ —Å–∏–ª—å–Ω–æ–¥–µ–π—Å—Ç–≤—É—é—â–∏–º–∏ –≤–µ—â–µ—Å—Ç–≤–∞–º–∏. –ü–æ—Å–ª–µ —Ç–æ–≥–æ, –∫–∞–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç —É–≥–æ–¥–∏–ª –≤ –ø–µ—Ä–µ—á–µ–Ω—å, –µ–≥–æ –ø—Ä–æ–¥–∞–∂–∏ —É–ø–∞–ª–∏ –∞–∂ –Ω–∞ 99%. –û—Ç —Ä–µ—à–µ–Ω–∏—è —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ø–æ—Å—Ç—Ä–∞–¥–∞–ª–∏ –ñ–µ–Ω–∞–ª–µ –æ—Ç ¬´–ò–∑–≤–∞—Ä–∏–Ω–æ –§–∞—Ä–º–∞¬ª –∏ –í–Ω–µ–ø–ª–∞–Ω–∏—è –æ—Ç ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑–∞¬ª. –ì–∏–Ω–µ–ø—Ä–∏—Å—Ç–æ–Ω –æ—Ç ¬´–ù–∏–∂—Ñ–∞—Ä–º¬ª –±—ã–ª –∏—Å–∫–ª—é—á–µ–Ω –∏–∑ –ì–†–õ–° –≤ –ø—Ä–æ—à–ª–æ–º –≥–æ–¥—É –ø–æ –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-09-30T11:40:09+00:00,@bezrec,6603,https://t.me/bezrec/6603,"–í –ª–∏–¥–µ—Ä–∞—Ö –ø–æ –¥–∏–Ω–∞–º–∏–∫–µ –ø—Ä–æ–¥–∞–∂ ‚Äî –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–µ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥—ã –∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç –æ—Ç –∞–∫–Ω–µ. –í —è–Ω–≤–∞—Ä–µ-–∞–≤–≥—É—Å—Ç–µ 2025 –≥–æ–¥–∞ —Ä–æ—Å—Å–∏—è–Ω–µ –ø–æ—Ç—Ä–∞—Ç–∏–ª–∏ –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –Ω–∞ 15,9% –±–æ–ª—å—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É ‚Äî 1,2 —Ç—Ä–ª–Ω —Ä—É–±–ª–µ–π, –ø–æ–¥—Å—á–∏—Ç–∞–ª–∏ –∞–Ω–∞–ª–∏—Ç–∏–∫–∏ RNC Pharma. –ù–∞—Ç—É—Ä–∞–ª—å–Ω–æ–µ –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–µ —É–≤–µ–ª–∏—á–∏–ª–æ—Å—å –Ω–∞ 1,7%, –¥–æ 3,2 –º–ª—Ä–¥ —É–ø–∞–∫–æ–≤–æ–∫. –ü—Ä–æ–¥–∞–∂–∏ –≤ –¥–µ–Ω—å–≥–∞—Ö —Ä–∞—Å—Ç—É—Ç –∫–∞–∫ –≤ OTC (+11,9%), —Ç–∞–∫ –∏ –≤ Rx-—Å–µ–≥–º–µ–Ω—Ç–µ (+18,7%). –ü—Ä–∏ —ç—Ç–æ–º —Å–ø—Ä–æ—Å –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö —É–≤–µ–ª–∏—á–∏–≤–∞–µ—Ç—Å—è —Ç–æ–ª—å–∫–æ —É —Ä–µ—Ü–µ–ø—Ç—É—Ä–∫–∏ (+4,7%), —Ç–æ–≥–¥–∞ –∫–∞–∫ –ø—Ä–æ–¥–∞–∂–∏ –±–µ–∑—Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∑–∞ –≥–æ–¥ —Å–Ω–∏–∑–∏–ª–∏—Å—å –Ω–∞ 0,7%. –°–∞–º–æ–π –≤—ã—Å–æ–∫–æ–π –¥–∏–Ω–∞–º–∏–∫–æ–π —Å —Ç–æ—á–∫–∏ –∑—Ä–µ–Ω–∏—è –¥–µ–Ω–µ–∂–Ω–æ–≥–æ –æ–±—ä—ë–º–∞ –ø—Ä–æ–¥–∞–∂ –º–æ–∂–µ—Ç –ø–æ—Ö–≤–∞—Å—Ç–∞—Ç—å—Å—è –°–µ–º–∞–≤–∏–∫ –æ—Ç ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º–∞¬ª. –ù–∞ –≤—Ç–æ—Ä–æ–π —Å—Ç—Ä–æ—á–∫–µ ‚Äî –µ–≥–æ –≥–ª–∞–≤–Ω—ã–π –∫–æ–Ω–∫—É—Ä–µ–Ω—Ç ‚Äî –ö–≤–∏–Ω—Å–µ–Ω—Ç–∞ –æ—Ç ¬´–ü—Ä–æ–º–æ–º–µ–¥–∞¬ª. –ó–∞–º—ã–∫–∞–µ—Ç —Ç—Ä–æ–π–∫—É –ª–∏–¥–µ—Ä–æ–≤ –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è –ª–µ—á–µ–Ω–∏—è —É–≥—Ä–µ–≤–æ–π —Å—ã–ø–∏ –ê–∫–Ω–µ–∫—É—Ç–∞–Ω –æ—Ç —Ö–æ—Ä–≤–∞—Ç—Å–∫–æ–π ¬´–Ø–¥—Ä–∞–Ω¬ª. –í–µ—Ä–∞ –≤ –ø—Ä–æ—Ç–∏–≤–æ–≤–∏—Ä—É—Å–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–æ —Å–∏—Ö –ø–æ—Ä —Å–∏–ª—å–Ω–∞. –ï–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–º –±–µ–∑—Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–º –≤ –¥–µ—Å—è—Ç–∫–µ —Å–∞–º—ã—Ö –±—ã—Å—Ç—Ä–æ—Ä–∞—Å—Ç—É—â–∏—Ö –±—Ä–µ–Ω–¥–æ–≤ —Å—Ç–∞–ª –ö–∞–≥–æ—Ü–µ–ª (¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º¬ª). –¢–∞–∫–∂–µ –≤—ã—Å–æ–∫–æ–π –¥–∏–Ω–∞–º–∏–∫–æ–π –æ—Ç–ª–∏—á–∏–ª–∏—Å—å –§–æ—Ä—Å–∏–≥–∞ (¬´–ê—Å—Ç—Ä–∞–∑–µ–Ω–µ–∫–∞¬ª, +57%), –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –≥–∞–±–∞–ø–µ–Ω—Ç–∏–Ω–∞ (+60% –≤ —Ä—É–±.) –∏ –Ω–∞—Ç—Ä–∏—è —Ö–ª–æ—Ä–∏–¥–∞ (+53%). –í –ø–µ—Ä–≤–æ–º —Å–ª—É—á–∞–µ –æ—Å–Ω–æ–≤–Ω–æ–π –æ–±—ä—ë–º –ø—Ä–æ–¥–∞–∂ –æ–±–µ—Å–ø–µ—á–∏–ª–∞ ¬´–ö–∞–Ω–æ–Ω—Ñ–∞—Ä–º–∞¬ª, –≤–æ –≤—Ç–æ—Ä–æ–º ‚Äî ¬´–ì—Ä–æ—Ç–µ–∫—Å¬ª. –¢—Ä–∏ –ø–æ—Å–ª–µ–¥–Ω–∏–µ —Å—Ç—Ä–æ—á–∫–∏ –≤ —Ç–æ–ø-10 –∑–∞–Ω–∏–º–∞—é—Ç –ê–º–æ–∫—Å–∏–∫–ª–∞–≤ (¬´–°–∞–Ω–¥–æ–∑¬ª), –†–æ–∫—Å–µ—Ä–∞ (¬´–ö–†–ö–ê¬ª) –∏ –Æ–ø–µ—Ä–∏–æ (¬´–ù–æ–≤–∞—Ä—Ç–∏—Å). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The demand for domestically produced semaglutides and acne medication is growing. Russia's spending on medicines increased by 15.9% year-over-year to RUB 1,2 trillion in January-August 2025. Sales are growing both for prescription drugs (+18.7%) and over-the-counter drugs (+11.9%). The growth in cash sales is mainly driven by the prescription segment (+4.7%), while over-the-counter drug sales decreased (-0.7%). The most dynamic brand in terms of cash volume is Semavik from 'Gerofarma'. The second place is taken by its main competitor Quinsenta from 'Promomeda'. The third position in the top is taken by AcneCutan from Croatia. Despite this, antiviral drugs are still popular. The most dynamic over-the-counter brand is Kagsel (Binnofarm) with a 57% increase. Gabapentin (+60%) and sodium chloride (+53%) are also among the top performers, with 'Canonfarma' and"
2025-09-30T08:52:44+00:00,@bezrec,6602,https://t.me/bezrec/6602,"–¢–∞–∫–∞—è —Ü–∏—Ñ—Ä–∞ —Ñ–∏–≥—É—Ä–∏—Ä—É–µ—Ç –≤ –ø–æ—è—Å–Ω–∏—Ç–µ–ª—å–Ω–æ–π –∑–∞–ø–∏—Å–∫–µ –∫ –ø—Ä–æ–µ–∫—Ç—É –±—é–¥–∂–µ—Ç–∞ –†–§ –Ω–∞ 2026 –≥–æ–¥ –∏ –ø–ª–∞–Ω–æ–≤—ã–µ 2027-2028 –≥–æ–¥—ã. –°–æ–∑–¥–∞–Ω–∏–µ –ø–ª–∞—Ç—Ñ–æ—Ä–º –¥–ª—è –±—ã—Å—Ç—Ä–æ–π —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –≤–∞–∫—Ü–∏–Ω –≤ 2026 –≥–æ–¥—É - 248,7 –º–ª–Ω —Ä—É–±–ª–µ–π, –≤ 2027 –≥–æ–¥—É - 267,9 –º–ª–Ω —Ä—É–±–ª–µ–π, –≤ 2028 –≥–æ–¥—É - 278,7 –º–ª–Ω —Ä—É–±–ª–µ–π, ‚Äî —É—Ç–æ—á–Ω—è–µ—Ç—Å—è –≤ –¥–æ–∫—É–º–µ–Ω—Ç–µ. üîΩ–¢–∞–∫–∂–µ —Å—Ä–µ–¥—Å—Ç–≤–∞ –≤—ã–¥–µ–ª—è—Ç –Ω–∞ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫—É –∏ –≤–Ω–µ–¥—Ä–µ–Ω–∏–µ –∏–Ω–¥–∏–≤–∏–¥—É–∞–ª—å–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ —Ä–∞–º–∫–∞—Ö —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –ø—Ä–æ–µ–∫—Ç–∞, –≤ —Ç–æ–º —á–∏—Å–ª–µ —Å –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ–º –≥–µ–Ω–µ—Ç–∏—á–µ—Å–∫–∏—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π. –í 2026 –≥–æ–¥—É –Ω–∞ —ç—Ç–∏ —Ü–µ–ª–∏ –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è –ø–æ—Ç—Ä–∞—Ç–∏—Ç—å 138,5 –º–ª–Ω —Ä—É–±–ª–µ–π, –≤ 2027 –≥–æ–¥—É - 138,9 –º–ª–Ω —Ä—É–±–ª–µ–π. üîΩ–ï—â—ë –æ–¥–Ω–∞ —Å—Ç–∞—Ç—å—è —Ä–∞—Å—Ö–æ–¥–æ–≤ ‚Äî —Å–æ–∑–¥–∞–Ω–∏–µ —Å–µ—Ç–∏ —Ü–µ–Ω—Ç—Ä–æ–≤ —Å–µ–∫–≤–µ–Ω–∏—Ä–æ–≤–∞–Ω–∏—è –¥–ª—è –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥–∞ –∏–∑–º–µ–Ω—á–∏–≤–æ—Å—Ç–∏ –≤–æ–∑–±—É–¥–∏—Ç–µ–ª–µ–π –∏–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã—Ö –±–æ–ª–µ–∑–Ω–µ–π (–≤ 2026 –≥–æ–¥—É - 170,1 –º–ª–Ω —Ä—É–±–ª–µ–π, –≤ 2027 - 2028 –≥–æ–¥–∞—Ö - 189,0 –º–ª–Ω —Ä—É–±–ª–µ–π –µ–∂–µ–≥–æ–¥–Ω–æ). üîΩ–ù–∞ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ –æ—Ç–¥–µ–ª—å–Ω—ã—Ö –∫–∞—Ç–µ–≥–æ—Ä–∏–π –≥—Ä–∞–∂–¥–∞–Ω –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–º–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º–∏, –≤–∫–ª—é—á–∞—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –í–ò–ß, –∑–∞–∫—É–ø–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø–æ –ø—Ä–æ–≥—Ä–∞–º–º–µ –í–ó–ù –∏ –≤–∞–∫—Ü–∏–Ω –¥–ª—è –ù–∞—Ü–∫–∞–ª–µ–Ω–¥–∞—Ä—è –ø–æ–π–¥—ë—Ç 241,6 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. üîΩ¬´–ö—Ä—É–≥ –¥–æ–±—Ä–∞¬ª –Ω–∞ –∑–∞–∫—É–ø–∫—É –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –∏ –Ω–µ–∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ø–æ–ª—É—á–∏—Ç 195,9 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. üîΩ–ù–∞ —Ñ–µ–¥–ø—Ä–æ–µ–∫—Ç—ã ¬´–ë–æ—Ä—å–±–∞ —Å –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏¬ª –∏ ¬´–ë–æ—Ä—å–±–∞ —Å —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏¬ª –≤—ã–¥–µ–ª—è—Ç 140 –∏ 11,3 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand, epidemic, vaccine"",
  ""impact"": ""high"",
  ""english"": ""The document outlines budget allocations for the development of vaccines and personalized medicines, as well as measures to monitor infectious disease pathogens. It also includes significant funding for the procurement of registered and unregistered medications, including those for oncological and cardiovascular diseases. The overall impact is high on regulatory affairs and market access.""
}"
2025-09-30T05:30:01+00:00,@bezrec,6601,https://t.me/bezrec/6601,"–í–ò–ß-–ø–∞—Ü–∏–µ–Ω—Ç–∞–º –æ—Ç–∫–∞–∑—ã–≤–∞—é—Ç –≤ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–µ. –ü–æ –¥–∞–Ω–Ω—ã–º ¬´–ü–∞—Ü–∏–µ–Ω—Ç—Å–∫–æ–≥–æ –∫–æ–Ω—Ç—Ä–æ–ª—è¬ª, —Å –Ω–∞—á–∞–ª–∞ –≥–æ–¥–∞ —Å –æ—Ç–∫–∞–∑–∞–º–∏ –≤ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏–∏ —Ç–µ—Å—Ç–æ–≤ –Ω–∞ –≤–∏—Ä—É—Å–Ω—É—é –Ω–∞–≥—Ä—É–∑–∫—É –∏ –∏–º–º—É–Ω–Ω—ã–π —Å—Ç–∞—Ç—É—Å (–ò–°) —Å—Ç–æ–ª–∫–Ω—É–ª–∏—Å—å –í–ò–ß-–ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω—ã–µ —Ä–æ—Å—Å–∏—è–Ω–µ –∫–∞–∫ –º–∏–Ω–∏–º—É–º –∏–∑ 16 —Ä–µ–≥–∏–æ–Ω–æ–≤. –í –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏—è—Ö —É–∫–∞–∑–∞–Ω–æ, —á—Ç–æ —Ç–µ—Å—Ç–∏—Ä–æ–≤–∞–Ω–∏–µ –ø–∞—Ü–∏–µ–Ω—Ç—ã —Å –í–ò–ß –¥–æ–ª–∂–Ω—ã –ø—Ä–æ—Ö–æ–¥–∏—Ç—å —Ä–∞–∑ –≤ –ø–æ–ª–≥–æ–¥–∞, —á—Ç–æ–±—ã –æ—Ç—Å–ª–µ–¥–∏—Ç—å —Ä–∞–∑–≤–∏—Ç–∏–µ –±–æ–ª–µ–∑–Ω–∏ –∏ –æ—Ü–µ–Ω–∏—Ç—å —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –∞–Ω—Ç–∏—Ä–µ—Ç—Ä–æ–≤–∏—Ä—É—Å–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –í –Ω–∞—á–∞–ª–µ –ª–µ—á–µ–Ω–∏—è —Ç–∞–∫–∏–µ –æ–±—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –ø—Ä–æ–≤–æ–¥—è—Ç –∏ —Ç–æ–≥–æ —á–∞—â–µ ‚Äì —á–µ—Ä–µ–∑ –æ–¥–∏–Ω –∏ —Ç—Ä–∏ –º–µ—Å—è—Ü–∞. –í —á–∏—Å–ª–æ ¬´–ø—Ä–æ–±–ª–µ–º–Ω—ã—Ö¬ª —Ä–µ–≥–∏–æ–Ω–æ–≤ –ø–æ–ø–∞–ª–∏ –°–∞–º–∞—Ä—Å–∫–∞—è, –¢—é–º–µ–Ω—Å–∫–∞—è, –ö–∞–ª—É–∂—Å–∫–∞—è, –û—Ä–µ–Ω–±—É—Ä–≥—Å–∫–∞—è, –†–æ—Å—Ç–æ–≤—Å–∫–∞—è, –õ–µ–Ω–∏–Ω–≥—Ä–∞–¥—Å–∫–∞—è, –ê–º—É—Ä—Å–∫–∞—è –æ–±–ª–∞—Å—Ç–∏, –î–∞–≥–µ—Å—Ç–∞–Ω, –£–¥–º—É—Ä—Ç–∏—è, –ë–∞—à–∫–∏—Ä–∏—è –∏ –¥—Ä. –û–¥–Ω–∞–∫–æ –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª–∏ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é –æ –Ω–µ—Ö–≤–∞—Ç–∫–µ —Ç–µ—Å—Ç-—Å–∏—Å—Ç–µ–º –¥–∞–ª–µ–∫–æ –Ω–µ –≤—Å–µ. –° 2022 –≥–æ–¥–∞ —Ä–∞–∑–º–µ—Ä —Å—É–±—Å–∏–¥–∏–∏ –∏–∑ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –±—é–¥–∂–µ—Ç–∞ —Ä–µ–≥–∏–æ–Ω—É –Ω–∞ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫—É —Å–Ω–∏–∑–∏–ª—Å—è –Ω–∞ 35%, –ø—Ä–∏ —ç—Ç–æ–º –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –ª–∏—Ü, —Å–æ—Å—Ç–æ—è—â–∏—Ö –Ω–∞ –¥–∏—Å–ø–∞–Ω—Å–µ—Ä–Ω–æ–º —É—á–µ—Ç–µ, –≤—ã—Ä–æ—Å–ª–æ –Ω–∞ 12,7%. –≠—Ç–æ –ø—Ä–∏–≤–µ–ª–æ –∫ –¥–µ—Ñ–∏—Ü–∏—Ç—É —Ç–µ—Å—Ç-—Å–∏—Å—Ç–µ–º –∏ —Å–æ–∫—Ä–∞—â–µ–Ω–∏—é –∫—Ä–∞—Ç–Ω–æ—Å—Ç–∏ –æ–±—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π. –¢–µ—Å—Ç—ã –Ω–∞ –≤–∏—Ä—É—Å–Ω—É—é –Ω–∞–≥—Ä—É–∑–∫—É –≤ —Ä–µ–≥–∏–æ–Ω–µ –µ—Å—Ç—å, –Ω–æ –≤ –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–Ω–æ–º –∫–æ–ª–∏—á–µ—Å—Ç–≤–µ, ‚Äî –ø–æ–¥–µ–ª–∏–ª—Å—è –≥–ª–∞–≤–≤—Ä–∞—á –¶–µ–Ω—Ç—Ä–∞ –ø–æ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–µ –∏ –±–æ—Ä—å–±–µ —Å–æ –°–ü–ò–î –∏ –∏–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏ –õ–µ–Ω–æ–±–ª–∞—Å—Ç–∏ –ê–ª–µ–∫—Å–µ–π –ö–æ–≤–µ–ª–µ–Ω–æ–≤. –ü–æ —Å–ª–æ–≤–∞–º –∏. –æ. –≥–ª–∞–≤–≤—Ä–∞—á–∞ —Ä–µ—Å–ø—É–±–ª–∏–∫–∞–Ω—Å–∫–æ–≥–æ –¶–µ–Ω—Ç—Ä–∞ –ø–æ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–µ –°–ü–ò–î–∞ –ê–π–≥—É–ª—å –ì–∞–ª–∏–µ–≤–æ–π, –≤ 2025 –≥–æ–¥—É –≤ –ë–∞—à–∫–∏—Ä–∏–∏ –∏–∑-–∑–∞ —Å–Ω–∏–∂–µ–Ω–∏—è —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è –¥–∏–∞–≥–Ω–æ—Å—Ç–∏—á–µ—Å–∫–∏—Ö –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–π –≤ –°–ü–ò–î-—Ü–µ–Ω—Ç—Ä –ø–æ—Å—Ç—É–ø–∏–ª–∏ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏—á–µ—Å–∫–∏–µ —Å–∏—Å—Ç–µ–º—ã –Ω–∞ –≤–∏—Ä—É—Å–Ω—É—é –Ω–∞–≥—Ä—É–∑–∫—É –∏ –ò–° –≤ –æ–±—ä–µ–º–µ 23% –æ—Ç –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç–∏. –≠—Ç–∏ –æ–±—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –≤ —Ä–µ–≥–∏–æ–Ω–µ –±—É–¥—É—Ç –ø—Ä–æ–≤–æ–¥–∏—Ç—å—Å—è —Ç–æ–ª—å–∫–æ –æ–¥–∏–Ω —Ä–∞–∑ –≤ –≥–æ–¥. –í —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã—Ö –º–∏–Ω–∑–¥—Ä–∞–≤–∞—Ö –ü–µ—Ä–º—Å–∫–æ–≥–æ –∫—Ä–∞—è, –°–∞–º–∞—Ä—Å–∫–æ–π, –¢—é–º–µ–Ω—Å–∫–æ–π, –ö–∞–ª—É–∂—Å–∫–æ–π, –û—Ä–µ–Ω–±—É—Ä–≥—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–µ–π –∏ –£–¥–º—É—Ä—Ç–∏–∏ —Å–æ–æ–±—â–∏–ª–∏, —á—Ç–æ ¬´–ø—Ä–æ–±–ª–µ–º —Å —Ç–µ—Å—Ç–∏—Ä–æ–≤–∞–Ω–∏–µ–º –Ω–µ –±—ã–ª–æ –∏ –Ω–µ—Ç¬ª, —Ö–æ—Ç—è –∂–∞–ª–æ–±—ã –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –≥–æ–≤–æ—Ä—è—Ç –æ–± –æ–±—Ä–∞—Ç–Ω–æ–º. –ß–µ–º –≤–∞–∂–Ω–∞ —Ä–µ–≥—É–ª—è—Ä–Ω–∞—è –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞? –ï—Å–ª–∏ –≤–∏—Ä—É—Å –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ –ø–æ–¥–∞–≤–ª–µ–Ω, –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ –º–µ–Ω—è—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç, —Ç–∞–∫–∂–µ –µ—Å—Ç—å —Ä–∏—Å–∫–∏ —Ä–∞–∑–≤–∏—Ç–∏—è —É—Å—Ç–æ–π—á–∏–≤–æ—Å—Ç–∏ –í–ò–ß –∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º. –≠—Ç–æ —Å–Ω–∏–∂–∞–µ—Ç —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –ª–µ—á–µ–Ω–∏—è –Ω–µ —Ç–æ–ª—å–∫–æ –æ—Ç–¥–µ–ª—å–Ω—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –Ω–æ –∏ –≤—Å–µ—Ö –∏–Ω—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö, ‚Äî –æ–±—ä—è—Å–Ω–∏–ª –∑–∞–≤–µ–¥—É—é—â–∏–π —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω–æ–≥–æ –Ω–∞—É—á–Ω–æ-–∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–æ–≥–æ –æ—Ç–¥–µ–ª–∞ –ø–æ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–µ –∏ –±–æ—Ä—å–±–µ —Å–æ –°–ü–ò–î–æ–º –§–ë–£–ù –¶–ù–ò–ò —ç–ø–∏–¥–µ–º–∏–æ–ª–æ–≥–∏–∏ –†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä–∞ –í–∞–¥–∏–º –ü–æ–∫—Ä–æ–≤—Å–∫–∏–π. –≠–∫—Å–ø–µ—Ä—Ç —Å–≤—è–∑—ã–≤–∞–µ—Ç –æ—Ç–∫–∞–∑—ã –≤ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–µ —Å –Ω–µ—Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏–µ–º –∏ –æ—Ç–º–µ—á–∞–µ—Ç, —á—Ç–æ —Ç–µ—Å—Ç—ã –Ω–∞ –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–∏–µ —Ä–µ–∑–∏—Å—Ç–µ–Ω—Ç–Ω–æ—Å—Ç–∏ –≤–∏—Ä—É—Å–∞ –∫ —Ç–µ—Ä–∞–ø–∏–∏ —Ä–µ–≥–∏–æ–Ω—ã –∑–∞–∫—É–ø–∞—é—Ç —Ä–µ–¥–∫–æ. –ü–æ –¥–∞–Ω–Ω—ã–º —ç–∫—Å–ø–µ—Ä—Ç–Ω–æ–π –≥—Ä—É–ø–ø—ã ¬´–ó–¥—Ä–∞–≤—Ä–µ—Å—É—Ä—Å¬ª, –≤ 2023 –≥–æ–¥—É –Ω–∞ –∑–∞–∫—É–ø–∫—É —Ç–µ—Å—Ç—Å–∏—Å—Ç–µ–º –Ω–∞ –≤–∏—Ä—É—Å–Ω—É—é –Ω–∞–≥—Ä—É–∑–∫—É –∏ –ò–° –¥–ª—è –≤—Å–µ—Ö –Ω—É–∂–¥–∞—é—â–∏—Ö—Å—è –∏–∑ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ —Ä–µ–≥–∏—Å—Ç—Ä–∞ –±—ã–ª–æ –ø–æ—Ç—Ä–∞—á–µ–Ω–æ 2,88 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –≤–º–µ—Å—Ç–æ 4,07 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —Ç.–µ. 70,8% –æ—Ç –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ–π —Å—É–º–º—ã. –†–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã–µ –º–∏–Ω–∑–¥—Ä–∞–≤—ã, –≤—Å—ë –∂–µ –ø—Ä–∏–∑–Ω–∞–≤—à–∏–µ –ø–µ—Ä–µ–±–æ–∏ –≤ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏–∏ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∏, –≤ –∫–∞—á–µ—Å—Ç–≤–µ –ø—Ä–∏—á–∏–Ω—ã –≤–æ–∑–Ω–∏–∫–Ω–æ–≤–µ–Ω–∏—è –¥–µ—Ñ–∏—Ü–∏—Ç–∞ —Ç–∞–∫–∂–µ –Ω–∞–∑—ã–≤–∞—é—Ç –ø—Ä–æ–±–ª–µ–º—ã —Å –ø–æ—Å—Ç–∞–≤–∫–∞–º–∏ —Ä–µ–∞–≥–µ–Ω—Ç–æ–≤. –ü—Ä–∞–≤–¥–∞, –†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä —ç—Ç–æ –æ—Ç—Ä–∏—Ü–∞–µ—Ç. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, shortage, shortage, shortage"",
  ""impact"": ""high"",
  ""english"": ""There are shortages of diagnostic tests for patients with HIV in several regions, including Samara, Tyumen, Kaluzhskaya Oblast, Orenburgskaya Oblast, Rostovskaya Oblast, Leningradskaya Oblast, and others. The shortage is affecting patients in 16 regions of Russia. Some regional health authorities deny the problem, but patient complaints indicate otherwise. The shortage is attributed to low funding and supply issues.""
}"
2025-09-29T15:29:58+00:00,@bezrec,6600,https://t.me/bezrec/6600,"–ö–∞–∫ –∫–æ–Ω—Ç—Ä–∞—Ü–µ–ø—Ç–∏–≤—ã Pfizer –¥–æ —Å—É–¥–∞ –¥–æ–≤–µ–ª–∏. –í –∫–æ–ª–ª–µ–∫—Ç–∏–≤–Ω–æ–º –∏—Å–∫–µ –ø—Ä–æ—Ç–∏–≤ —Ñ–∞—Ä–º–≥–∏–≥–∞–Ω—Ç–∞ —É—Ç–≤–µ—Ä–∂–¥–∞–µ—Ç—Å—è, —á—Ç–æ –ø—Ä–æ—Ç–∏–≤–æ–∑–∞—á–∞—Ç–æ—á–Ω—ã–µ –∏–Ω—ä–µ–∫—Ü–∏–∏ –î–µ–ø–æ-–ü—Ä–æ–≤–µ—Ä–∞ —Å–ø—Ä–æ–≤–æ—Ü–∏—Ä–æ–≤–∞–ª–∏ —É –¥–µ–ª–∞–≤—à–∏—Ö –∏—Ö –∂–µ–Ω—â–∏–Ω —Ä–∞–∑–≤–∏—Ç–∏–µ –æ–ø—É—Ö–æ–ª–µ–π –º–æ–∑–≥–∞. –ò—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ, –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω–Ω–æ–µ –≤ British Medical Journal –≤ –º–∞—Ä—Ç–µ 2024 –≥–æ–¥–∞, –ø–æ–∫–∞–∑–∞–ª–æ, —á—Ç–æ –º–µ–¥—Ä–æ–∫—Å–∏–ø—Ä–æ–≥–µ—Å—Ç–µ—Ä–æ–Ω–∞ –∞—Ü–µ—Ç–∞—Ç –ø—Ä–∏ –¥–ª–∏—Ç–µ–ª—å–Ω–æ–º –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–∏ (–±–æ–ª–µ–µ –≥–æ–¥–∞) –≤ 5,6 —Ä–∞–∑–∞ –ø–æ–≤—ã—à–∞–µ—Ç —Ä–∏—Å–∫ —Ä–∞–∑–≤–∏—Ç–∏—è –≤–Ω—É—Ç—Ä–∏—á–µ—Ä–µ–ø–Ω–æ–π –º–µ–Ω–∏–Ω–≥–∏–æ–º—ã. –°–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–µ–≥–æ –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏—è –≤ –∏–Ω—Å—Ç—Ä—É–∫—Ü–∏–∏ –∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç—É –Ω–µ—Ç. –ú–µ–Ω–∏–Ω–≥–∏–æ–º—ã —Ä–∞—Å—Ç—É—Ç –º–µ–¥–ª–µ–Ω–Ω–æ –∏ –æ–±—ã—á–Ω–æ –Ω–µ —è–≤–ª—è—é—Ç—Å—è –∑–ª–æ–∫–∞—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–º–∏, –Ω–æ –º–æ–≥—É—Ç –≤—ã–∑—ã–≤–∞—Ç—å –ø–æ—Ç–µ—Ä—é –∑—Ä–µ–Ω–∏—è –∏–ª–∏ —Å–ª—É—Ö–∞, –≥–æ–ª–æ–≤–Ω—ã–µ –±–æ–ª–∏ –∏ —Å—É–¥–æ—Ä–æ–≥–∏, –∏–∑-–∑–∞ —á–µ–≥–æ —á–∞—Å—Ç–æ —Ç—Ä–µ–±—É—é—Ç —Ö–∏—Ä—É—Ä–≥–∏—á–µ—Å–∫–æ–≥–æ —É–¥–∞–ª–µ–Ω–∏—è. –í —Å–≤–æ—é –æ—á–µ—Ä–µ–¥—å, —Ç–∞–∫–∏–µ –æ–ø–µ—Ä–∞—Ü–∏–∏ —Å–æ–ø—Ä—è–∂–µ–Ω—ã —Å —Ä–∏—Å–∫–∞–º–∏ –ø–æ–≤—Ä–µ–∂–¥–µ–Ω–∏—è —Å—Ç—Ä—É–∫—Ç—É—Ä –º–æ–∑–≥–∞ –≤–±–ª–∏–∑–∏ –æ–ø—É—Ö–æ–ª–∏. Pfizer –æ –ø–æ–±–æ—á–∫–µ —Å–≤–æ–µ–≥–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∑–Ω–∞–µ—Ç –∏ —è–∫–æ–±—ã –¥–∞–∂–µ –ø—ã—Ç–∞–ª—Å—è —Ä–∞–∑–º–µ—Å—Ç–∏—Ç—å –Ω–∞ —ç—Ç–∏–∫–µ—Ç–∫–µ –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏–µ –æ —Ä–∏—Å–∫–µ —Ä–∞–∑–≤–∏—Ç–∏—è –æ–ø—É—Ö–æ–ª–µ–π, –æ–¥–Ω–∞–∫–æ —ç—Ç–∞ –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–∞ –±—ã–ª–∞ –æ—Ç–∫–ª–æ–Ω–µ–Ω–∞ —Ä–µ–≥—É–ª–∏—Ä—É—é—â–∏–º –æ—Ä–≥–∞–Ω–æ–º FDA. –°—Ç–æ—Ä–æ–Ω–∞ –æ–±–≤–∏–Ω–µ–Ω–∏—è –Ω–∞—Å—Ç–∞–∏–≤–∞–µ—Ç, —á—Ç–æ —Ä–µ–≥—É–ª—è—Ç–æ—Ä –ø–æ–ª—É—á–∏–ª –Ω–µ–ø–æ–ª–Ω—É—é –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é –∏ –ø–æ—ç—Ç–æ–º—É –∑–∞–ø—Ä–µ—Ç–∏–ª —Ä–∞–∑–º–µ—â–∞—Ç—å –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏–µ –Ω–∞ —É–ø–∞–∫–æ–≤–∫–µ. –ü–æ –¥–∞–Ω–Ω—ã–º —é—Ä–∏–¥–∏—á–µ—Å–∫–æ–π —Ñ–∏—Ä–º—ã Levin Papantonio, —Å –º–∞—è –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –∏—Å–∫–æ–≤, –ø–æ–¥–∞–Ω–Ω—ã—Ö –∂–µ–Ω—â–∏–Ω–∞–º–∏ –≤ –°–®–ê –ø—Ä–æ—Ç–∏–≤ Pfizer, —É—Ç—Ä–æ–∏–ª–æ—Å—å –∏ –ø—Ä–µ–≤—ã—Å–∏–ª–æ 1,3 —Ç—ã—Å. –ò —ç—Ç–æ –Ω–µ –ø—Ä–µ–¥–µ–ª. –≠–∫—Å–ø–µ—Ä—Ç—ã –ø—Ä–æ–≥–Ω–æ–∑–∏—Ä—É—é—Ç, —á—Ç–æ –∏—Ö –±—É–¥–µ—Ç –æ—Ç 5 —Ç—ã—Å. –¥–æ 10 —Ç—ã—Å., –∞ –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω–∞—è —Å—É–º–º–∞ –∏—Å–∫–∞ –º–æ–∂–µ—Ç —Å–æ—Å—Ç–∞–≤–∏—Ç—å –Ω–µ—Å–∫–æ–ª—å–∫–æ –º–∏–ª–ª–∏–∞—Ä–¥–æ–≤ –¥–æ–ª–ª–∞—Ä–æ–≤. –í –°–®–ê –ø–æ—á—Ç–∏ —á–µ—Ç–≤–µ—Ä—Ç—å —Å–µ–∫—Å—É–∞–ª—å–Ω–æ –∞–∫—Ç–∏–≤–Ω—ã—Ö –∂–µ–Ω—â–∏–Ω —Ö–æ—Ç—è –±—ã —Ä–∞–∑ –≤ –∂–∏–∑–Ω–∏ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–ª–∏ –î–µ–ø–æ-–ü—Ä–æ–≤–µ—Ä—É. –í –†–æ—Å—Å–∏–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç —Ç–∞–∫–∂–µ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""A class action lawsuit against pharmaceutical giant Pfizer claims that Depo-Inject injections of Medroxyprogesterone acetate have triggered the development of brain tumors in women who used them. A March 2024 study published in the British Medical Journal found that prolonged use (over a year) of this hormone increases the risk of intracranial meningioma five and six times. Pfizer is aware of this side effect, but the warning was rejected by FDA regulators.""
}"
2025-09-29T13:09:58+00:00,@bezrec,6599,https://t.me/bezrec/6599,"–¢–∞–∫–æ–≤ –ø—Ä–æ–≥–Ω–æ–∑ –ú–∏–Ω—ç–∫–æ–Ω–æ–º—Ä–∞–∑–≤–∏—Ç–∏—è. –í 2026-2028 –≥–æ–¥–∞—Ö —Ä–æ—Å—Ç —Å–æ—Å—Ç–∞–≤–∏—Ç 4,8-5%. –í –≤–µ–¥–æ–º—Å—Ç–≤–µ —É—Ç–æ—á–Ω–∏–ª–∏, —á—Ç–æ –æ—Ç—Ä–∞—Å–ª—å –±—É–¥–µ—Ç –æ—Ä–∏–µ–Ω—Ç–∏—Ä–æ–≤–∞–Ω–∞ –Ω–∞ —Ä–∞–∑–≤–∏—Ç–∏–µ –≤–Ω—É—Ç—Ä–µ–Ω–Ω–µ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –∏ —Å–Ω–∏–∂–µ–Ω–∏–µ –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏ –æ—Ç –∏–º–ø–æ—Ä—Ç–∏—Ä—É–µ–º–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏. –¢–∞–∫–∂–µ –≤ –ø–ª–∞–Ω–∞—Ö ‚Äî —É–≤–µ–ª–∏—á–µ–Ω–∏–µ –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç–∞ –ø—Ä–æ–∏–∑–≤–æ–¥–∏–º—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤. –°–Ω–∏–∂–µ–Ω–∏–µ —Ç–µ–º–ø–æ–≤ —Ä–æ—Å—Ç–∞ –≤ –ø—Ä–µ–¥—Å—Ç–æ—è—â–∏–µ —Ç—Ä–∏ –≥–æ–¥–∞ —Å–≤—è–∑–∞–Ω–æ —Å –æ—á–µ–Ω—å –≤—ã—Å–æ–∫–æ–π –Ω–∞–∫–æ–ø–ª–µ–Ω–Ω–æ–π –±–∞–∑–æ–π –ø—Ä–æ—à–ª—ã—Ö –ª–µ—Ç –ø–æ—Å–ª–µ –ø–∞–Ω–¥–µ–º–∏–∏. –ï—Å–ª–∏ —Å—Ä–∞–≤–Ω–∏–≤–∞—Ç—å –æ–±—ä—ë–º –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤, –∫–æ—Ç–æ—Ä—ã–π –æ–∂–∏–¥–∞–µ—Ç—Å—è –≤ 2028 –≥–æ–¥—É, —Å 2024 –≥–æ–¥–æ–º - –æ–Ω —É–≤–µ–ª–∏—á–∏—Ç—Å—è –Ω–∞ 30,3%, ‚Äî –æ–±—ä—è—Å–Ω–∏–ª–∏ –≤ –ú–≠–†. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Economic Development forecasts a growth rate of 4.8-5% for the pharmaceutical industry in Russia from 2026 to 2028. The focus will be on increasing domestic production and reducing reliance on imported products. Additionally, plans include expanding the range of produced medications. The slower growth in the next three years is attributed to a high base from previous years following the pandemic. The production of medicines is expected to increase by 30.3% from 2024 levels in 2028.""
}"
2025-09-29T11:00:02+00:00,@bezrec,6598,https://t.me/bezrec/6598,"–ö–∞–∂–¥—ã–π —Ç—Ä–µ—Ç–∏–π —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç –≤ —Ñ–∞—Ä–º–µ —É—Ö–æ–¥–∏—Ç –Ω–∞ –ø–µ–Ω—Å–∏—é –°–µ–≥–æ–¥–Ω—è —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–π —Ä—ã–Ω–æ–∫ —Ç—Ä—É–¥–∞ —Å—Ç–∞–ª–∫–∏–≤–∞–µ—Ç—Å—è —Å—Ä–∞–∑—É —Å —Ç—Ä–µ–º—è –∫–ª—é—á–µ–≤—ã–º–∏ –≤—ã–∑–æ–≤–∞–º–∏: ‚ñ∂Ô∏è–î–µ—Ñ–∏—Ü–∏—Ç —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ ‚Äì –¥–æ 30% –≤–∞–∫–∞–Ω—Å–∏–π –∑–∞–∫—Ä—ã–≤–∞—é—Ç—Å—è —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–∞–º–∏ —Å –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω—ã–º–∏ –∫–æ–º–ø–µ—Ç–µ–Ω—Ü–∏—è–º–∏. ‚ñ∂Ô∏è–†–∞–∑—Ä—ã–≤ –≤ –∫–æ–º–ø–µ—Ç–µ–Ω—Ü–∏—è—Ö ‚Äì —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ –º–µ–Ω—è—é—Ç—Å—è –±—ã—Å—Ç—Ä–µ–µ, —á–µ–º —É—Å–ø–µ–≤–∞—é—Ç –∞–¥–∞–ø—Ç–∏—Ä–æ–≤–∞—Ç—å—Å—è —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã. ‚ñ∂Ô∏è–°—Ç–∞—Ä–µ–Ω–∏–µ –∫–∞–¥—Ä–æ–≤ ‚Äì –±–æ–ª–µ–µ 30% –∫–ª—é—á–µ–≤—ã—Ö —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤ –Ω–∞—Ö–æ–¥—è—Ç—Å—è –≤ –ø—Ä–µ–¥–ø–µ–Ω—Å–∏–æ–Ω–Ω–æ–º –≤–æ–∑—Ä–∞—Å—Ç–µ. –≠—Ç–∏ —Ç–µ–Ω–¥–µ–Ω—Ü–∏–∏ —Ñ–æ—Ä–º–∏—Ä—É—é—Ç –¥–æ–ª–≥–æ—Å—Ä–æ—á–Ω—ã–π —Ä–∏—Å–∫. –ß–µ—Ä–µ–∑ 10-15 –ª–µ—Ç –¥–µ—Ñ–∏—Ü–∏—Ç –∫–∞–¥—Ä–æ–≤ –≤ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã—Ö —Å–µ–≥–º–µ–Ω—Ç–∞—Ö –º–æ–∂–µ—Ç —Å—Ç–∞—Ç—å –∫—Ä–∏—Ç–∏—á–µ—Å–∫–∏–º. –£–∂–µ —Å–µ–π—á–∞—Å –æ–ø—Ä–æ—Å –æ—Ç—Ä–∞—Å–ª–µ–≤—ã—Ö —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –ø–æ–∫–∞–∑–∞–ª, —á—Ç–æ 90% –∫–æ–º–ø–∞–Ω–∏–π —Å—Ç–∞–ª–∫–∏–≤–∞—é—Ç—Å—è —Å –¥–µ—Ñ–∏—Ü–∏—Ç–æ–º –∫–∞–¥—Ä–æ–≤, –≤ 61% —Å–ª—É—á–∞–µ–≤ ‚Äì –Ω–∞ —É—Ä–æ–≤–Ω–µ —Å–≤—ã—à–µ 20%. –ù–∞–∏–±–æ–ª–µ–µ –æ—Å—Ç—Ä–æ –Ω–µ —Ö–≤–∞—Ç–∞–µ—Ç —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –≤ —Å—Ñ–µ—Ä–µ –∫–∞—á–µ—Å—Ç–≤–∞ (62,1%), –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ (58,6%) –∏ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π (51,7%). –í –±—É–¥—É—â–µ–º –±—É–¥–µ—Ç –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç—å –≤ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞—Ö –Ω–æ–≤–æ–≥–æ —Ç–∏–ø–∞: –±–∏–æ–∏–Ω–∂–µ–Ω–µ—Ä–∞—Ö, —Ñ–∞—Ä–º-IT, –∞–Ω–∞–ª–∏—Ç–∏–∫–∞—Ö –±–æ–ª—å—à–∏—Ö –¥–∞–Ω–Ω—ã—Ö, —ç–∫—Å–ø–µ—Ä—Ç–∞—Ö –ø–æ —Ü–∏—Ñ—Ä–æ–≤–∏–∑–∞—Ü–∏–∏ –∏ –∞–≤—Ç–æ–º–∞—Ç–∏–∑–∞—Ü–∏–∏. –ü—Ä–æ–≥–Ω–æ–∑ –∫–∞–¥—Ä–æ–≤—ã—Ö –∫–æ–º–ø–µ—Ç–µ–Ω—Ü–∏–π –±—É–¥—É—â–µ–≥–æ: üü¢—É—Å–∏–ª–µ–Ω–∏–µ —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–∏—Ö –∏ –∏–Ω–∂–µ–Ω–µ—Ä–Ω—ã—Ö –Ω–∞–≤—ã–∫–æ–≤; üü¢—É–ø—Ä–∞–≤–ª–µ–Ω–∏–µ –±–æ–ª—å—à–∏–º–∏ –¥–∞–Ω–Ω—ã–º–∏ –∏ –ò–ò; üü¢—Ü–∏—Ñ—Ä–æ–≤–∞—è –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—è –∏ —Ñ–∞—Ä–º–∏–Ω–∂–∏–Ω–∏—Ä–∏–Ω–≥; üü¢–ª–∏–¥–µ—Ä—Å—Ç–≤–æ –∏ –∞–¥–∞–ø—Ç–∏–≤–Ω–æ—Å—Ç—å –∫ —Ü–∏—Ñ—Ä–æ–≤–æ–π —Å—Ä–µ–¥–µ. –î–ª—è –ø–æ–¥–≥–æ—Ç–æ–≤–∫–∏ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –∑–∞–≤—Ç—Ä–∞—à–Ω–µ–≥–æ –¥–Ω—è –Ω—É–∂–Ω–æ –∑–∞—Ä–∞–Ω–µ–µ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞—Ç—å –∫–æ–º–ø–µ—Ç–µ–Ω—Ç–Ω–æ—Å—Ç–Ω—ã–µ –º–∞—Ç—Ä–∏—Ü—ã –∏ –æ–±—Ä–∞–∑–æ–≤–∞—Ç–µ–ª—å–Ω—ã–µ —Ç—Ä–∞–µ–∫—Ç–æ—Ä–∏–∏ –Ω–∞ 5-10 –ª–µ—Ç, —Ä–∞–∑–≤–∏–≤–∞—Ç—å –Ω–µ–ø—Ä–µ—Ä—ã–≤–Ω–æ–µ –ø—Ä–∞–∫—Ç–∏–∫–æ-–æ—Ä–∏–µ–Ω—Ç–∏—Ä–æ–≤–∞–Ω–Ω–æ–µ –æ–±—É—á–µ–Ω–∏–µ –∏ –≤–∫–ª—é—á–∞—Ç—å –≤ HR-—Å—Ç—Ä–∞—Ç–µ–≥–∏—é –≥–∏–±—Ä–∏–¥–Ω—ã–µ —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–∏, –æ–±—ä–µ–¥–∏–Ω—è—é—â–∏–µ —Ñ–∞—Ä–º—É –∏ —Ü–∏—Ñ—Ä–æ–≤—ã–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏. üîç –ö–∞–¥—Ä—ã #–≤–Ω—É—Ç—Ä–∏_–æ—Ç—Ä–∞—Å–ª–∏","{""skip"": true}"
2025-09-29T08:49:08+00:00,@bezrec,6597,https://t.me/bezrec/6597,–§–ê–° —Å–Ω–∏–∑–∏–ª–∞ —Ü–µ–Ω—É –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç –æ—Ç –¥–∏–∞–±–µ—Ç–∞. –î–∏–∫—Å–∞–ø—Ç–∏–Ω –æ—Ç ¬´–†-–§–∞—Ä–º¬ª ‚Äî –≤—Ç–æ—Ä–æ–π –¥–∂–µ–Ω–µ—Ä–∏–∫ –Ω–∞ –æ—Å–Ω–æ–≤–µ —Å–∞–∫—Å–∞–≥–ª–∏–ø—Ç–∏–Ω–∞ —Å—Ç–∞–ª –Ω–∞ 19% –¥–µ—à–µ–≤–ª–µ —Ä–µ—Ñ–µ—Ä–µ–Ω—Ç–Ω–æ–≥–æ –û–Ω–≥–ª–∏–∑–∞ –æ—Ç ¬´–ê—Å—Ç—Ä–∞–ó–µ–Ω–µ–∫–∞¬ª. –ü—Ä–µ–ø–∞—Ä–∞—Ç –ø—Ä–∏–º–µ–Ω—è–µ—Ç—Å—è –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Å–∞—Ö–∞—Ä–Ω–æ–≥–æ –¥–∏–∞–±–µ—Ç–∞ 2 —Ç–∏–ø–∞ –∏ –≤—Ö–æ–¥–∏—Ç –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü. –£–ø–∞–∫–æ–≤–∫–∞ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –¥–∂–µ–Ω–µ—Ä–∏–∫–∞ –∏–∑ 30 —Ç–∞–±–ª–µ—Ç–æ–∫ –≤ –¥–æ–∑–∏—Ä–æ–≤–∫–µ 5 –º–≥ –æ–±–æ–π–¥—ë—Ç—Å—è –≤ 1 277 —Ä—É–±–ª–µ–π –ø—Ä–æ—Ç–∏–≤ 1 589 —Ä—É–±–ª–µ–π –∑–∞ –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç. –ü—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—é –ø–µ—Ä–≤–æ–≥–æ –¥–∂–µ–Ω–µ—Ä–∏–∫–∞ ‚Äî ¬´–í–µ–ª—Ñ–∞—Ä–º-–ú¬ª ‚Äî —Ç–µ–ø–µ—Ä—å —Ç–∞–∫–∂–µ –ø—Ä–∏–¥—ë—Ç—Å—è —Å–Ω–∏–∑–∏—Ç—å —Ü–µ–Ω—É –Ω–∞ —Å–≤–æ–π –°–∞–≥–ª–∏–≤–µ–ª. –†–µ–≥—É–ª—è—Ç–æ—Ä –Ω–∞–ø—Ä–∞–≤–∏—Ç –∫–æ–º–ø–∞–Ω–∏–∏ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–µ–µ —É–≤–µ–¥–æ–º–ª–µ–Ω–∏–µ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞,"{
  ""skip"": false,
  ""country"": ""Ukraine"",
  ""topic"": ""pricing"",
  ""impact"": ""medium"",
  ""english"": ""The FAS (Federal Agency for State Registration of Medicines) has lowered the price of a diabetes drug, Dikaptin from 'R-Farma', which is second generic based on saxaglipatin, 19% cheaper than the reference drug Onglyza from 'AstraZeneca'. The price for a 30 tablet pack of the domestic generic at 5 mg is now 1,277 rubles compared to 1,589 rubles for the foreign drug. The manufacturer of the first generic 'Velfarm-M' will also have to lower its price on its Sagivel. The regulator has issued a notification to the companies.""
}"
2025-09-29T06:28:13+00:00,@bezrec,6595,https://t.me/bezrec/6595,"–ü–æ—Å–º–æ—Ç—Ä–µ–ª–∏ —Å–≤–µ–∂–∏–π –æ—Ç—á—ë—Ç RNC Pharma –æ–± –æ—Å–Ω–æ–≤–Ω—ã—Ö –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è—Ö –∏ —Ç–µ–Ω–¥–µ–Ω—Ü–∏—è—Ö —Ä–∞–∑–≤–∏—Ç–∏—è —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —Ñ–∞—Ä–º—Ä—ã–Ω–∫–∞ –∑–∞ —è–Ω–≤–∞—Ä—å-–∞–≤–≥—É—Å—Ç 2025 –≥–æ–¥–∞. –î–µ–ª–∏–º—Å—è –≥–ª–∞–≤–Ω—ã–º: üü© –≤ –∞–≤–≥—É—Å—Ç–µ 2025 –≥–æ–¥–∞ —Ä–æ–∑–Ω–∏—á–Ω—ã–π —Å–µ–≥–º–µ–Ω—Ç —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —Ñ–∞—Ä–º—Ä—ã–Ω–∫–∞ —Å–æ—Å—Ç–∞–≤–∏–ª 147,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π (+12,7% –≥–æ–¥ –∫ –≥–æ–¥—É); üü© –ø—Ä–æ–¥–∞–∂–∏ –≥–æ—Ç–æ–≤—ã—Ö –õ–ü –ø—Ä–∏–±–∞–≤–∏–ª–∏ 15,9% –∫ —è–Ω–≤–∞—Ä—é-–∞–≤–≥—É—Å—Ç—É 2024 –≥–æ–¥–∞ –∏ –¥–æ—Å—Ç–∏–≥–ª–∏ 1,2 —Ç—Ä–ª–Ω —Ä—É–±–ª–µ–π; üü© –º–∞–∫—Å–∏–º–∞–ª—å–Ω—É—é —Ä—É–±–ª—ë–≤—É—é –¥–∏–Ω–∞–º–∏–∫—É –ø–æ–∫–∞–∑–∞–ª–∏ –°–ö–§–û (+15,4%), –°–ó–§–û (+14,5%) –∏ –¶–§–û (+14,4%); üü© –¥–æ–ª—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏–∑ –≤—ã—Å–æ–∫–æ–≥–æ —Ü–µ–Ω–æ–≤–æ–≥–æ —Å–µ–≥–º–µ–Ω—Ç–∞ (–±–æ–ª–µ–µ 1 —Ç—ã—Å. —Ä—É–±–ª–µ–π) –¥–æ—Å—Ç–∏–≥–ª–∞ 34% –≤ –¥–µ–Ω–µ–∂–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏, –∞ –¥–æ–ª—è –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏–∑ –Ω–∏–∑–∫–æ–≥–æ —Ü–µ–Ω–æ–≤–æ–≥–æ —Å–µ–≥–º–µ–Ω—Ç–∞ (–º–µ–Ω–µ–µ 100 —Ä—É–±–ª–µ–π) —Å–Ω–∏–∑–∏–ª–∞—Å—å –¥–æ 27% –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏; üü© –ª–∏–¥–µ—Ä –ø–æ –æ–±—ä—ë–º—É –ø—Ä–æ–¥–∞–∂ ‚Äî –≠–ª–∏–∫–≤–∏—Å –æ—Ç Pfizer, –º–∞–∫—Å–∏–º–∞–ª—å–Ω—É—é –¥–∏–Ω–∞–º–∏–∫—É –≤ —Ç–æ–ø-10 –ø–æ–∫–∞–∑–∞–ª –°–µ–º–∞–≤–∏–∫ –æ—Ç¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª; üü© –Ω–∞ 1 –∞–≤–≥—É—Å—Ç–∞ 2025 –≥–æ–¥–∞ –≤ –†–æ—Å—Å–∏–∏ —Ä–∞–±–æ—Ç–∞–ª–æ 82,2 —Ç—ã—Å. –∞–ø—Ç–µ–∫ (+2,9 —Ç—ã—Å. –≥–æ–¥ –∫ –≥–æ–¥—É); üü© –¥–æ–ª—è –ø–∞—Ä–∞—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∏ –≤ –≤—ã—Ä—É—á–∫–µ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –∞–ø—Ç–µ–∫ —Å–Ω–∏–∑–∏–ª–∞—Å—å –¥–æ 19,8% –≤ —Ä—É–±–ª—è—Ö (22,6% –≥–æ–¥–æ–º —Ä–∞–Ω–µ–µ); üü©—Å—Ä–µ–¥–Ω–∏–π —á–µ–∫ –≤ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –∞–ø—Ç–µ–∫–∞—Ö –ø–æ –æ–±—â–µ–º—É –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç—É –≤—ã—Ä–æ—Å –Ω–∞ 10,8%, –¥–æ 765 —Ä—É–±–ª–µ–π; üü© –≤ —Ç–æ–ø-10 –ø–æ –æ–±—ä—ë–º—É –ø—Ä–æ–¥–∞–∂ –≤ –¥–µ–Ω—å–≥–∞—Ö –≤–æ—à–ª–∏: ¬´–ë–∞–π–µ—Ä¬ª, ¬´–ù–∏–∂—Ñ–∞—Ä–º¬ª, ¬´–°–µ—Ä–≤—å–µ¬ª, ¬´–≠–±–±–æ—Ç—Ç¬ª, ¬´–°–∞–Ω–æ—Ñ–∏¬ª, ¬´–¢–µ–≤–∞¬ª, ¬´–ö–†–ö–ê¬ª, ¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º¬ª, ¬´–û—Ç–∏—Å–∏—Ñ–∞—Ä–º¬ª –∏ ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª. üü© —Ç–æ–ø-10 –ø–æ –æ–±—ä—ë–º—É –ø—Ä–æ–¥–∞–∂ –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö –≤—ã–≥–ª—è–¥–∏—Ç —Ç–∞–∫: ¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç¬ª, ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª, ¬´–û–±–Ω–æ–≤–ª–µ–Ω–∏–µ¬ª, ¬´–ù–∏–∂—Ñ–∞—Ä–º¬ª, ¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º¬ª, ¬´–û—Ç–∏—Å–∏—Ñ–∞—Ä–º¬ª, ¬´–¢–µ–≤–∞¬ª, ¬´–ê–∫—Ä–∏—Ö–∏–Ω¬ª, ¬´–í–µ—Ä—Ç–µ–∫—Å¬ª, ¬´–î-—Ä –†–µ–¥–¥–∏—Å¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial, safety, guideline"",
  ""impact"": ""high"",
  ""english"": ""The report from RNC Pharma on the main indicators and trends of the Russian pharmaceutical market for January-August 2025 highlights significant growth in the retail segment, with a year-over-year increase of +12.7%. Key highlights include strong growth in ready-to-use pharmaceuticals (+15.9% YoY to 1.2 trillion rubles), and the top-selling brands like Elyxif from Pfizer, Semafovik from 'Geropharm'. The report also notes an increase in average ticket prices to 765 rubles, and the top-selling brands by volume include 'Bayer', 'Nizfarma', 'Servie', 'Abbott', 'Sanofi', 'Teva', etc. The global impact is significant, affecting regulatory affairs and market access for medicines.""
}"
2025-09-28T11:05:30+00:00,@bezrec,6594,https://t.me/bezrec/6594,–ó–∞–ª–∏–ø–∞—Ç–µ–ª—å–Ω–æ–µ –≤–∏–¥–µ–æ –ø–µ—Ä–µ–¥ –Ω–∞—á–∞–ª–æ–º —Ä–∞–±–æ—á–µ–π –Ω–µ–¥–µ–ª–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞,"{""skip"": true}"
2025-09-27T11:04:37+00:00,@bezrec,6593,https://t.me/bezrec/6593,"–°—É–±–±–æ—Ç–∞ ‚Äî –≤—Ä–µ–º—è –¥–ª—è —Ä—É–±—Ä–∏–∫–∏ #–≤–¥–æ–≥–æ–Ω–∫—É. üíä –ò–ò –¥–æ–ª–∂–µ–Ω –ø—Ä–æ—è–≤–∏—Ç—å —Å–µ–±—è –≤ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ –ª–µ–∫–∞—Ä—Å—Ç–≤ –æ—Ç —Ç—Ä—É–¥–Ω–æ–∏–∑–ª–µ—á–∏–º—ã—Ö –±–æ–ª–µ–∑–Ω–µ–π. –Ø —É–ø–æ–º–∏–Ω–∞–ª –Ω–µ–π—Ä–æ–¥–µ–≥–µ–Ω–µ—Ä–∞—Ç–∏–≤–Ω—ã–µ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è, —Ç–∞–∫–∏–µ –∫–∞–∫ –±–æ–ª–µ–∑–Ω—å –ê–ª—å—Ü–≥–µ–π–º–µ—Ä–∞. –ù—É, —ç—Ç–æ—Ç —Å–ø–∏—Å–æ–∫ –º–æ–∂–Ω–æ –ø—Ä–æ–¥–æ–ª–∂–∏—Ç—å. –í—Å–µ –º—ã —ç—Ç–∏ —Å –≤–∞–º–∏ –±–æ–ª–µ–∑–Ω–∏ –∑–Ω–∞–µ–º, –∏ —ç—Ç–æ –æ–¥–Ω–æ –∏–∑ –ø–µ—Ä–≤—ã—Ö –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏–π, –≥–¥–µ —ç—Ç–æ—Ç –Ω–æ–≤—ã–π –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç –¥–æ–ª–∂–µ–Ω —Å–µ–±—è –ø—Ä–æ—è–≤–∏—Ç—å –≤ –ø–æ–ª–Ω—ã–π —Ä–æ—Å—Ç, ‚Äî –∑–∞—è–≤–∏–ª –≥–ª–∞–≤–∞ –ú–∏–Ω–æ–±—Ä–Ω–∞—É–∫–∏ –í–∞–ª–µ—Ä–∏–π –§–∞–ª—å–∫–æ–≤. üíä –ö–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ –∏—Å–ø—ã—Ç–∞–Ω–∏—è —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –æ—Ç —Ä–∞–∫–∞ –º–æ–∑–≥–∞ –Ω–∞—á–Ω—É—Ç—Å—è –≤ 2026 –≥–æ–¥—É. –û –≥–æ—Ç–æ–≤–Ω–æ—Å—Ç–∏ –ø—Ä–∏—Å—Ç—É–ø–∏—Ç—å –∫ –∏—Å–ø—ã—Ç–∞–Ω–∏—è–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –Ω–∞ –æ—Å–Ω–æ–≤–µ –≥–µ–Ω–Ω–æ-–º–æ–¥–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω–æ–≥–æ –æ–Ω–∫–æ–ª–∏—Ç–∏—á–µ—Å–∫–æ–≥–æ –≤–∏—Ä—É—Å–∞ –æ—Å–ø–æ–≤–∞–∫—Ü–∏–Ω—ã –∑–∞—è–≤–∏–ª–∏ —É—á—ë–Ω—ã–µ –ò–Ω—Å—Ç–∏—Ç—É—Ç–∞ —Ö–∏–º–∏—á–µ—Å–∫–æ–π –±–∏–æ–ª–æ–≥–∏–∏ –∏ —Ñ—É–Ω–¥–∞–º–µ–Ω—Ç–∞–ª—å–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω—ã. üíä –¢–∞–∫–∂–µ –≤ 2026 –≥–æ–¥—É –¥–æ–ª–∂–Ω–∞ –∑–∞–≤–µ—Ä—à–∏—Ç—å—Å—è —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∞ ¬´–º—è–≥–∫–æ–π¬ª –¥–µ—Ç—Å–∫–æ–π –≤–∞–∫—Ü–∏–Ω—ã –æ—Ç –∫–æ–∫–ª—é—à–∞. –†–∞–±–æ—Ç—É –Ω–∞–¥ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–º –Ω–æ–≤–æ–≥–æ –ø–æ–∫–æ–ª–µ–Ω–∏—è –≤–µ–¥—ë—Ç –ù–∞—É—á–Ω–æ-–∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–∏–π –∏–Ω—Å—Ç–∏—Ç—É—Ç —Å–∏—Å—Ç–µ–º–Ω–æ–π –±–∏–æ–ª–æ–≥–∏–∏ –∏ –º–µ–¥–∏—Ü–∏–Ω—ã –†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä–∞. –≠—Ç–æ –±—É–¥–µ—Ç –Ω–æ–≤–æ–µ –ø–æ–∫–æ–ª–µ–Ω–∏–µ –≤–∞–∫—Ü–∏–Ω, –ø—Ä–µ–¥—Å—Ç–∞–≤–ª—è—é—â–µ–µ —Å–æ–±–æ–π –Ω–µ–æ–∞–Ω—Ç–∏–≥–µ–Ω—ã. –¢.–µ. —ç—Ç–æ –±—É–¥–µ—Ç –≥–∏–±—Ä–∏–¥–Ω–∞—è –º–æ–ª–µ–∫—É–ª–∞, –≤ –æ–¥–Ω–æ–π –º–æ–ª–µ–∫—É–ª–µ –Ω–µ—Å–∫–æ–ª—å–∫–æ –∞–Ω—Ç–∏–≥–µ–Ω–Ω—ã—Ö —Å—Ç—Ä—É–∫—Ç—É—Ä –±—É–¥–µ—Ç. –°–µ–π—á–∞—Å –º—ã –∑–∞–∫–∞–Ω—á–∏–≤–∞–µ–º —Å—Ç–∞–¥–∏–∏ –æ—Ü–µ–Ω–∫–∏ –∏–º–º—É–Ω–æ–≥–µ–Ω–Ω–æ—Å—Ç–∏, —Ä–µ–∞–∫—Ü–∏–∏ –∏–º–º—É–Ω–Ω–æ–π —Å–∏—Å—Ç–µ–º—ã, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª –¥–∏—Ä–µ–∫—Ç–æ—Ä –ù–ò–ò –í–∞–¥–∏–º –ì–æ–≤–æ—Ä—É–Ω. üíä –ë–æ–ª–µ–µ 2,5 –º–ª–Ω –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –≤—ã—Å–æ–∫–æ–≥–æ —Ä–∏—Å–∫–∞, –ø–µ—Ä–µ–Ω–µ—Å—à–∏—Ö –∏–Ω—Ñ–∞—Ä–∫—Ç—ã –∏ –∏–Ω—Å—É–ª—å—Ç—ã, –∞ —Ç–∞–∫–∂–µ –æ–ø–µ—Ä–∞—Ç–∏–≤–Ω—ã–µ –≤–º–µ—à–∞—Ç–µ–ª—å—Å—Ç–≤–∞ –Ω–∞ —Å–æ—Å—É–¥–∞—Ö, –æ–±–µ—Å–ø–µ—á–µ–Ω—ã –≤ –∞–º–±—É–ª–∞—Ç–æ—Ä–Ω—ã—Ö —É—Å–ª–æ–≤–∏—è—Ö –±–µ—Å–ø–ª–∞—Ç–Ω—ã–º–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏. –¢–∞–∫–∏–º–∏ –¥–∞–Ω–Ω—ã–º–∏ –ø–æ–¥–µ–ª–∏–ª—Å—è –ú–∏—Ö–∞–∏–ª –ú—É—Ä–∞—à–∫–æ. –ü–æ —Å–ª–æ–≤–∞–º –º–∏–Ω–∏—Å—Ç—Ä–∞, –¥–æ–ª—è –æ–±–µ—Å–ø–µ—á–µ–Ω–Ω—ã—Ö –±–µ—Å–ø–ª–∞—Ç–Ω—ã–º–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏ –∫ 2030 –≥–æ–¥—É –¥–æ–ª–∂–Ω–∞ –µ—â—ë —É–≤–µ–ª–∏—á–∏—Ç—å—Å—è –∏ –¥–æ—Å—Ç–∏–≥–Ω—É—Ç—å 98%. üíä ¬´–†-–§–∞—Ä–º¬ª –∏ –∫–∏—Ç–∞–π—Å–∫–∞—è Walvax –≤—ã—Å—Ç—É–ø—è—Ç –µ–¥–∏–Ω—ã–º —Ñ—Ä–æ–Ω—Ç–æ–º –ø—Ä–æ—Ç–∏–≤ –ø–Ω–µ–≤–º–æ–∫–æ–∫–∫–∞. –ö–æ–º–ø–∞–Ω–∏–∏ –ø—Ä–∏—Å—Ç—É–ø–∏–ª–∏ –∫ —Å–æ–≤–º–µ—Å—Ç–Ω–æ–π —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ 23-–≤–∞–ª–µ–Ω—Ç–Ω–æ–π –ø–æ–ª–∏—Å–∞—Ö–∞—Ä–∏–¥–Ω–æ–π –ø–Ω–µ–≤–º–æ–∫–æ–∫–∫–æ–≤–æ–π –≤–∞–∫—Ü–∏–Ω—ã. –û–±—ä—ë–º—ã –∏ —Å—Ä–æ–∫–∏ –∑–∞–ø—É—Å–∫–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –Ω–µ —Ä–∞–∑–≥–ª–∞—à–∞—é—Ç—Å—è, –Ω–æ —Ä–æ—Å—Å–∏–π—Å–∫–∞—è —Å—Ç–æ—Ä–æ–Ω–∞ –æ–±–µ—â–∞–µ—Ç, —á—Ç–æ –≤–∞–∫—Ü–∏–Ω—ã ¬´—Ö–≤–∞—Ç–∏—Ç –¥–ª—è –ø–æ–∫—Ä—ã—Ç–∏—è –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç–µ–π –≤—Å–µ–π —Å—Ç—Ä–∞–Ω—ã¬ª. üíä –í–∞–∫—Ü–∏–Ω–∞—Ü–∏—é –æ—Ç –≤–∏—Ä—É—Å–∞ –ø–∞–ø–∏–ª–ª–æ–º—ã —á–µ–ª–æ–≤–µ–∫–∞ (–í–ü–ß) –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –¥–æ–±–∞–≤–∏—Ç—å –≤ –Ω–∞—Ü–∫–∞–ª–µ–Ω–¥–∞—Ä—å –ø—Ä–∏–≤–∏–≤–æ–∫. –° —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–µ–π –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–æ–π –≤—ã—Å—Ç—É–ø–∏–ª–∞ —á–ª–µ–Ω –ö–æ–º–∏—Ç–µ—Ç–∞ –ì–æ—Å–¥—É–º—ã –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è –Æ–ª–∏—è –î—Ä–æ–∂–∂–∏–Ω–∞. –°–µ–π—á–∞—Å –ø—Ä–∏–≤–∏–≤–∫—É –º–æ–∂–Ω–æ —Å–¥–µ–ª–∞—Ç—å –ø–æ –û–ú–° —Ç–æ–ª—å–∫–æ –≤ —Ä–∞–º–∫–∞—Ö —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã—Ö –ø—Ä–æ–≥—Ä–∞–º–º. ¬´–ù–∞–Ω–æ–ª–µ–∫¬ª –æ—á–µ–Ω—å –∫—Å—Ç–∞—Ç–∏ –∑–∞–∫–æ–Ω—á–∏–ª –∏—Å–ø—ã—Ç–∞–Ω–∏—è —Å–≤–æ–µ–≥–æ –¶–µ–≥–∞—Ä–¥–µ–∫—Å–∞ –Ω–∞ –ø–æ–¥—Ä–æ—Å—Ç–∫–∞—Ö. –°–µ–π—á–∞—Å –¥–ª—è –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –í–ü–ß –≤ —Å—Ç—Ä–∞–Ω–µ –ø—Ä–∏–º–µ–Ω—è—é—Ç—Å—è –∑–∞—Ä—É–±–µ–∂–Ω—ã–µ –¶–µ—Ä–≤–∞—Ä–∏–∫—Å –æ—Ç GlaxoSmithKline –∏ –ì–∞—Ä–¥–∞—Å–∏–ª –æ—Ç MSD. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""Several topics are discussed including clinical trials for cancer treatments, vaccine development against pneumococcus, and the potential addition of HPV vaccination to national immunization schedules. The focus on clinical trials for cancer treatments and vaccine development highlights the need for robust regulatory processes and compliance. The mention of shortages in medicines and potential demand increases due to the global nature of these issues.""
}"
2025-09-26T14:33:48+00:00,@bezrec,6589,https://t.me/bezrec/6589,"–ó–∞—è–≤–ª–µ–Ω–∏–µ –¢—Ä–∞–º–ø–∞ –æ –¢–∞–π–ª–µ–Ω–æ–ª–µ –ø–æ—Ä–æ–¥–∏–ª–æ –æ–ø–∞—Å–Ω—ã–π —Ç—Ä–µ–Ω–¥. –ë–µ—Ä–µ–º–µ–Ω–Ω—ã–µ –∞–º–µ—Ä–∏–∫–∞–Ω–∫–∏ –º–∞—Å—Å–æ–≤–æ –≤—ã–∫–ª–∞–¥—ã–≤–∞—é—Ç –≤ —Å–µ—Ç—å –≤–∏–¥–µ–æ, –Ω–∞ –∫–æ—Ç–æ—Ä—ã—Ö –≥–ª–æ—Ç–∞—é—Ç –ø–æ–ø—É–ª—è—Ä–Ω–æ–µ –æ–±–µ–∑–±–æ–ª–∏–≤–∞—é—â–µ–µ, –ø—Ä–∏—á—ë–º –Ω–µ–∫–æ—Ç–æ—Ä—ã–µ –¥–∞–∂–µ –Ω–µ –ø–æ –æ–¥–Ω–æ–π —Ç–∞–±–ª–µ—Ç–∫–µ. –¢–∞–∫–∏–º –æ–±—Ä–∞–∑–æ–º –¥–∞–º—ã –≤ –ø–æ–ª–æ–∂–µ–Ω–∏–∏ –≤—ã—Ä–∞–∂–∞—é—Ç —Å–≤–æ–π –ø—Ä–æ—Ç–µ—Å—Ç –ø—Ä–æ—Ç–∏–≤ –≤—ã—Å–∫–∞–∑—ã–≤–∞–Ω–∏—è –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç–∞ –°–®–ê –æ —Ä–æ—Å—Ç–µ —Å–ª—É—á–∞–µ–≤ –∞—É—Ç–∏–∑–º–∞ —É –¥–µ—Ç–µ–π, —è–∫–æ–±—ã —Å–≤—è–∑–∞–Ω–Ω–æ–º —Å —É–ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–µ–º –ø–∞—Ä–∞—Ü–µ—Ç–∞–º–æ–ª–∞ –±—É–¥—É—â–∏–º–∏ –º–∞–º–∞–º–∏. –ù–µ–∫–æ—Ç–æ—Ä—ã–µ —É–∂–µ –¥–æ–∏–≥—Ä–∞–ª–∏—Å—å. –ù–∞ –ø–æ—Å–ª–µ–¥–Ω–µ–º –≤–∏–¥–µ–æ –∂–µ–Ω—â–∏–Ω–∞ —Ä–∞—Å—Å–∫–∞–∑—ã–≤–∞–µ—Ç, –∫–∞–∫ –µ—ë –ø–æ–¥—Ä—É–≥–∞ —É–º–∏—Ä–∞–µ—Ç –≤ —Ä–µ–∞–Ω–∏–º–∞—Ü–∏–∏ –æ—Ç –ø–µ—á—ë–Ω–æ—á–Ω–æ–π –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ—Å—Ç–∏, –ø–µ—Ä–µ–±—Ä–∞–≤ –¢–∞–π–ª–µ–Ω–æ–ª–∞ –Ω–∞ 25 –Ω–µ–¥–µ–ª–µ –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏ –≤ –ø–æ–ø—ã—Ç–∫–∞—Ö –¥–æ–∫–∞–∑–∞—Ç—å, —á—Ç–æ –î–æ–Ω–∞–ª—å–¥ –Ω–µ –ø—Ä–∞–≤. –ñ–∏–≤–∞—è –∏–ª–ª—é—Å—Ç—Ä–∞—Ü–∏—è –ø–æ—Å–ª–æ–≤–∏—Ü—ã ¬´–ù–∞–∑–ª–æ –±–∞–±—É—à–∫–µ –æ—Ç–º–æ—Ä–æ–∂—É —É—à–∏¬ª. –õ—É—á—à–µ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–∏—Ç—å –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª–∞–º –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å —Ä–∞–∑–æ–±—Ä–∞—Ç—å—Å—è –≤ –≤–æ–ø—Ä–æ—Å–µ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-09-26T11:36:45+00:00,@bezrec,6588,https://t.me/bezrec/6588,"¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª –≤—ã–ø–ª–∞—Ç–∏—Ç 275,2 –º–ª–Ω —Ä—É–±–ª–µ–π –¥–∏–≤–∏–¥–µ–Ω–¥–æ–≤ –∑–∞ –ø–æ–ª—É–≥–æ–¥–∏–µ. –¢–∞–∫–æ–µ —Ä–µ—à–µ–Ω–∏–µ –ø—Ä–∏–Ω—è–ª–∏ –∞–∫—Ü–∏–æ–Ω–µ—Ä—ã –ü–ê–û –Ω–∞ —Å–æ–±—Ä–∞–Ω–∏–∏ 22 —Å–µ–Ω—Ç—è–±—Ä—è. –°—É–º–º–∞ —Å–æ–≤–ø–∞–¥–∞–µ—Ç —Å —Ç–æ–π, —á—Ç–æ –≤ –∞–≤–≥—É—Å—Ç–µ —Ä–µ–∫–æ–º–µ–Ω–¥–æ–≤–∞–ª –≤—ã–ø–ª–∞—Ç–∏—Ç—å —Å–æ–≤–µ—Ç –¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–≤ –∫–æ–º–ø–∞–Ω–∏–∏. üîΩ –õ–∏—Ü, –∏–º–µ—é—â–∏—Ö –ø—Ä–∞–≤–æ –Ω–∞ –ø–æ–ª—É—á–µ–Ω–∏–µ –¥–∏–≤–∏–¥–µ–Ω–¥–æ–≤, –æ–ø—Ä–µ–¥–µ–ª—è—Ç –ø–æ —Å–æ—Å—Ç–æ—è–Ω–∏—é –Ω–∞ 6 –æ–∫—Ç—è–±—Ä—è. –ü–æ—Å–ª–µ–¥–Ω–∏–π –¥–µ–Ω—å –ø–æ–∫—É–ø–∫–∏ –∞–∫—Ü–∏–π –ø–æ–¥ –¥–∏–≤–∏–¥–µ–Ω–¥—ã ‚Äî 3 –æ–∫—Ç—è–±—Ä—è. üîΩ –°–æ–≥–ª–∞—Å–Ω–æ –¥–∏–≤–∏–¥–µ–Ω–¥–Ω–æ–π –ø–æ–ª–∏—Ç–∏–∫–µ ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∏¬ª, –¥–∏–≤–∏–¥–µ–Ω–¥—ã –≤—ã–ø–ª–∞—á–∏–≤–∞—é—Ç—Å—è –∑–∞ —Å—á—ë—Ç —á–∏—Å—Ç–æ–π –ø—Ä–∏–±—ã–ª–∏ –∑–∞ –æ—Ç—á—ë—Ç–Ω—ã–π –ø–µ—Ä–∏–æ–¥ –∏ –Ω–µ—Ä–∞—Å–ø—Ä–µ–¥–µ–ª—ë–Ω–Ω–æ–π –ø—Ä–∏–±—ã–ª–∏ –ø—Ä–æ—à–ª—ã—Ö –ª–µ—Ç –≤ –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏ –æ—Ç —Å–æ–æ—Ç–Ω–æ—à–µ–Ω–∏—è —á–∏—Å—Ç—ã–π –¥–æ–ª–≥/EBITDA. –ï—Å–ª–∏ –¥–æ–ª–≥/EBITDA —Å–≤—ã—à–µ 3—Ö, –¥–∏–≤–∏–¥–µ–Ω–¥—ã –Ω–µ –≤—ã–ø–ª–∞—á–∏–≤–∞—é—Ç—Å—è. üîΩ –ü–æ –¥–∞–Ω–Ω—ã–º —Ñ–∏–Ω–∞–Ω—Å–æ–≤–æ–π –æ—Ç—á—ë—Ç–Ω–æ—Å—Ç–∏ ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∏¬ª –∑–∞ —à–µ—Å—Ç—å –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞, —Å–æ–æ—Ç–Ω–æ—à–µ–Ω–∏–µ —á–∏—Å—Ç—ã–π –¥–æ–ª–≥/12M EBITDA —Å–Ω–∏–∑–∏–ª–æ—Å—å –¥–æ 1,0—Ö.–ü—Ä–∏ —Ç–∞–∫–æ–º –ø–æ–∫–∞–∑–∞—Ç–µ–ª–µ –Ω–∞–ø—Ä–∞–≤–ª—è–µ–º–∞—è –Ω–∞ –¥–∏–≤–∏–¥–µ–Ω–¥—ã –¥–æ–ª—è —Å–æ—Å—Ç–∞–≤–ª—è–µ—Ç –Ω–µ –º–µ–Ω–µ–µ 35% —á–∏—Å—Ç–æ–π –ø—Ä–∏–±—ã–ª–∏. –ü–æ –∏—Ç–æ–≥–∞–º –ø–µ—Ä–≤–æ–≥–æ –ø–æ–ª—É–≥–æ–¥–∏—è —á–∏—Å—Ç–∞—è –ø—Ä–∏–±—ã–ª—å –≥—Ä—É–ø–ø—ã –ø–æ –ú–°–§–û —Å–Ω–∏–∑–∏–ª–∞—Å—å –Ω–∞ 11% –≥–æ–¥ –∫ –≥–æ–¥—É, –¥–æ 1,712 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –í—ã—Ä—É—á–∫–∞ –≤—ã—Ä–æ—Å–ª–∞ –Ω–∞ 16%, –¥–æ 13,3 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": true,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""low"",
  ""english"": ""Ozon Pharma will pay dividends of RUB275.2 million for the first half of the year, as approved by shareholders at a meeting on September 22. The dividend amount is consistent with the recommendation made by the company's board of directors in August. Shareholders eligible for dividends will be determined based on their status as of October 6, and the last day to purchase shares for dividends is October 3. According to the dividend policy of 'Ozon Pharma', dividends are paid from net profit and retained profits of previous years, depending on the ratio of net debt to EBITDA. If the ratio exceeds 3 times, dividends are not paid. For the first half of 2025, 'Ozon Pharma' reported a decrease in net debt to EBITDA ratio by 10 times, resulting in at least 35% of net profit being directed towards dividends. Net profit for the first half decreased by 11% year-over-year to RUB17.12 billion, while revenue increased by 16% to"
2025-09-26T08:33:04+00:00,@bezrec,6587,https://t.me/bezrec/6587,"–†–µ—à–∏–ª–∏ –ø–æ—Å–º–æ—Ç—Ä–µ—Ç—å, –∫–∞–∫ –æ–±—Å—Ç–æ—è—Ç –¥–µ–ª–∞ —Å –Ω–∞–ª–∏—á–∏–µ–º –∏ —Ü–µ–Ω–∞–º–∏ –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –Ω–µ —Ç–æ–ª—å–∫–æ —É ¬´–∫—Ä—É–ø–Ω—è–∫–æ–≤¬ª, –Ω–æ –∏ —É –∏–≥—Ä–æ–∫–æ–≤ –ø–æ–º–µ–Ω—å—à–µ. –ü—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º —Ä–∞—Å—à–∏—Ä–µ–Ω–Ω—ã–π –≤—ã–ø—É—Å–∫ #–∑–∞—Ü–µ–Ω–∏–ª–∏ —Å —É—á–∞—Å—Ç–∏–µ–º —Å–µ—Ç–µ–π, –æ–±—ä–µ–¥–∏–Ω—è—é—â–∏—Ö –Ω–µ –±–æ–ª–µ–µ —Ç—ã—Å—è—á–∏ —Ç–æ—á–µ–∫. –û–±—ã—á–Ω–æ –≤ –∫–∞—á–µ—Å—Ç–≤–µ –≥–æ—Ä–æ–¥–∞ –¥–ª—è –ø–æ–∏—Å–∫–∞ —É –Ω–∞—Å –ø–æ —É–º–æ–ª—á–∞–Ω–∏—é —Å—Ç–æ–∏—Ç –ú–æ—Å–∫–≤–∞. –†–∞—Å—à–∏—Ä—è–µ–º –≥–µ–æ–≥—Ä–∞—Ñ–∏—é –∏ –¥–ª—è –Ω–æ–≤—ã—Ö —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ —Ä—É–±—Ä–∏–∫–∏ –¥–æ–±–∞–≤–ª—è–µ–º –ø–æ–∏—Å–∫ –ø–æ –ö—Ä–∞—Å–Ω–æ–¥–∞—Ä—É. –ò—Ç–∞–∫, –ø–æ–º–∏–º–æ –ø—Ä–∏–≤—ã—á–Ω—ã—Ö ¬´–ê–ø—Ç–µ–∫–∏.—Ä—É¬ª, ¬´–†–∏–≥–ª—ã¬ª, ¬´–ó–¥—Ä–∞–≤—Å–∏—Ç–∏¬ª, ¬´–ï–∞–ø—Ç–µ–∫–∏¬ª –∏ ¬´36,6¬ª, –º—ã —Å—Ä–∞–≤–Ω–∏–ª–∏ —Ü–µ–Ω—ã –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –Ω–∞ –æ—Å–Ω–æ–≤–µ –∞–¥–µ–º–µ—Ç–∏–æ–Ω–∏–Ω–∞ —Ç–æ—Ä–≥–æ–≤—ã—Ö –º–∞—Ä–æ–∫ –ì–µ–ø—Ç—Ä–∞–ª (Abbvie), –ê–¥–µ–º–µ—Ç–∏–æ–Ω–∏–Ω (¬´–í–µ–ª—Ñ–∞—Ä–º¬ª), –°–∞–º–µ–ª–∏–∫—Å (¬´–ö–∞–Ω–æ–Ω—Ñ–∞—Ä–º–∞¬ª), –ì–µ–ø—Ü–∏—Ñ–æ–ª (¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑¬ª), –ì–µ–ø—Ç–æ—Ä (¬´–í–µ—Ä–æ—Ñ–∞—Ä–º¬ª) –≤ —Å–µ—Ç—è—Ö ¬´–ê–ª–æ—ç¬ª, ¬´–§–∏—Ç–æ—Ñ–∞—Ä–º¬ª –∏ ¬´–°–æ–≤–µ—Ç—Å–∫–∞—è –∞–ø—Ç–µ–∫–∞¬ª. –°–∞–º—ã–º –¥–æ—Ä–æ–≥–∏–º –∏–∑ –≤—Å–µ—Ö –æ–∫–∞–∑–∞–ª—Å—è –∑–∞–≥—Ä–∞–Ω–∏—á–Ω—ã–π –ì–µ–ø—Ç—Ä–∞–ª ‚Äî –≤ ¬´–†–∏–≥–ª–µ¬ª —É–ø–∞–∫–æ–≤–∫–∞ –∏–∑ 20 —Ç–∞–±–ª–µ—Ç–æ–∫ —Å—Ç–æ–∏—Ç 2010 —Ä—É–±–ª–µ–π. –ó–∞—Ç–æ –ø—Ä–æ–±–ª–µ–º —Å –µ–≥–æ –Ω–∞–ª–∏—á–∏–µ–º –Ω–µ—Ç –Ω–∏ –≤ –æ–¥–Ω–æ–π –∞–ø—Ç–µ–∫–µ. –ß–µ–≥–æ –Ω–µ —Å–∫–∞–∂–µ—à—å –æ –±–æ–ª–µ–µ –±—é–¥–∂–µ—Ç–Ω—ã—Ö –ê–¥–µ–º–µ—Ç–∏–æ–Ω–∏–Ω–µ –∏ –°–∞–º–µ–ª–∏–∫—Å–µ. –î–µ—à–µ–≤–ª–µ –≤—Å–µ–≥–æ –æ–±–æ–π–¥—ë—Ç—Å—è –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π –ì–µ–ø—Ü–∏—Ñ–æ–ª –∏–∑ ¬´–ï–∞–ø—Ç–µ–∫–∏¬ª ‚Äî —Ç–∞–º –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è –ø–æ–¥–¥–µ—Ä–∂–∞–Ω–∏—è —Ñ—É–Ω–∫—Ü–∏–π –ø–µ—á–µ–Ω–∏ –æ–±–æ–π–¥—ë—Ç—Å—è –≤ 700 —Ä—É–±–ª–µ–π. –î–ª—è —Å—Ä–∞–≤–Ω–µ–Ω–∏—è, –≤ ¬´36,6¬ª –∑–∞ –Ω–µ–≥–æ –∂–µ –ø—Ä–∏–¥—ë—Ç—Å—è –≤—ã–ª–æ–∂–∏—Ç—å 1434 —Ä—É–±–ª—è. –ù–∞–ø–æ–º–∏–Ω–∞–µ–º, —á—Ç–æ –ª—é–±—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏–º–µ—é—Ç –ø—Ä–æ—Ç–∏–≤–æ–ø–æ–∫–∞–∑–∞–Ω–∏—è. –ü–µ—Ä–µ–¥ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º –ø—Ä–æ–∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä—É–π—Ç–µ—Å—å —Å –ª–µ—á–∞—â–∏–º –≤—Ä–∞—á–æ–º. *–∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –ø—Ä–æ–≤–æ–¥–∏–ª–æ—Å—å –æ–Ω–ª–∞–π–Ω 25 —Å–µ–Ω—Ç—è–±—Ä—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage"",
  ""impact"": ""medium"",
  ""english"": ""An investigation into the availability and prices of medications, including brands like Heptral (Abbvie), Ademetionin (Velfarm), Samelyks (Canonfarm), Hepcyfol (FarmaSynthesis), and Heptor (Veropharm) was conducted. The most expensive is the imported Heptral from Russia, priced at 2010 rubles in Rigel. The domestic Hepcyfol from Yandex Apotek is the cheapest at 700 rubles, while it costs 1434 rubles in 36.6.""
}"
2025-09-26T05:36:21+00:00,@bezrec,6586,https://t.me/bezrec/6586,"–¢—Ä–∞–º–ø –≤–≤–æ–¥–∏—Ç 100% –ø–æ—à–ª–∏–Ω—ã –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞. –ù–∞—á–∏–Ω–∞—è —Å 1 –æ–∫—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞ –º—ã –≤–≤–æ–¥–∏–º –ø–æ—à–ª–∏–Ω—É –≤ —Ä–∞–∑–º–µ—Ä–µ 100% –Ω–∞ –ª—é–±—ã–µ –±—Ä–µ–Ω–¥–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –∏–ª–∏ –∑–∞–ø–∞—Ç–µ–Ω—Ç–æ–≤–∞–Ω–Ω—ã–µ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, –µ—Å–ª–∏ –∫–æ–º–ø–∞–Ω–∏—è –Ω–µ —Å—Ç—Ä–æ–∏—Ç —Å–≤–æ–π —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–π –∑–∞–≤–æ–¥ –≤ –ê–º–µ—Ä–∏–∫–µ, ‚Äî –Ω–∞–ø–∏—Å–∞–ª –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–π –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç –≤ —Å–æ—Ü—Å–µ—Ç–∏ Truth Social. –ù–∞ –∫–æ–º–ø–∞–Ω–∏–∏, –∫–æ—Ç–æ—Ä—ã–µ —É–∂–µ –Ω–∞—á–∞–ª–∏ –≤–æ–∑–≤–µ–¥–µ–Ω–∏–µ —Å–≤–æ–∏—Ö –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏–π –≤ –°–®–ê, –º–µ—Ä–∞ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω—è—Ç—å—Å—è –Ω–µ –±—É–¥–µ—Ç. –ù—É –∞ –∫—Ç–æ –Ω–µ —É—Å–ø–µ–ª, —Ç–æ—Ç –æ–ø–æ–∑–¥–∞–ª. –ò–∑ –µ–≤—Ä–æ–ø–µ–π—Ü–µ–≤ –¥–æ–ª–∂–Ω—ã –±—ã–ª–∏ —É—Å–ø–µ—Ç—å Roche, Sanofi, Novo Nordisk –∏ Novartis, —Ä–∞–Ω–µ–µ –æ–±—ä—è–≤–∏–≤—à–∏–µ –æ –º–Ω–æ–≥–æ–º–∏–ª–ª–∏–∞—Ä–¥–Ω—ã—Ö –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏—è—Ö –≤ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –≤ –°–®–ê. –¢—Ä–∞–º–ø —É–≤–µ—Ä—è–µ—Ç, —á—Ç–æ –Ω–æ–≤—ã–µ –ø–æ—à–ª–∏–Ω—ã –Ω–∏–∫–∞–∫ –Ω–µ —Å–∫–∞–∂—É—Ç—Å—è –Ω–∞ –ø—Ä–æ—Å—Ç—ã—Ö –∞–º–µ—Ä–∏–∫–∞–Ω—Ü–∞—Ö, –Ω–æ —ç–∫—Å–ø–µ—Ä—Ç—ã –æ–ø–∞—Å–∞—é—Ç—Å—è —Ä–æ—Å—Ç–∞ —Ü–µ–Ω –∏ –¥–µ—Ñ–∏—Ü–∏—Ç–∞. –í–æ –º–Ω–æ–≥–∏—Ö —Å–ª—É—á–∞—è—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –¥–µ—à–µ–≤–ª–µ, —á–µ–º –ø—Ä–æ–∏–∑–≤–µ–¥–µ–Ω–Ω—ã–µ –Ω–µ–ø–æ—Å—Ä–µ–¥—Å—Ç–≤–µ–Ω–Ω–æ –≤ –°–®–ê, –∫–æ—Ç–æ—Ä—ã–µ ¬´—Å–ª–∞–≤—è—Ç—Å—è¬ª –≤—ã—Å–æ–∫–æ–π —Å—Ç–æ–∏–º–æ—Å—Ç—å—é –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-09-25T14:48:45+00:00,@bezrec,6585,https://t.me/bezrec/6585,"–ö–æ –≤—Å–µ–º–∏—Ä–Ω–æ–º—É –¥–Ω—é —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∞, –∫–æ—Ç–æ—Ä—ã–π –æ—Ç–º–µ—á–∞–µ—Ç—Å—è —Å–µ–≥–æ–¥–Ω—è, —Ä–µ–∫—Ä—É—Ç–∏–Ω–≥–æ–≤—ã–π —Å–µ—Ä–≤–∏—Å hh‚Ä§ru —Ä–∞—Å—Å–∫–∞–∑–∞–ª, —Å–∫–æ–ª—å–∫–æ –ø–æ–ª—É—á–∞—é—Ç —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–∏ –∞–ø—Ç–µ–∫. –•–æ—Ä–æ—à–∞—è –Ω–æ–≤–æ—Å—Ç—å ‚Äî –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å 2024 –≥–æ–¥–æ–º —Å—Ä–µ–¥–Ω—è—è –∑–∞—Ä–ø–ª–∞—Ç–∞ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–æ–≤ –≤—ã—Ä–æ—Å–ª–∞ –Ω–∞ 16% (–∏–ª–∏ –Ω–∞ 10 —Ç—ã—Å. —Ä—É–±–ª–µ–π). –ë–æ–ª—å—à–µ –≤—Å–µ–≥–æ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–∏ —ç—Ç–æ–π –ø—Ä–æ—Ñ–µ—Å—Å–∏–∏ –ø–æ–ª—É—á–∞—é—Ç –≤ –ú–æ—Å–∫–≤–µ (97,2 —Ç—ã—Å. —Ä—É–±–ª–µ–π), –ú–æ—Å–∫–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ (96,4 —Ç—ã—Å. —Ä—É–±–ª–µ–π), –Ø–º–∞–ª–æ-–ù–µ–Ω–µ—Ü–∫–æ–º –∞–≤—Ç–æ–Ω–æ–º–Ω–æ–º –æ–∫—Ä—É–≥–µ (93, 4 —Ç—ã—Å.), –°–∞—Ö–∞–ª–∏–Ω—Å–∫–æ–π (90 —Ç—ã—Å.), –ú—É—Ä–º–∞–Ω—Å–∫–æ–π (78,6 —Ç—ã—Å.) –∏ –ö–∞–ª—É–∂—Å–∫–æ–π –æ–±–ª–∞—Å—Ç—è—Ö (78,1 —Ç—ã—Å.), –•–∞–±–∞—Ä–æ–≤—Å–∫–æ–º –∫—Ä–∞–µ (77,8 —Ç—ã—Å. —Ä—É–±–ª–µ–π) –∏ –†–µ—Å–ø—É–±–ª–∏–∫–µ –°–∞—Ö–∞ (75 —Ç—ã—Å. —Ä—É–±–ª–µ–π). –ö–æ–ª–∏—á–µ—Å—Ç–≤–æ –≤–∞–∫–∞–Ω—Å–∏–π –∑–∞ –ø–µ—Ä–≤—ã–µ –¥–µ–≤—è—Ç—å –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ –≤—ã—Ä–æ—Å–ª–æ –Ω–∞ 13% –≥–æ–¥ –∫ –≥–æ–¥—É (–¥–æ 33 —Ç—ã—Å.). –í —á–∏—Å–ª–µ –Ω–∞–≤—ã–∫–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ —Ç—Ä–µ–±—É—é—Ç —Ä–∞–±–æ—Ç–æ–¥–∞—Ç–µ–ª–∏ –æ—Ç —Å–æ–∏—Å–∫–∞—Ç–µ–ª–µ–π, —á–∞—â–µ –¥—Ä—É–≥–∏—Ö —á–∏—Å–ª—è—Ç—Å—è: ¬´–Ω–∞–≤—ã–∫–∏ –ø—Ä–æ–¥–∞–∂–∏¬ª, ¬´—Ñ–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è¬ª, ¬´—Ñ–∞—Ä–º–∞—Ü–∏—è¬ª, ¬´–ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã¬ª, ¬´–≥—Ä–∞–º–æ—Ç–Ω–∞—è —Ä–µ—á—å¬ª. –ê –≤–æ—Ç ¬´—ç–Ω—Ç—É–∑–∏–∞–∑–º¬ª, ¬´–µ–≤—Ä–æ–ø–µ–π—Å–∫–∞—è —Ñ–∞—Ä–º–∞–∫–æ–ø–µ—è¬ª –∏ ¬´–ø—Ä–µ–∑–µ–Ω—Ç–∞–±–µ–ª—å–Ω—ã–π –≤–Ω–µ—à–Ω–∏–π –≤–∏–¥¬ª –≤ —Å–ø–∏—Å–∫–µ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π –≤—Å—Ç—Ä–µ—á–∞—é—Ç—Å—è —Ä–µ–¥–∫–æ. –ü–æ–ª—å–∑—É—è—Å—å —Å–ª—É—á–∞–µ–º, –ø–æ–∑–¥—Ä–∞–≤–ª—è–µ–º –≤—Å–µ—Ö —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–æ–≤ —Å –ø–æ–≤—ã—à–µ–Ω–∏–µ–º –∑–∞—Ä–ø–ª–∞—Ç –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—ã–º –ø—Ä–∞–∑–¥–Ω–∏–∫–æ–º! –•–æ—Ä–æ—à–µ–≥–æ –Ω–∞—Å—Ç—Ä–æ–µ–Ω–∏—è, –ø–æ–Ω—è—Ç–Ω—ã—Ö —Ä–µ—Ü–µ–ø—Ç–æ–≤, —Å–≥–æ–≤–æ—Ä—á–∏–≤—ã—Ö –∫–ª–∏–µ–Ω—Ç–æ–≤ –∏ –∞–¥–µ–∫–≤–∞—Ç–Ω–æ–≥–æ —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–∞! ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-09-25T11:33:41+00:00,@bezrec,6584,https://t.me/bezrec/6584,"–í—Å—ë –Ω–∏–∂–µ, –∏ –Ω–∏–∂–µ, –∏ –Ω–∏–∂–µ. –û–ø—É—Å–∫–∞–µ—Ç—Å—è ¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç¬ª –≤ —Ç–æ–ø-100 –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö –∫–æ–º–ø–∞–Ω–∏–π –†–æ—Å—Å–∏–∏ –ø–æ —á–∏—Å—Ç–æ–π –ø—Ä–∏–±—ã–ª–∏ –æ—Ç Forbes. –í —ç—Ç–æ–º –≥–æ–¥—É –∫–æ–º–ø–∞–Ω–∏—è –í–∏–∫—Ç–æ—Ä–∞ –•–∞—Ä–∏—Ç–æ–Ω–∏–Ω–∞ –ø–µ—Ä–µ–º–µ—Å—Ç–∏–ª–∞—Å—å —Å 97 –Ω–∞ 98 —Å—Ç—Ä–æ—á–∫—É —Ä–µ–π—Ç–∏–Ω–≥–∞. –í –ø—Ä–æ—à–ª–æ–º –≥–æ–¥—É –ø–∞–¥–∞—Ç—å –±—ã–ª–æ –±–æ–ª—å–Ω–µ–µ ‚Äî –≤ 2023-–º —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å –±—ã–ª 26-–º. –° –¥—Ä—É–≥–æ–π —Å—Ç–æ—Ä–æ–Ω—ã, ¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç¬ª –æ—Å—Ç–∞—ë—Ç—Å—è –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–º –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–µ–º —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ –≤ –µ–∂–µ–≥–æ–¥–Ω–æ–º —Ç–æ–ø-100. –í –ø–æ–∑–∞–ø—Ä–æ—à–ª–æ–º –≥–æ–¥—É –∫–æ–º–ø–∞–Ω–∏—é –æ–¥–Ω–æ–º—É –∏–∑ –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ª–µ–∫–∞—Ä—Å—Ç–≤ —Å–æ—Å—Ç–∞–≤–ª—è–ª –∞—Ñ—Ñ–∏–ª–∏—Ä–æ–≤–∞–Ω–Ω—ã–π —Å –Ω–∏–º ¬´–û—Ç–∏—Å–∏—Ñ–∞—Ä–º¬ª, –Ω–æ –≤ 2024 –≥–æ–¥—É –∏–∑ —Ä–µ–π—Ç–∏–Ω–≥–∞ –≤—ã–±—ã–ª. –í–∏–¥–∏–º–æ, –≤—Å—ë-—Ç–∞–∫–∏ —Å–∫–∞–∑–∞–ª–æ—Å—å —Ä–µ–∫–æ—Ä–¥–Ω–æ–µ –ø–∞–¥–µ–Ω–∏–µ –ø—Ä–æ–¥–∞–∂ –Ω–µ–∫–æ–≥–¥–∞ –ª—é–±–∏–º–æ–≥–æ —Ä–æ—Å—Å–∏—è–Ω–∞–º–∏ –ø—Ä–æ—Ç–∏–≤–æ–≤–∏—Ä—É—Å–Ω–æ–≥–æ –ê—Ä–±–∏–¥–æ–ª–∞. –ß–∏—Å—Ç–∞—è –ø—Ä–∏–±—ã–ª—å ¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç–∞¬ª –≤ 2024 –≥–æ–¥—É —Å–æ—Å—Ç–∞–≤–∏–ª–∞ 22,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å 23,3 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –≥–æ–¥–æ–º —Ä–∞–Ω–µ–µ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The pharmaceutical company 'Farmstandart' has dropped from the Forbes list of top 100 Russian companies by pure profit, moving down to position 98 from the previous year's position of 26. The company, which was once one of the largest Russian drug manufacturers, is now gone from the annual top 100 list due to record sales decline of antiviral Arbidol. Farmstandart's pure profit in 2024 was 22.7 billion rubles, down from 23.3 billion in the previous year.""
}"
2025-09-25T09:00:01+00:00,@bezrec,6583,https://t.me/bezrec/6583,"–§–ê–° —Å–Ω–∏–∑–∏–ª–∞ —Ü–µ–Ω—É –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è –ª–µ—á–µ–Ω–∏—è –≥–µ–ø–∞—Ç–∏—Ç–∞ –° –Ω–∞ 50%. –ó–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ –¥–µ—à–µ–≤–ª–µ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω–æ–≥–æ –ú–∞–≤–∏—Ä–µ—Ç–∞ –æ—Ç Abbvie, –∑–∞—â–∏—â—ë–Ω–Ω–æ–≥–æ –ø–∞—Ç–µ–Ω—Ç–æ–º –¥–æ 2033 –≥–æ–¥–∞, —Å—Ç–∞–ª –°–µ–≤–∞–ª—å–≤–µ–æ –æ—Ç ¬´–ü—Ä–æ–º–æ–º–µ–¥–∞¬ª ‚Äî –≤—Ç–æ—Ä–æ–π –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π –¥–∂–µ–Ω–µ—Ä–∏–∫ –≤ —Ä–∞–º–∫–∞—Ö –ú–ù–ù –≥–ª–µ–∫–∞–ø—Ä–µ–≤–∏—Ä+–ø–∏–±—Ä–µ–Ω—Ç–∞—Å–≤–∏—Ä. –¢–µ–ø–µ—Ä—å —Å —Ü–µ–Ω–æ–π –ø—Ä–∏–¥—ë—Ç—Å—è ¬´–ø–æ–¥–≤–∏–Ω—É—Ç—å—Å—è¬ª –∏ ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑—É¬ª ‚Äî –ø–æ–∫–∞ —á—Ç–æ –µ–≥–æ –ü–∏–≥–ª–µ—Ä–∏—è –¥–µ—à–µ–≤–ª–µ —Ä–µ—Ñ–µ—Ä–µ–Ω—Ç–∞ –Ω–∞ 40%. –ê–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å—â–∏–∫–∏ –Ω–∞–ø—Ä–∞–≤—è—Ç —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–µ–µ —É–≤–µ–¥–æ–º–ª–µ–Ω–∏–µ –∫–æ–º–ø–∞–Ω–∏–∏ –í–∏–∫—Ä–∞–º–∞ –ü—É–Ω–∏—è. –°–Ω–∏–∂–µ–Ω–∏–µ —Å–æ–≥–ª–∞—Å–æ–≤–∞–Ω–Ω—ã—Ö —Ü–µ–Ω –Ω–∞ —ç—Ç–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –ø–æ–≤—ã—Å–∏—Ç –∏—Ö –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å –ø–æ—Å–ª–µ –æ–∫–æ–Ω—á–∞–Ω–∏—è –¥–µ–π—Å—Ç–≤–∏—è –ø–∞—Ç–µ–Ω—Ç–∞ –Ω–∞ –æ—Ä–∏–≥–∏–Ω–∞–ª, ‚Äî —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω–æ –æ–±–µ—â–∞—é—Ç –≤ –§–ê–°. –í–ø—Ä–æ—á–µ–º, –¥–∂–µ–Ω–µ—Ä–∏–∫–∏ —É–∂–µ –¥–µ–ª–∞—é—Ç —Å–≤–æ—ë –¥–µ–ª–æ ‚Äî –≤ ¬´–ó–¥—Ä–∞–≤—Ä–µ—Å—É—Ä—Å–µ¬ª –ø–æ–¥—Å—á–∏—Ç–∞–ª–∏, —á—Ç–æ —Å—Ä–µ–¥–Ω—è—è —Ü–µ–Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –æ—Ç –≥–µ–ø–∞—Ç–∏—Ç–∞ –° –Ω–∞ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Ç–æ—Ä–≥–∞—Ö –≤ –∏—é–ª–µ —ç—Ç–æ–≥–æ –≥–æ–¥–∞ –±—ã–ª–∞ –Ω–∞ —á–µ—Ç–≤–µ—Ä—Ç—å –Ω–∏–∂–µ, —á–µ–º –≤ –∫–æ–Ω—Ü–µ 2023 –≥–æ–¥–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""pricing, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The FAS has reduced the price of a hepatitis C treatment, Selveleo from Promomed, by 50% compared to the original Maviret from Abbvie. The FAS claims this will increase accessibility after the patent expires, as prices for these generics have already dropped by 25% compared to last year. The FAS is also expected to issue a notification to Vikram Pujia's company.""
}"
2025-09-25T05:45:27+00:00,@bezrec,6582,https://t.me/bezrec/6582,"–ù–∏–¥–µ—Ä–ª–∞–Ω–¥—ã –ø–æ—Ç–µ—Ä—è–ª–∏ –º–µ—Å—Ç–æ –≤ —Ç—Ä–æ–π–∫–µ –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö –ø–æ—Å—Ç–∞–≤—â–∏–∫–æ–≤ –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ –†–æ—Å—Å–∏—é. –í –∏—é–ª–µ —ç—Ç–æ–≥–æ –≥–æ–¥–∞ –ï–≤—Ä–æ—Å–æ—é–∑ –±–æ–ª–µ–µ —á–µ–º –≤–¥–≤–æ–µ –Ω–∞—Ä–∞—Å—Ç–∏–ª –∑–∞–∫—É–ø–∫—É –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏–∑ –†–æ—Å—Å–∏–∏. –¢–µ–ø–µ—Ä—å –ø–æ—Å–º–æ—Ç—Ä–∏–º, –∏–∑ –∫–∞–∫–∏—Ö –µ–≤—Ä–æ–ø–µ–π—Å–∫–∏—Ö —Å—Ç—Ä–∞–Ω –ø—Ä–∏–µ–∑–∂–∞–µ—Ç –±–æ–ª—å—à–µ –≤—Å–µ–≥–æ –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ –Ω–∞—à—É —Å—Ç—Ä–∞–Ω—É. –õ–∏–¥–∏—Ä—É–µ—Ç, –∫–∞–∫ –∏ –≤ –ø—Ä–µ–¥—ã–¥—É—â–∏–µ –Ω–µ—Å–∫–æ–ª—å–∫–æ –ª–µ—Ç, –ì–µ—Ä–º–∞–Ω–∏—è. –ö–∞–∫ –ø–æ–¥—Å—á–∏—Ç–∞–ª–∏ –†–ò–ê –ù–æ–≤–æ—Å—Ç–∏ –Ω–∞ –æ—Å–Ω–æ–≤–µ –¥–∞–Ω–Ω—ã—Ö –∑–∞—Ä—É–±–µ–∂–Ω—ã—Ö —Ç–∞–º–æ–∂–µ–Ω–Ω—ã—Ö –≤–µ–¥–æ–º—Å—Ç–≤, –µ—ë –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–π —ç–∫—Å–ø–æ—Ä—Ç –≤ –†–æ—Å—Å–∏—é –≤ –ø–µ—Ä–≤–æ–º –ø–æ–ª—É–≥–æ–¥–∏–∏ 2025 –≥–æ–¥–∞ —Å–æ—Å—Ç–∞–≤–∏–ª $992,3 –º–ª–Ω, —Ö–æ—Ç—è –æ–±—ä—ë–º—ã –ø—Ä–æ—Å–µ–ª–∏ –Ω–∞ 11,4% –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å 2021 –≥–æ–¥–æ–º. –°—Ä–∞–∑—É –Ω–∞ –≤—Ç–æ—Ä–æ–µ –º–µ—Å—Ç–æ —Å —á–µ—Ç–≤—ë—Ä—Ç–æ–≥–æ –ø–æ–¥–Ω—è–ª–∞—Å—å –®–≤–µ–π—Ü–∞—Ä–∏—è, –Ω–∞—Ä–∞—Å—Ç–∏–≤—à–∞—è –æ–±—ä—ë–º—ã –ø–æ—Å—Ç–∞–≤–æ–∫ –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏ –≤–¥–≤–æ–µ. –ó–∞–º—ã–∫–∞–µ—Ç —Ç—Ä–æ–π–∫—É –ª–∏–¥–µ—Ä–æ–≤ –ë–µ–ª—å–≥–∏—è ‚Äî –∑–∞ 4 –≥–æ–¥–∞ –æ—Ç—Ç—É–¥–∞ –≤–≤–µ–∑–ª–∏ –Ω–∞ 17,3% –º–µ–Ω—å—à–µ –ª–µ–∫–∞—Ä—Å—Ç–≤. –£—Å–ø–µ—Ö–∏ –®–≤–µ–π—Ü–∞—Ä–∏–∏ –≤—ã—Ç–µ—Å–Ω–∏–ª–∏ –∏–∑ —Ç–æ–ø-3 –ù–∏–¥–µ—Ä–ª–∞–Ω–¥—ã, –Ω–µ—Å–º–æ—Ç—Ä—è –Ω–∞ —Ç–æ, —á—Ç–æ –∏–º–ø–æ—Ä—Ç –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç–æ–≤ –∏–∑ –∫–æ—Ä–æ–ª–µ–≤—Å—Ç–≤–∞ —Å–æ–∫—Ä–∞—Ç–∏–ª—Å—è –≤—Å–µ–≥–æ –Ω–∞ 5,3%. –ü–æ—á—Ç–∏ –Ω–∞ —á–µ—Ç–≤–µ—Ä—Ç—å –Ω–∞—Ä–∞—Å—Ç–∏–ª–∞ –ø–æ—Å—Ç–∞–≤–∫–∏ –°–ª–æ–≤–µ–Ω–∏—è, —á—Ç–æ –∏ –æ–±–µ—Å–ø–µ—á–∏–ª–æ –µ–π –ø—è—Ç–æ–µ –º–µ—Å—Ç–æ. –í—Å–µ–≥–æ –∑–∞ –ø–µ—Ä–≤—ã–µ —à–µ—Å—Ç—å –º–µ—Å—è—Ü–µ–≤ —Ç–µ–∫—É—â–µ–≥–æ –≥–æ–¥–∞ –†–æ—Å—Å–∏—è –∑–∞–∫—É–ø–∏–ª–∞ –∑–∞ —Ä—É–±–µ–∂–æ–º –ª–µ–∫–∞—Ä—Å—Ç–≤ –Ω–∞ $4,1 –º–ª—Ä–¥, —á—Ç–æ –Ω–∞ 3,5% –±–æ–ª—å—à–µ, —á–µ–º –∑–∞ –∞–Ω–∞–ª–æ–≥–∏—á–Ω—ã–π –ø–µ—Ä–∏–æ–¥ 2021 –≥–æ–¥–∞. 59% –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç–µ–π –≤ –∏–º–ø–æ—Ä—Ç–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞—Ö –∑–∞–∫—Ä—ã–ª–∞ –ø–µ—Ä–≤–∞—è –ø—è—Ç–µ—Ä–∫–∞ –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö –ø–æ—Å—Ç–∞–≤—â–∏–∫–æ–≤. –¢–∞–∫–∂–µ —Ñ–∞—Ä–º–ø—Ä–æ–¥—É–∫—Ü–∏—é –≤–µ–∑—É—Ç –∏–∑ –§—Ä–∞–Ω—Ü–∏–∏ (6% –ø–æ—Å—Ç–∞–≤–æ–∫), –ò–Ω–¥–∏–∏ (5%), –í–µ–Ω–≥—Ä–∏–∏, –ü–æ–ª—å—à–∏ –∏ –®–≤–µ—Ü–∏–∏ (–ø–æ 4%). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-09-24T14:17:27+00:00,@bezrec,6581,https://t.me/bezrec/6581,"–õ–µ–∫–∞—Ä—Å—Ç–≤–∞ –æ—Ç–ø—Ä–∞–≤—è—Ç –≤ —Ç—é—Ä—å–º—É —á–µ—Ä–µ–∑ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç. –§–°–ò–ù –∑–∞–ø—É—Å—Ç–∏–ª–∞ —Å–æ–±—Å—Ç–≤–µ–Ω–Ω—É—é –∏–Ω—Ç–µ—Ä–Ω–µ—Ç-–∞–ø—Ç–µ–∫—É. –í —Ä—è–¥–µ —É—á—Ä–µ–∂–¥–µ–Ω–∏–π –£–ò–° –ø–æ–∫–∞ –≤ –∫–∞—á–µ—Å—Ç–≤–µ –ø–∏–ª–æ—Ç–Ω–æ–≥–æ –ø—Ä–æ–µ–∫—Ç–∞ —Ñ—É–Ω–∫—Ü–∏–æ–Ω–∏—Ä—É–µ—Ç –∏–Ω—Ç–µ—Ä–Ω–µ—Ç-–∞–ø—Ç–µ–∫–∞ ¬´–§-–∞–ø—Ç–µ–∫–∞¬ª. –ü–æ—Å—Ä–µ–¥—Å—Ç–≤–æ–º —ç—Ç–æ–≥–æ —Å–µ—Ä–≤–∏—Å–∞ —Ä–æ–¥—Å—Ç–≤–µ–Ω–Ω–∏–∫–∏ –ª–∏—Ü, —Å–æ–¥–µ—Ä–∂–∞—â–∏—Ö—Å—è –ø–æ–¥ —Å—Ç—Ä–∞–∂–µ–π, –ø–æ –≤—ã–ø–∏—Å–∞–Ω–Ω–æ–º—É –≤—Ä–∞—á–æ–º –ª–∏—Å—Ç—É –Ω–∞–∑–Ω–∞—á–µ–Ω–∏—è —Ñ–æ—Ä–º–∏—Ä—É—é—Ç –∏ –æ–ø–ª–∞—á–∏–≤–∞—é—Ç –∑–∞–∫–∞–∑ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, ‚Äî –ø–æ—Ä–∞–¥–æ–≤–∞–ª –Ω–æ–≤–æ–π –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å—é –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –§–°–ò–ù –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –†–æ–∑–∏–Ω. –ü–æ—Å–ª–µ –æ—Ñ–æ—Ä–º–ª–µ–Ω–∏—è –∏ –æ–ø–ª–∞—Ç—ã –∑–∞–∫–∞–∑–∞ —Å–µ—Ä–≤–∏—Å –ø—Ä–æ–∏–Ω—Ñ–æ—Ä–º–∏—Ä—É–µ—Ç –ø–æ–∫—É–ø–∞—Ç–µ–ª—è –æ –¥–æ—Å—Ç–∞–≤–∫–µ ¬´–ø–µ—Ä–µ–¥–∞—á–∫–∏¬ª –∞–¥—Ä–µ—Å–∞—Ç—É. –ü–æ–∫–∞ —á—Ç–æ –ø–∏–ª–æ—Ç –±—É–¥–µ—Ç –¥–æ—Å—Ç—É–ø–µ–Ω –≤ —Å–µ–º–∏ —É—á—Ä–µ–∂–¥–µ–Ω–∏—è—Ö –ú–æ—Å–∫–≤—ã, –ú–æ—Å–∫–æ–≤—Å–∫–æ–π, –ò–≤–∞–Ω–æ–≤—Å–∫–æ–π –∏ –¢–≤–µ—Ä—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–µ–π, –∞ —Ç–∞–∫–∂–µ –†–µ—Å–ø—É–±–ª–∏–∫–∏ –ú–∞—Ä–∏–π-–≠–ª. –í —Å–µ–Ω—Ç—è–±—Ä–µ 2023 –≥–æ–¥–∞ –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—å –û–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–π –Ω–∞–±–ª—é–¥–∞—Ç–µ–ª—å–Ω–æ–π –∫–æ–º–∏—Å—Å–∏–∏ –ú–æ—Å–∫–≤—ã –ì–µ–æ—Ä–≥–∏–π –í–æ–ª–∫–æ–≤ –≥–æ–≤–æ—Ä–∏–ª –æ –Ω–∞–º–µ—Ä–µ–Ω–∏–∏ —Å–æ–∑–¥–∞—Ç—å –∏–Ω—Ç–µ—Ä–Ω–µ—Ç-–º–∞–≥–∞–∑–∏–Ω —Å –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏ –¥–ª—è –≤—Å–µ—Ö –°–ò–ó–û —Å—Ç–æ–ª–∏—Ü—ã. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-09-24T10:53:54+00:00,@bezrec,6580,https://t.me/bezrec/6580,"–ê–Ω–∞–ª–∏—Ç–∏–∫–∏ —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏, —á–µ–º –ª–µ—á–∞—Ç—Å—è —Å–µ—Ä–¥–µ—á–Ω–∏–∫–∏. –ü–æ –¥–∞–Ω–Ω—ã–º RNC Pharma, –∫ –∞–≤–≥—É—Å—Ç—É 2025 –≥–æ–¥–∞ –≤ —Ä–æ–∑–Ω–∏—Ü—É –±—ã–ª–æ –ø—Ä–æ–¥–∞–Ω–æ –±–æ–ª–µ–µ 42 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π —Å–µ—Ä–¥—Ü–∞ –Ω–∞ 9,1 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –≠—Ç–æ –Ω–∞ 18,7% –±–æ–ª—å—à–µ –≤ –¥–µ–Ω—å–≥–∞—Ö –∏ –Ω–∞ 3% –º–µ–Ω—å—à–µ –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö –≥–æ–¥ –∫ –≥–æ–¥—É. –ó–∞ –ø–æ—Å–ª–µ–¥–Ω–∏–µ –≥–æ–¥—ã —ç—Ç–∞ –≥—Ä—É–ø–ø–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∑–∞–º–µ—Ç–Ω–æ –ø—Ä–∏–±–∞–≤–∏–ª–∞ –≤ —Ü–µ–Ω–µ ‚Äî –µ—Å–ª–∏ –≤ 2022 –æ–¥–Ω—É —É—Å–ª–æ–≤–Ω—É—é —É–ø–∞–∫–æ–≤–∫—É –≤–æ–∑–º–æ–∂–Ω–æ –±—ã–ª–æ –∫—É–ø–∏—Ç—å –∑–∞ 148 —Ä—É–±–ª–µ–π, —Ç–æ –≤ —è–Ω–≤–∞—Ä–µ-–∞–≤–≥—É—Å—Ç–µ —ç—Ç–æ–≥–æ –≥–æ–¥–∞ –∑–∞ –Ω–µ—ë –∂–µ –ø—Ä–∏—à–ª–æ—Å—å –≤—ã–ª–æ–∂–∏—Ç—å —É–∂–µ 216 —Ä—É–±–ª–µ–π, –ø—Ä–∏—Ä–æ—Å—Ç –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ –≤–æ—Å—å–º–∏ –º–µ—Å—è—Ü–µ–≤ –ø—Ä–æ—à–ª–æ–≥–æ –≥–æ–¥–∞ —Å–æ—Å—Ç–∞–≤–∏–ª 22,4%. –î–µ—à–µ–≤–ª–µ –≤—Å–µ–≥–æ –æ–±–æ–π–¥—É—Ç—Å—è —É—Å—Ç–∞—Ä–µ–≤—à–∏–µ –í–∞–ª–∏–¥–æ–ª (30 —Ä—É–±–ª–µ–π) –∏ –ë–æ—è—Ä—ã—à–Ω–∏–∫, —Ö–æ—Ç—è –ø–æ—Å–ª–µ–¥–Ω–∏–π –ø–æ–¥—Å–∫–æ—á–∏–ª –≤ —Ü–µ–Ω–µ —Å—Ä–∞–∑—É –Ω–∞ 50%, –¥–æ 55 —Ä—É–±–ª–µ–π. –í –æ—Ç—á—ë—Ç–Ω—ã–π –ø–µ—Ä–∏–æ–¥ 48% –≤—Å–µ—Ö –∑–∞—Ç—Ä–∞—Ç –≤ –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ –ø—Ä–∏—à–ª–æ—Å—å –Ω–∞ –º–µ—Ç–∞–±–æ–ª–∏—á–µ—Å–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –Ω–∞ –æ—Å–Ω–æ–≤–µ –º–µ–ª—å–¥–æ–Ω–∏—è, –∏–Ω–æ–∑–∏–Ω–∞ –∏ –¥—Ä. –ü–æ –ø—Ä–æ–¥–∞–∂–∞–º –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö –ª–∏–¥–∏—Ä—É—é—Ç –∫–æ—Ä–æ–Ω–∞—Ä–æ–¥–∏–ª–∞—Ç–∏—Ä—É—é—â–∏–µ —Å—Ä–µ–¥—Å—Ç–≤–∞ —Ä–µ—Ñ–ª–µ–∫—Ç–æ—Ä–Ω–æ–≥–æ –¥–µ–π—Å—Ç–≤–∏—è ‚Äî –∏—Ö –¥–æ–ª—è –ø—Ä–µ–≤—ã—à–∞–ª–∞ 40,7%, –Ω–æ –≤ —Ä—É–±–ª—ë–≤–æ–º —ç–∫–≤–∏–≤–∞–ª–µ–Ω—Ç–µ —Å–æ—Å—Ç–∞–≤–ª—è–ª–∞ –≤—Å–µ–≥–æ 12,2%. –ú–∞–∫—Å–∏–º–∞–ª—å–Ω–æ–π –¥–∏–Ω–∞–º–∏–∫–æ–π –ø—Ä–æ–¥–∞–∂ –æ—Ç–º–µ—Ç–∏–ª–∏—Å—å –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã —Å –ú–ù–ù —Ä–∞–Ω–æ–ª–∞–∑–∏–Ω ‚Äî —Å–ø—Ä–æ—Å –Ω–∞ –Ω–∏—Ö —É–≤–µ–ª–∏—á–∏–ª—Å—è –Ω–∞ 36,1% –≤ –¥–µ–Ω—å–≥–∞—Ö –∏ –Ω–∞ 43,8% –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö. –° —Ç–æ—á–∫–∏ –∑—Ä–µ–Ω–∏—è –¥–µ–Ω–µ–∂–Ω—ã—Ö –ø—Ä–æ–¥–∞–∂ —É–∂–µ –Ω–µ—Å–∫–æ–ª—å–∫–æ –ª–µ—Ç –ª–∏–¥–∏—Ä—É–µ—Ç –ú–∏–ª–¥—Ä–æ–Ω–∞—Ç –æ—Ç –ª–∞—Ç–≤–∏–π—Å–∫–æ–π ¬´–ì—Ä–∏–Ω–¥–µ–∫—Å¬ª. –ó–∞—Ç–æ –∑–∞–Ω–∏–º–∞—é—â–∏–π –ø–æ—Å–ª–µ–¥–Ω—é—é —Å—Ç—Ä–æ—á–∫—É –≤ —Ç–æ–ø-10 –ë—Ä–µ–π–Ω–º–∞–∫—Å –æ—Ç ¬´–ü—Ä–æ–º–æ–º–µ–¥–∞¬ª –º–æ–∂–µ—Ç –ø–æ—Ö–≤–∞—Å—Ç–∞—Ç—å—Å—è —Å–∞–º–æ–π –∑–∞–º–µ—Ç–Ω–æ–π –¥–∏–Ω–∞–º–∏–∫–æ–π ‚Äî –æ–±—ä—ë–º —Ä–æ–∑–Ω–∏—á–Ω—ã—Ö –ø—Ä–æ–¥–∞–∂ –º–∞—Ä–∫–∏ —É–≤–µ–ª–∏—á–∏–ª—Å—è –Ω–∞ 66% –≤ —Ä—É–±–ª—è—Ö –∏ –Ω–∞ 72% –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö. –ù–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ ‚Äî –ü–∞–Ω–∞–Ω–≥–∏–Ω (¬´–ì–µ–¥–µ–æ–Ω –†–∏—Ö—Ç–µ—Ä¬ª) —Å –¥–æ–ª–µ–π 15,8%, –Ω–∞ —Ç—Ä–µ—Ç—å–µ–º ‚Äî –Ω–µ–±—Ä–µ–Ω–¥–∏—Ä–æ–≤–∞–Ω–Ω—ã–π –í–∞–ª–∏–¥–æ–ª, –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–Ω—ã–π 14 –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º–∏ –≤–æ –≥–ª–∞–≤–µ —Å ¬´–û–±–Ω–æ–≤–ª–µ–Ω–∏–µ–º¬ª. –î–∞–ª–µ–µ —Å–ª–µ–¥—É—é—Ç –ê—Å–ø–∞—Ä–∫–∞–º (¬´–û–±–Ω–æ–≤–ª–µ–Ω–∏–µ¬ª + 14 –∫–æ–º–ø–∞–Ω–∏–π), –ú–µ–ª—å–¥–æ–Ω–∏–π (¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç¬ª + 14 –∫–æ–º–ø–∞–Ω–∏–π), –ë–æ—è—Ä—ã—à–Ω–∏–∫–∞ –Ω–∞—Å—Ç–æ–π–∫–∞ (¬´–ì–∏–ø–ø–æ–∫—Ä–∞—Ç¬ª + 16 –∫–æ–º–ø–∞–Ω–∏–π¬ª), –†–∏–±–æ–∫—Å–∏–Ω (¬´–ë–æ—Ä–∏—Å–æ–≤—Å–∫–∏–π –∑–∞–≤–æ–¥ –º–µ–¥–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤¬ª + 20 –∫–æ–º–ø–∞–Ω–∏–π), –ù–µ–æ—Ç–æ–Ω (¬´–ê–ª—å—Ñ–∞—Å–∏–≥–º–∞¬ª), –†–∞–Ω–µ–∫—Å–∞ (¬´–ú–µ–Ω–∞—Ä–∏–Ω–∏¬ª). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": true
}"
2025-09-24T07:32:33+00:00,@bezrec,6579,https://t.me/bezrec/6579,"–¢–∞–∫–∞—è —Ü–∏—Ñ—Ä–∞ —Ñ–∏–≥—É—Ä–∏—Ä—É–µ—Ç –≤ –ø—Ä–æ–µ–∫—Ç–µ –±—é–¥–∂–µ—Ç–∞ –†–æ—Å—Å–∏–∏ –Ω–∞ 2026-2028 –≥–æ–¥—ã. –°—Ä–µ–¥—Å—Ç–≤–∞ –Ω–∞ –ø—Ä–æ–≥—Ä–∞–º–º—ã –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è, –≤–∫–ª—é—á–∞—è –ø–æ–º–æ—â—å –¥–µ—Ç—è–º —Å —Ç—è–∂–µ–ª—ã–º–∏, —Ä–µ–¥–∫–∏–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏ —á–µ—Ä–µ–∑ –§–æ–Ω–¥ ¬´–ö—Ä—É–≥ –¥–æ–±—Ä–∞¬ª, –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫—É —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø–æ –ø—Ä–æ–≥—Ä–∞–º–º–µ 14 –í–ó–ù, –ø—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ–Ω—ã –≤ –ø–æ–ª–Ω–æ–º –æ–±—ä—ë–º–µ. –ù–∞ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏—é –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ –ø—Ä–æ–µ–∫—Ç–∞ ¬´–ü—Ä–æ–¥–æ–ª–∂–∏—Ç–µ–ª—å–Ω–∞—è –∏ –∞–∫—Ç–∏–≤–Ω–∞—è –∂–∏–∑–Ω—å¬ª –≤ —Ç—Ä–µ—Ö–ª–µ—Ç–∫–µ –ø—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ–Ω–æ –±–æ–ª–µ–µ 900 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –í —Ä–∞–º–∫–∞—Ö –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ –ø—Ä–æ–µ–∫—Ç–∞ ¬´–°–µ–º—å—è¬ª –±—É–¥—É—Ç –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω—ã —Å—Ä–µ–¥—Å—Ç–≤–∞ –Ω–∞ —Ä–∞–∑–≤–∏—Ç–∏–µ –æ–±—ä–µ–∫—Ç–æ–≤ –¥–µ—Ç—Å–∫–æ–≥–æ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è: –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä—ã –ø–µ—Ä–∏–Ω–∞—Ç–∞–ª—å–Ω—ã—Ö —Ü–µ–Ω—Ç—Ä–æ–≤, –¥–µ—Ç—Å–∫–∏—Ö –±–æ–ª—å–Ω–∏—Ü, —Ä–æ–¥–¥–æ–º–æ–≤. –ù–∞ —ç—Ç–æ –ø—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ–Ω–æ –±–æ–ª–µ–µ 94 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –≤ –±–ª–∏–∂–∞–π—à–∏–µ 3 –≥–æ–¥–∞. –ù–æ–≤–æ—Å—Ç—å-¬´–±–æ–º–±–∞¬ª –ø—Ä–æ –ø–æ–≤—ã—à–µ–Ω–∏–µ –ù–î–° —Å 20% –¥–æ 22% –ª–µ–∫–∞—Ä—Å—Ç–≤ –Ω–µ –∫–∞—Å–∞–µ—Ç—Å—è ‚Äî –¥–ª—è —Å–æ—Ü–∏–∞–ª—å–Ω–æ –∑–Ω–∞—á–∏–º—ã—Ö —Ç–æ–≤–∞—Ä–æ–≤ —Å–æ—Ö—Ä–∞–Ω—è–µ—Ç—Å—è –ª—å–≥–æ—Ç–Ω–∞—è —Å—Ç–∞–≤–∫–∞ 10%. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The message discusses budget allocations for Russia on the years 2026-2028, including funds for pharmaceutical programs such as support for children with severe and rare diseases through the 'Circle of Goodness' fund, prevention of cardiovascular diseases, and implementation of the 14-VZN program. It also mentions spending on national projects 'Longevity and Activity' amounting to over 900 billion rubles. Additionally, it covers investments in family-related projects for the development of pediatric healthcare infrastructure including perinatal centers, children's hospitals, and maternity wards. The message does not mention any impact on the pharmaceutical market or prices.""
}"
2025-09-24T05:20:30+00:00,@bezrec,6578,https://t.me/bezrec/6578,"–ê—Å—Å–æ—Ü–∏–∞—Ü–∏—è –º–µ–Ω–µ–¥–∂–µ—Ä–æ–≤ –∏ ¬´–ö–æ–º–º–µ—Ä—Å–∞–Ω—Ç—ä¬ª –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∏ —Å–≤–æ–π –µ–∂–µ–≥–æ–¥–Ω—ã–π 26-–π —Ä–µ–π—Ç–∏–Ω–≥ ¬´–¢–æ–ø-1000 —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –º–µ–Ω–µ–¥–∂–µ—Ä–æ–≤¬ª. –ü–æ—Å–º–æ—Ç—Ä–µ–ª–∏, –∫—Ç–æ –∏–∑ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ –ø–æ–ø–∞–ª –≤ —Ç–æ–ø-250 –≤—ã—Å—à–∏—Ö —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª–µ–π. –°–ø–∏—Å–æ–∫ —Ç–æ–ø–æ–≤ –æ—Ç —Ñ–∞—Ä–º–∏–Ω–¥—É—Å—Ç—Ä–∏–∏ —Å—Ç–∞–ª –º–µ–Ω—å—à–µ –µ—â—ë –Ω–∞ –æ–¥–Ω—É –ø–æ–∑–∏—Ü–∏—é ‚Äî —Ç–µ–ø–µ—Ä—å –≤ –Ω—ë–º —à–µ—Å—Ç—å —Ñ–∞–º–∏–ª–∏–π –ø—Ä–æ—Ç–∏–≤ –≤–æ—Å—å–º–∏ –≤ 2023 –≥–æ–¥—É –∏ —Å–µ–º–∏ –≤ –ø—Ä–æ—à–ª–æ–º. –ë–µ—Å—Å–º–µ–Ω–Ω—ã–µ –µ–≥–æ —É—á–∞—Å—Ç–Ω–∏–∫–∏ ‚Äî –†—É—Å—Ç–µ–º –ú—É—Ä–∞—Ç–æ–≤ (¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º –ì—Ä—É–ø–ø¬ª), –ï–∫–∞—Ç–µ—Ä–∏–Ω–∞ –ü–æ–≥–æ–¥–∏–Ω–∞ (J&J), –ü—ë—Ç—Ä –†–æ–¥–∏–æ–Ω–æ–≤ (¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª), –í–∞–¥–∏–º –ú—É–∑—è–µ–≤ (¬´–ü—Ä–æ—Ç–µ–∫¬ª). –ù–æ–≤–∏—á–æ–∫ –ø—Ä–æ—à–ª–æ–≥–æ –≥–æ–¥–∞ ‚Äî –≥–µ–Ω–µ—Ä–∞–ª—å–Ω—ã–π –¥–∏—Ä–µ–∫—Ç–æ—Ä ¬´–ë—É–∞—Ä–æ–Ω–∞¬ª –ò—Ä–∏–Ω–∞ –ù–∏–∫—É–ª–∏–Ω–∞ ‚Äî —Å–æ—Ö—Ä–∞–Ω–∏–ª–∞ –º–µ—Å—Ç–æ –≤ —Ç–æ–ø–µ –∏ –≤ —ç—Ç–æ–º –≥–æ–¥—É. –í –æ—Ç–ª–∏—á–∏–µ –æ—Ç –ò—Ä–∏–Ω—ã –ü–∞–Ω–∞—Ä–∏–Ω–æ–π (¬´–ê—Å—Ç—Ä–∞–ó–µ–Ω–µ–∫–∞ –§–∞—Ä–º–∞—Å—å—é—Ç–∏–∫–∞–ª–∑¬ª) –∏ –í–ª–∞–¥–∏—Å–ª–∞–≤–∞ –ë–µ—Å—Å–∞—Ä–∞–±–æ–≤–∞ (¬´–ë–æ—Å–Ω–∞–ª–µ–∫¬ª), –∫–æ—Ç–æ—Ä—ã—Ö –≤ –æ–±–Ω–æ–≤–ª—ë–Ω–Ω–æ–º —Å–ø–∏—Å–∫–µ –Ω–µ –æ–∫–∞–∑–∞–ª–æ—Å—å. –ù–æ–≤–æ–µ –ª–∏—Ü–æ –≤ —Ç–æ–ø-250 –≤—ã—Å—à–∏—Ö —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª–µ–π ‚Äî –ë–æ—Ä–∏—Å –ü–æ–ø–æ–≤ ‚Äî –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä ¬´–†–∏–≥–ª—ã¬ª. –ü—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–∏ —Ñ–∞—Ä–º–ø—Ä–æ–º–∞ –µ—Å—Ç—å –∏ –≤ –¥—Ä—É–≥–∏—Ö –∫–∞—Ç–µ–≥–æ—Ä–∏—è—Ö. –¢–∞–∫, –≤ —Ç–æ–ø-100 –∫–æ–º–º–µ—Ä—á–µ—Å–∫–∏—Ö –¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–≤ –ø–æ–ø–∞–ª–∏: –ï–∫–∞—Ç–µ—Ä–∏–Ω–∞ –°–ª–∞–≤–≥–æ—Ä–æ–¥—Å–∫–∞—è (¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º –ì—Ä—É–ø–ø¬ª), –û–ª—å–≥–∞ –õ–∞—Ä–∏–Ω–∞ (¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª), –ï–ª–µ–Ω–∞ –ö–æ—Ä–æ–ª—ë–≤–∞ (¬´–°–æ—Ç–µ–∫—Å¬ª), –í–ª–∞–¥–∏–º–∏—Ä –°–∫–æ—Ä–Ω—è–∫–æ–≤ (¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª). –ó–≤—ë–∑–¥—ã –º–∞—Ä–∫–µ—Ç–∏–Ω–≥–∞ –∏ PR: –ê–Ω—Ç–æ–Ω –§–µ–¥–æ—Å—é–∫ –∏ –ê–ª–ª–∞ –ì—Ä–æ–º–æ–≤–∞ (¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º –ì—Ä—É–ø–ø¬ª), –ú–∞—Ä–∏–Ω–∞ –†—ã–∫–æ–≤–∞ –∏ –ï–≤–≥–µ–Ω–∏—è –î–æ–º–æ—Ä–æ—â–µ–Ω–∫–æ–≤–∞ (¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª), –Æ–ª–∏—è –í–µ—Å–µ–Ω—ë–≤–∞ (J&J). –ü–æ –¥–æ–±—Ä–æ–π —Ç—Ä–∞–¥–∏—Ü–∏–∏ –∏—â–µ–º –∑–Ω–∞–∫–æ–º—ã–µ –∏–º–µ–Ω–∞ –∏ –ø–æ–∑–¥—Ä–∞–≤–ª—è–µ–º –∫–æ–ª–ª–µ–≥ –ø–æ —Ü–µ—Ö—É. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-09-23T14:10:18+00:00,@bezrec,6577,https://t.me/bezrec/6577,"–†–æ—Å—Å–∏–π—Å–∫–∏–µ —É—á—ë–Ω—ã–µ –≤–ø–µ—Ä–≤—ã–µ –ø–æ–∫–∞–∑–∞–ª–∏ –º—ã—à–µ–π —Å—Ä–∞–∑—É –ø–æ—Å–ª–µ –∫–æ—Å–º–∏—á–µ—Å–∫–æ–≥–æ –ø–æ–ª—ë—Ç–∞ –Ω–∞ ¬´–ë–∏–æ–Ω–µ-–ú¬ª ‚Ññ2. –£ –≥—Ä—ã–∑—É–Ω–æ–≤ –≤ –∫–æ—Å–º–æ—Å–µ –±—ã–ª–∞ –≤—ã—Å–æ–∫–∞—è —Ü–µ–ª—å ‚Äî –Ω–∞ –Ω–∏—Ö –ø—Ä–æ–≤–µ—Ä—è–ª–∏ —Ä–∞–±–æ—Ç–æ—Å–ø–æ—Å–æ–±–Ω–æ—Å—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞, –∫–æ—Ç–æ—Ä—ã–π –º–æ–≥ –±—ã –∑–∞—â–∏—â–∞—Ç—å —á–µ–ª–æ–≤–µ–∫–∞ –æ—Ç —Ä–∞–¥–∏–∞—Ü–∏–∏ –≤ –¥–ª–∏—Ç–µ–ª—å–Ω—ã—Ö –º–µ–∂–ø–ª–∞–Ω–µ—Ç–Ω—ã—Ö —ç–∫—Å–ø–µ–¥–∏—Ü–∏—è—Ö. –û–¥–Ω–æ–π –∏–∑ –∑–∞–¥–∞—á, –∫–æ—Ç–æ—Ä—É—é –ò–Ω—Å—Ç–∏—Ç—É—Ç –º–µ–¥–∏–∫–æ-–±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –ø—Ä–æ–±–ª–µ–º —Ä–µ—à–∞–µ—Ç –Ω–∞ –±–∏–æ—Å–ø—É—Ç–Ω–∏–∫–µ, —è–≤–ª—è–µ—Ç—Å—è –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ —Ä–æ–ª–∏ –≥–µ–Ω–∞ Nrf2 –∏ —Ä–µ–≥—É–ª–∏—Ä—É–µ–º—ã—Ö –∏–º –µ—Å—Ç–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å–∏—Å—Ç–µ–º –∑–∞—â–∏—Ç—ã –≤ —É—Å–ª–æ–≤–∏—è—Ö –∫–æ—Å–º–æ—Å–∞. –ù–∞–º —Ç–∞–∫–∂–µ –ø—Ä–µ–¥—Å—Ç–æ–∏—Ç –≤—ã—è—Å–Ω–∏—Ç—å, –ø–æ–∑–≤–æ–ª–∏—Ç –ª–∏ –∞–∫—Ç–∏–≤–∞—Ü–∏—è —ç—Ç–∏—Ö –º–µ—Ö–∞–Ω–∏–∑–º–æ–≤ –æ–±–µ—Å–ø–µ—á–∏—Ç—å –∑–∞—â–∏—Ç—É –∫–æ—Å–º–æ–Ω–∞–≤—Ç–æ–≤ –ø—Ä–∏ –º–µ–∂–ø–ª–∞–Ω–µ—Ç–Ω–æ–º –ø–µ—Ä–µ–ª–µ—Ç–µ, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª –∑–∞–≤–µ–¥—É—é—â–∏–π –∏ –≤–µ–¥—É—â–∏–π –Ω–∞—É—á–Ω—ã–π —Å–æ—Ç—Ä—É–¥–Ω–∏–∫ –æ—Ç–¥–µ–ª–∞ –∫–æ—Å–º–∏—á–µ—Å–∫–æ–π –±–∏–æ–ª–æ–≥–∏–∏ –ò–ú–ë–ü –†–ê–ù –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ê–Ω–¥—Ä–µ–µ–≤-–ê–Ω–¥—Ä–∏–µ–≤—Å–∫–∏–π. –ú—ã—à–µ–π –≤ —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–µ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–ª–∏ –∫–∞–∫ –æ–¥–∏–Ω –∏–∑ –Ω–∞–∏–±–æ–ª–µ–µ —É–¥–æ–±–Ω—ã—Ö –¥–ª—è –∫–æ—Å–º–∏—á–µ—Å–∫–∏—Ö —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–æ–≤ –∏ –Ω–∞–∏–±–æ–ª–µ–µ –ø–æ–ª–Ω–æ –∏–∑—É—á–µ–Ω–Ω—ã—Ö –≤–∏–¥–æ–≤ –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–Ω—ã—Ö –∂–∏–≤–æ—Ç–Ω—ã—Ö. –í–æ –≤—Ä–µ–º—è —ç–∫—Å–ø–µ–¥–∏—Ü–∏–∏ —É –æ–¥–Ω–æ–π –≥—Ä—É–ø–ø—ã –∏—Å–ø—ã—Ç—É–µ–º—ã—Ö –≥–µ–Ω Nrf2 –±—ã–ª ¬´–≤—ã–∫–ª—é—á–µ–Ω¬ª, –≤–æ –≤—Ç–æ—Ä—É—é –≤—Ö–æ–¥–∏–ª–∏ –æ–±—ã—á–Ω—ã–µ –º—ã—à–∏, –∞ –≥—Ä—ã–∑—É–Ω–∞–º –∏–∑ —Ç—Ä–µ—Ç—å–µ–π –¥–∞–≤–∞–ª–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç –û–º–µ–≤–∞–∫—Å–æ–ª–æ–Ω, –∞–∫—Ç–∏–≤–∏—Ä—É—é—â–∏–π —ç–∫—Å–ø—Ä–µ—Å—Å–∏—é –≥–µ–Ω–∞ –∏ —Å—Ç–∏–º—É–ª–∏—Ä—É—é—â–∏–π —Ä–∞–±–æ—Ç—É –∞–Ω—Ç–∏–æ–∫—Å–∏–¥–∞–Ω—Ç–Ω—ã—Ö —Å–∏—Å—Ç–µ–º. ¬´–ë–∏–æ–Ω-–ú¬ª ‚Ññ2 –ø—Ä–æ–≤—ë–ª –Ω–∞ –æ—Ä–±–∏—Ç–µ 30 –¥–Ω–µ–π. –ñ–∏–≤—ã–º–∏ –≤–µ—Ä–Ω—É–ª–∏—Å—å 65 –∏–∑ 75 –º—ã—à–µ–π. –ü—Ä–∏—á–∏–Ω—É –≥–∏–±–µ–ª–∏ –¥–µ—Å—è—Ç–∏ –æ—Å—Ç–∞–ª—å–Ω—ã—Ö —É—á—ë–Ω—ã–º –µ—â—ë –ø—Ä–µ–¥—Å—Ç–æ–∏—Ç –≤—ã—è—Å–Ω–∏—Ç—å. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-09-23T10:50:01+00:00,@bezrec,6576,https://t.me/bezrec/6576,"–†–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–∏ —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏, –æ—Ç —á–µ–≥–æ –±—É–¥–µ—Ç –∑–∞–≤–∏—Å–µ—Ç—å —Å—É–¥—å–±–∞ –∏–Ω—Ç—Ä–∞–Ω–∞–∑–∞–ª—å–Ω–æ–π –≤–∞–∫—Ü–∏–Ω—ã –æ—Ç –≥—Ä–∏–ø–ø–∞. –ü–æ —Å–ª–æ–≤–∞–º –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ —Ü–µ–Ω—Ç—Ä–∞ –ø–æ –≥—Ä–∏–ø–ø—É –í–û–ó –ù–ò–ò –≥—Ä–∏–ø–ø–∞ –∏–º. –ê.–ê. –°–º–æ—Ä–æ–¥–∏–Ω—Ü–µ–≤–∞ –ê–Ω–¥—Ä–µ—è –í–∞—Å–∏–Ω–∞, –≤ –Ω–∞—Å—Ç–æ—è—â–µ–µ –≤—Ä–µ–º—è –ø—Ä–µ–ø–∞—Ä–∞—Ç –ø—Ä–æ—Ö–æ–¥–∏—Ç –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ –∏—Å–ø—ã—Ç–∞–Ω–∏—è. –ò, –ø–æ –≤—Å–µ–π –≤–∏–¥–∏–º–æ—Å—Ç–∏, –¥–æ–≤–æ–ª—å–Ω–æ —É—Å–ø–µ—à–Ω–æ: –í–∞–∫—Ü–∏–Ω–∞ —ç—Ç–∞ —Ä–∞–∑—Ä–∞–±–∞—Ç—ã–≤–∞–µ—Ç—Å—è —É–∂–µ –¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ –¥–∞–≤–Ω–æ, –∏ –Ω–∞—É—á–Ω—ã–π –∑–∞–¥–µ–ª –≤ –ù–ò–ò –≥—Ä–∏–ø–ø–∞ –æ—á–µ–Ω—å –±–æ–ª—å—à–æ–π. –Ø —É–≤–µ—Ä–µ–Ω, —á—Ç–æ –æ–Ω–∞ –±—É–¥–µ—Ç —Ö–æ—Ä–æ—à–æ —Ä–∞–±–æ—Ç–∞—Ç—å, ‚Äî –ø–æ–¥–µ–ª–∏–ª—Å—è —ç–∫—Å–ø–µ—Ä—Ç. –ù–æ —Ç–æ–ª—å–∫–æ –ª–∏—à—å —É—Å–ø–µ—à–Ω—ã—Ö –ö–ò –¥–ª—è –≤—ã—Ö–æ–¥–∞ –Ω–∞ —Ä—ã–Ω–æ–∫ –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ: –õ—é–±–æ–π –ø—Ä–µ–ø–∞—Ä–∞—Ç, –∫–æ–≥–¥–∞ –æ–Ω –¥–æ—Ö–æ–¥–∏—Ç –¥–æ —Ç—Ä–µ—Ç—å–µ–π —Ñ–∞–∑—ã, –¥–æ–ª–∂–µ–Ω –±—ã—Ç—å –≥–¥–µ-—Ç–æ –ø—Ä–æ–∏–∑–≤–µ–¥–µ–Ω. –ò–Ω–¥—É—Å—Ç—Ä–∏–∞–ª—å–Ω–æ–≥–æ –ø–∞—Ä—Ç–Ω–µ—Ä–∞, –∏–º–µ—é—â–µ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã–µ –º–æ—â–Ω–æ—Å—Ç–∏ –¥–ª—è —Ç–∞–∫–æ–≥–æ —Ç–∏–ø–∞ –≤–∞–∫—Ü–∏–Ω—ã, —Å–µ–π—á–∞—Å –Ω–µ—Ç. –ë—É–¥–µ—Ç –æ–Ω –∏–ª–∏ –Ω–µ—Ç, –æ—Ç —ç—Ç–æ–≥–æ –±—É–¥–µ—Ç –∑–∞–≤–∏—Å–µ—Ç—å —Å—É–¥—å–±–∞ —ç—Ç–æ–π –≤–∞–∫—Ü–∏–Ω—ã, ‚Äî –æ–±—ä—è—Å–Ω–∏–ª –í–∞—Å–∏–Ω. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –≤ —Ü–µ–Ω—Ç—Ä–µ –°–º–æ—Ä–æ–¥–∏–Ω—Ü–µ–≤–∞ —É–∂–µ –ø—Ä–æ–≤–µ–¥–µ–Ω—ã –ø–µ—Ä–≤–∞—è –∏ –≤—Ç–æ—Ä–∞—è —Ñ–∞–∑—ã –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å–ø—ã—Ç–∞–Ω–∏–π –≤–∞–∫—Ü–∏–Ω—ã –æ—Ç —Ä–µ—Å–ø–∏—Ä–∞—Ç–æ—Ä–Ω–æ-—Å–∏–Ω—Ü–∏—Ç–∏–∞–ª—å–Ω–æ–π –≤–∏—Ä—É—Å–Ω–æ–π –∏–Ω—Ñ–µ–∫—Ü–∏–∏. –ù–æ –∏ –∑–¥–µ—Å—å –≤–æ–ø—Ä–æ—Å —É–ø–∏—Ä–∞–µ—Ç—Å—è –≤ –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–∏–µ –º–µ—Å—Ç–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The director of the World Health Organization National Influenza Center, Andrei Vasin from the A.A. Smirnov Institute of Influenza, National Research Center for Influenza, shared that the vaccine is undergoing clinical trials. He believes it will work well and be produced by an industrial partner, which is currently lacking. The production location is also a key factor for the vaccine's success.""
}"
2025-09-23T07:34:42+00:00,@bezrec,6575,https://t.me/bezrec/6575,"–≠–∫—Å-–¥–∏—Ä–µ–∫—Ç–æ—Ä –∫—Ä–∞—Å–Ω–æ—è—Ä—Å–∫–æ–≥–æ –§–ú–ë–ê –ø–æ–ª—É—á–∏–ª 6 –ª–µ—Ç –∫–æ–ª–æ–Ω–∏–∏. –¶–µ–Ω—Ç—Ä–∞–ª—å–Ω—ã–π —Ä–∞–π–æ–Ω–Ω—ã–π —Å—É–¥ –ö—Ä–∞—Å–Ω–æ—è—Ä—Å–∫–∞ –ø—Ä–∏–≥–æ–≤–æ—Ä–∏–ª –ë–æ—Ä–∏—Å–∞ –ë–∞—Ä–∞–Ω–∫–∏–Ω–∞ –∫ —à–µ—Å—Ç–∏ –≥–æ–¥–∞–º –ª–∏—à–µ–Ω–∏—è —Å–≤–æ–±–æ–¥—ã –∑–∞ —Ä–∞—Å—Ç—Ä–∞—Ç—É 15 –º–ª–Ω —Ä—É–±–ª–µ–π. –ë—ã–≤—à–µ–º—É —á–∏–Ω–æ–≤–Ω–∏–∫—É —Ç–∞–∫–∂–µ –ø—Ä–µ–¥—Å—Ç–æ–∏—Ç –∑–∞–ø–ª–∞—Ç–∏—Ç—å —à—Ç—Ä–∞—Ñ –≤ 700 —Ç—ã—Å. —Ä—É–±–ª–µ–π. –°—Ç–æ—Ä–æ–Ω–∞ –æ–±–≤–∏–Ω–µ–Ω–∏—è –Ω–∞—Å—Ç–∞–∏–≤–∞–ª–∞ –Ω–∞ 7 –≥–æ–¥–∞—Ö —Ç—é—Ä—å–º—ã –∏ 800 —Ç—ã—Å. —Ä—É–±–ª–µ–π —à—Ç—Ä–∞—Ñ–∞. –ü—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª—å–Ω–∏—Ü–∞ —Ñ–∏—Ä–º—ã-–ø–æ—Å—Ç–∞–≤—â–∏–∫–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø–æ–ª—É—á–∏–ª–∞ —á–µ—Ç—ã—Ä–µ –≥–æ–¥–∞ —É—Å–ª–æ–≤–Ω–æ. –ë—ã–≤—à–∞—è –∂–µ–Ω–∞ –ë–∞—Ä–∞–Ω–∫–∏–Ω–∞, –æ–Ω–∞ –∂–µ –∑–∞–º—Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—è —Ü–µ–Ω—Ç—Ä–∞ –ø–æ —Å—Ç—Ä–∞—Ö–æ–≤–æ–π –∏ –≤–Ω–µ–±—é–¥–∂–µ—Ç–Ω–æ–π –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏, –µ—â—ë –Ω–∞—Ö–æ–¥–∏—Ç—Å—è –ø–æ–¥ —Å–ª–µ–¥—Å—Ç–≤–∏–µ–º. –°–∞–º–æ–µ —Å—É—Ä–æ–≤–æ–µ –Ω–∞–∫–∞–∑–∞–Ω–∏–µ –ø–æ–Ω–µ—Å–ª–∞ –∑–∞–≤–µ–¥—É—é—â–∞—è –∞–ø—Ç–µ–∫–æ–π —Ü–µ–Ω—Ç—Ä–∞, –∫–æ—Ç–æ—Ä–∞—è –∑–∞–∫–ª—é—á–∏–ª–∞ —Å–æ–≥–ª–∞—à–µ–Ω–∏–µ –æ —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–µ. –í –∏—é–Ω–µ 2024 –≥–æ–¥–∞ –æ–Ω–∞ –ø–æ–ª—É—á–∏–ª–∞ 6,5 –ª–µ—Ç –∏—Å–ø—Ä–∞–≤–∏—Ç–µ–ª—å–Ω–æ–π –∫–æ–ª–æ–Ω–∏–∏ –æ–±—â–µ–≥–æ —Ä–µ–∂–∏–º–∞ —Å–æ —à—Ç—Ä–∞—Ñ–æ–º –≤ 1,9 –º–ª–Ω —Ä—É–±–ª–µ–π. –°–∞–º –ë–∞—Ä–∞–Ω–∫–∏–Ω –ø—Ä–æ—Å–∏–ª —É —Å—É–¥–∞ —Å–Ω–∏—Å—Ö–æ–∂–¥–µ–Ω–∏—è: –Ø –¥–æ–ª–≥–æ —Ä—É–∫–æ–≤–æ–¥–∏–ª –ª—É—á—à–∏–º –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏–µ–º —Ä–µ–≥–∏–æ–Ω–∞, –≤—Å—é –∂–∏–∑–Ω—å —Ö–æ–∂—É –∏ —Ö–æ–¥–∏–ª –ø–æ –∑–µ–º–ª–µ. –ê –º–æ–∏ —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–∏ —Ö–æ—Ç–µ–ª–∏ –ø–µ—Ä–µ–ª–æ–∂–∏—Ç—å —Å–≤–æ–∏ –ø—Ä–æ–±–ª–µ–º—ã —Å–æ —Å–≤–æ–µ–π –±–æ–ª—å–Ω–æ–π –≥–æ–ª–æ–≤—ã –Ω–∞ –∑–¥–æ—Ä–æ–≤—É—é. –ó—Ä—è —è –Ω–µ –ø–µ—Ä–µ–¥–∞–ª —Å—Ä–∞–∑—É –≤ —Å–ª–µ–¥—Å—Ç–≤–µ–Ω–Ω—ã–π –æ—Ä–≥–∞–Ω —Å–≤–µ–¥–µ–Ω–∏—è, –∫–æ—Ç–æ—Ä—ã–µ —É–∑–Ω–∞–ª. –ö–∞—é—Å—å, —á—Ç–æ –Ω–µ –¥–æ—Å–º–æ—Ç—Ä–µ–ª. –ù–∞–ø–æ–º–Ω–∏–º, ¬´–Ω–µ –¥–æ—Å–º–æ—Ç—Ä–µ–ª¬ª –±—ã–≤—à–∏–π —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å —Ü–µ–Ω—Ç—Ä–∞ –§–ú–ë–ê –∑–∞ —Å—Ö–µ–º–æ–π —Ñ–∏–∫—Ç–∏–≤–Ω—ã—Ö –ø–æ—Å—Ç–∞–≤–æ–∫ –ª–µ–∫–∞—Ä—Å—Ç–≤. –° 2019-–≥–æ –ø–æ 2021 –≥–æ–¥ –∞–≥–µ–Ω—Ç—Å—Ç–≤–æ –∑–∞–ø–ª–∞—Ç–∏–ª–æ –∫–æ–º–ø–∞–Ω–∏–∏-–ø–æ—Å—Ç–∞–≤—â–∏–∫—É –∑–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –±–æ–ª–µ–µ 15 –º–ª–Ω —Ä—É–±–ª–µ–π, –Ω–æ –¥–æ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –æ–Ω–∏ —Ç–∞–∫ –∏ –Ω–µ –¥–æ—à–ª–∏. –ù–∞ –¥–µ–ª–µ –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç—ã –∑–∞–∫—É–ø–∞–ª–∏—Å—å –¥–ª—è –Ω—É–∂–¥ —ç–∫—Å-—Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—è —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ —Ñ–∏–ª–∏–∞–ª–∞ –∞–≥–µ–Ω—Ç—Å—Ç–≤–∞ –∏ –µ–≥–æ –∂–µ–Ω—ã, –∞ —Å–ø–∏—Å–æ–∫ –ø–æ—Å—Ç–∞–≤–ª–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –Ω–µ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–æ–≤–∞–ª —Ñ–∞–∫—Ç–∏—á–µ—Å–∫–æ–π –∑–∞–∫—É–ø–∫–µ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""The former director of the regional FMBA, Boris Barankin, received 6 years in prison for embezzling 15 million rubles. The court also imposed a fine of 700 thousand rubles on Barankin. The side of prosecution requested 7 years in prison and a fine of 800 thousand rubles. The representative of the drug supplier company received four years probation. The head of the pharmacy department at the center, who signed a cooperation agreement, received six and a half years in correctional labor with a fine of 1.9 million rubles. Barankin asked the court for leniency: 'I have long led a best medical institution of the region, I walked and walked over the land. My colleagues wanted to transfer their problems from sick heads to healthy ones. I was mistaken in not transferring the information immediately to the investigative authorities for a scheme of fictitious drug purchases. It is known that medicines were purchased for the needs of the regional office director and his wife, but the list of purchased drugs did"
2025-09-23T05:46:54+00:00,@bezrec,6574,https://t.me/bezrec/6574,"–ë–µ—Å–ø–ª–∞—Ç–Ω—ã—Ö –ø—Ä–∏–≤–∏–≤–æ–∫ –¥–ª—è –≥—Ä–∞–∂–¥–∞–Ω —Å—Ç–∞–Ω–µ—Ç –±–æ–ª—å—à–µ. –ù–µ —Å—Ä–∞–∑—É, –Ω–æ –ø–æ –º–µ—Ä–µ –≥–æ—Ç–æ–≤–Ω–æ—Å—Ç–∏ –º–∞—Å—Å–æ–≤–æ–≥–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–∏—Ö –≤–∞–∫—Ü–∏–Ω, –ø–æ–æ–±–µ—â–∞–ª –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—å –∫–æ–º–∏—Ç–µ—Ç–∞ –ì–æ—Å–¥—É–º—ã –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è –°–µ—Ä–≥–µ–π –õ–µ–æ–Ω–æ–≤. –í —Å–≤–æ—ë–º –∏–Ω—Ç–µ—Ä–≤—å—é –¢–ê–°–° –¥–µ–ø—É—Ç–∞—Ç –æ—Ç–¥–µ–ª—å–Ω–æ –æ—Å—Ç–∞–Ω–æ–≤–∏–ª—Å—è –Ω–∞ –±–æ—Ä—å–±–µ —Å –º–µ–Ω–∏–Ω–≥–æ–∫–æ–∫–∫–æ–º. –°–ª–æ–∂–Ω–æ—Å—Ç—å –ø—Ä–∏ —Å–æ–∑–¥–∞–Ω–∏–∏ –≤–∞–∫—Ü–∏–Ω—ã –æ—Ç —ç—Ç–æ–π –∏–Ω—Ñ–µ–∫—Ü–∏–∏ ‚Äî –≤ —Å—É—â–µ—Å—Ç–≤–æ–≤–∞–Ω–∏–∏ –Ω–µ—Å–∫–æ–ª—å–∫–∏—Ö —Å–µ—Ä–æ—Ç–∏–ø–æ–≤. –ù–æ —Å —ç—Ç–æ–π –Ω–∞–ø–∞—Å—Ç—å—é –æ–±–µ—â–∞–µ—Ç —Å–ø—Ä–∞–≤–∏—Ç—å—Å—è –§–ú–ë–ê: –†–∞–Ω–µ–µ –Ω–µ —Å—É—â–µ—Å—Ç–≤–æ–≤–∞–ª–æ –≤–∞–∫—Ü–∏–Ω—ã, –∫–æ—Ç–æ—Ä–∞—è –∑–∞—â–∏—â–∞–ª–∞ –±—ã –æ—Ç –≤—Å–µ—Ö —Å–µ—Ä–æ—Ç–∏–ø–æ–≤ –º–µ–Ω–∏–Ω–≥–æ–∫–æ–∫–∫–æ–≤–æ–π –∏–Ω—Ñ–µ–∫—Ü–∏–∏. –°–µ–π—á–∞—Å —Ç–∞–∫–∞—è –≤–∞–∫—Ü–∏–Ω–∞ —Å–æ–∑–¥–∞–Ω–∞, –æ–Ω–∞ –ø—Ä–æ—Ö–æ–¥–∏—Ç –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ –∏—Å–ø—ã—Ç–∞–Ω–∏—è. –°–æ–∑–¥–∞–Ω–∞ –§–µ–¥–µ—Ä–∞–ª—å–Ω—ã–º –º–µ–¥–∏–∫–æ-–±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–º –∞–≥–µ–Ω—Ç—Å—Ç–≤–æ–º. –ù–∞–ø–æ–º–Ω–∏–º, –∞–≥–µ–Ω—Ç—Å—Ç–≤–æ –æ–±–µ—â–∞–µ—Ç –≤—ã–≤–µ—Å—Ç–∏ –Ω–∞ —Ä—ã–Ω–æ–∫ —Å–≤–æ—é –≤–∞–∫—Ü–∏–Ω—É –æ—Ç –º–µ–Ω–∏–Ω–≥–æ–∫–æ–∫–∫–∞, –∑–∞—â–∏—â–∞—é—â—É—é –æ–¥–Ω–æ–≤—Ä–µ–º–µ–Ω–Ω–æ –æ—Ç –ø—è—Ç–∏ —Å–µ—Ä–æ—Ç–∏–ø–æ–≤ –º–µ–Ω–∏–Ω–≥–æ–∫–æ–∫–∫–∞ - A, B, C, W –∏ Y, –∫ 2027 –≥–æ–¥—É. –ü–æ —Å–ª–æ–≤–∞–º –õ–µ–æ–Ω–æ–≤–∞, —Ä–µ—à–µ–Ω–∏–µ –æ –≤–∫–ª—é—á–µ–Ω–∏–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –≤ –ù–∞—Ü–∫–∞–ª–µ–Ω–¥–∞—Ä—å –ø—Ä–∏–≤–∏–≤–æ–∫ –±—É–¥–µ—Ç –ø—Ä–∏–Ω—è—Ç–æ, ¬´–∫–∞–∫ —Ç–æ–ª—å–∫–æ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–æ –±—É–¥–µ—Ç –ø–æ–Ω–∏–º–∞—Ç—å, —á—Ç–æ –º–æ—â–Ω–æ—Å—Ç–µ–π –¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ, —á—Ç–æ–±—ã –ø—Ä–∏–≤–∏–≤–∞—Ç—å, –ø–æ –∫—Ä–∞–π–Ω–µ–π –º–µ—Ä–µ, –≥—Ä—É–ø–ø—É —Ä–∏—Å–∫–∞¬ª. –§–ú–ë–ê —á–µ—Å—Ç—å –∏ —Ö–≤–∞–ª–∞ (–æ—Å–æ–±–µ–Ω–Ω–æ, –µ—Å–ª–∏ —É–ª–æ–∂–∞—Ç—Å—è –≤ —Å—Ä–æ–∫–∏), –Ω–æ, —Å–ø—Ä–∞–≤–µ–¥–ª–∏–≤–æ—Å—Ç–∏ —Ä–∞–¥–∏, —Å–≤–æ–µ–π –ø—è—Ç–∏–≤–∞–ª–µ–Ω—Ç–Ω–æ—Å—Ç—å—é —Ç–∞–∫–∂–µ –º–æ–∂–µ—Ç –ø–æ—Ö–≤–∞—Å—Ç–∞—Ç—å—Å—è Penbraya –æ—Ç Pfizer, –æ–¥–æ–±—Ä–µ–Ω–Ω–∞—è FDA –µ—â—ë –≤ –æ–∫—Ç—è–±—Ä–µ 2023 –≥–æ–¥–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand, epidemic, vaccine"",
  ""impact"": ""medium"",
  ""english"": ""The chairman of the State Duma Committee on Health Care, Sergey Leonyov, promised more free vaccinations for citizens. He mentioned the fight against meningococcus in his interview to TASS. The difficulty with creating a vaccine for this infection is the existence of several serotypes. However, the FMBA promises to develop a vaccine that protects against all five serotypes of meningococcus - A, B, C, W and Y. The decision on including the drug in the National Vaccination Calendar will be made only when the state understands that there are enough resources to vaccinate, at least a risk group. The FMBA deserves praise (especially if it meets the deadlines), but Penbraya from Pfizer, approved by FDA in October 2023, also boasts its five-valency.""
}"
2025-09-22T15:05:03+00:00,@bezrec,6573,https://t.me/bezrec/6573,"–¢—Ä–∞–º–ø —Ä–∞—Å—Å–∫–∞–∂–µ—Ç, –∫–∞–∫ –ø–æ–±–µ–¥–∏—Ç—å –∞—É—Ç–∏–∑–º. –ü—Ä–µ–∑–∏–¥–µ–Ω—Ç –°–®–ê –≤ —Å–≤–æ—ë–º –≤—ã—Å—Ç—É–ø–ª–µ–Ω–∏–∏ –Ω–∞ —Ü–µ—Ä–µ–º–æ–Ω–∏–∏ –ø—Ä–æ—â–∞–Ω–∏—è —Å –∫–æ–Ω—Å–µ—Ä–≤–∞—Ç–∏–≤–Ω—ã–º –∞–∫—Ç–∏–≤–∏—Å—Ç–æ–º –ß–∞—Ä–ª–∏ –ö–∏—Ä–∫–æ–º –Ω–µ—Å–∫–æ–ª—å–∫–æ –æ—Ç–æ—à—ë–ª –æ—Ç —Ç–µ–º—ã –∏ –ø–æ–æ–±–µ—â–∞–ª –∞–º–µ—Ä–∏–∫–∞–Ω—Ü–∞–º ¬´–æ–¥–Ω—É –∏–∑ —Å–∞–º—ã—Ö –≤–∞–∂–Ω—ã—Ö –ø—Ä–µ—Å—Å-–∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–π –≤ —Å–≤–æ–µ–π –∂–∏–∑–Ω–∏¬ª. –î—É–º–∞—é, —ç—Ç–æ –≤–∞—Å –ø–æ—Ç—Ä—è—Å–µ—Ç. –ú–Ω–µ –∫–∞–∂–µ—Ç—Å—è, –º—ã –Ω–∞—à–ª–∏ —Ä–µ—à–µ–Ω–∏–µ –ø—Ä–æ–±–ª–µ–º—ã –∞—É—Ç–∏–∑–º–∞, ‚Äî –ø—Ä–∏–≤–æ–¥–∏—Ç —Å–ª–æ–≤–∞ –¢—Ä–∞–º–ø–∞ The Washington Post. –ö–∞–∫ –ø–∏—à–µ—Ç –∏–∑–¥–∞–Ω–∏–µ —Å–æ —Å—Å—ã–ª–∫–æ–π –Ω–∞ —á–µ—Ç—ã—Ä–µ –∏—Å—Ç–æ—á–Ω–∏–∫–∞, —ç—Ç–∏–º —Ä–µ—à–µ–Ω–∏–µ–º –¥–æ–ª–∂–µ–Ω —Å—Ç–∞—Ç—å –Ω–µ —Å–ª–∏—à–∫–æ–º –∏–∑–≤–µ—Å—Ç–Ω—ã–π –õ–µ–π–∫–æ–≤–æ—Ä–∏–Ω (—Ñ–æ–ª–∏–Ω–æ–≤–∞—è –∫–∏—Å–ª–æ—Ç–∞), –æ–±—ã—á–Ω–æ –Ω–∞–∑–Ω–∞—á–∞–µ–º—ã–π –¥–ª—è —É—Å—Ç—Ä–∞–Ω–µ–Ω–∏—è –ø–æ–±–æ—á–Ω—ã—Ö —ç—Ñ—Ñ–µ–∫—Ç–æ–≤ –Ω–µ–∫–æ—Ç–æ—Ä—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –¥–µ—Ñ–∏—Ü–∏—Ç–∞ –≤–∏—Ç–∞–º–∏–Ω–∞ B9. –Ø–∫–æ–±—ã, —Ä–∞–Ω–Ω–∏–µ –¥–≤–æ–π–Ω—ã–µ —Å–ª–µ–ø—ã–µ –ø–ª–∞—Ü–µ–±–æ-–∫–æ–Ω—Ç—Ä–æ–ª–∏—Ä—É–µ–º—ã–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –ø–æ–∫–∞–∑–∞–ª–∏, —á—Ç–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç –≤—ã–∑—ã–≤–∞–µ—Ç ¬´–∑–∞–º–µ—Ç–Ω—ã–µ —É–ª—É—á—à–µ–Ω–∏—è¬ª –≤ —Å–ø–æ—Å–æ–±–Ω–æ—Å—Ç–∏ –≥–æ–≤–æ—Ä–∏—Ç—å –∏ –ø–æ–Ω–∏–º–∞—Ç—å —Ä–µ—á—å —É –¥–µ—Ç–µ–π —Å –∞—É—Ç–∏–∑–º–æ–º. –í–ø—Ä–æ—á–µ–º, FDA –ø–æ–∫–∞ –ª–∏—à—å –∞–∫–∫—É—Ä–∞—Ç–Ω–æ –ø–æ–¥–±–∏—Ä–∞–µ—Ç —Å–ª–æ–≤–∞, —á—Ç–æ–±—ã —Å—Ñ–æ—Ä–º—É–ª–∏—Ä–æ–≤–∞—Ç—å –ø–æ–ª—É—á–µ–Ω–Ω—ã–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã, –∞ —Å–∞–º–æ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–µ –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ–º —ç–∫—Å–ø–µ—Ä—Ç–æ–≤ –ø—Ä–∏–∑–Ω–∞–Ω–æ –Ω–µ–∏–∑–ª–µ—á–∏–º—ã–º –≤ —Å–∏–ª—É —Å–≤–æ–µ–≥–æ –≥–µ–Ω–µ—Ç–∏—á–µ—Å–∫–æ–≥–æ –ø—Ä–æ–∏—Å—Ö–æ–∂–¥–µ–Ω–∏—è. –ù–æ —ç—Ç–æ –µ—â—ë –Ω–µ –≤—Å—ë, —á–µ–º —Å–æ–±–∏—Ä–∞–µ—Ç—Å—è ¬´—É–±–∏—Ç—å¬ª –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–π –ª–∏–¥–µ—Ä. –ü–æ –¥–∞–Ω–Ω—ã–º WP, –¢—Ä–∞–º–ø –Ω–∞–º–µ—Ä–µ–Ω –æ–±—ä—è–≤–∏—Ç—å, —á—Ç–æ —Ä–æ—Å—Ç —Å–ª—É—á–∞–µ–≤ –∞—É—Ç–∏–∑–º–∞ —É –¥–µ—Ç–µ–π –º–æ–∂–µ—Ç –±—ã—Ç—å —Å–≤—è–∑–∞–Ω —Å —É–ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–µ–º –±–µ—Ä–µ–º–µ–Ω–Ω—ã–º–∏ –ø–∞—Ä–∞—Ü–µ—Ç–∞–º–æ–ª–∞, –≤ —á–∞—Å—Ç–Ω–æ—Å—Ç–∏ –¢–∞–π–ª–µ–Ω–æ–ª–∞. –°–µ–π—á–∞—Å —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –∏–∑—É—á–∞—é—Ç —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –®–∫–æ–ª—ã –º–µ–¥–∏—Ü–∏–Ω—ã –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ —Ü–µ–Ω—Ç—Ä–∞ –ú–∞—É–Ω—Ç-–°–∏–Ω–∞–π (–ù—å—é-–ô–æ—Ä–∫) –∏ –ì–∞—Ä–≤–∞—Ä–¥—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ –Ω–∞ —ç—Ç—É —Ç–µ–º—É. –ü–æ–∫–∞ —á—Ç–æ –≤—ã–≥–ª—è–¥–∏—Ç –Ω–µ —Å–ª–∏—à–∫–æ–º —É–±–µ–¥–∏—Ç–µ–ª—å–Ω–æ –∏ –æ—á–µ–Ω—å —Å–º–∞—Ö–∏–≤–∞–µ—Ç –Ω–∞ –ª–æ–±–±–∏—Ä–æ–≤–∞–Ω–∏–µ –∏–Ω—Ç–µ—Ä–µ—Å–æ–≤ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –õ–µ–π–∫–æ–≤–æ—Ä–∏–Ω–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-09-22T10:45:48+00:00,@bezrec,6571,https://t.me/bezrec/6571,"–ò –µ—â—ë –ø—Ä–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–ª—è –≥–ª–∞–∑. –í RNC Pharma –ø–æ–¥—Å—á–∏—Ç–∞–ª–∏, —á—Ç–æ —Å –Ω–∞—á–∞–ª–∞ 2025 –≥–æ–¥–∞ —Ä–æ—Å—Å–∏—è–Ω–µ –ø–æ—Ç—Ä–∞—Ç–∏–ª–∏ –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–ª—è –ª–µ—á–µ–Ω–∏—è –≥–ª–∞—É–∫–æ–º—ã 8,1 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –≠—Ç–æ –Ω–∞ 13,7% –±–æ–ª—å—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É. –ù–∞—Ç—É—Ä–∞–ª—å–Ω–æ–µ –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–µ –≤—ã—Ä–æ—Å–ª–æ –Ω–∞ 5,7%, –î–û 13 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫. –ü–æ–ø—É–ª—è—Ä–Ω–æ—Å—Ç—å —ç—Ç–æ–π –≥—Ä—É–ø–ø—ã –ª–µ–∫–∞—Ä—Å—Ç–≤ —Ä–∞—Å—Ç—ë—Ç —Ç—Ä–µ—Ç–∏–π –≥–æ–¥ –ø–æ–¥—Ä—è–¥, —á—Ç–æ –º–æ–∂–µ—Ç –±—ã—Ç—å —Å–≤—è–∑–∞–Ω–æ –∫–∞–∫ —Å —É–≤–µ–ª–∏—á–µ–Ω–∏–µ–º —á–∏—Å–ª–∞ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –≥–ª–∞—É–∫–æ–º–æ–π, —Ç–∞–∫ –∏ —Å —Å–æ–≤–µ—Ä—à–µ–Ω—Å—Ç–≤–æ–≤–∞–Ω–∏–µ–º –º–µ—Ç–æ–¥–æ–≤ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∏. –ë–æ–ª–µ–µ 45% –æ—Ç –≤—Å–µ–≥–æ –¥–µ–Ω–µ–∂–Ω–æ–≥–æ –æ–±—ä—ë–º–∞ –ø—Ä–æ–¥–∞–∂ (–æ–∫–æ–ª–æ 3,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π) –æ–±–µ—Å–ø–µ—á–∏–≤–∞—é—Ç –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –Ω–∞ –æ—Å–Ω–æ–≤–µ –ª–∞—Ç–∞–Ω–æ–ø—Ä–æ—Å—Ç–∞ –∏ –¥–æ—Ä–∑–æ–ª–∞–º–∏–¥–∞ –∏–ª–∏ –∏—Ö –∫–æ–º–±–∏–Ω–∞—Ü–∏–π. –ü–æ –æ–±—ä—ë–º—É –¥–µ–Ω–µ–∂–Ω—ã—Ö –ø—Ä–æ–¥–∞–∂ –≤ –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ —É–≤–µ—Ä–µ–Ω–Ω–æ –ª–∏–¥–∏—Ä—É–µ—Ç –î–æ—Ä–∑–æ–ø—Ç —Ä—É–º—ã–Ω—Å–∫–æ–π ¬´–†–æ–º—Ñ–∞—Ä–º¬ª. –í—Ç–æ—Ä—É—é —Å—Ç—Ä–æ—á–∫—É –≤ —Ä–µ–π—Ç–∏–Ω–≥–µ —Å–æ—Ö—Ä–∞–Ω—è–µ—Ç –ê–∑–∞—Ä–≥–∞ –æ—Ç ¬´–ù–æ–≤–∞—Ä—Ç–∏—Å¬ª, –Ω–∞ —Ç—Ä–µ—Ç—å–µ–º –º–µ—Å—Ç–µ ‚Äî –ö—Å–∞–ª–∞—Ç–∞–Ω –æ—Ç ¬´–í–∏–∞—Ç—Ä–∏—Å¬ª. –¢—Ä–æ–π–∫–∞ –ª–∏–¥–µ—Ä–æ–≤ –æ—Å—Ç–∞—ë—Ç—Å—è –Ω–µ–∏–∑–º–µ–Ω–Ω–æ–π —É–∂–µ –Ω–µ—Å–∫–æ–ª—å–∫–æ –ª–µ—Ç, –Ω–µ—Å–º–æ—Ç—Ä—è –Ω–∞ –±–æ–ª—å—à–æ–µ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤ –∏ –Ω–æ–≤–∏–Ω–æ–∫. –ú–∞–∫—Å–∏–º–∞–ª—å–Ω–æ–π –¥–∏–Ω–∞–º–∏–∫–æ–π –ø—Ä–æ–¥–∞–∂ –æ—Ç–ª–∏—á–∏–ª–∏—Å—å –Ω–µ–±—Ä–µ–Ω–¥–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –ª–∞—Ç–∞–Ω–æ–ø—Ä–æ—Å—Ç–∞, –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–Ω—ã–µ —á–µ—Ç—ã—Ä—å–º—è —Ä–æ—Å—Å–∏–π—Å–∫–∏–º–∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º–∏ –≤–æ –≥–ª–∞–≤–µ —Å ¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç–æ–º¬ª. –í —Ç–æ–ø-10 –ø—Ä–æ—Ç–∏–≤–æ–≥–ª–∞—É–∫–æ–º–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Ç–∞–∫–∂–µ –≤–æ—à–ª–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –æ—Ç ¬´–°–µ–Ω—Ç–∏—Å—Å –§–∞—Ä–º–∞¬ª, ¬´–ê–ª–ª–µ—Ä–≥–∞–Ω¬ª –∏ ¬´–°–∞–Ω—Ç—ç–Ω¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""Russia's spending on glaucoma treatments rose by 13.7% year-over-year to RUB81 billion in the first half of 2025. Natural consumption grew by 5.7%, reaching around 13 million units. The popularity of this category of drugs has been increasing for the third year in a row, likely due to an increase in patients with glaucoma and advancements in diagnostic methods. Approximately 37% of the total sales volume (about RUB3.7 billion) are accounted for by latanoprost and dorzolamide-based drugs or their combinations. RUMFY Pharma's Dorzopt leads the market in terms of sales volume, followed by Azara from Novartis and Salcatan from Viatris. The top three positions have remained unchanged for several years despite the presence of many generics and new products. Non-branded latanoprost drugs, produced by four Russian manufacturers led by Farsand, have shown the highest sales growth. Other top-selling drugs include those from"
2025-09-22T08:33:00+00:00,@bezrec,6570,https://t.me/bezrec/6570,"–û—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è –ª–µ—á–µ–Ω–∏—è –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π —Å–µ—Ç—á–∞—Ç–∫–∏ –≥–ª–∞–∑–∞ —Å—Ç–∞–ª –Ω–∞ 18% –¥–µ—à–µ–≤–ª–µ —Ä–µ—Ñ–µ—Ä–µ–Ω—Ç–∞. –§–ê–° —Å–æ–≥–ª–∞—Å–æ–≤–∞–ª–∞ —Ü–µ–Ω—É –Ω–∞ –ø–µ—Ä–≤—ã–π –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π –¥–∂–µ–Ω–µ—Ä–∏–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –≠–π–ª–µ–∞ (–∞—Ñ–ª–∏–±–µ—Ä—Ü–µ–ø—Ç) –æ—Ç Bayer, —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–Ω—ã–π –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Ä–∞–∑–ª–∏—á–Ω—ã—Ö –≤–∏–¥–æ–≤ —É—Ö—É–¥—à–µ–Ω–∏—è –∑—Ä–µ–Ω–∏—è. –ö–æ–Ω—Ç–∏–Ω–∏—è –≤ —Ñ–æ—Ä–º–µ —Ä–∞—Å—Ç–≤–æ—Ä–∞ –¥–ª—è –≤–Ω—É—Ç—Ä–∏–≥–ª–∞–∑–Ω–æ–≥–æ –≤–≤–µ–¥–µ–Ω–∏—è –≤ –¥–æ–∑–∏—Ä–æ–≤–∫–µ 40 –º–≥/–º–ª —Ç–µ–ø–µ—Ä—å —Å—Ç–æ–∏—Ç 36,8 —Ç—ã—Å. —Ä—É–±–ª–µ–π, –∞ —Ç–∞–∫–∞—è –∂–µ —É–ø–∞–∫–æ–≤–∫–∞ —Ä–µ—Ñ–µ—Ä–µ–Ω—Ç–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ‚Äî 44,8 —Ç—ã—Å. —Ä—É–±–ª–µ–π. –ü–æ –¥–∞–Ω–Ω—ã–º –ì–†–õ–°, —Ä–µ–≥—É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏–µ –Ω–∞ –ö–æ–Ω—Ç–∏–Ω–∏—é –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∏—Ç ¬´–ì–µ–Ω–µ—Ä–∏—É–º—É¬ª. –í—Å–µ —Å—Ç–∞–¥–∏–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞, –≤–∫–ª—é—á–∞—è —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏—é, –æ—Å—É—â–µ—Å—Ç–≤–ª—è—é—Ç—Å—è –≤ –†–æ—Å—Å–∏–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""pricing, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The domestic drug for treating eye diseases became 18% cheaper than the reference. The FAS approved the price of Bayer's generic eye disease treatment, Eylea (afibuliprotic), developed for various vision impairments. The 40 mg/ml solution in the Contini form, priced at 368 thousand rubles, is now cheaper than the equivalent reference drug package which costs 448 thousand rubles. According to GRLS, the registration for Contini is held by 'Generium'. All stages of production including raw material are conducted in Russia.""
}"
2025-09-22T06:01:39+00:00,@bezrec,6569,https://t.me/bezrec/6569,"¬´–°–±–µ—Ä¬ª —Ä–∞—Å–ø—Ä–æ—â–∞–ª—Å—è —Å ¬´–ï–∞–ø—Ç–µ–∫–æ–π¬ª. ¬´–°–±–µ—Ä¬ª –ø—Ä–æ–¥–∞–ª —Å–≤–æ–∏ 45% –≤–æ –≤—Ç–æ—Ä–æ–π –ø–æ —Ä–∞–∑–º–µ—Ä—É –æ–Ω–ª–∞–π–Ω-–∞–ø—Ç–µ–∫–µ —Å—Ç—Ä—É–∫—Ç—É—Ä–∞–º, —Å–≤—è–∑–∞–Ω–Ω—ã–º —Å –ê–ª–µ–∫—Å–µ–µ–º –†–µ–ø–∏–∫–æ–º, –ø–∏—à—É—Ç ¬´–í–µ–¥–æ–º–æ—Å—Ç–∏¬ª. –¢–µ–ø–µ—Ä—å –∏–º –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∏—Ç 100% –≤ –û–û–û. –°–¥–µ–ª–∫–∞ –±—ã–ª–∞ –∑–∞–∫—Ä—ã—Ç–∞ —á–µ—Ç—ã—Ä–µ –º–µ—Å—è—Ü–∞ –Ω–∞–∑–∞–¥, –µ—ë —Å—É–º–º–∞ –Ω–µ —Ä–∞—Å–∫—Ä—ã–≤–∞–µ—Ç—Å—è. –ü–æ –¥–∞–Ω–Ω—ã–º –∏—Å—Ç–æ—á–Ω–∏–∫–∞, –±–ª–∏–∑–∫–æ–≥–æ –∫ ¬´–°–±–µ—Ä—É¬ª, –±–∞–Ω–∫ –≤ –Ω–∞–∫–ª–∞–¥–µ –Ω–µ –æ—Å—Ç–∞–ª—Å—è. –ö–∞–∫ –≤—Å—ë –Ω–∞—á–∏–Ω–∞–ª–æ—Å—å. –í 2020‚Äì2021 –≥–æ–¥–∞—Ö ¬´–°–±–µ—Ä¬ª –∏ —Å—Ç—Ä—É–∫—Ç—É—Ä—ã ¬´–†-—Ñ–∞—Ä–º¬ª –≤—ã–∫—É–ø–∏–ª–∏ –ø–æ 45% –≤ ¬´–ï–∞–ø—Ç–µ–∫–µ¬ª —á–µ—Ä–µ–∑ –û–û–û ¬´–¶–∏—Ñ—Ä–æ–≤—ã–µ –∞–∫—Ç–∏–≤—ã¬ª –∏ –∫–∏–ø—Ä—Å–∫—É—é Amsele Limited —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ. –ó–∞ —Å–≤–æ—é –¥–æ–ª—é –±–∞–Ω–∫ –∑–∞–ø–ª–∞—Ç–∏–ª 5,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ï—â—ë 10% –æ—Å—Ç–∞–ª–∏—Å—å —É –æ—Å–Ω–æ–≤–∞—Ç–µ–ª—è –∏ –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –ê–Ω—Ç–æ–Ω–∞ –ë—É–∑–¥–∞–ª–∏–Ω–∞. –û–Ω –ø–æ–ª–Ω–æ—Å—Ç—å—é –≤—ã—à–µ–ª –∏–∑ –±–∏–∑–Ω–µ—Å–∞ 3‚Äì4 –≥–æ–¥–∞ –Ω–∞–∑–∞–¥. –í 2022 –≥–æ–¥—É –¥–æ–ª—é –∫–∏–ø—Ä—Å–∫–æ–π Amsele Limited –ø—Ä–∏–æ–±—Ä–µ–ª–∞ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–∞—è –∫–æ–º–ø–∞–Ω–∏—è ¬´–ê–º—Å–µ–ª¬ª, –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∞–≤—à–∞—è –†–µ–ø–∏–∫—É (—Ç–æ–≥–¥–∞ –∂–µ –±–∏–∑–Ω–µ—Å–º–µ–Ω –≤—ã—à–µ–ª –∏–∑ —Å–æ—Å—Ç–∞–≤–∞ –≤–ª–∞–¥–µ–ª—å—Ü–µ–≤ –≥—Ä—É–ø–ø—ã ¬´–†-—Ñ–∞—Ä–º¬ª). –ü–æ—á–µ–º—É ¬´–°–±–µ—Ä¬ª —Ä–µ—à–∏–ª ¬´–∑–∞–≤—è–∑–∞—Ç—å¬ª —Å –∞–ø—Ç–µ—á–Ω—ã–º –±–∏–∑–Ω–µ—Å–æ–º. –î–∏—Ä–µ–∫—Ç–æ—Ä –ø–æ —Ä–∞–∑–≤–∏—Ç–∏—é RNC Pharma –ù–∏–∫–æ–ª–∞–π –ë–µ—Å–ø–∞–ª–æ–≤ —Å—á–∏—Ç–∞–µ—Ç —Å–¥–µ–ª–∫—É –ø–æ –ø—Ä–æ–¥–∞–∂–µ –¥–æ–ª–∏ –≤ ¬´–ï–∞–ø—Ç–µ–∫–µ¬ª –≤—ã–Ω—É–∂–¥–µ–Ω–Ω–æ–π –¥–ª—è ¬´–°–±–µ—Ä–∞¬ª: –î–ª—è –±–∞–Ω–∫–∞ —ç—Ç–æ —Å–ª–∏—à–∫–æ–º —É–∑–∫–æ–ø—Ä–æ—Ñ–∏–ª—å–Ω—ã–π –∏ –Ω–µ–±–æ–ª—å—à–æ–π –∞–∫—Ç–∏–≤, —É–ø—Ä–∞–≤–ª—è—Ç—å –∏–º —Å–ª–æ–∂–Ω–æ. –í –º–æ–º–µ–Ω—Ç –≤—Ö–æ–¥–∞ —Å—É—â–µ—Å—Ç–≤–æ–≤–∞–ª–∞ —É–≤–µ—Ä–µ–Ω–Ω–æ—Å—Ç—å, —á—Ç–æ —Ä–∞–∑—Ä–µ—à–∞—Ç –æ–Ω–ª–∞–π–Ω-–ø—Ä–æ–¥–∞–∂–∏ —Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, —á—Ç–æ –¥–∞–ª–æ –±—ã –±–∏–∑–Ω–µ—Å—É —Ä–æ—Å—Ç. –≠—Ç–æ–≥–æ –Ω–µ –ø—Ä–æ–∏–∑–æ—à–ª–æ, –∏ –∞–∫—Ç–∏–≤ –æ—Å—Ç–∞–ª—Å—è –ø—Ä–æ—Å—Ç–æ —Å–µ—Ç—å—é —Å—Ä–µ–¥–Ω–∏—Ö —Ä–∞–∑–º–µ—Ä–æ–≤. –ü–µ—Ä—Å–ø–µ–∫—Ç–∏–≤—ã —Ä–∞–∑–≤–∏—Ç–∏—è —É –ø—Ä–æ–µ–∫—Ç–∞ –µ—Å—Ç—å, –Ω–æ —Ä–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞ –ø–æ–∫–∞ –Ω–µ –ø–æ–∑–≤–æ–ª—è–µ—Ç —Ä–∞—Å—Å—á–∏—Ç—ã–≤–∞—Ç—å –Ω–∞ –≤—ã—Å–æ–∫—É—é –¥–∏–Ω–∞–º–∏–∫—É. –û—Å–Ω–æ–≤–∞—Ç–µ–ª—å Dsight –ê—Ä—Å–µ–Ω–∏–π –î–∞–±–±–∞—Ö –Ω–∞–∑—ã–≤–∞–µ—Ç ¬´–ï–∞–ø—Ç–µ–∫—É¬ª ¬´—Ç—è–∂—ë–ª—ã–º¬ª –∞–∫—Ç–∏–≤–æ–º –¥–ª—è ¬´–°–±–µ—Ä–∞¬ª. –ü–æ–º–∏–º–æ –ø–æ—Ç—Ä–∞—á–µ–Ω–Ω—ã—Ö –Ω–∞ –ø–æ–∫—É–ø–∫—É 45% 5,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, –±–∞–Ω–∫ –¥–æ–∫–∞–ø–∏—Ç–∞–ª–∏–∑–∏—Ä–æ–≤–∞–ª –∫–æ–º–ø–∞–Ω–∏—é —á–µ—Ä–µ–∑ –¥–æ–ª–≥ –ø—Ä–∏–º–µ—Ä–Ω–æ –Ω–∞ 10 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ü–æ –¥–∞–Ω–Ω—ã–º –°–ü–ê–†–ö, 2024 –≥–æ–¥ –∫–æ–º–ø–∞–Ω–∏—è –∑–∞–∫–æ–Ω—á–∏–ª–∞ —Å –≤—ã—Ä—É—á–∫–æ–π 32,9 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –ø—Ä–∏ —á–∏—Å—Ç–æ–º —É–±—ã—Ç–∫–µ 4,05 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –∏ —á–∏—Å—Ç–æ–º –¥–æ–ª–≥–µ 25 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –° –º–æ–º–µ–Ω—Ç–∞ –≤—Ö–æ–¥–∞ ¬´–°–±–µ—Ä–∞¬ª –∏ ¬´–†-—Ñ–∞—Ä–º¬ª –≤ –∞–∫—Ç–∏–≤ –µ–≥–æ —Å–æ–≤–æ–∫—É–ø–Ω—ã–π —É–±—ã—Ç–æ–∫ –¥–æ—Å—Ç–∏–≥ 18 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –í—Å—é –∫–æ–º–ø–∞–Ω–∏—é –î–∞–±–±–∞—Ö –æ—Ü–µ–Ω–∏–≤–∞–µ—Ç –≤ 0,3‚Äì0,5 –≤—ã—Ä—É—á–∫–∏, —Ç. –µ. –≤ 9‚Äì16 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ö–∞–∫–æ–π –∏–Ω—Ç–µ—Ä–µ—Å —É ¬´–†-–§–∞—Ä–º¬ª. –ö–∞–∫ –æ—Ç–º–µ—á–∞–µ—Ç –ë–µ—Å–ø–∞–ª–æ–≤, ¬´–†-—Ñ–∞—Ä–º¬ª –∏–∑–Ω–∞—á–∞–ª—å–Ω–æ —Ä–∞–±–æ—Ç–∞–ª–∞ –≤ —Å–µ–≥–º–µ–Ω—Ç–µ –≥–æ—Å–∑–∞–∫–∞–∑–∞, —Ç. –µ. –æ–ø—Ç–æ–≤—ã—Ö –ø—Ä–æ–¥–∞–∂: –í–æ–∑–º–æ–∂–Ω–æ, –±—É–¥—É—Ç –ø–ª–∞–Ω—ã –ø–æ —Ä–∞–∑–≤–∏—Ç–∏—é —Ä–æ–∑–Ω–∏—Ü—ã, –Ω–æ –±–æ–ª–µ–µ –≤–µ—Ä–æ—è—Ç–µ–Ω –ø–æ—Å–ª–µ–¥—É—é—â–∏–π –≤—ã—Ö–æ–¥ —Å —Ñ–∏–∫—Å–∞—Ü–∏–µ–π –ø—Ä–∏–±—ã–ª–∏. –î–∞–±–±–∞—Ö –ø—Ä–µ–¥–ø–æ–ª–∞–≥–∞–µ—Ç, —á—Ç–æ —Å—Ç—Ä—É–∫—Ç—É—Ä—ã, —Å–≤—è–∑–∞–Ω–Ω—ã–µ —Å –†–µ–ø–∏–∫–æ–º, —Ö–æ—Ç—è—Ç —Å–æ—Ö—Ä–∞–Ω–∏—Ç—å –≤–ª–∏—è–Ω–∏–µ –∏ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å —Ä–æ–∑–Ω–∏—Ü—É –∫–∞–∫ –∫–∞–Ω–∞–ª –¥–ª—è –ø—Ä–æ–¥–∞–∂ —Å–æ–±—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –ø–æ–ª—É—á–µ–Ω–∏—è –æ–±—Ä–∞—Ç–Ω–æ–π —Å–≤—è–∑–∏. –ù–æ –≤ –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–µ –ø—Ä–æ–¥–∞–∂–∞ –∞–∫—Ç–∏–≤–∞ –∏–ª–∏ —Å–ª–∏—è–Ω–∏–µ —Å –∫—Ä—É–ø–Ω—ã–º –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–æ–º –≤—ã–≥–ª—è–¥—è—Ç –ª–æ–≥–∏—á–Ω–µ–µ. –ù–∞–ø–æ–º–Ω–∏–º, –ª–µ—Ç–æ–º —Ö–æ–¥–∏–ª–∏ —Å–ª—É—Ö–∏ –æ –ø–æ–∫—É–ø–∫–µ ¬´–ï–∞–ø—Ç–µ–∫–∏¬ª Wildberries, –æ–¥–Ω–∞–∫–æ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å —ç—Ç—É –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é –æ–ø—Ä–æ–≤–µ—Ä–≥. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": true
}"
2025-09-21T11:02:47+00:00,@bezrec,6568,https://t.me/bezrec/6568,"–£—á—ë–Ω—ã–µ —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏, –∫–æ–º—É –Ω–µ –ø–æ—Ö—É–¥–µ—Ç—å –Ω–∞ –û–∑–µ–º–ø–∏–∫–µ. –ò—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª–∏ –∏–∑ –£–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ –ö–∏–æ—Ç–æ –≤—ã—è—Å–Ω–∏–ª–∏, —á—Ç–æ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –ø–æ—Ö—É–¥–µ–Ω–∏—è —Å –ø–æ–º–æ—â—å—é –∞–≥–æ–Ω–∏—Å—Ç–æ–≤ —Ä–µ—Ü–µ–ø—Ç–æ—Ä–æ–≤ GLP-1 –∑–∞–≤–∏—Å–∏—Ç –æ—Ç –æ—Å–æ–±–µ–Ω–Ω–æ—Å—Ç–µ–π –ø–∏—â–µ–≤–æ–≥–æ –ø–æ–≤–µ–¥–µ–Ω–∏—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –ò–∑–≤–µ—Å—Ç–Ω–æ, —á—Ç–æ —Ç–∞–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã —Å—Ç–∏–º—É–ª–∏—Ä—É—é—Ç –≤—ã—Ä–∞–±–æ—Ç–∫—É –∏–Ω—Å—É–ª–∏–Ω–∞ –∏ —É–º–µ–Ω—å—à–∞—é—Ç –∞–ø–ø–µ—Ç–∏—Ç, –Ω–æ —Å—Ä–∞–±–∞—Ç—ã–≤–∞—é—Ç –æ–Ω–∏ –Ω–µ —É –≤—Å–µ—Ö. –ß—Ç–æ–±—ã –≤—ã—è—Å–Ω–∏—Ç—å –ø–æ—á–µ–º—É, —É—á—ë–Ω—ã–µ –Ω–∞–±–ª—é–¥–∞–ª–∏ –∑–∞ 92 –ø–∞—Ü–∏–µ–Ω—Ç–∞–º–∏ —Å –¥–∏–∞–±–µ—Ç–æ–º 2 —Ç–∏–ø–∞ –≤ —Ç–µ—á–µ–Ω–∏–µ –≥–æ–¥–∞ –ø–æ—Å–ª–µ –Ω–∞—á–∞–ª–∞ —Ç–µ—Ä–∞–ø–∏–∏. –í—ã—è—Å–Ω–∏–ª–æ—Å—å, —á—Ç–æ –Ω–∞–∏–ª—É—á—à–∏—Ö —Ä–µ–∑—É–ª—å—Ç–∞—Ç–æ–≤ –¥–æ—Å—Ç–∏–≥–∞–ª–∏ —Ç–µ, –∫—Ç–æ –ø–µ—Ä–µ–µ–¥–∞–ª –∏–∑-–∑–∞ –≤–Ω–µ—à–Ω–∏—Ö —Ñ–∞–∫—Ç–æ—Ä–æ–≤ ‚Äî –∞–ø–ø–µ—Ç–∏—Ç–Ω–æ–≥–æ –∞—Ä–æ–º–∞—Ç–∞ –∏ –ø—Ä–∏–≤–ª–µ–∫–∞—Ç–µ–ª—å–Ω–æ–≥–æ –≤–∏–¥–∞ –±–ª—é–¥. –ü—Ä–∏ —ç—Ç–æ–º –ª—é–±–∏—Ç–µ–ª–∏ ¬´–∑–∞–µ–¥–∞—Ç—å —Å—Ç—Ä–µ—Å—Å¬ª —Ö—É–¥–µ–ª–∏ –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ –º–µ–¥–ª–µ–Ω–Ω–µ–µ –∏–ª–∏ –Ω–µ —Ö—É–¥–µ–ª–∏ –≤–æ–≤—Å–µ. –ê–≤—Ç–æ—Ä—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è —Å—á–∏—Ç–∞—é—Ç, —á—Ç–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã GLP-1 –æ—Ç–ª–∏—á–Ω–æ —Å–ø—Ä–∞–≤–ª—è—é—Ç—Å—è —Å —Ñ–∏–∑–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–º–∏ —Ä–µ–∞–∫—Ü–∏—è–º–∏ –Ω–∞ –≤–Ω–µ—à–Ω–∏–µ —Ä–∞–∑–¥—Ä–∞–∂–∏—Ç–µ–ª–∏, –Ω–æ –æ–∫–∞–∑—ã–≤–∞—é—Ç—Å—è –±–µ—Å—Å–∏–ª—å–Ω—ã –ø—Ä–æ—Ç–∏–≤ –ø—Å–∏—Ö–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –ø—Ä–∏—á–∏–Ω –ø–µ—Ä–µ–µ–¥–∞–Ω–∏—è. –ß—Ç–æ–±—ã –ª–µ—á–µ–Ω–∏–µ –ø—Ä–∏–Ω–µ—Å–ª–æ –º–∞–∫—Å–∏–º–∞–ª—å–Ω—É—é –ø–æ–ª—å–∑—É, –Ω–µ–æ–±—Ö–æ–¥–∏–º–∞ –ø—Ä–µ–¥–≤–∞—Ä–∏—Ç–µ–ª—å–Ω–∞—è –æ—Ü–µ–Ω–∫–∞ –ø–∏—â–µ–≤–æ–≥–æ –ø–æ–≤–µ–¥–µ–Ω–∏—è, —É–≤–µ—Ä–µ–Ω –≤–µ–¥—É—â–∏–π –∞–≤—Ç–æ—Ä —Ä–∞–±–æ—Ç—ã, –ø—Ä–æ—Ñ–µ—Å—Å–æ—Ä –î–∞–π—Å—É–∫—ç –Ø–±—ç. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-09-20T12:01:25+00:00,@bezrec,6567,https://t.me/bezrec/6567,"–í—Å—Ç—Ä–µ—á–∞–µ–º —Å—É–±–±–æ—Ç–Ω–∏–π –≤—ã–ø—É—Å–∫ —Ä—É–±—Ä–∏–∫–∏ #–≤–¥–æ–≥–æ–Ω–∫—É. üíä –í—å–µ—Ç–Ω–∞–º –∂–¥—ë—Ç —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞. –ü–µ—Ä–≤—ã–µ —á–µ—Ç—ã—Ä–µ –∫—Ä—É–ø–Ω—ã–µ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –¥–æ–ª–∂–Ω—ã –≤—ã–π—Ç–∏ –Ω–∞ –≤—å–µ—Ç–Ω–∞–º—Å–∫–∏–π —Ä—ã–Ω–æ–∫ –≤ 2026 –≥–æ–¥—É. –û–Ω–∏ —É–∂–µ –ø–æ–ª—É—á–∏–ª–∏ —Å–µ—Ä—Ç–∏—Ñ–∏–∫–∞—Ç GMP –ø–æ —Å—Ç–∞–Ω–¥–∞—Ä—Ç—É PIC/S. –ù–∞ –æ—á–µ—Ä–µ–¥–∏ ‚Äî –¥–æ—Å—å–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ú—ã –¥–≤–∞ –≥–æ–¥–∞ –ø—Ä–æ–≤–æ–¥–∏–ª–∏ —Ä–∞–±–æ—Ç—É, —á—Ç–æ–±—ã —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ GMP —É—Ç–≤–µ—Ä–¥–∏–ª–∏ –≤–æ –í—å–µ—Ç–Ω–∞–º–µ, –ø–æ—Ç–æ–º—É —á—Ç–æ —Ä–æ—Å—Å–∏–π—Å–∫–∏–π —Å—Ç–∞–Ω–¥–∞—Ä—Ç –ì–û–°–¢ –∏ —Å—Ç–∞–Ω–¥–∞—Ä—Ç GMP –æ—Ç–ª–∏—á–∞—é—Ç—Å—è. –û—á–µ–Ω—å –¥–æ–ª–≥–æ —É—Ç–≤–µ—Ä–∂–¥–∞–ª–∏, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä –ê–û ¬´–§–∞—Ä–º–≤—å–µ—Ç¬ª –ù–≥—É–µ–Ω–∞ –í—å–µ—Ç –ö—Ö–æ–∞. üíä ¬´–ê–±—Ä–∞—É-–î—é—Ä—Å–æ¬ª —Å–º–æ–∂–µ—Ç –≤—ã–ø—É—Å–∫–∞—Ç—å —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–µ –ø—Ä–æ–¥—É–∫—Ç—ã. –ü—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å –∏–≥—Ä–∏—Å—Ç–æ–≥–æ –ø–æ–¥–∞–ª –∑–∞—è–≤–∫—É –≤ –†–æ—Å–ø–∞—Ç–µ–Ω—Ç –Ω–∞ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—é —Ç–æ–≤–∞—Ä–Ω–æ–≥–æ –∑–Ω–∞–∫–∞ Abrau Club Cosmetics. –¢–æ–≤–∞—Ä–Ω—ã–π –∑–Ω–∞–∫ —Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä—É–µ—Ç—Å—è –ø–æ –¥–≤—É–º –∫–ª–∞—Å—Å–∞–º (‚Ññ 3 –∏ ‚Ññ 5) –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–æ–π –∫–ª–∞—Å—Å–∏—Ñ–∏–∫–∞—Ü–∏–∏ —Ç–æ–≤–∞—Ä–æ–≤ –∏ —É—Å–ª—É–≥, –≤ –Ω–∏—Ö –≤—Ö–æ–¥—è—Ç –∫–æ—Å–º–µ—Ç–∏—á–µ—Å–∫–∏–µ –∏ —Ç—É–∞–ª–µ—Ç–Ω—ã–µ –Ω–µ–º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ —Å—Ä–µ–¥—Å—Ç–≤–∞, –∞ —Ç–∞–∫–∂–µ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–µ –ø—Ä–æ–¥—É–∫—Ç—ã, –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –∏ –≤–µ—Ç–µ—Ä–∏–Ω–∞—Ä–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã. üíä –ü–æ–¥–ø–∏—Å—ã–≤–∞—Ç—å —Å–æ–≥–ª–∞—Å–∏–µ –Ω–∞ —É—á–∞—Å—Ç–∏–µ –≤ –ö–ò –ª–µ–∫–∞—Ä—Å—Ç–≤ –º–æ–∂–Ω–æ –±—É–¥–µ—Ç –Ω–∞ –±—É–º–∞–≥–µ. –°–µ–π—á–∞—Å –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω—ã–π –ª–∏—Å—Ç–æ–∫ –ø–∞—Ü–∏–µ–Ω—Ç–∞ –æ—Ñ–æ—Ä–º–ª—è–µ—Ç—Å—è –≤ –≤–∏–¥–µ —ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω–æ–≥–æ –¥–æ–∫—É–º–µ–Ω—Ç–∞ –∏ –¥–æ–ª–∂–µ–Ω –±—ã—Ç—å –ø–æ–¥–ø–∏—Å–∞–Ω —É—Å–∏–ª–µ–Ω–Ω–æ–π –∫–≤–∞–ª–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω–æ–π —ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω–æ–π –ø–æ–¥–ø–∏—Å—å—é (–£–ö–≠–ü) –∏–ª–∏ –ø—Ä–æ—Å—Ç–æ–π —ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω–æ–π –ø–æ–¥–ø–∏—Å—å—é —á–µ—Ä–µ–∑ –ï–°–ò–ê. –ê–≤—Ç–æ—Ä –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å–Ω–æ–π –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤—ã –°—Ç–∞–Ω–∏—Å–ª–∞–≤ –ù–∞—É–º–æ–≤ —Å—á–∏—Ç–∞–µ—Ç, —á—Ç–æ –ø—Ä–æ—Ü–µ–¥—É—Ä–∞ –æ–≥—Ä–∞–Ω–∏—á–∏–≤–∞–µ—Ç –ø—Ä–∞–≤–∞ –ø–æ–∂–∏–ª—ã—Ö –ª—é–¥–µ–π –∏ –¥–µ—Ç–µ–π. –ì–æ—Å–¥—É–º–∞ –ø—Ä–∏–Ω—è–ª–∞ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –≤ –ø–µ—Ä–≤–æ–º —á—Ç–µ–Ω–∏–∏. üíä Solopharm –∑–∞–ø—É—Å–∫–∞–µ—Ç –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –ø—Ä–µ–¥–Ω–∞–ø–æ–ª–Ω–µ–Ω–Ω—ã—Ö —à–ø—Ä–∏—Ü–µ–≤ –∏ —Ñ–ª–∞–∫–æ–Ω–æ–≤ —Å–æ —Å—à–∏—Ç–æ–π –≥–∏–∞–ª—É—Ä–æ–Ω–æ–≤–æ–π –∫–∏—Å–ª–æ—Ç–æ–π. –í –º–µ–¥–∏—Ü–∏–Ω–µ –æ–Ω–∞ –∏—Å–ø–æ–ª—å–∑—É–µ—Ç—Å—è –≤ —Ä–µ–≤–º–∞—Ç–æ–ª–æ–≥–∏–∏ –∏ —Ç—Ä–∞–≤–º–∞—Ç–æ–ª–æ–≥–∏–∏ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –∞—Ä—Ç—Ä–∏—Ç–∞, –∞—Ä—Ç—Ä–æ–∑–∞ –∏ –æ—Å—Ç–µ–æ–ø–æ—Ä–æ–∑–∞, —Ö—Ä—è—â–µ–≤–æ–π –¥–∏—Å—Ç—Ä–æ—Ñ–∏–∏, —Ä–µ–∞–±–∏–ª–∏—Ç–∞—Ü–∏–∏ –ø–æ—Å–ª–µ —Ç—Ä–∞–≤–º –∏ –¥—Ä. –í –ø—Ä–æ–µ–∫—Ç –≤–ª–æ–∂–µ–Ω–æ 400 –º–ª–Ω —Ä—É–±–ª–µ–π. üíä –ê–Ω–∞–ª–∏—Ç–∏–∫–∏ –ø–æ–¥—Å—á–∏—Ç–∞–ª–∏, —Å–∫–æ–ª—å–∫–æ —Ä–æ—Å—Å–∏—è–Ω–µ —Ç—Ä–∞—Ç—è—Ç –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞. –ü–æ –¥–∞–Ω–Ω—ã–º RNC Pharma, –∑–∞ –ø–µ—Ä–≤—ã–µ —Å–µ–º—å –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ —Å—É–º–º–∞—Ä–Ω—ã–π –æ–±—ä—ë–º —Å—Ä–µ–¥–Ω–µ–¥—É—à–µ–≤—ã—Ö –∑–∞—Ç—Ä–∞—Ç –Ω–∞ –ø–æ–∫—É–ø–∫—É –õ–ü —Å–æ—Å—Ç–∞–≤–∏–ª 7,1 —Ç—ã—Å. —Ä—É–±–ª–µ–π. –≠—Ç–æ –Ω–∞ 14,1% –±–æ–ª—å—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É. –í –ª–∏–¥–µ—Ä–∞—Ö ‚Äî –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥, –ú–æ—Å–∫–æ–≤—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å –∏ –ú–æ—Å–∫–≤–∞. –ú–∞–∫—Å–∏–º–∞–ª—å–Ω–æ–π –¥–∏–Ω–∞–º–∏–∫–æ–π —Å—Ä–µ–¥–Ω–µ–π —Å—É–º–º—ã –∑–∞—Ç—Ä–∞—Ç –Ω–∞ –æ–¥–Ω–æ–≥–æ –∂–∏—Ç–µ–ª—è –æ—Ç–ª–∏—á–∏–ª–∏—Å—å –ß–µ—á–Ω—è (+31%) –∏ –ß—É–∫–æ—Ç–∫–∞(+29,8%). –ü—Ä–∏ —ç—Ç–æ–º –≤ –ß–µ—á–Ω–µ, –∫–∞–∫ –∏ –≤ –ø—Ä–æ—à–ª–æ–º –≥–æ–¥—É, –æ—Ç–º–µ—á–µ–Ω –Ω–∞–∏–º–µ–Ω—å—à–∏–π –∞–±—Å–æ–ª—é—Ç–Ω—ã–π —Ä–∞–∑–º–µ—Ä —Ä–∞—Å—Ö–æ–¥–æ–≤ –Ω–∞ –ø–æ–∫—É–ø–∫—É –ª–µ–∫–∞—Ä—Å—Ç–≤. üíä –†–æ—Å—Ç–æ–≤—Å–∫–∞—è –∞–ø—Ç–µ–∫–∞ —É–¥–∏–≤–∏–ª–∞ –ø–æ–ª–Ω—ã–º –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–µ–º –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏–∑ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–≥–æ –º–∏–Ω–∏–º–∞–ª—å–Ω–æ–≥–æ –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç–∞. –¢–∞–∫–æ–µ –∑–∞ –≤—Å—é –ø—Ä–∞–∫—Ç–∏–∫—É –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–∞ –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–Ω–æ –≤–ø–µ—Ä–≤—ã–µ. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –≤ –û–û–û ¬´–§–∞—Ä–º+¬ª —Ä–∞–±–æ—Ç–∞–ª ¬´—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç¬ª –±–µ–∑ –ø—Ä–æ—Ñ–∏–ª—å–Ω–æ–≥–æ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è, —Å–µ—Ä—Ç–∏—Ñ–∏–∫–∞—Ç–∞ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞ –∏ –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–∏, –æ—Ç–ø—É—Å–∫–∞–≤—à–∏–π –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ —Å –Ω–∞—Ä—É—à–µ–Ω–∏—è–º–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, demand, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""A pharmacy in Rostov Oblast has been found to be completely out of essential medicines for the first time. This is in violation of regulations and practices set by Roszdranadzor. The situation highlights the need for better oversight in the pharmaceutical sector.""
}"
2025-09-19T15:59:58+00:00,@bezrec,6565,https://t.me/bezrec/6565,"–ü—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –ì—Ä–∞–º–º–∏–¥–∏–Ω–∞ ¬´—Å–ª–æ–≤–∏–ª–∏ –î–∂–∏–≥—É—Ä–¥—É¬ª. –ù–∏–∫–∏—Ç–∞ –î–∂–∏–≥—É—Ä–¥–∞ —Å—Ç–∞–ª ¬´–≥–æ–ª–æ—Å–æ–º¬ª –±–æ–ª—å–Ω–æ–≥–æ –≥–æ—Ä–ª–∞. –ê—Ä—Ç–∏—Å—Ç —Å–æ —Å–≤–æ–µ–π —É–∑–Ω–∞–≤–∞–µ–º–æ–π —Ö—Ä–∏–ø–æ—Ç—Ü–æ–π —Å–∏–º–≤–æ–ª–∏–∑–∏—Ä—É–µ—Ç –æ—Å–∏–ø—à–µ–µ –≥–æ—Ä–ª–æ ‚Äî —á–∞—Å—Ç—ã–π —Å–ø—É—Ç–Ω–∏–∫ –ø—Ä–æ—Å—Ç—É–¥–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, –∫–æ—Ç–æ—Ä—ã–π –≤—Å–µ–≥–¥–∞ –Ω–µ–∫—Å—Ç–∞—Ç–∏. –î–ª—è –Ω–µ–≥–æ –¥–∞–∂–µ —Ç–µ—Ä–º–∏–Ω —Å–ø–µ—Ü–∏–∞–ª—å–Ω—ã–π –ø—Ä–∏–¥—É–º–∞–ª–∏ ‚Äî ¬´—Å–ª–æ–≤–∏—Ç—å –î–∂–∏–≥—É—Ä–¥—É¬ª. –ù–∞ —à—Ç–æ—Ä–º–µ –º—ã —Ä–∞–∑–≥–æ–Ω—è–ª–∏ —Å–∏–º–ø—Ç–æ–º—ã –±–æ–ª—å–Ω–æ–≥–æ –≥–æ—Ä–ª–∞, —Ö—Ä–∏–ø–æ—Ç—É –∏ —Å—Ä–∞–∑—É –≤—Å–ø–æ–º–Ω–∏–ª–∏ –ù–∏–∫–∏—Ç—É –ë–æ—Ä–∏—Å–æ–≤–∏—á–∞. –°–Ω–∞—á–∞–ª–∞ –ø—Ä–æ—Å—Ç–æ –ø–æ—Å–º–µ—è–ª–∏—Å—å, –∞ –ø–æ—Ç–æ–º –ø–æ–Ω—è–ª–∏ ‚Äî —ç—Ç–æ –æ–Ω–æ, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏ –≤ –∞–≥–µ–Ω—Ç—Å—Ç–≤–µ Progression Group, –∫–æ—Ç–æ—Ä–æ–µ —Ä–∞–∑—Ä–∞–±–∞—Ç—ã–≤–∞–ª–æ –∫–∞–º–ø–∞–Ω–∏—é. –ó–≤—ë–∑–¥ –≤ —Ä–µ–∫–ª–∞–º—É –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø—Ä–∏–≥–ª–∞—à–∞—é—Ç —á–∞—Å—Ç–æ, –Ω–æ –ø–æ-–Ω–∞—Å—Ç–æ—è—â–µ–º—É –∑–∞–ø–æ–º–∏–Ω–∞—é—â–∏–º–∏—Å—è –æ–±—Ä–∞–∑—ã –ø–æ–ª—É—á–∞—é—Ç—Å—è –Ω–µ –≤—Å–µ–≥–¥–∞. –í —Å–≤–æ—ë –≤—Ä–µ–º—è —Å—ã–≥—Ä–∞—Ç—å –Ω–∞ —É–∑–Ω–∞–≤–∞–µ–º–æ–º –≥–æ–ª–æ—Å–µ –∏ –∏–Ω—Ç–æ–Ω–∞—Ü–∏—è—Ö —Ä–µ—à–∏–ª–∞ ¬´–ò–Ω—Ñ–∞–º–µ–¥ –ö¬ª –≤ —Ä–µ–∫–ª–∞–º–µ –ú–∏—Ä–∞–º–∏—Å—Ç–∏–Ω–∞. –†–æ–ª–∏–∫ –¥–µ–π—Å—Ç–≤–∏—Ç–µ–ª—å–Ω–æ –ø—Ä–∏–≤–ª—ë–∫ –≤–Ω–∏–º–∞–Ω–∏–µ...–∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å—â–∏–∫–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ –ø—Ä–∏–∑–Ω–∞–ª–∏ —Ä–µ–∫–ª–∞–º—É –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –Ω–µ–¥–æ—Å—Ç–æ–≤–µ—Ä–Ω–æ–π –∏ –≤—ã–∫–∞—Ç–∏–ª–∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—é —à—Ç—Ä–∞—Ñ –≤ 500 —Ç—ã—Å. —Ä—É–±–ª–µ–π. –ù–∞–¥–µ–µ–º—Å—è, ¬´–í–∞–ª–µ–Ω—Ç—É –§–∞—Ä–º¬ª –∏ –µ—ë –ì—Ä–∞–º–º–∏–¥–∏–Ω –º–∏–Ω—É–µ—Ç —á–∞—à–∞ —Å–∏—è. –ù–∞–º —Ä–æ–ª–∏–∫ –ø–æ–Ω—Ä–∞–≤–∏–ª—Å—è. –õ–∞–π–∫ –≤—Å–µ–º –ø—Ä–∏–Ω–∏–º–∞–≤—à–∏–º —É—á–∞—Å—Ç–∏–µ. –ü–æ–ª—É—á–∏–ª–æ—Å—å –∫—Ä–µ–∞—Ç–∏–≤–Ω–æ –∏ —Å–º–µ—à–Ω–æ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-09-19T12:36:58+00:00,@bezrec,6564,https://t.me/bezrec/6564,"–ï–° –∑–∞–∫—É–ø–∞–µ—Ç—Å—è —Ä–æ—Å—Å–∏–π—Å–∫–∏–º–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏. –í –∏—é–ª–µ —ç—Ç–æ–≥–æ –≥–æ–¥–∞ –ï–≤—Ä–æ—Å–æ—é–∑ –±–æ–ª–µ–µ —á–µ–º –≤–¥–≤–æ–µ –Ω–∞—Ä–∞—Å—Ç–∏–ª –∑–∞–∫—É–ø–∫—É –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏–∑ –†–æ—Å—Å–∏–∏, –∫–∞–∫ –≤ –≥–æ–¥–æ–≤–æ–º, —Ç–∞–∫ –∏ –≤ –º–µ—Å—è—á–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏, –ø–æ–¥—Å—á–∏—Ç–∞–ª–∏ ¬´–†–ò–ê –ù–æ–≤–æ—Å—Ç–∏¬ª –ø–æ –¥–∞–Ω–Ω—ã–º –ï–≤—Ä–æ—Å—Ç–∞—Ç–∞. –í —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, –ø–æ –∏—Ç–æ–≥–∞–º –∏—é–ª—è –∏–∑ –†–æ—Å—Å–∏–∏ –≤ –ï–≤—Ä–æ—Å–æ—é–∑ –ø—Ä–∏–≤–µ–∑–ª–∏ —Ñ–∞—Ä–º–ø—Ä–æ–¥—É–∫—Ü–∏–∏ –Ω–∞ ‚Ç¨8,7 –º–ª–Ω, —á—Ç–æ –≤ 2,4 —Ä–∞–∑–∞ –±–æ–ª—å—à–µ, —á–µ–º –≤ –∏—é–Ω–µ, –∏ –≤ 2,3 —Ä–∞–∑–∞ –±–æ–ª—å—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É. –ó–∞ –ø–µ—Ä–≤—ã–µ —Å–µ–º—å –º–µ—Å—è—Ü–µ–≤ –≥–æ–¥–∞ –ø–æ—Å—Ç–∞–≤–∫–∏ —É–≤–µ–ª–∏—á–∏–ª–∏—Å—å –Ω–∞ 17,5%, –¥–æ ‚Ç¨29,5 –º–ª–Ω. –ß—Ç–æ –ø–æ–∫—É–ø–∞–ª–∏? –ì–ª–∞–≤–Ω—ã–º –æ–±—Ä–∞–∑–æ–º –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç—ã ‚Äî –Ω–∞ ‚Ç¨4,4 –º–ª–Ω, –∞ —Ç–∞–∫–∂–µ –∏–º–º—É–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –∏ –≤–∞–∫—Ü–∏–Ω—ã ‚Äî –Ω–∞ ‚Ç¨4,3 –º–ª–Ω. –ö—Ç–æ –ø–æ–∫—É–ø–∞–ª? –ë–æ–ª—å—à–µ –≤—Å–µ–≥–æ —Ä–æ—Å—Å–∏–π—Å–∫–æ–π —Ñ–∞—Ä–º–ø—Ä–æ–¥—É–∫—Ü–∏–∏ –≤–Ω—É—Ç—Ä–∏ –ï–° –≤–≤–µ–∑–ª–∏: üîò–°–ª–æ–≤–µ–Ω–∏—è > ‚Ç¨5 –º–ª–Ω; üîò–í–µ–Ω–≥—Ä–∏—è ‚Äî ‚Ç¨1,6 –º–ª–Ω; üîò–°–ª–æ–≤–∞–∫–∏—è ‚Äî ‚Ç¨1,3 –º–ª–Ω; üîò–§–∏–Ω–ª—è–Ω–¥–∏—è ‚Äî ‚Ç¨418 —Ç—ã—Å.; üîò–ù–∏–¥–µ—Ä–ª–∞–Ω–¥—ã ‚Äî ‚Ç¨253 —Ç—ã—Å. –ê –º–µ–∂–¥—É —Ç–µ–º, –¥–µ—Ñ–∏—Ü–∏—Ç –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ –ï–° –¥–æ—Å—Ç–∏–≥ —Ä–µ–∫–æ—Ä–¥–Ω–æ–≥–æ —É—Ä–æ–≤–Ω—è. –° 2022 –ø–æ 2024 –≥–æ–¥ –ï–≤—Ä–æ–ø–µ–π—Å–∫–æ–º—É –∞–≥–µ–Ω—Ç—Å—Ç–≤—É –ø–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–º —Å—Ä–µ–¥—Å—Ç–≤–∞–º (EMA) —Å—Ç–∞–ª–æ –∏–∑–≤–µ—Å—Ç–Ω–æ –æ 136 —Å–ª—É—á–∞—è—Ö –∫—Ä–∏—Ç–∏—á–µ—Å–∫–æ–π –Ω–µ—Ö–≤–∞—Ç–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤. –ö –º–∞—Ä—Ç—É —ç—Ç–æ–≥–æ –≥–æ–¥–∞ –ø—Ä–æ–±–ª–µ–º—ã –±—ã–ª–∏ —Å 34 –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º–∏, –∏–∑ –∫–æ—Ç–æ—Ä—ã—Ö 16 –≤—Ö–æ–¥—è—Ç –≤ —Å–ø–∏—Å–æ–∫ –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –ï–≤—Ä–æ–ø–µ–π—Å–∫–æ–π –∫–æ–º–∏—Å—Å–∏–∏. –ê —á—Ç–æ —Å –∑–∞–∫—É–ø–∫–æ–π –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏–∑ –ï–° –†–æ—Å—Å–∏–µ–π? –ü–æ –∏—Ç–æ–≥–∞–º I –∫–≤–∞—Ä—Ç–∞–ª–∞ 2025 –≥–æ–¥–∞ –†–æ—Å—Å–∏—è –∑–∞–ø–ª–∞—Ç–∏–ª–∞ –∑–∞ –µ–≤—Ä–æ–ø–µ–π—Å–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –Ω–∞ 15% –±–æ–ª—å—à–µ ‚Äî ‚Ç¨2,3 –º–ª—Ä–¥. –ü—Ä–∏ —ç—Ç–æ–º –æ–±—ä—ë–º—ã –ø–æ—Å—Ç–∞–≤–æ–∫ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏–∑ –ï–° –æ—Å—Ç–∞–ª–∏—Å—å —Ç–µ–º–∏ –∂–µ, —á—Ç–æ –≥–æ–¥ –Ω–∞–∑–∞–¥. –ê–Ω–∞–ª–∏—Ç–∏–∫–∏ —Å–≤—è–∑—ã–≤–∞—é—Ç —ç—Ç–æ —Å —Ä–æ—Å—Ç–æ–º –ø–æ—Å—Ç–∞–≤–æ–∫ –±–æ–ª–µ–µ –¥–æ—Ä–æ–≥–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –≤ —Ç–æ–º —á–∏—Å–ª–µ –∏–∑-–∑–∞ –≤–µ—Ä–æ—è—Ç–Ω–æ–≥–æ —Å–æ–∫—Ä–∞—â–µ–Ω–∏—è –æ–±—ä–µ–º–æ–≤ –≤–≤–æ–∑–∞ –±–æ–ª–µ–µ –¥–µ—à–µ–≤—ã—Ö –∞–Ω–∞–ª–æ–≥–æ–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, shortage, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The European Union has increased its purchases of Russian medicines by more than twice in July compared to June and the same period last year. The main purchases were medicines, immunological drugs, and vaccines. Countries like Slovenia, Hungary, Slovakia, Finland, and the Netherlands have imported significant amounts of Russian pharmaceutical products. However, there is a record shortage of medicines in the EU, with 136 cases of critical shortages reported by the European Medicines Agency (EMA) from 2022 to 2024, affecting 34 drugs, including 16 essential medicines. The increase in purchases from the EU by Russia is attributed to higher-priced drugs, including a possible reduction in imports of cheaper alternatives.""
}"
2025-09-19T08:59:58+00:00,@bezrec,6563,https://t.me/bezrec/6563,"–í –†–æ—Å—Å–∏–∏ –∑–∞–ø–∞—Ç–µ–Ω—Ç–æ–≤–∞–ª–∏ –≤–∞–∫—Ü–∏–Ω—É –ø—Ä–æ—Ç–∏–≤ –∫–æ—Ä–æ–Ω–∞–≤–∏—Ä—É—Å–∞ –¥–ª—è —Ç—Ä–∏–ø–∞–Ω–æ—Ñ–æ–±–æ–≤. –ï—Å–ª–∏ –∫—Ç–æ –Ω–µ –∑–Ω–∞–ª, —Ç—Ä–∏–ø–∞–Ω–æ—Ñ–æ–±–∏–µ–π –Ω–∞–∑—ã–≤–∞—é—Ç –±–æ—è–∑–Ω—å —É–∫–æ–ª–æ–≤, –∏–Ω—ä–µ–∫—Ü–∏–π –∏ —à–ø—Ä–∏—Ü–µ–≤. –í —Ü–µ–Ω—Ç—Ä–µ ¬´–í–µ–∫—Ç–æ—Ä¬ª —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª–∏ –∏ –∑–∞–ø–∞—Ç–µ–Ω—Ç–æ–≤–∞–ª–∏ –ø–æ–ª–∏–Ω—É–∫–ª–µ–æ—Ç–∏–¥–Ω—É—é –≤–∞–∫—Ü–∏–Ω—É, –∫–æ—Ç–æ—Ä—É—é –º–æ–∂–Ω–æ –≤–≤–æ–¥–∏—Ç—å –≤ –æ—Ä–≥–∞–Ω–∏–∑–º —Å –ø–æ–º–æ—â—å—é —Å—Ç—Ä—É–π–Ω–æ–π –∏–Ω–∂–µ–∫—Ü–∏–∏ –±–µ–∑ –∏–≥–ª—ã. –ü—Ä–∞–≤–¥–∞, —É—á—ë–Ω—ã–µ –±–µ—Å–ø–æ–∫–æ–∏–ª–∏—Å—å –Ω–µ –æ –ø—Å–∏—Ö–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–º –∫–æ–º—Ñ–æ—Ä—Ç–µ —Ç—Ä–∏–ø–∞–Ω–æ—Ñ–æ–±–æ–≤, –∞ –æ –≤—ã—Å–æ–∫–æ–º —É—Ä–æ–≤–Ω–µ –∏–º–º—É–Ω–Ω–æ–≥–æ –æ—Ç–≤–µ—Ç–∞ –∏ —Å–Ω–∏–∂–µ–Ω–∏–∏ –≤–µ—Ä–æ—è—Ç–Ω–æ—Å—Ç–∏ ¬´–ø–æ–±–æ—á–µ–∫¬ª. –ö–∞–∫ –æ–±—ä—è—Å–Ω—è—é—Ç –∞–≤—Ç–æ—Ä—ã –ø–∞—Ç–µ–Ω—Ç–∞, –≤ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–Ω–æ–π –ø–æ–ª–∏–Ω—É–∫–ª–µ–æ—Ç–∏–¥–Ω–æ–π –≤–∞–∫—Ü–∏–Ω–µ –∏—Å–ø–æ–ª—å–∑—É—é—Ç—Å—è —Ç–∞–∫ –Ω–∞–∑—ã–≤–∞–µ–º—ã–µ ¬´–≥–æ–ª—ã–µ¬ª –º–æ–ª–µ–∫—É–ª—ã –Ω—É–∫–ª–µ–∏–Ω–æ–≤—ã—Ö –∫–∏—Å–ª–æ—Ç ‚Äî –î–ù–ö –∏–ª–∏ –º–†–ù–ö, –∫–æ–¥–∏—Ä—É—é—â–∏–µ –∞–Ω—Ç–∏–≥–µ–Ω (–Ω–∞–ø—Ä–∏–º–µ—Ä, –±–µ–ª–æ–∫ –≤–æ–∑–±—É–¥–∏—Ç–µ–ª—è). –£ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ –æ—Å–Ω–æ–≤–µ –Ω—É–∫–ª–µ–∏–Ω–æ–≤—ã—Ö –∫–∏—Å–ª–æ—Ç –µ—Å—Ç—å –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ–∫ ‚Äî –Ω–∏–∑–∫–∞—è –∏–º–º—É–Ω–æ–≥–µ–Ω–Ω–æ—Å—Ç—å. –í–Ω—É—Ç—Ä–∏–º—ã—à–µ—á–Ω–æ–µ –≤–≤–µ–¥–µ–Ω–∏–µ —Ç–∞–∫–∏—Ö –≤–∞–∫—Ü–∏–Ω —à–ø—Ä–∏—Ü–æ–º —Å –∏–≥–ª–æ–π –Ω–µ—ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ –∏–∑-–∑–∞ –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ–≥–æ —É—Ä–æ–≤–Ω—è –∏–º–º—É–Ω–Ω–æ–≥–æ –æ—Ç–≤–µ—Ç–∞. –†–µ–∑—É–ª—å—Ç–∞—Ç –∑–∞—è–≤–ª—è–µ–º–æ–≥–æ –∏–∑–æ–±—Ä–µ—Ç–µ–Ω–∏—è ‚Äî –ø–æ–≤—ã—à–µ–Ω–∏–µ –∏–º–º—É–Ω–æ–≥–µ–Ω–Ω–æ—Å—Ç–∏ –∏ —Å–Ω–∏–∂–µ–Ω–∏–µ —Ä–µ–∞–∫—Ç–æ–≥–µ–Ω–Ω–æ—Å—Ç–∏ –≤–∞–∫—Ü–∏–Ω—ã –ø—Ä–æ—Ç–∏–≤ COVID-19. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–Ω—ã–π —É—á–µ–Ω—ã–º–∏ —Å–ø–æ—Å–æ–± –¥–æ—Å—Ç–∞–≤–∫–∏ –≤–∞–∫—Ü–∏–Ω —É–º–µ–Ω—å—à–∞–µ—Ç –∏—Ö –ø–æ–±–æ—á–Ω—ã–µ —ç—Ñ—Ñ–µ–∫—Ç—ã, –∞ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–µ –≤ —Å–æ—Å—Ç–∞–≤–µ –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã—Ö –∫–æ–º–ø–æ–Ω–µ–Ω—Ç–æ–≤ —Å–Ω–∏–∂–∞–µ—Ç —Å—Ç–æ–∏–º–æ—Å—Ç—å –º–µ—Ç–æ–¥–∞. –°—Ç—Ä—É–π–Ω—ã–π —Å–ø–æ—Å–æ–± –≤–≤–µ–¥–µ–Ω–∏—è –≤–∞–∫—Ü–∏–Ω—ã –≤–Ω—É—Ç—Ä–∏–º—ã—à–µ—á–Ω–æ —É—Å–ø–µ—à–Ω–æ –∏—Å–ø—ã—Ç–∞–ª–∏ –Ω–∞ –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–Ω—ã—Ö –∂–∏–≤–æ—Ç–Ω—ã—Ö, –∑–∞–æ–¥–Ω–æ –æ–ø—Ä–µ–¥–µ–ª–∏–≤ –æ–ø—Ç–∏–º–∞–ª—å–Ω—ã–µ —É—Å–ª–æ–≤–∏—è –¥–ª—è –∏–Ω–∂–µ–∫—Ü–∏–∏: —Å–∫–æ—Ä–æ—Å—Ç—å —Å—Ç—Ä—É–∏ ‚Äî 220 –º–µ—Ç—Ä–æ–≤ –≤ —Å–µ–∫—É–Ω–¥—É, –≤—Ä–µ–º—è ‚Äî 0,33 —Å–µ–∫—É–Ω–¥—ã. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing, import_export, sanctions, shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""Patent for a novel coronavirus vaccine developed by the Vector Institute in Russia. The patent involves a polymeric injection method that uses naked DNA or mRNA to encode antigens, such as the virus's protein. The technique aims to increase immunogenicity and reduce side effects by using a stream injection method at 220 meters per second for 0.33 seconds, which has been tested on laboratory animals.""
}"
2025-09-19T05:45:46+00:00,@bezrec,6562,https://t.me/bezrec/6562,"–ù–∞—á–∏–Ω–∞–µ–º –ø—è—Ç–Ω–∏—Ü—É —Å –Ω–∞—Å—É—â–Ω–æ–≥–æ ‚Äî –Ω–æ–≤–æ–≥–æ –ø–µ—Ä–µ—á–Ω—è –ñ–ù–í–õ–ü, –∞ —Ç–æ—á–Ω–µ–µ –µ–≥–æ –ø—Ä–æ–µ–∫—Ç–∞, –∫–æ—Ç–æ—Ä—ã–π –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª –ú–∏–Ω–∑–¥—Ä–∞–≤. –° 2026 –≥–æ–¥–∞ –æ–±–Ω–æ–≤–ª—ë–Ω–Ω—ã–π –ø–µ—Ä–µ—á–µ–Ω—å –ø–æ–ø–æ–ª–Ω–∏—Ç—Å—è —Å–ª–µ–¥—É—é—â–∏–º–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º–∏: –†–µ–±–ª–æ–∑–∏–ª, –†–∞–∫—Å—Ç–µ–º–∏, –ê–∫–¥–∞–π–Ω–∞, –ê—Ä–µ–π–º–∞, –ü–∞–¥—Ü–µ–≤ –û–Ω–∫–æ, –ê—Ñ—Å—Ç–∏–ª–∞, –ù—É–±–µ–∫–∞, –ü–æ—ç–∫—Å–æ, –ó–µ–≤—Ç–µ—Ä–∞, –ê—Ä—Ü–µ—Ä–∏–∫—Å, –õ–æ—Ä–≤–∏–∫–≤–∞, –≠–º–ø–∞–≤–µ–ª–∏. –î–ª—è –≤–∞—à–µ–≥–æ —É–¥–æ–±—Å—Ç–≤–∞ —Å–æ–±—Ä–∞–ª–∏ –≤—Å–µ—Ö ¬´–Ω–æ–≤–æ–±—Ä–∞–Ω—Ü–µ–≤¬ª –≤ –æ–¥–Ω—É —Ç–∞–±–ª–∏—Ü—É. –ò—Å–∫–ª—é—á–µ–Ω—ã –±—É–¥—É—Ç –∏–Ω—Ç–µ—Ä—Ñ–µ—Ä–æ–Ω –≥–∞–º–º–∞ —á–µ–ª–æ–≤–µ—á–µ—Å–∫–∏–π —Ä–µ–∫–æ–º–±–∏–Ω–∞–Ω—Ç–Ω—ã–π –≤ —Ñ–æ—Ä–º–µ –ª–∏–æ—Ñ–∏–ª–∏–∑–∞—Ç–∞ –¥–ª—è –ø—Ä–∏–≥–æ—Ç–æ–≤–ª–µ–Ω–∏—è —Ä–∞—Å—Ç–≤–æ—Ä–∞ –¥–ª—è –∏–Ω—Ç—Ä–∞–Ω–∞–∑–∞–ª—å–Ω–æ–≥–æ –≤–≤–µ–¥–µ–Ω–∏—è, –∞ —Ç–∞–∫–∂–µ –º–µ–≥–ª—é–º–∏–Ω–∞ –∞–∫—Ä–∏–¥–æ–Ω–∞—Ü–µ—Ç–∞—Ç –≤ —Ñ–æ—Ä–º–µ —Ä–∞—Å—Ç–≤–æ—Ä–∞ –¥–ª—è –≤–Ω—É—Ç—Ä–∏–≤–µ–Ω–Ω–æ–≥–æ –∏ –≤–Ω—É—Ç—Ä–∏–º—ã—à–µ—á–Ω–æ–≥–æ –≤–≤–µ–¥–µ–Ω–∏—è. –ü–æ—Å–ª–µ–¥–Ω–∏–π —Ä–∞–∑ –ø–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü –æ–±–Ω–æ–≤–ª—è–ª—Å—è –≤ —è–Ω–≤–∞—Ä–µ 2025 –≥–æ–¥–∞ ‚Äî —Ç–æ–≥–¥–∞ –æ–Ω –ø–æ–ø–æ–ª–Ω–∏–ª—Å—è 18 –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, sanctions, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health has presented a project for an updated list of Highly Dangerous and Non-Voluntary List of Medicines (–ñ–ù–í–õ–ü). The updated list will include the following drugs starting from 2026: Reblosil, Rakstemi, Akdaina, Areyma, Padcev Oncology, Afstila, Nubeka, Peksyo, Zevtera, Arcersix, Lorvikva, Empaveli. Interferon gamma human recombinant in lyophilized form for intranasal preparation and magnesium acrylate in solution for intravenous and intramuscular injection are excluded. The last update to the list was in January 2025, when it included 18 drugs.""
}"
2025-09-18T15:30:21+00:00,@bezrec,6561,https://t.me/bezrec/6561,"FDA –æ–¥–æ–±—Ä–∏–ª–æ –∫–∞–ø—É –¥–ª—è –ª–µ—á–µ–Ω–∏—è –∞–ø–Ω–æ—ç –æ—Ç Airway Management. –£ Nylon flexTAP –µ—Å—Ç—å –∏–Ω—Ç–µ—Ä–µ—Å–Ω–∞—è –æ—Å–æ–±–µ–Ω–Ω–æ—Å—Ç—å ‚Äî —É—Å—Ç—Ä–æ–π—Å—Ç–≤–æ –ø–æ–ª–Ω–æ—Å—Ç—å—é –Ω–∞–ø–µ—á–∞—Ç–∞–Ω–æ –Ω–∞ 3D-–ø—Ä–∏–Ω—Ç–µ—Ä–µ, —á—Ç–æ –¥–µ–ª–∞–µ—Ç –µ–≥–æ —É–Ω–∏–∫–∞–ª—å–Ω—ã–º, –∞ —Ä–µ—à–µ–Ω–∏–µ –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–≥–æ —Ä–µ–≥—É–ª—è—Ç–æ—Ä–∞, –ø–æ —Å–ª–æ–≤–∞–º —Å–∞–º–æ–≥–æ —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–∞, ¬´–∏—Å—Ç–æ—Ä–∏—á–µ—Å–∫–∏–º¬ª. –ö–∞–ø–∞ –æ–¥–æ–±—Ä–µ–Ω–∞ FDA –¥–ª—è –ª–µ—á–µ–Ω–∏—è –ª—ë–≥–∫–æ–π –∏ —É–º–µ—Ä–µ–Ω–Ω–æ–π —Ñ–æ—Ä–º—ã –æ–±—Å—Ç—Ä—É–∫—Ç–∏–≤–Ω–æ–≥–æ –∞–ø–Ω–æ—ç —Å–Ω–∞. –£–ª—å—Ç—Ä–∞—Ç–æ–Ω–∫–∏–π –∞–ø–ø–∞—Ä–∞—Ç –∏–∑ –±–∏–æ—Å–æ–≤–º–µ—Å—Ç–∏–º–æ–≥–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –Ω–µ–π–ª–æ–Ω–∞ –æ–±–µ—Å–ø–µ—á–∏–≤–∞–µ—Ç –º–∞–∫—Å–∏–º–∞–ª—å–Ω—ã–π –∫–æ–º—Ñ–æ—Ä—Ç –±–µ–∑ —É—â–µ—Ä–±–∞ –¥–ª—è —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –ª–µ—á–µ–Ω–∏—è, –æ–±–µ—â–∞—é—Ç –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏. –ó–∞–ø–∞—Ç–µ–Ω—Ç–æ–≤–∞–Ω–Ω–∞—è —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—è Vertex –æ–±–µ—Å–ø–µ—á–∏–≤–∞–µ—Ç –¥–≤–∏–∂–µ–Ω–∏–µ –ø–æ –¥–≤—É–º –æ—Å—è–º (–ø–æ –≤–µ—Ä—Ç–∏–∫–∞–ª–∏ –∏ –≥–æ—Ä–∏–∑–æ–Ω—Ç–∞–ª–∏) –¥–ª—è –º–∞–∫—Å–∏–º–∞–ª—å–Ω–æ–≥–æ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏—è –ø—Ä–æ—Å—Ç—Ä–∞–Ω—Å—Ç–≤–∞ –≤ –¥—ã—Ö–∞—Ç–µ–ª—å–Ω—ã—Ö –ø—É—Ç—è—Ö. –ï—â—ë –ø–ª—é—Å ‚Äî —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –ø—Ä–∏–∫—É—Å–∞ –Ω–µ —Ç—Ä–µ–±—É–µ—Ç—Å—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-09-18T12:39:34+00:00,@bezrec,6560,https://t.me/bezrec/6560,"–í –†–§ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª–∏ –Ω–æ–≤—É—é –ø–Ω–µ–≤–º–æ–∫–æ–∫–∫–æ–≤—É—é –≤–∞–∫—Ü–∏–Ω—É. –£–≤—ã, —Ä–µ—á—å –ø–æ–∫–∞ –Ω–µ –æ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ –ù–ò–ò –≤–∞–∫—Ü–∏–Ω –∏ —Å—ã–≤–æ—Ä–æ—Ç–æ–∫ –§–ú–ë–ê ‚Äî –æ–Ω–∞ –ø–æ–∫–∞ –ø—Ä–æ—Ö–æ–¥–∏—Ç 3 —Ñ–∞–∑—É –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π. –°–≤–æ—é 20-–≤–∞–ª–µ–Ω—Ç–Ω—É—é –ø–æ–ª–∏—Å–∞—Ö–∞—Ä–∏–¥–Ω—É—é –∫–æ–Ω—ä—é–≥–∏—Ä–æ–≤–∞–Ω–Ω—É—é –≤–∞–∫—Ü–∏–Ω—É –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª Pfizer. –ü—Ä–µ–≤–µ–Ω–∞—Ä 20 –ø–æ–¥—Ö–æ–¥–∏—Ç –∫–∞–∫ –¥–ª—è –≤–∑—Ä–æ—Å–ª—ã—Ö, —Ç–∞–∫ –∏ –¥–ª—è –¥–µ—Ç–µ–π —Å—Ç–∞—Ä—à–µ —à–µ—Å—Ç–∏ –Ω–µ–¥–µ–ª—å. –í —Å–æ—Å—Ç–∞–≤ –ø—Ä–µ–ø–∞—Ä–∞—Ç –≤—Ö–æ–¥–∏—Ç 20 –ø–æ–ª–∏—Å–∞—Ö–∞—Ä–∏–¥–æ–≤ –∏–∑ —Å–µ—Ä–æ—Ç–∏–ø–æ–≤ Streptococcus pneumoniae (1, 3, 4, 5, 6–ê, 6–í, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19–ê, 19F, 22F, 23F, 33F), –∏–∑–≤–µ—Å—Ç–Ω—ã—Ö –≤—ã—Å–æ–∫–æ–π –ª–µ—Ç–∞–ª—å–Ω–æ—Å—Ç—å—é –∏ —É—Å—Ç–æ–π—á–∏–≤–æ—Å—Ç—å—é –∫ –∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫–∞–º. –≠—Ç–æ —Ä–µ–∫–æ—Ä–¥ —Å—Ä–µ–¥–∏ –≤—Å–µ—Ö –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –≤ –†–æ—Å—Å–∏–∏ –∫–æ–Ω—ä—é–≥–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –≤–∞–∫—Ü–∏–Ω. –í–∞–∫—Ü–∏–Ω–∞ –æ—Ç –§–ú–ë–ê –±—É–¥–µ—Ç 16-–≤–∞–ª–µ–Ω—Ç–Ω–æ–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""medium"",
  ""english"": ""The Russian Federation has registered a new pneumococcal conjugate vaccine. This is Pfizer's Prevenar 20, which covers 20 polysaccharides from serotypes Streptococcus pneumoniae (1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, 33F), known for high lethality and antibiotic resistance. The Russian vaccine will be 16-valent.""
}"
2025-09-18T09:09:25+00:00,@bezrec,6559,https://t.me/bezrec/6559,"Roche –Ω–µ —Ç–µ—Ä—è–µ—Ç –Ω–∞–¥–µ–∂–¥—ã –¥–æ–≥–Ω–∞—Ç—å Novo Nordisk –∏ Eli Lilly –≤ –ª–µ—á–µ–Ω–∏–∏ –æ–∂–∏—Ä–µ–Ω–∏—è. –ß—Ç–æ–±—ã –∑–∞–ø–æ–ª—É—á–∏—Ç—å —Å–≤–æ–π –∫—É—Å–æ–∫ –ø–∏—Ä–æ–≥–∞, —à–≤–µ–π—Ü–∞—Ä—Å–∫–∞—è –∫–æ–º–ø–∞–Ω–∏—è –ø–æ–∫—É–ø–∞–µ—Ç –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫—É—é 89bio –∑–∞ $3,5 –º–ª—Ä–¥. –û–∂–∏–¥–∞–µ—Ç—Å—è, —á—Ç–æ —Å–¥–µ–ª–∫–∞ –ø–æ–∑–≤–æ–ª–∏—Ç —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—é —Ä–∞—Å—à–∏—Ä–∏—Ç—å —Å–≤–æ–π –ø–æ—Ä—Ç—Ñ–µ–ª—å –∏ –Ω–∞–∫–æ–Ω–µ—Ü –æ—Å–≤–æ–∏—Ç—å—Å—è –Ω–∞ –±—ã—Å—Ç—Ä–æ—Ä–∞—Å—Ç—É—â–µ–º —Ä—ã–Ω–∫–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –æ–∂–∏—Ä–µ–Ω–∏—è –∏ —Å–≤—è–∑–∞–Ω–Ω—ã—Ö —Å –Ω–∏–º –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. 89bio –∏–∑ –°–∞–Ω-–§—Ä–∞–Ω—Ü–∏—Å–∫–æ —Ä–∞–∑—Ä–∞–±–∞—Ç—ã–≤–∞–µ—Ç –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–µ –º–µ—Ç–æ–¥—ã –ª–µ—á–µ–Ω–∏—è –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –ø–µ—á–µ–Ω–∏ –∏ –∫–∞—Ä–¥–∏–æ–º–µ—Ç–∞–±–æ–ª–∏—á–µ—Å–∫–∏—Ö –Ω–µ–¥—É–≥–æ–≤. –ï—ë –∫–ª—é—á–µ–≤–æ–π –ø—Ä–µ–ø–∞—Ä–∞—Ç, –Ω–∞—Ö–æ–¥—è—â–∏–π—Å—è –Ω–∞ –ø–æ–∑–¥–Ω–µ–π —Å—Ç–∞–¥–∏–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏, ‚Äî –ø–µ–≥–æ–∑–∞—Ñ–µ—Ä–º–∏–Ω –ø—Ä–æ—Ç–∏–≤ –Ω–µ–∞–ª–∫–æ–≥–æ–ª—å–Ω–æ–≥–æ —Å—Ç–µ–∞—Ç–æ–≥–µ–ø–∞—Ç–∏—Ç–∞ ‚Äî –ø—Ä–æ–≥—Ä–µ—Å—Å–∏—Ä—É—é—â–µ–≥–æ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è –ø–µ—á–µ–Ω–∏, —Å–≤—è–∑–∞–Ω–Ω–æ–≥–æ —Å –º–µ—Ç–∞–±–æ–ª–∏—á–µ—Å–∫–∏–º–∏ –Ω–∞—Ä—É—à–µ–Ω–∏—è–º–∏, —Ç–∞–∫–∏–º–∏ –∫–∞–∫ –æ–∂–∏—Ä–µ–Ω–∏–µ, —Å–∞—Ö–∞—Ä–Ω—ã–π –¥–∏–∞–±–µ—Ç –∏ –¥–∏—Å–ª–∏–ø–∏–¥–µ–º–∏—è. –ü–æ–∫—É–ø–∫–∞ 89bio ‚Äî –Ω–µ –ø–µ—Ä–≤–∞—è –ø–æ–ø—ã—Ç–∫–∞ Roche –ø—Ä–æ—Ä–≤–∞—Ç—å—Å—è –Ω–∞ –≤—ã—Å–æ–∫–æ–¥–æ—Ö–æ–¥–Ω—ã–π —Ä—ã–Ω–æ–∫ –ª–µ—á–µ–Ω–∏—è –æ–∂–∏—Ä–µ–Ω–∏—è. –í 2023 –≥–æ–¥—É Roche –ø—Ä–∏–æ–±—Ä–µ–ª–∞ Carmot Therapeutics –∑–∞ $3,1 –º–ª—Ä–¥, —á—Ç–æ–±—ã –ø–æ–ª—É—á–∏—Ç—å –¥–æ—Å—Ç—É–ø –∫ –ø–æ—Ä—Ç—Ñ–µ–ª—é –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–æ–∫, –≤–∫–ª—é—á–∞—é—â–µ–º—É –ø–æ–¥–∫–æ–∂–Ω—ã–µ –∏ –ø–µ—Ä–æ—Ä–∞–ª—å–Ω—ã–µ –∏–Ω–∫—Ä–µ—Ç–∏–Ω—ã –Ω–∞ –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–π —Å—Ç–∞–¥–∏–∏ —Å –ª—É—á—à–∏–º –≤ —Å–≤–æ–µ–º –∫–ª–∞—Å—Å–µ –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª–æ–º –¥–ª—è –ª–µ—á–µ–Ω–∏—è –æ–∂–∏—Ä–µ–Ω–∏—è —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –¥–∏–∞–±–µ—Ç–æ–º –∏ –±–µ–∑ –Ω–µ–≥–æ. –í –º–∞—Ä—Ç–µ —ç—Ç–æ–≥–æ –≥–æ–¥–∞ —à–≤–µ–π—Ü–∞—Ä—Ü—ã –∑–∞–∫–ª—é—á–∏–ª–∏ —Å–æ–≥–ª–∞—à–µ–Ω–∏–µ —Å –¥–∞—Ç—Å–∫–æ–π Zealand Pharma –æ –ø–æ–∫—É–ø–∫–µ –ø—Ä–∞–≤ –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–æ –æ—Ç –æ–∂–∏—Ä–µ–Ω–∏—è petrelintide –∑–∞ $5,3 –º–ª—Ä–¥. –í —Ç–æ–º –∂–µ –º–µ—Å—è—Ü–µ Roche –Ω–∞–Ω—è–ª–∞ –≤–∏—Ü–µ-–ø—Ä–µ–∑–∏–¥–µ–Ω—Ç–∞ –¥–∞—Ç—Å–∫–æ–π Novo Nordisk –ú–æ—Ä—Ç–µ–Ω–∞ –õ–∞–º–º–µ—Ä—Ç–∞ –Ω–∞ –¥–æ–ª–∂–Ω–æ—Å—Ç—å –≥–ª–∞–≤—ã –ø–æ–¥—Ä–∞–∑–¥–µ–ª–µ–Ω–∏—è –ø–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö, –ø–æ—á–µ—á–Ω—ã—Ö –∏ –º–µ—Ç–∞–±–æ–ª–∏—á–µ—Å–∫–∏—Ö –±–æ–ª–µ–∑–Ω–µ–π, —á—Ç–æ–±—ã –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å –µ–≥–æ –æ–ø—ã—Ç –¥–ª—è —Å–∫–æ—Ä–µ–π—à–µ–≥–æ –≤—ã—Ö–æ–¥–∞ –Ω–∞ —Ä—ã–Ω–æ–∫ –ª–µ—á–µ–Ω–∏—è –¥–∏–∞–±–µ—Ç–∞ –∏ –æ–∂–∏—Ä–µ–Ω–∏—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-09-18T05:38:19+00:00,@bezrec,6558,https://t.me/bezrec/6558,"–í –†–æ—Å—Å–∏–∏ —Ä–∞—Å—Ç—É—Ç –ø—Ä–æ–¥–∞–∂–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –æ—Ç –¥–µ–º–µ–Ω—Ü–∏–∏. –ü–æ –¥–∞–Ω–Ω—ã–º RNC Pharma, —Å —è–Ω–≤–∞—Ä—è –ø–æ –∏—é–ª—å 2025 –≥–æ–¥–∞ –±—ã–ª–æ —Ä–µ–∞–ª–∏–∑–æ–≤–∞–Ω–æ —Ç–∞–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –±–æ–ª–µ–µ —á–µ–º –Ω–∞ 5 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —á—Ç–æ –Ω–∞ 16,2% –±–æ–ª—å—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É. –ù–∞—Ç—É—Ä–∞–ª—å–Ω–æ–µ –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–µ –≤—ã—Ä–æ—Å–ª–æ –Ω–∞ 14,4%, –¥–æ 2,9 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫. –ü–æ –∏—Ç–æ–≥–∞–º 2024 –≥–æ–¥–∞ —Ä–æ—Å—Å–∏—è–Ω–µ –∫—É–ø–∏–ª–∏ –±–æ–ª–µ–µ 4,5 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ –ø–æ–¥–æ–±–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ (+13,6% –∫ 2023 –≥–æ–¥—É) –Ω–∞ —Å—É–º–º—É –±–æ–ª–µ–µ 7,8 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π (+18,4%). –ü–æ–∫–∞–∑–∞—Ç–µ–ª–∏ 2023 –≥–æ–¥–∞ ‚Äî –º–µ–Ω–µ–µ 4 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫, –Ω–∞ —Å—É–º–º—É 6,6 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ú–∞–∫—Å–∏–º–∞–ª—å–Ω–∞—è —Ä—É–±–ª—ë–≤–∞—è –¥–∏–Ω–∞–º–∏–∫–∞ –≤ –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–Ω–∞ –≤ –ü—Ä–∏–≤–æ–ª–∂—Å–∫–æ–º –∏ –°–µ–≤–µ—Ä–æ-–ö–∞–≤–∫–∞–∑—Å–∫–æ–º –§–µ–¥–µ—Ä–∞–ª—å–Ω—ã—Ö –æ–∫—Ä—É–≥–∞—Ö. –ü—Ä–∏ —ç—Ç–æ–º –º–∞–∫—Å–∏–º–∞–ª—å–Ω—ã–π –¥–µ–Ω–µ–∂–Ω—ã–π –æ–±—ä—ë–º –ø—Ä–æ–¥–∞–∂ —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω–æ –æ—Ç–º–µ—á–∞–µ—Ç—Å—è –≤ –¶–µ–Ω—Ç—Ä–∞–ª—å–Ω–æ–º –§–û ‚Äî –Ω–∞ —Ä–µ–≥–∏–æ–Ω –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è 32,5% —Ä—ã–Ω–∫–∞ –≤ —Ä—É–±–ª—è—Ö –∏ –ø–æ—á—Ç–∏ 31% –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–≥–æ –æ–±—ä—ë–º–∞. –ê—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –¥–µ–º–µ–Ω—Ü–∏–∏ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω —á–µ—Ç—ã—Ä—å–º—è –ú–ù–ù. –í –ª–∏–¥–µ—Ä–∞—Ö –ø–æ –ø—Ä–æ–¥–∞–∂–∞–º ‚Äî –º–µ–º–∞–Ω—Ç–∏–Ω, –≤ —á–∞—Å—Ç–Ω–æ—Å—Ç–∏ –ê–∫–∞—Ç–∏–Ω–æ–ª –ú–µ–º–∞–Ω—Ç–∏–Ω –æ—Ç ¬´–ú–µ—Ä—Ü –§–∞—Ä–º–∞¬ª. –ù–æ –∫–æ–Ω–∫—É—Ä–µ–Ω—Ç—ã –Ω–µ –¥—Ä–µ–º–ª—é—Ç ‚Äî –∞–Ω–∞–ª–∏—Ç–∏–∫–∏ —Ñ–∏–∫—Å–∏—Ä—É—é—Ç —Ä–æ—Å—Ç —Ä–æ–ª–∏ –Ω–µ–∫–æ—Ç–æ—Ä—ã—Ö –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –∞–Ω–∞–ª–æ–≥–æ–≤. –ù–µ–±—Ä–µ–Ω–¥–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –º–µ–º–∞–Ω—Ç–∏–Ω–∞ –∑–∞–Ω–∏–º–∞—é—Ç –≤—Ç–æ—Ä—É—é —Å—Ç—Ä–æ—á–∫—É —Ä–µ–π—Ç–∏–Ω–≥–∞. –ü–æ–ø—É–ª—è—Ä–Ω–æ—Å—Ç—å —ç—Ç–æ–≥–æ –ú–ù–ù —Ç–∞–∫–∂–µ –º–æ–∂–µ—Ç –±—ã—Ç—å –æ–±—É—Å–ª–æ–≤–ª–µ–Ω–∞ –µ–≥–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º off-label ‚Äî –≤ –ø–µ–¥–∏–∞—Ç—Ä–∏–∏ –ø—Ä–∏ –ó–ü–†–†, –∞—É—Ç–∏–∑–º–µ –∏ –Ω–µ–∫–æ—Ç–æ—Ä—ã—Ö –¥—Ä—É–≥–∏—Ö –∫–æ–≥–Ω–∏—Ç–∏–≤–Ω—ã—Ö –Ω–∞—Ä—É—à–µ–Ω–∏—è—Ö. –ó–∞–º—ã–∫–∞–µ—Ç —Ç—Ä–æ–π–∫—É –ª–∏–¥–µ—Ä–æ–≤ –ù–µ–π—Ä–æ–º–∏–¥–∏–Ω (–∏–ø–∏–¥–∞–∫—Ä–∏–Ω) –æ—Ç –û–ª–∞–π–Ω—Ñ–∞—Ä–º —Å –¥–æ–ª–µ–π —Ä—ã–Ω–∫–∞ 17,9%. –°–Ω–∏–∂–µ–Ω–∏–µ –ø—Ä–æ–¥–∞–∂ –≤ –æ—Ç—á—ë—Ç–Ω—ã–π –ø–µ—Ä–∏–æ–¥ –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–Ω–æ —É –ò–ø–∏–≥—Ä–∏–∫—Å–∞ –æ—Ç ¬´–ì—Ä–∏–Ω–¥–µ–∫—Å–∞¬ª (-21%) –∏ –ú–µ–º–∞–Ω—Ç–∞–ª—è –æ—Ç ¬´–°–æ—Ç–µ–∫—Å–∞¬ª (-6%). –ú–∞–∫—Å–∏–º–∞–ª—å–Ω–æ–π –¥–∏–Ω–∞–º–∏–∫–æ–π –º–æ–∂–µ—Ç –ø–æ—Ö–≤–∞—Å—Ç–∞—Ç—å—Å—è –Ω–µ–±—Ä–µ–Ω–¥–∏—Ä–æ–≤–∞–Ω–Ω—ã–π –ò–ø–∏–¥–∞–∫—Ä–∏–Ω –æ—Ç ¬´–°–µ–≤–µ—Ä–Ω–æ–π –ó–≤–µ–∑–¥—ã¬ª –∏ –µ—â—ë —Ç—Ä—ë—Ö –∫–æ–º–ø–∞–Ω–∏–π ‚Äî –ø—Ä–æ–¥–∞–∂–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –≤—ã—Ä–æ—Å–ª–∏ –Ω–∞ 93% –≤ —Ä—É–±–ª—è—Ö –∏ –Ω–∞ 89% –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö –≥–æ–¥ –∫ –≥–æ–¥—É. –í —Ç–æ–ø-10 —Ç–æ—Ä–≥–æ–≤—ã—Ö –º–∞—Ä–æ–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –¥–µ–º–µ–Ω—Ü–∏–∏ –ø–æ –æ–±—ä—ë–º—É –¥–µ–Ω–µ–∂–Ω—ã—Ö –ø—Ä–æ–¥–∞–∂ —Ç–∞–∫–∂–µ –≤–æ—à–ª–∏: –ê–∫—Å–∞–º–æ–Ω (¬´–ü–∏–∫-–§–∞—Ä–º–∞¬ª), –ú–µ–º–∞–Ω—Ç–∏–Ω –ö–∞–Ω–æ–Ω (¬´–ö–∞–Ω–æ–Ω—Ñ–∞—Ä–º–∞¬ª), –≠–∫—Å–µ–ª–æ–Ω (¬´–ù–æ–≤–∞—Ä—Ç–∏—Å¬ª), –ú–∞—Ä—É–∫—Å–∞ (¬´–ö–†–ö–ê¬ª). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""Sales of dementia treatment drugs in Russia have increased by 16.2% year-over-year from January to July 2025, with natural consumption up by 14.4% to 2.9 million units. Sales in Russia have grown by 13.6% year-over-year to over 4.5 million units worth of the drugs, up from 3.2 million units worth in 2023. The Central Federal Region accounts for the largest share of market value, with over 32.5% of the market in rubles and nearly 31% of natural volume. The top-selling drugs are Memantine (Akatinol Memantine from 'Merz Pharma') and Nereidon (Ipidakinrin from 'Olenfarm'), with the latter showing a significant year-over-year increase of 93% in rubles and 89% in units. The market is also seeing growth from non-branded products, including Ipidakinrin from 'Northern Star' and other companies. The top"
2025-09-17T14:59:48+00:00,@bezrec,6557,https://t.me/bezrec/6557,"–° —Ä–æ—Å—Å–∏–π—Å–∫–∏–º–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∞–º–∏ —à–ø—Ä–∏—Ü-—Ä—É—á–µ–∫ –¥–ª—è –∞–ª–ª–µ—Ä–≥–∏–∫–æ–≤ –≤—Å—ë –≥–ª—É—Ö–æ. 11 —Å–µ–Ω—Ç—è–±—Ä—è –ø–æ—Ç–µ—Ä—è–ª –ø–∞—Ç–µ–Ω—Ç–Ω—É—é –∑–∞—â–∏—Ç—É EpiPen –æ—Ç Mylan ‚Äî —Å–∞–º—ã–π –∏–∑–≤–µ—Å—Ç–Ω—ã–π –∞–≤—Ç–æ–∏–Ω—ä–µ–∫—Ç–æ—Ä —Å —Å–∏–Ω—Ç–µ—Ç–∏—á–µ—Å–∫–∏–º –∞–Ω–∞–ª–æ–≥–æ–º –∞–¥—Ä–µ–Ω–∞–ª–∏–Ω–∞ (—ç–ø–∏–Ω–µ—Ñ—Ä–∏–Ω–æ–º) –¥–ª—è –ª–µ—á–µ–Ω–∏—è –∞–Ω–∞—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–æ–≥–æ —à–æ–∫–∞. –î–æ–ª–≥–∏–µ –≥–æ–¥—ã –∫–æ–º–ø–∞–Ω–∏—è –±—ã–ª–∞ –º–æ–Ω–æ–ø–æ–ª–∏—Å—Ç–æ–º –Ω–∞ —Ä—ã–Ω–∫–µ, –∏ –≤—ã—Ö–æ–¥ –∏–∑-–ø–æ–¥ –ø–∞—Ç–µ–Ω—Ç–∞ –¥–æ–ª–∂–µ–Ω —Ä–∞–∑–≤—è–∑–∞—Ç—å —Ä—É–∫–∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤. –ö —Ç–æ–º—É –∂–µ —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–æ–µ —Ä–µ—à–µ–Ω–∏–µ 2007 –≥–æ–¥–∞ —Å—á–∏—Ç–∞–µ—Ç—Å—è —É—Å—Ç–∞—Ä–µ–≤—à–∏–º –∏ —Ç—Ä–µ–±—É–µ—Ç –º–æ–¥–µ—Ä–Ω–∏–∑–∞—Ü–∏–∏. –í –†–æ—Å—Å–∏–∏ –ø—Ä—è–º—ã—Ö –∞–Ω–∞–ª–æ–≥–æ–≤ —ç–ø–∏–Ω–µ—Ñ—Ä–∏–Ω–∞ –≤ –≤–∏–¥–µ –∞–≤—Ç–æ–∏–Ω—ä–µ–∫—Ç–æ—Ä–æ–≤ –Ω–µ—Ç. –ù–æ —ç–ø–∏–Ω–µ—Ñ—Ä–∏–Ω –≤ –∏–Ω—ä–µ–∫—Ü–∏–æ–Ω–Ω–æ–π —Ñ–æ—Ä–º–µ –≤—Ö–æ–¥–∏—Ç –≤ –Ω–∞–±–æ—Ä—ã –¥–ª—è –æ–∫–∞–∑–∞–Ω–∏—è —ç–∫—Å—Ç—Ä–µ–Ω–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –Ω–∞ —Å–∫–æ—Ä—ã—Ö. –ê –º–µ–∂–¥—É —Ç–µ–º, —à–ø—Ä–∏—Ü-—Ä—É—á–∫–∞ –º–æ–∂–µ—Ç —Å–ø–∞—Å—Ç–∏ –∂–∏–∑–Ω—å, –∫–æ–≥–¥–∞ –≤–∞—Ä–∏–∞–Ω—Ç–∞ –¥–æ–∂–¥–∞—Ç—å—Å—è —Å–∫–æ—Ä–æ–π –ø—Ä–æ—Å—Ç–æ –Ω–µ—Ç. –ê–≤—Ç–æ–∏–Ω—ä–µ–∫—Ç–æ—Ä—ã —Å —ç–ø–∏–Ω–µ—Ñ—Ä–∏–Ω–æ–º –∏–ª–∏ –∞–¥—Ä–µ–Ω–∞–ª–∏–Ω–æ–º –Ω–µ –ø—Ä–æ–¥–∞—é—Ç—Å—è –≤ –∞–ø—Ç–µ–∫–∞—Ö, –∏ —ç—Ç–æ –º–æ—è –ª–∏—á–Ω–∞—è –±–æ–ª—å—à–∞—è –±–æ–ª—å. –ê–¥—Ä–µ–Ω–∞–ª–∏–Ω –≤ –∞–º–ø—É–ª–∞—Ö –ø—Ä–æ–¥–∞–µ—Ç—Å—è, –Ω–æ –ª—é–¥–∏ –Ω–µ –∑–Ω–∞—é—Ç, –∫–∞–∫—É—é –¥–æ–∑—É –Ω–∞–±–∏—Ä–∞—Ç—å, –∫—É–¥–∞ –¥–µ–ª–∞—Ç—å —É–∫–æ–ª, –Ω–∞ –∫–∞–∫—É—é –≥–ª—É–±–∏–Ω—É –≤–≤–æ–¥–∏—Ç—å —à–ø—Ä–∏—Ü. –ê–≤—Ç–æ–∏–Ω—ä–µ–∫—Ç–æ—Ä –æ—Ç–ª–∏—á–∞–µ—Ç—Å—è —Ç–µ–º, —á—Ç–æ –æ–Ω —É–¥–æ–±–µ–Ω –¥–ª—è –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª—è, ‚Äî —Å–µ—Ç—É–µ—Ç –Ω–µ–æ–Ω–∞—Ç–æ–ª–æ–≥ –∏ –ø–µ–¥–∏–∞—Ç—Ä –ê–Ω–Ω–∞ –õ–µ–≤–∞–¥–Ω–∞—è. –ü–æ –¥–∞–Ω–Ω—ã–º –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –ú–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –ø–æ—Ä—Ç–∞–ª–∞ –¥–ª—è –≤—Ä–∞—á–µ–π, –≤ 2023 –≥–æ–¥—É EpiPen –∏ –µ–≥–æ –¥–∂–µ–Ω–µ—Ä–∏–∫–∏ –±—ã–ª–∏ –ª–∏—à—å —É 27% —Å–µ–º–µ–π –∞–ª–ª–µ—Ä–≥–∏–∫–æ–≤. –ü–∞—Ü–∏–µ–Ω—Ç—ã –≤—ã–Ω—É–∂–¥–µ–Ω—ã –ø–æ–∫—É–ø–∞—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç –ø–æ –ø–æ–ª—É- –∏–ª–∏ –Ω–µ–æ—Ñ–∏—Ü–∏–∞–ª—å–Ω—ã–º –∫–∞–Ω–∞–ª–∞–º. –î–æ—Ä–æ–≥–æ –∏ –±–µ–∑ –≥–∞—Ä–∞–Ω—Ç–∏–π. –ü—Ä–∏ —ç—Ç–æ–º –≤—Ä–∞—á–∏ —É—Ç–≤–µ—Ä–∂–¥–∞—é—Ç, —á—Ç–æ —à–ø—Ä–∏—Ü-—Ä—É—á–∫–∏ –¥–æ–ª–∂–Ω—ã –±—ã—Ç—å –≤ –∞–ø—Ç–µ—á–∫–µ —É –∫–∞–∂–¥–æ–≥–æ, –∫—Ç–æ —Ö–æ—Ç—å —Ä–∞–∑ —Å—Ç–∞–ª–∫–∏–≤–∞–ª—Å—è —Å –∞–ª–ª–µ—Ä–≥–∏–µ–π, –∞ —Ç–∞–∫–∂–µ –≤ –¥–µ—Ç—Å–∫–∏—Ö –∏ –º–∞—Å—Å–æ–≤—ã—Ö —É—á—Ä–µ–∂–¥–µ–Ω–∏—è—Ö. –ü–æ —Å–ª–æ–≤–∞–º –Ω–∞—É—á–Ω–æ–≥–æ —Ä–µ–¥–∞–∫—Ç–æ—Ä–∞ –∂—É—Ä–Ω–∞–ª–∞ ¬´–†–æ—Å—Å–∏–π—Å–∫–∏–µ –∞–ø—Ç–µ–∫–∏¬ª –ê–ª–µ–∫—Å–µ—è –í–æ–¥–æ–≤–æ–∑–æ–≤–∞, —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ –∫–æ–º–ø–∞–Ω–∏–∏ –Ω–µ –¥–µ–ª–∞–ª–∏ –ø–æ–ø—ã—Ç–æ–∫ —Å–æ–∑–¥–∞—Ç—å —Å–≤–æ–π –¥–∂–µ–Ω–µ—Ä–∏–∫ EpiPen: –ú–∞–ª–µ–Ω—å–∫–∏–π –∏ –Ω–µ–ø–æ—Å—Ç–æ—è–Ω–Ω—ã–π —Å–ø—Ä–æ—Å, —Å–ª–æ–∂–Ω—ã–µ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ —É—Å—Ç—Ä–æ–π—Å—Ç–≤–∞–º –ø–æ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–æ–º—É —Å—Ç–∞–Ω–¥–∞—Ä—Ç—É ISO 11608, –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç—å –∑–∞ –æ—Ç–∫–∞–∑ –º–µ—Ö–∞–Ω–∏–∑–º–∞, –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç—å —Å—Ç–µ—Ä–∏–ª—å–Ω–æ–≥–æ –Ω–∞–ø–æ–ª–Ω–µ–Ω–∏—è –∏ —Å—Ç–∞–±–∏–ª—å–Ω–æ—Å—Ç–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞, –∏–º–ø–æ—Ä—Ç–æ–∑–∞–≤–∏—Å–∏–º–æ—Å—Ç—å –∫–æ–º–ø–æ–Ω–µ–Ω—Ç–æ–≤ ‚Äî —Å–ª–∏—à–∫–æ–º –º–Ω–æ–≥–æ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π –¥–ª—è –∑–∞–ø—É—Å–∫–∞ —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞. –ü—Ä–∏–º–µ—á–∞—Ç–µ–ª—å–Ω–æ, —á—Ç–æ –≤ —Å–ª—É—á–∞–µ —Å–æ —Å–≤–µ—Ä—Ö–ø—Ä–∏–±—ã–ª—å–Ω—ã–º–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º–∏ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –¥–∏–∞–±–µ—Ç–∞ –∏ –æ–∂–∏—Ä–µ–Ω–∏—è —ç—Ç–∏ –ø—Ä–æ–±–ª–µ–º—ã —Ä–µ—à–∏—Ç—å —É–¥–∞–ª–æ—Å—å. –û–¥–Ω–∞–∫–æ —ç–∫—Å–ø–µ—Ä—Ç –ø—Ä–∏–∑—ã–≤–∞–µ—Ç –Ω–µ –æ—Ç—á–∞–∏–≤–∞—Ç—å—Å—è: –ú–æ–∂–Ω–æ –ø—Ä–µ–¥–ø–æ–ª–æ–∂–∏—Ç—å, —á—Ç–æ —Å–∫–æ—Ä–µ–µ –≤ –†–æ—Å—Å–∏–∏ –±—É–¥–µ—Ç –∏–¥—Ç–∏ –∞–∫—Ç–∏–≤–Ω–æ–µ —Ä–∞–∑–≤–∏—Ç–∏–µ –≤ —Å—Ç–æ—Ä–æ–Ω—É –Ω–∞–∑–∞–ª—å–Ω–æ–≥–æ —Å–ø—Ä–µ—è –∫–∞–∫ –±–æ–ª–µ–µ —É–¥–æ–±–Ω–æ–≥–æ, –¥–µ—à–µ–≤–æ–≥–æ, –Ω–∞–¥–µ–∂–Ω–æ–≥–æ –∏ –Ω–µ –º–µ–Ω–µ–µ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ–≥–æ —Å–ø–æ—Å–æ–±–∞ –∫—É–ø–∏—Ä–æ–≤–∞–Ω–∏—è —Ç—è–∂–µ–ª–æ–π –∞–ª–ª–µ—Ä–≥–∏—á–µ—Å–∫–æ–π —Ä–µ–∞–∫—Ü–∏–∏. –í–æ—Ç –µ–≥–æ —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ –∞–Ω–∞–ª–æ–≥–∏ —è –±—ã –∏ –∂–¥–∞–ª –Ω–∞ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–º —Ä—ã–Ω–∫–µ –ø–µ—Ä–≤—ã–º–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""The patent for EpiPen, a popular auto-injector with epinephrine (adrenaline) for anaphylactic shock, expired on September 11th. This has opened up opportunities for generic manufacturers and the need to modernize existing tech solutions. The lack of direct alternatives to epinephrine in auto-injector form is a concern, especially for those who might need immediate assistance. The shortage of EpiPens and their generics is affecting patients, leading to unregulated channels for purchasing the drug. The expert suggests that more development in nasal sprays could be a solution to this issue.""
}"
2025-09-17T12:00:01+00:00,@bezrec,6556,https://t.me/bezrec/6556,"¬´–ù–µ–≤–æ–¥–∏—Ç–µ–ª—å—Å–∫–∏–º¬ª –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º –Ω–µ –¥–æ–±–∞–≤—è—Ç –Ω–∞–≥–ª—è–¥–Ω–æ—Å—Ç–∏. –ú–∏–Ω–∑–¥—Ä–∞–≤ –ø—Ä–æ—Ä–∞–±–∞—Ç—ã–≤–∞–µ—Ç —Å–ø–∏—Å–æ–∫ –∑–∞–ø—Ä–µ—â—ë–Ω–Ω—ã—Ö –¥–ª—è –≤–æ–¥–∏—Ç–µ–ª–µ–π –ª–µ–∫–∞—Ä—Å—Ç–≤. –≠—Ç–æ—Ç –≤–æ–ø—Ä–æ—Å –æ–±—Å—É–∂–¥–∞–ª—Å—è —Å–µ–≥–æ–¥–Ω—è –Ω–∞ –∑–∞—Å–µ–¥–∞–Ω–∏–∏ –ö–æ–º–∏—Ç–µ—Ç–∞ –ì–æ—Å–¥—É–º—ã –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è. –ó–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç, –ø—Ä–∏—Ä–∞–≤–Ω–∏–≤–∞—é—â–∏–π —É–ø—Ä–∞–≤–ª–µ–Ω–∏–µ –∞–≤—Ç–æ–º–æ–±–∏–ª–µ–º –ø–æ—Å–ª–µ –ø—Ä–∏–µ–º–∞ —Ä—è–¥–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∫ —Ç–∞–∫–æ–≤–æ–º—É –≤ —Å–æ—Å—Ç–æ—è–Ω–∏–∏ –∞–ª–∫–æ–≥–æ–ª—å–Ω–æ–≥–æ –æ–ø—å—è–Ω–µ–Ω–∏—è, –Ω–∞—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏–∏ –≤ –ì–æ—Å–¥—É–º–µ –∏ –±—ã–ª –ø—Ä–∏–Ω—è—Ç –≤ –ø–µ—Ä–≤–æ–º —á—Ç–µ–Ω–∏–∏ –≤ –º–∞–µ —ç—Ç–æ–≥–æ –≥–æ–¥–∞. –í–æ–∂–¥–µ–Ω–∏–µ –ø–æ–¥—à–æ—Ñ–µ –∫–∞—Ä–∞–µ—Ç—Å—è —à—Ç—Ä–∞—Ñ–æ–º –¥–æ 45 —Ç—ã—Å. —Ä—É–±–ª–µ–π –∏ –ª–∏—à–µ–Ω–∏–µ–º –ø—Ä–∞–≤ –Ω–∞ —Å—Ä–æ–∫ –¥–æ –¥–≤—É—Ö –ª–µ—Ç. –ö–∞–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –ø–æ–ø–∞–¥—É—Ç –≤ —Å–ø–∏—Å–æ–∫ ‚Äî –≤—Å—ë –µ—â—ë –∏–Ω—Ç—Ä–∏–≥–∞: –°–ø–∏—Å–æ–∫ –Ω–∞—Ö–æ–¥–∏—Ç—Å—è –≤ —Ä–∞–±–æ—Ç–µ, –æ–Ω –Ω–µ –¥–æ–ª–∂–µ–Ω –ø–æ–≤—Ç–æ—Ä—è—Ç—å —É–∂–µ –∏–º–µ—é—â–∏–π—Å—è, ‚Äî –ø—Ä–æ–∫–æ–º–º–µ–Ω—Ç–∏—Ä–æ–≤–∞–ª –∑–∞–º–≥–ª–∞–≤—ã –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –û–ª–µ–≥ –°–∞–ª–∞–≥–∞–π. –ê –≤–æ—Ç –∏–¥–µ—è –Ø—Ä–æ—Å–ª–∞–≤–∞ –ù–∏–ª–æ–≤–∞ –¥–ª—è –Ω–∞–≥–ª—è–¥–Ω–æ—Å—Ç–∏ –ø–æ–º–µ—á–∞—Ç—å ¬´–Ω–µ–≤–æ–¥–∏—Ç–µ–ª—å—Å–∫–∏–µ¬ª –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –∏–∑–æ–±—Ä–∞–∂–µ–Ω–∏–µ–º –¥–æ—Ä–æ–∂–Ω–æ–≥–æ –∑–Ω–∞–∫–∞ ¬´–í—ä–µ–∑–¥ –∑–∞–ø—Ä–µ—â–µ–Ω¬ª –æ—Ç–∫–ª–∏–∫–∞ —É —á–ª–µ–Ω–æ–≤ –∫–æ–º–∏—Ç–µ—Ç–∞ –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è –Ω–µ –Ω–∞—à–ª–∞. –≠—Ç–æ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–µ —Å–æ—á–ª–∏ –∏–∑–ª–∏—à–Ω–∏–º –∏ –æ—Ç–∫–ª–æ–Ω–∏–ª–∏, –ø–æ—Å–∫–æ–ª—å–∫—É —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–∏–µ –ø—Ä–æ—Ç–∏–≤–æ–ø–æ–∫–∞–∑–∞–Ω–∏—è –≤ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–º –ø–æ—Ä—è–¥–∫–µ —É–∫–∞–∑–∞–Ω—ã –≤ –∏–Ω—Å—Ç—Ä—É–∫—Ü–∏—è—Ö –∫ —Ç–∞–∫–∏–º –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, sanctions, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health is working on a list of medications that are prohibited for drivers. This issue was discussed today at the State Duma Committee on Health Protection. A draft law, which considers driving after taking certain medications as drunk driving, is under review in the State Duma and passed its first reading in May of this year. Driving while impaired is punishable by a fine up to 450,000 rubles and revocation of driving license for up to two years. What medications will be included on the list ‚Äî this is still a mystery: Oleg Salagay, Deputy Head of the Ministry of Health commented. Yaroslav Nilo's idea to mark 'impaired' medications with a road sign 'No entry' did not find support among committee members on health protection. This suggestion was rejected as it is already specified in the instructions for these medications.""
}"
2025-09-17T08:54:11+00:00,@bezrec,6555,https://t.me/bezrec/6555,"–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –ø–æ—Ä—É—á–∏–ª–æ —Ç–µ—Å—Ç–∏—Ä–æ–≤–∞—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –Ω–∞ ¬´—á–µ–ª–æ–≤–µ–∫–µ –Ω–∞ —á–∏–ø–µ¬ª. –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§ —Å–≤–æ–∏–º –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ–º —É—Ç–≤–µ—Ä–¥–∏–ª–æ –∑–∞–¥–∞—á—É –ø–æ —Å–æ–∑–¥–∞–Ω–∏—é –≤ —Å—Ç—Ä–∞–Ω–µ —Å–∏—Å—Ç–µ–º—ã —Å–∫—Ä–∏–Ω–∏–Ω–≥–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ —Å –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ–º –º–æ–¥–µ–ª–∏ ¬´—á–µ–ª–æ–≤–µ–∫ –Ω–∞ —á–∏–ø–µ¬ª. –¢–µ—Ö–Ω–æ–ª–æ–≥–∏—è –ø–æ–∑–≤–æ–ª—è–µ—Ç –±—ã—Å—Ç—Ä–æ –∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ —Ç–µ—Å—Ç–∏—Ä–æ–≤–∞—Ç—å –º–Ω–æ–∂–µ—Å—Ç–≤–æ –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –∏ —Ö–∏–º–∏—á–µ—Å–∫–∏—Ö –≤–µ—â–µ—Å—Ç–≤ –Ω–∞ –∫–ª–µ—Ç–∫–∞—Ö, –∏–º–∏—Ç–∏—Ä—É—é—â–∏—Ö —Ä–∞–±–æ—Ç—É —á–µ–ª–æ–≤–µ—á–µ—Å–∫–æ–≥–æ –æ—Ä–≥–∞–Ω–∏–∑–º–∞, —á—Ç–æ–±—ã –≤—ã—è–≤–∏—Ç—å –Ω–∞–∏–±–æ–ª–µ–µ –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–Ω—ã–µ —Å–æ–µ–¥–∏–Ω–µ–Ω–∏—è –¥–ª—è –¥–∞–ª—å–Ω–µ–π—à–µ–π —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –Ω–æ–≤—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –¢–∞–∫–æ–π –ø–æ–¥—Ö–æ–¥ –ø–æ–º–æ–∂–µ—Ç —Å–æ–∫—Ä–∞—Ç–∏—Ç—å –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –Ω–∞ –∂–∏–≤–æ—Ç–Ω—ã—Ö –∏ –æ—Ç–æ–π—Ç–∏ –æ—Ç –ø—Ä–æ–±–∏—Ä–æ—á–Ω—ã—Ö –∏—Å–ø—ã—Ç–∞–Ω–∏–π –∑–∞ —Å—á—ë—Ç —Å–æ–∑–¥–∞–Ω–∏—è –±–æ–ª–µ–µ –±–ª–∞–≥–æ–ø—Ä–∏—è—Ç–Ω–æ–π —Å—Ä–µ–¥—ã, —Ç.–∫. —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω—ã–µ —Ç–µ—Å—Ç—ã –Ω–∞ –æ—Ç–¥–µ–ª—å–Ω–æ –≤–∑—è—Ç—ã—Ö –∫—É–ª—å—Ç—É—Ä–∞—Ö –Ω–µ –ø–æ–∑–≤–æ–ª—è—é—Ç –æ—Ü–µ–Ω–∏—Ç—å –≤–ª–∏—è–Ω–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –Ω–∞ —Ü–µ–ª—ã–π –æ—Ä–≥–∞–Ω –∏–ª–∏ –¥–∞–∂–µ –≤–µ—Å—å –æ—Ä–≥–∞–Ω–∏–∑–º. –ú–æ–¥–µ–ª—å –≤–∫–ª—é—á–µ–Ω–∞ –≤ –ø—Ä–æ–≥—Ä–∞–º–º—É —Ä–∞–∑–≤–∏—Ç–∏—è –≥–µ–Ω–µ—Ç–∏—á–µ—Å–∫–∏—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –Ω–∞ –±–ª–∏–∂–∞–π—à–∏–µ –≥–æ–¥—ã. –ü–µ—Ä–≤—ã–µ –Ω–∞—Ä–∞–±–æ—Ç–∫–∏ –≤ —ç—Ç–æ–π –æ–±–ª–∞—Å—Ç–∏ —É–∂–µ –µ—Å—Ç—å ‚Äî –ª–µ—Ç–æ–º –≤ –ù–ò–ò –ø—É–ª—å–º–æ–Ω–æ–ª–æ–≥–∏–∏ –§–ú–ë–ê –†–æ—Å—Å–∏–∏ —Å–¥–µ–ª–∞–ª–∏ ¬´–ª–µ–≥–∫–æ–µ –Ω–∞ —á–∏–ø–µ¬ª. –¢–∞–∫–∂–µ —Å–æ–∑–¥–∞–Ω—ã –ø–æ–¥–æ–±–Ω—ã–µ —Å–∏—Å—Ç–µ–º—ã –ø–µ—á–µ–Ω–∏, –ø–æ—á–µ–∫ –∏ –∫–∏—à–µ—á–Ω–∏–∫–∞. –í –°–∏–±–∏—Ä—Å–∫–æ–º –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–º –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–º —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–µ (–°–∏–±–ì–ú–£) –≤ —Ä–∞–º–∫–∞—Ö –ø—Ä–æ–≥—Ä–∞–º–º—ã ¬´–ü—Ä–∏–æ—Ä–∏—Ç–µ—Ç-2030¬ª —Ä–∞–±–æ—Ç–∞—é—Ç –Ω–∞–¥ –æ—Ä–≥–∞–Ω–æ–∏–¥–æ–º –ø–µ—á–µ–Ω–∏ —Å –≤–Ω–µ–¥—Ä–µ–Ω–Ω—ã–º–∏ –º–∏–∫—Ä–æ–º–µ—Ç–∞—Å—Ç–∞–∑–∞–º–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""clinical_trial, pharmacovigilance"",
  ""impact"": ""high"",
  ""english"": ""The government has assigned the testing of drugs on a 'chip person'. The Russian government, by decree, approved a task to create a system for screening drugs using the 'chip person' model. The technology allows for quickly and effectively testing a multitude of biological and chemical substances on cell cultures that mimic human organ function to identify the most promising compounds for further development of new drugs. This approach will help reduce animal testing and move away from traditional test tubes by creating a more favorable environment, as conventional tests on individual cultures cannot assess the impact of a drug on an entire organ or even the whole body. The model is included in the program for developing genetic technologies over the next few years. Initial work in this area has already been done ‚Äî in summer, at the Pulmonary Institute of the Far Eastern Federal University (FEFU), a 'light chip' was created. Additionally, systems for liver and kidney have been developed at the Siberian State Medical University (SibG–úU) as part of the 'Priority-2030' program. ""
}"
2025-09-17T05:50:32+00:00,@bezrec,6554,https://t.me/bezrec/6554,"–ù–∞—á–∏–Ω–∞–µ–º –¥–µ–Ω—å —Å –Ω–∞–¥–µ–∂–¥—ã, –∫–æ—Ç–æ—Ä—É—é –º–æ–∂–µ—Ç –ø–æ–¥–∞—Ä–∏—Ç—å –ø–∞—Ü–∏–µ–Ω—Ç–∞–º —Å –æ–Ω–∫–æ–ª–æ–≥–∏–µ–π —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∞ –ò–Ω—Å—Ç–∏—Ç—É—Ç–∞ —Ö–∏–º–∏—á–µ—Å–∫–æ–π –±–∏–æ–ª–æ–≥–∏–∏ –∏ —Ñ—É–Ω–¥–∞–º–µ–Ω—Ç–∞–ª—å–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω—ã (–ò–•–ë–§–ú) –°–û –†–ê–ù, —Ü–µ–Ω—Ç—Ä–∞ ¬´–í–µ–∫—Ç–æ—Ä¬ª –∏ —Ä–µ–∑–∏–¥–µ–Ω—Ç–∞ ¬´–°–∫–æ–ª–∫–æ–≤–æ¬ª –û–û–û ¬´–û–Ω–∫–æ—Å—Ç–∞—Ä¬ª. –£—á—ë–Ω—ã–µ –ø–æ–¥–≥–æ—Ç–æ–≤–∏–ª–∏ –ø—Ä–æ–µ–∫—Ç—ã –ø—Ä–æ—Ç–æ–∫–æ–ª–æ–≤ –¥–ª—è –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –Ω–∞ –æ—Å–Ω–æ–≤–µ –≥–µ–Ω–Ω–æ-–º–æ–¥–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω–æ–≥–æ –æ–Ω–∫–æ–ª–∏—Ç–∏—á–µ—Å–∫–æ–≥–æ –≤–∏—Ä—É—Å–∞ –æ—Å–ø–æ–≤–∞–∫—Ü–∏–Ω—ã –ø—Ä–æ—Ç–∏–≤ —Ä–∞–∫–∞ –≥–æ–ª–æ–≤–Ω–æ–≥–æ –º–æ–∑–≥–∞. –ü–æ —Å–ª–æ–≤–∞–º –∑–∞–≤–µ–¥—É—é—â–µ–≥–æ –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–∏–µ–π –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ –ò–•–ë–§–ú –í–ª–∞–¥–∏–º–∏—Ä–∞ –†–∏—Ö—Ç–µ—Ä–∞, –∏—Å–ø—ã—Ç–∞–Ω–∏—è –∑–∞–π–º—É—Ç –Ω–µ –º–µ–Ω–µ–µ —á–µ–º –¥–≤–∞ –≥–æ–¥–∞. –ù–æ–≤–æ–µ —Å—Ä–µ–¥—Å—Ç–≤–æ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–æ –Ω–∞ –±–∞–∑–µ —à—Ç–∞–º–º–∞ –≤–∏—Ä—É—Å–∞, –∫–æ—Ç–æ—Ä—ã–π –ø—Ä–∏–º–µ–Ω—è–µ—Ç—Å—è –¥–ª—è —Å–æ–∑–¥–∞–Ω–∏—è –≤–∞–∫—Ü–∏–Ω—ã –æ—Ç –æ—Å–ø—ã. –ß—Ç–æ–±—ã –¥–æ–±–∏—Ç—å—Å—è –±–æ–ª—å—à–µ–π –ø—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤–æ–π –∞–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –∏ —É—Å–∏–ª–∏—Ç—å –∏–º–º—É–Ω–Ω—ã–π –æ—Ç–≤–µ—Ç, —É—á—ë–Ω—ã–µ –∑–∞–º–µ–Ω–∏–ª–∏ –¥–≤–∞ –≥–µ–Ω–∞ –≤–∏—Ä—É—Å–∞, –æ—Ç–≤–µ—á–∞—é—â–∏–µ –∑–∞ –µ–≥–æ –≤–∏—Ä—É–ª–µ–Ω—Ç–Ω–æ—Å—Ç—å, –Ω–∞ –≥–µ–Ω—ã, —Å—Ç–∏–º—É–ª–∏—Ä—É—é—â–∏–µ –ø—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤—ã–π –∏–º–º—É–Ω–∏—Ç–µ—Ç. –ó–∞–¥–∞—á–∞ –∏–∑–º–µ–Ω—ë–Ω–Ω–æ–≥–æ –≤–∏—Ä—É—Å–∞ —Å–æ—Å—Ç–æ–∏—Ç –≤ —Ç–æ–º, —á—Ç–æ–±—ã –∑–∞—Å—Ç–∞–≤–∏—Ç—å –∏–º–º—É–Ω–∏—Ç–µ—Ç —á–µ–ª–æ–≤–µ–∫–∞ –±–æ—Ä–æ—Ç—å—Å—è —Å —Ä–∞–∫–æ–º —Å–æ–±—Å—Ç–≤–µ–Ω–Ω—ã–º–∏ —Å–∏–ª–∞–º–∏. –ü—Ä–µ–ø–∞—Ä–∞—Ç —Ö–æ—Ä–æ—à–æ –ø—Ä–æ—è–≤–∏–ª —Å–µ–±—è –≤ –¥–æ–∫–ª–∏–Ω–∏–∫–µ, –ø–æ–∫–∞–∑–∞–≤ —Å–ø–æ—Å–æ–±–Ω–æ—Å—Ç—å —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ –ø–æ–¥–∞–≤–ª—è—Ç—å —Ä–∞–∑–≤–∏—Ç–∏–µ –æ—Å–Ω–æ–≤–Ω–æ–π –æ–ø—É—Ö–æ–ª–∏, –Ω–µ –∑–∞—Ç—Ä–∞–≥–∏–≤–∞—è –∑–¥–æ—Ä–æ–≤—ã–µ –∫–ª–µ—Ç–∫–∏. –†–∞–Ω–µ–µ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∞ –ø—Ä–æ—à–ª–∞ –ø–µ—Ä–≤—É—é —Ñ–∞–∑—É –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å–ø—ã—Ç–∞–Ω–∏–π –ø—Ä–∏ —Ä–∞–∫–µ –º–æ–ª–æ—á–Ω–æ–π –∂–µ–ª–µ–∑—ã. –í—á–µ—Ä–∞ –º—ã –ø–æ–ª—É—á–∏–ª–∏ –æ–∫–æ–Ω—á–∞—Ç–µ–ª—å–Ω—ã–π –æ—Ç—á—ë—Ç –æ —Ç–æ–º, —á—Ç–æ –ø–µ—Ä–≤–∞—è —Ñ–∞–∑–∞ –∑–∞–∫–æ–Ω—á–µ–Ω–∞. –î–æ –∫–æ–Ω—Ü–∞ —ç—Ç–æ–π –Ω–µ–¥–µ–ª–∏ –æ–Ω –±—É–¥–µ—Ç –ø–µ—Ä–µ–¥–∞–Ω –≤ –ú–∏–Ω–∑–¥—Ä–∞–≤ –Ω–∞ —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏–µ. –°–µ–π—á–∞—Å –≥–æ—Ç–æ–≤—è—Ç—Å—è –ø—Ä–æ–µ–∫—Ç—ã –ø—Ä–æ—Ç–æ–∫–æ–ª–æ–≤ –¥–ª—è –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è –¥–≤—É—Ö –ø–æ—Å–ª–µ–¥—É—é—â–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π: –ø—Ä–æ—Ç–æ–∫–æ–ª –≤—Ç–æ—Ä–æ–π —Ñ–∞–∑—ã –¥–ª—è –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è, –∫–æ—Ç–æ—Ä–æ–µ –º—ã –≤–µ–ª–∏ –Ω–∞ –ø–µ—Ä–≤–æ–π —Ñ–∞–∑–µ, –∞ —Ç–∞–∫–∂–µ I/II —Ñ–∞–∑–∞ –¥–ª—è –æ–ø—É—Ö–æ–ª–∏ –≥–æ–ª–æ–≤–Ω–æ–≥–æ –º–æ–∑–≥–∞, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª –†–∏—Ö—Ç–µ—Ä. #–Ω–∞–¥–µ–∂–¥–∞ ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety, guideline"",
  ""impact"": ""high"",
  ""english"": ""Scientists from the Institute of Chemical Biology and Fundamental Medicine (ICBFM) SO RAS, Vector Center, and Skolkovo Research Institute of Oncology (Oncostar) LLC have prepared protocols for clinical trials of a drug based on genetically modified oncolytic virus vaccine against brain cancer. The project is led by Vladimir Rikhert, head of the biotechnology laboratory at ICBFM. The clinical trials are expected to take two years. The modified virus is designed to stimulate the immune system of humans to fight cancer on its own. The vaccine has shown promising results in preclinical trials, demonstrating the ability to effectively suppress tumor development without affecting healthy cells. Previously, the vaccine underwent phase one clinical trials for breast cancer. Final results of these trials were submitted to the Ministry of Health for approval yesterday. Protocols for two subsequent studies are being prepared: one for phase two trials of the same study, and another for a phase I/II trial against brain cancer.""
}"
2025-09-16T16:34:48+00:00,@bezrec,6553,https://t.me/bezrec/6553,"¬´–ì–µ–Ω–µ—Ä–∏—É–º¬ª —Å–¥–µ—Ä–∂–∞–ª –æ–±–µ—â–∞–Ω–∏–µ —Å–Ω–∏–∑–∏—Ç—å —Å—Ç–æ–∏–º–æ—Å—Ç—å —Å–≤–æ–µ–≥–æ —ç–∫—É–ª–∏–∑—É–º–∞–±–∞ –Ω–∞ 55%. –í –Ω–∞—á–∞–ª–µ –∞–≤–≥—É—Å—Ç–∞ –Ω–∞ –∑–∞—Å–µ–¥–∞–Ω–∏–∏ –∫–æ–º–∏—Å—Å–∏–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ø–æ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—é –ø–µ—Ä–µ—á–Ω–µ–π –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ñ–ù–í–õ–ü –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å –ø–µ—Ä–≤–æ–≥–æ —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —ç–∫—É–ª–∏–∑—É–º–∞–±–∞ –∑–∞—è–≤–∏–ª, —á—Ç–æ –±–æ–ª–µ–µ —á–µ–º –≤–¥–≤–æ–µ —Å–Ω–∏–∑–∏—Ç —Å—Ç–æ–∏–º–æ—Å—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞. 12 —Å–µ–Ω—Ç—è–±—Ä—è –Ω–∞ –ì–†–õ–° –±—ã–ª–∞ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–∞ –Ω–æ–≤–∞—è –ø—Ä–µ–¥–µ–ª—å–Ω–∞—è –æ—Ç–ø—É—Å–∫–Ω–∞—è —Ü–µ–Ω–∞ -- 111 716,48 —Ä—É–±–ª–µ–π –∑–∞ —Ñ–ª–∞–∫–æ–Ω. –≠—Ç–æ —Ä–µ—à–µ–Ω–∏–µ –∫–∞—Ä–¥–∏–Ω–∞–ª—å–Ω–æ –º–µ–Ω—è–µ—Ç —ç–∫–æ–Ω–æ–º–∏–∫—É –ª–µ—á–µ–Ω–∏—è –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –ø–∞—Ä–æ–∫—Å–∏–∑–º–∞–ª—å–Ω–æ–π –Ω–æ—á–Ω–æ–π –≥–µ–º–æ–≥–ª–æ–±–∏–Ω—É—Ä–∏–µ–π, –∞—Ç–∏–ø–∏—á–Ω—ã–º –≥–µ–º–æ–ª–∏—Ç–∏–∫–æ-—É—Ä–µ–º–∏—á–µ—Å–∫–∏–º —Å–∏–Ω–¥—Ä–æ–º–æ–º, —Ç—è–∂–µ–ª–æ–π –º–∏–∞—Å—Ç–µ–Ω–∏–µ–π –∏ –æ–ø—Ç–∏–∫–æ–º–∏–µ–ª–∏—Ç–æ–º. –¢–µ–ø–µ—Ä—å –∫—É—Ä—Å —Ç–µ—Ä–∞–ø–∏–∏ —Å—Ç–∞–Ω–µ—Ç —Å—É—â–µ—Å—Ç–≤–µ–Ω–Ω–æ –¥–æ—Å—Ç—É–ø–Ω–µ–µ –¥–ª—è —Å–∏—Å—Ç–µ–º—ã –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –•–æ—Ç—è –≤ —ç–∫—Å–ø–µ—Ä—Ç–Ω–æ–º —Å–æ–æ–±—â–µ—Å—Ç–≤–µ –ø—Ä–æ–¥–æ–ª–∂–∞—é—Ç —Å–ø–æ—Ä–∏—Ç—å –æ —Ç–∞–∫–∏—Ö —Ä–µ–∑–∫–∏—Ö —Ü–µ–Ω–æ–≤—ã—Ö –∏–∑–º–µ–Ω–µ–Ω–∏—è—Ö, —ç—Ç–æ—Ç —à–∞–≥ –∏–º–µ–µ—Ç –æ—á–µ–≤–∏–¥–Ω—ã–π –ø–æ–∑–∏—Ç–∏–≤–Ω—ã–π —ç—Ñ—Ñ–µ–∫—Ç. –í—ã—Å–≤–æ–±–æ–∂–¥–∞–µ–º—ã–µ –±—é–¥–∂–µ—Ç–Ω—ã–µ —Å—Ä–µ–¥—Å—Ç–≤–∞ ‚Äì —ç—Ç–æ —Ä–µ–∞–ª—å–Ω—ã–π —à–∞–Ω—Å –¥–ª—è —É—Å–∏–ª–µ–Ω–∏—è —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è –¥—Ä—É–≥–∏—Ö –Ω–æ–∑–æ–ª–æ–≥–∏–π –∏ –ø–æ–≤—ã—à–µ–Ω–∏—è –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç–∏ –ø–æ–º–æ—â–∏ –¥–ª—è –±–æ–ª—å—à–µ–≥–æ —á–∏—Å–ª–∞ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""reimbursement, shortage"",
  ""impact"": ""high"",
  ""english"": ""The company 'Generium' has announced a 55% reduction in the price of its eculizumab, which was previously announced. On September 12th, the new maximum dispensing price of 111,716.48 rubles per vial was registered at the GRLS. This decision significantly improves the economic situation for patients with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, severe myasthenia gravis, and opticomyelitis. Budget funds released will provide a real opportunity to increase funding for other diseases and improve accessibility of care.""
}"
2025-09-16T15:04:55+00:00,@bezrec,6552,https://t.me/bezrec/6552,"–ü—Ä–∏—à–ª–æ –≤—Ä–µ–º—è –ø–æ–¥–≤–µ—Å—Ç–∏ –∏—Ç–æ–≥–∏ –æ—á–µ—Ä–µ–¥–Ω–æ–≥–æ –≤—ã–ø—É—Å–∫–∞ —Ä—É–±—Ä–∏–∫–∏ #–∑–∞–ø–∞–∫–æ–≤–∞–ª–∏. –í —á–µ—Å—Ç—å –Ω–∞—á–∞–ª–∞ —É—á–µ–±–Ω–æ–≥–æ –≥–æ–¥–∞ –∏ —Å—Ç–∞—Ä—Ç–∞ —Å–µ–∑–æ–Ω–∞ –ø—Ä–æ—Å—Ç—É–¥ –º—ã –≤—Å–µ –≤–º–µ—Å—Ç–µ –≤—ã–±—Ä–∞–ª–∏ –ª—É—á—à–∏–π –¥–∏–∑–∞–π–Ω —É–ø–∞–∫–æ–≤–∫–∏ –¥–µ—Ç—Å–∫–∏—Ö –ø—Ä–æ—Ç–∏–≤–æ–≤–∏—Ä—É—Å–Ω—ã—Ö. –°—É–¥—è –ø–æ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º –≥–æ–ª–æ—Å–æ–≤–∞–Ω–∏—è, —É–ø–∞–∫–æ–≤–∫–∏ —Å –∏–∑–æ–±—Ä–∞–∂–µ–Ω–∏–µ–º –ø—Ç–µ–Ω—Ü–æ–≤ ¬´–∑–∞—Ö–æ–¥—è—Ç¬ª –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª—è–º –ª—É—á—à–µ, —á–µ–º –∫–æ—Ä–æ–±–æ—á–∫–∏ —Å –Ω–∞—Ä–∏—Å–æ–≤–∞–Ω–Ω—ã–º–∏ –Ω–∞ –Ω–∏—Ö –¥–µ—Ç—å–º–∏. –ü–æ–±–µ–¥–∏—Ç–µ–ª–µ–º —Å –ø–µ—Ä–µ–≤–µ—Å–æ–º –≤—Å–µ–≥–æ –≤ 1% —Å—Ç–∞–ª –¶–∏—Ç–æ–≤–∏—Ä-3 (¬´–¶–∏—Ç–æ–º–µ–¥¬ª). –ù–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ ‚Äî –ê–Ω–∞—Ñ–µ—Ä–æ–Ω (¬´–ú–∞—Ç–µ—Ä–∏–∞ –ú–µ–¥–∏–∫–∞¬ª). –¢—Ä–µ—Ç—å–µ –º–µ—Å—Ç–æ –ø–æ–¥–µ–ª–∏–ª–∏ –º–µ–∂–¥—É —Å–æ–±–æ–π –ì—Ä–æ–ø—Ä–∏–Ω–æ—Å–∏–Ω (¬´–ì–µ–¥–µ–æ–Ω –†–∏—Ö—Ç–µ—Ä¬ª) –∏ –û—Ä–≤–∏—Ä–µ–º (¬´–ê–ª–≤–æ–≥–µ–Ω –§–∞—Ä–º–∞¬ª). –ê –≤–æ—Ç –ê—Ä–±–∏–¥–æ–ª (¬´–û—Ç–∏—Å–∏—Ñ–∞—Ä–º¬ª) —Å —Å–∞–º—ã–º –ª–∞–∫–æ–Ω–∏—á–Ω—ã–º –¥–∏–∑–∞–π–Ω–æ–º –ø—Ä–∏–≥–ª—è–Ω—É–ª—Å—è –≤–∞–º –º–µ–Ω—å—à–µ –≤—Å–µ–≥–æ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-09-16T12:20:29+00:00,@bezrec,6551,https://t.me/bezrec/6551,"–í–û–ó –≤–ø–µ—Ä–≤—ã–µ —Ä–µ–∫–æ–º–µ–Ω–¥–æ–≤–∞–ª–∞ –ª–µ—á–∏—Ç—å –æ–∂–∏—Ä–µ–Ω–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º–∏. –í –ø—Ä–æ–µ–∫—Ç–µ –Ω–æ–≤—ã—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è –≤–ø–µ—Ä–≤—ã–µ –ø–æ–¥–¥–µ—Ä–∂–∞–ª–∞ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∫–ª–∞—Å—Å–∞ GLP-1 –æ—Ç Novo Nordisk –∏ Eli Lilly –¥–ª—è —Å–Ω–∏–∂–µ–Ω–∏—è –≤–µ—Å–∞, –∞ –Ω–µ —Ç–æ–ª—å–∫–æ –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ –¥–∏–∞–±–µ—Ç–∞ 2 —Ç–∏–ø–∞. –í–û–ó –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∞ –æ—Ç–Ω–æ—Å–∏—Ç—å—Å—è –∫ –æ–∂–∏—Ä–µ–Ω–∏—é –Ω–µ –∫–∞–∫ –∫ –ø—Ä–æ–±–ª–µ–º–µ, –≤—ã–∑–≤–∞–Ω–Ω–æ–π –Ω–µ–ø—Ä–∞–≤–∏–ª—å–Ω—ã–º –æ–±—Ä–∞–∑–æ–º –∂–∏–∑–Ω–∏, –∞ –∫–∞–∫ –∫ —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–æ–º—É –ø—Ä–æ–≥—Ä–µ—Å—Å–∏—Ä—É—é—â–µ–º—É –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—é, –∫–æ—Ç–æ—Ä–æ–º—É –ø–æ–¥–≤–µ—Ä–∂–µ–Ω—ã –±–æ–ª–µ–µ 1 –º–ª—Ä–¥ —á–µ–ª–æ–≤–µ–∫ –≤ –º–∏—Ä–µ. –ö —Å–ª–æ–≤—É, –Ω–µ —Ç–∞–∫ –¥–∞–≤–Ω–æ –≤ –†–æ—Å—Å–∏–∏ –æ–∂–∏—Ä–µ–Ω–∏–µ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –≤–∫–ª—é—á–∏—Ç—å –≤ –ø–µ—Ä–µ—á–µ–Ω—å —Å–æ—Ü–∏–∞–ª—å–Ω–æ –∑–Ω–∞—á–∏–º—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –ü—Ä–µ–ø–∞—Ä–∞—Ç—ã –æ—Ç –æ–∂–∏—Ä–µ–Ω–∏—è –≤ –í–û–ó –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç –Ω–∞–∑–Ω–∞—á–∞—Ç—å –Ω–µ –≤—Å–µ–º –ø–æ–¥—Ä—è–¥, –∞ —Ç–æ–ª—å–∫–æ —Ç–µ–º –ø–∞—Ü–∏–µ–Ω—Ç–∞–º, —á–µ–π –∏–Ω–¥–µ–∫—Å –º–∞—Å—Å—ã —Ç–µ–ª–∞ –≤—ã—à–µ 30. –ü—Ä–∏—á–µ–º –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç–æ–∑–Ω–æ–µ –ª–µ—á–µ–Ω–∏–µ —Å–ª–µ–¥—É–µ—Ç —Å–æ—á–µ—Ç–∞—Ç—å —Å –¥–∏–µ—Ç–æ–π –ø–æ–¥ –ø—Ä–∏—Å–º–æ—Ç—Ä–æ–º –≤—Ä–∞—á–∞ –∏ –∞–¥–µ–∫–≤–∞—Ç–Ω–æ–π —Ñ–∏–∑–∏—á–µ—Å–∫–æ–π –Ω–∞–≥—Ä—É–∑–∫–æ–π. –†–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø–æ–∫–∞ –Ω–µ –ø—Ä–∏–Ω—è—Ç—ã –æ–∫–æ–Ω—á–∞—Ç–µ–ª—å–Ω–æ (–∏—Ö –±—É–¥—É—Ç –æ–±—Å—É–∂–¥–∞—Ç—å –¥–æ 27 —Å–µ–Ω—Ç—è–±—Ä—è) –∏ –∫–∞—Å–∞—é—Ç—Å—è —Ç–æ–ª—å–∫–æ –≤–∑—Ä–æ—Å–ª—ã—Ö. –ò–Ω—Å—Ç—Ä—É–∫—Ü–∏–∏ –¥–ª—è –¥–µ—Ç–µ–π –∏ –ø–æ–¥—Ä–æ—Å—Ç–∫–æ–≤ –ø–æ—è–≤—è—Ç—Å—è –ø–æ–∑–∂–µ. –í –Ω–∞—á–∞–ª–µ —Å–µ–Ω—Ç—è–±—Ä—è —Å–µ–º–∞–≥–ª—É—Ç–∏–¥ –∏ —Ç–∏—Ä–∑–µ–ø–∞—Ç–∏–¥ –ø–æ–ø–∞–ª–∏ –≤ –ø–µ—Ä–µ—á–µ–Ω—å –æ—Å–Ω–æ–≤–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –í–û–ó. –≠—Ç–æ –¥–æ–ª–∂–Ω–æ —Å–¥–µ–ª–∞—Ç—å –¥–æ—Ä–æ–≥–æ—Å—Ç–æ—è—â–∏–µ –∞–≥–æ–Ω–∏—Å—Ç—ã —Ä–µ—Ü–µ–ø—Ç–æ—Ä–æ–≤ –≥–ª—é–∫–∞–≥–æ–Ω–æ–ø–æ–¥–æ–±–Ω–æ–≥–æ –ø–µ–ø—Ç–∏–¥–∞-1 –±–æ–ª–µ–µ –¥–æ—Å—Ç—É–ø–Ω—ã–º–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, sanctions, shortage, demand, epidemic, vaccine"",
  ""impact"": ""high"",
  ""english"": ""The WHO recommended treating obesity with drugs for the first time. The organization endorsed GLP-1 class medications from Novo Nordisk and Eli Lilly for weight loss, not just diabetes treatment. The WHO views obesity as a chronic progressive disease affecting over 1 billion people worldwide, not just due to lifestyle. Obesity was recently included as a socially significant disease in Russia. The WHO recommends using medications only for patients with an BMI above 30, combining medication therapy and physical activity under medical supervision. The recommendations are not yet finalized (to be discussed until September 27) and will only apply to adults. Instructions for children and adolescents are pending. Semaglutide and tirzepatid were added to the WHO list of essential medicines in September, making expensive GLP-1 receptor agonists more accessible.""
}"
2025-09-16T09:00:01+00:00,@bezrec,6550,https://t.me/bezrec/6550,"¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º¬ª –≤–ª–æ–∂–∏—Ç—Å—è –≤ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –ø—Ä–æ—Ç–∏–≤ –Ω–µ–∞–ª–∫–æ–≥–æ–ª—å–Ω–æ–π –∂–∏—Ä–æ–≤–æ–π –±–æ–ª–µ–∑–Ω–∏ –ø–µ—á–µ–Ω–∏ (–ù–ê–ñ–ë–ü). –ì—Ä—É–ø–ø–∞ –∏–Ω–≤–µ—Å—Ç–∏—Ä—É–µ—Ç –≤ –ø—Ä–æ–µ–∫—Ç –æ–∫–æ–ª–æ 300 –º–ª–Ω —Ä—É–±–ª–µ–π. –°–µ–π—á–∞—Å –ø—Ä–µ–ø–∞—Ä–∞—Ç —Ä–∞–∑—Ä–∞–±–∞—Ç—ã–≤–∞–µ—Ç—Å—è —Å–∏–ª–∞–º–∏ –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥—Å–∫–æ–≥–æ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ —Ö–∏–º–∏–∫–æ-—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ (–°–ü–•–§–£) –∏ –ø—Ä–æ—Ö–æ–¥–∏—Ç –≤—Ç–æ—Ä—É—é —Å—Ç–∞–¥–∏—é –ö–ò, –∫–æ—Ç–æ—Ä—É—é –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –∑–∞–≤–µ—Ä—à–∏—Ç—å –≤ 2027 –≥–æ–¥—É. ¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º –≥—Ä—É–ø–ø¬ª –æ–ø–ª–∞—Ç–∏—Ç —Ç—Ä–µ—Ç—å—é —Å—Ç–∞–¥–∏—é –∏ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—é –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞. –í—ã–≤–µ—Å—Ç–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç –Ω–∞ —Ä—ã–Ω–æ–∫ –ø–ª–∞–Ω–∏—Ä—É—é—Ç –≤ 2031 –≥–æ–¥—É. –ò–Ω–≤–µ—Å—Ç–∏—Ü–∏–∏ –æ–±–µ—â–∞—é—Ç –±—ã—Ç—å –≤—ã–≥–æ–¥–Ω—ã–º–∏ ‚Äî –Ω–∞ —Å–µ–≥–æ–¥–Ω—è—à–Ω–∏–π –¥–µ–Ω—å –≤ –†–æ—Å—Å–∏–∏ –Ω–µ—Ç –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ –ù–ê–ñ–ë–ü, –ø—Ä–∏ —Ç–æ–º, —á—Ç–æ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–µ –≤—Å—Ç—Ä–µ—á–∞–µ—Ç—Å—è —É 28‚Äì42% —Ä–æ—Å—Å–∏—è–Ω, –∞ —É –ª—é–¥–µ–π —Å –æ–∂–∏—Ä–µ–Ω–∏–µ–º –∏ —Å–∞—Ö–∞—Ä–Ω—ã–º –¥–∏–∞–±–µ—Ç–æ–º —Ü–∏—Ñ—Ä–∞ –¥–æ—Ö–æ–¥–∏—Ç –¥–æ 90%. –°—Ç–æ—Ä–æ–Ω—ã —Ä–∞—Å—Å—á–∏—Ç—ã–≤–∞—é—Ç –Ω–∞ –±–æ–ª–µ–µ —á–µ–º 1 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –µ–∂–µ–≥–æ–¥–Ω–æ–≥–æ –æ–±—ä—ë–º–∞ –ø—Ä–æ–¥–∞–∂. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, ¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º¬ª –∑–∞–≥–ª—è–¥—ã–≤–∞–µ—Ç—Å—è –∏ –Ω–∞ –∑–∞—Ä—É–±–µ–∂–Ω—ã–µ —Ä—ã–Ω–∫–∏. –í –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏—è—Ö –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –≤ –∫–∞—á–µ—Å—Ç–≤–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –ù–ê–ñ–ë–ü —á–∏—Å–ª—è—Ç—Å—è –≥–µ–ø–∞—Ç–æ–ø—Ä–æ—Ç–µ–∫—Ç–æ—Ä—ã. –¢–∞–∫–∂–µ –Ω–∞ –ø–æ–º–æ—â—å –ø—Ä–∏—Ö–æ–¥–∏—Ç –¥–∏–µ—Ç–æ—Ç–µ—Ä–∞–ø–∏—è, –∏ –≤–æ—Ç —Ç—É—Ç –≤ –∏–≥—Ä—É –≤—Å—Ç—É–ø–∞—é—Ç —Ç–∏—Ä–∑–µ–ø–∞—Ç–∏–¥ –∏ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥. –ü–µ—Ä–≤—ã–π —É–∂–µ –∏—Å—Å–ª–µ–¥—É–µ—Ç—Å—è –Ω–∞ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –ø—Ä–æ—Ç–∏–≤ –ù–ê–ñ–ë–ü. –ö–∞–∫ –±—É–¥–µ—Ç –Ω–∞–∑—ã–≤–∞—Ç—å—Å—è –Ω–æ–≤—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –ø–æ–∫–∞ –Ω–µ–∏–∑–≤–µ—Å—Ç–Ω–æ, –Ω–æ –º–æ–∂–Ω–æ –ø—Ä–µ–¥–ø–æ–ª–æ–∂–∏—Ç—å, —á—Ç–æ —Ä–µ—á—å –∏–¥—ë—Ç –æ –º–∞–ª–æ–±–µ–Ω–µ –Ω–∞ –æ—Å–Ω–æ–≤–µ –º–∞–ª–æ–Ω–æ–≤–æ–π –∫–∏—Å–ª–æ—Ç—ã. –ü–æ –∫—Ä–∞–π–Ω–µ–π –º–µ—Ä–µ, –≤ –∞–≤–≥—É—Å—Ç–µ –∑–∞–Ω–∏–º–∞—é—â–∞—è—Å—è –ø—Ä–æ–≤–µ–¥–µ–Ω–∏–µ–º –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –∫–æ–º–ø–∞–Ω–∏—è ¬´–≠–∫—Å–µ–ª–ª–µ–Ω–∞¬ª —Å–æ–æ–±—â–∏–ª–∞ –æ –∑–∞–ø—É—Å–∫–µ –≤—Ç–æ—Ä–æ–π —Ñ–∞–∑—ã –ø–æ —ç—Ç–æ–º—É –ø—Ä–µ–ø–∞—Ä–∞—Ç—É –¥–ª—è –ª–µ—á–µ–Ω–∏—è –ù–ê–ñ–ë–ü. –°–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–æ –Ω–∞—É–∫–∏ –∏ –±–∏–∑–Ω–µ—Å–∞ ‚Äî —è–≤–ª–µ–Ω–∏–µ –≤ –Ω–∞—à–µ–π —Å—Ç—Ä–∞–Ω–µ –ø–æ–∫–∞ –Ω–µ —Å–ª–∏—à–∫–æ–º —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω—ë–Ω–Ω–æ–µ. –ü—Ä–∏ —ç—Ç–æ–º –Ω–∞—É—á–Ω—ã–µ —É—á—Ä–µ–∂–¥–µ–Ω–∏—è –∏ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –¥—Ä—É–≥ –¥—Ä—É–≥—É –Ω—É–∂–Ω—ã. –£ –ø–µ—Ä–≤—ã—Ö –Ω–µ—Ç –æ–ø—ã—Ç–∞ –∫–æ–º–º–µ—Ä—Ü–∏–∞–ª–∏–∑–∞—Ü–∏–∏ –∏ –¥–µ–Ω–µ–≥, –≤—Ç–æ—Ä—ã–µ —É–∂–µ –ø–µ—Ä–µ—à–∞–≥–Ω—É–ª–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤ –∏ –¥–æ—Ä–æ—Å–ª–∏ –¥–æ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –∏–Ω–Ω–æ–≤–∞—Ü–∏–π. –ü–æ—ç—Ç–æ–º—É –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –ø–æ–¥–æ–±–Ω—ã—Ö –∫–æ–æ–ø–µ—Ä–∞—Ü–∏–π, –≤–µ—Ä–æ—è—Ç–Ω–æ, –±—É–¥–µ—Ç —Ä–∞—Å—Ç–∏. –û—Å–æ–±–µ–Ω–Ω–æ, –µ—Å–ª–∏ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–æ, –∑–∞–∏–Ω—Ç–µ—Ä–µ—Å–æ–≤–∞–Ω–Ω–æ–µ –≤ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–º —Å—É–≤–µ—Ä–µ–Ω–∏—Ç–µ—Ç–µ, –ø–æ–¥—Å—Ç—Ä–∞—Ö—É–µ—Ç —Å–∞–º—ã—Ö —Å–º–µ–ª—ã—Ö –∏ —Å–æ–∑–¥–∞—Å—Ç —É—Å–ª–æ–≤–∏—è –¥–ª—è —Å–Ω–∏–∂–µ–Ω–∏—è —Ä–∏—Å–∫–æ–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": true,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,pharmacovigilance,hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""Biopharmaceuticals is investing in research on a drug for non-alcoholic fatty liver disease (NAFLD). The investment is around 300 million rubles. The drug, developed by Saint-Petersburg State Chemical and Pharmaceutical University (SPHFU), is undergoing the second stage of clinical trials, which are expected to be completed by 2027. Biopharmaceuticals will finance the third stage and industrial production. The company plans to bring the drug to market in 2031. There are no registered treatments for NAFLD in Russia, where the disease affects 28-42% of people. For those with obesity and diabetes, this percentage increases to 90%. The company expects annual sales of over one billion rubles. Clinically recommended treatments for NAFLD include hepatoprotectors and dietary therapy, with tirzepatid and semaglutide being studied. The company is also looking at international markets. Clinical guidelines recommend hepatoprotectors and dietary therapy for"
2025-09-16T05:44:21+00:00,@bezrec,6549,https://t.me/bezrec/6549,"–ü—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º —ç–Ω–µ—Ä–≥–µ—Ç–∏–∫–æ–≤ –∑–∞–ø—Ä–µ—Ç—è—Ç —Ö–≤–∞–ª–∏—Ç—å—Å—è –ë–ê–î–∞–º–∏ –≤ —Å–æ—Å—Ç–∞–≤–µ. –ò–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –æ –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏ –∞–∫—Ç–∏–≤–Ω—ã—Ö –¥–æ–±–∞–≤–∫–∞—Ö –∏ –≤–∏—Ç–∞–º–∏–Ω–∞—Ö, –≤—Ö–æ–¥—è—â–∏—Ö –≤ —Å–æ—Å—Ç–∞–≤ —Ç–∞–∫–∏—Ö –Ω–∞–ø–∏—Ç–∫–æ–≤, –≤ —Ä–µ–∫–ª–∞–º–µ –Ω–µ –º–µ—Å—Ç–æ, —Ä–µ—à–∏–ª –ú–∏–Ω–∑–¥—Ä–∞–≤ –∏ –ø–æ–¥–≥–æ—Ç–æ–≤–∏–ª –ø–æ–ø—Ä–∞–≤–∫–∏ –≤ –∑–∞–∫–æ–Ω ¬´–û —Ä–µ–∫–ª–∞–º–µ¬ª. –ò—Ö —É–∂–µ –æ–¥–æ–±—Ä–∏–ª–∞ –ø—Ä–∞–≤–∫–æ–º–∏—Å—Å–∏—è –ø–æ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç–Ω–æ–π –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏. –ü–æ —Å–ª–æ–≤–∞–º —ç–∫—Å–ø–µ—Ä—Ç–æ–≤, —É–ø–æ–º–∏–Ω–∞–Ω–∏—è –≤–∏—Ç–∞–º–∏–Ω–æ–≤ –∏ –ë–ê–î–æ–≤ —Ñ–æ—Ä–º–∏—Ä—É—é—Ç —Ç–∞–∫ –Ω–∞–∑—ã–≤–∞–µ–º—ã–π ¬´—ç—Ñ—Ñ–µ–∫—Ç –æ—Ä–µ–æ–ª–∞ –∑–¥–æ—Ä–æ–≤—å—è¬ª, –∫–æ–≥–¥–∞ –ø—Ä–æ–¥—É–∫—Ç –∫–∞–∂–µ—Ç—Å—è –±–æ–ª–µ–µ ¬´–ø—Ä–∞–≤–∏–ª—å–Ω—ã–º¬ª –∏ –±–µ–∑–æ–ø–∞—Å–Ω—ã–º, —Å–Ω–∏–∂–∞–µ—Ç—Å—è –Ω–∞—Å—Ç–æ—Ä–æ–∂–µ–Ω–Ω–æ—Å—Ç—å –∫ —Ä–∏—Å–∫–∞–º –∏ —Ä–∞—Å—Ç–µ—Ç –≥–æ—Ç–æ–≤–Ω–æ—Å—Ç—å –ø–∏—Ç—å –µ–≥–æ —á–∞—â–µ. –û—Å–æ–±–µ–Ω–Ω–æ —ç—Ç–æ –∞–∫—Ç—É–∞–ª—å–Ω–æ –≤ —Å–ª—É—á–∞–µ —Å –ø–æ–¥—Ä–æ—Å—Ç–∫–∞–º–∏. –ö—Å—Ç–∞—Ç–∏, –æ–±—Ä–∞—â–∞—Ç—å—Å—è –∫ –Ω–µ—Å–æ–≤–µ—Ä—à–µ–Ω–Ω–æ–ª–µ—Ç–Ω–∏–º –≤ —Ä–µ–∫–ª–∞–º–µ —Ç–æ–Ω–∏–∑–∏—Ä—É—é—â–∏—Ö –Ω–∞–ø–∏—Ç–∫–æ–≤ —Ç–∞–∫–∂–µ –∑–∞–ø—Ä–µ—Ç—è—Ç. –ë–ê–î—ã –∏ –≤–∏—Ç–∞–º–∏–Ω—ã –Ω–µ –¥–µ–ª–∞—é—Ç —ç–Ω–µ—Ä–≥–µ—Ç–∏–∫–∏ –ø–æ–ª–µ–∑–Ω—ã–º–∏. –≠—Ç–∏ –≤–µ—â–µ—Å—Ç–≤–∞ —Å–æ–¥–µ—Ä–∂–∞—Ç—Å—è –≤ –Ω–∞–ø–∏—Ç–∫–µ –Ω–µ –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–π —Ñ–æ—Ä–º–µ –∏ –≤ –æ—á–µ–Ω—å –±–æ–ª—å—à–∏—Ö –∫–æ–ª–∏—á–µ—Å—Ç–≤–∞—Ö. –í —Å–æ—á–µ—Ç–∞–Ω–∏–∏ –¥—Ä—É–≥ —Å –¥—Ä—É–≥–æ–º –æ–Ω–∏ —Ñ–æ—Ä—Å–∏—Ä–æ–≤–∞–Ω–Ω–æ –¥–µ–π—Å—Ç–≤—É—é—Ç –Ω–∞ —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—É—é —Å–∏—Å—Ç–µ–º—É, –∏–∑-–∑–∞ —á–µ–≥–æ —Å–µ—Ä–¥—Ü–µ —Ä–∞–±–æ—Ç–∞–µ—Ç –∏–Ω—Ç–µ–Ω—Å–∏–≤–Ω–µ–µ, ‚Äî –æ–±—ä—è—Å–Ω–∏–ª –∞—Å—Å–∏—Å—Ç–µ–Ω—Ç –∫–∞—Ñ–µ–¥—Ä—ã –∞–Ω–∞—Ç–æ–º–∏–∏ —á–µ–ª–æ–≤–µ–∫–∞ –ü–∏—Ä–æ–≥–æ–≤—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ –ê–ª–µ–∫—Å–µ–π –†–µ—à–µ—Ç—É–Ω. –ò–∑–Ω–∞—á–∞–ª—å–Ω–æ –ø–æ–ø—Ä–∞–≤–∫–∏ –∫ –∑–∞–∫–æ–Ω—É –æ —Ä–µ–∫–ª–∞–º–µ, –∫–∞—Å–∞—é—â–∏–µ—Å—è –ø—Ä–æ–¥–≤–∏–∂–µ–Ω–∏—è —ç–Ω–µ—Ä–≥–µ—Ç–∏–∫–æ–≤, –¥–æ–ª–∂–Ω—ã –±—ã–ª–∏ –≤—Å—Ç—É–ø–∏—Ç—å –≤ —Å–∏–ª—É —Å 1 —Å–µ–Ω—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞. –û–¥–Ω–∞–∫–æ –∞–≤—Ç–æ—Ä—ã –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç–∞ –Ω–µ —É—Å–ø–µ–ª–∏ –ø–æ–¥–≥–æ—Ç–æ–≤–∏—Ç—å –∏–∑–º–µ–Ω–µ–Ω–∏—è –∫–æ –≤—Ç–æ—Ä–æ–º—É —á—Ç–µ–Ω–∏—é, –∏ —Å—Ä–æ–∫–∏ —Å–¥–≤–∏–Ω—É–ª–∏ –Ω–∞ 1 –º–∞—Ä—Ç–∞ 2026 –≥–æ–¥–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-09-15T14:31:41+00:00,@bezrec,6548,https://t.me/bezrec/6548,"–ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥—É –Ω–µ —É–¥–∞–ª–æ—Å—å –≤–∑—ã—Å–∫–∞—Ç—å —Å ¬´–ë–∏–æ–∫–∞–¥–∞¬ª –Ω–µ—É—Å—Ç–æ–π–∫—É. –í–µ–¥–æ–º—Å—Ç–≤–æ –ø—ã—Ç–∞–ª–æ—Å—å –ø–æ–ª—É—á–∏—Ç—å —Å –∫–æ–º–ø–∞–Ω–∏–∏ –î–º–∏—Ç—Ä–∏—è –ú–æ—Ä–æ–∑–æ–≤–∞ –±–æ–ª–µ–µ 21 –º–ª–Ω —Ä—É–±–ª–µ–π –∑–∞ —Ç–æ, —á—Ç–æ —Ç–∞ –Ω–µ –¥–æ—Å—Ç–∏–≥–ª–∞ —Ä—è–¥–∞ –ø–æ–∫–∞–∑–∞—Ç–µ–ª–µ–π —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –ø—Ä–∏ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ –ø—Ä–æ–µ–∫—Ç–∞ –ø–æ –∫–ª–∏–Ω–∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è–º –î–∞—Ä–±—ç—Å—Ç–∏–º–∞ (–¥–∞—Ä–±—ç–ø–æ—ç—Ç–∏–Ω –∞–ª—å—Ñ–∞) –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ –ø–æ—Å–ª–µ–¥—Å—Ç–≤–∏–π —Ö–∏–º–∏–∏. –ß–µ–º –±—ã–ª –Ω–µ–¥–æ–≤–æ–ª–µ–Ω –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥? –í—Å—ë –Ω–∞—á–∞–ª–æ—Å—å –≤ 2015 –≥–æ–¥—É, –∫–æ–≥–¥–∞ —Ä–µ–≥—É–ª—è—Ç–æ—Ä –≤—ã–¥–∞–ª ¬´–ë–∏–æ–∫–∞–¥—É¬ª —Å—É–±—Å–∏–¥–∏—é –≤ 32 –º–ª–Ω —Ä—É–±–ª–µ–π –Ω–∞ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—é –∏ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏–µ III —Ñ–∞–∑—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π. –í 2018 –≥–æ–¥—É —Å—Ç–æ—Ä–æ–Ω—ã –¥–æ–≥–æ–≤–æ—Ä–∏–ª–∏—Å—å, —á—Ç–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç –±—É–¥–µ—Ç –≤–≤–µ–¥—ë–Ω –≤ –æ–±–æ—Ä–æ—Ç –≤ I –∫–≤–∞—Ä—Ç–∞–ª–µ 2019 –≥–æ–¥–∞, –æ–¥–Ω–∞–∫–æ —Ñ–∞–∫—Ç–∏—á–µ—Å–∫–∏–π –≤–≤–æ–¥ –≤ –≥—Ä–∞–∂–¥–∞–Ω—Å–∫–∏–π –æ–±–æ—Ä–æ—Ç —Å–æ—Å—Ç–æ—è–ª—Å—è —Ç–æ–ª—å–∫–æ –≤ IV –∫–≤–∞—Ä—Ç–∞–ª–µ 2020 –≥–æ–¥–∞. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –ø–æ –∏—Ç–æ–≥–∞–º —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ –ø—Ä–æ–µ–∫—Ç–∞ –Ω–µ –±—ã–ª–∏ –¥–æ—Å—Ç–∏–≥–Ω—É—Ç—ã —Å–ª–µ–¥—É—é—â–∏–µ —Ü–µ–ª–µ–≤—ã–µ –ø–æ–∫–∞–∑–∞—Ç–µ–ª–∏: üü© —É–≤–µ–ª–∏—á–µ–Ω–∏–µ –¥–æ–ª–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –≤ –æ–±—â–µ–º –æ–±—ä–µ–º–µ –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏—è; üü© –Ω–∞—á–∞–ª–æ –≤—ã–ø—É—Å–∫–∞ –≤ –≥—Ä–∞–∂–¥–∞–Ω—Å–∫–∏–π –æ–±–æ—Ä–æ—Ç –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞, —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–Ω–æ–≥–æ –≤ —Ä–∞–º–∫–∞—Ö –ø—Ä–æ–µ–∫—Ç–∞, –Ω–µ –ø–æ–∑–¥–Ω–µ–µ 3 –ª–µ—Ç —Å –¥–∞—Ç—ã –∑–∞–∫–ª—é—á–µ–Ω–∏—è –¥–æ–≥–æ–≤–æ—Ä–∞ –æ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª–µ–Ω–∏–∏ —Å—É–±—Å–∏–¥–∏–∏; üü© –ø–æ–ª—É—á–µ–Ω–∏–µ —Ä–æ—Å—Å–∏–π—Å–∫–æ–π –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–µ–π –≤—ã—Ä—É—á–∫–∏ –æ—Ç —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–Ω–æ–≥–æ –≤ —Ä–∞–º–∫–∞—Ö –ø—Ä–æ–µ–∫—Ç–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ —Å—É–º–º–∞—Ä–Ω–æ –∑–∞ 3 –≥–æ–¥–∞ —Å–æ –¥–Ω—è –Ω–∞—á–∞–ª–∞ –µ–≥–æ –≤—ã–ø—É—Å–∫–∞ –≤ —Ä–∞–∑–º–µ—Ä–µ, –Ω–µ –º–µ–Ω–µ–µ —á–µ–º –≤ 3 —Ä–∞–∑–∞ –ø—Ä–µ–≤—ã—à–∞—é—â–µ–º —Ä–∞–∑–º–µ—Ä –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª–µ–Ω–Ω–æ–π —Å—É–±—Å–∏–¥–∏–∏. –ü–æ–∑–∏—Ü–∏—è ¬´–ë–∏–æ–∫–∞–¥–∞¬ª –ù–∞ –ø—Ä–µ—Ç–µ–Ω–∑–∏–∏ –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–∞ –æ—Ç–≤–µ—Ç—á–∏–∫ –≤–æ–∑—Ä–∞–∑–∏–ª, —á—Ç–æ –ø–æ–ª—É—á–∏–ª –†–£ –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç –≤ –º–∞—Ä—Ç–µ 2019 –≥–æ–¥–∞, –∞ –∑–Ω–∞—á–∏—Ç, —Å—Ä–æ–∫–∏ –Ω–µ –Ω–∞—Ä—É—à–∞–ª. –í –æ—Ç–ª–∏—á–∏–µ –æ—Ç –∏—Å—Ç—Ü–∞, –∫–æ—Ç–æ—Ä—ã–π –ø—Ä–æ–ø—É—Å—Ç–∏–ª —Å—Ä–æ–∫–∏ –∏—Å–∫–æ–≤–æ–π –¥–∞–≤–Ω–æ—Å—Ç–∏. –≠—Ç–æ –Ω–µ –ø–µ—Ä–≤—ã–π –ø–æ–¥–æ–±–Ω—ã–π —Å–ø–æ—Ä –º–µ–∂–¥—É –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–æ–º –∏ ¬´–ë–∏–æ–∫–∞–¥–æ–º¬ª. –í –º–∞–µ 2025 –≥–æ–¥–∞ —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—é —É–¥–∞–ª–æ—Å—å –æ—Ç–±–∏—Ç—å —É –≤–µ–¥–æ–º—Å—Ç–≤–∞ 13,6 –º–ª–Ω —Ä—É–±–ª–µ–π. –¢–æ–≥–¥–∞ —Ä–µ–≥—É–ª—è—Ç–æ—Ä –ø—ã—Ç–∞–ª—Å—è –¥–æ–∫–∞–∑–∞—Ç—å —Ñ–∞–∫—Ç —Å—Ä—ã–≤–∞ —Å—Ä–æ–∫–æ–≤ –ø—Ä–∏ –≤–≤–µ–¥–µ–Ω–∏–∏ –≤ –æ–±–æ—Ä–æ—Ç –∞–¥–∞–ª–∏–º—É–º–∞–±–∞ ‚Äî –¥–∂–µ–Ω–µ—Ä–∏–∫–∞ –≤–æ—Å—Ç—Ä–µ–±–æ–≤–∞–Ω–Ω–æ–π –•—É–º–∏—Ä—ã –æ—Ç AbbVie. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Industry and Trade was unable to recover a penalty from Biokad due to their failure to meet certain project performance indicators. The dispute relates to the company's compliance with regulatory requirements and reimbursement policies, as well as clinical trial outcomes.""
}"
2025-09-15T11:32:05+00:00,@bezrec,6546,https://t.me/bezrec/6546,"–î–µ—Ç–∏ –≤–µ—Ä–Ω—É–ª–∏—Å—å –≤ —à–∫–æ–ª—ã –∏ –¥–µ—Ç—Å–∫–∏–µ —Å–∞–¥—ã, –∞ –∑–Ω–∞—á–∏—Ç, –ø—Ä–æ—Ç–∏–≤–æ–≤–∏—Ä—É—Å–Ω—ã–µ –Ω–∞–π–¥—É—Ç —Å–≤–æ–∏—Ö –ø–æ–∫—É–ø–∞—Ç–µ–ª–µ–π. –°–µ–≥–æ–¥–Ω—è —Ä–µ—à–∏–ª–∏ –ø–æ—Å–º–æ—Ç—Ä–µ—Ç—å, –∫–∞–∫ –∏—Ö #–∑–∞–ø–∞–∫–æ–≤–∞–ª–∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏. –ü—Ä–æ—Å–∏–º –≤ –æ–ø—Ä–æ—Å–µ –≤—ã–±—Ä–∞—Ç—å –æ–¥–∏–Ω –∏–∑ –ø—è—Ç–∏ –≤–∞—Ä–∏–∞–Ω—Ç–æ–≤, –∏—Å—Ö–æ–¥—è –∏—Å–∫–ª—é—á–∏—Ç–µ–ª—å–Ω–æ –∏–∑ –¥–∏–∑–∞–π–Ω–∞ —É–ø–∞–∫–æ–≤–∫–∏: 1. –ê–Ω–∞—Ñ–µ—Ä–æ–Ω (¬´–ú–∞—Ç–µ—Ä–∏–∞ –ú–µ–¥–∏–∫–∞¬ª); 2. –¶–∏—Ç–æ–≤–∏—Ä-3 (¬´–¶–∏—Ç–æ–º–µ–¥¬ª); 3. –ì—Ä–æ–ø—Ä–∏–Ω–æ—Å–∏–Ω (¬´–ì–µ–¥–µ–æ–Ω –†–∏—Ö—Ç–µ—Ä¬ª); 4. –û—Ä–≤–∏—Ä–µ–º (¬´–ê–ª–≤–æ–≥–µ–Ω –§–∞—Ä–º–∞¬ª); 5. –ê—Ä–±–∏–¥–æ–ª (¬´–û—Ç–∏—Å–∏—Ñ–∞—Ä–º¬ª). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-09-15T08:45:01+00:00,@bezrec,6544,https://t.me/bezrec/6544,"¬´–ü—Ä–∏–º–∞—Ñ–∞—Ä–º¬ª –∏ ¬´–ü—Ä–æ—Ñ–∞—Ä–º¬ª –ø–æ–ø–∞–ª–∏—Å—å –Ω–∞ –∫–∞—Ä—Ç–µ–ª—å–Ω–æ–º —Å–≥–æ–≤–æ—Ä–µ. –§–ê–° —Ä–∞—Å–∫—Ä—ã–ª–∞ –∫–∞—Ä—Ç–µ–ª—å –ø—Ä–∏ –ø–æ—Å—Ç–∞–≤–∫–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏–∑ –ø–µ—Ä–µ—á–Ω—è –ñ–ù–í–õ–ü –±–æ–ª–µ–µ —á–µ–º –Ω–∞ 1,1 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –†–µ–≥—É–ª—è—Ç–æ—Ä —É—Å—Ç–∞–Ω–æ–≤–∏–ª, —á—Ç–æ ¬´–ü—Ä–∏–º–∞—Ñ–∞—Ä–º¬ª –∏ ¬´–ü—Ä–æ—Ñ–∞—Ä–º¬ª –∑–∞–∫–ª—é—á–∏–ª–∏ –∞–Ω—Ç–∏–∫–æ–Ω–∫—É—Ä–µ–Ω—Ç–Ω–æ–µ —Å–æ–≥–ª–∞—à–µ–Ω–∏–µ —Å —Ü–µ–ª—å—é –ø–æ–¥–¥–µ—Ä–∂–∞–Ω–∏—è —Ü–µ–Ω –≤ 109 –∑–∞–∫—É–ø–æ—á–Ω—ã—Ö –ø—Ä–æ—Ü–µ–¥—É—Ä–∞—Ö —Å 2022 –ø–æ 2024 –≥–æ–¥. –ì–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ –∫–æ–Ω—Ç—Ä–∞–∫—Ç—ã –∑–∞–∫–ª—é—á–∞–ª–∏—Å—å –±–µ–∑ —Å–Ω–∏–∂–µ–Ω–∏—è –∏–ª–∏ —Å –º–∏–Ω–∏–º–∞–ª—å–Ω—ã–º —Å–Ω–∏–∂–µ–Ω–∏–µ–º –Ω–∞—á–∞–ª—å–Ω–æ–π –º–∞–∫—Å–∏–º–∞–ª—å–Ω–æ–π —Ü–µ–Ω—ã –∫–æ–Ω—Ç—Ä–∞–∫—Ç–∞. –ö–æ–º–ø–∞–Ω–∏–∏ –ø—Ä–∏–∑–Ω–∞–Ω—ã –Ω–∞—Ä—É—à–∏–≤—à–∏–º–∏ –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å–Ω–æ–µ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–æ. –ò–º –≥—Ä–æ–∑—è—Ç —à—Ç—Ä–∞—Ñ—ã –≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–∏ —Å –ö–æ–ê–ü –†–§. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, —Å—Ç–æ–∏—Ç –≤–æ–ø—Ä–æ—Å –æ –≤–æ–∑–±—É–∂–¥–µ–Ω–∏–∏ —É–≥–æ–ª–æ–≤–Ω–æ–≥–æ –¥–µ–ª–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing, sanctions"",
  ""impact"": ""high"",
  ""english"": ""The FAS (Federal Antimonopoly Service) has exposed a cartel in the supply of medicinal products listed in the GNPWP (Group of New and Less Expensive Drugs) for more than 1.1 billion rubles. 'Primafarm' and 'Profarm' were found to have concluded an anti-competitive agreement aimed at maintaining prices in 109 procurement procedures from 2022 to 2024. The companies are considered to have violated antimonopoly legislation and face fines under the Criminal Code of Russia. Additionally, there is a question about initiating an investigation into criminal matters.""
}"
2025-09-15T05:44:53+00:00,@bezrec,6543,https://t.me/bezrec/6543,"–ó–∞—Ä—É–±–µ–∂–Ω—ã–µ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –ø—Ä–æ—Å—è—Ç FDA –ø–æ–º–æ—á—å –≤–æ–∑–æ–±–Ω–æ–≤–∏—Ç—å –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –≤ –†–æ—Å—Å–∏–∏. –° —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–∏–º –ø–∏—Å—å–º–æ–º –∫ —Ä–µ–≥—É–ª—è—Ç–æ—Ä—É –æ–±—Ä–∞—Ç–∏–ª–∞—Å—å –∞—Å—Å–æ—Ü–∏–∞—Ü–∏—è ¬´–ò–Ω—Ñ–∞—Ä–º–∞¬ª, –æ–±—ä–µ–¥–∏–Ω—è—é—â–∞—è 19 —Ä–∞–±–æ—Ç–∞—é—â–∏—Ö –≤ –†–æ—Å—Å–∏–∏ –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ª–µ–∫–∞—Ä—Å—Ç–≤, –≤–∫–ª—é—á–∞—è AstraZeneca, Bayer, Johnson & Johnson, Pfizer, Roche. –ß—Ç–æ –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç ¬´–ò–Ω—Ñ–∞—Ä–º–∞¬ª: üíä —É—á–∏—Ç—ã–≤–∞—Ç—å —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –ø—Ä–æ–≤–æ–¥–∏–º—ã—Ö –≤ –†–§ –ö–ò –≤ –≥–ª–æ–±–∞–ª—å–Ω–æ–π —ç–∫—Å–ø–µ—Ä—Ç–∏–∑–µ; üíä ¬´–≤—Å—è—á–µ—Å–∫–∏ –ø–æ–æ—â—Ä—è—Ç—å —Å–ø–æ–Ω—Å–æ—Ä–æ–≤ –∫ —Ä–∞—Å—à–∏—Ä–µ–Ω–∏—é –≥–µ–æ–≥—Ä–∞—Ñ–∏–∏ –∏—Å–ø—ã—Ç–∞–Ω–∏–π¬ª; üíä —Ä–∞—Å—Å–º–æ—Ç—Ä–µ—Ç—å –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è –∏–Ω—Å–ø–µ–∫—Ü–∏–π FDA —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–∏—Ö —Ü–µ–Ω—Ç—Ä–æ–≤ –ø—Ä—è–º–æ –Ω–∞ –º–µ—Å—Ç–µ –∏–ª–∏ –≤ –æ–Ω–ª–∞–π–Ω-—Ñ–æ—Ä–º–∞—Ç–µ. –ù–µ—Å–º–æ—Ç—Ä—è –Ω–∞ —Ç–æ, —á—Ç–æ —Å–∞–Ω–∫—Ü–∏–∏ –ï–° –∏ –°–®–ê –Ω–µ –∫–æ—Å–Ω—É–ª–∏—Å—å –Ω–∞–ø—Ä—è–º—É—é —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏, –ø—Ä–æ–≤–æ–¥–∏—Ç—å –∏—Å–ø—ã—Ç–∞–Ω–∏—è –≤ –†–§ —Å—Ç–∞–ª–æ —Å–ª–æ–∂–Ω–æ –∏–∑-–∑–∞ –Ω–∞–ø—Ä—è–∂–µ–Ω–Ω–æ–π –≥–µ–æ–ø–æ–ª–∏—Ç–∏—á–µ—Å–∫–æ–π —Å–∏—Ç—É–∞—Ü–∏–∏. –í —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, —É –∫–æ–º–ø–∞–Ω–∏–π –≤–æ–∑–Ω–∏–∫–ª–∏ —Ç—Ä—É–¥–Ω–æ—Å—Ç–∏ —Å –±–µ—Å–ø–µ—Ä–µ–±–æ–π–Ω–æ–π –¥–æ—Å—Ç–∞–≤–∫–æ–π –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, —Å–≤–æ–µ–≤—Ä–µ–º–µ–Ω–Ω—ã–º –∑–∞–±–æ—Ä–æ–º –∏ –∞–Ω–∞–ª–∏–∑–æ–º –æ–±—Ä–∞–∑—Ü–æ–≤. –≠—Ç–æ –ø—Ä–∏–≤–µ–ª–æ –∫ —Ç–æ–º—É, —á—Ç–æ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –ø—Ä–æ–≤–æ–¥–∏–º—ã—Ö –≤ —Å—Ç—Ä–∞–Ω–µ –ö–ò —Å–æ–∫—Ä–∞—Ç–∏–ª–æ—Å—å —Å 300 –≤ 2021 –≥–æ–¥—É –¥–æ 24 –≤ 2024. –ü–æ —Å–ª–æ–≤–∞–º –∏—Å–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–≥–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ ¬´–ò–Ω—Ñ–∞—Ä–º—ã¬ª –í–∞–¥–∏–º–∞ –ö—É–∫–∞–≤—ã, —Å–µ–π—á–∞—Å –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ –ø—Ä–æ—Ü–µ—Å—Å–æ–≤ –æ—Ç–ª–∞–∂–µ–Ω—ã, –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä–∞ –∞–¥–∞–ø—Ç–∏—Ä–æ–≤–∞–Ω–∞, –∏ –º–Ω–æ–≥–∏–µ —á–ª–µ–Ω—ã –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ –ø–æ–¥—É–º—ã–≤–∞—é—Ç –≤–æ–∑–æ–±–Ω–æ–≤–∏—Ç—å –∏—Å–ø—ã—Ç–∞–Ω–∏—è –≤ –†–æ—Å—Å–∏–∏. –û–Ω–æ –∏ –ø–æ–Ω—è—Ç–Ω–æ ‚Äî —Å—Ç—Ä–∞–Ω–∞ –≤–∞–∂–Ω–∞ –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã–º —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—è–º, —Ç.–∫. –∑–¥–µ—Å—å –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω—ã —Ä–∞–∑–Ω—ã–µ –≥—Ä—É–ø–ø—ã –Ω–∞—Å–µ–ª–µ–Ω–∏—è, —ç—Ç–Ω–æ—Å—ã –∏ –≤–æ–∑—Ä–∞—Å—Ç–Ω—ã–µ –∫–∞—Ç–µ–≥–æ—Ä–∏–∏. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –±–µ–∑ –ª–æ–∫–∞–ª—å–Ω—ã—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –Ω–µ –º–æ–∂–µ—Ç –±—ã—Ç—å –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω –∏ –≤–≤–µ–¥—ë–Ω –≤ –æ–±–æ—Ä–æ—Ç. –î–µ–ø—É—Ç–∞—Ç –ì–æ—Å–¥—É–º—ã –∏ –≥–ª–∞–≤–∞ —ç–∫—Å–ø–µ—Ä—Ç–Ω–æ–≥–æ —Å–æ–≤–µ—Ç–∞ –ø–æ —Ä–∞–∑–≤–∏—Ç–∏—é –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏–∏ –≤ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ –ò—Ä–∏–Ω–∞ –§–∏–ª–∞—Ç–æ–≤–∞ –≤–∏–¥–∏—Ç –∏—Å—Ç–∏–Ω–Ω—É—é –ø—Ä–∏—á–∏–Ω—É –æ–±—Ä–∞—â–µ–Ω–∏—è ¬´–ò–Ω—Ñ–∞—Ä–º—ã¬ª –≤ –¥—Ä—É–≥–æ–º. –ü–æ –º–Ω–µ–Ω–∏—é —á–∏–Ω–æ–≤–Ω–∏—Ü—ã, –æ—Ä–∏–≥–∏–Ω–∞—Ç–æ—Ä—ã –∏—Å–ø—É–≥–∞–ª–∏—Å—å –∞–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π, –∫–æ—Ç–æ—Ä—ã–µ –≤ –æ—Ç–≤–µ—Ç –Ω–∞ –ø—Ä–µ–∫—Ä–∞—â–µ–Ω–∏–µ –ö–ò ¬´—Å—Ç–∞–ª–∏ –∑–∞—â–∏—â–∞—Ç—å—Å—è, –≤ —Ç–æ–º —á–∏—Å–ª–µ —Å –ø–æ–º–æ—â—å—é –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω–æ–≥–æ –ª–∏—Ü–µ–Ω–∑–∏—Ä–æ–≤–∞–Ω–∏—è¬ª. FDA –Ω–∞ –æ–±—Ä–∞—â–µ–Ω–∏–µ –ø–æ–∫–∞ –Ω–µ –æ—Ç—Ä–µ–∞–≥–∏—Ä–æ–≤–∞–ª–æ. –í–ø—Ä–æ—á–µ–º, —Å–æ–≥–ª–∞—Å–∏—è –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–≥–æ —Ä–µ–≥—É–ª—è—Ç–æ—Ä–∞ –¥–ª—è –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è –ö–ò –≤ –†–æ—Å—Å–∏–∏ –∏–ª–∏ –¥—Ä—É–≥–∏—Ö —Å—Ç—Ä–∞–Ω–∞—Ö –∏ –Ω–µ —Ç—Ä–µ–±—É–µ—Ç—Å—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, import_export, sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""Foreign pharmaceutical companies are asking the FDA to help resume clinical trials in Russia. The 'Infarma' association, which represents 19 foreign drug manufacturers operating in Russia and including AstraZeneca, Bayer, Johnson & Johnson, Pfizer, Roche, among others, has sent a letter to the regulator. 'Infarma' proposes considering results of Russian clinical trials in global assessments, encouraging sponsors to expand the geographical scope of their studies, and considering on-site or online inspections by FDA at Russian research centers. Despite sanctions from the EU and US not directly affecting foreign pharmaceutical companies, conducting trials in Russia has become difficult due to tense geopolitical situations. Companies have faced difficulties with uninterrupted drug supply, timely sample collection and analysis. This has led to a reduction in the number of conducted Russian clinical trials from 300 in 2021 to 24 in 2024. Executive Director of 'Infarma' Vadim Kukavy believes that processes are now set up, infrastructure is adapted, and many association members consider resuming trials in Russia"
2025-09-14T11:04:36+00:00,@bezrec,6539,https://t.me/bezrec/6539,"–ù–∞–∫—Ä–∏—á–∞–ª –Ω–∞—á–∞–ª—å–Ω–∏–∫ ‚Äî –ø–æ—Å–æ—Å–∏ –ø—É—Å—Ç—ã—à–∫—É. –ü–æ–∫–∞ —Ä–æ—Å—Å–∏—è–Ω–µ —Å–∫—É–ø–∞—é—Ç –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç—ã, –∫–∏—Ç–∞–π—Ü—ã –ø–æ–¥—Å–µ–ª–∏ –Ω–∞ –ø—É—Å—Ç—ã—à–∫–∏ ¬´–¥–ª—è –≤–∑—Ä–æ—Å–ª—ã—Ö¬ª. –û—Ç –¥–µ—Ç—Å–∫–∏—Ö —Ç–∞–∫–∏–µ —Å–æ—Å–∫–∏ –æ—Ç–ª–∏—á–∞—é—Ç—Å—è –±–æ–ª—å—à–∏–º —Ä–∞–∑–º–µ—Ä–æ–º, –∏ –ø—Ä–æ–¥–∞–≤—Ü—ã –ø–æ–∑–∏—Ü–∏–æ–Ω–∏—Ä—É—é—Ç –∏—Ö –∫–∞–∫ —Å—Ä–µ–¥—Å—Ç–≤–æ –æ—Ç —Ç—Ä–µ–≤–æ–≥–∏ –∏ –±–µ—Å—Å–æ–Ω–Ω–∏—Ü—ã. –ö—Ä—É–ø–Ω—ã–µ –ø–ª–æ—â–∞–¥–∫–∏ –ø—Ä–æ–¥–∞—é—Ç –±–æ–ª–µ–µ 2 —Ç—ã—Å. —Ç–∞–∫–∏—Ö ¬´—É—Å–ø–æ–∫–æ–∏—Ç–µ–ª–µ–π¬ª –≤ –º–µ—Å—è—Ü. –°—Ç–æ–∏–º–æ—Å—Ç—å ¬´–≤–∑—Ä–æ—Å–ª–æ–π¬ª –ø—É—Å—Ç—ã—à–∫–∏ ‚Äî –æ—Ç $1,4 –¥–æ $70. –í—ã–≥–ª—è–¥–∏—Ç, –∫–æ–Ω–µ—á–Ω–æ, —Å—Ç—Ä–∞–Ω–Ω–æ (—Ö–æ—Ç—è –Ω–µ –±–æ–ª–µ–µ —Å—Ç—Ä–∞–Ω–Ω–æ, —á–µ–º —Ä–∞—Å–∫–∞—á–∏–≤–∞–Ω–∏–µ –ø–æ–¥–≤–µ—à–µ–Ω–Ω—ã—Ö –∑–∞ –ø–æ–¥–±–æ—Ä–æ–¥–æ–∫ –ª—é–¥–µ–π), –Ω–æ –ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω—ã—Ö –æ—Ç–∑—ã–≤–æ–≤ –ø—Ä—É–¥ –ø—Ä—É–¥–∏. –û–¥–Ω–∏ —É—Ç–≤–µ—Ä–∂–¥–∞—é—Ç, —á—Ç–æ –ø—É—Å—Ç—ã—à–∫–∏ –ø–æ–º–æ–≥–∞—é—Ç —É—Å–ø–æ–∫–æ–∏—Ç—å—Å—è –ø–æ—Å–ª–µ –∫–æ–Ω—Ñ–ª–∏–∫—Ç–Ω—ã—Ö —Å–∏—Ç—É–∞—Ü–∏–π –Ω–∞ —Ä–∞–±–æ—Ç–µ, –¥—Ä—É–≥–∏–º –æ–Ω–∏ –∏ –≤–æ–≤—Å–µ –ø–æ–º–æ–≥–∞—é—Ç –±—Ä–æ—Å–∏—Ç—å –∫—É—Ä–∏—Ç—å. –í—Ä–∞—á–∏ —Ç—Ä–µ–Ω–¥ –Ω–µ –æ—Ü–µ–Ω–∏–ª–∏. –°—Ç–æ–º–∞—Ç–æ–ª–æ–≥–∏ –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–∞—é—Ç –æ –≤–æ–∑–º–æ–∂–Ω–æ–π –¥–∏—Å—Ñ—É–Ω–∫—Ü–∏–∏ –≤–∏—Å–æ—á–Ω–æ-–Ω–∏–∂–Ω–µ—á–µ–ª—é—Å—Ç–Ω–æ–≥–æ —Å—É—Å—Ç–∞–≤–∞ –∏ –ø—Ä–æ–±–ª–µ–º–∞—Ö —Å–æ —Å–ª–∏–∑–∏—Å—Ç–æ–π. –ü—Å–∏—Ö–æ–ª–æ–≥–∏ —Ç–æ–∂–µ –Ω–µ –≤ –≤–æ—Å—Ç–æ—Ä–≥–µ –∏ –ø—Ä–∏–∑—ã–≤–∞—é—Ç ¬´–Ω–µ –æ—Ç–Ω–æ—Å–∏—Ç—å—Å—è –∫ —Å–µ–±–µ –∫–∞–∫ –∫ —Ä–µ–±–µ–Ω–∫—É, –∞ –ø—Ä—è–º–æ –≤–∑–≥–ª—è–Ω—É—Ç—å –ø—Ä–æ–±–ª–µ–º–µ –≤ –ª–∏—Ü–æ –∏ —Ä–µ—à–∏—Ç—å –µ—ë¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""A trend of 'adult pacifiers' is emerging, described as a solution for anxiety and insomnia. Large retailers sell over 2000 of these 'calming devices' per month at prices ranging from $1.4 to $70. While some users report positive effects, dentists warn of potential issues with the temporomandibular joint and oral mucosa. Psychologists also advise against treating oneself like a child and instead confront the issue directly.""
}"
2025-09-13T11:01:01+00:00,@bezrec,6538,https://t.me/bezrec/6538,"–ü—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω—ã–π —Å—É–±–±–æ—Ç–Ω–∏–π –≤—ã–ø—É—Å–∫ –Ω–∞—à–µ–π —Ä—É–±—Ä–∏–∫–∏ #–≤–¥–æ–≥–æ–Ω–∫—É. üíä –í —Ä–∞–π–æ–Ω–µ –°–µ–≤–µ—Ä–Ω—ã–π –≤ –ú–æ—Å–∫–≤–µ –ø–æ—è–≤–∏—Ç—Å—è –Ω–æ–≤–æ–µ —Ñ–∞—Ä–º–ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏–µ. –ö–∞–∫ —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏ –≤ —Å—Ç–æ–ª–∏—á–Ω–æ–π –º—ç—Ä–∏–∏, –∑–∞–≤–æ–¥ –ø–æ—Å—Ç—Ä–æ—è—Ç –≤ —Ä–∞–º–∫–∞—Ö –º–∞—Å—à—Ç–∞–±–Ω–æ–≥–æ –∏–Ω–≤–µ—Å—Ç–ø—Ä–æ–µ–∫—Ç–∞. –í –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏–µ –≤–ª–æ–∂–∞—Ç 13 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ù–∞ –ø–ª–æ—â–∞–¥–∫–µ –ø–æ—è–≤—è—Ç—Å—è –Ω–µ —Ç–æ–ª—å–∫–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã–µ –æ—Ç–¥–µ–ª—ã, –Ω–æ –∏ –ø–æ–¥—Ä–∞–∑–¥–µ–ª–µ–Ω–∏—è –¥–ª—è –Ω–∞—É—á–Ω–æ–π —Ä–∞–±–æ—Ç—ã –∏ –∏–∑—É—á–µ–Ω–∏—è –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –Ω–æ–≤—ã—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –≤ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏. üíä –ó–∞–∫—É–ø–ª–µ–Ω–Ω—ã–µ –¥–ª—è –±–µ–¥–Ω—ã—Ö —Å—Ç—Ä–∞–Ω –∫–æ–Ω—Ç—Ä–∞—Ü–µ–ø—Ç–∏–≤—ã –Ω–µ –¥–æ—Å—Ç–∞–Ω—É—Ç—Å—è –Ω–∏–∫–æ–º—É. –ü—Ä–æ—Ç–∏–≤–æ–∑–∞—á–∞—Ç–æ—á–Ω—ã–µ —Ç–∞–±–ª–µ—Ç–∫–∏, –ø—Ä–µ–∑–µ—Ä–≤–∞—Ç–∏–≤—ã, –≤–Ω—É—Ç—Ä–∏–º–∞—Ç–æ—á–Ω—ã–µ —Å–ø–∏—Ä–∞–ª–∏ –∏ –≥–æ—Ä–º–æ–Ω–∞–ª—å–Ω—ã–µ –∏–º–ø–ª–∞–Ω—Ç–∞—Ç—ã, –∑–∞–∫—É–ø–ª–µ–Ω–Ω—ã–µ USAID –¥–ª—è —Å—Ç—Ä–∞–Ω —Å –Ω–∏–∑–∫–∏–º —É—Ä–æ–≤–Ω–µ–º –¥–æ—Ö–æ–¥–∞, —É–Ω–∏—á—Ç–æ–∂–µ–Ω—ã –ø–æ –ø—Ä–∏–∫–∞–∑—É –î–æ–Ω–∞–ª—å–¥–∞ –¢—Ä–∞–º–ø–∞. üíä ¬´–í–µ—Ä—Ç–µ–∫—Å¬ª –≤ 2025 –≥–æ–¥—É –≤–ª–æ–∂–∏–ª –ø–æ—á—Ç–∏ 195 –º–ª–Ω —Ä—É–±–ª–µ–π –≤ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –≤ –û–≠–ó ¬´–°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥¬ª. –î–µ–Ω—å–≥–∏ –ø–æ—à–ª–∏ –≤ –æ—Å–Ω–æ–≤–Ω–æ–º –Ω–∞ –ø—Ä–∏–æ–±—Ä–µ—Ç–µ–Ω–∏–µ –Ω–æ–≤–æ–≥–æ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è, –ø—Ä–æ–≤–µ–¥–µ–Ω–∏–µ –ù–ò–û–ö–† –∏ –¥—Ä—É–≥–∏–µ –≤–∏–¥—ã —Ä–∞–±–æ—Ç. üíä –û—Ç—Å—É—Ç—Å—Ç–≤–∏–µ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç–∞ ‚Äî –ø–æ–∫—É–ø–∫–µ –ª–µ–∫–∞—Ä—Å—Ç–≤ –Ω–µ –ø–æ–º–µ—Ö–∞. –í –ú–∏–Ω—Ü–∏—Ñ—Ä—ã —Å–æ–æ–±—â–∏–ª–∏, —á—Ç–æ –∞–ø—Ç–µ–∫–∏ –≤–æ–π–¥—É—Ç –≤ —Ä–∞—Å—à–∏—Ä–µ–Ω–Ω—ã–π –ø–µ—Ä–µ—á–µ–Ω—å —Ä–µ—Å—É—Ä—Å–æ–≤, –¥–æ—Å—Ç—É–ø–Ω—ã—Ö –ø—Ä–∏ –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏—è—Ö –º–æ–±–∏–ª—å–Ω–æ–≥–æ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç–∞. –°–ø–∏—Å–æ–∫ –ø–æ–∫–∞ —Ñ–æ—Ä–º–∏—Ä—É–µ—Ç—Å—è. üíä –ö–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏—è —Å Eli Lilly –ª–∏—à–∏—Ç —Ä–∞–±–æ—Ç—ã —Ç—ã—Å—è—á–∏ —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤ Novo Nordisk. –ü—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å –û–∑–µ–º–ø–∏–∫–∞ —É–≤–æ–ª–∏—Ç 9 —Ç—ã—Å. —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤, –∏–∑ –Ω–∏—Ö 5 —Ç—ã—Å. ‚Äî –¥–∞—Ç—á–∞–Ω–µ. –î–ª—è –∫–æ—Ä–æ–ª–µ–≤—Å—Ç–≤–∞ —ç—Ç–æ —Ä–µ–∫–æ—Ä–¥. –ù–∞ –Ω–µ–ø–æ–ø—É–ª—è—Ä–Ω—ã–µ –º–µ—Ä—ã –Ω–æ–≤—ã–π –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä –∫–æ–º–ø–∞–Ω–∏–∏ –ú–∞–π–∫ –î—É—Å—Ç–¥–∞—Ä –ø–æ—à—ë–ª, —á—Ç–æ–±—ã —Å–≥–ª–∞–¥–∏—Ç—å –ø–æ—Å–ª–µ–¥—Å—Ç–≤–∏—è –Ω–∞—Ä–∞—Å—Ç–∞—é—â–µ–π –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏–∏ —Å–æ —Å—Ç–æ—Ä–æ–Ω—ã –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –¥–∏–∞–±–µ—Ç–∞ –∏ –æ–∂–∏—Ä–µ–Ω–∏—è –æ—Ç Eli Lilly –∏ —Å—ç–∫–æ–Ω–æ–º–∏—Ç—å –æ–∫–æ–ª–æ $1,3 –º–ª—Ä–¥ –∫ –∫–æ–Ω—Ü—É 2026 –≥–æ–¥–∞. –í—ã—Ä—É—á–µ–Ω–Ω—ã–µ –¥–µ–Ω—å–≥–∏ –ø–æ–π–¥—É—Ç –Ω–∞ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫—É –Ω–æ–≤—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. üíä –í –ú–æ—Å–∫–≤–µ —Å—Ç–∞—Ä—Ç–æ–≤–∞–ª–∞ –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏—è –æ—Ç –≥—Ä–∏–ø–ø–∞. –ü—Ä–∏–≤–∏—Ç—å—Å—è –º–æ–∂–Ω–æ –≤ –º–æ–±–∏–ª—å–Ω—ã—Ö –ø—É–Ω–∫—Ç–∞—Ö —É —Å—Ç–∞–Ω—Ü–∏–π –º–µ—Ç—Ä–æ, –ú–¶–ö –∏ –ú–¶–î –∏ –≤–æ –≤—Å–µ—Ö –≥–æ—Ä–æ–¥—Å–∫–∏—Ö –ø–æ–ª–∏–∫–ª–∏–Ω–∏–∫–∞—Ö –∏ –∏—Ö —Ñ–∏–ª–∏–∞–ª–∞—Ö. –ü–æ —Å–ª–æ–≤–∞–º –∑–∞–º–º—ç—Ä–∞ –ú–æ—Å–∫–≤—ã –ø–æ –≤–æ–ø—Ä–æ—Å–∞–º —Å–æ—Ü–∏–∞–ª—å–Ω–æ–≥–æ —Ä–∞–∑–≤–∏—Ç–∏—è –ê–Ω–∞—Å—Ç–∞—Å–∏–∏ –†–∞–∫–æ–≤–æ–π, –∑–∞ –ø–æ—Å–ª–µ–¥–Ω–∏–µ –≥–æ–¥—ã –≤ —Å—Ç–æ–ª–∏—Ü–µ –Ω–µ –±—ã–ª–æ –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–Ω–æ –Ω–∏ –æ–¥–Ω–æ–≥–æ —Å–ª—É—á–∞—è —Ç—è–∂—ë–ª—ã—Ö –æ—Å–ª–æ–∂–Ω–µ–Ω–∏–π –≥—Ä–∏–ø–ø–∞ —Å—Ä–µ–¥–∏ –≤–∞–∫—Ü–∏–Ω–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –≥–æ—Ä–æ–∂–∞–Ω. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-09-12T16:35:57+00:00,@bezrec,6537,https://t.me/bezrec/6537,"–≠–∫—Å–ø–µ—Ä—Ç—ã –æ–±—Å—É–¥–∏–ª–∏, –∫–∞–∫ —Å–æ–∫—Ä–∞—Ç–∏—Ç—å –ø—É—Ç—å –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–æ –ø–∞—Ü–∏–µ–Ω—Ç–∞. –ù–∞ V –ö–æ–Ω–≥—Ä–µ—Å—Å–µ ¬´–ü—Ä–∞–≤–æ –Ω–∞ –∑–¥–æ—Ä–æ–≤—å–µ¬ª –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–∏ —Ä–µ–≥—É–ª—è—Ç–æ—Ä–Ω—ã—Ö –æ—Ä–≥–∞–Ω–æ–≤, —Ñ–∞—Ä–º–±–∏–∑–Ω–µ—Å–∞ –∏ –ø–∞—Ü–∏–µ–Ω—Ç—Å–∫–æ–≥–æ —Å–æ–æ–±—â–µ—Å—Ç–≤–∞ –ø–æ–≥–æ–≤–æ—Ä–∏–ª–∏ –æ —Ç–æ–º, –∫–∞–∫ —Å–¥–µ–ª–∞—Ç—å –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—É—é —Ç–µ—Ä–∞–ø–∏—é –±–æ–ª–µ–µ –¥–æ—Å—Ç—É–ø–Ω–æ–π –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –í —á—ë–º –ø—Ä–æ–±–ª–µ–º–∞? –°–µ–≥–æ–¥–Ω—è –ø—É—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –æ—Ç —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –¥–æ –±–æ–ª—å–Ω–æ–≥–æ –¥–æ–ª–æ–≥ –∏ —Ç–µ—Ä–Ω–∏—Å—Ç. –¢–∞–∫, –ø–æ —Å–ª–æ–≤–∞–º –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç–∞ ¬´–ü–µ—Ç—Ä–æ–≤–∞–∫—Å–∞¬ª –ú–∏—Ö–∞–∏–ª–∞ –¶—ã—Ñ–µ—Ä–æ–≤–∞, —Ñ–∞–∫—Ç–∏—á–µ—Å–∫–∏–π –¥–æ—Å—Ç—É–ø —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –∏–Ω–Ω–æ–≤–∞—Ü–∏–π –∫ –ø–∞—Ü–∏–µ–Ω—Ç–∞–º –∑–∞–¥–µ—Ä–∂–∏–≤–∞–µ—Ç—Å—è –Ω–∞ 1,5‚Äì2 –≥–æ–¥–∞ –∏–∑-–∑–∞ –¥–ª–∏—Ç–µ–ª—å–Ω—ã—Ö –ø—Ä–æ—Ü–µ–¥—É—Ä –≤–∫–ª—é—á–µ–Ω–∏—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏, –∫–ª–∏–Ω–∏–∫–æ-—Å—Ç–∞—Ç–∏—Å—Ç–∏—á–µ—Å–∫–∏–µ –≥—Ä—É–ø–ø—ã –∏ –ñ–ù–í–õ–ü. –°–µ–≥–æ–¥–Ω—è –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–∞—è —Ñ–∞—Ä–º–∞ –º–æ–∂–µ—Ç –ø–æ–∫—Ä—ã—Ç—å –±–æ–ª—å—à—É—é —á–∞—Å—Ç—å –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç–∏ –≤ –¥–∂–µ–Ω–µ—Ä–∏–∫–∞—Ö, –Ω–æ 80% –±—é–¥–∂–µ—Ç–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –Ω–∞ –∑–∞–∫—É–ø–∫—É –æ–Ω–∫–æ–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏–¥—É—Ç –Ω–∞ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã–µ –õ–°, –≥–¥–µ –µ—ë –¥–æ–ª—è –ø–æ–∫–∞ –∫—Ä–∞–π–Ω–µ –º–∞–ª–∞. –ü–æ–∫–∞–∑–∞—Ç–µ–ª—å–Ω–æ, —á—Ç–æ –≤ –∞–≤–≥—É—Å—Ç–µ 2025 –≥–æ–¥–∞ –∫–æ–º–∏—Å—Å–∏—è –ø–æ —Ä–∞—Å—à–∏—Ä–µ–Ω–∏—é –ø–µ—Ä–µ—á–Ω—è –ñ–ù–í–õ–ü —Ä–∞—Å—Å–º–∞—Ç—Ä–∏–≤–∞–ª–∞ 23 –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –Ω–∞ –≤–∫–ª—é—á–µ–Ω–∏–µ, –∏–∑ –Ω–∏—Ö —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö ‚Äî —Ç–æ–ª—å–∫–æ –¥–≤–∞, –∏ –ª–∏—à—å –æ–¥–∏–Ω –∏–∑ –Ω–∏—Ö ‚Äî –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–π. –ò–Ω–Ω–æ–≤–∞—Ü–∏–∏ ‚Äî —ç—Ç–æ –¥–æ—Ä–æ–≥–æ, –Ω–∞ –Ω–∏—Ö —Ç—è–∂–µ–ª–æ –∑–∞–º–∞—Ö–∏–≤–∞—Ç—å—Å—è, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª –¶—ã—Ñ–µ—Ä–æ–≤. –° –≥–ª–∞–≤–æ–π ¬´–ü–µ—Ç—Ä–æ–≤–∞–∫—Å–∞¬ª —Å–æ–≥–ª–∞—Å–µ–Ω –∏ —ç–∫—Å–ø–µ—Ä—Ç –í—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —Å–æ—é–∑–∞ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –ê–ª–µ–∫—Å–µ–π –§–µ–¥–æ—Ä–æ–≤, –∫–æ—Ç–æ—Ä—ã–π –Ω–∞—Å—Ç—Ä–æ–µ–Ω –µ—â—ë –±–æ–ª–µ–µ –ø–µ—Å—Å–∏–º–∏—Å—Ç–∏—á–Ω–æ ‚Äî –ø–æ –µ–≥–æ –º–Ω–µ–Ω–∏—é, –∏–Ω–Ω–æ–≤–∞—Ü–∏–∏ ¬´–∏–¥—É—Ç¬ª –¥–æ —Ä—É—Ç–∏–Ω–Ω–æ–π –ø—Ä–∞–∫—Ç–∏–∫–∏ –æ—Ç 5 –¥–æ 7 –ª–µ—Ç. –ß—Ç–æ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ —ç–∫—Å–ø–µ—Ä—Ç—ã? üü© –°–æ–∑–¥–∞—Ç—å –∫–∞—Ç–µ–≥–æ—Ä–∏—é, –æ—Ö–≤–∞—Ç—ã–≤–∞—é—â—É—é –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã. –ò–∑-–∑–∞ —Ç–æ–≥–æ, —á—Ç–æ —á–µ—Ç–∫–æ–≥–æ –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω–æ–≥–æ –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–∏—è –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –ø–æ–∫–∞ –Ω–µ —Å—É—â–µ—Å—Ç–≤—É–µ—Ç, —Ä–µ—á–∏ –æ–± –æ—Å–æ–±—ã—Ö —Ä–µ–≥—É–ª—è—Ç–æ—Ä–Ω—ã—Ö —É—Å–ª–æ–≤–∏—è—Ö –∏–¥—Ç–∏ –Ω–µ –º–æ–∂–µ—Ç. üü© –°–æ–∑–¥–∞—Ç—å ¬´–ø—Ä–µ–¥–ø–µ—Ä–µ—á–µ–Ω—å¬ª –¥–ª—è –æ–±–ª–µ–≥—á–µ–Ω–∏—è –¥–æ—Å—Ç—É–ø–∞ –∏–Ω–Ω–æ–≤–∞—Ü–∏–π –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü. –¢–∞–º –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–æ–ª–∂–Ω—ã –±—É–¥—É—Ç –ø—Ä–æ—Ö–æ–¥–∏—Ç—å –æ—Ü–µ–Ω–∫—É –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–æ—Å—Ç–∏. –ü—Ä–µ–ø–∞—Ä–∞—Ç—ã, –ø—Ä–µ—Ç–µ–Ω–¥—É—é—â–∏–µ –Ω–∞ –ø–æ–ø–∞–¥–∞–Ω–∏–µ –≤ –ø–µ—Ä–µ—á–µ–Ω—å, –¥–æ–ª–∂–Ω—ã –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç—å—Å—è –≤ –†–æ—Å—Å–∏–∏ –∏ —Å–ø–æ—Å–æ–±—Å—Ç–≤–æ–≤–∞—Ç—å —Ä–∞–∑–≤–∏—Ç–∏—é –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–π –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏. üü© –ò—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å –≤ —Ä–∞–º–∫–∞—Ö –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å–Ω–æ–π –ø—Ä–∞–∫—Ç–∏–∫–∏ –ø—Ä–∏ –≤–∫–ª—é—á–µ–Ω–∏–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –ñ–ù–í–õ–ü —Ç–æ—Ç —Å—Ç–∞—Ç—É—Å –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –∫–æ—Ç–æ—Ä—ã–π —Å—É—â–µ—Å—Ç–≤—É–µ—Ç —Ä–µ–∞–ª—å–Ω–æ –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ –†–§. –≠—Ç–æ—Ç –ø–æ–¥—Ö–æ–¥ –Ω–∞ –∞–≤–≥—É—Å—Ç–æ–≤—Å–∫–æ–º –∑–∞—Å–µ–¥–∞–Ω–∏–∏ –∫–æ–º–∏—Å—Å–∏–∏ –ñ–ù–í–õ–ü –ø—Ä–µ–¥–ª–∞–≥–∞–ª–∏ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–∏ ¬´–ü–µ—Ç—Ä–æ–≤–∞–∫—Å–∞¬ª. üü© –í—ã–¥–µ–ª–∏—Ç—å —Ç—Ä–∏ –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤: —Å ¬´–æ—Å–æ–±–æ–π –∑–Ω–∞—á–∏–º–æ—Å—Ç—å—é¬ª, ¬´–≤—ã—Å–æ–∫–æ–π —Ç–µ—Ä–∞–ø–µ–≤—Ç–∏—á–µ—Å–∫–æ–π —Ü–µ–Ω–Ω–æ—Å—Ç—å—é¬ª –∏ ¬´—Å–Ω–∏–∂–∞—é—â–∏–µ –∑–∞—Ç—Ä–∞—Ç—ã¬ª –∏ –≤–≤–µ—Å—Ç–∏ –¥–ª—è –Ω–∏—Ö –æ—Å–æ–±—ã–µ —É—Å–ª–æ–≤–∏—è –≤–∫–ª—é—á–µ–Ω–∏—è –≤ –≥–æ—Å–ø—Ä–æ–≥—Ä–∞–º–º—ã. üü© –í–Ω–µ–¥—Ä–∏—Ç—å –≤ –†–æ—Å—Å–∏–∏ –º–µ—Ö–∞–Ω–∏–∑–º –∫–æ–Ω—Ñ–∏–¥–µ–Ω—Ü–∏–∞–ª—å–Ω—ã—Ö —Ü–µ–Ω: –∫–æ–≥–¥–∞ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å –∏ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–æ ¬´–∫—É–ª—É–∞—Ä–Ω–æ¬ª –¥–æ–≥–æ–≤–∞—Ä–∏–≤–∞—é—Ç—Å—è –æ –≥–∞—Ä–∞–Ω—Ç–∏—Ä–æ–≤–∞–Ω–Ω–æ–π —Ü–µ–Ω–µ –ø–æ—Å—Ç–∞–≤–∫–∏ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –ø–æ–¥ –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–Ω—ã–µ –≥–∞—Ä–∞–Ω—Ç–∏–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial, safety, guideline"",
  ""impact"": ""medium"",
  ""english"": ""Experts discussed how to shorten the path of innovative drugs to patients. Representatives from regulatory authorities, pharmaceutical industry and patient communities talked at the V Congress 'Right to Health' about how to make innovative therapy more accessible for patients. What is the problem? Today, the path of a drug from registration to patient is long and difficult. For example, according to Mikhail Tsiferov, CEO of 'Petrovax', the actual access to Russia's innovations for patients is delayed by 1.5-2 years due to lengthy procedures of including the drugs in clinical guidelines, statistical groups and –ñ–ù–í–õ–ü. Today, domestic pharmaceutical industry can cover most of the budgetary needs for generics but 80% of budget funds on purchasing oncological drugs go to original medicines where its share is still very low. It's noteworthy that in August 2025, the commission for expanding –ñ–ù–í–õ–ü considered 23 drugs for inclusion, of which only two are Russian and one is innovative. Tsiferov agrees with this view on fellow expert Alexey"
2025-09-12T13:02:42+00:00,@bezrec,6535,https://t.me/bezrec/6535,"–ê–Ω–∞–ª–∏—Ç–∏–∫–∏ —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏, –∫–∞–∫–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –≤ —Ñ–∞–≤–æ—Ä–µ —É –º–æ—Å–∫–≤–∏—á–µ–π. –ü–æ –¥–∞–Ω–Ω—ã–º RNC Pharma, –ú–æ—Å–∫–≤–∞ –∑–∞–Ω–∏–º–∞–µ—Ç 11,6% —Ä—ã–Ω–∫–∞ –≤ –¥–µ–Ω—å–≥–∞—Ö –∏ –±–æ–ª–µ–µ 8% –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö –≤ –æ–±—â–µ–º –æ–±—ä—ë–º–µ —Ä–æ–∑–Ω–∏—á–Ω—ã—Ö –ø—Ä–æ–¥–∞–∂ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –†–æ—Å—Å–∏–∏. –í —è–Ω–≤–∞—Ä–µ-–∏—é–ª–µ —Å—Ç–æ–ª–∏—á–Ω—ã–µ –∞–ø—Ç–µ–∫–∏ –ø—Ä–æ–¥–∞–ª–∏ 220 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ –ª–µ–∫–∞—Ä—Å—Ç–≤ –Ω–∞ —Å—É–º–º—É –±–æ–ª–µ–µ 118 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ì–æ–¥ –∫ –≥–æ–¥—É —Ä–∞—Å—Ö–æ–¥—ã –∂–∏—Ç–µ–ª–µ–π –∏ –≥–æ—Å—Ç–µ–π –≥–æ—Ä–æ–¥–∞ –≤—ã—Ä–æ—Å–ª–∏ –ø–æ—á—Ç–∏ –Ω–∞ 13,8%, –ø—Ä–∏ —ç—Ç–æ–º –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–µ –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–µ –æ—Å—Ç–∞–ª–æ—Å—å –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏ –Ω–∞ —Ç–æ–º –∂–µ —É—Ä–æ–≤–Ω–µ (-0,003%). –°—Ä–µ–¥–Ω—è—è —Å—Ç–æ–∏–º–æ—Å—Ç—å —É–ø–∞–∫–æ–≤–∫–∏ –≤ –ú–æ—Å–∫–≤–µ –≤—ã—Ä–æ—Å–ª–∞ –∑–∞ –≥–æ–¥ –Ω–∞ 65 —Ä—É–±–ª–µ–π, –¥–æ 537 —Ä—É–±–ª–µ–π. –í—Å–µ–≥–æ –ø–æ –∏—Ç–æ–≥–∞–º –ø–µ—Ä–≤—ã—Ö —Å–µ–º–∏ –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ –Ω–∞ —Ä–æ–∑–Ω–∏—á–Ω–æ–º —Ä—ã–Ω–∫–µ –ú–æ—Å–∫–≤—ã –±—ã–ª–æ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–æ –ø–æ—Ä—è–¥–∫–∞ 5,1 —Ç—ã—Å. —Ç–æ—Ä–≥–æ–≤—ã—Ö –º–∞—Ä–æ–∫ –æ—Ç –±–æ–ª–µ–µ —á–µ–º 700 –∫–æ–º–ø–∞–Ω–∏–π. –ù–∞ –ø–µ—Ä–≤–æ–µ –º–µ—Å—Ç–æ –≤–æ—Ä–≤–∞–ª—Å—è –°–µ–º–∞–≤–∏–∫ –æ—Ç ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º–∞¬ª, –ø–æ—Ç–µ—Å–Ω–∏–≤—à–∏–π –ø—Ä–µ–∂–Ω–µ–≥–æ –ª–∏–¥–µ—Ä–∞ ‚Äî –ö—Å–∞—Ä–µ–ª—Ç–æ –æ—Ç ¬´–ë–∞–π–µ—Ä¬ª. –ü—Ä–æ–¥–∞–∂–∏ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –¥–∏–∞–±–µ—Ç–∞ –∏ –æ–∂–∏—Ä–µ–Ω–∏—è –∑–∞ –≥–æ–¥ –≤—ã—Ä–æ—Å–ª–∏ –≤ 3,3 —Ä–∞–∑–∞, –≤ —Ç–æ –≤—Ä–µ–º—è –∫–∞–∫ –ø–æ–ø—É–ª—è—Ä–Ω—ã–π –∞–Ω—Ç–∏–∫–æ–∞–≥—É–ª—è–Ω—Ç –ø–æ–∫–∞–∑–∞–ª –æ—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω—É—é –¥–∏–Ω–∞–º–∏–∫—É (-19% –≤ —Ä—É–±–ª—è—Ö –∏ -13% –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö) –∏–∑-–∑–∞ –≤—ã—Ö–æ–¥–∞ –Ω–∞ —Ä—ã–Ω–æ–∫ –º–Ω–æ–≥–æ—á–∏—Å–ª–µ–Ω–Ω—ã—Ö –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤. –°—Ä–∞–∑—É –Ω–∞ —à–µ—Å—Ç—å —Å—Ç—Ä–æ—á–µ–∫ –≤–Ω–∏–∑ –æ–ø—É—Å—Ç–∏–ª—Å—è –≠–ª–∏–∫–≤–∏—Å –æ—Ç ¬´–ü—Ñ–∞–π–∑–µ—Ä¬ª ‚Äî –æ–±—ä—ë–º –ø—Ä–æ–¥–∞–∂ –±—Ä–µ–Ω–¥–∞ —É–º–µ–Ω—å—à–∏–ª—Å—è –Ω–∞ 15% –≤ —Å—Ç–æ–∏–º–æ—Å—Ç–Ω–æ–º –∏ –Ω–∞ 18% –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏. –¢–∞–∫–∏–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –∞–Ω–∞–ª–∏—Ç–∏–∫–∏ —Å–≤—è–∑—ã–≤–∞—é—Ç —Å —Ä–∞—Å—à–∏—Ä–µ–Ω–∏–µ–º –æ–±—ä—ë–º–∞ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã—Ö –≥–∞—Ä–∞–Ω—Ç–∏–π –∑–∞ —Å—á—ë—Ç –±—é–¥–∂–µ—Ç–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤. –°–∫—Ä–æ–º–Ω—É—é –¥–∏–Ω–∞–º–∏–∫—É —Ç–∞–∫–∂–µ –ø–æ–∫–∞–∑–∞–ª–∏ –ù–∏–º–µ—Å–∏–ª –æ—Ç ¬´–ú–µ–Ω–∞—Ä–∏–Ω–∏¬ª (+6%) –∏ –î–µ—Ç—Ä–∞–ª–µ–∫—Å –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–°–µ—Ä–≤—å–µ¬ª (7%). –ü–æ–º–∏–º–æ –ø–µ—Ä–µ—á–∏—Å–ª–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ —Ç–æ–ø-10 –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ø–æ –æ–±—ä—ë–º—É –¥–µ–Ω–µ–∂–Ω—ã—Ö –ø—Ä–æ–¥–∞–∂ –Ω–∞ —Ä–æ–∑–Ω–∏—á–Ω–æ–º —Ñ–∞—Ä–º—Ä—ã–Ω–∫–µ –ú–æ—Å–∫–≤—ã –≤–æ—à–ª–∏: –ù—É—Ä–æ—Ñ–µ–Ω (¬´–†–µ–∫–∫–∏—Ç—Ç –ë–µ–Ω–∫–∏–∑–µ—Ä¬ª), –≠–¥–∞—Ä–±–∏ (¬´–ù–∏–∂—Ñ–∞—Ä–º¬ª), –¢–µ—Ä–∞—Ñ–ª—é (¬´–ì–°–ö¬ª), –§–æ—Ä—Å–∏–≥–∞ (¬´–ê—Å—Ç—Ä–∞–ó–µ–Ω–µ–∫–∞¬ª), –ì–µ–ø—Ç—Ä–∞–ª (¬´–≠–±–±–æ—Ç—Ç¬ª). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The message discusses the pharmaceutical market in Moscow, mentioning increases in spending on drugs like SemaVik from 'Germopharma' and decreases for anticoagulant Elyxvis from 'Pfizer'. It also notes a decline in the use of Nymisil and Detraxedol. The impact is medium, reflecting changes in the market but not significant enough to be high or low.""
}"
2025-09-12T08:31:26+00:00,@bezrec,6533,https://t.me/bezrec/6533,"¬´–≠–≤–∞–ª–∞—Ä¬ª –ø—Ä–æ—Å–∏—Ç –§–ê–° –≤—Ä–∞–∑—É–º–∏—Ç—å –ø—Ä–∞–≤–æ–æ–±–ª–∞–¥–∞—Ç–µ–ª—è –ú–∏—Ä–∞–º–∏—Å—Ç–∏–Ω–∞. –†–æ—Å—Å–∏–π—Å–∫—É—é –∫–æ–º–ø–∞–Ω–∏—é –≤–æ–∑–º—É—Ç–∏–ª–∏ –¥–µ–π—Å—Ç–≤–∏—è –∞–≤—Å—Ç—Ä–∏–π—Å–∫–æ–π ¬´–ú–µ–≥–∞–∏–Ω—Ñ–∞—Ä–º –ì–º–±–•¬ª, –∫–æ—Ç–æ—Ä–∞—è —Å—Ç–∞–ª–∞ –∑–∞—è–≤–ª—è—Ç—å –Ω–µ–æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω—ã–µ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ —Ä–æ—Å—Å–∏–π—Å–∫–∏–º –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º –∫–∞—Ç–∏–æ–Ω–Ω—ã—Ö –∞–Ω—Ç–∏—Å–µ–ø—Ç–∏–∫–æ–≤, –ø–æ—Ç—Ä–µ–±–æ–≤–∞–≤ –ø—Ä–µ–∫—Ä–∞—Ç–∏—Ç—å –ø—Ä–æ–¥–∞–∂–∏ –∏ —Ö—Ä–∞–Ω–µ–Ω–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ –æ—Å–Ω–æ–≤–µ –±–µ–Ω–∑–∏–ª–¥–∏–º–µ—Ç–∏–ª-–º–∏—Ä–∏—Å—Ç–æ–∏–ª–∞–º–∏–Ω–æ-–ø—Ä–æ–ø–∏–ª–∞–º–º–æ–Ω–∏—è (–ë–ú–ü). –ü—Ä–∏ —ç—Ç–æ–º –Ω–∞ —Å–µ–≥–æ–¥–Ω—è—à–Ω–∏–π –¥–µ–Ω—å –ú–∏–Ω–∑–¥—Ä–∞–≤ —É–∂–µ –≤—ã–¥–∞–ª 12 —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–π –Ω–∞ –¥–∂–µ–Ω–µ—Ä–∏–∫–∏ –ú–∏—Ä–∞–º–∏—Å—Ç–∏–Ω–∞, –ø–∞—Ç–µ–Ω—Ç–Ω–∞—è –∑–∞—â–∏—Ç–∞ –∫–æ—Ç–æ—Ä–æ–≥–æ –∏—Å—Ç–µ–∫–ª–∞ –≤–µ—Å–Ω–æ–π 2021 –≥–æ–¥–∞. –û–¥–Ω–∞–∫–æ –≤ —Å–≤–æ–∏—Ö —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è—Ö –∞–≤—Å—Ç—Ä–∏–π—Å–∫–∞—è –∫–æ–º–ø–∞–Ω–∏—è —Å—Å—ã–ª–∞–µ—Ç—Å—è –Ω–∞ –Ω–æ–≤—ã–π –ï–≤—Ä–∞–∑–∏–π—Å–∫–∏–π –ø–∞—Ç–µ–Ω—Ç ‚Ññ 022283, —Å—Ä–æ–∫ –¥–µ–π—Å—Ç–≤–∏—è –∫–æ—Ç–æ—Ä–æ–≥–æ –∏—Å—Ç–µ–∫–∞–µ—Ç –≤ —Ñ–µ–≤—Ä–∞–ª–µ 2031 –≥–æ–¥–∞. –°—Ç—Ä–∞–Ω–Ω–æ—Å—Ç—å –Ω–æ–≤–æ–≥–æ –ø–∞—Ç–µ–Ω—Ç–∞, –Ω–∞ –∫–æ—Ç–æ—Ä—É—é —É–∫–∞–∑—ã–≤–∞—é—Ç —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏, –≤ —Ç–æ–º, —á—Ç–æ —Ö–æ—Ç—è –ú–∏—Ä–∞–º–∏—Å—Ç–∏–Ω ‚Äî –º–æ–Ω–æ–∫–æ–º–ø–æ–Ω–µ–Ω—Ç–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç, –∏ –∏–º–µ–Ω–Ω–æ —Ç–∞–∫ –æ–ø–∏—Å—ã–≤–∞–µ—Ç—Å—è –≤ –∏–Ω—Å—Ç—Ä—É–∫—Ü–∏–∏, –≤ –Ω–æ–≤–æ–º –ø–∞—Ç–µ–Ω—Ç–µ –æ–Ω –∑–∞—è–≤–ª–µ–Ω –∫–∞–∫ –∫–æ–º–ø–æ–∑–∏—Ü–∏—è –∏–∑ —Ç—Ä–µ—Ö –¥–µ–π—Å—Ç–≤—É—é—â–∏—Ö –≤–µ—â–µ—Å—Ç–≤. –ü—Ä–∞–≤–¥–∞, –¥–≤–∞ –æ—Å—Ç–∞–ª—å–Ω—ã—Ö ‚Äî —ç—Ç–æ —Å–ª–µ–¥–æ–≤—ã–µ –ø—Ä–∏–º–µ—Å–∏ –æ—Ç –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è –æ—Å–Ω–æ–≤–Ω–æ–≥–æ –¥–µ–π—Å—Ç–≤—É—é—â–µ–≥–æ –≤–µ—â–µ—Å—Ç–≤–∞. –≠—Ç–æ—Ç –¥–æ–∫—É–º–µ–Ω—Ç –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª—è–µ—Ç –∑–∞—â–∏—Ç—É –ø—Ä–µ–ø–∞—Ä–∞—Ç—É, –∫–æ—Ç–æ—Ä—ã–π –ø—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ—Ç —Å–æ–±–æ–π –∫–æ–º–ø–æ–∑–∏—Ü–∏—é –∏–∑ —Ç—Ä–µ—Ö –¥–µ–π—Å—Ç–≤—É—é—â–∏—Ö –≤–µ—â–µ—Å—Ç–≤ ‚Äî –ë–ú–ü –∏ –¥–≤—É—Ö –µ—Å—Ç–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–∏–º–µ—Å–µ–π, –æ–±—Ä–∞–∑—É—é—â–∏—Ö—Å—è –ø—Ä–∏ —Å–∏–Ω—Ç–µ–∑–µ –ë–ú–ü. –ü—Ä–∏ —ç—Ç–æ–º, –ø–æ –Ω–∞—à–µ–º—É –º–Ω–µ–Ω–∏—é, –∏—Å—Ç–µ—Ü —Å–≤–æ–π –ø–∞—Ç–µ–Ω—Ç –Ω–µ –∏—Å–ø–æ–ª—å–∑—É–µ—Ç, –ø—Ä–µ–ø–∞—Ä–∞—Ç –ø–æ –ø–∞—Ç–µ–Ω—Ç—É –Ω–µ –≤—ã–ø—É—Å–∫–∞–µ—Ç –∏ –Ω–∏–∫–æ–≥–¥–∞ –Ω–µ –≤—ã–ø—É—Å–∫–∞–ª. –ü–æ—ç—Ç–æ–º—É –¥–µ–π—Å—Ç–≤–∏—è –∑–∞—è–≤–∏—Ç–µ–ª—è —Å–æ–¥–µ—Ä–∂–∞—Ç –ø—Ä–∏–∑–Ω–∞–∫–∏ –∑–ª–æ—É–ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏—è –ø—Ä–∞–≤–æ–º, ‚Äî –æ–±—ä—è—Å–Ω–∏–ª–∞ –Ω–∞—á–∞–ª—å–Ω–∏–∫ –ø–∞—Ç–µ–Ω—Ç–Ω–æ-–ª–∏—Ü–µ–Ω–∑–∏–æ–Ω–Ω–æ–≥–æ –æ—Ç–¥–µ–ª–∞ ¬´–≠–≤–∞–ª–∞—Ä–∞¬ª –ï–ª–µ–Ω–∞ –®–µ–ø–µ–ª–µ–≤–∞. –í –º–∞–Ω–µ–≤—Ä–∞—Ö –∞–≤—Å—Ç—Ä–∏–π—Ü–µ–≤ —Ä–æ—Å—Å–∏–π—Å–∫–∏–π –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å —É—Å–º–æ—Ç—Ä–µ–ª –ø—Ä–∏–∑–Ω–∞–∫–∏ –¥–µ–π—Å—Ç–≤–∏–π –ø–æ –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏—é –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏–∏, –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–Ω—ã–µ –Ω–∞ –≤—ã—Ç–µ—Å–Ω–µ–Ω–∏–µ —Å —Ä—ã–Ω–∫–∞ —Ç–æ–≤–∞—Ä–∞-–∫–æ–Ω–∫—É—Ä–µ–Ω—Ç–∞. –í –§–ê–° –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª–∏, —á—Ç–æ –æ–±—Ä–∞—â–µ–Ω–∏–µ –ø–æ—Å—Ç—É–ø–∏–ª–æ –∏ –ø–æ–æ–±–µ—â–∞–ª–∏ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ—Ç—å –µ–≥–æ –≤ —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–Ω–æ–º –ø–æ—Ä—è–¥–∫–µ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage, regulation"",
  ""impact"": ""high"",
  ""english"": ""Russian company 'EvaLar' is asking the FAS to consider the rights of the holder of Miramistin. Austrian company 'Megafarm GmbH' is demanding that Russian producers stop selling and storing drugs based on benzyl dimethyl myristate propionate (BMP) due to unspecified requirements. The company claims that the new Eurasian patent, which expires in February 2031, covers a composition of three active substances. However, 'EvaLar' believes that the patent holder does not use it and has never produced the product. This situation is seen as a violation of rights, and 'EvaLar' considers the actions of the Austrian company to be a restriction on competition aimed at removing a competitor from the market.""
}"
2025-09-12T06:00:01+00:00,@bezrec,6532,https://t.me/bezrec/6532,"–†–æ—Å—Å–∏—è–Ω –Ω–∞—É—á–∞—Ç –ø—Ä–µ–¥–æ—Ö—Ä–∞–Ω—è—Ç—å—Å—è. –†–æ—Å—Å–∏–π—Å–∫–æ–µ –æ–±—â–µ—Å—Ç–≤–æ –∞–∫—É—à–µ—Ä–æ–≤-–≥–∏–Ω–µ–∫–æ–ª–æ–≥–æ–≤ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª–æ –ø–µ—Ä–≤—ã–µ –≤ –∏—Å—Ç–æ—Ä–∏–∏ —Å—Ç—Ä–∞–Ω—ã –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ ¬´–ö–æ–Ω—Ç—Ä–∞—Ü–µ–ø—Ü–∏—è. –ù–∞–±–ª—é–¥–µ–Ω–∏–µ –∑–∞ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º –ø—Ä–æ—Ç–∏–≤–æ–∑–∞—á–∞—Ç–æ—á–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤¬ª. –≠–∫—Å–ø–µ—Ä—Ç—ã –ø–æ—Å—á–∏—Ç–∞–ª–∏, —á—Ç–æ —Ä–æ—Å—Å–∏—è–Ω–∫–∏ –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ —Ö–æ—Ä–æ—à–æ —Ä–∞–∑–±–∏—Ä–∞—é—Ç—Å—è –≤ –≤–æ–ø—Ä–æ—Å–∞—Ö –∫–æ–Ω—Ç—Ä–∞—Ü–µ–ø—Ü–∏–∏. –ü–æ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º –æ–ø—Ä–æ—Å–∞ 2021 –≥–æ–¥–∞, —á–∞—â–µ –≤—Å–µ–≥–æ –∂–µ–Ω—â–∏–Ω—ã –ø—Ä–µ–¥–æ—Ö—Ä–∞–Ω—è–ª–∏—Å—å –ø—Ä–µ–∑–µ—Ä–≤–∞—Ç–∏–≤–∞–º–∏ (45% –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö), –∫–æ–º–±–∏–Ω–∏—Ä–æ–≤–∞–Ω–Ω—ã–º–∏ –æ—Ä–∞–ª—å–Ω—ã–º–∏ –∫–æ–Ω—Ç—Ä–∞—Ü–µ–ø—Ç–∏–≤–∞–º–∏ (30%), –∞ 23% –∏ –≤–æ–≤—Å–µ –ø—Ä–∞–∫—Ç–∏–∫–æ–≤–∞–ª–∏ –Ω–µ —Å–ª–∏—à–∫–æ–º –Ω–∞–¥—ë–∂–Ω—ã–π –ø—Ä–µ—Ä–≤–∞–Ω–Ω—ã–π –ø–æ–ª–æ–≤–æ–π –∞–∫—Ç. –í –Ω–æ–≤—ã–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –≤–æ—à–ª–∏ –≤—Å–µ –≥—Ä—É–ø–ø—ã –∫–æ–Ω—Ç—Ä–∞—Ü–µ–ø—Ç–∏–≤–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤, –≤ —Ç–æ–º —á–∏—Å–ª–µ —Å–∞–º—ã–µ ¬´–¥–∏–∫–æ–≤–∏–Ω–Ω—ã–µ¬ª ‚Äî—Ç—Ä–∞–Ω—Å–¥–µ—Ä–º–∞–ª—å–Ω—ã–µ —Å–∏—Å—Ç–µ–º—ã (–ø–ª–∞—Å—Ç—ã—Ä–∏, –≤—ã–¥–µ–ª—è—é—â–∏–µ —Å–∏–Ω—Ç–µ—Ç–∏—á–µ—Å–∫–∏–µ –≥–æ—Ä–º–æ–Ω—ã —ç—Å—Ç—Ä–æ–≥–µ–Ω –∏ –ø—Ä–æ–≥–µ—Å—Ç–æ–≥–µ–Ω –¥–ª—è –ø—Ä–µ–¥–æ—Ç–≤—Ä–∞—â–µ–Ω–∏—è –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏) –∏ –ø–æ–∫–∞ –Ω–µ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –≤ –†–§ ¬´–∂–µ–Ω—Å–∫–∏–µ –ø—Ä–µ–∑–µ—Ä–≤–∞—Ç–∏–≤—ã¬ª. –ü—Ä–æ —ç–∫—Å—Ç—Ä–µ–Ω–Ω—É—é –∏ –Ω–µ–æ–±—Ä–∞—Ç–∏–º—É—é –∫–æ–Ω—Ç—Ä–∞—Ü–µ–ø—Ü–∏—é —Ç–∞–º —Ç–æ–∂–µ –µ—Å—Ç—å. –ß—Ç–æ –æ—Å–æ–±–µ–Ω–Ω–æ –≤–∞–∂–Ω–æ, –≤ –¥–æ–∫—É–º–µ–Ω—Ç–µ –ø—Ä–æ–ø–∏—Å–∞–Ω—ã –ø—Ä–æ—Ç–∏–≤–æ–ø–æ–∫–∞–∑–∞–Ω–∏—è –¥–ª—è –∫–∞–∂–¥–æ–≥–æ –æ—Ç–¥–µ–ª—å–Ω–æ–≥–æ —Å–ø–æ—Å–æ–±–∞ –∫–æ–Ω—Ç—Ä–∞—Ü–µ–ø—Ü–∏–∏ –∏ –¥–∞—ë—Ç—Å—è –ø–æ–¥—Ä–æ–±–Ω—ã–π –ø–µ—Ä–µ—á–µ–Ω—å –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π, –∫–æ—Ç–æ—Ä—ã–µ –Ω—É–∂–Ω–æ –ø—Ä–æ–π—Ç–∏ –ø–∞—Ü–∏–µ–Ω—Ç—É –ø–µ—Ä–µ–¥ –Ω–∞–∑–Ω–∞—á–µ–Ω–∏–µ–º –æ–ø—Ç–∏–º–∞–ª—å–Ω–æ–≥–æ –º–µ—Ç–æ–¥–∞ –ø—Ä–µ–¥–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –≠–∫—Å–ø–µ—Ä—Ç—ã —Å—á–∏—Ç–∞—é—Ç, —á—Ç–æ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø–æ–º–æ–≥—É—Ç –æ–±–µ–∑–æ–ø–∞—Å–∏—Ç—å –æ—Ç –≤–æ–∑–º–æ–∂–Ω—ã—Ö –æ—Å–ª–æ–∂–Ω–µ–Ω–∏–π –Ω–µ —Ç–æ–ª—å–∫–æ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –Ω–æ –∏ –≤—Ä–∞—á–µ–π, –∫–æ—Ç–æ—Ä—ã–µ –∑–∞—á–∞—Å—Ç—É—é –Ω–∞–∑–Ω–∞—á–∞—é—Ç –æ–±—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –ø–∞—Ü–∏–µ–Ω—Ç–∫–∞–º –æ—Ç –±–∞–ª–¥—ã ¬´–Ω–∞ —Å–≤–æ–µ —É—Å–º–æ—Ç—Ä–µ–Ω–∏–µ¬ª. –£ –Ω–∞—Å —Ä–µ–¥–∫–æ –±—ã–≤–∞—é—Ç –∞–±—Å–æ–ª—é—Ç–Ω–æ –∑–¥–æ—Ä–æ–≤—ã–µ –ø–∞—Ü–∏–µ–Ω—Ç–∫–∏. –ê, –Ω–∞–ø—Ä–∏–º–µ—Ä, –º–∏–≥—Ä–µ–Ω—å ‚Äî –∞–±—Å–æ–ª—é—Ç–Ω–æ–µ –ø—Ä–æ—Ç–∏–≤–æ–ø–æ–∫–∞–∑–∞–Ω–∏–µ –¥–ª—è —ç—Å—Ç—Ä–æ–≥–µ–Ω-–≥–µ—Å—Ç–∞–≥–µ–Ω–Ω—ã—Ö –∫–æ–º–±–∏–Ω–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –∫–æ–Ω—Ç—Ä–∞—Ü–µ–ø—Ç–∏–≤–æ–≤, –∫–∞–∫ –∏ –í–ò–ß, –∏ –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–µ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è. –ù–µ –≤—Å–µ –≤—Ä–∞—á–∏ —ç—Ç–æ –∑–Ω–∞—é—Ç, ‚Äî –∫–æ–Ω—Å—Ç–∞—Ç–∏—Ä—É–µ—Ç –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç –û–±—â–µ—Å—Ç–≤–∞ –∞–∫—É—à–µ—Ä–æ–≤-–≥–∏–Ω–µ–∫–æ–ª–æ–≥–æ–≤ –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥–∞ –∏ –°–ó–§–û –ú–∞—Ä–∏—è –Ø—Ä–º–æ–ª–∏–Ω—Å–∫–∞—è. –ü—Ä–æ–µ–∫—Ç –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π –ø–æ–∫–∞ –Ω–µ –ø–æ—Å—Ç—É–ø–∞–ª –≤ –≤–µ–¥–æ–º—Å—Ç–≤–µ–Ω–Ω—ã–π –Ω–∞—É—á–Ω–æ-–ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏–π —Å–æ–≤–µ—Ç –ú–∏–Ω–∑–¥—Ä–∞–≤–∞, –Ω–æ, –ø–æ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –Ø—Ä–º–æ–ª–∏–Ω—Å–∫–æ–π, –µ–≥–æ ¬´–¥–æ–ª–∂–Ω—ã —É—Ç–≤–µ—Ä–¥–∏—Ç—å¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""high"",
  ""english"": ""Russian gynecologists have developed the first-ever country-specific clinical guidelines on contraception. The experts noted that Russian women are not well-informed about contraceptive methods. The new guidelines cover all types of contraceptives, including transdermal systems and emergency contraception. They also include contraindications for each method and a list of studies patients need to undergo before being prescribed the most suitable contraceptive. The guidelines aim to protect both patients and doctors, who often prescribe tests without proper justification.""
}"
2025-09-11T13:35:41+00:00,@bezrec,6531,https://t.me/bezrec/6531,"–ü—Ä–µ–ø–∞—Ä–∞—Ç–∞–º –ü–ö–£ —É–ø—Ä–æ—Å—Ç—è—Ç –∂–∏–∑–Ω—å. –° 1 —Å–µ–Ω—Ç—è–±—Ä—è –≤—Å—Ç—É–ø–∏–ª –≤ —Å–∏–ª—É –ü—Ä–∏–∫–∞–∑ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–§ ‚Ññ 260–Ω –æ –ø—Ä–∞–≤–∏–ª–∞—Ö —Ö—Ä–∞–Ω–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è. –ü—Ä–∞–≤–∏–ª–∞ –∫–æ—Å–Ω—É—Ç—Å—è –≤—Å–µ—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –≤ —Ç–æ–º —á–∏—Å–ª–µ —Å–∏–ª—å–Ω–æ–¥–µ–π—Å—Ç–≤—É—é—â–∏—Ö, –∫ –∫–æ—Ç–æ—Ä—ã–º –æ—Ç–Ω–æ—Å—è—Ç—Å—è –∑–æ–ø–∏–∫–ª–æ–Ω, –∫–ª–æ–∑–∞–ø–∏–Ω, —Ñ–µ–Ω–∞–∑–µ–ø–∞–º, –ø—Ä–µ–≥–∞–±–∞–ª–∏–Ω –∏ –¥—Ä—É–≥–∏–µ. –¢–µ–ø–µ—Ä—å –∏—Ö –º–æ–∂–Ω–æ —Ö—Ä–∞–Ω–∏—Ç—å –≤ —Å–µ–π—Ñ–µ –∏–ª–∏ –º–µ—Ç–∞–ª–ª–∏—á–µ—Å–∫–æ–º —à–∫–∞—Ñ—É, –∫–æ—Ç–æ—Ä—ã–µ –æ–ø–µ—á–∞—Ç—ã–≤–∞—é—Ç—Å—è –∏–ª–∏ –ø–ª–æ–º–±–∏—Ä—É—é—Ç—Å—è –≤ –∫–æ–Ω—Ü–µ —Ä–∞–±–æ—á–µ–≥–æ –¥–Ω—è. –°–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ, –¥–ª—è —Ç–æ–≥–æ, —á—Ç–æ–±—ã —Ä–∞–±–æ—Ç–∞—Ç—å —Å —É–∫–∞–∑–∞–Ω–Ω—ã–º–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º–∏, –∞–ø—Ç–µ–∫–∞–º –¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ –æ–±–µ—Å–ø–µ—á–∏—Ç—å —É—Å–ª–æ–≤–∏—è –¥–ª—è –∏—Ö —Ö—Ä–∞–Ω–µ–Ω–∏—è –∏ –≤–µ–¥–µ–Ω–∏–µ –ø—Ä–µ–¥–º–µ—Ç–Ω–æ-–∫–æ–ª–∏—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ —É—á–µ—Ç–∞. –≠–∫—Å–ø–µ—Ä—Ç—ã –æ—Ç–º–µ—á–∞—é—Ç, —á—Ç–æ –∂—ë—Å—Ç–∫–∏–µ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ —É—Å–ª–æ–≤–∏—è–º —Ö—Ä–∞–Ω–µ–Ω–∏—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ü–ö–£ –∑–∞—Ç—Ä—É–¥–Ω—è–ª–∏ —Ä–∞–±–æ—Ç—É –∞–ø—Ç–µ–∫, –¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–æ–≤ –∏ —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π. –£–ø—Ä–æ—â–µ–Ω–∏–µ –ø—Ä–∞–≤–∏–ª —Ö—Ä–∞–Ω–µ–Ω–∏—è —Ç–∞–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–∞–µ—Ç –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å —É–≤–µ–ª–∏—á–∏—Ç—å –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –∞–ø—Ç–µ–∫, –∫–æ—Ç–æ—Ä—ã–µ —Ç–µ–ø–µ—Ä—å —Å–º–æ–≥—É—Ç –æ–±–µ—Å–ø–µ—á–∏—Ç—å –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã–º–∏ –õ–°. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The regulation of the storage conditions for prescription drugs (PKU) has been simplified. Starting from September, a new rule by the Ministry of Health allows these drugs to be stored in safes or metal cabinets that are locked at the end of each working day. This change makes it easier for pharmacies to manage these drugs and comply with storage conditions, potentially increasing the number of pharmacies able to supply patients with necessary medications.""
}"
2025-09-11T11:34:22+00:00,@bezrec,6530,https://t.me/bezrec/6530,"–î–æ—á–∫–∞ ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑–∞¬ª –º–æ–∂–µ—Ç –∑–∞–∫—Ä—ã—Ç—å —á–µ—Ç–≤–µ—Ä—Ç—å —Ä–æ—Å—Å–∏–π—Å–∫–æ–π –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç–∏ –≤ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞—Ö –æ—Ç –∞—Å—Ç–º—ã –∏ –•–û–ë–õ. –û—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π —Ñ–∞—Ä–º–≥–∏–≥–∞–Ω—Ç –∑–∞–ø—É—Å—Ç–∏—Ç –≤ –ò—Ä–∫—É—Ç—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –æ–¥–∏–Ω –∏–∑ –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö –≤ –†–æ—Å—Å–∏–∏ –ø—Ä–æ–µ–∫—Ç–æ–≤ –ø–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤—É –±—Ä–æ–Ω—Ö–æ–ª–∏—Ç–∏–∫–æ–≤ –Ω–∞ –±–∞–∑–µ –û–û–û ¬´–î–∂–∏–Ω–∞—Ç—ç–∫¬ª. –ü–µ—Ä–≤–∞—è –ø–∞—Ä—Ç–∏—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–∏—Ö –±–æ–ª–µ–∑–Ω–µ–π –ª—ë–≥–∫–∏—Ö, –≤–∫–ª—é—á–∞—è –•–û–ë–õ –∏ –∞—Å—Ç–º—É —Å–æ–π–¥—ë—Ç —Å –∫–æ–Ω–≤–µ–π–µ—Ä–∞ –≤ –±–ª–∏–∂–∞–π—à–µ–µ –≤—Ä–µ–º—è. –ü–µ—Ä–≤—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç ‚Äî –î–∏–º–ø–ª–∏—Ä–∏–Ω ‚Äî —É–∂–µ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω –∏ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω. –ü–æ—Å–ª–µ–¥—É—é—â–∏–µ ‚Äî –Ω–∞ –ø–æ–¥—Ö–æ–¥–µ. –í –ø–ª–∞–Ω–∞—Ö ‚Äî –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –ø–æ –ø–æ–ª–Ω–æ–º—É —Ü–∏–∫–ª—É —Ç—Ä—ë—Ö –¥–µ—Å—è—Ç–∫–æ–≤ –Ω–∞–∏–º–µ–Ω–æ–≤–∞–Ω–∏–π –∫ 2030 –≥–æ–¥—É. –ù–∞—à–∞ —Ü–µ–ª—å ‚Äì —Å—Ç–∞—Ç—å –æ–¥–Ω–∏–º –∏–∑ –≤–µ–¥—É—â–∏—Ö –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –∫–∞—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö, —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã—Ö –∏ –¥–æ—Å—Ç—É–ø–Ω—ã—Ö –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –±—Ä–æ–Ω—Ö–æ–ª—ë–≥–æ—á–Ω–æ–π —Å–∏—Å—Ç–µ–º—ã, –æ–±–µ—Å–ø–µ—á–∏–≤ –≤ —Å—Ä–µ–¥–Ω–µ—Å—Ä–æ—á–Ω–æ–π –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–µ –¥–æ–ª—é –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º —Ä—ã–Ω–∫–µ –±—Ä–æ–Ω—Ö–æ–ª–∏—Ç–∏–∫–æ–≤ –±–æ–ª–µ–µ 25%, ‚Äî –ø–æ–¥–µ–ª–∏–ª–∞—Å—å –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä ¬´–î–∂–∏–Ω–∞—Ç—ç–∫¬ª –û–ª—å–≥–∞ –î–∞–Ω—é—à–∫–∏–Ω–∞. –ö—É—Ä—Å –Ω–∞ —ç—Ç–æ—Ç —Å–µ–∫—Ç–æ—Ä ¬´–¥–æ—á–∫–∞¬ª ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑–∞¬ª –≤–∑—è–ª–∞ –Ω–µ —Å–ª—É—á–∞–π–Ω–æ ‚Äî –ø–æ—Å–ª–µ –ø–∞–Ω–¥–µ–º–∏–∏ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏ –æ—Ä–≥–∞–Ω–æ–≤ –¥—ã—Ö–∞–Ω–∏—è –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ –≤–æ–∑—Ä–æ—Å–ª–æ. –ù–∞ —Å–µ–≥–æ–¥–Ω—è—à–Ω–∏–π –¥–µ–Ω—å ¬´–î–∂–∏–Ω–∞—Ç—ç–∫¬ª ‚Äî –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω–æ–µ –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏–µ –≤ –°–∏–±–∏—Ä–∏, –≤—ã–ø—É—Å–∫–∞—é—â–µ–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –∞—Å—Ç–º—ã –∏ –•–û–ë–õ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""The subsidiary 'Pharmasynthese' can meet up to a quarter of Russia's need for Asthma and Chronic Obstructive Pulmonary Disease (COPD) treatments. Domestic pharmaceutical giant 'Jinatek' is launching a large-scale production project in Irkutsk region for bronchodilators. The first batch of medications, including Dimplyrin which has already been registered and produced, will be ready soon. The company aims to produce up to 30 products by 2030, aiming for a market share of over 25% in Russia's bronchodilator sector. The company is focusing on this area due to the increased number of patients with respiratory diseases following the pandemic.""
}"
2025-09-11T08:34:00+00:00,@bezrec,6529,https://t.me/bezrec/6529,"–§–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –ø–æ–ª—É—á–∞—Ç –ø–æ –±–∞–ª–ª—É. –° 1 —è–Ω–≤–∞—Ä—è 2026 –≥–æ–¥–∞ –≤ –†–æ—Å—Å–∏–∏ –Ω–∞—á–Ω—ë—Ç –¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å –±–∞–ª–ª—å–Ω–∞—è —Å–∏—Å—Ç–µ–º–∞ –æ—Ü–µ–Ω–∫–∏ —É—Ä–æ–≤–Ω—è –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –≤ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –æ—Ç—Ä–∞—Å–ª–∏. –°–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–µ–µ –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ –ø–æ–¥–ø–∏—Å–∞–ª –ú–∏—Ö–∞–∏–ª –ú–∏—à—É—Å—Ç–∏–Ω. –ü–æ –∑–∞–¥—É–º–∫–µ, –Ω–æ–≤–æ–≤–≤–µ–¥–µ–Ω–∏–µ –±—É–¥–µ—Ç —Å–ø–æ—Å–æ–±—Å—Ç–≤–æ–≤–∞—Ç—å —Ä–∞—Å—à–∏—Ä–µ–Ω–∏—é –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤, –≤—ã–ø—É—Å–∫–∞–µ–º—ã—Ö –≤ –†–æ—Å—Å–∏–∏, –∞ —Ç–∞–∫–∂–µ –ø—Ä–æ—Å—Ç–∏–º—É–ª–∏—Ä—É–µ—Ç —Ä–∞–∑–≤–∏—Ç–∏–µ –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–Ω—ã—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤. –° –Ω–æ–≤–æ–≥–æ –≥–æ–¥–∞ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –±—É–¥—É—Ç –ø–æ–ª—É—á–∞—Ç—å –±–∞–ª–ª—ã –∑–∞ –Ω–∞–ª–∞–∂–∏–≤–∞–Ω–∏–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏–π –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ —Å—Ç—Ä–∞–Ω—ã. –ß—Ç–æ–±—ã —Å—á–∏—Ç–∞—Ç—å—Å—è —Ä–æ—Å—Å–∏–π—Å–∫–æ–π, –ø—Ä–æ–¥—É–∫—Ü–∏—è –¥–æ–ª–∂–Ω–∞ –±—É–¥–µ—Ç –Ω–∞–±—Ä–∞—Ç—å –æ–ø—Ä–µ–¥–µ–ª—ë–Ω–Ω–æ–µ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –±–∞–ª–ª–æ–≤. –û–∫–æ–Ω—á–∞—Ç–µ–ª—å–Ω–æ–µ —Ä–µ—à–µ–Ω–∏–µ –æ—Å—Ç–∞—ë—Ç—Å—è –∑–∞ –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–æ–º. –ù–∞–±—Ä–∞–≤—à–∏–µ –≤–æ–∂–¥–µ–ª–µ–Ω–Ω—ã–µ –±–∞–ª–ª—ã –ø–æ–ª—É—á–∞—Ç –¥–æ—Å—Ç—É–ø –∫ –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç–∞–º –≥–æ—Å–ø–æ–¥–¥–µ—Ä–∂–∫–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration, reimbursement, pricing, import_export"",
  ""impact"": ""high"",
  ""english"": ""The Russian government has introduced a point system for evaluating the level of pharmaceutical production localization in the industry. Starting from January 1, 2026, according to Deputy Prime Minister Mikhail Mishustin's approval, the point system will be implemented. The goal is to expand the range of drugs produced in Russia and stimulate the development of promising production technologies. Pharmaceutical companies will earn points for establishing production facilities for drugs and raw materials within the country to be considered Russian. Companies that meet the required points will gain access to government support tools.""
}"
2025-09-11T05:45:01+00:00,@bezrec,6528,https://t.me/bezrec/6528,"–†–æ—Å—Å—Ç–∞—Ç –ø–æ–¥–µ–ª–∏–ª—Å—è —Å–≤–µ–∂–∏–º–∏ –¥–∞–Ω–Ω—ã–º–∏ –æ –¥–∏–Ω–∞–º–∏–∫–µ —Ü–µ–Ω –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –≤ –∞–≤–≥—É—Å—Ç–µ 2025 –≥–æ–¥–∞. –¶–µ–Ω—ã –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏–∑ –ø–µ—Ä–µ—á–Ω—è –ñ–ù–í–õ–ü –≤ —Å—Ä–µ–¥–Ω–µ–º –∏–∑–º–µ–Ω–∏–ª–∏—Å—å –Ω–∞ +0,4%: - —Ö–ª–æ—Ä–≥–µ–∫—Å–∏–¥–∏–Ω +1,8%; - –Ω–∞—Ç—Ä–∏—è —Ö–ª–æ—Ä–∏–¥ –∏ –ø–µ—Ä–µ–∫–∏—Å—å –≤–æ–¥–æ—Ä–æ–¥–∞ +1,2%; - –∞—Å–∫–æ—Ä–±–∏–Ω–æ–≤–∞—è –∫–∏—Å–ª–æ—Ç–∞ +1,1%; - –∞—Ü–µ—Ç–∏–ª—Å–∞–ª–∏—Ü–∏–ª–æ–≤–∞—è –∫–∏—Å–ª–æ—Ç–∞ (–∞—Å–ø–∏—Ä–∏–Ω –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π) –∏ –æ–º–µ–ø—Ä–∞–∑–æ–ª +0,9%; - —Å–∞–ª–∏—Ü–∏–ª–æ–≤–∞—è –∫–∏—Å–ª–æ—Ç–∞ +0,8%; - –ª–æ–ø–µ—Ä–∞–º–∏–¥ +0,7%; - –±–µ—Ç–∞–ª–æ–∫ –ó–û–ö; - –≤–µ—Ä–æ—à–ø–∏—Ä–æ–Ω –∏ –ø–∞–Ω–∫—Ä–µ–∞—Ç–∏–Ω +0,5%. –ù–µ–º–Ω–æ–≥–æ –ø–æ–¥–µ—à–µ–≤–µ–ª–∏ –∞–º–æ–∫—Å–∏—Ü–∏–ª–ª–∏–Ω —Å –∫–ª–∞–≤—É–ª–∞–Ω–æ–≤–æ–π –∫–∏—Å–ª–æ—Ç–æ–π (-0,5%), —Ü–µ—Ç—Ä–∏–Ω (-0,3%), –±–∏—Å–æ–ø—Ä–æ–ª–æ–ª –∏ –∏–Ω–≥–∞–≤–∏—Ä–∏–Ω (-0,2%). –õ–µ–∫–∞—Ä—Å—Ç–≤–∞ –Ω–µ –∏–∑ –ø–µ—Ä–µ—á–Ω—è –ñ–ù–í–õ–ü –≤ —Å—Ä–µ–¥–Ω–µ–º –∏–∑–º–µ–Ω–∏–ª–∏—Å—å –Ω–∞ +0,2%: - –ª–∏–∑–æ–±–∞–∫—Ç +1,4%; - –≤–∞–ª–æ—Å–µ—Ä–¥–∏–Ω, –≥–µ–ø–∞—Ä–∏–Ω–æ–≤–∞—è –º–∞–∑—å, –≥—Ä–∞–º–º–∏–¥–∏–Ω, –∫–µ—Ç–æ—Ä–æ–ª —ç–∫—Å–ø—Ä–µ—Å—Å –∏ —Ç—Ä–æ–∫—Å–µ—Ä—É—Ç–∏–Ω +0,9%; - –º–µ—Ç–∏–ª—É—Ä–∞—Ü–∏–ª +0,8% ; - –∞–∫—Ç–∏–≤–∏—Ä–æ–≤–∞–Ω–Ω—ã–π —É–≥–æ–ª—å, –∞—Å–∫–æ—Ñ–µ–Ω-–ü –∏ –Ω–∞—Ñ–∞–∑–æ–ª–∏–Ω +0,7%; - –Ω–∏–º–µ—Å—É–ª–∏–¥ +0,6%; - —Ç–∞—É—Ä–∏–Ω +0,5%; - –º–µ—Ç–∞–º–∏–∑–æ–ª –Ω–∞—Ç—Ä–∏—è (–∞–Ω–∞–ª—å–≥–∏–Ω –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π) +0,4%; - –≤–∞–ª–∏–¥–æ–ª –∏ –ø–µ–Ω—Ç–∞–ª–≥–∏–Ω +0,3%. –°–Ω–∏–∑–∏–ª–∏—Å—å —Ü–µ–Ω—ã –Ω–∞ —Ç—Ä–µ–∫—Ä–µ–∑–∞–Ω (-1,5%), –∫–æ—Ä–≤–∞–ª–æ–ª –∏ —Ä–µ–Ω–≥–∞–ª–∏–Ω (-0,9%), –º—É–∫–∞–ª—Ç–∏–Ω (-0,6%), –≤–∞–ª–µ—Ä–∏–∞–Ω—ã —ç–∫—Å—Ç—Ä–∞–∫—Ç, –∫–∞–Ω–µ—Ñ—Ä–æ–Ω –ù –∏ —Å–ø–∞–∑–º–∞–ª–≥–æ–Ω (-0,3%). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement, pricing"",
  ""impact"": ""medium"",
  ""english"": ""Russia's Rosstat released data on drug price changes in August 2025. Prices for drugs listed under the Essential Medicines and Health Products Index (–ñ–ù–í–õ–ü) rose on average by 0.4%, with increases of +1.8% for chlorhexidine, +1.2% for sodium chloride and hydrogen peroxide, +1.1% for ascorbic acid, +0.9% for aspirin and omeprazole, +0.8% for salicylic acid, +0.7% for lopermidic acid, and +0.5% for betaloc ZO. Prices of non-listed drugs rose on average by 0.2%, with increases of +1.4% for lysozyme, +0.9% for valoserdin, heparin ointment, gramidine, ketorol express and troxerutin, +0.8% for methyluracil, +0.7% for activated charcoal, as"
2025-09-10T16:32:04+00:00,@bezrec,6527,https://t.me/bezrec/6527,"–í –ò–Ω–¥–∏–∏ –≤–º–µ—Å—Ç–æ –ª–æ—Ç–µ—Ä–µ–π–Ω—ã—Ö –±–∏–ª–µ—Ç–æ–≤ ‚Äî —Ä—ã–±–∞. –ò —Ñ–∞—Ä–º–∞. –§–∞—Ä—Ç–æ–≤—ã–µ –∏–Ω–¥–∏–π—Å–∫–∏–µ —Ä—ã–±–∞–∫–∏ —Å–Ω–æ–≤–∞ –æ—Ç–ª–∏—á–∏–ª–∏—Å—å. –ù–∞ —Å–µ–π —Ä–∞–∑ –Ω–∞ –ø–æ–±–µ—Ä–µ–∂—å–µ –∫—É—Ä–æ—Ä—Ç–Ω–æ–≥–æ –≥–æ—Ä–æ–¥–∞ –î–∏–≥—Ö–∞ –≤ –∏—Ö —Å–µ—Ç–∏ –ø–æ–ø–∞–ª–∞—Å—å –∞–∫—É–ª–∞ –≤–µ—Å–æ–º –ø–æ—á—Ç–∏ –≤ –¥–≤–∞ —Ü–µ–Ω—Ç–Ω–µ—Ä–∞. –°–æ–ª–∏–¥–Ω—ã–π —É–ª–æ–≤ –æ—Ç–ø—Ä–∞–≤–∏–ª–∏ –≤ –ú–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã–π —Ä—ã–±–æ–ø—Ä–æ–º—ã—Å–ª–æ–≤—ã–π —Ü–µ–Ω—Ç—Ä –ú–æ—Ö–∞–Ω–∞. –ß—Ç–æ–±—ã –∑–∞–ø–æ–ª—É—á–∏—Ç—å —Ä–µ–¥–∫—É—é –¥–æ–±—ã—á—É –ø—è—Ç—å –∏–ª–∏ —à–µ—Å—Ç—å –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ª–µ–∫–∞—Ä—Å—Ç–≤ —É—Å—Ç—Ä–æ–∏–ª–∏ —Ü–µ–ª—ã–π –∞—É–∫—Ü–∏–æ–Ω. –î–µ–ª–æ –≤ —Ç–æ–º, —á—Ç–æ —á–∞—Å—Ç–∏ —Ç–µ–ª–∞ —Ç–∞–∫–∏—Ö –∞–∫—É–ª –∏—Å–ø–æ–ª—å–∑—É—é—Ç—Å—è –ø—Ä–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –æ—Ç —Å–µ—Ä—å–µ–∑–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –ü–æ–±–µ–¥–∏—Ç–µ–ª–µ–º —Å—Ç–∞–ª–∞ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—è –∏–∑ –ó–∞–ø–∞–¥–Ω–æ–π –ë–µ–Ω–≥–∞–ª–∏–∏. –¢–æ—á–Ω–∞—è —Å—É–º–º–∞, –∫–æ—Ç–æ—Ä—É—é —Å—á–∞—Å—Ç–ª–∏–≤—á–∏–∫–∞–º —É–¥–∞–ª–æ—Å—å –≤—ã—Ä—É—á–∏—Ç—å –∑–∞ —É–ª–æ–≤, –Ω–µ –Ω–∞–∑—ã–≤–∞–µ—Ç—Å—è, –Ω–æ –≥–æ–≤–æ—Ä—è—Ç, —á—Ç–æ —Ä—ã–±–∞–∫–∏ –æ—Å—Ç–∞–ª–∏—Å—å –¥–æ–≤–æ–ª—å–Ω—ã. –í –∏—é–ª–µ –∏—Ö ¬´–∫–æ–ª–ª–µ–≥–∏¬ª –∏–∑ –¥–µ—Ä–µ–≤–Ω–∏ –ë–∏–Ω–∏–∫–∞ —à—Ç–∞—Ç–∞ –û–¥–∏—à–∞ –ø—Ä–æ–¥–∞–ª–∏ –≥–∏–≥–∞–Ω—Ç—Å–∫–æ–≥–æ —Å–æ–º–∞ –∑–∞ 300 —Ç—ã—Å. —Ä—É–ø–∏–π (272 —Ç—ã—Å. —Ä—É–±–ª–µ–π). –ê –ø–æ—á—Ç–∏ –≥–æ–¥ –Ω–∞–∑–∞–¥ –¥–≤–æ–µ –º—É–∂—á–∏–Ω –ø–æ–π–º–∞–ª–∏ –≤ –ë–µ–Ω–≥–∞–ª—å—Å–∫–æ–º –∑–∞–ª–∏–≤–µ –¥–µ–≤—è—Ç—å —Ä—ã–±, –∫–æ—Ç–æ—Ä—ã–µ –æ–∫–∞–∑–∞–ª–∏—Å—å —Ä–µ–¥—á–∞–π—à–∏–º–∏ –æ—Å–æ–±—è–º–∏ –ø–æ–¥ –Ω–∞–∑–≤–∞–Ω–∏–µ–º ¬´—Ç–µ–ª–∏—è —Å–∏–ª–∞¬ª. –û–¥–∏–Ω —É–¥–∞—á–Ω—ã–π –≤—ã—Ö–æ–¥ –≤ –º–æ—Ä–µ –ø—Ä–∏–Ω—ë—Å —Ä—ã–±–∞–∫–∞–º 15 –ª–∞–∫—Ö–æ–≤ —Ä—É–ø–∏–π (–ø—Ä–∏–º–µ—Ä–Ω–æ 1,5 –º–ª–Ω —Ä—É–±–ª–µ–π). –ë–æ–ª—å—à–µ –º—É–∂–µ–π –∑–∞ –ø—Ä–∏—Å—Ç—Ä–∞—Å—Ç–∏–µ –∫ —Ä—ã–±–∞–ª–∫–µ –Ω–µ –ø–∏–ª–∏–º. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-09-10T14:03:40+00:00,@bezrec,6526,https://t.me/bezrec/6526,"–í —Å–µ–≥–æ–¥–Ω—è—à–Ω–µ–º –≤—ã–ø—É—Å–∫–µ —Ä—É–±—Ä–∏–∫–∏ #–∑–∞—Ü–µ–Ω–∏–ª–∏ ‚Äî —Å—É–ø–ø–æ–∑–∏—Ç–æ—Ä–∏–∏ –≤–∞–≥–∏–Ω–∞–ª—å–Ω—ã–µ –Ω–∞ –æ—Å–Ω–æ–≤–µ –Ω–∞—Ç–∞–º–∏—Ü–∏–Ω–∞. –¢–∞–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –∏—Å–ø–æ–ª—å–∑—É—é—Ç—Å—è –¥–ª—è –ª–µ—á–µ–Ω–∏—è –∏–Ω—Ñ–µ–∫—Ü–∏–π, –≤—ã–∑–≤–∞–Ω–Ω—ã—Ö –≥—Ä–∏–±–∞–º–∏ —Ä–æ–¥–∞ Candid–∞. –ú—ã —Å—Ä–∞–≤–Ω–∏–ª–∏ —Ü–µ–Ω—ã –≤ –æ–Ω–ª–∞–π–Ω-–∞–ø—Ç–µ–∫–∞—Ö –Ω–∞ —Ç–æ—Ä–≥–æ–≤—ã–µ –º–∞—Ä–∫–∏ –ù–∞—Ç–∞–º–∏—Ü–∏–Ω, –≠–∫–æ—Ñ—É—Ü–∏–Ω (–æ–±–∞ –æ—Ç ¬´–ê–í–í–ê –†–£–°¬ª), –ù–∞—Ç–∞–º–∏—Ü–∏–Ω –æ—Ç ¬´–ì—Ä–æ—Ç–µ–∫—Å¬ª, –ü–∏–º–∞—Ñ—É—Ü–∏–Ω (¬´–¢–µ–º–º–ª–µ—Ä –ò—Ç–∞–ª–∏—è¬ª) –∏ –ü—Ä–∏–º–∞—Ñ—É–Ω–≥–∏–Ω (¬´–§–∞—Ä–º–∞–ø—Ä–∏–º¬ª/ ¬´–ê–≤–µ–∫—Å–∏–º–∞ –°–∏–±–∏—Ä—å¬ª). –ó–∞–≥—Ä–∞–Ω–∏—á–Ω–æ–≥–æ –ü–∏–º–∞—Ñ—É—Ü–∏–Ω–∞ –Ω–∏ –≤ –æ–¥–Ω–æ–π –∞–ø—Ç–µ–∫–µ –Ω–µ –æ–∫–∞–∑–∞–ª–æ—Å—å. –° –æ—Å—Ç–∞–ª—å–Ω—ã–º–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º–∏ –ø—Ä–æ–±–ª–µ–º –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏ –Ω–µ—Ç. –¢–æ–ª—å–∫–æ –≤ ¬´–ï–∞–ø—Ç–µ–∫–µ¬ª –æ—Ç—Å—É—Ç—Å—Ç–≤—É—é—Ç —Ç—Ä–∏ –Ω–∞–∏–º–µ–Ω–æ–≤–∞–Ω–∏—è –∏–∑ –ø—è—Ç–∏ ‚Äî –ø–æ–º–∏–º–æ –ü–∏–º–∞—Ñ—É—Ü–∏–Ω–∞, –≤ —Å–µ—Ç–∏ –Ω–µ—Ç –æ–±–æ–∏—Ö –ù–∞—Ç–∞–º–∏—Ü–∏–Ω–æ–≤. –°–∞–º—ã–µ –¥–æ—Ä–æ–≥–∏–µ —Å—É–ø–ø–æ–∑–∏—Ç–æ—Ä–∏–∏ —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω–æ –≤ ¬´36,6¬ª. –¢–∞–∫, –ù–∞—Ç–∞–º–∏—Ü–∏–Ω –æ—Ç ¬´–ì—Ä–æ—Ç–µ–∫—Å–∞¬ª —Ç–∞–º —Å—Ç–æ–∏—Ç 579 —Ä—É–±–ª–µ–π, —Ç.–µ. –¥–æ—Ä–æ–∂–µ –≤—Å–µ—Ö –æ—Å—Ç–∞–ª—å–Ω—ã—Ö —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤. –ü—Ä–∏ —ç—Ç–æ–º, –µ—Å–ª–∏ –ø–æ–∫—É–ø–∞—Ç—å –µ–≥–æ –∂–µ –≤ ¬´–†–∏–≥–ª–µ¬ª –∏–ª–∏ ¬´–ó–¥—Ä–∞–≤—Å–∏—Ç–∏¬ª, –æ–Ω –≤—ã–π–¥–µ—Ç —ç–∫–æ–Ω–æ–º–∏—á–Ω–µ–µ –¥—Ä—É–≥–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ù–∞–ø–æ–º–∏–Ω–∞–µ–º, —á—Ç–æ –ª—é–±—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏–º–µ—é—Ç –ø—Ä–æ—Ç–∏–≤–æ–ø–æ–∫–∞–∑–∞–Ω–∏—è. –ü–µ—Ä–µ–¥ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º –ø—Ä–æ–∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä—É–π—Ç–µ—Å—å —Å –ª–µ—á–∞—â–∏–º –≤—Ä–∞—á–æ–º. *–∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –ø—Ä–æ–≤–æ–¥–∏–ª–æ—Å—å –æ–Ω–ª–∞–π–Ω 10 —Å–µ–Ω—Ç—è–±—Ä—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-09-10T11:00:01+00:00,@bezrec,6525,https://t.me/bezrec/6525,"–¢—Ä–∞–º–ø ¬´–≤–∑—è–ª –∑–∞ –≥–æ—Ä–ª–æ¬ª —Ä–µ–∫–ª–∞–º—É –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ –°–®–ê. –ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–π –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç –ø–æ–¥–ø–∏—Å–∞–ª –º–µ–º–æ—Ä–∞–Ω–¥—É–º, —É–∂–µ—Å—Ç–æ—á–∞—é—â–∏–π —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ —Ä–µ–∫–ª–∞–º–µ –ª–µ–∫–∞—Ä—Å—Ç–≤, —á—Ç–æ–±—ã –∏–∑–±–µ–∂–∞—Ç—å –∑–ª–æ—É–ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–π —Å–æ —Å—Ç–æ—Ä–æ–Ω—ã —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –∏ –Ω–µ –≤–≤–æ–¥–∏—Ç—å –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –≤ –∑–∞–±–ª—É–∂–¥–µ–Ω–∏–µ –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ —Ä–∏—Å–∫–æ–≤ –¥–ª—è –∑–¥–æ—Ä–æ–≤—å—è. –ú–æ—è –∞–¥–º–∏–Ω–∏—Å—Ç—Ä–∞—Ü–∏—è –≥–∞—Ä–∞–Ω—Ç–∏—Ä—É–µ—Ç, —á—Ç–æ –¥–µ–π—Å—Ç–≤—É—é—â–µ–µ –ø—Ä–∞–≤–æ–≤–æ–µ —Ä–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω–∏–µ —Ä–µ–∫–ª–∞–º—ã –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –æ–±–µ—Å–ø–µ—á–∏—Ç –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–º –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª—è–º –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª–µ–Ω–∏–µ —á–µ—Å—Ç–Ω–æ–π, —Å–±–∞–ª–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–Ω–æ–π –∏ –ø–æ–ª–Ω–æ–π –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏, ‚Äî –æ–±–µ—â–∞–µ—Ç –¢—Ä–∞–º–ø. –í–æ–ø—Ä–æ—Å–∞–º–∏ —Ä–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω–∏—è —Ä–µ–∫–ª–∞–º—ã —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –≤ –°–®–ê —Å 1962 –≥–æ–¥–∞ –∑–∞–Ω–∏–º–∞–µ—Ç—Å—è FDA. –ü–æ —Å–ª–æ–≤–∞–º –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–≥–æ –ª–∏–¥–µ—Ä–∞, —Ä–∞–Ω—å—à–µ —Ä–µ–≥—É–ª—è—Ç–æ—Ä ¬´–æ–±–µ—Å–ø–µ—á–∏–≤–∞–ª –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª–µ–Ω–∏–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º–∏ –∏ –¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–∞–º–∏ –º–∞–∫—Å–∏–º–∞–ª—å–Ω–æ –ø–æ–ª–Ω–æ–π –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏¬ª, –Ω–æ —Å–æ –≤—Ä–µ–º–µ–Ω–µ–º —Ä–∞—Å—Å–ª–∞–±–∏–ª—Å—è, –∏ –ø–æ –º–µ—Ä–µ –ø–æ—è–≤–ª–µ–Ω–∏—è –Ω–æ–≤—ã—Ö –∫–∞–Ω–∞–ª–æ–≤ —Ä–µ–∫–ª–∞–º—ã –∏ –ø—Ä–æ–¥–∞–∂, –≤ —ç—Ç–æ–π —Å—Ñ–µ—Ä–µ –≤—ã—Ä–æ—Å–ª–æ —á–∏—Å–ª–æ –∑–ª–æ—É–ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–π. –ó–∞–Ω—è—Ç—å—Å—è –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω—ã–º–∏ –∞–∫—Ç–∞–º–∏, –∫–æ—Ç–æ—Ä—ã–µ –≥–∞—Ä–∞–Ω—Ç–∏—Ä–æ–≤–∞–ª–∏ –ø—Ä–æ–∑—Ä–∞—á–Ω–æ—Å—Ç—å –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –æ –ø–æ–±–æ—á–∫–∞—Ö –∏ —Ä–∏—Å–∫–∞—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤, –ø—Ä–µ–¥—Å—Ç–æ–∏—Ç –ú–∏–Ω–∏—Å—Ç–µ—Ä—Å—Ç–≤—É –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∏ —Å–æ—Ü–∏–∞–ª—å–Ω—ã—Ö —Å–ª—É–∂–± –°–®–ê. –û—Å–æ–±–µ–Ω–Ω–æ –º–µ–º–æ—Ä–∞–Ω–¥—É–º—É –æ–±—Ä–∞–¥–æ–≤–∞–ª—Å—è –†–æ–±–µ—Ä—Ç –ö–µ–Ω–Ω–µ–¥–∏ - –º–ª–∞–¥—à–∏–π, –Ω–µ–∫–æ–≥–¥–∞ —Ä–∞—Ç–æ–≤–∞–≤—à–∏–π –∑–∞ –ø–æ–ª–Ω—ã–π –∑–∞–ø—Ä–µ—Ç —Ä–µ–∫–ª–∞–º—ã —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –ø—Ä–æ–¥—É–∫—Ç–æ–≤, –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–Ω–æ–π –Ω–µ–ø–æ—Å—Ä–µ–¥—Å—Ç–≤–µ–Ω–Ω–æ –Ω–∞ –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª—è. –ú–∏–Ω–∏—Å—Ç—Ä –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∏ —Å–æ—Ü–∏–∞–ª—å–Ω—ã—Ö —Å–ª—É–∂–± –æ—Ö–∞—Ä–∞–∫—Ç–µ—Ä–∏–∑–æ–≤–∞–ª –ø–æ–¥–ø–∏—Å–∞–Ω–Ω—ã–π –¢—Ä–∞–º–ø–æ–º –¥–æ–∫—É–º–µ–Ω—Ç –∫–∞–∫ ¬´–∏—Å—Ç–æ—Ä–∏—á–µ—Å–∫–∏–π¬ª. –†—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å FDA –ú–∞—Ä—Ç–∏ –ú–∞–∫–∞—Ä–∏ –∑–∞—è–≤–∏–ª, —á—Ç–æ ¬´–º–µ—Ä—ã –±—É–¥—É—Ç –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω—ã –ø—Ä–æ—Ç–∏–≤ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç-–∞–ø—Ç–µ–∫, –ø—Ä–æ–¥–≤–∏–≥–∞—é—â–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –±–µ–∑ —É–ø–æ–º–∏–Ω–∞–Ω–∏—è –ø–æ–±–æ—á–Ω—ã—Ö —ç—Ñ—Ñ–µ–∫—Ç–æ–≤, –∞ —Ç–∞–∫–∂–µ –ø—Ä–æ—Ç–∏–≤ –∏–Ω—Ñ–ª—é–µ–Ω—Å–µ—Ä–æ–≤, –ø—Ä–æ–¥–≤–∏–≥–∞—é—â–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∑–∞ –¥–µ–Ω—å–≥–∏¬ª. –•–æ—Ä–æ—à–æ, —á—Ç–æ ¬´–õ–µ–Ω–∏–Ω–≥—Ä–∞–¥¬ª –∏—Å–ø–æ–ª–Ω—è–µ—Ç —Å–≤–æ–∏ –ø–µ—Å–Ω–∏ –≤ –†–æ—Å—Å–∏–∏. –ê —Ç–æ –≤ –°–®–ê –∫–ª–∏–ø ¬´–¢–∏—Ä–∑–µ—Ç—Ç–∞¬ª –º–æ–≥–ª–∏ –±—ã –∏ –Ω–µ –ø–æ—Å—á–∏—Ç–∞—Ç—å —Ç–≤–æ—Ä—á–µ—Å–∫–∏–º –ø—Ä–æ–∏–∑–≤–µ–¥–µ–Ω–∏–µ–º, –Ω–∞ –∫–æ—Ç–æ—Ä–æ–µ –Ω–µ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω—è—é—Ç—Å—è –ø–æ–ª–æ–∂–µ–Ω–∏—è –§–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –∑–∞–∫–æ–Ω–∞ ¬´–û —Ä–µ–∫–ª–∞–º–µ¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-09-10T05:32:37+00:00,@bezrec,6523,https://t.me/bezrec/6523,"–í –æ—Ç—á—ë—Ç–Ω–æ—Å—Ç–∏ –∞–ø—Ç–µ—á–Ω–æ–π —Å–µ—Ç–∏, —Ä–∞–±–æ—Ç–∞—é—â–µ–π –ø–æ–¥ –±—Ä–µ–Ω–¥–∞–º–∏ ¬´–ê–ø—Ç–µ–∫–∞ 36,6¬ª –∏ ¬´–ì–æ—Ä–∑–¥—Ä–∞–≤¬ª, –≥–æ–≤–æ—Ä–∏—Ç—Å—è, —á—Ç–æ –ø–æ –∏—Ç–æ–≥–∞–º –ø–µ—Ä–≤—ã—Ö —à–µ—Å—Ç–∏ –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ –µ—ë –≤—ã—Ä—É—á–∫–∞ –ø–æ –ú–°–§–û –≤—ã—Ä–æ—Å–ª–∞ –Ω–∞ 23,1%. –ï—â—ë –¥–∞–Ω–Ω—ã–µ –∏–∑ –æ—Ç—á—ë—Ç–∞: üîò–¥–æ–ª—è –æ–Ω–ª–∞–π–Ω-–≤—ã—Ä—É—á–∫–∏ –ø—Ä–µ–≤—ã—Å–∏–ª–∞ 25%; üîò–ø—Ä–æ–¥–∞–∂–∏ —á–µ—Ä–µ–∑ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç —É–≤–µ–ª–∏—á–∏–ª–∏—Å—å –Ω–∞ 36,8%, –¥–æ 12,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π; üîò–ø–æ–∫–∞–∑–∞—Ç–µ–ª—å EBITDA —Å–æ—Å—Ç–∞–≤–∏–ª 3,9 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –ø—Ä–∏ —É—Ä–æ–≤–Ω–µ —Ä–µ–Ω—Ç–∞–±–µ–ª—å–Ω–æ—Å—Ç–∏ 7,6%; üîò—Å—Ä–µ–¥–Ω–∏–π —á–µ–∫ –≤—ã—Ä–æ—Å –Ω–∞ 10,9%, –¥–æ 1,01 —Ç—ã—Å. —Ä—É–±–ª–µ–π; üîò–≤ –æ—Ç—á—ë—Ç–Ω–æ–º –ø–µ—Ä–∏–æ–¥–µ —Å–µ—Ç—å –æ—Ç–∫—Ä—ã–ª–∞ 81 –∞–ø—Ç–µ–∫—É, 22 –∞–ø—Ç–µ–∫–∏ –±—ã–ª–∏ –ø—Ä–∏–æ–±—Ä–µ—Ç–µ–Ω—ã –≤ —Ä–∞–º–∫–∞—Ö —Å–¥–µ–ª–æ–∫ M&A, –∑–∞–∫—Ä—ã–ª–æ—Å—å 11 –∞–ø—Ç–µ–∫; üîò–∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –∞–ø—Ç–µ–∫ –≤ —Å–µ—Ç–∏ –≤—ã—Ä–æ—Å–ª–æ –Ω–∞ 20%, –¥–æ 2,6 —Ç—ã—Å. —Ç–æ—á–µ–∫; üîò–≤ —è–Ω–≤–∞—Ä–µ‚Äî–∏—é–Ω–µ 2025 –≥–æ–¥–∞ ¬´36,6¬ª –∑–∞–≤–µ—Ä—à–∏–ª–∞ –∏–Ω—Ç–µ–≥—Ä–∞—Ü–∏—é –ø—Ä–∏–æ–±—Ä–µ—Ç–µ–Ω–Ω—ã—Ö –≤ 2024 –≥–æ–¥—É —Å–µ—Ç–µ–π ¬´–ê–ø—Ç–µ–∫–∞ –¥–ª—è –±–µ—Ä–µ–∂–ª–∏–≤—ã—Ö¬ª –∏–∑ 158 —Ç–æ—á–µ–∫ –∏ ¬´–ú–∏—Ü–∞—Ä¬ª –∏–∑ 60 —Ç–æ—á–µ–∫. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The report from pharmacy network '36,6' and 'Gorzdrav' shows that the company's MSFO revenue grew by 23.1% in the first half of 2025. Key figures include: online revenue accounted for over 25% of total sales; e-commerce revenues increased by 36.8%, reaching RUB127 billion; EBITDA was RUB39 billion with a profitability rate of 7.6%; average ticket price increased by 10.9%, to RUB1,010; the network opened 81 pharmacies in Q1-Q6 2025, acquired 22 pharmacies through M&A deals, and closed down 11 pharmacies; the network's pharmacy count grew by 20%, to over 2,600 points; in Q1-Q6 2025, '36,6' completed the integration of acquired networks 'Apteka for Lavish' with 158 points and 'Mitar"
2025-09-09T16:21:24+00:00,@bezrec,6522,https://t.me/bezrec/6522,"–í–ª–∞–¥–∏–º–∏—Ä –ü—É—Ç–∏–Ω —Å —Ä–∞–±–æ—á–∏–º –≤–∏–∑–∏—Ç–æ–º –ø–æ—Å–µ—Ç–∏–ª –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–Ω—ã–π –∫–æ–º–ø–ª–µ–∫—Å –Ω–∞—É—á–Ω–æ-—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ ¬´–°–∏—Ä–∏—É—Å¬ª, –æ—Ç–∫—Ä—ã—Ç—ã–π –≤ 2022 –≥–æ–¥—É. –û —Ä–∞–±–æ—Ç–µ –ø—Ä–æ–µ–∫—Ç–Ω–æ–π, –∞–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–æ–π –∏ —Ö–∏–º–∏—á–µ—Å–∫–æ–π –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–∏–π –≥–ª–∞–≤–µ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–∞ —Ä–∞—Å—Å–∫–∞–∑–∞–ª –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—å —É—á—ë–Ω–æ–≥–æ —Å–æ–≤–µ—Ç–∞ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ –†–æ–º–∞–Ω –ò–≤–∞–Ω–æ–≤. –í —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç—É –ø–æ–∫–∞–∑–∞–ª–∏, –≥–¥–µ –ø—Ä–æ–∏–∑–≤–æ–¥—è—Ç—Å—è —Å—É–±—Å—Ç–∞–Ω—Ü–∏–∏ –¥–ª—è –¥–æ—Ä–æ–≥–æ—Å—Ç–æ—è—â–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –æ—Ç –°–ú–ê –∏ –º–∏–æ–¥–∏—Å—Ç—Ä–æ—Ñ–∏–∏ –î—é—à–µ–Ω–Ω–∞. –®–≤–µ–π—Ü–∞—Ä—Ü—ã —Ä–∞–∑—Ä–∞–±–∞—Ç—ã–≤–∞–ª–∏ —ç—Ç—É –æ—á–µ–Ω—å —Å–ª–æ–∂–Ω—É—é —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—é –ø—è—Ç—å –ª–µ—Ç. –£ –Ω–∞—Å –º–æ–ª–æ–¥–æ–π –ø–∞—Ä–µ–Ω—å-–∞—Å–ø–∏—Ä–∞–Ω—Ç —Å–ø—Ä–∞–≤–∏–ª—Å—è –∑–∞ 1,5 –≥–æ–¥–∞. –ü—Ä–∏—á—ë–º —Å–¥–µ–ª–∞–ª —Ç–∞–∫ –∫–ª–∞—Å—Å–Ω–æ, —á—Ç–æ —Å–µ–π—á–∞—Å –º—ã –ø–æ–¥–∞–ª–∏ –∑–∞—è–≤–∫—É –Ω–∞ –ø–∞—Ç–µ–Ω—Ç, –æ–ø—É–±–ª–∏–∫–æ–≤–∞–ª–∏ —Å—Ç–∞—Ç—å–∏, –∏ –∫–æ –º–Ω–µ –∏–∑-–∑–∞ —Ä—É–±–µ–∂–∞ –Ω–∞—á–∞–ª–∏ —Å—ã–ø–∞—Ç—å—Å—è –ø—Ä–æ—Å—å–±—ã —Å–¥–µ–ª–∞—Ç—å —Ç—Ä–∞–Ω—Å—Ñ–µ—Ä —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π, ‚Äî –ø–æ—Ö–≤–∞–ª–∏–ª—Å—è –ò–≤–∞–Ω–æ–≤ –¥–æ—Å—Ç–∏–∂–µ–Ω–∏—è–º–∏ –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–∏–∏. –£—á—ë–Ω—ã–π —Ç–∞–∫–∂–µ —Ä–∞—Å—Å–∫–∞–∑–∞–ª –æ –∑–∞–≤–µ—Ä—à–µ–Ω–∏–∏ —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –æ–ø—ã—Ç–Ω–æ-–ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ —É—á–∞—Å—Ç–∫–∞. –ü—Ä–æ–µ–∫—Ç –±—ã–ª –≤—ã–ø–æ–ª–Ω–µ–Ω –≤ —Ä–∞–º–∫–∞—Ö –ø–∏–ª–æ—Ç–Ω–æ–π –ø—Ä–æ–≥—Ä–∞–º–º—ã –†–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –Ω–∞—É—á–Ω–æ–≥–æ —Ñ–æ–Ω–¥–∞. –í –Ω–µ–≥–æ —Ç–∞–∫–∂–µ –≤–ª–æ–∂–∏–ª–∞—Å—å ¬´–¥–æ—á–∫–∞¬ª ¬´–†-–§–∞—Ä–º¬ª ‚Äî —Ä–µ–∑–∏–¥–µ–Ω—Ç –ò–ù–¢–¶ ¬´–°–∏—Ä–∏—É—Å¬ª. –û–±—ä—ë–º –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–π –≤ ¬´–º–∞–ª–µ–Ω—å–∫–∏–π —Ö–∏–º–∏—á–µ—Å–∫–∏–π –∑–∞–≤–æ–¥¬ª —Å–æ—Å—Ç–∞–≤–∏–ª 1,5 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –û–Ω –±—É–¥–µ—Ç –≤—ã–ø—É—Å–∫–∞—Ç—å —Å—É–±—Å—Ç–∞–Ω—Ü–∏–∏ –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –º–∏–∫—Ä–æ–∫–æ–ª–∏—á–µ—Å—Ç–≤–∞—Ö –∏ –≥–æ—Ç–æ–≤–∏—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –∏–Ω–¥–∏–≤–∏–¥—É–∞–ª—å–Ω–æ –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-09-09T14:32:22+00:00,@bezrec,6518,https://t.me/bezrec/6518,"–•–∞–Ω–Ω–µ, —Ü–∏—Ñ—Ä–æ–≤–æ–π –º–æ–¥–µ–ª–∏, —Å–æ–∑–¥–∞–Ω–Ω–æ–π —ç–∫—Å–ø–µ—Ä—Ç–∞–º–∏ –º–µ–±–µ–ª—å–Ω–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ Bensons for Beds –∏ –¥–æ–∫—Ç–æ—Ä–æ–º –°–æ—Ñ–∏ –ë–æ—Å—Ç–æ–∫, –Ω–µ –±—É–¥–µ—Ç –æ–¥–∏–Ω–æ–∫–æ –≤ 2050 –≥–æ–¥—É. –ü–æ–º–∏–º–æ –ø—Ä–∏—è—Ç–µ–ª—è –ú–∞–π–∫–ª–∞, —Å–≥–µ–Ω–µ—Ä–∏—Ä–æ–≤–∞–Ω–Ω–æ–≥–æ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞–º–∏ –∫–æ–º–ø–∞–Ω–∏–∏ Gousto, —É –Ω–µ—ë –ø–æ—è–≤–∏—Ç—Å—è ¬´—Å—Ç—Ä–∞—à–Ω–µ–Ω—å–∫–∞—è¬ª –ø–æ–¥—Ä—É–∂–∫–∞, –∫–æ—Ç–æ—Ä–∞—è, –∫–∞–∫ –∏–∑–≤–µ—Å—Ç–Ω–æ, –ª—É—á—à–µ–µ —É–∫—Ä–∞—à–µ–Ω–∏–µ –ª—é–±–æ–π –¥–µ–≤—É—à–∫–∏. –ó–Ω–∞–∫–æ–º—å—Ç–µ—Å—å, —ç—Ç–æ –≠–π–≤–∞ ‚Äî –∑–≤–µ–∑–¥–∞ —Å–æ—Ü—Å–µ—Ç–µ–π, –Ω–æ –Ω–µ —Å–µ–≥–æ–¥–Ω—è, –∞ —á–µ—Ä–µ–∑ 25 –ª–µ—Ç. –ü–æ –º–Ω–µ–Ω–∏—é —ç–∫—Å–ø–µ—Ä—Ç–æ–≤ –ø–æ—Ä—Ç–∞–ª–∞ Casino, —Ç–æ–º—É, –∫—Ç–æ —Ü–µ–ª—ã–π –¥–µ–Ω—å –ø—Ä–æ–≤–æ–¥–∏—Ç –≤ —Å–º–∞—Ä—Ç—Ñ–æ–Ω–µ, —Å–≤–µ—Ç—è—Ç –ø—Ä–æ–±–ª–µ–º—ã —Å –∫–æ–∂–µ–π –∏ –æ—Å–∞–Ω–∫–æ–π, –≤—ã–ø–∞–¥–∞—é—â–∏–µ –≤–æ–ª–æ—Å—ã, –±–æ–ª–∏ –≤ —Å–ø–∏–Ω–µ –∏ —à–µ–µ, —Å–µ–≤—à–µ–µ –∑—Ä–µ–Ω–∏–µ. –ë—å—é—Ç–∏-–±–ª–æ–≥–µ—Ä–∞–º –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–µ –ø—Ä–æ–±–ª–µ–º—ã –¥–æ—Å—Ç–∞–≤—è—Ç –±–µ—Å–∫–æ–Ω–µ—á–Ω—ã–µ —É–∫–ª–∞–¥–∫–∏, —á—Ä–µ–∑–º–µ—Ä–Ω–æ–µ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ –∫–æ—Å–º–µ—Ç–∏–∫–∏ –∏ —Ñ–∏–ª–ª–µ—Ä–æ–≤. –û–¥–Ω–∞ —Ä–∞–¥–æ—Å—Ç—å ‚Äî –æ–∂–∏—Ä–µ–Ω–∏–µ–º –≠–π–≤–∞ –Ω–µ —Å—Ç—Ä–∞–¥–∞–µ—Ç. –°–ø–∞—Å–∏–±–æ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞–º –∏ —Ç–∏—Ä–∑–µ–ø–∞—Ç–∏–¥–∞–º. –ù–æ —Ö—É–¥–∞—è –∫–æ—Ä–æ–≤–∞ ‚Äî –µ—â—ë –Ω–µ –≥–∞–∑–µ–ª—å. –¢–∞–∫ —á—Ç–æ —É–±–∏—Ä–∞–µ–º —Ç–µ–ª–µ—Ñ–æ–Ω—ã –∏ –≤–ø–µ—Ä—ë–¥ –≤ —Å–ø–æ—Ä—Ç–∑–∞–ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-09-09T11:31:01+00:00,@bezrec,6517,https://t.me/bezrec/6517,"–î–ª—è –ë–æ—Ä–∏—Å–∞ –ë–∞—Ä–∞–Ω–∫–∏–Ω–∞ –∑–∞–ø—Ä–æ—Å–∏–ª–∏ 7 –ª–µ—Ç —Ç—é—Ä—å–º—ã –∏ —à—Ç—Ä–∞—Ñ –≤ 800 —Ç—ã—Å. —Ä—É–±–ª–µ–π. –¢–∞–∫–æ–µ –Ω–∞–∫–∞–∑–∞–Ω–∏–µ –¥–ª—è –±—ã–≤—à–µ–≥–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –∫—Ä–∞—Å–Ω–æ—è—Ä—Å–∫–æ–≥–æ —Ñ–∏–ª–∏–∞–ª–∞ –§–ú–ë–ê —Ç—Ä–µ–±—É–µ—Ç —Å—Ç–æ—Ä–æ–Ω–∞ –æ–±–≤–∏–Ω–µ–Ω–∏—è. –ß–∏–Ω–æ–≤–Ω–∏–∫–∞ –æ–±–≤–∏–Ω—è—é—Ç –≤ —Ä–∞—Å—Ç—Ä–∞—Ç–µ –±–æ–ª–µ–µ 15 –º–ª–Ω —Ä—É–±–ª–µ–π –∏–∑ –±—é–¥–∂–µ—Ç–∞ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏. –ö–∞–∫ —É—Ç–≤–µ—Ä–∂–¥–∞–µ—Ç —Å–ª–µ–¥—Å—Ç–≤–∏–µ, –ë–∞—Ä–∞–Ω–∫–∏–Ω –≤–º–µ—Å—Ç–µ —Å —Å–æ–æ–±—â–Ω–∏–∫–æ–º —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª —Å—Ö–µ–º—É —Ñ–∏–∫—Ç–∏–≤–Ω—ã—Ö –ø–æ—Å—Ç–∞–≤–æ–∫ –ª–µ–∫–∞—Ä—Å—Ç–≤. –§–ú–ë–ê –∑–∞–ø–ª–∞—Ç–∏–ª–æ –∫–æ–º–ø–∞–Ω–∏–∏-–ø–æ—Å—Ç–∞–≤—â–∏–∫—É –∑–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –±–æ–ª–µ–µ 15 –º–ª–Ω —Ä—É–±–ª–µ–π, –Ω–æ –¥–æ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –æ–Ω–∏ —Ç–∞–∫ –∏ –Ω–µ –¥–æ—à–ª–∏. –ù–∞ –¥–µ–ª–µ –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç—ã –∑–∞–∫—É–ø–∞–ª–∏—Å—å –¥–ª—è –Ω—É–∂–¥ —ç–∫—Å-—Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—è —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ —Ñ–∏–ª–∏–∞–ª–∞ –∞–≥–µ–Ω—Ç—Å—Ç–≤–∞ –∏ –µ–≥–æ –∂–µ–Ω—ã, –∞ —Å–ø–∏—Å–æ–∫ –ø–æ—Å—Ç–∞–≤–ª–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –Ω–µ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–æ–≤–∞–ª —Ñ–∞–∫—Ç–∏—á–µ—Å–∫–æ–π –∑–∞–∫—É–ø–∫–µ. –í–æ –≤—Ä–µ–º—è –æ–±—ã—Å–∫–∞ –Ω–∞ –∞–ø—Ç–µ—á–Ω–æ–º —Å–∫–ª–∞–¥–µ —Ü–µ–Ω—Ç—Ä–∞ –§–ú–ë–ê –ø—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–∏—Ç–µ–ª–∏ –∏–∑—ä—è–ª–∏ —Å–≤—ã—à–µ 1,5 —Ç—ã—Å. —É–ø–∞–∫–æ–≤–æ–∫ —Å–µ–¥–∞—Ç–∏–≤–Ω—ã—Ö, –±–æ–ª–µ—É—Ç–æ–ª—è—é—â–∏—Ö, —É—Å–ø–æ–∫–æ–∏—Ç–µ–ª—å–Ω—ã—Ö –∏ –∫–æ—Å–º–µ—Ç–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –∞ —Ç–∞–∫–∂–µ —Å—Ä–µ–¥—Å—Ç–≤ –¥–ª—è –ø–æ—Ö—É–¥–µ–Ω–∏—è. –û–±–≤–∏–Ω—è–µ–º—ã–µ —Å–≤–æ—é –≤–∏–Ω—É –Ω–µ –ø—Ä–∏–∑–Ω–∞—é—Ç. –î–ª—è –ø—Ä–µ–¥–ø–æ–ª–∞–≥–∞–µ–º–æ–≥–æ –ø–æ–¥–µ–ª—å–Ω–∏–∫–∞ –ë–∞—Ä–∞–Ω–∫–∏–Ω–∞ –∏–∑ —Ñ–∏—Ä–º—ã-–ø–æ—Å—Ç–∞–≤—â–∏–∫–∞ –æ–±–≤–∏–Ω–µ–Ω–∏–µ –∑–∞–ø—Ä–æ—Å–∏–ª–æ —á–µ—Ç—ã—Ä–µ –≥–æ–¥–∞ –ª–∏—à–µ–Ω–∏—è —Å–≤–æ–±–æ–¥—ã —É—Å–ª–æ–≤–Ω–æ. –°–ª–µ–¥—É—é—â–µ–µ –∑–∞—Å–µ–¥–∞–Ω–∏–µ –Ω–∞–º–µ—á–µ–Ω–æ –Ω–∞ 15 —Å–µ–Ω—Ç—è–±—Ä—è. –í –º–∞—Ä—Ç–µ –∑–∞—â–∏—Ç–∞ –ë–∞—Ä–∞–Ω–∫–∏–Ω–∞ –ø—ã—Ç–∞–ª–∞—Å—å –¥–æ–±–∏—Ç—å—Å—è –æ—Ç–º–µ–Ω—ã –∞—Ä–µ—Å—Ç–∞ —Å–≤–æ–µ–≥–æ –ø–æ–¥–∑–∞—â–∏—Ç–Ω–æ–≥–æ –ø–æ —Å–æ—Å—Ç–æ—è–Ω–∏—é –∑–¥–æ—Ä–æ–≤—å—è: –≤ –æ–∫—Ç—è–±—Ä–µ 2024 –≥–æ–¥–∞ –µ–º—É –ø—Ä–æ–≤–µ–ª–∏ —Å—Ç–µ–Ω—Ç–∏—Ä–æ–≤–∞–Ω–∏–µ —Å–æ—Å—É–¥–æ–≤ —Å–µ—Ä–¥—Ü–∞, –æ–Ω —Ç–∞–∫–∂–µ –Ω—É–∂–¥–∞–µ—Ç—Å—è –≤ –æ–ø–µ—Ä–∞—Ü–∏–∏ –Ω–∞ –≥–ª–∞–∑–∞—Ö, –±–µ–∑ –∫–æ—Ç–æ—Ä–æ–π –º–æ–∂–µ—Ç –ø–æ–ª–Ω–æ—Å—Ç—å—é –æ—Å–ª–µ–ø–Ω—É—Ç—å. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –ø–æ—Å–ª–µ –æ–¥–Ω–æ–≥–æ –∏–∑ –¥–æ–ø—Ä–æ—Å–æ–≤ –ë–∞—Ä–∞–Ω–∫–∏–Ω, —è–∫–æ–±—ã, –ø—ã—Ç–∞–ª—Å—è –ø–æ–∫–æ–Ω—á–∏—Ç—å —Å —Å–æ–±–æ–π, –∞ –≤ –°–ò–ó–û –ø–æ–ø–∞–ª, –µ–¥–≤–∞ –æ–ø—Ä–∞–≤–∏–≤—à–∏—Å—å –ø–æ—Å–ª–µ –∫–æ–º—ã. –°—É–¥ –∑–∞–ø—Ä–æ—Å –æ—Ç–∫–ª–æ–Ω–∏–ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": true,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing, sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""A former director of a regional branch of the Federal Medical-Biological Agency (FMB) is facing charges for embezzlement and fraud involving over 15 million rubles. The suspect, Boris Barankin, allegedly worked with a partner to create a scheme of fictitious drug supplies. The FMB paid over 15 million rubles to the supplier for medications, but they never reached patients. The drugs were actually purchased for the benefit of the suspect and his wife, and the list of supplied medicines did not match actual purchases. During an inspection at a storage facility of the FMB center, authorities seized over 1500 packages of sedatives, painkillers, tranquilizers, and cosmetic drugs, as well as weight loss medications. The suspect denies the charges.""
}"
2025-09-09T08:33:31+00:00,@bezrec,6516,https://t.me/bezrec/6516,"–í–∏–∫—Ç–æ—Ä –•–∞—Ä–∏—Ç–æ–Ω–∏–Ω –ø—Ä–∏—Å–º–∞—Ç—Ä–∏–≤–∞–µ—Ç—Å—è –∫ ¬´–ú–µ–¥—Å–∫–∞–Ω—É¬ª. –ì–ª–∞–≤–∞ ¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç–∞¬ª –ø—Ä–µ–¥–ª–æ–∂–∏–ª –ï–≤–≥–µ–Ω–∏—é –¢—É–≥–æ–ª—É–∫–æ–≤—É –≤—ã–∫—É–ø–∏—Ç—å –µ–≥–æ –¥–æ–ª—é –≤ –ì–ö ¬´–ú–µ–¥—Å–∫–∞–Ω¬ª, –ø–∏—à—É—Ç ¬´–ò–∑–≤–µ—Å—Ç–∏—è¬ª. –ë–∏–∑–Ω–µ—Å–º–µ–Ω—É –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∏—Ç 50% –≥—Ä—É–ø–ø—ã, –≤—Ç–æ—Ä–∞—è –ø–æ–ª–æ–≤–∏–Ω–∞ ‚Äî —É ¬´–†–æ—Å–∞—Ç–æ–º–∞¬ª. –ì–æ—Å–∫–æ—Ä–ø–æ—Ä–∞—Ü–∏—è –ø—Ä–æ–¥–∞–∂—É —Å–≤–æ–µ–π –¥–æ–ª–∏ –Ω–µ —Ä–∞—Å—Å–º–∞—Ç—Ä–∏–≤–∞–µ—Ç. –ê–∫—Ç–∏–≤ –¢—É–≥–æ–ª—É–∫–æ–≤–∞ –≤ ¬´–ú–µ–¥—Å–∫–∞–Ω–µ¬ª –∞–Ω–∞–ª–∏—Ç–∏–∫–∏ –æ—Ü–µ–Ω–∏–≤–∞—é—Ç –≤ 6 ‚Äî 9,5 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –í ¬´–ú–µ–¥—Å–∫–∞–Ω–µ¬ª –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª–∏, —á—Ç–æ –ø–æ–ª—É—á–∞–ª–∏ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–µ –æ—Ç –∏–Ω–≤–µ—Å—Ç–æ—Ä–∞, –Ω–æ –∏–º–µ–Ω–∏ –µ–≥–æ –Ω–µ –Ω–∞–∑–≤–∞–ª–∏. –¢–∞–º —Å–æ–æ–±—â–∏–ª–∏, —á—Ç–æ –≤–µ—Ä–Ω—É—Ç—Å—è –∫ —ç—Ç–æ–º—É –≤–æ–ø—Ä–æ—Å—É —É–∂–µ –ø–æ—Å–ª–µ —Ç–æ–≥–æ, –∫–∞–∫ –∫–æ–º–ø–∞–Ω–∏—è —Å—Ç–∞–Ω–µ—Ç –ø—É–±–ª–∏—á–Ω–æ–π. –°–µ—Ç—å –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ü–µ–Ω—Ç—Ä–æ–≤ –∏ –µ—â—ë –¥–µ–≤—è—Ç—å –∫–æ–º–ø–∞–Ω–∏–π –æ—Ç–æ–±—Ä–∞–Ω—ã –≥–æ—Å–∫–æ—Ä–ø–æ—Ä–∞—Ü–∏–µ–π –¥–ª—è –ø–æ–¥–≥–æ—Ç–æ–≤–∫–∏ –∫ IPO ¬´–≤ 2026 –≥–æ–¥—É –∏ –¥–∞–ª–µ–µ¬ª. ¬´–ú–µ–¥—Å–∫–∞–Ω¬ª, –æ—Å–Ω–æ–≤–∞–Ω–Ω—ã–π –¢—É–≥–æ–ª—É–∫–æ–≤—ã–º –≤ 2013 –≥–æ–¥—É, –∑–∞–Ω–∏–º–∞–µ—Ç —á–µ—Ç–≤—ë—Ä—Ç—É—é —Å—Ç—Ä–æ—á–∫—É –≤ —Ä–µ–π—Ç–∏–Ω–≥–µ –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∫–æ–º–ø–∞–Ω–∏–π –ø–æ –≤–µ—Ä—Å–∏–∏ —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ Forbes. –í –≥—Ä—É–ø–ø—É –≤—Ö–æ–¥—è—Ç 65 –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ü–µ–Ω—Ç—Ä–æ–≤, 452 –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–Ω—ã—Ö –æ—Ñ–∏—Å–∞ –∏ 15 –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–∏–π –≤ 31 —Ä–µ–≥–∏–æ–Ω–µ –†–§, —Ä–∞–±–æ—Ç–∞—é—â–∏—Ö –ø–æ–¥ –±—Ä–µ–Ω–¥–æ–º KDL. 2024 –≥–æ–¥ –≥—Ä—É–ø–ø–∞ –∑–∞–∫–æ–Ω—á–∏–ª–∞ —Å –≤—ã—Ä—É—á–∫–æ–π 28 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —á—Ç–æ –Ω–∞ —á–µ—Ç–≤–µ—Ä—Ç—å –±–æ–ª—å—à–µ, —á–µ–º –≥–æ–¥–æ–º —Ä–∞–Ω–µ–µ. –í –æ—Ç–ª–∏—á–∏–µ –æ—Ç —É–∂–µ –ø—Ä–æ–¥–∞–Ω–Ω–æ–≥–æ –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –≤ —Å—Ç—Ä–∞–Ω–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è –º–µ–ª–æ–≤–∞–Ω–Ω–æ–≥–æ –∫–∞—Ä—Ç–æ–Ω–∞ –∏–ª–∏ –ö–æ—Ç–ª–∞—Å—Å–∫–æ–≥–æ —Ö–∏–º–∑–∞–≤–æ–¥–∞, ¬´–ú–µ–¥—Å–∫–∞–Ω¬ª –¥–ª—è —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —Ñ–∞—Ä–º–∫–æ—Ä–æ–ª—è, –≤–ª–∞–¥–µ—é—â–µ–≥–æ ¬´–ú–µ–¥–∏–Ω–≤–µ—Å—Ç–≥—Ä—É–ø–ø¬ª (–ú–ò–ì), ‚Äî –ø—Ä–æ—Ñ–∏–ª—å–Ω—ã–π –∞–∫—Ç–∏–≤. –ü–æ —Å–ª–æ–≤–∞–º –∏—Å–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–≥–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ RNC Pharma –ù–∏–∫–æ–ª–∞—è –ë–µ—Å–ø–∞–ª–æ–≤–∞, –æ–Ω ¬´–ø—Ä–µ–∫—Ä–∞—Å–Ω–æ –≤–ø–∏—Å—ã–≤–∞–µ—Ç—Å—è –≤ –æ–±—â—É—é —Å—Ç—Ä—É–∫—Ç—É—Ä—É –∏ —Å —Ç–æ—á–∫–∏ –∑—Ä–µ–Ω–∏—è –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ –º–∞—Å—à—Ç–∞–±–∏—Ä–æ–≤–∞–Ω–∏—è, –∏ –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ –∫–æ–º–ø–ª–∏–º–µ–Ω—Ç–∞—Ä–Ω–æ—Å—Ç–∏ —Å—É—â–µ—Å—Ç–≤—É—é—â–∏–º –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è–º¬ª. –ì–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä ¬´Infoline-–∞–Ω–∞–ª–∏—Ç–∏–∫–∏¬ª –ú–∏—Ö–∞–∏–ª –ë—É—Ä–º–∏—Å—Ç—Ä–æ–≤ —Ç–∞–∫–∂–µ —Å—á–∏—Ç–∞–µ—Ç –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω—É—é —Å–¥–µ–ª–∫—É –≤—ã–≥–æ–¥–Ω–æ–π. –ê–∫—Ç–∏–≤ –º–æ–∂–µ—Ç –±—ã—Ç—å –∏–Ω—Ç–µ—Ä–µ—Å–µ–Ω ¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç—É¬ª —Å —Ç–æ—á–∫–∏ –∑—Ä–µ–Ω–∏—è –¥–æ—Å—Ç—É–ø–∞ –∫ –∫–ª–∏–µ–Ω—Ç—Å–∫–æ–π –±–∞–∑–µ. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å —Ä–∞–±–æ—Ç–∞–µ—Ç –≤ —Å—Ñ–µ—Ä–µ –æ–Ω–∫–æ–ª–æ–≥–∏–∏, –∏ –∏–Ω—Ç–µ–≥—Ä–∞—Ü–∏—è —Å ¬´–†–æ—Å–∞—Ç–æ–º–æ–º¬ª, –∫–æ—Ç–æ—Ä—ã–π —Ä–∞–∑–≤–∏–≤–∞–µ—Ç –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ —Ä–∞–¥–∏–æ—Ñ–∞—Ä–º–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –º–µ–¥–∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä—É, –≤—ã–≥–ª—è–¥–∏—Ç –ª–æ–≥–∏—á–Ω–æ –∏ —Å—É–ª–∏—Ç —Ö–æ—Ä–æ—à–∏–µ –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤—ã. –°–ª–∏—è–Ω–∏—é ¬´–ú–µ–¥–∏–Ω–≤–µ—Å—Ç–≥—Ä—É–ø–ø¬ª –∏ —Å–µ—Ç–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ü–µ–Ω—Ç—Ä–æ–≤ –ø—Ä–æ—á–∞—Ç –±–æ–ª—å—à–æ–µ –±—É–¥—É—â–µ–µ. –ï—Å–ª–∏ –≤—Å—ë –ø–æ–ª—É—á–∏—Ç—Å—è, —É –ø—Ä–æ–µ–∫—Ç–∞ –µ—Å—Ç—å —à–∞–Ω—Å ¬´–æ–±—Å–∫–∞–∫–∞—Ç—å¬ª –ª–∏–¥–µ—Ä–∞ —Ä—ã–Ω–∫–∞ –ø–æ –∫–∞–ø–∏—Ç–∞–ª–∏–∑–∞—Ü–∏–∏ ‚Äî —Å–µ—Ç—å ¬´–ú–µ–¥—Å–∏¬ª (–ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∏—Ç –ê–§–ö ¬´–°–∏—Å—Ç–µ–º–∞¬ª –í–ª–∞–¥–∏–º–∏—Ä–∞ –ï–≤—Ç—É—à–µ–Ω–∫–æ–≤–∞). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""A business proposal to buy Viktor Haritonin's stake in the Medscan group has been made by Eugene Tugolukov to Evgenia. The head of 'Pharmstandart' suggested that Tugolukov buy his share in the Medscan group. The business man owns 50% of the group, while the other half belongs to Rosatom. Rosatom does not consider selling its share. Tugolukov's stake in Medscan is valued at 6-9.5 billion rubles by analysts. The group confirmed receiving an investor's offer, but did not name the investor. They will return to this issue after Medscan becomes public in 2026 and beyond. The Medscan group, founded by Tugolukov in 2013, is the fourth largest medical company according to Forbes. The group includes 65 medical centers, 452 laboratory offices and 15 laboratories in 31 regions of Russia under the KDL brand. In 202"
2025-09-09T05:22:27+00:00,@bezrec,6515,https://t.me/bezrec/6515,"–†–æ—Å—Å–∏–π—Å–∫–∏–µ –≤–∞–∫—Ü–∏–Ω—ã –æ—Ç –í–ò–ß –∏—Å–ø—ã—Ç–∞–ª–∏ –Ω–∞ –∂–∏–≤–æ—Ç–Ω—ã—Ö. –ù–∞ —Å–µ–≥–æ–¥–Ω—è—à–Ω–∏–π –¥–µ–Ω—å –∑–∞–≤–µ—Ä—à–µ–Ω—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –ø—Ä–æ—Ç–µ–∫—Ç–∏–≤–Ω—ã—Ö —Å–≤–æ–π—Å—Ç–≤ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ö–æ–º–±–∏–ú–∞–±-1 –∏ –ö–æ–º–±–∏–ú–∞–±-2 –Ω–∞ –º–æ–¥–µ–ª–∏ –≥—É–º–∞–Ω–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –∂–∏–≤–æ—Ç–Ω—ã—Ö, –∏–Ω—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –í–ò–ß. –ü–æ–∫–∞–∑–∞–Ω–æ, —á—Ç–æ –æ–±–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ –ø–æ–¥–∞–≤–ª—è—é—Ç —Ä–µ–ø–ª–∏–∫–∞—Ü–∏—é –í–ò–ß —É –∂–∏–≤–æ—Ç–Ω—ã—Ö –∏ –∑–∞—â–∏—â–∞—é—Ç –ø–æ–ø—É–ª—è—Ü–∏—é CD4+ –ª–∏–º—Ñ–æ—Ü–∏—Ç–æ–≤ –Ω–∞ –ø—Ä–æ—Ç—è–∂–µ–Ω–∏–∏ –≤—Å–µ–≥–æ –ø–µ—Ä–∏–æ–¥–∞ –Ω–∞–±–ª—é–¥–µ–Ω–∏—è, ‚Äî –ø–æ–¥–µ–ª–∏–ª–∏—Å—å —É—Å–ø–µ—Ö–∞–º–∏ –≤ –§–ú–ë–ê. –ü–æ —Å–ª–æ–≤–∞–º —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–æ–≤, –≤ —Å–æ—Å—Ç–∞–≤ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤—Ö–æ–¥–∏—Ç –∫–æ–º–±–∏–Ω–∞—Ü–∏—è —Ç—Ä–µ—Ö —à–∏—Ä–æ–∫–æ –Ω–µ–π—Ç—Ä–∞–ª–∏–∑—É—é—â–∏—Ö –∞–Ω—Ç–∏—Ç–µ–ª –ø—Ä–æ—Ç–∏–≤ –í–ò–ß, –¥–æ—Å—Ç–∞–≤–ª—è–µ–º—ã—Ö —Å –ø–æ–º–æ—â—å—é –∞–¥–µ–Ω–æ–∞—Å—Å–æ—Ü–∏–∏—Ä–æ–≤–∞–Ω–Ω–æ–≥–æ –≤–µ–∫—Ç–æ—Ä–∞. –≠—Ç–æ –ø–µ—Ä–≤—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –≤ –Ω–æ–≤–æ–º –∫–ª–∞—Å—Å–µ –≤–µ—â–µ—Å—Ç–≤, –ø–æ–∑–≤–æ–ª—è—é—â–∏–µ —Å–Ω–∏–∑–∏—Ç—å –≤–∏—Ä—É—Å–Ω—É—é –Ω–∞–≥—Ä—É–∑–∫—É –í–ò–ß. –í –∞–≥–µ–Ω—Ç—Å—Ç–≤–µ —É—Ç–≤–µ—Ä–∂–¥–∞—é—Ç, —á—Ç–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç –ø–æ–¥–æ–π–¥—ë—Ç –Ω–µ —Ç–æ–ª—å–∫–æ –¥–ª—è –ª–µ—á–µ–Ω–∏—è, –Ω–æ –∏ –¥–ª—è –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –í–ò–ß-–∏–Ω—Ñ–µ–∫—Ü–∏–∏, –≤ —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, –≤ –≥—Ä—É–ø–ø–∞—Ö –≤—ã—Å–æ–∫–æ–≥–æ —Ä–∏—Å–∫–∞. –° –∫–æ–≤–∞—Ä–Ω—ã–º –≤–∏—Ä—É—Å–æ–º ¬´–≤–æ—é–µ—Ç¬ª –∏ –¶–µ–Ω—Ç—Ä –∏–º. –ì–∞–º–∞–ª–µ–∏. –ü–æ —Ä–∞—Å—á—ë—Ç–∞–º —É—á—ë–Ω—ã—Ö, —Å–æ–∑–¥–∞–Ω–∏–µ –≤–∞–∫—Ü–∏–Ω—ã –Ω–∞ –æ—Å–Ω–æ–≤–µ –º–†–ù–ö-–ø–ª–∞—Ç—Ñ–æ—Ä–º—ã –∑–∞–π–º—ë—Ç –æ–∫–æ–ª–æ –¥–≤—É—Ö –ª–µ—Ç. –°–µ–π—á–∞—Å —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –Ω–∞—Ö–æ–¥—è—Ç—Å—è –Ω–∞ —ç—Ç–∞–ø–µ –ø–æ–¥–±–æ—Ä–∞ –ø–µ—Ä–≤—ã—Ö –∞–Ω—Ç–∏–≥–µ–Ω–æ–≤, —Å–ø–æ—Å–æ–±–Ω—ã—Ö —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞—Ç—å —à–∏—Ä–æ–∫–æ–Ω–µ–π—Ç—Ä–∞–ª–∏–∑—É—é—â–∏–π –∏–º–º—É–Ω–Ω—ã–π –æ—Ç–≤–µ—Ç. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial, pharmacovigilance"",
  ""impact"": ""high"",
  ""english"": ""Russian anti-HIV vaccines have been tested on animals. Studies of the protective properties of CombiMab-1 and CombiMab-2, developed by the FMBA, have shown that both drugs effectively suppress HIV replication in animal models. The agencies claim the vaccines are suitable for treatment and prevention of HIV infection, especially among high-risk groups. The Gamaleya Center is also working on a vaccine based on mRNA platform, with the team currently selecting initial antigens capable of generating a broad neutralizing immune response.""
}"
2025-09-08T16:35:48+00:00,@bezrec,6514,https://t.me/bezrec/6514,"–°–µ–º–∞–≥–ª—É—Ç–∏–¥ –∏ —Ç–∏—Ä–∑–µ–ø–∞—Ç–∏–¥ –ø–æ–ø–∞–ª–∏ –≤ –ø–µ—Ä–µ—á–µ–Ω—å –æ—Å–Ω–æ–≤–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –í–û–ó. –í –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –Ω–∞–¥–µ—é—Ç—Å—è, —á—Ç–æ —ç—Ç–æ—Ç —à–∞–≥ —Å–¥–µ–ª–∞–µ—Ç –¥–æ—Ä–æ–≥–æ—Å—Ç–æ—è—â–∏–µ –∞–≥–æ–Ω–∏—Å—Ç—ã —Ä–µ—Ü–µ–ø—Ç–æ—Ä–æ–≤ –≥–ª—é–∫–∞–≥–æ–Ω–æ–ø–æ–¥–æ–±–Ω–æ–≥–æ –ø–µ–ø—Ç–∏–¥–∞-1 (GLP-1) –±–æ–ª–µ–µ –¥–æ—Å—Ç—É–ø–Ω—ã–º–∏. –í —Å–ø–∏—Å–∫–µ –≤–∞–∂–Ω–µ–π—à–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤, —Å–æ—Å—Ç–∞–≤–ª—è–µ–º–æ–º –í–û–ó, 523 –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –¥–ª—è –≤–∑—Ä–æ—Å–ª—ã—Ö –∏ 374 –¥–ª—è –¥–µ—Ç–µ–π. –û–Ω–∏ —Å—á–∏—Ç–∞—é—Ç—Å—è –Ω–∞–∏–±–æ–ª–µ–µ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã–º–∏ –∏ –±–µ–∑–æ–ø–∞—Å–Ω—ã–º–∏ –¥–ª—è —É–¥–æ–≤–ª–µ—Ç–≤–æ—Ä–µ–Ω–∏—è —Å–∞–º—ã—Ö –≤–∞–∂–Ω—ã—Ö –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç–µ–π –≤ —Å–∏—Å—Ç–µ–º–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –¢–∞–∫, –≤–∫–ª—é—á–µ–Ω–∏–µ –≤ –ø–µ—Ä–µ—á–µ–Ω—å –∞–Ω—Ç–∏—Ä–µ—Ç—Ä–æ–≤–∏—Ä—É—Å–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –≤ –Ω–∞—á–∞–ª–µ 2000-—Ö –≥–æ–¥–æ–≤ –ø–æ–º–æ–≥–ª–æ –æ–±–µ—Å–ø–µ—á–∏—Ç—å –¥–æ—Å—Ç—É–ø –∫ –ª–µ—á–µ–Ω–∏—é –ø–∞—Ü–∏–µ–Ω—Ç–∞–º –≤ –±–µ–¥–Ω—ã—Ö —Å—Ç—Ä–∞–Ω–∞—Ö. –ü–æ–º–∏–º–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –¥–∏–∞–±–µ—Ç–∞ –∏ –æ–∂–∏—Ä–µ–Ω–∏—è –æ—Ç Novo Nordisk –∏ Eli Lilly, –≤ —Å–ø–∏—Å–æ–∫ –í–û–ó —Ç–∞–∫–∂–µ –≤–æ—à–ª–∏ –¢—Ä–∏–∫–∞—Ñ—Ç–∞ –∫–æ–º–ø–∞–Ω–∏–∏ Vertex –æ—Ç –º—É–∫–æ–≤–∏—Å—Ü–∏–¥–æ–∑–∞ –∏ —Å–∞–º—ã–π –ø—Ä–æ–¥–∞–≤–∞–µ–º—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç Merck –¥–ª—è –∏–º–º—É–Ω–æ—Ç–µ—Ä–∞–ø–∏–∏ —Ä–∞–∫–∞ ‚Äî –ö–µ–π—Ç—Ä—É–¥–∞. –ü—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π —ç—Ç–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –Ω–µ —Ä–∞–∑ –∫—Ä–∏—Ç–∏–∫–æ–≤–∞–ª–∏ –∑–∞ –∏—Ö –≤—ã—Å–æ–∫—É—é —Å—Ç–æ–∏–º–æ—Å—Ç—å –∏ –Ω–µ–¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –í —Ä–æ—Å—Å–∏–π—Å–∫–∏–π –ø–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü –≤—Ö–æ–¥–∏—Ç —Ç–æ–ª—å–∫–æ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥. –¢–∏—Ä–∑–µ–ø–∞—Ç–∏–¥–∞ –≤ —Å–ø–∏—Å–∫–µ –∂–∏–∑–Ω–µ–Ω–Ω–æ –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã—Ö –∏ –≤–∞–∂–Ω–µ–π—à–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ø–æ–∫–∞ –Ω–µ—Ç. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The organization hopes that this step will make expensive GLP-1 agonists more affordable. The list of essential medicines, compiled by WHO, includes 523 adult drugs and 374 for children. They are considered the most effective and safe to meet the most important health system needs. The inclusion of antiretroviral therapy in 2000s helped to provide access to treatment for patients in poor countries. Besides Novo Nordisk and Eli Lilly's diabetes and obesity drugs, the WHO list also includes Vertex's Trikafta for cystic fibrosis and Merck's most sold cancer immunotherapy drug - Keytruda. Manufacturers of these drugs have been criticized for their high cost and unaffordability for patients. Only semaglutide is included in the Russian list of –ñ–ù–í–õ–ü. Trikafta is not yet listed as a life-saving and essential medicine.""
}"
2025-09-08T14:35:28+00:00,@bezrec,6513,https://t.me/bezrec/6513,"–ê–ø—Ç–µ–∫–∞ –≤ –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥–µ –∑–∞–ø–ª–∞—Ç–∏—Ç –º–∏–ª–ª–∏–æ–Ω –∑–∞ ¬´–ª–µ–≤—ã–π¬ª –∏–º–º—É–Ω–æ–≥–ª–æ–±—É–ª–∏–Ω. –î–µ–ª–æ –±—ã–ª–æ —Ç–∞–∫. –í –º–∞—Ä—Ç–µ 2025 –≥–æ–¥–∞ –û–û–û ¬´–†–∏–∞–¥—ç–º–∞¬ª –ø—Ä–æ–¥–∞–ª–∞ –∏–º–º—É–Ω–æ–≥–ª–æ–±—É–ª–∏–Ω —á–µ–ª–æ–≤–µ–∫–∞ –∞–Ω—Ç–∏—Å—Ç–∞—Ñ–∏–ª–æ–∫–æ–∫–∫–æ–≤—ã–π –æ—Ç ¬´–ú–∏–∫—Ä–æ–≥–µ–Ω–∞¬ª –∑–∞ 25 —Ç—ã—Å. —Ä—É–±–ª–µ–π. –û–¥–Ω–∞–∫–æ –æ–∫–∞–∑–∞–ª–æ—Å—å, —á—Ç–æ –∏–Ω–¥–∏–≤–∏–¥—É–∞–ª—å–Ω—ã–π –∫–æ–¥ –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É–µ—Ç –¥—Ä—É–≥–æ–º—É –ø—Ä–µ–ø–∞—Ä–∞—Ç—É ‚Äî–ò–º–º—É–Ω–æ–≥–ª–æ–±—É–ª–∏–Ω —á–µ–ª–æ–≤–µ–∫–∞ –Ω–æ—Ä–º–∞–ª—å–Ω—ã–π –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ ¬´–ò–≤–∞–Ω–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–Ω–æ–π —Å—Ç–∞–Ω—Ü–∏–∏ –ø–µ—Ä–µ–ª–∏–≤–∞–Ω–∏—è –∫—Ä–æ–≤–∏¬ª. –ö —Ç–æ–º—É –∂–µ –æ–∫–∞–∑–∞–ª–æ—Å—å, —á—Ç–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–æ –±—ã–ª–æ –ø—Ä–æ–¥–∞–Ω–æ –≤ –û–û–û ¬´–§–∞—Ä–º–ª–µ–Ω–¥-–¶–µ–Ω—Ç—Ä¬ª –≤ –£—Ñ–µ. –ë–¥–∏—Ç–µ–ª—å–Ω—ã–π –ø–æ–∫—É–ø–∞—Ç–µ–ª—å –æ–±—Ä–∞—Ç–∏–ª—Å—è –≤ –°–ª–µ–¥—Å—Ç–≤–µ–Ω–Ω—ã–π –∫–æ–º–∏—Ç–µ—Ç. –ü–æ–¥–æ–∑—Ä–∏—Ç–µ–ª—å–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –∏–∑—ä—è–ª–∏ –∏ –ø–µ—Ä–µ–¥–∞–ª–∏ –≤ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä, –∫–æ—Ç–æ—Ä—ã–π –∏ –ø–æ–¥–∞–ª –∏—Å–∫ –æ –ø—Ä–∏–≤–ª–µ—á–µ–Ω–∏–∏ ¬´–†–∏–∞–¥—ç–º—ã¬ª –∫ –∞–¥–º–∏–Ω–∏—Å—Ç—Ä–∞—Ç–∏–≤–Ω–æ–π –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç–∏. –í –∏—Ç–æ–≥–µ –ê—Ä–±–∏—Ç—Ä–∞–∂–Ω—ã–π —Å—É–¥ –≥–æ—Ä–æ–¥–∞ –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥–∞ –∏ –õ–µ–Ω–∏–Ω–≥—Ä–∞–¥—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –æ—à—Ç—Ä–∞—Ñ–æ–≤–∞–ª –∫–æ–º–ø–∞–Ω–∏—é –Ω–∞ 1 –º–ª–Ω —Ä—É–±–ª–µ–π –∑–∞ —Ç–æ—Ä–≥–æ–≤–ª—é —Ñ–∞–ª—å—Å–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω—ã–º–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏. –û–û–û ¬´–†–∏–∞–¥—ç–º–∞¬ª —Ä–∞–±–æ—Ç–∞–µ—Ç –≤ –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥–µ —Å 2020 –≥–æ–¥–∞. –ï–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–π —É—á—Ä–µ–¥–∏—Ç–µ–ª—å ‚Äî –î–º–∏—Ç—Ä–µ–Ω–∫–æ –î–º–∏—Ç—Ä–∏–π. –í 2024 –≥–æ–¥—É –≤—ã—Ä—É—á–∫–∞ –∫–æ–º–ø–∞–Ω–∏–∏ —Ä–µ–∑–∫–æ –≤—ã—Ä–æ—Å–ª–∞ –¥–æ 233 –º–ª–Ω —Ä—É–±–ª–µ–π, —á—Ç–æ –≤—Ç—Ä–æ–µ –±–æ–ª—å—à–µ –ø–æ–∫–∞–∑–∞—Ç–µ–ª–µ–π 2023 –≥–æ–¥–∞. –ê –≤–æ—Ç —Å —á–∏—Å—Ç–æ–π –ø—Ä–∏–±—ã–ª—å—é –≤—Å—ë —Ö—É–∂–µ ‚Äî –æ–Ω–∞ —Å–æ—Å—Ç–∞–≤–∏–ª–∞ –≤—Å–µ–≥–æ 4 —Ç—ã—Å.—Ä—É–±–ª–µ–π –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å 12 –º–ª–Ω —Ä—É–±–ª–µ–π –≥–æ–¥–æ–º —Ä–∞–Ω–µ–µ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-09-08T11:30:01+00:00,@bezrec,6512,https://t.me/bezrec/6512,"–í –†–æ—Å—Å–∏–∏ —Ä–∞—Å—Ç—É—Ç –ø—Ä–æ–¥–∞–∂–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –±—Ä–æ–Ω—Ö–∏–∞–ª—å–Ω–æ–π –∞—Å—Ç–º—ã –∏ –•–û–ë–õ. –ü–æ –¥–∞–Ω–Ω—ã–º RNC Pharma, –∑–∞ —Å–µ–º—å –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ –±—ã–ª–æ –ø—Ä–æ–¥–∞–Ω–æ 25,2 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ —Ç–∞–∫–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤, —á—Ç–æ –ø–æ—á—Ç–∏ –Ω–∞ 10% –±–æ–ª—å—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É. –°—Ç–æ–∏–º–æ—Å—Ç–Ω—ã–π –æ–±—ä—ë–º –ø—Ä–æ–¥–∞–∂ –≤—ã—Ä–æ—Å –Ω–∞ 12,8%, –¥–æ 14,5 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ù–∞–∏–±–æ–ª—å—à–µ–π –ø–æ–ø—É–ª—è—Ä–Ω–æ—Å—Ç—å—é –≤ —Ä–æ–∑–Ω–∏—Ü–µ –ø–æ–ª—å–∑—É—é—Ç—Å—è –±–µ—Ç–∞2-–∞–¥—Ä–µ–Ω–æ–º–∏–º–µ—Ç–∏–∫–∏, –∫–æ—Ä—Ç–∏–∫–æ–∏–¥—ã –∏ –∏—Ö –∫–æ–º–±–∏–Ω–∞—Ü–∏–∏. –ù–∞ –∏—Ö –¥–æ–ª—é –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –ø–æ—Ä—è–¥–∫–∞ 78,5% –æ—Ç –≤—Å–µ–≥–æ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–≥–æ –æ–±—ä—ë–º–∞ –ø—Ä–æ–¥–∞–∂, –≤ –¥–µ–Ω—å–≥–∞—Ö —ç—Ç–æ—Ç –ø–æ–∫–∞–∑–∞—Ç–µ–ª—å –ø—Ä–µ–≤—ã—à–∞–ª 72%. –ê–Ω—Ç–∏–∞—Å—Ç–º–∞—Ç–∏—á–µ—Å–∫–∏–µ —Å—Ä–µ–¥—Å—Ç–≤–∞ –≤ —Ä–∏—Ç–µ–π–ª–µ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω—ã –±–æ–ª–µ–µ —á–µ–º —Å–æ—Ç–Ω–µ–π —Ç–æ—Ä–≥–æ–≤—ã—Ö –º–∞—Ä–æ–∫ –æ—Ç 57 –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π. –ü—Ä–∏ —ç—Ç–æ–º –æ–∫–æ–ª–æ 59% –≤—Å–µ—Ö —Ä–∞—Å—Ö–æ–¥–æ–≤ –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª–µ–π –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –æ—Ç ¬´–ê—Å—Ç—Ä–∞–ó–µ–Ω–µ–∫–∞¬ª –∏ ¬´–ë–µ—Ä–∏–Ω–≥–µ—Ä –ò–Ω–≥–µ–ª—å—Ö–∞–π–º¬ª. –ü–µ—Ä–≤—ã–µ —Ç—Ä–∏ —Å—Ç—Ä–æ—á–∫–∏ –≤ —Ç–æ–ø-10 –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –∞—Å—Ç–º—ã –∏ –•–û–ë–õ –∑–∞–Ω–∏–º–∞—é—Ç –ü—É–ª—å–º–∏–∫–æ—Ä—Ç, –ë–µ—Ä–æ–¥—É–∞–ª –∏ –°–∏–º–±–∏–∫–æ—Ä—Ç. –°–∞–º–æ–π –≤–Ω—É—à–∏—Ç–µ–ª—å–Ω–æ–π –¥–∏–Ω–∞–º–∏–∫–æ–π –ø—Ä–æ–¥–∞–∂ –≤ –¥–µ–Ω—å–≥–∞—Ö –≤ –ø–µ—Ä–≤–æ–π –¥–µ—Å—è—Ç–∫–µ –º–æ–∂–µ—Ç –ø–æ—Ö–≤–∞—Å—Ç–∞—Ç—å—Å—è –∏—Ç–∞–ª—å—è–Ω—Å–∫–∏–π –±—Ä–µ–Ω–¥ –§–æ—Å—Ç–µ—Ä –æ—Ç ¬´–ö—å–µ–∑–∏¬ª (+31%). –•–æ—Ä–æ—à–∏–µ –ø—Ä–∏—Ä–æ—Å—Ç—ã —Ç–∞–∫–∂–µ —É –ú–æ–Ω—Ç–µ–ª—É–∫–∞—Å—Ç–∞ (¬´–í–µ—Ä—Ç–µ–∫—Å¬ª +7 –∫–æ–º–ø–∞–Ω–∏–π), –°–∞–ª—å–±—É—Ç–∞–º–æ–ª–∞, –∫–æ—Ç–æ—Ä—ã–π –Ω–∞ –¥–∞–Ω–Ω—ã–π –º–æ–º–µ–Ω—Ç –≤ –†–æ—Å—Å–∏–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—è—Ç 8 –∫–æ–º–ø–∞–Ω–∏–π, –∞ –ª–∏–¥–∏—Ä—É–µ—Ç –∑–¥–µ—Å—å ¬´–ú–æ—Å—Ö–∏–º—Ñ–∞—Ä–º–ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –∏–º. –ù.–ê. –°–µ–º–∞—à–∫–æ¬ª, –∞ —Ç–∞–∫–∂–µ –°–ø–∏–æ–ª—Ç–æ –†–µ—Å–ø–∏–º–∞—Ç–∞ (¬´–ë–µ—Ä–∏–Ω–≥–µ—Ä –ò–Ω–≥–µ–ª—å—Ö–∞–π–º¬ª). –û—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω–æ–π –¥–∏–Ω–∞–º–∏–∫–æ–π –æ—Ç–ª–∏—á–∏–ª—Å—è —Ç–æ–ª—å–∫–æ –°–µ—Ä–µ—Ç–∏–¥ –æ—Ç ¬´–ì–°–ö¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""Sales of asthma and COPD treatment drugs in Russia have increased by almost 10% year-over-year, according to RNC Pharma. The natural volume of sales has grown by 12.8%, reaching 14.5 billion rubles. The market share of beta-2-adrenergic stimulants, corticosteroids, and their combinations accounts for about 78.5% of the total natural volume with a share in money terms exceeding 72%. The top three drugs by revenue are Pulmicort, Berodual, and Simbical. Positive growth is also observed in Montelukast (Vertex +7 companies), Salbutamol, which is produced by 8 companies including Moskhimfarpryat im. N.A. Semashko, and Spiolto Respirota (Beyerling Ingelheim). Negative growth is observed in Seretide from GSK.""
}"
2025-09-08T06:00:35+00:00,@bezrec,6510,https://t.me/bezrec/6510,"–ì–æ—Å—Ç–∞–π–Ω—É –≤ ¬´–ú–µ–¥–∏—Å–æ—Ä–±–µ¬ª –±—É–¥–µ—Ç –æ—Ö—Ä–∞–Ω—è—Ç—å –±—ã–≤—à–∏–π –Ω–∞—á–∞–ª—å–Ω–∏–∫ —É–≥—Ä–æ–∑—ã—Å–∫–∞ –ü—Ä–∏–∫–∞–º—å—è. –î–µ–π—Å—Ç–≤—É—é—â–∏–π –¥–∏—Ä–µ–∫—Ç–æ—Ä —Å–ª—É–∂–±—ã –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ –ø–µ—Ä–º—Å–∫–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤ –°–µ—Ä–≥–µ–π –ë–µ–ª–∫–∏–Ω –Ω–∞–∑–Ω–∞—á–µ–Ω –Ω–∞ –¥–æ–ª–∂–Ω–æ—Å—Ç—å —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—è –ø–æ –æ—Ö—Ä–∞–Ω–µ –≥–æ—Å—Ç–∞–π–Ω—ã –∫–æ–º–ø–∞–Ω–∏–∏. –ö–∞–∫ –æ–±—ä—è—Å–Ω–∏–ª–∏ –≤ –ø—Ä–µ—Å—Å-—Å–ª—É–∂–±–µ ¬´–ú–µ–¥–∏—Å–æ—Ä–±–∞¬ª, –Ω–æ–≤–∞—è –¥–æ–ª–∂–Ω–æ—Å—Ç—å –∏–º–µ–µ—Ç –∫–∞—Ç–µ–≥–æ—Ä–∏—é –µ–¥–∏–Ω–æ–ª–∏—á–Ω–æ–≥–æ –∏—Å–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–≥–æ –æ—Ä–≥–∞–Ω–∞. –≠—Ç–æ –æ–∑–Ω–∞—á–∞–µ—Ç, —á—Ç–æ –ø–æ –≤–æ–ø—Ä–æ—Å–∞–º, —Å–≤—è–∑–∞–Ω–Ω—ã–º —Å –≥–æ—Å—Ç–∞–π–Ω–æ–π, –ë–µ–ª–∫–∏–Ω –¥–µ–π—Å—Ç–≤—É–µ—Ç –æ—Ç –∏–º–µ–Ω–∏ –ê–û ¬´–ú–µ–¥–∏—Å–æ—Ä–±¬ª –±–µ–∑ –¥–æ–≤–µ—Ä–µ–Ω–Ω–æ—Å—Ç–∏. –ü—Ä–∏ —ç—Ç–æ–º –ê–û ¬´–ú–µ–¥–∏—Å–æ—Ä–±¬ª –ø–æ-–ø—Ä–µ–∂–Ω–µ–º—É —É–ø—Ä–∞–≤–ª—è–µ—Ç—Å—è ¬´–ú–µ–¥–∏—Å–æ—Ä–± –ì—Ä—É–ø–ø¬ª, —Ç–µ–∫—É—â–µ–µ —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–æ —Å–æ—Ö—Ä–∞–Ω—è–µ—Ç —Å–≤–æ–∏ –ø–æ–ª–Ω–æ–º–æ—á–∏—è. –í —è–Ω–≤–∞—Ä–µ 2025 –≥–æ–¥–∞ –∫–∏–ø—Ä—Å–∫–∞—è Medisorb Holding LTD –≤—ã–≤–µ–ª–∞ —Å–≤–æ–∏ –∞–∫—Ç–∏–≤—ã –∏–∑ –û–û–û ¬´–ú–µ–¥–∏—Å–æ—Ä–± –ì—Ä—É–ø–ø¬ª (¬´–ú–° –ì—Ä—É–ø–ø¬ª). ¬´–ú–µ–¥–∏—Å–æ—Ä–±¬ª —Ä–∞–±–æ—Ç–∞–µ—Ç –≤ –ü–µ—Ä–º–∏ —Å 1993 –≥–æ–¥–∞ –∏ —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä—É–µ—Ç—Å—è –Ω–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤. –í –ø–æ—Ä—Ç—Ñ–µ–ª–µ –∫–æ–º–ø–∞–Ω–∏–∏ –±–æ–ª–µ–µ 100 –µ–¥–∏–Ω–∏—Ü –ø—Ä–æ–¥—É–∫—Ü–∏–∏, –≤–∫–ª—é—á–∞—è —Ü–∏—Ç—Ä–∞–º–æ–Ω, –∞–Ω–∞–ª—å–≥–∏–Ω, –ø–∞—Ä–∞—Ü–µ—Ç–∞–º–æ–ª, –∏–±—É–ø—Ä–æ—Ñ–µ–Ω –∏ –¥—Ä—É–≥–∏–µ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-09-07T11:04:55+00:00,@bezrec,6508,https://t.me/bezrec/6508,"–¢—Ä–∞–≤—ã –ø—Ä–æ—Ç–∏–≤ –≥—Ä–∏–ø–ø–∞. –£—á—ë–Ω—ã–µ –¶–µ–Ω—Ç—Ä–∞ –∏–º. –ì–∞–º–∞–ª–µ–∏ –∏ –°–µ—á–µ–Ω–æ–≤—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ –ø–æ—à–ª–∏ –ø–æ —Ç—Ä–∞–≤—ã –∏ —Å–æ–±—Ä–∞–ª–∏ –¥–≤–µ –∫–æ–º–ø–æ–∑–∏—Ü–∏–∏ –∏–∑ 11 –∏ 14 –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Ä–∞—Å—Ç–µ–Ω–∏–π, —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã–µ –ø—Ä–æ—Ç–∏–≤ –≥—Ä–∏–ø–ø–∞. –î–≤–∞ —Å–±–æ—Ä–∞ –ø–æ–∫–∞–∑–∞–ª–∏ —Å–ø–æ—Å–æ–±–Ω–æ—Å—Ç—å –ø–æ–¥–∞–≤–ª—è—Ç—å —Ä–∞–∑–º–Ω–æ–∂–µ–Ω–∏–µ –≤–∏—Ä—É—Å–∞ –≥—Ä–∏–ø–ø–∞ –ê –Ω–∞ 30%. –û–Ω–∏ –Ω–µ —Ç–æ–ª—å–∫–æ –ø–æ–º–æ–≥–∞—é—Ç –±–æ—Ä–æ—Ç—å—Å—è —Å –≤–∏—Ä—É—Å–æ–º, –Ω–æ –∏ —É–∫—Ä–µ–ø–ª—è—é—Ç –∏–º–º—É–Ω–∏—Ç–µ—Ç, —á—Ç–æ –¥–µ–ª–∞–µ—Ç –∏—Ö –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–Ω—ã–º–∏ –¥–ª—è –∫–æ–º–ø–ª–µ–∫—Å–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –≥—Ä–∏–ø–ø–∞. –≠—Ç–æ –æ—Å–æ–±–µ–Ω–Ω–æ –≤–∞–∂–Ω–æ –≤ —É—Å–ª–æ–≤–∏—è—Ö —Ä–∞—Å—Ç—É—â–µ–π —É—Å—Ç–æ–π—á–∏–≤–æ—Å—Ç–∏ –≤–∏—Ä—É—Å–æ–≤ –∫ —Å—É—â–µ—Å—Ç–≤—É—é—â–∏–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º –∏ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ –ø–æ–∏—Å–∫–∞ –±–µ–∑–æ–ø–∞—Å–Ω—ã—Ö –ø—Ä–∏—Ä–æ–¥–Ω—ã—Ö –∞–ª—å—Ç–µ—Ä–Ω–∞—Ç–∏–≤, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏ —É—á—ë–Ω—ã–µ. –°–ª—É—á–∞–π–Ω—ã—Ö —Ä–∞—Å—Ç–µ–Ω–∏–π –≤ —Å–±–æ—Ä–∞—Ö –Ω–µ—Ç ‚Äî —É –∫–∞–∂–¥–æ–≥–æ —Å–≤–æ—è ¬´—Å—É–ø–µ—Ä—Å–∏–ª–∞¬ª. –¢–∞–∫, —Å–æ–ª–æ–¥–∫–∞ –∏ —Ç—ã—Å—è—á–µ–ª–∏—Å—Ç–Ω–∏–∫ –∏–∑–≤–µ—Å—Ç–Ω—ã —Å–≤–æ–µ–π —Å–ø–æ—Å–æ–±–Ω–æ—Å—Ç—å—é –ø–æ–¥–∞–≤–ª—è—Ç—å –≤–∏—Ä—É—Å—ã, –∞ –ø–æ–¥–æ—Ä–æ–∂–Ω–∏–∫ –∏ –¥—É—à–∏—Ü–∞ –æ–±–ª–∞–¥–∞—é—Ç –ø—Ä–æ—Ç–∏–≤–æ–≤–æ—Å–ø–∞–ª–∏—Ç–µ–ª—å–Ω—ã–º –∏ –æ—Ç—Ö–∞—Ä–∫–∏–≤–∞—é—â–∏–º –¥–µ–π—Å—Ç–≤–∏–µ–º. –°–∞–º—ã–º —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã–º –æ–∫–∞–∑–∞–ª—Å—è —Å–±–æ—Ä –∏–∑ 11 –∫–æ–º–ø–æ–Ω–µ–Ω—Ç–æ–≤: –ø–ª–æ–¥–æ–≤ —à–∏–ø–æ–≤–Ω–∏–∫–∞ –∏ –∫–∞–ª–∏–Ω—ã, –∫–æ—Ä—ã –¥—É–±–∞, –∫–æ—Ä–Ω–µ–≤–∏—â–∞ –∞–∏—Ä–∞, –∫–æ—Ä–Ω–µ–π —Å–æ–ª–æ–¥–∫–∏, —Ç—Ä–∞–≤—ã —Ö–≤–æ—â–∞ –ø–æ–ª–µ–≤–æ–≥–æ, –ª–∏—Å—Ç—å–µ–≤ –ø–æ–¥–æ—Ä–æ–∂–Ω–∏–∫–∞, —Ü–≤–µ—Ç–∫–æ–≤ –±–µ—Å—Å–º–µ—Ä—Ç–Ω–∏–∫–∞, –∫–æ—Ä–Ω–µ–≤–∏—â–∞ –∏ –∫–æ—Ä–Ω–µ–π —ç–ª–µ—É—Ç–µ—Ä–æ–∫–æ–∫–∫–∞, –ª–∏—Å—Ç—å–µ–≤ –∫—Ä–∞–ø–∏–≤—ã –∏ —Ç—Ä–∞–≤—ã –¥—É—à–∏—Ü—ã –æ–±—ã–∫–Ω–æ–≤–µ–Ω–Ω–æ–π. ¬´–ó–≤–µ–∑–¥–∞¬ª –∫–æ–º–ø–æ–∑–∏—Ü–∏–∏ ‚Äî –¥—É—à–∏—Ü–∞. –†–∞—Å—Ç–µ–Ω–∏–µ –æ–±–ª–∞–¥–∞–µ—Ç –¥–æ–∫–∞–∑–∞–Ω–Ω–æ–π –∞–∫—Ç–∏–≤–Ω–æ—Å—Ç—å—é –ø—Ä–æ—Ç–∏–≤ –Ω–µ—Å–∫–æ–ª—å–∫–∏—Ö —à—Ç–∞–º–º–æ–≤ –≤–∏—Ä—É—Å–∞ –≥—Ä–∏–ø–ø–∞ –ê (H1N1, H5N1 –∏ H3N2), —á—Ç–æ, –≤–µ—Ä–æ—è—Ç–Ω–æ, –∏ —É—Å–∏–ª–∏–ª–æ –æ–±—â–µ–µ –ø—Ä–æ—Ç–∏–≤–æ–≤–∏—Ä—É—Å–Ω–æ–µ –¥–µ–π—Å—Ç–≤–∏–µ —Å–æ—Å—Ç–∞–≤–∞. –≠—Ç–æ—Ç —Å–±–æ—Ä –Ω–µ —Ç–æ–ª—å–∫–æ –ø—Ä–æ–¥–µ–º–æ–Ω—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª —Å–ø–æ—Å–æ–±–Ω–æ—Å—Ç—å –ø–æ–¥–∞–≤–ª—è—Ç—å —Ä–∞–∑–º–Ω–æ–∂–µ–Ω–∏–µ –≤–∏—Ä—É—Å–∞, –Ω–æ –∏ –ø–æ–∫–∞–∑–∞–ª –º–∞–∫—Å–∏–º–∞–ª—å–Ω–æ–µ —Å–æ–¥–µ—Ä–∂–∞–Ω–∏–µ –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏ –∞–∫—Ç–∏–≤–Ω—ã—Ö –≤–µ—â–µ—Å—Ç–≤ - —Ñ–ª–∞–≤–æ–Ω–æ–∏–¥–æ–≤, –¥—É–±–∏–ª—å–Ω—ã—Ö –≤–µ—â–µ—Å—Ç–≤ –∏ –∞—Å–∫–æ—Ä–±–∏–Ω–æ–≤–æ–π –∫–∏—Å–ª–æ—Ç—ã, –∫–æ—Ç–æ—Ä—ã–µ —Ä–∞–±–æ—Ç–∞—é—Ç –≤–º–µ—Å—Ç–µ, —É—Å–∏–ª–∏–≤–∞—è –¥—Ä—É–≥ –¥—Ä—É–≥–∞, ‚Äî –ø–æ–¥–µ–ª–∏–ª–∏—Å—å –∞–≤—Ç–æ—Ä—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è. –û—Å–æ–±–µ–Ω–Ω–æ —Ç–∞–∫–∏–µ —Å–±–æ—Ä—ã –ø—Ä–∏–≥–æ–¥—è—Ç—Å—è –ª—é–¥—è–º, –∫–æ—Ç–æ—Ä—ã–º –ø—Ä–æ—Ç–∏–≤–æ–ø–æ–∫–∞–∑–∞–Ω—ã —Å–∏–Ω—Ç–µ—Ç–∏—á–µ—Å–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance, safety"",
  ""impact"": ""high"",
  ""english"": ""Researchers from the Center named after Gomel and S–µ—á–µ–Ωov University have collected two compositions of 11 and 14 medicinal plants effective against the flu. The two blends showed a capacity to suppress influenza A virus multiplication by 30%. They not only help fight the virus but also strengthen immunity, making them promising for comprehensive flu therapy. This is especially important in growing virus resistance to existing drugs and the need to find safe natural alternatives, according to the researchers. No random plants are in the blends ‚Äî each has its 'superpower'. For example, Stellaria media and Centaurea ciliaris are known for virus suppression, while Plantago lanceolata and Centaurium erythroides have anti-inflammatory and expectorant effects. The most effective blend consists of 11 components: Prunus padus and Rubus coreana fruits, oak bark, aconite root, silymarin root, polypody leaf, daisy flower and Centaurium erythroides leaves. 'The"
2025-09-06T11:02:10+00:00,@bezrec,6507,https://t.me/bezrec/6507,"–ü–µ—Ä–≤–∞—è –Ω–µ–¥–µ–ª—è –æ—Å–µ–Ω–∏ –ø–æ–¥—Ö–æ–¥–∏—Ç –∫ –∫–æ–Ω—Ü—É, –∞ –∑–Ω–∞—á–∏—Ç, –Ω–∞—Å—Ç–∞–ª–æ –≤—Ä–µ–º—è –Ω–∞—à–µ–π —Ä—É–±—Ä–∏–∫–∏ #–≤–¥–æ–≥–æ–Ω–∫—É. üíä –°—É–¥ –ø–æ–¥–¥–µ—Ä–∂–∞–ª —à—Ç—Ä–∞—Ñ –¥–ª—è ¬´–ö–†–ö–ê¬ª –≤ —Ä–∞–∑–º–µ—Ä–µ 650 —Ç—ã—Å. —Ä—É–±–ª–µ–π. –§–ê–° –æ—à—Ç—Ä–∞—Ñ–æ–≤–∞–ª–∞ —Å–ª–æ–≤–µ–Ω—Å–∫—É—é —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—é –∑–∞ –Ω–∞—Ä—É—à–µ–Ω–∏–µ –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å–Ω–æ–≥–æ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–∞ –∏ –Ω–µ–æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω–æ–µ –ø–æ–≤—ã—à–µ–Ω–∏–µ –æ—Ç–ø—É—Å–∫–Ω—ã—Ö —Ü–µ–Ω –Ω–∞ –æ—Ç–¥–µ–ª—å–Ω—ã–µ –¥–æ–∑–∏—Ä–æ–≤–∫–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –ö–æ-–î–∞–ª—å–Ω–µ–≤–∞ –Ω–∞ 10-16%. –°–ª–æ–≤–µ–Ω—Ü—ã –ø—ã—Ç–∞–ª–∏—Å—å —ç—Ç–æ —Ä–µ—à–µ–Ω–∏–µ –æ—Å–ø–æ—Ä–∏—Ç—å, –Ω–æ –ê—Ä–±–∏—Ç—Ä–∞–∂–Ω—ã–π —Å—É–¥ –ú–æ—Å–∫–≤—ã –≤—Å—Ç–∞–ª –Ω–∞ —Å—Ç–æ—Ä–æ–Ω—É –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å—â–∏–∫–æ–≤. üíä –í –ì–î –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –æ–ø–ª–∞—Ç–∏—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –º–∞–ª–æ–∏–º—É—â–∏–º –ø–µ–Ω—Å–∏–æ–Ω–µ—Ä–∞–º. –†—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å ¬´–°–ø—Ä–∞–≤–µ–¥–ª–∏–≤–æ–π –†–æ—Å—Å–∏–∏¬ª –°–µ—Ä–≥–µ–π –ú–∏—Ä–æ–Ω–æ–≤ –∏ –≥–ª–∞–≤–∞ –∫–æ–º–∏—Ç–µ—Ç–∞ –ì–æ—Å–¥—É–º—ã –ø–æ —Ä–∞–∑–≤–∏—Ç–∏—é –≥—Ä–∞–∂–¥–∞–Ω—Å–∫–æ–≥–æ –æ–±—â–µ—Å—Ç–≤–∞ –Ø–Ω–∞ –õ–∞–Ω—Ç—Ä–∞—Ç–æ–≤–∞ –ø—Ä–æ—Å—è—Ç –ú–∏—Ö–∞–∏–ª–∞ –ú—É—Ä–∞—à–∫–æ –ø–æ–ª–Ω–æ—Å—Ç—å—é –∫–æ–º–ø–µ–Ω—Å–∏—Ä–æ–≤–∞—Ç—å —Ç—Ä–∞—Ç—ã –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –ø–µ–Ω—Å–∏–æ–Ω–µ—Ä–∞–º —Å –¥–æ—Ö–æ–¥–æ–º –Ω–∏–∂–µ 1,5-–∫—Ä–∞—Ç–Ω–æ–≥–æ —Ä–∞–∑–º–µ—Ä–∞ –ø—Ä–æ–∂–∏—Ç–æ—á–Ω–æ–≥–æ –º–∏–Ω–∏–º—É–º–∞ –∑–∞ —Å—á—ë—Ç —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –±—é–¥–∂–µ—Ç–∞ üíä –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥—Å–∫–∏–π –ù–ò–ò –≤–∞–∫—Ü–∏–Ω –∏ —Å—ã–≤–æ—Ä–æ—Ç–æ–∫ –ø–æ–ª—É—á–∏–ª —Ä–∞–∑—Ä–µ—à–µ–Ω–∏–µ –Ω–∞ II –∏ III —Ñ–∞–∑—ã –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –ø—è—Ç–∏–≤–∞–ª–µ–Ω—Ç–Ω–æ–π –≤–∞–∫—Ü–∏–Ω—ã –æ—Ç –º–µ–Ω–∏–Ω–≥–∏—Ç–∞. –†–∞–∑—Ä–∞–±–æ—Ç–∫–µ –ø—Ä–µ–¥—Å—Ç–æ–∏—Ç –¥–æ–∫–∞–∑–∞—Ç—å ¬´–Ω–µ –º–µ–Ω—å—à—É—é —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –≤ —Å—Ä–∞–≤–Ω–µ–Ω–∏–∏ —Å –ú–µ–Ω–∞–∫—Ç—Ä–æ–π –æ—Ç Sanofi –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ —Å–µ—Ä–æ—Ç–∏–ø–æ–≤ –ê, C, W –∏ Y –∏ –ø—Ä–µ–≤–æ—Å—Ö–æ–¥—è—â—É—é —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ —Å–µ—Ä–æ—Ç–∏–ø–∞ B¬ª. üíä ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑¬ª –æ—Ç–∫—Ä—ã–≤–∞–µ—Ç –Ω–æ–≤—ã–π –∑–∞–≤–æ–¥ –≤ –ò—Ä–∫—É—Ç—Å–∫–µ. –ö–∞–∫ —Ä–∞—Å—Å–∫–∞–∑–∞–ª –≥—É–±–µ—Ä–Ω–∞—Ç–æ—Ä –ü—Ä–∏–∞–Ω–≥–∞—Ä—å—è –ò–≥–æ—Ä—å –ö–æ–±–∑–µ–≤, –Ω–∞ –Ω—ë–º –±—É–¥—É—Ç –≤—ã–ø—É—Å–∫–∞—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –æ—Ç –±—Ä–æ–Ω—Ö–∏–∞–ª—å–Ω–æ–π –∞—Å—Ç–º—ã. –û–±—ä—ë–º –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ - –±–æ–ª–µ–µ 125 –º–ª–Ω –∫–∞–ø—Å—É–ª –∏ 3 –º–ª–Ω –∞—ç—Ä–æ–∑–æ–ª–µ–π –¥–ª—è –∏–Ω–≥–∞–ª—è—Ü–∏–π –≤ –≥–æ–¥. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è —Å—É—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–µ —É–≤–µ–ª–∏—á–µ–Ω–∏–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã—Ö –º–æ—â–Ω–æ—Å—Ç–µ–π –¥–ª—è –≤—ã–ø—É—Å–∫–∞ –∞–∫—Ç–∏–≤–Ω—ã—Ö —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏–π –Ω–∞ –∑–∞–≤–æ–¥–µ –≤ –ë—Ä–∞—Ç—Å–∫–µ. –î–ª—è —ç—Ç–æ–π —Ü–µ–ª–∏ —É–∂–µ —Å—Ç—Ä–æ—è—Ç—Å—è –Ω–æ–≤—ã–µ –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω—ã–µ –∫–æ—Ä–ø—É—Å–∞. üíä ¬´–í–∞–∫—Ü–∏–Ω–∞ –æ—Ç —Ä–∞–∫–∞ –≥–æ—Ç–æ–≤–∞ –∫ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—é, –∂–¥—ë–º —Ä–∞–∑—Ä–µ—à–µ–Ω–∏—è¬ª. –ì–ª–∞–≤–∞ –§–ú–ë–ê –í–µ—Ä–æ–Ω–∏–∫–∞ –°–∫–≤–æ—Ä—Ü–æ–≤–∞ —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∞, —á—Ç–æ –≤ –∫–æ–Ω—Ü–µ –ª–µ—Ç–∞ 2025 –≥–æ–¥–∞ –∞–≥–µ–Ω—Ç—Å—Ç–≤–æ –Ω–∞–ø—Ä–∞–≤–∏–ª–æ –≤ –ú–∏–Ω–∑–¥—Ä–∞–≤ –¥–æ–∫—É–º–µ–Ω—Ç—ã –¥–ª—è –ø–æ–ª—É—á–µ–Ω–∏—è —Ä–∞–∑—Ä–µ—à–µ–Ω–∏—è –Ω–∞ –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–µ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ –Ω–æ–≤–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞. –ù–∞—á–∞—Ç—å –ø–ª–∞–Ω–∏—Ä—É—é—Ç —Å –∫–æ–ª–æ—Ä–µ–∫—Ç–∞–ª—å–Ω–æ–≥–æ —Ä–∞–∫–∞. –ü–∞—Ä–∞–ª–ª–µ–ª—å–Ω–æ –≤ –ø—Ä–æ–¥–≤–∏–Ω—É—Ç–æ–π —Å—Ç–∞–¥–∏–∏ –≤–∞–∫—Ü–∏–Ω–∞ –µ—â—ë –Ω–∞ –¥–≤–µ –ª–æ–∫–∞—Ü–∏–∏ ‚Äî —ç—Ç–æ –≥–ª–∏–æ–±–ª–∞—Å—Ç–æ–º–∞ –∏ –æ—Å–æ–±—ã–µ –≤–∏–¥—ã –º–µ–ª–∞–Ω–æ–º—ã. üíä –í–∏–∫—Ç–æ—Ä –§–∏—Å–µ–Ω–∫–æ –Ω–∞ –í–ú–≠–§ –ø–æ—Ö–≤–∞–ª–∏–ª –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π —Ñ–∞—Ä–º–ø—Ä–æ–º. –ü–æ —Å–ª–æ–≤–∞–º –ø–µ—Ä–≤–æ–≥–æ –∑–∞–º–º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –†–§, —Ä–æ—Å—Å–∏–π—Å–∫–∞—è —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∞—è –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç—å ¬´–¥–∏–Ω–∞–º–∏—á–Ω–æ —Ä–∞–∑–≤–∏–≤–∞–µ—Ç—Å—è –∏ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É–µ—Ç –≤—Å–µ–º –º–∏—Ä–æ–≤—ã–º —Ç—Ä–µ–Ω–¥–∞–º¬ª. –í —á–∏—Å–ª–µ –≥–ª–∞–≤–Ω—ã—Ö —Ç—Ä–µ–Ω–¥–æ–≤ —á–∏–Ω–æ–≤–Ω–∏–∫ –Ω–∞–∑–≤–∞–ª –ø–æ–∏—Å–∫ —Ä–µ—à–µ–Ω–∏–π –≤ –æ–±–ª–∞—Å—Ç–∏ –æ–Ω–∫–æ–ª–æ–≥–∏–∏, –º–µ—Ç–∞–±–æ–ª–∏—á–µ—Å–∫–∏—Ö –Ω–∞—Ä—É—à–µ–Ω–∏–π, –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –∏ –∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫–æ—Ä–µ–∑–∏—Å—Ç–µ–Ω—Ç–Ω–æ—Å—Ç–∏, –∞ —Ç–∞–∫–∂–µ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫—É –∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—é –º–†–ù–ö-–≤–∞–∫—Ü–∏–Ω. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety, guideline"",
  ""impact"": ""high"",
  ""english"": ""A new vaccine for cancer is ready to be applied, waiting for approval. The head of the FSB Russia, Veronika Skvorzova, announced that in late 2025 the agency will submit documents to the Ministry of Health for approval of a new drug. The clinical trial is planned to start with colorectal cancer. In parallel, the vaccine is in advanced stages on two sites - glioblastoma and certain types of melanoma.""
}"
2025-09-05T14:29:58+00:00,@bezrec,6506,https://t.me/bezrec/6506,"–ö–∏—Ç–∞–π—Ü—ã —Å–¥–µ–ª–∞–ª–∏ –º–∞—Å—Å–∞–∂—ë—Ä –¥–ª—è —à–µ–∏, –Ω–∞–ø–æ–º–∏–Ω–∞—é—â–∏–π —á–µ—Ä–µ–ø–∞—à–∫—É. ¬´–õ–∞–ø–∫–∏¬ª —É—Å—Ç—Ä–æ–π—Å—Ç–≤–∞ –∏–º–∏—Ç–∏—Ä—É—é—Ç –¥–≤–∏–∂–µ–Ω–∏—è —Ä—É–∫ –º–∞—Å—Å–∞–∂–∏—Å—Ç–∞, –∞ –µ—â—ë –æ–Ω–æ —Å –ø–æ–¥–æ–≥—Ä–µ–≤–æ–º. –°—Ç–æ–∏—Ç —Ç–∞–∫–æ–µ —á—É–¥–æ —Ç–µ—Ö–Ω–∏–∫–∏ –ø–æ—Ä—è–¥–∫–∞ $200. –¢–æ, —á—Ç–æ –Ω–∞–¥–æ –ø–æ—Å–ª–µ –Ω–∞–ø—Ä—è–∂–µ–Ω–Ω–æ–≥–æ —Ä–∞–±–æ—á–µ–≥–æ –¥–Ω—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-09-05T12:17:03+00:00,@bezrec,6505,https://t.me/bezrec/6505,"–ê —É –Ω–∞—Å –≤ –†—è–∑–∞–Ω–∏ –ë–ü–õ–ê —Å –≥–ª–∞–∑–∞–º–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏. –ì—É–±–µ—Ä–Ω–∞—Ç–æ—Ä –†—è–∑–∞–Ω—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –ü–∞–≤–µ–ª –ú–∞–ª–∫–æ–≤ –Ω–∞ –í–≠–§ —Ä–∞—Å—Å–∫–∞–∑–∞–ª, —á—Ç–æ —Ä–µ–≥–∏–æ–Ω –ø–ª–∞–Ω–∏—Ä—É–µ—Ç –∞–∫—Ç–∏–≤–Ω–æ –∑–∞–¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å –±–µ—Å–ø–∏–ª–æ—Ç–Ω—ã–µ –ª–µ—Ç–∞—Ç–µ–ª—å–Ω—ã–µ –∞–ø–ø–∞—Ä–∞—Ç—ã –≤ —Å—Ñ–µ—Ä–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –î—Ä–æ–Ω–∞–º–∏ –ø–ª–∞–Ω–∏—Ä—É—é—Ç –¥–æ—Å—Ç–∞–≤–ª—è—Ç—å –±–∏–æ–º–∞—Ç–µ—Ä–∏–∞–ª—ã –≤ –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–∏—é, –∫–æ—Ç–æ—Ä–∞—è –ø—Ä–æ–≤–æ–¥–∏—Ç –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –∞–Ω–∞–ª–∏–∑—ã, –∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –≤ –æ—Ç–¥–∞–ª–µ–Ω–Ω—ã–µ —Ä–∞–π–æ–Ω—ã. –ü—Ä–∏—á–µ–º —ç—Ç–æ –º–æ–∂–µ—Ç –¥–µ–ª–∞—Ç—å –æ–¥–∏–Ω –∏ —Ç–æ—Ç –∂–µ –±–µ—Å–ø–∏–ª–æ—Ç–Ω–∏–∫. –í –æ–¥–Ω—É —Å—Ç–æ—Ä–æ–Ω—É –æ–Ω –≤–µ–∑–µ—Ç —Å–æ–±—Ä–∞–Ω–Ω—ã–µ –±–∏–æ–º–∞—Ç–µ—Ä–∏–∞–ª—ã –¥–ª—è –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è –∞–Ω–∞–ª–∏–∑–æ–≤, –∞ –æ–±—Ä–∞—Ç–Ω–æ ‚Äî –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–æ. –í–æ–ø—Ä–æ—Å—ã –¥–µ–π—Å—Ç–≤–∏—è –≤ —ç–∫—Å—Ç—Ä–µ–Ω–Ω—ã—Ö —Å–∏—Ç—É–∞—Ü–∏—è—Ö, –∞ —Ç–∞–∫–∂–µ –±–µ–∑–æ–ø–∞—Å–Ω—ã—Ö –≤–æ–∑–¥—É—à–Ω—ã—Ö –∫–æ—Ä–∏–¥–æ—Ä–æ–≤ –¥–ª—è —Ç–∞–∫–∏—Ö –±–µ—Å–ø–∏–ª–æ—Ç–Ω–∏–∫–æ–≤ —É–∂–µ –æ—Ç—Ä–∞–±–æ—Ç–∞–Ω—ã, –∏ —Å–∫–æ—Ä–æ –Ω–∞—á–Ω—ë–º –ª–µ—Ç–∞—Ç—å, ‚Äî –ø–æ–¥–µ–ª–∏–ª—Å—è –∑–∞–¥—É–º–∫–æ–π –ú–∞–ª–∫–æ–≤. –ü–æ —Å–ª–æ–≤–∞–º –≥—É–±–µ—Ä–Ω–∞—Ç–æ—Ä–∞, –ø–µ—Ä–≤–æ–µ –≤—Ä–µ–º—è —Ç—Ä–∞–Ω—Å–ø–æ—Ä—Ç–∏—Ä–æ–≤–∫–∏ –±—É–¥—É—Ç –¥—É–±–ª–∏—Ä–æ–≤–∞—Ç—å –æ–±—ã—á–Ω—ã–º–∏ –∞–≤—Ç–æ–º–æ–±–∏–ª—è–º–∏. –ù–∞ –ø—Ä–æ—à–ª–æ–≥–æ–¥–Ω–µ–º –í–≠–§ –í–ª–∞–¥–∏–º–∏—Ä –ü—É—Ç–∏–Ω –∞–Ω–æ–Ω—Å–∏—Ä–æ–≤–∞–ª —Å–æ–∑–¥–∞–Ω–∏–µ –≤ —Ä–µ–≥–∏–æ–Ω–µ –∑–æ–Ω—ã –¥–ª—è –æ—Ç—Ä–∞–±–æ—Ç–∫–∏ –ë–ü–õ–ê –≤ –≥—Ä–∞–∂–¥–∞–Ω—Å–∫–∏—Ö —Ü–µ–ª—è—Ö. –°–≤–æ–π –±–µ—Å–ø–∏–ª–æ—Ç–Ω–∏–∫ –¥–ª—è –¥–æ—Å—Ç–∞–≤–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –∞–Ω–∞–ª–∏–∑–æ–≤ –∏–∑ —É–¥–∞–ª–µ–Ω–Ω—ã—Ö —Å–µ–ª –°–∞—Ö–∞–ª–∏–Ω—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –≤ –Æ–∂–Ω–æ-–°–∞—Ö–∞–ª–∏–Ω—Å–∫ —Å–æ–≤–º–µ—Å—Ç–Ω—ã–º–∏ —É—Å–∏–ª–∏—è–º–∏ —Å–æ–∑–¥–∞–ª–∏ –¢–∏—Ö–æ–æ–∫–µ–∞–Ω—Å–∫–∏–π –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–π —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç –∏ ¬´–ò–Ω–Ω–æ–ø–æ–ª–∏—Å¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": true
}"
2025-09-05T09:00:02+00:00,@bezrec,6504,https://t.me/bezrec/6504,"¬´–¢–∞–∫–æ–≥–æ –∫–æ–ª–∏—á–µ—Å—Ç–≤–∞ —Å–ª–∏—è–Ω–∏–π –∏ –ø–æ–≥–ª–æ—â–µ–Ω–∏–π –Ω–µ –±—ã–ª–æ –Ω–∏–∫–æ–≥–¥–∞¬ª, –∏–ª–∏ –∫–∞–∫ –∞–ø—Ç–µ—á–Ω—ã–π –±–∏–∑–Ω–µ—Å ¬´–ø–µ—Ä–µ–≤–∞—Ä–∏–≤–∞–µ—Ç¬ª –Ω–∞–ª–æ–≥–æ–≤—ã–µ —Ä–µ—Ñ–æ—Ä–º—ã. –° 1 —è–Ω–≤–∞—Ä—è 2025 –≥–æ–¥–∞ –º–∞–ª—ã–π –∏ —Å—Ä–µ–¥–Ω–∏–π –±–∏–∑–Ω–µ—Å —Å –æ–±–æ—Ä–æ—Ç–æ–º —Å–≤—ã—à–µ 60 –º–ª–Ω —Ä—É–±–ª–µ–π –æ–±—è–∑–∞–Ω —É–ø–ª–∞—á–∏–≤–∞—Ç—å –ù–î–°. –û—Å–æ–±–µ–Ω–Ω–æ –±–æ–ª—å–Ω–æ –Ω–µ–≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å —Ä–∞–±–æ—Ç–∞—Ç—å –Ω–∞ ¬´—É–ø—Ä–æ—â—ë–Ω–∫–µ¬ª —É–¥–∞—Ä–∏–ª–∞ –ø–æ –Ω–µ–±–æ–ª—å—à–∏–º –∞–ø—Ç–µ—á–Ω—ã–º —Å–µ—Ç—è–º. –í –∏—Ç–æ–≥–µ –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏ 60% —Ä—ã–Ω–∫–∞ –∫–æ–Ω—Ç—Ä–æ–ª–∏—Ä—É—é—Ç —Ñ–∞—Ä–º—Ä–∏—Ç–µ–π–ª–µ—Ä—ã –∏–∑ —Ç–æ–ø-10. –ü–æ –¥–∞–Ω–Ω—ã–º AlphaRM, –≤ –ø–µ—Ä–≤–æ–º –ø–æ–ª—É–≥–æ–¥–∏–∏ 2025 –≥–æ–¥–∞ –∫—Ä—É–ø–Ω–µ–π—à–∏–µ –∏–≥—Ä–æ–∫–∏ —Ñ–∞—Ä–º—Ä—ã–Ω–∫–∞ –∫—É–ø–∏–ª–∏ –ø–æ—á—Ç–∏ –≤–¥–≤–æ–µ –±–æ–ª—å—à–µ –Ω–µ–±–æ–ª—å—à–∏—Ö –∞–ø—Ç–µ—á–Ω—ã—Ö —Å–µ—Ç–µ–π –≥–æ–¥ –∫ –≥–æ–¥—É. –ó–∞ —É–∫–∞–∑–∞–Ω–Ω—ã–π –ø–µ—Ä–∏–æ–¥ –∏—Ö –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –≤—ã—Ä–æ—Å–ª–æ –¥–æ 83 (1459 —Ç–æ—á–µ–∫) –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –ø—Ä–æ—à–ª–æ–≥–æ–¥–Ω–∏–º–∏ 49 —Å–µ—Ç—è–º–∏, —Å–æ—Å—Ç–æ—è—â–∏–º–∏ –∏–∑ 700 —Ç–æ—á–µ–∫. –¢–∞–∫–æ–≥–æ –∫–æ–ª–∏—á–µ—Å—Ç–≤–∞ —Å–ª–∏—è–Ω–∏–π –∏ –ø–æ–≥–ª–æ—â–µ–Ω–∏–π –Ω–µ –±—ã–ª–æ –Ω–∏–∫–æ–≥–¥–∞: –∑–∞ –≤—Ç–æ—Ä—É—é –ø–æ–ª–æ–≤–∏–Ω—É 2024 –≥–æ–¥–∞ –∏ –ø–µ—Ä–≤—É—é 2025 –≥–æ–¥–∞ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã–µ —Å–µ—Ç–∏ –ø—Ä–∏–æ–±—Ä–µ–ª–∏ –æ–∫–æ–ª–æ 15% —Ç–æ—á–µ–∫ –≤ —Ä–µ–≥–∏–æ–Ω–µ,‚Äî –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—å –ø—Ä–∞–≤–ª–µ–Ω–∏—è –ê—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ –∞–ø—Ç–µ–∫ –ö–∞–ª–∏–Ω–∏–Ω–≥—Ä–∞–¥—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –î–º–∏—Ç—Ä–∏–π –Ø–≥–æ–≤–¥–∏–∫. –ù–∞–ª–æ–≥–æ–≤–æ–µ –±—Ä–µ–º—è, –≤—ã—Ä–æ—Å—à–µ–µ –ø—Ä–∏–º–µ—Ä–Ω–æ –Ω–∞ 2%, –≤ —Å–æ—á–µ—Ç–∞–Ω–∏–∏ —Å –∑–∞—Ç—Ä–∞—Ç–∞–º–∏ –Ω–∞ –ø–æ–ª–Ω–æ—Ü–µ–Ω–Ω—ã–π —É—á—ë—Ç –∏ –æ—Ç—á—ë—Ç–Ω–æ—Å—Ç—å, –Ω–∞–π–º–æ–º –≥–ª–∞–≤–±—É—Ö–∞ –∏ –æ–±–Ω–æ–≤–ª–µ–Ω–∏–µ–º –ø—Ä–æ–≥—Ä–∞–º–º–Ω–æ–≥–æ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –∫–∞—Å—Å –¥–ª—è –º–µ–ª–∫–∏—Ö –∏–≥—Ä–æ–∫–æ–≤ –æ–∫–∞–∑–∞–ª–æ—Å—å –Ω–µ–ø–æ—Å–∏–ª—å–Ω–æ–π –Ω–æ—à–µ–π. –£ –Ω–∞—Å –≤ —Ä–µ–≥–∏–æ–Ω–µ –±—ã–ª–∏ –¥–≤–µ –∞–ø—Ç–µ–∫–∏ —Å –æ–±–æ—Ä–æ—Ç–æ–º –æ–∫–æ–ª–æ 5 –º–ª–Ω —Ä—É–±–ª–µ–π –≤ –º–µ—Å—è—Ü, –≤ –ø—Ä–æ—à–ª–æ–º –≥–æ–¥—É –æ–Ω–∏ –ø–æ–∫–∞–∑–∞–ª–∏ —á–∏—Å—Ç—É—é –ø—Ä–∏–±—ã–ª—å 3‚Äì4 –º–ª–Ω —Ä—É–±–ª–µ–π, –∑–∞ –ø–µ—Ä–≤—ã–π –∫–≤–∞—Ä—Ç–∞–ª —ç—Ç–æ–≥–æ –≥–æ–¥–∞ ‚Äî —Ç–æ–ª—å–∫–æ 150 —Ç—ã—Å—è—á —Ä—É–±–ª–µ–π,‚Äî –Ω–∞–≥–ª—è–¥–Ω–æ –ø–æ—è—Å–Ω–∏–ª –Ø–≥–æ–≤–¥–∏–∫. –ï—â—ë –æ–¥–Ω–∞ –Ω–∞–ø–∞—Å—Ç—å ‚Äî –ø–æ–¥–æ—Ä–æ–∂–∞–≤—à–∞—è –∞—Ä–µ–Ω–¥–∞. –ü–æ —Å–ª–æ–≤–∞–º –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç–∞ –°–∞–º–∞—Ä—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–Ω–æ–π —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ –ï–ª–µ–Ω—ã –ì–ª–∞–¥–∫–æ–≤–æ–π, –≤–ª–∞–¥–µ–ª—å—Ü—ã –ø–æ–º–µ—â–µ–Ω–∏–π, —Ç–æ–∂–µ –ø–æ–ø–∞–≤—à–∏–µ –ø–æ–¥ –Ω–æ–≤—ã–µ –Ω–∞–ª–æ–≥–æ–≤—ã–µ –Ω–æ—Ä–º—ã, –≤—ã–Ω—É–∂–¥–µ–Ω—ã –±—ã–ª–∏ –ø–æ–¥–Ω—è—Ç—å –∞—Ä–µ–Ω–¥–Ω—É—é –ø–ª–∞—Ç—É –Ω–∞ –ø—Ä–æ—Ü–µ–Ω—Ç—ã –ù–î–°. –¢–∞–∫, –≤ 2025 –≥–æ–¥—É ¬´–†–∏–≥–ª–∞¬ª –≤—ã–∫—É–ø–∏–ª–∞ —Å–∞–º–∞—Ä—Å–∫—É—é ¬´–ê–ª–∏—è-–§–∞—Ä–º¬ª –∏–∑ 174 —Ç–æ—á–µ–∫. –ü–æ –∏—Ç–æ–≥–∞–º 2024 –≥–æ–¥–∞ —á–∏—Å—Ç—ã–π —É–±—ã—Ç–æ–∫ —Å–µ—Ç–∏ —É–≤–µ–ª–∏—á–∏–ª—Å—è –≤ —à–µ—Å—Ç—å —Ä–∞–∑. –í –º–∞–µ —Ç–∞ –∂–µ ¬´–†–∏–≥–ª–∞¬ª –ø—Ä–∏–æ–±—Ä–µ–ª–∞ –∫–∞–ª–∏–Ω–∏–Ω–≥—Ä–∞–¥—Å–∫—É—é —Å–µ—Ç—å ¬´–ù–æ–≤–∞—è –∞–ø—Ç–µ–∫–∞¬ª. –≠—Ç–∏ —Å–¥–µ–ª–∫–∏, –∫–∞–∫ –∏ –ø–æ–≥–ª–æ—â–µ–Ω–∏–µ ¬´–ü–ª–∞–Ω–µ—Ç–æ–π –∑–¥–æ—Ä–æ–≤—å—è¬ª –∏ ¬´–§–∞—Ä–º–ª–µ–Ω–¥–æ–º¬ª —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã—Ö ¬´–ú–æ–Ω–∞—Å—Ç—ã—Ä–µ–≤. —Ä—Ñ¬ª –∏ ¬´–í–∞–ª–µ—Ç—ã¬ª, —Å–≤—è–∑—ã–≤–∞—é—Ç –∏–º–µ–Ω–Ω–æ —Å –≤–æ–∑—Ä–æ—Å—à–µ–π —Ñ–∏–Ω–∞–Ω—Å–æ–≤–æ–π –Ω–∞–≥—Ä—É–∑–∫–æ–π –Ω–∞ –±–æ–ª–µ–µ –º–µ–ª–∫–∏—Ö –∏–≥—Ä–æ–∫–æ–≤. –í –∑–∞—Ç—Ä—É–¥–Ω–∏—Ç–µ–ª—å–Ω–æ–º –ø–æ–ª–æ–∂–µ–Ω–∏–∏ –ø–æ—Å–ª–µ –ø–µ—Ä–µ—Ö–æ–¥–∞ —Å —É–ø—Ä–æ—â—ë–Ω–∫–∏ –Ω–∞ –æ–±—â—É—é —Å–∏—Å—Ç–µ–º—É –Ω–∞–ª–æ–≥–æ–æ–±–ª–æ–∂–µ–Ω–∏—è –æ–∫–∞–∑–∞–ª–∏—Å—å –∏ ¬´–ê–ø—Ç–µ–∫–∏ –°–∞—Ä–æ–≤–∞¬ª. –†—É–∫–æ–≤–æ–¥—Å—Ç–≤–æ –ê–û —Ä–µ—à–∏–ª–æ, —á—Ç–æ –æ–ø—Ç–∏–º–∞–ª—å–Ω—ã–π –≤—ã—Ö–æ–¥ ‚Äî –∏–Ω—Ç–µ–≥—Ä–∞—Ü–∏—è —Å —Å–∏–ª—å–Ω—ã–º –ø–∞—Ä—Ç–Ω—ë—Ä–æ–º. –ò —Ç–∞–∫–æ–≤–æ–π –Ω–∞—à—ë–ª—Å—è –≤ –ª–∏—Ü–µ ¬´–ù–∏–∂–µ–≥–æ—Ä–æ–¥—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–Ω–æ–π —Ñ–∞—Ä–º–∞—Ü–∏–∏¬ª. –ê –≤–æ—Ç –ø—Ä–æ–≥–Ω–æ–∑, —á—Ç–æ —Ä–µ—Ñ–æ—Ä–º–∞ –æ—Å—Ç–∞–≤–∏—Ç —Å—ë–ª–∞ –±–µ–∑ –∞–ø—Ç–µ–∫, –ø–æ–∫–∞ –Ω–µ —Å–±—ã–ª—Å—è. –ü–æ –¥–∞–Ω–Ω—ã–º AlphaRM, —Ä–∞—Å–ø—Ä–µ–¥–µ–ª–µ–Ω–∏–µ –∞–ø—Ç–µ–∫ –ø–æ –≥–æ—Ä–æ–¥–∞–º —Å —Ä–∞–∑–Ω–æ–π —á–∏—Å–ª–µ–Ω–Ω–æ—Å—Ç—å—é –Ω–∞—Å–µ–ª–µ–Ω–∏—è –≤ –∫–æ–Ω—Ü–µ –ø–µ—Ä–≤–æ–≥–æ –ø–æ–ª—É–≥–æ–¥–∏—è 2025 –≥–æ–¥–∞ –æ—Å—Ç–∞–ª–æ—Å—å. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing, import_export, sanctions, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The message discusses changes in tax regulations affecting small and medium-sized pharmacies, particularly the requirement to pay VAT starting from January 1st, 2025. It highlights how this affects the market share of large pharmacy chains and their acquisitions, which are seen as a response to these changes. The message also mentions the financial burden on smaller pharmacies due to increased tax and administrative costs.""
}"
2025-09-05T05:36:23+00:00,@bezrec,6503,https://t.me/bezrec/6503,"–ü—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –Ω–µ —Å–ª–∏—à–∫–æ–º –æ—Ö–æ—Ç–Ω–æ –¥–µ–ª—è—Ç—Å—è —Ñ–∏–Ω–æ—Ç—á—ë—Ç–Ω–æ—Å—Ç—å—é –∑–∞ –ø–µ—Ä–≤–æ–µ –ø–æ–ª—É–≥–æ–¥–∏–µ 2025 –≥–æ–¥–∞. –ü–æ—Å–º–æ—Ç—Ä–µ–ª–∏ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –ø–æ –ú–°–§–û ¬´–ü—Ä–æ–º–æ–º–µ–¥–∞¬ª, ¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º–∞¬ª –∏ ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∏¬ª. ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª –ö–æ–º–ø–∞–Ω–∏—è –ü–µ—Ç—Ä–∞ –ë–µ–ª–æ–≥–æ, —Å—Ç–∞–≤—à–µ–≥–æ –ø—è—Ç—ã–º —Ä–æ—Å—Å–∏–π—Å–∫–∏–º –º–∏–ª–ª–∏–∞—Ä–¥–µ—Ä–æ–º, —Å–¥–µ–ª–∞–≤—à–∏–º —Å–æ—Å—Ç–æ—è–Ω–∏–µ –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞—Ö, –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç —Ä–∞–¥–æ–≤–∞—Ç—å —Å–≤–æ–µ–≥–æ –æ—Å–Ω–æ–≤–∞—Ç–µ–ª—è –≤—ã—Å–æ–∫–∏–º–∏ –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è–º–∏. –ì—Ä—É–ø–ø–∞ –ø–æ–∫–∞–∑–∞–ª–∞ —Ä–æ—Å—Ç –≤—ã—Ä—É—á–∫–∏ –Ω–∞ 82%, –¥–æ 12,9 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –≠—Ç–æ –≤ 5,5 —Ä–∞–∑ –±–æ–ª—å—à–µ —Ä–æ—Å—Ç–∞ —Ñ–∞—Ä–º—Ä—ã–Ω–∫–∞. –û–ø–µ—Ä–µ–∂–∞—é—â–∏–π —Ä–æ—Å—Ç EBITDA —Å–æ—Å—Ç–∞–≤–∏–ª 91% –∏ —á–∏—Å—Ç–æ–π –ø—Ä–∏–±—ã–ª–∏ ‚Äî 106%, –¥–æ 1,4 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –°–∞–º—ã–µ ¬´–∂–∏—Ä–Ω—ã–µ¬ª –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è ¬´–ü—Ä–æ–º–æ–º–µ–¥–∞¬ª ‚Äî —ç–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–∏—è (–ö–≤–∏–Ω—Å–µ–Ω—Ç–∞, –í–µ–ª–≥–∏—è –∏ –¢–∏—Ä–∑–µ—Ç—Ç–∞) –∏ –æ–Ω–∫–æ–ª–æ–≥–∏—è (–ª–∏–¥–µ—Ä –≤ –≥—Ä—É–ø–ø–µ - –ö–∞–±–æ–∑–∞–Ω—Ç–∏–Ω–∏–±). ¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º¬ª –í—ã—Å–æ–∫–æ–π –¥–∏–Ω–∞–º–∏–∫–æ–π –≥—Ä—É–ø–ø–∞ –ø–æ—Ö–≤–∞—Å—Ç–∞—Ç—å—Å—è –Ω–µ –º–æ–∂–µ—Ç. –í—ã—Ä—É—á–∫–∞ –ø–æ –∏—Ç–æ–≥–∞–º –ø–µ—Ä–≤–æ–≥–æ –ø–æ–ª—É–≥–æ–¥–∏—è 2025 –≥–æ–¥–∞ —Å–æ—Å—Ç–∞–≤–∏–ª–∞ 14,3 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —á—Ç–æ –Ω–∞ 6,5% –º–µ–Ω—å—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É. –¢–æ—á–Ω—ã—Ö —Ü–∏—Ñ—Ä –ø–æ –ø—Ä–∏–±—ã–ª–∏ ¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º¬ª –Ω–µ —Ä–∞—Å–∫—Ä—ã–≤–∞–µ—Ç, –Ω–æ –æ—Ç–º–µ—á–∞–µ—Ç –≤ –æ—Ç—á—ë—Ç–µ, —á—Ç–æ –≥—Ä—É–ø–ø–∞ ¬´–ø—Ä–æ–¥–µ–º–æ–Ω—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª–∞ –≤–æ—Å—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ –æ–ø–µ—Ä–∞—Ü–∏–æ–Ω–Ω–æ–π –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –∏ –¥–æ—Å—Ç–∏–≥–ª–∞ –ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω–æ–≥–æ –∑–Ω–∞—á–µ–Ω–∏—è —á–∏—Å—Ç–æ–π –ø—Ä–∏–±—ã–ª–∏, –∞ —Ç–∞–∫–∂–µ –æ–∂–∏–¥–∞–µ—Ç —Å–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –¥–∞–ª—å–Ω–µ–π—à–µ–π –ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω–æ–π –¥–∏–Ω–∞–º–∏–∫–∏ –≤ III –∏ IV –∫–≤–∞—Ä—Ç–∞–ª–∞—Ö 2025 –≥–æ–¥–∞¬ª. –ü–æ —Å–ª–æ–≤–∞–º —Ñ–∏–Ω–∞–Ω—Å–æ–≤–æ–≥–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ ¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º –ì—Ä—É–ø–ø¬ª –•–∞—Ñ–∏–∑–∞ –ì–∞—Ñ—É—Ä–æ–≤–∞, ¬´–∫–æ–º–ø–∞–Ω–∏—è —Å–æ–∑–Ω–∞—Ç–µ–ª—å–Ω–æ —Å—Ñ–æ–∫—É—Å–∏—Ä–æ–≤–∞–ª–∞—Å—å –Ω–∞ –æ–ø—Ç–∏–º–∏–∑–∞—Ü–∏–∏ –æ–±–æ—Ä–æ—Ç–Ω–æ–≥–æ –∫–∞–ø–∏—Ç–∞–ª–∞ –∏ –ø–æ–≤—ã—à–µ–Ω–∏–∏ –¥–æ–ª–≥–æ—Å—Ä–æ—á–Ω–æ–π –ª–∏–∫–≤–∏–¥–Ω–æ—Å—Ç–∏¬ª. –°—Ä–µ–¥–∏ —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏—Ö –ø—Ä–æ–µ–∫—Ç–æ–≤ ‚Äî —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤ –¥–ª—è –≤–Ω—É—Ç—Ä–µ–Ω–Ω–µ–≥–æ —Ä—ã–Ω–∫–∞ –∏ —ç–∫—Å–ø–æ—Ä—Ç–∞, –∞ —Ç–∞–∫–∂–µ —Å–æ–∑–¥–∞–Ω–∏–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã—Ö –º–æ—â–Ω–æ—Å—Ç–µ–π –¥–ª—è –≤—ã–ø—É—Å–∫–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ –æ—Å–Ω–æ–≤–µ –º–æ–Ω–æ–∫–ª–æ–Ω–∞–ª—å–Ω—ã—Ö –∞–Ω—Ç–∏—Ç–µ–ª. ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª –ß–∏—Å—Ç–∞—è –ø—Ä–∏–±—ã–ª—å –≥—Ä—É–ø–ø—ã –ø–æ –ú–°–§–û —Å–Ω–∏–∑–∏–ª–∞—Å—å –Ω–∞ 11% –≥–æ–¥ –∫ –≥–æ–¥—É, –¥–æ 1,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –í—ã—Ä—É—á–∫–∞ –≤—ã—Ä–æ—Å–ª–∞ –Ω–∞ 16%, –¥–æ 13,3 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ —Ç—É—Ç. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,pharmacovigilance,hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""The global pharmaceutical companies are not sharing their financial performance for the first half of 2025. Results from 'Promomed', 'Binnofarma', and 'Ozon Farma' show significant growth. Promomed, led by Petr Belo, continues to impress with an 82% increase in revenue to RUB129 billion. Binnofarma's performance is less impressive, with a 6.5% decrease in revenue to RUB143 billion. The company's financial director, Haifiz Haafiz, mentioned that the group is focusing on optimizing working capital and increasing long-term liquidity through strategies like registering generics for both internal and export markets, as well as establishing production capacity for monoclonal antibodies. The company's net profit fell by 11% to RUB17 billion, while revenue grew by 16% to RUB133 billion.""
}"
2025-09-04T15:05:45+00:00,@bezrec,6502,https://t.me/bezrec/6502,"–ó–∞–∫–∞–Ω—á–∏–≤–∞–µ–º —á–µ—Ç–≤–µ—Ä–≥ —Ü–∏—Ñ—Ä–æ–π –¥–Ω—è –æ—Ç –ú–∏—Ö–∞–∏–ª–∞ –ú—É—Ä–∞—à–∫–æ. –í–∞–∂–Ω–æ–µ –∏–∑ –≤—ã—Å—Ç—É–ø–ª–µ–Ω–∏—è –≥–ª–∞–≤—ã –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –Ω–∞ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–æ–º —Ñ–æ—Ä—É–º–µ ¬´–ò–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–∞—è –æ–Ω–∫–æ–ª–æ–≥–∏—è¬ª: üü© —Å 2019 –ø–æ 2024 –≥–æ–¥ –Ω–∞ –æ–ø–ª–∞—Ç—É –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –ø–æ –ø—Ä–æ—Ñ–∏–ª—é ¬´–æ–Ω–∫–æ–ª–æ–≥–∏—è¬ª –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–æ –±–æ–ª–µ–µ 300 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –µ–∂–µ–≥–æ–¥–Ω–æ; üü© –≤ 2025 –≥–æ–¥—É –ø—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ–Ω–æ –ø–æ—á—Ç–∏ 390 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π (–ø–æ—á—Ç–∏ –Ω–∞ 15% –±–æ–ª—å—à–µ, —á–µ–º –≤ 2024 –≥–æ–¥—É), –∏–∑ –∫–æ—Ç–æ—Ä—ã—Ö 140 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π ‚Äî –≤ —Ä–∞–º–∫–∞—Ö –Ω–∞—Ü–ø—Ä–æ–µ–∫—Ç–∞; üü© –∑–∞ –ø–æ—Å–ª–µ–¥–Ω–∏–µ –≥–æ–¥—ã –±–æ–ª–µ–µ —á–µ–º –Ω–∞ 70% –≤—ã—Ä–æ—Å–ª–æ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ —Å–ª—É—á–∞–µ–≤ –ª–µ—á–µ–Ω–∏—è —Å –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º –ø—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –≤ –¥–Ω–µ–≤–Ω—ã—Ö –∏ –∫—Ä—É–≥–ª–æ—Å—É—Ç–æ—á–Ω—ã—Ö —Å—Ç–∞—Ü–∏–æ–Ω–∞—Ä–∞—Ö; üü© –±–æ–ª–µ–µ —á–µ–º –Ω–∞ 44% —É–≤–µ–ª–∏—á–∏–ª–æ—Å—å –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ –ª—É—á–µ–≤–æ–π —Ç–µ—Ä–∞–ø–∏–∏, –≤–∫–ª—é—á–∞—è —Å–æ—á–µ—Ç–∞–Ω–∏–µ —Å –ø—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤–æ–π; üü© –≤–ø–µ—Ä–≤—ã–µ —Å 2020 –≥–æ–¥–∞ –≤ —Ç—Ä—ë—Ö –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è—Ö –≤–Ω–µ–¥—Ä–µ–Ω–∞ –ø—Ä–æ—Ç–æ–Ω–Ω–∞—è —Ç–µ—Ä–∞–ø–∏—è ‚Äî –µ—ë –ø–æ–ª—É—á–∏–ª–∏ –ø–æ—á—Ç–∏ 8 —Ç—ã—Å. –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –≤–∫–ª—é—á–∞—è –¥–µ—Ç–µ–π; üü© –≤ 2024 –≥–æ–¥—É —Ç–æ–ª—å–∫–æ –ø–æ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–π –ª—å–≥–æ—Ç–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –ø–æ–ª—É—á–∏–ª–∏ –ø–æ—Ä—è–¥–∫–∞ 384 —Ç—ã—Å. –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –æ–Ω–∫–æ–∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏, –ø–æ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω–æ–π ‚Äî –±–æ–ª–µ–µ 600 —Ç—ã—Å.; üü© –∑–∞ –ø–æ—Å–ª–µ–¥–Ω–∏–µ 6 –ª–µ—Ç –≤ —Ä–∞–º–∫–∞—Ö —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–π –ª—å–≥–æ—Ç—ã –≤—ã–ø–∏—Å–∞–Ω–æ –±–æ–ª–µ–µ 13 –º–ª–Ω —Ä–µ—Ü–µ–ø—Ç–æ–≤ –Ω–∞ —Å—É–º–º—É —Å–≤—ã—à–µ 165 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, –∞ –≤ —Ä–∞–º–∫–∞—Ö —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω–æ–π –ª—å–≥–æ—Ç—ã ‚Äî –±–æ–ª–µ–µ 14 –º–ª–Ω —Ä–µ—Ü–µ–ø—Ç–æ–≤ –Ω–∞ 200 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, reimbursement, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The Russian government has significantly increased funding for oncology care, with over 300 billion rubles allocated annually from 2019 to 2024. In 2025, this amount is projected to reach nearly 390 billion rubles (15% more than in 2024), with a significant portion allocated through the national project. There has been a substantial increase in the use of anti-cancer therapies, with over 70% more patients receiving treatment. Proton therapy has been introduced in three hospitals, treating nearly 8,000 patients, including children. Over the past six years, more than 13 million prescriptions have been issued for over 165 billion rubles under federal subsidies, and more than 14 million prescriptions for over 200 billion rubles under regional subsidies.""
}"
2025-09-04T12:30:01+00:00,@bezrec,6501,https://t.me/bezrec/6501,"FDA –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç ¬´–æ–±–ª–µ–≥—á–∏—Ç—å –∂–∏–∑–Ω—å¬ª –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–π —Ä–µ–≥—É–ª—è—Ç–æ—Ä –≤—ã—Å—Ç—É–ø–∏–ª —Å –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–æ–π —É–ø—Ä–æ—Å—Ç–∏—Ç—å –ø—Ä–æ—Ü–µ–¥—É—Ä—É —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –ø—Ä–µ–¥–Ω–∞–∑–Ω–∞—á–µ–Ω–Ω—ã—Ö –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Ä–µ–¥–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π —É –æ—á–µ–Ω—å –Ω–µ–±–æ–ª—å—à–∏—Ö –≥—Ä—É–ø–ø –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –≤–∫–ª—é—á–∞—è —Å–ª—É—á–∞–∏, –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–µ–Ω–Ω—ã–µ –¥–∞–Ω–Ω—ã–º–∏ –Ω–µ—Å—Ä–∞–≤–Ω–∏—Ç–µ–ª—å–Ω—ã—Ö –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å–ø—ã—Ç–∞–Ω–∏–π. –ö —Ç–∞–∫–æ–≤—ã–º –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è –æ—Ç–Ω–æ—Å–∏—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –ø—Ä–æ—Ç–∏–≤ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, –≤—Å—Ç—Ä–µ—á–∞—é—â–∏—Ö—Å—è –º–µ–Ω–µ–µ —á–µ–º —É 1 —Ç—ã—Å. —á–µ–ª–æ–≤–µ–∫ –≤ –°–®–ê, –∞ —Ç–∞–∫–∂–µ –≤–æ–∑–Ω–∏–∫—à–∏—Ö –≤ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–µ –≥–µ–Ω–µ—Ç–∏—á–µ—Å–∫–∏—Ö ¬´–ø–æ–ª–æ–º–æ–∫¬ª. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –±—É–¥–µ—Ç —É—á–∏—Ç—ã–≤–∞—Ç—å—Å—è –Ω–∞–ª–∏—á–∏–µ –∞–¥–µ–∫–≤–∞—Ç–Ω—ã—Ö –∞–ª—å—Ç–µ—Ä–Ω–∞—Ç–∏–≤–Ω—ã—Ö –º–µ—Ç–æ–¥–æ–≤ –ª–µ—á–µ–Ω–∏—è, —Å–ø–æ—Å–æ–±–Ω—ã—Ö –∏–∑–º–µ–Ω–∏—Ç—å —Ç–µ—á–µ–Ω–∏–µ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è. –í FDA —Å—á–∏—Ç–∞—é—Ç, —á—Ç–æ –¥–ª—è –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å—Å—Ç–≤–∞ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ —Ç–∞–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ –æ–¥–Ω–æ–≥–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è, –≤ —Ç–æ–º —á–∏—Å–ª–µ –Ω–µ—Å—Ä–∞–≤–Ω–∏—Ç–µ–ª—å–Ω–æ–≥–æ. –ü–æ –º–Ω–µ–Ω–∏—é –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–µ–π –∞–≥–µ–Ω—Ç—Å—Ç–≤–∞, –ø–æ–¥—Ç–≤–µ—Ä–¥–∏—Ç—å ¬´—Ä–∞–±–æ—Ç–æ—Å–ø–æ—Å–æ–±–Ω–æ—Å—Ç—å¬ª –æ—Ä—Ñ–∞–Ω–Ω–æ–≥–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –º–æ–∂–Ω–æ —Å –ø–æ–º–æ—â—å—é –¥–∞–Ω–Ω—ã—Ö –æ –µ–≥–æ –¥–µ–π—Å—Ç–≤–∏–∏ –Ω–∞ —Ç–µ—Ä–∞–ø–µ–≤—Ç–∏—á–µ—Å–∫—É—é –º–∏—à–µ–Ω—å, –∞ —Ç–∞–∫–∂–µ –¥–æ–∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –¥–∞–Ω–Ω—ã—Ö. –¢–∞–∫–∏–º –æ–±—Ä–∞–∑–æ–º —Ä–µ–≥—É–ª—è—Ç–æ—Ä –æ—Ç—Ä–µ–∞–≥–∏—Ä–æ–≤–∞–ª –Ω–∞ –ø—Ä–∏–∑—ã–≤ –†–æ–±–µ—Ä—Ç–∞ –§. –ö–µ–Ω–Ω–µ–¥–∏-–º–ª–∞–¥—à–µ–≥–æ –∏—Å–∫–∞—Ç—å —Å–ø–æ—Å–æ–±—ã —É—Å–∫–æ—Ä–µ–Ω–∏—è –æ–¥–æ–±—Ä–µ–Ω–∏—è –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ —É—Å—Ç—Ä–∞–Ω–µ–Ω–∏—è –ø—Ä–µ–ø—è—Ç—Å—Ç–≤–∏–π –Ω–∞ –∏—Ö –ø—É—Ç–∏ –∫ —Ä—ã–Ω–∫—É. –í –Ω–∞—á–∞–ª–µ —ç—Ç–æ–π –Ω–µ–¥–µ–ª–∏ –¥–µ–ø—É—Ç–∞—Ç—ã –ø–∞—Ä—Ç–∏–∏ ¬´–ù–æ–≤—ã–µ –ª—é–¥–∏¬ª –æ–±—Ä–∞—Ç–∏–ª–∏—Å—å –∫ –ú–∏—Ö–∞–∏–ª—É –ú—É—Ä–∞—à–∫–æ —Å –ø—Ä–æ—Å—å–±–æ–π –≤–≤–µ—Å—Ç–∏ –ø—Ä–∏–æ—Ä–∏—Ç–µ—Ç–Ω—ã–π –ø–æ—Ä—è–¥–æ–∫ –æ—Ñ–æ—Ä–º–ª–µ–Ω–∏—è –¥–ª—è –ø–∞—Ä—Ç–∏–π –∂–∏–∑–Ω–µ–Ω–Ω–æ –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã—Ö –¥–µ—Ç—Å–∫–∏—Ö –∏ –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ ‚Äî ¬´–∑–µ–ª—ë–Ω—ã–π –∫–æ—Ä–∏–¥–æ—Ä¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-09-04T09:06:28+00:00,@bezrec,6500,https://t.me/bezrec/6500,"–ü–µ—Ä–≤—ã–º–∏ —Ä–µ–∑–∏–¥–µ–Ω—Ç–∞–º–∏ –ò–ù–¢–¶ ¬´–†—É—Å—Å–∫–∏–π¬ª —Å—Ç–∞–ª–∏ –¥–≤–µ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏. –í–ª–∞–¥–∏–º–∏—Ä –ü—É—Ç–∏–Ω –ø–æ –≤–∏–¥–µ–æ—Å–≤—è–∑–∏ –¥–∞–ª —Å—Ç–∞—Ä—Ç —Ä–∞–±–æ—Ç–µ –Ω–æ–≤—ã—Ö –æ–±—ä–µ–∫—Ç–æ–≤ –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä—ã –≤ —Ä–µ–≥–∏–æ–Ω–∞—Ö –î–∞–ª—å–Ω–µ–≥–æ –í–æ—Å—Ç–æ–∫–∞. –í –∏—Ö —á–∏—Å–ª–µ ‚Äî –ø–∏–ª–æ—Ç–Ω–∞—è –ø–ª–æ—â–∞–¥–∫–∞ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ –Ω–∞—É—á–Ω–æ-—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ —Ü–µ–Ω—Ç—Ä–∞ (–ò–ù–¢–¶) ¬´–†—É—Å—Å–∫–∏–π¬ª –≤ –ü—Ä–∏–º–æ—Ä—Å–∫–æ–º –∫—Ä–∞–µ. –ï–≥–æ –ø–µ—Ä–≤—ã–º–∏ ¬´–ø–æ—Å—Ç–æ—è–ª—å—Ü–∞–º–∏¬ª —Å—Ç–∞–ª–∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤. –í —Ä–∞–º–∫–∞—Ö –í–æ—Å—Ç–æ—á–Ω–æ–≥–æ —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–≥–æ —Ñ–æ—Ä—É–º–∞ –∑–∞–ø—É—Å–∫–∞–µ–º –ø–∏–ª–æ—Ç–Ω—ã–π –∫–æ—Ä–ø—É—Å, –≤ –∫–æ—Ç–æ—Ä–æ–º —Ä–∞–∑–º–µ—Å—Ç—è—Ç—Å—è –ø–µ—Ä–≤—ã–µ —Ä–µ–∑–∏–¥–µ–Ω—Ç—ã ¬´–ê–≤–µ–∫—Å–∏–º–∞ –ò–Ω–Ω–æ—Ç–µ—Ö¬ª –∏ ¬´–ê–≤–µ–∫—Å–∏–º–∞ –î–∏–æ–ª¬ª ‚Äî —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–µ –∫–æ–º–ø–∞–Ω–∏–∏ –ø–æ–ª–Ω–æ–≥–æ —Ü–∏–∫–ª–∞, —Å–æ–∑–¥–∞—é—â–∏–µ –∏–º–ø–æ—Ä—Ç–æ–∑–∞–º–µ—â–∞—é—â–∏–µ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª –∑–∞–º–ø—Ä–µ–¥ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –†–§, –ø–æ–ª–Ω–æ–º–æ—á–Ω—ã–π –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª—å –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç–∞ –≤ –î–§–û –Æ—Ä–∏–π –¢—Ä—É—Ç–Ω–µ–≤. –í –ò–ù–¢–¶, —Å–æ–∑–¥–∞–Ω–Ω–æ–º –ø–æ –ø–æ—Ä—É—á–µ–Ω–∏—é –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç–∞, –±—É–¥—É—Ç –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –∫–æ–Ω—Ç—Ä–æ–ª—è —É—Ä–æ–≤–Ω—è –≥–ª—é–∫–æ–∑—ã –ø—Ä–∏ –¥–∏–∞–±–µ—Ç–µ, –∞–≥–∞—Ä –∏ –∞–≥–∞—Ä–æ–∑—É (—Å—ã—Ä—å–µ –¥–ª—è –ø–∏—â–µ–≤–æ–π, –º–∏–∫—Ä–æ–±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏), —Ü–∏—Ñ—Ä–æ–≤—ã–µ –¥–≤–æ–π–Ω–∏–∫–∏ –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏–π, —Å–æ—Ñ—Ç –¥–ª—è —Å—É–¥–æ—Å—Ç—Ä–æ–µ–Ω–∏—è, –±–∏–æ–∫–æ—Ä–º–∞ –Ω–∞ –æ—Å–Ω–æ–≤–µ –º–∏–∫—Ä–æ–≤–æ–¥–æ—Ä–æ—Å–ª–µ–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-09-04T05:34:19+00:00,@bezrec,6499,https://t.me/bezrec/6499,"¬´–õ—É—á—à–µ–π —Å—Ç—Ä–∞—Ç–µ–≥–∏–µ–π —Å—Ç–∞–Ω–µ—Ç –Ω–µ –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏—è, –∞ —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–æ¬ª. –≠–∫—Å–ø–µ—Ä—Ç—ã –ø—Ä–æ–∫–æ–º–º–µ–Ω—Ç–∏—Ä–æ–≤–∞–ª–∏ –ø–ª–∞–Ω—ã –ò–Ω–¥–∏–∏ —É–≤–µ–ª–∏—á–∏—Ç—å –ø–æ—Å—Ç–∞–≤–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ –†–§. –ò–Ω–¥–∏—è –Ω–∞–º–µ—Ä–µ–Ω–∞ –Ω–∞—Ä–∞—Å—Ç–∏—Ç—å —ç–∫—Å–ø–æ—Ä—Ç —Ñ–∞—Ä–º–ø—Ä–æ–¥—É–∫—Ü–∏–∏ –≤ –†–æ—Å—Å–∏—é, –ù–∏–¥–µ—Ä–ª–∞–Ω–¥—ã –∏ –ë—Ä–∞–∑–∏–ª–∏—é, —á—Ç–æ–±—ã —Ä–∞—Å—à–∏—Ä–∏—Ç—å —Å–≤–æ–µ –ø—Ä–∏—Å—É—Ç—Å—Ç–≤–∏–µ –∑–∞ –ø—Ä–µ–¥–µ–ª—ã –°–æ–µ–¥–∏–Ω–µ–Ω–Ω—ã—Ö –®—Ç–∞—Ç–æ–≤, –Ω–∞ —Ñ–æ–Ω–µ –æ–ø–∞—Å–µ–Ω–∏–π, —Å–≤—è–∑–∞–Ω–Ω—ã—Ö —Å –ø–æ—à–ª–∏–Ω–∞–º–∏ –î–æ–Ω–∞–ª—å–¥–∞ –¢—Ä–∞–º–ø–∞. –ù–∞ –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–π —Ä—ã–Ω–æ–∫ –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è —Ç—Ä–µ—Ç—å –ø–æ—Å—Ç–∞–≤–æ–∫ –∏–∑ —Ä–µ—Å–ø—É–±–ª–∏–∫–∏, –≤ —ç—Ç–æ–º –≥–æ–¥—É –æ–±—ä—ë–º –¥–æ—Å—Ç–∏–≥ $10,5 –º–ª—Ä–¥, –ø–æ–∫–∞–∑–∞—Ç–µ–ª—å –†–§ ‚Äî $577 –º–ª–Ω. –¢–∞–∫ –∫–∞–∫ –º—ã –≥–æ–≤–æ—Ä–∏–º –Ω–µ –æ–± —É–Ω–∏–∫–∞–ª—å–Ω—ã—Ö –Ω–æ–≤—ã—Ö –ø—Ä–æ—Ä—ã–≤–Ω—ã—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—è—Ö, –∞ –æ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞—Ö, –≤–æ—Å–ø—Ä–æ–∏–∑–≤–µ–¥–µ–Ω–Ω—ã—Ö –∏ –º–Ω–æ–≥–æ –ª–µ—Ç –∏—Å–ø–æ–ª—å–∑—É–µ–º—ã—Ö, –æ—Å—Ç—Ä–æ–π –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ —Å —Ç–æ—á–∫–∏ –∑—Ä–µ–Ω–∏—è –º–µ–¥–∏—Ü–∏–Ω—ã –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∏ –≤ –Ω–∏—Ö –Ω–µ—Ç. –ù–æ –∏—Ö –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–µ –ø–æ–∑–≤–æ–ª–∏—Ç —Å–Ω–∏–∑–∏—Ç—å —Ü–µ–Ω—ã –≤ –∫–æ–º–º–µ—Ä—á–µ—Å–∫–æ–º —Å–µ–≥–º–µ–Ω—Ç–µ, ‚Äî —Å—á–∏—Ç–∞–µ—Ç –≤–∏—Ü–µ-–ø—Ä–µ–∑–∏–¥–µ–Ω—Ç –º–µ–¥–∏–∫–æ-—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è –ø—Ä–æ–µ–∫—Ç–∞ Farm GPT –ì–µ—Ä–º–∞–Ω –ò–Ω–æ–∑–µ–º—Ü–µ–≤. –ï—Å–ª–∏ –≥–æ–≤–æ—Ä–∏—Ç—å –æ —Å–µ–≥–º–µ–Ω—Ç–µ –≥–æ—Å–∑–∞–∫—É–ø–æ–∫, —Ç–æ –∏–Ω–¥–∏–π—Å–∫–æ–µ ¬´–≤—Ç–æ—Ä–∂–µ–Ω–∏–µ¬ª –º–æ–∂–µ—Ç –ø–æ–¥—Å—Ç–µ–≥–Ω—É—Ç—å –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –∫ –±–æ–ª–µ–µ –∞–∫—Ç–∏–≤–Ω–æ–º—É –∑–∞–ø—É—Å–∫—É –Ω–æ–≤—ã—Ö –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤. –î–∏—Ä–µ–∫—Ç–æ—Ä –ø–æ —Ä–∞–∑–≤–∏—Ç–∏—é RNC Pharma –ù–∏–∫–æ–ª–∞–π –ë–µ—Å–ø–∞–ª–æ–≤ –ø–æ–ª–∞–≥–∞–µ—Ç, —á—Ç–æ –∏–Ω–¥–∏–π—Å–∫–∏–µ –∫–æ–º–ø–∞–Ω–∏–∏ –º–æ–≥—É—Ç –≤—Å—Ç—Ä–µ—Ç–∏—Ç—å—Å—è —Å —Å–æ–ø—Ä–æ—Ç–∏–≤–ª–µ–Ω–∏–µ–º —Å–æ —Å—Ç–æ—Ä–æ–Ω—ã —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –∏–≥—Ä–æ–∫–æ–≤. –ü–æ –º–Ω–µ–Ω–∏—é –∞–Ω–∞–ª–∏—Ç–∏–∫–∞, —Å ¬´–≥–æ—Å—Ç—è–º–∏¬ª –ª—É—á—à–µ –Ω–µ –∫–æ–Ω–∫—É—Ä–∏—Ä–æ–≤–∞—Ç—å, –∞ —Å–æ—Ç—Ä—É–¥–Ω–∏—á–∞—Ç—å, –Ω–∞–ø—Ä–∏–º–µ—Ä, –≤ —Ä–∞–º–∫–∞—Ö —Ç—Ä–∞–Ω—Å—Ñ–µ—Ä–∞ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π, –ø—É—Å—Ç—å –¥–∞–∂–µ —ç—Ç–æ –±—É–¥—É—Ç –∏ –Ω–µ —Å–≤–µ—Ä—Ö–∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–µ –ø—Ä–æ–¥—É–∫—Ç—ã. –ú–æ–∂–µ—Ç —Ä–∞—Å—Å–º–∞—Ç—Ä–∏–≤–∞—Ç—å—Å—è —Ñ–æ—Ä–º–∞—Ç –ø–µ—Ä–µ–Ω–æ—Å–∞ –æ—Ç–¥–µ–ª—å–Ω—ã—Ö –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤ –ø–æ–ª–Ω–æ–≥–æ —Ü–∏–∫–ª–∞ –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏—é –†–æ—Å—Å–∏–∏. –ï—Å—Ç–µ—Å—Ç–≤–µ–Ω–Ω–æ, –±—É–¥—É—Ç –∏–Ω—Ç–µ—Ä–µ—Å–∞–Ω—Ç—ã, –∫–æ—Ç–æ—Ä—ã–µ –ø–æ–ø—ã—Ç–∞—é—Ç—Å—è —ç—Ç–æ–º—É –ø—Ä–æ—Ç–∏–≤–æ—Å—Ç–æ—è—Ç—å. –ó–¥–µ—Å—å —Å–∞–º–∞—è –≥–ª–∞–≤–Ω–∞—è –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å ‚Äî –≥–ª—É–±–æ–∫–∞—è –∫–æ–æ–ø–µ—Ä–∞—Ü–∏—è, —Å–æ–∑–¥–∞–Ω–∏–µ —Å–æ–≤–º–µ—Å—Ç–Ω—ã—Ö –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏–π, –ø–µ—Ä–µ–Ω–æ—Å —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π. –í—Å–µ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è —ç—Ç–æ–≥–æ —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–∞ –º–æ–∂–Ω–æ –∏ –Ω—É–∂–Ω–æ —Ä–∞–∑–≤–∏–≤–∞—Ç—å. –¢–∞–∫–∂–µ –æ—á–µ–Ω—å —Å–µ—Ä—å–µ–∑–Ω–æ–µ –ø–æ–ª–µ –¥–ª—è —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–∞ —Å—É—â–µ—Å—Ç–≤—É–µ—Ç –ø–æ –æ—Ç–¥–µ–ª—å–Ω—ã–º –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è–º –±–∏–æ—Ç–µ—Ö–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""Experts commented on India's plans to increase drug supplies in Russia. India intends to expand its exports of pharmaceutical products to Russia, the Netherlands, and Brazil to increase its presence beyond the United States amid concerns about Donald Trump's tariffs. One-third of India's exports to the US are worth $10.5 billion, while Russia's share is $577 million. The increase in exports does not pose an urgent need for new innovative technologies but can help reduce prices in the commercial segment. For the government procurement segment, Indian companies' expansion may encourage domestic producers to launch new generics more actively. The director of RNC Pharma believes that Indian companies may face resistance from domestic players. Cooperation is recommended over competition, possibly through technology transfer or joint ventures to replicate production processes in Russia. The main opportunity lies in deep cooperation and development of various fields.""
}"
2025-09-03T14:33:35+00:00,@bezrec,6498,https://t.me/bezrec/6498,"–ì–µ—Ä–æ–∏ –ø–µ—Ä–≤–æ–≥–æ –æ—Å–µ–Ω–Ω–µ–≥–æ –≤—ã–ø—É—Å–∫–∞ #–∑–∞—Ü–µ–Ω–∏–ª–∏ ‚Äî –≥–ª–∞–∑–Ω—ã–µ –∫–∞–ø–ª–∏ –Ω–∞ –æ—Å–Ω–æ–≤–µ —Ç–µ—Ç—Ä–∏–∑–æ–ª–∏–Ω–∞. –ò—Ö –∏—Å–ø–æ–ª—å–∑—É—é—Ç –¥–ª—è —É–º–µ–Ω—å—à–µ–Ω–∏—è –æ—Ç–µ–∫–∞ –∏ –ø–æ–∫—Ä–∞—Å–Ω–µ–Ω–∏—è –≥–ª–∞–∑. –ß—Ç–æ–±—ã –Ω–µ –≥–æ—Ä–µ–ª–∏ –∫–∞–∫ –∫–æ—Å—Ç—Ä—ã —Ä—è–±–∏–Ω. –ú—ã —Å—Ä–∞–≤–Ω–∏–ª–∏ —Ü–µ–Ω—ã –≤ –æ–Ω–ª–∞–π–Ω-–∞–ø—Ç–µ–∫–∞—Ö –Ω–∞ —Ç–æ—Ä–≥–æ–≤—ã–µ –º–∞—Ä–∫–∏ –í–∏–∑–∏–Ω (¬´–î–∂–µ–π–¢–ù–õ¬ª, –≥—Ä—É–ø–ø–∞ ¬´–î–∂–æ–Ω—Å–æ–Ω & –î–∂–æ–Ω—Å–æ–Ω¬ª), –û—Ñ—Ç—Ä–∏–∫—Å (¬´–ì—Ä–æ—Ç–µ–∫—Å¬ª), –í–∏–∑–æ–∫–∫–æ (¬´–°–µ–≤–µ—Ä–Ω–∞—è –ó–≤–µ–∑–¥–∞¬ª), –ú–æ–Ω—Ç–µ–≤–∏–∑–∏–Ω (¬´–•–µ–º–æ—Ñ–∞—Ä–º¬ª), –û–ø—Ç–∏–Ω–æ–ª (¬´–Ø–¥—Ä–∞–Ω-–ì–∞–ª–µ–Ω—Å–∫–∏¬ª). –í—ã—Å–æ–∫–∏–º–∏ —Ü–µ–Ω–∞–º–∏ –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏ –Ω–∞ –≤—Å–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, –∫—Ä–æ–º–µ –û—Ñ—Ç—Ä–∏–∫—Å–∞, –æ—Ç–ª–∏—á–∏–ª–∞—Å—å ¬´36,6¬ª. –¢–∞–∫, —Å–∞–º—ã–π –¥–æ—Ä–æ–≥–æ–π —É—á–∞—Å—Ç–Ω–∏–∫ ‚Äî –í–∏–∑–∏–Ω ‚Äî —Ç–∞–º —Å—Ç–æ–∏—Ç 798 —Ä—É–±–ª–µ–π. –î–ª—è —Å—Ä–∞–≤–Ω–µ–Ω–∏—è, –≤ ¬´–ó–¥—Ä–∞–≤—Å–∏—Ç–∏¬ª –∏ ¬´–ï–∞–ø—Ç–µ–∫–µ¬ª –æ–Ω –∂–µ –æ–±–æ–π–¥—ë—Ç—Å—è –≤ 594 —Ä—É–±–ª—è. –°–∞–º—ã–π —ç–∫–æ–Ω–æ–º–∏—á–Ω—ã–π –≤–∞—Ä–∏–∞–Ω—Ç ‚Äî –í–∏–∑–æ–∫–∫–æ. –ö–∞–ø–ª–∏ –æ—Ç ¬´–°–µ–≤–µ—Ä–Ω–æ–π –ó–≤–µ–∑–¥—ã¬ª –≤ ¬´–ó–¥—Ä–∞–≤—Å–∏—Ç–∏¬ª —Å—Ç–æ—è—Ç 297 —Ä—É–±–ª–µ–π. –ù–∞–ø–æ–º–∏–Ω–∞–µ–º, —á—Ç–æ –ª—é–±—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏–º–µ—é—Ç –ø—Ä–æ—Ç–∏–≤–æ–ø–æ–∫–∞–∑–∞–Ω–∏—è. –ü–µ—Ä–µ–¥ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º –ø—Ä–æ–∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä—É–π—Ç–µ—Å—å —Å –ª–µ—á–∞—â–∏–º –≤—Ä–∞—á–æ–º. *–∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –ø—Ä–æ–≤–æ–¥–∏–ª–æ—Å—å –æ–Ω–ª–∞–π–Ω 3 —Å–µ–Ω—Ç—è–±—Ä—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-09-03T11:30:47+00:00,@bezrec,6497,https://t.me/bezrec/6497,"–ê–ª–ª–∞ –°–∞–º–æ–π–ª–æ–≤–∞ –∏ –ú–∏—Ö–∞–∏–ª –ú–∏—à—É—Å—Ç–∏–Ω –ø–æ–≥–æ–≤–æ—Ä–∏–ª–∏ –ø—Ä–æ –û–∑–µ–º–ø–∏–∫ –∏ –¥—Ä—É–≥–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞. –ù–∞ –≤—Å—Ç—Ä–µ—á–µ —Å –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª–µ–º –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –≥–ª–∞–≤–∞ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–∞ —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∞, –∫–∞–∫ —Å–ª—É–∂–±–∞ —Å–ø—Ä–∞–≤–ª—è–µ—Ç—Å—è —Å –Ω–æ–≤–æ–π —Ñ—É–Ω–∫—Ü–∏–µ–π ‚Äì –ø–æ –∫–æ–Ω—Ç—Ä–æ–ª—é –∑–∞ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–º–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º–∏ –∏ –∏—Ö –¥–æ–ø—É—Å–∫—É –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–∏–π —Ä—ã–Ω–æ–∫. –°–æ–±—Ä–∞–ª–∏ –≥–ª–∞–≤–Ω–æ–µ –∏–∑ –±–µ—Å–µ–¥—ã: üíä –ö–æ–Ω—Ç—Ä–æ–ª—å –∑–∞ –∫–∞—á–µ—Å—Ç–≤–æ–º –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –æ—Å—É—â–µ—Å—Ç–≤–ª—è–µ—Ç—Å—è –∫–∞–∫ –ø–µ—Ä–µ–¥ –≤–≤–æ–¥–æ–º –≤ –≥—Ä–∞–∂–¥–∞–Ω—Å–∫–∏–π –æ–±–æ—Ä–æ—Ç, —Ç–∞–∫ –∏ –≤—ã–±–æ—Ä–æ—á–Ω–æ –ø–æ–∑–¥–Ω–µ–µ. üíä –° —ç—Ç–æ–≥–æ –≥–æ–¥–∞ –≤–µ–¥–æ–º—Å—Ç–≤–æ –ø—Ä–æ–≤–æ–¥–∏—Ç –∫–æ–Ω—Ç—Ä–æ–ª—å –∫–∞—á–µ—Å—Ç–≤–∞ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã—Ö –≥–µ–Ω–æ—Ç–µ—Ä–∞–ø–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤. –ù–∞–ø—Ä–∏–º–µ—Ä, –±—ã–ª–∏ –≤—ã–ø—É—â–µ–Ω—ã —Ä–æ—Å—Å–∏–π—Å–∫–∏–π –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –ø—Ä–æ—Ç–∏–≤ –±–æ–ª–µ–∑–Ω–∏ –ë–µ—Ö—Ç–µ—Ä–µ–≤–∞ (–¢—Ä–∏–±—É–≤–∏–∞ –æ—Ç ¬´–ë–∏–æ–∫–∞–¥¬ª), –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–ª—è –ª–µ—á–µ–Ω–∏—è –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö, —Ä–µ–¥–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, –æ—Å–æ–±–µ–Ω–Ω–æ —É –¥–µ—Ç–µ–π. üíä –ù–∞ —Å–µ–≥–æ–¥–Ω—è—à–Ω–∏–π –¥–µ–Ω—å —Ä—ã–Ω–æ–∫ –ø–æ–ª–Ω–æ—Å—Ç—å—é –æ–±–µ—Å–ø–µ—á–µ–Ω —Ä–æ—Å—Å–∏–π—Å–∫–∏–º–∏ –∞–Ω–∞–ª–æ–≥–∞–º–∏ —É—à–µ–¥—à–µ–≥–æ —Å —Ä—ã–Ω–∫–∞ –û–∑–µ–º–ø–∏–∫–∞ (–±–æ–ª—å—à–µ –≤—Å–µ—Ö –ø–æ—Å—Ç–∞—Ä–∞–ª–∏—Å—å, –∫–æ–Ω–µ—á–Ω–æ, ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª –∏ ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª). –í—Å–µ –æ–Ω–∏ –ø–æ–¥–ª–µ–∂–∞—Ç –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–º—É —Ç—â–∞—Ç–µ–ª—å–Ω–æ–º—É –∫–æ–Ω—Ç—Ä–æ–ª—é —Å–æ —Å—Ç–æ—Ä–æ–Ω—ã –≤–µ–¥–æ–º—Å—Ç–≤–∞. üíä –ó–∞ –∫–∞—á–µ—Å—Ç–≤–æ–º —Å–ª–µ–¥—è—Ç 13 –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–∏–π, –∫–æ—Ç–æ—Ä—ã–µ —Ä–∞–∑–≤—ë—Ä–Ω—É—Ç—ã –≤–æ –≤—Å–µ—Ö —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã—Ö –æ–∫—Ä—É–≥–∞—Ö. –í —ç—Ç–æ–º –≥–æ–¥—É –æ—Ç–∫—Ä—ã–ª–∞—Å—å –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–∏—è –≤ –î–æ–Ω–µ—Ü–∫–µ. üíä –û—á–µ–Ω—å –≤–∞–∂–Ω–æ–µ –ø–æ–¥—Å–ø–æ—Ä—å–µ ‚Äî —Å–∏—Å—Ç–µ–º–∞ –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏ –¥–≤–∏–∂–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ë–ª–∞–≥–æ–¥–∞—Ä—è –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω–æ–π —Å–∏—Å—Ç–µ–º–µ –∑–∞–∫—É–ø–æ–∫ –º–æ–Ω–∏—Ç–æ—Ä–∏—Ç—Å—è –¥–µ—Ñ–µ–∫—Ç—É—Ä–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. üíä –î–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ –æ—Ç–¥–∞–ª—ë–Ω–Ω—ã—Ö —É–≥–æ–ª–∫–∞—Ö —Å—Ç—Ä–∞–Ω—ã –æ–±–µ—Å–ø–µ—á–∏–≤–∞—é—Ç –§–ê–ü—ã. –í—Å–µ –æ–Ω–∏ –æ–±–µ—Å–ø–µ—á–µ–Ω—ã –ª–∏—Ü–µ–Ω–∑–∏–µ–π, —Å—Ä–æ–∫–∏ –≤—ã–¥–∞—á–∏ –∫–æ—Ç–æ—Ä–æ–π —Å–æ–∫—Ä–∞—Ç–∏–ª–∏—Å—å —Å 45 –¥–æ 5 –¥–Ω–µ–π. üíä –í –Ω–æ–≤—ã—Ö —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏—è—Ö –ø–æ–∫–∞ –Ω–µ—Ç —Å–∏—Å—Ç–µ–º—ã –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏ –¥–≤–∏–∂–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤. –ú–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥ –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç–Ω–æ–≥–æ –ø–µ—Ä–µ—á–Ω—è —Ç–∞–º –æ—Å—É—â–µ—Å—Ç–≤–ª—è–µ—Ç—Å—è —á–µ—Ä–µ–∑ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω—ã–µ –æ—Ä–≥–∞–Ω—ã. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""The head of the Russian Health Supervision Service discussed how the service controls innovative drugs and their approval on the Russian market. The quality of medicines is controlled both before they enter the civil market and later. This year, the service began to control the quality of innovative gene therapy drugs. The market is now fully supplied with Russian equivalents of Ozemik (mainly by 'Biovacad' and 'Promomed'). All these drugs are subject to strict control. There are 13 laboratories spread across all federal regions, including one in Donetsk. An information system for tracking drug purchases monitors the quality of medicines. Remote areas are covered by FAPs (Pharmacies), which have been granted licenses to issue them, with the license period shortened from 45 days to 5 days. However, there are no systems for tracking the movement of medicines in new territories; this is monitored through territorial authorities.""
}"
2025-09-03T09:12:01+00:00,@bezrec,6496,https://t.me/bezrec/6496,"–ü–µ—Ä–µ–≤–µ—Ä–Ω—ë–º –∫–∞–ª–µ–Ω–¥–∞—Ä—å –∏ –≤–æ–∑–æ–±–Ω–æ–≤–∏–º –Ω–∞—à—É —Ä—É–±—Ä–∏–∫—É #—Ñ–∞—Ä–º–Ω–∞–π–º. –°–µ–≥–æ–¥–Ω—è –ø–æ—Å–º–æ—Ç—Ä–µ–ª–∏, —á—Ç–æ –∏–Ω—Ç–µ—Ä–µ—Å–Ω–æ–≥–æ –≤ –ø–ª–∞–Ω–µ –≤–∞–∫–∞–Ω—Å–∏–π –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç ¬´–í–∞–ª–µ–Ω—Ç–∞ –§–∞—Ä–º¬ª, ¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º¬ª –∏ ¬´–†-–§–∞—Ä–º¬ª. –¢–∞–∫, —á—Ç–æ–±—ã ¬´–±—ã–ª–æ –≤—Å—ë –≤—Å–µ—Ä—å—ë–∑¬ª. ¬´–í–∞–ª–µ–Ω—Ç–∞ –§–∞—Ä–º¬ª: üîò–†—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å –≥—Ä—É–ø–ø—ã –æ–ø–µ—Ä–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ –∫–æ–Ω—Ç—Ä–æ–ª—è (–û–ö–ö) –í–∞–∫–∞–Ω—Å–∏—è —Å —Å–æ–ª–∏–¥–Ω—ã–º —Å–ø–∏—Å–∫–æ–º –æ–±—è–∑–∞–Ω–Ω–æ—Å—Ç–µ–π (–∞–∂ –∏–∑ 17 –ø—É–Ω–∫—Ç–æ–≤). –í–∑–∞–º–µ–Ω ‚Äî –∫–æ–Ω–∫—É—Ä–µ–Ω—Ç–æ—Å–ø–æ—Å–æ–±–Ω–∞—è –∑–∞—Ä–ø–ª–∞—Ç–∞, –±–æ–Ω—É—Å—ã, –î–ú–°, –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏—è –∞—Ä–µ–Ω–¥—ã –∂–∏–ª—å—è –∏ –¥—Ä—É–≥–∏–µ ¬´–ø–ª—é—à–∫–∏¬ª; üîò–ú–µ–Ω–µ–¥–∂–µ—Ä –ø–æ —Ä–∞–±–æ—Ç–µ —Å –ª–∏–¥–µ—Ä–∞–º–∏ –º–Ω–µ–Ω–∏—è –ù—É–∂–µ–Ω —á–µ–ª–æ–≤–µ–∫ —Å –≤—ã—Å—à–∏–º –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ–º –∏ –æ–ø—ã—Ç–æ–º —Ä–∞–±–æ—Ç—ã –Ω–∞ –ø–æ–∑–∏—Ü–∏–∏ Medical Science Liaison, Medical Advisor –æ—Ç 2-—Ö –ª–µ—Ç. –í–æ–∑–º–æ–∂–µ–Ω –≥–∏–±—Ä–∏–¥–Ω—ã–π —Ñ–æ—Ä–º–∞—Ç —Ä–∞–±–æ—Ç—ã; üîò–†—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å –≥—Ä—É–ø–ø—ã –ø–æ —Ä–∞–±–æ—Ç–µ —Å –∞–ø—Ç–µ—á–Ω—ã–º–∏ —Å–µ—Ç—è–º–∏ –î–æ–ª–∂–Ω–æ—Å—Ç—å –ø—Ä–µ–¥–ø–æ–ª–∞–≥–∞–µ—Ç —É–ø—Ä–∞–≤–ª–µ–Ω–∏–µ –∫–æ–º–∞–Ω–¥–æ–π –ö–ê–ú –ø–æ —Ä–∞–±–æ—Ç–µ —Å –ê–° –∏ –≤–µ–¥–µ–Ω–∏–µ –ø–µ—Ä–µ–≥–æ–≤–æ—Ä–æ–≤ —Å –ø–µ—Ä–≤—ã–º–∏ –ª–∏—Ü–∞–º–∏ –ê–°, –±–æ–ª–µ–µ 30 –ê–°. ¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º –ì—Ä—É–ø–ø¬ª: üîò–ì–ª–∞–≤–Ω—ã–π –±—É—Ö–≥–∞–ª—Ç–µ—Ä –†–∞–±–æ—Ç–∞—Ç—å –º–æ–∂–Ω–æ –∏–∑ –æ—Ñ–∏—Å–∞ –≤ –ú–æ—Å–∫–≤–µ –∏–ª–∏ –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –≤ –ø–æ—Å. –û–±–æ–ª–µ–Ω—Å–∫, —Å –µ–∂–µ–Ω–µ–¥–µ–ª—å–Ω—ã–º –ø–æ—Å–µ—â–µ–Ω–∏–µ–º –≤—Ç–æ—Ä–æ–π –ª–æ–∫–∞—Ü–∏–∏; üîò–ù–∞—á–∞–ª—å–Ω–∏–∫ –æ—Ç–¥–µ–ª–∞ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –∫–∞—á–µ—Å—Ç–≤–∞ –£—Å–ø–µ—à–Ω–æ–º—É –∫–∞–Ω–¥–∏–¥–∞—Ç—É —Å –≤—ã—Å—à–∏–º —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–º –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ–º –æ–±–µ—â–∞—é—Ç –æ–ø–ª–∞—á–∏–≤–∞–µ–º–æ–µ –ø–∏—Ç–∞–Ω–∏–µ –≤ –∑–∞–≤–æ–¥—Å–∫–æ–π —Å—Ç–æ–ª–æ–≤–æ–π, –æ–ø–ª–∞—á–∏–≤–∞–µ–º–æ–µ –æ–±—É—á–µ–Ω–∏–µ –≤ –≤—É–∑–∞—Ö –ö—É—Ä–≥–∞–Ω—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –∏ –º–∞—Ç–ø–æ–º–æ—â—å –ø—Ä–∏ —Ä–æ–∂–¥–µ–Ω–∏–∏ —Ä–µ–±—ë–Ω–∫–∞, –≤—Å—Ç—É–ø–ª–µ–Ω–∏–∏ –≤ –±—Ä–∞–∫, —Å–º–µ—Ä—Ç–∏ –±–ª–∏–∑–∫–∏—Ö —Ä–æ–¥—Å—Ç–≤–µ–Ω–Ω–∏–∫–æ–≤; üîò–†—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å –ø—Ä–æ–µ–∫—Ç–∞ –í–∞–∫–∞–Ω—Å–∏—è –æ—Ç–∫—Ä—ã—Ç–∞ –≤ R&D —Ü–µ–Ω—Ç—Ä–µ. –í —á–∏—Å–ª–µ –æ—Å–Ω–æ–≤–Ω—ã—Ö –æ–±—è–∑–∞–Ω–Ω–æ—Å—Ç–µ–π ‚Äî –∫—É—Ä–∏—Ä–æ–≤–∞–Ω–∏–µ –ø—Ä–æ–µ–∫—Ç–æ–≤ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –∏ –¥—Ä—É–≥–∏—Ö –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏–π –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏, –Ω–∞—á–∏–Ω–∞—è —Å –æ—Ü–µ–Ω–∫–∏ –ø—Ä–æ–µ–∫—Ç–∞ –∏ –¥–æ –ø–æ–ª—É—á–µ–Ω–∏—è –†–£. ¬´–†-–§–∞—Ä–º¬ª: üîò–î–∏—Ä–µ–∫—Ç–æ—Ä –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –≠—Ç–∞ –ø–æ–∑–∏—Ü–∏—è –æ—Ç–∫—Ä—ã—Ç–∞ –≤ –£—Ñ–µ, –ö—Ä–∞—Å–Ω–æ—è—Ä—Å–∫–µ, –¢–æ–º—Å–∫–µ –∏ –ù–æ–≤–æ—Å–∏–±–∏—Ä—Å–∫–µ. –ò–¥–µ–∞–ª—å–Ω—ã–π –∫–∞–Ω–¥–∏–¥–∞—Ç –¥–æ–ª–∂–µ–Ω –∏–º–µ—Ç—å –≤—ã—Å—à–µ–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–µ –∏–ª–∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–µ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ, –∞ —Ç–∞–∫–∂–µ –∑–Ω–∞—Ç—å –§–ó 44, –§–ó 223 –∏ –ø—Ä–æ—á–∏–µ –∑–∞–∫–æ–Ω—ã, —Ä–µ–≥—É–ª–∏—Ä—É—é—â–∏–µ –∑–∞–∫—É–ø–∫–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º–∏ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è–º–∏; üîò–ì–ª–∞–≤–Ω—ã–π —é—Ä–∏—Å–∫–æ–Ω—Å—É–ª—å—Ç (–≥—Ä—É–ø–ø–∞ –ø—Ä–∞–≤–æ–≤–æ–≥–æ —Å–æ–ø—Ä–æ–≤–æ–∂–¥–µ–Ω–∏—è –æ–±–æ—Ä–æ—Ç–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π) –£—Å–ø–µ—à–Ω–æ–º—É –∫–∞–Ω–¥–∏–¥–∞—Ç—É –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç –∏–Ω—Ç–µ—Ä–µ—Å–Ω—ã–π –±–æ–Ω—É—Å ‚Äî –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å —Å–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω–æ –Ω–∞–ø–æ–ª–Ω—è—Ç—å —Å–æ—Ü–ø–∞–∫–µ—Ç –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã–º–∏ –æ–ø—Ü–∏—è–º–∏ ‚Äî —Å–ø–æ—Ä—Ç, –ø–∏—Ç–∞–Ω–∏–µ, –æ–±—É—á–µ–Ω–∏–µ, –ø—É—Ç–µ—à–µ—Å—Ç–≤–∏—è –∏ –¥—Ä.; üîò–†—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å –∞–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–æ–π –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–∏–∏ (–û–ö–ö) –ü—Ä–∏–≤–µ—Ç—Å—Ç–≤—É–µ—Ç—Å—è –Ω–∞–ª–∏—á–∏–µ –¥–µ–π—Å—Ç–≤—É—é—â–µ–≥–æ —É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏—è –æ –ø–æ–≤—ã—à–µ–Ω–∏–∏ –∫–≤–∞–ª–∏—Ñ–∏–∫–∞—Ü–∏–∏ –ª–∏—Ü, –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω—ã—Ö –∑–∞ –∫–∞—á–µ—Å—Ç–≤–æ, –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –∏ –º–∞—Ä–∫–∏—Ä–æ–≤–∫—É –õ–°. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, sanctions, shortage, demand,vaccine"",
  ""impact"": ""high"",
  ""english"": ""This message discusses job openings at various pharmaceutical companies including Valenta Farm, Binnofarm Group, and R-Farm. It covers topics such as tender procurement, import/export controls, supply shortages, vaccine demand, and hospital policies. The message is relevant to regulatory affairs and market access for medicines.""
}"
2025-09-03T05:30:47+00:00,@bezrec,6495,https://t.me/bezrec/6495,"¬´–ù–æ–≤—ã–µ –ª—é–¥–∏¬ª –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –¥–∞—Ç—å –¥–µ—Ç—Å–∫–∏–º –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º ¬´–∑–µ–ª—ë–Ω—ã–π –∫–æ—Ä–∏–¥–æ—Ä¬ª. –° —Ç–∞–∫–æ–π –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–æ–π –≤—ã—Å—Ç—É–ø–∏–ª–∏ –¥–µ–ø—É—Ç–∞—Ç—ã —Ñ—Ä–∞–∫—Ü–∏–∏ –ê–Ω–Ω–∞ –°–∫—Ä–æ–∑–Ω–∏–∫–æ–≤–∞, –ö—Å–µ–Ω–∏—è –ì–æ—Ä—è—á–µ–≤–∞ –∏ –°–∞—Ä–¥–∞–Ω–∞ –ê–≤–∫—Å–µ–Ω—Ç—å–µ–≤–∞, –Ω–∞–ø—Ä–∞–≤–∏–≤—à–∏–µ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–µ–µ –æ–±—Ä–∞—â–µ–Ω–∏–µ –ú–∏—Ö–∞–∏–ª—É –ú—É—Ä–∞—à–∫–æ. –ù–æ—Ä–º—É –æ –≤–≤–µ–¥–µ–Ω–∏–∏ ¬´–∑–µ–ª—ë–Ω–æ–≥–æ –∫–æ—Ä–∏–¥–æ—Ä–∞¬ª –ø—Ä–∏ –≤–≤–æ–∑–µ –¥–µ—Ç—Å–∫–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è –∑–∞–∫—Ä–µ–ø–∏—Ç—å –≤ –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–∏ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ ‚Ññ 853 (–û–± —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏–∏ –ø—Ä–∞–≤–∏–ª –≤–≤–æ–∑–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –≤ –†–§). –ê–≤—Ç–æ—Ä—ã –æ–±—Ä–∞—â–µ–Ω–∏—è –æ—Ç–º–µ—á–∞—é—Ç, —á—Ç–æ –≤ –†–æ—Å—Å–∏–∏ –Ω–µ—Ç –º–µ—Ö–∞–Ω–∏–∑–º–∞ –ø—Ä–∏–æ—Ä–∏—Ç–µ—Ç–Ω–æ–≥–æ –∏ —É—Å–∫–æ—Ä–µ–Ω–Ω–æ–≥–æ –æ—Ñ–æ—Ä–º–ª–µ–Ω–∏—è –ø–∞—Ä—Ç–∏–π –∏–º–µ–Ω–Ω–æ –¥–µ—Ç—Å–∫–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤, —á—Ç–æ ¬´–ø—Ä–∏–≤–æ–¥–∏—Ç –∫ –∑–∞–¥–µ—Ä–∂–∫–∞–º –ø–æ—Å—Ç–∞–≤–æ–∫ –∏ –ø—Ä–µ–ø—è—Ç—Å—Ç–≤—É–µ—Ç —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ –∫–æ–Ω—Å—Ç–∏—Ç—É—Ü–∏–æ–Ω–Ω–æ–≥–æ –ø—Ä–∞–≤–∞ —Ä–µ–±–µ–Ω–∫–∞ –Ω–∞ –æ—Ö—Ä–∞–Ω—É –∑–¥–æ—Ä–æ–≤—å—è¬ª. –ë–æ–ª–µ–µ —Ç–æ–≥–æ, –ª—é–±—ã–µ –∑–∞–¥–µ—Ä–∂–∫–∏ –∑–¥–µ—Å—å ¬´–≤–µ–¥—É—Ç –∫ —Å—É—â–µ—Å—Ç–≤–µ–Ω–Ω—ã–º —Å–æ—Ü–∏–∞–ª—å–Ω—ã–º –ø–æ—Å–ª–µ–¥—Å—Ç–≤–∏—è–º, –≤–∫–ª—é—á–∞—è —É–≥—Ä–æ–∑—É —É—Ç—Ä–∞—Ç—ã –¥–æ—Å—Ç–∏–≥–Ω—É—Ç–æ–≥–æ —Ç–µ—Ä–∞–ø–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ —ç—Ñ—Ñ–µ–∫—Ç–∞¬ª. –ß—Ç–æ –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç ¬´–ù–æ–≤—ã–µ –ª—é–¥–∏¬ª: üíä –≤–≤–µ—Å—Ç–∏ –ø—Ä–∏–æ—Ä–∏—Ç–µ—Ç–Ω—ã–π –ø–æ—Ä—è–¥–æ–∫ –æ—Ñ–æ—Ä–º–ª–µ–Ω–∏—è –¥–ª—è –ø–∞—Ä—Ç–∏–π –∂–∏–∑–Ω–µ–Ω–Ω–æ –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã—Ö –¥–µ—Ç—Å–∫–∏—Ö –∏ –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ ‚Äî ¬´–∑–µ–ª—ë–Ω—ã–π –∫–æ—Ä–∏–¥–æ—Ä¬ª; üíä –æ–±—è–∑–∞—Ç—å –ú–∏–Ω–∑–¥—Ä–∞–≤ –≤—ã–¥–∞–≤–∞—Ç—å –∑–∞–∫–ª—é—á–µ–Ω–∏–µ –ø–æ —Ç–∞–∫–∏–º –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º –≤ —Å—Ä–æ–∫ –¥–æ –¥–≤—É—Ö —Ä–∞–±–æ—á–∏—Ö –¥–Ω–µ–π; üíä –æ–±—è–∑–∞—Ç—å –§–µ–¥–µ—Ä–∞–ª—å–Ω—É—é —Ç–∞–º–æ–∂–µ–Ω–Ω—É—é —Å–ª—É–∂–±—É –æ–±–µ—Å–ø–µ—á–∏–≤–∞—Ç—å –∏—Ö –≤—ã–ø—É—Å–∫ –±–µ–∑ –∑–∞–¥–µ—Ä–∂–µ–∫; üíä –ø–µ—Ä–µ—á–µ–Ω—å –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –∏–º–µ—é—â–∏—Ö –ø—Ä–∞–≤–æ –Ω–∞ ¬´–∑–µ–ª—ë–Ω—ã–π –∫–æ—Ä–∏–¥–æ—Ä¬ª, –±—É–¥–µ—Ç —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞—Ç—å—Å—è –∏ –µ–∂–µ–∫–≤–∞—Ä—Ç–∞–ª—å–Ω–æ –æ–±–Ω–æ–≤–ª—è—Ç—å—Å—è –ú–∏–Ω–∑–¥—Ä–∞–≤–æ–º. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, regulation"",
  ""impact"": ""high"",
  ""english"": ""The 'New People' propose to introduce a priority procedure for shipments of life-saving and orphan pediatric drugs, known as the 'green corridor'. They also suggest that the Ministry of Health issue a decision on such medications within two working days and that the Federal Customs Service ensure their release without delays. The list of drugs eligible for this 'green corridor' will be formed and updated quarterly by the Ministry of Health.""
}"
2025-09-02T14:35:10+00:00,@bezrec,6494,https://t.me/bezrec/6494,"–ó–∞–º–≥–ª–∞–≤—ã –º–∏–Ω–∑–¥—Ä–∞–≤–∞ –ò—Ä–∫—É—Ç—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –ø–æ–ª—É—á–∏–ª–∞ –¥–≤–∞ –≥–æ–¥–∞ –∑–∞ –º–∞—Ö–∏–Ω–∞—Ü–∏–∏ —Å –¢—Ä–∞–º–∞–¥–æ–ª–æ–º. –ï–ª–µ–Ω—É –ì–æ–ª–µ–Ω–µ—Ü–∫—É—é –ø—Ä–∏–∑–Ω–∞–ª–∏ –≤–∏–Ω–æ–≤–Ω–æ–π –≤ –ø—Ä–µ–≤—ã—à–µ–Ω–∏–∏ –¥–æ–ª–∂–Ω–æ—Å—Ç–Ω—ã—Ö –ø–æ–ª–Ω–æ–º–æ—á–∏–π –ø—Ä–∏ –∑–∞–∫—É–ø–∫–µ –ª–µ–∫–∞—Ä—Å—Ç–≤. –°—É–¥ —É—Å—Ç–∞–Ω–æ–≤–∏–ª, —á—Ç–æ –≤ 2019 –≥–æ–¥—É —á–∏–Ω–æ–≤–Ω–∏—Ü–∞ —É—Ç–≤–µ—Ä–¥–∏–ª–∞ –∑–∞—è–≤–∫–∏ –Ω–∞ –∑–∞–∫—É–ø–∫—É –æ–±–µ–∑–±–æ–ª–∏–≤–∞—é—â–µ–≥–æ –¢—Ä–∞–º–∞–¥–æ–ª–∞ –≤ –∫–æ–ª–∏—á–µ—Å—Ç–≤–µ, –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ –ø—Ä–µ–≤—ã—à–∞—é—â–µ–º –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç—å –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –æ–Ω–∫–æ–ª–æ–≥–∏–µ–π. –í—Å—ë —Ä–∞–¥–∏ ¬´—Å–æ–∑–¥–∞–Ω–∏—è –≤–∏–¥–∏–º–æ—Å—Ç–∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ–≥–æ —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–∞ –∏ –ø–æ–ª–Ω–æ–≥–æ —Ä–∞—Å—Ö–æ–¥–æ–≤–∞–Ω–∏—è —Å—É–±—Å–∏–¥–∏–π¬ª. –í –∏—Ç–æ–≥–µ –∏–∑–ª–∏—à–∫–∏ –∏—Å–ø–æ—Ä—Ç–∏–ª–∏—Å—å, –∏ –∏—Ö –ø—Ä–∏—à–ª–æ—Å—å —É—Ç–∏–ª–∏–∑–∏—Ä–æ–≤–∞—Ç—å. –£—â–µ—Ä–± –±—é–¥–∂–µ—Ç—É –æ—Ü–µ–Ω–∏–ª–∏ –±–æ–ª–µ–µ —á–µ–º –≤ 25 –º–ª–Ω —Ä—É–±–ª–µ–π. –¢–µ–ø–µ—Ä—å –ì–æ–ª–µ–Ω–µ—Ü–∫–æ–π, –∫ —Å–ª–æ–≤—É, —Å–≤–æ—é –≤–∏–Ω—É –Ω–µ –ø—Ä–∏–∑–Ω–∞–≤—à–µ–π, –ø—Ä–∏–¥—ë—Ç—Å—è –ø—Ä–æ–≤–µ—Å—Ç–∏ –¥–≤–∞ –≥–æ–¥–∞ –≤ –∫–æ–ª–æ–Ω–∏–∏-–ø–æ—Å–µ–ª–µ–Ω–∏–∏ –∏ –∑–∞–ø–ª–∞—Ç–∏—Ç—å –≤ –ø–æ–ª—å–∑—É —Ä–µ–≥–∏–æ–Ω–∞ –±–æ–ª–µ–µ 23 –º–ª–Ω —Ä—É–±–ª–µ–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, reimbursement, pricing, shortage"",
  ""impact"": ""high"",
  ""english"": ""The deputy head of the Health Department in Irkutsk Oblast was sentenced to two years for drug fraud involving tramadol. Elena Goleneckaya was found guilty of exceeding her official duties in purchasing drugs, approving orders for tramadol that significantly exceeded the patients' needs due to oncology. The excess was later disposed of, causing a loss to the budget exceeding 25 million rubles. Goleneckaya has not admitted guilt and will serve two years in prison and pay more than 23 million rubles to the region.""
}"
2025-09-02T11:30:44+00:00,@bezrec,6493,https://t.me/bezrec/6493,"–ú–∏–Ω–∑–¥—Ä–∞–≤ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –ø—Ä–æ–µ–∫—Ç –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞, —É—Å—Ç–∞–Ω–∞–≤–ª–∏–≤–∞—é—â–∏–π –ø–æ—Ä—è–¥–æ–∫ –∏ –∫—Ä–∏—Ç–µ—Ä–∏–∏ –¥–ª—è —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—è –ø–µ—Ä–µ—á–Ω—è –°–ó–õ–°. –§–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏–µ–º –ø–µ—Ä–µ—á–Ω—è –∑–∞–π–º–µ—Ç—Å—è —Å–ø–µ—Ü–∏–∞–ª—å–Ω–∞—è –º–µ–∂–≤–µ–¥–æ–º—Å—Ç–≤–µ–Ω–Ω–∞—è –∫–æ–º–∏—Å—Å–∏—è, –∫–æ—Ç–æ—Ä—É—é —É—Ç–≤–µ—Ä–¥–∏—Ç —Ä–µ–≥—É–ª—è—Ç–æ—Ä. –†–∞—Å—Å–º–∞—Ç—Ä–∏–≤–∞—Ç—å –∑–∞—è–≤–∫–∏ –æ—Ç –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –±—É–¥—É—Ç –Ω–µ —á–∞—â–µ –æ–¥–Ω–æ–≥–æ —Ä–∞–∑–∞ –≤ —Ç—Ä–∏ –º–µ—Å—è—Ü–∞. –í –∑–∞—Å–µ–¥–∞–Ω–∏—è—Ö —Ç–∞–∫–∂–µ –±—É–¥—É—Ç —É—á–∞—Å—Ç–≤–æ–≤–∞—Ç—å –≥–ª–∞–≤–Ω—ã–µ –≤–Ω–µ—à—Ç–∞—Ç–Ω—ã–µ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –ú–∏–Ω–∑–¥—Ä–∞–≤–∞. –ü—Ä–µ–¥–ø–æ–ª–∞–≥–∞–µ—Ç—Å—è, —á—Ç–æ –≤ –ø–µ—Ä–µ—á–Ω–µ –±—É–¥–µ—Ç –¥–≤–∞ —Ä–∞–∑–¥–µ–ª–∞, –∫–∞–∂–¥—ã–π —Å–æ —Å–≤–æ–∏–º–∏ –∫—Ä–∏—Ç–µ—Ä–∏—è–º–∏. –í –∏—Ö —á–∏—Å–ª–µ: üîò–ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –≤–∫–ª—é—á–µ–Ω –≤ –ø–µ—Ä–µ—á–µ–Ω—å –∂–∏–∑–Ω–µ–Ω–Ω–æ –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã—Ö –∏ –≤–∞–∂–Ω–µ–π—à–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ (–ñ–ù–í–õ–ü); üîò–∑–∞–∫—É–ø–∞–µ—Ç—Å—è –¥–ª—è –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –∏ (–∏–ª–∏) –º—É–Ω–∏—Ü–∏–ø–∞–ª—å–Ω—ã—Ö –Ω—É–∂–¥ –≤ —Ç–µ—á–µ–Ω–∏–µ –ø–æ—Å–ª–µ–¥–Ω–∏—Ö —Ç—Ä–µ—Ö –∫–∞–ª–µ–Ω–¥–∞—Ä–Ω—ã—Ö –ª–µ—Ç; üîò–ø—Ä–µ–¥–Ω–∞–∑–Ω–∞—á–µ–Ω –¥–ª—è –∏–º–º—É–Ω–æ–ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –∏–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã—Ö –±–æ–ª–µ–∑–Ω–µ–π –≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–∏ —Å –∫–∞–ª–µ–Ω–¥–∞—Ä–µ–º –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–∏—Ö –ø—Ä–∏–≤–∏–≤–æ–∫; üîò–ø–æ–ª—É—á–µ–Ω –∏–∑ –∫—Ä–æ–≤–∏, –ø–ª–∞–∑–º—ã –∫—Ä–æ–≤–∏ —á–µ–ª–æ–≤–µ–∫–∞; üîò—è–≤–ª—è–µ—Ç—Å—è –∞–Ω—Ç–∏–±–∞–∫—Ç–µ—Ä–∏–∞–ª—å–Ω—ã–º –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–º –∏ (–∏–ª–∏) –∫—Ä–æ–≤–µ–∑–∞–º–µ–Ω–∏—Ç–µ–ª–µ–º; üîò–ø—Ä–µ–ø–∞—Ä–∞—Ç –º–æ–∂–Ω–æ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç—å –≤ —Å—Ç—Ä–∞–Ω–∞—Ö –ï–ê–≠–° –Ω–∞ –≤—Å–µ—Ö —Å—Ç–∞–¥–∏—è—Ö. –í –∏—é–Ω–µ —Ñ–∏–Ω–∞–ª—å–Ω—É—é –≤–µ—Ä—Å–∏—é –ø–µ—Ä–µ—á–Ω—è —Å–∏—Å—Ç–µ–º–Ω–æ –∑–Ω–∞—á–∏–º—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health has developed a draft government regulation setting out the criteria and procedures for creating a list of systemically important medicines. The creation of this list will be handled by an inter-ministerial commission, which will be approved by the regulator. Applications from manufacturers will be considered no more than once every three months. The commission meetings will also include Deputy Chief Medical Officers from the Ministry of Health. It is proposed that the list will have two sections, each with their own criteria. These include: üîòa drug included in the list of essential and important medicines (–ñ–ù–í–õ–ü); üîòacquired for state or municipal needs over the last three calendar years; üîòdesigned for immunoprophylaxis of infectious diseases according to the vaccination schedule; üîòproduced from human blood or plasma; üîòan antibacterial drug and/or blood substitute; üîòcan be produced in countries of the EAEU at all stages. In June, a final version of the list of systemically important medicines was presented by the Ministry of Industry and Trade"
2025-09-02T09:00:01+00:00,@bezrec,6492,https://t.me/bezrec/6492,"–§–ê–° —Å–Ω–∏–∑–∏–ª–∞ —Ü–µ–Ω—É –Ω–∞ –ø–µ—Ä–≤—ã–π –±–∏–æ–∞–Ω–∞–ª–æ–≥ –≠–∫—Å–¥–∂–∏–≤—ã. –§–æ—Ä—Å–µ–¥–µ–Ω–æ –û–Ω–∫–æ –æ—Ç ¬´–ü–µ—Ç—Ä–æ–≤–∞–∫—Å–∞¬ª –¥–ª—è –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –∫–æ—Å—Ç–Ω—ã—Ö –æ—Å–ª–æ–∂–Ω–µ–Ω–∏–π —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏ —Å—Ç–∞–ª –Ω–∞ 16% –¥–µ—à–µ–≤–ª–µ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω–æ–≥–æ –≠–∫—Å–¥–∂–∏–≤–∞ (–¥–µ–Ω–æ—Å—É–º–∞–±) –æ—Ç Amgen. –¶–µ–Ω–∞ –∑–∞ 1 —Ñ–ª–∞–∫–æ–Ω —Ä–∞—Å—Ç–≤–æ—Ä–∞ –¥–ª—è –ø–æ–¥–∫–æ–∂–Ω–æ–≥–æ –≤–≤–µ–¥–µ–Ω–∏—è –≤ –¥–æ–∑–∏—Ä–æ–≤–∫–µ 120 –º–≥ (70 –º–≥/–º–ª) —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ —Å–æ–≥–ª–∞—Å–æ–≤–∞–Ω–∞ –Ω–∞ —É—Ä–æ–≤–Ω–µ 15 145 —Ä—É–±–ª–µ–π, —Ç–æ–≥–¥–∞ –∫–∞–∫ —Ç–∞–∫–∞—è –∂–µ —É–ø–∞–∫–æ–≤–∫–∞ —Ä–µ—Ñ–µ—Ä–µ–Ω—Ç–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ —Å—Ç–æ–∏—Ç 18 195 —Ä—É–±–ª–µ–π. –î–µ–Ω–æ—Å—É–º–∞–± –≤—Ö–æ–¥–∏—Ç –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü. –§–æ—Ä—Å–µ–¥–µ–Ω–æ –û–Ω–∫–æ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç—Å—è –≤ –ò—Ä–∞–Ω–µ, –Ω–∞ –∑–∞–≤–æ–¥–µ ¬´–ü–µ—Ç—Ä–æ–≤–∞–∫—Å–∞¬ª –≤ –ü–æ–¥–æ–ª—å—Å–∫–µ –æ—Å—É—â–µ—Å—Ç–≤–ª—è—é—Ç—Å—è —Å—Ç–∞–¥–∏–∏ –≤—Ç–æ—Ä–∏—á–Ω–æ–π/—Ç—Ä–µ—Ç–∏—á–Ω–æ–π —É–ø–∞–∫–æ–≤–∫–∏ –∏ –≤—ã–ø—É—Å–∫–∞—é—â–µ–≥–æ –∫–æ–Ω—Ç—Ä–æ–ª—è –∫–∞—á–µ—Å—Ç–≤–∞. –í –º–∞–µ –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å—â–∏–∫–∏ —Å–Ω–∏–∑–∏–ª–∏ —Ü–µ–Ω—É –Ω–∞ –µ—â—ë –æ–¥–∏–Ω –¥–µ–Ω–æ—Å—É–º–∞–± –æ—Ç Amgen ‚Äî –§–æ—Ä—Å–µ–¥–µ–Ω–æ –æ—Ç ¬´–ü–µ—Ç—Ä–æ–≤–∞–∫—Å–∞¬ª —Å—Ç–∞–ª –Ω–∞ 12% –¥–µ—à–µ–≤–ª–µ –ü—Ä–æ–ª–∏–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""pricing, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The price of the first biosimilar Exjiva (denosumab) from Petrovax, produced by the factory 'Petrovax' in Podolsk, was reduced by 16%. The price for a single vial of the drug in a dose of 120 mg (70 mg/ml) is now 15,145 rubles in Russia, while the original drug 'Prolia‚Ñ¢' from Amgen costs 18,195 rubles. Denosumab is included in the list of –ñ–ù–í–õ–ü (Essential Medicines). Antimonopoly authorities also reduced the price of another denosumab from Amgen - 'Petrovax' Forsenone, which is now 12% cheaper than Prolia‚Ñ¢.""
}"
2025-09-02T05:53:23+00:00,@bezrec,6491,https://t.me/bezrec/6491,"–ü—Ä–æ–¥–∞–∂–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Å–∏–º–ø—Ç–æ–º–æ–≤ –º–µ–Ω–æ–ø–∞—É–∑—ã ¬´–æ—á—É—Ö–∞–ª–∏—Å—å¬ª –ø–æ—Å–ª–µ –ø–æ—Å–ª–µ —É—Ö–æ–¥–∞ Orion Pharma. –ü–æ—Å–ª–µ –ø—Ä–µ–∫—Ä–∞—â–µ–Ω–∏—è –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω—ã—Ö –ø–æ—Å—Ç–∞–≤–æ–∫ –î–∏–≤–∏–≥–µ–ª—è (—ç—Å—Ç—Ä–∞–¥–∏–æ–ª) –¥–ª—è –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å–Ω–æ–π –≥–æ—Ä–º–æ–Ω–∞–ª—å–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –æ—Ç –ø—Ä–µ–∫—Ä–∞—Ç–∏–≤—à–µ–π –±–∏–∑–Ω–µ—Å-–æ–ø–µ—Ä–∞—Ü–∏–∏ –≤ –†–æ—Å—Å–∏–∏ —Ñ–∏–Ω—Å–∫–æ–π Orion Pharma –≤ —Å—Ç—Ä–∞–Ω–µ –Ω–µ–∫–æ—Ç–æ—Ä–æ–µ –≤—Ä–µ–º—è –æ—Ç–º–µ—á–∞–ª—Å—è –¥–µ—Ñ–∏—Ü–∏—Ç –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Å —ç—Å—Ç—Ä–æ–≥–µ–Ω–æ–º. –°–∏—Ç—É–∞—Ü–∏—è —Å—Ç–∞–ª–∞ –≤—ã—Ä–∞–≤–Ω–∏–≤–∞—Ç—å—Å—è –≤ 2024 –≥–æ–¥—É, –∫–æ–≥–¥–∞ –∞–Ω–∞–ª–∏—Ç–∏–∫–∏ RNC Pharma –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–ª–∏ –ø—Ä–∏—Ä–æ—Å—Ç –Ω–∞ —É—Ä–æ–≤–Ω–µ 25% –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö –∏ 16,7% –≤ —Ä—É–±–ª—è—Ö. –° —è–Ω–≤–∞—Ä—è –ø–æ –∏—é–ª—å 2025 –≥–æ–¥–∞ –±—ã–ª–æ —Ä–µ–∞–ª–∏–∑–æ–≤–∞–Ω–æ 1,4 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ —Ç–∞–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ 2,2 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –≠—Ç–æ –Ω–∞ 19,9% –±–æ–ª—å—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ –∏ –Ω–∞ 24,8% ‚Äî –≤ –¥–µ–Ω–µ–∂–Ω–æ–º. –†—ã–Ω–æ–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –º–µ–Ω–æ–ø–∞—É–∑–∞–ª—å–Ω–æ–π –≥–æ—Ä–º–æ–Ω–∞–ª—å–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω 14 —Ç–æ—Ä–≥–æ–≤—ã–º–∏ –º–∞—Ä–∫–∞–º–∏. –†—É–±–ª—ë–≤—ã–π –æ–±—ä—ë–º –ø—Ä–æ–¥–∞–∂ –ø–æ—á—Ç–∏ –ø–æ–ª–Ω–æ—Å—Ç—å—é (–±–æ–ª–µ–µ 99%) –æ–±–µ—Å–ø–µ—á–∏–≤–∞–µ—Ç—Å—è –∏–≥—Ä–æ–∫–∞–º–∏ –ø–µ—Ä–≤–æ–π –¥–µ—Å—è—Ç–∫–∏. –í –ª–∏–¥–µ—Ä–∞—Ö –ø–æ –ø—Ä–æ–¥–∞–∂–∞–º –≤ –¥–µ–Ω—å–≥–∞—Ö ‚Äî –≠—Å—Ç—Ä–æ–∂–µ–ª—å –æ—Ç ¬´–ë–µ–∑–µ–Ω –•–µ–ª—Å–∫–µ–∞¬ª, –Ω–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ ‚Äî –ü—Ä–æ–≥–∏–Ω–æ–≤–∞ –æ—Ç ¬´–ó–µ–Ω—Ç–∏–≤–∞¬ª, –Ω–∞ —Ç—Ä–µ—Ç—å–µ–º ‚Äî –û–≤–µ—Å—Ç–∏–Ω –æ—Ç ¬´–ê—Å–ø–µ–Ω –•–æ–ª–¥–∏–Ω–≥¬ª. –°–∞–º–æ–π –≤–Ω—É—à–∏—Ç–µ–ª—å–Ω–æ–π –¥–∏–Ω–∞–º–∏–∫–æ–π –º–æ–∂–µ—Ç –ø–æ—Ö–≤–∞—Å—Ç–∞—Ç—å—Å—è –î–ª—è–ñ–µ–Ω—Å –æ—Ç ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑–∞¬ª, –Ω–∞—Ä–∞—Å—Ç–∏–≤—à–∏–π –ø—Ä–æ–¥–∞–∂–∏ –ø–æ—á—Ç–∏ –≤ 2,4 —Ä–∞–∑–∞. –¢–∞–∫–∂–µ —Ö–æ—Ä–æ—à–∏–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã —É –≠—Å—Ç—Ä–æ–≤–∞–≥–∏–Ω–∞ –æ—Ç ¬´–ê–ª—Ç–∞–π–≤–∏—Ç–∞–º–∏–Ω—ã¬ª (+39%). –û—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω—É—é –¥–∏–Ω–∞–º–∏–∫—É –ø–æ–∫–∞–∑–∞–ª —Ç–æ–ª—å–∫–æ –û—Ä–Ω–∏–æ–Ω –æ—Ç ¬´–í–µ—Ä—Ç–µ–∫—Å–∞¬ª. –ò–Ω—Ç–µ—Ä–µ—Å–Ω–æ, —á—Ç–æ –∏ –î–∏–≤–∏–≥–µ–ª—å –≤—Å—ë –µ—â—ë —Å –Ω–∞–º–∏ ‚Äî –µ–≥–æ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏—è –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç—Å—è, –ø—Ä–∏—á—ë–º –≤ –¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ –∑–∞–º–µ—Ç–Ω—ã—Ö –æ–±—ä—ë–º–∞—Ö (–ø–æ—Ä—è–¥–∫–∞ 16 —Ç—ã—Å. —É–ø–∞–∫–æ–≤–æ–∫ —Å –Ω–∞—á–∞–ª–∞ –≥–æ–¥–∞). –ü–æ–º–∏–º–æ –ø–µ—Ä–µ—á–∏—Å–ª–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –≤ —Ç–æ–ø-10 —Ç–æ—Ä–≥–æ–≤—ã—Ö –º–∞—Ä–æ–∫ –¥–ª—è –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å–Ω–æ–π –≥–æ—Ä–º–æ–Ω–∞–ª—å–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –ø—Ä–∏ —Å–∏–º–ø—Ç–æ–º–∞—Ö –¥–µ—Ñ–∏—Ü–∏—Ç–∞ —ç—Å—Ç—Ä–æ–≥–µ–Ω–∞ —Ç–∞–∫–∂–µ –≤–æ—à–ª–∏: –û–≤–∏–ø–æ–ª –ö–ª–∏–æ (¬´–ê–∫—Ä–∏—Ö–∏–Ω¬ª), –ë–ª–∏—Å—Å–µ–ª—å (¬´–ò—Ç–∞–ª—Ñ–∞—Ä–º–∞–∫–æ¬ª), –≠—Å—Ç—Ä–æ–∫–∞–¥ (¬´–î—Ä. –ö–∞–¥–µ¬ª). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, shortage, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""Sales of hormone therapy drugs for menopausal symptoms have recovered after Finnish Orion Pharma ceased official supplies of Divalgent (estrogen) for hormone replacement therapy. There was a period of shortage in Russia following the cessation of Orion Pharma's business operation, but sales have increased by 25% in units and 16.7% in rubles from January to July 2025, compared to a year ago. The market for hormone therapy drugs for menopausal symptoms is represented by 14 trade brands, with the ruble volume of sales mainly provided by top ten players. The leader in terms of revenue is Estrole from 'Bezen Healthcare', followed by Progina from 'Zentiva' and Ovestin from 'Athenix'. The most dynamic growth is shown by ForJens from 'FarmaSynthesis', which has increased sales almost 2.4 times. Also good results are shown by Estrovagina from 'Albaitvitamins', which has increased sales by 39%. Only Orion from '"
2025-09-01T16:31:20+00:00,@bezrec,6490,https://t.me/bezrec/6490,–° –î–Ω—ë–º –∑–Ω–∞–Ω–∏–π –≤—Å–µ—Ö –ø—Ä–∏—á–∞—Å—Ç–Ω—ã—Ö! ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞,"{""skip"": true}"
2025-09-01T14:33:10+00:00,@bezrec,6489,https://t.me/bezrec/6489,"–†–æ—Å—Å–∏—è —É—Å–∏–ª–∏–≤–∞–µ—Ç –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏—é –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –º–µ–¥–∏–∑–¥–µ–ª–∏–π –õ–æ–∫–∞–ª–∏–∑–∞—Ü–∏—è –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π –∏ —Ä–∞—Å—Ö–æ–¥–Ω—ã—Ö –º–∞—Ç–µ—Ä–∏–∞–ª–æ–≤ —Å—Ç–∞–Ω–æ–≤–∏—Ç—Å—è –æ–±—â–µ–º–∏—Ä–æ–≤—ã–º —Ç—Ä–µ–Ω–¥–æ–º. –†–æ—Å—Å–∏—è ‚Äì –Ω–µ –∏—Å–∫–ª—é—á–µ–Ω–∏–µ. –° 1 —Å–µ–Ω—Ç—è–±—Ä—è –≤ –Ω–∞—à–µ–π —Å—Ç—Ä–∞–Ω–µ –≤—Å—Ç—É–ø–∞—é—Ç –≤ —Å–∏–ª—É –Ω–æ–≤—ã–µ –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω—ã–µ –∞–∫—Ç—ã. –û–Ω–∏ —Ä–µ–≥—É–ª–∏—Ä—É—é—Ç –æ–±–æ—Ä–æ—Ç –º–µ–¥–∏–∑–¥–µ–ª–∏–π: –æ—Ç –æ–±–Ω–æ–≤–ª–µ–Ω–Ω—ã—Ö —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π –∫ —Ç–µ—Ö–¥–æ–∫—É–º–µ–Ω—Ç–∞—Ü–∏–∏ –¥–æ –ø–æ–ª–Ω–æ–≥–æ –∑–∞–ø—Ä–µ—Ç–∞ –Ω–µ–º–∞—Ä–∫–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –ø–µ—Ä—á–∞—Ç–æ–∫. –≠—Ç–∏ –º–µ—Ä—ã –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω—ã –Ω–∞ –¥–æ—Å—Ç–∏–∂–µ–Ω–∏–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π –Ω–µ–∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏, –Ω–æ –≤ —Ç–æ –∂–µ –≤—Ä–µ–º—è —Ç—Ä–µ–±—É—é—Ç –æ—Ç —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –æ–±–µ—Å–ø–µ—á–∏—Ç—å –≤—ã—Å–æ–∫–æ–µ –∫–∞—á–µ—Å—Ç–≤–æ –ø—Ä–æ–¥—É–∫—Ü–∏–∏. –° –æ–¥–Ω–æ–π —Å—Ç–æ—Ä–æ–Ω—ã, –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ –ø–æ—Å—Ç–∞–≤–∏—Ç—å –∂–µ—Å—Ç–∫–∏–π –±–∞—Ä—å–µ—Ä –Ω–∞ –ø—É—Ç–∏ –∏–º–ø–æ—Ä—Ç–∞ –Ω–µ–∫–∞—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –∏ –æ–ø–∞—Å–Ω—ã—Ö –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –∏–∑–¥–µ–ª–∏–π, —Å –¥—Ä—É–≥–æ–π ‚Äì –æ–±–µ—Å–ø–µ—á–∏—Ç—å –∑–∞–∫–∞–∑–∞–º–∏ —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏—è, ‚Äì –æ—Ç–º–µ—á–∞–µ—Ç –≤ –∏–Ω—Ç–µ—Ä–≤—å—é –ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫—É –ê–Ω—Ç–æ–Ω –ü—Ä–æ–∑—É–º–µ–Ω—Ç–æ–≤, –¥–∏—Ä–µ–∫—Ç–æ—Ä –¥–∏–≤–∏–∑–∏–æ–Ω–∞ ¬´–ú–µ–¥–∏—Ü–∏–Ω–∞¬ª –∫–æ–º–ø–∞–Ω–∏–∏ –°–ò–ë–£–†. –ü–æ —Å–ª–æ–≤–∞–º —ç–∫—Å–ø–µ—Ä—Ç–∞, —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –≤ –Ω–∞—à–µ–π —Å—Ç—Ä–∞–Ω–µ —É–∂–µ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—Ç —Å—Ç—Ä–æ–≥–∏–º –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã–º —Å—Ç–∞–Ω–¥–∞—Ä—Ç–∞–º, –≤–∫–ª—é—á–∞—è —à–≤–µ–π—Ü–∞—Ä—Å–∫–∏–µ –∏ —é–∂–Ω–æ–∫–æ—Ä–µ–π—Å–∫–∏–µ. –ù–æ –µ—Å—Ç—å –æ–±–ª–∞—Å—Ç–∏, –≤ –∫–æ—Ç–æ—Ä—ã—Ö –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–º —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–∞–º –Ω—É–∂–Ω–æ –ø—Ä–∏–ª–æ–∂–∏—Ç—å —É—Å–∏–ª–∏—è –¥–ª—è –∑–∞–º–µ—â–µ–Ω–∏—è –∏–º–ø–æ—Ä—Ç–Ω—ã—Ö –º–µ–¥–∏–∑–¥–µ–ª–∏–π. –¢–∞–∫, –≤ –†–æ—Å—Å–∏–∏ –¥–æ —Å–∏—Ö –ø–æ—Ä –Ω–µ—Ç —Å–≤–æ–µ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –∏–Ω—Ñ—É–∑–∏–æ–Ω–Ω—ã—Ö —Å–∏—Å—Ç–µ–º, –¥–ª—è –∫–æ—Ç–æ—Ä—ã—Ö —Ç—Ä–µ–±—É—é—Ç—Å—è —É–Ω–∏–∫–∞–ª—å–Ω—ã–µ —Ä–µ—Ü–µ–ø—Ç—É—Ä—ã –ø–æ–ª–∏–≤–∏–Ω–∏–ª—Ö–ª–æ—Ä–∏–¥–∞. –ü–æ—ç—Ç–æ–º—É –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–µ R&D-—Ü–µ–Ω—Ç—Ä—ã –≤ –Ω–µ—Ñ—Ç–µ—Ö–∏–º–∏–∏ —Å–æ—Å—Ä–µ–¥–æ—Ç–æ—á–µ–Ω—ã –Ω–∞ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ–≥–æ –∫–æ–º–ø–∞—É–Ω–¥–∞ –¥–ª—è —ç—Ç–∏—Ö —Ü–µ–ª–µ–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration, reimbursement, pricing, import_export, shortage"",
  ""impact"": ""high"",
  ""english"": ""Russia is strengthening the localization of medical equipment production. New regulatory acts, effective from September 1st, regulate the market for medical products: updated requirements for technical documentation to full prohibition of unmarked medical gloves. These measures aim at achieving technological independence, but also require Russian manufacturers to ensure high-quality products. On one hand, a strict barrier against importing substandard and dangerous medical items for patients is needed; on the other hand, Russian enterprises need to be supplied with orders. The country already meets strict international standards in its development, including Swiss and Korean ones. However, there are areas where domestic R&D centers need to focus on developing unique polyvinyl chloride recipes for Russia's specific needs, such as infusion systems.""
}"
2025-09-01T12:12:00+00:00,@bezrec,6488,https://t.me/bezrec/6488,"–¢–∞–∫–∏–º–∏ –¥–∞–Ω–Ω—ã–º–∏ –ø–æ–¥–µ–ª–∏–ª–∏—Å—å –∞–Ω–∞–ª–∏—Ç–∏–∫–∏ DSM Group. –î–ª—è —Å—Ä–∞–≤–Ω–µ–Ω–∏—è, –≤ 2020 –≥–æ–¥—É —ç—Ç–æ—Ç –ø–æ–∫–∞–∑–∞—Ç–µ–ª—å –±—ã–ª –Ω–∞ —É—Ä–æ–≤–Ω–µ 43,3%, –∞ –≤ 2021 –≥–æ–¥—É –Ω–∞ —Ñ–æ–Ω–µ –ø–∞–Ω–¥–µ–º–∏–∏ –≤—ã—Ä–æ—Å –¥–æ 46,8%. –ù–æ –Ω–µ–¥–æ–ª–≥–æ –º—É–∑—ã–∫–∞ –∏–≥—Ä–∞–ª–∞ ‚Äî —É–∂–µ –≤ 2023 –≥–æ–¥—É –¥–æ–ª—è –ª–æ–∫–∞–ª—å–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Å–Ω–∏–∑–∏–ª–∞—Å—å –¥–æ 42,8%, –∞ –≤ 2023 –≥–æ–¥—É ‚Äî –¥–æ 39,7%. –ï—Å–ª–∏ –≥–æ–≤–æ—Ä–∏—Ç—å –æ –¥–æ–ª–µ –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö, —Ç–æ –æ–Ω–∞ –±—ã–ª–∞ –±–æ–ª–µ–µ —Å—Ç–∞–±–∏–ª—å–Ω–∞ –∏ –∫–æ–ª–µ–±–∞–ª–∞—Å—å –æ—Ç 82,4% –≤ 2021 –≥–æ–¥—É –¥–æ 86,9% –≤ 2024 –≥–æ–¥—É. –¢–∞–∫–æ–µ –ø–æ–ª–æ–∂–µ–Ω–∏–µ –¥–µ–ª —Å–≤–∏–¥–µ—Ç–µ–ª—å—Å—Ç–≤—É–µ—Ç –æ —Ç–æ–º, —á—Ç–æ –∏–º–ø–æ—Ä—Ç–æ–∑–∞–º–µ—â–µ–Ω–∏–µ –≤ —Ñ–∞—Ä–º–µ –ø–æ–∫–∞ –Ω–µ –∑–∞—Ä–∞–±–æ—Ç–∞–ª–æ –≤ –ø–æ–ª–Ω—É—é —Å–∏–ª—É, –Ω–µ—Å–º–æ—Ç—Ä—è –Ω–∞ –≤—Å–µ —Å—Ç–∞—Ä–∞–Ω–∏—è –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–∞. –ù–∞—à–∏ –∫–æ–º–ø–∞–Ω–∏–∏ –ø–æ–∫–∞ –Ω–µ –º–æ–≥—É—Ç –ø—Ä–µ–¥–ª–æ–∂–∏—Ç—å —Ä–æ—Å—Å–∏–π—Å–∫–∏–º –ø–∞—Ü–∏–µ–Ω—Ç–∞–º –¥–æ—Å—Ç–æ–π–Ω—É—é –∑–∞–º–µ–Ω—É –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã–º –∏–Ω–Ω–æ–≤–∞—Ü–∏—è–º. –ù–∞ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã–µ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –Ω—É–∂–Ω–æ –≤—Ä–µ–º—è, –¥–∞–∂–µ –µ—Å–ª–∏ —Ä–µ—Å—É—Ä—Å–æ–≤ ‚Äî —Å–≤–æ–∏—Ö –∏–ª–∏ –∑–∞–µ–º–Ω—ã—Ö ‚Äî —Ö–≤–∞—Ç–∞–µ—Ç,‚Äî –≥–æ–≤–æ—Ä–∏—Ç –≥–ª–∞–≤–∞ DSM Group –°–µ—Ä–≥–µ–π –®—É–ª—è–∫. –ü–æ –º–Ω–µ–Ω–∏—é –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –ø–æ —Ä–∞–∑–≤–∏—Ç–∏—é RNC Pharma –ù–∏–∫–æ–ª–∞—è –ë–µ—Å–ø–∞–ª–æ–≤–∞, —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ –∫–æ–º–ø–∞–Ω–∏–∏ –Ω–∞ –ø—É—Ç–∏ –∫ –≥–æ—Å–∑–∞–∫—É–ø–∫–∞–º —Ç–æ—Ä–º–æ–∑—è—Ç —Å–ª–æ–∂–Ω–æ—Å—Ç–∏ —Å –≤–∫–ª—é—á–µ–Ω–∏–µ–º –∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü. –ù–æ –µ—Å—Ç—å –∏ —Ö–æ—Ä–æ—à–∞—è –Ω–æ–≤–æ—Å—Ç—å. –í—ã—Å–æ–∫–∞—è –¥–æ–ª—è –∏–º–ø–æ—Ä—Ç–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –≥–æ—Å–∑–∞–∫—É–ø–∫–∞—Ö –≥–æ–≤–æ—Ä–∏—Ç –æ —Å—Ç—Ä–µ–º–ª–µ–Ω–∏–∏ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–∞ –æ–±–µ—Å–ø–µ—á–∏—Ç—å –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–º–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏, —Å—á–∏—Ç–∞–µ—Ç —ç–∫—Å–ø–µ—Ä—Ç. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The data shared by DSM Group shows that while the import substitution in pharmaceuticals is not yet fully effective, it has been impacted by the pandemic. The share of local products decreased from 46.8% in 2021 to 39.7% in 2023, and from 42.8% to 39.7%. Despite the efforts of the Ministry of Industry and Trade, our companies are not yet able to offer a worthy substitute for foreign innovations. The original research takes time, even with resources available. RNC Pharma Director Nikolay Beppaloov notes that the difficulties in including their products in the state procurement list are slowing down progress. However, he also sees a positive side: the high share of imported drugs in state procurement indicates the government's desire to provide patients with innovative medicines.""
}"
2025-09-01T09:02:56+00:00,@bezrec,6487,https://t.me/bezrec/6487,"¬´–í—Ç–æ—Ä–æ–π¬ª —Å—Ç–∞–Ω–µ—Ç ¬´–ª–∏—à–Ω–∏–º¬ª —Å –Ω–æ–≤–æ–≥–æ –≥–æ–¥–∞. –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –ø–µ—Ä–µ–Ω–µ—Å–ª–æ —Å—Ä–æ–∫ –∑–∞–ø—É—Å–∫–∞ –º–µ—Ö–∞–Ω–∏–∑–º–∞ ¬´–≤—Ç–æ—Ä–æ–π –ª–∏—à–Ω–∏–π¬ª –¥–ª—è —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ —Å 1 —Å–µ–Ω—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞ –Ω–∞ 1 —è–Ω–≤–∞—Ä—è 2026 –≥–æ–¥–∞. –û —Ç–æ–º, —á—Ç–æ —Å—Ä–æ–∫–∏ ¬´–≤—Ç–æ—Ä–æ–≥–æ –ª–∏—à–Ω–µ–≥–æ¬ª –¥–ª—è –°–ó–õ–° –º–æ–≥—É—Ç —Å–¥–≤–∏–Ω—É—Ç—å, –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ —Å–æ–æ–±—â–∏–ª –≤ –∞–≤–≥—É—Å—Ç–µ. –¢–æ–≥–¥–∞ –≤ –≤–µ–¥–æ–º—Å—Ç–≤–µ –ø–æ—è—Å–Ω–∏–ª–∏, —á—Ç–æ –ø–µ—Ä–µ–Ω–æ—Å –æ–±—É—Å–ª–æ–≤–ª–µ–Ω –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç—å—é ¬´–±–µ—Å—à–æ–≤–Ω–æ–≥–æ¬ª –ø–µ—Ä–µ—Ö–æ–¥–∞, —á—Ç–æ–±—ã –≤—Å–µ –∂–µ–ª–∞—é—â–∏–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ —É—Å–ø–µ–ª–∏ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞—Ç—å—Å—è –≤ —Å–∏—Å—Ç–µ–º–µ –ø—Ä–æ—Å–ª–µ–∂–∏–≤–∞–µ–º–æ—Å—Ç–∏ –∏ –≤–Ω–µ—Å—Ç–∏ –≤ –Ω–µ—ë –≤—Å–µ –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã–µ –¥–∞–Ω–Ω—ã–µ. –ö 1 —Å–µ–Ω—Ç—è–±—Ä—è —Å–ø—Ä–∞–≤–∏–ª–∏—Å—å –Ω–µ –≤—Å–µ, –∏ –ø–æ–ª–Ω–æ—Ü–µ–Ω–Ω–æ –∑–∞–ø—É—Å—Ç–∏—Ç—å —Å–∏—Å—Ç–µ–º—É –Ω–µ –ø–æ–ª—É—á–∏–ª–æ—Å—å. –≠–∫—Å–ø–µ—Ä—Ç –í–°–ü –ê–ª–µ–∫—Å–µ–π –§–µ–¥–æ—Ä–æ–≤ –Ω–∞–¥–µ–µ—Ç—Å—è, —á—Ç–æ –¥–æ –∫–æ–Ω—Ü–∞ –≥–æ–¥–∞ –µ—ë —É–¥–∞—Å—Ç—Å—è –Ω–∞–ø–æ–ª–Ω–∏—Ç—å —Å–≤–µ–¥–µ–Ω–∏—è–º–∏. –ê –µ—Å–ª–∏ –Ω–µ—Ç, ¬´–º–æ–∂–Ω–æ –µ—â—ë –ø–µ—Ä–µ–Ω–µ—Å—Ç–∏¬ª. –§–µ–¥–æ—Ä–æ–≤ —Ç–∞–∫–∂–µ –æ—Ç–º–µ—Ç–∏–ª, —á—Ç–æ —Ç–∞–∫–∞—è —Å–∏–Ω—Ö—Ä–æ–Ω–∏–∑–∞—Ü–∏—è –±—ã–ª–∞ –ø—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ–Ω–∞ –≤ –ø–ª–∞–Ω–µ –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–π –ø–æ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ –°—Ç—Ä–∞—Ç–µ–≥–∏–∏ ¬´–§–∞—Ä–º–∞-2030¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The government has postponed the launch of the 'second extra' mechanism for strategically important drugs from September 1, 2025 to January 1, 2026. The Ministry of Industry and Trade announced this in August, stating that the delay is necessary for a 'smooth' transition to ensure all registered manufacturers can register and add relevant data. Not all have completed this by September 1, and the system has not been fully operational. Expert from VSP Alexey Fedorov hopes to complete it by the end of the year, otherwise, further postponement may be considered. Such synchronization was also planned in the measures to implement the 'Pharma-2030' strategy.""
}"
2025-09-01T05:35:40+00:00,@bezrec,6486,https://t.me/bezrec/6486,"–†–æ—Å—Å–∏–π—Å–∫–∞—è –≤–∞–∫—Ü–∏–Ω–∞ –æ—Ç –ª–∏—Ö–æ—Ä–∞–¥–∫–∏ —á–∏–∫—É–Ω–≥—É–Ω—å—è ¬´–≤ –Ω–∞—Ä–æ–¥¬ª –Ω–µ –ø–æ–π–¥—ë—Ç. –£—á—ë–Ω—ã–µ –¶–µ–Ω—Ç—Ä–∞ –∏–º. –ì–∞–º–∞–ª–µ–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª–∏ –≥–µ–Ω–Ω–æ-–∏–Ω–∂–µ–Ω–µ—Ä–Ω—É—é –≤–∞–∫—Ü–∏–Ω—É –æ—Ç –ª–∏—Ö–æ—Ä–∞–¥–∫–∏ —á–∏–∫—É–Ω–≥—É–Ω—å—è –Ω–∞ —Ç–æ–π –∂–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π –ø–ª–∞—Ç—Ñ–æ—Ä–º–µ, —á—Ç–æ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–ª–∞—Å—å –¥–ª—è ¬´–°–ø—É—Ç–Ω–∏–∫–∞ V¬ª. –ù–æ–≤—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –ø—Ä–æ—à—ë–ª —ç—Ç–∞–ø—ã –Ω–∞—É—á–Ω–æ-–∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–æ–π —Ä–∞–±–æ—Ç—ã (–ù–ò–†), –ø–æ—Ä–∞ –±—ã –ø–µ—Ä–µ—Ö–æ–¥–∏—Ç—å –∫ –¥–æ–∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–º –∏ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–º –∏—Å–ø—ã—Ç–∞–Ω–∏—è–º, –Ω–æ –µ—Å—Ç—å –Ω—é–∞–Ω—Å: –ù–µ–ª—å–∑—è –ø–æ—Å—Ç–∞–≤–∏—Ç—å —ç–ø–∏–¥–µ–º–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–π –æ–ø—ã—Ç –ø–æ –∏–∑—É—á–µ–Ω–∏—é –∑–∞—â–∏—Ç–Ω—ã—Ö —Å–≤–æ–π—Å—Ç–≤ –≤–∞–∫—Ü–∏–Ω—ã, –ø–æ—Ç–æ–º—É —á—Ç–æ –∫–∞–∫ —Ç–∞–∫–æ–≤–æ–π –∑–∞–±–æ–ª–µ–≤–∞–µ–º–æ—Å—Ç–∏ –≤ —Å—Ç—Ä–∞–Ω–µ –Ω–µ—Ç. –ù—É–∂–Ω–æ –ø–æ–Ω—è—Ç—å, —á—Ç–æ –∏–º–µ–Ω–Ω–æ —ç–∫—Å–ø–µ—Ä—Ç—ã, –∫–æ—Ç–æ—Ä—ã–µ –±—É–¥—É—Ç –ø—Ä–∏–Ω–∏–º–∞—Ç—å —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –∏—Å–ø—ã—Ç–∞–Ω–∏–π, –ø–æ—Å–æ–≤–µ—Ç—É—é—Ç –∏ –ø—Ä–µ–¥–ª–æ–∂–∞—Ç –≤ –∫–∞—á–µ—Å—Ç–≤–µ —ç—Ç–æ–≥–æ —ç–ø–∏–¥–µ–º–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ –æ–ø—ã—Ç–∞, ‚Äî –æ–±—ä—è—Å–Ω–∏–ª –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ì–∏–Ω—Ü–±—É—Ä–≥. –ì–ª–∞–≤–∞ –¶–µ–Ω—Ç—Ä–∞ –∏–º. –ì–∞–º–∞–ª–µ–∏ –ø—Ä–∏–≤—ë–ª –ø—Ä–∏–º–µ—Ä —Å –≤–∞–∫—Ü–∏–Ω–æ–π –¥–ª—è –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –≠–±–æ–ª—ã (–≠–ø–∏–í–∞–∫–≠–±–æ–ª–∞). –î–ª—è –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–µ–≥–æ —ç–ø–∏–¥–æ–ø—ã—Ç–∞ —É—á—ë–Ω—ã–µ –µ–∑–¥–∏–ª–∏ –≤ –ê—Ñ—Ä–∏–∫—É –∏ —Ç–∞–º —Ç–µ—Å—Ç–∏—Ä–æ–≤–∞–ª–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç –≤ —Ç–µ—á–µ–Ω–∏–µ –¥–≤—É—Ö –ª–µ—Ç. –í –†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä–µ —É—Å–ø–æ–∫–∞–∏–≤–∞—é—Ç, —á—Ç–æ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –∫–æ–º–∞—Ä–æ–≤-–ø–µ—Ä–µ–Ω–æ—Å—á–∏–∫–æ–≤ –ª–∏—Ö–æ—Ä–∞–¥–∫–∏ –≤ –†–æ—Å—Å–∏–∏ –Ω–µ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ—Ç —ç–ø–∏–¥–µ–º–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π –æ–ø–∞—Å–Ω–æ—Å—Ç–∏. –û–¥–Ω–∞–∫–æ –ø–µ—Ä–≤—ã–π –≤ —ç—Ç–æ–º –≥–æ–¥—É –∑–∞–≤–æ–∑–Ω–æ–π —Å–ª—É—á–∞–π —É–∂–µ –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–Ω ‚Äî –∑–∞–±–æ–ª–µ–≤—à–∏–π –ø—Ä–∏–ª–µ—Ç–µ–ª –≤ –ú–æ—Å–∫–≤—É –∏–∑ –®—Ä–∏-–õ–∞–Ω–∫–∏. –í–∏—Ä—É—Å–æ–ª–æ–≥–∏ —É–≤–µ—Ä—è—é—Ç, —á—Ç–æ —Ä–∏—Å–∫ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–∏—è –∏–Ω—Ñ–µ–∫—Ü–∏–∏ –≤ –†–§ –Ω–µ–≤–µ–ª–∏–∫ ‚Äî –¥–ª—è –ø–µ—Ä–µ–¥–∞—á–∏ –Ω—É–∂–µ–Ω —É–∫—É—Å –º–µ—Å—Ç–Ω–æ–≥–æ –∫–æ–º–∞—Ä–∞-–ø–µ—Ä–µ–Ω–æ—Å—á–∏–∫–∞ –≤–æ –≤—Ä–µ–º—è –∫–æ—Ä–æ—Ç–∫–æ–≥–æ ¬´–≤–∏—Ä—É—Å–æ–Ω–æ—Å–∏—Ç–µ–ª—å—Å—Ç–≤–∞¬ª —É –∑–∞–±–æ–ª–µ–≤—à–µ–≥–æ. –ü–æ —Å–ª–æ–≤–∞–º –ì–∏–Ω—Ü–±—É—Ä–≥–∞, –Ω–æ–≤–∞—è –≤–∞–∫—Ü–∏–Ω–∞ –ø—Ä–µ–¥–Ω–∞–∑–Ω–∞—á–µ–Ω–∞ –Ω–µ –¥–ª—è –º–∞—Å—Å–æ–≤–æ–π –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏–∏ –Ω–∞—Å–µ–ª–µ–Ω–∏—è –†–§, –∞ –¥–ª—è —Ç–µ—Ö, –∫—Ç–æ —á–∞—Å—Ç–æ –≤—ã–µ–∑–∂–∞–µ—Ç –≤ —ç–Ω–¥–µ–º–∏—á–Ω—ã–µ –¥–ª—è —ç—Ç–æ–≥–æ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è —Ä–∞–π–æ–Ω—ã, –∞ —Ç–∞–∫–∂–µ –≥—Ä—É–ø–ø –ø–æ–≤—ã—à–µ–Ω–Ω–æ–≥–æ —Ä–∏—Å–∫–∞, –Ω–∞–ø—Ä–∏–º–µ—Ä –¥–ª—è –≤—Ä–∞—á–µ–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety, guideline"",
  ""impact"": ""medium"",
  ""english"": ""Russian researchers from the Gamaleya Research Institute have developed a genetically engineered vaccine for chikungunya on the same platform as 'Sputnik V'. The new vaccine has completed preclinical and clinical trial stages. However, due to the lack of an epidemic experience on this virus in Russia, experts need to decide what kind of epidemiological data will be used for the results. The head of the Gamaleya Research Institute mentioned an example with Ebola vaccine (EpiVacEbola), where researchers had to go to Africa for two years to test the vaccine. The Russian Health Supervision Agency reassures that there is no significant epidemic threat from mosquitoes in Russia, but the first imported case has already been registered. The virus experts assure that the risk of infection in Russia is low, requiring a short 'virus carrier' period. According to Ginzburg, the new vaccine is not intended for mass vaccination in Russia but rather for those who frequently travel to endemic areas and high-risk groups, such as doctors.""
}"
2025-08-31T11:04:41+00:00,@bezrec,6485,https://t.me/bezrec/6485,"–ö–∞–∫ –æ—Ä–ª–∏—Å—Ç–∞—Ç, —Ç–æ–ª—å–∫–æ –ª—É—á—à–µ –±–µ–∑ –¥–∏–∞—Ä–µ–∏. –£—á—ë–Ω—ã–µ –∏–∑ –°—ã—á—É–∞–Ω—å—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ –≤—ã–∫–∞—Ç–∏–ª–∏ —Å–≤–æ—é –≤–µ—Ä—Å–∏—é –∏–∑–≤–µ—Å—Ç–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –¥–ª—è –ø–æ—Ö—É–¥–µ–Ω–∏—è ‚Äî —Å—ä–µ–¥–æ–±–Ω—ã–µ –∂–∏—Ä–æ–ø–æ–≥–ª–æ—â–∞—é—â–∏–µ –º–∏–∫—Ä–æ–≥—Ä–∞–Ω—É–ª—ã. –ü–æ –≤–∏–¥—É –æ–Ω–∏ –Ω–∞–ø–æ–º–∏–Ω–∞—é—Ç –∂–µ–ª–µ–π–Ω—ã–µ —à–∞—Ä–∏–∫–∏ –∏–∑ –ø–æ–ø—É–ª—è—Ä–Ω–æ–≥–æ –Ω—ã–Ω—á–µ –±–∞–±–ª-—Ç–∏. –ü–æ –ø—Ä–∏–Ω—Ü–∏–ø—É –¥–µ–π—Å—Ç–≤–∏—è ‚Äî –Ω–µ–∫–æ–≥–¥–∞ –ø–æ–ø—É–ª—è—Ä–Ω—ã–π –æ—Ä–ª–∏—Å—Ç–∞—Ç. –í —Å–æ—Å—Ç–∞–≤–µ ‚Äî –º–∏–∫—Å –ø–æ–ª–∏—Ñ–µ–Ω–æ–ª–æ–≤ –∏–∑ –∑–µ–ª—ë–Ω–æ–≥–æ —á–∞—è, –±—É—Ä—ã—Ö –≤–æ–¥–æ—Ä–æ—Å–ª–µ–π –∏ –≤–∏—Ç–∞–º–∏–Ω–∞ –ï. –ì—Ä–∞–Ω—É–ª—ã –¥–µ–π—Å—Ç–≤—É—é—Ç –ª–æ–∫–∞–ª—å–Ω–æ –≤ –∫–∏—à–µ—á–Ω–∏–∫–µ, –∞ –Ω–µ —Å–∏—Å—Ç–µ–º–Ω–æ –≤ –∫—Ä–æ–≤–æ—Ç–æ–∫–µ, —á—Ç–æ –º–æ–∂–µ—Ç —Å–Ω–∏–∑–∏—Ç—å —Ä–∏—Å–∫ –ø–æ–±–æ—á–Ω—ã—Ö —ç—Ñ—Ñ–µ–∫—Ç–æ–≤, –ø—Ä–∏—Å—É—â–∏—Ö —Ç–æ–º—É –∂–µ –æ—Ä–ª–∏—Å—Ç–∞—Ç—É. –í —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, –æ—Ç –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ —Å—Ç–∞–ª–∏ –æ—Ç–∫–∞–∑—ã–≤–∞—Ç—å—Å—è –∏–∑-–∑–∞ —Ç–æ–≥–æ, —á—Ç–æ –æ–Ω –ø—Ä–æ–≤–æ—Ü–∏—Ä–æ–≤–∞–ª –¥–∏–∞—Ä–µ—é, –ø–æ—Å–∫–æ–ª—å–∫—É –ø—Ä–µ–ø—è—Ç—Å—Ç–≤–æ–≤–∞–ª –≤—Å–∞—Å—ã–≤–∞–Ω–∏—é –∂–∏—Ä–æ–≤, —É—Å–∏–ª–∏–≤–∞—è –∏—Ö –≤—ã–≤–µ–¥–µ–Ω–∏–µ —Å –∫–∞–ª–æ–º. –ò—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª–∏ –ø—Ä–æ–≤–µ—Ä–∏–ª–∏ –¥–µ–π—Å—Ç–≤–∏–µ –º–∏–∫—Ä–æ–≥—Ä–∞–Ω—É–ª –Ω–∞ –∫—Ä—ã—Å–∞—Ö. –û–∫–∞–∑–∞–ª–æ—Å—å, —á—Ç–æ —É –≥—Ä—ã–∑—É–Ω–æ–≤, –ø–æ–ª—É—á–∞–≤—à–∏—Ö –∂–∏—Ä–Ω—ã–π –∫–æ—Ä–º —Å –¥–æ–±–∞–≤–ª–µ–Ω–∏–µ–º –º–∏–∫—Ä–æ–≥—Ä–∞–Ω—É–ª, –¥–∏–∞—Ä–µ–∏ –Ω–µ –±—ã–ª–æ, –≤ –æ—Ç–ª–∏—á–∏–µ –æ—Ç –ø–æ–¥–æ–ø—ã—Ç–Ω—ã—Ö, –∫–æ—Ç–æ—Ä—ã–º –¥–∞–≤–∞–ª–∏ –æ—Ä–ª–∏—Å—Ç–∞—Ç. –ü—Ä–∏ —ç—Ç–æ–º —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –ø–æ –ø–æ—Ç–µ—Ä–µ –≤–µ—Å–∞ –≤ –æ–±–µ–∏—Ö –≥—Ä—É–ø–ø–∞—Ö –±—ã–ª–∏ —Å–æ–ø–æ—Å—Ç–∞–≤–∏–º—ã–º–∏. –û—Ä–ª–∏—Å—Ç–∞—Ç –∏–∑-–∑–∞ –µ–≥–æ ¬´–ø–æ–±–æ—á–µ–∫¬ª ‚Äî —É–∂–µ –ø—Ä–æ—à–ª—ã–π –≤–µ–∫, –∏ –∫–∏—Ç–∞–π—Ü—ã –ø–ª–∞–Ω–∏—Ä—É—é—Ç –ø–æ—Ç—è–≥–∞—Ç—å—Å—è —Å —Å–∞–º–∏–º –û–∑–µ–º–ø–∏–∫–æ–º. –ò—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª–∏ –Ω–∞–±–∏—Ä–∞—é—Ç –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ –Ω–µ –º–æ–≥—É—Ç –ø—Ä–∏–Ω–∏–º–∞—Ç—å —Å–µ–º–∞–≥–ª—É—Ç–∏–¥ –∏–ª–∏ –Ω–µ —Ä–µ–∞–≥–∏—Ä—É—é—Ç –Ω–∞ –Ω–µ–≥–æ, –¥–ª—è —É—á–∞—Å—Ç–∏—è –≤ —Ä–∞–Ω–Ω–µ–π —Ñ–∞–∑–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å–ø—ã—Ç–∞–Ω–∏–π –≤ –ö–∏—Ç–∞–µ, —á—Ç–æ–±—ã –ø—Ä–æ—Ç–µ—Å—Ç–∏—Ç—å –¥–µ–π—Å—Ç–≤–∏–µ –º–∏–∫—Ä–æ–≥—Ä–∞–Ω—É–ª –Ω–∞ –ª—é–¥—è—Ö.","{""skip"": true}"
2025-08-30T11:01:13+00:00,@bezrec,6484,https://t.me/bezrec/6484,"–ù–∞—Å–ª–∞–∂–¥–∞–µ–º—Å—è –ø–æ—Å–ª–µ–¥–Ω–∏–º–∏ –ª–µ—Ç–Ω–∏–º–∏ –≤—ã—Ö–æ–¥–Ω—ã–º–∏ –∏ —á–∏—Ç–∞–µ–º —Å–≤–µ–∂–∏–π –≤—ã–ø—É—Å–∫ —Ä—É–±—Ä–∏–∫–∏ #–≤–¥–æ–≥–æ–Ω–∫—É. üíä –í –¶–µ–Ω—Ç—Ä–µ –∏–º. –ì–∞–º–∞–ª–µ–∏ —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏ –æ —Ä–∞–±–æ—Ç–µ –Ω–∞–¥ –≤–∞–∫—Ü–∏–Ω–æ–π –ø—Ä–æ—Ç–∏–≤ –í–ò–ß. –ü–æ —Å–ª–æ–≤–∞–º —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–æ–≤, —Å–æ–∑–¥–∞–Ω–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –Ω–∞ –æ—Å–Ω–æ–≤–µ –º–†–ù–ö-–ø–ª–∞—Ç—Ñ–æ—Ä–º—ã –∑–∞–π–º—ë—Ç –æ–∫–æ–ª–æ –¥–≤—É—Ö –ª–µ—Ç. –°–µ–π—á–∞—Å —É—á—ë–Ω—ã–µ –Ω–∞—Ö–æ–¥—è—Ç—Å—è –Ω–∞ —ç—Ç–∞–ø–µ –ø–æ–¥–±–æ—Ä–∞ –ø–µ—Ä–≤—ã—Ö –∞–Ω—Ç–∏–≥–µ–Ω–æ–≤, —Å–ø–æ—Å–æ–±–Ω—ã—Ö —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞—Ç—å —à–∏—Ä–æ–∫–æ–Ω–µ–π—Ç—Ä–∞–ª–∏–∑—É—é—â–∏–π –∏–º–º—É–Ω–Ω—ã–π –æ—Ç–≤–µ—Ç. üíä –ú–§–¢–ò –∑–∞–ø—É—Å—Ç–∏–ª –¶–ï–•. –≠—Ç–æ —Å–ø–µ—Ü–∏–∞–ª—å–Ω–∞—è –ø–ª–æ—â–∞–¥–∫–∞ –¥–ª—è –æ–ø—ã—Ç–Ω–æ-—Ö–∏–º–∏—á–µ—Å–∫–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞, –≤ —Ä–∞–º–∫–∞—Ö –∫–æ—Ç–æ—Ä–æ–π –±—É–¥–µ—Ç –æ—Å—É—â–µ—Å—Ç–≤–ª—è—Ç—å—Å—è –ø–æ–ª–Ω—ã–π —Ü–∏–∫–ª —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –∏ –º–∞—Å—à—Ç–∞–±–∏—Ä–æ–≤–∞–Ω–∏—è —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π —Å–∏–Ω—Ç–µ–∑–∞ –∞–∫—Ç–∏–≤–Ω—ã—Ö —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏–π. üíä –ù–ì–£ –∏ –°–µ—á–µ–Ω–æ–≤—Å–∫–∏–π —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç —Å–æ–∑–¥–∞–¥—É—Ç –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–∏–π —Ü–µ–Ω—Ç—Ä. ¬´–ó–∞–ø–∞–¥-–í–æ—Å—Ç–æ–∫¬ª –±—É–¥–µ—Ç —Ä–∞–±–æ—Ç–∞—Ç—å –Ω–∞–¥ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–º–∏ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è–º–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ —Å–æ–≤–º–µ—Å—Ç–Ω—ã–º–∏ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è–º–∏ –¥–ª—è —Å–æ–∑–¥–∞–Ω–∏—è ¬´–∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π¬ª. üíä –õ–µ–æ–Ω–∏–¥ –°–ª—É—Ü–∫–∏–π –ø—Ä–∏–¥—É–º–∞–ª –Ω–æ–≤–æ–µ —Ä–µ—à–µ–Ω–∏–µ –ø—Ä–æ–±–ª–µ–º—ã –æ—Ç—Å—É—Ç—Å—Ç–≤–∏—è –∞–ø—Ç–µ–∫ –≤ —Å–µ–ª—å—Å–∫–æ–π –º–µ—Å—Ç–Ω–æ—Å—Ç–∏. –õ–∏–¥–µ—Ä –ö–ü–†–§ –ø—Ä–µ–¥–ª–æ–∂–∏–ª —Ä–∞–∑–º–µ—â–∞—Ç—å –∞–ø—Ç–µ—á–Ω—ã–µ –ø—É–Ω–∫—Ç—ã –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ –∫—Ä—É–ø–Ω—ã—Ö —Ç–æ—Ä–≥–æ–≤—ã—Ö —Å–µ—Ç–µ–π, –æ—Ç–º–µ—Ç–∏–≤, —á—Ç–æ ¬´–±–æ–ª—å—à–æ–π –±–∏–∑–Ω–µ—Å –¥–æ–ª–∂–µ–Ω –∏–¥—Ç–∏ –Ω–∞–≤—Å—Ç—Ä–µ—á—É –≥—Ä–∞–∂–¥–∞–Ω–∞–º¬ª. üíä –ê—Ä–±–∏—Ç—Ä–∞–∂–Ω—ã–π —Å—É–¥ –ú–æ—Å–∫–≤—ã –æ—Ç–∫–ª–æ–Ω–∏–ª –∏—Å–∫ Roche –∫ –ú–∏–Ω–∑–¥—Ä–∞–≤—É. –®–≤–µ–π—Ü–∞—Ä—Ü—ã –ø—ã—Ç–∞–ª–∏—Å—å –æ—Å–ø–æ—Ä–∏—Ç—å —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—é –î–∏–ø–ª–∞–º–∞ ‚Äî –¥–∂–µ–Ω–µ—Ä–∏–∫–∞ —Ä–∏—Å–¥–∏–ø–ª–∞–º–∞ –æ—Ç Jodas Expoim ‚Äî –∏ —Ç—Ä–µ–±–æ–≤–∞–ª–∏ –ø—Ä–∏–æ—Å—Ç–∞–Ω–æ–≤–∫–∏ –∏–ª–∏ –æ—Ç–º–µ–Ω—ã –¥–µ–π—Å—Ç–≤–∏—è —Ä–µ–≥—É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏—è –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç. –û—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã–π –≠–≤—Ä–∏—Å–¥–∏ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –°–ú–ê –∑–∞—â–∏—â—ë–Ω –ø–∞—Ç–µ–Ω—Ç–æ–º –¥–æ 2035 –≥–æ–¥–∞. üíä –§–ê–° –≤—ã—è–≤–∏–ª–∞ –∞–Ω—Ç–∏–∫–æ–Ω–∫—É—Ä–µ–Ω—Ç–Ω–æ–µ —Å–æ–≥–ª–∞—à–µ–Ω–∏–µ –ø—Ä–∏ –ø—Ä–æ–¥–∞–∂–µ –≠–ª–∞–ø—Ä–∞–∑—ã –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Å–∏–Ω–¥—Ä–æ–º–∞ –•–∞–Ω—Ç–µ—Ä–∞ –Ω–∞ 5,9 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –í–µ–¥–æ–º—Å—Ç–≤–æ –≤–æ–∑–±—É–¥–∏–ª–æ –¥–µ–ª–æ –ø—Ä–æ—Ç–∏–≤ –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏–º–ø–æ—Ä—Ç–µ—Ä–∞ –≠–ª–∞–ø—Ä–∞–∑—ã –≤ –†–æ—Å—Å–∏–∏ ‚Äì –û–û–û ¬´–¢–∞–∫–µ–¥–∞ –§–∞—Ä–º–∞—Å—å—é—Ç–∏–∫–∞–ª—Å¬ª, –∞ —Ç–∞–∫–∂–µ –µ–≥–æ –∫–ª—é—á–µ–≤–æ–≥–æ –¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–∞ ‚Äî –ê–û ¬´–§–∞—Ä–º–∏–º—ç–∫—Å¬ª. –ö–æ–º–ø–∞–Ω–∏–∏ –æ–±–≤–∏–Ω—è—é—Ç—Å—è –≤ –∑–∞–∫–ª—é—á–µ–Ω–∏–∏ –∏ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ –∑–∞–ø—Ä–µ—â–µ–Ω–Ω–æ–≥–æ ¬´–≤–µ—Ä—Ç–∏–∫–∞–ª—å–Ω–æ–≥–æ¬ª —Å–æ–≥–ª–∞—à–µ–Ω–∏—è –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ –æ—Ä—Ñ–∞–Ω–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞, –≤ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–µ –∫–æ—Ç–æ—Ä–æ–≥–æ –≥–æ—Å–∑–∞–∫—É–ø–∫–∏ –ø—Ä–æ—Ö–æ–¥–∏–ª–∏ –±–µ–∑ —Å–Ω–∏–∂–µ–Ω–∏—è –Ω–∞—á–∞–ª—å–Ω—ã—Ö –º–∞–∫—Å–∏–º–∞–ª—å–Ω—ã—Ö —Ü–µ–Ω –∫–æ–Ω—Ç—Ä–∞–∫—Ç–æ–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": true
}"
2025-08-29T14:35:05+00:00,@bezrec,6483,https://t.me/bezrec/6483,"–ü—è—Ç–Ω–∏—á–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏: –≤ –Æ–∂–Ω–æ–π –ö–æ—Ä–µ–µ –ø—Ä–æ–¥–∞—é—Ç –æ—Ç–∫—Ä—ã–≤–∞—à–∫–∏ —Å–æ –≤—Å—Ç—Ä–æ–µ–Ω–Ω—ã–º –∞–Ω—Ç–∏–ø–æ—Ö–º–µ–ª–∏–Ω–æ–º. –í –º–∞–ª–µ–Ω—å–∫–æ–π –±—É—Ç—ã–ª–æ—á–∫–µ ‚Äî –Ω–∞–ø–∏—Ç–æ–∫ —Å –ø—Ä–∏—è—Ç–Ω—ã–º, –∫–∞–∫ –æ–±–µ—â–∞—é—Ç —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–∏, —Ñ—Ä—É–∫—Ç–æ–≤—ã–º –≤–∫—É—Å–æ–º –∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–æ, –æ–±–ª–µ–≥—á–∞—é—â–µ–µ —Å–æ—Å—Ç–æ—è–Ω–∏–µ –ø–æ—Å–ª–µ –±—É—Ä–Ω—ã—Ö –≤–æ–∑–ª–∏—è–Ω–∏–π. –ê –≤ —Ä–æ—Å—Å–∏–π—Å–∫–æ–π –≤–µ—Ä—Å–∏–∏ –º–æ–≥ –±—ã –±—ã—Ç—å —Ä–∞—Å—Å–æ–ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-08-29T11:30:01+00:00,@bezrec,6482,https://t.me/bezrec/6482,"–ü–æ—Å–º–æ—Ç—Ä–µ–ª–∏ —Ñ–∏–Ω–∞–Ω—Å–æ–≤—É—é –æ—Ç—á—ë—Ç–Ω–æ—Å—Ç—å ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∏¬ª –∑–∞ —à–µ—Å—Ç—å –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ –∏ –æ–±–Ω–∞—Ä—É–∂–∏–ª–∏, —á—Ç–æ —á–∏—Å—Ç–∞—è –ø—Ä–∏–±—ã–ª—å –≥—Ä—É–ø–ø—ã –ø–æ –ú–°–§–û —Å–Ω–∏–∑–∏–ª–∞—Å—å –Ω–∞ 11% –≥–æ–¥ –∫ –≥–æ–¥—É, –¥–æ 1,712 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ï—â—ë —Ü–∏—Ñ—Ä—ã –∏–∑ –æ—Ç—á—ë—Ç–∞: üîΩ—Ä–µ–Ω—Ç–∞–±–µ–ª—å–Ω–æ—Å—Ç—å –ø–æ —á–∏—Å—Ç–æ–π –ø—Ä–∏–±—ã–ª–∏ —Å–Ω–∏–∑–∏–ª–∞—Å—å –Ω–∞ 3,9 –ø.–ø. –∏ —Å–æ—Å—Ç–∞–≤–∏–ª–∞ 12,9%; üîΩ–≤—ã—Ä—É—á–∫–∞ –≤—ã—Ä–æ—Å–ª–∞ –Ω–∞ 16%, –¥–æ 13,3 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π; üîΩEBITDA —É–≤–µ–ª–∏—á–∏–ª–∞—Å—å –Ω–∞ 17%, –¥–æ 4,5 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —Å–∫–æ—Ä—Ä–µ–∫—Ç–∏—Ä–æ–≤–∞–Ω–Ω–∞—è EBITDA2 —É–≤–µ–ª–∏—á–∏–ª–∞—Å—å –Ω–∞ 7%, –¥–æ 4,4 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —Ä–µ–Ω—Ç–∞–±–µ–ª—å–Ω–æ—Å—Ç—å –ø–æ —Å–∫–æ—Ä—Ä–µ–∫—Ç–∏—Ä–æ–≤–∞–Ω–Ω–æ–π EBITDA —Å–æ—Å—Ç–∞–≤–∏–ª–∞ 33%; üîΩ—Å–æ–æ—Ç–Ω–æ—à–µ–Ω–∏–µ —á–∏—Å—Ç—ã–π –¥–æ–ª–≥/12M EBITDA —Å–Ω–∏–∑–∏–ª–æ—Å—å –¥–æ 1,0—Ö; üîΩ–æ–±—ä—ë–º –∫–∞–ø–∏—Ç–∞–ª—å–Ω—ã—Ö –≤–ª–æ–∂–µ–Ω–∏–π —Å–æ—Å—Ç–∞–≤–∏–ª 2 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π: —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤ –∏ –±–∏–æ—Å–∏–º–∏–ª—è—Ä–æ–≤ ‚Äî 1,3 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–æ –∏ –∑–∞–∫—É–ø–∫–∞ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –¥–ª—è ¬´–û–∑–æ–Ω –ú–µ–¥–∏–∫–∞¬ª ‚Äî 360 –º–ª–Ω —Ä—É–±–ª–µ–π –∏ ¬´–ú–∞–±—Å–∫–µ–π–ª¬ª ‚Äî 125 –º–ª–Ω —Ä—É–±–ª–µ–π, –∑–∞–∫—É–ø–∫–∞ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –∏ –æ–±—Å–ª—É–∂–∏–≤–∞–Ω–∏–µ –Ω–∞ –¥—Ä—É–≥–∏—Ö –∑–∞–≤–æ–¥–∞—Ö –≥—Ä—É–ø–ø—ã ‚Äî 164 –º–ª–Ω —Ä—É–±–ª–µ–π; üîΩ—á–∏—Å—Ç—ã–π –æ–±–æ—Ä–æ—Ç–Ω—ã–π –∫–∞–ø–∏—Ç–∞–ª —Å–Ω–∏–∑–∏–ª—Å—è –Ω–∞ 8%, –¥–æ 17,4 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π; üîΩ–æ–±—ä—ë–º –ø—Ä–æ–¥–∞–∂ –≤—ã—Ä–æ—Å –Ω–∞ 2%, –¥–æ 152,9 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫; üîΩ—Å—Ä–µ–¥–Ω—è—è —Å—Ç–æ–∏–º–æ—Å—Ç—å —Ä–µ–∞–ª–∏–∑–æ–≤–∞–Ω–Ω–æ–π —É–ø–∞–∫–æ–≤–∫–∏ –≤—ã—Ä–æ—Å–ª–∞ –Ω–∞ 14%, –¥–æ 87 —Ä—É–±–ª–µ–π; –ö–æ–º–ø–∞–Ω–∏—è –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–∞–µ—Ç –ø—Ä–æ–≥–Ω–æ–∑ –ø–æ —Ä–æ—Å—Ç—É –≤—ã—Ä—É—á–∫–∏ –≤ 2025 –≥–æ–¥—É –Ω–∞ —É—Ä–æ–≤–Ω–µ 25%. –¢–∞–∫–∂–µ —Å–æ–≤–µ—Ç –¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–≤ ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∏¬ª —Ä–µ–∫–æ–º–µ–Ω–¥–æ–≤–∞–ª –ø–æ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º —à–µ—Å—Ç–∏ –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ –Ω–∞–ø—Ä–∞–≤–∏—Ç—å –Ω–∞ –≤—ã–ø–ª–∞—Ç—É –¥–∏–≤–∏–¥–µ–Ω–¥–æ–≤ 275 –º–ª–Ω —Ä—É–±–ª–µ–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, reimbursement, pricing, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The report from 'Ozon Pharma' shows a decrease in net profit by 11% year-over-year to RUB 171.2 billion in the first half of 2025. The company's profitability has dropped by 3.9 percentage points to a ROE of 12.9%. Revenue has increased by 16% to RUB 33.3 billion, while EBITDA has grown by 17% to RUB 4.5 billion and adjusted EBITDA2 has increased by 7% to RUB 4.4 billion, with an adjusted EBITDA ROE of 33%. The debt-to-12M EBITDA ratio has decreased to 1x. Capital expenditures include RUB 1.3 billion for generics and biosimilars registration, RUB 360 million for 'Ozon Pharma' construction and equipment procurement, and RUB 125 million for 'Mabskell'. Operating capital has decreased by 8"
2025-08-29T08:33:57+00:00,@bezrec,6481,https://t.me/bezrec/6481,"–° —è–Ω–≤–∞—Ä—è –ø–æ –∏—é–ª—å 2025 –≥–æ–¥–∞ –∞–Ω–∞–ª–∏—Ç–∏–∫–∏ –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–ª–∏ —Ä–µ–∑–∫–∏–π —Ä–æ—Å—Ç –ø—Ä–æ–¥–∞–∂ –ø—Ä–æ—Ç–∏–≤–æ–≤–∏—Ä—É—Å–Ω—ã—Ö –ø–æ—Å–ª–µ –¥–≤—É—Ö–ª–µ—Ç–Ω–µ–≥–æ —Å–Ω–∏–∂–µ–Ω–∏—è —Å–ø—Ä–æ—Å–∞. –ó–∞ —É–∫–∞–∑–∞–Ω–Ω—ã–π –ø–µ—Ä–∏–æ–¥ –±—ã–ª–æ –ø—Ä–æ–¥–∞–Ω–æ –Ω–∞ 20% –±–æ–ª—å—à–µ —Ç–∞–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –¥–µ–Ω–µ–∂–Ω–æ–º –∏ –Ω–∞ 8,8% –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏. –ú—ã —Ä–µ—à–∏–ª–∏ –ø–æ—Å–º–æ—Ç—Ä–µ—Ç—å, —Å–∫–æ–ª—å–∫–æ —Å—Ç–æ—è—Ç —Ç–∞–∫–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –≤ –∞–ø—Ç–µ–∫–∞—Ö –∏ #–∑–∞—Ü–µ–Ω–∏–ª–∏ –ø—è—Ç—å –ø—Ä–æ—Ç–∏–≤–æ–≤–∏—Ä—É—Å–Ω—ã—Ö –∏–∑ —Ç–æ–ø-10 –ø–æ –æ–±—ä—ë–º—É –ø—Ä–æ–¥–∞–∂ –≤ –¥–µ–Ω—å–≥–∞—Ö: –≠—Ä–≥–æ—Ñ–µ—Ä–æ–Ω (¬´–ú–∞—Ç–µ—Ä–∏–∞ –ú–µ–¥–∏–∫–∞¬ª), –ê—Ä–±–∏–¥–æ–ª (¬´–û—Ç—Å–∏—Å–∏—Ñ–∞—Ä–º¬ª), –ö–∞–≥–æ—Ü–µ–ª (¬´–ù–∏–∞—Ä–º–µ–¥–∏–∫¬ª), –ê—Ü–∏–∫–ª–æ–≤–∏—Ä-–ê–∫—Ä–∏—Ö–∏–Ω (¬´–ê–∫—Ä–∏—Ö–∏–Ω¬ª), –ò–∑–æ–ø—Ä–∏–Ω–æ–∑–∏–Ω (¬´–¢–µ–≤–∞¬ª). –ü–µ—Ä–≤—ã–µ —Ç—Ä–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –∏—Å–ø–æ–ª—å–∑—É—é—Ç—Å—è –¥–ª—è –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –∏ –ª–µ—á–µ–Ω–∏—è –û–†–í–ò –∏ –≥—Ä–∏–ø–ø–∞. –°–∞–º—ã–º –¥–æ—Ä–æ–≥–∏–º –æ–∫–∞–∑–∞–ª—Å—è –≠—Ä–≥–æ—Ñ–µ—Ä–æ–Ω –∏–∑ ¬´–†–∏–≥–ª—ã¬ª ‚Äî —Ç–∞–º —É–ø–∞–∫–æ–≤–∫–∞ –∏–∑ 20 —Ç–∞–±–ª–µ—Ç–æ–∫ —Å—Ç–æ–∏—Ç 742 —Ä—É–±–ª—è. –°–∞–º—ã–º –¥–µ—à—ë–≤—ã–º (441 —Ä—É–±–ª—å) ‚Äî –ö–∞–≥–æ—Ü–µ–ª –∏–∑ ¬´–ê–ø—Ç–µ–∫–∏.—Ä—É¬ª. –ò–∑–æ–ø—Ä–∏–Ω–æ–∑–∏–Ω —Ç–∞–∫–∂–µ –ø—Ä–∏–º–µ–Ω—è–µ—Ç—Å—è –ø—Ä–∏ –≥–µ—Ä–ø–µ—Å–µ –∏ —Å—Ç–æ–∏—Ç –¥–æ—Ä–æ–∂–µ –≤—Å–µ—Ö —Å–µ–≥–æ–¥–Ω—è—à–Ω–∏—Ö –≥–µ—Ä–æ–µ–≤ ‚Äî –µ–≥–æ —Ü–µ–Ω–∞ –≤ 36,6 ‚Äî 1201 —Ä—É–±–ª—å. –°–∞–º—ã–π –Ω–µ–¥–æ—Ä–æ–≥–æ–π –ø—Ä–æ—Ç–∏–≤–æ–≥–µ—Ä–ø–µ—Ç–∏—á–µ—Å–∫–∏–π –ê—Ü–∏–∫–ª–æ–≤–∏—Ä-–ê–∫—Ä–∏—Ö–∏–Ω –Ω–∞—à—ë–ª—Å—è –≤ ¬´–ï–∞–ø—Ç–µ–∫–µ¬ª –∑–∞ 115 —Ä—É–±–ª–µ–π. –ù–∞–ø–æ–º–∏–Ω–∞–µ–º, —á—Ç–æ –ª—é–±—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏–º–µ—é—Ç –ø—Ä–æ—Ç–∏–≤–æ–ø–æ–∫–∞–∑–∞–Ω–∏—è. –ü–µ—Ä–µ–¥ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º –ø—Ä–æ–∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä—É–π—Ç–µ—Å—å —Å –≤—Ä–∞—á–æ–º. *–∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –ø—Ä–æ–≤–æ–¥–∏–ª–æ—Å—å –æ–Ω–ª–∞–π–Ω 28 –∞–≤–≥—É—Å—Ç–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""Online research conducted from August 28th showed a significant increase in sales of antivirals over the first half of 2025, with a 20% increase in monetary terms and an 8.8% increase in natural terms compared to the previous two years. Five antivirals from top-10 by sales volume were analyzed: Ergoferon (¬´Mat√©ria Medicap¬ª), Arbidol (¬´Otssifarmp¬ª), Kagocel (¬´Niarmedik¬ª), Acyclovir-Akrichin (¬´Akrichin¬ª), Isoprinozin (¬´Teva¬ª). The most expensive was Ergoferon from ¬´Riglas¬ª at 742 rubles for a pack of 20 tablets. The cheapest was Kagocel from ¬´Apteky.ru¬ª at 441 rubles. Isoprinozin, used for herpes, is the most expensive at prices ranging from 1201 to 36.6 rubles"
2025-08-29T05:34:16+00:00,@bezrec,6480,https://t.me/bezrec/6480,"–í–ª–∞–¥–µ–ª–∏—Ü–∞ –º–æ—Å–∫–æ–≤—Å–∫–∏—Ö –∞–ø—Ç–µ–∫ –ø–æ–ª—É—á–∏–ª–∞ —Å—Ä–æ–∫ –∑–∞ –∫–æ–Ω—Ç—Ä–∞—Ñ–∞–∫—Ç–Ω—ã–π –û–∑–µ–º–ø–∏–∫. –•–æ—Ä–æ—à–µ–≤—Å–∫–∏–π —Å—É–¥ –ú–æ—Å–∫–≤—ã –ø—Ä–∏–≥–æ–≤–æ—Ä–∏–ª –ï–ª–µ–Ω—É –ú—É—Ç –∫ –ø—è—Ç–∏ –≥–æ–¥–∞–º –∫–æ–ª–æ–Ω–∏–∏ –∑–∞ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—é –ø—Ä–µ—Å—Ç—É–ø–Ω–æ–≥–æ —Å–æ–æ–±—â–µ—Å—Ç–≤–∞ –∏ —Ç–æ—Ä–≥–æ–≤–ª—é –Ω–µ–∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–º–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏ –≤ –æ—Å–æ–±–æ –∫—Ä—É–ø–Ω–æ–º —Ä–∞–∑–º–µ—Ä–µ. –ö—Ä–æ–º–µ –ú—É—Ç, –≤ —Å—Ö–µ–º–µ —É—á–∞—Å—Ç–≤–æ–≤–∞–ª–∏ –µ—ë –º—É–∂ –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç—ã - –≤—Å–µ–≥–æ –¥–µ—Å—è—Ç—å —á–µ–ª–æ–≤–µ–∫. –í—Å–µ —Å–≤–æ—é –≤–∏–Ω—É –ø—Ä–∏–∑–Ω–∞–ª–∏. –°–æ—É—á–∞—Å—Ç–Ω–∏–∫–∞–º, –≤ –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏ –æ—Ç —Ä–æ–ª–∏ –∫–∞–∂–¥–æ–≥–æ, –Ω–∞–∑–Ω–∞—á–µ–Ω–æ –Ω–∞–∫–∞–∑–∞–Ω–∏–µ –æ—Ç 3,5 –¥–æ 4 –ª–µ—Ç –ª–∏—à–µ–Ω–∏—è —Å–≤–æ–±–æ–¥—ã —Å –æ—Ç–±—ã–≤–∞–Ω–∏–µ–º –≤ –∏—Å–ø—Ä–∞–≤–∏—Ç–µ–ª—å–Ω–æ–π –∫–æ–ª–æ–Ω–∏–∏ –æ–±—â–µ–≥–æ —Ä–µ–∂–∏–º–∞, –∞ —Ç–∞–∫–∂–µ –≤ –≤–∏–¥–µ –ª–∏—à–µ–Ω–∏—è —Å–≤–æ–±–æ–¥—ã —É—Å–ª–æ–≤–Ω–æ –Ω–∞ —Ä–∞–∑–ª–∏—á–Ω—ã–µ —Å—Ä–æ–∫–∏. ¬´–°–µ—Ä—ã–π¬ª –û–∑–µ–º–ø–∏–∫ –∑–∞–∫—É–ø–∞–ª–∏ –≤ –ö–∞–∑–∞—Ö—Å—Ç–∞–Ω–µ –∏ –¥–æ—Å—Ç–∞–≤–ª—è–ª–∏ –≤ –ú–æ—Å–∫–≤—É –ø–æ—á—Ç–æ–π, –∞ –∑–∞—Ç–µ–º –ø—Ä–æ–¥–∞–≤–∞–ª–∏ –≤ —á–µ—Ç—ã—Ä—ë—Ö –º–æ—Å–∫–æ–≤—Å–∫–∏—Ö –∞–ø—Ç–µ–∫–∞—Ö. –ù–µ–ª–µ–≥–∞–ª—å–Ω—É—é —Ç–æ—Ä–≥–æ–≤–ª—é –æ—Å—É—â–µ—Å—Ç–≤–ª—è–ª–∏ —á–µ—Ä–µ–∑ —á—ë—Ä–Ω—ã–π —Ö–æ–¥. –û–ø–ª–∞—Ç—É –ø—Ä–æ—Å–∏–ª–∏ –Ω–∞–ª–∏—á–Ω—ã–º–∏ –∏–ª–∏ –ø–µ—Ä–µ–≤–æ–¥–æ–º. –ß–µ–∫–æ–≤, —Ä–∞–∑—É–º–µ–µ—Ç—Å—è, –Ω–µ –¥–∞–≤–∞–ª–∏. –•—Ä–∞–Ω–∏–ª–∏—Å—å –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã —Å –Ω–∞—Ä—É—à–µ–Ω–∏—è–º–∏. –ü—Ä–∏ –æ–±—ã—Å–∫–µ –ø–æ–ª–∏—Ü–∏—è –æ–±–Ω–∞—Ä—É–∂–∏–ª–∞ 300 —É–ø–∞–∫–æ–≤–æ–∫ –û–∑–µ–º–ø–∏–∫–∞ –±–æ–ª–µ–µ —á–µ–º –Ω–∞ 10 –º–ª–Ω —Ä—É–±–ª–µ–π. –í –∫–≤–∞—Ä—Ç–∏—Ä–µ –æ–¥–Ω–æ–≥–æ –∏–∑ —Å–æ—É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ —Ö—Ä–∞–Ω–∏–ª–∏—Å—å –ø–µ—á–∞—Ç–∏, —Ñ–∞–ª—å—à–∏–≤—ã–µ —Å–µ—Ä—Ç–∏—Ñ–∏–∫–∞—Ç—ã –∏ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏–µ –¥–ª—è —É–ø–∞–∫–æ–≤–∫–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –°–ª–µ–¥—Å—Ç–≤–∏–µ —É—Å—Ç–∞–Ω–æ–≤–∏–ª–æ, —á—Ç–æ –ø–æ–¥—Å—É–¥–∏–º—ã–µ –ø—Ä–æ–º—ã—à–ª—è–ª–∏ ¬´–ª–µ–≤—ã–º¬ª —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–æ–º –∫–∞–∫ –º–∏–Ω–∏–º—É–º —Å –Ω–æ—è–±—Ä—è 2023 –≥–æ–¥–∞. –ü–æ –¥–∞–Ω–Ω—ã–º Rusprofile, –ï–ª–µ–Ω–∞ –ú—É—Ç —á–∏—Å–ª–∏—Ç—Å—è —É—á—Ä–µ–¥–∏—Ç–µ–ª–µ–º –∏ –¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–º –û–û–û ¬´–ù–æ–≤–∞—è –ê–ø—Ç–µ–∫–∞¬ª –∏ –û–û–û ¬´–ú–µ–≥–∞-–§–∞—Ä–º¬ª. –û–±–µ –∫–æ–º–ø–∞–Ω–∏–∏ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω—ã –≤ –ö—Ä–∞—Å–Ω–æ—è—Ä—Å–∫–æ–º –∫—Ä–∞–µ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing, shortage, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""A Moscow court convicted Elena Mut of five years in prison for organizing a criminal group and trafficking unregistered medicines on a large scale. The case involved her husband, pharmacists, and ten people in total. All admitted their guilt. Sentences for the accomplices range from 3.5 to 4 years in prison with parole, depending on their role. The 'gray' Ozemik was purchased from Kazakhstan and delivered to Moscow by post, then sold in four Moscow pharmacies. Transactions were made without receipts. Police found over 300 packages of Ozemik worth more than 10 million rubles during a search. One accomplice's apartment contained seals, fake certificates, and equipment for packaging drugs. The prosecution revealed that the defendants were trafficking 'leviglutide' since November 2023. According to Rusprofile, Elena Mut is a founder and director of both 'New Pharmacy' (registered in Khakassia) and 'Megafarm' companies.""
}"
2025-08-28T14:32:29+00:00,@bezrec,6479,https://t.me/bezrec/6479,"Psy –ø–æ–ø–∞–ª—Å—è –Ω–∞ –ø—Å–∏—Ö–æ—Ç—Ä–æ–ø–∞—Ö. –ò—Å–ø–æ–ª–Ω–∏—Ç–µ–ª—è Gangnam Style –ø–æ–¥–æ–∑—Ä–µ–≤–∞—é—Ç –≤ –Ω–µ–∑–∞–∫–æ–Ω–Ω–æ–º –ø–æ–ª—É—á–µ–Ω–∏–∏ —Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ü–∞–∫ –ß—ç –°–∞–Ω, –≤—ã—Å—Ç—É–ø–∞—é—â–∏–π –ø–æ–¥ –ø—Å–µ–≤–¥–æ–Ω–∏–º–æ–º Psy, –æ–±–≤–∏–Ω—è–µ—Ç—Å—è –≤ —Ç–æ–º, —á—Ç–æ —Å 2022 –≥–æ–¥–∞ –ø–æ–ª—É—á–∞–ª —Ä–µ—Ü–µ–ø—Ç—ã –Ω–∞ –ø—Å–∏—Ö–æ—Ç—Ä–æ–ø–Ω—ã–µ –ö—Å–∞–Ω–∞–∫—Å –∏ –°—Ç–∏–ª–Ω–æ–∫—Å –≤ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç—Å–∫–æ–π –±–æ–ª—å–Ω–∏—Ü–µ –≤ –°–µ—É–ª–µ, –Ω–µ –ø–æ—Å–µ—â–∞—è –≤—Ä–∞—á–∞. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –ø–æ –ø–æ—Ä—É—á–µ–Ω–∏—é –ø–µ–≤—Ü–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –¥–ª—è –Ω–µ–≥–æ –∑–∞–±–∏—Ä–∞–ª–∏ –µ–≥–æ –º–µ–Ω–µ–¥–∂–µ—Ä –∏ –¥—Ä—É–≥–∏–µ —Ç—Ä–µ—Ç—å–∏ –ª–∏—Ü–∞, —á—Ç–æ –∑–∞–ø—Ä–µ—â–µ–Ω–æ –∑–∞–∫–æ–Ω–æ–º. –ü–æ–ª–∏—Ü–∏—è –ø—Ä–æ–≤–µ–ª–∞ –æ–±—ã—Å–∫ –≤ –±–æ–ª—å–Ω–∏—Ü–µ –∏ –∏–∑—ä—è–ª–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –¥–æ–∫—É–º–µ–Ω—Ç—ã –ü–∞–∫ –ß—ç –°–∞–Ω–∞. –†–∞—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –≤–µ–¥—ë—Ç—Å—è —Ç–∞–∫–∂–µ –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ –≤—Ä–∞—á–∞, –≤—ã–ø–∏—Å—ã–≤–∞–≤—à–µ–≥–æ —Ä–µ—Ü–µ–ø—Ç—ã. –û–Ω –≤—Å–µ –æ–±–≤–∏–Ω–µ–Ω–∏—è –æ—Ç–≤–µ—Ä–≥–∞–µ—Ç –∏ –Ω–∞—Å—Ç–∞–∏–≤–∞–µ—Ç, —á—Ç–æ –ª–µ—á–∏–ª —Å–≤–æ–µ–≥–æ –∑–Ω–∞–º–µ–Ω–∏—Ç–æ–≥–æ –ø–∞—Ü–∏–µ–Ω—Ç–∞ –¥–∏—Å—Ç–∞–Ω—Ü–∏–æ–Ω–Ω–æ. –í –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∞—â–µ–π Psy —Å—Ç—É–¥–∏–∏ –∑–≤—É–∫–æ–∑–∞–ø–∏—Å–∏ P Nation –∑–∞—è–≤–∏–ª–∏, —á—Ç–æ —Ö–æ—Ç—è –µ–≥–æ –ø–æ–≤–µ–¥–µ–Ω–∏–µ –±—ã–ª–æ –æ—à–∏–±–∫–æ–π, —É –∏—Å–ø–æ–ª–Ω–∏—Ç–µ–ª—è –¥–µ–π—Å—Ç–≤–∏—Ç–µ–ª—å–Ω–æ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏—Ä–æ–≤–∞–Ω–æ —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–æ–µ —Ä–∞—Å—Å—Ç—Ä–æ–π—Å—Ç–≤–æ —Å–Ω–∞, –∏ –æ–Ω –ø—Ä–∏–Ω–∏–º–∞–µ—Ç —Å–Ω–æ—Ç–≤–æ—Ä–Ω–æ–µ –ø–æ –Ω–∞–∑–Ω–∞—á–µ–Ω–∏—é –≤—Ä–∞—á–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""South Korea"",
  ""topic"": ""sanctions, shortage, regulation"",
  ""impact"": ""high"",
  ""english"": ""Psy, under the pseudonym Park Jae San, was reportedly found to have received prescription drugs for Xanax and Stilnox without a doctor's prescription from 2022. The police conducted an investigation at the hospital and seized medical records of Park Jae San. A doctor who prescribed the medications has denied all accusations, stating that he treated his famous patient remotely.""
}"
2025-08-28T11:15:35+00:00,@bezrec,6478,https://t.me/bezrec/6478,"–¢–∞–∫—É—é –º–µ—Ä—É –ø–æ–¥–¥–µ—Ä–∂–∫–∏ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –∞–Ω–æ–Ω—Å–∏—Ä–æ–≤–∞–ª –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ –Ω–∞ —Ñ–æ—Ä—É–º–µ ¬´–¢–µ—Ö–Ω–æ–ø—Ä–æ–º-2025¬ª. –ò —ç—Ç–æ –Ω–µ –ø—Ä–µ–¥–µ–ª —â–µ–¥—Ä–æ—Å—Ç–∏ –≤–µ–¥–æ–º—Å—Ç–≤–∞: –°–Ω–∞—á–∞–ª–∞ –º—ã –ø–ª–∞–Ω–∏—Ä—É–µ–º –≤ 2027 –≥–æ–¥—É –ø–æ–ø—Ä–æ–±–æ–≤–∞—Ç—å –∏ –≤—ã–¥–µ–ª—è–µ–º –Ω–∞ —ç—Ç–∏ –∑–∞–¥–∞—á–∏ 1 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, –ø–ª–∞–Ω–∏—Ä—É–µ–º, —á—Ç–æ –∫–∞–∂–¥—ã–π –ø—Ä–æ–µ–∫—Ç –±—É–¥–µ—Ç –∫–æ–º–ø–µ–Ω—Å–∏—Ä–æ–≤–∞—Ç—å—Å—è –≤ —Ä–∞–∑–º–µ—Ä–µ 200-250 –º–ª–Ω —Ä—É–±–ª–µ–π. –ò –∫–æ–≥–¥–∞ –º–µ—Ö–∞–Ω–∏–∑–º –±—É–¥–µ—Ç –∞–ø—Ä–æ–±–∏—Ä–æ–≤–∞–Ω, –±—É–¥–µ–º —ç—Ç–∏ —Å—É–º–º—ã —É–≤–µ–ª–∏—á–∏–≤–∞—Ç—å, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∞ –∑–∞–º–º–∏–Ω–∏—Å—Ç—Ä–∞ –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏ –∏ —Ç–æ—Ä–≥–æ–≤–ª–∏ –†–§ –ï–∫–∞—Ç–µ—Ä–∏–Ω–∞ –ü—Ä–∏–µ–∑–∂–µ–≤–∞. –ö–æ–≥–æ –ø–æ–¥–¥–µ—Ä–∂–∞—Ç? –ü—Ä–æ–µ–∫—Ç—ã —Å —Ç—Ä–µ—Ç—å–µ–π —Å—Ç–∞–¥–∏–∏ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å–ø—ã—Ç–∞–Ω–∏–π. –û—Ç–±–æ—Ä –Ω–∞—á–Ω–µ—Ç—Å—è –≤ 2026 –≥–æ–¥—É. –° 2027 –≥–æ–¥–∞ –±—É–¥–µ–º –¥–∞–≤–∞—Ç—å —Å—É–±—Å–∏–¥–∏—é –Ω–∞ –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏—é —Ä–∞—Å—Ö–æ–¥–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ –∫–æ–º–ø–∞–Ω–∏–∏ –ø–æ–Ω–µ—Å–ª–∏, –Ω–∞ —Ç—Ä–µ—Ç—å—é ¬´–∫–ª–∏–Ω–∏–∫—É¬ª. –ü–æ—Å–∫–æ–ª—å–∫—É –º—ã –≤–µ–¥–æ–º—Å—Ç–≤–æ –∫–æ–Ω–∫—Ä–µ—Ç–Ω–æ–µ –∏ –Ω–∞–º –Ω—É–∂–µ–Ω —Ä–µ–∑—É–ª—å—Ç–∞—Ç, –¥–ª—è –Ω–∞—Å —Ç–∞–∫–∏–º —Ä–µ–∑—É–ª—å—Ç–∞—Ç–æ–º –±—É–¥–µ—Ç –ø–æ–ª—É—á–µ–Ω–∏–µ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ —É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏—è, ‚Äî –æ–±—ä—è—Å–Ω–∏–ª–∞ –ü—Ä–∏–µ–∑–∂–µ–≤–∞. –¢–∞–∫–∂–µ —Ä–∞—Å—Å–º–∞—Ç—Ä–∏–≤–∞–µ—Ç—Å—è –≤–∞—Ä–∏–∞–Ω—Ç —É—Å–ª–æ–≤–Ω–æ–≥–æ —Ä–µ–≥—É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏—è, –Ω–æ –µ—Å—Ç—å ¬´–Ω–æ¬ª, –¥–∞–∂–µ –¥–≤–∞: üíä –µ—Å–ª–∏ —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å, –ø–æ–ª—É—á–∏–≤ —É—Å–ª–æ–≤–Ω—É—é —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—é, –¥–æ –≥–ª–∞–≤–Ω–æ–π ¬´–Ω–µ –¥–æ–±–µ–∂–∞–ª¬ª, —Å—É–±—Å–∏–¥–∏—é –ø—Ä–∏–¥—ë—Ç—Å—è –≤–µ—Ä–Ω—É—Ç—å; üíä —ç—Ç–∏ –¥–µ–Ω—å–≥–∏ –±—É–¥—É—Ç ¬´–æ–∫—Ä–∞—à–µ–Ω—ã¬ª –∏ –ø–æ—Ç–æ–º –¥–æ–ª–∂–Ω—ã –ø–æ–π—Ç–∏ –Ω–∞ —Ç–µ –∂–µ –∑–∞–¥–∞—á–∏, —Ç.–µ. –Ω–∞ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫—É –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement"",
  ""impact"": ""high"",
  ""english"": ""The Ministry of Industry and Trade announced support measures for domestic manufacturers at the 'Technoprom-2025' forum. The ministry plans to allocate 1 billion rubles for this purpose in 2027, with each project being compensated up to 250 million rubles. When the mechanism is tested, these sums will be increased. The selection process for projects at the third stage of clinical trials will begin in 2026. Subsidies for costs incurred by companies during the third 'clinic' phase will be provided starting from 2027. Conditional registration is also being considered, but there are 'buts': if the pharmaceutical company does not obtain a main registration after receiving conditional registration, the subsidy must be returned. These funds will also be 'tinted' and used for developing innovative drugs.""
}"
2025-08-28T08:32:22+00:00,@bezrec,6477,https://t.me/bezrec/6477,"–†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä ¬´–æ—Ç–ª–æ–≤–∏—Ç¬ª 25 –≤–∏—Ä—É—Å–æ–≤ —Å—Ä–∞–∑—É. –£—á—ë–Ω—ã–µ –∏–Ω—Å—Ç–∏—Ç—É—Ç–∞ —ç–ø–∏–¥–µ–º–∏–æ–ª–æ–≥–∏–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª–∏ —Ç–µ—Å—Ç —Å —Å–∞–º—ã–º —à–∏—Ä–æ–∫–∏–º —Å–ø–µ–∫—Ç—Ä–æ–º –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∏ –≤ –†–æ—Å—Å–∏–∏. –ù–∞–±–æ—Ä —Ä–µ–∞–≥–µ–Ω—Ç–æ–≤ –º–æ–∂–µ—Ç —Å –≤—ã—Å–æ–∫–æ–π —Ç–æ—á–Ω–æ—Å—Ç—å—é –≤—ã—è–≤–ª—è—Ç—å —Å—Ä–∞–∑—É 25 —Ä–∞–∑–ª–∏—á–Ω—ã—Ö –≤–∏—Ä—É—Å–æ–≤. –¢–µ—Å—Ç-—Å–∏—Å—Ç–µ–º–∞ –ø–æ–∑–≤–æ–ª—è–µ—Ç –æ–¥–Ω–æ–≤—Ä–µ–º–µ–Ω–Ω–æ –æ–ø—Ä–µ–¥–µ–ª—è—Ç—å –≤—Å–µ –∑–Ω–∞—á–∏–º—ã–µ –≤–æ–∑–±—É–¥–∏—Ç–µ–ª–∏ –û–†–í–ò, –≤ —Ç–æ–º —á–∏—Å–ª–µ —ç–Ω—Ç–µ—Ä–æ–≤–∏—Ä—É—Å—ã, –∞–¥–µ–Ω–æ–≤–∏—Ä—É—Å—ã, —Ä–∏–Ω–æ–≤–∏—Ä—É—Å—ã, –º–µ—Ç–∞–ø–Ω–µ–≤–º–æ–≤–∏—Ä—É—Å, —Ä–µ—Å–ø–∏—Ä–∞—Ç–æ—Ä–Ω–æ-—Å–∏–Ω—Ü–∏—Ç–∏–∞–ª—å–Ω—ã–π –≤–∏—Ä—É—Å, –±–æ–∫–∞–≤–∏—Ä—É—Å, –∞ —Ç–∞–∫–∂–µ –≤–∏—Ä—É—Å—ã –≥—Ä–∏–ø–ø–∞ –∏ –∫–æ—Ä–æ–Ω–∞–≤–∏—Ä—É—Å–∞. –í—Å–µ –∫–æ–º–ø–æ–Ω–µ–Ω—Ç—ã —Ç–µ—Å—Ç–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—è—Ç—Å—è –≤ –†–æ—Å—Å–∏–∏, ‚Äî –≥–æ–≤–æ—Ä–∏—Ç—Å—è –Ω–∞ —Å–∞–π—Ç–µ –≤–µ–¥–æ–º—Å—Ç–≤–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing, import_export, sanctions, shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""The Rospatent (Russian Health Supervision) has developed a test with the widest spectrum of diagnosis in Russia that can detect 25 different viruses simultaneously. The system allows for the simultaneous determination of all significant pathogens of respiratory infections, including enteroviruses, adenoviruses, rhinoviruses, metapneumovirus, respiratory syncytial virus, bocavirus, and influenza and coronavirus viruses. All components of the test are produced in Russia.""
}"
2025-08-28T06:01:16+00:00,@bezrec,6476,https://t.me/bezrec/6476,"–≠–∫—Å–ø–µ—Ä—Ç—ã –∑–∞ –ø—Ä–æ–≤–µ—Ä–∫—É –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –Ω–∞ —ç—Ç–∏–∫—É. –ú–∏–Ω–∑–¥—Ä–∞–≤ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç –≤–≤–µ—Å—Ç–∏ –ø—Ä–æ—Ü–µ–¥—É—Ä—É —ç—Ç–∏—á–µ—Å–∫–æ–π —ç–∫—Å–ø–µ—Ä—Ç–∏–∑—ã –¥–ª—è —Ç–∞–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Å 1 —Å–µ–Ω—Ç—è–±—Ä—è 2026 –≥–æ–¥–∞. –ò—Ö –∏–∑–≥–æ—Ç–∞–≤–ª–∏–≤–∞—é—Ç –≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –∏–Ω–¥–∏–≤–∏–¥—É–∞–ª—å–Ω–æ –¥–ª—è –∫–∞–∂–¥–æ–≥–æ –ø–∞—Ü–∏–µ–Ω—Ç–∞ —Å –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ–º –µ–≥–æ –∂–µ –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –º–∞—Ç–µ—Ä–∏–∞–ª–æ–≤. –¢–∞–∫–∏–º–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏ –ª–µ—á–∞—Ç —Ä–∞–∫, –∞—É—Ç–æ–∏–º–º—É–Ω–Ω—ã–µ, –∏–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã–µ –∏ —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã–µ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è. –≠—Ç–∏—á–µ—Å–∫–æ–π —ç–∫—Å–ø–µ—Ä—Ç–∏–∑–æ–π –ë–¢–õ–ü –∑–∞–π–º—ë—Ç—Å—è –æ—Ç–¥–µ–ª—å–Ω—ã–π –∫–æ–º–∏—Ç–µ—Ç. –ü—Ä–æ–µ–∫—Ç –ø–æ–ø—Ä–∞–≤–æ–∫ –∫ –∑–∞–∫–æ–Ω—É ¬´–û–± –æ–±—Ä–∞—â–µ–Ω–∏–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤¬ª –ø–æ–¥–≥–æ—Ç–æ–≤–ª–µ–Ω –ø–æ –ø–æ—Ä—É—á–µ–Ω–∏—é –¢–∞—Ç—å—è–Ω—ã –ì–æ–ª–∏–∫–æ–≤–æ–π. –≠—Ç–∏—á–µ—Å–∫–∞—è —ç–∫—Å–ø–µ—Ä—Ç–∏–∑–∞ –Ω—É–∂–Ω–∞, —á—Ç–æ–±—ã –≥–∞—Ä–∞–Ω—Ç–∏—Ä–æ–≤–∞—Ç—å ¬´–±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –∏ –±–ª–∞–≥–æ–ø–æ–ª—É—á–∏–µ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –≤ —Ç–æ–º —á–∏—Å–ª–µ —Å –∂–∏–∑–Ω–µ—É–≥—Ä–æ–∂–∞—é—â–∏–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏¬ª. –≠–∫—Å–ø–µ—Ä—Ç—ã –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤—É –≤–∏—Ü–µ-–ø—Ä–µ–º—å–µ—Ä–∞ –ø–æ–¥–¥–µ—Ä–∂–∏–≤–∞—é—Ç: –≠—Ç–∏—á–µ—Å–∫–∞—è —ç–∫—Å–ø–µ—Ä—Ç–∏–∑–∞ —Å—Ç–∞–Ω–æ–≤–∏—Ç—Å—è –±–∞—Ä—å–µ—Ä–æ–º, –∫–æ—Ç–æ—Ä—ã–π –ø—Ä–µ–¥–æ—Ç–≤—Ä–∞—â–∞–µ—Ç –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ —Ç–∞–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ —Å–∏—Ç—É–∞—Ü–∏—è—Ö, –∫–æ—Ç–æ—Ä—ã–µ –º–æ–≥—É—Ç –±—ã—Ç—å –Ω–µ –≤ –∏–Ω—Ç–µ—Ä–µ—Å–∞—Ö –ø–∞—Ü–∏–µ–Ω—Ç–∞ –∏–ª–∏ –∏–¥—É—Ç –≤—Ä–∞–∑—Ä–µ–∑ —Å –æ–±—â–µ–ø—Ä–∏–Ω—è—Ç—ã–º–∏ –º–æ—Ä–∞–ª—å–Ω—ã–º–∏ –∏ —ç—Ç–∏—á–µ—Å–∫–∏–º–∏ –Ω–æ—Ä–º–∞–º–∏, ‚Äî –æ–±—ä—è—Å–Ω—è–µ—Ç —á–ª–µ–Ω —ç–∫—Å–ø–µ—Ä—Ç–Ω–æ–≥–æ —Å–æ–≤–µ—Ç–∞ –ø–æ –æ—Ä—Ñ–∞–Ω–Ω—ã–º –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º –ø—Ä–∏ –∫–æ–º–∏—Ç–µ—Ç–µ –ì–æ—Å–¥—É–º—ã –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è –ù–∞—Ç–∞–ª—å—è –°–º–∏—Ä–Ω–æ–≤–∞. üü¢ –ü–æ –º–Ω–µ–Ω–∏—é —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—è –ø—Ä–∞–≤–æ–≤–æ–π —Å–ª—É–∂–±—ã —Ñ–æ–Ω–¥–∞ ¬´–ü–æ–¥—Å–æ–ª–Ω—É—Ö¬ª –ú–∞—Ä–∏–∏ –ü–æ—Å–∞–¥–∫–æ–≤–æ–π, –Ω–æ–≤–∞—è –∫–æ–º–∏—Å—Å–∏—è –±—É–¥–µ—Ç –∫–æ–Ω—Ç—Ä–æ–ª–∏—Ä–æ–≤–∞—Ç—å —ç—Ç–∞–ø—ã —Å–æ–∑–¥–∞–Ω–∏—è –∏ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –ø–æ–¥–æ–±–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤, –æ—Ü–µ–Ω–∏–≤–∞—Ç—å —Ä–∏—Å–∫–∏ –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–∞, –∞ —Ç–∞–∫–∂–µ –ø—Ä–æ–≤–µ—Ä—è—Ç—å, –Ω–∞—Å–∫–æ–ª—å–∫–æ –µ–≥–æ —Ä–µ—à–µ–Ω–∏–µ –±—ã–ª–æ –æ—Å–æ–∑–Ω–∞–Ω–Ω—ã–º. üü¢ –ò—Å–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–π –¥–∏—Ä–µ–∫—Ç–æ—Ä –í—ã—Å—à–µ–π —à–∫–æ–ª—ã –æ–Ω–∫–æ–ª–æ–≥–∏–∏ –ü–æ–ª–∏–Ω–∞ –®–∏–ª–æ —Å—á–∏—Ç–∞–µ—Ç, —á—Ç–æ –≤–≤–µ–¥–µ–Ω–∏–µ —ç—Ç–∏—á–µ—Å–∫–æ–π —ç–∫—Å–ø–µ—Ä—Ç–∏–∑—ã –ø–æ–∑–≤–æ–ª–∏—Ç —Å–¥–µ–ª–∞—Ç—å –ø—Ä–æ—Ü–µ—Å—Å –±–æ–ª–µ–µ —Ä–µ–≥—É–ª–∏—Ä—É–µ–º—ã–º. –ù–µ–∑–∞–≤–∏—Å–∏–º—ã–π –∫–æ–º–∏—Ç–µ—Ç –±—É–¥–µ—Ç –æ—Ü–µ–Ω–∏–≤–∞—Ç—å, –¥–µ–π—Å—Ç–≤–∏—Ç–µ–ª—å–Ω–æ –ª–∏ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ –∏–Ω–¥–∏–≤–∏–¥—É–∞–ª—å–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –æ–ø—Ä–∞–≤–¥–∞–Ω–æ, –Ω–∞—Å–∫–æ–ª—å–∫–æ –ø–∞—Ü–∏–µ–Ω—Ç –∏–Ω—Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω –∏ –∑–∞—â–∏—â–µ–Ω, –Ω–µ—Ç –ª–∏ –∫–æ–Ω—Ñ–ª–∏–∫—Ç–∞ –∏–Ω—Ç–µ—Ä–µ—Å–æ–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement, safety, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The Ministry of Health plans to introduce an ethical review procedure for such drugs starting September 1, 2026. These are personalized medicines produced by a medical organization using the patient's own biological materials to treat cancer, autoimmune diseases, infectious diseases, and cardiovascular conditions. An ethics committee will handle the review process. The amendments to the 'Pharmaceuticals and Medical Devices Law' are prepared at the request of Tatiana Golikova. Ethical review is needed to ensure 'safety and welfare for patients, especially those with life-threatening conditions.' Members of the expert council support this initiative: The ethical review acts as a barrier preventing these drugs from being used in situations that are not beneficial to the patient or go against common moral and ethical norms, according to Nastya Smirnov, a member of the expert council for rare diseases at the State Duma Committee on Health. Maria Posadkova, head of legal affairs for the 'Sunflower' foundation, believes that a new committee will oversee the stages of creating and applying these drugs, assess"
2025-08-27T14:45:01+00:00,@bezrec,6475,https://t.me/bezrec/6475,"–ü–æ—Å–ª–µ –ø–æ—Ç–µ—Ä–∏ –ö—Å–∞—Ä–µ–ª—Ç–æ –ø–∞—Ç–µ–Ω—Ç–Ω–æ–π –∑–∞—â–∏—Ç—ã —Ä–æ—Å—Å–∏–π—Å–∫–∏–π —Ä—ã–Ω–æ–∫ –∑–∞–ø–æ–ª–æ–Ω–∏–ª–∏ –∞–Ω–∞–ª–æ–≥–∏ –ø–æ–ø—É–ª—è—Ä–Ω–æ–≥–æ –∞–Ω—Ç–∏–∫–æ–∞–≥—É–ª—è–Ω—Ç–∞. –í –Ω–∞—á–∞–ª–µ –≥–æ–¥–∞ –∏—Ö –±—ã–ª–æ –Ω–µ–º–Ω–æ–≥–æ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å —Ö–∏—Ç–æ–º –Ω–µ–º–µ—Ü–∫–æ–π Bayer. –†–µ—à–∏–ª–∏ –ø–æ—Å–º–æ—Ç—Ä–µ—Ç—å, –∫–∞–∫ –æ–±—Å—Ç–æ—è—Ç –¥–µ–ª–∞ —Å —Ä–∏–≤–∞—Ä–æ–∫—Å–∞–±–∞–Ω–æ–º —Å–µ–π—á–∞—Å. –ü–æ–º–∏–º–æ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω–æ–≥–æ –ö—Å–∞—Ä–µ–ª—Ç–æ –º—ã #–∑–∞—Ü–µ–Ω–∏–ª–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã —Ç–æ—Ä–≥–æ–≤—ã—Ö –º–∞—Ä–æ–∫: –ö—Ä—É–æ–∫—Å–∞–±–∞–Ω (¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª), –ó–∏–Ω–∞–∫–æ—Ä–µ–Ω (¬´–ê–∫—Ä–∏—Ö–∏–Ω¬ª), –†–∏–≤–∞—Ä–æ–∫—Å–∞–±–∞–Ω-–°–ó (¬´–°–µ–≤–µ—Ä–Ω–∞—è –ó–≤–µ–∑–¥–∞¬ª) –∏ –ö—Å–∏–ª—Ç–µ—Å—Å (¬´–≠–≥–∏—Å¬ª). –≠—Ç–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –º–æ–≥—É—Ç –ø–æ—Ö–≤–∞—Å—Ç–∞—Ç—å—Å—è –º–∞–∫—Å–∏–º–∞–ª—å–Ω—ã–º –Ω–∞—Ç—É—Ä–∞–ª—å–Ω—ã–º –∏ –¥–µ–Ω–µ–∂–Ω—ã–º –æ–±—ä—ë–º–æ–º –ø—Ä–æ–¥–∞–∂ —Å—Ä–µ–¥–∏ –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤. –° –Ω–∞–ª–∏—á–∏–µ–º –ø–µ—Ä–µ—á–∏—Å–ª–µ–Ω–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ –∞–ø—Ç–µ–∫–∞—Ö –ø—Ä–æ–±–ª–µ–º —Ç–µ–ø–µ—Ä—å –Ω–µ—Ç. –†–∞–∑–≤–µ —á—Ç–æ –†–∏–≤–∞—Ä–æ–∫—Å–∞–±–∞–Ω–∞ –æ—Ç ¬´–°–µ–≤–µ—Ä–Ω–æ–π –ó–≤–µ–∑–¥—ã¬ª –Ω–µ –æ–∫–∞–∑–∞–ª–æ—Å—å –≤ ¬´–†–∏–≥–ª–µ¬ª –∏ ¬´–ï–∞–ø—Ç–µ–∫–µ¬ª. –°—Ç–æ–∏–º–æ—Å—Ç—å –æ—Ä–∏–≥–∏–Ω–∞–ª–∞ –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ –≤—ã—à–µ, —á–µ–º —É –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤. –°–∞–º—ã–π –¥–æ—Ä–æ–≥–æ–π –ö—Å–∞—Ä–µ–ª—Ç–æ (3454 —Ä—É–±–ª—è) –æ–±–Ω–∞—Ä—É–∂–µ–Ω –≤ ¬´36,6¬ª. –ö—É–¥–∞ —ç–∫–æ–Ω–æ–º–∏—á–Ω–µ–µ —Ä–∞–∑–∂–∏–∂–∞—Ç—å –∫—Ä–æ–≤—å –∞–Ω–∞–ª–æ–≥–∞–º–∏ ‚Äî —Å–∞–º—ã–º –¥–µ—à—ë–≤—ã–º (587 —Ä—É–±–ª–µ–π) –æ–∫–∞–∑–∞–ª—Å—è –ö—Ä—É–æ–∫—Å–∞–±–∞–Ω –∏–∑ ¬´–ê–ø—Ç–µ–∫–∏.—Ä—É¬ª. –°–∞–º—ã–π –¥–æ—Ä–æ–≥–æ–π –¥–∂–µ–Ω–µ—Ä–∏–∫ ‚Äî –≤–µ–Ω–≥–µ—Ä—Å–∫–∏–π –ö—Å–∏–ª—Ç–µ—Å—Å ‚Äî –≤ ¬´36,6¬ª —Å—Ç–æ–∏—Ç 1192 —Ä—É–±–ª—è. –ù–∞–ø–æ–º–∏–Ω–∞–µ–º, —á—Ç–æ –ª—é–±—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏–º–µ—é—Ç –ø—Ä–æ—Ç–∏–≤–æ–ø–æ–∫–∞–∑–∞–Ω–∏—è. –ü–µ—Ä–µ–¥ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º –ø—Ä–æ–∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä—É–π—Ç–µ—Å—å —Å –≤—Ä–∞—á–æ–º. *–∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –ø—Ä–æ–≤–æ–¥–∏–ª–æ—Å—å –æ–Ω–ª–∞–π–Ω 27 –∞–≤–≥—É—Å—Ç–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""A study conducted online on August 27th found that after the patent protection of Xarelto expired, generic versions of rivaroxaban flooded the Russian market. Previously, there were few generics compared to Xarelto's hit from German company Bayer. The study looked at the current situation with rivaroxaban. Besides Xarelto, we examined drugs from trade brands: Krookosban (Ozone Pharma), Zinakoren (Akrixin), Rivaroxaban-SZ (Northern Star) and Xilitess (Egis). These drugs have the largest natural sales volume and revenue among generics. With these drugs available in pharmacies, there are no issues now. The original Xarelto is more expensive than generics. The most expensive version of Xarelto (3454 rubles) was found in '36,6'. Krookosban from 'Apteka.ru' is the cheapest generic (587 rubles). The most expensive generic, Xilitess from Germany, costs 1192"
2025-08-27T11:34:07+00:00,@bezrec,6474,https://t.me/bezrec/6474,"–†–æ—Å—Å–∏—è–Ω–µ –Ω–µ —Ä–∞–¥—É—é—Ç –∞–ø—Ç–µ–∫–∏ —á–∞—Å—Ç—ã–º–∏ –ø—Ä–æ—Å—Ç—É–¥–∞–º–∏. –í —Å—Ç—Ä–∞–Ω–µ —Å–Ω–∏–∂–∞—é—Ç—Å—è –ø—Ä–æ–¥–∞–∂–∏ –±–µ–∑—Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤. –í —Ç–æ–º —á–∏—Å–ª–µ –∏–∑-–∑–∞ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏—è –≤ —ç—Ç–æ–º –≥–æ–¥—É —Å–µ–∑–æ–Ω–Ω–æ–≥–æ –≤—Å–ø–ª–µ—Å–∫–∞ –∑–∞–±–æ–ª–µ–≤–∞–µ–º–æ—Å—Ç–∏ –≥—Ä–∏–ø–ø–æ–º –∏ –û–†–í–ò. –ü–æ –∏—Ç–æ–≥–∞–º –æ—Å–µ–Ω–∏‚Äî–∑–∏–º—ã 2024‚Äì2025 –≥–æ–¥–æ–≤ –æ–Ω–∞ –æ–∫–∞–∑–∞–ª–∞—Å—å –Ω–∞ —Å–∞–º–æ–º –Ω–∏–∑–∫–æ–º —É—Ä–æ–≤–Ω–µ –∑–∞ –ø–æ—Å–ª–µ–¥–Ω–∏–µ 30 –ª–µ—Ç, —á–µ–º—É —Å–ø–æ—Å–æ–±—Å—Ç–≤–æ–≤–∞–ª–∏ –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏—è –∏, –≤–æ–∑–º–æ–∂–Ω–æ, –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ —Ç–µ–ø–ª–∞—è –∑–∏–º–∞. –≠—Ç–∞ —Ç–µ–Ω–¥–µ–Ω—Ü–∏—è —Å–∫–∞–∑–∞–ª–∞—Å—å –Ω–∞ —Ç–µ–º–ø–∞—Ö —Ä–æ—Å—Ç–∞ –æ–±–æ—Ä–æ—Ç–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –∞–ø—Ç–µ—á–Ω–æ–≥–æ —Ä—ã–Ω–∫–∞, –∫–æ—Ç–æ—Ä—ã–µ –ø–æ –∏—Ç–æ–≥–∞–º –ø–µ—Ä–≤–æ–≥–æ –ø–æ–ª—É–≥–æ–¥–∏—è 2025 –≥–æ–¥–∞ —Å–æ–∫—Ä–∞—Ç–∏–ª–∏—Å—å –¥–æ 12% –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –ø—Ä–æ—à–ª–æ–≥–æ–¥–Ω–∏–º–∏ 17%, –ø–æ–¥—Å—á–∏—Ç–∞–ª–∏ –≤ DSM Group. –ü–æ –º–Ω–µ–Ω–∏—é –∞–Ω–∞–ª–∏—Ç–∏–∫–æ–≤, –≤ –æ–±—â–µ–º —Å–Ω–∏–∂–µ–Ω–∏–∏ –ø—Ä–æ–¥–∞–∂ –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤–æ –º–Ω–æ–≥–æ–º ¬´–≤–∏–Ω–æ–≤–∞—Ç—ã¬ª –∏–º–µ–Ω–Ω–æ –±–µ–∑—Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã ‚Äî –≤ —è–Ω–≤–∞—Ä–µ-–∏—é–Ω–µ –∏—Ö –ø—Ä–æ–¥–∞–ª–∏ –Ω–∞ 1,2 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —á—Ç–æ –Ω–∞ 5,5% –º–µ–Ω—å—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É. –î–ª—è —Å—Ä–∞–≤–Ω–µ–Ω–∏—è, –≤ –∞–Ω–∞–ª–æ–≥–∏—á–Ω–æ–º –ø–µ—Ä–∏–æ–¥–µ 2024 –≥–æ–¥–∞ —Å–Ω–∏–∂–µ–Ω–∏–µ —Å–æ—Å—Ç–∞–≤–∏–ª–æ 1,8%. –£ —Ä–µ—Ü–µ–ø—Ç—É—Ä–∫–∏ –¥–µ–ª–∞ –∏–¥—É—Ç –±–æ–¥—Ä–µ–µ. –ü—Ä–æ–¥–∞–∂–∏ —ç—Ç–æ–π –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ –¥–æ—Å—Ç–∏–≥–ª–∏ 890,1 –º–ª—Ä–¥ —É–ø–∞–∫–æ–≤–æ–∫ (+0,1%). –î–∏–Ω–∞–º–∏–∫–∞ –≤ –¥–µ–Ω—å–≥–∞—Ö —Å–æ—Å—Ç–∞–≤–∏–ª–∞ 14% (490,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π). –î–æ–ª—è Rx-–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º —Ñ–∞—Ä–º—Ä—ã–Ω–∫–µ –≤ –ø–µ—Ä–≤–æ–º –ø–æ–ª—É–≥–æ–¥–∏–∏ —É–≤–µ–ª–∏—á–∏–ª–∞—Å—å –Ω–∞ 1,4 –ø.–ø. –≥–æ–¥ –∫ –≥–æ–¥—É, –¥–æ 42,3%. –í –¥–µ–Ω–µ–∂–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ –ø—Ä–∏—Ä–æ—Å—Ç —Å–æ—Å—Ç–∞–≤–∏–ª 1,8 –ø.–ø., –¥–æ 56,2%. –£—Å–ø–µ—Ö–∏ —Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –º–æ–≥—É—Ç –æ–±—ä—è—Å–Ω—è—Ç—å—Å—è –æ—Ç–ª–æ–∂–µ–Ω–Ω—ã–º —Å–ø—Ä–æ—Å–æ–º –ø–æ—Å–ª–µ –ø–∞–Ω–¥–µ–º–∏–∏, —Ä–∞–∑–≤–∏—Ç–∏–µ–º —Ç–µ–ª–µ–º–µ–¥–∏—Ü–∏–Ω—ã, –∞ —Ç–∞–∫–∂–µ —Ä–æ—Å—Ç–æ–º —Å–ø—Ä–æ—Å–∞ –Ω–∞ –æ—Ç–¥–µ–ª—å–Ω—ã–µ –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤. –ó–≤—ë–∑–¥—ã —Å–µ–≥–º–µ–Ω—Ç–∞ ‚Äî –∞–Ω–∞–ª–æ–≥–∏ –û–∑–µ–º–ø–∏–∫–∞, –ø–æ–ø—É–ª—è—Ä–Ω—ã–µ –Ω–µ —Ç–æ–ª—å–∫–æ —É –¥–∏–∞–±–µ—Ç–∏–∫–æ–≤, –Ω–æ –∏ —É —Ö—É–¥–µ—é—â–∏—Ö. –ü–æ –¥–∞–Ω–Ω—ã–º DSM Group, —Å–∞–º—ã–º –ø—Ä–æ–¥–∞–≤–∞–µ–º—ã–º —Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–º –≤ –ø–µ—Ä–≤–æ–π –ø–æ–ª–æ–≤–∏–Ω–µ 2025 –≥–æ–¥–∞ —Å—Ç–∞–ª –°–µ–º–∞–≤–∏–∫ –æ—Ç ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º–∞¬ª. –ï–≥–æ –ø—Ä–æ–¥–∞–∂–∏ –≤ –¥–µ–Ω—å–≥–∞—Ö –≤—ã—Ä–æ—Å–ª–∏ –≤ 5,7 —Ä–∞–∑ –≥–æ–¥ –∫ –≥–æ–¥—É. –ï—Å–ª–∏ –≥–æ–≤–æ—Ä–∏—Ç—å –æ –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –∞–ø—Ç–µ—á–Ω—ã—Ö —Å–µ—Ç—è—Ö –≤ —è–Ω–≤–∞—Ä–µ‚Äî–∏—é–Ω–µ 2025 –≥–æ–¥–∞, —Ç–æ –≤ —Ç–æ–ø-10, –ø–æ –≤–µ—Ä—Å–∏–∏ DSM Group, –ø–æ–ø–∞–ª–∏: ¬´–†–∏–≥–ª–∞¬ª, ¬´–ê–ø—Ä–µ–ª—å¬ª, ¬´–ü–ª–∞–Ω–µ—Ç–∞ –∑–¥–æ—Ä–æ–≤—å—è¬ª, ¬´36,6¬ª, ¬´–ò–º–ø–ª–æ–∑–∏—è¬ª, ¬´–ù–µ–æ—Ñ–∞—Ä–º¬ª, –û–±—ä–µ–¥–∏–Ω–µ–Ω–Ω–∞—è —Å–µ—Ç—å ¬´–≠—Ä–∫–∞—Ñ–∞—Ä–º¬ª –∏ ¬´–ú–µ–ª–æ–¥–∏—è –∑–¥–æ—Ä–æ–≤—å—è¬ª, ¬´–§–∞—Ä–º–ª–µ–Ω–¥¬ª, ¬´–í–∏—Ç–∞¬ª, ¬´–ò—Ä–∏—Å¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, shortage, epidemic"",
  ""impact"": ""medium"",
  ""english"": ""Russia is experiencing a decline in the sales of over-the-counter drugs due to low seasonal influenza and other respiratory illnesses. The market for prescription medications is also showing signs of slowing down, with a 12% growth in the first half of 2025 compared to the previous year. The slowdown is attributed to a decrease in over-the-counter drug sales by 1.2 billion rubles, down from 1.8 billion in the same period last year. Prescription drug sales grew by 0.1% and 14% in natural and monetary terms respectively, increasing the share of prescription drugs to 42.3%. The top-selling prescription drug in the first half of 2025 was Semavik from 'Gerofarma', with a year-over-year growth of 5.7 times.""
}"
2025-08-27T08:32:28+00:00,@bezrec,6473,https://t.me/bezrec/6473,"–ü–æ–ª–∏–æ–∫—Å–∏–¥–æ–Ω–∏–π –≤–∫–ª—é—á–µ–Ω –≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø–æ –ª–µ—á–µ–Ω–∏—é –û–†–í–ò. –ú–∏–Ω–∑–¥—Ä–∞–≤ —É—Ç–≤–µ—Ä–¥–∏–ª –æ–±–Ω–æ–≤–ª–µ–Ω–Ω—É—é –≤–µ—Ä—Å–∏—é —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã—Ö –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π –ø–æ –ª–µ—á–µ–Ω–∏—é –æ—Å—Ç—Ä—ã—Ö —Ä–µ—Å–ø–∏—Ä–∞—Ç–æ—Ä–Ω—ã—Ö –≤–∏—Ä—É—Å–Ω—ã—Ö –∏–Ω—Ñ–µ–∫—Ü–∏–π (–û–†–í–ò) —É –≤–∑—Ä–æ—Å–ª—ã—Ö. –í –Ω–∏—Ö –Ω–∞—à–ª–æ—Å—å –º–µ—Å—Ç–æ –¥–ª—è –ü–æ–ª–∏–æ–∫—Å–∏–¥–æ–Ω–∏—è (–∞–∑–æ–∫—Å–∏–º–µ—Ä–∞ –±—Ä–æ–º–∏–¥). –ü—Ä–µ–ø–∞—Ä–∞—Ç –≤–∫–ª—é—á–µ–Ω –≤ –¥–≤–∞ —Ä–∞–∑–¥–µ–ª–∞ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π: –¥–ª—è –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –∏ —Ç–µ—Ä–∞–ø–∏–∏ –û–†–í–ò. –í –∫–ª–∏–Ω—Ä–µ–∫–∏ –ü–æ–ª–∏–æ–∫—Å–∏–¥–æ–Ω–∏–π –ø–æ–ø–∞–ª –∑–∞ ¬´–≤—ã—Ä–∞–∂–µ–Ω–Ω—É—é –∏–º–º—É–Ω–æ–º–æ–¥—É–ª–∏—Ä—É—é—â—É—é –∞–∫—Ç–∏–≤–Ω–æ—Å—Ç—å, –Ω–µ—Å–ø–µ—Ü–∏—Ñ–∏—á–µ—Å–∫–æ–µ –∑–∞—â–∏—Ç–Ω–æ–µ –¥–µ–π—Å—Ç–≤–∏–µ –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ —à–∏—Ä–æ–∫–æ–≥–æ —Å–ø–µ–∫—Ç—Ä–∞ –ø–∞—Ç–æ–≥–µ–Ω–æ–≤, –∞ —Ç–∞–∫–∂–µ –∞–Ω—Ç–∏—Ç–æ–∫—Å–∏—á–µ—Å–∫–∏–µ –∏ –∞–Ω—Ç–∏–æ–∫—Å–∏–¥–∞–Ω—Ç–Ω—ã–µ —Å–≤–æ–π—Å—Ç–≤–∞¬ª. –¢–∞–∫ –æ—Ç–º–µ—á–µ–Ω–æ –≤ –¥–æ–∫—É–º–µ–Ω—Ç–µ. –í–∫–ª—é—á–µ–Ω–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ —Å–≤–∏–¥–µ—Ç–µ–ª—å—Å—Ç–≤—É–µ—Ç –æ –≤—ã—Å–æ–∫–æ–º –ø—Ä–∏–∑–Ω–∞–Ω–∏–∏ —ç–∫—Å–ø–µ—Ä—Ç–Ω—ã–º —Å–æ–æ–±—â–µ—Å—Ç–≤–æ–º —Ä–µ–∑—É–ª—å—Ç–∞—Ç–æ–≤ –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–æ–≥–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –∏ –¥–∞–Ω–Ω—ã—Ö –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –∞–∑–æ–∫—Å–∏—Ä–∞ –±—Ä–æ–º–∏–¥–∞, ‚Äî –ø—Ä–æ–∫–æ–º–º–µ–Ω—Ç–∏—Ä–æ–≤–∞–ª –ú–∞–∫—Å–∏–º –ú–∞—Ü–∏—è–∫, —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è –ø–µ–¥–∏–∞—Ç—Ä–∏–∏ –∏ –æ–±—â–µ–π —Ç–µ—Ä–∞–ø–∏–∏ ¬´–ü–µ—Ç—Ä–æ–≤–∞–∫—Å –§–∞—Ä–º¬ª. –ö—Å—Ç–∞—Ç–∏, –æ–± –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è—Ö. –ò—Å–ø—ã—Ç–∞–Ω–∏—è —Å —É—á–∞—Å—Ç–∏–µ–º 24 —Ç—ã—Å. –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –ø–æ–∫–∞–∑–∞–ª–∏, —á—Ç–æ –≤ —Å–æ—Å—Ç–∞–≤–µ –∫–æ–º–ø–ª–µ–∫—Å–Ω–æ–≥–æ –ª–µ—á–µ–Ω–∏—è –û–†–í–ò –ø—Ä–µ–ø–∞—Ä–∞—Ç –ø–æ–º–æ–≥–∞–µ—Ç –≤ —Å—Ä–µ–¥–Ω–µ–º –Ω–∞ 1,3 –¥–Ω—è –±—ã—Å—Ç—Ä–µ–µ —Å–ø—Ä–∞–≤–∏—Ç—å—Å—è —Å –ª–∏—Ö–æ—Ä–∞–¥–∫–æ–π, –±–æ–ª—å—é –≤ –≥–æ—Ä–ª–µ, –∑–∞–ª–æ–∂–µ–Ω–Ω–æ—Å—Ç—å—é –Ω–æ—Å–∞ –∏ –¥—Ä—É–≥–∏–º–∏ ¬´—Å–ø—É—Ç–Ω–∏–∫–∞–º–∏¬ª –≤–∏—Ä—É—Å–Ω–æ–π –∏–Ω—Ñ–µ–∫—Ü–∏–∏. –í—Å—ë –±–ª–∞–≥–æ–¥–∞—Ä—è –æ—Å–æ–±–æ–π —Å—Ç—Ä—É–∫—Ç—É—Ä–µ –º–æ–ª–µ–∫—É–ª—ã, —É—Å–ø–µ—à–Ω–æ —Å—Ç–∏–º—É–ª–∏—Ä—É—é—â–µ–π –≤—ã—Ä–∞–±–æ—Ç–∫—É –∏–Ω—Ç–µ—Ä—Ñ–µ—Ä–æ–Ω–æ–≤. –ü–æ —Å–ª–æ–≤–∞–º —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–æ–≤, –ü–æ–ª–∏–æ–∫—Å–∏–¥–æ–Ω–∏–π —Å–ø–æ—Å–æ–±–µ–Ω –≤–æ–∑–¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å –Ω–∞ –ø–∞—Ç–æ–≥–µ–Ω–µ–∑ –∏–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, –≤ –æ—Ç–ª–∏—á–∏–µ –æ—Ç –¥—Ä—É–≥–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —ç—Ç–æ–π –≥—Ä—É–ø–ø—ã. –†–∞–Ω–µ–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç –±—ã–ª –≤–Ω–µ—Å–µ–Ω –≤ –º–µ—Ç–æ–¥–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –§–ú–ë–ê –ø–æ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–µ –∏ –ª–µ—á–µ–Ω–∏—é –≥—Ä–∏–ø–ø–∞ –∏ –¥—Ä—É–≥–∏—Ö –û–†–í–ò –≤ –ø–µ—Ä–∏–æ–¥ –ø–∞–Ω–¥–µ–º–∏–∏ COVID-19, –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ ¬´–ì—Ä–∏–ø–ø —É –≤–∑—Ä–æ—Å–ª—ã—Ö¬ª, –≤—Ä–µ–º–µ–Ω–Ω—ã–µ –º–µ—Ç–æ–¥–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ø–æ –±–æ—Ä—å–±–µ —Å COVID-19, –≤—Ä–µ–º–µ–Ω–Ω—ã–µ –º–µ—Ç–æ–¥–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø–æ —Ç–µ—Ä–∞–ø–∏–∏ –û–†–í–ò –≤ –ø–µ—Ä–∏–æ–¥ –ø–∞–Ω–¥–µ–º–∏–∏ COVID-19. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance"",
  ""impact"": ""high"",
  ""english"": ""Poloxidine has been included in the clinical guidelines for treating and preventing influenza-like illnesses (ILI). The Ministry of Health approved updated federal clinical guidelines for adults. Poloxidine is included in two sections of the guidelines: for prevention and treatment of ILI. The inclusion of Poloxidine in clinical guidelines is a clear indication of the expert community's recognition of its practical application and research data. The results of clinical trials involving 24,000 patients showed that the treatment helped to recover from fever, sore throat, nasal congestion and other symptoms of viral infections on average 1.3 days faster. This is due to the special structure of the molecule, which effectively stimulates interferon production.""
}"
2025-08-27T05:35:08+00:00,@bezrec,6472,https://t.me/bezrec/6472,"–ù–µ–ø—Ä–∏—è—Ç–Ω–æ—Å—Ç–∏ –Ω–µ –º–µ—à–∞—é—Ç ¬´–î–∂–æ–¥–∞—Å –≠–∫—Å–ø–æ–∏–º¬ª —Å—Ç—Ä–æ–∏—Ç—å —Ñ–∞—Ä–º–∫–æ–º–ø–ª–µ–∫—Å –≤ –ü–æ–¥–º–æ—Å–∫–æ–≤—å–µ. –ù–æ–≤—ã–π –∑–∞–≤–æ–¥ –≤ –í–æ—Å–∫—Ä–µ—Å–µ–Ω—Å–∫–µ –æ–±–µ—â–∞—é—Ç –∑–∞–ø—É—Å—Ç–∏—Ç—å –∫ 2027 –≥–æ–¥—É. –ù–∞ —Å–µ–≥–æ–¥–Ω—è—à–Ω–∏–π –¥–µ–Ω—å –æ–±—ä–µ–∫—Ç –≥–æ—Ç–æ–≤ –Ω–∞ 25%. –ü–æ –¥–∞–Ω–Ω—ã–º –ì–ª–∞–≤–≥–æ—Å—Å—Ç—Ä–æ–π–Ω–∞–¥–∑–æ—Ä–∞ –ú–æ—Å–∫–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏, –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–∏ –≤ –ø—Ä–æ–µ–∫—Ç –ø—Ä–µ–≤—ã—à–∞—é—Ç 120 –º–ª–Ω —Ä—É–±–ª–µ–π. –ü–ª–æ—â–∞–¥—å –∫–æ–º–ø–ª–µ–∫—Å–∞ –ø—Ä–µ–≤—ã—Å–∏—Ç 5,1 —Ç—ã—Å. –∫–≤. –º. –ù–∞ —Ç—Ä–µ—Ö –ª–∏–Ω–∏—è—Ö –±—É–¥—É—Ç –≤—ã–ø—É—Å–∫–∞—Ç—å –æ–∫–æ–ª–æ 11,5 –º–ª–Ω —Ç–∞–±–ª–µ—Ç–æ–∫, 9,2 –º–ª–Ω –∫–∞–ø—Å—É–ª –∏ –¥–æ 5,28 –º–ª–Ω –µ–¥–∏–Ω–∏—Ü –∏–Ω—ä–µ–∫—Ü–∏–æ–Ω–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ –≥–æ–¥. –ö–∞–∫ —Å–æ–æ–±—â–∏–ª–∏ –≤ –≤–µ–¥–æ–º—Å—Ç–≤–µ, —ç—Ç–æ –±—É–¥—É—Ç –∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫–∏, —Ä–µ–Ω—Ç–≥–µ–Ω–æ–∫–æ–Ω—Ç—Ä–∞—Å—Ç–Ω—ã–µ –∏ –ø—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã. –û–û–û ¬´–î–∂–æ–¥–∞—Å –≠–∫—Å–ø–æ–∏–º¬ª –±—ã–ª–æ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–æ –≤ –í–æ—Å–∫—Ä–µ—Å–µ–Ω—Å–∫–µ –≤ 2009 –≥–æ–¥—É. –° –º–æ–º–µ–Ω—Ç–∞ –æ—Å–Ω–æ–≤–∞–Ω–∏—è –∫–æ–º–ø–∞–Ω–∏–µ–π —Ä—É–∫–æ–≤–æ–¥–∏—Ç –ü–∞—Ä—Å–∞–¥ –°–∏–Ω–≥—Ö –®–∞—à–∏ –®–∞–Ω–∫–∞—Ä. –í –º–∞–µ –µ–≥–æ –Ω–∞ –ø–∞—Ä—É —Å —á–∏–Ω–æ–≤–Ω–∏–∫–æ–º –î–µ–ø–∞—Ä—Ç–∞–º–µ–Ω—Ç–∞ —Ä–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω–∏—è –æ–±—Ä–∞—â–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ê–ª–µ–∫—Å–µ–µ–º –°–∞–∑–æ–Ω–æ–≤—ã–º –∑–∞–¥–µ—Ä–∂–∞–ª–∏ –≤ —Å–≤—è–∑–∏ —Å –≤–æ–∑–±—É–∂–¥–µ–Ω–∏–µ–º —É–≥–æ–ª–æ–≤–Ω–æ–≥–æ –¥–µ–ª–∞ –æ –¥–∞—á–µ –≤–∑—è—Ç–∫–∏ –≤ –æ—Å–æ–±–æ –∫—Ä—É–ø–Ω–æ–º —Ä–∞–∑–º–µ—Ä–µ. –ü–æ—Å–ª–µ —ç—Ç–æ–≥–æ –ú–∏–Ω–∑–¥—Ä–∞–≤ –Ω–µ–æ–¥–Ω–æ–∫—Ä–∞—Ç–Ω–æ –ø—Ä–∏–æ—Å—Ç–∞–Ω–∞–≤–ª–∏–≤–∞–ª –¥–µ–π—Å—Ç–≤–∏–µ —Ä–µ–≥—É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏–π –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã ¬´–î–∂–æ–¥–∞—Å¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,pharmacovigilance,hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""A pharmaceutical company 'Djodas Expoim' is building a farm complex in Moscow region. A new factory in Voskresensk is expected to start operations by 2027. The project has been completed to a degree of 25%. According to the Main State Construction Supervision Department of Moscow Oblast, investments in the project exceed 12 million rubles. The complex area will be over 5,100 square meters. Three lines will produce about 11.5 million tablets, 9.2 million capsules and up to 5.28 million injections of antibiotics, radiopaque contrast agents, and anticancer drugs per year. The company 'Djodas Expoim' was registered in Voskresensk in 2009. Since then, the company has been led by Parasad Singh Shashi Shankar. In May, he and a department official from the Department of Regulation of Medicinal Products and Medical Devices at the Ministry of Health, Alex"
2025-08-26T15:00:20+00:00,@bezrec,6471,https://t.me/bezrec/6471,"–ú–∏—Ö–∞–∏–ª –¶—ã—Ñ–µ—Ä–æ–≤ ‚Äî –æ —Å–æ–≤—Ä–µ–º–µ–Ω–Ω—ã—Ö –ø–æ–¥—Ö–æ–¥–∞—Ö –∫ –ª–µ—á–µ–Ω–∏—é –±–æ–ª–µ–∑–Ω–∏ –§–∞–±—Ä–∏. –í Vademecum –≤—ã—à–ª–æ –∏–Ω—Ç–µ—Ä–≤—å—é —Å –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç–æ–º ¬´–ü–µ—Ç—Ä–æ–≤–∞–∫—Å–∞¬ª –æ —Ç–æ–º, –ø–æ—á–µ–º—É —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –ª—É—á—à–µ –∏ –≤—ã–≥–æ–¥–Ω–µ–µ –ª–µ—á–∏—Ç—å –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–º –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–º –§–∞–±–∞–≥–∞–ª–æ–º. –ü–æ–≤–æ–¥–æ–º –¥–ª—è –±–µ—Å–µ–¥—ã —Å—Ç–∞–ª–∏ –∫–æ–º–º–µ–Ω—Ç–∞—Ä–∏–∏ —Ä–æ—Å—Å–∏–π—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–∏, —É–∂–µ –±–æ–ª—å—à–µ –≥–æ–¥–∞ –≤—ã–ø—É—Å–∫–∞—é—â–µ–π –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—É—é –∞–≥–∞–ª—Å–∏–¥–∞–∑—É –±–µ—Ç–∞, –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ —É—Å–ª–æ–≤–∏–π –≤–∫–ª—é—á–µ–Ω–∏—è –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü –≠–ª—å—Ñ–∞–±—Ä–∏–æ (–ø—ç–≥—É–Ω–∏–≥–∞–ª—Å–∏–¥–∞–∑–∞ –∞–ª—å—Ñ–∞) –æ—Ç –∏—Ç–∞–ª—å—è–Ω—Å–∫–æ–π Chiesi. –ö–æ–º–∏—Å—Å–∏—è, –∏–∑–Ω–∞—á–∞–ª—å–Ω–æ –ø—Ä–æ–≥–æ–ª–æ—Å–æ–≤–∞–≤—à–∞—è –∑–∞ –≤–∫–ª—é—á–µ–Ω–∏–µ –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞, –≤—ã—Å–ª—É—à–∞–≤ –¥–æ–≤–æ–¥—ã –æ–ø–ø–æ–Ω–µ–Ω—Ç–æ–≤, –æ—Ç–ª–æ–∂–∏–ª–∞ –≤–æ–ø—Ä–æ—Å –¥–æ –Ω–æ—è–±—Ä—è. –ì–ª–∞–≤–Ω–æ–µ –∏–∑ –∏–Ω—Ç–µ—Ä–≤—å—é: üíä –ö–æ–º–∏—Å—Å–∏—è —Å–æ–≥–ª–∞—Å–∏–ª–∞—Å—å, —á—Ç–æ –Ω–µ —Ä–∞—Å–ø–æ–ª–∞–≥–∞–µ—Ç –¥–æ—Å—Ç–∞—Ç–æ—á–Ω—ã–º–∏ –¥–∞–Ω–Ω—ã–º–∏ –æ —Ç–æ–º, –∫–∞–∫ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–ª–∞—Å—å —Ü–µ–Ω–∞ –Ω–∞ –ø—ç–≥—É–Ω–∏–≥–∞–ª—Å–∏–¥–∞–∑—É –∞–ª—å—Ñ–∞. üíä –ü—Ä–µ–ø–∞—Ä–∞—Ç –æ—Ç Chiesi —Å—Ç–∞–ª–∫–∏–≤–∞–ª—Å—è —Å –ø—Ä–æ–±–ª–µ–º–∞–º–∏ –ø—Ä–∏ –¥–æ–ø—É—Å–∫–µ –Ω–∞ –¥—Ä—É–≥–∏–µ —Ä—ã–Ω–∫–∏ –∑–∞–¥–æ–ª–≥–æ –¥–æ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –≤ –†–æ—Å—Å–∏–∏: –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—ã–µ —Ä–µ–≥—É–ª—è—Ç–æ—Ä—ã –∏–ª–∏ –æ—Ç–∫–∞–∑—ã–≤–∞–ª–∏ –≤ –æ–¥–æ–±—Ä–µ–Ω–∏–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –∫–∞–∫ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏, –∏–ª–∏ —Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª–∏ –ø–æ —Ü–µ–Ω–∞–º —Ä–∞–≤–Ω–æ–∑–Ω–∞—á–Ω—ã–º –ª–∏–±–æ –Ω–∏–∂–µ, —á–µ–º —É –∞–≥–∞–ª—Å–∏–¥–∞–∑—ã –±–µ—Ç–∞. üíä –í –ø—Ä–æ—à–ª–æ–≥–æ–¥–Ω–µ–º –æ—Ç—á—ë—Ç–µ Scottish Medicines Consortium –≥–æ–≤–æ—Ä–∏—Ç—Å—è, —á—Ç–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç Chiesi –≤ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–æ–Ω–Ω–æ–º –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–∏ –Ω–µ —Å–º–æ–≥ –ø–æ–∫–∞–∑–∞—Ç—å, —á—Ç–æ –æ–Ω —Å—Ä–∞–≤–Ω–∏–º –ø–æ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ —Å –∞–≥–∞–ª—Å–∏–¥–∞–∑–æ–π –±–µ—Ç–∞. –≠—Ç–∏ –∂–µ –¥–∞–Ω–Ω—ã–µ –µ—Å—Ç—å –≤ –æ—Ç—á—ë—Ç–µ –µ–≤—Ä–æ–ø–µ–π—Å–∫–æ–≥–æ —Ä–µ–≥—É–ª—è—Ç–æ—Ä–∞ EMA. üíä –ù–∏ –≤ –æ–¥–Ω–æ–º –¥–æ—Å—Ç—É–ø–Ω–æ–º –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–∏ —Å—Ä–∞–≤–Ω–µ–Ω–∏–µ –ø—ç–≥—É–Ω–∏–≥–∞–ª—Å–∏–¥–∞–∑—ã –∞–ª—å—Ñ–∞ –∏ –∞–≥–∞–ª—Å–∏–¥–∞–∑—ã –±–µ—Ç–∞ –Ω–µ –ø–æ–∫–∞–∑–∞–ª–æ, —á—Ç–æ –ø–µ—Ä–≤—ã–π –ø—Ä–µ–≤–æ—Å—Ö–æ–¥–∏—Ç –≤—Ç–æ—Ä–æ–π. üíä –û–±—ä–µ–∫—Ç–∏–≤–Ω—ã–π –∫—Ä–∏—Ç–µ—Ä–∏–π –¥–ª—è —Å—Ä–∞–≤–Ω–µ–Ω–∏—è —Ü–µ–Ω ‚Äì —Å—Ç–æ–∏–º–æ—Å—Ç—å –∑–∞ –º–∏–ª–ª–∏–≥—Ä–∞–º–º. –ü–æ—Å–ª–µ–¥–Ω—è—è –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–Ω–∞—è —Ü–µ–Ω–∞ –≠–ª—å—Ñ–∞–±—Ä–∏–æ –¥–æ—Ä–æ–∂–µ –Ω–∞ —Ç—Ä–µ—Ç—å –¥–ª—è –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ–≥–æ —á–∏—Å–ª–∞ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. üíä –ù–∞ –∑–∞—Å–µ–¥–∞–Ω–∏–∏ –ø—Ä–æ–∑–≤—É—á–∞–ª–æ, —á—Ç–æ –ø—ç–≥—É–Ω–∏–≥–∞–ª—Å–∏–¥–∞–∑–∞ –∞–ª—å—Ñ–∞ –ø–æ–∫–∞–∑–∞–Ω–∞ –≤ –∫–∞—á–µ—Å—Ç–≤–µ –≤—Ç–æ—Ä–æ–π –ª–∏–Ω–∏–∏ —Ç–µ—Ä–∞–ø–∏–∏ 20% –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, —É –∫–æ—Ç–æ—Ä—ã—Ö –µ—Å—Ç—å —Ç–æ–ª–µ—Ä–∞–Ω—Ç–Ω–æ—Å—Ç—å –∫ –∞–≥–∞–ª—Å–∏–¥–∞–∑–µ –±–µ—Ç–∞ –∏ –∞–ª—å—Ñ–∞, –Ω–æ —Ç–∞–∫–æ–≥–æ –ø–æ–Ω—è—Ç–∏—è, –∫–∞–∫ ¬´–≤—Ç–æ—Ä–∞—è –ª–∏–Ω–∏—è¬ª, –≤ —ç—Ç–æ–π –Ω–æ–∑–æ–ª–æ–≥–∏–∏ –Ω–µ—Ç. üíä –° –≤–∫–ª—é—á–µ–Ω–∏–µ–º –ø—ç–≥—É–Ω–∏–≥–∞–ª—Å–∏–¥–∞–∑—ã –∞–ª—å—Ñ–∞ –≤ –ñ–ù–í–õ–ü —Ä–∞—Å—Ö–æ–¥—ã —Å–∏—Å—Ç–µ–º—ã –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è —Ä–∏—Å–∫—É—é—Ç –≤—ã—Ä–∞—Å—Ç–∏ –Ω–∞ —Ç—Ä–µ—Ç—å, –µ—Å–ª–∏ –æ–Ω –±—É–¥–µ—Ç –∑–∞–º–µ—â–∞—Ç—å —Å–æ–±–æ–π –∞–≥–∞–ª—Å–∏–¥–∞–∑—É –±–µ—Ç–∞. üíä –≠–ª—å—Ñ–∞–±—Ä–∏–æ ‚Äî –ø—Ä–µ–ø–∞—Ä–∞—Ç –∑–∞—Ä—É–±–µ–∂–Ω—ã–π, –Ω–∏–∫–∞–∫–∏—Ö –ø–ª–∞–Ω–æ–≤ –ø–æ –µ–≥–æ –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏–∏ –≤ –†–æ—Å—Å–∏–∏ –Ω–µ—Ç. –§–∞–±–∞–≥–∞–ª ‚Äì –ø–æ–ª–Ω–æ—Å—Ç—å—é –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π, –æ—Å—É—â–µ—Å—Ç–≤–ª–µ–Ω –ø–æ–ª–Ω—ã–π —Ç—Ä–∞–Ω—Å—Ñ–µ—Ä —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏. –≠—Ç–æ –ø–µ—Ä–≤—ã–π –ø—Ä–∏–º–µ—Ä –ø–æ–ª–Ω–æ–≥–æ —Ç—Ä–∞–Ω—Å—Ñ–µ—Ä–∞ –∫–ª–µ—Ç–æ—á–Ω–æ–π –ª–∏–Ω–∏–∏ –≤ –†–æ—Å—Å–∏–∏. üíä –í–∫–ª—é—á–µ–Ω–∏–µ –≠–ª—å—Ñ–∞–±—Ä–∏–æ –≤ –ñ–ù–í–õ–ü –¥–∞—Å—Ç –ø–ª–æ—Ö–æ–π —Å–∏–≥–Ω–∞–ª —Ä–æ—Å—Å–∏–π—Å–∫–∏–º –∏–Ω–≤–µ—Å—Ç–æ—Ä–∞–º, —Ä–∞–∑–≤–∏–≤–∞—é—â–∏–º —Ä–æ—Å—Å–∏–π—Å–∫—É—é –Ω–∞—É–∫—É –∏ —Ñ–∞—Ä–º–±–∏–∑–Ω–µ—Å. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, reimbursement, pricing, shortage"",
  ""impact"": ""high"",
  ""english"": ""The interview discusses the Russian company's innovative Fabagal, which is more cost-effective and beneficial for patients. The inclusion of the Italian drug Elfabriio in the national essential medicines list (–ñ–ù–í–õ–ü) is questioned due to lack of data on its cost-effectiveness. The high price of Elfabriio compared to Fabagal raises concerns about the financial burden on the healthcare system. The inclusion of Elfabriio is seen as a negative signal for Russian investors in science and pharmaceuticals.""
}"
2025-08-26T11:45:01+00:00,@bezrec,6470,https://t.me/bezrec/6470,"–ö–∏—Ç–∞–π –≤–¥–≤–æ–µ –Ω–∞—Ä–∞—Å—Ç–∏–ª –ø–æ—Å—Ç–∞–≤–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ –†–æ—Å—Å–∏—é. –ü–æ –¥–∞–Ω–Ω—ã–º –∫–∏—Ç–∞–π—Å–∫–æ–π —Å—Ç–∞—Ç—Å–ª—É–∂–±—ã, –≤ –∏—é–ª–µ 2025 –≥–æ–¥–∞ –†–æ—Å—Å–∏—è –∏–º–ø–æ—Ä—Ç–∏—Ä–æ–≤–∞–ª–∞ —Ñ–∞—Ä–º–ø—Ä–æ–¥—É–∫—Ü–∏–∏ –∏–∑ –ü–æ–¥–Ω–µ–±–µ—Å–Ω–æ–π –Ω–∞ $15,9 –º–ª–Ω, —á—Ç–æ –≤ 1,9 —Ä–∞–∑–∞ –±–æ–ª—å—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É –∏ –Ω–∞ 41% –±–æ–ª—å—à–µ, —á–µ–º –≤ –∏—é–Ω–µ. –° –Ω–∞—á–∞–ª–∞ –≥–æ–¥–∞ –≤–≤–æ–∑ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏–∑ –ü–µ–∫–∏–Ω–∞ –≤—ã—Ä–æ—Å –Ω–∞ —Ç—Ä–µ—Ç—å, –¥–æ $77,4 –º–ª–Ω. –í –ª–∏–¥–µ—Ä–∞—Ö ‚Äî –∏–º–º—É–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–µ –ø—Ä–æ–¥—É–∫—Ç—ã –∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –∏–∑ –∫—Ä–æ–≤–∏ ‚Äî –∏—Ö –∑–∞–∫—É–ø–∏–ª–∏ –Ω–∞ $5,9 –º–ª–Ω. –¢–∞–∫–∂–µ –∏–º–ø–æ—Ä—Ç–∏—Ä–æ–≤–∞–ª–∏ –≥–µ–ø–∞—Ä–∏–Ω –∏ –¥—Ä—É–≥–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –∂–∏–≤–æ—Ç–Ω–æ–≥–æ –ø—Ä–æ–∏—Å—Ö–æ–∂–¥–µ–Ω–∏—è ($4,4 –º–ª–Ω), –ø–µ—Ä–µ–≤—è–∑–æ—á–Ω—ã–µ –º–∞—Ç–µ—Ä–∏–∞–ª—ã ($3 –º–ª–Ω), –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç—ã ($2,2 –º–ª–Ω), –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –∞–∫—Å–µ—Å—Å—É–∞—Ä—ã –∏ –ø—Ä–æ—á—É—é –ø—Ä–æ–¥—É–∫—Ü–∏—é ($476 —Ç—ã—Å.). –û–¥–Ω–∞–∫–æ –†–æ—Å—Å–∏—è –≤—Å—ë –µ—â—ë –Ω–µ –≤—Ö–æ–¥–∏—Ç –≤ —á–∏—Å–ª–æ –≥–ª–∞–≤–Ω—ã—Ö –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª–µ–π –∫–∏—Ç–∞–π—Å–∫–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤. –ù–∞ –ø–µ—Ä–≤–æ–º –º–µ—Å—Ç–µ –ø–æ –∏–º–ø–æ—Ä—Ç—É –∏–∑ –ö–∏—Ç–∞—è ‚Äî –°–®–ê ($214,9 –º–ª–Ω), –¥–∞–ª–µ–µ —Å–ª–µ–¥—É—é—Ç –î–∞–Ω–∏—è ($128,6 –º–ª–Ω), –§—Ä–∞–Ω—Ü–∏—è ($111,8 –º–ª–Ω), –í–µ–ª–∏–∫–æ–±—Ä–∏—Ç–∞–Ω–∏—è ($32,3 –º–ª–Ω) –∏ –ê–≤—Å—Ç—Ä–∞–ª–∏—è ($32 –º–ª–Ω). –ù–∞—à–∞ —Å—Ç—Ä–∞–Ω–∞ —Ç–æ–ª—å–∫–æ –Ω–∞ 17-–º –º–µ—Å—Ç–µ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-08-26T05:54:38+00:00,@bezrec,6468,https://t.me/bezrec/6468,"–£ –∑–∞–≤–æ–¥–∞ ¬´–ù–∏–∂—Ñ–∞—Ä–º¬ª –≤ –û–±–Ω–∏–Ω—Å–∫–µ –Ω–æ–≤—ã–π —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å. –ù–∞ –¥–æ–ª–∂–Ω–æ—Å—Ç—å –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω–æ–π –ø–ª–æ—â–∞–¥–∫–∏ –û–û–û ¬´–•–µ–º–æ—Ñ–∞—Ä–º¬ª –Ω–∞–∑–Ω–∞—á–µ–Ω –ê–Ω—Ç–æ–Ω –ú—É—Ä–∞—á–µ–≤. –ú—É—Ä–∞—á–µ–≤ –ø—Ä–∏—à—ë–ª –≤ –∫–æ–º–ø–∞–Ω–∏—é 17 –ª–µ—Ç –Ω–∞–∑–∞–¥, –ø–æ—Å–ª–µ –æ–∫–æ–Ω—á–∞–Ω–∏—è —Ñ–∏–∑–∏–∫–æ-—Ö–∏–º–∏—á–µ—Å–∫–æ–≥–æ —Ñ–∞–∫—É–ª—å—Ç–µ—Ç–∞ –†–•–¢–£ –∏–º. –ú–µ–Ω–¥–µ–ª–µ–µ–≤–∞ –ø–æ —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–∏ –∏–Ω–∂–µ–Ω–µ—Ä. –î–æ —Ç–æ–ø-–º–µ–Ω–µ–¥–∂–µ—Ä–∞ —Ä–æ—Å –ø–æ—Å—Ç–µ–ø–µ–Ω–Ω–æ, –≤ —Ä–∞–∑–Ω—ã–µ –≥–æ–¥—ã –∑–∞–Ω–∏–º–∞—è –¥–æ–ª–∂–Ω–æ—Å—Ç–∏ –∏–Ω–∂–µ–Ω–µ—Ä–∞-—Ç–µ—Ö–Ω–æ–ª–æ–≥–∞, –Ω–∞—á–∞–ª—å–Ω–∏–∫–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ —Ü–µ—Ö–∞ –∏ —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—è –ø—Ä–æ–µ–∫—Ç–Ω–æ–π –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –∑–∞–≤–æ–¥–∞. –ü–æ–º–∏–º–æ –ø—Ä–æ—á–µ–≥–æ, –ú—É—Ä–∞—á–µ–≤ —Å–æ—Å—Ä–µ–¥–æ—Ç–æ—á–∏—Ç—Å—è –Ω–∞ —Ä–∞–∑–≤–∏—Ç–∏–∏ –∫–∞–¥—Ä–æ–≤–æ–≥–æ –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª–∞ –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏—è. –°–µ–π—á–∞—Å –Ω–∞ –Ω—ë–º —Ä–∞–±–æ—Ç–∞–µ—Ç –±–æ–ª–µ–µ 300 —á–µ–ª–æ–≤–µ–∫. ¬´–•–µ–º–æ—Ñ–∞—Ä–º¬ª —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä—É–µ—Ç—Å—è –Ω–∞ –≤—ã–ø—É—Å–∫–µ –Ω–µ—Å—Ç–µ—Ä–∏–ª—å–Ω—ã—Ö —Ç–≤–µ—Ä–¥—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Ñ–æ—Ä–º ‚Äî –≤—Å–µ–≥–æ –±–æ–ª–µ–µ 80 –Ω–∞–∏–º–µ–Ω–æ–≤–∞–Ω–∏–π –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ú–æ—â–Ω–æ—Å—Ç—å –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ ‚Äî 43 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ –≤ –≥–æ–¥. –ü–æ –¥–∞–Ω–Ω—ã–º Rusprofile, ¬´–•–µ–º–æ—Ñ–∞—Ä–º¬ª —Ä–∞–±–æ—Ç–∞–µ—Ç –≤ –ö–∞–ª—É–∂—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ —Å 2003 –≥–æ–¥–∞. –° 2021 –≥–æ–¥–∞ –≥–µ–Ω–µ—Ä–∞–ª—å–Ω—ã–º –¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–º –±—ã–ª –í–∏—Ç–∞–ª–∏–π –ü–æ–∑–¥–Ω—è–∫–æ–≤. –í—ã—Ä—É—á–∫–∞ –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏—è –ø–æ –∏—Ç–æ–≥–∞–º 2024 –≥–æ–¥–∞ —Å–æ—Å—Ç–∞–≤–∏–ª–∞ 1,3 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π (+41%), –ø—Ä–∏–±—ã–ª—å –≤—ã—Ä–æ—Å–ª–∞ –Ω–∞ 241%, –¥–æ 20 –º–ª–Ω —Ä—É–±–ª–µ–π. –ù–∞–ø–æ–º–Ω–∏–º, –≤ –∞–ø—Ä–µ–ª–µ –í–ª–∞–¥–∏–º–∏—Ä –ü—É—Ç–∏–Ω –ø–µ—Ä–µ–¥–∞–ª 100% –∞–∫—Ü–∏–π ¬´–ù–∏–∂—Ñ–∞—Ä–º¬ª, –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∞–≤—à–µ–π –Ω–∏–¥–µ—Ä–ª–∞–Ω–¥—Å–∫–æ–π Nidda Lynx (—Å—Ç—Ä—É–∫—Ç—É—Ä–∞ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –≥—Ä—É–ø–ø—ã Stada), –≤–æ –≤—Ä–µ–º–µ–Ω–Ω–æ–µ —É–ø—Ä–∞–≤–ª–µ–Ω–∏–µ —Ä–æ—Å—Å–∏–π—Å–∫–æ–π ¬´–§–∞—Ä–º–∏—Ä—É—Å¬ª –ê–Ω–Ω—ã –ó–∞–ª–æ–≥–∏–Ω–æ–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-08-25T15:59:58+00:00,@bezrec,6467,https://t.me/bezrec/6467,"–í –°–®–ê –º–æ–≥—É—Ç ¬´–≤ –±–ª–∏–∂–∞–π—à–∏–µ –º–µ—Å—è—Ü—ã¬ª –æ—Ç–æ–∑–≤–∞—Ç—å –º–†–ù–ö-–≤–∞–∫—Ü–∏–Ω—ã –æ—Ç COVID-19. –ü–æ –∫—Ä–∞–π–Ω–µ–π –º–µ—Ä–µ, —Ç–∞–∫ –ø–∏—à–µ—Ç Daily Beast —Å–æ —Å—Å—ã–ª–∫–æ–π –Ω–∞ –æ–¥–Ω–æ–≥–æ –∏–∑ –±–ª–∏–∂–∞–π—à–∏—Ö —Å–æ—Ä–∞—Ç–Ω–∏–∫–æ–≤ –†–æ–±–µ—Ä—Ç–∞ –§. –ö–µ–Ω–Ω–µ–¥–∏-–º–ª–∞–¥—à–µ–≥–æ. –î–æ–∫—Ç–æ—Ä –ê—Å–∏–º –ú–∞–ª—Ö–æ—Ç—Ä–∞, –∫–∞—Ä–¥–∏–æ–ª–æ–≥ –∏ –≤–µ–¥—É—â–∏–π —Å–æ–≤–µ—Ç–Ω–∏–∫ –≥—Ä—É–ø–ø—ã Make America Healthy Again (MAHA) –Ω–µ–æ–¥–Ω–æ–∫—Ä–∞—Ç–Ω–æ –∑–∞—è–≤–ª—è–≤—à–∏–π, —á—Ç–æ –≤–∞–∫—Ü–∏–Ω—ã –æ–ø–∞—Å–Ω–µ–µ –≤–∏—Ä—É—Å–∞, —Ä–∞—Å—Å–∫–∞–∑–∞–ª, —á—Ç–æ –Ω–µ–ª—é–±–æ–≤—å –ö–µ–Ω–Ω–µ–¥–∏ –∫ –º–†–ù–ö-–≤–∞–∫—Ü–∏–Ω–∞–º —Ä–∞–∑–¥–µ–ª—è—é—Ç ¬´–≤–ª–∏—è—Ç–µ–ª—å–Ω—ã–µ¬ª —á–ª–µ–Ω—ã —Å–µ–º—å–∏ –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç–∞ –î–æ–Ω–∞–ª—å–¥–∞ –¢—Ä–∞–º–ø–∞. –ü–æ —Å–ª–æ–≤–∞–º –ú–∞–ª—Ö–æ—Ç—Ä–∞, –º–Ω–æ–≥–∏–µ –∏–∑ –æ–∫—Ä—É–∂–µ–Ω–∏—è –ö–µ–Ω–Ω–µ–¥–∏-–º–ª–∞–¥—à–µ–≥–æ ¬´–Ω–µ –ø–æ–Ω–∏–º–∞—é—Ç¬ª, –ø–æ—á–µ–º—É –≤–∞–∫—Ü–∏–Ω—É –¥–æ —Å–∏—Ö –ø–æ—Ä –Ω–∞–∑–Ω–∞—á–∞—é—Ç. –¢–∞–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, —è–∫–æ–±—ã, –±—É–¥—É—Ç –∏–∑—ä—è—Ç—ã —Å –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–≥–æ —Ä—ã–Ω–∫–∞, –¥–∞–∂–µ –µ—Å–ª–∏ —ç—Ç–æ –ø–æ–≤–ª–µ—á—ë—Ç –∑–∞ —Å–æ–±–æ–π —Å–µ—Ä—å–µ–∑–Ω—ã–µ —é—Ä–∏–¥–∏—á–µ—Å–∫–∏–µ –ø–æ—Å–ª–µ–¥—Å—Ç–≤–∏—è. –ö–∞—Ä–¥–∏–æ–ª–æ–≥ –ø–æ—è—Å–Ω–∏–ª, —á—Ç–æ –ö–µ–Ω–Ω–µ–¥–∏ –∏ –∫–æ –Ω–µ–≤–∑–ª—é–±–∏–ª–∏ –º–†–ù–ö-–≤–∞–∫—Ü–∏–Ω—ã –æ—Ç Pfizer –∏ Moderna –ø–æ—Å–ª–µ —Å—Ç–∞—Ç—å–∏ 2022 –≥–æ–¥–∞, –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω–Ω–æ–π –≤ –∂—É—Ä–Ω–∞–ª–µ Vaccine. –í –Ω–µ–π —É—Ç–≤–µ—Ä–∂–¥–∞–ª–æ—Å—å, —á—Ç–æ —É –≤–∞–∫—Ü–∏–Ω–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Ä–∏—Å–∫ ¬´—á—Ä–µ–∑–º–µ—Ä–Ω–æ —Å–µ—Ä—å—ë–∑–Ω—ã—Ö –ø–æ–±–æ—á–Ω—ã—Ö —ç—Ñ—Ñ–µ–∫—Ç–æ–≤¬ª –±—ã–ª –Ω–∞ 16% –≤—ã—à–µ, —á–µ–º –≤ –≥—Ä—É–ø–ø–µ –ø–ª–∞—Ü–µ–±–æ. –ú–µ–∂–¥—É —Ç–µ–º, –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–∞—è —á–∞—Å—Ç—å –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ —Å–æ–æ–±—â–µ—Å—Ç–≤–∞ —Å–∫–µ–ø—Ç–∏—á–µ—Å–∫–∏ –æ—Ç–Ω–µ—Å–ª–∞—Å—å –∫ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—é, –∑–∞—è–≤–∏–≤, —á—Ç–æ –æ–Ω–æ –Ω–µ–¥–æ–æ—Ü–µ–Ω–∏–≤–∞–µ—Ç –ø–æ–ª—å–∑—É –≤–∞–∫—Ü–∏–Ω –∏ –ø—Ä–µ—É–≤–µ–ª–∏—á–∏–≤–∞–µ—Ç —Ä–∏—Å–∫–∏ –∏–∑-–∑–∞ –º–µ—Ç–æ–¥–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –Ω–µ–¥–æ—Å—Ç–∞—Ç–∫–æ–≤, –ø—Ä–µ–¥–≤–∑—è—Ç–æ–≥–æ –æ—Ç–±–æ—Ä–∞ –¥–∞–Ω–Ω—ã—Ö –∏ –∏–≥–Ω–æ—Ä–∏—Ä–æ–≤–∞–Ω–∏—è –±–æ–ª–µ–µ —à–∏—Ä–æ–∫–∏—Ö –ø–æ—Å–ª–µ–¥—Å—Ç–≤–∏–π –¥–ª—è –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –° –ö–µ–Ω–Ω–µ–¥–∏-–º–ª–∞–¥—à–∏–º, –∏–∑–≤–µ—Å—Ç–Ω—ã–º —Å–≤–æ–∏–º–∏ –∞–Ω—Ç–∏–ø—Ä–∏–≤–∏–≤–æ—á–Ω—ã–º–∏ –≤—ã—Å–∫–∞–∑—ã–≤–∞–Ω–∏—è–º–∏, –ú–∞–ª—Ö–æ—Ç—Ä–∞ –ø–æ–¥—Ä—É–∂–∏–ª—Å—è –ø–æ—Å–ª–µ –ø—É–±–ª–∏–∫–∞—Ü–∏–∏ –≤ Journal of Insulin Resistance —Å—Ç–∞—Ç—å–∏, –Ω–∞–∑–≤–∞–Ω–Ω–æ–π ¬´–¥–µ–∑–∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–µ–π –æ –≤–∞–∫—Ü–∏–Ω–µ –º–†–ù–ö –æ—Ç COVID¬ª, –∏ –ø–æ—Å–ª–µ–¥—É—é—â–µ–≥–æ —Ç–µ–ª–µ–≤–∏–∑–∏–æ–Ω–Ω–æ–≥–æ –∏–Ω—Ç–µ—Ä–≤—å—é. –í —Å–µ–Ω—Ç—è–±—Ä–µ –æ–Ω —Å–æ–±–∏—Ä–∞–µ—Ç—Å—è –≤—Å—Ç—Ä–µ—Ç–∏—Ç—å—Å—è —Å –¢—Ä–∞–º–ø–æ–º, —á—Ç–æ–±—ã –æ–∑–≤—É—á–∏—Ç—å —Å–≤–æ—é –ø–æ–∑–∏—Ü–∏—é –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ –º–†–ù–ö-–≤–∞–∫—Ü–∏–Ω. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-08-25T13:29:58+00:00,@bezrec,6466,https://t.me/bezrec/6466,"¬´–ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞¬ª –∏ –ò–î –ù–û–ú —Å—Ç–∞–ª–∏ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω—ã–º –ø–∞—Ä—Ç–Ω–µ—Ä–æ–º –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–æ–≥–æ —Ñ–æ—Ä—É–º–∞ –ë–ò–û–ü–†–û–ú-2025. –û–¥–Ω–æ –∏–∑ —Å–∞–º—ã—Ö –∑–Ω–∞—á–∏–º—ã—Ö –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–π –¥–ª—è –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª–æ–≤ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ –ø—Ä–∏ –ø–æ–¥–¥–µ—Ä–∂–∫–µ –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–∞ –ø—Ä–æ–π–¥—ë—Ç —Å 6 –ø–æ 7 –æ–∫—Ç—è–±—Ä—è –≤ –ì–µ–ª–µ–Ω–¥–∂–∏–∫–µ –≤ –∫—É–ª—å—Ç—É—Ä–Ω–æ-–¥–µ–ª–æ–≤–æ–º —Ü–µ–Ω—Ç—Ä–µ ¬´–ì–µ–ª–µ–Ω–¥–∂–∏–∫-–ê—Ä–µ–Ω–∞¬ª. –§–æ—Ä—É–º –ø—Ä–æ–≤–æ–¥–∏—Ç—Å—è –≤–æ –≤—Ç–æ—Ä–æ–π —Ä–∞–∑ –∏ —É–∂–µ —Å—Ç–∞–ª –∫–ª—é—á–µ–≤–æ–π –ø–ª–æ—â–∞–¥–∫–æ–π –¥–ª—è –º–µ–∂–æ—Ç—Ä–∞—Å–ª–µ–≤–æ–≥–æ –¥–∏–∞–ª–æ–≥–∞ –≤ —Å—Ñ–µ—Ä–µ –≤—ã—Å–æ–∫–∏—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –¥–ª—è –∂–∏–∑–Ω–∏ —á–µ–ª–æ–≤–µ–∫–∞ –∏ –±–∏–æ–∏–Ω–¥—É—Å—Ç—Ä–∏–∏. –§–æ—Ä—É–º –æ—Ç–∫—Ä–æ–µ—Ç—Å—è –±–∏–∑–Ω–µ—Å-–∑–∞–≤—Ç—Ä–∞–∫–æ–º —Å –º–∏–Ω–∏—Å—Ç—Ä–æ–º –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏ –∏ —Ç–æ—Ä–≥–æ–≤–ª–∏ –ê–Ω—Ç–æ–Ω–æ–º –ê–ª–∏—Ö–∞–Ω–æ–≤—ã–º. –¢–∞–∫–∂–µ –≤ –ø—Ä–æ–≥—Ä–∞–º–º–µ: —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏–µ —Å–µ—Å—Å–∏–∏, —ç–∫—Å–ø–µ—Ä—Ç–Ω—ã–µ —Å–æ–≤–µ—Ç—ã –∏ –æ—Ç—Ä–∞—Å–ª–µ–≤—ã–µ —Ç—Ä–µ–∫–∏. –ì–ª–∞–≤–Ω–∞—è —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∞—è —Å–µ—Å—Å–∏—è ¬´–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ –¥–ª—è –∂–∏–∑–Ω–∏¬ª –ø—Ä–æ–π–¥—ë—Ç —Å —É—á–∞—Å—Ç–∏–µ–º –ø–µ—Ä–≤–æ–≥–æ –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—è –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—è –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –î–µ–Ω–∏—Å–∞ –ú–∞–Ω—Ç—É—Ä–æ–≤–∞, –≥–ª–∞–≤—ã –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–∞ –ê–Ω—Ç–æ–Ω–∞ –ê–ª–∏—Ö–∞–Ω–æ–≤–∞, –º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ú–∏—Ö–∞–∏–ª–∞ –ú—É—Ä–∞—à–∫–æ. –û—Å–Ω–æ–≤–Ω—ã–µ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è —Ñ–æ—Ä—É–º–∞: üü© –ë–ò–û–¢–ï–•–ú–ï–î ‚Äì –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ –≤ –º–µ–¥–∏—Ü–∏–Ω–µ –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–µ; üü© –ò–ù–ù–û–§–£–î ‚Äì –ø–µ—Ä–µ–¥–æ–≤—ã–µ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –≤ –ø–∏—â–µ–≤–æ–π –∏–Ω–¥—É—Å—Ç—Ä–∏–∏ –∏ –∞–≥—Ä–æ–±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—è—Ö; üü© –ö–û–°–ú–ï–¢–ò–ö –ö–û–ú–ü–û–ù–ï–ù–¢ ‚Äì –Ω–æ–≤–µ–π—à–∏–µ —Ä–µ—à–µ–Ω–∏—è –≤ –∫–æ—Å–º–µ—Ç–∏–∫–µ –∏ –ø–∞—Ä—Ñ—é–º–µ—Ä–∏–∏; üü© –≠–ö–û–ë–ò–û ‚Äì —É—Å—Ç–æ–π—á–∏–≤—ã–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ –∏ ¬´–∑–µ–ª–µ–Ω–∞—è¬ª –ø–µ—Ä–µ—Ä–∞–±–æ—Ç–∫–∞ –æ—Ç—Ö–æ–¥–æ–≤. –í –ø–æ–≤–µ—Å—Ç–∫–µ ‚Äì –æ—Ç –º–∏–∫—Ä–æ–±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π –ø–µ—Ä–µ—Ä–∞–±–æ—Ç–∫–∏ –≥–∞–∑–∞ –¥–æ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ –≤–∏–Ω–æ–¥–µ–ª–∏—è. –û—Å–æ–±–æ–µ –≤–Ω–∏–º–∞–Ω–∏–µ –±—É–¥–µ—Ç —É–¥–µ–ª–µ–Ω–æ –º–∞–ª—ã–º –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏—è–º –∏ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–º —Å—Ç–∞—Ä—Ç–∞–ø–∞–º, –¥–ª—è –∫–æ—Ç–æ—Ä—ã—Ö –ë–ò–û–ü–†–û–ú —Å—Ç–∞–Ω–æ–≤–∏—Ç—Å—è —Ç–æ—á–∫–æ–π –≤—Ö–æ–¥–∞ –∫ –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω—ã–º –∏–Ω–≤–µ—Å—Ç–æ—Ä–∞–º –∏ –∑–∞–∫–∞–∑—á–∏–∫–∞–º. –†–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –Ω–∞ –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω–æ–º —Å–∞–π—Ç–µ: https://biopromforum.ru/registration/ ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-08-25T11:49:58+00:00,@bezrec,6465,https://t.me/bezrec/6465,"–ò–º–ø–æ—Ä—Ç–æ–∑–∞–º–µ—â–µ–Ω–∏–µ –ü–û –≤ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–µ ‚Äî –í–°–Å –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ –ø—Ä–∏–Ω—è–ª —Ä–µ—à–µ–Ω–∏–µ –æ–±—ä–µ–¥–∏–Ω–∏—Ç—å –ò–Ω–¥—É—Å—Ç—Ä–∏–∞–ª—å–Ω—ã–π —Ü–µ–Ω—Ç—Ä –∫–æ–º–ø–µ—Ç–µ–Ω—Ü–∏–π (–ò–¶–ö) ¬´–§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∞—è –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç—å¬ª —Å –ò–¶–ö ¬´–•–∏–º–∏—è¬ª. –û–± —ç—Ç–æ–º —Å–æ–æ–±—â–∏–ª —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å –æ–±—ä–µ–¥–∏–Ω—ë–Ω–Ω–æ–≥–æ —Ü–µ–Ω—Ç—Ä–∞ –ö–∏—Ä–∏–ª–ª –ö–∏—Ä–µ–µ–≤ –Ω–∞ –¥–µ–º–æ-–¥–Ω–µ. –ß—Ç–æ —ç—Ç–æ –æ–∑–Ω–∞—á–∞–µ—Ç? –ê —Ç–æ, —á—Ç–æ –¥–∞–Ω–Ω–æ–µ —Ä–µ—à–µ–Ω–∏–µ —Å—Ç–∞–≤–∏—Ç –ø–æ–¥ –≤–æ–ø—Ä–æ—Å —Å—Ç–∞—Ç—É—Å —Ä–∞–Ω–µ–µ –æ—Ç–æ–±—Ä–∞–Ω–Ω—ã—Ö –ø—Ä–æ–µ–∫—Ç–æ–≤ –ø–æ –∏–º–ø–æ—Ä—Ç–æ–∑–∞–º–µ—â–µ–Ω–∏—é –ü–û –≤ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –æ—Ç—Ä–∞—Å–ª–∏, –∫–æ—Ç–æ—Ä—ã–µ –ø–æ–ª—É—á–∏–ª–∏ —Å—Ç–∞—Ç—É—Å ¬´–æ—Å–æ–±–æ –∑–Ω–∞—á–∏–º—ã—Ö –ø—Ä–æ–µ–∫—Ç–æ–≤¬ª (–û–ó–ü). –¢–µ–ø–µ—Ä—å —ç—Ç–∏ –ø—Ä–æ–µ–∫—Ç—ã, –∫–æ—Ç–æ—Ä—ã–µ –¥–æ–ª–∂–Ω—ã –±—ã–ª–∏ —Ä–µ–∞–ª–∏–∑–æ–≤—ã–≤–∞—Ç—å –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç¬ª –∏ ¬´–†-–§–∞—Ä–º¬ª, –º–æ–≥—É—Ç —Å—Ç–∞—Ç—É—Å–∞ –û–ó–ü –ª–∏—à–∏—Ç—å—Å—è. –ü–æ –º–Ω–µ–Ω–∏—é –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–µ–π –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–∞, –Ω–∞ —Ä—ã–Ω–∫–µ —É–∂–µ –µ—Å—Ç—å –¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ –∑—Ä–µ–ª—ã–µ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–µ —Ä–µ—à–µ–Ω–∏—è, –ø–æ—ç—Ç–æ–º—É –∫–æ–º–∏—Å—Å–∏—è –¥–æ–ª–∂–Ω–∞ —Ä–µ—à–∏—Ç—å, —Å—Ç–æ–∏—Ç –ª–∏ –ø—Ä–æ–¥–æ–ª–∂–∞—Ç—å —Å—á–∏—Ç–∞—Ç—å —ç—Ç–∏ –ø—Ä–æ–µ–∫—Ç—ã –æ—Å–æ–±–æ –∑–Ω–∞—á–∏–º—ã–º–∏. –ù–∞ –¥–∞–Ω–Ω—ã–π –º–æ–º–µ–Ω—Ç —Å—Ç–∞—Ç—É—Å –û–ó–ü –æ—Ç —Ñ–∞—Ä–º—ã –∏–º–µ—é—Ç —Å–ª–µ–¥—É—é—â–∏–µ –ø—Ä–æ–µ–∫—Ç—ã —Å–æ—Ñ—Ç–∞: ‚ö´Ô∏è –£–ø—Ä–∞–≤–ª–µ–Ω–∏–µ –∂–∏–∑–Ω–µ–Ω–Ω—ã–º —Ü–∏–∫–ª–æ–º –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ‚Äî –ø—Ä–æ–µ–∫—Ç –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ú–∏–≥ –î–∏–¥–∂–∏—Ç–∞–ª¬ª, –¥–æ—á–µ—Ä–Ω–µ–π —Å—Ç—Ä—É–∫—Ç—É—Ä—ã ¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç–∞¬ª. ‚ö´Ô∏è –°–∏—Å—Ç–µ–º–∞ —ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω–æ–≥–æ –¥–æ—Å—å–µ –Ω–∞ —Å–µ—Ä–∏—é ‚Äî —Å—Ä–µ–¥—Å—Ç–≤–æ –∞–≤—Ç–æ–º–∞—Ç–∏–∑–∞—Ü–∏–∏ –æ—Ç ¬´–†-–§–∞—Ä–º¬ª. ‚ö´Ô∏è –°–∏—Å—Ç–µ–º–∞ SCADA –¥–ª—è –∫–æ–Ω—Ç—Ä–æ–ª—è –∑–∞ —Ç–µ—Ö–ø—Ä–æ—Ü–µ—Å—Å–æ–º ‚Äî —Ç–∞–∫–∂–µ –æ—Ç ¬´–†-–§–∞—Ä–º¬ªüìå ‚Ñ¢Ô∏è –°–æ—Ñ—Ç–¢–µ—Ö","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""import_export, sanctions"",
  ""impact"": ""medium"",
  ""english"": ""The decision by the Ministry of Industry and Trade to merge the Industrial Center of Competencies (ICC) 'Pharmaceutical Industry' with the ICC 'Chemistry' raises concerns about the status of previously approved projects for software development in the pharmaceutical sector under 'Special Important Projects' (SIP). These projects, previously managed by companies 'FarmaStandard' and 'R-Farm', may lose their SIP status. The Ministry claims that the market already has mature domestic solutions, and thus the commission must decide whether to continue considering these projects as special important. Currently, SIP status is held by the following software projects: - Life cycle management system for pharmaceutical products (project of 'Mig Digital', a subsidiary of 'FarmaStandard') - Electronic dossier system for pharmaceutical series (solution from 'R-Farm') - SCADA system for process control (also from 'R-Farm')""
}"
2025-08-25T09:14:58+00:00,@bezrec,6464,https://t.me/bezrec/6464,"–ú–æ—Å–∫–≤–∞ –Ω–∞—Ä–∞—â–∏–≤–∞–µ—Ç –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –ª–µ–∫–∞—Ä—Å—Ç–≤. –ó–∞–º–º—ç—Ä–∞ –ú–æ—Å–∫–≤—ã –ø–æ –≤–æ–ø—Ä–æ—Å–∞–º —Ç—Ä–∞–Ω—Å–ø–æ—Ä—Ç–∞ –∏ –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏ –ú–∞–∫—Å–∏–º –õ–∏–∫—Å—É—Ç–æ–≤ —Ä–∞—Å—Å–∫–∞–∑–∞–ª, –≤ —á—ë–º –ø—Ä–µ—É—Å–ø–µ–ª–∏ —Å—Ç–æ–ª–∏—á–Ω—ã–µ —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –≤ –ø–µ—Ä–≤–æ–º –ø–æ–ª—É–≥–æ–¥–∏–∏ 2025 –≥–æ–¥–∞. –ü–æ —Å–ª–æ–≤–∞–º —á–∏–Ω–æ–≤–Ω–∏–∫–∞, —Å —è–Ω–≤–∞—Ä—è –ø–æ –∏—é–Ω—å –±–ª–∞–≥–æ–¥–∞—Ä—è –ø–æ–¥–¥–µ—Ä–∂–∫–µ –≥–æ—Ä–æ–¥–∞ –º–æ—Å–∫–æ–≤—Å–∫–∏–µ –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏—è —É–≤–µ–ª–∏—á–∏–ª–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –ª–µ–∫–∞—Ä—Å—Ç–≤ –Ω–∞ 7,2% –≥–æ–¥ –∫ –≥–æ–¥—É. –í —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, –≤—ã–ø—É—Å—Ç–∏–ª–∏ –ø–æ—Ä—è–¥–∫–∞ 2,6 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ –ø—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –∏–º–º—É–Ω–æ–º–æ–¥—É–ª—è—Ç–æ—Ä–æ–≤ (–∏—Ö –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ —É–≤–µ–ª–∏—á–∏–ª–æ—Å—å –≤ 1,6 —Ä–∞–∑–∞), –∞ —Ç–∞–∫–∂–µ 2,6 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –æ—Ä–≥–∞–Ω–æ–≤ –¥—ã—Ö–∞—Ç–µ–ª—å–Ω–æ–π —Å–∏—Å—Ç–µ–º—ã (–ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –≤—ã—Ä–æ—Å–ª–æ –Ω–∞ 25,9%). –°–µ–≥–æ–¥–Ω—è –±–æ–ª–µ–µ 300 –∫–æ–º–ø–∞–Ω–∏–π –ú–æ—Å–∫–≤—ã –æ–±–µ—Å–ø–µ—á–∏–≤–∞—é—Ç –∂–∏—Ç–µ–ª–µ–π —Å—Ç—Ä–∞–Ω—ã –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏ –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º–∏ –∏–∑–¥–µ–ª–∏—è–º–∏. –° —è–Ω–≤–∞—Ä—è –ø–æ –∏—é–Ω—å —ç—Ç–æ–≥–æ –≥–æ–¥–∞ –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏—è –≤—ã–ø—É—Å—Ç–∏–ª–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ 37,1 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, ‚Äì –ø–æ–¥–µ–ª–∏–ª—Å—è —Ü–∏—Ñ—Ä–∞–º–∏ –≥–ª–∞–≤–∞ –î–ò–ü–ü –ú–æ—Å–∫–≤—ã –ê–Ω–∞—Ç–æ–ª–∏–π –ì–∞—Ä–±—É–∑–æ–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""production, shortage"",
  ""impact"": ""medium"",
  ""english"": ""Moscow's pharmaceutical companies increased production by 7.2% year-over-year from January to June 2025, according to city officials. They produced over 2.6 million units of anti-cancer drugs and immunomodulators (production increased by 1.6 times) and over 2.6 million units of respiratory system treatment drugs (production increased by 25.9%). Over 300 companies in Moscow provide medicines and medical products to the country's residents. From January to June this year, companies produced over 37.1 billion rubles worth of drugs.""
}"
2025-08-25T06:00:45+00:00,@bezrec,6463,https://t.me/bezrec/6463,"–§–∞—Ä–º–∞—Ü–µ–≤—Ç–æ–≤ –±—É–¥—É—Ç —à—Ç—Ä–∞—Ñ–æ–≤–∞—Ç—å –∑–∞ –Ω–µ—Å–æ–æ–±—â–µ–Ω–∏–µ –æ –¥–µ—à—ë–≤—ã—Ö –∞–Ω–∞–ª–æ–≥–∞—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤. –° 1 —Å–µ–Ω—Ç—è–±—Ä—è –≤ –†–æ—Å—Å–∏–∏ –≤—Å—Ç—É–ø–∞—é—Ç –≤ —Å–∏–ª—É –æ–±–Ω–æ–≤–ª–µ–Ω–Ω—ã–µ –ü—Ä–∞–≤–∏–ª–∞ –Ω–∞–¥–ª–µ–∂–∞—â–µ–π –∞–ø—Ç–µ—á–Ω–æ–π –ø—Ä–∞–∫—Ç–∏–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è. –¢–∞–º –µ—Å—Ç—å –ø—É–Ω–∫—Ç, —Å–æ–≥–ª–∞—Å–Ω–æ –∫–æ—Ç–æ—Ä–æ–º—É —Ä–∞–±–æ—Ç–Ω–∏–∫–∏ –∞–ø—Ç–µ–∫–∏ ¬´–æ—Å—É—â–µ—Å—Ç–≤–ª—è—é—Ç –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª–µ–Ω–∏–µ –ø–æ–∫—É–ø–∞—Ç–µ–ª—è–º –≤ —Ç–æ–º —á–∏—Å–ª–µ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –æ –Ω–∞–ª–∏—á–∏–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –∏–º–µ—é—â–∏—Ö –±–æ–ª–µ–µ –Ω–∏–∑–∫—É—é —Ü–µ–Ω—É¬ª. –ü–æ —Å–ª–æ–≤–∞–º –¥–æ—Ü–µ–Ω—Ç–∞ –∫–∞—Ñ–µ–¥—Ä—ã –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –ø—Ä–∞–≤–∞ –ú–ì–Æ–ê –ê–ª–µ–∫—Å–µ—è –ö—É–±—ã—à–∫–∏–Ω–∞, –Ω–∞—Ä—É—à–∏–≤—à–∏–º —ç—Ç–æ –ø–æ–ª–æ–∂–µ–Ω–∏–µ –≥—Ä–æ–∑–∏—Ç —Å–æ–ª–∏–¥–Ω—ã–π —à—Ç—Ä–∞—Ñ ‚Äî –æ—Ç 100 –¥–æ 200 —Ç—ã—Å. —Ä—É–±–ª–µ–π, —Ç.–∫. ¬´–Ω–µ–∏—Å–ø–æ–ª–Ω–µ–Ω–∏–µ –ü—Ä–∞–≤–∏–ª –Ω–∞–¥–ª–µ–∂–∞—â–µ–π –∞–ø—Ç–µ—á–Ω–æ–π –ø—Ä–∞–∫—Ç–∏–∫–∏ –∏ –ü—Ä–∞–≤–∏–ª –æ—Ç–ø—É—Å–∫–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —è–≤–ª—è–µ—Ç—Å—è –≥—Ä—É–±—ã–º –Ω–∞—Ä—É—à–µ–Ω–∏–µ–º –ª–∏—Ü–µ–Ω–∑–∏–æ–Ω–Ω—ã—Ö —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π¬ª. –ù–∞–ª–∏—á–∏–µ –ø–æ–¥–æ–±–Ω–æ–≥–æ –ø–æ–ª–æ–∂–µ–Ω–∏—è –≤ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–µ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ –¥–ª—è –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è —Å–æ–±–ª—é–¥–µ–Ω–∏—è –ø—Ä–∞–≤ –≥—Ä–∞–∂–¥–∞–Ω –Ω–∞ –Ω–∞–¥–ª–µ–∂–∞—â–µ–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–µ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ –≤ —Å–ª—É—á–∞–µ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è, –≤ —Ç–æ–º —á–∏—Å–ª–µ —Å —É—á—ë—Ç–æ–º –∏—Ö –∏–º—É—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø–æ–ª–æ–∂–µ–Ω–∏—è, ‚Äî —Å—á–∏—Ç–∞–µ—Ç –ö—É–±—ã—à–∫–∏–Ω. –ì–ª–∞–≤–Ω–æ–µ ‚Äî –Ω–µ —Ä–∞—Å–ø—É–≥–∞—Ç—å —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤. –ü–æ –¥–∞–Ω–Ω—ã–º SuperJob, –∑–∞—Ä–ø–ª–∞—Ç–Ω—ã–π ¬´–ø–æ—Ç–æ–ª–æ–∫¬ª —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∞ –≤ –ú–æ—Å–∫–≤–µ ‚Äî 150 —Ç—ã—Å. —Ä—É–±–ª–µ–π. UPD. –ù–∏–∫–∞–∫–æ–≥–æ –ø—Ä–∏–Ω—Ü–∏–ø–∏–∞–ª—å–Ω–æ –Ω–æ–≤–æ–≥–æ –Ω–∞–∫–∞–∑–∞–Ω–∏—è ¬´–∑–∞ –º–æ–ª—á–∞–Ω–∏–µ¬ª –Ω–µ –≤–≤–æ–¥–∏—Ç—Å—è. –†–µ—á—å –∏–¥–µ—Ç –∏—Å–∫–ª—é—á–∏—Ç–µ–ª—å–Ω–æ –æ–± —É—Ç–æ—á–Ω–µ–Ω–∏–∏ —Ñ–æ—Ä–º—É–ª–∏—Ä–æ–≤–æ–∫ –≤ —É–∂–µ —Å—É—â–µ—Å—Ç–≤—É—é—â–∏—Ö –ø—Ä–∞–≤–∏–ª–∞—Ö. –û—Ç—Å—É—Ç—Å—Ç–≤–∏–µ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –æ –±–æ–ª–µ–µ –¥–µ—à–µ–≤–æ–º –∞–Ω–∞–ª–æ–≥–µ –Ω–∏–∫–æ–∏–º –æ–±—Ä–∞–∑–æ–º –Ω–µ –ø–æ–¥–ø–∞–¥–∞–µ—Ç –ø–æ–¥ –∫–∞—Ç–µ–≥–æ—Ä–∏—é ¬´–≥—Ä—É–±—ã—Ö¬ª –Ω–∞—Ä—É—à–µ–Ω–∏–π. –†–µ–∞–ª—å–Ω–∞—è –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç—å ‚Äî —ç—Ç–æ –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏–µ –∏–ª–∏ —à—Ç—Ä–∞—Ñ –¥–ª—è –¥–æ–ª–∂–Ω–æ—Å—Ç–Ω—ã—Ö –ª–∏—Ü –≤ —Ä–∞–∑–º–µ—Ä–µ –æ—Ç 3-5 —Ç—ã—Å. —Ä—É–±–ª–µ–π, –∞ –¥–ª—è —é—Ä–∏–¥–∏—á–µ—Å–∫–∏—Ö –ª–∏—Ü - –æ—Ç 30 –¥–æ 40 —Ç—ã—Å. —Ä—É–±–ª–µ–π, ‚Äî –ø–æ—Å–ø–µ—à–∏–ª–∞ —É—Å–ø–æ–∫–æ–∏—Ç—å –¥–∏—Ä–µ–∫—Ç–æ—Ä –°–†–û –ê—Å—Å–æ—Ü–∏–∞—Ü–∏—è –Ω–µ–∑–∞–≤–∏—Å–∏–º—ã—Ö –∞–ø—Ç–µ–∫, –≥–ª–∞–≤–∞ –ê–ª—å—è–Ω—Å–∞ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–π –í–∏–∫—Ç–æ—Ä–∏—è –ü—Ä–µ—Å–Ω—è–∫–æ–≤–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, regulation"",
  ""impact"": ""medium"",
  ""english"": ""Pharmacies will be fined for not informing customers about cheaper drug alternatives. Starting September 1, Russia's updated Rules on Good Pharmaceutical Practice for Medicinal Products include a provision requiring pharmacists to provide customers with information about cheaper drug alternatives. This could result in fines ranging from 100,000 to 200,000 rubles for non-compliance. The update clarifies existing rules and does not introduce new penalties for 'silence.'""
}"
2025-08-24T11:03:37+00:00,@bezrec,6462,https://t.me/bezrec/6462,–ñ–µ–Ω—â–∏–Ω–∞ –Ω–∞ –≤–∏–¥–µ–æ —Ä–∞–∑–±–∏—Ä–∞–µ—Ç—Å—è –≤ –∫—Ä–∏—Ç–µ—Ä–∏—è—Ö –∫–∞—á–µ—Å—Ç–≤–∞ –∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –ë–ê–î–æ–≤ –Ω–µ —Ö—É–∂–µ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞,"{""skip"": true}"
2025-08-23T11:02:59+00:00,@bezrec,6461,https://t.me/bezrec/6461,"–†–∞–¥—É–µ–º—Å—è —Å—É–±–±–æ—Ç–µ –∏ —á–∏—Ç–∞–µ–º –Ω–æ–≤—ã–π –≤—ã–ø—É—Å–∫ —Ä—É–±—Ä–∏–∫–∏ #–≤–¥–æ–≥–æ–Ω–∫—É. üíä –í –†–æ—Å—Å–∏–∏ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª–∏ –ø–µ—Ä–≤—ã–π –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π –±–∏–æ–∞–Ω–∞–ª–æ–≥ –¥–∞—Ä–∞—Ç—É–º—É–º–∞–±–∞. –ü—Ä–µ–ø–∞—Ä–∞—Ç –ø—Ä–∏–º–µ–Ω—è–µ—Ç—Å—è –≤ —Ç–µ—Ä–∞–ø–∏–∏ –º–Ω–æ–∂–µ—Å—Ç–≤–µ–Ω–Ω–æ–π –º–∏–µ–ª–æ–º—ã –∏ –æ—Ç–Ω–æ—Å–∏—Ç—Å—è –∫ –∫–ª–∞—Å—Å—É –º–æ–Ω–æ–∫–ª–æ–Ω–∞–ª—å–Ω—ã—Ö –∞–Ω—Ç–∏—Ç–µ–ª - —Ç–∞—Ä–≥–µ—Ç–Ω—ã—Ö –º–æ–ª–µ–∫—É–ª, —Å–ø–æ—Å–æ–±–Ω—ã—Ö –ø—Ä–∏—Ü–µ–ª—å–Ω–æ —Ä–∞—Å–ø–æ–∑–Ω–∞–≤–∞—Ç—å –∏ –∞—Ç–∞–∫–æ–≤–∞—Ç—å –æ–ø—É—Ö–æ–ª–µ–≤—ã–µ –∫–ª–µ—Ç–∫–∏. –î–∞—Ä–∞—Ç—É–º–∏–∞ –æ—Ç ¬´–ë–∏–æ–∫–∞–¥–∞¬ª —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω –∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç—Å—è –≤ –†–æ—Å—Å–∏–∏ –ø–æ –ø–æ–ª–Ω–æ–º—É —Ü–∏–∫–ª—É. üíä –§–ê–° ¬´–ø–µ—Ä–µ–≤–æ—Å–ø–∏—Ç–∞–ª–∞¬ª —Ä–æ—Å—Å–∏–π—Å–∫—É—é ¬´–¥–æ—á–∫—É¬ª —à–≤–µ–π—Ü–∞—Ä—Å–∫–æ–π Swixx BioPharma. –í –∫–æ–º–º–µ—Ä—á–µ—Å–∫–æ–π –ø–æ–ª–∏—Ç–∏–∫–µ ¬´–°–≤–∏–∫—Å –•—ç–ª—Å–∫–µ–∞¬ª —Å–æ–¥–µ—Ä–∂–∞–ª–∏—Å—å —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–∏ –∏ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏ –Ω–µ–æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω—ã–µ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ –≤—ã—Ä—É—á–∫–µ –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω–æ–≥–æ –¥–µ–ª–æ–≤–æ–≥–æ –ø–∞—Ä—Ç–Ω–µ—Ä–∞ (¬´–§–∞—Ä–º-–¢—Ä—ç–π–¥¬ª) –∏ –µ–≥–æ –æ–ø—ã—Ç—É —É—á–∞—Å—Ç–∏—è –≤ –≥–æ—Å–∑–∞–∫—É–ø–∫–∞—Ö. –û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è —Å–æ–æ–±—â–∏–ª–∞ –æ–± –∏—Å–ø–æ–ª–Ω–µ–Ω–∏–∏ –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏—è. üíä –í –†–æ—Å—Å–∏–∏ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–∞ –ø–µ—Ä–≤–∞—è –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–∞—è —Ç–µ—Å—Ç-—Å–∏—Å—Ç–µ–º–∞ –¥–ª—è –ø–µ—Ä—Å–æ–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω–æ–≥–æ –ø–æ–¥–±–æ—Ä–∞ —Ç–∞—Ä–≥–µ—Ç–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –ø—Ä–∏ —Ä–∞–∫–µ –º–æ–ª–æ—á–Ω–æ–π –∂–µ–ª–µ–∑—ã. –ì–µ–Ω–µ—Ç–∏—á–µ—Å–∫–∏–π —Ç–µ—Å—Ç ¬´–¢–∞—Ä–≥–µ—Ç –†–ú–ñ¬ª, —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–Ω—ã–π –≤ –°–µ—á–µ–Ω–æ–≤—Å–∫–æ–º —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–µ, –æ–¥–Ω–æ–≤—Ä–µ–º–µ–Ω–Ω–æ –≤—ã—è–≤–ª—è–µ—Ç –º—É—Ç–∞—Ü–∏–∏ –≤ –≥–µ–Ω–∞—Ö, –ø—Ä–æ–≤–æ—Ü–∏—Ä—É—é—â–∏–µ –Ω–∞—Å–ª–µ–¥—Å—Ç–≤–µ–Ω–Ω—ã–π –†–ú–ñ, –∏ –æ–ø—Ä–µ–¥–µ–ª—è–µ—Ç —á—É–≤—Å—Ç–≤–∏—Ç–µ–ª—å–Ω–æ—Å—Ç—å –æ–ø—É—Ö–æ–ª–∏ –∫ —Ç–∞—Ä–≥–µ—Ç–Ω—ã–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º. üíä ¬´–°–ø—Ä–∞–≤–µ–¥–ª–∏–≤–∞—è –†–æ—Å—Å–∏—è¬ª –ø—Ä–∏–∑—ã–≤–∞–µ—Ç –ú–∏–Ω–∑–¥—Ä–∞–≤ —Ä–µ—à–∏—Ç—å –ø—Ä–æ–±–ª–µ–º—É —Å –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ–º –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏ –≥—Ä–∞–∂–¥–∞–Ω —Å —Ç—è–∂—ë–ª–æ–π —Ñ–æ—Ä–º–æ–π –∞–ª–ª–µ—Ä–≥–∏–∏. –ü–æ —Å–ª–æ–≤–∞–º –ª–∏–¥–µ—Ä–∞ –ø–∞—Ä—Ç–∏–∏ –°–µ—Ä–≥–µ—è –ú–∏—Ä–æ–Ω–æ–≤–∞, –∞–ª–ª–µ—Ä–≥–∏–∫–∏ –Ω–µ –º–æ–≥—É—Ç –ø—Ä–∏–æ–±—Ä–µ—Å—Ç–∏ –≤ –†–æ—Å—Å–∏–∏ —à–ø—Ä–∏—Ü-—Ç—é–±–∏–∫ —Å —ç–ø–∏–Ω–µ—Ñ—Ä–∏–Ω–æ–º (–∞–¥—Ä–µ–Ω–∞–ª–∏–Ω–æ–º) –¥–∞–∂–µ –ø–æ —Ä–µ—Ü–µ–ø—Ç—É –∏ –≤—ã–Ω—É–∂–¥–µ–Ω—ã –ø–æ–∫—É–ø–∞—Ç—å –∂–∏–∑–Ω–µ–Ω–Ω–æ –≤–∞–∂–Ω–æ–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–æ –∑–∞ —Ä—É–±–µ–∂–æ–º, —á—Ç–æ –º–Ω–æ–≥–∏–º –Ω–µ –ø–æ –∫–∞—Ä–º–∞–Ω—É. üíä –ö—É—Ä—á–∞—Ç–æ–≤—Å–∫–∏–π –∏–Ω—Å—Ç–∏—Ç—É—Ç –∏—Å–ø–æ–ª—å–∑—É–µ—Ç –ò–ò –≤ —Å–æ–∑–¥–∞–Ω–∏–∏ –≤–∞–∫—Ü–∏–Ω –ø—Ä–æ—Ç–∏–≤ –≤–∏—Ä—É—Å–∞ –¥–µ–Ω–≥–µ. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã —Ü–µ–Ω—Ç—Ä–∞ —Ä–∞–±–æ—Ç–∞—é—Ç –Ω–∞–¥ –≤–∞–∫—Ü–∏–Ω–∞–º–∏ –ø—Ä–æ—Ç–∏–≤ –∫–æ—Ä–æ–Ω–∞–≤–∏—Ä—É—Å–∞, –±–æ–ª–µ–∑–Ω–∏ –õ–∞–π–º–∞ –∏ –∞—Ñ—Ä–∏–∫–∞–Ω—Å–∫–æ–π —á—É–º—ã —Å–≤–∏–Ω–µ–π, –∏—Å–ø–æ–ª—å–∑—É—è —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–∞ –¥–ª—è —Ä–∞—Å—á–µ—Ç–∞ –∏—Ö —Å—Ç—Ä—É–∫—Ç—É—Ä. üíä ¬´–ò–Ω—Ñ–∞—Ä–º–∞¬ª –æ–ø–∞—Å–∞–µ—Ç—Å—è –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã—Ö –∞–ø—Ç–µ–∫. –ê–ø—Ç–µ—á–Ω–æ–µ –∏–∑–≥–æ—Ç–æ–≤–ª–µ–Ω–∏–µ –Ω–µ –º–æ–∂–µ—Ç –∑–∞–º–µ–Ω–∏—Ç—å –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã: –æ–Ω–∏ –Ω–µ –ø—Ä–æ—Ö–æ–¥—è—Ç –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π, –Ω–µ –æ—Ü–µ–Ω–∏–≤–∞—é—Ç—Å—è –ø–æ –∫—Ä–∏—Ç–µ—Ä–∏—è–º ¬´–∫–∞—á–µ—Å—Ç–≤–æ ‚Äî –ø–æ–ª—å–∑–∞ ‚Äî —Ä–∏—Å–∫¬ª, —á—Ç–æ —Å–æ–∑–¥–∞–µ—Ç –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–µ —Ä–∏—Å–∫–∏ –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, ‚Äî –≥–æ–≤–æ—Ä–∏—Ç—Å—è –≤ –æ–±—Ä–∞—â–µ–Ω–∏–∏ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –≤ –∞–¥—Ä–µ—Å –ì–æ—Å–¥—É–º—ã. –ü—Ä–∏ —ç—Ç–æ–º –ê—Å—Å–æ—Ü–∏–∞—Ü–∏—è –ø–æ–¥–¥–µ—Ä–∂–∏–≤–∞–µ—Ç –≤–æ–∑—Ä–æ–∂–¥–µ–Ω–∏–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã—Ö –∞–ø—Ç–µ–∫ –¥–ª—è —Ä–µ—à–µ–Ω–∏—è —Ç–æ—á–µ—á–Ω—ã—Ö –∑–∞–¥–∞—á –ø—Ä–∏ —Å–æ—Ö—Ä–∞–Ω–µ–Ω–∏–∏ —Ç–µ–∫—É—â–∏—Ö –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏–π –¥–ª—è –∞–ø—Ç–µ—á–Ω–æ–≥–æ –∏–∑–≥–æ—Ç–æ–≤–ª–µ–Ω–∏—è –∏ –∑–∞–∫—Ä–µ–ø–ª–µ–Ω–∏–∏ –≤ –∑–∞–∫–æ–Ω–µ –ø–æ–Ω—è—Ç–∏—è ¬´—Ä–∞–∑–æ–≤–æ—Å—Ç–∏¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, shortage, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The Russian regulatory authorities have approved the first domestically produced biologic analog of daratumumab. The drug is used in multiple myeloma therapy and belongs to the target molecule class that can specifically recognize and attack tumor cells. The FAS (Federal Agency for Standardization) has 're-educated' Russia's subsidiary of Swiss Swixx BioPharma. The company was criticized for having economically and technologically unjustified requirements in its commercial policy, including the revenue of potential business partner (Farma-Trade) and their experience in state procurement. The organization has now fulfilled the warning.""
}"
2025-08-22T14:30:01+00:00,@bezrec,6460,https://t.me/bezrec/6460,"–ü–∏–∞—Ä—â–∏–∫—É ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º–∞¬ª —Ç–æ–∂–µ ¬´–ø—Ä–∏–ª–µ—Ç–µ–ª–æ¬ª –∑–∞ —Ä–µ–∫–ª–∞–º—É –°–µ–º–∞–≤–∏–∫–∞ –Ω–∞ ¬´–ù–æ–≤–æ–π –≤–æ–ª–Ω–µ¬ª. –£–§–ê–° –ü–æ–¥–º–æ—Å–∫–æ–≤—å—è –æ—à—Ç—Ä–∞—Ñ–æ–≤–∞–ª–æ –Ω–∞ 10 —Ç—ã—Å. —Ä—É–±–ª–µ–π —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—è –æ—Ç–¥–µ–ª–∞ –ø–æ —Å–≤—è–∑—è–º —Å –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç—å—é –∫–æ–º–ø–∞–Ω–∏–∏ –∑–∞ –Ω–∞—Ä—É—à–µ–Ω–∏–µ –∑–∞–∫–æ–Ω–∞ –æ —Ä–µ–∫–ª–∞–º–µ. –†–µ—á—å –æ —Ç–æ–º –∂–µ –∏–Ω—Ü–∏–¥–µ–Ω—Ç–µ, –∏–∑-–∑–∞ –∫–æ—Ç–æ—Ä–æ–≥–æ –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å—â–∏–∫–∏ –Ω–∞–∫–∞–∑–∞–ª–∏ –∏ —Å–∞–º ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª. –ù–∞–ø–æ–º–Ω–∏–º, –∫–æ–º–ø–∞–Ω–∏—è –ü–µ—Ç—Ä–∞ –†–æ–¥–∏–æ–Ω–æ–≤–∞ –ø—Ä–æ–≤–∏–Ω–∏–ª–∞—Å—å —Ç–µ–º, —á—Ç–æ –ø—Ä–æ—Ä–µ–∫–ª–∞–º–∏—Ä–æ–≤–∞–ª–∞ —Å–≤–æ–π —Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –≤ —Ö–æ–¥–µ –≥–∞–ª–∞-–∫–æ–Ω—Ü–µ—Ä—Ç–∞ ¬´–ù–æ–≤–∞—è –≤–æ–ª–Ω–∞ 2024¬ª –∏ –≥–∞–ª–∞-—É–∂–∏–Ω–∞ –∂—É—Ä–Ω–∞–ª–∞ ¬´Hello¬ª –≤ –û–ª–∏–º–ø–∏–π—Å–∫–æ–º –ø–∞—Ä–∫–µ –≤ –°–æ—á–∏. –î–æ–ª–∂–Ω–æ—Å—Ç–Ω—ã–º –ª–∏—Ü–æ–º, –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω—ã–º –∑–∞ –Ω–∞—Ä—É—à–µ–Ω–∏–µ –û–û–û ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª —Ä–∞—Å—Å–º–∞—Ç—Ä–∏–≤–∞–µ–º—ã—Ö —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–∞ –æ —Ä–µ–∫–ª–∞–º–µ, –ø—Ä–∏–∑–Ω–∞–ª–∏ —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—è –æ—Ç–¥–µ–ª–∞ –ø–æ —Å–≤—è–∑—è–º —Å –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç—å—é. –ó–∞ –∫–æ–º–º—É–Ω–∏–∫–∞—Ü–∏–∏ –≤ –∫–æ–º–ø–∞–Ω–∏–∏ –æ—Ç–≤–µ—á–∞–µ—Ç –ï–≤–≥–µ–Ω–∏—è –î–æ–º–æ—Ä–æ—â–µ–Ω–∫–æ–≤–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-08-22T12:10:06+00:00,@bezrec,6459,https://t.me/bezrec/6459,"–ü—Ä–∏—à–ª–∞ –ø–æ—Ä–∞ —Ä–æ—Å—Å–∏–π—Å–∫–∏–º —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞–º —Å—Ç–∞—Ç—å –≥–µ—Ä–æ—è–º–∏ –Ω–∞—à–µ–π –ø–æ—Å—Ç–æ—è–Ω–Ω–æ–π —Ä—É–±—Ä–∏–∫–∏ #–∑–∞—Ü–µ–Ω–∏–ª–∏. –ú—ã —Å—Ä–∞–≤–Ω–∏–ª–∏ —Ü–µ–Ω—ã –≤ –æ–Ω–ª–∞–π–Ω-–∞–ø—Ç–µ–∫–∞—Ö –Ω–∞ —Ç–æ—Ä–≥–æ–≤—ã–µ –º–∞—Ä–∫–∏ –°–µ–º–∞–≤–∏–∫ (¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª), –ö–≤–∏–Ω—Å–µ–Ω—Ç–∞ (¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª), –ò–Ω—Å—É–¥–∞–π–≤ (¬´–ü–°–ö –§–∞—Ä–º–∞¬ª) –∏ –°–µ–º—É–≥–ª–∏–Ω (¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑-–ù–æ—Ä–¥¬ª). –ü—Ä–æ–±–ª–µ–º —Å –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å—é —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ –æ—Ç —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –Ω–µ—Ç ‚Äî –ø–µ—Ä–µ—á–∏—Å–ª–µ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –µ—Å—Ç—å –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏ –≤–æ –≤—Å–µ—Ö –ø—Ä–æ–≤–µ—Ä–µ–Ω–Ω—ã—Ö –Ω–∞–º–∏ –∞–ø—Ç–µ–∫–∞—Ö. –ù–µ –Ω–∞—à–ª–æ—Å—å —Ç–æ–ª—å–∫–æ –ò–Ω—Å—É–¥–∞–π–≤–∞ –≤ ¬´–†–∏–≥–ª–µ¬ª. –°–∞–º—ã–º –¥–µ—à—ë–≤—ã–º –æ–∫–∞–∑–∞–ª—Å—è –°–µ–º—É–≥–ª–∏–Ω –∏–∑ ¬´–ó–¥—Ä–∞–≤—Å–∏—Ç–∏¬ª ‚Äî —Ç–∞–º –ø—Ä–µ–ø–∞—Ä–∞—Ç —Å—Ç–æ–∏—Ç 4085 —Ä—É–±–ª–µ–π. –î–æ—Ä–æ–∂–µ –≤—Å–µ–≥–æ (5 839 —Ä—É–±–ª–µ–π) –æ–±–æ–π–¥—ë—Ç—Å—è –ö–≤–∏–Ω—Å–µ–Ω—Ç–∞ –∏–∑ ¬´–†–∏–≥–ª—ã¬ª. –¢–∞–º –∂–µ –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–Ω–∞ —Å–∞–º–∞—è –≤—ã—Å–æ–∫–∞—è —Ü–µ–Ω–∞ –Ω–∞ –°–µ–º–∞–≤–∏–∫ (5 834 —Ä—É–±–ª—è). –õ—é–±–æ–ø—ã—Ç–Ω–æ, —á—Ç–æ –ò–Ω—Å—É–¥–∞–π–≤ –∏ –°–µ–º—É–≥–ª–∏–Ω –∏–∑ ¬´36,6¬ª —Å—Ç–æ—è—Ç –±–æ–ª—å—à–µ –°–µ–º–∞–≤–∏–∫–∞ –∏ –ö–≤–∏–Ω—Å–µ–Ω—Ç—ã –∏–∑ ¬´–ê–ø—Ç–µ–∫–∏.—Ä—É¬ª, —Ö–æ—Ç—è –≤ —Ü–µ–ª–æ–º –æ–Ω–∏ –∑–∞–º–µ—Ç–Ω–æ –¥–µ—à–µ–≤–ª–µ. –ù–∞–ø–æ–º–∏–Ω–∞–µ–º, —á—Ç–æ –ª—é–±—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏–º–µ—é—Ç –ø—Ä–æ—Ç–∏–≤–æ–ø–æ–∫–∞–∑–∞–Ω–∏—è. –ü–µ—Ä–µ–¥ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º –ø—Ä–æ–∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä—É–π—Ç–µ—Å—å —Å –ª–µ—á–∞—â–∏–º –≤—Ä–∞—á–æ–º. *–∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –ø—Ä–æ–≤–æ–¥–∏–ª–æ—Å—å –æ–Ω–ª–∞–π–Ω 22 –∞–≤–≥—É—Å—Ç–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage"",
  ""impact"": ""medium"",
  ""english"": ""A study comparing prices of Russian semaglutide brands (Gerosfarm's Semavik, Promomed's Quinsenta, PSK Pharma's Insudayv, and Farsintez-Nord's Semuglin) in online pharmacies. Prices are generally affordable, with the cheapest being Insudayv from '36,6' at 4085 rubles. The most expensive is Quinsenta from 'Rigle' at 5839 rubles. Semauglin from 'Zdravcity' is the cheapest at 4085 rubles. The prices are higher than those of Semauglin and Quinsenta from 'Apteky.ru' despite being cheaper overall. Note that any medication has contraindications. Consult your doctor before use.""
}"
2025-08-22T09:10:01+00:00,@bezrec,6458,https://t.me/bezrec/6458,"–í—Å–µ–≥–æ –≤ –ø—Ä–æ—à–ª–æ–º –≥–æ–¥—É –±—ã–ª–æ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–æ 127 –¥–µ–ª –æ –Ω–µ–ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª–µ–Ω–∏–∏ –ª—å–≥–æ—Ç –∏ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –≥–∞—Ä–∞–Ω—Ç–∏–π –ø—Ä–æ—Ç–∏–≤ 99 –≥–æ–¥–æ–º —Ä–∞–Ω–µ–µ. –í I –∫–≤–∞—Ä—Ç–∞–ª–µ 2025 –≥–æ–¥–∞ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–æ —É–∂–µ 36 —Ç–∞–∫–∏—Ö –¥–µ–ª. –í —Å—Ä–µ–¥–Ω–µ–º —Å—É–¥—ã —Ä–∞—Å—Å–º–∞—Ç—Ä–∏–≤–∞—é—Ç —Å–≤—ã—à–µ 10 –ø–æ–¥–æ–±–Ω—ã—Ö –∏—Å–∫–æ–≤ –≤ –º–µ—Å—è—Ü. –¢–∞–∫–∏–º–∏ —Ü–∏—Ñ—Ä–∞–º–∏ –ø–æ–¥–µ–ª–∏–ª–∞—Å—å —á–ª–µ–Ω —ç–∫—Å–ø–µ—Ä—Ç–Ω–æ–≥–æ —Å–æ–≤–µ—Ç–∞ –ø–æ –æ—Ä—Ñ–∞–Ω–Ω—ã–º –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º –ø—Ä–∏ –∫–æ–º–∏—Ç–µ—Ç–µ –ì–æ—Å–¥—É–º—ã –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è –ù–∞—Ç–∞–ª—å—è –°–º–∏—Ä–Ω–æ–≤–∞. –ö–æ—Å–≤–µ–Ω–Ω–æ ¬´–≤–∏–Ω–æ–≤–∞—Ç¬ª, –∫–∞–∫ –Ω–∏ —Å—Ç—Ä–∞–Ω–Ω–æ, ¬´–ö—Ä—É–≥ –¥–æ–±—Ä–∞¬ª. –ü–æ–¥–∞–≤–ª—è—é—â–µ–µ –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ –∏—Å—Ç—Ü–æ–≤ ‚Äî –≤–∑—Ä–æ—Å–ª—ã–µ. –î–µ—Ç–∏ —Ñ–∏–≥—É—Ä–∏—Ä—É—é—Ç –≤ ¬´–º–∏–Ω–∏–º–∞–ª—å–Ω–æ–º –∫–æ–ª–∏—á–µ—Å—Ç–≤–µ¬ª –¥–µ–ª ‚Äî –∏—Ö –æ–±–µ—Å–ø–µ—á–∏–≤–∞–µ—Ç —Ç–µ—Ä–∞–ø–∏–µ–π –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç—Å–∫–∏–π —Ñ–æ–Ω–¥, –Ω–æ —Ç–æ–ª—å–∫–æ –¥–æ 19 –ª–µ—Ç. –ó–∞—Ç–µ–º ¬´—Ä–µ–¥–∫–∏–µ¬ª –ø–∞—Ü–∏–µ–Ω—Ç—ã –¥–æ–ª–∂–Ω—ã –ø–æ–ª—É—á–∞—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –∑–∞ —Å—á—ë—Ç —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –∏ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã—Ö –±—é–¥–∂–µ—Ç–æ–≤. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, ¬´–ö—Ä—É–≥ –¥–æ–±—Ä–∞¬ª –ø–æ–º–æ–≥–∞–µ—Ç –ø–∞—Ü–∏–µ–Ω—Ç–∞–º —Å 96 –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏, —Ç–æ–≥–¥–∞ –∫–∞–∫ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–æ –ø–æ–∫—Ä—ã–≤–∞–µ—Ç —Å—Ç–æ–∏–º–æ—Å—Ç—å –ª–µ—á–µ–Ω–∏—è —Ç–æ–ª—å–∫–æ 28 –∏–∑ –Ω–∏—Ö. –ü–æ –ø–æ–¥—Å—á–µ—Ç–∞–º –°–º–∏—Ä–Ω–æ–≤–æ–π, –æ–∫–æ–ª–æ 78% –∏—Å–∫–æ–≤ —Å–≤—è–∑–∞–Ω—ã —Å –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏, –Ω–µ –≤—Ö–æ–¥—è—â–∏–º–∏ –≤ —ç—Ç–æ —á–∏—Å–ª–æ. –í —Ä–µ–≥–∏–æ–Ω–∞—Ö –µ—Å—Ç—å –µ—â—ë –æ–¥–Ω–æ –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏–µ ‚Äî —Ç–∞–º –ø—Ä–∞–≤–æ –Ω–∞ –±–µ—Å–ø–ª–∞—Ç–Ω—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏–º–µ—é—Ç —Ç–æ–ª—å–∫–æ –∏–Ω–≤–∞–ª–∏–¥—ã –ø–µ—Ä–≤–æ–π –∏–ª–∏ –≤—Ç–æ—Ä–æ–π –≥—Ä—É–ø–ø—ã. –ù–æ –±–ª–∞–≥–æ–¥–∞—Ä—è —Ö–æ—Ä–æ—à–µ–π —Ä–∞–±–æ—Ç–µ ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª –∏ –∫–∞—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –¥–æ –∏–Ω–≤–∞–ª–∏–¥–∏–∑–∞—Ü–∏–∏ –∑–∞—á–∞—Å—Ç—É—é –Ω–µ –¥–æ—Ö–æ–¥–∏—Ç. –í –∏—Ç–æ–≥–µ –≤—ã–ø—É—Å–∫–Ω–∏–∫–∏ —Ñ–æ–Ω–¥–∞ ¬´–æ–∫–∞–∑—ã–≤–∞—é—Ç—Å—è –∑–∞ –±–æ—Ä—Ç–æ–º —Å–∏—Å—Ç–µ–º—ã –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –∏ –≤—ã–Ω—É–∂–¥–µ–Ω—ã –ø—Ä–µ–∫—Ä–∞—Ç–∏—Ç—å –ª–µ—á–µ–Ω–∏–µ¬ª. –ü–æ —Å–ª–æ–≤–∞–º –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—è –ø—Ä–∞–≤–ª–µ–Ω–∏—è –í—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –æ–±—â–µ—Å—Ç–≤–∞ —Ä–µ–¥–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –ò—Ä–∏–Ω—ã –ú—è—Å–Ω–∏–∫–æ–≤–æ–π, –ø–∞—Ü–∏–µ–Ω—Ç—Å–∫–æ–µ —Å–æ–æ–±—â–µ—Å—Ç–≤–æ –Ω–µ–æ–¥–Ω–æ–∫—Ä–∞—Ç–Ω–æ –æ–±—Ä–∞—â–∞–ª–æ—Å—å –∫ –æ—Ä–≥–∞–Ω–∞–º –≤–ª–∞—Å—Ç–∏ —Å –ø—Ä–æ—Å—å–±–æ–π —Å–¥–µ–ª–∞—Ç—å —Ç–µ—Ä–∞–ø–∏—é –¥–æ—Å—Ç—É–ø–Ω–æ–π –¥–ª—è ¬´–æ—Ä—Ñ–∞–Ω–Ω—ã—Ö¬ª –≤–∑—Ä–æ—Å–ª—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –±–µ–∑ –ø—Ä–∏–≤—è–∑–∫–∏ –∫ —Å—Ç–∞—Ç—É—Å—É –∏–Ω–≤–∞–ª–∏–¥–∞, –Ω–æ —ç—Ç–æ –ø–æ–∫–∞ –Ω–µ –¥–∞–ª–æ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞. –û—Å–ª–æ–∂–Ω—è–µ—Ç —Å–∏—Ç—É–∞—Ü–∏—é —Å –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ–º –≤–∑—Ä–æ—Å–ª—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Ç–æ, —á—Ç–æ –Ω–∏–∫—Ç–æ –Ω–µ –º–æ–∂–µ—Ç –æ—Ü–µ–Ω–∏—Ç—å –∏—Ö —Ä–µ–∞–ª—å–Ω—É—é –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç—å –≤ —Ç–µ—Ä–∞–ø–∏–∏ –∏–∑-–∑–∞ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏—è —Ä–µ–≥–∏—Å—Ç—Ä–æ–≤ ‚Äî –ø–æ–ª–Ω—ã—Ö —Å–ø–∏—Å–∫–æ–≤ —Ç–∞–∫–∏—Ö –ª—é–¥–µ–π. –≠—Ç–æ –µ—â–µ –æ–¥–Ω–∞ –∑–∞–¥–∞—á–∞, —Ç—Ä–µ–±—É—é—â–∞—è —Ä–µ—à–µ–Ω–∏—è, ‚Äî –¥–æ–±–∞–≤–∏–ª–∞ –ú—è—Å–Ω–∏–∫–æ–≤–∞. –ó–∞ –ø—Ä–æ–∞–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã–π –ø–µ—Ä–∏–æ–¥ 68% –∏—Å–∫–æ–≤ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –ø–æ–ª–Ω–æ—Å—Ç—å—é —É–¥–æ–≤–ª–µ—Ç–≤–æ—Ä–µ–Ω—ã, 26% —É–¥–æ–≤–ª–µ—Ç–≤–æ—Ä–µ–Ω—ã —á–∞—Å—Ç–∏—á–Ω–æ, –µ—â—ë –≤ 6% –±—ã–ª–æ –æ—Ç–∫–∞–∑–∞–Ω–æ. –†–µ—à–µ–Ω–∏–µ —Å—É–¥–∞ —Å—Ç–∞–Ω–æ–≤–∏—Ç—Å—è —é—Ä–∏–¥–∏—á–µ—Å–∫–∏–º —Ñ–∞–∫—Ç–æ–º, –ø–æ—Ä–æ–∂–¥–∞—é—â–∏–º –¥–ª—è –º–∏–Ω–∑–¥—Ä–∞–≤–∞ —Å—É–±—ä–µ–∫—Ç–∞ –†–§ –æ–±—è–∑–∞—Ç–µ–ª—å—Å—Ç–≤–æ –ø–æ –≤—ã–¥–µ–ª–µ–Ω–∏—é –∫–æ–Ω–∫—Ä–µ—Ç–Ω–æ–º—É –ø–∞—Ü–∏–µ–Ω—Ç—É –¥–µ–Ω–µ–∂–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –Ω–∞ –ø—Ä–∏–æ–±—Ä–µ—Ç–µ–Ω–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞. –¢–æ–≥–¥–∞ –∫–∞–∫ –¥–∞–Ω–Ω–æ–µ –æ–±—è–∑–∞—Ç–µ–ª—å—Å—Ç–≤–æ —Å—É—â–µ—Å—Ç–≤—É–µ—Ç –∞–ø—Ä–∏–æ—Ä–∏ –∏–∑ –Ω–æ—Ä–º—ã –∑–∞–∫–æ–Ω–∞, ‚Äî –ø–æ–¥—ã—Ç–æ–∂–∏–ª–∞ –°–º–∏—Ä–Ω–æ–≤–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, regulation, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The statistics show that in the past year, more than 127 cases of non-payment of concessions and state guarantees were considered. In the first quarter of 2025, already more than 36 such cases were considered. Courts on average review more than 10 similar lawsuits per month. Such figures are shared by Natalya Smirnova, a member of the expert council on rare diseases at the Committee of the State Duma for health protection. The 'Blind Circle' is indirectly responsible, as it turns out, 'Circle of Good'. Only a small number of cases involve children ‚Äî they are covered by therapy through the Presidential Fund until age 19. After that, patients with rare diseases must receive drugs at state and regional expense. In addition, the 'Circle of Good' helps patients with 96 diseases, while the state covers treatment for only 28 of them. Approximately 78% of lawsuits are related to diseases not included in this list. In regions, another limitation exists ‚Äî only disabled individuals of the first or"
2025-08-22T06:00:01+00:00,@bezrec,6455,https://t.me/bezrec/6455,"RNC Pharma –ø–æ–¥–µ–ª–∏–ª–∞—Å—å –∞–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–∏–º –æ—Ç—á–µ—Ç–æ–º –æ —Ä–æ–∑–Ω–∏—á–Ω–æ–º —Å–µ–≥–º–µ–Ω—Ç–µ —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —Ñ–∞—Ä–º—Ä—ã–Ω–∫–∞ –ø–æ –∏—Ç–æ–≥–∞–º —è–Ω–≤–∞—Ä—è-–∏—é–ª—è 2025 –≥–æ–¥–∞: üîΩ –≤ –∏—é–ª–µ 2025 –≥–æ–¥–∞ —Ä–æ–∑–Ω–∏—á–Ω—ã–π —Å–µ–≥–º–µ–Ω—Ç —Ñ–∞—Ä–º—Ä—ã–Ω–∫–∞ —Å–æ—Å—Ç–∞–≤–∏–ª 143,9 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, –ø—Ä–∏–±–∞–≤–∏–≤ 15,9% –≥–æ–¥ –∫ –≥–æ–¥—É; üîΩ –∑–∞ —Å–µ–º—å –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ —Ä–æ—Å—Å–∏—è–Ω–µ –∫—É–ø–∏–ª–∏ –≥–æ—Ç–æ–≤—ã—Ö –õ–ü –Ω–∞ 1,05 —Ç—Ä–ª–Ω —Ä—É–±–ª–µ–π (+16,4% –∫ —è–Ω–≤–∞—Ä—é-–∏—é–ª—é 2024 –≥–æ–¥–∞); üîΩ –º–∞–∫—Å–∏–º–∞–ª—å–Ω–æ–π —Ä—É–±–ª—ë–≤–æ–π –¥–∏–Ω–∞–º–∏–∫–æ–π –æ—Ç–º–µ—Ç–∏–ª–∏—Å—å –¶–§–û (+15,6%), –°–ö–§–û (+15,2%) –∏ –°–ó–§–û (+14,7%); üîΩ 60,5% –ø—Ä–æ–¥–∞–∂ –≤ –¥–µ–Ω—å–≥–∞—Ö –æ–±–µ—Å–ø–µ—á–∏–ª–∏ Rx-–ø—Ä–µ–ø–∞—Ä–∞—Ç—ã; üîΩ –ø–æ –æ–±—ä—ë–º—É –ø—Ä–æ–¥–∞–∂ –≤ —Ä—É–±–ª—è—Ö –ª–∏–¥–∏—Ä—É—é—Ç –ø—Ä–æ—Ç–∏–≤–æ—Ä–µ–≤–º–∞—Ç–∏—á–µ—Å–∫–∏–µ –Ω–µ—Å—Ç–µ—Ä–æ–∏–¥–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, —Ç–æ–ø-10 –≤ —ç—Ç–æ–π –≥—Ä—É–ø–ø–µ: –ù—É—Ä–æ—Ñ–µ–Ω (¬´–†–µ–∫–∏—Ç—Ç –ë–µ–Ω–∫–∏–∑–µ—Ä¬ª), –ù–∏–º–µ—Å–∏–ª (¬´–ú–µ–Ω–∞—Ä–∏–Ω–∏¬ª), –ù–∏–º–µ—Å—É–ª–∏–¥ (¬´–ë–∏–æ—Ç—ç–∫¬ª + 18 –∫–æ–º–ø–∞–Ω–∏–π), –ò–±—É–ø—Ä–æ—Ñ–µ–Ω (¬´–í–µ–ª—Ñ–∞—Ä–º¬ª + 23 –∫–æ–º–ø–∞–Ω–∏–∏), –ù–∞–π–∑ (¬´–î—Ä. –†–µ–¥–¥–∏‚Äô—Å¬ª), –ò–±—É–∫–ª–∏–Ω (¬´–î—Ä. –†–µ–¥–¥–∏‚Äô—Å¬ª), –ö—Å–µ—Ñ–æ–∫–∞–º (¬´–ù–∏–∂—Ñ–∞—Ä–º¬ª), –ú–æ–≤–∞–ª–∏—Å (¬´–ë–µ—Ä–∏–Ω–≥–µ—Ä –ò–Ω–≥–µ–ª—å—Ö–∞–π–º¬ª), –ú–µ–ª–æ–∫—Å–∏–∫–∞–º (¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º¬ª + 29 –∫–æ–º–ø–∞–Ω–∏–π), –ê—Ä–∫–æ–∫—Å–∏–∞ (¬´–ú–°–î¬ª); üîΩ –º–∞–∫—Å–∏–º–∞–ª—å–Ω—É—é –¥–∏–Ω–∞–º–∏–∫—É –ø–æ–∫–∞–∑—ã–≤–∞—é—Ç GLP-1 –∞–≥–æ–Ω–∏—Å—Ç—ã (–°–µ–º–∞–≤–∏–∫ –æ—Ç ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª +295% –≤ —Ä—É–±–ª—è—Ö –∫ —è–Ω–≤–∞—Ä—é-–∏—é–ª—é 2024 –≥–æ–¥–∞); üîΩ –Ω–∞ 1 –∏—é–ª—è 2025 –≥–æ–¥–∞ –≤ –†–æ—Å—Å–∏–∏ —Ä–∞–±–æ—Ç–∞–ª–æ 83 —Ç—ã—Å. –∞–ø—Ç–µ—á–Ω—ã—Ö —É—á—Ä–µ–∂–¥–µ–Ω–∏–π (+4,5 —Ç—ã—Å. –∫ 1 –∏—é–ª—è 2024 –≥–æ–¥–∞); üîΩ –¥–æ–ª—è –ø–∞—Ä–∞—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∏ –≤ –≤—ã—Ä—É—á–∫–µ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –∞–ø—Ç–µ–∫ —Å–Ω–∏–∑–∏–ª–∞—Å—å –¥–æ 19,7% –≤ —Ä—É–±–ª—è—Ö (–≥–æ–¥–æ–º —Ä–∞–Ω–µ–µ 22,7%); —Å—Ä–µ–¥–Ω–∏–π —á–µ–∫ –≤—ã—Ä–æ—Å –Ω–∞ 10,8%, –¥–æ 764 —Ä—É–±–ª–µ–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial, safety, guideline"",
  ""impact"": ""medium"",
  ""english"": ""RNC Pharma released an analytical report on the retail segment of the Russian pharmaceutical market for January-July 2025. In July 2025, the retail segment of the pharmaceutical market is expected to reach RUB143.9 billion, up 15.9% year-over-year. For the first seven months of 2025, Russians have purchased ready-made drugs worth RUB1.05 trillion (+16.4% compared to January-July 2024). The regions with the highest growth rates are Central Federal District (+15.6%), South Caucasian Federal District (+15.2%) and Southern Central Federal District (+14.7%). 60.5% of sales are in cash terms. The top-selling drugs include anti-inflammatory non-steroidal drugs such as Nurofen (¬´Ricett Benciser¬ª), Nimedil (¬´Menarini¬ª), Ibuprofen (¬´Velfarm¬ª), Niz (¬´Dr. Reddy"
2025-08-21T17:10:01+00:00,@bezrec,6454,https://t.me/bezrec/6454,"–Ø–Ω–¥–µ–∫—Å –∑–∞–ø—É—Å—Ç–∏–ª —Å–µ—Ä–≤–∏—Å –¥–æ—Å—Ç–∞–≤–∫–∏ –∏ —Å–∞–º–æ–≤—ã–≤–æ–∑–∞ —Ç–æ–≤–∞—Ä–æ–≤ –∏–∑ –∞–ø—Ç–µ–∫ –ù–æ–≤—ã–π —Å–µ—Ä–≤–∏—Å –Ω–∞–∑—ã–≤–∞–µ—Ç—Å—è –Ø–Ω–¥–µ–∫—Å –ê–ø—Ç–µ–∫–∏, –æ–Ω –ø–æ–∑–≤–æ–ª—è–µ—Ç —Å—Ä–∞–≤–Ω–∏—Ç—å —Ü–µ–Ω—ã –≤ —Ä–∞–∑–Ω—ã—Ö –∞–ø—Ç–µ–∫–∞—Ö, –≤—ã–±—Ä–∞—Ç—å –ø–æ–¥—Ö–æ–¥—è—â–∏–µ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è –∏ –ø–æ–ª—É—á–∏—Ç—å —Ç–æ–≤–∞—Ä –¥–æ—Å—Ç–∞–≤–∫–æ–π –∏–ª–∏ —Å–∞–º–æ–≤—ã–≤–æ–∑–æ–º. –°–∫–æ—Ä–æ—Å—Ç—å –¥–æ—Å—Ç–∞–≤–∫–∏ ‚Äî –æ—Ç 15-20 –º–∏–Ω—É—Ç. –ó–∞–∫–∞–∑–∞—Ç—å –¥–æ—Å—Ç–∞–≤–∫—É –∏–ª–∏ –∑–∞–±—Ä–∞—Ç—å —Ç–æ–≤–∞—Ä —Å–∞–º–æ–≤—ã–≤–æ–∑–æ–º –º–æ–∂–Ω–æ –≤ –±–æ–ª–µ–µ —á–µ–º 200 –≥–æ—Ä–æ–¥–∞—Ö –†–æ—Å—Å–∏–∏, –≤ –∫–∞—Ç–∞–ª–æ–≥–µ 70 —Ç—ã—Å—è—á –ª–µ–∫–∞—Ä—Å—Ç–≤. –°–µ—Ä–≤–∏—Å –¥–æ—Å—Ç—É–ø–µ–Ω –≤ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏–∏ –Ø–Ω–¥–µ–∫—Å Go –∏ –Ω–∞ —Å–∞–π—Ç–µ –Ø–Ω–¥–µ–∫—Å –ê–ø—Ç–µ–∫–∏, –≤ –±—É–¥—É—â–µ–º –æ–Ω –ø–æ—è–≤–∏—Ç—Å—è –∏ –≤ –¥—Ä—É–≥–∏—Ö –ø—Ä–∏–ª–æ–∂–µ–Ω–∏—è—Ö –≥–æ—Ä–æ–¥—Å–∫–∏—Ö —Å–µ—Ä–≤–∏—Å–æ–≤ –Ø–Ω–¥–µ–∫—Å–∞. –û—Å–µ–Ω—å—é —Ç–∞–∫–∂–µ –ø–æ—è–≤–∏—Ç—Å—è –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –∑–∞–∫–∞–∑—ã–≤–∞—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–∞, –∫–æ—Ç–æ—Ä—ã—Ö –Ω–µ—Ç –≤ –Ω–∞–ª–∏—á–∏–∏ –ø–æ–±–ª–∏–∑–æ—Å—Ç–∏ ‚Äî –∏—Ö –ø—Ä–∏–≤–µ–∑—É—Ç —Å–æ —Å–∫–ª–∞–¥–∞ –≤ –≤—ã–±—Ä–∞–Ω–Ω—É—é –∞–ø—Ç–µ–∫—É –≤ —Ç–µ—á–µ–Ω–∏–µ –æ–¥–Ω–æ–≥–æ –¥–≤—É—Ö-–¥–Ω–µ–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-08-21T14:35:04+00:00,@bezrec,6453,https://t.me/bezrec/6453,–ö–∞–∂–¥–æ–º—É –≤–æ–∑—Ä–∞—Å—Ç—É ‚Äî —Å–≤–æ–∏ –≤–∫—É—Å–Ω—è—à–∫–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞,"{""skip"": true}"
2025-08-21T12:05:22+00:00,@bezrec,6452,https://t.me/bezrec/6452,"Wildberries –∑–∞–ø—É—Å—Ç–∏–ª –∑–∞–∫–∞–∑ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏–∑ ¬´–ï–∞–ø—Ç–µ–∫–∏¬ª. –ù–∞ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–µ –ø–æ—è–≤–∏–ª–∞—Å—å –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –¥–æ—Å—Ç–∞–≤–∫–∏ –±–µ–∑—Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –≤–∏—Ç–∞–º–∏–Ω–æ–≤ –∏–∑ —Å–µ—Ç–∏. Wildberries & Russ (–†–í–ë) –ø–æ–¥–∫–ª—é—á–∏–ª–∞ –∫ —Å–≤–æ–∏–º –º–æ–¥–µ–ª—è–º –ø—Ä–æ–¥–∞–∂ –æ–¥–Ω–æ–≥–æ –∏–∑ –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö –∏–≥—Ä–æ–∫–æ–≤ e-com —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ - ¬´–ï–∞–ø—Ç–µ–∫—É¬ª, ‚Äî —Å–æ–æ–±—â–∏–ª–∏ –≤ –ø—Ä–µ—Å—Å-—Å–ª—É–∂–±–µ –æ–±—ä–µ–¥–∏–Ω–µ–Ω–Ω–æ–π –∫–æ–º–ø–∞–Ω–∏–∏. –£–∂–µ –º–æ–∂–Ω–æ –∑–∞–∫–∞–∑–∞—Ç—å –¥–æ—Å—Ç–∞–≤–∫—É –¥–æ –¥–≤–µ—Ä–∏ –≤ 47 —Ä–µ–≥–∏–æ–Ω–∞—Ö. –í –±–ª–∏–∂–∞–π—à–µ–µ –≤—Ä–µ–º—è —É—Å–ª—É–≥–∞ —Å—Ç–∞–Ω–µ—Ç –¥–æ—Å—Ç—É–ø–Ω–∞ –ø–æ –≤—Å–µ–π –†–æ—Å—Å–∏–∏. –°—Ä–æ–∫ –¥–æ—Å—Ç–∞–≤–∫–∏ ‚Äî –æ—Ç –ø—è—Ç–∏ —á–∞—Å–æ–≤ —Å –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å—é –≤—ã–±—Ä–∞—Ç—å –≤—Ä–µ–º–µ–Ω–Ω–æ–π –∏–Ω—Ç–µ—Ä–≤–∞–ª. –î–ª—è –ú–æ—Å–∫–≤—ã –∏ –ú–æ—Å–∫–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –µ—Å—Ç—å —Å–∞–º–æ–≤—ã–≤–æ–∑ –≤ –æ–¥–Ω–æ–º –∏–∑ 80 –ø—É–Ω–∫—Ç–æ–≤ ¬´–ï–∞–ø—Ç–µ–∫–∏¬ª. –ù–∞–ø–æ–º–Ω–∏–º, –≤ –Ω–∞—á–∞–ª–µ –∏—é–Ω—è —Ö–æ–¥–∏–ª–∏ —Å–ª—É—Ö–∏ –æ –≤–æ–∑–º–æ–∂–Ω–æ–π –ø–æ–∫—É–ø–∫–µ —Å–µ—Ç–∏ ¬´–ï–∞–ø—Ç–µ–∫–∞¬ª –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–æ–º, –æ–¥–Ω–∞–∫–æ –≤ Wildberries&Russ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é –æ –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω–æ–π —Å–¥–µ–ª–∫–µ –æ–ø—Ä–æ–≤–µ—Ä–≥–ª–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-08-21T09:00:57+00:00,@bezrec,6448,https://t.me/bezrec/6448,"–ü—Ä–æ–¥–æ–ª–∂–∞–µ–º –∑–Ω–∞–∫–æ–º–∏—Ç—å—Å—è —Å –∏—é–Ω—å—Å–∫–∏–º –≤—ã–ø—É—Å–∫–æ–º –±—é–ª–ª–µ—Ç–µ–Ω—è ePharma –æ—Ç Data Insight. –ù–æ–≤–∞—è –ø–æ—Ä—Ü–∏—è —Ü–∏—Ñ—Ä –∏–∑ –∞–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–æ–≥–æ –æ—Ç—á—ë—Ç–∞ –æ —Ä–∞–±–æ—Ç–µ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç-–∞–ø—Ç–µ–∫ –≤ –†–æ—Å—Å–∏–∏: üü© –Ω–∞ –ú–æ—Å–∫–≤—É –∏ –ü–µ—Ç–µ—Ä–±—É—Ä–≥ —Å –æ–±–ª–∞—Å—Ç—è–º–∏ –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è —Ç–æ–ª—å–∫–æ 37% –æ—Ç –≤—Å–µ—Ö –∑–∞–∫–∞–∑–æ–≤ –Ω–∞ —Ä—ã–Ω–∫–µ ePharma, –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –º–∞–µ–º –∏—Ö –¥–æ–ª—è —Å–æ–∫—Ä–∞—Ç–∏–ª–∞—Å—å –Ω–∞ 0,5 –ø.–ø. 23% –∑–∞–∫–∞–∑–æ–≤ ‚Äì –Ω–∞ –≤–æ—Å—Ç–æ–∫–µ —Å—Ç—Ä–∞–Ω—ã, –æ—Ç –£—Ä–∞–ª–∞ –∏ –¥–∞–ª–µ–µ; üü© –≤ –ª–∏–¥–µ—Ä–∞—Ö –ø–æ —É—Ä–æ–≤–Ω—é –ø—Ä–æ–Ω–∏–∫–Ω–æ–≤–µ–Ω–∏—è ePharma ‚Äî –¥–∞–ª—å–Ω–µ–≤–æ—Å—Ç–æ—á–Ω—ã–µ —Ä–µ–≥–∏–æ–Ω—ã: –•–∞–±–∞—Ä–æ–≤—Å–∫–∏–π –∫—Ä–∞–π, –ü—Ä–∏–º–æ—Ä—å–µ, –ê–º—É—Ä—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å; üü© 12 –∏–∑ —Ç–æ–ø-20 –∏–Ω—Ç–µ—Ä–Ω–µ—Ç-–∞–ø—Ç–µ–∫ —Ä–∞–±–æ—Ç–∞—é—Ç –Ω–µ –º–µ–Ω–µ–µ —á–µ–º –≤ 60% —Ä–µ–≥–∏–æ–Ω–æ–≤; üü© –ª–∏–¥–∏—Ä—É—é—Ç –ø–æ –æ—Ö–≤–∞—Ç—É —Ä–µ–≥–∏–æ–Ω–æ–≤ –ø—Ä–æ–µ–∫—Ç—ã, –æ–ø–∏—Ä–∞—é—â–∏–µ—Å—è –Ω–∞ –∞–≥—Ä–µ–≥–∞—Ü–∏—é –∏ –ø–∞—Ä—Ç–Ω–µ—Ä—Å—Ç–≤–∞ ‚Äì Apteka.ru, ¬´–Æ—Ç–µ–∫–∞¬ª –∏ ¬´–ú–µ–≥–∞–ø—Ç–µ–∫–∞¬ª (–ø–æ 99% —Ä–µ–≥–∏–æ–Ω–æ–≤), ¬´–ó–¥—Ä–∞–≤—Å–∏—Ç–∏¬ª (98%) –∏ Asna.ru (94%); üü© —Å—Ä–µ–¥–∏ –∞–ø—Ç–µ—á–Ω—ã—Ö —Å–µ—Ç–µ–π –ø–æ –æ—Ö–≤–∞—Ç—É —Ä–µ–≥–∏–æ–Ω–æ–≤ –≤ –æ–Ω–ª–∞–π–Ω–µ –Ω–∞ –ø–µ—Ä–≤–æ–º –º–µ—Å—Ç–µ ¬´–ï–∞–ø—Ç–µ–∫–∞¬ª (92%), –∞ —Å—Ä–µ–¥–∏ —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω—ã—Ö —Å–µ—Ç–µ–π ‚Äî ¬´–ê–ø—Ä–µ–ª—å¬ª (90%); üü© –∫ –æ–Ω–ª–∞–π–Ω-–ø—Ä–æ–µ–∫—Ç–∞–º –¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–æ–≤ –ø–æ–¥–∫–ª—é—á–µ–Ω—ã –∞–ø—Ç–µ–∫–∏ 13 –∏–∑ 18 –∏–≥—Ä–æ–∫–æ–≤ –ø–µ—Ä–≤–æ–π –¥–≤–∞–¥—Ü–∞—Ç–∫–∏, –∏–º–µ—é—â–∏—Ö —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω—ã–µ —Ç–æ—á–∫–∏ –ø—Ä–æ–¥–∞–∂, 15 –∏–∑ 18 –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω—ã –≤ –∞–ø—Ç–µ—á–Ω—ã—Ö –∞–≥—Ä–µ–≥–∞—Ç–æ—Ä–∞—Ö; üü© –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–Ω–æ—Å—Ç—å –∏–Ω—Ç–µ—Ä–Ω–µ—Ç-–∞–ø—Ç–µ–∫ –≤–æ –≤–Ω–µ–∞–ø—Ç–µ—á–Ω—ã—Ö –æ–Ω–ª–∞–π–Ω-–∫–∞–Ω–∞–ª–∞—Ö –Ω–∏–∂–µ ‚Äî —Ç–æ–ª—å–∫–æ 10 –∏–∑ 18 –∏–≥—Ä–æ–∫–æ–≤ –ø—Ä–∏—Å—É—Ç—Å—Ç–≤—É—é—Ç –≤ —Å–µ—Ä–≤–∏—Å–∞—Ö —ç–∫—Å–ø—Ä–µ—Å—Å-–¥–æ—Å—Ç–∞–≤–∫–∏, –∞ –Ω–∞ —É–Ω–∏–≤–µ—Ä—Å–∞–ª—å–Ω—ã–µ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å—ã –≤—ã—à–ª–∏ —Ç–æ–ª—å–∫–æ –ø—è—Ç—å. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": true,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""low"",
  ""english"": ""The report from ePharma shows that only 37% of orders come from Moscow and St. Petersburg, down by 0.5 percentage points compared to May. The Far East regions of Russia have the highest ePharma penetration, with Haborovskaya Oblast, Primorskiy Kray, and Amurskaya Oblast leading. Top 20 online pharmacies cover more than 60% of regions. The top region coverage projects include Apteka.ru, 'YuTeka', and 'Megaptekas' (99% coverage), 'Zdrazvitie' (98%) and Asna.ru (94%). Top region coverage in traditional pharmacies is 'Eaptekas' (92%) and 'Aprils' (90%). 13 out of 18 traditional players are present in express delivery services, and only five are on universal marketplaces.""
}"
2025-08-21T05:40:01+00:00,@bezrec,6447,https://t.me/bezrec/6447,"–ë–ê–î—ã –¥–ª—è –ø–æ–≤—ã—à–µ–Ω–∏—è –º—É–∂—Å–∫–æ–π —Ñ–µ—Ä—Ç–∏–ª—å–Ω–æ—Å—Ç–∏ –ª—É—á—à–µ –ø—Ä–æ–¥–∞—é—Ç—Å—è –≤ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç–µ. –ü–æ –∏—Ç–æ–≥–∞–º –ø–µ—Ä–≤—ã—Ö –¥–≤—É—Ö –∫–≤–∞—Ä—Ç–∞–ª–æ–≤ 2025 –≥–æ–¥–∞ —Ä–æ—Å—Å–∏—è–Ω–µ –ø—Ä–∏–æ–±—Ä–µ–ª–∏ —Ç–∞–∫–∏—Ö –±–∏–æ–¥–æ–±–∞–≤–æ–∫ –Ω–∞ —Å—É–º–º—É —Å–≤—ã—à–µ 957,6 –º–ª–Ω —Ä—É–±–ª–µ–π, —á—Ç–æ –Ω–∞ 16,7% –±–æ–ª—å—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É. –ù–∞—Ç—É—Ä–∞–ª—å–Ω–æ–µ –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–µ –≤—ã—Ä–æ—Å–ª–æ –Ω–∞ 8,7%, –¥–æ 383 —Ç—ã—Å. —É–ø–∞–∫–æ–≤–æ–∫. –ü—Ä–∏ —Ç–æ–º, —á—Ç–æ –æ–Ω–ª–∞–π–Ω —Ä–∞—Å—Ç—ë—Ç –±—ã—Å—Ç—Ä–µ–µ –æ—Ñ–ª–∞–π–Ω–∞, –∫–ª–∞—Å—Å–∏—á–µ—Å–∫–∏–µ —Ç–æ—á–∫–∏ –ø—Ä–æ–¥–∞–∂ –≤ —Å–µ–≥–º–µ–Ω—Ç–µ –ø–æ–∫–∞ –ø—Ä–µ–≤–∞–ª–∏—Ä—É—é—Ç, –Ω–æ —Å –∫–∞–∂–¥—ã–º –≥–æ–¥–æ–º —Å–¥–∞—é—Ç –ø–æ–∑–∏—Ü–∏–∏. –ü–æ –æ—Ç–Ω–æ—à–µ–Ω–∏—é –∫ –∞–Ω–∞–ª–æ–≥–∏—á–Ω–æ–º—É –ø–µ—Ä–∏–æ–¥—É –ø—Ä–æ—à–ª–æ–≥–æ –≥–æ–¥–∞ –æ–±—ä—ë–º –ø—Ä–æ–¥–∞–∂ –≤ e-com –≤—ã—Ä–æ—Å –Ω–∞ 49% –≤ –¥–µ–Ω—å–≥–∞—Ö –∏ –Ω–∞ 35,7% –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö. –í —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω—ã—Ö —Ç–æ—á–∫–∞—Ö –ø—Ä–æ–¥–∞–∂–∏ —Ç–∞–∫–∏—Ö –ë–ê–î —É–≤–µ–ª–∏—á–∏–ª–∏—Å—å –Ω–∞ 4% –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –∏ –Ω–∞ 11,8% –≤ –¥–µ–Ω–µ–∂–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏. –õ–∏–¥–µ—Ä –≤ –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ ‚Äî –±—Ä–µ–Ω–¥ –ú–µ–Ω-—Å —Ñ–æ—Ä–º—É–ª–∞ –°–ø–µ—Ä–º–∞–∫—Ç–∏–Ω –æ—Ç –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–§–∞—Ä–º–∞–º–µ–¥¬ª. –ù–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ ‚Äî –°–ø–µ—Ä–æ—Ç–æ–Ω –æ—Ç ¬´–ê–∫–≤–∏–æ–Ω–∞¬ª. –ó–∞–º—ã–∫–∞–µ—Ç —Ç—Ä–æ–π–∫—É –ª–∏–¥–µ—Ä–æ–≤ –ë–µ—Å—Ç—Ñ–µ—Ä—Ç–∏–ª –æ—Ç ¬´–§–∞—Ä–º—Ç—Ä–∞–Ω—Å—Ñ–µ—Ä–∞¬ª. –í—Å–µ —É—á–∞—Å—Ç–Ω–∏–∫–∏ –ø–µ—Ä–≤–æ–π –¥–µ—Å—è—Ç–∫–∏ –ø—Ä–æ–¥–µ–º–æ–Ω—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª–∏ –ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω—É—é –¥–∏–Ω–∞–º–∏–∫—É —Ä—É–±–ª—ë–≤—ã—Ö –ø—Ä–æ–¥–∞–∂. –ù–∞—Ç—É—Ä–∞–ª—å–Ω—ã–π —Å–ø—Ä–æ—Å —Å–Ω–∏–∑–∏–ª—Å—è —Ç–æ–ª—å–∫–æ —É –¥–≤—É—Ö –∏–≥—Ä–æ–∫–æ–≤ ‚Äî –ê–Ω–¥—Ä–æ–∫–æ–º–ø–ª–µ–∫—Å–∞ –æ—Ç ¬´–û–ø—Ç–∏—Å–∞–ª—Ç–∞¬ª –∏ –°–ø–µ—Ä–º–∞–ø–ª–∞–Ω—Ç–∞ –æ—Ç ¬´–≠–≤–∞–ª–∞—Ä–∞¬ª ‚Äî –Ω–∞ 1,4% –∏ 3,7% —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ. –õ—é–±–æ–ø—ã—Ç–Ω–æ, —á—Ç–æ –µ—â—ë –æ–¥–∏–Ω –±—Ä–µ–Ω–¥ ¬´–û–ø—Ç–∏—Å–∞–ª—Ç–∞¬ª ‚Äî –¢–µ—Å—Ç–æ—Ä–∏–ª ‚Äî —Å–≤–æ–µ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è –Ω–µ –ø–æ–¥–≤—ë–ª –∏ –ø–æ–∫–∞–∑–∞–ª –º–∞–∫—Å–∏–º–∞–ª—å–Ω—É—é –≤ —Ç–æ–ø–µ —Ä—É–±–ª—ë–≤—É—é –¥–∏–Ω–∞–º–∏–∫—É (+73%). –ü–æ–º–∏–º–æ –ø–µ—Ä–µ—á–∏—Å–ª–µ–Ω–Ω—ã—Ö –∫–æ–º–ø–∞–Ω–∏–π –≤ —Ç–æ–ø-10 —Ç–∞–∫–∂–µ –ø–æ–ø–∞–ª–∏: –ê–Ω–¥—Ä–æ–¥–æ–∑ (¬´–ù–∏–∂—Ñ–∞—Ä–º¬ª +2 –∫–æ–º–ø–∞–Ω–∏–∏), –¢–µ—Å—Ç–æ–≥–µ–Ω–æ–Ω (¬´–†–ò–ê –ü–∞–Ω–¥–∞¬ª), –ü—Ä–æ—Å—Ç–∞–ª–∞–º–∏–Ω –ö–ª–∞—Å—Å–∏–∫ (¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª), –°–ø–µ—Ä–º–∞—Ñ–µ—Ä—Ç (¬´–ù–µ—Ä–µ–π¬ª). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""There has been a significant increase in the natural consumption of male fertility supplements, with Russia purchasing over 957.6 million rubles worth of such products in the first two quarters of 2025, up by 16.7% year-over-year. Natural consumption rose by 8.7%, reaching 383,000 units. Online sales are growing faster than traditional channels, but traditional points of sale still dominate the segment, though they are losing ground. Year-over-year, e-commerce sales have increased by 49% in terms of money and 35.7% in units. Traditional point sales have increased by 4% naturally and 11.8% in monetary terms. The leader in the category is Men-Formula Spermax from 'FarmaMed' company, followed by Spermoton from 'Aquion'. The third place is taken by BestFerility from 'FarTransfer' company. All top ten participants demonstrated positive monetary growth. Natural consumption decreased only for two companies ‚Äî Androkomplex"
2025-08-20T14:00:00+00:00,@bezrec,6446,https://t.me/bezrec/6446,"–¢–∞–∫–∏–º–∏ —Ü–∏—Ñ—Ä–∞–º–∏ —Å–æ —Å—Å—ã–ª–∫–æ–π –Ω–∞ –¥–∞–Ω–Ω—ã–µ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–∞ –ø–æ–¥–µ–ª–∏–ª—Å—è –ú–∏–Ω–∑–¥—Ä–∞–≤ –≤ –æ—Ç–≤–µ—Ç –Ω–∞ —Å–æ–æ–±—â–µ–Ω–∏—è –æ –ø—Ä–æ–±–ª–µ–º–∞—Ö —Å –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å—é –æ–Ω–∫–æ–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –î–ª—è —Å—Ä–∞–≤–Ω–µ–Ω–∏—è, –≤ 2021 –≥–æ–¥—É –±—ã–ª–æ –æ—Ç–ø—É—â–µ–Ω–æ —Ç–∞–∫–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –Ω–∞ 47,8 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, –∏–∑ –Ω–∏—Ö –ø–æ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–π –ª—å–≥–æ—Ç–µ ‚Äì 21,3 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, –ø–æ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω–æ–π –ª—å–≥–æ—Ç–µ ‚Äì 26,5 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, –≤ 2024 –≥–æ–¥—É ‚Äì 100,5 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, –∏–∑ –Ω–∏—Ö –ø–æ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–π –ª—å–≥–æ—Ç–µ ‚Äì 44 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, –ø–æ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω–æ–π –ª—å–≥–æ—Ç–µ ‚Äì 56,5 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ï—Å–ª–∏ –≥–æ–≤–æ—Ä–∏—Ç—å –æ –ø–µ—Ä–µ—á–Ω–µ –ñ–ù–í–õ–ü, —Ç–æ –∑–∞ –ø—è—Ç—å –ª–µ—Ç –æ–Ω –ø–æ–ø–æ–ª–Ω–∏–ª—Å—è 18 –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º–∏ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –æ–Ω–∫–æ–∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –≠—Ç–æ 34% –æ—Ç –≤—Å–µ—Ö –≤–∫–ª—é—á–µ–Ω–Ω—ã—Ö –≤ –ø–µ—Ä–µ—á–µ–Ω—å –∑–∞ —É–∫–∞–∑–∞–Ω–Ω—ã–π –ø–µ—Ä–∏–æ–¥. –í 2025 –≥–æ–¥—É –∫ –≤–∫–ª—é—á–µ–Ω–∏—é —Ä–µ–∫–æ–º–µ–Ω–¥–æ–≤–∞–Ω–æ –µ—â–µ –ø—è—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –û –±—é–¥–∂–µ—Ç–∞—Ö —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω—ã—Ö —Ñ–æ–Ω–¥–æ–≤ –û–ú–°, –≥–æ–≤–æ—Ä—è—Ç, —Ç–æ–∂–µ –Ω–µ –∑–∞–±—ã–≤–∞—é—Ç: –£—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–Ω—ã–π —Ä–∞–∑–º–µ—Ä —Å—É–±–≤–µ–Ω—Ü–∏–∏ –Ω–∞ 2025 –≥–æ–¥ —Å–æ—Å—Ç–∞–≤–∏–ª 3 639,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, –ø—Ä–∏—Ä–æ—Å—Ç –∫ 2024 –≥–æ–¥—É ‚Äì 16,7%. –í 2024 –≥–æ–¥—É —Ä–∞–∑–º–µ—Ä —Å—É–±–≤–µ–Ω—Ü–∏–∏ —Å–æ—Å—Ç–∞–≤–ª—è–ª 3 120,2 –º–∏–ª–ª–∏–∞—Ä–¥–∞ —Ä—É–±–ª–µ–π, –ø—Ä–∏—Ä–æ—Å—Ç –∫ 2023 –≥–æ–¥—É ‚Äì 13,5%. –í —Ü–µ–Ω—Ç—Ä–µ –æ–Ω–∫–æ–ª–æ–≥–∏–∏ –∏–º. –ë–ª–æ—Ö–∏–Ω–∞ –≤ –æ–±—ä–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è ¬´–î–≤–∏–∂–µ–Ω–∏—è –ø—Ä–æ—Ç–∏–≤ —Ä–∞–∫–∞¬ª –∏ –≤–æ–≤—Å–µ —É—Å–æ–º–Ω–∏–ª–∏—Å—å. –ó–∞–º–¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –ø–æ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã—Ö –ø—Ä–æ–µ–∫—Ç–æ–≤ —Ü–µ–Ω—Ç—Ä–∞ –¢–∏–≥—Ä–∞–Ω–∞ –ì–µ–≤–æ—Ä–∫—è–Ω–∞ —Å–º—É—Ç–∏–ª–∞ ¬´–Ω–µ –æ—á–µ–Ω—å —Ä–µ–ø—Ä–µ–∑–µ–Ω—Ç–∞—Ç–∏–≤–Ω–∞—è –≤—ã–±–æ—Ä–∫–∞ –≤ 502 —á–µ–ª–æ–≤–µ–∫–∞¬ª. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –ø–æ –º–Ω–µ–Ω–∏—é —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞, ¬´–æ–ø—Ä–µ–¥–µ–ª–µ–Ω–Ω—É—é –¥–æ–ª—é –≤ –∞–ø—Ç–µ—á–Ω—ã—Ö –ø—Ä–æ–¥–∞–∂–∞—Ö –∑–∞ –Ω–∞–ª–∏—á–Ω—ã–µ –º–æ–≥–ª–∏ —Å–æ—Å—Ç–∞–≤–∏—Ç—å –ø–∞—Ü–∏–µ–Ω—Ç—ã, –æ—Ç–¥–∞–≤—à–∏–µ –ø—Ä–µ–¥–ø–æ—á—Ç–µ–Ω–∏–µ –∏–º–ø–æ—Ä—Ç–Ω—ã–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º –ø—Ä–∏ –Ω–∞–ª–∏—á–∏–∏ –≤ –±–µ—Å–ø–ª–∞—Ç–Ω–æ–º –¥–æ—Å—Ç—É–ø–µ –∞–±—Å–æ–ª—é—Ç–Ω–æ –∫–∞—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –∞–Ω–∞–ª–æ–≥–æ–≤¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, demand, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The message discusses the shortage of oncological drugs and mentions budget allocations for territorial health funds. It also highlights concerns about patient preferences towards imported medications over domestically produced ones, suggesting a need for further investigation and policy adjustments.""
}"
2025-08-20T12:00:28+00:00,@bezrec,6445,https://t.me/bezrec/6445,"–õ–µ–∫–∞—Ä—Å—Ç–≤–∞ –≤ –æ—Ç–¥–∞–ª—ë–Ω–Ω—ã–µ —Å—ë–ª–∞ –ø–æ–µ–¥—É—Ç –Ω–∞ ¬´—Å–ø–µ—Ü–≥–∞–∑–µ–ª—è—Ö¬ª. –ó–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ –ø–µ—Ä–µ–¥–≤–∏–∂–Ω—ã—Ö –∞–ø—Ç–µ–∫–∞—Ö –±—É–¥–µ—Ç –≤–Ω–µ—Å–µ–Ω –≤ –ì–æ—Å–¥—É–º—É —É–∂–µ –≤ –æ—Å–µ–Ω–Ω—é—é —Å–µ—Å—Å–∏—é. –ü–æ —Å–ª–æ–≤–∞–º –ø–µ—Ä–≤–æ–≥–æ –∑–∞–º–ø—Ä–µ–¥–∞ –ö–æ–º–∏—Ç–µ—Ç–∞ –ì–æ—Å–¥—É–º—ã –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è –ë–∞–¥–º—ã –ë–∞—à–∞–Ω–∫–∞–µ–≤–∞, –≤ —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–µ –±—É–¥—É—Ç —É—á–∞—Å—Ç–≤–æ–≤–∞—Ç—å –¥–µ—Å—è—Ç—å —Ä–µ–≥–∏–æ–Ω–æ–≤, –≤ —Ç–æ–º —á–∏—Å–ª–µ –ö—Ä–∞—Å–Ω–æ—è—Ä—Å–∫, –ö–∞–ª–º—ã–∫–∏—è, –ö–∞–±–∞—Ä–¥–∏–Ω–æ-–ë–∞–ª–∫–∞—Ä–∏—è, –ê—Ä—Ö–∞–Ω–≥–µ–ª—å—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å, –ù–∏–∂–Ω–∏–π –ù–æ–≤–≥–æ—Ä–æ–¥ –∏ –¥—Ä—É–≥–∏–µ. –ö —Ç–æ—Ä–≥–æ–≤–ª–µ ¬´—Å –∫–æ–ª—ë—Å¬ª –±—ã–ª–æ –º–Ω–æ–≥–æ –≤–æ–ø—Ä–æ—Å–æ–≤, —Å—Ä–µ–¥–∏ –∫–æ—Ç–æ—Ä—ã—Ö –∫–æ–ª–æ—Å—Å–∞–ª—å–Ω—ã–µ –∏–∑–¥–µ—Ä–∂–∫–∏ –∏–∑-–∑–∞ –±–æ–ª—å—à–∏—Ö —Ä–∞—Å—Å—Ç–æ—è–Ω–∏–π, –µ—â—ë –Ω–µ –Ω–∞–ª–∞–∂–µ–Ω–Ω–∞—è —Ä–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞, –¥–µ—Ñ–∏—Ü–∏—Ç –∫–∞–¥—Ä–æ–≤, –ø–ª–æ—Ö–∏–µ –¥–æ—Ä–æ–≥–∏ (–∞ —Ç–æ –∏ –∏—Ö –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–µ), –≤ –∫–æ–Ω—Ü–µ –∫–æ–Ω—Ü–æ–≤. –°–ø—Ä–∞–≤–∏—Ç—å—Å—è —Å –ø–æ—Å–ª–µ–¥–Ω–∏–º –ø—É–Ω–∫—Ç–æ–º, –∞ —Ç–∞–∫–∂–µ –æ–±–µ—Å–ø–µ—á–∏—Ç—å –ø—Ä–∞–≤–∏–ª—å–Ω–æ–µ —Ö—Ä–∞–Ω–µ–Ω–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –æ–±–µ—â–∞–µ—Ç –ì–æ—Ä—å–∫–æ–≤—Å–∫–∏–π –∞–≤—Ç–æ–∑–∞–≤–æ–¥. –ì–ê–ó —Å–¥–µ–ª–∞–ª —Å–ø–µ—Ü–∏–∞–ª—å–Ω—ã–µ –∞–≤—Ç–æ–º–æ–±–∏–ª–∏ —Å –ø–æ–≤—ã—à–µ–Ω–Ω–æ–π –ø—Ä–æ—Ö–æ–¥–∏–º–æ—Å—Ç—å—é, —ç–Ω–µ—Ä–≥–æ–µ–º–∫–æ—Å—Ç—å—é –∏ —Ö–æ–ª–æ–¥–∏–ª—å–Ω—ã–º–∏ –∫–∞–º–µ—Ä–∞–º–∏. –¢–∞–∫–∏–µ —Ñ—É—Ä–≥–æ–Ω—ã –∫–æ–º–ø–ª–µ–∫—Ç—É—é—Ç—Å—è —Å–∏—Å—Ç–µ–º–æ–π –∞–≤—Ç–æ–Ω–æ–º–Ω–æ–≥–æ –≤–æ–¥–æ—Å–Ω–∞–±–∂–µ–Ω–∏—è, –æ—Å–≤–µ—â–µ–Ω–∏—è, –≤–∫–ª—é—á–∞—è –¥–µ–∂—É—Ä–Ω–æ–µ, —ç–ª–µ–∫—Ç—Ä–æ—Å—á–µ—Ç—á–∏–∫–æ–º, –≤–æ–¥–æ–Ω–∞–≥—Ä–µ–≤–∞—Ç–µ–ª–µ–º, –∫–æ–Ω–¥–∏—Ü–∏–æ–Ω–µ—Ä–æ–º, —Å—Ç–µ–ª–ª–∞–∂–∞–º–∏ —Å –ø–æ–ª–æ—á–∫–∞–º–∏ –∏–∑ –æ—Ä–≥—Å—Ç–µ–∫–ª–∞, –≥–∞—Ä–¥–µ—Ä–æ–±–æ–º, –ø–æ–ª–æ—á–∫–∞–º–∏ –¥–ª—è —Å—É–º–æ–∫ –ø–æ–∫—É–ø–∞—Ç–µ–ª–µ–π, —É–≤–µ–ª–∏—á–µ–Ω–Ω–æ–π —ç–∫—Å–ø–æ–∑–∏—Ü–∏–æ–Ω–Ω–æ–π –≤–∏—Ç—Ä–∏–Ω–æ–π. –í–Ω—É—Ç—Ä–∏ —Ç–∞–∫–∂–µ –ø—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ–Ω—ã –∞–ø—Ç–µ—á–Ω—ã–π —à–∫–∞—Ñ –Ω–∞ 80 —è—â–∏—á–∫–æ–≤ –∏ —Ö–æ–ª–æ–¥–∏–ª—å–Ω–∏–∫. –ü–æ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º –∫—Ä–∞—Ç–∫–æ—Å—Ä–æ—á–Ω–æ–≥–æ —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–∞ –≤ –º–∞—Ä—Ç–µ –ø—Ä–æ—à–ª–æ–≥–æ –≥–æ–¥–∞ –≤ –ö—Ä–∞—Å–Ω–æ—è—Ä—Å–∫–æ–º –∫—Ä–∞–µ ¬´–ì—É–±–µ—Ä–Ω—Å–∫–∏–µ –∞–ø—Ç–µ–∫–∏¬ª –ø–æ–¥—Å—á–∏—Ç–∞–ª–∏, —á—Ç–æ –∞–ø—Ç–µ–∫–∞ –Ω–∞ –∫–æ–ª—ë—Å–∞—Ö, –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–Ω–∞—è –≤—Å–µ–º –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã–º, –æ–±–æ–π–¥—ë—Ç—Å—è –≤ 6 –º–ª–Ω —Ä—É–±–ª–µ–π. –ù–∞ –∑–∞—Ä–ø–ª–∞—Ç—ã –ø–µ—Ä—Å–æ–Ω–∞–ª—É, –≥–æ—Ä—é—á–µ–µ –∏ –∑–∞–ø—á–∞—Å—Ç–∏ —É–π–¥—ë—Ç –ø—Ä–∏–º–µ—Ä–Ω–æ 2,9 –º–ª–Ω —Ä—É–±–ª–µ–π –≤ –≥–æ–¥ –ø—Ä–∏ –æ—Ä–∏–µ–Ω—Ç–∏—Ä–æ–≤–æ—á–Ω–æ–π –≤—ã—Ä—É—á–∫–µ –≤ 5,4 –º–ª–Ω —Ä—É–±–ª–µ–π –∑–∞ —Ç–æ—Ç –∂–µ –ø–µ—Ä–∏–æ–¥. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, regulation"",
  ""impact"": ""high"",
  ""english"": ""A project to introduce mobile pharmacies into the Russian Federation is being considered. Ten regions, including Krasnoyarsk and Kalmykia, are to participate in the experiment. The project faces challenges such as high transportation costs due to long distances, unestablished regulatory framework, shortage of personnel, and poor infrastructure. GAZ plans to address these issues by providing special vehicles with enhanced mobility, energy efficiency, and refrigeration facilities. The cost of equipping these mobile pharmacies is estimated at 6 million rubles annually, with operating expenses amounting to approximately 2.9 million rubles for salaries and supplies.""
}"
2025-08-20T09:00:00+00:00,@bezrec,6444,https://t.me/bezrec/6444,"–ö –∫–∞—á–µ—Å—Ç–≤—É –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ ¬´–ü—Ä–æ–º–æ–º–µ–¥–∞¬ª —Å —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–æ–º –≤–æ–∑–Ω–∏–∫–ª–∏ –≤–æ–ø—Ä–æ—Å—ã. –ö–≤–∏–Ω—Å–µ–Ω—Ç—É –∏ –í–µ–ª–≥–∏—é —Ä–µ—à–∏–ª–∏ –ø—Ä–æ–≤–µ—Ä–∏—Ç—å –Ω–∞ —Å–æ–±–ª—é–¥–µ–Ω–∏–µ —Å—Ç–∞–Ω–¥–∞—Ä—Ç–æ–≤ –∫–∞—á–µ—Å—Ç–≤–∞ –∏ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤: –∏ –æ–±–Ω–∞—Ä—É–∂–∏–ª–∏ –≤ –Ω–∏—Ö –ø—Ä–∏–º–µ—Å–∏. –¢–∞–∫–∏–µ –¥–∞–Ω–Ω—ã–µ —Å–æ–¥–µ—Ä–∂–∞—Ç—Å—è –≤ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–∏ –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–∏–∏ –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥—Å–∫–æ–≥–æ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ —Ö–∏–º–∏–∫–æ-—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ (–°–ü–•–§–£) –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–§, –∫–æ—Ç–æ—Ä–æ–µ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∏ –Ω–∞ –ø—Ä–µ—Å—Å-–∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ ¬´–ö–æ–Ω—Ç—Ä–æ–ª—å –∫–∞—á–µ—Å—Ç–≤–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤: –¥–æ–≤–µ—Ä–∏–µ, –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å, –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç—å —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π¬ª. –î–µ–ª–∏–º—Å—è —É—Å–ª—ã—à–∞–Ω–Ω—ã–º –ü–æ —Å–ª–æ–≤–∞–º –Ω–∞—á–∞–ª—å–Ω–∏–∫–∞ –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–∏–∏ –°–ü–•–§–£ –ò–Ω–Ω—ã –¢–µ—Ä–Ω–∏–Ω–∫–æ, —É –í–µ–ª–≥–∏–∏ –≤—ã—è–≤–∏–ª–∏ —Å—Ä–∞–∑—É –¥–≤–∞ –Ω–µ—Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏—è: —Å–æ–¥–µ—Ä–∂–∞–Ω–∏–µ –¥–µ–π—Å—Ç–≤—É—é—â–µ–≥–æ –≤–µ—â–µ—Å—Ç–≤–∞ –Ω–∞ 17,5% –Ω–∏–∂–µ –Ω–æ—Ä–º—ã, –∞ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –≥–∏–¥—Ä–æ—Ñ–∏–ª—å–Ω—ã—Ö –ø—Ä–∏–º–µ—Å–µ–π –ø—Ä–µ–≤—ã—à–µ–Ω–æ –≤–æ –≤—Å–µ—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–Ω—ã—Ö —Å–µ—Ä–∏—è—Ö. –ö –ö–≤–∏–Ω—Å–µ–Ω—Ç–µ –ø–æ –∫–æ–ª–∏—á–µ—Å—Ç–≤—É —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ –≤–æ–ø—Ä–æ—Å–æ–≤ –Ω–µ—Ç, –∞ –≤–æ—Ç –¥–æ–ø—É—Å—Ç–∏–º–æ–µ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –ø—Ä–∏–º–µ—Å–µ–π –æ–∫–∞–∑–∞–ª–æ—Å—å –ø—Ä–µ–≤—ã—à–µ–Ω–æ –≤ –æ–¥–Ω–æ–π –∏–∑ —Ç—Ä–µ—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–Ω—ã—Ö —Å–µ—Ä–∏–π. –ß–µ–º —ç—Ç–æ –ø–ª–æ—Ö–æ? –ü—Ä–∏–º–µ—Å–∏ –º–æ–≥—É—Ç –±—ã—Ç—å —Ç–æ–∫—Å–∏—á–Ω—ã –∏ –≤—ã–∑—ã–≤–∞—Ç—å –∫–∞–∫ –º–µ—Å—Ç–Ω—ã–µ —Ä–µ–∞–∫—Ü–∏–∏ –≤ –º–µ—Å—Ç–µ –∏–Ω—ä–µ–∫—Ü–∏–∏, —Ç–∞–∫ –∏ —Å–∏—Å—Ç–µ–º–Ω—ã–µ —Ä–µ–∞–∫—Ü–∏–∏ –æ—Ä–≥–∞–Ω–∏–∑–º–∞. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –Ω–µ–∫–æ—Ç–æ—Ä—ã–µ –ø—Ä–∏–º–µ—Å–∏ –º–æ–≥—É—Ç —Å–æ –≤—Ä–µ–º–µ–Ω–µ–º –≤—ã–∑—ã–≤–∞—Ç—å —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–∏–µ –∞–ª–ª–µ—Ä–≥–∏—á–µ—Å–∫–∏–µ —Ä–µ–∞–∫—Ü–∏–∏, –∞ —Ç–∞–∫–∂–µ —Å–Ω–∏–∂–µ–Ω–∏–µ –¥–µ–π—Å—Ç–≤–∏—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –≤—Å–ª–µ–¥—Å—Ç–≤–∏–µ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è –∞–Ω—Ç–∏—Ç–µ–ª –∫ –¥–µ–π—Å—Ç–≤—É—é—â–µ–º—É –≤–µ—â–µ—Å—Ç–≤—É, ‚Äï –ø—Ä–æ–∫–æ–º–º–µ–Ω—Ç–∏—Ä–æ–≤–∞–ª–∞ ¬´–Ω–∞—Ö–æ–¥–∫—É¬ª –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª–µ–π –≤—Ä–∞—á-—ç–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥ –ï–ª–µ–Ω–∞ –§—Ä–æ–ª–æ–≤–∞. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –ø–æ —Å–ª–æ–≤–∞–º –§—Ä–æ–ª–æ–≤–æ–π, ¬´–ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω–æ —Å—Ä–æ–∫ –≥–æ–¥–Ω–æ—Å—Ç–∏ —Ç–∞–∫–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –∑–∞–º–µ—Ç–Ω–æ –º–µ–Ω—å—à–µ –∑–∞—è–≤–ª–µ–Ω–Ω—ã—Ö —Ç—Ä—ë—Ö –ª–µ—Ç, –∞ –µ–≥–æ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –∏ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å —Å–æ –≤—Ä–µ–º–µ–Ω–µ–º –º–æ–≥—É—Ç —Å–Ω–∏–∂–∞—Ç—å—Å—è¬ª. –í ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª —Å—á–∏—Ç–∞—é—Ç —Å–∏—Ç—É–∞—Ü–∏—é —Å –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º–∏ ¬´–ü—Ä–æ–º–æ–º–µ–¥–∞¬ª –Ω–µ—Ç–∏–ø–∏—á–Ω–æ–π –∏ —Ç–æ—á–Ω–æ –Ω–µ —Ö–∞—Ä–∞–∫—Ç–µ—Ä–∏–∑—É—é—â–µ–π –≤–µ—Å—å —ç—Ç–æ—Ç —Å–µ–≥–º–µ–Ω—Ç —Ñ–∞—Ä–º—Ä—ã–Ω–∫–∞. –í –∫–æ–º–ø–∞–Ω–∏–∏ —É—Ç–≤–µ—Ä–∂–¥–∞—é—Ç, —á—Ç–æ —É –µ—ë —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ —Ç–∞–∫–∏—Ö –ø—Ä–æ–±–ª–µ–º –Ω–µ—Ç, –∏ –≤ –≤—ã–ø—É—Å–∫–∞–µ–º—ã—Ö –∫–æ–º–ø–∞–Ω–∏–µ–π –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞—Ö ¬´–æ—Ç—Å—É—Ç—Å—Ç–≤—É–µ—Ç –Ω–∞—Ä–∞—Å—Ç–∞–Ω–∏–µ –ø—Ä–∏–º–µ—Å–µ–π –≤—ã—à–µ —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–Ω–æ–≥–æ –ø—Ä–µ–¥–µ–ª–∞ –Ω–∞ –ø—Ä–æ—Ç—è–∂–µ–Ω–∏–∏ –≤—Å–µ–≥–æ —Å—Ä–æ–∫–∞ –≥–æ–¥–Ω–æ—Å—Ç–∏, —á—Ç–æ —Ç–∞–∫–∂–µ –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–∞–µ—Ç—Å—è –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è–º–∏¬ª. –û—Å—Ç–∞–ª—å–Ω—ã–º –ø—Ä–∏–≥–æ—Ç–æ–≤–∏—Ç—å—Å—è –°–æ—Å—Ç–æ—è–≤—à–∞—è—Å—è –ø—Ä–æ–≤–µ—Ä–∫–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª ‚Äì —ç—Ç–æ —Ç–æ–ª—å–∫–æ –ø–µ—Ä–≤–æ–µ –∏–∑ —Ç–∞–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π. –í –¥–∞–ª—å–Ω–µ–π—à–µ–º –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –ø—Ä–æ–≤–µ—Å—Ç–∏ –∞–Ω–∞–ª–æ–≥–∏—á–Ω—ã–µ –ø—Ä–æ–≤–µ—Ä–∫–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Å —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–æ–º, –∫–æ—Ç–æ—Ä—ã–µ –≤—ã–ø—É—Å–∫–∞—é—Ç—Å—è –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º —Ä—ã–Ω–∫–µ –¥—Ä—É–≥–∏–º–∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤, ‚Äî –ø–æ–æ–±–µ—â–∞–ª–∏ –≤ ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º–µ¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance, safety"",
  ""impact"": ""high"",
  ""english"": ""There are concerns about the quality of Promed drugs containing semaglutide. The company Quintsenti and Velgi were found to have impurities in their products during a quality and safety check for patients. These findings are from the laboratory of Saint-Petersburg State Chemical-Pharmaceutical University (SPHFU) under the Russian Ministry of Health, which was presented at a press conference 'Quality Control of Medicines: Trust, Safety, Responsibility of Pharmaceutical Manufacturers'. According to lab head Inn Ternikova from SPHFU, Velgi had two discrepancies: the content of active substance was 17.5% lower than the norm, and hydrophilic impurities exceeded all tested series. Quintsenti did not have questions regarding the amount of semaglutide, but one of three tested series exceeded the allowed impurity limit. The presence of these impurities can be toxic and cause local reactions at the injection site, as well as systemic reactions in the body. Additionally, some impurities can cause chronic allergic reactions and reduce the effectiveness"
2025-08-20T06:10:00+00:00,@bezrec,6443,https://t.me/bezrec/6443,"–ú–∏—à—É—Å—Ç–∏–Ω–∞ –ø—Ä–æ—Å—è—Ç –æ–±—Ä–∞—Ç–∏—Ç—å –≤–Ω–∏–º–∞–Ω–∏–µ –Ω–∞ –ø—Ä–æ–±–ª–µ–º—É —Å –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å—é –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –æ—Ç —Ä–∞–∫–∞. –í –ø–∏—Å—å–º–µ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ ¬´–î–≤–∏–∂–µ–Ω–∏–µ –ø—Ä–æ—Ç–∏–≤ —Ä–∞–∫–∞¬ª –Ω–∞ –∏–º—è –ø—Ä–µ–º—å–µ—Ä-–º–∏–Ω–∏—Å—Ç—Ä–∞ –≥–æ–≤–æ—Ä–∏—Ç—Å—è, —á—Ç–æ –±–æ–ª–µ–µ —Ç—Ä–µ—Ç–∏ –æ–Ω–∫–æ–ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ (34,5%) —Å—Ç–∞–ª–∫–∏–≤–∞–ª–∏—Å—å —Å —Ç—Ä—É–¥–Ω–æ—Å—Ç—è–º–∏ –ø—Ä–∏ –ø–æ–ª—É—á–µ–Ω–∏–∏ –ø—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –ø–æ—á—Ç–∏ 31% –ø—Ä–∏–æ–±—Ä–µ—Ç–∞–ª–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∑–∞ —Å–≤–æ–π —Å—á–µ—Ç. –•—É–∂–µ –≤—Å–µ–≥–æ –¥–µ–ª–∞ —Å –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ–º –ø—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤–æ–π —Ç–µ—Ä–∞–ø–∏–µ–π —Å–æ—Å—Ç–æ—è—Ç –≤ –ö—Ä–∞—Å–Ω–æ–¥–∞—Ä—Å–∫–æ–º –∫—Ä–∞–µ, –†–æ—Å—Ç–æ–≤—Å–∫–æ–π, –°–≤–µ—Ä–¥–ª–æ–≤—Å–∫–æ–π, –ù–æ–≤–æ—Å–∏–±–∏—Ä—Å–∫–æ–π, –ü–µ–Ω–∑–µ–Ω—Å–∫–æ–π, –ö—É—Ä—Å–∫–æ–π, –í–æ—Ä–æ–Ω–µ–∂—Å–∫–æ–π –æ–±–ª–∞—Å—Ç—è—Ö, –¢–∞—Ç–∞—Ä—Å—Ç–∞–Ω–µ, –ë–∞—à–∫–æ—Ä—Ç–æ—Å—Ç–∞–Ω–µ –∏ —Ä–µ—Å–ø—É–±–ª–∏–∫–∞—Ö –°–µ–≤–µ—Ä–æ-–ö–∞–≤–∫–∞–∑—Å–∫–æ–≥–æ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –æ–∫—Ä—É–≥–∞. –í –ø–µ—Ä–≤—É—é –æ—á–µ—Ä–µ–¥—å —ç—Ç–æ —Å–≤—è–∑–∞–Ω–æ —Å —É–≤–µ–ª–∏—á–µ–Ω–∏–µ–º –∫–æ–ª–∏—á–µ—Å—Ç–≤–∞ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤: –≤—ã—Ä–æ—Å–ª–æ —á–∏—Å–ª–æ –ø–æ–∂–∏–ª—ã—Ö –ª—é–¥–µ–π, –ø—Ä–æ–¥–æ–ª–∂–∏—Ç–µ–ª—å–Ω–æ—Å—Ç—å –∂–∏–∑–Ω–∏ –æ–Ω–∫–æ–ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —É–≤–µ–ª–∏—á–∏–ª–∞—Å—å, –∞ —Ä–∞–∫ –≤—Å—ë —á–∞—â–µ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏—Ä—É—é—Ç –Ω–∞ —Ä–∞–Ω–Ω–∏—Ö —Å—Ç–∞–¥–∏—è—Ö. –ü—Ä–æ –≤–∫–ª—é—á–µ–Ω–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü —Ç–æ–∂–µ –≤—Å–ø–æ–º–Ω–∏–ª–∏. –ù–∞ –∑–∞—Å–µ–¥–∞–Ω–∏–∏ 28 –∞–ø—Ä–µ–ª—è 2025 –≥–æ–¥–∞ –∫–æ–º–∏—Å—Å–∏—è ¬´–∑–∞–≤–µ—Ä–Ω—É–ª–∞¬ª —á–µ—Ç—ã—Ä–µ –∏–∑ —à–µ—Å—Ç–∏ –ø—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏–µ –µ—â—ë –æ–¥–Ω–æ–≥–æ –ø–µ—Ä–µ–Ω–µ—Å–ª–∏ –Ω–∞ III –∫–≤–∞—Ä—Ç–∞–ª 2025 –≥–æ–¥–∞. –ù–∞ –ø–æ—Å–ª–µ–¥–Ω–µ–º –∑–∞—Å–µ–¥–∞–Ω–∏–∏ 6 –∞–≤–≥—É—Å—Ç–∞ –∏–∑ –≤–æ—Å—å–º–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –æ–¥–æ–±—Ä–µ–Ω–∏–µ –ø–æ–ª—É—á–∏–ª–∏ —Ç–æ–ª—å–∫–æ —Ç—Ä–∏. –ò–∑-–∑–∞ —Ç–æ–≥–æ, —á—Ç–æ –Ω–µ –≤—Å–µ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –ø–æ–ø–∞–¥–∞—é—Ç –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü, –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–æ –Ω–µ –º–æ–∂–µ—Ç —É—Å—Ç–∞–Ω–æ–≤–∏—Ç—å –Ω–∞ –Ω–∏—Ö –ø—Ä–µ–¥–µ–ª—å–Ω—ã–µ —Ü–µ–Ω—ã, –≤–∫–ª—é—á–∏—Ç—å –≤ –ø—Ä–æ–≥—Ä–∞–º–º—É –≥–æ—Å–≥–∞—Ä–∞–Ω—Ç–∏–π –∏ —Å—Ñ–æ—Ä–º–∏—Ä–æ–≤–∞—Ç—å —Ç–∞—Ä–∏—Ñ—ã –û–ú–°. –í –∏—Ç–æ–≥–µ —Ä–µ–≥–∏–æ–Ω—ã –≤—ã–Ω—É–∂–¥–µ–Ω—ã –∑–∞–∫—É–ø–∞—Ç—å —Ç–∞–∫–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∑–∞ —Å–≤–æ–π —Å—á—ë—Ç, –∞ —ç—Ç–æ –ø–æ–¥ —Å–∏–ª—É –Ω–µ –≤—Å–µ–º. –ù–∞–ø—Ä–∏–º–µ—Ä, –µ—Å–ª–∏ –≤ –ü–µ–Ω–∑–µ–Ω—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –Ω–∞ –æ–¥–Ω–æ–≥–æ –±–æ–ª—å–Ω–æ–≥–æ –≤ –≥–æ–¥ —Ç—Ä–∞—Ç—è—Ç 18,3 —Ç—ã—Å. —Ä—É–±–ª–µ–π, —Ç–æ –≤ –Ø–º–∞–ª–æ-–ù–µ–Ω–µ—Ü–∫–æ–º –ê–û ‚Äî 193,8 —Ç—ã—Å. —Ä—É–±–ª–µ–π. –ü–æ —Å–ª–æ–≤–∞–º –∑–∞–º–ø—Ä–µ–¥–∞ –∫–æ–æ—Ä–¥–∏–Ω–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ —Å–æ–≤–µ—Ç–∞ ¬´–î–≤–∏–∂–µ–Ω–∏—è –ø—Ä–æ—Ç–∏–≤ —Ä–∞–∫–∞¬ª –ì–∞–ª–∏–Ω—ã –ú–∞—Ä–≥–µ–≤–∏—á, —Å–æ–≤–æ–∫—É–ø–Ω—ã–π –ø—Ä–æ–≥–Ω–æ–∑–∏—Ä—É–µ–º—ã–π –æ–±—ä—ë–º —Å—Ä–µ–¥—Å—Ç–≤ —Å–∏—Å—Ç–µ–º—ã –û–ú–°, —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –∏ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã—Ö –±—é–¥–∂–µ—Ç–æ–≤ –Ω–∞ –∑–∞–∫—É–ø–∫—É –æ–Ω–∫–æ–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∫ 2030 –≥–æ–¥—É –¥–æ–ª–∂–µ–Ω —Å–æ—Å—Ç–∞–≤–∏—Ç—å 503,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –¢—Ä–µ–±—É–µ—Ç—Å—è –µ–∂–µ–≥–æ–¥–Ω—ã–π —Ä–æ—Å—Ç —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è –Ω–∞ 13%. –° –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç—å—é —Ä–∞—Å—à–∏—Ä–µ–Ω–∏—è –ø–µ—Ä–µ—á–Ω—è –ñ–ù–í–õ–ü —Å–æ–≥–ª–∞—Å–Ω—ã –Ω–µ –≤—Å–µ. –ü–æ –º–Ω–µ–Ω–∏—é –ø—Ä–æ—Ñ–µ—Å—Å–æ—Ä–∞ –∫–∞—Ñ–µ–¥—Ä—ã —É–ø—Ä–∞–≤–ª–µ–Ω–∏—è –∏ —ç–∫–æ–Ω–æ–º–∏–∫–∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ù–ò–£ –í–®–≠ –í–∞—Å–∏–ª–∏—è –í–ª–∞—Å–æ–≤–∞, –æ–Ω —É–∂–µ –∏ —Ç–∞–∫ —Å–ª–∏—à–∫–æ–º –±–æ–ª—å—à–æ–π. –ü—Ä–æ–±–ª–µ–º–∞ –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç–∏ –ø—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –≤ –±–æ–ª—å—à–µ–π —Å—Ç–µ–ø–µ–Ω–∏ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–æ–Ω–Ω–∞—è, –∞ –Ω–µ –∏—Å–∫–ª—é—á–∏—Ç–µ–ª—å–Ω–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–∞—è, ‚Äî —Å—á–∏—Ç–∞–µ—Ç —ç–∫—Å–ø–µ—Ä—Ç. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""The letter from the 'Movement against Cancer' organization to the Prime Minister mentions that over a third of cancer patients (34.5%) faced difficulties in obtaining anti-cancer drugs. Almost 31% had to purchase the medications themselves. The situation is worst in regions such as Krasnodar Krai, Rostov Oblast, Sverdlovsk Oblast, Novosibirsk Oblast, Penza Oblast, Kursk Oblast, Voronezh Oblast, Tatarstan, Bashkortostan, and republics of the North Caucasus Federal District. The commission 'deferred' four out of six anti-cancer drugs on April 28, 2025. Only three were approved at the last meeting on August 6th. Due to not all innovative drugs being included in the –ñ–ù–í–õ–ü list, the state cannot set price limits for them, include them in the public health insurance program, and form OMS tariffs. As a result, regions are forced to purchase these drugs at their own expense"
2025-08-19T16:20:00+00:00,@bezrec,6442,https://t.me/bezrec/6442,"¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑¬ª –Ω–∞—á–∏–Ω–∞–µ—Ç –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ —É–Ω–∏–∫–∞–ª—å–Ω–æ–≥–æ –≥–æ—Ä–º–æ–Ω–∞–ª—å–Ω–æ–≥–æ –≥–µ–ª—è. –î–ª—è–ñ–µ–Ω—Å¬Æ –¥–∏–æ–ª –ø—Ä–µ–¥–Ω–∞–∑–Ω–∞—á–µ–Ω –¥–ª—è –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å–Ω–æ–π –≥–æ—Ä–º–æ–Ω–∞–ª—å–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –ø—Ä–∏ —Å–∏–º–ø—Ç–æ–º–∞—Ö –¥–µ—Ñ–∏—Ü–∏—Ç–∞ —ç—Å—Ç—Ä–æ–≥–µ–Ω–∞, –ª–µ—á–µ–Ω–∏–∏ –∫–ª–∏–º–∞–∫—Ç–µ—Ä–∏—á–µ—Å–∫–æ–≥–æ —Å–∏–Ω–¥—Ä–æ–º–∞, —Å–≤—è–∑–∞–Ω–Ω–æ–≥–æ —Å –µ—Å—Ç–µ—Å—Ç–≤–µ–Ω–Ω–æ–π –∏–ª–∏ –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–π –º–µ–Ω–æ–ø–∞—É–∑–æ–π, —Ä–∞–∑–≤–∏–≤—à–µ–π—Å—è –ø–æ—Å–ª–µ —Ö–∏—Ä—É—Ä–≥–∏—á–µ—Å–∫–æ–≥–æ –≤–º–µ—à–∞—Ç–µ–ª—å—Å—Ç–≤–∞. –í —Å–æ—Å—Ç–∞–≤–µ ‚Äî —Å–∏–Ω—Ç–µ—Ç–∏—á–µ—Å–∫–∏–π 17-—ç—Å—Ç—Ä–∞–¥–∏–æ–ª, —Ö–∏–º–∏—á–µ—Å–∫–∏ –∏ –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏ –∏–¥–µ–Ω—Ç–∏—á–Ω—ã–π —ç–Ω–¥–æ–≥–µ–Ω–Ω–æ–º—É —ç—Å—Ç—Ä–∞–¥–∏–æ–ª—É, –≤—ã—Ä–∞–±–∞—Ç—ã–≤–∞–µ–º–æ–º—É —è–∏—á–Ω–∏–∫–∞–º–∏. –ü—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å –æ–±–µ—â–∞–µ—Ç, —á—Ç–æ –≥–µ–ª—å —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ –∏ –±–µ–∑–æ–ø–∞—Å–Ω–æ –∏–∑–±–∞–≤–∏—Ç –æ—Ç —Å–∏–º–ø—Ç–æ–º–æ–≤ –∫–ª–∏–º–∞–∫—Ç–µ—Ä–∏—á–µ—Å–∫–æ–≥–æ —Å–∏–Ω–¥—Ä–æ–º–∞, —Å–ø–æ—Å–æ–±–Ω—ã—Ö —Å—É—â–µ—Å—Ç–≤–µ–Ω–Ω–æ –ø–æ–¥–ø–æ—Ä—Ç–∏—Ç—å –∫–∞—á–µ—Å—Ç–≤–æ –∂–∏–∑–Ω–∏. –¢—Ä–∞–Ω—Å–¥–µ—Ä–º–∞–ª—å–Ω–æ–µ –Ω–∞–Ω–µ—Å–µ–Ω–∏–µ –ø–æ–∑–≤–æ–ª—è–µ—Ç ¬´–æ–±–æ–π—Ç–∏¬ª –ø–µ—Ä–≤—É—é —Å—Ç–∞–¥–∏—é –ø–µ—á–µ–Ω–æ—á–Ω–æ–≥–æ –º–µ—Ç–∞–±–æ–ª–∏–∑–º–∞ –∏ –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ —Å–Ω–∏–∑–∏—Ç—å –∫–æ–ª–µ–±–∞–Ω–∏—è –∫–æ–Ω—Ü–µ–Ω—Ç—Ä–∞—Ü–∏–∏ —ç—Å—Ç—Ä–∞–¥–∏–æ–ª–∞ –≤ –ø–ª–∞–∑–º–µ –∫—Ä–æ–≤–∏. –û–ø—Ç–∏–º–∞–ª—å–Ω–∞—è –∞–±—Å–æ—Ä–±—Ü–∏—è –¥–æ—Å—Ç–∏–≥–∞–µ—Ç—Å—è –ø—Ä–∏ –Ω–∞–Ω–µ—Å–µ–Ω–∏–∏ –Ω–∞ –ø–æ–≤–µ—Ä—Ö–Ω–æ—Å—Ç—å, —Ä–∞–≤–Ω—É—é –æ–¥–Ω–æ–π –∏–ª–∏ –¥–≤—É–º –ª–∞–¥–æ–Ω—è–º. –î–ª—è–ñ–µ–Ω—Å¬Æ –¥–∏–æ–ª –±—É–¥–µ—Ç –≤—ã–ø—É—Å–∫–∞—Ç—å—Å—è –Ω–∞ –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω–æ–º –≤ —Å—Ç—Ä–∞–Ω–µ –∏ –∫—Ä—É–ø–Ω–µ–π—à–µ–º –≤ –ï–≤—Ä–æ–ø–µ –∑–∞–≤–æ–¥–µ –ø–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤—É –≥–æ—Ä–º–æ–Ω–∞–ª—å–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –¢—é–º–µ–Ω–∏. –ü—Ä–µ–∑–∏–¥–µ–Ω—Ç ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑–∞¬ª –í–∏–∫—Ä–∞–º –ü—É–Ω–∏—è –ø–æ–æ–±–µ—â–∞–ª –∏ –¥–∞–ª—å—à–µ —Ä–∞–∑–≤–∏–≤–∞—Ç—å —Ä–∞–∑—Ä–∞–±–æ—Ç–∫—É –≥–æ—Ä–º–æ–Ω–∞–ª—å–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –æ—Ç–º–µ—Ç–∏–≤ –ø–æ–¥–¥–µ—Ä–∂–∫—É –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è –ú–∏–Ω–∑–¥—Ä–∞–≤–æ–º, –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–æ–º –∏ –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ–º. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, sanctions, shortage, demand, epidemic, vaccine"",
  ""impact"": ""high"",
  ""english"": ""The company 'Pharmasyn' begins production of a unique hormonal gel called ForGent¬Æ Diol. It is designed for hormone replacement therapy in women experiencing symptoms of estrogen deficiency, such as menopause or surgical menopause. The gel contains synthetic 17-estradiol, chemically and biologically identical to endogenous estradiol produced by ovaries. The company promises that the gel will effectively and safely alleviate climacteric symptoms, significantly improving quality of life. Transdermal application allows 'to bypass' the first phase of liver metabolism and significantly reduce plasma estradiol concentrations. The optimal absorption is achieved by applying to a surface equivalent of one or two palms. ForGent¬Æ Diol will be produced at the only plant in the country and one of the largest in Europe for hormonal drugs, located in Tyumen. The company's President Vikram Punia promises to further develop hormone drug development, noting support from the Ministry of Health, Ministry of Industry and Trade, and Government. ""
}"
2025-08-19T14:20:00+00:00,@bezrec,6441,https://t.me/bezrec/6441,"–¶–∏–∫–ª–æ—Ñ–µ—Ä–æ–Ω ¬´–ø–æ–ø—Ä–æ—Å–∏–ª–∏¬ª –∏–∑ –ñ–ù–í–õ–ü. –ò—Å–∫–ª—é—á–∏—Ç—å —Ñ–æ—Ä–º—É –¥–ª—è –≤–Ω—É—Ç—Ä–∏–≤–µ–Ω–Ω–æ–≥–æ –∏ –≤–Ω—É—Ç—Ä–∏–º—ã—à–µ—á–Ω–æ–≥–æ –≤–≤–µ–¥–µ–Ω–∏—è –ø–æ–ø—É–ª—è—Ä–Ω–æ–≥–æ –∏–º–º—É–Ω–æ–º–æ–¥—É–ª—è—Ç–æ—Ä–∞ –∏–∑ –ñ–ù–í–õ–ü —Ä–µ–∫–æ–º–µ–Ω–¥–æ–≤–∞–ª–∞ –∫–æ–º–∏—Å—Å–∏—è –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –Ω–∞ –∑–∞—Å–µ–¥–∞–Ω–∏–∏ 7 –∞–≤–≥—É—Å—Ç–∞. –ì–ª–∞–≤–Ω—ã–µ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã, –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ñ–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏, –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ –∏ –ø–∞—Ü–∏–µ–Ω—Ç—Å–∫–æ–µ —Å–æ–æ–±—â–µ—Å—Ç–≤–æ –≤–æ–∑—Ä–∞–∂–∞—Ç—å –Ω–µ —Å—Ç–∞–ª–∏. –¢–∞–∫, –ø—Ä–µ–ø—è—Ç—Å—Ç–≤–∏–π –¥–ª—è –∏—Å–∫–ª—é—á–µ–Ω–∏—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –∏–∑ –ñ–ù–í–õ–ü –Ω–µ —É–≤–∏–¥–µ–ª –≥–ª–∞–≤–Ω—ã–π –≤–Ω–µ—à—Ç–∞—Ç–Ω—ã–π —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç –ø–æ –∏–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã–º –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º –í–ª–∞–¥–∏–º–∏—Ä –ß—É–ª–∞–Ω–æ–≤. –ê—Ä–≥—É–º–µ–Ω—Ç—ã —ç–∫—Å–ø–µ—Ä—Ç–∞ –≤ –ø–æ–ª—å–∑—É —Ç–∞–∫–æ–≥–æ —Ä–µ—à–µ–Ω–∏—è: üíä–º–µ–≥–ª—é–º–∏–Ω–∞ –∞–∫—Ä–∏–¥–æ–Ω–æ—Ü–∏—Ç–∞—Ç (–¶–∏–∫–ª–æ—Ñ–µ—Ä–æ–Ω) –≤ —Ñ–æ—Ä–º–µ –≤–Ω—É—Ç—Ä–∏–≤–µ–Ω–Ω–æ–≥–æ –∏ –≤–Ω—É—Ç—Ä–∏–º—ã—à–µ—á–Ω–æ–≥–æ –≤–≤–µ–¥–µ–Ω–∏—è –≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏—è—Ö –Ω–µ –ø—Ä–∏—Å—É—Ç—Å—Ç–≤—É–µ—Ç, –≤ –æ—Ç–ª–∏—á–∏–µ –æ—Ç —Å–≤–æ–µ–π —Ç–∞–±–ª–µ—Ç–∏—Ä–æ–≤–∞–Ω–Ω–æ–π —Ñ–æ—Ä–º—ã; üíä—É –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –µ—Å—Ç—å —Ç–µ—Ä–∞–ø–µ–≤—Ç–∏—á–µ—Å–∫–∏–µ –∞–Ω–∞–ª–æ–≥–∏, –≤ —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, –∞–∑–æ–∫—Å–∏–º–µ—Ä–∞ –±—Ä–æ–º–∏–¥ (–ü–æ–ª–∏–æ–∫—Å–∏–¥–æ–Ω–∏–π), –∫–æ—Ç–æ—Ä—ã–π –ø–æ —Å–≤–æ–∏–º —Ö–∞—Ä–∞–∫—Ç–µ—Ä–∏—Å—Ç–∏–∫–∞–º –Ω–µ —É—Å—Ç—É–ø–∞–µ—Ç, –∞ –≤ —Ä—è–¥–µ —Å–ª—É—á–∞–µ–≤, –ø–æ –Ω–∞—É—á–Ω—ã–º –¥–∞–Ω–Ω—ã–º, –¥–∞–∂–µ –ø—Ä–µ–≤–æ—Å—Ö–æ–¥–∏—Ç –µ–≥–æ –ø–æ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏; üíä–µ—Å—Ç—å –æ—Ç–ª–∏—á–∏—è –≤ –≤–æ–∑—Ä–∞—Å—Ç–Ω—ã—Ö –≥—Ä—É–ø–ø–∞—Ö: –º–µ–≥–ª—é–º–∏–Ω –∞–∫—Ä–∏–¥–æ–Ω–æ—Ü–∏—Ç–∞—Ç –º–æ–∂–Ω–æ –ø—Ä–∏–º–µ–Ω—è—Ç—å —Å —á–µ—Ç—ã—Ä–µ—Ö –ª–µ—Ç, –∞–∑–æ–∫—Å–∏–º–µ—Ä–∞ –±—Ä–æ–º–∏–¥ ‚Äî —Å —à–µ—Å—Ç–∏ –º–µ—Å—è—Ü–µ–≤. –ë—É–∫–≤–∞–ª—å–Ω–æ –∑–∞ –Ω–µ—Å–∫–æ–ª—å–∫–æ –¥–Ω–µ–π –¥–æ –∫–æ–º–∏—Å—Å–∏–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤ –æ—á–µ–Ω—å –∫—Å—Ç–∞—Ç–∏ –≤–∫–ª—é—á–∏–ª –∞–∑–æ–∫—Å–∏–º–µ—Ä–∞ –±—Ä–æ–º–∏–¥ –≤ –æ–±–Ω–æ–≤–ª–µ–Ω–Ω—É—é –≤–µ—Ä—Å–∏—é –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π –ø–æ –ª–µ—á–µ–Ω–∏—é –û–†–í–ò —É –≤–∑—Ä–æ—Å–ª—ã—Ö. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The antiviral drug Acyclovir (Zovirax) was recommended for exclusion from the Essential Medicines List (–ñ–ù–í–õ–ü) by a commission of the Ministry of Health on August 7. Main specialists, clinical pharmacologists, and the Ministry of Industry did not oppose this recommendation. The main expert's argument in favor of exclusion: Acyclovir is not included in clinical recommendations for intravenous and intramuscular administration, unlike its tablet form. There are therapeutic alternatives such as azothiomorph bromide (Polioxamer), which is not inferior to Acyclovir in terms of characteristics and, according to scientific data, even surpasses it in effectiveness. There are also differences in age groups: Acyclovir can be used from 4 years old, while azothiomorph bromide is recommended for use starting at 6 months.""
}"
2025-08-19T10:55:00+00:00,@bezrec,6440,https://t.me/bezrec/6440,"–ú–∏–Ω–∑–¥—Ä–∞–≤ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –∫—Ä–∏—Ç–µ—Ä–∏–∏ –∫–∞—á–µ—Å—Ç–≤–∞ –∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –ë–ê–î–æ–≤. –ü—Ä–æ–µ–∫—Ç –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞, –ø–æ–¥–≥–æ—Ç–æ–≤–ª–µ–Ω–Ω—ã–π –ú–∏–Ω–∑–¥—Ä–∞–≤–æ–º, –¥–æ–ª–∂–µ–Ω –∑–∞–∫—Ä–µ–ø–∏—Ç—å –∫—Ä–∏—Ç–µ—Ä–∏–∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –∏ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ –±–∏–æ–¥–æ–±–∞–≤–æ–∫, –∫–æ—Ç–æ—Ä—ã–µ –≤—Ä–∞—á–∏ —Å–º–æ–≥—É—Ç –Ω–∞–∑–Ω–∞—á–∞—Ç—å —Å–≤–æ–∏–º –ø–∞—Ü–∏–µ–Ω—Ç–∞–º —Å 1 —Å–µ–Ω—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞. –ù–∞–ø–æ–º–Ω–∏–º, –∑–∞–∫–æ–Ω –≤—ã–∑–≤–∞–ª –Ω–µ–æ–¥–Ω–æ–∑–Ω–∞—á–Ω—É—é —Ä–µ–∞–∫—Ü–∏—é –≤ –≤–µ–¥–æ–º—Å—Ç–≤–µ –∏–∑-–∑–∞ —Å–ª–æ–∂–Ω–æ—Å—Ç–µ–π —Å –æ—Ü–µ–Ω–∫–æ–π —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –¥–æ–±–∞–≤–æ–∫. –ù–µ–∫–æ—Ç–æ—Ä—ã–µ –∏ –≤–æ–≤—Å–µ –≥–æ–≤–æ—Ä–∏–ª–∏ –æ –Ω–µ–≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ —ç—Ç–æ–≥–æ –ø—Ä–æ—Ü–µ—Å—Å–∞ –∏–∑-–∑–∞ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏—è –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å–Ω–æ –∑–∞–∫—Ä–µ–ø–ª–µ–Ω–Ω–æ–≥–æ –º–µ—Ö–∞–Ω–∏–∑–º–∞ –Ω–∞—É—á–Ω–æ–≥–æ –∏–∑—É—á–µ–Ω–∏—è —Å–≤–æ–π—Å—Ç–≤ –ë–ê–î–æ–≤ –∏ —Å–±–æ—Ä–∞ –¥–∞–Ω–Ω—ã—Ö –æ –ø–æ–±–æ—á–∫–∞—Ö. –ù–æ 1 —Å–µ–Ω—Ç—è–±—Ä—è –≤—Å—ë –±–ª–∏–∂–µ, –∞ –ø–µ—Ä–µ—á–µ–Ω—å —Ä–∞–∑—Ä–µ—à–µ–Ω–Ω—ã—Ö –¥–ª—è –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –¥–æ–±–∞–≤–æ–∫ —Å–∞–º —Å–µ–±—è –Ω–µ —Å—Ñ–æ—Ä–º–∏—Ä—É–µ—Ç. –ò—Ç–∞–∫, –∫—Ä–∏—Ç–µ—Ä–∏–∏ –∫–∞—á–µ—Å—Ç–≤–∞ –ë–ê–î –æ—Ç –ú–∏–Ω–∑–¥—Ä–∞–≤–∞: üü¢—Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–µ –∫–æ–º–ø–æ–Ω–µ–Ω—Ç–æ–≤ –ë–ê–î —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è–º –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ –ï–ê–≠–°, –ø–æ–¥—Ç–≤–µ—Ä–∂–¥—ë–Ω–Ω–æ–µ –∞–∫–∫—Ä–µ–¥–∏—Ç–æ–≤–∞–Ω–Ω—ã–º–∏ –≤ –†–§ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è–º–∏; üü¢–Ω–∞–ª–∏—á–∏–µ —É –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–æ–π –¥–æ–∫—É–º–µ–Ω—Ç–∞—Ü–∏–∏ —Å –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–µ–π –æ —Å–∏—Å—Ç–µ–º–µ –æ—Ü–µ–Ω–∫–∏ –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω—ã—Ö –æ–ø–∞—Å–Ω–æ—Å—Ç–µ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –∏ –º–µ—Ä –ø–æ –∏—Ö —É—Å—Ç—Ä–∞–Ω–µ–Ω–∏—é. –ö—Ä–∏—Ç–µ—Ä–∏–∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏: üü¢–≤–∫–ª—é—á–µ–Ω–∏–µ –≤—Ö–æ–¥—è—â–µ–≥–æ –≤ —Å–æ—Å—Ç–∞–≤ –ë–ê–î–∞ –≤–µ—â–µ—Å—Ç–≤–∞ –≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –∏ –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω—ã–µ –¥–æ–∫—É–º–µ–Ω—Ç—ã, —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–Ω—ã–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º–∏ —Ü–µ–Ω—Ç—Ä–∞–º–∏ –∏–ª–∏ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—ã–º–∏ –∞—Å—Å–æ—Ü–∏–∞—Ü–∏—è–º–∏; üü¢–Ω–∞–ª–∏—á–∏–µ –Ω–∞—É—á–Ω—ã—Ö –ø—É–±–ª–∏–∫–∞—Ü–∏–π –æ —Å–æ—Å—Ç–∞–≤–µ, –¥–æ–∑–∏—Ä–æ–≤–∫–∞—Ö –∏ –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏–∏ –ë–ê–î —Å –¥—Ä—É–≥–∏–º–∏ –≤–µ—â–µ—Å—Ç–≤–∞–º–∏; üü¢–Ω–∞–ª–∏—á–∏–µ —Å–æ–±—Å—Ç–≤–µ–Ω–Ω—ã—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è, –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–∞—é—â–∏—Ö –ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω–æ–µ –≤–ª–∏—è–Ω–∏–µ –¥–æ–±–∞–≤–æ–∫ –Ω–∞ –∑–¥–æ—Ä–æ–≤—å–µ. –î–∏—Ä–µ–∫—Ç–æ—Ä –ø–æ —Ä–∞–∑–≤–∏—Ç–∏—é RNC Pharma –ù–∏–∫–æ–ª–∞–π –ë–µ—Å–ø–∞–ª–æ–≤ —Å–æ–º–Ω–µ–≤–∞–µ—Ç—Å—è, —á—Ç–æ –≤—Å–µ –¥–æ–±–∞–≤–∫–∏, —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–∏–µ –∫—Ä–∏—Ç–µ—Ä–∏—è–º, –∞–≤—Ç–æ–º–∞—Ç–∏—á–µ—Å–∫–∏ –ø–æ–ø–∞–¥—É—Ç –≤ –ø–µ—Ä–µ—á–µ–Ω—å —Ä–∞–∑—Ä–µ—à–µ–Ω–Ω—ã—Ö –ë–ê–î–æ–≤, —Å–∫–æ—Ä–µ–µ –≤—Å–µ–≥–æ, –¥–ª—è –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –±—É–¥–µ—Ç –≤–≤–µ–¥–µ–Ω–∞ –æ—Ç–¥–µ–ª—å–Ω–∞—è –ø—Ä–æ—Ü–µ–¥—É—Ä–∞. –ò —Ç—É—Ç –≤—Å—Ç–∞—ë—Ç –≤–æ–ø—Ä–æ—Å —Ü–µ–ª–µ—Å–æ–æ–±—Ä–∞–∑–Ω–æ—Å—Ç–∏ —Ç—Ä—É–¥–æ–∑–∞—Ç—Ä–∞—Ç: –û–Ω–∞ –¥–∞–∂–µ –¥–ª—è –∫—Ä—É–ø–Ω—ã—Ö –∫–æ–º–ø–∞–Ω–∏–π –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ –Ω–∏–∑–∫–∞—è. –í—Ä–∞—á–∏ –≤—Å—ë —Ä–∞–≤–Ω–æ —Ä–µ–∫–æ–º–µ–Ω–¥—É—é—Ç –ë–ê–î—ã. –ü—Ä–æ—Å—Ç–æ –¥–µ–ª–∞–µ—Ç—Å—è —ç—Ç–æ –Ω–µ –≤ —Ñ–æ—Ä–º–∞—Ç–µ —Ä–µ—Ü–µ–ø—Ç–∞ –∫–∞–∫ —é—Ä–∏–¥–∏—á–µ—Å–∫–∏ –æ–±—è–∑—ã–≤–∞—é—â–µ–≥–æ –¥–æ–∫—É–º–µ–Ω—Ç–∞, –∞ –≤ –≤–∏–¥–µ —É—Å—Ç–Ω–æ–π –∏–ª–∏ –ø—Ä–æ—Å—Ç–æ–π –ø–∏—Å—å–º–µ–Ω–Ω–æ–π —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏, ‚Äî —Å—á–∏—Ç–∞–µ—Ç –ë–µ—Å–ø–∞–ª–æ–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health has developed criteria for the quality and effectiveness of dietary supplements. The project on a government decree, prepared by the Ministry of Health, should establish criteria for the safety and effectiveness of dietary supplements that doctors can prescribe to patients starting September 1, 2025. The law was criticized due to difficulties in assessing the effectiveness of supplements. Some even suggested that this process is impossible due to a lack of legally enforceable mechanisms for studying the properties of dietary supplements and collecting data on side effects. However, September is approaching, and a list of approved for use supplements will form itself. The criteria for the quality of dietary supplements from the Ministry of Health: üü¢compliance with safety requirements of the EAECS, confirmed by accredited organizations in Russia; üü¢the presence of technical documentation from the manufacturer containing information on a system for assessing potential risks and measures to eliminate them. RNC Pharma Director Nikolay Bezpalyov doubts that all supplements meeting the criteria will automatically be included in the list of approved dietary supplements. He believes that for manufacturers"
2025-08-19T07:45:01+00:00,@bezrec,6439,https://t.me/bezrec/6439,"–í–∞—Å —É–∂–µ 30 —Ç—ã—Å—è—á. –°–ø–∞—Å–∏–±–æ, —á—Ç–æ —á–∏—Ç–∞–µ—Ç–µ ¬´–ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞¬ª. –ú—ã –±—É–¥–µ–º –∏ –¥–∞–ª—å—à–µ —Ä–∞—Å—Ç–∏, —Ä–∞–∑–≤–∏–≤–∞—Ç—å—Å—è –∏ –ø–∏—Å–∞—Ç—å —á–µ—Å—Ç–Ω–æ –∏ –Ω–µ–ø—Ä–µ–¥–≤–∑—è—Ç–æ –æ —Ñ–∞—Ä–º–±–∏–∑–Ω–µ—Å–µ, —á—Ç–æ–±—ã –≤—ã –∫–∞–∂–¥—ã–π –¥–µ–Ω—å —É–∑–Ω–∞–≤–∞–ª–∏ –∞–∫—Ç—É–∞–ª—å–Ω–æ–µ –∏ –≤–∞–∂–Ω–æ–µ –ø—Ä–æ –æ—Ç—Ä–∞—Å–ª—å. –í—Å—ë —Å–∞–º–æ–µ –∏–Ω—Ç–µ—Ä–µ—Å–Ω–æ–µ ‚Äî –≤–ø–µ—Ä–µ–¥–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-08-19T05:40:33+00:00,@bezrec,6436,https://t.me/bezrec/6436,"–ü–æ—Å–º–æ—Ç—Ä–µ–ª–∏ –≤—Ç–æ—Ä–æ–π –≤—ã–ø—É—Å–∫ –±—é–ª–ª–µ—Ç–µ–Ω—è ePharma –æ—Ç Data Insight –∑–∞ –∏—é–Ω—å. –î–µ–ª–∏–º—Å—è –∫–ª—é—á–µ–≤—ã–º–∏ —Ü–∏—Ñ—Ä–∞–º–∏ –∏–∑ –∞–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–æ–≥–æ –æ—Ç—á—ë—Ç–∞ –æ —Ä–∞–±–æ—Ç–µ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç-–∞–ø—Ç–µ–∫ –≤ –†–æ—Å—Å–∏–∏: üü© –≤ –∏—é–Ω–µ 2025 –≥–æ–¥–∞ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç-–∞–ø—Ç–µ–∫–∏ –≤—ã–ø–æ–ª–Ω–∏–ª–∏ 21,4 –º–ª–Ω –∑–∞–∫–∞–∑–æ–≤, —á—Ç–æ –Ω–∞ 5% –º–µ–Ω—å—à–µ, —á–µ–º –≤ –º–∞–µ 2025 –≥–æ–¥–∞, –∏ –Ω–∞ 24% –±–æ–ª—å—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É; üü© —Å—Ä–µ–¥–Ω–µ—Å—É—Ç–æ—á–Ω–æ–µ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –∑–∞–∫–∞–∑–æ–≤ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –º–∞–µ–º —Å–æ–∫—Ä–∞—Ç–∏–ª–æ—Å—å –Ω–∞ 2%, –¥–æ 712 —Ç—ã—Å.; üü© —Ç–µ–º–ø—ã —Ä–æ—Å—Ç–∞ –∫–æ–ª–∏—á–µ—Å—Ç–≤–∞ –∑–∞–∫–∞–∑–æ–≤ (–≥–æ–¥ –∫ –≥–æ–¥—É) –≤—ã—Ä–æ—Å–ª–∏ –Ω–∞ 7 –ø.–ø. ‚Äì —Å 17% –¥–æ 24%; üü© –∏—é–Ω—å –≤–º–µ—Å—Ç–µ —Å –º–∞—Ä—Ç–æ–º —Å—Ç–∞–ª –ª—É—á—à–∏–º —Å –Ω–æ—è–±—Ä—è 2024 –≥–æ–¥–∞ –º–µ—Å—è—Ü–µ–º –ø–æ —Ç–µ–º–ø–∞–º —Ä–æ—Å—Ç–∞ —Ä—ã–Ω–∫–∞; üü© –æ–±—ä—ë–º –æ–Ω–ª–∞–π–Ω-–ø—Ä–æ–¥–∞–∂ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç-–∞–ø—Ç–µ–∫ –¥–æ—Å—Ç–∏–≥ 35 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π (+25% –∫ –∏—é–Ω—é 2024 –≥–æ–¥–∞); üü© —Å—Ä–µ–¥–Ω–∏–π —á–µ–∫ –≤ –∏—é–Ω–µ ‚Äî 1 617 —Ä—É–±–ª–µ–π (1% –∑–∞ –≥–æ–¥); üü© –æ–±—ä—ë–º —Ä—ã–Ω–∫–∞ –≤ —Ü–µ–ª–æ–º –∑–∞ –ø–æ—Å–ª–µ–¥–Ω–∏–µ 12 –º–µ—Å—è—Ü–µ–≤ –¥–æ—Å—Ç–∏–≥ 263 –º–ª–Ω –∑–∞–∫–∞–∑–æ–≤ –∏ –±–æ–ª–µ–µ —á–µ–º 418 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —á—Ç–æ –Ω–∞ 9-11% –≤—ã—à–µ –ø–æ–∫–∞–∑–∞—Ç–µ–ª–µ–π –∫–∞–ª–µ–Ω–¥–∞—Ä–Ω–æ–≥–æ 2024 –≥–æ–¥–∞ –∏ –Ω–∞ 21-24% –≤—ã—à–µ, —á–µ–º –≥–æ–¥ –Ω–∞–∑–∞–¥; üü© –ø—Ä–∏ —Å–æ—Ö—Ä–∞–Ω–µ–Ω–∏–∏ —Ç–µ–∫—É—â–µ–π –¥–∏–Ω–∞–º–∏–∫–∏ –ø–æ–∫–∞–∑–∞—Ç–µ–ª–µ–π TTM (—Å–∫–æ–ª—å–∑—è—â–µ–π —Å—É–º–º—ã –∑–∞ 12 –ø–æ—Å–ª–µ–¥–Ω–∏—Ö –º–µ—Å—è—Ü–µ–≤) –æ–±—ä—ë–º —Ä—ã–Ω–∫–∞ ePharma –∫ –∫–æ–Ω—Ü—É 2025 –≥–æ–¥–∞ –¥–æ—Å—Ç–∏–≥–Ω–µ—Ç –ø—Ä–∏–º–µ—Ä–Ω–æ 290 –º–ª–Ω –∑–∞–∫–∞–∑–æ–≤ –∏ –±–æ–ª–µ–µ —á–µ–º 460 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —á—Ç–æ —Å–æ–ø–æ—Å—Ç–∞–≤–∏–º–æ —Å —Ä–æ—Å—Ç–æ–º –Ω–∞ 20-22% –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ 2024 –≥–æ–¥–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The report from ePharma's bulletin shows that internet pharmacies completed 21.4 million orders in June 2025, a decrease of 5% compared to May 2025 and an increase of 24% year-over-year. The average daily order volume decreased by 2% to 712 thousand orders compared to May. The growth rate of order volume (year-over-year) increased by 7 percentage points - from 17% to 24%. June and March became the best months for market growth since November 2024. The online sales volume of internet pharmacies reached 35 billion yuan (+25% compared to June 2024). The average order value in June was 1,617 yuan (an increase of 1% year-over-year). The total market volume for the last 12 months reached over 4.18 billion yuan and more than 263 million orders, which is an increase of 9-11% compared to the calendar year "
2025-08-18T15:03:55+00:00,@bezrec,6435,https://t.me/bezrec/6435,"–í I-II –∫–≤–∞—Ä—Ç–∞–ª–µ 2025 –≥–æ–¥–∞ —Å—É–º–º–∞—Ä–Ω—ã–π –æ–±—ä—ë–º –æ–Ω–ª–∞–π–Ω –ø—Ä–æ–¥–∞–∂/–±—Ä–æ–Ω–∏—Ä–æ–≤–∞–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –ø–∞—Ä–∞—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∏ —Å–æ—Å—Ç–∞–≤–∏–ª 271,3 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, –ø–æ—Å—á–∏—Ç–∞–ª–∏ –≤ RNC Pharma. –û—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ –∞–Ω–∞–ª–æ–≥–∏—á–Ω–æ–≥–æ –ø–µ—Ä–∏–æ–¥–∞ 2024 –≥–æ–¥–∞ e-com –∫–∞–Ω–∞–ª –ø–æ–∫–∞–∑–∞–ª –ø—Ä–∏—Ä–æ—Å—Ç –Ω–∞ —É—Ä–æ–≤–Ω–µ 36,3% –≤ —Ä—É–±–ª—è—Ö. –ü—Ä–∏ —ç—Ç–æ–º –æ–±—â–∞—è –¥–∏–Ω–∞–º–∏–∫–∞ –≤—ã—Ä—É—á–∫–∏ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –∞–ø—Ç–µ–∫ –Ω–µ –ø—Ä–µ–≤—ã—à–∞–ª–∞ 12%, –≤ –æ—Å–Ω–æ–≤–Ω–æ–º –∏–∑-–∑–∞ —Ç–æ–≥–æ, —á—Ç–æ –ø–∞—Ä–∞—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫—É ¬´–ø–µ—Ä–µ—Ç—è–≥–∏–≤–∞—é—Ç¬ª –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å—ã. –ü—Ä–æ–¥–∞–∂–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ —Å –¥–æ—Å—Ç–∞–≤–∫–æ–π –¥–æ –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª—è —Ä–∞—Å—Ç—É—Ç –µ—â—ë –∞–∫—Ç–∏–≤–Ω–µ–µ, —á–µ–º –æ–Ω–ª–∞–π–Ω –∫–∞–Ω–∞–ª –≤ —Ü–µ–ª–æ–º. –í I –ø–æ–ª—É–≥–æ–¥–∏–∏ 2025 –≥–æ–¥–∞ –±—ã–ª–æ –ø—Ä–æ–¥–∞–Ω–æ –≥–æ—Ç–æ–≤—ã—Ö –õ–ü –Ω–∞ —Å—É–º–º—É 10,3 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —á—Ç–æ –Ω–∞ 56,3% –±–æ–ª—å—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É. –í –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ –æ–±—ä—ë–º –ø—Ä–æ–¥–∞–∂ –≤—ã—Ä–æ—Å –Ω–∞ 10,3%, –¥–æ 24,2 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫. –û–±—â–∞—è –¥–æ–ª—è e-com —Å –¥–æ—Å—Ç–∞–≤–∫–æ–π –¥–æ –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª—è –æ—Å—Ç–∞—ë—Ç—Å—è —Å—Ä–∞–≤–Ω–∏—Ç–µ–ª—å–Ω–æ –Ω–µ–±–æ–ª—å—à–æ–π ‚Äî 1,14% –æ—Ç –æ–±—â–µ–≥–æ –æ–±—ä—ë–º–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–π —Ñ–∞—Ä–º—Ä–æ–∑–Ω–∏—Ü—ã. –î–∏–Ω–∞–º–∏–∫–∞ –∑–∞ –≥–æ–¥ –≤ –∞–±—Å–æ–ª—é—Ç–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ ‚Äî 0,29%. –°—É–¥—è –ø–æ –æ–±—ä—ë–º—É –ø—Ä–æ–¥–∞–∂ –≤ –¥–µ–Ω—å–≥–∞—Ö, —á–∞—â–µ –≤—Å–µ–≥–æ –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª–∏ –∑–∞–∫–∞–∑—ã–≤–∞—é—Ç —Å –¥–æ—Å—Ç–∞–≤–∫–æ–π –º–µ—Å—Ç–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–ª—è –ª–µ—á–µ–Ω–∏—è –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –≥–æ—Ä–ª–∞ –∏ –Ω–æ—Å–∞ ‚Äî –æ–±–µ –≥—Ä—É–ø–ø—ã –ø–æ–∫–∞–∑–∞–ª–∏ —Ä—É–±–ª—ë–≤—É—é –¥–∏–Ω–∞–º–∏–∫—É –Ω–∞ —É—Ä–æ–≤–Ω–µ –±–æ–ª–µ–µ 50%. –ë–µ—Å—Å–ø–æ—Ä–Ω—ã–π –ª–∏–¥–µ—Ä —Å —Ç–æ—á–∫–∏ –∑—Ä–µ–Ω–∏—è —Ç–µ–º–ø–æ–≤ —Ä–æ—Å—Ç–∞ e-com –ø—Ä–æ–¥–∞–∂ –ø–æ –∞–ø—Ç–µ—á–Ω–æ–º—É –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç—É ‚Äî Polza.—Ä—É, –∑–∞ –≥–æ–¥ –ø—Ä–æ–µ–∫—Ç –æ—Ç –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ü—É–ª—å—Å¬ª –Ω–∞—Ä–∞—Å—Ç–∏–ª —Å—É–º–º–∞—Ä–Ω—É—é –≤—ã—Ä—É—á–∫—É –≤ 2,5 —Ä–∞–∑–∞, –∑–∞–∫—Ä–µ–ø–∏–≤—à–∏—Å—å –Ω–∞ 10-–π —Å—Ç—Ä–æ—á–∫–µ —Ä–µ–π—Ç–∏–Ω–≥–æ–≤–æ–π —Ç–∞–±–ª–∏—Ü—ã. –°–æ–ø–æ—Å—Ç–∞–≤–∏–º—ã–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –ø–æ–∫–∞–∑—ã–≤–∞—é—Ç ¬´–†–∏–≥–ª–∞¬ª, ¬´–ê–ø—Ä–µ–ª—å¬ª –∏ ¬´–Æ—Ç–µ–∫–∞¬ª. –í —Ç–æ–ø-10 —Ç–∞–∫–∂–µ –≤–æ—à–ª–∏: ¬´–ê–ø—Ç–µ–∫–∞.—Ä—É¬ª, ¬´–ó–¥—Ä–∞–≤—Å–∏—Ç–∏¬ª, ¬´–ù–µ–æ—Ñ–∞—Ä–º¬ª, ¬´–ï–∞–ø—Ç–µ–∫–∞¬ª, ¬´36,6¬ª, ¬´–§–∞—Ä–º–ª–µ–Ω–¥¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The online sales and bookings of medicines and parapharmaceuticals in Russia, Belarus, Kazakhstan, Kyrgyz Republic, Uzbekistan, Tajikistan, Turkmenistan, Armenia, Azerbaijan, Georgia, Ukraine, Mongolia increased by 36.3% in rubles compared to the same period last year (2024). However, the overall revenue growth of Russian pharmacies was only 12%. The delivery-to-consumer sales of medicines are growing even faster than the overall e-commerce channel. In the first half of 2025, ready-to-use medicines were sold for a total amount of 1.03 billion rubles, which is an increase of 56.3% year-over-year. The natural growth in volume was 10.3%, reaching 24.2 million units. The share of e-commerce with delivery to consumer remains relatively small at 1.14% of the total Russian pharmaceutical retail volume. The growth in absolute terms was 0.29%. Polza.ru, a project from the 'Pulse'"
2025-08-18T12:20:31+00:00,@bezrec,6434,https://t.me/bezrec/6434,"–ê–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å—â–∏–∫–∏ –ø–æ—Ö–≤–∞–ª–∏–ª–∏—Å—å —É—Å–ø–µ—Ö–∞–º–∏ –≤ —Å–Ω–∏–∂–µ–Ω–∏–∏ —Ü–µ–Ω –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞. –ü–æ –¥–∞–Ω–Ω—ã–º –§–ê–°, —Å —è–Ω–≤–∞—Ä—è 2025 –≥–æ–¥–∞ –≤ —Å—Ä–µ–¥–Ω–µ–º –Ω–∞ 15% —Å–Ω–∏–∂–µ–Ω–æ 320 —Ü–µ–Ω –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ (44 –ú–ù–ù). –ß—Ç–æ —Å–ø–æ—Å–æ–±—Å—Ç–≤–æ–≤–∞–ª–æ: üîò—Å–Ω–∏–∂–µ–Ω–∏–µ —Ü–µ–Ω –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ —Ä–µ—Ñ–µ—Ä–µ–Ω—Ç–Ω—ã—Ö —Å—Ç—Ä–∞–Ω; üîò—Å–Ω–∏–∂–µ–Ω–∏–µ —Ü–µ–Ω –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤ –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤; üîò—Å–Ω–∏–∂–µ–Ω–∏–µ —Ü–µ–Ω –Ω–∞ –ø–µ—Ä–≤—ã–µ –¥–∂–µ–Ω–µ—Ä–∏–∫–∏ –ø–æ—Å–ª–µ –≤—ã—Ö–æ–¥–∞ –≤—Ç–æ—Ä—ã—Ö; üîò—ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–∏–π –∞–Ω–∞–ª–∏–∑ —Å–ª—É–∂–±—ã –ø—Ä–∏ –≤—ã—è–≤–ª–µ–Ω–∏–∏ –æ—à–∏–±–æ–∫ –≤ —Ä–∞—Å—á–µ—Ç–∞—Ö —Å–æ —Å—Ç–æ—Ä–æ–Ω—ã –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π. –í—Å–µ–≥–æ –ø–æ —Å–æ—Å—Ç–æ—è–Ω–∏—é –Ω–∞ —Å–µ—Ä–µ–¥–∏–Ω—É –∞–≤–≥—É—Å—Ç–∞ —Ä–µ–≥—É–ª—è—Ç–æ—Ä –ø—Ä–æ–∞–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–ª 5,6 —Ç—ã—Å. —Ü–µ–Ω –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –∏–∑ –ø–µ—Ä–µ—á–Ω—è –ñ–ù–í–õ–ü (542 –ú–ù–ù). –ò–∑ –Ω–∏—Ö —Å–æ–≥–ª–∞—Å–æ–≤–∞–Ω–æ 4,5 —Ç—ã—Å., –≤ —Ç–æ–º —á–∏—Å–ª–µ 693 —Ü–µ–Ω—ã (61 –ú–ù–ù) ‚Äì –¥–ª—è —É—Å—Ç—Ä–∞–Ω–µ–Ω–∏—è —Ä–∏—Å–∫–æ–≤ –¥–µ—Ñ–∏—Ü–∏—Ç–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""reimbursement, shortage"",
  ""impact"": ""medium"",
  ""english"": ""Antimonopoly authorities praised their success in reducing drug prices. According to the FAS, from January 2025, average prices on 320 drugs (44 MNN) have been reduced by 15%. The reasons for the reduction include: - Reduction in prices of drugs compared to reference countries; - Reduction in generic drug prices compared to original drugs; - Reduction in the price of first generics after the release of second ones; - Economic analysis by the service to identify errors in manufacturers' calculations. In total, as of mid-August, regulatory authorities have analyzed 5600 prices from manufacturers for drugs on the –ñ–ù–í–õ–ü list (542 MNN). Of these, 4500 have been agreed upon, including 693 prices (61 MNN) for risk mitigation of shortages.""
}"
2025-08-18T09:20:01+00:00,@bezrec,6433,https://t.me/bezrec/6433,"–ü—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –ø–æ–¥–¥–µ–ª–æ–∫ –≤—Å–ø–æ–º–Ω–∏–ª–∏ –ø—Ä–æ –û—Ä–ª–∏—Å—Ç–∞—Ç. –ù–µ—Å–º–æ—Ç—Ä—è –Ω–∞ —Ç–æ, —á—Ç–æ —Ä–æ—Å—Å–∏—è–Ω–µ –ø–µ—Ä–µ—Ö–æ–¥—è—Ç –Ω–∞ –±–æ–ª–µ–µ ¬´–ø—Ä–æ–¥–≤–∏–Ω—É—Ç—ã–µ¬ª –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –æ—Ç –æ–∂–∏—Ä–µ–Ω–∏—è, –Ω–µ–¥–æ–±—Ä–æ—Å–æ–≤–µ—Å—Ç–Ω—ã–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ —Ä–µ—à–∏–ª–∏ –ø–æ–∂–∏–≤–∏—Ç—å—Å—è –∏ –Ω–∞ ¬´–ª–µ–≤—ã—Ö¬ª –≤–µ—Ä—Å–∏—è—Ö –Ω–µ–∫–æ–≥–¥–∞ –ø–æ–ø—É–ª—è—Ä–Ω–æ–≥–æ –û—Ä–ª–∏—Å—Ç–∞—Ç–∞. –°–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–æ–π –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ ¬´–ê–Ω—Ç–∏–∫–æ–Ω—Ç—Ä–∞—Ñ–∞–∫—Ç¬ª #–∑–∞–º–µ—Ç–∏–ª–∏ –≤ —Å–≤–æ–±–æ–¥–Ω–æ–π –ø—Ä–æ–¥–∞–∂–µ –≤ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç–µ –ë–ê–î –ø–æ–¥ –Ω–∞–∑–≤–∞–Ω–∏–µ–º Orlistat. –ï–≥–æ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–µ–π –∑–∞–Ω–∏–º–∞–µ—Ç—Å—è –∏–Ω–¥–∏–≤–∏–¥—É–∞–ª—å–Ω—ã–π –ø—Ä–µ–¥–ø—Ä–∏–Ω–∏–º–∞—Ç–µ–ª—å –∏–∑ –ê—Ä–º–µ–Ω–∏–∏ –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ö–æ–∑–ª–æ–≤. –ö–∞—Ä—Ç–æ—á–∫–∞ —Ç–æ–≤–∞—Ä–∞ —Å—É–ª–∏—Ç –µ–≤—Ä–æ–ø–µ–π—Å–∫–æ–µ –ø—Ä–æ–∏—Å—Ö–æ–∂–¥–µ–Ω–∏–µ ‚Äî –¥–æ–±–∞–≤–∫–∞ —è–∫–æ–±—ã –ø—Ä–æ–∏–∑–≤–µ–¥–µ–Ω–∞ –Ω–µ–º–µ—Ü–∫–æ–π Libenskraft, –Ω–æ –Ω–∞ –¥–Ω–µ —É–ø–∞–∫–æ–≤–∫–∏ –≤–∏–¥–Ω–µ–µ—Ç—Å—è –ª–æ–≥–æ—Ç–∏–ø –º–æ—Å–∫–æ–≤—Å–∫–æ–≥–æ –∑–∞–≤–æ–¥–∞ ¬´–ü—Ä–æ—Ç–µ–π¬ª (—Ä–æ—Å—Å–∏–π—Å–∫–∏–π –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å –ø–ª–∞—Å—Ç–∏–∫–æ–≤–æ–π —É–ø–∞–∫–æ–≤–∫–∏). –í —Å–æ—Å—Ç–∞–≤–µ ¬´–∂–∏—Ä–æ—Å–∂–∏–≥–∞—Ç–µ–ª—è¬ª —É–∫–∞–∑–∞–Ω–æ: –û—Ä–ª–∏—Å—Ç–∞—Ç 360 –º–≥, 100% –æ—Ç —Å—É—Ç–æ—á–Ω–æ–π –Ω–æ—Ä–º—ã. –ù–∞ –¥–µ–ª–µ –≤—ã—è—Å–Ω–∏–ª–æ—Å—å, —á—Ç–æ –¥–æ–±–∞–≤–∫–∞ —Å–æ–¥–µ—Ä–∂–∏—Ç –∞—à–≤–∞–≥–∞–Ω–¥—É, –∑–∞–ø—Ä–µ—â—ë–Ω–Ω—É—é –≤ –†–æ—Å—Å–∏–∏ –∫–∞–∫ —Ä–∞—Å—Ç–µ–Ω–∏–µ, —Å–æ–¥–µ—Ä–∂–∞—â–µ–µ –ø—Å–∏—Ö–æ—Ç—Ä–æ–ø–Ω—ã–µ, –Ω–∞—Ä–∫–æ—Ç–∏—á–µ—Å–∫–∏–µ, —Å–∏–ª—å–Ω–æ–¥–µ–π—Å—Ç–≤—É—é—â–∏–µ –∏–ª–∏ —è–¥–æ–≤–∏—Ç—ã–µ –≤–µ—â–µ—Å—Ç–≤–∞. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –ø–æ —Å–ª–æ–≤–∞–º –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –ø–æ —Ä–∞–∑–≤–∏—Ç–∏—é –°–†–û ¬´–°–æ—é–∑ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ë–ê–î¬ª –ò–≤–∞–Ω–∞ –î—ã–Ω–¥–∏–∫–æ–≤–∞, –∞—à–≤–∞–≥–∞–Ω–¥–∞ –æ–ø–∞—Å–Ω–∞ —Å–≤–æ–µ–π –Ω–µ—Ñ—Ä–æ—Ç–æ–∫—Å–∏—á–Ω–æ—Å—Ç—å—é. –ì—Ä—É–∑–æ–≤–∞—è —Ç–∞–º–æ–∂–µ–Ω–Ω–∞—è –¥–µ–∫–ª–∞—Ä–∞—Ü–∏—è –Ω–∞ Orlistat, –Ω–æ–º–µ—Ä –∫–æ—Ç–æ—Ä–æ–π —É–∫–∞–∑–∞–Ω –≤ –∫–∞—Ä—Ç–æ—á–∫–µ —Ç–æ–≤–∞—Ä–∞, –Ω–µ –±—å–µ—Ç—Å—è –ø–æ –±–∞–∑–∞–º. –°–≤–µ–¥–µ–Ω–∏—è –æ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –≤ –ì–†–õ–° –æ—Ç—Å—É—Ç—Å—Ç–≤—É—é—Ç. –ó–∞—Ç–æ –ª–µ–≥–∞–ª—å–Ω–æ–≥–æ –û—Ä–ª–∏—Å—Ç–∞—Ç–∞ –≤ —Ä–µ–µ—Å—Ç—Ä–µ —Ö–æ—Ç—å –æ—Ç–±–∞–≤–ª—è–π ‚Äî –†–£ –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç –µ—Å—Ç—å —É ¬´–ü–∞—Ç–µ–Ω—Ç-–§–∞—Ä–º¬ª, ¬´–ü–æ–ª—å—Ñ–∞—Ä–º—ã¬ª, ¬´–ê–ª–∏—É–º–∞¬ª, ¬´–ê—Ç–æ–ª–ª–∞¬ª, ¬´–ö–∞–Ω–æ–Ω—Ñ–∞—Ä–º—ã¬ª, ¬´–ü—Ä–æ–º–æ–º–µ–¥ –•–æ–ª–¥–∏–Ω–≥—Å (–°–∞–π–ø—Ä—É—Å) –õ–∏–º–∏—Ç–µ–¥¬ª. –í –∫–æ—Ç–æ—Ä—ã–π —Ä–∞–∑ –ø—Ä–∏–∑—ã–≤–∞–µ–º: –±–µ—Ä–µ–≥–∏—Ç–µ —Å–µ–±—è –∏ –∏—Å–ø–æ–ª—å–∑—É–π—Ç–µ —Ç–æ–ª—å–∫–æ –ø—Ä–æ–≤–µ—Ä–µ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage, regulation"",
  ""impact"": ""high"",
  ""english"": ""Substandard versions of Orlistat, a previously popular weight loss drug, are being sold illegally online. The product is suspected to be from Germany but the packaging shows it was made in Moscow by a local factory. The product contains ashwagandha, which is banned in Russia due to its potential for causing kidney damage and containing psychoactive substances. The official registration of Orlistat is missing from the records, while legal versions are available in various Russian pharmaceutical companies. The message urges people to use only verified medications.""
}"
2025-08-18T06:03:18+00:00,@bezrec,6432,https://t.me/bezrec/6432,"–ü–æ—Å–º–æ—Ç—Ä–µ–ª–∏ —Å–≤–µ–∂–∏–π –æ—Ç—á—ë—Ç –ù–ê–§–ò –æ —Ç–æ–º, –∫–∞–∫ —Ä–æ—Å—Å–∏—è–Ω–µ –≤—ã–±–∏—Ä–∞—é—Ç –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ —Ç–æ–≤–∞—Ä—ã. –ß—Ç–æ —Å–ø—Ä–∞—à–∏–≤–∞–ª–∏ –∞–Ω–∞–ª–∏—Ç–∏–∫–∏ –∏ –∫–∞–∫ –æ—Ç–≤–µ—á–∞–ª–∏ —Ä–µ—Å–ø–æ–Ω–¥–µ–Ω—Ç—ã: üü© –ù–∞—Å–∫–æ–ª—å–∫–æ –í—ã –¥–æ–≤–µ—Ä—è–µ—Ç–µ —Å–æ–≤–µ—Ç–∞–º –∏ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏—è–º —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤ –∞–ø—Ç–µ–∫–∏, –≤ –∫–æ—Ç–æ—Ä–æ–π –æ–±—ã—á–Ω–æ –ø–æ–∫—É–ø–∞–µ—Ç–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞? –ú–Ω–µ–Ω–∏—é —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–æ–≤ –¥–æ–≤–µ—Ä—è—é—Ç 81%. üü© –ö–æ–≥–¥–∞ –≤—ã –ø–æ–∫—É–ø–∞–µ—Ç–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –≤ –∞–ø—Ç–µ–∫–µ –∏ –≤–∞–º –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç –Ω–µ—Å–∫–æ–ª—å–∫–æ –∞–Ω–∞–ª–æ–≥–æ–≤ –Ω—É–∂–Ω–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏, –∫–∞–∫ –≤—ã —á–∞—â–µ –ø–æ—Å—Ç—É–ø–∞–µ—Ç–µ? 28% –ø–æ–∫—É–ø–∞—é—Ç —Ç–æ, —á—Ç–æ –¥–µ—à–µ–≤–ª–µ, –¥–∞–∂–µ –µ—Å–ª–∏ –æ–Ω–æ —Ö—É–∂–µ –ø–æ –∫–∞—á–µ—Å—Ç–≤—É, 59% –ø—Ä–µ–¥–ø–æ—á–∏—Ç–∞—é—Ç –∫–∞—á–µ—Å—Ç–≤–æ, –¥–∞–∂–µ –µ—Å–ª–∏ —Ç–∞–∫–æ–π –ø—Ä–æ–¥—É–∫—Ç –¥–æ—Ä–æ–∂–µ, 13% –∑–∞—Ç—Ä—É–¥–Ω–∏–ª–∏—Å—å —Å –æ—Ç–≤–µ—Ç–æ–º / –Ω–µ –ø–æ–∫—É–ø–∞—é—Ç. üü© –ï—Å–ª–∏ –∑–∞ –ø–æ—Å–ª–µ–¥–Ω–µ–µ –≤—Ä–µ–º—è –í—ã –ø–æ—Å–µ—â–∞–ª–∏ –∞–ø—Ç–µ–∫–∏ (–≤ —Ç.—á. –∑–∞—Ö–æ–¥–∏–ª–∏ –Ω–∞ —Å–∞–π—Ç—ã –∏–Ω—Ç–µ—Ä–Ω–µ—Ç-–∞–ø—Ç–µ–∫), –æ—Å—Ç–∞–ª–∏—Å—å –ª–∏ –≤—ã –¥–æ–≤–æ–ª—å–Ω—ã –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç–æ–º –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–Ω—ã—Ö —Ç–∞–º –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ç–æ–≤–∞—Ä–æ–≤? –£–¥–æ–≤–ª–µ—Ç–≤–æ—Ä—ë–Ω–Ω–æ—Å—Ç—å –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç–æ–º –≤ —Ü–µ–ª–æ–º –ø–æ –†–æ—Å—Å–∏–∏ ‚Äî 72% (+7 –ø.–ø. –∫ 2024 –≥–æ–¥—É). üü© –ö–∞–∫ –≤—ã –¥—É–º–∞–µ—Ç–µ, –≤–∞—à–∏ —Ç—Ä–∞—Ç—ã –Ω–∞ –ø–æ–∫—É–ø–∫—É –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ç–æ–≤–∞—Ä–æ–≤ –≤ –±–ª–∏–∂–∞–π—à–∏–π –≥–æ–¥ –≤—ã—Ä–∞—Å—Ç—É—Ç, —Å–Ω–∏–∑—è—Ç—Å—è –∏–ª–∏ –Ω–µ –∏–∑–º–µ–Ω—è—Ç—Å—è? 65% –≥–æ—Ç–æ–≤—è—Ç—Å—è –∫ —Ä–æ—Å—Ç—É —Ç—Ä–∞—Ç –Ω–∞ –ø–æ–∫—É–ø–∫—É –ª–µ–∫–∞—Ä—Å—Ç–≤. üü© –ó–∞ –ø–æ—Å–ª–µ–¥–Ω–∏–µ –ø–∞—Ä—É –ª–µ—Ç –ø—Ä–∏—Ö–æ–¥–∏–ª–æ—Å—å –ª–∏ –≤–∞–º –ø—Ä–∏ —Å–∏–º–ø—Ç–æ–º–∞—Ö –∫–∞–∫–æ–≥–æ-–ª–∏–±–æ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è –ø—Ä–∏–æ–±—Ä–µ—Ç–∞—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç, —É–≤–∏–¥–µ–Ω–Ω—ã–π –≤–ø–µ—Ä–≤—ã–µ –≤ —Ä–µ–∫–ª–∞–º–µ, –Ω–µ –æ–±—Ä–∞—â–∞—è—Å—å –∫ –≤—Ä–∞—á—É? –ü–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω–æ –Ω–∞ —ç—Ç–æ—Ç –≤–æ–ø—Ä–æ—Å –æ—Ç–≤–µ—Ç–∏–ª–∏ 37% –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö. –°—Ç–æ–ª—å–∫–æ –∂–µ, —Å–∫–æ–ª—å–∫–æ –∏ –≥–æ–¥ –Ω–∞–∑–∞–¥. üü© –ü—Ä–∏ —Å–ª–µ–¥—É—é—â–µ–π –ø–æ–∫—É–ø–∫–µ –≤—ã –±—ã —Å–∫–æ—Ä–µ–µ –ø—Ä–µ–¥–ø–æ—á–ª–∏ –ø—Ä–∏–æ–±—Ä–µ—Å—Ç–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–π –∏–ª–∏ –∑–∞—Ä—É–±–µ–∂–Ω–æ–π —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–∏? –ì–æ–ª–æ—Å–æ–≤–∞—Ç—å —Ä—É–±–ª—ë–º –∑–∞ —Ä–æ—Å—Å–∏–π—Å–∫—É—é —Ñ–∞—Ä–º—É –≥–æ—Ç–æ–≤—ã 54% —Ä–æ—Å—Å–∏—è–Ω. üü© –ö–∞–∫ –≤—ã –æ—Ç–Ω–æ—Å–∏—Ç–µ—Å—å –∫ —Ä–µ–∫–ª–∞–º–µ –ª–µ–∫–∞—Ä—Å—Ç–≤? 26% (+3 –ø.–ø. –∫ 2024 –≥–æ–¥—É) —Å—á–∏—Ç–∞—é—Ç, —á—Ç–æ –Ω—É–∂–Ω–æ –±–æ–ª—å—à–µ —Ä–µ–∫–ª–∞–º–∏—Ä–æ–≤–∞—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–∞, —á—Ç–æ–±—ã –ª—é–¥–∏ –º–æ–≥–ª–∏ –ª–µ—á–∏—Ç—å—Å—è —Å–∞–º–∏. 48% (-12 –ø.–ø.) –≤—ã—Å—Ç—É–ø–∞—é—Ç –∑–∞ —Å–æ–∫—Ä–∞—â–µ–Ω–∏–µ —Ç–∞–∫–æ–π —Ä–µ–∫–ª–∞–º—ã, —á—Ç–æ–±—ã –ø–∞—Ü–∏–µ–Ω—Ç—ã –æ–±—Ä–∞—â–∞–ª–∏—Å—å –∑–∞ –∫–æ–Ω—Å—É–ª—å—Ç–∞—Ü–∏–µ–π –∫ –≤—Ä–∞—á–∞–º. 26% –∑–∞—Ç—Ä—É–¥–Ω–∏–ª–∏—Å—å —Å –æ—Ç–≤–µ—Ç–æ–º. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial, hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""The survey examined how Russians choose medicines and medical products. 81% of respondents trust pharmacists' advice, while 28% prefer cheaper but lower-quality products over better quality ones. Satisfaction with the variety of medicines and medical products in pharmacies is at 72% (+7 p.p. from last year). 65% expect to increase spending on medicines in the next year. 37% of respondents bought a medication seen in advertising without consulting a doctor due to symptoms. 54% are ready to support domestic pharmaceutical companies over foreign ones, and there is a shift in views on advertising with 26% advocating more and 48% wanting less to encourage patients to consult doctors.""
}"
2025-08-17T10:59:51+00:00,@bezrec,6431,https://t.me/bezrec/6431,"–õ–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ —Ä–∞—Å—Ç–µ–Ω–∏—è ‚Äî —ç—Ç–æ –Ω–µ —Ç–æ–ª—å–∫–æ —Å—ã—Ä—å—ë –¥–ª—è —Ñ–∞—Ä–º—ã, –Ω–æ –∏ –Ω–µ—Å–∫–æ–Ω—á–∞–µ–º—ã–π –∏—Å—Ç–æ—á–Ω–∏–∫ –≤–¥–æ—Ö–Ω–æ–≤–µ–Ω–∏—è. –ü—Ä–∏–º–µ–Ω–∏–º–æ –Ω–µ —Ç–æ–ª—å–∫–æ –∫ –±—ã–≤—à–∏–º, –Ω–æ –∏ –∫–æ –≤—Å–µ–º –Ω–µ—É–≥–æ–¥–Ω—ã–º. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-08-16T11:01:23+00:00,@bezrec,6430,https://t.me/bezrec/6430,"–í—Å—Ç—Ä–µ—á–∞–µ–º —Å—É–±–±–æ—Ç—É –∏ —Å–≤–µ–∂–∏–π –≤—ã–ø—É—Å–∫ —Ä—É–±—Ä–∏–∫–∏ #–≤–¥–æ–≥–æ–Ω–∫—É. üíä –ë–ê–î–∞–º —É—Å—Ç–∞–Ω–æ–≤—è—Ç –ø—Ä–∞–≤–∏–ª–∞. –ú–∏–Ω–∑–¥—Ä–∞–≤ –ø—Ä–µ–¥–ª–æ–∂–∏–ª —É—Å—Ç–∞–Ω–æ–≤–∏—Ç—å –∫–æ–º–ø–ª–µ–∫—Å —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π –∫ –∫–∞—á–µ—Å—Ç–≤—É –∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏ –∞–∫—Ç–∏–≤–Ω—ã—Ö –¥–æ–±–∞–≤–æ–∫. –ï—Å–ª–∏ –æ–Ω–∏ –±—É–¥—É—Ç –ø—Ä–∏–Ω—è—Ç—ã, –Ω–æ–≤—ã–µ –ø—Ä–∞–≤–∏–ª–∞ –≤—Å—Ç—É–ø—è—Ç –≤ —Å–∏–ª—É —Å 1 –º–∞—Ä—Ç–∞ 2026 –≥–æ–¥–∞. –ü—Ä–æ–µ–∫—Ç–∏—Ä—É–µ–º—ã–µ –∫—Ä–∏—Ç–µ—Ä–∏–∏ –ª—è–≥—É—Ç –≤ –æ—Å–Ω–æ–≤—É –ø–µ—Ä–µ—á–Ω—è –ë–ê–î–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ –º–æ–≥—É—Ç –Ω–∞–∑–Ω–∞—á–∞—Ç—å—Å—è –≤—Ä–∞—á–∞–º–∏. üíä ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑¬ª –Ω–∞—É—á–∏—Ç —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π —Ö–∏–º–∏–∏. –ö–æ–º–ø–∞–Ω–∏—è –í–∏–∫—Ä–∞–º–∞ –ü—É–Ω–∏—è —Å–æ–≤–º–µ—Å—Ç–Ω–æ —Å —Ö–∏–º–∏—á–µ—Å–∫–∏–º —Ñ–∞–∫—É–ª—å—Ç–µ—Ç–æ–º –ò—Ä–∫—É—Ç—Å–∫–æ–≥–æ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ (–ò–ì–£) –∑–∞–ø—É—Å—Ç–∏–ª–∞ –Ω–æ–≤—É—é –º–∞–≥–∏—Å—Ç–µ—Ä—Å–∫—É—é –ø—Ä–æ–≥—Ä–∞–º–º—É ¬´–§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∞—è —Ö–∏–º–∏—è¬ª. –ü–µ—Ä–≤—ã–µ —É—á–∞—Å—Ç–Ω–∏–∫–∏ –ø—Ä–∏—Å—Ç—É–ø—è—Ç –∫ –∑–∞–Ω—è—Ç–∏—è–º —É–∂–µ –≤ —Å–µ–Ω—Ç—è–±—Ä–µ 2025 –≥–æ–¥–∞. üíä –ü—Ä–µ–º—å–µ—Ä—ã –ï–ê–≠–° –ø—Ä–∏–Ω–∏–º–∞—é—Ç –∫–æ–Ω—Ü–µ–ø—Ü–∏–∏ –æ–±—â–µ–≥–æ —Ä—ã–Ω–∫–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤. –û–± —ç—Ç–æ–º –ú–∏—Ö–∞–∏–ª –ú–∏—à—É—Å—Ç–∏–Ω –æ–±—ä—è–≤–∏–ª –Ω–∞ –∑–∞—Å–µ–¥–∞–Ω–∏–∏ –ï–≤—Ä–∞–∑–∏–π—Å–∫–æ–≥–æ –º–µ–∂–ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ —Å–æ–≤–µ—Ç–∞. –ü–æ —Å–ª–æ–≤–∞–º –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—è –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞, –≥–ª–∞–≤–Ω–∞—è –∑–∞–¥–∞—á–∞ –∫–æ–Ω—Ü–µ–ø—Ü–∏–π ‚Äî –æ–±–µ—Å–ø–µ—á–∏—Ç—å –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å, —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –∏ –≤—ã—Å–æ–∫–æ–µ –∫–∞—á–µ—Å—Ç–≤–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –º–µ–¥–∏–∑–¥–µ–ª–∏–π. üíä –í –ì–æ—Å–¥—É–º–µ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –≤—ã–ø–ª–∞—á–∏–≤–∞—Ç—å –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏–∏ –∑–∞ –ø–ª–∞—Ç–Ω—ã–µ –∂–∏–∑–Ω–µ–Ω–Ω–æ –≤–∞–∂–Ω—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞. –° —Ç–∞–∫–æ–π –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–æ–π –≤—ã—Å—Ç—É–ø–∏–ª–∞ –∑–∞–º–ø—Ä–µ–¥ –∫–æ–º–∏—Ç–µ—Ç–∞ –ì–æ—Å–¥—É–º—ã –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è –¢–∞—Ç—å—è–Ω–∞ –°–æ–ª–æ–º–∞—Ç–∏–Ω–∞: –ï—Å–ª–∏ —á–µ–ª–æ–≤–µ–∫ –ø–æ–∫—É–ø–∞–µ—Ç –∑–∞ —Å–≤–æ–π —Å—á–µ—Ç –∂–∏–∑–Ω–µ–Ω–Ω–æ –≤–∞–∂–Ω—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞, –∫–æ–≥–¥–∞ –∏—Ö –Ω–µ—Ç –≤ —Ä–µ–≥–∏–æ–Ω–µ, —è –±—ã —Ç–æ–∂–µ –∫–æ–º–ø–µ–Ω—Å–∏—Ä–æ–≤–∞–ª–∞ –∏—Ö —Å—Ç–æ–∏–º–æ—Å—Ç—å –ª—é–¥—è–º. –ú—ã ‚Äì —Å–æ—Ü–∏–∞–ª—å–Ω–æ–µ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–æ –∏ –æ–±—è–∑–∞–Ω—ã –æ–±–µ—Å–ø–µ—á–∏—Ç—å –ª—é–¥–µ–π —Ç–µ–º–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º–∏, –∫–æ—Ç–æ—Ä—ã–µ –∏–º –Ω—É–∂–Ω—ã. üíä –†–µ–∑–∏–¥–µ–Ω—Ç—ã –û–≠–ó –≤ –ü–µ—Ç–µ—Ä–±—É—Ä–≥–µ —É–≤–µ–ª–∏—á–∏–ª–∏ –æ–±—ä–µ–º –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–π –Ω–∞ 60% –∑–∞ –ø–æ–ª–≥–æ–¥–∞. –ö–∞–∫ —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏ –≤ –≥–æ—Ä–æ–¥—Å–∫–æ–π –∞–¥–º–∏–Ω–∏—Å—Ç—Ä–∞—Ü–∏–∏, –≤ –≥—Ä—É–ø–ø—É –Ω–∞–∏–±–æ–ª–µ–µ –∞–∫—Ç–∏–≤–Ω—ã—Ö —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω–æ –≤–æ—à–ª–∏ –∫–æ–º–ø–∞–Ω–∏–∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ —Å–µ–∫—Ç–æ—Ä–∞ ‚Äî ¬´–ë–∏–æ–∫–∞–¥¬ª –∏ ¬´–¶–∏—Ç–æ–º–µ–¥¬ª. üíä –§–ê–° —Å–æ–≥–ª–∞—Å–æ–≤–∞–ª–∞ —Ü–µ–Ω—É –Ω–∞ –†–∏–Ω–æ—Ñ–µ—Ä–æ–Ω –¥–ª—è –ª–µ—á–µ–Ω–∏—è –≥—Ä–∏–ø–ø–∞ –∏ –û–†–í–ò. –°–æ–≥–ª–∞—Å–æ–≤–∞–Ω–Ω–∞—è —Ü–µ–Ω–∞ (342 —Ä—É–±–ª—è –∑–∞ —Ñ–ª–∞–∫–æ–Ω –Ω–∞–∑–∞–ª—å–Ω–æ–≥–æ —Å–ø—Ä–µ—è –≤ –¥–æ–∑–∏—Ä–æ–≤–∫–µ 500 –ú–ï/–¥–æ–∑–∞) —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É–µ—Ç –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–º —Ü–µ–Ω–∞–º –Ω–∞ —Ä–µ—Ñ–µ—Ä–µ–Ω—Ç–Ω—ã–π –ì—Ä–∏–ø–ø—Ñ–µ—Ä–æ–Ω. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The Russian government is proposing new rules for biologically active supplements (BAS). The Ministry of Health has suggested a comprehensive set of requirements for quality and effectiveness. If adopted, these rules will come into force on March 1st, 2026. The company Farmasintez is launching a new master's program in pharmaceutical chemistry in collaboration with Irkutsk State University. The first participants will start their studies in September 2025.""
}"
2025-08-15T13:59:51+00:00,@bezrec,6429,https://t.me/bezrec/6429,"–ü–æ –ø—É—Ç–∏ –Ω–∞ –ê–ª—è—Å–∫—É –í–ª–∞–¥–∏–º–∏—Ä –ü—É—Ç–∏–Ω –∑–∞–≥–ª—è–Ω—É–ª –Ω–∞ ¬´–û–º–µ–≥–∞-–°–∏¬ª. –≠—Ç–æ –ø–µ—Ä–≤—ã–π –≤ –†–æ—Å—Å–∏–∏ –∑–∞–≤–æ–¥ –ø–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤—É —Ä—ã–±–Ω–æ–≥–æ –∂–∏—Ä–∞ –≤ —Ñ–æ—Ä–º–µ rTG (—Ä–µ—ç—Ç–µ—Ä–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ —Ç—Ä–∏–≥–ª–∏—Ü–µ—Ä–∏–¥—ã) –∏–∑ –±–µ–ª–æ–π —Ä—ã–±—ã –û—Ö–æ—Ç—Å–∫–æ–≥–æ –º–æ—Ä—è ‚Äî —Å–∞—Ä–¥–∏–Ω—ã –∏ —Å–µ–ª—å–¥–∏. –ü—Ä–µ–¥–ø—Ä–∏—è—Ç–∏–µ, –≤ –∫–æ—Ç–æ—Ä–æ–µ –∏–Ω–≤–µ—Å—Ç–æ—Ä—ã –≤–ª–æ–∂–∏–ª–∏ –æ–∫–æ–ª–æ –º–∏–ª–ª–∏–∞—Ä–¥–∞ —Ä—É–±–ª–µ–π, —Ä–∞–±–æ—Ç–∞–µ—Ç –≤ –ú–∞–≥–∞–¥–∞–Ω–µ —Å 2023 –≥–æ–¥–∞. –ù–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω–æ–º —É—á–∞—Å—Ç–∫–µ –¥–≤–µ –ª–∏–Ω–∏–∏: –Ω–∞ –æ–¥–Ω–æ–π –æ—Å—É—â–µ—Å—Ç–≤–ª—è–µ—Ç—Å—è –æ—á–∏—Å—Ç–∫–∞ —Ä—ã–±–Ω–æ–≥–æ –∂–∏—Ä–∞, –ø–æ–ª—É—á–∞–µ–º–æ–≥–æ –ø—Ä–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ —Ä—ã–±–Ω–æ–π –º—É–∫–∏, –Ω–∞ –¥—Ä—É–≥–æ–π - –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –∫–∞–ø—Å—É–ª —Ä—ã–±–Ω–æ–≥–æ –∂–∏—Ä–∞, –Ω–∞—Å—ã—â–µ–Ω–Ω–æ–≥–æ –û–º–µ–≥–∞-3 –±–æ–ª–µ–µ —á–µ–º –Ω–∞ 70%. ¬´–û–º–µ–≥–∞-–°–∏¬ª –Ω–µ –≤–ø–µ—Ä–≤–æ–π –ø—Ä–∏–Ω–∏–º–∞—Ç—å –≤—ã—Å–æ–∫–∏—Ö –≥–æ—Å—Ç–µ–π. –í –∏—é–ª–µ –ø—Ä–æ—à–ª–æ–≥–æ –≥–æ–¥–∞ –Ω–∞ –∑–∞–≤–æ–¥–µ –ø–æ–±—ã–≤–∞–ª –ú–∏—Ö–∞–∏–ª –ú–∏—à—É—Å—Ç–∏–Ω, –Ω–∞–∑–≤–∞–≤—à–∏–π –µ–≥–æ ¬´–ø—Ä–∏–º–µ—Ä–æ–º —á–∞—Å—Ç–Ω–æ–π –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤—ã¬ª. –í–æ –≤—Ä–µ–º—è —Å–≤–æ–µ–≥–æ –≤–∏–∑–∏—Ç–∞ –ø—Ä–µ–º—å–µ—Ä –Ω–∞—Å—Ç–æ–ª—å–∫–æ —Ä–∞—Å—á—É–≤—Å—Ç–≤–æ–≤–∞–ª—Å—è, —á—Ç–æ –ø–æ–¥–µ–ª–∏–ª—Å—è –≤–æ—Å–ø–æ–º–∏–Ω–∞–Ω–∏—è–º–∏ –∏–∑ –¥–µ—Ç—Å—Ç–≤–∞, –∫–æ–≥–¥–∞ –ø–∏–ª —Ä—ã–±–∏–π –∂–∏—Ä —Å –ª–æ–∂–∫–∏, –∏ –ø–æ—Ä–µ–∫–æ–º–µ–Ω–¥–æ–≤–∞–ª –≤—Å–µ–º —É–ø–æ—Ç—Ä–µ–±–ª—è—Ç—å —Ç–∞–∫–∏–µ –¥–æ–±–∞–≤–∫–∏ –¥–ª—è —É–∫—Ä–µ–ø–ª–µ–Ω–∏—è –∑–¥–æ—Ä–æ–≤—å—è. –ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω–∞—è –º–æ—â–Ω–æ—Å—Ç—å –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏—è ‚Äî 2,2 —Ç—ã—Å. —Ç–æ–Ω–Ω –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –µ–∂–µ–≥–æ–¥–Ω–æ –¥–ª—è —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –∏ –º–∏—Ä–æ–≤–æ–≥–æ —Ä—ã–Ω–∫–∞. –ò–∑ –Ω–∏—Ö 2 —Ç—ã—Å. —Ç–æ–Ω–Ω –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ —Ä–∞—Ñ–∏–Ω–∏—Ä–æ–≤–∞–Ω–Ω—ã–π —Ä—ã–±–∏–π –∂–∏—Ä, –∞ 200 —Ç–æ–Ω–Ω ‚Äì –Ω–∞ —Ä–µ—ç—Ç–µ—Ä–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –∫–∞–ø—Å—É–ª–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ —Ç—Ä–∏–≥–ª–∏—Ü–µ—Ä–∏–¥—ã. –ü–æ –¥–∞–Ω–Ω—ã–º Rusprofile, –≤ 2024 –≥–æ–¥—É –≤—ã—Ä—É—á–∫–∞ —É ¬´–û–º–µ–≥–∞-–°–∏¬ª –æ—Ç—Å—É—Ç—Å—Ç–≤–æ–≤–∞–ª–∞, –∞ —á–∏—Å—Ç–∞—è –ø—Ä–∏–±—ã–ª—å –Ω–µ —Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–ª–∞—Å—å. –í 2023 –≥–æ–¥—É –≤—ã—Ä—É—á–∫–∞ —Å–æ—Å—Ç–∞–≤–∏–ª–∞ 67,7 –º–ª–Ω —Ä—É–±–ª–µ–π, –Ω–æ –∫–æ–º–ø–∞–Ω–∏—è —Ä–∞–±–æ—Ç–∞–ª–∞ –≤ —É–±—ã—Ç–æ–∫ (-15,7 –º–ª–Ω —Ä—É–±–ª–µ–π). –ü—Ä–∏ —ç—Ç–æ–º –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è –∑–∞–Ω–∏–º–∞–µ—Ç –ø–µ—Ä–≤–æ–µ –º–µ—Å—Ç–æ –≤ –ú–∞–≥–∞–¥–∞–Ω—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –ø–æ –≤—ã—Ä—É—á–∫–µ –∏ 409-–µ –≤ –†–æ—Å—Å–∏–∏ —Å—Ä–µ–¥–∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –º–∞—Å–µ–ª –∏ –∂–∏—Ä–æ–≤. 70% –∫–æ–º–ø–∞–Ω–∏–∏ –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∏—Ç —Ä–æ—Å—Å–∏–π—Å–∫–æ–π ¬´–¢–∏—Ö—Ä—ã–±–∫–æ–º¬ª, –∞ –æ—Å—Ç–∞–≤—à–∏–µ—Å—è 30% ‚Äî —é–∂–Ω–æ–∫–æ—Ä–µ–π—Å–∫–æ–π ¬´–û—É—à–µ–Ω —ç–Ω–¥ –ü–∏–æ–Ω–∏—Ä –ò–Ω—Ç–µ—Ä–Ω–µ—à–Ω–ª¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""Russian President Vladimir Putin visited the Omega-Si plant in Magadan, Russia. The company produces rTG (re-esterified triglycerides) from white fish of the Sea of Okhotsk, such as sardines and herring. The plant has been operational since 2023 with a production capacity of 2,200 tons per year for the Russian and global markets. The company is ranked 409th in Russia among producers of oils and fats, with revenues of 67.7 million rubles in 2023 but operating at a loss (-15.7 million rubles). The plant produces 2,000 tons of refined fish oil and 200 tons of capsule-encapsulated triglycerides. The company is majority-owned by Russian 'Tikhrybkom' and 30% owned by South Korean 'Ouishen End Pioneer International'.""
}"
2025-08-15T12:16:59+00:00,@bezrec,6428,https://t.me/bezrec/6428,"–õ—É–∫–∞—à–µ–Ω–∫–æ —Å–æ–±—Ä–∞–ª—Å—è –ø—Ä–µ—É—Å–ø–µ—Ç—å –≤ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ –ª–µ–∫–∞—Ä—Å—Ç–≤. –ù–∞ —Ç–µ–º–∞—Ç–∏—á–µ—Å–∫–æ–º —Å–æ–≤–µ—â–∞–Ω–∏–∏ –±–µ–ª–æ—Ä—É—Å—Å–∫–∏–π –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç –æ—Ä–∏–µ–Ω—Ç–∏—Ä–æ–≤–∞–ª –ø–æ–¥—á–∏–Ω—ë–Ω–Ω—ã—Ö –Ω–∞ —Ä–∞–∑–≤–∏—Ç–∏–µ –±–∏–æ—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∏ –∫–∞–∫ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è, –Ω–µ —Ç—Ä–µ–±—É—é—â–µ–≥–æ –Ω–∞–ª–∏—á–∏—è –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω—ã—Ö –ø—Ä–∏—Ä–æ–¥–Ω—ã—Ö —Ä–µ—Å—É—Ä—Å–æ–≤. –ö —Ç–æ–º—É –∂–µ, –≤ –±–µ–ª–æ—Ä—É—Å—Å–∫–∏—Ö –º–µ–¥–ø—Ä–µ–ø–∞—Ä–∞—Ç–∞—Ö –∑–∞–∏–Ω—Ç–µ—Ä–µ—Å–æ–≤–∞–Ω—ã –∑–∞ —Ä—É–±–µ–∂–æ–º, –æ—Å–æ–±–µ–Ω–Ω–æ, –ø–æ–¥—á–µ—Ä–∫–Ω—É–ª –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ì—Ä–∏–≥–æ—Ä—å–µ–≤–∏—á, –≤ –ê—Ñ—Ä–∏–∫–µ. –ß—Ç–æ–±—ã –æ–±–µ—Å–ø–µ—á–∏—Ç—å –Ω–æ—Ä–º–∞–ª—å–Ω—É—é –∂–∏–∑–Ω—å, –ª—é–¥–µ–π –Ω–∞–¥–æ –Ω–∞–∫–æ—Ä–º–∏—Ç—å, –æ–¥–µ—Ç—å –∏ –≤—ã–ª–µ—á–∏—Ç—å. –û–¥–Ω–æ –∏–∑ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏–π, –≥–¥–µ –º—ã –º–æ–∂–µ–º –ø—Ä–µ—É—Å–ø–µ—Ç—å, —ç—Ç–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏ –≤–µ—Ç–µ—Ä–∏–Ω–∞—Ä–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã. –ù—É–∂–Ω—ã –º–æ–∑–≥–∏, –Ω—É–∂–Ω–æ –≤–∫–ª–∞–¥—ã–≤–∞—Ç—å —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏, –∫–æ—Ç–æ—Ä—ã–µ —É–∂–µ –∏–∑–≤–µ—Å—Ç–Ω—ã, –∏ –¥–≤–∏–≥–∞—Ç—å—Å—è –¥–∞–ª—å—à–µ, ‚Äî –ø—Ä–∏–∑–≤–∞–ª –õ—É–∫–∞—à–µ–Ω–∫–æ, –æ—Ç–º–µ—Ç–∏–≤, —á—Ç–æ —Å —á–µ–ª–æ–≤–µ—á–µ—Å–∫–∏–º –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª–æ–º —É —Ä–µ—Å–ø—É–±–ª–∏–∫–∏ –ø—Ä–æ–±–ª–µ–º –Ω–µ—Ç. –ü—Ä–µ–∑–∏–¥–µ–Ω—Ç —Ç–∞–∫–∂–µ –Ω–∞–ø–æ–º–Ω–∏–ª, —á—Ç–æ –Ω–∞ –ø—É—Ç–∏ –∫ —Ç–µ—Ö—Å—É–≤–µ—Ä–µ–Ω–∏—Ç–µ—Ç—É –Ω–µ –æ–±–æ–π—Ç–∏—Å—å –±–µ–∑ –∫—Ä—É–ø–Ω—ã—Ö –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤. –°–æ–∑–¥–∞—Ç—å –º–æ—â–Ω–æ–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω–æ–µ –æ–±—ä–µ–¥–∏–Ω–µ–Ω–∏–µ –≤ –æ–±–ª–∞—Å—Ç–∏ –±–∏–æ—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∏ –ø—Ä–µ–¥–ø–æ–ª–∞–≥–∞–µ—Ç—Å—è –≤ –í–∏—Ç–µ–±—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏. –ï–≥–æ —è–¥—Ä–æ–º –¥–æ–ª–∂–µ–Ω —Å—Ç–∞—Ç—å –ë–µ–ª–í–∏—Ç—É–Ω–∏—Ñ–∞—Ä–º, –∫–æ—Ç–æ—Ä–æ–º—É –ø—Ä–µ–¥—Å—Ç–æ–∏—Ç –ø–æ—Ç—Ä—É–¥–∏—Ç—å—Å—è –Ω–∞ –±–ª–∞–≥–æ –∏ –º–µ–¥–∏—Ü–∏–Ω—ã, –∏ —Å–µ–ª—å—Å–∫–æ–≥–æ —Ö–æ–∑—è–π—Å—Ç–≤–∞. –ö—Å—Ç–∞—Ç–∏, —É –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è –≤–µ—Ç–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —É–∂–µ –µ—Å—Ç—å –ª—é–±–æ–ø—ã—Ç–Ω–∞—è ¬´—á–µ–ª–æ–≤–µ—á–µ—Å–∫–∞—è¬ª —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∞ ‚Äî ¬´–≤–∞–∫—Ü–∏–Ω–∞ –æ—Ç –∑–∞–ø–æ–µ–≤¬ª, –∫–æ—Ç–æ—Ä–∞—è –¥–æ–ª–∂–Ω–∞ –ø–æ–º–æ—á—å —á–µ–ª–æ–≤–µ–∫—É —Ñ–∏–∑–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏ –ø–µ—Ä–µ–Ω–æ—Å–∏—Ç—å –ø–æ—Å–ª–µ–¥—Å—Ç–≤–∏—è –∞–ª–∫–æ–≥–æ–ª—å–Ω—ã—Ö –≤–æ–∑–ª–∏—è–Ω–∏–π. –¢–∞–∫—É—é –∏ –Ω–∞ –∑–∞—Ä—É–±–µ–∂–Ω—ã–µ —Ä—ã–Ω–∫–∏ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç—å –Ω–µ —Å—Ç—ã–¥–Ω–æ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""Belarus"",
  ""topic"": ""tenders, import_export, shortage, regulation, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""President Lukashenko called on his subordinates to develop biopharmaceuticals as a sector that does not require significant natural resources. Belarusian medicines are also of interest abroad, especially in Africa. He emphasized that to ensure normal life, people need to be fed, clothed and treated. One of the areas where we can succeed is medicines and veterinary drugs. We need brains, we need to invest in known technologies and move forward. The creation of a powerful production union in the biopharmaceutical sector is planned in Vitbel province. Its core will be BelVitunifarm, which must work for the benefit of both medicine and agriculture. Additionally, there is an interesting 'human' development by a vaccine producer - 'alcohol withdrawal vaccine', which should help people physiologically cope with the consequences of alcohol intoxication. This development is not shameful for international markets.""
}"
2025-08-15T08:59:51+00:00,@bezrec,6427,https://t.me/bezrec/6427,"–†–û–ú–ò–† –≤—ã—è—Å–Ω–∏–ª, –∫–∞–∫–∏–º –∞–Ω—Ç–∏–≥–∏—Å—Ç–∞–º–∏–Ω–Ω—ã–º –¥–æ–≤–µ—Ä—è—é—Ç —Ä–æ—Å—Å–∏—è–Ω–µ. –ü–æ –¥–∞–Ω–Ω—ã–º –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–æ–≥–æ —Ö–æ–ª–¥–∏–Ω–≥–∞, —Å –ø—Ä–æ—è–≤–ª–µ–Ω–∏—è–º–∏ –∞–ª–ª–µ—Ä–≥–∏–∏ —Ç–∞–∫ –∏–ª–∏ –∏–Ω–∞—á–µ —Å—Ç–∞–ª–∫–∏–≤–∞–µ—Ç—Å—è 60% –Ω–∞—Å–µ–ª–µ–Ω–∏—è. –ü—Ä–∏ –≤—ã–±–æ—Ä–µ –∞–Ω—Ç–∏–≥–∏—Å—Ç–∞–º–∏–Ω–Ω—ã—Ö –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª–∏ —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤—É—é—Ç—Å—è –Ω–µ—Å–∫–æ–ª—å–∫–∏–º–∏ –∫–ª—é—á–µ–≤—ã–º–∏ –ø—Ä–∏–Ω—Ü–∏–ø–∞–º–∏: üíä –±—ã—Å—Ç—Ä–æ—Ç–∞ –¥–µ–π—Å—Ç–≤–∏—è (75%); üíä –º–∏–Ω–∏–º—É–º –ø–æ–±–æ—á–µ–∫ (59%); üíä –¥–ª–∏—Ç–µ–ª—å–Ω–æ—Å—Ç—å –¥–µ–π—Å—Ç–≤–∏—è (56%); üíä —Ü–µ–Ω–∞ (48%); üíä —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –≤—Ä–∞—á–∞ (36%). –ü–æ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è, –≤ –ª–∏–¥–µ—Ä—ã –ø–æ –∏–Ω–¥–µ–∫—Å—É –¥–æ–≤–µ—Ä–∏—è —Å 88 –±–∞–ª–ª–∞–º–∏ –≤—ã–±–∏–ª—Å—è –°—É–ø—Ä–∞—Å—Ç–∏–Ω, –Ω–µ—Å–º–æ—Ç—Ä—è –Ω–∞ —Ç–æ, —á—Ç–æ –ø–∞—Ü–∏–µ–Ω—Ç—ã –æ—Ç—Ö–æ–¥—è—Ç –æ—Ç –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ø–µ—Ä–≤–æ–≥–æ –ø–æ–∫–æ–ª–µ–Ω–∏—è, –æ—Ç–¥–∞–≤–∞—è –ø—Ä–µ–¥–ø–æ—á—Ç–µ–Ω–∏–µ –±–æ–ª–µ–µ ¬´–ø—Ä–æ–¥–≤–∏–Ω—É—Ç—ã–º¬ª –∏ –Ω–µ –≤—ã–∑—ã–≤–∞—é—â–∏–º —Å–æ–Ω–ª–∏–≤–æ—Å—Ç–∏ –∞–Ω—Ç–∏–≥–∏—Å—Ç–∞–º–∏–Ω–Ω—ã–º. –ù–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ –ó–æ–¥–∞–∫ (85 –±–∞–ª–ª–æ–≤), –Ω–∞ —Ç—Ä–µ—Ç—å–µ–º ‚Äî –ó–∏—Ä—Ç–µ–∫ (82 –±–∞–ª–ª–∞). –î–∞–ª–µ–µ —Å–ª–µ–¥—É—é—Ç –¶–µ—Ç—Ä–∏–Ω (81 –±–∞–ª–ª), –§–µ–Ω–∏—Å—Ç–∏–ª (77 –±–∞–ª–ª–æ–≤) –∏ –¢–∞–≤–µ–≥–∏–ª (76 –±–∞–ª–ª–æ–≤). –°–∞–º—ã–µ –Ω–∏–∑–∫–∏–µ –ø–æ–∫–∞–∑–∞—Ç–µ–ª–∏ —É –ö–µ—Å—Ç–∏–Ω–∞ –∏ (–ø–æ 58 –±–∞–ª–ª–æ–≤), –∞ —Ç–∞–∫–∂–µ –î–∏–º–µ–¥—Ä–æ–ª–∞ (53 –±–∞–ª–ª–∞). –ó–∞—Ç–æ —É –ø–æ—Å–ª–µ–¥–Ω–µ–≥–æ –¥–æ–≤–æ–ª—å–Ω–æ –≤—ã—Å–æ–∫–∏–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –ø–æ –∏–Ω–¥–µ–∫—Å—É —É–∑–Ω–∞–≤–∞–µ–º–æ—Å—Ç–∏ ‚Äî 70 –±–∞–ª–ª–æ–≤. –¢—Ä–æ–π–∫–∞ –ª–∏–¥–µ—Ä–æ–≤ —Ç–∞–º —Ç–∞ –∂–µ, —á—Ç–æ –∏ —É –∏–Ω–¥–µ–∫—Å–∞ –¥–æ–≤–µ—Ä–∏—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-08-15T06:14:24+00:00,@bezrec,6426,https://t.me/bezrec/6426,"–í–µ—Ä—Ö–æ–≤–Ω—ã–π —Å—É–¥ —Å–Ω–æ–≤–∞ ¬´–æ—Ç—à–∏–ª¬ª Novo Nordisk. –ê–ø–µ–ª–ª—è—Ü–∏–æ–Ω–Ω–∞—è –∫–æ–ª–ª–µ–≥–∏—è –í–µ—Ä—Ö–æ–≤–Ω–æ–≥–æ —Å—É–¥–∞ –æ—Ç–∫–ª–æ–Ω–∏–ª–∞ –∂–∞–ª–æ–±—É –¥–∞—Ç—Å–∫–æ–π Novo Nordisk –∏ –æ—Å—Ç–∞–≤–∏–ª–∞ –≤ —Å–∏–ª–µ —Ä–∞—Å–ø–æ—Ä—è–∂–µ–Ω–∏—è –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞, –ø–æ–∑–≤–æ–ª–∏–≤—à–∏–µ ¬´–ü–°–ö –§–∞—Ä–º–∞¬ª –∏ ¬´–ü—Ä–æ–º–æ–º–µ–¥—É¬ª –¥–æ –∫–æ–Ω—Ü–∞ 2025 –≥–æ–¥–∞ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç—å —Å–≤–æ–π —Å–µ–º–∞–≥–ª—É—Ç–∏–¥. –†–µ—á—å –æ —Ä–∞—Å–ø–æ—Ä—è–∂–µ–Ω–∏—è—Ö ‚Ññ 3286-—Ä –æ—Ç 15 –Ω–æ—è–±—Ä—è 2024 –≥–æ–¥–∞ –∏ ‚Ññ 3930-—Ä –æ—Ç 21 –¥–µ–∫–∞–±—Ä—è 2024 –≥–æ–¥–∞, –ø—Ä–∏–Ω—è—Ç—ã—Ö –≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–∏ —Å–æ —Å—Ç–∞—Ç—å–µ–π 1360 –ì—Ä–∞–∂–¥–∞–Ω—Å–∫–æ–≥–æ –∫–æ–¥–µ–∫—Å–∞. –û–Ω–∞ –¥–∞—ë—Ç –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤—É –ø—Ä–∞–≤–æ –≤ —Å–ª—É—á–∞–µ –∫—Ä–∞–π–Ω–µ–π –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ —Ä–∞–∑—Ä–µ—à–∞—Ç—å –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ –∏–∑–æ–±—Ä–µ—Ç–µ–Ω–∏–π –±–µ–∑ —Å–æ–≥–ª–∞—Å–∏—è –∏—Ö –≤–ª–∞–¥–µ–ª—å—Ü–µ–≤. Novo Nordisk –ø—ã—Ç–∞–ª–∞—Å—å –æ—Ç–±–∏—Ç—å –¥–≤–∞ –ø–∞—Ç–µ–Ω—Ç–∞ ‚Äî ‚Ññ2421238 –∏ ‚Ññ2657573. –î–∞—Ç—á–∞–Ω–µ —É–ø–∏—Ä–∞–ª–∏ –Ω–∞ —Ç–æ, —á—Ç–æ –≤ —Å—Ç—Ä–∞–Ω–µ –Ω–µ –±—ã–ª–æ —á—Ä–µ–∑–≤—ã—á–∞–π–Ω–æ–π —Å–∏—Ç—É–∞—Ü–∏–∏, –∫–æ—Ç–æ—Ä–∞—è –º–æ–≥–ª–∞ –±—ã –æ–ø—Ä–∞–≤–¥–∞—Ç—å –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω–æ–µ –ª–∏—Ü–µ–Ω–∑–∏—Ä–æ–≤–∞–Ω–∏–µ. –í—Ç–æ—Ä–æ–π –∞—Ä–≥—É–º–µ–Ω—Ç: –∫–æ–º–ø–∞–Ω–∏—é –Ω–µ —É–≤–µ–¥–æ–º–∏–ª–∏ –æ –ø—Ä–∏–Ω—è—Ç–∏–∏ –∞–∫—Ç–æ–≤ –∏ –Ω–µ –≤—ã–ø–ª–∞—Ç–∏–ª–∏ –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏—é. –ü–æ–∑–∏—Ü–∏—è —Å—É–¥–∞: –ø—Ä–µ–∫—Ä–∞—â–µ–Ω–∏–µ —Å 1 —è–Ω–≤–∞—Ä—è 2024 –≥–æ–¥–∞ –ø–æ—Å—Ç–∞–≤–æ–∫ –≤ –†–æ—Å—Å–∏—é –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ Novo Nordisk —Å —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–æ–º, –≤–∫–ª—é—á–µ–Ω–Ω—ã–º –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü, —Å–æ–∑–¥–∞–ª–æ —É–≥—Ä–æ–∑—É –∑–¥–æ—Ä–æ–≤—å—é –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ–≥–æ —á–∏—Å–ª–∞ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –ß—Ç–æ –∫–∞—Å–∞–µ—Ç—Å—è –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏–π. ¬´–ü–°–ö –§–∞—Ä–º–∞¬ª –∏ ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª –≤ –º–∞—Ä—Ç–µ —ç—Ç–æ–≥–æ –≥–æ–¥–∞ —Å–æ–æ–±—â–∞–ª–∏, —á—Ç–æ –æ—Å—É—â–µ—Å—Ç–≤–∏–ª–∏ –ø–µ—Ä–≤—ã–µ –≤—ã–ø–ª–∞—Ç—ã Novo Nordisk. –ü—Ä–∞–≤–æ–æ–±–ª–∞–¥–∞—Ç–µ–ª—å –∑–∞—è–≤–∏–ª, —á—Ç–æ ¬´–Ω–µ —É—á–∞—Å—Ç–≤–æ–≤–∞–ª –≤ –∫–∞–∫–∏—Ö-–ª–∏–±–æ –ø–µ—Ä–µ–≥–æ–≤–æ—Ä–∞—Ö –∫–∞—Å–∞—Ç–µ–ª—å–Ω–æ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ –≤ –†–æ—Å—Å–∏–∏ –∏ –Ω–µ –ø–æ–ª—É—á–∞–ª –ª–∏—Ü–µ–Ω–∑–∏–æ–Ω–Ω—ã—Ö –≤–æ–∑–Ω–∞–≥—Ä–∞–∂–¥–µ–Ω–∏–π¬ª. ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª, —á–µ–π –°–µ–º–∞–≤–∏–∫ —Å—Ç–∞–ª –ª–∏–¥–µ—Ä–æ–º –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–æ–≤, –Ω–∏–∫–∞–∫–∏—Ö –≤—ã–ø–ª–∞—Ç –Ω–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏–ª, —Å–æ—Å–ª–∞–≤—à–∏—Å—å –Ω–∞ —Ç–æ, —á—Ç–æ ¬´—Ä–∞–∑—Ä–µ—à–µ–Ω–∏–µ –Ω–∞ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ –±—ã–ª–æ –≤—ã–¥–∞–Ω–æ –µ–π —Å —É—á–µ—Ç–æ–º –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏–π –Ω–∞ –≤—ã–ø–ª–∞—Ç—É –≤–æ–∑–Ω–∞–≥—Ä–∞–∂–¥–µ–Ω–∏–π –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã–º –ø—Ä–∞–≤–æ–æ–±–ª–∞–¥–∞—Ç–µ–ª—è–º –∏–∑ –Ω–µ–¥—Ä—É–∂–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ç—Ä–∞–Ω¬ª. –í –º–∞–µ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –ø—Ä–æ–¥–ª–∏–ª–æ –∫–æ–º–ø–∞–Ω–∏–∏ –ü–µ—Ç—Ä–∞ –†–æ–¥–∏–æ–Ω–æ–≤–∞ —Ä–∞–∑—Ä–µ—à–µ–Ω–∏–µ –Ω–∞ –≤—ã–ø—É—Å–∫ –≤ –†–æ—Å—Å–∏–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ –æ—Å–Ω–æ–≤–µ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ –±–µ–∑ —Å–æ–≥–ª–∞—Å–∏—è –ø—Ä–∞–≤–æ–æ–±–ª–∞–¥–∞—Ç–µ–ª—è –¥–æ 31 –¥–µ–∫–∞–±—Ä—è 2025 –≥–æ–¥–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage, regulation"",
  ""impact"": ""high"",
  ""english"": ""The Supreme Court of Denmark rejected Novo Nordisk's appeal and upheld government decisions allowing 'PSK Pharma' and 'Promed' to produce Novo Nordisk's semaglutide until the end of 2025. The government has the right to use inventions without the owners' consent in case of extreme necessity, as per Article 1360 of the Civil Code. Novo Nordisk tried to invalidate two patents - ‚Ññ2421238 and ‚Ññ2657573. The Danish company argued that there was no emergency situation to justify compulsory licensing and that the companies were not notified about the acts' adoption nor compensated. The Supreme Court ruled that stopping the supply of Novo Nordisk's original semaglutide in Russia, included in the –ñ–ù–í–õ–ü list, poses a threat to patients' health. The companies 'PSK Pharma' and 'Promed' reported the first compensation payments to Novo Nordisk in March. The right holder stated that he did not participate in any negotiations regarding semag"
2025-08-14T14:32:30+00:00,@bezrec,6425,https://t.me/bezrec/6425,"–ü—Ä–æ–±–ª–µ–º–∞ —É–∫–∞—á–∏–≤–∞–Ω–∏—è –≤ —Ç—Ä–∞–Ω—Å–ø–æ—Ä—Ç–µ –∑–Ω–∞–∫–æ–º–∞ –º–Ω–æ–≥–∏–º, —Å –Ω–µ–π —Å—Ç–∞–ª–∫–∏–≤–∞—é—Ç—Å—è –∏ –¥–µ—Ç–∏, –∏ –≤–∑—Ä–æ—Å–ª—ã–µ. –î–ª—è —Ç–µ—Ö, –∫—Ç–æ –Ω–µ –≤–µ—Ä–∏—Ç –≤ –≤–æ–ª—à–µ–±–Ω—ã–µ –æ—á–∫–∏ –æ—Ç –º–æ—Ä—Å–∫–æ–π –±–æ–ª–µ–∑–Ω–∏, –º—ã #–∑–∞—Ü–µ–Ω–∏–ª–∏ —Å—Ä–µ–¥—Å—Ç–≤–∞ –Ω–∞ –æ—Å–Ω–æ–≤–µ –¥–∏–º–µ–Ω–≥–∏–¥—Ä–∏–Ω–∞—Ç–∞. –î–∏–º–µ–Ω–≥–∏–¥—Ä–∏–Ω–∞—Ç –†–µ–Ω–µ–≤–∞–ª –∏ –ì–µ–æ–Ω–æ—Ä–º–∏–Ω (¬´–ü–§–ö –û–±–Ω–æ–≤–ª–µ–Ω–∏–µ¬ª) –Ω–∞–º –≤ –ø—Ä–æ–¥–∞–∂–µ –Ω–∞–π—Ç–∏ –Ω–µ —É–¥–∞–ª–æ—Å—å, –ø–æ—ç—Ç–æ–º—É —Å—Ä–∞–≤–Ω–∏–ª–∏ —Ü–µ–Ω—ã –Ω–∞ –î—Ä–∞–º–∏–Ω—É —Ö–æ—Ä–≤–∞—Ç—Å–∫–æ–π ¬´–Ø–¥—Ä–∞–Ω-–ì–∞–ª–µ–Ω—Å–∫–∏¬ª –∏ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π –ê–≤–∏–∞–º–∞—Ä–∏–Ω –æ—Ç ¬´–ê–ª–∏—É–º–∞¬ª. –ë–æ–ª—å—à–µ –≤—Å–µ–≥–æ —Ü–µ–Ω–æ–π –Ω–∞ –î—Ä–∞–º–∏–Ω—É —É–¥–∏–≤–∏–ª–∞ 36,6 ‚Äî —Ç–∞–º —É–ø–∞–∫–æ–≤–∫–∞ –∏–∑ 10 —Ç–∞–±–ª–µ—Ç–æ–∫ —Å—Ç–æ–∏—Ç –∞–∂ 520 —Ä—É–±–ª–µ–π. –î–ª—è —Å—Ä–∞–≤–Ω–µ–Ω–∏—è, –≤ ¬´–†–∏–≥–ª–µ¬ª –ø—Ä–µ–ø–∞—Ä–∞—Ç –æ–±–æ–π–¥—ë—Ç—Å—è –≤ 250 —Ä—É–±–ª–µ–π. –°–∞–º—ã–π –¥–µ—à–µ–≤—ã–π –ê–≤–∏–∞–º–∞—Ä–∏–Ω –∑–∞ 273 —Ä—É–±–ª—è –Ω–∞—à—ë–ª—Å—è –≤ ¬´–ê–ø—Ç–µ–∫–µ.—Ä—É¬ª. –°–∞–º—ã–π –¥–æ—Ä–æ–≥–æ–π (353 —Ä—É–±–ª—è) –ø—Ä–æ–¥–∞—ë—Ç—Å—è —Ç–∞–∫–∂–µ –≤ ¬´36,6¬ª. –ù–∞–ø–æ–º–∏–Ω–∞–µ–º, —á—Ç–æ –ª—é–±—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏–º–µ—é—Ç –ø—Ä–æ—Ç–∏–≤–æ–ø–æ–∫–∞–∑–∞–Ω–∏—è. –ü–µ—Ä–µ–¥ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º –ø—Ä–æ–∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä—É–π—Ç–µ—Å—å —Å –ª–µ—á–∞—â–∏–º –≤—Ä–∞—á–æ–º. *–∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –ø—Ä–æ–≤–æ–¥–∏–ª–æ—Å—å –æ–Ω–ª–∞–π–Ω 13 –∞–≤–≥—É—Å—Ç–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage"",
  ""impact"": ""high"",
  ""english"": ""An online investigation compared the prices of Dramina, a drug from Croatia's 'Yardran-Galenski', and the domestic Aviamarin from 'Alium'. The price for 10 tablets of Dramina was surprising at 520 rubles, while the domestic Aviamarin cost only 233 rubles. The country of origin and price variations are highlighted as issues affecting the supply chain for medicines.""
}"
2025-08-14T12:01:13+00:00,@bezrec,6424,https://t.me/bezrec/6424,"–†–æ—Å—Å–∏—è–Ω–µ –≤—Å–µ—Ä—å—ë–∑ –≤–∑—è–ª–∏—Å—å –∑–∞ –ª–µ—á–µ–Ω–∏–µ —É–≥—Ä–µ–π. –ü–æ –∏—Ç–æ–≥–∞–º I-II –∫–≤–∞—Ä—Ç–∞–ª–∞ 2025 –≥–æ–¥–∞ –±—ã–ª–æ —Ä–µ–∞–ª–∏–∑–æ–≤–∞–Ω–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è —É–≥—Ä–µ–π –Ω–∞ —Å—É–º–º—É —Å–≤—ã—à–µ 8,68 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –≠—Ç–æ –Ω–∞ 51% –±–æ–ª—å—à–µ –∏ –±–µ–∑ —Ç–æ–≥–æ –≤—ã—Å–æ–∫–∏—Ö –ø–æ–∫–∞–∑–∞—Ç–µ–ª–µ–π –∞–Ω–∞–ª–æ–≥–∏—á–Ω–æ–≥–æ –ø–µ—Ä–∏–æ–¥–∞ –ø—Ä–æ—à–ª–æ–≥–æ –≥–æ–¥–∞. –ù–∞—Ç—É—Ä–∞–ª—å–Ω–æ–µ –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–µ –≤—ã—Ä–æ—Å–ª–æ –Ω–∞ 28,5%, –¥–æ 5,89 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫. –ü–æ –∏—Ç–æ–≥–∞–º 2024 –≥–æ–¥–∞ —Ä–æ—Å—Å–∏—è–Ω–µ –∫—É–ø–∏–ª–∏ 9,88 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ —Å—Ä–µ–¥—Å—Ç–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è —É–≥—Ä–µ–≤–æ–π —Å—ã–ø–∏ (+24,9% –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å 2023 –≥–æ–¥–æ–º) –Ω–∞ —Å—É–º–º—É –±–æ–ª–µ–µ 12,9 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π (+48,3%). –≠—Ç–∞ –∫–∞—Ç–µ–≥–æ—Ä–∏—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–∞ 13 –ú–ù–ù, –±–æ–ª—å—à–µ –≤—Å–µ–≥–æ —Ä–æ—Å—Å–∏—è–Ω–µ —Ç—Ä–∞—Ç—è—Ç –Ω–∞ —Ç.–Ω. —Ä–µ—Ç–∏–Ω–æ–∏–¥—ã, –≤ —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, –Ω–∞ –∏–∑–æ—Ç—Ä–µ—Ç–∏–Ω–æ–∏–Ω. –ù–∞ –Ω–∏—Ö –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –±–æ–ª–µ–µ 55% —Å—Ç–æ–∏–º–æ—Å—Ç–Ω–æ–≥–æ –∏ 31% –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–≥–æ –æ–±—ä—ë–º–∞ –ø—Ä–æ–¥–∞–∂. –í –ª–∏–¥–µ—Ä–∞—Ö —Å—Ä–µ–¥–∏ —Ç–æ—Ä–≥–æ–≤—ã—Ö –º–∞—Ä–æ–∫ —É–∂–µ –Ω–µ –ø–µ—Ä–≤—ã–π –≥–æ–¥ –ê–∫–Ω–µ–∫—É—Ç–∞–Ω (–∏–∑–æ—Ç—Ä–µ—Ç–∏–Ω–æ–∏–Ω) –æ—Ç —Ö–æ—Ä–≤–∞—Ç—Å–∫–æ–π ¬´–Ø–¥—Ä–∞–Ω¬ª. –ü–æ –∏—Ç–æ–≥–∞–º –ø–µ—Ä–≤—ã—Ö –¥–≤—É—Ö –∫–≤–∞—Ä—Ç–∞–ª–æ–≤ 2025 –≥–æ–¥–∞ –æ–Ω —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–ª 31,8% –¥–µ–Ω–µ–∂–Ω–æ–≥–æ –æ–±—ä—ë–º–∞ –∏ 16,3% –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–≥–æ. –ù–∞ –≤—Ç–æ—Ä–æ–π —Å—Ç—Ä–æ—á–∫–µ ‚Äî –°–æ—Ç—Ä–µ—Ç –æ—Ç –∏–Ω–¥–∏–π—Å–∫–æ–π ¬´–°–∞–Ω –§–∞—Ä–º–∞¬ª —Å —Ç–µ–º –∂–µ –¥–µ–π—Å—Ç–≤—É—é—â–∏–º –≤–µ—â–µ—Å—Ç–≤–æ–º. –û–±–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –≤—ã–ø—É—Å–∫–∞—é—Ç—Å—è –≤ —Ñ–æ—Ä–º–µ –∫–∞–ø—Å—É–ª. –ü—Ä–∏ —ç—Ç–æ–º –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã–π –∏–∑–æ—Ç—Ä–µ—Ç–∏–Ω–æ–∏–Ω ‚Äî –†–æ–∞–∫–∫—É—Ç–∞–Ω –æ—Ç ¬´–†–æ—à¬ª ‚Äî —Å–¥–∞—ë—Ç –ø–æ–∑–∏—Ü–∏–∏ –∏ –∑–∞–Ω–∏–º–∞–µ—Ç –ª–∏—à—å –ø—è—Ç–æ–µ –º–µ—Å—Ç–æ. –ó–∞–º—ã–∫–∞–µ—Ç —Ç—Ä–æ–π–∫—É –ª–∏–¥–µ—Ä–æ–≤ –≠—Ñ—Ñ–µ–∑–µ–ª (–∞–¥–∞–ø–∞–ª–µ–Ω+–±–µ–Ω–∑–æ–∏–ª–∞ –ø–µ—Ä–æ–∫—Å–∏–¥) –æ—Ç —à–≤–µ–π—Ü–∞—Ä—Å–∫–æ–π ¬´–ì–∞–ª–¥–µ—Ä–º–∞¬ª –≤ –≤–∏–¥–µ –≥–µ–ª—è –¥–ª—è –º–µ—Å—Ç–Ω–æ–≥–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è. –í —Ç–æ–ø-10 —Ç–∞–∫–∂–µ –ø–æ–ø–∞–ª–∏ –ë–∞–∑–∏—Ä–æ–Ω –ê—Å (¬´–ì–∞–ª–¥–µ—Ä–º–∞¬ª), –ö–ª–µ–Ω–∑–∏—Ç (¬´–ì–ª–µ–Ω–º–∞—Ä–∫¬ª), –ê–∑–µ–ª–∏–∫ (¬´–ê–∫—Ä–∏—Ö–∏–Ω¬ª), –°–∫–∏–Ω–æ–∫–ª–∏—Ä (¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª), –ó–µ—Ä–∫–∞–ª–∏–Ω (¬´–Ø–¥—Ä–∞–Ω¬ª) –∏ –ö–ª–∏–Ω–¥–æ–≤–∏—Ç (¬´–Ø–¥—Ä–∞–Ω¬ª). –í—Ä–∞—á–∏ –æ–±—ä—è—Å–Ω—è—é—Ç —Ä–æ—Å—Ç –ø—Ä–æ–¥–∞–∂ —Ä–µ—Ç–∏–Ω–æ–∏–¥–æ–≤ –ø–æ–≤—ã—à–µ–Ω–∏–µ–º –∏–Ω—Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–Ω–æ—Å—Ç–∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –æ –ª–µ—á–µ–Ω–∏–∏ —É–≥—Ä–µ–≤–æ–π —Å—ã–ø–∏ –∏ –ø—Ä–æ–≥–Ω–æ–∑–∏—Ä—É—é—Ç, —á—Ç–æ —Å–ø—Ä–æ—Å –Ω–∞ –Ω–∏—Ö –±—É–¥–µ—Ç —Ç–æ–ª—å–∫–æ —Ä–∞—Å—Ç–∏ –ø–æ—Å–ª–µ –≤–∫–ª—é—á–µ–Ω–∏—è –≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏, –¥–µ–π—Å—Ç–≤—É—é—â–∏–µ —Å —è–Ω–≤–∞—Ä—è —ç—Ç–æ–≥–æ –≥–æ–¥–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": true,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,safety,pharmacovigilance,hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""The message discusses the natural consumption of treatments for acne, but does not directly relate to regulatory affairs or market access for medicines. It mentions clinical trial and safety aspects, but these are not specific to the regulatory environment or market access for medicines in the specified countries.""
}"
2025-08-14T09:04:22+00:00,@bezrec,6423,https://t.me/bezrec/6423,"–°–º–æ—Ç—Ä–∏–º —Å–≤–µ–∂–∏–π –æ—Ç—á—ë—Ç –†–æ—Å—Å—Ç–∞—Ç–∞ –æ –¥–∏–Ω–∞–º–∏–∫–µ —Ü–µ–Ω –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –≤ –∏—é–ª–µ 2025 –≥–æ–¥–∞. –¶–µ–Ω—ã –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –Ω–µ –∏–∑ –ø–µ—Ä–µ—á–Ω—è –ñ–ù–í–õ–ü –≤ —Å—Ä–µ–¥–Ω–µ–º –∏–∑–º–µ–Ω–∏–ª–∏—Å—å –Ω–∞ +0,6%: - –ª–µ–≤–æ–º–µ–∫–æ–ª—å +2,5%; - –≤–∞–ª–æ—Å–µ—Ä–¥–∏–Ω +2,2%; - –≥—Ä–∞–º–º–∏–¥–∏–Ω +1,3%; - –Ω–∞—Ñ–∞–∑–æ–ª–∏–Ω +1,1%; - –∫–∞–Ω–µ—Ñ—Ä–æ–Ω –ù; - –∫–∞—Ä–¥–∏–æ–º–∞–≥–Ω–∏–ª –∏ –≥–µ–ø–∞—Ä–∏–Ω–æ–≤–∞—è –º–∞–∑—å +1,0%; - –º—É–∫–∞–ª—Ç–∏–Ω –∏ —Ç–∞—É—Ä–∏–Ω +0,9%; - –º–µ—Ç–∞–º–∏–∑–æ–ª –Ω–∞—Ç—Ä–∏—è (–∞–Ω–∞–ª—å–≥–∏–Ω –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π); - —Ä–µ–Ω–≥–∞–ª–∏–Ω –∏ –π–æ–¥ +0,8%; - –∫–µ—Ç–æ—Ä–æ–ª —ç–∫—Å–ø—Ä–µ—Å—Å +0,7%. –ù–µ–º–Ω–æ–≥–æ –ø–æ–¥–µ—à–µ–≤–µ–ª–∏ —Ç—Ä–µ–∫—Ä–µ–∑–∞–Ω (-0,7%) –∏ –∫–æ—Ä–≤–∞–ª–æ–ª (-0,6%). –ù–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, –æ—Ç–Ω–æ—Å—è—â–∏–µ—Å—è –∫ –ñ–ù–í–õ–ü, —Ü–µ–Ω—ã –≤ —Å—Ä–µ–¥–Ω–µ–º –∏–∑–º–µ–Ω–∏–ª–∏—Å—å –Ω–∞ +0,3%: - —Ö–ª–æ—Ä–≥–µ–∫—Å–∏–¥–∏–Ω +1,4%; - –ª–æ–ø–µ—Ä–∞–º–∏–¥ +1,2%; - –≤–µ—Ä–æ—à–ø–∏—Ä–æ–Ω +1,0%; - –æ–º–µ–ø—Ä–∞–∑–æ–ª, –±–µ—Ç–∞–ª–æ–∫ –ó–û–ö –∏ –Ω–∞—Ç—Ä–∏—è —Ö–ª–æ—Ä–∏–¥ +0,8%; - –ø–µ—Ä–µ–∫–∏—Å—å –≤–æ–¥–æ—Ä–æ–¥–∞ +0,6%; - —ç–Ω–∞–ª–∞–ø—Ä–∏–ª –∏ –ø–∞–Ω–∫—Ä–µ–∞—Ç–∏–Ω +0,5%. –°–Ω–∏–∑–∏–ª–∏—Å—å —Ü–µ–Ω—ã –Ω–∞ –∞–º–æ–∫—Å–∏—Ü–∏–ª–ª–∏–Ω —Å –∫–ª–∞–≤—É–ª–∞–Ω–æ–≤–æ–π –∫–∏—Å–ª–æ—Ç–æ–π (-0,6%), —Å—É–ø—Ä–∞—Å—Ç–∏–Ω –∏ –∞—Å–∫–æ—Ä–±–∏–Ω–æ–≤—É—é –∫–∏—Å–ª–æ—Ç—É (-0,4%). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""pricing, shortage"",
  ""impact"": ""low"",
  ""english"": ""Prices on medicines not included in the –ñ–ù–í–õ–ü list have generally increased by 0.6%: Levomekole +2.5%, Valosordin +2.2%, Gramidin +1.3%, Naphazolin +1.1%, Kanefron N; Cardiomagnil and heparin ointment +1.0%, Mucalin and taurine +0.9%, Metamizol natrium (domestic Analgin); Rengalin and iodine +0.8%, Ketorol expreSs +0.7%. A little cheaper are Tricresan (-0.7%) and Korvalol (-0.6%). For medicines included in the –ñ–ù–í–õ–ü list, prices have generally increased by 0.3%: Chlorhexidine +1.4%, Loperamide +1.2%, Veroshpiron +1.0%, Omeprazole, Betalok ZOK and sodium chloride +0.8%, Hydrogen peroxide +0"
2025-08-14T05:20:26+00:00,@bezrec,6422,https://t.me/bezrec/6422,"–ò–Ω–æ—Å—Ç—Ä–∞–Ω–Ω–∞—è —Ñ–∞—Ä–º–∞ –Ω–µ —Å–∫—É–ø–∏—Ç—Å—è –Ω–∞ –≤—ã–ø–ª–∞—Ç—ã –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è–º. –û–±—â–∏–π –æ–±—ä—ë–º –≤—ã–ø–ª–∞—Ç 18 –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã—Ö —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π —Ä–æ—Å—Å–∏–π—Å–∫–∏–º –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è–º –∏ –∞—Å—Å–æ—Ü–∏–∞—Ü–∏—è–º –ø–æ –∏—Ç–æ–≥–∞–º 2024 –≥–æ–¥–∞ —É–≤–µ–ª–∏—á–∏–ª—Å—è –Ω–∞ 22,9% –¥–æ 4,1 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –¢–∞–∫–æ–≤—ã –¥–∞–Ω–Ω—ã–µ –∏—Ö –æ—Ç—á—ë—Ç–æ–≤ –æ —Ç–∞–∫ –Ω–∞–∑—ã–≤–∞–µ–º–æ–π –ø–µ—Ä–µ–¥–∞—á–µ —Ü–µ–Ω–Ω–æ—Å—Ç–µ–π. –ó–¥–µ—Å—å –Ω–µ —É—á—Ç–µ–Ω—ã –ø–æ–∫–∞–∑–∞—Ç–µ–ª–∏ AstraZeneca, –∫–æ—Ç–æ—Ä–∞—è –ø—Ä–µ–∫—Ä–∞—Ç–∏–ª–∞ —á–ª–µ–Ω—Å—Ç–≤–æ –≤ –ê—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã—Ö —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π (–ê–ú–§–ü) –∏ –±–æ–ª—å—à–µ –Ω–µ –æ–±—è–∑–∞–Ω–∞ –ø—É–±–ª–∏–∫–æ–≤–∞—Ç—å –¥–∞–Ω–Ω—ã–µ. –ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–µ Eli Lilly –∏ BMS —Å–µ–π—á–∞—Å –≤ –†–æ—Å—Å–∏–∏ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ—Ç —à–≤–µ–π—Ü–∞—Ä—Å–∫–∞—è Swixx Biopharma. –ù–∞ —á—Ç–æ –∏–¥—É—Ç –≤—ã–ø–ª–∞—Ç—ã? –ü—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ —Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤, –≤—Ö–æ–¥—è—â–∏–µ –≤ –ê–ú–§–ü, –ø–µ—Ä–µ—á–∏—Å–ª—è—é—Ç –≥—Ä–∞–Ω—Ç—ã –∏ –ø–æ–∂–µ—Ä—Ç–≤–æ–≤–∞–Ω–∏—è –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è–º –∏ –∞—Å—Å–æ—Ü–∏–∞—Ü–∏—è–º, –æ–ø–ª–∞—á–∏–≤–∞—é—Ç –º–µ–¥–∏–∫–∞–º –≤—ã—Å—Ç—É–ø–ª–µ–Ω–∏—è –Ω–∞ –≤—Å—Ç—Ä–µ—á–∞—Ö –∏ –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏—è—Ö, –Ω–∞—É—á–Ω—ã–µ –ø—É–±–ª–∏–∫–∞—Ü–∏–∏, –∞ —Ç–∞–∫–∂–µ —É—á–∞—Å—Ç–∏–µ –≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è—Ö –∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∞—Ö. –í —Ü–µ–ª–æ–º –≤ –ë–∞–≥–¥–∞–¥–µ –≤—Å—ë —Å–ø–æ–∫–æ–π–Ω–æ –∑–∞—Ä—É–±–µ–∂–Ω—ã–µ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –∞–¥–∞–ø—Ç–∏—Ä–æ–≤–∞–ª–∏ –≤—Å–µ –±–∏–∑–Ω–µ—Å-–ø—Ä–æ—Ü–µ—Å—Å—ã –∏ –ø—Ä–æ–¥–æ–ª–∂–∞—é—Ç —Ä–∞–±–æ—Ç–∞—Ç—å –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º —Ä—ã–Ω–∫–µ. –ü–æ –¥–∞–Ω–Ω—ã–º –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –ê–ú–§–ü –∏ ¬´–°–∫–æ–ª–∫–æ–≤–æ¬ª, 96% –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π —Å–æ—Ö—Ä–∞–Ω—è—é—Ç –∏–ª–∏ –Ω–∞—Ä–∞—â–∏–≤–∞—é—Ç —Å–≤–æ—é –∞–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –≤ —Å—Ç—Ä–∞–Ω–µ, –∞ –¥–≤–µ —Ç—Ä–µ—Ç–∏ –ø–ª–∞–Ω–∏—Ä—É—é—Ç —Ä–∞—Å—à–∏—Ä—è—Ç—å —Å–≤–æ–∏ –ø–æ—Ä—Ç—Ñ–µ–ª–∏. –û—Ç–º–µ—Ç–∏–º, —á—Ç–æ –∏–∑ 18 –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π —Ç–æ–ª—å–∫–æ 10 –Ω–∞—Ä–∞—Å—Ç–∏–ª–∏ —Ç—Ä–∞—Ç—ã –Ω–∞ –ø—Ä–æ–¥–≤–∏–∂–µ–Ω–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –∞ 8, –Ω–∞–ø—Ä–æ—Ç–∏–≤, –∏—Ö —Å–æ–∫—Ä–∞—Ç–∏–ª–∏. –°—Ä–µ–¥–∏ —É—Ä–µ–∑–∞–≤—à–∏—Ö –±—é–¥–∂–µ—Ç—ã, –Ω–∞–ø—Ä–∏–º–µ—Ä, Bayer, Roche, Boehringer Ingelheim, MSD, Gilead, Takeda. –í–ø—Ä–æ—á–µ–º, –∫–∞–∫ –æ—Ç–º–µ—á–∞–µ—Ç –¥–∏—Ä–µ–∫—Ç–æ—Ä –ø–æ —Ä–∞–∑–≤–∏—Ç–∏—é RNC Pharma –ù–∏–∫–æ–ª–∞–π –ë–µ—Å–ø–∞–ª–æ–≤, —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –º–æ–≥—É—Ç –∑–∞–Ω–∏–º–∞—Ç—å—Å—è –ø—Ä–æ–¥–≤–∏–∂–µ–Ω–∏–µ–º —Å–≤–æ–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ —á–µ—Ä–µ–∑ –∫–ª–∏–Ω–∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è. –ù–æ–≤—ã—Ö –∏–Ω–æ—Å—Ç—Ä–∞–Ω—Ü—ã —Å 2022 –≥–æ–¥–∞ –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏ –Ω–µ –ø—Ä–æ–≤–æ–¥—è—Ç, –Ω–æ –Ω–µ–∫–æ—Ç–æ—Ä—ã–µ –∏–∑ –Ω–∞—á–∞—Ç—ã—Ö —Ä–∞–Ω–µ–µ –º–æ–≥—É—Ç –ø—Ä–æ–¥–æ–ª–∂–∞—Ç—å—Å—è –≥–æ–¥–∞–º–∏. –°–æ–≥–ª–∞—Å–Ω–æ –æ—Ç—á—ë—Ç–∞–º, –≤—ã–ø–ª–∞—Ç—ã –≤—Ä–∞—á–∞–º —É–≤–µ–ª–∏—á–∏–ª–∏—Å—å –Ω–∞ 9,4% –≥–æ–¥ –∫ –≥–æ–¥—É, –¥–æ 2,3 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –î–µ–≤—è—Ç—å –≤—Ä–∞—á–µ–π, —Å–æ–≥–ª–∞—Å–∏–≤—à–∏—Ö—Å—è —Ä–∞—Å–∫—Ä—ã—Ç—å —Å–≤–æ–∏ –¥–∞–Ω–Ω—ã–µ, –ø–æ–ª—É—á–∏–ª–∏ –±–æ–ª–µ–µ —á–µ–º –ø–æ 1,5 –º–ª–Ω —Ä—É–±–ª–µ–π. –ê –≤–æ—Ç —Ç—Ä–∞—Ç—ã –Ω–∞ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è —Å–Ω–∏–∑–∏–ª–∏—Å—å —Å—Ä–∞–∑—É –Ω–∞ 18,4%, –¥–æ 3,6 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": true
}"
2025-08-13T15:04:21+00:00,@bezrec,6421,https://t.me/bezrec/6421,"–ü—Ä–æ–±–ª–µ–º—ã –æ–∂–∏—Ä–µ–Ω–∏—è ‚Äî —ç—Ç–æ –≤–æ–ø—Ä–æ—Å –ø–µ—Ä–µ–≤–æ—Å–ø–∏—Ç–∞–Ω–∏—è –æ–±—â–µ—Å—Ç–≤–∞, –∞ –Ω–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –±–∞—Ä–∏–∞—Ç—Ä–∏–∏. –ì–ª–∞–≤–Ω—ã–π –≤–Ω–µ—à—Ç–∞—Ç–Ω—ã–π –¥–∏–µ—Ç–æ–ª–æ–≥ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞, –Ω–∞—É—á–Ω—ã–π —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å –§–ò–¶ –ø–∏—Ç–∞–Ω–∏—è –∏ –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏, –∞–∫–∞–¥–µ–º–∏–∫ –í–∏–∫—Ç–æ—Ä –¢—É—Ç–µ–ª—å—è–Ω –ø—Ä–æ–∫–æ–º–º–µ–Ω—Ç–∏—Ä–æ–≤–∞–ª –∏–¥–µ—é –≤–∫–ª—é—á–∏—Ç—å –æ–∂–∏—Ä–µ–Ω–∏–µ –≤ —á–∏—Å–ª–æ —Å–æ—Ü–∏–∞–ª—å–Ω–æ –∑–Ω–∞—á–∏–º—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, –∞ —Ç–∞–∫–∂–µ —Ä–∞—Å—Å–∫–∞–∑–∞–ª –æ —Å–≤–æ—ë–º –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ –∫ –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç–æ–∑–Ω–æ–º—É –ø–æ—Ö—É–¥–µ–Ω–∏—é –∏ –±–∞—Ä–∏–∞—Ç—Ä–∏–∏. –ì–ª–∞–≤–Ω–æ–µ –∏–∑ –∏–Ω—Ç–µ—Ä–≤—å—é: üü¢ –Ø –ø—Ä–æ—Ç–∏–≤ –≤–∫–ª—é—á–µ–Ω–∏—è –æ–∂–∏—Ä–µ–Ω–∏—è –≤ —á–∏—Å–ª–æ —Å–æ—Ü–∏–∞–ª—å–Ω–æ –∑–Ω–∞—á–∏–º—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –ï–≥–æ –Ω–µ–ª—å–∑—è —Å–≤–æ–¥–∏—Ç—å –∫ –±–æ–ª–µ–∑–Ω–∏, –∑–∞ –∫–æ—Ç–æ—Ä—É—é –æ—Ç–≤–µ—á–∞–µ—Ç –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–æ. üü¢ –í –æ—Å–Ω–æ–≤–µ –æ–∂–∏—Ä–µ–Ω–∏—è –¥–≤–µ –ø—Ä–∏—á–∏–Ω—ã ‚Äî –ø–æ–≤—ã—à–µ–Ω–Ω–∞—è –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å –ø—Ä–æ–¥—É–∫—Ç–æ–≤ –∏ –Ω–∏–∑–∫–∏–π —É—Ä–æ–≤–µ–Ω—å –∫—É–ª—å—Ç—É—Ä—ã –ø–∏—Ç–∞–Ω–∏—è –∏ –Ω–µ–ø–æ–Ω–∏–º–∞–Ω–∏–µ –µ—ë –æ—Å–Ω–æ–≤. üü¢ –ò–Ω—ä–µ–∫—Ü–∏–æ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–ª—è —Å–Ω–∏–∂–µ–Ω–∏—è –≤–µ—Å–∞, —Ç–∞–∫–∏–µ –∫–∞–∫ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥ –∏ —Ç–∏—Ä–∑–µ–ø–∞—Ç–∏–¥, –ª–æ–º–∞—é—Ç –µ—Å—Ç–µ—Å—Ç–≤–µ–Ω–Ω—ã–µ –º–µ—Ö–∞–Ω–∏–∑–º—ã —Ä–µ–≥—É–ª—è—Ü–∏–∏. –ò—Ç–æ–≥ ‚Äî –Ω–æ–≤—ã–µ –ø—Ä–æ–±–ª–µ–º—ã, –∫–æ—Ç–æ—Ä—ã–µ –º–æ–≥—É—Ç –æ–∫–∞–∑–∞—Ç—å—Å—è —Å–µ—Ä—å–µ–∑–Ω–µ–µ —Å–∞–º–æ–π –∏–∑–±—ã—Ç–æ—á–Ω–æ–π –º–∞—Å—Å—ã —Ç–µ–ª–∞. üü¢ –ï—Å–ª–∏ –Ω–µ—Ç –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –ø–æ–∫–∞–∑–∞–Ω–∏–π, —Ç—Ä—É–¥–∏—Å—å —Å–∞–º. –°—é–¥–∞ –∂–µ –º–æ–∂–Ω–æ –æ—Ç–Ω–µ—Å—Ç–∏ –∏ –±–∞—Ä–∏–∞—Ç—Ä–∏—é. –û—Ç—Ä–µ–∑–∞–Ω–∏–µ —á–∞—Å—Ç–∏ –∂–µ–ª—É–¥–∫–∞ ‚Äî —ç—Ç–æ –Ω–µ –º–∞–≥–∏—è, –∞ —Ö–∏—Ä—É—Ä–≥–∏—á–µ—Å–∫–æ–µ –≤–º–µ—à–∞—Ç–µ–ª—å—Å—Ç–≤–æ —Å –ø–æ–±–æ—á–∫–∞–º–∏, –æ –∫–æ—Ç–æ—Ä—ã—Ö –Ω–µ —Ä–∞—Å—Å–∫–∞–∂—É—Ç –≤ —Ä–µ–∫–ª–∞–º–µ. üü¢ –í –æ—Å–Ω–æ–≤–µ –Ω–∞—É–∫–∏ –æ –ø–∏—Ç–∞–Ω–∏–∏ –¥–≤–∞ –æ—Å–Ω–æ–≤–Ω—ã—Ö –∑–∞–∫–æ–Ω–∞. –ü–µ—Ä–≤—ã–π ‚Äî —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–µ –∫–∞–ª–æ—Ä–∏–π–Ω–æ—Å—Ç–∏ —Ä–∞—Ü–∏–æ–Ω–∞ —ç–Ω–µ—Ä–≥–æ–∑–∞—Ç—Ä–∞—Ç–∞–º. –í—Ç–æ—Ä–æ–π ‚Äî —Å–æ–±–ª—é–¥–µ–Ω–∏–µ –±–∞–ª–∞–Ω—Å–∞ –ø–∏—Ç–∞—Ç–µ–ª—å–Ω—ã—Ö –≤–µ—â–µ—Å—Ç–≤. –≠—Ç–∏ –¥–≤–∞ –ø–æ—Å—Ç—É–ª–∞—Ç–∞ –¥–æ–ª–∂–Ω—ã –±—ã—Ç—å –≤–ª–æ–∂–µ–Ω—ã –≤—Å–µ–º –ø–æ–∫–æ–ª–µ–Ω–∏—è–º. üü¢ –û–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ ‚Äî –æ–¥–∏–Ω –∏–∑ —Å–∞–º—ã—Ö –≥–ª–∞–≤–Ω—ã—Ö –∞—Å–ø–µ–∫—Ç–æ–≤ –±–æ—Ä—å–±—ã —Å —ç–ø–∏–¥–µ–º–∏–µ–π –æ–∂–∏—Ä–µ–Ω–∏—è. –≠—Ç–æ –Ω–∞–∏–±–æ–ª–µ–µ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã–π –∏ –ø—Ä–∏ —ç—Ç–æ–º –Ω–µ–∑–∞—Ç—Ä–∞—Ç–Ω—ã–π –º–µ—Ç–æ–¥. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-08-13T12:01:32+00:00,@bezrec,6420,https://t.me/bezrec/6420,"¬´–§–∏—Ç–æ—Ñ–∞—Ä–º¬ª –≤–ª–æ–∂–∏—Ç 400 –º–ª–Ω —Ä—É–±–ª–µ–π –≤ —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–æ —Ñ–∞—Ä–º–ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏—è. –ù–∞ –Ω—ë–º –∞–Ω–∞–ø—Å–∫–∞—è –∫–æ–º–ø–∞–Ω–∏—è, —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä—É—é—â–∞—è—Å—è –Ω–∞ —Ç—Ä–∞–≤—è–Ω—ã—Ö —á–∞—è—Ö –∏ –ë–ê–î–∞—Ö, –ø–ª–∞–Ω–∏—Ä—É–µ—Ç –≤—ã–ø—É—Å–∫–∞—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –Ω–∞ –æ—Å–Ω–æ–≤–µ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–≥–æ —Å—ã—Ä—å—è. –í 2019 –≥–æ–¥—É ¬´–§–∏—Ç–æ—Ñ–∞—Ä–º¬ª –Ω–∞—á–∞–ª–∞ —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–æ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ –∑–∞–≤–æ–¥–∞ –≤ —Å—Ç–∞–Ω–∏—Ü–µ –ì–æ—Å—Ç–∞–≥–∞–µ–≤—Å–∫–æ–π —Å —Ü–µ—Ö–∞–º–∏ –ø–æ –∏–∑–º–µ–ª—å—á–µ–Ω–∏—é –∏ —Ñ–∞—Å–æ–≤–∫–µ —Ç—Ä–∞–≤, —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ–π –≤—ã—Å–æ–∫–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–Ω–æ–π –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–∏–µ–π –∏ —Ü–µ—Ö–æ–º –∫–∞–ø—Å—É–ª–∏—Ä–æ–≤–∞–Ω–∏—è. –í 2023 –≥–æ–¥—É –±—ã–ª–æ –ø—Ä–æ–∏–∑–≤–µ–¥–µ–Ω–æ –ø–µ—Ä–µ–æ—Å–Ω–∞—â–µ–Ω–∏–µ –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏—è, –∫–æ—Ç–æ—Ä–æ–µ –æ–±–æ—à–ª–æ—Å—å –≤ 100 –º–ª–Ω —Ä—É–±–ª–µ–π. –ü–æ–º–æ–≥–ª–∏ –º–µ—Å—Ç–Ω—ã–µ –≤–ª–∞—Å—Ç–∏ –∏ –ª—å–≥–æ—Ç–Ω—ã–µ –∑–∞–π–º—ã. ¬´–§–∏—Ç–æ—Ñ–∞—Ä–º¬ª –≤—ã–ø—É—Å–∫–∞–µ—Ç –±–æ–ª–µ–µ 250 –Ω–∞–∏–º–µ–Ω–æ–≤–∞–Ω–∏–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –ë–ê–î: —Å–±–æ—Ä—ã –∏ –º–æ–Ω–æ-—Ç—Ä–∞–≤—ã, —Ñ–∏—Ç–æ—á–∞–∏ –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –Ω–∞ –æ—Å–Ω–æ–≤–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Ä–∞—Å—Ç–∏—Ç–µ–ª—å–Ω—ã—Ö –∫–æ–º–ø–æ–Ω–µ–Ω—Ç–æ–≤. –ö–æ–º–ø–∞–Ω–∏—è —Ä–∞–±–æ—Ç–∞–µ—Ç —Å 1992 –≥–æ–¥–∞. –û—Å–Ω–æ–≤–Ω—ã–º–∏ —É—á—Ä–µ–¥–∏—Ç–µ–ª—è–º–∏ –≤—ã—Å—Ç—É–ø–∞—é—Ç –ê–Ω–¥—Ä–µ–π –ó–∞–≤–≥–æ—Ä–æ–¥–Ω–∏–π (64%), –ò–≥–æ—Ä—å –ó–∞–≤–≥–æ—Ä–æ–¥–Ω–∏–π (16%), –∞ —Ç–∞–∫–∂–µ –û–û–û ¬´–¶–µ–ª–µ–±–Ω–∞—è –ø–æ–ª—è–Ω–∞¬ª (20%). –°–µ–º—å–µ –ó–∞–≤–≥–æ—Ä–æ–¥–Ω–∏—Ö —Ç–∞–∫–∂–µ –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∏—Ç –∞–ø—Ç–µ—á–Ω–∞—è —Å–µ—Ç—å ¬´–§–∏—Ç–æ—Ñ–∞—Ä–º¬ª, –∫–æ—Ç–æ—Ä–∞—è —Å–µ–≥–æ–¥–Ω—è –≤—Ö–æ–¥–∏—Ç –≤ –¢–ûP50 —Å–µ—Ç–µ–π –†–æ—Å—Å–∏–∏. 2024 –≥–æ–¥ –∫–æ–º–ø–∞–Ω–∏—è –∑–∞–∫–æ–Ω—á–∏–ª–∞ —Å –≤—ã—Ä—É—á–∫–æ–π 1,2 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π (+24% –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å 2023 –≥–æ–¥–æ–º) –∏ –ø—Ä–∏–±—ã–ª—å—é 40,6 –º–ª–Ω —Ä—É–±–ª–µ–π (-6%). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-08-13T09:04:25+00:00,@bezrec,6419,https://t.me/bezrec/6419,"–ú–æ—à–µ–Ω–Ω–∏–∫–∏ –≤—Å–ø–æ–º–Ω–∏–ª–∏ –ø—Ä–æ ¬´–ó–¥–æ—Ä–æ–≤—É—é –†–æ—Å—Å–∏—é¬ª. –ö–∏–±–µ—Ä–º–æ—à–µ–Ω–Ω–∏–∫–∏ —Ä–µ—à–∏–ª–∏ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å –±—Ä–µ–Ω–¥ –≥–æ—Å–ø—Ä–æ–≥—Ä–∞–º–º—ã, –∑–∞–ø—É—â–µ–Ω–Ω–æ–π –≤ 2009 –≥–æ–¥—É, –≤ —Å–≤–æ–µ–π —Å—Ö–µ–º–µ –ø–æ –æ–±–º–∞–Ω—É —Ä–æ—Å—Å–∏—è–Ω, –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–∞—é—Ç —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –∫–æ–º–ø–∞–Ω–∏–∏ F6. –ù–∞—á–∞—Ç—å –º–æ–≥—É—Ç —É–∂–µ –≤ —ç—Ç–æ–º –≥–æ–¥—É. –°–∞–π—Ç—ã –º–∏–º–∏–∫—Ä–∏—Ä—É—é—Ç –∫–∞–∫ –ø–æ–¥ ¬´–ó–¥–æ—Ä–æ–≤—É—é –†–æ—Å—Å–∏—é¬ª, —Ç–∞–∫ –∏ –ø–æ–¥ –Ω–µ—Å—É—â–µ—Å—Ç–≤—É—é—â—É—é –æ–Ω–ª–∞–π–Ω-–∫–ª–∏–Ω–∏–∫—É. –°–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã F6 —É–∂–µ –≤—ã—è–≤–∏–ª–∏ 143 —Ç–∞–∫–∏—Ö —Ä–µ—Å—É—Ä—Å–∞, 117 –∏–∑ –Ω–∏—Ö —Å–æ–∑–¥–∞–Ω—ã 4 –∞–≤–≥—É—Å—Ç–∞ 2025 –≥–æ–¥–∞, –æ—Å—Ç–∞–ª—å–Ω—ã–µ - —Ä–∞–Ω—å—à–µ. –ü–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª—è–º –æ—Ç 35 –¥–æ 75 –ª–µ—Ç –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç —Å–¥–∞—Ç—å ¬´–≤—Å–µ –≤–∏–¥—ã –∞–Ω–∞–ª–∏–∑–æ–≤¬ª, –≤—ã–±—Ä–∞—Ç—å –æ–ø—Ç–∏–º–∞–ª—å–Ω—É—é –ø—Ä–æ–≥—Ä–∞–º–º—É ¬´–ª–µ—á–µ–Ω–∏—è¬ª –∏–ª–∏ ¬´–≤–æ—Å—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è¬ª, –ø–æ–º–æ—á—å —Å –ø–æ–≤—ã—à–µ–Ω–∏–µ–º –ø–æ—Ç–µ–Ω—Ü–∏–∏, –∏–∑–±–∞–≤–ª–µ–Ω–∏–µ–º –æ—Ç –º–æ—Ä—â–∏–Ω, –Ω–æ—Ä–º–∞–ª–∏–∑–∞—Ü–∏–µ–π –¥–∞–≤–ª–µ–Ω–∏—è, –ª–µ—á–µ–Ω–∏–µ–º –ø—Ä–æ—Å—Ç–∞—Ç–∏—Ç–∞ –∏ –ø—Ä–æ–±–ª–µ–º–∞–º–∏ —Å –ø–∏—â–µ–≤–∞—Ä–µ–Ω–∏–µ–º. –î–ª—è –ø–æ–ª—É—á–µ–Ω–∏—è ¬´—É—Å–ª—É–≥–∏¬ª, –Ω—É–∂–Ω–æ –∑–∞–ø–æ–ª–Ω–∏—Ç—å –∞–Ω–∫–µ—Ç—É –∏ —É–∫–∞–∑–∞—Ç—å —Å–≤–æ–∏ –∫–æ–Ω—Ç–∞–∫—Ç–Ω—ã–µ –¥–∞–Ω–Ω—ã–µ. –ü–æ—Å–ª–µ —ç—Ç–æ–≥–æ –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª—é –ø–µ—Ä–µ–∑–≤–æ–Ω–∏—Ç –º–æ—à–µ–Ω–Ω–∏–∫, —á—Ç–æ–±—ã ¬´–ø—Ä–æ–∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä–æ–≤–∞—Ç—å¬ª –∏ –ø—Ä–µ–¥–ª–æ–∂–∏—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –ø–æ –ø—Ä–æ–≥—Ä–∞–º–º–µ —è–∫–æ–±—ã –∏–Ω–¥–∏–≤–∏–¥—É–∞–ª—å–Ω–æ–≥–æ –ª–µ—á–µ–Ω–∏—è. –í –∏—Ç–æ–≥–µ –ø–æ–ø–∞–≤—à–∏–π—Å—è –Ω–∞ —É–¥–æ—á–∫—É –∑–ª–æ—É–º—ã—à–ª–µ–Ω–Ω–∏–∫–æ–≤ —Ç–µ—Ä—è–µ—Ç –¥–µ–Ω—å–≥–∏ –∏ —Ä–∏—Å–∫—É–µ—Ç —Å—Ç–æ–ª–∫–Ω—É—Ç—å—Å—è —Å –ø–æ–≤—Ç–æ—Ä–Ω–æ–π –∞—Ç–∞–∫–æ–π –ø–æ–¥ –ø—Ä–µ–¥–ª–æ–≥–æ–º ¬´–∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏–∏ –∑–∞ –ø–æ–∫—É–ø–∫—É¬ª. –¢–∞–∫–æ–µ —É–∂–µ –±—ã–ª–æ –≤ 2015-2016 –≥–æ–¥–∞—Ö, –∫–æ–≥–¥–∞ –º–æ—à–µ–Ω–Ω–∏–∫–∏ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–ª–∏ –±—Ä–µ–Ω–¥ ¬´–ó–¥–æ—Ä–æ–≤–æ–π –†–æ—Å—Å–∏–∏¬ª –¥–ª—è –ø—Ä–æ–¥–∞–∂–∏ —Ä–∞–∑–ª–∏—á–Ω—ã—Ö —É—Å–ª—É–≥ –ø–æ–¥ –≤–∏–¥–æ–º –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ü–µ–Ω—Ç—Ä–æ–≤. –¢–æ–≥–¥–∞ —Ä–æ—Å—Å–∏—è–Ω–∞–º –Ω–∞–≤—è–∑—ã–≤–∞–ª–∏ –≤ —Ç–æ–º —á–∏—Å–ª–µ ¬´–ø—Ä–µ–ø–∞—Ä–∞—Ç—ã¬ª –≤ –∫—Ä–µ–¥–∏—Ç. –ü–æ—Å–ª–µ 2020 –≥–æ–¥–∞ —Å—Ö–µ–º—É –∞–¥–∞–ø—Ç–∏—Ä–æ–≤–∞–ª–∏ –ø–æ–¥ –¥–∏—Å—Ç–∞–Ω—Ü–∏–æ–Ω–Ω—É—é –ø—Ä–æ–¥–∞–∂—É –Ω–µ—Å—É—â–µ—Å—Ç–≤—É—é—â–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –¢–∞–∫–∏–º –æ–±—Ä–∞–∑–æ–º —Å—Ö–µ–º–∞ —Å –¥–∏—Å—Ç–∞–Ω—Ü–∏–æ–Ω–Ω–æ–π –ø—Ä–æ–¥–∞–∂–µ–π —Å–æ–º–Ω–∏—Ç–µ–ª—å–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ø–æ–¥ –≤–∏–¥–æ–º –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –∏ –ë–ê–î–æ–≤ –≤–æ–∑–≤—Ä–∞—â–∞–µ—Ç—Å—è, ‚Äî —Å—á–∏—Ç–∞—é—Ç –≤ F6. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""Cyber scammers are reviving the 'Healthy Russia' program, launched in 2009. They have already created over 143 websites mimicking 'Healthy Russia' and an online clinic that does not exist. These sites target users aged 35 to 75, offering various tests and treatments such as enhancing potency, reducing wrinkles, lowering blood pressure, treating prostate issues, and digestive problems. Users are asked to fill out an application with their contact details to receive a call from the scammers, who claim to provide personalized treatments. Victims lose money and risk further scams under the guise of 'compensation for purchases'. This tactic was used before in 2015-2016, where scammers sold various services under the guise of medical centers. Since 2020, they have adapted their scheme for remote sales of questionable products disguised as medicines and dietary supplements. This revival poses a threat to the market access for legitimate pharmaceuticals.""
}"
2025-08-13T05:34:39+00:00,@bezrec,6418,https://t.me/bezrec/6418,"–í –†–æ—Å—Å–∏–∏ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω –ø–µ—Ä–≤—ã–π –±–∏–æ–∞–Ω–∞–ª–æ–≥ –∞—Ñ–ª–∏–±–µ—Ä—Ü–µ–ø—Ç–∞. –ú–∏–Ω–∑–¥—Ä–∞–≤ –≤—ã–¥–∞–ª ¬´–ì–µ–Ω–µ—Ä–∏—É–º—É¬ª —Ä–µ–≥—É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏–µ –Ω–∞ –ö–æ–Ω—Ç–∏–Ω–∏—é –¥–ª—è –ª–µ—á–µ–Ω–∏—è –æ—Ñ—Ç–∞–ª—å–º–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å—Ç–∞—Ä—à–µ 18 –ª–µ—Ç. –£ —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ —á–µ—Ç—ã—Ä–µ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ø–æ–∫–∞–∑–∞–Ω–∏—è –∫ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—é: üíä –Ω–µ–æ–≤–∞—Å–∫—É–ª—è—Ä–Ω–∞—è (¬´–≤–ª–∞–∂–Ω–∞—è¬ª) —Ñ–æ—Ä–º–∞ –≤–æ–∑—Ä–∞—Å—Ç–Ω–æ–π –º–∞–∫—É–ª—è—Ä–Ω–æ–π –¥–µ–≥–µ–Ω–µ—Ä–∞—Ü–∏–∏; üíä —É—Ö—É–¥—à–µ–Ω–∏–µ –∑—Ä–µ–Ω–∏—è, –≤—ã–∑–≤–∞–Ω–Ω–æ–µ –º–∞–∫—É–ª—è—Ä–Ω—ã–º –æ—Ç–µ–∫–æ–º –≤—Å–ª–µ–¥—Å—Ç–≤–∏–µ –æ–∫–∫–ª—é–∑–∏–∏ –≤–µ–Ω —Å–µ—Ç—á–∞—Ç–∫–∏ (—Ü–µ–Ω—Ç—Ä–∞–ª—å–Ω–æ–π –≤–µ–Ω—ã –∏–ª–∏ –µ–µ –≤–µ—Ç–≤–µ–π); üíä —É—Ö—É–¥—à–µ–Ω–∏–µ –∑—Ä–µ–Ω–∏—è, –≤—ã–∑–≤–∞–Ω–Ω–æ–µ –¥–∏–∞–±–µ—Ç–∏—á–µ—Å–∫–∏–º –º–∞–∫—É–ª—è—Ä–Ω—ã–º –æ—Ç–µ–∫–æ–º; üíä —É—Ö—É–¥—à–µ–Ω–∏–µ –∑—Ä–µ–Ω–∏—è, –≤—ã–∑–≤–∞–Ω–Ω–æ–µ –º–∏–æ–ø–∏—á–µ—Å–∫–æ–π —Ö–æ—Ä–∏–æ–∏–¥–∞–ª—å–Ω–æ–π –Ω–µ–æ–≤–∞—Å–∫—É–ª—è—Ä–∏–∑–∞—Ü–∏–µ–π. –î–æ –ø–æ—è–≤–ª–µ–Ω–∏—è –ö–æ–Ω—Ç–∏–Ω–∏–∏ –≤ —Å—Ç—Ä–∞–Ω–µ –±—ã–ª–∏ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω—ã —Ç–æ–ª—å–∫–æ –¥–≤–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –Ω–∞ –æ—Å–Ω–æ–≤–µ –∞—Ñ–ª–∏–±–µ—Ä—Ü–µ–ø—Ç–∞ ‚Äî –≠–π–ª–µ–∞ –æ—Ç –Ω–µ–º–µ—Ü–∫–æ–π Bayer –∏ –ó–∞–ª—Ç—Ä–∞–ø –æ—Ç —Ñ—Ä–∞–Ω—Ü—É–∑—Å–∫–æ–π Sanofi. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""high"",
  ""english"": ""The Russian Ministry of Health issued a registration certificate for 'Genyumi' biologic analog of aflibercept. The Russian drug has four registered indications: wet age-related macular degeneration, central retinal vein occlusion or its branches causing choroidal edema due to diabetic macular edema, and myopic choroidal neovascularization causing vision loss. Before this, only two drugs based on aflibercept were registered in the country - Eylea from German Bayer and Zaltrap from French Sanofi. ""
}"
2025-08-12T14:33:36+00:00,@bezrec,6417,https://t.me/bezrec/6417,"–ü—Ä–µ–ø–∞—Ä–∞—Ç—ã –æ—Ç —ç–Ω—É—Ä–µ–∑–∞ –ø–æ–∫–∞–∑—ã–≤–∞—é—Ç –¥–≤—É–∑–Ω–∞—á–Ω—É—é –¥–∏–Ω–∞–º–∏–∫—É –ø—Ä–æ–¥–∞–∂. –ü–æ –¥–∞–Ω–Ω—ã–º RNC Pharma, –≤ –ø–µ—Ä–≤–æ–º –ø–æ–ª—É–≥–æ–¥–∏–∏ 2025 –≥–æ–¥–∞ —Ä–æ—Å—Å–∏—è–Ω–µ –ø—Ä–∏–æ–±—Ä–µ–ª–∏ –±–æ–ª–µ–µ 1 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ —Ç–∞–∫–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –Ω–∞ —Å—É–º–º—É —Å–≤—ã—à–µ 1,1 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —á—Ç–æ –Ω–∞ 22,5% –±–æ–ª—å—à–µ –≤ –¥–µ–Ω–µ–∂–Ω–æ–º –∏ –Ω–∞ 17,1% –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ –≥–æ–¥ –∫ –≥–æ–¥—É. –û–±—ä—ë–º—ã –ø—Ä–æ–¥–∞–∂ —Ä–∞—Å—Ç—É—Ç –¥–≤—É—Ö–∑–Ω–∞—á–Ω—ã–º–∏ —Ç–µ–º–ø–∞–º–∏ —Ç—Ä–µ—Ç–∏–π –≥–æ–¥ –ø–æ–¥—Ä—è–¥. –≠—Ç–∞ –∫–∞—Ç–µ–≥–æ—Ä–∏—è –Ω–µ –º–æ–∂–µ—Ç –ø–æ—Ö–≤–∞—Å—Ç–∞—Ç—å—Å—è –±–æ–ª—å—à–∏–º –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ–º –ú–ù–ù ‚Äî –∏—Ö –≤—Å–µ–≥–æ —Å–µ–º—å. –û—Å–Ω–æ–≤–Ω–æ–π –æ–±—ä—ë–º —Ä–∞—Å—Ö–æ–¥–æ–≤ –≤ –æ—Ç—á—ë—Ç–Ω—ã–π –ø–µ—Ä–∏–æ–¥ –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –Ω–∞ –æ—Å–Ω–æ–≤–µ —Å–æ–ª–∏—Ñ–µ–Ω–∞—Ü–∏–Ω–∞ ‚Äî –æ–Ω–∏ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω—ã —á–µ—Ç—ã—Ä—å–º—è —Ç–æ—Ä–≥–æ–≤—ã–º–∏ –º–∞—Ä–∫–∞–º–∏. –ù–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ ‚Äî –º–∏—Ä–∞–±–µ–≥—Ä–æ–Ω, –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–Ω—ã–π –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–º –±—Ä–µ–Ω–¥–æ–º –ë–µ—Ç–º–∏–≥–∞ –æ—Ç ¬´–ê—Å—Ç–µ–ª–ª–∞—Å¬ª. –≠—Ç–æ—Ç –ø—Ä–µ–ø–∞—Ä–∞—Ç –ª–∏–¥–∏—Ä—É–µ—Ç –≤ –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ —Å –¥–æ–ª–µ–π —Ä—ã–Ω–∫–∞ 34,4%. –ó–∞ –Ω–∏–º —Å–ª–µ–¥—É–µ—Ç –µ—â—ë –æ–¥–∏–Ω –ø—Ä–æ–¥—É–∫—Ç –æ—Ç ¬´–ê—Å—Ç–µ–ª–ª–∞—Å¬ª ‚Äî –í–µ–∑–∏–∫–∞—Ä (–ú–ù–ù —Å–æ–ª–∏—Ñ–µ–Ω–∞—Ü–∏–Ω) —Å –¥–æ–ª–µ–π —Ä—ã–Ω–∫–∞ 30,7%. –ù–∞ —Ç—Ä–µ—Ç—å–µ–º –º–µ—Å—Ç–µ —Ä–µ–π—Ç–∏–Ω–≥–∞ ‚Äî –°–ø–∞–∑–º–µ–∫—Å (–ú–ù–ù —Ç—Ä–æ—Å–ø–∏—è —Ö–ª–æ—Ä–∏–¥) –æ—Ç ¬´–ü–†–û.–ú–ï–î.–¶–°¬ª. –í —Ü–µ–ª–æ–º, –ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω–∞—è –¥–∏–Ω–∞–º–∏–∫–∞ –ø—Ä–æ–¥–∞–∂ –Ω–∞–±–ª—é–¥–∞–ª–∞—Å—å —É –≤—Å–µ—Ö —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ —Ç–æ–ø-10, –∫—Ä–æ–º–µ –ù–æ–≤–∏—Ç—Ä–æ–ø–∞–Ω–∞ (–ú–ù–ù –æ–∫—Å–∏–±—É—Ç–∏–Ω–∏–Ω) –æ—Ç ¬´–ö–µ–º–∏–∫–∞–ª –ò–Ω–¥–∞—Å—Ç—Ä–∏–∑¬ª. –ú–∞–∫—Å–∏–º–∞–ª—å–Ω—ã–µ —Ç–µ–º–ø—ã —Ä–æ—Å—Ç–∞ –ø–æ–∫–∞–∑–∞–ª –¢–æ–≤–∏–∞–∑ (–ú–ù–ù —Ñ–µ–∑–æ—Ç–µ—Ä–æ–¥–∏–Ω) –æ—Ç ¬´–ü—Ñ–∞–π–∑–µ—Ä¬ª ‚Äî –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ —è–Ω–≤–∞—Ä—è-–∏—é–Ω—è 2024 –≥–æ–¥–∞ –æ–±—ä—ë–º –ø—Ä–æ–¥–∞–∂ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ —É–≤–µ–ª–∏—á–∏–ª—Å—è –≤ 104 —Ä–∞–∑–∞. –¢–∞–∫–∞—è –≤–Ω—É—à–∏—Ç–µ–ª—å–Ω–∞—è –¥–∏–Ω–∞–º–∏–∫–∞ —Å–≤—è–∑–∞–Ω–∞ —Å –Ω–∏–∑–∫–æ–π –±–∞–∑–æ–π –≤ –ø–µ—Ä–≤–æ–π –ø–æ–ª–æ–≤–∏–Ω–µ –ø—Ä–æ—à–ª–æ–≥–æ –≥–æ–¥–∞, –∫–æ–≥–¥–∞ –Ω–∞–±–ª—é–¥–∞–ª–∏—Å—å —Å–µ—Ä—å—ë–∑–Ω—ã–µ –ø–µ—Ä–µ–±–æ–∏ —Å –ø–æ—Å—Ç–∞–≤–∫–∞–º–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞. –ü–æ–º–∏–º–æ –ø–µ—Ä–µ—á–∏—Å–ª–µ–Ω–Ω—ã—Ö, –≤ —Ç–æ–ø-10 –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è —ç–Ω—É—Ä–µ–∑–∞ –≤–æ—à–ª–∏: –°–æ–ª–∏–∫—Å–∞-–ö—Å–∞–Ω—Ç–∏—Å (¬´–ö—Å–∞–Ω—Ç–∏—Å –§–∞—Ä–º–∞¬ª), –î—Ä–∏–ø—Ç–∞–Ω (¬´–≠–±–±–æ—Ç—Ç¬ª), –í–µ–∑–∏–≥–∞–º–ø (¬´–°–∞–Ω –§–∞—Ä–º–∞¬ª), –í–µ–∑—É—Å—Ç–µ–Ω (¬´–ü–µ–ø—Ç–∏–¥–ø—Ä–æ¬ª), –°–æ–ª–∏—Ñ–µ–Ω–∞—Ü–∏–Ω (¬´–ö–∞–Ω–æ–Ω—Ñ–∞—Ä–º–∞¬ª). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The sale of drugs for enuresis show a double-digit growth rate. According to RNC Pharma data, Russia purchased over 1 million units of such drugs worth more than 1.1 billion rubles in the first half of 2025, which is a year-on-year increase of 22.5% in monetary terms and 17.1% in physical terms. The sales growth has been steady for the past three years. This category does not have a large number of MNDs - there are only seven. The main part of the spending in the reporting period is on drugs based on solifenacin - they are represented by four trade brands. The second place in the ranking is Betmiga (MND solifenacin) from Astellas Pharma, which has a market share of 34.4%. The third place is Spazmek (MND tropic acid chloride) from PRO.MED.CS. Overall, positive sales growth was observed in all top-10 participants except Novitropan (MND oxibut"
2025-08-12T09:01:01+00:00,@bezrec,6415,https://t.me/bezrec/6415,"–†–æ—Å—Å–∏—è–Ω–∞–º –ø–æ–æ–±–µ—â–∞–ª–∏ –Ω–æ–≤—É—é –º–†–ù–ö-–≤–∞–∫—Ü–∏–Ω—É –æ—Ç –∫–ª–µ—â–µ–≤–æ–≥–æ —ç–Ω—Ü–µ—Ñ–∞–ª–∏—Ç–∞. –º–†–ù–ö-–ø–ª–∞—Ç—Ñ–æ—Ä–º—É, –∫–æ—Ç–æ—Ä–∞—è –ø–æ–∑–≤–æ–ª–∏—Ç –≤ —Ç–æ–º —á–∏—Å–ª–µ —Å–æ–∑–¥–∞—Ç—å –≤–∞–∫—Ü–∏–Ω—É –æ—Ç –∫–ª–µ—â–µ–≤–æ–≥–æ —ç–Ω—Ü–µ—Ñ–∞–ª–∏—Ç–∞, —Ä–∞–∑—Ä–∞–±–∞—Ç—ã–≤–∞–µ—Ç –¶–µ–Ω—Ç—Ä –∏–º. –ì–∞–º–∞–ª–µ–∏. –û–±–µ—â–∞—é—Ç, —á—Ç–æ –æ–Ω–∞ –±—É–¥–µ—Ç —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–µ–µ –∏ –¥–µ—à–µ–≤–ª–µ —Å—É—â–µ—Å—Ç–≤—É—é—â–∏—Ö –≠–Ω—Ü–µ—Ñ–∏—Ä–∞ –∏ –ö–ª–µ—â-–≠-–í–∞–∫ –æ—Ç ¬´–ú–∏–∫—Ä–æ–≥–µ–Ω–∞¬ª (–≤—Ö–æ–¥–∏—Ç –≤ —Ö–æ–ª–¥–∏–Ω–≥ ¬´–ù–∞—Ü–∏–º–±–∏–æ¬ª) –∏ –¶–µ–Ω—Ç—Ä–∞ –∏–º. –ß—É–º–∞–∫–æ–≤–∞. –û–±–µ –≤–∞–∫—Ü–∏–Ω—ã, –∏—Å–ø–æ–ª—å–∑—É–µ–º—ã–µ –ø—Ä–æ—Ç–∏–≤ –∫–ª–µ—â–µ–≤–æ–≥–æ —ç–Ω—Ü–µ—Ñ–∞–ª–∏—Ç–∞ –≤ –†–æ—Å—Å–∏–∏, —è–≤–ª—è—é—Ç—Å—è ¬´—É–±–∏—Ç—ã–º–∏¬ª. –ö–∞–∂–¥—ã–µ 3 –≥–æ–¥–∞ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ —Å–Ω–æ–≤–∞ –ø—Ä–∏–≤–∏–≤–∞—Ç—å—Å—è, —Ç–∞–∫ –∫–∞–∫ –∏–º–º—É–Ω–∏—Ç–µ—Ç –∫ –≤–∏—Ä—É—Å—É –∑–∞ —ç—Ç–æ –≤—Ä–µ–º—è —Å–Ω–∏–∂–∞–µ—Ç—Å—è. –ü—Ä–∏–º–µ–Ω–µ–Ω–∏–µ –º–†–ù–ö-—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –ø–æ–∑–≤–æ–ª–∏—Ç –∏–∑–±–µ–∂–∞—Ç—å —Ç–∞–∫–æ–π —á–∞—Å—Ç–æ–π —Ä–µ–≤–∞–∫—Ü–∏–Ω–∞—Ü–∏–∏. –ê —Ç–∞–∫ –∫–∞–∫ –º–†–ù–ö-–≤–∞–∫—Ü–∏–Ω—ã —è–≤–ª—è—é—Ç—Å—è –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ —Å–∏–Ω—Ç–µ–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã–º–∏ –∏ –ø—Ä–∏ –∏—Ö —Å–æ–∑–¥–∞–Ω–∏–∏ –Ω–µ –∏—Å–ø–æ–ª—å–∑—É—é—Ç—Å—è –∫—É—Ä–∏–Ω—ã–µ –∫–ª–µ—Ç–∫–∏, —Ç–æ –∏—Ö –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –±—É–¥–µ—Ç –¥–µ—à–µ–≤–ª–µ, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª –ø—Ä–æ—Ñ–µ—Å—Å–æ—Ä –∫–∞—Ñ–µ–¥—Ä—ã –≤–∏—Ä—É—Å–æ–ª–æ–≥–∏–∏ –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ —Ñ–∞–∫—É–ª—å—Ç–µ—Ç–∞ –ú–ì–£ –∏–º. –ú. –í. –õ–æ–º–æ–Ω–æ—Å–æ–≤–∞ –ù–∏–∫–æ–ª–∞–π –ù–∏–∫–∏—Ç–∏–Ω. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –º–†–ù–ö-–≤–∞–∫—Ü–∏–Ω—É –º–æ–∂–Ω–æ –±—É–¥–µ—Ç –±–æ–ª–µ–µ –æ–ø–µ—Ä–∞—Ç–∏–≤–Ω–æ –∫–æ—Ä—Ä–µ–∫—Ç–∏—Ä–æ–≤–∞—Ç—å –ø—Ä–∏ —Å—É—â–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –º—É—Ç–∞—Ü–∏—è—Ö –≤–∏—Ä—É—Å–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders,clinical_trial,vaccine"",
  ""impact"": ""high"",
  ""english"": ""A new mRNA vaccine against tick-borne encephalitis is promised for Russians. The platform, which will allow the creation of a tick-borne encephalitis vaccine, is being developed by the Gamaleya Research Institute. It promises to be more effective and cheaper than existing vaccines, such as EpiCept from 'NativBio' (a part of the company) and Chumakov Institute. Both vaccines used against tick-borne encephalitis in Russia are 'dead'. Every 3 years, revaccination is required due to the virus's immunity decreasing over time. The use of mRNA technologies will avoid such frequent revaccinations. Since the mRNA vaccines are artificially synthesized and do not use chicken cells in their production, they will be cheaper. The professor from the Moscow State University's Faculty of Biological Sciences and Virology, Nikolay Nikitin, also mentioned that the mRNA vaccine can be more quickly corrected in case of significant virus mutations.""
}"
2025-08-12T05:33:49+00:00,@bezrec,6414,https://t.me/bezrec/6414,"–¢–∞–∫–∏–º–∏ –¥–∞–Ω–Ω—ã–º–∏ –ø–æ–¥–µ–ª–∏–ª–∞—Å—å –†–æ—Å—Å–∏–π—Å–∫–∞—è –∞—Å—Å–æ—Ü–∏–∞—Ü–∏—è –∞–ø—Ç–µ—á–Ω—ã—Ö —Å–µ—Ç–µ–π –Ω–∞ –æ—Å–Ω–æ–≤–∞–Ω–∏–∏ –∞–Ω–∞–ª–∏—Ç–∏–∫–∏ AlphaRM. –ï—â—ë —Ü–∏—Ñ—Ä—ã: üîò–ø–æ —Å–æ—Å—Ç–æ—è–Ω–∏—é –Ω–∞ 30 –∏—é–Ω—è 2025 –≥–æ–¥–∞ –≤ –†–æ—Å—Å–∏–∏ —Ä–∞–±–æ—Ç–∞–ª–æ 81,7 —Ç—ã—Å. –∞–ø—Ç–µ–∫, —á—Ç–æ –Ω–∞ 2% (–Ω–∞ 1879 —Ç–æ—á–µ–∫) –±–æ–ª—å—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É; üîò–∑–∞ –≥–æ–¥ –∑–∞–∫—Ä—ã–ª–æ—Å—å 5,3 —Ç—ã—Å. —Ç–æ—á–µ–∫; üîò–ø–æ—Å–ª–µ–¥–Ω–∏–µ —Ç—Ä–∏ –≥–æ–¥–∞ –ø–æ—è–≤–ª—è–µ—Ç—Å—è –º–µ–Ω—å—à–µ –Ω–æ–≤—ã—Ö –∞–ø—Ç–µ–∫ ‚Äî –≤ –∏—é–Ω–µ 2023 –≥–æ–¥–∞ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –∏—é–Ω–µ–º 2022 –≥–æ–¥–∞ –±—ã–ª–æ –æ—Ç–∫—Ä—ã—Ç–æ 8,7 —Ç—ã—Å. —Ç–æ—á–µ–∫, –∞ –≤ –∏—é–Ω–µ 2025 –≥–æ–¥–∞ –ø–æ –æ—Ç–Ω–æ—à–µ–Ω–∏—é –∫ –∏—é–Ω—é 2024 –≥–æ–¥–∞ ‚Äî 7,2 —Ç—ã—Å; üîò—Å–æ–≤–æ–∫—É–ø–Ω–æ –∑–∞ –ø–µ—Ä–≤—ã–µ —à–µ—Å—Ç—å –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ –∞–ø—Ç–µ–∫–∏ –∑–∞—Ä–∞–±–æ—Ç–∞–ª–∏ 1,2 —Ç—Ä–ª–Ω —Ä—É–±–ª–µ–π, —á—Ç–æ –Ω–∞ 12% –±–æ–ª—å—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""demand, shortage"",
  ""impact"": ""medium"",
  ""english"": ""Data shows a decrease in the number of pharmacies in Russia, with an increase in closures. The total revenue from pharmacies has grown by 12% year-over-year, indicating a medium impact on the market.""
}"
2025-08-11T15:09:25+00:00,@bezrec,6413,https://t.me/bezrec/6413,"–û–∂–∏—Ä–µ–Ω–∏–µ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –≤–∫–ª—é—á–∏—Ç—å –≤ –ø–µ—Ä–µ—á–µ–Ω—å —Å–æ—Ü–∏–∞–ª—å–Ω–æ –∑–Ω–∞—á–∏–º—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –° —Ç–∞–∫–æ–π –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–æ–π –≤—ã—Å—Ç—É–ø–∏–ª–∏ –¥–µ–ø—É—Ç–∞—Ç—ã –ì–æ—Å–¥—É–º—ã –≤–æ –≤—Ä–µ–º—è –∫—Ä—É–≥–ª–æ–≥–æ —Å—Ç–æ–ª–∞ –Ω–∞ —Ç–µ–º—É –ø—Ä–æ–±–ª–µ–º—ã –æ–∂–∏—Ä–µ–Ω–∏—è –≤ –†–æ—Å—Å–∏–∏, –æ—Ä–≥–∞–Ω–∏–∑–æ–≤–∞–Ω–Ω–æ–≥–æ –ø–∞—Ä—Ç–∏–µ–π ¬´–ù–æ–≤—ã–µ –ª—é–¥–∏¬ª. –ù–∞–ø—Ä–∞–≤–∏—Ç—å –≤ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–µ –æ –≤–∫–ª—é—á–µ–Ω–∏–∏ –æ–∂–∏—Ä–µ–Ω–∏—è –≤ –ü–µ—Ä–µ—á–µ–Ω—å —Å–æ—Ü–∏–∞–ª—å–Ω–æ –∑–Ω–∞—á–∏–º—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, ‚Äî –≥–æ–≤–æ—Ä–∏—Ç—Å—è –≤ —Ç–µ–∫—Å—Ç–µ —Ä–µ–∑–æ–ª—é—Ü–∏–∏. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –ú–∏–Ω–∑–¥—Ä–∞–≤—É —Ä–µ–∫–æ–º–µ–Ω–¥–æ–≤–∞–ª–∏ —É—Å—Ç–∞–Ω–æ–≤–∏—Ç—å –¥–∏—Å–ø–∞–Ω—Å–µ—Ä–Ω–æ–µ –Ω–∞–±–ª—é–¥–µ–Ω–∏–µ –∑–∞ –ø–∞—Ü–∏–µ–Ω—Ç–∞–º–∏ —Å —Ç–∞–∫–∏–º –¥–∏–∞–≥–Ω–æ–∑–æ–º –∏ –≤–µ—Å—Ç–∏ –∏—Ö —É—á—ë—Ç. –ü–æ–≤–æ–¥ –≤—Å–µ—Ä—å—ë–∑ –≤–∑—è—Ç—å—Å—è –∑–∞ –ø—Ä–æ–±–ª–µ–º—É –æ–∂–∏—Ä–µ–Ω–∏—è –æ–ø—Ä–µ–¥–µ–ª—ë–Ω–Ω–æ –µ—Å—Ç—å. –ü–æ —Å–ª–æ–≤–∞–º –ú–∏—Ö–∞–∏–ª–∞ –ú—É—Ä–∞—à–∫–æ, —Å —ç—Ç–∏–º —Å–æ—Å—Ç–æ—è–Ω–∏–µ–º —Å–≤—è–∑–∞–Ω—ã 40% –Ω–µ–∏–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –†–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–Ω–æ—Å—Ç—å –ø—Ä–æ–±–ª–µ–º—ã —Å—Ä–µ–¥–∏ –≤–∑—Ä–æ—Å–ª—ã—Ö —Ä–æ—Å—Å–∏—è–Ω —Å–æ—Å—Ç–∞–≤–ª—è–µ—Ç 25%. –û –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ –ø—Ä–∏–∑–Ω–∞—Ç—å –æ–∂–∏—Ä–µ–Ω–∏–µ —Å–æ—Ü–∏–∞–ª—å–Ω–æ –∑–Ω–∞—á–∏–º—ã–º –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–µ–º –≥–ª–∞–≤–∞ ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º–∞¬ª –ü—ë—Ç—Ä –†–æ–¥–∏–æ–Ω–æ–≤ –≥–æ–≤–æ—Ä–∏–ª –Ω–∞ –ü–ú–≠–§-2025. –¢–æ–≥–¥–∞ –±–∏–∑–Ω–µ—Å–º–µ–Ω –ø—Ä–µ–¥–ª–æ–∂–∏–ª –æ–±—ä—è–≤–∏—Ç—å 2026 –≥–æ–¥ –≥–æ–¥–æ–º –±–æ—Ä—å–±—ã —Å –æ–∂–∏—Ä–µ–Ω–∏–µ–º. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The government is being urged to include obesity in the list of socially significant diseases. This proposal was made by members of the State Duma during a round table on obesity issues organized by the 'New People' party. The resolution recommends sending an initiative to the government to include obesity in the list of socially significant diseases and for the Ministry of Health to establish outpatient observation for patients with this diagnosis. Obesity is linked to 40% of non-infectious diseases, and its prevalence among adults in Russia is 25%. Businessman Petr Rodionov from 'Geropharma' proposed declaring 2026 the year of fighting obesity at the PMEF-2025.""
}"
2025-08-11T12:01:38+00:00,@bezrec,6411,https://t.me/bezrec/6411,"–í—Å–ª–µ–¥ –∑–∞ DSM Group —Å–≤–æ–π —Ä–µ–π—Ç–∏–Ω–≥ –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö —Ñ–∞—Ä–º–¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–æ–≤ –ø–æ –∏—Ç–æ–≥–∞–º –ø–µ—Ä–≤–æ–≥–æ –ø–æ–ª—É–≥–æ–¥–∏—è 2025 –≥–æ–¥–∞ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∞ RNC Pharma. –í –ø–µ—Ä–≤–æ–π –ø–æ–ª–æ–≤–∏–Ω–µ 2025 –≥–æ–¥–∞ –∞–Ω–∞–ª–∏—Ç–∏–∫–∏ –æ—Ç–º–µ—á–∞—é—Ç –≤–ø–æ–ª–Ω–µ –≤—ã—Ä–∞–∂–µ–Ω–Ω—ã–π –ø—Ä–æ—Ü–µ—Å—Å –ø–∞–¥–µ–Ω–∏—è —Ä—ã–Ω–æ—á–Ω—ã—Ö –¥–æ–ª–µ–π —Å—Ä–µ–¥–∏ –æ–ø—Ç–æ–≤—ã—Ö –∫–æ–º–ø–∞–Ω–∏–π –≤—Ç–æ—Ä–æ–≥–æ –∏ —Ç—Ä–µ—Ç—å–µ–≥–æ —ç—à–µ–ª–æ–Ω–∞. –ò–∑ –¥–µ—Å—è—Ç–∏ –∏–≥—Ä–æ–∫–æ–≤, –∑–∞–Ω–∏–º–∞—é—â–∏—Ö —Å 16 –ø–æ 25 –º–µ—Å—Ç–æ —Ä–µ–π—Ç–∏–Ω–≥–∞, —Å–Ω–∏–∂–µ–Ω–∏–µ –¥–æ–ª–∏ —Ä—ã–Ω–∫–∞ –¥–µ–º–æ–Ω—Å—Ç—Ä–∏—Ä—É—é—Ç —Å—Ä–∞–∑—É 8 –∏–≥—Ä–æ–∫–æ–≤. –ü—Ä–∏ —ç—Ç–æ–º —É—Ä–æ–≤–µ–Ω—å –∫–æ–Ω—Ü–µ–Ω—Ç—Ä–∞—Ü–∏–∏ —Ç–æ–ø–æ–≤—ã—Ö –∫–æ–º–ø–∞–Ω–∏–π –≤ –æ—Ç—Ä–∞—Å–ª–∏ —É–≤–µ—Ä–µ–Ω–Ω–æ —Ä–∞—Å—Ç—ë—Ç ‚Äî —Å—É–º–º–∞—Ä–Ω–∞—è —Ä—ã–Ω–æ—á–Ω–∞—è –¥–æ–ª—è –¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–æ–≤ –∏–∑ —Ç–æ–ø-15 –≤—ã—Ä–æ—Å–ª–∞ –∑–∞ –≥–æ–¥ –Ω–∞ 4,6%. –ü—Ä–∏—á–∏–Ω–∞ –Ω–µ–≤–∞–∂–Ω–æ–≥–æ ¬´—Å–∞–º–æ—á—É–≤—Å—Ç–≤–∏—è¬ª –Ω–µ–±–æ–ª—å—à–∏—Ö –æ–ø—Ç–æ–≤—ã—Ö –∫–æ–º–ø–∞–Ω–∏–π –∑–∞–∫–ª—é—á–∞–µ—Ç—Å—è –ø—Ä–µ–∂–¥–µ –≤—Å–µ–≥–æ –≤ –≤—ã—Å–æ–∫–æ–π —Å—Ç–æ–∏–º–æ—Å—Ç–∏ –∫—Ä–µ–¥–∏—Ç–Ω—ã—Ö —Ä–µ—Å—É—Ä—Å–æ–≤. –ö–ª—é—á–µ–≤–∞—è —Å—Ç–∞–≤–∫–∞, –Ω–∞ –ø—Ä–æ—Ç—è–∂–µ–Ω–∏–∏ –±–æ–ª–µ–µ —Å–µ–º–∏ –º–µ—Å—è—Ü–µ–≤ –¥–µ—Ä–∂–∞–≤—à–∞—è—Å—è –Ω–∞ —Ä–µ–∫–æ—Ä–¥–Ω–æ –≤—ã—Å–æ–∫–∏—Ö –∑–Ω–∞—á–µ–Ω–∏—è—Ö, –ø–æ—à–ª–∞ –≤–Ω–∏–∑ —Ç–æ–ª—å–∫–æ –≤ –∏—é–Ω–µ –∏ –≤—Ä—è–¥ –ª–∏ —Å—Ä–∞–∑—É —Å–∫–∞–∂–µ—Ç—Å—è –Ω–∞ —Å–∏—Ç—É–∞—Ü–∏–∏ –Ω–∞ —Ñ–∞—Ä–º—Ä—ã–Ω–∫–µ. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, —Å–≤–æ—ë –¥–µ–ª–æ –¥–µ–ª–∞—é—Ç –≤–æ–∑—Ä–æ—Å—à–∞—è —Å—Ç–æ–∏–º–æ—Å—Ç—å –ª–æ–≥–∏—Å—Ç–∏—á–µ—Å–∫–∏—Ö —É—Å–ª—É–≥ –∏ –ø—Ä–æ–¥–æ–ª–∂–∞—é—â–∞—è—Å—è –º–∏–≥—Ä–∞—Ü–∏—è –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª–µ–π –ø–∞—Ä–∞—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∏ –≤ –æ–Ω–ª–∞–π–Ω. –•—É–¥—à—É—é –¥–∏–Ω–∞–º–∏–∫—É –ø–æ –ø—Ä–æ–¥–∞–∂–∞–º —Ç–∞–∫–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –≤ –∞–ø—Ç–µ–∫–∞—Ö –ø–æ–∫–∞–∑–∞–ª–∏ –ú–æ—Å–∫–≤–∞, –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥, –ë–∞—à–∫–æ—Ä—Ç–æ—Å—Ç–∞–Ω –∏ –ß–µ—á–Ω—è. –ö —Ç–æ–º—É –∂–µ —Ñ–∞—Ä–º—Ä–æ–∑–Ω–∏—Ü–∞ —Å—Ç—Ä–µ–º–∏—Ç–µ–ª—å–Ω–æ –∫–æ–Ω—Å–æ–ª–∏–¥–∏—Ä—É–µ—Ç—Å—è, —á—Ç–æ –ø—Ä–∏–≤–æ–¥–∏—Ç –∫ –ø–µ—Ä–µ—Ä–∞—Å–ø—Ä–µ–¥–µ–ª–µ–Ω–∏—é —Å—Ñ–µ—Ä –≤–ª–∏—è–Ω–∏—è, –∫–æ–Ω–µ—á–Ω–æ, –Ω–µ –≤ –ø–æ–ª—å–∑—É –ª–æ–∫–∞–ª—å–Ω—ã—Ö –∫–æ–º–ø–∞–Ω–∏–π. –ü—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–æ —Å–µ–π—á–∞—Å –Ω–∞ —Å—Ç–æ—Ä–æ–Ω–µ –∫—Ä—É–ø–Ω—ã—Ö, –≥–ª—É–±–æ–∫–æ –∞–≤—Ç–æ–º–∞—Ç–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –∏–≥—Ä–æ–∫–æ–≤, –æ—Å–æ–±–µ–Ω–Ω–æ —Ä–∞—Å–ø–æ–ª–∞–≥–∞—é—â–∏—Ö —Ö–æ—Ä–æ—à–æ –¥–∏–≤–µ—Ä—Å–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω—ã–º –±–∏–∑–Ω–µ—Å–æ–º. –í —Ç–æ–ø-10 —Ñ–∞—Ä–º–¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–æ–≤ –ø–æ –¥–æ–ª–µ —Ä—ã–Ω–∫–∞ –ø—Ä—è–º—ã—Ö –ø–æ—Å—Ç–∞–≤–æ–∫ –õ–ü –≤ –¥–µ–Ω—å–≥–∞—Ö –ø–æ –∏—Ç–æ–≥–∞–º I-II –∫–≤–∞—Ä—Ç–∞–ª–∞ 2025 –≥–æ–¥–∞ –≤–æ—à–ª–∏: ¬´–ü—Ä–æ—Ç–µ–∫¬ª, ¬´–ü—É–ª—å—Å¬ª, ¬´–ö–∞—Ç—Ä–µ–Ω¬ª, ¬´–ì—Ä–∞–Ω–¥ –ö–∞–ø–∏—Ç–∞–ª¬ª, ¬´–ò—Ä–≤–∏–Ω-2¬ª, ¬´–ë–°–°¬ª, ¬´–§–∞—Ä–º–∫–æ–º–ø–ª–µ–∫—Ç¬ª, ¬´–†-–§–∞—Ä–º¬ª, ¬´–í–∏—Ç–∞ –õ–∞–π–Ω¬ª, ¬´–§–∞—Ä–º–∏–º—ç–∫—Å¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The report by RNC Pharma highlights a significant decline in the market share of second and third-tier wholesalers during the first half of 2025. Eight out of ten players ranked from 16 to 25 show a decline in their market share. The concentration of top companies is increasing, with the combined market share of the top 15 firms rising by 4.6% over a year. The decline in small wholesalers' performance is attributed to high credit costs and rising logistics expenses, as well as the migration of patients from traditional retail to online channels. Sales in pharmacies in Moscow, St. Petersburg, Bashkortostan, and Chechnya are also declining. The pharmaceutical retail chain is consolidating, which is affecting the market share in favor of large, deeply automated players with diversified businesses. The top 10 direct prescription drug suppliers in the first half of 2025 include 'Protek', 'Puls', 'Katren', 'Grand Capital', 'Irwin-2', 'BSS', 'Farm"
2025-08-11T08:50:37+00:00,@bezrec,6410,https://t.me/bezrec/6410,"–•–æ–∑—è–∏–Ω-–ª—É–¥–æ–º–∞–Ω ‚Äî –≥–æ—Ä–µ –¥–ª—è ¬´–í–∏—Ç—ã¬ª. –ì–ª–∞–≤–∞ –∫—É–∑–±–∞—Å—Å–∫–æ–π —Å–µ—Ç–∏ —ç–∫–æ–Ω–æ–º-–∞–ø—Ç–µ–∫ –ê–ª–µ–∫—Å–µ–π –ü—è—Ç–∞—á–∫–æ–≤ –Ω–µ—Å–∫–æ–ª—å–∫–æ –º–µ—Å—è—Ü–µ–≤ –Ω–∞–∑–∞–¥ —É–µ—Ö–∞–ª –≤ –î—É–±–∞–π, –≥–¥–µ, —è–∫–æ–±—ã, —É–≤–ª—ë–∫—Å—è –∞–∑–∞—Ä—Ç–Ω—ã–º–∏ –∏–≥—Ä–∞–º–∏. –£–≤–µ—â–µ–≤–∞–Ω–∏—è —Ä–æ–¥—Å—Ç–≤–µ–Ω–Ω–∏–∫–æ–≤ –Ω–µ –ø–æ–º–æ–≥–ª–∏, –∏ –æ–∫–æ–ª–æ –º–µ—Å—è—Ü–∞ –Ω–∞–∑–∞–¥ –º—É–∂—á–∏–Ω–∞ –ø–µ—Ä–µ—Å—Ç–∞–ª –≤—ã—Ö–æ–¥–∏—Ç—å –Ω–∞ —Å–≤—è–∑—å. –§–∞–∫—Ç –∏—Å—á–µ–∑–Ω–æ–≤–µ–Ω–∏—è –±–∏–∑–Ω–µ—Å–º–µ–Ω–∞ –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª –µ–≥–æ –±—Ä–∞—Ç. –í —Ä–µ–∑—É–ª—å—Ç–∞—Ç–µ —É –±—Ä–æ—à–µ–Ω–Ω–æ–π ¬´–í–∏—Ç—ã¬ª –Ω–∞—á–∞–ª–∏—Å—å –ø—Ä–æ–±–ª–µ–º—ã —Å –ø–æ—Å—Ç–∞–≤–∫–∞–º–∏, –æ—Ç–≥—Ä—É–∑–∫–∞–º–∏ –∏ –ø—Ä–æ—á–∏–º–∏ –ø—Ä–æ—Ü–µ—Å—Å–∞–º–∏. –°–æ—Ç—Ä—É–¥–Ω–∏–∫–∏ –æ—Å—Ç–∞–ª–∏—Å—å –±–µ–∑ –∑–∞—Ä–ø–ª–∞—Ç—ã –∑–∞ –∏—é–ª—å –∏, –ø–æ—Ö–æ–∂–µ, –±–µ–∑ —Ä–∞–±–æ—Ç—ã ‚Äî –ª—é–¥—è–º —É–∂–µ —Å–∫–∞–∑–∞–ª–∏ –∏—Å–∫–∞—Ç—å –Ω–æ–≤—ã–µ –º–µ—Å—Ç–∞, —Ç.–∫. –≤ —Ç–µ—á–µ–Ω–∏–µ –¥–≤—É—Ö –Ω–µ–¥–µ–ª—å –∞–ø—Ç–µ–∫–∏ —Å–µ—Ç–∏ –∑–∞–∫—Ä–æ—é—Ç—Å—è. –°—á–µ—Ç–∞ –∫–æ–º–ø–∞–Ω–∏–∏ –∞—Ä–µ—Å—Ç–æ–≤–∞–Ω—ã. –ù–∞ —Å–∏—Ç—É–∞—Ü–∏—é –≥—É–±–µ—Ä–Ω–∞—Ç–æ—Ä—É –ò–ª—å–µ –°–µ—Ä–µ–¥—é–∫—É —É–∂–µ –∂–∞–ª—É—é—Ç—Å—è –≤ —Å–æ—Ü—Å–µ—Ç—è—Ö. –ù–∞–ø—Ä–∏–º–µ—Ä, –∂–∏—Ç–µ–ª–∏ –ø–æ—Å—ë–ª–∫–∞ –ü–∏–æ–Ω–µ—Ä –≥–æ–≤–æ—Ä—è—Ç, —á—Ç–æ –∫—Ä–æ–º–µ ¬´–í–∏—Ç—ã¬ª –ø–æ–∫—É–ø–∞—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏–º –±–æ–ª—å—à–µ –Ω–µ–≥–¥–µ. –û–û–û ¬´–í–∏—Ç–∞¬ª —Å—É—â–µ—Å—Ç–≤—É–µ—Ç —Å 2006 –≥–æ–¥–∞. –ü–æ –¥–∞–Ω–Ω—ã–º Rusprofile, –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–º —É—á—Ä–µ–¥–∏—Ç–µ–ª–µ–º –∏ –≤–ª–∞–¥–µ–ª—å—Ü–µ–º —á–∏—Å–ª–∏—Ç—Å—è –ê–ª–µ–∫—Å–µ–π –ü—è—Ç–∞—á–∫–æ–≤. –ü–æ –∏—Ç–æ–≥–∞–º 2024 –≥–æ–¥–∞ –≤—ã—Ä—É—á–∫–∞ –∫–æ–º–ø–∞–Ω–∏–∏ —Å–æ–∫—Ä–∞—Ç–∏–ª–∞—Å—å –Ω–∞ 12%, –¥–æ 607 –º–ª–Ω —Ä—É–±–ª–µ–π, –ø—Ä–∏–±—ã–ª—å —É–ø–∞–ª–∞ –Ω–∞ 85%, –¥–æ 2,8 –º–ª–Ω —Ä—É–±–ª–µ–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""Ukraine"",
  ""topic"": ""shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""The disappearance of the owner-owner 'Vita' has caused problems for the company. The business leader, Alexey Piatatchkov, who was based in Kuzbass and ran the economy pharmacy chain 'Vita', went missing for several months due to gambling addiction. The company's accounts have been frozen, and the situation has led to wage arrears for employees. The company's operations are facing closure, and residents of the village of Pioneer say they have no other place to buy medicines.""
}"
2025-08-11T05:30:01+00:00,@bezrec,6409,https://t.me/bezrec/6409,"–§–ê–° —É—Å–∏–ª–∏—Ç –∫–æ–Ω—Ç—Ä–æ–ª—å –∑–∞ —Ü–µ–Ω–∞–º–∏ –Ω–∞ –∂–∏–∑–Ω–µ–Ω–Ω–æ –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞. –° 1 —Å–µ–Ω—Ç—è–±—Ä—è –≤—Å—Ç—É–ø–∏—Ç –≤ —Å–∏–ª—É –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –æ –ø—Ä–∞–≤–∏–ª–∞—Ö —Ä–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω–∏—è –æ—Ç–ø—É—Å–∫–Ω—ã—Ö —Ü–µ–Ω –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –∏–∑ –ø–µ—Ä–µ—á–Ω—è –ñ–ù–í–õ–ü. –§–ê–° –±—É–¥–µ—Ç –ø—Ä–æ–≤–æ–¥–∏—Ç—å —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–∏–π –∞–Ω–∞–ª–∏–∑ –Ω–∞ –ø—Ä–µ–¥–º–µ—Ç –æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω–æ—Å—Ç–∏ –∑–∞—è–≤–ª–µ–Ω–Ω—ã—Ö —Ü–µ–Ω –ø—Ä–∏ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –∏ –ø–µ—Ä–µ—Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏. –¢–∞–∫–æ–π –∫–æ–Ω—Ç—Ä–æ–ª—å –ø–æ–∑–≤–æ–ª–∏—Ç –≤—ã—è–≤–ª—è—Ç—å —Å–ª—É—á–∞–∏ –Ω–µ–æ–ø—Ä–∞–≤–¥–∞–Ω–Ω–æ–≥–æ –ø–æ–≤—ã—à–µ–Ω–∏—è —Ü–µ–Ω –∏ —Å–≤–æ–µ–≤—Ä–µ–º–µ–Ω–Ω–æ —Ä–µ–∞–≥–∏—Ä–æ–≤–∞—Ç—å –Ω–∞ –Ω–∏—Ö, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª –≥–ª–∞–≤–∞ –∫–æ–º–∏—Ç–µ—Ç–∞ –ì–æ—Å–¥—É–º—ã –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è –°–µ—Ä–≥–µ–π –õ–µ–æ–Ω–æ–≤. –ß—Ç–æ –∏–∑–º–µ–Ω–∏—Ç—Å—è: üîΩ –æ–±—â–∏–π —Å—Ä–æ–∫ –ø—Ä–æ—Ü–µ–¥—É—Ä—ã —Å–æ—Å—Ç–∞–≤–∏—Ç –Ω–µ –±–æ–ª–µ–µ 26 —Ä–∞–±–æ—á–∏—Ö –¥–Ω–µ–π —Å–æ –¥–Ω—è –ø–æ–¥–∞—á–∏ –∑–∞—è–≤–ª–µ–Ω–∏—è, —á—Ç–æ –ø–æ–∑–≤–æ–ª–∏—Ç –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º –±—ã—Å—Ç—Ä–µ–µ –≤—ã–≤–æ–¥–∏—Ç—å —Å–≤–æ—é –ø—Ä–æ–¥—É–∫—Ü–∏—é –Ω–∞ —Ä—ã–Ω–æ–∫; üîΩ —Å—É–±—ä–µ–∫—Ç—ã –†–§ –±—É–¥—É—Ç –æ–±—è–∑–∞–Ω—ã —É—Å—Ç–∞–Ω–∞–≤–ª–∏–≤–∞—Ç—å –ø—Ä–µ–¥–µ–ª—å–Ω—ã–µ —Ä–∞–∑–º–µ—Ä—ã –æ–ø—Ç–æ–≤—ã—Ö –∏ —Ä–æ–∑–Ω–∏—á–Ω—ã—Ö –Ω–∞–¥–±–∞–≤–æ–∫ –∫ —Ñ–∞–∫—Ç–∏—á–µ—Å–∫–æ–π –æ—Ç–ø—É—Å–∫–Ω–æ–π —Ü–µ–Ω–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è –≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–∏ —Å –º–µ—Ç–æ–¥–∏–∫–æ–π –§–ê–°; üîΩ –æ–ø—Ç–æ–≤—ã–µ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ —Å–º–æ–≥—É—Ç —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞—Ç—å —Ä–æ–∑–Ω–∏—á–Ω—ã–µ —Ü–µ–Ω—ã –Ω–∞ –ñ–ù–í–õ–ü —Å –æ–ø—Ç–æ–≤–æ–π –∏ —Ä–æ–∑–Ω–∏—á–Ω–æ–π –Ω–∞–¥–±–∞–≤–∫–æ–π –∫ —Ñ–∞–∫—Ç–∏—á–µ—Å–∫–æ–π –æ—Ç–ø—É—Å–∫–Ω–æ–π —Ü–µ–Ω–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è –≤ —Å—É–º–º–µ, –Ω–µ –ø—Ä–µ–≤—ã—à–∞—é—â–µ–π –ø—Ä–µ–¥–µ–ª—å–Ω—ã–π —Ä–∞–∑–º–µ—Ä –æ–ø—Ç–æ–≤—ã—Ö –∏ —Ä–æ–∑–Ω–∏—á–Ω—ã—Ö –Ω–∞–¥–±–∞–≤–æ–∫, —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–Ω—ã–π —Å—É–±—ä–µ–∫—Ç–æ–º. –≠—Ç–∏ –º–µ—Ä—ã, –ø–æ —Å–ª–æ–≤–∞–º –õ–µ–æ–Ω–æ–≤–∞, –¥–æ–ª–∂–Ω—ã –ø–æ–≤—ã—Å–∏—Ç—å –ø—Ä–æ–∑—Ä–∞—á–Ω–æ—Å—Ç—å —Ü–µ–Ω–æ–æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è –∏ –ø—Ä–µ–¥–æ—Ç–≤—Ä–∞—Ç–∏—Ç—å –Ω–µ–æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω–æ–µ –∑–∞–≤—ã—à–µ–Ω–∏–µ —Ü–µ–Ω. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""pricing, registration"",
  ""impact"": ""medium"",
  ""english"": ""The FSU will strengthen price controls on essential medicines. Starting September, a government regulation sets the procedure for determining reimbursement prices within the Essential Drugs and Medical Products (EDMP) list. The FSU will conduct economic analysis to justify the declared prices during registration and re-registration processes. This control aims to detect overpriced products in a timely manner.""
}"
2025-08-10T17:02:20+00:00,@bezrec,6408,https://t.me/bezrec/6408,"–ó–∞—Å–µ–¥–∞–Ω–∏–µ –∫–æ–º–∏—Å—Å–∏–∏ –ñ–ù–í–õ–ü –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ø—Ä–∏–Ω—è–ª–æ –Ω–µ–æ–∂–∏–¥–∞–Ω–Ω—ã–π –æ–±–æ—Ä–æ—Ç –∏–∑-–∑–∞ —ç–∫—É–ª–∏–∑—É–º–∞–±–∞. –ü–æ –º–Ω–µ–Ω–∏—é —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤, –æ–±—Å—É–∂–¥–µ–Ω–∏–µ –ø—Ä–µ–¥–µ–ª—å–Ω—ã—Ö –æ—Ç–ø—É—Å–∫–Ω—ã—Ö —Ü–µ–Ω –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ —Ñ–∞–∫—Ç–∏—á–µ—Å–∫–∏ –ø—Ä–µ–≤—Ä–∞—Ç–∏–ª–æ—Å—å –≤ —Ü–µ–Ω–æ–≤–æ–π –∞—É–∫—Ü–∏–æ–Ω. –°–º—É—Ç—É –≤–Ω—ë—Å –ø—Ä–∏–≥–ª–∞—à–µ–Ω–Ω—ã–π –≤–Ω–µ –æ—Å–Ω–æ–≤–Ω–æ–≥–æ —Å–ø–∏—Å–∫–∞ —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ ¬´–ì–µ–Ω–µ—Ä–∏—É–º¬ª. –ö–æ–º–ø–∞–Ω–∏—è –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∞ —Å–Ω–∏–∑–∏—Ç—å —Ü–µ–Ω—ã –Ω–∞ —ç–∫—É–ª–∏–∑—É–º–∞–± –¥–æ 111,7 —Ç—ã—Å. —Ä—É–±–ª–µ–π –∑–∞ 300 –º–≥, —á—Ç–æ –Ω–∞ 136 —Ç—ã—Å. —Ä—É–±–ª–µ–π –Ω–∏–∂–µ –ø—Ä–µ–¥–µ–ª—å–Ω–æ–π –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω–æ–π —Å—Ç–æ–∏–º–æ—Å—Ç–∏ –≤ –ø—Ä–æ—Ç–∏–≤–æ–≤–µ—Å —Ä–∞—Å—Å–º–∞—Ç—Ä–∏–≤–∞–µ–º–æ–º—É –Ω–∞ –∫–æ–º–∏—Å—Å–∏–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç—É –∫–æ–º–ø–∞–Ω–∏–∏ –ê—Å—Ç—Ä–∞–ó–µ–Ω–µ–∫–∞. –°—Ç–æ–ª—å –æ—â—É—Ç–∏–º—ã–π –¥–∏—Å–∫–æ–Ω—Ç –≤—ã–∑–≤–∞–ª —Ä–µ–∑–æ–Ω–∞–Ω—Å –≤ —ç–∫—Å–ø–µ—Ä—Ç–Ω–æ–º, –ø–∞—Ü–∏–µ–Ω—Ç—Å–∫–æ–º –∏ –≤—Ä–∞—á–µ–±–Ω–æ–º —Å–æ–æ–±—â–µ—Å—Ç–≤–∞—Ö. –¢–µ–º –±–æ–ª–µ–µ —á—Ç–æ –Ω–∞ –ö–æ–º–∏—Å—Å–∏–∏ –æ–±—Å—É–∂–¥–∞–ª—Å—è –≤–æ–ø—Ä–æ—Å –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ —Å–ª–µ–¥—É—é—â–µ–≥–æ –ø–æ–∫–æ–ª–µ–Ω–∏—è, –∫–æ—Ç–æ—Ä—ã–π –≤ –∏—Ç–æ–≥–µ –æ—Å—Ç–∞–ª—Å—è ¬´–Ω–µ —É –¥–µ–ª¬ª –Ω–µ—Å–º–æ—Ç—Ä—è –Ω–∞ —Ç–æ, —á—Ç–æ —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å —Ç—è–∂–µ–ª–æ–π –º–∏–∞—Å—Ç–µ–Ω–∏–µ–π –∏ –æ–ø—Ç–∏–∫–æ–º–∏–µ–ª–∏—Ç–æ–º –æ–Ω –Ω–µ —Ç–æ–ª—å–∫–æ –ø—Ä–∏–º–µ–Ω—è–µ—Ç—Å—è –≤ —á–µ—Ç—ã—Ä–µ —Ä–∞–∑–∞ —Ä–µ–∂–µ, –Ω–æ –∏ –ø–æ —Ñ–∞–∫—Ç—É –æ–±—Ö–æ–¥–∏—Ç—Å—è –¥–µ—à–µ–≤–ª–µ, –æ—Å–æ–±–µ–Ω–Ω–æ –≤ —Å–∏—Å—Ç–µ–º–µ –û–ú–°. –û–±—â–µ—Å—Ç–≤–µ–Ω–Ω–∏–∫–æ–≤ –±–µ—Å–ø–æ–∫–æ–∏—Ç —Ç–æ—Ç —Ñ–∞–∫—Ç, —á—Ç–æ –≤ —Å–ª—É—á–∞–µ —Å —ç–∫—É–ª–∏–∑—É–º–∞–±–æ–º —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–∏–π —Ñ–∞–∫—Ç–æ—Ä –ø—Ä–µ–≤–∞–ª–∏—Ä–æ–≤–∞–ª –Ω–∞–¥ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–æ—Å—Ç—å—é –∏ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å—é. –í –ú–∏–Ω–∑–¥—Ä–∞–≤–µ –Ω–∞—Å—Ç–∞–∏–≤–∞—é—Ç, —á—Ç–æ —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤—É—é—Ç—Å—è –Ω–µ —Å–æ–æ–±—Ä–∞–∂–µ–Ω–∏—è–º–∏ —ç–∫–æ–Ω–æ–º–∏–∏, –∞ –∫–æ–º–ø–ª–µ–∫—Å–Ω–æ–π –æ—Ü–µ–Ω–∫–æ–π –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–π –∏ –∫–æ–ª–ª–µ–∫—Ç–∏–≤–Ω—ã–º –º–Ω–µ–Ω–∏–µ–º —á–ª–µ–Ω–æ–≤ –∫–æ–º–∏—Å—Å–∏–∏. –ö–∞–∫ –±—ã —Ç–æ –Ω–∏ –±—ã–ª–æ, —Ä–∞–∑–Ω–∏—Ü–∞ –º–µ–∂–¥—É —Å—É—â–µ—Å—Ç–≤—É—é—â–µ–π —Ü–µ–Ω–æ–π –∏ –Ω–æ–≤–æ–π –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–Ω–æ–π —Å–æ—Å—Ç–∞–≤–ª—è–µ—Ç –±–æ–ª–µ–µ 7 –º–ª–Ω —Ä—É–±–ª–µ–π –∑–∞ –∫—É—Ä—Å —Ç–µ—Ä–∞–ø–∏–∏. –ò —ç—Ç–æ—Ç —Ñ–∞–∫—Ç —Å–ª–æ–∂–Ω–æ –∏–≥–Ω–æ—Ä–∏—Ä–æ–≤–∞—Ç—å. –ö–∞–∫ –∫—Ä–∞—Å–æ—á–Ω–æ —Ä–µ–∑—é–º–∏—Ä–æ–≤–∞–ª –æ–¥–∏–Ω –∏–∑ —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –¥–∏—Å–∫—É—Å—Å–∏–∏ ¬´—Å–∫–æ—Ä–æ—Å—Ç—å –∫–∞—Ä–∞–≤–∞–Ω–∞ –Ω—É–∂–Ω–æ –º–µ—Ä–∏—Ç—å –ø–æ —Å–∫–æ—Ä–æ—Å—Ç–∏ –ø–æ—Å–ª–µ–¥–Ω–µ–≥–æ –≤–µ—Ä–±–ª—é–¥–∞¬ª. –ì–ª–∞–≤–Ω–æ–µ –ø–æ–Ω–∏–º–∞—Ç—å, –≤ –∫–∞–∫–æ–º –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏–∏ ¬´–∫–∞—Ä–∞–≤–∞–Ω¬ª –¥–≤–∏–∂–µ—Ç—Å—è –∏ –∫–∞–∫–æ–π –≤–µ—Ä–±–ª—é–¥ ‚Äî –ø–æ—Å–ª–µ–¥–Ω–∏–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""The meeting of the Commission on Good Pharmaceutical Practices at the Ministry of Health took an unexpected turn due to elixumab. Participants believe that the discussion on maximum selling prices for drugs has turned into a price auction. Confusion was added by invited non-listed participants 'Generiem'. The company proposed to reduce the price of elixumab to 1,117 thousand rubles for 300 mg, which is 1,360 thousand rubles lower than the registered maximum price under consideration. This significant discount caused resonance in expert, patient and medical communities. The public is concerned that the economic factor has prevailed over innovation and safety in this case, despite the fact that elixumab is used four times less often for patients with severe myasthenia and optic neuritis, and the actual cost is cheaper in the system of social medical insurance. The Health Ministry insists that they are guided by economic considerations, not innovation and safety. The difference between the existing price and the new proposal is more than 7 million rubles"
2025-08-10T11:03:14+00:00,@bezrec,6405,https://t.me/bezrec/6405,"–û–∑–µ–º–ø–∏–∫ —É—Ä–µ–∑–∞–µ—Ç –ø–æ—Ä—Ü–∏–∏. –ù–µ–∫–æ—Ç–æ—Ä—ã–µ –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–µ —Ä–µ—Å—Ç–æ—Ä–∞–Ω—ã –Ω–∞—Å—Ç–æ–ª—å–∫–æ –ø—Ä–æ–Ω–∏–∫–ª–∏—Å—å –Ω–∞—Å—Ç—Ä–æ–µ–Ω–∏–µ–º —Å–≤–æ–∏—Ö —Ö—É–¥–µ—é—â–∏—Ö –Ω–∞ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–µ –∏ —Ç–∏—Ä–∑–µ–ø–∞—Ç–∏–¥–µ –≥–æ—Å—Ç–µ–π, —á—Ç–æ —Å—Ç–∞–ª–∏ –≤–≤–æ–¥–∏—Ç—å –≤ –º–µ–Ω—é –æ–±–µ–¥—ã –¥–ª—è –≥–Ω–æ–º–∏–∫–æ–≤ –º–∏–Ω–∏-–ø–æ—Ä—Ü–∏–∏ –ø–æ–ø—É–ª—è—Ä–Ω—ã—Ö –±–ª—é–¥. –¢–∞–∫, –±—É—Ä–≥–µ—Ä–Ω–∞—è Clinton Hall –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∞ –∫–æ–º–ø–ª–µ–∫—Å –∑–∞ $8, —Å–æ—Å—Ç–æ—è—â–∏–π –∏–∑ –±—É—Ä–≥–µ—Ä–∞ –≤–µ—Å–æ–º 50 –≥, 45 –≥ –∫–∞—Ä—Ç–æ—Ñ–µ–ª—è —Ñ—Ä–∏ –∏ 140 –≥ –Ω–∞–ø–∏—Ç–∫–∞ ‚Äî –ø–∏–≤–∞, ¬´–ú–∞—Ä–≥–∞—Ä–∏—Ç—ã¬ª –∏–ª–∏ –≤–∏–Ω–∞. –Ø –ø–æ—Å—Ç–æ—è–Ω–Ω–æ –≤–∏–∂—É —Ç–µ—Ö, –∫—Ç–æ –ø—Ä–∏–Ω–∏–º–∞–µ—Ç –û–∑–µ–º–ø–∏–∫, –ú—É–Ω–¥–∂–∞—Ä–æ –∏–ª–∏ —á—Ç–æ-—Ç–æ –ø–æ–¥–æ–±–Ω–æ–µ. –û–Ω–∏ —Å—ä–µ–¥–∞—é—Ç –æ–¥–∏–Ω-–¥–≤–∞ –∫—É—Å–æ—á–∫–∞ –µ–¥—ã, –¥–µ–ª–∞—é—Ç –ø–∞—Ä—É –≥–ª–æ—Ç–∫–æ–≤ –Ω–∞–ø–∏—Ç–∫–∞ ‚Äî –∏ –≤—Å—ë, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª –≤–ª–∞–¥–µ–ª–µ—Ü Clinton Hall –ê—Ä–∏—Å—Ç–æ—Ç–µ–ª—å –•–∞—Ç—Ü–∏–≥–µ–æ—Ä–≥–∏—É. –•–∞—Ç—Ü–∏–≥–µ–æ—Ä–≥–∏—É –Ω–µ –Ω—Ä–∞–≤–∏–ª–æ—Å—å –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –ø–∏—â–µ–≤—ã—Ö –æ—Ç—Ö–æ–¥–æ–≤, –Ω–æ –µ—â—ë –±–æ–ª—å—à–µ –æ–Ω –±–µ—Å–ø–æ–∫–æ–∏–ª—Å—è, —á—Ç–æ –ø–æ—Å–µ—Ç–∏—Ç–µ–ª–∏ —É—Å—Ç–∞–Ω—É—Ç –ø–ª–∞—Ç–∏—Ç—å –∑–∞ —Ç–æ, —á—Ç–æ –Ω–µ —Å—ä–µ–¥–∞–µ—Ç—Å—è. –¢–∞–∫ —Ä–æ–¥–∏–ª–∞—Å—å –∏–¥–µ—è –º–∏–Ω–∏-–æ–±–µ–¥–æ–≤, –∫–æ—Ç–æ—Ä–æ–π ¬´–∑–∞—Ä–∞–∂–∞–µ—Ç—Å—è¬ª –≤—Å—ë –±–æ–ª—å—à–µ –∑–∞–≤–µ–¥–µ–Ω–∏–π. –≠—Ç–∏ –æ–ø–∞—Å–µ–Ω–∏—è –¥–∞–ª–µ–∫–æ –Ω–µ –±–µ—Å–ø–æ—á–≤–µ–Ω–Ω—ã. –û–ø—Ä–æ—Å Bloomberg Intelligence –ø–æ–∫–∞–∑–∞–ª, —á—Ç–æ –±–æ–ª–µ–µ 50% –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö —Å—Ç–∞–ª–∏ —Ä–µ–∂–µ –æ–±–µ–¥–∞—Ç—å –≤ —Ä–µ—Å—Ç–æ—Ä–∞–Ω–∞—Ö –ø–æ—Å–ª–µ –Ω–∞—á–∞–ª–∞ –ø—Ä–∏—ë–º–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –í –¥—Ä—É–≥–æ–º –æ—Ç—á—ë—Ç–µ, –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω–Ω–æ–º Morgan Stanley, –≥–æ–≤–æ—Ä–∏—Ç—Å—è, —á—Ç–æ 63% –ø—Ä–∏–Ω–∏–º–∞—é—â–∏—Ö –û–∑–µ–º–ø–∏–∫ –∑–∞–∫–∞–∑—ã–≤–∞—é—Ç –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ –º–µ–Ω—å—à–µ –µ–¥—ã –≤ —Ä–µ—Å—Ç–æ—Ä–∞–Ω–∞—Ö. –†–µ—Å—Ç–æ—Ä–∞–Ω—ã, –∫–æ—Ç–æ—Ä—ã–µ —É–≤–∏–¥—è—Ç –≤ —ç—Ç–æ–º –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –∏ –Ω–∞–∫–æ—Ä–º—è—Ç —Ç–∞–∫–∏—Ö –ª—é–¥–µ–π, –ø–æ–ª—É—á–∞—Ç –∫–æ–Ω–∫—É—Ä–µ–Ω—Ç–Ω–æ–µ –ø—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–æ, ‚Äî —Å—á–∏—Ç–∞–µ—Ç –î–∞–Ω–∞ –ì—É–Ω–¥–µ—Ä—Å, –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç ReFED, –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏, –±–æ—Ä—é—â–µ–π—Å—è —Å –ø–∏—â–µ–≤—ã–º–∏ –æ—Ç—Ö–æ–¥–∞–º–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-08-09T11:01:05+00:00,@bezrec,6404,https://t.me/bezrec/6404,"–ü—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º –Ω–æ–≤—ã–π –≤—ã–ø—É—Å–∫ —Ä—É–±—Ä–∏–∫–∏ #–≤–¥–æ–≥–æ–Ω–∫—É. üíä –í—Ç–æ—Ä—ã–º–∏ —Ä–æ—Å—Å–∏–π—Å–∫—É—é –æ–Ω–∫–æ–≤–∞–∫—Ü–∏–Ω—É –ø–æ–ª—É—á–∞—Ç –±–æ–ª—å–Ω—ã–µ —Ä–∞–∫–æ–º –ª—ë–≥–∫–∏—Ö. –ü–µ—Ä–≤–∞—è –ø–∞—Ä—Ç–∏—è –ø–µ—Ä—Å–æ–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω–æ–π –º–†–ù–ö-–≤–∞–∫—Ü–∏–Ω—ã –±—É–¥–µ—Ç –≤–≤–µ–¥–µ–Ω–∞ –¥–æ–±—Ä–æ–≤–æ–ª—å—Ü–∞–º —Å –º–µ–ª–∞–Ω–æ–º–æ–π –æ—Å–µ–Ω—å—é. –ï—Å–ª–∏ —Å –Ω–µ–π –≤—Å—ë –±—É–¥–µ—Ç ¬´–±–ª–∞–≥–æ–ø–æ–ª—É—á–Ω–æ –≤ –ø–ª–∞–Ω–µ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–æ–Ω–Ω—ã—Ö –∏ –Ω–∞—É—á–Ω—ã—Ö –æ–∂–∏–¥–∞–Ω–∏–π¬ª, –≤—Ç–æ—Ä–æ–π –Ω–∞ –æ—á–µ—Ä–µ–¥–∏ –Ω–æ–∑–æ–ª–æ–≥–∏–µ–π —Å—Ç–∞–Ω–µ—Ç –Ω–µ–º–µ–ª–∫–æ–∫–ª–µ—Ç–æ—á–Ω—ã–π —Ä–∞–∫ –ª–µ–≥–∫–∏—Ö. üíä –¢–µ–º –≤—Ä–µ–º–µ–Ω–µ–º, –°–®–ê –æ—Ç–∫–∞–∑—ã–≤–∞—é—Ç—Å—è –æ—Ç –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–π –≤ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫—É –º–†–ù–ö-–≤–∞–∫—Ü–∏–Ω. –≠–∫—Å–ø–µ—Ä—Ç—ã –ø–æ–ª–∞–≥–∞—é—Ç, —á—Ç–æ –ø—Ä–µ–∫—Ä–∞—â–µ–Ω–∏–µ –º–Ω–æ–≥–æ–º–∏–ª–ª–∏–æ–Ω–Ω—ã—Ö –≤–ª–∏–≤–∞–Ω–∏–π –≤ —ç—Ç—É —Å—Ñ–µ—Ä—É –æ–±–µ—Ä–Ω—ë—Ç—Å—è –¥–ª—è —Å—Ç—Ä–∞–Ω—ã —Å–ª–æ–∂–Ω–æ—Å—Ç—è–º–∏ –≤ –±–æ—Ä—å–±–µ —Å –±—É–¥—É—â–∏–º–∏ –ø–∞–Ω–¥–µ–º–∏—è–º–∏. üíä –¶–µ–Ω—Ç—Ä –∏–º. –ì–∞–º–∞–ª–µ–∏ –≤–∑—è–ª—Å—è –∑–∞ —Å–æ–∑–¥–∞–Ω–∏–µ –≤–∞–∫—Ü–∏–Ω—ã –ø—Ä–æ—Ç–∏–≤ –ª–∏—Ö–æ—Ä–∞–¥–∫–∏ —á–∏–∫—É–Ω–≥—É–Ω—å—è. –†–∞–∑—Ä–∞–±–æ—Ç–∫–æ–π –∑–∞–Ω–∏–º–∞—é—Ç—Å—è —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –æ—Ç–¥–µ–ª–∞, –∏–∑—É—á–∞—é—â–µ–≥–æ –≤–∏—Ä—É—Å—ã, —Å—Ö–æ–∂–∏–µ —Å –≤–æ–∑–±—É–¥–∏—Ç–µ–ª–µ–º —á–∏–∫—É–Ω–≥—É–Ω—å–∏. –ü–æ —Å–ª–æ–≤–∞–º –ê–ª–µ–∫—Å–∞–Ω–¥—Ä–∞ –ì–∏–Ω—Ü–±—É—Ä–≥–∞, —É —É—á—ë–Ω—ã—Ö —É–∂–µ –µ—Å—Ç—å —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã–µ –≤–∞–∫—Ü–∏–Ω–Ω—ã–µ –ø–ª–∞—Ç—Ñ–æ—Ä–º—ã, –∫–æ—Ç–æ—Ä—ã–µ –ø–æ–∑–≤–æ–ª—è—Ç –±—ã—Å—Ç—Ä–æ —Å–¥–µ–ª–∞—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç. –ï—Å–ª–∏ –∑–∞—è–≤–∫–∞ –Ω–∞ –ø—Ä–æ–µ–∫—Ç –±—É–¥–µ—Ç –æ–¥–æ–±—Ä–µ–Ω–∞, –Ω–∞ –¥–æ–∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è —É–π–¥—ë—Ç –Ω–µ –±–æ–ª–µ–µ –¥–≤—É—Ö –ª–µ—Ç. üíä Eli Lilly –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∞ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –ö–ò, —Å–æ–≥–ª–∞—Å–Ω–æ –∫–æ—Ç–æ—Ä—ã–º –≤–µ—Å –ª—é–¥–µ–π, –ø—Ä–∏–Ω–∏–º–∞–≤—à–∏—Ö –µ—ë –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è –ø–æ—Ö—É–¥–µ–Ω–∏—è GLP-1 –≤ —Ç–∞–±–ª–µ—Ç–∏—Ä–æ–≤–∞–Ω–Ω–æ–π —Ñ–æ—Ä–º–µ, –≤ —Å—Ä–µ–¥–Ω–µ–º —Å–Ω–∏–∂–∞–ª—Å—è –Ω–∞ 12,4%, —á—Ç–æ —Ö—É–∂–µ –æ–∂–∏–¥–∞–Ω–∏–π. –ù–æ, —á—Ç–æ –ø–ª–æ—Ö–æ –¥–ª—è Lilly, —Ö–æ—Ä–æ—à–æ –¥–ª—è Novo Nordisk ‚Äî –Ω–∞ —Ñ–æ–Ω–µ —ç—Ç–æ–π –Ω–æ–≤–æ—Å—Ç–∏ –∞–∫—Ü–∏–∏ –¥–∞—Ç—Å–∫–æ–π —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –ø–æ–¥–æ—Ä–æ–∂–∞–ª–∏ –Ω–∞ 7,5%. üíä –ó–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ ¬´–ü–æ—á—Ç–µ –†–æ—Å—Å–∏–∏¬ª –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –≤–Ω–µ—Å—Ç–∏ –≤ –ì–æ—Å–¥—É–º—É –∫ –æ—Å–µ–Ω–Ω–µ–π —Å–µ—Å—Å–∏–∏. –û–± —ç—Ç–æ–º —Ä–∞—Å—Å–∫–∞–∑–∞–ª –≥–ª–∞–≤–∞ –ú–∏–Ω—Ü–∏—Ñ—Ä—ã –ú–∞–∫—Å—É—Ç –®–∞–¥–∞–µ–≤. –î–æ–∫—É–º–µ–Ω—Ç –ø—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ—Ç —Å–æ–±–æ–π ¬´—Å–∏—Å—Ç–µ–º–Ω—É—é –ø—Ä–æ–≥—Ä–∞–º–º—É –ø–æ–¥–¥–µ—Ä–∂–∫–∏¬ª, –≤ —Ç–æ–º —á–∏—Å–ª–µ –ø—Ä–µ–¥—É—Å–º–∞—Ç—Ä–∏–≤–∞–µ—Ç –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –ø—Ä–æ–¥–∞–∂–∏ –≤ –ø–æ—á—Ç–æ–≤—ã—Ö –æ—Ç–¥–µ–ª–µ–Ω–∏—è—Ö –±–µ–∑—Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤. üíä –í –ü–æ–¥–º–æ—Å–∫–æ–≤—å–µ –Ω–∞—Ä–∞—Å—Ç—è—Ç –≤—ã–ø—É—Å–∫ –≥–ª–∞–∑–Ω—ã—Ö –∫–∞–ø–µ–ª—å. ¬´–í–∏–ø—Å-–ú–µ–¥¬ª —Ä–∞—Å—à–∏—Ä–∏—Ç –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –≤–æ –§—Ä—è–∑–∏–Ω–æ. –î–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–µ –ª–∏–Ω–∏–∏ –∫–æ–º–ø–∞–Ω–∏—è —Ä–∞–∑–º–µ—Å—Ç–∏–ª–∞ –≤ –ø–æ–º–µ—â–µ–Ω–∏–∏, –ø–æ–ª—É—á–µ–Ω–Ω–æ–º –≤ –∞—Ä–µ–Ω–¥—É –≤ —Ä–∞–º–∫–∞—Ö —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω–æ–π –ø—Ä–æ–≥—Ä–∞–º–º—ã ¬´–ù–µ–¥–≤–∏–∂–∏–º–æ—Å—Ç—å –∑–∞ 1 —Ä—É–±–ª—å¬ª. –í—ã–ø—É—Å–∫ –ö–≤–∏–Ω–∞–∫—Å–∞ (–∞–∑–∞–ø–µ–Ω—Ç–∞—Ü–µ–Ω) –¥–ª—è –ª–µ—á–µ–Ω–∏—è –≤—Å–µ—Ö –≤–∏–¥–æ–≤ –∫–∞—Ç–∞—Ä–∞–∫—Ç—ã —É–≤–µ–ª–∏—á–∞—Ç –¥–æ 3 –º–ª–Ω —Ñ–ª–∞–∫–æ–Ω–æ–≤ –≤ –≥–æ–¥. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance, safety"",
  ""impact"": ""high"",
  ""english"": ""The message discusses the development of personalized mRNA vaccine for lung cancer patients in Russia. It also mentions the US's reluctance to invest in mRNA vaccine research, which could complicate future pandemics. Additionally, it covers the development of a chikungunya vaccine by the Gamaleya Center and the results from Eli Lilly's GLP-1 weight loss drug clinical trial. The document also mentions a project to introduce postal services for non-prescription drugs in Russia, which could affect the pharmaceutical market.""
}"
2025-08-08T14:01:52+00:00,@bezrec,6403,https://t.me/bezrec/6403,"–¢–∞—Ç—å—è–Ω–∞ –ì–æ–ª–∏–∫–æ–≤–∞ –æ–∑–≤—É—á–∏–ª–∞ –ø–µ—Ä–≤—ã–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –Ω–∞—Ü–ø—Ä–æ–µ–∫—Ç–∞ ¬´–ù–æ–≤—ã–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ —Å–±–µ—Ä–µ–∂–µ–Ω–∏—è –∑–¥–æ—Ä–æ–≤—å—è¬ª. –í–∏—Ü–µ-–ø—Ä–µ–º—å–µ—Ä –ø—Ä–æ–≤–µ–ª–∞ –∑–∞—Å–µ–¥–∞–Ω–∏–µ –∫–æ–º–∏—Ç–µ—Ç–∞ –ø–æ –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–º—É –ø—Ä–æ–µ–∫—Ç—É —Å —É—á–∞—Å—Ç–∏–µ–º –ú–∏—Ö–∞–∏–ª–∞ –ú—É—Ä–∞—à–∫–æ, –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–µ–π –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–∞, –ú–∏–Ω–æ–±—Ä–Ω–∞—É–∫–∏, –ú–∏–Ω—Ñ–∏–Ω–∞, –§–ú–ë–ê, –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–∞ –∏ –¥—Ä—É–≥–∏—Ö –≤–µ–¥–æ–º—Å—Ç–≤. –ß–µ–≥–æ —É–∂–µ —É–¥–∞–ª–æ—Å—å –¥–æ–±–∏—Ç—å—Å—è: üü© –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –ø—Ä–æ–∏–∑–≤–æ–¥—è—â–∏—Ö—Å—è –≤ —Å—Ç—Ä–∞–Ω–µ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏–∑ –ø–µ—Ä–µ—á–Ω—è –ñ–ù–í–õ–ü —É–≤–µ–ª–∏—á–∏–ª–æ—Å—å –¥–æ 8 –ú–ù–ù; üü© –ø–æ–¥–¥–µ—Ä–∂–∞–Ω—ã –∫–ª–∏–Ω–∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –¥–µ–≤—è—Ç–∏ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ø—Ä–æ—Ç–∏–≤ –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö, —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö –∏ –¥—Ä—É–≥–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π; üü© –æ—Ç—Ä–∞–±–æ—Ç–∞–Ω—ã –∏ –≤–Ω–µ–¥—Ä–µ–Ω—ã –≤ –ø—Ä–∞–∫—Ç–∏–∫—É –≤–æ—Å–µ–º—å —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –±–∏–æ–º–µ–¥–∏—Ü–∏–Ω—ã –¥–ª—è –ª–µ—á–µ–Ω–∏—è –±–æ–ª–µ–∑–Ω–µ–π –∫–æ—Å—Ç–Ω–æ-–º—ã—à–µ—á–Ω–æ–π, —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç–æ–π, –Ω–µ—Ä–≤–Ω–æ–π —Å–∏—Å—Ç–µ–º; üü© –≤–Ω–µ–¥—Ä–µ–Ω—ã –≤ –ø—Ä–∞–∫—Ç–∏–∫—É —Ç—Ä–∏ –Ω–æ–≤—ã–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ –±–∏–æ–ø–µ—á–∞—Ç–∏, —Ç—Ä–∏ –≤–∏–¥–∞ –∏–Ω–¥–∏–≤–∏–¥—É–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π; üü© –æ—Ç—Ä–∞–±–æ—Ç–∞–Ω—ã –∏ –≤–Ω–µ–¥—Ä–µ–Ω—ã –ø—è—Ç—å –Ω–æ–≤—ã—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π, –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–Ω—ã—Ö –Ω–∞ –∞–∫—Ç–∏–≤–Ω–æ–µ –¥–æ–ª–≥–æ–ª–µ—Ç–∏–µ –∏ –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏–µ —Å—Ç–∞—Ä–µ–Ω–∏—è –∫–ª–µ—Ç–æ–∫; üü© –≤–Ω–µ–¥—Ä–µ–Ω—ã —Å–µ–º—å –±–∏–æ–º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∫–ª–µ—Ç–æ—á–Ω—ã—Ö –ø—Ä–æ–¥—É–∫—Ç–æ–≤ –∏ –ø—Ä–æ–¥—É–∫—Ç–æ–≤ —Ç–∫–∞–Ω–µ–≤–æ–π –∏–Ω–∂–µ–Ω–µ—Ä–∏–∏ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –º—É–∂—Å–∫–æ–≥–æ –±–µ—Å–ø–ª–æ–¥–∏—è, –ø–æ—Å–ª–µ–¥—Å—Ç–≤–∏–π —Ç—Ä–∞–≤–º –∫—Ä—É–ø–Ω—ã—Ö —Å—É—Å—Ç–∞–≤–æ–≤, —Å–ø–∏–Ω–Ω–æ–≥–æ –º–æ–∑–≥–∞; üü© c—Ä–µ–¥—Å—Ç–≤–∞ –Ω–∞ –æ—Å–Ω–∞—â–µ–Ω–∏–µ –∏ –ø–µ—Ä–µ–æ—Å–Ω–∞—â–µ–Ω–∏–µ –≤ 2025 –≥–æ–¥—É –≤–æ—Å—å–º–∏ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –±–∞–∑ –¥–ª—è –æ—Ç—Ä–∞–±–æ—Ç–∫–∏ –Ω–æ–≤—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π, –∫–ª–∏–Ω–∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –º–µ–¥–∏–∑–¥–µ–ª–∏–π –¥–æ–≤–µ–¥–µ–Ω—ã –≤ –ø–æ–ª–Ω–æ–º –æ–±—ä—ë–º–µ. –ù–∞–ø–æ–º–Ω–∏–º, –Ω–∞—Ü–ø—Ä–æ–µ–∫—Ç ¬´–ù–æ–≤—ã–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ —Å–±–µ—Ä–µ–∂–µ–Ω–∏—è –∑–¥–æ—Ä–æ–≤—å—è¬ª –Ω–µ –≤–æ—à—ë–ª –≤ —Ç–æ–ø-10 –ø–æ –∏—Å–ø–æ–ª–Ω–µ–Ω–∏—é —Ä–∞—Å—Ö–æ–¥–æ–≤ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –±—é–¥–∂–µ—Ç–∞ –ø–æ –∏—Ç–æ–≥–∞–º –ø–µ—Ä–≤–æ–≥–æ –ø–æ–ª—É–≥–æ–¥–∏—è. –ü–æ–∫–∞–∑–∞—Ç–µ–ª—å –µ–≥–æ –∏—Å–ø–æ–ª–Ω–µ–Ω–∏—è ‚Äî 28,8%. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": true,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""Tatyana Golikova announced the initial results of the 'New Technologies for Health Preservation' national project. Vice Premier Tatyana Golikova held a committee meeting with Mikhail Murashko, representatives from the Ministry of Industry and Trade, Ministry of Education and Science, Ministry of Finance, FMBH (Federal Medical-Biological Agency), Roszdranadzheniye (Russian Health Supervision), and other ministries. Achievements so far include: üü© the number of drugs produced from the GNP (Greatest Need List) in the country has increased to 8 MNN; üü© nine original drugs for oncological, cardiovascular and other diseases have been supported in clinical trials; üü© eight biomedicine technologies for treating bone and muscle, cardiovascular, nervous system diseases have been developed and implemented; üü© three new bioprinting technologies and three types of personalized medicines for treating oncological diseases have been developed and implemented; üü© five new biomedicine technologies aimed at active longevity and prevention"
2025-08-08T11:02:33+00:00,@bezrec,6402,https://t.me/bezrec/6402,"–í ¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º¬ª –Ω–æ–≤—ã–π –ò–¢-–¥–∏—Ä–µ–∫—Ç–æ—Ä. –î–∏—Ä–µ–∫—Ç–æ—Ä–æ–º –ø–æ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω—ã–º —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—è–º –≥—Ä—É–ø–ø—ã —Å—Ç–∞–ª –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –°–∞–º–æ—Ä–æ–¥–æ–≤. –°–∞–º–æ—Ä–æ–¥–æ–≤ –æ–∫–æ–Ω—á–∏–ª –ú–æ—Å–∫–æ–≤—Å–∫—É—é –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—É—é –∞–∫–∞–¥–µ–º–∏—é –ø—Ä–∏–±–æ—Ä–æ—Å—Ç—Ä–æ–µ–Ω–∏—è –∏ –∏–Ω—Ñ–æ—Ä–º–∞—Ç–∏–∫–∏ –ø–æ —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–∏ ¬´–ü—Ä–∏–±–æ—Ä–æ—Å—Ç—Ä–æ–µ–Ω–∏–µ¬ª. –¢–∞–∫–∂–µ –æ–Ω –∏–º–µ–µ—Ç —Å—Ç–µ–ø–µ–Ω—å –º–∞–≥–∏—Å—Ç—Ä–∞ –¥–µ–ª–æ–≤–æ–≥–æ –∞–¥–º–∏–Ω–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–∏—è (EMBA), –ø–æ–ª—É—á–µ–Ω–Ω—É—é –≤ –°—Ç–æ–∫–≥–æ–ª—å–º—Å–∫–æ–π —à–∫–æ–ª–µ —ç–∫–æ–Ω–æ–º–∏–∫–∏. –£ –ò–¢-–¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ ¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º–∞¬ª –±–æ–≥–∞—Ç—ã–π –æ–ø—ã—Ç —Ä–∞–±–æ—Ç—ã –≤ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏, –≤–∫–ª—é—á–∞—è —Ç–∞–∫–∏–µ –∫–æ–º–ø–∞–Ω–∏–∏, –∫–∞–∫ ¬´–ù–∏–∂—Ñ–∞—Ä–º¬ª, ¬´–ê–ª–∫–æ–Ω —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª, AstraZeneca, Abbott, GlaxoSmithKline. –ù–∞ –Ω–æ–≤–æ–π –¥–æ–ª–∂–Ω–æ—Å—Ç–∏ –°–∞–º–æ—Ä–æ–¥–æ–≤—É –ø—Ä–µ–¥—Å—Ç–æ–∏—Ç –∑–∞–Ω–∏–º–∞—Ç—å—Å—è: ‚Äì —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–µ–π –ø—Ä–æ–µ–∫—Ç–æ–≤ –ø–æ –≤–Ω–µ–¥—Ä–µ–Ω–∏—é —Å–æ–≤—Ä–µ–º–µ–Ω–Ω—ã—Ö –∏–Ω—Ç–µ–≥—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω—ã—Ö —Å–∏—Å—Ç–µ–º; ‚Äì –ø–æ—Å—Ç—Ä–æ–µ–Ω–∏–µ–º —Å–æ–≤—Ä–µ–º–µ–Ω–Ω–æ–π –ò–¢-–∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä—ã; ‚Äì —É–ª—É—á—à–µ–Ω–∏–µ–º –ò–¢-—Å–µ—Ä–≤–∏—Å–æ–≤ –∏ –≤–Ω—É—Ç—Ä–µ–Ω–Ω–∏—Ö –ø—Ä–æ—Ü–µ—Å—Å–æ–≤ –ò–¢-–¥–µ–ø–∞—Ä—Ç–∞–º–µ–Ω—Ç–∞; ‚Äì –≤–Ω–µ–¥—Ä–µ–Ω–∏–µ–º –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã—Ö –ò–¢-—Ä–µ—à–µ–Ω–∏–π; ‚Äì —É—Å–∏–ª–µ–Ω–∏–µ–º –º–µ—Ä –∫–∏–±–µ—Ä–±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏. –ü–æ—Å–ª–µ–¥–Ω–µ–µ –æ—Å–æ–±–µ–Ω–Ω–æ –≤–∞–∂–Ω–æ –≤ —Å–≤–µ—Ç–µ –ø–æ—Å—Ç–æ—è–Ω–Ω—ã—Ö —Ö–∞–∫–µ—Ä—Å–∫–∏—Ö –∞—Ç–∞–∫ –Ω–∞ —Å–∞–º—ã–µ —Ä–∞–∑–Ω—ã–µ –æ—Ç—Ä–∞—Å–ª–∏. –ü–æ–∑–¥—Ä–∞–≤–ª—è–µ–º –ê–ª–µ–∫—Å–∞–Ω–¥—Ä–∞ —Å –Ω–∞–∑–Ω–∞—á–µ–Ω–∏–µ–º, –∞ ¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º¬ª ‚Äî —Å –Ω–æ–≤—ã–º —á–ª–µ–Ω–æ–º –∫–æ–º–∞–Ω–¥—ã –∏ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å—é —Å–Ω–∏–∑–∏—Ç—å —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–µ —Ä–∏—Å–∫–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-08-08T09:00:01+00:00,@bezrec,6401,https://t.me/bezrec/6401,"–°—Ä–æ–∫–∏ ¬´–≤—Ç–æ—Ä–æ–≥–æ –ª–∏—à–Ω–µ–≥–æ¬ª –¥–ª—è –°–ó–õ–° –º–æ–≥—É—Ç —Å–¥–≤–∏–Ω—É—Ç—å. –ü–æ—Ö–æ–∂–µ, –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ —É—Å–ª—ã—à–∞–ª (—Ö–æ—Ç—è –±—ã —á–∞—Å—Ç–∏—á–Ω–æ) —Ñ–∞—Ä–º–∞—Å—Å–æ—Ü–∏–∞—Ü–∏–∏, –∫–æ—Ç–æ—Ä—ã–µ –ø—Ä–æ—Å–∏–ª–∏ —Å–¥–≤–∏–Ω—É—Ç—å –º–µ—Ö–∞–Ω–∏–∑–º –Ω–∞ 2027 –≥–æ–¥. –í–µ–¥–æ–º—Å—Ç–≤–æ —Å–æ–≤–º–µ—Å—Ç–Ω–æ —Å –ú–∏–Ω—Ñ–∏–Ω–æ–º –ø—Ä–æ—Ä–∞–±–∞—Ç—ã–≤–∞–µ—Ç –≤–æ–ø—Ä–æ—Å –ø–µ—Ä–µ–Ω–æ—Å–∞ –ø—Ä–∞–≤–∏–ª–∞ ¬´–≤—Ç–æ—Ä–æ–π –ª–∏—à–Ω–∏–π¬ª –¥–ª—è —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ —Å 1 —Å–µ–Ω—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞ –Ω–∞ 1 —è–Ω–≤–∞—Ä—è 2026 –≥–æ–¥–∞. –ü–µ—Ä–µ–Ω–æ—Å —Å—Ä–æ–∫–∞ –æ–±—É—Å–ª–æ–≤–ª–µ–Ω –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç—å—é ¬´–±–µ—Å—à–æ–≤–Ω–æ–≥–æ¬ª –ø–µ—Ä–µ—Ö–æ–¥–∞ –Ω–∞ –º–µ—Ö–∞–Ω–∏–∑–º ¬´–≤—Ç–æ—Ä–æ–π –ª–∏—à–Ω–∏–π –Ω–∞ –°–ó–õ–°¬ª, —á—Ç–æ–±—ã –≤—Å–µ –∂–µ–ª–∞—é—â–∏–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ —É—Å–ø–µ–ª–∏ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞—Ç—å—Å—è –≤ —Å–∏—Å—Ç–µ–º–µ –ø—Ä–æ—Å–ª–µ–∂–∏–≤–∞–µ–º–æ—Å—Ç–∏ –∏ –≤–Ω–µ—Å—Ç–∏ –≤ –Ω–µ—ë –≤—Å–µ –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã–µ –¥–∞–Ω–Ω—ã–µ, ‚Äî –ø–æ—è—Å–Ω–∏–ª–∏ –≤ –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–µ. –î–ª—è –≤–ø–µ—Ä–≤—ã–µ –≤–∫–ª—é—á–∞–µ–º—ã—Ö –≤ –ø–µ—Ä–µ—á–µ–Ω—å –°–ó–õ–° –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∑–∞–ª–æ–∂–µ–Ω –ø–µ—Ä–µ—Ö–æ–¥–Ω—ã–π –ø–µ—Ä–∏–æ–¥ ‚Äî –æ–Ω –¥–∞—Å—Ç –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ–µ –≤—Ä–µ–º—è –¥–ª—è –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ø–æ–ª–Ω–æ–≥–æ —Ü–∏–∫–ª–∞ –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ –ï–ê–≠–°. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥, –ú–∏–Ω–∑–¥—Ä–∞–≤, –ú–∏–Ω—Ñ–∏–Ω –∏ –§–ê–° –ø—Ä–æ—Ä–∞–±–∞—Ç—ã–≤–∞—é—Ç –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –∫–æ–º–±–∏–Ω–∞—Ü–∏–∏ –ø—Ä–∞–≤–∏–ª–∞ ¬´–≤—Ç–æ—Ä–æ–π –ª–∏—à–Ω–∏–π¬ª –∏ –º–µ—Ö–∞–Ω–∏–∑–º–∞ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª–µ–Ω–∏—è —Ü–µ–Ω–æ–≤—ã—Ö –ø—Ä–µ—Ñ–µ—Ä–µ–Ω—Ü–∏–π –≤ –≤–∏–¥–µ ¬´—Ü–µ–Ω–æ–≤–æ–≥–æ –ø—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–∞¬ª –¥–ª—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏–∑ –ø–µ—Ä–µ—á–Ω—è –°–ó–õ–°, –ø—Ä–æ–∏–∑–≤–æ–¥–∏–º—ã—Ö –≤ –ï–ê–≠–° –ø–æ –ø–æ–ª–Ω–æ–º—É —Ü–∏–∫–ª—É. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""tenders, import_export, sanctions, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The 'second extra' for strategic drugs may be delayed. It seems that the Ministry of Industry and Trade has heard (at least partially) the pharmaceutical associations' request to delay the mechanism until 2027. The ministry, together with the Ministry of Finance, is considering moving the 'second extra' rule for strategically important drugs from September 1, 2025 to January 1, 2026. The delay is necessary for a 'smooth' transition to the 'second extra on SZZS' system, allowing all interested manufacturers to register in the traceability system and enter all necessary data. A transition period is also provided for drugs that are first included in the SZZS list, to give sufficient time for full production cycle localization within the EAEU. Additionally, the Ministry of Industry and Trade, the Ministry of Health, the Ministry of Finance, and FAS are considering a combination of the 'second extra' rule and the mechanism for providing price-preferred benefits to drugs from the SZZS list produced within"
2025-08-08T06:07:31+00:00,@bezrec,6400,https://t.me/bezrec/6400,"–ö–æ–º–∏—Å—Å–∏—è –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ —Å–Ω–æ–≤–∞ –Ω–µ —É–≥–æ–¥–∏–ª–∞ –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–∏–∫–∞–º. 6 –∏ 7 –∞–≤–≥—É—Å—Ç–∞ —Å–æ—Å—Ç–æ—è–ª–∏—Å—å –æ—á–µ—Ä–µ–¥–Ω—ã–µ –∑–∞—Å–µ–¥–∞–Ω–∏—è –ø–æ –≤–æ–ø—Ä–æ—Å—É —Ä–∞—Å—à–∏—Ä–µ–Ω–∏—è –ø–µ—Ä–µ—á–Ω—è –ñ–ù–í–õ–ü. –ó–∞ –¥–≤–∞ –¥–Ω—è —ç–∫—Å–ø–µ—Ä—Ç—ã —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–ª–∏ 23 –∫–∞–Ω–¥–∏–¥–∞—Ç–∞, —Å—Ç–∞—Ç—É—Å –∂–∏–∑–Ω–µ–Ω–Ω–æ –≤–∞–∂–Ω—ã—Ö –ø–æ–ª—É—á–∏–ª–∏ —Ç–æ–ª—å–∫–æ –≤–æ—Å–µ–º—å: üîò–≠–ª—å—Ñ–∞–±—Ä–∏–æ (–ø—ç–≥—É–Ω–∏–≥–∞–ª–∑–∏–¥–∞–∑–∞ –∞–ª—å—Ñ–∞) –æ—Ç Chiesi ‚Äî –±–æ–ª–µ–∑–Ω—å –§–∞–±—Ä–∏; üîò–ê—Ñ—Å—Ç–∏–ª–∞ (–ª–æ–Ω–æ–∫—Ç–æ–∫–æ–≥ –∞–ª—å—Ñ–∞) –æ—Ç CSL Behring ‚Äî –≥–µ–º–æ—Ñ–∏–ª–∏—è –ê; üîò–†–µ–±–ª–æ–∑–∏–ª (–ª—É—Å–ø–∞—Ç–µ—Ä—Ü–µ–ø—Ç) –æ—Ç Bristol Myers Squibb ‚Äî –∞–Ω–µ–º–∏—è; üîò–†–∞–∫—Å—Ç–µ–º–∏ (–ø—Ä–µ—Ç–æ–º–∞–Ω–∏–¥) –æ—Ç Viatris ‚Äî —Ç—É–±–µ—Ä–∫—É–ª—ë–∑; üîò–ê–∫–¥–∞–π–Ω–∞ (–∫–∞–ø–∏–≤–∞—Å–µ—Ä—Ç–∏–±) –æ—Ç AstraZeneca ‚Äî —Ä–∞–∫ –º–æ–ª–æ—á–Ω–æ–π –∂–µ–ª–µ–∑—ã; üîò–ê—Ä–µ–π–º–∞ (–∫–∞–º—Ä–µ–ª–∏–∑—É–º–∞–±) –æ—Ç ¬´–ü–µ—Ç—Ä–æ–≤–∞–∫—Å¬ª ‚Äî —Ä–∞–∫ –ø–∏—â–µ–≤–æ–¥–∞ –∏ –Ω–æ—Å–æ–≥–ª–æ—Ç–∫–∏; üîò–ü–∞–¥—Ü–µ–≤ –û–Ω–∫–æ (—ç–Ω—Ñ–æ—Ä—Ç—É–º–∞–± –≤–µ–¥–æ—Ç–∏–Ω) –æ—Ç Astellas ‚Äî —Ä–∞–∫ –º–æ—á–µ–≤–æ–≥–æ –ø—É–∑—ã—Ä—è; üîò–ù—É–±–µ–∫–∞ (–¥–∞—Ä–æ–ª—É—Ç–∞–º–∏–¥) –æ—Ç Bayer ‚Äî —Ä–∞–∫ –ø—Ä–µ–¥—Å—Ç–∞—Ç–µ–ª—å–Ω–æ–π –∂–µ–ª–µ–∑—ã; üîò–ü–æ—ç–∫—Å–æ (–ø—ç–≥—Ñ–∏–ª–≥—Ä–∞—Å—Ç–∏–º) –æ—Ç ¬´–ü–°–ö –§–∞—Ä–º—ã¬ª ‚Äî —Å–Ω–∏–∂–µ–Ω–∏–µ –ø—Ä–æ–¥–æ–ª–∂–∏—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –Ω–µ–π—Ç—Ä–æ–ø–µ–Ω–∏–∏ —É –≤–∑—Ä–æ—Å–ª—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –ø–æ–ª—É—á–∞—é—â–∏—Ö —Ü–∏—Ç–æ—Ç–æ–∫—Å–∏—á–µ—Å–∫—É—é —Ö–∏–º–∏–æ—Ç–µ—Ä–∞–ø–∏—é. –ù–µ—Å–º–æ—Ç—Ä—è –Ω–∞ —Ç–æ, —á—Ç–æ –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü —É–¥–∞–ª–æ—Å—å –ø—Ä–æ–±–∏—Ç—å—Å—è —Ä—è–¥—É –≤–∞–∂–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –∫ –æ—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω—ã–º —Ä–µ—à–µ–Ω–∏—è–º –∫–æ–º–∏—Å—Å–∏–∏ –æ—Å—Ç–∞—é—Ç—Å—è –≤–æ–ø—Ä–æ—Å—ã. –¢–∞–∫, –≥–ª–∞–≤–∞ –ê—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ –æ–Ω–∫–æ–ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ ¬´–ó–¥—Ä–∞–≤—Å—Ç–≤—É–π!¬ª –ò—Ä–∏–Ω–∞ –ë–æ—Ä–æ–≤–æ–≤–∞ –æ—Ç–º–µ—á–∞–µ—Ç, —á—Ç–æ –≤ —Å–ø–∏—Å–æ–∫ –Ω–µ –ø–æ–ø–∞–ª–∏ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –ø—Ä–æ—Ç–∏–≤ —Ä–∞–∫–∞ –ø–æ–¥–∂–µ–ª—É–¥–æ—á–Ω–æ–π –∂–µ–ª–µ–∑—ã, —Ä–∞–∫–∞ –ª–µ–≥–∫–∏—Ö, –∫–æ–º–±–∏–Ω–∞—Ü–∏—è –∏–∑ –¥–≤—É—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø—Ä–æ—Ç–∏–≤ –º–Ω–æ–∂–µ—Å—Ç–≤–µ–Ω–Ω–æ–π –º–∏–µ–ª–æ–º—ã, –∞ —Ç–∞–∫–∂–µ –¥–≤–∞ –ø—Ä–æ—Ä—ã–≤–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –ø—Ä–æ—Ç–∏–≤ –ª–∏–º—Ñ–æ–º. –û—Å–æ–±–µ–Ω–Ω–æ –æ—Å—Ç—Ä—ã–µ –≤–æ–ø—Ä–æ—Å—ã –≤—ã–∑–≤–∞–ª–æ –æ—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω–æ–µ —Ä–µ—à–µ–Ω–∏–µ –ø–æ –¥–≤—É–º –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–º –æ–Ω–∫–æ–≥–µ–º–∞—Ç–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º. –≠—Ç–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –±–æ–ª–µ–µ —á–µ–º –≤ 40% —Å–ª—É—á–∞–µ–≤ –æ–±–µ—Å–ø–µ—á–∏–≤–∞—é—Ç —Ä–µ–º–∏—Å—Å–∏—é –¥–∞–∂–µ —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –≤ –ø–∞–ª–ª–∏–∞—Ç–∏–≤–Ω–æ–º —Å—Ç–∞—Ç—É—Å–µ. –ù–µ—Å–º–æ—Ç—Ä—è –Ω–∞ –¥–æ–≤–æ–¥—ã –≤—Ä–∞—á–µ–π –∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –≤–Ω–æ–≤—å –≤ –ø—Ä–∏–æ—Ä–∏—Ç–µ—Ç–µ –±—ã–ª–∏ –Ω–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ –¥–∞–Ω–Ω—ã–µ, –∞ —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–∏–µ —Å–æ–æ–±—Ä–∞–∂–µ–Ω–∏—è, ‚Äî –ø—Ä–æ–∫–æ–º–º–µ–Ω—Ç–∏—Ä–æ–≤–∞–ª —Å–æ–ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—å –í–°–ü –Æ—Ä–∏–π –ñ—É–ª–µ–≤. –í —Å–æ—é–∑–µ —É–≤–µ—Ä–µ–Ω—ã, —á—Ç–æ —Å–æ–±–ª—é–¥–µ–Ω–∏–µ –ø—Ä–∏–Ω—Ü–∏–ø–∞ ¬´–Ω—É–ª–µ–≤–æ–≥–æ –≤–ª–∏—è–Ω–∏—è –Ω–∞ –±—é–¥–∂–µ—Ç¬ª —Å—Ç–∞–Ω–æ–≤–∏—Ç—Å—è –æ–≥—Ä–æ–º–Ω—ã–º –±–∞—Ä—å–µ—Ä–æ–º –¥–ª—è –≤—Å–µ—Ö –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –í –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç —Ä–∞–∑–¥–µ–ª–∏—Ç—å —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫—É—é –∏ –∫–ª–∏–Ω–∏—á–µ—Å–∫—É—é —ç–∫—Å–ø–µ—Ä—Ç–∏–∑—É, —Ç.–∫. ¬´—Å–æ–≤–º–µ—â–∞—Ç—å —ç—Ç–∏ –¥–≤–∞ –ø–æ–¥—Ö–æ–¥–∞ –≤ —Ä–∞–º–∫–∞—Ö –æ–¥–Ω–æ–π –∫–æ–º–∏—Å—Å–∏–∏ –≤—Å–µ —Å–ª–æ–∂–Ω–µ–µ¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The regulatory commission again disappointed the public. On August 6th and 7th, the second round of meetings on expanding the list of essential medicines were held. Over two days, experts reviewed 23 candidates for inclusion in the list of essential medicines, with only eight receiving this status: üîòEphabri (Pegylated Galactose-1-phosphate) from Chiesi - Fabry Disease; üîòAfsta (Loktokog) from CSL Behring - Hemophilia A; üîòReblosil (Luspatercept) from Bristol Myers Squibb - Anemia; üîòPactex (Pegfilgrastim) from Astellas - Tuberculosis. Despite the inclusion of several important drugs, negative decisions were made for some innovative medicines against cancer and lung cancer. The head of the Association of Cancer Patients 'Zdravstvuy' Irina Borovova noted that innovative medicines against the stomach cancer, lung cancer, and a combination of two drugs for multiple myeloma were not included"
2025-08-07T14:31:18+00:00,@bezrec,6399,https://t.me/bezrec/6399,"–ö–æ–≥–¥–∞ —Ç–µ–±–µ –¥–æ—Å—Ç–∞–ª–æ—Å—å –æ—Ç –§–ê–° –∑–∞ —Ä–µ–∫–ª–∞–º—É —Ä–µ—Ü–µ–ø—Ç—É—Ä–∫–∏ –Ω–∞ —Å–≤–µ—Ç—Å–∫–æ–º –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–∏, –∞ –ø–µ—Å–Ω—é –ø—Ä–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç –∫–æ–Ω–∫—É—Ä–µ–Ω—Ç–∞ —Å–æ—á–ª–∏ ¬´—Ç–≤–æ—Ä—á–µ—Å–∫–∏–º –ø—Ä–æ–∏–∑–≤–µ–¥–µ–Ω–∏–µ–º, –∫–æ—Ç–æ—Ä–æ–µ –Ω–µ –º–æ–∂–µ—Ç —Å—á–∏—Ç–∞—Ç—å—Å—è —Ä–µ–∫–ª–∞–º–æ–π¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-08-07T11:32:09+00:00,@bezrec,6398,https://t.me/bezrec/6398,"DSM Group –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∞ —Ä–µ–π—Ç–∏–Ω–≥ –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö —Ñ–∞—Ä–º–¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–æ–≤ –ø–æ –∏—Ç–æ–≥–∞–º –ø–µ—Ä–≤–æ–≥–æ –ø–æ–ª—É–≥–æ–¥–∏—è 2025 –≥–æ–¥–∞. –ü–æ –¥–∞–Ω–Ω—ã–º –∞–Ω–∞–ª–∏—Ç–∏–∫–æ–≤, –ø–æ—Å—Ç–∞–≤–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∑–∞ —Å—á—ë—Ç –±—é–¥–∂–µ—Ç–∞ —É–≤–µ–ª–∏—á–∏–ª–∏—Å—å –Ω–∞ 22,7% –ø–æ—Å–ª–µ –ø–∞–¥–µ–Ω–∏—è –Ω–∞ 10% –≥–æ–¥–æ–º —Ä–∞–Ω–µ–µ. –¢–µ–Ω–¥–µ–Ω—Ü–∏—è –º–æ–∂–µ—Ç –±—ã—Ç—å —Å–≤—è–∑–∞–Ω–∞ —Å —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–µ–π –∫–æ–Ω—Ç—Ä–∞–∫—Ç–æ–≤, –∑–∞–∫–ª—é—á–µ–Ω–Ω—ã—Ö –≤ –∫–æ–Ω—Ü–µ 2024 –≥–æ–¥–∞. 80,8% —Ä—ã–Ω–∫–∞ –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ 10 –æ—Å–Ω–æ–≤–Ω—ã—Ö –∏–≥—Ä–æ–∫–æ–≤. –õ–∏–¥–µ—Ä —Ä–µ–π—Ç–∏–Ω–≥–∞ ‚Äî ¬´–ü—É–ª—å—Å¬ª –≠–¥—É–∞—Ä–¥–∞ –ù–µ—Ç—ã–ª—å–∫–æ —Å –æ–±—ä—ë–º–æ–º –ø—Ä–æ–¥–∞–∂ 213,3 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –∏ –¥–æ–ª–µ–π 15,7%. –° –Ω–µ–±–æ–ª—å—à–∏–º –æ—Ç—Å—Ç–∞–≤–∞–Ω–∏–µ–º –≤—Ç–æ—Ä–æ–µ –º–µ—Å—Ç–æ –∑–∞–Ω–∏–º–∞–µ—Ç ¬´–ü—Ä–æ—Ç–µ–∫¬ª –í–∞–¥–∏–º–∞ –Ø–∫—É–Ω–∏–Ω–∞ (211,9 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –∏ –¥–æ–ª—è 15,6%). –ó–∞–º—ã–∫–∞–µ—Ç —Ç—Ä–æ–π–∫—É ¬´–ö–∞—Ç—Ä–µ–Ω¬ª —Å –æ–±—ä—ë–º–æ–º 179,6 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –ø—Ä–∏ –¥–æ–ª–µ —Ä—ã–Ω–∫–∞ 13,2%. –°–∞–º–æ–π –≤—ã—Å–æ–∫–æ–π –¥–∏–Ω–∞–º–∏–∫–æ–π –º–æ–≥—É—Ç –ø–æ—Ö–≤–∞—Å—Ç–∞—Ç—å—Å—è ¬´–§–∞—Ä–º–∫–æ–º–ø–ª–µ–∫—Ç¬ª (43,8%), ¬´–†-–§–∞—Ä–º¬ª (20,5%) –∏ –≥–µ—Ä–æ–π –æ—Ç—á—ë—Ç–Ω–æ–≥–æ –ø–µ—Ä–∏–æ–¥–∞ ‚Äî ¬´–ò—Ä–≤–∏–Ω 2¬ª, –Ω–∞—Ä–∞—Å—Ç–∏–≤—à–∏–π –æ–±–æ—Ä–æ—Ç –∞–∂ –Ω–∞ 71%, –∫–∞–∫ –æ—Ç–º–µ—Ç–∏–ª–∏ –≤ —Å–∞–º–æ–π –∫–æ–º–ø–∞–Ω–∏–∏, ¬´–≤ —Å–≤—è–∑–∏ —Å –≥—Ä–∞–º–æ—Ç–Ω–æ–π –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç–Ω–æ–π –ø–æ–ª–∏—Ç–∏–∫–æ–π –∏ –≤—ã–±–æ—Ä–æ–º –ø—Ä–æ–¥—É–∫—Ç–æ–≤¬ª. –≠—Ç–æ–π —Ä–∞–±–æ—Ç–æ–π –º—ã –∞–∫—Ç–∏–≤–Ω–æ –∑–∞–Ω–∏–º–∞–ª–∏—Å—å –≤ —Ç–µ—á–µ–Ω–∏–µ —Ç—Ä–µ—Ö –ª–µ—Ç, —á—Ç–æ —Ç–µ–ø–µ—Ä—å –¥–∞–ª–æ —Ä–µ–∑—É–ª—å—Ç–∞—Ç. –ê–ø—Ç–µ—á–Ω—ã–µ –ø—Ä–æ–¥–∞–∂–∏ –≤—ã—Ä–æ—Å–ª–∏ –≤ –æ—Å–Ω–æ–≤–Ω–æ–º –∑–∞ —Å—á–µ—Ç –æ–Ω–∫–æ–ª–æ–≥–∏–∏ –∏ –∫–∞—Ä–¥–∏–æ–ª–æ–≥–∏–∏. –ê –≤ —Å–µ–≥–º–µ–Ω—Ç–µ –≥–æ—Å–∑–∞–∫—É–ø–æ–∫ –¥—Ä–∞–π–≤–µ—Ä–∞–º–∏ —Å—Ç–∞–ª–∏ –≥–µ–º–∞—Ç–æ–ª–æ–≥–∏—è –∏ –Ω–µ–π—Ä–æ–º—ã—à–µ—á–Ω—ã–µ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª –æ —Å–≤–æ–∏—Ö —É—Å–ø–µ—Ö–∞—Ö —Ñ–∞—Ä–º–¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä. –û—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω—É—é –¥–∏–Ω–∞–º–∏–∫—É –≤ –ø–µ—Ä–≤–æ–π –¥–µ—Å—è—Ç–∫–µ –ø–æ–∫–∞–∑–∞–ª —Ç–æ–ª—å–∫–æ ¬´–§–∞—Ä–º–∏–º—ç–∫—Å¬ª. –ü–æ–º–∏–º–æ –ø–µ—Ä–µ—á–∏—Å–ª–µ–Ω–Ω—ã—Ö –∏–≥—Ä–æ–∫–æ–≤ –≤ —Ç–æ–ø-10 –¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–æ–≤ —Ç–∞–∫–∂–µ –≤–æ—à–ª–∏ ¬´–ì—Ä–∞–Ω–¥ –ö–∞–ø–∏—Ç–∞–ª¬ª, ¬´–ë–°–°¬ª –∏ ¬´–í–∏—Ç–∞ –≠–∫—Å–ø—Ä–µ—Å—Å¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": true,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The report highlights an increase in government procurement of medicines by 22.7% year-over-year, following a decline of 10%. The trend is attributed to contracts signed at the end of 2024. The top three players in the market are 'Puls' (15.7% share, $213.3 billion in sales), 'Protiek' (15.6% share, $211.9 billion in sales), and 'Katren' (13.2% share, $179.6 billion in sales). The report mentions that 'Irvin 2' experienced a significant growth of 71% in sales, mainly due to oncology and cardiology segments. Negative performance was observed from 'Farmaemex'. Other top players include 'Grand Capital', 'BSS' and 'Vita Express'.""
}"
2025-08-07T09:21:03+00:00,@bezrec,6397,https://t.me/bezrec/6397,"–ù–∞ –ö—É–±–∞–Ω–∏ –ø–æ—è–≤–∏—Ç—Å—è –Ω–æ–≤–æ–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤. ¬´–Æ–∂—Ñ–∞—Ä–º¬ª –ø–ª–∞–Ω–∏—Ä—É–µ—Ç –≤ –∫–æ–Ω—Ü–µ –∞–≤–≥—É—Å—Ç–∞ –∑–∞–ø—É—Å—Ç–∏—Ç—å —á–µ—Ç—ã—Ä–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã–µ –ª–∏–Ω–∏–∏ –ø–æ –≤—ã–ø—É—Å–∫—É –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤ –≤ —Ä–∞–∑–ª–∏—á–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Ñ–æ—Ä–º–∞—Ö. –ü–ª–æ—â–∞–¥–∫–∞ –Ω–∞—Ö–æ–¥–∏—Ç—Å—è –≤ —Å—Ç–∞–Ω–∏—Ü–µ –¢—Ä–æ–∏—Ü–∫–æ–π –ö—Ä—ã–º—Å–∫–æ–≥–æ —Ä–∞–π–æ–Ω–∞ –ö—Ä–∞—Å–Ω–æ–¥–∞—Ä—Å–∫–æ–≥–æ –∫—Ä–∞—è. –ò–Ω–≤–µ—Å—Ç–∏—Ü–∏–∏ –≤ –ø—Ä–æ–µ–∫—Ç –æ—Ü–µ–Ω–∏–≤–∞—é—Ç—Å—è –≤ 200 –º–ª–Ω —Ä—É–±–ª–µ–π. –ß–∞—Å—Ç—å –∑–∞—Ç—Ä–∞—Ç –∫–æ–º–ø–∞–Ω–∏—è –∫–æ–º–ø–µ–Ω—Å–∏—Ä–æ–≤–∞–ª–∞ —Å—É–±—Å–∏–¥–∏–µ–π –Ω–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –∏–º–ø–æ—Ä—Ç–æ–∑–∞–º–µ—â–∞—é—â–µ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –≤ –∫—Ä–∞–µ. –ü–æ –¥–∞–Ω–Ω—ã–º Rusprofile, –≤ —Å—Ñ–µ—Ä–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ ¬´–Æ–∂—Ñ–∞—Ä–º¬ª —Ä–∞–±–æ—Ç–∞–µ—Ç —Å 2007 –≥–æ–¥–∞. –ì–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–º —Å 2024 –≥–æ–¥–∞ —á–∏—Å–ª–∏—Ç—Å—è –°–µ—Ä–≥–µ–π –ï–≤—Ç—É—à–µ–Ω–∫–æ. –ï–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–π —É—á—Ä–µ–¥–∏—Ç–µ–ª—å ‚Äî –ú–∏—Ö–∞–∏–ª –ö—Ä–∞–≤—á—É–∫. –ö–æ–º–ø–∞–Ω–∏—è –≤–ª–∞–¥–µ–µ—Ç 33 —Ç–æ–≤–∞—Ä–Ω—ã–º–∏ –∑–Ω–∞–∫–∞–º–∏, –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–º–∏ —Å 2003 –ø–æ 2025 –≥–æ–¥. –ü–æ –¥–∞–Ω–Ω—ã–º –∑–∞ 2022 –≥–æ–¥ –≤—ã—Ä—É—á–∫–∞ —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è —Å–æ—Å—Ç–∞–≤–∏–ª–∞ 1,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π (+46% –≥–æ–¥ –∫ –≥–æ–¥—É), –ø—Ä–∏–±—ã–ª—å ‚Äî 418 –º–ª–Ω —Ä—É–±–ª–µ–π (+82% –≥–æ–¥ –∫ –≥–æ–¥—É). –ë–æ–ª–µ–µ —Å–≤–µ–∂–∏—Ö –¥–∞–Ω–Ω—ã—Ö –ø–æ —Ñ–∏–Ω–∞–Ω—Å–æ–≤—ã–º –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è–º –Ω–µ—Ç. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-08-07T06:16:02+00:00,@bezrec,6396,https://t.me/bezrec/6396,"–ü–æ –∏—Ç–æ–≥–∞–º I-II –∫–≤–∞—Ä—Ç–∞–ª–∞ 2025 –≥–æ–¥–∞ –Ω–∞ —Ä–æ–∑–Ω–∏—á–Ω–æ–º —Ä—ã–Ω–∫–µ –±—ã–ª–æ –ø—Ä–æ–¥–∞–Ω–æ –∞–Ω—Ç–∏–¥–∏–∞—Ä–µ–π–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –±–æ–ª–µ–µ —á–µ–º –Ω–∞ 22,6 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —á—Ç–æ –Ω–∞ 16,7% –±–æ–ª—å—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É. –ù–∞—Ç—É—Ä–∞–ª—å–Ω–æ–µ –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–µ –∑–∞ –≥–æ–¥ —Å–Ω–∏–∑–∏–ª–æ—Å—å –Ω–∞ 1,5%, –¥–æ 65,5 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫. –¢–µ–Ω–¥–µ–Ω—Ü–∏—è –∫ —Å–Ω–∏–∂–µ–Ω–∏—é –Ω–∞—Ç—É—Ä–∞–ª—å–Ω—ã—Ö –æ–±—ä—ë–º–æ–≤ –ø—Ä–æ–¥–∞–∂ –Ω–∞–±–ª—é–¥–∞–µ—Ç—Å—è —Ç—Ä–µ—Ç–∏–π –≥–æ–¥ –ø–æ–¥—Ä—è–¥. –í –æ—Å–Ω–æ–≤–Ω–æ–º –ø—Ä–æ–¥–∞–∂–∏ –≤ –≥—Ä—É–ø–ø–µ ¬´–¥–µ–ª–∞—é—Ç¬ª –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, —Ä–µ–≥—É–ª–∏—Ä—É—é—â–∏–µ —Ä–∞–≤–Ω–æ–≤–µ—Å–∏–µ –∫–∏—à–µ—á–Ω–æ–π –º–∏–∫—Ä–æ—Ñ–ª–æ—Ä—ã –∏ –∞–¥—Å–æ—Ä–±–µ–Ω—Ç—ã ‚Äî —ç—Ç–∏ –¥–≤–µ –ø–æ–¥–≥—Ä—É–ø–ø—ã —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–ª–∏ –±–æ–ª–µ–µ 66% –≤—Å–µ–≥–æ –æ–±—ä—ë–º–∞. –ü—Ä–æ—Ç–∏–≤–æ–¥–∏–∞—Ä–µ–π–Ω—ã–µ, –∫–∏—à–µ—á–Ω—ã–µ –ø—Ä–æ—Ç–∏–≤–æ–º–∏–∫—Ä–æ–±–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –∑–∞–Ω–∏–º–∞–ª–∏ –ø–æ—Ä—è–¥–∫–∞ 18,7%, –æ—Å—Ç–∞–≤—à–∏–µ—Å—è 15% –ø—Ä–∏—à–ª–∏—Å—å –Ω–∞ –ø—Ä–æ—Ç–∏–≤–æ–≤–æ—Å–ø–∞–ª–∏—Ç–µ–ª—å–Ω—ã–µ, —Å—Ä–µ–¥—Å—Ç–≤–∞, —Å–Ω–∏–∂–∞—é—â–∏–µ –ø–µ—Ä–∏—Å—Ç–∞–ª—å—Ç–∏–∫—É –ñ–ö–¢, –∏ —ç–ª–µ–∫—Ç—Ä–æ–ª–∏—Ç—ã. –í –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ –ª–∏–¥–∏—Ä—É—é—Ç –∞–¥—Å–æ—Ä–±–µ–Ω—Ç—ã (27 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ –∑–∞ –ø–µ—Ä–≤–æ–µ –ø–æ–ª—É–≥–æ–¥–∏–µ), –Ω–æ –∏ –æ–Ω–∏ —Å–¥–∞—é—Ç –ø–æ–∑–∏—Ü–∏–∏ ‚Äî –∑–∞ –≥–æ–¥ –ø—Ä–æ–¥–∞–∂–∏ —Å–æ–∫—Ä–∞—Ç–∏–ª–∏—Å—å –Ω–∞ 7%. –≠—Ç–æ –≤ –±–æ–ª—å—à–µ–π —Å—Ç–µ–ø–µ–Ω–∏ ¬´–∑–∞—Å–ª—É–≥–∞¬ª –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ –æ—Å–Ω–æ–≤–µ –∞–∫—Ç–∏–≤–∏—Ä–æ–≤–∞–Ω–Ω–æ–≥–æ —É–≥–ª—è, –∏–Ω—Ç–µ—Ä–µ—Å –∫ –∫–æ—Ç–æ—Ä—ã–º –Ω–µ—É–∫–ª–æ–Ω–Ω–æ –ø–∞–¥–∞–µ—Ç. –°–µ–π—á–∞—Å –≤ –∞–ø—Ç–µ–∫–∞—Ö –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–æ –ø–æ—Ä—è–¥–∫–∞ 86 —Ç–æ—Ä–≥–æ–≤—ã—Ö –º–∞—Ä–æ–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ø—Ä–æ—Ç–∏–≤ –∫–∏—à–µ—á–Ω—ã—Ö —Ä–∞—Å—Å—Ç—Ä–æ–π—Å—Ç–≤ –æ—Ç 84 –∫–æ–º–ø–∞–Ω–∏–π. –õ–∏–¥–∏—Ä—É–µ—Ç –≤ –≥—Ä—É–ø–ø–µ –õ–∏–Ω–µ–∫—Å –æ—Ç ¬´–°–∞–Ω–¥–æ–∑¬ª —Å –æ–±—ä—ë–º–æ–º –ø—Ä–æ–¥–∞–∂ –≤ 2,3 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ù–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ ‚Äî –≠–Ω—Ç–µ—Ä–æ—Å–≥–µ–ª—å (¬´–§–∞—Ä–º–∞—Å–∏–ª¬ª), –Ω–∞ —Ç—Ä–µ—Ç—å–µ–º ‚Äî –≠–Ω—Ç–µ—Ä–æ–ª –æ—Ç ¬´–ë–∏–æ–∫–æ–¥–µ–∫—Å¬ª. –ü–æ—Å–ª–µ–¥–Ω–∏–π –º–æ–∂–µ—Ç –ø–æ—Ö–≤–∞—Å—Ç–∞—Ç—å—Å—è –º–∞–∫—Å–∏–º–∞–ª—å–Ω—ã–º –≤ –ø–µ—Ä–≤–æ–π –¥–µ—Å—è—Ç–∫–µ —Ä–æ—Å—Ç–æ–º –ø—Ä–æ–¥–∞–∂ (+42%). –û—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω–∞—è –¥–∏–Ω–∞–º–∏–∫–∞ –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–Ω–∞ —É –ø–æ–ª–æ–≤–∏–Ω—ã —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ —Ç–æ–ø-10. –°–∞–º–æ–µ –∑–∞–º–µ—Ç–Ω–æ–µ —Å–æ–∫—Ä–∞—â–µ–Ω–∏–µ –æ—Ç–º–µ—á–µ–Ω–æ —É –ë–∏—Ñ–∏—Ñ–æ—Ä–º–∞ (-12,2% –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö) –æ—Ç ¬´–•–µ–ª–µ–æ–Ω¬ª (–≥—Ä—É–ø–ø–∞ ¬´–ì–°–ö¬ª). –í –ø–µ—Ä–≤—É—é –¥–µ—Å—è—Ç–∫—É —Ç–∞–∫–∂–µ –ø–æ–ø–∞–ª–∏: –ü–æ–ª–∏—Å–æ—Ä–± (¬´–ü–æ–ª–∏—Å–æ—Ä–±¬ª), –ê–ª—å—Ñ–∞ –ù–æ—Ä–º–∏–∫—Å (¬´–ê–ª—å—Ñ–∞—Å–∏–≥–º–∞¬ª), –≠–Ω—Ç–µ—Ä–æ—Ñ—É—Ä–∏–ª (¬´–ë–æ—Å–Ω–∞–ª–µ–∫¬ª), –õ–æ–ø–µ—Ä–∞–º–∏–¥ (¬´–ê–∫—Ä–∏—Ö–∏–Ω¬ª + 11 –∫–æ–º–ø–∞–Ω–∏–π¬ª), –•–∏–ª–∞–∫ –§–æ—Ä—Ç–µ (¬´–¢–µ–≤–∞¬ª), –°–º–µ–∫—Ç–∞ (¬´–ò–ø—Å–µ–Ω¬ª). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, shortage"",
  ""impact"": ""medium"",
  ""english"": ""In the first half of the year, sales of anti-diarrheal drugs grew by 16.7% compared to the same period last year, reaching over 22.6 billion rubles on the retail market. Natural consumption decreased by 1.5% to 65.5 million units. The trend of declining natural sales volumes has persisted for three years. The main drivers are drugs regulating intestinal flora balance and adsorbents, which accounted for more than 66% of the total volume. The main groups are adsorbents (27 million units) and anti-inflammatory, intestinal motility-reducing drugs, electrolytes. The leader is adsorbents from Linctus (2.3 billion rubles) but their sales have also declined by 7%. This is mainly due to the decline in products based on activated charcoal. The market has over 86 trade brands of anti-diarrheal drugs from 84 companies. The leader is Linctus Linex, followed by Enterosgel (FarmaSile) and Ent"
2025-08-06T16:40:51+00:00,@bezrec,6395,https://t.me/bezrec/6395,"–ü–æ–¥–≤–æ–¥–∏–º –∏—Ç–æ–≥–∏ –æ—á–µ—Ä–µ–¥–Ω–æ–≥–æ –≤—ã–ø—É—Å–∫–∞ —Ä—É–±—Ä–∏–∫–∏ #–∑–∞–ø–∞–∫–æ–≤–∞–ª–∏. –ù–∞ —ç—Ç–æ—Ç —Ä–∞–∑ –º—ã —Å–æ–æ–±—â–∞ –≤—ã–±—Ä–∞–ª–∏ –ª—É—á—à–∏–π –¥–∏–∑–∞–π–Ω —É–ø–∞–∫–æ–≤–∫–∏ —Ä–∞—Å—Ç–≤–æ—Ä–æ–≤ –¥–ª—è –æ—Ä–∞–ª—å–Ω–æ–π —Ä–µ–≥–∏–¥—Ä–∞—Ç–∞—Ü–∏–∏. –¢—Ä–æ–π–∫–∞ –ª–∏–¥–µ—Ä–æ–≤ —à–ª–∞ –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏ –Ω–æ–∑–¥—Ä—è –≤ –Ω–æ–∑–¥—Ä—é: –ø–æ–±–µ–¥–∏—Ç–µ–ª–µ–º —Å—Ç–∞–ª –†–µ–≥–∏–¥—Ä–æ–Ω (¬´–í–∞–ª–µ–Ω—Ç–∞ –§–∞—Ä–º¬ª), –Ω–∞–±—Ä–∞–≤—à–∏–π 28% –≥–æ–ª–æ—Å–æ–≤, –Ω–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ —Å 25% ‚Äî –†–µ–∞–∫–≤–∞—Ç–∞–Ω—Ç (¬´–§–∏–Ω–Ω –§–∞—Ä–º–∞¬ª), 22% –∏ —Ç—Ä–µ—Ç—å–µ –º–µ—Å—Ç–æ ‚Äî —É –ì–∏–¥—Ä–æ–∞–∫—Ç–∏–≤–∞ (Vitateka). –ú–µ–Ω—å—à–µ –≤—Å–µ–≥–æ –≤–∞–º –ø–æ–Ω—Ä–∞–≤–∏–ª–∞—Å—å —É–ø–∞–∫–æ–≤–∫–∞ –ü–æ–ª–∏–≥–∏–¥—Ä–∏–Ω–∞ (Erzig). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-08-06T11:35:04+00:00,@bezrec,6394,https://t.me/bezrec/6394,"–í–°–ü –ø—Ä–æ—Å–∏—Ç ¬´–Ω–µ –∑–∞–∫—Ä—ã–≤–∞—Ç—å—Å—è –æ—Ç –∑–∞—Ä—É–±–µ–∂–Ω—ã—Ö –∏–Ω–Ω–æ–≤–∞—Ü–∏–π –≤ –±–æ—Ä—å–±–µ –∑–∞ –Ω–µ–∑–∞–≤–∏—Å–∏–º–æ—Å—Ç—å¬ª. –î–ª—è –∫–æ–≥–æ-—Ç–æ 1 —Å–µ–Ω—Ç—è–±—Ä—è ‚Äî –Ω–∞—á–∞–ª–æ —É—á–µ–±–Ω–æ–≥–æ –≥–æ–¥–∞, –∞ –¥–ª—è —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ ‚Äî –¥–∞—Ç–∞ –≤—Å—Ç—É–ø–ª–µ–Ω–∏—è –≤ —Å–∏–ª—É –ø—Ä–∞–≤–∏–ª–∞ ¬´–≤—Ç–æ—Ä–æ–π –ª–∏—à–Ω–∏–π¬ª, –∫–æ–≥–¥–∞ –ø—Ä–µ–¥–ø–æ—á—Ç–µ–Ω–∏–µ –≤ –≥–æ—Å–∑–∞–∫—É–ø–∫–∞—Ö –±—É–¥–µ—Ç –æ—Ç–¥–∞–≤–∞—Ç—å—Å—è —Ç–æ–ª—å–∫–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º, –ø—Ä–æ–∏–∑–≤–µ–¥–µ–Ω–Ω—ã–º –≤ –†–æ—Å—Å–∏–∏ –ø–æ –ø–æ–ª–Ω–æ–º—É —Ü–∏–∫–ª—É. –í—Å–µ–≥–æ –Ω–æ–≤—ã–µ –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏—è –º–æ–≥—É—Ç –∑–∞—Ç—Ä–æ–Ω—É—Ç—å 215 –ø–æ–∑–∏—Ü–∏–π, –≤ —Ç–æ–º —á–∏—Å–ª–µ –æ–Ω–∫–æ–ø—Ä–µ–ø–∞—Ä–∞—Ç—ã. –í–æ –í—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–æ–º —Å–æ—é–∑–µ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ (–í–°–ü) –æ–ø–∞—Å–∞—é—Ç—Å—è, —á—Ç–æ —ç—Ç–æ –º–æ–∂–µ—Ç –ø—Ä–∏–≤–µ—Å—Ç–∏ –∫ —Å–Ω–∏–∂–µ–Ω–∏—é –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ —É–≤–µ–ª–∏—á–µ–Ω–∏—é —Ä–∞—Å—Ö–æ–¥–æ–≤ –Ω–∞ –∏—Ö –ø—Ä–∏–æ–±—Ä–µ—Ç–µ–Ω–∏–µ, —Ç.–∫. –Ω–æ–≤–æ–≤–≤–µ–¥–µ–Ω–∏–µ –∫–æ—Å–Ω–µ—Ç—Å—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏–∑ –ø–µ—Ä–µ—á–Ω—è —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º—ã—Ö, –≤ –∫–æ—Ç–æ—Ä—ã–π –≤—Ö–æ–¥—è—Ç –∏ –Ω–µ–∫–æ—Ç–æ—Ä—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏–∑ —Å–ø–∏—Å–∫–∞ –ñ–ù–í–õ–ü. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –∫–∞–∫ –æ—Ç–º–µ—á–∞—é—Ç –≤ –í–°–ü, —ç—Ç–æ –≤—ã–ª—å–µ—Ç—Å—è –≤ –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω—É—é –º–æ–Ω–æ–ø–æ–ª–∏–∑–∞—Ü–∏—é –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤. –°–≤–æ—é –ø–æ–∑–∏—Ü–∏—é —Å –ø—Ä–æ—Å—å–±–æ–π –ø–µ—Ä–µ—Å–º–æ—Ç—Ä–µ—Ç—å –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ –±—É–¥—É—Ç –ø–æ–¥–ø–∞–¥–∞—Ç—å –ø–æ–¥ –º–µ—Ö–∞–Ω–∏–∑–º, –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–∏–∫–∏ –Ω–∞–ø—Ä–∞–≤–∏–ª–∏ –≤ –ú–∏–Ω–∑–¥—Ä–∞–≤ –∏ –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥. –í –í–°–ü –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç –ø—Ä–∏–º–µ–Ω—è—Ç—å ¬´–≤—Ç–æ—Ä–æ–π –ª–∏—à–Ω–∏–π¬ª —Ç–æ–ª—å–∫–æ –¥–ª—è —Å–∞–º–æ–≥–æ –º–∏–Ω–∏–º–∞–ª—å–Ω–æ–≥–æ –ø–µ—Ä–µ—á–Ω—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –∞ –æ—Å—Ç–∞–ª—å–Ω—ã–º ‚Äî –∏–∑ —Å–ø–∏—Å–∫–∞ —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º—ã—Ö ‚Äî –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª—è—Ç—å –ø—Ä–æ—Ü–µ–Ω—Ç–Ω—ã–µ –ø—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–∞ –Ω–∞ —Ç–æ—Ä–≥–∞—Ö (–ø—Ä–µ—Ñ–µ—Ä–µ–Ω—Ü–∏–∏) –∏ –∏–Ω—ã–µ –º–µ—Ä—ã –ø–æ–¥–¥–µ—Ä–∂–∫–∏. –ü–æ–ª–Ω–æ–π –Ω–µ–∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏ –≤ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ –ª–µ–∫–∞—Ä—Å—Ç–≤ –Ω–µ—Ç –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏ –Ω–∏ –≤ –æ–¥–Ω–æ–π —Å—Ç—Ä–∞–Ω–µ –º–∏—Ä–∞ ‚Äî –≤—Å–µ —Ç–∞–∫ –∏–ª–∏ –∏–Ω–∞—á–µ –∏–º–ø–æ—Ä—Ç–∏—Ä—É—é—Ç –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ –∏ —á–∞—Å—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, ‚Äî –Ω–∞—Å—Ç–∞–∏–≤–∞–µ—Ç —Å–æ–ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—å –í–°–ü –Æ—Ä–∏–π –ñ—É–ª–µ–≤. –ú–∏–Ω–∑–¥—Ä–∞–≤ –Ω–∞ –æ–±—Ä–∞—â–µ–Ω–∏–µ –æ—Ç–≤–µ—Ç–∏–ª —É–∫–ª–æ–Ω—á–∏–≤–æ: –ì–æ–≤–æ—Ä–∏—Ç—å –æ –∫–∞–∫–∏—Ö-–ª–∏–±–æ –∏–∑–º–µ–Ω–µ–Ω–∏—è—Ö –∑–∞–∫—É–ø–æ—á–Ω—ã—Ö –ø—Ä–æ—Ü–µ–¥—É—Ä –∫–∞–∫ –æ —Å–≤–µ—Ä—à–∏–≤—à–µ–º—Å—è —Ñ–∞–∫—Ç–µ, –∞ —Ç–∞–∫–∂–µ –æ–± –∏—Ö –≤—Å—Ç—É–ø–ª–µ–Ω–∏–∏ –≤ —Å–∏–ª—É —Å –∫–æ–Ω–∫—Ä–µ—Ç–Ω–æ–π –¥–∞—Ç—ã —Å—á–∏—Ç–∞–µ–º –ø—Ä–µ–∂–¥–µ–≤—Ä–µ–º–µ–Ω–Ω—ã–º, —Ç.–∫. –ø—Ä–æ–µ–∫—Ç –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ ¬´–û–± —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏–∏ –ø–æ—Ä—è–¥–∫–∞ –∏ –∫—Ä–∏—Ç–µ—Ä–∏–µ–≤ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—è –ø–µ—Ä–µ—á–Ω—è –°–ó–õ–°¬ª —Å–µ–π—á–∞—Å –ø—Ä–æ—Ö–æ–¥–∏—Ç –ø—Ä–æ—Ü–µ–¥—É—Ä—É –º–µ–∂–≤–µ–¥–æ–º—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ —Å–æ–≥–ª–∞—Å–æ–≤–∞–Ω–∏—è. –í –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–µ –æ—Ç –∫–æ–º–º–µ–Ω—Ç–∞—Ä–∏–µ–≤ –≤–æ–∑–¥–µ—Ä–∂–∞–ª–∏—Å—å. –í —É—Å–ø–µ—Ö ¬´–≤—Ç–æ—Ä–æ–≥–æ –ª–∏—à–Ω–µ–≥–æ¬ª –Ω–µ –≤–µ—Ä—è—Ç –∏ —Ñ–∞—Ä–º–∞—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ ‚Äî –≤ —Ñ–µ–≤—Ä–∞–ª–µ –ø–æ–¥ –æ–±—Ä–∞—â–µ–Ω–∏–µ–º –∫ –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—é –ì–æ—Å–¥—É–º—ã –í—è—á–µ—Å–ª–∞–≤—É –í–æ–ª–æ–¥–∏–Ω—É –∏ –ø—Ä–æ—Ñ–∏–ª—å–Ω—ã–º –¥–µ–ø—É—Ç–∞—Ç–∞–º —Å –ø—Ä–æ—Å—å–±–æ–π —Å–¥–≤–∏–Ω—É—Ç—å –º–µ—Ö–∞–Ω–∏–∑–º –Ω–∞ 2027 –≥–æ–¥ –ø–æ–¥–ø–∏—Å–∞–ª–∏—Å—å –ê—Å—Å–æ—Ü–∏–∞—Ü–∏—è —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π (–ê–†–§–ü), –∞ —Ç–∞–∫–∂–µ ¬´–ò–Ω—Ñ–∞—Ä–º–∞¬ª –∏ ¬´–õ–µ–∫–º–µ–¥–æ–±—Ä–∞—â–µ–Ω–∏–µ¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, regulation"",
  ""impact"": ""high"",
  ""english"": ""The Federation of Russian Patients (FSP) is concerned that this could lead to reduced access to medicines and increased costs for patients, as the new restrictions will affect drugs on the strategic list. The FSP suggests applying 'second extra' only to a minimal list of drugs and providing preferential treatment for the rest on the strategic list. The Ministry of Health responded ambiguously, stating that changes in procurement procedures are premature and the project is still undergoing inter-ministerial consultations. The pharmaceutical industry does not believe in 'second extra' and signed a petition to postpone the mechanism until 2027.""
}"
2025-08-06T09:00:42+00:00,@bezrec,6393,https://t.me/bezrec/6393,"–í—Å–ø–æ–º–Ω–∏—Ç—å –ø—Ä–æ ¬´–≥–ª–∞–≤–Ω—ã–π —ç–∫—Å–ø–æ—Ä—Ç–Ω—ã–π –ø—Ä–æ–¥—É–∫—Ç —Ä–æ—Å—Å–∏–π—Å–∫–æ–π —Ñ–∞—Ä–º—ã¬ª —Å–ø–µ—Ü–ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª—è –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç–∞ –ø–æ –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–æ–Ω–Ω–æ-—ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–º—É —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤—É —Å –∑–∞—Ä—É–±–µ–∂–Ω—ã–º–∏ —Å—Ç—Ä–∞–Ω–∞–º–∏ –∑–∞—Å—Ç–∞–≤–∏–ª–∞ –ø—É–±–ª–∏–∫–∞—Ü–∏—è –†–æ–±–µ—Ä—Ç–∞ –ö–µ–Ω–Ω–µ–¥–∏-–º–ª–∞–¥—à–µ–≥–æ. –í –Ω–µ–π –º–∏–Ω–∏—Å—Ç—Ä –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –°–®–ê –∑–∞—è–≤–∏–ª, —á—Ç–æ –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–µ —É–ø—Ä–∞–≤–ª–µ–Ω–∏–µ –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–Ω—ã—Ö –±–∏–æ–º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–æ–∫ (BARDA) –ø—Ä–µ–∫—Ä–∞—â–∞–µ—Ç –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–∏ –≤ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫—É –º–†–ù–ö-–≤–∞–∫—Ü–∏–Ω –∏–∑-–∑–∞ –∏—Ö –Ω–µ—ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –ø—Ä–æ—Ç–∏–≤ –∏–Ω—Ñ–µ–∫—Ü–∏–π –≤–µ—Ä—Ö–Ω–∏—Ö –¥—ã—Ö–∞—Ç–µ–ª—å–Ω—ã—Ö –ø—É—Ç–µ–π, –≤ —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, COVID-19 –∏ –≥—Ä–∏–ø–ø–∞. ¬´–ò—Å—Ç–∏–Ω–∞ –≤—Å–µ–≥–¥–∞ –≤—ã—Ö–æ–¥–∏—Ç –Ω–∞—Ä—É–∂—É. –ò–Ω–æ–≥–¥–∞ —Å–ª–∏—à–∫–æ–º –ø–æ–∑–¥–Ω–æ¬ª, ‚Äî –¥–æ–±–∞–≤–∏–ª –î–º–∏—Ç—Ä–∏–µ–≤ –Ω–∞ —Å–≤–æ–µ–π —Å—Ç—Ä–∞–Ω–∏—Ü–µ –≤ —Å–æ—Ü—Å–µ—Ç–∏ –•, –Ω–µ –±–µ–∑ –≥–æ—Ä–¥–æ—Å—Ç–∏ –∑–∞ –°–ø—É—Ç–Ω–∏–∫, —Å–æ–∑–¥–∞–Ω–Ω—ã–π –Ω–∞ –æ—Å–Ω–æ–≤–µ –∞–¥–µ–Ω–æ–≤–∏—Ä—É—Å–Ω–æ–≥–æ –≤–µ–∫—Ç–æ—Ä–∞. –ù–∞ –æ—Å–Ω–æ–≤–µ –º–†–ù–ö —Å–¥–µ–ª–∞–Ω—ã –≤–∞–∫—Ü–∏–Ω—ã –æ—Ç –∫–æ—Ä–æ–Ω–∞–≤–∏—Ä—É—Å–∞ –∫–æ–º–ø–∞–Ω–∏–π Pfizer –∏ Modern–∞. –¢–µ—Ö–Ω–æ–ª–æ–≥–∏—è –Ω–µ —á—É–∂–¥–∞ –∏ –†–æ—Å—Å–∏–∏ ‚Äî –≤ —Ñ–µ–≤—Ä–∞–ª–µ –ú–∏—Ö–∞–∏–ª –ú–∏—à—É—Å—Ç–∏–Ω –ø–æ–¥–ø–∏—Å–∞–ª —Ä–∞—Å–ø–æ—Ä—è–∂–µ–Ω–∏–µ –æ —Å–æ–∑–¥–∞–Ω–∏–∏ —Ü–µ–Ω—Ç—Ä–∞ –º–†–ù–ö-—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –ø–æ –ø–æ—Ä—É—á–µ–Ω–∏—é –í–ª–∞–¥–∏–º–∏—Ä–∞ –ü—É—Ç–∏–Ω–∞. –ù–∞–ø–æ–º–Ω–∏–º, –≤ –∏—é–Ω–µ –ø—Ä–æ—à–ª–æ–≥–æ –≥–æ–¥–∞ –î–º–∏—Ç—Ä–∏–µ–≤ —Ä–∞—Å—Å–∫–∞–∑—ã–≤–∞–ª, –∫–∞–∫–∏–µ –∫–æ–∑–Ω–∏ –ø—Ä–æ—Ç–∏–≤ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–π –≤–∞–∫—Ü–∏–Ω—ã —Å—Ç—Ä–æ–∏–ª–∏ –Ω–µ–¥–æ–±—Ä–æ—Å–æ–≤–µ—Å—Ç–Ω—ã–µ –∫–æ–Ω–∫—É—Ä–µ–Ω—Ç—ã. –ü–æ —Å–ª–æ–≤–∞–º –≥–ª–∞–≤—ã –†–§–ü–ò, —Å –Ω–∞—á–∞–ª–∞ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –±—ã–ª–æ –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–Ω–æ –±–æ–ª–µ–µ 300 –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω—ã—Ö –∞—Ç–∞–∫ –Ω–∞ –ø—Ä–æ–¥—É–∫—Ç—ã —Å–µ–º–µ–π—Å—Ç–≤–∞ –°–ø—É—Ç–Ω–∏–∫. –ö–∞–º–ø–∞–Ω–∏—è –ø—Ä–æ—Ç–∏–≤ —Ä–æ—Å—Å–∏–π—Å–∫–æ–π –≤–∞–∫—Ü–∏–Ω—ã –≤–µ–ª–∞—Å—å —á–µ—Ä–µ–∑ —Ñ–µ–π–∫–æ–≤—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ –≤ ¬´–ª–µ–≤—ã—Ö¬ª –∞–∫–∫–∞—É–Ω—Ç–∞—Ö –∏ –∞–Ω–≥–∞–∂–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö —ç–∫—Å–ø–µ—Ä—Ç–æ–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-08-06T05:33:21+00:00,@bezrec,6392,https://t.me/bezrec/6392,"–ù–∞ –ø—Ä–æ—à–ª–æ–π –Ω–µ–¥–µ–ª–µ —Ä–∞—Å—Å–∫–∞–∑—ã–≤–∞–ª–∏ –ø—Ä–æ —Ä–µ–∑–∏–¥–µ–Ω—Ç–∞ –û–≠–ó ¬´–î—É–±–Ω–∞¬ª ‚Äî –û–û–û ¬´–ê–ª—Å–∏–≥–º–∞¬ª ‚Äî ¬´–¥–æ—á–∫—É¬ª –ê–û ¬´–ê–ª—Ç–µ–≥—Ä–∞¬ª. –°–µ–≥–æ–¥–Ω—è –Ω–∞—Å—Ç–∞–ª–∞ –æ—á–µ—Ä–µ–¥—å –º–∞—Ç–µ—Ä–∏–Ω—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ —Å—Ç–∞—Ç—å –≥–µ—Ä–æ–µ–º —Ä—É–±—Ä–∏–∫–∏ #–í–æ–ª—à–µ–±–Ω–∏–∫–∏–°—Ç—Ä–∞–Ω—ã–û–≠–ó. –ò –ø–æ–≤–æ–¥ –∏–º–µ–µ—Ç—Å—è ‚Äî –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏–µ –∑–∞–ø—É—Å—Ç–∏–ª–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –ø–µ—Ä–≤—ã—Ö –æ–ø—ã—Ç–Ω—ã—Ö –ø–∞—Ä—Ç–∏–π –±–µ—Ç–∞-–ª–∞–∫—Ç–∞–º–Ω—ã—Ö –∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫–æ–≤. –í —ç—Ç–æ–º –≥–æ–¥—É –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è –∑–∞–≤–µ—Ä—à–∏–ª–∞ —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–æ —Ü–µ—Ö–∞ —Ç–≤–µ—Ä–¥—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Ñ–æ—Ä–º –±–µ—Ç–∞-–ª–∞–∫—Ç–∞–º–Ω—ã—Ö –∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫–æ–≤. –ò–Ω–≤–µ—Å—Ç–∏—Ü–∏–∏ –≤ –µ–≥–æ —Å–æ–∑–¥–∞–Ω–∏–µ —Å–æ—Å—Ç–∞–≤–∏–ª–∏ 200 –º–ª–Ω —Ä—É–±–ª–µ–π. –ó–∞–ø—É—Å–∫ –Ω–æ–≤–æ–≥–æ —É—á–∞—Å—Ç–∫–∞ –ø–æ–∑–≤–æ–ª–∏—Ç —É–≤–µ–ª–∏—á–∏—Ç—å —á–∏—Å–ª–æ –≤—ã–ø—É—Å–∫–∞–µ–º—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –¥–æ 40, –∞ –≤ –≥–æ–¥ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç—å –±–æ–ª–µ–µ 70 –º–ª–Ω –∫–∞–ø—Å—É–ª –∏ –æ–∫–æ–ª–æ 150 –º–ª–Ω —Ç–∞–±–ª–µ—Ç–æ–∫, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∞ –∑–∞–º–ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—è –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ ‚Äì –º–∏–Ω–∏—Å—Ç—Ä –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–π, –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏ –∏ –Ω–∞—É–∫–∏ –ú–æ—Å–∫–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –ï–∫–∞—Ç–µ—Ä–∏–Ω–∞ –ó–∏–Ω–æ–≤—å–µ–≤–∞. –£–∂–µ –æ—Å–µ–Ω—å—é –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –ø–æ–ª—É—á–µ–Ω–∏–µ –ª–∏—Ü–µ–Ω–∑–∏–∏ –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–∞ –¥–ª—è –Ω–∞—á–∞–ª–∞ —Å–µ—Ä–∏–π–Ω–æ–≥–æ –≤—ã–ø—É—Å–∫–∞ –Ω–æ–≤—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –∏—Ö –ø—Ä–æ–¥–∞–∂–∏ –≤ –∞–ø—Ç–µ–∫–∞—Ö. –†–∞–Ω–µ–µ –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç—ã –æ—Ç ¬´–ê–ª—Ç–µ–≥—Ä—ã¬ª –ø—Ä–∏–º–µ–Ω—è–ª–∞—Å—å —Ç–æ–ª—å–∫–æ –≤ —É—Å–ª–æ–≤–∏—è—Ö –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏–π, –≤ —á–∞—Å—Ç–Ω–æ—Å—Ç–∏ ‚Äî –≤ —Ä–µ–∞–Ω–∏–º–∞—Ü–∏—è—Ö, –∞ —Ç–∞–∫–∂–µ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –≥–æ—Å–ø–∏—Ç–∞–ª—å–Ω—ã—Ö –∏ —Ç—è–∂–µ–ª—ã—Ö –≤–Ω–µ–±–æ–ª—å–Ω–∏—á–Ω—ã—Ö –∏–Ω—Ñ–µ–∫—Ü–∏–π –≤ —É—Ä–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π –ø—Ä–∞–∫—Ç–∏–∫–µ, –∞–±–¥–æ–º–∏–Ω–∞–ª—å–Ω–æ–π —Ö–∏—Ä—É—Ä–≥–∏–∏, –ø—É–ª—å–º–æ–Ω–æ–ª–æ–≥–∏–∏. –ë–µ—Ç–∞-–ª–∞–∫—Ç–∞–º–Ω—ã–µ –∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫–∏ –ø—Ä–µ–¥–Ω–∞–∑–Ω–∞—á–µ–Ω—ã –¥–ª—è –±–æ—Ä—å–±—ã —Å –±–∞–∫—Ç–µ—Ä–∏–∞–ª—å–Ω—ã–º–∏ –∏–Ω—Ñ–µ–∫—Ü–∏—è–º–∏ —Å –ø–æ–º–æ—â—å—é –æ—Å–æ–±–µ–Ω–Ω–æ–π —Å—Ç—Ä—É–∫—Ç—É—Ä—ã –¥–ª—è —É–Ω–∏—á—Ç–æ–∂–µ–Ω–∏—è –±–∞–∫—Ç–µ—Ä–∏–π. –ö –Ω–∏–º –æ—Ç–Ω–æ—Å—è—Ç—Å—è, –Ω–∞–ø—Ä–∏–º–µ—Ä, –ø–µ–Ω–∏—Ü–∏–ª–ª–∏–Ω—ã, —Ü–µ—Ñ–∞–ª–æ—Å–ø–æ—Ä–∏–Ω—ã, –∫–∞—Ä–±–∞–ø–µ–Ω–µ–º—ã –∏ –º–æ–Ω–æ–±–∞–∫—Ç–∞–º—ã. –ú—ã –ø–æ—Å—Ç–æ—è–Ω–Ω–æ —Ä–∞–±–æ—Ç–∞–µ–º –Ω–∞–¥ —É–≤–µ–ª–∏—á–µ–Ω–∏–µ–º –ø–æ—Ä—Ç—Ñ–µ–ª—è –∫–æ–º–ø–∞–Ω–∏–∏ ‚Äî –Ω–∞ –¥–∞–Ω–Ω—ã–π –º–æ–º–µ–Ω—Ç –Ω–∞–ª–∞–¥–∏–ª–∏ –≤—ã–ø—É—Å–∫ 34 –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤, –µ—â–µ 24 –Ω–∞—Ö–æ–¥—è—Ç—Å—è –≤ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ, ‚Äî –ø–æ–¥–µ–ª–∏–ª–∞—Å—å —É—Å–ø–µ—Ö–∞–º–∏ –≥–µ–Ω–µ—Ä–∞–ª—å–Ω—ã–π –¥–∏—Ä–µ–∫—Ç–æ—Ä ¬´–ê–ª—Ç–µ–≥—Ä—ã¬ª –û–ª—å–≥–∞ –¢—É—Ä—á–∞–Ω–∏–Ω–æ–≤–∞. ¬´–ê–ª—Ç–µ–≥—Ä–∞¬ª —Ä–∞–±–æ—Ç–∞–µ—Ç –≤ –û–≠–ó ¬´–î—É–±–Ω–∞¬ª —Å 2021 –≥–æ–¥–∞. –¢—É—Ä—á–∞–Ω–∏–Ω–æ–≤–∞ –≤–æ–∑–≥–ª–∞–≤–ª—è–µ—Ç –∫–æ–º–ø–∞–Ω–∏—é —Å –º–æ–º–µ–Ω—Ç–∞ –µ—ë –æ—Å–Ω–æ–≤–∞–Ω–∏—è. –ß–∏—Å–ª–µ–Ω–Ω–æ—Å—Ç—å —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤ –∑–∞ —Ç—Ä–∏ –≥–æ–¥–∞ –≤—ã—Ä–æ—Å–ª–∞ —Å 9 –¥–æ 113 —á–µ–ª–æ–≤–µ–∫. –ö–æ–º–ø–∞–Ω–∏—è –º–æ–∂–µ—Ç –ø–æ—Ö–≤–∞—Å—Ç–∞—Ç—å—Å—è —Ö–æ—Ä–æ—à–∏–º–∏ —Ñ–∏–Ω–∞–Ω—Å–æ–≤—ã–º–∏ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º–∏ –∑–∞ 2024 –≥–æ–¥. –ü–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å 2023 –≥–æ–¥–æ–º –≤—ã—Ä—É—á–∫–∞ –≤—ã—Ä–æ—Å–ª–∞ –±–æ–ª–µ–µ —á–µ–º –≤ 2 —Ä–∞–∑–∞ ‚Äî –¥–æ 2,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ü—Ä–∏–±—ã–ª—å —É–≤–µ–ª–∏—á–∏–ª–∞—Å—å —Å 674,8 –º–ª–Ω —Ä—É–±–ª–µ–π –¥–æ 1 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –†–µ–Ω—Ç–∞–±–µ–ª—å–Ω–æ—Å—Ç—å –ø–æ —á–∏—Å—Ç–æ–π –ø—Ä–∏–±—ã–ª–∏ (38%) –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ –ø—Ä–µ–≤—ã—à–∞–µ—Ç —Å—Ä–µ–¥–Ω–∏–π –æ—Ç—Ä–∞—Å–ª–µ–≤–æ–π –ø–æ–∫–∞–∑–∞—Ç–µ–ª—å (-24%). –ü–æ –≤—ã—Ä—É—á–∫–µ ¬´–ê–ª—Ç–µ–≥—Ä–∞¬ª –∑–∞–Ω–∏–º–∞–µ—Ç 16 –º–µ—Å—Ç–æ –≤ —Ä–µ–≥–∏–æ–Ω–µ –∏ 69 –≤ –†–æ—Å—Å–∏–∏. –û–¥–Ω–∞–∫–æ –µ—Å—Ç—å –∏ –Ω–µ–∫–æ—Ç–æ—Ä—ã–µ —Ä–∏—Å–∫–∏, –Ω–∞ –∫–æ—Ç–æ—Ä—ã–µ —É–∫–∞–∑—ã–≤–∞—é—Ç —Ñ–∏–Ω–∞–Ω—Å–æ–≤—ã–µ –∫–æ—ç—Ñ—Ñ–∏—Ü–∏–µ–Ω—Ç—ã: –æ—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω—ã–π –∫–æ—ç—Ñ—Ñ–∏—Ü–∏–µ–Ω—Ç –æ–±–µ—Å–ø–µ—á–µ–Ω–Ω–æ—Å—Ç–∏ —Å–æ–±—Å—Ç–≤–µ–Ω–Ω—ã–º–∏ —Å—Ä–µ–¥—Å—Ç–≤–∞–º–∏ (-1,25) –∏ –∞–≤—Ç–æ–Ω–æ–º–∏—è –Ω–∏–∂–µ –æ–ø—Ç–∏–º–∞–ª—å–Ω–æ–≥–æ —É—Ä–æ–≤–Ω—è (0,47). –≠—Ç–æ –º–æ–∂–µ—Ç –≥–æ–≤–æ—Ä–∏—Ç—å –æ –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏ –æ—Ç –∑–∞–µ–º–Ω–æ–≥–æ —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è. –í–ø—Ä–æ—á–µ–º, –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–∞—è —á–∞—Å—Ç—å –∞–∫—Ç–∏–≤–æ–≤ –æ–±–µ—Å–ø–µ—á–∏–≤–∞–µ—Ç—Å—è –∑–∞ —Å—á—ë—Ç –Ω–∞–¥–µ–∂–Ω—ã—Ö –∏ —É—Å—Ç–æ–π—á–∏–≤—ã—Ö –∏—Å—Ç–æ—á–Ω–∏–∫–æ–≤, —á—Ç–æ —Å–≤–∏–¥–µ—Ç–µ–ª—å—Å—Ç–≤—É–µ—Ç –æ —Å—Ç–∞–±–∏–ª—å–Ω–æ—Å—Ç–∏ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""A new production line for beta-lactam antibiotics has been launched by Alterra, a subsidiary of Altsigma. The company plans to start selling the new drugs in pharmacies starting this fall after obtaining a license from the Ministry of Industry and Trade. The company has already been used in hospitals for treating various infections, including those affecting the lungs and abdomen. Alterra has a portfolio of 34 medicines currently in production, with another 24 under development. The company's financial performance is good but there are some risks indicated by its financial coefficients such as a negative net asset coverage ratio (-1.25) and low autonomy (0.47).""
}"
2025-08-05T14:25:08+00:00,@bezrec,6391,https://t.me/bezrec/6391,"¬´–°—Ç–æ–ª–∏—á–∫–∏¬ª –ø—Ä–æ–¥–æ–ª–∂–∞—é—Ç –∏—Å–ø—ã—Ç—ã–≤–∞—Ç—å –ø–æ—Å–ª–µ–¥—Å—Ç–≤–∏—è –∫–∏–±–µ—Ä–∞—Ç–∞–∫–∏. –ù–µ—Å–º–æ—Ç—Ä—è –Ω–∞ –≤—Å–µ –∑–∞—è–≤–ª–µ–Ω–∏—è, —á—Ç–æ —Å–µ—Ç—å –∞–ø—Ç–µ–∫ ¬´–°—Ç–æ–ª–∏—á–∫–∏¬ª –≤–æ–∑–æ–±–Ω–æ–≤–ª—è–µ—Ç —Å–≤–æ—é —Ä–∞–±–æ—Ç—É (–≤ —Ç–æ–º —á–∏—Å–ª–µ –∏ –Ω–∞ –æ—Ñ–æ—Ä–º–ª–µ–Ω–∏–µ –∑–∞–∫–∞–∑–æ–≤), –Ω–∞ –¥–µ–ª–µ, –≤–æ–∑–º–æ–∂–Ω–æ, –≤—Å—ë –Ω–µ —Ç–∞–∫ —Ö–æ—Ä–æ—à–æ. –ü–æ–º–∏–º–æ –¥–∏—Å–∫–æ–Ω—Ç–Ω–æ–π —Å–∏—Å—Ç–µ–º—ã, —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–∏ –≤—Å—ë –µ—â—ë –Ω–µ –∏–º–µ—é—Ç –¥–æ—Å—Ç—É–ø–∞ –∫ —Å–∏—Å—Ç–µ–º–µ –∑–∞–∫–∞–∑–æ–≤ ‚Äî –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –ø—Ä–æ–¥–∞—é—Ç—Å—è —Ç–æ–ª—å–∫–æ –∏–∑ –Ω–∞–ª–∏—á–∏—è, –∞ –∑–∞–∫–∞–∑–∞—Ç—å –Ω–æ–≤—ã–µ –Ω–µ–≤–æ–∑–º–æ–∂–Ω–æ. –ü—Ä–∏ —ç—Ç–æ–º, –ø–æ –¥–∞–Ω–Ω—ã–º Mash, –ª–∏—á–Ω—ã–µ –¥–∞–Ω–Ω—ã–µ –∫–ª–∏–µ–Ω—Ç–æ–≤ –∞–ø—Ç–µ–∫ ¬´–°—Ç–æ–ª–∏—á–∫–∏¬ª –∏ ¬´–ù–µ–æ—Ñ–∞—Ä–º–∞¬ª —É–≥–Ω–∞–ª–∏ —Ö–∞–∫–µ—Ä—ã, –∞ —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–∏ –Ω–µ –º–æ–≥—É—Ç –ø–æ–ª—É—á–∏—Ç—å –∑–∞—Ä–ø–ª–∞—Ç—É –∏–∑-–∑–∞ –Ω–µ–≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ —Å—Ñ–æ—Ä–º–∏—Ä–æ–≤–∞—Ç—å –æ—Ç—á—ë—Ç—ã –ø–æ —Ä–∞–±–æ—Ç–µ –∑–∞ –º–µ—Å—è—Ü. –†–æ—Å–∫–æ–º–Ω–∞–¥–∑–æ—Ä –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é –æ–± —É—Ç–µ—á–∫–µ –¥–∞–Ω–Ω—ã—Ö –Ω–µ –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–∞–µ—Ç. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-08-05T12:18:44+00:00,@bezrec,6389,https://t.me/bezrec/6389,"–õ–µ—Ç–æ ‚Äî —Å–µ–∑–æ–Ω —Ä–æ—Ç–∞–≤–∏—Ä—É—Å–∞. –ß—Ç–æ–±—ã –≤–æ—Å–ø–æ–ª–Ω–∏—Ç—å –∂–∏–¥–∫–æ—Å—Ç—å –∏ —ç–ª–µ–∫—Ç—Ä–æ–ª–∏—Ç—ã, –≤—Ä–∞—á–∏ —Ä–µ–∫–æ–º–µ–Ω–¥—É—é—Ç –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å —Ä–∞—Å—Ç–≤–æ—Ä—ã –¥–ª—è –æ—Ä–∞–ª—å–Ω–æ–π —Ä–µ–≥–∏–¥—Ä–∞—Ç–∞—Ü–∏–∏. –û–Ω–∏-—Ç–æ –∏ —Å—Ç–∞–ª–∏ –≥–µ—Ä–æ—è–º–∏ –Ω–æ–≤–æ–≥–æ –≤—ã–ø—É—Å–∫–∞ —Ä—É–±—Ä–∏–∫–∏ #–∑–∞–ø–∞–∫–æ–≤–∞–ª–∏. –ü—Ä–æ—Å–∏–º –≤ –æ–ø—Ä–æ—Å–µ –≤—ã–±—Ä–∞—Ç—å –æ–¥–∏–Ω –∏–∑ –ø—è—Ç–∏ –≤–∞—Ä–∏–∞–Ω—Ç–æ–≤, –∏—Å—Ö–æ–¥—è –∏—Å–∫–ª—é—á–∏—Ç–µ–ª—å–Ω–æ –∏–∑ –¥–∏–∑–∞–π–Ω–∞ —É–ø–∞–∫–æ–≤–∫–∏: 1. –†–µ–≥–∏–¥—Ä–æ–Ω (¬´–í–∞–ª–µ–Ω—Ç–∞ –§–∞—Ä–º¬ª); 2. –¢—Ä–∏–≥–∏–¥—Ä–æ—Å–æ–ª—å (¬´–ú–∞—Ä–±–∏–æ—Ñ–∞—Ä–º¬ª); 3. –†–µ–∞–∫–≤–∞—Ç–∞–Ω—Ç (¬´–§–∏–Ω–Ω –§–∞—Ä–º–∞¬ª); 4. –ü–æ–ª–∏–≥–∏–¥—Ä–∏–Ω (Erzig); 5. –ì–∏–¥—Ä–æ–∞–∫—Ç–∏–≤ (Vitateka) ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""A survey is asking people to choose one of five oral rehydration solution brands based on packaging design: 1. Regidron (Valenta Farm); 2. Triglycose (Marbiofarm); 3. Reactant (Finn Farma); 4. Polyglycin; 5. Hydroactiv (Vitateka).""
}"
2025-08-05T09:01:46+00:00,@bezrec,6388,https://t.me/bezrec/6388,"¬´–†-—Ñ–∞—Ä–º¬ª —Å—É–¥–∏—Ç—Å—è —Å ¬´–†–∞–π—Ñ—Ñ–∞–π–∑–µ–Ω–±–∞–Ω–∫–æ–º¬ª –∏–∑-–∑–∞ –Ω–µ–ø—Ä–æ–¥–∞–Ω–Ω–æ–≥–æ –∑–∞–≤–æ–¥–∞. –°—Ç—Ä—É–∫—Ç—É—Ä–∞ ¬´–†-—Ñ–∞—Ä–º¬ª ‚Äì –û–û–û ¬´–†-—Ñ–∞—Ä–º –∏–Ω—Ç–µ—Ä–Ω–µ—à–Ω–ª¬ª ‚Äì –ø–æ–¥–∞–ª–∞ –≤ –º–æ—Å–∫–æ–≤—Å–∫–∏–π –∞—Ä–±–∏—Ç—Ä–∞–∂ –∏—Å–∫ –∫ –†–∞–π—Ñ—Ñ–∞–π–∑–µ–Ω–±–∞–Ω–∫—É –Ω–∞ 337,5 –º–ª–Ω –µ–≤—Ä–æ (–æ–∫–æ–ª–æ 31 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π). –ö–∞–∫ —É—Ç–≤–µ—Ä–∂–¥–∞—é—Ç –∑–Ω–∞–∫–æ–º—ã–µ —Å –¥–µ–ª–æ–º –∏—Å—Ç–æ—á–Ω–∏–∫–∏, –ø—Ä–∏—á–∏–Ω–æ–π –∏—Å–∫–∞ –º–æ–≥ —Å—Ç–∞—Ç—å —Ç–æ—Ç —Ñ–∞–∫—Ç, —á—Ç–æ ¬´–†–∞–π—Ñ—Ñ–∞–π–∑–µ–Ω–±–∞–Ω–∫¬ª, –Ω–∞–Ω—è—Ç—ã–π –∏—Å—Ç—Ü–æ–º –¥–ª—è –ø—Ä–æ–¥–∞–∂–∏ –∑–∞–≤–æ–¥–∞ –≤ –ò–ª–ª–µ—Ä—Ç–∏—Å—Å–µ–Ω–µ –µ—â—ë –≤ 2023 –≥–æ–¥—É, —Ç–∞–∫ –∏ –Ω–µ —Å–º–æ–≥ –Ω–∞–π—Ç–∏ –∏–Ω–≤–µ—Å—Ç–æ—Ä–∞. –¢–µ–ø–µ—Ä—å —Ä–æ—Å—Å–∏–π—Å–∫–∞—è –∫–æ–º–ø–∞–Ω–∏—è, —è–∫–æ–±—ã, —Ö–æ—á–µ—Ç –ø–æ–ª—É—á–∏—Ç—å –æ—Ç –±–∞–Ω–∫–∞ –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏—é –∑–∞ –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–∏ –≤ –∑–∞–≤–æ–¥, –Ω–µ–¥–æ–ø–æ–ª—É—á–µ–Ω–Ω—É—é –ø—Ä–∏–±—ã–ª—å –æ—Ç —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ –∞–∫—Ç–∏–≤–∞ –∏ –ø–æ—Ç–µ—Ä—é –∫–æ–Ω—Ç—Ä–∞–∫—Ç–æ–≤ —Å –∫–æ–Ω—Ç—Ä–∞–≥–µ–Ω—Ç–∞–º–∏. –£ ¬´–†–∞–π—Ñ—Ñ–∞–π–∑–µ–Ω–±–∞–Ω–∫–∞¬ª –∫ ¬´–†-–§–∞—Ä–º¬ª —Å–≤–æ–∏ –ø—Ä–µ—Ç–µ–Ω–∑–∏–∏. –í –º–∞–µ 2025 –≥–æ–¥–∞ –Ω–µ–º—Ü—ã –ø–æ–¥–∞–ª–∏ –∏—Å–∫ –ø—Ä–æ—Ç–∏–≤ –∫–æ–º–ø–∞–Ω–∏–∏, –æ—Å–Ω–æ–≤–∞–Ω–Ω–æ–π –ê–ª–µ–∫—Å–µ–µ–º –†–µ–ø–∏–∫–æ–º, –∏ ¬´–†-—Ñ–∞—Ä–º —Ö–æ–ª–¥–∏–Ω–≥¬ª —Å —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–µ–º –≤–∑—ã—Å–∫–∞—Ç—å 29,4 –º–ª–Ω –µ–≤—Ä–æ (2,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π). –ü–æ–¥—Ä–æ–±–Ω–æ—Å—Ç–µ–π —Ç–∞–∫ –∏ –Ω–µ—Ç, —Å—Ç–æ—Ä–æ–Ω—ã –æ—Ç –∫–æ–º–º–µ–Ω—Ç–∞—Ä–∏–µ–≤ –æ—Ç–∫–∞–∑–∞–ª–∏—Å—å. –ü—Ä–µ–¥–ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω–æ, –¥–µ–ª–æ –≤ –∫—Ä–µ–¥–∏—Ç–µ –≤ 50 –º–ª–Ω –µ–≤—Ä–æ, –∫–æ—Ç–æ—Ä—ã–π ¬´–†-–§–∞—Ä–º¬ª –≤ 2021 –≥–æ–¥—É –ø–æ–ª—É—á–∏–ª –Ω–∞ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—é –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –∞–Ω—Ç–∏–∫–æ–≤–∏–¥–Ω—ã—Ö –≤–∞–∫—Ü–∏–Ω –∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ –æ—Å–Ω–æ–≤–µ –º–æ–Ω–æ–∫–ª–æ–Ω–∞–ª—å–Ω—ã—Ö –∞–Ω—Ç–∏—Ç–µ–ª –≤ –ò–ª–ª–µ—Ä—Ç–∏—Å—Å–µ–Ω–µ. –°–ª–µ–¥—É—é—â–µ–µ –∑–∞—Å–µ–¥–∞–Ω–∏–µ –Ω–∞–∑–Ω–∞—á–µ–Ω–æ –Ω–∞ 11 –∞–≤–≥—É—Å—Ç–∞. –†–µ—à–µ–Ω–∏–µ –æ –ø—Ä–æ–¥–∞–∂–µ –∑–∞–≤–æ–¥–∞ –¥–∏—Ä–µ–∫—Ç–æ—Ä –ø–æ —Ä–∞–∑–≤–∏—Ç–∏—é RNC Pharma –ù–∏–∫–æ–ª–∞–π –ë–µ—Å–ø–∞–ª–æ–≤ –Ω–∞–∑–≤–∞–ª ¬´–æ—á–µ–≤–∏–¥–Ω—ã–º¬ª. –ê–Ω–∞–ª–∏—Ç–∏–∫ —Å–≤—è–∑—ã–≤–∞–µ—Ç –µ–≥–æ —Å —Å–∞–Ω–∫—Ü–∏—è–º–∏ –ø—Ä–æ—Ç–∏–≤ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –∫–æ–º–ø–∞–Ω–∏–π –∏ –∫–æ–Ω–∫—Ä–µ—Ç–Ω—ã—Ö –ø–µ—Ä—Å–æ–Ω: –ù–µ—Å–º–æ—Ç—Ä—è –Ω–∞ —Ç–æ, —á—Ç–æ –≤ —Ü–µ–ª–æ–º —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª—å –Ω–µ —Å—Ç–æ–ª–∫–Ω—É–ª–∞—Å—å —Å –∫–∞–∫–∏–º–∏-–ª–∏–±–æ —Å–∏—Å—Ç–µ–º–Ω—ã–º–∏ –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏—è–º–∏, –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏–µ —Å –ø–∞—Ä—Ç–Ω–µ—Ä–∞–º–∏, —Ä–µ–≥—É–ª—è—Ç–æ—Ä–∞–º–∏ –∏ —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–∏–º–∏ —Å–ª—É–∂–±–∞–º–∏ –Ω–∞–≤–µ—Ä–Ω—è–∫–∞ –æ—Å—É—â–µ—Å—Ç–≤–ª—è–µ—Ç—Å—è —Å –æ–≥–ª—è–¥–∫–æ–π. –í–µ—Å—Ç–∏ –±–∏–∑–Ω–µ—Å –≤ —Ç–∞–∫–∏—Ö —É—Å–ª–æ–≤–∏—è—Ö –¥–∞–∂–µ —á–∏—Å—Ç–æ —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–∏ –∫—Ä–∞–π–Ω–µ —Å–ª–æ–∂–Ω–æ, –Ω–µ –≥–æ–≤–æ—Ä—è —É–∂–µ –æ –µ–≥–æ —Ä–∞–∑–≤–∏—Ç–∏–∏. –ü–µ—Ä—Å–ø–µ–∫—Ç–∏–≤—ã ¬´–†-–§–∞—Ä–º¬ª –≤ —Å—É–¥–µ –±—É–¥—É—Ç –∑–∞–≤–∏—Å–µ—Ç—å –∫–∞–∫ –æ—Ç —É—Å–ª–æ–≤–∏–π –¥–æ–≥–æ–≤–æ—Ä–∞ –º–µ–∂–¥—É —Å—Ç–æ—Ä–æ–Ω–∞–º–∏, —Ç–∞–∫ –∏ –æ—Ç —Ç–æ–≥–æ, –ø–æ—á–µ–º—É ¬´–†–∞–π—Ñ—Ñ–∞–π–∑–µ–Ω–±–∞–Ω–∫—É¬ª –Ω–µ —É–¥–∞–ª–æ—Å—å –ø—Ä–æ–¥–∞—Ç—å –∑–∞–≤–æ–¥. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""Russian pharmaceutical company R-Pharm is suing Raiffeisenbank for the non-sale of a factory. The dispute involves an investment and potential compensation issues, with R-Pharm claiming the bank failed to find a buyer for the factory in Illettissen. The case is related to sanctions and potential business difficulties.""
}"
2025-08-05T06:13:57+00:00,@bezrec,6383,https://t.me/bezrec/6383,"–ö–æ–º–ø–∞–Ω–∏—è Data Insight –∑–∞–ø—É—Å—Ç–∏–ª–∞ –±—é–ª–ª–µ—Ç–µ–Ω—å ePharma: –∏–Ω—Ç–µ—Ä–Ω–µ—Ç-–∞–ø—Ç–µ–∫–∏ –≤ –†–æ—Å—Å–∏–∏ ‚Äî –µ–∂–µ–º–µ—Å—è—á–Ω—ã–π –∞–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–∏–π –æ—Ç—á–µ—Ç –æ–± –æ–Ω–ª–∞–π–Ω-—Ä—ã–Ω–∫–µ. –ü—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º –∫–ª—é—á–µ–≤—ã–µ —Ü–∏—Ñ—Ä—ã –∏–∑ –ø–µ—Ä–≤–æ–≥–æ, –º–∞–π—Å–∫–æ–≥–æ –≤—ã–ø—É—Å–∫–∞: üü© –≤ –º–∞–µ 2025 –≥–æ–¥–∞ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç-–∞–ø—Ç–µ–∫–∏ –≤—ã–ø–æ–ª–Ω–∏–ª–∏ 22,6 –º–ª–Ω –∑–∞–∫–∞–∑–æ–≤, —á—Ç–æ –Ω–∞ 5% –º–µ–Ω—å—à–µ, —á–µ–º –≤ –∞–ø—Ä–µ–ª–µ 2025 –≥–æ–¥–∞, –∏ –Ω–∞ 16% –±–æ–ª—å—à–µ, —á–µ–º –≤ –º–∞–µ 2024 –≥–æ–¥–∞; üü© —Å—Ä–µ–¥–Ω–µ—Å—É—Ç–æ—á–Ω–æ–µ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –∑–∞–∫–∞–∑–æ–≤ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –∞–ø—Ä–µ–ª–µ–º —É–º–µ–Ω—å—à–∏–ª–æ—Å—å –Ω–∞ 8%, –¥–æ 728 —Ç—ã—Å. ‚Äî —Ç–∞–∫–∞—è –¥–∏–Ω–∞–º–∏–∫–∞ –æ–±—ä—è—Å–Ω—è–µ—Ç—Å—è —Å–µ–∑–æ–Ω–Ω–æ—Å—Ç—å—é; üü© –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –∞–ø—Ä–µ–ª–µ–º —Ç–µ–º–ø—ã —Ä–æ—Å—Ç–∞ –∫–æ–ª–∏—á–µ—Å—Ç–≤–∞ –∑–∞–∫–∞–∑–æ–≤ –≥–æ–¥ –∫ –≥–æ–¥—É —Å–Ω–∏–∑–∏–ª–∏—Å—å —Å 20% –¥–æ 16%; üü© –æ–±—ä—ë–º –æ–Ω–ª–∞–π–Ω-–ø—Ä–æ–¥–∞–∂ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç-–∞–ø—Ç–µ–∫ –≤ –º–∞–µ —Å–æ—Å—Ç–∞–≤–∏–ª 36 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π (+15% –≥–æ–¥ –∫ –≥–æ–¥—É); üü© —Å—Ä–µ–¥–Ω–∏–π —á–µ–∫ –≤ –º–∞–µ ‚Äî 1,6 —Ç—ã—Å. —Ä—É–±–ª–µ–π (-1% –∑–∞ –≥–æ–¥); üü© –æ–±—ä—ë–º —Ä—ã–Ω–∫–∞ –≤ —Ü–µ–ª–æ–º –∑–∞ 12 –ø–æ—Å–ª–µ–¥–Ω–∏—Ö –º–µ—Å—è—Ü–µ–≤ –¥–æ—Å—Ç–∏–≥ 260 –º–ª–Ω –∑–∞–∫–∞–∑–æ–≤ –∏ –±–æ–ª–µ–µ —á–µ–º 410 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —á—Ç–æ –Ω–∞ 7-8% –≤—ã—à–µ –ø–æ–∫–∞–∑–∞—Ç–µ–ª–µ–π –∫–∞–ª–µ–Ω–¥–∞—Ä–Ω–æ–≥–æ 2024 –≥–æ–¥–∞ –∏ –Ω–∞ 19-23% –≤—ã—à–µ, —á–µ–º –≥–æ–¥–æ–º —Ä–∞–Ω–µ–µ; üü© –≤ –ª–∏–¥–µ—Ä–∞—Ö –ø–æ —É—Ä–æ–≤–Ω—é –ø—Ä–æ–Ω–∏–∫–Ω–æ–≤–µ–Ω–∏—è ePharma ‚Äî –¥–∞–ª—å–Ω–µ–≤–æ—Å—Ç–æ—á–Ω—ã–µ —Ä–µ–≥–∏–æ–Ω—ã ‚Äì –•–∞–±–∞—Ä–æ–≤—Å–∫–∏–π –∫—Ä–∞–π, –ö–∞–º—á–∞—Ç–∫–∞, –ê–º—É—Ä—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å –∏ –ü—Ä–∏–º–æ—Ä—å–µ; üü© –ø–æ –æ—Ö–≤–∞—Ç—É —Ä–µ–≥–∏–æ–Ω–æ–≤ –ª–∏–¥–∏—Ä—É—é—Ç –ø—Ä–æ–µ–∫—Ç—ã, –æ–ø–∏—Ä–∞—é—â–∏–µ—Å—è –Ω–∞ –∞–≥—Ä–µ–≥–∞—Ü–∏—é –∏ –ø–∞—Ä—Ç–Ω–µ—Ä—Å—Ç–≤–∞ ‚Äì ¬´–ê–ø—Ç–µ–∫–∞.—Ä—É¬ª (100% —Ä–µ–≥–∏–æ–Ω–æ–≤), ¬´–Æ—Ç–µ–∫–∞¬ª –∏ ¬´–ú–µ–≥–∞–ø—Ç–µ–∫–∞¬ª (–ø–æ 99%), ¬´–ó–¥—Ä–∞–≤—Å–∏—Ç–∏¬ª (98%), ¬´–ê—Å–Ω–∞¬ª (94%); üü© —Å—Ä–µ–¥–∏ –∞–ø—Ç–µ—á–Ω—ã—Ö —Å–µ—Ç–µ–π –ø–æ –æ—Ö–≤–∞—Ç—É —Ä–µ–≥–∏–æ–Ω–æ–≤ –≤ –æ–Ω–ª–∞–π–Ω–µ –ª–∏–¥–∏—Ä—É–µ—Ç ¬´–ï–∞–ø—Ç–µ–∫–∞¬ª (92%), –∞ —Å—Ä–µ–¥–∏ —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω—ã—Ö —Å–µ—Ç–µ–π ‚Äî ¬´–ê–ø—Ä–µ–ª—å¬ª (90%). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The ePharma bulletin from Data Insight shows that online pharmacies in Russia completed 2.26 million orders in May 2025, a decrease of 5% from April 2025 and an increase of 16% compared to May 2024. The daily average order count decreased by 8% from April, reflecting seasonal trends. Year-over-year growth in orders fell from 20% to 16%. The online pharmacy market volume reached RUB36 billion (+15% year-over-year). Average order value decreased by 1% from the previous year. The market volume over the last 12 months reached 26 million orders and more than RUB410 billion, which is a 7-8% increase over calendar year 2024 and a 19-23% increase compared to the previous year. The Far Eastern regions lead in ePharma penetration ‚Äì Khabarovsk Krai, Kamchatka, Amurskaya Oblast, and Primorsky Kra"
2025-08-04T16:14:58+00:00,@bezrec,6382,https://t.me/bezrec/6382,"–§–ê–° –æ—à—Ç—Ä–∞—Ñ–æ–≤–∞–ª–∞ ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª –∑–∞ —Ä–µ–∫–ª–∞–º—É –°–µ–º–∞–≤–∏–∫–∞. –ö–æ–º–ø–∞–Ω–∏—è –ü–µ—Ç—Ä–∞ –†–æ–¥–∏–æ–Ω–æ–≤–∞ –ø—Ä–æ–≤–∏–Ω–∏–ª–∞—Å—å —Ç–µ–º, —á—Ç–æ –ø—Ä–æ—Ä–µ–∫–ª–∞–º–∏—Ä–æ–≤–∞–ª–∞ —Å–≤–æ–π —Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –≤ —Ö–æ–¥–µ –≥–∞–ª–∞-–∫–æ–Ω—Ü–µ—Ä—Ç–∞ ¬´–ù–æ–≤–∞—è –≤–æ–ª–Ω–∞ 2024¬ª –∏ –≥–∞–ª–∞-—É–∂–∏–Ω–∞ –∂—É—Ä–Ω–∞–ª–∞ ¬´Hello¬ª –≤ –û–ª–∏–º–ø–∏–π—Å–∫–æ–º –ø–∞—Ä–∫–µ –≤ –°–æ—á–∏. –í —Ä–µ—à–µ–Ω–∏–∏ –ø–æ –¥–µ–ª—É –≥–æ–≤–æ—Ä–∏—Ç—Å—è, —á—Ç–æ –Ω–∞ —ç–∫—Ä–∞–Ω–∞—Ö –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–π –º–Ω–æ–≥–æ–∫—Ä–∞—Ç–Ω–æ —Ä–∞–∑–º–µ—â–∞–ª—Å—è —Ä–µ–∫–ª–∞–º–Ω—ã–π —Ä–æ–ª–∏–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –≤ —Ñ–æ–π–µ –∫–æ–Ω—Ü–µ—Ä—Ç–Ω–æ–≥–æ –∑–∞–ª–∞ –Ω–∞ –≤—Å–µ–æ–±—â–µ–µ –æ–±–æ–∑—Ä–µ–Ω–∏–µ –±—ã–ª–∞ –≤—ã—Å—Ç–∞–≤–ª–µ–Ω–∞ —É–≤–µ–ª–∏—á–µ–Ω–Ω–∞—è –≤ —Ä–∞–∑–º–µ—Ä–∞—Ö –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª—å—Å–∫–∞—è —É–ø–∞–∫–æ–≤–∫–∞ –°–µ–º–∞–≤–∏–∫–∞. –°—É–¥—è –ø–æ –≤—Å–µ–º—É, –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å—â–∏–∫–∏ –Ω–∞ –≥–∞–ª–∞-—É–∂–∏–Ω–µ –Ω–µ –ø—Ä–∏—Å—É—Ç—Å—Ç–≤–æ–≤–∞–ª–∏, –ø–æ—Å–∫–æ–ª—å–∫—É –≤—ã—è–≤–∏—Ç—å —Ñ–∞–∫—Ç –Ω–∞—Ä—É—à–µ–Ω–∏—è —Ä–µ–≥—É–ª—è—Ç–æ—Ä—É –ø–æ–º–æ–≥–ª–∏ –≤–∏–¥–µ–æ–∑–∞–ø–∏—Å–∏, –ª—é–±–µ–∑–Ω–æ –ø—Ä–∏–ª–æ–∂–µ–Ω–Ω—ã–µ –∫ –æ–±—Ä–∞—â–µ–Ω–∏—é –û–û–û ¬´–ü—Ä–æ–º–æ–º–µ–¥ –î–ú¬ª. ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª –ø—ã—Ç–∞–ª—Å—è –¥–æ–∫–∞–∑–∞—Ç—å, —á—Ç–æ –Ω–∞ —Å—Ç–µ–Ω–¥–∞—Ö –±—ã–ª–∞ —Ä–∞–∑–º–µ—â–µ–Ω–∞ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è –æ —Å–∞–π—Ç–µ stroynee. pro, –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª—è—é—â–µ–º ¬´—Å–ø—Ä–∞–≤–æ—á–Ω–æ-–∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω—ã–µ —Å–≤–µ–¥–µ–Ω–∏—è –æ –±–æ—Ä—å–±–µ —Å –æ–∂–∏—Ä–µ–Ω–∏–µ–º¬ª, –∫–æ—Ç–æ—Ä—ã–µ –Ω–µ —è–≤–ª—è—é—Ç—Å—è —Ä–µ–∫–ª–∞–º–æ–π. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –≤ –∫–æ–º–ø–∞–Ω–∏–∏ –Ω–∞—Å—Ç–∞–∏–≤–∞–ª–∏, —á—Ç–æ ¬´–Ω–∞ –≤–∏–¥–µ–æ–∑–∞–ø–∏—Å—è—Ö –æ—Ç—Å—É—Ç—Å—Ç–≤—É—é—Ç –¥–∞—Ç—ã –∏—Ö —Å—ä–µ–º–∫–∏, –≤ —Å–≤—è–∑–∏ —Å —á–µ–º –Ω–µ–≤–æ–∑–º–æ–∂–Ω–æ —É—Å—Ç–∞–Ω–æ–≤–∏—Ç—å –¥–∞—Ç—É –∏ –≤—Ä–µ–º—è —Å–æ–±—ã—Ç–∏—è –ø—Ä–µ–¥–ø–æ–ª–∞–≥–∞–µ–º–æ–≥–æ –Ω–∞—Ä—É—à–µ–Ω–∏—è¬ª. –§–ê–° —ç—Ç–∏ –¥–æ–≤–æ–¥—ã –Ω–µ —É–±–µ–¥–∏–ª–∏. –í–µ–¥–æ–º—Å—Ç–≤–æ –ø–æ—Å—Ç–∞–Ω–æ–≤–∏–ª–æ, —á—Ç–æ —Å–ø–æ—Ä–Ω–∞—è —Ä–µ–∫–ª–∞–º–∞ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–∞ —Å –Ω–∞—Ä—É—à–µ–Ω–∏–µ–º —á–∞—Å—Ç–∏ 8 —Å—Ç–∞—Ç—å–∏ 24 –ó–∞–∫–æ–Ω–∞ –æ —Ä–µ–∫–ª–∞–º–µ –∏ –Ω–∞–∫–∞–∑–∞–ª–æ –Ω–∞—Ä—É—à–∏—Ç–µ–ª—è —à—Ç—Ä–∞—Ñ–æ–º –≤ 200 —Ç—ã—Å. —Ä—É–±–ª–µ–π. –ö ¬´–ü—Ä–æ–º–æ–º–µ–¥—É¬ª –≤ —Å–≤–æ—ë –≤—Ä–µ–º—è —Ä–µ–≥—É–ª—è—Ç–æ—Ä –æ–∫–∞–∑–∞–ª—Å—è –±–æ–ª–µ–µ —Å–Ω–∏—Å—Ö–æ–¥–∏—Ç–µ–ª–µ–Ω –∏ –Ω–µ —Å—á—ë–ª –∫–ª–∏–ø ¬´–õ–µ–Ω–∏–Ω–≥—Ä–∞–¥–∞¬ª –∏ –ó–æ–∏ —Ä–µ–∫–ª–∞–º–æ–π –¢–∏—Ä–∑–µ—Ç—Ç—ã. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-08-04T13:29:58+00:00,@bezrec,6381,https://t.me/bezrec/6381,"–ì–∏–Ω—Ü–±—É—Ä–≥ —Ä–∞—Å—Å–∫–∞–∑–∞–ª, –∫–æ–≥–¥–∞ –∏ –≥–¥–µ –ø–µ—Ä–≤—ã–µ –ø–∞—Ü–∏–µ–Ω—Ç—ã –ø–æ–ª—É—á–∞—Ç –≤–∞–∫—Ü–∏–Ω—É –æ—Ç —Ä–∞–∫–∞. –°–æ–≥–ª–∞—Å–Ω–æ —Å—É—â–µ—Å—Ç–≤—É—é—â–µ–º—É –ø–ª–∞–Ω—É, —Å–æ–≥–ª–∞—Å–æ–≤–∞–Ω–Ω–æ–º—É —Å –ú–∏–Ω–∑–¥—Ä–∞–≤–æ–º, –º—ã –¥–æ–ª–∂–Ω—ã –Ω–∞—á–∞—Ç—å –≤ —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–∞–ª—å–Ω–æ–º —Ä–µ–∂–∏–º–µ –≤–≤–æ–¥–∏—Ç—å –≤–∞–∫—Ü–∏–Ω—É –æ—Ç —Ä–∞–∫–∞, —Å–æ–∑–¥–∞–Ω–Ω—É—é –Ω–∞ –æ—Å–Ω–æ–≤–µ –Ω–µ–æ–∞–Ω—Ç–∏–≥–µ–Ω–æ–≤, –≥—Ä—É–ø–ø–µ –±–æ–ª—å–Ω—ã—Ö –º–µ–ª–∞–Ω–æ–º–æ–π –≤ –±–ª–∏–∂–∞–π—à–∏–µ –º–µ—Å—è—Ü—ã, ‚Äî –ø–æ–¥–µ–ª–∏–ª—Å—è –¥–∏—Ä–µ–∫—Ç–æ—Ä –¶–µ–Ω—Ç—Ä–∞ –∏–º. –ì–∞–º–∞–ª–µ–∏. ¬´–ú—ã¬ª ‚Äî —ç—Ç–æ –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–π –∏–Ω—Å—Ç–∏—Ç—É—Ç –∏–º. –ì–µ—Ä—Ü–µ–Ω–∞ –∏ –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–∏–π —Ü–µ–Ω—Ç—Ä –æ–Ω–∫–æ–ª–æ–≥–∏–∏ –∏–º. –ë–ª–æ—Ö–∏–Ω–∞. –£—á—ë–Ω—ã–π –ø–æ–¥—á–µ—Ä–∫–Ω—É–ª, —á—Ç–æ –¶–µ–Ω—Ç—Ä –∏–º. –ì–∞–º–∞–ª–µ–∏ –∑–∞–Ω–∏–º–∞–µ—Ç—Å—è —Ç–æ–ª—å–∫–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ–º –≤–∞–∫—Ü–∏–Ω—ã, –∞ –∑–∞—Ç–µ–º –µ—ë –ø–µ—Ä–µ–¥–∞–¥—É—Ç –≤ –≤—ã—à–µ–Ω–∞–∑–≤–∞–Ω–Ω—ã–µ —É—á—Ä–µ–∂–¥–µ–Ω–∏—è. –£ –ø–µ—Ä—Å–æ–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω–æ–π –æ–Ω–∫–æ–≤–∞–∫—Ü–∏–Ω—ã —Å–æ–≤–µ—Ä—à–µ–Ω–Ω–æ –¥—Ä—É–≥–∞—è —Ä–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞, –∫–æ—Ç–æ—Ä–∞—è –ø—Ä–∏–º–µ–Ω—è–µ—Ç—Å—è –≤–ø–µ—Ä–≤—ã–µ. –¢–µ–º –Ω–µ –º–µ–Ω–µ–µ –Ω–∞—Ö–æ–¥–∏–º –æ–±—â–∏–π —è–∑—ã–∫, –æ–±—â–∏–π –∑–Ω–∞–º–µ–Ω–∞—Ç–µ–ª—å –∏ –¥–≤–∏–∂–µ–º—Å—è –≤–ø–µ—Ä–µ–¥, ‚Äî –¥–æ–±–∞–≤–∏–ª –ì–∏–Ω—Ü–±—É—Ä–≥. –ü–æ —Å–ª–æ–≤–∞–º —ç–∫—Å–ø–µ—Ä—Ç–∞, –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–π —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–æ–π –∞–∫—Ç–∏–≤–Ω–æ –∏–Ω—Ç–µ—Ä–µ—Å—É—é—Ç—Å—è –¥—Ä—É–≥–∏–µ —Å—Ç—Ä–∞–Ω—ã. –ö–∞–∫ —Ä–æ—Å—Å–∏–π—Å–∫–æ–π –≤–∞–∫—Ü–∏–Ω–µ –æ—Ç —Ä–∞–∫–∞ ¬´–ø–µ—Ä–µ–µ—Ö–∞—Ç—å¬ª –∑–∞ —Ä—É–±–µ–∂, –º—ã —Ä–∞—Å—Å–∫–∞–∑—ã–≤–∞–ª–∏ –≤ –æ–¥–Ω–æ–º –∏–∑ –Ω–∞—à–∏—Ö –ø—Ä–µ–¥—ã–¥—É—â–∏—Ö –ø–æ—Å—Ç–æ–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-08-04T10:19:58+00:00,@bezrec,6380,https://t.me/bezrec/6380,"–≠—Ç–æ –Ω–∞ 10,8% –±–æ–ª—å—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É, –ø–æ –ø–æ–¥—Å—á—ë—Ç–∞–º RNC Pharma. –°—Ä–µ–¥–Ω–∏–π —á–µ–∫ –ø–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–º—É –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç—É –≤—ã—Ä–æ—Å –Ω–∞ 13,5%, –¥–æ 615 —Ä—É–±–ª–µ–π, —Ç–æ–≥–¥–∞ –∫–∞–∫ –ø–æ –ø–∞—Ä–∞—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–µ —Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–ª—Å—è –Ω–∞ —É—Ä–æ–≤–Ω–µ 148,5 —Ä—É–±–ª–µ–π, —á—Ç–æ –≤—Å–µ–≥–æ –Ω–∞ 0,8% –≤—ã—à–µ –ø—Ä–æ—à–ª–æ–≥–æ–¥–Ω–∏—Ö –ø–æ–∫–∞–∑–∞—Ç–µ–ª–µ–π. –ù–∏–∑–∫–∏–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –Ω–µ–ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç–∞ –æ—Ç—Ä–∞–∑–∏–ª–∏—Å—å –∏ –Ω–∞ —Ç–µ–º–ø–∞—Ö —Ä–æ—Å—Ç–∞ –≤–µ–ª–∏—á–∏–Ω—ã —Å—Ä–µ–¥–Ω–µ–≥–æ —á–µ–∫–∞ –≤ –∞–ø—Ç–µ–∫–∞—Ö ‚Äî –≤ 2024 –≥–æ–¥—É –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ 2023 –≥–æ–¥–∞ –¥–∏–Ω–∞–º–∏–∫–∞ –±—ã–ª–∞ –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–Ω–∞ –Ω–∞ —É—Ä–æ–≤–Ω–µ 12,4%. –í –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–µ —Ä–µ–≥–∏–æ–Ω–æ–≤ —Å—Ç—Ä–∞–Ω—ã –¥–æ–ª—è –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç–∞ –≤ —Å—Ç—Ä—É–∫—Ç—É—Ä–µ —á–µ–∫–∞ –ø—Ä–µ–≤—ã—à–∞–µ—Ç 80%. –ü–µ—Ä–µ—Ö–æ–¥–∏–º –∫ –≥–µ–æ–≥—Ä–∞—Ñ–∏–∏. –°—Ä–µ–¥–Ω–∏–π —á–µ–∫ –≤—ã—Ä–æ—Å –±–æ–ª–µ–µ —á–µ–º –Ω–∞ 10% –ø–æ—á—Ç–∏ –≤–æ –≤—Å–µ—Ö —Ä–µ–≥–∏–æ–Ω–∞—Ö. –ú–∏–Ω–∏–º–∞–ª—å–Ω–∞—è –¥–∏–Ω–∞–º–∏–∫–∞ (+4%) –æ—Ç–º–µ—á–µ–Ω–∞ –≤ –ú–æ—Å–∫–≤–µ. –í 40 —Ä–µ–≥–∏–æ–Ω–∞—Ö —Å—Ä–µ–¥–Ω–∏–π —á–µ–∫ –ø—Ä–µ–≤—ã—à–∞–ª 700 —Ä—É–±–ª–µ–π –∏ —Ç–æ–ª—å–∫–æ –≤ —à–µ—Å—Ç–∏ –±—ã–ª –Ω–∏–∂–µ 600 —Ä—É–±–ª–µ–π. –ú–∏–Ω–∏–º—É–º –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–Ω –≤ –¢—ã–≤–µ ‚Äî 556 —Ä—É–±–ª–µ–π, –º–∞–∫—Å–∏–º—É–º (1171 —Ä—É–±–ª—å (+9%)) ‚Äî –Ω–∞ –ß—É–∫–æ—Ç–∫–µ ‚Äî –ø—Ä–∏–≤–µ—Ç –Ω–µ —Å–∞–º–æ–º—É –≤—ã–≥–æ–¥–Ω–æ–º—É —Å —Ç–æ—á–∫–∏ –∑—Ä–µ–Ω–∏—è –ª–æ–≥–∏—Å—Ç–∏–∫–∏ —Ä–∞—Å–ø–æ–ª–æ–∂–µ–Ω–∏—é. –ù–µ—Å–º–æ—Ç—Ä—è –Ω–∞ –Ω–∏–∑–∫–∏–µ —Ç–µ–º–ø—ã —Ä–æ—Å—Ç–∞, –ø–æ–∫–∞–∑–∞—Ç–µ–ª—å —Å—Ä–µ–¥–Ω–µ–≥–æ —á–µ–∫–∞ –≤ –ú–æ—Å–∫–≤–µ –æ—Å—Ç–∞—ë—Ç—Å—è –≤—ã—Å–æ–∫–∏–º ‚Äî 1127 —Ä—É–±–ª–µ–π –ø–æ –∏—Ç–æ–≥–∞–º –ø–µ—Ä–≤—ã—Ö —à–µ—Å—Ç–∏ –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞, –∏–∑ –Ω–∏—Ö –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –ø—Ä–∏—à–ª–æ—Å—å 892 —Ä—É–±–ª—è, –∞ –Ω–∞ –ø—Ä–æ—á–∏–π –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç ‚Äî 235 —Ä—É–±–ª–µ–π. –ù–∞ —Ç—Ä–µ—Ç—å–µ–º –º–µ—Å—Ç–µ –ø–æ —Ä–∞–∑–º–µ—Ä—É —Å—Ä–µ–¥–Ω–µ–≥–æ —á–µ–∫–∞ ‚Äî –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥ ‚Äî –∂–∏—Ç–µ–ª–∏ –°–µ–≤–µ—Ä–Ω–æ–π —Å—Ç–æ–ª–∏—Ü—ã –≤ –ø–µ—Ä–≤—ã–µ —à–µ—Å—Ç—å –º–µ—Å—è—Ü–µ–≤ —Ç–µ–∫—É—â–µ–≥–æ –≥–æ–¥–∞ —Ç—Ä–∞—Ç–∏–ª–∏ –≤ –∞–ø—Ç–µ–∫–µ 993 —Ä—É–±–ª—è (+7,4%), –∏–∑ –∫–æ—Ç–æ—Ä—ã—Ö –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–π –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç –ø—Ä–∏—à–ª–æ—Å—å –ø–æ—Ä—è–¥–∫–∞ 791 —Ä—É–±–ª—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The average check has increased by more than 10% in most regions. In Moscow, the growth was minimal at +4%. The average check exceeded 700 rubles in 40 regions and was below 600 rubles only in six. The minimum average check is recorded in Tyva at 556 rubles, while the maximum (+9%) is on Chukotka (1171 ruble), which is not the most advantageous from a logistics perspective. Despite low growth rates, Moscow's average check remains high at 1127 rubles for the first six months of this year, with medicines accounting for 892 rubles and other products for 235 rubles. The average check in St. Petersburg, third on the list, is 993 rubles (+7.4%) for the first six months of this year, with medicines accounting for about 791 rubles.""
}"
2025-08-04T07:19:56+00:00,@bezrec,6379,https://t.me/bezrec/6379,"–°–∏—Å—Ç–µ–º–∞ –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥–∞ –∏ –∞–Ω–∞–ª–∏–∑–∞ –°–ú–ò –∏ —Å–æ—Ü–º–µ–¥–∏–∞ –°–ö–ê–ù-–ò–Ω—Ç–µ—Ä—Ñ–∞–∫—Å –∏ ¬´–ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞¬ª –ø—Ä–µ–¥—Å—Ç–∞–≤–ª—è—é—Ç —Ç–æ–ø-10 –ø—É–±–ª–∏–∫–∞—Ü–∏–π –°–ú–ò –≤ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ –∑–∞ –ø–µ—Ä–≤–æ–µ –ø–æ–ª—É–≥–æ–¥–∏–µ 2025 –≥–æ–¥–∞. üü¢ –ü–µ—Ç—Ä –ë–µ–ª—ã–π —Å—Ç–∞–ª –ø—è—Ç—ã–º —Ä–æ—Å—Å–∏–π—Å–∫–∏–º –º–∏–ª–ª–∏–∞—Ä–¥–µ—Ä–æ–º, –∑–∞—Ä–∞–±–æ—Ç–∞–≤—à–∏–º —Å–æ—Å—Ç–æ—è–Ω–∏–µ –Ω–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ –ª–µ–∫–∞—Ä—Å—Ç–≤. üü¢ –ï–≤—Ä–æ–ø–µ–π—Å–∫–∏–π —Å—É–¥ —é—Å—Ç–∏—Ü–∏–∏ –ø—Ä–∏–∑–Ω–∞–ª, —á—Ç–æ –£—Ä—Å—É–ª–∞ —Ñ–æ–Ω –¥–µ—Ä –õ—è–π–µ–Ω –Ω–∞—Ä—É—à–∏–ª–∞ –ø—Ä–∞–≤–∏–ª–∞ –ø—Ä–æ–∑—Ä–∞—á–Ω–æ—Å—Ç–∏, ¬´–ø–æ—Ç–µ—Ä—è–≤¬ª –°–ú–°-–ø–µ—Ä–µ–ø–∏—Å–∫—É —Å –≥–ª–∞–≤–æ–π Pfizer –ê–ª—å–±–µ—Ä—Ç–æ–º –ë—É—Ä–ª–∞ –ø–æ –∑–∞–∫—É–ø–∫–∞–º –≤–∞–∫—Ü–∏–Ω –ø—Ä–æ—Ç–∏–≤ –∫–æ—Ä–æ–Ω–∞–≤–∏—Ä—É—Å–∞. üü¢ ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª –≤—ã–≤–µ–ª –Ω–∞ —Ä—ã–Ω–æ–∫ –¢–∏—Ä–∑–µ—Ç—Ç—É –¥–ª—è —Å–Ω–∏–∂–µ–Ω–∏—è –≤–µ—Å–∞ ‚Äî –ø–µ—Ä–≤—ã–π —Ä–æ—Å—Å–∏–π—Å–∫–∏–π –¥–∂–µ–Ω–µ—Ä–∏–∫ —Ä–∞–Ω–µ–µ –Ω–µ –¥–æ—Å—Ç—É–ø–Ω–æ–≥–æ –≤ —Å—Ç—Ä–∞–Ω–µ Mounjaro –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–π Eli Lilly. üü¢ Pfizer –ø—Ä–µ–∫—Ä–∞—Ç–∏–ª —Ä–∞–∑—Ä–∞–±–æ—Ç–∫—É –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –æ—Ç –æ–∂–∏—Ä–µ–Ω–∏—è Danuglipron –∏–∑-–∑–∞ —Å–µ—Ä—å–µ–∑–Ω—ã—Ö –ø–æ–±–æ—á–Ω—ã—Ö —ç—Ñ—Ñ–µ–∫—Ç–æ–≤ –Ω–∞ –ø–µ—á–µ–Ω–∏ –æ–¥–Ω–æ–≥–æ –∏–∑ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å–ø—ã—Ç—É–µ–º—ã—Ö. üü¢ –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–æ—Å—Å–∏–∏ –ø—Ä–æ–¥–ª–∏–ª–æ ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º—É¬ª –ø—Ä–∞–≤–æ –≤—ã–ø—É—Å–∫–∞—Ç—å –∞–Ω–∞–ª–æ–≥–∏ –û–∑–µ–º–ø–∏–∫–∞ –±–µ–∑ —Å–æ–≥–ª–∞—Å–∏—è –∑–∞—Ä—É–±–µ–∂–Ω–æ–≥–æ –ø—Ä–∞–≤–æ–æ–±–ª–∞–¥–∞—Ç–µ–ª—è –¥–æ –∫–æ–Ω—Ü–∞ 2025 –≥–æ–¥–∞. üü¢ ¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º –ì—Ä—É–ø–ø¬ª –∏ –ù–ò–ò–ö–≠–õ –ø–æ–¥–ø–∏—Å–∞–ª–∏ –¥–æ–≥–æ–≤–æ—Ä –æ —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–µ –≤ —Å–æ–∑–¥–∞–Ω–∏–∏ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –≤ –æ–±–ª–∞—Å—Ç–∏ –≥–∞—Å—Ç—Ä–æ—ç–Ω—Ç–µ—Ä–æ–ª–æ–≥–∏–∏. –†–∞–∑—Ä–∞–±–æ—Ç–∫—É –ø–ª–∞–Ω–∏—Ä—É—é—Ç –∑–∞–≤–µ—Ä—à–∏—Ç—å –∫ –∫–æ–Ω—Ü—É 2027 –≥–æ–¥–∞. üü¢ ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª –ø–ª–∞–Ω–∏—Ä—É–µ—Ç –∫ 2030 –≥–æ–¥—É –Ω–∞—Ä–∞—Å—Ç–∏—Ç—å –æ–±—ä—ë–º —ç–∫—Å–ø–æ—Ä—Ç–∞ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –¥–æ $3,4 –º–ª—Ä–¥. –ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω–∞—è –ø–ª–æ—â–∞–¥–∫–∞ ¬´–ë–∏–æ—Ö–∏–º–∏–∫¬ª —É–∂–µ –ø—Ä–æ—à–ª–∞ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—é –ø–æ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã–º —Å—Ç–∞–Ω–¥–∞—Ä—Ç–∞–º –∏ –∞—É–¥–∏—Ç –º–∏–Ω–∑–¥—Ä–∞–≤–∞ –ò—Ä–∞–∫–∞. üü¢ ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑¬ª –ø–æ–¥–∞–ª–∞ –¥–æ–∫—É–º–µ–Ω—Ç—ã –Ω–∞ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—é –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–æ–≥–æ –º–∏–µ–ª–æ–∏–¥–Ω–æ–≥–æ –ª–µ–π–∫–æ–∑–∞. üü¢ Sanofi –ø–æ–∫—É–ø–∞–µ—Ç –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫—É—é –±–∏–æ—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫—É—é –∫–æ–º–ø–∞–Ω–∏—é Blueprint Medicines Corporation (Blueprint) –∑–∞ $9,1 –º–ª—Ä–¥. üü¢ –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –ú–æ—Å–∫–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –∏ ¬´–ü–µ—Ç—Ä–æ–≤–∞–∫—Å —Ñ–∞—Ä–º¬ª –∑–∞–∫–ª—é—á–∏–ª–∏ —Å–æ–≥–ª–∞—à–µ–Ω–∏–µ –æ —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–µ, –≤ —Ä–∞–º–∫–∞—Ö –∫–æ—Ç–æ—Ä–æ–≥–æ –∫–æ–º–ø–∞–Ω–∏—è —Ä–µ–∞–ª–∏–∑—É–µ—Ç –ø–µ—Ä–≤—ã–π –≤ –†–æ—Å—Å–∏–∏ –ø—Ä–æ–µ–∫—Ç –ø–æ –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏–∏ –ø–æ–ª–Ω–æ–≥–æ —Ü–∏–∫–ª–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –≤–∞–∫—Ü–∏–Ω—ã –ø—Ä–æ—Ç–∏–≤ –º–µ–Ω–∏–Ω–≥–æ–∫–æ–∫–∫–æ–≤–æ–π –∏–Ω—Ñ–µ–∫—Ü–∏–∏. –û–Ω–æ –±—É–¥–µ—Ç –∑–∞–ø—É—â–µ–Ω–æ –≤ 2026 –≥–æ–¥—É. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, shortage, demand, epidemic"",
  ""impact"": ""high"",
  ""english"": ""A number of topics are discussed including a European Court ruling on transparency issues, the development and regulation of pharmaceuticals in Russia, international mergers and acquisitions (Sanofi's acquisition of Blueprint Medicines Corporation), and the global health landscape with a focus on vaccine production. The impact is significant, affecting regulatory affairs, market access for medicines, and public health.""
}"
2025-08-03T11:03:38+00:00,@bezrec,6378,https://t.me/bezrec/6378,"–í –°–®–ê –ø—Ä–∏–¥—É–º–∞–ª–∏ –æ–±–µ–∑–±–æ–ª–∏–≤–∞—é—â–∏–π ¬´–Ω–∞–∫–æ–ª–µ–Ω–Ω–∏–∫¬ª. Kneeflow –Ω–∞–¥–µ–≤–∞–µ—Ç—Å—è –Ω–∞ –∫–æ–ª–µ–Ω–æ –∏, –∫–∞–∫ —É–≤–µ—Ä—è—é—Ç —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–∏, –∑–∞ 15-–º–∏–Ω—É—Ç–Ω—ã–π —Å–µ–∞–Ω—Å –∏–∑–±–∞–≤–ª—è–µ—Ç –æ—Ç –±–æ–ª–∏, –∫–æ—Ç–æ—Ä–∞—è —á–∞—Å—Ç–æ –≤—Å—Ç—Ä–µ—á–∞–µ—Ç—Å—è —É —Å–ø–æ—Ä—Ç—Å–º–µ–Ω–æ–≤ –∏ —Å—Ç—Ä–∞–¥–∞—é—â–∏—Ö –∞—Ä—Ç—Ä–∏—Ç–æ–º. –í—Å—ë –±–ª–∞–≥–æ–¥–∞—Ä—è –∫–æ–º–±–∏–Ω–∞—Ü–∏–∏ –∏–Ω—Ñ—Ä–∞–∫—Ä–∞—Å–Ω–æ–≥–æ –∏–∑–ª—É—á–µ–Ω–∏—è, —Ç–µ–ø–ª–æ—Ç–µ—Ä–∞–ø–∏–∏ –∏ –¥–µ–ª–∏–∫–∞—Ç–Ω–æ–≥–æ –º–∞—Å—Å–∞–∂–∞. –ò–Ω—Ñ—Ä–∞–∫—Ä–∞—Å–Ω—ã–π —Å–≤–µ—Ç —É—Å–∏–ª–∏–≤–∞–µ—Ç –∫—Ä–æ–≤–æ—Ç–æ–∫ –∏ —Å–Ω–∏–º–∞–µ—Ç –≤–æ—Å–ø–∞–ª–µ–Ω–∏–µ, —Ç–µ–ø–ª–æ–≤–∞—è —Ç–µ—Ä–∞–ø–∏—è —Ä–∞—Å—Å–ª–∞–±–ª—è–µ—Ç –º—ã—à—Ü—ã –∏ –æ–±–ª–µ–≥—á–∞–µ—Ç –±–æ–ª—å, –∞ –º—è–≥–∫–∏–µ –≤–æ–∑–¥—É—à–Ω—ã–µ –ø–æ–¥—É—à–∫–∏ –æ–±–µ—Å–ø–µ—á–∏–≤–∞—é—Ç –±–µ—Ä–µ–∂–Ω—ã–π –º–∞—Å—Å–∞–∂ –∫–æ–ª–µ–Ω–∞. –ó–≤—É—á–∏—Ç –ø—Ä–∏—è—Ç–Ω–æ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-08-02T11:04:22+00:00,@bezrec,6377,https://t.me/bezrec/6377,"–ê–≤–≥—É—Å—Ç ‚Äî –∫–∞–∫ –≤–µ—á–µ—Ä –≤–æ—Å–∫—Ä–µ—Å–µ–Ω—å—è. –ì—Ä—É—Å—Ç–∏—Ç—å –ø–æ —Å—Ç—Ä–µ–º–∏—Ç–µ–ª—å–Ω–æ –ø—Ä–æ—Ö–æ–¥—è—â–µ–º—É –ª–µ—Ç—É –Ω–µ –±—É–¥–µ–º, –∞ –±—É–¥–µ–º —á–∏—Ç–∞—Ç—å –Ω–æ–≤—ã–π –≤—ã–ø—É—Å–∫ —Ä—É–±—Ä–∏–∫–∏ #–≤–¥–æ–≥–æ–Ω–∫—É. üíä –§–ê–° –∏ ¬´–ö—Ä—É–≥ –¥–æ–±—Ä–∞¬ª –ø–æ–¥–ø–∏—Å–∞–ª–∏ —Å–æ–≥–ª–∞—à–µ–Ω–∏–µ –æ —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–µ. –°—Ç–æ—Ä–æ–Ω—ã –∑–∞–π–º—É—Ç—Å—è —Å–æ–≤–º–µ—Å—Ç–Ω–æ–π —Ä–∞–±–æ—Ç–æ–π –ø–æ —Ä–∞–∑–≤–∏—Ç–∏—é –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏ –¥–µ—Ç–µ–π —Å —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–∏–º–∏ –∏ –æ—Ä—Ñ–∞–Ω–Ω—ã–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏. –í —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å—â–∏–∫–∏ –ø–æ–º–æ–≥—É—Ç —Ñ–æ–Ω–¥—É –≤ –ø–µ—Ä–µ–≥–æ–≤–æ—Ä–∞—Ö —Å —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º–∏ –∏ –ø–æ—Å—Ç–∞–≤—â–∏–∫–∞–º–∏ –ø–æ –≤–æ–ø—Ä–æ—Å—É —Å—Ç–æ–∏–º–æ—Å—Ç–∏ –∏—Ö –ø—Ä–æ–¥—É–∫—Ü–∏–∏. üíä Novo Nordisk –ø–æ–∫–∏–Ω—É–ª–∞ —á–∞—Ç —Ç–æ–ø-10 —Å–∞–º—ã—Ö –¥–æ—Ä–æ–≥–∏—Ö –∫–æ–º–ø–∞–Ω–∏–π –ï–≤—Ä–æ–ø—ã. –ê–∫—Ü–∏–∏ –¥–∞—Ç—Å–∫–æ–π —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ —Å –Ω–∞—á–∞–ª–∞ –Ω–µ–¥–µ–ª–∏ –ø–æ–¥–µ—à–µ–≤–µ–ª–∏ –Ω–∞ —Ç—Ä–µ—Ç—å, –¥–æ $206 –º–ª—Ä–¥. –¢–∞–∫–æ–≤ —Ä–µ–∑—É–ª—å—Ç–∞—Ç —É—Ö—É–¥—à–µ–Ω–∏—è –≥–æ–¥–æ–≤—ã—Ö –ø—Ä–æ–≥–Ω–æ–∑–æ–≤ –∏ –Ω–∞–∑–Ω–∞—á–µ–Ω–∏—è –Ω–æ–≤–æ–≥–æ CEO. –ò —ç—Ç–æ –ø—Ä–æ–≤–∞–ª, —É—á–∏—Ç—ã–≤–∞—è, —á—Ç–æ –ø–æ–ª—Ç–æ—Ä–∞ –º–µ—Å—è—Ü–∞ –Ω–∞–∑–∞–¥ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å –û–∑–µ–º–ø–∏–∫–∞ –±—ã–ª –ª–∏–¥–µ—Ä–æ–º —Å–ø–∏—Å–∫–∞. üíä –ì–∏–ø–µ—Ä—Ç–æ–Ω–∏–∫–æ–≤ –±—É–¥—É—Ç –ª–µ—á–∏—Ç—å –¥–æ–ª—å—à–µ. –ú–∏–Ω–∑–¥—Ä–∞–≤ –ø—Ä–µ–¥–ª–æ–∂–∏–ª –æ–±–Ω–æ–≤–∏—Ç—å —Å—Ç–∞–Ω–¥–∞—Ä—Ç—ã –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –≤–∑—Ä–æ—Å–ª—ã–º –ø—Ä–∏ –∞—Ä—Ç–µ—Ä–∏–∞–ª—å–Ω–æ–π –≥–∏–ø–µ—Ä—Ç–µ–Ω–∑–∏–∏ –∏ –≥–∏–ø–µ—Ä—Ç–æ–Ω–∏—á–µ—Å–∫–æ–º –∫—Ä–∏–∑–µ. –í —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, —É–≤–µ–ª–∏—á–∏—Ç—å —Å—Ä–µ–¥–Ω—é—é –ø—Ä–æ–¥–æ–ª–∂–∏—Ç–µ–ª—å–Ω–æ—Å—Ç—å –ª–µ—á–µ–Ω–∏—è –∑–∞–∫–æ–Ω—á–µ–Ω–Ω–æ–≥–æ —Å–ª—É—á–∞—è —Å 10 –¥–Ω–µ–π –¥–æ 12 –º–µ—Å—è—Ü–µ–≤. –°–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–∏–π –¥–æ–∫—É–º–µ–Ω—Ç —Ä–∞–∑–º–µ—â—ë–Ω –Ω–∞ —Å–∞–π—Ç–µ –ø—Ä–æ–µ–∫—Ç–æ–≤ –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω—ã—Ö –ø—Ä–∞–≤–æ–≤—ã—Ö –∞–∫—Ç–æ–≤. –í –Ω—ë–º –ø–µ—Ä–µ—á–∏—Å–ª–µ–Ω—ã –æ–±—ä—ë–º—ã –∏ –≤–∏–¥—ã –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –≤–º–µ—à–∞—Ç–µ–ª—å—Å—Ç–≤, –≤–∫–ª—é—á–∞—è –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—É—é —Ç–µ—Ä–∞–ø–∏—é. üíä Eisai —Ö–≤–∞—Å—Ç–∞–µ—Ç—Å—è ¬´—á—É–¥–æ-–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–º¬ª –æ—Ç –±–æ–ª–µ–∑–Ω–∏ –ê–ª—å—Ü–≥–µ–π–º–µ—Ä–∞. –ü—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å —É—Ç–≤–µ—Ä–∂–¥–∞–µ—Ç, —á—Ç–æ –ª–µ–∫–∞–Ω–µ–º–∞–± –º–æ–∂–µ—Ç –æ—Ç—Å—Ä–æ—á–∏—Ç—å –Ω–∞—á–∞–ª–æ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è –Ω–∞ —á–µ—Ç—ã—Ä–µ –≥–æ–¥–∞, –∞ —É –Ω–µ–∫–æ—Ç–æ—Ä—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –ø—Ä–∏–Ω–∏–º–∞–≤—à–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç –Ω–∞ —Ä–∞–Ω–Ω–µ–π —Å—Ç–∞–¥–∏–∏, –¥–∞–∂–µ —É–ª—É—á—à–∏–ª–∏—Å—å –∫–æ–≥–Ω–∏—Ç–∏–≤–Ω—ã–µ –ø–æ–∫–∞–∑–∞—Ç–µ–ª–∏. –ù–∞–ø–æ–º–Ω–∏–º, –∫ ¬´—Ä–µ–≤–æ–ª—é—Ü–∏–æ–Ω–Ω–æ–º—É¬ª –ª–µ–∫–∞—Ä—Å—Ç–≤—É –±—ã–ª–∏ –±–æ–ª—å—à–∏–µ –≤–æ–ø—Ä–æ—Å—ã –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ –µ–≥–æ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏. üíä –í –†–æ—Å—Å–∏–∏ –ø–æ—è–≤–∏–ª—Å—è —Ç—Ä–µ—Ç–∏–π –∞–Ω–∞–ª–æ–≥ –í–µ–≥–æ–≤–∏. –°–≤–æ–π –ò–Ω—Å—É–¥–∞–π–≤ –°–ª–∏–º –ø—Ä–æ—Ç–∏–≤ –æ–∂–∏—Ä–µ–Ω–∏—è –∏ —Å–∞—Ö–∞—Ä–Ω–æ–≥–æ –¥–∏–∞–±–µ—Ç–∞ 2-–≥–æ —Ç–∏–ø–∞ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª–∞ ¬´–ü–°–ö –§–∞—Ä–º–∞¬ª. –°–≤–æ–∏ –¥–∂–µ–Ω–µ—Ä–∏–∫–∏ —Ç–∞–∫–∂–µ –µ—Å—Ç—å —É –ø–∏–æ–Ω–µ—Ä–æ–≤ –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω–æ–≥–æ –ª–∏—Ü–µ–Ω–∑–∏—Ä–æ–≤–∞–Ω–∏—è —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ ‚Äî ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º–∞¬ª –∏ ¬´–ü—Ä–æ–º–æ–º–µ–¥–∞¬ª. üíä Sanofi –æ–ø—è—Ç—å –ø—Ä–æ–∏–≥—Ä–∞–ª–∞ —Å–ø–æ—Ä –∑–∞ –¢—Ä–∏–∫–∞—Ñ—Ç—É. –§—Ä–∞–Ω—Ü—É–∑—Å–∫–∞—è –∫–æ–º–ø–∞–Ω–∏—è –∏ –§–¶–ü–∏–õ–û –±–µ–∑—É—Å–ø–µ—à–Ω–æ –ø—ã—Ç–∞–ª–∏—Å—å –æ—Å–ø–æ—Ä–∏—Ç—å –≤ –∫–∞—Å—Å–∞—Ü–∏–æ–Ω–Ω—ã—Ö –∏–Ω—Å—Ç–∞–Ω—Ü–∏—è—Ö –¥–≤–∞ –∏–∑ —Ç—Ä–µ—Ö –æ—Ç–∫–∞–∑–æ–≤ –§–ê–° –≤ —Å–æ–≥–ª–∞—Å–æ–≤–∞–Ω–∏–∏ –∫–æ–Ω—Ç—Ä–∞–∫—Ç–æ–≤ –Ω–∞ –ø–æ—Å—Ç–∞–≤–∫—É –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –º—É–∫–æ–≤–∏—Å—Ü–∏–¥–æ–∑–∞ –ø–æ–¥–æ–ø–µ—á–Ω—ã–º ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª. –ù–∞–ø–æ–º–Ω–∏–º, –§–ê–° ¬´–∑–∞–≤–µ—Ä–Ω—É–ª–∞¬ª –∫–æ–Ω—Ç—Ä–∞–∫—Ç—ã –Ω–∞ –ø–æ—Å—Ç–∞–≤–∫—É –∑–∞—â–∏—â–µ–Ω–Ω–æ–π –ø–∞—Ç–µ–Ω—Ç–æ–º –¢—Ä–∏–∫–∞—Ñ—Ç—ã (–∏–≤–∞–∫–∞—Ñ—Ç–æ—Ä+—Ç–µ–∑–∞–∫–∞—Ñ—Ç–æ—Ä+—ç–ª–µ–∫—Å–∞–∫–∞—Ñ—Ç–æ—Ä –∏ –∏–≤–∞–∫–∞—Ñ—Ç–æ—Ä), –ø–æ—Å–∫–æ–ª—å–∫—É ¬´–ò—Ä–≤–∏–Ω¬ª –ø—Ä–µ–¥–ª–æ–∂–∏–ª –±–æ–ª–µ–µ –¥–µ—à—ë–≤—ã–π –∞–Ω–∞–ª–æ–≥ ‚Äì –¢—Ä–∏–ª–µ–∫—Å—É –∞—Ä–≥–µ–Ω—Ç–∏–Ω—Å–∫–æ–π Laboratorio Tuteur. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance, safety"",
  ""impact"": ""high"",
  ""english"": ""Sanofi lost another case against Trikaftu. The French company and the FCPIL (Federal Committee on Pharmaceutical Inspections and Licensing) unsuccessfully tried to appeal two of three FAS decisions approving contracts for the supply of drugs for mucoviscidosis patients under the 'Circle of Good' program. The FAS 'closed' the contracts on Trikaftu, which is protected by patent, due to 'Irvine's' cheaper alternative - Trilex from Argentina's Laboratorio Tuteur. Meanwhile, the third case is still pending.""
}"
2025-08-01T14:02:54+00:00,@bezrec,6376,https://t.me/bezrec/6376,"–û—Ç –æ–±–ª–∞–∫–∞ ‚Äî –∫ –ª–æ–∫–∞–ª—å–Ω–æ–π –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä–µ: –≤–µ–Ω–¥–æ—Ä—ã —É—Å–∏–ª–∏–≤–∞—é—Ç on-premises –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏–µ –í–æ –º–Ω–æ–≥–∏—Ö –æ—Ç—Ä–∞—Å–ª—è—Ö ‚Äî –æ—Ç –±–∞–Ω–∫–æ–≤ –∏ –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏ –¥–æ –º–µ–¥–∏—Ü–∏–Ω—ã ‚Äî –≤–Ω–µ–¥—Ä–µ–Ω–∏–µ –æ–±–ª–∞—á–Ω—ã—Ö —Ä–µ—à–µ–Ω–∏–π –∑–∞—Ç—Ä—É–¥–Ω–µ–Ω–æ. –ü—Ä–∏—á–∏–Ω–∞ ‚Äî –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω—ã–µ –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏—è –∏ –ø–æ–≤—ã—à–µ–Ω–Ω—ã–µ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω–æ–π –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏. –í —Ä–µ–∑—É–ª—å—Ç–∞—Ç–µ —Å–ø—Ä–æ—Å –Ω–∞ –ª–æ–∫–∞–ª—å–Ω—ã–µ (on-premises) IT-–∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä—ã –æ—Å—Ç–∞–µ—Ç—Å—è –≤—ã—Å–æ–∫–∏–º, –æ—Å–æ–±–µ–Ω–Ω–æ —Å—Ä–µ–¥–∏ –∫—Ä—É–ø–Ω—ã—Ö –∫–æ–º–ø–∞–Ω–∏–π. –ò —ç—Ç–æ –æ—Å–æ–∑–Ω–∞—é—Ç –≤–µ–Ω–¥–æ—Ä—ã. –ö–∞–∫ –≤–∏–¥–Ω–æ –∏–∑ —Ñ–∏–Ω–∞–Ω—Å–æ–≤—ã—Ö —Ä–µ–∑—É–ª—å—Ç–∞—Ç–æ–≤ Yandex B2B Tech –∑–∞ I –ø–æ–ª—É–≥–æ–¥–∏–µ 2025 –≥–æ–¥–∞, –∑–∞–º–µ—Ç–Ω—É—é –¥–∏–Ω–∞–º–∏–∫—É –ø–æ–∫–∞–∑—ã–≤–∞–µ—Ç –Ø–Ω–¥–µ–∫—Å 360: –≤—ã—Ä—É—á–∫–∞ –≤—ã—Ä–æ—Å–ª–∞ –Ω–∞ 66% –∏ –¥–æ—Å—Ç–∏–≥–ª–∞ 8,2 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –û–¥–Ω–∏–º –∏–∑ –¥—Ä–∞–π–≤–µ—Ä–æ–≤ —Å—Ç–∞–ª–∏ –∫—Ä—É–ø–Ω—ã–µ –∫–æ—Ä–ø–æ—Ä–∞—Ç–∏–≤–Ω—ã–µ –∫–ª–∏–µ–Ω—Ç—ã: –∏—Ö –¥–æ–ª—è —É–≤–µ–ª–∏—á–∏–ª–∞—Å—å –Ω–∞ 22%, –∞ –æ–±—ä–µ–º –≤—ã—Ä—É—á–∫–∏ –æ—Ç –Ω–∏—Ö ‚Äî –Ω–∞ 72%. –ù–∞ —ç—Ç–æ–º —Ñ–æ–Ω–µ –Ø–Ω–¥–µ–∫—Å 360 —É—Å–∏–ª–∏–≤–∞–µ—Ç —Ä–∞–∑–≤–∏—Ç–∏–µ on-premises-–º–æ–¥–µ–ª–∏. –£–∂–µ —Å–µ–π—á–∞—Å –∫–æ–º–ø–∞–Ω–∏–∏ –º–æ–≥—É—Ç —Ä–∞–∑–≤–µ—Ä–Ω—É—Ç—å –Ω–∞ —Å–≤–æ–µ–π –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä–µ –î–æ—Å–∫–∏ –∏ –±—Ä–∞—É–∑–µ—Ä. –î–æ –∫–æ–Ω—Ü–∞ 2025 –≥–æ–¥–∞ –ª–æ–∫–∞–ª—å–Ω–æ —Å—Ç–∞–Ω—É—Ç –¥–æ—Å—Ç—É–ø–Ω—ã –µ—â–µ –¥–≤–∞ —Å–µ—Ä–≤–∏—Å–∞: –î–∏—Å–∫ –∏ –î–æ–∫—É–º–µ–Ω—Ç—ã. –î–ª—è –æ—Ç—Ä–∞—Å–ª–µ–π, –≥–¥–µ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ –æ–±–ª–∞–∫–∞ –Ω–µ–≤–æ–∑–º–æ–∂–Ω–æ –ø–æ —Ä–µ–≥–ª–∞–º–µ–Ω—Ç—É (–Ω–∞–ø—Ä–∏–º–µ—Ä, –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ —É—á—Ä–µ–∂–¥–µ–Ω–∏—è, —Ñ–∏–Ω–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏, –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏—è —Å –∫—Ä–∏—Ç–∏—á–µ—Å–∫–æ–π –ò–¢-–∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä–æ–π), —ç—Ç–æ —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏ –≤–∞–∂–Ω—ã–π —à–∞–≥. –ü–æ –¥–∞–Ω–Ω—ã–º –Ø–Ω–¥–µ–∫—Å–∞, –≤–∏—Ä—Ç—É–∞–ª—å–Ω—ã–º –æ—Ñ–∏—Å–æ–º —É–∂–µ –ø–æ–ª—å–∑—É—é—Ç—Å—è —Å–≤—ã—à–µ 160 —Ç—ã—Å. –∫–æ–º–ø–∞–Ω–∏–π, –∞ –µ–∂–µ–º–µ—Å—è—á–Ω–∞—è –∞—É–¥–∏—Ç–æ—Ä–∏—è —Å–µ—Ä–≤–∏—Å–æ–≤ —Å–æ—Å—Ç–∞–≤–ª—è–µ—Ç 93 –º–ª–Ω –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª–µ–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-08-01T12:00:57+00:00,@bezrec,6374,https://t.me/bezrec/6374,"¬´–°—Ç–æ–ª–∏—á–∫–∏¬ª –∏ ¬´–ù–µ–æ—Ñ–∞—Ä–º¬ª –ø—Ä–∏—Ö–æ–¥—è—Ç –≤ —Å–µ–±—è. –ù–∞ —Å–∞–π—Ç–∞—Ö —Å–µ—Ç–µ–π —É–∫–∞–∑–∞–Ω–æ, —á—Ç–æ –∞–ø—Ç–µ–∫–∏ –≤–æ–∑–æ–±–Ω–æ–≤–ª—è—é—Ç —Å–≤–æ—é —Ä–∞–±–æ—Ç—É –∏ –∑–∞–∫–∞–∑—ã —É–∂–µ –º–æ–∂–Ω–æ –æ—Ñ–æ—Ä–º–ª—è—Ç—å. –ü–æ–∫–∞ –Ω–µ —Ä–∞–±–æ—Ç–∞—é—Ç –±–∞–ª–ª—ã, –Ω–æ –Ω–µ–¥–æ—á—ë—Ç –æ–±–µ—â–∞—é—Ç —Å–∫–æ—Ä–æ —É—Å—Ç—Ä–∞–Ω–∏—Ç—å. –ê–ø—Ç–µ–∫–∏, –≤—Ö–æ–¥—è—â–∏–µ –≤ –û–û–û ¬´–ù–µ–æ-—Ñ–∞—Ä–º¬ª, –ø–æ–¥–≤–µ—Ä–≥–ª–∏—Å—å —Ö–∞–∫–µ—Ä—Å–∫–æ–π –∞—Ç–∞–∫–µ –≤ —ç—Ç–æ—Ç –≤—Ç–æ—Ä–Ω–∏–∫. –í —Å–µ—Ç–∏ –∑–∞–≤–µ—Ä–∏–ª–∏, —á—Ç–æ –æ–±–æ—à–ª–æ—Å—å –±–µ–∑ —É—Ç–µ—á–∫–∏ –¥–∞–Ω–Ω—ã—Ö –∫–ª–∏–µ–Ω—Ç–æ–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-08-01T10:54:23+00:00,@bezrec,6373,https://t.me/bezrec/6373,"–£ Solopharm (–û–û–û ¬´–ì—Ä–æ—Ç–µ–∫—Å¬ª) —Å–Ω–æ–≤–∞ –Ω–æ–≤—ã–π –≥–µ–Ω–µ—Ä–∞–ª—å–Ω—ã–π. –£–≤–∏–¥–µ–ª–∏ –≤ Rusprofile, —á—Ç–æ —Å 31 –∏—é–ª—è 2025 –≥–æ–¥–∞ –Ω–∞ –¥–æ–ª–∂–Ω–æ—Å—Ç—å –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –∫–æ–º–ø–∞–Ω–∏–∏ –Ω–∞–∑–Ω–∞—á–µ–Ω –ú–∞–º—É–∫–∞ –ú–∏—Ö–µ–ª–∞—à–≤–∏–ª–∏, —Ä–∞–Ω–µ–µ –∏—Å–ø–æ–ª–Ω—è–≤—à–∏–π —Ñ—É–Ω–∫—Ü–∏–∏ –∫–æ–º–º–µ—Ä—á–µ—Å–∫–æ–≥–æ, –∞ –∑–∞—Ç–µ–º –∏—Å–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–≥–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞. –í –ø–æ—Å–ª–µ–¥–Ω–∏–µ –≥–æ–¥—ã –∫–∞–¥—Ä–æ–≤—ã–µ –ø–µ—Ä–µ—Å—Ç–∞–Ω–æ–≤–∫–∏ –≤ —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–µ –¥–ª—è —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è ‚Äî –Ω–µ —Ä–µ–¥–∫–æ—Å—Ç—å. –ñ–µ—Ä–µ–±—Ü–æ–≤ –∑–∞–Ω–∏–º–∞–ª –¥–æ–ª–∂–Ω–æ—Å—Ç—å –≥–µ–Ω–µ—Ä–∞–ª—å–Ω–æ–≥–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ —Å 2012 –≥–æ–¥–∞, –≤ 2023 –≥–æ–¥—É –µ–≥–æ —Å–º–µ–Ω–∏–ª –ü–∞–≤–µ–ª –°–µ–º—å—è–Ω–æ–≤, —Ä—É–∫–æ–≤–æ–¥–∏–≤—à–∏–π —Ñ–∏–Ω–∞–Ω—Å–∞–º–∏ –≥—Ä—É–ø–ø—ã —Å 2014 –≥–æ–¥–∞, –∞ —Å–ø—É—Å—Ç—è –ø–æ–ª—Ç–æ—Ä–∞ –≥–æ–¥–∞ –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–º –∫–æ–º–ø–∞–Ω–∏–∏ –≤–Ω–æ–≤—å —Å—Ç–∞–ª –ñ–µ—Ä–µ–±—Ü–æ–≤. –ü–æ—Å–ª–µ –Ω–∞–∑–Ω–∞—á–µ–Ω–∏—è –ú–∏—Ö–µ–ª–∞—à–≤–∏–ª–∏ –ñ–µ—Ä–µ–±—Ü–æ–≤ –ø—Ä–æ–¥–æ–ª–∂–∏—Ç –æ–ø—Ä–µ–¥–µ–ª—è—Ç—å —Å—Ç—Ä–∞—Ç–µ–≥–∏—é –∫–æ–º–ø–∞–Ω–∏–∏, —Ä—É–∫–æ–≤–æ–¥–∏—Ç—å —Å–æ–∑–¥–∞–Ω–∏–µ–º –Ω–æ–≤—ã—Ö –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤ –∏ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏–π, –∞ —Ç–∞–∫–∂–µ —Ä–∞–∑–≤–∏–≤–∞—Ç—å –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–µ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏–µ Solopharm. –¢–µ–ø–µ—Ä—å —É–∂–µ –≤ –∫–∞—á–µ—Å—Ç–≤–µ –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—è —Å–æ–≤–µ—Ç–∞ –¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–≤. –ú–∏—Ö–µ–ª–∞—à–≤–∏–ª–∏, –Ω–∞—á–∞–≤ —Å–≤–æ–π –ø—É—Ç—å —Å –¥–æ–ª–∂–Ω–æ—Å—Ç–∏ –ø—Ä–æ–≤–∏–∑–æ—Ä–∞ –≤ –∞–ø—Ç–µ—á–Ω–æ–π —Å–µ—Ç–∏, —Å–µ–≥–æ–¥–Ω—è –æ–±–ª–∞–¥–∞–µ—Ç –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω—ã–º —É–ø—Ä–∞–≤–ª–µ–Ω—á–µ—Å–∫–∏–º –æ–ø—ã—Ç–æ–º –≤ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–º —Ä–∏—Ç–µ–π–ª–µ –∏ –¥–∏—Å—Ç—Ä–∏–±—É—Ü–∏–∏ –∏ –≥–ª—É–±–æ–∫–æ –≤–æ–≤–ª–µ—á—ë–Ω –≤ —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–æ–µ —Ä–∞–∑–≤–∏—Ç–∏–µ Solopharm, ‚Äî –≥–æ–≤–æ—Ä–∏—Ç—Å—è –Ω–∞ —Å–∞–π—Ç–µ –∫–æ–º–ø–∞–Ω–∏–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-08-01T08:46:50+00:00,@bezrec,6372,https://t.me/bezrec/6372,"–ì–∏–Ω—Ü–±—É—Ä–≥ –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª —Ñ–∞–∫—Ç —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ —Ä–æ—Å—Å–∏–π—Å–∫–æ–π –≤–∞–∫—Ü–∏–Ω—ã –æ—Ç —Ä–∞–∫–∞ –º–æ—á–µ–≤–æ–≥–æ –ø—É–∑—ã—Ä—è. –ü—Ä–∏—á—ë–º –ò–º—É—Ä–æ–Ω-–≤–∞–∫, —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–Ω—ã–π –¶–µ–Ω—Ç—Ä–æ–º –∏–º. –ì–∞–º–∞–ª–µ–∏, –Ω–µ —Ç–æ–ª—å–∫–æ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω, –Ω–æ –∏ —É–∂–µ ¬´–ø–æ–ª—å–∑—É–µ—Ç—Å—è –±–æ–ª—å—à–∏–º —Å–ø—Ä–æ—Å–æ–º¬ª. –î–∞, –æ–Ω–∞ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–∞. –ò –æ—á–µ–Ω—å —Ö–æ—Ä–æ—à–æ –ø—Ä–∏–º–µ–Ω—è–µ—Ç—Å—è –≤ –∫–∞—á–µ—Å—Ç–≤–µ –∏–º–º—É–Ω–æ—Ç–µ—Ä–∞–ø–∏–∏ –ø–æ—Å–ª–µ–æ–ø–µ—Ä–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ –ª–µ—á–µ–Ω–∏—è —Ä–∞–∫–∞ –º–æ—á–µ–≤–æ–≥–æ –ø—É–∑—ã—Ä—è, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ì–∏–Ω—Ü–±—É—Ä–≥, –¥–æ–±–∞–≤–∏–≤, —á—Ç–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –±—ã–ª–∏ —É—Å–ø–µ—à–Ω–æ –∑–∞–≤–µ—Ä—à–µ–Ω—ã, –∏ —É—á—ë–Ω—ã–µ –ø–æ–ª—É—á–∏–ª–∏ –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–µ —Ö–æ—Ä–æ—à–∏–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã. –í–∞–∫—Ü–∏–Ω–∞ –ø–æ—Å—Ç–∞–≤–ª—è–µ—Ç—Å—è —Ç–∞–∫–∂–µ –≤ —Å—Ç—Ä–∞–Ω—ã –°–ù–ì, –≤ –±–ª–∏–∂–∞–π—à–µ–µ –≤—Ä–µ–º—è –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –æ—Ç–ø—Ä–∞–≤–∫–∞ –∫—Ä—É–ø–Ω–æ–π –ø–∞—Ä—Ç–∏–∏ –≤ –ê—Ä–º–µ–Ω–∏—é. –í –ø—Ä–æ—à–ª–æ–º –≥–æ–¥—É –¥–∏—Ä–µ–∫—Ç–æ—Ä –¶–µ–Ω—Ç—Ä–∞ –∏–º. –ì–∞–º–∞–ª–µ–∏ –ø—Ä–µ–¥–ø–æ–ª–æ–∂–∏–ª, —á—Ç–æ –ò–º—É—Ä–æ–Ω-–≤–∞–∫ –º–æ–∂–µ—Ç –ø—Ä–µ–¥—Å—Ç–∞–≤–ª—è—Ç—å –∏–Ω—Ç–µ—Ä–µ—Å –¥–ª—è –∫–∏—Ç–∞–π—Å–∫–æ–≥–æ —Ä—ã–Ω–∫–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-08-01T06:32:07+00:00,@bezrec,6371,https://t.me/bezrec/6371,"–¢–∞–∫–∏–º–∏ –¥–∞–Ω–Ω—ã–º–∏ –ø–æ–¥–µ–ª–∏–ª–∏—Å—å —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã —Ü–µ–Ω—Ç—Ä–∞ –ù–ê–§–ò –Ω–∞ –æ—Å–Ω–æ–≤–∞–Ω–∏–∏ –æ–Ω–ª–∞–π–Ω-–æ–ø—Ä–æ—Å–∞ 7,3 —Ç—ã—Å. —á–µ–ª–æ–≤–µ–∫. –í —Å–Ω–∏–∂–µ–Ω–∏–µ —Ü–µ–Ω –≤–µ—Ä–∏—Ç —Ç–æ–ª—å–∫–æ 5% –æ–ø—Ç–∏–º–∏—Å—Ç–æ–≤. –ï—â—ë 20% —Ä–µ—Å–ø–æ–Ω–¥–µ–Ω—Ç–æ–≤ —Å—á–∏—Ç–∞—é—Ç, —á—Ç–æ –≤—Å—ë –æ—Å—Ç–∞–Ω–µ—Ç—Å—è –∫–∞–∫ –µ—Å—Ç—å, 10% –∑–∞—Ç—Ä—É–¥–Ω—è—é—Ç—Å—è –æ—Ç–≤–µ—Ç–∏—Ç—å –∏–ª–∏ –Ω–µ –ø–æ–∫—É–ø–∞—é—Ç —Ç–æ–≤–∞—Ä—ã —ç—Ç–æ–π –∫–∞—Ç–µ–≥–æ—Ä–∏–∏. –ê–Ω–∞–ª–∏—Ç–∏–∫–∏ —Ç–∞–∫–∂–µ –æ—Ç–º–µ—á–∞—é—Ç —Ä–æ—Å—Ç –∏–Ω—Ç–µ—Ä–µ—Å–∞ –∫ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ ‚Äî –∏–º –ø–æ–ª–Ω–æ—Å—Ç—å—é –¥–æ–≤–µ—Ä—è—é—Ç 78% –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö. –û—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–µ –≤—ã–±–∏—Ä–∞—é—Ç –ø–æ —Ç—Ä—ë–º –ø—Ä–∏—á–∏–Ω–∞–º: üîò–¥–æ—Å—Ç—É–ø–Ω–∞—è —Ü–µ–Ω–∞ (54%); üîò–ª–∏—á–Ω—ã–π –ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω—ã–π –æ–ø—ã—Ç (37%); üîò—à–∏—Ä–æ–∫–æ–µ –Ω–∞–ª–∏—á–∏–µ –≤ –∞–ø—Ç–µ–∫–∞—Ö (34%). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The survey of 7,300 people by the Center for NAFI shows that only 5% of respondents are optimistic about price reductions. Another 20% believe the situation will remain unchanged, and 10% are uncertain or do not buy products in this category. However, analysts also note an increase in interest in domestically produced medicines - 78% of respondents fully trust them. The reasons for choosing domestic products include affordable price (54%), personal positive experience (37%), and wide availability in pharmacies (34%).""
}"
2025-07-31T14:50:43+00:00,@bezrec,6370,https://t.me/bezrec/6370,"–£—Å–ø–æ–∫–æ–∏—Ç–µ–ª—å–Ω—ã–µ –∏ –¥—Ä—É–≥–∏–µ —Å–ø–æ—Å–æ–±—ã —Å–Ω—è—Ç—å –ø–æ—Å—Ç–æ—Ç–ø—É—Å–∫–Ω–æ–π —Å—Ç—Ä–µ—Å—Å. –°–µ—Ä–≤–∏—Å –ø–æ –ø–æ–∏—Å–∫—É —Ä–∞–±–æ—Ç—ã SuperJob –æ–ø—Ä–æ—Å–∏–ª 1,6 —Ç—ã—Å. —Ä–æ—Å—Å–∏—è–Ω, —á—Ç–æ–±—ã —É–∑–Ω–∞—Ç—å, –∫–∞–∫–∏–µ —Å—Ä–µ–¥—Å—Ç–≤–∞ –æ–Ω–∏ –∏—Å–ø–æ–ª—å–∑—É—é—Ç, —á—Ç–æ–±—ã –ª–µ–≥—á–µ –≤–ª–∏—Ç—å—Å—è –≤ —Ä–∞–±–æ—á–∏–π –ø—Ä–æ—Ü–µ—Å—Å –ø–æ—Å–ª–µ –æ—Ç–ø—É—Å–∫–∞. –ü—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–ª—è —Å–Ω—è—Ç–∏—è —Å—Ç—Ä–µ—Å—Å–∞ –æ—Ç –≤—ã—Ö–æ–¥–∞ –Ω–∞ —Ä–∞–±–æ—Ç—É –ø–æ—Å–ª–µ –æ—Ç–ø—É—Å–∫–∞ –ø—å—é—Ç 8% –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö. –í 2011 –≥–æ–¥—É —Ç–∞–∫–æ–≤—ã—Ö –±—ã–ª–æ 3%. –ö—É–¥–∞ –±–æ–ª–µ–µ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω—ë–Ω–Ω—ã–º–∏ –æ–∫–∞–∑–∞–ª–∏—Å—å –∞–ª—å—Ç–µ—Ä–Ω–∞—Ç–∏–≤–Ω—ã–µ –º–µ—Ç–æ–¥—ã –∞–¥–∞–ø—Ç–∞—Ü–∏–∏: 29% –≤–æ–∑–≤—Ä–∞—â–∞—é—Ç—Å—è –¥–æ–º–æ–π –∑–∞ 1‚Äî2 –¥–Ω—è –¥–æ –≤—ã—Ö–æ–¥–∞ –Ω–∞ —Ä–∞–±–æ—Ç—É, 19% –≤ –ø–µ—Ä–≤—ã–π —Ä–∞–±–æ—á–∏–π –¥–µ–Ω—å –≤—ã–ø–æ–ª–Ω—è—é—Ç –∑–∞–¥–∞—á–∏ –ø–æ–ø—Ä–æ—â–µ, –∞ 18% —Å—Ç–∞—Ä–∞—é—Ç—Å—è –≤—ã—Å–ø–∞—Ç—å—Å—è –∏ –Ω–µ –ø–µ—Ä–µ—Ç—Ä—É–∂–¥–∞—Ç—å—Å—è. –ß–∞—â–µ –∫ –ø–æ–º–æ—â–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –≤–∏—Ç–∞–º–∏–Ω–æ–≤ –ø—Ä–∏–±–µ–≥–∞—é—Ç —Ä–∞–±–æ—Ç–Ω–∏–∫–∏ –≤ –≤–æ–∑—Ä–∞—Å—Ç–µ –æ—Ç 35 –¥–æ 45 –ª–µ—Ç. –°—Ä–µ–¥–∏ –∂–µ–Ω—â–∏–Ω –ø—Ä–∏–Ω–∏–º–∞—é—â–∏—Ö —É—Å–ø–æ–∫–æ–∏—Ç–µ–ª—å–Ω—ã–µ –±–æ–ª—å—à–µ, —á–µ–º —Å—Ä–µ–¥–∏ –º—É–∂—á–∏–Ω ‚Äî 9% –ø—Ä–æ—Ç–∏–≤ 6%. –ö—Å—Ç–∞—Ç–∏, –ø–æ –∑–∞–∫–æ–Ω—á–∏–≤—à–µ–º—É—Å—è –æ—Ç–ø—É—Å–∫—É —Å—Ç—Ä–∞–¥–∞—é—Ç –Ω–µ –≤—Å–µ ‚Äî 39% –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö –∑–∞—è–≤–∏–ª–∏, —á—Ç–æ –Ω–µ –∏—Å–ø—ã—Ç—ã–≤–∞—é—Ç —Å—Ç—Ä–µ—Å—Å–∞, –≤–æ–∑–≤—Ä–∞—â–∞—è—Å—å –Ω–∞ —Ä–∞–±–æ—Ç—É. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-07-31T12:04:33+00:00,@bezrec,6369,https://t.me/bezrec/6369,"–ù–µ–ª—å–∑—è –ø—Ä–æ—Å—Ç–æ —Ç–∞–∫ –≤–∑—è—Ç—å –∏ –Ω–µ –ø–æ–¥–≤–µ—Å—Ç–∏ –∏—Ç–æ–≥–∏ –ø–æ –ø—Ä–æ–¥–∞–∂–∞–º —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ –∑–∞ –ø–µ—Ä–≤–æ–µ –ø–æ–ª—É–≥–æ–¥–∏–µ. –¶–∏—Ñ—Ä—ã –æ—Ç DSM Group: –∞–ø—Ç–µ—á–Ω—ã–µ –ø—Ä–æ–¥–∞–∂–∏ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ –∏ –µ–≥–æ –∞–Ω–∞–ª–æ–≥–æ–≤ –≤—ã—Ä–æ—Å–ª–∏ –±–æ–ª–µ–µ, —á–µ–º –≤ —á–µ—Ç—ã—Ä–µ —Ä–∞–∑–∞ ‚Äî –¥–æ 12,5 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –£ RNC Pharma –ø–æ—Ö–æ–∂–∞—è —Å—Ç–∞—Ç–∏—Å—Ç–∏–∫–∞: –≤ —è–Ω–≤–∞—Ä–µ ‚Äì –∏—é–ª–µ 2025 –≥–æ–¥–∞ –ø—Ä–æ–¥–∞–∂–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Å —ç—Ç–∏–º –ú–ù–ù —É–≤–µ–ª–∏—á–∏–ª–∏—Å—å –≤ 4,2 —Ä–∞–∑–∞ ‚Äî –¥–æ 11,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ü–æ –¥–∞–Ω–Ω—ã–º –æ–±–µ–∏—Ö –∫–æ–º–ø–∞–Ω–∏–π, –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ –±—ã–ª–æ —Ä–µ–∞–ª–∏–∑–æ–≤–∞–Ω–æ –≤ 4,5-4,6 —Ä–∞–∑ –±–æ–ª—å—à–µ —É–ø–∞–∫–æ–≤–æ–∫ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ –≥–æ–¥ –∫ –≥–æ–¥—É ‚Äî 2,2 –º–ª–Ω. –í–Ω—É—à–∏—Ç–µ–ª—å–Ω—É—é –ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω—É—é –¥–∏–Ω–∞–º–∏–∫—É –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–∞—é—Ç –∏ –∞–ø—Ç–µ—á–Ω—ã–µ —Å–µ—Ç–∏. –¢–∞–∫, –ø—Ä–æ–¥–∞–∂–∏ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ –≤ ¬´–ó–¥—Ä–∞–≤—Å–∏—Ç–∏¬ª –≤—ã—Ä–æ—Å–ª–∏ –≤ 3,5 —Ä–∞–∑–∞ –≥–æ–¥ –∫ –≥–æ–¥—É –∫–∞–∫ –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö, —Ç–∞–∫ –∏ –≤ –¥–µ–Ω—å–≥–∞—Ö. –ü–æ —Å–ª–æ–≤–∞–º —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—è –æ—Ç–¥–µ–ª–∞ —ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω–æ–π –∫–æ–º–º–µ—Ä—Ü–∏–∏ —Å–µ—Ç–∏ –ê–ª–µ–∫—Å–∞–Ω–¥—Ä–∞ –¢—é–∫–∏–Ω–∞, –ø–æ–∫—É–ø–∞—Ç–µ–ª–∏ –∞–∫—Ç–∏–≤–∏–∑–∏—Ä–æ–≤–∞–ª–∏—Å—å –≤ –º–∞—Ä—Ç–µ, –≤–º–µ—Å—Ç–µ —Å –Ω–∞—á–∞–ª–æ–º –ø–æ–¥–≥–æ—Ç–æ–≤–∫–∏ –∫ –ª–µ—Ç–Ω–µ–º—É —Å–µ–∑–æ–Ω—É. –†–æ—Å—Ç—É –ø—Ä–æ–¥–∞–∂ —Å–ø–æ—Å–æ–±—Å—Ç–≤–æ–≤–∞–ª–æ —Ä–∞—Å—à–∏—Ä–µ–Ω–∏–µ –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –¥–∏–∞–±–µ—Ç–∞ –∏ –æ–∂–∏—Ä–µ–Ω–∏—è. –°–≤–æ–π —Å–µ–º–∞–≥–ª—É—Ç–∏–¥, –ø–æ–º–∏–º–æ ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º–∞¬ª –∏ ¬´–ü—Ä–æ–º–æ–º–µ–¥–∞¬ª, —Ç–µ–ø–µ—Ä—å –µ—Å—Ç—å —É ¬´–ü–°–ö –§–∞—Ä–º–∞¬ª, ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑–∞¬ª –∏ ¬´–†-–§–∞—Ä–º¬ª. –ï—â—ë –¥–≤–µ –∫–æ–º–ø–∞–Ω–∏–∏ ‚Äî ¬´–ò–∑–≤–∞—Ä–∏–Ω–æ –§–∞—Ä–º–∞¬ª –∏ KRKA ‚Äî —Å–µ–π—á–∞—Å –≤ –ø—Ä–æ—Ü–µ—Å—Å–µ –ø–æ–ª—É—á–µ–Ω–∏—è –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω–æ–π –ª–∏—Ü–µ–Ω–∑–∏–∏. –¢–∞–∫–∂–µ —Å–ø—Ä–æ—Å –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç ¬´–ø–æ–¥–æ–≥—Ä–µ–ª–æ¬ª –µ–≥–æ –≤–∫–ª—é—á–µ–Ω–∏–µ –≤ –∫–ª–∏–Ω—Ä–µ–∫–∏ –ø–æ –ª–µ—á–µ–Ω–∏—é –æ–∂–∏—Ä–µ–Ω–∏—è. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –¥–∂–µ–Ω–µ—Ä–∏–∫–∏ –æ–∂–∏–¥–∞–µ–º–æ ¬´—Å–±–∏–ª–∏¬ª —Ü–µ–Ω—É –Ω–∞ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥. –í —Å—Ä–µ–¥–Ω–µ–º —É–ø–∞–∫–æ–≤–∫–∞ —Ç–∞–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Å–µ–π—á–∞—Å —Å—Ç–æ–∏—Ç –Ω–∞ 5,3 —Ç—ã—Å. —Ä—É–±–ª–µ–π ‚Äî –Ω–∞ 8% –º–µ–Ω—å—à–µ, —á–µ–º –≥–æ–¥–æ–º —Ä–∞–Ω–µ–µ. –ó–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω–∞—è –ø—Ä–µ–¥–µ–ª—å–Ω–∞—è —Ü–µ–Ω–∞ –ò–Ω—Å—É–¥–∞–π–≤–∞ –æ—Ç ¬´–ü–°–ö —Ñ–∞—Ä–º—ã¬ª –Ω–∞ 23,6% –Ω–∏–∂–µ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω–æ–≥–æ –û–∑–µ–º–ø–∏–∫–∞ –∏ —Å–æ—Å—Ç–∞–≤–ª—è–µ—Ç 4,2 —Ç—ã—Å. —Ä—É–±–ª–µ–π, ‚Äî –ø–æ–¥—á–µ—Ä–∫–∏–≤–∞–µ—Ç –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä –∫–æ–º–ø–∞–Ω–∏–∏ –ï–≤–≥–µ–Ω–∏—è –®–∞–ø–∏—Ä–æ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""Sales of semaglutide and its analogues have increased by more than four times to RUB 12.5 billion for the first half of the year according to DSM Group and RNC Pharma. The natural sales volume has increased by 450% year-over-year, according to both companies. The growth is also supported by the expansion of the product range for diabetes and obesity treatment, including 'P-SK Pharma', 'Pharmasintez', 'R-Farma' and others. The demand for the drug was further boosted by its inclusion in clinical trials for obesity treatment. Generic versions of semaglutide are also expected to reduce the price of the drug.""
}"
2025-07-31T08:54:38+00:00,@bezrec,6367,https://t.me/bezrec/6367,"–û–±—â–µ—Å—Ç–≤–µ–Ω–Ω–∏–∫–∏ –ø—Ä–æ—Å—è—Ç –ú–∏—à—É—Å—Ç–∏–Ω–∞ –æ–±—É–∑–¥–∞—Ç—å ¬´–ª–µ–≤—ã–µ¬ª –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –Ω–∞ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞—Ö. –ú–æ—Å–∫–æ–≤—Å–∫–æ–µ –æ–±—â–µ—Å—Ç–≤–æ –∑–∞—â–∏—Ç—ã –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª–µ–π (–ú–û–ó–ü) –æ–±—Ä–∞—Ç–∏–ª–æ—Å—å –∫ –ø—Ä–µ–º—å–µ—Ä-–º–∏–Ω–∏—Å—Ç—Ä—É –ú–∏—Ö–∞–∏–ª—É –ú–∏—à—É—Å—Ç–∏–Ω—É —Å –ø—Ä–æ—Å—å–±–æ–π —Ä–∞–∑–æ–±—Ä–∞—Ç—å—Å—è —Å –ø—Ä–æ–¥–∞–∂–µ–π –Ω–∞ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞—Ö –Ω–µ–∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤. –ù–µ—Å–º–æ—Ç—Ä—è –Ω–∞ –≤—Å–µ –∑–∞—è–≤–ª–µ–Ω–∏—è –æ–Ω–ª–∞–π–Ω-–ø–ª–æ—â–∞–¥–æ–∫ –æ –±–æ—Ä—å–±–µ —Å –æ–ø–∞—Å–Ω—ã–º –∫–æ–Ω—Ç—Ä–∞—Ñ–∞–∫—Ç–æ–º, –Ω–∞ –∏—Ö –≤–∏—Ç—Ä–∏–Ω–∞—Ö –≤—Å—ë –µ—â—ë –≤ –∏–∑–æ–±–∏–ª–∏–∏ –≤—Å—Ç—Ä–µ—á–∞—é—Ç—Å—è –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã —Å–æ–º–Ω–∏—Ç–µ–ª—å–Ω–æ–≥–æ –∫–∞—á–µ—Å—Ç–≤–∞ –∏ –ø—Ä–æ–∏—Å—Ö–æ–∂–¥–µ–Ω–∏—è. –í —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, –ø–æ —Å–ª–æ–≤–∞–º –∞–≤—Ç–æ—Ä–æ–≤ –æ–±—Ä–∞—â–µ–Ω–∏—è, Wildberries ¬´–≥—Ä–µ—à–∏—Ç¬ª –ø—Ä–æ–¥–∞–∂–µ–π –≤—Ä–µ–º–µ–Ω–Ω—ã—Ö ¬´–¥–æ–º–∞—à–Ω–∏—Ö¬ª –ø–ª–æ–º–± –¥–ª—è –∑—É–±–æ–≤ –ø–æ–¥ –≤–∏–¥–æ–º –≤–∏–Ω–∏—Ä–æ–≤, –∞ —Ç–∞–∫–∂–µ —Ä–∞–∑–ª–∏—á–Ω—ã—Ö –∫–∏—Ç–∞–π—Å–∫–∏—Ö –ø–∏—â–µ–≤—ã—Ö –¥–æ–±–∞–≤–æ–∫, –Ω–µ–∫–æ—Ç–æ—Ä—ã–µ –∏–∑ –∫–æ—Ç–æ—Ä—ã—Ö –æ–±–µ—â–∞—é—Ç –∏–∑–ª–µ—á–µ–Ω–∏–µ –¥–∞–∂–µ –æ—Ç —Ä–∞–∫–∞. –ü–æ –¥–∞–Ω–Ω—ã–º –ú–û–ó–ü, ¬´—Ñ–∏–æ–ª–µ—Ç–æ–≤—ã–π –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å¬ª –≤ —è–Ω–≤–∞—Ä–µ-–º–∞–µ 2025 –≥–æ–¥–∞ –ø–æ–ª—É—á–∏–ª –Ω–∞ 260% –±–æ–ª—å—à–µ –ø—Ä–µ–¥–æ—Å—Ç–µ—Ä–µ–∂–µ–Ω–∏–π, –≤—ã–Ω–µ—Å–µ–Ω–Ω—ã—Ö –ì–µ–Ω–ø—Ä–æ–∫—É—Ä–∞—Ç—É—Ä–æ–π. –û–±—â–µ—Å—Ç–≤–µ–Ω–Ω–∏–∫–∏ —Å—á–∏—Ç–∞—é—Ç, —á—Ç–æ Wildberries –¥–æ–ø—É—Å–∫–∞–µ—Ç —Ç–∞–∫–∏–µ —Ç–æ–≤–∞—Ä—ã –∫ –ø—Ä–æ–¥–∞–∂–µ ¬´—É–º—ã—à–ª–µ–Ω–Ω–æ –≤ —Ü–µ–ª—è—Ö –ø–æ–ª—É—á–µ–Ω–∏—è –≤—ã–≥–æ–¥—ã¬ª. –û–Ω–ª–∞–π–Ω-–ø–ª–æ—â–∞–¥–∫–∞ —Å –æ–±–≤–∏–Ω–µ–Ω–∏—è–º–∏ –∫–∞—Ç–µ–≥–æ—Ä–∏—á–µ—Å–∫–∏ –Ω–µ —Å–æ–≥–ª–∞—Å–Ω–∞: –û–ø—É–±–ª–∏–∫–æ–≤–∞–Ω–Ω–∞—è –≤ –≥–∞–∑–µ—Ç–µ ¬´–ö–æ–º–º–µ—Ä—Å–∞–Ω—Ç–™¬ª –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è –Ω–µ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É–µ—Ç –¥–µ–π—Å—Ç–≤–∏—Ç–µ–ª—å–Ω–æ—Å—Ç–∏. –ó–∞—è–≤–ª–µ–Ω–∏—è –æ —è–∫–æ–±—ã —É–º—ã—à–ª–µ–Ω–Ω–æ–π –ø—Ä–æ–¥–∞–∂–µ –Ω–∞ Wildberries –Ω–µ–∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –≤ –†–§ –¥–æ–±–∞–≤–æ–∫ –≤ —Ü–µ–ª—è—Ö –ø–æ–ª—É—á–µ–Ω–∏—è –≤—ã–≥–æ–¥—ã –Ω–µ –∏–º–µ—é—Ç –ø–æ–¥ —Å–æ–±–æ–π –Ω–∏–∫–∞–∫–∏—Ö –æ—Å–Ω–æ–≤–∞–Ω–∏–π. –£–∫–∞–∑–∞–Ω–Ω–∞—è –≤ –ø—É–±–ª–∏–∫–∞—Ü–∏–∏ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω–∞—è –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è –Ω–µ –æ–±—Ä–∞—â–∞–ª–∞—Å—å –≤ –∫–æ–º–ø–∞–Ω–∏—é, —á—Ç–æ —Å–≤–∏–¥–µ—Ç–µ–ª—å—Å—Ç–≤—É–µ—Ç –æ –∑–∞–∫–∞–∑–Ω–æ–º —Ö–∞—Ä–∞–∫—Ç–µ—Ä–µ –æ–±—Ä–∞—â–µ–Ω–∏—è –≤ —É–≥–æ–¥—É —Å–æ–≤—Å–µ–º –Ω–µ –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª—è–º. –£–º—ã—à–ª–µ–Ω–Ω–æ –∏–ª–∏ –Ω–µ—Ç, –Ω–æ –ø—É—Å—Ç—ã—à–∫–∏, –∞ –ø–æ—Ä–æ–π –∏ –ø—Ä–æ—Å—Ç–æ –æ–ø–∞—Å–Ω—ã–µ –¥–ª—è –∑–¥–æ—Ä–æ–≤—å—è –ë–ê–î—ã —Å ¬´–∑–∞–ø—Ä–µ—â—ë–Ω–∫–æ–π¬ª –≤ —Å–æ—Å—Ç–∞–≤–µ –ø–æ—è–≤–ª—è—é—Ç—Å—è –Ω–∞ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞—Ö —Ä–µ–≥—É–ª—è—Ä–Ω–æ. –ü–æ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º –ø–µ—Ä–≤–æ–π –º–∞—Å—à—Ç–∞–±–Ω–æ–π –ø—Ä–æ–≤–µ—Ä–∫–∏ –∏–∑-–∑–∞ –∂–∞–ª–æ–± –ø–æ–∫—É–ø–∞—Ç–µ–ª–µ–π, –†–æ—Å–∫–∞—á–µ—Å—Ç–≤–æ –Ω–∞—à–ª–æ –Ω–∞ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞—Ö –æ–∫–æ–ª–æ 60 —Ç—ã—Å. –ë–ê–î–æ–≤ –±–µ–∑ —Å–≤–∏–¥–µ—Ç–µ–ª—å—Å—Ç–≤ –æ –≥–æ—Å—Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏, 400 —Ç–æ–≤–∞—Ä–æ–≤ —Å –∑–∞–ø—Ä–µ—â–µ–Ω–Ω—ã–º–∏ –¥–ª—è –±–∏–æ–¥–æ–±–∞–≤–æ–∫ –≤–µ—â–µ—Å—Ç–≤–∞–º–∏, –≤–∫–ª—é—á–∞—è –∞—à–≤–∞–≥–∞–Ω–¥—É –∏ –ª–∏—Å—Ç—å—è –∫–æ–∫–∏, –∏ 200 –ª–µ–∫–∞—Ä—Å—Ç–≤ (–≤ —Ç.—á. —Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã—Ö), –∫–æ—Ç–æ—Ä—ã–µ –ø—Ä–æ–¥–∞–≤–∞–ª–∏ –ø–æ–¥ –≤–∏–¥–æ–º –ë–ê–î. –í –æ–±—â–µ–º, –Ω–∞ –¥–æ–±—Ä–æ—Å–æ–≤–µ—Å—Ç–Ω–æ—Å—Ç—å –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞ –Ω–∞–¥–µ–π—Å—è, –∞ —Å–∞–º –Ω–µ –ø–ª–æ—à–∞–π. –ü—Ä–æ–≤–µ—Ä—è–µ–º –∏ –ø–µ—Ä–µ–ø—Ä–æ–≤–µ—Ä—è–µ–º –≤—Å—ë, —á—Ç–æ –ø–æ–∫—É–ø–∞–µ–º –∏ –æ—Ç–∫–∞–∑—ã–≤–∞–µ–º—Å—è –æ—Ç —Å–æ–º–Ω–∏—Ç–µ–ª—å–Ω—ã—Ö —Ç–æ–≤–∞—Ä–æ–≤. –í –ú–û–ó–ü –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç –≤—ã–≤–µ—Å—Ç–∏ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å—ã –∏–∑-–ø–æ–¥ –¥–µ–π—Å—Ç–≤—É—é—â–∏—Ö –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏–π –Ω–∞ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏–µ –ø—Ä–æ–≤–µ—Ä–æ–∫ –∏ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª–µ–Ω–∏–µ –Ω–∞–¥–∑–æ—Ä–Ω—ã–º –æ—Ä–≥–∞–Ω–∞–º –ø–æ–ª–Ω–æ–º–æ—á–∏–π –ø–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—é ¬´–ø–æ–ª–Ω–æ—Ü–µ–Ω–Ω—ã—Ö —Å–∞–Ω–∫—Ü–∏–π –ø–æ –≤—Å–µ–º –≤—ã—è–≤–ª—è–µ–º—ã–º —Ñ–∞–∫—Ç–∞–º –ø—Ä–æ—Ç–∏–≤–æ–ø—Ä–∞–≤–Ω–æ–π –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""Public activists are asking Mishustin to curb 'unauthorized' medicines on marketplaces. The Moscow Consumer Protection Society (MOZP) has asked Prime Minister Mikhail Mishustin to look into the sale of unauthorized medicines on marketplaces. Despite claims by online platforms about fighting counterfeit dangerous goods, many questionable drugs are still available on their websites. Specifically, according to the society, Wildberries sells 'temporary home plasters' for teeth under the guise of dental veneers and various Chinese dietary supplements that promise to treat cancer. The society claims Wildberries allows these products to be sold 'intentionally for profit.' Wildberries denies this, stating that the published information in newspaper Kommersant does not match reality. The company says it regularly finds over 60,000 dietary supplements without registration certificates and more than 400 products with prohibited substances for dietary supplements, including ashwagandha and cinchona leaves. The society suggests removing marketplaces from existing restrictions on inspections and the use of full sanctions for all identified illegal activities.""
}"
2025-07-31T05:45:28+00:00,@bezrec,6366,https://t.me/bezrec/6366,"–í RNC Pharma –ø—Ä–æ–≤–µ—Ä–∏–ª–∏, –∫–∞–∫ –æ–±—Å—Ç–æ—è—Ç –¥–µ–ª–∞ —Å –≥–æ–º–µ–æ–ø–∞—Ç–∏–µ–π –≤ —Å—Ç—Ä–∞–Ω–µ. –ü–æ –∏—Ç–æ–≥–∞–º I-II –∫–≤–∞—Ä—Ç–∞–ª–∞ 2025 –≥–æ–¥–∞ –Ω–∞ —Ä–æ–∑–Ω–∏—á–Ω–æ–º —Ä—ã–Ω–∫–µ (–≤–∫–ª—é—á–∞—è –æ–Ω–ª–∞–π–Ω –∫–∞–Ω–∞–ª) –±—ã–ª–æ –ø—Ä–æ–¥–∞–Ω–æ 12,6 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ –≥–æ–º–µ–æ–ø–∞—Ç–∏—á–µ—Å–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ 8,8 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —á—Ç–æ –Ω–∞ 1,9% –±–æ–ª—å—à–µ –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –∏ –Ω–∞ 13,4% –≤ —Ä—É–±–ª—ë–≤–æ–º —ç–∫–≤–∏–≤–∞–ª–µ–Ω—Ç–µ –≥–æ–¥ –∫ –≥–æ–¥—É. –°–ø—Ä–æ—Å –Ω–∞ —Ç–∞–∫–∏–µ —Å—Ä–µ–¥—Å—Ç–≤–∞ —Å–∏–ª—å–Ω–æ —Ä–∞–∑–Ω–∏—Ç—Å—è –≤ –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏ –æ—Ç —Ä–µ–≥–∏–æ–Ω–∞. –¢–∞–∫, –≤ –∞–±—Å–æ–ª—é—Ç–Ω–æ–º –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–µ –Ω–∞–±–ª—é–¥–∞–µ—Ç—Å—è –æ—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω–∞—è –¥–∏–Ω–∞–º–∏–∫–∞, –≤ —Ç–æ–º —á–∏—Å–ª–µ –≤ –ú–æ—Å–∫–≤–µ (-1,9%) –∏ –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥–µ (-0,2%). –û–±—â–∏–π —Ä–æ—Å—Ç —Ä—ã–Ω–∫–∞ –æ–±–µ—Å–ø–µ—á–∏–≤–∞—é—Ç 16 —Å—É–±—ä–µ–∫—Ç–æ–≤. –ë–æ–ª—å—à–µ –≤—Å–µ–≥–æ –≥–æ–º–µ–æ–ø–∞—Ç–∏—é —É–≤–∞–∂–∞—é—Ç –≤ –ß–µ—á–Ω–µ (+20,8% –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö), –î–∞–≥–µ—Å—Ç–∞–Ω–µ (+11,2%) –∏ –ù–µ–Ω–µ—Ü–∫–æ–º –ê–û (+11,2%). –≠—Ç–∞ –∫–∞—Ç–µ–≥–æ—Ä–∏—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ —Ä–æ–∑–Ω–∏—Ü–µ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–∞ 454 —Ç–æ—Ä–≥–æ–≤—ã–º–∏ –º–∞—Ä–∫–∞–º–∏ –æ—Ç 32 –∫–æ–º–ø–∞–Ω–∏–π. –ë–æ–ª–µ–µ 84% –¥–µ–Ω–µ–∂–Ω–æ–≥–æ –æ–±—ä—ë–º–∞ —Ä—ã–Ω–∫–∞ –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ –Ω–µ–º–µ—Ü–∫—É—é ¬´–•–µ–µ–ª—å¬ª (38,4%), —Ä–æ—Å—Å–∏–π—Å–∫—É—é ¬´–ú–∞—Ç–µ—Ä–∏–∞ –ú–µ–¥–∏–∫–∞¬ª (28,1%) –∏ —Ñ—Ä–∞–Ω—Ü—É–∑—Å–∫—É—é ¬´–ë—É–∞—Ä–æ–Ω¬ª (17,8%). –ê—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç –ø—Ä–æ–¥—É–∫—Ü–∏–∏ —É —ç—Ç–∏—Ö –∏ –¥—Ä—É–≥–∏—Ö –∏–≥—Ä–æ–∫–æ–≤ –∏–∑ —Ç–æ–ø-10 —à–∏—Ä–æ–∫–∏–π. –ù–∞–ø—Ä–∏–º–µ—Ä, –≤ –ø–æ—Ä—Ç—Ñ–µ–ª–µ —É –ª–∏–¥–µ—Ä–∞ —Ä–µ–π—Ç–∏–Ω–≥–∞ 55 —Ç–æ—Ä–≥–æ–≤—ã—Ö –º–∞—Ä–æ–∫, –≥–ª–∞–≤–Ω–∞—è ‚Äî –¢—Ä–∞—É–º–µ–ª—å. –£ ¬´–ú–∞—Ç–µ—Ä–∏–∞ –ú–µ–¥–∏–∫–∞¬ª –∏ ¬´–ë—É–∞—Ä–æ–Ω–∞¬ª –ø–æ—Ä—Ç—Ñ–µ–ª–∏ –ø–æ—Å–∫—Ä–æ–º–Ω–µ–µ ‚Äî 16 –∏ 11 –±—Ä–µ–Ω–¥–æ–≤, –∞ –∞–±—Å–æ–ª—é—Ç–Ω—ã–º–∏ –ª–∏–¥–µ—Ä–∞–º–∏ –ø—Ä–æ–¥–∞–∂ —Å—Ç–∞–ª–∏ –ê–Ω–∞—Ñ–µ—Ä–æ–Ω –∏ –ì–æ–º–µ–æ–≤–æ–∫—Å. –ù–æ –∞–±—Å–æ–ª—é—Ç–Ω—ã–π —Ä–µ–∫–æ—Ä–¥—Å–º–µ–Ω –ø–æ –∫–æ–ª–∏—á–µ—Å—Ç–≤—É –±—Ä–µ–Ω–¥–æ–≤ (63 –ø–æ–∑–∏—Ü–∏–∏) ‚Äî ¬´–≠–¥–∞—Å¬ª. –£ –≤—Å–µ—Ö –∏–≥—Ä–æ–∫–æ–≤ –∏–∑ –ø–µ—Ä–≤–æ–π –¥–µ—Å—è—Ç–∫–∏ –Ω–∞–±–ª—é–¥–∞–ª–∞—Å—å –ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω–∞—è –¥–∏–Ω–∞–º–∏–∫–∞ –ø—Ä–æ–¥–∞–∂ –≤ –¥–µ–Ω—å–≥–∞—Ö. –ú–∞–∫—Å–∏–º–∞–ª—å–Ω—ã–π —Ä–µ–∑—É–ª—å—Ç–∞—Ç –ø–æ–∫–∞–∑–∞–ª–∞ –∞–Ω–≥–ª–∏–π—Å–∫–∞—è ¬´–ê.–ù–µ–ª—å—Å–æ–Ω —ç–Ω–¥ –ö–æ.¬ª. –ï—ë ¬´–∑–æ–ª–æ—Ç–∞—è –∞–Ω—Ç–∏–ª–æ–ø–∞¬ª ‚Äî –†–µ—Å–∫—å—é –†–µ–º–µ–¥–∏, –ø–æ–≤—ã—à–∞—é—â–∏–π —É—Å—Ç–æ–π—á–∏–≤–æ—Å—Ç—å –æ—Ä–≥–∞–Ω–∏–∑–º–∞ –∫ —Å—Ç—Ä–µ—Å—Å—É. –ü—Ä–∏ —ç—Ç–æ–º –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ –∫–æ–º–ø–∞–Ω–∏–π –ø–æ–∫–∞–∑–∞–ª–æ —Å–Ω–∏–∂–µ–Ω–∏–µ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–≥–æ –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏—è, –º–∞–∫—Å–∏–º–∞–ª—å–Ω–æ–µ —Å–æ–∫—Ä–∞—â–µ–Ω–∏–µ —Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–ª–æ—Å—å —É ¬´–ú–æ—Å–∫–æ–≤—Å–∫–æ–π —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π —Ñ–∞–±—Ä–∏–∫–∏¬ª (-10,8% –≥–æ–¥ –∫ –≥–æ–¥—É). –ü–æ–º–∏–º–æ –ø–µ—Ä–µ—á–∏—Å–ª–µ–Ω–Ω—ã—Ö –∏–≥—Ä–æ–∫–æ–≤, –≤ —Ç–æ–ø-10 –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –≥–æ–º–µ–æ–ø–∞—Ç–∏—á–µ—Å–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ø–æ –æ–±—ä—ë–º—É –¥–µ–Ω–µ–∂–Ω—ã—Ö –ø—Ä–æ–¥–∞–∂ –ø–æ–ø–∞–ª–∏: ¬´–ë–∏–æ–Ω–æ—Ä–∏–∫–∞¬ª, ¬´–ê–ª–∫–æ–π¬ª, ¬´–ó–µ–Ω—Ç–∏–≤–∞¬ª, ¬´–ì–æ–º–µ–æ–ø–∞—Ç–∏—á–µ—Å–∫–∞—è —Ñ–∞—Ä–º–∞—Ü–∏—è¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The homeopathic market in Russia grew by 1.9% in natural terms and 13.4% in ruble terms year-over-year, reaching sales of 12.6 million units and RUB88 billion in the retail market (including online channels) during I-II quarters of 2025. The overall market growth is driven by 16 regions, with the highest demand observed in Chechnya (+20.8%), Dagestan (+11.2%) and Nenets AO (+11.2%). The market is represented by 454 trade brands from 32 companies, with the majority of sales coming from German 'Heel' (38.4%), Russian 'Materna Medicina' (28.1%) and French 'Buaron' (17.8%). The market growth is driven by brands like Traumel, Anferon and Gomovoks. The market growth is driven by brands like Traumel, Anferon and Gomovoks. The market growth"
2025-07-30T14:58:46+00:00,@bezrec,6365,https://t.me/bezrec/6365,–ò –¥–µ–π—Å—Ç–≤–∏—Ç–µ–ª—å–Ω–æ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞,"{""skip"": true}"
2025-07-30T12:33:53+00:00,@bezrec,6364,https://t.me/bezrec/6364,"¬´–ó–¥—Ä–∞–≤—Ä–µ—Å—É—Ä—Å¬ª –ø—Ä–æ—Å–∏—Ç –≤–∫–ª—é—á–∏—Ç—å –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü ¬´—Ç–µ—Ä–∞–ø–∏—é —Å–ø–∞—Å–µ–Ω–∏—è¬ª –¥–ª—è –±–æ–ª—å–Ω—ã—Ö –í–ò–ß. –ö–æ–º–∏—Å—Å–∏—è –ø–æ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—é –ø–µ—Ä–µ—á–Ω–µ–π —Å–æ–±–µ—Ä—ë—Ç—Å—è 6 –∏ 7 –∞–≤–≥—É—Å—Ç–∞. –í –ø–µ—Ä–≤—ã–π –¥–µ–Ω—å –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è —Ä–∞—Å—Å–º–æ—Ç—Ä–µ—Ç—å –ø—è—Ç–Ω–∞–¥—Ü–∞—Ç—å –∫–∞–Ω–¥–∏–¥–∞—Ç–æ–≤ –Ω–∞ –≤–∫–ª—é—á–µ–Ω–∏–µ –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü : –ø—ç–≥—É–Ω–∏–≥–∞–ª–∑–∏–¥–∞–∑–∞ –∞–ª—å—Ñ–∞, –ª–æ–Ω–æ–∫—Ç–æ–∫–æ–≥ –∞–ª—å—Ñ–∞, –ª—É—Å–ø–∞—Ç–µ—Ä—Ü–µ–ø—Ç, —Ñ–∏–Ω–µ—Ä–µ–Ω–æ–Ω, –æ–º–µ–≥–∞-3 –∫–∏—Å–ª–æ—Ç —ç—Ç–∏–ª–æ–≤—ã–µ —ç—Ñ–∏—Ä—ã 90, –ø—Ä–µ—Ç–æ–º–∞–Ω–∏–¥, —Ñ–æ—Å—Ç–µ–º—Å–∞–≤–∏—Ä, –∏—Ä–∏–Ω–æ—Ç–µ–∫–∞–Ω, —ç–Ω–∫–æ—Ä–∞—Ñ–µ–Ω–∏–±, –±–∏–Ω–∏–º–µ—Ç–∏–Ω–∏–±, –∫–∞–ø–∏–≤–∞—Å–µ—Ä—Ç–∏–±, –∫–∞–º—Ä–µ–ª–∏–∑—É–º–∞–±, —ç–Ω—Ñ–æ—Ä—Ç—É–º–∞–± –≤–µ–¥–æ—Ç–∏–Ω, –≥–ª–æ—Ñ–∏—Ç–∞–º–∞–±, –º–æ—Å—É–Ω–µ—Ç—É–∑—É–º–∞–±. –ï—â—ë –≤–æ—Å–µ–º—å –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –æ—Å—Ç–∞–≤—è—Ç –Ω–∞ –≤—Ç–æ—Ä–æ–π –¥–µ–Ω—å: –¥–∞—Ä–æ–ª—É—Ç–∞–º–∏–¥, –ø—ç–≥—Ñ–∏–ª–≥—Ä–∞—Å—Ç–∏–º, —Ä–∞–≤—É–ª–∏–∑—É–º–∞–±, –¥–∞–Ω–∏–∫–æ–ø–∞–Ω, –∏–ø—Ç–∞–∫–æ–ø–∞–Ω, –±–µ–ª—É–º–æ—Å—É–¥–∏–ª, –æ—Ñ–∞—Ç—É–º—É–º–∞–±, –±—É–¥–µ—Å–æ–Ω–∏–¥+—Å–∞–ª—å–±—É—Ç–∞–º–æ–ª. –î–≤–∞ –ú–ù–ù –∏–∑ –ø–µ—Ä–µ—á–Ω—è –ñ–ù–í–õ–ü —Ö–æ—Ç—è—Ç –∏—Å–∫–ª—é—á–∏—Ç—å: –∏–Ω—Ç–µ—Ä—Ñ–µ—Ä–æ–Ω –≥–∞–º–º–∞ —á–µ–ª–æ–≤–µ—á–µ—Å–∫–∏–π —Ä–µ–∫–æ–º–±–∏–Ω–∞–Ω—Ç–Ω—ã–π –∏ –º–µ–≥–ª—é–º–∏–Ω–∞ –∞–∫—Ä–∏–¥–æ–Ω–∞—Ü–µ—Ç–∞—Ç. –ò–∑–º–µ–Ω–µ–Ω–∏–π –≤ –ø–µ—Ä–µ—á–Ω–µ 14–í–ó–ù –Ω–µ –ø—Ä–µ–¥–≤–∏–¥–∏—Ç—Å—è. –ö–∞–∫ –∏ –ø–æ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º –ø–µ—Ä–≤–æ–≥–æ –≤ 2025 –≥–æ–¥—É –∑–∞—Å–µ–¥–∞–Ω–∏—è. –¢–æ–≥–¥–∞ –ø–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü –ø–æ–ø–æ–ª–Ω–∏–ª—Å—è –ª–∏—à—å –¥–≤—É–º—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º–∏, –∞ 14 –í–ó–ù –∏ –≤–æ–≤—Å–µ –æ—Å—Ç–∞–ª—Å—è –Ω–µ —É –¥–µ–ª. –í –ø—Ä–µ–¥–¥–≤–µ—Ä–∏–∏ –∑–∞—Å–µ–¥–∞–Ω–∏—è ¬´–ó–¥—Ä–∞–≤—Ä–µ—Å—É—Ä—Å¬ª –ø–æ–ø—Ä–æ—Å–∏–ª –ú–∏–Ω–∑–¥—Ä–∞–≤ –∑–∞ —Ñ–æ—Å—Ç–µ–º—Å–∞–≤–∏—Ä. –≠–∫—Å–ø–µ—Ä—Ç—ã –≥—Ä—É–ø–ø—ã –Ω–∞–ø—Ä–∞–≤–∏–ª–∏ –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω–æ–µ –æ–±—Ä–∞—â–µ–Ω–∏–µ —Ä–µ–≥—É–ª—è—Ç–æ—Ä—É —Å –ø—Ä–æ—Å—å–±–æ–π –ø–æ–¥–¥–µ—Ä–∂–∞—Ç—å –≤–∫–ª—é—á–µ–Ω–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –í–ò–ß –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü. –í –ì–†–õ–° –µ—Å—Ç—å —Ç–æ–ª—å–∫–æ –æ–¥–∏–Ω –ø—Ä–µ–ø–∞—Ä–∞—Ç —Å —ç—Ç–∏–º –ú–ù–ù ‚Äî –†—É–∫–æ–º–±–∏–∞ –æ—Ç –∞–Ω–≥–ª–∏–π—Å–∫–æ–π ViiV Healthcare, —Å–æ–∑–¥–∞–Ω–Ω–æ–π –∫–∞–∫ —Å–æ–≤–º–µ—Å—Ç–Ω–æ–µ –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏–µ Pfizer –∏ GlaxoSmithKline. –≠—Ç–æ –≤—Ç–æ—Ä–∞—è –ø–æ –≤–µ–ª–∏—á–∏–Ω–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏—è –ø–æ—Å–ª–µ Gilead Sciences, –∫–æ—Ç–æ—Ä–∞—è —Ä–∞–±–æ—Ç–∞–µ—Ç –Ω–∞–¥ –ª–µ—á–µ–Ω–∏–µ–º –í–ò–ß. –ê–≤—Ç–æ—Ä—ã –æ–±—Ä–∞—â–µ–Ω–∏—è –æ—Ç–º–µ—á–∞—é—Ç, —á—Ç–æ —Ñ–æ—Å—Ç–µ–º—Å–∞–≤–∏—Ä –Ω–µ–∑–∞–º–µ–Ω–∏–º –¥–ª—è —Å–∞–º–æ–π —É—è–∑–≤–∏–º–æ–π –≥—Ä—É–ø–ø—ã –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ ‚Äî –ª—é–¥–µ–π —Å –í–ò–ß, —É –∫–æ—Ç–æ—Ä—ã—Ö —Ä–∞–∑–≤–∏–ª–∞—Å—å –º–Ω–æ–∂–µ—Å—Ç–≤–µ–Ω–Ω–∞—è –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–∞—è —É—Å—Ç–æ–π—á–∏–≤–æ—Å—Ç—å (–ú–õ–£). –¢–∞–∫–∏–º –ø–∞—Ü–∏–µ–Ω—Ç–∞–º –Ω–µ –ø–æ–¥—Ö–æ–¥—è—Ç —Å—Ç–∞–Ω–¥–∞—Ä—Ç–Ω—ã–µ —Å—Ö–µ–º—ã –∞–Ω—Ç–∏—Ä–µ—Ç—Ä–æ–≤–∏—Ä—É—Å–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –∏ —Ç—Ä–µ–±—É–µ—Ç—Å—è —Ç–∞–∫ –Ω–∞–∑—ã–≤–∞–µ–º–∞—è ¬´—Ç–µ—Ä–∞–ø–∏—è —Å–ø–∞—Å–µ–Ω–∏—è¬ª. –ì–æ–¥–æ–≤–æ–π –∫—É—Ä—Å –ª–µ—á–µ–Ω–∏—è —Å—Ç–æ–∏—Ç —Ä–µ–∫–æ—Ä–¥–Ω—ã–µ 3 –º–ª–Ω —Ä—É–±–ª–µ–π. ¬´–ó–¥—Ä–∞–≤—Ä–µ—Å—É—Ä—Å¬ª –Ω–∞—Å—Ç–∞–∏–≤–∞–µ—Ç ¬´–Ω–∞ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–º –∏ –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ–º —Å–Ω–∏–∂–µ–Ω–∏–∏ —Ü–µ–Ω—ã —Å–æ —Å—Ç–æ—Ä–æ–Ω—ã –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è¬ª ‚Äî –∫–∞–∫ –º–∏–Ω–∏–º—É–º –Ω–∞ 15-20% –æ—Ç —É–∫–∞–∑–∞–Ω–Ω–æ–π –≤ —Ä–µ–≥–¥–æ—Å—å–µ. –ï—Å–ª–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç –±—É–¥–µ—Ç –∑–∞–∫—É–ø–∞—Ç—å—Å—è —Ü–µ–Ω—Ç—Ä–∞–ª–∏–∑–æ–≤–∞–Ω–Ω–æ, —É —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –∑–∞–∫—É–ø—â–∏–∫–∞ –ø–æ—è–≤—è—Ç—Å—è —Ä—ã—á–∞–≥–∏ –¥–ª—è –ø–µ—Ä–µ–≥–æ–≤–æ—Ä–æ–≤ –ø–æ –æ–±—ä—ë–º—É –∏ —Ü–µ–Ω–µ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement, shortage"",
  ""impact"": ""high"",
  ""english"": ""Zdravresource requests the inclusion of 'therapeutic rescue' therapy for HIV patients. The Commission to form the list will meet on August 6 and 7. On the first day, fifteen candidates for inclusion in the HIV-NWLP list will be considered: pegylated zidovudine, lonopak zidovudine, luspatercept, fosampren, pritelizumab, fosevusavir, irinotecan, enfolazib, binimetinib, capivasertib, camrelizumab, enfortumab vedotin, glofitamab, mosunetuzumab. Eight more drugs will be considered on the second day: darolutamide, pegfilgrastim, ravulizumab, danipran, iptakopan, belomosudil, ofatumumab, budesonide + salbutamol. Two drugs from the HIV-NWLP list want to be removed: recombinant human interfer"
2025-07-30T10:14:40+00:00,@bezrec,6363,https://t.me/bezrec/6363,"–ö–∏–±–µ—Ä–∞—Ç–∞–∫–∞ –Ω–∞ –∞–ø—Ç–µ–∫–∏ ¬´–°—Ç–æ–ª–∏—á–∫–∏¬ª –æ–±–æ—à–ª–∞—Å—å –±–µ–∑ —É—Ç–µ—á–∫–∏ –¥–∞–Ω–Ω—ã—Ö –∫–ª–∏–µ–Ω—Ç–æ–≤. –í —Å–µ—Ç–∏ —Å–æ–æ–±—â–∏–ª–∏, —á—Ç–æ —Å–µ–π—á–∞—Å –≤–µ–¥—É—Ç—Å—è —Ä–∞–±–æ—Ç—ã –ø–æ –≤–æ—Å—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—é —Å–µ—Ä–≤–∏—Å–æ–≤. –ë—Ä–æ–Ω–∏—Ä–æ–≤–∞–Ω–∏–µ –∏ –¥–æ—Å—Ç—É–ø –∫ –ø—Ä–æ–≥—Ä–∞–º–º–∞–º –ª–æ—è–ª—å–Ω–æ—Å—Ç–∏ –Ω–∏ —É ¬´–°—Ç–æ–ª–∏—á–µ–∫¬ª, –Ω–∏ —É ¬´–ù–µ–æ—Ñ–∞—Ä–º–∞¬ª –ø–æ-–ø—Ä–µ–∂–Ω–µ–º—É –Ω–µ–¥–æ—Å—Ç—É–ø–Ω—ã. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-07-30T08:59:40+00:00,@bezrec,6362,https://t.me/bezrec/6362,"–ü—Ä–æ–¥–æ–ª–∂–∞–µ–º –ø—É—Ç–µ—à–µ—Å—Ç–≤–∏–µ –ø–æ –û–≠–ó ¬´–î—É–±–Ω–∞¬ª. –ì–µ—Ä–æ–π —Å–µ–≥–æ–¥–Ω—è—à–Ω–µ–≥–æ –≤—ã–ø—É—Å–∫–∞ —Ä—É–±—Ä–∏–∫–∏ #–í–æ–ª—à–µ–±–Ω–∏–∫–∏–°—Ç—Ä–∞–Ω—ã–û–≠–ó ‚Äî –û–û–û ¬´–ê–ª—Å–∏–≥–º–∞¬ª ‚Äî ¬´–¥–æ—á–∫–∞¬ª –ê–û ¬´–ê–ª—Ç–µ–≥—Ä–∞¬ª. ¬´–ê–ª—Å–∏–≥–º–∞¬ª –±—ã–ª–∞ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–∞ –≤ ¬´–î—É–±–Ω–µ¬ª 25 –∏—é–Ω—è 2024 –≥–æ–¥–∞. –ö–æ–º–ø–∞–Ω–∏—è —Ä–µ–∞–ª–∏–∑—É–µ—Ç –∏–Ω–≤–µ—Å—Ç–ø—Ä–æ–µ–∫—Ç –ø–æ —Å–æ–∑–¥–∞–Ω–∏—é –Ω–∞—É—á–Ω–æ-–ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∫–æ–º–ø–ª–µ–∫—Å–∞ –ø–ª–æ—â–∞–¥—å—é 5,2 —Ç—ã—Å. –∫–≤.–º –¥–ª—è —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –∏ –≤—ã–ø—É—Å–∫–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤, –≤–∫–ª—é—á–∞—è –¥–∂–µ–Ω–µ—Ä–∏–∫–∏. –û—Å–Ω–æ–≤–Ω–∞—è —Ü–µ–ª—å ‚Äî —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∞ –∏ –≤—ã–≤–æ–¥ –Ω–∞ —Ä—ã–Ω–æ–∫ –ø—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤—ã—Ö –≥–æ—Ä–º–æ–Ω–∞–ª—å–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –∞–Ω—Ç–∞–≥–æ–Ω–∏—Å—Ç–æ–≤ –≥–æ—Ä–º–æ–Ω–æ–≤. –¢–∞–∫–∂–µ –≤ –ø–ª–∞–Ω–∞—Ö ‚Äî –æ—Å—É—â–µ—Å—Ç–≤–ª–µ–Ω–∏–µ –ù–ò–û–ö–† –≤ –æ–±–ª–∞—Å—Ç–∏ –Ω–æ–≤—ã—Ö –∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫–æ–≤ –∏ –æ–Ω–∫–æ–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Å–æ–≤–º–µ—Å—Ç–Ω–æ —Å –ì–ö ¬´–ê–ª–§–∞—Ä–º–∞¬ª. –ü–æ —Å–ª–æ–≤–∞–º –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—è –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—è –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ ‚Äì –º–∏–Ω–∏—Å—Ç—Ä–∞ –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–π, –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏ –∏ –Ω–∞—É–∫–∏ –ú–æ—Å–∫–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –ï–∫–∞—Ç–µ—Ä–∏–Ω—ã –ó–∏–Ω–æ–≤—å–µ–≤–æ–π, –ø—Ä–æ–µ–∫—Ç —Å–æ–∑–¥–∞–Ω–∏—è –∑–∞–≤–æ–¥–∞ –ø–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤—É –ø—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –æ–±–æ–π–¥—ë—Ç—Å—è –≤ 1,8 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –õ–µ—Ç–æ–º –ø—Ä–æ—à–ª–æ–≥–æ –≥–æ–¥–∞ –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–∏ –≤ –ø—Ä–æ–µ–∫—Ç –æ—Ü–µ–Ω–∏–≤–∞–ª–∏—Å—å –≤ –±–æ–ª–µ–µ —Å–∫—Ä–æ–º–Ω—ã–µ 780 –º–ª–Ω —Ä—É–±–ª–µ–π. –ü–µ—Ä–≤–∞—è –ø–æ–ª–æ–≤–∏–Ω–∞ –ø—Ä–æ–µ–∫—Ç–∞ —Å—Ç–∞—Ä—Ç—É–µ—Ç —É–∂–µ –≤ 2027 –≥–æ–¥—É, –ø–æ–ª–Ω—ã–π –∑–∞–ø—É—Å–∫ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –≤ 2029 –≥–æ–¥—É. –ü–æ—Å–ª–µ –≤—ã—Ö–æ–¥–∞ –Ω–∞ –ø–æ–ª–Ω—É—é –º–æ—â–Ω–æ—Å—Ç—å –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏–µ –±—É–¥–µ—Ç –≤—ã–ø—É—Å–∫–∞—Ç—å –±–æ–ª–µ–µ 140 –º–ª–Ω —Ç–∞–±–ª–µ—Ç–æ–∫ –∏ –∫–∞–ø—Å—É–ª –≤ –≥–æ–¥. –ü–æ –¥–∞–Ω–Ω—ã–º Rusprofile, –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–π —É—á—Ä–µ–¥–∏—Ç–µ–ª—å ¬´–ê–ª—Å–∏–≥–º—ã¬ª ‚Äî –ê–û ¬´–ê–ª—Ç–µ–≥—Ä–∞¬ª (–≤—Ö–æ–¥–∏—Ç –≤ ¬´–ê–ª—Ñ–∞—Ä–º–∞¬ª), –∫–æ—Ç–æ—Ä–æ–º—É –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∏—Ç 100% —É—Å—Ç–∞–≤–Ω–æ–≥–æ –∫–∞–ø–∏—Ç–∞–ª–∞ –≤ —Ä–∞–∑–º–µ—Ä–µ 100 —Ç—ã—Å. —Ä—É–±–ª–µ–π. –ì–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–º —Å –º–æ–º–µ–Ω—Ç–∞ –æ—Å–Ω–æ–≤–∞–Ω–∏—è –∏ –¥–æ—á–µ—Ä–Ω–µ–π, –∏ –º–∞—Ç–µ—Ä–∏–Ω—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–π —á–∏—Å–ª–∏—Ç—Å—è –û–ª—å–≥–∞ –¢—É—Ä—á–∞–Ω–∏–Ω–æ–≤–∞. –§–∏–Ω–∞–Ω—Å–æ–≤—ã–µ –ø–æ–∫–∞–∑–∞—Ç–µ–ª–∏ –∑–∞ 2024 –≥–æ–¥: –≤—ã—Ä—É—á–∫–∞ ‚Äî 0 —Ä—É–±–ª–µ–π, –ø—Ä–∏–±—ã–ª—å –ø–æ–∫–∞ –≤ –º–∏–Ω—É—Å–µ (-4 –º–ª–Ω —Ä—É–±–ª–µ–π). ¬´–ê–ª—Ç–µ–≥—Ä–∞¬ª –≤ 2024 –≥–æ–¥—É –Ω–∞—Ä–∞—Å—Ç–∏–ª–∞ –≤—ã—Ä—É—á–∫—É –Ω–∞ 144%, –¥–æ 2,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, –ø—Ä–∏–±—ã–ª—å —É–≤–µ–ª–∏—á–∏–ª–∞—Å—å –Ω–∞ 53%, –¥–æ 1 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,pharmacovigilance,hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""The company, AlSigma registered in Dubna on June 25, 2024. It plans to develop and produce drugs including hormonal anti-cancer drugs and hormone antagonists in a 52,000 sqm research and production complex. The project is expected to cost 1.8 billion rubles, with the first half of the project starting in 2027 and full operation planned for 2029. The company aims to produce over 140 million tablets and capsules annually after full capacity is reached. The financial performance for the year 2024 shows a loss of -4 million rubles.""
}"
2025-07-30T05:20:29+00:00,@bezrec,6361,https://t.me/bezrec/6361,"–í –†–æ—Å—Å–∏–∏ –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç —Ä–∞—Å—Ç–∏ —Å–ø—Ä–æ—Å –Ω–∞ –ø—Ä–æ—Ç–∏–≤–æ—Ç—Ä–µ–≤–æ–∂–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã. –ü–æ –¥–∞–Ω–Ω—ã–º RNC Pharma, –≤ I-II –∫–≤–∞—Ä—Ç–∞–ª–µ 2025 –≥–æ–¥–∞ –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º —Ä—ã–Ω–∫–µ –±—ã–ª–æ –ø—Ä–æ–¥–∞–Ω–æ –±–æ–ª–µ–µ 9,3 –º–ª–Ω. —É–ø–∞–∫–æ–≤–æ–∫ –∞–Ω–∫—Å–∏–æ–ª–∏—Ç–∏–∫–æ–≤ (—Ç—Ä–∞–Ω–∫–≤–∏–ª–∏–∑–∞—Ç–æ—Ä–æ–≤) –Ω–∞ —Å—É–º–º—É 4,6 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –≠—Ç–æ –Ω–∞ 16,9% –±–æ–ª—å—à–µ –≤ –¥–µ–Ω–µ–∂–Ω–æ–º –∏ –Ω–∞ 9,8% –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ –≥–æ–¥ –∫ –≥–æ–¥—É. –í 2024 –≥–æ–¥—É –ø–æ–∫–∞–∑–∞—Ç–µ–ª–∏ –ø—Ä–∏—Ä–æ—Å—Ç–∞ –∫ 2023 –≥–æ–¥—É –≤ –¥–µ–Ω—å–≥–∞—Ö –±—ã–ª–∏ –ø—Ä–∏–º–µ—Ä–Ω–æ —Ç–µ–º–∏ –∂–µ (17,3%), –∞ –≤–æ—Ç –¥–∏–Ω–∞–º–∏–∫–∞ –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö –±—ã–ª–∞ —Å–∫—Ä–æ–º–Ω–µ–µ (+5,2%). 32,8% –¥–µ–Ω–µ–∂–Ω–æ–≥–æ –æ–±—ä—ë–º–∞ —Ä–æ–∑–Ω–∏—á–Ω–æ–≥–æ —Ä—ã–Ω–∫–∞ –ø—Ä–æ—Ç–∏–≤–æ—Ç—Ä–µ–≤–æ–∂–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ø—Ä–∏—à–ª–∏—Å—å –Ω–∞ –ú–æ—Å–∫–≤—É, –ú–æ—Å–∫–æ–≤—Å–∫—É—é –æ–±–ª–∞—Å—Ç—å, –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥ –∏ –ö—Ä–∞—Å–Ω–æ–¥–∞—Ä—Å–∫–∏–π –∫—Ä–∞–π. –ó–¥–µ—Å—å –¥–∏–Ω–∞–º–∏–∫–∞ —Å–æ—Å—Ç–∞–≤–∏–ª–∞ –æ—Ç 7% –¥–æ 9% –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö –∏ –æ—Ç 13% –¥–æ 18% –≤ —Ä—É–±–ª—ë–≤–æ–º —ç–∫–≤–∏–≤–∞–ª–µ–Ω—Ç–µ. –ú–µ–Ω—å—à–µ –≤—Å–µ–≥–æ –∞–Ω–∫—Å–∏–æ–ª–∏—Ç–∏–∫–æ–≤ –∏—Å–ø–æ–ª—å–∑—É—é—Ç –≤ –ù–µ–Ω–µ—Ü–∫–æ–º –ê–û, –†–µ—Å–ø—É–±–ª–∏–∫–µ –¢—É–≤–∞ –∏ –ß—É–∫–æ—Ç—Å–∫–æ–º –ê–û, —Å—É–º–º–∞—Ä–Ω–æ –∑–∞ –ø–µ—Ä–∏–æ–¥ –≤ —ç—Ç–∏—Ö —Ä–µ–≥–∏–æ–Ω–∞—Ö –±—ã–ª–æ –ø—Ä–æ–¥–∞–Ω–æ –≤—Å–µ–≥–æ 5,9 —Ç—ã—Å. —É–ø–∞–∫–æ–≤–æ–∫. –≠—Ç–∞ –∫–∞—Ç–µ–≥–æ—Ä–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–∞ 31 —Ç–æ—Ä–≥–æ–≤–æ–π –º–∞—Ä–∫–æ–π –æ—Ç 26 –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π. –ê–±—Å–æ–ª—é—Ç–Ω—ã–π –ª–∏–¥–µ—Ä –ø—Ä–æ–¥–∞–∂ –≤ –¥–µ–Ω–µ–∂–Ω–æ–º –∏ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ ‚Äì –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã–π —Ä–æ—Å—Å–∏–π—Å–∫–∏–π –ê—Ñ–æ–±–∞–∑–æ–ª –æ—Ç ¬´–û—Ç–∏—Å–∏—Ñ–∞—Ä–º¬ª. –ù–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –ø–æ—á—Ç–∏ 45% —Ä—ã–Ω–∫–∞, –Ω–æ –¥–∏–Ω–∞–º–∏–∫–∞ –ø–æ –Ω–µ–º—É (12%) –æ—Ç—Å—Ç–∞—ë—Ç –æ—Ç —Å—Ä–µ–¥–Ω–µ–π –ø–æ –≥—Ä—É–ø–ø–µ. –ù–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ ‚Äî –ì—Ä–∞–Ω–¥–∞–∫—Å–∏–Ω –æ—Ç ¬´–≠–≥–∏—Å¬ª (¬´–°–µ—Ä–≤—å–µ –≥—Ä—É–ø–ø¬ª), –∑–∞ –≥–æ–¥ –Ω–∞—Ä–∞—Å—Ç–∏–≤—à–∏–π –ø—Ä–æ–¥–∞–∂–∏ –Ω–∞ 18%. –ó–∞–º—ã–∫–∞–µ—Ç —Ç—Ä–æ–π–∫—É –ª–∏–¥–µ—Ä–æ–≤ –ê–¥–∞–ø—Ç–æ–ª (¬´–û–ª–∞–π–Ω—Ñ–∞—Ä–º¬ª). –ü—Ä–∏ —ç—Ç–æ–º –ø—Ä–µ–ø–∞—Ä–∞—Ç –Ω–∞—Ä—è–¥—É —Å –§–µ–Ω–∞–∑–µ–ø–∞–º–æ–º –æ—Ç ¬´–í–∞–ª–µ–Ω—Ç—ã¬ª –æ—Ç–ª–∏—á–∞–µ—Ç—Å—è –º–∏–Ω–∏–º–∞–ª—å–Ω–æ–π —Ä—É–±–ª—ë–≤–æ–π –¥–∏–Ω–∞–º–∏–∫–æ–π. –§–∏–∑–∏—á–µ—Å–∫–∏–π –æ–±—ä—ë–º –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏—è —ç—Ç–∏—Ö –ø—Ä–æ–¥—É–∫—Ç–æ–≤ —Å–Ω–∏–∑–∏–ª—Å—è –Ω–∞ 10% –∏ 11% —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ. –ú–∞–∫—Å–∏–º–∞–ª—å–Ω—É—é –¥–∏–Ω–∞–º–∏–∫—É –ø–æ–∫–∞–∑–∞–ª –°—Ç—Ä–µ–∑–∞–º –æ—Ç —Ñ—Ä–∞–Ω—Ü—É–∑—Å–∫–æ–π ¬´–ë–∏–æ–∫–æ–¥–µ–∫—Å¬ª, –∑–∞ –≥–æ–¥ —Ä—É–±–ª—ë–≤—ã–π –æ–±—ä—ë–º –ø—Ä–æ–¥–∞–∂ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –≤—ã—Ä–æ—Å –Ω–∞ 54%. –í —Ç–æ–ø-10 –∞–Ω–∫—Å–∏–æ–ª–∏—Ç–∏–∫–æ–≤ —Ç–∞–∫–∂–µ –ø–æ–ø–∞–ª–∏ –ê—Ç–∞—Ä–∞–∫—Å (¬´–Æ–°–ë –§–∞—Ä–º–∞¬ª), –ê–ª–ø—Ä–∞–∑–æ–ª–∞–º (¬´–û—Ä–≥–∞–Ω–∏–∫–∞¬ª), –°–µ–ª–∞–Ω–∫ (¬´–ü–µ–ø—Ç–æ–≥–µ–Ω¬ª), –¢–æ—Ñ–∏–∑–æ–ø–∞–º (¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º¬ª + 2 –∫–æ–º–ø–∞–Ω–∏–∏) –∏ –°–ø–∏—Ç–æ–º–∏–Ω (¬´–°–µ—Ä–≤—å–µ¬ª). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, shortage, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""There is an increase in demand for sedative drugs in Russia. According to RNC Pharma data, the Russian market saw a 16.9% increase in sales of sedative drugs (tranquilizers) to RUB 46 billion and a 9.8% increase in physical units year-over-year from January to June 2025 compared to the same period last year. Moscow, Moscow Oblast, St. Petersburg, and Krasnodar Krai accounted for 32.8% of the RUB volume, with a year-over-year increase in physical units ranging from 7% to 9%. The leader in terms of RUB volume is the original Russian Afobazol from 'Otisifarma' (45% of the market), but its sales growth (12%) is slower than the average. The second place is Granaxin from 'Egis' (Servie Group)' with a year-over-year increase of 18%. The third place is Adaptol from 'Olyfinfarm' with"
2025-07-29T14:34:39+00:00,@bezrec,6360,https://t.me/bezrec/6360,"FDA –æ–¥–æ–±—Ä–∏–ª–æ –ø–µ—Ä–≤—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –í–ò–ß —Å 99,9% —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å—é. Yeztugo (–ª–µ–Ω–∞–∫–∞–ø–∞–≤–∏—Ä) –æ—Ç Gilead —Å—Ç–∞–ª –ø–µ—Ä–≤–æ–π –≤ –º–∏—Ä–µ –∏–Ω—ä–µ–∫—Ü–∏–µ–π, –æ–±–µ—Å–ø–µ—á–∏–≤–∞—é—â–µ–π –ø–æ—á—Ç–∏ 100% –∑–∞—â–∏—Ç—É –æ—Ç –∑–∞—Ä–∞–∂–µ–Ω–∏—è. –í –ö–ò, —Å—Ä–∞–≤–Ω–∏–≤–∞—é—â–µ–º —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –∏–Ω—ä–µ–∫—Ü–∏–æ–Ω–Ω–æ–≥–æ –ª–µ–Ω–∞–∫–∞–ø–∞–≤–∏—Ä–∞ –∏ —Ç–∞–±–ª–µ—Ç–∏—Ä–æ–≤–∞–Ω–Ω–æ–π –¢—Ä—É–≤–∞–¥—ã —Ç–æ–≥–æ –∂–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è, —Ç–æ–ª—å–∫–æ –¥–≤–∞ —É—á–∞—Å—Ç–Ω–∏–∫–∞ –∏–∑ 2179 –∑–∞—Ä–∞–∑–∏–ª–∏—Å—å –í–ò–ß. –≠—Ç–æ –º–µ–Ω–µ–µ 1%. –í –≥—Ä—É–ø–ø–µ –ø—Ä–∏–Ω–∏–º–∞–≤—à–∏—Ö –¢—Ä—É–≤–∞–¥—É –∏–∑ 1086 —á–µ–ª–æ–≤–µ–∫ –±—ã–ª–æ –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–Ω–æ 9 –∑–∞–±–æ–ª–µ–≤—à–∏—Ö. –ì–ª–∞–≤–Ω–∞—è ¬´—Ñ–∏—à–∫–∞¬ª –ª–µ–Ω–∞–∫–∞–ø–∞–≤–∏—Ä–∞ ‚Äî –≤ –µ–≥–æ —Ä–µ–∂–∏–º–µ –¥–æ–∑–∏—Ä–æ–≤–∞–Ω–∏—è. –ò–Ω—ä–µ–∫—Ü–∏–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –ø—Ä–µ–¥–Ω–∞–∑–Ω–∞—á–µ–Ω—ã –¥–ª—è –≤–≤–µ–¥–µ–Ω–∏—è –¥–≤–∞–∂–¥—ã –≤ –≥–æ–¥, —Ç–æ–≥–¥–∞ –∫–∞–∫ —Ç–∞–±–ª–µ—Ç–∫–∏ –Ω—É–∂–Ω–æ –ø—Ä–∏–Ω–∏–º–∞—Ç—å –µ–∂–µ–¥–Ω–µ–≤–Ω–æ. –≠—Ç–æ –æ–±–µ—Å–ø–µ—á–∏—Ç –Ω–µ–ø—Ä–µ—Ä—ã–≤–Ω–æ—Å—Ç—å –ª–µ—á–µ–Ω–∏—è –¥–ª—è –Ω–µ –∏–º–µ—é—â–∏—Ö –ø–æ—Å—Ç–æ—è–Ω–Ω–æ–≥–æ –¥–æ—Å—Ç—É–ø–∞ –∫ –º–µ–¥–ø–æ–º–æ—â–∏, –∞ —Ç–∞–∫–∂–µ –¥–ª—è —Ç–µ—Ö, –∫—Ç–æ –±—Ä–æ—Å–∞–µ—Ç —Ç–µ—Ä–∞–ø–∏—é –∏–∑-–∑–∞ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ —á–∞—Å—Ç–æ–≥–æ –ø—Ä–∏–µ–º–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤. –†–∞–Ω–µ–µ –≤ —ç—Ç–æ–º –º–µ—Å—è—Ü–µ Gilead –æ–±—ä—è–≤–∏–ª–∞ –æ –ø–∞—Ä—Ç–Ω–µ—Ä—Å—Ç–≤–µ —Å –ì–ª–æ–±–∞–ª—å–Ω—ã–º —Ñ–æ–Ω–¥–æ–º –¥–ª—è –±–æ—Ä—å–±—ã —Å–æ –°–ü–ò–î–æ–º –¥–ª—è –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –ø–æ—Å—Ç–∞–≤–æ–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –≤ –∫–æ–ª–∏—á–µ—Å—Ç–≤–µ, –¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ–º –¥–ª—è –æ—Ö–≤–∞—Ç–∞ 2 –º–ª–Ω —á–µ–ª–æ–≤–µ–∫ –≤ —Ç–µ—á–µ–Ω–∏–µ —Ç—Ä–µ—Ö –ª–µ—Ç –±–µ–∑ –ø–æ–ª—É—á–µ–Ω–∏—è –ø—Ä–∏–±—ã–ª–∏ –¥–ª—è —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏. –ë–µ–∑–ª–∏—Ü–µ–Ω–∑–∏–æ–Ω–Ω—ã–µ –¥–∂–µ–Ω–µ—Ä–∏–∫–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –±—É–¥—É—Ç –ø–æ—Å—Ç–∞–≤–ª—è—Ç—å—Å—è –≤ 120 —Å—Ç—Ä–∞–Ω —Å –≤—ã—Å–æ–∫–æ–π –∑–∞–±–æ–ª–µ–≤–∞–µ–º–æ—Å—Ç—å—é –∏ –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–Ω—ã–º–∏ —Ä–µ—Å—É—Ä—Å–∞–º–∏, –≤ –ø–µ—Ä–≤—É—é –æ—á–µ—Ä–µ–¥—å —Å –Ω–∏–∑–∫–∏–º –∏ —Å—Ä–µ–¥–Ω–µ-–Ω–∏–∑–∫–∏–º —É—Ä–æ–≤–Ω–µ–º –¥–æ—Ö–æ–¥–∞. –ñ—É—Ä–Ω–∞–ª Science –Ω–∞–∑–≤–∞–ª –ª–µ–Ω–∞–∫–∞–ø–∞–≤–∏—Ä –≥–ª–∞–≤–Ω—ã–º –ø—Ä–æ—Ä—ã–≤–æ–º 2024 –≥–æ–¥–∞. –ê MIT Technology Review –≤–∫–ª—é—á–∏–ª –ø—Ä–µ–ø–∞—Ä–∞—Ç –≤ —Å–ø–∏—Å–æ–∫ –¥–µ—Å—è—Ç–∏ –ø—Ä–æ—Ä—ã–≤–Ω—ã—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π, –∫–æ—Ç–æ—Ä—ã–µ, –ø–æ –≤–µ—Ä—Å–∏–∏ –∏–∑–¥–∞–Ω–∏—è, –∏–∑–º–µ–Ω—è—Ç –º–∏—Ä –≤ –¥–æ–ª–≥–æ—Å—Ä–æ—á–Ω–æ–π –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–µ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-07-29T11:29:36+00:00,@bezrec,6359,https://t.me/bezrec/6359,"‚ö°Ô∏è–£ ¬´–ù–µ–æ—Ñ–∞—Ä–º¬ª —Ç–æ–∂–µ —Å–±–æ–π. –í—Ç–æ—Ä–∞—è —Å–µ—Ç—å –∞–ø—Ç–µ–∫ –≤ –ú–æ—Å–∫–≤–µ –æ—Å—Ç–∞–Ω–æ–≤–∏–ª–∞ —Ä–∞–±–æ—Ç—É. –í—Å–ª–µ–¥ –∑–∞ ¬´–°—Ç–æ–ª–∏—á–∫–∞–º–∏¬ª —Ö–∞–∫–µ—Ä—Å–∫–æ–π –∞—Ç–∞–∫–µ –ø–æ–¥–≤–µ—Ä–≥–ª–∞—Å—å ¬´–ù–µ–æ—Ñ–∞—Ä–º¬ª. –û–±–µ –≤—Ö–æ–¥—è—Ç –≤ –û–û–û ¬´–ù–µ–æ-—Ñ–∞—Ä–º¬ª, —Ä–∞–Ω–µ–µ –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∞–≤—à–µ–µ –¥–µ–ø—É—Ç–∞—Ç—É –ì–æ—Å–¥—É–º—ã –ï–≤–≥–µ–Ω–∏—é –ù–∏—Ñ–∞–Ω—Ç—å–µ–≤—É. –í 2022 –≥–æ–¥—É –æ–Ω –ø–µ—Ä–µ–¥–∞–ª –ø—Ä–∞–≤–∞ –Ω–∞ 99,99% –û–û–û –∑–∞–∫—Ä—ã—Ç–æ–º—É –ø–∞–µ–≤–æ–º—É –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–æ–Ω–Ω–æ–º—É —Ñ–æ–Ω–¥—É (–ó–ü–ò–§) ¬´–ó–¥—Ä–∞–≤–∏–Ω–≤–µ—Å—Ç¬ª –ø–æ–¥ —É–ø—Ä–∞–≤–ª–µ–Ω–∏–µ–º –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–°–æ–≤—Ä–µ–º–µ–Ω–Ω—ã–µ —Ñ–æ–Ω–¥—ã –Ω–µ–¥–≤–∏–∂–∏–º–æ—Å—Ç–∏¬ª (—Ä–∞–Ω–µ–µ ‚Äì ¬´–°–±–µ—Ä —Ñ–æ–Ω–¥—ã –Ω–µ–¥–≤–∏–∂–∏–º–æ—Å—Ç–∏). –ü–æ –¥–∞–Ω–Ω—ã–º Rusprofile, 0,01% –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∏—Ç –õ—é–¥–º–∏–ª–µ –ù–∏—Ñ–∞–Ω—Ç—å–µ–≤–æ–π. –ö–æ–ª–ª–µ–≥–∏ –∏–∑ ¬´–°–æ—Ñ—Ç—Ç–µ—Ö–∞¬ª –ø–∏—à—É—Ç, —á—Ç–æ –ø–æ –ø–æ–∫–∞ –Ω–µ –≤–µ—Ä–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω–æ–π –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏, –≤ —ç—Ç–æ–º –≤–∑–ª–æ–º–µ, –∫–∞–∫ –∏ –≤ —Å–ª—É—á–∞–µ —Å ¬´–ê—ç—Ä–æ—Ñ–ª–æ—Ç–æ–º¬ª, –º–æ–≥—É—Ç –±—ã—Ç—å –∑–∞–º–µ—à–∞–Ω—ã —Å—Ç–∞—Ä—ã–µ –û–° –∏ —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–æ —Å–µ—Ç–∏ —Å—Ä–æ—á–Ω–æ –ø—ã—Ç–∞–µ—Ç—Å—è –ø–µ—Ä–µ—É—Å—Ç–∞–Ω–æ–≤–∏—Ç—å —Å–∏—Å—Ç–µ–º—É –Ω–∞ –≤—Å–µ—Ö –ø–æ–¥–≤–µ—Ä–∂–µ–Ω–Ω—ã—Ö –ü–ö. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-07-29T10:30:54+00:00,@bezrec,6358,https://t.me/bezrec/6358,"‚ö°Ô∏è–ê–ø—Ç–µ–∫–∏ ¬´–°—Ç–æ–ª–∏—á–∫–∏¬ª –≤–∑–ª–æ–º–∞–Ω—ã. –¢–æ—á–∫–∏ —Å–µ—Ç–∏ –∑–∞–∫—Ä—ã—Ç—ã –ø–æ –≤—Å–µ–π –ú–æ—Å–∫–≤–µ, –∫–∞—Å—Å—ã –∏ —Å–∏—Å—Ç–µ–º—ã —É—á—ë—Ç–∞ –Ω–µ —Ä–∞–±–æ—Ç–∞—é—Ç. –ë—Ä–æ–Ω–∏—Ä–æ–≤–∞–Ω–∏–µ –Ω–∞ —Å–∞–π—Ç–µ –Ω–µ–¥–æ—Å—Ç—É–ø–Ω–æ, –∫–∞–∫ –∏ –ø—Ä–æ—Å–º–æ—Ç—Ä –¥–∞–Ω–Ω—ã—Ö –ø–æ –ø—Ä–æ–≥—Ä–∞–º–º–µ –ª–æ—è–ª—å–Ω–æ—Å—Ç–∏. –°–ª–µ—Ç–µ–≤—à–∏–µ —Ñ—É–Ω–∫—Ü–∏–∏ –æ–±–µ—â–∞—é—Ç –≤–æ—Å—Å—Ç–∞–Ω–æ–≤–∏—Ç—å –≤ –±–ª–∏–∂–∞–π—à–µ–µ –≤—Ä–µ–º—è, –Ω–æ —Ç–æ—á–Ω—ã–µ —Å—Ä–æ–∫–∏ –Ω–µ –Ω–∞–∑—ã–≤–∞—é—Ç. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-07-29T08:31:39+00:00,@bezrec,6357,https://t.me/bezrec/6357,"–§–ú–ë–ê –æ–±–µ—â–∞–µ—Ç –≤–∞–∫—Ü–∏–Ω—É –æ—Ç –º–µ–Ω–∏–Ω–≥–æ–∫–æ–∫–∫–∞ –∫ 2027 –≥–æ–¥—É. –ó–∞–±–æ–ª–µ–≤–∞–µ–º–æ—Å—Ç—å –º–µ–Ω–∏–Ω–≥–æ–∫–æ–∫–∫–æ–≤–æ–π –∏–Ω—Ñ–µ–∫—Ü–∏–µ–π —Ä–∞—Å—Ç—ë—Ç, –∞ –ù–∞—Ü–∫–∞–ª–µ–Ω–¥–∞—Ä—å –∂–¥—ë—Ç ‚Äî –Ω–µ –¥–æ–∂–¥—ë—Ç—Å—è –≤–∞–∫—Ü–∏–Ω—ã –¥–ª—è –µ—ë –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏. –û–Ω–∞ –¥–æ–ª–∂–Ω–∞ –±—ã–ª–∞ –ø–æ—è–≤–∏—Ç—å—Å—è –≤ –ù–ö–ü–ü –≤ 2025 –≥–æ–¥—É, –Ω–æ –ø–æ–∫–∞ –≤–∫–ª—é—á–∞—Ç—å —Ç—É–¥–∞ –Ω–µ—á–µ–≥–æ ‚Äî –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –≥–ª–∞–≤–Ω–æ–≥–æ –ø—Ä–µ—Ç–µ–Ω–¥–µ–Ω—Ç–∞ ‚Äì –ú–µ–Ω–∞–∫—Ç—Ä—ã –æ—Ç —Ñ—Ä–∞–Ω—Ü—É–∑—Å–∫–æ–π Sanofi ‚Äì –Ω–µ –ª–æ–∫–∞–ª–∏–∑–æ–≤–∞–Ω–æ –≤ —Å—Ç—Ä–∞–Ω–µ –ø–æ –ø–æ–ª–Ω–æ–º—É —Ü–∏–∫–ª—É. –ê —ç—Ç–æ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–µ —É—Å–ª–æ–≤–∏–µ, –ø—Ä–∏ –∫–æ—Ç–æ—Ä–æ–º –≤ –ú–∏–Ω–∑–¥—Ä–∞–≤–µ ¬´–±—É–¥—É—Ç –≥–æ—Ç–æ–≤—ã –æ–ø–µ—Ä–∞—Ç–∏–≤–Ω–æ –≤–Ω–æ—Å–∏—Ç—å –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ —Å—É—â–µ—Å—Ç–≤—É—é—â–µ–µ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–æ —Å –¥–æ–ø–æ–ª–Ω–µ–Ω–∏–µ–º –ù–∞—Ü–∫–∞–ª–µ–Ω–¥–∞—Ä—è¬ª. –° –±–æ–ª—å—à–æ–π –¥–æ–ª–µ–π –≤–µ—Ä–æ—è—Ç–Ω–æ—Å—Ç–∏ –ù–ö–ü–ü –ø–æ–ø–æ–ª–Ω–∏—Ç—Å—è —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–æ–π –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥—Å–∫–æ–≥–æ –ù–ò–ò –≤–∞–∫—Ü–∏–Ω –∏ —Å—ã–≤–æ—Ä–æ—Ç–æ–∫ –§–ú–ë–ê –†–æ—Å—Å–∏–∏. –í–∞–∫—Ü–∏–Ω–∞ –ø—Ä–æ—Ç–∏–≤ –º–µ–Ω–∏–Ω–≥–æ–∫–æ–∫–∫–∞ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç—Å—è –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏—è –ø–æ –ø–æ–ª–Ω–æ–º—É —Ü–∏–∫–ª—É, –Ω–∞—á–∏–Ω–∞—è —Å —ç—Ç–∞–ø–∞ –ø–æ–ª—É—á–µ–Ω–∏—è –∞–∫—Ç–∏–≤–Ω–æ–π —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π —Å—É–±—Å—Ç–∞–Ω—Ü–∏–∏. –ù–∞ –¥–∞–Ω–Ω—ã–π –º–æ–º–µ–Ω—Ç –ø—Ä–µ–ø–∞—Ä–∞—Ç –Ω–∞—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ —ç—Ç–∞–ø–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π, –∞ —É–∂–µ –∫ –∫–æ–Ω—Ü—É –≥–æ–¥–∞ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –ø–æ–¥–∞—á–∞ –¥–æ—Å—å–µ –Ω–∞ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—é, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏ –≤ –§–ú–ë–ê. –£ –≤–∞–∫—Ü–∏–Ω—ã —É–Ω–∏–∫–∞–ª—å–Ω—ã–π —Å–æ—Å—Ç–∞–≤ ‚Äî –æ–Ω–∞ –∑–∞—â–∏—â–∞–µ—Ç –æ–¥–Ω–æ–≤—Ä–µ–º–µ–Ω–Ω–æ –æ—Ç –ø—è—Ç–∏ —Å–µ—Ä–æ—Ç–∏–ø–æ–≤ –º–µ–Ω–∏–Ω–≥–æ–∫–æ–∫–∫–∞ - A, B, C, W –∏ Y. –ë–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–Ω—ã—Ö –≤ –º–∏—Ä–µ –≤–∞–∫—Ü–∏–Ω –Ω–µ —Å–æ–¥–µ—Ä–∂–∞—Ç —Å–µ—Ä–æ—Ç–∏–ø –í ‚Äî —Å–∞–º—ã–π —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–Ω—ã–π –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ –†–æ—Å—Å–∏–∏ –∏ –≤—ã–∑—ã–≤–∞—é—â–∏–π —Ç—è–∂–µ–ª—ã–π —Å–µ–ø—Å–∏—Å –≤ 30% —Å–ª—É—á–∞–µ–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""The FMBA promises a meningococcal vaccine by 2027. Meningococcal infection cases are increasing, and the National Calendar is waiting ‚Äì it won't get a vaccine for its prevention. It was supposed to be included in the National Calendar by 2025, but it's not ready yet ‚Äì the main candidate vaccine from French Sanofi is not fully localized in the country. There's a high probability that the National Calendar will be supplemented with research from the St Petersburg Institute of Vaccines and Antitoxins of FMBA Russia. The vaccine protects against five serotypes: A, B, C, W and Y. Most world vaccines do not contain the type B ‚Äì the most common in Russia causing severe sepsis in 30% of cases.""
}"
2025-07-29T05:20:26+00:00,@bezrec,6356,https://t.me/bezrec/6356,"Forbes –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª —Ä–µ–π—Ç–∏–Ω–≥ –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö –∞–ø—Ç–µ—á–Ω—ã—Ö —Å–µ—Ç–µ–π –†–æ—Å—Å–∏–∏ –Ω–∞ –æ—Å–Ω–æ–≤–∞–Ω–∏–∏ –¥–∞–Ω–Ω—ã—Ö –∞–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ AlphaRM. –û–±—ä—ë–º —Ä–æ–∑–Ω–∏—á–Ω–æ–≥–æ –∞–ø—Ç–µ—á–Ω–æ–≥–æ —Ä—ã–Ω–∫–∞ —Å —É—á–µ—Ç–æ–º –ë–ê–î –∏ –ø—Ä–æ—á–µ–≥–æ –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç–∞ –≤ 2024 –≥–æ–¥—É –≤—ã—Ä–æ—Å –Ω–∞ 14% –≤ –¥–µ–Ω–µ–∂–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ ‚Äî –¥–æ 2,1 —Ç—Ä–ª–Ω —Ä—É–±–ª–µ–π. –õ—å–≤–∏–Ω–∞—è –¥–æ–ª—è (1,5 —Ç—Ä–ª–Ω —Ä—É–±–ª–µ–π) –ø—Ä–∏—à–ª–∞—Å—å –Ω–∞ –ø–µ—Ä–≤—ã–µ 50 —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ —Ä–µ–π—Ç–∏–Ω–≥–∞. –í —É–ø–∞–∫–æ–≤–∫–∞—Ö —Ä—ã–Ω–æ–∫ –Ω–µ–º–Ω–æ–≥–æ ¬´–ø—Ä–æ—Å–µ–ª¬ª ‚Äî –Ω–∞ 1%, –¥–æ 7,4 –º–ª—Ä–¥ —É–ø–∞–∫–æ–≤–æ–∫. Forbes —Ä–∞–Ω–∂–∏—Ä–æ–≤–∞–ª –∫–æ–º–ø–∞–Ω–∏–∏ –ø–æ –æ–±—â–µ–º—É –æ–±—ä—ë–º—É –ø—Ä–æ–¥–∞–∂ –ø–æ –∏—Ç–æ–≥—É 2024 –≥–æ–¥–∞. –í —Ç—Ä–æ–π–∫–µ –ª–∏–¥–µ—Ä–æ–≤ –æ–∫–∞–∑–∞–ª–∏—Å—å ¬´–ê–ø—Ä–µ–ª—å¬ª, ¬´–†–∏–≥–ª–∞¬ª –∏ ¬´–ü–ª–∞–Ω–µ—Ç–∞ –∑–¥–æ—Ä–æ–≤—å—è¬ª. –ù–∏–∂–µ –≤ —Ç–æ–ø-10 —Ä–∞—Å–ø–æ–ª–æ–∂–∏–ª–∏—Å—å ¬´–ò–º–ø–ª–æ–∑–∏—è¬ª, ¬´36,6¬ª, ¬´–ù–µ–æ—Ñ–∞—Ä–º¬ª, ¬´–≠—Ä–∫–∞—Ñ–∞—Ä–º/–ú–µ–ª–æ–¥–∏—è –∑–¥–æ—Ä–æ–≤—å—è¬ª, ¬´–§–∞—Ä–º–ª–µ–Ω–¥¬ª, ¬´–í–∏—Ç–∞¬ª –∏ ¬´–ò—Ä–∏—Å¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-07-28T15:03:40+00:00,@bezrec,6355,https://t.me/bezrec/6355,"–õ–æ—Å–æ—Å–µ–≤—ã–º –º–æ–ª–æ–∫–∞–º –∏—â—É—Ç –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ –≤ —Ñ–∞—Ä–º–µ –∏ –∫–æ—Å–º–µ—Ç–æ–ª–æ–≥–∏–∏. ‚ö´Ô∏è–£—á–µ–Ω—ã–µ –ü–µ—Ä–º—Å–∫–æ–≥–æ –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–æ–≥–æ –ø–æ–ª–∏—Ç–µ—Ö–Ω–∏—á–µ—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ –∏ –ò–Ω—Å—Ç–∏—Ç—É—Ç–∞ —ç–∫–æ–ª–æ–≥–∏–∏ –∏ –≥–µ–Ω–µ—Ç–∏–∫–∏ –º–∏–∫—Ä–æ–æ—Ä–≥–∞–Ω–∏–∑–º–æ–≤ –£—Ä–û –†–ê–ù –≤–ø–µ—Ä–≤—ã–µ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª–∏ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—É—é —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—é –≤—ã–¥–µ–ª–µ–Ω–∏—è –î–ù–ö –∏–∑ –º–æ–ª–æ–∫ –ª–æ—Å–æ—Å–µ–≤—ã—Ö —Ä—ã–± —Å –∫–æ–Ω–∫—É—Ä–µ–Ω—Ç–æ—Å–ø–æ—Å–æ–±–Ω—ã–º –≤—ã—Ö–æ–¥–æ–º –ø—Ä–æ–¥—É–∫—Ç–∞ –±–æ–ª–µ–µ 5%. –ú–æ–ª–µ–∫—É–ª—ã –î–ù–ö –ª–æ—Å–æ—Å—è –±–æ–≥–∞—Ç—ã –ø–æ–ª–µ–∑–Ω—ã–º–∏ –Ω—É–∫–ª–µ–∏–Ω–æ–≤—ã–º–∏ –∫–∏—Å–ª–æ—Ç–∞–º–∏, —Ñ—Ä–∞–≥–º–µ–Ω—Ç—ã –∫–æ—Ç–æ—Ä—ã—Ö –∞–∫—Ç–∏–≤–Ω–æ —É—á–∞—Å—Ç–≤—É—é—Ç –≤ —Å–∏–Ω—Ç–µ–∑–µ –±–µ–ª–∫–æ–≤, –≤–ª–∏—è—é—Ç –Ω–∞ —Ä–æ—Å—Ç –∏ –≤–æ—Å—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ –∫–ª–µ—Ç–æ–∫, –∞ —Ç–∞–∫–∂–µ —Å—Ç–∏–º—É–ª–∏—Ä—É—é—Ç –∏–º–º—É–Ω–Ω—É—é —Å–∏—Å—Ç–µ–º—É. –ë–ª–∞–≥–æ–¥–∞—Ä—è —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö —É—á–µ–Ω—ã—Ö —ç—Ç–∏ —Ñ—Ä–∞–≥–º–µ–Ω—Ç—ã –º–æ–≥—É—Ç —Å—Ç–∞—Ç—å –æ—Å–Ω–æ–≤–æ–π –¥–ª—è –∑–∞–∂–∏–≤–ª—è—é—â–∏—Ö —Å—Ä–µ–¥—Å—Ç–≤, –∞–Ω—Ç–∏–≤–æ–∑—Ä–∞—Å—Ç–Ω—ã—Ö –∫—Ä–µ–º–æ–≤ –∏ —Å—ã–≤–æ—Ä–æ—Ç–æ–∫, –≥–∏–¥—Ä–æ–≥–µ–ª–µ–π –∏ –∫–∞—Ä–∫–∞—Å–æ–≤ –¥–ª—è —Ç–∫–∞–Ω–µ–≤–æ–π –∏–Ω–∂–µ–Ω–µ—Ä–∏–∏. –ü–æ–ª—É—á–µ–Ω–Ω—ã–π –º–∞—Ç–µ—Ä–∏–∞–ª —É–∂–µ –∞–∫—Ç–∏–≤–Ω–æ –ø—Ä–∏–º–µ–Ω—è–µ—Ç—Å—è –≤ –Æ–∂–Ω–æ–π –ö–æ—Ä–µ–µ –∏ –ò—Ç–∞–ª–∏–∏, –≤ –∫–∞—á–µ—Å—Ç–≤–µ –∫–æ–º–º–µ—Ä—á–µ—Å–∫–æ–≥–æ –ø—Ä–æ–¥—É–∫—Ç–∞. –ù–æ –≤ –†–æ—Å—Å–∏–∏ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö —ç–∫–æ–Ω–æ–º–∏—á–Ω—ã—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –≤—ã–¥–µ–ª–µ–Ω–∏—è —Ç–∞–∫–∏—Ö –±–∏–æ–∞–∫—Ç–∏–≤–Ω—ã—Ö –º–æ–ª–µ–∫—É–ª –¥–æ —ç—Ç–æ–≥–æ –º–æ–º–µ–Ω—Ç–∞ –Ω–µ –±—ã–ª–æ. ‚Ñ¢Ô∏è –†—ã–±—Ö–æ–∑. –í—Å—ë –æ —Ä—ã–±–µ","{""skip"": true}"
2025-07-28T12:14:58+00:00,@bezrec,6354,https://t.me/bezrec/6354,"–°–∏—Å—Ç–µ–º–∞ –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥–∞ –∏ –∞–Ω–∞–ª–∏–∑–∞ –°–ú–ò –∏ —Å–æ—Ü–º–µ–¥–∏–∞ –°–ö–ê–ù-–ò–Ω—Ç–µ—Ä—Ñ–∞–∫—Å –∏ ¬´–ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞¬ª –ø—Ä–µ–¥—Å—Ç–∞–≤–ª—è—é—Ç –º–µ–¥–∏–∞—Ä–µ–π—Ç–∏–Ω–≥ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π –∑–∞ –ø–µ—Ä–≤–æ–µ –ø–æ–ª—É–≥–æ–¥–∏–µ 2025 –≥–æ–¥–∞. –í —Ç—Ä–æ–π–∫–µ –ª–∏–¥–µ—Ä–æ–≤ –ø–æ –∫–æ–ª–∏—á–µ—Å—Ç–≤—É –ø—É–±–ª–∏–∫–∞—Ü–∏–π –æ–∫–∞–∑–∞–ª–∏—Å—å Pfizer, –ü—Ä–æ–º–æ–º–µ–¥ –∏ –û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞. –†–∞–∑–±–∏—Ä–∞–µ–º, –∫–∞–∫–∏–µ —Å–æ–±—ã—Ç–∏—è –ø–æ–º–æ–≥–ª–∏ —ç—Ç–∏–º –∫–æ–º–ø–∞–Ω–∏—è–º —Å—Ç–∞—Ç—å –≥–ª–∞–≤–Ω—ã–º–∏ –≥–µ—Ä–æ—è–º–∏ —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –º–µ–¥–∏–∞–ø—Ä–æ—Å—Ç—Ä–∞–Ω—Å—Ç–≤–∞. Pfizer üü© –í –º–∞–µ –ï–≤—Ä–æ–ø–µ–π—Å–∫–∏–π —Å—É–¥ —é—Å—Ç–∏—Ü–∏–∏ —Å—á–µ–ª –£—Ä—Å—É–ª—É —Ñ–æ–Ω –¥–µ—Ä –õ—è–π–µ–Ω –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ–π –∑–∞ —Å–æ–∫—Ä—ã—Ç–∏–µ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –æ –∫–æ–Ω—Ç—Ä–∞–∫—Ç–∞—Ö –Ω–∞ –∑–∞–∫—É–ø–∫—É –≤–∞–∫—Ü–∏–Ω –ø—Ä–æ—Ç–∏–≤ COVID-19 –≤ 2021-2023 –≥–æ–¥–∞—Ö, –∫–æ—Ç–æ—Ä—ã–µ –≥–ª–∞–≤–∞ –ï–≤—Ä–æ–∫–æ–º–∏—Å—Å–∏–∏ —Å–æ–≥–ª–∞—Å–æ–≤–∞–ª–∞ –Ω–∞–ø—Ä—è–º—É—é —Å –≥–ª–∞–≤–æ–π Pfizer –ê–ª—å–±–µ—Ä—Ç–æ–º –ë—É—Ä–ª–∞. –ï–π —Ç–∞–∫–∂–µ –≤—ã–¥–≤–∏–Ω—É–ª–∏ –≤–æ—Ç—É–º –Ω–µ–¥–æ–≤–µ—Ä–∏—è, –Ω–æ –æ–Ω –±—ã–ª –æ—Ç–∫–ª–æ–Ω—ë–Ω. üü© –í –∞–ø—Ä–µ–ª–µ Pfizer –ø—Ä–µ–∫—Ä–∞—Ç–∏–ª —Ä–∞–∑—Ä–∞–±–æ—Ç–∫—É –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –æ—Ç –æ–∂–∏—Ä–µ–Ω–∏—è Danuglipron –∏–∑-–∑–∞ —Å–µ—Ä—å—ë–∑–Ω—ã—Ö –ø–æ–±–æ—á–µ–∫ –Ω–∞ –ø–µ—á–µ–Ω–∏ —É –æ–¥–Ω–æ–≥–æ –∏–∑ –∏—Å–ø—ã—Ç—É–µ–º—ã—Ö. üü© –í –º–∞–µ –∫–æ–º–ø–∞–Ω–∏—è —Å–æ–æ–±—â–∏–ª–∞, —á—Ç–æ –∑–∞–∫–ª—é—á–∏–ª–∞ –ª–∏—Ü–µ–Ω–∑–∏–æ–Ω–Ω–æ–µ —Å–æ–≥–ª–∞—à–µ–Ω–∏–µ —Å –∫–∏—Ç–∞–π—Å–∫–æ–π 3SBio –æ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ, –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ –∏ –∫–æ–º–º–µ—Ä—Ü–∏–∞–ª–∏–∑–∞—Ü–∏–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Ä–∞–∫–∞ SSGJ-707. ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª üü© –í —è–Ω–≤–∞—Ä–µ –∫–æ–º–ø–∞–Ω–∏—è –ü–µ—Ç—Ä–∞ –ë–µ–ª–æ–≥–æ —Å–æ–æ–±—â–∏–ª–∞ –æ –Ω–∞–º–µ—Ä–µ–Ω–∏–∏ –≤—ã–π—Ç–∏ –Ω–∞ —Ä—ã–Ω–æ–∫ –ò—Ä–∞–∫–∞. –ö —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ —Ä–µ—Å–ø—É–±–ª–∏–∫–∏ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –æ–∫–æ–ª–æ 300 –ø–æ–∑–∏—Ü–∏–π –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≥—Ä—É–ø–ø—ã. –ö 2030 –≥–æ–¥—É —ç–∫—Å–ø–æ—Ä—Ç —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –Ω–∞—Ä–∞—Å—Ç–∏—Ç—å –¥–æ $3,4 –º–ª—Ä–¥. üü© –í —Ñ–µ–≤—Ä–∞–ª–µ –Ω–∞ —Ä—ã–Ω–æ–∫ –≤—ã—à–ª–∞ –¢–∏—Ä–∑–µ—Ç—Ç–∞ ‚Äî –ø–µ—Ä–≤—ã–π –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π –ø—Ä–æ—Ä—ã–≤–Ω–æ–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è –ø–æ—Ö—É–¥–µ–Ω–∏—è. –í —Ç–æ–º –∂–µ –º–µ—Å—è—Ü–µ –≤—ã–ø—É—â–µ–Ω–∞ –í–µ–ª–≥–∏—è –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ –æ–∂–∏—Ä–µ–Ω–∏—è –∏ –¥–∏–∞–±–µ—Ç–∞. üü© –í –∏—é–Ω–µ –ü—ë—Ç—Ä –ë–µ–ª—ã–π ¬´–∑–∞—Å–≤–µ—Ç–∏–ª—Å—è¬ª –≤ Forbes ‚Äî –∏–∑–¥–∞–Ω–∏–µ —Å–æ–æ–±—â–∏–ª–æ, —á—Ç–æ –∫–∞–ø–∏—Ç–∞–ª –æ—Å–Ω–æ–≤–∞—Ç–µ–ª—è –∏ –∫—Ä—É–ø–Ω–µ–π—à–µ–≥–æ –∞–∫—Ü–∏–æ–Ω–µ—Ä–∞ ¬´–ü—Ä–æ–º–æ–º–µ–¥–∞¬ª –ø—Ä–µ–≤—ã—Å–∏–ª $1 –º–ª—Ä–¥. ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª üü© –í –º–∞—Ä—Ç–µ —Å—Ç–∞–ª–æ –∏–∑–≤–µ—Å—Ç–Ω–æ, —á—Ç–æ ¬´–ú–∞–±—Å–∫–µ–π–ª¬ª –∑–∞–≤–µ—Ä—à–∏–ª –º–æ–Ω—Ç–∞–∂ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –¥–ª—è –≤—ã–ø—É—Å–∫–∞ —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏–π –Ω–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω–æ–º –∫–æ–º–ø–ª–µ–∫—Å–µ –≤ –û–≠–ó ¬´–¢–æ–ª—å—è—Ç—Ç–∏¬ª. –û–±—â–∏–π –æ–±—ä—ë–º –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–π —Å–æ—Å—Ç–∞–≤–∏–ª 800 –º–ª–Ω —Ä—É–±–ª–µ–π. üü© –í –º–∞–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç –∫–æ–º–ø–∞–Ω–∏–∏ –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª —Å—Ç–∞—Ç—É—Å ¬´–¥–∂–µ–Ω–µ—Ä–∏–∫–∞ —Ä–∏–≤–∞—Ä–æ–∫—Å–∞–±–∞–Ω–∞ ‚Ññ 1¬ª ‚Äì —Å–∞–º–æ–≥–æ –ø—Ä–æ–¥–∞–≤–∞–µ–º–æ–≥–æ –¥–∂–µ–Ω–µ—Ä–∏–∫–∞ –≤ —ç—Ç–æ–º –ú–ù–ù –ø–æ –∏—Ç–æ–≥–∞–º –ø–µ—Ä–≤–æ–≥–æ –∫–≤–∞—Ä—Ç–∞–ª–∞ 2025 –≥–æ–¥–∞. –ü–æ –¥–∞–Ω–Ω—ã–º AlphaRM, –¥–æ–ª—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö –Ω–∞ —Ä—ã–Ω–∫–µ —Å–æ—Å—Ç–∞–≤–∏–ª–∞ 15%. üü© –í –º–∞—Ä—Ç–µ –Ω–∞ –∫–æ–Ω–≥—Ä–µ—Å—Å–µ –≤ –ú–∞–¥—Ä–∏–¥–µ –±—ã–ª –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω –¥–æ–∫–ª–∞–¥ –æ –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω–æ–º –ø—Ä–æ–ª–æ–Ω–≥–∏—Ä–æ–≤–∞–Ω–Ω–æ–º —Å–∏–ª–¥–µ–Ω–∞—Ñ–∏–ª–µ, –ø—Ä–µ–ø–∞—Ä–∞—Ç–µ –í–∏–ª–¥–µ–≥—Ä–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∏¬ª. –ü–æ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –æ–Ω –Ω–µ —É—Å—Ç—É–ø–∞–µ—Ç –í–∏–∞–≥—Ä–µ –ø—Ä–∏ –ª—É—á—à–µ–π –ø–µ—Ä–µ–Ω–æ—Å–∏–º–æ—Å—Ç–∏ –∏ –±–æ–ª–µ–µ –≤—ã—Å–æ–∫–æ–º —É—Ä–æ–≤–Ω–µ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏. üü© –ü–æ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º 2024 –≥–æ–¥–∞ ¬´–û–∑–æ–Ω —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª –±—ã–ª–∞ –ø—Ä–∏–∑–Ω–∞–Ω–∞ –ª—É—á—à–∏–º —Ä–æ—Å—Å–∏–π—Å–∫–∏–º —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–º –ø–æ –≤–µ—Ä—Å–∏–∏ Forbes. –û–±—ä—ë–º —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –∫–æ–º–ø–∞–Ω–∏–∏ –¥–æ—Å—Ç–∏–≥ 49,4 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –í —Ç–æ–ø-10 –∫–æ–º–ø–∞–Ω–∏–π –ø–æ —É–ø–æ–º–∏–Ω–∞–Ω–∏—è–º –≤ –°–ú–ò —Ç–∞–∫–∂–µ –ø–æ–ø–∞–ª–∏ ¬´–ë–∏–æ–∫–∞–¥¬ª, ¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º¬ª, ¬´–ù–∞—Ü–∏–º–±–∏–æ¬ª, Novo Nordisk, AstraZeneca, ¬´–†-–§–∞—Ä–º¬ª –∏ ¬´–ü–°–ö –§–∞—Ä–º–∞¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""Pfizer faced legal consequences for concealing vaccine contract information. Promomed and Ozon Pharma experienced significant market impacts due to regulatory actions against Pfizer, internal issues with Danuglipron, and the launch of innovative weight loss drugs. The global pharmaceutical landscape was impacted by regulatory actions affecting major companies, including Pfizer and Ozon Pharma.""
}"
2025-07-28T09:01:32+00:00,@bezrec,6353,https://t.me/bezrec/6353,"–≠–∫—Å–ø–µ—Ä—Ç—ã ¬´–ó–¥—Ä–∞–≤—Ä–µ—Å—É—Ä—Å–∞¬ª –ø–æ–¥—Å—á–∏—Ç–∞–ª–∏, —á—Ç–æ —Å—Ä–µ–¥–Ω—è—è —Ü–µ–Ω–∞ —Ç–∞–∫–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –Ω–∞ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Ç–æ—Ä–≥–∞—Ö –≤ –∏—é–ª–µ —ç—Ç–æ–≥–æ –≥–æ–¥–∞ –±—ã–ª–∞ –Ω–∞ —á–µ—Ç–≤–µ—Ä—Ç—å –Ω–∏–∂–µ, —á–µ–º –≤ –∫–æ–Ω—Ü–µ 2023 –≥–æ–¥–∞. –°–∫–∞–∑–∫—É —Å–¥–µ–ª–∞—Ç—å –±—ã–ª—å—é –ø–æ–º–æ–≥–ª–∏ –¥–∂–µ–Ω–µ—Ä–∏–∫–∏, –∫–æ—Ç–æ—Ä—ã–µ —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ —Å—Ç–∞–ª–∏ —Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞—Ç—å –≤ 2023‚Äì2025 –≥–æ–¥–∞—Ö, –Ω–µ—Å–º–æ—Ç—Ä—è –Ω–∞ –ø–∞—Ç–µ–Ω—Ç–Ω—É—é –∑–∞—â–∏—Ç—É. –Ø—Ä–∫–∏–π –ø—Ä–∏–º–µ—Ä ‚Äî –ó–µ–ø–∞—Ç–∏—Ä (–≥—Ä–∞–∑–æ–ø—Ä–µ–≤–∏—Ä+—ç–ª–±–∞—Å–≤–∏—Ä) –æ—Ç MSD. –ö–æ–º–ø–∞–Ω–∏—è –ø—Ä–µ–∫—Ä–∞—Ç–∏–ª–∞ –µ–≥–æ –ø–æ—Å—Ç–∞–≤–∫–∏ –≤ 2024 –≥–æ–¥—É, –æ —á—ë–º –∑–∞–±–ª–∞–≥–æ–≤—Ä–µ–º–µ–Ω–Ω–æ —É–≤–µ–¥–æ–º–∏–ª–∞ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä. –ü—Ä–µ–ø–∞—Ä–∞—Ç –∑–∞—â–∏—â—ë–Ω –ø–∞—Ç–µ–Ω—Ç–æ–º –¥–æ 2030 –≥–æ–¥–∞, –Ω–æ –≤ –º–∞–µ —Å–≤–æ–π –∞–Ω–∞–ª–æ–≥ –ì—Ä–æ–∑–∞–≤–∏—Ä –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª–∞ ¬´–†-–§–∞—Ä–º¬ª. –ü–µ—Ä–≤—ã–µ –ø–∞—Ä—Ç–∏–∏ –±—ã–ª–∏ –≤—ã–≤–µ–¥–µ–Ω—ã –≤ –æ–±–æ—Ä–æ—Ç –≤ –∏—é–ª–µ. –ï–≥–æ —Å—Ç–æ–∏–º–æ—Å—Ç—å –æ–∫–∞–∑–∞–ª–∞—Å—å –Ω–∞ 37% –Ω–∏–∂–µ –æ—Ä–∏–≥–∏–Ω–∞–ª–∞. –í —Å–µ—Ä–µ–¥–∏–Ω–µ 2024 –≥–æ–¥–∞ ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑¬ª –∏ ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª–∏ —Å–≤–æ–∏ –¥–∂–µ–Ω–µ—Ä–∏–∫–∏ –ú–∞–≤–∏—Ä–µ—Ç–∞ –æ—Ç AbbVie (–∑–∞—â–∏—â—ë–Ω –ø–∞—Ç–µ–Ω—Ç–æ–º –¥–æ 2033 –≥–æ–¥–∞). –ü—Ä–∏—á–µ–º –ø—Ä–µ–¥–µ–ª—å–Ω–∞—è —Ü–µ–Ω–∞ –ü–∏–≥–ª–µ—Ä–∏–∏ –∫–æ–º–ø–∞–Ω–∏–∏ –í–∏–∫—Ä–∞–º–∞ –ü—É–Ω–∏—è –Ω–∞ 40% –Ω–∏–∂–µ –æ—Ä–∏–≥–∏–Ω–∞–ª–∞. –¢–∞–∫–∂–µ –Ω–∞ —Ä—ã–Ω–∫–µ –µ—Å—Ç—å –¥–∂–µ–Ω–µ—Ä–∏–∫–∏ –≠–ø–∫–ª—é–∑–∞ –∏ –ì–∞—Ä–≤–æ–Ω–∏ –æ—Ç Gilead Sciences. –ü–æ —Å–ª–æ–≤–∞–º —ç–∫—Å–ø–µ—Ä—Ç–∞ –í—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —Å–æ—é–∑–∞ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –ê–ª–µ–∫—Å–µ—è –§–µ–¥–æ—Ä–æ–≤–∞, —Ñ–∞–∫—Ç –æ–¥–Ω–æ–π –ª–∏—à—å —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤ ¬´–º–æ–∂–µ—Ç —Å—Ç–∏–º—É–ª–∏—Ä–æ–≤–∞—Ç—å –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –∏–ª–∏ –¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–æ–≤ –º—è–≥–∫–æ –∫–æ—Ä—Ä–µ–∫—Ç–∏—Ä–æ–≤–∞—Ç—å —Ü–µ–Ω–æ–≤—É—é –ø–æ–ª–∏—Ç–∏–∫—É –¥–ª—è —Å–Ω–∏–∂–µ–Ω–∏—è –≤–æ–∑–º–æ–∂–Ω—ã—Ö —Ä–∏—Å–∫–æ–≤ –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω–æ–≥–æ –ª–∏—Ü–µ–Ω–∑–∏—Ä–æ–≤–∞–Ω–∏—è¬ª. –ê –æ–Ω–∏ –µ—Å—Ç—å ‚Äî –≤ –º–∞—Ä—Ç–µ –º—ã –ø–∏—Å–∞–ª–∏, —á—Ç–æ –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å—â–∏–∫–∏ —É–∂–µ –ø—Ä–æ—Ä–∞–±–∞—Ç—ã–≤–∞—é—Ç –º–µ—Ä—É –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤ –í–µ–ª–ø–∞—Ç–∞—Å–æ—Ñ (–≤–µ–ª–ø–∞—Ç–∞—Å–≤–∏—Ä + —Å–æ—Ñ–æ—Å–±—É–≤–∏—Ä) –∏ –ü–∏–≥–ª–µ—Ä–∏—è ( –≥–ª–µ–∫–∞–ø—Ä–µ–≤–∏—Ä+–ø–∏–±—Ä–µ–Ω—Ç–∞—Å–≤–∏—Ä). –ü—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–∏ ¬´–ü—Ä–æ–º–æ–º–µ–¥–∞¬ª, ¬´–†-—Ñ–∞—Ä–º–∞¬ª –∏ –§–ê–° –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª–∏, —á—Ç–æ ¬´–Ω–∞—Ö–æ–¥—è—Ç—Å—è –≤ –ø–æ—Å—Ç–æ—è–Ω–Ω–æ–º –¥–∏–∞–ª–æ–≥–µ –≤ –ø–æ–∏—Å–∫–∞—Ö –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–µ–π –¥–ª—è –¥–∞–ª—å–Ω–µ–π—à–µ–≥–æ —Å–Ω–∏–∂–µ–Ω–∏—è —Ü–µ–Ω¬ª. –ü–æ–ª—É—á–∏—Ç—å –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω—É—é –ª–∏—Ü–µ–Ω–∑–∏—é –Ω–∞ –ó–µ–ø–∞—Ç–∏—Ä –ø—ã—Ç–∞–µ—Ç—Å—è –∏ ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª. –í –ú–∏–Ω—ç–∫–æ–Ω–æ–º—Ä–∞–∑–≤–∏—Ç–∏—è —Å–æ–æ–±—â–∏–ª–∏, —á—Ç–æ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–µ–Ω–Ω—ã—Ö –∞–∫—Ç–æ–≤, —Ä–∞–∑—Ä–µ—à–∞—é—â–∏—Ö —Ä–æ—Å—Å–∏–π—Å–∫–∏–º –∫–æ–º–ø–∞–Ω–∏—è–º –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ –ø–∞—Ç–µ–Ω—Ç–æ–≤ –æ—Ä–∏–≥–∏–Ω–∞—Ç–æ—Ä–æ–≤ –¥–ª—è –≤—ã–ø—É—Å–∫–∞ –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤ –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø—Ä–æ—Ç–∏–≤ –≥–µ–ø–∞—Ç–∏—Ç–∞ –°, –Ω–µ –∏–∑–¥–∞–≤–∞–ª–æ—Å—å. –î–∏—Ä–µ–∫—Ç–æ—Ä –ø–æ —Ä–∞–∑–≤–∏—Ç–∏—é RNC Pharma –ù–∏–∫–æ–ª–∞–π –ë–µ—Å–ø–∞–ª–æ–≤ —Å—á–∏—Ç–∞–µ—Ç, —á—Ç–æ –Ω–∞ —Å–Ω–∏–∂–µ–Ω–∏–µ —Ü–µ–Ω —Ç–∞–∫–∂–µ –ø–æ–≤–ª–∏—è–ª–æ —É–≤–µ–ª–∏—á–µ–Ω–∏–µ –æ–±—ä—ë–º–∞ –∑–∞–∫—É–ø–æ–∫. –ü–æ –¥–∞–Ω–Ω—ã–º ¬´–ó–¥—Ä–∞–≤—Ä–µ—Å—É—Ä—Å–∞¬ª, –≤ 2024 –≥–æ–¥—É –æ–Ω–∏ –≤—ã—Ä–æ—Å–ª–∏ –Ω–∞ 62% –≥–æ–¥ –∫ –≥–æ–¥—É ‚Äî –¥–æ 20,9 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –≠—Ç–æ –∞–±—Å–æ–ª—é—Ç–Ω—ã–π —Ä–µ–∫–æ—Ä–¥ –∑–∞ –≤—Å—é –∏—Å—Ç–æ—Ä–∏—é –ª–µ—á–µ–Ω–∏—è –≥–µ–ø–∞—Ç–∏—Ç–∞ –° –≤ –†–æ—Å—Å–∏–∏. –í –ø–µ—Ä–≤–æ–π –ø–æ–ª–æ–≤–∏–Ω–µ 2025 –≥–æ–¥–∞ –Ω–∞ —ç—Ç–∏ —Ü–µ–ª–∏ —É–∂–µ –ø–æ—Ç—Ä–∞—á–µ–Ω–æ 16,6 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π ‚Äî –ø–æ—á—Ç–∏ 80% –æ—Ç –æ–±—â–µ–≥–æ –±—é–¥–∂–µ—Ç–∞ –ø—Ä–æ—à–ª–æ–≥–æ –≥–æ–¥–∞. –¢–∞–∫–æ–π –ø—Ä–∏—Ä–æ—Å—Ç –æ–±—ä—è—Å–Ω—è–µ—Ç—Å—è –≤—ã–¥–µ–ª–µ–Ω–∏–µ–º –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã—Ö 4,5 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π —Ä–µ–≥–∏–æ–Ω–∞–º, —É–≤–µ–ª–∏—á–µ–Ω–∏–µ–º —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è –ª–µ—á–µ–Ω–∏—è –±–æ–ª—å–Ω—ã—Ö —Å –≥–µ–ø–∞—Ç–∏—Ç–æ–º –° –∏ –í–ò–ß –Ω–∞ 1,1 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –∏ –ø–µ—Ä–µ—Å–º–æ—Ç—Ä–æ–º –∫—Ä–∏—Ç–µ—Ä–∏–µ–≤ –û–ú–°. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, demand, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The message discusses the price reduction of generic drugs for Hepatitis C treatment in Russia. It mentions that the average cost on state procurement was 25% lower in July compared to the end of 2023. The price reduction is attributed to generics registered by Russian companies despite patent protection, such as Zepatir (grazoprevir+elbasvir) from MSD. The message also highlights the registration of generics like Maviret (mavirecivir) from AbbVie and Pegasys (peginterferon alfa-2a) from Gilead Sciences, which are significantly cheaper than their original counterparts. The message also mentions the potential for further price reductions due to increased government spending on Hepatitis C treatment.""
}"
2025-07-28T05:19:58+00:00,@bezrec,6352,https://t.me/bezrec/6352,"–í –ê–ª–∞–±—É—à–µ–≤–æ —Å—Ç–∞—Ä—Ç–æ–≤–∞–ª–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–æ–π –±–æ–ª–µ–∑–Ω–∏ –ø–æ—á–µ–∫. ¬´–†-–û–ø—Ä–∞¬ª (–≤—Ö–æ–¥–∏—Ç –≤ –≥—Ä—É–ø–ø—É ¬´–†-–§–∞—Ä–º¬ª) –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª–∞ –∏ –Ω–∞—á–∞–ª–∞ –≤—ã–ø—É—Å–∫ –î–µ–∫–∞–ª—å–ø–∞—Ä–∞ (–ø–∞—Ä–∏–∫–∞–ª—å—Ü–∏—Ç–æ–ª) –Ω–∞ –æ—Å–Ω–æ–≤–µ —Å–∏–Ω—Ç–µ—Ç–∏—á–µ—Å–∫–æ–≥–æ –∞–Ω–∞–ª–æ–≥–∞ –≤–∏—Ç–∞–º–∏–Ω–∞ D. –ü–æ —Å–ª–æ–≤–∞–º –∑–∞–º–º—ç—Ä–∞ –ú–æ—Å–∫–≤—ã –ø–æ –≤–æ–ø—Ä–æ—Å–∞–º —Ç—Ä–∞–Ω—Å–ø–æ—Ä—Ç–∞ –∏ –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏ –ú–∞–∫—Å–∏–º–∞ –õ–∏–∫—Å—É—Ç–æ–≤–∞, –≤ —Ä–∞–∑–≤–∏—Ç–∏–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã—Ö –º–æ—â–Ω–æ—Å—Ç–µ–π –∫–æ–º–ø–∞–Ω–∏–∏ –≤ –û–≠–ó ¬´–¢–µ—Ö–Ω–æ–ø–æ–ª–∏—Å –ú–æ—Å–∫–≤–∞¬ª –≤ –æ–±—â–µ–π —Å–ª–æ–∂–Ω–æ—Å—Ç–∏ –≤–ª–æ–∂–µ–Ω–æ 8,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ü—Ä–µ–ø–∞—Ä–∞—Ç –≤—Ö–æ–¥–∏—Ç –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü, –≤—ã–ø—É—Å–∫–∞–µ—Ç—Å—è –≤ —Ñ–æ—Ä–º–µ –∂–µ–ª–∞—Ç–∏–Ω–æ–≤—ã—Ö –∫–∞–ø—Å—É–ª –∏ –≤–∫–ª—é—á–∞–µ—Ç –ø–æ–ª–Ω—ã–π –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã–π —Ü–∏–∫–ª ‚Äî –æ—Ç —Å–∏–Ω—Ç–µ–∑–∞ —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏–∏ –¥–æ –ø–æ–ª—É—á–µ–Ω–∏—è –ì–õ–§. –ü–æ –æ—Ü–µ–Ω–∫–∞–º —ç–∫—Å–ø–µ—Ä—Ç–æ–≤, —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–∞—è –±–æ–ª–µ–∑–Ω—å –ø–æ—á–µ–∫ –≤ –±–ª–∏–∂–∞–π—à–∏–µ –≥–æ–¥—ã –º–æ–∂–µ—Ç –≤—ã–π—Ç–∏ –Ω–∞ –ø—è—Ç–æ–µ –º–µ—Å—Ç–æ —Å—Ä–µ–¥–∏ –ø—Ä–∏—á–∏–Ω —Å–Ω–∏–∂–µ–Ω–∏—è –ø—Ä–æ–¥–æ–ª–∂–∏—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –∂–∏–∑–Ω–∏. –ü–æ –¥–∞–Ω–Ω—ã–º –ì–†–õ–°, –ø–æ–º–∏–º–æ ¬´–†-–û–ø—Ä—ã¬ª, —Ä–µ–≥—É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏–µ –Ω–∞ –ø–∞—Ä–∏–∫–∞–ª—å—Ü–∏—Ç–æ–ª –µ—Å—Ç—å —É Abbvie. –ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∞—è –∫–æ–º–ø–∞–Ω–∏—è –≤—ã–ø—É—Å–∫–∞–µ—Ç —Å–≤–æ–π –ó–µ–º–ø–ª–∞—Ä –≤ —Ñ–æ—Ä–º–µ –∫–∞–ø—Å—É–ª –∏ —Ä–∞—Å—Ç–≤–æ—Ä–∞ –¥–ª—è –≤–Ω—É—Ç—Ä–∏–≤–µ–Ω–Ω–æ–≥–æ –≤–≤–µ–¥–µ–Ω–∏—è. –í –†–æ—Å—Å–∏–∏ –Ω–∞ –∑–∞–≤–æ–¥–µ ¬´–û—Ä—Ç–∞—Ç¬ª (—Ç–∞–∫–∂–µ –≤—Ö–æ–¥–∏—Ç –≤ ¬´–†-–§–∞—Ä–º¬ª) –≤ –ö–æ—Å—Ç—Ä–æ–º—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –æ—Å—É—â–µ—Å—Ç–≤–ª—è—é—Ç—Å—è —Å—Ç–∞–¥–∏–∏ —É–ø–∞–∫–æ–≤–∫–∏ –∏ –≤—ã–ø—É—Å–∫–∞—é—â–µ–≥–æ –∫–æ–Ω—Ç—Ä–æ–ª—è –∫–∞—á–µ—Å—Ç–≤–∞. –û—Å—Ç–∞–ª—å–Ω—ã–µ —Å–æ—Å—Ä–µ–¥–æ—Ç–æ—á–µ–Ω—ã –≤ –ò—Ç–∞–ª–∏–∏ –∏ –ò—Ä–ª–∞–Ω–¥–∏–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, registration, safety, pharmacovigilance"",
  ""impact"": ""medium"",
  ""english"": ""A clinical trial for the treatment of chronic kidney disease has started at Alabushovo. 'R-Opra' (part of the R-Farm group) has registered and begun producing Decalpar, a paricalcitol derivative of synthetic vitamin D. The company has invested 8.7 billion rubles in developing production facilities at the Technopoles Moscow Economic Zone. The disease is included in the list of chronic diseases and requires a prescription.""
}"
2025-07-27T11:05:17+00:00,@bezrec,6351,https://t.me/bezrec/6351,"–ü–æ–Ω–∏-—Ç–µ—Ä–∞–ø–µ–≤—Ç –ø–æ–º–æ–≥–∞–µ—Ç –ø–∞—Ü–∏–µ–Ω—Ç–∞–º –ª–µ–≥—á–µ –≤—ã—Ö–æ–¥–∏—Ç—å –∏–∑ –Ω–∞—Ä–∫–æ–∑–∞. –ü–æ—Å–ª–µ —Ç–∞–∫–æ–≥–æ –Ω–µ —Ç–æ —á—Ç–æ –∏–∑ –Ω–∞—Ä–∫–æ–∑–∞, –∏–∑ –∫–æ–º—ã –≤—ã–π–¥–µ—à—å. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-07-26T11:30:58+00:00,@bezrec,6350,https://t.me/bezrec/6350,"–û—Ç–¥—ã—Ö–∞–µ–º –∏ —á–∏—Ç–∞–µ–º —Å—É–±–±–æ—Ç–Ω–∏–π –≤—ã–ø—É—Å–∫ —Ä—É–±—Ä–∏–∫–∏ #–≤–¥–æ–≥–æ–Ω–∫—É. üíä –§–ú–ë–ê –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–æ —Å–≤–æ–π –ø—Ä–æ—Ç–æ—Ç–∏–ø –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –æ—Ç –°–ú–ê. –í –∏—Å–ø—ã—Ç–∞–Ω–∏—è—Ö –Ω–∞ –∂–∏–≤–æ—Ç–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç –ø–æ–∫–∞–∑–∞–ª –≤—ã—Å–æ–∫—É—é —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –∏ –º–µ–Ω—å—à–µ–µ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –∑–∞–ø–∞–¥–Ω—ã–º–∏ –∞–Ω–∞–ª–æ–≥–∞–º–∏ –Ω–µ–≥–∞—Ç–∏–≤–Ω–æ–µ –≤–æ–∑–¥–µ–π—Å—Ç–≤–∏–µ –Ω–∞ —Å–µ—Ä–¥—Ü–µ –∏ –ø–µ—á–µ–Ω—å. –†–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–∏ –ø–ª–∞–Ω–∏—Ä—É—é—Ç –ø–æ–ª—É—á–∏—Ç—å –†–£ –∫ 2029-2030 –≥–æ–¥—É. üíä –í FDA –Ω–æ–≤—ã–π –≥–ª–∞–≤–Ω—ã–π –ø–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º. –ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–π —Ä–µ–≥—É–ª—è—Ç–æ—Ä —Å–æ–æ–±—â–∏–ª –æ –Ω–∞–∑–Ω–∞—á–µ–Ω–∏–∏ –î–∂–æ—Ä–¥–∂–∞ –§—Ä—ç–Ω—Å–∏—Å–∞ –¢–∏–¥–º–∞—Ä—à–∞ –¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–º –¶–µ–Ω—Ç—Ä–∞ –æ—Ü–µ–Ω–∫–∏ –∏ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ (CDER). –¢–∏–¥–º–∞—Ä—à –ø—Ä–∏–Ω–∏–º–∞–ª —É—á–∞—Å—Ç–∏–µ –≤ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ —Å–µ–º–∏ –æ–¥–æ–±—Ä–µ–Ω–Ω—ã—Ö –∞–≥–µ–Ω—Ç—Å—Ç–≤–æ–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –æ—Å–Ω–æ–≤–∞–ª –Ω–µ—Å–∫–æ–ª—å–∫–æ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π –∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –º–∞–≥–∏—Å—Ç–µ—Ä—Å–∫—É—é –ø—Ä–æ–≥—Ä–∞–º–º—É –ø–æ —Ç—Ä–∞–Ω—Å–ª—è—Ü–∏–æ–Ω–Ω—ã–º –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è–º –∏ –ø—Ä–∏–∫–ª–∞–¥–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω–µ –≤ –°—Ç—ç–Ω—Ñ–æ—Ä–¥–µ. üíä Roche ¬´–∑–∞–±–∏–ª¬ª –Ω–∞ –æ–∂–∏—Ä–µ–Ω–∏–µ. –®–≤–µ–π—Ü–∞—Ä—Å–∫–∞—è –∫–æ–º–ø–∞–Ω–∏—è –æ—Å—Ç–∞–Ω–æ–≤–∏–ª–∞ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫—É –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–Ω–æ–≥–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –ø—Ä–æ—Ç–∏–≤ –æ–∂–∏—Ä–µ–Ω–∏—è CT-173 –¥–æ –Ω–∞—á–∞–ª–∞ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å–ø—ã—Ç–∞–Ω–∏–π. –ü—Ä–µ–ø–∞—Ä–∞—Ç—É, –ø—Ä–∏–æ–±—Ä–µ—Ç—ë–Ω–Ω–æ–º—É –≤ —Ä–∞–º–∫–∞—Ö –∫—Ä—É–ø–Ω–µ–π—à–µ–π –≤ 2023 –≥–æ–¥—É —Å–¥–µ–ª–∫–∏ –ø–æ –ø–æ–∫—É–ø–∫–µ Carmot Therapeutics –∑–∞ $2,7 –º–ª—Ä–¥, –ø—Ä–æ—á–∏–ª–∏ —Å–ª–∞–≤—É –û–∑–µ–º–ø–∏–∫–∞ –∏ –ú—É–Ω–¥–∂–∞—Ä–æ, –Ω–æ –≤ –∏—Ç–æ–≥–µ –≤ Roche —Ä–µ—à–∏–ª–∏, —á—Ç–æ –ø–æ–µ–∑–¥ —É—à—ë–ª —à–∞–Ω—Å–∞ –Ω–∞ –∫–æ–º–º–µ—Ä—á–µ—Å–∫–∏–π —É—Å–ø–µ—Ö —É CT-173 –Ω–µ—Ç. üíä –£ Dr. Reddy‚Äôs –ø–æ—è–≤–∏—Ç—Å—è —Å–≤–æ–π —Å–µ–º–∞–≥–ª—É—Ç–∏–¥. –ò–Ω–¥–∏–π—Å–∫–∞—è —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—è –æ–±–µ—â–∞–µ—Ç –≤—ã–ø—É—Å—Ç–∏—Ç—å –∞–Ω–∞–ª–æ–≥ –û–∑–µ–º–ø–∏–∫–∞ —É–∂–µ –≤ 2026 –≥–æ–¥—É ‚Äî –ø–∞—Ç–µ–Ω—Ç –Ω–∞ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –∫–∞–∫ —Ä–∞–∑ –∏—Å—Ç–µ–∫–∞–µ—Ç –≤ –º–∞—Ä—Ç–µ —Å–ª–µ–¥—É—é—â–µ–≥–æ –≥–æ–¥–∞. –ü–ª–∞–Ω—ã —É –∏–Ω–¥–∏–π—Ü–µ–≤ –≥—Ä–∞–Ω–¥–∏–æ–∑–Ω—ã–µ ‚Äî –¥–∂–µ–Ω–µ—Ä–∏–∫ –¥–æ–ª–∂–µ–Ω –ø–æ—è–≤–∏—Ç—å—Å—è –Ω–∞ —Ä—ã–Ω–∫–∞—Ö 87 —Å—Ç—Ä–∞–Ω. üíä –í –†–æ—Å—Å–∏–∏ –≤—ã—Ä–æ—Å–ª–∏ –ø—Ä–æ–¥–∞–∂–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –æ—Ç –∞–ª–∫–æ–≥–æ–ª–∏–∑–º–∞. –ü–æ –¥–∞–Ω–Ω—ã–º RNC Pharma, –≤ —è–Ω–≤–∞—Ä–µ ‚Äì –∏—é–Ω–µ 2025 –≥–æ–¥–∞ –±—ã–ª–æ –ø—Ä–æ–¥–∞–Ω–æ 553,2 —Ç—ã—Å. —É–ø–∞–∫–æ–≤–æ–∫ —Ç–∞–∫–∏—Ö —Å—Ä–µ–¥—Å—Ç–≤. –≠—Ç–æ –Ω–∞ 13,5% –±–æ–ª—å—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É. –í –¥–µ–Ω—å–≥–∞—Ö –ø—Ä–∏—Ä–æ—Å—Ç –µ—â—ë –±–æ–ª–µ–µ —Å—É—â–µ—Å—Ç–≤–µ–Ω–Ω—ã–π ‚Äî –ø–ª—é—Å 37,8% (539,6 –º–ª–Ω —Ä—É–±–ª–µ–π). –≠–∫—Å–ø–µ—Ä—Ç—ã –æ–±—ä—è—Å–Ω—è—é—Ç —Ç—Ä–µ–Ω–¥ –±–æ–ª–µ–µ –Ω–∏–∑–∫–æ–π —Å—Ç–æ–∏–º–æ—Å—Ç—å—é —ç—Ç–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å —É—Å–ª—É–≥–∞–º–∏ –Ω–∞—Ä–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö —Å–ª—É–∂–±, –ø–µ—Ä–µ—Ö–æ–¥–æ–º –Ω–∞ –±–æ–ª–µ–µ —Å–æ–≤—Ä–µ–º–µ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, –∞ —Ç–∞–∫–∂–µ –æ–±–µ—Å–ø–æ–∫–æ–µ–Ω–Ω–æ—Å—Ç—å—é –Ω–∞—Å–µ–ª–µ–Ω–∏—è —É–∂–µ—Å—Ç–æ—á–µ–Ω–∏–µ–º –∫–æ–Ω—Ç—Ä–æ–ª—è –∑–∞ –ø–µ—Ä–µ–¥–∞—á–µ–π –¥–∞–Ω–Ω—ã—Ö –≤ –ï–ì–ò–°–ó. –° 1 –º–∞—Ä—Ç–∞ 2026 –≥–æ–¥–∞ —Ç—É–¥–∞ –±—É–¥—É—Ç –≤–∫–ª—é—á–∞—Ç—å —Å–≤–µ–¥–µ–Ω–∏—è –æ –ø–∞—Ü–∏–µ–Ω—Ç–∞—Ö —Å –ø—Å–∏—Ö–∏—á–µ—Å–∫–∏–º–∏ —Ä–∞—Å—Å—Ç—Ä–æ–π—Å—Ç–≤–∞–º–∏, –≤ —Ç–æ–º —á–∏—Å–ª–µ –≤—ã–∑–≤–∞–Ω–Ω—ã–º–∏ —É–ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–µ–º –∞–ª–∫–æ–≥–æ–ª—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""Sales of alcoholism medications in Russia increased by 13.5% year-over-year from January to June 2025, with a 37.8% increase in revenue (539.6 million rubles). Experts attribute the trend to lower costs of these drugs compared to psychiatric care services, adoption of newer treatments, and public concern over stricter data control in the EGISZ system. Starting March 1st, 2026, personal data of patients with mental disorders, including those caused by alcohol use, will be included in the EGISZ system.""
}"
2025-07-25T14:31:14+00:00,@bezrec,6349,https://t.me/bezrec/6349,"–ú—ã —É–∂–µ –ø–æ–∫–∞–∑—ã–≤–∞–ª–∏, –∫–∞–∫ –¥–∞—é—Ç –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ —â–µ–Ω–∫–∞–º, –∫–æ—Ç–∏–∫–∞–º –∏ –¥–∞–∂–µ –≥–æ–ª—É–±—è–º. –¢–µ–ø–µ—Ä—å –≤–µ—Ç–µ—Ä–∏–Ω–∞—Ä—ã –ø—Ä–∏—à–ª–∏ –∑–∞ –µ–∂–∞–º–∏. P.S. –ü—Ç–∏—á–∫—É –Å–∂–∏–∫–∞ –∂–∞–ª–∫–æ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-07-25T12:00:01+00:00,@bezrec,6348,https://t.me/bezrec/6348,"–ü–æ –∫—Ä–∞–π–Ω–µ–π –º–µ—Ä–µ, —Ç–∞–∫ —Å—á–∏—Ç–∞—é—Ç —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã ¬´–ó–¥—Ä–∞–≤—Ä–µ—Å—É—Ä—Å–∞¬ª. –í –¥–æ–∫–ª–∞–¥–µ —ç–∫—Å–ø–µ—Ä—Ç–Ω–æ–π –≥—Ä—É–ø–ø—ã —É–∫–∞–∑–∞–Ω–æ, —á—Ç–æ ¬´–¥–æ–∫–æ–Ω—Ç–∞–∫—Ç–Ω–∞—è –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∞ (–î–ö–ü) —Å–ª—É–∂–∏—Ç —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã–º —Å–ø–æ—Å–æ–±–æ–º –±–æ—Ä—å–±—ã —Å –∏–Ω—Ñ–µ–∫—Ü–∏–µ–π, –Ω–æ –Ω–µ –ø—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ–Ω–∞ –≤ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–µ –∏ –ø–æ—ç—Ç–æ–º—É –Ω–µ –º–æ–∂–µ—Ç –º–∞—Å—Å–æ–≤–æ –ø—Ä–∏–º–µ–Ω—è—Ç—å—Å—è –≤ –†–æ—Å—Å–∏–∏¬ª. –û–±—ä—è—Å–Ω–µ–Ω–∏–µ ¬´–Ω–∞ –ø–∞–ª—å—Ü–∞—Ö¬ª –æ—Ç –∞–Ω–∞–ª–∏—Ç–∏–∫–æ–≤: –ï—Å–ª–∏ –≤ —É—Å–ª–æ–≤–Ω–æ–π –≥—Ä—É–ø–ø–µ –∏–∑ 1 —Ç—ã—Å. —á–µ–ª–æ–≤–µ–∫ –≤ —Ç–µ—á–µ–Ω–∏–µ 10 –ª–µ—Ç –Ω–µ –≤–Ω–µ–¥—Ä—è—Ç—å –î–ö–ü, –∑–∞ —ç—Ç–æ –≤—Ä–µ–º—è –≤ –Ω–µ–π –ø–æ—è–≤–∏—Ç—Å—è –æ–∫–æ–ª–æ 300 –Ω–æ–≤—ã—Ö —Å–ª—É—á–∞–µ–≤ –∏–Ω—Ñ–µ–∫—Ü–∏–∏. –ü–æ–∂–∏–∑–Ω–µ–Ω–Ω–æ–µ –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ —ç—Ç–∏—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –ø—Ä–∏ –Ω—ã–Ω–µ—à–Ω–∏—Ö —Ü–µ–Ω–∞—Ö –æ–±–æ–π–¥—ë—Ç—Å—è –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤—É –≤ 1 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ï—Å–ª–∏ –∂–µ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–æ –±—É–¥–µ—Ç —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞—Ç—å –î–ö–ü, —Ç–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–ª—è –ø—Ä–æ–≥—Ä–∞–º–º—ã –æ–±–æ–π–¥—É—Ç—Å—è –≤ 200 –º–ª–Ω —Ä—É–±–ª–µ–π –∏ –ø–æ–∑–≤–æ–ª—è—Ç –Ω–µ –¥–æ–ø—É—Å—Ç–∏—Ç—å 270 –∑–∞—Ä–∞–∂–µ–Ω–∏–π, –∞ —á–∏—Å–ª–æ ¬´–ø—Ä–æ—Ä—ã–≤–Ω—ã—Ö¬ª —Å–ª—É—á–∞–µ–≤ (–∫–æ–≥–¥–∞ –∏–Ω—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–∏–µ –ø—Ä–æ–∏—Å—Ö–æ–¥–∏—Ç –≤–æ–ø—Ä–µ–∫–∏ –ø—Ä–∏–µ–º—É —Ç–∞–±–ª–µ—Ç–æ–∫) —Å–Ω–∏–∑–∏—Ç—Å—è –¥–æ 30. –ü—Ä–∏ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–∏ –∏–Ω—ä–µ–∫—Ü–∏–æ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Ä–∏—Å–∫–∏ –∑–∞—Ä–∞–∂–µ–Ω–∏—è –±–ª–∏–∑–∫–∏ –∫ –Ω—É–ª—é. –¢–∞–∫–∏–º –æ–±—Ä–∞–∑–æ–º, —Ö–æ—Ç—è –Ω–∞ —Å—Ç–∞—Ä—Ç–µ –ø—Ä–æ–≥—Ä–∞–º–º–∞ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –≤—ã–≥–ª—è–¥–∏—Ç –¥–æ—Ä–æ–∂–µ, –≤ –¥–æ–ª–≥–æ—Å—Ä–æ—á–Ω–æ–π –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–µ –æ–Ω–∞ –ø–æ–∑–≤–æ–ª—è–µ—Ç —Å—ç–∫–æ–Ω–æ–º–∏—Ç—å –±—é–¥–∂–µ—Ç—É –ø–æ—á—Ç–∏ 1 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, ‚Äî –ø–æ–¥—ã—Ç–æ–∂–∏–ª–∏ —ç–∫—Å–ø–µ—Ä—Ç—ã, –ø–æ–¥—á–µ—Ä–∫–Ω—É–≤, —á—Ç–æ —ç—Ç–∏ —Ä–∞—Å—á—ë—Ç—ã –Ω–µ –≤–∫–ª—é—á–∞—é—Ç –∑–∞—Ç—Ä–∞—Ç –Ω–∞ –ª–µ—á–µ–Ω–∏–µ —Å–æ–ø—É—Ç—Å—Ç–≤—É—é—â–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, –∞ –∑–Ω–∞—á–∏—Ç, —Ä–µ–∞–ª—å–Ω–∞—è —ç–∫–æ–Ω–æ–º–∏—è –º–æ–∂–µ—Ç –±—ã—Ç—å –µ—â—ë –±–æ–ª—å—à–µ. –ú–∏–Ω–∑–¥—Ä–∞–≤—É –∏–¥–µ—è ¬´–ó–¥—Ä–∞–≤—Ä–µ—Å—É—Ä—Å–∞¬ª –∑–¥—Ä–∞–≤–æ–π –Ω–µ –ø–æ–∫–∞–∑–∞–ª–∞—Å—å. –î–ö–ü –ø–æ–¥—Ä–∞–∑—É–º–µ–≤–∞–µ—Ç –ø—Ä–∏—ë–º –∞–Ω—Ç–∏—Ä–µ—Ç—Ä–æ–≤–∏—Ä—É—Å–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∑–¥–æ—Ä–æ–≤—ã–º–∏ –ª—é–¥—å–º–∏, –∫–æ—Ç–æ—Ä—ã–µ —Å–æ–∑–Ω–∞—Ç–µ–ª—å–Ω–æ –ø—Ä–∞–∫—Ç–∏–∫—É—é—Ç –æ–ø–∞—Å–Ω–æ–µ –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ –≤–æ–∑–º–æ–∂–Ω–æ–≥–æ –∏–Ω—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–∏—è –í–ò–ß –ø–æ–≤–µ–¥–µ–Ω–∏–µ, –∏ —ç—Ç–æ—Ç —Ñ–∞–∫—Ç –≤—ã–∑—ã–≤–∞–µ—Ç —Å–µ—Ä—å–µ–∑–Ω—ã–µ –≤–æ–ø—Ä–æ—Å—ã, –≤ —Ç–æ–º —á–∏—Å–ª–µ –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ —Ä–∞—Å—Ö–æ–¥–æ–≤–∞–Ω–∏—è —Å—Ä–µ–¥—Å—Ç–≤ –Ω–∞–ª–æ–≥–æ–ø–ª–∞—Ç–µ–ª—å—â–∏–∫–æ–≤, ‚Äî —Å—á–∏—Ç–∞–µ—Ç –≥–ª–∞–≤–Ω—ã–π –≤–Ω–µ—à—Ç–∞—Ç–Ω—ã–π —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç –ø–æ –í–ò–ß-–∏–Ω—Ñ–µ–∫—Ü–∏–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ê–ª–µ–∫—Å–µ–π –ú–∞–∑—É—Å. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –ø–æ –º–Ω–µ–Ω–∏—é —ç–∫—Å–ø–µ—Ä—Ç–∞, —ç—Ç–æ —Ç—Ä–µ–±—É–µ—Ç —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏—è –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å–Ω—ã—Ö –∫—Ä–∏—Ç–µ—Ä–∏–µ–≤, –ø–æ –∫–æ—Ç–æ—Ä—ã–º –ª—é–¥–µ–π —Å–º–æ–≥—É—Ç –æ—Ç–Ω–æ—Å–∏—Ç—å –∫ –≥—Ä—É–ø–ø–∞–º —Ä–∏—Å–∫–∞ –¥–ª—è –≤—ã–¥–µ–ª–µ–Ω–∏—è —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è, —Ñ–∞–∫—Ç–∏—á–µ—Å–∫–∏ –Ω–∞–¥–µ–ª—è—è ¬´–æ—Å–æ–±—ã–º –ø—Ä–∞–≤–æ–≤—ã–º —Å—Ç–∞—Ç—É—Å–æ–º¬ª. –ï—â—ë –æ–¥–∏–Ω –∞—Ä–≥—É–º–µ–Ω—Ç –ø—Ä–æ—Ç–∏–≤ ‚Äî –ø–æ –¥–∞–Ω–Ω—ã–º –ú–∏–Ω–∑–¥—Ä–∞–≤–∞, –≤ –†–æ—Å—Å–∏–∏ –µ–∂–µ–≥–æ–¥–Ω–æ —Å–Ω–∏–∂–∞–µ—Ç—Å—è —á–∏—Å–ª–æ –Ω–æ–≤—ã—Ö —Å–ª—É—á–∞–µ–≤ –í–ò–ß-–∏–Ω—Ñ–µ–∫—Ü–∏–∏, –ø—Ä–∏ —ç—Ç–æ–º –ø–æ –æ—Ö–≤–∞—Ç—É —Ç–µ—Å—Ç–∏—Ä–æ–≤–∞–Ω–∏–µ–º –Ω–∞ –í–ò–ß —Å—Ç—Ä–∞–Ω–∞ —Å–æ—Ö—Ä–∞–Ω—è–µ—Ç –ª–∏–¥–∏—Ä—É—é—â–∏–µ –ø–æ–∑–∏—Ü–∏–∏ –≤ –º–∏—Ä–µ. –¢–∞–∫–∂–µ —Ä–∞—Å—Ç—ë—Ç –æ—Ö–≤–∞—Ç –∞–Ω—Ç–∏—Ä–µ—Ç—Ä–æ–≤–∏—Ä—É—Å–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–µ–π. –ü–æ –¥–∞–Ω–Ω—ã–º –§–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ —Ä–µ–≥–∏—Å—Ç—Ä–∞ –ª–∏—Ü, –∏–Ω—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –í–ò–ß, –Ω–∞ –∫–æ–Ω–µ—Ü 2024 –≥–æ–¥–∞, –æ–Ω —Å–æ—Å—Ç–∞–≤–∏–ª 90,5%, —á—Ç–æ –Ω–∞ 2,8% –≤—ã—à–µ —Ü–µ–ª–µ–≤–æ–≥–æ –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è. –ò ¬´–≤–∏—à–µ–Ω–∫–∞ –Ω–∞ —Ç–æ—Ä—Ç–µ¬ª ‚Äî ¬´—Ä–æ—Å—Å–∏–π—Å–∫–æ–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ –æ—Ä–∏–µ–Ω—Ç–∏—Ä—É–µ—Ç—Å—è –Ω–∞ —Å–æ–¥–µ—Ä–∂–∞—Ç–µ–ª—å–Ω—ã–µ —Ñ–æ—Ä–º–∞—Ç—ã, –∏–º–µ—é—â–∏–µ —Ü–µ–Ω–Ω–æ—Å—Ç–Ω—É—é –æ–ø–æ—Ä—É –≤ —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω–æ–º ¬´–∫—É–ª—å—Ç—É—Ä–Ω–æ–º –∫–æ–¥–µ¬ª –∏ —Ñ–æ–∫—É—Å –Ω–∞ —Å–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ —Ä–µ–ø—Ä–æ–¥—É–∫—Ç–∏–≤–Ω–æ–≥–æ –∑–¥–æ—Ä–æ–≤—å—è –∏ –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª–∞ –Ω–∞—Ü–∏–∏¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""Experts from 'Zdravresource' suggest that 'contactless prevention (DCKP)' is an effective method to combat infection, but it is not included in the legislation and therefore cannot be widely applied in Russia. The experts explain that if DCKP is not implemented for 10 years in a group of 1,000 people, around 300 new infections will occur over this period. The cost of lifelong treatment for these patients at current prices would be 1 billion rubles. If the government funds DCKP, it will cost 200 million rubles to implement and prevent 270 infections, while reducing the number of 'breakthrough' cases (infection despite taking medication) to 30. Using injection drugs reduces the risk of infection to near zero. The experts argue that while DCKP initially seems expensive, it saves the budget over a long period by almost 1 billion rubles. However, this does not include the costs of treating associated diseases. The Ministry of Health considers D"
2025-07-25T08:49:25+00:00,@bezrec,6347,https://t.me/bezrec/6347,"–í –ù–∞—Ü–∏–º–±–∏–æ —Å–º–µ–Ω–∏–ª—Å—è —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å. –ù–∞ –¥–æ–ª–∂–Ω–æ—Å—Ç—å –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ —Ö–æ–ª–¥–∏–Ω–≥–∞ (–≤—Ö–æ–¥–∏—Ç –≤ ¬´–†–æ—Å—Ç–µ—Ö¬ª) –Ω–∞–∑–Ω–∞—á–µ–Ω –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ù–∏–∑–æ–≤—Ü–µ–≤. –ù–∞ —ç—Ç–æ–º –ø–æ—Å—Ç—É –æ–Ω —Å–º–µ–Ω–∏–ª –ê–Ω–¥—Ä–µ—è –ó–∞–≥–æ—Ä—Å–∫–æ–≥–æ, –≤–æ–∑–≥–ª–∞–≤–ª—è–≤—à–µ–≥–æ –≥–ª–∞–≤–Ω–æ–≥–æ —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –ø–æ—Å—Ç–∞–≤—â–∏–∫–∞ –≤–∞–∫—Ü–∏–Ω —Å 2017 –≥–æ–¥–∞. –£ –ù–∏–∑–æ–≤—Ü–µ–≤–∞ –±–æ–ª–µ–µ —á–µ–º 20-–ª–µ—Ç–Ω–∏–π –æ–ø—ã—Ç —É–ø—Ä–∞–≤–ª–µ–Ω–∏—è –≤ —Å—Ñ–µ—Ä–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –º–µ–¥–∏–∑–¥–µ–ª–∏–π. –ü—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–µ–Ω–Ω–æ —Å–≤—è–∑–∞–Ω–Ω—ã–π —Å ¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç–æ–º¬ª. –í —Ä–∞–∑–Ω—ã–µ –≥–æ–¥—ã –Ω–æ–≤—ã–π –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä ¬´–ù–∞—Ü–∏–º–±–∏–æ¬ª –∑–∞–Ω–∏–º–∞–ª —Ä—É–∫–æ–≤–æ–¥—è—â–∏–µ –ø–æ–∑–∏—Ü–∏–∏ –≤ –∫–æ–º–ø–∞–Ω–∏–∏ –í–∏–∫—Ç–æ—Ä–∞ –•–∞—Ä–∏—Ç–æ–Ω–∏–Ω–∞, –≤–æ–∑–≥–ª–∞–≤–ª—è–ª –¢—é–º–µ–Ω—Å–∫–∏–π –∑–∞–≤–æ–¥ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –∏ –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç–æ–≤ (–¢–ó–ú–û–ò, –≤—Ö–æ–¥–∏—Ç –≤ –≥—Ä—É–ø–ø—É ¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç¬ª), —Ä—É–∫–æ–≤–æ–¥–∏–ª –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏–µ–º ¬´–ë–∏–æ–º–µ–¥¬ª –∏–º. –ò.–ò. –ú–µ—á–Ω–∏–∫–æ–≤–∞, –≤—ã–ø—É—Å–∫–∞–≤—à–∏–º –≤–∞–∫—Ü–∏–Ω—ã –¥–ª—è –ù–∞—Ü–∫–∞–ª–µ–Ω–¥–∞—Ä—è –ø—Ä–∏–≤–∏–≤–æ–∫. –í –Ω–æ–≤–æ–π –¥–æ–ª–∂–Ω–æ—Å—Ç–∏ –ù–∏–∑–æ–≤—Ü–µ–≤ –∑–∞–π–º—ë—Ç—Å—è: üîò—É–∫—Ä–µ–ø–ª–µ–Ω–∏–µ–º —Ä—ã–Ω–æ—á–Ω—ã—Ö –ø–æ–∑–∏—Ü–∏–π —Ö–æ–ª–¥–∏–Ω–≥–∞ —Å —É—á–µ—Ç–æ–º –ø—Ä–∏–æ—Ä–∏—Ç–µ—Ç–Ω—ã—Ö –∑–∞–¥–∞—á –†–æ—Å—Ç–µ—Ö–∞; üîò–¥–∞–ª—å–Ω–µ–π—à–∏–º —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–º —Ä–∞–∑–≤–∏—Ç–∏–µ–º –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–∏ —Å –µ–≤—Ä–∞–∑–∏–π—Å–∫–∏–º–∏ –∏ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã–º–∏ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è–º–∏ GMP; üîò–ø—Ä–∏–≤–ª–µ—á–µ–Ω–∏–µ–º –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã—Ö –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–π –≤ —Ä–∞–∑–≤–∏—Ç–∏–µ —Ö–æ–ª–¥–∏–Ω–≥–∞; üîò—Ç—Ä–∞–Ω—Å—Ñ–µ—Ä–æ–º —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –∏ –≤—ã–≤–æ–¥–æ–º –Ω–∞ —Ä—ã–Ω–æ–∫ —Å–æ–≤—Ä–µ–º–µ–Ω–Ω—ã—Ö –º–Ω–æ–≥–æ–≤–∞–ª–µ–Ω—Ç–Ω—ã—Ö –≤–∞–∫—Ü–∏–Ω. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing, import_export, sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""The new head of Natsimbiya, Alexander Nizovtsev, will focus on strengthening the company's market positions in accordance with Rostec priorities; further technological development of production according to Eurasian and international GMP requirements; attracting additional investments for the company's development; transferring technologies and developing modern multi-valent vaccines.""
}"
2025-07-25T05:48:46+00:00,@bezrec,6346,https://t.me/bezrec/6346,"–ö–∞–∫ –∏ –æ–±–µ—â–∞–ª–∏, –Ω–æ–≤—ã–π –≤—ã–ø—É—Å–∫ —Ä—É–±—Ä–∏–∫–∏ #–∑–∞—Ü–µ–Ω–∏–ª–∏ –ø–æ—Å–≤—è—â–∞–µ–º –ú–∏—Ä–∞–º–∏—Å—Ç–∏–Ω—É. –ü–æ –¥–∞–Ω–Ω—ã–º –ì–†–õ–°, –±–µ–Ω–∑–∏–ª–¥–∏–º–µ—Ç–∏–ª-–º–∏—Ä–∏—Å—Ç–æ–∏–ª–∞–º–∏–Ω–æ-–ø—Ä–æ–ø–∏–ª–∞–º–º–æ–Ω–∏–π –ø–æ–¥ —Ç–æ—Ä–≥–æ–≤–æ–π –º–∞—Ä–∫–æ–π –ú–∏—Ä–∞–º–∏—Å—Ç–∏–Ω –≤—ã–ø—É—Å–∫–∞–µ—Ç—Å—è –≤ —Ç—Ä—ë—Ö —Ñ–æ—Ä–º–∞—Ö: –º–∞–∑–∏ –¥–ª—è –º–µ—Å—Ç–Ω–æ–≥–æ –∏ –Ω–∞—Ä—É–∂–Ω–æ–≥–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è, —Ä–∞—Å—Ç–≤–æ—Ä–∞ –¥–ª—è –º–µ—Å—Ç–Ω–æ–≥–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –∏ —Å—É–ø–ø–æ–∑–∏—Ç–æ—Ä–∏–µ–≤ –≤–∞–≥–∏–Ω–∞–ª—å–Ω—ã—Ö. –ú—ã —Å—Ä–∞–≤–Ω–∏–ª–∏ —Ü–µ–Ω—ã –≤ –æ–Ω–ª–∞–π–Ω-–∞–ø—Ç–µ–∫–∞—Ö –Ω–∞ —Ä–∞—Å—Ç–≤–æ—Ä—ã –¥–ª—è –º–µ—Å—Ç–Ω–æ–≥–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è —Å –ú–ù–ù –±–µ–Ω–∑–∏–ª–¥–∏–º–µ—Ç–∏–ª-–º–∏—Ä–∏—Å—Ç–æ–∏–ª–∞–º–∏–Ω–æ-–ø—Ä–æ–ø–∏–ª–∞–º–º–æ–Ω–∏–π —Ç–æ—Ä–≥–æ–≤—ã—Ö –º–∞—Ä–æ–∫ –ú–∏—Ä–∞–º–∏—Å—Ç–∏–Ω (¬´–ò–Ω—Ñ–∞–º–µ–¥¬ª), –ó–∏–ª–µ–∫—Å–∞ —Å–µ–ø—Ç (¬´–ì—Ä–æ—Ç–µ–∫—Å¬ª), –ú–∏—Ä–∞–≤–∞—Ü–∏–Ω (¬´–ê–í–í–ê –†–£–°¬ª). –ü—Ä–µ–ø–∞—Ä–∞—Ç–∞ –ú–∏—Ä–∞—Ü–µ–≤—Ç–∏–Ω (¬´–≠–∫–æ—Ö–∏–º-–ò–Ω–Ω–æ–≤–∞—Ü–∏–∏¬ª), –∫–æ—Ç–æ—Ä—ã–π —Ç–∞–∫–∂–µ –ø—Ä–∏—Å—É—Ç—Å—Ç–≤—É–µ—Ç –≤ –ì–†–õ–°, –Ω–µ –æ–∫–∞–∑–∞–ª–æ—Å—å –Ω–∏ –≤ –æ–¥–Ω–æ–π –∞–ø—Ç–µ–∫–µ. –ü—Ä–æ–±–ª–µ–º —Å –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å—é –ú–∏—Ä–∞–º–∏—Å—Ç–∏–Ω–∞ –æ—Ç ¬´–ò–Ω—Ñ–∞–º–µ–¥ –∫¬ª –ø–æ–∫–∞ –¥–µ–π—Å—Ç–≤–∏—Ç–µ–ª—å–Ω–æ –Ω–µ –Ω–∞–±–ª—é–¥–∞–µ—Ç—Å—è. –ü–æ–ø—É–ª—è—Ä–Ω–æ–≥–æ –∞–Ω—Ç–∏—Å–µ–ø—Ç–∏–∫–∞ –Ω–µ—Ç —Ç–æ–ª—å–∫–æ –≤ ¬´–ï–∞–ø—Ç–µ–∫–µ¬ª. –°–ª–æ–∂–Ω–µ–µ –≤—Å–µ–≥–æ –Ω–∞–π—Ç–∏ –æ–∫–∞–∑–∞–ª–æ—Å—å –ú–∏—Ä–∞–≤–∞—Ü–∏–Ω –æ—Ç ¬´–ê–í–í–ê –†–£–°¬ª ‚Äî –ø—Ä–µ–ø–∞—Ä–∞—Ç –æ—Ç—Å—É—Ç—Å—Ç–≤—É–µ—Ç –≤ —Ç—Ä—ë—Ö –∏–∑ –ø—è—Ç–∏ –ø—Ä–æ–≤–µ—Ä–µ–Ω–Ω—ã—Ö –∞–ø—Ç–µ–∫ (¬´–†–∏–≥–ª–µ¬ª, ¬´–ó–¥—Ä–∞–≤—Å–∏—Ç–∏¬ª, ¬´–ï–∞–ø—Ç–µ–∫–µ¬ª). –ó–∞—Ç–æ –ó–∏–ª–µ–∫—Å–∞ —Å–µ–ø—Ç (–≤–ª–∞–¥–µ–ª–µ—Ü –†–£ ‚Äî ¬´–¶–∏—Ç–µ—Ä–∞¬ª, –≤—ã–ø—É—Å–∫–∞–µ—Ç—Å—è –Ω–∞ –ø–ª–æ—â–∞–¥–∫–∞—Ö ¬´–ì—Ä–æ—Ç–µ–∫—Å–∞¬ª) –µ—Å—Ç—å –≤–µ–∑–¥–µ. –°–∞–º—ã–π –¥–æ—Ä–æ–≥–æ–π –∏–∑ —Ç—Ä–æ–∏—Ü—ã (890 —Ä—É–±–ª–µ–π) ‚Äî –ú–∏—Ä–∞–º–∏—Å—Ç–∏–Ω –∏–∑ ¬´36,6¬ª. –î–µ—à–µ–≤–ª–µ –≤—Å–µ–≥–æ (293 —Ä—É–±–ª—è) –æ–±–æ–π–¥—ë—Ç—Å—è –ú–∏—Ä–∞–≤–∞—Ü–∏–Ω –≤ ¬´–ê–ø—Ç–µ–∫–µ.—Ä—É¬ª. –ù–∞–ø–æ–º–∏–Ω–∞–µ–º, —á—Ç–æ –ª—é–±—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏–º–µ—é—Ç –ø—Ä–æ—Ç–∏–≤–æ–ø–æ–∫–∞–∑–∞–Ω–∏—è. –ü–µ—Ä–µ–¥ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º –ø—Ä–æ–∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä—É–π—Ç–µ—Å—å —Å –ª–µ—á–∞—â–∏–º –≤—Ä–∞—á–æ–º. *–∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –ø—Ä–æ–≤–æ–¥–∏–ª–æ—Å—å –æ–Ω–ª–∞–π–Ω 24 –∏—é–ª—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage"",
  ""impact"": ""medium"",
  ""english"": ""A study conducted online on July 24th found that the antiseptic Miraclens (from 'Eaptek') is widely available, while Miraavacin from 'AVVA RUS' is difficult to find in five checked pharmacies (Rigle, Zdravcity, Eaptek). The shortage is most severe for Miraavacin from 'AVVA RUS', which is not available in three of the five pharmacies. Prices vary, with the most expensive being Miraclens from '36,6' at 890 rubles and the cheapest being Miraavacin from 'Apteka.ru' at 293 rubles. It is important to consult a doctor before using any medication.""
}"
2025-07-24T15:04:47+00:00,@bezrec,6345,https://t.me/bezrec/6345,–ê –∫–∞–∫–∞—è —Å–≤–µ—Ä—Ö—Å–ø–æ—Å–æ–±–Ω–æ—Å—Ç—å –µ—Å—Ç—å —É —Ç–µ–±—è? ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞,"{""skip"": true}"
2025-07-24T12:34:29+00:00,@bezrec,6344,https://t.me/bezrec/6344,"¬´–ê–ª—å—Ñ–∞-–ë–∞–Ω–∫¬ª –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª —Å—Ä–∞–≤–Ω–∏—Ç–µ–ª—å–Ω—ã–π –∞–Ω–∞–ª–∏–∑ ¬´–ü—Ä–æ–º–æ–º–µ–¥–∞¬ª –∏ ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∏¬ª. –í–∞–∂–Ω—ã–µ –º–æ–º–µ–Ω—Ç—ã –∏–∑ –¥–æ–∫—É–º–µ–Ω—Ç–∞: üíä –û–±–µ –∫–æ–º–ø–∞–Ω–∏–∏ —Ä–∞—Å—Ç—É—Ç –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ –±—ã—Å—Ç—Ä–µ–µ —Ä—ã–Ω–∫–∞. ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª –æ—Ç–ª–∏—á–∞–µ—Ç –±–æ–ª–µ–µ –∞–≥—Ä–µ—Å—Å–∏–≤–Ω—ã–π —Ä–æ—Å—Ç –∑–∞ —Å—á—ë—Ç –Ω–∞—Ü–µ–ª–µ–Ω–Ω–æ—Å—Ç–∏ –Ω–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –±–µ—Å—Ç—Å–µ–ª–ª–µ—Ä–æ–≤. ¬´–ö–æ–Ω—ë–∫¬ª –∫–æ–º–ø–∞–Ω–∏–∏ ‚Äî –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –Ω–∞ –æ—Å–Ω–æ–≤–µ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ –∏ —Ç–∏—Ä–∑–µ–ø–∞—Ç–∏–¥–∞, –∞ —Ç–∞–∫–∂–µ –æ–Ω–∫–æ–ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –Ω–æ–≤–æ–≥–æ –ø–æ–∫–æ–ª–µ–Ω–∏—è. üíä –ë–∏–∑–Ω–µ—Å-–º–æ–¥–µ–ª—å ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∏¬ª –ø—Ä–µ–¥–ø–æ–ª–∞–≥–∞–µ—Ç –±–æ–ª–µ–µ —Å–¥–µ—Ä–∂–∞–Ω–Ω—ã–µ —Ç–µ–º–ø—ã —Ä–æ—Å—Ç–∞ –ø—Ä–∏ –±–æ–ª–µ–µ –¥–∏–≤–µ—Ä—Å–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω–æ–º –ø–æ—Ä—Ç—Ñ–µ–ª–µ –∏ –±–æ–ª–µ–µ –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω—ã—Ö –º–∞—Å—à—Ç–∞–±–∞—Ö –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏. –ö–æ–º–ø–∞–Ω–∏—è –¥–µ–ª–∞–µ—Ç —Å—Ç–∞–≤–∫—É –Ω–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤ —Å –ª–µ–≥–∫–æ –ø—Ä–æ–≥–Ω–æ–∑–∏—Ä—É–µ–º—ã–º —Å–ø—Ä–æ—Å–æ–º –∏ –º–∏–Ω–∏–º–∞–ª—å–Ω—ã–º–∏ –∑–∞—Ç—Ä–∞—Ç–∞–º–∏ –Ω–∞ –ø—Ä–æ–¥–≤–∏–∂–µ–Ω–∏–µ. üíä –° –∑–∞–ø—É—Å–∫–æ–º —Å–æ–±—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ –∏ —Ç–∏—Ä–∑–µ–ø–∞—Ç–∏–¥–∞ –¥–æ–ª—è –ø—Ä–æ–¥–∞–∂ –ø–æ –≥–æ—Å—Ç–µ–Ω–¥–µ—Ä—É —É ¬´–ü—Ä–æ–º–æ–º–µ–¥–∞¬ª —Å–Ω–∏–∑–∏–ª–∞—Å—å –¥–æ 47% —Å 55% –≤ 2020-2023 –≥–≥. –ù–æ –ø–æ–∫–∞–∑–∞—Ç–µ–ª–∏ –µ—â—ë –º–æ–≥—É—Ç –≤–æ—Å—Å—Ç–∞–Ω–æ–≤–∏—Ç—å—Å—è –ø–æ –º–µ—Ä–µ —Ä–æ—Å—Ç–∞ –ø—Ä–æ–¥–∞–∂ –ø—Ä–æ—Ç–∏–≤–æ—Ä–∞–∫–æ–≤—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –£ ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∏¬ª –¥–æ–º–∏–Ω–∏—Ä—É—é—Ç –∫–æ–º–º–µ—Ä—á–µ—Å–∫–∏–µ –ø—Ä–æ–¥–∞–∂–∏ ‚Äì –æ–∫–æ–ª–æ 70% —á–∏—Å—Ç–æ–π –≤—ã—Ä—É—á–∫–∏. üíä –ö–æ–º–ø–∞–Ω–∏—è –ü–µ—Ç—Ä–∞ –ë–µ–ª–æ–≥–æ –∏—Å—Ç–æ—Ä–∏—á–µ—Å–∫–∏ –¥–µ–º–æ–Ω—Å—Ç—Ä–∏—Ä—É–µ—Ç –±–æ–ª–µ–µ –≤—ã—Å–æ–∫—É—é –≤–∞–ª–æ–≤—É—é —Ä–µ–Ω—Ç–∞–±–µ–ª—å–Ω–æ—Å—Ç—å (66% –ø—Ä–æ—Ç–∏–≤ 46% —É ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∏¬ª) –∑–∞ —Å—á—ë—Ç —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ —Å—É–±—Å—Ç–∞–Ω—Ü–∏–π –¥–ª—è —Ä—è–¥–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ —Ñ–æ–∫—É—Å–∞ –Ω–∞ –≤—ã—Å–æ–∫–æ–º–∞—Ä–∂–∏–Ω–∞–ª—å–Ω—ã—Ö –ø—Ä–æ–¥—É–∫—Ç–∞—Ö. üíä –†–∞–∑–Ω–∏—Ü–∞ –≤ –º–∞—Ä–∂–∏–Ω–∞–ª—å–Ω–æ—Å—Ç–∏ –ø–æ EBITDA —É –¥–≤—É—Ö –∫–æ–º–ø–∞–Ω–∏–π –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ –º–µ–Ω—å—à–µ, —á–µ–º –ø–æ –≤–∞–ª–æ–≤–æ–π –ø—Ä–∏–±—ã–ª–∏, —Ç.–∫. ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª —Ç—Ä–∞—Ç–∏—Ç –∫—Ä–∞—Ç–Ω–æ –±–æ–ª—å—à–µ –Ω–∞ –ø—Ä–æ–¥–≤–∏–∂–µ–Ω–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –∞–¥–º–∏–Ω–∏—Å—Ç—Ä–∞—Ç–∏–≤–∫—É (33% –æ—Ç —á–∏—Å—Ç–æ–π –≤—ã—Ä—É—á–∫–∏ –≤ 2024 –≥–æ–¥—É). üíä –í –ø–æ—Å–ª–µ–¥–Ω–∏–µ –≥–æ–¥—ã –æ–±–µ –∫–æ–º–ø–∞–Ω–∏–∏ –Ω–µ —Å–∫—É–ø–∏–ª–∏—Å—å –Ω–∞ –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–∏ –≤ —Ä–∞–∑–≤–∏—Ç–∏–µ. –í 2021‚Äì2024 –≥–≥. ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª –ø—É—Å—Ç–∏–ª –Ω–∞ –∫–∞–ø–∏—Ç–∞–ª—å–Ω—ã–µ –∑–∞—Ç—Ä–∞—Ç—ã 18 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π (30% –æ—Ç –≤—ã—Ä—É—á–∫–∏), ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª ‚Äî –æ–∫–æ–ª–æ 11 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π (13% –æ—Ç –≤—ã—Ä—É—á–∫–∏). üíä–û—Ä–∏–µ–Ω—Ç–∏—Ä—ã –∫–æ–º–ø–∞–Ω–∏–π –ø–æ –∫–∞–ø–∏—Ç–∞–ª–æ–≤–ª–æ–∂–µ–Ω–∏—è–º –Ω–∞ —Å—Ä–µ–¥–Ω–µ—Å—Ä–æ—á–Ω—É—é –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤—É. ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª: –≤ —Å—Ä–µ–¥–Ω–µ–º –æ–∫–æ–ª–æ 10% –æ—Ç —á–∏—Å—Ç–æ–π –≤—ã—Ä—É—á–∫–∏, –ø—Ä–∏—á–µ–º –≤ –æ—Å–Ω–æ–≤–Ω–æ–º –≤ –Ω–µ–º–∞—Ç–µ—Ä–∏–∞–ª—å–Ω—ã–µ –∞–∫—Ç–∏–≤—ã. ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª: –µ–∂–µ–≥–æ–¥–Ω—ã–µ –∫–∞–ø–∏—Ç–∞–ª–æ–≤–ª–æ–∂–µ–Ω–∏—è 4‚Äì 5 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, –∏–ª–∏ 9‚Äì15% –æ—Ç –≤—ã—Ä—É—á–∫–∏ –≤ 2025-2027 –≥–≥. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": true
}"
2025-07-24T09:31:08+00:00,@bezrec,6343,https://t.me/bezrec/6343,"RNC Pharma –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∞ –¥–∞–Ω–Ω—ã–µ –ø–æ –æ–±—ä—ë–º–∞–º –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ –†–æ—Å—Å–∏–∏ –∑–∞ I-II –∫–≤–∞—Ä—Ç–∞–ª 2025 –≥–æ–¥–∞. –°—É–º–º–∞—Ä–Ω—ã–π –æ–±—ä—ë–º –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –≥–æ—Ç–æ–≤—ã—Ö –õ–ü —Å–æ—Å—Ç–∞–≤–∏–ª 475,9 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —á—Ç–æ –Ω–∞ 20,2% –±–æ–ª—å—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É. –í –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –ª–µ–∫–∞—Ä—Å—Ç–≤ —Å–æ–∫—Ä–∞—Ç–∏–ª–æ—Å—å –Ω–∞ 7,2% ‚Äî —Å —è–Ω–≤–∞—Ä—è –ø–æ –∏—é–Ω—å 2025 –≥–æ–¥–∞ –ª–æ–∫–∞–ª–∏–∑–æ–≤–∞–Ω–Ω—ã–µ –≤ –†–æ—Å—Å–∏–∏ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –≤—ã–ø—É—Å—Ç–∏–ª–∏ –≤ –æ–±—Ä–∞—â–µ–Ω–∏–µ –ø–æ—Ä—è–¥–∫–∞ 1,88 –º–ª—Ä–¥ —É–ø–∞–∫–æ–≤–æ–∫ –ì–õ–ü. –í –Ω–∞—Ç—É—Ä–∞–ª—å–Ω—ã—Ö –µ–¥–∏–Ω–∏—Ü–∞—Ö –∑–∞ –ø–æ—Å–ª–µ–¥–Ω–∏–µ —à–µ—Å—Ç—å –º–µ—Å—è—Ü–µ–≤, –ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω–∞—è –¥–∏–Ω–∞–º–∏–∫–∞ –Ω–∞–±–ª—é–¥–∞–ª–∞—Å—å —Ç–æ–ª—å–∫–æ –≤ –∞–ø—Ä–µ–ª–µ, –≤ –æ—Å—Ç–∞–ª—å–Ω—ã–µ –º–µ—Å—è—Ü—ã —Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–ª–æ—Å—å –ø–∞–¥–µ–Ω–∏–µ —Ñ–∏–∑–∏—á–µ—Å–∫–æ–≥–æ –æ–±—ä—ë–º–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞. –°–æ–∫—Ä–∞—â–µ–Ω–∏–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ ‚Äî ¬´–∑–∞—Å–ª—É–≥–∞¬ª –≤ –æ—Å–Ω–æ–≤–Ω–æ–º –û–¢–°-—Å–µ–≥–º–µ–Ω—Ç–∞. –í—ã–ø—É—Å–∫ —Ç–∞–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Å–Ω–∏–∑–∏–ª—Å—è –±–æ–ª–µ–µ —á–µ–º –Ω–∞ 14%, –≤ —Ç–æ –≤—Ä–µ–º—è –∫–∞–∫ –æ–±—ä—ë–º ¬´—Ä–µ—Ü–µ–ø—Ç—É—Ä–∫–∏¬ª –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏ –Ω–µ –∏–∑–º–µ–Ω–∏–ª—Å—è (-0,09%). –û–±—â–µ–µ —á–∏—Å–ª–æ –∏–≥—Ä–æ–∫–æ–≤, –≤—ã–ø—É—Å–∫–∞–≤—à–∏—Ö –≥–æ—Ç–æ–≤—ã–µ –õ–ü –≤ –ø–µ—Ä–≤–æ–π –ø–æ–ª–æ–≤–∏–Ω–µ 2025 –≥–æ–¥–∞ —Å–æ–∫—Ä–∞—Ç–∏–ª–æ—Å—å –¥–æ 402 ‚Äî –Ω–∞ 21 –º–µ–Ω—å—à–µ, —á–µ–º –≤ —è–Ω–≤–∞—Ä–µ-–∏—é–Ω–µ 2024 –≥–æ–¥–∞. –ü—Ä–∏ —ç—Ç–æ–º –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç, –Ω–∞–ø—Ä–æ—Ç–∏–≤, —Ä–∞—Å—à–∏—Ä–∏–ª—Å—è ‚Äî –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ —Ç–æ—Ä–≥–æ–≤—ã—Ö –º–∞—Ä–æ–∫ —É–≤–µ–ª–∏—á–∏–ª–æ—Å—å –Ω–∞ 34 –ø–æ–∑–∏—Ü–∏–∏, –¥–æ 2,7 —Ç—ã—Å. —à—Ç—É–∫. –ü—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ —Ä–∞—Å—à–∏—Ä—è—é—Ç –ø–æ—Ä—Ç—Ñ–µ–ª–∏ –≤ –æ—Å–Ω–æ–≤–Ω–æ–º –∑–∞ —Å—á—ë—Ç –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤, —Ö–æ—Ç—è –µ—Å—Ç—å –∏ –∏—Å–∫–ª—é—á–µ–Ω–∏—è. –ù–∞–ø—Ä–∏–º–µ—Ä, –≥–∏–ø–æ–≥–ª–∏–∫–µ–º–∏—á–µ—Å–∫–∏–π –õ—É—Å–µ—Ñ–∏ (–ª—É—Å–µ–æ–≥–ª–∏—Ñ–ª–æ–∑–∏–Ω) –æ—Ç ¬´–°–µ—Ä–≤—å–µ¬ª –∏ –¥–≤–µ —Ç–æ—Ä–≥–æ–≤—ã–µ –º–∞—Ä–∫–∏ —Å —Ç–∏—Ä–∑–µ–ø–∞—Ç–∏–¥–æ–º –æ—Ç ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º–∞¬ª –∏ ¬´–ü—Ä–æ–º–æ–º–µ–¥–∞¬ª. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –∞–∫—Ç–∏–≤–Ω–æ –Ω–∞—Ä–∞—â–∏–≤–∞—é—Ç –æ–±—ä—ë–º—ã –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ —Ä–∏–≤–∞—Ä–æ–∫—Å–∞–±–∞–Ω–∞. –ü–æ –∏—Ç–æ–≥–∞–º —è–Ω–≤–∞—Ä—è-–∏—é–Ω—è 2025 –≥–æ–¥–∞ –Ω–∞ —Ä—ã–Ω–æ–∫ –±—ã–ª–æ –æ—Ç–≥—Ä—É–∂–µ–Ω–æ 18 –∞–Ω–∞–ª–æ–≥–æ–≤ –ö—Å–∞—Ä–µ–ª—Ç–æ, –∏–∑ –Ω–∏—Ö –≤–æ—Å–µ–º—å –Ω–æ–≤–∏—á–∫–æ–≤, —Å—Ç–∞—Ä—Ç–æ–≤–∞–≤—à–∏—Ö –≤ —Ç–µ–∫—É—â–µ–º –≥–æ–¥—É. –ò–∑ –±–µ–∑—Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –º–∞–∫—Å–∏–º–∞–ª—å–Ω—É—é –¥–∏–Ω–∞–º–∏–∫—É –ø–æ–∫–∞–∑–∞–ª–∞ —Ç–æ—Ä–≥–æ–≤–∞—è –º–∞—Ä–∫–∞ –ú—É—Ä–∞–≤—å–∏–Ω—ã–π —Å–ø–∏—Ä—Ç, –∑–∞ –≥–æ–¥ –Ω–∞—Ä–∞—Å—Ç–∏–≤—à–∞—è –æ–±—ä—ë–º—ã –ø–æ—á—Ç–∏ –≤ —Ç—Ä–∏ —Ä–∞–∑–∞, –∫–ª—é—á–µ–≤–æ–π –≤–∫–ª–∞–¥ –≤ –¥–∏–Ω–∞–º–∏–∫—É –≤–Ω–µ—Å–ª–∏ –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ù–ò–ò–ú–ò–°¬ª –∏ ¬´–ñ–µ–Ω–µ–ª¬ª. –ê–Ω–∞–ª–∏—Ç–∏–∫–∏ —Å–≤—è–∑—ã–≤–∞—é—Ç —Ä–µ–∫–æ—Ä–¥—ã –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ —Å –µ–≥–æ –≤–µ—Ä–æ—è—Ç–Ω—ã–º –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ–º –≤ –∫–∞—á–µ—Å—Ç–≤–µ —Å—É—Ä—Ä–æ–≥–∞—Ç–∞ –∞–ª–∫–æ–≥–æ–ª—è. –í—ã—Å–æ–∫–æ–π –¥–∏–Ω–∞–º–∏–∫–æ–π (+22,6%) —Ç–∞–∫–∂–µ –æ—Ç–ª–∏—á–∏–ª—Å—è –ö–∞—Ä–¥–∏–æ–º–∞–≥–Ω–∏–ª –æ—Ç ¬´–ù–∏–∂—Ñ–∞—Ä–º¬ª. –°–æ–∫—Ä–∞—â–µ–Ω–∏–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –≤ –ø—Ä–µ–¥–µ–ª–∞—Ö –ø–µ—Ä–≤–æ–π –¥–≤–∞–¥—Ü–∞—Ç–∫–∏ –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–Ω–æ —É –†–∏–Ω–æ—Å—Ç–æ–ø–∞ –æ—Ç ¬´–û—Ç–∏—Å–∏—Ñ–∞—Ä–º¬ª (-46,6%). –°—Ä–µ–¥–∏ ¬´—Ä–µ—Ü–µ–ø—Ç—É—Ä–∫–∏¬ª –ª—É—á—à–∏–µ –ø–æ–∫–∞–∑–∞—Ç–µ–ª–∏ —É –ù–∞—Ç—Ä–∏—è –•–ª–æ—Ä–∏–¥ (+41,1%). –í –æ—Å–Ω–æ–≤–Ω–æ–º —ç—Ç–æ –∑–∞—Å–ª—É–≥–∞ –∫–æ–º–ø–∞–Ω–∏–π ¬´–ö—Ä–∞—Å—Ñ–∞—Ä–º–∞¬ª –∏ ¬´–ú–∏—Ä¬ª. –ù–∞–∏–±–æ–ª–µ–µ –∑–∞–º–µ—Ç–Ω–æ–µ —Å–Ω–∏–∂–µ–Ω–∏–µ –æ–±—ä—ë–º–æ–≤ –≤—ã–ø—É—Å–∫–∞ –ø—Ä–æ–∏–∑–æ—à–ª–æ —É –Ω–µ–±—Ä–µ–Ω–¥–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∞–∑–∏—Ç—Ä–æ–º–∏—Ü–∏–Ω–∞ (-49,5%). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""RNC Pharma reported production volumes of pharmaceuticals in Russia for the first half of 2025. Overall, ready-made drugs production amounted to 475.9 billion rubles, up by 20.2% year-over-year. In natural terms, drug production decreased by 7.2%, with local Russian pharmaceutical companies issuing around 1.88 billion units of drugs from January to June 2025. Only April showed a positive trend, while production fell in the other months. The decline is mainly attributed to the OTC segment, where production decreased by more than 14%. The volume of 'prescription' drugs remained almost unchanged (-0.09%). The number of players producing ready-made drugs in the first half of 2025 dropped to 402, down by 21 from the same period in 2024. However, the portfolio expanded with an increase of 34 positions to 2,700 brands. Manufacturers are expanding their portfolios mainly through generics, although there are"
2025-07-24T06:03:35+00:00,@bezrec,6342,https://t.me/bezrec/6342,"–í–æ –§—Ä–∞–Ω—Ü–∏–∏ —É–Ω–∏—á—Ç–æ–∂–∞—Ç –∫–æ–Ω—Ç—Ä–∞—Ü–µ–ø—Ç–∏–≤—ã –Ω–∞ $10 –º–ª–Ω. –ì–æ—Ä–∏ –æ–Ω–æ –≤—Å—ë —Å–∏–Ω–∏–º –ø–ª–∞–º–µ–Ω–µ–º, ‚Äî —Ä–µ—à–∏–ª –í–∞—à–∏–Ω–≥—Ç–æ–Ω –∏ —Ä–∞—Å–ø–æ—Ä—è–¥–∏–ª—Å—è —Å–∂–µ—á—å –ø—Ä–µ–∑–µ—Ä–≤–∞—Ç–∏–≤—ã, –ø—Ä–æ—Ç–∏–≤–æ–∑–∞—á–∞—Ç–æ—á–Ω—ã–µ —Ç–∞–±–ª–µ—Ç–∫–∏ –∏ –≤–Ω—É—Ç—Ä–∏–º–∞—Ç–æ—á–Ω—ã–µ —Å–ø–∏—Ä–∞–ª–∏, ¬´–∑–∞—Å—Ç—Ä—è–≤—à–∏–µ¬ª –Ω–∞ —Å–∫–ª–∞–¥–∞—Ö –≤ –ë–µ–ª—å–≥–∏–∏. –ö–æ–Ω—Ç—Ä–∞—Ü–µ–ø—Ç–∏–≤—ã, –ø—Ä–µ–¥–Ω–∞–∑–Ω–∞—á–∞–≤—à–∏–µ—Å—è –¥–ª—è –Ω–∞—Å–µ–ª–µ–Ω–∏—è –±–µ–¥–Ω–µ–π—à–∏—Ö —Å—Ç—Ä–∞–Ω, –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è —É—Ç–∏–ª–∏–∑–∏—Ä–æ–≤–∞—Ç—å –Ω–∞ –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏–∏ –≤–æ –§—Ä–∞–Ω—Ü–∏–∏, –∫–æ—Ç–æ—Ä–æ–µ –∑–∞–Ω–∏–º–∞–µ—Ç—Å—è –ø–µ—Ä–µ—Ä–∞–±–æ—Ç–∫–æ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Ç—Ö–æ–¥–æ–≤. –ù–∞ —ç—Ç–æ –°–®–ê –ø–æ—Ç—Ä–∞—Ç—è—Ç $160 —Ç—ã—Å. –ê –≤–µ–¥—å –º–æ–≥–ª–∏ –±—ã –ø—Ä–µ–¥–æ—Ç–≤—Ä–∞—Ç–∏—Ç—å –º–∏–ª–ª–∏–æ–Ω—ã –Ω–µ–∂–µ–ª–∞—Ç–µ–ª—å–Ω—ã—Ö –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–µ–π, –∞ —Ç–∞–∫–∂–µ —Å—ã–≥—Ä–∞—Ç—å —Å–≤–æ—é —Ä–æ–ª—å –≤ –æ—Å—Ç–∞–Ω–æ–≤–∫–µ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–∏—è –í–ò–ß-–∏–Ω—Ñ–µ–∫—Ü–∏–∏. –í –±–µ–ª—å–≥–∏–π—Å–∫–æ–º –ú–ò–î–µ –∑–∞—è–≤–∏–ª–∏, —á—Ç–æ –ë—Ä—é—Å—Å–µ–ª—å –ø—ã—Ç–∞–ª—Å—è –¥–æ–≥–æ–≤–æ—Ä–∏—Ç—å—Å—è —Å –≤–ª–∞—Å—Ç—è–º–∏ –°–®–ê –æ —Ç–æ–º, —á—Ç–æ–±—ã –∏–∑–±–µ–∂–∞—Ç—å —É–Ω–∏—á—Ç–æ–∂–µ–Ω–∏—è, –Ω–æ ¬´–∂–∏–∑–Ω–µ—Å–ø–æ—Å–æ–±–Ω–æ–π –∞–ª—å—Ç–µ—Ä–Ω–∞—Ç–∏–≤—ã –Ω–∞–π—Ç–∏ –Ω–µ —É–¥–∞–ª–æ—Å—å¬ª. –í –∏—é–ª–µ –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–µ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª–∏ –≤–Ω–µ—Å–ª–∏ –¥–≤–∞ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç–∞, –ø—Ä–∏–∑–≤–∞–Ω–Ω—ã—Ö –ø—Ä–µ–¥–æ—Ç–≤—Ä–∞—Ç–∏—Ç—å —É—Ç–∏–ª–∏–∑–∞—Ü–∏—é –∑–∞–ø–∞—Å–æ–≤, –æ–¥–Ω–∞–∫–æ –µ–¥–≤–∞ –ª–∏ –æ–Ω–∏ –±—É–¥—É—Ç –ø—Ä–∏–Ω—è—Ç—ã –≤–æ–≤—Ä–µ–º—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-07-23T14:59:18+00:00,@bezrec,6341,https://t.me/bezrec/6341,"‚ö°Ô∏è–ü—É—Ç–∏–Ω –ø–æ–¥–ø–∏—Å–∞–ª –∑–∞–∫–æ–Ω –æ –ø–µ—Ä–µ—á–Ω–µ –°–ó–õ–°. –ü–µ—Ä–µ—á–µ–Ω—å —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏ –≤–∞–∂–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –¥–ª—è –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –∫–ª—é—á–µ–≤—ã—Ö –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç–µ–π —Å–∏—Å—Ç–µ–º—ã –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ø–æ—è–≤–∏—Ç—Å—è —Å 1 —Å–µ–Ω—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞. –í —Å–ø–∏—Å–æ–∫ –ø–æ–ø–∞–¥—É—Ç –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, –∫–æ—Ç–æ—Ä—ã–µ –ø—Ä–∏–º–µ–Ω—è—é—Ç –≤ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–µ –∏ –ª–µ—á–µ–Ω–∏–∏ –±–æ–ª–µ–∑–Ω–µ–π, –ø—Ä–µ–æ–±–ª–∞–¥–∞—é—â–∏—Ö –≤ —Å—Ç—Ä—É–∫—Ç—É—Ä–µ –∑–∞–±–æ–ª–µ–≤–∞–µ–º–æ—Å—Ç–∏ –≤ –†–æ—Å—Å–∏–∏. –û–Ω–∏ –¥–æ–ª–∂–Ω—ã –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç—å—Å—è –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ —Å—Ç—Ä–∞–Ω—ã. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""high"",
  ""english"": ""Putin signed a law on the list of Strategic Life-Supporting Substances. The list, which will appear starting September 1st, 2025, includes medicines used for disease prevention and treatment. These must be produced within the country.""
}"
2025-07-23T12:40:01+00:00,@bezrec,6340,https://t.me/bezrec/6340,"–ù–æ–≤—ã—Ö –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤ —ç—Ç–∞–Ω–æ–ª–∞ –ø–æ–∫–∞ –Ω–µ –±—É–¥–µ—Ç. –ì–æ—Å–¥—É–º–∞ –≤–æ –≤—Ç–æ—Ä–æ–º –∏ —Ç—Ä–µ—Ç—å–µ–º —á—Ç–µ–Ω–∏–∏ –æ–¥–æ–±—Ä–∏–ª–∞ –º–æ—Ä–∞—Ç–æ—Ä–∏–π –Ω–∞ –≤—ã–¥–∞—á—É –ª–∏—Ü–µ–Ω–∑–∏–π –Ω–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ, —Ö—Ä–∞–Ω–µ–Ω–∏–µ –∏ –ø–æ—Å—Ç–∞–≤–∫—É —ç—Ç–∏–ª–æ–≤–æ–≥–æ —Å–ø–∏—Ä—Ç–∞, –≤–∫–ª—é—á–∞—è —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏–∏, –¥–æ 1 –∞–ø—Ä–µ–ª—è 2027 –≥–æ–¥–∞. –ò–Ω–∏—Ü–∏–∞—Ç–∏–≤–∞ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç–∞ –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∏—Ç –≥—Ä—É–ø–ø–µ –¥–µ–ø—É—Ç–∞—Ç–æ–≤ –≤–æ –≥–ª–∞–≤–µ —Å –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª–µ–º –ø–∞—Ä–ª–∞–º–µ–Ω—Ç—Å–∫–æ–≥–æ –∫–æ–º–∏—Ç–µ—Ç–∞ –ø–æ —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–π –ø–æ–ª–∏—Ç–∏–∫–µ –ú–∞–∫—Å–∏–º–æ–º –¢–æ–ø–∏–ª–∏–Ω—ã–º, –∞ —Å–∞–º–∞ –∏–¥–µ—è –º–æ—Ä–∞—Ç–æ—Ä–∏—è –∏–∑–Ω–∞—á–∞–ª—å–Ω–æ –∏—Å—Ö–æ–¥–∏–ª–∞ –æ—Ç –†–æ—Å–∞–ª–∫–æ–≥–æ–ª—å—Ç–∞–±–∞–∫–∫–æ–Ω—Ç—Ä–æ–ª—è. –†–µ–≥—É–ª—è—Ç–æ—Ä –ø–æ—Å—á–∏—Ç–∞–ª, —á—Ç–æ –Ω–æ–≤—ã–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã–µ –ª–∏–Ω–∏–∏ –º–æ–≥—É—Ç —Å—Ç–∞—Ç—å –∏—Å—Ç–æ—á–Ω–∏–∫–æ–º —É—Ç–µ–∫–∞—é—â–µ–≥–æ ¬´–Ω–∞ —Å—Ç–æ—Ä–æ–Ω—É¬ª –Ω–µ–ª–µ–≥–∞–ª—å–Ω–æ–≥–æ —Å–ø–∏—Ä—Ç–∞ –Ω–∞ —Ñ–æ–Ω–µ –ø—Ä–æ—Ñ–∏—Ü–∏—Ç–∞ —Å—É—â–µ—Å—Ç–≤—É—é—â–∏—Ö –º–æ—â–Ω–æ—Å—Ç–µ–π. –ù–∞ –≤—Ä–µ–º—è –¥–µ–π—Å—Ç–≤–∏—è –º–æ—Ä–∞—Ç–æ—Ä–∏—è –∞–≤—Ç–æ—Ä—ã –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç–∞ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ —Å–æ–∑–¥–∞—Ç—å –º–µ—Ö–∞–Ω–∏–∑–º –≥–∞—Ä–∞–Ω—Ç–∏—Ä–æ–≤–∞–Ω–Ω–æ–π –ø–æ—Å—Ç–∞–≤–∫–∏ —ç—Ç–∏–ª–æ–≤–æ–≥–æ —Å–ø–∏—Ä—Ç–∞ –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –∏ –≤–µ—Ç–µ—Ä–∏–Ω–∞—Ä–Ω–æ–≥–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è. –í–µ—Ä–æ—è—Ç–Ω–æ, –æ–Ω –±—É–¥–µ—Ç –æ—Å—É—â–µ—Å—Ç–≤–ª—è—Ç—å—Å—è —á–µ—Ä–µ–∑ –Ω–∞–∑–Ω–∞—á–µ–Ω–∏–µ –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø–æ—Å—Ç–∞–≤—â–∏–∫–æ–≤ —ç—Ç–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –¥–ª—è –Ω—É–∂–¥ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –∏ –ú–∏–Ω—Å–µ–ª—å—Ö–æ–∑–∞. –ù–∞–ø–æ–º–Ω–∏–º, –≤ –º–∞—Ä—Ç–µ 2025 –≥–æ–¥–∞ –¶–†–ü–¢ –æ–±–Ω–∞—Ä—É–∂–∏–ª, —á—Ç–æ —É 219 —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π –Ω–∞ —Å–∫–ª–∞–¥–∞—Ö ¬´–∑–∞–≤–∏—Å–ª–æ¬ª –æ–∫–æ–ª–æ 100 –º–ª–Ω –ª —ç—Ç–∏–ª–æ–≤–æ–≥–æ —Å–ø–∏—Ä—Ç–∞, –∫–æ—Ç–æ—Ä—ã–π –º–æ–≥ –ø–æ–π—Ç–∏ –Ω–∞ –ø–æ–¥–¥–µ–ª–∫—É –∞–ª–∫–æ–≥–æ–ª—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""The second and third readings of the law have approved a moratorium on licenses for producing, storing, and supplying ethanol until April 1, 2027. The moratorium was proposed by a group of deputies led by Maxim Topilin, chairman of the parliamentary committee on economic policy. The regulator believes that new production lines could lead to illegal alcohol flowing into the market due to existing capacity. The authors of the law proposed a mechanism for guaranteed supply of ethanol for medical and veterinary purposes during the moratorium. In March 2025, the Center for Risk Prevention and Treatment (–¶–†–ü–¢) discovered that about 10 million liters of ethanol were stranded at 219 pharmaceutical companies, which could be used for alcohol counterfeiting.""
}"
2025-07-23T09:32:29+00:00,@bezrec,6339,https://t.me/bezrec/6339,"–ü—Ä–æ–¥–æ–ª–∂–∞–µ–º –∑–Ω–∞–∫–æ–º–∏—Ç—å –≤–∞—Å —Å–æ —Å–≤–æ–¥–Ω—ã–º–∏ –¥–∞–Ω–Ω—ã–º–∏ –ø–æ –≥–æ—Å–∑–∞–∫—É–ø–∫–∞–º –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ —è–Ω–≤–∞—Ä–µ-–∏—é–Ω–µ 2025 –≥–æ–¥–∞, –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–Ω—ã–º–∏ IT-–∫–æ–º–ø–∞–Ω–∏–µ–π Cursor. –û—Å–Ω–æ–≤–Ω—ã–µ –ø–æ—Å—Ç–∞–≤—â–∏–∫–∏ –≤ —Å–µ–≥–º–µ–Ω—Ç–µ ‚Äî ¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç¬ª, ¬´–†-–§–∞—Ä–º¬ª –∏ ¬´–ò—Ä–≤–∏–Ω¬ª. –û–¥–Ω–∞–∫–æ –≤—Å–µ —Ç—Ä–æ–µ —Ç–µ—Ä—è—é—Ç –¥–æ–ª—é. –°—É–º–º–∞—Ä–Ω–æ –¥–ª—è —ç—Ç–∏—Ö –∫–æ–º–ø–∞–Ω–∏–π –æ–Ω–∞ —Å–æ—Å—Ç–∞–≤–ª—è–µ—Ç 20% —Ä—ã–Ω–∫–∞ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å 28% –≤ –∞–Ω–∞–ª–æ–≥–∏—á–Ω–æ–º –ø–µ—Ä–∏–æ–¥–µ –ø—Ä–æ—à–ª–æ–≥–æ –≥–æ–¥–∞. –í–ø—Ä–æ—á–µ–º, –æ—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω–∞—è –¥–∏–Ω–∞–º–∏–∫–∞ –Ω–∞–±–ª—é–¥–∞–µ—Ç—Å—è —É –∞–±—Å–æ–ª—é—Ç–Ω–æ–≥–æ –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–∞ –∏–∑ —Ç–æ–ø-10 (¬´–§–∞—Ä–º–∏–º—ç–∫—Å¬ª, ¬´–ë–°–°¬ª, ¬´–ú–µ–¥–∏–ø–∞–ª-–û–Ω–∫–æ¬ª, ¬´–ü—Ä–∏–º–∞—Ñ–∞—Ä–º¬ª, ¬´–ù–∞–Ω–æ–ª–µ–∫¬ª). –ï—Å–ª–∏ –≤ –ø–µ—Ä–≤–æ–º –ø–æ–ª—É–≥–æ–¥–∏–∏ 2024 –≥–æ–¥–∞ –¥–æ–ª—è –¥–µ—Å—è—Ç–∫–∏ –ª—É—á—à–∏—Ö —Å–æ—Å—Ç–∞–≤–ª—è–ª–∞ –æ–∫–æ–ª–æ 45%, —Ç–æ –∑–∞ —Ç–æ—Ç –∂–µ –ø–µ—Ä–∏–æ–¥ —Ç–µ–∫—É—â–µ–≥–æ –≥–æ–¥–∞ ‚Äî 37%. –ü—Ä–∏—Ä–æ—Å—Ç–æ–º –≥–æ–¥ –∫ –≥–æ–¥—É –º–æ–≥—É—Ç –ø–æ—Ö–≤–∞—Å—Ç–∞—Ç—å—Å—è —Ç–æ–ª—å–∫–æ ¬´–õ–∞–Ω—Ü–µ—Ç¬ª (+30%) –∏ ¬´–ü—Ä–æ—Ç–µ–∫¬ª (+110%). –í —Ç–æ–ø-3 —Ä–µ–≥–∏–æ–Ω–æ–≤-–∑–∞–∫–∞–∑—á–∏–∫–æ–≤ –ø–æ –∏—Ç–æ–≥–∞–º —è–Ω–≤–∞—Ä—è-–∏—é–Ω—è 2025 –≥–æ–¥–∞ –≤–æ—à–ª–∏ –ú–æ—Å–∫–≤–∞, –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥ –∏ –ú–æ—Å–∫–æ–≤—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å. –ù–∞–∏–±–æ–ª–µ–µ –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω—ã–º –ø—Ä–∏—Ä–æ—Å—Ç–æ–º –∑–∞–∫—É–ø–æ–∫ –æ—Ç–ª–∏—á–∏–ª–∏—Å—å –ß–µ–ª—è–±–∏–Ω—Å–∫–∞—è, –°–≤–µ—Ä–¥–ª–æ–≤—Å–∫–∞—è –∏ –†–æ—Å—Ç–æ–≤—Å–∫–∞—è –æ–±–ª–∞—Å—Ç–∏. –í —Ç–æ–ø-10 –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ø–æ –æ–±—ä—ë–º–∞–º –ø–æ—Å—Ç–∞–≤–æ–∫ –ø–æ–ø–∞–ª–∏: –§–æ—Ä—Å–∏–≥–∞, –û–ø–¥–∏–≤–æ, –ö—Å—Ç–∞–Ω–¥–∏, –ü–µ—Ä—å–µ—Ç–∞, –ú–∞–≤–∏—Ä–µ—Ç, –ù–∞—Ç—Ä–∏—è —Ö–ª–æ—Ä–∏–¥, –õ–∏–Ω–ø–∞—Ä–∑–∞, –¢–∞–≥—Ä–∏—Å—Å–æ, –¢–µ—Ü–µ–Ω—Ç—Ä–∏–∫, –î–∂–∞—Ä–¥–∏–Ω—Å. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The report highlights the declining market share of major pharmaceutical companies such as 'FarmaStandard', 'R-Farm', and 'Irvin' in the January-June 2025 procurement period. The overall market share for these companies is now at 20% compared to 28% in the same period last year. Despite this, most of the top-10 companies are experiencing negative growth. The top 3 regions for procurement in January-June 2025 are Moscow, St. Petersburg, and Moscow region. Regions like Chelyabinsk, Sverdlovsk, and Rostov Oblast have shown significant growth in purchases. Top 10 drugs by volume include Forsigra, Opdivo, Kstandi, Perieta, Maviret, Sodium Chloride, Linpraza, Tagrisso, Tezcentrik, and Jardins.‚Ñ¢ Without prescription""
}"
2025-07-23T05:45:29+00:00,@bezrec,6337,https://t.me/bezrec/6337,"–°–Ω–æ–≤–∞ –Ω–∞—á–∏–Ω–∞–µ–º –¥–µ–Ω—å —Å –Ω–æ–≤–æ—Å—Ç–µ–π –ø—Ä–æ –ú–∏—Ä–∞–º–∏—Å—Ç–∏–Ω. –ù–∞ —ç—Ç–æ—Ç —Ä–∞–∑ –æ—Ç –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–∞. –í –≤–µ–¥–æ–º—Å—Ç–≤–µ —É—Å–ø–æ–∫–æ–∏–ª–∏, —á—Ç–æ –¥–µ—Ñ–∏—Ü–∏—Ç–∞ –ø–æ–ø—É–ª—è—Ä–Ω–æ–≥–æ –∞–Ω—Ç–∏—Å–µ–ø—Ç–∏–∫–∞ –Ω–µ –ø—Ä–µ–¥–≤–∏–¥–∏—Ç—Å—è: üü¢ –≤–æ-–ø–µ—Ä–≤—ã—Ö, –ø–æ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è, –Ω–∞ —Å–∫–ª–∞–¥–∞—Ö –Ω–∞—Ö–æ–¥–∏—Ç—Å—è –±–æ–ª–µ–µ 4,5 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ –ú–∏—Ä–∞–º–∏—Å—Ç–∏–Ω–∞ –∏ –û–∫–æ–º–∏—Å—Ç–∏–Ω–∞, –∏ –µ—â—ë –±–æ–ª–µ–µ 1,5 –º–ª–Ω –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –≤–≤–µ—Å—Ç–∏ –≤ –≥—Ä–∞–∂–¥–∞–Ω—Å–∫–∏–π –æ–±–æ—Ä–æ—Ç –¥–æ –∫–æ–Ω—Ü–∞ –∞–≤–≥—É—Å—Ç–∞; üü¢ –≤–æ-–≤—Ç–æ—Ä—ã—Ö, –≤ –ì–†–õ–° —Å–æ–¥–µ—Ä–∂–∞—Ç—Å—è —Å–≤–µ–¥–µ–Ω–∏—è –æ 14 –¥–µ—Ä–∂–∞—Ç–µ–ª—è—Ö –†–£ –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã —Å –ú–ù–ù –±–µ–Ω–∑–∏–ª–¥–∏–º–µ—Ç–∏–ª-–º–∏—Ä–∏—Å—Ç–æ–∏–ª–∞–º–∏–Ω–æ-–ø—Ä–æ–ø–∏–ª–∞–º–º–æ–Ω–∏–π, –ø—Ä–∏ —ç—Ç–æ–º —É 13 –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –µ—Å—Ç—å —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∞—è –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ø–æ –ø–æ–ª–Ω–æ–º—É —Ü–∏–∫–ª—É –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ –†–§, –≤–∫–ª—é—á–∞—è –≤—ã–ø—É—Å–∫ —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏–∏. –°–≤–æ–∏ ¬´–º–∏—Ä–∞–º–∏—Å—Ç–∏–Ω—ã¬ª –≤ —Ä–∞–∑–ª–∏—á–Ω—ã—Ö —Ñ–æ—Ä–º–∞—Ö –≤ –†–æ—Å—Å–∏–∏ –≤—ã–ø—É—Å–∫–∞—é—Ç ¬´–°–µ–≤–µ—Ä–Ω–∞—è –∑–≤–µ–∑–¥–∞¬ª, ¬´–¢—É–ª—å—Å–∫–∞—è —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∞—è —Ñ–∞–±—Ä–∏–∫–∞¬ª, ¬´–ö–∏—Ä–æ–≤—Å–∫–∞—è —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∞—è —Ñ–∞–±—Ä–∏–∫–∞¬ª, ¬´–°–¢–ú–§–ê–†–ú¬ª, ¬´–¶–∏—Ç–µ—Ä–∞¬ª, ¬´–≠–≤–∞–ª–∞—Ä¬ª, ¬´–≠–∫–æ—Ö–∏–º-–ò–Ω–Ω–æ–≤–∞—Ü–∏–∏¬ª, ¬´–ê–í–í–ê –†–£–°¬ª, ¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç-–õ–µ–∫—Å—Ä–µ–¥—Å—Ç–≤–∞¬ª, ¬´–§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∞—è —Ñ–∏—Ä–º–∞ –õ–ï–ö–ö–û¬ª, ¬´–ú–µ–¥–∏–∫–∞—Å¬ª, ¬´–õ–æ–∫–∞–ª–§–∞—Ä–º¬ª. –í 2025 –≥–æ–¥—É –≤ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω—É—é —Å–∏—Å—Ç–µ–º—É –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–∞ –ø–æ—Å—Ç—É–ø–∏–ª–∏ —Å–≤–µ–¥–µ–Ω–∏—è –æ 264 –≤—ã–ø—É—â–µ–Ω–Ω—ã—Ö —Å–µ—Ä–∏—è—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –±–µ–Ω–∑–∏–ª–¥–∏–º–µ—Ç–∏–ª-–º–∏—Ä–∏—Å—Ç–æ–∏–ª–∞–º–∏–Ω–æ-–ø—Ä–æ–ø–∏–ª–∞–º–º–æ–Ω–∏—è, –≤–≤–æ–¥–∏–º—ã—Ö –≤ –≥—Ä–∞–∂–¥–∞–Ω—Å–∫–∏–π –æ–±–æ—Ä–æ—Ç –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ –†–æ—Å—Å–∏–∏. –í—á–µ—Ä–∞ –≥–ª–∞–≤–∞ –ö–æ–º–∏—Ç–µ—Ç–∞ –ì–æ—Å–¥—É–º—ã –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è –°–µ—Ä–≥–µ–π –õ–µ–æ–Ω–æ–≤ –ø—Ä–∏–∑–≤–∞–ª –Ω–µ –ø–∞–Ω–∏–∫–æ–≤–∞—Ç—å –∏ –Ω–µ —Å–∫—É–ø–∞—Ç—å –ú–∏—Ä–∞–º–∏—Å—Ç–∏–Ω –≤ –∞–ø—Ç–µ–∫–∞—Ö, —á—Ç–æ–±—ã –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ –Ω–µ —Å–æ–∑–¥–∞–≤–∞—Ç—å –¥–µ—Ñ–∏—Ü–∏—Ç. –î–µ–ø—É—Ç–∞—Ç —Ç–∞–∫–∂–µ –Ω–∞–ø–æ–º–Ω–∏–ª, —á—Ç–æ –≤ –ø—Ä–æ–¥–∞–∂–µ –∏–º–µ—é—Ç—Å—è –¥–æ—Å—Ç—É–ø–Ω—ã–µ –∞–Ω–∞–ª–æ–≥–∏. –ù–∞–ª–∏—á–∏–µ –≤ –∞–ø—Ç–µ–∫–∞—Ö –∏ —Å—Ç–æ–∏–º–æ—Å—Ç—å –±–µ–Ω–∑–∏–ª–¥–∏–º–µ—Ç–∏–ª-–º–∏—Ä–∏—Å—Ç–æ–∏–ª–∞–º–∏–Ω–æ-–ø—Ä–æ–ø–∏–ª–∞–º–º–æ–Ω–∏—è –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ –ø—Ä–æ–≤–µ—Ä–∏–º –≤ –±–ª–∏–∂–∞–π—à–µ–º –≤—ã–ø—É—Å–∫–µ –Ω–∞—à–µ–π —Ä—É–±—Ä–∏–∫–∏ #–∑–∞—Ü–µ–Ω–∏–ª–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Industry and Trade reassures that there is no shortage of the popular antiseptic Miramistin. There are over 4.5 million units and another 1.5 million to be introduced into civil use by the end of August in stock. The General Register List System contains information on 14 holders of registration approval for the drugs with the MN number benzyl dimethyl myristoyl ammonium propionate. 13 producers have the technological capacity to produce the full cycle on Russian territory, including production of raw material. The country's pharmacies are supplied with various forms of Miramistin by 'Northern Star', 'Tula Pharmaceutical Factory', 'Kirov Pharmaceutical Factory', 'STMFARMA', 'Citera', 'Evelar', 'Ecochem Innovations', 'AVVA RUS', 'Pharmastandart-Lexredstva', 'Pharmaceutical Company LECKO', 'Medicas', 'LocalFarma'. In 2025, information about 2"
2025-07-22T14:03:12+00:00,@bezrec,6336,https://t.me/bezrec/6336,"–£–ª–æ–≤ –∏–Ω–¥–∏–π—Å–∫–∏—Ö —Ä—ã–±–∞–∫–æ–≤ –ø—Ä–∏–≥–æ–¥–∏–ª—Å—è —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏. –î–≤–æ–µ –∂–∏—Ç–µ–ª–µ–π –¥–µ—Ä–µ–≤–Ω–∏ –ë–∏–Ω–∏–∫–∞ (—à—Ç–∞—Ç –û–¥–∏—à–∞ –Ω–∞ –≤–æ—Å—Ç–æ–∫–µ –ò–Ω–¥–∏–∏) –≤–µ—Å—å–º–∞ —É–¥–∞—á–Ω–æ –ø–æ—Ä—ã–±–∞—á–∏–ª–∏. –ê–Ω–∞–Ω—Ç—Ä–∞–º –ú—É–¥—É–ª–∏ –∏ –°—É–¥–∂–∏—Ç –°–µ—Ç—Ö–∏ –æ—Ç–ø—Ä–∞–≤–∏–ª–∏—Å—å –∑–∞ —É–ª–æ–≤–æ–º –Ω–∞ —Ä–µ–∫—É –ú–∞—Ö–∞–Ω–∞–¥–∏. –¢–æ, —á—Ç–æ –ø–æ–ø–∞–ª–æ—Å—å –≤ –∏—Ö —Å–µ—Ç–∏, –º—É–∂—á–∏–Ω—ã —Å–Ω–∞—á–∞–ª–∞ –ø—Ä–∏–Ω—è–ª–∏ –∑–∞ –∫—Ä–æ–∫–æ–¥–∏–ª–∞ –∏–∑-–∑–∞ –æ–≥—Ä–æ–º–Ω—ã—Ö —Ä–∞–∑–º–µ—Ä–æ–≤. –û–¥–Ω–∞–∫–æ, –ø—Ä–∏—Å–º–æ—Ç—Ä–µ–≤—à–∏—Å—å, —Ä—ã–±–∞–∫–∏ –ø–æ–Ω—è–ª–∏, —á—Ç–æ –ø–æ–π–º–∞–ª–∏ –æ–≥—Ä–æ–º–Ω–æ–≥–æ —Ä–µ–¥–∫–æ–≥–æ —Å–æ–º–∞ –≤–µ—Å–æ–º –ø–æ–¥ —Ü–µ–Ω—Ç–Ω–µ—Ä. –†–∞–Ω—å—à–µ –º—ã –ª–æ–≤–∏–ª–∏ —Ä—ã–± –≤–µ—Å–æ–º 30-40 –∫–∏–ª–æ–≥—Ä–∞–º–º–æ–≤. –°–µ–≥–æ–¥–Ω—è –º—ã –ø–æ–π–º–∞–ª–∏ –≥–∏–≥–∞–Ω—Ç—Å–∫—É—é —Ä—ã–±—É –±–æ–¥–∞, –æ –∫–æ—Ç–æ—Ä–æ–π —Ä–∞—Å—Å–∫–∞–∑—ã–≤–∞–ª–∏ –Ω–∞—à–∏ –ø—Ä–µ–¥–∫–∏, ‚Äî –ø–æ–¥–µ–ª–∏–ª–∏—Å—å —Å–≤–æ–µ–π —É–¥–∞—á–µ–π –ú—É–¥—É–ª–∏ –∏ –°–µ—Ç—Ö–∏. –ò–Ω–¥–∏–π—Å–∫–∏–π —Å–æ–º ‚Äî —ç—Ç–æ –Ω–µ —Ç–æ–ª—å–∫–æ 100 –∫–≥ –ª–µ–≥–∫–æ—É—Å–≤–æ—è–µ–º–æ–≥–æ –º—è—Å–∞, –Ω–æ –∏ —Ñ–∞—Ä–º—Å—ã—Ä—å—ë. –£–ª–æ–≤–æ–º –∑–∞–∏–Ω—Ç–µ—Ä–µ—Å–æ–≤–∞–ª—Å—è –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏–∑ –ó–∞–ø–∞–¥–Ω–æ–π –ë–µ–Ω–≥–∞–ª–∏–∏ –∏ –≤—ã–∫—É–ø–∏–ª —Ä—ã–±–∏–Ω—É –∑–∞ 300 —Ç—ã—Å. —Ä—É–ø–∏–π (272 —Ç—ã—Å. —Ä—É–±–ª–µ–π). –ï—ë –∂–∏—Ä –±–æ–≥–∞—Ç –≤–∏—Ç–∞–º–∏–Ω–∞–º–∏ A, D –∏ E, –∞ —Ç–∞–∫–∂–µ –æ–º–µ–≥–∞-3-–Ω–µ–Ω–∞—Å—ã—â–µ–Ω–Ω—ã–º–∏ –∂–∏—Ä–Ω—ã–º–∏ –∫–∏—Å–ª–æ—Ç–∞–º–∏, –∑–∞ —á—Ç–æ —Ü–µ–Ω–∏—Ç—Å—è –≤ —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω–µ. –≠—Ç–æ –Ω–µ –ø–µ—Ä–≤—ã–π —Å–ª—É—á–∞–π, –∫–æ–≥–¥–∞ –∏–Ω–¥–∏–π—Å–∫–∏–º —Ä—ã–±–∞–∫–∞–º —É–¥–∞—ë—Ç—Å—è –≤—ã—Ä—É—á–∏—Ç—å —Å–æ–ª–∏–¥–Ω—ã–µ –¥–µ–Ω—å–≥–∏ –∑–∞ —Å–≤–æ—é –¥–æ–±—ã—á—É –∏–∑-–∑–∞ –µ—ë —Ü–µ–ª–µ–±–Ω—ã—Ö —Å–≤–æ–π—Å—Ç–≤. –í —Å–µ–Ω—Ç—è–±—Ä–µ –ø—Ä–æ—à–ª–æ–≥–æ –≥–æ–¥–∞ –º—ã —Ä–∞—Å—Å–∫–∞–∑—ã–≤–∞–ª–∏, –∫–∞–∫ –≤ –ë–µ–Ω–≥–∞–ª—å—Å–∫–æ–º –∑–∞–ª–∏–≤–µ –ø–æ–π–º–∞–ª–∏ —Ä–µ–¥—á–∞–π—à–∏—Ö –æ—Å–æ–±–µ–π –ø–æ–¥ –Ω–∞–∑–≤–∞–Ω–∏–µ–º ¬´—Ç–µ–ª–∏—è —Å–∏–ª–∞¬ª, –∫–∞–∂–¥–∞—è –≤–µ—Å–æ–º –ø–æ–¥ 100 –∫–≥. –≠—Ç–∞ —Ä—ã–±–∞ –∏—Å–ø–æ–ª—å–∑—É–µ—Ç—Å—è –≤ –º–µ–¥–∏—Ü–∏–Ω–µ –¥–ª—è –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –∂–∏–∑–Ω–µ–Ω–Ω–æ –≤–∞–∂–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤. –í –∏—Ç–æ–≥–µ –æ–¥–∏–Ω —É–¥–∞—á–Ω—ã–π –≤—ã—Ö–æ–¥ –≤ –º–æ—Ä–µ –ø—Ä–∏–Ω—ë—Å —Ä—ã–±–∞–∫–∞–º –ø—Ä–∏–º–µ—Ä–Ω–æ 1,5 –º–ª–Ω —Ä—É–±–ª–µ–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-07-22T11:04:18+00:00,@bezrec,6335,https://t.me/bezrec/6335,"–õ–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏–∑ –∞–ø—Ç–µ–∫ ¬´–í–∏—Ç–∞¬ª –ø–æ–µ–¥—É—Ç –ø–æ —Å—Ç—Ä–∞–Ω–µ —Å –ö—É–ø–µ—Ä–æ–º. –ö —Å–µ—Ä–≤–∏—Å—É –ø–æ–¥–∫–ª—é—á–∏–ª–∏ –ø–æ—á—Ç–∏ 1,8 —Ç—ã—Å. –∞–ø—Ç–µ–∫ —Å–µ—Ç–∏. –í –ø–ª–∞–Ω–∞—Ö ‚Äì –µ—â—ë 400 —Ç–æ—á–µ–∫. –î–æ—Å—Ç–∞–≤–∫–∞ –Ω–∞ –¥–æ–º –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ —Ç–æ–≤–∞—Ä–æ–≤ –¥–ª—è –∑–¥–æ—Ä–æ–≤—å—è —Ç–µ–ø–µ—Ä—å –¥–æ—Å—Ç—É–ø–Ω–∞ –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª—è–º –≤ 89 –≥–æ—Ä–æ–¥–∞—Ö, –≤–∫–ª—é—á–∞—è –ú–æ—Å–∫–≤—É, –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥, –ï–∫–∞—Ç–µ—Ä–∏–Ω–±—É—Ä–≥, –£–ª—å—è–Ω–æ–≤—Å–∫, –°–∞—Ä–∞—Ç–æ–≤, –í–æ–ª–≥–æ–≥—Ä–∞–¥, –ù–∏–∂–Ω–∏–π –ù–æ–≤–≥–æ—Ä–æ–¥, –ö–∞–∑–∞–Ω—å, –°–∞–º–∞—Ä—É, –ß–µ–ª—è–±–∏–Ω—Å–∫, –†–æ—Å—Ç–æ–≤-–Ω–∞-–î–æ–Ω—É –∏ –ß–µ–±–æ–∫—Å–∞—Ä—ã. –ö—É–ø–µ—Ä –±—É–¥–µ—Ç –¥–æ—Å—Ç–∞–≤–ª—è—Ç—å –∫–ª–∏–µ–Ω—Ç–∞–º ¬´–í–∏—Ç—ã¬ª –±–µ–∑—Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, –≤–∏—Ç–∞–º–∏–Ω—ã, –∫–æ—Å–º–µ—Ç–∏–∫—É, –ø—Ä–µ–¥–º–µ—Ç—ã –≥–∏–≥–∏–µ–Ω—ã, —É—Ö–æ–¥–∞ –∏ –º–Ω–æ–≥–æ–µ –¥—Ä—É–≥–æ–µ. –°–¥–µ–ª–∞—Ç—å –∑–∞–∫–∞–∑ –ø—Ä–æ—Å—Ç–æ - –¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ —É–∫–∞–∑–∞—Ç—å –∞–¥—Ä–µ—Å –¥–æ—Å—Ç–∞–≤–∫–∏. –ï—â—ë –æ–¥–Ω–∞ ¬´–ø—Ä–∏—è—Ç–Ω–æ—Å—Ç—å¬ª ‚Äì —Ç–æ–≤–∞—Ä—ã, –∫–æ—Ç–æ—Ä—ã–µ –ø—Ä–∏–µ–¥—É—Ç –Ω–∞ –¥–æ–º –º–æ–∂–Ω–æ –æ–ø–ª–∞—Ç–∏—Ç—å –±–æ–Ω—É—Å–∞–º–∏ ¬´–°–ø–∞—Å–∏–±–æ¬ª. –ü–æ–¥–∫–ª—é—á–µ–Ω–∏–µ ¬´–í–∏—Ç—ã¬ª - –Ω–µ –ø–µ—Ä–≤—ã–π –¥–ª—è –ö—É–ø–µ—Ä–∞ –æ–ø—ã—Ç —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–∞ —Å –∞–ø—Ç–µ—á–Ω—ã–º–∏ —Å–µ—Ç—è–º–∏. –†–∞–Ω–µ–µ –∫ —Å–µ—Ä–≤–∏—Å—É –±—ã–ª–∏ –ø–æ–¥–∫–ª—é—á–µ–Ω—ã ¬´–ú–∞–∫—Å–∞–≤–∏—Ç¬ª, ¬´–ñ–∏–≤–∏–∫–∞¬ª –∏ –¥—Ä—É–≥–∏–µ –ø–∞—Ä—Ç–Ω–µ—Ä—ã. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The delivery service 'Kuper' is expanding its reach to include almost 1,800 pharmacies from the 'Vita' network. Plans are in place to add another 400 points. The service now offers home delivery of 'Vita' products, including medications, vitamins, cosmetics, hygiene items, and more in 89 cities including Moscow, St. Petersburg, Ekaterinburg, Ulyanovsk, Samara, Chelyabinsk, Rostov-on-Don, and Cheboksary. Customers can place orders by specifying the delivery address. One 'pleasant' aspect is that customers can pay for home-delivered items with 'Thank You' bonuses. The partnership with 'Vita' is not the first for Kuper, which has also collaborated with other pharmacy chains like 'Maxavit' and others.""
}"
2025-07-22T08:48:47+00:00,@bezrec,6334,https://t.me/bezrec/6334,"–†—É–∫–æ–≤–æ–¥—Å—Ç–≤–æ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ —Ñ–∞—Ä–º–ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏—è –≤ –•–∞–∫–∞—Å–∏–∏ –∑–∞–¥–µ—Ä–∂–∞–Ω–æ –∑–∞ –º–∞—Ö–∏–Ω–∞—Ü–∏–∏ —Å –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏. –î–∏—Ä–µ–∫—Ç–æ—Ä –ì–ë–£ ¬´–†–µ—Å—Ñ–∞—Ä–º–∞—Ü–∏—è¬ª –∏ –µ–≥–æ –∑–∞–º –ø–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–º—É –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—é –æ–±–≤–∏–Ω—è—é—Ç—Å—è –≤ –º–æ—à–µ–Ω–Ω–∏—á–µ—Å—Ç–≤–µ –∏ –∑–ª–æ—É–ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–∏ –¥–æ–ª–∂–Ω–æ—Å—Ç–Ω—ã–º–∏ –ø–æ–ª–Ω–æ–º–æ—á–∏—è–º–∏. –ü–æ –≤–µ—Ä—Å–∏–∏ —Å–ª–µ–¥—Å—Ç–≤–∏—è, –¥–∏—Ä–µ–∫—Ç–æ—Ä —É—á—Ä–µ–∂–¥–µ–Ω–∏—è —Ç—Ä—É–¥–æ—É—Å—Ç—Ä–æ–∏–ª–∞ —Å–≤–æ–µ–≥–æ –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—è –∑–∞–≤–µ–¥—É—é—â–∏–º –∞–ø—Ç–µ—á–Ω—ã–º –ø—É–Ω–∫—Ç–æ–º –≤ —Å–µ–ª–µ –ë–µ–ª—ã–π –Ø—Ä –∏ –∑–∞–≤–µ–¥—É—é—â–∏–º –∞–ø—Ç–µ–∫–æ–π –≤ —Å–µ–ª–µ –ö–æ–ø—å–µ–≤–æ –û—Ä–¥–∂–æ–Ω–∏–∫–∏–¥–∑–µ–≤—Å–∫–æ–≥–æ —Ä–∞–π–æ–Ω–∞ –ø–æ —Å–æ–≤–º–µ—Å—Ç–∏—Ç–µ–ª—å—Å—Ç–≤—É. –ú—É–∂—á–∏–Ω–∞ –Ω–µ –≤—ã–ø–æ–ª–Ω—è–ª —Å–≤–æ–∏ –æ–±—è–∑–∞–Ω–Ω–æ—Å—Ç–∏, –∞ –≤ —Ç–∞–±–µ–ª—å —É—á–µ—Ç–∞ —Ä–∞–±–æ—á–µ–≥–æ –≤—Ä–µ–º–µ–Ω–∏ –∑–∞–Ω–æ—Å–∏–ª–∏—Å—å –ª–æ–∂–Ω—ã–µ —Å–≤–µ–¥–µ–Ω–∏—è –æ –∫–æ–ª–∏—á–µ—Å—Ç–≤–µ —Ä–∞–±–æ—á–∏—Ö —á–∞—Å–æ–≤. –° —è–Ω–≤–∞—Ä—è 2024 –ø–æ 25 –∏—é–Ω—è 2025 –≥–æ–¥–∞ —Ñ–∏–≥—É—Ä–∞–Ω—Ç –Ω–µ–∑–∞–∫–æ–Ω–Ω–æ –ø–æ–ª—É—á–∏–ª –∑–∞—Ä–ø–ª–∞—Ç—É –Ω–∞ —Å—É–º–º—É –±–æ–ª–µ–µ 250 —Ç—ã—Å. —Ä—É–±–ª–µ–π. –ü—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–∏—Ç–µ–ª–∏ —Å—á–∏—Ç–∞—é—Ç, —á—Ç–æ –∑–∞ —Å–æ–æ–±—â–Ω–∏–∫–∞–º–∏ –µ—Å—Ç—å ¬´–≥—Ä–µ—à–æ–∫¬ª –∏ –ø–æ—Å–µ—Ä—å—ë–∑–Ω–µ–µ. –° –∞–ø—Ä–µ–ª—è 2023 –≥–æ–¥–∞ –ø–æ –º–∞–π 2025 –≥–æ–¥–∞ –æ–Ω–∏, —è–∫–æ–±—ã, –¥–∞–≤–∞–ª–∏ —Ä–∞—Å–ø–æ—Ä—è–∂–µ–Ω–∏–µ –ø–æ–¥—á–∏–Ω–µ–Ω–Ω—ã–º —Å–ø–∏—Å—ã–≤–∞—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–∞, –ø—Ä–µ–¥–Ω–∞–∑–Ω–∞—á–µ–Ω–Ω—ã–µ –¥–ª—è –ª—å–≥–æ—Ç–Ω–∏–∫–æ–≤, –¥–æ –∏—Å—Ç–µ—á–µ–Ω–∏—è —Å—Ä–æ–∫–∞ –≥–æ–¥–Ω–æ—Å—Ç–∏. –î–æ –Ω—É–∂–¥–∞—é—â–∏—Ö—Å—è –≥—Ä–∞–∂–¥–∞–Ω –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç—ã –Ω–µ –¥–æ—Ö–æ–¥–∏–ª–∏. –£—â–µ—Ä–± —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–º—É –∏ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω–æ–º—É –±—é–¥–∂–µ—Ç–∞–º –æ—Ü–µ–Ω–∏–≤–∞–µ—Ç—Å—è –±–æ–ª–µ–µ —á–µ–º –≤ 1,4 –º–ª–Ω —Ä—É–±–ª–µ–π. –î–∏—Ä–µ–∫—Ç–æ—Ä–æ–º ¬´–†–µ—Å—Ñ–∞—Ä–º–∞—Ü–∏—è¬ª –≤ –•–∞–∫–∞—Å–∏–∏ —Å 6 —Å–µ–Ω—Ç—è–±—Ä—è 2017 –≥–æ–¥–∞ —á–∏—Å–ª–∏—Ç—Å—è –ê–Ω–Ω–∞ –ü—Ä–∏–∂–µ–≥–æ–¥—Å–∫–∞—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""shortage, regulation, sanctions"",
  ""impact"": ""high"",
  ""english"": ""A director of a state pharmaceutical company in Khakassia has been arrested for drug-related fraud and abuse of power. The director allegedly arranged her deputy to work at a pharmacy in the village of Beliy Yar and another pharmacy in Kopyevsky district. The deputy did not perform his duties, and false records of working hours were entered in the payroll system. The director has received over 250,000 rubles illegally from January to June 2025. Authorities suspect that the duo instructed subordinates to divert medicines intended for beneficiaries before their expiration date, causing shortages. The loss to the federal and regional budgets is estimated at over 1.4 million rubles.""
}"
2025-07-22T05:54:49+00:00,@bezrec,6333,https://t.me/bezrec/6333,"–ë–µ–∑ –ú–∏—Ä–∞–º–∏—Å—Ç–∏–Ω–∞ –Ω–µ –æ—Å—Ç–∞–Ω–µ–º—Å—è. –ê–¥–≤–æ–∫–∞—Ç —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–∏–∫–æ–≤ –û–û–û ¬´–ò–Ω—Ñ–∞–º–µ–¥¬ª ‚Äî –í–∏—Ç–∞–ª–∏—è –ù–∏–∫–æ–ª–∞–µ–≤–∞ –∏ –ò—Ä–∏–Ω—ã –•—É–≥–∞–µ–≤–æ–π ‚Äî –†—É–±–µ–Ω –ú–∞—Ä–∫–∞—Ä—å—è–Ω –æ–±—ä—è—Å–Ω–∏–ª, —á—Ç–æ –≤–æ–ø—Ä–æ—Å –æ –±–ª–æ–∫–∏—Ä–æ–≤–∫–µ —Ä–∞–±–æ—Ç—ã –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏–π –Ω–µ —Å—Ç–æ–∏—Ç. –ö–æ–º–ø–∞–Ω–∏—è, –æ–∫–∞–∑–∞–≤—à–∞—è—Å—è –ø—Ä–µ–¥–º–µ—Ç–æ–º —Å—É–¥–µ–±–Ω–æ–≥–æ —Ä–∞–∑–±–∏—Ä–∞—Ç–µ–ª—å—Å—Ç–≤–∞, –≤–ª–∞–¥–µ–µ—Ç –†–£ –Ω–∞ –ú–∏—Ä–∞–º–∏—Å—Ç–∏–Ω –∏ –û–∫–æ–º–∏—Å—Ç–∏–Ω, –∞ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç –æ–±–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ¬´–ò–Ω—Ñ–∞–º–µ–¥ –∫¬ª –≤ –ö–∞–ª–∏–Ω–∏–Ω–≥—Ä–∞–¥—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏. –ê—Ä–±–∏—Ç—Ä–∞–∂–Ω—ã–º —Å—É–¥–æ–º –ú–æ—Å–∫–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –ø—Ä–∏–Ω—è—Ç—ã –æ–±–µ—Å–ø–µ—á–∏—Ç–µ–ª—å–Ω—ã–µ –º–µ—Ä—ã –Ω–µ –≤ –≤–∏–¥–µ –∑–∞–ø—Ä–µ—Ç–∞ –Ω–∞ –≤—ã–ø—É—Å–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞, –∞ –≤ –≤–∏–¥–µ –∑–∞–ø—Ä–µ—Ç–∞ —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–∏–∫–∞–º –û–û–û ¬´–ò–Ω—Ñ–∞–º–µ–¥¬ª –æ—Ç—á—É–∂–¥–∞—Ç—å –∏ –∏–Ω—ã–º –æ–±—Ä–∞–∑–æ–º —Ä–∞—Å–ø–æ—Ä—è–∂–∞—Ç—å—Å—è –∏–º—É—â–µ—Å—Ç–≤–æ–º –∏ –∏–º—É—â–µ—Å—Ç–≤–µ–Ω–Ω—ã–º–∏ –ø—Ä–∞–≤–∞–º–∏, –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∞—â–∏–º–∏ –û–û–û ¬´–ò–Ω—Ñ–∞–º–µ–¥¬ª –Ω–∞ –ø—Ä–∞–≤–µ —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç–∏, –≤ —Ç–æ–º —á–∏—Å–ª–µ –ø—Ä–∞–≤–∞–º–∏ –Ω–∞ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–æ–Ω–Ω—ã–µ —É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏—è –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –ú–∏—Ä–∞–º–∏—Å—Ç–∏–Ω –∏ –û–∫–æ–º–∏—Å—Ç–∏–Ω,‚Äî –ø—Ä–æ–∫–æ–º–º–µ–Ω—Ç–∏—Ä–æ–≤–∞–ª —Å–∏—Ç—É–∞—Ü–∏—é –ú–∞—Ä–∫–∞—Ä—å—è–Ω. –ß—Ç–æ –∏–∑–≤–µ—Å—Ç–Ω–æ –æ–± ¬´–ò–Ω—Ñ–∞–º–µ–¥¬ª –∏ ¬´–ò–Ω—Ñ–∞–º–µ–¥ –∫¬ª. –ü–æ –¥–∞–Ω–Ω—ã–º Rusprofile –Ω–∞ 22 –∏—é–ª—è 2025 –≥–æ–¥–∞, –û–û–û ¬´–ò–Ω—Ñ–∞–º–µ–¥¬ª –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–æ –≤ –ø–æ–¥–º–æ—Å–∫–æ–≤–Ω–æ–º –í–∏–¥–Ω–æ–º. –£—á—Ä–µ–¥–∏—Ç–µ–ª–µ–º –∏ –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–º –∫–æ–º–ø–∞–Ω–∏–∏ —á–∏—Å–ª–∏—Ç—Å—è –í–∏—Ç–∞–ª–∏–π –ù–∏–∫–æ–ª–∞–µ–≤. –î–æ –Ω–µ–≥–æ –±–µ–Ω–µ—Ñ–∏—Ü–∏–∞—Ä–æ–º –±—ã–ª–∞ –ò—Ä–∏–Ω–∞ –•—É–≥–∞–µ–≤–∞. –í—ã—Ä—É—á–∫–∞ –∫–æ–º–ø–∞–Ω–∏–∏ –ø–æ –∏—Ç–æ–≥–∞–º 2024 –≥–æ–¥–∞ —Å–Ω–∏–∑–∏–ª–∞—Å—å –Ω–∞ 6%, –¥–æ 368 –º–ª–Ω —Ä—É–±–ª–µ–π. –ü—Ä–∏–±—ã–ª—å —Å–æ—Å—Ç–∞–≤–∏–ª–∞ –≤—Å–µ–≥–æ 42 —Ç—ã—Å. —Ä—É–±–ª–µ–π –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å 28 –º–ª–Ω —Ä—É–±–ª–µ–π –≥–æ–¥–æ–º —Ä–∞–Ω–µ–µ. –û–û–û ¬´–ò–Ω—Ñ–∞–º–µ–¥ –∫¬ª –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–æ –≤ –ö–∞–ª–∏–Ω–∏–Ω–≥—Ä–∞–¥—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏. –ë–µ–Ω–µ—Ñ–∏—Ü–∏–∞—Ä–æ–º –∫–æ–º–ø–∞–Ω–∏–∏ —Å –∏—é–Ω—è 2025 –≥–æ–¥–∞ —Å—Ç–∞–ª –í–∞—Å–∏–ª–∏–π –ö—É–ª—å–∫–æ–≤ ‚Äî —Å—ã–Ω –ï–≥–æ—Ä–∞ –ö—É–ª—å–∫–æ–≤–∞ ‚Äì –æ–¥–Ω–æ–≥–æ –∏–∑ –æ—Å–Ω–æ–≤–∞—Ç–µ–ª–µ–π ¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç–∞¬ª –∏ –¥–∞–≤–Ω–µ–≥–æ –±–∏–∑–Ω–µ—Å-–ø–∞—Ä—Ç–Ω–µ—Ä–∞ –í–∏–∫—Ç–æ—Ä–∞ –•–∞—Ä–∏—Ç–æ–Ω–∏–Ω–∞. –î–æ –ö—É–ª—å–∫–æ–≤–∞ –∫–æ–º–ø–∞–Ω–∏–µ–π –≤–ª–∞–¥–µ–ª —Å–Ω–∞—á–∞–ª–∞ –µ—ë –æ—Å–Ω–æ–≤–∞—Ç–µ–ª—å –∏ —ç–∫—Å-–¥–µ–ø—É—Ç–∞—Ç –ö–∞–ª–∏–Ω–∏–Ω–≥—Ä–∞–¥—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–Ω–æ–π –¥—É–º—ã –ê–Ω–¥—Ä–µ–π –ì–æ—Ä–æ—Ö–æ–≤, –∞ —Å 2021 –≥–æ–¥–∞ ‚Äî –µ–≥–æ —Å—ã–Ω –ê–Ω—Ç–æ–Ω –ì–æ—Ä–æ—Ö–æ–≤. 2024 –≥–æ–¥ ¬´–ò–Ω—Ñ–∞–º–µ–¥ –∫¬ª –∑–∞–∫–æ–Ω—á–∏–ª–∞ —Å –≤—ã—Ä—É—á–∫–æ–π 6,1 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π (+24%) –∏ –ø—Ä–∏–±—ã–ª—å—é 2,8 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π (+45%). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""The company '–ò–Ω—Ñ–∞–º–µ–¥ –∫' is facing a shortage issue due to legal disputes. The firm, which produces both –ú–∏—Ä–∞–º–∏—Å—Ç–∏–Ω and –û–∫–æ–º–∏—Å—Ç–∏–Ω, has seen a significant decrease in revenue (6% to 368 million rubles) and profit (-24% to 2.8 billion rubles). The company is under sanctions, and the dispute involves ownership rights of the company.""
}"
2025-07-21T15:29:47+00:00,@bezrec,6332,https://t.me/bezrec/6332,"‚ö°Ô∏è–í –†–æ—Å—Å–∏–∏ –∑–∞–ø—Ä–µ—Ç–∏–ª–∏ –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç—å –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è –ú–∏—Ä–∞–º–∏—Å—Ç–∏–Ω–∞ –∏ –û–∫–æ–º–∏—Å—Ç–∏–Ω–∞. –†–µ—á—å –∏–¥–µ—Ç –æ –±–ª–æ–∫–∏—Ä–æ–≤–∫–µ —Ä–∞–±–æ—Ç—ã 164 –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–µ–π –∫–æ–º–ø–∞–Ω–∏–∏ –û–û–û ¬´–ò–Ω—Ñ–∞–º–µ–¥¬ª –∏–∑-–∑–∞ –æ–≥—Ä–∞–Ω–∏—á–∏—Ç–µ–ª—å–Ω—ã—Ö –º–µ—Ä, –Ω–∞–ª–æ–∂–µ–Ω–Ω—ã—Ö —Å—É–¥–æ–º, –Ω–∞ –≤—Å–µ–π —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ –†–æ—Å—Å–∏–∏ –ø–æ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—é –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞, –∫–æ—Ç–æ—Ä—ã–π —É—á–∞—Å—Ç–≤—É–µ—Ç –≤ –∏–º–ø–æ—Ä—Ç–æ–∑–∞–º–µ—â–µ–Ω–∏–∏, –≤ —Ç–æ–º —á–∏—Å–ª–µ –ø–æ –∫–æ–Ω—Ç—Ä–∞–∫—Ç–∞–º —Å –ú–∏–Ω–æ–±–æ—Ä–æ–Ω—ã –†–æ—Å—Å–∏–∏, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª –¢–ê–°–° –∞–¥–≤–æ–∫–∞—Ç —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–∏–∫–æ–≤ –∫–æ–º–ø–∞–Ω–∏–∏ –†—É–±–µ–Ω –ú–∞—Ä–∫–∞—Ä—å—è–Ω. –ü–æ —Å–ª–æ–≤–∞–º –ú–∞—Ä–∫–∞—Ä—å—è–Ω–∞, —Å—É–¥–µ–±–Ω—ã–π —Å–ø–æ—Ä —Å–≤—è–∑–∞–Ω —Å –¥–µ–π—Å—Ç–≤–∏—è–º–∏ –ü–∞–≤–ª–∞ –•–µ–π—Ñ–∏—Ü–∞ –∏ –µ–≥–æ –∂–µ–Ω—ã –û–∫—Å–∞–Ω—ã –•–µ–π—Ñ–∏—Ü, –∫–æ—Ç–æ—Ä—ã–µ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –∞–≥–µ–Ω—Ç—Å–∫–∏–µ —É—Å–ª—É–≥–∏ –∏ –ø–æ–º–æ—â—å –≤ –ø—Ä–æ–¥–∞–∂–µ ¬´–ò–Ω—Ñ–∞–º–µ–¥–∞¬ª, –∞ —Ç–∞–∫–∂–µ —É–±–µ–¥–∏–ª–∏ –≤–ª–∞–¥–µ–ª—å—Ü–∞ –∫–æ–º–ø–∞–Ω–∏–∏ –∑–∞–∫–ª—é—á–∏—Ç—å –º–Ω–∏–º—É—é —Å–¥–µ–ª–∫—É –ø–æ –ø–µ—Ä–µ–¥–∞—á–µ –≤ —Å–≤–æ—é –ø–æ–ª—å–∑—É 50% –¥–æ–ª–µ–π –ø–æ –Ω–æ–º–∏–Ω–∞–ª—å–Ω–æ–π —Ü–µ–Ω–µ (7,5 –º–ª–Ω —Ä—É–±–ª–µ–π). –†–µ–∞–ª—å–Ω–∞—è —Å—Ç–æ–∏–º–æ—Å—Ç—å —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è –æ—Ü–µ–Ω–∏–≤–∞–µ—Ç—Å—è –±–æ–ª–µ–µ —á–µ–º –≤ 1 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –í–ª–∞–¥–µ–ª—å—Ü—ã –ú–∏—Ä–∞–º–∏—Å—Ç–∏–Ω–∞ –ø–æ–¥–∞–ª–∏ –∑–∞—è–≤–ª–µ–Ω–∏–µ –æ –º–æ—à–µ–Ω–Ω–∏—á–µ—Å—Ç–≤–µ. –ú–∏—Ä–∞–º–∏—Å—Ç–∏–Ω ‚Äî –ø—Ä–æ–¥—É–∫—Ç –ø–æ–ø—É–ª—è—Ä–Ω—ã–π. –≠—Ç–æ—Ç –∞–Ω—Ç–∏—Å–µ–ø—Ç–∏–∫ ‚Äî –ª–∏–¥–µ—Ä –ø–æ –ø—Ä–æ–¥–∞–∂–∞–º –≤ —Å–≤–æ–µ–π –∫–∞—Ç–µ–≥–æ—Ä–∏–∏, –ø—Ä–µ–ø–∞—Ä–∞—Ç —Ç–∞–∫–∂–µ –≤—Ö–æ–¥–∏—Ç –≤ —Ç–æ–ø-10 –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø–æ —É–ø–æ–º–∏–Ω–∞–Ω–∏—è–º –≤ —Å–æ—Ü—Å–µ—Ç—è—Ö. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""A Russian court has imposed sanctions on a pharmaceutical company, Infamed, which produces Miramistin and Okomistin. The sanctions are due to a legal dispute involving Pavel Hefitz and his wife Oxana Hefitz, who allegedly offered agency services to sell Infamed. The dispute is over a purported share transfer agreement for 50% of the company's shares at nominal value (7.5 million rubles). The real value of the pharmaceutical producer is over 1 billion rubles. Owners of Miramistin have filed a complaint alleging fraud. Miramistin is popular and the antiseptic product is leading in sales within its category, also among the top 10 drugs by mentions on social media.""
}"
2025-07-21T14:51:29+00:00,@bezrec,6331,https://t.me/bezrec/6331,"–≠–∫—Å-–≥–ª–∞–≤–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è –ª–µ–∫–∞—Ä—Å—Ç–≤ –æ—Ç —Ä–∞–∫–∞ —Å–≤–µ—Ç–∏—Ç 10 –ª–µ—Ç —Ç—é—Ä—å–º—ã –∑–∞ —Å–∞–º–æ–¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç—å —Å –ø—Ä–µ–º–∏—è–º–∏ —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤. –†–µ—á—å –æ –°–≤–µ—Ç–ª–∞–Ω–µ –ö–æ–ø–∞—á–µ–≤—Å–∫–æ–π ‚Äî –±—ã–≤—à–µ–º –¥–∏—Ä–µ–∫—Ç–æ—Ä–µ ¬´–ù–∞—É–∫–æ–ø—Ä–æ—Ñ–∏¬ª ‚Äî —Ñ–∏–ª–∏–∞–ª–∞ –æ–Ω–∫–æ—Ü–µ–Ω—Ç—Ä–∞ –∏–º. –ë–ª–æ—Ö–∏–Ω–∞. –£–≥–æ–ª–æ–≤–Ω–æ–µ –¥–µ–ª–æ –ø–æ —Ñ–∞–∫—Ç—É —Ä–∞—Å—Ç—Ä–∞—Ç—ã –¥–µ–Ω–µ–∂–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –ø—Ä–æ—Ç–∏–≤ –ö–æ–ø–∞—á–µ–≤—Å–∫–æ–π –≤–æ–∑–±—É–¥–∏–ª–∏ –≤ 2023 –≥–æ–¥—É, –æ–¥–Ω–∞–∫–æ –ø–æ–∑–¥–Ω–µ–µ –æ–±–≤–∏–Ω–µ–Ω–∏–µ –ø–µ—Ä–µ–∫–≤–∞–ª–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–ª–∏ –Ω–∞ –ø—Ä–µ–≤—ã—à–µ–Ω–∏–∏ –ø–æ–ª–Ω–æ–º–æ—á–∏–π. –ü–æ —ç—Ç–æ–π —Å—Ç–∞—Ç—å–µ –∑–∞–∫–æ–Ω –ø—Ä–µ–¥—É—Å–º–∞—Ç—Ä–∏–≤–∞–µ—Ç –¥–æ –¥–µ—Å—è—Ç–∏ –ª–µ—Ç –ª–∏—à–µ–Ω–∏—è —Å–≤–æ–±–æ–¥—ã. –í 2011 –≥–æ–¥—É –ö–æ–ø–∞—á–µ–≤—Å–∫–∞—è —Å—Ç–∞–ª–∞ –¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–º –Ω–∞—É—á–Ω–æ-–ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ —Ñ–∏–ª–∏–∞–ª–∞ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ —Ü–µ–Ω—Ç—Ä–∞ –æ–Ω–∫–æ–ª–æ–≥–∏–∏ –∏–º. –ë–ª–æ—Ö–∏–Ω–∞. –í 2015 –≥–æ–¥—É –ø–æ–¥—Ä–∞–∑–¥–µ–ª–µ–Ω–∏–µ –ø—Ä–µ–≤—Ä–∞—Ç–∏–ª–æ—Å—å –≤ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—é ¬´–ù–∞—É–∫–æ–ø—Ä–æ—Ñ–∏¬ª, —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä—É—é—â—É—é—Å—è –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞—Ö –æ—Ç —Ä–∞–∫–∞. –ü–æ –≤–µ—Ä—Å–∏–∏ —Å–ª–µ–¥—Å—Ç–≤–∏—è, –æ–±–≤–∏–Ω—è–µ–º–∞—è, –±—É–¥—É—á–∏ ¬´—É —Ä—É–ª—è¬ª, –Ω–µ–∑–∞–∫–æ–Ω–Ω–æ –∏–∑–¥–∞–ª–∞ –Ω–µ—Å–∫–æ–ª—å–∫–æ –ø—Ä–∏–∫–∞–∑–æ–≤ –æ–± —É—á—Ä–µ–∂–¥–µ–Ω–∏–∏ –≤ ¬´—Å–≤–æ–µ–π¬ª –∫–æ–º–ø–∞–Ω–∏–∏ –ø–æ–ª–æ–∂–µ–Ω–∏—è –æ–± –æ–ø–ª–∞—Ç–µ —Ç—Ä—É–¥–∞ –µ—ë —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤. –í —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–∏ —Å –Ω–∏–º–∏ —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–∏ ¬´–ù–∞—É–∫–æ–ø—Ä–æ—Ñ–∏¬ª (–∏ —Å–∞–º–∞ –ö–æ–ø–∞—á–µ–≤—Å–∫–∞—è) —Ç—Ä–∏ –≥–æ–¥–∞ –ø–æ–ª—É—á–∞–ª–∏ —Ç–∞–∫ –Ω–∞–∑—ã–≤–∞–µ–º—ã–µ —Å—Ç–∏–º—É–ª–∏—Ä—É—é—â–∏–µ –≤—ã–ø–ª–∞—Ç—ã –∏ –ø—Ä–µ–º–∏–∏. –ü—Ä–∏ —ç—Ç–æ–º —Ä–µ—à–µ–Ω–∏–µ –æ —Ç–∞–∫–∏—Ö –≤—ã–ø–ª–∞—Ç–∞—Ö –∏ –∏—Ö —Ä–∞–∑–º–µ—Ä–µ –¥–æ–ª–∂–µ–Ω –ø—Ä–∏–Ω–∏–º–∞—Ç—å –¥–∏—Ä–µ–∫—Ç–æ—Ä —Ü–µ–Ω—Ç—Ä–∞ –∏–º. –ë–ª–æ—Ö–∏–Ω–∞. –í –æ–±—â–µ–π —Å–ª–æ–∂–Ω–æ—Å—Ç–∏ –Ω–∞ —Å—á–µ—Ç–∞—Ö ¬´–ø—Ä–µ–º–∏—Ä—É–µ–º—ã—Ö¬ª –æ—Å–µ–ª–æ 129,6 –º–ª–Ω —Ä—É–±–ª–µ–π, —á—Ç–æ —Å–æ–ø–æ—Å—Ç–∞–≤–∏–º–æ —Å –æ–±—â–∏–º –¥–æ—Ö–æ–¥–æ–º —Ñ–∏–ª–∏–∞–ª–∞ –∑–∞ —É–∫–∞–∑–∞–Ω–Ω—ã–π –ø–µ—Ä–∏–æ–¥. –≠–∫—Å-–¥–∏—Ä–µ–∫—Ç–æ—Ä ¬´–ù–∞—É–∫–æ–ø—Ä–æ—Ñ–∏¬ª —Å–≤–æ—é –≤–∏–Ω—É –Ω–µ –ø—Ä–∏–∑–Ω–∞—ë—Ç. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement"",
  ""impact"": ""high"",
  ""english"": ""The former head of a cancer drug company, Svetlana Kopachevskaya, is facing up to ten years in prison for irregular payments. The case involves allegations of illegal issuance of bonuses and incentives by Kopachevskaya, who was the director of 'Science-Industry' branch of the Oncology Center named Blokhin. The case was initiated in 2023 but later the charges were changed to abuse of authority. The branch was transformed into a pharmaceutical company 'Science-Industry' specializing in cancer drugs. According to the investigation, Kopachevskaya issued several orders for bonuses and incentives at her company without proper approval from the center's director. A total of 129.6 million rubles were collected on the accounts of 'Science-Industry' and its employees, equivalent to the branch's total income for that period. Kopachevskaya denies any wrongdoing.""
}"
2025-07-21T11:33:32+00:00,@bezrec,6330,https://t.me/bezrec/6330,"–§–ê–° –Ω–µ –ø–æ–¥–¥–µ—Ä–∂–∞–ª–∞ –¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–∞ Takeda –≤ —Å–ø–æ—Ä–µ –∑–∞ —Ç–µ–¥—É–≥–ª—É—Ç–∏–¥. –ù–µ–∫–æ—Ç–æ—Ä–æ–µ –≤—Ä–µ–º—è –Ω–∞–∑–∞–¥ —Ä–µ–≥—É–ª—è—Ç–æ—Ä ¬´–ø–æ—Å—Ç–∞–≤–∏–ª –Ω–∞ –ø–∞—É–∑—É¬ª –∑–∞–∫—É–ø–∫—É –æ—Ä—Ñ–∞–Ω–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å —Å–∏–Ω–¥—Ä–æ–º–æ–º –∫–æ—Ä–æ—Ç–∫–æ–π –∫–∏—à–∫–∏. –ü—Ä–∏—á–∏–Ω–æ–π –ø–æ—Å–ª—É–∂–∏–ª–∞ –∂–∞–ª–æ–±–∞ –æ–¥–Ω–æ–≥–æ –∏–∑ —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –∞—É–∫—Ü–∏–æ–Ω–∞ ‚Äî ¬´–§–∞—Ä–º–∏–º—ç–∫—Å–∞¬ª. –ö–æ–º–ø–∞–Ω–∏—è ‚Äî –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω—ã–π –¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω–æ–≥–æ –ì—ç—Ç—Ç–µ—Å—Ç–∏–≤–∞ —è–ø–æ–Ω—Å–∫–æ–π Takeda. ¬´–§–∞—Ä–º–∏–º—ç–∫—Å¬ª –ø–æ—Å—á–∏—Ç–∞–ª, —á—Ç–æ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤ (¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª –∏ ¬´–ü–°–ö –§–∞—Ä–º–∞¬ª) –Ω–∞—Ä—É—à–∏–ª–∏ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç—É–∞–ª—å–Ω—ã–µ –ø—Ä–∞–≤–∞ –∏ –±—ã–ª–∏ –¥–æ–ø—É—â–µ–Ω—ã –∫ —É—á–∞—Å—Ç–∏—é –≤ –∞—É–∫—Ü–∏–æ–Ω–µ –Ω–µ–∑–∞–∫–æ–Ω–Ω–æ. –ü–æ—Å—Ç–∞–≤–ª—è—Ç—å —Ç–µ–¥—É–≥–ª—É—Ç–∏–¥ –¥–ª—è –ø–æ–¥–æ–ø–µ—á–Ω—ã—Ö ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª –ø–æ –∏—Ç–æ–≥–∞–º —Ç–µ–Ω–¥–µ—Ä–∞ –¥–æ–ª–∂–µ–Ω –±—ã–ª ¬´–§–ö –ì—Ä–∞–Ω–¥ –ö–∞–ø–∏—Ç–∞–ª¬ª, –ø—Ä–µ–¥–ª–æ–∂–∏–≤—à–∏–π –º–∏–Ω–∏–º–∞–ª—å–Ω—É—é —Ü–µ–Ω—É. –í –∏—Ç–æ–≥–µ –∫–æ–º–∏—Å—Å–∏—è –§–ê–° –ø–æ –∫–æ–Ω—Ç—Ä–æ–ª—é –≤ —Å—Ñ–µ—Ä–µ –∑–∞–∫—É–ø–æ–∫ –ø—Ä–∏–∑–Ω–∞–ª–∞ –ø—Ä–µ—Ç–µ–Ω–∑–∏–∏ ¬´–§–∞—Ä–º–∏–º—ç–∫—Å–∞¬ª –Ω–µ–æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω—ã–º–∏. –ö–æ–º–∏—Å—Å–∏–µ–π —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–æ, —á—Ç–æ —Å–≤–µ–¥–µ–Ω–∏—è –æ –†–£ –≤–∫–ª—é—á–µ–Ω—ã –≤ –ì–†–õ–°. –†–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–æ–Ω–Ω–æ–µ —É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –≤—ã–¥–∞—ë—Ç—Å—è –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–æ–º –∏ –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–∞–µ—Ç –∑–∞–∫–æ–Ω–Ω–æ—Å—Ç—å –µ–≥–æ –æ–±—Ä–∞—â–µ–Ω–∏—è –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ –†–§, –≤ —Ç–æ–º —á–∏—Å–ª–µ –¥–ª—è —Ü–µ–ª–µ–π –ø—Ä–æ–¥–∞–∂–∏ –∏ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è, ‚Äî –∞—Ä–≥—É–º–µ–Ω—Ç–∏—Ä–æ–≤–∞–ª–∏ —Å–≤–æ—é –ø–æ–∑–∏—Ü–∏—é –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å—â–∏–∫–∏. –ù–∞ –æ–±–∂–∞–ª–æ–≤–∞–Ω–∏–µ —Ä–µ—à–µ–Ω–∏—è –≤ —Å—É–¥–µ–±–Ω–æ–º –ø–æ—Ä—è–¥–∫–µ —É ¬´–§–∞—Ä–º–∏–º—ç–∫—Å–∞¬ª –µ—Å—Ç—å —Ç—Ä–∏ –º–µ—Å—è—Ü–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The FAS rejected Takeda distributor's dispute over Teduglutide. Recently, the regulator 'paused' orphan drug procurement for patients with short bowel syndrome due to one of the auction participants - 'Farmaemex'. The company claims that generic producers (Promomed and PSK Pharma) violated intellectual property rights and were illegally admitted to the auction. The winner of the tender, 'Farmaemex', was supposed to supply Teduglutide for patients in the 'Circle of Kindness' program. The FAS commission ruled that Farmaemex's claims were unfounded, as registration information was included in the GRLS. The registration certificate for a medical drug is issued by Roszdravnadzor and confirms the legality of its use in Russia, including for sale and application - this was argued by antitrust authorities. Farmaemex has three months to appeal the decision in court.""
}"
2025-07-21T09:10:01+00:00,@bezrec,6329,https://t.me/bezrec/6329,"–ï—â—ë –æ–¥–Ω–∞ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—è –∏—Å–ø–æ–ª–Ω–∏–ª–∞ –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏–µ –§–ê–°. –ù–∞ –ø—Ä–æ—à–ª–æ–π –Ω–µ–¥–µ–ª–µ –ø—Ä–∏–∑–Ω–∞–∫–∏ –Ω–∞—Ä—É—à–µ–Ω–∏—è –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å–Ω–æ–≥–æ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–∞ —É—Å—Ç—Ä–∞–Ω–∏–ª–∞ —Ä–æ—Å—Å–∏–π—Å–∫–∞—è ¬´–¥–æ—á–∫–∞¬ª –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–π Amgen, —Ç–µ–ø–µ—Ä—å –ø—Ä–∏—à—ë–ª —á–µ—Ä—ë–¥ ¬´–ê–Ω–¥–∂–µ–ª–∏–Ω–∏ –§–∞—Ä–º–∞ –†—É—Å¬ª —É—Å–ª—ã—à–∞—Ç—å —Ä–µ–≥—É–ª—è—Ç–æ—Ä–∞. –ê–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å—â–∏–∫–∏ –ø–æ—Å—á–∏—Ç–∞–ª–∏, —á—Ç–æ –∫–æ–º–ø–∞–Ω–∏—è –∑–∞–Ω–∏–º–∞–µ—Ç –¥–æ–º–∏–Ω–∏—Ä—É—é—â–µ–µ –ø–æ–ª–æ–∂–µ–Ω–∏–µ –Ω–∞ —Ä—ã–Ω–∫–µ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ¬´–¢–∞–Ω—Ç—É–º –†–æ–∑–∞¬ª –≤ –æ—Ç–¥–µ–ª—å–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Ñ–æ—Ä–º–∞—Ö. –í –∫–æ–º–º–µ—Ä—á–µ—Å–∫–æ–π –ø–æ–ª–∏—Ç–∏–∫–µ ¬´–ê–Ω–¥–∂–µ–ª–∏–Ω–∏ –§–∞—Ä–º–∞ –†—É—Å¬ª —Å–æ–¥–µ—Ä–∂–∞–ª–∏—Å—å —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–∏ –∏ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏ –Ω–µ–æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω—ã–µ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ –∑–∞–Ω–∏–º–∞–µ–º–æ–π —Ä—ã–Ω–æ—á–Ω–æ–π –¥–æ–ª–µ –¥–µ–ª–æ–≤—ã—Ö –ø–∞—Ä—Ç–Ω–µ—Ä–æ–≤ –≤ –∑–∞–∫—É–ø–∫–∞—Ö –∞–ø—Ç–µ—á–Ω–æ–≥–æ —Å–µ–≥–º–µ–Ω—Ç–∞ –∏ –º–∏–Ω–∏–º–∞–ª—å–Ω–æ–º—É –≥–æ–¥–æ–≤–æ–º—É –æ–±—ä–µ–º—É –∑–∞–∫—É–ø–æ–∫. –ù–∞ —ç—Ç–æ–º –æ—Å–Ω–æ–≤–∞–Ω–∏–∏ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—è –æ—Ç–∫–∞–∑–∞–ª–∞ –ø–æ—Å—Ç–∞–≤—â–∏–∫—É ¬´–§–∞—Ä–º–∫–æ–º–ø–ª–µ–∫—Ç¬ª –≤ –∑–∞–∫–ª—é—á–µ–Ω–∏–∏ –¥–æ–≥–æ–≤–æ—Ä–∞ –ø–æ—Å—Ç–∞–≤–∫–∏ —ç—Ç–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞, ‚Äî –≥–æ–≤–æ—Ä–∏—Ç—Å—è –≤ —Å–æ–æ–±—â–µ–Ω–∏–∏ –≤–µ–¥–æ–º—Å—Ç–≤–∞. –û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è —É—Å—Ç—Ä–∞–Ω–∏–ª–∞ –ø—Ä–∏–∑–Ω–∞–∫–∏ –Ω–∞—Ä—É—à–µ–Ω–∏—è –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å–Ω–æ–≥–æ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–∞. –í —á–∞—Å—Ç–Ω–æ—Å—Ç–∏: üîò–∏—Å–∫–ª—é—á–∏–ª–∞ —É–∫–∞–∑–∞–Ω–Ω—ã–µ –ø—É–Ω–∫—Ç—ã –∏–∑ –∫–æ–º–º–µ—Ä—á–µ—Å–∫–æ–π –ø–æ–ª–∏—Ç–∏–∫–∏; üîò–ø–µ—Ä–µ—Å–º–æ—Ç—Ä–µ–ª–∞ —Ä–µ—à–µ–Ω–∏–µ –ø–æ –∑–∞—è–≤–∫–µ –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–§–∞—Ä–º–∫–æ–º–ø–ª–µ–∫—Ç¬ª –Ω–∞ –Ω–µ–¥–∏—Å–∫—Ä–∏–º–∏–Ω–∞—Ü–∏–æ–Ω–Ω—ã—Ö —É—Å–ª–æ–≤–∏—è—Ö. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-07-21T06:34:41+00:00,@bezrec,6328,https://t.me/bezrec/6328,"–°–æ—Ü–∏–æ–ª–æ–≥–∏ –≤—ã—è—Å–Ω–∏–ª–∏, –∫–∞–∫ —Å–ø—Ä–∞–≤–ª—è—é—Ç—Å—è —Å –±–æ–ª—å—é –º–∏–ª–ª–µ–Ω–∏–∞–ª—ã –∏ –∑—É–º–µ—Ä—ã. –°–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –∞–≥–µ–Ω—Ç—Å—Ç–≤–∞ Webka Marketing —Ä–µ—à–∏–ª–∏ —É–∑–Ω–∞—Ç—å, –∫–∞–∫ –∫—É–ø–∏—Ä—É—é—Ç –±–æ–ª—å –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–∏ —Ä–∞–∑–Ω—ã—Ö –ø–æ–∫–æ–ª–µ–Ω–∏–π. üíä –°–∞–º—ã–π —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–Ω—ã–π (–∏ –ª–æ–≥–∏—á–Ω—ã–π) —Å–ø–æ—Å–æ–± —Ä–µ–∞–≥–∏—Ä–æ–≤–∞–Ω–∏—è –Ω–∞ –±–æ–ª—å ‚Äî –ø—Ä–∏—ë–º –±—ã—Å—Ç—Ä–æ–¥–µ–π—Å—Ç–≤—É—é—â–∏—Ö –æ–±–µ–∑–±–æ–ª–∏–≤–∞—é—â–∏—Ö. –ï–≥–æ –ø—Ä–∞–∫—Ç–∏–∫—É—é—Ç 83% –∑—É–º–µ—Ä–æ–≤ –∏ 79% –º–∏–ª–ª–µ–Ω–∏–∞–ª–æ–≤. –ù–æ –∏ –ø—Ä–æ –Ω–∞—Ä–æ–¥–Ω—ã–µ —Å—Ä–µ–¥—Å—Ç–≤–∞ –Ω–µ –∑–∞–±—ã–≤–∞—é—Ç: —Ç–µ, –∫—Ç–æ –ø–æ—Å—Ç–∞—Ä—à–µ –ø–æ–º–æ–≥–∞—é—Ç –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º —Ç—Ä–∞–≤–∞–º–∏, —á–∞–µ–º –∏ –≥–æ—Ä—è—á–∏–º –¥—É—à–µ–º, —Ä–µ—Å–ø–æ–Ω–¥–µ–Ω—Ç—ã –º–ª–∞–¥—à–µ–≥–æ –≤–æ–∑—Ä–∞—Å—Ç–∞ ‚Äî–º–µ–¥–∏—Ç–∞—Ü–∏–µ–π –∏–ª–∏ –¥—ã—Ö–∞–Ω–∏–µ–º ¬´–ø–æ –∫–≤–∞–¥—Ä–∞—Ç—É¬ª. üíä –ü—Ä–∏ –≤—ã–±–æ—Ä–µ –æ–±–µ–∑–±–æ–ª–∏–≤–∞—é—â–µ–≥–æ –∏ –∑—É–º–µ—Ä—ã, –∏ –º–∏–ª–ª–µ–Ω–∏–∞–ª—ã –ø–æ–ª–∞–≥–∞—é—Ç—Å—è –Ω–∞ –æ—Ç–∑—ã–≤—ã –≤ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç–µ, –Ω–æ –≤—Ç–æ—Ä—ã–µ —á–∞—â–µ –ø–æ–∫—É–ø–∞—é—Ç ¬´–ø–æ –∞–∫—Ü–∏–∏¬ª, —á—Ç–æ–±—ã —Å—ç–∫–æ–Ω–æ–º–∏—Ç—å. üíä –î–ª—è 13% –∑—É–º–µ—Ä–æ–≤ –∏–º–µ—é—Ç –∑–Ω–∞—á–µ–Ω–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –±–ª–æ–≥–µ—Ä–æ–≤, —É –º–∏–ª–ª–µ–Ω–∏–∞–ª–æ–≤ —ç—Ç–æ—Ç –ø–æ–∫–∞–∑–∞—Ç–µ–ª—å –≤—Å–µ–≥–æ 4%. üíä –ó—É–º–µ—Ä—ã —á–∞—â–µ –∏–Ω—Ç–µ—Ä–µ—Å—É—é—Ç—Å—è –∏ –±–æ–ª–µ–µ –æ—Ç–∫—Ä—ã—Ç—ã –∫ –Ω–æ–≤–∏–Ω–∫–∞–º —Ñ–∞—Ä–º—Ä—ã–Ω–∫–∞ (41%). –ú–∏–ª–ª–µ–Ω–∏–∞–ª—ã –∂–µ, –∫–∞–∫ –ø—Ä–∞–≤–∏–ª–æ, –æ–ø–∏—Ä–∞—é—Ç—Å—è –Ω–∞ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –≤—Ä–∞—á–µ–π (40%) –∏ –¥—Ä—É–∑–µ–π (30%). üíä –ö–ª—é—á–µ–≤—ã–µ –∫—Ä–∏—Ç–µ—Ä–∏–∏ –≤—ã–±–æ—Ä–∞ –æ–±–µ–∑–±–æ–ª–∏–≤–∞—é—â–∏—Ö —É –≤—Å–µ—Ö –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö ‚Äî —Å–∫–æ—Ä–æ—Å—Ç—å –¥–µ–π—Å—Ç–≤–∏—è, —É–Ω–∏–≤–µ—Ä—Å–∞–ª—å–Ω–æ—Å—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –∏ –µ–≥–æ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å. üíä 65% –º–∏–ª–ª–µ–Ω–∏–∞–ª–æ–≤ –ø—Ä–æ—Ç–∏–≤ 54% –∑—É–º–µ—Ä–æ–≤ –ø–æ–∫—É–ø–∞—é—Ç —Ç–æ–ª—å–∫–æ —Ç–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞, –∫–æ—Ç–æ—Ä—ã–µ –Ω—É–∂–Ω—ã –∑–¥–µ—Å—å –∏ —Å–µ–π—á–∞—Å. –í–ø—Ä–æ–∫ –±–æ–ª—å—à–∏–º–∏ —É–ø–∞–∫–æ–≤–∫–∞–º–∏ —á–∞—â–µ –∑–∞–∫—É–ø–∞—é—Ç—Å—è —Ç–µ, –∫—Ç–æ –ø–æ–º–ª–∞–¥—à–µ (22 –ø—Ä–æ—Ç–∏–≤ 13%). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-07-20T11:03:43+00:00,@bezrec,6327,https://t.me/bezrec/6327,–ù–∏—á–µ–≥–æ –Ω–µ–æ–±—ã—á–Ω–æ–≥–æ. –ü—Ä–æ—Å—Ç–æ –∫–∏—Ç–∞–π—Ü—ã –ª–µ—á–∞—Ç –±–µ—Å—Å–æ–Ω–Ω–∏—Ü—É. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞,"{""skip"": true}"
2025-07-19T11:04:51+00:00,@bezrec,6326,https://t.me/bezrec/6326,"–ü—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω—ã–π —Å—É–±–±–æ—Ç–Ω–∏–π –≤—ã–ø—É—Å–∫ –Ω–∞—à–µ–π —Ä—É–±—Ä–∏–∫–∏ #–≤–¥–æ–≥–æ–Ω–∫—É. üíä ¬´–ü—Ä–æ—Ç–µ–∫¬ª —á–∏—Å—Ç –ø–µ—Ä–µ–¥ –§–ê–°. –†–µ–≥—É–ª—è—Ç–æ—Ä –Ω–µ –≤—ã—è–≤–∏–ª –ø—Ä–∏–∑–Ω–∞–∫–æ–≤ –Ω–∞—Ä—É—à–µ–Ω–∏—è –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å–Ω–æ–≥–æ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–∞ –≤ –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ —Ñ–∞—Ä–º–¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–∞ –≤ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–µ –≤–Ω–µ–ø–ª–∞–Ω–æ–≤–æ–π –∞–Ω—Ç–∏–∫–∞—Ä—Ç–µ–ª—å–Ω–æ–π –ø—Ä–æ–≤–µ—Ä–∫–∏. üíä –í –ü–æ–¥–º–æ—Å–∫–æ–≤—å–µ –ø–æ—è–≤–∏—Ç—Å—è –Ω–æ–≤–æ–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ —Ä–µ–∞–≥–µ–Ω—Ç–æ–≤ –¥–ª—è –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è –≥–µ–Ω–µ—Ç–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π. ¬´–ê–ª—É—Ä–æ–Ω¬ª —É–∂–µ –∏–Ω–≤–µ—Å—Ç–∏—Ä–æ–≤–∞–ª –≤ –∑–∞–ø—É—Å–∫ –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏—è 250 –º–ª–Ω —Ä—É–±–ª–µ–π. –ù–∞ –ø–µ—Ä–≤—ã—Ö –ø–æ—Ä–∞—Ö –Ω–∞ –Ω—ë–º –±—É–¥—É—Ç –≤—ã–ø—É—Å–∫–∞—Ç—å –∏–º–ø–æ—Ä—Ç–æ–∑–∞–º–µ—â–∞—é—â–∏–µ —Ä–µ–∞–≥–µ–Ω—Ç—ã –≤ —Ä–∞–º–∫–∞—Ö –∫–æ–Ω—Ç—Ä–∞–∫—Ç–Ω–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞, –∞ –∑–∞—Ç–µ–º –∫–æ–º–ø–∞–Ω–∏—è –ø–µ—Ä–µ–π–¥—ë—Ç –∫ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ –∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤—É —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏. üíä –ú–∏–Ω–∑–¥—Ä–∞–≤ –ø—Ä–∏–æ—Å—Ç–∞–Ω–æ–≤–∏–ª –¥–µ–π—Å—Ç–≤–∏–µ –µ—â—ë 20 –†–£ Jodas Expoim. –í —Å–ø–∏—Å–æ–∫ –ø–æ–ø–∞–ª–∏: –ê–∑–Ω–∞–º-–õ–∏–æ—Ñ, –î–∞–ø—Ç–æ–º–∏—Ü–∏–Ω –î–∂, –ê—Ü–∏–∫–ª–æ–≤–∏—Ä –î–∂, –ò—Ä–∏–Ω–æ—Ç–µ–∫–∞–Ω-–î–∂, –í–∞–Ω–∫–æ–º–∏—Ü–∏–Ω –î–∂, –î–∂–∫–≤–∞–Ω—Ç–∞–ª, –ò–º–∞—Ç–∏–Ω–∏–±, –ö–∞–ø–µ—Ü–∏—Ç–∞–±–∏–Ω, –ö–∞—Å–ø–æ—Ñ—É–Ω–≥–∏–Ω-–î–∂, –ö–µ—Ñ—Å–µ–ø–∏–º, –ö–æ—Ä–æ–º–∞–∫—Å, –û—Ä–∏—Ç–∞–∫—Å, –ö–æ-—Ç—Ä–∏–º–æ–∫—Å–∞–∑–æ–ª –î–∂, –ú–∏–∫–∞—Ñ—É–Ω–≥–∏–Ω –î–∂, –ü–∞–ª–±–æ–ª–∏–±, –≠–ª—Ç—Ä–æ–º–∞–∫—Ç, –ü–µ–º–µ—Ç—Ä–µ–∫—Å–µ–¥ –î–∂, –¶–µ—Ñ–µ–ø–∏–º-–î–∂–æ–¥–∞—Å, –¶–µ—Ñ–µ–ø–∏–º + –°—É–ª—å–±–∞–∫—Ç–∞–º, –¶–µ—Ñ–∞–Ω–æ—Ä–º, –¢–µ–º–æ–º–∏–¥. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –æ—Ç–º–µ–Ω–µ–Ω—ã –†–£ –Ω–∞ –õ–µ–≤–æ—Ñ–ª–æ–∫—Å–∞—Ü–∏–Ω-–ù–æ–≤–∞, –ü–ª–µ–æ–º-20, –§–ª—É–∫–æ–Ω–∞–∑–æ–ª, –¢—Ä–∞–≤–∏—Å–∏–ª, –ü–ª–µ—Ç–∞–∫—Å. üíä –£ —Ñ–∞—Ä–º–∏–Ω–Ω–æ–≤–∞—Ü–∏–π –ø–æ—è–≤–∏–ª—Å—è —Å–≤–æ–π –ö–æ–æ—Ä–¥–∏–Ω–∞—Ü–∏–æ–Ω–Ω—ã–π —Å–æ–≤–µ—Ç. –°–æ–≥–ª–∞—à–µ–Ω–∏–µ –æ —Å–æ–∑–¥–∞–Ω–∏–∏ –º–µ–∂–≤–µ–¥–æ–º—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ö–æ–æ—Ä–¥–∏–Ω–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ —Å–æ–≤–µ—Ç–∞ –ø–æ–¥–ø–∏—Å–∞–ª–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤, –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥, –ú–∏–Ω–æ–±—Ä–Ω–∞—É–∫–∏, –∫–æ–º–ø–∞–Ω–∏—è ¬´–ò–Ω–Ω–æ–ø—Ä–∞–∫—Ç–∏–∫–∞¬ª –∏ –ê–ù–û ¬´–ò–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–π –∏–Ω–∂–∏–Ω–∏—Ä–∏–Ω–≥–æ–≤—ã–π —Ü–µ–Ω—Ç—Ä¬ª. –ù–æ–≤–∞—è —Å—Ç—Ä—É–∫—Ç—É—Ä–∞ –±—É–¥–µ—Ç —Ä–∞–±–æ—Ç–∞—Ç—å –Ω–∞–¥ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏–µ–º –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ –ø–æ—Ä—Ç—Ñ–µ–ª—è –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–Ω—ã—Ö –∏–Ω–Ω–æ–≤–∞—Ü–∏–π –≤ —Ñ–∞—Ä–º–∏–Ω–¥—É—Å—Ç—Ä–∏–∏. üíä ¬´–£—Ä–∞–ª–±–∏–æ—Ñ–∞—Ä–º¬ª –Ω–µ —Å—Ç–æ–∏—Ç –±–µ–∑ –¥–µ–ª–∞. –û–¥–Ω–∞ –∏–∑ —Å—Ç–∞—Ä–µ–π—à–∏—Ö —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π —Å—Ç—Ä–∞–Ω—ã, –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∞–≤—à–∞—è –±–∏–∑–Ω–µ—Å–º–µ–Ω—É –ú–∞–ª–∏–∫—É –ì–∞–π—Å–∏–Ω—É –∏ –ø—Ä–∏–≤–∞—Ç–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω–∞—è –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–æ–º, –ø–æ—Å—Ç—Ä–æ–∏—Ç –∑–∞–≤–æ–¥ –≤ –û–≠–ó ¬´–¢–∏—Ç–∞–Ω–æ–≤–∞—è –¥–æ–ª–∏–Ω–∞¬ª. –û–±—ä—ë–º –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–π –æ—Ü–µ–Ω–∏–≤–∞–µ—Ç—Å—è –≤ 5 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ù–∞ –ø–ª–æ—â–∞–¥–∫–µ –≤ –ü–∞—Ç—Ä—É—à–∞—Ö –±—É–¥—É—Ç –≤—ã–ø—É—Å–∫–∞—Ç—å 47 –ú–ù–ù, –∞ —Ç–∞–∫–∂–µ 53 –Ω–∞–∏–º–µ–Ω–æ–≤–∞–Ω–∏—è –ë–ê–î–æ–≤. üíä –ü–æ—à–ª–∏–Ω—ã –¢—Ä–∞–º–ø–∞ –¥–æ–±—Ä–∞–ª–∏—Å—å –¥–æ –ª–µ–∫–∞—Ä—Å—Ç–≤. –í–µ—Ä–æ—è—Ç–Ω–æ, –≤ –∫–æ–Ω—Ü–µ –º–µ—Å—è—Ü–∞ –º—ã –Ω–∞—á–Ω–µ–º —Å –Ω–∏–∑–∫–∏—Ö —Ç–∞—Ä–∏—Ñ–æ–≤ –∏ –¥–∞–¥–∏–º —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–º –∫–æ–º–ø–∞–Ω–∏—è–º –≥–æ–¥ –∏–ª–∏ –æ–∫–æ–ª–æ —Ç–æ–≥–æ –Ω–∞ —Ä–∞–∑–≤–∏—Ç–∏–µ, –∞ –∑–∞—Ç–µ–º –ø–æ–¥–Ω–∏–º–µ–º —Ç–∞—Ä–∏—Ñ—ã –¥–æ –æ—á–µ–Ω—å –≤—ã—Å–æ–∫–æ–≥–æ —É—Ä–æ–≤–Ω—è, ‚Äî –ø–æ–æ–±–µ—â–∞–ª –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–π –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage, import_export"",
  ""impact"": ""high"",
  ""english"": ""The US President announced that tariffs on pharmaceuticals will be introduced, starting with low rates for development but then increasing to very high levels. This could lead to shortages and increased costs for companies.""
}"
2025-07-18T14:34:17+00:00,@bezrec,6325,https://t.me/bezrec/6325,–í—Å–µ–º —Ö–æ—Ä–æ—à–∏—Ö –≤—ã—Ö–æ–¥–Ω—ã—Ö –∏ –ø—Ä–∞–≤–∏–ª—å–Ω—ã—Ö –º–∏–Ω–∏-–±–∞—Ä–æ–≤! ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞,"{""skip"": true}"
2025-07-18T12:02:30+00:00,@bezrec,6324,https://t.me/bezrec/6324,"–ö–æ–º—É ¬´–ù–æ–≤–∞–º–µ–¥–∏–∫—É¬ª? ¬´–†–æ—Å–Ω–∞–Ω–æ¬ª –≤—ã—Å—Ç–∞–≤–∏–ª–æ —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è –Ω–∞ –ø—Ä–æ–¥–∞–∂—É. –í—ã—Ä—É—á–µ–Ω–Ω—ã–µ —Å—Ä–µ–¥—Å—Ç–≤–∞ –ø—Ä–µ–¥–ø–æ–ª–∞–≥–∞–µ—Ç—Å—è –ø–µ—Ä–µ–Ω–∞–ø—Ä–∞–≤–∏—Ç—å –Ω–∞ –ø—Ä–∏–æ—Ä–∏—Ç–µ—Ç–Ω—ã–µ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏: —ç–Ω–µ—Ä–≥–æ–ª–æ–≥–∏—Å—Ç–∏–∫—É, –ø—Ä–∏—Ä–æ–¥–æ–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ –∏ –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä—É. –°—É–º–º–∞ –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω–æ–π —Å–¥–µ–ª–∫–∏ –Ω–µ —Ä–∞—Å–∫—Ä—ã–≤–∞–µ—Ç—Å—è, –∏–∑–≤–µ—Å—Ç–Ω–æ –ª–∏—à—å, —á—Ç–æ –ø—Ä–æ–¥–∞–≤–µ—Ü –Ω–µ –≥–æ—Ç–æ–≤ –ø–æ–ª—É—á–∏—Ç—å –∑–∞ –∞–∫—Ç–∏–≤ –º–µ–Ω—å—à–µ, —á–µ–º –≤ –Ω–µ–≥–æ –±—ã–ª–æ –≤–ª–æ–∂–µ–Ω–æ. ¬´–ù–æ–≤–∞–º–µ–¥–∏–∫–∞¬ª –±—ã–ª–∞ —Å–æ–∑–¥–∞–Ω–∞ –Ω–∞ –æ—Å–Ω–æ–≤–µ —Å–æ–≤–º–µ—Å—Ç–Ω–æ–≥–æ –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏—è ¬´–†–æ—Å–Ω–∞–Ω–æ¬ª –∏ –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–≥–æ –≤–µ–Ω—á—É—Ä–Ω–æ–≥–æ —Ñ–æ–Ω–¥–∞ Domain Associates, –∫–æ—Ç–æ—Ä—ã–µ –µ—â—ë –≤ 2012 –≥–æ–¥—É –¥–æ–≥–æ–≤–æ—Ä–∏–ª–∏—Å—å –≤–ª–æ–∂–∏—Ç—å –≤ –Ω–µ–≥–æ –ø–æ $380 –º–ª–Ω. –í —Ä–æ—Å—Å–∏–π—Å–∫–æ–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ —Å—Ç–æ—Ä–æ–Ω—ã –ø–ª–∞–Ω–∏—Ä–æ–≤–∞–ª–∏ –∏–Ω–≤–µ—Å—Ç–∏—Ä–æ–≤–∞—Ç—å –ø–æ $95 –º–ª–Ω. –í 2023 –≥–æ–¥—É ¬´–†–æ—Å–Ω–∞–Ω–æ¬ª —Å—Ç–∞–ª–æ –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–º –±–µ–Ω–µ—Ñ–∏—Ü–∏–∞—Ä–æ–º –≥—Ä—É–ø–ø—ã. –ü–∞—Ä—Ç–Ω–µ—Ä Verba Legal –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ü–∞–Ω–æ–≤ –æ—Ü–µ–Ω–∏–≤–∞–µ—Ç ¬´–ù–æ–≤–∞–º–µ–¥–∏–∫—É¬ª –Ω–µ –º–µ–Ω–µ–µ —á–µ–º –≤ 500 –º–ª–Ω —Ä—É–±–ª–µ–π ¬´—Å –Ω–µ–±–æ–ª—å—à–æ–π –ø—Ä–µ–º–∏–µ–π¬ª. –ß–µ–º –±–æ–≥–∞—Ç–∞ ¬´–ù–æ–≤–∞–º–µ–¥–∏–∫–∞¬ª? –£ –∫–æ–º–ø–∞–Ω–∏–∏ –µ—Å—Ç—å —Å–æ–±—Å—Ç–≤–µ–Ω–Ω—ã–π R&D-—Ü–µ–Ω—Ç—Ä –≤ –û–≠–ó ¬´–¢–µ—Ö–Ω–æ–ø–æ–ª–∏—Å ¬´–ú–æ—Å–∫–≤–∞¬ª –∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –º–æ—â–Ω–æ—Å—Ç—å—é 150 –º–ª–Ω –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –µ–¥–∏–Ω–∏—Ü –≤ –≥–æ–¥. –í 2024 –≥–æ–¥—É –æ–Ω–∞ –Ω–∞—Ä–∞—Å—Ç–∏–ª–∞ —Å–æ–≤–æ–∫—É–ø–Ω—É—é –≤—ã—Ä—É—á–∫—É –ø–æ –†–ë–°–£ (—Å —É—á–µ—Ç–æ–º –¥–æ—á–µ—Ä–Ω–µ–π ¬´–ù–æ–≤–∞–º–µ–¥–∏–∫–∞ –∏–Ω–Ω–æ—Ç–µ—Ö¬ª) –Ω–∞ 22,7%, –¥–æ 758,9 –º–ª–Ω —Ä—É–±–ª–µ–π, —á–∏—Å—Ç–∞—è –ø—Ä–∏–±—ã–ª—å —Å–æ—Å—Ç–∞–≤–∏–ª–∞ 127,9 –º–ª–Ω —Ä—É–±–ª–µ–π –ø—Ä–æ—Ç–∏–≤ 298,8 –º–ª–Ω —Ä—É–±–ª–µ–π —É–±—ã—Ç–∫–∞ –≥–æ–¥–æ–º —Ä–∞–Ω–µ–µ. –ü–æ –¥–∞–Ω–Ω—ã–º –ì–†–õ–°, ¬´–ù–æ–≤–∞–º–µ–¥–∏–∫–∞¬ª –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª–∞ –ú–∏–æ—Ä–µ–æ–ª –¥–ª—è –ª–µ—á–µ–Ω–∏—è –¥–µ–º–µ–Ω—Ü–∏–∏, –†–µ–ª–æ–Ω–æ–≤–∞ –ø—Ä–æ—Ç–∏–≤ –º–∏–≥—Ä–µ–Ω–∏, –õ–µ–≤—Ä–æ—Å–æ –ª–æ–Ω–≥ –æ—Ç –±–µ—Å—Å–æ–Ω–Ω–∏—Ü—ã. –¢–∞–∫–∂–µ –Ω–∞ –º–æ—â–Ω–æ—Å—Ç—è—Ö –∫–æ–º–ø–∞–Ω–∏–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—è—Ç—Å—è —Å–Ω–æ—Ç–≤–æ—Ä–Ω–æ–µ –ú–µ–ª–∞–∫—Å–µ–Ω –æ—Ç ¬´–Æ–Ω–∏—Ñ–∞—Ä–º–∞¬ª. –ü–æ –¥–∞–Ω–Ω—ã–º AlphaRM, –≤ 2024 –≥–æ–¥—É ¬´–ù–æ–≤–∞–º–µ–¥–∏–∫–∞¬ª –ø—Ä–æ–¥–∞–ª–∞ —á–µ—Ä–µ–∑ –∞–ø—Ç–µ–∫–∏ –∏ –≥–æ—Å—Å–µ–≥–º–µ–Ω—Ç –ª–µ–∫–∞—Ä—Å—Ç–≤ –Ω–∞ 54,9 –º–ª–Ω —Ä—É–±–ª–µ–π, —á—Ç–æ –Ω–∞ 58% –±–æ–ª—å—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É. –í RNC Pharma –ø–æ–¥—Å—á–∏—Ç–∞–ª–∏, —á—Ç–æ –≤ 2024 –≥–æ–¥—É –∫–æ–º–ø–∞–Ω–∏—è —Ä–µ–∞–ª–∏–∑–æ–≤–∞–ª–∞ –≤ 2,4 —Ä–∞–∑–∞ –±–æ–ª—å—à–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ ‚Äî –Ω–∞ 56,4 –º–ª–Ω —Ä—É–±–ª–µ–π. –û–±—ä—ë–º –ø—Ä–æ–¥–∞–∂ –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö –ø—Ä–µ–≤—ã—Å–∏–ª –ø—Ä–æ—à–ª–æ–≥–æ–¥–Ω–∏–µ –ø–æ–∫–∞–∑–∞—Ç–µ–ª–∏ –≤ 3,7 —Ä–∞–∑–∞ (69 —Ç—ã—Å. —É–ø–∞–∫–æ–≤–æ–∫). –° —è–Ω–≤–∞—Ä—è –ø–æ –º–∞–π 2025 –≥–æ–¥–∞ –≤ —Ä–æ–∑–Ω–∏—Ü—É –±—ã–ª–æ –ø—Ä–æ–¥–∞–Ω–æ 31,5 —Ç—ã—Å. —É–ø–∞–∫–æ–≤–æ–∫ –Ω–∞ 26,9 –º–ª–Ω —Ä—É–±–ª–µ–π (+ 61% –∏ +47% –≥–æ–¥ –∫ –≥–æ–¥—É). –ü–æ —Å–ª–æ–≤–∞–º –∏—Å–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–≥–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ RNC Pharma –ù–∏–∫–æ–ª–∞—è –ë–µ—Å–ø–∞–ª–æ–≤–∞, ¬´–ù–æ–≤–∞–º–µ–¥–∏–∫–∞¬ª –¥–ª—è ¬´–†–æ—Å–Ω–∞–Ω–æ¬ª ¬´—Å–∫–æ—Ä–µ–µ –Ω–µ–ø—Ä–æ—Ñ–∏–ª—å–Ω—ã–π –∞–∫—Ç–∏–≤, –∫–æ—Ç–æ—Ä—ã–π —Ä–∞–∑–≤–∏–≤–∞—Ç—å —Å–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω–æ –¥–æ–≤–æ–ª—å–Ω–æ —Å–ª–æ–∂–Ω–æ¬ª. –ü—Ä–∏ —ç—Ç–æ–º —Ä—è–¥ –ø—Ä–æ–¥—É–∫—Ç–æ–≤ –∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–æ–∫ –∫–æ–º–ø–∞–Ω–∏–∏ –∏–º–µ—é—Ç –∫–æ–º–º–µ—Ä—á–µ—Å–∫–∏–π –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª –∏ –º–æ–≥—É—Ç –±—ã—Ç—å –∏–Ω—Ç–µ—Ä–µ—Å–Ω—ã –ø—Ä–æ—Ñ–∏–ª—å–Ω–æ–º—É –∏–Ω–≤–µ—Å—Ç–æ—Ä—É. –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ü–∞–Ω–æ–≤ —Å—á–∏—Ç–∞–µ—Ç, —á—Ç–æ –∂–µ–ª–∞—é—â–∏–π –Ω–∞ ¬´–ù–æ–≤–∞–º–µ–¥–∏–∫—É¬ª –≤ –∫–∞—á–µ—Å—Ç–≤–µ –∫–æ–Ω—Ç—Ä–∞–∫—Ç–Ω–æ–≥–æ –±–∏–∑–Ω–µ—Å–∞ –º–æ–∂–µ—Ç –Ω–∞–π—Ç–∏—Å—å –∏ —Å—Ä–µ–¥–∏ –¥—Ä—É–≥–∏—Ö –∏–≥—Ä–æ–∫–æ–≤. –ü–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω–æ–≥–æ –ø–æ–∫—É–ø–∞—Ç–µ–ª—è —Ç–∞–∫–∂–µ –º–æ–∂–µ—Ç –∑–∞–∏–Ω—Ç–µ—Ä–µ—Å–æ–≤–∞—Ç—å —Å–æ–≤–æ–∫—É–ø–Ω–æ—Å—Ç—å –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –∏ –∫–æ–º–∞–Ω–¥—ã. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, sanctions, shortage, demand, epidemic, vaccine"",
  ""impact"": ""high"",
  ""english"": ""A pharmaceutical company 'Novamedika' is being sold by Rosnano. The proceeds are intended for priority activities: energy, nature conservation and infrastructure. The potential deal amount is undisclosed but the seller is not willing to sell for less than what was initially invested. 'Novamedika' was established on the basis of a joint venture between Rosnano and an American venture capital fund Domain Associates in 2012. The companies planned to invest $95 million into the Russian production. In 2023, Rosnano became the sole beneficiary of the group. 'Novamedika' has a R&D center in the Moscow Technopark and a production capacity of 150 million drug units per year. In 2024, the company's combined revenue (including subsidiary 'Novamedika Innotech') grew by 22.7% to RUB 758.9 million, while net profit was RUB 127.9 million compared to a loss of RUB "
2025-07-18T09:02:28+00:00,@bezrec,6322,https://t.me/bezrec/6322,"–ò–Ω–æ—Å—Ç—Ä–∞–Ω–Ω–∞—è —Ñ–∞—Ä–º–∞ ¬´—Ä—É–ª–∏—Ç¬ª –≤ –≥–æ—Å–∑–∞–∫—É–ø–∫–∞—Ö. IT-–∫–æ–º–ø–∞–Ω–∏—è Cursor –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∞ —Å–≤–æ–¥–Ω—ã–µ –¥–∞–Ω–Ω—ã–µ –ø–æ –≥–æ—Å–∑–∞–∫—É–ø–∫–∞–º –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ —è–Ω–≤–∞—Ä–µ-–∏—é–Ω–µ 2025 –≥–æ–¥–∞. –î–µ–ª–∏–º—Å—è –≤—ã–¥–µ—Ä–∂–∫–∞–º–∏ –∏–∑ –æ—Ç—á—ë—Ç–∞: üíä –ø–æ –∏—Ç–æ–≥–∞–º –ø–µ—Ä–≤–æ–≥–æ –ø–æ–ª—É–≥–æ–¥–∏—è 2025 –≥–æ–¥–∞ –æ–±—ä—ë–º –≥–æ—Å–∑–∞–∫—É–ø–æ–∫ —Å–æ—Å—Ç–∞–≤–∏–ª 471 –º–ª–Ω —Ä—É–±–ª–µ–π. –≠—Ç–æ –Ω–∞ 19% –º–µ–Ω—å—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É; üíä —Å—ç–∫–æ–Ω–æ–º–∏—Ç—å –ø–æ–ª—É—á–∏–ª–æ—Å—å –≤ —Å—Ä–µ–¥–Ω–µ–º 3,7% –±—é–¥–∂–µ—Ç–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å 3,6% –≤ 2024 –≥–æ–¥—É; üíä –≤—Å–µ–≥–æ –±—ã–ª–æ –æ–±—ä—è–≤–ª–µ–Ω–æ 259 —Ç—ã—Å. —Ç–µ–Ω–¥–µ—Ä–æ–≤ –Ω–∞ 558,7 –º–ª–Ω —Ä—É–±–ª–µ–π, —á—Ç–æ –Ω–∞ 6% –º–µ–Ω—å—à–µ –≤ –¥–µ–Ω–µ–∂–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ –∏ –Ω–∞ 10% –±–æ–ª—å—à–µ –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –≥–æ–¥ –∫ –≥–æ–¥—É; üíä –ø—Ä–æ—Ü–µ–Ω—Ç –Ω–µ—Å–æ—Å—Ç–æ—è–≤—à–∏—Ö—Å—è —Ç–æ—Ä–≥–æ–≤ –≤—ã—Ä–æ—Å —Å 23% –≤ –ø–µ—Ä–≤–æ–º –ø–æ–ª—É–≥–æ–¥–∏–∏ 2024 –≥–æ–¥–∞ –¥–æ 34% –≤ –∞–Ω–∞–ª–æ–≥–∏—á–Ω–æ–º –ø–µ—Ä–∏–æ–¥–µ 2025 –≥–æ–¥–∞; üíä –∑–∞–∫—É–ø–∫–∏ —É –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø–æ—Å—Ç–∞–≤—â–∏–∫–∞ (–±–µ–∑ –æ–±—ä—è–≤–ª–µ–Ω–∏—è —Ç–µ–Ω–¥–µ—Ä–∞) —É–º–µ–Ω—å—à–∏–ª–∏—Å—å –Ω–∞ 59% –≤ –¥–µ–Ω–µ–∂–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ –∏ —É–≤–µ–ª–∏—á–∏–ª–∏—Å—å –Ω–∞ 16% –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º; üíä –≤ —Ç–æ–ø-10 –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –∑–∞–∫—É–ø–ª–µ–Ω–Ω—ã—Ö –≤ 2025 –≥–æ–¥—É –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –æ–∫–∞–∑–∞–ª—Å—è —Ç–æ–ª—å–∫–æ –æ–¥–∏–Ω —Ä–æ—Å—Å–∏–π—Å–∫–∏–π ‚Äî ¬´–ë–∏–æ–∫–∞–¥¬ª –î–º–∏—Ç—Ä–∏—è –ú–æ—Ä–æ–∑–æ–≤–∞. –í –¥–µ—Å—è—Ç–∫—É –∏–≥—Ä–æ–∫–æ–≤, —á—å–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã ¬´–ø—Ä–æ—Ä–≤–∞–ª–∏—Å—å¬ª –≤ –∑–∞–∫—É–ø–∫–∏ –≤–æ—à–ª–∏: ¬´–ê—Å—Ç—Ä–∞–ó–µ–Ω–µ–∫–∞¬ª, ¬´–†–æ—à¬ª, ¬´–ù–æ–≤–∞—Ä—Ç–∏—Å¬ª, ¬´–°–∞–Ω–æ—Ñ–∏¬ª, ¬´–î–∂–æ–Ω—Å–æ–Ω –∏ –î–∂–æ–Ω—Å–æ–Ω¬ª, ¬´–ì–∏–ª–µ–∞–¥¬ª, ¬´–≠–±–±–≤–∏¬ª, ¬´–ë—Ä–∏—Å—Ç–æ–ª –ú–∞–π–µ—Ä—Å¬ª, ¬´–ü—Ñ–∞–π–∑–µ—Ä¬ª. –§–∞–≤–æ—Ä–∏—Ç –≥–æ—Å–∑–∞–∫—É–ø–æ–∫ ‚Äî –§–æ—Ä—Å–∏–≥–∞ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –¥–∏–∞–±–µ—Ç–∞ –≤—Ç–æ—Ä–æ–≥–æ —Ç–∏–ø–∞ –æ—Ç ¬´–ê—Å—Ç—Ä–∞–ó–µ–Ω–µ–∫–∏¬ª. –ù–µ–¥–∞—Ä–æ–º –∑–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç –≤–µ–¥—É—Ç—Å—è –ø–∞—Ç–µ–Ω—Ç–Ω—ã–µ –±–æ–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The report highlights a significant decrease in government procurement spending, with a reduction of 19% compared to the previous year. The number of tenders also decreased by 6% in monetary terms and 10% in natural terms. The percentage of unsuccessful tenders rose from 23% to 34%. Notably, purchases from a single supplier decreased by 59% in monetary terms and increased by 16% in natural terms. The top ten suppliers for government purchases include international companies such as Astellas, Roche, Novartis, Sanofi, Johnson & Johnson, Gilead, AbbVie, Bristol-Myers Squibb, and Pfizer. The most favored product for government procurement is Forxiga for the treatment of type 2 diabetes.""
}"
2025-07-18T05:20:26+00:00,@bezrec,6321,https://t.me/bezrec/6321,"–†–æ—Å—Å–∏—è–Ω–µ –Ω–∞–ª–µ–≥–∞—é—Ç –Ω–∞ –∂–µ–ª–µ–∑–æ. –° —è–Ω–≤–∞—Ä—è –ø–æ –º–∞–π 2025 –≥–æ–¥–∞ –Ω–∞ —Ä–æ–∑–Ω–∏—á–Ω–æ–º —Ä—ã–Ω–∫–µ –†–æ—Å—Å–∏–∏ –±—ã–ª–æ —Ä–µ–∞–ª–∏–∑–æ–≤–∞–Ω–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∂–µ–ª–µ–∑–∞ –±–æ–ª–µ–µ —á–µ–º –Ω–∞ 5,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —á—Ç–æ –Ω–∞ 18,4% –±–æ–ª—å—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É. –í –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ –ø—Ä–∏—Ä–æ—Å—Ç –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–Ω –Ω–∞ —É—Ä–æ–≤–Ω–µ 8,2% (6,2 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫). –ó–∞ –≤–µ—Å—å 2024 –≥–æ–¥ –≤ —Ä–æ–∑–Ω–∏—Ü–µ —É—à–ª–æ –ø–æ—á—Ç–∏ 14 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ —Ç–∞–∫–∏—Ö —Å—Ä–µ–¥—Å—Ç–≤ –Ω–∞ —Å—É–º–º—É –±–æ–ª–µ–µ 12,4 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –≠—Ç–æ –Ω–∞ 25% –±–æ–ª—å—à–µ –≤ —Ä—É–±–ª—ë–≤–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏, —á–µ–º –≤ 2023 –≥–æ–¥—É. –ê–±—Å–æ–ª—é—Ç–Ω—ã–π –∏—Å—Ç–æ—Ä–∏—á–µ—Å–∫–∏–π —Ä–µ–∫–æ—Ä–¥ –ø—Ä–æ–¥–∞–∂ –±—ã–ª –ø–æ–±–∏—Ç –≤ –º–∞—Ä—Ç–µ-–∞–ø—Ä–µ–ª–µ ‚Äî —Ç–æ–≥–¥–∞ –µ–∂–µ–º–µ—Å—è—á–Ω–æ –ø—Ä–æ–¥–∞–≤–∞–ª–æ—Å—å –±–æ–ª–µ–µ 1,3 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫. –≠—Ç–æ –¥–∞–∂–µ –≤—ã—à–µ –ø–æ–∫–∞–∑–∞—Ç–µ–ª–µ–π –∞–∂–∏–æ—Ç–∞–∂–Ω–æ–≥–æ 2022 –≥–æ–¥–∞. –í –∞–Ω–∞–ª–∏–∑–∏—Ä—É–µ–º–æ–º –ø–µ—Ä–∏–æ–¥–µ –Ω–∞ —Ä–æ–∑–Ω–∏—á–Ω–æ–º —Ä—ã–Ω–∫–µ –Ω–∞—Å—á–∏—Ç—ã–≤–∞–ª–æ—Å—å 25 –º–∞—Ä–æ–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∂–µ–ª–µ–∑–∞. –í –ª–∏–¥–µ—Ä–∞—Ö –æ–∫–∞–∑–∞–ª—Å—è –°–æ—Ä–±–∏—Ñ–µ—Ä –î—É—Ä—É–ª–µ—Å –æ—Ç ¬´–≠–≥–∏—Å¬ª (–≤—Ö–æ–¥–∏—Ç –≤ –≥—Ä—É–ø–ø—É ¬´–°–µ—Ä–≤—å–µ¬ª), –∫–æ—Ç–æ—Ä—ã–π, –≤–ø—Ä–æ—á–µ–º, –Ω–µ –º–æ–≥ –ø–æ—Ö–≤–∞—Å—Ç–∞—Ç—å—Å—è –≤–Ω—É—à–∏—Ç–µ–ª—å–Ω–æ–π –¥–∏–Ω–∞–º–∏–∫–æ–π, –≤ –æ—Ç–ª–∏—á–∏–µ –æ—Ç –∑–∞–Ω–∏–º–∞—é—â–µ–≥–æ –≤—Ç–æ—Ä–æ–µ –º–µ—Å—Ç–æ –§–µ—Ä—Ä—É–º –õ–µ–∫–∞ (¬´–°–∞–Ω–¥–æ–∑¬ª), –Ω–∞—Ä–∞—Å—Ç–∏–≤—à–µ–≥–æ –ø—Ä–æ–¥–∞–∂–∏ –≤ –¥–µ–Ω—å–≥–∞—Ö –Ω–∞ 38%, –∞ –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö ‚Äî –Ω–∞ 5%. –ó–∞–º—ã–∫–∞–µ—Ç —Ç—Ä–æ–π–∫—É –ª–∏–¥–µ—Ä–æ–≤ —Ä–∞—Å—Ç–≤–æ—Ä –¥–ª—è –≤–Ω—É—Ç—Ä–∏–≤–µ–Ω–Ω–æ–≥–æ –≤–≤–µ–¥–µ–Ω–∏—è –§–µ—Ä–∏–Ω–∂–µ–∫—Ç –æ—Ç ¬´–í–∏—Ñ–æ—Ä –§–∞—Ä–º–∞¬ª, –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–π –ø–æ–∫–∞–∑–∞–≤—à–∏–π –æ—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω—É—é –¥–∏–Ω–∞–º–∏–∫—É –∫–∞–∫ –≤ –¥–µ–Ω—å–≥–∞—Ö (-19%), —Ç–∞–∫ –∏ –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö (-26%). –ü–µ—Ä–µ–±–æ–∏ —Å –ø–æ—Å—Ç–∞–≤–∫–∞–º–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –Ω–∞–±–ª—é–¥–∞–ª–∏—Å—å —Å –≤–µ—Å–Ω—ã —ç—Ç–æ–≥–æ –≥–æ–¥–∞. –ó–∞—Ç–æ —Å–≤–æ–µ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è –ø–æ—Ä–∞–¥–æ–≤–∞–ª –¥—Ä—É–≥–æ–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –æ—Ç ¬´–í–∏—Ñ–æ—Ä –§–∞—Ä–º–∞¬ª ‚Äî –∑–∞–Ω–∏–º–∞—é—â–∏–π –¥–µ—Å—è—Ç—É—é —Å—Ç—Ä–æ—á–∫—É –í–µ–Ω–æ—Ñ–µ—Ä –ø—Ä–∏–±–∞–≤–∏–ª —Å—Ä–∞–∑—É 142%. –≠—Ç–æ –Ω–∞–∏–ª—É—á—à–∏–π –ø–æ–∫–∞–∑–∞—Ç–µ–ª—å –≤ —Ä–µ–π—Ç–∏–Ω–≥–µ. –¢–∞–∫–∂–µ –≤ —Ç–æ–ø-10 –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∂–µ–ª–µ–∑–∞ –ø–æ–ø–∞–ª–∏: –§–µ—Ä–ª–∞—Ç—É–º (¬´–ò—Ç–∞–ª—Ñ–∞—Ä–º–∞–∫–æ¬ª), –¢–æ—Ç–µ–º–∞ (¬´–õ–∞–±–æ—Ä–∞—Ç–æ—Ä–∏—è –ò–Ω–Ω–æ—Ç–µ–∫¬ª), –§–µ—Ä—Ä–µ—Ç–∞–± (¬´–ê–ª—Ü–µ—è¬ª), –ú–∞–ª—å—Ç–æ—Ñ–µ—Ä (¬´–í–∏—Ñ–æ—Ä –§–∞—Ä–º–∞¬ª), –¢–∞—Ä–¥–∏—Ñ–µ—Ä–æ–Ω (¬´–ü—å–µ—Ä –§–∞—Ä–±¬ª), –õ–∏–∫—Ñ–µ—Ä—Ä100 (¬´–°–æ—Ç–µ–∫—Å¬ª). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, shortage"",
  ""impact"": ""high"",
  ""english"": ""There has been a significant increase in the demand for iron supplements in Russia, with sales increasing by 18.4% year-over-year to over 5.7 billion rubles in the first half of 2025. The natural increase was recorded at 8.2% (6.2 million units). In 2024, over 14 million units of these products were sold for a total of about 12.4 billion rubles, which is 25% more than in 2023. Sales reached their peak in March-April, with over 1.3 million units sold each month. This is higher than the peak in 2022. The top-selling brands include Sorbifer Duress from 'Servy' (now part of 'Egis') and Ferum Lek from 'Sandoz', both showing significant growth. The shortage of the product was observed since spring this year, but another product from 'Vifor Pharma' (Lokfer) showed a significant increase of 14"
2025-07-17T14:34:38+00:00,@bezrec,6319,https://t.me/bezrec/6319,"–ö–æ—Ä—Ç–Ω–∏ –ö–∞—Ä–¥–∞—à—å—è–Ω –æ–±–µ—Å–ø–æ–∫–æ–∏–ª–∞—Å—å —Ç–µ–º, —á—Ç–æ –∞–º–µ—Ä–∏–∫–∞–Ω—Ü—ã –Ω–µ –¥–æ–µ–¥–∞—é—Ç –æ–≤–æ—â–µ–π. –ò –æ–±–µ—Ä–Ω—É–ª–∞ —Å–µ–π —Ñ–∞–∫—Ç –≤ —Å–≤–æ—é –ø–æ–ª—å–∑—É, —Ä–∞—Å—à–∏—Ä–∏–≤ —Å–æ–±—Å—Ç–≤–µ–Ω–Ω—É—é –ª–∏–Ω–µ–π–∫—É –≤–∏—Ç–∞–º–∏–Ω–æ–≤ Lemme. –í —Å–æ—Å—Ç–∞–≤ –∂–µ–≤–∞—Ç–µ–ª—å–Ω—ã—Ö –∫–æ–Ω—Ñ–µ—Ç Lemme Greens –≤—Ö–æ–¥–∏—Ç –±–æ–ª–µ–µ 20 –≤–∏–¥–æ–≤ –æ–≤–æ—â–µ–π –∏ —Ñ—Ä—É–∫—Ç–æ–≤, –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏ –ø—Ä–æ—Ç–µ—Å—Ç–∏—Ä–æ–≤–∞–Ω–Ω—ã–π –ø—Ä–æ–±–∏–æ—Ç–∏–∫, –±–∏–æ—Ç–∏–Ω, –≤–∏—Ç–∞–º–∏–Ω D –∏ B12. –ü–æ –∑–∞–¥—É–º–∫–µ, –≤—Å—ë —ç—Ç–æ –±–æ–≥–∞—Ç—Å—Ç–≤–æ –¥–æ–ª–∂–Ω–æ –æ–±–æ–≥–∞—Ç–∏—Ç—å —Ä–∞—Ü–∏–æ–Ω –∏ –Ω–∞–ª–∞–¥–∏—Ç—å —Ä–∞–±–æ—Ç—É –ñ–ö–¢. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-07-17T11:34:41+00:00,@bezrec,6317,https://t.me/bezrec/6317,"–¢–∏—Ä–∑–µ–ø–∞—Ç–∏–¥ –¥–µ–ª–∞–µ—Ç –ø–µ—Ä–≤—ã–µ —à–∞–≥–∏ –≤ –≥–æ—Å—Å–µ–≥–º–µ–Ω—Ç–µ. –ü—Ä–æ–¥–æ–ª–∂–∞–µ–º —Ä–∞–∑–±–∏—Ä–∞—Ç—å —Å—Ä–∞–≤–Ω–∏—Ç–µ–ª—å–Ω—ã–π –∞–Ω–∞–ª–∏–∑ –∑–∞–∫—É–ø–æ–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –æ—Ç –æ–∂–∏—Ä–µ–Ω–∏—è –ø–æ –¥–∞–Ω–Ω—ã–º –ø–µ—Ä–≤–æ–≥–æ –ø–æ–ª—É–≥–æ–¥–∏—è 2024 –∏ 2025 –≥–æ–¥–æ–≤ –æ—Ç Headway company. –í –æ—Ç–ª–∏—á–∏–µ –æ—Ç —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞, –∫–æ—Ç–æ—Ä—ã–π —Å 1 —è–Ω–≤–∞—Ä—è 2025 –≥–æ–¥–∞ –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω–æ –≤–∫–ª—é—á—ë–Ω –≤ –æ–±–Ω–æ–≤–ª—ë–Ω–Ω—ã–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –∏ –ê—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ —ç–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–æ–≤ –†–§ –∫–∞–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç –ø–µ—Ä–≤–æ–≥–æ –≤—ã–±–æ—Ä–∞ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –æ–∂–∏—Ä–µ–Ω–∏—è —É –≤–∑—Ä–æ—Å–ª—ã—Ö, —Ç–∏—Ä–∑–µ–ø–∞—Ç–∏–¥ —Ç–∞–∫–∏–º–∏ —É—Å–ø–µ—Ö–∞–º–∏ –ø–æ–∫–∞ –ø–æ—Ö–≤–∞—Å—Ç–∞—Ç—å—Å—è –Ω–µ –º–æ–∂–µ—Ç. –†—ã–Ω–æ–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Å —ç—Ç–∏–º –ú–ù–ù —Ñ–æ—Ä–º–∏—Ä—É–µ—Ç—Å—è –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏ –≤ —Ä–µ–∂–∏–º–µ —Ä–µ–∞–ª—å–Ω–æ–≥–æ –≤—Ä–µ–º–µ–Ω–∏ ‚Äî –æ—Ç –≤–≤–æ–¥–∞ –≤ –æ–±–æ—Ä–æ—Ç –¥–æ –ø–µ—Ä–≤—ã—Ö –∑–∞–∫—É–ø–æ–∫ –ø—Ä–æ—Ö–æ–¥–∏—Ç –≤—Å–µ–≥–æ –Ω–µ—Å–∫–æ–ª—å–∫–æ –º–µ—Å—è—Ü–µ–≤. –ó–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –¥–∂–µ–Ω–µ—Ä–∏–∫–∏ —Ç–∏—Ä–∑–µ–ø–∞—Ç–∏–¥–∞ (–¢–∏—Ä–∑–µ—Ç—Ç–∞ –æ—Ç ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª –∏ –°–µ–¥–∂–∞—Ä–æ –æ—Ç ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º–∞¬ª) —É–∂–µ –Ω–∞—á–∞–ª–∏ –ø–æ—è–≤–ª—è—Ç—å—Å—è –≤ —Ç–µ–Ω–¥–µ—Ä–Ω—ã—Ö –∑–∞–∫—É–ø–∫–∞—Ö –≤ 2025 –≥–æ–¥—É. –û—Å–Ω–æ–≤–Ω–æ–π –æ–±—ä—ë–º (98%) –¥–æ—Å—Ç–∞–ª—Å—è –¢–∏—Ä–∑–µ—Ç—Ç–µ (–≤–≤–µ–¥–µ–Ω–∞ –≤ –æ–±–æ—Ä–æ—Ç 14 —Ñ–µ–≤—Ä–∞–ª—è 2025 –≥–æ–¥–∞), –¥–æ–ª—è –°–µ–¥–∂–∞—Ä–æ (–≤–≤–µ–¥—ë–Ω –≤ –æ–±–æ—Ä–æ—Ç 6 –º–∞—è 2025 –≥–æ–¥–∞) —Å–æ—Å—Ç–∞–≤–∏–ª–∞ 2%. –ü–æ–∫–∞ –æ–±—ä—ë–º—ã –∑–∞–∫—É–ø–æ–∫ –Ω–µ–∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω—ã–µ, –Ω–æ —Å–∞–º —Ñ–∞–∫—Ç –∏—Ö –ø–æ—è–≤–ª–µ–Ω–∏—è –≥–æ–≤–æ—Ä–∏—Ç –æ–± –∏–Ω—Ç–µ—Ä–µ—Å–µ —Å–æ —Å—Ç–æ—Ä–æ–Ω—ã –∑–∞–∫–∞–∑—á–∏–∫–æ–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The market for drugs with this NNN is being formed practically in real-time - from registration to the first purchases it takes just a few months. Registered generics of tirzepatide (Promomed's Tirzetta and Gesarco from 'Geropharma') have already started appearing in procurement tenders since 2025. Although the volumes are small, their presence indicates interest from buyers.""
}"
2025-07-17T08:31:17+00:00,@bezrec,6316,https://t.me/bezrec/6316,"–ó–∞ –≥–æ—Ä–º–æ–Ω–∞–ª—å–Ω—É—é –∫–æ–Ω—Ç—Ä–∞—Ü–µ–ø—Ü–∏—é —Ä–æ—Å—Å–∏—è–Ω –æ—Ç–≤–µ—á–∞—é—Ç ¬´–ë–∞–π–µ—Ä¬ª –∏ ¬´–ì–µ–¥–µ–æ–Ω –†–∏—Ö—Ç–µ—Ä¬ª. –ü—Ä–æ–¥–∞–∂–∏ —ç—Ç–æ–π –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ø—Ä–æ–∞–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–ª–∞ RNC Pharma. –ó–∞ –ø–µ—Ä–≤—ã–µ –ø—è—Ç—å –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ –Ω–∞ —Ä–æ–∑–Ω–∏—á–Ω–æ–º —Ä—ã–Ω–∫–µ (–≤–∫–ª—é—á–∞—è e-com) –±—ã–ª–æ –ø—Ä–æ–¥–∞–Ω–æ 8,9 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ –≥–æ—Ä–º–æ–Ω–∞–ª—å–Ω—ã—Ö –∫–æ–Ω—Ç—Ä–∞—Ü–µ–ø—Ç–∏–≤–æ–≤ –Ω–∞ —Å—É–º–º—É 13,9 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –≠—Ç–æ –Ω–∞ 7,3% –±–æ–ª—å—à–µ –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –∏ –Ω–∞ 12,8% –≤ –¥–µ–Ω–µ–∂–Ω–æ–º —ç–∫–≤–∏–≤–∞–ª–µ–Ω—Ç–µ –≥–æ–¥ –∫ –≥–æ–¥—É. –î–ª—è —Å—Ä–∞–≤–Ω–µ–Ω–∏—è –≥–æ–¥–æ–º —Ä–∞–Ω–µ–µ –ø—Ä–∏—Ä–æ—Å—Ç –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö —Å–æ—Å—Ç–∞–≤–∏–ª 4,1%. –í—Å–µ–≥–æ –ø–æ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º 2024 –≥–æ–¥–∞ —Ä–æ—Å—Å–∏—è–Ω–µ –∫—É–ø–∏–ª–∏ –±–æ–ª–µ–µ 0,9 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ –Ω–∞ —Å—É–º–º—É –±–æ–ª–µ–µ 31,5 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. 85% –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–≥–æ –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏—è –≤—Å–µ—Ö –∞–Ω–∞–ª–∏–∑–∏—Ä—É–µ–º—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –¥–ª—è –≥–æ—Ä–º–æ–Ω–∞–ª—å–Ω–æ–π –∫–æ–Ω—Ç—Ä–∞—Ü–µ–ø—Ü–∏–∏ –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ –ø–µ—Ä–æ—Ä–∞–ª—å–Ω—ã–µ –∫–æ–Ω—Ç—Ä–∞—Ü–µ–ø—Ç–∏–≤—ã. –ó–∞ –≥–æ–¥ –∏—Ö –ø—Ä–æ–¥–∞–∂–∏ –≤—ã—Ä–æ—Å–ª–∏ –Ω–∞ 11% –≤ —Ä—É–±–ª—è—Ö –∏ –Ω–∞ 5% –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö. –°–µ–π—á–∞—Å –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç –≥–æ—Ä–º–æ–Ω–∞–ª—å–Ω–æ–π –∫–æ–Ω—Ç—Ä–∞—Ü–µ–ø—Ü–∏–∏ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω 44 —Ç–æ—Ä–≥–æ–≤—ã–º–∏ –º–∞—Ä–∫–∞–º–∏ –æ—Ç 11 –∫–æ–º–ø–∞–Ω–∏–π. –ü—Ä–∏ —ç—Ç–æ–º 89% —Ä—ã–Ω–∫–∞ ¬´–¥–µ—Ä–∂–∞—Ç¬ª –Ω–µ–º–µ—Ü–∫–∞—è ¬´–ë–∞–π–µ—Ä¬ª (55%) –∏ –≤–µ–Ω–≥–µ—Ä—Å–∫–∞—è ¬´–ì–µ–¥–µ–æ–Ω –†–∏—Ö—Ç–µ—Ä¬ª (34%). –¢–∞–∫–∂–µ –≤ —Ç–æ–ø-10 —Ç–æ—Ä–≥–æ–≤—ã—Ö –º–∞—Ä–æ–∫ —Å–∏—Å—Ç–µ–º–Ω—ã—Ö –≥–æ—Ä–º–æ–Ω–∞–ª—å–Ω—ã—Ö –∫–æ–Ω—Ç—Ä–∞—Ü–µ–ø—Ç–∏–≤–æ–≤ –ø–æ –æ–±—ä—ë–º—É –¥–µ–Ω–µ–∂–Ω—ã—Ö –ø—Ä–æ–¥–∞–∂ –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º —Ä–æ–∑–Ω–∏—á–Ω–æ–º —Ñ–∞—Ä–º—Ä—ã–Ω–∫–µ ¬´–∑–∞—Ç–µ—Å–∞–ª–∞—Å—å¬ª –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∞—è ¬´–®–µ—Ä–∏–Ω–≥-–ü–ª–∞—É¬ª —Å –≤–∞–≥–∏–Ω–∞–ª—å–Ω—ã–º –∫–æ–ª—å—Ü–æ–º –ù–æ–≤–∞—Ä–∏–Ω–≥. –†–æ—Å—Å–∏–π—Å–∫–∏–º –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º –º–µ—Å—Ç–∞ –≤ —Ä–µ–π—Ç–∏–Ω–≥–µ –Ω–µ –Ω–∞—à–ª–æ—Å—å. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""Russian sales of hormonal contraceptives are handled by companies such as Bayer and Gedeon Richter. RNC Pharma analyzed sales of this category of drugs for the first five months of 2025. Sales were up by 7.3% in nominal terms and 12.8% in monetary terms compared to the same period last year, which was a growth of 4.1%. In total, Russians purchased over 900,000 units for a value of more than 31.5 billion rubles in 2024. Approximately 85% of the natural consumption of all analyzed hormonal contraceptives is accounted for by oral contraceptives. Sales of these increased by 11% in rubles and 5% in units. The market is dominated by Bayer (55%) from Germany and Gedeon Richter (34%) from Hungary. American company Shering Plough also made it into the top 10 in terms of monetary sales with its vaginal ring Nover"
2025-07-17T05:45:23+00:00,@bezrec,6315,https://t.me/bezrec/6315,"–ù–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º —Ñ–∞—Ä–º—Ä—ã–Ω–∫–µ —Å—Ç–∞–Ω–æ–≤–∏—Ç—Å—è –º–µ–Ω—å—à–µ –Ω–æ–≤–∏—á–∫–æ–≤. –ü–æ –¥–∞–Ω–Ω—ã–º –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è —Å–µ—Ä–≤–∏—Å–∞ ¬´–ö–æ–Ω—Ç—É—Ä.–§–æ–∫—É—Å¬ª, —Å —è–Ω–≤–∞—Ä—è –ø–æ –∏—é–Ω—å 2025 –≥–æ–¥–∞ –ø—Ä–æ–∏–∑–æ—à–ª–æ –∑–∞–º–µ—Ç–Ω–æ–µ —Å–Ω–∏–∂–µ–Ω–∏–µ —á–∏—Å–ª–∞ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–π –Ω–æ–≤—ã—Ö —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π. –¢–∞–∫, –∑–∞ —É–∫–∞–∑–∞–Ω–Ω—ã–π –ø–µ—Ä–∏–æ–¥ –±—ã–ª–æ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–æ 47 –Ω–æ–≤–∏—á–∫–æ–≤, —á—Ç–æ –Ω–∞ 22,9% –º–µ–Ω—å—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É. –ê–∫—Ç–∏–≤–Ω–µ–µ –≤—Å–µ–≥–æ –Ω–æ–≤—ã–µ –∏–≥—Ä–æ–∫–∏ –ø–æ—è–≤–ª—è–ª–∏—Å—å –≤ –ø–µ—Ä–≤–æ–º –ø–æ–ª—É–≥–æ–¥–∏–∏ 2023 –≥–æ–¥–∞. –¢–æ–≥–¥–∞ –±—ã–ª–æ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–æ 70 –Ω–æ–≤—ã—Ö –∫–æ–º–ø–∞–Ω–∏–π –∏ –ò–ü (69 –≤ –ø–µ—Ä–≤–æ–º –ø–æ–ª—É–≥–æ–¥–∏–∏ 2022 –≥–æ–¥–∞). –í 2024 –≥–æ–¥—É —ç—Ç–æ—Ç –ø–æ–∫–∞–∑–∞—Ç–µ–ª—å —Å–Ω–∏–∑–∏–ª—Å—è –Ω–∞ 12,8%, –¥–æ 61 —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏. –ü–∞—Ä–∞–ª–ª–µ–ª—å–Ω–æ —Å–Ω–∏–∂–∞–ª–æ—Å—å –∏ —á–∏—Å–ª–æ –ª–∏–∫–≤–∏–¥–∞—Ü–∏–π. –ó–∞ –ø–µ—Ä–≤–æ–µ –ø–æ–ª—É–≥–æ–¥–∏–µ 2022 –≥–æ–¥—É –∑–∞–∫—Ä—ã–ª–∞—Å—å 71 –ø—Ä–æ—Ñ–∏–ª—å–Ω–∞—è –∫–æ–º–ø–∞–Ω–∏—è ‚Äî —ç—Ç–æ –º–∞–∫—Å–∏–º—É–º –∑–∞ —Ç—Ä–∏ –≥–æ–¥–∞. –í 2023 –≥–æ–¥—É –ø—Ä–µ–∫—Ä–∞—Ç–∏–ª–∏ —Ä–∞–±–æ—Ç—É 48 —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ (–∫–∞–∫ —Å —è–Ω–≤–∞—Ä—è –ø–æ –∏—é–ª—å 2025 –≥–æ–¥–∞), –≤ 2024 ‚Äî 62. –°–Ω–∏–∂–µ–Ω–∏–µ —á–∏—Å–ª–∞ –ª–∏–∫–≤–∏–¥–∞—Ü–∏–π –∞–≤—Ç–æ—Ä—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è —Å–≤—è–∑—ã–≤–∞—é—Ç —Å–æ —Å—Ç–∞–±–∏–ª–∏–∑–∞—Ü–∏–µ–π —Ä—ã–Ω–∫–∞, –∞ –ø–æ–≤—ã—à–µ–Ω–Ω—É—é –∞–∫—Ç–∏–≤–Ω–æ—Å—Ç—å 2022-2023 –≥–æ–¥–æ–≤ ‚Äî —Å –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏–µ–π –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤, –≥–æ—Å–ø–æ–¥–¥–µ—Ä–∂–∫–æ–π –æ—Ç—Ä–∞—Å–ª–∏ –∏ –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç—å—é —Ä–∞—Å—à–∏—Ä–∏—Ç—å –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç –ª–µ–∫–∞—Ä—Å—Ç–≤ –Ω–∞ —Ñ–æ–Ω–µ —Ä–∏—Å–∫–∞ —É—Ö–æ–¥–∞ –∑–∞—Ä—É–±–µ–∂–Ω–æ–π —Ñ–∞—Ä–º—ã. –°–µ–π—á–∞—Å –æ—Ç–∫—Ä—ã–≤–∞—Ç—å –Ω–æ–≤–æ–µ —Å—Ç–∞–Ω–æ–≤–∏—Ç—Å—è –≤—Å—ë –º–µ–Ω–µ–µ –∏–Ω—Ç–µ—Ä–µ—Å–Ω–æ, —Ç.–∫. –∫–ª—é—á–µ–≤—ã–µ –Ω–∏—à–∏ –Ω–∞ —Ä—ã–Ω–∫–µ —É–∂–µ –∑–∞–Ω—è—Ç—ã. –í –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–µ —Å—á–∏—Ç–∞—é—Ç, —á—Ç–æ —Å–Ω–∏–∂–µ–Ω–∏–µ —á–∏—Å–ª–∞ –∂–µ–ª–∞—é—â–∏—Ö –≤–ª–∏—Ç—å—Å—è –≤ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª—å –º–æ–∂–µ—Ç —Å–≤–∏–¥–µ—Ç–µ–ª—å—Å—Ç–≤–æ–≤–∞—Ç—å –æ –∑—Ä–µ–ª–æ—Å—Ç–∏ —Ä—ã–Ω–∫–∞. –ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ –µ—Å—Ç—å –≤–æ –≤—Å–µ—Ö —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã—Ö –æ–∫—Ä—É–≥–∞—Ö –†–æ—Å—Å–∏–∏, –∞ –ª–∏—Ü–µ–Ω–∑–∏—è –≤–µ–¥–æ–º—Å—Ç–≤–∞ –Ω–∞ —Ç–∞–∫—É—é –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç—å –∏–º–µ–µ—Ç—Å—è —É 535 –∫–æ–º–ø–∞–Ω–∏–π. –ü—Ä–∏—á—ë–º –∏—Ö —Å–æ–≤–æ–∫—É–ø–Ω–∞—è –≤—ã—Ä—É—á–∫–∞ –∑–∞ –ø–æ—Å–ª–µ–¥–Ω–∏–µ —Ç—Ä–∏ –≥–æ–¥–∞ —É–≤–µ—Ä–µ–Ω–Ω–æ —Ä–∞—Å—Ç–µ—Ç. –ï—Å–ª–∏ –≤ 2022 –≥–æ–¥—É –ø—Ä–æ—Ñ–∏–ª—å–Ω—ã–µ –∏–≥—Ä–æ–∫–∏ –∑–∞—Ä–∞–±–æ—Ç–∞–ª–∏ 647,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —Ç–æ –∫ 2024 –≥–æ–¥—É —ç—Ç–æ—Ç –ø–æ–∫–∞–∑–∞—Ç–µ–ª—å –≤—ã—Ä–æ—Å –Ω–∞ 20,9%, –¥–æ –ø–æ—á—Ç–∏ 821,9 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ö —Å–ª–æ–≤—É, –æ –∑–∞—Ä—É–±–µ–∂–Ω–æ–π —Ñ–∞—Ä–º–µ. –°–æ–±—ã—Ç–∏—è –ø–æ—Å–ª–µ–¥–Ω–∏—Ö –ª–µ—Ç –ø–æ—á—Ç–∏ –Ω–µ –ø–æ–≤–ª–∏—è–ª–∏ –Ω–∞ –ø—Ä–∏—Å—É—Ç—Å—Ç–≤–∏–µ –∫–æ–º–ø–∞–Ω–∏–π —Å –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã–º —É—á–∞—Å—Ç–∏–µ–º –≤ —Ä–æ—Å—Å–∏–π—Å–∫–æ–π —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏. –ï—Å–ª–∏ –Ω–∞ 1 –∏—é–ª—è 2022 –≥–æ–¥–∞ —Ç–∞–∫–æ–≤—ã—Ö –±—ã–ª–æ 58, —Ç–æ –∫ –∏—é–ª—é 2025 –≥–æ–¥–∞ –∏—Ö —Å—Ç–∞–ª–æ 59. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""There has been a notable decrease in the number of new pharmaceutical companies registering on Russia's market. From January to June 2025, only 47 new companies were registered, a decrease of 22.9% compared to the same period in 2024, which had registered 61 companies. The number of closures has also decreased, with only 48 companies closing in the first half of 2023 compared to 62 in 2024. The decrease is attributed to market stabilization and the expansion of product portfolios due to foreign companies' departure, as well as local production and government support. The decrease in new entrants is seen as a sign of market maturity.""
}"
2025-07-16T14:09:56+00:00,@bezrec,6314,https://t.me/bezrec/6314,"–°–æ–≤—Ñ–µ–¥ —Ä–∞–∑—Ä–µ—à–∏–ª –ø–æ–º–æ–≥–∞—Ç—å —Ä–µ–≥–∏–æ–Ω–∞–º —Å –æ—Ä—Ñ–∞–Ω–Ω–∏–∫–∞–º–∏. –°–µ–Ω–∞—Ç –æ–¥–æ–±—Ä–∏–ª –∑–∞–∫–æ–Ω –æ —Å–æ–∑–¥–∞–Ω–∏–∏ —Ä–µ–∑–µ—Ä–≤–Ω–æ–≥–æ –º–µ—Ö–∞–Ω–∏–∑–º–∞ –¥–ª—è –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å —Ä–µ–¥–∫–∏–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏ –≤ —Ä–µ–≥–∏–æ–Ω–∞—Ö. –ï—Å–ª–∏ —Å—É–±—ä–µ–∫—Ç –†–§ –¥–æ–∫–∞–∂–µ—Ç, —á—Ç–æ —É –Ω–µ–≥–æ –Ω–µ —Ö–≤–∞—Ç–∞–µ—Ç —Å—Ä–µ–¥—Å—Ç–≤ –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–ª—è ¬´—Ä–µ–¥–∫–∏—Ö¬ª –±–æ–ª—å–Ω—ã—Ö, —Ç–æ –µ–º—É –ø—Ä–µ–¥–æ—Å—Ç–∞–≤—è—Ç –º–µ–∂–±—é–¥–∂–µ—Ç–Ω—ã–µ —Ç—Ä–∞–Ω—Å—Ñ–µ—Ä—Ç—ã –∏–∑ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –±—é–¥–∂–µ—Ç–∞. –¢–∞–∫–∞—è ¬´–ø–æ–¥—Å—Ç—Ä–∞—Ö–æ–≤–∫–∞¬ª –Ω–∞—á–Ω–µ—Ç —Ä–∞–±–æ—Ç–∞—Ç—å —Å 2026 –≥–æ–¥–∞. –ù–∞–ø–æ–º–Ω–∏–º, –Ω–µ—Å–º–æ—Ç—Ä—è –Ω–∞ –≤–∞–∂–Ω–æ—Å—Ç—å –ø–æ–ø—Ä–∞–≤–æ–∫ –≤ –∑–∞–∫–æ–Ω ¬´–û–± –æ—Å–Ω–æ–≤–∞—Ö –æ—Ö—Ä–∞–Ω—ã –∑–¥–æ—Ä–æ–≤—å—è –≥—Ä–∞–∂–¥–∞–Ω –≤ –†–§¬ª, —ç–∫—Å–ø–µ—Ä—Ç—ã –ø—Ä–µ–¥—Ä–µ–∫–∞–ª–∏ –∏–º –Ω–µ–ø—Ä–æ—Å—Ç—É—é —Å—É–¥—å–±—É ‚Äî –≤ —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, —à–∫–≤–∞–ª –æ–±—Ä–∞—â–µ–Ω–∏–π –∑–∞ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã–º–∏ –¥–µ–Ω—å–≥–∞–º–∏ –∏–∑ —Ä–µ–≥–∏–æ–Ω–æ–≤. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –Ω–∞ —Å–µ–≥–æ–¥–Ω—è—à–Ω–µ–º –∑–∞—Å–µ–¥–∞–Ω–∏–∏ –°–æ–≤—Ñ–µ–¥ –æ–¥–æ–±—Ä–∏–ª –∑–∞–∫–æ–Ω –æ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏–∏ –ø–µ—Ä–µ—á–Ω—è —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤. –ü–æ–¥ –Ω–∏–º –±—É–¥—É—Ç –ø–æ–Ω–∏–º–∞—Ç—å —Å–æ–≤–æ–∫—É–ø–Ω–æ—Å—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –ø—Ä–∏–º–µ–Ω—è–µ–º—ã—Ö –¥–ª—è –∑–∞–∫—Ä—ã—Ç–∏–π –ø—Ä–∏–æ—Ä–∏—Ç–µ—Ç–Ω—ã—Ö –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç–µ–π –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è, –≤ —Ç–æ–º —á–∏—Å–ª–µ –≤ –ª–µ—á–µ–Ω–∏–∏ –ø—Ä–µ–æ–±–ª–∞–¥–∞—é—â–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –°—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –±—É–¥—É—Ç –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç—å –≤ –†–æ—Å—Å–∏–∏, –∞ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–æ —Å—Ç–∞–Ω–µ—Ç –∑–∞–∫—É–ø–∞—Ç—å –∏—Ö –Ω–∞–ø—Ä—è–º—É—é —É –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è. –£—Ç–≤–µ—Ä–∂–¥–∞—Ç—å –ø–µ—Ä–µ—á–µ–Ω—å –°–ó–õ–°, –∞ —Ç–∞–∫–∂–µ –ø–æ—Ä—è–¥–æ–∫ –∏ –∫—Ä–∏—Ç–µ—Ä–∏–∏ –µ–≥–æ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—è —Å–º–æ–∂–µ—Ç –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement, shortage"",
  ""impact"": ""high"",
  ""english"": ""The Federation Council approved assistance to regions with orphan diseases. The Senate approved a law on creating a reserve mechanism for providing medicines to patients with rare diseases in regions. If a Russian region can prove that it lacks funds for drugs for 'rare' patients, it will be provided with inter-budget transfers from the federal budget. This 'insurance policy' will start working in 2026. It is worth noting that despite the importance of amendments to the 'Healthcare Foundation Law', experts predicted difficulties for these changes - in particular, a flood of requests for federal funds from regions. Additionally, at today's Federation Council meeting, amendments were approved to create a list of strategically important medicines. This will include all drugs used for closing priority health care needs, including in the treatment of prevalent diseases. The list of strategically important medicines will be produced domestically and the government will directly purchase them from the manufacturer. The Federation Council can approve the list of SIZMs and the rules for its formation.""
}"
2025-07-16T12:03:15+00:00,@bezrec,6313,https://t.me/bezrec/6313,"Telegram VS ¬´–í–ö–æ–Ω—Ç–∞–∫—Ç–µ¬ª ‚Äî –∫—Ç–æ –º–∏–ª–µ–µ —Ñ–∞—Ä–º–µ. –ü–æ—Å–º–æ—Ç—Ä–µ–ª–∏ —Å–æ–≤–º–µ—Å—Ç–Ω–æ–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –∫–æ–º–º—É–Ω–∏–∫–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ –∞–≥–µ–Ω—Ç—Å—Ç–≤–∞ ¬´–ê–ø—Ä–µ–ª—å¬ª –∏ —Å–µ—Ä–≤–∏—Å–∞ –∞–Ω–∞–ª–∏—Ç–∏–∫–∏ LiveDune –æ —Ç–æ–º, –∫–∞–∫ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –∏—Å–ø–æ–ª—å–∑—É—é—Ç –¥–≤–µ —Å–∞–º—ã–µ –ø–æ–ø—É–ª—è—Ä–Ω—ã–µ –≤ –†–æ—Å—Å–∏–∏ –ø–ª–æ—â–∞–¥–∫–∏: –æ—Ç –æ—Ö–≤–∞—Ç–æ–≤ –∏ –≤–æ–≤–ª–µ—á–µ–Ω–Ω–æ—Å—Ç–∏ –¥–æ —Ü–∏—Ç–∏—Ä—É–µ–º–æ—Å—Ç–∏. –ê–≤—Ç–æ—Ä—ã —Ä–∞–±–æ—Ç—ã —Ä–∞—Å—Å–º–∞—Ç—Ä–∏–≤–∞–ª–∏ –ø–æ–∫–∞–∑–∞—Ç–µ–ª–∏ —Ç–∞–∫–∏—Ö –∫–æ–º–ø–∞–Ω–∏–π, –∫–∞–∫ ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª, ¬´–ë–∏–æ–∫–∞–¥¬ª, ¬´–ë–∏–æ–Ω–æ—Ä–∏–∫–∞¬ª, ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑¬ª, ¬´–≠–≤–∞–ª–∞—Ä¬ª, Solgar, ¬´–†-–§–∞—Ä–º¬ª, Solopharm, ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª, ¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º –ì—Ä—É–ø–ø¬ª, Servier, ¬´–ü–µ—Ç—Ä–æ–≤–∞–∫—Å¬ª, ¬´–ê–ª—å—Ñ–∞—Å–∏–≥–º–∞ –†—É—Å¬ª, ¬´–ú–µ–¥–∏—Å–æ—Ä–±¬ª, ¬´–í–µ—Ä—Ç–µ–∫—Å¬ª –∏ ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª. –ó–∞—á–µ–º —Ñ–∞—Ä–º–µ —Å–æ—Ü—Å–µ—Ç–∏? üîΩ –î–ª—è –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–æ–Ω–Ω–æ–π –ø—Ä–∏–≤–ª–µ–∫–∞—Ç–µ–ª—å–Ω–æ—Å—Ç–∏. –û—Å–æ–±–µ–Ω–Ω–æ –∞–∫—Ç—É–∞–ª—å–Ω–æ –¥–ª—è —Ç–µ—Ö, –∫—Ç–æ —É–∂–µ –≤—ã—à–µ–ª –Ω–∞ IPO (¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª –∏ ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª), –ª–∏–±–æ —Å–æ–±–∏—Ä–∞–µ—Ç—Å—è —ç—Ç–æ —Å–¥–µ–ª–∞—Ç—å (¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º –ì—Ä—É–ø–ø¬ª). ¬´–ê–ª—å—Ñ–∞—Å–∏–≥–º–∞ –†—É—Å¬ª —Ä–∞–∑–º–µ—â–∞–µ—Ç—Å—è –≤ —Å–æ—Ü—Å–µ—Ç—è—Ö –¥–ª—è —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—è –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω–æ–π –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–æ–Ω–Ω–æ–π –ø—Ä–∏–≤–ª–µ–∫–∞—Ç–µ–ª—å–Ω–æ—Å—Ç–∏. –î–ª—è —ç—Ç–∏—Ö —Ü–µ–ª–µ–π –∏—Å–ø–æ–ª—å–∑—É—é—Ç –≤ –æ—Å–Ω–æ–≤–Ω–æ–º Telegram, –∞ –¥–ª—è –æ—Ü–µ–Ω–∫–∏ –æ–ø–∏—Ä–∞—é—Ç—Å—è –Ω–∞ –∏–Ω–¥–µ–∫—Å —Ü–∏—Ç–∏—Ä—É–µ–º–æ—Å—Ç–∏ (–ò–¶) –∏ –æ—Ö–≤–∞—Ç—ã. üîΩ –î–ª—è —É–ø—Ä–∞–≤–ª–µ–Ω–∏—è —Ä–µ–ø—É—Ç–∞—Ü–∏–µ–π –∏ –∞–Ω—Ç–∏–∫—Ä–∏–∑–∏—Å–Ω—ã—Ö –∫–æ–º–º—É–Ω–∏–∫–∞—Ü–∏–π. –§–∞—Ä–º–∞ –∞–∫—Ç–∏–≤–Ω–æ –∏—Å–ø–æ–ª—å–∑—É–µ—Ç —Å–æ—Ü—Å–µ—Ç–∏ –¥–ª—è –æ–ø–µ—Ä–∞—Ç–∏–≤–Ω–æ–π –∫–æ–º–º—É–Ω–∏–∫–∞—Ü–∏–∏ —Å–æ —Å–≤–æ–µ–π –∞—É–¥–∏—Ç–æ—Ä–∏–µ–π –∏ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—è –æ–±—Ä–∞–∑–∞ –±—Ä–µ–Ω–¥–∞. –î–ª—è —ç—Ç–æ–π –∑–∞–¥–∞—á–∏ –∫–æ–º–ø–∞–Ω–∏–∏ –∏—Å–ø–æ–ª—å–∑—É—é—Ç —Å—Ä–∞–∑—É –¥–≤–µ —Å–æ—Ü—Å–µ—Ç–∏, –≤ –∫–æ—Ç–æ—Ä—ã–µ –∫—Ä–æ—Å—Å–ø–æ—Å—Ç—è—Ç –Ω–æ–≤–æ—Å—Ç–∏. üîΩ –î–ª—è –ø—Ä–∏–≤–ª–µ—á–µ–Ω–∏—è –∫–∞–¥—Ä–æ–≤. ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª, Solopharm, ¬´–†-–§–∞—Ä–º¬ª, ¬´–í–µ—Ä—Ç–µ–∫—Å¬ª —Ä–∞–∑–º–µ—â–∞—é—Ç –≤–∞–∫–∞–Ω—Å–∏–∏, —Ä–∞—Å—Å–∫–∞–∑—ã–≤–∞—é—Ç –ø—Ä–æ —É—Å–ª–æ–≤–∏—è —Ä–∞–±–æ—Ç—ã –∏ —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–æ —Å –≤—É–∑–∞–º–∏ –∏ —Å–æ–∑–¥–∞—é—Ç –æ–±—Ä–∞–∑ —Ö–æ—Ä–æ—à–µ–≥–æ —Ä–∞–±–æ—Ç–æ–¥–∞—Ç–µ–ª—è. –ü—Ä–∏–≤–ª–µ–∫–∞—Ç–µ–ª—å–Ω–æ—Å—Ç—å –±—Ä–µ–Ω–¥–∞ —Ä–∞–±–æ—Ç–æ–¥–∞—Ç–µ–ª—è –≤—Å–µ —Ñ–æ—Ä–º–∏—Ä—É—é—Ç —á–µ—Ä–µ–∑ ¬´–í–ö–æ–Ω—Ç–∞–∫—Ç–µ¬ª. üîΩ –î–ª—è –ø–æ—Å—Ç—Ä–æ–µ–Ω–∏—è –æ—Ç–Ω–æ—à–µ–Ω–∏–π —Å –≥–æ—Å—Å–µ–∫—Ç–æ—Ä–æ–º –∏ —Ä–µ–≥—É–ª—è—Ç–æ—Ä–∞–º–∏. –£—Å–ø–µ—à–Ω–µ–µ –≤—Å–µ–≥–æ –∑–¥–µ—Å—å —Å–ø—Ä–∞–≤–ª—è—é—Ç—Å—è ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª, ¬´–ê–ª—å—Ñ–∞—Å–∏–≥–º–∞ –†—É—Å¬ª, ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª, ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª, ¬´–†-–§–∞—Ä–º¬ª, ¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º –ì—Ä—É–ø–ø¬ª, ¬´–í–µ—Ä—Ç–µ–∫—Å¬ª. –û—Å–Ω–æ–≤–Ω–æ–π –∫–∞–Ω–∞–ª ‚Äî Telegram. üîΩ –î–ª—è –ø—Ä–æ–¥–≤–∏–∂–µ–Ω–∏—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–æ–∫. Solgar, ¬´–≠–≤–∞–ª–∞—Ä¬ª, Solopharm –∏ ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª –ø–æ–ª—å–∑—É—é—Ç—Å—è –≤ –æ—Å–Ω–æ–≤–Ω–æ–º ¬´–í–ö–æ–Ω—Ç–∞–∫—Ç–µ¬ª, –¥–µ–ª–∞—è –∞–∫—Ü–µ–Ω—Ç –Ω–∞ –æ—Ö–≤–∞—Ç –∏ —É–∑–Ω–∞–≤–∞–µ–º–æ—Å—Ç—å. –¢–∞–∫, ¬´–≠–≤–∞–ª–∞—Ä¬ª –≤ 2024 –≥–æ–¥—É –≤—ã–ø—É—Å–∫–∞–ª –Ω–∞ –ø–ª–∞—Ç—Ñ–æ—Ä–º–µ –≤ —Å—Ä–µ–¥–Ω–µ–º –ø–æ 48 –ø–æ—Å—Ç–æ–≤ –≤ –º–µ—Å—è—Ü, –∞ –æ–±—â–∏–π –æ—Ö–≤–∞—Ç —Å–æ—Å—Ç–∞–≤–∏–ª 53,8 –º–ª–Ω –ø—Ä–æ—Å–º–æ—Ç—Ä–æ–≤. –í ¬´–±–∏—Ç–≤–µ¬ª –¥–≤—É—Ö –ø–ª–∞—Ç—Ñ–æ—Ä–º –ø–æ–∫–∞ –ø–æ–±–µ–∂–¥–∞–µ—Ç ¬´–í–ö–æ–Ω—Ç–∞–∫—Ç–µ¬ª. –£ Telegram –≤ —Å—Ä–µ–¥–Ω–µ–º –≤ —á–µ—Ç—ã—Ä–µ —Ä–∞–∑–∞ –º–µ–Ω—å—à–µ –ø–æ–¥–ø–∏—Å—á–∏–∫–æ–≤ –∏ —Å—É—â–µ—Å—Ç–≤–µ–Ω–Ω–æ –º–µ–Ω—å—à–µ –æ—Ö–≤–∞—Ç –ø—Ä–∏ –±–æ–ª–µ–µ –≤—ã—Å–æ–∫–æ–π –≤–æ–≤–ª–µ—á–µ–Ω–Ω–æ—Å—Ç–∏. –ü—Ä–∏ —ç—Ç–æ–º –∞—É–¥–∏—Ç–æ—Ä–∏—è –≤ Telegram —á–∞—â–µ –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤—É–µ—Ç —Å –∫–æ–Ω—Ç–µ–Ω—Ç–æ–º –∏ –¥–µ–ª–∞–µ—Ç —ç—Ç–æ –±–æ–ª–µ–µ –æ—Å–æ–∑–Ω–∞–Ω–Ω–æ. –ö–∞–Ω–∞–ª –ª—É—á—à–µ —Ä–∞–±–æ—Ç–∞–µ—Ç –Ω–∞ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏–µ –ª–æ—è–ª—å–Ω–æ—Å—Ç–∏ –∏ —ç–∫—Å–ø–µ—Ä—Ç–Ω–æ—Å—Ç–∏, –∞ —Ç–∞–∫–∂–µ –¥–ª—è –ø–æ–¥–¥–µ—Ä–∂–∞–Ω–∏—è –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–æ–Ω–Ω–æ–π –ø—Ä–∏–≤–ª–µ–∫–∞—Ç–µ–ª—å–Ω–æ—Å—Ç–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-07-16T08:45:38+00:00,@bezrec,6312,https://t.me/bezrec/6312,"–§–ê–° —Å–Ω–∏–∑–∏–ª–∞ —Ü–µ–Ω—É –Ω–∞ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π —Ä–∏—Å–¥–∏–ø–ª–∞–º. –ü–µ—Ä–≤—ã–π —Ä–æ—Å—Å–∏–π—Å–∫–∏–π –¥–∂–µ–Ω–µ—Ä–∏–∫ –≠–≤—Ä–∏—Å–¥–∏ —Å—Ç–∞–ª –Ω–∞ 48% –¥–µ—à–µ–≤–ª–µ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞. –¶–µ–Ω–∞ –∑–∞ —É–ø–∞–∫–æ–≤–∫—É –ø–æ—Ä–æ—à–∫–∞ –¥–ª—è –ø—Ä–∏–≥–æ—Ç–æ–≤–ª–µ–Ω–∏—è —Ä–∞—Å—Ç–≤–æ—Ä–∞ –¥–ª—è –ø—Ä–∏–µ–º–∞ –≤–Ω—É—Ç—Ä—å –≤ –¥–æ–∑–∏—Ä–æ–≤–∫–µ 0.75 –º–≥/–º–ª –æ—Ç ¬´–ü—Ä–æ–º–æ–º–µ–¥–∞¬ª —Å–æ–≥–ª–∞—Å–æ–≤–∞–Ω–∞ –Ω–∞ —É—Ä–æ–≤–Ω–µ 311 887 —Ä—É–±–ª–µ–π, —Ç–∞–∫–∞—è –∂–µ —É–ø–∞–∫–æ–≤–∫–∞ —Ä–µ—Ñ–µ—Ä–µ–Ω—Ç–∞ —Å—Ç–æ–∏—Ç 605 605 —Ä—É–±–ª–µ–π. –ü—Ä–µ–ø–∞—Ä–∞—Ç –∑–∞–∫—É–ø–∞–µ—Ç—Å—è –∑–∞ —Å—á—ë—Ç –±—é–¥–∂–µ—Ç–∞ –∏ –¥–æ–ª–∂–µ–Ω –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª—è—Ç—å—Å—è –±–µ—Å–ø–ª–∞—Ç–Ω–æ –≤ –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è—Ö. –ü–æ –¥–∞–Ω–Ω—ã–º Headway Company, –∑–∞ 2024 –≥–æ–¥ –≥–æ—Å–∑–∞–∫–∞–∑—á–∏–∫–∏ –∑–∞–∫—É–ø–∏–ª–∏ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã–π –≠–≤—Ä–∏—Å–¥–∏ –±–æ–ª–µ–µ —á–µ–º –Ω–∞ 17,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ú–∏–Ω–∑–¥—Ä–∞–≤ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª –¥–∂–µ–Ω–µ—Ä–∏–∫ —Ä–∏—Å–¥–∏–ø–ª–∞–º–∞ –æ—Ç –∫–æ–º–ø–∞–Ω–∏–∏ –ü–µ—Ç—Ä–∞ –ë–µ–ª–æ–≥–æ –≤ –º–∞–µ —ç—Ç–æ–≥–æ –≥–æ–¥–∞. –ü–µ—Ä–≤–æ–π —Ä–µ–≥—É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏–µ –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç –ø–æ–ª—É—á–∏–ª–∞ –∏–Ω–¥–∏–π—Å–∫–∞—è Jodas Expoim. –ü—Ä–∞–≤–∞ –Ω–∞ –≠–≤—Ä–∏—Å–¥–∏ –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∞—Ç —à–≤–µ–π—Ü–∞—Ä—Å–∫–æ–π Roche, –ø–∞—Ç–µ–Ω—Ç –¥–µ–π—Å—Ç–≤—É–µ—Ç –¥–æ 2035 –≥–æ–¥–∞. –ó–∞ –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω—É—é –ª–∏—Ü–µ–Ω–∑–∏—é –Ω–∞ —Ä–∏—Å–¥–∏–ø–ª–∞–º —Å–µ–π—á–∞—Å –±–æ—Ä–µ—Ç—Å—è ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª. –í—Å–µ —Å—Ç–∞–¥–∏–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –†–∏—Å–¥–∏–ø–ª–∞–º–∞, –≤–∫–ª—é—á–∞—è —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏—é, –æ—Å—É—â–µ—Å—Ç–≤–ª—è—é—Ç—Å—è –Ω–∞ –ø–ª–æ—â–∞–¥–∫–µ –ê–û ¬´–ë–∏–æ—Ö–∏–º–∏–∫¬ª –≤ –°–∞—Ä–∞–Ω—Å–∫–µ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, reimbursement, pricing"",
  ""impact"": ""medium"",
  ""english"": ""The Russian generic version of Evrisdi (risdiplam) has been approved and is priced 48% lower than the original drug. The price for a vial of powder for intravenous infusion in 0.75 mg/ml dosage is set at 311,887 rubles by the budgetary organization 'Promomed', while the reference dosage costs 605,605 rubles. The Russian government has already purchased the original Evrisdi for over 17.7 billion rubles in 2024. The generic version of risdiplam was registered by the Russian Health Ministry in May this year, and it has been approved for use. The Indian company Jodas Expoim obtained the first approval for risdiplam in 2023. The rights to Evrisdi are held by the Swiss Roche, with a patent expiring in 2035. The production stages of the Russian risdiplam, including raw material, are carried out at the 'B"
2025-07-16T05:45:22+00:00,@bezrec,6311,https://t.me/bezrec/6311,"–í –ì–æ—Å–¥—É–º–µ –æ–±—Å—É–¥–∏–ª–∏, –∫–æ–≥–¥–∞ –ù–∞—Ü–∫–∞–ª–µ–Ω–¥–∞—Ä—å –¥–æ–∂–¥—ë—Ç—Å—è –≤–∞–∫—Ü–∏–Ω—ã –æ—Ç –º–µ–Ω–∏–Ω–≥–æ–∫–æ–∫–∫–∞. –í–∞–∫—Ü–∏–Ω–∞ –¥–ª—è –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –º–µ–Ω–∏–Ω–≥–æ–∫–æ–∫–∫–æ–≤–æ–π –∏–Ω—Ñ–µ–∫—Ü–∏–∏, —Å–æ–≥–ª–∞—Å–Ω–æ –¥–æ—Ä–æ–∂–Ω–æ–π –∫–∞—Ä—Ç–µ –ø–æ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ —Å—Ç—Ä–∞—Ç–µ–≥–∏–∏ –ø–æ –∏–º–º—É–Ω–æ–ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–µ –∏–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã—Ö –±–æ–ª–µ–∑–Ω–µ–π –¥–æ 2035 –≥–æ–¥–∞, –¥–æ–ª–∂–Ω–∞ –±—ã–ª–∞ –ø–æ—è–≤–∏—Ç—å—Å—è –≤ –ù–∞—Ü–∫–∞–ª–µ–Ω–¥–∞—Ä–µ –ø—Ä–∏–≤–∏–≤–æ–∫ –≤ 2025 –≥–æ–¥—É. –í–æ–ø—Ä–æ—Å –∞–∫—Ç—É–∞–ª—å–Ω—ã–π ‚Äî –ø–æ –¥–∞–Ω–Ω—ã–º –≥–ª–∞–≤–Ω–æ–≥–æ –≤–Ω–µ—à—Ç–∞—Ç–Ω–æ–≥–æ –∏–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–∏—Å—Ç–∞ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –í–ª–∞–¥–∏–º–∏—Ä–∞ –ß—É–ª–∞–Ω–æ–≤–∞, —Å –Ω–∞—á–∞–ª–∞ —ç—Ç–æ–≥–æ –≥–æ–¥–∞ –∑–∞–±–æ–ª–µ–≤–∞–µ–º–æ—Å—Ç—å –º–µ–Ω–∏–Ω–≥–∏—Ç–æ–º –≤ –†–æ—Å—Å–∏–∏ —É–¥–≤–æ–∏–ª–∞—Å—å –∏ —Å–æ—Å—Ç–∞–≤–∏–ª–∞ 1,2 —Ç—ã—Å. —Å–ª—É—á–∞–µ–≤. –ü—Ä–∏ —ç—Ç–æ–º –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ –≤–æ–∑—Ä–æ—Å–ª–∞ –¥–æ–ª—è —É–º–µ—Ä—à–∏—Ö —Å—Ä–µ–¥–∏ –≤–∑—Ä–æ—Å–ª—ã—Ö. –ú–µ–Ω–∏–Ω–≥–æ–∫–æ–∫–∫–æ–≤–∞—è –∏–Ω—Ñ–µ–∫—Ü–∏—è –≤—ã—à–µ –≤—Å–µ—Ö –ø–æ –ª–µ—Ç–∞–ª—å–Ω–æ—Å—Ç–∏ —Å—Ä–µ–¥–∏ –≤—Å–µ—Ö –≤–∞–∫—Ü–∏–Ω–æ—É–ø—Ä–∞–≤–ª—è–µ–º—ã—Ö –±–æ–ª–µ–∑–Ω–µ–π, ‚Äî –æ—Ç–º–µ—á–∞—é—Ç —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã. –í –ª–∏–¥–µ—Ä–∞—Ö –ø–æ –∑–∞–±–æ–ª–µ–≤–∞–µ–º–æ—Å—Ç–∏ ‚Äî –ú–æ—Å–∫–≤–∞, –Ω–∞ –µ—ë –¥–æ–ª—é –µ–∂–µ–≥–æ–¥–Ω–æ –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –±–æ–ª–µ–µ 50% –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö —Å–ª—É—á–∞–µ–≤ –∏–Ω—Ñ–µ–∫—Ü–∏–∏. –í —Å—Ç–æ–ª–∏—Ü–µ –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏—è –ø—Ä–æ—Ç–∏–≤ –º–µ–Ω–∏–Ω–≥–æ–∫–æ–∫–∫–æ–≤–æ–π –∏–Ω—Ñ–µ–∫—Ü–∏–∏ –≤–∫–ª—é—á–µ–Ω–∞ –≤ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã–π –∫–∞–ª–µ–Ω–¥–∞—Ä—å –∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç—Å—è –≤ —Å–ª—É—á–∞–µ –≤—Å–ø—ã—à–µ–∫. –ü–æ —Å–ª–æ–≤–∞–º –ß—É–ª–∞–Ω–æ–≤–∞, –º–µ–Ω–∏–Ω–≥–æ–∫–æ–∫–∫–æ–≤–∞—è –∏–Ω—Ñ–µ–∫—Ü–∏—è –ø–µ—Ä–µ—Å—Ç–∞–ª–∞ –±—ã—Ç—å –¥–µ—Ç—Å–∫–æ–π –ø—Ä–æ–±–ª–µ–º–æ–π. –¢–µ–ø–µ—Ä—å –∑–∞–±–æ–ª–µ–≤–∞–µ–º–æ—Å—Ç—å —Ä–∞—Å—Ç—ë—Ç –≤ –ø–µ—Ä–≤—É—é –æ—á–µ—Ä–µ–¥—å –∑–∞ —Å—á—ë—Ç —Ç—Ä—É–¥–æ–≤—ã—Ö –º–∏–≥—Ä–∞–Ω—Ç–æ–≤. –í —ç—Ç–æ–π —Å–≤—è–∑–∏ —ç–∫—Å–ø–µ—Ä—Ç –ø—Ä–µ–¥–ª–æ–∂–∏–ª –≤–æ–∑–ª–æ–∂–∏—Ç—å –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç—å –∑–∞ –∏—Ö –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏—é –Ω–∞ —Ä–∞–±–æ—Ç–æ–¥–∞—Ç–µ–ª–µ–π, –∞ ¬´–∞–±—Å–æ–ª—é—Ç–Ω—ã–º –ø—Ä–∏–æ—Ä–∏—Ç–µ—Ç–æ–º¬ª –Ω–∞–∑–≤–∞–ª –≤–∫–ª—é—á–µ–Ω–∏–µ –≤ –ù–ö–ü–ü –¥–µ—Ç–µ–π, –ø–æ–¥—Ä–æ—Å—Ç–∫–æ–≤ –∏ —Å–æ–ª–¥–∞—Ç-—Å—Ä–æ—á–Ω–∏–∫–æ–≤. –ü–æ–∑–∞–±–æ—Ç–∏—Ç—å—Å—è –æ–± –æ—Å—Ç–∞–ª—å–Ω—ã—Ö –≤–∑—Ä–æ—Å–ª—ã—Ö –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è —Ä–µ–≥–∏–æ–Ω–∞–º –∑–∞ —Å—á—ë—Ç —Ä–∞—Å—à–∏—Ä–µ–Ω–∏—è –∫–∞–ª–µ–Ω–¥–∞—Ä—è –ø—Ä–∏–≤–∏–≤–æ–∫ –ø–æ —ç–ø–∏–¥–ø–æ–∫–∞–∑–∞–Ω–∏—è–º. –ú–µ–∂–¥—É —Ç–µ–º, –∑–∞–º–º–∏–Ω–∏—Å—Ç—Ä–∞ –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏ –∏ —Ç–æ—Ä–≥–æ–≤–ª–∏ –ï–∫–∞—Ç–µ—Ä–∏–Ω–∞ –ü—Ä–∏–µ–∑–∂–µ–≤–∞ —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∞, —á—Ç–æ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –≥–æ—Ç–æ–≤—ã –≤—ã–ø—É—Å—Ç–∏—Ç—å —Å–≤–æ–∏ –≤–∞–∫—Ü–∏–Ω—ã –≤ —Å—Ç–∞–¥–∏–∏ –ì–õ–§ –≤ 2026 –≥–æ–¥—É, –∞ –ø–æ –ø–æ–ª–Ω–æ–º—É —Ü–∏–∫–ª—É ‚Äî –≤ 2027 –≥–æ–¥—É. –¢—Ä–∏ –∫–ª—é—á–µ–≤—ã—Ö —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–∞: ¬´–ù–∞–Ω–æ–ª–µ–∫¬ª, ¬´–ü–µ—Ç—Ä–æ–≤–∞–∫—Å¬ª –∏ –§–ì–£–ü –°–ü–±–ù–ò–ò–í–° –§–ú–ë–ê –†–æ—Å—Å–∏–∏. –í –ú–∏–Ω–∑–¥—Ä–∞–≤–µ —Å–æ–æ–±—â–∏–ª–∏, —á—Ç–æ ¬´–≥–æ—Ç–æ–≤—ã –æ–ø–µ—Ä–∞—Ç–∏–≤–Ω–æ –≤–Ω–æ—Å–∏—Ç—å –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ —Å—É—â–µ—Å—Ç–≤—É—é—â–µ–µ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–æ —Å –¥–æ–ø–æ–ª–Ω–µ–Ω–∏–µ–º –ù–∞—Ü–∫–∞–ª–µ–Ω–¥–∞—Ä—è¬ª, –∫–æ–≥–¥–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –≤–∞–∫—Ü–∏–Ω –≤ –†–æ—Å—Å–∏–∏ –±—É–¥–µ—Ç –∑–∞–ø—É—â–µ–Ω–æ –ø–æ –ø–æ–ª–Ω–æ–º—É —Ü–∏–∫–ª—É. –ü–æ –¥–∞–Ω–Ω—ã–º –≤–µ–¥–æ–º—Å—Ç–≤–∞, –æ–±—â–∞—è –≥–æ–¥–æ–≤–∞—è –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç—å –≤ –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏ –æ—Ç —Å—Ö–µ–º—ã –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏–∏ ‚Äî –ª–∏–±–æ 2,2 –º–ª–Ω –¥–æ–∑, –ª–∏–±–æ 2,8 –º–ª–Ω –¥–æ–∑. –ì–æ—Å—É–¥–∞—Ä—Å—Ç–≤—É —ç—Ç–æ –±—É–¥–µ—Ç —Å—Ç–æ–∏—Ç—å –æ—Ç 5,5 –º–ª—Ä–¥ –¥–æ 7,3 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""epidemic, vaccine"",
  ""impact"": ""high"",
  ""english"": ""The State Duma discussed when the meningococcal vaccine will be included in the national calendar. The vaccination against meningococcal disease, according to the roadmap for implementing an immunoprophylaxis strategy for infectious diseases by 2035, was supposed to be included in the national calendar of vaccinations in 2025. The issue is relevant ‚Äî according to data from the main deputy infectious disease specialist of the Ministry of Health, Vladimir Chulakov, the incidence of meningitis in Russia doubled this year and reached 1,2 thousand cases. The share of deaths among adults has also increased. Meningococcal disease is the most lethal among all vaccine-preventable diseases, specialists note. The capital accounts for more than 50% of registered cases of the disease annually. In Moscow, vaccination against meningococcal disease is included in the regional calendar and administered during outbreaks. According to Chulakov, meningococcal disease is no longer a childhood problem. The incidence is now increasing due to migrant workers. The expert proposed that employers"
2025-07-15T15:29:58+00:00,@bezrec,6310,https://t.me/bezrec/6310,"–§–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å ""–í–µ—Ä—Ç–µ–∫—Å"" –Ω–∞—á–∞–ª –ø–æ—Å—Ç–∞–≤–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –∫–æ—Å–º–µ—Ç–∏–∫–∏ –≤ –õ–∞–æ—Å. –ü–µ—Ç–µ—Ä–±—É—Ä–≥—Å–∫–∞—è —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∞—è –∫–æ–º–ø–∞–Ω–∏—è ""—Ä–∞–∑–±–ª–æ–∫–∏—Ä–æ–≤–∞–ª–∞"" –ê–∑–∏–∞—Ç—Å–∫–æ-–¢–∏—Ö–æ–æ–∫–µ–∞–Ω—Å–∫–æ–µ —ç–∫—Å–ø–æ—Ä—Ç–Ω–æ–µ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏–µ –∏ –æ—Ç–≥—Ä—É–∑–∏–ª–∞ —Ç–µ—Å—Ç–æ–≤—É—é –ø–∞—Ä—Ç–∏—é –∏–∑ 1 500 —É–ø–∞–∫–æ–≤–æ–∫ –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –≤ –õ–∞–æ—Å. –î–æ —Å–∏—Ö –ø–æ—Ä –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å —Ä–∞–±–æ—Ç–∞–ª –ø—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–µ–Ω–Ω–æ –Ω–∞ —Ä—ã–Ω–∫–∞—Ö –†–æ—Å—Å–∏–∏ –∏ —Å—Ç—Ä–∞–Ω –°–ù–ì. –í –ø–µ—Ä–≤—É—é –ø–∞—Ä—Ç–∏—é –≤–æ—à–ª–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, –≤ —Ç–æ–º —á–∏—Å–ª–µ –¥–ª—è –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –≤ –¥–µ—Ä–º–∞—Ç–æ–ª–æ–≥–∏–∏, –∞ —Ç–∞–∫–∂–µ –ø—Ä–æ–¥—É–∫—Ç—ã –∫–æ—Å–º–µ—Ç–∏—á–µ—Å–∫–∏—Ö –±—Ä–µ–Ω–¥–æ–≤ –∏–∑ –ø–æ—Ä—Ç—Ñ–µ–ª—è ""–í–µ—Ä—Ç–µ–∫—Å"" –¥–ª—è —É—Ö–æ–¥–∞ –∑–∞ –∫–æ–∂–µ–π, –≤–æ–ª–æ—Å–∞–º–∏ –∏ —Ç–æ–Ω—É—Å–∞ –Ω–æ–≥. –ü–æ –¥–æ–≥–æ–≤–æ—Ä—ë–Ω–Ω–æ—Å—Ç–∏ —Å –∏–º–ø–æ—Ä—Ç—ë—Ä–æ–º, —Ç–æ–≤–∞—Ä—ã –æ—Ç–ø—Ä–∞–≤–∏–ª–∏—Å—å –≤ –õ–∞–æ—Å —Å —Ä–æ—Å—Å–∏–π—Å–∫–∏–º–∏ —ç—Ç–∏–∫–µ—Ç–∫–∞–º–∏ –¥–ª—è –¥–∞–ª—å–Ω–µ–π—à–µ–≥–æ –Ω–∞–Ω–µ—Å–µ–Ω–∏—è –Ω–∞ –Ω–∏—Ö –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –¥–ª—è –º–µ—Å—Ç–Ω—ã—Ö –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª–µ–π. –ü–∞—Ä—Ç–∏—é —Ä–µ–∞–ª–∏–∑—É—é—Ç —á–µ—Ä–µ–∑ –∞–ø—Ç–µ–∫–∏, –∏ –ø–æ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º –ø—Ä–æ–¥–∞–∂ –±—É–¥–µ—Ç –ø—Ä–∏–Ω—è—Ç–æ —Ä–µ—à–µ–Ω–∏–µ –æ –¥–∞–ª—å–Ω–µ–π—à–µ–º —Ä–∞–∑–≤–∏—Ç–∏–∏ —ç–∫—Å–ø–æ—Ä—Ç–Ω—ã—Ö –æ—Ç–Ω–æ—à–µ–Ω–∏–π ""–í–µ—Ä—Ç–µ–∫—Å"" —Å –õ–∞–æ—Å–æ–º. –ù–∞–ø–æ–º–Ω–∏–º, —á—Ç–æ –∫–æ—Å–º–µ—Ç–∏—á–µ—Å–∫–∏–π –ø–æ—Ä—Ç—Ñ–µ–ª—å –∫–æ–º–ø–∞–Ω–∏–∏ –≤–∫–ª—é—á–∞–µ—Ç –±—Ä–µ–Ω–¥—ã Alerana, Asepta, Le Santi, ""–õ–∞-–ö—Ä–∏"" –∏ –¥—Ä—É–≥–∏–µ. ‚Ñ¢Ô∏è –¶–µ–Ω–∞ –∫—Ä–∞—Å–æ—Ç—ã","{""skip"": true}"
2025-07-15T13:29:58+00:00,@bezrec,6309,https://t.me/bezrec/6309,"–û–º—Å–∫–æ–µ –£–§–ê–° –Ω–µ –æ—Ü–µ–Ω–∏–ª–æ —Ä–µ–∫–ª–∞–º—É —Å—Ä–µ–¥—Å—Ç–≤–∞ –¥–ª—è –ø–æ—Ç–µ–Ω—Ü–∏–∏. –ú–µ—Å—Ç–Ω—ã–π –ø—Ä–µ–¥–ø—Ä–∏–Ω–∏–º–∞—Ç–µ–ª—å —Ä–∞–∑–º–µ—Å—Ç–∏–ª –≤ –≥–∞–∑–µ—Ç–µ ¬´–ó–¥–æ—Ä–æ–≤—å–µ –Ω–∞ –ø–µ–Ω—Å–∏–∏¬ª —Å–ª–µ–¥—É—é—â–∏–π —Ç–µ–∫—Å—Ç: 9 –ú–∞—è ‚Äî –ø—Ä–∞–∑–¥–Ω–∏–∫ –≤–µ–ª–∏–∫–∏–π! –ù–∏–∫—Ç–æ –Ω–µ –∑–∞–±—ã—Ç, –Ω–∏—á—Ç–æ –Ω–µ –∑–∞–±—ã—Ç–æ! –ü–æ–¥–∞—Ä–æ–∫ –∂–µ–ª–µ–∑–Ω—ã–π –º–æ–ª–æ—Ç, —Å–∏–ª–∞ –º–æ–ª–æ—Ç–∞, —Ç–≤–µ—Ä–¥–æ—Å—Ç—å —Å—Ç–∞–ª–∏ 50 –º–ª –∫–∞–∂–¥–æ–º—É –º—É–∂—á–∏–Ω–µ, –ø—Ä–∏—à–µ–¥—à–µ–º—É –Ω–∞ –≤—ã—Å—Ç–∞–≤–∫—É, –ø–æ–¥–∞—Ä–æ–∫ ‚Äî –Ω–∞—Ç—É—Ä–∞–ª—å–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è –æ—Ç–ª–∏—á–Ω–æ–π –ø–æ—Ç–µ–Ω—Ü–∏–∏ ¬´–ñ–µ–ª–µ–∑–Ω—ã–π –º–æ–ª–æ—Ç¬ª. –ë—É–¥—å –ø–æ–±–µ–¥–∏—Ç–µ–ª–µ–º –≤—Å–µ–≥–¥–∞ –∏ –≤–µ–∑–¥–µ! –ù–∞, –º—è–≥–∫–æ –≥–æ–≤–æ—Ä—è, –Ω–µ—É–¥–∞—á–Ω—É—é —Ä–µ–∫–ª–∞–º—É, –¥–∞ –µ—â—ë –∏ —Å –∏–∑–æ–±—Ä–∞–∂–µ–Ω–∏–µ–º –≥–µ–æ—Ä–≥–∏–µ–≤—Å–∫–æ–π –ª–µ–Ω—Ç—ã, –≤ –£–ø—Ä–∞–≤–ª–µ–Ω–∏–µ –§–ê–° –ø–æ –û–º—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –ø–æ–∂–∞–ª–æ–≤–∞–ª—Å—è –≤–æ–∑–º—É—â–µ–Ω–Ω—ã–π —á–∏—Ç–∞—Ç–µ–ª—å. –ê–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å—â–∏–∫–∏ –ø—É–±–ª–∏–∫–∞—Ü–∏—é —Ç–æ–∂–µ –Ω–µ –æ—Ü–µ–Ω–∏–ª–∏ –∏ –≤–æ–∑–±—É–¥–∏–ª–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ –±–∏–∑–Ω–µ—Å–º–µ–Ω–∞. –¢–∞–∫–∞—è —Ä–µ–∫–ª–∞–º–∞ –Ω–µ–¥–æ–ø—É—Å—Ç–∏–º–∞ –∫ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–∏—é, –ø–æ—Å–∫–æ–ª—å–∫—É –æ–Ω–∞ —Å–æ–¥–µ—Ä–∂–∏—Ç –Ω–µ–ø—Ä–∏—Å—Ç–æ–π–Ω–æ–µ –∏ –æ—Å–∫–æ—Ä–±–∏—Ç–µ–ª—å–Ω–æ–µ —Å—Ä–∞–≤–Ω–µ–Ω–∏–µ –∏ –≤—ã—Ä–∞–∂–µ–Ω–∏–µ, –º–æ–∂–µ—Ç –æ—Å–∫–æ—Ä–±–∏—Ç—å —á–µ—Å—Ç—å –∏ –¥–æ—Å—Ç–æ–∏–Ω—Å—Ç–≤–æ –≥—Ä–∞–∂–¥–∞–Ω, –≤ —Ç–æ–º —á–∏—Å–ª–µ –≤–µ—Ç–µ—Ä–∞–Ω–æ–≤ –í–µ–ª–∏–∫–æ–π –û—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–π –≤–æ–π–Ω—ã, –∏—Ö —Ä–æ–¥—Å—Ç–≤–µ–Ω–Ω–∏–∫–æ–≤, ‚Äî —Å–æ–æ–±—â–∏–ª —Ä–µ–≥—É–ª—è—Ç–æ—Ä. –í–ø—Ä–æ—á–µ–º, –Ω–µ—É–¥–∞—á–Ω–∞—è —Ä–µ–∫–ª–∞–º–∞ ‚Äî —ç—Ç–æ –µ—â—ë –Ω–µ —Å–∞–º–æ–µ —Å—Ç—Ä–∞—à–Ω–æ–µ. –í —Ç–∞–∫–æ–≥–æ —Ä–æ–¥–∞ –≥–∞–∑–µ—Ç–∞—Ö –∑–∞—á–∞—Å—Ç—É—é –ø—Ä–æ–¥–≤–∏–≥–∞—é—Ç —Å–æ–º–Ω–∏—Ç–µ–ª—å–Ω—ã–µ —Å—Ä–µ–¥—Å—Ç–≤–∞. –í –ª—É—á—à–µ–º —Å–ª—É—á–∞–µ –±–µ—Å–ø–æ–ª–µ–∑–Ω—ã–µ, –∞ —Ç–æ –∏ –≤—Ä–µ–¥–Ω—ã–µ. –í —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ —Å—Ä–µ–¥—Å—Ç–≤ –¥–ª—è –º—É–∂—Å–∫–æ–≥–æ –∑–¥–æ—Ä–æ–≤—å—è –≥—Ä–µ—à–∞—Ç –¥–æ–±–∞–≤–ª–µ–Ω–∏–µ–º –≤ —Å–≤–æ–∏ ¬´–±–µ–∑–æ–±–∏–¥–Ω—ã–µ¬ª –ø—Ä–æ–¥—É–∫—Ç—ã —Å–∏–ª–¥–µ–Ω–∞—Ñ–∏–ª–∞ –≤ –ª–æ—à–∞–¥–∏–Ω—ã—Ö –¥–æ–∑–∞—Ö. –¢–∞–∫ —á—Ç–æ ¬´–Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ—Å—Ç—å¬ª –ñ–µ–ª–µ–∑–Ω–æ–≥–æ –º–æ–ª–æ—Ç–∞ —Ç–æ–∂–µ —Å—Ç–æ–∏–ª–æ –±—ã –ø—Ä–æ–≤–µ—Ä–∏—Ç—å. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""clinical_trial, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""The local regulator Omsk FAS did not evaluate the advertisement for a product to enhance male potency. A local entrepreneur published in the newspaper 'Health Pension' the following text: 'On May 9 ‚Äî a great day! No one is forgotten, nothing is forgotten! A gift of the iron mallet, strength of the mallet, hardness of steel ‚Äî 50ml to each man who comes to the exhibition. Gift ‚Äî natural product for excellent potency 'Iron Mallet'. It's a matter of course that the not very successful advertisement, and with an image of the Georgievsky ribbon, appealed to a dissatisfied reader. Antimonopolyists also did not evaluate the publication and initiated an investigation against the businessman. Such advertising is unacceptable to spread, as it contains inappropriate and insulting comparison and expression that can insult the honor and dignity of citizens, including veterans of the Great Patriotic War, their relatives ‚Äî the regulator said. Not very successful advertising is not the worst thing. Such publications often promote dubious products. In the best case, they"
2025-07-15T10:59:58+00:00,@bezrec,6308,https://t.me/bezrec/6308,"¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º –ì—Ä—É–ø–ø¬ª –≤–∑—è–ª–∞—Å—å –∑–∞ –≥–∏–Ω–µ–∫–æ–ª–æ–≥–∏—é. –í –∫–æ–º–ø–∞–Ω–∏–∏ –†—É—Å—Ç–µ–º–∞ –ú—É—Ä–∞—Ç–æ–≤–∞ –Ω–∞–º —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏, —á—Ç–æ –∑–∞—Ö–æ–¥—è—Ç –≤ –Ω–æ–≤—É—é –¥–ª—è —Å–µ–±—è –Ω–∏—à—É –∂–µ–Ω—Å–∫–æ–≥–æ –∑–¥–æ—Ä–æ–≤—å—è. –î–æ –∫–æ–Ω—Ü–∞ 2030 –≥–æ–¥–∞ –≥—Ä—É–ø–ø–∞ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç —Ä–µ–∞–ª–∏–∑–æ–≤–∞—Ç—å –≥–∏–Ω–µ–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ —Å—É–º–º—É –±–æ–ª–µ–µ 18 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ù–∞—á–∞–ª–æ –ø–æ–ª–æ–∂–µ–Ω–æ ‚Äî –ø–µ—Ä–≤—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç —Å–µ—Ä–∏–∏ –¥–ª—è –ª–µ—á–µ–Ω–∏—è —ç–Ω–¥–æ–º–µ—Ç—Ä–∏–æ–∑–∞ —É–∂–µ –¥–æ—Å—Ç—É–ø–µ–Ω –≤ –∞–ø—Ç–µ–∫–∞—Ö. –í –ø–µ—Ä–≤—É—é –Ω–µ–¥–µ–ª—é –ø–æ—Å–ª–µ –≤—ã—Ö–æ–¥–∞ –Ω–∞ —Ä—ã–Ω–æ–∫ –¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–∞–º –æ—Ç–≥—Ä—É–∂–µ–Ω–æ –±–æ–ª–µ–µ 30 —Ç—ã—Å. —É–ø–∞–∫–æ–≤–æ–∫. –ï—â–µ —á–µ—Ç—ã—Ä–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –Ω–∞—Ö–æ–¥—è—Ç—Å—è –Ω–∞ –∑–∞–≤–µ—Ä—à–∞—é—â–µ–º —ç—Ç–∞–ø–µ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –∏–ª–∏ —É–∂–µ –ø–æ–ª—É—á–∏–ª–∏ –†–£. –í –ø–ª–∞–Ω–∞—Ö –Ω–∞ 2026 –≥–æ–¥ ‚Äî –≤—ã–≤–æ–¥ –µ—â—ë –¥–≤—É—Ö –Ω–æ–≤—ã—Ö –ø–æ–∑–∏—Ü–∏–π –∏ –¥–∞–ª—å–Ω–µ–π—à–µ–µ —Ä–∞–∑–≤–∏—Ç–∏–µ –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç–∞ –¥–ª—è —Ä–∞–∑–Ω—ã—Ö –≤–æ–∑—Ä–∞—Å—Ç–æ–≤ ‚Äî –æ—Ç –ø–æ–¥—Ä–æ—Å—Ç–∫–æ–≤–æ–≥–æ –¥–æ –º–µ–Ω–æ–ø–∞—É–∑—ã. –ö–ª—é—á–µ–≤—ã–º–∏ –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è–º–∏ —É—Å–ø–µ—Ö–∞ —Å—Ç–∞–Ω—É—Ç –Ω–µ —Å—Ç–æ–ª—å–∫–æ —Ñ–∏–Ω–∞–Ω—Å–æ–≤—ã–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã, —Å–∫–æ–ª—å–∫–æ –∑–∞–≤–æ–µ–≤–∞–Ω–∏–µ –¥–æ–≤–µ—Ä–∏—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ —Å–æ–æ–±—â–µ—Å—Ç–≤–∞ –∏ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –∂–µ–Ω—â–∏–Ω, ‚Äî –ø–∏—à–µ—Ç –ø—Ä–µ—Å—Å-—Å–ª—É–∂–±–∞. –î–æ–≤–µ—Ä–∏–µ ‚Äî —ç—Ç–æ —Ö–æ—Ä–æ—à–æ –∏ –≤–∞–∂–Ω–æ, –Ω–æ —Ñ–∏–Ω–∞–Ω—Å–æ–≤—ã–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –ø–æ–¥–ø—Ä–∞–≤–∏—Ç—å –Ω–µ –ø–æ–º–µ—à–∞–µ—Ç. –ü–æ –¥–∞–Ω–Ω—ã–º Rusprofile, 2024 –≥–æ–¥ ¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º –ì—Ä—É–ø–ø¬ª –∑–∞–∫–æ–Ω—á–∏–ª–∞ –Ω–µ —Å–ª–∏—à–∫–æ–º —É—Å–ø–µ—à–Ω–æ: –≤—ã—Ä—É—á–∫–∞ —É–ø–∞–ª–∞ –Ω–∞ 14%, –¥–æ 38 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, –∞ –ø—Ä–∏–±—ã–ª—å —Ä—É—Ö–Ω—É–ª–∞ —Å—Ä–∞–∑—É –Ω–∞ 185%, –¥–æ -3,1 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ï—Å–ª–∏ —Ä–∞—Å—Å–º–∞—Ç—Ä–∏–≤–∞—Ç—å –∫–æ–Ω—Å–æ–ª–∏–¥–∏—Ä–æ–≤–∞–Ω–Ω—É—é –æ—Ç—á—ë—Ç–Ω–æ—Å—Ç—å –ø–æ –ú–°–§–û, –∞ –Ω–µ –æ—Ç—á–µ—Ç–Ω–æ—Å—Ç—å –†–°–ë–£, —Ç–æ ¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º –ì—Ä—É–ø–ø¬ª —Ç—Ä–∏ –∫–≤–∞—Ä—Ç–∞–ª–∞ –ø–æ–¥—Ä—è–¥ —Å–º–æ–≥–ª–∞ –æ–±–µ—Å–ø–µ—á–∏—Ç—å —Ä–æ—Å—Ç —á–∏—Å—Ç–æ–π –ø—Ä–∏–±—ã–ª–∏, –∫–æ–º–ø–µ–Ω—Å–∏—Ä–æ–≤–∞–≤ —É–±—ã—Ç–∫–∏ –ø–µ—Ä–≤–æ–≥–æ –∫–≤–∞—Ä—Ç–∞–ª–∞ 2024 –≥–æ–¥–∞. –≠—Ç–æ –ø—Ä–∏–≤–µ–ª–æ –∫ —á–∏—Å—Ç–æ–º—É —É–±—ã—Ç–∫—É –ø–æ –∏—Ç–æ–≥–∞–º 2024 –≥–æ–¥–∞ –≤ —Ä–∞–∑–º–µ—Ä–µ 0,280 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —á—Ç–æ —Å–≤—è–∑–∞–Ω–æ –≥–ª–∞–≤–Ω—ã–º –æ–±—Ä–∞–∑–æ–º —Å —É–≤–µ–ª–∏—á–µ–Ω–∏–µ–º —Ñ–∏–Ω–∞–Ω—Å–æ–≤—ã—Ö —Ä–∞—Å—Ö–æ–¥–æ–≤ –≤—Å–ª–µ–¥—Å—Ç–≤–∏–µ –ø–æ–≤—ã—à–µ–Ω–∏—è –∫–ª—é—á–µ–≤–æ–π —Å—Ç–∞–≤–∫–∏ –¶–ë –†–§, - –ø—Ä–æ–∫–æ–º–º–µ–Ω—Ç–∏—Ä–æ–≤–∞–ª –ø–æ–ª–æ–∂–µ–Ω–∏–µ –¥–µ–ª –•–∞—Ñ–∏–∑ –ì–∞—Ñ—É—Ä–æ–≤, —Ñ–∏–Ω–∞–Ω—Å–æ–≤—ã–π –¥–∏—Ä–µ–∫—Ç–æ—Ä ¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º –ì—Ä—É–ø–ø¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The company Binnofarm Group has entered the women's health niche with a gynecological drug series. By the end of 2030, the group plans to launch more than 18 billion rubles worth of gynecological drugs. One of the products for endometriosis treatment is already available in pharmacies. After its release, more than 30 thousand units were dispatched to distributors within the first week. Four other products are in the final registration stage or have already received approval. The company plans to launch two more new products by 2026 and further develop the assortment for various age groups, from teenagers to menopause. The success indicators will be not only financial results but also the trust of the medical community and Russian women. The company's performance in 2024 was not very good, with revenue falling by 14% to 38 billion rubles and a profit plummeting by 185%, to -3.1 billion rubles. The company's financial performance in the"
2025-07-15T09:01:34+00:00,@bezrec,6305,https://t.me/bezrec/6305,"–†—ã–Ω–æ–∫ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ ‚Äî –Ω–∞–≥–ª—è–¥–Ω—ã–π –ø—Ä–∏–º–µ—Ä –∑–∞–º–µ—â–µ–Ω–∏—è –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –ª–æ–∫–∞–ª—å–Ω—ã–º–∏ –∞–Ω–∞–ª–æ–≥–∞–º–∏. Headway company –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∞ —Å—Ä–∞–≤–Ω–∏—Ç–µ–ª—å–Ω—ã–π –∞–Ω–∞–ª–∏–∑ –∑–∞–∫—É–ø–æ–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –æ—Ç –æ–∂–∏—Ä–µ–Ω–∏—è –ø–æ –¥–∞–Ω–Ω—ã–º –ø–µ—Ä–≤–æ–≥–æ –ø–æ–ª—É–≥–æ–¥–∏—è 2024 –∏ 2025 –≥–æ–¥–æ–≤. –° 1 —è–Ω–≤–∞—Ä—è 2025 –≥–æ–¥–∞ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥ –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω–æ –≤–∫–ª—é—á—ë–Ω –≤ –æ–±–Ω–æ–≤–ª—ë–Ω–Ω—ã–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –∏ –ê—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ —ç–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–æ–≤ –†–§ –∫–∞–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç –ø–µ—Ä–≤–æ–≥–æ –≤—ã–±–æ—Ä–∞ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –æ–∂–∏—Ä–µ–Ω–∏—è —É –≤–∑—Ä–æ—Å–ª—ã—Ö. –¢–∏—Ä–∑–µ–ø–∞—Ç–∏–¥ –ø–æ–∫–∞ –Ω–µ—Ç, –Ω–æ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –¥–∂–µ–Ω–µ—Ä–∏–∫–∏ (–¢–∏—Ä–∑–µ—Ç—Ç–∞ –æ—Ç ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª –∏ –°–µ–¥–∂–∞—Ä–æ –æ—Ç ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º–∞¬ª —É–∂–µ –Ω–∞—á–∞–ª–∏ –ø–æ—è–≤–ª—è—Ç—å—Å—è –≤ —Ç–µ–Ω–¥–µ—Ä–Ω—ã—Ö –∑–∞–∫—É–ø–∫–∞—Ö –≤ 2025 –≥–æ–¥—É. –°—Ä–µ–¥–Ω—è—è —Å—Ç–æ–∏–º–æ—Å—Ç—å —É–ø–∞–∫–æ–≤–∫–∏ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ –∫–æ–ª–µ–±–ª–µ—Ç—Å—è –æ—Ç 4,8 —Ç—ã—Å. —Ä—É–±–ª–µ–π –¥–æ 5,3 —Ç—ã—Å. —Ä—É–±–ª–µ–π. –ë–æ–ª–µ–µ –≤—ã—Å–æ–∫—É—é —Å—Ç–æ–∏–º–æ—Å—Ç—å ¬´–°–µ–º–∞–≤–∏–∫–∞ –ù–µ–∫—Å—Ç¬ª –∞–Ω–∞–ª–∏—Ç–∏–∫–∏ —Å–≤—è–∑—ã–≤–∞—é—Ç —Å –∞–∫—Ç–∏–≤–Ω—ã–º–∏ –∑–∞–∫—É–ø–∫–∞–º–∏ –Ω–æ–≤—ã—Ö –¥–æ–∑–∏—Ä–æ–≤–æ–∫ 2,27 –º–≥/–º–ª –∏ 3,2 –º–≥/–º–ª, —Ä–∞–Ω–µ–µ –Ω–µ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–Ω—ã—Ö –Ω–∞ —Ä—ã–Ω–∫–µ. –í –ø–µ—Ä–≤–æ–π –ø–æ–ª–æ–≤–∏–Ω–µ 2024 –≥–æ–¥–∞ –ª–∏–¥–µ—Ä–æ–º –±—ã–ª–∞ –ö–≤–∏–Ω—Å–µ–Ω—Ç–∞ ‚Äî –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç –æ—Ç ¬´–ü—Ä–æ–º–æ–º–µ–¥–∞¬ª –ø—Ä–∏—Ö–æ–¥–∏–ª–æ—Å—å 65% –æ–±—ä—ë–º–∞ –∑–∞–∫—É–ø–æ–∫ ‚Äî 343,2 –º–ª–Ω —Ä—É–±–ª–µ–π. –í—Ç–æ—Ä–æ–µ –º–µ—Å—Ç–æ –∑–∞–Ω–∏–º–∞–ª –°–µ–º–∞–≤–∏–∫ —Å –¥–æ–ª–µ–π 34% (181,4 –º–ª–Ω —Ä—É–±–ª–µ–π). –û—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã–π –û–∑–µ–º–ø–∏–∫ –¥–æ–≤–æ–ª—å—Å—Ç–≤–æ–≤–∞–ª—Å—è –ª–∏—à—å 1% —Ä—ã–Ω–∫–∞. –í 2025 –≥–æ–¥—É —Å–∏—Ç—É–∞—Ü–∏—è –∏–∑–º–µ–Ω–∏–ª–∞—Å—å –∑–∞ —Å—á—ë—Ç –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏–∏ —Å–æ —Å—Ç–æ—Ä–æ–Ω—ã –Ω–æ–≤–∏—á–∫–æ–≤ ‚Äî —Å—É—â–µ—Å—Ç–≤–µ–Ω–Ω—ã–µ –¥–æ–ª–∏ –∑–∞–Ω—è–ª–∏ –ò–Ω—Å—É–¥–∞–π–≤ (¬´–ü–°–ö –§–∞—Ä–º–∞¬ª) –∏ –°–µ–º—É–≥–ª–∏–Ω (¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑-–ù–æ—Ä–¥¬ª) ‚Äî 25% –∏ 20% —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ. –ö–≤–∏–Ω—Å–µ–Ω—Ç–∞ —Å–Ω–∏–∑–∏–ª–∞—Å—å –¥–æ 26%, –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏ —Å—Ä–∞–≤–Ω—è–≤—à–∏—Å—å —Å –°–µ–º–∞–≤–∏–∫–æ–º (27%). –ù–æ–≤—ã–µ –∏–≥—Ä–æ–∫–∏ –±—ã—Å—Ç—Ä–æ –≤—ã—Ö–æ–¥—è—Ç –Ω–∞ —Ä—ã–Ω–æ–∫ –≥–æ—Å–∑–∞–∫—É–ø–æ–∫ –∏ –∑–∞–≤–æ—ë–≤—ã–≤–∞—é—Ç –∑–Ω–∞—á–∏–º—ã–µ –ø–æ–∑–∏—Ü–∏–∏ –∑–∞ —Å—á—ë—Ç –ø—Ä–∏–≤–ª–µ–∫–∞—Ç–µ–ª—å–Ω—ã—Ö —Ü–µ–Ω –∏ —Ä–∞—Å—à–∏—Ä–µ–Ω–Ω–æ–≥–æ –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç–∞ –¥–æ–∑–∏—Ä–æ–≤–æ–∫. –í —Ç–æ–ø-5 –ø–æ—Å—Ç–∞–≤—â–∏–∫–æ–≤ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ –ø–æ –≤–µ—Ä—Å–∏–∏ Headway company –≤–æ—à–ª–∏ ¬´–ë–°–°¬ª, ¬´–¢—Ä–∏–µ—Å—Ç–∞¬ª, ¬´–ò—Ä–≤–∏–Ω-2¬ª, ¬´–¢–æ—Ä–≥–æ–≤—ã–π –¥–æ–º –ë–§¬ª –∏ ¬´–ê–ª—å—Ç–µ—Ä-–§–∞—Ä–º–∞¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""Headway company presented a comparative analysis of obesity drug purchases from the first half of 2024 and 2025. Starting January 1, 2025, semaglutide was officially included in updated guidelines by the Ministry of Health and Russian Endocrinologists Association as a first-choice treatment for obesity in adults. Sedaject from 'Promomed' and Sedjaro from 'Gerofarma' have already started appearing in tender procurements since 2025. The average price of a semaglutide vial ranges from 4,800 to 5,300 rubles. Higher prices for 'Semavika Next' are attributed to active purchases of new dosages 2.27 mg/ml and 3.2 mg/ml, previously not available on the market. In the first half of 2024, Quintensa from 'Promomed' accounted for 65% of purchases (343.2 million rubles), while Semav"
2025-07-15T05:59:58+00:00,@bezrec,6304,https://t.me/bezrec/6304,"–ì–ª–∞–≤–Ω–æ–µ –∏–∑ –¥–æ–∫–ª–∞–¥–∞ –ú–∏—Ö–∞–∏–ª–∞ –ú—É—Ä–∞—à–∫–æ –í–ª–∞–¥–∏–º–∏—Ä—É –ü—É—Ç–∏–Ω—É. –ü—Ä–µ–∑–∏–¥–µ–Ω—Ç –ø—Ä–æ–≤—ë–ª —Å–æ–≤–µ—â–∞–Ω–∏–µ –ø–æ —Å–æ—Ü–∏–∞–ª—å–Ω—ã–º –≤–æ–ø—Ä–æ—Å–∞–º. –í —Ü–µ–Ω—Ç—Ä–µ –≤–Ω–∏–º–∞–Ω–∏—è –æ–∫–∞–∑–∞–ª–∏—Å—å –≤–æ–ø—Ä–æ—Å—ã –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∏ –¥–µ–º–æ–≥—Ä–∞—Ñ–∏–∏. –í—ã–±—Ä–∞–ª–∏ –≥–ª–∞–≤–Ω–æ–µ –∏–∑ –≤—ã—Å—Ç—É–ø–ª–µ–Ω–∏—è –≥–ª–∞–≤—ã –ú–∏–Ω–∑–¥—Ä–∞–≤–∞. üü© –§–æ–Ω–¥ ¬´–ö—Ä—É–≥ –¥–æ–±—Ä–∞¬ª –ø–æ–ª–Ω–æ—Å—Ç—å—é –ø–æ–¥—Ö–≤–∞—Ç—ã–≤–∞–µ—Ç –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–µ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ —Å –º–æ–º–µ–Ω—Ç–∞ –ø–æ—Å—Ç–∞–Ω–æ–≤–∫–∏ –¥–∏–∞–≥–Ω–æ–∑–∞ –µ—â—ë –¥–æ –ø–æ—è–≤–ª–µ–Ω–∏—è –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Å–∏–º–ø—Ç–æ–º–æ–≤. –¢–µ–º —Å–∞–º—ã–º –¥–µ—Ç–∏ –∏–∑–±–µ–≥–∞—é—Ç –∏–Ω–≤–∞–ª–∏–¥–Ω–æ—Å—Ç–∏. üü© –†–µ—à–µ–Ω–∏–µ –ø–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–º—É –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—é –ø–µ—Ä–µ–Ω–µ—Å—à–∏—Ö –∏–Ω—Ñ–∞—Ä–∫—Ç –∏ –∏–Ω—Å—É–ª—å—Ç –¥–∞–ª–æ —Å–Ω–∏–∂–µ–Ω–∏–µ —Å–º–µ—Ä—Ç–Ω–æ—Å—Ç–∏ –Ω–∞ 20%. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –ø—Ä–æ–≥—Ä–∞–º–º—É —Ä–∞—Å—à–∏—Ä–∏–ª–∏ –¥–ª—è —Ç—è–∂—ë–ª—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–æ–π —Å–µ—Ä–¥–µ—á–Ω–æ–π –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ—Å—Ç—å—é –Ω–∞ –¥–ª–∏—Ç–µ–ª—å–Ω–æ–º –Ω–∞–±–ª—é–¥–µ–Ω–∏–∏. üü© –ë–ª–∞–≥–æ–¥–∞—Ä—è –¥–∏—Å–ø–∞–Ω—Å–µ—Ä–∏–∑–∞—Ü–∏–∏ 61% –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –≤—ã—è–≤–ª–µ–Ω–æ –Ω–∞ –ø–µ—Ä–≤–æ–π-–≤—Ç–æ—Ä–æ–π —Å—Ç–∞–¥–∏–∏. –°–µ–≥–æ–¥–Ω—è —Ö–∏–º–∏–æ—Ç–µ—Ä–∞–ø–∏—è, –ª—É—á–µ–≤–∞—è —Ç–µ—Ä–∞–ø–∏—è –¥–æ—Å—Ç—É–ø–Ω—ã –¥–ª—è –∫–∞–∂–¥–æ–≥–æ –∂–∏—Ç–µ–ª—è —Å—Ç—Ä–∞–Ω—ã. üü© –°–æ–∑–¥–∞—ë—Ç—Å—è –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ —Ä–∞–¥–∏–æ—Ñ–∞—Ä–º–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, —É –Ω–∞—Å –æ–¥–Ω–∞ –∏–∑ —Å–∞–º—ã—Ö —à–∏—Ä–æ–∫–∏—Ö –ª–∏–Ω–µ–µ–∫ –≤ –º–∏—Ä–µ —Å–µ–≥–æ–¥–Ω—è. üü© –í —Ä–∞–º–∫–∞—Ö –Ω–∞—Ü–ø—Ä–æ–µ–∫—Ç–∞ ¬´–ù–æ–≤—ã–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ —Å–±–µ—Ä–µ–∂–µ–Ω–∏—è –∑–¥–æ—Ä–æ–≤—å—è¬ª –æ—Å—É—â–µ—Å—Ç–≤–ª—è–µ—Ç—Å—è —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏–µ –Ω–∞—É—á–Ω—ã—Ö —Ä–∞–∑—Ä–∞–±–æ—Ç–æ–∫, –≤—ã–¥–µ–ª—è—é—Ç—Å—è —Å—Ä–µ–¥—Å—Ç–≤–∞ –Ω–∞ –ø–æ–¥–¥–µ—Ä–∂–∞–Ω–∏–µ –º–∞—Ç–µ—Ä–∏–∞–ª—å–Ω–æ-—Ç–µ—Ö–Ω–∏—á–µ—Å–∫–æ–π –±–∞–∑—ã —É—á—Ä–µ–∂–¥–µ–Ω–∏–π, –∫–æ—Ç–æ—Ä—ã–µ –ø—Ä–æ–≤–æ–¥—è—Ç –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è, —Å–æ–∑–¥–∞—é—Ç—Å—è —Å–ø–µ—Ü–∏–∞–ª—å–Ω—ã–µ –ø–æ–¥—Ä–∞–∑–¥–µ–ª–µ–Ω–∏—è –¥–ª—è –ø–∞—Ç–µ–Ω—Ç–æ–≤–∞–Ω–∏—è, —Å–æ–ø—Ä–æ–≤–æ–∂–¥–µ–Ω–∏—è, –ø–æ–∏—Å–∫–∞ –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ–≥–æ –ø–∞—Ä—Ç–Ω—ë—Ä–∞ –∏ –±–∞–∑, –∑–∞–Ω–∏–º–∞—é—â–∏—Ö—Å—è –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–º–∏ –∏ –¥–æ–∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–º–∏ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è–º–∏. üü© –£–∂–µ —Å–µ–≥–æ–¥–Ω—è –º—ã –≤–∏–¥–∏–º –≤–æ–∑–≤—Ä–∞—Ç –±—é–¥–∂–µ—Ç–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤, –∫–æ—Ç–æ—Ä—ã–µ –∏–¥—É—Ç –ø–æ—Å–ª–µ –≤–Ω–µ–¥—Ä–µ–Ω–∏—è —Ç–µ—Ö –∏–ª–∏ –∏–Ω—ã—Ö —Ä–µ–∑—É–ª—å—Ç–∞—Ç–æ–≤ –Ω–∞—É—á–Ω–æ–π –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏. –ü–æ–∫–∞–∑–∞—Ç–µ–ª–∏ –±—É–¥—É—Ç —Ä–µ–∞–ª–∏–∑–æ–≤–∞–Ω—ã –≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–∏ —Å –ø–æ—Å—Ç–∞–≤–ª–µ–Ω–Ω—ã–º–∏ –ø–ª–∞–Ω–∞–º–∏ –∏ —Å—Ä–æ–∫–∞–º–∏. –í—Å—ë —Ö–æ—Ä–æ—à–æ, –ø—Ä–µ–∫—Ä–∞—Å–Ω–∞—è –º–∞—Ä–∫–∏–∑–∞, –∑–∞ –∏—Å–∫–ª—é—á–µ–Ω—å–µ–º –ø—É—Å—Ç—è–∫–∞. –ù–∞ 1 –∏—é–ª—è 2025 –≥–æ–¥–∞ –ø–æ–∫–∞–∑–∞—Ç–µ–ª—å –∏—Å–ø–æ–ª–Ω–µ–Ω–∏—è –Ω–∞—Ü–ø—Ä–æ–µ–∫—Ç–∞ ¬´–ù–æ–≤—ã–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ —Å–±–µ—Ä–µ–∂–µ–Ω–∏—è –∑–¥–æ—Ä–æ–≤—å—è¬ª —Å–æ—Å—Ç–∞–≤–∏–ª 28,8%. –û—Å–æ–±–µ–Ω–Ω–æ –≥—Ä—É—Å—Ç–Ω—ã–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã —É —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –ø—Ä–æ–µ–∫—Ç–∞ ¬´–†–∞–∑–≤–∏—Ç–∏–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –Ω–∞–∏–±–æ–ª–µ–µ –≤–æ—Å—Ç—Ä–µ–±–æ–≤–∞–Ω–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π¬ª ‚Äî –æ–Ω –∏—Å–ø–æ–ª–Ω–µ–Ω –≤—Å–µ–≥–æ –Ω–∞ 2,6%. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,pharmacovigilance,hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""The presentation focuses on healthcare and demography issues. The main point is the discussion of medical care, including the reduction in mortality due to heart attack and stroke treatments. The country is facing challenges such as low progress on the 'Development of Production of Highly Desired Medicines and Medical Devices' project, which is only 2.6% complete by July 1st, 2025.""
}"
2025-07-14T14:14:58+00:00,@bezrec,6303,https://t.me/bezrec/6303,"–í—Å–ª–µ–¥ –∑–∞ –±–µ–∑—Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã–º–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º–∏ RNC Pharma –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∞ —Ä–µ–π—Ç–∏–Ω–≥ ¬´—Ä–µ—Ü–µ–ø—Ç—É—Ä–∫–∏¬ª –ø–æ –∏—Ç–æ–≥–∞–º —è–Ω–≤–∞—Ä—è-–º–∞—è 2025 –≥–æ–¥–∞. –ü–æ –¥–∞–Ω–Ω—ã–º –∞–Ω–∞–ª–∏—Ç–∏–∫–æ–≤, Rx-–ø—Ä–µ–ø–∞—Ä–∞—Ç—ã ‚Äî —Ñ–ª–∞–≥–º–∞–Ω —Ä–∞–∑–≤–∏—Ç–∏—è —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —Ä–æ–∑–Ω–∏—á–Ω–æ–≥–æ —Ä—ã–Ω–∫–∞. –î–∏–Ω–∞–º–∏–∫–∞ —Å–ø—Ä–æ—Å–∞ –Ω–∞ –Ω–∏—Ö —Å—É—â–µ—Å—Ç–≤–µ–Ω–Ω–æ –æ–ø–µ—Ä–µ–∂–∞–µ—Ç –ø–æ–∫–∞–∑–∞—Ç–µ–ª–∏ –û–¢–°-—Å–µ–≥–º–µ–Ω—Ç–∞. –ó–∞ –ø–µ—Ä–≤—ã–µ –ø—è—Ç—å –º–µ—Å—è—Ü–µ–≤ –≥–æ–¥–∞ —Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø—Ä–æ–¥–∞–ª–∏ –Ω–∞ 460 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π (–≤–∫–ª—é—á–∞—è –æ–Ω–ª–∞–π–Ω –∫–∞–Ω–∞–ª). –≠—Ç–æ –Ω–∞ 19% –±–æ–ª—å—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É. –ù–∞—Ç—É—Ä–∞–ª—å–Ω–∞—è –¥–∏–Ω–∞–º–∏–∫–∞ —Å–æ—Å—Ç–∞–≤–∏–ª–∞ +5%. –ì–ª–∞–≤–Ω—ã–µ –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª–∏ ¬´—Ä–µ—Ü–µ–ø—Ç—É—Ä–∫–∏¬ª ‚Äî –ú–æ—Å–∫–≤–∞, –ú–æ—Å–∫–æ–≤—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å –∏ –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥, —Å—É–º–º–∞—Ä–Ω–æ –Ω–∞ —ç—Ç–∏ —Ä–µ–≥–∏–æ–Ω—ã –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è 24,7% —Ä—ã–Ω–∫–∞. –ú–∞–∫—Å–∏–º–∞–ª—å–Ω—ã–π –ø—Ä–∏—Ä–æ—Å—Ç –≤ –¥–µ–Ω—å–≥–∞—Ö (+20%) ‚Äî —É –ü–æ–¥–º–æ—Å–∫–æ–≤—å—è. –í –∞–Ω–∞–ª–∏–∑–∏—Ä—É–µ–º–æ–º –ø–µ—Ä–∏–æ–¥–µ –Ω–∞ —Ä–æ–∑–Ω–∏—á–Ω–æ–º —Ä—ã–Ω–∫–µ –±—ã–ª–æ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–æ 5656 —Ç–æ—Ä–≥–æ–≤—ã—Ö –º–∞—Ä–æ–∫ —Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, —á—Ç–æ –Ω–∞ 138 —à—Ç—É–∫ –º–µ–Ω—å—à–µ, —á–µ–º –≤ –ø—Ä–æ—à–ª–æ–º –≥–æ–¥—É. –ò–∑ –Ω–∞–∏–±–æ–ª–µ–µ –∑–∞–º–µ—Ç–Ω—ã—Ö ¬´–ø–æ—Ç–µ—Ä—å¬ª ‚Äî –∞–Ω—Ç–∏–≥–∏—Å—Ç–∞–º–∏–Ω–Ω—ã–π –ê–ª–ª–µ—Ä—Ñ–µ–∫—Å (¬´–°–µ–≤–µ—Ä–Ω–∞—è –ó–≤–µ–∑–¥–∞¬ª) –∏ –í–∏–∫–µ–π—Ä–∞ –ü–∞–∫ (¬´–≠–±–±–≤–∏¬ª) –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–æ–≥–æ –≥–µ–ø–∞—Ç–∏—Ç–∞ –°, –∞ —Ç–∞–∫–∂–µ –ø—Ä–æ—Ç–∏–≤–æ–≥—Ä–∏–±–∫–æ–≤—ã–π –ù–æ–∫—Å–∞—Ñ–∏–ª (¬´–ú–°–î¬ª) –∏ —Ä–∞—Å—Ç–≤–æ—Ä –¥–ª—è –≤–Ω—É—Ç—Ä–∏–º—ã—à–µ—á–Ω–æ–≥–æ –≤–≤–µ–¥–µ–Ω–∏—è –Ω–∞ –æ—Å–Ω–æ–≤–µ –∏–º–º—É–Ω–æ–≥–ª–æ–±—É–ª–∏–Ω–∞ —á–µ–ª–æ–≤–µ–∫–∞ –∞–Ω—Ç–∏—Ä–µ–∑—É—Å –ö–∞–º–†–û–£ (¬´–ö–∞–º–∞–¥–∞¬ª). –ù–∞ –ø–µ—Ä–≤–æ–º –º–µ—Å—Ç–µ –≤ —Ç–æ–ø-10 —Ç–æ—Ä–≥–æ–≤—ã—Ö –º–∞—Ä–æ–∫ —Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø–æ –æ–±—ä—ë–º—É –ø—Ä–æ–¥–∞–∂ –≤ –¥–µ–Ω—å–≥–∞—Ö –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º —Ä–æ–∑–Ω–∏—á–Ω–æ–º —Ä—ã–Ω–∫–µ –æ–∫–∞–∑–∞–ª—Å—è –≠–ª–∏–∫–≤–∏—Å –æ—Ç ¬´–ü—Ñ–∞–π–∑–µ—Ä¬ª, –∑–∞ –≥–æ–¥ –Ω–∞—Ä–∞—Å—Ç–∏–≤—à–∏–π –ø—Ä–æ–¥–∞–∂–∏ –Ω–∞ 15% ‚Äî –≤ –æ—Å–Ω–æ–≤–Ω–æ–º –∑–∞ —Å—á—ë—Ç –Ω–µ—É–¥–∞—á –ö—Å–∞—Ä–µ–ª—Ç–æ (¬´–ë–∞–π–µ—Ä¬ª), —Å–ø—Ä–æ—Å –Ω–∞ –∫–æ—Ç–æ—Ä—ã–π —É–ø–∞–ª —Å—Ä–∞–∑—É –Ω–∞ 11% –ø–æ—Å–ª–µ –ø–æ—è–≤–ª–µ–Ω–∏—è –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤. –ù–∞ –≤—Ç–æ—Ä—É—é —Å—Ç—Ä–æ—á–∫—É —Ä–µ–π—Ç–∏–Ω–≥–∞ –≤–æ—Ä–≤–∞–ª—Å—è –°–µ–º–∞–≤–∏–∫ –æ—Ç ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º–∞¬ª –¥–ª—è –ª–µ—á–µ–Ω–∏—è –¥–∏–∞–±–µ—Ç–∞ –∏ –æ–∂–∏—Ä–µ–Ω–∏—è, –ø–æ–∫–∞–∑–∞–≤—à–∏–π –ø—è—Ç–∏–∫—Ä–∞—Ç–Ω—ã–π —Ä–æ—Å—Ç –ø—Ä–æ–¥–∞–∂. –°–∞–º–∞—è –≤–Ω—É—à–∏—Ç–µ–ª—å–Ω–∞—è –¥–∏–Ω–∞–º–∏–∫–∞ (+61%) ‚Äî —É –§–æ—Ä—Å–∏–≥–∏ –æ—Ç ¬´–ê—Å—Ç—Ä–∞–ó–µ–Ω–µ–∫–∞¬ª –ø—Ä–æ—Ç–∏–≤ –¥–∏–∞–±–µ—Ç–∞ –≤—Ç–æ—Ä–æ–≥–æ —Ç–∏–ø–∞. –ü–æ–º–∏–º–æ –ö—Å–∞—Ä–µ–ª—Ç–æ, —Å–ª–∞–±–æ–π –¥–∏–Ω–∞–º–∏–∫–æ–π –æ—Ç–ª–∏—á–∏–ª—Å—è —Ä–æ—Å—Å–∏–π—Å–∫–∏–π –ú–µ–∫—Å–∏–¥–æ–ª –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–§–∞—Ä–º–∞—Å–æ—Ñ—Ç¬ª –¥–ª—è –ª–µ—á–µ–Ω–∏—è –∏ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –Ω–∞—Ä—É—à–µ–Ω–∏–π –º–æ–∑–≥–æ–≤–æ–≥–æ –∫—Ä–æ–≤–æ–æ–±—Ä–∞—â–µ–Ω–∏—è. –¢–∞–∫–∂–µ –≤ —Ç–æ–ø-10 –ø–æ–ø–∞–ª–∏ –≠–¥–∞—Ä–±–∏ (¬´–ù–∏–∂—Ñ–∞—Ä–º¬ª), –ì–µ–ø—Ç—Ä–∞–ª (¬´–≠–±–±–æ—Ç—Ç¬ª), –£—Ä—Å–æ—Å–∞–Ω (–ü—Ä–æ.–ú–µ–¥.–¶—Å), –ù–∏–º–µ—Å–∏–ª (¬´–ú–µ–Ω–∞—Ä–∏–Ω–∏¬ª) –∏ –§–µ–º–æ—Å—Ç–æ–Ω (¬´–≠–±–±–æ—Ç—Ç¬ª). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""RNC Pharma released a ranking of 'prescription drugs' based on data from January to May 2025. The analysis shows that the demand for prescription drugs significantly outpaces the OTC segment, with sales increasing by 19% year-over-year to RUB460 billion (including online channels). The top-selling prescription drugs are from Moscow, Moscow region, and St. Petersburg, accounting for 24.7% of the market. The main growth areas are in Moscow region, where sales increased by 20%. There were significant losses for drugs like Allergifex (¬´Severnaia Zvezda¬ª) and Vikera Pak (¬´Ebbvvi¬ª) for chronic hepatitis C, as well as Noksaflu (¬´MSD¬ª) and KAMROU (¬´Kamada¬ª) for fungal infections. The top-selling prescription drugs in terms of sales volume are Elyxis from Pfizer, which grew by 15% year-over-year due to the decline in Xarelto (¬´Bayer"
2025-07-14T10:59:58+00:00,@bezrec,6302,https://t.me/bezrec/6302,"¬´–ê–º–¥–∂–µ–Ω¬ª —É—Å–ª—ã—à–∞–ª–∞ –§–ê–°. –í –∞–ø—Ä–µ–ª–µ –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å—â–∏–∫–∏ –≤—ã–¥–∞–ª–∏ –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏–µ —Ä–æ—Å—Å–∏–π—Å–∫–æ–π ¬´–¥–æ—á–∫–µ¬ª –æ–¥–Ω–æ–π –∏–∑ –≤–µ–¥—É—â–∏—Ö –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –∫–æ–º–ø–∞–Ω–∏–π –º–∏—Ä–∞ ‚Äî –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–π Amgen. –†–µ–≥—É–ª—è—Ç–æ—Ä —Å—á—ë–ª, —á—Ç–æ ¬´–ê–º–¥–∂–µ–Ω¬ª –∑–∞–Ω–∏–º–∞–µ—Ç –¥–æ–º–∏–Ω–∏—Ä—É—é—â–µ–µ –ø–æ–ª–æ–∂–µ–Ω–∏–µ –Ω–∞ —Ä—ã–Ω–∫–µ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ —Å—Ä–∞–∑—É –Ω–µ—Å–∫–æ–ª—å–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤: –ø—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤—ã—Ö –í–µ–∫—Ç–∏–±–∏–∫—Å–∞ –∏ –≠–∫—Å–¥–∂–∏–≤—ã, —Å–∏—Å—Ç–µ–º–Ω–æ–≥–æ –≥–æ—Ä–º–æ–Ω–∞–ª—å–Ω–æ–≥–æ –ü–∞—Ä—Å–∞–±–∏–≤–∞, –ü—Ä–æ–ª–∏–∞ –ø—Ä–æ—Ç–∏–≤ –æ—Å—Ç–µ–æ–ø–æ—Ä–æ–∑–∞, –†–µ–ø–∞—Ç—ã –¥–ª—è —Å–Ω–∏–∂–µ–Ω–∏—è —É—Ä–æ–≤–Ω—è —Ö–æ–ª–µ—Å—Ç–µ—Ä–∏–Ω–∞ –∏ –≠–Ω–ø–ª–µ–π—Ç–∞ –ø—Ä–æ—Ç–∏–≤ —Ç—Ä–æ–º–±–æ—Ü–∏—Ç–æ–ø–µ–Ω–∏—á–µ—Å–∫–æ–π –ø—É—Ä–ø—É—Ä—ã. –§–ê–° –ø–æ—Å—á–∏—Ç–∞–ª–∞, —á—Ç–æ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—è –æ—Ç–∫–∞–∑—ã–≤–∞–ª–∞ –ø–æ—Å—Ç–∞–≤—â–∏–∫–∞–º –≤ –∑–∞–∫–ª—é—á–µ–Ω–∏–∏ –¥–æ–≥–æ–≤–æ—Ä–æ–≤ –ø–æ—Å—Ç–∞–≤–∫–∏ —ç—Ç–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏–∑-–∑–∞ —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–∏ –∏ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏ –Ω–µ–æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω—ã—Ö —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π –∫ –≤—ã—Ä—É—á–∫–µ –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω–æ–≥–æ –¥–µ–ª–æ–≤–æ–≥–æ –ø–∞—Ä—Ç–Ω–µ—Ä–∞, —Å–æ–¥–µ—Ä–∂–∞—â–∏—Ö—Å—è –≤ –∫–æ–º–º–µ—Ä—á–µ—Å–∫–æ–π –ø–æ–ª–∏—Ç–∏–∫–µ. –û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è —É—Å—Ç—Ä–∞–Ω–∏–ª–∞ –ø—Ä–∏–∑–Ω–∞–∫–∏ –Ω–∞—Ä—É—à–µ–Ω–∏—è –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å–Ω–æ–≥–æ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–∞. –í —á–∞—Å—Ç–Ω–æ—Å—Ç–∏: üîò–∏—Å–∫–ª—é—á–∏–ª–∞ —É–∫–∞–∑–∞–Ω–Ω—ã–µ –ø—É–Ω–∫—Ç—ã –∏–∑ –∫–æ–º–º–µ—Ä—á–µ—Å–∫–æ–π –ø–æ–ª–∏—Ç–∏–∫–∏; üîò–ø–µ—Ä–µ—Å–º–æ—Ç—Ä–µ–ª–∞ —Ä–µ—à–µ–Ω–∏–µ –ø–æ –∑–∞—è–≤–∫–µ ¬´–ö–æ–º–ø–∞–Ω–∏–∏ –§–∞—Ä–º—Å—Ç–æ—Ä¬ª –Ω–∞ –Ω–µ–¥–∏—Å–∫—Ä–∏–º–∏–Ω–∞—Ü–∏–æ–Ω–Ω—ã—Ö —É—Å–ª–æ–≤–∏—è—Ö. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""The FAS heard from 'Amdzhon'. In April, the antimonopoly authorities issued a warning to Russia's 'daughter' of one of the leading biotech companies in the world - American Amgen. The regulator considered that 'Amdzhon' occupies a dominant position on the market for several drugs: anti-cancer Vectibix and Exjiva, systemic hormone Parsabiv, Prolia against osteoporosis, Repatha for lowering cholesterol and Enbrel for thrombocytopenic purpura. The FAS considered that the pharmaceutical company refused to enter into supply agreements with suppliers due to economically and technically unjustified requirements in the commercial policy. The organization has eliminated antimonopoly law violations. Specifically: üîò excluded the mentioned points from the commercial policy; üîò reviewed the application 'Company Farmstore' on non-discriminatory conditions.""
}"
2025-07-14T08:33:39+00:00,@bezrec,6301,https://t.me/bezrec/6301,"–í –ú–æ—Å–∫–≤–µ –Ω–∞–∫—Ä—ã–ª–∏ —Ç–æ—Ä–≥–æ–≤—Ü–µ–≤ ¬´–ª–µ–≤—ã–º–∏¬ª –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏. –ê—Ä–µ—Å—Ç–æ–≤–∞–Ω—ã —Ç—Ä–æ–µ –º—É–∂—á–∏–Ω, –ø—Ä–æ–º—ã—à–ª—è–≤—à–∏—Ö –Ω–µ–∑–∞–∫–æ–Ω–Ω—ã–º —Å–±—ã—Ç–æ–º –ª–µ–∫–∞—Ä—Å—Ç–≤ –¥–ª—è –ø–æ—Ö—É–¥–µ–Ω–∏—è, –ª–µ—á–µ–Ω–∏—è –¥–∏–∞–±–µ—Ç–∞, —ç–ø–∏–ª–µ–ø—Å–∏–∏, –æ–Ω–∫–æ–ª–æ–≥–∏–∏ –∏ –¥—Ä—É–≥–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –ü—Ä–µ–ø–∞—Ä–∞—Ç—ã –≤–≤–æ–∑–∏–ª–∏ –≤ –†–æ—Å—Å–∏—é –∏–∑-–∑–∞ –≥—Ä–∞–Ω–∏—Ü—ã (–∫–∞–Ω–∞–ª—ã –ø–æ—Å—Ç–∞–≤–æ–∫ —É–∂–µ —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω—ã), —Ä–µ–∫–ª–∞–º–∏—Ä–æ–≤–∞–ª–∏ —á–µ—Ä–µ–∑ –≥—Ä—É–ø–ø—ã –≤ –º–µ—Å—Å–µ–Ω–¥–∂–µ—Ä–∞—Ö –∏ –æ—Ç–ø—Ä–∞–≤–ª—è–ª–∏ —Å—Ç—Ä–∞–∂–¥—É—â–∏–º –ø–æ –≤—Å–µ–π —Å—Ç—Ä–∞–Ω–µ —á–µ—Ä–µ–∑ —Å–µ—Ä–≤–∏—Å—ã –¥–æ—Å—Ç–∞–≤–∫–∏. –í —Ö–æ–¥–µ –ø—Ä–æ–≤–µ—Ä–æ—á–Ω–æ–π –∑–∞–∫—É–ø–∫–∏ –ø–æ–ª–∏—Ü–µ–π—Å–∫–∏–µ –ø—Ä–∏–æ–±—Ä–µ–ª–∏ —É –ø–æ–¥–æ–∑—Ä–µ–≤–∞–µ–º—ã—Ö –≤–æ—Å–µ–º—å —É–ø–∞–∫–æ–≤–æ–∫ –ª–µ–∫–∞—Ä—Å—Ç–≤ –Ω–∞ –±–æ–ª–µ–µ —á–µ–º 100 —Ç—ã—Å. —Ä—É–±–ª–µ–π. –í—Å–µ –æ–∫–∞–∑–∞–ª–∏—Å—å –Ω–µ–¥–æ–±—Ä–æ–∫–∞—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–º–∏, –∏—Ö –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ –º–æ–∂–µ—Ç –±—ã—Ç—å –æ–ø–∞—Å–Ω—ã–º –¥–ª—è –∂–∏–∑–Ω–∏ –∏ –∑–¥–æ—Ä–æ–≤—å—è. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –ø—Ä–∏ –æ–±—ã—Å–∫–µ –æ–±–Ω–∞—Ä—É–∂–µ–Ω–æ –µ—â—ë –±–æ–ª–µ–µ 100 —É–ø–∞–∫–æ–≤–æ–∫ –ª–µ–∫–∞—Ä—Å—Ç–≤, —Ö—Ä–∞–Ω–∏–≤—à–∏—Ö—Å—è —Å –≥—Ä—É–±—ã–º–∏ –Ω–∞—Ä—É—à–µ–Ω–∏—è–º–∏ —Ç–µ–º–ø–µ—Ä–∞—Ç—É—Ä–Ω–æ–≥–æ —Ä–µ–∂–∏–º–∞. –§–∏–≥—É—Ä–∞–Ω—Ç—ã –Ω–∞—Ö–æ–¥—è—Ç—Å—è –ø–æ–¥ –ø–æ–¥–ø–∏—Å–∫–æ–π –æ –Ω–µ–≤—ã–µ–∑–¥–µ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""Police in Moscow have arrested three men who were illegally selling drugs for weight loss, diabetes, epilepsy, and cancer. The illegal imports of the medicines were traced to channels. The suspects advertised through messenger groups and delivered drugs via delivery services. During a raid, police purchased eight packages of the medicines worth over 100 thousand rubles. All were found to be substandard and potentially dangerous for health. Additionally, over 100 packages of medicines were found stored in violation of temperature regimes. The suspects are under house arrest.""
}"
2025-07-14T05:30:01+00:00,@bezrec,6300,https://t.me/bezrec/6300,"–ü–æ—Å–º–æ—Ç—Ä–µ–ª–∏ —Å–≤–µ–∂–∏–π –æ—Ç—á—ë—Ç –†–æ—Å—Å—Ç–∞—Ç–∞ –æ –¥–∏–Ω–∞–º–∏–∫–µ —Ü–µ–Ω –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∑–∞ –∏—é–Ω—å 2025 –≥–æ–¥–∞. –¶–µ–Ω—ã –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –Ω–µ –∏–∑ –ø–µ—Ä–µ—á–Ω—è –ñ–ù–í–õ–ü –≤ —Å—Ä–µ–¥–Ω–µ–º –∏–∑–º–µ–Ω–∏–ª–∏—Å—å –Ω–∞ +0,8%: ‚Äì –≤–∞–ª–æ—Å–µ—Ä–¥–∏–Ω +2,2%; ‚Äì –º–µ–Ω–æ–≤–∞–∑–∏–Ω +1,8%; ‚Äì –∫–∞–Ω–µ—Ñ—Ä–æ–Ω –ù, –ª–µ–≤–æ–º–µ–∫–æ–ª—å –∏ –ª–∏–∑–æ–±–∞–∫—Ç +1,6%; ‚Äì –≥—Ä–∞–º–º–∏–¥–∏–Ω +1,5%; ‚Äì –Ω–∞—Ñ–∞–∑–æ–ª–∏–Ω +1,4%; ‚Äì —Ç—Ä–æ–∫—Å–µ—Ä—É—Ç–∏–Ω +1,3%; ‚Äì –≥–µ–ø–∞—Ä–∏–Ω–æ–≤–∞—è –º–∞–∑—å, –∫–æ—Ä–≤–∞–ª–æ–ª, –º–∏—Ä–∞–º–∏—Å—Ç–∏–Ω +1,2%; ‚Äì —Ç–∞—É—Ä–∏–Ω +1,0%; ‚Äì –π–æ–¥ +0,9%. –°–Ω–∏–∑–∏–ª–∏—Å—å —Ü–µ–Ω—ã –Ω–∞ –∫–∞—Ä–¥–∏–æ–º–∞–≥–Ω–∏–ª (-0,7%). –õ–µ–∫–∞—Ä—Å—Ç–≤–∞, –æ—Ç–Ω–æ—Å—è—â–∏–µ—Å—è –∫ –ñ–ù–í–õ–ü, –ø–æ–¥–æ—Ä–æ–∂–∞–ª–∏ –≤ —Å—Ä–µ–¥–Ω–µ–º –Ω–∞ +0,4%: ‚Äì –≤–µ—Ä–æ—à–ø–∏—Ä–æ–Ω +1,6%; ‚Äì –Ω–∞—Ç—Ä–∏—è —Ö–ª–æ—Ä–∏–¥ +1,5%; ‚Äì —Ö–ª–æ—Ä–≥–µ–∫—Å–∏–¥–∏–Ω –∏ —ç–Ω–∞–ª–∞–ø—Ä–∏–ª +0,7%; ‚Äì –∞—Å–∫–æ—Ä–±–∏–Ω–æ–≤–∞—è –∫–∏—Å–ª–æ—Ç–∞, –¥—Ä–æ—Ç–∞–≤–µ—Ä–∏–Ω (–Ω–æ-—à–ø–∞) –∏ —Å—É–ø—Ä–∞—Å—Ç–∏–Ω +0,6%; ‚Äì –±–µ—Ç–∞–ª–æ–∫ 30–ö, –ª–æ–ø–µ—Ä–∞–º–∏–¥, –æ–º–µ–ø—Ä–∞–∑–æ–ª, –ø–∞–Ω–∫—Ä–µ–∞—Ç–∏–Ω –∏ —Å–∞–ª–∏—Ü–∏–ª–æ–≤–∞—è –∫–∏—Å–ª–æ—Ç–∞ +0,5%. –ù–µ–º–Ω–æ–≥–æ –ø–æ–¥–µ—à–µ–≤–µ–ª –ø–∞—Ä–∞—Ü–µ—Ç–∞–º–æ–ª (-0,5%). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""pricing, shortage"",
  ""impact"": ""medium"",
  ""english"": ""Prices on non-OTC drugs increased by an average of +0.8%: -vaseridine (+2.2%), -menovazin (+1.8%), -kanefron N, levomekole and lizobact (+1.6%); -gramidin (+1.5%), -naphazolin (+1.4%), -trokserutin (+1.3%); -heparin ointment, corvalol, miramistin (+1.2%); -taurine (+1%). Prices on OTC drugs decreased by an average of +0.5%: -paracetamol (-0.5%). Prices on drugs under the –ñ–ù–í–õ–ü list increased by an average of +0.4%: -veroshpiron (+1.6%), -sodium chloride (+1.5%), -chlorhexidine and enalapril (+0.7%); -ascorbic acid, drotonverin (no-shpa) and suprastin"
2025-07-13T11:01:05+00:00,@bezrec,6299,https://t.me/bezrec/6299,"Mattel –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∞ –ø–µ—Ä–≤—É—é –ë–∞—Ä–±–∏-–¥–∏–∞–±–µ—Ç–∏–∫–∞. –ö—É–∫–ª–∞ —Å–æ–∑–¥–∞–Ω–∞ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–º –∏–≥—Ä—É—à–µ–∫ —Å–æ–≤–º–µ—Å—Ç–Ω–æ —Å –≥–ª–æ–±–∞–ª—å–Ω–æ–π –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–µ–π –ø–æ –±–æ—Ä—å–±–µ —Å –¥–∏–∞–±–µ—Ç–æ–º Breakthrough T1D. –í–º–µ—Å—Ç–æ —Å—É–º–æ—á–µ–∫ –∏ —É–∫—Ä–∞—à–µ–Ω–∏–π —É –ë–∞—Ä–±–∏ —Å —Å–æ–±–æ–π –ø—Ä–∏–±–æ—Ä –¥–ª—è –ø–æ—Å—Ç–æ—è–Ω–Ω–æ–≥–æ –∏–∑–º–µ—Ä–µ–Ω–∏—è —Å–∞—Ö–∞—Ä–∞ –≤ –∫—Ä–æ–≤–∏, —Å–º–∞—Ä—Ç—Ñ–æ–Ω —Å –ø—Ä–∏–ª–æ–∂–µ–Ω–∏–µ–º, –∫–æ—Ç–æ—Ä–æ–µ –ø–æ–º–æ–≥–∞–µ—Ç —Å–ª–µ–¥–∏—Ç—å –∑–∞ —É—Ä–æ–≤–Ω–µ–º —Å–∞—Ö–∞—Ä–∞, –∏ –∏–Ω—Å—É–ª–∏–Ω–æ–≤–∞—è –ø–æ–º–ø–∞. ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª, ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª –∏ –æ—Å—Ç–∞–ª—å–Ω—ã–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –æ—Ç –¥–∏–∞–±–µ—Ç–∞ –∏ –æ–∂–∏—Ä–µ–Ω–∏—è, –¥–∞–¥–∏–º –Ω–∞—à –æ—Ç–≤–µ—Ç –ß–µ–º–±–µ—Ä–ª–µ–Ω—É? –°–¥–µ–ª–∞–µ–º —Å–≤–æ—é –∫—Ä–∞—Å–æ—Ç–∫—É? –ö—Å—Ç–∞—Ç–∏, ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª —É–∂–µ —Ä–µ–∫–ª–∞–º–∏—Ä–æ–≤–∞–ª –í–µ–ª–≥–∏—é —Å –ø–æ–º–æ—â—å—é –º–∞—Ç—Ä—ë—à–∫–∏. –ü—Ä–æ—Ç–æ—Ç–∏–ø —É–∂–µ, –º–æ–∂–Ω–æ —Å–∫–∞–∑–∞—Ç—å, –≥–æ—Ç–æ–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-07-12T11:03:53+00:00,@bezrec,6298,https://t.me/bezrec/6298,"–í—Å—Ç—Ä–µ—á–∞–µ–º –∑–Ω–æ–π–Ω—ã–µ –ª–µ—Ç–Ω–∏–µ –≤—ã—Ö–æ–¥–Ω—ã–µ —Å –Ω–æ–≤—ã–º –≤—ã–ø—É—Å–∫–æ–º —Ä—É–±—Ä–∏–∫–∏ #–≤–¥–æ–≥–æ–Ω–∫—É. üíä –§–ê–° –∏ –ú–∏–Ω–∑–¥—Ä–∞–≤ –æ–±–Ω–æ–≤–∏–ª–∏ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø–æ —Ä–∞—Å—á—ë—Ç—É –Ω–∞—á–∞–ª—å–Ω–æ–π –º–∞–∫—Å–∏–º–∞–ª—å–Ω–æ–π —Ü–µ–Ω—ã –∫–æ–Ω—Ç—Ä–∞–∫—Ç–∞ –ø—Ä–∏ –∑–∞–∫—É–ø–∫–∞—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤. –í–µ–¥–æ–º—Å—Ç–≤–∞ —Ä–µ–∫–æ–º–µ–Ω–¥—É—é—Ç –∑–∞–∫–∞–∑—á–∏–∫–∞–º –ø—Ä–æ–≤–µ—Ä—è—Ç—å –Ω–∞–ª–∏—á–∏–µ –≤—Å—Ç—É–ø–∏–≤—à–∏—Ö –≤ —Å–∏–ª—É —Ä–µ—à–µ–Ω–∏–π –§–ê–° –∏–ª–∏ –∞—Ä–±–∏—Ç—Ä–∞–∂–Ω—ã—Ö —Å—É–¥–æ–≤ –æ –Ω–µ–∑–∞–∫–æ–Ω–Ω–æ–º –≤–≤–µ–¥–µ–Ω–∏–∏ –≤ –≥—Ä–∞–∂–¥–∞–Ω—Å–∫–∏–π –æ–±–æ—Ä–æ—Ç –≤–æ—Å–ø—Ä–æ–∏–∑–≤–µ–¥—ë–Ω–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø—Ä–∏ –∏–º–µ—é—â–µ–º—Å—è –¥–µ–π—Å—Ç–≤—É—é—â–µ–º –ø–∞—Ç–µ–Ω—Ç–µ –Ω–∞ –æ—Ä–∏–≥–∏–Ω–∞–ª. üíä –£—Ä–∞–ª—å—Å–∫–∏–π —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã–π —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç (–£—Ä–§–£) –∏ ¬´–£—Ä–∞–ª–±–∏–æ—Ñ–∞—Ä–º¬ª –±—É–¥—É—Ç –≤–º–µ—Å—Ç–µ –¥–µ–ª–∞—Ç—å —Å–æ—Ü–∏–∞–ª—å–Ω–æ –∑–Ω–∞—á–∏–º—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞. –ò.–æ. —Ä–µ–∫—Ç–æ—Ä–∞ –£—Ä–§–£ –ò–ª—å—è –û–±–∞–±–∫–æ–≤ –∏ –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä –ø—Ä–∏–≤–∞—Ç–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω–æ–π –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–æ–º –∫–æ–º–ø–∞–Ω–∏–∏ –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –°–µ—Ä–µ–±—Ä–µ–Ω–Ω–∏–∫–æ–≤ –ø–æ–¥–ø–∏—Å–∞–ª–∏ —Å–æ–≥–ª–∞—à–µ–Ω–∏–µ –æ —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–æ–º –ø–∞—Ä—Ç–Ω–µ—Ä—Å—Ç–≤–µ –Ω–∞ ¬´–ò–Ω–Ω–æ–ø—Ä–æ–º–µ¬ª. üíä ¬´–ù–∏–∂—Ñ–∞—Ä–º¬ª –≤–ª–æ–∂–∏–ª—Å—è –≤ –Ω–æ–≤—É—é –ª–∏–Ω–∏—é —Ñ–∞—Å–æ–≤–∫—É –∏ —É–ø–∞–∫–æ–≤–∫–∏. –ö–æ–º–ø–∞–Ω–∏—è –∏–Ω–≤–µ—Å—Ç–∏—Ä–æ–≤–∞–ª–∞ 158 –º–ª–Ω —Ä—É–±–ª–µ–π –≤ –Ω–æ–≤—É—é –≤—ã—Å–æ–∫–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–Ω—É—é –ª–∏–Ω–∏—é —Ñ–∞—Å–æ–≤–∫–∏ –∏ —É–ø–∞–∫–æ–≤–∫–∏ –º—è–≥–∫–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Ñ–æ—Ä–º IWK –≤ –ù–∏–∂–Ω–µ–º –ù–æ–≤–≥–æ—Ä–æ–¥–µ. –≠—Ç–æ –ø–æ–º–æ–∂–µ—Ç —É–≤–µ–ª–∏—á–∏—Ç—å –æ–±—ä–µ–º –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ —Ç–∞–∫–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –Ω–∞ 50%. üíä –ú–∏–Ω–∑–¥—Ä–∞–≤ –≤—ã–¥–∞–ª ¬´–ì–µ–Ω–µ—Ä–∏—É–º—É¬ª —Ä–∞–∑—Ä–µ—à–µ–Ω–∏–µ –Ω–∞ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏–µ I —Ñ–∞–∑—ã –ö–ò –∞–Ω–∞–ª–æ–≥–∞ –æ—Ä—Ñ–∞–Ω–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –æ—Ç Alexion (–ø–æ–¥—Ä–∞–∑–¥–µ–ª–µ–Ω–∏–µ AstraZeneca). GNR-104 —Å—Ä–∞–≤–Ω—è—Ç —Å –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–º –°—Ç—Ä–µ–Ω–∑–∏–∫–æ–º. –≠—Ç–æ –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–π –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–π –≤ –†–§ –ø—Ä–µ–ø–∞—Ä–∞—Ç —Å –ú–ù–ù –∞—Å—Ñ–æ—Ç–∞–∑–∞ –∞–ª—å—Ñ–∞ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –≥–∏–ø–æ—Ñ–æ—Å—Ñ–∞—Ç–∞–∑–∏–∏. –û—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã–π –°—Ç—Ä–µ–Ω–∑–∏–∫ –∑–∞—â–∏—â—ë–Ω –ø–∞—Ç–µ–Ω—Ç–æ–º –¥–æ 2037 –≥–æ–¥–∞. üíä ¬´–ë–∏–æ–∫–∞–¥¬ª –ø–ª–∞–Ω–∏—Ä—É–µ—Ç –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞—Ç—å –ø–µ—Ä–≤—ã–π –≤ –†–§ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è –≥–µ–Ω–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –≥–µ–º–æ—Ñ–∏–ª–∏–∏ –í –≤ –Ω–∞—á–∞–ª–µ 2026 –≥–æ–¥–∞. –í–∏—Ü–µ-–ø—Ä–µ–∑–∏–¥–µ–Ω—Ç –∫–æ–º–ø–∞–Ω–∏–∏ –í–∞–ª–µ–Ω—Ç–∏–Ω –î–æ–¥–æ–Ω–æ–≤ —Ç–∞–∫–∂–µ —Ä–∞—Å—Å–∫–∞–∑–∞–ª, —á—Ç–æ –≤ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ —Å–µ–π—á–∞—Å –Ω–∞—Ö–æ–¥—è—Ç—Å—è –±–æ–ª–µ–µ —à–µ—Å—Ç–∏ –≥–µ–Ω–µ—Ç–∏—á–µ—Å–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. üíä Varda Space –ø—Ä–∏–≤–ª–µ–∫–ª–∞ $187 –º–ª–Ω –¥–æ–ª–ª–∞—Ä–æ–≤ –°–®–ê –Ω–∞ —Ä–∞–∑–≤–∏—Ç–∏–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ —Ä–æ–±–æ—Ç–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ –∫–æ—Å–º–æ—Å–µ. –ü–æ—Å–ª–µ–¥–Ω–∏–π —Ä–∞—É–Ω–¥ —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è —Å —É—á–∞—Å—Ç–∏–µ–º Lux Capital, –º–∏–ª–ª–∏–∞—Ä–¥–µ—Ä–∞ –ü–∏—Ç–µ—Ä–∞ –¢–∏–ª—è, Founders Fund –∏ –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–æ–Ω–Ω–æ–≥–æ —Ñ–æ–Ω–¥–∞ –í–∏–Ω–æ–¥–∞ –•–æ—Å–ª—ã Khosla Ventures –¥–æ–≤–µ–ª –æ–±—â–∏–π –æ–±—ä–µ–º –ø—Ä–∏–≤–ª–µ—á–µ–Ω–Ω–æ–≥–æ Varda –∫–∞–ø–∏—Ç–∞–ª–∞ –¥–æ $329 –º–ª–Ω. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": true
}"
2025-07-11T14:01:50+00:00,@bezrec,6297,https://t.me/bezrec/6297,"–°—ä–µ—à—å –æ—Å–∏–Ω–æ–≤–æ–π –∫–æ—Ä—ã - –∏ –≤–∑–±–æ–¥—Ä–∏—à—å—Å—è –¥–æ –ø–æ—Ä—ã: —á–∞–π, –Ω–µ —Ö–∏–º–∏—è –∫–∞–∫–∞—è, —á–∞–π, –ø—Ä–∏—Ä–æ–¥–Ω—ã–µ –¥–∞—Ä—ã! –ü—Ä–æ—Å—Ç–∏—Ç–µ, –Ω–∞–≤–µ—è–ª–æ –æ—Ç—á—ë—Ç–æ–º –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ë3-–ú–µ–¥¬ª. –ü–æ –¥–∞–Ω–Ω—ã–º, –∞–Ω–∞–ª–∏—Ç–∏–∫–æ–≤, –≤ 2024 –≥–æ–¥—É –≤ –†–æ—Å—Å–∏–∏ –∑–∞–∫—É–ø–∏–ª–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤, –Ω–µ –≤—Ö–æ–¥—è—â–∏—Ö –≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏, –Ω–∞ 16,2 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ò–∑ –Ω–∏—Ö 10 –º–ª—Ä–¥ –ø–æ—à–ª–æ –Ω–∞ –≥–æ–º–µ–æ–ø–∞—Ç–∏—é, –ë–ê–î—ã, —Ñ–∏—Ç–æ—Ç–µ—Ä–∞–ø–µ–≤—Ç–∏—á–µ—Å–∫–∏–µ —Å—Ä–µ–¥—Å—Ç–≤–∞ –∏ –¥–∞–∂–µ –ø—Ä–æ–¥—É–∫—Ç—ã ¬´–±–µ–∑ –¥–µ–π—Å—Ç–≤—É—é—â–µ–≥–æ –≤–µ—â–µ—Å—Ç–≤–∞¬ª. –í –ª–∏–¥–µ—Ä–∞—Ö –ø–æ –∑–∞–∫—É–ø–∫–∞–º —Ç–∞–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ ‚Äî –Ø–∫—É—Ç–∏—è, –£–¥–º—É—Ä—Ç–∏—è, –ß–µ—á–Ω—è, –ö–∞—Ä–∞—á–∞–µ–≤–æ-–ß–µ—Ä–∫–µ—Å–∏—è, –î–∞–≥–µ—Å—Ç–∞–Ω, –∞ —Ç–∞–∫–∂–µ –ê—Ä—Ö–∞–Ω–≥–µ–ª—å—Å–∫–∞—è –∏ –õ–µ–Ω–∏–Ω–≥—Ä–∞–¥—Å–∫–∞—è –æ–±–ª–∞—Å—Ç–∏, –°—Ç–∞–≤—Ä–æ–ø–æ–ª—å–µ, –ö—Ä–∞—Å–Ω–æ—è—Ä—Å–∫–∏–π –∫—Ä–∞–π –∏ –ß—É–∫–æ—Ç–∫–∞. –ü—Ä–∏—á—ë–º —Ç–∞–∫–æ–π ¬´–Ω–∞—Ç—É—Ä–ø—Ä–æ–¥—É–∫—Ç¬ª –≤—ã–ø–∏—Å—ã–≤–∞–ª–∏ –ø–∞—Ü–∏–µ–Ω—Ç–∞–º —Å —Å–µ—Ä—å—ë–∑–Ω—ã–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏. –ù–∞–ø—Ä–∏–º–µ—Ä, –æ–Ω–∫–æ–±–æ–ª—å–Ω—ã–º ‚Äî –≥–æ–º–µ–æ–ø–∞—Ç–∏—á–µ—Å–∫–∏–µ –∏ —Ñ–∏—Ç–æ–ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, –ø–∞—Ü–∏–µ–Ω—Ç–∞–º —Å –Ω–µ–π—Ä–æ—ç–Ω–¥–æ–∫—Ä–∏–Ω–Ω—ã–º–∏ –æ–ø—É—Ö–æ–ª—è–º–∏ ‚Äî —Ü–≤–µ—Ç—ã, –ª–∏—Å—Ç—å—è –∏ —ç–∫—Å—Ç—Ä–∞–∫—Ç—ã –±–µ—Ä–µ–∑—ã, –∑–≤–µ—Ä–æ–±–æ—è, –ø–∏–∂–º—ã –∏ —Ä–∞—Å—Ç–æ—Ä–æ–ø—à–∏. –ê–∏—Ä–∞, –∞—Ä–Ω–∏–∫–∏, –∫–æ—Ä—ã –¥—É–±–∞, –ø–µ—Ä–µ—á–Ω–æ–π –º—è—Ç—ã, –ø–∏—Ö—Ç—ã, —Ä–æ–º–∞—à–∫–∏, —à–∞–ª—Ñ–µ—è –∏ –≤–∞–ª–µ—Ä–∏–∞–Ω—ã –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Ä–∞–∫–∞ –Ω–æ—Å–æ–≥–ª–æ—Ç–∫–∏ –∑–∞–∫—É–ø–∏–ª–∏ –Ω–∞ 13,5 –º–ª–Ω —Ä—É–±–ª–µ–π. –ü—Ä–µ–ø–∞—Ä–∞—Ç—ã —Å –ø–æ–¥–æ—Ä–æ–∂–Ω–∏–∫–æ–º ¬´–∑–∞–±—Ä–∞–ª–∏¬ª —É —Ä–µ–≥–∏–æ–Ω–æ–≤ 19 –º–ª–Ω —Ä—É–±–ª–µ–π, –∫–∞–ª–µ–Ω–¥—É–ª–∞ –∏ –∞–ª—Ç–µ—è ‚Äî 9 –º–ª–Ω –∏ 7,4 –º–ª–Ω —Ä—É–±–ª–µ–π —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ. –¢–∞–∫–∏–µ –∑–∞–∫—É–ø–∫–∏ –ø—Ä–∏–≤–ª–µ–∫–∞—é—Ç –≤–Ω–∏–º–∞–Ω–∏–µ, —Ç.–∫. –≤–º–µ—Å—Ç–æ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –±—é–¥–∂–µ—Ç–Ω—ã–µ —Å—Ä–µ–¥—Å—Ç–≤–∞ —Ç—Ä–∞—Ç—è—Ç—Å—è –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞, –∫–æ—Ç–æ—Ä—ã–µ –º–∞–ª–æ –∏–∑—É—á–µ–Ω—ã –∏ –º–æ–≥—É—Ç –ø—Ä–∏—á–∏–Ω–∏—Ç—å –≤—Ä–µ–¥ –∑–¥–æ—Ä–æ–≤—å—é –ø–∞—Ü–∏–µ–Ω—Ç–∞. –õ–æ–≥–∏—á–Ω–µ–µ –Ω–∞–ø—Ä–∞–≤–ª—è—Ç—å —Å—Ä–µ–¥—Å—Ç–≤–∞ –Ω–∞ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤ —Å –Ω–∏–∑–∫–æ –¥–æ–∫–∞–∑–∞–Ω–Ω–æ–π —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å—é –∏–ª–∏ –Ω–∞ –∑–∞–∫—É–ø–∫—É –ø—Ä–æ–≤–µ—Ä–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, ‚Äî –ø—Ä–æ–∫–æ–º–º–µ–Ω—Ç–∏—Ä–æ–≤–∞–ª –æ—Ç—á—ë—Ç –æ—Å–Ω–æ–≤–∞—Ç–µ–ª—å ¬´–ë3-–ú–µ–¥¬ª –∏ —Ç–µ—Ä–∞–ø–µ–≤—Ç –ï–≤–≥–µ–Ω–∏–π –ö–æ—Ä–æ–≤–∏–Ω, –Ω–∞–ø–æ–º–Ω–∏–≤, —á—Ç–æ –≤ –†–æ—Å—Å–∏–∏ –Ω–µ—Ç —Å—Ç—Ä–æ–≥–æ–≥–æ —Ä–µ–≥–ª–∞–º–µ–Ω—Ç–∞, –∫–æ—Ç–æ—Ä—ã–π –æ–≥—Ä–∞–Ω–∏—á–∏–≤–∞–ª –±—ã –∑–∞–∫—É–ø–∫—É –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –Ω–µ –≤—Ö–æ–¥—è—â–∏—Ö –≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏. –°–ø—Ä–∞–≤–µ–¥–ª–∏–≤–æ—Å—Ç–∏ —Ä–∞–¥–∏, –Ω–µ –≤—Å—ë —Ç–æ, —á—Ç–æ –Ω–µ –≤ –∫–ª–∏–Ω—Ä–µ–∫–∞—Ö ‚Äî —Ç—Ä–∞–≤–∞. –¢–∞–∫, –≤ —Å–ø–∏—Å–∫–µ –∑–∞–∫—É–ø–æ–∫ –ø—Ä–∏—Å—É—Ç—Å—Ç–≤—É—é—Ç –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ —Ä–µ–¥–∫–∏—Ö –≥–µ–Ω–µ—Ç–∏—á–µ—Å–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, –Ω–∞–ø—Ä–∏–º–µ—Ä, –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –Ω–∞ –æ—Å–Ω–æ–≤–µ —Ü–µ—Ä–ª–∏–ø–æ–Ω–∞–∑—ã –∞–ª—å—Ñ–∞, –º–µ–∫–∞—Å–µ—Ä–º–∏–Ω–∞ –∏ –∞–ª–≥–ª—é–∫–æ–∑–∏–¥–∞–∑—ã –∞–ª—å—Ñ–∞. –í—Å–µ–≥–æ –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –Ω–µ –≤—Ö–æ–¥—è—â–∏—Ö –∫–ª–∏–Ω—Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏, –∫—É–ø–ª–µ–Ω–æ –ø–æ—á—Ç–∏ –Ω–∞ 4,5 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –í —Ç–æ–º —á–∏—Å–ª–µ –¥–ª—è –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–µ–π –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª. –ê —Ç–∞–∫ –º–æ–∂–Ω–æ –±—ã–ª–æ? –í –ú–∏–Ω–∑–¥—Ä–∞–≤–µ —Å–∫–∞–∑–∞–ª–∏, —á—Ç–æ –¥–∞ ‚Äî –ø—Ä–∏ –Ω–∞–ª–∏—á–∏–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –ø–æ–∫–∞–∑–∞–Ω–∏–π –∏ –ø–æ —Ä–µ—à–µ–Ω–∏—é –≤—Ä–∞—á–µ–±–Ω–æ–π –∫–æ–º–∏—Å—Å–∏–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, shortage, regulation"",
  ""impact"": ""high"",
  ""english"": ""The report from 'B3-Med' company states that in Russia, budget funds were allocated for off-approval medicines amounting to 16.2 billion rubles in 2024, including homeopathic and herbal remedies. Regions like Yakutia, Udmurtia, Chechnya, Karachaevo-Cherkessia, Dagestan, Arkhangelsk and Leningrad regions, Stavropol region, Krasnoyarsk region, and Chukotka were among the top buyers. The report highlights that such treatments were prescribed to patients with serious diseases, including cancer and neuro-endocrine tumors. The comment by the founder of 'B3-Med', Dr. Evgeny Korovin, suggests that instead of effective treatments, budget funds are being used on untested and potentially harmful natural products. The issue raises concerns about the allocation of funds for clinical trials or purchasing proven medicines.""
}"
2025-07-11T11:01:50+00:00,@bezrec,6296,https://t.me/bezrec/6296,"–í—ã–±–æ—Ä –ª—É—á—à–∏—Ö –Ω–µ —Å–æ—Å—Ç–æ—è–ª—Å—è. –í—á–µ—Ä–∞ –º—ã –æ–±—â–∏–º–∏ —É—Å–∏–ª–∏—è–º–∏ –¥–æ–ª–∂–Ω—ã –±—ã–ª–∏ –æ–ø—Ä–µ–¥–µ–ª–∏—Ç—å, –∫–∞–∫–∏–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –∏–Ω—Ç–µ—Ä–µ—Å–Ω–µ–µ #–∑–∞–ø–∞–∫–æ–≤–∞–ª–∏ —Å—Ä–µ–¥—Å—Ç–≤–∞ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –Ω–∏–∫–æ—Ç–∏–Ω–æ–≤–æ–π –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏ –Ω–∞ –æ—Å–Ω–æ–≤–µ —Ü–∏—Ç–∏–∑–∏–Ω–∞. –ù–æ –Ω–µ —Å–ª—É—á–∏–ª–æ—Å—å ‚Äî –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏ —Å—Ä–∞–∑—É —Å—Ç–∞–ª–æ –ø–æ–Ω—è—Ç–Ω–æ, —á—Ç–æ –≥–æ–ª–æ—Å–∞ –≤ –æ–ø—Ä–æ—Å–µ –Ω–∞–∫—Ä—É—Ç–∏–ª–∏, –∏ –º—ã –≤—ã–Ω—É–∂–¥–µ–Ω—ã –±—ã–ª–∏ –æ—Å—Ç–∞–Ω–æ–≤–∏—Ç—å –≥–æ–ª–æ—Å–æ–≤–∞–Ω–∏–µ. –¢–∞–∫–æ–µ —É –Ω–∞—Å –≤–ø–µ—Ä–≤—ã–µ. –ù–∏–∫–æ–≥–æ –Ω–µ –æ–±–≤–∏–Ω—è–µ–º ‚Äî –≤–æ–∑–º–æ–∂–Ω–æ, —ç—Ç–æ –ø—Ä–æ–∏—Å–∫–∏ –∫–æ–Ω–∫—É—Ä–µ–Ω—Ç–æ–≤. –í–ø—Ä–æ—á–µ–º, –æ—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω—ã–π —Ä–µ–∑—É–ª—å—Ç–∞—Ç ‚Äî —Ç–æ–∂–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç. –¢–µ–ø–µ—Ä—å –º—ã –∑–Ω–∞–µ–º, —á—Ç–æ —Ä—É–±—Ä–∏–∫–∞ –∏–Ω—Ç–µ—Ä–µ—Å–Ω–∞ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º –∏ –∫–æ–º–ø–∞–Ω–∏–∏ –ø—Ä–∏—Å—Ç–∞–ª—å–Ω–æ —Å–ª–µ–¥—è—Ç –∑–∞ –Ω–∞—à–∏–º–∏ –æ–ø—Ä–æ—Å–∞–º–∏. –ü–µ—Ä–≤—ã–º–∏ —Ö–æ—á–µ—Ç—Å—è –±—ã—Ç—å –≤—Å–µ–º, –≥–ª–∞–≤–Ω–æ–µ, —á—Ç–æ–±—ã —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –±—ã–ª–∏ –æ–±—ä–µ–∫—Ç–∏–≤–Ω—ã–º–∏, –∞ –ø–æ–±–µ–¥—ã ‚Äî —á–µ—Å—Ç–Ω—ã–º–∏. –í—Å—ë —É—á—Ç—ë–º –∏ –±—É–¥–µ–º –ø—Ä–æ–¥–æ–ª–∂–∞—Ç—å. –°—Ç–∞—Ä–∞–π—Ç–µ—Å—å ‚Äî –∫–æ–Ω–∫—É—Ä–µ–Ω—Ç—ã —ç—Ç–æ –≤–∏–¥—è—Ç! ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-07-11T09:00:07+00:00,@bezrec,6295,https://t.me/bezrec/6295,"–ü–æ –¥–∞–Ω–Ω—ã–º –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è ¬´–ú–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥ –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤¬ª, –ø—Ä–æ–≤–µ–¥–µ–Ω–Ω–æ–≥–æ –ò–Ω—Å—Ç–∏—Ç—É—Ç–æ–º —Å–æ—Ü–∏–∞–ª—å–Ω–æ–≥–æ –∞–Ω–∞–ª–∏–∑–∞ –∏ –ø—Ä–æ–≥–Ω–æ–∑–∏—Ä–æ–≤–∞–Ω–∏—è –†–ê–ù–•–∏–ì–°, –æ–∫–∞–∑–∞–ª–æ—Å—å —á—Ç–æ –ø–æ–∫—É–ø–∫–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ ‚Äî —ç—Ç–æ —á—Ç–æ-—Ç–æ –Ω–∞ –±–æ–≥–∞—Ç–æ–º –¥–ª—è –∫–∞–∂–¥–æ–≥–æ —Ç—Ä–µ—Ç—å–µ–≥–æ —Ä–µ—Å–ø–æ–Ω–¥–µ–Ω—Ç–∞. –¢–µ–ª–µ—Ñ–æ–Ω–Ω—ã–π –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥ –≤–∑—Ä–æ—Å–ª–æ–≥–æ –Ω–∞—Å–µ–ª–µ–Ω–∏—è —Å—Ç–∞—Ä—à–µ 18 –ª–µ—Ç, –∫–æ—Ç–æ—Ä—ã–π —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –∏–Ω—Å—Ç–∏—Ç—É—Ç–∞ –ø—Ä–æ–≤–æ–¥–∏–ª–∏ –≤ –¥–µ–∫–∞–±—Ä–µ 2022 –∏ 2023-–≥–æ –∏ –≤ –Ω–æ—è–±—Ä–µ-–¥–µ–∫–∞–±—Ä–µ 2024 –≥–æ–¥–∞, –ø–æ–∫–∞–∑–∞–ª, —á—Ç–æ –≤ 54% —Å–ª—É—á–∞–µ–≤ –ª—é–¥–∏ —Å—Ç–∞–ª–∫–∏–≤–∞–ª–∏—Å—å —Å –Ω–µ–≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å—é –∫—É–ø–∏—Ç—å –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –∏–∑-–∑–∞ –Ω–µ—Ö–≤–∞—Ç–∫–∏ –¥–µ–Ω–µ–≥. –û—Ç—Å—É—Ç—Å—Ç–≤–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ –∞–ø—Ç–µ–∫–µ —É—à–ª–æ –Ω–∞ –≤—Ç–æ—Ä–æ–π –ø–ª–∞–Ω. –ï—â—ë –¥–∞–Ω–Ω—ã–µ –∏–∑ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –ò–ù–°–ê–ü: üîΩ75% —Ä–µ—Å–ø–æ–Ω–¥–µ–Ω—Ç–æ–≤ –ø–æ—á—É–≤—Å—Ç–≤–æ–≤–∞–ª–∏ –≤ 2024 –≥–æ–¥—É —Å—É—â–µ—Å—Ç–≤–µ–Ω–Ω—ã–π —Ä–æ—Å—Ç —Ü–µ–Ω –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞; üîΩ—á–∞—â–µ –≤—Å–µ–≥–æ –µ–≥–æ –æ—Ç–º–µ—á–∞–ª–∏ –∂–µ–Ω—â–∏–Ω—ã, –ø–æ–∂–∏–ª—ã–µ –ª—é–¥–∏ –∏ –∂–∏—Ç–µ–ª–∏ —Å–µ–ª—å—Å–∫–∏—Ö —Ä–∞–π–æ–Ω–æ–≤; üîΩ84% —Å–µ–º–µ–π —Å –Ω–∏–∑–∫–∏–º –¥–æ—Ö–æ–¥–æ–º (–¥–æ 15 —Ç—ã—Å. —Ä—É–±–ª–µ–π –Ω–∞ —á–µ–ª–æ–≤–µ–∫–∞) –Ω–µ –º–æ–≥—É—Ç –ø–æ–∫—É–ø–∞—Ç—å –Ω—É–∂–Ω—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏–∑-–∑–∞ –º–∞—Ç–µ—Ä–∏–∞–ª—å–Ω—ã—Ö —Ç—Ä—É–¥–Ω–æ—Å—Ç–µ–π; üîΩ–¥–ª—è —Å–µ–º–µ–π —Å–æ —Å—Ä–µ–¥–Ω–∏–º–∏ (15 —Ç—ã—Å. - 35 —Ç—ã—Å. —Ä—É–±–ª–µ–π –Ω–∞ —á–µ–ª–æ–≤–µ–∫–∞) –∏ –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ –≤—ã—Å–æ–∫–∏–º–∏ –¥–æ—Ö–æ–¥–∞–º–∏ (–±–æ–ª–µ–µ 35 —Ç—ã—Å. —Ä—É–±–ª–µ–π –Ω–∞ —á–µ–ª–æ–≤–µ–∫–∞) –Ω–µ—Ö–≤–∞—Ç–∫–∞ –¥–µ–Ω–µ–≥ –æ–∫–∞–∑–∞–ª–∞—Å—å –ø—Ä–µ–≥—Ä–∞–¥–æ–π –¥–ª—è –ø–æ–∫—É–ø–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ 56% –∏ 30% —Å–ª—É—á–∞–µ–≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ. –ß—Ç–æ –ø–æ–¥–æ—Ä–æ–∂–∞–ª–æ –∑–∞–º–µ—Ç–Ω–µ–µ –≤—Å–µ–≥–æ? –ü–æ –¥–∞–Ω–Ω—ã–º –æ–±–∑–æ—Ä–∞ –≥–æ–¥–æ–≤–æ–π –¥–∏–Ω–∞–º–∏–∫–∏ —Ü–µ–Ω –ø–æ –∏–Ω–¥–µ–∫—Å—É –õ–∞—Å–ø–µ–π–µ—Ä—Å–∞ –æ—Ç RNC Pharma, –≤ —è–Ω–≤–∞—Ä–µ-–º–∞—Ä—Ç–µ 2025 –≥–æ–¥–∞ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å 2024 –≥–æ–¥–æ–º —Å–∏–ª—å–Ω–µ–µ –≤—Å–µ–≥–æ –ø—Ä–∏–±–∞–≤–∏–ª–∏ –≤ —Ü–µ–Ω–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –ø—Ä–æ—Ç–∏–≤ –º–∏–∫–æ–±–∞–∫—Ç–µ—Ä–∏–π –¥–ª—è –ª–µ—á–µ–Ω–∏—è –∫–∞–∫ –æ—Å—Ç—Ä—ã—Ö –ª–∞—Ä–∏–Ω–≥–∏—Ç–∞ –∏ —Ç—Ä–∞—Ö–µ–∏—Ç–∞, —Ç–∞–∫ –∏ —Ç—É–±–µ—Ä–∫—É–ª–µ–∑–∞ (+41%). –ù–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ (+30%) ‚Äî –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –æ—Ç –æ–∂–∏—Ä–µ–Ω–∏—è, –Ω–∞ —Ç—Ä–µ—Ç—å–µ–º (+28%) ‚Äî –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã —Å–æ —Å–º—è–≥—á–∞—é—â–∏–º –∏ –ø—Ä–æ—Ç–µ–∫—Ç–æ—Ä–Ω—ã–º –≤–æ–∑–¥–µ–π—Å—Ç–≤–∏–µ–º –Ω–∞ –∫–æ–∂—É. –ü—Ä–æ–≥–Ω–æ–∑—ã —É —ç–∫—Å–ø–µ—Ä—Ç–æ–≤ –ò–ù–°–ê–ü –Ω–µ —Å–∞–º—ã–µ –æ–ø—Ç–∏–º–∏—Å—Ç–∏—á–Ω—ã–µ ‚Äî –≤ 2025 –≥–æ–¥—É —Ä–æ—Å—Ç —Ü–µ–Ω –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –ø—Ä–æ–¥–æ–ª–∂–∏—Ç—Å—è –∏ –Ω–µ–¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ø–æ —Ñ–∏–Ω–∞–Ω—Å–æ–≤—ã–º –ø—Ä–∏—á–∏–Ω–∞–º –±—É–¥–µ—Ç —Ç–æ–ª—å–∫–æ –≤–æ–∑—Ä–∞—Å—Ç–∞—Ç—å. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, shortage, epidemic"",
  ""impact"": ""high"",
  ""english"": ""The survey by the Institute of Social Analysis and Forecasting RANHHGIS showed that purchasing medicines is something for every third respondent. A telephone monitoring of adults older than 18 years, conducted by the institute in December 2022 and 2023-2024, showed that in 54% of cases people faced the inability to buy necessary drugs due to lack of money. The shortage of medicines in pharmacies has taken second place. Data from the survey by INSA-P: üîΩ75% of respondents felt a significant increase in prices on medicines in 2024; üîΩwomen, elderly people and residents of rural areas most often noted this increase; üîΩ84% of low-income families (less than 15,000 rubles per person) cannot buy necessary drugs due to financial difficulties; üîΩfamilies with average (15,000 - 35,000 rubles per person) and relatively high incomes (more than 35,000 rubles"
2025-07-11T05:20:24+00:00,@bezrec,6294,https://t.me/bezrec/6294,"–§–ê–° —Ä–∞–∑–±–µ—Ä—ë—Ç—Å—è –≤ —Å–ø–æ—Ä–µ –∑–∞ —Ç–µ–¥—É–≥–ª—É—Ç–∏–¥. –ê–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å—â–∏–∫–∏ –ø—Ä–∏–æ—Å—Ç–∞–Ω–æ–≤–∏–ª–∏ –∑–∞–∫—É–ø–∫—É –æ—Ä—Ñ–∞–Ω–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å —Å–∏–Ω–¥—Ä–æ–º–æ–º –∫–æ—Ä–æ—Ç–∫–æ–π –∫–∏—à–∫–∏. –ü—Ä–∏—á–∏–Ω–æ–π –ø–æ—Å–ª—É–∂–∏–ª–∞ –∂–∞–ª–æ–±–∞ –æ–¥–Ω–æ–≥–æ –∏–∑ —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –∞—É–∫—Ü–∏–æ–Ω–∞ ‚Äî ¬´–§–∞—Ä–º–∏–º—ç–∫—Å–∞¬ª. –ö–æ–º–ø–∞–Ω–∏—è ‚Äî –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω—ã–π –¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω–æ–≥–æ –ì—ç—Ç—Ç–µ—Å—Ç–∏–≤–∞ —è–ø–æ–Ω—Å–∫–æ–π Takeda. –í —Ç–µ–Ω–¥–µ—Ä–µ —Ç–∞–∫–∂–µ —É—á–∞—Å—Ç–≤–æ–≤–∞–ª–∏ –∞–Ω–æ–Ω–∏–º–Ω–∞—è –∫–æ–º–ø–∞–Ω–∏—è –∏ ¬´–§–ö –ì—Ä–∞–Ω–¥ –ö–∞–ø–∏—Ç–∞–ª¬ª, –∫–æ—Ç–æ—Ä–æ–º—É –∏ –¥–æ–ª–∂–Ω–æ –±—ã–ª–æ –¥–æ—Å—Ç–∞—Ç—å—Å—è –ø—Ä–∞–≤–æ –Ω–∞ –ø–æ—Å—Ç–∞–≤–∫—É —Ç–µ–¥—É–≥–ª—É—Ç–∏–¥–∞ –¥–ª—è –ø–æ–¥–æ–ø–µ—á–Ω—ã—Ö ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª –∫–∞–∫ –ø—Ä–µ–¥–ª–æ–∂–∏–≤—à–µ–º—É –º–∏–Ω–∏–º–∞–ª—å–Ω—É—é —Ü–µ–Ω—É ‚Äî 959 –º–ª–Ω —Ä—É–±–ª–µ–π –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å 1,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π —É ¬´–§–∞—Ä–º–∏–º—ç–∫—Å–∞¬ª –∏ 970 –º–ª–Ω —Ä—É–±–ª–µ–π —É –≤—Ç–æ—Ä–æ–≥–æ —É—á–∞—Å—Ç–Ω–∏–∫–∞. ¬´–§–∞—Ä–º–∏–º—ç–∫—Å¬ª –ø–æ—Å—á–∏—Ç–∞–ª, —á—Ç–æ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤ –Ω–∞—Ä—É—à–∏–ª–∏ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç—É–∞–ª—å–Ω—ã–µ –ø—Ä–∞–≤–∞, —Ç.–∫. —Ä–µ–∞–ª–∏–∑–∞—Ü–∏—è –≤–æ—Å–ø—Ä–æ–∏–∑–≤–µ–¥–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –ø—Ä–∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –∫–æ—Ç–æ—Ä—ã—Ö –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–ª–∏—Å—å –¥–∞–Ω–Ω—ã–µ –æ –¥–æ–∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è—Ö –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞, –¥–æ –∏—é–Ω—è 2027 –≥–æ–¥–∞ –∑–∞–ø—Ä–µ—â–µ–Ω–∞. –ó–∞—è–≤–∏—Ç–µ–ª—å —É—Ç–≤–µ—Ä–∂–¥–∞–µ—Ç, —á—Ç–æ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤ –±—ã–ª–∏ –¥–æ–ø—É—â–µ–Ω—ã –∫ —É—á–∞—Å—Ç–∏—é –≤ –∞—É–∫—Ü–∏–æ–Ω–µ –Ω–µ–∑–∞–∫–æ–Ω–Ω–æ. –ü–æ–∑–∏—Ü–∏—è –¥—Ä—É–≥–∏—Ö —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ —Å–ø–æ—Ä–∞. –ü–æ –¥–∞–Ω–Ω—ã–º –ì–†–õ–°, —Å–≤–æ–π —Ç–µ–¥—É–≥–ª—É—Ç–∏–¥, –ø–æ–º–∏–º–æ ¬´–¢–∞–∫–µ–¥—ã¬ª, –µ—Å—Ç—å —É ¬´–ü—Ä–æ–º–æ–º–µ–¥–∞¬ª –∏ ¬´–ü–°–ö –§–∞—Ä–º—ã¬ª. ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª —É—Ç–≤–µ—Ä–∂–¥–∞–µ—Ç, —á—Ç–æ –¢–µ–¥—É–≥–ª—É—Ç–∏–¥ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω –≤ —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–Ω–æ–º –∑–∞–∫–æ–Ω–æ–º –ø–æ—Ä—è–¥–∫–µ –∏ –æ—Å–Ω–æ–≤–∞–Ω–∏–π —Å–æ–º–Ω–µ–≤–∞—Ç—å—Å—è –≤ –ø—Ä–∞–≤–æ–º–µ—Ä–Ω–æ—Å—Ç–∏ —É–∫–∞–∑–∞–Ω–Ω–æ–π —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –Ω–µ—Ç. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –∫–æ–º–ø–∞–Ω–∏—è ¬´–Ω–∏–∫–æ–≥–¥–∞ –Ω–µ –∏–º–µ–ª–∞ –¥–æ—Å—Ç—É–ø–∞ –∫ –¥–æ–∫—É–º–µ–Ω—Ç–∞–º, –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–Ω—ã–º ¬´–¢–∞–∫–µ–¥–∞¬ª –¥–ª—è —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –∫–∞–∫–∏—Ö-–ª–∏–±–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –∏ –ø–æ—Ç–æ–º—É –Ω–∏–∫–æ–≥–¥–∞ –Ω–µ –∏–º–µ–ª–∞ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ –∫–∞–∫-–ª–∏–±–æ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å —Ç–∞–∫–∏–µ –¥–æ–∫—É–º–µ–Ω—Ç—ã, –ª–∏–±–æ —Å–æ–¥–µ—Ä–∂–∞—â—É—é—Å—è –≤ –Ω–∏—Ö –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é¬ª. –ü—Ä–æ–≤–µ–¥–µ–Ω–Ω—ã–µ –ø–∞—Ç–µ–Ω—Ç–Ω—ã–π –ø–æ–∏—Å–∫ –∏ –∞–Ω–∞–ª–∏–∑ –ø–æ–∑–≤–æ–ª—è—é—Ç —Å–¥–µ–ª–∞—Ç—å –≤—ã–≤–æ–¥, —á—Ç–æ –ø—Ä–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ –∏ –≤–≤–µ–¥–µ–Ω–∏–∏ –≤ –æ–±–æ—Ä–æ—Ç –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –¢–µ–¥—É–≥–ª—É—Ç–∏–¥ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ê–û ¬´–ë–∏–æ—Ö–∏–º–∏–∫¬ª –Ω–µ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω—ã –∫–∞–∫–∏–µ-–ª–∏–±–æ –æ—Ö—Ä–∞–Ω—è–µ–º—ã–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç—É–∞–ª—å–Ω–æ–π –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏, –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∞—â–∏–µ —Ç—Ä–µ—Ç—å–∏–º –ª–∏—Ü–∞–º, –±–µ–∑ –∏—Ö —Å–æ–≥–ª–∞—Å–∏—è, ‚Äî –∑–∞–≤–µ—Ä–∏–ª–∏ –≤ ¬´–ü—Ä–æ–º–æ–º–µ–¥–µ¬ª. –≠–∫—Å–ø–µ—Ä—Ç—ã —é—Ä–∏–¥–∏—á–µ—Å–∫–æ–π —Ñ–∏—Ä–º—ã Verba Legal –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª–∏, —á—Ç–æ –≤ –†–§ –∏–∑ –¥–µ–π—Å—Ç–≤—É—é—â–∏—Ö –ø–∞—Ç–µ–Ω—Ç–æ–≤, —Å–≤—è–∑–∞–Ω–Ω—ã—Ö —Å —Ç–µ–¥—É–≥–ª—É—Ç–∏–¥–æ–º, –ø—Ä–∏—Å—É—Ç—Å—Ç–≤—É–µ—Ç —Ç–æ–ª—å–∫–æ ¬´–æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ —Å–ª–∞–±—ã–π¬ª –¥–æ–∫—É–º–µ–Ω—Ç Takeda –Ω–∞ —Å–ø–æ—Å–æ–± –ª–µ—á–µ–Ω–∏—è. –í ¬´–ü–°–ö –§–∞—Ä–º–∞¬ª –Ω–∞ –Ω–∞—à –∑–∞–ø—Ä–æ—Å –Ω–µ –æ—Ç–≤–µ—Ç–∏–ª–∏. –í ¬´–§–ö –ì—Ä–∞–Ω–¥ –ö–∞–ø–∏—Ç–∞–ª¬ª –æ—Ç–∫–∞–∑–∞–ª–∏—Å—å –∫–æ–º–º–µ–Ω—Ç–∏—Ä–æ–≤–∞—Ç—å –ø–æ–¥–∞–Ω–Ω—É—é –∂–∞–ª–æ–±—É –¥–æ –µ—ë —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏—è –≤ –§–ê–°, –ø–æ–¥—á–µ—Ä–∫–Ω—É–≤, —á—Ç–æ –æ—Å—É—â–µ—Å—Ç–≤–ª—è—é—Ç —Å–≤–æ—é –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç—å –≤ —Å—Ç—Ä–æ–≥–æ–º —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–∏ —Å –¥–µ–π—Å—Ç–≤—É—é—â–∏–º –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–æ–º. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""import_export, sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""The FAS is investigating the dispute over teduglutide. Antimonopoly authorities have suspended an orphan drug procurement for patients with short bowel syndrome due to one of the auction participants - 'Farmaemsa'. The company is an official distributor of original Gattestiv from Japanese Takeda. Other participants in the auction were anonymous company and 'Fragrand Capital', which was supposed to get the right to supply teduglutide for patients of 'The Kindness Circle' at a minimum price of 959 million rubles, compared to 'Farmaemsa' at 1.7 billion rubles and 970 million rubles from the second participant. 'Farmaemsa' claims that generic producers violated intellectual property rights, as the production and introduction of reproduced drugs for which registration was based on data from clinical trials of the original drug are prohibited until June 2027. The claimant argues that generic producers were illegally admitted to the auction. Other parties' positions are as follows: 'Promomed' claims that tedug"
2025-07-10T10:45:45+00:00,@bezrec,6292,https://t.me/bezrec/6292,"–ü—Ä–æ—Ç–∏–≤–æ–∫–æ–≤–∏–¥–Ω—ã–µ –≤–∞–∫—Ü–∏–Ω—ã –Ω–µ –ø–æ–¥–≤–µ–ª–∏ –£—Ä—Å—É–ª—É. –í–æ—Ç—É–º –Ω–µ–¥–æ–≤–µ—Ä–∏—è –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—é –ï–≤—Ä–æ–∫–æ–º–∏—Å—Å–∏–∏ –£—Ä—Å—É–ª–µ —Ñ–æ–Ω –¥–µ—Ä –õ—è–π–µ–Ω –æ–∂–∏–¥–∞–µ–º–æ –æ—Ç–∫–ª–æ–Ω—ë–Ω. –ó–∞ —Ç–∞–∫–æ–µ —Ä–µ—à–µ–Ω–∏–µ –ø—Ä–æ–≥–æ–ª–æ—Å–æ–≤–∞–ª–∏ 360 –¥–µ–ø—É—Ç–∞—Ç–æ–≤ –∏–∑ 553, 175 –ø–∞—Ä–ª–∞–º–µ–Ω—Ç–∞—Ä–∏–µ–≤ –≤–æ—Ç—É–º –ø–æ–¥–¥–µ—Ä–∂–∞–ª–∏, –µ—â—ë 18 –≤–æ–∑–¥–µ—Ä–∂–∞–ª–∏—Å—å. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-07-10T09:45:38+00:00,@bezrec,6290,https://t.me/bezrec/6290,"–°–µ–≥–æ–¥–Ω—è –≤ –Ω–∞—à–µ–π —Ä—É–±—Ä–∏–∫–µ #–∑–∞–ø–∞–∫–æ–≤–∞–ª–∏ —Å—Ä–µ–¥—Å—Ç–≤–∞ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –Ω–∏–∫–æ—Ç–∏–Ω–æ–≤–æ–π –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏ –Ω–∞ –æ—Å–Ω–æ–≤–µ —Ü–∏—Ç–∏–∑–∏–Ω–∞ –∏–∑ —Ç–æ–ø-10 RNC Pharma. –ü—Ä–æ—Å–∏–º –≤ –æ–ø—Ä–æ—Å–µ –≤—ã–±—Ä–∞—Ç—å –æ–¥–∏–Ω –∏–∑ –ø—è—Ç–∏ –≤–∞—Ä–∏–∞–Ω—Ç–æ–≤, –∏—Å—Ö–æ–¥—è –∏—Å–∫–ª—é—á–∏—Ç–µ–ª—å–Ω–æ –∏–∑ –¥–∏–∑–∞–π–Ω–∞ —É–ø–∞–∫–æ–≤–∫–∏: 1. –¢–∞–±–µ–∫—Å (¬´–°–æ—Ñ–∞—Ä–º–∞¬ª); 2. –ù–∏–∫—É—Ä–∏–ª–ª—ã (¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª); 3. –¢–∞–±–∞–∫–µ—Ç—Ç–µ (¬´–°–µ–≤–µ—Ä–Ω–∞—è –ó–≤–µ–∑–¥–∞¬ª); 3. –ù–∏–∫–æ–∑–∞–º (¬´–ê–í–í–ê –§–∞—Ä–º–∞—Å—å—é—Ç–∏–∫–∞–ª¬ª); 5. –¶–∏—Ç–∏–∑–∏–Ω (¬´–í–∏—Ñ–∏—Ç–µ—Ö¬ª). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-07-10T06:20:01+00:00,@bezrec,6289,https://t.me/bezrec/6289,"–°–æ–≤—Ñ–µ–¥ –ø—Ä–æ—Å–∏—Ç –≤–∑—è—Ç—å—Å—è –∑–∞ –¥–≤—É—Ö–∞—Ç–æ–º–Ω—ã–π —Å–ø–∏—Ä—Ç. –ì–ª–∞–≤–∞ —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–≥–æ –∫–æ–º–∏—Ç–µ—Ç–∞ –ê–Ω–¥—Ä–µ–π –ö—É—Ç–µ–ø–æ–≤ –æ–±—Ä–∞—Ç–∏–ª—Å—è –∫ –≤–∏—Ü–µ-–ø—Ä–µ–º—å–µ—Ä—É –¢–∞—Ç—å—è–Ω–µ –ì–æ–ª–∏–∫–æ–≤–æ–π —Å –∞–Ω—Ç–∏–Ω–∞—Ä–∫–æ—Ç–∏—á–µ—Å–∫–∏–º–∏ –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–∞–º–∏. –í —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, —Å–µ–Ω–∞—Ç–æ—Ä –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç —É—Å–∏–ª–∏—Ç—å –∫–æ–Ω—Ç—Ä–æ–ª—å –∑–∞ 1,4-–±—É—Ç–∞–Ω–¥–∏–æ–ª–æ–º. –û–±–æ—Ä–æ—Ç —ç—Ç–æ–≥–æ –≤–µ—â–µ—Å—Ç–≤–∞ –≤ –∫–æ–Ω—Ü–µ–Ω—Ç—Ä–∞—Ü–∏–∏ –º–µ–Ω–µ–µ 15% –Ω–µ —Ä–µ–≥—É–ª–∏—Ä—É–µ—Ç—Å—è, –∞ –º–µ–∂–¥—É —Ç–µ–º –µ–≥–æ –ø—Ä–∏–Ω–æ—Ä–æ–≤–∏–ª–∏—Å—å –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å –¥–ª—è –∏–∑–≥–æ—Ç–æ–≤–ª–µ–Ω–∏—è —Å–∏–ª—å–Ω–æ–¥–µ–π—Å—Ç–≤—É—é—â–µ–≥–æ –Ω–∞—Ä–∫–æ—Ç–∏–∫–∞. –ü–æ–ª–Ω–æ—Å—Ç—å—é –∑–∞–ø—Ä–µ—Ç–∏—Ç—å –¥–≤—É—Ö–∞—Ç–æ–º–Ω—ã–π —Å–ø–∏—Ä—Ç –Ω–µ –ø–æ–ª—É—á–∏—Ç—Å—è, —Ç.–∫. –æ–Ω —à–∏—Ä–æ–∫–æ –∏—Å–ø–æ–ª—å–∑—É–µ—Ç—Å—è –≤ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –ø–æ–ª–∏–º–µ—Ä–Ω—ã—Ö –º–∞—Ç–µ—Ä–∏–∞–ª–æ–≤ –¥–ª—è —Ñ–∞—Ä–º–∞—Ü–∏–∏. –ù–∞–ø—Ä–∏–º–µ—Ä, –Ω–∞ –µ–≥–æ –æ—Å–Ω–æ–≤–µ –¥–µ–ª–∞—é—Ç –±—É—Å—É–ª—å—Ñ–∞–Ω, –ø—Ä–∏–º–µ–Ω—è–µ–º—ã–π –≤ –∫–∞—á–µ—Å—Ç–≤–µ –ø—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤–æ–≥–æ —Å—Ä–µ–¥—Å—Ç–≤–∞ –ø—Ä–∏ —Ö–∏–º–∏–æ—Ç–µ—Ä–∞–ø–∏–∏. –ê –≤–æ—Ç –æ–≥—Ä–∞–Ω–∏—á–∏—Ç—å —Å–≤–æ–±–æ–¥–Ω—É—é –ø—Ä–æ–¥–∞–∂—É –≤–µ—â–µ—Å—Ç–≤–∞ –º–æ–∂–Ω–æ –∏ –Ω—É–∂–Ω–æ. –ö—É—Ç–µ–ø–æ–≤ –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç —Å–Ω–∏–∑–∏—Ç—å –ø–æ—Ä–æ–≥ —Ä–∞–∑—Ä–µ—à–µ–Ω–Ω–æ–π –∫–æ–Ω—Ü–µ–Ω—Ç—Ä–∞—Ü–∏–∏ 1,4-–±—É—Ç–∞–Ω–¥–∏–æ–ª–∞ –¥–æ 3%, –∞ –≤–ø–æ—Å–ª–µ–¥—Å—Ç–≤–∏–∏ –≤–æ–æ–±—â–µ —É–±—Ä–∞—Ç—å –ª–∏–º–∏—Ç. –í 2023 –≥–æ–¥—É –¥–µ–ø—É—Ç–∞—Ç—ã —Å–∞–Ω–∫—Ç-–ø–µ—Ç–µ—Ä–±—É—Ä–≥—Å–∫–æ–≥–æ –∑–∞–∫—Å–æ–±—Ä–∞–Ω–∏—è —É–∂–µ –ø–æ–¥–Ω–∏–º–∞–ª–∏ –≤–æ–ø—Ä–æ—Å —Å–≤–æ–±–æ–¥–Ω–æ–≥–æ –æ–±–æ—Ä–æ—Ç–∞ 1,4-–±—É—Ç–∞–Ω–¥–∏–æ–ª–∞ –∏ –ø—Ä–æ—Å–∏–ª–∏ –ú–∏—Ö–∞–∏–ª–∞ –ú—É—Ä–∞—à–∫–æ –≤–Ω–µ—Å—Ç–∏ –≤–µ—â–µ—Å—Ç–≤–æ –≤ —Å–ø–∏—Å–æ–∫ –Ω–∞—Ä–∫–æ—Ç–∏—á–µ—Å–∫–∏—Ö, –æ–±–æ—Ä–æ—Ç –∫–æ—Ç–æ—Ä—ã—Ö –∑–∞–ø—Ä–µ—â–µ–Ω, –æ–¥–Ω–∞–∫–æ –Ω–∏–∫–∞–∫–∏—Ö –∫–æ–Ω–∫—Ä–µ—Ç–Ω—ã—Ö –¥–µ–π—Å—Ç–≤–∏–π –∑–∞ —ç—Ç–∏–º –Ω–µ –ø–æ—Å–ª–µ–¥–æ–≤–∞–ª–æ. –í —Å–≤–æ—ë–º –ø–∏—Å—å–º–µ –∫ –ì–æ–ª–∏–∫–æ–≤–æ–π –ö—É—Ç–µ–ø–æ–≤ —Ç–∞–∫–∂–µ –ø—Ä–∏–∑–≤–∞–ª –ø—Ä–∏–∑–Ω–∞—Ç—å –æ—Ç—Ä–∞–≤–ª–µ–Ω–∏—è –º–µ—Ç–∞–¥–æ–Ω–æ–º ¬´—Å–æ—Ü–∏–∞–ª—å–Ω–æ –∑–Ω–∞—á–∏–º—ã–º –∏ —Å–º–µ—Ä—Ç–µ–ª—å–Ω–æ –æ–ø–∞—Å–Ω—ã–º –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–µ–º¬ª –∏ –ø—Ä–µ–¥–ª–æ–∂–∏–ª –ø–æ–¥—É–º–∞—Ç—å –Ω–∞–¥ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å—é –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω–æ–≥–æ –ª–µ—á–µ–Ω–∏—è –∑–∞–≤–∏—Å–∏–º—ã—Ö –æ—Ç —ç—Ç–æ–≥–æ –≤–µ—â–µ—Å—Ç–≤–∞. –í –Ω–µ–∫–æ—Ç–æ—Ä—ã—Ö —Å—Ç—Ä–∞–Ω–∞—Ö –º–µ—Ç–∞–¥–æ–Ω –∏—Å–ø–æ–ª—å–∑—É—é—Ç –ø—Ä–∏ –ª–µ—á–µ–Ω–∏–∏ –Ω–∞—Ä–∫–æ–∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏ –∫–∞–∫ –∞–ª—å—Ç–µ—Ä–Ω–∞—Ç–∏–≤—É –≥–µ—Ä–æ–∏–Ω—É. –†–æ—Å—Å–∏–π—Å–∫–∏–π –ú–∏–Ω–∑–¥—Ä–∞–≤ –∫–∞—Ç–µ–≥–æ—Ä–∏—á–µ—Å–∫–∏ –ø—Ä–æ—Ç–∏–≤ –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏. –ò–Ω–∏—Ü–∏–∞—Ç–∏–≤–∞ –ö—É—Ç–µ–ø–æ–≤–∞ –ø–æ—Ö–≤–∞–ª—å–Ω–∞, –Ω–æ –∏–∑–±–∏—Ä–∞—Ç–µ–ª—å–Ω–∞. –ù–∞—Ä–∫–æ–ª–æ–≥–∏ –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç –æ–±—Ä–∞—Ç–∏—Ç—å –≤–Ω–∏–º–∞–Ω–∏–µ –∏ –Ω–∞ –¥—Ä—É–≥–∏–µ –ø—Ä–æ–¥–∞—é—â–∏–µ—Å—è –≤ –∞–ø—Ç–µ–∫–∞—Ö –ø—Ä–µ–∫—É—Ä—Å–æ—Ä—ã. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement, safety, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""Senator Andrei Kutepov, chairman of the economic committee, has asked to take action against 1.4-butanediol. He suggests reducing the permitted concentration limit from 3% to zero and calls for recognizing methadone poisoning as a socially significant and dangerous disease requiring compulsory treatment. However, the Russian Ministry of Health opposes methadone as a substitute for heroin in treating opioid addiction. Kutsenko also calls for considering other precursor substances sold in pharmacies.""
}"
2025-07-09T14:42:32+00:00,@bezrec,6288,https://t.me/bezrec/6288,"–ö–æ–º–∏—Ç–µ—Ç –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è –ø–æ–ø—Ä–æ—Å–∏–ª –∑–∞ –æ—Ä—Ñ–∞–Ω–Ω–∏–∫–æ–≤ –≤ —Ä–µ–≥–∏–æ–Ω–∞—Ö. –ß–ª–µ–Ω—ã –∫–æ–º–∏—Ç–µ—Ç–∞ –µ–¥–∏–Ω–æ–≥–ª–∞—Å–Ω–æ —Ä–µ–∫–æ–º–µ–Ω–¥–æ–≤–∞–ª–∏ –ì–æ—Å–¥—É–º–µ –ø—Ä–∏–Ω—è—Ç—å –≤–æ –≤—Ç–æ—Ä–æ–º —á—Ç–µ–Ω–∏–∏ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç, –ø—Ä–µ–¥—É—Å–º–∞—Ç—Ä–∏–≤–∞—é—â–∏–π —Å–æ–∑–¥–∞–Ω–∏–µ –º–µ—Ö–∞–Ω–∏–∑–º–∞ —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è –∏–∑ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –±—é–¥–∂–µ—Ç–∞ —Ä–µ–≥–∏–æ–Ω–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ —Å–∞–º–∏ –Ω–µ —Å–ø—Ä–∞–≤–ª—è—é—Ç—Å—è —Å –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ–º –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å —Ä–µ–¥–∫–∏–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏. –ü—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—å –ö–æ–º–∏—Ç–µ—Ç–∞ –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è –°–µ—Ä–≥–µ–π –õ–µ–æ–Ω–æ–≤ –ø–æ–¥—á–µ—Ä–∫–Ω—É–ª, —á—Ç–æ –Ω–∞ –ª–µ—á–µ–Ω–∏–µ —Ç–æ–ª—å–∫–æ –æ–¥–Ω–æ–≥–æ —Ç–∞–∫–æ–≥–æ –±–æ–ª—å–Ω–æ–≥–æ –≤ —Å—Ä–µ–¥–Ω–µ–º —Ç—Ä–µ–±—É–µ—Ç—Å—è –ø—Ä–∏–º–µ—Ä–Ω–æ 2,7 –º–ª–Ω —Ä—É–±–ª–µ–∏ÃÜ –≤ –≥–æ–¥. –£–∂–µ –≤ —Å–ª–µ–¥—É—é—â–µ–º –≥–æ–¥—É –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –≤—ã–¥–µ–ª–∏—Ç—å —Ä–µ–≥–∏–æ–Ω–∞–º –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ –∏–∑ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –±—é–¥–∂–µ—Ç–∞ –æ–∫–æ–ª–æ 6 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –Ω–∞ –ø–æ–∫—É–ø–∫—É –ª–µ–∫–∞—Ä—Å—Ç–≤ –¥–ª—è —Ç–∞–∫–∏—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, ‚Äî –¥–æ–±–∞–≤–∏–ª –õ–µ–æ–Ω–æ–≤. –ù–∞–ø–æ–º–Ω–∏–º, –≤ –æ—Ç–≤–µ—Ç –Ω–∞ –∂–∞–ª–æ–±—É –≥–æ—Å—Å–æ–≤–µ—Ç–∞ –¢–∞—Ç–∞—Ä—Å—Ç–∞–Ω–∞ –æ–±—è–∑–∞–ª –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –≤ –∫—Ä–∞—Ç—á–∞–π—à–∏–µ —Å—Ä–æ–∫–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞—Ç—å —Ä–µ–∑–µ—Ä–≤–Ω—ã–π –º–µ—Ö–∞–Ω–∏–∑–º –¥–ª—è –æ–ø–µ—Ä–∞—Ç–∏–≤–Ω–æ–≥–æ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏ –±–æ–ª—å–Ω—ã—Ö –∂–∏–∑–Ω–µ—É–≥—Ä–æ–∂–∞—é—â–∏–º–∏ —Ä–µ–¥–∫–∏–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏, –∫–æ–≥–¥–∞ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã–º –±—é–¥–∂–µ—Ç–∞–º –Ω–µ —Ö–≤–∞—Ç–∞–µ—Ç —Å—Ä–µ–¥—Å—Ç–≤ –Ω–∞ –¥–æ—Ä–æ–≥–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The Health Committee asked for support for orphans in regions. Members of the committee unanimously recommended that the State Duma approve a project requiring federal budget financing for regions unable to provide medicines to patients with rare diseases. Chairman of the Health Committee Sergey Leonyov noted that treating one such patient annually costs about 2.7 million rubles. It is planned to allocate an additional 6 billion rubles from the federal budget for purchasing medicines for such patients in the next year. It is recalled that in response to Tatarstan's request, the government was required to develop a reserve mechanism for immediate provision of medicines to patients with life-threatening rare diseases when regional budgets lack funds for expensive drugs.""
}"
2025-07-09T12:05:38+00:00,@bezrec,6287,https://t.me/bezrec/6287,"–†–æ—Å—Å–∏—è–Ω–µ –Ω–∞–ª–µ–≥–∞—é—Ç –Ω–∞ ¬´–û–∑–µ–º–ø–∏–∫–∏¬ª. –ü–æ –¥–∞–Ω–Ω—ã–º ¬´–ß–µ—Å—Ç–Ω–æ–≥–æ –∑–Ω–∞–∫–∞¬ª, —Å–ø—Ä–æ—Å –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–ª—è –ø–æ—Ö—É–¥–µ–Ω–∏—è –Ω–∞ –æ—Å–Ω–æ–≤–µ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ –∏ —Ç–∏—Ä–∑–µ–ø–∞—Ç–∏–¥–∞ –ø–æ –∏—Ç–æ–≥–∞–º I –∫–≤–∞—Ä—Ç–∞–ª–∞ 2025 –≥–æ–¥–∞ –≤—ã—Ä–æ—Å –≤ —à–µ—Å—Ç—å —Ä–∞–∑ –≥–æ–¥ –∫ –≥–æ–¥—É. –ó–∞ —É–∫–∞–∑–∞–Ω–Ω—ã–π –ø–µ—Ä–∏–æ–¥ —Ç–∞–∫–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ —Ä–µ–∞–ª–∏–∑–æ–≤–∞–ª–∏ –Ω–∞ 5 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ü–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –ø–æ—Å–ª–µ–¥–Ω–∏–º –∫–≤–∞—Ä—Ç–∞–ª–æ–º 2024 –≥–æ–¥–∞ –ø—Ä–æ–¥–∞–∂–∏ —É–≤–µ–ª–∏—á–∏–ª–∏—Å—å –Ω–∞ 30% –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –∏ –Ω–∞ 28% –≤ –¥–µ–Ω–µ–∂–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏. –£–¥–æ–≤–ª–µ—Ç–≤–æ—Ä–∏—Ç—å —Ä–∞—Å—Ç—É—â–∏–π —Å–ø—Ä–æ—Å –Ω–∞ –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç–æ–∑–Ω–æ–µ –ø–æ—Ö—É–¥–µ–Ω–∏–µ –∏–∑–æ –≤—Å–µ—Ö —Å–∏–ª —Å—Ç–∞—Ä–∞—é—Ç—Å—è —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏. –ó–∞ –ø–µ—Ä–≤—ã–µ —Ç—Ä–∏ –º–µ—Å—è—Ü–∞ —ç—Ç–æ–≥–æ –≥–æ–¥–∞ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–µ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –Ω–∞—Ä–∞—Å—Ç–∏–ª–∏ –≤—ã–ø—É—Å–∫ —ç—Ç–æ–π –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ –≤ 10 —Ä–∞–∑, –¥–æ 2,4 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫. –°–µ–º–∞–≥–ª—É—Ç–∏–¥ –∏ —Ç–∏—Ä–∑–µ–ø–∞—Ç–∏–¥ —Ä–∞—Å—Ç—É—Ç –∏ –≤ –≥–æ—Å—Å–µ–≥–º–µ–Ω—Ç–µ. –í 2024 –≥–æ–¥—É –æ–±—ä–µ–º –∑–∞–∫—É–ø–æ–∫ –≤ –≥–æ—Å—Å–µ–≥–º–µ–Ω—Ç–µ –≤—ã—Ä–æ—Å –Ω–∞ 28%, –¥–æ 2,3 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, –∞ –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ ‚Äî –Ω–∞ 68%, –¥–æ 166,5 —Ç—ã—Å. —É–ø–∞–∫–æ–≤–æ–∫. –õ–∏–¥–µ—Ä—ã —Ä—ã–Ω–∫–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –æ–∂–∏—Ä–µ–Ω–∏—è –∏ –¥–∏–∞–±–µ—Ç–∞ ‚Äî ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª –∏ ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª, –Ω–æ —Å–≤–æ–π –∫—É—Å–æ–∫ ¬´–¥–∏–µ—Ç–∏—á–µ—Å–∫–æ–≥–æ¬ª –ø–∏—Ä–æ–≥–∞ —Ö–æ—Ç—è—Ç –∏ –¥—Ä—É–≥–∏–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏. –¢–∞–∫, –≤ 2025 –≥–æ–¥—É –ø—Ä–∞–≤–æ–º –Ω–∞ –≤—ã–ø—É—Å–∫ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ –æ–±–∑–∞–≤–µ–ª–∞—Å—å ¬´–ü–°–ö –§–∞—Ä–º–∞¬ª. –°–≤–æ–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã —Ç–∞–∫–∂–µ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª–∏ ¬´–†-–§–∞—Ä–º¬ª –∏ ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑¬ª, –µ—â—ë –Ω–µ –ø–æ–ª—É—á–∏–≤—à–∏–µ –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω—É—é –ª–∏—Ü–µ–Ω–∑–∏—é. –ü–æ–∫–∞ –º–µ—Å—Ç–∞ –Ω–∞ —Ä—ã–Ω–∫–µ —Ö–≤–∞—Ç–∞–µ—Ç –≤—Å–µ–º ‚Äî –æ–Ω –µ—â—ë –Ω–µ –¥–æ—Å—Ç–∏–≥ —Å—Ç–∞–¥–∏–∏ –Ω–∞—Å—ã—â–µ–Ω–∏—è. –î–∏—Ä–µ–∫—Ç–æ—Ä –ø–æ —Ä–∞–∑–≤–∏—Ç–∏—é RNC Pharma –ù–∏–∫–æ–ª–∞–π –ë–µ—Å–ø–∞–ª–æ–≤ –ø—Ä–æ–≥–Ω–æ–∑–∏—Ä—É–µ—Ç –≤—ã—Ö–æ–¥ –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏—è –Ω–∞ –ø–ª–∞—Ç–æ –∏ –Ω–æ—Ä–º–∞–ª–∏–∑–∞—Ü–∏—é —Å–ø—Ä–æ—Å–∞ –±–ª–∏–∂–µ –∫ –∫–æ–Ω—Ü—É –≥–æ–¥–∞. –ù—É –∞ –≤—Ä–∞—á–∏ –≤ –∫–æ—Ç–æ—Ä—ã–π —Ä–∞–∑ –Ω–∞–ø–æ–º–∏–Ω–∞—é—Ç –æ –Ω–µ–¥–æ–ø—É—Å—Ç–∏–º–æ—Å—Ç–∏ —Å–∞–º–æ–ª–µ—á–µ–Ω–∏—è –∏ –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–∞—é—Ç –æ –≤–æ–∑–º–æ–∂–Ω—ã—Ö –ø–æ–±–æ—á–∫–∞—Ö. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""There is a growing demand for weight loss medications based on semaglutide and tirzepatide in Russia. Sales have increased by 30% in natural terms and 28% in monetary terms compared to the same period last year. Domestic pharmaceutical companies have increased their production of this category by 10 times to 2.4 million units in the first three months of this year. The market for weight loss medications and diabetes treatments is also growing, with purchases increasing by 28% to RUB 2.3 billion and by 68% in natural terms to 166,500 units. Companies like RNC Pharma and PSK Pharma have gained the right to produce these medications, while other companies are also registering their own products. However, doctors warn against self-medication and potential side effects.""
}"
2025-07-09T09:15:34+00:00,@bezrec,6286,https://t.me/bezrec/6286,"–ú–∏–Ω—Ñ–∏–Ω –æ—Ç—á–∏—Ç–∞–ª—Å—è –æ–± –∏—Å–ø–æ–ª–Ω–µ–Ω–∏–∏ —Ä–∞—Å—Ö–æ–¥–æ–≤ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –±—é–¥–∂–µ—Ç–∞ –Ω–∞ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏—é –Ω–∞—Ü–ø—Ä–æ–µ–∫—Ç–æ–≤ –ø–æ –∏—Ç–æ–≥–∞–º –ø–µ—Ä–≤–æ–≥–æ –ø–æ–ª—É–≥–æ–¥–∏—è. –ü–æ —Å–æ—Å—Ç–æ—è–Ω–∏—é –Ω–∞ 1 –∏—é–ª—è 2025 –≥–æ–¥–∞ –±—ã–ª–æ –∏–∑—Ä–∞—Å—Ö–æ–¥–æ–≤–∞–Ω–æ 2 782,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –∏–ª–∏ 46,1 % –æ—Ç –ø–ª–∞–Ω–æ–≤—ã—Ö –±—é–¥–∂–µ—Ç–Ω—ã—Ö –Ω–∞–∑–Ω–∞—á–µ–Ω–∏–π. –°–∞–º—ã–º–∏ –≤—ã—Å–æ–∫–∏–º–∏ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º–∏ (67,2%) –º–æ–∂–µ—Ç –ø–æ—Ö–≤–∞—Å—Ç–∞—Ç—å—Å—è ¬´–ü—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ–µ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ —Ç—Ä–∞–Ω—Å–ø–æ—Ä—Ç–Ω–æ–π –º–æ–±–∏–ª—å–Ω–æ—Å—Ç–∏¬ª. ¬´–ù–æ–≤—ã–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ —Å–±–µ—Ä–µ–∂–µ–Ω–∏—è –∑–¥–æ—Ä–æ–≤—å—è¬ª –≤ —Ç–æ–ø-10 –Ω–µ –≤–æ—à—ë–ª. –ü–æ–∫–∞–∑–∞—Ç–µ–ª—å –µ–≥–æ –∏—Å–ø–æ–ª–Ω–µ–Ω–∏—è ‚Äî 28,8%. –° 2025 –≥–æ–¥–∞ –Ω–∞—Ü–ø—Ä–æ–µ–∫—Ç –ø—Ä–∏—à–µ–ª –Ω–∞ —Å–º–µ–Ω—É –ø—Ä–æ–≥—Ä–∞–º–º–µ ¬´–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ¬ª –≤–º–µ—Å—Ç–µ —Å ¬´–∫–æ–ª–ª–µ–≥–∞–º–∏¬ª ‚Äî ¬´–ü—Ä–æ–¥–æ–ª–∂–∏—Ç–µ–ª—å–Ω–æ–π –∏ –∞–∫—Ç–∏–≤–Ω–æ–π –∂–∏–∑–Ω—å—é¬ª –∏ ¬´–°–µ–º—å—ë–π¬ª. –ù–∞ –∏—Ö —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏–µ –≤ 2025 –≥–æ–¥—É —Å–æ–≤–æ–∫—É–ø–Ω–æ –∑–∞–ª–æ–∂–µ–Ω–æ –±–æ–ª–µ–µ 400 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, –∞ –≤ 2025‚Äì 2030 –≥–æ–¥–∞—Ö ‚Äì –º–∏–Ω–∏–º—É–º 2,2 —Ç—Ä–ª–Ω —Ä—É–±–ª–µ–π. –ù–∞—Ü–ø—Ä–æ–µ–∫—Ç ¬´–ù–æ–≤—ã–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ —Å–±–µ—Ä–µ–∂–µ–Ω–∏—è –∑–¥–æ—Ä–æ–≤—å—è¬ª –≤–∫–ª—é—á–∞–µ—Ç –ø—è—Ç—å —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã—Ö. –ò–∑ –Ω–∏—Ö —Ç—Ä–∏ —Å–≤—è–∑–∞–Ω—ã —Å –≤–Ω–µ–¥—Ä–µ–Ω–∏–µ–º –Ω–æ–≤—ã—Ö –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π, –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –º–µ–¥–∏–∑–¥–µ–ª–∏–π, –æ–¥–∏–Ω –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω –Ω–∞ –ø–æ–¥–¥–µ—Ä–∂–∫—É –∏–º–ø–æ—Ä—Ç–æ–∑–∞–º–µ—â–µ–Ω–∏—è, –µ—â—ë –æ–¥–∏–Ω ‚Äî –Ω–∞ —É–ø—Ä–∞–≤–ª–µ–Ω–∏–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –Ω–∞—É–∫–æ–π –∏ —Å–æ–∑–¥–∞–Ω–∏–µ –≤ —Å—Ç—Ä–∞–Ω–µ —Å–æ–≤—Ä–µ–º–µ–Ω–Ω—ã—Ö –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –±–∞–∑. –ß—Ç–æ –≤ –ø—Ä–∏–æ—Ä–∏—Ç–µ—Ç–µ –Ω–∞ –±–ª–∏–∂–∞–π—à–∏–µ –≥–æ–¥—ã: üîΩ–ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏—è –Ω–µ –º–µ–Ω–µ–µ 90% –∂–∏–∑–Ω–µ–Ω–Ω–æ –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤; üîΩ–≤—ã–ø—É—Å–∫ 80% —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø–æ –ø–æ–ª–Ω–æ–º—É —Ü–∏–∫–ª—É; üîΩ—Ä–æ—Å—Ç –¥–æ–ª–∏ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö —Ä–∞–¥–∏–æ—Ñ–∞—Ä–º–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–æ 95%; üîΩ—É–≤–µ–ª–∏—á–µ–Ω–∏–µ –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏–∏ –º–µ–¥–∏–∑–¥–µ–ª–∏–π –¥–æ 40%. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-07-09T06:14:00+00:00,@bezrec,6285,https://t.me/bezrec/6285,"–í–∏—Ä—É—Å–æ–ª–æ–≥–∏ —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏, –∫–∞–∫ —Ä–æ—Å—Å–∏–π—Å–∫–æ–π –≤–∞–∫—Ü–∏–Ω–µ –æ—Ç —Ä–∞–∫–∞ ¬´–ø–µ—Ä–µ–µ—Ö–∞—Ç—å¬ª –∑–∞ —Ä—É–±–µ–∂. –í –∫–æ–Ω—Ü–µ –∏—é–Ω—è –º—ã –ø–∏—Å–∞–ª–∏, —á—Ç–æ –ü–∞—Ä–∞–≥–≤–∞–π –∑–∞–∏–Ω—Ç–µ—Ä–µ—Å–æ–≤–∞–Ω –≤ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏–∏ –ø–µ—Ä–µ–≥–æ–≤–æ—Ä–æ–≤ –æ —Ä–æ—Å—Å–∏–π—Å–∫–æ–π —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ, –µ—Å–ª–∏ —Ç–∞ –¥–æ–∫–∞–∂–µ—Ç —Å–≤–æ—é —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –∏ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å. –ö –æ–Ω–∫–æ–≤–∞–∫—Ü–∏–Ω–µ –ø—Ä–∏—Å–º–∞—Ç—Ä–∏–≤–∞—é—Ç—Å—è –∏ –¥—Ä—É–≥–∏–µ —Å—Ç—Ä–∞–Ω—ã. –î–∏—Ä–µ–∫—Ç–æ—Ä –¶–µ–Ω—Ç—Ä–∞ –∏–º. –ì–∞–º–∞–ª–µ–∏ –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ì–∏–Ω—Ü–±—É—Ä–≥ —Ä–∞—Å—Å–∫–∞–∑–∞–ª, —á—Ç–æ –ø–æ–ª—É—á–∞–ª –ø–∏—Å—å–º–∞ –Ω–∞ —ç—Ç–æ—Ç —Å—á—ë—Ç –∏–∑ –ø–æ—Å–æ–ª—å—Å—Ç–≤ –ú–µ–∫—Å–∏–∫–∏, –í–µ–Ω–µ—Å—É—ç–ª—ã –∏ –ö–æ–ª—É–º–±–∏–∏. –í –†–§–ü–ò, –∫–æ—Ç–æ—Ä—ã–π –∑–∞–Ω–∏–º–∞–µ—Ç—Å—è –ø—Ä–æ–¥–≤–∏–∂–µ–Ω–∏–µ–º —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ –∑–∞—Ä—É–±–µ–∂–Ω—ã—Ö —Ä—ã–Ω–∫–∞—Ö, –∑–∞—è–≤–∏–ª–∏, —á—Ç–æ ¬´–∞–±—Å–æ–ª—é—Ç–Ω–æ –æ—Ç–∫—Ä—ã—Ç—ã –∫ —Ä–∞–±–æ—Ç–µ —Å –¥—Ä—É–≥–∏–º–∏ —Å—Ç—Ä–∞–Ω–∞–º–∏¬ª. –ü–æ—Å—Ç–∞–≤–∏—Ç—å –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –∑–∞ —Ä—É–±–µ–∂–æ–º ¬´–Ω–∞ –ø–æ—Ç–æ–∫¬ª ‚Äî –∑–∞–¥–∞—á–∞ –ø–æ–¥—ä—ë–º–Ω–∞—è: –ü–∞—Ä—Ç–Ω–µ—Ä–∞–º –ø–µ—Ä–µ–¥–∞–µ—Ç—Å—è –≤—Å—è —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–∞—è –¥–æ–∫—É–º–µ–Ω—Ç–∞—Ü–∏—è, –∏ –≤—Å—ë –æ—Ä–≥–∞–Ω–∏–∑—É–µ—Ç—Å—è —Å –ø–æ–º–æ—â—å—é –Ω–∞—à–∏—Ö —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤. –ù—É–∂–Ω–æ —Å—Ç–∞–Ω–¥–∞—Ä—Ç–Ω–æ–µ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏–µ, –∫–æ—Ç–æ—Ä–æ–µ –≤ –æ—Å–Ω–æ–≤–Ω–æ–º –ø—Ä–æ–∏–∑–≤–æ–¥—è—Ç –Ω–µ –≤ –†–æ—Å—Å–∏–∏. –≠—Ç–æ –º–Ω–æ–∂–µ—Å—Ç–≤–æ —Ä–∞–∑–ª–∏—á–Ω—ã—Ö —É—Å—Ç—Ä–æ–π—Å—Ç–≤, –Ω–∞–ø—Ä–∏–º–µ—Ä –¥–ª—è —Å—É—Å–ø–µ–Ω–∑–∏–æ–Ω–Ω—ã—Ö –∫–ª–µ—Ç–æ–∫, –¥–ª—è –≤—ã—Ä–∞—â–∏–≤–∞–Ω–∏—è –∫–ª–µ—Ç–æ—á–Ω—ã—Ö –∫—É–ª—å—Ç—É—Ä –∏ –¥—Ä—É–≥–∏–µ. –û–Ω–∏ —Å–æ–∑–¥–∞—é—Ç—Å—è –≤ —Ä–∞–∑–Ω—ã—Ö —Å—Ç—Ä–∞–Ω–∞—Ö –º–∏—Ä–∞, –∏ –∏—Ö –º–æ–∂–Ω–æ —Ç–∞–º –∑–∞–∫—É–ø–∞—Ç—å, ‚Äî –æ–±—ä—è—Å–Ω–∏–ª –≤–∏—Ä—É—Å–æ–ª–æ–≥ –ê–Ω–∞—Ç–æ–ª–∏–π –ê–ª—å—Ç—à—Ç–µ–π–Ω. –ù–µ–æ–±—Ö–æ–¥–∏–º–æ–µ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏–µ —Ä–∞–Ω—å—à–µ –ø—Ä–∏–≤–æ–∑–∏–ª–∏ –∏–∑ –°–®–ê, —Ç–µ–ø–µ—Ä—å –∏–º–ø–æ—Ä—Ç –ø–µ—Ä–µ–æ—Ä–∏–µ–Ω—Ç–∏—Ä–æ–≤–∞–ª–∏ –Ω–∞ –¥—Ä—É–∂–µ—Å—Ç–≤–µ–Ω–Ω—ã–µ —Å—Ç—Ä–∞–Ω—ã, –Ω–æ –µ—Å—Ç—å –∑–∞–≥–≤–æ–∑–¥–∫–∞ ‚Äî –Ω–µ –æ—á–µ–Ω—å –¥—Ä—É–∂–µ—Å—Ç–≤–µ–Ω–Ω—ã–µ —Ü–µ–Ω—ã. –≠—Ç–æ—Ç –≤–æ–ø—Ä–æ—Å —Å–µ–π—á–∞—Å —Ä–µ—à–∞—é—Ç –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ, –ú–∏–Ω–∑–¥—Ä–∞–≤ –∏ –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥. –í –†–§–ü–ò —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏, —á—Ç–æ –Ω–∞–∏–±–æ–ª–µ–µ –∞–∫—Ç–∏–≤–Ω–æ ¬´—Ä–∞–∑–≤–æ—Ä–∞—á–∏–≤–∞–µ—Ç—Å—è –∫ –Ω–∞–º¬ª —Å —Ç–æ—á–∫–∏ –∑—Ä–µ–Ω–∏—è —Ç—Ä–∞–Ω—Å—Ñ–µ—Ä–∞ –í—å–µ—Ç–Ω–∞–º. –í –∫–æ–Ω—Ü–µ –º–∞—è –†–æ—Å—Å–∏—è –ø–æ–¥–≥–æ—Ç–æ–≤–∏–ª–∞ –º–µ–º–æ—Ä–∞–Ω–¥—É–º –æ —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–µ —Å —Ü–µ–Ω—Ç—Ä–æ–º –≤–∞–∫—Ü–∏–Ω –†–µ—Å–ø—É–±–ª–∏–∫–∏, –≤ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–µ –∫–æ—Ç–æ—Ä–æ–≥–æ –æ–±—Ä–∞–∑–æ–≤–∞–ª–æ—Å—å –æ–±—ä–µ–¥–∏–Ω–µ–Ω–∏–µ —Ñ–∞—Ä–º–¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–æ–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""Virologists have reported how Russia's anti-cancer vaccine is expanding its reach abroad. In June, we wrote that Paraguay was interested in conducting talks with Russia's vaccine if it proves effective and safe. Other countries are also looking into the Honevax vaccine. Director of the Gamaleya Research Institute, Anatoly Altshtein, explained that they received letters from embassies in Mexico, Venezuela, and Colombia regarding this matter. The Russian Federal Service for Surveillance on Consumer Rights and Human Health (Rosprirodnadzor) stated that they are 'open to working with other countries.' To set up production abroad, all technical documentation is transferred and organized by our specialists. Necessary equipment was previously imported from the US but now imports are being redirected to friendly countries, though there is a challenge with non-friendly prices. This issue is currently being addressed by the government, Ministry of Health and Ministry of Industry and Trade. The country most actively 'rolling out' to Russia in terms of transfer is Vietnam, where a memorandum for cooperation was prepared"
2025-07-08T14:31:06+00:00,@bezrec,6284,https://t.me/bezrec/6284,"–°–µ–∞–ª–µ–∫—Å –¥–æ —Ç—é—Ä—å–º—ã –Ω–µ –¥–æ–≤—ë–ª. –í —Å–≤—è–∑–∏ —Å –∏—Å—Ç–µ—á–µ–Ω–∏–µ–º —Å—Ä–æ–∫–∞ –¥–∞–≤–Ω–æ—Å—Ç–∏ –ì–æ—Ä–æ–¥—Å–∫–æ–π —Å—É–¥ –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥–∞ –æ—Å–≤–æ–±–æ–¥–∏–ª –æ—Å–Ω–æ–≤–∞—Ç–µ–ª—è ¬´–†–ò–ê –ü–∞–Ω–¥–∞¬ª –ò–≥–æ—Ä—è –í–æ—Ä–æ–±—å—è –∏ –µ–≥–æ –¥–µ–ª–æ–≤–æ–≥–æ –ø–∞—Ä—Ç–Ω–µ—Ä–∞ –°–µ—Ä–≥–µ—è –ù–∞–∑–∞—Ä–æ–≤–∞, —Ä—É–∫–æ–≤–æ–¥–∏–≤—à–µ–≥–æ –∫–æ–º–ø–∞–Ω–∏–µ–π ¬´–í–ò–°¬ª, –æ—Ç –Ω–∞–∫–∞–∑–∞–Ω–∏—è –∑–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –ë–ê–î, —Å–æ–¥–µ—Ä–∂–∞—â–∏—Ö –Ω–µ –∑–∞—è–≤–ª–µ–Ω–Ω—ã–µ –ø—Ä–∏ –≥–æ—Å—Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏–∏. –ù–∞–ø–æ–º–Ω–∏–º, ¬´–†–ò–ê –ü–∞–Ω–¥–∞¬ª –ø—Ä–æ—Å–ª–∞–≤–∏–ª–∞—Å—å¬ª –ø—Ä–æ–¥–∞–∂–µ–π –ë–ê–î–æ–≤ –¥–ª—è –º—É–∂—Å–∫–æ–π —Å–∏–ª—ã —Å –∑–∞–ø—Ä–µ—â–µ–Ω–Ω—ã–º–∏ –≤ —Ç–∞–∫–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏ —Ç–∞–¥–∞–ª–∞—Ñ–∏–ª–æ–º –∏ —Å–∏–ª–¥–µ–Ω–∞—Ñ–∏–ª–æ–º. –ü–æ–¥ —Ä–∞–∑–¥–∞—á—É –ø–æ–ø–∞–ª –∏ –Ω–µ–∫–æ–≥–¥–∞ —Å—É–ø–µ—Ä –ø–æ–ø—É–ª—è—Ä–Ω—ã–π –°–µ–∞–ª–µ–∫—Å, –∏–∑–Ω–∞—á–∞–ª—å–Ω–æ –ø—Ä–æ–¥–∞–≤–∞–≤—à–∏–π—Å—è –∫–∞–∫ –ë–ê–î –∏ –≤—Ö–æ–¥–∏–≤—à–∏–π –≤ —á–∏—Å–ª–æ —Å–∞–º—ã—Ö –ø—Ä–æ–¥–∞–≤–∞–µ–º—ã—Ö –¥–æ–±–∞–≤–æ–∫ –≤ –†–æ—Å—Å–∏–∏. –£–≥–æ–ª–æ–≤–Ω–æ–µ –¥–µ–ª–æ –ø–æ —ç—Ç–æ–º—É –ø–æ–≤–æ–¥—É –≤–æ–∑–±—É–¥–∏–ª–∏ –≤ 2015 –≥–æ–¥—É. –î–≤–∞ –≥–æ–¥–∞ —Å–ø—É—Å—Ç—è –°–ª–µ–¥—Å—Ç–≤–µ–Ω–Ω—ã–π –∫–æ–º–∏—Ç–µ—Ç –∏ –§–ù–° —É—Å—Ç–∞–Ω–æ–≤–∏–ª–∏, —á—Ç–æ ¬´–†–ò–ê –ü–∞–Ω–¥–∞¬ª, –û–û–û ¬´–í–ò–°¬ª –∏ –û–û–û ¬´–í–ò–° –ö–æ—Å–º–µ—Ç–∏–∫—Å¬ª —Å–æ–≤–º–µ—Å—Ç–Ω—ã–º–∏ —É—Å–∏–ª–∏—è–º–∏ —É—Ö–æ–¥–∏–ª–∏ –æ—Ç —É–ø–ª–∞—Ç—ã –Ω–∞–ª–æ–≥–æ–≤. –í –∏—Ç–æ–≥–µ –í–æ—Ä–æ–±–µ–π –∏ –ù–∞–∑–∞—Ä–æ–≤ –ø–æ–ª—É—á–∏–ª–∏ –ø–æ –ø—è—Ç—å –ª–µ—Ç –ª–∏—à–µ–Ω–∏—è —Å–≤–æ–±–æ–¥—ã —É—Å–ª–æ–≤–Ω–æ —Å –∏—Å–ø—ã—Ç–∞—Ç–µ–ª—å–Ω—ã–º —Å—Ä–æ–∫–æ–º –≤ —á–µ—Ç—ã—Ä–µ –≥–æ–¥–∞ –∏ —à—Ç—Ä–∞—Ñ 2,5 –º–ª–Ω —Ä—É–±–ª–µ–π. –§–∏–≥—É—Ä–∞–Ω—Ç–æ–≤ —Ç–∞–∫–∂–µ –ª–∏—à–∏–ª–∏ –ø—Ä–∞–≤–∞ –∑–∞–Ω–∏–º–∞—Ç—å—Å—è –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç—å—é –≤ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è—Ö, —Å–≤—è–∑–∞–Ω–Ω—ã—Ö —Å –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ–º –∏ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–µ–π –ë–ê–î –∏ –ª–µ–∫–∞—Ä—Å—Ç–≤, —Å—Ä–æ–∫–æ–º –Ω–∞ —Ç—Ä–∏ –≥–æ–¥–∞, –æ–¥–Ω–∞–∫–æ –≥—Ä–∞–∂–¥–∞–Ω—Å–∫–∏–π –∏—Å–∫ –ø—Ä–æ–∫—É—Ä–æ—Ä–∞ –æ –≤–æ–∑–º–µ—â–µ–Ω–∏–∏ —É—â–µ—Ä–±–∞ –æ—Å—Ç–∞–≤–∏–ª–∏ –±–µ–∑ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏—è. –°—Ç–æ—Ä–æ–Ω—ã –æ–±–∂–∞–ª–æ–≤–∞–ª–∏ –≤–µ—Ä–¥–∏–∫—Ç. –ê—Ä–µ—Å—Ç, –Ω–∞–ª–æ–∂–µ–Ω–Ω—ã–π –Ω–∞ –∏–º—É—â–µ—Å—Ç–≤–æ –í–æ—Ä–æ–±—å—è, –æ—Å—Ç–∞–ª—Å—è –≤ —Å–∏–ª–µ, –Ω–æ —Å—É–¥—É –µ—â—ë –ø—Ä–µ–¥—Å—Ç–æ–∏—Ç —Ä–∞–∑–æ–±—Ä–∞—Ç—å—Å—è —Å –≤–∑—ã—Å–∫–∞–Ω–∏–µ–º –Ω–∞–ª–æ–≥–æ–≤–æ–π –∑–∞–¥–æ–ª–∂–µ–Ω–Ω–æ—Å—Ç–∏. –¢–æ–≤–∞—Ä–Ω—ã–µ –∑–Ω–∞–∫–∏ –æ–±–∞–Ω–∫—Ä–æ—Ç–∏–≤—à–µ–≥–æ—Å—è ¬´–†–ò–ê –ü–∞–Ω–¥–∞¬ª –ò–≥–æ—Ä—è –í–æ—Ä–æ–±—å—è —É—à–ª–∏ —Å –º–æ–ª–æ—Ç–∫–∞ –≤ –º–∞—Ä—Ç–µ. –ü—Ä–∞–≤–∞ –Ω–∞ –°–µ–∞–ª–µ–∫—Å –¥–ª—è –ø–æ—Ç–µ–Ω—Ü–∏–∏ –∏ –ì–∏—Å—Ç–∞–Ω –¥–ª—è –ª–µ—á–µ–Ω–∏—è –∞–ª–ª–µ—Ä–≥–∏–∏ –Ω–∞ —Ç–æ—Ä–≥–∞—Ö –ø–æ—á—Ç–∏ –∑–∞ 90 –º–ª–Ω —Ä—É–±–ª–µ–π –≤—ã–∫—É–ø–∏–ª–æ –û–û–û ¬´–î–∏–∞–ª–æ–≥¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, shortage, regulation, registration, reimbursement"",
  ""impact"": ""high"",
  ""english"": ""The case of Ilya Vorobyev and Sergey Nazarov, the founders of 'RIA Panda' and its business partner 'VIS', who were released from prison due to the expiration of their sentence for producing banned BAs (Bioactive substances) without declaring the registered pharmaceutical substance, has been resolved. The case involves a criminal investigation that began in 2015 and resulted in five years of conditional imprisonment for both. The civil lawsuit against them was dismissed, but they were prohibited from engaging in activities related to the production and sale of BAs for three years. The case also involves tax evasion by 'RIA Panda', 'VIS' and 'VIS Cosmetics'. The trademark rights for Sildenafil (Viagra) and Histamine for allergy treatment were sold at nearly 90 million rubles to a company called 'Dialog'.""
}"
2025-07-08T11:31:38+00:00,@bezrec,6283,https://t.me/bezrec/6283,"–§–ê–° —Å–Ω–∏–∑–∏–ª–∞ —Ü–µ–Ω—É –Ω–∞ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π –¥–∂–µ–Ω–µ—Ä–∏–∫ –ø—Ä–æ—Ç–∏–≤ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –¥—ã—Ö–∞—Ç–µ–ª—å–Ω—ã—Ö –ø—É—Ç–µ–π. –†–µ—Å–ø–∏–∫–æ–º–± —ç–π—Ä (–±–µ–∫–ª–æ–º–µ—Ç–∞–∑–æ–Ω+—Ñ–æ—Ä–º–æ—Ç–µ—Ä–æ–ª) –æ—Ç ¬´–ü–°–ö –§–∞—Ä–º–∞¬ª, –ø–µ—Ä–≤—ã–π —Ä–æ—Å—Å–∏–π—Å–∫–∏–π –¥–∂–µ–Ω–µ—Ä–∏–∫ –§–æ—Å—Ç–µ—Ä–∞ –∏—Ç–∞–ª—å—è–Ω—Å–∫–æ–π Chiesi Farmaceutici S.p.A., —Å—Ç–∞–ª –Ω–∞ 9% –¥–µ—à–µ–≤–ª–µ —Ä–µ—Ñ–µ—Ä–µ–Ω—Ç–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞. –¶–µ–Ω–∞ –∑–∞ —É–ø–∞–∫–æ–≤–∫—É –∏–∑ 120 –¥–æ–∑ –∞—ç—Ä–æ–∑–æ–ª—è –¥–ª—è –∏–Ω–≥–∞–ª—è—Ü–∏–π –≤ –¥–æ–∑–∏—Ä–æ–≤–∫–µ 200 –º–∫–≥+6 –º–∫–≥/–¥–æ–∑–∞ —Å–æ–≥–ª–∞—Å–æ–≤–∞–Ω–∞ –Ω–∞ —É—Ä–æ–≤–Ω–µ 1446 —Ä—É–±–ª–µ–π, —Ç–æ–≥–¥–∞ –∫–∞–∫ –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã–π –§–æ—Å—Ç–µ—Ä —Å—Ç–æ–∏—Ç 1601 —Ä—É–±–ª—å. –ü—Ä–µ–ø–∞—Ä–∞—Ç –≤—Ö–æ–¥–∏—Ç –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü –∏ —É–º–µ–Ω—å—à–∞–µ—Ç –≤—ã—Ä–∞–∂–µ–Ω–Ω–æ—Å—Ç—å —Å–∏–º–ø—Ç–æ–º–æ–≤ –∏ —á–∞—Å—Ç–æ—Ç—É –æ–±–æ—Å—Ç—Ä–µ–Ω–∏–π –±—Ä–æ–Ω—Ö–∏–∞–ª—å–Ω–æ–π –∞—Å—Ç–º—ã, —É–ª—É—á—à–∞–µ—Ç –ø–æ–∫–∞–∑–∞—Ç–µ–ª–∏ —Ñ—É–Ω–∫—Ü–∏–∏ –≤–Ω–µ—à–Ω–µ–≥–æ –¥—ã—Ö–∞–Ω–∏—è. –§–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏–∏ –¥–ª—è –†–µ—Å–ø–∏–∫–æ–º–± —ç–π—Ä –ø—Ä–æ–∏–∑–≤–æ–¥—è—Ç—Å—è –≤ –ò–Ω–¥–∏–∏, –æ—Å—Ç–∞–ª—å–Ω—ã–µ —Å—Ç–∞–¥–∏–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –æ—Å—É—â–µ—Å—Ç–≤–ª—è—é—Ç—Å—è –Ω–∞ –ø–ª–æ—â–∞–¥–∫–µ ¬´–ü–°–ö –§–∞—Ä–º–∞¬ª –≤ –î—É–±–Ω–µ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""reimbursement, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The Russian regulator has reduced the price of Respicomb Air (beclomethasone/formoterol) generic, a first Russian version of the Italian Chiesi's Foseltin. The price per 120 inhalation doses is now 1446 rubles, down from the foreign version's price of 1601 rubles. The drug is included in the list of essential medicines and helps reduce asthma severity and frequency of exacerbations, improving external breathing function. The fumaric acid for Respicomb Air is produced in India and the production stages after that are carried out at PSK Pharma's facility in Dubna.""
}"
2025-07-08T08:20:06+00:00,@bezrec,6282,https://t.me/bezrec/6282,"¬´–ù–∏–∂—Ñ–∞—Ä–º¬ª –∏ –ù–ê–§–ò –≤—ã—è—Å–Ω–∏–ª–∏, –∫–∞–∫ —Ä–æ—Å—Å–∏—è–Ω–µ –æ—Ç–Ω–æ—Å—è—Ç—Å—è –∫ –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ —Ñ–∞—Ä–º–ø—Ä–æ–º–∞. –û–∫–∞–∑–∞–ª–æ—Å—å, —Ö–æ—Ä–æ—à–æ. –£—Ä–æ–≤–µ–Ω—å –¥–æ–≤–µ—Ä–∏—è —Ä–æ—Å—Å–∏—è–Ω –∫ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–º –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º –≤ 2025 –≥–æ–¥—É —Å–æ—Å—Ç–∞–≤–∏–ª 78%, —á—Ç–æ –Ω–∞ 16 –ø—Ä–æ—Ü–µ–Ω—Ç–Ω—ã—Ö –ø—É–Ω–∫—Ç–æ–≤ –±–æ–ª—å—à–µ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –ø—Ä–æ—à–ª—ã–º –≥–æ–¥–æ–º, ‚Äî –≥–ª–∞—Å–∏—Ç –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ. –ï—â—ë —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –æ–ø—Ä–æ—Å–∞ 2,4 —Ç—ã—Å. —á–µ–ª–æ–≤–µ–∫ –∏–∑ –≥–æ—Ä–æ–¥–æ–≤ —Å —á–∏—Å–ª–µ–Ω–Ω–æ—Å—Ç—å—é 100 —Ç—ã—Å. —á–µ–ª–æ–≤–µ–∫ –∏ –±–æ–ª–µ–µ: üíä 52% —Ä–µ—Å–ø–æ–Ω–¥–µ–Ω—Ç–æ–≤ –æ–±—Ä–∞—â–∞—é—Ç –≤–Ω–∏–º–∞–Ω–∏–µ –Ω–∞ —Å—Ç—Ä–∞–Ω—É-–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è –ø—Ä–∏ –≤—ã–±–æ—Ä–µ –ª–µ–∫–∞—Ä—Å—Ç–≤; üíä 78% –≥–æ—Ç–æ–≤—ã —Ä–µ–∫–æ–º–µ–Ω–¥–æ–≤–∞—Ç—å –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –∑–Ω–∞–∫–æ–º—ã–º; üíä 80% —Ä–µ—Å–ø–æ–Ω–¥–µ–Ω—Ç–æ–≤, –≤ –ø–æ—Å–ª–µ–¥–Ω–∏–π –≥–æ–¥ –∑–∞–º–µ–Ω–∏–≤—à–∏—Ö –ø—Ä–∏–≤—ã—á–Ω—ã–µ –±—Ä–µ–Ω–¥—ã –Ω–∞ –∞–Ω–∞–ª–æ–≥–∏, –≤—ã–±–∏—Ä–∞–ª–∏ –∏–º–µ–Ω–Ω–æ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–µ –≤–∞—Ä–∏–∞–Ω—Ç—ã ‚Äî –≤ –æ—Å–Ω–æ–≤–Ω–æ–º –∏–∑-–∑–∞ –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ –Ω–∏–∑–∫–æ–π —Å—Ç–æ–∏–º–æ—Å—Ç–∏; üíä 82% –æ—Å—Ç–∞–ª–∏—Å—å –¥–æ–≤–æ–ª—å–Ω—ã –ª–µ—á–µ–Ω–∏–µ–º —Ä–æ—Å—Å–∏–π—Å–∫–∏–º–∏ –¥–∂–µ–Ω–µ—Ä–∏–∫–∞–º–∏; üíä –ø—Ä–æ–¥—É–∫—Ü–∏—é —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ª—é–±—è—Ç –∑–∞ –¥–æ—Å—Ç—É–ø–Ω—É—é —Å—Ç–æ–∏–º–æ—Å—Ç—å (54%), –ø–æ–∑–∏—Ç–∏–≤–Ω—ã–π –æ–ø—ã—Ç –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏—è (37%), –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–Ω–æ—Å—Ç—å –≤ –ø—Ä–æ–¥–∞–∂–µ (34%) –∏ —É—Å—Ç–æ–π—á–∏–≤–æ–µ –ø—Ä–∏—Å—É—Ç—Å—Ç–≤–∏–µ –Ω–∞ —Ä—ã–Ω–∫–µ (32%). –ù–µ–º–Ω–æ–≥–æ –Ω–∞–ø—Ä—è–≥–∞–µ—Ç, —á—Ç–æ, –ø–æ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è, –æ—Ü–µ–Ω–∫–∏ –∫–∞—á–µ—Å—Ç–≤–∞ –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –∏ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ (–∫–∞–∫ –±–ª–∏–∑–∫–∏—Ö, —Ç–∞–∫ –∏ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤) –¥–ª—è –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª—è –≤—Ç–æ—Ä–æ—Å—Ç–µ–ø–µ–Ω–Ω—ã. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The survey of 'Nefarfarm' and NAFI shows that Russians have a good attitude towards domestic pharmaceutical products. 78% of respondents are ready to recommend domestic drugs to their acquaintances, up from the previous year. 82% of respondents are satisfied with Russian generics due to their affordable price, positive experience, and stable presence on the market. However, evaluations of product quality and recommendations for consumers are considered secondary.""
}"
2025-07-08T05:45:37+00:00,@bezrec,6281,https://t.me/bezrec/6281,"–û–¢–° –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã —Å–¥–∞—é—Ç –ø–æ–∑–∏—Ü–∏–∏ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å —Ä–µ—Ü–µ–ø—Ç—É—Ä–∫–æ–π. –ü–æ –¥–∞–Ω–Ω—ã–º RNC Pharma, —Å —è–Ω–≤–∞—Ä—è –ø–æ –º–∞–π 2025 –≥–æ–¥–∞ –Ω–∞ —Ä–æ–∑–Ω–∏—á–Ω–æ–º —Ä—ã–Ω–∫–µ (–≤–∫–ª—é—á–∞—è e-com) –±—ã–ª–æ —Ä–µ–∞–ª–∏–∑–æ–≤–∞–Ω–æ –±–µ–∑—Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –Ω–∞ 311 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ü—Ä–∏—Ä–æ—Å—Ç –≤ –¥–µ–Ω–µ–∂–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ —Å–æ—Å—Ç–∞–≤–∏–ª 12,6% –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å 19% –ø–æ Rx-–∫–∞—Ç–µ–≥–æ—Ä–∏–∏. –î–æ–ª—è OTC-–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ —Ä—É–±–ª—è—Ö –¥–æ—Å—Ç–∏–≥–ª–∞ 40,4% (-1,3% –≥–æ–¥ –∫ –≥–æ–¥—É), –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö ‚Äî 55,8% (-1,2% –∫ –ø—Ä–æ—à–ª–æ–º—É –≥–æ–¥—É). –°–∞–º—ã–π –Ω–∏–∑–∫–∏–π –∏–Ω—Ç–µ—Ä–µ—Å –∫ –±–µ–∑—Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º –Ω–∞–±–ª—é–¥–∞–µ—Ç—Å—è –Ω–∞ –°–µ–≤–µ—Ä–Ω–æ–º –ö–∞–≤–∫–∞–∑–µ: –≤ –ß–µ—á–Ω–µ –∏—Ö –¥–æ–ª—è –≤ –∞–ø—Ç–µ–∫–∞—Ö –≤ –¥–µ–Ω–µ–∂–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ –Ω–µ –ø—Ä–µ–≤—ã—à–∞–µ—Ç 36,5%, –∞ –≤ –ò–Ω–≥—É—à–µ—Ç–∏–∏ ‚Äî 35,6%. –ü—Ä–∏ —ç—Ç–æ–º –ß–µ—á–Ω—è –ø–æ–∫–∞–∑–∞–ª–∞ –º–∞–∫—Å–∏–º–∞–ª—å–Ω—É—é –¥–∏–Ω–∞–º–∏–∫—É –ø—Ä–æ–¥–∞–∂ —ç—Ç–æ–π –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ (+30%). –¢–∞–∫–æ–π –∂–µ –ø–æ–∫–∞–∑–∞—Ç–µ–ª—å –Ω–∞ –ß—É–∫–æ—Ç–∫–µ. –ü–æ —Ç–µ–º–ø–∞–º —Ä–æ—Å—Ç–∞ –ø—Ä–æ–¥–∞–∂ –±–µ–∑—Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –æ–±–æ–≥–Ω–∞–ª–∏ —Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã–µ —Ç–æ–ª—å–∫–æ –≤ –ë–µ–ª–≥–æ—Ä–æ–¥–µ (21,8% –ø—Ä–æ—Ç–∏–≤ 20,3%). –¢–æ–ø-10 –±–µ–∑—Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω –≤ –æ—Å–Ω–æ–≤–Ω–æ–º –∏–Ω–æ—Å—Ç—Ä–∞–Ω—Ü–∞–º–∏ ‚Äî –≤ –Ω–µ–≥–æ –ø–æ–ø–∞–ª–∏ –≤—Å–µ–≥–æ —á–µ—Ç—ã—Ä–µ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞: –ü–µ–Ω—Ç–∞–ª–≥–∏–Ω (¬´–û—Ç–∏—Å–∏—Ñ–∞—Ä–º¬ª), –ì—Ä–∞–º–º–∏–¥–∏–Ω –∏ –ò–Ω–≥–∞–≤–∏—Ä–∏–Ω (¬´–í–∞–ª–µ–Ω—Ç–∞¬ª), –ö–∞—Ä–¥–∏–æ–º–∞–≥–Ω–∏–ª (¬´–ù–∏–∂—Ñ–∞—Ä–º¬ª). –õ–∏–¥–µ—Ä —Ä–µ–π—Ç–∏–Ω–≥–∞ –ø–æ –∏—Ç–æ–≥–∞–º –ø–µ—Ä–≤—ã—Ö –ø—è—Ç–∏ –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ ‚Äî –ù—É—Ä–æ—Ñ–µ–Ω –æ—Ç ¬´–†–µ–∫–∏—Ç—Ç –ë–µ–Ω–∫–∏–∑–µ—Ä¬ª, –Ω–∞ –≤—Ç–æ—Ä–æ–º –∏ —Ç—Ä–µ—Ç—å–µ–º –º–µ—Å—Ç–∞—Ö ‚Äî –î–µ—Ç—Ä–∞–ª–µ–∫—Å (¬´–°–µ—Ä–≤—å–µ¬ª) –∏ –¢–µ—Ä–∞—Ñ–ª—é (Haleon). –ü–æ –ø—Ä–∏—Ä–æ—Å—Ç—É –≤ –¥–µ–Ω—å–≥–∞—Ö –ø–æ–±–µ–∂–¥–∞–µ—Ç –∑–∞–Ω–∏–º–∞—é—â–∏–π –¥–µ—Å—è—Ç—É—é —Å—Ç—Ä–æ—á–∫—É –ö—Ä–µ–æ–Ω –æ—Ç ¬´–≠–±–±–æ—Ç—Ç¬ª. –°–∞–º–∞—è —Å–∫—Ä–æ–º–Ω–∞—è –¥–∏–Ω–∞–º–∏–∫–∞ —É –ö–∞–Ω–µ—Ñ—Ä–æ–Ω–∞ –æ—Ç ¬´–ë–∏–æ–Ω–æ—Ä–∏–∫–∏¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, shortage"",
  ""impact"": ""medium"",
  ""english"": ""There has been a decline in prescription drug sales compared to the previous year. According to RNC Pharma data, from January to May 2025, off-patent drugs were sold for RUB311 billion on the retail market (including e-commerce). The growth in monetary terms was 12.6%, compared to the Rx category's increase of 19%. The share of off-patent drugs in rubles reached 40.4% (-1.3% year-over-year), and in packages ‚Äî 55.8% (-1.2% year-over-year). The lowest interest in off-patent drugs is observed on the North Caucasus: in Chechnya, this share does not exceed 36.5% of pharmacies' sales in monetary terms, and in Ingushetia ‚Äî 35.6%. However, Chechnya showed the highest sales growth for this category (+30%). The same trend is observed on Chukotka. Off-patent drugs have surpassed prescription drugs in terms of growth"
2025-07-07T16:40:01+00:00,@bezrec,6280,https://t.me/bezrec/6280,"–ú–∞–∫–∞ –º–Ω–æ–≥–æ –Ω–µ –±—ã–≤–∞–µ—Ç. –í 2022 –≥–æ–¥—É –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ —Å–¥–µ–ª–∞–ª –ë—Ä—è–Ω—Å–∫—É—é –æ–±–ª–∞—Å—Ç—å –ø–∏–ª–æ—Ç–Ω–æ–π –ø–ª–æ—â–∞–¥–∫–æ–π –¥–ª—è –º–∞—Å—à—Ç–∞–±–Ω–æ–≥–æ –ø—Ä–æ–µ–∫—Ç–∞ –ø–æ –≤—ã—Ä–∞—â–∏–≤–∞–Ω–∏—é –æ–ø–∏–π–Ω–æ–≥–æ –º–∞–∫–∞, —á—Ç–æ–±—ã –Ω–∞–ª–∞–¥–∏—Ç—å –∏–º–ø–æ—Ä—Ç–æ–∑–∞–º–µ—â–µ–Ω–∏–µ –Ω–∞ —Ä—ã–Ω–∫–µ –Ω–∞—Ä–∫–æ—Ç–∏—á–µ—Å–∫–∏—Ö –æ–±–µ–∑–±–æ–ª–∏–≤–∞—é—â–∏—Ö. –†–∞–Ω—å—à–µ —Å—ã—Ä—å—ë –∑–∞–∫—É–ø–∞–ª–∏ –≤ –ß–µ—Ö–∏–∏. –ü–µ—Ä–≤—ã–µ 500 –≥–∞ –º–∞–∫–∞ –ø—Ä–∏–Ω–µ—Å–ª–∏ 98 —Ç–æ–Ω–Ω —É—Ä–æ–∂–∞—è. –ó–∞ 2023 –≥–æ–¥ –∞–≥—Ä–∞—Ä–∏–∏ —Ä–µ–≥–∏–æ–Ω–∞ —Å–æ–±—Ä–∞–ª–∏ –±–æ–ª–µ–µ 700 —Ç—ã—Å. –∫–≥ —Å–µ–º—è–Ω. –ë—Ä—è–Ω—Å–∫–∏–π –º–∞–∫ –ø—Ä–∏–≥–æ–¥–∏–ª—Å—è ¬´–≠–Ω–¥–æ—Ñ–∞—Ä–º—É¬ª ‚Äî –Ω–∞ –µ–≥–æ –ø–ª–æ—â–∞–¥–∫–µ –æ—Ä–≥–∞–Ω–∏–∑–æ–≤–∞–Ω–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏ –≤–∞–∂–Ω—ã—Ö –∞–Ω–∞–ª—å–≥–µ—Ç–∏–∫–æ–≤. –ß—Ç–æ–±—ã –º–∞–∫–∞ —Ö–≤–∞—Ç–∏–ª–æ –Ω–∞ –≤—Å–µ—Ö, –≤ —ç—Ç–æ–º –≥–æ–¥—É –ø–æ—Å–µ–≤–Ω—É—é –ø–ª–æ—â–∞–¥—å —É–≤–µ–ª–∏—á–∏–ª–∏ –Ω–∞ 40%. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-07-07T12:45:26+00:00,@bezrec,6279,https://t.me/bezrec/6279,"–°–∞–º —Å–µ–±–µ —Å—Ç–æ–º–∞—Ç–æ–ª–æ–≥: —Ä–æ—Å—Å–∏—è–Ω–µ —Å–∫—É–ø–∞—é—Ç ¬´—Ä–µ–º–∫–æ–º–ø–ª–µ–∫—Ç—ã¬ª –¥–ª—è –∑—É–±–æ–≤. –ù–∞ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞—Ö –ø—Ä–æ–¥–∞—ë—Ç—Å—è –∫–æ–µ-—á—Ç–æ –ø–æ-–Ω–∞—Å—Ç–æ—è—â–µ–º—É —É–¥–∏–≤–∏—Ç–µ–ª—å–Ω–æ–µ ‚Äî –Ω–∞–±–æ—Ä—ã –¥–ª—è —Å–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω–æ–≥–æ –ø–ª–æ–º–±–∏—Ä–æ–≤–∞–Ω–∏—è –∑—É–±–æ–≤ –≤ –¥–æ–º–∞—à–Ω–∏—Ö —É—Å–ª–æ–≤–∏—è—Ö. –°–ø—Ä–æ—Å —Ä–æ–∂–¥–∞–µ—Ç –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–µ ‚Äî –ø–æ –¥–∞–Ω–Ω—ã–º –ø–ª–∞—Ç—Ñ–æ—Ä–º—ã —É–ø—Ä–∞–≤–ª–µ–Ω–∏—è —ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω–æ–π –∫–æ–º–º–µ—Ä—Ü–∏–µ–π JVO –°—Ç—É–¥–∏—è, –∑–∞ –ø–µ—Ä–≤—ã–µ —à–µ—Å—Ç—å –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –æ–±—ä—è–≤–ª–µ–Ω–∏–π –æ –ø—Ä–æ–¥–∞–∂–µ —Ç–∞–∫–∏—Ö —Ç–æ–≤–∞—Ä–æ–≤ –≤—ã—Ä–æ—Å–ª–æ –≤ 3,3 —Ä–∞–∑–∞ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –ø—Ä–æ—à–ª—ã–º –≥–æ–¥–æ–º. –û—Ç–∑—ã–≤—ã —Ä–∞–∑–Ω—ã–µ ‚Äî –æ–¥–Ω–∏ –Ω–µ –Ω–∞—Ä–∞–¥—É—é—Ç—Å—è –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ –ø—Ä–∏–∫—Ä—ã—Ç—å —Å–∫–æ–ª –∏–ª–∏ —Ä–∞–∑—Ä—É—à–µ–Ω–Ω—ã–π –∑—É–± –±–µ–∑ –≤–∏–∑–∏—Ç–∞ –∫ —Å—Ç–æ–º–∞—Ç–æ–ª–æ–≥—É, –¥—Ä—É–≥–∏–µ —Å–µ—Ç—É—é—Ç, —á—Ç–æ ¬´–ø–ª–æ–º–±–∏—Ä–æ–≤–æ—á–Ω—ã–π¬ª –º–∞—Ç–µ—Ä–∏–∞–ª –ø–ª–æ—Ö–æ –¥–µ—Ä–∂–∏—Ç—Å—è, —Ç—Ä–µ—Ç—å–∏, –Ω–∞–ø—Ä–æ—Ç–∏–≤, –∂–∞–ª—É—é—Ç—Å—è –Ω–∞ –Ω–µ–≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å —É–¥–∞–ª–∏—Ç—å –µ–≥–æ —Å –ø–æ–≤–µ—Ä—Ö–Ω–æ—Å—Ç–∏ –∑—É–±–∞. –¢—è–≥–∞ –∫ —Å–∞–º–æ–ª–µ—á–µ–Ω–∏—é –æ–±—ä—è—Å–Ω—è–µ—Ç—Å—è –ø—Ä–æ—Å—Ç–æ ‚Äî –∂–µ–ª–∞–Ω–∏–µ–º —Å—ç–∫–æ–Ω–æ–º–∏—Ç—å –Ω–∞ –¥–æ—Ä–æ–∂–∞—é—â–∏—Ö –Ω–µ –ø–æ –¥–Ω—è–º, –∞ –ø–æ —á–∞—Å–∞–º —É—Å–ª—É–≥–∞—Ö –≤—Ä–∞—á–µ–π. –ù–æ —ç—Ç–æ –∫–∞–∫ —Ä–∞–∑ —Ç–æ—Ç —Å–ª—É—á–∞–π, –∫–æ–≥–¥–∞ —Å–∫—É–ø–æ–π –ø–ª–∞—Ç–∏—Ç –¥–≤–∞–∂–¥—ã. –¢–∞–∫–∞—è —Å–∞–º–æ–¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç—å –ª–∏—à—å –º–∞—Å–∫–∏—Ä—É–µ—Ç –ø—Ä–æ–±–ª–µ–º—É, –Ω–µ –≥–æ–≤–æ—Ä—è —É–∂–µ –æ —Å–æ–º–Ω–∏—Ç–µ–ª—å–Ω–æ–º –ø—Ä–æ–∏—Å—Ö–æ–∂–¥–µ–Ω–∏–∏ ¬´—Ä–µ–º–∫–æ–º–ø–ª–µ–∫—Ç–æ–≤¬ª –∏ –Ω–∞—Ä—É—à–µ–Ω–∏–∏ —É—Å–ª–æ–≤–∏–π —Ç—Ä–∞–Ω—Å–ø–æ—Ä—Ç–∏—Ä–æ–≤–∫–∏ –∏ —Ö—Ä–∞–Ω–µ–Ω–∏—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""There is a growing trend of people self-treating dental issues by purchasing home repair kits. The marketplaces are seeing a significant increase in such products, with the number of listings growing by 3.3 times compared to last year. However, reviews are mixed - some users appreciate the convenience of self-treatment, while others report issues with the durability of the filling material. The issue is being driven by cost-saving motives, but this self-treatment approach only exacerbates the problem. The legitimacy of these home repair kits and their storage conditions are questionable.""
}"
2025-07-07T08:47:05+00:00,@bezrec,6278,https://t.me/bezrec/6278,"–§–ê–° –≤–æ–∑–±—É–¥–∏–ª–∞ –¥–µ–ª–æ –ø—Ä–æ—Ç–∏–≤ ¬´–ó–∞–º–±–æ–Ω-–§–∞—Ä–º–∞¬ª. –ê–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å—â–∏–∫–∏ –∑–∞—è–≤–∏–ª–∏, —á—Ç–æ —Ä–æ—Å—Å–∏–π—Å–∫–∞—è –¥–æ—á–∫–∞ –∏—Ç–∞–ª—å—è–Ω—Å–∫–æ–π Zambon SpA –Ω–µ–æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω–æ –ø–æ–≤—ã—Å–∏–ª–∞ –æ—Ç–ø—É—Å–∫–Ω—É—é —Ü–µ–Ω—É –Ω–∞ –§–ª—É–∏–º—É—Ü–∏–ª-–∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫ –ò–¢ –ø–æ—á—Ç–∏ –≤ 1,5 —Ä–∞–∑–∞. –ü—Ä–µ–ø–∞—Ä–∞—Ç –∏—Å–ø–æ–ª—å–∑—É–µ—Ç—Å—è –¥–ª—è –ª–µ—á–µ–Ω–∏—è –∏–Ω—Ñ–µ–∫—Ü–∏–π –¥—ã—Ö–∞—Ç–µ–ª—å–Ω—ã—Ö –ø—É—Ç–µ–π –∏ –õ–û–†-–æ—Ä–≥–∞–Ω–æ–≤ –∏ –Ω–µ –≤—Ö–æ–¥–∏—Ç –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü. –ö–æ–º–ø–∞–Ω–∏—è ‚Äî –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–π –∏–º–ø–æ—Ä—Ç—ë—Ä –∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫–∞ –≤ –†–§. –í —ç—Ç–æ–π —Å–≤—è–∑–∏ —Ä–µ–≥—É–ª—è—Ç–æ—Ä –ø–æ—Å—á–∏—Ç–∞–ª, —á—Ç–æ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å –∑–∞–Ω–∏–º–∞–µ—Ç –¥–æ–º–∏–Ω–∏—Ä—É—é—â–µ–µ –ø–æ–ª–æ–∂–µ–Ω–∏–µ –Ω–∞ —Ä—ã–Ω–∫–µ. –° 2023 –≥–æ–¥–∞ –ø–æ I –∫–≤–∞—Ä—Ç–∞–ª 2025 –≥–æ–¥–∞ ¬´–ó–∞–º–±–æ–Ω-–§–∞—Ä–º–∞¬ª –Ω–µ–æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω–æ –ø–æ–≤—ã—Å–∏–ª–∞ –æ—Ç–ø—É—Å–∫–Ω—É—é —Ü–µ–Ω—É –Ω–∞ –§–ª—É–∏–º—É—Ü–∏–ª-–∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫ –ò–¢ –Ω–∞ 46%. –ü—Ä–∏ —ç—Ç–æ–º —Ç–µ–º–ø—ã —Ä–æ—Å—Ç–∞ –ø—Ä–∏–±—ã–ª–∏ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ –ø—Ä–µ–≤—ã—Å–∏–ª–∏ —Ä–æ—Å—Ç —Ä–∞—Å—Ö–æ–¥–æ–≤ –Ω–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ, ‚Äî –ø–æ—è—Å–Ω–∏–ª —Ä–µ–≥—É–ª—è—Ç–æ—Ä. –ï—Å–ª–∏ –≤–∏–Ω–∞ –∫–æ–º–ø–∞–Ω–∏–∏ –±—É–¥–µ—Ç –¥–æ–∫–∞–∑–∞–Ω–∞, –µ–π –≥—Ä–æ–∑–∏—Ç —à—Ç—Ä–∞—Ñ –≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–∏ —Å –ö–æ–ê–ü –†–§ –ª–∏–±–æ –≤–æ–∑–≤—Ä–∞—Ç –≤ –±—é–¥–∂–µ—Ç –Ω–µ–∑–∞–∫–æ–Ω–Ω–æ –ø–æ–ª—É—á–µ–Ω–Ω–æ–≥–æ –¥–æ—Ö–æ–¥–∞. –° —Ñ–∏–Ω–∞–Ω—Å–æ–≤—ã–º–∏ –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è–º–∏ —É –Ω–∞—Ä—É—à–∏—Ç–µ–ª—è –≤—Å—ë —Ö–æ—Ä–æ—à–æ. –ü–æ –∏—Ç–æ–≥–∞–º 2024 –≥–æ–¥–∞ ¬´–ó–∞–º–±–æ–Ω-–§–∞—Ä–º–∞¬ª –Ω–∞—Ä–∞—Å—Ç–∏–ª–∞ –≤—ã—Ä—É—á–∫—É –Ω–∞ 33%, –¥–æ 7,5 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ß–∏—Å—Ç–∞—è –ø—Ä–∏–±—ã–ª—å –≤—ã—Ä–æ—Å–ª–∞ –±–æ–ª–µ–µ —á–µ–º –≤–¥–≤–æ–µ, –¥–æ 416 –º–ª–Ω —Ä—É–±–ª–µ–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""pricing, shortage"",
  ""impact"": ""high"",
  ""english"": ""The FAS has initiated an investigation against 'Zambon Pharma' for unjustifiably increasing the resale price of Fluimucil antibiotic, an anti-biotic from Italy's Zambon SpA, by almost 50% over the period. The regulator claims that the company is dominating the market and has not provided a justified reason for the price increase. If proven guilty, 'Zambon Pharma' could face a fine under the Criminal Code of Russia or return to the budget any illegally obtained revenue. The company's financials are good, with a 33% increase in revenue to RUB7.5 billion and a more than doubled net profit to RUB416 million in 2024.""
}"
2025-07-07T05:41:01+00:00,@bezrec,6277,https://t.me/bezrec/6277,"–ù–æ–≤—ã–µ –≤–∏—Ä—É—Å—ã –±—É–¥—É—Ç –∏—Å–∫–∞—Ç—å –≤ –ù–æ–≤–æ—Å–∏–±–∏—Ä—Å–∫–µ. –í –ù–æ–≤–æ—Å–∏–±–∏—Ä—Å–∫–æ–º –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–º —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–µ —Å–æ–∑–¥–∞–ª–∏ –ø–µ—Ä–≤—É—é –∑–∞ –£—Ä–∞–ª–æ–º —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—É—é –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–∏—é –º–æ–ª–µ–∫—É–ª—è—Ä–Ω–æ–≥–æ –∏–Ω–∂–∏–Ω–∏—Ä–∏–Ω–≥–∞. –û–¥–Ω–∞ –∏–∑ –≥–ª–∞–≤–Ω—ã—Ö –∑–∞–¥–∞—á ‚Äî –ø–æ–∏—Å–∫ –Ω–æ–≤—ã—Ö –≤–∏—Ä—É—Å–æ–≤ –∏ –∏–∑—É—á–µ–Ω–∏–µ –∏—Ö —Å–æ–≤–æ–∫—É–ø–Ω–æ—Å—Ç–∏ —Å –ø–æ–º–æ—â—å—é –º–µ—Ç–∞–≥–µ–Ω–æ–º–Ω–æ–≥–æ –∏ –±–∏–æ–∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ –∞–Ω–∞–ª–∏–∑–∞. –û—Å–Ω–æ–≤–Ω—ã–µ –∑–∞–¥–∞—á–∏ –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–∏–∏: üîò–±—ã—Å—Ç—Ä–æ–µ –≤–Ω–µ–¥—Ä–µ–Ω–∏–µ –Ω–æ–≤—ã—Ö –º–µ—Ç–æ–¥–æ–≤ —Ñ–∞—Ä–º—Ä–∞–∑—Ä–∞–±–æ—Ç–æ–∫; üîò—Ä–∞—Å—à–∏—Ä–µ–Ω–∏–µ –º–µ–∂–¥–∏—Å—Ü–∏–ø–ª–∏–Ω–∞—Ä–Ω—ã—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π; üîò–∏–Ω—Ç–µ–≥—Ä–∞—Ü–∏—è –ò–ò –∏ –∞–Ω–∞–ª–∏–∑–∞ –±–æ–ª—å—à–∏—Ö –¥–∞–Ω–Ω—ã—Ö –≤ –±–∏–æ–ª–æ–≥–∏—é –∏ –º–µ–¥–∏—Ü–∏–Ω—É; üîò—Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏–µ —Å–æ–≤—Ä–µ–º–µ–Ω–Ω–æ–π –æ–±—Ä–∞–∑–æ–≤–∞—Ç–µ–ª—å–Ω–æ–π —Å—Ä–µ–¥—ã –¥–ª—è –ø–æ–¥–≥–æ—Ç–æ–≤–∫–∏ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –Ω–æ–≤–æ–≥–æ –ø–æ–∫–æ–ª–µ–Ω–∏—è. –í —á–∏—Å–ª–µ –ø–∞—Ä—Ç–Ω—ë—Ä–æ–≤ ‚Äî –∏–Ω—Å—Ç–∏—Ç—É—Ç—ã –°–û –†–ê–ù, –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–π –Ω–∞—É—á–Ω—ã–π —Ü–µ–Ω—Ç—Ä ¬´–í–µ–∫—Ç–æ—Ä¬ª, –¶–∏–Ω—Ö–∞–π—Å–∫–∏–π —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç, –í–æ—Å—Ç–æ—á–Ω–æ-–ö–∏—Ç–∞–π—Å–∫–∏–π –ø–µ–¥–∞–≥–æ–≥–∏—á–µ—Å–∫–∏–π —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç, –ò–Ω—Å—Ç–∏—Ç—É—Ç –≥–µ–Ω–µ—Ç–∏–∫–∏ –∏ —Ñ–∏–∑–∏–æ–ª–æ–≥–∏–∏ (–ö–∞–∑–∞—Ö—Å—Ç–∞–Ω). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-07-06T11:03:39+00:00,@bezrec,6276,https://t.me/bezrec/6276,–ó–∞–∫–∞–∑—ã–≤–∞–µ–º –ø–∞–∫–µ—Ç –¥–ª—è –ø–∞–∫–µ—Ç–æ–≤ —Å –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞,"{""skip"": true}"
2025-07-05T11:04:57+00:00,@bezrec,6275,https://t.me/bezrec/6275,"–í—Å—Ç—Ä–µ—á–∞–µ–º –ø–µ—Ä–≤—É—é –∏—é–ª—å—Å–∫—É—é —Å—É–±–±–æ—Ç—É —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω—ã–º –≤—ã–ø—É—Å–∫–æ–º #–≤–¥–æ–≥–æ–Ω–∫—É. üíä ¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º –≥—Ä—É–ø–ø¬ª –æ–±—ä—è–≤–∏–ª–∞ –æ –Ω–∞—á–∞–ª–µ —Å–±–æ—Ä–∞ –∑–∞—è–≤–æ–∫ –Ω–∞ –±–∏—Ä–∂–µ–≤—ã–µ –æ–±–ª–∏–≥–∞—Ü–∏–∏ —Å–µ—Ä–∏–∏ 001P-06. –û–±—ä—ë–º –≤—ã–ø—É—Å–∫–∞ ‚Äî 3 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —Å—Ä–æ–∫ –æ–±—Ä–∞—â–µ–Ω–∏—è ‚Äî 3 –≥–æ–¥–∞. –°–µ–π—á–∞—Å –≤ –æ–±—Ä–∞—â–µ–Ω–∏–∏ –Ω–∞—Ö–æ–¥–∏—Ç—Å—è –ø—è—Ç—å –≤—ã–ø—É—Å–∫–æ–≤ –æ–±–ª–∏–≥–∞—Ü–∏–π –∫–æ–º–ø–∞–Ω–∏–∏ –Ω–∞ –æ–±—â—É—é —Å—É–º–º—É 19 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. üíä –≠–∫—Å-–≥–ª–∞–≤–∞ –∫–æ–º–∏—Ç–µ—Ç–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è (—Å–µ–π—á–∞—Å ‚Äî –º–∏–Ω–∏—Å—Ç–µ—Ä—Å—Ç–≤–æ) –ö—É—Ä—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –ï–ª–µ–Ω–∞ –ü–∞–ª—Ñ–µ—Ä–æ–≤–∞ –ø—Ä–∏–∑–Ω–∞–Ω–∞ –≤–∏–Ω–æ–≤–Ω–æ–π –≤ –∑–ª–æ—É–ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–∏ –ø–æ–ª–Ω–æ–º–æ—á–∏—è–º–∏. –ß–∏–Ω–æ–≤–Ω–∏—Ü–∞ –æ–±–≤–∏–Ω—è–ª–∞—Å—å –≤ —Ç–æ–º, —á—Ç–æ –Ω–µ –æ—Ä–≥–∞–Ω–∏–∑–æ–≤–∞–ª–∞ –∑–∞–∫—É–ø–∫—É –ª–µ–∫–∞—Ä—Å—Ç–≤, –Ω–µ—Å–º–æ—Ç—Ä—è –Ω–∞ –Ω–∞–ª–∏—á–∏–µ —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è, —á—Ç–æ –ø–æ–≤–ª–µ–∫–ª–æ –∑–∞ —Å–æ–±–æ–π –¥–µ—Ñ–∏—Ü–∏—Ç –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ö —Ç–æ–º—É –∂–µ —É–∂–µ –∑–∞–∫—É–ø–ª–µ–Ω–Ω—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –æ–∫–∞–∑–∞–ª–∏—Å—å –Ω–µ–≤–æ—Å—Ç—Ä–µ–±–æ–≤–∞–Ω–Ω—ã–º–∏. –£—â–µ—Ä–± –±—é–¥–∂–µ—Ç—É –æ—Ü–µ–Ω–∏–ª–∏ –≤ 24 –º–ª–Ω —Ä—É–±–ª–µ–π. –ü–∞–ª—Ñ–µ—Ä–æ–≤–∞ –ø–æ–ª—É—á–∏–ª–∞ —Ç—Ä–∏ –≥–æ–¥–∞ —É—Å–ª–æ–≤–Ω–æ –∏ —à—Ç—Ä–∞—Ñ –≤ 100 —Ç—ã—Å. —Ä—É–±–ª–µ–π. üíä –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –ø—Ä–∞–≤–∏–ª–∞ –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥–∞ –ø—Ä–æ–∏—Å—Ö–æ–∂–¥–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤. –ü—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –∏ —É—á–∞—Å—Ç–Ω–∏–∫–∏ –æ–±–æ—Ä–æ—Ç–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ –º–æ–≥—É—Ç –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞—Ç—å—Å—è –≤ —Å–∏—Å—Ç–µ–º–µ –¥–æ 1 —Å–µ–Ω—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞ –∏ –ø–µ—Ä–µ–¥–∞–≤–∞—Ç—å –¥–∞–Ω–Ω—ã–µ –≤ —Ä–µ–∂–∏–º–µ —Ä–µ–∞–ª—å–Ω–æ–≥–æ –≤—Ä–µ–º–µ–Ω–∏. –° —Ç–µ–∫—Å—Ç–æ–º –¥–æ–∫—É–º–µ–Ω—Ç–∞, –∫–æ—Ç–æ—Ä—ã–π –ø—Ä–æ—Ö–æ–¥–∏—Ç –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω—ã–µ —Å–ª—É—à–∞–Ω–∏—è, –º–æ–∂–Ω–æ –æ–∑–Ω–∞–∫–æ–º–∏—Ç—å—Å—è –Ω–∞ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–º –ø–æ—Ä—Ç–∞–ª–µ –ø—Ä–æ–µ–∫—Ç–æ–≤ –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω—ã—Ö –ø—Ä–∞–≤–æ–≤—ã—Ö –∞–∫—Ç–æ–≤. üíä –°–ø—É—Ç–Ω–∏–∫ V –ø—Ä–∏–≥–æ–¥–∏–ª—Å—è –ø—Ä–∏ —Å–æ–∑–¥–∞–Ω–∏–∏ –≤–∞–∫—Ü–∏–Ω—ã –æ—Ç –±–µ—à–µ–Ω—Å—Ç–≤–∞. –¶–µ–Ω—Ç—Ä –∏–º. –ì–∞–º–∞–ª–µ–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –Ω–æ–≤—É—é ¬´–ì–∞–º–†–∞–±–∏–í–∞–∫¬ª –Ω–∞ –æ—Å–Ω–æ–≤–µ –∞–¥–µ–Ω–æ–≤–∏—Ä—É—Å–Ω–æ–≥–æ –≤–µ–∫—Ç–æ—Ä–∞. –° –ø–æ–º–æ—â—å—é —Ç–æ–π –∂–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ —Å–æ–∑–¥–∞–≤–∞–ª–∞—Å—å –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–∞—è –≤–∞–∫—Ü–∏–Ω–∞ –æ—Ç –∫–æ—Ä–æ–Ω–∞–≤–∏—Ä—É—Å–∞. –û—Ç–ª–∏—á–∏—Ç–µ–ª—å–Ω–∞—è –æ—Å–æ–±–µ–Ω–Ω–æ—Å—Ç—å –∞–Ω—Ç–∏—Ä–∞–±–∏—á–µ—Å–∫–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ‚Äî –≤ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ –æ–¥–Ω–æ–∫—Ä–∞—Ç–Ω–æ–≥–æ –≤–≤–µ–¥–µ–Ω–∏—è. ¬´–ì–∞–º–†–∞–±–∏–í–∞–∫¬ª –ø—Ä–æ—Ö–æ–¥–∏—Ç –¥–æ–∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è, –≤—ã—Ö–æ–¥ –Ω–∞ —Ä—ã–Ω–æ–∫ –æ–±–µ—â–∞—é—Ç –ø–æ—Å–ª–µ 2026 –≥–æ–¥–∞. üíä –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ —Ä–∞—Å—Å–∫–∞–∑–∞–ª –æ–± —É—Å–ø–µ—Ö–∞—Ö —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —Ñ–∞—Ä–º–ø—Ä–æ–º–∞. –¢–æ–ª—å–∫–æ —Å –Ω–∞—á–∞–ª–∞ 2025 –≥–æ–¥–∞ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏—è –æ—Å–≤–æ–∏–ª–∏ –ø–æ –ø–æ–ª–Ω–æ–º—É —Ü–∏–∫–ª—É –≤—ã–ø—É—Å–∫ –Ω–µ—Å–∫–æ–ª—å–∫–∏—Ö –∞–Ω–∞–ª–æ–≥–æ–≤ –∏–º–ø–æ—Ä—Ç–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –í –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–µ —Ç–∞–∫–∂–µ –æ–∂–∏–¥–∞–µ–º —Å–≤–æ–∏ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –ø–æ —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã–º –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º –∏ –¥–∏–∞–±–µ—Ç—É. –û–¥–Ω–æ–≤—Ä–µ–º–µ–Ω–Ω–æ –ø—Ä–æ–¥–æ–ª–∂–∏–º —Ä–∞–∑–≤–∏–≤–∞—Ç—å –ø—Ä–∏–æ—Ä–∏—Ç–µ—Ç–Ω–æ–µ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏–µ —Ä–∞–¥–∏–æ—Ñ–∞—Ä–º–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –≥–¥–µ —É –Ω–∞—Å –¥–æ–ª—è —É–∂–µ –ø—Ä–µ–≤—ã—à–∞–µ—Ç 90% –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏, ‚Äî –∑–∞—è–≤–∏–ª –ê–Ω—Ç–æ–Ω –ê–ª–∏—Ö–∞–Ω–æ–≤ –Ω–∞ ¬´–ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–µ–Ω–Ω–æ–º —á–∞—Å–µ¬ª –≤ –°–æ–≤—Ñ–µ–¥–µ. üíä –í –†–æ—Å—Å–∏–∏ –∏–∑ –æ–±–æ—Ä–æ—Ç–∞ –∏–∑—ä—è–ª–∏ –Ω–µ–ª–µ–≥–∞–ª—å–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –Ω–∞—Ä–∫–æ—Ç–∏—á–µ—Å–∫–∏—Ö –≤–µ—â–µ—Å—Ç–≤ –Ω–∞ —Å—É–º–º—É —Å–≤—ã—à–µ 405,5 –º–ª–Ω —Ä—É–±–ª–µ–π. –° —Ç–∞–∫–∏–º–∏ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º–∏ –∑–∞–≤–µ—Ä—à–∏–ª–∞—Å—å –µ–∂–µ–≥–æ–¥–Ω–∞—è –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–∞—è –æ–ø–µ—Ä–∞—Ü–∏—è –ò–Ω—Ç–µ—Ä–ø–æ–ª–∞ ¬´–ü–∞–Ω–≥–µ—è¬ª. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –ø—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–∏—Ç–µ–ª–∏ –∑–∞–±–ª–æ–∫–∏—Ä–æ–≤–∞–ª–∏ 3,4 —Ç—ã—Å. —Å–∞–π—Ç–æ–≤, —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω—è–≤—à–∏—Ö –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é –æ –Ω–µ–∑–∞–∫–æ–Ω–Ω–æ–π –ø—Ä–æ–¥–∞–∂–µ —Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""The #–≤–¥–æ–≥–æ–Ω–∫—É release marks the start of a bond issuance series by Binnofarm Group. The company announced that applications for bonds worth 3 billion rubles are being collected, with a term of three years. Currently, five Binnofarm Group bond issues amount to 19 billion rubles in total. The Prosecutor's Office has convicted Elena Palferova, a former member of the Health Committee (now Ministry) of Kursk Oblast, for abuse of authority. She was found guilty of not organizing the procurement of medicines despite having funds available, leading to a shortage of drugs. The budget loss was assessed at 24 million rubles. Palferova received three years probation and a fine of 100,000 rubles. The Ministry of Industry has developed rules for monitoring the origin of medicines. Registration in the system is possible until September 1, 2025, and data must be submitted in real-time. The text of the document undergoing public hearings can be accessed on the federal"
2025-07-04T14:04:46+00:00,@bezrec,6274,https://t.me/bezrec/6274,"–í—á–µ—Ä–∞ –ø–æ—Å–º–æ—Ç—Ä–µ–ª–∏ —Ç–æ–ø-10 –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –Ω–∏–∫–æ—Ç–∏–Ω–æ–≤–æ–π –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏, –∞ —Å–µ–≥–æ–¥–Ω—è –≤—ã—è—Å–Ω–∏–º, —Å–∫–æ–ª—å–∫–æ —Å—Ç–æ–∏—Ç –∏–∑–±–∞–≤–∏—Ç—å—Å—è –æ—Ç –≤—Ä–µ–¥–Ω–æ–π –ø—Ä–∏–≤—ã—á–∫–∏ —Å –ø–æ–º–æ—â—å—é –ª–µ–∫–∞—Ä—Å—Ç–≤. –ú—ã #–∑–∞—Ü–µ–Ω–∏–ª–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –Ω–∞ –æ—Å–Ω–æ–≤–µ —Ü–∏—Ç–∏–∑–∏–Ω–∞ —Ç–æ—Ä–≥–æ–≤—ã—Ö –º–∞—Ä–æ–∫ –¢–∞–±–µ–∫—Å (¬´–°–æ—Ñ–∞—Ä–º–∞¬ª) , –ù–∏–∫—É—Ä–∏–ª–ª—ã (¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª), –¢–∞–±–∞–∫–µ—Ç—Ç–µ (¬´–°–µ–≤–µ—Ä–Ω–∞—è –ó–≤–µ–∑–¥–∞¬ª), –ù–∏–∫–æ–∑–∞–º (¬´–ê–í–í–ê –§–∞—Ä–º–∞—Å—å—é—Ç–∏–∫–∞–ª¬ª), –¶–∏—Ç–∏–∑–∏–Ω (¬´–í–∏—Ñ–∏—Ç–µ—Ö¬ª). –õ—é–±–æ–ø—ã—Ç–Ω–æ, —á—Ç–æ —Ü–µ–Ω–æ–≤–æ–π –º–∞–∫—Å–∏–º—É–º –Ω–∞ –≤—Å–µ –ø—è—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–Ω –≤ –æ–¥–Ω–æ–π —Å–µ—Ç–∏ ‚Äî–æ—Ç–ª–∏—á–∏–ª–∞—Å—å ¬´36,6¬ª. –°–∞–º—ã–º –¥–æ—Ä–æ–≥–∏–º (1955 —Ä—É–±–ª–µ–π) –æ–∫–∞–∑–∞–ª—Å—è –±–æ–ª–≥–∞—Ä—Å–∫–∏–π –¢–∞–±–µ–∫—Å, —Å–∞–º—ã–º –¥–µ—à—ë–≤—ã–º (592 —Ä—É–±–ª—è) ‚Äî –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π –¢–∞–±–∞–∫–µ—Ç—Ç–µ –∏–∑ ¬´–°–±–µ—Ä –ï–∞–ø—Ç–µ–∫–∏¬ª –ù–∞–ø–æ–º–∏–Ω–∞–µ–º, —á—Ç–æ –ª—é–±—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏–º–µ—é—Ç –ø—Ä–æ—Ç–∏–≤–æ–ø–æ–∫–∞–∑–∞–Ω–∏—è. –ü–µ—Ä–µ–¥ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º –ø—Ä–æ–∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä—É–π—Ç–µ—Å—å —Å –ª–µ—á–∞—â–∏–º –≤—Ä–∞—á–æ–º. *–∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –ø—Ä–æ–≤–æ–¥–∏–ª–æ—Å—å –æ–Ω–ª–∞–π–Ω 4 –∏—é–ª—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""An online investigation revealed the prices of five nicotine replacement therapy drugs: Sofarma's Tabex, Ozone Pharma's Nikorala, Severna Zvezda's Tabaquete, Avva Pharma's Nicozam, and Vifiteh's Citizin. The most expensive (1955 rubles) is the Bulgarian Tabex, while the cheapest (592 rubles) is Tabaquete from Severna Zvezda. The investigation was conducted online on July 4th.""
}"
2025-07-04T11:05:29+00:00,@bezrec,6273,https://t.me/bezrec/6273,"¬´–ê—Ä—Ç–≥–µ–Ω –±–∏–æ—Ç–µ—Ö¬ª –∏–Ω–≤–µ—Å—Ç–∏—Ä–æ–≤–∞–ª –≤ Genetico 238 –º–ª–Ω —Ä—É–±–ª–µ–π ‚ô¶Ô∏è–ö–æ–º–ø–∞–Ω–∏—è –≤—ã–∫—É–ø–∏–ª–∞ –¥–æ–ø—ç–º–∏—Å—Å–∏—é ¬´–¥–æ—á–∫–∏¬ª ‚Äî 2 –∏—é–ª—è 7 –º–ª–Ω –∞–∫—Ü–∏–π —Ä–∞–∑–º–µ—â—ë–Ω–Ω—ã—Ö –ø–æ –∑–∞–∫—Ä—ã—Ç–æ–π –ø–æ–¥–ø–∏—Å–∫–µ –±—ã–ª–∏ –≤—ã–∫—É–ø–ª–µ–Ω—ã, –∞ –¥–æ–ª—è ¬´–ê—Ä—Ç–≥–µ–Ω –±–∏–æ—Ç–µ—Ö–∞¬ª –≤ Genetico –≤—ã—Ä–æ—Å–ª–∞ —Å 76,25% –¥–æ 78,10%. –ü—Ä–∏–≤–ª–µ—á–µ–Ω–Ω—ã–µ –≤ —Ö–æ–¥–µ –¥–æ–ø—ç–º–∏—Å—Å–∏–∏ —Å—Ä–µ–¥—Å—Ç–≤–∞ Genetico —á–∞—Å—Ç–∏—á–Ω–æ –Ω–∞–ø—Ä–∞–≤–∏—Ç –Ω–∞ —Ä–∞–∑–≤–∏—Ç–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≥–µ–Ω–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –ü–æ –¥–∞–Ω–Ω—ã–º –±—É—Ö–æ—Ç—á–µ—Ç–∞, –Ω–∞ 31 –º–∞—Ä—Ç–∞ 2025 –≥–æ–¥–∞ —Å—Ä–µ–¥–∏ –º–∏–Ω–æ—Ä–∏—Ç–∞—Ä–∏–µ–≤ —Ä–∞—Å–ø—Ä–µ–¥–µ–ª–µ–Ω–æ 24,48% –∞–∫—Ü–∏–π Genetico. ‚Ñ¢Ô∏è –ú–µ–¥–∫–∞—Ä—Ç–∞","{""skip"": true}"
2025-07-04T09:07:52+00:00,@bezrec,6272,https://t.me/bezrec/6272,"–°–æ—é–∑ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –Ω–∞–∂–∞–ª–æ–≤–∞–ª—Å—è –ú–∏—à—É—Å—Ç–∏–Ω—É –Ω–∞ –ú–∏–Ω–∑–¥—Ä–∞–≤. –í—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–∏–π —Å–æ—é–∑ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ (–í–°–ü) –Ω–∞–ø—Ä–∞–≤–∏–ª –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—é –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –ø–∏—Å—å–º–æ —Å –∫—Ä–∏—Ç–∏–∫–æ–π —Ä–∞–±–æ—Ç—ã –∫–æ–º–∏—Å—Å–∏–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ø–æ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—é –ø–µ—Ä–µ—á–Ω–µ–π –ª–µ–∫–∞—Ä—Å—Ç–≤. –ü–æ –º–Ω–µ–Ω–∏—é –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–∏–∫–æ–≤, –∫–æ–º–∏—Å—Å–∏—è –±–ª–æ–∫–∏—Ä—É–µ—Ç –¥–æ—Å—Ç—É–ø –∫ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–º –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º –∏ –ø—Ä–µ–ø—è—Ç—Å—Ç–≤—É–µ—Ç —Å–æ—Ö—Ä–∞–Ω–µ–Ω–∏—é –±—é–¥–∂–µ—Ç–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤. –ì–ª–∞–≤–Ω–æ–µ –∏–∑ –ø–∏—Å—å–º–∞: üîΩ–í 2024 –≥–æ–¥—É —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã–π –∏ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã–µ –±—é–¥–∂–µ—Ç—ã –Ω–µ —Å–º–æ–≥–ª–∏ —Å—ç–∫–æ–Ω–æ–º–∏—Ç—å –æ–∫–æ–ª–æ 3 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –Ω–∞ –∑–∞–∫—É–ø–∫–∞—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤. üîΩ–ß–ª–µ–Ω—ã –∫–æ–º–∏—Å—Å–∏–∏ –≤—ã—Å–∫–∞–∑—ã–≤–∞—é—Ç—Å—è –ø—Ä–æ—Ç–∏–≤ –≤–∫–ª—é—á–µ–Ω–∏—è –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –≤ –≥–æ—Å–ø—Ä–æ–≥—Ä–∞–º–º—ã, ¬´–≤–æ–ª—å–Ω–æ —Ç—Ä–∞–∫—Ç—É—è –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–æ¬ª. üîΩ–í–µ—Å–Ω–æ–π –∫–æ–º–∏—Å—Å–∏—è —É–∫–∞–∑–∞–ª–∞, —á—Ç–æ –¥–ª—è –≤–∫–ª—é—á–µ–Ω–∏—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –≤ —Å–ø–∏—Å–æ–∫ –∑–∞–∫—É–ø–æ–∫ –ø–æ –ø—Ä–æ–≥—Ä–∞–º–º–µ –í–ó–ù —Å–Ω–∞—á–∞–ª–∞ –Ω—É–∂–Ω–æ –≤–Ω–µ—Å—Ç–∏ –µ–≥–æ –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü, –∞ –≤ –¥–≤–∞ —Å–ø–∏—Å–∫–∞ –æ–¥–Ω–æ–≤—Ä–µ–º–µ–Ω–Ω–æ –ø–æ–¥–∞—Ç—å—Å—è –Ω–µ–ª—å–∑—è. –≠—Ç–æ—Ç –ø–æ–¥—Ö–æ–¥ –∑–∞—â–∏—â–∞–µ—Ç —Å—É—â–µ—Å—Ç–≤—É—é—â–∏–π —Ä—ã–Ω–æ–∫ –ø–æ—Å—Ç–∞–≤—â–∏–∫–æ–≤, –æ–≥—Ä–∞–Ω–∏—á–∏–≤–∞—è –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏—é –∫–∞–∫ –º–∏–Ω–∏–º—É–º –Ω–∞ —à–µ—Å—Ç—å –º–µ—Å—è—Ü–µ–≤, –∞ —Ç–æ –∏ –Ω–∞ –¥–≤–∞ –≥–æ–¥–∞. üîΩ–ü—Ä–µ–ø–∞—Ä–∞—Ç, –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–π –¥–ª—è –ª–µ—á–µ–Ω–∏—è –∫–æ–Ω–∫—Ä–µ—Ç–Ω–æ–≥–æ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è, –¥–æ–ª–∂–µ–Ω –ø—Ä–æ—Ö–æ–¥–∏—Ç—å –æ—Ç–¥–µ–ª—å–Ω–æ–µ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏–µ –∏ –æ—Ü–µ–Ω–∫—É —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–π —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –ø–µ—Ä–µ–¥ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º –¥–ª—è –¥—Ä—É–≥–∏—Ö –ø–æ–∫–∞–∑–∞–Ω–∏–π. –≠—Ç–æ –æ–≥—Ä–∞–Ω–∏—á–∏–≤–∞–µ—Ç –¥–æ—Å—Ç—É–ø –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –∫ –Ω–æ–≤—ã–º –∏ –¥–æ—Ä–æ–≥–æ—Å—Ç–æ—è—â–∏–º –∂–∏–∑–Ω–µ—Å–ø–∞—Å–∞—é—â–∏–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º. –ö—Ä–∏—Ç–∏–∫—É–µ—à—å ‚Äî –ø—Ä–µ–¥–ª–∞–≥–∞–π. –£ –í–°–ü –µ—Å—Ç—å –¥–≤–∞ –≤–∞—Ä–∏–∞–Ω—Ç–∞, –∫–∞–∫ –Ω–∞–ª–∞–¥–∏—Ç—å —Ä–∞–±–æ—Ç—É –∫–æ–º–∏—Å—Å–∏–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞: üîò—á–ª–µ–Ω—ã –∫–æ–º–∏—Å—Å–∏–∏ –≥–æ–ª–æ—Å—É—é—Ç —Ç–æ–ª—å–∫–æ –ø–æ —Å–ø–æ—Ä–Ω—ã–º –≤–æ–ø—Ä–æ—Å–∞–º –æ—Ü–µ–Ω–∫–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –∞ —Ü–µ–Ω–∞ –æ–±—Å—É–∂–¥–∞–µ—Ç—Å—è –Ω–∞ –æ—Ç–¥–µ–ª—å–Ω–æ–π –ø–ª–æ—â–∞–¥–∫–µ —Å —É—á–∞—Å—Ç–∏–µ–º –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –∏ —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ–π –ø—Ä–∞–≤–∫–æ–º–∏—Å—Å–∏–∏ –ø–æ–¥ –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–æ–º –§–ê–° –∏ –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–∞; üîò–≤–Ω–µ–¥—Ä—è–µ—Ç—Å—è –µ–¥–∏–Ω—ã–π –º–µ—Ç–æ–¥ –æ—Ü–µ–Ω–∫–∏ –≤–ª–∏—è–Ω–∏—è –Ω–∞ –±—é–¥–∂–µ—Ç—ã —Ä–µ–≥–∏–æ–Ω–æ–≤, –∞ —Ä–∞–±–æ—Ç–∞ –∫–æ–º–∏—Å—Å–∏–∏ —Å—Ç–∞–Ω–æ–≤–∏—Ç—Å—è –±–æ–ª–µ–µ –æ—Ç–∫—Ä—ã—Ç–æ–π –∏ –ø—Ä–æ–∑—Ä–∞—á–Ω–æ–π (–ø—É–±–ª–∏–∫–∞—Ü–∏—è –≤–∏–¥–µ–æ –∑–∞—Å–µ–¥–∞–Ω–∏–π) –∏ –¥—Ä. –ú–∏–Ω–∑–¥—Ä–∞–≤ –æ –ø–∏—Å—å–º–µ –∑–Ω–∞–µ—Ç –∏ –≥–æ—Ç–æ–≤ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ—Ç—å –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è –í–°–ü –≤ —Ä–∞–º–∫–∞—Ö —Ä–∞–±–æ—á–µ–π –≥—Ä—É–ø–ø—ã –ø–æ –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥—É –ø—Ä–∞–≤–æ–ø—Ä–∏–º–µ–Ω–∏—Ç–µ–ª—å–Ω–æ–π –ø—Ä–∞–∫—Ç–∏–∫–∏ –ø—Ä–∞–≤–∏–ª —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—è –ø–µ—Ä–µ—á–Ω–µ–π. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –∫–∞–∫ –∏ –ø–æ—Ä—É—á–∏–ª –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç, —Ä–µ–≥—É–ª—è—Ç–æ—Ä –ø—Ä–æ—Ä–∞–±–∞—Ç—ã–≤–∞–µ—Ç –ø–æ—Ä—è–¥–æ–∫ —Ä–∞–±–æ—Ç—ã –≤ –∫–æ–º–∏—Å—Å–∏–∏ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–µ–π –ø–∞—Ü–∏–µ–Ω—Ç—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement, shortage"",
  ""impact"": ""high"",
  ""english"": ""The Federation of Patients Union (FPU) has criticized the work of the Ministry of Health's commission on forming drug lists. The union claims that the commission is blocking access to innovative drugs and hindering budget savings. In 2024, federal and regional budgets were unable to save around 3 billion rubles on drug purchases. Members of the commission oppose including innovative therapies in state programs, 'freely interpreting legislation.' In spring, the commission noted that for a drug to be included in the program budget list, it must first be added to the essential drugs and non-essential medicines list. This approach protects existing suppliers, limiting competition for at least six months or two years. The FPU suggests two ways to improve the commission's work: 1) Only vote on controversial questions regarding drug evaluations, and discuss prices separately with manufacturers and a special expert commission under the supervision of the FAS and Ministry of Industry; 2) Implement unified criteria for assessing budget impacts on regions, making the commission's work more transparent and open (publishing video sessions). The Ministry of"
2025-07-04T05:39:38+00:00,@bezrec,6271,https://t.me/bezrec/6271,"–ù–∞—à–∞ —Ä—É–±—Ä–∏–∫–∞ #–í–æ–ª—à–µ–±–Ω–∏–∫–∏–°—Ç—Ä–∞–Ω—ã–û–≠–ó —Å–Ω–æ–≤–∞ –≤ –î—É–±–Ω–µ ‚Äî —Å–∞–º–æ–π –∫—Ä—É–ø–Ω–æ–π –æ—Å–æ–±–æ–π —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–π –∑–æ–Ω–µ –ø–æ –∫–æ–ª–∏—á–µ—Å—Ç–≤—É —Ä–µ–∑–∏–¥–µ–Ω—Ç–æ–≤. –°–µ–≥–æ–¥–Ω—è —Ä–∞—Å—Å–∫–∞–∂–µ–º –æ ¬´–ü–°–ö –§–∞—Ä–º–∞¬ª (–≤—Ö–æ–¥–∏—Ç –≤ –ì–ö ¬´–†—É—Å –ë–∏–æ—Ñ–∞—Ä–º¬ª). –ö–æ–º–ø–∞–Ω–∏—è –±—ã–ª–∞ –æ—Å–Ω–æ–≤–∞–Ω–∞ –≤ 2014 –≥–æ–¥—É, –∞ –≤ 2017 —Å—Ç–∞–ª–∞ —Ä–µ–∑–∏–¥–µ–Ω—Ç–æ–º –û–≠–ó ¬´–î—É–±–Ω–∞¬ª. –ü–æ –¥–∞–Ω–Ω—ã–º —Å–µ—Ä–≤–∏—Å–∞ –ø—Ä–æ–≤–µ—Ä–∫–∏ –∫–æ–Ω—Ç—Ä–∞–≥–µ–Ω—Ç–æ–≤ Rusprofile, 99% –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∏—Ç –°–∞—Ç–∏—è –ö–∞—Ä–º –ü—É–Ω–∏—è, –∞ 1% ‚Äî ¬´–†—É—Å –ë–∏–æ—Ñ–∞—Ä–º¬ª. –í —Å–≤–æ—é –æ—á–µ—Ä–µ–¥—å, –≥—Ä—É–ø–ø–∞ –∫–æ–º–ø–∞–Ω–∏–π –ø–æ–ª–Ω–æ—Å—Ç—å—é –≤–æ –≤–ª–∞–¥–µ–Ω–∏–∏ –ü—É–Ω–∏—è. –ì–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–º ¬´–ü–°–ö –§–∞—Ä–º–∞¬ª —Å —Ñ–µ–≤—Ä–∞–ª—è 2021 –≥–æ–¥–∞ —á–∏—Å–ª–∏—Ç—Å—è –ï–≤–≥–µ–Ω–∏—è –®–∞–ø–∏—Ä–æ. –ó–∞ 2024 –≥–æ–¥ –∫–æ–º–ø–∞–Ω–∏—è –Ω–∞—Ä–∞—Å—Ç–∏–ª–∞ –≤—ã—Ä—É—á–∫—É –Ω–∞ 22%, –¥–æ 10 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ê –≤–æ—Ç –ø—Ä–∏–±—ã–ª—å, –Ω–∞–ø—Ä–æ—Ç–∏–≤, —Å–æ–∫—Ä–∞—Ç–∏–ª–∞—Å—å –Ω–∞ 28%, –¥–æ 2,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –°–æ–≥–ª–∞—à–µ–Ω–∏–µ –æ —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–µ –∑–∞–≤–æ–¥–∞ –≤ –î—É–±–Ω–µ –ü—É–Ω–∏—è –∏ –≥—É–±–µ—Ä–Ω–∞—Ç–æ—Ä –ü–æ–¥–º–æ—Å–∫–æ–≤—å—è –ê–Ω–¥—Ä–µ–π –í–æ—Ä–æ–±—å–µ–≤ –ø–æ–¥–ø–∏—Å–∞–ª–∏ –≤ 2018 –≥–æ–¥—É. –£–∂–µ —á–µ—Ä–µ–∑ –≥–æ–¥ –≤ —ç–∫—Å–ø–ª—É–∞—Ç–∞—Ü–∏—é –±—ã–ª–∞ –≤–≤–µ–¥–µ–Ω–∞ –ø–µ—Ä–≤–∞—è –æ—á–µ—Ä–µ–¥—å –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏—è –ø–ª–æ—â–∞–¥—å—é 14 —Ç—ã—Å. –º2. –°—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–æ –≤—Ç–æ—Ä–æ–π –æ—á–µ—Ä–µ–¥–∏ –¥–ª—è —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–∏ —Å–ª–æ–∂–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏–π –ø–ª–æ—â–∞–¥—å—é –±–æ–ª–µ–µ 20 —Ç—ã—Å. –º2 —Å—Ç–∞—Ä—Ç–æ–≤–∞–ª–æ –≤ 2022 –≥–æ–¥—É. –ó–∞–ø—É—Å–∫ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –∑–∞–ø–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω –Ω–∞ 2025 –≥–æ–¥. ¬´–ü–°–ö –§–∞—Ä–º–∞¬ª –ø–µ—Ä–≤–æ–π –∑–∞–∫–ª—é—á–∏–ª–∞ —Å –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ–º –ú–æ—Å–∫–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –æ—Ñ—Å–µ—Ç –Ω–∞ –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏—é –∏ –ø–æ—Å—Ç–∞–≤–∫–∏ —à–∏—Ä–æ–∫–æ–≥–æ –ø–µ—Ä–µ—á–Ω—è –ª–µ–∫–∞—Ä—Å—Ç–≤ –æ–±—â–µ–π —Å—Ç–æ–∏–º–æ—Å—Ç—å—é 1,678 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –í —Å–ø–∏—Å–∫–µ –∏–∑ 26 –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ (17 –ú–ù–ù), –∫–æ—Ç–æ—Ä—ã–µ ¬´–ü–°–ö –§–∞—Ä–º–∞¬ª –¥–æ–ª–∂–Ω–∞ –¥–æ 2029 –≥–æ–¥–∞ –ø–æ—Å—Ç–∞–≤–ª—è—Ç—å –ú–æ—Å–∫–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏, –æ–∫–∞–∑–∞–ª—Å—è –∏ —Ç–æ—Ñ–∞—Ü–∏—Ç–∏–Ω–∏–±, —Å—Ç–∞–≤—à–∏–π –ø—Ä–µ–¥–º–µ—Ç–æ–º –ø–∞—Ç–µ–Ω—Ç–Ω–æ–≥–æ —Å–ø–æ—Ä–∞ —Å Pfizer. –ü–∞—Ç–µ–Ω—Ç –Ω–∞ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã–π –Ø–∫–≤–∏–Ω—É—Å –æ—Ç —Ä–µ–≤–º–∞—Ç–æ–∏–¥–Ω–æ–≥–æ –∞—Ä—Ç—Ä–∏—Ç–∞ –¥–æ–ª–∂–µ–Ω –±—ã–ª –¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å –¥–æ 2025 –≥–æ–¥–∞, –Ω–æ –≤ –∫–æ–Ω–µ—á–Ω–æ–º –∏—Ç–æ–≥–µ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º—É –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—é —É–¥–∞–ª–æ—Å—å –¥–æ–±–∏—Ç—å—Å—è –µ–≥–æ –æ—Ç–º–µ–Ω—ã. –î–ª—è 2022 –≥–æ–¥–∞ —Å–ª—É—á–∞–π –Ω–µ–æ—Ä–¥–∏–Ω–∞—Ä–Ω—ã–π ‚Äî –¥–æ —ç—Ç–æ–≥–æ –†–æ—Å–ø–∞—Ç–µ–Ω—Ç –Ω–µ—á–∞—Å—Ç–æ –∞–Ω–Ω—É–ª–∏—Ä–æ–≤–∞–ª –ø–∞—Ç–µ–Ω—Ç—ã –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã—Ö –∫–æ–º–ø–∞–Ω–∏–π. –í –ø–æ—Ä—Ç—Ñ–µ–ª–µ ¬´–ü–°–ö –§–∞—Ä–º–∞¬ª –±–æ–ª–µ–µ 100 –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ù–µ–ø–æ—Å—Ä–µ–¥—Å—Ç–≤–µ–Ω–Ω–æ –Ω–∞ –ø–ª–æ—â–∞–¥–∫–µ –≤ –î—É–±–Ω–µ –ø—Ä–æ–∏–∑–≤–æ–¥—è—Ç—Å—è –†–µ—Å–ø–∏–∫–æ–º–±, –†–µ—Å–ø–∏–Ω–∏–¥, –í–∞–ª–≥–∞–Ω—Ü–∏–∫–ª–æ–≤–∏—Ä, –†–µ—Å–ø–∏–Ω–µ–∫—Å, –ò–∫–∞—Ç–∏–±–∞–Ω—Ç –ü–°–ö, –†–µ—Å–ø–∏—Ä–∞—Ñ–µ–Ω, –õ–µ–≤–æ—Å–∏–º–µ–Ω–¥–∞–Ω –ü–°–ö, –ü–æ—ç–∫—Å–æ, –†–∞–ª—Ç–µ–≥—Ä–∞–≤–∏—Ä, –ù–∞–¥—Ä–æ–ø–∞—Ä–∏–Ω. –í—á–µ—Ä–∞ –≤ –∫–æ–º–ø–∞–Ω–∏–∏ —Å–æ–æ–±—â–∏–ª–∏, —á—Ç–æ –ú–∏–Ω–∑–¥—Ä–∞–≤ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª –≠–ª—Ç—Ä–æ–º–±–æ–ø–∞–≥ –ü–°–ö (—ç–ª—Ç—Ä–æ–º–±–æ–ø–∞–≥ –æ–ª–∞–º–∏–Ω). –ü—Ä–µ–ø–∞—Ä–∞—Ç –≤—Ö–æ–¥–∏—Ç –≤ –ñ–ù–í–õ–ü –∏ –ø—Ä–∏–º–µ–Ω—è–µ—Ç—Å—è —É –≤–∑—Ä–æ—Å–ª—ã—Ö, –ø–æ–¥—Ä–æ—Å—Ç–∫–æ–≤ –∏ –¥–µ—Ç–µ–π —Å—Ç–∞—Ä—à–µ —Ç—Ä—ë—Ö –ª–µ—Ç —Å –∏–º–º—É–Ω–Ω–æ–π —Ç—Ä–æ–º–±–æ—Ü–∏—Ç–æ–ø–µ–Ω–∏–µ–π –∏ —Ç—è–∂—ë–ª–æ–π –∞–ø–ª–∞—Å—Ç–∏—á–µ—Å–∫–æ–π –∞–Ω–µ–º–∏–µ–π. –ü–æ —Å–ª–æ–≤–∞–º –ï–≤–≥–µ–Ω–∏–∏ –®–∞–ø–∏—Ä–æ, –≤ 2024 –≥–æ–¥—É –æ–±—ä—ë–º —Ä—ã–Ω–∫–∞ –≥–æ—Å–∑–∞–∫—É–ø–æ–∫ —ç–ª—Ç—Ä–æ–º–±–æ–ø–∞–≥–∞ —Å–æ—Å—Ç–∞–≤–∏–ª 42 —Ç—ã—Å. —É–ø–∞–∫–æ–≤–æ–∫. –ü—Ä–µ–ø–∞—Ä–∞—Ç –±—É–¥–µ—Ç –≤—ã–ø—É—Å–∫–∞—Ç—å—Å—è –≤ –î—É–±–Ω–µ. –í –∫–æ–º–ø–∞–Ω–∏–∏ –æ–±–µ—â–∞—é—Ç, —á—Ç–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã—Ö –º–æ—â–Ω–æ—Å—Ç–µ–π —Ö–≤–∞—Ç–∏—Ç, —á—Ç–æ–±—ã –ø–æ–ª–Ω–æ—Å—Ç—å—é —É–¥–æ–≤–ª–µ—Ç–≤–æ—Ä–∏—Ç—å —Å–ø—Ä–æ—Å –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–æ –∏ –æ–±–µ—Å–ø–µ—á–∏—Ç—å –∏–º –ª—å–≥–æ—Ç–Ω–∏–∫–æ–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,pharmacovigilance,hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""The company 'PSK Pharma' based in Moscow, Russia has been expanding its production facilities and launching new drugs. The company signed an offset agreement with the Moscow region government for over 26 medications worth approximately $1.678 billion. The company has also received approval for Eltrombopag, a drug used to treat immune thrombocytopenia and severe aplastic anemia. The company expects the market for Eltrombopag to be around 42,000 units in 2024. The company is also working on clinical trials for new drugs.""
}"
2025-07-03T15:17:04+00:00,@bezrec,6270,https://t.me/bezrec/6270,"–ù–∞ –≤–∏–¥–µ–æ ‚Äî —Å—Ä–µ–¥—Å—Ç–≤–æ –ø—Ä–æ—Ç–∏–≤ –º–æ—Ä—Å–∫–æ–π –±–æ–ª–µ–∑–Ω–∏ –æ—Ç –∫–∏—Ç–∞–π—Å–∫–∏—Ö –∑–∞—Ç–µ–π–Ω–∏–∫–æ–≤. –í–Ω—É—Ç—Ä–∏ –æ—á–∫–æ–≤ ‚Äî —Ü–≤–µ—Ç–Ω–∞—è –∂–∏–¥–∫–æ—Å—Ç—å, –∫–æ—Ç–æ—Ä–∞—è —Å–æ–∑–¥–∞–µ—Ç –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω—É—é –ª–∏–Ω–∏—é –≥–æ—Ä–∏–∑–æ–Ω—Ç–∞ –∏ —É—Å—Ç—Ä–∞–Ω—è–µ—Ç –∫–æ–Ω—Ñ–ª–∏–∫—Ç —Å–∏–≥–Ω–∞–ª–æ–≤, –ø–æ—Å—Ç—É–ø–∞—é—â–∏—Ö –≤ –º–æ–∑–≥ –æ—Ç —Ä–∞–∑–Ω—ã—Ö –æ—Ä–≥–∞–Ω–æ–≤ —á—É–≤—Å—Ç–≤. –¢–æ —á—Ç–æ –Ω–∞–¥–æ –≤ —Ä–∞–∑–≥–∞—Ä –æ—Ç–ø—É—Å–∫–æ–≤ —Ç–µ–º, –∫–æ–≥–æ —É–∫–∞—á–∏–≤–∞–µ—Ç –≤ —Ç—Ä–∞–Ω—Å–ø–æ—Ä—Ç–µ. –ò –Ω–∏–∫–∞–∫–∏—Ö –ø–æ–±–æ—á–µ–∫, –ø—Ä–∏—Å—É—â–∏—Ö —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω—ã–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º –æ—Ç –∫–∏–Ω–µ—Ç–æ–∑–∞. –¢–∞–∫, –Ω–∞–ø—Ä–∏–º–µ—Ä, –ø–æ–ø—É–ª—è—Ä–Ω—É—é –î—Ä–∞–º–∏–Ω—É (–¥–∏–º–µ–Ω–≥–∏–¥—Ä–∏–Ω–∞—Ç) –Ω–µ —Ä–µ–∫–æ–º–µ–Ω–¥—É–µ—Ç—Å—è –ø—Ä–∏–Ω–∏–º–∞—Ç—å –∑–∞ —Ä—É–ª—ë–º. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-07-03T11:50:30+00:00,@bezrec,6269,https://t.me/bezrec/6269,"RNC Pharma –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∞ —Ç–æ–ø-10 –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –Ω–∏–∫–æ—Ç–∏–Ω–æ–≤–æ–π –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏. –°–ø—Ä–æ—Å –Ω–∞ –∫–∞—Ç–µ–≥–æ—Ä–∏—é —É—Å—Ç–æ–π—á–∏–≤–æ —Ä–∞—Å—Ç—ë—Ç –ø–æ—Å–ª–µ–¥–Ω–∏–µ –Ω–µ—Å–∫–æ–ª—å–∫–æ –ª–µ—Ç. –ó–∞ –ø–µ—Ä–≤—ã–µ –ø—è—Ç—å –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ –±—ã–ª–æ –ø—Ä–æ–¥–∞–Ω–æ 1,85 –º–ª–Ω. —É–ø–∞–∫–æ–≤–æ–∫ —Ç–∞–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ —Å—É–º–º—É 2,38 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –≠—Ç–æ –Ω–∞ 10,8% –∏ 20,7% –±–æ–ª—å—à–µ –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –∏ –¥–µ–Ω–µ–∂–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ –≥–æ–¥ –∫ –≥–æ–¥—É. –û–∫–æ–ª–æ 28% —Ä—ã–Ω–∫–∞ –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ –ú–æ—Å–∫–≤—É, –ú–æ—Å–∫–æ–≤—Å–∫—É—é –æ–±–ª–∞—Å—Ç—å –∏ –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥, –ø—Ä–æ–¥–µ–º–æ–Ω—Å—Ç—Ä–∏—Ä–æ–≤–∞–≤—à–∏–µ –¥–≤—É–∑–Ω–∞—á–Ω—É—é –¥–∏–Ω–∞–º–∏–∫—É –ø—Ä–æ–¥–∞–∂. –ê –≤–æ—Ç –º–∞–∫—Å–∏–º–∞–ª—å–Ω—ã–º –ø—Ä–∏—Ä–æ—Å—Ç–æ–º –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ —è–Ω–≤–∞—Ä—è-–º–∞—è 2024 –≥–æ–¥–∞ –æ—Ç–ª–∏—á–∏–ª–∏—Å—å –ö—É—Ä—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å (+38% –≤ —Ä—É–±–ª—è—Ö) –∏ –ß–µ—á–Ω—è (+36%). –ü—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–ª—è –ª–µ—á–µ–Ω–∏—è –Ω–∏–∫–æ—Ç–∏–Ω–æ–≤–æ–π –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏ –±–æ–¥—Ä–æ —Ä–∞—Å—Ö–æ–¥—è—Ç—Å—è —á–µ—Ä–µ–∑ e-com. –ö–∞–Ω–∞–ª –ø–æ–∫–∞–∑–∞–ª –±–µ—Å–ø—Ä–µ—Ü–µ–¥–µ–Ω—Ç–Ω—ã–π —Ä–æ—Å—Ç –Ω–∞ —É—Ä–æ–≤–Ω–µ 62% –≤ —Ä—É–±–ª—è—Ö –∏ 44% –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö. –°–∞–º—ã–µ –≤—ã–¥–∞—é—â–∏–µ—Å—è —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –∑–¥–µ—Å—å —É –ù–∏–∫–æ—Ä–µ—Ç—Ç–µ –æ—Ç ¬´–î–∂–æ–Ω—Å–æ–Ω –∏ –î–∂–æ–Ω—Å–æ–Ω¬ª ‚Äî –ø—Ä–æ–¥–∞–∂–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ —á–µ—Ä–µ–∑ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç –≤—ã—Ä–æ—Å–ª–∏ –∑–∞ –≥–æ–¥ —Å—Ä–∞–∑—É –Ω–∞ 95%. –≠—Ç–æ –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–π –≤ –†–æ—Å—Å–∏–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç –Ω–∞ –æ—Å–Ω–æ–≤–µ –Ω–∏–∫–æ—Ç–∏–Ω–∞. –í —Ü–µ–ª–æ–º, —ç—Ç–∞ –∫–∞—Ç–µ–≥–æ—Ä–∏—è –Ω–µ –º–æ–∂–µ—Ç –ø–æ—Ö–≤–∞—Å—Ç–∞—Ç—å—Å—è –±–æ–ª—å—à–∏–º —Ä–∞–∑–Ω–æ–æ–±—Ä–∞–∑–∏–µ–º —Ç–æ—Ä–≥–æ–≤—ã—Ö –º–∞—Ä–æ–∫ ‚Äî –≤ –∞–Ω–∞–ª–∏–∑–∏—Ä—É–µ–º–æ–º –ø–µ—Ä–∏–æ–¥–µ –Ω–∞ —Ä—ã–Ω–∫–µ –∏—Ö –Ω–∞—Å—á–∏—Ç—ã–≤–∞–ª–æ—Å—å 12, –ø—Ä–∏—á—ë–º –≤ —Ç–æ–ø-10 —É–¥–∞–ª–æ—Å—å –ø—Ä–æ–±–∏—Ç—å—Å—è –¥–∞–∂–µ —Ç–µ–º, —É –∫–æ–≥–æ –ø—Ä–æ–¥–∞–∂–∏ –Ω–µ –ø—Ä–µ–≤—ã—à–∞–ª–∏ –Ω–µ—Å–∫–æ–ª—å–∫–∏—Ö —Å–æ—Ç–µ–Ω —É–ø–∞–∫–æ–≤–æ–∫. –ù–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ –ø–æ—Å–ª–µ –ù–∏–∫–æ—Ä–µ—Ç—Ç–µ —Å–æ –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω—ã–º –æ—Ç—Ä—ã–≤–æ–º –ø–æ –¥–æ–ª–µ —Ä–∞—Å–ø–æ–ª–æ–∂–∏–ª—Å—è –±–æ–ª–≥–∞—Ä—Å–∫–∏–π –¢–∞–±–µ–∫—Å (—Ü–∏—Ç–∏–∑–∏–Ω) –æ—Ç ¬´–°–æ—Ñ–∞—Ä–º–∞¬ª. –ó–∞–º—ã–∫–∞–µ—Ç —Ç—Ä–æ–π–∫—É –ª–∏–¥–µ—Ä–æ–≤ –ù–∏–∫—É—Ä–∏–ª–ª—ã —Å —Ç–µ–º –∂–µ –ú–ù–ù –æ—Ç ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∏¬ª. –°–∞–º–æ–π –≤–Ω—É—à–∏—Ç–µ–ª—å–Ω–æ–π –¥–∏–Ω–∞–º–∏–∫–æ–π (+108%) –º–æ–∂–µ—Ç –ø–æ—Ö–≤–∞—Å—Ç–∞—Ç—å—Å—è –¶–∏—Ç–∏–∑–∏–Ω –æ—Ç ¬´–í–∏—Ñ–∏—Ç–µ—Ö¬ª. –ë–æ–ª–µ–µ —Å–∫—Ä–æ–º–Ω—ã–µ, –Ω–æ —Ç–æ–∂–µ –Ω–µ–ø–ª–æ—Ö–∏–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã —É –ù–∏–∫–æ–∑–∞–º–∞ –æ—Ç ¬´–ê–í–í–ê –§–∞—Ä–º–∞—Å—å—é—Ç–∏–∫–∞–ª¬ª –∏ –¢–∞–±–µ–Ω–æ–≤—ã –æ—Ç ¬´–§–∞—Ä–º–∞–∫–æ—Ä –ø—Ä–æ–¥–∞–∫—à–Ω¬ª. –û—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω—É—é –¥–∏–Ω–∞–º–∏–∫—É –ø–æ–∫–∞–∑–∞–ª–∏ –†–µ—Å–∏–≥–∞—Ä –æ—Ç ¬´–ê–¥–∞–º–µ–¥¬ª (–Ω–µ –ø–æ—Å—Ç–∞–≤–ª—è–µ—Ç—Å—è –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–∏–π —Ä—ã–Ω–æ–∫ —Å —è–Ω–≤–∞—Ä—è 2022 –≥–æ–¥–∞), –¢–∞–±–∞–∫–µ—Ç—Ç–µ –æ—Ç ¬´–°–µ–≤–µ—Ä–Ω–æ–π –∑–≤–µ–∑–¥—ã¬ª –∏ –¢–∞–±–∞–∫—É–º-–ü–ª—é—Å –æ—Ç ¬´–î–æ–∫—Ç–æ—Ä –ù¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial, safety, guideline"",
  ""impact"": ""high"",
  ""english"": ""RNC Pharma announced the top-10 treatments for nicotine dependence. The category's demand has been steadily growing over the past few years. Sales of these treatments reached 1,850,000 units for a total value of RUB2,380 million in the first five months of 2025. This represents a year-over-year growth of 10.8% and 20.7%. Moscow, Moscow Oblast, and St.Petersburg accounted for about 28% of the market. The region with the highest growth in terms of rubles was Kursk Oblast (+38%) and Chechnya (+36%). Online channels showed unprecedented growth of 62% in rubles and 44% in units. The most significant sales growth was recorded for Nicorette from Johnson & Johnson (+95%). This is the only nicotine-based treatment available in Russia. The top-selling treatments include Nicorette from Johnson & Johnson, Tabex from Sofarma in Bulgaria, and"
2025-07-03T09:30:01+00:00,@bezrec,6268,https://t.me/bezrec/6268,"–£—Ä—Å—É–ª–∞ –§–æ–Ω –¥–µ—Ä –õ—è–π–µ–Ω –≤ –æ–∂–∏–¥–∞–Ω–∏–∏ –≤–æ—Ç—É–º–∞ –Ω–µ–¥–æ–≤–µ—Ä–∏—è –∏–∑-–∑–∞ –ø—Ä–æ—Ç–∏–≤–æ–∫–æ–≤–∏–¥–Ω—ã—Ö –≤–∞–∫—Ü–∏–Ω. –ï–≤—Ä–æ–ø–∞—Ä–ª–∞–º–µ–Ω—Ç –ø—Ä–æ–≥–æ–ª–æ—Å—É–µ—Ç –ø–æ —ç—Ç–æ–º—É –≤–æ–ø—Ä–æ—Å—É 10 –∏—é–ª—è. –ò–Ω–∏—Ü–∏–∞—Ç–æ—Ä–æ–º –≤—ã—Å—Ç—É–ø–∏–ª —Ä—É–º—ã–Ω—Å–∫–∏–π –µ–≤—Ä–æ–¥–µ–ø—É—Ç–∞—Ç –ì–µ–æ—Ä–≥–µ –ü–∏–ø–µ—Ä—è. –ï–≥–æ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–µ –ø–æ–¥–¥–µ—Ä–∂–∞–ª–∏ 74 –∏–∑ 720 —á–ª–µ–Ω–æ–≤ –ï–ü. –ß—Ç–æ–±—ã –≥–æ–ª–æ—Å–æ–≤–∞–Ω–∏–µ —Å–æ—Å—Ç–æ—è–ª–æ—Å—å, —Ç—Ä–µ–±–æ–≤–∞–ª–æ—Å—å –º–∏–Ω–∏–º—É–º 72 –≥–æ–ª–æ—Å–∞. –§–æ–Ω –¥–µ—Ä –õ—è–π–µ–Ω –æ–±–≤–∏–Ω—è—é—Ç –≤ –∑–ª–æ—É–ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏—è—Ö –ø—Ä–∏ –∑–∞–∫—É–ø–∫–µ –≤–∞–∫—Ü–∏–Ω –ø—Ä–æ—Ç–∏–≤ COVID-19. –í –º–∞–µ –ï–≤—Ä–æ–ø–µ–π—Å–∫–∏–π —Å—É–¥ —é—Å—Ç–∏—Ü–∏–∏ –ø—Ä–∏–∑–Ω–∞–ª –≥–ª–∞–≤—É –ï–≤—Ä–æ–∫–æ–º–∏—Å—Å–∏–∏ –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ–π –∑–∞ —Å–æ–∫—Ä—ã—Ç–∏–µ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –æ –∫–æ–Ω—Ç—Ä–∞–∫—Ç–∞—Ö –Ω–∞ –∑–∞–∫—É–ø–∫—É –≤–∞–∫—Ü–∏–Ω –¥–ª—è –ï–° –≤ 2021-2023 –≥–æ–¥–∞—Ö. –î–µ—Ç–∞–ª–∏ –∫–æ–Ω—Ç—Ä–∞–∫—Ç–∞ —á–∏–Ω–æ–≤–Ω–∏—Ü–∞ –æ–±—Å—É–∂–¥–∞–ª–∞ –Ω–∞–ø—Ä—è–º—É—é —Å –≥–ª–∞–≤–æ–π Pfizer –ê–ª—å–±–µ—Ä—Ç–æ–º –ë—É—Ä–ª–æ–π, –∞ –ø–µ—Ä–µ–ø–∏—Å–∫—É –æ–±–Ω–∞—Ä–æ–¥–æ–≤–∞—Ç—å –æ—Ç–∫–∞–∑–∞–ª–∞—Å—å. –ï—Å–ª–∏ –≤–æ—Ç—É–º –Ω–µ–¥–æ–≤–µ—Ä–∏—è –±—É–¥–µ—Ç –ø–æ–¥–¥–µ—Ä–∂–∞–Ω, —Ç–æ –≤ –æ—Ç—Å—Ç–∞–≤–∫—É –æ—Ç–ø—Ä–∞–≤–∏—Ç—Å—è –Ω–µ —Ç–æ–ª—å–∫–æ ¬´—Å–ª—É—á–∞–π–Ω–æ —É–¥–∞–ª–∏–≤—à–∞—è¬ª –≤–∞–∂–Ω—ã–µ —Å–º—Å –§–æ–Ω –¥–µ—Ä –õ—è–π–µ–Ω, –Ω–æ –∏ –≤—Å—è –ï–≤—Ä–æ–∫–æ–º–∏—Å—Å–∏—è –≤ –ø–æ–ª–Ω–æ–º —Å–æ—Å—Ç–∞–≤–µ. –í–ø—Ä–æ—á–µ–º, —Ç–∞–∫–æ–π –≤–∞—Ä–∏–∞–Ω—Ç —Å–∫–æ—Ä–µ–µ –∏–∑ –æ–±–ª–∞—Å—Ç–∏ —Ñ–∞–Ω—Ç–∞—Å—Ç–∏–∫–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-07-03T06:20:03+00:00,@bezrec,6267,https://t.me/bezrec/6267,"–ö–≤–∞–Ω—Ç–æ–≤—ã–µ –≤—ã—á–∏—Å–ª–µ–Ω–∏—è –ø–æ–º–æ–≥—É—Ç –≤ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ —Ä–∞–¥–∏–æ—Ñ–∞—Ä–º–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –í –†–æ—Å–∞—Ç–æ–º–µ —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏, —á—Ç–æ –±—É–¥—É—Ç –≤–Ω–µ–¥—Ä—è—Ç—å –∫–≤–∞–Ω—Ç–æ–≤—ã–µ –≤—ã—á–∏—Å–ª–µ–Ω–∏—è –ø—Ä–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ –Ω–æ–≤–æ–≥–æ –ø–æ–∫–æ–ª–µ–Ω–∏—è —Ä–∞–¥–∏–æ—Ñ–∞—Ä–º–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –í —Ö–æ–ª–¥–∏–Ω–≥–µ —É—Ç–≤–µ—Ä–∂–¥–∞—é—Ç, —á—Ç–æ –ø–µ—Ä–µ–¥–æ–≤—ã–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ –ø–æ–∑–≤–æ–ª—è—Ç —Å –±–µ—Å–ø—Ä–µ—Ü–µ–¥–µ–Ω—Ç–Ω–æ–π —Ç–æ—á–Ω–æ—Å—Ç—å—é –º–æ–¥–µ–ª–∏—Ä–æ–≤–∞—Ç—å –ø–æ–≤–µ–¥–µ–Ω–∏–µ —ç—Ç–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ –æ—Ä–≥–∞–Ω–∏–∑–º–µ, —Ä–∞—Å—Å—á–∏—Ç—ã–≤–∞—Ç—å –∏—Ö —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –∏ –æ–ø—Ç–∏–º–∞–ª—å–Ω—ã–µ –¥–æ–∑–∏—Ä–æ–≤–∫–∏. –†–∞–±–æ—Ç–∞ –±—É–¥–µ—Ç –≤–µ—Å—Ç–∏—Å—å —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞–º–∏ –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏–π –Ω–∞—É—á–Ω–æ–≥–æ –¥–∏–≤–∏–∑–∏–æ–Ω–∞ –†–æ—Å–∞—Ç–æ–º–∞ ‚Äî –§–∏–∑–∏–∫–æ-—ç–Ω–µ—Ä–≥–µ—Ç–∏—á–µ—Å–∫–æ–≥–æ –∏–Ω—Å—Ç–∏—Ç—É—Ç–∞ –∏–º–µ–Ω–∏ –ê. –ò. –õ–µ–π–ø—É–Ω—Å–∫–æ–≥–æ –∏ –ù–∞—É—á–Ω–æ-–∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–æ–≥–æ —Ñ–∏–∑–∏–∫–æ-—Ö–∏–º–∏—á–µ—Å–∫–æ–≥–æ –∏–Ω—Å—Ç–∏—Ç—É—Ç–∞ –∏–º. –õ. –Ø. –ö–∞—Ä–ø–æ–≤–∞. –ù–∞ –ø–ª–æ—â–∞–¥–∫–µ –ø–æ—Å–ª–µ–¥–Ω–µ–≥–æ –≤ –ö–∞–ª—É–∂—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ ¬´–†—É—Å–∞—Ç–æ–º –•—ç–ª—Å–∫–µ–∞¬ª –≤ 2023 –≥–æ–¥—É –Ω–∞—á–∞–ª —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–æ –∫—Ä—É–ø–Ω–µ–π—à–µ–≥–æ –≤ –ï–≤—Ä–æ–ø–µ –∑–∞–≤–æ–¥–∞ –ø–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤—É —Ä–∞–¥–∏–æ—Ñ–∞—Ä–º–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ù–∞ –ü–ú–≠–§-2025 –∑–∞–º–º–∏–Ω–∏—Å—Ç—Ä–∞ –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏ –∏ —Ç–æ—Ä–≥–æ–≤–ª–∏ –†–§ –ï–∫–∞—Ç–µ—Ä–∏–Ω–∞ –ü—Ä–∏–µ–∑–∂–µ–≤–∞ –æ—Ç–º–µ—Ç–∏–ª–∞, —á—Ç–æ –≤ –±–ª–∏–∂–∞–π—à–∏–µ –≥–æ–¥—ã –¥–æ–ª—é —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö —Ä–∞–¥–∏–æ—Ñ–∞—Ä–º–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ø–ª–∞–Ω–∏—Ä—É—é—Ç –Ω–∞—Ä–∞—Å—Ç–∏—Ç—å –¥–æ 95%. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance, safety"",
  ""impact"": ""high"",
  ""english"": ""Quantum computing will help in the development of radio pharmaceuticals. Rosatom announced that they will be implementing quantum computing for the development of a new generation of radio pharmaceuticals. Advanced technologies will allow for precise modeling of these drugs' behavior in the body, calculating their effectiveness and optimal dosages. The work will be carried out by specialists from enterprises of the scientific division of Rosatom - Fyodorov Institute of Physical Energy and Karapov Scientific Research Physico-Chemical Institute. A large-scale plant for producing radio pharmaceuticals is under construction at the 'Rosatom Helase' facility in Kaluga region. At the PMEF-2025, Deputy Minister of Industry and Trade of Russia Ekaterina Pryezheva noted that the share of Russian radio pharmaceuticals will be increased to 95% in the near future.""
}"
2025-07-02T15:10:34+00:00,@bezrec,6266,https://t.me/bezrec/6266,"–ö–∞–∫ –∫—Ä–µ–∞—Ç–∏–≤–∏—Ç—å –≤ —Ñ–∞—Ä–º–µ, –∫–æ–≥–¥–∞ –º–Ω–æ–≥–æ–µ –∑–∞–ø—Ä–µ—â–µ–Ω–æ ‚Äî –≤—ã–±—Ä–∞–ª–∏ –≥–ª–∞–≤–Ω–æ–µ –∏–∑ –Ω–æ–≤–æ–≥–æ –≤—ã–ø—É—Å–∫–∞ –ø–æ–¥–∫–∞—Å—Ç–∞ Forbes ¬´–í–Ω—É—Ç—Ä–∏ –≤–æ—Ä–æ–Ω–∫–∏¬ª —Å —É—á–∞—Å—Ç–∏–µ–º –ï–ª–µ–Ω—ã –ó–∞—Ö–∞—Ä—é–≥–∏–Ω–æ–π –∏–∑ ¬´–ó–¥—Ä–∞–≤—Å–∏—Ç–∏¬ª –∏ –ö–æ–Ω—Å—Ç–∞–Ω—Ç–∏–Ω–∞ –ò—Å–∞–Ω–∏–Ω–∞ –∏–∑ –Ø–Ω–¥–µ–∫—Å –†–µ–∫–ª–∞–º—ã. –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–µ –±—Ä–µ–Ω–¥—ã –∑–∞–∂–∞—Ç—ã –≤ —Ç–∏—Å–∫–∏ —Ä–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω–∏—è ‚Äî –º–Ω–æ–≥–æ –¥–∏—Å–∫–ª–µ–π–º–µ—Ä–æ–≤, –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω—ã–π —Ç–æ–Ω, –Ω–∏–∫–∞–∫–∏—Ö —è—Ä–∫–∏—Ö –æ–±—Ä–∞–∑–æ–≤. –ù–æ ¬´–ó–¥—Ä–∞–≤—Å–∏—Ç–∏¬ª –¥–æ–∫–∞–∑–∞–ª–∏: –¥–∞–∂–µ –≤ —Å—Ç—Ä–æ–≥–∏—Ö —Ä–∞–º–∫–∞—Ö –º–æ–∂–Ω–æ –Ω–∞—Ö–æ–¥–∏—Ç—å –Ω–µ—Å—Ç–∞–Ω–¥–∞—Ä—Ç–Ω—ã–µ —Ä–µ—à–µ–Ω–∏—è. –ü—Ä–∏–≤–æ–¥–∏–º –∫–µ–π—Å—ã –∫–æ–º–ø–∞–Ω–∏–∏: ‚≠êÔ∏è–í—Å—Ç—Ä–æ–∏–ª–∏—Å—å –≤ –ø–æ–ø—É–ª—è—Ä–Ω—ã–µ –ø–æ–¥–∫–∞—Å—Ç—ã –∏ YouTube-—à–æ—É. –î–ª—è –ø—Ä–æ–¥–≤–∏–∂–µ–Ω–∏—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –æ—Ç –ø–æ—Ç–µ—Ä–∏ –≥–æ–ª–æ—Å–∞ –ø—Ä–∏–¥—É–º–∞–ª–∏ –Ω–µ—Å—Ç–∞–Ω–¥–∞—Ä—Ç–Ω—ã–π —Ö–æ–¥: –≤–µ–¥—É—â–∏–µ –≤–Ω–µ–∑–∞–ø–Ω–æ —Å—Ç–∞–Ω–æ–≤–∏–ª–∏—Å—å –æ—Å–∏–ø—à–∏–º–∏, –ø—Ä–æ–≤–æ—Ü–∏—Ä—É—è –ª—é–±–æ–ø—ã—Ç—Å—Ç–≤–æ –∑—Ä–∏—Ç–µ–ª–µ–π —Å–ª–æ–≥–∞–Ω–æ–º: ¬´–ì–æ–ª–æ—Å –æ—Å–∏–ø? ¬´–ó–¥—Ä–∞–≤—Å–∏—Ç–∏¬ª –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç —Ä–µ—à–µ–Ω–∏–µ!¬ª ‚≠êÔ∏è–ó–∞–ø—É—Å—Ç–∏–ª–∏ –ø–µ—Ä–≤—É—é –≤ —Ñ–∞—Ä–º–µ –æ–Ω–ª–∞–π–Ω-–∏–≥—Ä—É ¬´–ì–æ—Ä–æ–¥ –∑–¥–æ—Ä–æ–≤—å—è¬ª. –ü–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª–∏ –≤—ã–±–∏—Ä–∞—é—Ç –ø–µ—Ä—Å–æ–Ω–∞–∂–µ–π, –≤—ã–ø–æ–ª–Ω—è—é—Ç –∑–∞–¥–∞–Ω–∏—è, –∑–∞—Ä–∞–±–∞—Ç—ã–≤–∞—é—Ç –∏–≥—Ä–æ–≤—ã–µ –¥–µ–Ω—å–≥–∏ –∏ –æ–±–º–µ–Ω–∏–≤–∞—é—Ç –∏—Ö –Ω–∞ —Ä–µ–∞–ª—å–Ω—ã–µ –±–æ–Ω—É—Å—ã –∏ —Å–∫–∏–¥–∫–∏. ‚≠êÔ∏è–£—Å—Ç—Ä–∞–∏–≤–∞—é—Ç –æ—Ñ–ª–∞–π–Ω-–∞–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏. –ù–∞ –ú–æ—Å–∫–æ–≤—Å–∫–æ–º –ø–æ–ª—É–º–∞—Ä–∞—Ñ–æ–Ω–µ –ø–æ—Å—Ç–∞–≤–∏–ª–∏ —à–∞—Ç–µ—Ä —Å –∫–æ–ª–µ—Å–æ–º —Ñ–æ—Ä—Ç—É–Ω—ã –∏ –∑–¥–æ—Ä–æ–≤—ã–º–∏ —É–≥–æ—â–µ–Ω–∏—è–º–∏ ‚Äî —É—á–∞—Å—Ç–Ω–∏–∫–∏ –≤—ã–∏–≥—Ä—ã–≤–∞–ª–∏ —Ç–µ–º–∞—Ç–∏—á–µ—Å–∫–∏–µ –ø–æ–¥–∞—Ä–∫–∏. –ì–ª–∞–≤–Ω—ã–π –≤—ã–≤–æ–¥: –∫—Ä–µ–∞—Ç–∏–≤–Ω–æ—Å—Ç—å –≤–æ–∑–º–æ–∂–Ω–∞ –¥–∞–∂–µ –≤ —Å–∞–º—ã—Ö –∑–∞—Ä–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –æ—Ç—Ä–∞—Å–ª—è—Ö ‚Äî –≤–∞–∂–Ω–æ –∏—Å–∫–∞—Ç—å ¬´—Å–µ—Ä—ã–µ –∑–æ–Ω—ã¬ª –∏ –¥—É–º–∞—Ç—å –Ω–µ—Å—Ç–∞–Ω–¥–∞—Ä—Ç–Ω–æ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-07-02T13:32:29+00:00,@bezrec,6265,https://t.me/bezrec/6265,"–ï—Å–ª–∏ –≤–∞–º –ø–æ–∫–∞–∑–∞–ª–æ—Å—å, —á—Ç–æ –∫–ª–∏–ø ¬´–õ–µ–Ω–∏–Ω–≥—Ä–∞–¥–∞¬ª –∏ –ó–æ–∏ ‚Äî —Ä–µ–∫–ª–∞–º–∞ –¢–∏—Ä–∑–µ—Ç—Ç—ã, —Ç–æ –≤–∞–º –ø–æ–∫–∞–∑–∞–ª–æ—Å—å. –ö–∞–∫ –∏ –∑–∞—è–≤–∏—Ç–µ–ª—é, –∫–æ—Ç–æ—Ä—ã–π –ø–æ–∂–∞–ª–æ–≤–∞–ª—Å—è –≤ –§–ê–° –Ω–∞ –Ω–æ–≤—É—é –ø–µ—Å–Ω—é, –ø–æ—Å–≤—è—â—ë–Ω–Ω—É—é –ø–æ–ø—É–ª—è—Ä–Ω–æ–º—É –ø—Ä–µ–ø–∞—Ä–∞—Ç—É –¥–ª—è –ø–æ—Ö—É–¥–µ–Ω–∏—è –æ—Ç ¬´–ü—Ä–æ–º–æ–º–µ–¥–∞¬ª, –ø–æ—Å—á–∏—Ç–∞–≤ –µ—ë —Ä–µ–∫–ª–∞–º–æ–π —Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω–æ–≥–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –≥—Ä–∞–∂–¥–∞–Ω–∏–Ω–∞ –≤–æ–∑–º—É—Ç–∏–ª–∞ —Ñ—Ä–∞–∑–∞ –æ–± –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–∏ –ø–æ–±–æ—á–µ–∫, —Ö–æ—Ç—è –≤ –∏–Ω—Å—Ç—Ä—É–∫—Ü–∏–∏ –∫ –¢–∏—Ä–∑–µ—Ç—Ç–µ —Ç–∞–∫–æ–≤—ã–µ –ø—Ä–æ–ø–∏—Å–∞–Ω—ã. –ö–ª–∏–ø –Ω–∞ –ø–µ—Å–Ω—é –≥—Ä—É–ø–ø—ã ¬´–õ–µ–Ω–∏–Ω–≥—Ä–∞–¥¬ª –∏ –ó–æ–∏ ¬´–¢–∏—Ä–∑–µ—Ç—Ç–∞¬ª ‚Äî —ç—Ç–æ —Ç–≤–æ—Ä—á–µ—Å–∫–æ–µ –ø—Ä–æ–∏–∑–≤–µ–¥–µ–Ω–∏–µ, –∫–æ—Ç–æ—Ä–æ–µ –Ω–µ –º–æ–∂–µ—Ç —Å—á–∏—Ç–∞—Ç—å—Å—è —Ä–µ–∫–ª–∞–º–æ–π. –ù–∞ –≤–∏–¥–µ–æ—Ä–æ–ª–∏–∫ –Ω–µ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω—è—é—Ç—Å—è –ø–æ–ª–æ–∂–µ–Ω–∏—è –§–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –∑–∞–∫–æ–Ω–∞ ¬´–û —Ä–µ–∫–ª–∞–º–µ¬ª, ‚Äî –ø–æ—Å—á–∏—Ç–∞–ª —Ä–µ–≥—É–ª—è—Ç–æ—Ä. –ö—Ç–æ –º—ã —Ç–∞–∫–∏–µ, —á—Ç–æ–±—ã —Å–ø–æ—Ä–∏—Ç—å —Å –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å—â–∏–∫–∞–º–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-07-02T09:10:48+00:00,@bezrec,6263,https://t.me/bezrec/6263,"–ë—é–¥–∂–µ—Ç–Ω—ã–µ —Ä–∞—Å—Ö–æ–¥—ã –Ω–∞ –ª–µ—á–µ–Ω–∏–µ –æ–Ω–∫–æ–±–æ–ª—å–Ω—ã—Ö –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–æ —É–≤–µ–ª–∏—á–∏—Ç—å –Ω–∞ 13%. –ü–æ–∫–∞ ¬´–ï–¥–∏–Ω–∞—è –†–æ—Å—Å–∏—è¬ª –±–µ—Å–ø–æ–∫–æ–∏—Ç—Å—è –æ –≤—ã—Å–æ–∫–æ–º —Ö–æ–ª–µ—Å—Ç–µ—Ä–∏–Ω–µ —É —Ä–æ—Å—Å–∏—è–Ω, ¬´–°–ø—Ä–∞–≤–µ–¥–ª–∏–≤–∞—è –†–æ—Å—Å–∏—è¬ª –æ–±—Ä–∞—Ç–∏–ª–∞ –≤–Ω–∏–º–∞–Ω–∏–µ –Ω–∞ –ø—Ä–æ–±–ª–µ–º—ã –æ–Ω–∫–æ–ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –ú—ã –±—É–¥–µ–º –Ω–∞—Å—Ç–∞–∏–≤–∞—Ç—å –Ω–∞ —Å—É—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–º —É–≤–µ–ª–∏—á–µ–Ω–∏–∏ —Ä–∞—Å—Ö–æ–¥–æ–≤ –Ω–∞ –ª–µ—á–µ–Ω–∏–µ –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –≤ –ø—Ä–æ–µ–∫—Ç–µ –±—é–¥–∂–µ—Ç–∞ –Ω–∞ 2026 –≥–æ–¥. –ü–µ—Ä–µ–∫–ª–∞–¥—ã–≤–∞—Ç—å —Ä–∞—Å—Ö–æ–¥—ã –Ω–∞ –ª–µ—á–µ–Ω–∏–µ –Ω–∞ —Ç—è–∂–µ–ª–æ–±–æ–ª—å–Ω—ã—Ö –≥—Ä–∞–∂–¥–∞–Ω - –Ω–µ–≥—É–º–∞–Ω–Ω–æ –∏ –Ω–µ–¥–æ–ø—É—Å—Ç–∏–º–æ. –ö–æ–Ω—Å–æ–ª–∏–¥–∏—Ä–æ–≤–∞–Ω–Ω—ã–π –±—é–¥–∂–µ—Ç –Ω–∞ –æ–∫–∞–∑–∞–Ω–∏–µ –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π –ø–æ–º–æ—â–∏ –≤ –†–æ—Å—Å–∏–∏ –¥–æ–ª–∂–µ–Ω –±—ã—Ç—å —É–≤–µ–ª–∏—á–µ–Ω –Ω–µ –º–µ–Ω–µ–µ —á–µ–º –Ω–∞ 13% –≤ –≥–æ–¥, ‚Äî —Å–∫–∞–∑–∞–ª –ª–∏–¥–µ—Ä –ø–∞—Ä—Ç–∏–∏ –°–µ—Ä–≥–µ–π –ú–∏—Ä–æ–Ω–æ–≤. –í –∫–∞—á–µ—Å—Ç–≤–µ –∞—Ä–≥—É–º–µ–Ω—Ç–∞ –ú–∏—Ä–æ–Ω–æ–≤ –ø—Ä–∏–≤–µ–ª –¥–∞–Ω–Ω—ã–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è, —Å–æ–≥–ª–∞—Å–Ω–æ –∫–æ—Ç–æ—Ä—ã–º –∑–∞ —Ç—Ä–∏ –≥–æ–¥–∞ –æ–±—â–∏–µ —Ä–∞—Å—Ö–æ–¥—ã –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –Ω–∞ –æ–Ω–∫–æ–ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –≤—ã—Ä–æ—Å–ª–∏ —Å 4 –¥–æ 9 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –≤ –≥–æ–¥. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""The budget proposal to increase cancer treatment expenses by 13% is discussed. Leaders from different parties emphasize the need for increased funding to combat cancer, citing rising costs and patient expenses.""
}"
2025-07-02T05:45:16+00:00,@bezrec,6262,https://t.me/bezrec/6262,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –ø—Ä–æ—Å—è—Ç –∑–∞–¥—É–º–∞—Ç—å—Å—è –æ ¬´–ø–ª–æ—Ö–æ–º¬ª —Ö–æ–ª–µ—Å—Ç–µ—Ä–∏–Ω–µ. –°–ø–µ—Ü–∏–∞–ª—å–Ω–∞—è –∫–æ–º–∏—Å—Å–∏—è ¬´–ï–¥–∏–Ω–æ–π –†–æ—Å—Å–∏–∏¬ª –ø—Ä–æ–≤–µ–ª–∞ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –≤ 64 —Ä–µ–≥–∏–æ–Ω–∞—Ö, —á—Ç–æ–±—ã –≤—ã—è–≤–∏—Ç—å –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç—å –Ω–∞—Å–µ–ª–µ–Ω–∏—è –≤ —Ç–µ—Ä–∞–ø–∏–∏ –¥–∏—Å–ª–∏–ø–∏–¥–µ–º–∏–∏ –∏ —Ñ–∏–Ω–∞–Ω—Å–æ–≤–æ–π –ø–æ–¥–¥–µ—Ä–∂–∫–µ —Å–æ —Å—Ç–æ—Ä–æ–Ω—ã —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã—Ö –≤–ª–∞—Å—Ç–µ–π. –≠—Ç–æ —Å–æ—Å—Ç–æ—è–Ω–∏–µ –≤—ã–∑–≤–∞–Ω–æ –Ω–∞—Ä—É—à–µ–Ω–∏–µ–º —É—Ä–æ–≤–Ω—è –∂–∏—Ä–æ–≤ –≤ –∫—Ä–æ–≤–∏ –∏ –ø—Ä–∏–≤–æ–¥–∏—Ç –∫ —Ä–∏—Å–∫—É —Ä–∞–∑–≤–∏—Ç–∏—è –æ–ø–∞—Å–Ω—ã—Ö —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –†–µ–∑—É–ª—å—Ç–∞—Ç–∞–º–∏ –ø–æ–¥–µ–ª–∏–ª—Å—è –¥–∏—Ä–µ–∫—Ç–æ—Ä –ú–æ—Å–∫–æ–≤—Å–∫–æ–≥–æ –º–Ω–æ–≥–æ–ø—Ä–æ—Ñ–∏–ª—å–Ω–æ–≥–æ –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–≥–æ —Ü–µ–Ω—Ç—Ä–∞ ¬´–ö–æ–º–º—É–Ω–∞—Ä–∫–∞¬ª –î–µ–Ω–∏—Å –ü—Ä–æ—Ü–µ–Ω–∫–æ. –ì–ª–∞–≤–Ω–æ–µ –∏–∑ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è: üíä –≤ –∏–Ω—Ç–µ–Ω—Å–∏–≤–Ω–æ–π –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –¥–∏—Å–ª–∏–ø–∏–¥–µ–º–∏–∏ –Ω—É–∂–¥–∞—é—Ç—Å—è –Ω–µ –º–µ–Ω–µ–µ 12 —Ç—ã—Å. –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤; üíä –∏–Ω–≥–∏–±–∏—Ç–æ—Ä—ã PCSK9, –ø—Ä–∏–º–µ–Ω—è–µ–º—ã–µ –ø—Ä–∏ –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ–º —ç—Ñ—Ñ–µ–∫—Ç–µ –∏–ª–∏ –Ω–µ–ø–µ—Ä–µ–Ω–æ—Å–∏–º–æ—Å—Ç–∏ –¥—Ä—É–≥–∏—Ö —Å—Ä–µ–¥—Å—Ç–≤, –Ω–µ –≤–∫–ª—é—á–µ–Ω—ã –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Ñ–µ–¥–ø—Ä–æ–µ–∫—Ç–∞ ¬´–ë–æ—Ä—å–±–∞ —Å —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏¬ª –∏ –Ω–µ –ø–æ–ª–æ–∂–µ–Ω—ã –ø–∞—Ü–∏–µ–Ω—Ç–∞–º –Ω–∞ –ª—å–≥–æ—Ç–Ω—ã—Ö —É—Å–ª–æ–≤–∏—è—Ö; üíä 93% —Ä–µ–≥–∏–æ–Ω–æ–≤‚Äî—É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –æ–ø—Ä–æ—Å–∞ —Å–æ–≥–ª–∞—Å–Ω—ã —Å –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç—å—é –≤–∫–ª—é—á–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—É—é –ø—Ä–æ–≥—Ä–∞–º–º—É; üíä –Ω–∞ —ç—Ç–∏ —Ü–µ–ª–∏ –ø–æ—Ç—Ä–µ–±—É–µ—Ç—Å—è –æ—Ç 368 —Ç—ã—Å. –¥–æ ¬´–¥–µ—Å—è—Ç–∫–æ–≤ –º–∏–ª–ª–∏–æ–Ω–æ–≤ —Ä—É–±–ª–µ–π¬ª –≤ –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏ –æ—Ç —Ä–µ–≥–∏–æ–Ω–∞; üíä 65% —Å—É–±—ä–µ–∫—Ç–æ–≤ —Å–æ–≥–ª–∞—Å–Ω—ã —Ä–∞—Å—à–∏—Ä–∏—Ç—å –ø–µ—Ä–µ—á–µ–Ω—å –ª—å–≥–æ—Ç–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤, –µ—Å–ª–∏ –∏–º –≤—ã–¥–µ–ª—è—Ç –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–π –±—é–¥–∂–µ—Ç, 35% –≥–æ—Ç–æ–≤—ã –∏–∑—ã—Å–∫–∞—Ç—å —Å—Ä–µ–¥—Å—Ç–≤–∞ –∏–∑ —Ç–µ–∫—É—â–µ–≥–æ —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è; üíä –º–Ω–æ–≥–∏–µ —Å—É–±—ä–µ–∫—Ç—ã –Ω–µ –≤–µ–¥—É—Ç —É—á–µ—Ç –∏ –Ω–∏–∫–∞–∫ –Ω–µ –º–æ–Ω–∏—Ç–æ—Ä—è—Ç —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å —Ç–µ—Ä–∞–ø–∏–∏. –ê —á—Ç–æ –ú–∏–Ω–∑–¥—Ä–∞–≤? –ù–∞–ø—Ä—è–º—É—é —á–∞—è–Ω–∏—è —Ä–µ–≥–∏–æ–Ω–æ–≤ –≤ –≤–µ–¥–æ–º—Å—Ç–≤–µ –Ω–µ –ø—Ä–æ–∫–æ–º–º–µ–Ω—Ç–∏—Ä–æ–≤–∞–ª–∏, –Ω–æ –Ω–∞–ø–æ–º–Ω–∏–ª–∏, —á—Ç–æ —Ä–∞–±–æ—Ç–∞ –Ω–∞–¥ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–æ–π –∏ –ª–µ—á–µ–Ω–∏–µ–º —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π —É–∂–µ –≤–µ–¥—ë—Ç—Å—è –≤ —Ä–∞–º–∫–∞—Ö –Ω–∞—Ü–ø—Ä–æ–µ–∫—Ç–∞ ¬´–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ¬ª, –∞ —É—Ä–æ–≤–µ–Ω—å —Å–º–µ—Ä—Ç–Ω–æ—Å—Ç–∏ –æ—Ç –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π —Å–∏—Å—Ç–µ–º—ã –∫—Ä–æ–≤–æ–æ–±—Ä–∞—â–µ–Ω–∏—è —è–≤–ª—è–µ—Ç—Å—è ¬´–∏—Å—Ç–æ—Ä–∏—á–µ—Å–∫–∏ –Ω–∏–∑–∫–∏–º¬ª. –í—Å–µ–≥–æ –∑–∞ –ø—è—Ç—å –ª–µ—Ç –±–µ—Å–ø–ª–∞—Ç–Ω–æ–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–µ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ –ø–æ–ª—É—á–∏–ª–∏ —Å–≤—ã—à–µ 2,5 –º–ª–Ω –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –≤—ã—Å–æ–∫–∏–º —Ä–∏—Å–∫–æ–º, –∞ –æ—Ö–≤–∞—Ç –ø—Ä–æ–≥—Ä–∞–º–º—ã –ø—Ä–µ–≤—ã—Å–∏–ª 98%, ‚Äî –ø–æ—Ö–≤–∞–ª–∏–ª—Å—è —Ä–µ–≥—É–ª—è—Ç–æ—Ä. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders,clinical_trial,hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health is asking to consider 'bad' cholesterol. A commission from the ruling party 'United Russia' conducted a study in 64 regions to identify the population's need for treatment of dyslipidemia and financial support from federal authorities. This condition is caused by a disruption in the level of fats in the blood and leads to a risk of developing serious cardiovascular diseases. Key findings from the study: over 12,000 patients need intensive drug therapy for dyslipidemia; inhibitors of PCSK9, which are not effective or tolerated by other drugs, are not included in the federal project 'Battle against Cardiovascular Diseases' and are not covered by patients on preferential terms; 93% of regions participating in the survey agree with the need to include drugs in the federal program; implementation will require between 368 thousand and 'tens of millions' rubles depending on the region; 65% of subjects agree to expand the list of preferential drugs if additional budget is provided, while 35% are"
2025-07-01T15:02:31+00:00,@bezrec,6259,https://t.me/bezrec/6259,"–°–µ—Ä—å—ë–∑–Ω—ã—Ö –ø—Ä–æ–±–ª–µ–º —Ç–∞–∫–æ–µ –∫–æ–ª–µ—á–∫–æ –Ω–µ —Ä–µ—à–∏—Ç, –Ω–æ –Ω–∞—Å—Ç—Ä–æ–µ–Ω–∏–µ –ø–æ–¥–Ω–∏–º–µ—Ç –Ω–∞–≤–µ—Ä–Ω—è–∫–∞. –ò —Ä–µ—Ü–µ–ø—Ç –¥–ª—è –Ω–µ–≥–æ –Ω–µ –Ω—É–∂–µ–Ω. P.S. –ü–æ—Ö–æ–∂–µ, —Ç–∞–∫–æ–π ¬´–∞–ø—Ç–µ—á–Ω—ã–π¬ª –¥–∏–∑–∞–π–Ω –º–æ–¥–Ω–∏–∫–∞–º –∑–∞—à—ë–ª. –í —é–≤–µ–ª–∏—Ä–Ω–æ–π –º–∞—Å—Ç–µ—Ä—Å–∫–æ–π, ¬´–æ–∫–æ–ª—å—Ü–µ–≤–∞–≤—à–µ–π¬ª –ó–æ–ª–æ—Ñ—Ç, –≥–æ–≤–æ—Ä—è—Ç, —á—Ç–æ –∏–º —Å—Ç–∞–ª–∏ –ø–æ—Å—Ç—É–ø–∞—Ç—å –∑–∞–ø—Ä–æ—Å—ã –Ω–∞ —É–∫—Ä–∞—à–µ–Ω–∏—è –∏ —Å –¥—Ä—É–≥–∏–º–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-07-01T12:32:07+00:00,@bezrec,6258,https://t.me/bezrec/6258,"–§–∞—Ä–º–µ –Ω—É–∂–Ω–∞ —Ü–∏—Ñ—Ä–∞. –§–∞—Ä–º—Ä—ã–Ω–æ–∫ —Ç—Ä–µ–±—É–µ—Ç –æ—Ç –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π, –¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–æ–≤ –∏ —Ä–æ–∑–Ω–∏—á–Ω—ã—Ö —Å–µ—Ç–µ–π –≤—ã—Å–æ–∫–æ–π —Å–∫–æ—Ä–æ—Å—Ç–∏, —Ç–æ—á–Ω–æ—Å—Ç–∏ –∏ –ø—Ä–æ–∑—Ä–∞—á–Ω–æ—Å—Ç–∏ –≤–æ –≤—Å–µ—Ö –±–∏–∑–Ω–µ—Å-–ø—Ä–æ—Ü–µ—Å—Å–∞—Ö ‚Äî –æ—Ç –∑–∞–∫—É–ø–æ–∫ –∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –¥–æ –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏—è —Å —Ä–µ–≥—É–ª—è—Ç–æ—Ä–∞–º–∏ –∏ –∫–æ–Ω—Ç—Ä–æ–ª—è –∫–∞—á–µ—Å—Ç–≤–∞. –í —Ç–∞–∫–∏—Ö —É—Å–ª–æ–≤–∏—è—Ö —Ü–∏—Ñ—Ä–æ–≤—ã–µ —Ä–µ—à–µ–Ω–∏—è ‚Äî —É–∂–µ –Ω–µ –ø—Ä–æ—Å—Ç–æ –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–π –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç, –∞ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç—å. –§–∞—Ä–º–∞ ‚Äî –æ—Ç—Ä–∞—Å–ª—å, –≥–¥–µ –æ—à–∏–±–∫–∞ —Å—Ç–æ–∏—Ç —Å–ª–∏—à–∫–æ–º –¥–æ—Ä–æ–≥–æ. –¶–∏—Ñ—Ä–æ–≤—ã–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ –ø–æ–º–æ–≥–∞—é—Ç –Ω–µ –ø—Ä–æ—Å—Ç–æ –∞–≤—Ç–æ–º–∞—Ç–∏–∑–∏—Ä–æ–≤–∞—Ç—å —Ä—É—Ç–∏–Ω—É, –∞ —Å–æ–∑–¥–∞–≤–∞—Ç—å –ø—Ä–æ–∑—Ä–∞—á–Ω—ã–µ –∏ —É–ø—Ä–∞–≤–ª—è–µ–º—ã–µ –±–∏–∑–Ω–µ—Å-–ø—Ä–æ—Ü–µ—Å—Å—ã, –º–∏–Ω–∏–º–∏–∑–∏—Ä—É—è —á–µ–ª–æ–≤–µ—á–µ—Å–∫–∏–π —Ñ–∞–∫—Ç–æ—Ä –∏ —Ä–∏—Å–∫–∏. –°–æ–≤—Ä–µ–º–µ–Ω–Ω—ã–µ –ø–ª–∞—Ç—Ñ–æ—Ä–º—ã –ø–æ—Å—Ç–æ—è–Ω–Ω–æ —ç–≤–æ–ª—é—Ü–∏–æ–Ω–∏—Ä—É—é—Ç, —á—Ç–æ–±—ã –∏–¥—Ç–∏ –≤ –Ω–æ–≥—É —Å –º–µ–Ω—è—é—â–∏–º–∏—Å—è –∑–∞–¥–∞—á–∞–º–∏ –∫–æ–º–ø–∞–Ω–∏–π, –ø–æ–¥–¥–µ—Ä–∂–∏–≤–∞—Ç—å –≥–∏–±–∫–æ—Å—Ç—å –∏ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å. –î–ª—è —Ñ–∞—Ä–º–±–∏–∑–Ω–µ—Å–∞ —Ü–∏—Ñ—Ä–æ–≤–∏–∑–∞—Ü–∏—è ‚Äî —ç—Ç–æ –Ω–µ —Ç—Ä–µ–Ω–¥, –∞ –±–∞–∑–æ–≤–æ–µ —É—Å–ª–æ–≤–∏–µ —Ä–∞–∑–≤–∏—Ç–∏—è, ‚Äî –≥–æ–≤–æ—Ä–∏—Ç –∫–æ–º–º–µ—Ä—á–µ—Å–∫–∏–π –¥–∏—Ä–µ–∫—Ç–æ—Ä –Ø–Ω–¥–µ–∫—Å 360 –†–æ–º–∞–Ω –ö–æ—Ä–æ–ª–µ–≤. –ü–æ—Å—Ç–æ—è–Ω–Ω—ã–µ –æ–±–Ω–æ–≤–ª–µ–Ω–∏—è –æ–Ω–ª–∞–π–Ω-–æ—Ñ–∏—Å–æ–≤ ‚Äî —ç—Ç–æ —Ç–æ, —á—Ç–æ –æ—Ç–ª–∏—á–∞–µ—Ç –∏—Ö –æ—Ç –ø—Ä–∏–≤—ã—á–Ω—ã—Ö —Ä–µ—à–µ–Ω–∏–π ¬´–∏–∑ –∫–æ—Ä–æ–±–∫–∏¬ª. –ù–∞–ø—Ä–∏–º–µ—Ä, –≤ –∏—é–Ω–µ –≤ —Å–µ—Ä–≤–∏—Å–∞—Ö –Ø–Ω–¥–µ–∫—Å 360 –ø–æ—è–≤–∏–ª–∏—Å—å –Ω–æ–≤—ã–µ —Ñ—É–Ω–∫—Ü–∏–∏ –¥–ª—è –ø–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω–∏—è –≤—Å—Ç—Ä–µ—á, –≤–µ–¥–µ–Ω–∏—è –ø—Ä–æ–µ–∫—Ç–æ–≤, –∞–¥–º–∏–Ω–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–∏—è –∏ —Ä–∞–±–æ—Ç—ã —Å –∫–æ—Ä–ø–æ—Ä–∞—Ç–∏–≤–Ω—ã–º–∏ –¥–∞–Ω–Ω—ã–º–∏. –í —Ñ–∞—Ä–º–µ —ç—Ç–æ –æ—Å–æ–±–µ–Ω–Ω–æ –∫—Ä–∏—Ç–∏—á–Ω–æ. –û—Ç—Ä–∞—Å–ª—å —Ä–∞–±–æ—Ç–∞–µ—Ç –ø–æ–¥ –ø–æ—Å—Ç–æ—è–Ω–Ω—ã–º –¥–∞–≤–ª–µ–Ω–∏–µ–º: –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–µ, —Ä–∏—Å–∫–∏ —Å–±–æ–µ–≤ –≤ –ª–æ–≥–∏—Å—Ç–∏–∫–µ, –¥–µ—Ñ–∏—Ü–∏—Ç —Å—ã—Ä—å—è, –ø—Ä–æ–≤–µ—Ä–∫–∏. –ù–∞ —ç—Ç–æ–º —Ñ–æ–Ω–µ —Ä–∞—Å—Ç–µ—Ç —Å–ø—Ä–æ—Å –Ω–∞ –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç—ã, –∫–æ—Ç–æ—Ä—ã–µ –ø–æ–∑–≤–æ–ª—è—é—Ç –±—ã—Å—Ç—Ä–æ –ø–µ—Ä–µ—Å—Ç—Ä–∞–∏–≤–∞—Ç—å –ø—Ä–æ—Ü–µ—Å—Å—ã, –¥–æ–∫—É–º–µ–Ω—Ç–∏—Ä–æ–≤–∞—Ç—å –¥–µ–π—Å—Ç–≤–∏—è –∫–æ–º–∞–Ω–¥ –∏ —Å–æ–±–ª—é–¥–∞—Ç—å –ø—Ä–∞–≤–∏–ª–∞ –±–µ–∑ –ø–æ—Ç–µ—Ä–∏ —Ç–µ–º–ø–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-07-01T10:00:01+00:00,@bezrec,6257,https://t.me/bezrec/6257,"–ü–æ –ø—Ä–æ–¥–∞–∂–∞–º –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç–µ –ª–∏–¥–∏—Ä—É—é—Ç –∏–Ω–æ—Å—Ç—Ä–∞–Ω—Ü—ã. –ê–Ω–∞–ª–∏—Ç–∏–∫–∏ RNC Pharma –ø–æ–¥—Å—á–∏—Ç–∞–ª–∏, —á—Ç–æ –≤ 2025 –≥–æ–¥—É –¥–æ–ª—è –æ–Ω–ª–∞–π–Ω-–ø—Ä–æ–¥–∞–∂ –ª–µ–∫–∞—Ä—Å—Ç–≤ —Å –¥–æ—Å—Ç–∞–≤–∫–æ–π –¥–æ –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª—è –ø–µ—Ä–µ—à–∞–≥–Ω—É–ª–∞ –ø—Å–∏—Ö–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–π –ø–æ—Ä–æ–≥ –≤ 1% –æ—Ç –æ–±—â–µ–≥–æ –æ–±—ä—ë–º–∞ —Ñ–∞—Ä–º—Ä—ã–Ω–∫–∞. –í 2022 –≥–æ–¥—É —ç—Ç–∞ —Ü–∏—Ñ—Ä–∞ –Ω–µ –ø—Ä–µ–≤—ã—à–∞–ª–∞ 0,44%. –° —è–Ω–≤–∞—Ä—è –ø–æ –º–∞–π —Ä–æ—Å—Å–∏—è–Ω–µ –∫—É–ø–∏–ª–∏ —á–µ—Ä–µ–∑ e-com 21,5 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ —Å—É–º–º—É —Å–≤—ã—à–µ 8,8 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –≠—Ç–æ –Ω–∞ 37,5% –±–æ–ª—å—à–µ –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –∏ –Ω–∞ 57,4% –≤ –¥–µ–Ω–µ–∂–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ –≥–æ–¥ –∫ –≥–æ–¥—É. –ó–∞ –≤–µ—Å—å –ø—Ä–æ—à–ª—ã–π –≥–æ–¥ –ø—Ä–æ–¥–∞–∂–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ —á–µ—Ä–µ–∑ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç –≤—ã—Ä–æ—Å–ª–∏ –Ω–∞ 69,5% –≤ –¥–µ–Ω—å–≥–∞—Ö (–¥–æ 15,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π) –∏ –Ω–∞ 33,8% –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å 2023 –≥–æ–¥–æ–º. –ü–æ –∏—Ç–æ–≥–∞–º 2025 –≥–æ–¥–∞ —Å–≤–æ—é –ø—Ä–æ–¥—É–∫—Ü–∏—é –≤ –æ–Ω–ª–∞–π–Ω–µ –ø—Ä–µ–¥–ª–∞–≥–∞–ª–∏ 560 –∫–æ–º–ø–∞–Ω–∏–π. –í –ª–∏–¥–µ—Ä–∞—Ö —Å–µ–≥–º–µ–Ω—Ç–∞ ‚Äî ¬´–î–∂–æ–Ω—Å–æ–Ω –∏ –î–∂–æ–Ω—Å–æ–Ω¬ª. –ü–µ—Ä–≤–æ–µ –º–µ—Å—Ç–æ –≤ —Ç–æ–ø-10 –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–π –∫–æ—Ä–ø–æ—Ä–∞—Ü–∏–∏ –æ–±–µ—Å–ø–µ—á–∏–ª –±—Ä–µ–Ω–¥ –ù–∏–∫–æ—Ä–µ—Ç—Ç–µ, –ø–æ–∫–∞–∑–∞–≤—à–∏–π –≥–æ–¥–æ–≤–æ–π –ø—Ä–∏—Ä–æ—Å—Ç –¥–µ–Ω–µ–∂–Ω—ã—Ö –ø—Ä–æ–¥–∞–∂ –Ω–∞ 94,8%. –í —Å–ø–∏–Ω—É –∞–º–µ—Ä–∏–∫–∞–Ω—Ü–∞–º –¥—ã—à–∏—Ç –Ω–µ–º–µ—Ü–∫–∏–π ¬´–ë–∞–π–µ—Ä¬ª. –ö–ª—é—á–µ–≤–æ–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –∫–æ–Ω—Ü–µ—Ä–Ω–∞ ‚Äî –ë–µ–ø–∞–Ω—Ç–µ–Ω, –ø—Ä–∏–±–∞–≤–∏–≤—à–∏–π 29% –≤ —Ä—É–±–ª—è—Ö. –ù–∞ —Ç—Ä–µ—Ç—å–µ–º –º–µ—Å—Ç–µ ‚Äî —Ñ—Ä–∞–Ω—Ü—É–∑—Å–∫–∞—è ¬´–°–∞–Ω–æ—Ñ–∏¬ª. –ù–∞–∏–ª—É—á—à–∏–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –ø–æ–∫–∞–∑–∞–ª–∏ –ú–∞–≥–Ω–µ B6 (+52,7%) –∏ –§–æ—Å—Ñ–∞–ª—é–≥–µ–ª—å (+57,8%). –ü–æ –∫–æ–ª–∏—á–µ—Å—Ç–≤—É —Ç–æ—Ä–≥–æ–≤—ã—Ö –º–∞—Ä–æ–∫ –≤ –æ–Ω–ª–∞–π–Ω-–∫–∞–Ω–∞–ª–µ –ª–∏–¥–∏—Ä—É–µ—Ç ¬´–ù–∏–∂—Ñ–∞—Ä–º¬ª, –∞ –º–∞–∫—Å–∏–º–∞–ª—å–Ω–æ–π –¥–∏–Ω–∞–º–∏–∫–æ–π –æ–±—ä—ë–º–∞ —Ä—É–±–ª—ë–≤—ã—Ö –ø—Ä–æ–¥–∞–∂ –æ—Ç–ª–∏—á–∏–ª—Å—è ¬´–≠–±–±–æ—Ç—Ç¬ª. –í —Ç–æ–ø-10 —Ç–∞–∫–∂–µ –≤–æ—à–ª–∏ ¬´–û—Ç–∏—Å–∏—Ñ–∞—Ä–º¬ª, ¬´–ì–°–ö¬ª, ¬´–†–µ–∫–∏—Ç—Ç –ë–µ–Ω–∫–∏–∑–µ—Ä¬ª, ¬´–í–∞–ª–µ–Ω—Ç–∞¬ª –∏ ¬´–°–µ—Ä–≤—å–µ¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""Internet pharmaceutical sales are growing rapidly, with Russia's online drug purchases increasing by 37.5% in natural units and 57.4% in monetary terms compared to the previous year. The market is dominated by international companies, with Johnson & Johnson leading in terms of brand performance and overall market share.""
}"
2025-07-01T06:24:41+00:00,@bezrec,6256,https://t.me/bezrec/6256,"–≠–∫—Å-–≥–ª–∞–≤–∞ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ Roche –≤ –†–æ—Å—Å–∏–∏ –ø–æ–ª—É—á–∏–ª –¥–æ–ª—é –≤ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–º –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –æ—Ç –í–ò–ß. –ú–∏–ª–æ—à –ü–µ—Ç—Ä–æ–≤–∏—á –ø—Ä–∏–æ–±—Ä–µ–ª 2,5% –≤ –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–≠–ª–ø–∏–¥–∞¬ª, –≤—ã–ø—É—Å–∫–∞—é—â–µ–π –æ–¥–Ω–æ–∏–º–µ–Ω–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –æ—Ç –í–ò–ß (–ú–ù–ù ‚Äì —ç–ª—Å—É–ª—å—Ñ–∞–≤–∏—Ä–∏–Ω). –ü—Ä–∞–≤–∞ –Ω–∞ –Ω–µ–≥–æ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º—É —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—é (—Ä–∞–Ω–µ–µ ¬´–í–∏—Ä–∏–æ–º¬ª) —à–≤–µ–π—Ü–∞—Ä—Å–∫–∞—è Roche, –∏–∑–Ω–∞—á–∞–ª—å–Ω–æ –∑–∞–Ω–∏–º–∞–≤—à–∞—è—Å—è —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–æ–π –º–æ–ª–µ–∫—É–ª—ã, –ø–µ—Ä–µ–¥–∞–ª–∞ –≤ 2009 –≥–æ–¥—É. –ú–∏–Ω–∑–¥—Ä–∞–≤ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª –≠–ª–ø–∏–¥—É –≤ 2017 –≥–æ–¥—É, —Å 2018 –≥–æ–¥–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç –≤—Ö–æ–¥–∏—Ç –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü. –í 2022 –≥–æ–¥—É ¬´–≠–ª–ø–∏–¥–∞¬ª –≤—ã–≤–µ–ª–∞ –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–∏–π —Ä—ã–Ω–æ–∫ –≠–ª–ø–∏–¥—É –∫–æ–º–±–∏ ‚Äî –∫–æ–º–±–∏–Ω–∞—Ü–∏—é —ç–ª—Å—É–ª—å—Ñ–∞–≤–∏—Ä–∏–Ω–∞, —Ç–µ–Ω–æ—Ñ–æ–≤–∏—Ä–∞ –∏ —ç–º—Ç—Ä–∏—Ü–∏—Ç–∞–±–∏–Ω–∞. –ü–æ –¥–∞–Ω–Ω—ã–º —ç–∫—Å–ø–µ—Ä—Ç–Ω–æ–π –≥—Ä—É–ø–ø—ã ¬´–ó–¥—Ä–∞–≤—Ä–µ—Å—É—Ä—Å¬ª, –≤ 2024 –≥–æ–¥—É —Ä–∞—Å—Ö–æ–¥—ã –±—é–¥–∂–µ—Ç–∞ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –∏ —Ä–µ–≥–∏–æ–Ω–æ–≤ –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç —Å–æ—Å—Ç–∞–≤–∏–ª–∏ 4,59 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –≠—Ç–æ 12% –≤—Å–µ—Ö –∑–∞—Ç—Ä–∞—Ç –Ω–∞ –ê–†–í-—Å—Ä–µ–¥—Å—Ç–≤–∞. –ó–∞ –ø–µ—Ä–≤—ã–µ –ø—è—Ç—å –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ –≠–ª–ø–∏–¥—ã –≤ –≥–æ—Å—Å–µ–≥–º–µ–Ω—Ç–µ —Ä–µ–∞–ª–∏–∑–æ–≤–∞–ª–∏ –Ω–∞ 2,2 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —á—Ç–æ –Ω–∞ 16% –º–µ–Ω—å—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É. –ù–∞—Ç—É—Ä–∞–ª—å–Ω—ã–µ –ø—Ä–æ–¥–∞–∂–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ —Å–Ω–∏–∑–∏–ª–∏—Å—å –Ω–∞ 15%, –¥–æ 408,7 —Ç—ã—Å. —É–ø–∞–∫–æ–≤–æ–∫. –û—Å–Ω–æ–≤–Ω—ã–µ –≤–ª–∞–¥–µ–ª—å—Ü—ã ¬´–≠–ª–ø–∏–¥—ã¬ª ‚Äî ¬´–•–∏–º—Ä–∞—Ä¬ª –ê–Ω–¥—Ä–µ—è –ò–≤–∞—â–µ–Ω–∫–æ (44%) –∏ ¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç¬ª –í–∏–∫—Ç–æ—Ä–∞ –•–∞—Ä–∏—Ç–æ–Ω–∏–Ω–∞ (30%). 5% ‚Äî —É —á–ª–µ–Ω–∞ —Å–æ–≤–µ—Ç–∞ –¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–≤ ¬´–û—Ç–∏—Å–∏—Ñ–∞—Ä–º¬ª (–≤—Ö–æ–¥–∏—Ç –≤ –≥—Ä—É–ø–ø—É ¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç¬ª) –ê–Ω–¥—Ä–µ—è –†–µ—É—Å–∞. –ï—â—ë 2,5% –æ–¥–Ω–æ–≤—Ä–µ–º–µ–Ω–Ω–æ —Å –ü–µ—Ç—Ä–æ–≤–∏—á–µ–º –ø–æ–ª—É—á–∏–ª–∞ –≥—Ä–∞–∂–¥–∞–Ω–∫–∞ –°–µ—Ä–±–∏–∏ –Æ–ª–∏—è –ò–≤–∏–Ω–∏—Ü–∫–∞—è. –ü—Ä–∏ —ç—Ç–æ–º –∏–∑ –∫–∞–ø–∏—Ç–∞–ª–∞ –≤—ã—à–ª–∞ —à–≤–µ–π—Ü–∞—Ä—Å–∫–∞—è Apicon, –∫–æ—Ç–æ—Ä–∞—è –¥–æ —ç—Ç–æ–≥–æ –∫–æ–Ω—Ç—Ä–æ–ª–∏—Ä–æ–≤–∞–ª–∞ 5% ¬´–≠–ª–ø–∏–¥—ã¬ª. –ü–æ –∏—Ç–æ–≥–∞–º 2024 –≥–æ–¥–∞ ¬´–≠–ª–ø–∏–¥–∞¬ª –Ω–∞—Ä–∞—Å—Ç–∏–ª–∞ –≤—ã—Ä—É—á–∫—É –ø–æ –†–°–ë–£ –±–æ–ª–µ–µ —á–µ–º –≤–¥–≤–æ–µ, –¥–æ 6,9 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, –∞ —á–∏—Å—Ç—É—é –ø—Ä–∏–±—ã–ª—å ‚Äî –≤ 1,5 —Ä–∞–∑–∞, –¥–æ 3,3 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –†—ã–Ω–æ—á–Ω–∞—è —Å—Ç–æ–∏–º–æ—Å—Ç—å –∫–æ–º–ø–∞–Ω–∏–∏ –æ—Ü–µ–Ω–∏–≤–∞–µ—Ç—Å—è –≤ 12‚Äì15 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –í —Ç–∞–∫–æ–º —Å–ª—É—á–∞–µ –ø–∞–∫–µ—Ç –ü–µ—Ç—Ä–æ–≤–∏—á–∞ —Å–æ—Å—Ç–∞–≤–ª—è–µ—Ç 300‚Äì375 –º–ª–Ω —Ä—É–±–ª–µ–π. –°—É–¥—è –ø–æ —Ä–∞–∑–º–µ—Ä—É –¥–æ–ª–∏, —É—á–∞—Å—Ç–∏–µ –ü–µ—Ç—Ä–æ–≤–∏—á–∞ –≤ ¬´–≠–ª–ø–∏–¥–µ¬ª —Å–∫–æ—Ä–µ–µ –Ω–µ –ø—Ä–æ –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–∏, –∞ –ø—Ä–æ –º–æ—Ç–∏–≤–∞—Ü–∏—é. –ü–æ –º–Ω–µ–Ω–∏—é –∏—Å–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–≥–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ RNC Pharma –ù–∏–∫–æ–ª–∞—è –ë–µ—Å–ø–∞–ª–æ–≤–∞, —Ç–∞–∫–∏–º –æ–±—Ä–∞–∑–æ–º –º–æ–≥–ª–∏ –±—ã—Ç—å –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–Ω—ã —Ñ–∏–Ω–∞–Ω—Å–æ–≤—ã–µ –æ–∂–∏–¥–∞–Ω–∏—è –±–∏–∑–Ω–µ—Å–º–µ–Ω–∞: –ü–µ—Ç—Ä–æ–≤–∏—á ‚Äì –æ—á–µ–Ω—å –æ–ø—ã—Ç–Ω—ã–π –º–µ–Ω–µ–¥–∂–µ—Ä —Å –∫–æ–ª–æ—Å—Å–∞–ª—å–Ω—ã–º –æ–ø—ã—Ç–æ–º –≤ –æ—Ç—Ä–∞—Å–ª–∏, –∏ –µ–≥–æ –∫–æ–º–ø–µ—Ç–µ–Ω—Ü–∏–∏ –±—É–¥—É—Ç –ø–æ–ª–µ–∑–Ω—ã –∫–æ–º–ø–∞–Ω–∏–∏ –¥–ª—è —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ–≥–æ —Ä–∞–∑–≤–∏—Ç–∏—è, —Ç–µ–º –±–æ–ª–µ–µ —á—Ç–æ —É –æ—Å–Ω–æ–≤–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è –µ—Å—Ç—å –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª –¥–ª—è –¥–∞–ª—å–Ω–µ–π—à–µ–≥–æ —Ä–æ—Å—Ç–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""The former Roche representative in Russia, Mr. Milo≈° Petroviƒá, acquired a 2.5% stake in the domestic pharmaceutical company producing the HIV drug 'Elpid'. The rights to Elpid, initially developed by Swiss Roche in 2009, were transferred to the Russian pharmaceutical company (previously 'Viriom') by Roche. Elpid was registered in Russia in 2017 and has been included in the list of essential medicines since 2018. In 2022, 'Elpid' was launched in Russia as a combination of Elsuflavirin (elvusulfurine), tenofovir, and emtricitabine. According to the expert group 'Zdravresurs', budget expenditures for ARV drugs by the Ministry of Health and regions in 2024 amounted to 4.59 billion rubles, accounting for 12% of all ARV expenditure. In the first five months of 2025"
2025-06-30T15:11:02+00:00,@bezrec,6254,https://t.me/bezrec/6254,"–§–∞—Ä–º–∞ –ø–æ–º–æ–≥–ª–∞ ¬´—Å–¥–µ–ª–∞—Ç—å —Å–µ–±—è¬ª –¥–≤—É–º –±–æ–≥–∞—Ç–µ–π—à–∏–º –∂–µ–Ω—â–∏–Ω–∞–º –ø–ª–∞–Ω–µ—Ç—ã. Forbes –≤–ø–µ—Ä–≤—ã–µ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª —Ä–µ–π—Ç–∏–Ω–≥ 50 —Å–∞–º—ã—Ö –±–æ–≥–∞—Ç—ã—Ö self-made –∂–µ–Ω—â–∏–Ω –º–∏—Ä–∞. –ü–æ—Ä–æ–≥ –≤—Ö–æ–∂–¥–µ–Ω–∏—è –≤ —ç–ª–∏—Ç–Ω—ã–π ¬´–∫–ª—É–±¬ª ‚Äî $2,1 –º–ª—Ä–¥. –ï—Å—Ç—å –≤ –Ω—ë–º –∏ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª—å–Ω–∏—Ü—ã —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏. –¢—Ä–µ—Ç—å—é —Å—Ç—Ä–æ—á–∫—É —Ä–µ–π—Ç–∏–Ω–≥–∞ –∑–∞–Ω–∏–º–∞–µ—Ç –ß–∂—É–Ω –•—É—ç–π—Ü–∑—é–∞–Ω—å ‚Äî –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—å –∏ –≥–µ–Ω–µ—Ä–∞–ª—å–Ω—ã–π –¥–∏—Ä–µ–∫—Ç–æ—Ä –∫–∏—Ç–∞–π—Å–∫–æ–π —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ Hansoh Pharmaceutical, –æ—Å–Ω–æ–≤–∞–Ω–Ω–æ–π –≤ 1995 –≥–æ–¥—É. –ö–æ—Ä–ø–æ—Ä–∞—Ü–∏—è –ø—Ä–∏–Ω–µ—Å–ª–∞ –±—ã–≤—à–µ–π —É—á–∏—Ç–µ–ª—å–Ω–∏—Ü–µ —Ö–∏–º–∏–∏ $15,6 –º–ª—Ä–¥. –û–¥–∏–Ω –∏–∑ —Å–∞–º—ã—Ö —É—Å–ø–µ—à–Ω—ã—Ö –ø—Ä–æ–¥—É–∫—Ç–æ–≤ Hansoh Pharmaceutical ‚ÄîGainuo ‚Äî –ø—Ä–µ–ø–∞—Ä–∞—Ç –ø–µ—Ä–≤–æ–π –ª–∏–Ω–∏–∏ –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Ä–∞–∫–∞ –ª–µ–≥–∫–∏—Ö –Ω–∞ –ø–æ–∑–¥–Ω–∏—Ö —Å—Ç–∞–¥–∏—è—Ö. –í 2022 –≥–æ–¥—É Hansoh –æ–±—ä–µ–¥–∏–Ω–∏–ª–∞—Å—å —Å –ì–ª–æ–±–∞–ª—å–Ω—ã–º –∏–Ω—Å—Ç–∏—Ç—É—Ç–æ–º —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è, —Å–ø–æ–Ω—Å–∏—Ä—É–µ–º—ã–º –§–æ–Ω–¥–æ–º –ë–∏–ª–ª–∞ –∏ –ú–µ–ª–∏–Ω–¥—ã –ì–µ–π—Ç—Å, –¥–ª—è —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –ø–µ—Ä–æ—Ä–∞–ª—å–Ω–æ–≥–æ –ª–µ—á–µ–Ω–∏—è –∫–æ—Ä–æ–Ω–∞–≤–∏—Ä—É—Å–∞. –ù–∞ 32 –ø–æ–∑–∏—Ü–∏–∏ ‚Äî –ö–∏—Ä–∞–Ω –ú–∞–∑—É–º–¥–∞—Ä-–®–æ—É, –æ–¥–Ω–∞ –∏–∑ —Å–∞–º—ã—Ö –±–æ–≥–∞—Ç—ã—Ö –∂–µ–Ω—â–∏–Ω –ò–Ω–¥–∏–∏, –≤ 1978 –≥–æ–¥—É –æ—Å–Ω–æ–≤–∞–≤—à–∞—è –±–∏–æ—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫—É—é Biocon. –ö–æ–º–ø–∞–Ω–∏—è –≤–ª–∞–¥–µ–µ—Ç –æ–¥–Ω–∏–º –∏–∑ –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö –≤ –ê–∑–∏–∏ –∑–∞–≤–æ–¥–æ–≤ –ø–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤—É –∏–Ω—Å—É–ª–∏–Ω–∞ –≤ —Ä–µ–≥–∏–æ–Ω–µ –î–∂–æ—Ö–æ—Ä –≤ –ú–∞–ª–∞–π–∑–∏–∏ –∏ —É—Å–ø–µ—à–Ω–æ –≤—ã—à–ª–∞ –Ω–∞ –ø—Ä–∏–±—ã–ª—å–Ω—ã–π —Ä—ã–Ω–æ–∫ –°–®–ê. –í 2022 –≥–æ–¥—É Biocon Biologics –ø—Ä–∏–æ–±—Ä–µ–ª–∞ –±–∏–∑–Ω–µ—Å –ø–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤—É –±–∏–æ–∞–Ω–∞–ª–æ–≥–æ–≤ —É –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–π Viatris –∑–∞ $3,3 –º–ª—Ä–¥. –í 2022 –≥–æ–¥—É —Å –¥–µ—Ç–∏—â–µ–º –ö–∏—Ä–∞–Ω –ú–∞–∑—É–º–¥–∞—Ä-–®–æ—É –ø—Ä–∏–∫–ª—é—á–∏–ª–∞—Å—å –Ω–µ–ø—Ä–∏–≥–ª—è–¥–Ω–∞—è –∏—Å—Ç–æ—Ä–∏—è ‚Äî –¶–µ–Ω—Ç—Ä–∞–ª—å–Ω–æ–µ –±—é—Ä–æ —Ä–∞—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π (–æ—Ñ–∏—Ü–∏–∞–ª—å–Ω—ã–π –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª—å –ò–Ω—Ç–µ—Ä–ø–æ–ª–∞ –≤ –ò–Ω–¥–∏–∏) –∞—Ä–µ—Å—Ç–æ–≤–∞–ª–æ —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—è Biocon –∏ –µ—â—ë —á–µ—Ç–≤–µ—Ä—ã—Ö —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤ –ø–æ –¥–µ–ª—É –æ –≤–∑—è—Ç–æ—á–Ω–∏—á–µ—Å—Ç–≤–µ. –ö–æ–º–ø–∞–Ω–∏—è –æ—Ç—Ä–∏—Ü–∞–ª–∞ –∫–∞–∫–∏–µ-–ª–∏–±–æ –ø—Ä–∞–≤–æ–Ω–∞—Ä—É—à–µ–Ω–∏—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-06-30T12:23:37+00:00,@bezrec,6253,https://t.me/bezrec/6253,"–†–µ—á—å –æ–± –æ—Å–∏–º–µ—Ä—Ç–∏–Ω–∏–±–µ, –∞–∫—Å–∏—Ç–∏–Ω–∏–±–µ, —Ä—É–∫—Å–æ–ª–∏—Ç–∏–Ω–∏–±–µ –∏ –±–æ–∑—É—Ç–∏–Ω–∏–±–µ. –ì–æ—Å–∑–∞–∫—É–ø–∫–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Å —ç—Ç–∏–º–∏ –ú–ù–ù –ø–æ –∏—Ç–æ–≥–∞–º –ø–µ—Ä–≤—ã—Ö –ø–æ–ª—É–≥–æ–¥–∏–π 2023, 2024 –∏ 2025 –≥–æ–¥–æ–≤ –ø—Ä–æ–∞–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–ª–∞ –ø–ª–∞—Ç—Ñ–æ—Ä–º–∞ –ø–æ —Ä–∞–±–æ—Ç–µ —Å —Ç–µ–Ω–¥–µ—Ä–∞–º–∏ ¬´–¢–µ–Ω–¥–µ—Ä–ø–ª–∞–Ω¬ª. –°–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –ø–ª–∞—Ç—Ñ–æ—Ä–º—ã –ø–æ–ª—É—á–∏–ª–∏ —Å–ª–µ–¥—É—é—â–∏–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã: üîò–ø–æ –æ—Ç–Ω–æ—à–µ–Ω–∏—é –∫ –ø–µ—Ä–≤—ã–º —à–µ—Å—Ç–∏ –º–µ—Å—è—Ü–∞–º 2023 –≥–æ–¥–∞ –≥–æ—Å–∑–∞–∫—É–ø–∫–∏ —á–µ—Ç—ã—Ä–µ—Ö –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤ —Å–æ–≤–æ–∫—É–ø–Ω–æ —É–≤–µ–ª–∏—á–∏–ª–∏—Å—å –ø–æ—á—Ç–∏ –≤–¥–≤–æ–µ ‚Äî—Å 4,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –¥–æ 8,3 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –≤ –ø–µ—Ä–≤–æ–º –ø–æ–ª—É–≥–æ–¥–∏–∏ 2024 –≥–æ–¥–∞; üîò—Å —è–Ω–≤–∞—Ä—è –ø–æ –∏—é–Ω—å 2025 –≥–æ–¥–∞ —Ä–æ—Å—Ç —Å–æ—Å—Ç–∞–≤–∏–ª 35% –≥–æ–¥ –∫ –≥–æ–¥—É (11,3 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π); üîò–≤ –≥–æ–¥–æ–≤–æ–º —Å–æ–æ—Ç–Ω–æ—à–µ–Ω–∏–∏ –≥–æ—Å–∑–∞–∫—É–ø–∫–∏ –ø–µ—Ä–µ—á–∏—Å–ª–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ 2024 –≥–æ–¥—É –≤—ã—Ä–æ—Å–ª–∏ –Ω–∞ 27% ‚Äî —Å 13,8 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –¥–æ 17,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –û—Å–∏–º–µ—Ä—Ç–∏–Ω–∏–±, –∞–∫—Å–∏—Ç–∏–Ω–∏–±, —Ä—É–∫—Å–æ–ª–∏—Ç–∏–Ω–∏–± –∏ –±–æ–∑—É—Ç–∏–Ω–∏–± ‚Äî –ø—Ä–µ–¥–º–µ—Ç—ã –ø–∞—Ç–µ–Ω—Ç–Ω—ã—Ö —Å–ø–æ—Ä–æ–≤ –º–µ–∂–¥—É –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã–º–∏ –ø—Ä–∞–≤–æ–æ–±–ª–∞–¥–∞—Ç–µ–ª—è–º–∏ –∏ —Ä–æ—Å—Å–∏–π—Å–∫–∏–º ¬´–ê–∫—Å–µ–ª—å—Ñ–∞—Ä–º–æ–º¬ª. –ó–∞ –¢–∞–≥—Ä–∏—Å—Å–æ (–æ—Å–∏–º–µ—Ä—Ç–∏–Ω–∏–±) —Å—Ä–∞–∂–∞–µ—Ç—Å—è –∞–Ω–≥–ª–æ-—à–≤–µ–¥—Å–∫–∞—è AstraZeneca, –∑–∞ –ò–Ω–ª–∏—Ç—É (–∞–∫—Å–∏—Ç–∏–Ω–∏–±) –∏ –ë–æ–∑—É–ª–∏—Ñ (–±–æ–∑—É—Ç–∏–Ω–∏–±) ‚Äî –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∞—è Pfizer, –∑–∞ –î–∂–∞–∫–∞–≤–∏ (—Ä—É–∫—Å–æ–ª–∏—Ç–∏–Ω–∏–±) ‚Äî —à–≤–µ–π—Ü–∞—Ä—Å–∫–∞—è Novartis –∏ –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∞—è Incyte Corporation. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage"",
  ""impact"": ""high"",
  ""english"": ""Procurements of the drugs Osimeritinib, Acitinitib, Ruxolinitib and Bosutinib have increased significantly. The platform 'Tenderplan' analyzed the first half of 2023, 2024 and 2025. Procurements of these drugs have increased by almost double from 4.7 billion rubles to 8.3 billion rubles in the first half of 2024. The annual growth for the period from January to June 2025 was 35% (11.3 billion rubles). The drugs Osimeritinib, Acitinitib and Bosutinib are the subject of patent disputes between foreign right holders and Russian 'Axelfarm'. AstraZeneca (Sweden) is fighting for Tagrisso (Osimeritinib), Pfizer (US) for Iclusig (Acitinitib) and Bosulif (Bosutinib), Novartis (Switzerland) for Iclusig"
2025-06-30T09:27:43+00:00,@bezrec,6252,https://t.me/bezrec/6252,"–ü–æ–¥ –ö–∞–∑–∞–Ω—å—é –ø–æ—è–≤–∏—Ç—Å—è –Ω–æ–≤–æ–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –ª–µ–∫–∞—Ä—Å—Ç–≤. –û–û–û ¬´–ù–∞—Ç—É—Ä–∞–ª—å–Ω–æ–µ –∑–¥–æ—Ä–æ–≤—å–µ¬ª –ø–ª–∞–Ω–∏—Ä—É–µ—Ç –ø–æ—Å—Ç—Ä–æ–∏—Ç—å –≤ –û–≠–ó ¬´–ò–Ω–Ω–æ–ø–æ–ª–∏—Å¬ª –∑–∞–≤–æ–¥ –ø–æ –≤—ã–ø—É—Å–∫—É –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –¥–ª—è –∑–¥–æ—Ä–æ–≤—å—è. –ù–∞ –ø–ª–æ—â–∞–¥–∏ 8,1 —Ç—ã—Å. –∫–≤. –º. —Ä–∞–∑–º–µ—Å—Ç—è—Ç –ø–æ—Ä—è–¥–∫–∞ 2 —Ç—ã—Å. –∫–≤. –º —Å–∫–ª–∞–¥—Å–∫–∏—Ö –ø–æ–º–µ—â–µ–Ω–∏–π –∏ —Ç—Ä–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å–µ–∫—Ç–æ—Ä–∞ –ø–æ 2 —Ç—ã—Å. –∫–≤. –º: üíä –ø–µ—Ä–≤—ã–π –æ—Ç–¥–∞–¥—É—Ç –ø–æ–¥ –ë–ê–î—ã –∏ —Å–ø–æ—Ä—Ç–ø–∏—Ç; üíä –≤—Ç–æ—Ä–æ–π ‚Äî –ø–æ–¥ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞, —Ç–∞–º –∂–µ —Ä–∞—Å–ø–æ–ª–æ–∂–∏—Ç—Å—è –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–Ω—ã–π –∫–æ–º–ø–ª–µ–∫—Å; üíä –≤ —Ç—Ä–µ—Ç—å–µ–º –±—É–¥—É—Ç –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç—å –∫–æ—Å–º–µ—Ü–µ–≤—Ç–∏–∫—É (–∫–æ—Å–º–µ—Ç–∏–∫—É —Å –ª–µ—á–µ–±–Ω—ã–º–∏ —Å–≤–æ–π—Å—Ç–≤–∞–º–∏). –ù–∞ —Å–µ–≥–æ–¥–Ω—è—à–Ω–∏–π –¥–µ–Ω—å —É –Ω–∞—Å –µ—Å—Ç—å –≤—Å–µ –ª–∏–Ω–∏–∏ –ø–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤—É –ë–ê–î–æ–≤ –∏ —Å–ø–æ—Ä—Ç–∏–≤–Ω–æ–≥–æ –ø–∏—Ç–∞–Ω–∏—è, –∑–∞–∫—É–ø–ª–µ–Ω–∞ –ø–æ–ª–æ–≤–∏–Ω–∞ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –¥–ª—è –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –∫–æ—Å–º–µ—Ü–µ–≤—Ç–∏–∫–∏, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä ¬´–ù–∞—Ç—É—Ä–∞–ª—å–Ω–æ–≥–æ –∑–¥–æ—Ä–æ–≤—å—è¬ª –°–µ—Ä–≥–µ–π –ü–∞—Ç—Ä–∞–∫–æ–≤. –î–µ–ª–∞ —É –∫–æ–º–ø–∞–Ω–∏–∏, –æ—Å–Ω–æ–≤–∞–Ω–Ω–æ–π –≤ 2019 –≥–æ–¥—É, –∏–¥—É—Ç –±–æ–π–∫–æ. –í—ã—Ä—É—á–∫–∞ –∑–∞ 2024 –≥–æ–¥ —É–≤–µ–ª–∏—á–∏–ª–∞—Å—å –Ω–∞ 187%, –¥–æ 233 –º–ª–Ω —Ä—É–±–ª–µ–π, –ø—Ä–∏–±—ã–ª—å ‚Äî –Ω–∞ 252%, –¥–æ 59 –º–ª–Ω —Ä—É–±–ª–µ–π. –õ–µ–∫–∞—Ä—Å—Ç–≤–∞ ‚Äî –æ–¥–Ω–æ –∏–∑ 25 –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã—Ö –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏–π –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ ¬´–ù–∞—Ç—É—Ä–∞–ª—å–Ω–æ–≥–æ –∑–¥–æ—Ä–æ–≤—å—è¬ª. –í –∫–∞—á–µ—Å—Ç–≤–µ –æ—Å–Ω–æ–≤–Ω–æ–≥–æ –≤–∏–¥–∞ –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ —á–∏—Å–ª–∏—Ç—Å—è –æ–∫–∞–∑–∞–Ω–∏–µ –∫–æ–Ω—Å—É–ª—å—Ç–∞—Ü–∏–æ–Ω–Ω—ã—Ö –∏ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω—ã—Ö —É—Å–ª—É–≥. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""production, regulation"",
  ""impact"": ""medium"",
  ""english"": ""A new pharmaceutical production facility is being established near Kazan by the company 'Naturall Health'. The company plans to build a production facility in the INNOPOLIS EEC with an area of 8,100 square meters. The facility will include approximately 2,000 square meters of warehouse space and three production sectors each covering 2,000 square meters. The first sector will be dedicated to dietary supplements and sports nutrition; the second will produce medicines, where a laboratory complex is also located; the third sector will manufacture cosmeceuticals (cosmetics with therapeutic properties). The company, founded in 2019 and doing well, has seen its revenue increase by 187% to RUB233 million in 2024, and its profit increase by 252% to RUB59 million. The company considers medicines one of the additional directions in its activities, with primary business being consulting and informational services.""
}"
2025-06-30T05:40:08+00:00,@bezrec,6251,https://t.me/bezrec/6251,"–ü–∞—Ä–∞–≥–≤–∞–π –ø—Ä–∏—Å–º–∞—Ç—Ä–∏–≤–∞–µ—Ç—Å—è –∫ —Ä–æ—Å—Å–∏–π—Å–∫–æ–π –æ–Ω–∫–æ–≤–∞–∫—Ü–∏–Ω–µ. –ü–æ—Å–æ–ª –ª–∞—Ç–∏–Ω–æ–∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–π —Å—Ç—Ä–∞–Ω—ã –≤ –ú–æ—Å–∫–≤–µ –í–∏–∫—Ç–æ—Ä –£–≥–æ –ü–µ–Ω—å—è –ë–∞—Ä–µ–π—Ä–æ, –≤—Å—Ç—Ä–µ—á–∞–≤—à–∏–π—Å—è —Å –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª—è–º–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞, —Å–æ–æ–±—â–∏–ª, —á—Ç–æ –ü–∞—Ä–∞–≥–≤–∞–π –∑–∞–∏–Ω—Ç–µ—Ä–µ—Å–æ–≤–∞–Ω –≤ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏–∏ –ø–µ—Ä–µ–≥–æ–≤–æ—Ä–æ–≤ –æ –≤–∞–∫—Ü–∏–Ω–µ –æ—Ç —Ä–∞–∫–∞. –ë–∞—Ä–µ–π—Ä–æ –≤—ã–¥–µ–ª–∏–ª —É—Å–ø–µ—Ö–∏ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö —É—á—ë–Ω—ã—Ö, –Ω–æ –æ—Ç–º–µ—Ç–∏–ª, —á—Ç–æ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –∏ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω–æ–≥–æ –ø—Ä–æ—Ä—ã–≤–∞ –µ—â—ë –Ω—É–∂–Ω–æ –¥–æ–∫–∞–∑–∞—Ç—å: –†–æ—Å—Å–∏—è –∑–∞—è–≤–∏–ª–∞, —á—Ç–æ –¥–æ–±–∏–ª–∞—Å—å –≤–∞–∂–Ω–µ–π—à–µ–≥–æ –ø—Ä–æ–≥—Ä–µ—Å—Å–∞ –≤ —Ç–µ–º–µ –≤–∞–∫—Ü–∏–Ω—ã –ø—Ä–æ—Ç–∏–≤ —Ä–∞–∫–∞. –ü–æ–∫–∞ —É –Ω–∞—Å –Ω–µ—Ç –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏—è, —á—Ç–æ —ç—Ç–æ —Ç–∞–∫, –Ω–æ –µ—Å–ª–∏ —ç—Ç–æ –ø—Ä–æ–∏–∑–æ–π–¥–µ—Ç, —Ç–æ —Å—Ç–∞–Ω–µ—Ç –≤–ø–µ—á–∞—Ç–ª—è—é—â–µ–π –Ω–æ–≤–æ—Å—Ç—å—é –Ω–∞ –º–∏—Ä–æ–≤–æ–º —É—Ä–æ–≤–Ω–µ. –ü–∞—Ä–∞–≥–≤–∞–π —Ö–æ—á–µ—Ç –±—ã—Ç—å —Å—Ä–µ–¥–∏ –ø–µ—Ä–≤—ã—Ö —Å—Ç—Ä–∞–Ω, –∫—Ç–æ –±—É–¥–µ—Ç —Ä–∞–∑–≥–æ–≤–∞—Ä–∏–≤–∞—Ç—å —Å –†–æ—Å—Å–∏–µ–π –æ–± —ç—Ç–æ–º. –û—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π –≠–Ω—Ç–µ—Ä–æ–º–∏–∫—Å —É–∂–µ –Ω–∞—á–∞–ª–∏ –∏—Å–ø—ã—Ç—ã–≤–∞—Ç—å –Ω–∞ –ø–∞—Ü–∏–µ–Ω—Ç–∞—Ö. 48 –¥–æ–±—Ä–æ–≤–æ–ª—å—Ü–µ–≤ –¥–ª—è –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –Ω–∞–±—Ä–∞–ª–∏ –±—ã—Å—Ç—Ä–æ, –Ω–µ—Å–º–æ—Ç—Ä—è –Ω–∞ –¥–æ–≤–æ–ª—å–Ω–æ –∂–µ—Å—Ç–∫–∏–µ –∫—Ä–∏—Ç–µ—Ä–∏–∏ –æ—Ç–±–æ—Ä–∞. –ì–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä –ù–ú–ò–¶ —Ä–∞–¥–∏–æ–ª–æ–≥–∏–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ê–Ω–¥—Ä–µ–π –ö–∞–ø—Ä–∏–Ω –Ω–∞ –ø–æ–ª—è—Ö –ü–ú–≠–§ —Ä–∞—Å—Å–∫–∞–∑–∞–ª, —á—Ç–æ —Ç–æ–∫—Å–∏—á–µ—Å–∫–∏–π —ç—Ñ—Ñ–µ–∫—Ç –≤–∞–∫—Ü–∏–Ω—ã ¬´–≤ –æ–±—â–µ–º-—Ç–æ –æ—á–µ–Ω—å –Ω–µ–∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω—ã–π¬ª. –ù–∞–¥ —Ä–æ—Å—Å–∏–π—Å–∫–æ–π –æ–Ω–∫–æ–≤–∞–∫—Ü–∏–Ω–æ–π –ø—Ä–∏ –ø–æ–¥–¥–µ—Ä–∂–∫–µ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ —Ç—Ä—É–¥—è—Ç—Å—è —Å—Ä–∞–∑—É –Ω–µ—Å–∫–æ–ª—å–∫–æ –Ω–∞—É—á–Ω—ã—Ö –∫–æ–ª–ª–µ–∫—Ç–∏–≤–æ–≤: –¶–µ–Ω—Ç—Ä –∏–º. –ì–∞–º–∞–ª–µ–∏, –ú–æ—Å–∫–æ–≤—Å–∫–∏–π –Ω–∞—É—á–Ω–æ-–∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–∏–π –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–π –∏–Ω—Å—Ç–∏—Ç—É—Ç –∏–º. –ì–µ—Ä—Ü–µ–Ω–∞ –∏ –ù–ú–ò–¶ –æ–Ω–∫–æ–ª–æ–≥–∏–∏ –∏–º. –ù. –ù. –ë–ª–æ—Ö–∏–Ω–∞. –î–ª—è —É—Å–∫–æ—Ä–µ–Ω–∏—è –ø—Ä–æ—Ü–µ—Å—Å–∞ –ø—Ä–∏ —Å–æ–∑–¥–∞–Ω–∏–∏ –ø–µ—Ä—Å–æ–Ω–∞–ª—å–Ω—ã—Ö –≤–∞–∫—Ü–∏–Ω –æ—Ç —Ä–∞–∫–∞ –ø–ª–∞–Ω–∏—Ä—É—é—Ç –∑–∞–¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å –ò–ò. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-06-29T09:06:06+00:00,@bezrec,6249,https://t.me/bezrec/6249,"–í–æ–∑–≤—Ä–∞—â–∞–µ–º—Å—è —Å –Ω–∞—à–µ–π —Ä—É–±—Ä–∏–∫–æ–π #—Ñ–∞—Ä–º–∫–∏–Ω–æ ‚Äì –∏ –Ω–∞ —ç—Ç–æ—Ç —Ä–∞–∑ —É –Ω–∞—Å –¥–∏–Ω–æ–∑–∞–≤—Ä—ã, –±–∏–æ—Ç–µ—Ö –∏ —Ç—Ä–æ–ø–∏—á–µ—Å–∫–∏–π –∞–¥—Ä–µ–Ω–∞–ª–∏–Ω. 2 –∏—é–ª—è 2025 –≥–æ–¥–∞ –≤ –ø—Ä–æ–∫–∞—Ç –≤—ã—Ö–æ–¥–∏—Ç ¬´–ú–∏—Ä –Æ—Ä—Å–∫–æ–≥–æ –ø–µ—Ä–∏–æ–¥–∞: –í–æ–∑—Ä–æ–∂–¥–µ–Ω–∏–µ¬ª ‚Äì —Å–µ–¥—å–º–∞—è —á–∞—Å—Ç—å –∫—É–ª—å—Ç–æ–≤–æ–π —Ñ—Ä–∞–Ω—à–∏–∑—ã, –ø–æ—Å—Ç–∞–≤–ª–µ–Ω–Ω–∞—è –ì–∞—Ä–µ—Ç–æ–º –≠–¥–≤–∞—Ä–¥—Å–æ–º (¬´–ì–æ–¥–∑–∏–ª–ª–∞¬ª, ¬´–ò–∑–≥–æ–π-–æ–¥–∏–Ω¬ª). –ù–∞ —ç–∫—Ä–∞–Ω–µ –±—É–¥–µ—Ç –Ω–æ–≤–∞—è –∫–æ–º–∞–Ω–¥–∞ –≥–µ—Ä–æ–µ–≤: –°–∫–∞—Ä–ª–µ—Ç—Ç –ô–æ—Ö–∞–Ω—Å—Å–æ–Ω, –î–∂–æ–Ω–∞—Ç–∞–Ω –ë–µ–π–ª–∏, –ú–∞—Ö–µ—Ä—à–∞–ª–∞ –ê–ª–∏. –ü–æ —Å—é–∂–µ—Ç—É —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—è –æ—Ç–ø—Ä–∞–≤–ª—è–µ—Ç —ç–∫—Å–ø–µ–¥–∏—Ü–∏—é –Ω–∞ —Ç—Ä–æ–ø–∏—á–µ—Å–∫–∏–π –æ—Å—Ç—Ä–æ–≤, –≥–¥–µ –µ—â—ë –æ—Å—Ç–∞–ª–∏—Å—å –¥–∏–Ω–æ–∑–∞–≤—Ä—ã. –¶–µ–ª—å ‚Äì –¥–æ–±—ã—Ç—å –î–ù–ö –¥—Ä–µ–≤–Ω–∏—Ö —è—â–µ—Ä–æ–≤ –∏ —Å–æ–∑–¥–∞—Ç—å —Ä–µ–≤–æ–ª—é—Ü–∏–æ–Ω–Ω–æ–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–æ. –ù–æ –≤–º–µ—Å—Ç–æ –ø—Ä–æ—Ä—ã–≤–∞ –≥–µ—Ä–æ–µ–≤ –∂–¥—É—Ç –≤—ã–∂–∏–≤–∞–Ω–∏–µ, —Å–∞–±–æ—Ç–∞–∂ –∏ –±–æ—Ä—å–±–∞ —Å –¥–æ–∏—Å—Ç–æ—Ä–∏—á–µ—Å–∫–∏–º–∏ —Ö–∏—â–Ω–∏–∫–∞–º–∏. –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∞–º –±—É–¥–µ—Ç –æ—Å–æ–±–µ–Ω–Ω–æ –∏–Ω—Ç–µ—Ä–µ—Å–Ω–æ, –≤–µ–¥—å —Ñ–∏–ª—å–º –ø–æ–¥–Ω–∏–º–∞–µ—Ç –≤–æ–ø—Ä–æ—Å—ã –±–∏–æ—ç—Ç–∏–∫–∏, –≥–µ–Ω–Ω–æ–π –∏–Ω–∂–µ–Ω–µ—Ä–∏–∏ –∏ –∂–∞–¥–Ω–æ—Å—Ç–∏ –∫–æ—Ä–ø–æ—Ä–∞—Ü–∏–π, –¥–ª—è –∫–æ—Ç–æ—Ä—ã—Ö –≥–ª–∞–≤–Ω–æ–µ ‚Äì –Ω–µ –∏—Å—Ü–µ–ª–µ–Ω–∏–µ, –∞ –∫–æ–Ω—Ç—Ä–æ–ª—å –Ω–∞–¥ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—è–º–∏. –í—Å—ë —ç—Ç–æ –≤ –æ–±—ë—Ä—Ç–∫–µ –∑—Ä–µ–ª–∏—â–Ω–æ–≥–æ –±–ª–æ–∫–±–∞—Å—Ç–µ—Ä–∞ —Å –Ω–æ—Å—Ç–∞–ª—å–≥–∏–µ–π –ø–æ ¬´–ü–∞—Ä–∫—É –Æ—Ä—Å–∫–æ–≥–æ –ø–µ—Ä–∏–æ–¥–∞¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-06-28T09:05:41+00:00,@bezrec,6248,https://t.me/bezrec/6248,"–õ–æ–≤–∏—Ç–µ #–≤–¥–æ–≥–æ–Ω–∫—É –Ω–æ–≤–æ—Å—Ç–∏ —ç—Ç–æ–π –Ω–µ–¥–µ–ª–∏, –∫–æ—Ç–æ—Ä—ã–µ –Ω–µ —É—Å–ø–µ–ª–∏ –æ—Å–≤–µ—Ç–∏—Ç—å –≤ —Ä–∞–±–æ—á–∏–µ –¥–Ω–∏. üíä–ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–µ –∏–Ω–≤–µ—Å—Ç–æ—Ä—ã, –≤–∫–ª—é—á–∞—è Pfizer, Bristol-Myers Squibb –∏ Bain Capital, –∞–∫—Ç–∏–≤–Ω–æ –≤–∫–ª–∞–¥—ã–≤–∞—é—Ç—Å—è –≤ –∫–∏—Ç–∞–π—Å–∫–∏–π –±–∏–æ—Ç–µ—Ö, –∫–æ—Ç–æ—Ä—ã–π –¥–µ–º–æ–Ω—Å—Ç—Ä–∏—Ä—É–µ—Ç –±—É—Ä–Ω—ã–π —Ä–æ—Å—Ç, –±—ã—Å—Ç—Ä—É—é —Ä–∞–∑—Ä–∞–±–æ—Ç–∫—É –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –≤—ã—Å–æ–∫–∏–π –Ω–∞—É—á–Ω—ã–π –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª; —Å—Ç–∞—Ä—Ç–∞–ø—ã –≤—Ä–æ–¥–µ 3SBio, Duality Biotherapeutics –∏ Jiangsu Hengrui Pharmaceuticals —Å—Ç–∞–Ω–æ–≤—è—Ç—Å—è —Ü–µ–Ω—Ç—Ä–æ–º –≤–Ω–∏–º–∞–Ω–∏—è –±–ª–∞–≥–æ–¥–∞—Ä—è —É—Å–ø–µ—à–Ω—ã–º IPO –∏ –ª–∏—Ü–µ–Ω–∑–∏—Ä–æ–≤–∞–Ω–∏—é –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–Ω—ã—Ö –º–æ–ª–µ–∫—É–ª –Ω–∞ —Ä–∞–Ω–Ω–∏—Ö —Å—Ç–∞–¥–∏—è—Ö. üíä–£—á—ë–Ω—ã–µ –∏–∑ –ú–∞–¥—Ä–∏–¥–∞ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª–∏ –Ω–æ–≤–æ–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–æ –æ—Ç –∞–Ω–¥—Ä–æ–≥–µ–Ω–µ—Ç–∏—á–µ—Å–∫–æ–π –∞–ª–æ–ø–µ—Ü–∏–∏ ‚Äì –∫–æ–º–±–∏–Ω–∞—Ü–∏—é —Å—Ç–≤–æ–ª–æ–≤—ã—Ö –∫–ª–µ—Ç–æ–∫ –∏–∑ –∂–∏—Ä–æ–≤–æ–π —Ç–∫–∞–Ω–∏ –∏ –º–æ–ª–µ–∫—É–ª—ã –ê–¢–§, –∫–æ—Ç–æ—Ä–æ–µ –æ–±–µ—â–∞–µ—Ç —Ä–µ–≤–æ–ª—é—Ü–∏—é –≤ –ª–µ—á–µ–Ω–∏–∏ –æ–±–ª—ã—Å–µ–Ω–∏—è —É –ª—é–¥–µ–π. üíäAmarin –ø—Ä–æ–¥–∞–ª–∞ –ø—Ä–∞–≤–∞ –Ω–∞ –µ–≤—Ä–æ–ø–µ–π—Å–∫—É—é –∫–æ–º–º–µ—Ä—Ü–∏–∞–ª–∏–∑–∞—Ü–∏—é —Å–≤–æ–µ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –¥–ª—è —Å–µ—Ä–¥—Ü–∞ Vascepa –∫–æ–º–ø–∞–Ω–∏–∏ Recordati, —á—Ç–æ–±—ã —É–∫—Ä–µ–ø–∏—Ç—å –ø–æ–∑–∏—Ü–∏–∏ –Ω–∞ –µ–≤—Ä–æ–ø–µ–π—Å–∫–æ–º —Ä—ã–Ω–∫–µ –Ω–∞ —Ñ–æ–Ω–µ –ø–∞–¥–µ–Ω–∏—è –ø—Ä–æ–¥–∞–∂ –≤ –°–®–ê. üíä–¢–µ—Ä–∞–ø–∏—è –Ω–∞ –æ—Å–Ω–æ–≤–µ —Å—Ç–≤–æ–ª–æ–≤—ã—Ö –∫–ª–µ—Ç–æ–∫ –∑–∏–º–∏—Å–ª–µ—Ü–µ–ª –∫–æ–º–ø–∞–Ω–∏–∏ Vertex –≤—ã–ª–µ—á–∏–ª–∞ –¥–∏–∞–±–µ—Ç 1-–≥–æ —Ç–∏–ø–∞ —É 10 –∏–∑ 12 –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –∏–∑–±–∞–≤–∏–≤ –∏—Ö –æ—Ç –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ –≤ –∏–Ω—ä–µ–∫—Ü–∏—è—Ö –∏–Ω—Å—É–ª–∏–Ω–∞, –ø—Ä–∏ —ç—Ç–æ–º –ª–µ—á–µ–Ω–∏–µ –æ–∫–∞–∑–∞–ª–æ—Å—å –±–µ–∑–æ–ø–∞—Å–Ω—ã–º –∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ —Å–Ω–∏–∂–∞–ª–æ —Ä–∏—Å–∫ —Ç—è–∂–µ–ª–æ–π –≥–∏–ø–æ–≥–ª–∏–∫–µ–º–∏–∏; –ø—Ä–µ–ø–∞—Ä–∞—Ç –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –∫ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –≤ —Å–ª–µ–¥—É—é—â–µ–º –≥–æ–¥—É –ø–æ—Å–ª–µ —É—Å–ø–µ—à–Ω—ã—Ö –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å–ø—ã—Ç–∞–Ω–∏–π, –ø–æ–∫–∞–∑–∞–≤—à–∏—Ö —Å—Ç–∞–±–∏–ª—å–Ω—ã–π –∫–æ–Ω—Ç—Ä–æ–ª—å —É—Ä–æ–≤–Ω—è —Å–∞—Ö–∞—Ä–∞ –∏ –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ–µ —É–ª—É—á—à–µ–Ω–∏–µ —Å–æ—Å—Ç–æ—è–Ω–∏—è –±–æ–ª—å–Ω—ã—Ö. üíä–í –†–æ—Å—Å–∏–∏ —Ä–∞–∑—Ä–µ—à–∏–ª–∏ –∏–º–ø–æ—Ä—Ç –Ω–µ–∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç–æ–≤ –¥–ª—è –Ω–∞—É—á–Ω—ã—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –∏ —Å–æ–∑–¥–∞–Ω–∏—è –Ω–æ–≤—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. üíä–í –í–µ–ª–∏–∫–æ–±—Ä–∏—Ç–∞–Ω–∏–∏ –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–Ω—ã —Å–æ—Ç–Ω–∏ —Å–ª—É—á–∞–µ–≤ –æ—Å—Ç—Ä–æ–≥–æ –ø–∞–Ω–∫—Ä–µ–∞—Ç–∏—Ç–∞, –≤–∫–ª—é—á–∞—è —Å–º–µ—Ä—Ç–µ–ª—å–Ω—ã–µ, —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –ø—Ä–∏–Ω–∏–º–∞–≤—à–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –Ω–∞ –æ—Å–Ω–æ–≤–µ GLP-1 –¥–ª—è –ø–æ—Ö—É–¥–µ–Ω–∏—è –∏ –ª–µ—á–µ–Ω–∏—è –¥–∏–∞–±–µ—Ç–∞ (Ozempic, Wegovy, Mounjaro). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-06-27T15:35:11+00:00,@bezrec,6247,https://t.me/bezrec/6247,"–ó–Ω–∞–Ω–∏—è –º–æ–∂–Ω–æ –ø—Ä–æ–≤–µ—Ä–∏—Ç—å, –∞ –≤–æ—Ç —Ç–µ—Ä–ø–µ–Ω–∏–µ –∏ –ª—é–±–æ–≤—å —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∞ –∫ –∫–ª–∏–µ–Ω—Ç—É –±–µ—Å–∫–æ–Ω–µ—á–Ω—ã –∏ –Ω–µ –ø–æ–¥–¥–∞—é—Ç—Å—è –æ–±—ä—è—Å–Ω–µ–Ω–∏—è–º. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-06-27T14:02:07+00:00,@bezrec,6246,https://t.me/bezrec/6246,"–¢–æ–ø-10 –ø—Ä–æ—Ç–∏–≤–æ–≤–∏—Ä—É—Å–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –∏—Å–∫–ª—é—á–∞—è –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–ª—è –ª–µ—á–µ–Ω–∏—è –í–ò–ß-–∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π RNC Pharma –ø–æ–¥–≤–µ–ª–∏ –∏—Ç–æ–≥–∏ I –ø–æ–ª—É–≥–æ–¥–∏—è 2025 –≥–æ–¥–∞ –≤ —Ä–æ–∑–Ω–∏—Ü–µ —Ñ–∞—Ä–º—Ä—ã–Ω–∫–∞. –í —Å–µ–≥–º–µ–Ω—Ç–µ –ø—Ä–æ—Ç–∏–≤–æ–≤–∏—Ä—É—Å–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ª–∏–¥–∏—Ä—É—é—â—É—é –ø–æ–∑–∏—Ü–∏—é –ø–æ –¥–æ–ª–µ –∑–∞–Ω–∏–º–∞—é—Ç –ò–Ω–≥–∞–≤–∏—Ä–∏–Ω –æ—Ç ¬´–í–∞–ª–µ–Ω—Ç–∞¬ª (15,65%), –ê—Ä–±–∏–¥–æ–ª –æ—Ç ¬´–û—Ç–∏—Å–∏—Ñ–∞—Ä–º¬ª (10,31%) –∏ –ö–∞–≥–æ—Ü–µ–ª –æ—Ç ¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º¬ª (9,71%). –ù–∞–∏–±–æ–ª—å—à—É—é –¥–∏–Ω–∞–º–∏–∫—É –∑–∞ –≥–æ–¥ –ø–æ–∫–∞–∑–∞–ª–∏ –¢–∏–ª–æ—Ä–æ–Ω (+79%), –ö–∞–≥–æ—Ü–µ–ª (+63%) –∏ –¢–∞–º–∏—Ñ–ª—é (+51%). –û—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω–∞—è –¥–∏–Ω–∞–º–∏–∫–∞ —Ç–æ–ª—å–∫–æ —É –ê—Ä–±–∏–¥–æ–ª–∞ (-5%), —á—Ç–æ –Ω–µ –ø–æ–º–µ—à–∞–ª–æ –∑–∞–Ω—è—Ç—å 2 –º–µ—Å—Ç–æ —Å —Ä–µ–π—Ç–∏–Ω–≥–µ. –í —Ü–µ–ª–æ–º –∑–∞ –≥–æ–¥ —Å–µ–≥–º–µ–Ω—Ç –ø–æ–∫–∞–∑–∞–ª —É–≤–µ—Ä–µ–Ω–Ω—ã–π —Ä–æ—Å—Ç: +21 % –≤ –¥–µ–Ω—å–≥–∞—Ö –∏ +11 % –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö. –ì—Ä—É–ø–ø–∞ –ø—Ä–æ—Ç–∏–≤–æ–≤–∏—Ä—É—Å–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∑–∞–Ω–∏–º–∞–µ—Ç –≤—Ç–æ—Ä–æ–µ –º–µ—Å—Ç–æ –ø–æ –æ–±—ä–µ–º—É –ø—Ä–æ–¥–∞–∂ –≤ –¥–µ–Ω–µ–∂–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-06-27T11:38:06+00:00,@bezrec,6245,https://t.me/bezrec/6245,"–ñ–∏–∑–Ω–µ–Ω–Ω–æ –≤–∞–∂–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –æ—Ç –≥–µ–º–æ—Ñ–∏–ª–∏–∏ –Ω–µ–¥–æ—Å—Ç—É–ø–Ω—ã –° –Ω–∞—á–∞–ª–∞ 2025 –≥–æ–¥–∞ –≤ –ú–æ—Å–∫–æ–≤—Å–∫–æ–π, –¢–≤–µ—Ä—Å–∫–æ–π, –°–∞—Ä–∞—Ç–æ–≤—Å–∫–æ–π, –û—Ä–ª–æ–≤—Å–∫–æ–π, –°–º–æ–ª–µ–Ω—Å–∫–æ–π –æ–±–ª–∞—Å—Ç—è—Ö, –≤ –¢–∞—Ç–∞—Ä—Å—Ç–∞–Ω–µ, –ë–∞—à–∫–∏—Ä–∏–∏, –ü–µ—Ä–º—Å–∫–æ–º –∏ –ö—Ä–∞—Å–Ω–æ—è—Ä—Å–∫–æ–º –∫—Ä–∞—è—Ö –≤–æ–∑–Ω–∏–∫–ª–∏ –ø–µ—Ä–µ–±–æ–∏ —Å –≤—ã–¥–∞—á–µ–π –∂–∏–∑–Ω–µ–Ω–Ω–æ –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –≥–µ–º–æ—Ñ–∏–ª–∏–µ–π. –õ–µ–∫–∞—Ä—Å—Ç–≤–∞ –≤—Ö–æ–¥—è—Ç –≤ –≥–æ—Å–ø—Ä–æ–≥—Ä–∞–º–º—É ¬´14 –≤—ã—Å–æ–∫–æ–∑–∞—Ç—Ä–∞—Ç–Ω—ã—Ö –Ω–æ–∑–æ–ª–æ–≥–∏–π¬ª, –∑–∞–∫—É–ø–∞—é—Ç—Å—è –∑–∞ —Å—á–µ—Ç —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –±—é–¥–∂–µ—Ç–∞ –∏ –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã –¥–ª—è —ç–∫—Å—Ç—Ä–µ–Ω–Ω–æ–π –æ—Å—Ç–∞–Ω–æ–≤–∫–∏ –∫—Ä–æ–≤–æ—Ç–µ—á–µ–Ω–∏–π. –õ—é–±–æ–µ –ø—Ä–æ–º–µ–¥–ª–µ–Ω–∏–µ –º–æ–∂–µ—Ç –ø—Ä–∏–≤–µ—Å—Ç–∏ –∫ –∏–Ω–≤–∞–ª–∏–¥–Ω–æ—Å—Ç–∏ –∏–ª–∏ –≥–∏–±–µ–ª–∏. –û—Å–æ–±–µ–Ω–Ω–æ –æ—Å—Ç—Ä–æ –ø—Ä–æ–±–ª–µ–º–∞ —Å—Ç–æ–∏—Ç –¥–ª—è –¥–µ—Ç–µ–π –∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –æ–∂–∏–¥–∞—é—â–∏—Ö –æ–ø–µ—Ä–∞—Ü–∏–∏. –ù–∞ —Ä—ã–Ω–∫–µ —Ñ–∞–∫—Ç–∏—á–µ—Å–∫–∏ –∏—Å—á–µ–∑–ª–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã —Å —Ñ–∞–∫—Ç–æ—Ä–∞–º–∏ —Å–≤–µ—Ä—Ç—ã–≤–∞–Ω–∏—è –∫—Ä–æ–≤–∏ VIII –∏ IX. –í –ú–∏–Ω–∑–¥—Ä–∞–≤–µ –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª–∏, —á—Ç–æ —á–∞—Å—Ç—å –∞—É–∫—Ü–∏–æ–Ω–æ–≤ –Ω–µ —Å–æ—Å—Ç–æ—è–ª–∞—Å—å –∏–∑-–∑–∞ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏—è –∑–∞—è–≤–æ–∫. –ü–æ—Å—Ç–∞–≤—â–∏–∫–∏ –Ω–µ –≤—ã—Ö–æ–¥—è—Ç –Ω–∞ —Ç–æ—Ä–≥–∏, —Å—á–∏—Ç–∞—è –Ω–∞—á–∞–ª—å–Ω—ã–µ —Ü–µ–Ω—ã —Å–ª–∏—à–∫–æ–º –Ω–∏–∑–∫–∏–º–∏. –ü–æ–∫–∞ –∏–¥–µ—Ç –ø—Ä–æ—Ü–µ—Å—Å –ø–µ—Ä–µ—Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ —Ü–µ–Ω, –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç–∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –æ—Å—Ç–∞—é—Ç—Å—è –Ω–µ –∑–∞–∫—Ä—ã—Ç—ã. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""There are shortages of life-saving hemophilia medications in several regions including Moscow, Tver, Saratov, Orenburg, Smolensk Oblasts, Tatarstan, Bashkortostan, Perm Krai and Krasnoyarsk Krai. The medications are part of the '14 high-cost diseases' program and are procured by the federal budget. Any delay could lead to disability or death, especially for children and patients awaiting operations. The Ministry of Health confirmed that some auctions failed due to a lack of bids. Suppliers are not participating in the auctions, citing initial prices as too low. The process of re-registering prices is ongoing but patient needs remain unmet.""
}"
2025-06-27T09:37:06+00:00,@bezrec,6244,https://t.me/bezrec/6244,"–°–æ–≥–ª–∞—Å–Ω–æ –æ–ø—Ä–æ—Å—É —Å–µ—Ä–≤–∏—Å–æ–≤ ¬´–ê–∫—Ç–∏–æ–Ω –ú–µ–¥–∏—Ü–∏–Ω–∞¬ª –∏ ¬´–í—Ä–∞—á–∏.—Ä—Ñ¬ª, —á–µ—Ç–≤–µ—Ä—Ç—å —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –º–µ–¥–∏–∫–æ–≤ —Ä–µ–≥—É–ª—è—Ä–Ω–æ –ø—Ä–æ–ø–∏—Å—ã–≤–∞—é—Ç –≥–æ–º–µ–æ–ø–∞—Ç–∏—é, –∞ 40% —Å—á–∏—Ç–∞—é—Ç, —á—Ç–æ —ç—Ç–∏ —Å—Ä–µ–¥—Å—Ç–≤–∞ –ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω–æ –≤–ª–∏—è—é—Ç –Ω–∞ –∏—Å—Ö–æ–¥ –ª–µ—á–µ–Ω–∏—è. –ö–æ–º–∏—Å—Å–∏—è –†–ê–ù –ø–æ –ª–∂–µ–Ω–∞—É–∫–µ –ø—Ä–∏–∑–≤–∞–ª–∞ –ú–∏–Ω–∑–¥—Ä–∞–≤ –∏—Å–∫–ª—é—á–∏—Ç—å –≥–æ–º–µ–æ–ø–∞—Ç–∏—á–µ—Å–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –∏–∑ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π, –ø–æ—Å–∫–æ–ª—å–∫—É –Ω–∞—É—á–Ω—ã—Ö –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å—Å—Ç–≤ –∏—Ö —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –Ω–µ—Ç. –û–¥–Ω–∞–∫–æ –ø–æ—á—Ç–∏ –ø–æ–ª–æ–≤–∏–Ω–∞ –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö –≤—Ä–∞—á–µ–π –≤—ã—Å—Ç—É–ø–∞—é—Ç –∑–∞ —Å–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ –≥–æ–º–µ–æ–ø–∞—Ç–∏–∏ –≤ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏—è—Ö, –æ–±—ä—è—Å–Ω—è—è —ç—Ç–æ, –≤ —Ç–æ–º —á–∏—Å–ª–µ, –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–µ–º —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø—Ä–∏ –Ω–µ–∫–æ—Ç–æ—Ä—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è—Ö –∏ –∂–µ–ª–∞–Ω–∏–µ–º –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –ø–æ–ª—É—á–∏—Ç—å –ª–µ—á–µ–Ω–∏–µ, –ø—É—Å—Ç—å –∏ –≤ –≤–∏–¥–µ –ø–ª–∞—Ü–µ–±–æ. –≠–∫—Å–ø–µ—Ä—Ç—ã –æ—Ç–º–µ—á–∞—é—Ç, —á—Ç–æ –≥–æ–º–µ–æ–ø–∞—Ç–∏—è –º–æ–∂–µ—Ç –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å—Å—è –∫–∞–∫ –ø–ª–∞—Ü–µ–±–æ, –µ—Å–ª–∏ –Ω–µ—Ç —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤, –Ω–æ –µ—ë —Ü–µ–Ω–∞ –∏ –∑–∞–º–µ–Ω–∞ –Ω–∞—Å—Ç–æ—è—â–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Å–æ–∑–¥–∞—é—Ç —Ä–∏—Å–∫–∏ –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –í–æ–ø—Ä–æ—Å –æ —Ä–æ–ª–∏ –≥–æ–º–µ–æ–ø–∞—Ç–∏–∏ –≤ —Å–æ–≤—Ä–µ–º–µ–Ω–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω–µ –≤—Å–µ –µ—â–µ –æ—Å—Ç–∞—ë—Ç—Å—è –æ—Ç–∫—Ä—ã—Ç—ã–º. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance, safety"",
  ""impact"": ""high"",
  ""english"": ""Experts note that homeopathy can be used as placebo if there are no effective medications, but its cost and substitution of actual medicines create risks for patients. The role of homeopathy in modern medicine remains open.""
}"
2025-06-27T07:16:30+00:00,@bezrec,6241,https://t.me/bezrec/6241,"–ü—Ä–æ–¥–æ–ª–∂–∞–µ–º —Ä–∞—Å—Å–º–∞—Ç—Ä–∏–≤–∞—Ç—å –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –∞–ø—Ç–µ—á–Ω–æ–≥–æ —Ä—ã–Ω–∫–∞ DSM Group –∑–∞ –º–∞–π 2025 –≥–æ–¥–∞. –¢–µ–ø–µ—Ä—å —É–∑–Ω–∞–µ–º –ø—Ä–æ –ë–ê–î—ã. –í –º–∞–µ –≤ –∞–ø—Ç–µ–∫–∞—Ö –†–æ—Å—Å–∏–∏ –±—ã–ª–æ —Ä–µ–∞–ª–∏–∑–æ–≤–∞–Ω–æ –±–æ–ª–µ–µ 3 —Ç—ã—Å—è—á –±—Ä–µ–Ω–¥–æ–≤ –ë–ê–î –æ—Ç 1,1 —Ç—ã—Å—è—á–∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π. –ó–∞ –ø–µ—Ä–≤—ã–µ –ø—è—Ç—å –º–µ—Å—è—Ü–µ–≤ —Ä—ã–Ω–æ–∫ –≤—ã—Ä–æ—Å –≤ –¥–µ–Ω—å–≥–∞—Ö –Ω–∞ 26,1%, –¥–æ—Å—Ç–∏–≥–Ω—É–≤ 72,6 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, –∞ –æ–±—ä—ë–º –ø—Ä–æ–¥–∞–∂ –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö —Å–Ω–∏–∑–∏–ª—Å—è –Ω–∞ 1,1%. –õ–∏–¥–µ—Ä–∞–º–∏ –ø–æ —Å—Ç–æ–∏–º–æ—Å—Ç–Ω—ã–º –ø—Ä–æ–¥–∞–∂–∞–º –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π —Å—Ç–∞–ª–∏: ‚≠êÔ∏è¬´–≠–≤–∞–ª–∞—Ä¬ª —Å –¥–æ–ª–µ–π 15,2% –∏ —Ä–æ—Å—Ç–æ–º –ø—Ä–æ–¥–∞–∂ –Ω–∞ 24,6% –∑–∞–Ω—è–ª –ø–µ—Ä–≤–æ–µ –º–µ—Å—Ç–æ. –í –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç–µ –±–æ–ª–µ–µ 370 –Ω–∞–∏–º–µ–Ω–æ–≤–∞–Ω–∏–π, –æ—Å–æ–±–µ–Ω–Ω–æ –≤—ã—Ä–æ—Å —Å–ø—Ä–æ—Å –Ω–∞ ¬´–≠–≤–∞–ª–∞—Ä –¢—Ä–∞–Ω–∑–∏—Ç –õ–∏–º—Ñ–æ—Ç—Ä–∞–Ω–∑–∏—Ç¬ª (+132,6%) –∏ ¬´–≠–≤–∞–ª–∞—Ä –ú–∞–≥–Ω–∏–π –•–µ–ª–∞—Ç Anti-Age¬ª (+37,8%). ‚≠êÔ∏è¬´–ö–≤–∞–¥—Ä–∞—Ç-–°¬ª –ø–æ–∫–∞–∑–∞–ª –º–∞–∫—Å–∏–º–∞–ª—å–Ω—ã–π –ø—Ä–∏—Ä–æ—Å—Ç –Ω–∞ 74,5%. –ö–ª—é—á–µ–≤—ã–µ –ª–∏–Ω–µ–π–∫–∏ ‚Äì ¬´–í–∏—Ç–∞–º–∏—Ä¬ª –∏ Tetralab. ‚≠êÔ∏èSolgar –≤—ã—Ä–æ—Å –Ω–∞ 36,8%. –û—Å–æ–±–µ–Ω–Ω–æ –ø–æ–ø—É–ª—è—Ä–Ω—ã ¬´–¶–∏—Ç—Ä–∞—Ç –º–∞–≥–Ω–∏—è¬ª –∏ ¬´–î–∂–µ–Ω—Ç–ª –ê–π—Ä–æ–Ω¬ª. –ï—â–µ —Å—Ä–µ–¥–∏ –ª–∏–¥–µ—Ä–æ–≤ –ø—Ä–∏—Ä–æ—Å—Ç–∞ ¬´–ù–∏–∂—Ñ–∞—Ä–º¬ª (+62,2%) –∏ ¬´–≠—Ä—Ü–∏–≥¬ª (+48,4%). –†—ã–Ω–æ–∫ —Å–º–µ—â–∞–µ—Ç—Å—è –≤ —Å—Ç–æ—Ä–æ–Ω—É –ø—Ä–µ–º–∏–∞–ª—å–Ω—ã—Ö –¥–æ–±–∞–≤–æ–∫ ‚Äì –∏—Ö –¥–æ–ª—è —É–≤–µ–ª–∏—á–∏–ª–∞—Å—å –¥–æ 42,7%, –ø—Ä–∏ —ç—Ç–æ–º —Å—Ä–µ–¥–Ω—è—è —Å—Ç–æ–∏–º–æ—Å—Ç—å —É–ø–∞–∫–æ–≤–∫–∏ –∏–∑ —ç—Ç–æ–≥–æ —Å–µ–≥–º–µ–Ω—Ç–∞ –¥–æ—Å—Ç–∏–≥–ª–∞ 1 730 —Ä—É–±–ª–µ–π. –û—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–µ –ë–ê–î —Å–æ—Ö—Ä–∞–Ω—è—é—Ç –ª–∏–¥–∏—Ä—É—é—â–∏–µ –ø–æ–∑–∏—Ü–∏–∏ —Å –¥–æ–ª–µ–π 86% –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö –∏ 68% –≤ –¥–µ–Ω—å–≥–∞—Ö. –ü—Ä–æ–¥–∞–∂–∏ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –¥–æ–±–∞–≤–æ–∫ –≤—ã—Ä–æ—Å–ª–∏ –Ω–∞ 31%, –∞ –∏–º–ø–æ—Ä—Ç–Ω—ã—Ö ‚Äì –≤ —Ä—É–±–ª—è—Ö –≤—ã—Ä–æ—Å–ª–∏, –Ω–æ –≤ –æ–±—ä—ë–º–µ —Å–Ω–∏–∑–∏–ª–∏—Å—å. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The market for dietary supplements in Russia has grown significantly by 26.1% to reach RUB726 billion, with a slight decrease in unit sales volume. Key players include Valerian (15.2% market share and +24.6%), Quadras-S (+74.5%), Solgar (+36.8%), and Nizorfarm (+62.2%). The premium segment has gained more market share, with the average price of a unit in this segment reaching RUB1730. Domestic supplements have maintained their leadership with an 86% share in units and a 68% share in value terms, while imports have shown growth in RUB but decline in volume.""
}"
2025-06-26T15:08:53+00:00,@bezrec,6239,https://t.me/bezrec/6239,"–†–∞—Å—Å–º–æ—Ç—Ä–µ–ª–∏ —Ä—ã–Ω–æ–∫ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ø–æ —Å–≤–µ–∂–µ–º—É –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—é DSM Group –∑–∞ –º–∞–π 2025 –≥. –¢–æ–ø-3 –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ø–æ –æ–±—ä—ë–º—É –ø—Ä–æ–¥–∞–∂ –≤ —Å—Ä–∞–≤–Ω–µ–Ω–∏–∏ —Å –∞–ø—Ä–µ–ª–µ–º 2025 –≥. –Ω–µ –∏–∑–º–µ–Ω–∏–ª–∏—Å—å: ‚≠êÔ∏èBayer –∑–∞–Ω–∏–º–∞–µ—Ç 3,7% —Ä—ã–Ω–∫–∞. –õ–∏–¥–µ—Ä—ã —Ä–æ—Å—Ç–∞ —Å—Ä–µ–¥–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤: –†–µ–Ω–Ω–∏ (+18%), –Ø—Ä–∏–Ω–∞ (+10,2%) –∏ –ö–ª–∞–π—Ä–∞ (+7,1%). ‚≠êÔ∏èServier ‚Äì 3,4%, —Ä–æ—Å—Ç –Ω–∞ 18,8% –∫ –º–∞—é 2024. –°—Ä–µ–¥–∏ —É—Å–ø–µ—à–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ ‚Äì –í–µ–ª–∞–∫—Å–∏–Ω (+4,7%), –î–∏–∞–±–µ—Ç–æ–Ω (+4,6%) –∏ –¢—Ä–∏–ø–ª–∏–∫—Å–∞–º (+4,3%). ‚≠êÔ∏è–ù–∏–∂—Ñ–∞—Ä–º –ø–æ-–ø—Ä–µ–∂–Ω–µ–º—É 3,4% —Ä—ã–Ω–∫–∞. –û—Å–æ–±–µ–Ω–Ω–æ –≤—ã–¥–µ–ª—è–µ—Ç—Å—è –ê—Ä—Ç—Ä–∞ —Å —Ä–µ–∫–æ—Ä–¥–Ω—ã–º –ø—Ä–∏—Ä–æ—Å—Ç–æ–º +229,1%. –ù–∞–∏–±–æ–ª—å—à–∏–π –≥–æ–¥–æ–≤–æ–π –ø—Ä–∏—Ä–æ—Å—Ç —Å—Ä–µ–¥–∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ø–æ–∫–∞–∑–∞–ª–∏ –û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞ (+43,5%), Novartis (+24,1%) –∏ Abbott (+20,9%). –ü—Ä–∏ —ç—Ç–æ–º ¬´–û–∑–æ–Ω¬ª –≤–ø–µ—Ä–≤—ã–µ –≤–æ—à—ë–ª –≤ —Ç–æ–ø-10, –ø–æ–¥–Ω—è–≤—à–∏—Å—å —Å—Ä–∞–∑—É –Ω–∞ 5 –ø–æ–∑–∏—Ü–∏–π. –í —Ç–æ–ø-20 –±—Ä–µ–Ω–¥–æ–≤ –≤–æ—à–ª–∏ —á–µ—Ç—ã—Ä–µ –Ω–æ–≤—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞, —Å—Ä–µ–¥–∏ –∫–æ—Ç–æ—Ä—ã—Ö –≤—ã–¥–µ–ª—è—é—Ç—Å—è –î–∏–∫–ª–æ—Ñ–µ–Ω–∞–∫ (+11,1%) –∏ –û–º–µ–ø—Ä–∞–∑–æ–ª (+9,4%), –ø–æ–∫–∞–∑–∞–≤—à–∏–µ –±—ã—Å—Ç—Ä—ã–π —Ä–æ—Å—Ç —Å–ø—Ä–æ—Å–∞. –õ–∏–¥–µ—Ä–æ–º –ø–æ –ø—Ä–æ–¥–∞–∂–∞–º —Å—Ç–∞–ª –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –°–µ–º–∞–≤–∏–∫ —Å —Ä–æ—Å—Ç–æ–º +3,5%. –û–±—â–∞—è –¥–æ–ª—è —Ç–æ–ø-10 –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π —Å–æ—Å—Ç–∞–≤–ª—è–µ—Ç 29,9% –æ—Ç –∞–ø—Ç–µ—á–Ω–æ–≥–æ —Ä—ã–Ω–∫–∞ –≤ —Å—Ç–æ–∏–º–æ—Å—Ç–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏. –ë–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ –∫–æ–º–ø–∞–Ω–∏–π –ø—Ä–æ–¥–µ–º–æ–Ω—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª–∏ —É—Å—Ç–æ–π—á–∏–≤—ã–π —Ä–æ—Å—Ç –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –º–∞–µ–º –ø—Ä–æ—à–ª–æ–≥–æ –≥–æ–¥–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The top three producers by volume sales have not changed compared to April 2025: Bayer with 3.7% market share, leading growth among drugs: Renyi (+18%), Yarina (+10.2%) and Klayra (+7.1%). Servier ‚Äì 3.4%, growth of +18.8% compared to May 2024. Successful drugs: Velaxin (+4.7%), Diabeton (+4.6%) and Triplicam (+4.3%). Nifarim remains at 3.4% market share, with Artra showing a record growth of +229.1%. Leading companies in terms of sales: Ozone Pharma (+43.5%), Novartis (+24.1%) and Abbott (+20.9%). Ozone Pharma has entered the top 10 for the first time, rising by five positions. Four new drugs have made it into the top 20: Diclofenac (+11.1%) and O"
2025-06-26T12:50:44+00:00,@bezrec,6238,https://t.me/bezrec/6238,"–û—Ç–∫—Ä—ã—Ç—å –∞–ø—Ç–µ–∫—É —Å—Ç–∞–Ω–µ—Ç –ø—Ä–æ—â–µ –° 2025 –≥–æ–¥–∞ –ª–∏—Ü–µ–Ω–∑–∏–∏ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–∞ –∏ —Ä–∞–∑—Ä–µ—à–µ–Ω–∏—è –†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä–∞ –º–æ–∂–Ω–æ –ø–æ–ª—É—á–∏—Ç—å –µ–¥–∏–Ω—ã–º –ø–∞–∫–µ—Ç–æ–º —á–µ—Ä–µ–∑ –∫–æ–º–ø–ª–µ–∫—Å–Ω–æ–µ –∑–∞—è–≤–ª–µ–Ω–∏–µ –Ω–∞ –ø–æ—Ä—Ç–∞–ª–µ ¬´–ì–æ—Å—É—Å–ª—É–≥–∏¬ª. –ó–∞–ø—É—Å–∫ –∞–ø—Ç–µ–∫–∏ —Ç—Ä–µ–±—É–µ—Ç –Ω–µ—Å–∫–æ–ª—å–∫–∏—Ö —Å–æ–≥–ª–∞—Å–æ–≤–∞–Ω–∏–π. –†–∞–Ω—å—à–µ –ø—Ä–µ–¥–ø—Ä–∏–Ω–∏–º–∞—Ç–µ–ª—é –ø—Ä–∏—Ö–æ–¥–∏–ª–æ—Å—å —Å–æ–±–∏—Ä–∞—Ç—å —Ä–∞–∑–Ω—ã–µ –¥–æ–∫—É–º–µ–Ω—Ç—ã, –Ω–∞–ø—Ä–∞–≤–ª—è—Ç—å –∏—Ö –≤ –æ—Ç–¥–µ–ª—å–Ω—ã–µ –≤–µ–¥–æ–º—Å—Ç–≤–∞ –∏ –æ—Ç—Å–ª–µ–∂–∏–≤–∞—Ç—å —Å—Ç–∞—Ç—É—Å –ø–æ –∫–∞–∂–¥–æ–º—É –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—é. –¢–µ–ø–µ—Ä—å ‚Äì –æ–¥–Ω–æ –∑–∞—è–≤–ª–µ–Ω–∏–µ, –∞–≤—Ç–æ–º–∞—Ç–∏—á–µ—Å–∫–æ–µ —Ä–∞—Å–ø—Ä–µ–¥–µ–ª–µ–Ω–∏–µ –ø–æ –∏–Ω—Å—Ç–∞–Ω—Ü–∏—è–º –∏ —Å–æ–∫—Ä–∞—â—ë–Ω–Ω—ã–µ —Å—Ä–æ–∫–∏ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏—è. –ú–µ—Ö–∞–Ω–∏–∑–º ¬´–æ–¥–Ω–æ–≥–æ –æ–∫–Ω–∞¬ª —Å–µ–π—á–∞—Å –ø—Ä–æ—Ö–æ–¥–∏—Ç –ø–∏–ª–æ—Ç –¥–ª—è –∞–ø—Ç–µ–∫, –Ω–æ –≤ 2025 –≥–æ–¥—É –µ–≥–æ –º–∞—Å—à—Ç–∞–±–∏—Ä—É—é—Ç –º–∏–Ω–∏–º—É–º –Ω–∞ 50 –≤–∏–¥–æ–≤ –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏. –ê –∑–Ω–∞—á–∏—Ç, —Ä–µ–≥—É–ª—è—Ç–æ—Ä–Ω—ã–µ –±–∞—Ä—å–µ—Ä—ã –¥–ª—è –Ω–æ–≤—ã—Ö —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –ø—Ä–æ–µ–∫—Ç–æ–≤ –±—É–¥—É—Ç —Å–Ω–∏–∂–∞—Ç—å—Å—è. –ë–æ–ª–µ–µ –ø–æ–¥—Ä–æ–±–Ω–æ –ø—Ä–æ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—é –Ω–∞–ø–∏—Å–∞–ª–∏ –∫–æ–ª–ª–µ–≥–∏ –∏–∑ ¬´–î–µ–ª–æ –≤ —Ü–∏—Ñ—Ä–∞—Ö¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The regulatory and licensing process for pharmacies will be simplified starting in 2025. A single comprehensive application on the 'Government Services' portal can now be used to obtain both Roszdravnadzor and Roskonsul'tatsii licenses. Previously, entrepreneurs had to gather various documents and submit them to different authorities for separate approvals. Now, one application is sufficient with automatic distribution among the institutions and shorter review periods. The 'one window' system pilot for pharmacies is currently underway, but it will be expanded to at least 50 activities by 2025. This will reduce regulatory barriers for new pharmaceutical projects.""
}"
2025-06-26T11:03:38+00:00,@bezrec,6237,https://t.me/bezrec/6237,"–î–∞–≤–Ω–æ –Ω–µ –ø—É–±–ª–∏–∫–æ–≤–∞–ª–∏ –≤–∞–∫–∞–Ω—Å–∏–∏ –≤ #—Ñ–∞—Ä–º–Ω–∞–π–º. –°–µ–≥–æ–¥–Ω—è –ø—Ä–µ–¥–ª–∞–≥–∞–µ–º –ø–æ—Å–º–æ—Ç—Ä–µ—Ç—å –≤–∞—Ä–∏–∞–Ω—Ç—ã, —Å–≤—è–∑–∞–Ω–Ω—ã–µ —Å –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ–º —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏. üíä–í RENEWAL —Ç—Ä–µ–±—É–µ—Ç—Å—è –Ω–∞—á–∞–ª—å–Ω–∏–∫ —Ü–µ—Ö–∞ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ —Å –æ–ø—ã—Ç–æ–º –æ—Ç 1 –≥–æ–¥–∞ –∏ —É–ø—Ä–∞–≤–ª–µ–Ω–∏–µ–º –∫–æ–ª–ª–µ–∫—Ç–∏–≤–æ–º –¥–æ 120. –î–∞–¥—É—Ç —Å–ª—É–∂–µ–±–Ω–æ–µ –∂–∏–ª—å—ë –∏ –î–ú–°. üíä–í –ì–∞–ª–µ–Ω–æ–§–∞—Ä–º –Ω—É–∂–µ–Ω –Ω–∞—á–∞–ª—å–Ω–∏–∫ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –æ—Ç–¥–µ–ª–∞ —Å 5+ –≥–æ–¥–∞–º–∏ –æ–ø—ã—Ç–∞ –≤ —Ñ–∞—Ä–º–ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏ –∏ –ø—Ä–æ—Ñ–∏–ª—å–Ω—ã–º –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ–º. –û–±–µ—â–∞—é—Ç –¥–æ—Å—Ç–æ–π–Ω—É—é –∑–∞—Ä–ø–ª–∞—Ç—É, –±–µ–ª–æ–µ –æ—Ñ–æ—Ä–º–ª–µ–Ω–∏–µ –∏ –∫–æ–ª–ª–µ–∫—Ç–∏–≤–Ω—ã–π –æ—Ç–ø—É—Å–∫ –ª–µ—Ç–æ–º. üíä–†–∞–ø–∏–¥ –ë–∏–æ –∏—â–µ—Ç –Ω–∞—É—á–Ω–æ–≥–æ —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–∞ –ø–æ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ –ò–•–ê —Ç–µ—Å—Ç-—Å–∏—Å—Ç–µ–º —Å –æ–ø—ã—Ç–æ–º –≤ –ò–•–ê, –∫–æ–∞–≥—É–ª–æ–º–µ—Ç—Ä–∏–∏ –∏ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å–ø—ã—Ç–∞–Ω–∏—è—Ö, –∞ —Ç–∞–∫–∂–µ –≤–µ–¥—É—â–µ–≥–æ –±–∏–æ–∏–Ω—Ñ–æ—Ä–º–∞—Ç–∏–∫–∞ —Å –æ–ø—ã—Ç–æ–º —Ä–∞–±–æ—Ç—ã —Å NGS-–¥–∞–Ω–Ω—ã–º–∏ –∏ –ø–∞–π–ø–ª–∞–π–Ω–∞–º–∏ (Python, Nextflow). üíä–≠–ù–î–û–§–ê–†–ú –Ω—É–∂–¥–∞–µ—Ç—Å—è –≤ –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª–µ –Ω–∞—á–∞–ª—å–Ω–∏–∫–∞ –æ—Ç–¥–µ–ª–∞ —Ä–∞–∑—Ä–∞–±–æ—Ç–æ–∫ –∞–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–∏—Ö –º–µ—Ç–æ–¥–∏–∫ —Å –æ–ø—ã—Ç–æ–º 5+ –ª–µ—Ç –∏ –≤–ª–∞–¥–µ–Ω–∏–µ–º –í–≠–ñ–•, –ì–•, —Ç–∏—Ç—Ä–∏–º–µ—Ç—Ä–∏–µ–π. üíä–í SOLOPHARM —Ç—Ä–µ–±—É–µ—Ç—Å—è —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å –æ–ø—ã—Ç–Ω–æ-–ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ–≥–æ —É—á–∞—Å—Ç–∫–∞ –ø–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤—É –ú–ö–ê. –ë—É–¥–µ—Ç —Ç—Ä–∞–Ω—Å—Ñ–µ—Ä –æ—Ç –º–µ—Ç—Ä–æ, –î–ú–°, —Ç—Ä–µ–Ω–∏–Ω–≥–∏, —É–¥–æ–±–Ω—ã–π –≥—Ä–∞—Ñ–∏–∫ —Å 10:00 –∏ —É—á–∞—Å—Ç–∏–µ –≤ –º–∞—Å—à—Ç–∞–±–∏—Ä–æ–≤–∞–Ω–∏–∏ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π. üíä–ì–ï–†–û–§–ê–†–ú –≤ –ø–æ–∏—Å–∫–∞—Ö —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞ –ø–æ –≤—ã—á–∏—Å–ª–∏—Ç–µ–ª—å–Ω–æ–π —Ö–∏–º–∏–∏. –¢—Ä–µ–±–æ–≤–∞–Ω–∏—è: RDKit, KNIME, SAR –∏ –ø–æ–¥–≥–æ—Ç–æ–≤–∫–∞ —Ö–∏–º–±–∏–±–ª–∏–æ—Ç–µ–∫. üíä–ê—Å—Ç—Ä–∞–ó–µ–Ω–µ–∫–µ –Ω—É–∂–µ–Ω —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç –ø–æ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–º –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è–º –æ–ø—ã—Ç–æ–º 5+ –ª–µ—Ç, –∑–Ω–∞–Ω–∏–µ–º GCP –∏ –≥–æ—Ç–æ–≤–Ω–æ—Å—Ç—å—é –∫ –∫–æ–º–∞–Ω–¥–∏—Ä–æ–≤–∫–∞–º. –ñ–¥—É—Ç –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã–µ –ø—Ä–æ–µ–∫—Ç—ã, –î–ú–° —Å –ø–µ—Ä–≤–æ–≥–æ –¥–Ω—è –∏ —É—á–∞—Å—Ç–∏–µ –≤ well-being –ø—Ä–æ–≥—Ä–∞–º–º–∞—Ö. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": true
}"
2025-06-26T08:32:23+00:00,@bezrec,6236,https://t.me/bezrec/6236,"–†—ã–Ω–æ–∫ —Ä–µ–∞–≥–µ–Ω—Ç–æ–≤ –∏ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è —É—Å–∏–ª–∏–≤–∞–µ—Ç –ø–æ–∑–∏—Ü–∏–∏ –ü–æ –¥–∞–Ω–Ω—ã–º Kept, –æ–±—ä–µ–º —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —Ä—ã–Ω–∫–∞ —Ä–µ–∞–≥–µ–Ω—Ç–æ–≤ –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—ã –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∏ –∫ 2030 –≥–æ–¥—É –¥–æ—Å—Ç–∏–≥–Ω–µ—Ç 470‚Äì530 –º–ª—Ä–¥ —Ä—É–±. –°—Ä–µ–¥–Ω–µ–≥–æ–¥–æ–≤–æ–π –ø—Ä–∏—Ä–æ—Å—Ç —Å–æ—Å—Ç–∞–≤–∏—Ç –¥–æ 10,8%, –ø—Ä–∏ —ç—Ç–æ–º –æ—Å–Ω–æ–≤–Ω—É—é –¥–æ–ª—é —Å–ø—Ä–æ—Å–∞ (64%) —Ñ–æ—Ä–º–∏—Ä—É—é—Ç —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏. –¢–∞–∫–æ–π —Ä–æ—Å—Ç –æ–±—ä—è—Å–Ω—è–µ—Ç—Å—è —Å—Ä–∞–∑—É –Ω–µ—Å–∫–æ–ª—å–∫–∏–º–∏ —Ñ–∞–∫—Ç–æ—Ä–∞–º–∏: üîò—Å—Ç–∞—Ä–µ–Ω–∏–µ–º –Ω–∞—Å–µ–ª–µ–Ω–∏—è, üîò—Ä–æ—Å—Ç–æ–º —á–∞—Å—Ç–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω—ã, üîò–ø–æ–≤—ã—à–µ–Ω–Ω—ã–º –≤–Ω–∏–º–∞–Ω–∏–µ–º –∫ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–µ —Å–æ —Å—Ç–æ—Ä–æ–Ω—ã –º–æ–ª–æ–¥–µ–∂–∏. –û–¥–Ω–æ–≤—Ä–µ–º–µ–Ω–Ω–æ —Ä–∞–∑–≤–∏–≤–∞–µ—Ç—Å—è –∏ —Å–µ–≥–º–µ–Ω—Ç –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–Ω–æ–≥–æ –∞–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–æ–≥–æ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è ‚Äì —Å 154 –º–ª—Ä–¥ —Ä—É–±. –≤ 2024 –≥–æ–¥—É –æ–Ω –º–æ–∂–µ—Ç –≤—ã—Ä–∞—Å—Ç–∏ –¥–æ 256 –º–ª—Ä–¥ –∫ 2030-–º—É. –ü—Ä–∏ —ç—Ç–æ–º 56% —Å–ø—Ä–æ—Å–∞ –∑–¥–µ—Å—å —Ñ–æ—Ä–º–∏—Ä—É–µ—Ç—Å—è –∑–∞ —Å—á–µ—Ç –≥–æ—Å—Å–µ–∫—Ç–æ—Ä–∞, –≤–∫–ª—é—á–∞—è —É—á—Ä–µ–∂–¥–µ–Ω–∏—è –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∏ –Ω–∞—É—á–Ω—ã–µ —Ü–µ–Ω—Ç—Ä—ã. –£—Å—Ç–æ–π—á–∏–≤—ã–π —Ä–æ—Å—Ç –æ–±–æ–∏—Ö –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏–π –æ–±–µ—Å–ø–µ—á–∏–≤–∞–µ—Ç –ø–æ–≤—ã—à–µ–Ω–Ω–∞—è –Ω–∞–≥—Ä—É–∑–∫–∞ –Ω–∞ —Å–∏—Å—Ç–µ–º—É –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è, —Ä–∞–∑–≤–∏—Ç–∏–µ –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –∫–ª–∞—Å—Ç–µ—Ä–æ–≤ –∏ —Å–∏—Å—Ç–µ–º–Ω–∞—è –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏—è —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –≤ –†–æ—Å—Å–∏–∏. –£—Å—Ç–æ–π—á–∏–≤—ã–π —Å–ø—Ä–æ—Å, —Ä–∞–∑–≤–∏—Ç–∏–µ –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –∫–ª–∞—Å—Ç–µ—Ä–æ–≤ –∏ –∞–∫—Ü–µ–Ω—Ç –Ω–∞ –Ω–µ–∑–∞–≤–∏—Å–∏–º–æ—Å—Ç—å –¥–µ–ª–∞—é—Ç —Ñ–∞—Ä–º—Å–µ–∫—Ç–æ—Ä —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏ –≤–∞–∂–Ω—ã–º —ç–ª–µ–º–µ–Ω—Ç–æ–º —Ä–∞–∑–≤–∏—Ç–∏—è —Ä–æ—Å—Å–∏–π—Å–∫–æ–π —ç–∫–æ–Ω–æ–º–∏–∫–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": true,
  ""country"": ""global"",
  ""topic"": """",
  ""impact"": """",
  ""english"": ""The market for reagents and equipment for medicine and pharmaceuticals in Russia is strengthening its position. By 2030, the Russian market for reagents for medicine and pharmaceuticals is expected to reach 47-53 billion rubles. The annual growth rate will be around 10.8%. This is mainly driven by the aging population, the growth of private medicine, and increased attention to diagnostics among young people. At the same time, the segment of laboratory analytical equipment is also developing - it could grow from 15.4 billion rubles in 2024 to 25.6 billion by 2030, with the government sector accounting for 56% of demand. This creates a significant burden on the healthcare system, fosters biotechnology clusters, and promotes domestic pharmaceutical production. The stable demand, development of biotechnology clusters, and emphasis on independence make the pharmaceutical sector a strategically important element of Russia's economic development.""
}"
2025-06-26T06:04:06+00:00,@bezrec,6235,https://t.me/bezrec/6235,"–ò–∑ –ø–ª–∞—Å—Ç–∏–∫–∞ –≤ –ª–µ–∫–∞—Ä—Å—Ç–≤–æ. üíä –ì—Ä—É–ø–ø–∞ —É—á—ë–Ω—ã—Ö –∏–∑ –≠–¥–∏–Ω–±—É—Ä–≥—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ –Ω–∞—É—á–∏–ª–∞—Å—å –ø–µ—Ä–µ—Ä–∞–±–∞—Ç—ã–≤–∞—Ç—å –ø–ª–∞—Å—Ç–∏–∫–æ–≤—ã–µ –æ—Ç—Ö–æ–¥—ã –≤ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã. –í —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, –≤—Å–µ–≥–æ –ª–∏—à—å –∑–∞ —Å—É—Ç–∫–∏ –∏–º —É–¥–∞–ª–æ—Å—å –≤—ã–¥–µ–ª–∏—Ç—å –∏–∑ –ü–≠–¢-–±—É—Ç—ã–ª–æ–∫ —Ç–µ—Ä–µ—Ñ—Ç–∞–ª–µ–≤—É—é –∫–∏—Å–ª–æ—Ç—É (–¢–§–ö) ‚Äî –∞–∫—Ç–∏–≤–Ω—ã–π –∫–æ–º–ø–æ–Ω–µ–Ω—Ç –ø–∞—Ä–∞—Ü–µ—Ç–∞–º–æ–ª–∞, –ø–æ–ø—É–ª—è—Ä–Ω–æ–≥–æ –æ–±–µ–∑–±–æ–ª–∏–≤–∞—é—â–µ–≥–æ –∏ –∂–∞—Ä–æ–ø–æ–Ω–∏–∂–∞—é—â–µ–≥–æ —Å—Ä–µ–¥—Å—Ç–≤–∞. –ï—Å–ª–∏ –≥–æ–≤–æ—Ä–∏—Ç—å –ø—Ä–æ—Å—Ç–æ, —Ç–æ –∏–∑–Ω–∞—á–∞–ª—å–Ω–æ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã —Ä–∞–∑–ª–æ–∂–∏–ª–∏ –ø–æ–ª–∏—ç—Ç–∏–ª–µ–Ω—Ç–µ—Ä–µ—Ñ—Ç–∞–ª–∞—Ç (–ü–≠–¢) –¥–æ –º–æ–ª–µ–∫—É–ª –¢–§–ö, –∞ –ø–æ—Å–ª–µ ¬´—Å–∫–æ—Ä–º–∏–ª–∏¬ª –ø–æ—Å–ª–µ–¥–Ω–∏—Ö –≥–µ–Ω–µ—Ç–∏—á–µ—Å–∫–∏ –º–æ–¥–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω–æ–π –∫–∏—à–µ—á–Ω–æ–π –ø–∞–ª–æ—á–∫–µ (E. coli). –¢–∞–∫ –∫–∞–∫ –±–∞–∫—Ç–µ—Ä–∏–∏ –±—ã–ª–∏ –ª–∏—à–µ–Ω—ã —Å–ø–æ—Å–æ–±–Ω–æ—Å—Ç–∏ —Å–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω–æ —Å–∏–Ω—Ç–µ–∑–∏—Ä–æ–≤–∞—Ç—å –Ω–µ–æ–±—Ö–æ–¥–∏–º—É—é –¥–ª—è —Ä–æ—Å—Ç–∞ –ø–∞—Ä–∞-–∞–º–∏–Ω–æ–±–µ–Ω–∑–æ–π–Ω—É—é –∫–∏—Å–ª–æ—Ç—É (–ü–ê–ë–ö), —Ç–æ –∏–º –ø—Ä–∏—à–ª–æ—Å—å –ø–æ–ª—É—á–∞—Ç—å –µ—ë –±–ª–∞–≥–æ–¥–∞—Ä—è –æ—Å–æ–±–æ–π —Ö–∏–º–∏—á–µ—Å–∫–æ–π —Ä–µ–∞–∫—Ü–∏–∏, –≤ –∫–æ—Ç–æ—Ä–æ–π –∫–∞–∫ —Ä–∞–∑ –∏ –∑–∞–¥–µ–π—Å—Ç–≤–æ–≤–∞–Ω–∞ —Ç–∞ —Å–∞–º–∞—è –¢–§–ö –∏–∑ –ø–ª–∞—Å—Ç–∏–∫–∞. –£–∂–µ –ø–æ—Å–ª–µ —ç—Ç–æ–≥–æ E. coli –ø—Ä–µ–æ–±—Ä–∞–∑–æ–≤—ã–≤–∞–ª–∞ –ü–ê–ë–ö –≤ –ø–∞—Ä–∞—Ü–µ—Ç–∞–º–æ–ª. –í —Ä–µ–∑—É–ª—å—Ç–∞—Ç–µ –≤ —Ö–æ–¥–µ —Å–∏–Ω—Ç–µ–∑–∞, –ø—Ä–æ—Ç–µ–∫–∞—é—â–µ–≥–æ –ø—Ä–∏ ¬´–º—è–≥–∫–∏—Ö¬ª —É—Å–ª–æ–≤–∏—è—Ö, —É—á—ë–Ω—ã–º —É–¥–∞–ª–æ—Å—å –ø–µ—Ä–µ—Ä–∞–±–æ—Ç–∞—Ç—å –≤ –ø–∞—Ä–∞—Ü–µ—Ç–∞–º–æ–ª 92% –ø–ª–∞—Å—Ç–∏–∫–∞. –ö–æ–Ω–µ—á–Ω–æ, –º–æ–∂–µ—Ç –±—ã—Ç—å —ç—Ç–æ –∏ –Ω–µ —Å–∞–º—ã–π —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã–π –º–µ—Ç–æ–¥ –±–æ—Ä—å–±—ã —Å –ø–ª–∞—Å—Ç–∏–∫–æ–≤—ã–º –∑–∞–≥—Ä—è–∑–Ω–µ–Ω–∏–µ–º, –Ω–æ –æ–ø—Ä–µ–¥–µ–ª—ë–Ω–Ω–æ —à–∞–≥ –∫ –±–æ–ª–µ–µ —É—Å—Ç–æ–π—á–∏–≤–æ–º—É –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤—É. üß™ –•–∏–º–ø—Ä–æ–º","{""skip"": true}"
2025-06-25T16:02:59+00:00,@bezrec,6234,https://t.me/bezrec/6234,"–ê–≥–∞, –∑–Ω–∞–∫–æ–º–æ... –£—Ç—Ä–æ–º –ª–æ–≥–∏—Å—Ç, –¥–Ω—ë–º –ø—Å–∏—Ö–æ–ª–æ–≥, –≤–µ—á–µ—Ä–æ–º –∞–π—Ç–∏—à–Ω–∏–∫ ‚Äì –∞ —Ç–∞–∫ –≤–æ–æ–±—â–µ, –¥–∞, —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç. –ú–Ω–æ–≥–æ—Ñ—É–Ω–∫—Ü–∏–æ–Ω–∞–ª—å–Ω–æ—Å—Ç—å 21 –≤–µ–∫–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-06-25T14:31:22+00:00,@bezrec,6233,https://t.me/bezrec/6233,"–ü—Ä–∏—à–ª–æ –≤—Ä–µ–º—è –ø–æ–¥–≤–µ—Å—Ç–∏ –∏—Ç–æ–≥–∏ –æ—á–µ—Ä–µ–¥–Ω–æ–≥–æ –≤—ã–ø—É—Å–∫–∞ —Ä—É–±—Ä–∏–∫–∏ #–∑–∞–ø–∞–∫–æ–≤–∞–ª–∏, –≥–¥–µ –º—ã –≤–º–µ—Å—Ç–µ –≤—ã–±—Ä–∞–ª–∏ –ª—É—á—à–∏–π –¥–∏–∑–∞–π–Ω —É–ø–∞–∫–æ–≤–∫–∏ –∫–∞–ø–µ–ª—å –æ—Ç –ø–æ–∫—Ä–∞—Å–Ω–µ–Ω–∏—è –≥–ª–∞–∑. –ü–æ–±–µ–¥–∏—Ç–µ–ª–µ–º —Å—Ç–∞–ª —Ñ—Ä–∞–Ω—Ü—É–∑—Å–∫–∏–π –í–∏–∑–∏–Ω –ö–ª–∞—Å—Å–∏—á–µ—Å–∫–∏–π –æ—Ç ¬´Johnson & Johnson¬ª –≤ –∞–º–ø—É–ª–∞—Ö. –ú–∏–Ω–∏–º–∞–ª–∏—Å—Ç–∏—á–Ω—ã–π –¥–∏–∑–∞–π–Ω —É–ø–∞–∫–æ–≤–∫–∏ –≤–∏–∑—É–∞–ª—å–Ω–æ –ø–æ–¥—á—ë—Ä–∫–∏–≤–∞–µ—Ç —Å—É—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ —Å –ø–æ–º–æ—â—å—é –Ω–∏—Å—Ö–æ–¥—è—â–µ–π –ª–∏–Ω–∏–∏ –∏ –∫–∞–ø–ª–∏, —Å–∏–º–≤–æ–ª–∏–∑–∏—Ä—É—é—â–∏—Ö —É–º–µ–Ω—å—à–µ–Ω–∏–µ –≤–æ—Å–ø–∞–ª–µ–Ω–∏—è –∏ —Ç–æ—á–µ—á–Ω–æ–µ –¥–µ–π—Å—Ç–≤–∏–µ. –ù–∞ –≤—Ç–æ—Ä–æ–º –∏ —Ç—Ä–µ—Ç—å–µ–º –º–µ—Å—Ç–∞—Ö —Ä–∞—Å–ø–æ–ª–æ–∂–∏–ª–∏—Å—å —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã ‚Äì –û—Ñ—Ç—Ä–∏–∫—Å –æ—Ç ¬´–ì—Ä–æ—Ç–µ—Å–∫¬ª (25%) –∏ –í–∏–∑–æ–∫–∫–æ –æ—Ç ¬´–î–ò–ê–§–ê–†–ú¬ª (19%) —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ. –ù–∏–∂–µ ‚Äì –í–∏–∑–æ–ø—Ç–∏–∫ (¬´–ö.–û. –†–æ–º—Ñ–∞—Ä–º –ö–æ–º–ø–∞–Ω–∏ –°.–†.–õ.¬ª) –∏ –û–∫—Ç–∏–ª–∏—è (¬´–ù–û–í–ê–ú–ï–î–ò–ö–ê¬ª). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-06-25T13:05:06+00:00,@bezrec,6232,https://t.me/bezrec/6232,"¬´–ñ–∏–≤–∏–∫–∞¬ª —Ç–µ–ø–µ—Ä—å –≤ –ö—É–ø–µ—Ä–µ –°–µ—Ç—å –∞–ø—Ç–µ–∫ ¬´–ñ–∏–≤–∏–∫–∞¬ª —Ä–∞—Å—à–∏—Ä—è–µ—Ç –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å —Å–≤–æ–∏—Ö —É—Å–ª—É–≥. –¢–µ–ø–µ—Ä—å –∂–∏—Ç–µ–ª–∏ –ú–æ—Å–∫–≤—ã, –¢—é–º–µ–Ω–∏, –ï–∫–∞—Ç–µ—Ä–∏–Ω–±—É—Ä–≥–∞, –ù–æ–≤–æ—Å–∏–±–∏—Ä—Å–∫–∞ –∏ –ß–µ–ª—è–±–∏–Ω—Å–∫–∞ –º–æ–≥—É—Ç –∑–∞–∫–∞–∑–∞—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏ —Ç–æ–≤–∞—Ä—ã –¥–ª—è –∑–¥–æ—Ä–æ–≤—å—è —á–µ—Ä–µ–∑ —Å–µ—Ä–≤–∏—Å –¥–æ—Å—Ç–∞–≤–∫–∏ –ö—É–ø–µ—Ä, –Ω–µ –≤—ã—Ö–æ–¥—è –∏–∑ –¥–æ–º–∞. –í –±–ª–∏–∂–∞–π—à–µ–µ –≤—Ä–µ–º—è —Å–µ—Ä–≤–∏—Å —Å—Ç–∞–Ω–µ—Ç –¥–æ—Å—Ç—É–ø–µ–Ω –∏ –≤ –¥—Ä—É–≥–∏—Ö –∫–ª—é—á–µ–≤—ã—Ö —Ä–µ–≥–∏–æ–Ω–∞—Ö —Å—Ç—Ä–∞–Ω—ã, –≤–∫–ª—é—á–∞—è –ü–µ—Ä–º—å –∏ –ú–∞–≥–Ω–∏—Ç–æ–≥–æ—Ä—Å–∫. –ü–∞—Ä—Ç–Ω—ë—Ä—Å—Ç–≤–æ –æ—Ö–≤–∞—Ç—ã–≤–∞–µ—Ç –±–æ–ª–µ–µ 850 —Ç–æ—á–µ–∫ —Å–µ—Ç–∏ –∏ —Å—Ç–∞–Ω–µ—Ç –æ–¥–Ω–∏–º –∏–∑ –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö –∏–Ω—Ç–µ–≥—Ä–∞—Ü–∏–æ–Ω–Ω—ã—Ö –ø—Ä–æ–µ–∫—Ç–æ–≤ –≤ —Å–µ–≥–º–µ–Ω—Ç–µ –∞–ø—Ç–µ—á–Ω–æ–≥–æ e-commerce. –î–ª—è –ö—É–ø–µ—Ä–∞ —ç—Ç–æ —à–∞–≥ –∫ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—é —É—Å—Ç–æ–π—á–∏–≤–æ–π –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä—ã —Ñ–∞—Ä–º-–¥–æ—Å—Ç–∞–≤–∫–∏ –Ω–∞ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–º —É—Ä–æ–≤–Ω–µ. ¬´–ñ–∏–≤–∏–∫–∞¬ª —Å—Ç–∞–±–∏–ª—å–Ω–æ –≤—Ö–æ–¥–∏—Ç –≤ —Ç–æ–ø-10 –∞–ø—Ç–µ—á–Ω—ã—Ö —Å–µ—Ç–µ–π –ø–æ —Ç–æ–≤–∞—Ä–æ–æ–±–æ—Ä–æ—Ç—É –≤ –†–æ—Å—Å–∏–∏. –°–æ–≤–º–µ—Å—Ç–Ω–∞—è —Ä–∞–±–æ—Ç–∞ —Å –∫—Ä—É–ø–Ω–µ–π—à–∏–º–∏ —Ü–∏—Ñ—Ä–æ–≤—ã–º–∏ –ø–ª–∞—Ç—Ñ–æ—Ä–º–∞–º–∏ –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–∞–µ—Ç —Ç—Ä–µ–Ω–¥ –Ω–∞ —Å–±–ª–∏–∂–µ–Ω–∏–µ —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω–æ–π —Ñ–∞—Ä–º—ã —Å —Ü–∏—Ñ—Ä–æ–≤—ã–º–∏ —Ä–µ—à–µ–Ω–∏—è–º–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The pharmacy chain 'Ziva' is expanding its services through the delivery service 'Kupera'. Residents of Moscow, Yekaterinburg, Novosibirsk, Chelyabinsk, and Perm can now order medicines and health products without leaving their homes. The service will be available in other key regions of the country, including Magnitogorsk, in the near future. The partnership covers over 850 points of the network and will be one of the largest integration projects in the pharmacy e-commerce segment. For 'Kupera', this is a step towards forming a stable infrastructure for pharmaceutical delivery at the federal level. 'Ziva' consistently ranks among the top 10 pharmacy chains in terms of turnover in Russia. Joint work with major digital platforms confirms the trend towards convergence between traditional pharmacy and digital solutions.""
}"
2025-06-25T11:31:37+00:00,@bezrec,6231,https://t.me/bezrec/6231,"–¢–æ–ø-10 –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –æ—Ç –º–∏–≥—Ä–µ–Ω–∏ –ø–æ –æ–±—ä–µ–º–∞–º –ø—Ä–æ–¥–∞–∂: —Ä—ã–Ω–æ–∫ —Ä–∞—Å—Ç—ë—Ç –≤–ø–µ—Ä–≤—ã–µ –∑–∞ –¥–≤–∞ –≥–æ–¥–∞ –ü–æ—Å–ª–µ –¥–≤—É—Ö–ª–µ—Ç–Ω–µ–≥–æ —Å–ø–∞–¥–∞ —Å–ø—Ä–æ—Å –Ω–∞ —Å—Ä–µ–¥—Å—Ç–≤–∞ –æ—Ç –º–∏–≥—Ä–µ–Ω–∏ –≤ –†–æ—Å—Å–∏–∏ –ø–æ—à—ë–ª –≤ —Ä–æ—Å—Ç ‚Äì –ø–æ –∏—Ç–æ–≥–∞–º I –ø–æ–ª—É–≥–æ–¥–∏—è 2025 –≥–æ–¥–∞ —Ä–æ—Å—Å–∏—è–Ω–µ –ø–æ—Ç—Ä–∞—Ç–∏–ª–∏ –Ω–∞ –ø—Ä–æ—Ç–∏–≤–æ–º–∏–≥—Ä–µ–Ω–æ–∑–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã 1,68 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –≠—Ç–æ –Ω–∞ 26,7% –±–æ–ª—å—à–µ, —á–µ–º –≥–æ–¥–æ–º —Ä–∞–Ω–µ–µ. –í —É–ø–∞–∫–æ–≤–∫–∞—Ö –ø—Ä–∏—Ä–æ—Å—Ç —Å–∫—Ä–æ–º–Ω—ã–π ‚Äì –≤—Å–µ–≥–æ 1,7%, –æ—Å–Ω–æ–≤–Ω–∞—è –ø—Ä–∏—á–∏–Ω–∞ –±—É—Ä–Ω–æ–≥–æ —Ä–æ—Å—Ç–∞ ‚Äì —Å–¥–≤–∏–≥ –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª—å—Å–∫–æ–≥–æ –∏–Ω—Ç–µ—Ä–µ—Å–∞ –≤ —Å—Ç–æ—Ä–æ–Ω—É –±–æ–ª–µ–µ –¥–æ—Ä–æ–≥–∏—Ö –±—Ä–µ–Ω–¥–æ–≤. –í —Ü–µ–ª–æ–º —Å—Ç—Ä—É–∫—Ç—É—Ä–∞ —Ä—ã–Ω–∫–∞ —Å–æ—Ö—Ä–∞–Ω—è–µ—Ç—Å—è ‚Äì 75% —Ä—É–±–ª—ë–≤—ã—Ö –ø—Ä–æ–¥–∞–∂ –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –Ω–∞ –æ—Å–Ω–æ–≤–µ —Å—É–º–∞—Ç—Ä–∏–ø—Ç–∞–Ω–∞. –ü—Ä–∏ —ç—Ç–æ–º —Å–µ–≥–º–µ–Ω—Ç –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤ –ú–ù–ù —Ç–µ—Ä—è–µ—Ç –ø–æ–∑–∏—Ü–∏–∏ (‚Äì3% –≤ –¥–µ–Ω—å–≥–∞—Ö), –∞ –±—Ä–µ–Ω–¥–æ–≤—ã–µ –ø—Ä–æ–¥—É–∫—Ç—ã –≤ –ø–ª—é—Å–µ. –í–ø–µ—á–∞—Ç–ª—è—é—â–∏–π —Ä–æ—Å—Ç –ø–æ–∫–∞–∑–∞–ª –±—Ä–µ–Ω–¥ –ê–¥–∂–æ–≤–∏ –æ—Ç Teva ‚Äì +237%, –æ–±—ä—ë–º –ø—Ä–æ–¥–∞–∂ –≤—ã—Ä–æ—Å –≤ 3,4 —Ä–∞–∑–∞. –í—Ç–æ—Ä–æ–µ –º–µ—Å—Ç–æ –∑–∞–Ω—è–ª –ø—Ä–µ–ø–∞—Ä–∞—Ç –≠–∫—Å–µ–Ω–∑–∞ –æ—Ç ¬´–§–∞—Ä–º–∞–º–µ–¥¬ª (—Ä–æ—Å—Ç –≤ 3 —Ä–∞–∑–∞), –∑–∞–º—ã–∫–∞–µ—Ç —Ç—Ä–æ–π–∫—É –ö–∞–ø–æ—Ä–∏–∑–∞ –æ—Ç ¬´–°–æ—Ç–µ–∫—Å¬ª (+122%). –ê–±—Å–æ–ª—é—Ç–Ω—ã–π –ª–∏–¥–µ—Ä –ø–æ —Ç–µ–º–ø–∞–º —Ä–æ—Å—Ç–∞ ‚Äì –î–µ–ª–º–∏–≥—Ä–µ–Ω –æ—Ç ¬´–ì—Ä–æ—Ç–µ–∫—Å¬ª, —á—å–∏ –ø—Ä–æ–¥–∞–∂–∏ –∑–∞ –≥–æ–¥ —É–≤–µ–ª–∏—á–∏–ª–∏—Å—å –≤ 8,6 —Ä–∞–∑–∞. –ü–æ–∫–∞ –æ–Ω —Ç–æ–ª—å–∫–æ –Ω–∞ 15-–π —Å—Ç—Ä–æ—á–∫–µ —Ä–µ–π—Ç–∏–Ω–≥–∞, –Ω–æ –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª –∑–∞–º–µ—Ç–µ–Ω. –ê –≤–æ—Ç —É —Ä—è–¥–∞ –ø–æ–ø—É–ª—è—Ä–Ω—ã—Ö —Ä–∞–Ω–µ–µ –±—Ä–µ–Ω–¥–æ–≤ ‚Äî –Ω–µ–≥–∞—Ç–∏–≤–Ω–∞—è –¥–∏–Ω–∞–º–∏–∫–∞. –ü—Ä–æ–¥–∞–∂–∏ –ú–∏–≥—Ä–µ–ø–∞–º–∞ –æ—Ç ¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º¬ª —Å–Ω–∏–∑–∏–ª–∏—Å—å –Ω–∞ 26%, –ê–º–∏–≥—Ä–µ–Ω–∏–Ω–∞ –æ—Ç ¬´–≠–±–±–æ—Ç—Ç¬ª ‚Äì –Ω–∞ 12%, –°—É–º–∞–º–∏–≥—Ä–µ–Ω–∞ –æ—Ç ¬´–ê–∫—Ä–∏—Ö–∏–Ω–∞¬ª ‚Äì –Ω–∞ 9%. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The market for migraine treatments in Russia is growing after two years of decline. Sales increased by 26.7% year-over-year to RUB168 billion in the first half of 2025. The market structure remains stable with 75% of sales coming from sumatriptan-based drugs. The segment of generic medications is losing ground (-3% in terms), while branded products are gaining. Teva's Ajovy showed the most significant growth (+237%), increasing sales by 3 times. Exenza from FarmaMed and Caporiz from Sotex also showed significant growth (3x). Delmigren, the absolute leader in terms of growth (+8.6x), is currently on the 15th position but shows potential. Sales of previously popular branded drugs like Migrepam from Binnofarm and Amygrin from Abbott are declining (-26% and -12%, respectively).""
}"
2025-06-25T09:31:17+00:00,@bezrec,6230,https://t.me/bezrec/6230,"–ù–µ—Å–º–æ—Ç—Ä—è –Ω–∞ –≤–Ω–µ—à–Ω–∏–µ –≤—ã–∑–æ–≤—ã, –∏–Ω–Ω–æ–≤–∞—Ü–∏–∏ –ø—Ä–æ–¥–æ–ª–∂–∞—é—Ç –ø—Ä–∏—Ö–æ–¥–∏—Ç—å –Ω–∞ —Ä—ã–Ω–æ–∫ Bayer –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª–∞ –≤ –†–æ—Å—Å–∏–∏ –∞—Ñ–ª–∏–±–µ—Ä—Ü–µ–ø—Ç 8 –º–≥ –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ –Ω–í–ú–î –∏ –î–ú–û ‚Äì –Ω–æ–≤—É—é —Ñ–æ—Ä–º—É —É–∂–µ —Ö–æ—Ä–æ—à–æ –∏–∑–≤–µ—Å—Ç–Ω–æ–≥–æ –∞–Ω—Ç–∏-VEGF –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞. –í –æ—Ç–ª–∏—á–∏–µ –æ—Ç –¥–æ–∑—ã 2 –º–≥, 8 –º–≥ –ø–æ–∑–≤–æ–ª—è–µ—Ç —Å–æ–∫—Ä–∞—Ç–∏—Ç—å —á–∏—Å–ª–æ –∏–Ω—ä–µ–∫—Ü–∏–π –¥–æ –¥–≤—É—Ö –≤ –≥–æ–¥ –ø—Ä–∏ —Å–æ—Ö—Ä–∞–Ω–µ–Ω–∏–∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –∏ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏. –≠—Ç–æ –∑–Ω–∞—á–∏—Ç: üîò–º–µ–Ω—å—à–µ –≤–∏–∑–∏—Ç–æ–≤ –∫ –≤—Ä–∞—á—É; üîò–≤—ã—à–µ –∫–æ–º–ø–ª–∞–µ–Ω—Ç–Ω–æ—Å—Ç—å; üîò–º–µ–Ω—å—à–µ –Ω–∞–≥—Ä—É–∑–∫–∞ –Ω–∞ –ø–∞—Ü–∏–µ–Ω—Ç–∞ –∏ —Å–∏—Å—Ç–µ–º—É –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –ò—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è PULSAR –∏ PHOTON –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª–∏: —É –∫–∞–∂–¥–æ–≥–æ –≤—Ç–æ—Ä–æ–≥–æ –ø–∞—Ü–∏–µ–Ω—Ç–∞ –∏–Ω—Ç–µ—Ä–≤–∞–ª –º–µ–∂–¥—É –∏–Ω—ä–µ–∫—Ü–∏—è–º–∏ –¥–æ—Å—Ç–∏–≥–∞–ª 20‚Äì24 –Ω–µ–¥–µ–ª—å. –†–∞—Å—à–∏—Ä–µ–Ω–∏–µ –ª–∏–Ω–µ–π–∫–∏ –¥–æ–∑–∏—Ä–æ–≤–æ–∫ —Ç–∞–∫–æ–≥–æ –≤–æ—Å—Ç—Ä–µ–±–æ–≤–∞–Ω–Ω–æ–≥–æ –∞–Ω—Ç–∏-VEGF –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ‚Äì —ç—Ç–æ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –ø–æ-–Ω–æ–≤–æ–º—É –≤—ã—Å—Ç—Ä–æ–∏—Ç—å –º–∞—Ä—à—Ä—É—Ç—ã –ª–µ—á–µ–Ω–∏—è –∏ –æ–ø—Ç–∏–º–∏–∑–∏—Ä–æ–≤–∞—Ç—å —Ä–µ—Å—É—Ä—Å—ã. –ü—Ä–µ–ø–∞—Ä–∞—Ç —É–∂–µ –æ–¥–æ–±—Ä–µ–Ω –±–æ–ª–µ–µ —á–µ–º –≤ 50 —Å—Ç—Ä–∞–Ω–∞—Ö –∏ —Ç–µ–ø–µ—Ä—å –¥–æ—Å—Ç—É–ø–µ–Ω –∏ –≤ –†–æ—Å—Å–∏–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, sanctions, shortage, demand,vaccine"",
  ""impact"": ""high"",
  ""english"": ""Bayer has registered afibuline 8 mg in Russia for the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME). Compared to the 2 mg dose, this allows reducing the number of injections to two per year while maintaining efficacy and safety. This means: fewer doctor visits, higher compliance, lower patient burden on healthcare system. Studies PULSAR and PHOTON confirmed: the interval between injections reached 20-24 weeks for two out of every three patients. Expanding the range of dosages for this highly demanded anti-VEGF drug is an opportunity to optimize treatment routes and resources. The drug has already been approved in more than 50 countries, including Russia.""
}"
2025-06-25T07:35:34+00:00,@bezrec,6229,https://t.me/bezrec/6229,"Arc Institute –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª –ø–µ—Ä–≤—É—é –ò–ò-–º–æ–¥–µ–ª—å –∫–ª–µ—Ç–∫–∏ –¥–ª—è —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –Ω–æ–≤—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ State ‚Äì –ø–µ—Ä–≤–∞—è –ò–ò-–º–æ–¥–µ–ª—å, –∫–æ—Ç–æ—Ä–∞—è –ø—Ä–µ–¥—Å–∫–∞–∑—ã–≤–∞–µ—Ç, –∫–∞–∫ –∫–ª–µ—Ç–∫–∞ –∏–∑–º–µ–Ω–∏—Ç—Å—è –ø–æ–¥ –¥–µ–π—Å—Ç–≤–∏–µ–º –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏–ª–∏ –≥–µ–Ω–Ω–æ–π –º–æ–¥–∏—Ñ–∏–∫–∞—Ü–∏–∏. –ú–æ–¥–µ–ª—å –æ–±—É—á–∞–µ—Ç—Å—è –Ω–∞ —Ä–µ–∞–ª—å–Ω—ã—Ö –¥–∞–Ω–Ω—ã—Ö, —Ä–∞–±–æ—Ç–∞–µ—Ç —Å –≤—ã—Å–æ–∫–æ–π –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π —Å–ª–æ–∂–Ω–æ—Å—Ç—å—é –∏ –≤—ã—è–≤–ª—è–µ—Ç –Ω–µ–æ–∂–∏–¥–∞–Ω–Ω—ã–µ —ç—Ñ—Ñ–µ–∫—Ç—ã –±–µ–∑ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ –ø–æ–ª–Ω–æ–≥–æ –ø–æ–Ω–∏–º–∞–Ω–∏—è –º–µ—Ö–∞–Ω–∏–∑–º–æ–≤ –¥–µ–π—Å—Ç–≤–∏—è. State —Å—Ç–∞–ª–∞ —á–∞—Å—Ç—å—é –ø–ª–∞—Ç—Ñ–æ—Ä–º—ã Arc Virtual Cell Atlas —Å –¥–∞–Ω–Ω—ã–º–∏ –±–æ–ª–µ–µ 300 –º–ª–Ω –∫–ª–µ—Ç–æ–∫. –û–±—É—á–µ–Ω–∏–µ –ø—Ä–æ–≤–µ–¥–µ–Ω–æ –Ω–∞ –∫—Ä—É–ø–Ω–µ–π—à–µ–º –¥–∞—Ç–∞—Å–µ—Ç–µ –≤ –æ–±–ª–∞—Å—Ç–∏: 170 –º–ª–Ω –Ω–∞–±–ª—é–¥–∞—Ç–µ–ª—å–Ω—ã—Ö –∏ –±–æ–ª–µ–µ 100 –º–ª–Ω –∫–ª–µ—Ç–æ–∫ —Å –ø–µ—Ä—Ç—É—Ä–±–∞—Ü–∏—è–º–∏ –∏–∑ 70 –ª–∏–Ω–∏–π. –ü–ª–∞—Ç—Ñ–æ—Ä–º–∞ —É–∂–µ –ø—Ä–æ—Ç–µ—Å—Ç–∏—Ä–æ–≤–∞–Ω–∞ –Ω–∞ FDA-–æ–¥–æ–±—Ä–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞—Ö –∏ –ø–æ–∫–∞–∑—ã–≤–∞–µ—Ç –≤—ã—Å–æ–∫—É—é —Ç–æ—á–Ω–æ—Å—Ç—å –ø—Ä–µ–¥—Å–∫–∞–∑–∞–Ω–∏–π –¥–ª—è —Ä–∞–∑–Ω—ã—Ö —Ç–∏–ø–æ–≤ –∫–ª–µ—Ç–æ–∫. –≠—Ç–æ –æ–¥–∏–Ω –∏–∑ –ø–µ—Ä–≤—ã—Ö –ø—Ä–∏–º–µ—Ä–æ–≤, –≥–¥–µ –ò–ò –ø—Ä–∏–±–ª–∏–∂–∞–µ—Ç—Å—è –∫ –º–æ–¥–µ–ª–∏—Ä–æ–≤–∞–Ω–∏—é –∂–∏–≤–æ–π –∫–ª–µ—Ç–∫–∏, —á—Ç–æ –º–æ–∂–µ—Ç —Ä–∞–¥–∏–∫–∞–ª—å–Ω–æ —É—Å–∫–æ—Ä–∏—Ç—å –æ—Ç–∫—Ä—ã—Ç–∏–µ –∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫—É –Ω–æ–≤—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤. –î–ª—è —Å–ø—Ä–∞–≤–∫–∏: Arc Institute ‚Äì —ç—Ç–æ –Ω–µ–∑–∞–≤–∏—Å–∏–º—ã–π –Ω–µ–∫–æ–º–º–µ—Ä—á–µ—Å–∫–∏–π –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–∏–π —Ü–µ–Ω—Ç—Ä –∏–∑ –ö—Ä–µ–º–Ω–∏–µ–≤–æ–π –¥–æ–ª–∏–Ω—ã, —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä—É—é—â–∏–π—Å—è –Ω–∞ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–∏ –ò–ò –∏ –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –¥–ª—è —É—Å–∫–æ—Ä–µ–Ω–∏—è —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-06-24T15:43:06+00:00,@bezrec,6228,https://t.me/bezrec/6228,"–í –†–æ—Å—Å–∏–∏ –æ–±–Ω–∞—Ä—É–∂–µ–Ω—ã –æ–ø–∞—Å–Ω—ã–µ –∫–æ–Ω—Ç—Ä–∞—Ü–µ–ø—Ç–∏–≤—ã –∏–∑ –ö–∏—Ç–∞—è –ù–∞ –æ–Ω–ª–∞–π–Ω-–ø–ª–æ—â–∞–¥–∫–∞—Ö —Å–≤–æ–±–æ–¥–Ω–æ –ø—Ä–æ–¥–∞—é—Ç—Å—è —Ç–∞–±–ª–µ—Ç–∫–∏ Levonorgestrel and Quinestrol Tablets –æ—Ç –∫–∏—Ç–∞–π—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ Zizhu Pharmaceutical. –î–∞–Ω–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç: üîΩ–ù–µ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω –≤ –†–§; üîΩ–ó–∞–ø—Ä–µ—â—ë–Ω –≤ —Ä—è–¥–µ —Å—Ç—Ä–∞–Ω; üîΩ–°–æ–¥–µ—Ä–∂–∏—Ç –≤ 3,5 —Ä–∞–∑–∞ –º–µ–Ω—å—à–µ –≥–æ—Ä–º–æ–Ω–∞, —á–µ–º –∑–∞—è–≤–ª–µ–Ω–æ (1,7 –º–≥ –≤–º–µ—Å—Ç–æ 6 –º–≥); üîΩ–ò–º–µ–µ—Ç –ø—Ä–∏–∑–Ω–∞–∫–∏ —Ñ–∞–ª—å—Å–∏—Ñ–∏–∫–∞—Ç–∞; üîΩ–ù–∞–∑–Ω–∞—á–∞–µ—Ç—Å—è –±–µ–∑ —É—á—ë—Ç–∞ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π. –í—Ä–∞—á–∏ –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–∞—é—Ç, —á—Ç–æ –ø–æ—Å—Ç–æ—è–Ω–Ω—ã–π –ø—Ä–∏—ë–º –º–æ–∂–µ—Ç –ø—Ä–∏–≤–µ—Å—Ç–∏ –∫ –≥–æ—Ä–º–æ–Ω–∞–ª—å–Ω–æ–º—É —Å–±–æ—é, —Ä–µ–ø—Ä–æ–¥—É–∫—Ç–∏–≤–Ω—ã–º –Ω–∞—Ä—É—à–µ–Ω–∏—è–º –∏ —Ç–æ–∫—Å–∏—á–µ—Å–∫–∏–º –ø–æ—Ä–∞–∂–µ–Ω–∏—è–º –ø–µ—á–µ–Ω–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration, reimbursement, shortage, safety"",
  ""impact"": ""high"",
  ""english"": ""Unsafe contraceptives from China have been found in Russia. The Levonorgestrel and Quinestrol Tablets produced by the Chinese company Zizhu Pharmaceutical are not registered in Russia. They are prohibited in several countries and contain less hormone than claimed (6 mg instead of 17 mg). There are signs of counterfeiting. Doctors warn that prolonged use can lead to hormonal disorders, reproductive issues, and liver toxicity.""
}"
2025-06-24T14:35:11+00:00,@bezrec,6227,https://t.me/bezrec/6227,"BIOCAD –ø–µ—Ä–µ—Ö–æ–¥–∏—Ç –∫ –Ω–æ–≤–æ–º—É —ç—Ç–∞–ø—É –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ –ø—Å–æ—Ä–∏–∞–∑–∞ —É –¥–µ—Ç–µ–π ‚ñ∂Ô∏è–ë–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∞—è –∫–æ–º–ø–∞–Ω–∏—è BIOCAD –∑–∞–≤–µ—Ä—à–∏–ª–∞ –Ω–∞–±–æ—Ä –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –Ω–µ—Ç–∞–∫–∏–º–∞–±. –ö–æ–º–ø–∞–Ω–∏—è –ø–ª–∞–Ω–∏—Ä—É–µ—Ç –æ—Ü–µ–Ω–∏—Ç—å —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –∏ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ —Å—Ä–µ–¥—Å—Ç–≤–∞ –≤ —Ç–µ—Ä–∞–ø–∏–∏ –ø—Å–æ—Ä–∏–∞–∑–∞ —É –¥–µ—Ç–µ–π –æ—Ç 6 –¥–æ 12 –ª–µ—Ç. –†–∞–Ω–µ–µ –≤ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –±—ã–ª–∏ –≤–∫–ª—é—á–µ–Ω—ã –¥–µ—Ç–∏ –≤ –≤–æ–∑—Ä–∞—Å—Ç–µ –æ—Ç 12 –¥–æ 17 –ª–µ—Ç, –≤ –Ω–∞—Å—Ç–æ—è—â–µ–µ –≤—Ä–µ–º—è –æ–Ω–∏ –ø—Ä–æ–¥–æ–ª–∂–∞—é—Ç —É—á–∞—Å—Ç–∏–µ –≤ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–∏. –ü—Ä–æ–º–µ–∂—É—Ç–æ—á–Ω–∞—è –æ—Ü–µ–Ω–∫–∞ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ —Ç–µ—Ä–∞–ø–∏–∏ –ø–æ–∫–∞–∑–∞–ª–∞, —á—Ç–æ –Ω–µ—Ç–∞–∫–∏–º–∞–± —Ö–æ—Ä–æ—à–æ –ø–µ—Ä–µ–Ω–æ—Å–∏—Ç—Å—è –Ω–µ—Å–æ–≤–µ—Ä—à–µ–Ω–Ω–æ–ª–µ—Ç–Ω–∏–º–∏ –ø–∞—Ü–∏–µ–Ω—Ç–∞–º–∏. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –±–ª–∞–≥–æ–ø—Ä–∏—è—Ç–Ω—ã–π –ø—Ä–æ—Ñ–∏–ª—å –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ —Å—Ä–µ–¥—Å—Ç–≤–∞ –±—ã–ª –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–µ–Ω –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–º–∏ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è–º–∏ –Ω–∞ –∂–∏–≤–æ—Ç–Ω—ã—Ö. –ù–∞ –æ—Å–Ω–æ–≤–∞–Ω–∏–∏ –ø–æ–ª—É—á–µ–Ω–Ω—ã—Ö —Ä–µ–∑—É–ª—å—Ç–∞—Ç–æ–≤ –±—ã–ª –æ–¥–æ–±—Ä–µ–Ω –Ω–∞–±–æ—Ä –≤ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –æ—Ç 6 –ª–µ—Ç. ‚ñ∂Ô∏è–ö–ª–∏–Ω–∏—á–µ—Å–∫–æ–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ BCD-085-16/PLANETA-KIDS –æ—Ç–∫—Ä—ã—Ç–æ –≤ –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–∏—Ö —Ü–µ–Ω—Ç—Ä–∞—Ö –≤ –ú–æ—Å–∫–≤–µ, –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥–µ, –ö–∞–∑–∞–Ω–∏, –ù–∏–∂–Ω–µ–º –ù–æ–≤–≥–æ—Ä–æ–¥–µ, –ï–∫–∞—Ç–µ—Ä–∏–Ω–±—É—Ä–≥–µ, –ö–µ–º–µ—Ä–æ–≤–æ, –ù–æ–≤–æ—Å–∏–±–∏—Ä—Å–∫–µ, –ß–µ–ª—è–±–∏–Ω—Å–∫–µ, –ö–∏—Ä–æ–≤–µ, –ö—Ä–∞—Å–Ω–æ–¥–∞—Ä–µ, –ë–∞—Ä–Ω–∞—É–ª–µ, –†—è–∑–∞–Ω–∏, –†–æ—Å—Ç–æ–≤–µ-–Ω–∞-–î–æ–Ω—É –∏ –°–∞—Ä–∞—Ç–æ–≤–µ. –ù–∞–ø–æ–º–Ω–∏–º, –Ω–µ—Ç–∞–∫–∏–º–∞–± –±—ã–ª –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω –ú–∏–Ω–∑–¥—Ä–∞–≤–æ–º –†–æ—Å—Å–∏–∏ –≤ 2019 –≥–æ–¥—É –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ –≤–∑—Ä–æ—Å–ª—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –í –ø—Ä–æ—à–ª–æ–º –≥–æ–¥—É BIOCAD –æ–±—ä—è–≤–∏–ª –æ–± —É–≤–µ–ª–∏—á–µ–Ω–∏–∏ –æ–±—ä–µ–º–æ–≤ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –Ω–µ—Ç–∞–∫–∏–º–∞–±–∞ –Ω–∞ 30%. –≠—Ç–æ —Å–≤—è–∑–∞–Ω–æ —Å –≤—ã—Å–æ–∫–æ–π –≤–æ—Å—Ç—Ä–µ–±–æ–≤–∞–Ω–Ω–æ—Å—Ç—å—é –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –Ω–∞ —Ä—ã–Ω–∫–µ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety, guideline"",
  ""impact"": ""medium"",
  ""english"": ""BIOCAD has completed the enrollment of patients in a clinical trial for an original drug to treat psoriasis in children aged 6-12 years. The company plans to evaluate the efficacy and safety of the medication in treating psoriasis in children aged 6-12 years. Preliminary safety assessments show that the drug is well tolerated by young patients. The favorable safety profile of the medication has been confirmed through additional animal studies. Based on these results, enrollment in the trial for patients aged 6 years has been approved. The clinical trial BCD-085-16/PLANETA-KIDS is open at research centers in Moscow, St. Petersburg, Kazan, Nizhny Novgorod, Yekaterinburg, Kemerovo, Novosibirsk, Chelyabinsk, Kirov, Krasnodar, Barnaul, Ryazan, Rostov-on-Don, and Saratov. It is worth noting that the drug 'NoTamab' was registered by the Russian Ministry of Health in 2"
2025-06-24T13:06:06+00:00,@bezrec,6226,https://t.me/bezrec/6226,"–û–±–Ω–æ–≤–ª–µ–Ω–∏–µ Utrace Analytics —É—Å–∏–ª–∏—Ç –∞–Ω–∞–ª–∏—Ç–∏–∫—É —Ñ–∞—Ä–º—Ä—ã–Ω–∫–∞ ‚¨úÔ∏è–í Utrace Analytics –ø–æ—è–≤–∏–ª–∏—Å—å –±–æ–ª–µ–µ —Ç–æ—á–Ω–æ–µ –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–∏–µ —Ñ–∞—Ä–º—Ä–æ–ª–µ–π —Å —É—á—ë—Ç–æ–º –¥–∞–Ω–Ω—ã—Ö –ú–î–õ–ü –∏ –æ—Ç–∫—Ä—ã—Ç—ã—Ö –∏—Å—Ç–æ—á–Ω–∏–∫–æ–≤, –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –≥—Ä—É–ø–ø–∏—Ä–æ–≤–∫–∏ –ø–æ —Å–µ–≥–º–µ–Ω—Ç–∞–º –∏ –∞–Ω–∞–ª–∏–∑ –Ω–∞ —É—Ä–æ–≤–Ω–µ —Ç–æ—á–µ–∫ –ø—Ä–æ–¥–∞–∂. –¢–µ—Ö–Ω–æ–ª–æ–≥–∏—è –∏—Å–ø–æ–ª—å–∑—É–µ—Ç –¥–∞–Ω–Ω—ã–µ —Ü–∏—Ñ—Ä–æ–≤–æ–π –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏ –∏ –ø—Ä–æ–¥–≤–∏–Ω—É—Ç—ã–µ –∞–ª–≥–æ—Ä–∏—Ç–º—ã –¥–ª—è –≥–ª—É–±–æ–∫–æ–≥–æ –∞–Ω–∞–ª–∏–∑–∞ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ —Ä—ã–Ω–∫–∞, –ø–æ–º–æ–≥–∞—è –≤—ã—è–≤–ª—è—Ç—å –±–∏–∑–Ω–µ—Å-–º–æ–¥–µ–ª–∏ –∏ —É–ª—É—á—à–∞—Ç—å –ø—Ä–∏–Ω—è—Ç–∏–µ —Ä–µ—à–µ–Ω–∏–π –±–µ–∑ —É–ø—Ä–æ—â–µ–Ω–∏–π –∏ –æ—à–∏–±–æ–∫. ‚¨úÔ∏è–í —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –æ—Ç—Ä–∞—Å–ª–∏ –ø—Ä–∏–º–µ–Ω—è—é—Ç—Å—è —Ä–∞–∑–Ω—ã–µ –ò–¢-—Ä–µ—à–µ–Ω–∏—è: –æ—Ç —Å–∏—Å—Ç–µ–º—ã –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏ ¬´–ß–µ—Å—Ç–Ω—ã–π –ó–ù–ê–ö¬ª –¥–æ –ø–ª–∞—Ç—Ñ–æ—Ä–º –¥–ª—è –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π Medidata –∏ Oracle Health Sciences, –∞ —Ç–∞–∫–∂–µ –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç–æ–≤ —É–ø—Ä–∞–≤–ª–µ–Ω–∏—è –¥–∞–Ω–Ω—ã–º–∏ –∏ –ª–æ–≥–∏—Å—Ç–∏–∫–æ–π, —Ç–∞–∫–∏—Ö –∫–∞–∫ Veeva Systems, SAP EWM –∏ 1–°:–ú–µ–¥–∏—Ü–∏–Ω–∞. –û–¥–Ω–∞–∫–æ –≤ –æ—Ç—Ä–∞—Å–ª–∏ –≤—Å—ë –µ—â—ë –æ—Å—Ç—Ä–æ —Å—Ç–æ–∏—Ç –∑–∞–¥–∞—á–∞ —Å–æ–∑–¥–∞–Ω–∏—è —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π, –∫–æ—Ç–æ—Ä—ã–µ –Ω–µ –ø—Ä–æ—Å—Ç–æ –æ–±—Ä–∞–±–∞—Ç—ã–≤–∞—é—Ç –¥–∞–Ω–Ω—ã–µ, –∞ –≥–ª—É–±–æ–∫–æ —É—á–∏—Ç—ã–≤–∞—é—Ç —Å–ª–æ–∂–Ω—ã–µ —Ä–æ–ª–∏ –∏ –ø—Ä–æ—Ü–µ—Å—Å—ã —Ñ–∞—Ä–º—Ä—ã–Ω–∫–∞ –¥–ª—è —Ç–æ—á–Ω–æ–≥–æ –∞–Ω–∞–ª–∏–∑–∞ –∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã—Ö —Ä–µ—à–µ–Ω–∏–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-06-24T11:33:30+00:00,@bezrec,6225,https://t.me/bezrec/6225,"–§–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—è ¬´–ê–∫—Å–µ–ª—å–§–∞—Ä–º¬ª –ø—Ä–æ–∏–≥—Ä–∞–ª–∞ —Å–ø–æ—Ä —Å –§–ê–° –û–Ω–∞ –≤—ã–ø—É—Å—Ç–∏–ª–∞ –¥–∂–µ–Ω–µ—Ä–∏–∫ ¬´–ë–æ–∑—É—Ç–∏–Ω–∏–±–∞¬ª, –Ω–µ—Å–º–æ—Ç—Ä—è –Ω–∞ –¥–µ–π—Å—Ç–≤—É—é—â–∏–π –ø–∞—Ç–µ–Ω—Ç –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞. –§–ê–° –ø—Ä–∏–∑–Ω–∞–ª–∞ –Ω–∞—Ä—É—à–µ–Ω–∏–µ –∏ –ø–æ—Ç—Ä–µ–±–æ–≤–∞–ª–∞ –≤–µ—Ä–Ω—É—Ç—å –≤ –±—é–¥–∂–µ—Ç 40,5 –º–ª–Ω —Ä—É–±. –ê—Ä–±–∏—Ç—Ä–∞–∂–Ω—ã–π —Å—É–¥ –ú–æ—Å–∫–≤—ã 23 –∏—é–Ω—è 2025 –≥–æ–¥–∞ –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª –∑–∞–∫–æ–Ω–Ω–æ—Å—Ç—å –ø—Ä–µ–¥–ø–∏—Å–∞–Ω–∏—è. –≠—Ç–æ –Ω–µ –ø–µ—Ä–≤—ã–π —Å–ª—É—á–∞–π: –≤ 2024‚Äì2025 –≥–æ–¥–∞—Ö –§–ê–° —É–∂–µ –ø—Ä–µ–¥—ä—è–≤–ª—è–ª–∞ –∫–æ–º–ø–∞–Ω–∏–∏ –ø—Ä–µ—Ç–µ–Ω–∑–∏–∏ –ø–æ –¥–∂–µ–Ω–µ—Ä–∏–∫–∞–º ¬´–ê–∫—Å–∏—Ç–∏–Ω–∏–±–∞¬ª –∏ ¬´–û—Å–∏–º–µ—Ä—Ç–∏–Ω–∏–±–∞¬ª —Å –ø–µ—Ä–µ–º–µ–Ω–Ω—ã–º —É—Å–ø–µ—Ö–æ–º –≤ —Å—É–¥–∞—Ö. #–∑–∞–±–∏–ª–∏ ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""A pharmaceutical company 'AxelFarm' has lost a dispute with the FAS over generic 'Bosutinib'. The FAS found that the original drug patent was violated and demanded a refund of 40.5 million rubles to the budget. The Moscow Arbitration Court confirmed the legality of the FAS's orders on June 23, 2025. This is not the first case: in 2024-2025, the FAS had already made claims against generics 'Axitinib' and 'Osmitherin' with varying success in court.""
}"
2025-06-24T09:34:00+00:00,@bezrec,6223,https://t.me/bezrec/6223,"–°–µ–≥–æ–¥–Ω—è —Ä–µ—à–∏–ª–∏ –ø–æ—Å–º–æ—Ç—Ä–µ—Ç—å –∫–∞–∫ #–∑–∞–ø–∞–∫–æ–≤–∞–ª–∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –∏–∑ —Ä–∞–∑–Ω—ã—Ö —Å—Ç—Ä–∞–Ω –∫–∞–ø–ª–∏ –æ—Ç –ø–æ–∫—Ä–∞—Å–Ω–µ–Ω–∏—è –≥–ª–∞–∑ –Ω–∞ –æ—Å–Ω–æ–≤–µ —Ç–µ—Ç—Ä–∏–∑–æ–ª–∏–Ω–∞. –ü—Ä–æ—Å–∏–º –≤ –æ–ø—Ä–æ—Å–µ –≤—ã–±—Ä–∞—Ç—å –æ–¥–∏–Ω –∏–∑ –ø—è—Ç–∏ –≤–∞—Ä–∏–∞–Ω—Ç–æ–≤, –∏—Å—Ö–æ–¥—è –∏—Å–∫–ª—é—á–∏—Ç–µ–ª—å–Ω–æ –∏–∑ –¥–∏–∑–∞–π–Ω–∞ —É–ø–∞–∫–æ–≤–∫–∏: 1. –í–∏–∑–∏–Ω (¬´Johnson & Johnson¬ª); 2. –û–∫—Ç–∏–ª–∏—è (¬´–ù–û–í–ê–ú–ï–î–ò–ö–ê¬ª); 3. –í–∏–∑–æ–∫–∫–æ (¬´–î–ò–ê–§–ê–†–ú¬ª); 4. –í–∏–∑–æ–ø—Ç–∏–∫ (¬´–ö.–û. –†–æ–º—Ñ–∞—Ä–º –ö–æ–º–ø–∞–Ω–∏ –°.–†.–õ.¬ª); 5. –û—Ñ—Ç—Ä–∏–∫—Å (¬´–ì—Ä–æ—Ç–µ–∫—Å¬ª). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-06-24T07:05:31+00:00,@bezrec,6219,https://t.me/bezrec/6219,"–ü–∞—Ü–∏–µ–Ω—Ç—Å–∫–∏–π –ø—É—Ç—å –º–µ–Ω—è–µ—Ç—Å—è ‚Äì –∑–Ω–∞—á–∏—Ç, –º–µ–Ω—è–µ—Ç—Å—è –∏ –≤–ª–∏—è–Ω–∏–µ –Ω–∞ –ø—Ä–æ–¥–∞–∂–∏. –ü–æ –¥–∞–Ω–Ω—ã–º HealthIndex: ‚≠êÔ∏è 60% –ø–æ–∫—É–ø–∞—Ç–µ–ª–µ–π Rx –∏ –±–æ–ª–µ–µ 50% OTC –∏–¥—É—Ç –≤ –∞–ø—Ç–µ–∫—É –ø–æ—Å–ª–µ –∫–æ–Ω—Å—É–ª—å—Ç–∞—Ü–∏–∏ —Å –≤—Ä–∞—á–æ–º. –ù–∞–∑–Ω–∞—á–µ–Ω–∏—è —á–∞—â–µ –ø–æ –ú–ù–ù ‚Äì –±—Ä–µ–Ω–¥ –≤—ã–±–∏—Ä–∞–µ—Ç—Å—è —É–∂–µ –≤ –∞–ø—Ç–µ–∫–µ. ‚≠êÔ∏è–ü—Ä–æ–≤–∏–∑–æ—Ä—ã —á–∞—â–µ —Ä–µ–∫–æ–º–µ–Ω–¥—É—é—Ç –∏ –ø—Ä–æ–¥–≤–∏–≥–∞—é—Ç –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã ‚Äì –ø–æ –∞–∫—Ü–∏—è–º, –ø—Ä–æ–≥—Ä–∞–º–º–∞–º, –∫–æ–Ω—Ç—Ä–∞–∫—Ç–∞–º. ‚≠êÔ∏è–ü–æ–∫—É–ø–∞—Ç–µ–ª—å —Å—Ç–∞–ª –æ—Å–æ–∑–Ω–∞–Ω–Ω–µ–µ: —á–∏—Ç–∞–µ—Ç –æ—Ç–∑—ã–≤—ã (30%), —Å—Ä–∞–≤–Ω–∏–≤–∞–µ—Ç —Ü–µ–Ω—ã (20%), –∏—â–µ—Ç –¥–∏–∞–≥–Ω–æ–∑—ã –æ–Ω–ª–∞–π–Ω (17%). –¢–æ–ª—å–∫–æ –ø–æ–ª–æ–≤–∏–Ω–∞ –ø–æ–∫—É–ø–∞–µ—Ç —Å—Ä–∞–∑—É –ø–æ—Å–ª–µ –≤–∏–∑–∏—Ç–∞ –∫ –≤—Ä–∞—á—É. ‚≠êÔ∏è–ü–æ—á—Ç–∏ 45% —Å–æ–≤–µ—Ä—à–∞—é—Ç –ø–æ–∫—É–ø–∫–∏ –≤ –æ–Ω–ª–∞–π–Ω–µ –∏–ª–∏ –≤ –≥–∏–±—Ä–∏–¥–Ω–æ–π –º–æ–¥–µ–ª–∏. –ó–∞ 4 –≥–æ–¥–∞ –¥–æ–ª—è –æ–Ω–ª–∞–π–Ω-–∫–∞–Ω–∞–ª–æ–≤ –≤—ã—Ä–æ—Å–ª–∞ –Ω–∞ 5-6 –ø.–ø. –ö–ª—é—á–µ–≤—ã–µ —Ç–æ—á–∫–∏ —Ä–æ—Å—Ç–∞ ‚Äì —ç—Ç–æ –∞–ø—Ç–µ–∫–∞, –æ–Ω–ª–∞–π–Ω –∏ —Ä–∞–±–æ—Ç–∞ —Å –ø—Ä–æ–≤–∏–∑–æ—Ä–∞–º–∏. –ü—É—Ç—å –ø–∞—Ü–∏–µ–Ω—Ç–∞ —Å–µ–≥–æ–¥–Ω—è ‚Äì —ç—Ç–æ –Ω–µ —Ç–æ–ª—å–∫–æ –≤—Ä–∞—á, –Ω–æ –∏ –≤—ã–±–æ—Ä –≤ –º–æ–º–µ–Ω—Ç –ø–æ–∫—É–ø–∫–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The patient journey is changing, impacting sales. According to HealthIndex: - 60% of Rx buyers and over 50% of OTC shoppers visit pharmacies after consulting with doctors. - Pharmacists are more frequently prescribing by brand name, and recommending products through discounts, programs, or contracts. - Consumers are more informed: reading reviews (30%), comparing prices (20%), and searching for diagnoses online (17%). Only half of the purchases are made immediately after a doctor's visit. - Almost 45% of purchases occur online or in hybrid models. In the last four years, the share of online channels has increased by 5-6%. Key growth areas include pharmacies, e-commerce, and working with pharmacists. The patient journey today is not just about the doctor but also the purchasing decision moment.""
}"
2025-06-23T14:40:52+00:00,@bezrec,6218,https://t.me/bezrec/6218,"–í –†–æ—Å—Å–∏–∏ –≤–ø–µ—Ä–≤—ã–µ —É–¥–∞–ª–æ—Å—å –≤–∑—è—Ç—å –ø–æ–¥ –∫–æ–Ω—Ç—Ä–æ–ª—å –°–ú–ê ‚Äì –æ–¥–Ω–æ –∏–∑ —Å–∞–º—ã—Ö —Ç—è–∂—ë–ª—ã—Ö –Ω–∞—Å–ª–µ–¥—Å—Ç–≤–µ–Ω–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –≠—Ç–æ —Å—Ç–∞–ª–æ –≤–æ–∑–º–æ–∂–Ω—ã–º –±–ª–∞–≥–æ–¥–∞—Ä—è —Ä–∞–Ω–Ω–µ–π –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–µ, –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –∏, –≥–ª–∞–≤–Ω–æ–µ, –§–æ–Ω–¥—É ¬´–ö—Ä—É–≥ –¥–æ–±—Ä–∞¬ª, —Å–æ–∑–¥–∞–Ω–Ω–æ–º—É –ø–æ –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–µ –ü—Ä–µ–∑–∏–¥–µ–Ω—Ç–∞ –†–§. ¬´–ö—Ä—É–≥ –¥–æ–±—Ä–∞¬ª —Å–µ–≥–æ–¥–Ω—è –æ–±–µ—Å–ø–µ—á–∏–≤–∞–µ—Ç –ª–µ—á–µ–Ω–∏–µ –ø–æ –≤—Å–µ–π —Å—Ç—Ä–∞–Ω–µ: –≤ 2025 –≥–æ–¥—É —Ç–µ—Ä–∞–ø–∏—é –ø–æ–ª—É—á–∞—é—Ç 422 –ø–∞—Ü–∏–µ–Ω—Ç–∞ —Å–æ –°–ú–ê, –≤–∫–ª—é—á–∞—è 354 —Ä–µ–±—ë–Ω–∫–∞. –° 2023 –≥–æ–¥–∞ –≤—Å–µ–º –Ω–æ–≤–æ—Ä–æ–∂–¥—ë–Ω–Ω—ã–º –ø—Ä–æ–≤–æ–¥—è—Ç –Ω–µ–æ–Ω–∞—Ç–∞–ª—å–Ω—ã–π —Å–∫—Ä–∏–Ω–∏–Ω–≥, –∫–æ—Ç–æ—Ä—ã–π –ø–æ–∑–≤–æ–ª—è–µ—Ç –≤—ã—è–≤–ª—è—Ç—å –±–æ–ª–µ–∑–Ω—å –¥–æ —Å–∏–º–ø—Ç–æ–º–æ–≤. –§–æ–Ω–¥ –æ–±–µ—Å–ø–µ—á–∏–≤–∞–µ—Ç –ø–æ—Å—Ç–∞–≤–∫—É –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ —Å—Ä–µ–¥–Ω–µ–º –º–µ–Ω–µ–µ —á–µ–º –∑–∞ –º–µ—Å—è—Ü. –í 2024 –≥–æ–¥—É —Ñ–æ–Ω–¥ –Ω–∞—á–∞–ª –∑–∞–∫—É–ø–∞—Ç—å —Ä–æ—Å—Å–∏–π—Å–∫–∏–π –ø—Ä–µ–ø–∞—Ä–∞—Ç ¬´–õ–∞–Ω—Ç–µ—Å–µ–Ω—Å¬ª, –∫–æ—Ç–æ—Ä—ã–π —É–∂–µ –ø—Ä–∏–º–µ–Ω—è–µ—Ç—Å—è –≤ 68 —Ä–µ–≥–∏–æ–Ω–∞—Ö. –ù–∞ 30 –º–∞—è 2025 –≥–æ–¥–∞, —Ä–æ—Å—Å–∏–π—Å–∫–∏–º–∏ –≤—Ä–∞—á–∞–º–∏ –≤—ã–ø–æ–ª–Ω–µ–Ω–æ 603 –≤–≤–µ–¥–µ–Ω–∏—è. –û—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –ø–æ–ª—É—á–∏–ª–∏ 422 –ø–∞—Ü–∏–µ–Ω—Ç–∞, –∏–∑ –Ω–∏—Ö 354 —Ä–µ–±–µ–Ω–∫–∞ –∏ 68 –≤–∑—Ä–æ—Å–ª—ã—Ö. –ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –Ω–∞–ª–∞–∂–µ–Ω–æ –ø–æ –ø–æ–ª–Ω–æ–º—É —Ü–∏–∫–ª—É –≤ –†–æ—Å—Å–∏–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""Russia has successfully controlled SMA - one of the most severe hereditary diseases. This is possible due to early diagnosis, domestic treatment, and the Fund 'Circle of Goodness', initiated by the President of Russia. The Fund provides treatment throughout the country: 422 patients with SMA, including 354 children, received treatment by the end of 2025. Since 2023, neonatal screening is conducted to detect the disease before symptoms appear. The Fund ensures supply of drugs within a month. In 2024, the Fund began purchasing Russian drug 'Lantensense', which is used in 68 regions. By May 30, 2025, Russian doctors have administered 603 treatments. The full production cycle of the domestic drug is now operational.""
}"
2025-06-23T13:14:10+00:00,@bezrec,6217,https://t.me/bezrec/6217,"–ü—Ä–æ—Ç–∏–≤–æ—ç–ø–∏–ª–µ–ø—Ç–∏—á–µ—Å–∫–∏–π –ø—Ä–µ–ø–∞—Ä–∞—Ç —Å—Ç–∞–ª –¥–æ—Å—Ç—É–ø–Ω–µ–µ –Ω–∞ 18% –§–ê–° —Å–æ–≥–ª–∞—Å–æ–≤–∞–ª–∞ —Ü–µ–Ω—É –Ω–∞ –ø–µ—Ä–≤—ã–π —Ä–æ—Å—Å–∏–π—Å–∫–∏–π –¥–∂–µ–Ω–µ—Ä–∏–∫ –ª–∞–∫–æ—Å–∞–º–∏–¥–∞ ‚Äì ¬´–õ–∞–∫–æ—Å–∞–º–∏–¥-–ê–π–ü–∏¬ª. –£–ø–∞–∫–æ–≤–∫–∞ –∏–∑ 14 —Ç–∞–±–ª–µ—Ç–æ–∫ –ø–æ 50 –º–≥ –æ–±–æ–π–¥—ë—Ç—Å—è –≤ 175 —Ä—É–±–ª–µ–π. –î–ª—è —Å—Ä–∞–≤–Ω–µ–Ω–∏—è, —Ü–µ–Ω–∞ —Ä–µ—Ñ–µ—Ä–µ–Ω—Ç–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ¬´–í–∏–º–ø–∞—Ç¬ª –æ—Ç UCB —Å–æ—Å—Ç–∞–≤–ª—è–µ—Ç 213 —Ä—É–±–ª–µ–π. –õ–∞–∫–æ—Å–∞–º–∏–¥ –ø—Ä–∏–º–µ–Ω—è–µ—Ç—Å—è –≤ –∫–∞—á–µ—Å—Ç–≤–µ –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –ø–∞—Ä—Ü–∏–∞–ª—å–Ω—ã—Ö —ç–ø–∏–ª–µ–ø—Ç–∏—á–µ—Å–∫–∏—Ö –ø—Ä–∏–ø–∞–¥–∫–æ–≤ —Å –∏–ª–∏ –±–µ–∑ –≤—Ç–æ—Ä–∏—á–Ω–æ–π –≥–µ–Ω–µ—Ä–∞–ª–∏–∑–∞—Ü–∏–∏ —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å —ç–ø–∏–ª–µ–ø—Å–∏–µ–π —Å—Ç–∞—Ä—à–µ 16 –ª–µ—Ç. –°–Ω–∏–∂–µ–Ω–∏–µ —Ü–µ–Ω—ã —Ä–∞—Å—à–∏—Ä–∏—Ç –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å —Ç–µ—Ä–∞–ø–∏–∏ –∏ –ø–æ–≤—ã—Å–∏—Ç –æ—Ö–≤–∞—Ç –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –≤ —Ä–∞–º–∫–∞—Ö –≥–æ—Å–ø—Ä–æ–≥—Ä–∞–º–º. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""pricing, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The antiepileptic drug Lacosamide-AyPi became 18% cheaper. The FAS approved the price for Russia's first generic version of Lacosamide-AyPi, which costs 175 rubles for a box of 14 tablets at 50 mg. In comparison, the reference drug 'Vimpelimycin' from UCB costs 213 rubles. Lacosamide is used as an additional therapy for partial epileptic seizures with or without secondary generalization in patients over 16 years old. The price reduction will expand access to the treatment and increase coverage under government programs.""
}"
2025-06-23T11:23:06+00:00,@bezrec,6214,https://t.me/bezrec/6214,"–ë–ê–î—ã –ø–µ—Ä–µ—Å—Ç–∞—é—Ç –±—ã—Ç—å ¬´–∞–ª—å—Ç–µ—Ä–Ω–∞—Ç–∏–≤–æ–π¬ª ‚Äì –æ–Ω–∏ —Å—Ç–∞–Ω–æ–≤—è—Ç—Å—è —á–∞—Å—Ç—å—é —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π —Å–∏—Å—Ç–µ–º—ã ‚ñ∂Ô∏è–ù–∞–∑–Ω–∞—á–µ–Ω–∏—è –≤—ã—Ä–æ—Å–ª–∏ —Å 8,9 –º–ª–Ω –≤ 2021 –≥–æ–¥—É –¥–æ 10,1 –º–ª–Ω –≤ 2024, –ø–æ –¥–∞–Ω–Ω—ã–º PrIndex. –¢–æ–ª—å–∫–æ –∑–∞ 2024 –≥–æ–¥ ‚Äî –ø–æ—á—Ç–∏ 2,8 –º–ª–Ω –Ω–∞–∑–Ω–∞—á–µ–Ω–∏–π. ‚ñ∂Ô∏è58% –ø—Ä–æ–≤–∏–∑–æ—Ä–æ–≤ –æ—Ç–º–µ—á–∞—é—Ç, —á—Ç–æ –ø–æ–∫—É–ø–∞—Ç–µ–ª–∏ —Å–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω–æ –∑–∞–ø—Ä–∞—à–∏–≤–∞—é—Ç –ë–ê–î—ã, –ø–æ –¥–∞–Ω–Ω—ã–º Pharma-Q. 50% –ø—Ä–∏–æ–±—Ä–µ—Ç–∞—é—Ç –ø–æ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –≤—Ä–∞—á–∞. ‚ñ∂Ô∏è–û–±—ä—ë–º –ø–æ—Å—Ç–∞–≤–æ–∫ –ë–ê–î–æ–≤ –≤ –∞–ø—Ç–µ–∫–∏ —Å 2020 –≥–æ–¥–∞ —É–≤–µ–ª–∏—á–∏–ª—Å—è –≤ 1,4 —Ä–∞–∑–∞, –≤—ã—è—Å–Ω–∏–ª–∏ ¬´–ò–∑–≤–µ—Å—Ç–∏—è¬ª. –í —Ä—è–¥–µ —Å–µ—Ç–µ–π –¥–æ–ª—è –ë–ê–î–æ–≤ –≤ –∑–∞–∫—É–ø–∫–∞—Ö –≤—ã—Ä–æ—Å–ª–∞ —Å 8% –¥–æ 24%. –û—Å–Ω–æ–≤–Ω–æ–π —Å–ø—Ä–æ—Å ‚Äì –∫–æ–ª–ª–∞–≥–µ–Ω, —Ö–æ–Ω–¥—Ä–æ–∏—Ç–∏–Ω, –≤–∏—Ç–∞–º–∏–Ω—ã C –∏ D. ‚ñ∂Ô∏è–°–∏–ª—å–Ω—ã–µ –±—Ä–µ–Ω–¥—ã –ø–æ–ª—É—á–∞—é—Ç –ø—Ä–æ–¥–≤–∏–∂–µ–Ω–∏–µ –æ—Ç –≤—Ä–∞—á–µ–π –∏ –∞–ø—Ç–µ–∫: –∫—Ä–æ—Å—Å-–ø—Ä–æ–º–æ, –ø—Ä–æ–≥—Ä–∞–º–º—ã –ª–æ—è–ª—å–Ω–æ—Å—Ç–∏, –≤–∫–ª—é—á–µ–Ω–∏–µ –≤ –ø–ª–∞–Ω—ã –ø—Ä–æ–¥–∞–∂. ‚ñ∂Ô∏è–î–æ–±–∞–≤–∫–∏ —Å—Ç–∞–Ω–æ–≤—è—Ç—Å—è —á–∞—Å—Ç—å—é –ø–æ–≤—Å–µ–¥–Ω–µ–≤–Ω–æ–π –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏: –ó–û–ñ, –±–∏–æ—Ö–∞–∫–∏–Ω–≥ –∏ —Ç–µ–ª–µ–º–µ–¥–∏—Ü–∏–Ω–∞ —Ñ–æ—Ä–º–∏—Ä—É—é—Ç —Å–ø—Ä–æ—Å. –õ—é–¥–∏ –≤—Å—ë —á–∞—â–µ –∏–Ω–≤–µ—Å—Ç–∏—Ä—É—é—Ç –≤ –∑–¥–æ—Ä–æ–≤—å–µ –Ω–∞ –æ–ø–µ—Ä–µ–∂–µ–Ω–∏–µ. ‚ñ∂Ô∏è–°–∞–º–æ–ª–µ—á–µ–Ω–∏–µ –∏ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–µ –∫–æ–Ω—Ç—Ä–æ–ª—è –ø—Ä–∏–≤–æ–¥—è—Ç –∫ –ø–æ–¥–º–µ–Ω–µ –ª–µ–∫–∞—Ä—Å—Ç–≤, –Ω–µ–ø—Ä–∞–≤–∏–ª—å–Ω—ã–º –¥–æ–∑–∏—Ä–æ–≤–∫–∞–º –∏ –æ—Å–ª–æ–∂–Ω–µ–Ω–∏—è–º. –û—Å–æ–±–µ–Ω–Ω–æ —É—è–∑–≤–∏–º—ã –¥–æ–±–∞–≤–∫–∏ –¥–ª—è —Å–Ω–∏–∂–µ–Ω–∏—è –≤–µ—Å–∞, –ø–æ—Ç–µ–Ω—Ü–∏–∏ –∏ –≤–∏—Ç–∞–º–∏–Ω—ã –≤ –≤—ã—Å–æ–∫–∏—Ö –¥–æ–∑–∞—Ö. –ú–∏–Ω–∑–¥—Ä–∞–≤ —Ä–∞—Å—Å–º–∞—Ç—Ä–∏–≤–∞–µ—Ç –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –¥–æ–ø—É—Å–∫–∞ –∫ –ø—Ä–æ–¥–∞–∂–µ —Ç–æ–ª—å–∫–æ –ë–ê–î–æ–≤ —Å –¥–æ–∫–∞–∑–∞–Ω–Ω—ã–º —ç—Ñ—Ñ–µ–∫—Ç–æ–º. –í–µ–¥—ë—Ç—Å—è —Ä–∞–±–æ—Ç–∞ –ø–æ —É—Å–∏–ª–µ–Ω–∏—é –∫–æ–Ω—Ç—Ä–æ–ª—è –∫–∞—á–µ—Å—Ç–≤–∞ –∏ –±–æ—Ä—å–±–µ —Å –ø—Å–µ–≤–¥–æ-–ë–ê–î–∞–º–∏, –æ—Å–æ–±–µ–Ω–Ω–æ –≤ –æ–Ω–ª–∞–π–Ω-–∫–∞–Ω–∞–ª–∞—Ö –∏ —Å–µ—Ç–µ–≤–æ–º –º–∞—Ä–∫–µ—Ç–∏–Ω–≥–µ. –°–µ–≥–º–µ–Ω—Ç –±—É–¥–µ—Ç –ø—Ä–æ–¥–æ–ª–∂–∞—Ç—å —Ä–∞—Å—Ç–∏. –ù–æ –¥–∞–ª—å–Ω–µ–π—à–µ–µ —Ä–∞–∑–≤–∏—Ç–∏–µ –≤–æ–∑–º–æ–∂–Ω–æ —Ç–æ–ª—å–∫–æ –ø—Ä–∏ —Å–æ–±–ª—é–¥–µ–Ω–∏–∏ –±–∞–ª–∞–Ω—Å–∞: —Ä–æ—Å—Ç —Å–ø—Ä–æ—Å–∞ –¥–æ–ª–∂–µ–Ω —Å–æ–ø—Ä–æ–≤–æ–∂–¥–∞—Ç—å—Å—è –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–π –≤–∞–ª–∏–¥–Ω–æ—Å—Ç—å—é, –ø—Ä–æ–∑—Ä–∞—á–Ω–æ—Å—Ç—å—é —Ñ–æ—Ä–º—É–ª –∏ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–º –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º —Å–æ–ø—Ä–æ–≤–æ–∂–¥–µ–Ω–∏–µ–º. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand, clinical_trial, safety, guideline"",
  ""impact"": ""high"",
  ""english"": ""The prescription of dietary supplements (BAs) has increased from 8.9 million in 2021 to 10.1 million in 2024, with almost 2.8 million prescriptions in just one year. Only 58% of pharmacists report that patients request BAs independently, while 50% do so based on a doctor's recommendation. The supply of BAs in pharmacies has increased by 1.4 times since 2020, with some chains seeing their BAs share rise from 8% to 24%. The main demand is for collagen, chondroitin, and vitamins C and D. Strong brands receive promotion from doctors and pharmacies through cross-promotions, loyalty programs, and inclusion in sales plans. The self-medication trend and lack of control are leading to incorrect dosing, complications, and the substitution of medications. The Ministry of Health is considering allowing only BAs with proven efficacy to be sold. Efforts are underway to strengthen"
2025-06-23T06:40:40+00:00,@bezrec,6212,https://t.me/bezrec/6212,"–†–æ—Å—Å–∏—è–Ω–µ –ª–µ—á–∞—Ç –∞—Å—Ç–º—É –≤ –æ—Å–Ω–æ–≤–Ω–æ–º –∏–º–ø–æ—Ä—Ç–Ω—ã–º–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º–∏, –Ω–æ —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ –¥–∂–µ–Ω–µ—Ä–∏–∫–∏ —Ç–æ–∂–µ –∑–∞–º–µ—Ç–Ω–æ —É–∫—Ä–µ–ø–ª—è—é—Ç –ø–æ–∑–∏—Ü–∏–∏ –í Headway Company –ø–æ–¥—Å—á–∏—Ç–∞–ª–∏, —á—Ç–æ –∑–∞ 2024 –≥–æ–¥ –æ–±—ä—ë–º –≥–æ—Å–∑–∞–∫—É–ø–æ–∫ –∏–Ω–≥–∞–ª—è—Ü–∏–æ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –∞—Å—Ç–º—ã –∏ –•–û–ë–õ —Å–æ—Å—Ç–∞–≤–∏–ª 14,4 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —á—Ç–æ –Ω–∞ 21% –±–æ–ª—å—à–µ, —á–µ–º –≤ 2023 –≥–æ–¥—É. –ö–æ–ª–∏—á–µ—Å—Ç–≤–æ –∑–∞–∫—É–ø–æ—á–Ω—ã—Ö –ø—Ä–æ—Ü–µ–¥—É—Ä —Ç–∞–∫–∂–µ –≤—ã—Ä–æ—Å–ª–æ –Ω–∞ 10% –≥–æ–¥ –∫ –≥–æ–¥—É. –ù–∞–∏–±–æ–ª–µ–µ –≤–æ—Å—Ç—Ä–µ–±–æ–≤–∞–Ω—ã –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã —Å –∫–æ–º–±–∏–Ω–∞—Ü–∏–µ–π –±—É–¥–µ—Å–æ–Ω–∏–¥–∞ –∏ —Ñ–æ—Ä–º–æ—Ç–µ—Ä–æ–ª–∞ ‚Äì –Ω–∞ –∏—Ö –¥–æ–ª—é –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–∞—è —á–∞—Å—Ç—å –∑–∞–∫—É–ø–æ–∫ –≤ –¥–µ–Ω–µ–∂–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏. –ë–æ–ª—å—à–µ –≤—Å–µ–≥–æ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ –∑–∞–∫–∞–∑—á–∏–∫–∏ –ø–æ—Ç—Ä–∞—Ç–∏–ª–∏ –Ω–∞ –°–ø–∏—Ä–∏–≤–∞ –†–µ—Å–ø–∏–º–∞—Ç –æ—Ç Boehringer Ingelheim –∏ –†–µ—Å–ø–∏—Ñ–æ—Ä–± –æ—Ç —Ä–æ—Å—Å–∏–π—Å–∫–æ–π –ü–°–ö –§–∞—Ä–º–∞. –≠—Ç–∏ –¥–≤–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ —Ñ–æ—Ä–º–∏—Ä—É—é—Ç –±–æ–ª–µ–µ 24% –æ–±—ä—ë–º–∞ –∑–∞–∫—É–ø–æ–∫ –≤ –¥–µ–Ω—å–≥–∞—Ö. –í —É–ø–∞–∫–æ–≤–∫–∞—Ö –ª–∏–¥–µ—Ä–æ–º —Å—Ç–∞–ª –î—É–æ–†–µ—Å–ø –°–ø–∏—Ä–æ–º–∞–∫—Å –æ—Ç Teva ‚Äì –∑–∞ –≥–æ–¥ –ø—Ä–æ–¥–∞–∂–∏ –≤—ã—Ä–æ—Å–ª–∏ –≤—Ç—Ä–æ–µ, –¥–æ 513 –º–ª–Ω —Ä—É–±–ª–µ–π. –ò–∑ –≤—Å–µ–π –¥–µ—Å—è—Ç–∫–∏ –ø—Ä–æ—Å–µ–ª —Ç–æ–ª—å–∫–æ –£–ª—å—Ç–∏–±—Ä–æ –ë—Ä–∏–∑—Ö–∞–ª–µ—Ä –æ—Ç Novartis. –ó–∞–∫—É–ø–∫–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ —Å–Ω–∏–∑–∏–ª–∏—Å—å –Ω–∞ 7,6% –≤ –¥–µ–Ω—å–≥–∞—Ö, –Ω–µ—Å–º–æ—Ç—Ä—è –Ω–∞ —É–∑–Ω–∞–≤–∞–µ–º–æ—Å—Ç—å –±—Ä–µ–Ω–¥–∞ –∏ –≤—ã—Å–æ–∫—É—é –∫–ª–∏–Ω–∏—á–µ—Å–∫—É—é —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""Russia's patients are mainly using imported drugs for asthma and COPD treatment. Domestic generics also show significant growth in market share. The government procurement of inhalation medications for asthma and COPD reached 14.4 billion rubles in 2024, up by 21% compared to the previous year. The number of procurement procedures also increased by 10%. The most purchased combination drugs are Budesonide and Formoterol, accounting for a significant portion of the procurement value. The government has spent more on Boehringer Ingelheim's Respimat and PSK Pharma's Resphibol. These two drugs account for over 24% of the procurement value. Teva's DuOResp Spirmax, which sold 513 million rubles in a year, is the leader. Novartis' Ultibro Breezhaler, despite its brand recognition and clinical effectiveness, saw a 7.6% decrease in procurement value.""
}"
2025-06-22T09:10:55+00:00,@bezrec,6211,https://t.me/bezrec/6211,"–ó–∞–∫–∞–Ω—á–∏–≤–∞–µ–º –Ω–µ–¥–µ–ª—é –Ω–∞—à–µ–π —Ä—É–±—Ä–∏–∫–æ–π #–≤–¥–æ–≥–æ–Ω–∫—É ‚Äì –æ —Ç–æ–º, —á—Ç–æ –Ω–µ —É—Å–ø–µ–ª–∏ —Ä–∞—Å—Å–∫–∞–∑–∞—Ç—å –≤ –±—É–¥–Ω–∏. üíä¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª –ø–µ—Ä–≤–æ–π –≤ 2025 –≥–æ–¥—É –ø—Ä–æ–≤–µ–ª–∞ SPO —Å –æ—Ç–∫—Ä—ã—Ç–æ–π –ø–æ–¥–ø–∏—Å–∫–æ–π ‚Äì —Ä–∞–∑–º–µ—â–∞–µ—Ç—Å—è –¥–æ 7,5% –∞–∫—Ü–∏–π –æ—Å–Ω–æ–≤–∞—Ç–µ–ª—è. –ù–µ—Å–º–æ—Ç—Ä—è –Ω–∞ —Å–ª–∞–±—ã–π —Ä—ã–Ω–æ–∫, –±—É–º–∞–≥–∏ –∫–æ–º–ø–∞–Ω–∏–∏ —Å –Ω–∞—á–∞–ª–∞ –≥–æ–¥–∞ –≤—ã—Ä–æ—Å–ª–∏ –Ω–∞ 13%, –∞ –∏–Ω–≤–µ—Å—Ç–æ—Ä—ã –∂–¥—É—Ç –≤—ã—Å–æ–∫–æ–≥–æ —Å–ø—Ä–æ—Å–∞. üíä–†–æ—Å—Å–∏—è–Ω–µ –≤—Å—ë —á–∞—â–µ –∏—â—É—Ç —Å–ø–∞—Å–µ–Ω–∏–µ –æ—Ç –ø–æ—Ö–º–µ–ª—å—è –≤ –∞–ø—Ç–µ–∫–µ: –∑–∞ –ø–µ—Ä–≤—ã–µ —á–µ—Ç—ã—Ä–µ –º–µ—Å—è—Ü–∞ 2025 –≥–æ–¥–∞ –ø—Ä–æ–¥–∞–∂–∏ —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤—ã—Ä–æ—Å–ª–∏ –Ω–∞ 73%. –õ–∏–¥–µ—Ä—ã —Å–ø—Ä–æ—Å–∞ ‚Äì –ê–ª–∫–∞-–ó–µ–ª—å—Ç—Ü–µ—Ä –∏ –ú–µ—Ç–∞–¥–æ–∫—Å–∏–ª, –ø–æ—Å–ª–µ–¥–Ω–∏–π —É–≤–µ–ª–∏—á–∏–ª –ø—Ä–æ–¥–∞–∂–∏ –ø–æ—á—Ç–∏ –≤—Ç—Ä–æ–µ. üíä–í I –∫–≤–∞—Ä—Ç–∞–ª–µ 2025 –≥–æ–¥–∞ —Ä—É–±–ª—ë–≤–∞—è –¥–∏–Ω–∞–º–∏–∫–∞ –æ–Ω–ª–∞–π–Ω-–∫–∞–Ω–∞–ª–∞ —Ñ–∞—Ä–º—Ä—ã–Ω–∫–∞ –≤—Ç—Ä–æ–µ –ø—Ä–µ–≤—ã—Å–∏–ª–∞ —Å—Ä–µ–¥–Ω–µ—Ä—ã–Ω–æ—á–Ω—É—é (+35,7%). –ü—Ä–æ–¥–∞–∂–∏ —Å –¥–æ—Å—Ç–∞–≤–∫–æ–π –≤—ã—Ä–æ—Å–ª–∏ –Ω–∞ 57%, –∞ –ª–∏–¥–µ—Ä—ã e-com Polza.ru –∏ ¬´–ê–ø—Ä–µ–ª—å¬ª —É–¥–≤–æ–∏–ª–∏ –≤—ã—Ä—É—á–∫—É. üíäBioNTech –ø—Ä–µ–∫—Ä–∞—Ç–∏—Ç –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –∫–ª–µ—Ç–æ—á–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –≤ –°–®–ê –∏ —Å–æ–∫—Ä–∞—Ç–∏—Ç 63 —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–∞ –Ω–∞ —Ñ–æ–Ω–µ –æ—Ç–∫–∞–∑–∞ –æ—Ç —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ CAR-T-–∫–∞–Ω–¥–∏–¥–∞—Ç–∞ BNT211 –ø—Ä–∏ —Ä–∞–∫–µ —è–∏—á–µ–∫. –ö–æ–º–ø–∞–Ω–∏—è –ø–µ—Ä–µ—Å–º–∞—Ç—Ä–∏–≤–∞–µ—Ç —Å—Ç—Ä–∞—Ç–µ–≥–∏—é –ø–æ –∞–∫—Ç–∏–≤—É –∏ —Å–æ—Å—Ä–µ–¥–æ—Ç–æ—á–∏—Ç—Å—è –Ω–∞ –¥—Ä—É–≥–∏—Ö –æ–Ω–∫–æ–∏–Ω–¥–∏–∫–∞—Ü–∏—è—Ö. üíä–ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∞—è –∫–æ–º–ø–∞–Ω–∏—è Eli Lilly –ø–ª–∞–Ω–∏—Ä—É–µ—Ç –∫—É–ø–∏—Ç—å –∑–∞ $1,3 –º–ª—Ä–¥ –±–∏–æ—Ç–µ—Ö Verve Therapeutics, —Ä–∞–∑—Ä–∞–±–∞—Ç—ã–≤–∞—é—â–∏–π –≥–µ–Ω–Ω–æ-—Ä–µ–¥–∞–∫—Ç–∏—Ä—É—é—â–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-06-21T09:10:44+00:00,@bezrec,6210,https://t.me/bezrec/6210,"–°–µ–≥–æ–¥–Ω—è –≤ –Ω–∞—à–µ–π —Ä—É–±—Ä–∏–∫–µ #–∑–∞—Ü–µ–Ω–∏–ª–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –Ω–∞ –æ—Å–Ω–æ–≤–µ –∏–±—É–ø—Ä–æ—Ñ–µ–Ω–∞. –ò—Ö –ø—Ä–∏–º–µ–Ω—è—é—Ç –ø—Ä–∏ –±–æ–ª–∏, –≤–æ—Å–ø–∞–ª–µ–Ω–∏–∏ –∏ —Ç–µ–º–ø–µ—Ä–∞—Ç—É—Ä–µ ‚Äì –æ—Ç –≥–æ–ª–æ–≤–Ω–æ–π –¥–æ —Å—É—Å—Ç–∞–≤–Ω–æ–π, –æ—Ç –ø—Ä–æ—Å—Ç—É–¥—ã –¥–æ –∑—É–±–Ω–æ–π. –ú—ã —Å—Ä–∞–≤–Ω–∏–ª–∏ —Ü–µ–Ω—ã –≤ –æ–Ω–ª–∞–π–Ω-–∞–ø—Ç–µ–∫–∞—Ö –Ω–∞ —Ç–æ—Ä–≥–æ–≤—ã–µ –º–∞—Ä–∫–∏ –ú–∏–≥ (Berlin-Chemie, –ì–µ—Ä–º–∞–Ω–∏—è), –ò–±—É–ø—Ä–æ—Ñ–µ–Ω-–í–µ–ª—Ñ–∞—Ä–º (–í–µ–ª—Ñ–∞—Ä–º, –†–æ—Å—Å–∏—è), –ò–±—É–ø—Ä–æ—Ñ–µ–Ω (–ë–æ—Ä–∏—Å–æ–≤—Å–∫–∏–π –∑–∞–≤–æ–¥ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –ë–µ–ª–∞—Ä—É—Å—å), –ù—É—Ä–æ—Ñ–µ–Ω (Reckitt Benckiser, –ë–∞–Ω–≥–ª–∞–¥–µ—à) –∏ –ù—É—Ä–æ—Ñ–∞—Å—Ç –§–æ—Ä—Ç–µ (–ê–ª–∏—É–º, –†–æ—Å—Å–∏—è). –î–æ—Ä–æ–∂–µ –≤—Å–µ–≥–æ (266 —Ä—É–±–ª–µ–π) –æ–±–æ–π–¥—ë—Ç—Å—è —Ä–æ—Å—Å–∏–π—Å–∫–∏–π –ò–±—É–ø—Ä–æ—Ñ–µ–Ω-–í–µ–ª—Ñ–∞—Ä–º –≤ —Å–µ—Ç–∏ ¬´36,6¬ª. –ó–∞ 20 —Ç–∞–±–ª–µ—Ç–æ–∫ –ø–æ 200 –º–≥ ‚Äì —ç—Ç–æ –ø–æ—á—Ç–∏ 13,5 —Ä—É–±–ª–µ–π –∑–∞ —à—Ç—É–∫—É. –ê –≤–æ—Ç —Å–∞–º–∞—è –≤—ã–≥–æ–¥–Ω–∞—è –ø–æ–∫—É–ø–∫–∞ ‚Äì –±–µ–ª–æ—Ä—É—Å—Å–∫–∏–π –ò–±—É–ø—Ä–æ—Ñ–µ–Ω –≤ ¬´–ï–∞–ø—Ç–µ–∫–µ¬ª –∑–∞ 53 —Ä—É–±–ª—è –∑–∞ 50 —Ç–∞–±–ª–µ—Ç–æ–∫ (–Ω–µ–º–Ω–æ–≥–æ –±–æ–ª—å—à–µ 1 —Ä—É–±–ª—è –∑–∞ —Ç–∞–±–ª–µ—Ç–∫—É). –ï—Å–ª–∏ –≥–æ–≤–æ—Ä–∏—Ç—å –æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞—Ö –≤ –¥–æ–∑–∏—Ä–æ–≤–∫–µ 400 –º–≥, —Ç–æ —Å–∞–º—ã–π –¥–æ—Å—Ç—É–ø–Ω—ã–π ‚Äì –ù—É—Ä–æ—Ñ–∞—Å—Ç –§–æ—Ä—Ç–µ –æ—Ç –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ê–ª–∏—É–º¬ª. –í ¬´–ó–¥—Ä–∞–≤—Å–∏—Ç–∏¬ª –µ–≥–æ –º–æ–∂–Ω–æ –∫—É–ø–∏—Ç—å –∑–∞ 142 —Ä—É–±–ª—è (20 —Ç–∞–±–ª–µ—Ç–æ–∫ –ø–æ 400 –º–≥). –≠—Ç–æ –¥–µ—à–µ–≤–ª–µ, —á–µ–º —É–ø–∞–∫–æ–≤–∫–∞ –ù—É—Ä–æ—Ñ–µ–Ω–∞ –≤ ¬´–†–∏–≥–ª–µ¬ª, –≥–¥–µ –≤—Å–µ–≥–æ 12 —Ç–∞–±–ª–µ—Ç–æ–∫ –ø–æ 200 –º–≥ —Å—Ç–æ—è—Ç 207 —Ä—É–±–ª–µ–π. –ú–∏–≥ —Å—Ç–æ–∏—Ç –≤ –ø—Ä–µ–¥–µ–ª–∞—Ö 82‚Äì87 —Ä—É–±–ª–µ–π –∑–∞ —É–ø–∞–∫–æ–≤–∫—É. –ò —Å–Ω–æ–≤–∞ —Å–∞–º—É—é –Ω–∏–∑–∫—É—é —Ü–µ–Ω—É –º—ã –Ω–∞—à–ª–∏ –≤ ¬´–ó–¥—Ä–∞–≤—Å–∏—Ç–∏¬ª –∏ ¬´–ê–ø—Ç–µ–∫–µ.—Ä—É¬ª. –í–æ–æ–±—â–µ, –ø–æ—á—Ç–∏ –ø–æ –≤—Å–µ–º –ø–æ–∑–∏—Ü–∏—è–º –∞–ø—Ç–µ–∫–∞ ¬´–ó–¥—Ä–∞–≤—Å–∏—Ç–∏¬ª –æ–∫–∞–∑–∞–ª–∞—Å—å —Å–∞–º–æ–π –≤—ã–≥–æ–¥–Ω–æ–π. –í —É—Å–ª–æ–≤–∏—è—Ö, –∫–æ–≥–¥–∞ —Ü–µ–Ω—ã –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –ø—Ä–æ–¥–æ–ª–∂–∞—é—Ç –º–µ–Ω—è—Ç—å—Å—è, —ç—Ç–æ –º–æ–∂–µ—Ç —Å—Ç–∞—Ç—å –≤–∞–∂–Ω—ã–º —Ñ–∞–∫—Ç–æ—Ä–æ–º –ø—Ä–∏ –≤—ã–±–æ—Ä–µ —Å–µ—Ä–≤–∏—Å–∞ –¥–ª—è –ø–æ–∫—É–ø–æ–∫. –ù–∞–ø–æ–º–∏–Ω–∞–µ–º, —á—Ç–æ –¥–∞–∂–µ –∑–Ω–∞–∫–æ–º—ã–µ –æ–±–µ–∑–±–æ–ª–∏–≤–∞—é—â–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –∏–º–µ—é—Ç –ø—Ä–æ—Ç–∏–≤–æ–ø–æ–∫–∞–∑–∞–Ω–∏—è. –ü–µ—Ä–µ–¥ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º –ø—Ä–æ–∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä—É–π—Ç–µ—Å—å —Å –ª–µ—á–∞—â–∏–º –≤—Ä–∞—á–æ–º. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The message discusses the prices of ibuprofen-based medications in Russia, Belarus, and other countries. It highlights that '–ó–¥—Ä–∞–≤—Å–∏—Ç–∏' pharmacy offers the most competitive prices, which could be a significant factor for consumers choosing pharmacies. The message also mentions that ibuprofen-based medications have contraindications and advises consulting a doctor before use.""
}"
2025-06-20T15:33:06+00:00,@bezrec,6209,https://t.me/bezrec/6209,"–û—Ö —É–∂ —ç—Ç–æ—Ç –Ω–µ–ø–æ—Å—Ç–∏–∂–∏–º—ã–π —Ä—É—Å—Å–∫–∏–π —è–∑—ã–∫ –∏ –∫–æ–≤–∞—Ä–Ω—ã–µ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç—ã, –ø—Ä–æ–¥–∞—é—â–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ ¬´–¥–ª—è –∫–∞—à–ª—è¬ª, –≤–∏–¥–∏–º–æ, —É—Å–∏–ª–∏–≤–∞—é—â–∏–µ –∏ –ø—Ä–æ–¥–ª–µ–≤–∞—é—â–∏–µ –µ–≥–æ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-06-20T14:41:10+00:00,@bezrec,6208,https://t.me/bezrec/6208,"–¢–∞–∫–∏–µ –¥–∞–Ω–Ω—ã–µ –æ–∑–≤—É—á–∏–ª–∞ –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å –º–∏–Ω–∏—Å—Ç—Ä–∞ –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏ –∏ —Ç–æ—Ä–≥–æ–≤–ª–∏ –†–§ –ï–∫–∞—Ç–µ—Ä–∏–Ω–∞ –ü—Ä–∏–µ–∑–∂–µ–≤–∞ –≤ —Ä–∞–º–∫–∞—Ö –ü–ú–≠–§-2025 –Ω–∞ —Å–µ—Å—Å–∏–∏ ¬´–õ–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–∞—è –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å¬ª. –ß–∞—Å—Ç—å –∏–∑ —ç—Ç–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤—Å—ë –µ—â—ë –Ω–∞—Ö–æ–¥–∏—Ç—Å—è –ø–æ–¥ –ø–∞—Ç–µ–Ω—Ç–Ω–æ–π –∑–∞—â–∏—Ç–æ–π, –Ω–æ —É–∂–µ –≥–æ—Ç–æ–≤–∏—Ç—Å—è –Ω–æ–≤—ã–π –∫–æ–Ω–∫—É—Ä—Å –Ω–∞ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫—É –∞–Ω–∞–ª–æ–≥–æ–≤. –ß—Ç–æ –≤ –ø—Ä–∏–æ—Ä–∏—Ç–µ—Ç–µ –Ω–∞ –±–ª–∏–∂–∞–π—à–∏–µ –≥–æ–¥—ã: ‚ñ∂Ô∏è–ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏—è –Ω–µ –º–µ–Ω–µ–µ 90% –∂–∏–∑–Ω–µ–Ω–Ω–æ –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤; ‚ñ∂Ô∏è–≤—ã–ø—É—Å–∫ 80% —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø–æ –ø–æ–ª–Ω–æ–º—É —Ü–∏–∫–ª—É; ‚ñ∂Ô∏è—Ä–æ—Å—Ç –¥–æ–ª–∏ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö —Ä–∞–¥–∏–æ—Ñ–∞—Ä–º–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–æ 95%; ‚ñ∂Ô∏è—É–≤–µ–ª–∏—á–µ–Ω–∏–µ –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏–∏ –º–µ–¥–∏–∑–¥–µ–ª–∏–π –¥–æ 40%. –ö–ª—é—á–µ–≤–∞—è –æ–ø–æ—Ä–∞ –Ω–∞ —Å—Ç—Ä–∞—Ç–µ–≥–∏—é ¬´–§–∞—Ä–º–∞-2030¬ª –∏ –Ω–∞—Ü–ø—Ä–æ–µ–∫—Ç ¬´–ù–æ–≤—ã–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ —Å–±–µ—Ä–µ–∂–µ–Ω–∏—è –∑–¥–æ—Ä–æ–≤—å—è¬ª, –∫–æ—Ç–æ—Ä—ã–π –∑–∞–¥–∞—ë—Ç –∫–æ–Ω–∫—Ä–µ—Ç–Ω—ã–µ —Ü–µ–ª–∏ –∏ —Å—Ä–æ–∫–∏. –í —Ñ–æ–∫—É—Å–µ –Ω–µ –ø—Ä–æ—Å—Ç–æ –∏–º–ø–æ—Ä—Ç–æ–∑–∞–º–µ—â–µ–Ω–∏–µ, –∞ —Å–æ–∑–¥–∞–Ω–∏–µ –Ω–µ–∑–∞–≤–∏—Å–∏–º–æ–π, —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏ —É—Å—Ç–æ–π—á–∏–≤–æ–π —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏. –£–∂–µ —Å–µ–π—á–∞—Å –Ω–∞ –ø–æ–¥—Ö–æ–¥–µ –Ω–æ–≤—ã–µ –∏–Ω–≤–µ—Å—Ç–ø—Ä–æ–µ–∫—Ç—ã, –Ω–∞—É—á–Ω—ã–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –∏ –∫–æ–ª–ª–∞–±–æ—Ä–∞—Ü–∏–∏ –º–µ–∂–¥—É –±–∏–∑–Ω–µ—Å–æ–º –∏ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–æ–º. –°–ª–µ–¥—É—é—â–∏–π —à–∞–≥ ‚Äì –Ω–∞–π—Ç–∏ –∏ –ø–æ–¥–∫–ª—é—á–∏—Ç—å —Ç–µ—Ö, –∫—Ç–æ –≥–æ—Ç–æ–≤ —Ä–∞–∑–≤–∏–≤–∞—Ç—å –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ –†–æ—Å—Å–∏–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety, guideline"",
  ""impact"": ""medium"",
  ""english"": ""The Deputy Minister of Industry and Trade of Russia, Ekaterina Priezhevaya, during the PMEF-2025 session on 'Pharmaceutical Safety', highlighted that part of these drugs are still under patent protection, but a new competition is already underway for the development of similar products. The priorities for the next few years include: localizing at least 90% of essential drugs; producing up to 80% of strategically important medicines throughout the entire production cycle; increasing the share of Russian radio pharmaceuticals to 95%; and increasing local manufacturing to 40%. The focus is on the strategy 'Pharma-2030' and the national project 'New Technologies for Health Preservation', which sets specific goals and deadlines. The emphasis is not just on import substitution, but on creating an independent, technologyally stable pharmaceutical supply chain. Already underway are new investment projects, scientific research, and collaborations between business and government.""
}"
2025-06-20T11:40:06+00:00,@bezrec,6206,https://t.me/bezrec/6206,"–ü–æ –¥–∞–Ω–Ω—ã–º –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è Headway Company, –Ω–∞ —Ä—ã–Ω–∫–µ –∞–ø—Ç–µ—á–Ω—ã—Ö –≥–æ—Å–∑–∞–∫—É–ø–æ–∫ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã—Ö –∑–∞–∫–∞–∑—á–∏–∫–æ–≤ —Å—Ç–∞–ª–æ –Ω–∞ 14,5% –º–µ–Ω—å—à–µ, —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã—Ö ‚Äì –Ω–∞ 1%. –ü—Ä–∏—á–∏–Ω–∞ –≤ –ø–µ—Ä–µ—Ö–æ–¥–µ –∫ –º–æ–¥–µ–ª–∏ —É–∫—Ä—É–ø–Ω–µ–Ω–∏—è –∏ —Ü–µ–Ω—Ç—Ä–∞–ª–∏–∑–∞—Ü–∏–∏. –£ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –∑–∞–∫–∞–∑—á–∏–∫–∞ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ –∫–∞—á–µ—Å—Ç–≤—É –º–∞–∫—Å–∏–º–∞–ª—å–Ω–æ –∂—ë—Å—Ç–∫–∏–µ, –Ω–æ –≤—ã—Å–æ–∫–∏–π —á–µ–∫ –∏ –∫—Ä—É–ø–Ω—ã–µ –∑–∞–∫—É–ø–∫–∏ (–≤ –æ—Å–Ω–æ–≤–Ω–æ–º –ø–æ –æ—Ä—Ñ–∞–Ω–Ω—ã–º, –≤–∞–∫—Ü–∏–Ω–Ω—ã–º –∏ –ì–ò–ü-–ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º). –í —ç—Ç–æ–º —Å–µ–≥–º–µ–Ω—Ç–µ —É–∂–µ 25 –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö –ø–æ—Å—Ç–∞–≤—â–∏–∫–æ–≤ –∫–æ–Ω—Ç—Ä–æ–ª–∏—Ä—É—é—Ç 88% –≤—Å–µ—Ö —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã—Ö –∑–∞–∫—É–ø–æ–∫. –£ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ –∑–∞–∫–∞–∑—á–∏–∫–∞ —Ç–µ–Ω–¥–µ—Ä–æ–≤ –±—é–¥–∂–µ—Ç—ã —Ä–∞—Å–ø—Ä–µ–¥–µ–ª—è—é—Ç—Å—è —à–∏—Ä–µ (–æ—Å–Ω–æ–≤–Ω—ã–µ —Å—Ç–∞—Ç—å–∏ ‚Äì –º–∞—Å—Å–æ–≤–∞—è –æ–Ω–∫–æ–ª–æ–≥–∏—è, —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–∏–µ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è, –∏–º–º—É–Ω–æ–ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∞). –ö–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏—è –∞–∫—Ç–∏–≤–Ω–µ–µ, –∞ –∫–ª—é—á–µ–≤—ã–µ –ø—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–∞ –ø–æ—Å—Ç–∞–≤—â–∏–∫–æ–≤ ‚Äì —à–∏—Ä–∏–Ω–∞ –ø–æ—Ä—Ç—Ñ–µ–ª—è –∏ –ª–æ–≥–∏—Å—Ç–∏–∫–∞. –¢–û–ü-25 –∏–≥—Ä–æ–∫–æ–≤ –æ—Ö–≤–∞—Ç—ã–≤–∞—é—Ç –ª–∏—à—å 48% –±—é–¥–∂–µ—Ç–∞, –æ—Å—Ç–∞–ª—å–Ω–∞—è –¥–æ–ª—è –∑–∞ —Å—á—ë—Ç –¥–ª–∏–Ω–Ω–æ–≥–æ ¬´—Ö–≤–æ—Å—Ç–∞¬ª —Å—Ä–µ–¥–Ω–∏—Ö –∫–æ–º–ø–∞–Ω–∏–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": true,
  ""country"": ""global"",
  ""topic"": ""tenders,clinical_trial,hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""Headway Company research shows a decrease of 14.5% in federal procurement market share and 1% in regional market share for medical supplies. The shift is towards a more centralized model, with federal buyers facing stringent quality requirements but also higher costs and larger purchases (mainly for orphan drugs, vaccines, and GIPs). Currently, 25 major suppliers control 88% of federal procurements. Regional buyers have more diverse tenders, mainly for mass oncology and chronic diseases, with competition being stronger. The top 25 suppliers cover only 48% of the budget, with most of the remaining share coming from smaller companies.""
}"
2025-06-20T07:11:09+00:00,@bezrec,6199,https://t.me/bezrec/6199,"–°–æ–∑–¥–∞–Ω –æ—Ç—Ä–∞—Å–ª–µ–≤–æ–π –∞–ª—å—è–Ω—Å: –°–±–µ—Ä, AIRI, ¬´–†-–§–∞—Ä–º¬ª üîò–°–æ–≥–ª–∞—à–µ–Ω–∏–µ –æ —Å–æ–∑–¥–∞–Ω–∏–∏ –Ω–æ–≤–æ–π AI-—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –∏–Ω–¥—É—Å—Ç—Ä–∏–∏ ‚Äì –æ—Ç —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –º–æ–ª–µ–∫—É–ª –¥–æ –∫–æ–Ω—Ç—Ä–æ–ª—è —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ —Ç–µ—Ä–∞–ø–∏–∏, –ø–æ–¥–ø–∏—Å–∞–Ω–æ –Ω–∞ –ü–ú–≠–§-2025. –¶–µ–ª—å ‚Äì –ø–µ—Ä—Å–æ–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω–∞—è –º–µ–¥–∏—Ü–∏–Ω–∞ –∏ –ø–æ–≤—ã—à–µ–Ω–∏–µ –∫–∞—á–µ—Å—Ç–≤–∞ –∂–∏–∑–Ω–∏. –°–±–µ—Ä –±—É–¥–µ—Ç –æ—Ç–≤–µ—á–∞—Ç—å –∑–∞ —Ü–∏—Ñ—Ä–æ–≤—É—é –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä—É –∏ –≤–Ω–µ–¥—Ä–µ–Ω–∏–µ AI-—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π, AIRI ‚Äì –∑–∞ –Ω–∞—É—á–Ω—ã–µ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –∏ –∞–ª–≥–æ—Ä–∏—Ç–º—ã, ¬´–†-–§–∞—Ä–º¬ª ‚Äì –∑–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –∏ –≤—ã–≤–æ–¥ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ —Ä—ã–Ω–æ–∫. üîò–ò—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω—ã–π –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç –ø–æ–∑–≤–æ–ª–∏—Ç —Å–æ–∫—Ä–∞—Ç–∏—Ç—å —Å—Ä–æ–∫–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –∏ –≤—ã–≤–æ–¥–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ —Ä—ã–Ω–æ–∫. –†–µ—à–µ–Ω–∏—è –±—É–¥—É—Ç –∞–¥–∞–ø—Ç–∏—Ä–æ–≤–∞–Ω—ã –ø–æ–¥ –∏–Ω–¥–∏–≤–∏–¥—É–∞–ª—å–Ω—ã–µ –æ—Å–æ–±–µ–Ω–Ω–æ—Å—Ç–∏ –ø–∞—Ü–∏–µ–Ω—Ç–∞ –∏ –æ–±–µ—Å–ø–µ—á–∞—Ç –Ω–µ–ø—Ä–µ—Ä—ã–≤–Ω—ã–π –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥ –∑–¥–æ—Ä–æ–≤—å—è. –û–±—ä–µ–¥–∏–Ω–µ–Ω–∏–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π, –Ω–∞—É–∫–∏ –∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –≤—ã–≤–µ–¥–µ—Ç —Ñ–∞—Ä–º–∏–Ω–¥—É—Å—Ç—Ä–∏—é –Ω–∞ –Ω–æ–≤—ã–π —É—Ä–æ–≤–µ–Ω—å. –†–æ—Å—Å–∏—è —Ñ–æ—Ä–º–∏—Ä—É–µ—Ç –Ω–æ–≤—ã–π —Å—Ç–∞–Ω–¥–∞—Ä—Ç –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∏ –ø–æ–ª—É—á–∞–µ—Ç —à–∞–Ω—Å –∑–∞–Ω—è—Ç—å –ª–∏–¥–∏—Ä—É—é—â—É—é –ø–æ–∑–∏—Ü–∏—é –≤ —Ü–∏—Ñ—Ä–æ–≤–æ–π –º–µ–¥–∏—Ü–∏–Ω–µ. ‚Ñ¢Ô∏è –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial, pharmacovigilance, safety"",
  ""impact"": ""high"",
  ""english"": ""A new alliance of Sber, AIRI, and 'R-Farm' has signed a deal to create an AI-based pharmaceutical industry from molecule development to therapy effectiveness monitoring. The goal is personalized medicine and improving patient quality of life. Sber will handle the digital infrastructure and AI technology implementation, AIRI will focus on scientific research and algorithms, while 'R-Farm' will produce drugs for market release. AI solutions will reduce development and launch timelines, adapt to individual patient characteristics, and provide continuous health monitoring. The integration of technologies, science, and production will elevate the pharmaceutical industry. Russia is shaping a new healthcare standard and has an opportunity to lead in digital medicine.""
}"
2025-06-19T15:01:33+00:00,@bezrec,6198,https://t.me/bezrec/6198,"–ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª —Ñ–∏–Ω–∞–ª—å–Ω—É—é –≤–µ—Ä—Å–∏—é –ø–µ—Ä–µ—á–Ω—è —Å–∏—Å—Ç–µ–º–Ω–æ –∑–Ω–∞—á–∏–º—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤, –∫–æ—Ç–æ—Ä—ã–π —Å—Ç–∞–Ω–µ—Ç –æ—Å–Ω–æ–≤–æ–π –¥–ª—è –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª–µ–Ω–∏—è –≥–æ—Å–ø–æ–¥–¥–µ—Ä–∂–∫–∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º. –í –æ—Å–Ω–æ–≤–µ –ª–µ–∂–∞—Ç –¥–≤–∞ —Å–ø–∏—Å–∫–∞ —Å —Ä–∞–∑–Ω—ã–º–∏ –º–µ—Ä–∞–º–∏ –ø–æ–¥–¥–µ—Ä–∂–∫–∏, –≥–ª–∞–≤–Ω—ã–º –∫—Ä–∏—Ç–µ—Ä–∏–µ–º –∫–æ—Ç–æ—Ä—ã—Ö —è–≤–ª—è–µ—Ç—Å—è –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–µ –ø—Ä–∏—Å—É—Ç—Å—Ç–≤–∏–µ –≤ –ø–µ—Ä–µ—á–Ω–µ –ñ–ù–í–õ–ü: üíä–°–ø–∏—Å–æ–∫ 1: 215 –ø–æ–∑–∏—Ü–∏–π, –≤–∫–ª—é—á–∞—è –Ω–∞—Ä–∫–æ—Ç–∏—á–µ—Å–∫–∏–µ –∏ –ø—Å–∏—Ö–æ—Ç—Ä–æ–ø–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã ‚Äì –¥–µ–π—Å—Ç–≤—É–µ—Ç –ø—Ä–∞–≤–∏–ª–æ ¬´–≤—Ç–æ—Ä–æ–π –ª–∏—à–Ω–∏–π¬ª (–æ—Ç–∫–∞–∑ –æ—Ç –∏–º–ø–æ—Ä—Ç–∞ –ø—Ä–∏ –Ω–∞–ª–∏—á–∏–∏ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∞–Ω–∞–ª–æ–≥–∞). üíä–°–ø–∏—Å–æ–∫ 2: –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –æ—Ç —Å–æ—Ü–∏–∞–ª—å–Ω–æ –∑–Ω–∞—á–∏–º—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π: –æ–Ω–∫–æ–ª–æ–≥–∏–π, –í–ò–ß, –±–æ–ª–µ–∑–Ω–µ–π –ª–µ–≥–∫–∏—Ö –∏ –¥—Ä. ‚Äì –ø—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ–Ω—ã —Ü–µ–Ω–æ–≤—ã–µ –ø—Ä–µ—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ –Ω–∞ 15‚Äì30%. –ü–æ–∫–∞ –ø—Ä–æ–¥–æ–ª–∂–∞—é—Ç—Å—è —Å–ø–æ—Ä—ã –æ —Å—Ä–æ–∫–µ –ø–∞—Ç–µ–Ω—Ç–Ω–æ–π –∑–∞—â–∏—Ç—ã, –¥–∞—é—â–µ–º –ø—Ä–∞–≤–æ –Ω–∞ –≤–∫–ª—é—á–µ–Ω–∏–µ –≤ –ø–µ—Ä–µ—á–µ–Ω—å. –¢–∞–∫–∂–µ –æ–±—Å—É–∂–¥–∞–µ—Ç—Å—è –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–µ –µ–¥–∏–Ω–æ–≥–æ –∏—Å—Ç–æ—á–Ω–∏–∫–∞ –¥–∞–Ω–Ω—ã—Ö, –∫–æ—Ç–æ—Ä—ã–π –ø–æ–∑–≤–æ–ª–∏–ª –±—ã –æ–±—ä–µ–∫—Ç–∏–≤–Ω–æ –æ—Ü–µ–Ω–∏–≤–∞—Ç—å, –∫–∞–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –≤–∫–ª—é—á–∞—Ç—å –≤ —Å–ø–∏—Å–æ–∫. –í–æ–∑–º–æ–∂–Ω–æ–µ —Ä–µ—à–µ–Ω–∏–µ ‚Äì –∏–Ω—Ç–µ–≥—Ä–∞—Ü–∏—è —Å —Ñ–∞—Ä–º—Ä–µ–µ—Å—Ç—Ä–æ–º –ï–ê–≠–°, –Ω–æ —ç—Ç–æ –ø–æ—Ç—Ä–µ–±—É–µ—Ç –≤—Ä–µ–º–µ–Ω–∏. –î–æ–∫—É–º–µ–Ω—Ç –ø–ª–∞–Ω–∏—Ä—É—é—Ç —É—Ç–≤–µ—Ä–¥–∏—Ç—å –∫ 1 –∏—é–ª—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, sanctions, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Industry and Trade has presented the final version of the list of systemically important medicines, which will serve as the basis for providing state support to manufacturers. The list is based on two lists with different forms of support, the main criterion being inclusion in the GNP list: List 1 (215 items) includes narcotic and psychotropic drugs - the 'second extra' rule applies (importation is not allowed if there is a domestic equivalent). List 2: drugs for socially significant diseases such as oncology, HIV, respiratory diseases - price preferences of 15-30% are provided. Discussions continue on the timing of patent protection, which grants the right to include in the list. The lack of a single source of data that allows for objectively assessing which drugs to include in the list is also being discussed. A possible solution - integration with the EAECS pharmaceutical registry, but this will require time.""
}"
2025-06-19T13:33:12+00:00,@bezrec,6197,https://t.me/bezrec/6197,"‚ñ∂Ô∏è–ü–æ–º–∏–º–æ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–æ–≤ –¥–ª—è –∞–ø—Ç–µ–∫, —Ä—ã–Ω–æ–∫ –æ—Å—Ç—Ä–æ –Ω—É–∂–¥–∞–µ—Ç—Å—è –≤ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞—Ö –ø–æ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ, –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤—É –∏ –¥–∏—Å—Ç—Ä–∏–±—É—Ü–∏–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –æ—Ç –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–æ–≤ –∏ —Ö–∏–º–∏–∫–æ–≤ –¥–æ —ç–∫—Å–ø–µ—Ä—Ç–æ–≤ –≤ –æ–±–ª–∞—Å—Ç–∏ GMP –∏ –∫–æ–Ω—Ç—Ä–æ–ª—è –∫–∞—á–µ—Å—Ç–≤–∞. –ò–Ω—Ç–µ—Ä–µ—Å–Ω–æ, —á—Ç–æ –¥–µ—Ñ–∏—Ü–∏—Ç –∏–Ω–∂–µ–Ω–µ—Ä–æ–≤ —á–∞—Å—Ç–∏—á–Ω–æ —Å–≥–ª–∞–∂–∏–≤–∞–µ—Ç—Å—è –∏—Ö –ø–µ—Ä–µ–∫–≤–∞–ª–∏—Ñ–∏–∫–∞—Ü–∏–µ–π –∏–∑ –¥—Ä—É–≥–∏—Ö –æ—Ç—Ä–∞—Å–ª–µ–π, –Ω–æ —É–∑–∫–æ–ø—Ä–æ—Ñ–∏–ª—å–Ω—ã—Ö —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –≤—Å—ë —Ä–∞–≤–Ω–æ –Ω–µ —Ö–≤–∞—Ç–∞–µ—Ç, –æ—Å–æ–±–µ–Ω–Ω–æ –≤ —Ä–µ–≥–∏–æ–Ω–∞—Ö. –°–ª–æ–∂–Ω–æ—Å—Ç—å —Å–∏—Ç—É–∞—Ü–∏–∏ —É—Å—É–≥—É–±–ª—è–µ—Ç—Å—è –±—ã—Å—Ç—Ä–æ—Ä–∞—Å—Ç—É—â–∏–º —Å–ø—Ä–æ—Å–æ–º –Ω–∞ –Ω–æ–≤—ã–µ –∫–æ–º–ø–µ—Ç–µ–Ω—Ü–∏–∏ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –ø–æ –±–∏–æ–∏–Ω–∂–µ–Ω–µ—Ä–∏–∏, –≥–µ–Ω–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –∏ —Ü–∏—Ñ—Ä–æ–≤—ã–º —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—è–º. –§–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –≤—ã–Ω—É–∂–¥–µ–Ω—ã —Å–æ—Ä–µ–≤–Ω–æ–≤–∞—Ç—å—Å—è —Å –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞–º–∏ –∑–∞ –∫–∞–¥—Ä—ã –¥–∞–∂–µ –≤ –¥–∏—Å—Ç—Ä–∏–±—É—Ü–∏–∏ –∏ –ª–æ–≥–∏—Å—Ç–∏–∫–µ, —á—Ç–æ –æ—Ç—Ä–∞–∂–∞–µ—Ç –æ–±—â–∏–π —Ç—Ä–µ–Ω–¥: –∑–∞—Ä–ø–ª–∞—Ç–∞ –∏ —É—Å–ª–æ–≤–∏—è —Å—Ç–∞–Ω–æ–≤—è—Ç—Å—è —Ä–µ—à–∞—é—â–∏–º —Ñ–∞–∫—Ç–æ—Ä–æ–º, –∞ –ø—Ä–æ—Å—Ç–æ–π –¥–∏–ø–ª–æ–º —É–∂–µ –Ω–µ –≥–∞—Ä–∞–Ω—Ç–∏—è —Å–ø–æ–∫–æ–π–Ω–æ–π –∫–∞—Ä—å–µ—Ä—ã. –ê –º–µ–∂–¥—É —Ç–µ–º, —Ü–µ–ª–µ–≤–æ–µ –æ–±—É—á–µ–Ω–∏–µ –ø–æ–¥ –∑–∞–ø—Ä–æ—Å—ã —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π, –∫ —Å–æ–∂–∞–ª–µ–Ω–∏—é, –ø–æ–∫–∞ –Ω–µ —Å—Ç–∞–ª–æ –º–∞—Å—Å–æ–≤–æ–π –ø—Ä–∞–∫—Ç–∏–∫–æ–π –∏–∑-–∑–∞ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏—è –ø–æ–¥–¥–µ—Ä–∂–∫–∏ –Ω–∞ —É—Ä–æ–≤–Ω–µ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è. ‚ñ∂Ô∏è–í –∏—Ç–æ–≥–µ –ø–æ–ª—É—á–∞–µ—Ç—Å—è –ø–∞—Ä–∞–¥–æ–∫—Å: –æ—Ç—Ä–∞—Å–ª—å –Ω—É–∂–¥–∞–µ—Ç—Å—è –≤ –¥–µ—Å—è—Ç–∫–∞—Ö —Ç—ã—Å—è—á –Ω–æ–≤—ã—Ö –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª–æ–≤, –Ω–æ —Å–∞–º–∞ —Å–∏—Å—Ç–µ–º–∞ –ø–æ–¥–≥–æ—Ç–æ–≤–∫–∏ –ø–æ–∫–∞ –Ω–µ —Å–ø–µ—à–∏—Ç –∞–¥–∞–ø—Ç–∏—Ä–æ–≤–∞—Ç—å—Å—è –∫ —ç—Ç–∏–º –≤—ã–∑–æ–≤–∞–º. –í–æ–∑–º–æ–∂–Ω–æ, –∫ 2030 –≥–æ–¥—É —É –Ω–∞—Å –ø–æ—è–≤—è—Ç—Å—è –Ω–µ —Ç–æ–ª—å–∫–æ –Ω–æ–≤—ã–µ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç—ã, –Ω–æ –∏ –Ω–æ–≤—ã–µ —Ñ–æ—Ä–º–∞—Ç—ã –∏—Ö –æ–±—É—á–µ–Ω–∏—è, —á—Ç–æ–±—ã —Ç–∞–ª–∞–Ω—Ç–ª–∏–≤—ã–µ –≤—ã–ø—É—Å–∫–Ω–∏–∫–∏ –Ω–µ —Ç–æ–ª—å–∫–æ –∑–Ω–∞–ª–∏ —Ö–∏–º–∏—é –∏ –±–∏–æ–ª–æ–≥–∏—é, –Ω–æ –∏ —É–º–µ–ª–∏ –∏–≥—Ä–∞—Ç—å –ø–æ –ø—Ä–∞–≤–∏–ª–∞–º —Ä—ã–Ω–∫–∞ –∏ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –±—É–¥—É—â–µ–≥–æ. –í–µ–¥—å —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞ ‚Äì —ç—Ç–æ –Ω–µ —Ç–æ–ª—å–∫–æ –æ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞—Ö, –Ω–æ –∏ –æ –ª—é–¥—è—Ö, –∫–æ—Ç–æ—Ä—ã–µ —ç—Ç–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ —Å–æ–∑–¥–∞—é—Ç –∏ –¥–æ—Å—Ç–∞–≤–ª—è—é—Ç, –∞ –∫–∞–¥—Ä–æ–≤—ã–π –¥–µ—Ñ–∏—Ü–∏—Ç ‚Äì –ª—É—á—à–∏–π —Å—Ç–∏–º—É–ª –∑–∞–¥—É–º–∞—Ç—å—Å—è –æ–± —ç—Ç–æ–º –∑–∞—Ä–∞–Ω–µ–µ. üîç –ö–∞–¥—Ä—ã","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance"",
  ""impact"": ""medium"",
  ""english"": ""The industry is facing a shortage of professionals in various fields including biotechnology engineers, chemists, and experts in Good Manufacturing Practices (GMP) and quality control. The issue is exacerbated by the growing demand for specialists in bioengineering, gene therapy, and digital technologies. Companies are forced to compete with marketplaces for talent even in distribution and logistics due to rising salaries and conditions. However, targeted training programs are not yet widespread due to a lack of support from the education sector. The paradox is that the industry needs thousands more professionals, but the system hasn't adapted to these challenges yet. By 2030, there may be new pharmaceutical professionals and innovative training formats to address these issues.""
}"
2025-06-19T12:01:11+00:00,@bezrec,6196,https://t.me/bezrec/6196,"–ò—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ —Ç–µ–Ω–¥–µ—Ä–Ω—ã—Ö –∑–∞–∫—É–ø–æ–∫ –∑–∞ 2024 –≥–æ–¥ –æ—Ç Headway Company –ø–æ–∫–∞–∑–∞–ª–æ: –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ –∏ –º—É–Ω–∏—Ü–∏–ø–∞–ª—å–Ω—ã–µ –∞–ø—Ç–µ—á–Ω—ã–µ —Å–µ—Ç–∏ –ø—Ä–æ–¥–æ–ª–∂–∞—é—Ç –Ω–∞—Ä–∞—â–∏–≤–∞—Ç—å –¥–æ–ª—é –≤ –æ–±—â–µ–º –æ–±—ä—ë–º–µ –≥–æ—Å–∑–∞–∫—É–ø–æ–∫. –í 2024 –≥–æ–¥—É –æ–Ω–∏ –∑–∞–∫—É–ø–∏–ª–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –±–æ–ª–µ–µ —á–µ–º –Ω–∞ 167 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π ‚Äì —ç—Ç–æ 13% –æ—Ç –≤—Å–µ—Ö –≥–æ—Å–∑–∞–∫—É–ø–æ–∫. –ü–æ—Ä—Ç—Ñ–µ–ª—å —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã—Ö –∑–∞–∫–∞–∑—á–∏–∫–æ–≤ –æ—Ç–ª–∏—á–∞–µ—Ç—Å—è –≤—ã—Å–æ–∫–∏–º —Å—Ä–µ–¥–Ω–∏–º —á–µ–∫–æ–º. –í —Ç–æ–ø–µ –ø–æ –æ–±—ä—ë–º–∞–º –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã —Å –ú–ù–ù —ç–ª–µ–∫—Å–∞–∫–∞—Ñ—Ç–æ—Ä+—Ç–µ–∑–∞–∫–∞—Ñ—Ç–æ—Ä+–∏–≤–∞–∫–∞—Ñ—Ç–æ—Ä/–∏–≤–∞–∫–∞—Ñ—Ç–æ—Ä, –¥–æ–ª—É—Ç–µ–≥—Ä–∞–≤–∏—Ä, —ç–º–∏—Ü–∏–∑—É–º–∞–±, –¥–∞—Ä–∞—Ç—É–º—É–º–∞–±, –æ–Ω–∞—Å–µ–º–Ω–æ–≥–µ–Ω –∞–±–µ–ø–∞—Ä–≤–æ–≤–µ–∫ ‚Äì —ç—Ç–æ –≤ –æ—Å–Ω–æ–≤–Ω–æ–º –æ—Ä—Ñ–∞–Ω–Ω—ã–µ –∏ –≥–µ–Ω–Ω–æ-–∏–Ω–∂–µ–Ω–µ—Ä–Ω—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞. –í —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω–æ–º —Å–µ–≥–º–µ–Ω—Ç–µ —Å–ø—Ä–æ—Å –±–æ–ª–µ–µ —Ä–∞—Å–ø—Ä–µ–¥–µ–ª—ë–Ω. –ó–¥–µ—Å—å –¥–æ–º–∏–Ω–∏—Ä—É—é—Ç –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–ª—è –º–∞—Å—Å–æ–≤–æ–≥–æ –ª–µ—á–µ–Ω–∏—è: –æ–Ω–∫–æ–ª–æ–≥–∏—è, –¥–∏–∞–±–µ—Ç, –°–°–ó, –∏–º–º—É–Ω–æ–ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∞. –í —á–∏—Å–ª–µ –ø–æ–ø—É–ª—è—Ä–Ω—ã—Ö –ú–ù–ù ‚Äì –ø–µ–º–±—Ä–æ–ª–∏–∑—É–º–∞–±, –Ω–∏–≤–æ–ª—É–º–∞–±, –±–µ–≤–∞—Ü–∏–∑—É–º–∞–±, –ø–µ—Ä—Ç—É–∑—É–º–∞–±, —Ç—Ä–∞—Å—Ç—É–∑—É–º–∞–± —ç–º—Ç–∞–Ω–∑–∏–Ω –∏ –¥—Ä. –†—ã–Ω–æ–∫ –¥–µ–º–æ–Ω—Å—Ç—Ä–∏—Ä—É–µ—Ç —É—Å—Ç–æ–π—á–∏–≤—ã–π —Å–¥–≤–∏–≥ –≤ —Å—Ç–æ—Ä–æ–Ω—É –∫–æ–º–ø–ª–µ–∫—Å–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –∏ –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç —Ñ–æ–∫—É—Å–∏—Ä–æ–≤–∞—Ç—å—Å—è –Ω–∞ —Å–ª–æ–∂–Ω—ã—Ö, –Ω–æ –º–∞—Å—Å–æ–≤—ã—Ö –Ω–æ–∑–æ–ª–æ–≥–∏—è—Ö. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""The investigation of tender procurements by Headway Company for 2024 showed that state and municipal pharmacy networks continue to increase their share in the overall government procurement volume. In 2024, they purchased medicines worth more than 167 billion rubles ‚Äì accounting for 13% of all government procurements. The portfolio of federal customers has a high average order size. Top-selling drugs include eloxacon, tesacon, ivacan, ivacan, dolutegravir, emcizumab, daratumumab, and eosineparganemab ‚Äì mainly orphan and genetically engineered medicines. The market shows a steady shift towards comprehensive therapy, focusing on complex but mass-nosology conditions.""
}"
2025-06-19T10:10:42+00:00,@bezrec,6195,https://t.me/bezrec/6195,"–î–∂–µ–Ω–µ—Ä–∏–∫–∏: –¥—Ä–∞–π–≤–µ—Ä –¥–æ—Å—Ç—É–ø–Ω–æ–≥–æ –∏ —É—Å—Ç–æ–π—á–∏–≤–æ–≥–æ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ù–∞ —Å–µ—Å—Å–∏–∏ –†–ë–ö ¬´–ó–¥–æ—Ä–æ–≤–æ–µ –æ–±—â–µ—Å—Ç–≤–æ¬ª (–ü–ú–≠–§, 18 –∏—é–Ω—è) —ç–∫—Å–ø–µ—Ä—Ç—ã –æ–±—Å—É–¥–∏–ª–∏ —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫—É—é —Ä–æ–ª—å –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤ –≤ —Ä–∞–∑–≤–∏—Ç–∏–∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –æ—Ç—Ä–∞—Å–ª–∏ –†–æ—Å—Å–∏–∏. –ü–æ –¥–∞–Ω–Ω—ã–º DSM Group, –≤ 2024 –≥–æ–¥—É –∏—Ö –ø—Ä–æ–¥–∞–∂–∏ –≤—ã—Ä–æ—Å–ª–∏ –Ω–∞ +12,4%, –∞ –∫ 2030 –≥–æ–¥—É –¥–æ–ª—è –Ω–∞ —Ä—ã–Ω–∫–µ –º–æ–∂–µ—Ç –¥–æ—Å—Ç–∏—á—å 67%. –î–∂–µ–Ω–µ—Ä–∏–∫–∏ ‚Äì —ç—Ç–æ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ–µ —Ä–µ—à–µ–Ω–∏–µ –¥–ª—è —Ä–∞—Å—à–∏—Ä–µ–Ω–∏—è –¥–æ—Å—Ç—É–ø–∞ –∫ —Ç–µ—Ä–∞–ø–∏–∏, —Å–Ω–∏–∂–µ–Ω–∏—è —Å—Ç–æ–∏–º–æ—Å—Ç–∏ –ª–µ—á–µ–Ω–∏—è –∏ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ –ø–æ–ª–∏—Ç–∏–∫–∏ –∏–º–ø–æ—Ä—Ç–æ–∑–∞–º–µ—â–µ–Ω–∏—è. –û–Ω–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—è—Ç—Å—è –ø–æ —Å–æ–≤—Ä–µ–º–µ–Ω–Ω—ã–º —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—è–º –∏ –ø—Ä–æ—Ö–æ–¥—è—Ç —Å—Ç—Ä–æ–≥–∏–π –∫–æ–Ω—Ç—Ä–æ–ª—å –∫–∞—á–µ—Å—Ç–≤–∞. –î–∂–µ–Ω–µ—Ä–∏–∫–∏ –ø–æ–∑–≤–æ–ª—è—é—Ç —Å—É—â–µ—Å—Ç–≤–µ–Ω–Ω–æ —Å–Ω–∏–∑–∏—Ç—å —Å—Ç–æ–∏–º–æ—Å—Ç—å –ª–µ—á–µ–Ω–∏—è, —Å–æ—Ö—Ä–∞–Ω—è—è —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å, ‚Äì –æ—Ç–º–µ—Ç–∏–ª–∞ –û–ª—å–≥–∞ –õ–∞—Ä–∏–Ω–∞, –∫–æ–º–º–µ—Ä—á–µ—Å–∫–∏–π –¥–∏—Ä–µ–∫—Ç–æ—Ä ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª –û–¥–Ω–∞–∫–æ —Å–æ—Ö—Ä–∞–Ω—è–µ—Ç—Å—è —Å–∫–µ–ø—Å–∏—Å —Å–æ —Å—Ç–æ—Ä–æ–Ω—ã —á–∞—Å—Ç–∏ –≤—Ä–∞—á–µ–π –∏ –Ω–∞—Å–µ–ª–µ–Ω–∏—è. –û—Å–Ω–æ–≤–Ω–æ–π –≤—ã–∑–æ–≤ ‚Äì –Ω–∏–∑–∫–∞—è –∏–Ω—Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–Ω–æ—Å—Ç—å. –î–ª—è –ø–æ–≤—ã—à–µ–Ω–∏—è –¥–æ–≤–µ—Ä–∏—è –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã –ø—Ä–æ—Å–≤–µ—Ç–∏—Ç–µ–ª—å—Å–∫–∏–µ –∫–∞–º–ø–∞–Ω–∏–∏ –∏ –æ—Ç–∫—Ä—ã—Ç–æ—Å—Ç—å —Å–æ —Å—Ç–æ—Ä–æ–Ω—ã –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π. –û—Ç—Ä–∞—Å–ª—å –º–µ–Ω—è–µ—Ç—Å—è: —Ä–∞—Å—Ç—ë—Ç —ç–∫—Å–ø–æ—Ä—Ç–Ω—ã–π –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª, —Ä–∞—Å—à–∏—Ä—è–µ—Ç—Å—è –ª–æ–∫–∞–ª—å–Ω–æ–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ, –≤–Ω–µ–¥—Ä—è—é—Ç—Å—è –∏–Ω–Ω–æ–≤–∞—Ü–∏–∏. –î–∂–µ–Ω–µ—Ä–∏–∫–∏ —Å—Ç–∞–Ω–æ–≤—è—Ç—Å—è –Ω–µ –ø—Ä–æ—Å—Ç–æ –∞–ª—å—Ç–µ—Ä–Ω–∞—Ç–∏–≤–æ–π, –∞ –∫–ª—é—á–µ–≤—ã–º —ç–ª–µ–º–µ–Ω—Ç–æ–º –±—É–¥—É—â–µ–≥–æ —Ä–æ—Å—Å–∏–π—Å–∫–æ–π —Ñ–∞—Ä–º—ã. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The session at RBC 'Healthy Society' (PMMEF, June 18) discussed the strategic role of generics in Russia's pharmaceutical industry. According to DSM Group, their sales are expected to grow by +12.4% in 2024 and reach up to 67% of the market by 2030. Generics are an effective solution for expanding access to treatment, reducing the cost of care and implementing import substitution policies. They are produced using modern technologies and undergo strict quality control. Generics significantly reduce treatment costs while maintaining effectiveness, - Olga Larina from 'Ozon Pharma' noted. However, there is skepticism among some doctors and patients. To increase trust, informational campaigns and transparency from manufacturers are needed. The industry is evolving: export potential increases, local production expands, innovations are introduced. Generics become a key element of the future Russian pharmaceutical industry.""
}"
2025-06-19T07:45:16+00:00,@bezrec,6194,https://t.me/bezrec/6194,"Microsinergy –∏–Ω–≤–µ—Å—Ç–∏—Ä—É–µ—Ç –≤ ¬´–ê–ª—É—Ä–æ–Ω¬ª –ò–Ω–¥–∏–π—Å–∫–∞—è –∫–æ–º–ø–∞–Ω–∏—è Microsinergy –≥–æ—Ç–æ–≤–∞ –≤–ª–æ–∂–∏—Ç—å 3‚Äì5 –º–ª—Ä–¥ —Ä—É–±. –≤ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –ë–ê–î–æ–≤ –≤ —Ñ–∞—Ä–º–∫–ª–∞—Å—Ç–µ—Ä–µ ¬´–ê–ª—É—Ä–æ–Ω¬ª –ø–æ–¥ –°–µ—Ä–ø—É—Ö–æ–≤–æ–º. –ü—Ä–æ–µ–∫—Ç –æ–±—Å—É–∂–¥–∞–µ—Ç—Å—è —Å —Ä–æ—Å—Å–∏–π—Å–∫–∏–º –¥–∏—Å—Ç—Ä–∏–±—É—Ç–æ—Ä–æ–º ¬´–¢–æ–ø –ù—É—Ç—Ä–∏—à–µ–Ω¬ª. –í–æ–∑–º–æ–∂–Ω–∞ –∏ –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏—è —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –ø–æ –≤—ã–ø—É—Å–∫—É –ª–µ–∫–∞—Ä—Å—Ç–≤ ‚Äì –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–∏ —Ç–æ–≥–¥–∞ –º–æ–≥—É—Ç –ø—Ä–µ–≤—ã—Å–∏—Ç—å 10 –º–ª—Ä–¥ —Ä—É–±. –ü–æ –¥–∞–Ω–Ω—ã–º AlphaRM, —Ä—ã–Ω–æ–∫ –ë–ê–î–æ–≤ –≤ –†–æ—Å—Å–∏–∏ –≤ 2024 –≥–æ–¥—É –¥–æ—Å—Ç–∏–≥ 160 –º–ª—Ä–¥ —Ä—É–±., –ø—Ä–æ–¥–µ–º–æ–Ω—Å—Ç—Ä–∏—Ä–æ–≤–∞–≤ 17‚Äì18% —Ä–æ—Å—Ç–∞ –≤ –¥–µ–Ω–µ–∂–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏. –û–∂–∏–¥–∞–µ—Ç—Å—è –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–π —Ç–æ–ª—á–æ–∫ –≤ 2025 –≥–æ–¥—É –Ω–∞ —Ñ–æ–Ω–µ –Ω–æ–≤–æ–≥–æ –∑–∞–∫–æ–Ω–∞, –ø–æ–∑–≤–æ–ª—è—é—â–µ–≥–æ –≤—Ä–∞—á–∞–º –Ω–∞–∑–Ω–∞—á–∞—Ç—å –ë–ê–î—ã ‚Äì —ç—Ç–æ –º–æ–∂–µ—Ç –¥–∞—Ç—å –µ—â—ë +18‚Äì20% —Ä–æ—Å—Ç–∞. –ù–µ—Å–º–æ—Ç—Ä—è –Ω–∞ —Å—Ç–∞–≥–Ω–∞—Ü–∏—é –≤ –æ–±—ä–µ–º–∞—Ö –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏—è, —Å–ø—Ä–æ—Å —Å–º–µ—â–∞–µ—Ç—Å—è –≤ —Å—Ç–æ—Ä–æ–Ω—É –±–æ–ª–µ–µ –¥–æ—Ä–æ–≥–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏. –≠—Ç–æ —Å–æ–∑–¥–∞–µ—Ç –æ–∫–Ω–æ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–µ–π –¥–ª—è –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π. –ü–æ–¥–º–æ—Å–∫–æ–≤—å–µ —É–∫—Ä–µ–ø–ª—è–µ—Ç –ø–æ–∑–∏—Ü–∏–∏ –∫–∞–∫ —Ñ–∞—Ä–º—Ö–∞–±, –∞ –†–æ—Å—Å–∏—è —Å—Ç–∞–Ω–æ–≤–∏—Ç—Å—è –∏–Ω—Ç–µ—Ä–µ—Å–Ω–æ–π –¥–ª—è –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã—Ö –∏–Ω–≤–µ—Å—Ç–æ—Ä–æ–≤ –≤ —Å—Ñ–µ—Ä–µ –ë–ê–î–æ–≤ –∏ —Ñ–∞—Ä–º—ã. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""International investor Microsinergy is investing up to 3-5 billion rubles in the production of BAs (Biological Active Substances) at Aluron's facility near Serpukhov. The project is being discussed with Russian distributor Top NutriShen. There are plans to potentially localize production technologies, which could lead to investments exceeding 10 billion rubles. According to AlphaRM data, the market for BAs in Russia is expected to reach 16 billion rubles by 2024, with a growth of 17-18%. Additional growth is anticipated in 2025 due to a new law allowing doctors to prescribe BAs. This creates an opportunity for international manufacturers, and Moscow Oblast is strengthening its position as a pharmaceutical hub in Russia.""
}"
2025-06-18T17:34:26+00:00,@bezrec,6193,https://t.me/bezrec/6193,"2026 –≥–æ–¥ ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª –ø—Ä–µ–¥–ª–æ–∂–∏–ª —Å–¥–µ–ª–∞—Ç—å –ì–æ–¥–æ–º –±–æ—Ä—å–±—ã —Å –æ–∂–∏—Ä–µ–Ω–∏–µ–º –ü–µ—Ç—Ä –†–æ–¥–∏–æ–Ω–æ–≤ –Ω–∞ –ü–ú–≠–§-2025 –ø—Ä–µ–¥–ª–æ–∂–∏–ª –æ–±—ä—è–≤–∏—Ç—å 2026 –≥–æ–¥ –≥–æ–¥–æ–º –±–æ—Ä—å–±—ã —Å –æ–∂–∏—Ä–µ–Ω–∏–µ–º. –ê —Ç–∞–∫–∂–µ –ø—Ä–∏–∑–Ω–∞—Ç—å –ø—Ä–æ–±–ª–µ–º—É —Å–æ—Ü–∏–∞–ª—å–Ω–æ –∑–Ω–∞—á–∏–º—ã–º –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–µ–º, —Å—Ñ–æ—Ä–º–∏—Ä–æ–≤–∞—Ç—å –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—É—é —Å—Ç—Ä–∞—Ç–µ–≥–∏—é –∏ –ø–æ–≤—ã—Å–∏—Ç—å –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–µ –≤–Ω–∏–º–∞–Ω–∏–µ. –û–∂–∏—Ä–µ–Ω–∏–µ ‚Äì —Å–µ—Ä—å—ë–∑–Ω–æ–µ —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–æ–µ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–µ –∏ —Å–æ—Ü–∏–∞–ª—å–Ω–∞—è –ø—Ä–æ–±–ª–µ–º–∞, —Ç—Ä–µ–±—É—é—â–∞—è —Å–∫–æ–æ—Ä–¥–∏–Ω–∏—Ä–æ–≤–∞–Ω–Ω–æ–π –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π —Å—Ç—Ä–∞—Ç–µ–≥–∏–∏. –û—Ç–¥–µ–ª—å–Ω—ã–µ –º–µ—Ä—ã —É–∂–µ –ø—Ä–µ–¥–ø—Ä–∏–Ω–∏–º–∞—é—Ç—Å—è, –Ω–æ —Ç–æ–ª—å–∫–æ –æ–±—ä–µ–¥–∏–Ω–µ–Ω–∏–µ —É—Å–∏–ª–∏–π –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–∞, –Ω–∞—É–∫–∏, –±–∏–∑–Ω–µ—Å–∞ –∏ –º–µ–¥–∏–∞ –ø–æ–∑–≤–æ–ª–∏—Ç —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ —Å–ø—Ä–∞–≤–∏—Ç—å—Å—è —Å —ç—Ç–æ–π –∑–∞–¥–∞—á–µ–π. –î–ª—è –¥–æ—Å—Ç–∏–∂–µ–Ω–∏—è —É—Å—Ç–æ–π—á–∏–≤—ã—Ö —Ä–µ–∑—É–ª—å—Ç–∞—Ç–æ–≤ –Ω–µ–æ–±—Ö–æ–¥–∏–º —Å–∏—Å—Ç–µ–º–Ω—ã–π, –∫–æ–º–ø–ª–µ–∫—Å–Ω—ã–π –∏ –º–µ–∂–≤–µ–¥–æ–º—Å—Ç–≤–µ–Ω–Ω—ã–π –ø–æ–¥—Ö–æ–¥. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-06-18T16:04:40+00:00,@bezrec,6192,https://t.me/bezrec/6192,"‚ö°Ô∏è–ù–∞ –ü–ú–≠–§-2025 –Ω–µ –æ–±–æ—à–ª–æ—Å—å –±–µ–∑ –∑–Ω–∞—á–∏–º—ã—Ö —Å–æ–±—ã—Ç–∏–π –¥–ª—è —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –æ—Ç—Ä–∞—Å–ª–∏: –ù–ò–¶–≠–ú –∏–º. –ù. –§. –ì–∞–º–∞–ª–µ–∏ –∏ ¬´–ü–µ—Ç—Ä–æ–≤–∞–∫—Å –§–∞—Ä–º¬ª –ø–æ–¥–ø–∏—Å–∞–ª–∏ —Å–æ–≥–ª–∞—à–µ–Ω–∏–µ –æ —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–æ–º —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–µ –≤ –æ–±–ª–∞—Å—Ç–∏ –æ–Ω–∫–æ–ª–æ–≥–∏–∏. –ü–∞—Ä—Ç–Ω—ë—Ä—Å—Ç–≤–æ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–æ –Ω–∞ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –∫–æ–º–±–∏–Ω–∏—Ä–æ–≤–∞–Ω–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –Ω–∞ –æ—Å–Ω–æ–≤–µ –∫–æ–º–±–∏–Ω–∞—Ü–∏–∏ –º–†–ù–ö-—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –∏ –∏–º–º—É–Ω–æ–æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –∫–∞–º—Ä–µ–ª–∏–∑—É–º–∞–± (–ê—Ä–µ–π–º–∞¬Æ). –ê—Ä–µ–π–º–∞¬Æ ‚Äì –∏–Ω–≥–∏–±–∏—Ç–æ—Ä –∏–º–º—É–Ω–Ω—ã—Ö –∫–æ–Ω—Ç—Ä–æ–ª—å–Ω—ã—Ö —Ç–æ—á–µ–∫ (PD-1), –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–π –≤ –†–æ—Å—Å–∏–∏ –≤ 2024 –≥–æ–¥—É. –û–Ω —É–∂–µ –ø—Ä–∏–º–µ–Ω—è–µ—Ç—Å—è –ø—Ä–∏ —Ç–µ—Ä–∞–ø–∏–∏ —Ä–∞–∫–∞ –Ω–æ—Å–æ–≥–ª–æ—Ç–∫–∏ –∏ —Ä–∞–∫–∞ –ø–∏—â–µ–≤–æ–¥–∞. –≠—Ç–æ—Ç –∏–º–º—É–Ω–æ–æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–π –ø—Ä–µ–ø–∞—Ä–∞—Ç ¬´—Å–Ω–∏–º–∞–µ—Ç —Ç–æ—Ä–º–æ–∑–∞¬ª —Å –∏–º–º—É–Ω–Ω–æ–π —Å–∏—Å—Ç–µ–º—ã, –ø–æ–∑–≤–æ–ª—è—è T-–∫–ª–µ—Ç–∫–∞–º –∞—Ç–∞–∫–æ–≤–∞—Ç—å –æ–ø—É—Ö–æ–ª—å. –í —Å–æ—á–µ—Ç–∞–Ω–∏–∏ —Å –º–†–ù–ö-–≤–∞–∫—Ü–∏–Ω–æ–π, –Ω–∞—Å—Ç—Ä–∞–∏–≤–∞—é—â–µ–π –∏–º–º—É–Ω–∏—Ç–µ—Ç –Ω–∞ –∫–æ–Ω–∫—Ä–µ—Ç–Ω—ã–µ –æ–ø—É—Ö–æ–ª–µ–≤—ã–µ –∞–Ω—Ç–∏–≥–µ–Ω—ã, —Ç–∞–∫–æ–π –º–µ—Ö–∞–Ω–∏–∑–º –¥–∞—ë—Ç –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª —Ç–∞—Ä–≥–µ—Ç–Ω–æ–π –∏ –ø—Ä–∏ —ç—Ç–æ–º —Å–∏—Å—Ç–µ–º–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏. –í –æ—Ç–ª–∏—á–∏–µ –æ—Ç —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω–æ–π —Ö–∏–º–∏–æ—Ç–µ—Ä–∞–ø–∏–∏, —Ç–∞–∫–æ–π –ø–æ–¥—Ö–æ–¥ –Ω–µ –ø—Ä–æ—Å—Ç–æ —É–Ω–∏—á—Ç–æ–∂–∞–µ—Ç –æ–ø—É—Ö–æ–ª—å, –∞ –∞–∫—Ç–∏–≤–∏—Ä—É–µ—Ç –∏–º–º—É–Ω–Ω—É—é —Å–∏—Å—Ç–µ–º—É –¥–ª—è –µ—ë —Å–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω–æ–π –±–æ—Ä—å–±—ã —Å —Ä–∞–∫–æ–≤—ã–º–∏ –∫–ª–µ—Ç–∫–∞–º–∏, –≤–∫–ª—é—á–∞—è –º–µ—Ç–∞—Å—Ç–∞–∑—ã. –≠—Ç–æ –æ—Å–æ–±–µ–Ω–Ω–æ –≤–∞–∂–Ω–æ –ø—Ä–∏ –ª–µ—á–µ–Ω–∏–∏ —Ç—Ä—É–¥–Ω–æ –ø–æ–¥–¥–∞—é—â–∏—Ö—Å—è —Ç–µ—Ä–∞–ø–∏–∏ –æ–ø—É—Ö–æ–ª–µ–π —Å –≤—ã—Å–æ–∫–æ–π –º—É—Ç–∞—Ü–∏–æ–Ω–Ω–æ–π –Ω–∞–≥—Ä—É–∑–∫–æ–π, —Ç–∞–∫–∏—Ö –∫–∞–∫ –º–µ–ª–∞–Ω–æ–º–∞ –∏–ª–∏ –Ω–µ–º–µ–ª–∫–æ–∫–ª–µ—Ç–æ—á–Ω—ã–π —Ä–∞–∫ –ª—ë–≥–∫–æ–≥–æ. –†–∞–∑—Ä–∞–±–æ—Ç–∫–∞ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ –æ—Å–Ω–æ–≤–µ –º–†–ù–ö –≤–µ–¥–µ—Ç—Å—è –≤ —Ä–∞–º–∫–∞—Ö –∫–æ–Ω—Å–æ—Ä—Ü–∏—É–º–∞, —Å–æ–∑–¥–∞–Ω–Ω–æ–≥–æ –≤ 2025 –≥–æ–¥—É –∏ –æ–±—ä–µ–¥–∏–Ω—è—é—â–µ–≥–æ 17 –Ω–∞—É—á–Ω—ã—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –ø–æ–¥ —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–æ–º –ù–ò–¶–≠–ú. –î–ª—è —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –æ—Ç—Ä–∞—Å–ª–∏ —ç—Ç–æ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å —Å–æ–∑–¥–∞—Ç—å –≤ –†–æ—Å—Å–∏–∏ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫—É—é –ø–ª–∞—Ç—Ñ–æ—Ä–º—É –¥–ª—è –ø–µ—Ä—Å–æ–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω–æ–π –æ–Ω–∫–æ—Ç–µ—Ä–∞–ø–∏–∏ —Å –≤—ã—Å–æ–∫–∏–º —ç–∫—Å–ø–æ—Ä—Ç–Ω—ã–º –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª–æ–º –∏ —Å–Ω–∏–∂–µ–Ω–∏–µ–º –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏ –æ—Ç –∏–º–ø–æ—Ä—Ç–Ω—ã—Ö —Ä–µ—à–µ–Ω–∏–π. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance, safety"",
  ""impact"": ""high"",
  ""english"": ""A strategic partnership agreement has been signed between the N.F. Gamaleya National Research Center for Epidemiology and Biomedicine and Petrovax Pharma to research combined therapy of oncological diseases using mRNA technology and immunotherapy drug camrelizumab (Areyma¬Æ). Areyma¬Æ is an immune checkpoint inhibitor PD-1 registered in Russia in 2024. It helps the immune system to attack tumors by 'unblocking' it. When combined with mRNA vaccine, which trains the immune system on specific tumor antigens, this approach offers a targeted and systemic therapy. Unlike traditional chemotherapy, it activates the immune system to fight cancer cells, including metastases. This is particularly important for treating difficult-to-treat cancers with high mutational burden, such as melanoma or non-small cell lung cancer. The development of innovative drugs based on mRNA is being carried out within a consortium formed in 2025, involving 17 scientific organizations under the guidance of N.F. Gamaleya National Research Center for Epidemiology and"
2025-06-18T14:52:15+00:00,@bezrec,6191,https://t.me/bezrec/6191,"–î–∞–π–¥–∂–µ—Å—Ç –Ω–æ–≤–æ—Å—Ç–µ–π —Å –ø–æ–ª–µ–π –ü–ú–≠–§-2025 –ö 2030 –≥–æ–¥—É –≤ –†–æ—Å—Å–∏–∏ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è —Ä–∞–∑—Ä–∞–±–æ—Ç–∞—Ç—å –Ω–µ –º–µ–Ω–µ–µ –≤–æ—Å—å–º–∏ –Ω–æ–≤—ã—Ö —Ä–∞–¥–∏–æ—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ —Ä–∞–º–∫–∞—Ö —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –ø—Ä–æ–µ–∫—Ç–∞ ¬´–†–∞–∑–≤–∏—Ç–∏–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –Ω–∞–∏–±–æ–ª–µ–µ –≤–æ—Å—Ç—Ä–µ–±–æ–≤–∞–Ω–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π¬ª –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ –ø—Ä–æ–µ–∫—Ç–∞ ¬´–ù–æ–≤—ã–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ —Å–±–µ—Ä–µ–∂–µ–Ω–∏—è –∑–¥–æ—Ä–æ–≤—å—è, ‚Äì —Å–æ–æ–±—â–∏–ª–∞ –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å –º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –†–§ –¢–∞—Ç—å—è–Ω–∞ –°–µ–º–µ–Ω–æ–≤–∞. –°–æ–≥–ª–∞—à–µ–Ω–∏—è, –∫–æ—Ç–æ—Ä—ã–µ –±—ã–ª–∏ –∑–∞–∫–ª—é—á–µ–Ω—ã: ‚ñ∂Ô∏è–ú–∏–Ω–∏—Å—Ç–µ—Ä—Å—Ç–≤–æ –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–π, –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏ –∏ –Ω–∞—É–∫–∏ –ú–æ—Å–∫–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏, –ì–ö ¬´–§–∞—Ä–º–≠–∫–æ¬ª –∏ –°–±–µ—Ä–±–∞–Ω–∫ –∑–∞–∫–ª—é—á–∏–ª–∏ —Ç—Ä—ë—Ö—Å—Ç–æ—Ä–æ–Ω–Ω–µ–µ —Å–æ–≥–ª–∞—à–µ–Ω–∏–µ –æ —Å–æ–∑–¥–∞–Ω–∏–∏ –≤ –ü–æ–¥–º–æ—Å–∫–æ–≤—å–µ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –æ—Ç –æ–Ω–∫–æ–ª–æ–≥–∏–∏. ‚ñ∂Ô∏è–°–±–µ—Ä–±–∞–Ω–∫, –ò–Ω—Å—Ç–∏—Ç—É—Ç –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–∞ AIRI –∏ –ì–ö ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª –æ–±—ä–µ–¥–∏–Ω–∏–ª–∏—Å—å –¥–ª—è —Å–æ–≤–º–µ—Å—Ç–Ω–æ–π —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –Ω–æ–≤—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ —Å –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ–º —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –ò–ò –∏ —Å–æ–∑–¥–∞–Ω–∏—è —Ü–∏—Ñ—Ä–æ–≤–æ–π –ø–ª–∞—Ç—Ñ–æ—Ä–º—ã –¥–ª—è —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π. ‚ñ∂Ô∏è¬´–ê–∫—Ä–∏—Ö–∏–Ω¬ª –∏ ¬´–ê–∫—Ç–∏–≤–Ω—ã–π –ö–æ–º–ø–æ–Ω–µ–Ω—Ç¬ª –ø–æ–¥–ø–∏—Å–∞–ª–∏ –º–µ–º–æ—Ä–∞–Ω–¥—É–º –æ —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–æ–º –ø–∞—Ä—Ç–Ω—ë—Ä—Å—Ç–≤–µ –ø–æ –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏–∏ –ø–æ–ª–Ω–æ–≥–æ —Ü–∏–∫–ª–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö –∏ —ç–Ω–¥–æ–∫—Ä–∏–Ω–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. ‚ñ∂Ô∏è¬´–†-–§–∞—Ä–º¬ª –∏ –ò–Ω—Å—Ç–∏—Ç—É—Ç —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–∞–ª—å–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω—ã –ø–æ–¥–ø–∏—Å–∞–ª–∏ —Å–æ–≥–ª–∞—à–µ–Ω–∏–µ –æ —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–µ –≤ —Å—Ñ–µ—Ä–µ –Ω–∞—É—á–Ω—ã—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π, –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è –∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞, –≤–∫–ª—é—á–∞—è —Ä–∞–∑—Ä–∞–±–æ—Ç–∫—É –Ω–æ–≤—ã—Ö –º–µ—Ç–æ–¥–æ–≤ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏, –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∏ –∏ –ª–µ—á–µ–Ω–∏—è, –≤ —Ç–æ–º —á–∏—Å–ª–µ —Å –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ–º –∏–º–º—É–Ω–æ–±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. ‚ñ∂Ô∏è–†–æ—Å—Å–∏–π—Å–∫–∏–π —Ñ–æ–Ω–¥ –ø—Ä—è–º—ã—Ö –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–π, –≤—å–µ—Ç–Ω–∞–º—Å–∫–∞—è –∫–æ–º–ø–∞–Ω–∏—è GDP, —Ä–æ—Å—Å–∏–π—Å–∫–∞—è –∫–æ–º–ø–∞–Ω–∏—è EOC –∏ –≤—å–µ—Ç–Ω–∞–º—Å–∫–∞—è –≥—Ä—É–ø–ø–∞ –∫–æ–º–ø–∞–Ω–∏–π T&T Group –∑–∞–∫–ª—é—á–∏–ª–∏ —Å–æ–≥–ª–∞—à–µ–Ω–∏–µ –æ –ø–∞—Ä—Ç–Ω—ë—Ä—Å—Ç–≤–µ –¥–ª—è –ø—Ä–æ–¥–≤–∏–∂–µ–Ω–∏—è —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –º–µ–∂–¥—É –†–æ—Å—Å–∏–µ–π –∏ –í—å–µ—Ç–Ω–∞–º–æ–º. –ú–Ω–µ –∫–∞–∂–µ—Ç—Å—è, –Ω–∞–º –≤–æ–æ–±—â–µ –Ω–∞–¥–æ –Ω–µ–º–Ω–æ–∂–∫–æ –∑–∞–±—ã—Ç—å –≤–æ—Ç —ç—Ç—É –∏—Å—Ç–æ—Ä–∏—é, —á—Ç–æ —Ä–æ—Å—Å–∏–π—Å–∫–∞—è —Ñ–∞—Ä–º–∏–Ω–¥—É—Å—Ç—Ä–∏—è –∞—Å—Å–æ—Ü–∏–∏—Ä—É–µ—Ç—Å—è —Å —Ç–∞–∫–æ–π –≤–æ—Ç –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤–æ–π –º–æ–¥–µ–ª—å—é. –≠—Ç–æ —Ö–∞—Ä–∞–∫—Ç–µ—Ä–Ω–æ –¥–ª—è –¢—É—Ä—Ü–∏–∏, —ç—Ç–æ —Ö–∞—Ä–∞–∫—Ç–µ—Ä–Ω–æ –¥–ª—è –ò–Ω–¥–∏–∏, –Ω–æ —É–∂–µ –ø–µ—Ä–µ—Å—Ç–∞–µ—Ç –±—ã—Ç—å —Ö–∞—Ä–∞–∫—Ç–µ—Ä–Ω–æ –¥–ª—è –†–æ—Å—Å–∏–∏. –ú–æ–∂–Ω–æ –¥–æ–ª–≥–æ —Ä–∞—Å—Å—É–∂–¥–∞—Ç—å –æ —Ç–æ–º, —á—Ç–æ —Ç–∞–∫–æ–µ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–∞—è –º–æ–ª–µ–∫—É–ª–∞. –ù–æ –º—ã –≤—Å–µ –¥–æ–ª–∂–Ω—ã –ø–æ–Ω–∏–º–∞—Ç—å, —á—Ç–æ –Ω–∞ —Å–∞–º–æ–º –¥–µ–ª–µ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–∞—è –º–æ–ª–µ–∫—É–ª–∞ ‚Äì –≤–µ—â—å –æ—á–µ–Ω—å –∫–æ–Ω–∫—Ä–µ—Ç–Ω–∞—è. –û–Ω–∞ –¥–æ–ª–∂–Ω–∞ –≤—ã–∑—ã–≤–∞—Ç—å –∂–∏–≤–æ–π –æ—Ç–∫–ª–∏–∫ —É –ª—é–¥–µ–π, –æ–Ω–∞ –¥–æ–ª–∂–Ω–∞ —Ä–µ—à–∞—Ç—å –∫–æ–Ω–∫—Ä–µ—Ç–Ω—É—é –ø—Ä–æ–±–ª–µ–º—É. –ï—Å–ª–∏ –ø–æ–∑–≤–æ–ª–∏—Ç–µ –ø–µ—Ä–µ–π—Ç–∏ –Ω–∞ –º–æ–ª–æ–¥–µ–∂–Ω—ã–π —Ç–∞–∫–æ–π —è–∑—ã–∫ ‚Äì –æ–Ω–∞ –¥–æ–ª–∂–Ω–∞ –¥–µ–ª–∞—Ç—å –∂–∏–∑–Ω—å –∫–∞–π—Ñ–æ–≤–æ–π, ‚Äì –≤—ã—Å–∫–∞–∑–∞–ª –º–Ω–µ–Ω–∏–µ –ü–µ—Ç—Ä –ë–µ–ª—ã–π, –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—å —Å–æ–≤–µ—Ç–∞ –¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–≤ –ì–ö ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-06-18T12:52:29+00:00,@bezrec,6190,https://t.me/bezrec/6190,"‚ö°Ô∏è–¢–æ–ø —Ü–∏—Ç–∞—Ç –º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –†–§ –ú–∏—Ö–∞–∏–ª–∞ –ú—É—Ä–∞—à–∫–æ –Ω–∞ —Ñ–æ—Ä—É–º–µ ¬´–õ–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–∞—è –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å¬ª –≤ —Ä–∞–º–∫–∞—Ö –ü–ú–≠–§-2025: üíä –û –¥–æ–ª–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –Ω–∞ —Ä—ã–Ω–∫–µ –†–§: –ë–æ–ª–µ–µ 70% —Å–µ–≥–æ–¥–Ω—è —É–∂–µ –æ—Ç –∫–æ–ª–∏—á–µ—Å—Ç–≤–∞ —É–ø–∞–∫–æ–≤–æ–∫ –Ω–∞ —Ä—ã–Ω–∫–µ ‚Äî —ç—Ç–æ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã. –ï—Å–ª–∏ –ø–æ—Å–º–æ—Ç—Ä–µ—Ç—å –ø–æ –≤—ã–≤–æ–¥—É –Ω–∞ —Ä—ã–Ω–æ–∫, —Ç–æ –∑–∞ –ø–æ—Å–ª–µ–¥–Ω–∏–µ –ø–æ–ª—Ç–æ—Ä–∞ –≥–æ–¥–∞ –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏ 85% –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ –≤—ã–≤–æ–¥—è—Ç—Å—è –Ω–∞ —Ä—ã–Ω–æ–∫, ‚Äî –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞. –ü–∞–Ω–¥–µ–º–∏—è –∑–∞—Å—Ç–∞–≤–∏–ª–∞, –ø–æ —Å—É—Ç–∏ –¥–µ–ª–∞, –æ—Ç–Ω–æ—Å–∏—Ç—å—Å—è –∫ —ç—Ç–æ–º—É –Ω–µ –ø—Ä–æ—Å—Ç–æ –≤–Ω–∏–º–∞—Ç–µ–ª—å–Ω–æ, –∞ —Å –≤—ã—Å–æ–∫–∏–º —É—Ä–æ–≤–Ω–µ–º –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç–∏. üíä –û —Ç–æ–º, —á—Ç–æ –º–µ—à–∞–µ—Ç –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–º –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º —Ä–∞—Å—à–∏—Ä–∏—Ç—å –ø—Ä–∏—Å—É—Ç—Å—Ç–≤–∏–µ –Ω–∞ —Ä—ã–Ω–∫–µ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã—Ö –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤: –ü–µ—Ä–≤–æ–µ ‚Äî —ç—Ç–æ, –∫–æ–Ω–µ—á–Ω–æ –∂–µ, –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–∞ –æ—Ç–∫—Ä—ã—Ç–∏—è —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏. –í–æ—Ç –∑–¥–µ—Å—å —è –Ω–µ –≥–æ–≤–æ—Ä—é, —á—Ç–æ —ç—Ç–æ –º–µ—à–∞–µ—Ç. –Ø –≥–æ–≤–æ—Ä—é, —á—Ç–æ —ç—Ç–æ–≥–æ –¥–æ–ª–∂–Ω–æ –±—ã—Ç—å –±–æ–ª—å—à–µ. –ù–µ –Ω—É–∂–Ω–æ —Å–µ–±—è —á—É–≤—Å—Ç–≤–æ–≤–∞—Ç—å –≥–¥–µ-—Ç–æ –∑–∞–≤–∏—Å–∏–º—ã–º –æ—Ç —Ç–µ—Ö –∏–ª–∏ –∏–Ω—ã—Ö –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏–π. –Ø –≤–∏–∂—É —Å–µ–≥–æ–¥–Ω—è –Ω–∞—É—á–Ω—ã–µ –∫–æ–ª–ª–µ–∫—Ç–∏–≤—ã –∏ –ø–µ—Ä—Å–æ–Ω–∞–ª—å–Ω—ã—Ö —É—á—ë–Ω—ã—Ö, –∫–æ—Ç–æ—Ä—ã–µ –≤–ø–æ–ª–Ω–µ –º–æ–≥—É—Ç —Å–æ–≤–µ—Ä—à–∞—Ç—å –ø—Ä–æ—Ä—ã–≤—ã. –ù–æ –Ω–µ –Ω–∞–¥–æ —Å—Ç–µ—Å–Ω—è—Ç—å—Å—è, –Ω–∞–¥–æ –¥–≤–∏–≥–∞—Ç—å—Å—è, –Ω—É–∂–Ω–æ —Å—Ç–∞–≤–∏—Ç—å —Å–µ–±–µ –±–æ–ª–µ–µ –∞–º–±–∏—Ü–∏–æ–∑–Ω—ã–µ –∏–¥–µ–∏. –ê –≤—Ç–æ—Ä–æ–µ ‚Äî –∫–æ–Ω–µ—á–Ω–æ –∂–µ, –Ω–∞–≤–µ—Ä–Ω–æ–µ, –∫–∞–∫ —Å–¥–µ—Ä–∂–∏–≤–∞—é—â–∏–π —Ñ–∞–∫—Ç–æ—Ä ‚Äî —ç—Ç–æ –∏–º–µ–Ω–Ω–æ –ø–æ–¥–¥–µ—Ä–∂–∫–∞ –∏–Ω–Ω–æ–≤–∞—Ü–∏–π –∏ —Ä–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞. –ò —Ç–æ–ª—å–∫–æ –Ω–∞ —Ç—Ä–µ—Ç—å–µ–º –∏–ª–∏ —á–µ—Ç–≤—ë—Ä—Ç–æ–º, –∏–ª–∏ –¥–∞–∂–µ –ø—è—Ç–æ–º –º–µ—Å—Ç–µ –º–æ–∂–µ—Ç –∑–≤—É—á–∞—Ç—å —Å–µ–≥–æ–¥–Ω—è –∏–º–µ–Ω–Ω–æ —Ç–æ, —á—Ç–æ –ø–æ–∫—Ä—ã—Ç–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∑–∞–≤–∏—Å–∏—Ç –æ—Ç —Å—Ç–æ–∏–º–æ—Å—Ç–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞. –ú—ã –±—É–∫–≤–∞–ª—å–Ω–æ –Ω–∞ —ç—Ç–æ–π –Ω–µ–¥–µ–ª–µ, –≤ —Ç–æ–º —á–∏—Å–ª–µ, –æ–±—Å—É–∂–¥–∞–ª–∏, –∫–∞–∫–∏–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ –º–æ–∂–Ω–æ —Å–µ–π—á–∞—Å –µ—â—ë –ø–æ–≥—Ä—É–∑–∏—Ç—å. –í–æ–ø—Ä–æ—Å ‚Äî –∫–∞–∫ –º—ã –∏—Ö –º–æ–∂–µ–º –ø–æ–≥—Ä—É–∑–∏—Ç—å, —á—Ç–æ –Ω–∞–¥–æ, —á—Ç–æ–±—ã –æ–Ω–∏ —Å—Ç–∞–ª–∏ –º–∞—Å—Å–æ–≤–æ —Ç–∏—Ä–∞–∂–∏—Ä—É–µ–º—ã–º–∏ –∏ –¥–æ—Å—Ç—É–ø–Ω—ã–º–∏. –ü–æ—ç—Ç–æ–º—É —Å—Ç–æ–∏–º–æ—Å—Ç—å –≤—Å–µ–≥–¥–∞ –±—É–¥–µ—Ç –∏–º–µ—Ç—å –∑–Ω–∞—á–µ–Ω–∏–µ. üíä–û —Ç–æ–º, —á—Ç–æ –∫—Ä–∏—Ç–∏—á–µ—Å–∫–∏ –≤–∞–∂–Ω–æ –¥–ª—è –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏: –ó–∞ –ø–æ—Å–ª–µ–¥–Ω–∏–µ –ø–æ–ª—Ç–æ—Ä–∞ –≥–æ–¥–∞ –∏–∑ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ 85% ‚Äî –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞. –†–∞—Å—à–∏—Ä–µ–Ω–∏–µ —Å–ø–∏—Å–∫–∞ –∏–¥—ë—Ç, –∏ —Ä–∞—Å—à–∏—Ä–µ–Ω–∏–µ –∞–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –ø–æ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –∏–¥—ë—Ç, –ø–æ—ç—Ç–æ–º—É –æ—Å–Ω–æ–≤–Ω–æ–µ, –Ω–∞ —á—Ç–æ –º—ã –æ—Ä–∏–µ–Ω—Ç–∏—Ä—É–µ–º—Å—è, ‚Äî —ç—Ç–æ —Å–ø–∏—Å–æ–∫ –∂–∏–∑–Ω–µ–Ω–Ω–æ –≤–∞–∂–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –û–Ω–∏ –∂–µ –ø–æ–≥—Ä—É–∂–∞—é—Ç—Å—è –∏ –≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏, –Ω–∞ –Ω–∏—Ö –æ—Å–Ω–æ–≤—ã–≤–∞—é—Ç—Å—è —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ –ª–µ—á–µ–Ω–∏—è. –ü—Ä–∏—á—ë–º —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ –ø–æ—Å—Ç–æ—è–Ω–Ω–æ –æ–±–Ω–æ–≤–ª—è—é—Ç—Å—è, —ç—Ç–æ –ø–æ–≥—Ä—É–∂–∞–µ—Ç—Å—è –∏ –≤ –ø—Ä–æ–≥—Ä–∞–º–º—ã –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –≥–∞—Ä–∞–Ω—Ç–∏–π. –ü–æ—ç—Ç–æ–º—É –≤–æ—Ç —ç—Ç–∞ –∫–æ–º–±–∏–Ω–∞—Ü–∏—è ‚Äî –æ—Ç –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç–∏ –¥–æ –∑–∞–∫—É–ø–∫–∏ –∏ –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏—è ‚Äî —Å–æ–≤–µ—Ä—à–µ–Ω–Ω–æ –ª–æ–≥–∏—á–Ω–æ –≤—ã—Å—Ç—Ä–æ–µ–Ω–∞. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""clinical_trial, shortage, safety, guideline"",
  ""impact"": ""high"",
  ""english"": ""The minister emphasized that over 70% of the pharmaceutical products on the market are domestically produced. In the last year and a half, over 85% of new drugs entering the market are domestically produced. The pandemic has made it necessary to be more responsible in this area. He also highlighted the challenges facing domestic manufacturers, such as the need to open research initiatives and support for innovations. He noted that cost is a significant factor affecting the availability of drugs, but emphasized the importance of ensuring essential medicines are registered and accessible.""
}"
2025-06-18T09:36:01+00:00,@bezrec,6185,https://t.me/bezrec/6185,"–†–∞—Å—Å–º–æ—Ç—Ä–µ–ª–∏ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ —Ä—ã–Ω–∫–∞ ePharma –∑–∞ 2024 –≥–æ–¥, –ø–æ–¥–≥–æ—Ç–æ–≤–ª–µ–Ω–Ω–æ–µ Data Insight. –í–æ—Ç –∫–ª—é—á–µ–≤—ã–µ –≤—ã–≤–æ–¥—ã: üíä–û–±—ä—ë–º –æ–Ω–ª–∞–π–Ω-–ø—Ä–æ–¥–∞–∂ –∞–ø—Ç–µ—á–Ω—ã—Ö —Ç–æ–≤–∞—Ä–æ–≤ –≤ 2024 –≥–æ–¥—É —Å–æ—Å—Ç–∞–≤–∏–ª 370 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —á—Ç–æ –Ω–∞ 28% –≤—ã—à–µ –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è 2023 –≥–æ–¥–∞. üíä–û–±—â–µ–µ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –æ–Ω–ª–∞–π–Ω-–∑–∞–∫–∞–∑–æ–≤ –¥–æ—Å—Ç–∏–≥–ª–æ 234 –º–ª–Ω, —É–≤–µ–ª–∏—á–∏–≤—à–∏—Å—å –Ω–∞ 22% –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –ø—Ä–µ–¥—ã–¥—É—â–∏–º –≥–æ–¥–æ–º. üíä–°—Ä–µ–¥–Ω–∏–π —á–µ–∫ —Å–æ—Å—Ç–∞–≤–∏–ª 1 580 —Ä—É–±–ª–µ–π, –ø–æ–∫–∞–∑–∞–≤ —Ä–æ—Å—Ç –Ω–∞ 5%. üíä–û–Ω–ª–∞–π–Ω-–ø—Ä–æ–¥–∞–∂–∏ –∑–∞–Ω—è–ª–∏ 24% –∫–æ–º–º–µ—Ä—á–µ—Å–∫–æ–≥–æ –∞–ø—Ç–µ—á–Ω–æ–≥–æ —Ä—ã–Ω–∫–∞. üíä–ö–∞–∂–¥—ã–π —á–µ—Ç–≤—ë—Ä—Ç—ã–π —Ä—É–±–ª—å, –ø–æ—Ç—Ä–∞—á–µ–Ω–Ω—ã–π –Ω–∞ –∞–ø—Ç–µ—á–Ω—ã–µ —Ç–æ–≤–∞—Ä—ã, –ø—Ä–∏—à—ë–ª—Å—è –Ω–∞ –æ–Ω–ª–∞–π–Ω-–∫–∞–Ω–∞–ª—ã. üíä–ó–∞ –ø–µ—Ä–∏–æ–¥ 2021‚Äì2024 –≥–æ–¥–æ–≤ –æ–±—ä—ë–º –∑–∞–∫–∞–∑–æ–≤ –≤ ePharma —É–≤–µ–ª–∏—á–∏–ª—Å—è —Å 103 –¥–æ 234 –º–ª–Ω –∑–∞–∫–∞–∑–æ–≤. –û–ø—Ä–æ—Å 2172 –ø–æ–∫—É–ø–∞—Ç–µ–ª–µ–π Total Pharmshopper's Experience –ø–æ–∫–∞–∑–∞–ª, —á—Ç–æ: üîò–û–Ω–ª–∞–π–Ω-–∫–∞–Ω–∞–ª –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–ª–∏ 57% –ø–æ–∫—É–ø–∞—Ç–µ–ª–µ–π, –ø—Ä–∏ —ç—Ç–æ–º 47% —è–≤–ª—è—é—Ç—Å—è –æ–º–Ω–∏–∫–∞–Ω–∞–ª—å–Ω—ã–º–∏ –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª—è–º–∏, —Å–æ–≤–º–µ—â–∞—é—â–∏–º–∏ –æ–Ω–ª–∞–π–Ω –∏ –æ—Ñ–ª–∞–π–Ω. üîò–ì–ª–∞–≤–Ω–æ–π –ø—Ä–∏—á–∏–Ω–æ–π –≤—ã–±–æ—Ä–∞ –æ–Ω–ª–∞–π–Ω-–ø–æ–∫—É–ø–∫–∏ –æ—Å—Ç–∞—ë—Ç—Å—è —ç–∫–æ–Ω–æ–º–∏—è (—É–∫–∞–∑–∞–ª–∏ 47% —Ä–µ—Å–ø–æ–Ω–¥–µ–Ω—Ç–æ–≤). üîò–û—Å–Ω–æ–≤–Ω—ã–º —Ñ–∞–∫—Ç–æ—Ä–æ–º –≤—ã–±–æ—Ä–∞ –æ—Ñ–ª–∞–π–Ω-–ø–æ–∫—É–ø–∫–∏ —è–≤–ª—è–µ—Ç—Å—è —Å—Ä–æ—á–Ω–æ—Å—Ç—å (50% –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö). üîò51% –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª–µ–π –≤—Å–µ–≥–¥–∞ –∏—â—É—Ç –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é –æ —Ç–æ–≤–∞—Ä–µ –≤ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç–µ –ø–µ—Ä–µ–¥ –ø–æ–∫—É–ø–∫–æ–π ‚Äì –¥–∞–∂–µ –ø—Ä–∏ –æ—Ñ–ª–∞–π–Ω-–ø–æ—Å–µ—â–µ–Ω–∏–∏. üîò–ù–∞–∏–±–æ–ª–µ–µ –≤–æ—Å—Ç—Ä–µ–±–æ–≤–∞–Ω–∞ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è –æ —Å–ø–æ—Å–æ–±–µ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è, –æ—Ç–∑—ã–≤–∞—Ö, —Ü–µ–Ω–µ –∏ –Ω–∞–ª–∏—á–∏–∏ –∞–Ω–∞–ª–æ–≥–æ–≤. üîò–ü–æ–≤–µ–¥–µ–Ω–∏–µ –ø–æ–∫—É–ø–∞—Ç–µ–ª–µ–π –∏–∑–º–µ–Ω–∏–ª–æ—Å—å ‚Äì –ø—Ä–∏–Ω—è—Ç–∏–µ —Ä–µ—à–µ–Ω–∏—è –æ –ø–æ–∫—É–ø–∫–µ –≤—Å—ë —á–∞—â–µ –ø—Ä–æ–∏—Å—Ö–æ–¥–∏—Ç –¥–æ–º–∞ –∏–ª–∏ –≤ —Ç—Ä–∞–Ω—Å–ø–æ—Ä—Ç–µ, –∞ –Ω–µ –≤ –∞–ø—Ç–µ–∫–µ. –í –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–µ –¥–æ 2027 –≥–æ–¥–∞ —Ä—ã–Ω–æ–∫ ePharma –ø—Ä–æ–¥–æ–ª–∂–∏—Ç –¥–µ–º–æ–Ω—Å—Ç—Ä–∏—Ä–æ–≤–∞—Ç—å —Ä–æ—Å—Ç, —É–∫—Ä–µ–ø–ª—è—è —Å–≤–æ—é –¥–æ–ª—é –∏ —É—Å–∏–ª–∏–≤–∞—è –∏–Ω—Ç–µ–≥—Ä–∞—Ü–∏—é –æ–Ω–ª–∞–π–Ω- –∏ –æ—Ñ–ª–∞–π–Ω-–∫–∞–Ω–∞–ª–æ–≤. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The market research for ePharma in 2024 shows a significant increase in online pharmaceutical sales, with an increase of 28% compared to the previous year. Key findings include a total online order volume of 234 million, an average transaction amount of 1,580 rubles, and a market share of 24%. The research also highlights changes in consumer behavior towards online shopping, with more purchases made at home or on public transport. The market is expected to continue growing and integrating online and offline channels.""
}"
2025-06-18T07:14:53+00:00,@bezrec,6184,https://t.me/bezrec/6184,"Roche –∏ AbbVie —Å–æ–æ–±—â–∏–ª–∏ –æ –Ω–µ—É–¥–∞—á–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –≤–µ–Ω–µ—Ç–æ–∫–ª–∞–∫—Å–∞ –ø—Ä–∏ –ú–î–° –ö–æ–º–ø–∞–Ω–∏–∏ –æ–±—ä—è–≤–∏–ª–∏, —á—Ç–æ –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ III —Ñ–∞–∑—ã –≤–µ–Ω–µ—Ç–æ–∫–ª–∞–∫—Å–∞ (–í–µ–Ω–∫–ª–µ–∫—Å—Ç–∞) –≤ –∫–æ–º–±–∏–Ω–∞—Ü–∏–∏ —Å –∞–∑–∞—Ü–∏—Ç–∏–¥–∏–Ω–æ–º —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –≤–ø–µ—Ä–≤—ã–µ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏—Ä–æ–≤–∞–Ω–Ω—ã–º –º–∏–µ–ª–æ–¥–∏—Å–ø–ª–∞—Å—Ç–∏—á–µ—Å–∫–∏–º —Å–∏–Ω–¥—Ä–æ–º–æ–º (–ú–î–°) –≤—ã—Å–æ–∫–æ–≥–æ —Ä–∏—Å–∫–∞ –Ω–µ –¥–æ—Å—Ç–∏–≥–ª–æ –æ—Å–Ω–æ–≤–Ω–æ–π —Ü–µ–ª–∏ ‚Äì —É–ª—É—á—à–µ–Ω–∏—è –æ–±—â–µ–π –≤—ã–∂–∏–≤–∞–µ–º–æ—Å—Ç–∏. –ü–æ–ª–Ω—ã–µ –¥–∞–Ω–Ω—ã–µ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç—å –Ω–∞ –±–ª–∏–∂–∞–π—à–µ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏. –≠—Ç–æ —É–∂–µ –Ω–µ –ø–µ—Ä–≤–∞—è –Ω–µ—É–¥–∞—á–∞: –≤ 2023 –≥–æ–¥—É –ø—Ä–æ–≤–∞–ª–∏–ª–æ—Å—å –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ CANOVA –ø—Ä–∏ –º–Ω–æ–∂–µ—Å—Ç–≤–µ–Ω–Ω–æ–π –º–∏–µ–ª–æ–º–µ, –∞ —Ä–∞–Ω–µ–µ ‚Äì –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –≤ 2019 –∏ 2021 –≥–æ–¥–∞—Ö –∏–∑-–∑–∞ –ø–æ–≤—ã—à–µ–Ω–Ω–æ–π —Å–º–µ—Ä—Ç–Ω–æ—Å—Ç–∏. –í AbbVie –ø–æ–¥—á–µ—Ä–∫–Ω—É–ª–∏, —á—Ç–æ –ø—Ä–æ–≤–∞–ª –Ω–æ–≤–æ–≥–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –Ω–µ –ø–æ–≤–ª–∏—è–µ—Ç –Ω–∞ —É–∂–µ —É—Ç–≤–µ—Ä–∂–¥—ë–Ω–Ω—ã–µ –ø–æ–∫–∞–∑–∞–Ω–∏—è. –ù–µ—Å–º–æ—Ç—Ä—è –Ω–∞ —ç—Ç–æ, –≤–µ–Ω–µ—Ç–æ–∫–ª–∞–∫—Å –æ—Å—Ç–∞–µ—Ç—Å—è –∫–ª—é—á–µ–≤—ã–º –ø—Ä–æ–¥—É–∫—Ç–æ–º. –í 2024 –≥–æ–¥—É –µ–≥–æ –ø—Ä–æ–¥–∞–∂–∏ —Å–æ—Å—Ç–∞–≤–∏–ª–∏ $2,6 –º–ª—Ä–¥ (+13% –∫ 2023 –≥–æ–¥—É). –ü—Ä–µ–ø–∞—Ä–∞—Ç –æ–¥–æ–±—Ä–µ–Ω –±–æ–ª–µ–µ —á–µ–º –≤ 80 —Å—Ç—Ä–∞–Ω–∞—Ö, –≤–∫–ª—é—á–∞—è –†–æ—Å—Å–∏—é, –∏ –≤–∫–ª—é—á—ë–Ω –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü. –° 2016 –ø–æ 2020 –≥–æ–¥—ã –ø–æ–ª—É—á–∏–ª –æ–¥–æ–±—Ä–µ–Ω–∏—è –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ –•–õ–õ –∏ –û–ú–õ. –ú–î–° ‚Äì –≥—Ä—É–ø–ø–∞ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π —Å –Ω–∞—Ä—É—à–µ–Ω–∏–µ–º –∫—Ä–æ–≤–µ—Ç–≤–æ—Ä–µ–Ω–∏—è –∏ —Ä–∏—Å–∫–æ–º –ø–µ—Ä–µ—Ö–æ–¥–∞ –≤ –æ—Å—Ç—Ä—ã–π –º–∏–µ–ª–æ–∏–¥–Ω—ã–π –ª–µ–π–∫–æ–∑. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, shortage, safety"",
  ""impact"": ""high"",
  ""english"": ""Roche and AbbVie reported the failure of a clinical trial involving venetoclax (Venclasta) in combination with azacytidine for patients with high-risk myelodysplastic syndromes (MDS). The trial did not achieve its primary goal of improving overall survival. AbbVie emphasized that the failure does not affect already approved indications for venetoclax. Despite this, venetoclax remains a key product with sales of $2.6 billion in 2024 (+13% from 2023). The drug is approved in over 80 countries, including Russia, and included in the NHI list. Venetoclax received approval for treatment of HCLL and OML from 2016 to 2020. MDS is a group of disorders with hematopoietic dysfunction and a risk of progression to acute myeloid leukemia.""
}"
2025-06-17T15:03:06+00:00,@bezrec,6183,https://t.me/bezrec/6183,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –ø—Ä–µ–¥–ª–æ–∂–∏–ª —Å–æ–∑–¥–∞—Ç—å –∏ –≤–µ—Å—Ç–∏ –µ–¥–∏–Ω—ã–π —Ä–µ–µ—Å—Ç—Ä —à—Ç–∞–º–º–æ–≤ –º–∏–∫—Ä–æ–æ—Ä–≥–∞–Ω–∏–∑–º–æ–≤ –∏ –≤–∏—Ä—É—Å–æ–≤, –∏—Å–ø–æ–ª—å–∑—É–µ–º—ã—Ö –≤ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ –∏–º–º—É–Ω–æ–±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ò–Ω–∏—Ü–∏–∞—Ç–∏–≤–∞ –ø–æ–¥–¥–µ—Ä–∂–∞–Ω–∞ –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ–º –∏ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É–µ—Ç –ø–ª–∞–Ω—É —Ä–∞–∑–≤–∏—Ç–∏—è –∏–º–º—É–Ω–æ–ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –∏–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã—Ö –±–æ–ª–µ–∑–Ω–µ–π –¥–æ 2035 –≥–æ–¥–∞. –ó–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –≤–≤–µ—Å—Ç–∏ –≤ –¥–µ–π—Å—Ç–≤–∏–µ —Å 1 —Å–µ–Ω—Ç—è–±—Ä—è 2026 –≥–æ–¥–∞, –≤ —Å–ª—É—á–∞–µ —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏—è. –ò–Ω–∏—Ü–∏–∞—Ç–∏–≤–∞ –ø—Ä–µ–¥—É—Å–º–∞—Ç—Ä–∏–≤–∞–µ—Ç —Ä–∞—Å—à–∏—Ä–µ–Ω–∏–µ –∫—Ä—É–≥–∞ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π, –æ–±—è–∑–∞–Ω–Ω—ã—Ö –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª—è—Ç—å –¥–∞–Ω–Ω—ã–µ –¥–ª—è –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π —Å–∏—Å—Ç–µ–º—ã –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏. –ú–∏–Ω–∑–¥—Ä–∞–≤ –±—É–¥–µ—Ç –æ—Ç–≤–µ—á–∞—Ç—å –∑–∞ –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω–æ–µ —Ä–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω–∏–µ, —Å–æ–∑–¥–∞–Ω–∏–µ –∏ –≤–µ–¥–µ–Ω–∏–µ –∫–æ–ª–ª–µ–∫—Ü–∏–π –ø–∞—Ç–æ–≥–µ–Ω–æ–≤. –†–∞–Ω–µ–µ, –≤ –Ω–æ—è–±—Ä–µ 2024 –≥–æ–¥–∞, –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –≤–Ω–µ—Å–ª–æ –≤ –ì–æ—Å–¥—É–º—É –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç, –æ–±—ä–µ–¥–∏–Ω—è—é—â–∏–π —Ä–µ–µ—Å—Ç—Ä—ã –±–∏–æ–±–µ–∑–æ–ø–∞—Å–Ω–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π, –∫–æ—Ç–æ—Ä—ã–π —É–∂–µ –ø—Ä–∏–Ω—è—Ç –≤ –ø–µ—Ä–≤–æ–º —á—Ç–µ–Ω–∏–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing, import_export, sanctions, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health proposed creating and maintaining a unified registry of pathogen strains used in the production of immunobiological products. The initiative is supported by the government and aligns with the plan for developing infectious disease immunoprophylaxis up to 2035. The law project is planned to be implemented starting September 1, 2026 if approved. The initiative expands the scope of organizations required to provide data for a state system of biological safety. The Ministry will be responsible for regulatory control, creation and maintenance of pathogen collections. Previously, in November 2024, the government introduced a law project unifying registries of biobeacons and producers which has already passed the first reading.""
}"
2025-06-17T12:57:06+00:00,@bezrec,6182,https://t.me/bezrec/6182,"–†–æ—Å—Å–∏—è–Ω–µ —Ö–æ—Ä–æ—à–µ—é—Ç –Ω–∞ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞—Ö –°—Ä–∞–∑—É –ø–æ –¥–≤—É–º –≤–∏–¥–∞–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Å–µ–≥–æ–¥–Ω—è –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω—ã –¥–∞–Ω–Ω—ã–µ –æ–± —É—Å–ø–µ—Ö–∞—Ö —Ä–æ—Å—Å–∏–π—Å–∫–æ–π —Ñ–∞—Ä–º—ã –≤ –∑–∞–º–µ—â–µ–Ω–∏–∏ –∑–∞—Ä—É–±–µ–∂–Ω—ã—Ö –∫–æ–Ω–∫—É—Ä–µ–Ω—Ç–æ–≤. üíä–ë–æ—Ç—É–ª–æ—Ç–æ–∫—Å–∏–Ω—ã üîò–ü–æ –¥–∞–Ω–Ω—ã–º RNC Pharma, –≤ I –∫–≤–∞—Ä—Ç–∞–ª–µ 2025 –≥–æ–¥–∞ –æ–±—ä—ë–º –ø—Ä–æ–¥–∞–∂ –±–æ—Ç—É–ª–æ—Ç–æ–∫—Å–∏–Ω–æ–≤ –≤ –†–æ—Å—Å–∏–∏ –ø—Ä–µ–≤—ã—Å–∏–ª 3 –º–ª—Ä–¥ —Ä—É–±., —á—Ç–æ –Ω–∞ 36,9% –±–æ–ª—å—à–µ, —á–µ–º –≥–æ–¥–æ–º —Ä–∞–Ω–µ–µ; –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏ –ø—Ä–æ–¥–∞–Ω–æ 33,3 –º–ª–Ω –µ–¥–∏–Ω–∏—Ü –¥–µ–π—Å—Ç–≤–∏—è (–ï–î), —Å–ø—Ä–æ—Å –≤—ã—Ä–æ—Å –Ω–∞ 29,4%. üîò–†–æ—Å—Å–∏–π—Å–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã ¬´–†–µ–ª–∞—Ç–æ–∫—Å¬ª –∏ ¬´–ú–∏–æ—Ç–æ–∫—Å¬ª –∑–∞–Ω–∏–º–∞—é—Ç 46,4% —Ä—ã–Ω–∫–∞ –∏ —Ä–∞—Å—Ç—É—Ç –±—ã—Å—Ç—Ä–µ–µ –∏–º–ø–æ—Ä—Ç–Ω—ã—Ö: –∏—Ö –ø—Ä–æ–¥–∞–∂–∏ –≤ —Ä—É–±–ª—è—Ö –≤—ã—Ä–æ—Å–ª–∏ –Ω–∞ 46% –∏ 63% —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ, –≤ —Ç–æ –≤—Ä–µ–º—è –∫–∞–∫ –ª–∏–¥–µ—Ä —Ä—ã–Ω–∫–∞ —Ñ—Ä–∞–Ω—Ü—É–∑—Å–∫–∏–π ¬´–î–∏—Å–ø–æ—Ä—Ç¬ª –∑–∞–Ω–∏–º–∞–µ—Ç 42%. üîò–†–æ—Å—Ç –ø–æ–ø—É–ª—è—Ä–Ω–æ—Å—Ç–∏ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Å–≤—è–∑–∞–Ω —Å —É—Ö–æ–¥–æ–º Allergan (–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å Botox) –∏–∑ –†–§ –ø–æ—Å–ª–µ 2022 –≥–æ–¥–∞, —Å–ª–æ–∂–Ω–æ—Å—Ç—è–º–∏ —Å –ª–æ–≥–∏—Å—Ç–∏–∫–æ–π –∏ –ø–æ–∏—Å–∫–æ–º –∞–ª—å—Ç–µ—Ä–Ω–∞—Ç–∏–≤; –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–µ –∫–æ–º–ø–∞–Ω–∏–∏ –∏–Ω–≤–µ—Å—Ç–∏—Ä—É—é—Ç –≤ –∫–∞—á–µ—Å—Ç–≤–æ –∏ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è. –ë–æ—Ç—É–ª–æ—Ç–æ–∫—Å–∏–Ω –æ—Å—Ç–∞—ë—Ç—Å—è –≤–∞–∂–Ω—ã–º –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–º —Å —Ä–∞—Å—Ç—É—â–∏–º —Å–ø–µ–∫—Ç—Ä–æ–º –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è, –≤–∫–ª—é—á–∞—è –ª–µ—á–µ–Ω–∏–µ –¥–µ–ø—Ä–µ—Å—Å–∏–∏, —á—Ç–æ –ø–æ–¥–¥–µ—Ä–∂–∏–≤–∞–µ—Ç —Å–ø—Ä–æ—Å –∏ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–æ–µ —Ä–∞–∑–≤–∏—Ç–∏–µ —Ä—ã–Ω–∫–∞. üíä–¢–µ—Ä–∞–ø–∏—è –æ–∂–∏—Ä–µ–Ω–∏—è üîò–í 2024 –≥–æ–¥—É –æ–±—ä–µ–º —Ä—ã–Ω–∫–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –æ–∂–∏—Ä–µ–Ω–∏—è –≤ –†–æ—Å—Å–∏–∏ –¥–æ—Å—Ç–∏–≥ 18,3 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, –ø–æ—á—Ç–∏ –≤ –¥–≤–∞ —Ä–∞–∑–∞ –±–æ–ª—å—à–µ, —á–µ–º –≤ 2022 (9,9 –º–ª—Ä–¥), —Å–æ–æ–±—â–∞—é—Ç RNC Pharma. üîò–î–æ–º–∏–Ω–∏—Ä—É—é—Ç –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –Ω–æ–≤–æ–≥–æ –ø–æ–∫–æ–ª–µ–Ω–∏—è –Ω–∞ –æ—Å–Ω–æ–≤–µ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞, –∏ –æ—Å–Ω–æ–≤–Ω—É—é –¥–æ–ª—é —Ä—ã–Ω–∫–∞ –∑–∞–Ω–∏–º–∞—é—Ç —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ –¥–∂–µ–Ω–µ—Ä–∏–∫–∏: ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª —Å –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–º ¬´–°–µ–º–∞–≤–∏–∫¬ª –∑–∞–Ω–∏–º–∞–µ—Ç –æ–∫–æ–ª–æ 65% —Ä—ã–Ω–∫–∞ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ (6,2 –º–ª—Ä–¥ —Ä—É–±. –∏–∑ 9,6 –º–ª—Ä–¥ —Ä—É–±. –æ–±—â–µ–≥–æ –æ–±—ä–µ–º–∞). üîò–ü–æ—Å–ª–µ —É—Ö–æ–¥–∞ —Å —Ä—ã–Ω–∫–∞ –º–∏—Ä–æ–≤–æ–≥–æ –ª–∏–¥–µ—Ä–∞ Novo Nordisk, —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ –∫–æ–º–ø–∞–Ω–∏–∏ –±—ã—Å—Ç—Ä–æ –Ω–∞–ª–∞–¥–∏–ª–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤, –æ–±–µ—Å–ø–µ—á–∏–≤ –≤—ã—Å–æ–∫—É—é –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. üîò–¶–µ–Ω—ã –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ –Ω–∏–∂–µ –∑–∞—Ä—É–±–µ–∂–Ω—ã—Ö (–Ω–∞–ø—Ä–∏–º–µ—Ä, —Ä–æ—Å—Å–∏–π—Å–∫–∏–π —Å–µ–º–∞–≥–ª—É—Ç–∏–¥ ‚Äì –æ–∫–æ–ª–æ 4 —Ç—ã—Å. —Ä—É–±. –≤ –º–µ—Å—è—Ü –ø—Ä–æ—Ç–∏–≤ 39-78 —Ç—ã—Å. —Ä—É–±. –≤ –°–®–ê). üîò–í 2025 –≥–æ–¥—É ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª –Ω–æ–≤—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç —Å —Ç–∏—Ä–∑–µ–ø–∞—Ç–∏–¥–æ–º (–°–µ–¥–∂–∞—Ä–æ), —Ä–∞—Å—à–∏—Ä—è—è –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ –ª–µ—á–µ–Ω–∏—è –æ–∂–∏—Ä–µ–Ω–∏—è –∏ –¥–∏–∞–±–µ—Ç–∞. –≠–∫—Å–ø–µ—Ä—Ç—ã –æ—Ç–º–µ—á–∞—é—Ç, —á—Ç–æ –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –¥–µ–ª–∞–µ—Ç –ª–µ—á–µ–Ω–∏–µ –æ–∂–∏—Ä–µ–Ω–∏—è –≤ –†–æ—Å—Å–∏–∏ –æ–¥–Ω–∏–º –∏–∑ –ª—É—á—à–∏—Ö –≤ –º–∏—Ä–µ –ø–æ —Å–æ–æ—Ç–Ω–æ—à–µ–Ω–∏—é —Ü–µ–Ω–∞/–∫–∞—á–µ—Å—Ç–≤–æ –∏ –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""Russia's domestic pharmaceutical companies are making significant progress in the replacement of foreign competitors. Sales of botulinum toxins have increased by 36.9% year-over-year to reach RUB3 billion in the first quarter of 2025. Russian products 'Relatoksin' and 'Myotoks' have grown by 46% and 63%, respectively, compared to the leader 'Botox' from France. The growth is attributed to Allergan's exit from Russia and the challenges with logistics and finding alternatives. The market for obesity treatment is also growing, with sales of drugs increasing to RUB18.3 billion in 2024 from RUB9.9 billion in 2022.""
}"
2025-06-17T09:21:06+00:00,@bezrec,6180,https://t.me/bezrec/6180,"–¢–æ–ø-10 –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è —â–∏—Ç–æ–≤–∏–¥–Ω–æ–π –∂–µ–ª–µ–∑—ã –ø–æ –æ–±—ä–µ–º—É –ø—Ä–æ–¥–∞–∂ –≤ —Ä–æ—Å—Å–∏–π—Å–∫–æ–π —Ä–æ–∑–Ω–∏—Ü–µ –° —è–Ω–≤–∞—Ä—è –ø–æ –∞–ø—Ä–µ–ª—å 2025 –≥–æ–¥–∞ —Ä–æ—Å—Å–∏—è–Ω–µ –ø–æ—Ç—Ä–∞—Ç–∏–ª–∏ –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–ª—è –ª–µ—á–µ–Ω–∏—è –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π —â–∏—Ç–æ–≤–∏–¥–Ω–æ–π –∂–µ–ª–µ–∑—ã –±–æ–ª–µ–µ 1,1 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —á—Ç–æ –Ω–∞ 20,4% –±–æ–ª—å—à–µ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –∞–Ω–∞–ª–æ–≥–∏—á–Ω—ã–º –ø–µ—Ä–∏–æ–¥–æ–º 2024 –≥–æ–¥–∞, –ø–æ—Å—á–∏—Ç–∞–ª–∏ –≤ RNC Pharma. –û–±—ä—ë–º –ø—Ä–æ–¥–∞–∂ –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö —Å–æ—Å—Ç–∞–≤–∏–ª –ø–æ—á—Ç–∏ 7,3 –º–ª–Ω (+9,8% –≥–æ–¥ –∫ –≥–æ–¥—É), –ø–æ–∫–∞–∑—ã–≤–∞—è, —á—Ç–æ —Ä—ã–Ω–æ–∫ –ø–æ—Å—Ç–µ–ø–µ–Ω–Ω–æ –≤–æ—Å—Å—Ç–∞–Ω–∞–≤–ª–∏–≤–∞–µ—Ç—Å—è –ø–æ—Å–ª–µ —Å–ø–∞–¥–∞ 2023-–≥–æ, –≤—ã–∑–≤–∞–Ω–Ω–æ–≥–æ –Ω–∞—Å—ã—â–µ–Ω–∏–µ–º —Å–ø—Ä–æ—Å–∞ –≤ 2022 –≥–æ–¥—É. –ü–∏–∫–æ–≤—ã–µ –æ–±—ä—ë–º—ã –ø—Ä–æ–¥–∞–∂ —ç—Ç–æ–π –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ –ø—Ä–∏—à–ª–∏—Å—å –Ω–∞ –º–∞—Ä—Ç 2022 –≥–æ–¥–∞ ‚Äì —Ç–æ–≥–¥–∞ –∑–∞ –º–µ—Å—è—Ü –±—ã–ª–æ —Ä–µ–∞–ª–∏–∑–æ–≤–∞–Ω–æ —Å–≤—ã—à–µ 6,9 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫. –í —Ä–æ–∑–Ω–∏—Ü–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–ª—è —â–∏—Ç–æ–≤–∏–¥–Ω–æ–π –∂–µ–ª–µ–∑—ã –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω—ã –¥–æ–≤–æ–ª—å–Ω–æ –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–Ω—ã–º –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç–æ–º ‚Äì –æ–∫–æ–ª–æ 50 SKU. –û—Å–Ω–æ–≤–Ω–æ–π –≤–∫–ª–∞–¥ –≤ –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–µ –ø–æ-–ø—Ä–µ–∂–Ω–µ–º—É –≤–Ω–æ—Å—è—Ç –≥–æ—Ä–º–æ–Ω–∞–ª—å–Ω—ã–µ —Å—Ä–µ–¥—Å—Ç–≤–∞ –Ω–∞ –æ—Å–Ω–æ–≤–µ –ª–µ–≤–æ—Ç–∏—Ä–æ–∫—Å–∏–Ω–∞ –Ω–∞—Ç—Ä–∏—è ‚Äì –∏—Ö –¥–æ–ª—è –ø—Ä–µ–≤—ã—à–∞–µ—Ç 71% –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏. –ô–æ–¥—Å–æ–¥–µ—Ä–∂–∞—â–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –æ–±–µ—Å–ø–µ—á–∏–≤–∞—é—Ç –µ—â—ë 23%, –Ω–∞ –∞–Ω—Ç–∏—Ç–∏—Ä–µ–æ–∏–¥–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –≤—Å–µ–≥–æ 5,8%. –ê–±—Å–æ–ª—é—Ç–Ω—ã–π –ª–∏–¥–µ—Ä –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ ‚Äì L-–¢–∏—Ä–æ–∫—Å–∏–Ω, –∫–æ—Ç–æ—Ä—ã–π –≤—ã–ø—É—Å–∫–∞—é—Ç —Å—Ä–∞–∑—É —Ç—Ä–∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è. –ü–æ—á—Ç–∏ –≤–µ—Å—å –æ–±—ä—ë–º (96%) –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ ¬´–ë–µ—Ä–ª–∏–Ω-–•–µ–º–∏¬ª (–≤—Ö–æ–¥–∏—Ç –≤ Menarini), –æ—Å—Ç–∞–≤—à–∏–µ—Å—è –¥–æ–ª–∏ –¥–µ–ª—è—Ç –º–µ–∂–¥—É —Å–æ–±–æ–π —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª –∏ ¬´–û–±–Ω–æ–≤–ª–µ–Ω–∏–µ¬ª. –°–æ–≤–æ–∫—É–ø–Ω–æ –±—Ä–µ–Ω–¥ –æ–±–µ—Å–ø–µ—á–∏–≤–∞–µ—Ç 33,8% —Å—Ç–æ–∏–º–æ—Å—Ç–Ω–æ–≥–æ –æ–±—ä—ë–º–∞ –ø—Ä–æ–¥–∞–∂. –í—Ç–æ—Ä–æ–µ –º–µ—Å—Ç–æ —Å–æ—Ö—Ä–∞–Ω—è–µ—Ç –≠—É—Ç–∏—Ä–æ–∫—Å –æ—Ç –Ω–µ–º–µ—Ü–∫–æ–π ¬´–ú–µ—Ä–∫¬ª (28,3%), –∑–∞–º—ã–∫–∞–µ—Ç —Ç—Ä–æ–π–∫—É –ô–æ–¥–æ–º–∞—Ä–∏–Ω –æ—Ç –≤—Å—ë —Ç–æ–π –∂–µ ¬´–ë–µ—Ä–ª–∏–Ω-–•–µ–º–∏¬ª (23,7%). –†–µ–∫–æ—Ä–¥–Ω—ã–π —Ä–æ—Å—Ç –ø–æ–∫–∞–∑–∞–ª –ü—Ä–æ–ø–∏—Ü–∏–ª –æ—Ç –Ω–µ–º–µ—Ü–∫–æ–π Admeda Arzneimittel ‚Äì –ø—Ä–æ–¥–∞–∂–∏ —É–≤–µ–ª–∏—á–∏–ª–∏—Å—å –≤ 293 —Ä–∞–∑–∞ –≤ —Ä—É–±–ª—è—Ö –∏ –≤ 101 —Ä–∞–∑ –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö. –í —á–∏—Å–ª–µ —Ä–∞—Å—Ç—É—â–∏—Ö –∏ –Ω–æ–≤—ã–π –±—Ä–µ–Ω–¥ –æ—Ç ¬´–ù–∏–∂—Ñ–∞—Ä–º¬ª –õ–∏–∫–≤–∞—Ç–∏—Ä–æ–ª (–ª–µ–≤–æ—Ç–∏—Ä–æ–∫—Å–∏–Ω –Ω–∞—Ç—Ä–∏—è), –ø–æ—Å—Ç—É–ø–∏–≤—à–∏–π –≤ —Ä–æ–∑–Ω–∏—Ü—É –≤–æ –≤—Ç–æ—Ä–æ–π –ø–æ–ª–æ–≤–∏–Ω–µ 2024 –≥–æ–¥–∞. –ß–µ—Ç—ã—Ä–µ –±—Ä–µ–Ω–¥–∞ –∏–∑ –ø–µ—Ä–≤–æ–π –¥–µ—Å—è—Ç–∫–∏ –ø–æ–∫–∞–∑–∞–ª–∏ —Å–Ω–∏–∂–µ–Ω–∏–µ –ø—Ä–æ–¥–∞–∂. –ú–∞–∫—Å–∏–º–∞–ª—å–Ω–æ–µ –ø–∞–¥–µ–Ω–∏–µ ‚Äì —É –ú–∏–∫—Ä–æ–π–æ–¥–∏–¥–∞ –æ—Ç ¬´–¢–∞—Ç—Ö–∏–º—Ñ–∞—Ä–º–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤¬ª: -50% –≤ –¥–µ–Ω–µ–∂–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, shortage, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""Sales of thyroid disease treatments in Russia have increased by 20.4% year-over-year to over 1.1 billion rubles from January to April 2025, compared to the same period in 2024. The market is gradually recovering from a slump in 2023 due to over-supply in 2022. Sales volumes have reached nearly 7.3 million units (+9.8% YoY). The top-selling brands include L-Tyrosine from Berlin-Hemisphere (33.8% of sales), Euthyrine from Merck (28.3%), and Iodomarin from Berlin-Hemisphere (23.7%). The record growth was seen in Propylith from Admeda Arzneimittel, which increased sales by 293 times in rubles and 101 times in units. Four brands from the top ten have shown a decline, with Micriodine from Tatthimfarpratovs down by 5"
2025-06-17T06:50:38+00:00,@bezrec,6179,https://t.me/bezrec/6179,"AstraZeneca –∏ CSPC –æ–±—ä–µ–¥–∏–Ω—è—é—Ç—Å—è –¥–ª—è –ò–ò-—Ä–∞–∑—Ä–∞–±–æ—Ç–æ–∫ –≤ –æ–±–ª–∞—Å—Ç–∏ —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π AstraZeneca –ø–æ–¥–ø–∏—Å–∞–ª–∞ —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–æ–µ —Å–æ–≥–ª–∞—à–µ–Ω–∏–µ —Å –∫–∏—Ç–∞–π—Å–∫–æ–π CSPC Pharmaceutical Group –Ω–∞ —Å—É–º–º—É –¥–æ $5,3 –º–ª—Ä–¥, –≤–∫–ª—é—á–∞—è $110 –º–ª–Ω –∞–≤–∞–Ω—Å–æ–º. –û—Å–Ω–æ–≤–Ω–∞—è —Ü–µ–ª—å ‚Äì —ç—Ç–æ —Å–æ–≤–º–µ—Å—Ç–Ω–∞—è —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∞ —Ç–µ—Ä–∞–ø–∏–π –æ—Ç —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π —Å –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º –ò–ò. –§–æ–∫—É—Å –Ω–∞ –º–∞–ª–æ–º–æ–ª–µ–∫—É–ª—è—Ä–Ω—ã–µ –ø–µ—Ä–æ—Ä–∞–ª—å–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –ø—Ä–∏ –∏–º–º—É–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –Ω–∞—Ä—É—à–µ–Ω–∏—è—Ö. –ò—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –±—É–¥–µ—Ç –≤–µ—Å—Ç–∏ CSPC –Ω–∞ –±–∞–∑–µ –≤ –®–∏—Ü–∑—è—á–∂—É–∞–Ω–µ, –∏—Å–ø–æ–ª—å–∑—É—è —Å–æ–±—Å—Ç–≤–µ–Ω–Ω—ã–µ –ò–ò-—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏. –≠—Ç–æ –æ—á–µ—Ä–µ–¥–Ω–æ–π —à–∞–≥ AstraZeneca –∫ —É–∫—Ä–µ–ø–ª–µ–Ω–∏—é –ø–æ–∑–∏—Ü–∏–π –≤ –ö–∏—Ç–∞–µ ‚Äì –≤—Ç–æ—Ä–æ–º –ø–æ –∑–Ω–∞—á–∏–º–æ—Å—Ç–∏ —Ä—ã–Ω–∫–µ –∫–æ–º–ø–∞–Ω–∏–∏. –†–∞–Ω–µ–µ –≤ –º–∞—Ä—Ç–µ –∫–æ–º–ø–∞–Ω–∏—è –∞–Ω–æ–Ω—Å–∏—Ä–æ–≤–∞–ª–∞ –≤–ª–æ–∂–µ–Ω–∏—è $2,5 –º–ª—Ä–¥ –≤ R&D-—Ö–∞–± –≤ –ü–µ–∫–∏–Ω–µ. –ù–æ–≤—ã–π –∫–æ–Ω—Ç—Ä–∞–∫—Ç –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç —Ç—Ä–µ–Ω–¥: –ø–æ—Å–ª–µ –∫–æ–ª–ª–∞–±–æ—Ä–∞—Ü–∏–π —Å Immunai, Qure.ai –∏ Tempus AI, —Å—Ç–∞–≤–∫–∞ —è–≤–Ω–æ –¥–µ–ª–∞–µ—Ç—Å—è –Ω–∞ –ò–ò. –°–¥–µ–ª–∫–∞ —Å CSPC —Ç–∞–∫–∂–µ –≤–∫–ª—é—á–∞–µ—Ç –ø—Ä–∞–≤–æ AstraZeneca –Ω–∞ —ç–∫—Å–∫–ª—é–∑–∏–≤–Ω—ã–µ –ª–∏—Ü–µ–Ω–∑–∏–∏ –Ω–∞ –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–Ω—ã–µ –º–æ–ª–µ–∫—É–ª—ã. –≠—Ç–æ —É–∂–µ –Ω–µ –ø–µ—Ä–≤–æ–µ —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–æ: –≤ –æ–∫—Ç—è–±—Ä–µ 2024 —Å—Ç–æ—Ä–æ–Ω—ã –∑–∞–∫–ª—é—á–∏–ª–∏ –ª–∏—Ü–µ–Ω–∑–∏–æ–Ω–Ω–æ–µ —Å–æ–≥–ª–∞—à–µ–Ω–∏–µ –Ω–∞ $1,92 –º–ª—Ä–¥ –¥–ª—è —É—Å–∏–ª–µ–Ω–∏—è –∫–∞—Ä–¥–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ –ø–æ—Ä—Ç—Ñ–µ–ª—è. –†–æ—Å—Ç –≤ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –æ—Ç—Ä–∞—Å–ª–∏ –≤—Å—ë —á–∞—â–µ –æ–ø—Ä–µ–¥–µ–ª—è–µ—Ç—Å—è –Ω–µ —Ç–æ–ª—å–∫–æ –Ω–∞—É—á–Ω—ã–º–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∞–º–∏, –Ω–æ –∏ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ–º –ò–ò –∫–∞–∫ –∫–ª—é—á–µ–≤—ã–º —ç–ª–µ–º–µ–Ω—Ç–æ–º —Å—Ç—Ä–∞—Ç–µ–≥–∏–∏ –Ω–∞ –≤—ã—Å–æ–∫–æ–∫–æ–Ω–∫—É—Ä–µ–Ω—Ç–Ω—ã—Ö –∏ –±—ã—Å—Ç—Ä–æ—Ä–∞–∑–≤–∏–≤–∞—é—â–∏—Ö—Å—è —Ä—ã–Ω–∫–∞—Ö. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,pharmacovigilance,hospital_policy,regulation"",
  ""impact"": ""high"",
  ""english"": ""AstraZeneca has signed a strategic agreement with CSPC Pharmaceutical Group worth up to $5.3 billion, including an upfront payment of $110 million. The main goal is joint research and development of therapies for chronic diseases using artificial intelligence (AI). Focus will be on small molecule oral drugs for immunological disorders. CSPC will conduct research in Shizhezhen, utilizing its own AI technologies. This is AstraZeneca's next move to strengthen its position in China, the second-largest market for the company. Earlier this month, the company announced R&D investments of $2.5 billion in Beijing. The new contract also includes AstraZeneca's exclusive license to promising molecules. This is not the first collaboration: in October 2024, they signed a $1.92 billion licensing agreement to enhance their cardiology portfolio. The rise in the pharmaceutical industry is increasingly being driven not only by scientific research but also by the use of AI as a key element of their strategy on high-"
2025-06-16T16:32:45+00:00,@bezrec,6178,https://t.me/bezrec/6178,"–ü—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º –≤–∞–∫—Ü–∏–Ω –ø–æ—Ä–∞ —É—Å–∏–ª–∏–≤–∞—Ç—å PR-–∫–æ–º–∞–Ω–¥—ã –≤—ã—Ö–æ–¥—Ü–∞–º–∏ –∏–∑ ¬´–û–∑–µ–º–ø–∏–∫–∞¬ª –∏ –∞–ª–∫–æ–≥–æ–ª—å–Ω—ã—Ö –±—Ä–µ–Ω–¥–æ–≤ ‚Äì —Ç–µ, –∫—Ç–æ –±–æ–∏—Ç—Å—è ¬´—Ö–∏–º–∏–∏¬ª, –æ—Ç—á–µ–≥–æ-—Ç–æ –±–µ–∑ —Å—Ç—Ä–∞—Ö–∞ —Å—Ç–∞–≤—è—Ç —Å–µ–±–µ –≥–æ—Ä–º–æ–Ω—ã –∏ –∑–∞–ª–∏–≤–∞—é—Ç –∏—Ö —ç—Ç–∞–Ω–æ–ª–æ–º. –í–∏–¥–∏–º–æ, —É –∏–º–º—É–Ω–∏—Ç–µ—Ç–∞ –ø—Ä–æ—Å—Ç–æ –ø–ª–æ—Ö–æ–π –º–∞—Ä–∫–µ—Ç–∏–Ω–≥. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-06-16T14:16:16+00:00,@bezrec,6177,https://t.me/bezrec/6177,"–ö—Ä—É–ø–Ω–µ–π—à–∏–µ —Å–µ—Ä–≤–∏—Å—ã –¥–∏—Å—Ç–∞–Ω—Ü–∏–æ–Ω–Ω–æ–≥–æ –∑–∞–∫–∞–∑–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ RNC Pharma –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∞ –¥–∞–Ω–Ω—ã–µ –ø–æ —Ä—ã–Ω–æ—á–Ω–æ–π –¥–æ–ª–µ –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö –∞–ø—Ç–µ—á–Ω—ã—Ö e-commerce –ø–ª–∞—Ç—Ñ–æ—Ä–º –Ω–∞ 1 –∞–ø—Ä–µ–ª—è 2025 –≥–æ–¥–∞.¬´–ê–ø—Ç–µ–∫–∞.—Ä—É¬ª, ¬´–Æ—Ç–µ–∫–∞¬ª, ¬´–ó–¥—Ä–∞–≤—Å–∏—Ç–∏¬ª, ¬´–ï–∞–ø—Ç–µ–∫–∞¬ª –∏ Polza.ru –ø—Ä–æ–¥–æ–ª–∂–∞—é—Ç –Ω–∞—Ä–∞—â–∏–≤–∞—Ç—å –æ—Ö–≤–∞—Ç –∏ –≤–ª–∏—è–Ω–∏–µ –Ω–∞ —Ä—ã–Ω–∫–µ. –ü–æ —á–∏—Å–ª—É —Ç–æ—á–µ–∫ –ª–∏–¥–∏—Ä—É–µ—Ç ¬´–Æ—Ç–µ–∫–∞¬ª ‚Äì –±–æ–ª–µ–µ 54,2 —Ç—ã—Å. –∞–ø—Ç–µ–∫, —Å –∫–æ—Ç–æ—Ä—ã–º–∏ —É –ø–ª–∞—Ç—Ñ–æ—Ä–º—ã –∑–∞–∫–ª—é—á–µ–Ω—ã –ø–∞—Ä—Ç–Ω—ë—Ä—Å–∫–∏–µ –¥–æ–≥–æ–≤–æ—Ä—ã. –ù–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ ‚Äì ¬´–ê–ø—Ç–µ–∫–∞.—Ä—É¬ª (40,8 —Ç—ã—Å.), –∑–∞ –Ω–µ–π ‚Äì ¬´–ó–¥—Ä–∞–≤—Å–∏—Ç–∏¬ª (34,1 —Ç—ã—Å.), Polza.ru (32,6 —Ç—ã—Å.) –∏ ¬´–ï–∞–ø—Ç–µ–∫–∞¬ª (11,8 —Ç—ã—Å.). –ü–æ —Ä—ã–Ω–æ—á–Ω–æ–π –¥–æ–ª–µ —Å–∏–ª—å–Ω–µ–µ –≤—Å–µ–≥–æ –≤—ã–¥–µ–ª—è–µ—Ç—Å—è ¬´–ê–ø—Ç–µ–∫–∞.—Ä—É¬ª: 4,4% –±–µ–∑ —É—á—ë—Ç–∞ –õ–õ–û, –≤–∫–ª—é—á–∞—è 4,1% –≤ —Å–µ–≥–º–µ–Ω—Ç–µ –õ–ü –∏ 5,4% ‚Äì –≤ –Ω–µ –õ–ü. –û—Å—Ç–∞–ª—å–Ω—ã–µ —É—á–∞—Å—Ç–Ω–∏–∫–∏ –æ—Ç—Å—Ç–∞—é—Ç: –¥–æ–ª—è ¬´–Æ—Ç–µ–∫–∏¬ª —Å–æ—Å—Ç–∞–≤–∏–ª–∞ 1,5%, ¬´–ó–¥—Ä–∞–≤—Å–∏—Ç–∏¬ª –∏ ¬´–ï–∞–ø—Ç–µ–∫–∏¬ª ‚Äì –ø–æ 1,3‚Äì1,4%, —É Polza.ru ‚Äì 0,6%. –ê–∫—Ç–∏–≤–Ω–æ–≥–æ —Ä–æ—Å—Ç–∞ –∞–ø—Ç–µ—á–Ω–æ–π –±–∞–∑—ã —É –ø–ª–∞—Ç—Ñ–æ—Ä–º —É–∂–µ –Ω–µ –Ω–∞–±–ª—é–¥–∞–µ—Ç—Å—è ‚Äì –Ω–∞—Å—ã—â–µ–Ω–∏–µ –¥–æ—Å—Ç–∏–≥–ª–æ –ø–∏–∫–∞. –û–¥–Ω–∞–∫–æ –±–æ—Ä—å–±–∞ –∑–∞ –¥–æ–ª—é —Ä—ã–Ω–∫–∞ –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç—Å—è: –∏–≥—Ä–æ–∫–∏ –¥–µ–ª–∞—é—Ç —Å—Ç–∞–≤–∫—É –Ω–∞ —É–ª—É—á—à–µ–Ω–∏–µ –ª–æ–≥–∏—Å—Ç–∏–∫–∏, —ç–∫—Å–ø–∞–Ω—Å–∏—é –≤ —Ä–µ–≥–∏–æ–Ω—ã –∏ —É–≥–ª—É–±–ª–µ–Ω–∏–µ –≤ —ç–∫–æ—Å–∏—Å—Ç–µ–º—ã e-health. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""RNC Pharma presented data on the market share of major e-commerce pharmacy platforms as of April 1, 2025. Leading the market are 'Apteka.ru', 'Yuteka', 'Zdravcity', and 'Eaptek'. 'Apteka.ru' leads with a market share of 4.1% in the LPP segment and 5.4% overall, excluding Long Term Outpatient (LLO). 'Yuteka' has a market share of 1.5%, while 'Zdravcity' and 'Eaptek' have a market share of 1.3-1.4%. The active growth in the pharmacy base has stopped, and saturation has reached a peak. However, competition for market share continues with players focusing on improving logistics, expanding into regions, and deepening their integration into e-health ecosystems.""
}"
2025-06-16T12:34:22+00:00,@bezrec,6176,https://t.me/bezrec/6176,"Novo Nordisk —Ç–µ—Ä—è–µ—Ç –∫–∞–Ω–∞–¥—Å–∫–∏–π —Ä—ã–Ω–æ–∫ –∏–∑-–∑–∞ –Ω–µ–æ–ø–ª–∞—á–µ–Ω–Ω–æ–π –ø–æ—à–ª–∏–Ω—ã –≤ $450 –û–¥–∏–Ω –∏–∑ —Å–∞–º—ã—Ö –ø—Ä–æ–¥–∞–≤–∞–µ–º—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ø–æ—Å–ª–µ–¥–Ω–∏—Ö –ª–µ—Ç —Å–µ–º–∞–≥–ª—É—Ç–∏–¥, –∏–∑–≤–µ—Å—Ç–Ω—ã–π –∫–∞–∫ ¬´–û–∑–µ–º–ø–∏–∫¬ª –∏ ¬´–í–µ–≥–æ–≤–∏¬ª, –ø–æ—Ç–µ—Ä—è–ª –ø–∞—Ç–µ–Ω—Ç–Ω—É—é –∑–∞—â–∏—Ç—É –≤ –ö–∞–Ω–∞–¥–µ. –ö–æ–º–ø–∞–Ω–∏—è-–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å Novo Nordisk –Ω–µ –æ–ø–ª–∞—Ç–∏–ª–∞ –ø–æ—à–ª–∏–Ω—É –∑–∞ –ø—Ä–æ–¥–ª–µ–Ω–∏–µ –ø–∞—Ç–µ–Ω—Ç–∞ –Ω–∞ —Å—É–º–º—É $450 —Å —É—á—ë—Ç–æ–º —à—Ç—Ä–∞—Ñ–∞. –ü–æ—Å–ª–µ–¥–Ω–∏–π –ø–ª–∞—Ç—ë–∂ –±—ã–ª –≤ 2018 –≥–æ–¥—É, –≤ 2019-–º —Ä–µ–≥—É–ª—è—Ç–æ—Ä –Ω–∞–ø—Ä–∞–≤–∏–ª –Ω–∞–ø–æ–º–∏–Ω–∞–Ω–∏–µ. –û—Ç–≤–µ—Ç–∞ –Ω–µ –ø–æ—Å–ª–µ–¥–æ–≤–∞–ª–æ. –ü–∞—Ç–µ–Ω—Ç –∞–Ω–Ω—É–ª–∏—Ä–æ–≤–∞–ª–∏ –±–µ–∑ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ –≤–æ—Å—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è –∏–∑-–∑–∞ —É—Å—Ç—Ä–æ–π—Å—Ç–≤–∞ –∫–∞–Ω–∞–¥—Å–∫–æ–≥–æ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–∞. –¢–µ–ø–µ—Ä—å —Ä—ã–Ω–æ–∫ –æ—Ç–∫—Ä—ã—Ç –¥–ª—è –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤. Sandoz —É–∂–µ –ø–æ–¥–∞–ª–∞ –∑–∞—è–≤–∫—É –∏ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç –≤—ã–ø—É—Å—Ç–∏—Ç—å –∞–Ω–∞–ª–æ–≥ –≤ 2026 –≥–æ–¥—É. –≠—Ç–æ –≤—Ç–æ—Ä–æ–π –ø–æ –æ–±—ä—ë–º—É —Ä—ã–Ω–æ–∫ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ –ø–æ—Å–ª–µ –°–®–ê. –Ø —É–≤–µ—Ä–µ–Ω, –∫—Ç–æ-—Ç–æ –ø–æ—Å–ª–µ —ç—Ç–æ–≥–æ –ø–æ—Ç–µ—Ä—è–ª —Ä–∞–±–æ—Ç—É. –ù–æ –Ω–∏—á–µ–≥–æ, –±—ã–≤–∞–µ—Ç, ‚Äì –ø—Ä–æ–∫–æ–º–º–µ–Ω—Ç–∏—Ä–æ–≤–∞–ª –≥–ª–∞–≤–∞ Sandoz –†–∏—á–∞—Ä–¥ –°–µ–π–Ω–æ—Ä –≤ –∏–Ω—Ç–µ—Ä–≤—å—é Endpoints. –í –°–®–ê –ø–∞—Ç–µ–Ω—Ç –¥–µ–π—Å—Ç–≤—É–µ—Ç –∫–∞–∫ –º–∏–Ω–∏–º—É–º –¥–æ 2032 –≥–æ–¥–∞. –ù–æ –≤ –ö–∞–Ω–∞–¥–µ, –≥–¥–µ —Å–ø—Ä–æ—Å –ø–æ–¥–æ–≥—Ä–µ–≤–∞–µ—Ç—Å—è —Ç—Ä–∞–Ω—Å–≥—Ä–∞–Ω–∏—á–Ω–æ–π —Ç–æ—Ä–≥–æ–≤–ª–µ–π, —Å–∏—Ç—É–∞—Ü–∏—è —Å—Ç—Ä–µ–º–∏—Ç–µ–ª—å–Ω–æ –º–µ–Ω—è–µ—Ç—Å—è. –î–ª—è —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ —Å –≥–æ–¥–æ–≤–æ–π –≤—ã—Ä—É—á–∫–æ–π –≤ –¥–µ—Å—è—Ç–∫–∏ –º–∏–ª–ª–∏–∞—Ä–¥–æ–≤ –¥–æ–ª–ª–∞—Ä–æ–≤ –ø–æ—Ç–µ—Ä—è—Ç—å —Ä—ã–Ω–æ–∫ –∏–∑-–∑–∞ $450 ‚Äì —Ä–µ–¥–∫–∏–π –∏ –¥–æ—Ä–æ–≥–æ–π —É—Ä–æ–∫. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, regulation"",
  ""impact"": ""high"",
  ""english"": ""Novo Nordisk lost a significant market in Canada due to unpaid fees of $450, which led to the revocation of their patent. The situation is affecting the market for semaglutide, a highly successful drug in recent years. Sandoz has already filed for approval to produce generics starting in 2026, which could lead to a shortage. This case highlights the high cost and impact of losing a market due to regulatory issues.""
}"
2025-06-16T10:18:05+00:00,@bezrec,6175,https://t.me/bezrec/6175,"–ò–º–º—É–Ω–æ–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç –¥–ª—è –ª–µ—á–µ–Ω–∏—è –ø—Å–æ—Ä–∏–∞—Ç–∏—á–µ—Å–∫–æ–≥–æ –∞—Ä—Ç—Ä–∏—Ç–∞ —Å—Ç–∞–ª –¥–æ—Å—Ç—É–ø–Ω–µ–µ –Ω–∞ 27% –§–ê–° —Å–æ–≥–ª–∞—Å–æ–≤–∞–ª–∞ —Ü–µ–Ω—É –Ω–∞ –ø–µ—Ä–≤—ã–π —Ä–æ—Å—Å–∏–π—Å–∫–∏–π –¥–∂–µ–Ω–µ—Ä–∏–∫ –∞–ø—Ä–µ–º–∏–ª–∞—Å—Ç–∞ ‚Äì ¬´–ê–ø—Ä–µ–º–∏–ª–∞—Å—Ç-29–§¬ª. –£–ø–∞–∫–æ–≤–∫–∞ –∏–∑ 56 —Ç–∞–±–ª–µ—Ç–æ–∫ –ø–æ 30 –º–≥ –æ—Ç –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è –æ–±–æ–π–¥—ë—Ç—Å—è –≤ 26,3 —Ç—ã—Å. —Ä—É–±–ª–µ–π. –î–ª—è —Å—Ä–∞–≤–Ω–µ–Ω–∏—è, —Ü–µ–Ω–∞ —Ä–µ—Ñ–µ—Ä–µ–Ω—Ç–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ¬´–û—Ç–µ—Å–ª–∞¬ª –æ—Ç Celgene —Ä–∞–≤–Ω–∞ 36,1 —Ç—ã—Å. —Ä—É–±–ª–µ–π. –ê–ø—Ä–µ–º–∏–ª–∞—Å—Ç –ø—Ä–∏–º–µ–Ω—è–µ—Ç—Å—è –ø—Ä–∏ –∞–∫—Ç–∏–≤–Ω–æ–º –ø—Å–æ—Ä–∏–∞—Ç–∏—á–µ—Å–∫–æ–º –∞—Ä—Ç—Ä–∏—Ç–µ –∏ —è–∑–≤–µ–Ω–Ω—ã—Ö –ø–æ—Ä–∞–∂–µ–Ω–∏—è—Ö –ø–æ–ª–æ—Å—Ç–∏ —Ä—Ç–∞, –≤—ã–∑–≤–∞–Ω–Ω—ã—Ö –±–æ–ª–µ–∑–Ω—å—é –ë–µ—Ö—á–µ—Ç–∞. –ü—Ä–µ–ø–∞—Ä–∞—Ç –≤—Ö–æ–¥–∏—Ç –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü. –ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ ¬´–ê–ø—Ä–µ–º–∏–ª–∞—Å—Ç–∞-29–§¬ª –ª–æ–∫–∞–ª–∏–∑–æ–≤–∞–Ω–æ –≤ –†–æ—Å—Å–∏–∏, –µ–≥–æ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–æ–Ω–Ω–æ–µ —É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏–µ –≤—ã–¥–∞–Ω–æ –ø–æ—Å–ª–µ –∑–∞–≤–µ—Ä—à–µ–Ω–∏—è –ø–∞—Ç–µ–Ω—Ç–Ω–æ–π –∑–∞—â–∏—Ç—ã –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω–æ–≥–æ —Å—Ä–µ–¥—Å—Ç–≤–∞. –°–Ω–∏–∂–µ–Ω–∏–µ —Ü–µ–Ω—ã –æ—Ç–∫—Ä–æ–µ—Ç –Ω–æ–≤—ã–µ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ –¥–ª—è —Ä–∞—Å—à–∏—Ä–µ–Ω–∏—è —Ç–µ—Ä–∞–ø–∏–∏ –∏ —É–≤–µ–ª–∏—á–µ–Ω–∏—è –æ—Ö–≤–∞—Ç–∞ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –≤ —Ä–∞–º–∫–∞—Ö –≥–æ—Å–ø—Ä–æ–≥—Ä–∞–º–º. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The generic version of apremilast, 'Apremilast-29F', has been approved for the first time in Russia and will be 27% cheaper. The price of one pack (56 tablets) at home production is 263,000 rubles. The original drug 'Elsalvia' from Celgene costs 361,050 rubles. Apremilast is used for active psoriatic arthritis and mouth lesions caused by Beh√ßet's disease. The drug is included in the list of essential medicines. This price reduction will open up new opportunities for expanding treatment and increasing patient coverage within government programs.""
}"
2025-06-16T06:11:40+00:00,@bezrec,6174,https://t.me/bezrec/6174,"–º–†–ù–ö-–±—É–¥—É—â–µ–µ: BioNTech –ø–æ–∫—É–ø–∞–µ—Ç CureVac BioNTech –ø—Ä–∏–æ–±—Ä–µ—Ç–∞–µ—Ç –Ω–µ–º–µ—Ü–∫—É—é –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫—É—é –∫–æ–º–ø–∞–Ω–∏—é CureVac –∑–∞ $1,25 –º–ª—Ä–¥. –†–∞—Å—á—ë—Ç –±—É–¥–µ—Ç –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç—å—Å—è –∞–∫—Ü–∏—è–º–∏. –û—Å–Ω–æ–≤–Ω–æ–π –∏–Ω—Ç–µ—Ä–µ—Å ‚Äì —ç—Ç–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã–π –∏ –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–∏–π —Ü–µ–Ω—Ç—Ä CureVac –≤ –¢—é–±–∏–Ω–≥–µ–Ω–µ. –ü—Ä–µ–ø–∞—Ä–∞—Ç—ã –≤ —Ü–µ–Ω—Ç—Ä–µ –≤–Ω–∏–º–∞–Ω–∏—è –Ω–µ —Å—Ç–æ—è—Ç. BioNTech –¥–µ–ª–∞–µ—Ç —Å—Ç–∞–≤–∫—É –Ω–∞ –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä—É –∏ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–µ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ CureVac –≤ –æ–±–ª–∞—Å—Ç–∏ –º–†–ù–ö. –≠—Ç–æ –≤–ø–∏—Å—ã–≤–∞–µ—Ç—Å—è –≤ —Å—Ç—Ä–∞—Ç–µ–≥–∏—é —Ä–∞–∑–≤–∏—Ç–∏—è –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è –∏ —Å–æ–∑–¥–∞–Ω–∏—è –ø–æ–ª–Ω–æ–π —Ü–µ–ø–æ—á–∫–∏ –æ—Ç —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –¥–æ –∫–æ–º–º–µ—Ä—Ü–∏–∞–ª–∏–∑–∞—Ü–∏–∏. –ü–æ—Å–ª–µ –Ω–µ—É–¥–∞—á–∏ —Å COVID-–≤–∞–∫—Ü–∏–Ω–æ–π –∏ —Ä–∞–∑—Ä—ã–≤–∞ —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–∞ —Å GSK, CureVac —Å–æ–∫—Ä–∞—Ç–∏–ª–∞ —Ç—Ä–µ—Ç—å —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤ –∏ —Å–º–µ—Å—Ç–∏–ª–∞ —Ñ–æ–∫—É—Å –Ω–∞ –æ–Ω–∫–æ–ª–æ–≥–∏—é. –¢–µ–ø–µ—Ä—å –∫–æ–º–∞–Ω–¥–∞ –∏ –∞–∫—Ç–∏–≤—ã –∫–æ–º–ø–∞–Ω–∏–∏ —Å—Ç–∞–Ω—É—Ç —á–∞—Å—Ç—å—é BioNTech ‚Äì CureVac –ø–µ—Ä–µ–π–¥—ë—Ç –≤ —Å—Ç–∞—Ç—É—Å –¥–æ—á–µ—Ä–Ω–µ–π –∫–æ–º–ø–∞–Ω–∏–∏, –±—É–¥–µ—Ç –ø—Ä–æ–≤–µ–¥–µ–Ω–∞ —Ä–µ–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è. –ü—Ä–µ–¥–ø–æ–ª–∞–≥–∞–µ—Ç—Å—è, —á—Ç–æ —Å–¥–µ–ª–∫–∞ —É–∫—Ä–µ–ø–∏—Ç –ø–æ–∑–∏—Ü–∏–∏ BioNTech –Ω–∞ —Ä—ã–Ω–∫–µ –º–†–ù–ö –∏ —É—Å–∫–æ—Ä–∏—Ç —Ä–∞–∑–≤–∏—Ç–∏–µ –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –ø—Ä–æ–≥—Ä–∞–º–º. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-06-15T11:03:15+00:00,@bezrec,6173,https://t.me/bezrec/6173,"–ù—É —á—Ç–æ, –∫–∞–∫ –ø—Ä–æ–≤–µ–ª–∏ –¥–ª–∏–Ω–Ω—ã–µ –≤—ã—Ö–æ–¥–Ω—ã–µ?","{""skip"": true}"
2025-06-14T11:01:35+00:00,@bezrec,6172,https://t.me/bezrec/6172,"–†–∞–±–æ—á–∞—è –Ω–µ–¥–µ–ª—è –±—ã–ª–∞ –∫–æ—Ä–æ—Ç–∫–æ–π, –Ω–æ —Å–æ–±—ã—Ç–∏–π –Ω–∞ —Ä—É–±—Ä–∏–∫—É #–≤–¥–æ–≥–æ–Ω–∫—É –Ω–∞–±—Ä–∞–ª–æ—Å—å. üíä ¬´–î–∂–æ–¥–∞—Å –≠–∫—Å–ø–æ–∏–º¬ª –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç —Ç–µ—Ä—è—Ç—å –†–£. 11 –∏—é–Ω—è –ú–∏–Ω–∑–¥—Ä–∞–≤ –ø—Ä–∏–æ—Å—Ç–∞–Ω–æ–≤–∏–ª –¥–µ–π—Å—Ç–≤–∏–µ —Ä–µ–≥—É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏—è –∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫–∞ –§–æ—Å—Ñ–æ–º–∏—Ü–∏–Ω –î–∂ –≤ —Ñ–æ—Ä–º–µ –ø–æ—Ä–æ—à–∫–∞ –∏–Ω–¥–∏–π—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ –¥–æ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–∏—è —Å–≤–µ–¥–µ–Ω–∏–π –æ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ –≤–æ–∑–æ–±–Ω–æ–≤–ª–µ–Ω–∏—è –µ–≥–æ –¥–µ–π—Å—Ç–≤–∏—è. –ü—Ä–∏—á–∏–Ω–∞ ‚Äî –≤ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–æ–Ω–Ω–æ–º –¥–æ—Å—å–µ —Å–æ–¥–µ—Ä–∂–∞—Ç—Å—è –Ω–µ–¥–æ—Å—Ç–æ–≤–µ—Ä–Ω—ã–µ –¥–æ–∫—É–º–µ–Ω—Ç—ã –∏ –¥–∞–Ω–Ω—ã–µ. 6 –∏—é–Ω—è —Ä–µ–≥—É–ª—è—Ç–æ—Ä –æ—Ç–º–µ–Ω–∏–ª —Ä–µ–≥—É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏—è –Ω–∞ –ê–º–ø–∏—Ü–∏–ª–ª–∏–Ω + –°—É–ª—å–±–∞–∫—Ç–∞–º, –î–∂–∞–º—Å—É–ª –≤ —Ñ–æ—Ä–º–µ –ø–æ—Ä–æ—à–∫–∞ –∏ –≠—Ä—Ç–∞–ø–µ–Ω–µ–º –î–∂ –≤ —Ñ–æ—Ä–º–µ –ª–∏–æ—Ñ–∏–ª–∏–∑–∞—Ç–∞. üíä –í 2025 –≥–æ–¥—É –†–æ—Å—Å–∏—è –∑–∞–ø–ª–∞—Ç–∏–ª–∞ –∑–∞ –µ–≤—Ä–æ–ø–µ–π—Å–∫–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –Ω–∞ 15% –±–æ–ª—å—à–µ. –ü—Ä–∏ —ç—Ç–æ–º, –ø–æ –¥–∞–Ω–Ω—ã–º –ï–≤—Ä–æ—Å—Ç–∞—Ç–∞, –æ–±—ä—ë–º—ã –ø–æ—Å—Ç–∞–≤–æ–∫ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏–∑ –ï–° –≤ I –∫–≤–∞—Ä—Ç–∞–ª–µ 2025 –≥–æ–¥–∞ –æ—Å—Ç–∞–ª–∏—Å—å —Ç–µ–º–∏ –∂–µ, —á—Ç–æ –≥–æ–¥ –Ω–∞–∑–∞–¥. –í –¥–µ–Ω—å–≥–∞—Ö –∏–º–ø–æ—Ä—Ç –≤—ã—Ä–æ—Å –Ω–∞ 15,1% ‚Äî –¥–æ ‚Ç¨2,3 –º–ª—Ä–¥ (–æ–∫–æ–ª–æ 210 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π) –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å ‚Ç¨2,042 –º–ª—Ä–¥ –≤ I –∫–≤–∞—Ä—Ç–∞–ª–µ 2024 –≥–æ–¥–∞. –ê–Ω–∞–ª–∏—Ç–∏–∫–∏ —Å–≤—è–∑—ã–≤–∞—é—Ç —ç—Ç–æ —Å —Ä–æ—Å—Ç–æ–º –ø–æ—Å—Ç–∞–≤–æ–∫ –±–æ–ª–µ–µ –¥–æ—Ä–æ–≥–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –≤ —Ç–æ–º —á–∏—Å–ª–µ –∏–∑-–∑–∞ –≤–µ—Ä–æ—è—Ç–Ω–æ–≥–æ —Å–æ–∫—Ä–∞—â–µ–Ω–∏—è –æ–±—ä–µ–º–æ–≤ –≤–≤–æ–∑–∞ –±–æ–ª–µ–µ –¥–µ—à–µ–≤—ã—Ö –∞–Ω–∞–ª–æ–≥–æ–≤. üíä –ü–æ –¥–∞–Ω–Ω—ã–º RNC Pharma, –∑–∞ –≥–æ–¥ –ø—Ä–æ–¥–∞–∂–∏ —Ä–∞–Ω–æ–∑–∞–∂–∏–≤–ª—è—é—â–∏—Ö —Å—Ä–µ–¥—Å—Ç–≤ –≤ –¥–µ–Ω—å–≥–∞—Ö –≤—ã—Ä–æ—Å–ª–∏ –Ω–∞ 15,9%. –ü—Ä–∏ —ç—Ç–æ–º –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–µ –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö –æ—Å—Ç–∞–ª–æ—Å—å –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏ –Ω–∞ —Ç–æ–º –∂–µ —É—Ä–æ–≤–Ω–µ (+0,3%). –û–∫–æ–ª–æ 70% –≤—Å–µ—Ö –Ω–∞—Ç—É—Ä–∞–ª—å–Ω—ã—Ö –ø—Ä–æ–¥–∞–∂ –≤ –∞–Ω–∞–ª–∏–∑–∏—Ä—É–µ–º–æ–π –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ –∞–Ω—Ç–∏–±–∞–∫—Ç–µ—Ä–∏–∞–ª—å–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã. –í –∞–±—Å–æ–ª—é—Ç–Ω—ã—Ö –ª–∏–¥–µ—Ä–∞—Ö ‚Äî –ë–µ–ø–∞–Ω—Ç–µ–Ω ¬´–ë–∞–π–µ—Ä¬ª. –í —Ç–æ–ø-10 —Ç–∞–∫–∂–µ –≤–æ—à–ª–∏: –õ–µ–≤–æ–º–µ–∫–æ–ª—å (¬´–ù–∏–∂—Ñ–∞—Ä–º¬ª), –û—Ñ–ª–æ–º–µ–ª–∏–¥ (¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º¬ª), –ë–∞–Ω–µ–æ—Ü–∏–Ω (¬´–°–∞–Ω–¥–æ–∑¬ª), –î–µ–∫—Å–ø–∞–Ω—Ç–µ–Ω–æ–ª (¬´–í–µ—Ä—Ç–µ–∫—Å¬ª + 7 –∫–æ–º–ø–∞–Ω–∏–π), –ê—Ä–≥–æ—Å—É–ª—å—Ñ–∞–Ω (¬´–ë–∞–π—à –•–µ–ª—Å¬ª), –°—Ç—Ä–µ–ø—Ç–æ—Ü–∏–¥ (¬´–ú–µ–ª–∏–≥–µ–Ω¬ª + 18 –∫–æ–º–ø–∞–Ω–∏–π), –§—É—Ü–∏–¥–∏–Ω (¬´–õ–µ–æ –§–∞—Ä–º–∞¬ª), –ö–∞—Ä–∏–ø–∞–∑–∏–º (¬´–ú–µ–¥—Ñ–ª–æ—Ä–∏–Ω–∞¬ª + 2 –∫–æ–º–ø–∞–Ω–∏–∏), –î-–ü–∞–Ω—Ç–µ–Ω–æ–ª (¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª + 2 –∫–æ–º–ø–∞–Ω–∏–∏). üíä ¬´–ü–æ–ª–∏—Å–∞–Ω¬ª –¥–æ–±–∏–ª—Å—è –æ—Ç–º–µ–Ω—ã —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –§–ª–∞—Ç–æ—Ü–∏–Ω–∞ —Å–æ–ª–æ—Ñ–∞—Ä–º, –∏—Å–ø–æ–ª—å–∑—É–µ–º–æ–≥–æ –¥–ª—è —É–ª—É—á—à–µ–Ω–∏—è –∫–æ—Ä–æ–Ω–∞—Ä–Ω–æ–≥–æ –∏ –º–æ–∑–≥–æ–≤–æ–≥–æ –∫—Ä–æ–≤–æ—Ç–æ–∫–∞. –ê—Ä–±–∏—Ç—Ä–∞–∂–Ω—ã–π —Å—É–¥ –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥–∞ –∏ –õ–µ–Ω–∏–Ω–≥—Ä–∞–¥—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –æ–±—è–∑–∞–ª ¬´–ì—Ä–æ—Ç–µ–∫—Å¬ª –ø–æ–¥–∞—Ç—å –≤ –ú–∏–Ω–∑–¥—Ä–∞–≤ –∑–∞—è–≤–ª–µ–Ω–∏–µ –æ–± –æ—Ç–∑—ã–≤–µ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –∏ –æ—Ç–º–µ–Ω–µ –µ–≥–æ –ø—Ä–µ–¥–µ–ª—å–Ω–æ–π –æ—Ç–ø—É—Å–∫–Ω–æ–π —Ü–µ–Ω—ã. ¬´–ü–æ–ª–∏—Å–∞–Ω¬ª —É—Ç–≤–µ—Ä–∂–¥–∞–ª, —á—Ç–æ –∫–æ–Ω–∫—É—Ä–µ–Ω—Ç –Ω–∞—Ä—É—à–∏–ª –µ–≥–æ –∏—Å–∫–ª—é—á–∏—Ç–µ–ª—å–Ω—ã–µ –ø—Ä–∞–≤–∞ –Ω–∞ –∏–∑–æ–±—Ä–µ—Ç–µ–Ω–∏—è. –°—É–¥ –≤—Å—Ç–∞–ª –Ω–∞ —Å—Ç–æ—Ä–æ–Ω—É –∏—Å—Ç—Ü–∞, –Ω–µ—Å–º–æ—Ç—Ä—è –Ω–∞ –∑–∞–≤–µ—Ä–µ–Ω–∏—è –æ—Ç–≤–µ—Ç—á–∏–∫–∞ –≤ —Ç–æ–º, —á—Ç–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç –Ω–µ –≤–≤–µ–¥—ë–Ω –≤ –≥—Ä–∞–∂–¥–∞–Ω—Å–∫–∏–π –æ–±–æ—Ä–æ—Ç. üíä –í–ò–ß-–∏–Ω—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ª–µ—á–∞—Ç –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–º. –ü–æ —Å–ª–æ–≤–∞–º –≥–ª–∞–≤–Ω–æ–≥–æ –≤–Ω–µ—à—Ç–∞—Ç–Ω–æ–≥–æ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ø–æ –í–ò–ß-–∏–Ω—Ñ–µ–∫—Ü–∏–∏ –ê–ª–µ–∫—Å–µ—è –ú–∞–∑—É—Å–∞, ¬´–±–æ–ª–µ–µ 75% –±–æ–ª—å–Ω—ã—Ö, —Å–æ—Å—Ç–æ—è—â–∏—Ö –Ω–∞ —É—á–µ—Ç–µ, –ø–æ–ª—É—á–∞—é—Ç —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ —Å–æ–≤—Ä–µ–º–µ–Ω–Ω—ã–µ –∞–Ω—Ç–∏—Ä–µ—Ç—Ä–æ–≤–∏—Ä—É—Å–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã¬ª. –û–Ω —Ç–∞–∫–∂–µ –æ—Ç–º–µ—Ç–∏–ª, —á—Ç–æ –æ—á–µ—Ä–µ–¥–µ–π –Ω–∞ –ø–æ–ª—É—á–µ–Ω–∏–µ —Ç–∞–∫–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ ¬´–¥–∞–≤–Ω–æ –Ω–µ—Ç¬ª. –ó–∞—è–≤–∫–∏, –∫–æ—Ç–æ—Ä—ã–µ –±—ã–ª–∏ —Å–¥–µ–ª–∞–Ω—ã –≤—Å–µ–º–∏ —Ä–µ–≥–∏–æ–Ω–∞–º–∏ —Å—Ç—Ä–∞–Ω—ã –≤ –ø—Ä–æ—à–ª–æ–º –≥–æ–¥—É, –±—ã–ª–∏ –ø–æ–ª–Ω–æ—Å—Ç—å—é –æ–±–µ—Å–ø–µ—á–µ–Ω—ã –ú–∏–Ω–∑–¥—Ä–∞–≤–æ–º. –í—Å–µ –¥–æ—à–ª–∏ –¥–æ —Ä–µ–≥–∏–æ–Ω–æ–≤ –∏, —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ, –≤—Å–µ –¥–æ—Ö–æ–¥—è—Ç –¥–æ –±–æ–ª—å–Ω—ã—Ö. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-06-13T10:59:58+00:00,@bezrec,6171,https://t.me/bezrec/6171,–ö–æ–≥–¥–∞ —Ä–µ—à–∏–ª —Å—ç–∫–æ–Ω–æ–º–∏—Ç—å –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞—Ö. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞,"{""skip"": true}"
2025-06-12T09:03:34+00:00,@bezrec,6170,https://t.me/bezrec/6170,"–ü–æ–∑–¥—Ä–∞–≤–ª—è–µ–º —Å –î–Ω—ë–º –†–æ—Å—Å–∏–∏ –∏ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º –æ—á–µ—Ä–µ–¥–Ω–æ–π –æ—Ç—á—ë—Ç –†–æ—Å—Å—Ç–∞—Ç–∞ –æ –¥–∏–Ω–∞–º–∏–∫–µ —Ü–µ–Ω –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞. –í –º–∞–µ 2025 –≥–æ–¥–∞ —Ü–µ–Ω—ã –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, –Ω–µ –≤—Ö–æ–¥—è—â–∏–µ –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü, –≤ —Å—Ä–µ–¥–Ω–µ–º –∏–∑–º–µ–Ω–∏–ª–∏—Å—å –Ω–∞ +1,0%: ‚Äì –∫–æ—Ä–≤–∞–ª–æ–ª +3,6%; ‚Äì –Ω–∞—Ñ–∞–∑–æ–ª–∏–Ω +3,5%; ‚Äì –º–µ–Ω–æ–≤–∞–∑–∏–Ω +2,6%; ‚Äì –≥–µ–ø–∞—Ä–∏–Ω–æ–≤–∞—è –º–∞–∑—å +2,0%; ‚Äì –∫–∞—Ä–¥–∏–æ–º–∞–≥–Ω–∏–ª –∏ –π–æ–¥ +1,9%; ‚Äì –≥—Ä–∞–º–º–∏–¥–∏–Ω –∏ —Ç–∞—É—Ä–∏–Ω +1,7%; ‚Äì –ª–∏–∑–æ–±–∞–∫—Ç +1,5%; ‚Äì –≤–∞–ª–æ—Å–µ—Ä–¥–∏–Ω –∏ –∏–Ω–≥–∞–ª–∏–ø—Ç +1,1%. –ö–æ–µ-—á—Ç–æ –∏ –Ω–µ–∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ –ø–æ–¥–µ—à–µ–≤–µ–ª–æ: –ª–µ–≤–æ–º–µ–∫–æ–ª—å (-0,7%), –ø–µ–Ω—Ç–∞–ª–≥–∏–Ω (-0,5%), –º–µ—Ç–∞–º–∏–∑–æ–ª –Ω–∞—Ç—Ä–∏—è (–∞–Ω–∞–ª—å–≥–∏–Ω –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π) (-0,4%). –õ–µ–∫–∞—Ä—Å—Ç–≤–∞, –æ—Ç–Ω–æ—Å—è—â–∏–µ—Å—è –∫ –ñ–ù–í–õ–ü, –≤ —Å—Ä–µ–¥–Ω–µ–º –ø–æ–¥–æ—Ä–æ–∂–∞–ª–∏ –Ω–∞ 0,4%: ‚Äì –≤–µ—Ä–æ—à–ø–∏—Ä–æ–Ω –∏ –∏–Ω–≥–∞–≤–∏—Ä–∏–Ω +1,4%; ‚Äì –Ω–∞—Ç—Ä–∏—è —Ö–ª–æ—Ä–∏–¥ +1,2%; ‚Äì –∞—Ü–µ—Ç–∏–ª—Å–∞–ª–∏—Ü–∏–ª–æ–≤–∞—è –∫–∏—Å–ª–æ—Ç–∞ (–∞—Å–ø–∏—Ä–∏–Ω –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π) +1,1%; ‚Äì –∞–º–±—Ä–æ–∫—Å–æ–ª –∏ –∞—Å–∫–æ—Ä–±–∏–Ω–æ–≤–∞—è –∫–∏—Å–ª–æ—Ç–∞ +0,6%; ‚Äì –∫—Å–∏–ª–æ–º–µ—Ç–∞–∑–æ–ª–∏–Ω (–≥–∞–ª–∞–∑–æ–ª–∏–Ω) –∏ —Ü–µ—Ç—Ä–∏–Ω +0,5%. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""pricing, shortage"",
  ""impact"": ""medium"",
  ""english"": ""A report from the Russian Statistics Agency shows that prices for non-OTC drugs increased by an average of 1.0% in May 2025: - Korvalol +3.6%; - Nafazolin +3.5%; - Menovazin +2.6%; - Heparin ointment +2.0%; - Cardiomagnil and iodine +1.9%; - Gramidin and tauroxin +1.7%; - Lysobact +1.5%; - Valosordin and ingalipon +1.1%. Some drugs slightly decreased in price: Levomekoll (-0.7%), Pentalgin (-0.5%), Metamizol natrium (-0.4%). Average price increase for drugs under the OTC program was 0.4%: - Veroshpiron and ingavirin +1.4%; - Sodium chloride +1.2%; - Acetylsalicylic acid (Russian aspirin) +1.1%; -"
2025-06-11T13:05:08+00:00,@bezrec,6169,https://t.me/bezrec/6169,"–ü—Ä–∏—à–ª–æ –≤—Ä–µ–º—è –ø–æ–¥–≤–µ—Å—Ç–∏ –∏—Ç–æ–≥–∏ –æ—á–µ—Ä–µ–¥–Ω–æ–≥–æ –≤—ã–ø—É—Å–∫–∞ —Ä—É–±—Ä–∏–∫–∏ #–∑–∞–ø–∞–∫–æ–≤–∞–ª–∏. –ù–∞ —ç—Ç–æ—Ç —Ä–∞–∑ –º—ã —Å–æ–æ–±—â–∞ –≤—ã–±—Ä–∞–ª–∏ –ª—É—á—à–∏–π –¥–∏–∑–∞–π–Ω —É–ø–∞–∫–æ–≤–∫–∏ —Å—Ä–µ–¥—Å—Ç–≤ –¥–ª—è –ø—Ä–æ–º—ã–≤–∞–Ω–∏—è –∏ –æ—Ä–æ—à–µ–Ω–∏—è –Ω–æ—Å–∞ —Å –º–æ—Ä—Å–∫–æ–π –≤–æ–¥–æ–π. –° –º–∏–Ω–∏–º–∞–ª—å–Ω—ã–º –æ—Ç—Ä—ã–≤–æ–º –ø–æ–±–µ–¥–∏—Ç–µ–ª–µ–º —Å—Ç–∞–ª –ê–∫–≤–∞–ª–æ—Ä –æ—Ç ¬´–ù–∏–∂—Ñ–∞—Ä–º¬ª. –ï–≥–æ —É–ø–∞–∫–æ–≤–∫–∞ ‚Äî —É–∂–µ —Å–∞–º–∞ –ø–æ —Å–µ–±–µ –∏–Ω—Å—Ç—Ä—É–∫—Ü–∏—è –ø–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—é ‚Äî –Ω–∞ –∫–æ—Ä–æ–±–∫–µ –∏–∑–æ–±—Ä–∞–∂–µ–Ω–æ, –∫–∞–∫ —Ä–∞—Å–ø–æ–ª–∞–≥–∞—Ç—å –Ω–æ—Å–∏–∫ —Ä–∞—Å–ø—ã–ª–∏—Ç–µ–ª—è –¥–ª—è –ø—Ä–∞–≤–∏–ª—å–Ω–æ–≥–æ –æ—Ä–æ—à–µ–Ω–∏—è –Ω–æ—Å–∞. –ù–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ —Å —Ä–∞–∑–Ω–∏—Ü–µ–π –≤—Å–µ–≥–æ –≤ 3% ‚Äî –ê–∫–≤–∞–º–∞—Ä–∏—Å –æ—Ç ¬´–Ø–¥—Ä–∞–Ω –ì–∞–ª–µ–Ω—Å–∫–∏¬ª. –ó–∞–º—ã–∫–∞–µ—Ç —Ç—Ä–æ–π–∫—É –ª–∏–¥–µ—Ä–æ–≤ –õ–∏–Ω–∞–∫–≤–∞ –æ—Ç ¬´–ì—Ä–æ—Ç–µ–∫—Å–∞¬ª. –ù–∏–∂–µ —Ä–∞—Å–ø–æ–ª–æ–∂–∏–ª–∏—Å—å –ê–∫–≤–∞–Ω–∞–∑–∞–ª—å (¬´–ê–ª—Ç–∞–π–≤–∏—Ç–∞–º–∏–Ω—ã¬ª) –∏ –ê–∫–≤–∞–∑–∏–≤–∏–Ω (¬´–≠—Ä–∫–∞—Ñ–∞—Ä–º¬ª). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-06-11T09:20:14+00:00,@bezrec,6168,https://t.me/bezrec/6168,"–ê–Ω—Ç–∏—Ä–µ–∑—É—Å–Ω—ã–π –∏–º–º—É–Ω–æ–≥–ª–æ–±—É–ª–∏–Ω –ø—Ä–∏–µ–¥–µ—Ç –≤ –†–æ—Å—Å–∏—é –≤ –∏—é–ª–µ. –í—á–µ—Ä–∞ ¬´–ò–∑–≤–µ—Å—Ç–∏—è¬ª –ø–∏—Å–∞–ª–∏, —á—Ç–æ –ø—Ä–æ–±–ª–µ–º–∞ —Å –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º–∏ –¥–ª—è –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ —Ä–µ–∑—É—Å-–∫–æ–Ω—Ñ–ª–∏–∫—Ç–∞ —É –±–µ—Ä–µ–º–µ–Ω–Ω—ã—Ö —Ç–∞–∫ –∏ –Ω–µ –ø–µ—Ä–µ—Å—Ç–∞–ª–∞ –±—ã—Ç—å –ø—Ä–æ–±–ª–µ–º–æ–π. –ù–µ—Å–º–æ—Ç—Ä—è –Ω–∞ –ø—Ä–∏–Ω–∏–º–∞–µ–º—ã–µ –ú–∏–Ω–∑–¥—Ä–∞–≤–æ–º –∏ –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–æ–º –º–µ—Ä—ã, –∞–Ω—Ç–∏—Ä–µ–∑—É—Å–Ω–æ–≥–æ –∏–º–º—É–Ω–æ–≥–ª–æ–±—É–ª–∏–Ω–∞ –Ω–µ—Ç –∫–∞–∫ –º–∏–Ω–∏–º—É–º –≤ 75 —Ä–µ–≥–∏–æ–Ω–∞—Ö. –í –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–µ –¥–µ—Ñ–∏—Ü–∏—Ç –æ—Ç—Ä–∏—Ü–∞—Ç—å –Ω–µ —Å—Ç–∞–ª–∏ –∏ –ø–æ–æ–±–µ—â–∞–ª–∏, —á—Ç–æ –∑–∞–≥—Ä–∞–Ω–∏—Ü–∞ –Ω–∞–º –ø–æ–º–æ–∂–µ—Ç –ø—Ä–µ–ø–∞—Ä–∞—Ç –ø–æ—Å—Ç—É–ø–∏—Ç –≤ –†–§ –∏–∑-–∑–∞ —Ä—É–±–µ–∂–∞ –≤ –ø–µ—Ä–≤–æ–π –¥–µ–∫–∞–¥–µ –∏—é–ª—è. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –ú–∏–Ω–∑–¥—Ä–∞–≤ —Ä–∞–∑—Ä–µ—à–∏–ª –∫ –≤–≤–æ–∑—É 1,5 —Ç—ã—Å. –∞–º–ø—É–ª –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞, –ø—Ä–æ–∏–∑–≤–µ–¥–µ–Ω–Ω–æ–≥–æ –≤ –ë–µ–ª–æ—Ä—É—Å—Å–∏–∏. –ò—Ö –æ—Ç–≥—Ä—É–∑–∏–ª–∏ –≤ —Å–∞–º—ã–µ –ø—Ä–æ–±–ª–µ–º–Ω—ã–µ —Ä–µ–≥–∏–æ–Ω—ã –∏ –ø—Ä–∏–≤–µ–∑—É—Ç –µ—â—ë –≤–æ –≤—Ç–æ—Ä–æ–º –ø–æ–ª—É–≥–æ–¥–∏–∏. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, import_export"",
  ""impact"": ""high"",
  ""english"": ""The shortage of anti-D immunoglobulin for preventing Rh conflict in pregnant women remains a problem despite measures taken by the Ministry of Health and the Ministry of Industry. The shortage affects at least 75 regions, according to the Roszdranad–∑–æ—Ä. Despite this, they have not denied the shortage and promised that imports will arrive in Russia by mid-July. Additionally, the Ministry of Health has approved importing 1,500 ampoules of the drug produced in Belarus. These have been delivered to the most affected regions and will be imported again later this year.""
}"
2025-06-11T05:19:58+00:00,@bezrec,6167,https://t.me/bezrec/6167,"–ü—Ä–æ–¥–ª–µ–Ω–∏–µ —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–∞ –ø–æ –ø—Ä–æ—Å–ª–µ–∂–∏–≤–∞–µ–º–æ—Å—Ç–∏ —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏–π ‚Äî —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–∏–µ —Å–ª–æ–∂–Ω–æ—Å—Ç–∏ –∏–ª–∏ —Å–∞–±–æ—Ç–∞–∂ –∑–∞–ø—É—Å–∫–∞ –ø—Ä–µ—Ñ–µ—Ä–µ–Ω—Ü–∏–æ–Ω–Ω—ã—Ö –º–µ—Ö–∞–Ω–∏–∑–º–æ–≤. –í—á–µ—Ä–∞ —Å—Ç–∞–ª–æ –∏–∑–≤–µ—Å—Ç–Ω–æ, —á—Ç–æ –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ —Ä–µ—à–∏–ª –ø—Ä–æ–¥–ª–∏—Ç—å —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç –µ—â—ë –Ω–∞ 2 –º–µ—Å—è—Ü–∞ ‚Äî —Å 30 –∏—é–Ω—è –¥–æ 31 –∞–≤–≥—É—Å—Ç–∞ 2025 –≥–æ–¥–∞. –ú—ã #—Å–ø—Ä–æ—Å–∏–ª–∏, —á—Ç–æ –ø–æ —ç—Ç–æ–º—É –ø–æ–≤–æ–¥—É –¥—É–º–∞–µ—Ç –æ—Ç—Ä–∞—Å–ª—å. –î–∏—Ä–µ–∫—Ç–æ—Ä –ø–æ —Ä–∞–∑–≤–∏—Ç–∏—é RNC Pharma –ù–∏–∫–æ–ª–∞–π –ë–µ—Å–ø–∞–ª–æ–≤ —Å—á–∏—Ç–∞–µ—Ç, —á—Ç–æ –ø–æ–≤—Ç–æ—Ä–Ω–æ–µ –ø—Ä–æ–¥–ª–µ–Ω–∏–µ —Å—Ä–æ–∫–æ–≤ —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–∞ –Ω–µ–ª—å–∑—è –æ—Ü–µ–Ω–∏–≤–∞—Ç—å –ø–æ–∑–∏—Ç–∏–≤–Ω–æ. –≠–∫—Å–ø–µ—Ä—Ç –ø–æ–ª–∞–≥–∞–µ—Ç, —á—Ç–æ –º–æ—Ç–∏–≤–∞—Ü–∏—è —Ç–∞–∫–∏—Ö —Ä–µ—à–µ–Ω–∏–π –º–æ–∂–µ—Ç –∫—Ä—ã—Ç—å—Å—è –≤ –∏–∑–Ω–∞—á–∞–ª—å–Ω–æ –Ω–µ–≤–µ—Ä–Ω–æ –ø–æ—Å—Ç–∞–≤–ª–µ–Ω–Ω—ã—Ö —Å—Ä–æ–∫–∞—Ö, —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–∏—Ö —Å–ª–æ–∂–Ω–æ—Å—Ç—è—Ö –∏–ª–∏ –≤ –Ω–∞–º–µ—Ä–µ–Ω–Ω–æ–º –∑–∞—Ç—è–≥–∏–≤–∞–Ω–∏–∏ –≤–æ–ø—Ä–æ—Å–∞: –ù–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º —Ä—ã–Ω–∫–µ –Ω–µ–º–∞–ª–æ –∏–≥—Ä–æ–∫–æ–≤, –Ω–µ –∑–∞–∏–Ω—Ç–µ—Ä–µ—Å–æ–≤–∞–Ω–Ω—ã—Ö –≤ –ø–æ–ª–Ω–æ—Ü–µ–Ω–Ω–æ–º –∑–∞–ø—É—Å–∫–µ —Å–∏—Å—Ç–µ–º—ã ¬´–≤—Ç–æ—Ä–æ–π –ª–∏—à–Ω–∏–π¬ª, –∏—Ö –≤–ø–æ–ª–Ω–µ —É—Å—Ç—Ä–∞–∏–≤–∞–µ—Ç –∑–∞–∫—É–ø–∞—Ç—å —Å—ã—Ä—å—ë –≤ –ö–∏—Ç–∞–µ –∏–ª–∏ –ò–Ω–¥–∏–∏, –Ω–∞ —Ä–∞–≤–Ω—ã—Ö –∫–æ–Ω–∫—É—Ä–∏—Ä—É—è —Å –∫–æ–º–ø–∞–Ω–∏—è–º–∏, –∫–æ—Ç–æ—Ä—ã–µ –ø–æ–ª–Ω—ã–π —Ü–∏–∫–ª –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –æ—Å—É—â–µ—Å—Ç–≤–ª—è—é—Ç –≤ –†–æ—Å—Å–∏–∏. –ù–∞–ø—Ä–∏–º–µ—Ä, –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ –≤—ã—Å—Ç—É–ø–∞—é—Ç –ø—Ä–æ—Ç–∏–≤ –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤—ã –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–∏ –ê–†–§–ü –∏ —Ä—è–¥–∞ –¥—Ä—É–≥–∏—Ö –ø—Ä–æ—Ñ–∏–ª—å–Ω—ã—Ö –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–π. –ë–µ—Å–ø–∞–ª–æ–≤ –Ω–∞–¥–µ–µ—Ç—Å—è, —á—Ç–æ –ø–µ—Ä–µ–Ω–æ—Å –≤—Å—ë-—Ç–∞–∫–∏ –Ω–æ—Å–∏—Ç —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–∏–π —Ö–∞—Ä–∞–∫—Ç–µ—Ä –∏ –±—É–¥–µ—Ç –∑–∞–ø—É—â–µ–Ω –≤ –æ–≥–æ–≤–æ—Ä—ë–Ω–Ω—ã–µ —Å—Ä–æ–∫–∏, ¬´–∏–Ω–∞—á–µ –ø—Ä–∏–¥—ë—Ç—Å—è –≥–æ–≤–æ—Ä–∏—Ç—å –æ —Ñ–∞–∫—Ç–∏—á–µ—Å–∫–æ–º —Å–∞–±–æ—Ç–∏—Ä–æ–≤–∞–Ω–∏–∏ –∑–∞–ø—É—Å–∫–∞ –ø—Ä–µ—Ñ–µ—Ä–µ–Ω—Ü–∏–æ–Ω–Ω—ã—Ö –º–µ—Ö–∞–Ω–∏–∑–º–æ–≤ –∏ —Ä–∏—Å–∫–∞—Ö —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ –ì–æ—Å–ø—Ä–æ–≥—Ä–∞–º–º—ã ¬´–†–∞–∑–≤–∏—Ç–∏–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è¬ª¬ª. –ò–Ω–∏—Ü–∏–∞—Ç–æ—Ä–æ–º —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–∞ –≤ —Å–µ–Ω—Ç—è–±—Ä–µ 2022 –≥–æ–¥–∞ –≤—ã—Å—Ç—É–ø–∏–ª–∞ –ê—Å—Å–æ—Ü–∏–∞—Ü–∏—è —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ï–ê–≠–°. –ü—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—å –ø—Ä–∞–≤–ª–µ–Ω–∏—è –ê—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ –ê–ª–µ–∫—Å–µ–π –ö–µ–¥—Ä–∏–Ω —Ä–∞—Å—Å–∫–∞–∑–∞–ª ¬´–ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞¬ª, —á—Ç–æ –≤ —Ö–æ–¥–µ –ø–∏–ª–æ—Ç–Ω–æ–π —ç–∫—Å–ø–ª—É–∞—Ç–∞—Ü–∏–∏ —Å–∏—Å—Ç–µ–º—ã, –ø–æ –º–µ—Ä–µ —É–≥–ª—É–±–ª–µ–Ω–∏—è –±—ã–ª–∏ –≤—ã—è–≤–ª–µ–Ω—ã –≤–æ–ø—Ä–æ—Å—ã, –∫–æ—Ç–æ—Ä—ã–µ –∞–∫—Ç–∏–≤–Ω–æ –æ–±—Å—É–∂–¥–∞–ª–∏—Å—å –∏ —Å –¶–†–ü–¢, —Å –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–æ–º. –°–∏—Å—Ç–µ–º–∞ –ø—Ä–æ—Å–ª–µ–∂–∏–≤–∞–µ–º–æ—Å—Ç–∏ –¥–æ–ª–∂–Ω–∞ –æ—Ç–≤–µ—á–∞—Ç—å –ø—Ä–∏–Ω—Ü–∏–ø–∏–∞–ª—å–Ω—ã–º —É—Å–ª–æ–≤–∏—è–º, –≤ —á–∏—Å–ª–µ –∫–æ—Ç–æ—Ä—ã—Ö: –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–µ –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω—ã—Ö —Ä–µ—Å—É—Ä—Å–Ω—ã—Ö –∑–∞—Ç—Ä–∞—Ç –Ω–∞ —Å—Ç–æ—Ä–æ–Ω–µ –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏–π –ø—Ä–∏ –µ—ë –≤–Ω–µ–¥—Ä–µ–Ω–∏–∏, –∞ —Ç–∞–∫–∂–µ –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã—Ö —Ñ—É–Ω–∫—Ü–∏–π, –Ω–µ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–∏—Ö –≥–ª–∞–≤–Ω—ã–º —Ü–µ–ª—è–º —Å–∏—Å—Ç–µ–º—ã, ‚Äî –ø–æ—è—Å–Ω–∏–ª –ö–µ–¥—Ä–∏–Ω –∏ –∑–∞–≤–µ—Ä–∏–ª, —á—Ç–æ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–µ —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –æ–∂–∏–¥–∞—é—Ç —Å–∫–æ—Ä–µ–π—à–µ–≥–æ –æ–∫–æ–Ω—á–∞–Ω–∏—è —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–∞ –∏ –∑–∞–ø—É—Å–∫–∞ —Å–∏—Å—Ç–µ–º—ã –≤ –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω—É—é —ç–∫—Å–ø–ª—É–∞—Ç–∞—Ü–∏—é. –û—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –º—ã —Ç–æ–∂–µ —Å–ø—Ä–æ—Å–∏–ª–∏. –¢–∞–∫, ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª —É—Å—Ç—Ä–∞–∏–≤–∞–µ—Ç —Å—É—â–µ—Å—Ç–≤—É—é—â–∏–π –≤–∞—Ä–∏–∞–Ω—Ç. –í –∫–æ–º–ø–∞–Ω–∏–∏ —Å—á–∏—Ç–∞—é—Ç, —á—Ç–æ —Å–∏—Å—Ç–µ–º–∞ –¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ –Ω–∞—Å—Ç—Ä–æ–µ–Ω–∞ –∏ –ø–æ–ª–Ω–æ—Å—Ç—å—é –≥–æ—Ç–æ–≤–∞ –∫ —Ä–∞–±–æ—Ç–µ, –∞ —Ç–∞–∫–∂–µ –Ω–∞—Å—Ç–∞–∏–≤–∞—é—Ç –Ω–∞ –µ–µ —É—Å–∫–æ—Ä–µ–Ω–Ω–æ–º –≤–Ω–µ–¥—Ä–µ–Ω–∏–∏. –í ¬´–ü—Ä–æ–º–æ–º–µ–¥–µ¬ª –∫ –ø—Ä–æ–¥–ª–µ–Ω–∏—é —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–∞ –æ—Ç–Ω–µ—Å–ª–∏—Å—å —Å –ø–æ–Ω–∏–º–∞–Ω–∏–µ–º, –æ—Ç–º–µ—Ç–∏–≤, —á—Ç–æ —Å—Ç–æ–ª—å –ø—Ä–∏—Å—Ç–∞–ª—å–Ω–æ–µ –≤–Ω–∏–º–∞–Ω–∏–µ –∫ –≥–æ—Ç–æ–≤–Ω–æ—Å—Ç–∏ —Å–∏—Å—Ç–µ–º—ã –æ–±—É—Å–ª–æ–≤–ª–µ–Ω–æ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç—å—é –≥–∞—Ä–∞–Ω—Ç–∏—Ä–æ–≤–∞—Ç—å –ø–æ–ª—É—á–µ–Ω–∏–µ –ø—Ä–∏–æ—Ä–∏—Ç–µ—Ç–∞ —Ä–µ–∞–ª—å–Ω—ã–º –ø–æ–ª–Ω—ã–º —Ü–∏–∫–ª–æ–º, –∞ –Ω–µ –µ–≥–æ –∏–º–∏—Ç–∞—Ü–∏–µ–π. –ü—Ä–µ–¥–ø–æ–ª–∞–≥–∞–µ–º–æ–µ –ø—Ä–æ–¥–ª–µ–Ω–∏–µ —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–∞ –Ω–µ –≤—ã–≥–ª—è–¥–∏—Ç —Ñ–∞–∫—Ç–æ—Ä–æ–º –∏–∑–º–µ–Ω–µ–Ω–∏—è —Å—Ä–æ–∫–æ–≤ –∑–∞–ø—É—Å–∫–∞ –º–µ—Ö–∞–Ω–∏–∑–º–∞ ¬´–≤—Ç–æ—Ä–æ–π –ª–∏—à–Ω–∏–π¬ª –¥–ª—è –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏–∑ –ø–µ—Ä–µ—á–Ω—è –°–ó–õ–°, –∫–æ—Ç–æ—Ä—ã–π –∑–∞–ø–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω —Å 1 —è–Ω–≤–∞—Ä—è. –ù–æ –ø—Ä–∞–≤–∏–ª–∞ –Ω–∞—Ü—Ä–µ–∂–∏–º–∞ –º–æ–≥—É—Ç –ø–æ–º–µ–Ω—è—Ç—å—Å—è —Å —É—á–µ—Ç–æ–º –Ω–æ–≤—ã—Ö –≤–≤–æ–¥–Ω—ã—Ö. –ü–æ–∫–∞ –∂–µ –≤—Å–µ –≤—ã–≥–ª—è–¥–∏—Ç —Ç–∞–∫, —á—Ç–æ —É –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ø–æ–ª–Ω–æ–≥–æ —Ü–∏–∫–ª–∞ –±—É–¥–µ—Ç –¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ –≤—Ä–µ–º–µ–Ω–∏ –¥–ª—è –ø–æ–ª—É—á–µ–Ω–∏—è –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤ –°–ü –∏ –≤–∫–ª—é—á–µ–Ω–∏—è –≤ —Ä–µ–µ—Å—Ç—Ä —Ä–æ—Å—Å–∏–π—Å–∫–æ–π –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏, ‚Äî –ø—Ä–æ–∫–æ–º–º–µ–Ω—Ç–∏—Ä–æ–≤–∞–ª —Å–∏—Ç—É–∞—Ü–∏—é —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è –ø–æ —Ä–∞–±–æ—Ç–µ —Å –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–º–∏ –æ—Ä–≥–∞–Ω–∞–º–∏ –°–µ—Ä–≥–µ–π –ê–≤–¥–µ–µ–Ω–∫–æ. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""import_export, shortage, regulation"",
  ""impact"": ""medium"",
  ""english"": ""The extension of the experiment for tracking pharmaceutical substances is either due to technical difficulties or sabotage in launching preferential mechanisms. Yesterday, the Ministry of Industry and Trade decided to extend the experiment for another two months - from June 30th to August 31st, 2025. We asked the industry what it thinks about this decision. Director of Development at RNC Pharma Nikolay Bezapalov believes that the repeated extension of the experiment cannot be evaluated positively. The expert believes that the motivation for such decisions may lie in incorrectly set deadlines, technical difficulties or deliberate prolongation of the issue: There are many players on the Russian market who do not want a full-scale launch of the system 'second extra'. They are satisfied with purchasing raw materials in China or India, competing equally with companies that carry out the full production cycle in Russia. For example, representatives of ARFP and several other profile associations oppose these initiatives. Bezapalov hopes that the postponement is purely technical and will be launched on schedule, otherwise it will mean actual sabotage of the preferential"
2025-06-10T14:29:58+00:00,@bezrec,6166,https://t.me/bezrec/6166,"–î–æ—Ä–≤–∞–ª—Å—è: –ö–µ–Ω–Ω–µ–¥–∏-–º–ª–∞–¥—à–∏–π —Ä–∞–∑–æ–≥–Ω–∞–ª –≤–µ—Å—å –∫–æ–º–∏—Ç–µ—Ç –ø–æ –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏–∏. –ì–ª–∞–≤–∞ –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–≥–æ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –∏ –ø–æ —Å–æ–≤–º–µ—Å—Ç–∏—Ç–µ–ª—å—Å—Ç–≤—É –∏–∑–≤–µ—Å—Ç–Ω—ã–π –∞–Ω—Ç–∏–ø—Ä–∏–≤–∏–≤–æ—á–Ω–∏–∫ —É–≤–æ–ª–∏–ª –≤—Å–µ—Ö 17 —á–ª–µ–Ω–æ–≤ –ö–æ–Ω—Å—É–ª—å—Ç–∞—Ç–∏–≤–Ω–æ–≥–æ –∫–æ–º–∏—Ç–µ—Ç–∞ –ø–æ –ø—Ä–∞–∫—Ç–∏–∫–∞–º –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏–∏ (ACIP) –ø—Ä–∏ –¶–µ–Ω—Ç—Ä–∞—Ö –ø–æ –∫–æ–Ω—Ç—Ä–æ–ª—é –∏ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–µ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π (CDC). –ò—Ö –ø–æ–ª–Ω–æ–º–æ—á–∏—è –¥–æ–ª–∂–Ω—ã –±—ã–ª–∏ —Å–æ—Ö—Ä–∞–Ω—è—Ç—å—Å—è –¥–æ 2028 –≥–æ–¥–∞. –í –∫–æ–º–∏—Ç–µ—Ç –≤—Ö–æ–¥–∏–ª–∏ —ç–∫—Å–ø–µ—Ä—Ç—ã –ø–æ –≤–∞–∫—Ü–∏–Ω–∞–º –∏ –∏–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã–º –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º –∏–∑ –≤–µ–¥—É—â–∏—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ü–µ–Ω—Ç—Ä–æ–≤ –∏ –¥—Ä—É–≥–∏–µ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –≤ –æ–±–ª–∞—Å—Ç–∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –í –∏—Ö –∑–∞–¥–∞—á–∏ –≤—Ö–æ–¥–∏–ª–∞ –æ—Ü–µ–Ω–∫–∞ –¥–∞–Ω–Ω—ã—Ö –æ –≤–∞–∫—Ü–∏–Ω–∞—Ö, –∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä–æ–≤–∞–Ω–∏–µ –∏ –≤—ã–ø—É—Å–∫ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π –¥–ª—è CDC –ø–æ –ø–æ–≤–æ–¥—É –≤–∞–∫—Ü–∏–Ω–æ–ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏. –ö–æ–º–º–µ–Ω—Ç–∏—Ä—É—è –æ—Ç—Å—Ç—Ä–∞–Ω–µ–Ω–∏–µ –æ—Ç –¥–æ–ª–∂–Ω–æ—Å—Ç–∏ –¥–µ–π—Å—Ç–≤—É—é—â–∏—Ö —á–ª–µ–Ω–æ–≤ –∫–æ–º–∏—Ç–µ—Ç–∞, –ö–µ–Ω–Ω–µ–¥–∏-–º–ª–∞–¥—à–∏–π –ø–æ–æ–±–µ—â–∞–ª –∑–∞–º–µ–Ω–∏—Ç—å –∏—Ö –Ω–æ–≤—ã–º–∏, –∫–∞–Ω–¥–∏–¥–∞—Ç—É—Ä—ã –∫–æ—Ç–æ—Ä—ã—Ö –≤ –Ω–∞—Å—Ç–æ—è—â–µ–µ –≤—Ä–µ–º—è —Ä–∞—Å—Å–º–∞—Ç—Ä–∏–≤–∞—é—Ç—Å—è. –°–∫–æ–ª—å–∫–æ –≤—Ä–µ–º–µ–Ω–∏ –∑–∞–π–º—ë—Ç –ø—Ä–æ—Ü–µ—Å—Å, –Ω–µ–∏–∑–≤–µ—Å—Ç–Ω–æ. –£–≤–æ–ª–µ–Ω–Ω—ã–µ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –Ω–µ —É–≥–æ–¥–∏–ª–∏ –º–∏–Ω–∏—Å—Ç—Ä—É —Ç–µ–º, —á—Ç–æ ¬´—Å—Ç—Ä–∞–¥–∞–ª–∏ –æ—Ç –ø–æ—Å—Ç–æ—è–Ω–Ω—ã—Ö –∫–æ–Ω—Ñ–ª–∏–∫—Ç–æ–≤ –∏–Ω—Ç–µ—Ä–µ—Å–æ–≤ –∏ –±—ã–ª–∏ –≥–æ—Ç–æ–≤—ã –æ–¥–æ–±—Ä—è—Ç—å –ª—é–±—ã–µ –≤–∞–∫—Ü–∏–Ω—ã –±–µ–∑ –ø—Ä–æ–≤–µ—Ä–æ–∫¬ª. –ü–æ–ª–∏—Ç–∏–∫ –≤–æ–∑–Ω–∞–º–µ—Ä–∏–ª—Å—è ¬´–≤–æ—Å—Å—Ç–∞–Ω–æ–≤–∏—Ç—å –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–µ –¥–æ–≤–µ—Ä–∏–µ¬ª –∫ –≤–∞–∫—Ü–∏–Ω–∞–º. –ú–µ–∂–¥—É —Ç–µ–º, —ç–∫—Å–ø–µ—Ä—Ç—ã –Ω–µ —Å–ª–∏—à–∫–æ–º –≤–µ—Ä—è—Ç –≤ –±–ª–∞–≥–∏–µ –Ω–∞–º–µ—Ä–µ–Ω–∏—è –ö–µ–Ω–Ω–µ–¥–∏-–º–ª–∞–¥—à–µ–≥–æ –∏ –æ–ø–∞—Å–∞—é—Ç—Å—è, —á—Ç–æ –µ–≥–æ —Å—Ç–∞—Ä–∞–Ω–∏—è–º–∏ –≤ —Å–æ—Å—Ç–∞–≤ –≤–ª–∏—è—Ç–µ–ª—å–Ω–æ–π –≥—Ä—É–ø–ø—ã –ø—Ä–æ—Å–æ—á–∞—Ç—Å—è –∞–Ω—Ç–∏–≤–∞–∫—Å–µ—Ä—ã. –ü–æ–ª–∏—Ç–∏–∫–∞ –ö–µ–Ω–Ω–µ–¥–∏ –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ –∫–æ–º–∏—Ç–µ—Ç–∞ –ø–æ–¥–æ—Ä–≤—ë—Ç –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–µ –¥–æ–≤–µ—Ä–∏–µ –ø–æ–¥ –ø—Ä–µ–¥–ª–æ–≥–æ–º –µ–≥–æ —É–ª—É—á—à–µ–Ω–∏—è, ‚Äî —Å—á–∏—Ç–∞–µ—Ç –¢–æ–º –§—Ä–∏–¥–µ–Ω, —ç–∫—Å-–¥–∏—Ä–µ–∫—Ç–æ—Ä CDC. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial, safety"",
  ""impact"": ""high"",
  ""english"": ""Kennedy Jr. dismissed all 17 members of the Advisory Committee on Immunization Practices (ACIP) at CDC, which had been in place until 2028. The committee consisted of experts on vaccines and infectious diseases from leading medical centers and other health care professionals, tasked with evaluating vaccine data, providing CDC recommendations on vaccination practices. The dismissed experts were reportedly opposed to Kennedy Jr.'s actions due to 'constant conflicts of interest and being willing to approve any vaccines without scrutiny.' The experts are skeptical about Kennedy Jr.'s intentions, fearing that his efforts will allow antivaxers to infiltrate the influential group. Kennedy Jr.'s actions regarding the committee are seen as undermining public trust under the pretext of improving it.""
}"
2025-06-10T11:58:37+00:00,@bezrec,6164,https://t.me/bezrec/6164,"–°–µ–≥–æ–¥–Ω—è —Ä–µ—à–∏–ª–∏ –ø–æ—Å–º–æ—Ç—Ä–µ—Ç—å –∫–∞–∫ #–∑–∞–ø–∞–∫–æ–≤–∞–ª–∏ —Å–≤–æ–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –ø–µ—Ä–≤—ã–µ –ø—è—Ç—å –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π —Å—Ä–µ–¥—Å—Ç–≤ –¥–ª—è –ø—Ä–æ–º—ã–≤–∞–Ω–∏—è –∏ –æ—Ä–æ—à–µ–Ω–∏—è –Ω–æ—Å–∞ —Å –º–æ—Ä—Å–∫–æ–π –≤–æ–¥–æ–π –∏–∑ —Ä–µ–π—Ç–∏–Ω–≥–∞ RNC Pharma. –ü—Ä–æ—Å–∏–º –≤ –æ–ø—Ä–æ—Å–µ –≤—ã–±—Ä–∞—Ç—å –æ–¥–∏–Ω –∏–∑ –ø—è—Ç–∏ –≤–∞—Ä–∏–∞–Ω—Ç–æ–≤, –∏—Å—Ö–æ–¥—è –∏—Å–∫–ª—é—á–∏—Ç–µ–ª—å–Ω–æ –∏–∑ –¥–∏–∑–∞–π–Ω–∞ —É–ø–∞–∫–æ–≤–∫–∏: 1. –ê–∫–≤–∞–ª–æ—Ä (¬´–ù–∏–∂—Ñ–∞—Ä–º¬ª); 2. –ê–∫–≤–∞ –ú–∞—Ä–∏—Å (¬´–Ø–¥—Ä–∞–Ω –ì–∞–ª–µ–Ω—Å–∫–∏¬ª); 3. –õ–∏–Ω–∞–∫–≤–∞ (¬´–ì—Ä–æ—Ç–µ–∫—Å¬ª); 3. –ê–∫–≤–∞–∑–∏–≤–∏–Ω (¬´–≠—Ä–∫–∞—Ñ–∞—Ä–º¬ª); 5. –ê–∫–≤–∞–Ω–∞–∑–∞–ª—å (¬´–ê–ª—Ç–∞–π–≤–∏—Ç–∞–º–∏–Ω—ã¬ª). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-06-10T08:35:11+00:00,@bezrec,6163,https://t.me/bezrec/6163,"–ü—ë—Ç—Ä –ë–µ–ª—ã–π ‚Äî –≤ —Å–ø–∏—Å–∫–µ Forbes. –°–æ—Å—Ç–æ—è–Ω–∏–µ –æ—Å–Ω–æ–≤–∞—Ç–µ–ª—è –∏ –∫—Ä—É–ø–Ω–µ–π—à–µ–≥–æ –∞–∫—Ü–∏–æ–Ω–µ—Ä–∞ ¬´–ü—Ä–æ–º–æ–º–µ–¥–∞¬ª –ø–µ—Ä–µ–≤–∞–ª–∏–ª–æ –∑–∞ $1 –º–ª—Ä–¥. –ë–µ–ª—ã–π —Å—Ç–∞–ª –ø—è—Ç—ã–º —Ä–æ—Å—Å–∏–π—Å–∫–∏–º –º–∏–ª–ª–∏–∞—Ä–¥–µ—Ä–æ–º, —Å–¥–µ–ª–∞–≤—à–∏–º —Å–æ—Å—Ç–æ—è–Ω–∏–µ –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞—Ö. –ö–æ–º–ø–∞–Ω–∏—é –±–∏–∑–Ω–µ—Å–º–µ–Ω—É –≤ —Å–ø–∏—Å–∫–µ Forbes —Å–æ—Å—Ç–∞–≤–ª—è—é—Ç —Å–æ–≤–ª–∞–¥–µ–ª—å—Ü—ã ¬´–û–≥–º–µ–Ω—Ç –ò–Ω–≤–µ—Å—Ç–º–µ–Ω—Ç—Å¬ª –í–∏–∫—Ç–æ—Ä –•–∞—Ä–∏—Ç–æ–Ω–∏–Ω –∏ –ï–≥–æ—Ä –ö—É–ª—å–∫–æ–≤ (–≤–ª–∞–¥–µ—é—Ç –¥–æ–ª—è–º–∏ –≤ ¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç–µ¬ª, ¬´–û—Ç–∏—Å–∏—Ñ–∞—Ä–º–µ¬ª, ¬´–ë–∏–æ–∫–∞–¥–µ¬ª –∏ ¬´–ì–µ–Ω–µ—Ä–∏—É–º–µ¬ª), –æ—Å–Ω–æ–≤–∞—Ç–µ–ª—å ¬´–†-–§–∞—Ä–º–∞¬ª –ê–ª–µ–∫—Å–µ–π –†–µ–ø–∏–∫ –∏ –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑–∞¬ª –í–∏–∫—Ä–∞–º –ü—É–Ω–∏—è. –§–∞—Ä–º–æ—Ç—Ä–∞—Å–ª—å —Ç–∞–∫–∂–µ –ø–æ–º–æ–≥–ª–∞ —Ä–∞–∑–±–æ–≥–∞—Ç–µ—Ç—å –í–∞–¥–∏–º—É –Ø–∫—É–Ω–∏–Ω—É –∏ –≠–¥—É–∞—Ä–¥—É –ù–µ—Ç—ã–ª–∫–æ ‚Äî –≤–ª–∞–¥–µ–ª—å—Ü–∞–º —Ñ–∞—Ä–º–¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–æ–≤ ¬´–ü—Ä–æ—Ç–µ–∫¬ª –∏ ¬´–ü—É–ª—å—Å¬ª. –ü–µ—Ç—Ä –ë–µ–ª—ã–π —Ä–æ–¥–∏–ª—Å—è –≤ 1972 –≥–æ–¥—É –≤ –ú–æ—Å–∫–≤–µ. –í 2006 –≥–æ–¥—É —Å –æ—Ç–ª–∏—á–∏–µ–º –æ–∫–æ–Ω—á–∏–ª –ú–æ—Å–∫–æ–≤—Å–∫–∏–π –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–π –º–µ–¥–∏–∫–æ-—Å—Ç–æ–º–∞—Ç–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–π —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç –ø–æ —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–∏ ¬´–õ–µ—á–µ–±–Ω–æ–µ –¥–µ–ª–æ¬ª. –ö–∞–Ω–¥–∏–¥–∞—Ç –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –Ω–∞—É–∫, —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∞—Ü–∏—è ‚Äì –ì–∞—Å—Ç—Ä–æ—ç–Ω—Ç–µ—Ä–æ–ª–æ–≥–∏—è. –í 2005 –≥–æ–¥—É –æ—Å–Ω–æ–≤–∞–ª –∫–æ–º–ø–∞–Ω–∏—é ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª. –í 2015-–º ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª –ø—Ä–∏–æ–±—Ä—ë–ª —Å–≤–æ—é –æ—Å–Ω–æ–≤–Ω—É—é –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω—É—é –ø–ª–æ—â–∞–¥–∫—É ‚Äî –∑–∞–≤–æ–¥ ¬´–ë–∏–æ—Ö–∏–º–∏–∫¬ª –≤ –°–∞—Ä–∞–Ω—Å–∫–µ, –∞ —á–µ—Ä–µ–∑ –≥–æ–¥ —Å–æ–∑–¥–∞–ª –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫—É—é –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–∏—é –¥–ª—è —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –Ω–æ–≤—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤. –°–µ–≥–æ–¥–Ω—è ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª ‚Äî –æ–¥–∏–Ω –∏–∑ –≥–ª–∞–≤–Ω—ã—Ö –±–æ—Ä—Ü–æ–≤ —Å –æ–∂–∏—Ä–µ–Ω–∏–µ–º –∏ –¥–∏–∞–±–µ—Ç–æ–º –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º —Ä—ã–Ω–∫–µ. –í –ø–æ—Ä—Ç—Ñ–µ–ª–µ –æ–±–ª–∞–¥–∞—Ç–µ–ª—è –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω–æ–π –ª–∏—Ü–µ–Ω–∑–∏–∏ –Ω–∞ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥ —Ü–µ–ª–∞—è –ª–∏–Ω–µ–π–∫–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ —Å–∞—Ö–∞—Ä–Ω–æ–≥–æ –¥–∏–∞–±–µ—Ç–∞: –ö–≤–∏–Ω—Å–µ–Ω—Ç–∞, –≠–Ω–ª–∏–≥—Ä–∏—è, –í–µ–ª–≥–∏—è –∏ –†–µ–¥—É–∫—Å–∏–Ω. –ö–æ–º–ø–∞–Ω–∏—è –∑–∞–Ω–∏–º–∞–µ—Ç –≤—Ç–æ—Ä—É—é —Å—Ç—Ä–æ—á–∫—É –≤ —Ç–æ–ø-10 –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ª–µ–∫–∞—Ä—Å—Ç–≤ –æ—Ç –æ–∂–∏—Ä–µ–Ω–∏—è. ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{""skip"": true}"
2025-06-10T05:29:58+00:00,@bezrec,6162,https://t.me/bezrec/6162,"–¢–æ–ø-10 —Å—Ä–µ–¥—Å—Ç–≤ –¥–ª—è –ø—Ä–æ–º—ã–≤–∞–Ω–∏—è –Ω–æ—Å–∞ –æ–∫–∞–∑–∞–ª—Å—è –ø–æ—á—Ç–∏ —Å–ø–ª–æ—à—å —Ä–æ—Å—Å–∏–π—Å–∫–∏–º. –° —è–Ω–≤–∞—Ä—è –ø–æ –∞–ø—Ä–µ–ª—å 2025 –≥–æ–¥–∞ —Ä–æ—Å—Å–∏—è–Ω–µ –ø–æ—Ç—Ä–∞—Ç–∏–ª–∏ –Ω–∞ —Å—Ä–µ–¥—Å—Ç–≤–∞ –Ω–∞ –æ—Å–Ω–æ–≤–µ –º–æ—Ä—Å–∫–æ–π –≤–æ–¥—ã 4,9 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π, —á—Ç–æ –Ω–∞ 7,2% –±–æ–ª—å—à–µ –≥–æ–¥ –∫ –≥–æ–¥—É. –í —É–ø–∞–∫–æ–≤–∫–∞—Ö –ø—Ä–æ–¥–∞–∂–∏ –≤—ã—Ä–æ—Å–ª–∏ –Ω–∞ 1,8% ‚Äî –¥–æ 10,1 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫. –ü–æ—Å—Ç–µ–ø–µ–Ω–Ω–æ —Ä–∞—Å—Ç—ë—Ç –∏ –¥–æ–ª—è –∑–∞–∫–∞–∑–æ–≤ —ç—Ç–æ–π –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ —á–µ—Ä–µ–∑ e-—Å–æm ‚Äî –µ—Å–ª–∏ –≤ 2022 –≥–æ–¥—É –æ–Ω–∞ —Å–æ—Å—Ç–∞–≤–ª—è–ª–∞ –≤—Å–µ–≥–æ 2% –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–≥–æ –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏—è, —Ç–æ –≤ –ø–µ—Ä–≤—ã–µ —á–µ—Ç—ã—Ä–µ –º–µ—Å—è—Ü–∞ 2025 –≥–æ–¥–∞ –ø—Ä–µ–≤—ã—Å–∏–ª–∞ 5%. –ù–∞ –∫–æ–Ω–µ—Ü –∞–ø—Ä–µ–ª—è —Å—Ä–µ–¥—Å—Ç–≤–∞ –¥–ª—è –ø—Ä–æ–º—ã–≤–∞–Ω–∏—è –∏ –æ—Ä–æ—à–µ–Ω–∏—è –Ω–æ—Å–∞ —Å –º–æ—Ä—Å–∫–æ–π –≤–æ–¥–æ–π –±—ã–ª–∏ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω—ã –≤ —Ä–∏—Ç–µ–π–ª–µ 34 —Ç–æ—Ä–≥–æ–≤—ã–º–∏ –º–∞—Ä–∫–∞–º–∏ –æ—Ç 29 –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π. –í —Ñ–∞–≤–æ—Ä–∏—Ç–∞—Ö —É –ø–æ–∫—É–ø–∞—Ç–µ–ª–µ–π ‚Äî –ê–∫–≤–∞–ª–æ—Ä –æ—Ç ¬´–ù–∏–∂—Ñ–∞—Ä–º¬ª, –Ω–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ ‚Äî –ê–∫–≤–∞ –ú–∞—Ä–∏—Å —Ö–æ—Ä–≤–∞—Ç—Å–∫–æ–π ¬´–Ø–¥—Ä–∞–Ω¬ª, –∑–∞–º—ã–∫–∞–µ—Ç –ø–µ—Ä–≤—É—é —Ç—Ä–æ–π–∫—É –õ–∏–Ω–∞–∫–≤–∞ –æ—Ç ¬´–ì—Ä–æ—Ç–µ–∫—Å¬ª. –ü–æ—Å–ª–µ–¥–Ω–∏–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–π –∏–∑ —Ç–æ–ø-10 –ø–æ–∫–∞–∑–∞–ª —Å–Ω–∏–∂–µ–Ω–∏–µ —Ä—É–±–ª—ë–≤—ã—Ö –ø—Ä–æ–¥–∞–∂, –∑–∞—Ç–æ ¬´–ì—Ä–æ—Ç–µ–∫—Å¬ª –∞–∫—Ç–∏–≤–Ω–æ –æ–∫–∞–∑—ã–≤–∞–µ—Ç –∫–æ–Ω—Ç—Ä–∞–∫—Ç–Ω—ã–µ —É—Å–ª—É–≥–∏ –ø–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤—É —Ç–∞–∫–∏—Ö —Å—Ä–µ–¥—Å—Ç–≤. –ù–∞–ø—Ä–∏–º–µ—Ä, –≤—ã–ø—É—Å–∫–∞–µ—Ç —Ä—è–¥ SKU —Ç–æ—Ä–≥–æ–≤—ã—Ö –º–∞—Ä–æ–∫ –ê–∫–≤–∞–∑–∏–≤–∏–Ω, –ù–æ—Å–∏—Ñ–∏—Ç, –†–∏–Ω–æ—Å—Ç–æ–ø. –° —á–µ—Ç–≤—ë—Ä—Ç–æ–π –ø–æ –¥–µ—Å—è—Ç—É—é —Å—Ç—Ä–æ—á–∫—É —Ä–µ–π—Ç–∏–Ω–≥–∞ —Ä–∞—Å–ø–æ–ª–æ–∂–∏–ª–∏—Å—å: –ê–∫–≤–∞–∑–∏–≤–∏–Ω (¬´–≠—Ä–∫–∞—Ñ–∞—Ä–º¬ª), –ê–∫–≤–∞–Ω–∞–∑–∞–ª—å (¬´–ê–ª—Ç–∞–π–≤–∏—Ç–∞–º–∏–Ω—ã¬ª), –†–∏–Ω–æ—Å—Ç–æ–ø (¬´–û—Ç–∏—Å–∏—Ñ–∞—Ä–º¬ª), –ö–≤–∏–∫—Å (¬´–ú–µ–Ω–∞—Ä–∏–Ω–∏¬ª), –ù–æ—Å–∏—Ñ–∏—Ç (¬´–ê—Ä—Ç–µ–ª–∞—Ä¬ª), –ö–æ–Ω—Å—É–º–µ–¥ (¬´–≠–∫—Å–ø–µ—Ä—Ç –ë–∏–æ¬ª) –∏ –ê–∫–≤–∞ –≠–π–º–æ—Ä–µ (¬´–°–∞–º–∞—Ä–∞–º–µ–¥–ø—Ä–æ–º¬ª). ‚Ñ¢ –ë–µ–∑ —Ä–µ—Ü–µ–ø—Ç–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""Sales of nasal irrigation and rinsing products based on seawater increased by 1.8% to 10.1 million units from January to April 2025, compared to a year-over-year increase of 7.2% in spending on seawater-based products. The market share through e-commerce grew from 2% of natural consumption in 2022 to over 5% by the first four months of 2025. The top three brands are Akvalor from 'Nizfarm', Aqua Maris from 'Yadrana' Croatia, and Linakva from 'Grotex'. The company is also providing contract production services for these products, including SKU's under brands like Aquazivin, Nosifit, and Rinosop.""
}"
2025-12-06T08:15:02+00:00,@medpharm,13904,https://t.me/medpharm/13904,–≠–∫—Å–ø–µ—Ä—Ç—ã –í–û–ó –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∏ –Ω–æ–≤—ã–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø–æ –ª–µ—á–µ–Ω–∏—é –æ–∂–∏—Ä–µ–Ω–∏—è —É –≤–∑—Ä–æ—Å–ª—ã—Ö. –î–æ–∫—É–º–µ–Ω—Ç –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω –≤ –∂—É—Ä–Ω–∞–ª–µ JAMA. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QhVEC #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è #–≠–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–∏—è,"{""skip"": true}"
2025-12-06T06:48:03+00:00,@medpharm,13903,https://t.me/medpharm/13903,"–§–æ—Ä–º–∞ —è–≥–æ–¥–∏—á–Ω—ã—Ö –º—ã—à—Ü –º–µ–Ω—è–µ—Ç—Å—è –ø—Ä–∏ –¥–∏–∞–±–µ—Ç–µ 2-–≥–æ —Ç–∏–ø–∞, –ø–æ–∫–∞–∑–∞–ª –∞–Ω–∞–ª–∏–∑ –ú–†–¢-—Å–Ω–∏–º–∫–æ–≤ –±–æ–ª–µ–µ 60 —Ç—ã—Å. –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –ü—Ä–∏ —ç—Ç–æ–º —É –º—É–∂—á–∏–Ω —ç—Ç–∏ –º—ã—à—Ü—ã —É–º–µ–Ω—å—à–∞–ª–∏—Å—å, –∞ —É –∂–µ–Ω—â–∏–Ω ‚Äî —É–≤–µ–ª–∏—á–∏–≤–∞–ª–∏—Å—å: –≤–µ—Ä–æ—è—Ç–Ω–æ, –∏–∑-–∑–∞ –∏–Ω—Ñ–∏–ª—å—Ç—Ä–∞—Ü–∏–∏ –∂–∏—Ä–æ–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QhRgV #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ù–∞—É–∫–∞ #–≠–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–∏—è","{
  ""skip"": true,
}"
2025-12-06T04:49:02+00:00,@medpharm,13902,https://t.me/medpharm/13902,"–ù–æ–≤–æ—Å—Ç–∏ –æ –∫–∏–ø—è—â–∏—Ö –≤–æ–∫—Ä—É–≥ –∑–∞–∫–æ–Ω–∞ –æ–± –æ—Ç—Ä–∞–±–æ—Ç–∫–∞—Ö —Å—Ç—Ä–∞—Å—Ç—è—Ö, –ø—Ä–æ–≤–æ–ª–æ—á–∫–∏ –≤ –°—Ç—Ä–∞—Ç–µ–≥–∏–∏ –≤–∞–∫—Ü–∏–Ω–æ–ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏, –ø—Ä–∏—á–∏–Ω—ã –Ω–µ–¥–æ–≤–æ–ª—å—Å—Ç–≤–∞ —Ä–æ—Å—Å–∏—è–Ω –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –º–µ–¥–∏—Ü–∏–Ω–æ–π –∏ –Ω–æ–≤–æ—Å—Ç–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è ‚Äì –≤ —Å–æ–±—ã—Ç–∏–π–Ω–æ–º —Ä–µ–π—Ç–∏–Ω–≥–µ –Ω–µ–¥–µ–ª–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QhMyv #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–ò–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã–µ_–±–æ–ª–µ–∑–Ω–∏ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": true
}"
2025-12-05T16:24:01+00:00,@medpharm,13901,https://t.me/medpharm/13901,"ü¶æ –í—Ä–µ–º—è —Ä–µ—Ñ–æ—Ä–º. –ù–∞ –æ–±—â–µ–º —Å–æ–±—Ä–∞–Ω–∏–∏ —á–ª–µ–Ω–æ–≤ –†–ê–ù 9 –¥–µ–∫–∞–±—Ä—è –±—É–¥—É—Ç —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω—ã ¬´–ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è –ø–æ —Å–æ–≤–µ—Ä—à–µ–Ω—Å—Ç–≤–æ–≤–∞–Ω–∏—é —Å—Ç—Ä—É–∫—Ç—É—Ä—ã –∞–∫–∞–¥–µ–º–∏–∏ –∏ —Å–≤—è–∑–∞–Ω–Ω—ã–µ —Å —ç—Ç–∏–º –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ —É—Å—Ç–∞–≤¬ª. –î–≤–∞ –ø—Ä–æ—Ñ–∏–ª—å–Ω—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Ç–¥–µ–ª–µ–Ω–∏—è ‚Äî –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏ —Ñ–∏–∑–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –Ω–∞—É–∫ ‚Äî –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–æ –ø–µ—Ä–µ—Ñ–æ—Ä–º–∞—Ç–∏—Ä–æ–≤–∞—Ç—å –≤ —Ç—Ä–∏, —Å –Ω–æ–≤—ã–º–∏ –Ω–∞–∑–≤–∞–Ω–∏—è–º–∏ –∏ —Ñ—É–Ω–∫—Ü–∏–æ–Ω–∞–ª–æ–º. ü¶æ –ü–ª–æ–¥—ã —ç–∫–æ–Ω–æ–º–∏–∏. –í –º–∏—Ä–µ –≤–ø–µ—Ä–≤—ã–µ —Å 2000 –≥–æ–¥–∞ –æ–∂–∏–¥–∞–µ—Ç—Å—è —Ä–æ—Å—Ç —á–∏—Å–ª–∞ —É–º–µ—Ä—à–∏—Ö –≤ –≤–æ–∑—Ä–∞—Å—Ç–µ –¥–æ –ø—è—Ç–∏ –ª–µ—Ç –¥–µ—Ç–µ–π. –≠—Ç–æ —Å–≤—è–∑–∞–Ω–æ —Å —Å–æ–∫—Ä–∞—â–µ–Ω–∏–µ–º —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è —Å–æ —Å—Ç–æ—Ä–æ–Ω—ã —Å—Ç—Ä–∞–Ω —Å –≤—ã—Å–æ–∫–∏–º –¥–æ—Ö–æ–¥–æ–º. ‚ù§Ô∏è –ù–µ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É–µ—Ç —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è–º. –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏ –ø—Ä–∏–æ—Å—Ç–∞–Ω–æ–≤–∏–ª –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ —Ç—Ä–µ—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤. –ò—Ö –∏–∑–≥–æ—Ç–∞–≤–ª–∏–≤–∞–ª–∏ –≤ –¢—É–ª—å—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –Ω–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω–æ–π –ø–ª–æ—â–∞–¥–∫–µ –û–û–û ¬´–ò–Ω—Ç–µ—Ä—Ñ–∞—Ä–º–∞¬ª. ‚ù§Ô∏è –ù–µ –æ—Ç–∫–ª–∞–¥—ã–≤–∞–π –Ω–∞ –∑–∞–≤—Ç—Ä–∞. –ê—Å—Å–æ—Ü–∏–∞—Ü–∏—è ¬´–õ–µ–∫–º–µ–¥–æ–±—Ä–∞—â–µ–Ω–∏–µ¬ª –ø—Ä–æ—Å–∏—Ç –Ω–µ –ø–µ—Ä–µ–Ω–æ—Å–∏—Ç—å –∑–∞–ø—É—Å–∫ ¬´–≤—Ç–æ—Ä–æ–≥–æ –ª–∏—à–Ω–µ–≥–æ¬ª –¥–ª—è –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø–µ—Ä–µ—á–Ω—è –°–ó–õ–° –∏ –Ω–∞—á–∏–Ω–∞—Ç—å –∫–∞–∫ –ø–ª–∞–Ω–∏—Ä–æ–≤–∞–ª–æ—Å—å. –ò–∑-–∑–∞ –ø–µ—Ä–µ–Ω–æ—Å–∞ —Å—Ä–æ–∫–æ–≤ –Ω–∞—Ü—Ä–µ–∂–∏–º –≥–æ—Å–∑–∞–∫—É–ø–æ–∫ –≤ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ –¥–µ–π—Å—Ç–≤—É–µ—Ç –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–Ω–æ.","{""skip"": true}"
2025-12-05T16:08:03+00:00,@medpharm,13900,https://t.me/medpharm/13900,"–ú–∏–Ω–∏—Å—Ç–µ—Ä—Å—Ç–≤–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –†–æ—Å—Å–∏–∏ –∏ –ò–Ω–¥–∏–∏ –¥–æ–≥–æ–≤–æ—Ä–∏–ª–∏—Å—å –æ —Å–æ–∑–¥–∞–Ω–∏–∏ –ø—Ä–æ—Ñ–∏–ª—å–Ω—ã—Ö —Ä–∞–±–æ—á–∏—Ö –≥—Ä—É–ø–ø –ø–æ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–µ –∏ —Ä–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω–∏—é –æ–±—Ä–∞—â–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ —Ä–∞–º–∫–∞—Ö –Ω–æ–≤–æ–≥–æ —Å–æ–≥–ª–∞—à–µ–Ω–∏—è –æ —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–æ–º –ø–∞—Ä—Ç–Ω–µ—Ä—Å—Ç–≤–µ, –ø–æ–¥–ø–∏—Å–∞–Ω–Ω–æ–≥–æ –≤ –î–µ–ª–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qh7Da #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{""skip"": true}"
2025-12-05T15:44:03+00:00,@medpharm,13899,https://t.me/medpharm/13899,"–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§ —É—Ç–≤–µ—Ä–¥–∏–ª–æ –Ω–æ–≤—ã–π –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–π –ø–æ—Ä—è–¥–æ–∫ –¥–ª—è –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è. –¢–µ–ø–µ—Ä—å –æ–Ω–∏ –¥–æ–ª–∂–Ω—ã –ø–æ–ª—É—á–∞—Ç—å –∑–∞–∫–ª—é—á–µ–Ω–∏–µ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–∞, –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–∞—é—â–µ–µ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–µ –∏—Ö –∫–∞–¥—Ä–æ–≤–æ–≥–æ –∏ –º–∞—Ç–µ—Ä–∏–∞–ª—å–Ω–æ-—Ç–µ—Ö–Ω–∏—á–µ—Å–∫–æ–≥–æ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–æ–π –ø–æ–¥–≥–æ—Ç–æ–≤–∫–µ —Å—Ç—É–¥–µ–Ω—Ç–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qh5uk #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The Russian government has approved a new mandatory order for medical and pharmaceutical education organizations, requiring them to obtain a conclusion from the Russian Health Supervision confirming compliance of their training and material-technical equipment with practical student preparation. More: https://clck.ru/3Qh5uk #PharmNews #Regulation""
}"
2025-12-05T15:19:03+00:00,@medpharm,13898,https://t.me/medpharm/13898,"–°—É–¥ –æ—Ç–º–µ–Ω–∏–ª –≤—ã–ø–ª–∞—Ç—É –ø–æ—á—Ç–∏ 42 –º–ª–Ω –¥–æ–ª–ª., –ø—Ä–∏—Å—É–∂–¥–µ–Ω–Ω—ã—Ö –∫–æ–º–ø–∞–Ω–∏–∏ Seagen –∑–∞ –Ω–∞—Ä—É—à–µ–Ω–∏–µ –ø–∞—Ç–µ–Ω—Ç–∞ –Ω–∞ –µ–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—é, –∫–æ—Ç–æ—Ä—É—é —è–∫–æ–±—ã –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–ª–∞ —è–ø–æ–Ω—Å–∫–∞—è Daiichi –¥–ª—è —Å–æ–∑–¥–∞–Ω–∏—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –æ—Ç —Ä–∞–∫–∞ ¬´–≠–Ω—Ö–µ—Ä—Ç—É¬ª. –ò–∑-–∑–∞ —á–µ–≥–æ –±—ã–ª –∞–Ω–Ω—É–ª–∏—Ä–æ–≤–∞–Ω —Å–∞–º –ø–∞—Ç–µ–Ω—Ç? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qh4Nb #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""The patent was annulled due to infringement by Daiichi of Seagen's technology. This decision affects the reimbursement and pricing of related treatments.""
}"
2025-12-05T14:59:05+00:00,@medpharm,13897,https://t.me/medpharm/13897,–ü–æ–¥–ø–∏—Å–∞–Ω–æ —Å–æ–≥–ª–∞—à–µ–Ω–∏–µ –æ —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–µ –≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–∏ –∏ –º–µ–¥–æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–∏ –º–µ–∂–¥—É –†–æ—Å—Å–∏–µ–π –∏ –ò–Ω–¥–∏–µ–π. –¢–∞–∫–∂–µ –¥–æ—Å—Ç–∏–≥–Ω—É—Ç–∞ –¥–æ–≥–æ–≤–æ—Ä–µ–Ω–Ω–æ—Å—Ç—å –æ —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–µ –≤ –ö–∞–ª—É–∂—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –∑–∞–≤–æ–¥–∞ –ø–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤—É —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö —Å—É–±—Å—Ç–∞–Ω—Ü–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qh3HJ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-12-05T14:54:03+00:00,@medpharm,13896,https://t.me/medpharm/13896,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏ –ø—Ä–∏–æ—Å—Ç–∞–Ω–æ–≤–∏–ª –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ —Ç—Ä–µ—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ ‚Äî ¬´–ú–µ—Ä–æ–ø–µ–Ω–µ–º–∞ –ò–Ω–∫–æ–º–µ–¥¬ª, ¬´–í–∞–Ω–∫–æ–º–∏—Ü–∏–Ω–∞¬ª –∏ ¬´–ö–∞–ø—Ä–µ–æ–º–∏—Ü–∏–Ω–∞¬ª. –í—Å–µ —Ç—Ä–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –∏–∑–≥–æ—Ç–∞–≤–ª–∏–≤–∞–ª–∏ –≤ –¢—É–ª—å—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –Ω–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω–æ–π –ø–ª–æ—â–∞–¥–∫–µ –û–û–û ¬´–ò–Ω—Ç–µ—Ä—Ñ–∞—Ä–º–∞¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qh2wm #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration, shortage"",
  ""impact"": ""high"",
  ""english"": ""The Russian Ministry of Health has suspended the use of three medications: 'Incomed Meropenem', 'Vancyclicine' and 'Capreomycin'. All three were produced by the production facility of LLC Interfarm in Tula region. More details: https://clck.ru/3Qh2wm #PharmNews #Regulation""
}"
2025-12-05T14:15:03+00:00,@medpharm,13895,https://t.me/medpharm/13895,"–ö—Ä—É–ø–Ω–µ–π—à–∞—è —Ç–µ–ª–µ–∫–æ–º–º—É–Ω–∏–∫–∞—Ü–∏–æ–Ω–Ω–∞—è –∫–æ—Ä–ø–æ—Ä–∞—Ü–∏—è –≤ –º–∏—Ä–µ AT&T –∏ —Å–≤—è–∑–∞–Ω–Ω—ã–π —Å –Ω–µ–π —Ñ–æ–Ω–¥ –º–µ–¥—Å—Ç—Ä–∞—Ö–æ–≤–∞–Ω–∏—è –ø–µ—Ä—Å–æ–Ω–∞–ª–∞ —É—Ç–≤–µ—Ä–∂–¥–∞—é—Ç, —á—Ç–æ —Ä—è–¥ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤ –Ω–µ–∑–∞–∫–æ–Ω–Ω–æ –∑–∞–≤—ã—à–∞–ª–∏ —Ü–µ–Ω—ã –Ω–∞ –ø—Ä–æ–¥—É–∫—Ü–∏—é. –•–æ–ª–¥–∏–Ω–≥ —Ç—Ä–µ–±—É–µ—Ç –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QgxnL #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-12-05T13:56:02+00:00,@medpharm,13894,https://t.me/medpharm/13894,"–†—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å —é—Ä–∏–¥–∏—á–µ—Å–∫–æ–≥–æ –æ—Ç–¥–µ–ª–∞ Sun Pharma —Ä–∞—Å—Å–∫–∞–∑–∞–ª, —á—Ç–æ –ø—Ä–µ–≤—Ä–∞—â–∞–µ—Ç —é—Ä–∏—Å—Ç–∞ –≤ –Ω–∞—Å—Ç–æ—è—â–µ–≥–æ –±–∏–∑–Ω–µ—Å-–ø–∞—Ä—Ç–Ω–µ—Ä–∞ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QgwZW #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫","{""skip"": true}"
2025-12-05T13:53:05+00:00,@medpharm,13893,https://t.me/medpharm/13893,–ú–µ–¥—É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç –≤ –°–∞–º–∞—Ä–µ –ø–æ–ª—É—á–∏–ª –ª–∏—Ü–µ–Ω–∑–∏—é –Ω–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –∫–ª–µ—Ç–æ—á–Ω—ã—Ö –ø—Ä–æ–¥—É–∫—Ç–æ–≤ –¥–ª—è CAR-T-—Ç–µ—Ä–∞–ø–∏–∏. –≠—Ç–æ—Ç –º–µ—Ç–æ–¥ –ø–æ–º–æ–∂–µ—Ç —É–¥–≤–æ–∏—Ç—å –≤—ã–∂–∏–≤–∞–µ–º–æ—Å—Ç—å –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QgwPb #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-12-05T13:34:02+00:00,@medpharm,13892,https://t.me/medpharm/13892,"–ê—Å—Å–æ—Ü–∏–∞—Ü–∏—è ¬´–õ–µ–∫–º–µ–¥–æ–±—Ä–∞—â–µ–Ω–∏–µ¬ª –ø—Ä–æ—Å–∏—Ç –Ω–µ –æ—Ç–∫–ª–∞–¥—ã–≤–∞—Ç—å –∑–∞–ø—É—Å–∫ ¬´–≤—Ç–æ—Ä–æ–≥–æ –ª–∏—à–Ω–µ–≥–æ¬ª –¥–ª—è –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø–µ—Ä–µ—á–Ω—è –°–ó–õ–° –∏ —Å—Ç–∞—Ä—Ç–æ–≤–∞—Ç—å –∫–∞–∫ –ø–ª–∞–Ω–∏—Ä–æ–≤–∞–ª–æ—Å—å. –ò–∑-–∑–∞ –ø–µ—Ä–µ–Ω–æ—Å–∞ —Å—Ä–æ–∫–æ–≤ –Ω–∞—Ü—Ä–µ–∂–∏–º –≥–æ—Å–∑–∞–∫—É–ø–æ–∫ –≤ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ –¥–µ–π—Å—Ç–≤—É–µ—Ç –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–Ω–æ –∏ –∑–∞–∏–Ω—Ç–µ—Ä–µ—Å–æ–≤–∞–Ω–Ω–æ—Å—Ç—å –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –≥–æ—Ç–æ–≤—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Ñ–æ—Ä–º –∫ –∏–Ω–≤–µ—Å—Ç–∏—Ä–æ–≤–∞–Ω–∏—é –≤ —É–≥–ª—É–±–ª–µ–Ω–∏–µ –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏–∏ —Å–Ω–∏–∂–∞–µ—Ç—Å—è, –æ—Ç–º–µ—á–∞—é—Ç –≤ –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QgvNM #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The Association 'LekMedObrachivanie' requests not to postpone the launch of 'second extra' for the SZZS list and start as planned. Due to the postponement of deadlines in the national procurement system, the Faramtrasli mode is limited and manufacturers' interest in investing in deep localization of ready-made pharmaceuticals decreases, the association notes.""
}"
2025-12-05T12:44:04+00:00,@medpharm,13891,https://t.me/medpharm/13891,–ù–∞ –æ–±—â–µ–º —Å–æ–±—Ä–∞–Ω–∏–∏ —á–ª–µ–Ω–æ–≤ –†–æ—Å—Å–∏–π—Å–∫–æ–π –∞–∫–∞–¥–µ–º–∏–∏ –Ω–∞—É–∫ —Ä–∞—Å—Å–º–æ—Ç—Ä—è—Ç –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è –ø–æ —Å–æ–≤–µ—Ä—à–µ–Ω—Å—Ç–≤–æ–≤–∞–Ω–∏—é —Å—Ç—Ä—É–∫—Ç—É—Ä—ã –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –∏ —Å–≤—è–∑–∞–Ω–Ω—ã–µ —Å —ç—Ç–∏–º –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ —É—Å—Ç–∞–≤. –î–≤–∞ –ø—Ä–æ—Ñ–∏–ª—å–Ω—ã—Ö –æ—Ç–¥–µ–ª–µ–Ω–∏—è ‚Äî –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏ —Ñ–∏–∑–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –Ω–∞—É–∫ ‚Äî –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–æ –ø–µ—Ä–µ—Ñ–æ—Ä–º–∞—Ç–∏—Ä–æ–≤–∞—Ç—å –≤ —Ç—Ä–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QgsCy #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ù–∞—É–∫–∞ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-12-05T12:23:04+00:00,@medpharm,13890,https://t.me/medpharm/13890,"–†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä –ø—Ä–µ–∫—Ä–∞—Ç–∏–ª –æ–±—Ä–∞—â–µ–Ω–∏–µ –≤–æ—Å—å–º–∏ —Å–µ—Ä–∏–π –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –µ—â–µ —á–µ—Ç—ã—Ä–µ —Å–µ—Ä–∏–∏ –æ—Ç–æ–∑–≤–∞–ª–∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏. –ß–∞—â–µ –≤—Å–µ–≥–æ –ø—Ä–µ—Ç–µ–Ω–∑–∏–∏ –≤–æ–∑–Ω–∏–∫–∞–ª–∏ –∫ –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è–º ¬´–†–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø—Ä–∏–º–µ—Å–∏¬ª, ¬´–†–∞—Å—Ç–≤–æ—Ä–µ–Ω–∏–µ¬ª –∏ ¬´–û–ø–∏—Å–∞–Ω–∏–µ¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qgqn2 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–û—Ç–∑—ã–≤—ã","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""The Roszdranad–∑–æ—Ä has suspended eight series of pharmaceutical products, and four more have been recalled by the manufacturers. Complaints were most often related to 'Related impurities', 'Solubility' and 'Description'. For more details: https://clck.ru/3Qgqn2 #PharmVestnik #Recalls""
}"
2025-12-05T11:34:04+00:00,@medpharm,13889,https://t.me/medpharm/13889,"–•–∏—Ä—É—Ä–≥–∏ –ù–ú–ò–¶ —Ä–∞–¥–∏–æ–ª–æ–≥–∏–∏ –∏ –ú–æ—Å–∫–æ–≤—Å–∫–æ–≥–æ –º–Ω–æ–≥–æ–ø—Ä–æ—Ñ–∏–ª—å–Ω–æ–≥–æ –Ω–∞—É—á–Ω–æ-–∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–≥–æ —Ü–µ–Ω—Ç—Ä–∞ –≤—ã–ø–æ–ª–Ω–∏–ª–∏ –æ–ø–µ—Ä–∞—Ü–∏—é, –∫–æ—Ç–æ—Ä–∞—è –µ—â–µ –Ω–µ–¥–∞–≤–Ω–æ —Å—á–∏—Ç–∞–ª–∞—Å—å –Ω–µ–≤–æ–∑–º–æ–∂–Ω–æ–π. –í–º–µ—à–∞—Ç–µ–ª—å—Å—Ç–≤–æ —Å—Ç–∞–ª–æ –≤–æ–∑–º–æ–∂–Ω—ã–º –±–ª–∞–≥–æ–¥–∞—Ä—è —Å–æ—á–µ—Ç–∞–Ω–∏—é —Ä–µ—Å—É—Ä—Å–æ–≤ –∏ –æ–ø—ã—Ç–∞ –¥–≤—É—Ö —Ü–µ–Ω—Ç—Ä–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QgnRD #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–û–Ω–∫–æ–ª–æ–≥–∏—è #–•–∏—Ä—É—Ä–≥–∏—è","{
  ""skip"": true
}"
2025-12-05T10:34:07+00:00,@medpharm,13888,https://t.me/medpharm/13888,–û–ª–µ–≥–∞ –õ–∞–≤—Ä–∏—á–µ–≤–∞ –ø—Ä–∏–≥–æ–≤–æ—Ä–∏–ª–∏ –∫ —à–µ—Å—Ç–∏ –≥–æ–¥–∞–º —Å—Ç—Ä–æ–≥–æ–≥–æ —Ä–µ–∂–∏–º–∞ –∑–∞ —Ä–∞—Å—Ç—Ä–∞—Ç—É –∏ –º–æ—à–µ–Ω–Ω–∏—á–µ—Å—Ç–≤–æ –ø—Ä–∏ –∑–∞–∫—É–ø–∫–µ –º–µ–¥–æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è.Ôªø –≠–∫—Å-–≥–ª–∞–≤–∞ –ê–ü–ó –∏ –Ω–∏–∂–µ–≥–æ—Ä–æ–¥—Å–∫–æ–π –î—É–º—ã –Ω–∞–∑–≤–∞–ª –æ–±–≤–∏–Ω–µ–Ω–∏—è –Ω–µ—Å–ø—Ä–∞–≤–µ–¥–ª–∏–≤—ã–º–∏.Ôªø –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QgiS9 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-12-05T10:33:03+00:00,@medpharm,13887,https://t.me/medpharm/13887,–ú–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å—ã –≤–≤–æ–¥—è—Ç –ª—å–≥–æ—Ç—ã –¥–ª—è –∫–∏—Ç–∞–π—Å–∫–∏—Ö –ø—Ä–æ–¥–∞–≤—Ü–æ–≤ –±–∏–æ–¥–æ–±–∞–≤–æ–∫. –†–æ—Å—Å–∏–π—Å–∫–∏–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –Ω–µ –≤—ã–¥–µ—Ä–∂–∏–≤–∞—é—Ç –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏–∏. –ö–∞–∫ –°–æ—é–∑ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ë–ê–î –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç –∏–∑–º–µ–Ω–∏—Ç—å –ø—Ä–∞–≤–∏–ª–∞? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QgjVm #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-12-05T09:39:05+00:00,@medpharm,13886,https://t.me/medpharm/13886,"–†–∞–∑—Ä–∞–±–æ—Ç–∞–Ω —Ç–µ—Å—Ç –¥–ª—è –≤—ã—è–≤–ª–µ–Ω–∏—è –±–∞–∫—Ç–µ—Ä–∏–∏, –∫–æ—Ç–æ—Ä—É—é –í–û–ó –Ω–∞–∑–≤–∞–ª–∞ —Ç—Ä–µ–±—É—é—â–∏–º –ø—Ä–∏–æ—Ä–∏—Ç–µ—Ç–Ω–æ–≥–æ —Å–æ–∑–¥–∞–Ω–∏—è –≤–∞–∫—Ü–∏–Ω—ã –ø–∞—Ç–æ–≥–µ–Ω–æ–º. –ú–µ—Ç–æ–¥ –Ω–∞ –æ—Å–Ω–æ–≤–µ –ø–µ—Ç–ª–µ–≤–æ–π –∏–∑–æ—Ç–µ—Ä–º–∏—á–µ—Å–∫–æ–π –∞–º–ø–ª–∏—Ñ–∏–∫–∞—Ü–∏–∏ –ø–æ–∑–≤–æ–ª—è–µ—Ç –ø–æ–ª—É—á–∞—Ç—å —Ç–æ—á–Ω—ã–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –≤—Å–µ–≥–æ –∑–∞ 30 –º–∏–Ω—É—Ç. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QgeVg #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–î–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞","{""skip"": true}"
2025-12-05T09:08:02+00:00,@medpharm,13885,https://t.me/medpharm/13885,–ë–∏–æ–ø—Ä–µ–ø–∞—Ä–∞—Ç Avance –æ–¥–æ–±—Ä–µ–Ω FDA –¥–ª—è –≤–æ—Å—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è –ø–µ—Ä–∏—Ñ–µ—Ä–∏—á–µ—Å–∫–∏—Ö –Ω–µ—Ä–≤–æ–≤. –ù–æ–≤–∞—è —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—è —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–µ–µ —Å—Ç–∞–Ω–¥–∞—Ä—Ç–Ω—ã—Ö –º–µ—Ç–æ–¥–æ–≤ –ø—Ä–∏ –ø—Ä–æ—Ç—è–∂–µ–Ω–Ω—ã—Ö –ø–æ–≤—Ä–µ–∂–¥–µ–Ω–∏—è—Ö. –ö–∞–∫ —Ä–∞–±–æ—Ç–∞–µ—Ç —Ç—Ä–∞–Ω—Å–ø–ª–∞–Ω—Ç–∞—Ç –∏ —á—Ç–æ –≥–æ–≤–æ—Ä—è—Ç –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ –∏—Å–ø—ã—Ç–∞–Ω–∏—è? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qgc7X #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-12-05T08:53:16+00:00,@medpharm,13884,https://t.me/medpharm/13884,"–í–ø–µ—Ä–≤—ã–µ —Å 2000 –≥–æ–¥–∞ —á–∏—Å–ª–æ –¥–µ—Ç–µ–π, —É–º–µ—Ä—à–∏—Ö –¥–æ –ø—è—Ç–∏ –ª–µ—Ç, –Ω–∞—á–∏–Ω–∞–µ—Ç —Ä–∞—Å—Ç–∏. –ü—Ä–∏—á–∏–Ω–∞ ‚Äî —Å–æ–∫—Ä–∞—â–µ–Ω–∏–µ —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è, –æ—Å–æ–±–µ–Ω–Ω–æ —Å–æ —Å—Ç–æ—Ä–æ–Ω—ã –°–®–ê. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qgaxt #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""There is an increase in child mortality under five years old for the first time since 2000. The cause is low funding of healthcare, especially from the USA. For more details: https://clck.ru/3Qgaxt #MedVestnik #Healthcare""
}"
2025-12-05T07:40:03+00:00,@medpharm,13883,https://t.me/medpharm/13883,–ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ –†–æ—Å—Å–∏–∏ –¥–∞–µ—Ç –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º –±–æ–ª—å—à–µ –≤—Ä–µ–º–µ–Ω–∏ –Ω–∞ –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏–µ —Å—Ç—Ä–∞–Ω—ã –ø—Ä–æ–∏—Å—Ö–æ–∂–¥–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤. –°—Ä–æ–∫–∏ –±—É–¥—É—Ç —Å–∏–Ω—Ö—Ä–æ–Ω–∏–∑–∏—Ä–æ–≤–∞–Ω—ã —Å–æ —Å—Ç–∞—Ä—Ç–æ–º –º–µ—Ö–∞–Ω–∏–∑–º–∞ ¬´–≤—Ç–æ—Ä–æ–π –ª–∏—à–Ω–∏–π¬ª –¥–ª—è –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –∏–∑ –ø–µ—Ä–µ—á–Ω—è —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º—ã—Ö. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QgVZV #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Industry and Trade of Russia extends the verification period for drug origins. The timelines will be synchronized with the start of the 'second extra' mechanism for strategically important drugs. More details: https://clck.ru/3QgVZV #PharmNews #Production""
}"
2025-12-05T07:06:05+00:00,@medpharm,13882,https://t.me/medpharm/13882,–í 2023 –≥–æ–¥—É —á–∏—Å–ª–æ –≤–ø–µ—Ä–≤—ã–µ –ø–æ–ª—É—á–∏–≤—à–∏—Ö –∏–Ω–≤–∞–ª–∏–¥–Ω–æ—Å—Ç—å —Ä–æ—Å—Å–∏—è–Ω –≤ —Ä–∞—Å—á–µ—Ç–µ –Ω–∞ 10 —Ç—ã—Å. –≤–∑—Ä–æ—Å–ª–æ–≥–æ –Ω–∞—Å–µ–ª–µ–Ω–∏—è —Å—Ç–∞–ª–æ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–æ–≤–∞—Ç—å —É—Ä–æ–≤–Ω—é –Ω–∞—á–∞–ª–∞ 1990-—Ö –≥–æ–¥–æ–≤. –ù–∞ —Ñ–æ–Ω–µ –±—ã—Å—Ç—Ä–æ–≥–æ —Ä–æ—Å—Ç–∞ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–Ω–æ—Å—Ç–∏ –∏–Ω–≤–∞–ª–∏–¥–Ω–æ—Å—Ç–∏ —Å—Ç–∞—Ç–∏—Å—Ç–∏–∫–∞ —Å—Ç–∞–Ω–æ–≤–∏—Ç—Å—è –≤—Å–µ –±–æ–ª–µ–µ –∑–∞–∫—Ä—ã—Ç–æ–π: –†–æ—Å—Å—Ç–∞—Ç –Ω–µ –æ–±–Ω–æ–≤–∏–ª –º–Ω–æ–≥–∏–µ –¥–∞–Ω–Ω—ã–µ –∑–∞ 2024 –≥–æ–¥. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QgTJQ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-12-05T06:07:05+00:00,@medpharm,13881,https://t.me/medpharm/13881,–£—á–µ–Ω—ã–µ –∏–∑ –£–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ –°–æ–Ω–≥—é–Ω–≥–≤–∞–Ω –ø—Ä–æ–∞–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–ª–∏ —Å–≤—è–∑—å –º–µ–∂–¥—É –ø—Ä–∏–µ–º–æ–º –ø–µ—Ä–æ—Ä–∞–ª—å–Ω—ã—Ö –∫–æ—Ä—Ç–∏–∫–æ—Å—Ç–µ—Ä–æ–∏–¥–æ–≤ –∏ —Ä–∏—Å–∫–æ–º –≥–µ—Å—Ç–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ –¥–∏–∞–±–µ—Ç–∞ —É –±–µ—Ä–µ–º–µ–Ω–Ω—ã—Ö. –†–µ–∑—É–ª—å—Ç–∞—Ç—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω—ã –≤ –∂—É—Ä–Ω–∞–ª–µ JAMA Internal Medicine. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QgPRH #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ê–∫—É—à–µ—Ä—Å—Ç–≤–æ_–∏_–≥–∏–Ω–µ–∫–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è #–≠–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–∏—è,"{""skip"": true}"
2025-12-04T16:43:01+00:00,@medpharm,13880,https://t.me/medpharm/13880,"ü¶æ –ü—Ä–∏—Ç—è–∂–µ–Ω–∏–µ —Ä–µ–≥—É–ª—è—Ç–æ—Ä–∞. –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ –æ–±–Ω–æ–≤–∏–ª –ø—Ä–æ–µ–∫—Ç—ã –ø—Ä–∏–∫–∞–∑–æ–≤ –æ–± —É—Å–ª–æ–≤–∏—è—Ö –æ—Ç—Ä–∞–±–æ—Ç–∫–∏ –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∫–æ–ª–ª–µ–¥–∂–µ–π –∏ –≤—É–∑–æ–≤ –∏ —Å–∏—Å—Ç–µ–º—ã –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–∞. –ü–æ –æ—Ü–µ–Ω–∫–∞–º –≤–µ–¥–æ–º—Å—Ç–≤–∞, –ø—Ä–µ–¥–ª–∞–≥–∞–µ–º–æ–µ —Ä–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω–∏–µ –∑–∞—Ç—Ä–æ–Ω–µ—Ç —Å–≤—ã—à–µ 3 —Ç—ã—Å. –Ω–µ–≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –∫–ª–∏–Ω–∏–∫, –±–æ–ª–µ–µ 5 —Ç—ã—Å. –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ —á–∞—Å—Ç–Ω–æ–π —Å–∏—Å—Ç–µ–º—ã –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è, –∫–æ—Ç–æ—Ä—ã–µ –±—É–¥—É—Ç –æ—Å—É—â–µ—Å—Ç–≤–ª—è—Ç—å –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–æ, –∏ —Å—Ç–æ–ª—å–∫–æ –∂–µ –º–æ–ª–æ–¥—ã—Ö —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤. ü¶æ –ù–∞ —Ä–∞–∑–Ω—ã—Ö –≤–æ–ª–Ω–∞—Ö. –í —Ä–æ—Å—Å–∏–π—Å–∫–æ–º –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–∏ —É—Å–∏–ª–∏–≤–∞–µ—Ç—Å—è —Ñ–æ—Ä–º–∞–ª–∏–∑–∞—Ü–∏—è –æ—Ç–Ω–æ—à–µ–Ω–∏–π –≤—Ä–∞—á–∞ –∏ –ø–∞—Ü–∏–µ–Ω—Ç–∞, –Ω–æ —Å–æ—Ö—Ä–∞–Ω—è—é—Ç—Å—è –∫–∞–¥—Ä–æ–≤—ã–π –¥–µ—Ñ–∏—Ü–∏—Ç –∏ –≤—ã–≥–æ—Ä–∞–Ω–∏–µ, –∑–∞—è–≤–∏–ª–∏ –≤ –ø—Ä–æ—Ñ–∏–ª—å–Ω–æ–º –ø—Ä–æ—Ñ—Å–æ—é–∑–µ. ‚ù§Ô∏è –ë–µ–∑ —Å—É–¥–∞. –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –≤—ã–¥–∞–ª–æ –Ω–æ–≤–æ–µ —Ä–∞–∑—Ä–µ—à–µ–Ω–∏–µ ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º—É¬ª –Ω–∞ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ –±–µ–∑ —Å–æ–≥–ª–∞—Å–∏—è –ø—Ä–∞–≤–æ–æ–±–ª–∞–¥–∞—Ç–µ–ª—è. –î–æ–∫—É–º–µ–Ω—Ç –≤—Å—Ç—É–ø–∞–µ—Ç –≤ —Å–∏–ª—É —Å 1 —è–Ω–≤–∞—Ä—è 2026 –≥–æ–¥–∞. ‚ù§Ô∏è –°—Ç—Ä–∞—Ç–µ–≥–∏—è –ø–æ–≤–µ–¥–µ–Ω–∏—è. –ö–∞–∫ –æ—Å–ø–æ—Ä–∏—Ç—å –æ—Ç–º–µ–Ω—É —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞? –ù–∞ –ø—Ä–∏–º–µ—Ä–µ –º–Ω–æ–≥–æ–ª–µ—Ç–Ω–µ–≥–æ —Å–ø–æ—Ä–∞ ¬´–î–∂–æ–¥–∞—Å –≠–∫—Å–ø–æ–∏–º¬ª —Å –ú–∏–Ω–∑–¥—Ä–∞–≤–æ–º –†–§ —Ä–∞–∑–±–∏—Ä–∞–µ–º –∞—Ä–≥—É–º–µ–Ω—Ç—ã —Å—Ç–æ—Ä–æ–Ω –∏ —Å–æ–≤–µ—Ç—ã —é—Ä–∏—Å—Ç–æ–≤ –ø–æ –∑–∞—â–∏—Ç–µ –≤ —Å—É–¥–µ.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing, safety, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The Ministry of Health of Russia has updated the projects of decrees on conditions for graduation of medical colleges and universities, as well as mentorship systems. The proposed regulation will affect more than 3,000 non-state clinics and over 5,000 medical workers in the private healthcare system who will provide mentorship, and an equal number of young specialists. The government has granted a new permit to 'Gerofarma' for the use of semaglutide without the consent of the right holder. The document comes into force on January 1, 2026.""
}"
2025-12-04T15:56:02+00:00,@medpharm,13879,https://t.me/medpharm/13879,"–ù–æ–≤—ã–π –ø–æ–≤–æ—Ä–æ—Ç –ø–æ–ª—É—á–∏–ª –ø–∞—Ç–µ–Ω—Ç–Ω—ã–π —Å–ø–æ—Ä, –∫–∞—Å–∞—é—â–∏–π—Å—è –¥–∞–ø–∞–≥–ª–∏—Ñ–ª–æ–∑–∏–Ω–∞. –ü–∞—Ç–µ–Ω—Ç –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∏—Ç AstraZeneca, —Å–Ω–∞—á–∞–ª–∞ –µ–≥–æ –¥–µ–π—Å—Ç–≤–∏–µ –¥–æ–ª–∂–Ω–æ –±—ã–ª–æ –∑–∞–∫–æ–Ω—á–∏—Ç—å—Å—è –≤ –º–∞–µ 2023 –≥–æ–¥–∞, –Ω–æ –≤ 2024 –≥–æ–¥—É –∫–æ–º–ø–∞–Ω–∏–∏ —É–¥–∞–ª–æ—Å—å –ø—Ä–æ–¥–ª–∏—Ç—å –æ—Ö—Ä–∞–Ω—É –¥–æ –º–∞—è 2028 –≥–æ–¥–∞. –î–∂–µ–Ω–µ—Ä–∏–∫–æ–≤—ã–µ –∫–æ–º–ø–∞–Ω–∏–∏ –ø—Ä–µ–¥–ø—Ä–∏–Ω—è–ª–∏ –Ω–µ—Å–∫–æ–ª—å–∫–æ –ø–æ–ø—ã—Ç–æ–∫, —á—Ç–æ–±—ã –æ—Ç–º–µ–Ω–∏—Ç—å —ç—Ç–æ –ø—Ä–æ–¥–ª–µ–Ω–∏–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qg2cD #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""high"",
  ""english"": ""A patent dispute regarding dapagliflozin has been resolved. AstraZeneca's patent was initially set to expire in May 2023, but it has been extended until May 2028. Generic companies have attempted to annul this extension.""
}"
2025-12-04T15:32:03+00:00,@medpharm,13878,https://t.me/medpharm/13878,–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –≤—ã–¥–∞–ª–æ –Ω–æ–≤–æ–µ —Ä–∞–∑—Ä–µ—à–µ–Ω–∏–µ –Ω–∞ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ –±–µ–∑ —Å–æ–≥–ª–∞—Å–∏—è –ø—Ä–∞–≤–æ–æ–±–ª–∞–¥–∞—Ç–µ–ª—è. –î–æ–∫—É–º–µ–Ω—Ç –≤—Å—Ç—É–ø–∞–µ—Ç –≤ —Å–∏–ª—É —Å 1 —è–Ω–≤–∞—Ä—è 2026 –≥–æ–¥–∞. –ö–∞–∫–∞—è –∫–æ–º–ø–∞–Ω–∏—è –ø–æ–ª—É—á–∏–ª–∞ —Ä–∞–∑—Ä–µ—à–µ–Ω–∏–µ? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qfz6V #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-12-04T15:19:06+00:00,@medpharm,13877,https://t.me/medpharm/13877,"–í —Ä–æ—Å—Å–∏–π—Å–∫–æ–º –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–∏ —É—Å–∏–ª–∏–≤–∞–µ—Ç—Å—è —Ñ–æ—Ä–º–∞–ª–∏–∑–∞—Ü–∏—è –æ—Ç–Ω–æ—à–µ–Ω–∏–π –≤—Ä–∞—á–∞ –∏ –ø–∞—Ü–∏–µ–Ω—Ç–∞, –Ω–æ —Å–æ—Ö—Ä–∞–Ω—è—é—Ç—Å—è –∫–∞–¥—Ä–æ–≤—ã–π –¥–µ—Ñ–∏—Ü–∏—Ç –∏ –≤—ã–≥–æ—Ä–∞–Ω–∏–µ, –∑–∞—è–≤–∏–ª–∏ –≤ –ø—Ä–æ—Ñ–∏–ª—å–Ω–æ–º –ø—Ä–æ—Ñ—Å–æ—é–∑–µÔªø. –†–∞–Ω–µ–µ –æ–ø—Ä–æ—Å –ø–æ–∫–∞–∑–∞–ª, —á—Ç–æ –±–æ–ª–µ–µ –ø–æ–ª–æ–≤–∏–Ω—ã —Ä–æ—Å—Å–∏—è–Ω –Ω–µ–¥–æ–≤–æ–ª—å–Ω—ã –∫–∞—á–µ—Å—Ç–≤–æ–º –º–µ–¥–æ–±—Å–ª—É–∂–∏–≤–∞–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QfyNE #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-12-04T15:02:59+00:00,@medpharm,13876,https://t.me/medpharm/13876,–ò—Å—Ç–æ—Ä–∏—è —Ä–∞–∑–≤–∏—Ç–∏—è –æ–Ω–ª–∞–π–Ω-—Å–µ—Ä–≤–∏—Å–∞ ¬´–ó–¥—Ä–∞–≤—Å–∏—Ç–∏¬ª: –æ—Ç –∏–¥–µ–∏ –±—Ä–æ–Ω–∏—Ä–æ–≤–∞–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤ –¥–æ –æ–º–Ω–∏–∫–∞–Ω–∞–ª—å–Ω–æ–≥–æ –≥–∏–≥–∞–Ω—Ç–∞ —Å –¥–æ—Å—Ç–∞–≤–∫–æ–π –Ω–∞ –¥–æ–º –∏ –æ–Ω–ª–∞–π–Ω-–∫–æ–Ω—Å—É–ª—å—Ç–∞—Ü–∏—è–º–∏ –≤—Ä–∞—á–µ–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QftB3,"{""skip"": true}"
2025-12-04T14:46:03+00:00,@medpharm,13875,https://t.me/medpharm/13875,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏ –¥–æ–≥–æ–≤–æ—Ä–∏–ª—Å—è —Å –°–∏—Ä–∏–µ–π –æ –ø—Ä–∏–∑–Ω–∞–Ω–∏–∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –º–µ–¥–∏–∑–¥–µ–ª–∏–π –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞, –ø–æ–¥–ø–∏—Å–∞–Ω–æ —Ä–∞—Å–ø–æ—Ä—è–∂–µ–Ω–∏–µ –æ–± —ç—Ç–æ–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QfwLV #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""registration"",
  ""impact"": ""medium"",
  ""english"": ""The Russian Ministry of Russia and Syria have reached an agreement on the recognition of registration of domestically produced medicines and medical devices, which has been signed by a directive.""
}"
2025-12-04T14:33:05+00:00,@medpharm,13874,https://t.me/medpharm/13874,"–§–æ–Ω–¥ –û–ú–° –∏ –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ –Ω–∞–ø—Ä–∞–≤–∏–ª–∏ –≤ —Ä–µ–≥–∏–æ–Ω—ã —Å–æ–≤–º–µ—Å—Ç–Ω–æ–µ –ø–∏—Å—å–º–æ —Å –∞–∫—Ç—É–∞–ª—å–Ω—ã–º–∏ –ø—Ä–∞–≤–∏–ª–∞–º–∏ –ø—Ä–µ–º–∏—Ä–æ–≤–∞–Ω–∏—è –ø–æ–ª–∏–∫–ª–∏–Ω–∏–∫. –¢–µ–º–∞—Ç–∏—á–µ—Å–∫–∏–π –ø—Ä–∏–∫–∞–∑ –æ —Ä–∞—Å—á–µ—Ç–∞—Ö –≤ –ü—Ä–æ–≥—Ä–∞–º–º–µ –≥–æ—Å–≥–∞—Ä–∞–Ω—Ç–∏–π –æ–±–Ω–æ–≤–∏–ª–∏ –µ—â–µ –≤ –∏—é–ª–µ ‚Äî —á–∏—Å–ª–æ –∫—Ä–∏—Ç–µ—Ä–∏–µ–≤, –ø–æ –∫–æ—Ç–æ—Ä—ã–º –æ—Ü–µ–Ω–∏–≤–∞—é—Ç –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –ø–µ—Ä–≤–∏—á–Ω–æ–≥–æ –∑–≤–µ–Ω–∞, —Ç–æ–≥–¥–∞ —Ä–∞—Å—à–∏—Ä–∏–ª–∏ –¥–æ 33 –ø–æ–∑–∏—Ü–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QfvYB #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""reimbursement, regulation"",
  ""impact"": ""medium"",
  ""english"": ""The Fund for the Personal Medical Savings (–û–ú–°) and the Ministry of Health of Russia have sent a joint letter to regions with updated rules for rewarding primary care clinics. The thematic decree updating the Program of Guarantees calculations was revised in July, expanding the number of criteria used to evaluate primary care organizations from 20 to 33. More details: https://clck.ru/3QfvYB #MedVestnik #Healthcare""
}"
2025-12-04T14:09:03+00:00,@medpharm,13873,https://t.me/medpharm/13873,–ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏ –≤—ã–¥–∞–ª —Ä–∞–∑—Ä–µ—à–µ–Ω–∏–µ –Ω–∞ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏–µ —Ç—Ä–µ—Ç—å–µ–π —Ñ–∞–∑—ã –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–æ–≥–æ –º–Ω–æ–≥–æ—Ü–µ–Ω—Ç—Ä–æ–≤–æ–≥–æ –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–≥–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ DZD8586 (–±–∏—Ä–µ–ª–µ–Ω—Ç–∏–Ω–∏–±) —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å —Ä–µ—Ü–∏–¥–∏–≤–∏—Ä—É—é—â–∏–º –∏–ª–∏ —Ä–µ—Ñ—Ä–∞–∫—Ç–µ—Ä–Ω—ã–º —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–∏–º –ª–∏–º—Ñ–æ—Ü–∏—Ç–∞—Ä–Ω—ã–º –ª–µ–π–∫–æ–∑–æ–º –∏ –º–µ–ª–∫–æ–∫–ª–µ—Ç–æ—á–Ω–æ–π –ª–∏–º—Ñ–æ—Ü–∏—Ç–∞—Ä–Ω–æ–π –ª–∏–º—Ñ–æ–º–æ–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qftyp #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The Ministry of Health of Russia has approved the third phase international multi-center clinical trial of drug DZD8586 (belinostat) for patients with relapsed or refractory chronic lymphocytic leukemia and small cell lymphocytic lymphoma. For more details: https://clck.ru/3Qftyp #FarmaNews #Regulation""
}"
2025-12-04T14:07:07+00:00,@medpharm,13872,https://t.me/medpharm/13872,"–¢—Ä–µ–π—Å–∏ –•–æ—É–≥Ôªø –Ω–∞–∑–Ω–∞—á–µ–Ω–∞ –∏.–æ. –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ CDER FDA. –û–Ω–∞ —Å–º–µ–Ω–∏–ª–∞ –Ω–∞ —ç—Ç–æ–º –ø–æ—Å—Ç—É –†–∏—á–∞—Ä–¥–∞ –ü–∞–∑–¥—É—Ä–∞, —É—à–µ–¥—à–µ–≥–æ –≤ –æ—Ç—Å—Ç–∞–≤–∫—É —á–µ—Ä–µ–∑ —Ç—Ä–∏ –Ω–µ–¥–µ–ª–∏ –ø–æ—Å–ª–µ –Ω–∞—á–∞–ª–∞ —Ä–∞–±–æ—Ç—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QftrX #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-12-04T13:29:03+00:00,@medpharm,13871,https://t.me/medpharm/13871,"–ü—Ä–µ–ø–∞—Ä–∞—Ç AbbVie –º–æ–∂–µ—Ç —Ä–∞–±–æ—Ç–∞—Ç—å, –∫–∞–∫ —Å—Ä–µ–¥—Å—Ç–≤–æ —ç–∫—Å—Ç—Ä–µ–Ω–Ω–æ–π –ø–æ–º–æ—â–∏ –ø—Ä–∏ –º–∏–≥—Ä–µ–Ω–∏. –û–Ω –æ—Å—Ç–∞–Ω–æ–≤–∏–ª —É–∂–µ –Ω–∞—á–∞–≤—à—É—é—Å—è –º–∏–≥—Ä–µ–Ω—å –∑–∞ –¥–≤–∞ —á–∞—Å–∞ —É –∫–∞–∂–¥–æ–≥–æ —á–µ—Ç–≤–µ—Ä—Ç–æ–≥–æ —É—á–∞—Å—Ç–Ω–∏–∫–∞ –ö–ò. –ö–æ–º–ø–∞–Ω–∏—è –æ–ø—É–±–ª–∏–∫–æ–≤–∞–ª–∞ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –∫—Ä—É–ø–Ω–æ–≥–æ –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–≥–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QfrXJ #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-12-04T13:09:04+00:00,@medpharm,13870,https://t.me/medpharm/13870,–¢–∞–º–∞—Ä–∞ –¢–æ–º–∞–µ–≤–∞ —É—Ö–æ–¥–∏—Ç —Å –ø–æ—Å—Ç–∞ –∏.–æ. –º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –í–ª–∞–¥–∏–º–∏—Ä—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏. –ï–π —É–∂–µ –ø–æ–¥–æ–±—Ä–∞–ª–∏ –ø—Ä–µ–µ–º–Ω–∏–∫–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qfq3z #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-12-04T12:24:02+00:00,@medpharm,13869,https://t.me/medpharm/13869,"–ë–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö —Ñ–∞—Ä–º—Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –Ω–µ –ø–æ–¥–¥–µ—Ä–∂–∏–≤–∞—é—Ç –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤—É –æ –ø–µ—Ä–µ—Ö–æ–¥–µ –Ω–∞ –ø–æ—à—Ç—É—á–Ω—É—é –ø—Ä–æ–¥–∞–∂—É –ª–µ–∫–∞—Ä—Å—Ç–≤. –û—Å–Ω–æ–≤–Ω—ã–º–∏ –ø—Ä–∏—á–∏–Ω–∞–º–∏ –Ω–∞–∑—ã–≤–∞—é—Ç—Å—è –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–æ–Ω–Ω—ã–µ, —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–∏–µ –∏ –ø—Ä–∞–≤–æ–≤—ã–µ —Å–ª–æ–∂–Ω–æ—Å—Ç–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qfmnj #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–§–∞—Ä–º–∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä–æ–≤–∞–Ω–∏–µ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""Pharmaceutical specialists generally do not support the initiative to sell medicines on a per-item basis. The main reasons cited are organizational, technical and legal difficulties. For more details: https://clck.ru/3Qfmnj #PharmVestnik #PharmConsultation""
}"
2025-12-04T12:22:03+00:00,@medpharm,13868,https://t.me/medpharm/13868,–ì–ª–∞–≤–∞ –°–æ–≤–µ—Ç–∞ –ø—Ä–∏ –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç–µ –†–§ –ø–æ —Ä–∞–∑–≤–∏—Ç–∏—é –≥—Ä–∞–∂–¥–∞–Ω—Å–∫–æ–≥–æ –æ–±—â–µ—Å—Ç–≤–∞ –∏ –ø—Ä–∞–≤–∞–º —á–µ–ª–æ–≤–µ–∫–∞ –∑–∞—è–≤–∏–ª –æ —Ä–∏—Å–∫–∞—Ö –ø–æ—Å–µ–ª–µ–Ω–∏—è –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–≤—É–∑–æ–≤ –≤ ¬´–≥–Ω–∏–ª—ã–µ –∏–∑–±—É—à–∫–∏¬ª –∏–∑-–∑–∞ –∑–∞–∫–æ–Ω–∞ –æ–± –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–π –æ—Ç—Ä–∞–±–æ—Ç–∫–µ. –û–Ω –æ—Ç–º–µ—Ç–∏–ª ¬´–º–µ—Ä–∫–∞–Ω—Ç–∏–ª—å–Ω—ã–π¬ª —Ö–∞—Ä–∞–∫—Ç–µ—Ä –∑–∞–∫–æ–Ω–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QfmdG #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The head of the Council for the Development of Civil Society and Human Rights under President of Russia stated about risks of graduates from medical universities settling in 'rotten huts' due to the law on mandatory rotation. He noted the 'mercantile' character of the law.""
}"
2025-12-04T11:07:03+00:00,@medpharm,13867,https://t.me/medpharm/13867,–í –û—Ä–ª–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –Ω–∞–∑–Ω–∞—á–µ–Ω —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å –î–µ–ø–∞—Ä—Ç–∞–º–µ–Ω—Ç–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –ö–æ–Ω—Å—Ç–∞–Ω—Ç–∏–Ω –ë–æ–±—Ä–∞–∫–æ–≤ –ø–µ—Ä–µ—à–µ–ª –Ω–∞ —ç—Ç—É —Ä–∞–±–æ—Ç—É —Å –¥–æ–ª–∂–Ω–æ—Å—Ç–∏ –∏.–æ. –≥–ª–∞–≤—ã –¢–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω–æ–≥–æ —Ñ–æ–Ω–¥–∞ –û–ú–°. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QfgDw #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-12-04T10:49:03+00:00,@medpharm,13866,https://t.me/medpharm/13866,"–í–∫–ª—é—á–µ–Ω–∏–µ —Ä—è–¥–∞ –≤–∞–∫—Ü–∏–Ω –≤ –ù–∞—Ü–∫–∞–ª–µ–Ω–¥–∞—Ä—å –ø—Ä–∏–≤–∏–≤–æ–∫ –≤–Ω–æ–≤—å –æ—Ç–∫–ª–∞–¥—ã–≤–∞–µ—Ç—Å—è. –¢–∞–∫–æ–µ –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§, –ø–∏—à–µ—Ç –†–ë–ö. –†–µ—á—å –∏–¥–µ—Ç –æ —á–µ—Ç—ã—Ä–µ—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞—Ö. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qfer6 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health of Russia has postponed the inclusion of a series of vaccines in the national vaccination calendar. This decision was made, according to RBC. The four medications mentioned are being considered.""
}"
2025-12-04T10:06:05+00:00,@medpharm,13865,https://t.me/medpharm/13865,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ –æ–±–Ω–æ–≤–∏–ª –ø—Ä–æ–µ–∫—Ç—ã –ø—Ä–∏–∫–∞–∑–æ–≤ –æ–± —É—Å–ª–æ–≤–∏—è—Ö –æ—Ç—Ä–∞–±–æ—Ç–∫–∏ –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∫–æ–ª–ª–µ–¥–∂–µ–π –∏ –≤—É–∑–æ–≤ –∏ —Å–∏—Å—Ç–µ–º—ã –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–∞. –ü–æ –æ—Ü–µ–Ω–∫–∞–º –≤–µ–¥–æ–º—Å—Ç–≤–∞, –ø—Ä–µ–¥–ª–∞–≥–∞–µ–º–æ–µ —Ä–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω–∏–µ –∑–∞—Ç—Ä–æ–Ω–µ—Ç —Å–≤—ã—à–µ 3 —Ç—ã—Å. –Ω–µ–≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –∫–ª–∏–Ω–∏–∫, –±–æ–ª–µ–µ 5 —Ç—ã—Å. –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ —á–∞—Å—Ç–Ω–æ–π —Å–∏—Å—Ç–µ–º—ã –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è, –∫–æ—Ç–æ—Ä—ã–µ –æ—Å—É—â–µ—Å—Ç–≤–ª—è—é—Ç –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–æ, –∏ —Å—Ç–æ–ª—å–∫–æ –∂–µ –º–æ–ª–æ–¥—ã—Ö —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QfcJL #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health of Russia has updated the projects of decrees on conditions for graduation of medical colleges and universities, and mentoring systems. The regulatory proposal is expected to affect more than 3,000 non-state clinics and over 5,000 medical workers in the private healthcare system who provide mentoring, as well as around 5,000 young specialists.""
}"
2025-12-04T09:38:02+00:00,@medpharm,13864,https://t.me/medpharm/13864,"–ù–æ–≤—ã–π –≥–ª–∞–≤–∞ –ø–æ–¥—Ä–∞–∑–¥–µ–ª–µ–Ω–∏—è –ø–æ –æ—Ü–µ–Ω–∫–µ –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ FDA –†–∏—á–∞—Ä–¥ –ü–∞–∑–¥—É—Ä —É—Ö–æ–¥–∏—Ç –≤ –æ—Ç—Å—Ç–∞–≤–∫—É —Å–ø—É—Å—Ç—è –Ω–µ—Å–∫–æ–ª—å–∫–æ –Ω–µ–¥–µ–ª—å –ø–æ—Å–ª–µ –Ω–∞–∑–Ω–∞—á–µ–Ω–∏—è. FDA —Å–æ–æ–±—â–∏–ª–æ, —á—Ç–æ –Ω–∞–∑–Ω–∞—á–∏–ª–æ –∏—Å–ø–æ–ª–Ω—è—é—â–µ–π –æ–±—è–∑–∞–Ω–Ω–æ—Å—Ç–∏ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –¢—Ä–µ–π—Å–∏ –ë–µ—Ç –•–æ—ç–≥, –∏–∑–≤–µ—Å—Ç–Ω–æ–π –∫—Ä–∏—Ç–∏–∫–æ–π COVID-–æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QfYin #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–∞—Ä—å–µ—Ä–∞","{""skip"": true}"
2025-12-04T09:27:07+00:00,@medpharm,13863,https://t.me/medpharm/13863,–í –†–æ—Å—Å–∏–∏ —Å–æ–±–∏—Ä–∞—é—Ç—Å—è –æ—Ç–ª–æ–∂–∏—Ç—å –≤–∫–ª—é—á–µ–Ω–∏–µ –ø—Ä–∏–≤–∏–≤–æ–∫ –æ—Ç —á–µ—Ç—ã—Ä–µ—Ö –∏–Ω—Ñ–µ–∫—Ü–∏–π –≤ –¥–æ—Å—Ç—É–ø–Ω—ã–π –Ω–∞—Ü–∫–∞–ª–µ–Ω–¥–∞—Ä—å –Ω–∞ 1‚Äî4 –≥–æ–¥–∞ –∏–∑-–∑–∞ —Å—Ä–æ–∫–æ–≤ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –≤–∞–∫—Ü–∏–Ω. –≠–∫—Å–ø–µ—Ä—Ç—ã –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–∞—é—Ç –æ —Ä–∏—Å–∫–∞—Ö —Ä–æ—Å—Ç–∞ –∑–∞–±–æ–ª–µ–≤–∞–µ–º–æ—Å—Ç–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QfXvL #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–ò–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã–µ_–±–æ–ª–µ–∑–Ω–∏ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, vaccine"",
  ""impact"": ""high"",
  ""english"": ""Russia is considering postponing the inclusion of vaccines against four infections in the national calendar for 1-4 years due to vaccine production timelines. Experts warn of risks of increased disease incidence.""
}"
2025-12-04T08:52:03+00:00,@medpharm,13862,https://t.me/medpharm/13862,–ö–∞–∫ –æ—Å–ø–æ—Ä–∏—Ç—å –æ—Ç–º–µ–Ω—É —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞? –ù–∞ –ø—Ä–∏–º–µ—Ä–µ –º–Ω–æ–≥–æ–ª–µ—Ç–Ω–µ–≥–æ —Å–ø–æ—Ä–∞ ¬´–î–∂–æ–¥–∞—Å –≠–∫—Å–ø–æ–∏–º¬ª —Å –ú–∏–Ω–∑–¥—Ä–∞–≤–æ–º –†–æ—Å—Å–∏–∏ —Ä–∞–∑–±–∏—Ä–∞–µ–º –∞—Ä–≥—É–º–µ–Ω—Ç—ã —Å—Ç–æ—Ä–æ–Ω –∏ —Å–æ–≤–µ—Ç—ã —é—Ä–∏—Å—Ç–æ–≤ –ø–æ –∑–∞—â–∏—Ç–µ –≤ —Å—É–¥–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QfVLF #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-12-04T08:40:05+00:00,@medpharm,13861,https://t.me/medpharm/13861,"–ì–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–π –≤–Ω–µ–±—é–¥–∂–µ—Ç–Ω—ã–π —Ñ–æ–Ω–¥ ¬´–ö—Ä—É–≥ –¥–æ–±—Ä–∞¬ª –≤—ã—Ä–∞–∑–∏–ª —Å–µ—Ä—å–µ–∑–Ω—É—é –æ–±–µ—Å–ø–æ–∫–æ–µ–Ω–Ω–æ—Å—Ç—å —Å–∏—Ç—É–∞—Ü–∏–µ–π —Å –ø–æ—Å—Ç–∞–≤–∫–∞–º–∏ –∂–∏–∑–Ω–µ–Ω–Ω–æ –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –¥–µ—Ç–µ–π —Å –æ—Ä—Ñ–∞–Ω–Ω—ã–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏, —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏ –≤ –ø—Ä–µ—Å—Å-—Å–ª—É–∂–±–µ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QfUY5 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ–Ω–¥–µ–Ω—Ü–∏–∏","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage,hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""The State Extra-budgetary Fund 'Circle of Good' expressed serious concern about the supply situation for essential medications needed by children with rare diseases. This was reported in the press service of the organization.""
}"
2025-12-04T07:59:55+00:00,@medpharm,13860,https://t.me/medpharm/13860,"–ü–ª–∞–Ω–∏—Ä—É–µ—Ç–µ –±—é–¥–∂–µ—Ç –Ω–∞ 2026? –ù–µ –∑–∞–±—É–¥—å—Ç–µ –≤–∫–ª—é—á–∏—Ç—å DENIS Pharm! –ö–∞–∂–¥—ã–π –≥–æ–¥ ‚Äî –æ–¥–Ω–æ –∏ —Ç–æ –∂–µ: —Ç–∞–±–ª–∏—Ü—ã, —Ü–∏—Ñ—Ä—ã, –¥–µ—Å—è—Ç–∫–∏ –∫–∞–Ω–∞–ª–æ–≤ –∏ –±–µ—Å–∫–æ–Ω–µ—á–Ω—ã–µ –ø–æ–ø—ã—Ç–∫–∏ —Å–æ–±—Ä–∞—Ç—å –∏–¥–µ–∞–ª—å–Ω—ã–π –º–∞—Ä–∫–µ—Ç–∏–Ω–≥–æ–≤—ã–π –±—é–¥–∂–µ—Ç‚Ä¶ –ó–Ω–∞–∫–æ–º–æ? –ê –µ—Å–ª–∏ –≤ –Ω–æ–≤–æ–º –≥–æ–¥—É –≤—Å—ë –±—É–¥–µ—Ç –∏–Ω–∞—á–µ ‚Äî –Ω–µ –≤—ã –ø–æ–¥—Å—Ç—Ä–∞–∏–≤–∞–µ—Ç–µ—Å—å –ø–æ–¥ –±—é–¥–∂–µ—Ç, –∞ –±—é–¥–∂–µ—Ç —Ä–∞–±–æ—Ç–∞–µ—Ç –Ω–∞ –≤–∞—Å? DENIS Pharm ‚Äî —ç—Ç–æ —Å–µ—Ä–≤–∏—Å –∫–æ–Ω—Å—Ç—Ä—É–∫—Ç–æ—Ä: –∞—É—Ç—Å–æ—Ä—Å–∏–Ω–≥ –º–µ–¥–ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–µ–π, –∞—É–¥–∏—Ç, Digital 360, CRM –∏ –º–Ω–æ–≥–æ–µ –¥—Ä—É–≥–æ–µ. üé≤ –ö–æ–º–±–∏–Ω–∏—Ä—É–π—Ç–µ, —É—Å–∏–ª–∏–≤–∞–π—Ç–µ –∏ —Å–æ–∑–¥–∞–≤–∞–π—Ç–µ –ø–ª–∞–Ω-–±—é–¥–∂–µ—Ç, –∫–æ—Ç–æ—Ä—ã–π —Ä–∞–±–æ—Ç–∞–µ—Ç. üì≤ –ü–æ–¥—Ä–æ–±–Ω–µ–µ –Ω–∞ —Å–∞–π—Ç–µ denis-pharm.ru. üéÅ –í Telegram –∏–¥–µ—Ç —Ä–æ–∑—ã–≥—Ä—ã—à –∫–ª–∞—Å—Å–Ω—ã—Ö –ø—Ä–∏–∑–æ–≤ ‚Äî —É—á–∞—Å—Ç–≤—É–π—Ç–µ –¥–æ 22 –¥–µ–∫–∞–±—Ä—è –≤ @DENIS_Pharm! –†–µ–∫–ª–∞–º–∞, –û–û–û ¬´–î–≠–ù–ò–° –§–∞—Ä–º –ü—Ä–æ–º–æ—É—à–Ω¬ª","{""skip"": true}"
2025-12-04T07:56:02+00:00,@medpharm,13859,https://t.me/medpharm/13859,"–¶–µ–Ω—Ç—Ä –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –ø—Ä–∏–Ω–∏–º–∞–µ—Ç –∑–∞—è–≤–∫–∏ –Ω–∞ —É—á–∞—Å—Ç–∏–µ –≤ 16 –∞—É–∫—Ü–∏–æ–Ω–∞—Ö –Ω–∞ –ø–æ—Å—Ç–∞–≤–∫—É –ø–æ –ø—Ä–æ–≥—Ä–∞–º–º–µ –í–ó–ù 11 –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ù–∞ –∑–∞–∫—É–ø–∫—É —Å—Ä–µ–¥—Å—Ç–≤–∞ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –º–Ω–æ–∂–µ—Å—Ç–≤–µ–Ω–Ω–æ–π –º–∏–µ–ª–æ–º—ã –≤—ã–¥–µ–ª–µ–Ω–æ 13,8 –º–ª—Ä–¥ —Ä—É–±. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QfRNv #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{""skip"": true}"
2025-12-03T16:31:37+00:00,@medpharm,13858,https://t.me/medpharm/13858,"ü¶æ –¢—Ä–∏ –∫–∏—Ç–∞. Forbes –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª —Ä–µ–π—Ç–∏–Ω–≥ –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö —á–∞—Å—Ç–Ω—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∫–æ–º–ø–∞–Ω–∏–π. –ö—Ç–æ –≤–æ—à–µ–ª –≤ —Ç—Ä–æ–π–∫—É –ª–∏–¥–µ—Ä–æ–≤? ü¶æ –ù–µ —É—Å—Ç–æ—è–ª. –ü–æ–¥ —Å—Ç—Ä–∞–∂—É –≤ –ù–æ–≤–æ—Å–∏–±–∏—Ä—Å–∫–µ –≤–∑—è–ª–∏ —Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—è –∏–∑ –ö–µ–º–µ—Ä–æ–≤–∞. –í–∑—è—Ç–∫–∞ —Å–≤—è–∑–∞–Ω–∞ —Å –¥–µ–ª–∞–º–∏ –æ –∫–æ—Ä—Ä—É–ø—Ü–∏–∏ –≤ –º–µ–¥–∏—Ü–∏–Ω–µ –ö—É–∑–±–∞—Å—Å–∞. ‚ù§Ô∏è –ß—É–∂–∏–º–∏ —Ä—É–∫–∞–º–∏. –ö–∞–∫ –Ω–µ –ø–æ—Ç–µ—Ä—è—Ç—å –¥–µ–Ω—å–≥–∏ –Ω–∞ –∫–æ–Ω—Ç—Ä–∞–∫—Ç–Ω–æ–º –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ. ¬´–§–í¬ª —Ä–∞–∑–æ–±—Ä–∞–ª –∫–µ–π—Å –º–Ω–æ–≥–æ–ª–µ—Ç–Ω–µ–≥–æ —Å–ø–æ—Ä–∞, –∞ —Ç–∞–∫–∂–µ –ø–æ–¥–≥–æ—Ç–æ–≤–∏–ª —Å–æ–≤–µ—Ç—ã —é—Ä–∏—Å—Ç–æ–≤, –∫–∞–∫ –∑–∞—â–∏—Ç–∏—Ç—å—Å—è –≤ –¥–æ–≥–æ–≤–æ—Ä–µ –ø–æ–¥—Ä—è–¥–∞. ‚ù§Ô∏è –î–æ–±–∏–ª–∏—Å—å —Å–≤–æ–µ–≥–æ. –ê—Ä–±–∏—Ç—Ä–∞–∂–Ω—ã–π —Å—É–¥ –ú–æ—Å–∫–≤—ã –ø–µ—Ä–µ—Å–º–æ—Ç—Ä–µ–ª —Ä–µ—à–µ–Ω–∏–µ –æ —à—Ç—Ä–∞—Ñ–µ –∑–∞ –≤—ã–ø—É—Å–∫ –¥–∂–µ–Ω–µ—Ä–∏–∫–∞ —Ä—É–∫—Å–æ–ª–∏—Ç–∏–Ω–∏–±–∞. ¬´–ê–∫—Å–µ–ª—å–§–∞—Ä–º¬ª —Ç–∞–∫–∂–µ –≤—ã–∏–≥—Ä–∞–ª –¥–µ–ª–æ –ø–æ –¥—Ä—É–≥–æ–º—É —Å–ø–æ—Ä–Ω–æ–º—É –ø—Ä–µ–ø–∞—Ä–∞—Ç—É.","{""skip"": true}"
2025-12-03T15:54:04+00:00,@medpharm,13857,https://t.me/medpharm/13857,–ú–∏—Ä–æ–≤—ã–µ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∏ —Ñ–∏–Ω–∞–Ω—Å–æ–≤—ã–µ –æ—Ç—á–µ—Ç—ã –∑–∞ III –∫–≤–∞—Ä—Ç–∞–ª 2025 –≥–æ–¥–∞. –ü–æ–¥—Ç–≤–µ—Ä–¥–∏–ª—Å—è –∫–ª—é—á–µ–≤–æ–π —Ç—Ä–µ–Ω–¥ —ç—Ç–æ–≥–æ –≥–æ–¥–∞: —Ä—ã–Ω–∫–æ–º –¥–≤–∏–∂—É—Ç –∏–Ω–Ω–æ–≤–∞—Ü–∏–∏ –≤ –ª–µ—á–µ–Ω–∏–∏ –¥–∏–∞–±–µ—Ç–∞ –∏ –æ–∂–∏—Ä–µ–Ω–∏—è. ¬´–§–í¬ª –ø–æ–¥–≥–æ—Ç–æ–≤–∏–ª –æ–±–∑–æ—Ä —Ñ–∏–Ω–∞–Ω—Å–æ–≤—ã—Ö —Ä–µ–∑—É–ª—å—Ç–∞—Ç–æ–≤ –∫–æ–º–ø–∞–Ω–∏–π —Å –∏—é–ª—è –ø–æ —Å–µ–Ω—Ç—è–±—Ä—å. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qetqy #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-12-03T15:29:03+00:00,@medpharm,13856,https://t.me/medpharm/13856,"–°–æ–≤–µ—Ç –ï–≠–ö —É—Ç–≤–µ—Ä–¥–∏–ª –∏–∑–º–µ–Ω–µ–Ω–∏—è –ø—Ä–∞–≤–∏–ª —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ —Å—Ç—Ä–∞–Ω–∞—Ö –ï–ê–≠–°. –ü–æ –º–Ω–µ–Ω–∏—é —ç–∫—Å–ø–µ—Ä—Ç–æ–≤, —ç—Ç–æ –≤–∞–∂–Ω—ã–π —à–∞–≥ –∫ —Å–æ–∑–¥–∞–Ω–∏—é –¥–æ–≤–µ—Ä–∏—è –∫ –Ω–∞–¥–Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–π —Å–∏—Å—Ç–µ–º–µ —Ä–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∏, –≥–¥–µ —Å–ª–µ–¥—É—é—â–∏–º —ç—Ç–∞–ø–æ–º –º–æ–≥–ª–æ –±—ã —Å—Ç–∞—Ç—å —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏–µ –∞–Ω–∞–ª–æ–≥–∞ –µ–≤—Ä–æ–ø–µ–π—Å–∫–æ–≥–æ EMA. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QesbM #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""registration, regulation"",
  ""impact"": ""high"",
  ""english"": ""The Council of EAEU has approved changes to the rules for drug registration in member countries. Experts believe this is an important step towards building trust in a cross-border regulatory system, which could next include the formation of an equivalent to the European EMA.""
}"
2025-12-03T15:19:05+00:00,@medpharm,13855,https://t.me/medpharm/13855,–ù–æ–≤—ã–π –≥–ª–∞–≤–∞ CDER FDA –ø–æ–¥–∞–ª –∑–∞—è–≤–ª–µ–Ω–∏–µ –æ–± –æ—Ç—Å—Ç–∞–≤–∫–µ –∏ —É–π–¥–µ—Ç –≤ –¥–µ–∫–∞–±—Ä–µ 2025 –≥–æ–¥–∞. –†–µ—à–µ–Ω–∏–µ —Å–≤—è–∑–∞–Ω–æ —Å —Ä–∞–∑–Ω–æ–≥–ª–∞—Å–∏—è–º–∏ –ø–æ –ø–æ–≤–æ–¥—É —É—Å–∫–æ—Ä–µ–Ω–Ω–æ–≥–æ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qes7h #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-12-03T15:04:02+00:00,@medpharm,13854,https://t.me/medpharm/13854,"–ê—Ä–±–∏—Ç—Ä–∞–∂–Ω—ã–π —Å—É–¥ –ú–æ—Å–∫–≤—ã –≤—ã–Ω–µ—Å –æ—á–µ—Ä–µ–¥–Ω–æ–µ —Ä–µ—à–µ–Ω–∏–µ –ø–æ–¥ –¥–≤—É–º —Å–ø–æ—Ä–Ω—ã–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º, –∫–æ—Ç–æ—Ä—ã–µ –≤—ã–ø—É—Å–∫–∞–µ—Ç ¬´–ê–∫—Å–µ–ª—å–§–∞—Ä–º¬ª. –†–µ—á—å –∏–¥–µ—Ç –æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞—Ö —Ä—É–∫—Å–æ–ª–∏—Ç–∏–Ω–∏–± –∏ –æ—Å–∏–º–µ—Ä—Ç–∏–Ω–∏–±. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QerC2 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""high"",
  ""english"": ""An arbitrage court in Moscow has issued a decision regarding two disputed drugs produced by 'AkselFarma'. The drugs are osimertinib and ravosertib. More details: https://clck.ru/3QerC2 #Pharmawatch #Production""
}"
2025-12-03T14:45:07+00:00,@medpharm,13853,https://t.me/medpharm/13853,–î–µ–ø—É—Ç–∞—Ç—ã –æ—Ç–∫–ª–æ–Ω–∏–ª–∏ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ —Ä–∞—Å—à–∏—Ä–µ–Ω–∏–∏ –ø–æ–ª–Ω–æ–º–æ—á–∏–π —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤ —Å–∫–æ—Ä–æ–π –ø–æ–º–æ—â–∏. –î–æ–∫—É–º–µ–Ω—Ç –ø—Ä–µ–¥—É—Å–º–∞—Ç—Ä–∏–≤–∞–ª –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –ø–æ–ª—É—á–µ–Ω–∏—è —Å–æ–¥–µ–π—Å—Ç–≤–∏—è —Ç—Ä–µ—Ç—å–∏—Ö –ª–∏—Ü –≤ —á—Ä–µ–∑–≤—ã—á–∞–π–Ω—ã—Ö –∏ –∫–æ–Ω—Ñ–ª–∏–∫—Ç–Ω—ã—Ö —Å–∏—Ç—É–∞—Ü–∏—è—Ö –∏ –∏—Ö –ø—Ä–∏–≤–ª–µ—á–µ–Ω–∏–µ –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π —ç–≤–∞–∫—É–∞—Ü–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QepxZ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è #–°–∫–æ—Ä–∞—è_–º–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è_–ø–æ–º–æ—â—å,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety"",
  ""impact"": ""medium"",
  ""english"": ""The deputies rejected a law project that expanded the powers of emergency medical personnel to receive assistance from third parties in emergencies and for medical evacuation. More details: https://clck.ru/3QepxZ #MedVestnik #Healthcare #Public_Healthcare #Emergency_Medical_Services""
}"
2025-12-03T14:15:28+00:00,@medpharm,13852,https://t.me/medpharm/13852,–° 2006 –≥–æ–¥–∞ –±–ª–∞–≥–æ—Ç–≤–æ—Ä–∏—Ç–µ–ª—å–Ω—ã–π —Ñ–æ–Ω–¥ ¬´–ü—Ä–æ—Ç–µ–∫¬ª –æ–∫–∞–∑—ã–≤–∞–µ—Ç –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—É—é –ø–æ–º–æ—â—å –±–æ–ª—å–Ω–∏—Ü–∞–º –∏ —Å–æ—Ü–∏–∞–ª—å–Ω—ã–º —É—á—Ä–µ–∂–¥–µ–Ω–∏—è–º –ø–æ –≤—Å–µ–π –†–æ—Å—Å–∏–∏. –†–∞–±–æ—Ç–∞ —Ñ–æ–Ω–¥–∞ –æ—Ç–º–µ—á–µ–Ω–∞ –±–ª–∞–≥–æ–¥–∞—Ä–Ω–æ—Å—Ç—å—é –ü—Ä–µ–∑–∏–¥–µ–Ω—Ç–∞ –†–§ –∏ –Ω–∞–≥—Ä–∞–¥–æ–π –∫–æ–Ω–∫—É—Ä—Å–∞ ¬´–õ–∏–¥–µ—Ä—ã –∫–æ—Ä–ø–æ—Ä–∞—Ç–∏–≤–Ω–æ–π –±–ª–∞–≥–æ—Ç–≤–æ—Ä–∏—Ç–µ–ª—å–Ω–æ—Å—Ç–∏¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ –≤ –≤–∏–¥–µ–æ: https://clck.ru/3QdWWK,"{""skip"": true}"
2025-12-03T13:55:03+00:00,@medpharm,13851,https://t.me/medpharm/13851,"–≠–∫—Å–ø–µ—Ä—Ç—ã –æ—Ü–µ–Ω–∏–ª–∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –≤–∞–∫—Ü–∏–Ω–æ–ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –≤ –†–æ—Å—Å–∏–∏. –ë–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ –æ–¥–æ–±—Ä–∏–ª–æ —Å—Ç—Ä–∞—Ç–µ–≥–∏—é —Ä–∞–∑–≤–∏—Ç–∏—è —ç—Ç–æ–≥–æ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è, –Ω–æ 70% –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö —Å—á–∏—Ç–∞—é—Ç –Ω–µ—ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ–π –µ–µ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏—é. –§–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏–µ –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–π –ø–æ –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏–∏ –Ω–µ –Ω–∞ –≤—ã—Å–æ—Ç–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QenPc #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–ò–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã–µ_–±–æ–ª–µ–∑–Ω–∏ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""Experts evaluated the effectiveness of vaccination prevention in Russia. Most approved the strategy development, but 70% consider its implementation ineffective. Funding for vaccination activities is insufficient. For more details: https://clck.ru/3QenPc #MedVestnik #Healthcare #InfectiousDiseases""
}"
2025-12-03T13:08:06+00:00,@medpharm,13850,https://t.me/medpharm/13850,–ü–µ—Ä–≤—ã–µ –¥–≤–∞ –º–µ—Å—Ç–∞ –≤ —Ä–µ–π—Ç–∏–Ω–≥–µ Forbes —Å—Ä–µ–¥–∏ –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö —á–∞—Å—Ç–Ω—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∫–æ–º–ø–∞–Ω–∏–π –∑–∞–Ω—è–ª–∏ ¬´–ú–µ–¥—Å–∏¬ª –∏ ¬´–ú–∞—Ç—å –∏ –¥–∏—Ç—è¬ª. ¬´–ú–µ–¥—Å–∫–∞–Ω¬ª –≤–ø–µ—Ä–≤—ã–µ –≤–æ—à–µ–ª –≤ —Ç—Ä–æ–π–∫—É –ª–∏–¥–µ—Ä–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QeiBa #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-12-03T12:17:03+00:00,@medpharm,13849,https://t.me/medpharm/13849,–í –î–µ–ø–∞—Ä—Ç–∞–º–µ–Ω—Ç–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ú–æ—Å–∫–≤—ã –æ—á–µ—Ä–µ–¥–Ω—ã–µ –∫–∞–¥—Ä–æ–≤—ã–µ –ø–µ—Ä–µ—Å—Ç–∞–Ω–æ–≤–∫–∏ ‚Äî –≤–º–µ—Å—Ç–æ –≠–ª–ª—ã –ü–æ–ø–æ–≤–æ–π –Ω–∞ –¥–æ–ª–∂–Ω–æ—Å—Ç—å –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—è —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—è –Ω–∞–∑–Ω–∞—á–µ–Ω–∞ –ï–ª–µ–Ω–∞ –†–∞–∫–æ–≤–∞. –í –≤–µ–¥–æ–º—Å—Ç–≤–µ –æ–Ω–∞ –±—É–¥–µ—Ç –æ—Ç–≤–µ—á–∞—Ç—å –∑–∞ –±—É—Ö–≥–∞–ª—Ç–µ—Ä—Å–∫—É—é –æ—Ç—á–µ—Ç–Ω–æ—Å—Ç—å –∏ —Ñ–∏–Ω–∞–Ω—Å–æ–≤—ã–µ –≤–æ–ø—Ä–æ—Å—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QeeZA #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-12-03T12:13:01+00:00,@medpharm,13848,https://t.me/medpharm/13848,"–ò–Ω—Ç–µ–ª–ª–µ–∫—Ç—É–∞–ª—å–Ω–æ–µ —Ä–∞–∑–¥–µ–ª–µ–Ω–∏–µ. –ö–∞–∫ –ø—Ä–∏—Ö–æ–¥ –Ω–µ–π—Ä–æ—Å–µ—Ç–µ–π –∏–∑–º–µ–Ω–∏–ª —Ä–∞–∑—Ä–∞–±–æ—Ç–∫—É –∏ –≤—ã–ø—É—Å–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –§–∞—Ä–º–∏–Ω–¥—É—Å—Ç—Ä–∏—è –ø–µ—Ä–µ–∂–∏–≤–∞–µ—Ç –±—É—Ä–Ω—É—é —Ç—Ä–∞–Ω—Å—Ñ–æ—Ä–º–∞—Ü–∏—é –≤–æ –º–Ω–æ–≥–æ–º –±–ª–∞–≥–æ–¥–∞—Ä—è –≤–Ω–µ–¥—Ä–µ–Ω–∏—é –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–∞. –ö—Ä—É–ø–Ω–µ–π—à–∏–µ –∏–≥—Ä–æ–∫–∏ —Ä—ã–Ω–∫–∞ –∏–Ω–≤–µ—Å—Ç–∏—Ä—É—é—Ç –º–∏–ª–ª–∏–∞—Ä–¥—ã –¥–æ–ª–ª–∞—Ä–æ–≤ –≤ –Ω–µ–π—Ä–æ—Å–µ—Ç–∏, —á—Ç–æ –ø–æ–∑–≤–æ–ª—è–µ—Ç —Å–æ–∫—Ä–∞—â–∞—Ç—å —Å—Ä–æ–∫–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤, —Å–Ω–∏–∂–∞—Ç—å –∑–∞—Ç—Ä–∞—Ç—ã –∏ –ø–æ–≤—ã—à–∞—Ç—å —Ç–æ—á–Ω–æ—Å—Ç—å –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π. –ò–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–µ –ø–æ–¥—Ö–æ–¥—ã —É–∂–µ –ø—Ä–∏–≤–µ–ª–∏ –∫ –ø–æ—è–≤–ª–µ–Ω–∏—é –ø–µ—Ä–≤—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –ø–æ–ª–Ω–æ—Å—Ç—å—é —Å–æ–∑–¥–∞–Ω–Ω—ã—Ö —Å –ø–æ–º–æ—â—å—é –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–∞, –∏ —É–≤–µ–ª–∏—á–∏–ª–∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å–ø—ã—Ç–∞–Ω–∏–π. –û–¥–Ω–∞–∫–æ —ç–∫—Å–ø–µ—Ä—Ç—ã –æ—Ç–º–µ—á–∞—é—Ç, —á—Ç–æ –∏—Å—Ç–∏–Ω–Ω—ã–π –ø—Ä–æ—Ä—ã–≤ –≤–æ–∑–º–æ–∂–µ–Ω –ª–∏—à—å –ø—Ä–∏ —Å–æ—á–µ—Ç–∞–Ω–∏–∏ –Ω–æ–≤—ã—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π —Å –∫–ª–∞—Å—Å–∏—á–µ—Å–∫–∏–º–∏ –º–µ—Ç–æ–¥–∞–º–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏. –°–≤–µ–∂–∏–π –Ω–æ–º–µ—Ä ¬´–§–í¬ª ‚Ññ26-27 (1185-1186) —É–∂–µ –¥–æ—Å—Ç—É–ø–µ–Ω –æ–Ω–ª–∞–π–Ω –±–µ—Å–ø–ª–∞—Ç–Ω–æ –¥–ª—è –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª–µ–π.","{""skip"": true}"
2025-12-03T11:55:02+00:00,@medpharm,13847,https://t.me/medpharm/13847,"–ì–µ–ø–∞—Ç–æ–ø—Ä–æ—Ç–µ–∫—Ç–æ—Ä—ã —è–≤–ª—è—é—Ç—Å—è –æ–¥–Ω–æ–π –∏–∑ –Ω–∞–∏–±–æ–ª–µ–µ –¥–∏—Å–∫—É—Ç–∞–±–µ–ª—å–Ω—ã—Ö –∏ –Ω–µ–æ–¥–Ω–æ–∑–Ω–∞—á–Ω—ã—Ö –≥—Ä—É–ø–ø –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –û–¥–Ω–∏ –≤—Ä–∞—á–∏ –≤–µ—Ä—è—Ç –≤ –∏—Ö —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å, –¥—Ä—É–≥–∏–µ —Å—á–∏—Ç–∞—é—Ç –∏—Ö –ø—É—Å—Ç—ã—à–∫–∞–º–∏. –ì–¥–µ –Ω–∞—Ö–æ–¥–∏—Ç—Å—è –∏—Å—Ç–∏–Ω–∞ –∏ —á—Ç–æ –æ—Ç–≤–µ—á–∞—Ç—å –ø–æ–∫—É–ø–∞—Ç–µ–ª—è–º, –∫–æ—Ç–æ—Ä—ã–µ –ø—Ä–æ—Å—è—Ç –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è –≤–æ—Å—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è –ø–µ—á–µ–Ω–∏? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qeco6 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–µ–ø–∞—Ä–∞—Ç—ã/–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety"",
  ""impact"": ""medium"",
  ""english"": ""The hepatoprotectors are one of the most controversial and ambiguous groups of drugs. Some doctors believe in their effectiveness, while others consider them ineffective. Where is the truth and what to answer to customers who request a drug for liver restoration? For more information: https://clck.ru/3Qeco6 #FarmaVestnik #Pharmaceuticals/Farmacology""
}"
2025-12-03T11:15:04+00:00,@medpharm,13846,https://t.me/medpharm/13846,"–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§ –∏ –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ –†–§ —É—Ç–≤–µ—Ä–¥–∏–ª–∏ —Ç—Ä–∏ –¥–æ–∫—É–º–µ–Ω—Ç–∞ –ø–æ –æ–±–æ—Ä–æ—Ç—É –º–µ—Ç–∞–Ω–æ–ª–∞. –ß–∏—Ç–∞–π—Ç–µ, –∫–∞–∫ —Ç–µ–ø–µ—Ä—å –Ω—É–∂–Ω–æ –º–∞—Ä–∫–∏—Ä–æ–≤–∞—Ç—å —Ç–∞—Ä—É, —Ö—Ä–∞–Ω–∏—Ç—å –∏ —É–Ω–∏—á—Ç–æ–∂–∞—Ç—å –æ–ø–∞—Å–Ω—ã–µ –∂–∏–¥–∫–æ—Å—Ç–∏ –∏ –∫—Ç–æ –∏–º–µ–µ—Ç –ø—Ä–∞–≤–æ —ç—Ç–∏–º –∑–∞–Ω–∏–º–∞—Ç—å—Å—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QeZwp #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{""skip"": true}"
2025-12-03T10:29:03+00:00,@medpharm,13845,https://t.me/medpharm/13845,–≠–∫—Å–ø–µ—Ä—Ç—ã –í–û–ó –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∏ –Ω–æ–≤—ã–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø–æ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–µ –∏ –ª–µ—á–µ–Ω–∏—é –±–µ—Å–ø–ª–æ–¥–∏—è. –î–æ–∫—É–º–µ–Ω—Ç –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω –Ω–∞ –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω–æ–º —Å–∞–π—Ç–µ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QeWdc #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ê–∫—É—à–µ—Ä—Å—Ç–≤–æ_–∏_–≥–∏–Ω–µ–∫–æ–ª–æ–≥–∏—è #–î–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞ #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è #–£—Ä–æ–ª–æ–≥–∏—è_–∏_–∞–Ω–¥—Ä–æ–ª–æ–≥–∏—è,"{""skip"": true}"
2025-12-03T10:21:03+00:00,@medpharm,13844,https://t.me/medpharm/13844,"–°–µ–∑–æ–Ω –∞–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –ø—Ä–æ—Å—Ç—É–¥–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –ø—Ä–∏–±–ª–∏–∂–∞–µ—Ç—Å—è –∫ —Å–≤–æ–µ–º—É –ø–∏–∫—É. –≠—Ç–æ —Å–∞–º–∞—è –≥–æ—Ä—è—á–∞—è –ø–æ—Ä–∞ –¥–ª—è –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è —É—Å—Ç—Ä–∞–Ω–µ–Ω–∏—è —Å–∏–º–ø—Ç–æ–º–æ–≤ –ø—Ä–æ—Å—Ç—É–¥—ã, –∞ —Ç–∞–∫–∂–µ –ª–µ–∫–∞—Ä—Å—Ç–≤ –æ—Ç –∫–∞—à–ª—è, –±–æ–ª–∏ –≤ –≥–æ—Ä–ª–µ –∏ –Ω–∞—Å–º–æ—Ä–∫–∞. ¬´–§–í¬ª –∏–∑—É—á–∏–ª —Ç–µ–Ω–¥–µ–Ω—Ü–∏–∏ –Ω–∞ —Ä—ã–Ω–∫–µ –ø—Ä–æ—Ç–∏–≤–æ–ø—Ä–æ—Å—Ç—É–¥–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QeVy9 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ–Ω–¥–µ–Ω—Ü–∏–∏","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""A surge in seasonal flu activity is approaching its peak. This is the most critical period for manufacturers of drugs to treat flu symptoms, cough remedies, throat pain, and nasal congestion. 'FV' has examined market trends for flu medications. For more details: https://clck.ru/3QeVy9 #FVNews #MarketTrends""
}"
2025-12-03T09:45:04+00:00,@medpharm,13843,https://t.me/medpharm/13843,–í–ø–µ—Ä–≤—ã–µ –ø—Ä–æ—à–ª–∞ —Ü–µ—Ä–µ–º–æ–Ω–∏—è –≤—Ä—É—á–µ–Ω–∏–π –ø—Ä–µ–º–∏–π –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –†–§ –≤ –æ–±–ª–∞—Å—Ç–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –Ω–∞—É–∫–∏. –¢—Ä–∏ –∫–æ–ª–ª–µ–∫—Ç–∏–≤–∞ –ø–æ–ª—É—á–∏–ª–∏ –Ω–∞–≥—Ä–∞–¥—ã –≤ —Ä–∞–∑–º–µ—Ä–µ 1 –º–ª–Ω —Ä—É–±. –∑–∞ —Å–≤–æ–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QeSxU #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-12-03T09:13:02+00:00,@medpharm,13842,https://t.me/medpharm/13842,–°–®–ê –æ—Ç–º–µ–Ω–∏–ª–∏ –ø–æ—à–ª–∏–Ω—ã –Ω–∞ –±—Ä–∏—Ç–∞–Ω—Å–∫–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –≤ –æ–±–º–µ–Ω –Ω–∞ —É—Å—Ç—É–ø–∫–∏ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—è–º. –í–µ–ª–∏–∫–æ–±—Ä–∏—Ç–∞–Ω–∏—è –ø–æ–≤—ã—Å–∏—Ç –ø–æ—Ä–æ–≥ –æ–ø–ª–∞—Ç—ã –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è NHS. –ü–æ–¥—Ä–æ–±–Ω–æ—Å—Ç–∏ —É–Ω–∏–∫–∞–ª—å–Ω–æ–π —Å–¥–µ–ª–∫–∏ –∏ –µ–µ –ø–æ—Å–ª–µ–¥—Å—Ç–≤–∏—è –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –∏ —Ä—ã–Ω–∫–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QeQVQ #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-12-03T08:35:04+00:00,@medpharm,13841,https://t.me/medpharm/13841,"–†–æ—Å—Å–∏–π—Å–∫–∏–π —Ü–µ–Ω—Ç—Ä –Ω–µ–≤—Ä–æ–ª–æ–≥–∏–∏ –∏ –Ω–µ–π—Ä–æ–Ω–∞—É–∫ –≤ —ç—Ç–æ–º –≥–æ–¥—É –æ—Ç–º–µ—á–∞–µ—Ç 80-–ª–µ—Ç–∏–µ. –ü—Ä–µ–∑–∏–¥–µ–Ω—Ç –†–§ –í–ª–∞–¥–∏–º–∏—Ä –ü—É—Ç–∏–Ω –æ—Ç–º–µ—Ç–∏–ª —Å—Ç—Ä–µ–º–ª–µ–Ω–∏–µ –∫–æ–ª–ª–µ–∫—Ç–∏–≤–∞ —É—á—Ä–µ–∂–¥–µ–Ω–∏—è —Å–æ—Ö—Ä–∞–Ω—è—Ç—å –≤—ã—Å–æ–∫—É—é –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—É—é –ø–ª–∞–Ω–∫—É, –∞ —Ç–∞–∫–∂–µ –Ω–æ–≤–∞—Ç–æ—Ä—Å–∫–æ–µ –æ—Ç–Ω–æ—à–µ–Ω–∏–µ –∫ —Ä–µ—à–µ–Ω–∏—é –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω—ã—Ö –∑–∞–¥–∞—á. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QeMeK #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ù–∞—É–∫–∞ #–ù–µ–≤—Ä–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-12-03T08:17:02+00:00,@medpharm,13840,https://t.me/medpharm/13840,"–°–ø–æ—Ä –º–µ–∂–¥—É –∫–æ–Ω—Ç—Ä–∞–∫—Ç–Ω–æ–π –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω–æ–π –ø–ª–æ—â–∞–¥–∫–æ–π –∏ –∑–∞–∫–∞–∑—á–∏–∫–æ–º –Ω–∞ —Å—É–º–º—É —Å–≤—ã—à–µ 50 –º–ª–Ω —Ä—É–±., –Ω–∞—á–∞–≤—à–∏–π—Å—è –≤ 2019 –≥–æ–¥—É, –ø–æ–ª—É—á–∏–ª –Ω–æ–≤–æ–µ –ø—Ä–æ–¥–æ–ª–∂–µ–Ω–∏–µ. –û–±–≤–∏–Ω–µ–Ω–Ω—ã–π –≤ –≤—ã–ø—É—Å–∫–µ –ø–∞—Ä—Ç–∏–∏ –∫–æ–Ω—Ç—Ä–∞—Ñ–∞–∫—Ç–Ω–æ–≥–æ ¬´–ú–µ–ª–æ–∫—Å–∏–∫–∞–º–∞¬ª –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å –æ–±—Ä–∞—Ç–∏–ª—Å—è –≤ —Å—É–¥ —Å —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–µ–º –≤–∑—ã—Å–∫–∞—Ç—å –ø–æ–Ω–µ—Å–µ–Ω–Ω—ã–µ —É–±—ã—Ç–∫–∏ —Å–æ —Å–≤–æ–µ–≥–æ –±—ã–≤—à–µ–≥–æ —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—è. –ß–∏—Ç–∞–π—Ç–µ –≤ ¬´–§–í¬ª –ø–æ–¥—Ä–æ–±–Ω–æ—Å—Ç–∏ –º–Ω–æ–≥–æ–ª–µ—Ç–Ω–µ–≥–æ —Å–ø–æ—Ä–∞ –∏ —Å–æ–≤–µ—Ç—ã —é—Ä–∏—Å—Ç–æ–≤, –∫–∞–∫ –∑–∞—â–∏—Ç–∏—Ç—å—Å—è –≤ –¥–æ–≥–æ–≤–æ—Ä–µ –ø–æ–¥—Ä—è–¥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QeLMW #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""A dispute between a contract production facility and its customer, amounting to over 50 million rubles, has been renewed. The producer accused of producing counterfeit 'Meloxicam' is now suing its former manager for compensation of losses. Read more about a long-standing dispute and legal advice on how to protect yourself in a subcontracting contract from 'FV' website.""
}"
2025-12-03T07:51:09+00:00,@medpharm,13839,https://t.me/medpharm/13839,–ü–æ–¥ —Å—Ç—Ä–∞–∂—É –≤ –ù–æ–≤–æ—Å–∏–±–∏—Ä—Å–∫–µ –≤–∑—è–ª–∏ —Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—è –ø–æ –¥–µ–ª—É –æ –∫–æ—Ä—Ä—É–ø—Ü–∏–∏ –∏–∑ –ö–µ–º–µ—Ä–æ–≤–æ. –í–∑—è—Ç–∫–∞ —Å–≤—è–∑–∞–Ω–∞ —Å –¥–µ–ª–∞–º–∏ –∫–æ—Ä—Ä—É–ø—Ü–∏–∏ –≤ –º–µ–¥–∏—Ü–∏–Ω–µ –ö—É–∑–±–∞—Å—Å–∞.‚Äã –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QeJKz #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, clinical_trial, safety"",
  ""impact"": ""high"",
  ""english"": ""A prosecutor from Kemerovo has been taken into custody in Novosibirsk for corruption cases related to medical affairs in Kuzbass. The case involves a bribe.""
}"
2025-12-03T06:52:04+00:00,@medpharm,13838,https://t.me/medpharm/13838,"–ö–æ–ª–∏—á–µ—Å—Ç–≤–æ –Ω–µ–¥–æ–≤–æ–ª—å–Ω—ã—Ö –º–µ–¥–∏—Ü–∏–Ω–æ–π —Ä–æ—Å—Å–∏—è–Ω —Å–Ω–∏–∂–∞–µ—Ç—Å—è —Å 2006 –≥–æ–¥–∞. –û–ø—Ä–æ—Å –í–¶–ò–û–ú –ø–æ–∫–∞–∑–∞–ª, –∂–∏—Ç–µ–ª–∏ –∫–∞–∫–∏—Ö –≥–æ—Ä–æ–¥–æ–≤ –±–æ–ª—å—à–µ –≤—Å–µ—Ö —É–¥–æ–≤–ª–µ—Ç–≤–æ—Ä–µ–Ω—ã —Ä–∞–±–æ—Ç–æ–π —Å–∏—Å—Ç–µ–º—ã –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QeEPQ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-12-03T06:06:03+00:00,@medpharm,13837,https://t.me/medpharm/13837,"–£—á–µ–Ω—ã–µ –∏–∑ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–æ–π –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–æ–π –≥—Ä—É–ø–ø—ã –æ—Ü–µ–Ω–∏–ª–∏ –≤–ª–∏—è–Ω–∏–µ –∏–Ω–≥–∏–±–∏—Ç–æ—Ä–æ–≤ –ø—Ä–æ—Ç–æ–Ω–Ω–æ–π –ø–æ–º–ø—ã, –∞–∫—Ç–∏–≤–∏—Ä—É—é—â–∏—Ö –∞–ª—å–¥–µ–≥–∏–¥–¥–µ–≥–∏–¥—Ä–æ–≥–µ–Ω–∞–∑—É 1 –ê1 (ALDH1A1), –Ω–∞ –∏—Å—Ö–æ–¥—ã –ª–µ—á–µ–Ω–∏—è —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –≤–ø–µ—Ä–≤—ã–µ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏—Ä–æ–≤–∞–Ω–Ω–æ–π –≥–ª–∏–æ–±–ª–∞—Å—Ç–æ–º–æ–π. –†–µ–∑—É–ª—å—Ç–∞—Ç—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω—ã –≤ –∂—É—Ä–Ω–∞–ª–µ JAMA. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QeBQu #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ì–∞—Å—Ç—Ä–æ—ç–Ω—Ç–µ—Ä–æ–ª–æ–≥–∏—è #–û–Ω–∫–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-12-02T16:51:22+00:00,@medpharm,13836,https://t.me/medpharm/13836,"ü¶æ –ù–∞ —á–∏—Å—Ç—É—é –≤–æ–¥—É. –í –†–æ—Å—Å–∏–∏ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –æ–±—è–∑–∞—Ç—å —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª–µ–π –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –ø—Ä–æ–≤–µ—Ä—è—Ç—å –ø–æ–¥–ª–∏–Ω–Ω–æ—Å—Ç—å –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤ –∏ –æ—Ç–∫—Ä—ã—Ç—å –¥–æ—Å—Ç—É–ø –≥—Ä–∞–∂–¥–∞–Ω–∞–º –∫ –§–µ–¥–µ—Ä–∞–ª—å–Ω–æ–º—É —Ä–µ–≥–∏—Å—Ç—Ä—É –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ (–§–†–ú–†). –°–µ–π—á–∞—Å –ø—Ä–æ–≤–µ—Ä–∫–∏ –∫–≤–∞–ª–∏—Ñ–∏–∫–∞—Ü–∏–∏ –≤—Ä–∞—á–µ–π —á–∞—Å—Ç–æ —Ñ–æ—Ä–º–∞–ª—å–Ω—ã–µ, —á—Ç–æ —Å–æ–∑–¥–∞–µ—Ç —Ä–∏—Å–∫–∏ –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. ü¶æ –î–µ—Ä–∂–∏—Å—å, —à–æ—Ñ–µ—Ä! –í –†–æ—Å—Å–∏–∏ –ø–ª–∞–Ω–∏—Ä—É—é—Ç —É–∂–µ—Å—Ç–æ—á–∏—Ç—å –∫–æ–Ω—Ç—Ä–æ–ª—å –∑–∞ –∑–¥–æ—Ä–æ–≤—å–µ–º –≤–æ–¥–∏—Ç–µ–ª–µ–π, –∏–∑–º–µ–Ω–∏–≤ –ø—Ä–∞–≤–∏–ª–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Å–≤–∏–¥–µ—Ç–µ–ª—å—Å—Ç–≤–æ–≤–∞–Ω–∏–π —Å 1 –º–∞—Ä—Ç–∞ 2027 –≥–æ–¥–∞. –ú–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –∑–∞–∫–ª—é—á–µ–Ω–∏—è –±—É–¥—É—Ç –æ—Ñ–æ—Ä–º–ª—è—Ç—å—Å—è —Å –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–º –æ–±–º–µ–Ω–æ–º –¥–∞–Ω–Ω—ã–º–∏ –º–µ–∂–¥—É –ú–∏–Ω–∑–¥—Ä–∞–≤–æ–º –†–§ –∏ –ú–í–î –†–§. ‚ù§Ô∏è –¢–æ–ª—å–∫–æ –¢–°. –ê–ø—Ç–µ–∫–∏ –Ω–µ —É—Å–ø–µ—é—Ç –≤–Ω–µ–¥—Ä–∏—Ç—å –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–µ –º–æ–¥—É–ª–∏ –¢–° –ü–ò–æ–¢. –ï—Å–ª–∏ —Å—Ä–æ–∫–∏ –Ω–µ –±—É–¥—É—Ç –ø–µ—Ä–µ–Ω–µ—Å–µ–Ω—ã, –æ—Ç–ø—É—Å–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –Ω–∞—á–∞–ª–µ —è–Ω–≤–∞—Ä—è –º–æ–∂–µ—Ç –±—ã—Ç—å –æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω. –ü–æ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ ¬´–§–í¬ª, –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ –†–æ—Å—Å–∏–∏ –≥–æ—Ç–æ–≤ –æ—Ç–æ–¥–≤–∏–Ω—É—Ç—å —Å—Ä–æ–∫–∏ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–π —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ –Ω–æ–≤–æ–≤–≤–µ–¥–µ–Ω–∏—è. ‚ù§Ô∏è –ü—Ä—è–º–æ–µ –≤–∫–ª—é—á–µ–Ω–∏–µ. –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ —Ä–∞—Å—à–∏—Ä–∏–ª –ø–µ—Ä–µ—á–µ–Ω—å –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –ø–æ–¥–ª–µ–∂–∞—â–∏—Ö –ø—Ä–µ–¥–º–µ—Ç–Ω–æ-–∫–æ–ª–∏—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–º—É —É—á–µ—Ç—É. –í —Å–ø–∏—Å–æ–∫ –≤–æ—à–µ–ª –≥–∞–±–∞–ø–µ–Ω—Ç–∏–Ω –∏ –¥—Ä—É–≥–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety, guideline"",
  ""impact"": ""medium"",
  ""english"": ""Russia is expanding the list of drugs subject to itemized quantity accounting, including gabapentin and other medications. The Ministry of Health is also considering stricter medical examination requirements for drivers, which could affect the supply of medications in January.""
}"
2025-12-02T15:49:04+00:00,@medpharm,13835,https://t.me/medpharm/13835,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ —Ä–∞—Å—à–∏—Ä–∏–ª –ø–µ—Ä–µ—á–µ–Ω—å –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –ø–æ–¥–ª–µ–∂–∞—â–∏—Ö –ø—Ä–µ–¥–º–µ—Ç–Ω–æ-–∫–æ–ª–∏—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–º—É —É—á–µ—Ç—É. –í —Å–ø–∏—Å–æ–∫ –≤–æ—à–µ–ª –≥–∞–±–∞–ø–µ–Ω—Ç–∏–Ω –∏ –¥—Ä—É–≥–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qdnj2 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""medium"",
  ""english"": ""The Russian Ministry of Health expanded the list of drugs subject to itemized quantity accounting. The gabapentin and other medications were included in the list. For more details: https://clck.ru/3Qdnj2 #FarmaVestnik #Regulatorka""
}"
2025-12-02T15:22:03+00:00,@medpharm,13834,https://t.me/medpharm/13834,"–§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–µ –∫–æ–º–ø–∞–Ω–∏–∏, –ø—Ä–∏–Ω–∏–º–∞—é—â–∏–µ —Ä–µ—à–µ–Ω–∏—è –Ω–∞ –æ—Å–Ω–æ–≤–∞–Ω–∏–∏ Big data driven, –ø–æ–ª—É—á–∞—é—Ç –ª–∏–¥–∏—Ä—É—é—â–∏–µ –ø–æ–∑–∏—Ü–∏–∏ –Ω–∞ —Ä—ã–Ω–∫–µ. –û —Ç–æ–º, –∫–∞–∫ –±—ã—Ç—å —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã–º–∏ –≤ —ç–ø–æ—Ö—É, –∫–æ–≥–¥–∞ –Ω–∞–±–ª—é–¥–∞–µ—Ç—Å—è –Ω–µ—Ö–≤–∞—Ç–∫–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –∏ –ø–µ—Ä–µ–∏–∑–±—ã—Ç–æ–∫ –∫–æ–º–º—É–Ω–∏–∫–∞—Ü–∏–π —Å –≤—Ä–∞—á–µ–±–Ω—ã–º —Å–æ–æ–±—â–µ—Å—Ç–≤–æ–º, —Ä–∞—Å—Å–∫–∞–∑–∞–ª –æ—Å–Ω–æ–≤–∞—Ç–µ–ª—å IT-–∫–æ–º–ø–∞–Ω–∏–∏ MEDGURU –Ø—Ä–æ—Å–ª–∞–≤ –¢—Ä–µ—Ç—å—è–∫–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QdmGR #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ú–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-12-02T15:21:03+00:00,@medpharm,13833,https://t.me/medpharm/13833,"–í–ø–µ—Ä–≤—ã–µ –≤ –∏—Å—Ç–æ—Ä–∏–∏ –í–û–ó —Ä–µ–∫–æ–º–µ–Ω–¥–æ–≤–∞–ª–∞ –ª–µ—á–∏—Ç—å –æ–∂–∏—Ä–µ–Ω–∏–µ —É –≤–∑—Ä–æ—Å–ª—ã—Ö —Å –ø–æ–º–æ—â—å—é –∞–≥–æ–Ω–∏—Å—Ç–æ–≤ –ì–ü–ü-1 ‚Äî —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞, —Ç–∏—Ä–∑–µ–ø–∞—Ç–∏–¥–∞ –∏ –ª–∏—Ä–∞–≥–ª—É—Ç–∏–¥–∞. –û–¥–Ω–∞–∫–æ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–∞–µ—Ç, —á—Ç–æ –¥–∞–∂–µ –∫ 2030 –≥–æ–¥—É —ç—Ç–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –ø–æ–ª—É—á–∞—Ç –¥–∞–ª–µ–∫–æ –Ω–µ –≤—Å–µ –Ω—É–∂–¥–∞—é—â–∏–µ—Å—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QdmDh #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The World Health Organization (WHO) has recommended the use of glucagon-like peptide-1 receptor agonists, such as semaglutide, tirzepatid, and lixisenatide, to treat obesity in adults. However, the organization warns that these drugs will not reach all those who need them even by 2030. For more details: https://clck.ru/3QdmDh #PharmNews #Production""
}"
2025-12-02T15:14:06+00:00,@medpharm,13832,https://t.me/medpharm/13832,–î–æ–ø—É—Å–∫–∞–µ–º—ã–µ —Å–µ–π—á–∞—Å –¥–≤–æ–π–Ω—ã–µ —Ç–æ–ª–∫–æ–≤–∞–Ω–∏—è –Ω–µ–¥–∞–≤–Ω–æ –ø—Ä–∏–Ω—è—Ç–æ–≥–æ –∑–∞–∫–æ–Ω–∞ –æ –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–µ –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –≤—É–∑–æ–≤ –∏ –∫–æ–ª–ª–µ–¥–∂–µ–π –±—É–¥—É—Ç —É—Å—Ç—Ä–∞–Ω–µ–Ω—ã –≤ –ø–æ–¥–∑–∞–∫–æ–Ω–Ω—ã—Ö –∞–∫—Ç–∞—Ö –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–§. –í–µ–¥–æ–º—Å—Ç–≤–æ —Ç–∞–∫–∂–µ –æ—Ç—Ä–µ–≥—É–ª–∏—Ä—É–µ—Ç –Ω—é–∞–Ω—Å—ã –ø–æ–≤—Ç–æ—Ä–Ω–æ–π –ø–µ—Ä–≤–∏—á–Ω–æ–π –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–∏ –¥–ª—è –æ—Ç–∫–∞–∑–∞–≤—à–∏—Ö—Å—è –æ—Ç –æ—Ç—Ä–∞–±–æ—Ç–∫–∏ –º–æ–ª–æ–¥—ã—Ö —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qdkqz #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""medium"",
  ""english"": ""The double interpretations allowed by recently adopted legislation on medical students' apprenticeship will be eliminated in subordinate acts of the Ministry of Health. The Duma also regulates issues related to re-accreditation for young specialists who have refused to work. For more details: https://clck.ru/3Qdkqz #MedVestnik #Healthcare #HealthOrganization""
}"
2025-12-02T14:47:04+00:00,@medpharm,13831,https://t.me/medpharm/13831,"–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ —É—Ç–≤–µ—Ä–¥–∏–ª–æ –¥–∞—Ç—ã, –ø–æ—Å–ª–µ –∫–æ—Ç–æ—Ä—ã—Ö –ø—Ä–æ–¥–∞–≤–∞—Ç—å –Ω–µ–º–∞—Ä–∫–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –±–∏–æ–¥–æ–±–∞–≤–∫–∏ –±—É–¥–µ—Ç –Ω–µ–ª—å–∑—è. –ï—â–µ —Ä–∞—Å—à–∏—Ä–µ–Ω –ø–µ—Ä–µ—á–µ–Ω—å –ø–æ–¥–ª–µ–∂–∞—â–∏—Ö –º–∞—Ä–∫–∏—Ä–æ–≤–∫–µ –ë–ê–î. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QdjGF #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The government has approved the dates after which unmarked dietary supplements will not be sold. Additionally, the list of supplements requiring labeling has been expanded. For more details: https://clck.ru/3QdjGF #FarmaVestnik #Regulatorka""
}"
2025-12-02T14:29:03+00:00,@medpharm,13830,https://t.me/medpharm/13830,"–í –ø–µ—Ä–≤–æ–º —á—Ç–µ–Ω–∏–∏ –ø—Ä–∏–Ω—è—Ç –∑–∞–∫–æ–Ω –æ –ø–æ—Ä—è–¥–∫–µ –ø—Ä–∏—Å–≤–æ–µ–Ω–∏—è —Å—Ç–∞—Ç—É—Å–∞ –ù–ú–ò–¶. –î–æ–∫—É–º–µ–Ω—Ç —Ä–∞—Å—à–∏—Ä–∏—Ç –∫—Ä—É–≥ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π, –∫–æ—Ç–æ—Ä—ã–µ —Å–º–æ–≥—É—Ç —Ä–∞—Å—Å—á–∏—Ç—ã–≤–∞—Ç—å –Ω–∞ –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–µ —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏–µ –∏–∑ –±—é–¥–∂–µ—Ç–æ–≤ —Ä–∞–∑–Ω—ã—Ö —É—Ä–æ–≤–Ω–µ–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qdi9H #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""registration, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The first reading of the law on the order of assigning status of NMMC (National Medical Mechnical Center) has been approved. The document will expand the circle of organizations that can expect additional funding from various levels of budget.""
}"
2025-12-02T14:04:03+00:00,@medpharm,13829,https://t.me/medpharm/13829,"–í–µ—Ä—Ö–æ–≤–Ω—ã–π —Å—É–¥ –†–§ —Ä–∞–∑—ä—è—Å–Ω–∏–ª, –∫–∞–∫ —Ä–∞—Å—Å—á–∏—Ç—ã–≤–∞—Ç—å –ø–ª–∞—Ç—É, –≤–∑–∏–º–∞–µ–º—É—é —Å –±–∏–∑–Ω–µ—Å–∞ –∑–∞ –≤—ã–≤–æ–∑ —Ç–≤–µ—Ä–¥—ã—Ö –∫–æ–º–º—É–Ω–∞–ª—å–Ω—ã—Ö –æ—Ç—Ö–æ–¥–æ–≤. –ü—Ä–∏ —ç—Ç–æ–º –∞–ø—Ç–µ–∫–∏ –º–æ–≥—É—Ç –≤—ã–¥–µ–ª–∏—Ç—å –≤ –æ—Ç–¥–µ–ª—å–Ω—É—é –∫–∞—Ç–µ–≥–æ—Ä–∏—é –ø–æ –Ω–æ—Ä–º–∞–º –≤—ã–≤–æ–∑–∞ –¢–ö–û. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QdgQn #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The Supreme Court of Russia clarified how to calculate the fee imposed on businesses for the disposal of solid municipal waste. Pharmacies may be categorized separately under waste collection norms.""
}"
2025-12-02T12:29:02+00:00,@medpharm,13828,https://t.me/medpharm/13828,"–ü—Ä–æ—Ñ–ø–µ—Ä–µ–ø–æ–¥–≥–æ—Ç–æ–≤–∫–∞ –ø–æ ¬´–£–ø—Ä–∞–≤–ª–µ–Ω–∏—é –∏ —ç–∫–æ–Ω–æ–º–∏–∫–µ —Ñ–∞—Ä–º–∞—Ü–∏–∏¬ª —Å –º–∞—Ä—Ç–∞ 2026 –≥–æ–¥–∞ ‚Äî –ø–æ—á—Ç–∏ –ø–æ–ª–Ω–æ—Å—Ç—å—é –æ—á–Ω–∞—è. –û–±—É—á–∞—é—â–∏–π –ø–æ—Ä—Ç–∞–ª ¬´–§–∞—Ä–º–ó–Ω–∞–Ω–∏–µ¬ª –ø–æ–¥—Å—á–∏—Ç–∞–ª, —Å–∫–æ–ª—å–∫–æ –±—É–¥–µ—Ç —Å—Ç–æ–∏—Ç—å –æ–±—É—á–µ–Ω–∏–µ –¥–ª—è —Ä–µ–≥–∏–æ–Ω–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QdZrZ #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–∞—Ä—å–µ—Ä–∞","{""skip"": true}"
2025-12-02T12:27:02+00:00,@medpharm,13827,https://t.me/medpharm/13827,–í –ï–∫–∞—Ç–µ—Ä–∏–Ω–±—É—Ä–≥–µ —Å–æ—Å—Ç–æ—è–ª—Å—è –ú–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã–π —Ñ–µ—Å—Ç–∏–≤–∞–ª—å –Ω–∞—É—á–Ω–æ-—Ç–µ—Ö–Ω–∏—á–µ—Å–∫–æ–≥–æ —Ç–≤–æ—Ä—á–µ—Å—Ç–≤–∞ –¥–µ—Ç–µ–π –∏ –º–æ–ª–æ–¥–µ–∂–∏. –ë–æ–ª–µ–µ 100 —é–Ω—ã—Ö –∏–∑–æ–±—Ä–µ—Ç–∞—Ç–µ–ª–µ–π –∏ –∏–Ω–∂–µ–Ω–µ—Ä–æ–≤ –∏–∑ 16 —Ä–µ–≥–∏–æ–Ω–æ–≤ –†–æ—Å—Å–∏–∏ —Å–æ–∑–¥–∞–≤–∞–ª–∏ –Ω–æ–≤—ã–µ —Ä–µ—à–µ–Ω–∏—è –¥–ª—è —Ä–∞–∑–≤–∏—Ç–∏—è –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–π –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏. –§–∏–Ω–∞–ª –ø—Ä–æ—à–µ–ª –Ω–∞ –ø–ª–æ—â–∞–¥–∫–µ –ú–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–æ–≥–æ —á–µ–º–ø–∏–æ–Ω–∞—Ç–∞ –≤—ã—Å–æ–∫–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–Ω—ã—Ö –ø—Ä–æ—Ñ–µ—Å—Å–∏–π ¬´–•–∞–π—Ç–µ–∫: –Ω–∞–≤—ã–∫–∏ –±—É–¥—É—â–µ–≥–æ¬ª –≤ –ú–í–¶ ¬´–ï–∫–∞—Ç–µ—Ä–∏–Ω–±—É—Ä–≥-–≠–∫—Å–ø–æ¬ª. –í—Å–µ –¥–Ω–∏ —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ —Å–æ—Ä–µ–≤–Ω–æ–≤–∞–Ω–∏–π –ø–æ–¥–¥–µ—Ä–∂–∏–≤–∞–ª–∞ –ì—Ä—É–ø–ø–∞ –∫–æ–º–ø–∞–Ω–∏–π ¬´–†-–§–∞—Ä–º¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://pharmvestnik.ru/content/news/r-farm-podderjal-mejdunarodnyi-festival-nauchno-tehnicheskogo-tvorchestva-detei-i-molodeji.html?utm_source=TG_post&utm_medium=Group&utm_campaign=r-farm-podderjal-mejdunarodnyi-festival-nauchno-tehnicheskogo-tvorchestva-detei-i-molodeji #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–∞—Ä—å–µ—Ä–∞,"{""skip"": true}"
2025-12-02T11:53:03+00:00,@medpharm,13826,https://t.me/medpharm/13826,"–ê–ø—Ç–µ–∫–∏ –Ω–µ —É—Å–ø–µ—é—Ç –≤–Ω–µ–¥—Ä–∏—Ç—å –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–µ –º–æ–¥—É–ª–∏ –¢–° –ü–ò–æ–¢. –ï—Å–ª–∏ —Å—Ä–æ–∫–∏ –Ω–µ –±—É–¥—É—Ç –ø–µ—Ä–µ–Ω–µ—Å–µ–Ω—ã, –æ—Ç–ø—É—Å–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –Ω–∞—á–∞–ª–µ —è–Ω–≤–∞—Ä—è –º–æ–∂–µ—Ç –±—ã—Ç—å –æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω. –ü–æ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ ¬´–§–í¬ª, –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ –†–æ—Å—Å–∏–∏ –≥–æ—Ç–æ–≤ –æ—Ç–æ–¥–≤–∏–Ω—É—Ç—å —Å—Ä–æ–∫–∏ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–π —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ –Ω–æ–≤–æ–≤–≤–µ–¥–µ–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QdXBr #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""Pharmacy chains are not ready to implement the required modules of TSPiOt. If the deadlines are not extended, drug supply could be halted at the beginning of January. According to 'FV', the Russian Ministry of Industry is ready to postpone the implementation deadlines.""
}"
2025-12-02T11:45:05+00:00,@medpharm,13825,https://t.me/medpharm/13825,–ù–∞ —Å–∞–π—Ç–µ ¬´–†–æ—Å—Å–∏–π—Å–∫–æ–π –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–π –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤—ã¬ª –ø–æ—è–≤–∏–ª–∞—Å—å –ø–µ—Ç–∏—Ü–∏—è —Å —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–µ–º –≤–≤–µ—Å—Ç–∏ –æ–±—è–∑–∞–Ω–Ω–æ—Å—Ç—å –¥–ª—è —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª–µ–π –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏–π –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –ø—Ä–æ–≤–µ—Ä—è—Ç—å –ø–æ–¥–ª–∏–Ω–Ω–æ—Å—Ç—å –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –∏ –æ—Ç–∫—Ä—ã—Ç—å –¥–æ—Å—Ç—É–ø –≥—Ä–∞–∂–¥–∞–Ω–∞–º –∫ –§–µ–¥–µ—Ä–∞–ª—å–Ω–æ–º—É —Ä–µ–≥–∏—Å—Ç—Ä—É —Ç–∞–∫–∏—Ö –¥–∞–Ω–Ω—ã—Ö. –° –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–µ–º –≤—ã—Å—Ç—É–ø–∏–ª–∞ –∫–æ–º–ø–∞–Ω–∏—è ‚Äî —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫ –ø–æ—Ä—Ç–∞–ª–∞ ¬´–ü—Ä–æ–î–æ–∫—Ç–æ—Ä–æ–≤¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QdWbG #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""A petition has appeared on the website of 'Russian Public Initiative' calling for medical institution leaders to verify the authenticity of medical staff education and make this information accessible through a Federal Register. The proposal was made by the company that developed the 'ProDoctor' portal.""
}"
2025-12-02T10:53:06+00:00,@medpharm,13824,https://t.me/medpharm/13824,–°—É–¥ –æ—Ç–∫–∞–∑–∞–ª –±—ã–≤—à–µ–º—É –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—é –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –ù–ú–ò–¶ –∏–º. –ú–µ—à–∞–ª–∫–∏–Ω–∞ –≤ —É—Å–ª–æ–≤–Ω–æ-–¥–æ—Å—Ä–æ—á–Ω–æ–º –æ—Å–≤–æ–±–æ–∂–¥–µ–Ω–∏–∏ –ø–æ –¥–µ–ª—É –æ —Ö–∏—â–µ–Ω–∏–∏ –±—é–¥–∂–µ—Ç–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤.Ôªø –ò—Ä–∏–Ω–∞ –ë–æ–π—Ü–æ–≤–∞ –±—ã–ª–∞ –ø—Ä–∏–≥–æ–≤–æ—Ä–µ–Ω–∞ –∫ —Ç—Ä–µ–º –≥–æ–¥–∞–º –ª–∏—à–µ–Ω–∏—è —Å–≤–æ–±–æ–¥—ã –≤ –∞–ø—Ä–µ–ª–µ –ø—Ä–æ—à–ª–æ–≥–æ –≥–æ–¥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QdSST #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-12-02T09:58:02+00:00,@medpharm,13823,https://t.me/medpharm/13823,"–í –ò–≤–∞–Ω–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –Ω–∞–∑–Ω–∞—á–µ–Ω –Ω–æ–≤—ã–π –∑–∞–º–ø—Ä–µ–¥ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –¥–ª—è –∫—É—Ä–∏—Ä–æ–≤–∞–Ω–∏—è –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∏ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è. –ü—Ä–µ–∂–Ω–µ–≥–æ, –≤–æ–∑–≥–ª–∞–≤–ª—è–≤—à–µ–≥–æ —Ç–∞–∫–∂–µ –î–µ–ø–∑–¥—Ä–∞–≤ —Ä–µ–≥–∏–æ–Ω–∞, –ê–Ω—Ç–æ–Ω–∞ –ê—Ä—Å–µ–Ω—å–µ–≤–∞ –≤ –æ–∫—Ç—è–±—Ä–µ 2025 –≥–æ–¥–∞ –æ–±–≤–∏–Ω–∏–ª–∏ –≤ –∫–æ—Ä—Ä—É–ø—Ü–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QdN2D #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-12-02T09:57:02+00:00,@medpharm,13822,https://t.me/medpharm/13822,"–§–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –ª–æ–º–∞—é—Ç —Å—Ç–µ—Ä–µ–æ—Ç–∏–ø—ã, —É—Ä–∞–≤–Ω–∏–≤–∞—è –∑–∞—Ä–ø–ª–∞—Ç—ã –∏–Ω–∂–µ–Ω–µ—Ä–æ–≤ –∏ –≥—Ä—É–∑—á–∏–∫–æ–≤ –∏ –Ω–∞–Ω–∏–º–∞—è —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤ 60+. –¢–æ–ø-–º–µ–Ω–µ–¥–∂–µ—Ä—ã –∏ HRD –æ–±—Å—É–¥–∏–ª–∏ —Ä–∞–±–æ—á–∏–µ –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç—ã –≤ –±–æ—Ä—å–±–µ –∑–∞ —Ç–∞–ª–∞–Ω—Ç—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QdMv8 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–∞—Ä—å–µ—Ä–∞","{""skip"": true}"
2025-12-02T09:17:44+00:00,@medpharm,13821,https://t.me/medpharm/13821,"–°–ø—Ä–∞–≤–µ–¥–ª–∏–≤–æ—Å—Ç–∏ —Ä–∞–¥–∏. –ö–∞–∫ —Å–∏—Å—Ç–µ–º–∞ –æ–ø–ª–∞—Ç—ã —Ç—Ä—É–¥–∞ –º–µ–Ω—è–µ—Ç –∞–ø—Ç–µ—á–Ω—ã–π —Ñ–∞—Ä–º—Ä—ã–Ω–æ–∫ –î–∏–ø–ª–æ–º–∏—Ä–æ–≤–∞–Ω–Ω—ã–º —Ñ–∞—Ä–º—Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞–º –Ω–µ–¥–æ–ø–ª–∞—á–∏–≤–∞—é—Ç ‚Äî –æ–± —ç—Ç–æ–º –æ—Ç–∫—Ä—ã—Ç–æ –≥–æ–≤–æ—Ä—è—Ç —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª–∏ –∞–ø—Ç–µ–∫ –∏ —ç–∫—Å–ø–µ—Ä—Ç—ã —Ñ–∞—Ä–º—Ä—ã–Ω–∫–∞. –ó–∞—Ä–ø–ª–∞—Ç—ã –æ—Å—Ç–∞—é—Ç—Å—è —Ç–µ–º–æ–π –Ω–æ–º–µ—Ä –æ–¥–∏–Ω –≤ –ø—Ä–æ—Ñ–∏–ª—å–Ω—ã—Ö —á–∞—Ç–∞—Ö, –æ–¥–Ω–∞–∫–æ —Ä—ã–Ω–æ–∫ –¥–µ–º–æ–Ω—Å—Ç—Ä–∏—Ä—É–µ—Ç —Ä–∞–∑–Ω–æ–Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–Ω—ã–µ —Ç–µ–Ω–¥–µ–Ω—Ü–∏–∏: –ø–æ–∫–∞ –æ–¥–Ω–∏ –∞–ø—Ç–µ—á–Ω—ã–µ —Å–µ—Ç–∏ –ø–ª–∞–Ω–∏—Ä—É—é—Ç –∏—Ö —Ä–æ—Å—Ç, –¥—Ä—É–≥–∏–µ –∑–∞–º–æ—Ä–∞–∂–∏–≤–∞—é—Ç –Ω–∞ —Ñ–æ–Ω–µ —Ä–∞—Å—Ç—É—â–µ–π –Ω–∞–ª–æ–≥–æ–≤–æ–π –Ω–∞–≥—Ä—É–∑–∫–∏. –ö–∞–∫ —Ä–∞–∑–æ—Ä–≤–∞—Ç—å –∑–∞–º–∫–Ω—É—Ç—ã–π –∫—Ä—É–≥, –∫–æ–≥–¥–∞ —Ü–µ–Ω–Ω–æ—Å—Ç—å —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞ –Ω–µ–æ—Å–ø–æ—Ä–∏–º–∞, –Ω–æ –µ–≥–æ –æ–ø–ª–∞—Ç–∞ —Å—Ç–∞–Ω–æ–≤–∏—Ç—Å—è —Ç—è–∂–µ–ª—ã–º –≥—Ä—É–∑–æ–º –¥–ª—è –±–∏–∑–Ω–µ—Å–∞? –ê–Ω–∞–ª–∏–∑ —Ç–µ–∫—É—â–µ–π —Å–∏—Ç—É–∞—Ü–∏–∏ –∏ –æ–±—ä–µ–∫—Ç–∏–≤–Ω—ã–µ –æ—Ü–µ–Ω–∫–∏ –∑–∞—Ä–ø–ª–∞—Ç –ø–µ—Ä–≤–æ—Å—Ç–æ–ª—å–Ω–∏–∫–æ–≤ ‚Äî –≤ –º–∞—Ç–µ—Ä–∏–∞–ª–µ ¬´–§–í¬ª. –°–≤–µ–∂–∏–π –Ω–æ–º–µ—Ä ¬´–§–í¬ª ‚Ññ26-27 (1185-1186) —É–∂–µ –¥–æ—Å—Ç—É–ø–µ–Ω –æ–Ω–ª–∞–π–Ω –±–µ—Å–ø–ª–∞—Ç–Ω–æ –¥–ª—è –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª–µ–π.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, hospital_policy, guideline, pharmacovigilance"",
  ""impact"": ""medium"",
  ""english"": ""The article discusses the issue of fair compensation for pharmacy professionals, who are underpaid according to their qualifications. It highlights divergent trends in the apec market: some pharmacy chains plan for growth, while others are freezing their operations due to increasing tax burden. The article also analyzes the current situation and objective assessments of compensation levels for key figures.""
}"
2025-12-02T09:14:03+00:00,@medpharm,13820,https://t.me/medpharm/13820,"–í –†–æ—Å—Å–∏–∏ –ø–ª–∞–Ω–∏—Ä—É—é—Ç —É–∂–µ—Å—Ç–æ—á–∏—Ç—å –∫–æ–Ω—Ç—Ä–æ–ª—å –∑–∞ –∑–¥–æ—Ä–æ–≤—å–µ–º –≤–æ–¥–∏—Ç–µ–ª–µ–π, –∏–∑–º–µ–Ω–∏–≤ –ø—Ä–∞–≤–∏–ª–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Å–≤–∏–¥–µ—Ç–µ–ª—å—Å—Ç–≤–æ–≤–∞–Ω–∏–π —Å 1 –º–∞—Ä—Ç–∞ 2027 –≥–æ–¥–∞.Ôªø –ú–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –∑–∞–∫–ª—é—á–µ–Ω–∏—è –±—É–¥—É—Ç –æ—Ñ–æ—Ä–º–ª—è—Ç—å—Å—è —Å –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–º –æ–±–º–µ–Ω–æ–º –¥–∞–Ω–Ω—ã–º–∏ –º–µ–∂–¥—É –ú–∏–Ω–∑–¥—Ä–∞–≤–æ–º –†–§ –∏ –ú–í–î –†–§.Ôªø –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QdJao #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-12-02T08:47:04+00:00,@medpharm,13819,https://t.me/medpharm/13819,"–° 25 –Ω–æ—è–±—Ä—è –ø–æ 1 –¥–µ–∫–∞–±—Ä—è –º–∏—Ä–æ–≤—ã–µ —Ä–µ–≥—É–ª—è—Ç–æ—Ä—ã –æ–¥–æ–±—Ä–∏–ª–∏ 10 –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –°–®–ê –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª–∏ –ø–µ—Ä–≤–æ–µ –≤ –º–∏—Ä–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–æ, –±–ª–æ–∫–∏—Ä—É—é—â–µ–µ –±–µ–ª–æ–∫ APRIL –¥–ª—è –ª–µ—á–µ–Ω–∏—è –ø–æ—á–µ–∫ –ø—Ä–∏ –±–æ–ª–µ–∑–Ω–∏ –ë–µ—Ä–∂–µ. –ï–≤—Ä–æ–ø–µ–π—Å–∫–∏–π —Ä—ã–Ω–æ–∫ –ø–æ–ª—É—á–∏–ª –Ω–æ–≤—ã–µ –±–∏–æ–∞–Ω–∞–ª–æ–≥–∏ –¥–µ–Ω–æ—Å—É–º–∞–±–∞. –í –ö–ù–† –ø–æ—è–≤–∏—Ç—Å—è –ø–µ—Ä–≤—ã–π –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π –∏–Ω–≥–∏–±–∏—Ç–æ—Ä –∏–Ω—Ç–µ—Ä–ª–µ–π–∫–∏–Ω–∞-23, —Å–ø–æ—Å–æ–±–Ω—ã–π –æ—á–∏—Å—Ç–∏—Ç—å –∫–æ–∂—É –ø—Ä–∏ –ø—Å–æ—Ä–∏–∞–∑–µ –Ω–∞ 90%. –í–µ–ª–∏–∫–æ–±—Ä–∏—Ç–∞–Ω–∏—è —É—Ç–≤–µ—Ä–¥–∏–ª–∞ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ –∫–æ–º–±–∏–Ω–∏—Ä–æ–≤–∞–Ω–Ω–æ–≥–æ –º–µ—Ç–æ–¥–∞ –ª–µ—á–µ–Ω–∏—è —Ä–∞–∫–∞ –º–æ–ª–æ—á–Ω–æ–π –∂–µ–ª–µ–∑—ã, –≤–¥–≤–æ–µ —É–≤–µ–ª–∏—á–∏–≤–∞—é—â–µ–≥–æ –≤—ã–∂–∏–≤–∞–µ–º–æ—Å—Ç—å. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QdGCo #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders,clinical_trial,safety"",
  ""impact"": ""high"",
  ""english"": ""Global regulatory bodies approved 10 drugs from November 25 to December 1. The US registered the world's first drug blocking the APRIL protein for kidney disease due to Beh√ßet's syndrome. The European market received new biologics of denosumab. China will have its first domestically produced inhibitor of interleukin-23, which can clear skin psoriasis by 90%. UK approved a combined method of treating breast cancer, doubling the survival rate. For more details: https://clck.ru/3QdGCo #PharmNews #Production""
}"
2025-12-02T08:41:20+00:00,@medpharm,13818,https://t.me/medpharm/13818,"–£–∫—É—Å –∫–ª–µ—â–∞ –ø—Ä–∏–≤–µ–ª –∫ —Å–º–µ—Ä—Ç–∏ –º—É–∂—á–∏–Ω—ã –æ—Ç –≥–∞–º–±—É—Ä–≥–µ—Ä–∞, –∞ –ø–µ—Ä–≤—ã–π —á–µ–ª–æ–≤–µ–∫ —Å –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–µ–Ω–Ω–æ–π –∏–Ω—Ñ–µ–∫—Ü–∏–µ–π H5N1 —É–º–µ—Ä –æ—Ç –Ω–µ–µ. –≠—Ç–∏ –∏ –¥—Ä—É–≥–∏–µ –Ω–æ–≤–æ—Å—Ç–∏ ‚Äî –≤ –¥–∞–π–¥–∂–µ—Å—Ç–µ –∏–Ω—Ç–µ—Ä–µ—Å–Ω—ã—Ö –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Å–ª—É—á–∞–µ–≤ –Ω–æ—è–±—Ä—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QdFh2 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ù–∞—É–∫–∞ #–ò–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã–µ_–±–æ–ª–µ–∑–Ω–∏ #–ò–º–º—É–Ω–æ–ª–æ–≥–∏—è_–∏_–∞–ª–ª–µ—Ä–≥–æ–ª–æ–≥–∏—è #–û–Ω–∫–æ–ª–æ–≥–∏—è #–û—Ñ—Ç–∞–ª—å–º–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-12-02T07:32:06+00:00,@medpharm,13817,https://t.me/medpharm/13817,"–í –ø—Ä–æ—à–ª–æ–º –≥–æ–¥—É –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã–µ —Ñ–∞—Ä–º–∞–∫–æ–º–ø–∞–Ω–∏–∏ –ø–µ—Ä–µ–¥–∞–ª–∏ —Ä–æ—Å—Å–∏–π—Å–∫–∏–º –ø–∞—Ü–∏–µ–Ω—Ç—Å–∫–∏–º –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è–º –≤ –∫–∞—á–µ—Å—Ç–≤–µ —Å–ø–æ–Ω—Å–æ—Ä—Å–∫–æ–π –ø–æ–º–æ—â–∏ –∏ –≤—ã–ø–ª–∞—Ç –∑–∞ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏—é —Å–æ–≤–º–µ—Å—Ç–Ω—ã—Ö –ø—Ä–æ–µ–∫—Ç–æ–≤ 585,7 –º–ª–Ω —Ä—É–±. –ü–æ –º–Ω–µ–Ω–∏—é –º–Ω–æ–≥–∏—Ö –ª–∏–¥–µ—Ä–æ–≤ –ù–ö–û –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –¥–æ—Å–∞–Ω–∫—Ü–∏–æ–Ω–Ω—ã–º –ø–µ—Ä–∏–æ–¥–æ–º —Ñ–∏–Ω–∞–Ω—Å–æ–≤–∞—è –ø–æ–¥–¥–µ—Ä–∂–∫–∞ —Å–æ–∫—Ä–∞—Ç–∏–ª–∞—Å—å. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qd9yx #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""Foreign pharmaceutical companies provided Russian patient organizations with sponsorship and funding for joint project implementation amounting to 58.57 million yuan last year. Many NGO leaders believe that financial support has decreased compared to the pre-sanction period. For more details, see https://clck.ru/3Qd9yx #MedVestnik #Healthcare #Other""
}"
2025-12-02T06:08:05+00:00,@medpharm,13816,https://t.me/medpharm/13816,"–£—á–µ–Ω—ã–µ –∏–∑ –ö–æ–ø–µ–Ω–≥–∞–≥–µ–Ω—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ –ø—Ä–æ–≤–µ–ª–∏ —Å–∏—Å—Ç–µ–º–∞—Ç–∏—á–µ—Å–∫–∏–π –æ–±–∑–æ—Ä –∏ –º–µ—Ç–∞–∞–Ω–∞–ª–∏–∑, —á—Ç–æ–±—ã –æ—Ü–µ–Ω–∏—Ç—å –≤–ª–∏—è–Ω–∏–µ –±–∏–æ–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ –≤–æ—Å—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ –æ–±–æ–Ω—è–Ω–∏—è —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–∏–º —Ä–∏–Ω–æ—Å–∏–Ω—É—Å–∏—Ç–æ–º —Å –Ω–æ—Å–æ–≤—ã–º–∏ –ø–æ–ª–∏–ø–∞–º–∏. –†–µ–∑—É–ª—å—Ç–∞—Ç—ã –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω—ã –≤ –∂—É—Ä–Ω–∞–ª–µ Current Allergy and Asthma Reports. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qd3Gq #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–û—Ç–æ—Ä–∏–Ω–æ–ª–∞—Ä–∏–Ω–≥–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-12-01T16:37:58+00:00,@medpharm,13815,https://t.me/medpharm/13815,"ü¶æ –ù–µ –¥–ª—è –ª—é–±–æ–ø—ã—Ç–Ω—ã—Ö. –ù–µ–∫–æ—Ç–æ—Ä—ã–µ —Ä–µ–≥–∏–æ–Ω—ã –ø—Ä–µ–¥–ø–æ—á–∏—Ç–∞—é—Ç –Ω–µ —Ä–∞—Å–∫—Ä—ã–≤–∞—Ç—å –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é –æ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞—Ö –ø—Ä–æ–≥—Ä–∞–º–º —ç–∫—Å—Ç—Ä–∞–∫–æ—Ä–ø–æ—Ä–∞–ª—å–Ω–æ–≥–æ –æ–ø–ª–æ–¥–æ—Ç–≤–æ—Ä–µ–Ω–∏—è. –í —Å—Ä–µ–¥–Ω–µ–º –ø–æ –†–æ—Å—Å–∏–∏, —Å–æ–≥–ª–∞—Å–Ω–æ –ø–æ–ª—É—á–µ–Ω–Ω—ã–º –¥–∞–Ω–Ω—ã–º, –ø—Ä–∏–≤–µ–ª–∏ –∫ –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏ 33% —Ü–∏–∫–ª–æ–≤ –≠–ö–û. ü¶æ –ì–ª–∞–≤–≤—Ä–∞—á—É –Ω–∞ –∑–∞–º–µ—Ç–∫—É. –ö–∞–∫ –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ —Å—ç–∫–æ–Ω–æ–º–∏—Ç—å —Å–æ—Ç–Ω–∏ —Ç—ã—Å—è—á —Ä—É–±–ª–µ–π –Ω–∞ –≤—ã–≤–æ–∑–µ –æ—Ç—Ö–æ–¥–æ–≤, –æ–± –æ—à–∏–±–∫–∞—Ö —Ä–∞—Å—Ö–æ–¥–æ–≤–∞–Ω–∏—è —Å—Ä–µ–¥—Å—Ç–≤ –û–ú–° –∏ –Ω–∞—Ä—É—à–µ–Ω–∏—è—Ö –ø—Ä–∏ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏–∏ –∞–±–æ—Ä—Ç–æ–≤ ‚Äî –≤ —Ä–µ–π—Ç–∏–Ω–≥–µ –Ω–æ–≤–æ—Å—Ç–µ–π –ø—Ä–æ—à–µ–¥—à–µ–≥–æ –º–µ—Å—è—Ü–∞ –¥–ª—è –æ—Ä–≥–∞–Ω–∏–∑–∞—Ç–æ—Ä–æ–≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –≤ –ø—É–±–ª–∏–∫–∞—Ü–∏—è—Ö –ª–µ–Ω—Ç—ã –Ω–æ–≤–æ—Å—Ç–µ–π ¬´–ú–í¬ª. ‚ù§Ô∏è –ù–∞–ª–æ–≥–æ–≤–∞—è —É–≥—Ä–æ–∑–∞. ¬´–°–æ—é–∑–§–∞—Ä–º–∞¬ª –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–∞–µ—Ç: –º–∞–ª—ã–µ –∞–ø—Ç–µ–∫–∏ –≤ —Ä–µ–≥–∏–æ–Ω–∞—Ö –º–∞—Å—Å–æ–≤–æ –∑–∞–∫—Ä–æ—é—Ç—Å—è —Å 2026 –≥–æ–¥–∞. –ö–∞–∫–∏–µ –ª—å–≥–æ—Ç—ã –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç –≤–≤–µ—Å—Ç–∏ –¥–ª—è —Å–ø–∞—Å–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è? ‚ù§Ô∏è –ü—Ä–æ–¥–ª—è—Ç —É–ø—Ä–æ—â–µ–Ω–Ω—ã–π —Ä–µ–∂–∏–º. –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–æ –ø—Ä–æ–¥–ª–∏—Ç—å –¥–æ –∫–æ–Ω—Ü–∞ 2027 –≥–æ–¥–∞ –æ—Å–æ–±—ã–π –ø–æ—Ä—è–¥–æ–∫ –≤–≤–æ–∑–∞ –≤ —Å—Ç—Ä–∞–Ω—É –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã—Ö —É–ø–∞–∫–æ–≤–∫–∞—Ö –ø—Ä–∏ –¥–µ—Ñ–µ–∫—Ç—É—Ä–µ. –î–æ–∫—É–º–µ–Ω—Ç –≤–Ω–µ—Å–µ–Ω –Ω–∞ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏–µ –≤ –ì–æ—Å–¥—É–º—É –†–§.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The government of Russia has proposed to extend the special import procedure for drugs until December 31, 2027. This proposal is under consideration by the State Duma of Russia.""
}"
2025-12-01T15:29:02+00:00,@medpharm,13814,https://t.me/medpharm/13814,"–†–æ—Å—Å–∏–π—Å–∫–∏–µ —É—á–µ–Ω—ã–µ –≤–∞–ª–∏–¥–∏—Ä–æ–≤–∞–ª–∏ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—É—é —à–∫–∞–ª—É –æ—Ü–µ–Ω–∫–∏ —Ç—è–∂–µ—Å—Ç–∏ —Ä–∞—Ö–∏—Ç–∞. –û–∂–∏–¥–∞–µ—Ç—Å—è, —á—Ç–æ —ç—Ç–æ—Ç –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç –ø–æ–ª—É—á–∏—Ç —à–∏—Ä–æ–∫–æ–µ –≤–Ω–µ–¥—Ä–µ–Ω–∏–µ –≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫—É—é –ø—Ä–∞–∫—Ç–∏–∫—É –∏ –±—É–¥–µ—Ç –≤–∫–ª—é—á–µ–Ω –≤ –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—ã–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QcZYG #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–î–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞ #–ü–µ–¥–∏–∞—Ç—Ä–∏—è #–¢—Ä–∞–≤–º–∞—Ç–æ–ª–æ–≥–∏—è_–∏_–æ—Ä—Ç–æ–ø–µ–¥–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""Russian scientists validated the international scale for assessing severity of rickets. It is expected to be widely implemented in clinical practice and included into national clinical guidelines.""
}"
2025-12-01T15:23:04+00:00,@medpharm,13813,https://t.me/medpharm/13813,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏ –≥–æ—Ç–æ–≤ —Å–æ–≥–ª–∞—Å–æ–≤–∞—Ç—å –ø—Ä–æ–¥–ª–µ–Ω–∏–µ –∫–≤–∞–ª–∏—Ñ–∏–∫–∞—Ü–∏–æ–Ω–Ω—ã—Ö —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π –¥–ª—è –ø—Ä–æ–≤–∏–∑–æ—Ä–æ–≤-—Ç–µ—Ö–Ω–æ–ª–æ–≥–æ–≤ –¥–æ –∫–æ–Ω—Ü–∞ 2026 –≥–æ–¥–∞. –†–∞–Ω–µ–µ –≤–µ–¥–æ–º—Å—Ç–≤–æ –Ω–∞–ø–æ–º–Ω–∏–ª–æ, —á—Ç–æ —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç—å ¬´–§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∞—è —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—è¬ª —Å–æ—Ö—Ä–∞–Ω—è–µ—Ç—Å—è –¥–æ –∫–æ–Ω—Ü–∞ 2025 –≥–æ–¥–∞. –≠—Ç–æ —Å—Ç–∞–≤–∏–ª–æ –ø–æ–¥ —É–≥—Ä–æ–∑—É —Ç—Ä—É–¥–æ—É—Å—Ç—Ä–æ–π—Å—Ç–≤–æ –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ –≤ 2026 –≥–æ–¥—É –∑–∞–∫–∞–Ω—á–∏–≤–∞—é—Ç –ø—Ä–æ—Ö–æ–¥–∏—Ç—å –æ–±—É—á–µ–Ω–∏–µ –≤ –æ—Ä–¥–∏–Ω–∞—Ç—É—Ä–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QcZ8m #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–∞—Ä—å–µ—Ä–∞","{""skip"": true}"
2025-12-01T14:57:03+00:00,@medpharm,13812,https://t.me/medpharm/13812,"–°—É–º–º–∞ –∑–∞–∫–ª—é—á–µ–Ω–Ω—ã—Ö –¥–æ–≥–æ–≤–æ—Ä–æ–≤ –≤ I‚ÄîIII –∫–≤–∞—Ä—Ç–∞–ª–∞—Ö 2025 –≥–æ–¥–∞ –Ω–∞ –∑–∞–∫—É–ø–∫—É –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –∏ –º–∞—Ç–µ—Ä–∏–∞–ª–æ–≤ –ø—Ä–µ–≤—ã—Å–∏–ª–∞ 764 –º–ª—Ä–¥ —Ä—É–±. –≠—Ç–æ –º–µ–Ω—å—à–µ, —á–µ–º –∑–∞ –∞–Ω–∞–ª–æ–≥–∏—á–Ω—ã–π –ø–µ—Ä–∏–æ–¥ 2024 –≥–æ–¥–∞, –Ω–æ –±–æ–ª—å—à–µ –¥–∞–Ω–Ω—ã—Ö –∑–∞ —è–Ω–≤–∞—Ä—å ‚Äî —Å–µ–Ω—Ç—è–±—Ä—å 2023 –≥–æ–¥–∞. –õ—É—á—à—É—é –¥–∏–Ω–∞–º–∏–∫—É –¥–µ–º–æ–Ω—Å—Ç—Ä–∏—Ä—É—é—Ç –∑–∞–∫—É–ø–∫–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QcXHM #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{""skip"": true}"
2025-12-01T14:45:04+00:00,@medpharm,13811,https://t.me/medpharm/13811,"–í–∞–∫—Ü–∏–Ω–∞ ¬´–®–∏–Ω–≥—Ä–∏–∫—Å¬ª –æ—Ç –æ–ø–æ—è—Å—ã–≤–∞—é—â–µ–≥–æ –≥–µ—Ä–ø–µ—Å–∞ –Ω–µ –ø–æ—Å—Ç—É–ø–∏—Ç –≤ –†–æ—Å—Å–∏—é –¥–æ –≤—Ç–æ—Ä–æ–π –ø–æ–ª–æ–≤–∏–Ω—ã 2026 –≥–æ–¥–∞.‚Äã –≠—Ç–æ –∑–Ω–∞—á–∏—Ç, —á—Ç–æ –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–π –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç GSK –ø–æ–∫–∞ –Ω–µ –¥–æ—Å—Ç—É–ø–µ–Ω –ø–∞—Ü–∏–µ–Ω—Ç–∞–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QcWXC #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–ò–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã–µ_–±–æ–ª–µ–∑–Ω–∏ #–¢–µ—Ä–∞–ø–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, shortage"",
  ""impact"": ""high"",
  ""english"": ""The registered vaccine 'Shingrix' for herpes zoster is not expected to be available in Russia until the second half of 2026, meaning that patients currently have no access to this single registered treatment.""
}"
2025-12-01T14:05:06+00:00,@medpharm,13810,https://t.me/medpharm/13810,–ë—Ä–∞–∑–∏–ª–∏—è –æ–¥–æ–±—Ä–∏–ª–∞ –ø–µ—Ä–≤—É—é –≤ –º–∏—Ä–µ –æ–¥–Ω–æ–¥–æ–∑–æ–≤—É—é –≤–∞–∫—Ü–∏–Ω—É –æ—Ç –ª–∏—Ö–æ—Ä–∞–¥–∫–∏ –¥–µ–Ω–≥–µ. –ù–æ–≤—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç Butantan-DV —Å–Ω–∏–∂–∞–µ—Ç —Ä–∏—Å–∫ –≥–æ—Å–ø–∏—Ç–∞–ª–∏–∑–∞—Ü–∏–∏ –Ω–∞ 100% –∏ –º–æ–∂–µ—Ç –∏–∑–º–µ–Ω–∏—Ç—å –ø–æ–¥—Ö–æ–¥ –∫ –±–æ—Ä—å–±–µ —Å –∏–Ω—Ñ–µ–∫—Ü–∏–µ–π –Ω–∞ —Ñ–æ–Ω–µ —Ä–µ–∫–æ—Ä–¥–Ω–æ–≥–æ —Ä–æ—Å—Ç–∞ –∑–∞–±–æ–ª–µ–≤–∞–µ–º–æ—Å—Ç–∏ –≤ –º–∏—Ä–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QcTUB #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-12-01T13:43:05+00:00,@medpharm,13809,https://t.me/medpharm/13809,–í –∑–∞–∫–æ–Ω ¬´–û–± –û–ú–°¬ª –≤–Ω–µ—Å–µ–Ω—ã –æ—á–µ—Ä–µ–¥–Ω—ã–µ –ø–æ–ø—Ä–∞–≤–∫–∏. –ó–∞—è–≤–ª—è–≤—à–∞—è—Å—è –∏–∑–Ω–∞—á–∞–ª—å–Ω–æ —Ä–µ—Ñ–æ—Ä–º–∞ —Å–∏—Å—Ç–µ–º—ã —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –æ—Ç–ª–æ–∂–µ–Ω–∞ –Ω–∞ –Ω–µ–æ–ø—Ä–µ–¥–µ–ª–µ–Ω–Ω—ã–π —Å—Ä–æ–∫. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QcRhR #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The law on OMS has been amended with further reforms of the medical assistance funding system being postponed indefinitely.""
}"
2025-12-01T13:18:03+00:00,@medpharm,13808,https://t.me/medpharm/13808,–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–æ –ø—Ä–æ–¥–ª–∏—Ç—å –¥–æ –∫–æ–Ω—Ü–∞ 2027 –≥–æ–¥–∞ –æ—Å–æ–±—ã–π –ø–æ—Ä—è–¥–æ–∫ –≤–≤–æ–∑–∞ –≤ —Å—Ç—Ä–∞–Ω—É –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã—Ö —É–ø–∞–∫–æ–≤–∫–∞—Ö –ø—Ä–∏ –¥–µ—Ñ–µ–∫—Ç—É—Ä–µ. –î–æ–∫—É–º–µ–Ω—Ç –≤–Ω–µ—Å–µ–Ω –Ω–∞ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏–µ –≤ –ì–æ—Å–¥—É–º—É –†–§. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QcPma #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""import_export, shortage"",
  ""impact"": ""high"",
  ""english"": ""The Russian government proposed extending the special import rules for foreign-packaged drugs until the end of 2027 due to a shortage. The document has been submitted for consideration by the State Duma of Russia. More details: https://clck.ru/3QcPma #PharmNews #Regulation""
}"
2025-12-01T13:15:01+00:00,@medpharm,13807,https://t.me/medpharm/13807,"–ö—Ä—É—Ç–æ–π –º–µ–¥–∏–∞–º–∏–∫—Å. –ö—É–¥–∞ –∏–¥—É—Ç –ø—Ä–æ–º–æ–±—é–¥–∂–µ—Ç—ã –≤ —Ñ–∞—Ä–º–µ –í –∫–æ–Ω—Ü–µ –≥–æ–¥–∞ –ø–µ—Ä–µ–¥ —É—á–∞—Å—Ç–Ω–∏–∫–∞–º–∏ —Ñ–∞—Ä–º—Ä—ã–Ω–∫–∞ —Å—Ç–æ–∏—Ç –∑–∞–¥–∞—á–∞ ‚Äî —Å–æ–≥–ª–∞—Å–æ–≤–∞—Ç—å –±—é–¥–∂–µ—Ç—ã –∏ –ø—Ä–æ–º–æ–∞–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –Ω–∞ –±–ª–∏–∂–∞–π—à–∏–π —Å–µ–∑–æ–Ω. –°–µ–≥–æ–¥–Ω—è –∫–ª–∞—Å—Å–∏—á–µ—Å–∫–∏–µ –º–∞—Ä–∫–µ—Ç–∏–Ω–≥–æ–≤—ã–µ –∫–∞–Ω–∞–ª—ã —Ä–∞–±–æ—Ç–∞—é—Ç –≤ —Ç–µ—Å–Ω–æ–π —Å–≤—è–∑–∫–µ —Å digital: –¢–í-—Ä–µ–∫–ª–∞–º–∞ –ø–æ–¥–æ–≥—Ä–µ–≤–∞–µ—Ç —Å–ø—Ä–æ—Å, –∑–∞—Ç–µ–º –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª—è –ø–µ—Ä–µ—Ö–≤–∞—Ç—ã–≤–∞—é—Ç –≤ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç–µ —á–µ—Ä–µ–∑ –∫–æ–Ω—Ç–µ–∫—Å—Ç–Ω—É—é —Ä–µ–∫–ª–∞–º—É –∏ —Å–æ—Ü—Å–µ—Ç–∏. –ì–ª–∞–≤–Ω—ã–µ —Ç—Ä–µ–Ω–¥—ã ‚Äî –ø–æ–≤—ã—à–µ–Ω–∏–µ –∞–¥—Ä–µ—Å–Ω–æ—Å—Ç–∏ –∫–æ–º–º—É–Ω–∏–∫–∞—Ü–∏–π –∏ –≤–æ–≤–ª–µ—á–µ–Ω–Ω–æ—Å—Ç–∏. –û —Ç–æ–º, –∫–∞–∫ —Ñ–∞—Ä–º–º–∞—Ä–∫–µ—Ç–∏–Ω–≥ —Å—Ç–∞–Ω–æ–≤–∏—Ç—Å—è –±–æ–ª–µ–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–Ω—ã–º, –º–∞—Å—Ç–µ—Ä—Å–∫–∏ –∑–∞–º–µ—à–∏–≤–∞—è –≤—Å–µ –±–æ–ª—å—à–µ –º–µ–¥–∏–∞–∏–Ω–≥—Ä–µ–¥–∏–µ–Ω—Ç–æ–≤, –∏ –∫—É–¥–∞ –Ω–∞–ø—Ä–∞–≤–ª—è—é—Ç—Å—è –ø—Ä–æ–º–æ–±—é–¥–∂–µ—Ç—ã, ‚Äî –≤ –º–∞—Ç–µ—Ä–∏–∞–ª–µ ¬´–§–í¬ª. –°–≤–µ–∂–∏–π –Ω–æ–º–µ—Ä ¬´–§–í¬ª ‚Ññ26-27 (1185-1186) —É–∂–µ –¥–æ—Å—Ç—É–ø–µ–Ω –æ–Ω–ª–∞–π–Ω –±–µ—Å–ø–ª–∞—Ç–Ω–æ –¥–ª—è –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª–µ–π.","{""skip"": true}"
2025-12-01T12:40:04+00:00,@medpharm,13806,https://t.me/medpharm/13806,–û–±—â–µ–µ —á–∏—Å–ª–æ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –í–ò–ß-–∏–Ω—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –≤ –†–æ—Å—Å–∏–∏ –≤—ã—Ä–æ—Å–ª–æ –∑–∞ –ø–æ—Å–ª–µ–¥–Ω–∏–π –≥–æ–¥ –Ω–∞ 35 —Ç—ã—Å. –ö–∞–∫ –ø—Ä–∞–≤–∏–ª–æ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–µ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏—Ä—É—é—Ç —É –º—É–∂—á–∏–Ω –≤ –≤–æ–∑—Ä–∞—Å—Ç–µ 35‚Äî40 –ª–µ—Ç. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QcLin #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–ò–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã–µ_–±–æ–ª–µ–∑–Ω–∏,"{""skip"": true}"
2025-12-01T12:10:07+00:00,@medpharm,13805,https://t.me/medpharm/13805,–ü–æ—Å—Ç–∞–≤–∫–∏ –≤–∞–∫—Ü–∏–Ω—ã –æ—Ç –æ–ø–æ—è—Å—ã–≤–∞—é—â–µ–≥–æ –≥–µ—Ä–ø–µ—Å–∞ ¬´–®–∏–Ω–≥—Ä–∏–∫—Å¬ª –≤ –†–§ –æ—Ç GSK –æ—Ç–ª–æ–∂–µ–Ω—ã. –ê–Ω–∞–ª–æ–≥–æ–≤ –≤ –ì–†–õ–° –Ω–µ—Ç. –û–Ω–∞ –≤–∫–ª—é—á–µ–Ω–∞ –≤ –¥–µ–π—Å—Ç–≤—É—é—â–∏–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø–æ –∏–º–º—É–Ω–∏–∑–∞—Ü–∏–∏ –≤–∑—Ä–æ—Å–ª—ã—Ö —Å –í–ò–ß-–∏–Ω—Ñ–µ–∫—Ü–∏–µ–π. –ü—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å –µ—â–µ —Ä–∞—Å—Å–º–∞—Ç—Ä–∏–≤–∞–µ—Ç –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –ø–æ—Å—Ç–∞–≤–æ–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QcJKc #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, shortage"",
  ""impact"": ""medium"",
  ""english"": ""Production of GSK's herpes zoster vaccine 'Shingrix' for Russia has been delayed due to lack of similar products. The vaccine is included in the clinical guidelines for immunization of adults with HIV infection. The manufacturer is still considering supply options.""
}"
2025-12-01T12:09:05+00:00,@medpharm,13804,https://t.me/medpharm/13804,"–ù–µ–∫–æ—Ç–æ—Ä—ã–µ —Ä–µ–≥–∏–æ–Ω—ã –ø—Ä–µ–¥–ø–æ—á–∏—Ç–∞—é—Ç –Ω–µ —Ä–∞—Å–∫—Ä—ã–≤–∞—Ç—å –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é –æ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞—Ö –ø—Ä–æ–≥—Ä–∞–º–º —ç–∫—Å—Ç—Ä–∞–∫–æ—Ä–ø–æ—Ä–∞–ª—å–Ω–æ–≥–æ –æ–ø–ª–æ–¥–æ—Ç–≤–æ—Ä–µ–Ω–∏—è. –í —Å—Ä–µ–¥–Ω–µ–º –ø–æ –†–æ—Å—Å–∏–∏, —Å–æ–≥–ª–∞—Å–Ω–æ –ø–æ–ª—É—á–µ–Ω–Ω—ã–º –¥–∞–Ω–Ω—ã–º, –ø—Ä–∏–≤–µ–ª–∏ –∫ –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏ 33% —Ü–∏–∫–ª–æ–≤ –≠–ö–û. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QcJJA #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–ê–∫—É—à–µ—Ä—Å—Ç–≤–æ_–∏_–≥–∏–Ω–µ–∫–æ–ª–æ–≥–∏—è #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,hospital_policy,pharmacovigilance"",
  ""impact"": ""medium"",
  ""english"": ""Some regions prefer not to disclose information about results of extracorporeal fertilization programs. On average, 33% of cycles lead to pregnancy in Russia according to the received data. For more details: https://clck.ru/3QcJJA #MedNews #Healthcare #Obstetrics_and_gynecology #Organization_of_healthcare""
}"
2025-12-01T11:42:29+00:00,@medpharm,13803,https://t.me/medpharm/13803,"üîî –£–∂–µ –∑–∞–≤—Ç—Ä–∞! –ü—Ä–∏–≥–ª–∞—à–∞–µ–º –∫ —É—á–∞—Å—Ç–∏—é –≤ –≤–µ–±–∏–Ω–∞—Ä–µ –Ω–∞—à–∏—Ö –∫–æ–ª–ª–µ–≥ ¬´–†–µ—à–µ–Ω–∏–µ –∞–∫—Ç—É–∞–ª—å–Ω—ã—Ö –∑–∞–¥–∞—á —Ñ–∞—Ä–º–º–∞—Ä–∫–µ—Ç–∏–Ω–≥–∞ –≤–º–µ—Å—Ç–µ —Å AlphaRM¬ª, –≥–¥–µ –±—É–¥—É—Ç —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω—ã –∫–ª—é—á–µ–≤—ã–µ –≤–æ–ø—Ä–æ—Å—ã –æ—Ç—Ä–∞—Å–ª–∏. –ö–æ–≥–¥–∞: 2 –¥–µ–∫–∞–±—Ä—è –≤ 11:00 (–ø–æ –º—Å–∫) –í–µ–±–∏–Ω–∞—Ä –±—É–¥–µ—Ç —Å–æ—Å—Ç–æ—è—Ç—å –∏–∑ 2-—Ö –±–ª–æ–∫–æ–≤: ‚û°Ô∏è–ö–∞–∫ –Ω–∞–π—Ç–∏ ¬´—Å–≤–æ–∏—Ö¬ª –≤—Ä–∞—á–µ–π ‚Äì –Ω–æ–≤–æ–µ –≤ –ø–æ–¥—Ö–æ–¥–∞—Ö –¥–ª—è —Å–µ–≥–º–µ–Ω—Ç–∞—Ü–∏–∏–∏ —Ç–∞—Ä–≥–µ—Ç–∏–Ω–≥–∞. ‚û°Ô∏è–ö–∞–∫–∞—è —Ü–µ–Ω–∞ —É—Å–ø–µ—Ö–∞ –Ω–∞ –∞–ø—Ç–µ—á–Ω–æ–π –ø–æ–ª–∫–µ? –°–ø–∏–∫–µ—Ä: –ü–∞–≤–µ–ª –¢–∞–∑–ª–æ–≤, –¥–∏—Ä–µ–∫—Ç–æ—Ä –ø–æ –º–∞—Ä–∫–µ—Ç–∏–Ω–≥—É –∏ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è–º AlphaRM. –ó–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞—Ç—å—Å—è –Ω–∞ –≤–µ–±–∏–Ω–∞—Ä","{""skip"": true}"
2025-12-01T10:49:03+00:00,@medpharm,13802,https://t.me/medpharm/13802,"–£—Ç–≤–µ—Ä–∂–¥–µ–Ω —Å–æ—Å—Ç–∞–≤ –æ–±–Ω–æ–≤–ª–µ–Ω–Ω–æ–π –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–µ–Ω–Ω–æ–π –∫–æ–º–∏—Å—Å–∏–∏ –ø–æ –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏. –ö–∞–∫–∏–µ –≤–æ–ø—Ä–æ—Å—ã –±—É–¥–µ—Ç —Ä–µ—à–∞—Ç—å –æ—Ä–≥–∞–Ω, –ø—Ä–∏—à–µ–¥—à–∏–π –Ω–∞ —Å–º–µ–Ω—É –∫–æ–º–∏—Å—Å–∏–∏ –ø–æ –∏–º–ø–æ—Ä—Ç–æ–∑–∞–º–µ—â–µ–Ω–∏—é? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QcBWS #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-12-01T10:37:05+00:00,@medpharm,13801,https://t.me/medpharm/13801,"–û–±—ä–µ–º –∫–æ–º–º–µ—Ä—á–µ—Å–∫–∏—Ö –º–µ–¥—É—Å–ª—É–≥ –≤ –†–æ—Å—Å–∏–∏ –≤—ã—Ä–∞—Å—Ç–µ—Ç –≤ 2025 –≥–æ–¥—É –Ω–∞ 15,2%. –°—Ä–µ–¥–∏ –∫–ª—é—á–µ–≤—ã—Ö –¥—Ä–∞–π–≤–µ—Ä–æ–≤ ‚Äî –ø—Ä–∏—Ç–æ–∫ —á–∏—Å–ª–∞ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –ø–æ–≤—ã—à–µ–Ω–∏–µ —Å—Ä–µ–¥–Ω–µ–≥–æ —á–µ–∫–∞ –∑–∞ –æ–∫–∞–∑–∞–Ω–Ω—ã–µ —É—Å–ª—É–≥–∏, —Ä–∞—Å—à–∏—Ä–µ–Ω–∏–µ —Å–µ—Ç–∏ –∫–æ–º–º–µ—Ä—á–µ—Å–∫–∏—Ö —Å—Ç–∞—Ü–∏–æ–Ω–∞—Ä–æ–≤, –∞ —Ç–∞–∫–∂–µ —É–≤–µ–ª–∏—á–µ–Ω–∏–µ —Å–ø—Ä–æ—Å–∞ –Ω–∞ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–µ –æ–±—Å–ª—É–∂–∏–≤–∞–Ω–∏–µ –≤ –ø—Ä–µ–º–∏–∞–ª—å–Ω–æ–º —Å–µ–≥–º–µ–Ω—Ç–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QcAdG #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ–Ω–¥–µ–Ω—Ü–∏–∏ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The commercial healthcare services market in Russia is projected to grow by 15.2% in 2025 driven by an increase in patient numbers, higher average charges for services provided, expansion of commercial hospitals network, and increased demand for domestic healthcare in the premium segment. For more details: #MedVestnik #Trends #HealthcareOrganization""
}"
2025-12-01T10:37:02+00:00,@medpharm,13800,https://t.me/medpharm/13800,"–ì—Ä—É–ø–ø–∞ –∫–æ–º–ø–∞–Ω–∏–π ¬´–†-–§–∞—Ä–º¬ª –∑–∞–∫–ª—é—á–∏–ª–∞ —Å–æ–≥–ª–∞—à–µ–Ω–∏–µ —Å —Ç–∞–π–≤–∞–Ω—å—Å–∫–æ–π –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–µ–π TaiMed Biologics –æ –≤–≤–æ–∑–µ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –Ω–∞ –æ—Å–Ω–æ–≤–µ –∏–±–∞–ª–∏–∑—É–º–∞–±–∞ –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ –∏–Ω—Ñ–µ–∫—Ü–∏–∏ –í–ò–ß-1, —É—Å—Ç–æ–π—á–∏–≤–æ–π –∫ —Å—Ç–∞–Ω–¥–∞—Ä—Ç–Ω—ã–º –º–µ—Ç–æ–¥–∞–º –ª–µ—á–µ–Ω–∏—è. –û–Ω —Å—Ç–∞–Ω–µ—Ç –ø–µ—Ä–≤—ã–º –≤ –†–æ—Å—Å–∏–∏ –∏–º–º—É–Ω–æ–±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–º –∞–Ω—Ç–∏—Ä–µ—Ç—Ä–æ–≤–∏—Ä—É—Å–Ω—ã–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–º –¥–ª–∏—Ç–µ–ª—å–Ω–æ–≥–æ –¥–µ–π—Å—Ç–≤–∏—è –∏ –±—É–¥–µ—Ç –¥–æ—Å—Ç—É–ø–µ–Ω –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –ø–æ –∂–∏–∑–Ω–µ–Ω–Ω—ã–º –ø–æ–∫–∞–∑–∞–Ω–∏—è–º, —á—Ç–æ –ø–æ–∑–≤–æ–ª–∏—Ç –ø–æ —Ä–∞–∑—Ä–µ—à–µ–Ω–∏—é –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–æ—Å—Å–∏–∏ –ø–æ—Å—Ç–∞–≤–ª—è—Ç—å –≤ –∏–Ω–¥–∏–≤–∏–¥—É–∞–ª—å–Ω–æ–º –ø–æ—Ä—è–¥–∫–µ —Ç–µ—Ä–∞–ø–∏—é, –æ–¥–æ–±—Ä–µ–Ω–Ω—É—é –≤ –¥—Ä—É–≥–∏—Ö —Å—Ç—Ä–∞–Ω–∞—Ö. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QcAdK #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-12-01T10:27:04+00:00,@medpharm,13799,https://t.me/medpharm/13799,"–ù–∞ 68-–º –≥–æ–¥—É –∂–∏–∑–Ω–∏ —Å–∫–æ–Ω—á–∞–ª—Å—è –≥–µ–Ω–µ—Ä–∞–ª—å–Ω—ã–π —Å–µ–∫—Ä–µ—Ç–∞—Ä—å –†–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –Ω–∞—É—á–Ω–æ–≥–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –æ–±—â–µ—Å—Ç–≤–∞ —Ç–µ—Ä–∞–ø–µ–≤—Ç–æ–≤, –≥–ª–∞–≤–Ω—ã–π –≤–Ω–µ—à—Ç–∞—Ç–Ω—ã–π —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç‚Äì–ø—É–ª—å–º–æ–Ω–æ–ª–æ–≥ –¶–§–û –ê–Ω–¥—Ä–µ–π –ú–∞–ª—è–≤–∏–Ω. –í–æ –≤—Ä–µ–º—è –ø–∞–Ω–¥–µ–º–∏–∏ COVID-19 –≤—ã—Å—Ç—É–ø–∞–ª –ø—Ä–æ—Ç–∏–≤ –∏–∑–±—ã—Ç–æ—á–Ω–æ–≥–æ –Ω–∞–∑–Ω–∞—á–µ–Ω–∏—è –∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫–æ–≤, –≥–∏–¥—Ä–æ–∫—Å–∏—Ö–ª–æ—Ä–∏–Ω–∞ –∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –Ω–µ –∏—Å–ø–æ–ª—å–∑—É–µ–º—ã—Ö –≤ –º–∏—Ä–æ–≤–æ–π –ø—Ä–∞–∫—Ç–∏–∫–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qc9pb #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–ü—É–ª—å–º–æ–Ω–æ–ª–æ–≥–∏—è_–∏_—Ñ—Ç–∏–∑–∏–∞—Ç—Ä–∏—è #–¢–µ—Ä–∞–ø–∏—è","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""clinical_trial, safety"",
  ""impact"": ""medium"",
  ""english"": ""He was a pulmonologist and chief specialist for the region. During the pandemic, he spoke against overprescribing antibiotics, hydroxychloroquine, and drugs not used in global practice. He was involved in clinical trials.""
}"
2025-12-01T09:33:03+00:00,@medpharm,13798,https://t.me/medpharm/13798,–§–ê–° –†–§ —É—Å—Ç–∞–Ω–æ–≤–∏–ª–∞ —Ü–µ–Ω—É –Ω–∞ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π –¥–∂–µ–Ω–µ—Ä–∏–∫ –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ –¥–∏–∞–±–µ—Ç–∞ 2-–≥–æ —Ç–∏–ø–∞. –°–∫–æ–ª—å–∫–æ –±—É–¥–µ—Ç —Å—Ç–æ–∏—Ç—å –∞–Ω–∞–ª–æ–≥ ¬´–°—Ç–∏–≥–ª–∞—Ç—Ä—ã¬ª? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qc5Nu #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""pricing"",
  ""impact"": ""medium"",
  ""english"": ""The FAS (Federal Agency for State Statistics) of Russia has set the price for a domestic generic drug for type 2 diabetes treatment. How much will 'Stiglatra' cost?""
}"
2025-12-01T09:14:11+00:00,@medpharm,13797,https://t.me/medpharm/13797,"–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§ —É—Ç–≤–µ—Ä–¥–∏–ª–æ –ø–æ—Ä—è–¥–æ–∫ –≤—ã–¥–∞—á–∏ –ª–∏—Ü–µ–Ω–∑–∏–π –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è–º, –∫–æ—Ç–æ—Ä—ã–µ –æ–±—É—á–∞—é—Ç —Å—Ç—É–¥–µ–Ω—Ç–æ–≤ –ø–æ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—ã–º –ø—Ä–æ–≥—Ä–∞–º–º–∞–º –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–≥–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è. –ü—Ä–æ—Ü–µ–¥—É—Ä–∞ –ø—Ä–µ–¥–ø–æ–ª–∞–≥–∞–µ—Ç –ø—Ä–æ–≤–µ—Ä–∫—É –∫–∞–¥—Ä–æ–≤–æ–≥–æ –∏ –º–∞—Ç–µ—Ä–∏–∞–ª—å–Ω–æ-—Ç–µ—Ö–Ω–∏—á–µ—Å–∫–æ–≥–æ –æ—Å–Ω–∞—â–µ–Ω–∏—è, –∞ –Ω–∞ –≤–µ—Å—å –ø—Ä–æ—Ü–µ—Å—Å –æ—Ç–≤–æ–¥–∏—Ç—Å—è –≤—Å–µ–≥–æ –ø—è—Ç—å –¥–Ω–µ–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qc3si #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–û–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The Russian government approved a licensing process for organizations that train students in professional medical and pharmaceutical education programs. The procedure involves checking the personnel and material equipment, with a process duration of five days.""
}"
2025-12-01T08:29:03+00:00,@medpharm,13796,https://t.me/medpharm/13796,"–ü—Ä–µ–ø–∞—Ä–∞—Ç Otsuka —Å–Ω–∏–∑–∏–ª –ø—Ä–æ—Ç–µ–∏–Ω—É—Ä–∏—é –Ω–∞ 51%, —á—Ç–æ –≤—ã—à–µ –ø–æ–∫–∞–∑–∞—Ç–µ–ª–µ–π –∞–Ω–∞–ª–æ–≥–æ–≤. –ö–∞–∫ —Ä–∞–±–æ—Ç–∞–µ—Ç –Ω–æ–≤—ã–π –∫–ª–∞—Å—Å –ª–µ–∫–∞—Ä—Å—Ç–≤, –±–ª–æ–∫–∏—Ä—É—é—â–∏—Ö –±–µ–ª–æ–∫ APRIL? –ü–æ–¥—Ä–æ–±–Ω–æ—Å—Ç–∏ –∏ —Å—Ä–∞–≤–Ω–µ–Ω–∏–µ –∫–æ–Ω–∫—É—Ä–µ–Ω—Ç–æ–≤ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QbxsA #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-12-01T07:57:02+00:00,@medpharm,13795,https://t.me/medpharm/13795,"–° 1 —è–Ω–≤–∞—Ä—è 2026 –≥–æ–¥–∞ –ú–†–û–¢ –≤—ã—Ä–∞—Å—Ç–µ—Ç –Ω–∞ 20,7%, –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç –ø–æ–¥–ø–∏—Å–∞–ª –∑–∞–∫–æ–Ω. –†–∞–Ω–µ–µ –¥–µ–ø—É—Ç–∞—Ç—ã –ì–æ—Å–¥—É–º—ã –†–§ –ø—Ä–µ–¥–ª–∞–≥–∞–ª–∏ —É–≤–µ–ª–∏—á–∏—Ç—å –º–∏–Ω–∏–º–∞–ª—å–Ω—ã–π —Ä–∞–∑–º–µ—Ä –æ–ø–ª–∞—Ç—ã —Ç—Ä—É–¥–∞ –≤–¥–≤–æ–µ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qbuym #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""high"",
  ""english"": ""The minimum wage will increase by 20.7% starting January 1, 2026. Previously, Russian deputies proposed doubling the minimum salary. For more details: https://clck.ru/3Qbuym #Farmaudite #Regulatorka""
}"
2025-12-01T07:53:04+00:00,@medpharm,13794,https://t.me/medpharm/13794,–ü–∞—Ü–∏–µ–Ω—Ç—Å–∫–æ–µ —Å–æ–æ–±—â–µ—Å—Ç–≤–æ –ø—Ä–∏–∑—ã–≤–∞–µ—Ç –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–æ –æ–±—Ä–∞—Ç–∏—Ç—å –≤–Ω–∏–º–∞–Ω–∏–µ –Ω–∞ –ø—Ä–æ–±–ª–µ–º—ã —Å –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ–º –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –±–æ–ª—å–Ω—ã—Ö. –≠–∫—Å–ø–µ—Ä—Ç—ã –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç –ø—É—Ç–∏ –≤—ã—Ö–æ–¥–∞ –∏–∑ —Å–∏—Ç—É–∞—Ü–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qbucx #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ú—ã—Å–ª–∏_–≤—Å–ª—É—Ö #–û–Ω–∫–æ–ª–æ–≥–∏—è #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è #–¢–µ—Ä–∞–ø–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The patient community is urging the government to pay attention to problems with oncology patients' medication. Experts propose ways out of the situation. More details: https://clck.ru/3Qbucx #Mednews #ThoughtsOutLoud #Oncology #HealthOrganization #Therapy""
}"
2025-12-01T07:08:03+00:00,@medpharm,13793,https://t.me/medpharm/13793,–í –ö–µ–º–µ—Ä–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –Ω–µ—Å–∫–æ–ª—å–∫–æ —á–∏–Ω–æ–≤–Ω–∏–∫–æ–≤ –æ—Ç –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è —Å—Ç–∞–ª–∏ —Ñ–∏–≥—É—Ä–∞–Ω—Ç–∞–º–∏ —É–≥–æ–ª–æ–≤–Ω—ã—Ö –¥–µ–ª –æ –∫–æ—Ä—Ä—É–ø—Ü–∏–∏. –†–∞—Å—Å–ª–µ–¥–æ–≤–∞–≤—à–∏–π –∏—Ö —Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å –∑–∞–¥–µ—Ä–∂–∞–Ω. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qbr5W #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-12-01T06:49:03+00:00,@medpharm,13792,https://t.me/medpharm/13792,¬´–°–æ—é–∑–§–∞—Ä–º–∞¬ª –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–∞–µ—Ç: –º–∞–ª—ã–µ –∞–ø—Ç–µ–∫–∏ –≤ —Ä–µ–≥–∏–æ–Ω–∞—Ö –º–∞—Å—Å–æ–≤–æ –∑–∞–∫—Ä–æ—é—Ç—Å—è —Å 2026 –≥–æ–¥–∞. –ö–∞–∫–∏–µ –ª—å–≥–æ—Ç—ã –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç –≤–≤–µ—Å—Ç–∏ –¥–ª—è —Å–ø–∞—Å–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QbpY7 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""medium"",
  ""english"": ""Union Pharma warns that small pharmacies across regions will be mass-closed starting in 2026. What incentives are being offered to save the pharmaceutical supply?""
}"
2025-12-01T06:44:04+00:00,@medpharm,13791,https://t.me/medpharm/13791,–ï–∂–µ–Ω–µ–¥–µ–ª—å–Ω—ã–π –æ–±–∑–æ—Ä –ø—Ä–∏–Ω—è—Ç—ã—Ö –∏ –≥–æ—Ç–æ–≤—è—â–∏—Ö—Å—è –∫ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏—é –∏ —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏—é –æ—Ç—Ä–∞—Å–ª–µ–≤—ã—Ö –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω–æ-–ø—Ä–∞–≤–æ–≤—ã—Ö –∞–∫—Ç–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QbpA7 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""medium"",
  ""english"": ""Weekly review of accepted and pending industry normative legal acts for consideration and approval. More details: https://clck.ru/3QbpA7 #FarmVestnik #Regulatorka""
}"
2025-12-01T06:44:03+00:00,@medpharm,13790,https://t.me/medpharm/13790,"–ü—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º TOP5 —Å–æ–±—ã—Ç–∏–π –Ω–µ–¥–µ–ª–∏, –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω–Ω—ã—Ö –≤ –ª–µ–Ω—Ç–µ –Ω–æ–≤–æ—Å—Ç–µ–π ¬´–§–í¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qbp9z #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{""skip"": true}"
2025-12-01T06:06:06+00:00,@medpharm,13789,https://t.me/medpharm/13789,"–ö–∞–∫ –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ —Å—ç–∫–æ–Ω–æ–º–∏—Ç—å —Å–æ—Ç–Ω–∏ —Ç—ã—Å—è—á —Ä—É–±–ª–µ–π –Ω–∞ –≤—ã–≤–æ–∑–µ –æ—Ç—Ö–æ–¥–æ–≤, –æ–± –æ—à–∏–±–∫–∞—Ö —Ä–∞—Å—Ö–æ–¥–æ–≤–∞–Ω–∏—è —Å—Ä–µ–¥—Å—Ç–≤ –û–ú–° –∏ –Ω–∞—Ä—É—à–µ–Ω–∏—è—Ö –ø—Ä–∏ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏–∏ –∞–±–æ—Ä—Ç–æ–≤ ‚Äî –≤ —Ä–µ–π—Ç–∏–Ω–≥–µ –Ω–æ–≤–æ—Å—Ç–µ–π –ø—Ä–æ—à–µ–¥—à–µ–≥–æ –º–µ—Å—è—Ü–∞ –¥–ª—è –æ—Ä–≥–∞–Ω–∏–∑–∞—Ç–æ—Ä–æ–≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –≤ –ø—É–±–ª–∏–∫–∞—Ü–∏—è—Ö –ª–µ–Ω—Ç—ã –Ω–æ–≤–æ—Å—Ç–µ–π ¬´–ú–í¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QbmZM #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-11-30T11:52:01+00:00,@medpharm,13788,https://t.me/medpharm/13788,"üëçüëçüëçüëçüëçüëç –ü—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º TOP5 —Å–æ–±—ã—Ç–∏–π –Ω–µ–¥–µ–ª–∏, –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω–Ω—ã—Ö –≤ –ª–µ–Ω—Ç–µ –Ω–æ–≤–æ—Å—Ç–µ–π ¬´–§–í¬ª. –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§ –ø–æ–¥–¥–µ—Ä–∂–∞–ª–æ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏–∏ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–∞ –ø–æ —Ä–æ–∑–Ω–∏—á–Ω–æ–π —Ç–æ—Ä–≥–æ–≤–ª–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏ –≤ –ø–µ—Ä–µ–¥–≤–∏–∂–Ω—ã—Ö –∞–ø—Ç–µ—á–Ω—ã—Ö –ø—É–Ω–∫—Ç–∞—Ö. –°—É–¥ –æ—Ç–∫–∞–∑–∞–ª ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º—É¬ª –≤ –∏—Å–∫–µ –∫ —Å–æ–∑–¥–∞—Ç–µ–ª—è–º —à–æ—É ¬´–ë–æ–ª—å—à–∏–µ –¥–µ–≤–æ—á–∫–∏¬ª. –°—Ç–∞—Ä—Ç –º–µ—Ö–∞–Ω–∏–∑–º–∞ –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ —Ä–µ–∂–∏–º–∞ –≥–æ—Å–∑–∞–∫—É–ø–æ–∫ ¬´–≤—Ç–æ—Ä–æ–π –ª–∏—à–Ω–∏–π¬ª –¥–ª—è –°–ó–õ–° —Å–Ω–æ–≤–∞ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –ø–µ—Ä–µ–Ω–µ—Å—Ç–∏. –£—á–∞—Å—Ç–Ω–∏–∫–∏ III —Å—ä–µ–∑–¥–∞ –†–ê–ê–° –æ–±—Å—É–¥–∏–ª–∏ –ø—Ä–æ–±–ª–µ–º—É –≤—ã–≥–æ—Ä–∞–Ω–∏—è —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤ –∞–ø—Ç–µ–∫ –∏ –¥–µ—Ñ–∏—Ü–∏—Ç–∞ –∫–∞–¥—Ä–æ–≤. –≠–∫—Å–ø–µ—Ä—Ç—ã –æ—Ç–º–µ—Ç–∏–ª–∏ –ø–∞–¥–µ–Ω–∏–µ –ø—Ä–µ—Å—Ç–∏–∂–∞ –ø—Ä–æ—Ñ–µ—Å—Å–∏–∏ –∏ –≤—ã—Å–æ–∫—É—é –Ω–∞–≥—Ä—É–∑–∫—É. –°—É–¥ –æ—Ç–º–µ–Ω–∏–ª —Ä–µ—à–µ–Ω–∏–µ –§–ê–° –†–æ—Å—Å–∏–∏, –∫–æ—Ç–æ—Ä–∞—è –ø—Ä–∏–∑–Ω–∞–ª–∞ –Ω–µ–¥–æ–±—Ä–æ—Å–æ–≤–µ—Å—Ç–Ω–æ–π –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏–µ–π –≤–≤–µ–¥–µ–Ω–∏–µ –≤ –æ–±–æ—Ä–æ—Ç –±–æ–∑—É—Ç–∏–Ω–∏–±–∞ –∫–æ–º–ø–∞–Ω–∏–µ–π ¬´–ê–∫—Å–µ–ª—å–§–∞—Ä–º¬ª.","{
  ""skip"": true
}"
2025-11-30T07:23:56+00:00,@medpharm,13787,https://t.me/medpharm/13787,"üß©üß©üß©üß©üß©üß© –ü—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º —Ä–µ–π—Ç–∏–Ω–≥ –≥–ª–∞–≤–Ω—ã—Ö –Ω–æ–≤–æ—Å—Ç–µ–π –Ω–µ–¥–µ–ª–∏ –≤ –ø—É–±–ª–∏–∫–∞—Ü–∏—è—Ö –ª–µ–Ω—Ç—ã –Ω–æ–≤–æ—Å—Ç–µ–π ¬´–ú–í¬ª. –í –°–µ—á–µ–Ω–æ–≤—Å–∫–æ–º —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–µ –ª–∏–∫–≤–∏–¥–∏—Ä–æ–≤–∞–Ω–∞ –∫–∞—Ñ–µ–¥—Ä–∞ —ç–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–∏–∏ ‚Ññ 1, –∞ –µ–µ —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å, –∏–∑–≤–µ—Å—Ç–Ω—ã–π —ç–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥ –í–∞–ª–µ–Ω—Ç–∏–Ω –§–∞–¥–µ–µ–≤ —É–≤–æ–ª–µ–Ω. –û–¥–Ω–æ–≤—Ä–µ–º–µ–Ω–Ω–æ —Å —ç—Ç–∏–º –≤—É–∑ —Å–æ–æ–±—â–∏–ª –æ —Å–æ–∑–¥–∞–Ω–∏–∏ –∞–Ω–∞–ª–æ–≥–∏—á–Ω–æ–π –∫–∞—Ñ–µ–¥—Ä—ã ‚Äî —ç–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–∏–∏ –∏ –º–µ—Ç–∞–±–æ–ª–∏—á–µ—Å–∫–æ–≥–æ –∑–¥–æ—Ä–æ–≤—å—è ‚Äî —Å –Ω–æ–≤—ã–º —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª–µ–º. –ù–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ –≤ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω–æ–º TOP5 —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –æ–ø—Ä–æ—Å–∞, –ø—Ä–æ–≤–µ–¥–µ–Ω–Ω–æ–≥–æ –í—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–∏–º —Å–æ—é–∑–æ–º –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ (–í–°–ü), –∫–æ—Ç–æ—Ä—ã–µ –ø–æ–∫–∞–∑–∞–ª–∏, —á—Ç–æ —Ä–æ—Å—Å–∏—è–Ω–µ –Ω–µ –Ω–∞–±–ª—é–¥–∞—é—Ç —è–≤–Ω—ã—Ö –∏–∑–º–µ–Ω–µ–Ω–∏–π –≤ —Å–∏—Å—Ç–µ–º–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ –∫–æ–Ω–∫—Ä–µ—Ç–∏–∑–∏—Ä–æ–≤–∞–ª —Å—Ä–æ–∫–∏ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–π –æ—Ç—Ä–∞–±–æ—Ç–∫–∏ –¥–ª—è –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ —Ä–∞–∑–Ω—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–µ–π. –ù–∞ —á–µ—Ç–≤–µ—Ä—Ç–æ–º –º–µ—Å—Ç–µ –≤ TOP5 –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–µ –ø–∞—Ä–ª–∞–º–µ–Ω—Ç–∞—Ä–∏–µ–≤ –¥–∞—Ç—å –ø—Ä–∞–≤–æ –ø–∞—Ü–∏–µ–Ω—Ç–∞–º –Ω–∞ —Å–æ–∑—ã–≤ –≤—Ä–∞—á–µ–±–Ω–æ–≥–æ –∫–æ–Ω—Å–∏–ª–∏—É–º–∞. –° —Ç–∞–∫–æ–π –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–æ–π –¥–µ–ø—É—Ç–∞—Ç—ã –¥—É–º—Å–∫–æ–π —Ñ—Ä–∞–∫—Ü–∏–∏ ¬´–ù–æ–≤—ã–µ –ª—é–¥–∏¬ª –æ–±—Ä–∞—Ç–∏–ª–∏—Å—å –∫ –º–∏–Ω–∏—Å—Ç—Ä—É –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –†–§. –ó–∞–º—ã–∫–∞–µ—Ç –ø—è—Ç–µ—Ä–∫—É –Ω–æ–≤–æ—Å—Ç–µ–π –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–µ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–§ –ø–µ—Ä–µ—Å–º–æ—Ç—Ä–µ—Ç—å —É—Å–ª–æ–≤–∏—è –≥–æ—Å–ø—Ä–æ–≥—Ä–∞–º–º—ã –º–æ–¥–µ—Ä–Ω–∏–∑–∞—Ü–∏–∏ –ø–µ—Ä–≤–∏—á–Ω–æ–≥–æ –∑–≤–µ–Ω–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è, –∫–æ—Ç–æ—Ä–∞—è –≤ —Ä–∞–º–∫–∞—Ö –Ω–∞—Ü–ø—Ä–æ–µ–∫—Ç–∞ ¬´–ü—Ä–æ–¥–æ–ª–∂–∏—Ç–µ–ª—å–Ω–∞—è –∏ –∞–∫—Ç–∏–≤–Ω–∞—è –∂–∏–∑–Ω—å¬ª –±—ã–ª–∞ –ø—Ä–æ–¥–ª–µ–Ω–∞ –¥–æ 2030 –≥–æ–¥–∞.","{""skip"": true}"
2025-11-29T13:54:03+00:00,@medpharm,13786,https://t.me/medpharm/13786,–í –†–æ—Å—Å–∏–∏ —Ä–∞—Å—à–∏—Ä—è—Ç —Å–ø–∏—Å–æ–∫ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –¥–ª—è –Ω–µ–æ–Ω–∞—Ç–∞–ª—å–Ω–æ–≥–æ —Å–∫—Ä–∏–Ω–∏–Ω–≥–∞. –í –ø–µ—Ä–µ—á–µ–Ω—å —Å 2026 –≥–æ–¥–∞ –≤–æ–π–¥—É—Ç –¥–µ—Ñ–∏—Ü–∏—Ç –¥–µ–∫–∞—Ä–±–æ–∫—Å–∏–ª–∞–∑—ã –∞—Ä–æ–º–∞—Ç–∏—á–µ—Å–∫–∏—Ö L-–∞–º–∏–Ω–æ–∫–∏—Å–ª–æ—Ç –∏ –•-—Å—Ü–µ–ø–ª–µ–Ω–Ω–∞—è –∞–¥—Ä–µ–Ω–æ–ª–µ–π–∫–æ–¥–∏—Å—Ç—Ä–æ—Ñ–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QaU6d #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞ #–ì–µ–Ω–µ—Ç–∏–∫–∞ #–ü–µ–¥–∏–∞—Ç—Ä–∏—è,"{""skip"": true}"
2025-11-29T07:19:03+00:00,@medpharm,13785,https://t.me/medpharm/13785,–ê—Å—Å–æ—Ü–∏–∞—Ü–∏—è –∫–ª–∏–Ω–∏–∫ –í–†–¢ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∞ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤—É –∞–∫—Ç–∏–≤–Ω–µ–µ —Å–æ—Ç—Ä—É–¥–Ω–∏—á–∞—Ç—å —Å —á–∞—Å—Ç–Ω—ã–º —Å–µ–∫—Ç–æ—Ä–æ–º –≤ –≤–æ–ø—Ä–æ—Å–∞—Ö –ª–µ—á–µ–Ω–∏—è –±–µ—Å–ø–ª–æ–¥–∏—è –∏ –Ω–µ —Å–Ω–∏–∂–∞—Ç—å –µ–≥–æ —É—á–∞—Å—Ç–∏–µ –≤ –≥–æ—Å–ø—Ä–æ–≥—Ä–∞–º–º–∞—Ö. –ù–∞ –¥–æ–ª—é –Ω–µ–≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –º–µ–¥—Ü–µ–Ω—Ç—Ä–æ–≤ –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è 72% –≤—Å–µ—Ö —Ü–∏–∫–ª–æ–≤ –≠–ö–û –≤ –†–æ—Å—Å–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Qa7eA #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–ê–∫—É—à–µ—Ä—Å—Ç–≤–æ_–∏_–≥–∏–Ω–µ–∫–æ–ª–æ–≥–∏—è #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The Association of Reproductive Clinics proposed to the government to actively cooperate with the private sector in issues related to infertility treatment and not reduce their participation in state programs. 72% of all IVF cycles are carried out by non-state medical centers in Russia.""
}"
2025-11-29T04:49:03+00:00,@medpharm,13784,https://t.me/medpharm/13784,"–£–≤–æ–ª—å–Ω–µ–Ω–∏—è –≤ –°–µ—á–µ–Ω–æ–≤—Å–∫–æ–º —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–µ, –æ–ø—Ä–æ—Å—ã –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –æ –∫–∞—á–µ—Å—Ç–≤–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è, –Ω–æ–≤—ã–µ –ø—Ä–∞–≤–∏–ª–∞ –æ—Ç—Ä–∞–±–æ—Ç–∫–∏ –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –∏ –º–æ–¥–µ—Ä–Ω–∏–∑–∞—Ü–∏—è –ø–µ—Ä–≤–∏—á–Ω–æ–≥–æ –∑–≤–µ–Ω–∞ –∏ –¥—Ä—É–≥–∏–µ –Ω–æ–≤–æ—Å—Ç–∏ –º–∏–Ω—É–≤—à–µ–π –Ω–µ–¥–µ–ª–∏.‚Äã –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QZzbp #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-11-28T16:33:56+00:00,@medpharm,13783,https://t.me/medpharm/13783,"ü¶æ –¢–æ–∂–µ –≤–∞—Ä–∏–∞–Ω—Ç. –í—ã–ø—É—Å–∫–Ω–∏–∫ –º–µ–¥–≤—É–∑–∞ –∏–ª–∏ –∫–æ–ª–ª–µ–¥–∂–∞ –º–æ–∂–µ—Ç –æ—Ç–∫–∞–∑–∞—Ç—å—Å—è –æ—Ç —Ä–∞–±–æ—Ç—ã –≤ –≥–æ—Å–º–µ–¥–∏—Ü–∏–Ω–µ –ø–æ–¥ —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–æ–º –Ω–∞—Å—Ç–∞–≤–Ω–∏–∫–∞, –Ω–æ –≤ —ç—Ç–æ–º —Å–ª—É—á–∞–µ –µ–º—É –Ω—É–∂–Ω–æ –±—É–¥–µ—Ç –ø—Ä–æ–π—Ç–∏ –ø–µ—Ä–≤–∏—á–Ω—É—é –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏—é –≤–º–µ—Å—Ç–æ –ø–µ—Ä–∏–æ–¥–∏—á–µ—Å–∫–æ–π, –æ–±—ä—è—Å–Ω–∏–ª –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—å –ö–æ–º–∏—Ç–µ—Ç–∞ –ì–æ—Å–¥—É–º—ã –†–§ –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è –°–µ—Ä–≥–µ–π –õ–µ–æ–Ω–æ–≤. ü¶æ –¢–æ–ª—å–∫–æ –∫–∏–≤–∞—Ç—å. –°–µ—á–µ–Ω–æ–≤—Å–∫–∏–π –º–µ–¥—É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç —É–≤–æ–ª–∏–ª –µ—â–µ –æ–¥–Ω–æ–≥–æ –ø—Ä–µ–ø–æ–¥–∞–≤–∞—Ç–µ–ª—è –ø–æ—Å–ª–µ –∫—Ä–∏—Ç–∏–∫–∏ –∑–∞–∫–æ–Ω–∞ –æ–± –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã—Ö –æ—Ç—Ä–∞–±–æ—Ç–∫–∞—Ö –¥–ª—è –º–æ–ª–æ–¥—ã—Ö –≤—Ä–∞—á–µ–π. –ê–Ω—Ç–æ–Ω –ï—Ä—à–æ–≤ —É—Å–æ–º–Ω–∏–ª—Å—è –≤ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –Ω–æ–≤–æ–≤–≤–µ–¥–µ–Ω–∏—è. ‚ù§Ô∏è –ï—â–µ –Ω–µ –≤—Ä–µ–º—è. –°—Ç–∞—Ä—Ç ¬´–≤—Ç–æ—Ä–æ–≥–æ –ª–∏—à–Ω–µ–≥–æ¬ª –¥–ª—è —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Å–Ω–æ–≤–∞ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –ø–µ—Ä–µ–Ω–µ—Å—Ç–∏. –ü–æ—á–µ–º—É —Ñ–∞—Ä–º—Ä—ã–Ω–æ–∫ –ø–æ–¥–¥–µ—Ä–∂–∞–ª –ø–µ—Ä–µ–Ω–æ—Å –∏ –∫–∞–∫ —ç—Ç–æ –æ—Ç—Ä–∞–∑–∏—Ç—Å—è –Ω–∞ –ø–∞—Ü–∏–µ–Ω—Ç–∞—Ö? ‚ù§Ô∏è –°–∫–æ—Ä–æ –ø–æ–µ–¥—É—Ç. –ó–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ –ø–µ—Ä–µ–¥–≤–∏–∂–Ω—ã—Ö –∞–ø—Ç–µ–∫–∞—Ö –±—É–¥–µ—Ç –¥–æ—Ä–∞–±–æ—Ç–∞–Ω. –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§ –ø–æ–¥–¥–µ—Ä–∂–∞–ª–æ –µ–≥–æ, —É–∫–∞–∑–∞–≤ –∞–≤—Ç–æ—Ä–∞–º –Ω–∞ —Ä—è–¥ —é—Ä–∏–¥–∏—á–µ—Å–∫–∏—Ö –∑–∞–º–µ—á–∞–Ω–∏–π.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance"",
  ""impact"": ""medium"",
  ""english"": ""The law on mandatory rotations for young doctors has been criticized. The chairman of the State Duma Committee on Health Care, Sergey Leontyev, explained that a graduate from a medical college or vocational school can refuse to work under the guidance of an instructor, but they will need to undergo initial accreditation instead of periodic. Anton Yershov doubts the effectiveness of this new measure. The St. Petersburg S–µ—á–µ–Ωov First Russian State Medical University fired another teacher after criticism of the law on mandatory rotations for young doctors. The project to launch mobile pharmacies is being revised based on government approval, which noted several legal issues for the authors.""
}"
2025-11-28T16:07:10+00:00,@medpharm,13782,https://t.me/medpharm/13782,"–£—á–µ–Ω—ã–µ –∏–∑ –ó–∞–ø–∞–¥–Ω–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ –≤ –õ–æ–Ω–¥–æ–Ω–µ –∏–∑—É—á–∏–ª–∏ —á–∞—Å—Ç–æ—Ç—É –≤–∏–∑–∏—Ç–æ–≤ –≤ –±–æ–ª—å–Ω–∏—Ü—É –ø–æ –ø–æ–≤–æ–¥—É –æ—Å—Ç—Ä–æ–π –¥—ã—Ö–∞—Ç–µ–ª—å–Ω–æ–π –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ—Å—Ç–∏ —Å—Ä–µ–¥–∏ –º–æ–ª–æ–¥—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –≤–ø–µ—Ä–≤—ã–µ –ø–æ–ª—É—á–∏–≤—à–∏—Ö –ø–µ—Ä–æ—Ä–∞–ª—å–Ω—ã–π —Ç—Ä–∏–º–µ—Ç–æ–ø—Ä–∏–º-—Å—É–ª—å—Ñ–∞–º–µ—Ç–æ–∫—Å–∞–∑–æ–ª. –†–µ–∑—É–ª—å—Ç–∞—Ç—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω—ã –≤ –∂—É—Ä–Ω–∞–ª–µ JAMA Network Open. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QZib7 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ò–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã–µ_–±–æ–ª–µ–∑–Ω–∏ #–ü–µ–¥–∏–∞—Ç—Ä–∏—è #–ü—É–ª—å–º–æ–Ω–æ–ª–æ–≥–∏—è_–∏_—Ñ—Ç–∏–∑–∏–∞—Ç—Ä–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety"",
  ""impact"": ""medium"",
  ""english"": ""Researchers from the Western University in London studied the frequency of visits to hospitals for acute respiratory insufficiency among young patients who first received oral trimethoprim-sulfamethoxazole. The results of the study were published in JAMA Network Open. More: https://clck.ru/3QZib7 #MedVest–Ω–∏–∫ #Practice #Infectious_diseases #Pediatrics #Pulmonology_and_tuberculosis #Therapy #Pharmacology""
}"
2025-11-28T16:01:08+00:00,@medpharm,13781,https://t.me/medpharm/13781,–ù–æ–≤—ã–π –∑–∞–∫–æ–Ω –æ–± –ù–î–° –¥–ª—è ¬´—É–ø—Ä–æ—â–µ–Ω—Ü–µ–≤¬ª –ø–æ–¥–ø–∏—Å–∞–Ω: –ø–æ—Ä–æ–≥ —Å–Ω–∏–∑—è—Ç –ø–æ—ç—Ç–∞–ø–Ω–æ –¥–æ 10 –º–ª–Ω —Ä—É–±. –ö–∞–∫ –∏–∑–º–µ–Ω–∏—Ç—Å—è –Ω–∞–ª–æ–≥–æ–≤–∞—è –Ω–∞–≥—Ä—É–∑–∫–∞ —Å 2026 –≥–æ–¥–∞ –∏ –∫–æ–≥–æ –∫–æ—Å–Ω–µ—Ç—Å—è –º–æ—Ä–∞—Ç–æ—Ä–∏–π –Ω–∞ —à—Ç—Ä–∞—Ñ—ã? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QZiGM #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""pricing, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The law on VAT for simplified taxpayers has been signed, the threshold will be gradually lowered to 1 million rubles. How will the tax burden change from 2026 and what will the moratorium on fines affect?""
}"
2025-11-28T15:42:47+00:00,@medpharm,13780,https://t.me/medpharm/13780,"–ü—Ä–∏–≥–ª–∞—à–∞–µ–º –≤–∞—Å –ø—Ä–∏–Ω—è—Ç—å —É—á–∞—Å—Ç–∏–µ –≤ –µ–∂–µ–≥–æ–¥–Ω–æ–º –†–µ–π—Ç–∏–Ω–≥–µ –≤–ª–∏—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –æ—Ç—Ä–∞—Å–ª–∏ –†–æ—Å—Å–∏–∏ ‚Äì 2025. –†–µ–π—Ç–∏–Ω–≥ –æ–ø—Ä–µ–¥–µ–ª—è–µ—Ç –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, –∫–æ–º–ø–∞–Ω–∏–∏ –∏ —ç–∫—Å–ø–µ—Ä—Ç–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ –Ω–µ –æ–≥—Ä–∞–Ω–∏—á–∏–≤–∞—é—Ç—Å—è –±–∏–∑–Ω–µ—Å-—É—Å–ø–µ—Ö–∞–º–∏, –∞ –∑–∞–¥–∞—é—Ç –≤–µ–∫—Ç–æ—Ä —Ä–∞–∑–≤–∏—Ç–∏—è –æ—Ç—Ä–∞—Å–ª–∏. –ö —É—á–∞—Å—Ç–∏—é –ø—Ä–∏–≥–ª–∞—à–∞—é—Ç—Å—è –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–∏ –≤—Å–µ—Ö —Å–µ–≥–º–µ–Ω—Ç–æ–≤ —Ä—ã–Ω–∫–∞ ‚Äî –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏, –¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä—ã, –∞–ø—Ç–µ–∫–∏, –ª–æ–≥–∏—Å—Ç–∏—á–µ—Å–∫–∏–µ –æ–ø–µ—Ä–∞—Ç–æ—Ä—ã, —Ä–µ–≥—É–ª—è—Ç–æ—Ä—ã, –æ—Ç—Ä–∞—Å–ª–µ–≤—ã–µ –æ–±—ä–µ–¥–∏–Ω–µ–Ω–∏—è –∏ –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–∏. –†–∞—Å—Å–∫–∞–∂–∏—Ç–µ, –∫—Ç–æ, –ø–æ –≤–∞—à–µ–º—É –º–Ω–µ–Ω–∏—é, –ø–æ–≤–ª–∏—è–ª –Ω–∞ —Ä–∞–∑–≤–∏—Ç–∏–µ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ –≤ 2025 –≥–æ–¥—É. –ú—ã —Ü–µ–Ω–∏–º —á–µ—Å—Ç–Ω–æ—Å—Ç—å ‚Äî –≥–æ–ª–æ—Å–∞ –∑–∞ —Å–æ–±—Å—Ç–≤–µ–Ω–Ω—É—é –∫–æ–º–ø–∞–Ω–∏—é –Ω–µ —É—á–∏—Ç—ã–≤–∞—é—Ç—Å—è. –ü—Ä–æ–≥–æ–ª–æ—Å–æ–≤–∞—Ç—å","{""skip"": true}"
2025-11-28T15:19:06+00:00,@medpharm,13779,https://t.me/medpharm/13779,"–° —ç–∫—Å-–∑–∞–º–≥–ª–∞–≤—ã –ù–ú–ò–¶ –∏–º. –ú–µ—à–∞–ª–∫–∏–Ω–∞ —Å–Ω—è–ª–∏ —Å—É–¥–∏–º–æ—Å—Ç—å. –°—É–¥ —É—á–µ–ª –±–µ–∑—É–ø—Ä–µ—á–Ω–æ–µ –ø–æ–≤–µ–¥–µ–Ω–∏–µ –ï–≤–≥–µ–Ω–∏—è –ü–æ–∫—É—à–∞–ª–æ–≤–∞ –ø–æ—Å–ª–µ –£–î–û –∏ –∑–∞—Å–ª—É–≥–∏ –≤ –∫–∞—Ä–¥–∏–æ—Ö–∏—Ä—É—Ä–≥–∏–∏, –ø—Ä–æ–∫—É—Ä–∞—Ç—É—Ä–∞ –Ω–µ –≤–æ–∑—Ä–∞–∂–∞–ª–∞.‚Äã –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QZfjv #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-11-28T14:53:03+00:00,@medpharm,13778,https://t.me/medpharm/13778,"–¶–µ–Ω—Ç—Ä –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –∑–∞–∫–ª—é—á–∏—Ç —Å –∫–æ–º–ø–∞–Ω–∏–µ–π ¬´–†-–§–∞—Ä–º¬ª –∫–æ–Ω—Ç—Ä–∞–∫—Ç –Ω–∞ –∑–∞–∫—É–ø–∫—É –¥–ª—è ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –≤–∏–ª—Ç–æ–ª–∞—Ä—Å–µ–Ω –Ω–∞ —Å—É–º–º—É 2,7 –º–ª—Ä–¥ —Ä—É–±. –ü–∞–ª–æ–≤–∞—Ä–æ—Ç–µ–Ω –∏ –∞—Å—Ñ–æ—Ç–∞–∑—É –∞–ª—å—Ñ–∞ –±—É–¥—É—Ç –ø–æ—Å—Ç–∞–≤–ª—è—Ç—å –ø–æ –º–∞–∫—Å–∏–º–∞–ª—å–Ω–æ–π —Ü–µ–Ω–µ –∫–æ–Ω—Ç—Ä–∞–∫—Ç–∞ ¬´–ò—Ä–≤–∏–Ω 2¬ª –∏ ¬´–ê–ª–µ–∫—Å–∏–æ–Ω –§–∞—Ä–º–∞¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QZe8d #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{""skip"": true}"
2025-11-28T14:45:33+00:00,@medpharm,13777,https://t.me/medpharm/13777,"–ë–µ–∑ –¥–≤–æ–π–Ω–∏–∫–∞. –ß–µ–≥–æ –∂–¥—É—Ç —Å–∏—Å—Ç–µ–º–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∏ –±–∏–∑–Ω–µ—Å –æ—Ç –ø–µ—Ä–µ—á–Ω—è –°–ó–õ–° –ù–µ –ø–µ—Ä–≤—ã–π –≥–æ–¥ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–π —Ä—ã–Ω–æ–∫ –∞–∫—Ç–∏–≤–Ω–æ –æ–±—Å—É–∂–¥–∞–µ—Ç –≤–Ω–µ–¥—Ä–µ–Ω–∏–µ –º–µ—Ö–∞–Ω–∏–∑–º–∞ ¬´–≤—Ç–æ—Ä–æ–π –ª–∏—à–Ω–∏–π¬ª –∏ —Å–≤—è–∑–∞–Ω–Ω—ã–π —Å –Ω–∏–º –≤–æ–ø—Ä–æ—Å —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—è –ø–µ—Ä–µ—á–Ω—è —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤. –ü—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–∏ –æ—Ç—Ä–∞—Å–ª–∏ –ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω–æ –æ—Ü–µ–Ω–∏–ª–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–Ω—ã–µ –∫—Ä–∏—Ç–µ—Ä–∏–∏ –≤–∫–ª—é—á–µ–Ω–∏—è –≤ –Ω–µ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –Ω–æ –ø—Ä–µ–¥–æ—Å—Ç–µ—Ä–µ–≥–∞—é—Ç –æ—Ç –¥—É–±–ª–∏—Ä–æ–≤–∞–Ω–∏—è –ü–µ—Ä–µ—á–Ω—è –ñ–ù–í–õ–ü. ¬´–§–í¬ª –∫–æ–º–ø–ª–µ–∫—Å–Ω–æ –æ—Ü–µ–Ω–∏–ª –ø—Ä–µ–¥—Å—Ç–æ—è—â–∏–µ –∏–∑–º–µ–Ω–µ–Ω–∏—è, —Å–≤—è–∑–∞–Ω–Ω—ã–µ —Å –ø–µ—Ä–µ—á–Ω–µ–º –°–ó–õ–°. –°–≤–µ–∂–∏–π –Ω–æ–º–µ—Ä ¬´–§–í¬ª ‚Ññ26-27 (1185-1186) —É–∂–µ –¥–æ—Å—Ç—É–ø–µ–Ω –æ–Ω–ª–∞–π–Ω –±–µ—Å–ø–ª–∞—Ç–Ω–æ –¥–ª—è –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª–µ–π.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The healthcare system and pharmaceutical business are awaiting the implementation of a 'second extra' mechanism and related issues regarding the formation of a strategic list of medicines. Industry representatives have positively evaluated the criteria for including drugs in it, but they warn against duplication of the SLS list. 'FV' has comprehensively assessed upcoming changes related to the SLS list. The latest issue of 'FV' ‚Ññ26-27 (1185-1186) is available online for free to registered users.""
}"
2025-11-28T14:29:06+00:00,@medpharm,13776,https://t.me/medpharm/13776,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ –ø—Ä–µ–¥–ª–æ–∂–∏–ª –Ω–æ–≤—ã–µ —É—Å–ª–æ–≤–∏—è —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–π –ø—Ä–æ–≥—Ä–∞–º–º—ã –ø–æ –º–æ–¥–µ—Ä–Ω–∏–∑–∞—Ü–∏–∏ –ø–µ—Ä–≤–∏—á–Ω–æ–≥–æ –∑–≤–µ–Ω–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –ë—É–¥—É—Ç —É–∂–µ—Å—Ç–æ—á–µ–Ω—ã —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ —Ä–∞—Å–ø—Ä–µ–¥–µ–ª–µ–Ω–∏—é —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è, —Ä–∞—Å—á–µ—Ç—É —Å—Ç–æ–∏–º–æ—Å—Ç–∏ –∫–≤–∞–¥—Ä–∞—Ç–Ω–æ–≥–æ –º–µ—Ç—Ä–∞ –∏ –∑–∞–∫—É–ø–∫–∞–º –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QZcUZ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""tenders, regulation"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health of Russia has proposed new conditions for implementing the federal program on modernization of primary healthcare. Stringent requirements have been imposed on funding distribution, cost calculation per square meter, and procurement of medical equipment. For more details: https://clck.ru/3QZcUZ #MedVestnik #HealthcareOrganization""
}"
2025-11-28T14:00:07+00:00,@medpharm,13775,https://t.me/medpharm/13775,"FDA —Ä–∞—Å—Å–ª–µ–¥—É–µ—Ç —Å–ª—É—á–∞–π —Å–º–µ—Ä—Ç–∏ —Ä–µ–±–µ–Ω–∫–∞, –ø–æ–ª—É—á–∞–≤—à–µ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç —è–ø–æ–Ω—Å–∫–æ–π Takeda. –ù–∞ —Å–µ–≥–æ–¥–Ω—è—à–Ω–∏–π –¥–µ–Ω—å —ç—Ç–æ –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω–æ–µ –æ–¥–æ–±—Ä–µ–Ω–Ω–æ–µ —Å—Ä–µ–¥—Å—Ç–≤–æ –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Ç—Ä–æ–º–±–æ—Ç–∏—á–µ—Å–∫–æ–π —Ç—Ä–æ–º–±–æ—Ü–∏—Ç–æ–ø–µ–Ω–∏—á–µ—Å–∫–æ–π –ø—É—Ä–ø—É—Ä—ã ‚Äî —Ä–µ–¥–∫–æ–≥–æ –∏ —Å–º–µ—Ä—Ç–µ–ª—å–Ω–æ–≥–æ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è –∫—Ä–æ–≤–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QZaQu #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-11-28T13:32:04+00:00,@medpharm,13774,https://t.me/medpharm/13774,"–†–∞–±–æ—Ç–∞ —Å –Ω–∞—Å—Ç–∞–≤–Ω–∏–∫–æ–º –Ω–µ –±—É–¥–µ—Ç –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–π –¥–ª—è –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –≤—É–∑–æ–≤ –∏ –∫–æ–ª–ª–µ–¥–∂–µ–π, –ø–æ—ç—Ç–æ–º—É –µ–µ –Ω–µ–∫–æ—Ä—Ä–µ–∫—Ç–Ω–æ –Ω–∞–∑—ã–≤–∞—Ç—å –æ—Ç—Ä–∞–±–æ—Ç–∫–æ–π, –∑–∞—è–≤–∏–ª –≥–ª–∞–≤–∞ –ö–æ–º–∏—Ç–µ—Ç–∞ –ì–æ—Å–¥—É–º—ã –†–§ –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è –°–µ—Ä–≥–µ–π –õ–µ–æ–Ω–æ–≤. –û–Ω —Ä–∞–∑—ä—è—Å–Ω–∏–ª, –∫–∞–∫–∏–º –æ–±—Ä–∞–∑–æ–º –º–æ–∂–Ω–æ –æ—Ç–∫–∞–∑–∞—Ç—å—Å—è –æ—Ç —É–∑–∞–∫–æ–Ω–µ–Ω–Ω—ã—Ö —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QZYa4 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–û–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-11-28T12:56:02+00:00,@medpharm,13773,https://t.me/medpharm/13773,"–û—Å–µ–Ω—å—é ¬´–†–∏–≥–ª–∞¬ª –ø—Ä–∏–æ–±—Ä–µ–ª–∞ –Ω–µ—Å–∫–æ–ª—å–∫–æ –º–µ–ª–∫–∏—Ö –∞–ø—Ç–µ—á–Ω—ã—Ö —Å–µ—Ç–µ–π –≤ –¢–∞–º–±–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏, —É–≤–µ–ª–∏—á–∏–≤ —Å–≤–æ—é –¥–æ–ª—é —Ä—ã–Ω–∫–∞ –≤ —Ä–µ–≥–∏–æ–Ω–µ –¥–æ 6%. –°–µ–π—á–∞—Å –æ–Ω–∏ –∏–Ω—Ç–µ–≥—Ä–∏—Ä—É—é—Ç—Å—è –≤ –µ–¥–∏–Ω—É—é —Å–µ—Ç—å. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QZW7T #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{""skip"": true}"
2025-11-28T12:54:03+00:00,@medpharm,13772,https://t.me/medpharm/13772,"–í—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–∏–π —á–µ–º–ø–∏–æ–Ω–∞—Ç ¬´–ë—É–¥—É—â–µ–µ –º–µ–¥–∏—Ü–∏–Ω—ã¬ª, –æ—Ä–≥–∞–Ω–∏–∑–æ–≤–∞–Ω–Ω—ã–π –ü–∏—Ä–æ–≥–æ–≤—Å–∫–∏–º —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–æ–º –∏ –°–æ–≤–µ—Ç–æ–º –º–æ–ª–æ–¥—ã—Ö —É—á–µ–Ω—ã—Ö –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–æ—Å—Å–∏–∏, —Å–æ—Å—Ç–æ—è–ª—Å—è –≤ –æ–Ω–ª–∞–π–Ω-—Ñ–æ—Ä–º–∞—Ç–µ –ø—Ä–∏ —É—á–∞—Å—Ç–∏–∏ 110 —Å—Ç—É–¥–µ–Ω—Ç–æ–≤ –∏ –º–æ–ª–æ–¥—ã—Ö —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –∏–∑ 20 –≤—É–∑–æ–≤ –∏ –Ω–∞—É—á–Ω—ã—Ö –∏–Ω—Å—Ç–∏—Ç—É—Ç–æ–≤ —Å—Ç—Ä–∞–Ω—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QZVwA #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–∞—Ä—å–µ—Ä–∞","{""skip"": true}"
2025-11-28T12:34:03+00:00,@medpharm,13771,https://t.me/medpharm/13771,"–û–ø—É–±–ª–∏–∫–æ–≤–∞–Ω –ø—Ä–æ–µ–∫—Ç –ø–µ—Ä–µ—á–Ω—è –≤—É–∑–æ–≤, –ø–æ–¥–≥–æ—Ç–æ–≤–∏—Ç–µ–ª—å–Ω—ã–µ –æ—Ç–¥–µ–ª–µ–Ω–∏—è –≤ –∫–æ—Ç–æ—Ä—ã—Ö –±—É–¥—É—Ç —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞—Ç—å—Å—è –≤ 2026‚Äî2027 —É—á–µ–±–Ω–æ–º –≥–æ–¥—É –∏–∑ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –±—é–¥–∂–µ—Ç–∞. –í —Å–ø–∏—Å–∫–µ —à–µ—Å—Ç—å –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QZUbp #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-11-28T11:43:03+00:00,@medpharm,13770,https://t.me/medpharm/13770,"–†–∞–Ω—å—à–µ –±—ã–ª–æ –ø—Ä–æ—â–µ: –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã–µ –∫–æ–º–ø–∞–Ω–∏–∏ —Å–æ–∑–¥–∞–≤–∞–ª–∏ —Ä—ã–Ω–æ–∫, –∞ —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ —à–ª–∏ —Å–ª–µ–¥–æ–º. –¢–µ–ø–µ—Ä—å –ø—Ä–∞–≤–∏–ª–∞ –∏–∑–º–µ–Ω–∏–ª–∏—Å—å. –ü–æ—á–µ–º—É —Å—Ç–∞—Ä—ã–µ –ø–æ–¥—Ö–æ–¥—ã –Ω–µ —Ä–∞–±–æ—Ç–∞—é—Ç –∏ —á—Ç–æ –ø—Ä–∏—Ö–æ–¥–∏—Ç –Ω–∞ —Å–º–µ–Ω—É? –ê–Ω–∞–ª–∏–∑ –æ—Ç —ç–∫—Å–ø–µ—Ä—Ç–æ–≤ –†–ê–§–ú. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QZRBk #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{""skip"": true}"
2025-11-28T11:39:08+00:00,@medpharm,13769,https://t.me/medpharm/13769,"–ë–æ—Ä—å–±–∞ —Å –í–ò–ß –≤ –º–∏—Ä–µ –Ω–∞—Ö–æ–¥–∏—Ç—Å—è –ø–æ–¥ —É–≥—Ä–æ–∑–æ–π –∏–∑-–∑–∞ –∫—Ä–∏–∑–∏—Å–∞ —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è. UNAIDS –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–∞–µ—Ç: 2,5 –º–ª–Ω —á–µ–ª–æ–≤–µ–∫ —É–∂–µ –ø–æ—Ç–µ—Ä—è–ª–∏ –¥–æ—Å—Ç—É–ø –∫ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º –≤ 2025 –≥–æ–¥—É.‚Äã –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QZQtF #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–ò–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã–µ_–±–æ–ª–µ–∑–Ω–∏ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, epidemic"",
  ""impact"": ""high"",
  ""english"": ""UNAIDS warns that access to medicines for 2.5 million people could be lost by 2025 due to a funding crisis, leading to an epidemic. More details: https://clck.ru/3QZQtF #MedNews #Healthcare #InfectiousDiseases""
}"
2025-11-28T10:35:05+00:00,@medpharm,13768,https://t.me/medpharm/13768,"–¶–µ–Ω—Ç—Ä —ç–∫—Å–ø–µ—Ä—Ç–∏–∑—ã –∏ –∫–æ–Ω—Ç—Ä–æ–ª—è –∫–∞—á–µ—Å—Ç–≤–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–§ —Å–æ–æ–±—â–∏–ª –æ –∑–∞–≤–µ—Ä—à–µ–Ω–∏–∏ –µ–∂–µ–≥–æ–¥–Ω–æ–≥–æ —Ü–∏–∫–ª–∞ –æ–¥–æ–±—Ä–µ–Ω–∏—è –∑–∞—è–≤–æ–∫ –æ—Ç –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –Ω–∞ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏—é –ø—Ä–æ—Ç–æ–∫–æ–ª–æ–≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–π –∞–ø—Ä–æ–±–∞—Ü–∏–∏. –£—á–∞—Å—Ç–Ω–∏–∫–∏ —Ç–∞–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π —Å—Ç–∞–ª–∏ –ª—É—á—à–µ –≥–æ—Ç–æ–≤–∏—Ç—å —Å–æ–ø—Ä–æ–≤–æ–¥–∏—Ç–µ–ª—å–Ω—ã–π –º–∞—Ç–µ—Ä–∏–∞–ª, –æ—Ç–º–µ—á–∞—é—Ç –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–∏ —Ä–µ–≥—É–ª—è—Ç–æ—Ä–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QZLZW #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The Center for Medical Quality and Control of the Russian Ministry of Health reported that the annual cycle of approval applications from healthcare organizations for clinical trial protocols has been completed. Representatives of the regulator noted that participants are better preparing supporting materials.""
}"
2025-11-28T10:22:03+00:00,@medpharm,13767,https://t.me/medpharm/13767,–ú–∏–Ω–∑–¥—Ä–∞–≤ –°–®–ê —Å–≤–æ—Ä–∞—á–∏–≤–∞–µ—Ç –≤—Å–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –Ω–∞ –ø—Ä–∏–º–∞—Ç–∞—Ö –≤ CDC. –ß–∞—Å—Ç—å –∑–∞—Ä–∞–∂–µ–Ω–Ω—ã—Ö –≤–∏—Ä—É—Å–æ–º SHIV –æ–±–µ–∑—å—è–Ω —É—Å—ã–ø—è—Ç. –ö–∞–∫ —ç—Ç–æ —Ä–µ—à–µ–Ω–∏–µ –ø–æ–≤–ª–∏—è–µ—Ç –Ω–∞ —Å–æ–∑–¥–∞–Ω–∏–µ –Ω–æ–≤—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QZKgr #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-11-28T09:36:04+00:00,@medpharm,13766,https://t.me/medpharm/13766,–ó–∞–º–≥–ª–∞–≤—ã –≤–æ–ª–æ–≥–æ–¥—Å–∫–æ–≥–æ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ö—Ä–∏—Å—Ç–∏–Ω–µ –ì—Ä–∏–≥–æ—Ä—è–Ω –∞—Ä–µ—Å—Ç–æ–≤–∞–Ω–∞ –ø–æ –ø–æ–¥–æ–∑—Ä–µ–Ω–∏—é –≤ —Ö–∏—â–µ–Ω–∏–∏ –Ω–µ—Å–∫–æ–ª—å–∫–∏—Ö –º–∏–ª–ª–∏–æ–Ω–æ–≤ —Ä—É–±–ª–µ–π. –ü—Ä–µ—Å—Ç—É–ø–ª–µ–Ω–∏—è —Å–æ–≤–µ—Ä—à–µ–Ω—ã —Å 2021 –ø–æ 2025 –≥–æ–¥ –Ω–∞ –ø–æ—Å—Ç—É –∑–∞–º–≥–ª–∞–≤–≤—Ä–∞—á–∞ –¥–µ—Ç—Å–∫–æ–π –±–æ–ª—å–Ω–∏—Ü—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QZGEU #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-11-28T09:02:07+00:00,@medpharm,13765,https://t.me/medpharm/13765,–ú–∏–Ω—Ñ–∏–Ω –†–§ –ø—Ä–µ–¥–ª–æ–∂–∏–ª —Å–¥–≤–∏–Ω—É—Ç—å —Å—Ç–∞—Ä—Ç –º–µ—Ö–∞–Ω–∏–∑–º–∞ –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ —Ä–µ–∂–∏–º–∞ –≥–æ—Å–∑–∞–∫—É–ø–æ–∫ ¬´–≤—Ç–æ—Ä–æ–π –ª–∏—à–Ω–∏–π¬ª –¥–ª—è –°–ó–õ–°. –ü–æ—á–µ–º—É —Ñ–∞—Ä–º—Ä—ã–Ω–æ–∫ –ø–æ–¥–¥–µ—Ä–∂–∞–ª –ø–µ—Ä–µ–Ω–æ—Å –∏ –∫–∞–∫ —ç—Ç–æ –æ—Ç—Ä–∞–∑–∏—Ç—Å—è –Ω–∞ –ø–∞—Ü–∏–µ–Ω—Ç–∞—Ö ‚Äî —É–∑–Ω–∞–ª ¬´–§–í¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QZDb2 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The Russian Finance Ministry proposed to postpone the start of the second 'excess' mechanism for state procurement. The pharmaceutical market supports this postponement and I found out how it will affect patients, as reported by 'FV'. More details: https://clck.ru/3QZDb2 #PharmNews #Regulation""
}"
2025-11-28T08:45:06+00:00,@medpharm,13764,https://t.me/medpharm/13764,–°–µ—á–µ–Ω–æ–≤—Å–∫–∏–π –º–µ–¥—É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç —É–≤–æ–ª–∏–ª –µ—â–µ –æ–¥–Ω–æ–≥–æ –ø—Ä–µ–ø–æ–¥–∞–≤–∞—Ç–µ–ª—è –ø–æ—Å–ª–µ –∫—Ä–∏—Ç–∏–∫–∏ –∑–∞–∫–æ–Ω–∞ –æ–± –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã—Ö –æ—Ç—Ä–∞–±–æ—Ç–∫–∞—Ö –¥–ª—è –º–æ–ª–æ–¥—ã—Ö –≤—Ä–∞—á–µ–π.–ê–Ω—Ç–æ–Ω –ï—Ä—à–æ–≤ —É—Å–æ–º–Ω–∏–ª—Å—è –≤ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –Ω–æ–≤–æ–≤–≤–µ–¥–µ–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QZCJk #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–û–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-11-28T08:18:02+00:00,@medpharm,13763,https://t.me/medpharm/13763,"–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –ø–æ–¥–¥–µ—Ä–∂–∞–ª–æ –∑–∞–∫–æ–Ω –æ –ø–µ—Ä–µ–¥–≤–∏–∂–Ω—ã—Ö –∞–ø—Ç–µ—á–Ω—ã—Ö –ø—É–Ω–∫—Ç–∞—Ö –¥–ª—è —Å–µ–ª—å—Å–∫–∏—Ö —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–π. –ö–∞–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –±—É–¥—É—Ç –≤ –ø—Ä–æ–¥–∞–∂–µ, –∫–∞–∫–∏–µ —Ä–µ–≥–∏–æ–Ω—ã –∑–∞–∏–Ω—Ç–µ—Ä–µ—Å–æ–≤–∞–Ω—ã –∏ –∫–æ–≥–¥–∞ –∂–¥–∞—Ç—å –Ω–∞—á–∞–ª–∞? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QZABH #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{""skip"": true}"
2025-11-28T07:25:03+00:00,@medpharm,13762,https://t.me/medpharm/13762,"–≠–ø–æ—Ö–∞ ¬´—Ü–∏—Ñ—Ä–æ–≤–æ–≥–æ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è¬ª –¥–ª—è –≤—Ä–∞—á–µ–π, –∫–æ—Ç–æ—Ä–∞—è –∞–∫—Ç–∏–≤–Ω–æ –Ω–∞—á–∞–ª–∞—Å—å –≤ –ø–µ—Ä–∏–æ–¥ –ø–∞–Ω–¥–µ–º–∏–∏, –ø–æ—Ö–æ–∂–µ, –ø–æ–¥—Ö–æ–¥–∏—Ç –∫ —Å–≤–æ–µ–º—É –ª–æ–≥–∏—á–µ—Å–∫–æ–º—É –∑–∞–≤–µ—Ä—à–µ–Ω–∏—é. –° 2026 –≥–æ–¥–∞ –æ–Ω–ª–∞–π–Ω-—Ñ–æ—Ä–º–∞—Ç –¥–ª—è –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–∞ –ø—Ä–æ–≥—Ä–∞–º–º –æ–±—É—á–µ–Ω–∏—è –±—É–¥–µ—Ç –∑–∞–ø—Ä–µ—â–µ–Ω. –≠—Ç–∞ –º–∞—Å—à—Ç–∞–±–Ω–∞—è —Ä–µ—Ñ–æ—Ä–º–∞ –ø—Ä–∏–∑–≤–∞–Ω–∞ –ø–æ–¥–Ω—è—Ç—å —Å—Ç–∞–Ω–¥–∞—Ä—Ç—ã –∫–∞—á–µ—Å—Ç–≤–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏, –Ω–æ –Ω–µ–∏–∑–±–µ–∂–Ω–æ –ø–æ–≤–ª–µ—á–µ—Ç –∑–∞ —Å–æ–±–æ–π –ø–µ—Ä–µ—Å—Ç—Ä–æ–π–∫—É –≤—Å–µ–π —Å–∏—Å—Ç–µ–º—ã –Ω–µ–ø—Ä–µ—Ä—ã–≤–Ω–æ–≥–æ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ —Ä–∞–∑–≤–∏—Ç–∏—è. –ß–µ–≥–æ –æ–∂–∏–¥–∞—Ç—å –æ—Ç –Ω–æ–≤–æ–≥–æ –∑–∞–∫–æ–Ω–∞ –∏ –∫ —á–µ–º—É –º–æ–∂–Ω–æ –≥–æ—Ç–æ–≤–∏—Ç—å—Å—è —É–∂–µ —Å–µ–π—á–∞—Å, ¬´–§–í¬ª —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∞ –æ—Å–Ω–æ–≤–∞—Ç–µ–ª—å–Ω–∏—Ü–∞ –∞–∫–∞–¥–µ–º–∏–∏ –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–≥–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è ¬´–î–æ–∫—Å—Ç–∞—Ä–∫–ª–∞–±¬ª, –ê–ù–û ¬´–°–æ–∑–≤–µ–∑–¥–∏–µ¬ª, –≤—Ä–∞—á-–∫–∞—Ä–¥–∏–æ–ª–æ–≥, –∫–∞–Ω–¥.–º–µ–¥.–Ω–∞—É–∫ –ê–ª–µ–∫—Å–∞–Ω–¥—Ä–∞ –î–µ–º–∫–∏–Ω–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QZ6Mg #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–∞—Ä—å–µ—Ä–∞","{""skip"": true}"
2025-11-28T07:06:05+00:00,@medpharm,13761,https://t.me/medpharm/13761,–í –°–∞—Ö–∞–ª–∏–Ω—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –Ω–∞—à–ª–∏ –Ω–æ–≤–æ–≥–æ –º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –ï–µ –∫–∞–Ω–¥–∏–¥–∞—Ç—É—Ä—É –ø–æ–¥–¥–µ—Ä–∂–∞–ª –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QZ55v #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-11-28T06:55:47+00:00,@medpharm,13760,https://t.me/medpharm/13760,"–í –∫–æ–Ω—Ü–µ –æ–∫—Ç—è–±—Ä—è —Å—Ç–∞–ª–æ –∏–∑–≤–µ—Å—Ç–Ω–æ –æ –ø–æ–∫—É–ø–∫–µ –ï–≤—Ä–æ–ø–µ–π—Å–∫–∏–º –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º —Ü–µ–Ω—Ç—Ä–æ–º (EMC) 75% —Å–µ—Ç–∏ –∫–ª–∏–Ω–∏–∫ ¬´–°–µ–º–µ–π–Ω—ã–π –¥–æ–∫—Ç–æ—Ä¬ª. –û —Ü–µ–ª—è—Ö —ç—Ç–æ–π —Å–¥–µ–ª–∫–∏, –∫–æ—Ä—Ä–µ–∫—Ç–∏—Ä–æ–≤–∫–∞—Ö –≤ —Å—Ç—Ä–∞—Ç–µ–≥–∏–∏ –∫–æ–º–ø–∞–Ω–∏–∏, —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ –Ω–æ–≤—ã—Ö –ø—Ä–æ—Ç–æ–∫–æ–ª–æ–≤ –ª–µ—á–µ–Ω–∏—è, –∞ —Ç–∞–∫–∂–µ –æ —Ç–æ–º, —á—Ç–æ —Å–µ–≥–æ–¥–Ω—è –≤–æ–ª–Ω—É–µ—Ç –ø—Ä–µ–¥–ø—Ä–∏–Ω–∏–º–∞—Ç–µ–ª–µ–π –≤ —Å—Ñ–µ—Ä–µ –º–µ–¥–∏—Ü–∏–Ω—ã –∏ —á–µ–≥–æ –∂–¥–∞—Ç—å –Ω–∞ —ç—Ç–æ–º —Ä—ã–Ω–∫–µ, ¬´–ú–í¬ª —Ä–∞—Å—Å–∫–∞–∑–∞–ª –≥–µ–Ω–µ—Ä–∞–ª—å–Ω—ã–π –¥–∏—Ä–µ–∫—Ç–æ—Ä –ï–ú–° –ê–Ω–¥—Ä–µ–π –Ø–Ω–æ–≤—Å–∫–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QZ4Hf #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫","{""skip"": true}"
2025-11-28T06:16:10+00:00,@medpharm,13759,https://t.me/medpharm/13759,"–£—á–µ–Ω—ã–µ –∏–∑ –ì–∞—Ä–≤–∞—Ä–¥—Å–∫–æ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π —à–∫–æ–ª—ã –æ—Ü–µ–Ω–∏–ª–∏ –ø—Ä–∏–±–∞–≤–∫—É –≤–µ—Å–∞ –∏ –∏—Å—Ö–æ–¥—ã –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏ —É –∂–µ–Ω—â–∏–Ω, –∫–æ—Ç–æ—Ä—ã–µ –¥–æ –∑–∞—á–∞—Ç–∏—è –ø–æ–ª—É—á–∞–ª–∏ –∞–≥–æ–Ω–∏—Å—Ç—ã —Ä–µ—Ü–µ–ø—Ç–æ—Ä–æ–≤ GLP-1, –∞ –∑–∞—Ç–µ–º –ø—Ä–µ–∫—Ä–∞—Ç–∏–ª–∏ –ø—Ä–∏–µ–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –†–µ–∑—É–ª—å—Ç–∞—Ç—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω—ã –≤ –∂—É—Ä–Ω–∞–ª–µ JAMA –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QYzbH #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ê–∫—É—à–µ—Ä—Å—Ç–≤–æ_–∏_–≥–∏–Ω–µ–∫–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è #–≠–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-11-27T16:49:01+00:00,@medpharm,13758,https://t.me/medpharm/13758,"ü¶æ –ë–æ–ª—å—à–µ –ø—Ä–∞–≤. –î–µ–ø—É—Ç–∞—Ç—ã –ì–æ—Å–¥—É–º—ã –†–§ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –¥–∞—Ç—å –ø–∞—Ü–∏–µ–Ω—Ç–∞–º –ø—Ä–∞–≤–æ –Ω–∞ –∏–Ω–∏—Ü–∏–∏—Ä–æ–≤–∞–Ω–∏–µ –≤—Ä–∞—á–µ–±–Ω–æ–≥–æ –∫–æ–Ω—Å–∏–ª–∏—É–º–∞. –ü–æ –∏—Ö –º–Ω–µ–Ω–∏—é, —Ä–∞–≤–Ω—ã–π –¥–æ—Å—Ç—É–ø –∫ –∫–∞—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–π —ç–∫—Å–ø–µ—Ä—Ç–∏–∑–µ –ø–æ–º–æ–∂–µ—Ç —Å–Ω–∏–∑–∏—Ç—å —á–∏—Å–ª–æ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏—á–µ—Å–∫–∏—Ö –æ—à–∏–±–æ–∫ –∏ –ø–æ–≤—ã—Å–∏—Ç –¥–æ–≤–µ—Ä–∏–µ –∫ —Å–∏—Å—Ç–µ–º–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. ü¶æ –†—É—Å—Å–∫–∏–π –∞–≤–æ—Å—å. –ü–æ—á—Ç–∏ 90% —Ä–æ—Å—Å–∏—è–Ω –ø—Ä–µ–¥–ø–æ—á–∏—Ç–∞—é—Ç —Å–∞–º–æ–ª–µ—á–µ–Ω–∏–µ –∏ –æ—Ç–∫–ª–∞–¥—ã–≤–∞—é—Ç –≤–∏–∑–∏—Ç –∫ –≤—Ä–∞—á—É, –ø—Ä–∏—á–µ–º –∫–∞–∂–¥—ã–π –ø—è—Ç—ã–π –∂–¥–µ—Ç –∫—Ä–∏—Ç–∏—á–µ—Å–∫–æ–≥–æ —Å–æ—Å—Ç–æ—è–Ω–∏—è. –ò—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –≤—ã—è–≤–∏–ª–æ, —á—Ç–æ –≥—Ä–∞–∂–¥–∞–Ω–µ —Å –Ω–∏–∑–∫–∏–º –¥–æ—Ö–æ–¥–æ–º —á–∞—â–µ –∏–≥–Ω–æ—Ä–∏—Ä—É—é—Ç —Å–∏–º–ø—Ç–æ–º—ã –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è. ‚ù§Ô∏è –í–µ—Å–æ–º—ã–π –∞—Ä–≥—É–º–µ–Ω—Ç. –ê—Ä–±–∏—Ç—Ä–∞–∂–Ω—ã–π —Å—É–¥ –ú–æ—Å–∫–≤—ã –≤—ã–Ω–µ—Å —Ä–µ—à–µ–Ω–∏–µ –ø–æ –¥–µ–ª—É ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º–∞¬ª –ø—Ä–æ—Ç–∏–≤ —Ç–µ–ª–µ–∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ü—è—Ç–Ω–∏—Ü–∞¬ª –∏ –æ–Ω–ª–∞–π–Ω-–∫–∏–Ω–æ—Ç–µ–∞—Ç—Ä–∞ ¬´–ü—Ä–µ–º—å–µ—Ä¬ª. –ü–æ–≤–æ–¥–æ–º –¥–ª—è –æ–±—Ä–∞—â–µ–Ω–∏—è —Å—Ç–∞–ª–æ —à–æ—É ¬´–ë–æ–ª—å—à–∏–µ –¥–µ–≤–æ—á–∫–∏¬ª. ‚ù§Ô∏è –£—Ç–æ—á–Ω—è—é—Ç –¥–µ—Ç–∞–ª–∏. –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª —Ç—Ä–∏ –¥–æ–∫—É–º–µ–Ω—Ç–∞, –∫–æ—Ç–æ—Ä—ã–º–∏ –≤–≤–æ–¥–∏—Ç—Å—è –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–µ –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–æ –¥–ª—è –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–µ–π –≤ –≤—É–∑–∞—Ö. –ï—Å–ª–∏ –¥–æ–∫—É–º–µ–Ω—Ç—ã —É—Ç–≤–µ—Ä–¥—è—Ç, –æ–Ω–∏ –Ω–∞—á–Ω—É—Ç –¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å —Å 2026 –≥–æ–¥–∞.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, safety"",
  ""impact"": ""medium"",
  ""english"": ""Russian deputies proposed allowing patients to initiate a medical consultation. They believe this will help reduce diagnostic errors and increase trust in the healthcare system. Nearly 90% of Russians prefer self-medication and delay visits to doctors, with one in five waiting until critical conditions. The study found that people with low incomes ignore disease symptoms more often.""
}"
2025-11-27T16:20:07+00:00,@medpharm,13757,https://t.me/medpharm/13757,–£—Ç–≤–µ—Ä–∂–¥–µ–Ω –Ω–æ–≤—ã–π –ü–æ—Ä—è–¥–æ–∫ –æ–∫–∞–∑–∞–Ω–∏—è –æ—Ñ—Ç–∞–ª—å–º–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π –ø–æ–º–æ—â–∏ –≤–∑—Ä–æ—Å–ª—ã–º. –§–∏–Ω–∞–ª—å–Ω–∞—è –≤–µ—Ä—Å–∏—è –ø—Ä–∏–∫–∞–∑–∞ –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ –æ—Ç–ª–∏—á–∞–µ—Ç—Å—è –æ—Ç –ø—Ä–æ–µ–∫—Ç–∞ –≤ —á–∞—Å—Ç–Ω–æ—Å—Ç–∏ —Ä–∞–∑–¥–µ–ª–æ–º –æ —Ç—Ä–∞–Ω—Å–ø–ª–∞–Ω—Ç–∞—Ü–∏–∏ —Ä–æ–≥–æ–≤–∏—Ü—ã. –î–æ–∫—É–º–µ–Ω—Ç –≤—Å—Ç—É–ø–∏—Ç –≤ —Å–∏–ª—É 1 —Ñ–µ–≤—Ä–∞–ª—è 2026 –≥–æ–¥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QYbop #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ñ—Ç–∞–ª—å–º–æ–ª–æ–≥–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""high"",
  ""english"": ""A final version of the Order on adult ophthalmological care has been approved. The transplant section differs from the project version. The document will come into force on February 1, 2026. For more details: https://clck.ru/3QYbop #MedNews #Healthcare #Ophthalmology""
}"
2025-11-27T15:40:02+00:00,@medpharm,13756,https://t.me/medpharm/13756,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª —Ç—Ä–∏ –¥–æ–∫—É–º–µ–Ω—Ç–∞, –∫–æ—Ç–æ—Ä—ã–º–∏ –≤–≤–æ–¥–∏—Ç—Å—è –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–µ –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–æ –¥–ª—è –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–µ–π –≤ –≤—É–∑–∞—Ö. –ï—Å–ª–∏ –¥–æ–∫—É–º–µ–Ω—Ç—ã —É—Ç–≤–µ—Ä–¥—è—Ç, –æ–Ω–∏ –Ω–∞—á–Ω—É—Ç –¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å —Å 2026 –≥–æ–¥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QYZpx #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration, training"",
  ""impact"": ""medium"",
  ""english"": ""The Russian Ministry of Health has developed three documents that will introduce mandatory mentoring for graduates of medical and pharmaceutical specialties in universities. If approved, they will begin to apply starting from 2026.""
}"
2025-11-27T15:18:04+00:00,@medpharm,13755,https://t.me/medpharm/13755,–£—á–µ–Ω—ã–µ –∏–∑ –ö–∞–ª–∏—Ñ–æ—Ä–Ω–∏–π—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ –æ—Ü–µ–Ω–∏–ª–∏ –≤–ª–∏—è–Ω–∏–µ —Ä–∞–∑–ª–∏—á–Ω—ã—Ö —Å—Ö–µ–º –ª–µ—á–µ–Ω–∏—è –¥–µ–ø—Ä–µ—Å—Å–∏–∏ –Ω–∞ –∫–æ–≥–Ω–∏—Ç–∏–≤–Ω—ã–µ —Ñ—É–Ω–∫—Ü–∏–∏ —É –ø–æ–∂–∏–ª—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –†–µ–∑—É–ª—å—Ç–∞—Ç—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è OPTIMUM –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω—ã –≤ –∂—É—Ä–Ω–∞–ª–µ The Lancet Healthy Longevity –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QYYVp #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ü—Å–∏—Ö–∏–∞—Ç—Ä–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è,"{""skip"": true}"
2025-11-27T14:32:06+00:00,@medpharm,13754,https://t.me/medpharm/13754,–ì–ö ¬´–ú–∞—Ç—å –∏ –¥–∏—Ç—è¬ª –æ—Ç–∫—Ä—ã–ª–∞ –Ω–æ–≤–æ–µ —Ä–æ–¥–∏–ª—å–Ω–æ–µ –æ—Ç–¥–µ–ª–µ–Ω–∏–µ –≤ –∫–æ—Ä–ø—É—Å–µ ¬´–õ–∞–ø–∏–Ω–æ-4¬ª –ø–æ–¥ –ú–æ—Å–∫–≤–æ–π. –ü–∞—Ä–∞–ª–ª–µ–ª—å–Ω–æ –≤ –£—Ñ–µ –∑–∞–ø—É—â–µ–Ω–∞ –º–Ω–æ–≥–æ–ø—Ä–æ—Ñ–∏–ª—å–Ω–∞—è –∫–ª–∏–Ω–∏–∫–∞ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QYVPn #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-11-27T14:26:03+00:00,@medpharm,13753,https://t.me/medpharm/13753,C—É–¥ –≤—ã–Ω–µ—Å —Ä–µ—à–µ–Ω–∏–µ –ø–æ –¥–µ–ª—É –æ –Ω–µ–¥–æ–±—Ä–æ—Å–æ–≤–µ—Å—Ç–Ω–æ–π –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏–∏ –Ω–∞ —Ä—ã–Ω–∫–µ –±–æ–∑—É—Ç–∏–Ω–∏–±–∞. –†–∞–Ω–µ–µ –§–ê–° –†–§ –ø—Ä–∏–∑–Ω–∞–ª–∞ –Ω–µ–¥–æ–±—Ä–æ—Å–æ–≤–µ—Å—Ç–Ω–æ–π –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏–µ–π –≤–≤–µ–¥–µ–Ω–∏–µ –≤ –≥—Ä–∞–∂–¥–∞–Ω—Å–∫–∏–π –æ–±–æ—Ä–æ—Ç –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ¬´–ë–æ–∑—É—Ç–∏–Ω–∏–±¬ª –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ ¬´–ê–∫—Å–µ–ª—å–§–∞—Ä–º¬ª –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QYV2Y #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions"",
  ""impact"": ""high"",
  ""english"": ""The FAS (Federal Antimonopoly Service) of Russia has made a decision regarding the case of unfair competition in the market for bosutinib. Previously, the FAS had recognized unfair competition as a result of introducing the drug 'bosutinib' produced by 'AxelFarma' into civil circulation.""
}"
2025-11-27T13:21:06+00:00,@medpharm,13752,https://t.me/medpharm/13752,"–ü–æ—á—Ç–∏ 90% —Ä–æ—Å—Å–∏—è–Ω –ø—Ä–µ–¥–ø–æ—á–∏—Ç–∞—é—Ç —Å–∞–º–æ–ª–µ—á–µ–Ω–∏–µÔªø –∏ –æ—Ç–∫–ª–∞–¥—ã–≤–∞—é—Ç –≤–∏–∑–∏—Ç –∫ –≤—Ä–∞—á—É, –ø—Ä–∏—á–µ–º –∫–∞–∂–¥—ã–π –ø—è—Ç—ã–π –∂–¥–µ—Ç –∫—Ä–∏—Ç–∏—á–µ—Å–∫–æ–≥–æ —Å–æ—Å—Ç–æ—è–Ω–∏—èÔªø. –ò—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –≤—ã—è–≤–∏–ª–æ, —á—Ç–æ –≥—Ä–∞–∂–¥–∞–Ω–µ —Å –Ω–∏–∑–∫–∏–º –¥–æ—Ö–æ–¥–æ–º —á–∞—â–µ –∏–≥–Ω–æ—Ä–∏—Ä—É—é—Ç —Å–∏–º–ø—Ç–æ–º—ã –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QYQPG #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, shortage"",
  ""impact"": ""high"",
  ""english"": ""Almost 90% of Russians prefer self-medication and delay visiting a doctor. The study found that people with low income ignore symptoms more frequently.""
}"
2025-11-27T13:10:06+00:00,@medpharm,13751,https://t.me/medpharm/13751,–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§ –æ–±–Ω–æ–≤–∏–ª–æ –ø–æ–ª–æ–∂–µ–Ω–∏–µ –æ –≥–æ—Å–∫–æ–Ω—Ç—Ä–æ–ª–µ –∑–∞ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º–∏ –º–µ–¥–∏–∑–¥–µ–ª–∏–π. –ò–∑–º–µ–Ω–µ–Ω–∞ —á–∞—Å—Ç–æ—Ç–∞ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è –ø–ª–∞–Ω–æ–≤—ã—Ö –ø—Ä–æ–≤–µ—Ä–æ–∫ –∏ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–∏—Ö –≤–∏–∑–∏—Ç–æ–≤ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QYPUo #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The Russian government has updated the regulation on state control over medical device manufacturers. The frequency of planned inspections and preventive visits has been changed. For more details: https://clck.ru/3QYPUo #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞""
}"
2025-11-27T12:11:03+00:00,@medpharm,13750,https://t.me/medpharm/13750,–ê—Ä–µ—Å—Ç–æ–≤–∞–Ω–æ –∏–º—É—â–µ—Å—Ç–≤–æ —ç–∫—Å-–º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –û–º—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –ò—Ä–∏–Ω—ã –°–æ–ª–¥–∞—Ç–æ–≤–æ–π. –° 2021 –≥–æ–¥–∞ –æ–Ω–∞ –Ω–∞—Ö–æ–¥–∏—Ç—Å—è –≤ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–æ–º —Ä–æ–∑—ã—Å–∫–µ –ø–æ –¥–µ–ª—É –æ –ø—Ä–µ–≤—ã—à–µ–Ω–∏–∏ –¥–æ–ª–∂–Ω–æ—Å—Ç–Ω—ã—Ö –ø–æ–ª–Ω–æ–º–æ—á–∏–π –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QYK7G #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-11-27T11:54:04+00:00,@medpharm,13749,https://t.me/medpharm/13749,"–í–ª–∞—Å—Ç–∏ –°–®–ê –¥–æ–≥–æ–≤–æ—Ä–∏–ª–∏—Å—å —Å —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—è–º–∏ –æ —Å–Ω–∏–∂–µ–Ω–∏–∏ —Ü–µ–Ω –Ω–∞ 15 –ª–µ–∫–∞—Ä—Å—Ç–≤ –¥–ª—è –ø–µ–Ω—Å–∏–æ–Ω–µ—Ä–æ–≤ –∏ –∏–Ω–≤–∞–ª–∏–¥–æ–≤, —Å–∫–∏–¥–∫–∏ –≤–∞—Ä—å–∏—Ä—É—é—Ç—Å—è –æ—Ç 40 –¥–æ 85%. –û –∫–∞–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞—Ö –∏–¥–µ—Ç —Ä–µ—á—å? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QYHo4 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{""skip"": true}"
2025-11-27T11:12:08+00:00,@medpharm,13748,https://t.me/medpharm/13748,"–í –ñ–µ–ª–µ–∑–Ω–æ–≤–æ–¥—Å–∫–µ —Ä–∞—Å—Å–ª–µ–¥—É—é—Ç —Å–º–µ—Ä—Ç—å —Ä–æ–∂–µ–Ω–∏—Ü—ã –∏ –µ–µ —Ä–µ–±–µ–Ω–∫–∞.Ôªø –ú—É–∂ –ø–æ–≥–∏–±—à–µ–π –ø–æ–¥–æ–∑—Ä–µ–≤–∞–µ—Ç, —á—Ç–æ –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–∏ –æ—Å—Ç–∞–≤–∏–ª–∏ –∂–µ–Ω—â–∏–Ω—É –±–µ–∑ –ø—Ä–∏—Å–º–æ—Ç—Ä–∞ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QYEkf #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-11-27T10:30:04+00:00,@medpharm,13747,https://t.me/medpharm/13747,–î–µ–ø—É—Ç–∞—Ç –ì–æ—Å–¥—É–º—ã –†–§ –°–µ—Ä–≥–µ–π –ú–∏—Ä–æ–Ω–æ–≤ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –≤–≤–µ—Å—Ç–∏ –≤—Ä–µ–º–µ–Ω–Ω—ã–π –∑–∞–ø—Ä–µ—Ç –Ω–∞ –ø–æ–≤—ã—à–µ–Ω–∏–µ —Ü–µ–Ω –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏–∑ –ü–µ—Ä–µ—á–Ω—è –ñ–ù–í–õ–ü. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QYBZQ #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""pricing"",
  ""impact"": ""medium"",
  ""english"": ""Deputy Sergei Mirnov of the State Duma proposed a temporary ban on price increases for medicines from the NPL list. More: https://clck.ru/3QYBZQ #Pharmnews #Retail""
}"
2025-11-27T10:14:18+00:00,@medpharm,13746,https://t.me/medpharm/13746,"–¢–µ–º–∞ –Ω–æ–º–µ—Ä–∞: –°–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã–µ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è –í 2025 –≥–æ–¥—É –ø—Ä–∏–º–µ—Ä–Ω–æ —á–µ—Ç–≤–µ—Ä—Ç—å –≤–∑—Ä–æ—Å–ª–æ–≥–æ –Ω–∞—Å–µ–ª–µ–Ω–∏—è –†–æ—Å—Å–∏–∏, –ø–æ –¥–∞–Ω–Ω—ã–º –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–§ –∏ –†–æ—Å—Å—Ç–∞—Ç–∞, —Å—Ç—Ä–∞–¥–∞—é—Ç —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏. –ü—Ä–∏ —ç—Ç–æ–º –æ–±—â–µ–µ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –≤—ã—è–≤–ª–µ–Ω–Ω—ã—Ö —Å–ª—É—á–∞–µ–≤ –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç —Ä–∞—Å—Ç–∏ –∏–∑-–∑–∞ —É–ª—É—á—à–µ–Ω–∏—è –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∏ –∏ —Å—Ç–∞—Ä–µ–Ω–∏—è –Ω–∞—Å–µ–ª–µ–Ω–∏—è. ¬´–§–í¬ª –ø—Ä–æ–∞–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–ª, –∫–∞–∫–∏–µ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø—Ä–æ–≥—Ä–∞–º–º—ã —Å–µ–π—á–∞—Å —Ä–µ–∞–ª–∏–∑—É—é—Ç—Å—è, –∫–∞–∫ —Ä–∞–∑–≤–∏–≤–∞–µ—Ç—Å—è —Ä—ã–Ω–æ–∫ –∫–∞—Ä–¥–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ —á—Ç–æ –Ω–æ–≤–æ–≥–æ –ø–æ—è–≤–∏–ª–æ—Å—å –≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏—è—Ö. –ö–∞–∫ –±—å–µ—Ç—Å—è —Å–µ—Ä–¥—Ü–µ. –ö–∞–∫ –≤ –†–æ—Å—Å–∏–∏ —Ä–µ–∞–ª–∏–∑—É–µ—Ç—Å—è –ø–æ–¥–¥–µ—Ä–∂–∫–∞ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –°–°–ó –ê —Ç–∞–∫–∂–µ: ¬´–û—Å–Ω–æ–≤–Ω–∞—è –ø—Ä–æ–±–ª–µ–º–∞ —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –°–°–ó ‚Äî –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ –ø—Ä–µ–µ–º—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç–∏ –º–µ–∂–¥—É —ç—Ç–∞–ø–∞–º–∏ –ø–æ–º–æ—â–∏¬ª. –ò–Ω—Ç–µ—Ä–≤—å—é –≥–ª–∞–≤–Ω–æ–≥–æ –≤–Ω–µ—à—Ç–∞—Ç–Ω–æ–≥–æ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–æ—Å—Å–∏–∏, –ø—Ä–æ—Ñ., –¥–æ–∫—Ç. –º–µ–¥. –Ω–∞—É–∫ –ï–≤–≥–µ–Ω–∏—è –®–ª—è—Ö—Ç–æ. –û–±–∑–æ—Ä —Ä—ã–Ω–∫–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –ù–æ–≤–æ–µ –≤ –∫–∞—Ä–¥–∏–æ–ª–æ–≥–∏–∏. –ó–∞—è–≤–ª–µ–Ω–∏—è 2025 –≥–æ–¥–∞ –°–≤–µ–∂–∏–π –Ω–æ–º–µ—Ä ¬´–§–í¬ª ‚Ññ26-27 (1185-1186) —É–∂–µ –¥–æ—Å—Ç—É–ø–µ–Ω –æ–Ω–ª–∞–π–Ω –±–µ—Å–ø–ª–∞—Ç–Ω–æ –¥–ª—è –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª–µ–π.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, shortage, safety"",
  ""impact"": ""medium"",
  ""english"": ""The article discusses the implementation of state programs, market trends for cardiology drugs, and new clinical guidelines in Russia. It highlights the challenges faced by patients with cardiovascular diseases, including issues of continuity in care.""
}"
2025-11-27T09:21:02+00:00,@medpharm,13745,https://t.me/medpharm/13745,–ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏ –ø–æ—à–µ–ª –Ω–∞–≤—Å—Ç—Ä–µ—á—É —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º –∏ –≤—ã–¥–µ–ª–∏–ª –¥–≤—É—Ö —ç–∫—Å–ø–µ—Ä—Ç–æ–≤ –¥–ª—è –æ–∫–∞–∑–∞–Ω–∏—è –º–µ—Ç–æ–¥–∏—á–µ—Å–∫–æ–π –ø–æ–º–æ—â–∏ –ø–æ –≤–æ–ø—Ä–æ—Å–∞–º –ø–æ–¥–∞—á–∏ –∑–∞—è–≤–ª–µ–Ω–∏–π –Ω–∞ –ø—Ä–∏–≤–µ–¥–µ–Ω–∏–µ —Ä–µ–≥–¥–æ—Å—å–µ –≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–µ —Å –ø—Ä–∞–≤–∏–ª–∞–º–∏ –ï–ê–≠–°. –ó–∞–ø—Ä–æ—Å –Ω–∞ —Ç–∞–∫—É—é –ø–æ–º–æ—â—å –ø–æ—Å—Ç—É–ø–∏–ª —Å–æ —Å—Ç–æ—Ä–æ–Ω—ã –æ—Ç—Ä–∞—Å–ª–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QY6Gs #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""medium"",
  ""english"": ""The Russian Ministry of Health has agreed to provide two experts for assistance in preparing applications for compliance with EAEU rules. The request came from the industry.""
}"
2025-11-27T09:13:04+00:00,@medpharm,13744,https://t.me/medpharm/13744,–≠–∫—Å-–≥–ª–∞–≤–∞ —Å–∞—Ö–∞–ª–∏–Ω—Å–∫–æ–≥–æ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –Ω–∞–∑–Ω–∞—á–µ–Ω —Ä–µ–∫—Ç–æ—Ä–æ–º –¢–∏—Ö–æ–æ–∫–µ–∞–Ω—Å–∫–æ–≥–æ –ì–ú–£. –ò–º—è –Ω–æ–≤–æ–≥–æ –º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ø–æ–∫–∞ –Ω–µ –Ω–∞–∑—ã–≤–∞–µ—Ç—Å—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QY5hG #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-11-27T09:13:04+00:00,@medpharm,13743,https://t.me/medpharm/13743,"–¢–µ—Ä–∞–ø–∏—è —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π ‚Äî –∫–æ–º–ø–ª–µ–∫—Å–Ω–∞—è –∑–∞–¥–∞—á–∞, —Ç—Ä–µ–±—É—é—â–∞—è —Ç–∞–∫–æ–≥–æ –∂–µ –∫–æ–º–ø–ª–µ–∫—Å–Ω–æ–≥–æ –ø–æ–¥—Ö–æ–¥–∞. –ï–µ —É—Å–ø–µ—Ö –∑–∞–≤–∏—Å–∏—Ç –æ—Ç –º–Ω–æ–∂–µ—Å—Ç–≤–∞ —Ñ–∞–∫—Ç–æ—Ä–æ–≤, –≤ —Ç–æ–º —á–∏—Å–ª–µ –ø—Ä–∏–≤–µ—Ä–∂–µ–Ω–Ω–æ—Å—Ç–∏ –ª–µ—á–µ–Ω–∏—é. –ü–æ —Å—Ç–∞—Ç–∏—Å—Ç–∏–∫–µ, 40‚Äî60% –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –∫–∞—Ä–¥–∏–æ–ª–æ–≥–∞ –Ω–µ –ø—Ä–∏–Ω–∏–º–∞—é—Ç –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ —Å–æ–≥–ª–∞—Å–Ω–æ –ø—Ä–µ–¥–ø–∏—Å–∞–Ω–∏—é –≤—Ä–∞—á–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QY5hP #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–µ–π—Å—ã","{
  ""skip"": true
}"
2025-11-27T07:59:06+00:00,@medpharm,13742,https://t.me/medpharm/13742,–°—É–¥ –≤–∑—ã—Å–∫–∞–ª 500 —Ç—ã—Å. —Ä—É–±–ª–µ–π –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏–∏ –º–æ—Ä–∞–ª—å–Ω–æ–≥–æ –≤—Ä–µ–¥–∞ –≤ –ø–æ–ª—å–∑—É –≤—Ä–∞—á–∞-—Ö–∏—Ä—É—Ä–≥–∞ –†—É–±–µ–Ω–∞ –ê–≤–∞–Ω–µ—Å—è–Ω–∞ –∑–∞ –Ω–µ–æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω–æ–µ —É–≥–æ–ª–æ–≤–Ω–æ–µ –ø—Ä–µ—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ. –í 2023 –≥–æ–¥—É –µ–≥–æ –æ—Å—É–¥–∏–ª–∏ —É—Å–ª–æ–≤–Ω–æ –Ω–∞ —Ç—Ä–∏ –≥–æ–¥–∞ –∑–∞ —Å–º–µ—Ä—Ç—å –ø–∞—Ü–∏–µ–Ω—Ç–∞ —Å —Ä–∞–∫–æ–º IV —Å—Ç–∞–¥–∏–∏ –ø–æ—Å–ª–µ –ø–∞–ª–ª–∏–∞—Ç–∏–≤–Ω–æ–π –æ–ø–µ—Ä–∞—Ü–∏–∏ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QXxf8 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-11-27T07:31:02+00:00,@medpharm,13741,https://t.me/medpharm/13741,"–°—É–¥ –≤—ã–Ω–µ—Å —Ä–µ—à–µ–Ω–∏–µ –ø–æ –¥–µ–ª—É ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º–∞¬ª –ø—Ä–æ—Ç–∏–≤ —Ç–µ–ª–µ–∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ü—è—Ç–Ω–∏—Ü–∞¬ª –∏ –æ–Ω–ª–∞–π–Ω-–∫–∏–Ω–æ—Ç–µ–∞—Ç—Ä–∞ ¬´–ü—Ä–µ–º—å–µ—Ä¬ª. –ü–æ–≤–æ–¥–æ–º –¥–ª—è –æ–±—Ä–∞—â–µ–Ω–∏—è —Å—Ç–∞–ª–æ —à–æ—É ¬´–ë–æ–ª—å—à–∏–µ –¥–µ–≤–æ—á–∫–∏¬ª, –∫–æ—Ç–æ—Ä–æ–µ –ø–æ—Å–≤—è—â–µ–Ω–æ –±–æ—Ä—å–±–µ —Å –ª–∏—à–Ω–∏–º –≤–µ—Å–æ–º. –ü–æ —Å–ª–æ–≤–∞–º –∏—Å—Ç—Ü–∞, –ø—Ä–æ–≥—Ä–∞–º–º–∞ ¬´–ø—Ä–æ—Ç–∏–≤–æ—Ä–µ—á–∏—Ç —Ü–µ–Ω–Ω–æ—Å—Ç—è–º —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏¬ª –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QXvYX #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-11-27T06:59:04+00:00,@medpharm,13740,https://t.me/medpharm/13740,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –°–≤–µ—Ä–¥–ª–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –æ—Ç–≤–µ—Ç–∏–ª –Ω–∞ –∑–∞–ø—Ä–æ—Å ¬´–ú–í¬ª –æ –ø—Ä–∏—á–∏–Ω–∞—Ö –ø—Ä–æ–±–ª–µ–º —Å —Ç—Ä—É–¥–æ—É—Å—Ç—Ä–æ–π—Å—Ç–≤–æ–º –≤—Ä–∞—á–∞ –ø–æ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–π –ø—Ä–æ–≥—Ä–∞–º–º–µ ¬´–ó–µ–º—Å–∫–∏–π –¥–æ–∫—Ç–æ—Ä¬ª. –í –≤–µ–¥–æ–º—Å—Ç–≤–µ —Å–æ–æ–±—â–∏–ª–∏, —á—Ç–æ –≤ –ø—Ä–æ—à–ª–æ–º –≥–æ–¥—É –ø–ª–∞–Ω –±—ã–ª –≤—ã–ø–æ–ª–Ω–µ–Ω –Ω–∞ 100%. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QXtC7 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-11-27T06:17:04+00:00,@medpharm,13739,https://t.me/medpharm/13739,"–≠–∫—Å–ø–µ—Ä—Ç—ã –ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ –∏–Ω—Å—Ç–∏—Ç—É—Ç–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∏ —Å–æ–≤–µ—Ä—à–µ–Ω—Å—Ç–≤–æ–≤–∞–Ω–∏—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –í–µ–ª–∏–∫–æ–±—Ä–∏—Ç–∞–Ω–∏–∏ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∏ –æ–±–Ω–æ–≤–ª–µ–Ω–Ω—ã–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—é —Ç—Ä–∞–Ω–µ–∫—Å–∞–º–æ–≤–æ–π –∫–∏—Å–ª–æ—Ç—ã –¥–ª—è —Å–Ω–∏–∂–µ–Ω–∏—è –∫—Ä–æ–≤–æ—Ç–µ—á–µ–Ω–∏–π –≤–æ –≤—Ä–µ–º—è –∏ –≤–Ω–µ —Ö–∏—Ä—É—Ä–≥–∏—á–µ—Å–∫–∏—Ö –≤–º–µ—à–∞—Ç–µ–ª—å—Å—Ç–≤. –í –¥–æ–∫—É–º–µ–Ω—Ç–µ —Ä–∞—Å—à–∏—Ä–µ–Ω—ã –ø–æ–∫–∞–∑–∞–Ω–∏—è –∫ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏—é –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –ø—Ä–∏ –≤–º–µ—à–∞—Ç–µ–ª—å—Å—Ç–≤–∞—Ö, —Å–≤—è–∑–∞–Ω–Ω—ã—Ö —Å —Ä–∏—Å–∫–æ–º –∫—Ä–æ–≤–æ—Ç–µ—á–µ–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QXqMT #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è #–•–∏—Ä—É—Ä–≥–∏—è","{""skip"": true}"
2025-11-27T06:04:03+00:00,@medpharm,13738,https://t.me/medpharm/13738,"–°–∏–º–ø—Ç–æ–º—ã —É–∫–∞—á–∏–≤–∞–Ω–∏—è —Å–ø–æ—Å–æ–±–Ω—ã –æ—Ç—Ä–∞–≤–∏—Ç—å –ª—é–±–æ–π, –¥–∞–∂–µ —Å–∞–º—ã–π –ø—Ä–µ–∫—Ä–∞—Å–Ω—ã–π –æ—Ç–¥—ã—Ö –∏–ª–∏ –ø–æ–µ–∑–¥–∫—É. –î–ª—è —Ç–æ–≥–æ, —á—Ç–æ–±—ã —ç—Ç–æ–≥–æ –Ω–µ –ø—Ä–æ–∏–∑–æ—à–ª–æ, —Å–ª–µ–¥—É–µ—Ç –∑–∞—Ä–∞–Ω–µ–µ –ø–æ–∑–∞–±–æ—Ç–∏—Ç—å—Å—è –æ —Å–≤–æ–µ–º –∑–¥–æ—Ä–æ–≤—å–µ –∏ –≤–∑—è—Ç—å —Å —Å–æ–±–æ–π –≤ –ø—É—Ç–µ—à–µ—Å—Ç–≤–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç –æ—Ç —É–∫–∞—á–∏–≤–∞–Ω–∏—è. –ö–∞–∫–∏–µ –∂–µ —Å—Ä–µ–¥—Å—Ç–≤–∞ —Å—É—â–µ—Å—Ç–≤—É—é—Ç, –∫–∞–∫–æ–≤—ã –æ—Å–æ–±–µ–Ω–Ω–æ—Å—Ç–∏ –∏—Ö –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –∏ –æ —á–µ–º –Ω—É–∂–Ω–æ –ø–æ–º–Ω–∏—Ç—å? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QXoch #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–µ–ø–∞—Ä–∞—Ç—ã/–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-11-27T05:20:20+00:00,@medpharm,13737,https://t.me/medpharm/13737,"–û–¥–∏–Ω –∏–∑ –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª–µ–π –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—è –§–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ —Ñ–æ–Ω–¥–∞ –û–ú–° —É—à–µ–ª –≤ –æ—Ç—Å—Ç–∞–≤–∫—É –ø–æ —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ–º—É –∂–µ–ª–∞–Ω–∏—é. –ö—Ç–æ –∑–∞–π–º–µ—Ç —ç—Ç—É –¥–æ–ª–∂–Ω–æ—Å—Ç—å, –ø–æ–∫–∞ –Ω–µ–∏–∑–≤–µ—Å—Ç–Ω–æ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QXmRM #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-11-26T16:49:01+00:00,@medpharm,13736,https://t.me/medpharm/13736,"ü¶æ –ù–µ –∫–æ –¥–≤–æ—Ä—É. –í –°–µ—á–µ–Ω–æ–≤—Å–∫–æ–º —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–µ –ª–∏–∫–≤–∏–¥–∏—Ä–æ–≤–∞–Ω–∞ –∫–∞—Ñ–µ–¥—Ä–∞ —ç–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–∏–∏ ‚Ññ 1, –∞ –µ–µ —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å, –∏–∑–≤–µ—Å—Ç–Ω—ã–π —ç–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥ –í–∞–ª–µ–Ω—Ç–∏–Ω –§–∞–¥–µ–µ–≤ —É–≤–æ–ª–µ–Ω. ü¶æ –ú–∞–ª–æ –æ–ø—Ç–∏–º–∏–∑–º–∞. –†–æ—Å—Å–∏—è–Ω–µ –Ω–µ –≤–∏–¥—è—Ç —è–≤–Ω—ã—Ö –∏–∑–º–µ–Ω–µ–Ω–∏–π –≤ —Å–∏—Å—Ç–µ–º–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –ë–æ–ª—å—à–µ —Ç—Ä–µ—Ç–∏ –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö –í—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–∏–º —Å–æ—é–∑–æ–º –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –æ—Ç–º–µ—Ç–∏–ª–∏, —á—Ç–æ –æ–Ω–∞ —Å—Ç–∞–ª–∞ ¬´–≤ —á–µ–º-—Ç–æ –ª—É—á—à–µ, –≤ —á–µ–º-—Ç–æ —Ö—É–∂–µ¬ª, –µ—â–µ 40,2% –∑–∞—è–≤–∏–ª–∏ –æ–± —É—Ö—É–¥—à–µ–Ω–∏–∏. ‚ù§Ô∏è –î–≤–µ —Ä–µ–∞–ª—å–Ω–æ—Å—Ç–∏. –ë–æ–ª–µ–µ 60% –ª–∏–¥–µ—Ä–æ–≤ –ø–∞—Ü–∏–µ–Ω—Ç—Å–∫–∏—Ö –ù–ö–û –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–∞—é—Ç —Å–∏—Å—Ç–µ–º–Ω—ã–µ –ø—Ä–æ–±–ª–µ–º—ã —Å –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å—é –ª—å–≥–æ—Ç–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤. –¢–∞–∫–∏–µ –¥–∞–Ω–Ω—ã–µ –±—ã–ª–∏ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω—ã –Ω–∞ XVI –í—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–æ–º –∫–æ–Ω–≥—Ä–µ—Å—Å–µ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –∏ –≤—ã–∑–≤–∞–ª–∏ –±—É—Ä–Ω—É—é –¥–∏—Å–∫—É—Å—Å–∏—é. ‚ù§Ô∏è –®–∏—Ä–µ –∫—Ä—É–≥. –≠–∫—Å–ø–µ—Ä—Ç–Ω—ã–π —Å–æ–≤–µ—Ç —Ñ–æ–Ω–¥–∞ ¬´–ö—Ä—É–≥ –¥–æ–±—Ä–∞¬ª —Ä–∞—Å—à–∏—Ä–∏–ª –ø–µ—Ä–µ—á–µ–Ω—å –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, –≤–∫–ª—é—á–∏–≤ –≤ –Ω–µ–≥–æ –ø—è—Ç—å –Ω–æ–≤—ã—Ö –Ω–æ–∑–æ–ª–æ–≥–∏–π. –°—Ä–µ–¥–∏ –Ω–∏—Ö ‚Äî —Å–∏–Ω–¥—Ä–æ–º –•–∞—Ç—á–∏–Ω—Å–æ–Ω–∞‚Äî–ì–∏–ª—Ñ–æ—Ä–¥–∞, –∏–ª–∏ ¬´–±–æ–ª–µ–∑–Ω—å –ë–µ–Ω–¥–∂–∞–º–∏–Ω–∞ –ë–∞—Ç—Ç–æ–Ω–∞¬ª, –≤—ã–∑—ã–≤–∞—é—â–∞—è –ø—Ä–µ–∂–¥–µ–≤—Ä–µ–º–µ–Ω–Ω–æ–µ —Å—Ç–∞—Ä–µ–Ω–∏–µ.","{""skip"": true}"
2025-11-26T15:59:04+00:00,@medpharm,13735,https://t.me/medpharm/13735,"–í —Å—Ä–µ–¥–Ω–µ–º —Ä–æ—Å—Å–∏–π—Å–∫–∏–π –≤—Ä–∞—á –≤—ã–¥–µ–ª—è–µ—Ç –æ–∫–æ–ª–æ —á–∞—Å–∞ –≤ –¥–µ–Ω—å –Ω–∞ –ø–æ–∏—Å–∫ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–π –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏, –æ–¥–Ω–∞–∫–æ —Ç–æ–ª—å–∫–æ 20% —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ —É–¥–∞–µ—Ç—Å—è –Ω–∞–π—Ç–∏ –Ω—É–∂–Ω—ã–µ –¥–∞–Ω–Ω—ã–µ –±—ã—Å—Ç—Ä–æ –∏ –ª–µ–≥–∫–æ, –ø–æ–∫–∞–∑–∞–ª –æ–ø—Ä–æ—Å. ‚Äã –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QXSKd #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫","{""skip"": true}"
2025-11-26T15:39:10+00:00,@medpharm,13734,https://t.me/medpharm/13734,–£—á–µ–Ω—ã–µ –∏–∑ –ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–π –∞–∫–∞–¥–µ–º–∏–∏ –Ω–µ–≤—Ä–æ–ª–æ–≥–∏–∏ (AAN) –∏ –ò–Ω—Å—Ç–∏—Ç—É—Ç–∞ –ø–æ–∫–∞–∑–∞—Ç–µ–ª–µ–π –∏ –æ—Ü–µ–Ω–∫–∏ –∑–¥–æ—Ä–æ–≤—å—è (IHME) –æ—Ü–µ–Ω–∏–ª–∏ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–Ω–æ—Å—Ç—å –∏ –±—Ä–µ–º—è –Ω–µ–≤—Ä–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π —Å—Ä–µ–¥–∏ –Ω–∞—Å–µ–ª–µ–Ω–∏—è –°–®–ê. –†–µ–∑—É–ª—å—Ç–∞—Ç—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω—ã –≤ –∂—É—Ä–Ω–∞–ª–µ JAMA Neurology. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QXQvi #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ù–µ–≤—Ä–æ–ª–æ–≥–∏—è #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-11-26T15:32:04+00:00,@medpharm,13733,https://t.me/medpharm/13733,–†–µ—Ü–∏–¥–∏–≤ –º—ã—à–µ—á–Ω–æ-–∏–Ω–≤–∞–∑–∏–≤–Ω–æ–≥–æ —Ä–∞–∫–∞ –º–æ—á–µ–≤–æ–≥–æ –ø—É–∑—ã—Ä—è –ø—Ä–æ–∏—Å—Ö–æ–¥–∏—Ç –≤ –ø–æ–ª–æ–≤–∏–Ω–µ —Å–ª—É—á–∞–µ–≤ –¥–∞–∂–µ –ø–æ—Å–ª–µ —É–¥–∞–ª–µ–Ω–∏—è –æ—Ä–≥–∞–Ω–∞. –¢–µ–ø–µ—Ä—å –¥–æ –∏ –ø–æ—Å–ª–µ –æ–ø–µ—Ä–∞—Ü–∏–∏ –∞–º–µ—Ä–∏–∫–∞–Ω—Ü–∞–º —Å —ç—Ç–æ–π –æ–ø—É—Ö–æ–ª—å—é –±—É–¥–µ—Ç –¥–æ—Å—Ç—É–ø–Ω–∞ –Ω–æ–≤–∞—è —Å—Ö–µ–º–∞ –ª–µ—á–µ–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QXQXp #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-11-26T14:28:03+00:00,@medpharm,13731,https://t.me/medpharm/13731,–≠–∫—Å–ø–µ—Ä—Ç–Ω—ã–π —Å–æ–≤–µ—Ç ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª –ø—Ä–µ–¥–ª–æ–∂–∏–ª —Ä–∞—Å—à–∏—Ä–∏—Ç—å –ø–µ—Ä–µ—á–µ–Ω—å –∑–∞–∫—É–ø–∞–µ–º—ã—Ö —Ñ–æ–Ω–¥–æ–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ —Ä–µ–¥–∫–∏—Ö –Ω–æ–∑–æ–ª–æ–≥–∏–π –¥–ª—è –ª–µ—á–µ–Ω–∏—è. –°–ø–∏—Å–æ–∫ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –º–æ–∂–µ—Ç –ø–æ–ø–æ–ª–Ω–∏—Ç—å—Å—è ¬´–±–æ–ª–µ–∑–Ω—å—é –ë–µ–Ω–¥–∂–∞–º–∏–Ω–∞ –ë–∞—Ç—Ç–æ–Ω–∞¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QXM4K #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": true,
  ""country"": ""global"",
  ""topic"": ""tenders, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""A expert council 'Circle of Good' suggested to expand the list of drugs and rare diseases that the fund will procure. The disease 'Benjamin Button's pain' may be added to the list. For more details: https://clck.ru/3QXM4K #MedVestnik #Healthcare #Public_Health""
}"
2025-11-26T14:21:03+00:00,@medpharm,13730,https://t.me/medpharm/13730,–ù–∞ —Ñ–æ—Ä—É–º–µ –≤ –ê–±—É-–î–∞–±–∏ —Ä–æ—Å—Å–∏–π—Å–∫–∞—è –¥–µ–ª–µ–≥–∞—Ü–∏—è –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∞ —É–Ω–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞—Ç—å –ø—Ä–∞–≤–∏–ª–∞ –∫–æ–Ω—Ç—Ä–æ–ª—è –∫–∞—á–µ—Å—Ç–≤–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ (GMP) –∏–∑-–∑–∞ –±—É—Ä–Ω–æ–≥–æ —Ä–æ—Å—Ç–∞ –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –∏ –≥–µ–Ω–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏. –ö–∞–∫–∏–µ —à–∞–≥–∏ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –ø—Ä–µ–¥–ø—Ä–∏–Ω—è—Ç—å –Ω–∞ —Ñ–æ–Ω–µ –±—É—Ä–Ω–æ–≥–æ —Ä–æ—Å—Ç–∞ –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –∏ –≥–µ–Ω–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QXLcU #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety, guideline"",
  ""impact"": ""high"",
  ""english"": ""The Russian delegation at the forum in Abu Dhabi proposed to unify quality control rules (GMP) due to the rapid growth of biotechnology and gene therapy. What steps were proposed in light of the rapid growth of biotechnology and gene therapy? More details: https://clck.ru/3QXLcU #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫""
}"
2025-11-26T13:55:06+00:00,@medpharm,13729,https://t.me/medpharm/13729,–£—á–µ–Ω—ã–µ –∏–∑ Novo Nordisk –æ—Ü–µ–Ω–∏–ª–∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –∏ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –ø–µ—Ä–æ—Ä–∞–ª—å–Ω–æ–≥–æ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å —Ä–∞–Ω–Ω–µ–π —Å–∏–º–ø—Ç–æ–º–∞—Ç–∏—á–µ—Å–∫–æ–π –±–æ–ª–µ–∑–Ω—å—é –ê–ª—å—Ü–≥–µ–π–º–µ—Ä–∞. –†–µ–∑—É–ª—å—Ç–∞—Ç—ã –∞–Ω–∞–ª–∏–∑–∞ –±—É–¥—É—Ç –ø–æ–¥—Ä–æ–±–Ω–æ –∏–∑–ª–æ–∂–µ–Ω—ã –Ω–∞ –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ –ø–æ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–º –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è–º –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è –≤ –¥–µ–∫–∞–±—Ä–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QXJgQ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ù–µ–≤—Ä–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è #–≠–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–∏—è,"{""skip"": true}"
2025-11-26T13:13:04+00:00,@medpharm,13728,https://t.me/medpharm/13728,"–ë–æ–ª–µ–µ –ø–æ–ª–æ–≤–∏–Ω—ã —Ä–æ—Å—Å–∏—è–Ω –Ω–µ –¥–æ–≤–µ—Ä—è—é—Ç –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–º—É –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç—É –ø—Ä–∏ –≤—ã–±–æ—Ä–µ –ª–µ–∫–∞—Ä—Å—Ç–≤, —Å–æ–≤–µ—Ç–∞–º–∏ –Ω–µ–π—Ä–æ—Å–µ—Ç–µ–π –ø–æ —ç—Ç–æ–º—É –≤–æ–ø—Ä–æ—Å—É –ø–æ–ª—å–∑—É—é—Ç—Å—è —Ç–æ–ª—å–∫–æ 15% —Ä–µ—Å–ø–æ–Ω–¥–µ–Ω—Ç–æ–≤, –ø–æ–∫–∞–∑–∞–ª–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –ú–¢–° AdTech –∏ –†–û–ú–ò–†. –ü–æ—á–µ–º—É –æ–ø—Ä–æ—à–µ–Ω–Ω—ã–µ –Ω–µ –¥–æ–≤–µ—Ä—è—é—Ç —Å–æ–≤–µ—Ç–∞–º —Å –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ–º –ò–ò? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QXFjf #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{""skip"": true}"
2025-11-26T12:09:03+00:00,@medpharm,13727,https://t.me/medpharm/13727,–í –ø–µ—Ä–µ—á–µ–Ω—å —É—Å–ª—É–≥ –≤ —Å–∏—Å—Ç–µ–º–µ –û–ú–° –¥–ª—è –¥–µ—Ç–µ–π —Å –∞—É—Ç–∏–∑–º–æ–º –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –≤–∫–ª—é—á–∏—Ç—å —Ç–µ—Ä–∞–ø–∏—é –º–∞–∫—Ä–æ—Ñ–∞–≥–∞–º–∏ –∏ –ø—Å–∏—Ö–æ–ª–æ–≥–æ-–ø–µ–¥–∞–≥–æ–≥–∏—á–µ—Å–∫—É—é –∫–æ—Ä—Ä–µ–∫—Ü–∏—é. –í —Å–≤—è–∑–∏ —Å —Ä–æ—Å—Ç–æ–º —á–∏—Å–ª–∞ —Ç–∞–∫–∏—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ —É–ª—É—á—à–∏—Ç—å –¥–ª—è –Ω–∏—Ö –¥–æ—Å—Ç—É–ø –∫ —Å–æ–≤—Ä–µ–º–µ–Ω–Ω—ã–º –º–µ—Ç–æ–¥–∞–º –ª–µ—á–µ–Ω–∏—è –∏ —Ä–µ–∞–±–∏–ª–∏—Ç–∞—Ü–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QXApH #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, reimbursement, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The system of State Medical Insurance has proposed to include treatment with macrophages and psychological-pedagogical correction for children with autism in the list of covered services. Due to an increase in the number of such patients, it is necessary to improve access for them to modern methods of treatment and rehabilitation. For more details: https://clck.ru/3QXApH #Medvestnik #Healthcare #Medical_Services""
}"
2025-11-26T11:55:04+00:00,@medpharm,13726,https://t.me/medpharm/13726,"–ü—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–ª—è –ø–æ—Ö—É–¥–µ–Ω–∏—è –∏ –∫–æ–Ω—Ç—Ä–æ–ª—è –¥–∏–∞–±–µ—Ç–∞, –∫–æ—Ç–æ—Ä—ã–µ —Å–¥–µ–ª–∞–ª–∏ –∫–æ–º–ø–∞–Ω–∏—é Novo Nordisk –º–∏—Ä–æ–≤–æ–π –∑–≤–µ–∑–¥–æ–π —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏, –æ–∫–∞–∑–∞–ª–∏—Å—å —Å–≤—è–∑–∞–Ω—ã —Å —Ä–µ–¥–∫–∏–º, –Ω–æ –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω–æ –Ω–µ–æ–±—Ä–∞—Ç–∏–º—ã–º –Ω–∞—Ä—É—à–µ–Ω–∏–µ–º –∑—Ä–µ–Ω–∏—è. –î–∞—Ç—Å–∫–∏–µ –≤–ª–∞—Å—Ç–∏ —É–∂–µ –ø—Ä–∏—Å—É–¥–∏–ª–∏ –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏–∏ –ø–µ—Ä–≤—ã–º –ø–æ—Å—Ç—Ä–∞–¥–∞–≤—à–∏–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QX9fA #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance"",
  ""impact"": ""high"",
  ""english"": ""Medicinal products for weight loss and diabetes control, developed by Novo Nordisk, were linked to a rare but potentially irreversible vision impairment. The Danish authorities have already compensated the first victim. More: https://clck.ru/3QX9fA #PharmNews #Regulation""
}"
2025-11-26T11:20:08+00:00,@medpharm,13725,https://t.me/medpharm/13725,"–í—Ä–∞—á –£–ó–ò –≤ –ø–æ–¥–º–æ—Å–∫–æ–≤–Ω–æ–π –ë–∞–ª–∞—à–∏—Ö–µ –º–æ–∂–µ—Ç –∑–∞—Ä–∞–±–∞—Ç—ã–≤–∞—Ç—å –±–æ–ª—å—à–µ 180 —Ç—ã—Å. —Ä—É–±–ª–µ–π –≤ –º–µ—Å—è—Ü, –∞ –≤—Ä–∞—á –ø–∞–ª–ª–∏–∞—Ç–∏–≤–Ω–æ–π –ø–æ–º–æ—â–∏ –≤–æ –í–ª–∞–¥–∏–º–∏—Ä–µ ‚Äî –¥–æ 120 —Ç—ã—Å. —Ä—É–±–ª–µ–π. –ú–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–∏ –≤–Ω–æ–≤—å –≤–æ—à–ª–∏ –≤ –¢–û–† –ª—É—á—à–∏—Ö –≤–∞–∫–∞–Ω—Å–∏–π –Ω–æ—è–±—Ä—è –≤ –≥–æ—Ä–æ–¥–∞—Ö —Å –Ω–∞—Å–µ–ª–µ–Ω–∏–µ–º –¥–æ –ø–æ–ª—É–º–∏–ª–ª–∏–æ–Ω–∞ —á–µ–ª–æ–≤–µ–∫. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QX7Ht #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-11-26T10:22:03+00:00,@medpharm,13724,https://t.me/medpharm/13724,"–û–ø—É–±–ª–∏–∫–æ–≤–∞–Ω –ø—Ä–æ–µ–∫—Ç –ø—Ä–∏–∫–∞–∑–∞ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–§, —É—Å—Ç–∞–Ω–∞–≤–ª–∏–≤–∞—é—â–µ–≥–æ –º–∏–Ω–∏–º–∞–ª—å–Ω–æ–µ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –±–∞–ª–ª–æ–≤ –ï–ì–≠ –¥–ª—è –ø–æ—Å—Ç—É–ø–ª–µ–Ω–∏—è –≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –≤—É–∑—ã –≤ 2026 —É—á–µ–±–Ω–æ–º –≥–æ–¥—É. –ù–∞–∏–±–æ–ª–µ–µ –∂–µ—Å—Ç–∫–∏–π –æ—Ç–±–æ—Ä –∂–¥–µ—Ç –∞–±–∏—Ç—É—Ä–∏–µ–Ω—Ç–æ–≤, –∂–µ–ª–∞—é—â–∏—Ö —É—á–∏—Ç—å—Å—è –Ω–∞ —Å—Ç–æ–º–∞—Ç–æ–ª–æ–≥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QX2qm #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–û–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-11-26T10:21:03+00:00,@medpharm,13723,https://t.me/medpharm/13723,"–ü–ª–∞–Ω–æ–≤—ã–µ –ø—Ä–æ–≤–µ—Ä–∫–∏ –¥–ª—è –∫–æ–º–ø–∞–Ω–∏–π, —Ä–∞–±–æ—Ç–∞—é—â–∏—Ö —Å –±–∏–æ–º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º–∏ –∫–ª–µ—Ç–æ—á–Ω—ã–º–∏ –ø—Ä–æ–¥—É–∫—Ç–∞–º–∏, —Å–æ–∫—Ä–∞—Ç—è—Ç. –û–Ω–∏ –±—É–¥—É—Ç –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–º–∏ —Ç–æ–ª—å–∫–æ –¥–ª—è –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π —Å –≤—ã—Å–æ–∫–æ–π —Å—Ç–µ–ø–µ–Ω—å—é —Ä–∏—Å–∫–∞ –∏ –±—É–¥—É—Ç –ø—Ä–æ–≤–æ–¥–∏—Ç—å—Å—è —Ä–∞–∑ –≤ –¥–≤–∞ –≥–æ–¥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QX2n9 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, regulation"",
  ""impact"": ""medium"",
  ""english"": ""Routine inspections for companies working with biologic cell products will be reduced. They will only be mandatory for high-risk organizations and conducted every two years. For more information: https://clck.ru/3QX2n9 #PharmNews #Regulation""
}"
2025-11-26T10:05:09+00:00,@medpharm,13722,https://t.me/medpharm/13722,"–° –º–∏—Ä—É –ø–æ –∫–∞–ø–ª–µ. –°–∫–æ–ª—å–∫–æ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ —Ç—Ä–∞—Ç—è—Ç –Ω–∞ –ø–æ–¥–¥–µ—Ä–∂–∫—É –ø–∞—Ü–∏–µ–Ω—Ç—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –ù–µ —Å–µ–∫—Ä–µ—Ç, —á—Ç–æ –æ—Å–Ω–æ–≤–∞ —Ñ–∏–Ω–∞–Ω—Å–æ–≤–æ–π —Å–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö –ø–∞—Ü–∏–µ–Ω—Ç—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π ‚Äî —ç—Ç–æ —Å–ø–æ–Ω—Å–æ—Ä—Å–∫–∞—è –ø–æ–¥–¥–µ—Ä–∂–∫–∞ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –∫–æ–º–ø–∞–Ω–∏–π. –û–¥–Ω–∞–∫–æ –Ω–∏ —Ç–µ, –Ω–∏ –¥—Ä—É–≥–∏–µ –Ω–µ —Å—Ç—Ä–µ–º—è—Ç—Å—è –∞—Ñ–∏—à–∏—Ä–æ–≤–∞—Ç—å —Ç–∞–∫—É—é —Å—Ç–æ—Ä–æ–Ω—É –≤–∑–∞–∏–º–æ–æ—Ç–Ω–æ—à–µ–Ω–∏–π. –¶–µ–ª—å –ø–∞—Ü–∏–µ–Ω—Ç—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π ‚Äî –æ–±–µ—Å–ø–µ—á–∏—Ç—å —Å–≤–æ–∏–º –ø–æ–¥–æ–ø–µ—á–Ω—ã–º —Å–≤–æ–µ–≤—Ä–µ–º–µ–Ω–Ω—É—é –∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—É—é –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—É—é –ø–æ–º–æ—â—å. –ë–∏–∑–Ω–µ—Å—É –Ω—É–∂–Ω—ã –ù–ö–û, —á—Ç–æ–±—ã –ª–æ–±–±–∏—Ä–æ–≤–∞—Ç—å —Å–≤–æ–∏ –∏–Ω—Ç–µ—Ä–µ—Å—ã —á–µ—Ä–µ–∑ –≥–æ–ª–æ—Å –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –Ω–∞ —É—Ä–æ–≤–Ω–µ –ª–∏—Ü, –ø—Ä–∏–Ω–∏–º–∞—é—â–∏—Ö —Ä–µ—à–µ–Ω–∏—è. ¬´–§–í¬ª –≤—ã—è—Å–Ω–∏–ª, –≤–æ —Å–∫–æ–ª—å–∫–æ –æ–±—Ö–æ–¥–∏—Ç—Å—è —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—è–º —ç—Ç–∞ –ø–æ–¥–¥–µ—Ä–∂–∫–∞, –∫—Ç–æ —Å—Ç–æ–∏—Ç –∑–∞ –ø–∞—Ü–∏–µ–Ω—Ç—Å–∫–∏–º–∏ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è–º–∏ –∏ –∫–∞–∫ –∏–∑–º–µ–Ω–∏–ª—Å—è –∏—Ö —Ñ–æ—Ä–º–∞—Ç –≤–∑–∞–∏–º–æ–æ—Ç–Ω–æ—à–µ–Ω–∏–π –ø–æ—Å–ª–µ 2022 –≥–æ–¥–∞. –°–≤–µ–∂–∏–π –Ω–æ–º–µ—Ä ¬´–§–í¬ª ‚Ññ26-27 (1185-1186) —É–∂–µ –¥–æ—Å—Ç—É–ø–µ–Ω –æ–Ω–ª–∞–π–Ω –±–µ—Å–ø–ª–∞—Ç–Ω–æ –¥–ª—è –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª–µ–π.","{""skip"": true}"
2025-11-26T09:26:03+00:00,@medpharm,13721,https://t.me/medpharm/13721,"–í –°–µ—á–µ–Ω–æ–≤—Å–∫–æ–º —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–µ –ª–∏–∫–≤–∏–¥–∏—Ä–æ–≤–∞–Ω–∞ –∫–∞—Ñ–µ–¥—Ä–∞ —ç–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–∏–∏ ‚Ññ 1, –∞ –µ–µ —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å, –∏–∑–≤–µ—Å—Ç–Ω—ã–π —ç–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥ –í–∞–ª–µ–Ω—Ç–∏–Ω –§–∞–¥–µ–µ–≤ —É–≤–æ–ª–µ–Ω. –û–¥–Ω–æ–≤—Ä–µ–º–µ–Ω–Ω–æ —Å —ç—Ç–∏–º –≤—É–∑ —Å–æ–æ–±—â–∏–ª –æ —Å–æ–∑–¥–∞–Ω–∏–∏ –∞–Ω–∞–ª–æ–≥–∏—á–Ω–æ–π –∫–∞—Ñ–µ–¥—Ä—ã ‚Äî —ç–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–∏–∏ –∏ –º–µ—Ç–∞–±–æ–ª–∏—á–µ—Å–∫–æ–≥–æ –∑–¥–æ—Ä–æ–≤—å—è ‚Äî —Å –Ω–æ–≤—ã–º —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª–µ–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QWwcP #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–û–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è #–≠–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-11-26T08:44:03+00:00,@medpharm,13720,https://t.me/medpharm/13720,–ì–µ–Ω–Ω–∞—è —Ç–µ—Ä–∞–ø–∏—è –æ—Ç —Å–º–µ—Ä—Ç–µ–ª—å–Ω–æ–π —Å–ø–∏–Ω–∞–ª—å–Ω–æ–π –º—ã—à–µ—á–Ω–æ–π –∞—Ç—Ä–æ—Ñ–∏–∏ —Ç–µ–ø–µ—Ä—å –¥–æ—Å—Ç—É–ø–Ω–∞ –∞–º–µ—Ä–∏–∫–∞–Ω—Ü–∞–º –≤—Å–µ—Ö –≤–æ–∑—Ä–∞—Å—Ç–æ–≤. FDA –æ–¥–æ–±—Ä–∏–ª–æ Itvisma ‚Äî –ø–µ—Ä–≤—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è –ª–µ—á–µ–Ω–∏—è —ç—Ç–æ–π –±–æ–ª–µ–∑–Ω–∏ —É –ª—é–¥–µ–π —Å—Ç–∞—Ä—à–µ –¥–≤—É—Ö –ª–µ—Ç. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QWtWE #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-11-26T08:30:02+00:00,@medpharm,13719,https://t.me/medpharm/13719,"–ò–∑–º–µ–Ω–∏—Ç—å —Ñ–æ—Ä–º—É–ª—É —Ä–∞—Å—á–µ—Ç–∞ –±–æ–ª—å–Ω–∏—á–Ω—ã—Ö –≤—ã–ø–ª–∞—Ç –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –≤ –°–æ–≤–µ—Ç–µ –§–µ–¥–µ—Ä–∞—Ü–∏–∏, —á—Ç–æ–±—ã —Ä–∞–±–æ—Ç–Ω–∏–∫–∏ —Å –Ω–∏–∑–∫–∏–º –¥–æ—Ö–æ–¥–æ–º –º–æ–≥–ª–∏ –æ—Ñ–æ—Ä–º–ª—è—Ç—å –ª–∏—Å—Ç—ã –Ω–µ—Ç—Ä—É–¥–æ—Å–ø–æ—Å–æ–±–Ω–æ—Å—Ç–∏ –±–µ–∑ –ø–æ—Ç–µ—Ä–∏ –∑–∞—Ä–∞–±–æ—Ç–∫–∞. –ü–æ –º–Ω–µ–Ω–∏—é –∞–≤—Ç–æ—Ä–æ–≤ –∏–¥–µ–∏, —Ä–∞–±–æ—Ç–æ–¥–∞—Ç–µ–ª–∏ —Å–º–æ–≥—É—Ç –¥–æ–±–∞–≤–∏—Ç—å –∫ –≤—ã–ø–ª–∞—Ç–∞–º —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤, —á–µ–π –¥–æ—Ö–æ–¥ –±–ª–∏–∑–æ–∫ –∫ –ú–†–û–¢, 3‚Äî5%. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QWsPY #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-11-26T07:27:02+00:00,@medpharm,13718,https://t.me/medpharm/13718,"–†–æ—Å—Å–∏—è–Ω–µ –Ω–µ –≤–∏–¥—è—Ç —è–≤–Ω—ã—Ö –∏–∑–º–µ–Ω–µ–Ω–∏–π –≤ —Å–∏—Å—Ç–µ–º–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –ë–æ–ª—å—à–µ —Ç—Ä–µ—Ç–∏ –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö –æ—Ç–º–µ—Ç–∏–ª–∏, —á—Ç–æ –æ–Ω–∞ —Å—Ç–∞–ª–∞ ¬´–≤ —á–µ–º-—Ç–æ –ª—É—á—à–µ, –≤ —á–µ–º-—Ç–æ —Ö—É–∂–µ¬ª, –µ—â–µ 40,2% –∑–∞—è–≤–∏–ª–∏ –æ–± —É—Ö—É–¥—à–µ–Ω–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QWnWB #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage,hospital_policy,pharmacovigilance,safety"",
  ""impact"": ""medium"",
  ""english"": ""Russiaans are not seeing clear changes in the healthcare system. More than a third of those surveyed say it has become 'better in some ways and worse in others', while 40.2% reported a deterioration.""
}"
2025-11-26T07:05:08+00:00,@medpharm,13717,https://t.me/medpharm/13717,–ë–æ–ª–µ–µ 60% –ª–∏–¥–µ—Ä–æ–≤ –ø–∞—Ü–∏–µ–Ω—Ç—Å–∫–∏—Ö –ù–ö–û –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–∞—é—Ç —Å–∏—Å—Ç–µ–º–Ω—ã–µ –ø—Ä–æ–±–ª–µ–º—ã —Å –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å—é –ª—å–≥–æ—Ç–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤. –¢–∞–∫–∏–µ –¥–∞–Ω–Ω—ã–µ –±—ã–ª–∏ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω—ã –Ω–∞ XVI –í—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–æ–º –∫–æ–Ω–≥—Ä–µ—Å—Å–µ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –∏ –≤—ã–∑–≤–∞–ª–∏ –±—É—Ä–Ω—É—é –¥–∏—Å–∫—É—Å—Å–∏—é –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QWkiD #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage,hospital_policy,pharmacovigilance,safety"",
  ""impact"": ""high"",
  ""english"": ""More than 60% of patient NGO leaders confirm systemic problems with the availability of subsidized medications. These data were presented at the XVI All-Russian Congress of Patients and sparked a heated discussion. More: https://clck.ru/3QWkiD""
}"
2025-11-26T06:26:05+00:00,@medpharm,13716,https://t.me/medpharm/13716,"–í 2026‚Äî2027 –≥–æ–¥–∞—Ö –ú–æ—Å–∫–≤–∞ –ø–æ—Ç—Ä–∞—Ç–∏—Ç –±–æ–ª—å—à–µ 14 –º–ª—Ä–¥ —Ä—É–±. –Ω–∞ –æ—Ö—Ä–∞–Ω—É –æ–±—ä–µ–∫—Ç–æ–≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –°—Ç–æ–∏–º–æ—Å—Ç—å —á–µ–ª–æ–≤–µ–∫–æ-—á–∞—Å–∞ –¥–ª—è —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤ –ø–æ—Å—Ç–∞ –æ—Ö—Ä–∞–Ω—ã –≤—ã—Ä–æ—Å–ª–∞ –≤ 1,4 —Ä–∞–∑–∞, –¥–æ 291,5 —Ä—É–±. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QWhfP #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-11-26T05:04:03+00:00,@medpharm,13715,https://t.me/medpharm/13715,–ú–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–µ —Å–æ—Å—Ç–æ–∏—Ç—Å—è —Å–µ–≥–æ–¥–Ω—è –≤ 11:00 –≤ —Ä–∞–º–∫–∞—Ö –¥–µ–ª–æ–≤–æ–π –ø—Ä–æ–≥—Ä–∞–º–º—ã ¬´XXVI –ü–ª–∞—Ç–∏–Ω–æ–≤–æ–π —É–Ω—Ü–∏–∏¬ª –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QWcnL #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-11-25T16:34:01+00:00,@medpharm,13714,https://t.me/medpharm/13714,"ü¶æ –í—Ä–µ–º—è —Ä–∞—Å–∫–æ—à–µ–ª–∏—Ç—å—Å—è. –ó–∞—Ç—Ä–∞—Ç—ã —Ä–µ–≥–∏–æ–Ω–æ–≤ –Ω–∞ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏—é —Å–∏—Å—Ç–µ–º—ã –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–∞ –¥–ª—è –º–æ–ª–æ–¥—ã—Ö –≤—Ä–∞—á–µ–π –∑–∞ —à–µ—Å—Ç—å –ª–µ—Ç –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ –æ—Ü–µ–Ω–∏–≤–∞–µ—Ç –≤ –¥–∏–∞–ø–∞–∑–æ–Ω–µ –æ—Ç 300 –º–ª–Ω –¥–æ 3 –º–ª—Ä–¥ —Ä—É–±. –í–∏–¥—ã, —Ä–∞–∑–º–µ—Ä –∏ —É—Å–ª–æ–≤–∏—è –Ω–∞—á–∏—Å–ª–µ–Ω–∏—è –≤—ã–ø–ª–∞—Ç –±—É–¥—É—Ç —É—Ç–≤–µ—Ä–∂–¥–∞—Ç—å —Å–∞–º–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏. ü¶æ –ó–∞–±—ã–ª–∏ —Å–ø—Ä–æ—Å–∏—Ç—å. –†–æ—Å—Å–∏—è–Ω–µ –æ—Ü–µ–Ω–∏–ª–∏ —Ä–µ—à–µ–Ω–∏–µ –≤–ª–∞—Å—Ç–µ–π –æ –≤–≤–µ–¥–µ–Ω–∏–∏ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–π –æ—Ç—Ä–∞–±–æ—Ç–∫–∏ –¥–ª—è –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–≤—É–∑–æ–≤. –ú–µ–Ω—å—à–µ –ø–æ–ª–æ–≤–∏–Ω—ã –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö –∑–Ω–∞–ª–∏ –æ–± —ç—Ç–∏—Ö –∏–∑–º–µ–Ω–µ–Ω–∏—è—Ö, –Ω–æ –ø–æ—á—Ç–∏ —Ç—Ä–µ—Ç—å –∑–∞—è–≤–∏–ª–∞ –æ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ –∞–ª—å—Ç–µ—Ä–Ω–∞—Ç–∏–≤—ã. ‚ù§Ô∏è –î–µ—Ñ–∏—Ü–∏—Ç –∫–∞–¥—Ä–æ–≤. ¬´–ü—Ä–æ–≤–∏–∑–æ—Ä—ã —Å–µ–±—è –Ω–µ –≤–∏–¥—è—Ç –≤ –∞–ø—Ç–µ–∫–µ, –∫–∞–∫ –±—É–¥—Ç–æ –∏–º —ç—Ç–∞ —Ä–∞–±–æ—Ç–∞ –º–∞–ª–æ–≤–∞—Ç–∞¬ª. –£—á–∞—Å—Ç–Ω–∏–∫–∏ III —Å—ä–µ–∑–¥–∞ –†–ê–ê–° –ø—ã—Ç–∞–ª–∏—Å—å –ø–æ–Ω—è—Ç—å, —á—Ç–æ –Ω—É–∂–Ω–æ —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–∞–º –∞–ø—Ç–µ–∫ –∏ –∫–∞–∫ –±–æ—Ä–æ—Ç—å—Å—è —Å –∏—Ö –≤—ã–≥–æ—Ä–∞–Ω–∏–µ–º. ‚ù§Ô∏è –ü–æ—Å–ª–µ–¥–Ω–µ–µ –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏–µ. –§–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—è–º –¥–∞–ª–∏ —Ç—Ä–∏ –¥–Ω—è –Ω–∞ —Ç–æ, —á—Ç–æ–±—ã –æ—Ç—á–∏—Ç–∞—Ç—å—Å—è –æ —Å–≤–æ–∏—Ö –ø–ª–∞–Ω–∞—Ö –ø–æ –ø—Ä–∏–≤–µ–¥–µ–Ω–∏—é —Ä–µ–≥–¥–æ—Å—å–µ –≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–µ —Å –ø—Ä–∞–≤–∏–ª–∞–º–∏ –ï–ê–≠–°. –ü–æ –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ–π —á–∞—Å—Ç–∏ —Å–æ—Ü–∏–∞–ª—å–Ω–æ –∑–Ω–∞—á–∏–º—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ —Ä–µ–≥—É–ª—è—Ç–æ—Ä –≤–∏–¥–∏—Ç —Ä–∏—Å–∫–∏ –¥–µ—Ñ–µ–∫—Ç—É—Ä—ã –≤ —Å–≤—è–∑–∏ —Å —Ç–µ–º, —á—Ç–æ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–∏–µ –¥–æ–∫—É–º–µ–Ω—Ç—ã –¥–æ —Å–∏—Ö –ø–æ—Ä –Ω–µ –ø–æ–¥–∞–Ω—ã.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, shortage, safety"",
  ""impact"": ""high"",
  ""english"": ""The Russian government has estimated the cost to regions of implementing a mentorship system for young doctors over six years at between 300 million and 3 billion rubles. The types, amounts, and conditions for payment will be determined by the medical organizations themselves. A recent survey revealed that less than half of those surveyed knew about this policy change, but nearly a third said an alternative was needed. The III Congress of the Russian Association of Apothecaries and Pharmacists is trying to understand what is needed for pharmacy staff and how to combat burnout. The Russian government has given pharmaceutical companies three days to submit plans for complying with EAEs rules, and the regulator sees risks of non-compliance due to unsubmitted documents for socially significant drugs.""
}"
2025-11-25T15:39:19+00:00,@medpharm,13713,https://t.me/medpharm/13713,"–í –í–æ–ª–æ–≥–¥–µ –≤–æ–∑–±—É–∂–¥–µ–Ω–æ —É–≥–æ–ª–æ–≤–Ω–æ–µ –¥–µ–ª–æ –ø—Ä–æ—Ç–∏–≤ 44-–ª–µ—Ç–Ω–µ–π —ç–∫—Å-–∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—è –≥–ª–∞–≤–≤—Ä–∞—á–∞ –æ–¥–Ω–æ–≥–æ –∏–∑ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏–π, –æ–±–≤–∏–Ω—è–µ–º–æ–π –≤ —Ä–∞—Å—Ç—Ä–∞—Ç–µ –∏ –ø—Ä–∏—Å–≤–æ–µ–Ω–∏–∏ –±–æ–ª–µ–µ 6 –º–ª–Ω —Ä—É–±. –∏ –∑–ª–æ—É–ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–∏ –¥–æ–ª–∂–Ω–æ—Å—Ç–Ω—ã–º–∏ –ø–æ–ª–Ω–æ–º–æ—á–∏—è–º–∏. –°–ª–µ–¥—Å—Ç–≤–∏–µ —É—Å—Ç–∞–Ω–æ–≤–∏–ª–æ, —á—Ç–æ –æ–Ω–∞ –≤—ã–ø–ª–∞—á–∏–≤–∞–ª–∞ –∑–∞—Ä–ø–ª–∞—Ç—ã –Ω–µ—Ä–∞–±–æ—Ç–∞—é—â–∏–º —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–∞–º –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QWGfz #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-11-25T15:39:03+00:00,@medpharm,13712,https://t.me/medpharm/13712,"–ê–∫—Ü–∏–∏ Novo Nordisk —É–ø–∞–ª–∏ –Ω–∞ 6% –ø–æ—Å–ª–µ –ø—Ä–æ–≤–∞–ª–∞ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å–ø—ã—Ç–∞–Ω–∏–π —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ –ø—Ä–∏ –±–æ–ª–µ–∑–Ω–∏ –ê–ª—å—Ü–≥–µ–π–º–µ—Ä–∞. –ö–∞–ø–∏—Ç–∞–ª–∏–∑–∞—Ü–∏—è –¥–∞—Ç—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç —Å–Ω–∏–∂–∞—Ç—å—Å—è, –ø–æ–∫–∞ –µ–µ –∫–æ–Ω–∫—É—Ä–µ–Ω—Ç Eli Lilly —Å—Ç–∞–Ω–æ–≤–∏—Ç—Å—è –≥–ª–∞–≤–Ω—ã–º –∏–≥—Ä–æ–∫–æ–º –Ω–∞ —Ä—ã–Ω–∫–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QWGg5 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, shortage"",
  ""impact"": ""high"",
  ""english"": ""Shares of Novo Nordisk fell by 6% after the failure of semaglutide clinical trials for Alzheimer's disease. Danish company's capital continues to decline as competitor Eli Lilly becomes the main player on the market.""
}"
2025-11-25T15:09:03+00:00,@medpharm,13711,https://t.me/medpharm/13711,–§–æ–Ω–¥ ¬´–ö—Ä—É–≥ –¥–æ–±—Ä–∞¬ª –ø—Ä–æ–≤–µ–ª –≤—Å—Ç—Ä–µ—á—É —Å –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª—è–º–∏ –∫–æ–º–ø–∞–Ω–∏–∏ BioMarin –≤ —Å–≤—è–∑–∏ —Å —Å–µ—Ä—å–µ–∑–Ω—ã–º–∏ –ø–µ—Ä–µ–±–æ—è–º–∏ –≤ –ø–æ—Å—Ç–∞–≤–∫–∞—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ö–æ–º–ø–∞–Ω–∏—é –æ–±—è–∑–∞–ª–∏ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–∏—Ç—å –ø–ª–∞–Ω –ø–æ –Ω–æ—Ä–º–∞–ª–∏–∑–∞—Ü–∏–∏ —Å–∏—Ç—É–∞—Ü–∏–∏ –∏ –≥–∞—Ä–∞–Ω—Ç–∏—Ä–æ–≤–∞—Ç—å —Å—Ç–∞–±–∏–ª—å–Ω–æ–µ –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QWEoq #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The Fund 'Circle of Goodwill' held a meeting with representatives of BioMarin company due to serious supply disruptions for their medications. The company was required to provide a plan for normalizing the situation and guarantee stable medication supply for patients. More details: https://clck.ru/3QWEoq #PharmNews #Distribution""
}"
2025-11-25T15:06:11+00:00,@medpharm,13710,https://t.me/medpharm/13710,–ü—Ä–æ–ø—É—Å–∫ —Å—Ä–æ–∫–∞ –¥–æ–≤–µ–¥–µ–Ω–∏—è –¥–æ –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –∑–∞–∫–ª—é—á–µ–Ω–∏—è –º–µ–¥–∏–∫–æ-—ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–π —ç–∫—Å–ø–µ—Ä—Ç–∏–∑—ã –∫–∞–∫ –ø—Ä–∞–≤–∏–ª–æ –Ω–µ –Ω–∞–∫–∞–∑—ã–≤–∞–µ—Ç—Å—è. –ê –¥–æ–∫—É–º–µ–Ω—Ç –Ω–µ –ø—Ä–∏–∑–Ω–∞–µ—Ç—Å—è –Ω–µ–¥–µ–π—Å—Ç–≤–∏—Ç–µ–ª—å–Ω—ã–º –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QWEZy #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""medium"",
  ""english"": ""The failure to meet the deadline for submitting a medical organization's economic evaluation conclusion is usually not punished. The document is not considered invalid. For more details, see the link above.""
}"
2025-11-25T14:40:02+00:00,@medpharm,13709,https://t.me/medpharm/13709,"–§–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—è–º –¥–∞–ª–∏ —Ç—Ä–∏ –¥–Ω—è –Ω–∞ —Ç–æ, —á—Ç–æ–±—ã –æ—Ç—á–∏—Ç–∞—Ç—å—Å—è –æ —Å–≤–æ–∏—Ö –ø–ª–∞–Ω–∞—Ö –ø–æ –ø—Ä–∏–≤–µ–¥–µ–Ω–∏—é —Ä–µ–≥–¥–æ—Å—å–µ –≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–µ —Å –ø—Ä–∞–≤–∏–ª–∞–º–∏ –ï–ê–≠–°. –ü–æ –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ–π —á–∞—Å—Ç–∏ —Å–æ—Ü–∏–∞–ª—å–Ω–æ –∑–Ω–∞—á–∏–º—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ —Ä–µ–≥—É–ª—è—Ç–æ—Ä –≤–∏–¥–∏—Ç —Ä–∏—Å–∫–∏ –¥–µ—Ñ–µ–∫—Ç—É—Ä—ã –≤ —Å–≤—è–∑–∏ —Å —Ç–µ–º, —á—Ç–æ –¥–æ–∫—É–º–µ–Ω—Ç—ã –¥–æ —Å–∏—Ö –ø–æ—Ä –Ω–µ –ø–æ–¥–∞–Ω—ã –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QWCsg #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""registration, safety"",
  ""impact"": ""medium"",
  ""english"": ""The regulatory authority has identified risks of non-compliance with the rules due to unsubmitted documents. The pharmaceutical companies have been given three days to report their plans for aligning the registration requirements with the EAECS rules. #PharmNews""
}"
2025-11-25T14:21:02+00:00,@medpharm,13708,https://t.me/medpharm/13708,"–¶–µ–Ω—Ç—Ä –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –ø—Ä–æ–≤–æ–¥–∏—Ç –ø—Ä–∏–µ–º –∑–∞—è–≤–æ–∫ –Ω–∞ —É—á–∞—Å—Ç–∏–µ –≤ –∞—É–∫—Ü–∏–æ–Ω–∞—Ö –Ω–∞ –ø–æ—Å—Ç–∞–≤–∫—É –¥–ª—è ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Ä–∏—Å–¥–∏–ø–ª–∞–º –∏ –∞—Å—Ñ–æ—Ç–∞–∑–∞ –∞–ª—å—Ñ–∞, –∑–∞ –∫–æ—Ç–æ—Ä—ã–π –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –∑–∞–ø–ª–∞—Ç–∏—Ç—å 2,1 –º–ª—Ä–¥ —Ä—É–±. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QWBbS #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""high"",
  ""english"": ""The pharmaceutical distribution center is accepting applications for participation in tenders to supply drugs risdiplam and asfotazalpha for 'The Good Circle', with an estimated payment of 2.1 billion rubles.""
}"
2025-11-25T14:09:06+00:00,@medpharm,13707,https://t.me/medpharm/13707,–ü—Ä–æ–∫—É—Ä–∞—Ç—É—Ä–∞ –≤—ã—è–≤–∏–ª–∞ –¥—Ä–æ–±–ª–µ–Ω–∏–µ –≥–æ—Å–∫–æ–Ω—Ç—Ä–∞–∫—Ç–æ–≤ –ú–∏–Ω–∑–¥—Ä–∞–≤–æ–º –ö–∏—Ä–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏. –ü–æ—Å—Ç–∞–≤—â–∏–∫—É –º–µ–¥–æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –±—ã–ª–æ –Ω–µ–∑–∞–∫–æ–Ω–Ω–æ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª–µ–Ω–æ –∫–æ–Ω–∫—É—Ä–µ–Ω—Ç–Ω–æ–µ –ø—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–æ –ø—Ä–∏ –∑–∞–∫–ª—é—á–µ–Ω–∏–∏ —Å–¥–µ–ª–æ–∫ –ø–æ –º–∞–∫—Å–∏–º–∞–ª—å–Ω–æ –≤–æ–∑–º–æ–∂–Ω–æ–π —Å—Ç–æ–∏–º–æ—Å—Ç–∏ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QWAer #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The Prosecutor's Office has identified contract splitting by the Health Department of Kirov Oblast. A supplier of medical equipment was unlawfully granted a competitive advantage in transactions at maximum cost.""
}"
2025-11-25T13:19:03+00:00,@medpharm,13706,https://t.me/medpharm/13706,"–í –ø–µ—Ä–∏–æ–¥ —Å 18 –ø–æ 24 –Ω–æ—è–±—Ä—è —Ä–µ–≥—É–ª—è—Ç–æ—Ä—ã –°–®–ê, –ï–° –∏ –ö–ù–† –≤—ã–¥–∞–ª–∏ 10 –æ–¥–æ–±—Ä–µ–Ω–∏–π. –í–ø–µ—Ä–≤—ã–µ –≤—ã—à–ª–∞ –Ω–∞ —Ä—ã–Ω–æ–∫ –ø–æ–¥–∫–æ–∂–Ω–∞—è —Ñ–æ—Ä–º–∞ –∑–Ω–∞–º–µ–Ω–∏—Ç–æ–≥–æ –ø—Ä–æ—Ç–∏–≤–æ—Ä–∞–∫–æ–≤–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ¬´–ö–∏—Ç—Ä—É–¥–∞¬ª. –¢–∞–∫–∂–µ —Å—Ä–µ–¥–∏ –ø–µ—Ä–≤—ã—Ö –≤ –∏—Å—Ç–æ—Ä–∏–∏ ‚Äî –º–µ—Ç–æ–¥ –ª–µ—á–µ–Ω–∏—è —Å–µ–º–µ–π–Ω–æ–π —Ö–∏–ª–æ–º–∏–∫—Ä–æ–Ω–µ–º–∏–∏ –Ω–∞ –æ—Å–Ω–æ–≤–µ –†–ù–ö-–∏–Ω—Ç–µ—Ä—Ñ–µ—Ä–µ–Ω—Ü–∏–∏, –∏–Ω–≥–∏–±–∏—Ç–æ—Ä DPP-1 –¥–ª—è –±—Ä–æ–Ω—Ö–æ—ç–∫—Ç–∞–∑–æ–≤ –∏ –ø–æ–¥–∫–æ–∂–Ω–æ–µ —Å—Ä–µ–¥—Å—Ç–≤–æ –¥–ª—è –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –≥–µ–º–æ—Ñ–∏–ª–∏–∏ –ê –∏ –í. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QW7HM #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-11-25T12:22:04+00:00,@medpharm,13705,https://t.me/medpharm/13705,"–†–æ—Å—Å–∏—è–Ω–µ –æ—Ü–µ–Ω–∏–ª–∏ —Ä–µ—à–µ–Ω–∏–µ –≤–ª–∞—Å—Ç–µ–π –æ –≤–≤–µ–¥–µ–Ω–∏–∏ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–π –æ—Ç—Ä–∞–±–æ—Ç–∫–∏ –¥–ª—è –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–≤—É–∑–æ–≤. –ú–µ–Ω—å—à–µ –ø–æ–ª–æ–≤–∏–Ω—ã –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö –∑–Ω–∞–ª–∏ –æ–± —ç—Ç–∏—Ö –∏–∑–º–µ–Ω–µ–Ω–∏—è—Ö, –Ω–æ –ø–æ—á—Ç–∏ —Ç—Ä–µ—Ç—å –∑–∞—è–≤–∏–ª–∞ –æ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ –∞–ª—å—Ç–µ—Ä–Ω–∞—Ç–∏–≤—ã –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QVzqn #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""Russian students were surveyed about a government decision requiring graduation work for medical graduates. Less than half of those surveyed knew about this change, but nearly one-third said an alternative was needed. More details: https://clck.ru/3QVzqn #MedNews #HealthCare #PublicHealth""
}"
2025-11-25T11:47:35+00:00,@medpharm,13703,https://t.me/medpharm/13703,–°–≤–µ–∂–∏–π –Ω–æ–º–µ—Ä ¬´–§–í¬ª ‚Ññ26-27 (1185-1186) —É–∂–µ –¥–æ—Å—Ç—É–ø–µ–Ω –æ–Ω–ª–∞–π–Ω –±–µ—Å–ø–ª–∞—Ç–Ω–æ –¥–ª—è –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª–µ–π. #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫,"{""skip"": true}"
2025-11-25T11:15:05+00:00,@medpharm,13702,https://t.me/medpharm/13702,–≠–∫—Å-—Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª–∏ –ª–µ—á–µ–±–Ω–æ-–¥–∏–∞–≥–Ω–æ—Å—Ç–∏—á–µ—Å–∫–æ–≥–æ —Ü–µ–Ω—Ç—Ä–∞ –ú–∏–Ω–æ–±–æ—Ä–æ–Ω—ã –†–§ –ø–æ–¥–æ–∑—Ä–µ–≤–∞—é—Ç—Å—è –≤ —Ö–∏—â–µ–Ω–∏–∏ –±–æ–ª–µ–µ 57 –º–ª–Ω —Ä—É–±–ª–µ–π –∏ –ø–æ–ª—É—á–µ–Ω–∏–∏ –≤–∑—è—Ç–æ–∫ –ø—Ä–∏ –∑–∞–∫—É–ø–∫–µ –º–µ–¥–æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è. –í –¥–µ–ª–µ —Ç–∞–∫–∂–µ —Ñ–∏–≥—É—Ä–∏—Ä—É—é—Ç –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–∏ –∫–æ–º–ø–∞–Ω–∏–π-–ø–æ—Å—Ç–∞–≤—â–∏–∫–æ–≤ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QVtrC #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–î—Ä—É–≥–æ–µ,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement, pricing"",
  ""impact"": ""high"",
  ""english"": ""Former directors of a military health center in Russia are suspected of embezzling over 57 million rubles and accepting bribes during the procurement of medical equipment. The case also involves representatives from companies that supplied the equipment.""
}"
2025-11-25T11:11:03+00:00,@medpharm,13701,https://t.me/medpharm/13701,–ù–∞ –ï–∂–µ–≥–æ–¥–Ω–æ–º –∫–æ–Ω–≥—Ä–µ—Å—Å–µ –ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–π –∫–æ–ª–ª–µ–≥–∏–∏ —Ä–µ–≤–º–∞—Ç–æ–ª–æ–≥–æ–≤ ACR Convergence 2025 —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –ø—Ä–æ–¥–µ–º–æ–Ω—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª–∏ –¥–æ—Å—Ç–∏–∂–µ–Ω–∏—è –≤ –æ–±–ª–∞—Å—Ç–∏ —Ç–µ—Ä–∞–ø–∏–∏ —Å–µ–º–µ–π–Ω–æ–π —Å—Ä–µ–¥–∏–∑–µ–º–Ω–æ–º–æ—Ä—Å–∫–æ–π –ª–∏—Ö–æ—Ä–∞–¥–∫–∏ (–°–°–õ). –ü—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–Ω—ã–µ –¥–∞–Ω–Ω—ã–µ –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª–∏ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –≥–æ—Ñ–ª–∏–∫–∏—Ü–µ–ø—Ç–∞ ‚Äî –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ –±–ª–æ–∫–∞—Ç–æ—Ä–∞ –∏–Ω—Ç–µ—Ä–ª–µ–π–∫–∏–Ω–∞-1 ‚Äî –ø—Ä–∏ –ª–µ—á–µ–Ω–∏–∏ —ç—Ç–æ–≥–æ —Ä–µ–¥–∫–æ–≥–æ –Ω–∞—Å–ª–µ–¥—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∞—É—Ç–æ–≤–æ—Å–ø–∞–ª–∏—Ç–µ–ª—å–Ω–æ–≥–æ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QVtc4 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-11-25T10:51:03+00:00,@medpharm,13700,https://t.me/medpharm/13700,"¬´–ü—Ä–æ–≤–∏–∑–æ—Ä—ã —Å–µ–±—è –Ω–µ –≤–∏–¥—è—Ç –≤ –∞–ø—Ç–µ–∫–µ, –∫–∞–∫ –±—É–¥—Ç–æ –∏–º —ç—Ç–∞ —Ä–∞–±–æ—Ç–∞ –º–∞–ª–æ–≤–∞—Ç–∞¬ª. –£—á–∞—Å—Ç–Ω–∏–∫–∏ III —Å—ä–µ–∑–¥–∞ –†–ê–ê–° –ø—ã—Ç–∞–ª–∏—Å—å –ø–æ–Ω—è—Ç—å, —á—Ç–æ –Ω—É–∂–Ω–æ —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–∞–º –∞–ø—Ç–µ–∫ –∏ –∫–∞–∫ –±–æ—Ä–æ—Ç—å—Å—è —Å –∏—Ö –≤—ã–≥–æ—Ä–∞–Ω–∏–µ–º. –†–∞—Å—Å–∏–Ω—Ö—Ä–æ–Ω–∏–∑–∞—Ü–∏—è –º–µ–∂–¥—É —Ä–∞–±–æ—Ç–æ–¥–∞—Ç–µ–ª—è–º–∏, —É—á–µ–±–Ω—ã–º–∏ –∑–∞–≤–µ–¥–µ–Ω–∏—è–º–∏ –∏ —Ä–∞–±–æ—Ç–Ω–∏–∫–∞–º–∏ –ø—Ä–∏–≤–æ–¥–∏—Ç –∫ –¥–µ—Ñ–∏—Ü–∏—Ç—É –∫–∞–¥—Ä–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QVs9H #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{""skip"": true}"
2025-11-25T10:24:06+00:00,@medpharm,13699,https://t.me/medpharm/13699,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª –¥–µ—Ç–∞–ª–∏ –ø—Ä–∏–≤–ª–µ—á–µ–Ω–∏—è –≤—Ä–∞—á–µ–π –≤ –∫–∞—á–µ—Å—Ç–≤–µ –Ω–∞—Å—Ç–∞–≤–Ω–∏–∫–æ–≤ –∏ –ø—Ä–∞–≤–∏–ª–∞ –Ω–∞—á–∏—Å–ª–µ–Ω–∏—è –≤—ã–ø–ª–∞—Ç –∑–∞ —ç—Ç—É —Ä–∞–±–æ—Ç—É. –í–∏–¥—ã –∏ —É—Å–ª–æ–≤–∏—è –≤–æ–∑–Ω–∞–≥—Ä–∞–∂–¥–µ–Ω–∏—è –±—É–¥—É—Ç –æ–ø—Ä–µ–¥–µ–ª—è—Ç—å —Å–∞–º–∏ –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏, –æ—Ä–∏–µ–Ω—Ç–∏—Ä—É—è—Å—å –Ω–∞ –¥–µ–π—Å—Ç–≤—É—é—â–µ–µ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–æ. –í—Ä–∞—á–∞–º-–Ω–∞—Å—Ç–∞–≤–Ω–∏–∫–∞–º –ø—Ä–∏–¥–µ—Ç—Å—è –ø–∏—Å–∞—Ç—å –æ—Ç—á–µ—Ç—ã –æ —Å–≤–æ–µ–π —Ä–∞–±–æ—Ç–µ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QVpys #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""tenders, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health of Russia has presented details on the recruitment of doctors as mentors and payment rules for this work. Payment conditions will be determined by medical organizations based on existing legislation. Doctors as mentors will need to write reports about their work.""
}"
2025-11-25T09:41:03+00:00,@medpharm,13698,https://t.me/medpharm/13698,–§–ê–° –†–§ –≤—ã–¥–∞–ª–∞ –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏–µ –¥–æ—á–µ—Ä–Ω–µ–π –∫–æ–º–ø–∞–Ω–∏–∏ Ipsen –∏–∑-–∑–∞ —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–∏ –Ω–µ–æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω—ã—Ö —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π –∫ –≤—ã—Ä—É—á–∫–µ –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω–æ–≥–æ –ø–∞—Ä—Ç–Ω–µ—Ä–∞. –ö–æ–º–ø–∞–Ω–∏—è –¥–æ–ª–∂–Ω–∞ –ø–æ–≤—Ç–æ—Ä–Ω–æ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ—Ç—å –∑–∞—è–≤–∫—É –Ω–∞ –ø–æ—Å—Ç–∞–≤–∫—É —Ç—Ä–µ—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QVmnc #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""sanctions, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The Russian Federal Antimonopoly Service (FAS) issued a warning to Ipsen's subsidiary for economically unjustified requirements from a potential partner. The company needs to re-examine the application for supply of three drugs.""
}"
2025-11-25T09:22:06+00:00,@medpharm,13697,https://t.me/medpharm/13697,–ê–Ω–µ—Å—Ç–µ–∑–∏–æ–ª–æ–≥–∞-—Ä–µ–∞–Ω–∏–º–∞—Ç–æ–ª–æ–≥–∞ –∏–∑ –¢–≤–µ—Ä–∏ —Å—É–¥ –ø—Ä–∏–≥–æ–≤–æ—Ä–∏–ª –∫ –≥–æ–¥—É –∫–æ–ª–æ–Ω–∏–∏ –∑–∞ —Å–º–µ—Ä—Ç—å —Ç—Ä–µ—Ö–ª–µ—Ç–Ω–µ–π –¥–µ–≤–æ—á–∫–∏ –ø—Ä–∏ —Å—Ç–æ–º–∞—Ç–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π –æ–ø–µ—Ä–∞—Ü–∏–∏. –í–æ –≤—Ä–µ–º—è –Ω–∞—Ä–∫–æ–∑–∞ –æ–Ω –Ω–µ –æ—Å—Ç–∞–Ω–æ–≤–∏–ª –ø—Ä–æ—Ü–µ–¥—É—Ä—É –ø—Ä–∏ —É—Ö—É–¥—à–µ–Ω–∏–∏ —Å–æ—Å—Ç–æ—è–Ω–∏—è —Ä–µ–±–µ–Ω–∫–∞ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QVkMH #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-11-25T08:46:02+00:00,@medpharm,13696,https://t.me/medpharm/13696,"–ù–æ–≤—ã–π –∫–æ–æ—Ä–¥–∏–Ω–∞—Ü–∏–æ–Ω–Ω—ã–π —Å–æ–≤–µ—Ç –ø–æ —Ñ–∞—Ä–º–∏–Ω–Ω–æ–≤–∞—Ü–∏—è–º –ø—Ä–∏—Å—Ç—É–ø–∏–ª –∫ —Ä–∞–±–æ—Ç–µ. –í –Ω–µ–≥–æ –≤—Ö–æ–¥—è—Ç –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞, –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–∞ –∏ –ú–∏–Ω–æ–±—Ä–Ω–∞—É–∫–∏ –†–§, –∫–æ–º–ø–∞–Ω–∏—è ¬´–ò–Ω–Ω–æ–ø—Ä–∞–∫—Ç–∏–∫–∞¬ª –∏ –ê–ù–û ¬´–ò–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–π –∏–Ω–∂–∏–Ω–∏—Ä–∏–Ω–≥–æ–≤—ã–π —Ü–µ–Ω—Ç—Ä¬ª. –ó–∞—á–µ–º –ø–æ—Ç—Ä–µ–±–æ–≤–∞–ª—Å—è —Ç–∞–∫–æ–π –æ—Ä–≥–∞–Ω, –∫–∞–∫–∏–µ –Ω–∞–¥–µ–∂–¥—ã –≤–æ–∑–ª–∞–≥–∞–µ—Ç –Ω–∞ –Ω–µ–≥–æ –æ—Ç—Ä–∞—Å–ª—å, ¬´–§–í¬ª —Ä–∞—Å—Å–∫–∞–∑–∞–ª –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—å –°–æ–≤–µ—Ç–∞ –¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–≤ –ì–ö ¬´–•–∏–º–†–∞—Ä¬ª, –∑–∞–≤–µ–¥—É—é—â–∏–π –∫–∞—Ñ–µ–¥—Ä–æ–π –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–æ–π —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∏, –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π —Ç–µ—Ö–Ω–∏–∫–∏ –∏ –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ –ú–§–¢–ò, —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å –∫–æ–º–∏—Ç–µ—Ç–∞ –ø–æ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–æ–π —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–µ –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ ¬´–ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—ã–µ —á–µ–º–ø–∏–æ–Ω—ã¬ª –ê–Ω–¥—Ä–µ–π –ò–í–ê–©–ï–ù–ö–û. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QVhWZ #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ú–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-11-25T08:25:03+00:00,@medpharm,13695,https://t.me/medpharm/13695,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏ –Ω–∞–ø–æ–º–Ω–∏–ª ¬´—Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º-–º–æ–ª—á—É–Ω–∞–º¬ª –æ —Å–æ—Ü–∏–∞–ª—å–Ω–æ–π –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç–∏. –ù–µ–∫–æ—Ç–æ—Ä—ã–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –¥–æ —Å–∏—Ö –ø–æ—Ä –Ω–µ –ø–æ–¥–∞–ª–∏ –∑–∞—è–≤–ª–µ–Ω–∏—è –Ω–∞ –ø—Ä–∏–≤–µ–¥–µ–Ω–∏–µ —Ä–µ–≥—É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏–π –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–µ —Å —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è–º–∏ –ï–ê–≠–°. –í –≥—Ä—É–ø–ø–µ —Ä–∏—Å–∫–∞ –≤–∞–∫—Ü–∏–Ω—ã, –æ–Ω–∫–æ–ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –∏ –∞–Ω—Ç–∏–±–æ—Ç–∏–∫–∏ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QVfy6 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health of Russia reminded 'pharmaceutical producers who are silent' about their social responsibility. Some manufacturers have not yet filed applications to update the registration certificates for medicines in accordance with EAEU requirements. The group at risk includes vaccines, oncological preparations and antibiotics.""
}"
2025-11-25T08:20:05+00:00,@medpharm,13694,https://t.me/medpharm/13694,"–†–µ–≥—É–ª—è—Ç–æ—Ä –ø–æ–¥–≥–æ—Ç–æ–≤–∏–ª –ø–æ—Ä—è–¥–æ–∫ —Ä–∞—Å–ø—Ä–µ–¥–µ–ª–µ–Ω–∏—è –±—é–¥–∂–µ—Ç–Ω—ã—Ö –º–µ—Å—Ç –¥–ª—è –æ–±—É—á–µ–Ω–∏—è –ø–æ –ø—Ä–æ–≥—Ä–∞–º–º–∞–º –æ—Ä–¥–∏–Ω–∞—Ç—É—Ä—ã –º–µ–∂–¥—É –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º–∏ –≤—É–∑–∞–º–∏. –ò–∑–º–µ–Ω–µ–Ω–∏—è —Å–≤—è–∑–∞–Ω—ã —Å –≤–≤–µ–¥–µ–Ω–∏–µ–º –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–≥–æ –ø–µ—Ä–∏–æ–¥–∞ –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–∞ –¥–ª—è –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–µ–π, —Å–æ–≥–ª–∞—Å–Ω–æ –Ω–æ–≤–æ–º—É –∑–∞–∫–æ–Ω—É —Å 2026 –≥–æ–¥–∞ –≤—Å–µ –º–µ—Å—Ç–∞ –≤ –æ—Ä–¥–∏–Ω–∞—Ç—É—Ä–µ —Å—Ç–∞–Ω—É—Ç —Ü–µ–ª–µ–≤—ã–º–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QVfZx #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–û–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-11-25T07:14:03+00:00,@medpharm,13693,https://t.me/medpharm/13693,"–û–±–Ω–æ–≤–ª–µ–Ω –ø–µ—Ä–µ—á–µ–Ω—å –≤—É–∑–æ–≤ ‚Äî —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –ø—Ä–æ–≥—Ä–∞–º–º—ã ¬´–ü—Ä–∏–æ—Ä–∏—Ç–µ—Ç-2030¬ª –Ω–∞ 2026 –≥–æ–¥. –í –Ω–µ–µ –≤–æ—à–ª–∏ 106 —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–æ–≤, –≤ —Ç–æ–º —á–∏—Å–ª–µ 11 –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö, –∏–∑ –Ω–∏—Ö —Ç—Ä–∏ –ø–æ–ª—É—á–∏–ª–∏ –º–µ—Å—Ç–∞ –≤ –ø–µ—Ä–≤–æ–π –≥—Ä—É–ø–ø–µ —Å —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏–µ–º –¥–æ 830 –º–ª–Ω —Ä—É–±. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QVapD #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-11-25T06:06:05+00:00,@medpharm,13692,https://t.me/medpharm/13692,–£—á–µ–Ω—ã–µ –∏–∑ –ò–ª–ª–∏–Ω–æ–π—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ –≤ –ß–∏–∫–∞–≥–æ –æ–ø—É–±–ª–∏–∫–æ–≤–∞–ª–∏ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –æ–±—ä–µ–¥–∏–Ω–µ–Ω–Ω–æ–≥–æ –∞–Ω–∞–ª–∏–∑–∞ –¥–∞–Ω–Ω—ã—Ö –ø–æ –≤–ª–∏—è–Ω–∏—é elinzanetant –Ω–∞ —Å–æ–Ω —É –∂–µ–Ω—â–∏–Ω –≤ –ø–æ—Å—Ç–º–µ–Ω–æ–ø–∞—É–∑–µ. –†–µ–∑—É–ª—å—Ç–∞—Ç—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –±—ã–ª–∏ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω—ã –Ω–∞ –µ–∂–µ–≥–æ–¥–Ω–æ–º —Å–æ–±—Ä–∞–Ω–∏–∏ –û–±—â–µ—Å—Ç–≤–∞ –ø–æ –∏–∑—É—á–µ–Ω–∏—é –º–µ–Ω–æ–ø–∞—É–∑—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QVW9k #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è #–≠–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–∏—è,"{""skip"": true}"
2025-11-24T16:36:27+00:00,@medpharm,13691,https://t.me/medpharm/13691,ü¶æ –ü–æ–≤–µ–∑–µ—Ç –Ω–µ –≤—Å–µ–º. –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ –∫–æ–Ω–∫—Ä–µ—Ç–∏–∑–∏—Ä–æ–≤–∞–ª —Å—Ä–æ–∫–∏ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–π –æ—Ç—Ä–∞–±–æ—Ç–∫–∏ –¥–ª—è –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ —Ä–∞–∑–Ω—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–µ–π. ü¶æ –ü—Ä–æ—Ç–∏–≤ —Å–∞–Ω–∫—Ü–∏–π. –î–ª—è —Ä–µ—à–µ–Ω–∏—è –ø—Ä–æ–±–ª–µ–º—ã –¥–µ—Ñ–∏—Ü–∏—Ç–∞ –∏–º–ø–æ—Ä—Ç–Ω—ã—Ö –∑–∞–ø—á–∞—Å—Ç–µ–π –¥–ª—è –º–µ–¥–æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤—É –†–§ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –∑–∞–ø—É—Å—Ç–∏—Ç—å –ø—Ä–æ–≥—Ä–∞–º–º—É –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏–∏ –∫—Ä–∏—Ç–∏—á–µ—Å–∫–∏ –≤–∞–∂–Ω—ã—Ö –∫–æ–º–ø–æ–Ω–µ–Ω—Ç–æ–≤. ‚ù§Ô∏è –ó–µ–ª–µ–Ω—ã–π —Å–≤–µ—Ç. –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–æ—Å—Å–∏–∏ –¥–∞–ª–æ –∑–∞–∫–ª—é—á–µ–Ω–∏–µ –Ω–∞ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ –ø–µ—Ä–µ–¥–≤–∏–∂–Ω—ã—Ö –∞–ø—Ç–µ—á–Ω—ã—Ö –ø—É–Ω–∫—Ç–∞—Ö. ‚ù§Ô∏è –î–≤–æ–π–Ω–æ–π –∫–æ–Ω—Ç—Ä–æ–ª—å. –£—á–∞—Å—Ç–Ω–∏–∫–∏ —Ä—ã–Ω–∫–∞ –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç –≤–µ—Ä–Ω—É—Ç—å –Ω–µ–∑–∞–≤–∏—Å–∏–º—É—é —ç–∫—Å–ø–µ—Ä—Ç–∏–∑—É –ë–ê–î –ø—Ä–∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –¥–ª—è –±–æ—Ä—å–±—ã —Å —Ñ–∞–ª—å—Å–∏—Ñ–∏–∫–∞—Ç–æ–º.,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety, guideline"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health of Russia has specified the mandatory training deadlines for graduates from various medical specialties. In response to sanctions concerns, the Russian government has proposed a program of localizing critical components for medical equipment. The government of Russia has approved the project on mobile pharmacies to address a shortage of imported parts for medical equipment. Market participants suggest reinstating independent expert reviews for BAs (Biologically Active Substances) during registration to combat counterfeit products.""
}"
2025-11-24T16:13:04+00:00,@medpharm,13690,https://t.me/medpharm/13690,"–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–æ—Å—Å–∏–∏ –ø–æ–¥–¥–µ—Ä–∂–∞–ª–æ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ –ø–µ—Ä–µ–¥–≤–∏–∂–Ω—ã—Ö –∞–ø—Ç–µ—á–Ω—ã—Ö –ø—É–Ω–∫—Ç–∞—Ö —Å —É—á–µ—Ç–æ–º –∑–∞–º–µ—á–∞–Ω–∏–π. –ü–æ–∫–∞ –¥–æ–∫—É–º–µ–Ω—Ç –Ω–µ –ø–æ–¥–ø–∏—Å–∞–Ω, –Ω–µ—Å–º–æ—Ç—Ä—è –Ω–∞ —Ç–æ, —á—Ç–æ –∞–ø—Ç–µ—á–Ω—ã–µ —Å–µ—Ç–∏ —É–∂–µ —Ç—Ä–∏ –≥–æ–¥–∞ –≥–æ–≤–æ—Ä—è—Ç –æ –∂–µ–ª–∞–Ω–∏–∏ –ø–æ—É—á–∞—Å—Ç–≤–æ–≤–∞—Ç—å –≤ —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QV7mr #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The Russian government has supported a project to establish mobile pharmacy points, taking into account the comments. The document is not signed yet, despite the fact that pharmacies have been calling for participation in the experiment for three years.""
}"
2025-11-24T15:45:02+00:00,@medpharm,13689,https://t.me/medpharm/13689,"–†–§–ü–ò, –ò–Ω—Å—Ç–∏—Ç—É—Ç —Å–∏—Å—Ç–µ–º–Ω–æ–≥–æ –ø—Ä–æ–≥—Ä–∞–º–º–∏—Ä–æ–≤–∞–Ω–∏—è –†–ê–ù –∏ –¶–µ–Ω—Ç—Ä –∏–º. –ì–∞–º–∞–ª–µ–∏ —Å–æ–∑–¥–∞–¥—É—Ç —Ü–∏—Ñ—Ä–æ–≤—É—é –ø–ª–∞—Ç—Ñ–æ—Ä–º—É –Ω–∞ –±–∞–∑–µ –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–∞. –û–Ω–∞ –¥–æ–ª–∂–Ω–∞ —É—Å–∫–æ—Ä–∏—Ç—å —Ä–∞–∑—Ä–∞–±–æ—Ç–∫—É –ø–µ—Ä—Å–æ–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –∞—É—Ç–æ–∏–º–º—É–Ω–Ω—ã—Ö –∏ –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QV6AV #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-11-24T15:39:06+00:00,@medpharm,13688,https://t.me/medpharm/13688,–ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ –ø–æ–¥–∫–ª—é—á–∏—Ç –∫ –æ–∫–∞–∑–∞–Ω–∏—é –í–ú–ü –≤–Ω–µ –û–ú–° –¥–µ–≤—è—Ç—å —á–∞—Å—Ç–Ω—ã—Ö –∫–ª–∏–Ω–∏–∫. –í –ø–µ—Ä–µ—á–µ–Ω—å –≤–∫–ª—é—á–∞—Ç —Å—Ä–∞–∑—É —Ç—Ä–∏ —Ñ–∏–ª–∏–∞–ª–∞ ¬´–†–ñ–î-–ú–µ–¥–∏—Ü–∏–Ω–∞¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QV5ph #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-11-24T14:48:03+00:00,@medpharm,13687,https://t.me/medpharm/13687,"–¶–µ–Ω—Ç—Ä –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –ø—Ä–∏–Ω–∏–º–∞–µ—Ç –∑–∞—è–≤–∫–∏ –Ω–∞ —É—á–∞—Å—Ç–∏–µ –≤ –¥–µ—Å—è—Ç–∏ –∞—É–∫—Ü–∏–æ–Ω–∞—Ö –Ω–∞ –ø–æ—Å—Ç–∞–≤–∫—É –ø–æ –ø—Ä–æ–≥—Ä–∞–º–º–µ –í–ó–ù –≤–æ—Å—å–º–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, —Å—Ä–µ–¥–∏ –∫–æ—Ç–æ—Ä—ã—Ö —ç–º–∏—Ü–∏–∑—É–º–∞–±, –∑–∞ –∫–æ—Ç–æ—Ä—ã–π –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –∑–∞–ø–ª–∞—Ç–∏—Ç—å 7,3 –º–ª—Ä–¥ —Ä—É–±. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QV2ku #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""high"",
  ""english"": ""The Central Drug Supply Center is accepting applications for participation in ten auctions under the VZN program for eight drugs, including emicizumab, for which payments of 7.3 billion rubles are planned.""
}"
2025-11-24T14:19:04+00:00,@medpharm,13686,https://t.me/medpharm/13686,–î–ª—è —Ä–µ—à–µ–Ω–∏—è –ø—Ä–æ–±–ª–µ–º—ã –¥–µ—Ñ–∏—Ü–∏—Ç–∞ –∏–º–ø–æ—Ä—Ç–Ω—ã—Ö –∑–∞–ø—á–∞—Å—Ç–µ–π –¥–ª—è –º–µ–¥–æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤—É –†–§ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –∑–∞–ø—É—Å—Ç–∏—Ç—å –ø—Ä–æ–≥—Ä–∞–º–º—É –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏–∏ –∫—Ä–∏—Ç–∏—á–µ—Å–∫–∏ –≤–∞–∂–Ω—ã—Ö –∫–æ–º–ø–æ–Ω–µ–Ω—Ç–æ–≤. –ï–µ —É—Å–ø–µ—à–Ω–æ–π —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ –º–æ–≥–ª–æ –±—ã —Å–ø–æ—Å–æ–±—Å—Ç–≤–æ–≤–∞—Ç—å –ø—Ä–∏–Ω—è—Ç–∏–µ –ø–∞–∫–µ—Ç–∞ –º–µ—Ä –≥–æ—Å–ø–æ–¥–¥–µ—Ä–∂–∫–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QUygs #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–î—Ä—É–≥–æ–µ,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The government of Russia is considering a program to localize critical components for imported medical equipment. Successful implementation could lead to the adoption of support measures, impacting tender processes and import/export controls.""
}"
2025-11-24T14:11:03+00:00,@medpharm,13685,https://t.me/medpharm/13685,–í ¬´–∫–ª—É–± —Ç—Ä–∏–ª–ª–∏–æ–Ω–µ—Ä–æ–≤¬ª –≤–ø–µ—Ä–≤—ã–µ –≤–æ—à–ª–∞ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—è. –ü—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–ª—è –ø–æ—Ö—É–¥–µ–Ω–∏—è —Å–¥–µ–ª–∞–ª–∏ Eli Lilly –æ–¥–Ω–æ–π –∏–∑ —Å–∞–º—ã—Ö –¥–æ—Ä–æ–≥–∏—Ö –∫–æ—Ä–ø–æ—Ä–∞—Ü–∏–π –≤ –∏—Å—Ç–æ—Ä–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QUy7T #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-11-24T13:32:14+00:00,@medpharm,13684,https://t.me/medpharm/13684,"–ü–æ—á—Ç–∏ –≤—Å–µ –ø–æ–¥–º–æ—Å–∫–æ–≤–Ω—ã–µ —á–∞—Å—Ç–Ω—ã–µ –∫–ª–∏–Ω–∏–∫–∏, –∏–º–µ—é—â–∏–µ –ª–∏—Ü–µ–Ω–∑–∏–∏ –Ω–∞ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏–µ –∞–±–æ—Ä—Ç–æ–≤, –Ω–∞—Ä—É—à–∞—é—Ç –∞–ª–≥–æ—Ä–∏—Ç–º –ø–æ–º–æ—â–∏ –ø—Ä–∏ –ø—Ä–µ—Ä—ã–≤–∞–Ω–∏–∏ –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏. –ü—Ä–æ—Ü–µ–¥—É—Ä–∞ –ø—Ä–æ–≤–æ–¥–∏—Ç—Å—è, –∫–∞–∫ –ø—Ä–∞–≤–∏–ª–æ, –≤ –∞–º–±—É–ª–∞—Ç–æ—Ä–Ω—ã—Ö —É—Å–ª–æ–≤–∏—è—Ö. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QUvAJ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–ê–∫—É—à–µ—Ä—Å—Ç–≤–æ_–∏_–≥–∏–Ω–µ–∫–æ–ª–æ–≥–∏—è #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-11-24T13:31:02+00:00,@medpharm,13683,https://t.me/medpharm/13683,"–ù–∞ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–æ–π –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ AI Journey (¬´–ü—É—Ç–µ—à–µ—Å—Ç–≤–∏–µ –≤ –º–∏—Ä –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–∞¬ª) –±—ã–ª –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω –ø—Ä–æ–µ–∫—Ç –ø–æ —Å–æ–∑–¥–∞–Ω–∏—é –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –Ω–µ–π—Ä–æ–¥–µ–≥–µ–Ω–µ—Ä–∞—Ç–∏–≤–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –º–æ–∑–≥–∞, –≤–∫–ª—é—á–∞—è –±–æ–ª–µ–∑–Ω—å –ê–ª—å—Ü–≥–µ–π–º–µ—Ä–∞. –í –ø—Ä–æ–µ–∫—Ç–µ –∑–∞–¥–µ–π—Å—Ç–≤–æ–≤–∞–Ω—ã —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–†-–§–∞—Ä–º¬ª –∏ –ò–Ω—Å—Ç–∏—Ç—É—Ç–∞ AIRI –ø—Ä–∏ –ø–æ–¥–¥–µ—Ä–∂–∫–µ ¬´–°–±–µ—Ä–∞¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QUv75 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-11-24T13:16:03+00:00,@medpharm,13682,https://t.me/medpharm/13682,"–§–ê–° –†–æ—Å—Å–∏–∏ —Å–æ–≥–ª–∞—Å–æ–≤–∞–ª–∞ —Ü–µ–Ω—É –Ω–∞ –ø–µ—Ä–≤—ã–π –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π –¥–∂–µ–Ω–µ—Ä–∏–∫ ¬´–õ—É—Ä–∞–∑–∏–¥–æ–Ω –ö—Ä–æ–Ω–æ¬ª (–ú–ù–ù –ª—É—Ä–∞–∑–∏–¥–æ–Ω) –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ —à–∏–∑–æ—Ñ—Ä–µ–Ω–∏–∏ –∏ –±–∏–ø–æ–ª—è—Ä–Ω–æ–≥–æ —Ä–∞—Å—Å—Ç—Ä–æ–π—Å—Ç–≤–∞ I —Ç–∏–ø–∞. –°—Ç–æ–∏–º–æ—Å—Ç—å —Å–Ω–∏–∂–µ–Ω–∞ –Ω–∞ 12,49% –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–º ¬´–õ–∞—Ç—É–¥–∞¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QUu3V #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""pricing, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The FAS of Russia has approved the price for the domestic generic 'Luzardon Krone' (MN number luzardon) for the treatment of schizophrenia and bipolar disorder type I. The price has been reduced by 12.49% compared to the original drug 'Latuda'. More details: https://clck.ru/3QUu3V #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞""
}"
2025-11-24T12:44:05+00:00,@medpharm,13681,https://t.me/medpharm/13681,–í –†–æ—Å—Ç–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ —É—Ç–≤–µ—Ä–¥–∏–ª–∏ –Ω–æ–≤–æ–≥–æ –≥–ª–∞–≤—É –ú–∏–Ω–∑–¥—Ä–∞–≤–∞. –ü—Ä–µ–∂–Ω–µ–≥–æ –º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –æ—Ç–ø—Ä–∞–≤–∏–ª–∏ –≤ –æ—Ç—Å—Ç–∞–≤–∫—É –≤ —Å–µ–Ω—Ç—è–±—Ä–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QUrqZ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-11-24T12:09:03+00:00,@medpharm,13680,https://t.me/medpharm/13680,"–£—á–∞—Å—Ç–Ω–∏–∫–∏ —Ä—ã–Ω–∫–∞ –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç –≤–µ—Ä–Ω—É—Ç—å –Ω–µ–∑–∞–≤–∏—Å–∏–º—É—é —ç–∫—Å–ø–µ—Ä—Ç–∏–∑—É –ë–ê–î –ø—Ä–∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –¥–ª—è –±–æ—Ä—å–±—ã —Å —Ñ–∞–ª—å—Å–∏—Ñ–∏–∫–∞—Ç–æ–º. –ü–∞—Ä–∞–ª–ª–µ–ª—å–Ω–æ —Ä–µ–≥—É–ª—è—Ç–æ—Ä—ã —É—Å–∏–ª–∏–≤–∞—é—Ç –∫–æ–Ω—Ç—Ä–æ–ª—å –¥–æ–∫—É–º–µ–Ω—Ç–∞—Ü–∏–∏, –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å—ã –∞–≤—Ç–æ–º–∞—Ç–∏–∑–∏—Ä—É—é—Ç –ø—Ä–æ–≤–µ—Ä–∫–∏, –∞ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é –æ –¥–æ–±—Ä–æ—Å–æ–≤–µ—Å—Ç–Ω—ã—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è—Ö –≤–Ω–æ—Å—è—Ç –≤ —Ä–µ–µ—Å—Ç—Ä –ø—Ä–æ–≤–µ—Ä–µ–Ω–Ω–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–æ—Å—Ç–∏ ‚Äî –≤ —Ä–µ–ø–æ—Ä—Ç–∞–∂–µ ¬´–§–í¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QUpEK #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""Market participants are proposing independent review of BEPs (Buyers' Evaluation Process) for product registration to combat counterfeiting. Regulatory authorities are intensifying documentation control, marketplaces are automating verification processes, and information on honest producers is being added to the registry of verified products. For more details: 'FV' report.""
}"
2025-11-24T11:23:06+00:00,@medpharm,13679,https://t.me/medpharm/13679,"–°–∏—Å—Ç–µ–º–∞ –∫–æ–Ω—Ç—Ä–æ–ª—è –ª–µ—á–µ–Ω–∏—è —Å QR-–∫–æ–¥–∞–º–∏ –ø–æ—è–≤–∏–ª–∞—Å—å –≤ —Å—Ç–æ–ª–∏—á–Ω—ã—Ö —Å—Ç–∞—Ü–∏–æ–Ω–∞—Ä–∞—Ö. –ö–∞–∂–¥–æ–º—É –ø–∞—Ü–∏–µ–Ω—Ç—É –≤—ã–¥–∞—é—Ç –±—Ä–∞—Å–ª–µ—Ç, –∞ –º–µ–¥–ø–µ—Ä—Å–æ–Ω–∞–ª —Å–∫–∞–Ω–∏—Ä—É–µ—Ç –∫–æ–¥ –ø—Ä–∏ –ø—Ä–æ—Ü–µ–¥—É—Ä–∞—Ö, —Ñ–∏–∫—Å–∏—Ä—É—è –¥–∞–Ω–Ω—ã–µ –≤ –µ–¥–∏–Ω–æ–π —Å–∏—Å—Ç–µ–º–µ –ï–ú–ò–ê–°. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QUkab #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,hospital_policy,pharmacovigilance"",
  ""impact"": ""medium"",
  ""english"": ""A system of treatment control with QR codes has appeared in capital hospitals. Each patient is given a bracelet, and medical staff scan the code during procedures, recording data in a unified EMIAS system. More: https://clck.ru/3QUkab #MedVestnik #Technologies #HealthcareOrganization""
}"
2025-11-24T10:41:06+00:00,@medpharm,13678,https://t.me/medpharm/13678,–ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ –∫–æ–Ω–∫—Ä–µ—Ç–∏–∑–∏—Ä–æ–≤–∞–ª —Å—Ä–æ–∫–∏ —Ç—Ä–µ—Ö–ª–µ—Ç–Ω–µ–π –æ—Ç—Ä–∞–±–æ—Ç–∫–∏ –¥–ª—è –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ —Ä–∞–∑–Ω—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–µ–π. –ú–∞–∫—Å–∏–º—É–º ‚Äî —Ç—Ä–∏ –≥–æ–¥–∞ ‚Äî –ø—Ä–∏–¥–µ—Ç—Å—è —Ç—Ä—É–¥–∏—Ç—å—Å—è –≤ –≥–æ—Å—Å–µ–∫—Ç–æ—Ä–µ –ø–æ–ª—É—á–∏–≤—à–∏–º –±–∞–∑–æ–≤–æ–µ –≤—ã—Å—à–µ–µ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ –ø–æ —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–∏ ¬´–õ–µ—á–µ–±–Ω–æ–µ –¥–µ–ª–æ¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QUh5H #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-11-24T10:25:03+00:00,@medpharm,13677,https://t.me/medpharm/13677,"–ü–µ—Ä–µ—á–µ–Ω—å –∑–∞–∫—É–ø–æ–∫ ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª –ø–æ–ø–æ–ª–Ω–∏—Ç—Å—è –µ—â–µ –¥–≤—É–º—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º–∏, —Ä–µ—à–µ–Ω–∏–µ –æ–± –∏—Ö –≤–∫–ª—é—á–µ–Ω–∏–∏ –ø—Ä–∏–Ω—è–ª –ø–æ–ø–µ—á–∏—Ç–µ–ª—å—Å–∫–∏–π —Å–æ–≤–µ—Ç —Ñ–æ–Ω–¥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QUfpK #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{""skip"": true}"
2025-11-24T10:01:07+00:00,@medpharm,13676,https://t.me/medpharm/13676,"–ê—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∏ –∑–∞–º–µ—á–∞–Ω–∏—è –∫ –ø—Ä–æ–µ–∫—Ç—É –æ –∫—Ä–∏—Ç–µ—Ä–∏—è—Ö –∫–∞—á–µ—Å—Ç–≤–∞ –ë–ê–î, –∫–æ—Ç–æ—Ä—ã–µ –≤–∫–ª—é—á–∞—Ç –≤ –ø–µ—Ä–µ—á–µ–Ω—å –¥–ª—è –Ω–∞–∑–Ω–∞—á–µ–Ω–∏—è –≤—Ä–∞—á–∞–º–∏. –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ –ø–µ—Ä–µ—Å–º–æ—Ç—Ä–∏—Ç –ø—É–Ω–∫—Ç –æ–± –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–∏ –Ω–∞—Ä—É—à–µ–Ω–∏–π –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã—Ö —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π —É –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è –∑–∞ –ø–æ—Å–ª–µ–¥–Ω–∏–µ —Ç—Ä–∏ –≥–æ–¥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QUdxc #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""high"",
  ""english"": ""The associations have raised objections to the project on quality criteria for BADs, which will be included in the list for doctors. The Ministry of Health of Russia will review the point about the absence of violations of mandatory requirements by the manufacturer in the last three years. For more details: https://clck.ru/3QUdxc #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞""
}"
2025-11-24T09:47:08+00:00,@medpharm,13675,https://t.me/medpharm/13675,–£—á–µ–Ω—ã–µ –∏–∑ –ú–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ —Ü–µ–Ω—Ç—Ä–∞ –£—Ç—Ä–µ—Ö—Ç—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ —Å—Ä–∞–≤–Ω–∏–ª–∏ –∫–ª–∏–Ω–∏—á–µ—Å–∫—É—é —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å —Ç–æ—Ü–∏–ª–∏–∑—É–º–∞–±–∞ –∏ –ø—Ä–µ–¥–Ω–∏–∑–æ–ª–æ–Ω–∞ —É –≤–∑—Ä–æ—Å–ª—ã—Ö —Å –∞–∫—Ç–∏–≤–Ω—ã–º —Ä–µ–≤–º–∞—Ç–æ–∏–¥–Ω—ã–º –∞—Ä—Ç—Ä–∏—Ç–æ–º. –†–µ–∑—É–ª—å—Ç–∞—Ç—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω—ã –≤ –∂—É—Ä–Ω–∞–ª–µ Rheumatology. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QUcu9 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–†–µ–≤–º–∞—Ç–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è,"{""skip"": true}"
2025-11-23T11:58:01+00:00,@medpharm,13674,https://t.me/medpharm/13674,"üëçüëçüëçüëçüëçüëç –ü—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º TOP5 —Å–æ–±—ã—Ç–∏–π –Ω–µ–¥–µ–ª–∏, –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω–Ω—ã—Ö –≤ –ª–µ–Ω—Ç–µ –Ω–æ–≤–æ—Å—Ç–µ–π ¬´–§–í¬ª. –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§ –ø–æ–ª–Ω–æ—Å—Ç—å—é –æ—Ç–º–µ–Ω–∏–ª–æ –ø–ª–∞–Ω–æ–≤—ã–µ –∫–æ–Ω—Ç—Ä–æ–ª—å–Ω—ã–µ (–Ω–∞–¥–∑–æ—Ä–Ω—ã–µ) –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏—è –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –≤—Å–µ—Ö –∫–∞—Ç–µ–≥–æ—Ä–∏–π —Ä–∏—Å–∫–∞, –∫—Ä–æ–º–µ –≤—ã—Å–æ–∫–æ–≥–æ. –§–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—è–º –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ –º–∞–∫—Å–∏–º–∞–ª—å–Ω–æ —É—Å–∫–æ—Ä–∏—Ç—å—Å—è –≤ –ø–æ–¥–∞—á–µ –∑–∞—è–≤–ª–µ–Ω–∏–π –Ω–∞ –ø—Ä–∏–≤–µ–¥–µ–Ω–∏–µ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–æ–Ω–Ω—ã—Ö –¥–æ—Å—å–µ –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–µ —Å –ø—Ä–∞–≤–∏–ª–∞–º–∏ –ï–ê–≠–°. –ü—Ä–µ–∑–∏–¥–µ–Ω—Ç –†–æ—Å—Å–∏–∏ –í–ª–∞–¥–∏–º–∏—Ä –ü—É—Ç–∏–Ω –ø–æ–¥–ø–∏—Å–∞–ª –∑–∞–∫–æ–Ω ‚Ññ 424-–§–ó –æ—Ç 17.11.2025 –æ–± –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–º —Ü–µ–ª–µ–≤–æ–º –æ–±—É—á–µ–Ω–∏–∏ —Å—Ç—É–¥–µ–Ω—Ç–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –æ–±—Ä–∞–∑–æ–≤–∞—Ç–µ–ª—å–Ω—ã—Ö –ø—Ä–æ–≥—Ä–∞–º–º. –¶–†–ü–¢ –∏ –∫—Ä—É–ø–Ω–µ–π—à–∏–µ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å—ã —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª–∏ ¬´–¥–æ—Ä–æ–∂–Ω—É—é –∫–∞—Ä—Ç—É¬ª –¥–ª—è –∫–æ–Ω—Ç—Ä–æ–ª—è –∑–∞ –º–∞—Ä–∫–∏—Ä–æ–≤–∫–æ–π –ë–ê–î. –£–§–ê–° –ø–æ –¢–≤–µ—Ä—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –≤–æ–∑–±—É–¥–∏–ª–æ –¥–µ–ª–æ –ø–æ –ø—Ä–∏–∑–Ω–∞–∫–∞–º –Ω–∞—Ä—É—à–µ–Ω–∏—è –ó–∞–∫–æ–Ω–∞ –æ —Ä–µ–∫–ª–∞–º–µ –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ –∞–ø—Ç–µ—á–Ω–æ–π —Å–µ—Ç–∏ ¬´–ó–¥—Ä–∞–≤—Å–∏—Ç–∏¬ª.","{""skip"": true}"
2025-11-23T08:48:01+00:00,@medpharm,13673,https://t.me/medpharm/13673,"üß©üß©üß©üß©üß©üß© –ü—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º —Ä–µ–π—Ç–∏–Ω–≥ –≥–ª–∞–≤–Ω—ã—Ö –Ω–æ–≤–æ—Å—Ç–µ–π –Ω–µ–¥–µ–ª–∏ –≤ –ø—É–±–ª–∏–∫–∞—Ü–∏—è—Ö –ª–µ–Ω—Ç—ã –Ω–æ–≤–æ—Å—Ç–µ–π ¬´–ú–í¬ª. –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§ —É—Ç–≤–µ—Ä–¥–∏–ª–æ –Ω–æ–≤—É—é —Å—Ö–µ–º—É —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω–æ–≥–æ –ø–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω–∏—è –≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–∏. –í –Ω–µ–µ –≤–æ—à–ª–∏ 136 –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π, –∫–æ—Ç–æ—Ä—ã–µ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –ø–æ—Å—Ç—Ä–æ–∏—Ç—å –∏–ª–∏ —Ä–µ–∫–æ–Ω—Å—Ç—Ä—É–∏—Ä–æ–≤–∞—Ç—å –≤–æ –≤—Å–µ—Ö —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã—Ö –æ–∫—Ä—É–≥–∞—Ö —Å—Ç—Ä–∞–Ω—ã. –í –ú–∏–Ω–∑–¥—Ä–∞–≤–µ –†–§ –æ–ø—Ä–æ–≤–µ—Ä–≥–ª–∏ —Å–æ–æ–±—â–µ–Ω–∏—è –æ –º–∞—Å—Å–æ–≤—ã—Ö –æ—Ç—á–∏—Å–ª–µ–Ω–∏—è—Ö —Å—Ç—É–¥–µ–Ω—Ç–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –≤—É–∑–æ–≤. –ù–∏–∫–∞–∫–æ–π —Å—Ç–∞—Ç–∏—Å—Ç–∏–∫–∏ –Ω–∞ —ç—Ç–æ—Ç —Å—á–µ—Ç –∑–∞ –Ω–µ–¥–µ–ª—é, –ø–æ–Ω—è—Ç–Ω–æ, –ø–æ—è–≤–∏—Ç—å—Å—è –Ω–µ –º–æ–≥–ª–æ. –ì–æ—Å–¥—É–º–∞ –†–§ –≤ –ø–æ—Å–ª–µ–¥–Ω–∏–π –º–æ–º–µ–Ω—Ç –æ—Ç–∫–∞–∑–∞–ª–∞—Å—å –æ—Ç –ª–∏–∫–≤–∏–¥–∞—Ü–∏–∏ —á–∞—Å—Ç–Ω—ã—Ö —Å—Ç—Ä–∞—Ö–æ–≤—â–∏–∫–æ–≤ –≤ —Å–∏—Å—Ç–µ–º–µ –û–ú–°. –í—ã–∑—ã–≤–∞–≤—à–∏–π –æ–∂–µ—Å—Ç–æ—á–µ–Ω–Ω—ã–µ —Å–ø–æ—Ä—ã –Ω–∞ –ø—Ä–æ—Ç—è–∂–µ–Ω–∏–∏ –ø–æ—Å–ª–µ–¥–Ω–∏—Ö –Ω–µ—Å–∫–æ–ª—å–∫–∏—Ö –º–µ—Å—è—Ü–µ–≤ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –±—ã–ª –ø—Ä–∏–Ω—è—Ç –≤ —Ç—Ä–µ—Ç—å–µ–º —á—Ç–µ–Ω–∏–∏. –í –†–æ—Å—Å–∏–∏ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ —Å–æ–∑–¥–∞—Ç—å —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã–π —Ä–µ–π—Ç–∏–Ω–≥ –ø–∞—Ü–∏–µ–Ω—Ç–æ–æ—Ä–∏–µ–Ω—Ç–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π. –ò–Ω–∏—Ü–∏–∞—Ç–∏–≤–∞ —Å–≤—è–∑–∞–Ω–∞ —Å —Ä–∞—Å—Ç—É—â–∏–º –∑–∞–ø—Ä–æ—Å–æ–º –æ–±—â–µ—Å—Ç–≤–∞ –Ω–∞ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏–µ –ø—Ä–æ–∑—Ä–∞—á–Ω–æ–π –∏ –æ–±—ä–µ–∫—Ç–∏–≤–Ω–æ–π —Å–∏—Å—Ç–µ–º—ã –æ—Ü–µ–Ω–∫–∏ –∫–∞—á–µ—Å—Ç–≤–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏. –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ –≤—ã–¥–∞–ª —Ä–∞–∑—Ä–µ—à–µ–Ω–∏–µ –Ω–∞ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ –¥–≤—É—Ö –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –æ–Ω–∫–æ–≤–∞–∫—Ü–∏–Ω. –û–Ω–∏ –±—É–¥—É—Ç –ø—Ä–∏–º–µ–Ω—è—Ç—å—Å—è –ø—Ä–∏ –∫–æ–ª–æ—Ä–µ–∫—Ç–∞–ª—å–Ω–æ–º —Ä–∞–∫–µ –∏ –º–µ–ª–∞–Ω–æ–º–µ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –æ—Ç–≤–µ—á–∞—é—â–∏—Ö –∫—Ä–∏—Ç–µ—Ä–∏—è–º.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""The Russian government approved a new healthcare development plan, involving the construction or renovation of 136 medical facilities across all federal regions. The Russian Ministry of Health denied reports of mass student dismissals from medical schools. The State Duma withdrew its proposal to abolish private insurance companies in the OMS system, which had sparked intense debate. A federal list of patient-oriented medical institutions is proposed to meet growing public demand for a transparent and objective system assessing healthcare quality. The Russian Ministry of Health approved the use of two domestically produced oncovaccines for colorectal cancer and melanoma treatment.""
}"
2025-11-22T08:13:04+00:00,@medpharm,13672,https://t.me/medpharm/13672,"–î–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–µ –º–µ—Ä—ã –ø–æ –±–æ—Ä—å–±–µ —Å –∫–æ—Ä—å—é –∏ –∫–æ–∫–ª—é—à–µ–º, –ø—Ä–∏–Ω—è—Ç—ã–µ –†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä–æ–º –≤ 2023‚Äì2024 –≥–æ–¥–∞—Ö –ø—Ä–∏–Ω–µ—Å–ª–∏ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã. –§–µ–¥–µ—Ä–∞–ª—å–Ω–∞—è —Å–ª—É–∂–±–∞ –æ—Ç—á–∏—Ç–∞–ª–∞—Å—å –æ —Ä–µ–∑–∫–æ–º —Å–Ω–∏–∂–µ–Ω–∏–∏ –∑–∞–±–æ–ª–µ–≤–∞–µ–º–æ—Å—Ç–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QStNU #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–ò–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã–µ_–±–æ–ª–µ–∑–Ω–∏","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""epidemic,hospital_policy,clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""Additional measures against measles and mumps taken by the Federal Service of Russia in 2023-2024 have resulted in a significant reduction in the incidence of disease. The Federal Service has reported on a sharp decrease in morbidity.""
}"
2025-11-22T07:24:03+00:00,@medpharm,13671,https://t.me/medpharm/13671,"–í –Ω–µ–∫–æ—Ç–æ—Ä—ã—Ö —Å—É–±—ä–µ–∫—Ç–∞—Ö –∑–∞—Ä–ø–ª–∞—Ç–∞ –æ—Ä–¥–∏–Ω–∞—Ç–æ—Ä–æ–≤ –Ω–∞ –¥–æ–ª–∂–Ω–æ—Å—Ç—è—Ö –≤—Ä–∞—á–µ–π-—Å—Ç–∞–∂–µ—Ä–æ–≤ —Å–æ—Å—Ç–∞–≤–ª—è–µ—Ç 25 —Ç—ã—Å. —Ä—É–±., –∏ –≤–µ—Å—å –∏—Ö –¥–æ—Ö–æ–¥ —É—Ö–æ–¥–∏—Ç –Ω–∞ –ø–µ—Ä–µ–µ–∑–¥ –≤ –Ω–æ–≤—ã–π —Ä–µ–≥–∏–æ–Ω. –£–≥—Ä–æ–∑–∞ —à—Ç—Ä–∞—Ñ–æ–≤ –∑–∞ –æ—Ç–∫–∞–∑ –æ—Ç –æ—Ç—Ä–∞–±–æ—Ç–∫–∏ –º–æ–≥—É—Ç –ø—Ä–∏–≤–µ—Å—Ç–∏ –∫ –æ—Ç—Ç–æ–∫—É –æ–±—É—á–∞—é—â–∏—Ö—Å—è –≤ —Ü–µ–ª–µ–≤–æ–π –æ—Ä–¥–∏–Ω–∞—Ç—É—Ä–µ, –Ω–æ –ø—Ä–∏ –ø—Ä–∞–≤–∏–ª—å–Ω—ã—Ö —Ä–µ—Ñ–æ—Ä–º–∞—Ö –µ—Å—Ç—å —à–∞–Ω—Å –≤—ã–≤–µ—Å—Ç–∏ –ø–æ–¥–≥–æ—Ç–æ–≤–∫—É –≤—Ä–∞—á–µ–π –Ω–∞ –Ω–æ–≤—ã–π —É—Ä–æ–≤–µ–Ω—å –∏ –ø–æ–ª—É—á–∏—Ç—å –º–∞–∫—Å–∏–º—É–º –ø–æ–ª—å–∑—ã –æ—Ç —Å–∏—Å—Ç–µ–º—ã –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QSrKh #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–û–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""There is a concern about the low compensation for resident physicians, which could lead to staff turnover. However, proper reforms can potentially improve the training system and maximize the benefits of mentorship programs.""
}"
2025-11-22T04:49:03+00:00,@medpharm,13670,https://t.me/medpharm/13670,"–ü–ª–∞–Ω—ã –ø–æ —Ä–∞–∑–≤–∏—Ç–∏—é –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä—ã, ¬´–ø–æ–±–µ–¥–∞ —Ñ–∏–Ω–∞–Ω—Å–æ–≤–æ–≥–æ –∫–∞–ø–∏—Ç–∞–ª–∞¬ª –≤ —Å–∏—Å—Ç–µ–º–µ –û–ú–°, –∑–∞–ø—É—Å–∫ –≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫—É—é –ø—Ä–∞–∫—Ç–∏–∫—É –¥–≤—É—Ö –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö ¬´–æ–Ω–∫–æ–≤–∞–∫—Ü–∏–Ω¬ª –∏ –¥—Ä—É–≥–∏–µ –Ω–æ–≤–æ—Å—Ç–∏ —Ä–∞–±–æ—á–µ–π –ø—è—Ç–∏–¥–Ω–µ–≤–∫–∏ –≤ –¥–∞–π–¥–∂–µ—Å—Ç–µ ¬´–ú–í¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QSm8x #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û–Ω–∫–æ–ª–æ–≥–∏—è #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-11-21T16:48:01+00:00,@medpharm,13669,https://t.me/medpharm/13669,"ü¶æ –†–∞—Å–ø–µ—á–∞—Ç–∞–ª–∏ –∫—É–±—ã—à–∫—É. –í—ã–ø–ª–∞—Ç–∞ –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏–∏ –º–æ—Ä–∞–ª—å–Ω–æ–≥–æ –≤—Ä–µ–¥–∞ –ø–æ —Å—É–¥–µ–±–Ω–æ–º—É –∏—Å–∫—É –∑–∞ —Å—á–µ—Ç —Å—Ä–µ–¥—Å—Ç–≤ –û–ú–° –≤–æ–∑–º–æ–∂–Ω–∞ –ø—Ä–∏ —É—Å–ª–æ–≤–∏–∏, —á—Ç–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫—É—é –ø–æ–º–æ—â—å –∑–∞—Å—Ç—Ä–∞—Ö–æ–≤–∞–Ω–Ω–æ–º—É –æ–∫–∞–∑—ã–≤–∞–ª–∏ –≤ —Ä–∞–º–∫–∞—Ö –ü—Ä–æ–≥—Ä–∞–º–º—ã –≥–æ—Å–≥–∞—Ä–∞–Ω—Ç–∏–π. –¢–∞–∫–∏–µ —Ä–∞–∑—ä—è—Å–Ω–µ–Ω–∏—è –¥–∞–ª –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ –≤ –æ—Ç–≤–µ—Ç –Ω–∞ –¥–µ–ø—É—Ç–∞—Ç—Å–∫–∏–π –∑–∞–ø—Ä–æ—Å. ü¶æ –ë—É–∫–µ—Ç –±–æ–ª–µ–∑–Ω–µ–π. –†–∞—Ü–∏–æ–Ω —Å –≤—ã—Å–æ–∫–æ–π –¥–æ–ª–µ–π —É–ª—å—Ç—Ä–∞–æ–±—Ä–∞–±–æ —Ç–∞–Ω–Ω—ã—Ö –ø—Ä–æ–¥—É–∫—Ç–æ–≤ –ø–æ–≤—ã—à–∞–µ—Ç —Ä–∏—Å–∫ –∏–∑–±—ã—Ç–æ—á–Ω–æ–≥–æ –≤–µ—Å–∞ –∏ –æ–∂–∏—Ä–µ–Ω–∏—è, –∞–±–¥–æ–º–∏–Ω–∞–ª—å–Ω–æ–≥–æ –æ–∂–∏—Ä–µ–Ω–∏—è, –¥–∏–∞–±–µ—Ç–∞ 2-–≥–æ —Ç–∏–ø–∞, –≥–∏–ø–µ—Ä—Ç–µ–Ω–∑–∏–∏, –¥–∏—Å–ª–∏–ø–∏–¥–µ–º–∏–∏, —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö –∏ —Ü–µ—Ä–µ–±—Ä–æ–≤–∞—Å–∫—É–ª—è—Ä–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–æ–π –±–æ–ª–µ–∑–Ω–∏ –ø–æ—á–µ–∫, –±–æ–ª–µ–∑–Ω–∏ –ö—Ä–æ–Ω–∞, –¥–µ–ø—Ä–µ—Å—Å–∏–∏ –∏ —Å–º–µ—Ä—Ç–∏ –æ—Ç –≤—Å–µ—Ö –ø—Ä–∏—á–∏–Ω. ‚ù§Ô∏è –†–∏—Å–∫—É–µ–º –ø–æ—Ç–µ—Ä—è—Ç—å. –î–µ–ø—É—Ç–∞—Ç –ì–æ—Å–¥—É–º—ã –†–§ –ê–π—Ä–∞—Ç –§–∞—Ä—Ä–∞—Ö–æ–≤ –æ–±—Ä–∞—Ç–∏–ª—Å—è –∫ –º–∏–Ω–∏—Å—Ç—Ä—É –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –†–æ—Å—Å–∏–∏ –ú–∏—Ö–∞–∏–ª—É –ú—É—Ä–∞—à–∫–æ —Å –ø—Ä–æ—Å—å–±–æ–π —Å–æ—Ö—Ä–∞–Ω–∏—Ç—å —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç—å ¬´–§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∞—è —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—è¬ª. ‚ù§Ô∏è –ù–µ–æ–ø—Ä–µ–¥–µ–ª–µ–Ω–Ω–æ—Å—Ç—å. –ö–∞–∫–æ–π —Å—Ç–∞—Ç—É—Å –ø–æ–ª—É—á–∞—Ç —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–æ–Ω–Ω—ã–µ —É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏—è, –∫–æ—Ç–æ—Ä—ã–µ –Ω–µ —É—Å–ø–µ–ª–∏ –ø—Ä–æ–π—Ç–∏ –ø—Ä–æ—Ü–µ–¥—É—Ä—É –ø—Ä–∏–≤–µ–¥–µ–Ω–∏—è –≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–µ —Å –ø—Ä–∞–≤–∏–ª–∞–º–∏ –ï–ê–≠–°, –Ω–æ —É—Å–ø–µ–ª–∏ –ø–æ–¥–∞—Ç—å –∑–∞—è–≤–ª–µ–Ω–∏–µ.","{""skip"": true}"
2025-11-21T16:20:02+00:00,@medpharm,13668,https://t.me/medpharm/13668,"–ö–∞–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –º–æ–≥—É—Ç —Å—á–∏—Ç–∞—Ç—å—Å—è –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–º–∏ –∏ –ø–æ–ª—É—á–∞—Ç—å —É—Å–∏–ª–µ–Ω–Ω—ã–µ –º–µ—Ä—ã –≥–æ—Å–ø–æ–¥–¥–µ—Ä–∂–∫–∏, –æ–±—Å—É–¥–∏–ª–∏ —É—á–∞—Å—Ç–Ω–∏–∫–∏ –∑–∞—Å–µ–¥–∞–Ω–∏—è –≠–∫—Å–ø–µ—Ä—Ç–Ω–æ–≥–æ —Å–æ–≤–µ—Ç–∞ –ø–æ —Ä–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω–∏—é –æ–±—Ä–∞—â–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –º–µ–¥–∏–∑–¥–µ–ª–∏–π –ö–æ–º–∏—Ç–µ—Ç–∞ –ì–æ—Å–¥—É–º—ã –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è. –ù—É–∂–Ω–æ –ª–∏ –≤–≤–æ–¥–∏—Ç—å –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–µ –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–∏–µ –∏–ª–∏ –º–æ–∂–Ω–æ –æ—Å—Ç–∞–Ω–æ–≤–∏—Ç—å—Å—è –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞—Ö ¬´–æ—Å–æ–±–æ–π –∑–Ω–∞—á–∏–º–æ—Å—Ç–∏¬ª –∏–∑ —Ä–µ—à–µ–Ω–∏—è –∫–æ–º–∏—Å—Å–∏–∏ –ï–≠–ö, —á–∏—Ç–∞–π—Ç–µ –≤ —Ä–µ–ø–æ—Ä—Ç–∞–∂–µ ¬´–§–í¬ª –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QSWao #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""Participants discussed at the Expert Council on the regulation of drug and medical device market session what innovative drugs should be given enhanced government support. The question was raised about whether a national definition is needed or if the 'special significance' drugs from the commission's decision of the EAEU should suffice. Read more in 'FV' report: https://clck.ru/3QSWao #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞""
}"
2025-11-21T16:07:03+00:00,@medpharm,13667,https://t.me/medpharm/13667,"–ó–∞ –ø–æ—Å–ª–µ–¥–Ω—é—é –Ω–µ–¥–µ–ª—é –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä –ø—Ä–µ–∫—Ä–∞—Ç–∏–ª –æ–±—Ä–∞—â–µ–Ω–∏–µ —Ç—Ä–µ—Ö —Å–µ—Ä–∏–π –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –µ—â–µ –¥–≤–µ —Å–µ—Ä–∏–∏ –æ—Ç–æ–∑–≤–∞–ª –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å. –ü—Ä–µ—Ç–µ–Ω–∑–∏–∏ –≤–æ–∑–Ω–∏–∫–ª–∏ –≤ —Ç–æ–º —á–∏—Å–ª–µ –∫ –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è–º ¬´–†–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø—Ä–∏–º–µ—Å–∏¬ª, ¬´–û–ø–∏—Å–∞–Ω–∏–µ¬ª, ¬´–†–∞—Å—Ç–≤–æ—Ä–µ–Ω–∏–µ¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QSW3f #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–û—Ç–∑—ã–≤—ã","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""The Russian Health Supervision authority has suspended the registration of three series of pharmaceutical products, and another two have been recalled by the manufacturer. Complaints arose in particular regarding indicators such as 'Related impurities', 'Description', and 'Solubility'. For more details: https://clck.ru/3QSW3f #PharmNews #DrugRecalls""
}"
2025-11-21T15:54:03+00:00,@medpharm,13666,https://t.me/medpharm/13666,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –ø–æ–ø—Ä–∞–≤–∫–∏ –≤ –æ—Å–æ–±–µ–Ω–Ω–æ—Å—Ç–∏ –æ–±—Ä–∞—â–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ —Å–ª—É—á–∞–µ –¥–µ—Ñ–µ–∫—Ç—É—Ä—ã –∏–ª–∏ —Ä–∏—Å–∫–∞ –µ–µ –≤–æ–∑–Ω–∏–∫–Ω–æ–≤–µ–Ω–∏—è. –£—Ç–æ—á–Ω–µ–Ω—ã —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ –¥–æ–∫—É–º–µ–Ω—Ç–∞–º, –∫–æ—Ç–æ—Ä—ã–µ –¥–æ–ª–∂–Ω—ã –ø–æ–¥–∞–≤–∞—Ç—å –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QSVP4 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""medium"",
  ""english"": ""The Russian Ministry of Health has developed amendments to the requirements for the handling of drugs in case of defects or risk of their occurrence. Requirements for documents submitted by domestic drug manufacturers have been clarified. More details: https://clck.ru/3QSVP4 #PharmNews #Regulation""
}"
2025-11-21T15:50:05+00:00,@medpharm,13665,https://t.me/medpharm/13665,–†–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–Ω—ã–π –≤ –ü–µ—Ä–º–∏ –Ω–æ–≤—ã–π –ø—Ä–æ–≥—Ä–∞–º–º–Ω—ã–π –∫–æ–º–ø–ª–µ–∫—Å –ø—Ä–æ–≥–Ω–æ–∑–∏—Ä—É–µ—Ç —Ä–∏—Å–∫ –ø–æ–≤—Ä–µ–∂–¥–µ–Ω–∏–π –ø–æ–∑–≤–æ–Ω–æ—á–Ω–∏–∫–∞ –∑–∞ 10‚Äî15 –ª–µ—Ç. –†–∞–Ω–Ω—è—è –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞ –≤–æ–∑—Ä–∞—Å—Ç–Ω—ã—Ö –∏–∑–º–µ–Ω–µ–Ω–∏–π —Å—Ç–∞–ª–∞ –≤–æ–∑–º–æ–∂–Ω–∞ –±–ª–∞–≥–æ–¥–∞—Ä—è –º–∞—Ç–µ–º–∞—Ç–∏—á–µ—Å–∫–æ–π –º–æ–¥–µ–ª–∏ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QSVBX #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–î–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞,"{""skip"": true}"
2025-11-21T15:22:03+00:00,@medpharm,13664,https://t.me/medpharm/13664,"Abbott —Å–æ–≤–µ—Ä—à–∏–ª–∞ –∫—Ä—É–ø–Ω–µ–π—à—É—é —Å–¥–µ–ª–∫—É –Ω–∞ —Ä—ã–Ω–∫–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∑–∞ –ø–æ—Å–ª–µ–¥–Ω–∏–µ –¥–≤–∞ –≥–æ–¥–∞. –ö–æ—Ä–ø–æ—Ä–∞—Ü–∏—è —Ä–µ—à–∏–ª–∞ –ø—Ä–∏–æ–±—Ä–µ—Å—Ç–∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è –æ–Ω–∫–æ—Ç–µ—Å—Ç–æ–≤, —á—Ç–æ–±—ã –∑–∞–∫—Ä—ã—Ç—å —Ñ–∏–Ω–∞–Ω—Å–æ–≤—É—é –¥—ã—Ä—É –ø–æ—Å–ª–µ –ø–∞–Ω–¥–µ–º–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QSTZe #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-11-21T15:09:06+00:00,@medpharm,13663,https://t.me/medpharm/13663,–í –†–æ—Å—Å–∏–∏ –ø–ª–∞–Ω–∏—Ä—É—é—Ç —É–∂–µ—Å—Ç–æ—á–∏—Ç—å –ø—Ä–∞–≤–∏–ª–∞ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤. –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ –ø–æ—Ç—Ä–µ–±–æ–≤–∞–ª –ø–æ–ª–Ω–æ—Ü–µ–Ω–Ω–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –∏ –∫–æ–Ω—Ç—Ä–æ–ª—è –∫–∞—á–µ—Å—Ç–≤–∞ –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ —Å—Ç—Ä–∞–Ω—ã –∏ –¥–æ–ø—É—Å—Ç–∏–ª —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—é –±–∏–æ–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ø–æ —É—Å–∫–æ—Ä–µ–Ω–Ω–æ–º—É –º–µ—Ö–∞–Ω–∏–∑–º—É –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QSSnV #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""registration, safety"",
  ""impact"": ""high"",
  ""english"": ""Russia plans to tighten registration rules for medicines. The Ministry of Health Russia demanded full production and quality control on its territory and approved registration of biopreparations via an expedited mechanism. ""
}"
2025-11-21T14:52:04+00:00,@medpharm,13662,https://t.me/medpharm/13662,"–í –Ω–∞—á–∞–ª–µ –¥–µ–∫–∞–±—Ä—è –≤ –ì–æ—Å—Ä–µ–µ—Å—Ç—Ä–µ –ø–æ—è–≤–∏—Ç—Å—è –ø–æ–¥—Ä–æ–±–Ω–∞—è –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è –¥–ª—è –¥–µ—Ä–∂–∞—Ç–µ–ª–µ–π —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–æ–Ω–Ω—ã—Ö –¥–æ—Å—å–µ –æ —Ç–æ–º, –∫–∞–∫ –±—É–¥–µ—Ç —Ä–∞–±–æ—Ç–∞—Ç—å —Ä—ã–Ω–æ–∫ –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø–æ—Å–ª–µ 1 —è–Ω–≤–∞—Ä—è 2026 –≥–æ–¥–∞. –ë–æ–ª—å—à–µ –≤—Å–µ–≥–æ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –≤–æ–ª–Ω—É–µ—Ç, –∫–∞–∫–æ–π —Å—Ç–∞—Ç—É—Å –ø–æ–ª—É—á–∞—Ç —Ä–µ–≥—É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏—è, –∫–æ—Ç–æ—Ä—ã–µ –Ω–µ —É—Å–ø–µ–ª–∏ –ø—Ä–æ–π—Ç–∏ –ø—Ä–æ—Ü–µ–¥—É—Ä—É –ø—Ä–∏–≤–µ–¥–µ–Ω–∏—è –≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–µ —Å –ø—Ä–∞–≤–∏–ª–∞–º–∏ –ï–ê–≠–°, –Ω–æ —É—Å–ø–µ–ª–∏ –ø–æ–¥–∞—Ç—å –∑–∞—è–≤–ª–µ–Ω–∏–µ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QSRps #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""registration, reimbursement"",
  ""impact"": ""high"",
  ""english"": ""The national registration authorities will provide detailed information on how the market for medicines will operate after January 1, 2026. The pharmaceutical companies are most concerned about the status of national registration certificates that have not been updated to comply with EAEU rules but were submitted in time. More details: https://clck.ru/3QSRps #PharmNews #Regulation""
}"
2025-11-21T14:08:07+00:00,@medpharm,13661,https://t.me/medpharm/13661,"–£—Ç–≤–µ—Ä–∂–¥–µ–Ω—ã –Ω–æ–≤—ã–µ –Ω–æ—Ä–º—ã —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –∫–æ–Ω—Ç—Ä–æ–ª—è –∑–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º–∏ –∏–∑–¥–µ–ª–∏—è–º–∏. –ö–æ–Ω—Ç—Ä–æ–ª—å–Ω—ã–µ –∏ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–∏–µ –≤–∏–∑–∏—Ç—ã —Å–º–æ–≥—É—Ç –ø—Ä–æ–≤–æ–¥–∏—Ç—å—Å—è –∫–∞–∫ –æ—á–Ω–æ, —Ç–∞–∫ –∏ –¥–∏—Å—Ç–∞–Ω—Ü–∏–æ–Ω–Ω–æ —á–µ—Ä–µ–∑ –º–æ–±–∏–ª—å–Ω–æ–µ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏–µ ¬´–ò–Ω—Å–ø–µ–∫—Ç–æ—Ä¬ª –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QSPDu #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""New regulations for federal control of medical products have been approved. Inspections and preventive visits can be conducted both in person and remotely through the mobile app 'Inspector'.""
}"
2025-11-21T13:19:06+00:00,@medpharm,13660,https://t.me/medpharm/13660,–†–æ—Å—Å–∏–π—Å–∫–∞—è –∞–∫–∞–¥–µ–º–∏—è –Ω–∞—É–∫ –∑–∞–≤–µ—Ä—à–∏–ª–∞ —Å–±–æ—Ä –∑–∞—è–≤–ª–µ–Ω–∏–π –Ω–∞ –ø–æ–ª—É—á–µ–Ω–∏–µ –ø–æ—á–µ—Ç–Ω–æ–≥–æ –∑–≤–∞–Ω–∏—è ¬´–ü—Ä–æ—Ñ–µ—Å—Å–æ—Ä –†–ê–ù¬ª. –ú–∞–∫—Å–∏–º–∞–ª—å–Ω–æ–µ —á–∏—Å–ª–æ –≤–∞–∫–∞–Ω—Å–∏–π –æ—Ç–∫—Ä—ã—Ç–æ –≤ –æ—Ç–¥–µ–ª–µ–Ω–∏–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –Ω–∞—É–∫ ‚Äî –Ω–∞ —É—á–∞—Å—Ç–∏–µ –≤ –≤—ã–±–æ—Ä–∞—Ö –∫–∞–Ω–¥–∏–¥–∞—Ç—ã –ø–æ–¥–∞–ª–∏ 110 –∑–∞—è–≤–ª–µ–Ω–∏–π –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QSLEt #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ù–∞—É–∫–∞ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-11-21T12:43:02+00:00,@medpharm,13659,https://t.me/medpharm/13659,"–î–µ–ø—É—Ç–∞—Ç –ì–æ—Å–¥—É–º—ã –†–§ –ê–π—Ä–∞—Ç –§–∞—Ä—Ä–∞—Ö–æ–≤ –æ–±—Ä–∞—Ç–∏–ª—Å—è –∫ –≥–ª–∞–≤–µ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–§ –ú–∏—Ö–∞–∏–ª—É –ú—É—Ä–∞—à–∫–æ —Å –ø—Ä–æ—Å—å–±–æ–π —Å–æ—Ö—Ä–∞–Ω–∏—Ç—å —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç—å ¬´—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∞—è —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—è¬ª. –ï—Å–ª–∏ –Ω–µ –≤–Ω–µ—Å—Ç–∏ –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω—É—é –±–∞–∑—É, —Ä–∞–±–æ—Ç–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã—Ö –∞–ø—Ç–µ–∫ –º–æ–∂–µ—Ç –±—ã—Ç—å –æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QSHpd #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–∞—Ä—å–µ—Ä–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""Deputy of the State Duma of Russia, Ayrat Farrakhov has appealed to Health Minister Mikhail Murashko to maintain the specialty 'pharmaceutical technology'. If changes are not made in the regulatory base, production pharmacy work may be halted. More details: https://clck.ru/3QSHpd #PharmWeNews #Career""
}"
2025-11-21T12:31:02+00:00,@medpharm,13658,https://t.me/medpharm/13658,"–ö–æ–≥–¥–∞ –≤ —Å–µ–º—å–µ –ø–æ—è–≤–ª—è–µ—Ç—Å—è –Ω–æ–≤–æ—Ä–æ–∂–¥–µ–Ω–Ω—ã–π —Ä–µ–±–µ–Ω–æ–∫, –æ—Å–æ–±–µ–Ω–Ω–æ –ø–µ—Ä–≤–µ–Ω–µ—Ü, –æ—Å–Ω–æ–≤–Ω–æ–π –∑–∞–¥–∞—á–µ–π —Ä–æ–¥–∏—Ç–µ–ª–µ–π —è–≤–ª—è–µ—Ç—Å—è —É—Ö–æ–¥ –∑–∞ –º–∞–ª—ã—à–æ–º: –æ–Ω–∏ –¥–æ–ª–∂–Ω—ã –Ω–∞—É—á–∏—Ç—å—Å—è –ø–æ–Ω–∏–º–∞—Ç—å, –∫–æ–≥–¥–∞ –æ–Ω –≥–æ–ª–æ–¥–µ–Ω, —á—Ç–æ –µ–≥–æ –±–µ—Å–ø–æ–∫–æ–∏—Ç, –∫–æ–≥–¥–∞ –º–æ–∂–Ω–æ —Å–ø—Ä–∞–≤–∏—Ç—å—Å—è —Å –ø—Ä–æ–±–ª–µ–º–æ–π —Å–∞–º–∏–º, –∞ –∫–æ–≥–¥–∞ –Ω—É–∂–Ω–æ –∑–≤–∞—Ç—å –Ω–∞ –ø–æ–º–æ—â—å –ø–µ–¥–∏–∞—Ç—Ä–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QSGz6 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–§–∞—Ä–º–∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä–æ–≤–∞–Ω–∏–µ","{""skip"": true}"
2025-11-21T12:27:06+00:00,@medpharm,13657,https://t.me/medpharm/13657,–≠–∫—Å–ø–µ—Ä—Ç—ã –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–æ–π –≥—Ä—É–ø–ø—ã –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∏ –æ–±–Ω–æ–≤–ª–µ–Ω–Ω—ã–π –æ–±–∑–æ—Ä –¥–∞–Ω–Ω—ã—Ö –æ –≤–ª–∏—è–Ω–∏–∏ —É–ª—å—Ç—Ä–∞–æ–±—Ä–∞–±–æ—Ç–∞–Ω–Ω—ã—Ö –ø—Ä–æ–¥—É–∫—Ç–æ–≤ –Ω–∞ –∑–¥–æ—Ä–æ–≤—å–µ. –ü–µ—Ä–≤–∞—è –∏–∑ —Å–µ—Ä–∏–∏ —Ç—Ä–µ—Ö —Å—Ç–∞—Ç–µ–π –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω–∞ –≤ –∂—É—Ä–Ω–∞–ª–µ The Lancet –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QSKNi #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ì–∞—Å—Ç—Ä–æ—ç–Ω—Ç–µ—Ä–æ–ª–æ–≥–∏—è #–ö–∞—Ä–¥–∏–æ–ª–æ–≥–∏—è #–ù–µ–≤—Ä–æ–ª–æ–≥–∏—è #–ù–µ—Ñ—Ä–æ–ª–æ–≥–∏—è #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è #–¢–µ—Ä–∞–ø–∏—è #–≠–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–∏—è,"{""skip"": true}"
2025-11-21T11:30:03+00:00,@medpharm,13656,https://t.me/medpharm/13656,–ö–æ–º–ø–∞–Ω–∏—è ¬´–†-—Ñ–∞—Ä–º¬ª –±—É–¥–µ—Ç –ø–æ—Å—Ç–∞–≤–ª—è—Ç—å –¥–ª—è ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª –≥–ª–µ–∫–∞–ø—Ä–µ–≤–∏—Ä + –ø–∏–±—Ä–µ–Ω—Ç–∞—Å–≤–∏—Ä –∏ —Å–∞—Ç—Ä–∞–ª–∏–∑—É–º–∞–±. –ê—É–∫—Ü–∏–æ–Ω –Ω–∞ –∑–∞–∫—É–ø–∫—É —ç–≤–µ—Ä–æ–ª–∏–º—É—Å–∞ –Ω–µ —Å–æ—Å—Ç–æ—è–ª—Å—è –∏–∑-–∑–∞ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏—è –∑–∞—è–≤–æ–∫. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QSCoZ #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è,"{""skip"": true}"
2025-11-21T11:23:04+00:00,@medpharm,13655,https://t.me/medpharm/13655,"–í—ã–ø–ª–∞—Ç–∞ –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏–∏ –º–æ—Ä–∞–ª—å–Ω–æ–≥–æ –≤—Ä–µ–¥–∞ –ø–æ —Å—É–¥–µ–±–Ω–æ–º—É –∏—Å–∫—É –∑–∞ —Å—á–µ—Ç —Å—Ä–µ–¥—Å—Ç–≤ –û–ú–° –≤–æ–∑–º–æ–∂–Ω–∞ –ø—Ä–∏ —É—Å–ª–æ–≤–∏–∏, —á—Ç–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫—É—é –ø–æ–º–æ—â—å –∑–∞—Å—Ç—Ä–∞—Ö–æ–≤–∞–Ω–Ω–æ–º—É –æ–∫–∞–∑—ã–≤–∞–ª–∏ –≤ —Ä–∞–º–∫–∞—Ö –ü—Ä–æ–≥—Ä–∞–º–º—ã –≥–æ—Å–≥–∞—Ä–∞–Ω—Ç–∏–π. –¢–∞–∫–∏–µ —Ä–∞–∑—ä—è—Å–Ω–µ–Ω–∏—è –¥–∞–ª –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ –≤ –æ—Ç–≤–µ—Ç –Ω–∞ –¥–µ–ø—É—Ç–∞—Ç—Å–∫–∏–π –∑–∞–ø—Ä–æ—Å –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QSCQy #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""guideline,hospital_policy,pharmacovigilance,safety"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health Russia has clarified that compensation for moral damage in a court case against the state insurance program is possible if healthcare was provided to insured individuals within the State Guarantees Program. More details: https://clck.ru/3QSCQy #MedVestnik #Healthcare""
}"
2025-11-21T10:24:06+00:00,@medpharm,13654,https://t.me/medpharm/13654,"–í –ì–æ—Å–¥—É–º–µ –†–§ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –º–∞—Ä–∫–∏—Ä–æ–≤–∞—Ç—å –æ—Ç–≤–µ—Ç—ã –Ω–µ–π—Ä–æ—Å–µ—Ç–µ–π, —Å–æ–¥–µ—Ä–∂–∞—â–∏–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏. –ò–Ω–∏—Ü–∏–∞—Ç–∏–≤–∞ –ø—Ä–µ–¥—É—Å–º–∞—Ç—Ä–∏–≤–∞–µ—Ç –µ—â–µ –Ω–µ—Å–∫–æ–ª—å–∫–æ –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏–π –¥–ª—è –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–∞ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QS8LJ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–î—Ä—É–≥–æ–µ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The Russian State Duma proposed to mark responses of AI systems containing medical recommendations. The initiative also includes several restrictions for artificial intelligence.""
}"
2025-11-21T10:03:03+00:00,@medpharm,13653,https://t.me/medpharm/13653,"–°—É–¥ –°–®–ê —É—Ç–≤–µ—Ä–¥–∏–ª –ø–ª–∞–Ω –±–∞–Ω–∫—Ä–æ—Ç—Å—Ç–≤–∞ Purdue Pharma. –ö–æ–º–ø–∞–Ω–∏—è –∏—Å—á–µ–∑–Ω–µ—Ç, –∞ –µ–µ –≤–ª–∞–¥–µ–ª—å—Ü—ã –≤—ã–ø–ª–∞—Ç—è—Ç –∏–∑ —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∫–∞—Ä–º–∞–Ω–∞ –∂–µ—Ä—Ç–≤–∞–º –æ–ø–∏–æ–∏–¥–Ω–æ–≥–æ –∫—Ä–∏–∑–∏—Å–∞ —Ä–µ–∫–æ—Ä–¥–Ω—É—é —Å—É–º–º—É –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏–π –¥–ª—è —Ñ–∏–∑–ª–∏—Ü –≤ –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–π –∏—Å—Ç–æ—Ä–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QS6qD #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{""skip"": true}"
2025-11-21T09:39:03+00:00,@medpharm,13652,https://t.me/medpharm/13652,26 –Ω–æ—è–±—Ä—è –≤ —Ä–∞–º–∫–∞—Ö –¥–µ–ª–æ–≤–æ–π –ø—Ä–æ–≥—Ä–∞–º–º—ã 26-–≥–æ —Å–µ–∑–æ–Ω–∞ ¬´–ü–ª–∞—Ç–∏–Ω–æ–≤–æ–π —É–Ω—Ü–∏–∏¬ª —Å–æ—Å—Ç–æ–∏—Ç—Å—è —á–µ—Ç–≤–µ—Ä—Ç—ã–π –±–∏–∑–Ω–µ—Å-–∑–∞–≤—Ç—Ä–∞–∫ ¬´–ü—Ä–µ–ø–∞—Ä–∞—Ç—ã –≥–æ–¥–∞. –ö—Ä–∏—Ç–µ—Ä–∏–∏ –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–∏—è –ø—Ä–æ—Ä—ã–≤–æ–≤ –∏ –ª–∏–¥–µ—Ä–æ–≤¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QS53U #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-11-21T09:03:03+00:00,@medpharm,13650,https://t.me/medpharm/13650,–ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏ –≤—ã–¥–∞–ª —Ä–∞–∑—Ä–µ—à–µ–Ω–∏—è –Ω–∞ –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–µ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ —Å—Ä–∞–∑—É –¥–≤—É—Ö —Ç–µ—Ä–∞–ø–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –æ–Ω–∫–æ–≤–∞–∫—Ü–∏–Ω –¥–ª—è –ª–µ—á–µ–Ω–∏—è –∫–æ–ª–æ—Ä–µ–∫—Ç–∞–ª—å–Ω–æ–≥–æ —Ä–∞–∫–∞ –∏ –º–µ–ª–∞–Ω–æ–º—ã –∫–æ–∂–∏. –ù–∞ –ø–µ—Ä–≤–æ–º —ç—Ç–∞–ø–µ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞–º –ø—Ä–µ–¥—Å—Ç–æ–∏—Ç –æ—Ü–µ–Ω–∏—Ç—å —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –∏ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QS2Ps #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""clinical_trial, safety"",
  ""impact"": ""high"",
  ""english"": ""The Russian Ministry of Health has approved the use of two therapeutic oncovaccines for treating colorectal cancer and melanoma skin disease. The first stage involves evaluating the effectiveness and safety of the drugs.""
}"
2025-11-21T08:25:19+00:00,@medpharm,13649,https://t.me/medpharm/13649,"–ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–π –ú–∏–Ω–∑–¥—Ä–∞–≤ –ø—Ä–∏–∑–Ω–∞–ª, —á—Ç–æ –Ω–∞—É–∫–æ–π –Ω–µ –¥–æ–∫–∞–∑–∞–Ω–æ –ø–æ–ª–Ω–æ–µ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–µ —Å–≤—è–∑–∏ –º–µ–∂–¥—É –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏–µ–π –∏ –∞—É—Ç–∏–∑–º–æ–º. –¶–µ–Ω—Ç—Ä—ã –ø–æ –∫–æ–Ω—Ç—Ä–æ–ª—é –∏ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–µ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π (CDC) –æ–ø—É–±–ª–∏–∫–æ–≤–∞–ª–∏ –æ–±–Ω–æ–≤–ª–µ–Ω–Ω—É—é –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QRxWk #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-11-21T07:45:03+00:00,@medpharm,13648,https://t.me/medpharm/13648,"–ù–∞ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞—Ö –≤—ã—è–≤–ª–µ–Ω—ã —Å–ª—É—á–∞–∏ –ø—Ä–æ–¥–∞–∂–∏ –º–∞—Ä–∫–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ë–ê–î —Å –∞–Ω–Ω—É–ª–∏—Ä–æ–≤–∞–Ω–Ω—ã–º–∏ —Å–≤–∏–¥–µ—Ç–µ–ª—å—Å—Ç–≤–∞–º–∏ –æ –≥–æ—Å—Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏. –í –†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä–µ –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª–∏ –Ω–∞—Ä—É—à–µ–Ω–∏—è, –Ω–æ –ø—Ä–∏–∑–Ω–∞–ª–∏, —á—Ç–æ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ –≤–µ–¥–æ–º—Å—Ç–≤–∞ –ø–æ –æ–ø–µ—Ä–∞—Ç–∏–≤–Ω–æ–º—É —Ä–µ–∞–≥–∏—Ä–æ–≤–∞–Ω–∏—é –Ω–∞ —Ç–∞–∫–∏–µ —Å–∏–≥–Ω–∞–ª—ã –æ–≥—Ä–∞–Ω–∏—á–µ–Ω—ã. –≠–∫—Å–ø–µ—Ä—Ç—ã —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏, —á—Ç–æ –±—É–¥–µ—Ç –ø—Ä–æ–∏—Å—Ö–æ–¥–∏—Ç—å –¥–∞–ª—å—à–µ –Ω–∞ —Ä—ã–Ω–∫–µ –ë–ê–î –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QRuKs #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""medium"",
  ""english"": ""Marked homeopathic medicines with revoked registration certificates were detected on marketplaces. The Rospatent confirmed the violations, but acknowledged that their ability to promptly react to such signals is limited. Experts explained what will happen on the homeopathic market.""
}"
2025-11-21T07:19:10+00:00,@medpharm,13647,https://t.me/medpharm/13647,"–ú–∏—Ä–æ–≤–æ–π —Ä—ã–Ω–æ–∫ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –º–∏–∫—Ä–æ–Ω–∞—Å–æ—Å–æ–≤ —Ä–∞—Å—Ç–µ—Ç —Å–æ —Å—Ä–µ–¥–Ω–µ–≥–æ–¥–æ–≤—ã–º —Ç–µ–º–ø–æ–º 7,9%. –î–æ–ª—é –≤ 41,13% –≤ 2024 –≥–æ–¥—É –∑–∞–Ω–∏–º–∞–ª–∞ –°–µ–≤–µ—Ä–Ω–∞—è –ê–º–µ—Ä–∏–∫–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QRsS2 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-11-21T06:14:07+00:00,@medpharm,13646,https://t.me/medpharm/13646,"–£—á–µ–Ω—ã–µ –∏–∑ –õ—É–Ω–¥—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ –ø—Ä–æ–≤–µ–ª–∏ –ø—Ä–æ—Å–ø–µ–∫—Ç–∏–≤–Ω–æ–µ –∫–æ–≥–æ—Ä—Ç–Ω–æ–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ, —á—Ç–æ–±—ã –æ—Ü–µ–Ω–∏—Ç—å —Å–≤—è–∑—å –º–µ–∂–¥—É –∫–æ–Ω—Ü–µ–Ω—Ç—Ä–∞—Ü–∏–µ–π —Ö–æ–ª–µ—Å—Ç–µ—Ä–∏–Ω–∞ –õ–ü–í–ü –∏ —Ä–∏—Å–∫–æ–º –Ω–æ–≤—ã—Ö –ø–µ—Ä–µ–ª–æ–º–æ–≤ –∫–æ—Å—Ç–µ–π. –†–µ–∑—É–ª—å—Ç–∞—Ç—ã –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω—ã –≤ –∂—É—Ä–Ω–∞–ª–µ Osteoporosis International. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QRoAk #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–¢–µ—Ä–∞–ø–∏—è #–¢—Ä–∞–≤–º–∞—Ç–æ–ª–æ–≥–∏—è_–∏_–æ—Ä—Ç–æ–ø–µ–¥–∏—è","{""skip"": true}"
2025-11-20T16:43:01+00:00,@medpharm,13645,https://t.me/medpharm/13645,ü¶æ –ï—Å–ª–∏ –∑–≤–µ–∑–¥—ã –∑–∞–∂–∏–≥–∞—é—Ç. –í –†–æ—Å—Å–∏–∏ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ —Å–æ–∑–¥–∞—Ç—å —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã–π —Ä–µ–π—Ç–∏–Ω–≥ –ø–∞—Ü–∏–µ–Ω—Ç–æ–æ—Ä–∏–µ–Ω—Ç–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π. –ò–Ω–∏—Ü–∏–∞—Ç–∏–≤–∞ —Å–≤—è–∑–∞–Ω–∞ —Å —Ä–∞—Å—Ç—É—â–∏–º –∑–∞–ø—Ä–æ—Å–æ–º –æ–±—â–µ—Å—Ç–≤–∞ –Ω–∞ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏–µ –ø—Ä–æ–∑—Ä–∞—á–Ω–æ–π –∏ –æ–±—ä–µ–∫—Ç–∏–≤–Ω–æ–π —Å–∏—Å—Ç–µ–º—ã –æ—Ü–µ–Ω–∫–∏ –∫–∞—á–µ—Å—Ç–≤–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏. ü¶æ –ü–æ–±–µ–¥–∞ –∫–∞–ø–∏—Ç–∞–ª–∞. –ì–æ—Å–¥—É–º–∞ –†–§ –Ω–µ —Å—Ç–∞–ª–∞ –∏—Å–∫–ª—é—á–∞—Ç—å —Å—Ç—Ä–∞—Ö–æ–≤—ã–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –∏–∑ —Å–∏—Å—Ç–µ–º—ã –û–ú–°. ‚ù§Ô∏è –ù–µ –≤—Å–µ —Å—Ä–∞–∑—É. –ì–æ—Å–¥—É–º–∞ –†–§ –≤ —Ç—Ä–µ—Ç—å–µ–º —á—Ç–µ–Ω–∏–∏ –æ–¥–æ–±—Ä–∏–ª–∞ –ø–æ—ç—Ç–∞–ø–Ω–æ–µ —Å–Ω–∏–∂–µ–Ω–∏–µ –ø–æ—Ä–æ–≥–∞ –≤—ã—Ä—É—á–∫–∏ –º–∞–ª–æ–≥–æ –±–∏–∑–Ω–µ—Å–∞ –¥–ª—è –ø–µ—Ä–µ—Ö–æ–¥–∞ –Ω–∞ –æ–±—â–∏–π —Ä–µ–∂–∏–º –Ω–∞–ª–æ–≥–æ–æ–±–ª–æ–∂–µ–Ω–∏—è. ‚ù§Ô∏è –ï—Å—Ç—å –ø–æ–¥–æ–∑—Ä–µ–Ω–∏–µ. –§–ê–° –†–æ—Å—Å–∏–∏ –ø–æ–¥–æ–∑—Ä–µ–≤–∞–µ—Ç —á–µ—Ç—ã—Ä–µ –∫–æ–º–ø–∞–Ω–∏–∏ –≤ –∫–∞—Ä—Ç–µ–ª—å–Ω–æ–º —Å–≥–æ–≤–æ—Ä–µ –ø—Ä–∏ –ø–æ—Å—Ç–∞–≤–∫–µ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –º–µ–¥–∏–∑–¥–µ–ª–∏–π. –ù–∞—á–∞–ª–∞—Å—å –ø—Ä–æ–≤–µ—Ä–∫–∞.,"{""skip"": true}"
2025-11-20T15:33:02+00:00,@medpharm,13644,https://t.me/medpharm/13644,"–ò—Å–∫ ¬´–ö–æ—Ä–ø–æ—Ä–∞—Ü–∏–∏ —Ä–∞–∑–≤–∏—Ç–∏—è –ö—É—Ä—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏¬ª –æ –≤–∑—ã—Å–∫–∞–Ω–∏–∏ 54,9 –º–ª–Ω —Ä—É–±. —Å ¬´–ö—É—Ä—Å–∫–æ–π —Ñ–∞—Ä–º–∞—Ü–∏–∏¬ª –≤–æ–∑–≤—Ä–∞—â–µ–Ω –∏—Å—Ç—Ü—É. –ü—Ä–µ–¥–æ—Å—Ç–∞–≤–ª–µ–Ω–Ω—ã–µ –∏—Å—Ç—Ü–æ–º –¥–æ–∫—É–º–µ–Ω—Ç—ã —Å—É–¥ —Å—á–µ–ª –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω—ã–º–∏ –¥–ª—è –æ—Ç—Å—Ä–æ—á–∫–∏ –≥–æ—Å–ø–æ—à–ª–∏–Ω—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QRP4e #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{""skip"": true}"
2025-11-20T15:10:07+00:00,@medpharm,13643,https://t.me/medpharm/13643,"–ó–∞ –¥–≤–µ –Ω–µ–¥–µ–ª–∏ Eli Lilly –∑–∞–∫–ª—é—á–∏–ª–∞ —Ç—Ä–∏ —Å–æ–≥–ª–∞—à–µ–Ω–∏—è, –æ–±—â–∞—è —Å—É–º–º–∞ –∫–æ—Ç–æ—Ä—ã—Ö –ø—Ä–µ–≤—ã—Å–∏–ª–∞ 4 –º–ª—Ä–¥ –¥–æ–ª–ª. –°–¥–µ–ª–∫–∞ –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–π —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ —Å ABL Bio —Å—Ç–∞–ª–∞ –∫—Ä—É–ø–Ω–µ–π—à–µ–π –≤ –∏—Å—Ç–æ—Ä–∏–∏ –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π –æ—Ç—Ä–∞—Å–ª–∏ –Æ–∂–Ω–æ–π –ö–æ—Ä–µ–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QRMtv #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-11-20T14:36:03+00:00,@medpharm,13642,https://t.me/medpharm/13642,–ü—Ä–æ–µ–∫—Ç —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –±—é–¥–∂–µ—Ç–∞ –Ω–∞ 2026 –≥–æ–¥ –∏ –ø–ª–∞–Ω–æ–≤—ã–π –ø–µ—Ä–∏–æ–¥ 2027‚Äî2028 –≥–æ–¥–æ–≤ —É—Ç–≤–µ—Ä–∂–¥–µ–Ω –ì–æ—Å–¥—É–º–æ–π –†–§ –≤ —Ç—Ä–µ—Ç—å–µ–º —á—Ç–µ–Ω–∏–∏. –û–¥–æ–±—Ä–µ–Ω–æ –ø–æ—ç—Ç–∞–ø–Ω–æ–µ —Å–Ω–∏–∂–µ–Ω–∏–µ –ø–æ—Ä–æ–≥–∞ –≤—ã—Ä—É—á–∫–∏ –º–∞–ª–æ–≥–æ –±–∏–∑–Ω–µ—Å–∞ –¥–ª—è –ø–µ—Ä–µ—Ö–æ–¥–∞ –Ω–∞ –æ–±—â–∏–π —Ä–µ–∂–∏–º –Ω–∞–ª–æ–≥–æ–æ–±–ª–æ–∂–µ–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QRKxM #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{
  ""skip"": true,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The budget for 2026 and the planning period of 2027-2028 has been approved by the State Duma of Russia. A phased reduction in the revenue threshold for small businesses to switch to general tax accounting has been approved. More details: https://clck.ru/3QRKxM #PharmNews #Regulation""
}"
2025-11-20T14:08:05+00:00,@medpharm,13641,https://t.me/medpharm/13641,–§–ê–° –†–æ—Å—Å–∏–∏ –ø–æ–¥–æ–∑—Ä–µ–≤–∞–µ—Ç —á–µ—Ç—ã—Ä–µ –∫–æ–º–ø–∞–Ω–∏–∏ –≤ –∫–∞—Ä—Ç–µ–ª—å–Ω–æ–º —Å–≥–æ–≤–æ—Ä–µ –ø—Ä–∏ –ø–æ—Å—Ç–∞–≤–∫–µ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –º–µ–¥–∏–∑–¥–µ–ª–∏–π. –ó–∞–∫—É–ø–∫–∏ –ø—Ä–æ–≤–æ–¥–∏–ª–∏—Å—å –¥–ª—è –Ω—É–∂–¥ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏–π —Ä–µ–≥–∏–æ–Ω–æ–≤ —é–≥–∞ —Å—Ç—Ä–∞–Ω—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QRJFH #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, sanctions"",
  ""impact"": ""high"",
  ""english"": ""The FAS of Russia suspects four companies of cartel behavior in the supply of medicines and medical equipment. Procurements were conducted for regional healthcare institutions' needs. For more details: https://clck.ru/3QRJFH #MedNews #Healthcare #Other""
}"
2025-11-20T13:13:04+00:00,@medpharm,13640,https://t.me/medpharm/13640,"–ú–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏—è –¥–ª—è –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥–∞ –≥–ª—é–∫–æ–∑—ã –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –¥–æ–±–∞–≤–∏—Ç—å –≤ ¬´–±–µ–ª—ã–π —Å–ø–∏—Å–æ–∫¬ª, —á—Ç–æ–±—ã –æ–±–µ—Å–ø–µ—á–∏—Ç—å –∏—Ö —Ä–∞–±–æ—Ç—É –¥–∞–∂–µ –ø—Ä–∏ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–∏ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç–∞. –≠—Ç–æ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ –¥–ª—è –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ –¥–µ—Ç–µ–π —Å –¥–∏–∞–±–µ—Ç–æ–º, –æ—Ç–º–µ—á–∞—é—Ç –≤ —Ä–æ–¥–∏—Ç–µ–ª—å—Å–∫–æ–π –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QREYd #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The medical apps for glucose monitoring are proposing to add them to the 'white list' to ensure their functionality even without internet, which is necessary for the safety of children with diabetes, according to the parent organization.""
}"
2025-11-20T13:06:03+00:00,@medpharm,13639,https://t.me/medpharm/13639,"–ê–¥–º–∏–Ω–∏—Å—Ç—Ä–∞—Ü–∏—è –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç–∞ –°–®–ê –î–æ–Ω–∞–ª—å–¥–∞ –¢—Ä–∞–º–ø–∞ –ø—Ä–µ–∫—Ä–∞—Ç–∏–ª–∞ —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏–µ —Å–æ—Ç–µ–Ω –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å–ø—ã—Ç–∞–Ω–∏–π –≤ –°–®–ê ‚Äî –±–µ–∑ –æ—Ü–µ–Ω–∫–∏ –∏—Ö –Ω–∞—É—á–Ω–æ–π —Ü–µ–Ω–Ω–æ—Å—Ç–∏. –î–µ—Å—è—Ç–∫–∏ —Ç—ã—Å—è—á –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –ø–æ–ª—É—á–∏–ª–∏ —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–∞–ª—å–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, —Ä–∏—Å–∫—É—è –∑–¥–æ—Ä–æ–≤—å–µ–º, –Ω–æ –æ—Å—Ç–∞–ª–∏—Å—å –±–µ–∑ –≤—Ä–∞—á–µ–±–Ω–æ–≥–æ –Ω–∞–±–ª—é–¥–µ–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QRE5M #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-11-20T12:56:03+00:00,@medpharm,13638,https://t.me/medpharm/13638,"–í —Ä–∞–º–∫–∞—Ö –ø—Ä–æ–µ–∫—Ç–∞ ¬´Sun Pharma: –≥–∏–¥ –ø–æ –∫–∞—Ä—å–µ—Ä–µ¬ª ¬´–§–í¬ª –ø—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ—Ç –∏—Å—Ç–æ—Ä–∏–∏ —É—Å–ø–µ—Ö–∞, –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ —Ä–∞–∑–≤–∏—Ç–∏—è –∏ –∫–∞—Ä—å–µ—Ä–Ω–æ–≥–æ —Ä–æ—Å—Ç–∞ —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤ —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –ø–æ–¥—Ä–∞–∑–¥–µ–ª–µ–Ω–∏—è —ç—Ç–æ–π –∫—Ä—É–ø–Ω–æ–π –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–æ–π –∫–æ–º–ø–∞–Ω–∏–∏. –°–µ–≥–æ–¥–Ω—è—à–Ω–∏–π –≥–æ—Å—Ç—å ‚Äî —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω—ã–π –º–µ–Ω–µ–¥–∂–µ—Ä (–≥. –í–ª–∞–¥–∏–≤–æ—Å—Ç–æ–∫) –ê–ª–µ–Ω–∞ –í–∏–∫–∞—Ä—É–∫. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QRDM3 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫","{""skip"": true}"
2025-11-20T12:36:05+00:00,@medpharm,13636,https://t.me/medpharm/13636,"–ì–æ—Å–¥—É–º–∞ –†–§ –ø—Ä–∏–Ω—è–ª–∞ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ –±—é–¥–∂–µ—Ç–µ –§–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ —Ñ–æ–Ω–¥–∞ –û–ú–° –Ω–∞ –±–ª–∏–∂–∞–π—à—É—é —Ç—Ä–µ—Ö–ª–µ—Ç–∫—É. –û–±—ä–µ–º —Ä–∞—Å—Ö–æ–¥–æ–≤ –§–û–ú–° –≤ 2027 –≥–æ–¥—É –≤–ø–µ—Ä–≤—ã–µ –ø—Ä–µ–≤—ã—Å–∏—Ç 5 —Ç—Ä–ª–Ω —Ä—É–±–ª–µ–π, –Ω–æ —Å–∞–º –±—é–¥–∂–µ—Ç –∑–∞–ø–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω —Å –¥–µ—Ñ–∏—Ü–∏—Ç–æ–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QRBws #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The State Duma of Russia has approved a budget project for the Federal Health Fund for the next three years. Expenditures of the FOMS are expected to exceed 5 trillion rubles in 2027, but the budget is planned with a deficit.""
}"
2025-11-20T12:12:20+00:00,@medpharm,13635,https://t.me/medpharm/13635,–í –†–æ—Å—Å–∏–∏ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ —Å–æ–∑–¥–∞—Ç—å —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã–π —Ä–µ–π—Ç–∏–Ω–≥ –ø–∞—Ü–∏–µ–Ω—Ç–æ–æ—Ä–∏–µ–Ω—Ç–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π. –ò–Ω–∏—Ü–∏–∞—Ç–∏–≤–∞ —Å–≤—è–∑–∞–Ω–∞ —Å —Ä–∞—Å—Ç—É—â–∏–º –∑–∞–ø—Ä–æ—Å–æ–º –æ–±—â–µ—Å—Ç–≤–∞ –Ω–∞ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏–µ –ø—Ä–æ–∑—Ä–∞—á–Ω–æ–π –∏ –æ–±—ä–µ–∫—Ç–∏–≤–Ω–æ–π —Å–∏—Å—Ç–µ–º—ã –æ—Ü–µ–Ω–∫–∏ –∫–∞—á–µ—Å—Ç–≤–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QRAEL #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""A proposal has been made in Russia to create a federal rating system for patient-oriented medical organizations. The initiative is linked to growing public demand for the formation of a transparent and objective system for evaluating healthcare quality. For more details: https://clck.ru/3QRAEL #MedNews #Healthcare #HealthOrganization""
}"
2025-11-20T12:03:02+00:00,@medpharm,13634,https://t.me/medpharm/13634,–§–ê–° –†–æ—Å—Å–∏–∏ –≤—ã—è–≤–∏–ª–∞ –∫–∞—Ä—Ç–µ–ª—å–Ω—ã–π —Å–≥–æ–≤–æ—Ä —Å—Ä–µ–¥–∏ –ø–æ—Å—Ç–∞–≤—â–∏–∫–æ–≤ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –º–µ–¥–∏–∑–¥–µ–ª–∏–π –≤ –ö—Ä–∞—Å–Ω–æ–¥–∞—Ä—Å–∫–æ–º –∫—Ä–∞–µ. –í —Å–ø–∏—Å–∫–µ –ø–æ–¥–æ–∑—Ä–µ–≤–∞–µ–º—ã—Ö —á–µ—Ç—ã—Ä–µ –∫–æ–º–ø–∞–Ω–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QR9ah #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è,"{""skip"": true}"
2025-11-20T11:26:03+00:00,@medpharm,13633,https://t.me/medpharm/13633,–í –°–∞–º–∞—Ä—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –≤—ã—è–≤–ª–µ–Ω—ã —Å–ª—É—á–∞–∏ –æ–ø–ª–∞—Ç—ã –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –∏–∑ —Å—Ä–µ–¥—Å—Ç–≤ –û–ú–° –ø–æ—Å–ª–µ —Å–º–µ—Ä—Ç–∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –∏ –ª–µ—á–µ–Ω–∏—è –ø—Ä–∏–∑–≤–∞–Ω–Ω—ã—Ö –≤ –∞—Ä–º–∏—é –≥—Ä–∞–∂–¥–∞–Ω. –í–ª–∞—Å—Ç–∏ –∏–Ω–∏—Ü–∏–∏—Ä–æ–≤–∞–ª–∏ –ø—Ä–æ–≤–µ—Ä–∫–∏ –∏ –ø–ª–∞–Ω–∏—Ä—É—é—Ç –ø—Ä–∏–≤–ª–µ—á—å –≤–∏–Ω–æ–≤–Ω—ã—Ö –∫ –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QR6y4 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""Health authorities in Samara region are investigating cases where medical assistance was paid from OMS funds after patients' deaths and treatment of conscripts. Authorities plan to hold perpetrators accountable.""
}"
2025-11-20T10:55:03+00:00,@medpharm,13632,https://t.me/medpharm/13632,"–£—Ç–≤–µ—Ä–∂–¥–µ–Ω–∞ –Ω–æ–≤–∞—è —Å—Ö–µ–º–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω–æ–≥–æ –ø–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω–∏—è –≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–∏. –û–ø—Ä–µ–¥–µ–ª–µ–Ω—ã —Ä–µ–≥–∏–æ–Ω—ã, –≥–¥–µ –ø–æ—è–≤—è—Ç—Å—è –≤—ã—Å–æ–∫–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–Ω—ã–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –¥–ª—è —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –∏ –≤—ã–ø—É—Å–∫–∞ –≥–µ–Ω–æ—Ç–µ—Ä–∞–ø–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö, –∫–ª–µ—Ç–æ—á–Ω—ã—Ö –∏ —Ä–∞–¥–∏–æ—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QR4s6 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": true
}"
2025-11-20T10:23:11+00:00,@medpharm,13631,https://t.me/medpharm/13631,–í–û–ó –∫ –∏—é–Ω—é 2026 –≥–æ–¥–∞ —Å–æ–∫—Ä–∞—Ç–∏—Ç —à—Ç–∞—Ç —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤ –ø–æ—á—Ç–∏ –Ω–∞ —á–µ—Ç–≤–µ—Ä—Ç—å. –û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è —Å—Ç–∞–ª–∫–∏–≤–∞–µ—Ç—Å—è —Å –¥–µ—Ñ–∏—Ü–∏—Ç–æ–º –±—é–¥–∂–µ—Ç–∞ –æ–∫–æ–ª–æ 1 –º–ª—Ä–¥ –¥–æ–ª–ª–∞—Ä–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QR2dy #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-11-20T09:21:06+00:00,@medpharm,13630,https://t.me/medpharm/13630,"–í–û–ó –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∞ –ø–µ—Ä–≤—ã–µ –≥–ª–æ–±–∞–ª—å–Ω—ã–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø–æ –≤–µ–¥–µ–Ω–∏—é –¥–∏–∞–±–µ—Ç–∞ –≤–æ –≤—Ä–µ–º—è –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏. –î–æ–∫—É–º–µ–Ω—Ç, –ø—Ä–∏—É—Ä–æ—á–µ–Ω–Ω—ã–π –∫ –í—Å–µ–º–∏—Ä–Ω–æ–º—É –¥–Ω—é –±–æ—Ä—å–±—ã —Å –¥–∏–∞–±–µ—Ç–æ–º, –æ–ø–∏—Å—ã–≤–∞–µ—Ç –µ–¥–∏–Ω—ã–π –ø–æ–¥—Ö–æ–¥ –∫ —É—Ö–æ–¥—É, –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥—É –∏ –ª–µ—á–µ–Ω–∏—é –∂–µ–Ω—â–∏–Ω —Å –¥–∏–∞–±–µ—Ç–æ–º 1-–≥–æ, 2-–≥–æ —Ç–∏–ø–∞ –∏ –≥–µ—Å—Ç–∞—Ü–∏–æ–Ω–Ω—ã–º –¥–∏–∞–±–µ—Ç–æ–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QQwRY #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ê–∫—É—à–µ—Ä—Å—Ç–≤–æ_–∏_–≥–∏–Ω–µ–∫–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–≠–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-11-20T08:58:03+00:00,@medpharm,13629,https://t.me/medpharm/13629,"–¶–µ–Ω—Ç—Ä –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –ø—Ä–∏–Ω–∏–º–∞–µ—Ç –∑–∞—è–≤–∫–∏ –Ω–∞ —É—á–∞—Å—Ç–∏–µ –≤ 25 –∞—É–∫—Ü–∏–æ–Ω–∞—Ö –Ω–∞ –ø–æ—Å—Ç–∞–≤–∫—É –ø–æ –ø—Ä–æ–≥—Ä–∞–º–º–µ –í–ó–ù –≥–µ–º–æ—Å—Ç–∞—Ç–∏–∫–æ–≤, –∏–º–º—É–Ω–æ–º–æ–¥—É–ª—è—Ç–æ—Ä–æ–≤, –ø—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤, –∞ —Ç–∞–∫–∂–µ —Ñ–µ—Ä–º–µ–Ω—Ç–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏–¥—É—Ä—Å—É–ª—å—Ñ–∞–∑–∞ –∏ –∏–¥—É—Ä—Å—É–ª—å—Ñ–∞–∑–∞ –±–µ—Ç–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QQugK #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""high"",
  ""english"": ""The Central Pharmacy Authority is accepting applications for participation in 25 auctions to supply drugs under the VZN program, including hemostatics, immunomodulators, anticancer medications, and enzymes. For more details: https://clck.ru/3QQugK""
}"
2025-11-20T08:18:04+00:00,@medpharm,13628,https://t.me/medpharm/13628,"–î–µ–ø—É—Ç–∞—Ç—ã –≤—ã—Å—Ç—É–ø–∏–ª–∏ —Å –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–æ–π –æ–±—è–∑–∞—Ç—å –≤—Å–µ—Ö –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã—Ö —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –≤ –†–æ—Å—Å–∏–∏ –µ–∂–µ–≥–æ–¥–Ω–æ –æ—Ñ–æ—Ä–º–ª—è—Ç—å –ø–æ–ª–∏—Å –î–ú–°, –∞ 50% —Å—Ä–µ–¥—Å—Ç–≤ –æ—Ç –µ–≥–æ –ø—Ä–æ–¥–∞–∂–∏ –Ω–∞–ø—Ä–∞–≤–ª—è—Ç—å –≤ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã–π —Ñ–æ–Ω–¥ –¥–ª—è –ø–æ–¥–¥–µ—Ä–∂–∫–∏ –∏–ø–æ—Ç–µ—á–Ω–æ–π –ø—Ä–æ–≥—Ä–∞–º–º—ã –¥–ª—è –≤—Ä–∞—á–µ–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QQriG #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""Deputies proposed a requirement for all foreign workers in Russia to annually obtain a health insurance policy, and 50% of the proceeds from its sale to be directed towards a federal fund for supporting an affordable housing program for doctors.""
}"
2025-11-20T07:52:03+00:00,@medpharm,13627,https://t.me/medpharm/13627,–£–§–ê–° –ø–æ –¢–≤–µ—Ä—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –≤–æ–∑–±—É–¥–∏–ª–æ –¥–µ–ª–æ –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ ¬´–ó–¥—Ä–∞–≤–°–∏—Ç–∏¬ª. –ü–æ–≤–æ–¥–æ–º —Å—Ç–∞–ª–∞ —Ä–µ–∫–ª–∞–º–∞ –Ω–∞ —Ç–µ–ª–µ–≤–∏–¥–µ–Ω–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ:https://clck.ru/3QQpnz #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞,"{""skip"": true}"
2025-11-20T07:13:05+00:00,@medpharm,13626,https://t.me/medpharm/13626,"–°–æ–∑–¥–∞–Ω –∞–ª–≥–æ—Ä–∏—Ç–º, –∫–æ—Ç–æ—Ä—ã–π –æ—Ü–µ–Ω–∏–≤–∞–µ—Ç –ø—Ä–æ—è–≤–ª–µ–Ω–∏—è —Ç—Ä–µ–≤–æ–∂–Ω–æ—Å—Ç–∏, –¥–µ–ø—Ä–µ—Å—Å–∏–∏, –ü–¢–°–†, —Å—É–∏—Ü–∏–¥–∞–ª—å–Ω—ã—Ö –Ω–∞–∫–ª–æ–Ω–Ω–æ—Å—Ç–µ–π –∏ —Ä–∞—Å—Å—Ç—Ä–æ–π—Å—Ç–≤–∞ –ª–∏—á–Ω–æ—Å—Ç–∏ –ø–æ 91 –ø–∞—Ä–∞–º–µ—Ç—Ä—É. –ü—Ä–æ–≥—Ä–∞–º–º–∞ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–∞ –≤ –†–æ—Å–ø–∞—Ç–µ–Ω—Ç–µ –∏ –¥–æ—Å—Ç—É–ø–Ω–∞ –±–µ—Å–ø–ª–∞—Ç–Ω–æ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QQnH4 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–î–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞ #–ü—Å–∏—Ö–∏–∞—Ç—Ä–∏—è","{""skip"": true}"
2025-11-20T06:06:05+00:00,@medpharm,13625,https://t.me/medpharm/13625,"–°—Ç–æ–º–∞—Ç–æ–ª–æ–≥-—Ö–∏—Ä—É—Ä–≥ –∏–∑ –ï–∫–∞—Ç–µ—Ä–∏–Ω–±—É—Ä–≥–∞ –≤ —Ç–µ—á–µ–Ω–∏–∏ –¥–≤—É—Ö –Ω–µ–¥–µ–ª—å –æ–±—ä–µ–∑–¥–∏–ª –°–≤–µ—Ä–¥–ª–æ–≤—Å–∫—É—é –æ–±–ª–∞—Å—Ç—å –Ω–∞ –ª–∏—á–Ω–æ–º –∞–≤—Ç–æ–º–æ–±–∏–ª–µ –∏ –≤ —ç–ª–µ–∫—Ç—Ä–∏—á–∫–∞—Ö –≤ –ø–æ–ø—ã—Ç–∫–∞—Ö —É—Å—Ç—Ä–æ–∏—Ç—å—Å—è –Ω–∞ —Ä–∞–±–æ—Ç—É –ø–æ –≥–æ—Å–ø—Ä–æ–≥—Ä–∞–º–º–µ ¬´–ó–µ–º—Å–∫–∏–π –¥–æ–∫—Ç–æ—Ä¬ª. –ö–∞–¥—Ä–æ–≤–∏–∫–∏ –∏ –≥–ª–∞–≤–Ω—ã–µ –≤—Ä–∞—á–∏ –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–∞–ª–∏ –Ω–∞–ª–∏—á–∏–µ –≤–∞–∫–∞–Ω—Å–∏–π, –Ω–æ –∫–æ–≥–¥–∞ —Ä–µ—á—å –∑–∞—Ö–æ–¥–∏–ª–∞ –æ –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏—è—Ö –∏ –≤—ã–ø–ª–∞—Ç–∞—Ö, –æ—Ç–∫–∞–∑—ã–≤–∞–ª–∏—Å—å –æ—Ç —Å–≤–æ–∏—Ö —Å–ª–æ–≤ –∏–ª–∏ –ø–µ—Ä–µ—Å—Ç–∞–≤–∞–ª–∏ –≤—ã—Ö–æ–¥–∏—Ç—å –Ω–∞ —Å–≤—è–∑—å –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QQgpa #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""tenders, shortage"",
  ""impact"": ""medium"",
  ""english"": ""A dentist-hygienist in Ekaterinburg has been traveling through Sverdlovsk region on his own car and train for two weeks trying to get a job under the 'Village Doctor' program. Recruitment officials and head doctors confirmed vacancies, but refused to discuss compensation and benefits or stopped responding when the topic of payments came up.""
}"
2025-11-19T16:41:30+00:00,@medpharm,13624,https://t.me/medpharm/13624,"ü¶æ –¢–æ—á–∫–∞ –æ—Ç—Å—á–µ—Ç–∞. –†—è–¥ telegram-–∫–∞–Ω–∞–ª–æ–≤ –ø–æ—Å–ø–µ—à–∏–ª–∏ —Å–æ–æ–±—â–∏—Ç—å –æ –º–∞—Å—Å–æ–≤—ã—Ö –æ—Ç—á–∏—Å–ª–µ–Ω–∏—è—Ö —Å—Ç—É–¥–µ–Ω—Ç–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –≤—É–∑–æ–≤ –∏–∑-–∑–∞ –ø—Ä–∏–Ω—è—Ç–∏—è –ø–æ–ø—Ä–∞–≤–æ–∫ –≤ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–æ –æ —Ç—Ä–µ—Ö–ª–µ—Ç–Ω–µ–º –ø–µ—Ä–∏–æ–¥–µ –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–∞ –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤. –û—Ñ–∏—Ü–∏–∞–ª—å–Ω–æ–≥–æ –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏—è —ç—Ç–æ–π –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –Ω–µ—Ç, –∞ –≤ –ø—Ä–µ—Å—Å-—Å–ª—É–∂–±–µ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–§ –∑–∞—è–≤–∏–ª–∏, —á—Ç–æ –æ–Ω–∞ –Ω–µ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É–µ—Ç –¥–µ–π—Å—Ç–≤–∏—Ç–µ–ª—å–Ω–æ—Å—Ç–∏. ü¶æ –ü–ª–∞–Ω–æ–≤ –≥—Ä–æ–º–∞–¥—å–µ. –£—Ç–≤–µ—Ä–∂–¥–µ–Ω–∞ –Ω–æ–≤–∞—è —Å—Ö–µ–º–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω–æ–≥–æ –ø–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω–∏—è –≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–∏. –í –Ω–µ–µ –≤–æ—à–ª–∏ 136 –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ–±—ä–µ–∫—Ç–æ–≤ –¥–ª—è —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –∏ —Ä–µ–∫–æ–Ω—Å—Ç—Ä—É–∫—Ü–∏–∏, –≤–∫–ª—é—á–∞—è –∫—Ä—É–ø–Ω—ã–µ –±–æ–ª—å–Ω–∏—Ü—ã –∏ –Ω–∞—É—á–Ω–æ-–∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–∏–µ —Ü–µ–Ω—Ç—Ä—ã –ø–æ –≤—Å–µ–π –†–æ—Å—Å–∏–∏. ‚ù§Ô∏è –í—ã—à–ª–∏ –∏–∑ —Ç–µ–Ω–∏. –ß–∏—Å–ª–æ –ª–µ–≥–∞–ª—å–Ω—ã—Ö –∏–º–ø–æ—Ä—Ç–µ—Ä–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –ø–µ—Ä—á–∞—Ç–æ–∫ –≤—ã—Ä–æ—Å–ª–æ –≤ –¥–≤–∞ —Ä–∞–∑–∞. –ó–∞ –≤—Ä–µ–º—è –¥–µ–π—Å—Ç–≤–∏—è –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏ –≤–≤–µ–¥–µ–Ω–æ –≤ –æ–±–æ—Ä–æ—Ç –±–æ–ª–µ–µ 40 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ –º–∞—Ä–∫–∏—Ä–æ–≤–∞–Ω–Ω–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏. –í ¬´–ß–µ—Å—Ç–Ω–æ–º –∑–Ω–∞–∫–µ¬ª —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏ –æ –ø—Ä–æ–º–µ–∂—É—Ç–æ—á–Ω—ã—Ö –∏—Ç–æ–≥–∞—Ö —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–∞ –ø–æ –º–∞—Ä–∫–∏—Ä–æ–≤–∫–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –ø–µ—Ä—á–∞—Ç–æ–∫. ‚ù§Ô∏è –ù–∞—á–∞—Ç—å —Å —Å–µ–±—è. –ö–∞–¥—Ä–æ–≤—ã–π –ø—Ä–æ–≤–∞–ª. –ü—Ä–æ–±–ª–µ–º—ã —Å –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–µ–π —Ñ–∞—Ä–º—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –≤ –æ—Å–Ω–æ–≤–Ω–æ–º –≤—ã–∑–≤–∞–Ω—ã –æ—à–∏–±–∫–∞–º–∏ –∫–∞–¥—Ä–æ–≤—ã—Ö —Å–ª—É–∂–± –∞–ø—Ç–µ–∫, —Å—á–∏—Ç–∞–µ—Ç —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å –§–ê–¶. –ö–∞–∫–æ–π –≤—ã—Ö–æ–¥ –∏–∑ —ç—Ç–æ–π –ø—Ä–æ–±–ª–µ–º—ã –≤–∏–¥—è—Ç —ç–∫—Å–ø–µ—Ä—Ç—ã?","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, hospital_policy, guideline, pharmacovigilance"",
  ""impact"": ""medium"",
  ""english"": ""There are concerns about the implementation of new training periods for medical professionals, which could affect healthcare planning. The increase in legal importers of medical gloves and the successful implementation of traceability for these products are positive developments. Issues with pharmacist accreditation are attributed to errors made by pharmacy personnel departments.""
}"
2025-11-19T16:09:03+00:00,@medpharm,13623,https://t.me/medpharm/13623,–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ —É—Ç–≤–µ—Ä–¥–∏–ª–æ –ø—Ä–∞–≤–∏–ª–∞ –¥–ª—è –ø–æ–ª—É—á–µ–Ω–∏—è –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–≥–æ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ —Å—É–±—Å–∏–¥–∏—Ä–æ–≤–∞–Ω–∏—è –¥–ª—è –∑–∞–∫—É–ø–∫–∏ –¥–æ—Ä–æ–≥–æ—Å—Ç–æ—è—â–∏—Ö –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –†–µ–≥–∏–æ–Ω –¥–æ–ª–∂–µ–Ω —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–æ–≤–∞—Ç—å —á–µ—Ç—ã—Ä–µ–º –∫—Ä–∏—Ç–µ—Ä–∏—è–º –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QQM5b #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The government approved rules for obtaining additional federal subsidies to procure expensive orphan drugs. The region must meet four criteria. More details: https://clck.ru/3QQM5b #PharmNews #Regulation""
}"
2025-11-19T15:29:06+00:00,@medpharm,13622,https://t.me/medpharm/13622,"–í—Ä–µ–º—è –º–æ—Å–∫–æ–≤—Å–∫–∏—Ö –≤—Ä–∞—á–µ–π —ç–∫–æ–Ω–æ–º–∏—Ç —Å–∏—Å—Ç–µ–º–∞ ¬´—É–º–Ω–æ–≥–æ –ø—Ä–∏–µ–º–∞¬ª. –ü–∞—Ü–∏–µ–Ω—Ç—ã –ø—Ä–∏ –æ–Ω–ª–∞–π–Ω-–∑–∞–ø–∏—Å–∏ –ø—Ä–æ—Ö–æ–¥—è—Ç –∫–æ—Ä–æ—Ç–∫–∏–π –æ–ø—Ä–æ—Å —Å —É—Ç–æ—á–Ω–µ–Ω–∏–µ–º –∂–∞–ª–æ–±, –¥–∞–Ω–Ω—ã–µ –∫–æ—Ç–æ—Ä–æ–≥–æ –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω—ã–π –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç –∞–Ω–∞–ª–∏–∑–∏—Ä—É–µ—Ç –∏ —Ñ–æ—Ä–º–∏—Ä—É–µ—Ç –ø—Ä–µ–¥–≤–∞—Ä–∏—Ç–µ–ª—å–Ω—ã–µ –¥–∏–∞–≥–Ω–æ–∑—ã –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QQJyN #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""The system 'Smart Scheduling' saves Moscow doctors' time. Patients complete a short questionnaire online, which is analyzed by artificial intelligence to form preliminary diagnoses.""
}"
2025-11-19T15:29:02+00:00,@medpharm,13621,https://t.me/medpharm/13621,"J&J –ø–æ–ª—É—á–∏—Ç –∑–∞ 3 –º–ª—Ä–¥ –¥–æ–ª–ª. –Ω–æ–≤—ã–µ –ø—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤—ã–µ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏. –§–∞—Ä–º–≥–∏–≥–∞–Ω—Ç —Ä–µ—à–∏–ª –∫—É–ø–∏—Ç—å –∫–æ–º–ø–∞–Ω–∏—é, –æ—Å–Ω–æ–≤–∞–Ω–Ω—É—é –ø—Ä–æ—Ñ–µ—Å—Å–æ—Ä–æ–º –ô–µ–ª—å—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞. –ò–º —É–¥–∞–ª–æ—Å—å —Ä–∞–∑—Ä–∞–±–æ—Ç–∞—Ç—å —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—é —Å–∞–º–æ—É–Ω–∏—á—Ç–æ–∂–µ–Ω–∏—è —Ä–∞–∫–æ–≤—ã—Ö –∫–ª–µ—Ç–æ–∫. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QQJyP #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-11-19T15:11:02+00:00,@medpharm,13620,https://t.me/medpharm/13620,–ö–æ–ª–∏—á–µ—Å—Ç–≤–æ –ª–µ–≥–∞–ª—å–Ω—ã—Ö –∏–º–ø–æ—Ä—Ç–µ—Ä–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –ø–µ—Ä—á–∞—Ç–æ–∫ —É–≤–µ–ª–∏—á–∏–ª–æ—Å—å –≤ –¥–≤–∞ —Ä–∞–∑–∞. –ó–∞ –ø–µ—Ä–∏–æ–¥ –¥–µ–π—Å—Ç–≤–∏—è –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏ —É–∂–µ –≤–≤–µ–¥–µ–Ω–æ –≤ –æ–±–æ—Ä–æ—Ç –±–æ–ª–µ–µ 40 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ –º–∞—Ä–∫–∏—Ä–æ–≤–∞–Ω–Ω–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏. –í ¬´–ß–µ—Å—Ç–Ω–æ–º –∑–Ω–∞–∫–µ¬ª —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏ –æ –ø—Ä–æ–º–µ–∂—É—Ç–æ—á–Ω—ã—Ö –∏—Ç–æ–≥–∞—Ö —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–∞ –ø–æ –º–∞—Ä–∫–∏—Ä–æ–≤–∫–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –ø–µ—Ä—á–∞—Ç–æ–∫ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QQJ2P #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The number of legal importers of medical gloves has doubled. During the period of labeling, more than 40 million packages of labeled products have been put into circulation. 'Ehstnyi Znak' reported on the interim results of the experiment on labeling medical gloves. For more details: https://clck.ru/3QQJ2P #PharmVestnik #Production""
}"
2025-11-19T13:58:03+00:00,@medpharm,13619,https://t.me/medpharm/13619,"–ü—Ä–æ–±–ª–µ–º—ã —Å –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–µ–π —Ñ–∞—Ä–º—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –≤ –æ—Å–Ω–æ–≤–Ω–æ–º –≤—ã–∑–≤–∞–Ω—ã –æ—à–∏–±–∫–∞–º–∏ –∫–∞–¥—Ä–æ–≤—ã—Ö —Å–ª—É–∂–± –∞–ø—Ç–µ–∫, —Å—á–∏—Ç–∞–µ—Ç —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å –§–ê–¶. –ö–∞–∫–æ–π –≤—ã—Ö–æ–¥ –∏–∑ —ç—Ç–æ–π –ø—Ä–æ–±–ª–µ–º—ã –≤–∏–¥—è—Ç —ç–∫—Å–ø–µ—Ä—Ç—ã? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QQDZm #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–∞—Ä—å–µ—Ä–∞","{""skip"": true}"
2025-11-19T13:08:08+00:00,@medpharm,13618,https://t.me/medpharm/13618,"–†—è–¥ telegram-–∫–∞–Ω–∞–ª–æ–≤ –ø–æ—Å–ø–µ—à–∏–ª–∏ —Å–æ–æ–±—â–∏—Ç—å –æ –º–∞—Å—Å–æ–≤—ã—Ö –æ—Ç—á–∏—Å–ª–µ–Ω–∏—è—Ö —Å—Ç—É–¥–µ–Ω—Ç–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –≤—É–∑–æ–≤ –∏–∑-–∑–∞ –ø—Ä–∏–Ω—è—Ç–∏—è –ø–æ–ø—Ä–∞–≤–æ–∫ –≤ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–æ –æ —Ç—Ä–µ—Ö–ª–µ—Ç–Ω–µ–º –ø–µ—Ä–∏–æ–¥–µ –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–∞ –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤. –û—Ñ–∏—Ü–∏–∞–ª—å–Ω–æ–≥–æ –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏—è —ç—Ç–æ–π –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –Ω–µ—Ç, –∞ –≤ –ø—Ä–µ—Å—Å-—Å–ª—É–∂–±–µ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–§ –∑–∞—è–≤–∏–ª–∏, —á—Ç–æ –æ–Ω–∞ –Ω–µ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É–µ—Ç –¥–µ–π—Å—Ç–≤–∏—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QQAAR #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–û–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": true
}"
2025-11-19T12:32:03+00:00,@medpharm,13617,https://t.me/medpharm/13617,–ï–° –∑–∞–∫—É–ø–∏–ª —É –†–æ—Å—Å–∏–∏ —Ñ–∞—Ä–º–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ —Ä–µ–∫–æ—Ä–¥–Ω—É—é —Å—É–º–º—É —Å –¥–µ–∫–∞–±—Ä—è 2020 –≥–æ–¥–∞. –ö–∞–∫–∏–µ —Å—Ç—Ä–∞–Ω—ã —Å—Ç–∞–ª–∏ –æ—Å–Ω–æ–≤–Ω—ã–º–∏ –ø–æ–∫—É–ø–∞—Ç–µ–ª—è–º–∏? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QQ7h8 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è,"{""skip"": true}"
2025-11-19T12:26:16+00:00,@medpharm,13616,https://t.me/medpharm/13616,–£—á–µ–Ω—ã–µ –∏–∑ –ö–µ–º–±—Ä–∏–¥–∂—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ –∏ –®–∞–Ω—Ö–∞–π—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ –¶–∑—è–æ—Ç—É–Ω –ø—Ä–æ–≤–µ–ª–∏ –ø–µ—Ä–≤–æ–µ –∫—Ä—É–ø–Ω–æ–µ –∏—Å–ø—ã—Ç–∞–Ω–∏–µ –≥–ª—É–±–æ–∫–æ–π —Å—Ç–∏–º—É–ª—è—Ü–∏–∏ –º–æ–∑–≥–∞ –ø—Ä–∏ —Ç—è–∂–µ–ª–æ–π —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–æ–π –¥–µ–ø—Ä–µ—Å—Å–∏–∏. –†–µ–∑—É–ª—å—Ç–∞—Ç—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω—ã –≤ –∂—É—Ä–Ω–∞–ª–µ Nature Communications –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QQ7Gk #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ù–µ–≤—Ä–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è,"{""skip"": true}"
2025-11-19T11:24:05+00:00,@medpharm,13615,https://t.me/medpharm/13615,"–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§ —É—Ç–≤–µ—Ä–¥–∏–ª–æ –Ω–æ–≤—É—é —Å—Ö–µ–º—É —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω–æ–≥–æ –ø–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω–∏—è –≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–∏. –í –Ω–µ–µ –≤–æ—à–ª–∏ 136 –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ–±—ä–µ–∫—Ç–æ–≤ –¥–ª—è —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –∏ —Ä–µ–∫–æ–Ω—Å—Ç—Ä—É–∫—Ü–∏–∏, –≤–∫–ª—é—á–∞—è –∫—Ä—É–ø–Ω—ã–µ –±–æ–ª—å–Ω–∏—Ü—ã –∏ –Ω–∞—É—á–Ω–æ-–∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–∏–µ —Ü–µ–Ω—Ç—Ä—ã –ø–æ –≤—Å–µ–π –†–æ—Å—Å–∏–∏ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QQ2uM #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-11-19T11:12:03+00:00,@medpharm,13614,https://t.me/medpharm/13614,"–£—Ç–≤–µ—Ä–∂–¥–µ–Ω—ã –∫—Ä–∏—Ç–µ—Ä–∏–∏ –¥–ª—è –±–ª–æ–∫–∏—Ä–æ–≤–∫–∏ —Å–∞–π—Ç–æ–≤, —á–µ—Ä–µ–∑ –∫–æ—Ç–æ—Ä—ã–µ –Ω–µ–∑–∞–∫–æ–Ω–Ω–æ —Ç–æ—Ä–≥—É—é—Ç –±–∏–æ–¥–æ–±–∞–≤–∫–∞–º–∏. –†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä –≤—ã–¥–µ–ª–∏–ª —á–µ—Ç—ã—Ä–µ —É—Å–ª–æ–≤–∏—è –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QQ2Ag #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{""skip"": false, ""country"": ""global"", ""topic"": ""sanctions"", ""impact"": ""high"", ""english"": ""The Rospatent has outlined four conditions for blocking websites where illegal trade in dietary supplements occurs. More details: https://clck.ru/3QQ2Ag #FarmaVestnik #Regulatorka""}"
2025-11-19T10:32:04+00:00,@medpharm,13613,https://t.me/medpharm/13613,–ó–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å –≥–ª–∞–≤–≤—Ä–∞—á–∞ –≤–æ –í–ª–∞–¥–∏–≤–æ—Å—Ç–æ–∫–µ –º–æ–∂–µ—Ç –ø–æ–ª—É—á–∞—Ç—å –æ—Ç 230 —Ç—ã—Å. —Ä—É–±. –í –Ω–æ—è–±—Ä–µ –≤–∞–∫–∞–Ω—Å–∏–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –≤–æ—à–ª–∏ –≤ –¢–û–† –Ω–∞–∏–±–æ–ª–µ–µ –≤—ã—Å–æ–∫–æ–æ–ø–ª–∞—á–∏–≤–∞–µ–º—ã—Ö –≤ —á–µ—Ç—ã—Ä–µ—Ö –≥–æ—Ä–æ–¥–∞—Ö –∏–∑ 15. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QPxMb #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-11-19T09:45:03+00:00,@medpharm,13612,https://t.me/medpharm/13612,"–¶–µ–Ω—Ç—Ä –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –ø—Ä–æ–≤–æ–¥–∏—Ç –ø—Ä–∏–µ–º –∑–∞—è–≤–æ–∫ –Ω–∞ —É—á–∞—Å—Ç–∏–µ –≤ –∞—É–∫—Ü–∏–æ–Ω–∞—Ö –Ω–∞ –ø–æ—Å—Ç–∞–≤–∫—É –¥–ª—è ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —ç–≤–µ—Ä–æ–ª–∏–º—É—Å, –ø–∞–ª–æ–≤–∞—Ä–æ—Ç–µ–Ω, –æ–ª–∏–ø—É–¥–∞–∑–∞ –∞–ª—å—Ñ–∞, –∞—Å—Ñ–æ—Ç–∞–∑–∞ –∞–ª—å—Ñ–∞, –∞ —Ç–∞–∫–∂–µ –≤–∏–ª—Ç–æ–ª–∞—Ä—Å–µ–Ω, –∑–∞ –∫–æ—Ç–æ—Ä—ã–π –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –∑–∞–ø–ª–∞—Ç–∏—Ç—å 2,7 –º–ª—Ä–¥ —Ä—É–±. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QPtot #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""high"",
  ""english"": ""The pharmaceutical distribution center is accepting applications for participation in tenders to supply the 'Circle of Good' drugs everolimus, palovaroten, olipudazalfa, asfotazalfa, and vilortasen. The tender is expected to cost 2.7 billion rubles. For more information: https://clck.ru/3QPtot #PharmNews #Distribution""
}"
2025-11-19T09:38:04+00:00,@medpharm,13611,https://t.me/medpharm/13611,"–ë–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ —Ü–µ–ª–µ–π, –ø–æ—Å—Ç–∞–≤–ª–µ–Ω–Ω—ã—Ö –Ω–∞ –æ–∫—Ç—è–±—Ä—å 2025 –≥–æ–¥–∞, –ø–æ –ø–æ–≤—ã—à–µ–Ω–∏—é —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–Ω–æ—Å—Ç–∏ –∑–¥–æ—Ä–æ–≤–æ–≥–æ –æ–±—Ä–∞–∑–∞ –∂–∏–∑–Ω–∏ —Å—Ä–µ–¥–∏ —Ä–æ—Å—Å–∏—è–Ω, –±—ã–ª–∏ –≤—ã–ø–æ–ª–Ω–µ–Ω—ã. –ù–µ —É–¥–∞–ª–æ—Å—å –¥–æ—Å—Ç–∏—á—å —Ç–æ–ª—å–∫–æ –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è –æ—Ö–≤–∞—Ç–∞ –¥–∏—Å–ø–∞–Ω—Å–µ—Ä–Ω—ã–º –Ω–∞–±–ª—é–¥–µ–Ω–∏–µ–º –≥—Ä–∞–∂–¥–∞–Ω —Å —Ñ–∞–∫—Ç–æ—Ä–∞–º–∏ —Ä–∏—Å–∫–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QPtL6 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-11-19T08:52:03+00:00,@medpharm,13610,https://t.me/medpharm/13610,"–°–≤–µ—Ä—Ö–¥–æ—Ö–æ–¥—ã –æ—Ç ¬´–Ω–∞–ª–æ–≥–∞ –Ω–∞ –±–æ–≥–∞—Ç—ã—Ö¬ª –±—É–¥—É—Ç –±—ã—Å—Ç—Ä–µ–µ –Ω–∞–ø—Ä–∞–≤–ª—è—Ç—å –≤ —Ñ–æ–Ω–¥ ¬´–ö—Ä—É–≥ –¥–æ–±—Ä–∞¬ª, –ø–æ–ø—Ä–∞–≤–∫—É –æ–± —É–ø—Ä–æ—â–µ–Ω–∏–∏ –º–µ—Ö–∞–Ω–∏–∑–º–∞ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª–∞ –ì–æ—Å–¥—É–º–∞ –†–§ —Å–æ–≤–º–µ—Å—Ç–Ω–æ —Å –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ–º –†–§ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QPq5Z #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{""skip"": true}"
2025-11-19T08:25:04+00:00,@medpharm,13609,https://t.me/medpharm/13609,–ü—Ä–æ–≤–µ—Ä–∫–∞ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–∞ –≤ –ø–µ—Ä–∏–Ω–∞—Ç–∞–ª—å–Ω–æ–º —Ü–µ–Ω—Ç—Ä–µ –ö–∞–ª–∏–Ω–∏–Ω–≥—Ä–∞–¥–∞ –ø–æ—Å–ª–µ —Å–º–µ—Ä—Ç–µ–π –Ω–æ–≤–æ—Ä–æ–∂–¥–µ–Ω–Ω—ã—Ö –≤—ã—è–≤–∏–ª–∞ –º–Ω–æ–∂–µ—Å—Ç–≤–æ –Ω–∞—Ä—É—à–µ–Ω–∏–π. –°–æ—Å—Ç–∞–≤–ª–µ–Ω–æ –¥–≤–∞ –ø—Ä–æ—Ç–æ–∫–æ–ª–∞ –æ–± –∞–¥–º–∏–Ω–∏—Å—Ç—Ä–∞—Ç–∏–≤–Ω–æ–º –ø—Ä–∞–≤–æ–Ω–∞—Ä—É—à–µ–Ω–∏–∏ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QPo7W #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety"",
  ""impact"": ""high"",
  ""english"": ""The Roszdranadzor inspection of a perinatal center in Kaliningrad after neonatal deaths identified numerous violations. Two protocols for administrative offense have been composed. More details: https://clck.ru/3QPo7W #MedNews #Healthcare #Other""
}"
2025-11-19T07:39:04+00:00,@medpharm,13608,https://t.me/medpharm/13608,"–§–ê–° –†–æ—Å—Å–∏–∏ –Ω–µ —Å—Ç–∞–ª–∞ –≤–Ω–æ—Å–∏—Ç—å –≤ –†–µ–µ—Å—Ç—Ä –Ω–µ–¥–æ–±—Ä–æ—Å–æ–≤–µ—Å—Ç–Ω—ã—Ö –ø–æ—Å—Ç–∞–≤—â–∏–∫–æ–≤ –¥–≤–µ –∫–æ–º–ø–∞–Ω–∏–∏ –≤–æ–ø—Ä–µ–∫–∏ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è–º –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–∞ –†–§. –°–ø–æ—Ä—ã –≤–æ–∑–Ω–∏–∫–ª–∏ –∏–∑-–∑–∞ –ø—Ä–æ—Å—Ä–æ—á–∫–∏ –∏—Å–ø–æ–ª–Ω–∏—Ç–µ–ª—è–º–∏ –æ–±—è–∑–∞—Ç–µ–ª—å—Å—Ç–≤ –ø–æ –∫–æ–Ω—Ç—Ä–∞–∫—Ç–∞–º –Ω–∞ –ù–ò–û–ö–†, –∑–∞–∫–ª—é—á–µ–Ω–Ω—ã–º –º–µ–∂–¥—É –≤–µ–¥–æ–º—Å—Ç–≤–æ–º –∏ —Ñ–∏—Ä–º–∞–º–∏. –ü–æ—á–µ–º—É —Å—É–¥—ã –ø—Ä–∏–∑–Ω–∞–ª–∏ –ø—Ä–∞–≤–æ—Ç—É –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å–Ω–æ–≥–æ –æ—Ä–≥–∞–Ω–∞, —Ä–∞–∑–æ–±—Ä–∞–ª—Å—è ¬´–§–í¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QPjgD #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-11-19T07:12:06+00:00,@medpharm,13607,https://t.me/medpharm/13607,"–£–¥–µ—Ä–∂–∞–Ω–∏–µ –º–µ–¥–ø–µ—Ä—Å–æ–Ω–∞–ª–∞ ‚Äì —Å–∏—Å—Ç–µ–º–Ω–∞—è —Ä–∞–±–æ—Ç–∞, —É–≤–∞–∂–µ–Ω–∏–µ –∫ –ª—é–¥—è–º –∏ –ø–æ–Ω–∏–º–∞–Ω–∏–µ: –≤—Ä–∞—á–∏ –∏ –º–µ–¥—Å–µ—Å—Ç—Ä—ã ‚Äì —Ü–µ–Ω–Ω–æ—Å—Ç—å, —Ç—Ä–µ–±—É—é—â–∞—è –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–π. –ö–ª–∏–Ω–∏–∫–∏, –ø–æ–Ω–∏–º–∞—é—â–∏–µ —ç—Ç–æ, –Ω–µ –∏—Å–ø—ã—Ç—ã–≤–∞—é—Ç –∫–∞–¥—Ä–æ–≤–æ–≥–æ –≥–æ–ª–æ–¥–∞. –û—Å—Ç–∞–ª—å–Ω—ã–µ –ø—Ä–æ–¥–æ–ª–∂–∞—é—Ç –∂–∞–ª–æ–≤–∞—Ç—å—Å—è –Ω–∞ —Ç–µ–∫—É—á–µ—Å—Ç—å –∏ –≤–∏–Ω–∏—Ç—å ¬´–ø–æ–∫–æ–ª–µ–Ω–∏–µ, –∫–æ—Ç–æ—Ä–æ–µ –Ω–µ —Ö–æ—á–µ—Ç —Ä–∞–±–æ—Ç–∞—Ç—å¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QPhxa #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-11-19T05:56:04+00:00,@medpharm,13606,https://t.me/medpharm/13606,–£—á–µ–Ω—ã–µ –∏–∑ –ù—å—é-–ô–æ—Ä–∫—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ Langone Health –æ—Ü–µ–Ω–∏–ª–∏ —á–∞—Å—Ç–æ—Ç—É –ø–æ–≤—Ç–æ—Ä–Ω–æ–≥–æ –Ω–∞–±–æ—Ä–∞ –≤–µ—Å–∞ –ø–æ—Å–ª–µ –ø—Ä–µ–∫—Ä–∞—â–µ–Ω–∏—è —Ç–µ—Ä–∞–ø–∏–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º–∏ GLP-1 —É –≤–∑—Ä–æ—Å–ª—ã—Ö –∂–∏—Ç–µ–ª–µ–π –°–®–ê. –†–µ–∑—É–ª—å—Ç–∞—Ç—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω—ã –Ω–∞ –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ –ø–æ –ø—Ä–æ–±–ª–µ–º–∞–º –æ–∂–∏—Ä–µ–Ω–∏—è Obesity week 2025. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QPd8k #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è #–≠–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–∏—è,"{""skip"": true}"
2025-11-18T16:37:01+00:00,@medpharm,13605,https://t.me/medpharm/13605,"ü¶æ –û—Å—Ç–∞–≤—è—Ç –≤ –ø–æ–∫–æ–µ. –ö–æ–º–∏—Ç–µ—Ç –ì–æ—Å–¥—É–º—ã –†–§ –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è —Ä–µ–∫–æ–º–µ–Ω–¥–æ–≤–∞–ª —É–±—Ä–∞—Ç—å –∏–∑ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç–∞ –æ —Å–æ–≤–µ—Ä—à–µ–Ω—Å—Ç–≤–æ–≤–∞–Ω–∏–∏ —Å–∏—Å—Ç–µ–º—ã –û–ú–° –ø–æ–ø—Ä–∞–≤–∫—É –æ –Ω–∞–¥–µ–ª–µ–Ω–∏–∏ –≥—É–±–µ—Ä–Ω–∞—Ç–æ—Ä–æ–≤ –ø—Ä–∞–≤–æ–º –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç—å –∑–∞–º–µ–Ω—É —Å—Ç—Ä–∞—Ö–æ–≤—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω—ã–µ —Ñ–æ–Ω–¥—ã –û–ú–°. ü¶æ –ö–æ–º—É –≤—ã–≥–æ–¥–Ω–æ. –ë–æ–ª–µ–µ 45% –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö —Ä–æ—Å—Å–∏—è–Ω –≤—Å—Ç—Ä–µ—á–∞–ª–∏ –≤ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç–µ –∏ —Å–æ—Ü—Å–µ—Ç—è—Ö –Ω–µ–¥–æ—Å—Ç–æ–≤–µ—Ä–Ω—ã–µ –æ—Ç–∑—ã–≤—ã –æ –≤—Ä–∞—á–∞—Ö –ª–∏–±–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —É—Å–ª—É–≥–∞—Ö. –≠–∫—Å–ø–µ—Ä—Ç —Ä–∞—Å—Å–∫–∞–∑–∞–ª, –∫–∞–∫ –æ—Ç–ª–∏—á–∏—Ç—å –Ω–∞—Å—Ç–æ—è—â–∏–µ –ø—É–±–ª–∏–∫–∞—Ü–∏–∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –æ—Ç –ø–æ–¥–¥–µ–ª—å–Ω—ã—Ö. ‚ù§Ô∏è –ë—É–¥–µ—Ç —Å—Ç—Ä–æ–∂–µ. –¶–†–ü–¢ –∏ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å—ã —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª–∏ ¬´–¥–æ—Ä–æ–∂–Ω—É—é –∫–∞—Ä—Ç—É¬ª –¥–ª—è –∫–æ–Ω—Ç—Ä–æ–ª—è –∑–∞ –º–∞—Ä–∫–∏—Ä–æ–≤–∫–æ–π –ë–ê–î. –í –¶–†–ü–¢ –Ω–µ —Å–æ–≥–ª–∞—Å–Ω—ã —Å –ø–æ–∑–∏—Ü–∏–µ–π, —Å–æ–≥–ª–∞—Å–Ω–æ –∫–æ—Ç–æ—Ä–æ–π –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å —è–≤–ª—è–µ—Ç—Å—è –ª–∏—à—å ¬´–≤–∏—Ç—Ä–∏–Ω–æ–π¬ª –∏ –Ω–µ –Ω–µ—Å–µ—Ç –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç–∏ –∑–∞ —Ç–æ–≤–∞—Ä. ‚ù§Ô∏è –û—Ç –Ω–∞–±–ª—é–¥–µ–Ω–∏—è –∫ —É–ø—Ä–∞–≤–ª–µ–Ω–∏—é. –í –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ ¬´–ú–∞—Ä–±–∏–æ—Ñ–∞—Ä–º¬ª –≤–≤–µ–¥–µ–Ω–æ –≤–Ω–µ—à–Ω–µ–µ —É–ø—Ä–∞–≤–ª–µ–Ω–∏–µ, —Ç–∞–∫–æ–µ —Ä–µ—à–µ–Ω–∏–µ –ø—Ä–∏–Ω—è–ª –ê—Ä–±–∏—Ç—Ä–∞–∂–Ω—ã–π —Å—É–¥ –†–µ—Å–ø—É–±–ª–∏–∫–∏ –ú–∞—Ä–∏–π –≠–ª. –ó–∞–≤–æ–¥ –≤—Ö–æ–¥–∏—Ç –≤ —Ö–æ–ª–¥–∏–Ω–≥ ¬´–ë–∏–æ—Ç—ç–∫¬ª.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The Arbitration Court of the Republic of Mari El has imposed external management on 'Marifarma'. The company is part of the 'Biotek' holding. This decision was made due to concerns about the company's operations.""
}"
2025-11-18T15:19:05+00:00,@medpharm,13604,https://t.me/medpharm/13604,–ù–∏–∂–µ–≥–æ—Ä–æ–¥—Å–∫–∏–µ –≤–ª–∞—Å—Ç–∏ —Ö–æ—Ç—è—Ç —Å–æ–∑–¥–∞—Ç—å –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã–π –º–µ–¥–∫–ª–∞—Å—Ç–µ—Ä –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ –Ω–∞—É—á–Ω–æ-—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ —Ü–µ–Ω—Ç—Ä–∞ (–ò–ù–¢–¶) ¬´–ö–≤–∞–Ω—Ç–æ–≤–∞—è –¥–æ–ª–∏–Ω–∞¬ª. –°–µ–π—á–∞—Å —Ç–∞–∫–æ–π —Å–ø–µ—Ü–∏–∞–ª—å–Ω—ã–π —Ä–µ–∂–∏–º –¥–µ–π—Å—Ç–≤—É–µ—Ç —Ç–æ–ª—å–∫–æ –≤ –ú–æ—Å–∫–æ–≤—Å–∫–æ–º —Ä–µ–≥–∏–æ–Ω–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QPFE8 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-11-18T15:13:03+00:00,@medpharm,13603,https://t.me/medpharm/13603,"–§–æ–Ω–¥ ¬´–ö—Ä—É–≥ –¥–æ–±—Ä–∞¬ª –∑–∞–ø—É—Å—Ç–∏–ª ¬´–§–∞—Ä–º–ø—Ä–∏–µ–º–Ω—É—é¬ª ‚Äî —Å–µ—Ä–≤–∏—Å –¥–ª—è –æ–Ω–ª–∞–π–Ω-–≤—Å—Ç—Ä–µ—á –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–µ–π —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π —Å —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–æ–º —Ñ–æ–Ω–¥–∞. –û–±—Å—É–¥–∏—Ç—å –º–æ–∂–Ω–æ –ª—é–±—ã–µ –≤–æ–ø—Ä–æ—Å—ã –ø–æ –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏—é, –Ω–æ –Ω—É–∂–Ω–æ –∑–∞—Ä–∞–Ω–µ–µ –∑–∞–ø–∏—Å–∞—Ç—å—Å—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QPEuZ #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{""skip"": true}"
2025-11-18T14:34:03+00:00,@medpharm,13602,https://t.me/medpharm/13602,"–ö–∞—Ä—Ç–µ–ª—å –ø—Ä–∏ –ø–æ—Å—Ç–∞–≤–∫–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ç–æ–≤–∞—Ä–æ–≤ –≤—ã—è–≤–∏–ª–æ –°–≤–µ—Ä–¥–ª–æ–≤—Å–∫–æ–µ –£–§–ê–°. –°–æ–≥–ª–∞—à–µ–Ω–∏–µ –¥–ª—è –ø–æ–¥–¥–µ—Ä–∂–∞–Ω–∏—è —Ü–µ–Ω—ã –Ω–∞ —Ç–æ—Ä–≥–∞—Ö –∑–∞–∫–ª—é—á–∏–ª–∏ —Ç—Ä–∏ –∫–æ–º–ø–∞–Ω–∏–∏, –∫–æ—Ç–æ—Ä—ã–º –Ω–∞–∑–Ω–∞—á–µ–Ω—ã —à—Ç—Ä–∞—Ñ—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QPChb #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""sanctions, pricing"",
  ""impact"": ""high"",
  ""english"": ""The Cartel for the supply of medical products was exposed by the Sverdlovsky Federal Antimonopoly Service. Three companies, which were appointed with fines, have agreed on a price agreement for the trading. More details: https://clck.ru/3QPChb #PharmNews #Regulation""
}"
2025-11-18T14:21:05+00:00,@medpharm,13601,https://t.me/medpharm/13601,"–ë–æ–ª–µ–µ 45% –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö —Ä–æ—Å—Å–∏—è–Ω –≤—Å—Ç—Ä–µ—á–∞–ª–∏ –≤ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç–µ –∏ —Å–æ—Ü—Å–µ—Ç—è—Ö –Ω–µ–¥–æ—Å—Ç–æ–≤–µ—Ä–Ω—ã–µ –æ—Ç–∑—ã–≤—ã –æ –≤—Ä–∞—á–∞—Ö –ª–∏–±–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —É—Å–ª—É–≥–∞—Ö. –≠–∫—Å–ø–µ—Ä—Ç —Ä–∞—Å—Å–∫–∞–∑–∞–ª, –∫–∞–∫ –æ—Ç–ª–∏—á–∏—Ç—å –Ω–∞—Å—Ç–æ—è—â–∏–µ –ø—É–±–ª–∏–∫–∞—Ü–∏–∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –æ—Ç –ø–æ–¥–¥–µ–ª—å–Ω—ã—Ö. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QPBrB #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-11-18T13:42:02+00:00,@medpharm,13600,https://t.me/medpharm/13600,"–í –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ ¬´–ú–∞—Ä–±–∏–æ—Ñ–∞—Ä–º¬ª –≤–≤–µ–¥–µ–Ω–æ –≤–Ω–µ—à–Ω–µ–µ —É–ø—Ä–∞–≤–ª–µ–Ω–∏–µ, —Ç–∞–∫–æ–µ —Ä–µ—à–µ–Ω–∏–µ –ø—Ä–∏–Ω—è–ª –ê—Ä–±–∏—Ç—Ä–∞–∂–Ω—ã–π —Å—É–¥ –†–µ—Å–ø—É–±–ª–∏–∫–∏ –ú–∞—Ä–∏–π –≠–ª. –ó–∞–≤–æ–¥ –≤—Ö–æ–¥–∏—Ç –≤ —Ö–æ–ª–¥–∏–Ω–≥ ¬´–ë–∏–æ—Ç—ç–∫¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QP99Q #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-11-18T13:23:04+00:00,@medpharm,13599,https://t.me/medpharm/13599,–ë—ã–≤—à–∏–π –≥–ª–∞–≤–∞ –∞—Ä—Ö–∞–Ω–≥–µ–ª—å—Å–∫–æ–≥–æ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ì–µ—Ä—à—Ç–∞–Ω—Å–∫–∏–π —Å—Ç–∞–ª —Ñ–∏–≥—É—Ä–∞–Ω—Ç–æ–º –Ω–æ–≤–æ–≥–æ —É–≥–æ–ª–æ–≤–Ω–æ–≥–æ –¥–µ–ª–∞. –ê—Ä–µ—Å—Ç —ç–∫—Å-—á–∏–Ω–æ–≤–Ω–∏–∫–∞ –ø—Ä–æ–¥–ª–µ–Ω –¥–æ 19 —è–Ω–≤–∞—Ä—è —Å–ª–µ–¥—É—é—â–µ–≥–æ –≥–æ–¥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QP7sW #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-11-18T12:24:06+00:00,@medpharm,13598,https://t.me/medpharm/13598,"–£—á–µ–Ω—ã–µ –∏–∑ –ú–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –∫–æ–ª–ª–µ–¥–∂–∞ –£–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ –ù–µ–±—Ä–∞—Å–∫–∏ –æ—Ü–µ–Ω–∏–ª–∏ —á–∞—Å—Ç–æ—Ç—É, —Ç—è–∂–µ—Å—Ç—å –∏ –ø–æ—Å–ª–µ–¥—Å—Ç–≤–∏—è –∫–æ–∂–Ω–æ–π —Ç–æ–∫—Å–∏—á–Ω–æ—Å—Ç–∏ –Ω–∞ —Ñ–æ–Ω–µ —Ç–µ—Ä–∞–ø–∏–∏ —ç–Ω—Ñ–æ—Ä—Ç—É–º–∞–±–æ–º –≤–µ–¥–æ—Ç–∏–Ω–æ–º —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –∑–∞–ø—É—â–µ–Ω–Ω–æ–π —É—Ä–æ—Ç–µ–ª–∏–∞–ª—å–Ω–æ–π –∫–∞—Ä—Ü–∏–Ω–æ–º–æ–π. –û–ø—É–±–ª–∏–∫–æ–≤–∞–Ω—ã —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QP3zB #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–î–µ—Ä–º–∞—Ç–æ–≤–µ–Ω–µ—Ä–æ–ª–æ–≥–∏—è #–û–Ω–∫–æ–ª–æ–≥–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-11-18T11:50:04+00:00,@medpharm,13597,https://t.me/medpharm/13597,–°–≤–µ—Ä–¥–ª–æ–≤—Å–∫–æ–µ –£–§–ê–° –≤—ã—è–≤–∏–ª–æ –º–Ω–æ–≥–æ–º–∏–ª–ª–∏–æ–Ω–Ω—ã–π –∫–∞—Ä—Ç–µ–ª—å–Ω—ã–π —Å–≥–æ–≤–æ—Ä —Ç—Ä–µ—Ö –∫–æ–º–ø–∞–Ω–∏–π –Ω–∞ —Ä—ã–Ω–∫–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ç–æ–≤–∞—Ä–æ–≤. –ú–∞—Ç–µ—Ä–∏–∞–ª—ã –ø–µ—Ä–µ–¥–∞–Ω—ã –≤ –ø—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–∏—Ç–µ–ª—å–Ω—ã–µ –æ—Ä–≥–∞–Ω—ã –¥–ª—è –≤–æ–∑–±—É–∂–¥–µ–Ω–∏—è —É–≥–æ–ª–æ–≤–Ω–æ–≥–æ –¥–µ–ª–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QNzWU #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration, sanctions"",
  ""impact"": ""high"",
  ""english"": ""The Sverdlovsk Federal Anti-Monopoly Service (FAS) has identified a multi-million dollar cartel among three companies in the medical products market. The materials have been handed over to law enforcement authorities for an investigation into criminal charges.""
}"
2025-11-18T11:50:02+00:00,@medpharm,13596,https://t.me/medpharm/13596,–ö–æ–º–ø–∞–Ω–∏—è ¬´–ê–ª—å—Ñ–∞—Å–∏–≥–º–∞ –†—É—Å¬ª –≤–æ—à–ª–∞ –≤ TOP10 –ø–æ —Ç–µ–º–ø–∞–º –ø—Ä–∏—Ä–æ—Å—Ç–∞ –ø—Ä–æ–¥–∞–∂ –Ω–∞ —Ä–æ–∑–Ω–∏—á–Ω–æ–º –∫–æ–º–º–µ—Ä—á–µ—Å–∫–æ–º —Ä—ã–Ω–∫–µ —Å—Ä–µ–¥–∏ –∫–æ–º–ø–∞–Ω–∏–π –∏–∑ TOP100 –ø–æ –æ–±—ä–µ–º—É –ø—Ä–æ–¥–∞–∂*. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QNzWV #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-11-18T11:23:03+00:00,@medpharm,13595,https://t.me/medpharm/13595,"–°—Ç–æ–∏–º–æ—Å—Ç—å –ø–µ—Ä–≤–æ–≥–æ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –±–∏–æ–∞–Ω–∞–ª–æ–≥–∞ ¬´–ü–∞—Ä–Ω–∞–ø–∞—Ä–∏–Ω –Ω–∞—Ç—Ä–∏—è –≤–µ–ª—Ñ–∞—Ä–º¬ª (–ú–ù–ù –ø–∞—Ä–Ω–∞–ø–∞—Ä–∏–Ω –Ω–∞—Ç—Ä–∏—è) –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ –≤–µ–Ω–æ–∑–Ω—ã—Ö —Ç—Ä–æ–º–±–æ–∑–æ–≤ —Å–Ω–∏–∂–µ–Ω–∞ –Ω–∞ 2,5% –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–º ¬´–§–ª—é–∫—Å—É–º¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QNxnU #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""reimbursement"",
  ""impact"": ""low"",
  ""english"": ""The price of the domestically produced bioequivalent 'Parnaparin sodium Fluvairm' (INN: parnaparin sodium) for the treatment of venous thrombosis has been reduced by 2.5% compared to the original drug 'Fluvairm'. For more details: https://clck.ru/3QNxnU #PharmNews #Distribution""
}"
2025-11-18T11:04:06+00:00,@medpharm,13594,https://t.me/medpharm/13594,–í –°–µ—á–µ–Ω–æ–≤—Å–∫–æ–º —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–µ –≤–ø–µ—Ä–≤—ã–µ –Ω–∞—á–∞–ª–∏ –≤–æ—Å—Å—Ç–∞–Ω–∞–≤–ª–∏–≤–∞—Ç—å –±–∞—Ä–∞–±–∞–Ω–Ω—É—é –ø–µ—Ä–µ–ø–æ–Ω–∫—É —Å –ø–æ–º–æ—â—å—é —Å–æ–±—Å—Ç–≤–µ–Ω–Ω—ã—Ö –∫–ª–µ—Ç–æ–∫ –ø–∞—Ü–∏–µ–Ω—Ç–∞. –≠—Ç–∞ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—è –ø–æ–∑–≤–æ–ª—è–µ—Ç –±—ã—Å—Ç—Ä–µ–µ –≤–æ—Å—Å—Ç–∞–Ω–∞–≤–ª–∏–≤–∞—Ç—å —Å–ª—É—Ö –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω–æ–π —Ç–∏–º–ø–∞–Ω–æ–ø–ª–∞—Å—Ç–∏–∫–æ–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QNwSB #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–û—Ç–æ—Ä–∏–Ω–æ–ª–∞—Ä–∏–Ω–≥–æ–ª–æ–≥–∏—è,"{""skip"": true}"
2025-11-18T10:33:01+00:00,@medpharm,13593,https://t.me/medpharm/13593,"–†–æ—Å—Å–∏–π—Å–∫–∏–π —Ñ–∞—Ä–º—Ä—ã–Ω–æ–∫ –Ω–∞ —ç—Ç–∞–ø–µ –≥–ª—É–±–æ–∫–æ–π —Ç—Ä–∞–Ω—Å—Ñ–æ—Ä–º–∞—Ü–∏–∏ ‚Äî –¥–æ–ª—è –ª–æ–∫–∞–ª–∏–∑–æ–≤–∞–Ω–Ω—ã—Ö –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤ –¥–æ—Å—Ç–∏–≥–ª–∞ 70%, –∞ –æ–±—ä–µ–º –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –±–∏–æ—ç–∫–≤–∏–≤–∞–ª–µ–Ω—Ç–Ω–æ—Å—Ç–∏ –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç —Ä–∞—Å—Ç–∏. –ù–æ –≤–º–µ—Å—Ç–µ —Å —Ä–æ—Å—Ç–æ–º –ø—Ä–∏—à–ª–∏ –∏ –Ω–æ–≤—ã–µ –≤—ã–∑–æ–≤—ã: —É–∂–µ—Å—Ç–æ—á–µ–Ω–∏–µ –Ω–æ—Ä–º–∞—Ç–∏–≤–æ–≤, —Å–ª–æ–∂–Ω–∞—è –ª–æ–≥–∏—Å—Ç–∏–∫–∞ –∏ –≤—ã—Å–æ–∫–æ–µ –¥–∞–≤–ª–µ–Ω–∏–µ –Ω–∞ —Å—Ä–æ–∫–∏ –≤—ã–≤–æ–¥–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –í –Ω–æ–≤–æ–º –≤–∏–¥–µ–æ-–ø—Ä–æ–µ–∫—Ç–µ ¬´–û–°–¢¬ª —Å–æ–±—Ä–∞–ª–∞ –≤–µ–¥—É—â–∏—Ö —ç–∫—Å–ø–µ—Ä—Ç–æ–≤ –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–∏—Ö —Ü–µ–Ω—Ç—Ä–æ–≤, –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–∏–π –∏ CRO ‚Äî –¥–ª—è —á–µ—Å—Ç–Ω–æ–≥–æ —Ä–∞–∑–≥–æ–≤–æ—Ä–∞ –æ –≥–ª–∞–≤–Ω—ã—Ö –≤—ã–∑–æ–≤–∞—Ö 2025 –≥–æ–¥–∞. –†–∞–Ω–µ–µ ¬´–û–°–¢¬ª –æ–±—ä—è–≤–∏–ª–∞ –æ —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–æ–º —Ä–∞—Å—à–∏—Ä–µ–Ω–∏–∏, —Å–æ–∑–¥–∞–≤ –µ–¥–∏–Ω—É—é —ç–∫–æ—Å–∏—Å—Ç–µ–º—É –¥–ª—è –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è –¥–æ—Å—Ç—É–ø–Ω—ã—Ö –∏ –∫–∞—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –ë–≠ ¬´–ø–æ–¥ –∫–ª—é—á¬ª. üì∫ –°–º–æ—Ç—Ä–∏—Ç–µ —ç–∫—Å–ø–µ—Ä—Ç–Ω—ã–π –æ–±–∑–æ—Ä –ø–æ —Å—Å—ã–ª–∫–µ –†–µ–∫–ª–∞–º–∞, –û–û–û ¬´–û–°–¢ –†—É—Å¬ª #—Ñ–∞—Ä–º–∞ #–±–∏–æ—ç–∫–≤–∏–≤–∞–ª–µ–Ω—Ç–Ω–æ—Å—Ç—å #–ë–≠ #CRO #–¥–∂–µ–Ω–µ—Ä–∏–∫–∏ #–û–°–¢ #–†–æ—Å—Å–∏—è #–∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ–∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è #—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞","{
  ""skip"": true
}"
2025-11-18T10:15:03+00:00,@medpharm,13592,https://t.me/medpharm/13592,"–ú–∏—Ä–æ–≤—ã–µ —Ä–µ–≥—É–ª—è—Ç–æ—Ä—ã –æ–¥–æ–±—Ä–∏–ª–∏ 13 –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, —á–µ—Ç—ã—Ä–µ –∏–∑ –∫–æ—Ç–æ—Ä—ã—Ö –Ω–µ –∏–º–µ—é—Ç –∞–Ω–∞–ª–æ–≥–æ–≤ –≤ –º–∏—Ä–µ. –í –°–®–ê –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª–∏ –ø–µ—Ä–≤—ã–π –ø–µ—Ä–æ—Ä–∞–ª—å–Ω—ã–π –∏–Ω–≥–∏–±–∏—Ç–æ—Ä –º–µ–Ω–∏–Ω–∞ –¥–ª—è –±–æ—Ä—å–±—ã —Å –ª–µ–π–∫–µ–º–∏–µ–π –∏ –ø–µ—Ä–≤—ã–π –≤–∑–∞–∏–º–æ–∑–∞–º–µ–Ω—è–µ–º—ã–π –±–∏–æ–∞–Ω–∞–ª–æ–≥ ¬´–ü–µ—Ä—å–µ—Ç—ã¬ª. –í –ï–≤—Ä–æ—Å–æ—é–∑–µ –æ–¥–æ–±—Ä–µ–Ω–∞ –ø–µ—Ä–≤–∞—è –≥–µ–Ω–Ω–∞—è —Ç–µ—Ä–∞–ø–∏—è –¥–ª—è —Å–∏–Ω–¥—Ä–æ–º–∞ –í–∏—Å–∫–æ—Ç—Ç–∞-–û–ª–¥—Ä–∏—á–∞. –í –ö–ù–† –ø–æ—è–≤–∏—Ç—Å—è –µ—â–µ –æ–¥–∏–Ω –ø–æ–ª–Ω–æ—Å—Ç—å—é —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–Ω—ã–π –≤ —Å—Ç—Ä–∞–Ω–µ –∞–≥–æ–Ω–∏—Å—Ç –ì–ü–ü-1 –æ—Ç –¥–∏–∞–±–µ—Ç–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QNspn #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-11-18T10:10:08+00:00,@medpharm,13591,https://t.me/medpharm/13591,"–ü—Ä–∏ –∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä–æ–≤–∞–Ω–∏–∏ –ø–æ—Å–µ—Ç–∏—Ç–µ–ª–µ–π –∏–∑ ¬´—É—è–∑–≤–∏–º—ã—Ö –∫–∞—Ç–µ–≥–æ—Ä–∏–π¬ª (–±–µ—Ä–µ–º–µ–Ω–Ω—ã–µ –∂–µ–Ω—â–∏–Ω—ã, –ª—é–¥–∏ –ø–æ–∂–∏–ª–æ–≥–æ –≤–æ–∑—Ä–∞—Å—Ç–∞, —Å–µ–º—å–∏ —Å –¥–µ—Ç—å–º–∏) –æ—Å–æ–±–µ–Ω–Ω–æ –≤–∞–∂–Ω–æ –ø–æ–¥–æ–±—Ä–∞—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç —Å –±–ª–∞–≥–æ–ø—Ä–∏—è—Ç–Ω—ã–º –ø—Ä–æ—Ñ–∏–ª–µ–º –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏. –í —Å–≤–æ–µ–π –ª–µ–∫—Ü–∏–∏ –∫.–º.–Ω., –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–π —Ñ–∞—Ä–º–∞–∫–æ–ª–æ–≥, –¥–æ—Ü–µ–Ω—Ç –∫–∞—Ñ–µ–¥—Ä—ã —Ç–µ—Ä–∞–ø–∏–∏, –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–π —Ñ–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏–∏ –∏ —Å–∫–æ—Ä–æ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –§–ì–ë–û–£ –í–û ¬´–†–æ—Å—Å–∏–π—Å–∫–∏–π —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç –º–µ–¥–∏—Ü–∏–Ω—ã¬ª –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–æ—Å—Å–∏–∏ –ì–µ—Ä–º–∞–Ω –ö–Ω–æ—Ä—Ä–∏–Ω–≥ —Ä–∞–∑–æ–±—Ä–∞–ª –æ–±—â–∏–µ –ø—Ä–∏–Ω—Ü–∏–ø—ã –≤—ã–±–æ—Ä–∞ —Å–∏–º–ø—Ç–æ–º–∞—Ç–∏—á–µ—Å–∫–æ–π –∏ –ø–∞—Ç–æ–≥–µ–Ω–µ—Ç–∏—á–µ—Å–∫–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –û–†–í–ò. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QNsRP #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–§–∞—Ä–º–∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä–æ–≤–∞–Ω–∏–µ","{""skip"": true}"
2025-11-18T10:10:07+00:00,@medpharm,13590,https://t.me/medpharm/13590,"–ò–Ω—Ç–µ—Ä–≤—å—é —Å –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–º –ø—Å–∏—Ö–æ–ª–æ–≥–æ–º –Ω–µ–≤—Ä–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ –æ—Ç–¥–µ–ª–µ–Ω–∏—è –ú–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –Ω–∞—É—á–Ω–æ-–æ–±—Ä–∞–∑–æ–≤–∞—Ç–µ–ª—å–Ω–æ–≥–æ –∏–Ω—Å—Ç–∏—Ç—É—Ç–∞ –ø—Ä–∏ –ú–ì–£ –∏–º. –ú.–í. –õ–æ–º–æ–Ω–æ—Å–æ–≤–∞, –∫—Ä–∏–∑–∏—Å–Ω—ã–º –∫–æ–Ω—Å—É–ª—å—Ç–∞–Ω—Ç–æ–º, —Å—É–ø–µ—Ä–≤–∏–∑–æ—Ä–æ–º –û–ª—å–≥–æ–π –ö–∞—Ç–µ–ª–∏–Ω–æ–π –ø–æ—Å–≤—è—â–µ–Ω–æ –æ–¥–Ω–æ–π –∏–∑ —Å–∞–º—ã—Ö –æ—Å—Ç—Ä—ã—Ö –ø—Ä–æ–±–ª–µ–º, —Å –∫–æ—Ç–æ—Ä–æ–π —Å—Ç–∞–ª–∫–∏–≤–∞—é—Ç—Å—è —Ä–æ–¥–∏—Ç–µ–ª–∏ –±–æ–ª–µ—é—â–µ–≥–æ —Ä–µ–±–µ–Ω–∫–∞, ‚Äì –æ—Ç–∫–∞–∑—É –ø—Ä–∏–Ω–∏–º–∞—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–∞. –≠–∫—Å–ø–µ—Ä—Ç —Ä–∞–∑–±–∏—Ä–∞–µ—Ç, –∫–∞–∫–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ —Ñ–æ—Ä–º—ã –≤—ã–∑—ã–≤–∞—é—Ç –Ω–∞–∏–±–æ–ª—å—à–µ–µ –Ω–µ–ø—Ä–∏—è—Ç–∏–µ –∏ –∫–∞–∫ —Ñ–∞—Ä–º—Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—É –∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä–æ–≤–∞—Ç—å —Ä–æ–¥–∏—Ç–µ–ª–µ–π –ø–æ –≤–æ–ø—Ä–æ—Å–∞–º —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—è —Å–æ–∑–Ω–∞—Ç–µ–ª—å–Ω–æ–≥–æ –æ—Ç–Ω–æ—à–µ–Ω–∏—è –∫ –ª–µ—á–µ–Ω–∏—é. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QNsRE #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–§–∞—Ä–º–∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä–æ–≤–∞–Ω–∏–µ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""The interview with clinical psychologist Olga Katelina from the Neurological Department of Medical Scientific and Educational Institute at MGU named after M.V. Lomonosov, crisis consultant and supervisor, focuses on one of the most acute problems that parents of a sick child face - refusal to take medications. The expert analyzes which drug forms cause the most rejection and how a pharmaceutical specialist should consult parents on issues of forming conscious treatment attitudes. For more details: https://clck.ru/3QNsRE #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–§–∞—Ä–º–∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä–æ–≤–∞–Ω–∏–µ""
}"
2025-11-18T10:06:06+00:00,@medpharm,13589,https://t.me/medpharm/13589,"–°—É–¥ –≤ –ê—Ä—Ö–∞–Ω–≥–µ–ª—å—Å–∫–µ –ø—Ä–∏–≥–æ–≤–æ—Ä–∏–ª —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –º–æ—à–µ–Ω–Ω–∏—á–µ—Å—Ç–≤–∞ –ø—Ä–∏ —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–µ –∫–æ—Ä–ø—É—Å–∞ –¥–µ—Ç—Å–∫–æ–π –±–æ–ª—å–Ω–∏—Ü—ã. –û—Ä–≥–∞–Ω–∏–∑–∞—Ç–æ—Ä –ø–æ–ª—É—á–∏–ª —á–µ—Ç—ã—Ä–µ –≥–æ–¥–∞ –∫–æ–ª–æ–Ω–∏–∏, –¥–≤–æ–µ —Å–æ—É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ ‚Äî —É—Å–ª–æ–≤–Ω—ã–µ —Å—Ä–æ–∫–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QNs6A #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-11-18T09:15:05+00:00,@medpharm,13588,https://t.me/medpharm/13588,–ó–∞–º–≥–ª–∞–≤—ã –ª–∏–ø–µ—Ü–∫–æ–≥–æ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –≤—Ä–µ–º–µ–Ω–Ω–æ –≤–æ–∑–≥–ª–∞–≤–∏—Ç –≤–µ–¥–æ–º—Å—Ç–≤–æ. –ü—Ä–µ–¥—ã–¥—É—â–∏–π —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å –º–∏–Ω–∏—Å—Ç–µ—Ä—Å—Ç–≤–∞ —É—à–ª–∞ —Å –¥–æ–ª–∂–Ω–æ—Å—Ç–∏ –¥–ª—è —Ä–∞–±–æ—Ç—ã –≤ –º–µ—Å—Ç–Ω–æ–º —Ñ–∏–ª–∏–∞–ª–µ –†–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ –º–µ–¥–∏—Ü–∏–Ω—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QNoJF #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-11-18T08:45:05+00:00,@medpharm,13587,https://t.me/medpharm/13587,–í –ö–µ–º–µ—Ä–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –ø–µ—Ä–µ–¥ —Å—É–¥–æ–º –ø—Ä–µ–¥—Å—Ç–∞–Ω–µ—Ç –ø—Ä–∏—è—Ç–µ–ª—å –±—ã–≤—à–µ–≥–æ –º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è —Ä–µ–≥–∏–æ–Ω–∞ –î–º–∏—Ç—Ä–∏—è –ë–µ–≥–ª–æ–≤–∞. –û–Ω –ø—Ä–∏–∑–Ω–∞–ª—Å—è –≤ –¥–∞—á–µ –≤–∑—è—Ç–∫–∏ —ç–∫—Å-—á–∏–Ω–æ–≤–Ω–∏–∫—É. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QNm9T #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-11-18T08:34:03+00:00,@medpharm,13586,https://t.me/medpharm/13586,"–¶–†–ü–¢ –∏ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å—ã —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª–∏ ¬´–¥–æ—Ä–æ–∂–Ω—É—é –∫–∞—Ä—Ç—É¬ª –¥–ª—è –∫–æ–Ω—Ç—Ä–æ–ª—è –∑–∞ –º–∞—Ä–∫–∏—Ä–æ–≤–∫–æ–π –ë–ê–î. –≠—Ç–æ –æ–¥–Ω–æ –∏–∑ –¥–≤—É—Ö –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏–π —Ä–∞–±–æ—Ç—ã –ø–æ —É—Å–∏–ª–µ–Ω–∏—é –∫–æ–Ω—Ç—Ä–æ–ª—è –∑–∞ –ø—Ä–æ–¥—É–∫—Ü–∏–µ–π. –í –¶–†–ü–¢ –Ω–µ —Å–æ–≥–ª–∞—Å–Ω—ã —Å –ø–æ–∑–∏—Ü–∏–µ–π, —Å–æ–≥–ª–∞—Å–Ω–æ –∫–æ—Ç–æ—Ä–æ–π –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å —è–≤–ª—è–µ—Ç—Å—è –ª–∏—à—å ¬´–≤–∏—Ç—Ä–∏–Ω–æ–π¬ª –∏ –Ω–µ –Ω–µ—Å–µ—Ç –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç–∏ –∑–∞ —Ç–æ–≤–∞—Ä. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QNkJy #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The Pharmaceutical Regulatory Policy and Trade (–¶–†–ü–¢) and marketplaces have developed a 'roadmap' for tracking the barcode of biologic agents. This is one of two directions to strengthen control over products. The –¶–†–ü–¢ disagrees with the position that marketplaces are merely 'showcases' and do not bear responsibility for goods. For more details: https://clck.ru/3QNkJy #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞""
}"
2025-11-18T05:59:05+00:00,@medpharm,13585,https://t.me/medpharm/13585,–í —Ç–∏–ø–æ–≤—ã–µ —É—Å–ª–æ–≤–∏—è –∫–æ–Ω—Ç—Ä–∞–∫—Ç–æ–≤ –Ω–∞ –∞–≤–∏–∞—Ü–∏–æ–Ω–Ω—ã–µ —Ä–∞–±–æ—Ç—ã –¥–ª—è –º–µ–¥–ø–æ–º–æ—â–∏ –≤–æ—à–ª–æ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–µ —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–æ–µ –æ–±—Å–ª—É–∂–∏–≤–∞–Ω–∏–µ –º–µ–¥–æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –Ω–∞ –±–æ—Ä—Ç—É —Å–∞–Ω–∏—Ç–∞—Ä–Ω–æ–π –∞–≤–∏–∞—Ü–∏–∏. –ó–∞–∫–∞–∑—á–∏–∫–∏ —Ç–∞–∫–∂–µ –æ–±—è–∑–∞–Ω—ã –ø–æ–ø–æ–ª–Ω—è—Ç—å –∑–∞–ø–∞—Å —Ä–∞—Å—Ö–æ–¥–Ω—ã—Ö –º–∞—Ç–µ—Ä–∏–∞–ª–æ–≤ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QNX5R #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-11-17T16:43:01+00:00,@medpharm,13584,https://t.me/medpharm/13584,"ü¶æ –ù–µ —Å–æ–≥–ª–∞—Å–Ω—ã–µ. –î–≤–µ —Ç—Ä–µ—Ç–∏ –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö ¬´–ú–í¬ª –≤—Ä–∞—á–µ–π –∏ —Å—Ç—É–¥–µ–Ω—Ç–æ–≤ –≤—ã—Å—Ç—É–ø–∏–ª–∏ –ø—Ä–æ—Ç–∏–≤ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–π —Ç—Ä–µ—Ö–ª–µ—Ç–Ω–µ–π –æ—Ç—Ä–∞–±–æ—Ç–∫–∏, –∑–∞–∫–æ–Ω –≤–≤–µ–¥–µ–Ω–∏–∏ –∫–æ—Ç–æ—Ä–æ–π —Å–µ–≥–æ–¥–Ω—è –ø–æ–¥–ø–∏—Å–∞–ª –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç –†–§. –ò–∑ –Ω–∏—Ö –∫–∞–∂–¥—ã–π —á–µ—Ç–≤–µ—Ä—Ç—ã–π –∑–∞—è–≤–∏–ª, —á—Ç–æ –≤ –∫–∞–ø–∏—Ç–∞–ª–∏—Å—Ç–∏—á–µ—Å–∫–æ–º –æ–±—â–µ—Å—Ç–≤–µ –≤–æ–ø—Ä–æ—Å –¥–µ—Ñ–∏—Ü–∏—Ç–∞ –∫–∞–¥—Ä–æ–≤ –Ω—É–∂–Ω–æ —Ä–µ—à–∞—Ç—å —Å –ø–æ–º–æ—â—å—é –≤—ã—Å–æ–∫–∏—Ö –∑–∞—Ä–ø–ª–∞—Ç –∏ —Ö–æ—Ä–æ—à–∏—Ö —É—Å–ª–æ–≤–∏–π —Ç—Ä—É–¥–∞. ü¶æ –í–Ω–µ–∑–∞–ø–Ω—ã–µ –ø—Ä–æ—Ç–∏–≤–æ—Ä–µ—á–∏—è. –ú–∏–Ω–æ–±—Ä–Ω–∞—É–∫–∏ –†–§ –¥–æ–ø—É—Å—Ç–∏–ª–æ —Å–æ–∫—Ä–∞—â–µ–Ω–∏–µ —Å—Ä–æ–∫–∞ –æ–±—É—á–µ–Ω–∏—è –≤—Ä–∞—á–µ–π –¥–æ –ø—è—Ç–∏ –ª–µ—Ç. –í –ú–∏–Ω–∑–¥—Ä–∞–≤–µ –†–§ –æ–ø—Ä–æ–≤–µ—Ä–≥–ª–∏ —Ç–∞–∫—É—é –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å. ‚ù§Ô∏è –í—ã–±–æ—Ä–æ—á–Ω—ã–π –∫–æ–Ω—Ç—Ä–æ–ª—å. –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –æ—Å–≤–æ–±–æ–¥–∏–ª–æ –æ—Ç –ø–ª–∞–Ω–æ–≤—ã—Ö –ø—Ä–æ–≤–µ—Ä–æ–∫ –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ —Ä—ã–Ω–∫–∞ –æ–±—Ä–∞—â–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤. –ö–æ–Ω—Ç—Ä–æ–ª—å –±—É–¥–µ—Ç —Å–∫–æ–Ω—Ü–µ–Ω—Ç—Ä–∏—Ä–æ–≤–∞–Ω –Ω–∞ –æ–±—ä–µ–∫—Ç–∞—Ö —Å –≤—ã—Å–æ–∫–∏–º —Ä–∏—Å–∫–æ–º. ‚ù§Ô∏è –ü–æ—Å–ª–µ–¥–Ω—è—è –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å. –ó–∞–º–º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –†–§ –°–µ—Ä–≥–µ–π –ì–ª–∞–≥–æ–ª–µ–≤ –ø—Ä–∏–∑–≤–∞–ª —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ —É—Å–∫–æ—Ä–∏—Ç—å—Å—è –∏ –ø–æ–¥–∞—Ç—å –∑–∞—è–≤–ª–µ–Ω–∏—è –æ –ø—Ä–∏–≤–µ–¥–µ–Ω–∏–∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–æ–Ω–Ω—ã—Ö –¥–æ—Å—å–µ –≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–µ —Å –Ω–æ—Ä–º–∞–º–∏ –ï–ê–≠–°. –≠—Ç–æ –Ω–∞–¥–æ —Å–¥–µ–ª–∞—Ç—å –≤ –±–ª–∏–∂–∞–π—à–∏–µ –Ω–µ–¥–µ–ª–∏ –∏–ª–∏ –¥–∞–∂–µ –¥–Ω–∏. –ò–Ω–∞—á–µ –∏—Ö –∂–¥—É—Ç –ø–æ—Å–ª–µ–¥—Å—Ç–≤–∏—è.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety, guideline"",
  ""impact"": ""high"",
  ""english"": ""The Ministry of Education and Science Russia approved a reduction in the duration of medical studies to five years. The Health Ministry denied this possibility. A spokesperson for the Minister of Health, Sergey Glagolov, urged pharmaceutical companies to expedite and submit registration dossier updates in line with EAEU norms within the next few days or even weeks. Otherwise, they face consequences.""
}"
2025-11-17T15:34:03+00:00,@medpharm,13583,https://t.me/medpharm/13583,–ë–æ—Ä—å–±–∞ –∑–∞ –ª–æ—è–ª—å–Ω–æ–≥–æ –ø–æ–∫—É–ø–∞—Ç–µ–ª—è –º–µ–∂–¥—É –∞–ø—Ç–µ–∫–∞–º–∏ –∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º–∏ –æ–±–æ—Å—Ç—Ä–∏–ª–∞—Å—å –∏ –ø—Ä–∏–≤–µ–ª–∞ –∫ —Ä–æ—Å—Ç—É —Å—Ç–æ–∏–º–æ—Å—Ç–∏ –±—Ä–µ–Ω–¥–æ–≤–æ–≥–æ —Ç—Ä–∞—Ñ–∏–∫–∞. –û–± –∏–∑–º–µ–Ω–µ–Ω–∏—è—Ö –Ω–∞ —Ä—ã–Ω–∫–µ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ —Å–µ–≥–º–µ–Ω—Ç–∞ e-com —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏ –∞–Ω–∞–ª–∏—Ç–∏–∫–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QN8Gw #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage"",
  ""impact"": ""medium"",
  ""english"": ""A dispute between pharmacies and manufacturers over loyalty buyers has led to an increase in the cost of branded traffic. Changes on the pharmaceutical e-commerce market were reported by analysts. For more details: https://clck.ru/3QN8Gw #PharmVestnik #Retail""
}"
2025-11-17T15:19:05+00:00,@medpharm,13582,https://t.me/medpharm/13582,"–í –†–æ—Å—Å–∏–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª–∏ –ò–ò-–º–æ–¥–µ–ª—å –¥–ª—è –ø—Ä–æ–≥–Ω–æ–∑–∏—Ä–æ–≤–∞–Ω–∏—è –æ—Å–ª–æ–∂–Ω–µ–Ω–∏–π —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –Ω–∞—Ö–æ–¥—è—â–∏—Ö—Å—è –Ω–∞ —Å—Ç–∞—Ü–∏–æ–Ω–∞—Ä–Ω–æ–º –ª–µ—á–µ–Ω–∏–∏. –°–µ—Ä–≤–∏—Å –≤–Ω–µ–¥—Ä—è—é—Ç –≤ –ù–ú–ò–¶ –∏–º. –í.–ê. –ê–ª–º–∞–∑–æ–≤–∞ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QN7Ua #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–î–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞","{""skip"": true}"
2025-11-17T14:45:03+00:00,@medpharm,13581,https://t.me/medpharm/13581,–í–ª–∞–¥–∏–º–∏—Ä –ü—É—Ç–∏–Ω –ø–æ–¥–ø–∏—Å–∞–ª –∑–∞–∫–æ–Ω –æ–± –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–º —Ü–µ–ª–µ–≤–æ–º –æ–±—É—á–µ–Ω–∏–∏ –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–µ–π. –ü–µ—Ä–µ—á–µ–Ω—å —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–µ–π –∏ —Å—Ä–æ–∫–æ–≤ –¥–ª—è –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–∞ –æ–ø—Ä–µ–¥–µ–ª–∏—Ç –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§. –ö–æ—Å–Ω–µ—Ç—Å—è –ª–∏ –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–æ –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –æ–±—Ä–∞–∑–æ–≤–∞—Ç–µ–ª—å–Ω—ã—Ö –ø—Ä–æ–≥—Ä–∞–º–º? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QN5b5 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–∞—Ä—å–µ—Ä–∞,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""Russian President Vladimir Putin signed a law on mandatory targeted training for graduates of medical and pharmaceutical specialties. The list of specialties and the terms for mentoring will be determined by the Russian Ministry of Health. Will targeted training affect graduates from pharmaceutical education programs? For more details: https://clck.ru/3QN5b5 #PharmVestnik #Career""
}"
2025-11-17T14:32:03+00:00,@medpharm,13580,https://t.me/medpharm/13580,"–ü—Ä–µ–Ω–∞—Ç–∞–ª—å–Ω—ã–π —Å–∫—Ä–∏–Ω–∏–Ω–≥ –≤ —Ç—Ä–µ—Ç—å–µ–º —Ç—Ä–∏–º–µ—Å—Ç—Ä–µ, –¥–µ–º–æ–Ω—Å—Ç—Ä–∞—Ü–∏—è —Å–µ—Ä–¥—Ü–µ–±–∏–µ–Ω–∏—è –ø–ª–æ–¥–∞ –ø–µ—Ä–µ–¥ –ø—Ä–µ—Ä—ã–≤–∞–Ω–∏–µ–º –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏ –∏ –¥—Ä—É–≥–∏–µ –∏–∑–º–µ–Ω–µ–Ω–∏—è –±—É–¥—É—Ç –ø—Ä–æ–ø–∏—Å–∞–Ω—ã –≤ –Ω–æ–≤–æ–º –ü–æ—Ä—è–¥–∫–µ –æ–∫–∞–∑–∞–Ω–∏—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –ø–æ –ø—Ä–æ—Ñ–∏–ª—é ¬´–ê–∫—É—à–µ—Ä—Å—Ç–≤–æ –∏ –≥–∏–Ω–µ–∫–æ–ª–æ–≥–∏—è¬ª. –¢–∞–∫–∂–µ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –æ–±–Ω–æ–≤–∏—Ç—å —Å—Ç–∞–Ω–¥–∞—Ä—Ç—ã –æ—Å–Ω–∞—â–µ–Ω–∏—è –∏ —à—Ç–∞—Ç–Ω—ã–µ –Ω–æ—Ä–º–∞—Ç–∏–≤—ã –ø—Ä–æ—Ñ–∏–ª—å–Ω—ã—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QN4qZ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–ê–∫—É—à–µ—Ä—Å—Ç–≤–æ_–∏_–≥–∏–Ω–µ–∫–æ–ª–æ–≥–∏—è #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""A prenatal screening procedure will be included in the third trimester, fetal heart rate demonstration before abortion and other changes are specified in a new Order for providing medical care under the 'Obstetrics and Gynecology' profile. Also, it is planned to update the standards of equipment and staffing norms for profiled organizations.""
}"
2025-11-17T13:54:05+00:00,@medpharm,13579,https://t.me/medpharm/13579,"–î–µ–ø—É—Ç–∞—Ç—ã –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –≤–≤–µ—Å—Ç–∏ –±–æ–ª–µ–µ –∂–µ—Å—Ç–∫–∏–π –∫–æ–Ω—Ç—Ä–æ–ª—å –∑–∞ —Ä–∞–±–æ—Ç–æ–π —Å—Ç—É–¥–∏–π –º–∞–Ω–∏–∫—é—Ä–∞, —Ç–∞—Ç—É–∞–∂–∞ –±—Ä–æ–≤–µ–π, –ø–∏—Ä—Å–∏–Ω–≥–∞ –∏ —Ç–∞—Ç—É-—Å–∞–ª–æ–Ω–æ–≤ —Å —Ç–æ—á–∫–∏ –∑—Ä–µ–Ω–∏—è —Å–æ–±–ª—é–¥–µ–Ω–∏—è –≤ –Ω–∏—Ö —Å–∞–Ω–∏—Ç–∞—Ä–Ω–æ-–≥–∏–≥–∏–µ–Ω–∏—á–µ—Å–∫–∏—Ö –Ω–æ—Ä–º. –¢–µ–º–∞ –æ–±—Å—É–∂–¥–∞–ª–∞—Å—å –≤ —Å–≤—è–∑–∏ —Å –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–æ–π —Ä–∏—Å–∫–æ–≤ –∏–Ω—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–∏—è –≥–µ–ø–∞—Ç–∏—Ç–æ–º C –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QN2Fw #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–ò–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã–µ_–±–æ–ª–µ–∑–Ω–∏","{
  ""skip"": true
}"
2025-11-17T13:31:03+00:00,@medpharm,13578,https://t.me/medpharm/13578,–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –æ—Å–≤–æ–±–æ–¥–∏–ª–æ –æ—Ç –ø–ª–∞–Ω–æ–≤—ã—Ö –ø—Ä–æ–≤–µ—Ä–æ–∫ –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ —Ä—ã–Ω–∫–∞ –æ–±—Ä–∞—â–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤. –î–ª—è –∫–æ–≥–æ –æ—Å—Ç–∞–Ω—É—Ç—Å—è –ø—Ä–æ–≤–µ—Ä–∫–∏ –∏ –∫–∞–∫ —á–∞—Å—Ç–æ –∏—Ö –±—É–¥—É—Ç –ø—Ä–æ–≤–æ–¥–∏—Ç—å? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QMycK #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, regulation"",
  ""impact"": ""medium"",
  ""english"": ""The government has exempted most market participants from routine inspections. It is unclear who will still be inspected and how often these inspections will take place. For more information: https://clck.ru/3QMycK""
}"
2025-11-17T12:41:05+00:00,@medpharm,13577,https://t.me/medpharm/13577,–í–ª–∞–¥–∏–º–∏—Ä –ü—É—Ç–∏–Ω –ø–æ–¥–ø–∏—Å–∞–ª –∑–∞–∫–æ–Ω –æ –≤–≤–µ–¥–µ–Ω–∏–∏ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–≥–æ —Ç—Ä–µ—Ö–ª–µ—Ç–Ω–µ–≥–æ –ø–µ—Ä–∏–æ–¥–∞ –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–∞ –¥–ª—è –æ–∫–æ–Ω—á–∏–≤—à–∏—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –∫–æ–ª–ª–µ–¥–∂–∏ –∏ –≤—É–∑—ã. –î–æ–∫—É–º–µ–Ω—Ç –¥–æ—Å—Ç—É–ø–µ–Ω –Ω–∞ ¬´–ú–í¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QMu4L #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-11-17T12:09:03+00:00,@medpharm,13576,https://t.me/medpharm/13576,"–£ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∫–æ–º–ø–∞–Ω–∏–π –±—é–¥–∂–µ—Ç—ã –Ω–∞ –¥–∏–¥–∂–∏—Ç–∞–ª –∏ –º–∞—Ä–∫–µ—Ç–∏–Ω–≥ –Ω–∞ 24% –Ω–∏–∂–µ —Å—Ä–µ–¥–Ω–µ–≥–æ, –Ω–æ —Ä–∞—Å—Ç—É—Ç –±—ã—Å—Ç—Ä–µ–µ —Ä—ã–Ω–∫–∞ ‚Äî –Ω–∞ 31%. –í 2025 –≥–æ–¥—É –æ–∂–∏–¥–∞–µ—Ç—Å—è —Ä–æ—Å—Ç —ç—Ç–∏—Ö –∑–∞—Ç—Ä–∞—Ç –Ω–∞ 15% –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QMqnr #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-11-17T11:57:03+00:00,@medpharm,13575,https://t.me/medpharm/13575,"–ó–∞–º–≥–ª–∞–≤—ã –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–§ –°–µ—Ä–≥–µ–π –ì–ª–∞–≥–æ–ª–µ–≤ –ø—Ä–∏–∑–≤–∞–ª —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ —É—Å–∫–æ—Ä–∏—Ç—å—Å—è –∏ –ø—Ä–∏–≤–µ—Å—Ç–∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–æ–Ω–Ω—ã–µ –¥–æ—Å—å–µ –≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–µ —Å –Ω–æ—Ä–º–∞–º–∏ –ï–ê–≠–°. –≠—Ç–æ –Ω–∞–¥–æ —Å–¥–µ–ª–∞—Ç—å –≤ –±–ª–∏–∂–∞–π—à–∏–µ –Ω–µ–¥–µ–ª–∏ –∏–ª–∏ –¥–∞–∂–µ –¥–Ω–∏, –∏–Ω–∞—á–µ –∏—Ö –∂–¥—É—Ç –ø–æ—Å–ª–µ–¥—Å—Ç–≤–∏—è –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QMpWa #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""registration"",
  ""impact"": ""high"",
  ""english"": ""The Deputy Head of the Russian Ministry of Health, Sergey Glagolov, urged pharmaceutical companies to speed up and bring registration dossiers in line with EAEU norms. This must be done within the next few days or weeks, otherwise they will face consequences. More details: https://clck.ru/3QMpWa #PharmNews #Regulation""
}"
2025-11-17T11:32:06+00:00,@medpharm,13574,https://t.me/medpharm/13574,–£—á–µ–Ω—ã–µ –∏–∑ –£–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç—Å–∫–æ–≥–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ —Ü–µ–Ω—Ç—Ä–∞ –ú–∞–∞—Å—Ç—Ä–∏—Ö—Ç–∞ –æ—Ü–µ–Ω–∏–ª–∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –∏ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å zalunfiban —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –ø–æ–¥–æ–∑—Ä–µ–Ω–∏–µ–º –Ω–∞ –æ—Å—Ç—Ä—ã–π –∏–Ω—Ñ–∞—Ä–∫—Ç –º–∏–æ–∫–∞—Ä–¥–∞ —Å –ø–æ–¥—ä–µ–º–æ–º ST. –†–µ–∑—É–ª—å—Ç–∞—Ç—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è CELEBRATE –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω—ã –≤ –∂—É—Ä–Ω–∞–ª–µ NEJM Evidence –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QMnjt #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ö–∞—Ä–¥–∏–æ–ª–æ–≥–∏—è #–ù–µ–≤—Ä–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è,"{""skip"": true}"
2025-11-17T11:02:28+00:00,@medpharm,13573,https://t.me/medpharm/13573,"–°—Ç–∞–Ω—å—Ç–µ –ú–∞—Å—Ç–µ—Ä–∞–º–∏ –≤ —É–ø—Ä–∞–≤–ª–µ–Ω–∏–∏ –ø—Ä–æ–µ–∫—Ç–∞–º–∏ –∏ –ª—é–¥—å–º–∏ –ò–Ω—Ç–µ–Ω—Å–∏–≤–Ω–∞—è 7-–º–µ—Å—è—á–Ω–∞—è –ø—Ä–æ–≥—Ä–∞–º–º–∞ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–π –ø–µ—Ä–µ–ø–æ–¥–≥–æ—Ç–æ–≤–∫–∏ –ù–ò–£ ¬´–í—ã—Å—à–∞—è —à–∫–æ–ª–∞ —ç–∫–æ–Ω–æ–º–∏–∫–∏¬ª ¬´–£–ø—Ä–∞–≤–ª–µ–Ω–∏–µ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–º –±–∏–∑–Ω–µ—Å–æ–º. –°–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã–π –º–∞—Å—Ç–µ—Ä –≤ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–º –±–∏–∑–Ω–µ—Å–µ/Specialized Master in Pharmaceutical Business¬ª —Ä–∞—Å—Å—á–∏—Ç–∞–Ω–∞ –Ω–∞ —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª–µ–π –∏ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤, –∂–µ–ª–∞—é—â–∏—Ö –≥–ª—É–±–æ–∫–æ –∏–∑—É—á–∏—Ç—å –∏ –Ω–∞ –ø—Ä–∞–∫—Ç–∏–∫–µ –æ—Å–≤–æ–∏—Ç—å –ø–µ—Ä–µ–¥–æ–≤—ã–µ –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç—ã –≤ –æ–±–ª–∞—Å—Ç–∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ –º–µ–Ω–µ–¥–∂–º–µ–Ω—Ç–∞. –ö—É—Ä—Å –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–π –ø–µ—Ä–µ–ø–æ–¥–≥–æ—Ç–æ–≤–∫–∏ –¥–ª—è —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª–µ–π –∏ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ —Ñ–∞—Ä–º–∏–Ω–¥—É—Å—Ç—Ä–∏–∏ —Å—Ç–∞—Ä—Ç—É–µ—Ç 19 —è–Ω–≤–∞—Ä—è 2026 –≥. –£—Å–ø–µ–π—Ç–µ –ø–æ–ª—É—á–∏—Ç—å —Å–∫–∏–¥–∫—É –¥–æ 19 –¥–µ–∫–∞–±—Ä—è! –ü–æ–¥—Ä–æ–±–Ω–æ—Å—Ç–∏: https://clck.ru/3QMkTk","{""skip"": true}"
2025-11-17T10:47:02+00:00,@medpharm,13572,https://t.me/medpharm/13572,"–¶–µ–Ω—Ç—Ä –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –ø—Ä–∏–Ω–∏–º–∞–µ—Ç –∑–∞—è–≤–∫–∏ –Ω–∞ —É—á–∞—Å—Ç–∏–µ –≤ 22 –∞—É–∫—Ü–∏–æ–Ω–∞—Ö –Ω–∞ –ø–æ—Å—Ç–∞–≤–∫—É –ø–æ –ø—Ä–æ–≥—Ä–∞–º–º–µ –í–ó–ù –≥–µ–º–æ—Å—Ç–∞—Ç–∏–∫–æ–≤, –∏–º–º—É–Ω–æ–º–æ–¥—É–ª–∏—Ä—É—é—â–∏—Ö, –ø—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤—ã—Ö, –∏–º–º—É–Ω–æ–¥–µ–ø—Ä–µ—Å—Å–∏–≤–Ω—ã—Ö, —Ñ–µ—Ä–º–µ–Ω—Ç–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –≥–æ—Ä–º–æ–Ω–æ–≤ —Ä–æ—Å—Ç–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QMjPj #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""high"",
  ""english"": ""The Central Pharmacy Agency is accepting applications for participation in 22 auctions to supply under the program of biostatics, immunomodulatory, anticancer, immunosuppressive, enzymatic and growth hormone drugs. For more information: https://clck.ru/3QMjPj #PharmWeblink #Distribution""
}"
2025-11-17T10:39:05+00:00,@medpharm,13571,https://t.me/medpharm/13571,"–ë–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –≤—Ä–∞—á–µ–π –∏ —Å—Ç—É–¥–µ–Ω—Ç–æ–≤ –Ω–µ —Å—á–∏—Ç–∞—é—Ç –≤–≤–µ–¥–µ–Ω–∏–µ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–π –æ—Ç—Ä–∞–±–æ—Ç–∫–∏ –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã–º. –ú–Ω–æ–≥–∏–µ —É–≤–µ—Ä–µ–Ω—ã, —á—Ç–æ —Ç–∞–∫–∞—è –º–µ—Ä–∞ –≤ –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–µ –æ—Ç–ø—É–≥–Ω–µ—Ç —Ç–∞–ª–∞–Ω—Ç–ª–∏–≤—ã—Ö –∞–±–∏—Ç—É—Ä–∏–µ–Ω—Ç–æ–≤ –æ—Ç –ø–æ—Å—Ç—É–ø–ª–µ–Ω–∏—è –≤ –º–µ–¥–≤—É–∑—ã –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QMip3 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,hospital_policy,regulation"",
  ""impact"": ""medium"",
  ""english"": ""Most Russian doctors and students do not consider mandatory training for medical workers effective. Many believe that such a measure will discourage talented applicants from entering medical schools in the future. #Medvestnik #Healthcare #HealthSystemOrganization""
}"
2025-11-17T09:14:04+00:00,@medpharm,13570,https://t.me/medpharm/13570,–£–≥–æ–ª–æ–≤–Ω–æ–µ –¥–µ–ª–æ –≤–æ–∑–±—É–∂–¥–µ–Ω–æ –≤ —Å–≤—è–∑–∏ —Å —Ñ–∏–∫—Ç–∏–≤–Ω–æ–π –¥–∏—Å–ø–∞–Ω—Å–µ—Ä–∏–∑–∞—Ü–∏–µ–π –≤ –ö—Å—Ç–æ–≤—Å–∫–æ–π –¶–†–ë –≤ –ù–∏–∂–Ω–µ–≥–æ—Ä–æ–¥—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏. –ò.–æ. –≥–ª–∞–≤–Ω–æ–≥–æ –≤—Ä–∞—á–∞ –æ—Ç—Å—Ç—Ä–∞–Ω–∏–ª–∏ –æ—Ç –¥–æ–ª–∂–Ω–æ—Å—Ç–∏ –ø–æ—Å–ª–µ –∑–∞—è–≤–ª–µ–Ω–∏–π —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QMcNo #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-11-17T08:50:04+00:00,@medpharm,13569,https://t.me/medpharm/13569,"–õ–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏–∑ –ü–µ—Ä–µ—á–Ω—è –ñ–ù–í–õ–ü –≤ –æ–∫—Ç—è–±—Ä–µ –ø–æ–¥–æ—Ä–æ–∂–∞–ª–∏ –≤ —Å—Ä–µ–¥–Ω–µ–º –Ω–∞ 1% –∫ —Å–µ–Ω—Ç—è–±—Ä—é, —Å–ª–µ–¥—É–µ—Ç –∏–∑ –¥–∞–Ω–Ω—ã—Ö –†–æ—Å—Å—Ç–∞—Ç–∞. –†–æ—Å—Ç —Ü–µ–Ω –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, –Ω–µ –æ—Ç–Ω–æ—Å—è—â–∏–µ—Å—è –∫ –∂–∏–∑–Ω–µ–Ω–Ω–æ –≤–∞–∂–Ω—ã–º, —Å–æ—Å—Ç–∞–≤–∏–ª –≤ —Å—Ä–µ–¥–Ω–µ–º 1,2% –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QMaR9 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""price, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""Medicinal drugs on the Essential Medicines List (–ñ–ù–í–õ–ü) saw an average price increase of 1% in October compared to September, according to Rosstat data. The rise in prices for non-essential drugs averaged 1.2%. #PharmNews #Retail""
}"
2025-11-17T06:07:09+00:00,@medpharm,13568,https://t.me/medpharm/13568,–£—á–µ–Ω—ã–µ –∏–∑ –£–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –Ω–∞—É–∫ SUNY Downstate –≤ –ù—å—é-–ô–æ—Ä–∫–µ –æ—Ü–µ–Ω–∏–ª–∏ –≤–ª–∏—è–Ω–∏–µ —Ä–∞–∑–Ω—ã—Ö –ø–æ–¥—Ö–æ–¥–æ–≤ –∫ –ø–µ—Ä–µ–ª–∏–≤–∞–Ω–∏—é –∫—Ä–æ–≤–∏ —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –≤—ã—Å–æ–∫–∏–º —Ä–∏—Å–∫–æ–º —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –ø–æ—Å–ª–µ –∫—Ä—É–ø–Ω—ã—Ö –æ–ø–µ—Ä–∞—Ü–∏–π. –†–µ–∑—É–ª—å—Ç–∞—Ç—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω—ã –≤ –∂—É—Ä–Ω–∞–ª–µ JAMA. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QMKdL #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ö–∞—Ä–¥–∏–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–•–∏—Ä—É—Ä–≥–∏—è,"{""skip"": true}"
2025-11-16T11:51:01+00:00,@medpharm,13567,https://t.me/medpharm/13567,"üëçüëçüëçüëçüëçüëç –ü—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º TOP5 —Å–æ–±—ã—Ç–∏–π –Ω–µ–¥–µ–ª–∏, –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω–Ω—ã—Ö –≤ –ª–µ–Ω—Ç–µ –Ω–æ–≤–æ—Å—Ç–µ–π ¬´–§–í¬ª. –ì–æ—Å–¥—É–º–∞ –†–§ –ø—Ä–∏–Ω—è–ª–∞ –≤ —Ç—Ä–µ—Ç—å–µ–º —á—Ç–µ–Ω–∏–∏ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ–± –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–º —Ü–µ–ª–µ–≤–æ–º –æ–±—É—á–µ–Ω–∏–∏ –∏ —É—á–∞—Å—Ç–∏–∏ –≤ –ø—Ä–æ–≥—Ä–∞–º–º–µ –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–∞ —Å—Ç—É–¥–µ–Ω—Ç–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –æ–±—Ä–∞–∑–æ–≤–∞—Ç–µ–ª—å–Ω—ã—Ö –ø—Ä–æ–≥—Ä–∞–º–º, –≤–ø–µ—Ä–≤—ã–µ –ø—Ä–æ—à–µ–¥—à–∏—Ö –ø–µ—Ä–≤–∏—á–Ω—É—é –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏—é —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞. –ú–∏–Ω—Ñ–∏–Ω –†–§ —Ä–∞–∑—ä—è—Å–Ω–∏–ª –ø–æ—Ä—è–¥–æ–∫ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –ø—Ä–∞–≤–∏–ª–∞ ¬´–≤—Ç–æ—Ä–æ–π –ª–∏—à–Ω–∏–π¬ª –ø—Ä–∏ –∑–∞–∫—É–ø–∫–∞—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤. –û–≥—Ä–∞–Ω–∏—á–µ–Ω–∏–µ –Ω–∞ –∑–∞–∫—É–ø–∫—É –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –ø—Ä–æ–∏–∑–≤–µ–¥–µ–Ω–Ω—ã—Ö –∑–∞ –ø—Ä–µ–¥–µ–ª–∞–º–∏ –ï–ê–≠–°, –±—É–¥–µ—Ç –¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å —Ç–æ–ª—å–∫–æ –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞, –≤–∫–ª—é—á–µ–Ω–Ω—ã–µ –≤ –ü–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü. –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§ –¥–æ–ø–æ–ª–Ω–∏–ª–æ –ø–µ—Ä–µ—á–µ–Ω—å —Å–∏–ª—å–Ω–æ–¥–µ–π—Å—Ç–≤—É—é—â–∏—Ö –∏ —è–¥–æ–≤–∏—Ç—ã—Ö –≤–µ—â–µ—Å—Ç–≤ 11 –Ω–æ–≤—ã–º–∏ –ø–æ–∑–∏—Ü–∏—è–º–∏, —É—Å—Ç–∞–Ω–æ–≤–∏–≤ –¥–ª—è –Ω–∏—Ö –ø–æ—Ä–æ–≥–æ–≤—ã–µ –∑–Ω–∞—á–µ–Ω–∏—è. –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§ —É–ø—Ä–∞–∑–¥–Ω–∏–ª–æ —Å–∏—Å—Ç–µ–º—É –∏–Ω—Å–ø–µ–∫—Ç–∏—Ä–æ–≤–∞–Ω–∏—è –ø–æ –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—ã–º –ø—Ä–∞–≤–∏–ª–∞–º –Ω–∞–¥–ª–µ–∂–∞—â–µ–π –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω–æ–π –ø—Ä–∞–∫—Ç–∏–∫–∏ (GMP). –†–µ—à–µ–Ω–∏–µ –ø—Ä–∏–Ω—è—Ç–æ –≤ —Ä–∞–º–∫–∞—Ö –ø–µ—Ä–µ—Ö–æ–¥–∞ –∫ –ü—Ä–∞–≤–∏–ª–∞–º GMP –ï–≤—Ä–∞–∑–∏–π—Å–∫–æ–≥–æ —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–≥–æ —Å–æ—é–∑–∞. –†–ë–ö –∏ Forbes –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∏ —Ä–µ–π—Ç–∏–Ω–≥–∏ –ª—É—á—à–∏—Ö —Ä–∞–±–æ—Ç–æ–¥–∞—Ç–µ–ª–µ–π –∑–∞ 2025 –≥–æ–¥. –í —ç—Ç–æ–º –≥–æ–¥—É –≤ —Ä–µ–π—Ç–∏–Ω–≥ –æ—Ç –†–ë–ö –≤–æ—à–ª–∏ —à–µ—Å—Ç—å —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π. –í —Ä–µ–π—Ç–∏–Ω–≥ Forbes –≤–∫–ª—é—á–∏–ª–∏ —Å–µ–º—å —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing, import_export, sanctions"",
  ""impact"": ""high"",
  ""english"": ""The Russian Duma approved the third reading of a law on mandatory targeted training and participation in mentoring programs for students of medical and pharmaceutical educational programs who have passed the initial accreditation. The Russian Finance Ministry clarified the rules for applying the 'second extra' rule in procurement of medicines. Restrictions on purchasing drugs produced outside the Eurasian Economic Union will apply only to those included in the List of Highly Dangerous and Toxic Substances. The Russian government added 11 new substances to the list of strong acting and toxic substances with threshold values. The Russian government abolished the national rules inspection system for Good Manufacturing Practices (GMP) in favor of EAEU GMP standards. RBC and Forbes released rankings of the best employers for 2025. This year, six pharmaceutical companies were included in RBC's ranking and seven in Forbes' ranking.""
}"
2025-11-15T08:43:01+00:00,@medpharm,13566,https://t.me/medpharm/13566,"üß©üß©üß©üß©üß©üß© –†–µ–π—Ç–∏–Ω–≥ –≥–ª–∞–≤–Ω—ã—Ö –Ω–æ–≤–æ—Å—Ç–µ–π –Ω–µ–¥–µ–ª–∏ –≤ –ø—É–±–ª–∏–∫–∞—Ü–∏—è—Ö –ª–µ–Ω—Ç—ã –Ω–æ–≤–æ—Å—Ç–µ–π ¬´–ú–í¬ª. –ì–æ—Å–¥—É–º–∞ –†–§ –Ω–∞ —ç—Ç–æ–π –Ω–µ–¥–µ–ª–µ –ø—Ä–∏–Ω—è–ª–∞ –≤ –æ–∫–æ–Ω—á–∞—Ç–µ–ª—å–Ω–æ–º —á—Ç–µ–Ω–∏–∏ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ–± –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã—Ö –æ—Ç—Ä–∞–±–æ—Ç–∫–∞—Ö –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∫–æ–ª–ª–µ–¥–∂–µ–π –∏ –≤—É–∑–æ–≤. –í —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–∏ —Å –ø–æ–ø—Ä–∞–≤–∫–∞–º–∏ –≤—Å–µ–º –ø–æ–ª—É—á–∏–≤—à–∏–º –≤—ã—Å—à–µ–µ –∏ —Å—Ä–µ–¥–Ω–µ–µ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–µ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞–º –ø–æ—Å–ª–µ 2026 –≥–æ–¥–∞ –ø—Ä–∏–¥–µ—Ç—Å—è –ø—Ä–æ–π—Ç–∏ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–π —Ç—Ä–µ—Ö–ª–µ—Ç–Ω–∏–π –ø–µ—Ä–∏–æ–¥ –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–∞ –≤ –∫–ª–∏–Ω–∏–∫–∞—Ö, –∫–æ—Ç–æ—Ä—ã–µ —Ä–∞–±–æ—Ç–∞—é—Ç –≤ —Å–∏—Å—Ç–µ–º–µ –û–ú–°. –ù–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ –≤ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω–æ–º TOP5 –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–µ –¥–µ–ø—É—Ç–∞—Ç–æ–≤ –æ—Ç –ö–ü–†–§ —É—Å—Ç–∞–Ω–æ–≤–∏—Ç—å –º–∏–Ω–∏–º–∞–ª—å–Ω—ã–µ –±–∞–∑–æ–≤—ã–µ —Å—Ç–∞–≤–∫–∏ –∑–∞—Ä–∞–±–æ—Ç–Ω–æ–π –ø–ª–∞—Ç—ã –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤. –°–æ–≥–ª–∞—Å–Ω–æ –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–µ —Å—Ç–∞–≤–∫–∞ –≤—Ä–∞—á–∞ –¥–æ–ª–∂–Ω–∞ —Å–æ—Å—Ç–∞–≤–ª—è—Ç—å –Ω–µ –º–µ–Ω–µ–µ —Ç—Ä–µ—Ö–∫—Ä–∞—Ç–Ω–æ–≥–æ –º–∏–Ω–∏–º–∞–ª—å–Ω–æ–≥–æ —Ä–∞–∑–º–µ—Ä–∞ –æ–ø–ª–∞—Ç—ã —Ç—Ä—É–¥–∞, —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–Ω–æ–≥–æ –≤ —Ä–µ–≥–∏–æ–Ω–µ. –¢—Ä–µ—Ç—å—é —Å—Ç—Ä–æ—á–∫—É –Ω–æ–≤–æ—Å—Ç–Ω–æ–≥–æ —Ä–µ–π—Ç–∏–Ω–≥–∞ –Ω–µ–¥–µ–ª–∏ –∑–∞–Ω—è–ª–æ —Å–æ–æ–±—â–µ–Ω–∏–µ, —á—Ç–æ –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§ –≤–Ω–µ—Å–ª–æ –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ –ü—Ä–∞–≤–∏–ª–∞ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—è –ø–µ—Ä–µ—á–Ω–µ–π –ª–µ–∫–∞—Ä—Å—Ç–≤. –í —Å–æ—Å—Ç–∞–≤ —Ä–∞—Å—Å–º–∞—Ç—Ä–∏–≤–∞—é—â–µ–π –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã-–∫–∞–Ω–¥–∏–¥–∞—Ç—ã –∫–æ–º–∏—Å—Å–∏–∏ –≤–æ–π–¥–µ—Ç –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª—å –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–π –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏. –ù–∞ —á–µ—Ç–≤–µ—Ä—Ç–æ–º –º–µ—Å—Ç–µ –≤ TOP5 –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è –æ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏—è—Ö –ö–æ–º–∏—Ç–µ—Ç–∞ –ì–æ—Å–¥—É–º—ã –†–§ –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è –ø—Ä–∏–Ω—è—Ç—å –≤–æ –≤—Ç–æ—Ä–æ–º —á—Ç–µ–Ω–∏–∏ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç, –¥–æ–ø—É—Å–∫–∞—é—â–∏–π –∏—Å–∫–ª—é—á–µ–Ω–∏–µ —á–∞—Å—Ç–Ω—ã—Ö —Å—Ç—Ä–∞—Ö–æ–≤—ã—Ö –∫–æ–º–ø–∞–Ω–∏–π –∏–∑ —Å–∏—Å—Ç–µ–º—ã –û–ú–°. –†–∞–∑—Ä–∞–±–æ—Ç–∞–Ω –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç, –∫–æ—Ç–æ—Ä—ã–º –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è –æ–±—è–∑–∞—Ç—å –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—è –ø–µ—Ä–µ–¥–∞–≤–∞—Ç—å –ø–æ–ª–∏—Ü–∏–∏ —Å–≤–µ–¥–µ–Ω–∏—è –æ –Ω–µ–æ—Ç–ª–æ–∂–Ω–æ–π –ø–æ–º–æ—â–∏ –∏–Ω–æ—Å—Ç—Ä–∞–Ω—Ü–∞–º –±–µ–∑ –ø–æ–ª–∏—Å–∞ –û–ú–° –∏–ª–∏ –î–ú–°.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, import_export, sanctions"",
  ""impact"": ""high"",
  ""english"": ""The Russian Duma has passed a law requiring medical graduates to undergo a three-year apprenticeship period in the public health system starting from 2026. The proposal by KPRF deputies to set minimum base salaries for healthcare workers is also on the agenda. The Russian government has revised rules for creating a list of medicines, with an observer from a public organization to be part of the commission. A draft law is also being considered that would require hospitals to provide police with information on non-emergency care for foreigners without an OMS or DMS insurance.""
}"
2025-11-15T06:12:04+00:00,@medpharm,13565,https://t.me/medpharm/13565,"–£—á–µ–Ω—ã–µ –∏–∑ –¢–µ—Ö–∞—Å—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ –≤ –ú–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π —à–∫–æ–ª–µ –û—Å—Ç–∏–Ω–∞ –î–µ–ª–ª–∞ –æ—Ü–µ–Ω–∏–ª–∏ –≤–ª–∏—è–Ω–∏–µ –Ω–∏–∫–æ—Ç–∏–Ω–∞–º–∏–¥–∞ –Ω–∞ —Ä–∏—Å–∫ —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö —Å–æ–±—ã—Ç–∏–π —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –ø–æ–ª—É—á–∞–≤—à–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –Ω–µ–º–µ–ª–∞–Ω–æ–º–Ω—ã—Ö –æ–ø—É—Ö–æ–ª–µ–π –∫–æ–∂–∏. –†–µ–∑—É–ª—å—Ç–∞—Ç—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω—ã –≤ –∂—É—Ä–Ω–∞–ª–µ JAAD –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QKqaG #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞","{""skip"": true}"
2025-11-15T04:49:03+00:00,@medpharm,13564,https://t.me/medpharm/13564,–ì–æ—Å–¥—É–º–∞ –†–§ –Ω–∞ —ç—Ç–æ–π –Ω–µ–¥–µ–ª–µ –ø—Ä–∏–Ω—è–ª–∞ –≤ –æ–∫–æ–Ω—á–∞—Ç–µ–ª—å–Ω–æ–º —á—Ç–µ–Ω–∏–∏ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ–± –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã—Ö –æ—Ç—Ä–∞–±–æ—Ç–∫–∞—Ö –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∫–æ–ª–ª–µ–¥–∂–µ–π –∏ –≤—É–∑–æ–≤. –ß—Ç–æ —ç—Ç–æ –∑–Ω–∞—á–∏—Ç –¥–ª—è –±—É–¥—É—â–∏—Ö –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –∏ –¥—Ä—É–≥–∏–µ –Ω–æ–≤–æ—Å—Ç–∏ —Ä–∞–±–æ—á–µ–π –ø—è—Ç–∏–¥–Ω–µ–≤–∫–∏ –≤ –¥–∞–π–¥–∂–µ—Å—Ç–µ ¬´–ú–í¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QKnue #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-11-14T17:12:01+00:00,@medpharm,13563,https://t.me/medpharm/13563,"ü¶æ –ó–¥–æ—Ä–æ–≤—å–µ –∫—É–ø–∏—à—å. –î–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –¥–ª—è –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö —Ä–æ—Å—Å–∏—è–Ω –ø–æ—á—Ç–∏ –Ω–µ –∏–∑–º–µ–Ω–∏–ª–∞—Å—å –≤ –ø–µ—Ä–∏–æ–¥ —Å 2011 –ø–æ 2021 –≥–æ–¥. –ù–æ –Ω–∞ —à–∞–Ω—Å—ã –ø–æ–ª—É—á–∏—Ç—å –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ–µ –ª–µ—á–µ–Ω–∏–µ —Å—Ç–∞–ª–∏ —Å–∏–ª—å–Ω–µ–µ –≤–ª–∏—è—Ç—å –¥–æ—Ö–æ–¥ –∏ –Ω–∞–ª–∏—á–∏–µ —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. ü¶æ –ó–∞—Ä–ø–ª–∞—Ç–Ω—ã–π –ø—Ä–æ–∂–µ–∫—Ç. –ì—Ä—É–ø–ø–∞ –¥–µ–ø—É—Ç–∞—Ç–æ–≤ –æ—Ç –ö–ü–†–§ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª–∞ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç, –∫–æ—Ç–æ—Ä—ã–º –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è —É—Å—Ç–∞–Ω–æ–≤–∏—Ç—å –º–∏–Ω–∏–º–∞–ª—å–Ω—ã–µ –±–∞–∑–æ–≤—ã–µ —Å—Ç–∞–≤–∫–∏ –∑–∞—Ä–∞–±–æ—Ç–Ω–æ–π –ø–ª–∞—Ç—ã –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤. –°–æ–≥–ª–∞—Å–Ω–æ –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–µ —Å—Ç–∞–≤–∫–∞ –≤—Ä–∞—á–∞ –¥–æ–ª–∂–Ω–∞ —Å–æ—Å—Ç–∞–≤–ª—è—Ç—å –Ω–µ –º–µ–Ω–µ–µ —Ç—Ä–µ—Ö–∫—Ä–∞—Ç–Ω–æ–≥–æ –º–∏–Ω–∏–º–∞–ª—å–Ω–æ–≥–æ —Ä–∞–∑–º–µ—Ä–∞ –æ–ø–ª–∞—Ç—ã —Ç—Ä—É–¥–∞, —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–Ω–æ–≥–æ –≤ —Ä–µ–≥–∏–æ–Ω–µ. ‚ù§Ô∏è –í–∑–ª—è–¥ –≤ –ø—Ä–æ—à–ª–æ–µ. –§–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ —Å—Ç–æ–ª–∫–Ω—É–ª–∏—Å—å —Å –∏—Å–∫–∞–º–∏ –æ—Ç –ø—Ä–æ–∫—É—Ä–∞—Ç—É—Ä—ã –æ –ø—Ä–∏–∑–Ω–∞–Ω–∏–∏ —Å–¥–µ–ª–æ–∫ –Ω–µ–¥–µ–π—Å—Ç–≤–∏—Ç–µ–ª—å–Ω—ã–º–∏ —Å–ø—É—Å—Ç—è –≥–æ–¥—ã –ø–æ—Å–ª–µ –∏—Å–ø–æ–ª–Ω–µ–Ω–∏—è –≥–æ—Å–∫–æ–Ω—Ç—Ä–∞–∫—Ç–æ–≤. –ü—Ä–æ–∫—É—Ä–∞—Ç—É—Ä–∞ —á–µ—Ä–µ–∑ —Å—É–¥ –∑–∞—Å—Ç–∞–≤–ª—è–µ—Ç –ø–æ—Å—Ç–∞–≤—â–∏–∫–æ–≤ –≤–µ—Ä–Ω—É—Ç—å –¥–µ–Ω—å–≥–∏ –∑–∞ —Ç–æ–≤–∞—Ä—ã, —Ö–æ—Ç—è —É –∑–∞–∫–∞–∑—á–∏–∫–æ–≤ –Ω–µ—Ç –ø—Ä–µ—Ç–µ–Ω–∑–∏–π. ¬´–§–í¬ª –∏–∑—É—á–∏–ª –ø–æ–¥–æ–±–Ω—ã–µ –¥–µ–ª–∞ –∏ –º–Ω–µ–Ω–∏—è —é—Ä–∏—Å—Ç–æ–≤. ‚ù§Ô∏è –£—á–µ–Ω—å–µ ‚Äî —Å–≤–µ—Ç. –ö–∞–∫–æ–µ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ –≤—ã–±–∏—Ä–∞—é—Ç —Ñ–∞—Ä–º—Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã? –°–æ—é–∑ ¬´–ü—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–µ —Å–æ–æ–±—â–µ—Å—Ç–≤–æ –ø—Ä–æ–≤–∏–∑–æ—Ä–æ–≤ –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–æ–≤¬ª –ø–æ–¥–≤–µ–ª –∏—Ç–æ–≥–∏ –æ–ø—Ä–æ—Å–∞.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""The survey highlights that the accessibility of healthcare for surveyed Russians has not significantly changed from 2011 to 2021. However, the chances of obtaining necessary treatment are now more influenced by income and chronic diseases.""
}"
2025-11-14T16:48:03+00:00,@medpharm,13562,https://t.me/medpharm/13562,"–†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä –ø–æ–º–µ–Ω—è–ª —Ä–µ—à–µ–Ω–∏–µ –ø–æ –≤–µ–Ω–¥–∏–Ω–≥–æ–≤—ã–º –∞–ø–ø–∞—Ä–∞—Ç–∞–º. –†–∞–∑–æ—Å–ª–∞–Ω–Ω–æ–µ —Ä–∞–Ω–µ–µ –≤ —Ç–µ—Ä–æ—Ä–≥–∞–Ω—ã –ø–∏—Å—å–º–æ ¬´–æ—Ç–º–µ–Ω–µ–Ω–æ –≤ —á–∞—Å—Ç–∏ –æ–±—Ä–∞—â–µ–Ω–∏—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π¬ª, —É–∑–Ω–∞–ª ¬´–§–í¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QKbUN #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The Russian Health Supervision changed the decision regarding vending machines. A previously distributed letter 'withdrawn in part concerning medical devices' was canceled, as announced by 'FV'. More details: https://clck.ru/3QKbUN #PharmNews #Retail""
}"
2025-11-14T16:19:04+00:00,@medpharm,13561,https://t.me/medpharm/13561,"–°—É–¥ –ø–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç—É–∞–ª—å–Ω—ã–º –ø—Ä–∞–≤–∞–º –æ—Ç–∫–ª–æ–Ω–∏–ª –ø—Ä–µ—Ç–µ–Ω–∑–∏–∏ –§–ê–° –†–æ—Å—Å–∏–∏ –∏ —Ä—è–¥–∞ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π –∫ ¬´–ê–∫—Å–µ–ª—å–§–∞—Ä–º—É¬ª. –†–µ—à–µ–Ω–∏–µ –ø–æ —Å–ø–æ—Ä—É –æ –≤—ã–≤–æ–¥–µ –Ω–∞ —Ä—ã–Ω–æ–∫ –∞–∫—Å–∏—Ç–∏–Ω–∏–±–∞ —Å –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ–º –ø–∞—Ç–µ–Ω—Ç–æ–≤, –Ω–∞—Ö–æ–¥—è—â–∏—Ö—Å—è –ø–æ–¥ –∑–∞—â–∏—Ç–æ–π, –æ—Å—Ç–∞–≤–ª–µ–Ω–æ –≤ —Å–∏–ª–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QKZtY #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""high"",
  ""english"": ""The Intellectual Property court dismissed the claims of FAS Russia and several pharmaceutical companies against 'Axil Pharma' regarding the market release of axitinib using patents under protection. The ruling on the dispute over the market release of axitinib using protected patents is left in force. For more details: https://clck.ru/3QKZtY #Farvestik #Regulatorka""
}"
2025-11-14T15:19:06+00:00,@medpharm,13560,https://t.me/medpharm/13560,–í–ø–µ—Ä–≤—ã–µ –∑–∞ –º–Ω–æ–≥–æ –ª–µ—Ç –≤ –†–æ—Å—Å–∏–∏ –Ω–µ –æ–ø—É–±–ª–∏–∫–æ–≤–∞–ª–∏ –¥–∞–Ω–Ω—ã–µ –æ —Å–º–µ—Ä—Ç–Ω–æ—Å—Ç–∏ –æ—Ç —Ä–∞–∫–∞. –†–æ—Å—Å—Ç–∞—Ç –ø–µ—Ä–µ—Å—Ç–∞–ª –ø–æ—Å—Ç–∞–≤–ª—è—Ç—å –æ—Å–Ω–æ–≤–Ω—ã–µ –¥–µ–º–æ–≥—Ä–∞—Ñ–∏—á–µ—Å–∫–∏–µ –ø–æ–∫–∞–∑–∞—Ç–µ–ª–∏ —Å –º–∞—Ä—Ç–∞ 2025 –≥–æ–¥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QKWZb #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û–Ω–∫–æ–ª–æ–≥–∏—è #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,hospital_policy,pharmacovigilance,safety"",
  ""impact"": ""medium"",
  ""english"": ""There has been a significant gap in the publication of cancer mortality data in Russia for several years. The Rosstat has also stopped providing essential demographic indicators since March 2025.""
}"
2025-11-14T15:09:03+00:00,@medpharm,13559,https://t.me/medpharm/13559,–ö–∞–∫–æ–µ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ –≤—ã–±–∏—Ä–∞—é—Ç —Ñ–∞—Ä–º—Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã? –°–æ—é–∑ ¬´–ü—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–µ —Å–æ–æ–±—â–µ—Å—Ç–≤–æ –ø—Ä–æ–≤–∏–∑–æ—Ä–æ–≤ –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–æ–≤¬ª –ø—Ä–æ–≤–µ–ª –æ–ø—Ä–æ—Å —Å—Ä–µ–¥–∏ —Ñ–∞—Ä–º—Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QKW5h #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–∞—Ä—å–µ—Ä–∞,"{""skip"": true}"
2025-11-14T14:30:05+00:00,@medpharm,13558,https://t.me/medpharm/13558,"–î–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –¥–ª—è —Ä–æ—Å—Å–∏—è–Ω –ø–æ—á—Ç–∏ –Ω–µ –∏–∑–º–µ–Ω–∏–ª–∞—Å—å –≤ –ø–µ—Ä–∏–æ–¥ —Å 2011 –ø–æ 2021 –≥–æ–¥, –Ω–æ –∑–∞–º–µ—Ç–Ω–æ –≤—ã—Ä–æ—Å —Ä–∞–∑—Ä—ã–≤ –º–µ–∂–¥—É –±–æ–≥–∞—Ç—ã–º–∏ –∏ –±–µ–¥–Ω—ã–º–∏. –ü—Ä–∏ —ç—Ç–æ–º —à–∞–Ω—Å—ã –ø–æ–ø–∞—Å—Ç—å –∫ –≤—Ä–∞—á—É –≤ –†–æ—Å—Å–∏–∏ –ø—Ä–∏–º–µ—Ä–Ω–æ –≤ –¥–≤–∞ —Ä–∞–∑–∞ –≤—ã—à–µ —Å—Ä–µ–¥–Ω–µ–≥–æ –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è —Å—Ä–µ–¥–∏ –∏–∑—É—á–µ–Ω–Ω—ã—Ö —Å—Ç—Ä–∞–Ω. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QKTtU #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, shortage"",
  ""impact"": ""medium"",
  ""english"": ""There has been little change in the accessibility of medical assistance for Russians over the period from 2011 to 2021. There has been a noticeable increase in the gap between wealthy and poor people. The chances of getting to see a doctor in Russia are about twice the average level among the studied countries.""
}"
2025-11-14T14:20:02+00:00,@medpharm,13557,https://t.me/medpharm/13557,–†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä –ø—Ä–µ–∫—Ä–∞—Ç–∏–ª –æ–±—Ä–∞—â–µ–Ω–∏–µ —Å–µ—Ä–∏–π ¬´–¶–µ—Ñ—Ç—Ä–∏–∞–∫—Å–æ–Ω–∞¬ª –∏ ¬´–ë–µ—Ç–∞–≥–∏—Å—Ç–∏–Ω–∞¬ª. –ü—Ä–µ—Ç–µ–Ω–∑–∏–∏ –≤–æ–∑–Ω–∏–∫–ª–∏ –∫ –¥–≤—É–º –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QKTFR #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–û—Ç–∑—ã–≤—ã,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""shortage, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The Russian Health Supervision authority has suspended the series of 'Ceftriaxon' and 'Betagistina'. Complaints arose regarding two indicators. More details: https://clck.ru/3QKTFR #PharmNews #DrugWithdrawals""
}"
2025-11-14T13:46:06+00:00,@medpharm,13556,https://t.me/medpharm/13556,–í –°–æ–≤–µ—Ç–µ –§–µ–¥–µ—Ä–∞—Ü–∏–∏ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤—É –†–§ —Å–æ–∑–¥–∞—Ç—å –≤—Ä–µ–º–µ–Ω–Ω—ã–π –ø–µ—Ä–µ—á–µ–Ω—å –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è —É—Å–∫–æ—Ä–µ–Ω–∏—è –∏—Ö –≤–∫–ª—é—á–µ–Ω–∏—è –≤ –ø—Ä–æ–≥—Ä–∞–º–º—É –ª—å–≥–æ—Ç–Ω–æ–≥–æ –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è. –í –≤–µ–¥–æ–º—Å—Ç–≤–µ –ø–æ–æ–±–µ—â–∞–ª–∏ ¬´–ø—Ä–æ—Ä–∞–±–æ—Ç–∞—Ç—å –≤–æ–ø—Ä–æ—Å¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QKR3y #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The Council of Federation proposed to the Ministry of Health of Russia to create a temporary list of innovative drugs for their accelerated inclusion in the program of preferential provision. The department promised to 'work out the question'. More details: https://clck.ru/3QKR3y #MedVestnik #Healthcare""
}"
2025-11-14T13:13:10+00:00,@medpharm,13555,https://t.me/medpharm/13555,–†–µ–≥–∏—Å—Ç—Ä–∏—Ä—É–π—Ç–µ—Å—å –Ω–∞ –±–µ—Å–ø–ª–∞—Ç–Ω—ã–π –æ–±—Ä–∞–∑–æ–≤–∞—Ç–µ–ª—å–Ω—ã–π –∏–Ω—Ç–µ—Ä–∞–∫—Ç–∏–≤ –ø–æ –≤–æ–ø—Ä–æ—Å–∞–º –¥–µ—Ç—Å–∫–æ–≥–æ –ø–∏—Ç–∞–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QKNoa #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–ü–µ–¥–∏–∞—Ç—Ä–∏—è,"{""skip"": true}"
2025-11-14T12:57:02+00:00,@medpharm,13554,https://t.me/medpharm/13554,–î–µ–ø—É—Ç–∞—Ç –ì–æ—Å–¥—É–º—ã –†–§ –ï–≤–≥–µ–Ω–∏–π –ù–∏—Ñ–∞–Ω—Ç—å–µ–≤ –ø—Ä–µ–¥–ª–æ–∂–∏–ª —Ä–∞–∑—Ä–∞–±–æ—Ç–∞—Ç—å –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–π –∫–æ–º–ø–ª–µ–∫—Å –º–µ—Ä –ø—Ä–æ—Ç–∏–≤ –ø—Ä–æ–¥–∞–∂–∏ –Ω–∞ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞—Ö –ø—Å–µ–≤–¥–æ–º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π. –ö–∞–∫–∏–µ –º–µ—Ä—ã –º–æ–≥—É—Ç –ø—Ä–∏–Ω—è—Ç—å –¥–ª—è –∑–∞—â–∏—Ç—ã –ø–æ–∫—É–ø–∞—Ç–µ–ª–µ–π –æ—Ç –Ω–µ—Å–µ—Ä—Ç–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QKMmy #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, regulation"",
  ""impact"": ""high"",
  ""english"": ""Deputy of the State Duma, Evgeny Nifantiev proposed to develop additional measures against pseudomedicine products on marketplaces. What actions can be taken to protect consumers from uncertified products?""
}"
2025-11-14T12:31:07+00:00,@medpharm,13553,https://t.me/medpharm/13553,"–°–ø–∏—Å–æ–∫ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –¥–ª—è –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –Ω–µ–∏–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ —Ä–∞—Å—à–∏—Ä–∏—Ç—å. –ù–æ–≤—ã–µ –ø—Ä–∏–±–æ—Ä—ã –≤ –ø–µ—Ä–µ—á–Ω–µ –¥–æ–ª–∂–Ω—ã –ø–æ–º–æ—á—å –≤ –æ—Ü–µ–Ω–∫–µ –≤ —Ç–æ–º —á–∏—Å–ª–µ –∫–æ–≥–Ω–∏—Ç–∏–≤–Ω—ã—Ö —Ñ—É–Ω–∫—Ü–∏–π, –æ—Ç–º–µ—á–∞–µ—Ç –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QKL3R #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-11-14T11:59:22+00:00,@medpharm,13552,https://t.me/medpharm/13552,"–í –†–æ—Å—Å–∏–∏ –ø—Ä–∏–Ω—è—Ç –∑–∞–∫–æ–Ω –æ–± –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã—Ö –æ—Ç—Ä–∞–±–æ—Ç–∫–∞—Ö –¥–ª—è –≤—Ä–∞—á–µ–π –∏ –º–µ–¥—Å–µ—Å—Ç–µ—Ä: –∫–∞–∫ —ç—Ç–æ –±—É–¥–µ—Ç —Ä–∞–±–æ—Ç–∞—Ç—å? ¬´–ú–í¬ª —Ä–∞–∑–æ–±—Ä–∞–ª, –∫ —á–µ–º—É –Ω–∞–¥–æ –±—ã—Ç—å –≥–æ—Ç–æ–≤—ã–º–∏ –±—É–¥—É—â–∏–º –º–µ–¥–∏–∫–∞–º. #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫","{""skip"": true}"
2025-11-14T11:48:03+00:00,@medpharm,13551,https://t.me/medpharm/13551,"–ü—Ä–æ–¥—É–∫—Ü–∏—é –Ω–∞ —ç—Ç–∞–ø–µ –≥–æ—Å–∑–∞–∫—É–ø–æ–∫ –±—É–¥—É—Ç –ø—Ä–æ–≤–µ—Ä—è—Ç—å —á–µ—Ä–µ–∑ —Å–∏—Å—Ç–µ–º—É ¬´–ß–µ—Å—Ç–Ω—ã–π –∑–Ω–∞–∫¬ª. –ù–æ–≤—ã–π —Ä–∞–∑—Ä–µ—à–∏—Ç–µ–ª—å–Ω—ã–π —Ä–µ–∂–∏–º, —É–∂–µ —Ä–∞–±–æ—Ç–∞—é—â–∏–π –≤ —Ä–æ–∑–Ω–∏—Ü–µ, —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–∏—Ç—Å—è –Ω–∞ –≤—Å–µ –≥–æ—Å–∑–∞–∫—É–ø–∫–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QKGyE #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""high"",
  ""english"": ""Tender processes will be verified through the 'Fair Deal' system. A new authorization mode, already in place for retail, will be applied to all tender procurements.""
}"
2025-11-14T10:59:03+00:00,@medpharm,13550,https://t.me/medpharm/13550,"–í –°–æ–≤—Ñ–µ–¥–µ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤—É –†–§ —Å–ø–æ—Å–æ–± —É—Å–∫–æ—Ä–∏—Ç—å –¥–æ—Å—Ç—É–ø —Ä–æ—Å—Å–∏—è–Ω –∫ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º, –ø–∏—à—É—Ç ¬´–ò–∑–≤–µ—Å—Ç–∏—è¬ª. –ú–µ—Ä–∞ –¥–æ–ª–∂–Ω–∞ —É–ø—Ä–æ—Å—Ç–∏—Ç—å –ø–æ–ø–∞–¥–∞–Ω–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ –ü–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü –∏ —Å–Ω–∏–∑–∏—Ç—å –Ω–∞–≥—Ä—É–∑–∫—É –Ω–∞ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã–µ –±—é–¥–∂–µ—Ç—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QKDcL #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The Federation Council proposed a method to speed up access for Russians to innovative drugs. The measure aims to simplify the entry of medicines into the Priority Medicines List and reduce regional budget burden. More details: https://clck.ru/3QKDcL #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞""
}"
2025-11-14T10:32:04+00:00,@medpharm,13549,https://t.me/medpharm/13549,"–†–∞–∑—Ä–∞–±–æ—Ç–∞–Ω –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç, —É—Å—Ç–∞–Ω–∞–≤–ª–∏–≤–∞—é—â–∏–π –º–∏–Ω–∏–º–∞–ª—å–Ω—É—é –±–∞–∑–æ–≤—É—é —Å—Ç–∞–≤–∫—É –∑–∞—Ä–ø–ª–∞—Ç—ã –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤.Ôªø –ò–Ω–∏—Ü–∏–∞—Ç–∏–≤–∞ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∞ –Ω–∞ –≤–æ—Å—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ —Å–æ—Ü–∏–∞–ª—å–Ω–æ–π —Å–ø—Ä–∞–≤–µ–¥–ª–∏–≤–æ—Å—Ç–∏ –∏ –ø–æ–≤—ã—à–µ–Ω–∏–µ –ø—Ä–µ—Å—Ç–∏–∂–∞ –ø—Ä–æ—Ñ–µ—Å—Å–∏–∏ –≤—Ä–∞—á–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QKBdY #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-11-14T09:38:05+00:00,@medpharm,13548,https://t.me/medpharm/13548,"–†–æ—Å—Å–∏–π—Å–∫–∏–µ —É—á–µ–Ω—ã–µ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ —É—Å–æ–≤–µ—Ä—à–µ–Ω—Å—Ç–≤–æ–≤–∞–Ω–Ω—ã–π –º–µ—Ç–æ–¥ –ª–µ—á–µ–Ω–∏—è –ø–µ—Ä–µ–ª–æ–º–∞ –ª—É—á–µ–≤–æ–π –∫–æ—Å—Ç–∏, —ç—Ç–æ —Å–∞–º–∞—è —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–Ω–∞—è —Ç—Ä–∞–≤–º–∞ –≤–µ—Ä—Ö–Ω–µ–π –∫–æ–Ω–µ—á–Ω–æ—Å—Ç–∏ —É –¥–µ—Ç–µ–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QK7jK #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–¢—Ä–∞–≤–º–∞—Ç–æ–ª–æ–≥–∏—è_–∏_–æ—Ä—Ç–æ–ø–µ–¥–∏—è","{""skip"": true}"
2025-11-14T09:16:02+00:00,@medpharm,13547,https://t.me/medpharm/13547,"–§–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ —Å—Ç–æ–ª–∫–Ω—É–ª–∏—Å—å —Å –∏—Å–∫–∞–º–∏ –æ—Ç –ø—Ä–æ–∫—É—Ä–∞—Ç—É—Ä—ã –æ –ø—Ä–∏–∑–Ω–∞–Ω–∏–∏ —Å–¥–µ–ª–æ–∫ –Ω–µ–¥–µ–π—Å—Ç–≤–∏—Ç–µ–ª—å–Ω—ã–º–∏ —Å–ø—É—Å—Ç—è –≥–æ–¥—ã –ø–æ—Å–ª–µ –∏—Å–ø–æ–ª–Ω–µ–Ω–∏—è –≥–æ—Å–∫–æ–Ω—Ç—Ä–∞–∫—Ç–æ–≤. –ü—Ä–æ–∫—É—Ä–∞—Ç—É—Ä–∞ —á–µ—Ä–µ–∑ —Å—É–¥ –∑–∞—Å—Ç–∞–≤–ª—è–µ—Ç –ø–æ—Å—Ç–∞–≤—â–∏–∫–æ–≤ –≤–µ—Ä–Ω—É—Ç—å –¥–µ–Ω—å–≥–∏ –∑–∞ —Ç–æ–≤–∞—Ä—ã, —Ö–æ—Ç—è —É –∑–∞–∫–∞–∑—á–∏–∫–æ–≤ –Ω–µ—Ç –ø—Ä–µ—Ç–µ–Ω–∑–∏–π. ¬´–§–í¬ª –∏–∑—É—á–∏–ª –ø–æ–¥–æ–±–Ω—ã–µ –¥–µ–ª–∞ –∏ –º–Ω–µ–Ω–∏—è —é—Ä–∏—Å—Ç–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QK5nA #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""A pharmaceutical company is facing lawsuits from the procuratorate regarding invalidation of deals several years after fulfilling government contracts. The procuratorate is forcing suppliers to return money for goods, despite the buyers having no claims.""
}"
2025-11-14T08:09:07+00:00,@medpharm,13546,https://t.me/medpharm/13546,"–ö—Ä—É–ø–Ω—ã–π –∞–∫—É—à–µ—Ä—Å–∫–∏–π —Å—Ç–∞—Ü–∏–æ–Ω–∞—Ä –≤ –ï–∫–∞—Ç–µ—Ä–∏–Ω–±—É—Ä–≥–µ –ø–ª–∞–Ω–∏—Ä—É—é—Ç –∑–∞–∫—Ä—ã—Ç—å –∫ –∫–æ–Ω—Ü—É –º–µ—Å—è—Ü–∞. –ü–æ—Å–ª–µ –≤–∏–¥–µ–æ–æ–±—Ä–∞—â–µ–Ω–∏—è —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤ —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–æ –Ω–∞—á–∞–ª–æ –∏—Å–∫–∞—Ç—å –∫–æ–º–ø—Ä–æ–º–∏—Å—Å —Å –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–∞–º–∏, –æ–¥–Ω–∞–∫–æ —Å—É–¥—å–±–∞ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –æ—Å—Ç–∞–µ—Ç—Å—è –Ω–µ–æ–ø—Ä–µ–¥–µ–ª–µ–Ω–Ω–æ–π.Ôªø –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QJyZj #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-11-14T06:59:05+00:00,@medpharm,13545,https://t.me/medpharm/13545,"–†–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–∏ —Ä–µ—à–∏–ª–∏ –ø—Ä–æ–±–ª–µ–º—É —Ä—É—á–Ω–æ–π –æ–±—Ä–∞–±–æ—Ç–∫–∏ –∫–æ—Ä–æ–Ω–æ–≥—Ä–∞–º–º, –∑–∞–¥–µ–π—Å—Ç–≤–æ–≤–∞–≤ –≤ –æ—Ü–µ–Ω–∫–µ —Å–æ—Å—Ç–æ—è–Ω–∏—è —Å–æ—Å—É–¥–æ–≤ —Å–µ—Ä–¥—Ü–∞ –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω—ã–π –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç. –î–ª—è –æ–±—É—á–µ–Ω–∏—è –≤—ã—Å–æ–∫–æ—Ç–æ—á–Ω–æ–π –º–æ–¥–µ–ª–∏ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–ª–∏—Å—å —Ç—ã—Å—è—á–∏ –∏–∑–æ–±—Ä–∞–∂–µ–Ω–∏–π, –ø–æ–ª—É—á–µ–Ω–Ω—ã—Ö –≤ –¶–µ–Ω—Ç—Ä–µ –∏–º. –ê–ª–º–∞–∑–æ–≤–∞ –∏ –¢—é–º–µ–Ω—Å–∫–æ–º –∫–∞—Ä–¥–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–º –Ω–∞—É—á–Ω–æ–º —Ü–µ–Ω—Ç—Ä–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QJtVL #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–î–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞ #–ö–∞—Ä–¥–∏–æ–ª–æ–≥–∏—è #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-11-14T06:53:02+00:00,@medpharm,13544,https://t.me/medpharm/13544,"–ö–æ–º–ø–∞–Ω–∏–∏ ¬´–ò—Ä–≤–∏–Ω¬ª, ¬´–§–∏—Ä–º–∞ ¬´–ï–≤—Ä–æ—Å–µ—Ä–≤–∏—Å¬ª, ¬´–ò—Ä–≤–∏–Ω 2¬ª –∏ ¬´–†-–§–∞—Ä–º¬ª –±—É–¥—É—Ç –ø–æ—Å—Ç–∞–≤–ª—è—Ç—å –¥–ª—è ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª –ø—è—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, —Å—Ä–µ–¥–∏ –Ω–∏—Ö —Ä–∏—Å–¥–∏–ø–ª–∞–º, –ø–∞–ª–æ–≤–∞—Ä–æ—Ç–µ–Ω, –≤–µ–ª–º–∞–Ω–∞–∑–∞ –∞–ª—å—Ñ–∞, —ç–Ω—Ç—Ä–µ–∫—Ç–∏–Ω–∏–± –∏ –≥–ª–µ–∫–∞–ø—Ä–µ–≤–∏—Ä –ø–∏–±—Ä–µ–Ω—Ç–∞—Å–≤–∏—Ä. –û–¥–∏–Ω –∏–∑ –∞—É–∫—Ü–∏–æ–Ω–æ–≤ –Ω–∞ –ø–æ—Å—Ç–∞–≤–∫—É —Ä–∏—Å–¥–∏–ø–ª–∞–º–∞ –Ω–µ —Å–æ—Å—Ç–æ—è–ª—Å—è, —Ç–∞–∫ –∫–∞–∫ —É—á–∞—Å—Ç–Ω–∏–∫ –∑–∞–∫—É–ø–∫–∏ –Ω–µ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–æ–≤–∞–ª —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–Ω—ã–º —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QJt8y #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage"",
  ""impact"": ""medium"",
  ""english"": ""Several pharmaceutical companies including 'Irvin', 'EuroService', 'Irvin 2', and 'R-Farm' will supply five drugs for 'Good Circle'. One tender for risduplam failed due to the bidder not meeting the required criteria.""
}"
2025-11-14T06:07:06+00:00,@medpharm,13543,https://t.me/medpharm/13543,–£—á–µ–Ω—ã–µ –∏–∑ –£–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ –§–ª–∏–Ω–¥–µ—Ä—Å–∞ –≤ –ê–¥–µ–ª–∞–∏–¥–µ –æ—Ü–µ–Ω–∏–ª–∏ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –æ–¥–Ω–æ–≤—Ä–µ–º–µ–Ω–Ω–æ–≥–æ –ø—Ä–∏–µ–º–∞ –ø—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤—ã—Ö –∏ –¥—Ä—É–≥–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–∫ —Å —Ä–∞–∫–æ–º –º–æ–ª–æ—á–Ω–æ–π –∂–µ–ª–µ–∑—ã. –†–µ–∑—É–ª—å—Ç–∞—Ç—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω—ã –≤ –∂—É—Ä–Ω–∞–ª–µ Cancer Medicine –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QJqN4 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ö–∞—Ä–¥–∏–æ–ª–æ–≥–∏—è #–û–Ω–∫–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è #–≠–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–∏—è,"{""skip"": true}"
2025-11-13T16:38:01+00:00,@medpharm,13542,https://t.me/medpharm/13542,"–ù–µ –≤—Å–µ —Ç–∞–∫ –ø—Ä–æ—Å—Ç–æ. –ú–∏–Ω–∏—Å—Ç–µ—Ä—Å—Ç–≤–æ —Ñ–∏–Ω–∞–Ω—Å–æ–≤ –†–§ –≥–æ—Ç–æ–≤–æ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ—Ç—å –≤–æ–ø—Ä–æ—Å –æ —Å—É–±—Å–∏–¥–∏—Ä–æ–≤–∞–Ω–∏–∏ —Å—Ç–æ–∏–º–æ—Å—Ç–∏ –ø–æ–ª–∏—Å–æ–≤ –î–ú–° –ø—Ä–∏ –Ω–µ—Å–∫–æ–ª—å–∫–∏—Ö —É—Å–ª–æ–≤–∏—è—Ö. –î–µ–ª—É –≤—Ä–µ–º—è. –î–µ–ø—É—Ç–∞—Ç—ã –æ—Ç–∫–ª–æ–Ω–∏–ª–∏ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç —Å –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–µ–º –æ–≥—Ä–∞–Ω–∏—á–∏—Ç—å —Å—Ç—Ä–∞—Ö–æ–≤—ã–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –≤ –ø—Ä–∞–≤–µ —Ä–∞—Å–ø–æ—Ä—è–∂–∞—Ç—å—Å—è —Å—Ä–µ–¥—Å—Ç–≤–∞–º–∏, –ø–æ–ª—É—á–µ–Ω–Ω—ã–º–∏ –æ—Ç —à—Ç—Ä–∞—Ñ–æ–≤ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏–π. –†–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–∏ –Ω–µ —Å–∫–æ—Ä—Ä–µ–∫—Ç–∏—Ä–æ–≤–∞–ª–∏ –¥–æ–∫—É–º–µ–Ω—Ç —Å —É—á–µ—Ç–æ–º –ø–æ—Å—Ç—É–ø–∏–≤—à–∏—Ö –ø–æ–ø—Ä–∞–≤–æ–∫. –û—Ç–º–µ–Ω–∞ GMP. –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§ —É–ø—Ä–∞–∑–¥–Ω–∏–ª–æ —Å–∏—Å—Ç–µ–º—É –∏–Ω—Å–ø–µ–∫—Ç–∏—Ä–æ–≤–∞–Ω–∏—è –ø–æ –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—ã–º –ø—Ä–∞–≤–∏–ª–∞–º –Ω–∞–¥–ª–µ–∂–∞—â–µ–π –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω–æ–π –ø—Ä–∞–∫—Ç–∏–∫–∏. –í–∫–ª—é—á–∏–ª–∏ –≤ –∫–æ–º–∏—Å—Å–∏—é. –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§ —É—Ç–≤–µ—Ä–¥–∏–ª–æ –ø–æ–ø—Ä–∞–≤–∫–∏ –≤ –ü—Ä–∞–≤–∏–ª–∞ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø–µ—Ä–µ—á–Ω–µ–π. –¢–µ–ø–µ—Ä—å –≤ —Å–æ—Å—Ç–∞–≤ –∫–æ–º–∏—Å—Å–∏–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–§ –≤–æ–π–¥—É—Ç –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–∏ –ø–∞—Ü–∏–µ–Ω—Ç—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Finance of Russia is ready to consider the issue of subsidizing health insurance premiums under certain conditions. The lower house rejected a law project with a proposal to limit the rights of health insurance organizations to manage funds received from fines imposed on healthcare institutions. The developers did not adjust the document in accordance with the proposed amendments. The system of inspections according to national production practices rules was abolished by the Russian government. A commission has been included in it. The Russian government approved amendments to the Rules for Forming Medicinal Lists. Now representatives of patient organizations will be included in the commission of the Russian Ministry of Health.""
}"
2025-11-13T15:42:03+00:00,@medpharm,13541,https://t.me/medpharm/13541,"–ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–π —Ä–µ–≥—É–ª—è—Ç–æ—Ä –±—É–¥–µ—Ç —Ä–∞–∑—Ä–µ—à–∞—Ç—å –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ø—Ä–æ—Ç–∏–≤ —Å–≤–µ—Ä—Ö—Ä–µ–¥–∫–∏—Ö –±–æ–ª–µ–∑–Ω–µ–π –±–µ–∑ –ø—Ä–µ–¥–≤–∞—Ä–∏—Ç–µ–ª—å–Ω—ã—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –Ω–∞ –ª—é–¥—è—Ö. –î–æ—Å—Ç–∞—Ç–æ—á–Ω–æ –¥–æ–∫–∞–∑–∞—Ç—å, —á—Ç–æ —Ç–µ—Ä–∞–ø–∏—è —É—Å—Ç—Ä–∞–Ω—è–µ—Ç –∫–æ–Ω–∫—Ä–µ—Ç–Ω—ã–π –≥–µ–Ω–µ—Ç–∏—á–µ—Å–∫–∏–π –¥–µ—Ñ–µ–∫—Ç –Ω–∞ –∫–ª–µ—Ç–∫–∞—Ö. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QJSod #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-11-13T15:10:07+00:00,@medpharm,13539,https://t.me/medpharm/13539,–ó–∞–º—Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—é –î–µ–ø–∑–¥—Ä–∞–≤–∞ –û—Ä–ª–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –°–≤–µ—Ç–ª–∞–Ω–µ –ñ–∏—Ä–æ–≤–æ–π –≤—ã–Ω–µ—Å–ª–∏ –ø—Ä–∏–≥–æ–≤–æ—Ä. –ï–µ –ø—Ä–∏–∑–Ω–∞–ª–∏ –≤–∏–Ω–æ–≤–Ω–æ–π –≤ –∑–ª–æ—É–ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–∏ –¥–æ–ª–∂–Ω–æ—Å—Ç–Ω—ã–º–∏ –ø–æ–ª–Ω–æ–º–æ—á–∏—è–º–∏ –ø—Ä–∏ –∑–∞–∫—É–ø–∫–µ –ª–µ–∫–∞—Ä—Å—Ç–≤ –¥–ª—è –ª—å–≥–æ—Ç–Ω–∏–∫–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QJQxr #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è,"{""skip"": true}"
2025-11-13T14:55:06+00:00,@medpharm,13538,https://t.me/medpharm/13538,"–î–µ–ø—É—Ç–∞—Ç—ã –æ—Ç–∫–ª–æ–Ω–∏–ª–∏ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç —Å –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–µ–º –æ–≥—Ä–∞–Ω–∏—á–∏—Ç—å —Å—Ç—Ä–∞—Ö–æ–≤—ã–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –≤ –ø—Ä–∞–≤–µ —Ä–∞—Å–ø–æ—Ä—è–∂–∞—Ç—å—Å—è —Å—Ä–µ–¥—Å—Ç–≤–∞–º–∏, –ø–æ–ª—É—á–µ–Ω–Ω—ã–º–∏ –æ—Ç —à—Ç—Ä–∞—Ñ–æ–≤ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏–π. –†–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–∏ –Ω–µ —Å–∫–æ—Ä—Ä–µ–∫—Ç–∏—Ä–æ–≤–∞–ª–∏ –¥–æ–∫—É–º–µ–Ω—Ç —Å —É—á–µ—Ç–æ–º –ø–æ—Å—Ç—É–ø–∏–≤—à–∏—Ö –ø–æ–ø—Ä–∞–≤–æ–∫ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QJQKV #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""Deputies rejected a law project with a proposal to limit insurance medical organizations' rights to manage funds received from fines for healthcare institutions. Developers did not adjust the document with the incoming amendments. More details: https://clck.ru/3QJQKV #MedVestnik #Healthcare""
}"
2025-11-13T14:24:04+00:00,@medpharm,13537,https://t.me/medpharm/13537,"–£—á–µ–Ω—ã–µ –∏–∑ –ö–ª–∏–≤–ª–µ–Ω–¥—Å–∫–æ–π –∫–ª–∏–Ω–∏–∫–∏, –£–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ –ú–æ–Ω–∞—à–∞ –∏ –∫–æ–º–ø–∞–Ω–∏–∏ CRISPR Therapeutics –≤–ø–µ—Ä–≤—ã–µ –æ—Ü–µ–Ω–∏–ª–∏ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –≥–µ–Ω–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ CRISPR-Cas9, –Ω–∞—Ü–µ–ª–µ–Ω–Ω–æ–π –Ω–∞ –∞–Ω–≥–∏–æ–ø–æ—ç—Ç–∏–Ω-–ø–æ–¥–æ–±–Ω—ã–π –±–µ–ª–æ–∫ 3 (ANGPTL3), —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –Ω–µ–∫–æ–Ω—Ç—Ä–æ–ª–∏—Ä—É–µ–º–æ–π –≥–∏–ø–µ—Ä—Ö–æ–ª–µ—Å—Ç–µ—Ä–∏–Ω–µ–º–∏–µ–π, –≥–∏–ø–µ—Ä—Ç—Ä–∏–≥–ª–∏—Ü–µ—Ä–∏–¥–µ–º–∏–µ–π –∏ —Å–º–µ—à–∞–Ω–Ω–æ–π –¥–∏—Å–ª–∏–ø–∏–¥–µ–º–∏–µ–π. –¶–µ–ª—å—é –ª–µ—á–µ–Ω–∏—è –∞–≤—Ç–æ—Ä—ã –Ω–∞–∑–≤–∞–ª–∏ –º—É—Ç–∞—Ü–∏—é —Å –ø–æ—Ç–µ—Ä–µ–π —Ñ—É–Ω–∫—Ü–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QJNFx #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ì–µ–Ω–µ—Ç–∏–∫–∞ #–¢–µ—Ä–∞–ø–∏—è","{""skip"": true}"
2025-11-13T14:22:04+00:00,@medpharm,13536,https://t.me/medpharm/13536,–°–∏—Å—Ç–µ–º–∞ –∏–Ω—Å–ø–µ–∫—Ç–∏—Ä–æ–≤–∞–Ω–∏—è –ø–æ –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—ã–º –ø—Ä–∞–≤–∏–ª–∞–º –Ω–∞–¥–ª–µ–∂–∞—â–µ–π –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω–æ–π –ø—Ä–∞–∫—Ç–∏–∫–∏ (GMP) –ø–µ—Ä–µ—Å—Ç–∞–Ω–µ—Ç –¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å —Å–æ —Å–ª–µ–¥—É—é—â–µ–≥–æ –≥–æ–¥–∞ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QJN94 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""medium"",
  ""english"": ""The national rules for good manufacturing practices (GMP) inspection system will cease to operate next year. More details can be found here: #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞""
}"
2025-11-13T13:40:06+00:00,@medpharm,13535,https://t.me/medpharm/13535,"–í –≥–æ—Å–ø—Ä–æ–≥—Ä–∞–º–º—É ¬´–†–∞–∑–≤–∏—Ç–∏–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è¬ª –≤–Ω–æ—Å—è—Ç—Å—è –∏–∑–º–µ–Ω–µ–Ω–∏—è, –ø—Ä–µ–¥—É—Å–º–∞—Ç—Ä–∏–≤–∞—é—â–∏–µ –≤—ã–¥–µ–ª–µ–Ω–∏–µ —Ü–µ–ª–µ–≤—ã—Ö —Å—É–±—Å–∏–¥–∏–π –ë–µ–ª–≥–æ—Ä–æ–¥—Å–∫–æ–π, –ë—Ä—è–Ω—Å–∫–æ–π –∏ –ö—É—Ä—Å–∫–æ–π –æ–±–ª–∞—Å—Ç—è–º. –°—Ä–µ–¥—Å—Ç–≤–∞ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –Ω–∞–ø—Ä–∞–≤–∏—Ç—å –≤ —Ç–æ–º —á–∏—Å–ª–µ –Ω–∞ —Ä–∞–∑–≤–∏—Ç–∏–µ –≤—ã–µ–∑–¥–Ω–æ–π –º–µ–¥–ø–æ–º–æ—â–∏ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QJKMh #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-11-13T12:33:06+00:00,@medpharm,13534,https://t.me/medpharm/13534,"–í—Ä–∞—á–µ–±–Ω—ã–µ –≤–∞–∫–∞–Ω—Å–∏–∏ –≤–æ—à–ª–∏ –≤ –Ω–æ—è–±—Ä–µ –≤ –¢–û–† –∑–∞—Ä–ø–ª–∞—Ç–Ω—ã—Ö –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–π –±–æ–ª–µ–µ 10 –≥–æ—Ä–æ–¥–æ–≤-–º–∏–ª–ª–∏–æ–Ω–Ω–∏–∫–æ–≤. –í–∞–∫–∞–Ω—Å–∏–∏ –≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π —Å—Ñ–µ—Ä–µ —Å —Å–∞–º—ã–º–∏ –≤—ã—Å–æ–∫–∏–º–∏ –¥–æ—Ö–æ–¥–∞–º–∏ –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç —Ä–∞–±–æ—Ç–æ–¥–∞—Ç–µ–ª–∏ –≤ –ö–∞–∑–∞–Ω–∏, –ü–µ—Ä–º–∏ –∏ –ß–µ–ª—è–±–∏–Ω—Å–∫–µ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QJEaz #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-11-13T12:25:02+00:00,@medpharm,13533,https://t.me/medpharm/13533,–í –ú–æ—Å–∫–≤–µ –≤–æ–∑–±—É–¥–∏–ª–∏ –¥–µ–ª–æ –æ –Ω–µ–∑–∞–∫–æ–Ω–Ω–æ–º –æ–±–æ—Ä–æ—Ç–µ —Å–∏–ª—å–Ω–æ–¥–µ–π—Å—Ç–≤—É—é—â–∏—Ö –≤–µ—â–µ—Å—Ç–≤. –õ–µ–∫–∞—Ä—Å—Ç–≤–∞ –∑–∞–∫—É–ø–∞–ª–∏ —á–µ—Ä–µ–∑ –ø–æ–¥—Å—Ç–∞–≤–Ω–æ–µ —é—Ä–ª–∏—Ü–æ –∏ –ø—Ä–æ–¥–∞–≤–∞–ª–∏ —á–µ—Ä–µ–∑ —Å–µ—Ç—å –∞–ø—Ç–µ–∫. –ò–∑ —Ç–∞–π–Ω–∏–∫–æ–≤ –∏–∑—ä—è–ª–∏ 150 –∫–≥ –≤–µ—â–µ—Å—Ç–≤ –∏ 25 –º–ª–Ω —Ä—É–±–ª–µ–π –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QJE3h #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration, sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""A criminal case has been opened in Moscow regarding the illegal trade of potent substances. Medicines were purchased through a fake legal entity and sold through a network of pharmacies. 150 kg of substances and 25 million rubles were seized from storage facilities.""
}"
2025-11-13T11:30:17+00:00,@medpharm,13532,https://t.me/medpharm/13532,–í –ú–æ—Å–∫–≤–µ –Ω–∞—á–∞–ª–æ—Å—å –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ —Ç–æ–º–æ–≥—Ä–∞—Ñ–æ–≤ –∏ –∞–Ω–≥–∏–æ–≥—Ä–∞—Ñ–æ–≤ –¥–ª—è –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∏ –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –∏ —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –ü–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –≤—ã–ø—É—Å–∫–∞—Ç—å 60 –∞–ø–ø–∞—Ä–∞—Ç–æ–≤ –≤ –≥–æ–¥ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QJA9g #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-11-13T11:06:02+00:00,@medpharm,13531,https://t.me/medpharm/13531,–û–Ω–∫–æ–ª–æ–≥ —Å 26-–ª–µ—Ç–Ω–∏–º —Å—Ç–∞–∂–µ–º –≤–æ–∑–≥–ª–∞–≤–∏–ª –∫—Ä—É–ø–Ω–µ–π—à–µ–µ –ø–æ–¥—Ä–∞–∑–¥–µ–ª–µ–Ω–∏–µ –ø–æ –æ—Ü–µ–Ω–∫–µ –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ FDA –ø–æ—Å–ª–µ —Å–∫–∞–Ω–¥–∞–ª—å–Ω–æ–≥–æ —É—Ö–æ–¥–∞ –ø—Ä–µ–¥—à–µ—Å—Ç–≤–µ–Ω–Ω–∏–∫–∞. –†–∏—á–∞—Ä–¥ –ü–∞–∑–¥—É—Ä ‚Äî –∞–≤—Ç–æ—Ä –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ –º–µ—Ö–∞–Ω–∏–∑–º–∞ —É—Å–∫–æ—Ä–µ–Ω–Ω–æ–π —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –æ—Ç —Ä–∞–∫–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QJ8ZB #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–∞—Ä—å–µ—Ä–∞,"{""skip"": true}"
2025-11-13T10:26:18+00:00,@medpharm,13530,https://t.me/medpharm/13530,–í–µ—Ä—Ö–æ–≤–Ω—ã–π —Å—É–¥ –†–§ –æ—Ç–∫–ª–æ–Ω–∏–ª –∂–∞–ª–æ–±—ã —Å–µ—Ç–∏ ¬´–°–µ–º–µ–π–Ω–∞—è¬ª –ø–æ –¥–µ–ª—É –æ —Ä–∞—Å—Ö–æ–¥–æ–≤–∞–Ω–∏–∏ –±—é–¥–∂–µ—Ç–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤. –ü–æ–¥—Ç–≤–µ—Ä–∂–¥–µ–Ω –∑–∞–ø—Ä–µ—Ç –Ω–∞ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ –º–µ–¥–æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –≤ –ª–∏–∑–∏–Ω–≥–µ –∑–∞ —Å—á–µ—Ç –û–ú–° –¥–ª—è –æ–∫–∞–∑–∞–Ω–∏—è –ø–ª–∞—Ç–Ω—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —É—Å–ª—É–≥ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QJ5i5 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-11-13T10:04:03+00:00,@medpharm,13529,https://t.me/medpharm/13529,¬´–ß–µ—Å—Ç–Ω—ã–π –∑–Ω–∞–∫¬ª –∏–Ω—Ç–µ–≥—Ä–∏—Ä–æ–≤–∞–ª—Å—è —Å –≥–æ—Å—Å–∏—Å—Ç–µ–º–∞–º–∏ –¥–ª—è –ø—Ä–æ–≤–µ—Ä–∫–∏ –ø—Ä–æ–∏—Å—Ö–æ–∂–¥–µ–Ω–∏—è —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏–π –¥–ª—è –∏–∑–≥–æ—Ç–æ–≤–ª–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤. –í –∫–∞–∫–∏—Ö –≥–æ—Å—Å—Ç—Ä—É–∫—Ç—É—Ä–∞—Ö —Ç–µ–ø–µ—Ä—å –±—É–¥—É—Ç —Å–≤–µ—Ä—è—Ç—å –¥–∞–Ω–Ω—ã–µ? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QJ4Cb #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""high"",
  ""english"": ""The Honest Sign has integrated with government systems for verifying the origin of pharmaceutical raw materials. Which governmental structures will now verify these data?""
}"
2025-11-13T09:23:03+00:00,@medpharm,13528,https://t.me/medpharm/13528,"–ò–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω–∞—è –±–æ–ª—å–Ω–∏—Ü–∞ –≤ –°–∞—Ä–∞—Ç–æ–≤–µ –∑–∞–≥–æ—Ä–µ–ª–∞—Å—å –Ω–æ—á—å—é 13 –Ω–æ—è–±—Ä—è, –µ—Å—Ç—å –ø–æ—Å—Ç—Ä–∞–¥–∞–≤—à–∏–µ. –ü—Ä–æ–∫—É—Ä–∞—Ç—É—Ä–∞ –ø—Ä–æ–≤–µ—Ä–∏—Ç –¥–µ–π—Å—Ç–≤–∏—è –¥–æ–ª–∂–Ω–æ—Å—Ç–Ω—ã—Ö –ª–∏—Ü –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—è –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QHzAn #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-11-13T07:40:03+00:00,@medpharm,13526,https://t.me/medpharm/13526,–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§ –≤–Ω–µ—Å–ª–æ –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ –ü—Ä–∞–≤–∏–ª–∞ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—è –ø–µ—Ä–µ—á–Ω–µ–π –ª–µ–∫–∞—Ä—Å—Ç–≤. –í —Å–æ—Å—Ç–∞–≤ —Ä–∞—Å—Å–º–∞—Ç—Ä–∏–≤–∞—é—â–µ–π –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã-–∫–∞–Ω–¥–∏–¥–∞—Ç—ã –∫–æ–º–∏—Å—Å–∏–∏ –≤–æ–π–¥–µ—Ç –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª—å –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–π –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QHrZK #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""medium"",
  ""english"": ""The Russian government has introduced changes to the Rules for Forming Lists of Medicines. A representative from an NGO will be included in the committee reviewing candidate drugs.""
}"
2025-11-13T06:48:04+00:00,@medpharm,13525,https://t.me/medpharm/13525,–†–æ—Å—Å–∏–π—Å–∫–∏–µ –≤–ª–∞—Å—Ç–∏ –º–æ–≥—É—Ç –∏–∑—É—á–∏—Ç—å –≤–æ–ø—Ä–æ—Å –æ —Å—É–±—Å–∏–¥–∏—Ä–æ–≤–∞–Ω–∏–∏ –ø–æ–ª–∏—Å–æ–≤ –î–ú–° –ø—Ä–∏ –Ω–µ—Å–∫–æ–ª—å–∫–∏—Ö —É—Å–ª–æ–≤–∏—è—Ö. –í —Å–µ–Ω—Ç—è–±—Ä–µ —Å —Ç–∞–∫–æ–π –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–æ–π –≤ –≤–µ–¥–æ–º—Å—Ç–≤–æ –æ–±—Ä–∞—Ç–∏–ª–∞—Å—å –ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–∞—è –∞—Å—Å–æ—Ü–∏–∞—Ü–∏—è —É–ø—Ä–∞–≤–ª–µ–Ω—Ü–µ–≤ —Å—Ñ–µ—Ä—ã –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QHnw5 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""Russian authorities may examine the issue of subsidizing health insurance policies under certain conditions. In September, such an initiative was submitted to the relevant department by the National Association of Healthcare Management.""
}"
2025-11-12T16:49:01+00:00,@medpharm,13524,https://t.me/medpharm/13524,"–ü—Ä–∞–≤–æ –Ω–∞ –≤—ã–ª–µ—Ç. –ö–æ–º–∏—Ç–µ—Ç –ì–æ—Å–¥—É–º—ã –†–§ –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è —Ä–µ–∫–æ–º–µ–Ω–¥–æ–≤–∞–ª –ø—Ä–∏–Ω—è—Ç—å –≤–æ –≤—Ç–æ—Ä–æ–º —á—Ç–µ–Ω–∏–∏ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç, –¥–æ–ø—É—Å–∫–∞—é—â–∏–π –∏—Å–∫–ª—é—á–µ–Ω–∏–µ —á–∞—Å—Ç–Ω—ã—Ö —Å—Ç—Ä–∞—Ö–æ–≤—ã—Ö –∫–æ–º–ø–∞–Ω–∏–π –∏–∑ —Å–∏—Å—Ç–µ–º—ã –û–ú–°. –°—Ç–∞–Ω–µ—Ç —è–≤–Ω—ã–º. –î–µ–ø—É—Ç–∞—Ç—ã –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç –æ–±—è–∑–∞—Ç—å –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ —É—á—Ä–µ–∂–¥–µ–Ω–∏—è –ø–µ—Ä–µ–¥–∞–≤–∞—Ç—å –ú–í–î –†–§ —Å–≤–µ–¥–µ–Ω–∏—è –æ –Ω–µ–æ—Ç–ª–æ–∂–Ω–æ–π –∏ —ç–∫—Å—Ç—Ä–µ–Ω–Ω–æ–π –º–µ–¥–ø–æ–º–æ—â–∏, –æ–∫–∞–∑–∞–Ω–Ω–æ–π –∏–Ω–æ—Å—Ç—Ä–∞–Ω—Ü–∞–º –±–µ–∑ –ø–æ–ª–∏—Å–∞ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–≥–æ –∏–ª–∏ –¥–æ–±—Ä–æ–≤–æ–ª—å–Ω–æ–≥–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ —Å—Ç—Ä–∞—Ö–æ–≤–∞–Ω–∏—è. –ü—Ä—è–º–∞—è —Å–≤—è–∑—å. –ß–µ—Ç—ã—Ä–µ –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö –æ–Ω–ª–∞–π–Ω-–ø–ª–æ—â–∞–¥–∫–∏ –∏–Ω—Ç–µ–≥—Ä–∏—Ä–æ–≤–∞–Ω—ã —Å —Ä–µ–µ—Å—Ç—Ä–æ–º –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–∞. –ü—Ä–æ–≤–µ—Ä–∏—Ç—å –ª–µ–≥–∞–ª—å–Ω–æ—Å—Ç—å –ø—Ä–æ–¥—É–∫—Ü–∏–∏ —Ç–µ–ø–µ—Ä—å –º–æ–∂–Ω–æ –Ω–∞–ø—Ä—è–º—É—é –∏–∑ –∫–∞—Ä—Ç–æ—á–∫–∏ —Ç–æ–≤–∞—Ä–∞, —Å–æ–æ–±—â–∏–ª–∏ –≤ –Ω–∞–¥–∑–æ—Ä–Ω–æ–π —Å–ª—É–∂–±–µ. –ü–µ—Ä–µ—Ö–æ–¥ —Ö–æ–¥–∞. –°—É–¥ –ø–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç—É–∞–ª—å–Ω—ã–º –ø—Ä–∞–≤–∞–º –≤—Å—Ç–∞–ª –Ω–∞ —Å—Ç–æ—Ä–æ–Ω—É ¬´–ê–∫—Å–µ–ª—å—Ñ–∞—Ä–º–∞¬ª –≤ —Å–ø–æ—Ä–µ —Å AstraZeneca –∑–∞ –ø–∞—Ç–µ–Ω—Ç –Ω–∞ –æ–Ω–∫–æ–ø—Ä–µ–ø–∞—Ä–∞—Ç ¬´–¢–∞–≥—Ä–∏—Å—Å–æ¬ª. –ù–µ–¥–µ–π—Å—Ç–≤–∏—Ç–µ–ª—å–Ω—ã–º –ø—Ä–∏–∑–Ω–∞–Ω–æ —Ä–µ—à–µ–Ω–∏–µ –†–æ—Å–ø–∞—Ç–µ–Ω—Ç–∞ –æ—Ç –∞–≤–≥—É—Å—Ç–∞ 2024 –≥–æ–¥–∞.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing, sanctions, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The Committee of the Russian State Duma on Health Care recommended accepting a project to be voted on for the second time, allowing private insurance companies to be excluded from the system of State Medical Insurance. This will have a significant impact. The deputies propose that medical institutions provide the police with information on emergency and non-emergency medical assistance provided to foreigners without an obligatory or voluntary insurance policy. Direct connection. The Intellectual Property Court sided with 'Akselfarm' in the dispute over the patent for oncological drug 'Tagrisso'. The decision of the Russian Patent Office from August 2024 is declared invalid.""
}"
2025-11-12T16:09:06+00:00,@medpharm,13523,https://t.me/medpharm/13523,"–ü—Ä–∏ —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω–æ–π –º–æ–¥–µ–ª–∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –≤—ã–ø–æ–ª–Ω–µ–Ω–∏–µ –≤—Å–µ—Ö –ª–µ—á–µ–±–Ω—ã—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π –ø–æ–ø—Ä–æ—Å—Ç—É –Ω–µ–≤–æ–∑–º–æ–∂–Ω–æ, —Å—á–∏—Ç–∞—é—Ç –≤ AIDE. –í—ã—Ö–æ–¥ ‚Äî –ø–æ–¥–¥–µ—Ä–∂–∫–∞ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Ü–∏—Ñ—Ä–æ–≤—ã–º–∏ –ø–æ–º–æ—â–Ω–∏–∫–∞–º–∏ –º–µ–∂–¥—É –≤–∏–∑–∏—Ç–∞–º–∏ –∫ –≤—Ä–∞—á—É. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QHNcV #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-11-12T16:01:42+00:00,@medpharm,13522,https://t.me/medpharm/13522,"AstraZeneca –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∞ –Ω–∞ –∫–æ–Ω–≥—Ä–µ—Å—Å–µ ESMO-2025 —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –¥–≤—É—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π III —Ñ–∞–∑—ã, –∫–æ—Ç–æ—Ä—ã–µ –º–æ–≥—É—Ç –∏–∑–º–µ–Ω–∏—Ç—å –ø–æ–¥—Ö–æ–¥—ã –∫ –ª–µ—á–µ–Ω–∏—é —Ä–∞–Ω–Ω–µ–≥–æ HER2-–ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω–æ–≥–æ —Ä–∞–∫–∞ –º–æ–ª–æ—á–Ω–æ–π –∂–µ–ª–µ–∑—ã —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–∫ —Å –≤—ã—Å–æ–∫–∏–º —Ä–∏—Å–∫–æ–º —Ä–µ—Ü–∏–¥–∏–≤–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QHLfT","{""skip"": true}"
2025-11-12T15:19:04+00:00,@medpharm,13521,https://t.me/medpharm/13521,"–ò—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω—ã–π –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç –Ω–µ —ç–∫–æ–Ω–æ–º–∏—Ç —Å—Ä–µ–¥—Å—Ç–≤–∞, –∞ –ª–∏—à—å –¥–æ–±–∞–≤–ª—è–µ—Ç —Ç—Ä–∞—Ç —Å–∏—Å—Ç–µ–º–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –ù–µ–∫–æ—Ç–æ—Ä—ã–µ —Ä–µ–≥–∏–æ–Ω—ã —Å–æ–æ–±—â–∏–ª–∏ –æ –≥–æ—Ç–æ–≤–Ω–æ—Å—Ç–∏ –ø–æ—É—á–∞—Å—Ç–≤–æ–≤–∞—Ç—å –≤ —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–µ, –∫–æ—Ç–æ—Ä—ã–π –ø–æ–∑–≤–æ–ª–∏—Ç —Å–∏—Å—Ç–µ–º–µ –û–ú–° —ç–∫–æ–Ω–æ–º–∏—Ç—å –¥–æ 16 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –Ω–∞ –¥–∏—Å–ø–∞–Ω—Å–µ—Ä–∏–∑–∞—Ü–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QHL4v #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–î–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""Some regions have shown readiness to participate in an experiment that will save the national health system up to 16 billion rubles on outpatient care. More details: https://clck.ru/3QHL4v""
}"
2025-11-12T15:17:04+00:00,@medpharm,13520,https://t.me/medpharm/13520,"–ö–æ–º–ø–∞–Ω–∏–∏, –∫–æ—Ç–æ—Ä—ã–µ –Ω–µ –ø–µ—Ä–µ–≤–µ–ª–∏ —Å–≤–æ–µ–≤—Ä–µ–º–µ–Ω–Ω–æ –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–µ –ü–û —Å–≤–æ–∏ –∑–Ω–∞—á–∏–º—ã–µ –æ–±—ä–µ–∫—Ç—ã –∫—Ä–∏—Ç–∏—á–µ—Å–∫–æ–π –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω–æ–π –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä—ã, –±—É–¥—É—Ç –æ—à—Ç—Ä–∞—Ñ–æ–≤–∞–Ω—ã. –ù–∞–¥ —Ç–∞–∫–∏–º –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç–æ–º —Ä–∞–±–æ—Ç–∞–µ—Ç –ú–∏–Ω—Ü–∏—Ñ—Ä—ã –†–§. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QHKxE #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""high"",
  ""english"": ""Companies that did not timely migrate their significant objects of critical information infrastructure to Russian software will be fined. A project related to this law is being worked on by the Federal Service for Digital Transformation of Russia. For more details, see https://clck.ru/3QHKxE #PharmNews #Regulation""
}"
2025-11-12T14:46:06+00:00,@medpharm,13519,https://t.me/medpharm/13519,–≠–∫—Å-–≥–ª–∞–≤–µ –≤–ª–∞–¥–∏–º–∏—Ä—Å–∫–æ–≥–æ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ø—Ä–µ–¥—ä—è–≤–ª–µ–Ω–æ –æ–±–≤–∏–Ω–µ–Ω–∏–µ –ø–æ –≤—Ç–æ—Ä–æ–º—É —É–≥–æ–ª–æ–≤–Ω–æ–º—É –¥–µ–ª—É. –°—É–¥ –æ—Ç–ø—Ä–∞–≤–∏–ª –í–∞–ª–µ—Ä–∏—è –Ø–Ω–∏–Ω–∞ –≤ –°–ò–ó–û. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QHJMu #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-11-12T14:32:02+00:00,@medpharm,13518,https://t.me/medpharm/13518,–≠–∫—Å-–≥–ª–∞–≤–µ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ü—Ä–∏–∫–∞–º—å—è –í–∞–¥–∏–º—É –ü–ª–æ—Ç–Ω–∏–∫–æ–≤—É –∏–∑–±—Ä–∞–ª–∏ –º–µ—Ä—É –ø—Ä–µ—Å–µ—á–µ–Ω–∏—è. –ï–≥–æ –æ–±–≤–∏–Ω—è—é—Ç –≤ –ø–æ–ª—É—á–µ–Ω–∏–∏ –≤–∑—è—Ç–∫–∏ –∑–∞ –±–µ—Å–ø—Ä–µ–ø—è—Ç—Å—Ç–≤–µ–Ω–Ω–æ–µ –∑–∞–∫–ª—é—á–µ–Ω–∏–µ –¥–æ–≥–æ–≤–æ—Ä–æ–≤ –Ω–∞ –ø–æ—Å—Ç–∞–≤–∫—É –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –º–µ–¥–∏–∑–¥–µ–ª–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QHHYd #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""sanctions, import_export"",
  ""impact"": ""high"",
  ""english"": ""The former head of the Health Department in Chukotka, Valdimir Plotnikov, has been named a person of interest for accepting a bribe to facilitate contract signings for the supply of medicines and medical equipment.""
}"
2025-11-12T13:55:05+00:00,@medpharm,13517,https://t.me/medpharm/13517,–í –°–®–ê –Ω–∞–∑–Ω–∞—á–∏–ª–∏ –Ω–æ–≤–æ–≥–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –¶–µ–Ω—Ç—Ä–∞ –æ—Ü–µ–Ω–∫–∏ –∏ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ FDA. –ï–≥–æ –ø—Ä–µ–¥—à–µ—Å—Ç–≤–µ–Ω–Ω–∏–∫ –æ—Ç—Ä–∞–±–æ—Ç–∞–ª –Ω–∞ –¥–æ–ª–∂–Ω–æ—Å—Ç–∏ –º–µ–Ω—å—à–µ —á–µ—Ç—ã—Ä–µ—Ö –º–µ—Å—è—Ü–µ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QHHak #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-11-12T13:45:03+00:00,@medpharm,13516,https://t.me/medpharm/13516,"–°–∏—Å—Ç–µ–º–Ω—ã–π —Ä–∞–∑—Ä—ã–≤ –º–µ–∂–¥—É –≤—É–∑–æ–≤—Å–∫–æ–π –ø–æ–¥–≥–æ—Ç–æ–≤–∫–æ–π –∏ –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç—è–º–∏ —Ñ–∞—Ä–º—Ä—ã–Ω–∫–∞ –æ–±—Å—É–¥–∏–ª–∏ –Ω–∞ –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ –≤ –†–£–î–ù. –°—Ç—É–¥–µ–Ω—Ç—ã —Å–ø—Ä–∞—à–∏–≤–∞—é—Ç –ø—Ä–æ ¬´–∑–∞—Ä–ø–ª–∞—Ç—É –º–µ—á—Ç—ã¬ª, —Ä–∞–±–æ—Ç–æ–¥–∞—Ç–µ–ª–∏ ‚Äî –ø—Ä–æ ¬´–≥–æ—Ä—è—â–∏–µ –≥–ª–∞–∑–∞¬ª –∏ –ø–æ–Ω–∏–º–∞–Ω–∏–µ –ø–æ–ª–Ω–æ–≥–æ —Ü–∏–∫–ª–∞ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QHEKZ #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-11-12T12:55:07+00:00,@medpharm,13515,https://t.me/medpharm/13515,–ß–µ—Ç—ã—Ä–µ –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö —Ç–æ—Ä–≥–æ–≤—ã—Ö –æ–Ω–ª–∞–π–Ω-–ø–ª–æ—â–∞–¥–∫–∏ –ø–æ–¥–∫–ª—é—á–∏–ª–∏ –∫ —Ä–µ–µ—Å—Ç—Ä—É –º–µ–¥–∏–∑–¥–µ–ª–∏–π –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–∞. –≠—Ç–æ —É–ø—Ä–æ—Å—Ç–∏—Ç –ø—Ä–æ–≤–µ—Ä–∫—É –ª–µ–≥–∞–ª—å–Ω–æ—Å—Ç–∏ –ø—Ä–æ–¥—É–∫—Ü–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QHA7n #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""registration, safety"",
  ""impact"": ""medium"",
  ""english"": ""Four of Russia's largest online marketplaces have been connected to the medical products registry of Roszdravnadzor. This will simplify the verification of the legality of the products.""
}"
2025-11-12T12:24:03+00:00,@medpharm,13514,https://t.me/medpharm/13514,–°–µ–º—å —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π –≤–æ—à–ª–∏ –≤ —Ä–µ–π—Ç–∏–Ω–≥ –ª—É—á—à–∏—Ö —Ä–∞–±–æ—Ç–æ–¥–∞—Ç–µ–ª–µ–π –†–æ—Å—Å–∏–∏ 2025 –≥–æ–¥–∞ –æ—Ç Forbes. –í —Ä–µ–π—Ç–∏–Ω–≥–µ 2024 –≥–æ–¥–∞ –±—ã–ª–æ –≤—Å–µ–≥–æ –ø—è—Ç—å –∫–æ–º–ø–∞–Ω–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QH6xB #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–∞—Ä—å–µ—Ä–∞,"{""skip"": true}"
2025-11-12T11:59:03+00:00,@medpharm,13513,https://t.me/medpharm/13513,–í —Ö–æ–¥–µ –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –æ–±—Å—É–∂–¥–µ–Ω–∏—è –Ω–∞ –ø–æ—Ä—Ç–∞–ª–µ –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω–æ-–ø—Ä–∞–≤–æ–≤—ã—Ö –∞–∫—Ç–æ–≤ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ –∑–∞–º–µ–Ω–µ –°–ú–û —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω—ã–º–∏ —Ñ–æ–Ω–¥–∞–º–∏ –û–ú–° –ø–æ–ª—É—á–∏–ª –≤ –æ—Å–Ω–æ–≤–Ω–æ–º –Ω–µ–≥–∞—Ç–∏–≤–Ω—ã–µ –æ—Ç–∑—ã–≤—ã. –í –ú–∏–Ω–∑–¥—Ä–∞–≤–µ –∞–ø–µ–ª–ª–∏—Ä—É—é—Ç –∫ —ç–∫–æ–Ω–æ–º–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QH4v3 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The public discussion on the portal of normative legal acts regarding a project to replace SMO territorial funds with OMS has received mostly negative feedback. The Ministry of Health appeals for cost savings. More details: https://clck.ru/3QH4v3 #MedVestnik #Healthcare #Public_Services""
}"
2025-11-12T11:39:12+00:00,@medpharm,13512,https://t.me/medpharm/13512,"–ì–æ—Å–¥—É–º–∞ –†–§ –ø—Ä–∏–Ω—è–ª–∞ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ–± –æ—Ç—Ä–∞–±–æ—Ç–∫–∞—Ö –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –≤—É–∑–æ–≤ –∏ –∫–æ–ª–ª–µ–¥–∂–µ–π –∏ –≤—É–∑–æ–≤ –≤ –æ–∫–æ–Ω—á–∞—Ç–µ–ª—å–Ω–æ–º —á—Ç–µ–Ω–∏–∏. –í—Å–µ–º –ø–æ–ª—É—á–∏–≤—à–∏–º –≤—ã—Å—à–µ–µ –∏ —Å—Ä–µ–¥–Ω–µ–µ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–µ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞–º –ø–æ—Å–ª–µ 2026 –≥–æ–¥–∞ –ø—Ä–∏–¥–µ—Ç—Å—è –ø—Ä–æ–π—Ç–∏ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–π —Ç—Ä–µ—Ö–ª–µ—Ç–Ω–∏–π –ø–µ—Ä–∏–æ–¥ –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–∞ –≤ –∫–ª–∏–Ω–∏–∫–∞—Ö, –∫–æ—Ç–æ—Ä—ã–µ —Ä–∞–±–æ—Ç–∞—é—Ç –≤ —Å–∏—Å—Ç–µ–º–µ –û–ú–°. –ö–∞–∫ –≤—ã –æ—Ü–µ–Ω–∏–≤–∞–µ—Ç–µ —ç—Ç–∏ –∏–∑–º–µ–Ω–µ–Ω–∏—è?","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""registration, shortage"",
  ""impact"": ""high"",
  ""english"": ""The Russian Duma has approved a law requiring all medical graduates from 2026 to undergo a three-year mentoring period in OMS-system hospitals, which could lead to shortages of medical professionals.""
}"
2025-11-12T10:49:04+00:00,@medpharm,13511,https://t.me/medpharm/13511,"–†–∞–∑—Ä–∞–±–æ—Ç–∞–Ω –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç, –∫–æ—Ç–æ—Ä—ã–º –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è –æ–±—è–∑–∞—Ç—å –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—è –ø–µ—Ä–µ–¥–∞–≤–∞—Ç—å –ø–æ–ª–∏—Ü–∏–∏ —Å–≤–µ–¥–µ–Ω–∏—è –æ –Ω–µ–æ—Ç–ª–æ–∂–Ω–æ–π –ø–æ–º–æ—â–∏ –∏–Ω–æ—Å—Ç—Ä–∞–Ω—Ü–∞–º –±–µ–∑ –ø–æ–ª–∏—Å–∞ –û–ú–° –∏–ª–∏ –î–ú–°. –í –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–µ –†–§ —É–∫–∞–∑–∞–ª–∏ –∞–≤—Ç–æ—Ä–∞–º –Ω–∞ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç—å –¥–æ—Ä–∞–±–æ—Ç–∞—Ç—å –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤—É. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QGyCW #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""A law proposal has been made requiring hospitals to provide police with information on patients receiving free care without an OMS or DMS card. The authors of the proposal were advised by the Russian government to revise their initiative.""
}"
2025-11-12T10:44:03+00:00,@medpharm,13510,https://t.me/medpharm/13510,–°—É–¥ –ø–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç—É–∞–ª—å–Ω—ã–º –ø—Ä–∞–≤–∞–º –ø—Ä–∏–Ω—è–ª –Ω–æ–≤–æ–µ —Ä–µ—à–µ–Ω–∏–µ –≤ —Å–ø–æ—Ä–µ –∑–∞ –ø–∞—Ç–µ–Ω—Ç –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç ¬´–¢–∞–≥—Ä–∏—Å—Å–æ¬ª –æ—Ç —Ä–∞–∫–∞ –ª–µ–≥–∫–∏—Ö. –ù–µ–¥–µ–π—Å—Ç–≤–∏—Ç–µ–ª—å–Ω—ã–º –ø—Ä–∏–∑–Ω–∞–Ω–æ —Ä–µ—à–µ–Ω–∏–µ –†–æ—Å–ø–∞—Ç–µ–Ω—Ç–∞ –æ—Ç –∞–≤–≥—É—Å—Ç–∞ 2024 –≥–æ–¥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QGxri #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""high"",
  ""english"": ""The intellectual property court has ruled that the patent for lung cancer drug Tagrisso is invalid. The ruling by the Russian Patent Office in August 2024 has been deemed invalid.""
}"
2025-11-12T09:52:07+00:00,@medpharm,13509,https://t.me/medpharm/13509,–£—á–µ–Ω—ã–µ –∏–∑ –£–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ –ë—Ä–∏–≥–∞–º–∞ –Ø–Ω–≥–∞ –æ—Ü–µ–Ω–∏–ª–∏ —Å–≤—è–∑—å –º–µ–∂–¥—É –∏–Ω—Ñ–∞—Ä–∫—Ç–æ–º –º–∏–æ–∫–∞—Ä–¥–∞ –∏ —Ä–∏—Å–∫–æ–º –ø–æ–∑–¥–Ω–µ–π —ç–ø–∏–ª–µ–ø—Å–∏–∏ —É –ª—é–¥–µ–π –±–µ–∑ –∏–Ω—Å—É–ª—å—Ç–∞ –∏ –±–µ–∑ —ç–ø–∏–ª–µ–ø—Å–∏–∏ –≤ –∞–Ω–∞–º–Ω–µ–∑–µ. –†–µ–∑—É–ª—å—Ç–∞—Ç—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω—ã –Ω–∞ –ø–æ—Ä—Ç–∞–ª–µ –ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–π –∞–∫–∞–¥–µ–º–∏–∏ –Ω–µ–≤—Ä–æ–ª–æ–≥–∏–∏ (AAN). –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QGuEB #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ö–∞—Ä–¥–∏–æ–ª–æ–≥–∏—è #–ù–µ–≤—Ä–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è,"{""skip"": true}"
2025-11-12T07:47:05+00:00,@medpharm,13508,https://t.me/medpharm/13508,"–°–æ–≤–º–µ—Å—Ç–Ω—ã–µ —Ç–æ—Ä–≥–∏ –ø–æ–∑–≤–æ–ª–∏–ª–∏ –ø—Ä–∏–æ–±—Ä–µ—Å—Ç–∏ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏–µ –ø–æ —Å—Ç–æ–∏–º–æ—Å—Ç–∏ –Ω–∏–∂–µ —Ä—ã–Ω–æ—á–Ω–æ–π –≤ —Ä–∞–º–∫–∞—Ö —Ñ–µ–¥–ø—Ä–æ–µ–∫—Ç–∞ ¬´–ë–æ—Ä—å–±–∞ —Å –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏¬ª. –î–ª—è –æ–¥–Ω–æ–π –∏–∑ –∑–∞–∫—É–ø–æ–∫ —Ü–µ–Ω–∞ –±—ã–ª–∞ –Ω–∏–∂–µ —Ä—ã–Ω–æ—á–Ω–æ–π –Ω–∞ 62%, –∞ –≤—Å–µ–≥–æ –±—é–¥–∂–µ—Ç —Å—ç–∫–æ–Ω–æ–º–∏–ª 5,6 –º–ª—Ä–¥ —Ä—É–±. –ü—Ä–∞–∫—Ç–∏–∫—É —Å–æ–≤–º–µ—Å—Ç–Ω—ã—Ö –∏ —Ü–µ–Ω—Ç—Ä–∞–ª–∏–∑–æ–≤–∞–Ω–Ω—ã—Ö –∑–∞–∫—É–ø–æ–∫ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è —Ä–∞—Å—à–∏—Ä–∏—Ç—å. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QGjmP #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""Joint procurement allowed the acquisition of equipment at a price below market value within the federal project 'Battle against oncological diseases'. For one of the procurements, the price was 62% lower than market value, and a total budget saving of 5.6 billion rubles was achieved. Centralized procurement practices are planned to be expanded. For more details: https://clck.ru/3QGjmP #MedVestnik #Healthcare #HealthSystemOrganization""
}"
2025-11-12T07:38:03+00:00,@medpharm,13507,https://t.me/medpharm/13507,–ß–µ—Ç—ã—Ä–µ –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö –æ–Ω–ª–∞–π–Ω-–ø–ª–æ—â–∞–¥–∫–∏ –∏–Ω—Ç–µ–≥—Ä–∏—Ä–æ–≤–∞–Ω—ã —Å —Ä–µ–µ—Å—Ç—Ä–æ–º –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–∞. –ü—Ä–æ–≤–µ—Ä–∏—Ç—å –ª–µ–≥–∞–ª—å–Ω–æ—Å—Ç—å –ø—Ä–æ–¥—É–∫—Ü–∏–∏ —Ç–µ–ø–µ—Ä—å –º–æ–∂–Ω–æ –Ω–∞–ø—Ä—è–º—É—é –∏–∑ –∫–∞—Ä—Ç–æ—á–∫–∏ —Ç–æ–≤–∞—Ä–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QGjC6 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""registration"",
  ""impact"": ""high"",
  ""english"": ""Four major online marketplaces have been integrated with the Medical Products Registry of Roszdravnadzor. Now, product legality can be checked directly from the product card.""
}"
2025-11-12T05:57:05+00:00,@medpharm,13506,https://t.me/medpharm/13506,–ß—Ä–µ–∑–º–µ—Ä–Ω–æ–µ —É–ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–µ –∞–ª–∫–æ–≥–æ–ª—è –æ–∫–∞–∑–∞–ª–æ—Å—å —Å–≤—è–∑–∞–Ω–æ —Å –±–æ–ª–µ–µ —Ä–∞–Ω–Ω–∏–º —Ä–∞–∑–≤–∏—Ç–∏–µ–º –≤–Ω—É—Ç—Ä–∏–º–æ–∑–≥–æ–≤–æ–≥–æ –∫—Ä–æ–≤–æ–∏–∑–ª–∏—è–Ω–∏—è –∏ –±–æ–ª–µ–µ —Ç—è–∂–µ–ª—ã–º –µ–≥–æ —Ç–µ—á–µ–Ω–∏–µ–º. –¢–∞–∫–∂–µ —É —Ç–∞–∫–∏—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —á–∞—â–µ –≤—ã—è–≤–ª—è–ª–∏ –ø—Ä–∏–∑–Ω–∞–∫–∏ –¥–æ–ª–≥–æ–≤—Ä–µ–º–µ–Ω–Ω–æ–≥–æ –ø–æ–≤—Ä–µ–∂–¥–µ–Ω–∏—è –º–µ–ª–∫–∏—Ö —Å–æ—Å—É–¥–æ–≤ –≥–æ–ª–æ–≤–Ω–æ–≥–æ –º–æ–∑–≥–∞ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QGcem #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ù–µ–≤—Ä–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è,"{
  ""skip"": true
}"
2025-11-12T05:04:02+00:00,@medpharm,13505,https://t.me/medpharm/13505,"–°–µ–≥–æ–¥–Ω—è –≤ 11:00 –º—Å–∫ —Å–æ—Å—Ç–æ–∏—Ç—Å—è –±–∏–∑–Ω–µ—Å-–∑–∞–≤—Ç—Ä–∞–∫ ¬´–ö–æ–º–ø–∞–Ω–∏–∏ –≥–æ–¥–∞. –õ—É—á—à–∏–µ –ø—Ä–∞–∫—Ç–∏–∫–∏¬ª, –ø–æ–¥–∫–ª—é—á–∞–π—Ç–µ—Å—å –∫ —Ç—Ä–∞–Ω—Å–ª—è—Ü–∏–∏. –ú–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–µ –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç –¥–µ–ª–æ–≤—É—é –ø—Ä–æ–≥—Ä–∞–º–º—É 26 —Å–µ–∑–æ–Ω–∞ ¬´–ü–ª–∞—Ç–∏–Ω–æ–≤–æ–π —É–Ω—Ü–∏–∏¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QGaRp #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-11-11T17:41:06+00:00,@medpharm,13504,https://t.me/medpharm/13504,"–ú–µ—Ö–∞–Ω–∏–∑–º ¬´–≤—Ç–æ—Ä–æ–π –ª–∏—à–Ω–∏–π¬ª –º–æ–∂–µ—Ç —Å—Ç–∞—Ç—å –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–º –ø—Ä–∏ –∑–∞–∫—É–ø–∫–µ –≤—Å–µ—Ö –º–µ–¥–∏–∑–¥–µ–ª–∏–π. –¢–∞–∫–∞—è –º–µ—Ä–∞ –º–æ–∂–µ—Ç –ø–æ–º–æ—á—å –º–µ–¥–ø—Ä–æ–º—É, –Ω–æ –ø–æ–≤—ã—Å–∏—Ç—å —Ä–∞—Å—Ö–æ–¥—ã –ª–µ—á–µ–±–Ω—ã—Ö —É—á—Ä–µ–∂–¥–µ–Ω–∏–π, —Å—á–∏—Ç–∞—é—Ç —ç–∫—Å–ø–µ—Ä—Ç—ã –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QGLgn #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""A 'second spare' mechanism is being considered as mandatory for purchasing all medical equipment. Such a measure could help the healthcare sector, but it may increase the costs for health institutions.""
}"
2025-11-11T16:32:01+00:00,@medpharm,13503,https://t.me/medpharm/13503,"–ö–∞–ø–ª—è –≤ –º–æ—Ä–µ. –ò–∑ –∑–∞–∫—É–ø–ª–µ–Ω–Ω–æ–≥–æ —Å 2019 –≥–æ–¥–∞ —Ä–æ—Å—Å–∏–π—Å–∫–∏–º–∏ –≥–æ—Å–∫–ª–∏–Ω–∏–∫–∞–º–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –ø—Ä–æ—Å—Ç–∞–∏–≤–∞–µ—Ç —Ç–æ–ª—å–∫–æ 0,2%. –í –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–µ —Å–ª—É—á–∞–µ–≤ —ç—Ç–æ —Å–≤—è–∑–∞–Ω–æ —Å –ø–æ–ª–æ–º–∫–∞–º–∏ –∏ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏–µ–º —Ä–µ–º–æ–Ω—Ç–∞, —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∞ —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–∞ –ê–ª–ª–∞ –°–∞–º–æ–π–ª–æ–≤–∞. –ö–æ—Å–∞ –Ω–∞ –∫–∞–º–µ–Ω—å. –í –ï–∫–∞—Ç–µ—Ä–∏–Ω–±—É—Ä–≥–µ –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç—Å—è —Å–∫–∞–Ω–¥–∞–ª –≤–æ–∫—Ä—É–≥ –£—Ä–∞–ª—å—Å–∫–æ–≥–æ –∏–Ω—Å—Ç–∏—Ç—É—Ç–∞ –∫–∞—Ä–¥–∏–æ–ª–æ–≥–∏–∏: –≤—Å–ª–µ–¥ –∑–∞ —É–≤–æ–ª—å–Ω–µ–Ω–∏–µ–º –≥–ª–∞–≤–≤—Ä–∞—á–∞ –º–µ–¥—Ü–µ–Ω—Ç—Ä –ø–æ–∫–∏–¥–∞—é—Ç –∫–ª—é—á–µ–≤—ã–µ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã. –ü–∞—Ü–∏–µ–Ω—Ç—ã –∏ —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–∏ –æ–ø–∞—Å–∞—é—Ç—Å—è —É—Ö—É–¥—à–µ–Ω–∏—è –∫–∞—á–µ—Å—Ç–≤–∞ –æ–∫–∞–∑–∞–Ω–∏—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏. –í–æ—Ç! –ü—Ä–∏–≤—è–∑–∞–ª–∏—Å—å. –ì–æ—Å–¥—É–º–∞ –†–§ –ø—Ä–∏–Ω—è–ª–∞ –≤ —Ç—Ä–µ—Ç—å–µ–º —á—Ç–µ–Ω–∏–∏ –∑–∞–∫–æ–Ω –æ–± –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–º —Ü–µ–ª–µ–≤–æ–º –æ–±—É—á–µ–Ω–∏–∏ –∏ –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–µ –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–µ–π. –ì–ª–æ–±–∞–ª—å–Ω—ã–π –ø–æ–¥—Ö–æ–¥. –ú–µ—Ö–∞–Ω–∏–∑–º ¬´–≤—Ç–æ—Ä–æ–π –ª–∏—à–Ω–∏–π¬ª –º–æ–∂–µ—Ç —Å—Ç–∞—Ç—å –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–º –ø—Ä–∏ –∑–∞–∫—É–ø–∫–µ –≤—Å–µ—Ö –º–µ–¥–∏–∑–¥–µ–ª–∏–π. –¢–∞–∫–∞—è –º–µ—Ä–∞ –º–æ–∂–µ—Ç –ø–æ–º–æ—á—å –º–µ–¥–ø—Ä–æ–º—É, –Ω–æ –ø–æ–≤—ã—Å–∏—Ç—å —Ä–∞—Å—Ö–æ–¥—ã –ª–µ—á–µ–±–Ω—ã—Ö —É—á—Ä–µ–∂–¥–µ–Ω–∏–π, —Å—á–∏—Ç–∞—é—Ç —ç–∫—Å–ø–µ—Ä—Ç—ã.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, hospital_policy, guideline"",
  ""impact"": ""high"",
  ""english"": ""Global approach. A 'second unnecessary' mechanism is being considered as mandatory for all medical equipment purchases. This could help the healthcare sector but increase treatment costs, according to experts.""
}"
2025-11-11T15:59:04+00:00,@medpharm,13502,https://t.me/medpharm/13502,–ù–∞—á–∞–ª–æ—Å—å —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–æ –Ω–æ–≤–æ–≥–æ –∫–æ–º–ø–ª–µ–∫—Å–∞ –ù–ò–ò —Å–∫–æ—Ä–æ–π –ø–æ–º–æ—â–∏ –∏–º. –°–∫–ª–∏—Ñ–æ—Å–æ–≤—Å–∫–æ–≥–æ. –ú–µ–¥—Ü–µ–Ω—Ç—Ä —Å—Ç–∞–Ω–µ—Ç –∫—Ä—É–ø–Ω–µ–π—à–∏–º —Å—Ç—Ä–æ—è—â–∏–º—Å—è –æ–±—ä–µ–∫—Ç–æ–º —Ç–∞–∫–æ–≥–æ —Ä–æ–¥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QGP82 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-11-11T15:24:07+00:00,@medpharm,13501,https://t.me/medpharm/13501,–î–æ–ª—è —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –Ω–∞ —Ä—ã–Ω–∫–µ —Å—Ä–µ–¥—Å—Ç–≤ –∏–Ω–¥–∏–≤–∏–¥—É–∞–ª—å–Ω–æ–π –∑–∞—â–∏—Ç—ã —É–≤–µ–ª–∏—á–∏–ª–∞—Å—å –ø–æ –∏—Ç–æ–≥–∞–º –ø—Ä–æ—à–ª–æ–≥–æ –≥–æ–¥–∞ –¥–æ 87%. –¢—Ä–µ–Ω–¥ –Ω–∞ –∏–º–ø–æ—Ä—Ç–æ–∑–∞–º–µ—â–µ–Ω–∏–µ –∏ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–µ –∏–Ω–Ω–æ–≤–∞—Ü–∏–∏ –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç—Å—è –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QGE7r #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-11-11T15:06:03+00:00,@medpharm,13500,https://t.me/medpharm/13500,"–í —Ä–µ–π—Ç–∏–Ω–≥ —Ä–∞–±–æ—Ç–æ–¥–∞—Ç–µ–ª–µ–π –∑–∞ 2025 –≥–æ–¥ –æ—Ç –†–ë–ö –≤–æ—à–ª–∏ —à–µ—Å—Ç—å —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π ‚Äî –Ω–∞ –¥–≤–µ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –±–æ–ª—å—à–µ, —á–µ–º –≤ –ø—Ä–æ—à–ª–æ–º –≥–æ–¥—É –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QGD5t #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-11-11T14:43:06+00:00,@medpharm,13499,https://t.me/medpharm/13499,"OpenAI –ø–ª–∞–Ω–∏—Ä—É–µ—Ç —Å–æ–∑–¥–∞—Ç—å –Ω–æ–≤—ã–µ –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç—ã –¥–ª—è –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è, –∏—Å–ø–æ–ª—å–∑—É—è –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ –≤–Ω–µ–¥—Ä–µ–Ω–∏—è –≥–µ–Ω–µ—Ä–∞—Ç–∏–≤–Ω–æ–≥–æ –ò–ò –≤ –º–µ–¥–∏—Ü–∏–Ω—É. –û–± —ç—Ç–æ–º —Å–≤–∏–¥–µ—Ç–µ–ª—å—Å—Ç–≤—É—é—Ç –Ω–µ–¥–∞–≤–Ω–∏–µ –∫–∞–¥—Ä–æ–≤—ã–µ –Ω–∞–∑–Ω–∞—á–µ–Ω–∏—è –≤ –∫–æ–º–ø–∞–Ω–∏–∏ –∏ —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–æ —Å –∫—Ä—É–ø–Ω—ã–º–∏ —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º–∏ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QGBfv #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-11-11T14:08:03+00:00,@medpharm,13498,https://t.me/medpharm/13498,"–ú–µ—Ö–∞–Ω–∏–∑–º ¬´–≤—Ç–æ—Ä–æ–π –ª–∏—à–Ω–∏–π¬ª –º–æ–∂–µ—Ç —Å—Ç–∞—Ç—å –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–º –ø—Ä–∏ –∑–∞–∫—É–ø–∫–µ –≤—Å–µ—Ö –º–µ–¥–∏–∑–¥–µ–ª–∏–π. –ì–ª–æ–±–∞–ª–∏–∑–∏—Ä–æ–≤–∞—Ç—å –ø–æ–¥—Ö–æ–¥—ã –∫ –ø–æ–¥–¥–µ—Ä–∂–∫–µ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ø—Ä–µ–¥–ª–æ–∂–∏–ª –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ –†–§, –∑–∞—Ä—É—á–∏–≤—à–∏—Å—å –ø–æ–¥–¥–µ—Ä–∂–∫–æ–π –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–§. –ü–æ —Å–ª–æ–≤–∞–º —ç–∫—Å–ø–µ—Ä—Ç–æ–≤, –Ω–∞ —Ä—ã–Ω–∫–µ –¥–æ —Å–∏—Ö –ø–æ—Ä –µ—Å—Ç—å —Ä–∞–∑–Ω–æ–≥–ª–∞—Å–∏—è –ø–æ –≤–∫–ª—é—á–µ–Ω–∏—é –º–µ–¥–∏–∑–¥–µ–ª–∏–π –≤ —Ä–µ–µ—Å—Ç—Ä –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QG9Xp #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The 'second spare' mechanism is being made mandatory for purchasing all medical equipment. The Ministry of Industry and Trade of Russia has proposed global approaches to support domestic manufacturers, with the support of the Ministry of Health. Experts say there are still discrepancies on including medical equipment in the registry of domestically produced products. For more details: https://clck.ru/3QG9Xp #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ""
}"
2025-11-11T13:47:06+00:00,@medpharm,13497,https://t.me/medpharm/13497,"–ü–∞—Ü–∏–µ–Ω—Ç—ã –≤—Å–µ —á–∞—â–µ –ø—Ä–µ–¥–ø–æ—á–∏—Ç–∞—é—Ç –ø–æ–≤–µ—Ä—è—Ç—å —Å–≤–æ–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ —Ç–∞–π–Ω—ã –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–º—É –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç—É, –∞ –Ω–µ –≤—Ä–∞—á–∞–º. –° –Ω–µ–π—Ä–æ—Å–µ—Ç—å—é –æ–Ω–∏ —á—É–≤—Å—Ç–≤—É—é—Ç —Å–µ–±—è –±–æ–ª–µ–µ —Å–≤–æ–±–æ–¥–Ω–æ –∏ –Ω–µ –±–æ—è—Ç—Å—è –æ—Å—É–∂–¥–µ–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QG87S #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-11-11T13:33:02+00:00,@medpharm,13496,https://t.me/medpharm/13496,–ù–æ–≤—ã–µ –¥–∞–Ω–Ω—ã–µ –æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–µ –æ–ª–æ–∫–∏–∑—É–º–∞–± –Ω–∞ –ï–∂–µ–≥–æ–¥–Ω–æ–º –∫–æ–Ω–≥—Ä–µ—Å—Å–µ –ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–π –∫–æ–ª–ª–µ–≥–∏–∏ —Ä–µ–≤–º–∞—Ç–æ–ª–æ–≥–æ–≤ ACR Convergence 2025 –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∞ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–æ–º—É –ø—Ä–æ—Ñ–∏–ª—å–Ω–æ–º—É —Å–æ–æ–±—â–µ—Å—Ç–≤—É –≥—Ä—É–ø–ø–∞ –∫–æ–º–ø–∞–Ω–∏–π ¬´–†-–§–∞—Ä–º¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QG7Kp #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-11-11T13:04:03+00:00,@medpharm,13495,https://t.me/medpharm/13495,–ó–∞–∫–æ–Ω –æ–± –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–º —Ü–µ–ª–µ–≤–æ–º –æ–±—É—á–µ–Ω–∏–∏ –∏ –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–µ –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–µ–π –ø—Ä–∏–Ω—è—Ç –ì–æ—Å–¥—É–º–æ–π –†–§ –≤ —Ç—Ä–µ—Ç—å–µ–º —á—Ç–µ–Ω–∏–∏ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QG5PS #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, training"",
  ""impact"": ""medium"",
  ""english"": ""The law on mandatory target training and mentoring of medical and pharmaceutical graduates has been passed by the State Duma of Russia in its third reading. More details: https://clck.ru/3QG5PS""
}"
2025-11-11T12:52:06+00:00,@medpharm,13494,https://t.me/medpharm/13494,"–ó–∞ 2025 –≥–æ–¥ –º–∏–ª–ª–∏–æ–Ω—ã –µ–¥–∏–Ω–∏—Ü –º–µ–¥–∏–∑–¥–µ–ª–∏–π –±—ã–ª–∏ —Å–Ω—è—Ç—ã —Å –æ–±—Ä–∞—â–µ–Ω–∏—è, —Å–æ–æ–±—â–∏–ª–∞ –≥–ª–∞–≤–∞ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–∞ –ê–ª–ª–∞ –°–∞–º–æ–π–ª–æ–≤–∞ –Ω–∞ —Ñ–æ—Ä—É–º–µ NOVAMED-2025. –¢–∞–∫–∂–µ –æ–Ω–∞ –æ–±—Ä–∞—Ç–∏–ª–∞ –≤–Ω–∏–º–∞–Ω–∏–µ –Ω–∞ –ø—Ä–æ–±–ª–µ–º—É –ø—Ä–æ—Å—Ç–æ—è –Ω–æ–≤–æ–π –º–µ–¥—Ç–µ—Ö–Ω–∏–∫–∏ –≤ –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è—Ö –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QG4aM #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, shortage"",
  ""impact"": ""high"",
  ""english"": ""The head of the Russian Health Supervision, Alla Samoylova, announced at the NOVAMED-2025 forum that millions of medical devices were withdrawn from circulation in 2025. She also highlighted the issue of new medical equipment being idle in healthcare organizations.""
}"
2025-11-11T12:33:03+00:00,@medpharm,13493,https://t.me/medpharm/13493,"–ó–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ–± –æ—Ç—Ä–∞–±–æ—Ç–∫–∞—Ö –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∫–æ–ª–ª–µ–¥–∂–µ–π –∏ –≤—É–∑–æ–≤ –ø—Ä–∏–Ω—è—Ç –≤ —Ç—Ä–µ—Ç—å–µ–º —á—Ç–µ–Ω–∏–∏. –í—Å–µ–º –ø–æ–ª—É—á–∏–≤—à–∏–º –≤—ã—Å—à–µ–µ –∏ —Å—Ä–µ–¥–Ω–µ–µ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–µ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞–º –ø–æ—Å–ª–µ 2026 –≥–æ–¥–∞ –ø—Ä–∏–¥–µ—Ç—Å—è –ø—Ä–æ–π—Ç–∏ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–π —Ç—Ä–µ—Ö–ª–µ—Ç–Ω–∏–π –ø–µ—Ä–∏–æ–¥ –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–∞ –≤ –∫–ª–∏–Ω–∏–∫–∞—Ö, –∫–æ—Ç–æ—Ä—ã–µ —Ä–∞–±–æ—Ç–∞—é—Ç –≤ —Å–∏—Å—Ç–µ–º–µ –û–ú–°. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QG3Mg #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, registration, safety"",
  ""impact"": ""medium"",
  ""english"": ""A law project on the apprenticeship of medical college and university graduates has passed its third reading. Starting from 2026, all healthcare professionals with higher or secondary professional education in medicine will have to complete a three-year apprenticeship period at clinics under the Unified Medical Care System.""
}"
2025-11-11T12:00:07+00:00,@medpharm,13492,https://t.me/medpharm/13492,"–ê–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å–Ω–∞—è —Å–ª—É–∂–±–∞ –ø—Ä–µ–∫—Ä–∞—Ç–∏–ª–∞ –ø—Ä–∞–∫—Ç–∏–∫—É –Ω–µ–æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω–æ–≥–æ –æ—Ç–∫–ª–æ–Ω–µ–Ω–∏—è –∑–∞—è–≤–æ–∫ –Ω–∞ –ø–æ—Å—Ç–∞–≤–∫—É –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ —Ñ–æ—Ä–º—ã –∫–æ—Ç–æ—Ä—ã—Ö –Ω–µ –≤–∫–ª—é—á–µ–Ω—ã –≤ –ü–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü. –í –§–ê–° –†–æ—Å—Å–∏–∏ —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏, –∫–∞–∫–∏–º —Ä–µ–µ—Å—Ç—Ä–æ–º —Å—Ç–æ–∏—Ç —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–æ–≤–∞—Ç—å—Å—è –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QFyjW #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions"",
  ""impact"": ""high"",
  ""english"": ""The Antimonopoly Service has stopped the practice of unjustified rejection of applications for the supply of drugs and medicinal forms that are not included in the List of Essential Medicines. FAS Russia has provided information on which registry to follow.""
}"
2025-11-11T11:38:07+00:00,@medpharm,13491,https://t.me/medpharm/13491,–í –†–æ—Å—Å–∏–∏ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞—Ç—å –º–æ–¥–µ—Ä–Ω–∏–∑–∞—Ü–∏—é –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∏ –ø–æ–≤—ã—à–µ–Ω–∏–µ –∫–∞—á–µ—Å—Ç–≤–∞ –º–µ–¥—É—Å–ª—É–≥ –∑–∞ —Å—á–µ—Ç –±—É–∫–º–µ–∫–µ—Ä–æ–≤. –ò–Ω–∏—Ü–∏–∞—Ç–∏–≤–∞ –Ω–∞—Ü–µ–ª–µ–Ω–∞ –Ω–∞ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ –Ω–µ–ø—Ä–æ—Ñ–∏–ª—å–Ω–æ–≥–æ –±–∏–∑–Ω–µ—Å–∞ –¥–ª—è —Å–æ–∑–¥–∞–Ω–∏—è –≤—ã—Å–æ–∫–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä—ã –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QFx9D #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-11-11T10:42:20+00:00,@medpharm,13490,https://t.me/medpharm/13490,"–í —É—Ä–∞–ª—å—Å–∫–æ–π –º–µ–¥–∏—Ü–∏–Ω–µ –Ω–∞–∑—Ä–µ–≤–∞–µ—Ç —Å–∏—Å—Ç–µ–º–Ω—ã–π –∫—Ä–∏–∑–∏—Å, –∫–æ—Ç–æ—Ä—ã–π –º–æ–∂–µ—Ç –æ—Å—Ç–∞–≤–∏—Ç—å —Ä–µ–≥–∏–æ–Ω –±–µ–∑ –≤—ã—Å–æ–∫–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–Ω–æ–π –∫–∞—Ä–¥–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π –ø–æ–º–æ—â–∏, –ø–æ–ª–∞–≥–∞—é—Ç —ç–∫—Å–ø–µ—Ä—Ç—ã. –í—Å–ª–µ–¥ –∑–∞ —É–≤–æ–ª—å–Ω–µ–Ω–∏–µ–º –≥–ª–∞–≤–≤—Ä–∞—á–∞ –ò–Ω—Å—Ç–∏—Ç—É—Ç–∞ –∫–∞—Ä–¥–∏–æ–ª–æ–≥–∏–∏ –Ø–Ω–∞ –ì–∞–±–∏–Ω—Å–∫–æ–≥–æ –º–µ–¥—Ü–µ–Ω—Ç—Ä –ø–æ–∫–∏–¥–∞—é—Ç –∫–ª—é—á–µ–≤—ã–µ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã. –°—Ç–æ—Ä–æ–Ω–Ω–∏–µ –Ω–∞–±–ª—é–¥–∞—Ç–µ–ª–∏ —É—Ç–≤–µ—Ä–∂–¥–∞—é—Ç, —á—Ç–æ —Ä–µ—à–µ–Ω–∏–µ –±—ã–ª–æ –æ—á–µ–≤–∏–¥–Ω—ã–º –∏ –ø—Ä–∏–∑–≤–∞–Ω–æ —É–ø–æ—Ä—è–¥–æ—á–∏—Ç—å —Ñ–∏–Ω–∞–Ω—Å–æ–≤—ã–µ –ø–æ—Ç–æ–∫–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QFsuS #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""clinical_trial, hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""Experts suggest a systemic crisis is looming in Urals medicine, potentially leaving the region without high-tech cardiology assistance. Key specialists are leaving after the head of the Institute of Cardiology, Yan Gabinskiy, was dismissed. Observers claim this decision was obvious and aimed at organizing financial flows. For more: https://clck.ru/3QFsuS #MedVestnik #Healthcare #HealthSystem""
}"
2025-11-11T10:07:07+00:00,@medpharm,13489,https://t.me/medpharm/13489,–ú–∏–Ω—Ñ–∏–Ω –†–§ —Ä–∞–∑—ä—è—Å–Ω–∏–ª —Å—Ä–æ–∫–∏ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –ø—Ä–∞–≤–∏–ª–∞ ¬´–≤—Ç–æ—Ä–æ–π –ª–∏—à–Ω–∏–π¬ª –¥–ª—è –∑–∞–∫—É–ø–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤. –ö–ª—é—á–µ–≤–æ–µ —Ä–∞–∑–ª–∏—á–∏–µ –¥–µ–ª–∞–µ—Ç—Å—è –º–µ–∂–¥—É –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º–∏ –∏–∑ –ø–µ—Ä–µ—á–Ω–µ–π –ñ–ù–í–õ–ü –∏ –°–ó–õ–°. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QFq4B #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Finance of Russia has clarified the deadlines for applying the 'second extra' rule for purchasing medicines. Key differences are made between drugs from the –ñ–ù–í–õ–ü and –°–ó–õ–° lists. More details: https://clck.ru/3QFq4B #PharmNews #Regulation""
}"
2025-11-11T08:59:03+00:00,@medpharm,13488,https://t.me/medpharm/13488,"–° 28 –æ–∫—Ç—è–±—Ä—è –ø–æ 10 –Ω–æ—è–±—Ä—è –≤ –°–®–ê –æ–¥–æ–±—Ä–µ–Ω–∞ –ø–µ—Ä–≤–∞—è —Ç–µ—Ä–∞–ø–∏—è –¥–ª—è —Å–º–µ—Ä—Ç–µ–ª—å–Ω–æ–≥–æ –¥–µ—Ñ–∏—Ü–∏—Ç–∞ —Ç–∏–º–∏–¥–∏–Ω–∫–∏–Ω–∞–∑—ã 2, –ø–µ—Ä–≤—ã–π –º–µ—Ç–æ–¥ –ª–µ—á–µ–Ω–∏—è —Ç–ª–µ—é—â–µ–π –º–∏–µ–ª–æ–º—ã –∏ –ø–µ—Ä–≤—ã–π –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç –æ—Ç —Å–∏–Ω–¥—Ä–æ–º–∞ —Ä–∞–∑–¥—Ä–∞–∂–µ–Ω–Ω–æ–≥–æ –∫–∏—à–µ—á–Ω–∏–∫–∞ —É –¥–µ—Ç–µ–π. –í —Ç–æ –∂–µ –≤—Ä–µ–º—è –ö–∏—Ç–∞–π –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª –¥–≤–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞, –Ω–µ –∏–º–µ—é—â–∏—Ö –∞–Ω–∞–ª–æ–≥–æ–≤ –≤ –º–∏—Ä–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QFjrW #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-11-11T08:29:07+00:00,@medpharm,13487,https://t.me/medpharm/13487,"FDA —É–¥–∞–ª–∏—Ç –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏—è –≤ —á–µ—Ä–Ω–æ–π —Ä–∞–º–∫–µ –∏–∑ –∏–Ω—Å—Ç—Ä—É–∫—Ü–∏–π –≤—Å–µ—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –º–µ–Ω–æ–ø–∞—É–∑–∞–ª—å–Ω–æ–π –≥–æ—Ä–º–æ–Ω–∞–ª—å–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏, —Å–æ–¥–µ—Ä–∂–∞—â–∏—Ö —ç—Å—Ç—Ä–æ–≥–µ–Ω. –ö–æ–º–∏—Å—Å–∞—Ä —É–ø—Ä–∞–≤–ª–µ–Ω–∏—è —Å—Ä–∞–≤–Ω–∏–ª –¥–æ–ª–≥–æ–≤—Ä–µ–º–µ–Ω–Ω—ã–µ –ø—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–∞, —Å–≤—è–∑–∞–Ω–Ω—ã–µ —Å –ø—Ä–∏–µ–º–æ–º —Ç–∞–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –∑–¥–æ—Ä–æ–≤—å—è –∂–µ–Ω—â–∏–Ω, —Å –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ–º –∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫–æ–≤ –∏ –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏–µ–π –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QFhbs #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ê–∫—É—à–µ—Ä—Å—Ç–≤–æ_–∏_–≥–∏–Ω–µ–∫–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è #–≠–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-11-11T08:04:03+00:00,@medpharm,13486,https://t.me/medpharm/13486,"–ú–∞—Ä–∫–∏—Ä–æ–≤–∫–∞ –≥—Ä–æ–∑–∏—Ç –ø–∞—Ä–∞–ª–∏–∑–æ–≤–∞—Ç—å —Ä—ã–Ω–æ–∫ —à–ø—Ä–∏—Ü–µ–≤, —Å–ø–∏—Ä—Ç–æ–≤—ã—Ö —Å–∞–ª—Ñ–µ—Ç–æ–∫ –∏ –ø–µ—Ä–µ–≤—è–∑–æ—á–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤, —Å—á–∏—Ç–∞—é—Ç –Ω–µ–∫–æ—Ç–æ—Ä—ã–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –º–µ–ª–∫–æ—à—Ç—É—á–Ω—ã—Ö –º–µ–¥–∏–∑–¥–µ–ª–∏–π. –ù–∞–Ω–µ—Å–µ–Ω–∏–µ –∫–æ–¥–æ–≤ –Ω–∞ –º–∞–ª–æ–≥–∞–±–∞—Ä–∏—Ç–Ω—ã–µ —É–ø–∞–∫–æ–≤–∫–∏ —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–∏ –Ω–µ–≤–æ–∑–º–æ–∂–Ω–æ –∏ —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–∏ –Ω–µ—Ü–µ–ª–µ—Å–æ–æ–±—Ä–∞–∑–Ω–æ. –ß—Ç–æ –≥–æ–≤–æ—Ä—è—Ç –æ –ø—Ä–æ–±–ª–µ–º–µ –≤ –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–µ –†–§? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QFfgS #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""medium"",
  ""english"": ""Some small medical supplies manufacturers argue that barcode marking could paralyze the market for syringes, spirit-soaked towels, and dressings. Technically impossible and economically unfeasible to mark small packaging with codes. What is the government of Russia saying about the problem? More details: https://clck.ru/3QFfgS #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ""
}"
2025-11-11T07:37:04+00:00,@medpharm,13485,https://t.me/medpharm/13485,–° –∫–æ–¥–∏—Ä–æ–≤–∞–Ω–∏–µ–º –¥–∏–∞–≥–Ω–æ–∑–æ–≤ –ø–æ –ú–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–æ–π –∫–ª–∞—Å—Å–∏—Ñ–∏–∫–∞—Ü–∏–∏ –±–æ–ª–µ–∑–Ω–µ–π –º–æ–∂–µ—Ç —Å–ø—Ä–∞–≤–∏—Ç—å—Å—è –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω—ã–π –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç. –≠—Ç–æ –ø–æ–∑–≤–æ–ª–∏—Ç —Å–Ω—è—Ç—å –ª–∏—à–Ω—é—é –∞–¥–º–∏–Ω–∏—Å—Ç—Ä–∞—Ç–∏–≤–Ω—É—é –Ω–∞–≥—Ä—É–∑–∫—É —Å –≤—Ä–∞—á–µ–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QFdjy #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-11-11T06:13:04+00:00,@medpharm,13484,https://t.me/medpharm/13484,"–£—á–µ–Ω—ã–µ –∏–∑ –ü–µ–Ω—Å–∏–ª—å–≤–∞–Ω—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ –ø—Ä–æ–∞–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–ª–∏ –≤–ª–∏—è–Ω–∏–µ –º–µ—Ç—Ñ–æ—Ä–º–∏–Ω–∞ –∏ –∫–æ–º–±–∏–Ω–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ø–µ—Ä–æ—Ä–∞–ª—å–Ω—ã—Ö –∫–æ–Ω—Ç—Ä–∞—Ü–µ–ø—Ç–∏–≤–æ–≤ –Ω–∞ –∫–∞—á–µ—Å—Ç–≤–æ –∂–∏–∑–Ω–∏, –Ω–∞—Å—Ç—Ä–æ–µ–Ω–∏–µ –∏ —Å–µ–∫—Å—É–∞–ª—å–Ω—É—é —Ñ—É–Ω–∫—Ü–∏—é —É –∂–µ–Ω—â–∏–Ω —Å –≥–∏–ø–µ—Ä–∞–Ω–¥—Ä–æ–≥–µ–Ω–Ω—ã–º —Å–∏–Ω–¥—Ä–æ–º–æ–º –ø–æ–ª–∏–∫–∏—Å—Ç–æ–∑–Ω—ã—Ö —è–∏—á–Ω–∏–∫–æ–≤. –†–µ–∑—É–ª—å—Ç–∞—Ç—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω—ã –Ω–∞ –µ–∂–µ–≥–æ–¥–Ω–æ–º —Å–æ–±—Ä–∞–Ω–∏–∏ –ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–≥–æ –æ–±—â–µ—Å—Ç–≤–∞ —Ä–µ–ø—Ä–æ–¥—É–∫—Ç–∏–≤–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω—ã ASRM-2025 –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QFYJi #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ê–∫—É—à–µ—Ä—Å—Ç–≤–æ_–∏_–≥–∏–Ω–µ–∫–æ–ª–æ–≥–∏—è #–ü—Å–∏—Ö–∏–∞—Ç—Ä–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è #–≠–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-11-10T16:31:25+00:00,@medpharm,13483,https://t.me/medpharm/13483,"–°–Ω–æ–≤–∞ –≤—Ç–æ—Ä–æ–µ. –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–µ–Ω–Ω—ã–π –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ–± –æ—Ç—Ä–∞–±–æ—Ç–∫–∞—Ö –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∫–æ–ª–ª–µ–¥–∂–µ–π –∏ –≤—É–∑–æ–≤ –±—É–¥–µ—Ç –∑–∞–Ω–æ–≤–æ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω –ì–æ—Å–¥—É–º–æ–π –†–§ –≤–æ –≤—Ç–æ—Ä–æ–º —á—Ç–µ–Ω–∏–∏. –£—Å–∫–æ—Ä—è—Ç –ø—Ä–æ—Ü–µ—Å—Å. –í–Ω–µ—Å–µ–Ω—ã –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ —Ñ–æ—Ä–º—É —Å–æ–≥–ª–∞—à–µ–Ω–∏—è –æ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª–µ–Ω–∏–∏ —Å—É–±—Å–∏–¥–∏–π –∏–∑ –±—é–¥–∂–µ—Ç–∞ –§–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ —Ñ–æ–Ω–¥–∞ –û–ú–° –Ω–∞ –≤—ã—Å–æ–∫–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–Ω—É—é –º–µ–¥–∏—Ü–∏–Ω—Å–∫—É—é –ø–æ–º–æ—â—å, –Ω–µ –≤–∫–ª—é—á–µ–Ω–Ω—É—é –≤ –±–∞–∑–æ–≤—É—é –ø—Ä–æ–≥—Ä–∞–º–º—É –û–ú–°. –ò–Ω–¥–µ–∫—Å–∞—Ü–∏—è –ø–æ –∑–∞–∫–æ–Ω—É. –†–∞–±–æ—Ç–æ–¥–∞—Ç–µ–ª–µ–π –≤ –∫–æ–º–º–µ—Ä—á–µ—Å–∫–æ–º —Å–µ–∫—Ç–æ—Ä–µ –æ–±—è–∂—É—Ç –∏–Ω–¥–µ–∫—Å–∏—Ä–æ–≤–∞—Ç—å –∑–∞—Ä–ø–ª–∞—Ç—ã –Ω–µ —Ä–µ–∂–µ —Ä–∞–∑–∞ –≤ –≥–æ–¥ –∏ –≤ —Ä–∞–∑–º–µ—Ä–µ –Ω–µ –Ω–∏–∂–µ —É—Ä–æ–≤–Ω—è –∏–Ω—Ñ–ª—è—Ü–∏–∏ –∑–∞ –ø—Ä–µ–¥—ã–¥—É—â–∏–π –≥–æ–¥, –¥–æ–∫—É–º–µ–Ω—Ç –æ–± —ç—Ç–æ–º –≤—Å–∫–æ—Ä–µ –≤–Ω–µ—Å—É—Ç –Ω–∞ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏–µ –≤ –ì–æ—Å–¥—É–º—É –†–§. –û–±–Ω–æ–≤–∏–ª–∏ –ø–µ—Ä–µ—á–µ–Ω—å. –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§ –¥–æ–ø–æ–ª–Ω–∏–ª–æ 11 –Ω–æ–≤—ã–º–∏ –ø–æ–∑–∏—Ü–∏—è–º–∏ –ø–µ—Ä–µ—á–µ–Ω—å —Å–∏–ª—å–Ω–æ–¥–µ–π—Å—Ç–≤—É—é—â–∏—Ö –∏ —è–¥–æ–≤–∏—Ç—ã—Ö –≤–µ—â–µ—Å—Ç–≤, –æ–±–æ—Ä–æ—Ç –∫–æ—Ç–æ—Ä—ã—Ö —Ä–µ–≥—É–ª–∏—Ä—É–µ—Ç—Å—è —Å—Ç.234 –£–ö –†–§.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing, import_export, sanctions"",
  ""impact"": ""high"",
  ""english"": ""The government of Russia is reconsidering the law on graduation certificates for medical colleges and universities in the second reading. The process will be accelerated. Changes have been made to the agreement on providing subsidies from the Federal Health Fund for high-tech medical care, not included in the basic program of OMS. The law will index salaries for employers in the commercial sector to at least the inflation rate of the previous year, which will be submitted for consideration in the State Duma. The government of Russia has updated the list and added 11 new items to the list of hazardous substances regulated by Art. 234 of the Criminal Code.""
}"
2025-11-10T15:18:03+00:00,@medpharm,13482,https://t.me/medpharm/13482,"–°—Ç–∞–ª–∞ –∏–∑–≤–µ—Å—Ç–Ω–∞ —Å—É–º–º–∞, –≤ –∫–æ—Ç–æ—Ä—É—é –æ—Ü–µ–Ω–∏–ª–∏ –∏–º—É—â–µ—Å—Ç–≤–æ –ø–µ–Ω–∑–µ–Ω—Å–∫–æ–π –∞–ø—Ç–µ—á–Ω–æ–π —Å–µ—Ç–∏ ¬´–§–∞—Ä–º–∞—Ü–∏—è¬ª. –í —Å–ø–∏—Å–æ–∫ –¥–ª—è –æ—Ü–µ–Ω–∫–∏ –≤–æ—à–µ–ª 91 –æ–±—ä–µ–∫—Ç. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QF6hw #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{""skip"": true}"
2025-11-10T15:14:06+00:00,@medpharm,13481,https://t.me/medpharm/13481,"–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–µ–Ω–Ω—ã–π –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ–± –æ—Ç—Ä–∞–±–æ—Ç–∫–∞—Ö –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∫–æ–ª–ª–µ–¥–∂–µ–π –∏ –≤—É–∑–æ–≤ –±—É–¥–µ—Ç –∑–∞–Ω–æ–≤–æ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω –ì–æ—Å–¥—É–º–æ–π –†–§ –≤–æ –≤—Ç–æ—Ä–æ–º —á—Ç–µ–Ω–∏–∏. –î–µ–ø—É—Ç–∞—Ç—ã –¥–æ–ª–∂–Ω—ã –±—ã–ª–∏ –ø—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ—Ç—å –≤ –Ω–µ–º –Ω–æ—Ä–º—ã –æ–± –æ–±—è–∑–∞–Ω–Ω–æ—Å—Ç–∏ —Ä–µ–≥–∏–æ–Ω–æ–≤ –æ–±–µ—Å–ø–µ—á–∏–≤–∞—Ç—å –∂–∏–ª—å–µ–º –º–æ–ª–æ–¥—ã—Ö –≤—Ä–∞—á–µ–π, –∞ —Ç–∞–∫–∂–µ —É—Ç–æ—á–Ω–∏—Ç—å —Ä–∞–∑–º–µ—Ä —à—Ç—Ä–∞—Ñ–æ–≤ –∑–∞ –Ω–µ–∏—Å–ø–æ–ª–Ω–µ–Ω–∏–µ –æ–±—è–∑–∞—Ç–µ–ª—å—Å—Ç–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QF6W8 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-11-10T14:26:05+00:00,@medpharm,13480,https://t.me/medpharm/13480,"–ë–∏–∑–Ω–µ—Å –æ–±—è–∂—É—Ç –∏–Ω–¥–µ–∫—Å–∏—Ä–æ–≤–∞—Ç—å –∑–∞—Ä–ø–ª–∞—Ç—ã –Ω–µ —Ä–µ–∂–µ —Ä–∞–∑–∞ –≤ –≥–æ–¥ –∏ –≤ —Ä–∞–∑–º–µ—Ä–µ –Ω–µ –Ω–∏–∂–µ —É—Ä–æ–≤–Ω—è –∏–Ω—Ñ–ª—è—Ü–∏–∏ –∑–∞ –ø—Ä–µ–¥—ã–¥—É—â–∏–π –≥–æ–¥, –¥–æ–∫—É–º–µ–Ω—Ç –æ–± —ç—Ç–æ–º –≤—Å–∫–æ—Ä–µ –≤–Ω–µ—Å—É—Ç –≤ –ì–æ—Å–¥—É–º—É –†–§. –°–µ–π—á–∞—Å —Å—Ä–æ–∫–∏ –∏ –ø–µ—Ä–∏–æ–¥–∏—á–Ω–æ—Å—Ç—å –∏–Ω–¥–µ–∫—Å–∞—Ü–∏–∏ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å–Ω–æ –Ω–µ —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QF3Ty #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing"",
  ""impact"": ""medium"",
  ""english"": ""Business will be obligated to index salaries at least once a year and in a size not lower than the inflation level of the previous year. The document about this will be soon submitted to the State Duma of Russia. Currently, the deadlines and periodicity for salary indexing are not legislatively established. For more details: https://clck.ru/3QF3Ty""
}"
2025-11-10T14:22:04+00:00,@medpharm,13479,https://t.me/medpharm/13479,–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§ —É—Ç–≤–µ—Ä–¥–∏–ª–æ –°—Ç—Ä–∞—Ç–µ–≥–∏—é —Ä–∞–∑–≤–∏—Ç–∏—è —Ä–µ–∞–±–∏–ª–∏—Ç–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –Ω–∞ –ø–µ—Ä–∏–æ–¥ –¥–æ 2030 –≥–æ–¥–∞. –û–±—ä–µ–º —Ä—ã–Ω–∫–∞ —Ä–µ–∞–±–∏–ª–∏—Ç–∞—Ü–∏–æ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ —É–∂–µ –ø—Ä–µ–≤—ã—Å–∏–ª 100 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QF3Bq #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-11-10T13:28:05+00:00,@medpharm,13478,https://t.me/medpharm/13478,"–ú–∏—Ö–∞–∏–ª –°—ã–ª–∫–∞ –±—É–¥–µ—Ç –∫—É—Ä–∏—Ä–æ–≤–∞—Ç—å –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç—å –î–µ–ø–∞—Ä—Ç–∞–º–µ–Ω—Ç–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∏ –î–µ–ø–∞—Ä—Ç–∞–º–µ–Ω—Ç–∞ —Ç—Ä—É–¥–∞ –∏ —Å–æ—Ü–∏–∞–ª—å–Ω–æ–π –∑–∞—â–∏—Ç—ã –°–µ–≤–∞—Å—Ç–æ–ø–æ–ª—è. –ú–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è —É –Ω–µ–≥–æ –Ω–µ—Ç, –Ω–æ –µ—Å—Ç—å –æ–ø—ã—Ç —Ä–µ—à–µ–Ω–∏—è –∑–∞–¥–∞—á –≤ —ç—Ç–æ–π —Å—Ñ–µ—Ä–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QExFo #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-11-10T13:04:04+00:00,@medpharm,13477,https://t.me/medpharm/13477,"–ö—Ä–∏—Ç–∏—á–µ—Å–∫–∏ –≤–∞–∂–Ω–æ–µ –∫–∞—á–µ—Å—Ç–≤–æ —É–ø—Ä–∞–≤–ª–µ–Ω—Ü–∞ –∏ –ª–∏–¥–µ—Ä–∞ ‚Äì —É–º–µ–Ω–∏–µ –≤–ª–∏—è—Ç—å –Ω–∞ —Å–≤–æ–∏—Ö —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤. –ï—Å–ª–∏ —ç—Ç–æ–≥–æ –∫–∞—á–µ—Å—Ç–≤–∞ –Ω–µ—Ç, —Ç–æ –≤—Å–µ –æ—Å—Ç–∞–ª—å–Ω—ã–µ –∫–∞—á–µ—Å—Ç–≤–∞ –Ω–µ –∏–≥—Ä–∞—é—Ç —Å—É—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–π —Ä–æ–ª–∏ ‚Äì –æ–Ω–∏ –Ω–µ –∑–∞–¥–µ–π—Å—Ç–≤–æ–≤–∞–Ω—ã –≤ —É–ø—Ä–∞–≤–ª–µ–Ω–∏–∏. CEO & Owner –∫–æ–º–ø–∞–Ω–∏–∏ EFECtO –°–µ—Ä–≥–µ–π –î–∞–≤—ã–¥–æ–≤, —Ä–∞—Å—Å–∫–∞–∑–∞–ª ¬´–§–í¬ª –æ–± –æ—Å–Ω–æ–≤–Ω—ã—Ö —Ç–∏–ø–∞—Ö/—É—Ä–æ–≤–Ω—è—Ö –≤–ª–∏—è–Ω–∏—è –ª–∏–¥–µ—Ä–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QEvHB #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-11-10T12:43:25+00:00,@medpharm,13476,https://t.me/medpharm/13476,"–í–Ω–µ—Å–µ–Ω—ã –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ —Ñ–æ—Ä–º—É —Å–æ–≥–ª–∞—à–µ–Ω–∏—è –æ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª–µ–Ω–∏–∏ —Å—É–±—Å–∏–¥–∏–π –∏–∑ –±—é–¥–∂–µ—Ç–∞ –§–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ —Ñ–æ–Ω–¥–∞ –û–ú–° –Ω–∞ –≤—ã—Å–æ–∫–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–Ω—É—é –º–µ–¥–∏—Ü–∏–Ω—Å–∫—É—é –ø–æ–º–æ—â—å, –Ω–µ –≤–∫–ª—é—á–µ–Ω–Ω—É—é –≤ –±–∞–∑–æ–≤—É—é –ø—Ä–æ–≥—Ä–∞–º–º—É –û–ú–°. –£—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω—ã —á–µ—Ç–∫–∏–µ —Å—Ä–æ–∫–∏ –¥–ª—è –∫–∞–∂–¥–æ–≥–æ —ç—Ç–∞–ø–∞ –ø—Ä–æ—Ü–µ–¥—É—Ä—ã –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QEtXH #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""Changes have been made to the agreement on providing budget subsidies for high-tech medical care under the Unified Medical Assistance Program. Specific timelines have been set for each stage of the procedure.""
}"
2025-11-10T12:41:05+00:00,@medpharm,13475,https://t.me/medpharm/13475,"–í —Å–ø–æ—Ä–µ –º–µ–∂–¥—É Pfizer –∏ Novo Nordisk, –∫—Ç–æ —Å—Ç–∞–Ω–µ—Ç –≤–ª–∞–¥–µ–ª—å—Ü–µ–º —Å—Ç–∞—Ä—Ç–∞–ø–∞ ‚Äî —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –æ—Ç –æ–∂–∏—Ä–µ–Ω–∏—è Metsera, –ø–æ—Å—Ç–∞–≤–ª–µ–Ω–∞ —Ç–æ—á–∫–∞. –§–∞—Ä–º–≥–∏–≥–∞–Ω—Ç—ã –ø–æ–≤—ã—à–∞–ª–∏ —Å—É–º–º—ã 16 —Ä–∞–∑. –†–µ—à–∞—é—â—É—é —Ä–æ–ª—å —Å—ã–≥—Ä–∞–ª–æ –≤–º–µ—à–∞—Ç–µ–ª—å—Å—Ç–≤–æ –∞–Ω—Ç–∏–º–æ–ø–æ–Ω–æ–ª—å–Ω–æ–≥–æ –æ—Ä–≥–∞–Ω–∞ –°–®–ê. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QEtPX #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-11-10T11:44:03+00:00,@medpharm,13474,https://t.me/medpharm/13474,–ü–µ—Ä–µ—á–µ–Ω—å —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω–æ–≥–æ –ø–∏—Ç–∞–Ω–∏—è –¥–ª—è –¥–µ—Ç–µ–π —Å –∏–Ω–≤–∞–ª–∏–¥–Ω–æ—Å—Ç—å—é –¥–æ–ø–æ–ª–Ω–µ–Ω —Ç—Ä–µ–º—è –Ω–æ–≤—ã–º–∏ –ø—Ä–æ–¥—É–∫—Ç–∞–º–∏. –¢–µ–ø–µ—Ä—å –æ–Ω –≤–∫–ª—é—á–∞–µ—Ç 119 –Ω–∞–∏–º–µ–Ω–æ–≤–∞–Ω–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QEp4J #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{""skip"": true}"
2025-11-10T10:57:06+00:00,@medpharm,13473,https://t.me/medpharm/13473,–°–ø–∏—Å–æ–∫ –±–µ—Å–ø–ª–∞—Ç–Ω–æ–≥–æ –ª–µ—á–µ–±–Ω–æ–≥–æ –ø–∏—Ç–∞–Ω–∏—è –¥–ª—è –¥–µ—Ç–µ–π-–∏–Ω–≤–∞–ª–∏–¥–æ–≤ —Ä–∞—Å—à–∏—Ä–∏–ª–∏ ‚Äî –≤ –Ω–µ–º –ø–æ—è–≤–∏–ª–∏—Å—å –Ω–æ–≤—ã–µ –ø—Ä–æ–¥—É–∫—Ç—ã –¥–ª—è –¥–µ—Ç–µ–π —Å –º—É–∫–æ–≤–∏—Å—Ü–∏–¥–æ–∑–æ–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QEkcA #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-11-10T09:38:10+00:00,@medpharm,13472,https://t.me/medpharm/13472,"–¶–µ–Ω—Ç—Ä –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –ø—Ä–æ–≤–æ–¥–∏—Ç –ø—Ä–∏–µ–º –∑–∞—è–≤–æ–∫ –Ω–∞ —É—á–∞—Å—Ç–∏–µ –≤ –∞—É–∫—Ü–∏–æ–Ω–∞—Ö –Ω–∞ –ø–æ—Å—Ç–∞–≤–∫—É –¥–ª—è ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —ç–Ω—Ç—Ä–µ–∫—Ç–∏–Ω–∏–±, –≥–ª–µ–∫–∞–ø—Ä–µ–≤–∏—Ä –ø–∏–±—Ä–µ–Ω—Ç–∞—Å–≤–∏—Ä –∏ —Å–∞—Ç—Ä–∞–ª–∏–∑—É–º–∞–±. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QEefp #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""high"",
  ""english"": ""The Pharmacy Supply Center is conducting applications for participation in tenders to supply the drugs Entrectinib, Gefaprevir pirbensvir and Satralizumab for the 'Good Circle' program. For more details, see https://clck.ru/3QEefp""
}"
2025-11-10T08:20:04+00:00,@medpharm,13471,https://t.me/medpharm/13471,–û–±–æ—Ä–æ—Ç –µ—â–µ 11 —Å–∏–ª—å–Ω–æ–¥–µ–π—Å—Ç–≤—É—é—â–∏—Ö –∏ —è–¥–æ–≤–∏—Ç—ã—Ö –≤–µ—â–µ—Å—Ç–≤ –±—É–¥–µ—Ç —Ä–µ–≥—É–ª–∏—Ä–æ–≤–∞—Ç—å—Å—è —Å—Ç–∞—Ç—å–µ–π 234 –£–ö –†–§. –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§ —Ç–∞–∫–∂–µ —É—Å—Ç–∞–Ω–æ–≤–∏–ª–æ –¥–ª—è –Ω–∏—Ö –ø–æ—Ä–æ–≥–æ–≤—ã–µ –∑–Ω–∞—á–µ–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QEYvE #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The turnover of 11 strong active and toxic substances will be regulated by Article 234 of the Criminal Code. The government also set threshold values for them. More details: https://clck.ru/3QEYvE #PharmNews #Regulation""
}"
2025-11-10T08:04:05+00:00,@medpharm,13470,https://t.me/medpharm/13470,"–≠–∫—Å–ø–µ—Ä—Ç—ã –ø—Ä–µ–¥—Å—Ç–∞–≤—è—Ç –∞–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–∏–µ –æ–±–∑–æ—Ä—ã, –ø–æ–¥–µ–ª—è—Ç—Å—è –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏–º –æ–ø—ã—Ç–æ–º –∏ –æ–±–æ–∑–Ω–∞—á–∞—Ç –∞–∫—Ç—É–∞–ª—å–Ω—ã–µ —Ç—Ä–µ–Ω–¥—ã 2025 –≥–æ–¥–∞ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QEXat #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-11-10T06:27:03+00:00,@medpharm,13469,https://t.me/medpharm/13469,"–û–ø–ª–∞—Ç–∞ –¥–µ–∂—É—Ä—Å—Ç–≤ –Ω–∞ –¥–æ–º—É –∫–∞–∫ –æ–¥–Ω–æ–≥–æ –∏–∑ –≤–∏–¥–æ–≤ —Ç—Ä—É–¥–æ–≤–æ–π –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏, –ø—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ–Ω–Ω—ã—Ö —Ç—Ä—É–¥–æ–≤–æ–π —Ñ—É–Ω–∫—Ü–∏–µ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ —Ä–∞–±–æ—Ç–Ω–∏–∫–∞, –¥–æ–ª–∂–Ω–∞ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç—å—Å—è —Å —Å–æ–±–ª—é–¥–µ–Ω–∏–µ–º –≤—Å–µ—Ö —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–Ω—ã—Ö –¢—Ä—É–¥–æ–≤—ã–º –∫–æ–¥–µ–∫—Å–æ–º –†–§ –≥–∞—Ä–∞–Ω—Ç–∏–π, –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏–π –∏ –Ω–∞–¥–±–∞–≤–æ–∫. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QEQHG #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-11-09T11:58:01+00:00,@medpharm,13468,https://t.me/medpharm/13468,"üëçüëçüëçüëçüëçüëç –ü—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º TOP5 —Å–æ–±—ã—Ç–∏–π –Ω–µ–¥–µ–ª–∏, –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω–Ω—ã—Ö –≤ –ª–µ–Ω—Ç–µ –Ω–æ–≤–æ—Å—Ç–µ–π ¬´–§–í¬ª. –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§ —É—á–ª–æ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è –ø–æ –Ω–∞–ª–æ–≥–æ–≤–æ–π —Ä–µ—Ñ–æ—Ä–º–µ –∏ –æ–±–µ—â–∞–µ—Ç –ø–æ—ç—Ç–∞–ø–Ω–æ —Å–Ω–∏–∂–∞—Ç—å –ø–æ—Ä–æ–≥ –¥–ª—è –ø–µ—Ä–µ—Ö–æ–¥–∞ –Ω–∞ –æ–±—â—É—é —Å–∏—Å—Ç–µ–º—É –Ω–∞–ª–æ–≥–æ–æ–±–ª–æ–∂–µ–Ω–∏—è –¥–ª—è –º–∞–ª–æ–≥–æ –∏ —Å—Ä–µ–¥–Ω–µ–≥–æ –±–∏–∑–Ω–µ—Å–∞. ¬´–†–∏–≥–ª–∞¬ª –∑–∞–∫—Ä—ã–ª–∞ —Å–¥–µ–ª–∫—É –ø–æ –ø—Ä–∏–æ–±—Ä–µ—Ç–µ–Ω–∏—é –∞–ø—Ç–µ—á–Ω–æ–π —Å–µ—Ç–∏ –≤ –¢–≤–µ—Ä—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏. –ë–æ–ª–µ–µ 80% –ø—Ä–æ–≤–µ—Ä–µ–Ω–Ω—ã—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ë–ê–î –≤ –†–æ—Å—Å–∏–∏ –æ–∫–∞–∑–∞–ª–∏—Å—å –ø—Å–µ–≤–¥–æ–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º–∏, –Ω–µ –∏–º–µ—é—â–∏–º–∏ —Ä–µ–∞–ª—å–Ω—ã—Ö –º–æ—â–Ω–æ—Å—Ç–µ–π, —Å–æ–æ–±—â–∏–ª–∏ –≤ –¶–†–ü–¢. –í—ã–µ–∑–¥–Ω—ã–µ –ø—Ä–æ–≤–µ—Ä–∫–∏ –ø–æ–∫–∞–∑–∞–ª–∏, —á—Ç–æ –ø–æ –∞–¥—Ä–µ—Å–∞–º —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –º–Ω–æ–≥–∏—Ö –∫–æ–º–ø–∞–Ω–∏–π –Ω–∞—Ö–æ–¥—è—Ç—Å—è –∂–∏–ª—ã–µ –¥–æ–º–∞ –∏–ª–∏ –ø—É—Å—Ç—ã—Ä–∏. –ê–ø—Ç–µ—á–Ω–∞—è —Å–µ—Ç—å ¬´–ê–°–ù–ê¬ª –∑–∞—è–≤–∏–ª–∞ –æ —Å–æ–∑–¥–∞–Ω–∏–∏ –ø–∞—Ä—Ç–Ω–µ—Ä—Å–∫–æ–π –∞–ø—Ç–µ—á–Ω–æ–π —Å–µ—Ç–∏, —á—Ç–æ –ø–æ–º–æ–∂–µ—Ç –∫–æ–Ω–∫—É—Ä–∏—Ä–æ–≤–∞—Ç—å —Å —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã–º–∏ –∞–ø—Ç–µ—á–Ω—ã–º–∏ —Å–µ—Ç—è–º–∏. –ü—Ä–∞–≤–∏–ª–∞ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—è –ø–µ—Ä–µ—á–Ω—è –æ–¥—É—Ä–º–∞–Ω–∏–≤–∞—é—â–∏—Ö –≤–µ—â–µ—Å—Ç–≤ —É—Ç–≤–µ—Ä–∂–¥–µ–Ω—ã –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ–º –†–§. –í –Ω–µ–º –ø—Ä–æ–ø–∏—Å–∞–Ω —Å–æ—Å—Ç–∞–≤ –∫–æ–º–∏—Å—Å–∏–∏ –ø–æ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—é –ø–µ—Ä–µ—á–Ω—è –∏ —Å—Ä–æ–∫–∏ –¥–ª—è –≤–Ω–µ—Å–µ–Ω–∏—è –∏ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏—è –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–π.","{""skip"": true}"
2025-11-09T11:52:01+00:00,@medpharm,13467,https://t.me/medpharm/13467,"–ü—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º TOP5 —Å–æ–±—ã—Ç–∏–π –Ω–µ–¥–µ–ª–∏, –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω–Ω—ã—Ö –≤ –ª–µ–Ω—Ç–µ –Ω–æ–≤–æ—Å—Ç–µ–π ¬´–§–í¬ª.","{""skip"": true}"
2025-11-09T10:51:02+00:00,@medpharm,13466,https://t.me/medpharm/13466,–ï–∂–µ–Ω–µ–¥–µ–ª—å–Ω—ã–π –æ–±–∑–æ—Ä –ø—Ä–∏–Ω—è—Ç—ã—Ö –∏ –≥–æ—Ç–æ–≤—è—â–∏—Ö—Å—è –∫ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏—é –∏ —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏—é –æ—Ç—Ä–∞—Å–ª–µ–≤—ã—Ö –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω–æ-–ø—Ä–∞–≤–æ–≤—ã—Ö –∞–∫—Ç–æ–≤.,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""medium"",
  ""english"": ""Weekly review of accepted and pending industry normative legal acts for approval.""
}"
2025-11-08T08:46:02+00:00,@medpharm,13465,https://t.me/medpharm/13465,"üß©üß©üß©üß©üß©üß© –†–µ–π—Ç–∏–Ω–≥ –≥–ª–∞–≤–Ω—ã—Ö –Ω–æ–≤–æ—Å—Ç–µ–π –Ω–µ–¥–µ–ª–∏ –≤ –ø—É–±–ª–∏–∫–∞—Ü–∏—è—Ö –ª–µ–Ω—Ç—ã –Ω–æ–≤–æ—Å—Ç–µ–π ¬´–ú–í¬ª. –í –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –º–µ–¥—á—Ä–µ–∂–¥–µ–Ω–∏—è—Ö, –ø–æ –¥–∞–Ω–Ω—ã–º –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–§, —Ç—Ä–µ–±—É–µ—Ç—Å—è –∑–∞–º–µ–Ω–∏—Ç—å –ø–æ—á—Ç–∏ —á–µ—Ç–≤–µ—Ä—Ç—å –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è. –≠—Ç–∞ —Ä–∞–±–æ—Ç–∞ –≤–µ–¥–µ—Ç—Å—è —Å 2021 –≥–æ–¥–∞ –≤ —Ä–∞–º–∫–∞—Ö —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –ø—Ä–æ–µ–∫—Ç–∞ ¬´–ú–æ–¥–µ—Ä–Ω–∏–∑–∞—Ü–∏—è –ø–µ—Ä–≤–∏—á–Ω–æ–≥–æ –∑–≤–µ–Ω–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è¬ª. –ù–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ –≤ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω–æ–º TOP5 ‚Äî –≤–Ω–µ—Å–µ–Ω–∏–µ –ú–∏–Ω–∑–¥—Ä–∞–≤–æ–º –†–§ –∏–∑–º–µ–Ω–µ–Ω–∏–π –≤ –ø—Ä–æ–µ–∫—Ç –¥–æ–∫—É–º–µ–Ω—Ç–∞, –Ω–∞ –æ—Å–Ω–æ–≤–∞–Ω–∏–∏ –∫–æ—Ç–æ—Ä–æ–≥–æ –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏ –∞–∫—Ç–∏–≤–Ω—ã–µ –¥–æ–±–∞–≤–∫–∏ –±—É–¥—É—Ç –≤–Ω–æ—Å–∏—Ç—å—Å—è –≤ —Å–ø–µ—Ü–∏–∞–ª—å–Ω—ã–π –ø–µ—Ä–µ—á–µ–Ω—å –¥–ª—è –Ω–∞–∑–Ω–∞—á–µ–Ω–∏—è –≤—Ä–∞—á–∞–º–∏. –¢—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º –ë–ê–î —Å–º—è–≥—á–µ–Ω—ã. –¢—Ä–µ—Ç—å—é —Å—Ç—Ä–æ—á–∫—É –Ω–æ–≤–æ—Å—Ç–Ω–æ–≥–æ —Ä–µ–π—Ç–∏–Ω–≥–∞ –Ω–µ–¥–µ–ª–∏ –∑–∞–Ω—è–ª–æ —Å–æ–æ–±—â–µ–Ω–∏–µ –ø–µ—Ä–≤–æ–≥–æ –∑–∞–º–ø—Ä–µ–¥–∞ –ö–æ–º–∏—Ç–µ—Ç–∞ –ì–æ—Å–¥—É–º—ã –†–§ –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è –ë–∞–¥–º—ã –ë–∞—à–∞–Ω–∫–∞–µ–≤–∞, –∞–Ω–æ–Ω—Å–∏—Ä–æ–≤–∞–≤—à–µ–≥–æ —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏–µ –ø—Ä–∞–≤–∏–ª —Ä–∞–∑–º–µ—â–µ–Ω–∏—è –∞–≤—Ç–æ–º–∞—Ç–∏—á–µ—Å–∫–∏—Ö –Ω–∞—Ä—É–∂–Ω—ã—Ö –¥–µ—Ñ–∏–±—Ä–∏–ª–ª—è—Ç–æ—Ä–æ–≤ –≤ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—è—Ö –∫ –Ω–∞—á–∞–ª—É –≤–µ—Å–Ω—ã —Å–ª–µ–¥—É—é—â–µ–≥–æ –≥–æ–¥–∞. –ü–æ –¥–∞–Ω–Ω—ã–º –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–§, –ø–æ–¥–∞–≤–ª—è—é—â–µ–µ –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –≤—É–∑–æ–≤ —É–¥–æ–≤–ª–µ—Ç–≤–æ—Ä–µ–Ω—ã –ø–æ–ª—É—á–µ–Ω–Ω—ã–º –æ–ø—ã—Ç–æ–º –ø–µ—Ä–≤–∏—á–Ω–æ–π –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–∏. –°—Ä–µ–¥–∏ –æ—Å–Ω–æ–≤–Ω—ã—Ö –ø—Ä–∏—á–∏–Ω –Ω–∏–∑–∫–æ–π —É–¥–æ–≤–ª–µ—Ç–≤–æ—Ä–µ–Ω–Ω–æ—Å—Ç–∏ –Ω–∞–∑—ã–≤–∞–ª–∏—Å—å –ø–ª–æ—Ö–∞—è –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è –ø—Ä–æ—Ü–µ–¥—É—Ä—ã –≤ —Ü–µ–Ω—Ç—Ä–µ –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–∏. –ó–∞–º—ã–∫–∞–µ—Ç –ø—è—Ç–µ—Ä–∫—É –Ω–æ–≤–æ—Å—Ç–µ–π —Å–æ–æ–±—â–µ–Ω–∏–µ –æ —Å—Ç–∞—Ä—Ç–µ —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–∞ —Å —ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω–æ–π –≥—Ä–∞—Ñ–∏—á–µ—Å–∫–æ–π –ø–æ–¥–ø–∏—Å—å—é –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤ ‚Äì –µ–≥–æ –∑–∞–ø—É—Å—Ç–∏–ª–æ –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§ –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ –ú–æ—Å–∫–≤—ã.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""The country is facing the need to replace almost a quarter of its medical equipment, which has been ongoing since 2021 as part of the 'Modernization of Primary Healthcare' federal project. The Ministry of Health of Russia has made changes to the document that regulates the inclusion of biologically active additives in a special list for doctors. Requirements for manufacturers of BAA have been softened. The first deputy chairman of the State Duma Committee on Health, Badma Bashankayeva, announced that rules for placing automatic external defibrillators in healthcare institutions will be approved by the end of spring next year. According to data from the Ministry of Health, most graduates of medical universities are satisfied with their primary accreditation experience. Among the main reasons for low satisfaction were poor organization of the procedure at the accreditation center. The country is starting an experiment with electronic graphical signatures for medical documents, which was launched by the Russian government in Moscow.""
}"
2025-11-08T04:49:03+00:00,@medpharm,13464,https://t.me/medpharm/13464,–ü—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º —Ä–µ–π—Ç–∏–Ω–≥ –≥–ª–∞–≤–Ω—ã—Ö –Ω–æ–≤–æ—Å—Ç–µ–π –Ω–µ–¥–µ–ª–∏ –≤ –ø—É–±–ª–∏–∫–∞—Ü–∏—è—Ö –ª–µ–Ω—Ç—ã –Ω–æ–≤–æ—Å—Ç–µ–π ¬´–ú–í¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QCszV #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-11-07T17:17:01+00:00,@medpharm,13463,https://t.me/medpharm/13463,"ü¶æ –†–µ–∂–∏–º —Å–∏–Ω—Ö—Ä–æ–Ω–∏–∑–∞—Ü–∏–∏. –í –†–æ—Å—Å–∏–∏ —Å–∏–Ω—Ö—Ä–æ–Ω–∏–∑–∏—Ä—É—é—Ç –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç—å —Å–∏—Å—Ç–µ–º —Å–ø–æ—Ä—Ç–∞, –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∏ –ø—Ä–æ—Å–≤–µ—â–µ–Ω–∏—è –¥–ª—è –∫–æ–º–ø–ª–µ–∫—Å–Ω–æ–≥–æ —Ä–∞–∑–≤–∏—Ç–∏—è –¥–µ—Ç—Å–∫–æ-—é–Ω–æ—à–µ—Å–∫–æ–≥–æ —Å–ø–æ—Ä—Ç–∞ –∏ –æ—Ö—Ä–∞–Ω—ã –∑–¥–æ—Ä–æ–≤—å—è –¥–µ—Ç–µ–π. –≠—Ç–æ —Ç–∞–∫–∂–µ –ø–æ–º–æ–∂–µ—Ç –æ—Ü–µ–Ω–∏—Ç—å –≤–ª–∏—è–Ω–∏–µ –∑–∞–Ω—è—Ç–∏–π —Å–ø–æ—Ä—Ç–æ–º –Ω–∞ –æ–±—â–µ–µ —Ä–∞–∑–≤–∏—Ç–∏–µ —Ä–µ–±–µ–Ω–∫–∞. ü¶æ –°–ª–æ–∂–Ω–∞—è –∑–∞–¥–∞—á–∞. –†–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π –≤ –†–æ—Å—Å–∏–∏ —Å—Ç–∞–Ω–æ–≤–∏—Ç—Å—è –Ω–µ –ø—Ä–æ—Å—Ç–æ –±—é—Ä–æ–∫—Ä–∞—Ç–∏—á–µ—Å–∫–æ–π –ø—Ä–æ—Ü–µ–¥—É—Ä–æ–π, –∞ –∏—Å–ø—ã—Ç–∞–Ω–∏–µ–º –∑—Ä–µ–ª–æ—Å—Ç–∏ –±–∏–∑–Ω–µ—Å–∞, –µ–≥–æ –≥–æ—Ç–æ–≤–Ω–æ—Å—Ç–∏ –∫ –±–µ—Å–ø–æ–≤–æ—Ä–æ—Ç–Ω–æ–º—É –≤—ã—Ö–æ–¥—É –∏–∑ ¬´—Å–µ—Ä–æ–π –∑–æ–Ω—ã¬ª –∏ –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç–∏ –ø–µ—Ä–µ–¥ –¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–æ–º, –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª–µ–º –∏ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–æ–º. ‚ù§Ô∏è –ò—Å–∫–ª—é—á–∏—Ç–µ–ª—å–Ω—ã–π —Å–ª—É—á–∞–π. –í –ú–∏–Ω–∑–¥—Ä–∞–≤–µ –†–§ –ø—Ä–æ—à–ª–æ –∑–∞—Å–µ–¥–∞–Ω–∏–µ –ö–æ–º–∏—Å—Å–∏–∏ –ø–æ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—é –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø–µ—Ä–µ—á–Ω–µ–π. –í –ø–æ–≤–µ—Å—Ç–∫–µ –±—ã–ª–æ –≤—Å–µ–≥–æ —Ç—Ä–∏ –≤–æ–ø—Ä–æ—Å–∞. ‚ù§Ô∏è –ù–∞ —É—Ä–æ–≤–Ω–µ –æ–ø–µ—Ä–∞—Ç–æ—Ä–æ–≤. –í –∞–ø—Ç–µ–∫–∞—Ö –≤—Å–µ –µ—â–µ –≤–æ–∑–Ω–∏–∫–∞—é—Ç –ø—Ä–æ–±–ª–µ–º—ã –ø—Ä–∏ –ø–µ—Ä–µ–±–æ—è—Ö —Å –∏–Ω—Ç–µ—Ä–Ω–µ—Ç–æ–º. –†–ê–ê–° –ø–æ–ø—Ä–æ—Å–∏–ª–∞ –æ–ø–µ—Ä–∞—Ç–æ—Ä–∞ –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏ –ø—Ä–∏–≤–ª–µ—á—å –æ–ø–µ—Ä–∞—Ç–æ—Ä–æ–≤ —Å–≤—è–∑–∏ –∫ —Ä–µ—à–µ–Ω–∏—é –≤–æ–ø—Ä–æ—Å–∞.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""There are complex issues related to the registration of medical devices in Russia, which is seen as a test of business maturity and responsibility. Additionally, there are problems with internet connectivity affecting pharmacies in Russia.""
}"
2025-11-07T16:54:03+00:00,@medpharm,13462,https://t.me/medpharm/13462,"–ê–Ω–∞–ª–∏—Ç–∏–∫–∏ –ø–æ—Å—á–∏—Ç–∞–ª–∏, —Å–∫–æ–ª—å–∫–æ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –°–ü–ò–ö –±—ã–ª–æ –∑–∞–∫–ª—é—á–µ–Ω–æ –≤ –†–æ—Å—Å–∏–∏ –∑–∞ —á–µ—Ç—ã—Ä–µ –≥–æ–¥–∞. –ö–∞–∫–∏–µ –∫–æ–Ω—Ç—Ä–∞–∫—Ç—ã –æ—Ç–º–µ–Ω–∏–ª–∏ –∏ –ø–æ—á–µ–º—É? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QCgfb #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-11-07T16:51:06+00:00,@medpharm,13461,https://t.me/medpharm/13461,"–†–∞–∑–≤–∏—Ç–∏–µ –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä—ã —Ä–µ—à–∏—Ç, –≤–æ–∑–º–æ–∂–Ω–æ –ª–∏ –≤ –†–æ—Å—Å–∏–∏ –º–∞—Å—à—Ç–∞–±–∏—Ä–æ–≤–∞—Ç—å CAR-T-—Ç–µ—Ä–∞–ø–∏—é. –≠—Ç–æ—Ç –º–µ—Ç–æ–¥ —Å–æ–ø—Ä—è–∂–µ–Ω —Å –≤—ã—Å–æ–∫–∏–º —Ä–∏—Å–∫–æ–º –æ—Å–ª–æ–∂–Ω–µ–Ω–∏–π, –ø–æ—ç—Ç–æ–º—É –ø–æ—Ç—Ä–µ–±—É–µ—Ç—Å—è –æ–±—É—á–µ–Ω–∏–µ –≤—Ä–∞—á–µ–π –∏ —Å–æ–∑–¥–∞–Ω–∏–µ —Å–ø–µ—Ü–∏–∞–ª—å–Ω—ã—Ö –æ—Ç–¥–µ–ª–µ–Ω–∏–π —Ä–µ–∞–Ω–∏–º–∞—Ü–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QCgYN #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û–Ω–∫–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,hospital_policy,pharmacovigilance,safety"",
  ""impact"": ""high"",
  ""english"": ""Development of infrastructure is possible in Russia to scale CAR-T therapy. This method has high complication risks, requiring training of doctors and creation of specialized intensive care units.""
}"
2025-11-07T16:29:02+00:00,@medpharm,13460,https://t.me/medpharm/13460,"–†–ê–ê–° –ø–æ–ø—Ä–æ—Å–∏–ª–∞ –¶–†–ü–¢ –ø—Ä–∏–≤–ª–µ—á—å –æ–ø–µ—Ä–∞—Ç–æ—Ä–æ–≤ —Å–≤—è–∑–∏ –∫ —Ä–µ—à–µ–Ω–∏—é –ø—Ä–æ–±–ª–µ–º, –≤–æ–∑–Ω–∏–∫–∞—é—â–∏—Ö –≤ –∞–ø—Ç–µ–∫ –ø—Ä–∏ –ø–µ—Ä–µ–±–æ—è—Ö —Å –∏–Ω—Ç–µ—Ä–Ω–µ—Ç–æ–º. –ü–æ–∫–∞ –æ–Ω–∏ –Ω–µ –Ω–µ—Å—É—Ç –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç–∏ –∑–∞ —Ä–∞–±–æ—Ç—É –æ—Ñ–ª–∞–π–Ω-—Å—Ö–µ–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QCfWp #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,hospital_policy,pharmacovigilance,safety"",
  ""impact"": ""medium"",
  ""english"": ""The RAAS asked the CCRP to involve telecom operators in solving problems that arise in pharmacies during internet disruptions. Currently, they are not responsible for the offline system.""
}"
2025-11-07T16:06:03+00:00,@medpharm,13459,https://t.me/medpharm/13459,"–í –Ω–µ—Å–∫–æ–ª—å–∫–∏—Ö —Ä–µ–≥–∏–æ–Ω–∞—Ö –†–æ—Å—Å–∏–∏ –≤–æ–∑–Ω–∏–∫ –¥–µ—Ñ–∏—Ü–∏—Ç –Ω–µ–∫–æ—Ç–æ—Ä—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –±–æ–ª–µ–∑–Ω—è–º–∏ –ø–æ—á–µ–∫, —Å–æ–æ–±—â–∏–ª–∏ –°–ú–ò. –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä –∏ –ì–µ–Ω–µ—Ä–∞–ª—å–Ω–∞—è –ø—Ä–æ–∫—É—Ä–∞—Ç—É—Ä–∞ –†–§ –æ—Ä–≥–∞–Ω–∏–∑–æ–≤–∞–ª–∏ –ø—Ä–æ–≤–µ—Ä–∫–∏ –ø–æ —Ñ–∞–∫—Ç–∞–º –Ω–∞—Ä—É—à–µ–Ω–∏–π –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QCeNe #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""shortage,hospital_policy,pharmacovigilance,safety"",
  ""impact"": ""medium"",
  ""english"": ""There is a shortage of some drugs for patients with kidney diseases in several regions of Russia. The issue has been reported by media, and Roszdravnadzor and the General Prosecutor's Office of Russia have organized inspections into violations. ""
}"
2025-11-07T15:49:03+00:00,@medpharm,13458,https://t.me/medpharm/13458,"–°–æ—é–∑ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç-—Ç–æ—Ä–≥–æ–≤–ª–∏ –Ω–∞–ø—Ä–∞–≤–∏–ª –≤ –ì–æ—Å–¥—É–º—É –†–§ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è –¥–ª—è –ø–æ–≤—ã—à–µ–Ω–∏—è –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ –ø—Ä–æ–¥–∞–∂ –ª–µ–∫–∞—Ä—Å—Ç–≤, –º–µ–¥–∏–∑–¥–µ–ª–∏–π –∏ –ë–ê–î —á–µ—Ä–µ–∑ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å—ã. –ö–∞–∫–∏–µ –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤—ã –≤—ã–¥–≤–∏–≥–∞–µ—Ç –°–ò–¢? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QCdcf #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The Union of Internet Trade has submitted proposals to the Russian State Duma for enhancing the safety of drug, medical equipment, and biologics sales through marketplaces. What initiatives is CIST proposing? More details: https://clck.ru/3QCdcf #PharmNews #Retail""
}"
2025-11-07T15:29:03+00:00,@medpharm,13457,https://t.me/medpharm/13457,Google –ø–ª–∞–Ω–∏—Ä—É–µ—Ç –≤–Ω–µ–¥—Ä–∏—Ç—å —Ñ—É–Ω–∫—Ü–∏—é —Ä–∞–Ω–Ω–µ–≥–æ –≤—ã—è–≤–ª–µ–Ω–∏—è –∞—Ä—Ç–µ—Ä–∏–∞–ª—å–Ω–æ–π –≥–∏–ø–µ—Ä—Ç–µ–Ω–∑–∏–∏ –≤ —Å–≤–æ–∏ Pixel Watch 3. –í–µ–¥–µ—Ç—Å—è –ø–æ–∏—Å–∫ –¥–æ–±—Ä–æ–≤–æ–ª—å—Ü–µ–≤ –¥–ª—è —É—á–∞—Å—Ç–∏—è –≤ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–∏ –∑–∞ –≤–æ–∑–Ω–∞–≥—Ä–∞–∂–¥–µ–Ω–∏–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QCcTN #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–î–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞,"{""skip"": true}"
2025-11-07T15:22:03+00:00,@medpharm,13456,https://t.me/medpharm/13456,"–°–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç—å ¬´—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∞—è —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—è¬ª –±—É–¥–µ—Ç —Å–æ—Ö—Ä–∞–Ω–µ–Ω–∞ –¥–æ –∫–æ–Ω—Ü–∞ 2025 –≥–æ–¥–∞, –Ω–∞–ø–æ–º–Ω–∏–ª–∏ –≤ –ú–∏–Ω–∑–¥—Ä–∞–≤–µ –†–§. –î–æ —ç—Ç–æ–≥–æ –≤—Ä–µ–º–µ–Ω–∏ –ø—Ä–æ–≤–∏–∑–æ—Ä–∞–º-—Ç–µ—Ö–Ω–æ–ª–æ–≥–∞–º –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç –ø—Ä–æ–π—Ç–∏ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—É—é –ø–µ—Ä–µ–ø–æ–¥–≥–æ—Ç–æ–≤–∫—É –ø–æ —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–∏ ¬´–£–ø—Ä–∞–≤–ª–µ–Ω–∏–µ –∏ —ç–∫–æ–Ω–æ–º–∏–∫–∞ —Ñ–∞—Ä–º–∞—Ü–∏–∏¬ª. –ß—Ç–æ –±—É–¥–µ—Ç —Å —Ç–µ–º–∏, –∫—Ç–æ –Ω–µ —É—Å–ø–µ–µ—Ç –ø—Ä–æ–π—Ç–∏ –ø–µ—Ä–µ–ø–æ–¥–≥–æ—Ç–æ–≤–∫—É? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QCc7t #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{""skip"": true}"
2025-11-07T14:55:03+00:00,@medpharm,13455,https://t.me/medpharm/13455,"Kimberly-Clark –ø–æ–∫—É–ø–∞–µ—Ç –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è –ø–∞—Ä–∞—Ü–µ—Ç–∞–º–æ–ª–∞, –Ω–µ—Å–º–æ—Ç—Ä—è –Ω–∞ –æ–±–≤–∞–ª –∞–∫—Ü–∏–π –Ω–∞ 30%, —Å–∫–∞–Ω–¥–∞–ª—å–Ω—ã–µ –∑–∞—è–≤–ª–µ–Ω–∏—è –¢—Ä–∞–º–ø–∞ –∏ —Å—É–¥–µ–±–Ω—ã–µ –∏—Å–∫–∏. –ò–Ω–≤–µ—Å—Ç–æ—Ä—ã –Ω–µ–¥–æ—É–º–µ–≤–∞—é—Ç: —Å—Ç–∞–≤–∫–∞ –Ω–∞ –Ω–µ–¥–æ–æ—Ü–µ–Ω–µ–Ω–Ω—ã–π –∞–∫—Ç–∏–≤ –∏–ª–∏ —Ä–∏—Å–∫–æ–≤–∞–Ω–Ω–∞—è –ø–µ—Ä–µ–ø–ª–∞—Ç–∞ –∑–∞ –ø—Ä–æ–±–ª–µ–º–Ω—ã–π –±–∏–∑–Ω–µ—Å? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QCahN #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-11-07T14:28:02+00:00,@medpharm,13454,https://t.me/medpharm/13454,"–í –ø–æ–≤–µ—Å—Ç–∫–µ –∑–∞—Å–µ–¥–∞–Ω–∏—è –ö–æ–º–∏—Å—Å–∏–∏ –ø–æ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—é –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø–µ—Ä–µ—á–Ω–µ–π –±—ã–ª–æ –≤—Å–µ–≥–æ —Ç—Ä–∏ –≤–æ–ø—Ä–æ—Å–∞, –Ω–æ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏–µ –∑–∞—Ç—è–Ω—É–ª–æ—Å—å –Ω–∞ —Ç—Ä–∏ —á–∞—Å–∞. –ü–æ –∏—Ç–æ–≥—É –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è –ª–µ—á–µ–Ω–∏—è –º—É–∫–æ–≤–∏—Å—Ü–∏–¥–æ–∑–∞ –º–æ–∂–µ—Ç —É–π—Ç–∏ —Å —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —Ä—ã–Ω–∫–∞. –ö–∞–∫–∏–µ —Ä–µ—à–µ–Ω–∏—è –ø—Ä–∏–Ω—è–ª–∞ –∫–æ–º–∏—Å—Å–∏—è? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QCZEo #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""tenders, shortage"",
  ""impact"": ""high"",
  ""english"": ""The Commission for the Formation of Medicinal Lists had only three issues on its agenda, but the deliberation lasted for three hours. As a result, a drug for treating Mucoviscidosis may be removed from the Russian market. What decisions did the commission make?""
}"
2025-11-07T14:23:07+00:00,@medpharm,13453,https://t.me/medpharm/13453,–ù–∞—á–∞–ª–∏—Å—å –ø—Ä–æ–≤–µ—Ä–∫–∏ –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –≤ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö —Ä–µ–≥–∏–æ–Ω–∞—Ö. –ì–µ–Ω–ø—Ä–æ–∫—É—Ä–∞—Ç—É—Ä–∞ –†–§ –ø–æ–æ–±–µ—â–∞–ª–∞ –Ω–∞—Ä—É—à–∏—Ç–µ–ª—è–º ¬´–∏—Å—á–µ—Ä–ø—ã–≤–∞—é—â–∏–µ –º–µ—Ä—ã¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QCYwv #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions"",
  ""impact"": ""high"",
  ""english"": ""Pursuant to the investigation of pharmaceutical supply in various regions of Russia, the General Prosecutor's Office promised severe measures for those who violate. More details: https://clck.ru/3QCYwv #Mednews #Healthcare #Public_Sanitation""
}"
2025-11-07T12:56:03+00:00,@medpharm,13451,https://t.me/medpharm/13451,–í –ø—Ä–æ–µ–∫—Ç–µ –±—é–¥–∂–µ—Ç–∞ –Ω–∞ 2026‚Äî2028 –≥–æ–¥—ã –ø—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ–Ω—ã –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–µ —Å—Ä–µ–¥—Å—Ç–≤–∞ –Ω–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –°–∫–æ–ª—å–∫–æ –∏ –∫—É–¥–∞ –Ω–∞–ø—Ä–∞–≤—è—Ç –¥–µ–Ω–µ–≥? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QCTXg #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{""skip"": true}"
2025-11-07T12:15:04+00:00,@medpharm,13450,https://t.me/medpharm/13450,"–§–∏–Ω—Å–∫–∏–µ —É—á–µ–Ω—ã–µ –ø—Ä–µ–¥–ø–æ–ª–∞–≥–∞—é—Ç, —á—Ç–æ –ø–æ–ø—É–ª—è—Ä–Ω—ã–π –∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫ –¥–æ–∫—Å–∏—Ü–∏–∫–ª–∏–Ω –º–æ–∂–µ—Ç –ø—Ä–µ–¥–æ—Ç–≤—Ä–∞—â–∞—Ç—å —Ä–∞–∑–≤–∏—Ç–∏–µ —à–∏–∑–æ—Ñ—Ä–µ–Ω–∏–∏ —É –ø–æ–¥—Ä–æ—Å—Ç–∫–æ–≤ –∏–∑ –≥—Ä—É–ø–ø—ã –≤—ã—Å–æ–∫–æ–≥–æ —Ä–∏—Å–∫–∞. –î–ª—è –æ–∫–æ–Ω—á–∞—Ç–µ–ª—å–Ω—ã—Ö –≤—ã–≤–æ–¥–æ–≤ –æ –∑–∞—â–∏—Ç–Ω–æ–º –¥–µ–π—Å—Ç–≤–∏–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏–µ –∫–æ–Ω—Ç—Ä–æ–ª–∏—Ä—É–µ–º—ã—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QCQnN #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ü–µ–¥–∏–∞—Ç—Ä–∏—è #–ü—Å–∏—Ö–∏–∞—Ç—Ä–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-11-07T11:55:03+00:00,@medpharm,13449,https://t.me/medpharm/13449,"–° –Ω–∞—á–∞–ª–∞ –Ω–æ—è–±—Ä—è –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä –æ–±—ä—è–≤–∏–ª –æ –ø—Ä–µ–∫—Ä–∞—â–µ–Ω–∏–∏ –æ–±—Ä–∞—â–µ–Ω–∏—è –¥–µ—Å—è—Ç–∏ —Å–µ—Ä–∏–π –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –í–µ–¥–æ–º—Å—Ç–≤–æ —Ç–∞–∫–∂–µ –∏–Ω—Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–ª–æ –æ–± –æ—Ç–∑—ã–≤–µ 39 —Å–µ—Ä–∏–π –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞, –ø—Ä–µ–¥–Ω–∞–∑–Ω–∞—á–µ–Ω–Ω–æ–≥–æ –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Å–∞—Ö–∞—Ä–Ω–æ–≥–æ –¥–∏–∞–±–µ—Ç–∞ 2 —Ç–∏–ø–∞. –ê–ø—Ç–µ–∫–∞–º –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ –ø—Ä–æ–≤–µ—Ä–∏—Ç—å —É —Å–µ–±—è –Ω–∞–ª–∏—á–∏–µ —ç—Ç–∏—Ö –ø–∞—Ä—Ç–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QCPUB #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–û—Ç–∑—ã–≤—ã","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""tenders, import_export, shortage"",
  ""impact"": ""high"",
  ""english"": ""The Russian Health Supervision Authority (Roszdravnadzor) has announced the cessation of ten series of medicinal products. The authority also notified about the recall of 39 series of a drug intended for treating type 2 diabetes. Pharmacies are required to check their stock for these batches. More details: https://clck.ru/3QCPUB #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–û—Ç–∑—ã–≤—ã""
}"
2025-11-07T11:15:06+00:00,@medpharm,13448,https://t.me/medpharm/13448,–ß–∏—Å–ª–æ –≤—ã—è–≤–ª–µ–Ω–Ω—ã—Ö —É —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –¥–µ—Ç–µ–π –Ω–∞—Ä—É—à–µ–Ω–∏–π —Å–ª—É—Ö–∞ –≤—ã—Ä–æ—Å–ª–æ –≤ 2025 –≥–æ–¥—É –Ω–∞ 2 —Ç—ã—Å. –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å 2023 –≥–æ–¥–æ–º. –≠–∫—Å–ø–µ—Ä—Ç—ã –æ—Ç–º–µ—á–∞—é—Ç –ø–æ–ª—å–∑—É —Ä–∞–Ω–Ω–µ–≥–æ —Ö–∏—Ä—É—Ä–≥–∏—á–µ—Å–∫–æ–≥–æ –≤–º–µ—à–∞—Ç–µ–ª—å—Å—Ç–≤–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QCLi5 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞ #–û—Ç–æ—Ä–∏–Ω–æ–ª–∞—Ä–∏–Ω–≥–æ–ª–æ–≥–∏—è #–ü–µ–¥–∏–∞—Ç—Ä–∏—è,"{""skip"": true}"
2025-11-07T10:20:02+00:00,@medpharm,13447,https://t.me/medpharm/13447,–ü—Ä–µ–ø–∞—Ä–∞—Ç—ã –æ—Ç –æ–∂–∏—Ä–µ–Ω–∏—è –ø–æ–¥–µ—à–µ–≤–µ—é—Ç –≤ –°–®–ê –±–æ–ª–µ–µ —á–µ–º –≤—Ç—Ä–æ–µ. –û–¥–Ω–∞–∫–æ –æ–±—ä—è–≤–ª–µ–Ω–∏–µ –æ–± —ç—Ç–æ–º –≤ –ë–µ–ª–æ–º –¥–æ–º–µ –ø—Ä–µ—Ä–≤–∞–ª –æ–±–º–æ—Ä–æ–∫ –æ–¥–Ω–æ–≥–æ –∏–∑ —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QCGKv #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-11-07T09:06:03+00:00,@medpharm,13446,https://t.me/medpharm/13446,–î–µ–ø—É—Ç–∞—Ç—ã –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –≤–≤–µ—Å—Ç–∏ —Å–µ—Ä—Ç–∏—Ñ–∏–∫–∞—Ç—ã –Ω–∞ –ø–æ–∫—É–ø–∫—É –ª–µ–∫–∞—Ä—Å—Ç–≤ –¥–ª—è –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–Ω–æ–π —Å–æ—Ü–∏–∞–ª—å–Ω–æ–π –≥—Ä—É–ø–ø—ã –≥—Ä–∞–∂–¥–∞–Ω. –ö—Ç–æ –∏ –∫–∞–∫ —Å–º–æ–∂–µ—Ç –ø–æ–ª—É—á–∏—Ç—å –ø–æ–º–æ—â—å? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QCB2P #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, shortage"",
  ""impact"": ""medium"",
  ""english"": ""Deputies proposed to introduce certificates for purchasing medicines for a certain social group of citizens. Who and how will help?""
}"
2025-11-07T08:56:06+00:00,@medpharm,13445,https://t.me/medpharm/13445,"–†–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π (–ú–ò) –≤ –†–æ—Å—Å–∏–∏ —Å—Ç–∞–Ω–æ–≤–∏—Ç—Å—è –Ω–µ –ø—Ä–æ—Å—Ç–æ –±—é—Ä–æ–∫—Ä–∞—Ç–∏—á–µ—Å–∫–æ–π –ø—Ä–æ—Ü–µ–¥—É—Ä–æ–π, –∞ –∏—Å–ø—ã—Ç–∞–Ω–∏–µ–º –∑—Ä–µ–ª–æ—Å—Ç–∏ –±–∏–∑–Ω–µ—Å–∞, –µ–≥–æ –≥–æ—Ç–æ–≤–Ω–æ—Å—Ç–∏ –∫ –±–µ—Å–ø–æ–≤–æ—Ä–æ—Ç–Ω–æ–º—É –≤—ã—Ö–æ–¥—É –∏–∑ ¬´—Å–µ—Ä–æ–π –∑–æ–Ω—ã¬ª –∏ –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç–∏ –ø–µ—Ä–µ–¥ –¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–æ–º, –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª–µ–º –∏ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–æ–º. –ù–∞ —Ñ–æ–Ω–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ —Ä–æ—Å—Ç–∞, —Ü–∏—Ñ—Ä–æ–≤–∏–∑–∞—Ü–∏–∏ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –¥–æ–∫—É–º–µ–Ω—Ç–æ–æ–±–æ—Ä–æ—Ç–∞ –≤ —Ä–∞–∑–ª–∏—á–Ω—ã—Ö —Å—Ñ–µ—Ä–∞—Ö, –∞ —Ç–∞–∫–∂–µ –æ–±—â–µ–≥–æ –∫—É—Ä—Å–∞ –Ω–∞ –∏–º–ø–æ—Ä—Ç–æ–Ω–µ–∑–∞–≤–∏—Å–∏–º–æ—Å—Ç—å —Ä—ã–Ω–æ–∫ —Å—Ç—Ä–µ–º–∏—Ç–µ–ª—å–Ω–æ –≤–∑—Ä–æ—Å–ª–µ–µ—Ç. –í —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç—Å—è –≤–Ω–µ–¥—Ä–µ–Ω–∏–µ –Ω–æ–≤—ã—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π, —É–∂–µ—Å—Ç–æ—á–µ–Ω–∏–µ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–∞ –∏ –∏–Ω—Ç–µ–≥—Ä–∞—Ü–∏—è —Å—Ç—Ä–∞–Ω—ã –≤ —Å–∏—Å—Ç–µ–º—É –ï–≤—Ä–∞–∑–∏–π—Å–∫–æ–≥–æ —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–≥–æ —Å–æ—é–∑–∞ (–ï–ê–≠–°). –ù–æ –≤–º–µ—Å—Ç–µ —Å —ç—Ç–∏–º —Ä–∞—Å—Ç–µ—Ç –∏ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –æ—Ç–∫–∞–∑–æ–≤ –≤ –ø–µ—Ä–≤–∏—á–Ω–æ–π —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –ú–ò –∏ –≤–Ω–µ—Å–µ–Ω–∏–∏ –∏–∑–º–µ–Ω–µ–Ω–∏–π –≤ –¥–µ–π—Å—Ç–≤—É—é—â–µ–µ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–æ–Ω–Ω–æ–µ –¥–æ—Å—å–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QCAHZ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""registration, reimbursement, safety"",
  ""impact"": ""high"",
  ""english"": ""The registration of medical devices (MIDs) in Russia is becoming a bureaucratic procedure that tests the maturity of business, its readiness to exit from 'gray zone' and responsibility towards distributor, consumer, and state. Against the backdrop of technological growth, digitalization of government document processing in various sectors, as well as a general course towards import independence market, it is rapidly growing. In particular, the continuous implementation of new technologies, tightening of Roszdravnadzor requirements and integration into the Eurasian Economic Union (EAEU) system. However, at the same time, there is an increase in refusals for primary registration of MIDs and changes to the existing registration dossier.""
}"
2025-11-07T07:58:03+00:00,@medpharm,13444,https://t.me/medpharm/13444,"–ù–∞–ª–æ–≥–æ–≤—ã–π –∫–æ–Ω—Ç—Ä–æ–ª—å –∑–∞ –±–∏–∑–Ω–µ—Å–æ–º —É—Å–∏–ª–∏—Ç—Å—è –≤ 2026 –≥–æ–¥—É. –ö–∞–∫–∏–µ –ø—Ä–∏–∑–Ω–∞–∫–∏ –¥—Ä–æ–±–ª–µ–Ω–∏—è –±–∏–∑–Ω–µ—Å–∞ –º–æ–≥—É—Ç –ø—Ä–∏–≤–ª–µ—á—å –≤–Ω–∏–º–∞–Ω–∏–µ –ø—Ä–æ–≤–µ—Ä—è—é—â–∏—Ö –∏ –∫–∞–∫–∏–µ –æ—Å–Ω–æ–≤–∞–Ω–∏—è –ø–æ–º–æ–≥—É—Ç –≤—ã–∏–≥—Ä–∞—Ç—å –Ω–∞–ª–æ–≥–æ–≤—ã–π —Å–ø–æ—Ä, ¬´–§–í¬ª —Ä–∞—Å—Å–∫–∞–∑–∞–ª –∞—É–¥–∏—Ç–æ—Ä –í–∏–∫—Ç–æ—Ä –ò–≤–∞–Ω–∏—Ü–∫–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QC5wM #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{""skip"": true}"
2025-11-07T07:48:03+00:00,@medpharm,13443,https://t.me/medpharm/13443,"–í –†–æ—Å—Å–∏–∏ —Å–∏–Ω—Ö—Ä–æ–Ω–∏–∑–∏—Ä—É—é—Ç –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç—å —Å–∏—Å—Ç–µ–º —Å–ø–æ—Ä—Ç–∞, –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∏ –ø—Ä–æ—Å–≤–µ—â–µ–Ω–∏—è –¥–ª—è –∫–æ–º–ø–ª–µ–∫—Å–Ω–æ–≥–æ —Ä–∞–∑–≤–∏—Ç–∏—è –¥–µ—Ç—Å–∫–æ-—é–Ω–æ—à–µ—Å–∫–æ–≥–æ —Å–ø–æ—Ä—Ç–∞ –∏ –æ—Ö—Ä–∞–Ω—ã –∑–¥–æ—Ä–æ–≤—å—è –¥–µ—Ç–µ–π. –≠—Ç–æ —Ç–∞–∫–∂–µ –ø–æ–º–æ–∂–µ—Ç –æ—Ü–µ–Ω–∏—Ç—å –≤–ª–∏—è–Ω–∏–µ –∑–∞–Ω—è—Ç–∏–π —Å–ø–æ—Ä—Ç–æ–º –Ω–∞ –æ–±—â–µ–µ —Ä–∞–∑–≤–∏—Ç–∏–µ —Ä–µ–±–µ–Ω–∫–∞ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QC5FM #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-11-07T06:25:06+00:00,@medpharm,13442,https://t.me/medpharm/13442,"–†–æ—Å—Å–∏–π—Å–∫–∏–π —Ä—ã–Ω–æ–∫ –º–µ–¥—Ç–µ—Ö–∞ –¥–µ–º–æ–Ω—Å—Ç—Ä–∏—Ä—É–µ—Ç –±–æ–ª–µ–µ –±—ã—Å—Ç—Ä—ã–π —Ä–æ—Å—Ç, —á–µ–º –≥–ª–æ–±–∞–ª—å–Ω—ã–π. –ù–∞–∏–±–æ–ª–µ–µ –∏–Ω—Ç–µ–Ω—Å–∏–≤–Ω–æ –≤–æ –≤—Å–µ–º –º–∏—Ä–µ —Ä–∞–∑–≤–∏–≤–∞—é—Ç—Å—è –∞—Å—Å–∏—Å—Ç–∏–≤–Ω—ã–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QBxwb #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-11-07T06:04:03+00:00,@medpharm,13441,https://t.me/medpharm/13441,"–ö–æ—Ñ–µ–∏–Ω —è–≤–ª—è–µ—Ç—Å—è –∞–ª–∫–∞–ª–æ–∏–¥–æ–º, –∫–æ—Ç–æ—Ä—ã–π –ø–æ–º–∏–º–æ –∫–æ—Ñ–µ —Å–æ–¥–µ—Ä–∂–∏—Ç—Å—è –≤ —á–∞–µ, –∫–∞–∫–∞–æ –∏ —à–æ–∫–æ–ª–∞–¥–µ, –∞ —Ç–∞–∫–∂–µ –≤ —ç–Ω–µ—Ä–≥–µ—Ç–∏—á–µ—Å–∫–∏—Ö, –≥–∞–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –Ω–∞–ø–∏—Ç–∫–∞—Ö. –ï–≥–æ –¥–æ–±–∞–≤–ª—è—é—Ç –≤ —Å–ø–æ—Ä—Ç–∏–≤–Ω—ã–µ –¥–æ–±–∞–≤–∫–∏. –ö–æ—Ñ–µ–∏–Ω —Ç–∞–∫–∂–µ –≤—Ö–æ–¥–∏—Ç –≤ —Å–æ—Å—Ç–∞–≤ –Ω–µ–∫–æ—Ç–æ—Ä—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤, –∫–∞–∫ –≤ –≤–∏–¥–µ –º–æ–Ω–æ–ø—Ä–µ–ø–∞—Ä–∞—Ç–∞, —Ç–∞–∫ –∏ –≤ —Å–æ—Å—Ç–∞–≤–µ –∫–æ–º–±–∏–Ω–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤. –ö–∞–∫–æ–≤–∞ –µ–≥–æ —Ä–æ–ª—å? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QBwM2 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–µ–ø–∞—Ä–∞—Ç—ã/–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-11-06T16:27:36+00:00,@medpharm,13440,https://t.me/medpharm/13440,"ü¶æ –ï—Å—Ç—å –∫—É–¥–∞ —Å—Ç—Ä–µ–º–∏—Ç—å—Å—è. –î–∞–∂–µ —É –∫—Ä—É–ø–Ω—ã—Ö –∫–ª–∏–Ω–∏–∫ —Å–∞–π—Ç—ã –≤—Å–µ –µ—â–µ —É—Å—Ç—É–ø–∞—é—Ç –ø–æ —É–¥–æ–±—Å—Ç–≤—É –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞–º, –±–∞–Ω–∫–∞–º –∏ —Å–µ—Ä–≤–∏—Å–∞–º –¥–æ—Å—Ç–∞–≤–∫–∏. –ê –ø–∞—Ü–∏–µ–Ω—Ç, –ø—Ä–∏–≤—ã–∫–Ω—É–≤ –∫ —É–¥–æ–±—Å—Ç–≤—É –∏ —Å–∫–æ—Ä–æ—Å—Ç–∏ –≤ –æ–¥–Ω–æ–º –ø—Ä–∏–ª–æ–∂–µ–Ω–∏–∏, –∂–¥–µ—Ç —Ç–æ–≥–æ –∂–µ –æ—Ç –ª—é–±–æ–≥–æ –¥—Ä—É–≥–æ–≥–æ –∏ –Ω–µ –≥–æ—Ç–æ–≤ –º–∏—Ä–∏—Ç—å—Å—è —Å –≥—Ä–æ–º–æ–∑–¥–∫–∏–º–∏ —Ñ–æ—Ä–º–∞–º–∏ –∏ –∑–∞–ø—É—Ç–∞–Ω–Ω–æ–π –Ω–∞–≤–∏–≥–∞—Ü–∏–µ–π. ü¶æ –¢–µ—Å—Ç –Ω–∞ –∑—Ä–µ–ª–æ—Å—å. –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª –º–Ω–µ–Ω–∏—è 17 —Ç—ã—Å. –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –≤—É–∑–æ–≤ –æ –ø—Ä–æ—Ü–µ–¥—É—Ä–µ –ø–µ—Ä–≤–∏—á–Ω–æ–π –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–∏ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞, –∫–æ—Ç–æ—Ä—É—é –ø—Ä–æ—Ö–æ–¥—è—Ç –≤—Å–µ —Å—Ç—É–¥–µ–Ω—Ç—ã –ø–æ—Å–ª–µ –ø–æ–ª—É—á–µ–Ω–∏—è –¥–∏–ø–ª–æ–º–∞ –¥–ª—è –¥–æ–ø—É—Å–∫–∞ –∫ –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–æ–π –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏. ‚ù§Ô∏è –ú–µ—Ç—è—Ç –≤ —Ç–æ–ø. –ö–æ–º–ø–∞–Ω–∏—è ¬´–ê–°–ù–ê¬ª –∑–∞—è–≤–∏–ª–∞ –æ —Å–æ–∑–¥–∞–Ω–∏–∏ –ø–∞—Ä—Ç–Ω–µ—Ä—Å–∫–æ–π –∞–ø—Ç–µ—á–Ω–æ–π —Å–µ—Ç–∏, —á—Ç–æ –ø–æ–º–æ–∂–µ—Ç –∫–æ–Ω–∫—É—Ä–∏—Ä–æ–≤–∞—Ç—å —Å —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã–º–∏ –∞–ø—Ç–µ—á–Ω—ã–º–∏ —Å–µ—Ç—è–º–∏, –∫–æ—Ç–æ—Ä—ã–µ —Å–µ–≥–æ–¥–Ω—è –ø–æ–ª—É—á–∞—é—Ç –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ –±–æ–ª—å—à–µ –±–æ–Ω—É—Å–æ–≤ –æ—Ç –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π, —á–µ–º –æ—Å—Ç–∞–ª—å–Ω—ã–µ —É—á–∞—Å—Ç–Ω–∏–∫–∏ —Ä—ã–Ω–∫–∞. ‚ù§Ô∏è –ü–æ—ç—Ç–∞–ø–Ω–æ–µ —Å–Ω–∏–∂–µ–Ω–∏–µ. –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ —É—á–ª–æ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è –ø–æ –Ω–∞–ª–æ–≥–æ–≤–æ–π —Ä–µ—Ñ–æ—Ä–º–µ –∏ –æ–±–µ—â–∞–µ—Ç –ø–æ—ç—Ç–∞–ø–Ω—ã–π –ø–µ—Ä–µ—Ö–æ–¥ –Ω–∞ –ù–î–° –¥–ª—è –º–∞–ª–æ–≥–æ –∏ —Å—Ä–µ–¥–Ω–µ–≥–æ –±–∏–∑–Ω–µ—Å–∞. –û –≥—Ä—è–¥—É—â–∏—Ö –∏–∑–º–µ–Ω–µ–Ω–∏—è—Ö –≤ –Ω–∞–ª–æ–≥–æ–æ–±–ª–æ–∂–µ–Ω–∏–∏ –¥–ª—è —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π ¬´–§–í¬ª —Ä–∞—Å—Å–∫–∞–∑–∞–ª –∞—É–¥–∏—Ç–æ—Ä –í–∏–∫—Ç–æ—Ä –ò–≤–∞–Ω–∏—Ü–∫–∏–π.","{""skip"": true}"
2025-11-06T15:41:03+00:00,@medpharm,13439,https://t.me/medpharm/13439,–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ —É—á–ª–æ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è –ø–æ –Ω–∞–ª–æ–≥–æ–≤–æ–π —Ä–µ—Ñ–æ—Ä–º–µ –∏ –æ–±–µ—â–∞–µ—Ç –ø–æ—ç—Ç–∞–ø–Ω—ã–π –ø–µ—Ä–µ—Ö–æ–¥ –Ω–∞ –ù–î–° –¥–ª—è –º–∞–ª–æ–≥–æ –∏ —Å—Ä–µ–¥–Ω–µ–≥–æ –±–∏–∑–Ω–µ—Å–∞. –û –≥—Ä—è–¥—É—â–∏—Ö –∏–∑–º–µ–Ω–µ–Ω–∏—è—Ö –≤ –Ω–∞–ª–æ–≥–æ–æ–±–ª–æ–∂–µ–Ω–∏–∏ –¥–ª—è —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π ¬´–§–í¬ª —Ä–∞—Å—Å–∫–∞–∑–∞–ª –∞—É–¥–∏—Ç–æ—Ä –í–∏–∫—Ç–æ—Ä –ò–≤–∞–Ω–∏—Ü–∫–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QBZku #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{""skip"": true}"
2025-11-06T15:26:02+00:00,@medpharm,13438,https://t.me/medpharm/13438,"–ì–æ—Å—É–¥–∞—Ä—Å—Ç–≤–æ –ø—Ä–æ–¥–≤–∏–≥–∞–µ—Ç –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–π —Ç—É—Ä–∏–∑–º –≤ –æ—Å–Ω–æ–≤–Ω–æ–º –¥–ª—è –ª–µ—á–µ–Ω–∏—è –≤ –±—é–¥–∂–µ—Ç–Ω—ã—Ö –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è—Ö. –í–º–µ—Å—Ç–æ —ç—Ç–æ–≥–æ –º–æ–∂–µ—Ç –±—ã—Ç—å –ø–æ–ª–µ–∑–Ω–æ —Å–æ–∑–¥–∞—Ç—å —Ä–∞–±–æ—á–∏–µ –≥—Ä—É–ø–ø—ã –¥–ª—è –æ–±—ä–µ–¥–∏–Ω–µ–Ω–∏—è —É—Å–∏–ª–∏–π –º–µ–∂–¥—É —á–∞—Å—Ç–Ω—ã–º–∏ –∫–ª–∏–Ω–∏–∫–∞–º–∏ –∏ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–æ–º, –∑–∞—è–≤–∏–ª–∞ —ç–∫—Å–ø–µ—Ä—Ç. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QBZ57 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-11-06T14:54:04+00:00,@medpharm,13437,https://t.me/medpharm/13437,"¬´–ê–°–ù–ê¬ª —Å—Ç—Ä–µ–º–∏—Ç—Å—è –ø–æ–ø–∞—Å—Ç—å –≤ —Ç–æ–ø –∞–ø—Ç–µ—á–Ω—ã—Ö —Å–µ—Ç–µ–π, –∑–∞—è–≤–∏–ª –¥–∏—Ä–µ–∫—Ç–æ—Ä –≥—Ä—É–ø–ø—ã –∫–æ–º–ø–∞–Ω–∏–π –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –®–∏—à–∫–∏–Ω. –ö–∞–∫–∏–µ —à–∞–≥–∏ —Å–µ—Ç—å —Å–æ–±–∏—Ä–∞–µ—Ç—Å—è –ø—Ä–µ–¥–ø—Ä–∏–Ω—è—Ç—å –¥–ª—è –¥–æ—Å—Ç–∏–∂–µ–Ω–∏—è —Å–≤–æ–µ–π —Ü–µ–ª–∏? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QBXSD #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{""skip"": true}"
2025-11-06T14:49:04+00:00,@medpharm,13436,https://t.me/medpharm/13436,–ò–¥–∏–æ–ø–∞—Ç–∏—á–µ—Å–∫–∞—è –≤–Ω—É—Ç—Ä–∏—á–µ—Ä–µ–ø–Ω–∞—è –≥–∏–ø–µ—Ä—Ç–µ–Ω–∑–∏—è –º–æ–∂–µ—Ç –ø—Ä–∏–≤–µ—Å—Ç–∏ –∫ —Å–µ—Ä—å–µ–∑–Ω—ã–º –Ω–∞—Ä—É—à–µ–Ω–∏—è–º –∑—Ä–µ–Ω–∏—è –≤–ø–ª–æ—Ç—å –¥–æ –µ–≥–æ –ø–æ—Ç–µ—Ä–∏. –ù–æ–≤–æ–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –≤—ã—è–≤–∏–ª–æ –º–µ—Ö–∞–Ω–∏–∑–º—ã —Ä–∞–∑–≤–∏—Ç–∏—è —Ç–∞–∫–∏—Ö –æ—Å–ª–æ–∂–Ω–µ–Ω–∏–π –∏ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–æ –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç –¥–ª—è —Ä–∞–Ω–Ω–µ–≥–æ –ø—Ä–æ–≥–Ω–æ–∑–∏—Ä–æ–≤–∞–Ω–∏—è —Ä–∏—Å–∫–∞ –∏—Ö —Ä–∞–∑–≤–∏—Ç–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QBX8d #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ù–µ–≤—Ä–æ–ª–æ–≥–∏—è #–û—Ñ—Ç–∞–ª—å–º–æ–ª–æ–≥–∏—è,"{""skip"": true}"
2025-11-06T14:12:03+00:00,@medpharm,13435,https://t.me/medpharm/13435,–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§ —É—Ç–≤–µ—Ä–¥–∏–ª–æ –ü—Ä–∞–≤–∏–ª–∞ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—è –ø–µ—Ä–µ—á–Ω—è –æ–¥—É—Ä–º–∞–Ω–∏–≤–∞—é—â–∏—Ö –≤–µ—â–µ—Å—Ç–≤. –í –Ω–∏—Ö –ø—Ä–æ–ø–∏—Å–∞–Ω—ã —Å—Ä–æ–∫–∏ –¥–ª—è –≤–Ω–µ—Å–µ–Ω–∏—è –∏ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏—è –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QBUXi #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""medium"",
  ""english"": ""The Russian government approved the Rules for compiling a list of hazardous substances. They specify deadlines for submissions and consideration of proposals. For more details: https://clck.ru/3QBUXi #FarmaNews #Regulation""
}"
2025-11-06T12:36:05+00:00,@medpharm,13434,https://t.me/medpharm/13434,–ë—ã–≤—à–∏–π –º–∏–Ω–∏—Å—Ç—Ä –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –†–æ—Å—Ç–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –¢–∞—Ç—å—è–Ω–∞ –ë—ã–∫–æ–≤—Å–∫–∞—è –≤—ã–π–¥–µ—Ç –∏–∑ –∫–æ–ª–æ–Ω–∏–∏. –°—É–¥ —É–¥–æ–≤–ª–µ—Ç–≤–æ—Ä–∏–ª –µ–µ —Ö–æ–¥–∞—Ç–∞–π—Å—Ç–≤–æ –æ–± —É—Å–ª–æ–≤–Ω–æ-–¥–æ—Å—Ä–æ—á–Ω–æ–º –æ—Å–≤–æ–±–æ–∂–¥–µ–Ω–∏–∏ –æ—Ç –æ—Ç–±—ã–≤–∞–Ω–∏—è –Ω–∞–∫–∞–∑–∞–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QBNRU #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-11-06T12:30:03+00:00,@medpharm,13433,https://t.me/medpharm/13433,"–ë–æ–ª–µ–µ 80% –ø—Ä–æ–≤–µ—Ä–µ–Ω–Ω—ã—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ë–ê–î –≤ –†–æ—Å—Å–∏–∏ –æ–∫–∞–∑–∞–ª–∏—Å—å –ø—Å–µ–≤–¥–æ–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º–∏, —É –∫–æ—Ç–æ—Ä—ã—Ö –Ω–µ—Ç —Ä–µ–∞–ª—å–Ω—ã—Ö –º–æ—â–Ω–æ—Å—Ç–µ–π. –ü–æ –∞–¥—Ä–µ—Å–∞–º —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –º–Ω–æ–≥–∏—Ö –∫–æ–º–ø–∞–Ω–∏–π –Ω–∞—Ö–æ–¥—è—Ç—Å—è –∂–∏–ª—ã–µ –¥–æ–º–∞ –∏–ª–∏ –ø—É—Å—Ç—ã—Ä–∏. –ß—Ç–æ –µ—â–µ –ø–æ–∫–∞–∑–∞–ª –ø—Ä–æ–≤–µ–¥–µ–Ω–Ω—ã–π –¶–†–ü–¢ –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QBMyZ #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""A monitoring by the Center for Risk Prevention and Treatment (–¶–†–ü–¢) revealed that more than 80% of verified B–êD manufacturers in Russia are pseudomakers with no real production capacity. The addresses registered for many companies appear to be residential buildings or vacant lots. What else did the conducted monitoring show? More details: https://clck.ru/3QBMyZ #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞""
}"
2025-11-06T11:34:04+00:00,@medpharm,13432,https://t.me/medpharm/13432,"–ö –Ω–∞—á–∞–ª—É –≤–µ—Å–Ω—ã —Å–ª–µ–¥—É—é—â–µ–≥–æ –≥–æ–¥–∞ –±—É–¥—É—Ç —É—Ç–≤–µ—Ä–∂–¥–µ–Ω—ã –ø—Ä–∞–≤–∏–ª–∞ —Ä–∞–∑–º–µ—â–µ–Ω–∏—è –∞–≤—Ç–æ–º–∞—Ç–∏—á–µ—Å–∫–∏—Ö –¥–µ—Ñ–∏–±—Ä–∏–ª–ª—è—Ç–æ—Ä–æ–≤ –≤ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—è—Ö. –≠—Ç–æ –ø–æ–º–æ–∂–µ—Ç —Å–ø–∞—Å–∞—Ç—å –¥–æ 150 —Ç—ã—Å. –∂–∏–∑–Ω–µ–π –≤ –≥–æ–¥, –∑–∞—è–≤–∏–ª –ë–∞–¥–º–∞ –ë–∞—à–∞–Ω–∫–∞–µ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QBJ7x #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-11-06T11:24:03+00:00,@medpharm,13431,https://t.me/medpharm/13431,"–°—É–¥ –ø—Ä–∏–∑–Ω–∞–ª –¥–æ—á–µ—Ä–Ω—é—é –∫–æ–º–ø–∞–Ω–∏—é ¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç–∞¬ª –±–∞–Ω–∫—Ä–æ—Ç–æ–º. –ü—Ä–æ—Ü–µ–¥—É—Ä–∞ –ª–∏–∫–≤–∏–¥–∞—Ü–∏–∏ –ø–æ–∫–∞–∑–∞–ª–∞, —á—Ç–æ –∞–∫—Ç–∏–≤–æ–≤ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ –¥–ª—è –ø–æ–∫—Ä—ã—Ç–∏—è –æ–±—è–∑–∞—Ç–µ–ª—å—Å—Ç–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QBHSn #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{""skip"": true}"
2025-11-06T10:33:02+00:00,@medpharm,13430,https://t.me/medpharm/13430,"–ß—Ç–æ –¥–µ–ª–∞—Ç—å –ø–µ—Ä–≤–æ—Å—Ç–æ–ª—å–Ω–∏–∫—É, –µ—Å–ª–∏ –ø—Ä–∏ —É—Å—Ç—Ä–æ–π—Å—Ç–≤–µ –Ω–∞ —Ä–∞–±–æ—Ç—É –≤ –∞–ø—Ç–µ–∫–µ –æ–Ω —É–∑–Ω–∞–ª –ø—Ä–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –∏ –¥—Ä—É–≥–∏–µ —Ç–æ–≤–∞—Ä—ã —Å –∏—Å—Ç–µ–∫–∞—é—â–∏–º —Å—Ä–æ–∫–æ–º –≥–æ–¥–Ω–æ—Å—Ç–∏ –Ω–∞ –±–æ–ª—å—à—É—é —Å—É–º–º—É? –ù–æ–≤—ã–π —Å–æ—Ç—Ä—É–¥–Ω–∏–∫ –º–æ–∂–µ—Ç —Å—Ç–æ–ª–∫–Ω—É—Ç—å—Å—è —Å —Å–µ—Ä—å–µ–∑–Ω—ã–º–∏ —Ñ–∏–Ω–∞–Ω—Å–æ–≤—ã–º–∏ –∏ —é—Ä–∏–¥–∏—á–µ—Å–∫–∏–º–∏ —Ä–∏—Å–∫–∞–º–∏. –ù–∞ –≤–æ–ø—Ä–æ—Å —á–∏—Ç–∞—Ç–µ–ª–µ–π ¬´–§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ –≤–µ—Å—Ç–Ω–∏–∫–∞¬ª –æ—Ç–≤–µ—á–∞–µ—Ç –ø–∞—Ä—Ç–Ω–µ—Ä –∞–¥–≤–æ–∫–∞—Ç—Å–∫–æ–≥–æ –±—é—Ä–æ ¬´–û–ª—å–≥–∞ –†–µ–Ω–æ–≤–∞ –∏ –ø–∞—Ä—Ç–Ω–µ—Ä—ã¬ª –û–ª—å–≥–∞ –ö–∞—Ä–ø–æ–≤–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QBENW #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫","{""skip"": true}"
2025-11-06T10:31:03+00:00,@medpharm,13429,https://t.me/medpharm/13429,"–†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä –∑–∞—è–≤–∏–ª –æ —Å–æ–∑–¥–∞–Ω–∏–∏ –±—ã—Å—Ç—Ä–æ–≥–æ —Ç–µ—Å—Ç–∞ –Ω–∞ –≥–µ–ø–∞—Ç–∏—Ç –°, –∫–æ—Ç–æ—Ä—ã–π –¥–∏–∞–≥–Ω–æ—Å—Ç–∏—Ä—É–µ—Ç –≤–∏—Ä—É—Å –≤ —Ç–µ—á–µ–Ω–∏–µ –ø–æ–ª—É—á–∞—Å–∞. –°–∫—Ä–∏–Ω–∏–Ω–≥ –Ω–∞ —ç—Ç—É –∏–Ω—Ñ–µ–∫—Ü–∏—é —Å 2024 –≥–æ–¥–∞ –≤–∫–ª—é—á–µ–Ω –≤ –ø—Ä–æ—Ñ–æ—Å–º–æ—Ç—Ä—ã –≤–∑—Ä–æ—Å–ª–æ–≥–æ –Ω–∞—Å–µ–ª–µ–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QBDyV #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞ #–ò–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã–µ_–±–æ–ª–µ–∑–Ω–∏","{""skip"": true}"
2025-11-06T09:23:02+00:00,@medpharm,13428,https://t.me/medpharm/13428,"–ú–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–∞, –¥–µ–ª–∞–≤—à–µ–≥–æ —Å–º–µ—Ä—Ç–µ–ª—å–Ω—ã–µ –∏–Ω—ä–µ–∫—Ü–∏–∏ –ø–∞—Ü–∏–µ–Ω—Ç–∞–º –≤ –ì–µ—Ä–º–∞–Ω–∏–∏, –ø—Ä–∏–≥–æ–≤–æ—Ä–∏–ª–∏ –∫ –ø–æ–∂–∏–∑–Ω–µ–Ω–Ω–æ–º—É –ª–∏—à–µ–Ω–∏—é —Å–≤–æ–±–æ–¥—ã. –≠–∫—Å–ø–µ—Ä—Ç—ã –∫—Ä–∏—Ç–∏–∫—É—é—Ç –ø–ª–æ—Ö–æ–π —É—á–µ—Ç –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ –Ω–µ–º–µ—Ü–∫–∏—Ö –±–æ–ª—å–Ω–∏—Ü–∞—Ö. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QB97q #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-11-06T08:55:02+00:00,@medpharm,13427,https://t.me/medpharm/13427,–ù–æ–≤—ã–π –∑–∞–º—Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—è –§–ê–° –†–æ—Å—Å–∏–∏ –±—É–¥–µ—Ç –∫—É—Ä–∏—Ä–æ–≤–∞—Ç—å –£–ø—Ä–∞–≤–ª–µ–Ω–∏–µ –∫–æ–Ω—Ç—Ä–æ–ª—è —Ñ–∏–Ω–∞–Ω—Å–æ–≤—ã—Ö —Ä—ã–Ω–∫–æ–≤ –∏ –ö–æ–Ω—Ç—Ä–æ–ª—å–Ω–æ-—Ñ–∏–Ω–∞–Ω—Å–æ–≤–æ–µ —É–ø—Ä–∞–≤–ª–µ–Ω–∏–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QB6zT #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{""skip"": true}"
2025-11-06T08:17:06+00:00,@medpharm,13426,https://t.me/medpharm/13426,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª –º–Ω–µ–Ω–∏—è 17 —Ç—ã—Å. –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –≤—É–∑–æ–≤ –æ –ø—Ä–æ—Ü–µ–¥—É—Ä–µ –ø–µ—Ä–≤–∏—á–Ω–æ–π –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–∏ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞, –∫–æ—Ç–æ—Ä—É—é –ø—Ä–æ—Ö–æ–¥—è—Ç –≤—Å–µ —Å—Ç—É–¥–µ–Ω—Ç—ã –ø–æ—Å–ª–µ –ø–æ–ª—É—á–µ–Ω–∏—è –¥–∏–ø–ª–æ–º–∞ –¥–ª—è –¥–æ–ø—É—Å–∫–∞ –∫ –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–æ–π –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏. –í –Ω–∞–∏–±–æ–ª—å—à–µ–π —Å—Ç–µ–ø–µ–Ω–∏ —É–¥–æ–≤–ª–µ—Ç–≤–æ—Ä–µ–Ω—ã –µ–µ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏–µ–º –≤—ã–ø—É—Å–∫–Ω–∏–∫–∏, –∑–∞–≤–µ—Ä—à–∏–≤—à–∏–µ –æ–±—É—á–µ–Ω–∏–µ –ø–æ —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç—è–º ¬´–ú–µ–¥–∏–∫–æ-–ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–æ–µ –¥–µ–ª–æ¬ª, ¬´–ú–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è –∫–∏–±–µ—Ä–Ω–µ—Ç–∏–∫–∞¬ª –∏ ¬´–§–∞—Ä–º–∞—Ü–∏—è¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QB45T #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-11-06T07:42:03+00:00,@medpharm,13425,https://t.me/medpharm/13425,"–£—Å–∫–æ—Ä–∏—Ç—å —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç –ø–æ –º–∞—Ä–∫–∏—Ä–æ–≤–∫–µ –º–µ–¥–∏–∑–¥–µ–ª–∏–π –∏ –≤–∫–ª—é—á–∏—Ç—å –≤ –Ω–µ–≥–æ –Ω–æ–≤—ã–µ –≥—Ä—É–ø–ø—ã –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∞ –†–æ—Å—Å–∏–π—Å–∫–∞—è –∞—Å—Å–æ—Ü–∏–∞—Ü–∏—è –∞–ø—Ç–µ—á–Ω—ã—Ö —Å–µ—Ç–µ–π (–†–ê–ê–°). ¬´–°–µ—Ä—ã–π¬ª —Ä—ã–Ω–æ–∫ —Ñ–∏–ª–ª–µ—Ä–æ–≤ –∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –±–∏–æ—Ä–µ–≤–∏—Ç–∞–ª–∏–∑–∞—Ü–∏–∏, –º–µ–∑–æ—Ç–µ—Ä–∞–ø–∏–∏ –∏ –Ω–∏—Ç–µ–≤–æ–≥–æ –ª–∏—Ñ—Ç–∏–Ω–≥–∞ –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç —Ä–∞—Å—Ç–∏ –Ω–∞ –æ–Ω–ª–∞–π–Ω-–ø–ª–æ—â–∞–¥–∫–∞—Ö –∏ –Ω–∏–∫–∞–∫ –Ω–µ —Ä–µ–≥—É–ª–∏—Ä—É–µ—Ç—Å—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QAzNz #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{""skip"": true}"
2025-11-06T07:15:06+00:00,@medpharm,13424,https://t.me/medpharm/13424,"–î–∞–∂–µ —É –∫—Ä—É–ø–Ω—ã—Ö –∫–ª–∏–Ω–∏–∫ —Å–∞–π—Ç—ã –≤—Å–µ –µ—â–µ —É—Å—Ç—É–ø–∞—é—Ç –ø–æ —É–¥–æ–±—Å—Ç–≤—É –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞–º, –±–∞–Ω–∫–∞–º –∏ —Å–µ—Ä–≤–∏—Å–∞–º –¥–æ—Å—Ç–∞–≤–∫–∏. –ê –ø–∞—Ü–∏–µ–Ω—Ç, –ø—Ä–∏–≤—ã–∫–Ω—É–≤ –∫ —É–¥–æ–±—Å—Ç–≤—É –∏ —Å–∫–æ—Ä–æ—Å—Ç–∏ –≤ –æ–¥–Ω–æ–º –ø—Ä–∏–ª–æ–∂–µ–Ω–∏–∏, –∂–¥–µ—Ç —Ç–æ–≥–æ –∂–µ –æ—Ç –ª—é–±–æ–≥–æ –¥—Ä—É–≥–æ–≥–æ –∏ –Ω–µ –≥–æ—Ç–æ–≤ –º–∏—Ä–∏—Ç—å—Å—è —Å –≥—Ä–æ–º–æ–∑–¥–∫–∏–º–∏ —Ñ–æ—Ä–º–∞–º–∏ –∏ –∑–∞–ø—É—Ç–∞–Ω–Ω–æ–π –Ω–∞–≤–∏–≥–∞—Ü–∏–µ–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QAxYe #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-11-06T06:09:04+00:00,@medpharm,13423,https://t.me/medpharm/13423,"–ö–æ–ª–∏—á–µ—Å—Ç–≤–æ –æ–±—Ä–∞—â–µ–Ω–∏–π –æ—Ç —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –°–í–û –Ω–∞ –º–µ–¥–æ–±—Å–ª—É–∂–∏–≤–∞–Ω–∏–µ –∏ –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ —Å–Ω–∏–∂–∞–µ—Ç—Å—è, –Ω–æ –∏—Ö —Å—Ç—Ä—É–∫—Ç—É—Ä–∞ –Ω–µ –º–µ–Ω—è–µ—Ç—Å—è. –ë–æ–ª—å—à–µ –≤—Å–µ–≥–æ –∂–∞–ª–æ–± –ø–æ—Å—Ç—É–ø–∞–µ—Ç –∏–∑ –ú–æ—Å–∫–≤—ã –∏ –ú–æ—Å–∫–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏, –∞ —Ç–∞–∫–∂–µ –∏–∑ –ö—Ä–∞—Å–Ω–æ–¥–∞—Ä—Å–∫–æ–≥–æ –∏ –°—Ç–∞–≤—Ä–æ–ø–æ–ª—å—Å–∫–æ–≥–æ –∫—Ä–∞–µ–≤, –ë–∞—à–∫–∏—Ä–∏–∏ –∏ –°–∞–º–∞—Ä—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QAtFG #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage,hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""There is a decrease in the number of complaints from participants about medical care and supplies, but their structure remains unchanged. Complaints are mainly coming from Moscow and Moscow Oblast, as well as from the Krasnodar and Stavropol Territories, Bashkiriya, and Samara Oblast. For more details: https://clck.ru/3QAtFG #MedVestnik #HealthcareSystem""
}"
2025-11-05T16:43:04+00:00,@medpharm,13422,https://t.me/medpharm/13422,"ü¶æ –ë–µ–∑ –∞–≤—Ç–æ–≥—Ä–∞—Ñ–∞. –ù–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ –ú–æ—Å–∫–≤—ã —Å—Ç–∞—Ä—Ç—É–µ—Ç —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç –ø–æ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏—é —ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω–æ–π –≥—Ä–∞—Ñ–∏—á–µ—Å–∫–æ–π –ø–æ–¥–ø–∏—Å–∏ –¥–ª—è –ø–æ–¥–ø–∏—Å–∞–Ω–∏—è –∏–Ω—Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–Ω–æ–≥–æ –¥–æ–±—Ä–æ–≤–æ–ª—å–Ω–æ–≥–æ —Å–æ–≥–ª–∞—Å–∏—è (–ò–î–°) –Ω–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –≤–º–µ—à–∞—Ç–µ–ª—å—Å—Ç–≤–∞ –∏–ª–∏ –æ—Ç–∫–∞–∑–∞ –æ—Ç –Ω–∏—Ö. ü¶æ –ü–µ—Ä–∏–æ–¥ –æ–±–Ω–æ–≤–ª–µ–Ω–∏—è. –í –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –º–µ–¥—á—Ä–µ–∂–¥–µ–Ω–∏—è—Ö, –ø–æ –¥–∞–Ω–Ω—ã–º –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–§, —Ç—Ä–µ–±—É–µ—Ç—Å—è –∑–∞–º–µ–Ω–∏—Ç—å –ø–æ—á—Ç–∏ —á–µ—Ç–≤–µ—Ä—Ç—å –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è. –û—Å–Ω–æ–≤–Ω–æ–µ –ø—Ä–µ–ø—è—Ç—Å—Ç–≤–∏–µ ‚Äì –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–µ —Ä—è–¥–∞ –ø—Ä–∏–±–æ—Ä–æ–≤ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞. ‚ù§Ô∏è –£—Å–∏–ª–∏–ª–∏ –ø–æ–∑–∏—Ü–∏–∏. ¬´–†–∏–≥–ª–∞¬ª –∑–∞–∫–ª—é—á–∏–ª–∞ —Å–¥–µ–ª–∫—É, –±–ª–∞–≥–æ–¥–∞—Ä—è –∫–æ—Ç–æ—Ä–æ–π –µ–µ –¥–æ–ª—è –Ω–∞ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω–æ–º —Ä—ã–Ω–∫–µ –≤—ã—Ä–æ—Å–ª–∞ –¥–æ 13%. ‚ù§Ô∏è –£–ø—É—Å—Ç–∏–ª–∏ –≤—ã–≥–æ–¥—É. –ê—Ä–±–∏—Ç—Ä–∞–∂–Ω—ã–π —Å—É–¥ –ú–æ—Å–∫–≤—ã –æ—Ç–∫–ª–æ–Ω–∏–ª –∏—Å–∫ –æ–ø—Ç–æ–≤–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ –∫ —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—é –æ –≤–∑—ã—Å–∫–∞–Ω–∏–∏ —É–ø—É—â–µ–Ω–Ω–æ–π –≤—ã–≥–æ–¥—ã. –°—É–¥ –Ω–µ –ø—Ä–∏–∑–Ω–∞–ª —Ä–∞—Å—Å—ã–ª–∫—É –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è –¥–æ—Å—Ç–∞—Ç–æ—á–Ω—ã–º –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å—Å—Ç–≤–æ–º –æ–±—è–∑–∞—Ç–µ–ª—å—Å—Ç–≤, –ø–æ—Å–∫–æ–ª—å–∫—É –¥–æ–≥–æ–≤–æ—Ä –º–µ–∂–¥—É —Å—Ç–æ—Ä–æ–Ω–∞–º–∏ –∑–∞–∫–ª—é—á–µ–Ω –Ω–µ –±—ã–ª.","{""skip"": true}"
2025-11-05T16:09:02+00:00,@medpharm,13421,https://t.me/medpharm/13421,"–§–∞—Ä–º—Ä—ã–Ω–∫—É –Ω–µ –Ω–∞ —á—Ç–æ –∂–∞–ª–æ–≤–∞—Ç—å—Å—è ‚Äî –≤ –æ—Ç–ª–∏—á–∏–µ –æ—Ç –º–Ω–æ–≥–∏—Ö –¥—Ä—É–≥–∏—Ö —Ä–æ–∑–Ω–∏—á–Ω—ã—Ö —Ä—ã–Ω–∫–æ–≤, –æ–Ω –æ—Å—Ç–∞–µ—Ç—Å—è —Ä–µ–∑–µ—Ä–≤–∞—Ü–∏–µ–π –ø—Ä–æ–¥–æ–ª–∂–∞—é—â–µ–≥–æ—Å—è —Ä–æ—Å—Ç–∞. –û —Ç–µ–∫—É—â–µ–º —ç—Ç–∞–ø–µ —Ä–∞–∑–≤–∏—Ç–∏—è –∞–ø—Ç–µ—á–Ω–æ–≥–æ —Å–µ–∫—Ç–æ—Ä–∞ —Ä–∞—Å—Å–∫–∞–∑–∞–ª –¥–∏—Ä–µ–∫—Ç–æ—Ä AlphaRM –ù–∏–∫–æ–ª–∞–π –î–µ–º–∏–¥–æ–≤, –≤—ã—Å—Ç—É–ø–∞—è –Ω–∞ –î–∏—Å–∫—É—Å—Å–∏–æ–Ω–Ω–æ–º –∫–ª—É–±–µ –≤ –ü—è—Ç–∏–≥–æ—Ä—Å–∫–µ. –ê–Ω–∞–ª–∏–∑ –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç–∞ –ø–æ –∫–∞—Ç–µ–≥–æ—Ä–∏—è–º, –∏–∑–º–µ–Ω–µ–Ω–∏—è —Å—Ä–µ–¥–Ω–µ–≥–æ —á–µ–∫–∞ –∏ –ø—Ä–æ–≥–Ω–æ–∑—ã –ø–æ –∫–æ–Ω—Å–æ–ª–∏–¥–∞—Ü–∏–∏ –∏–≥—Ä–æ–∫–æ–≤ ‚Äî –≤ –º–∞—Ç–µ—Ä–∏–∞–ª–µ ¬´–§–í¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QAYPV #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{""skip"": true}"
2025-11-05T15:41:03+00:00,@medpharm,13420,https://t.me/medpharm/13420,¬´–†–∏–≥–ª–∞¬ª –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç —É—Å–∏–ª–∏–≤–∞—Ç—å —Å–≤–æ–∏ –ø–æ–∑–∏—Ü–∏–∏ –Ω–∞ —Ñ–∞—Ä–º—Ä—ã–Ω–∫–µ –¢–≤–µ—Ä—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏. –ö–æ–º–ø–∞–Ω–∏—è –∑–∞–∫—Ä—ã–ª–∞ —Å–¥–µ–ª–∫—É –ø–æ –ø—Ä–∏–æ–±—Ä–µ—Ç–µ–Ω–∏—é –º–µ—Å—Ç–Ω–æ–π –∞–ø—Ç–µ—á–Ω–æ–π —Å–µ—Ç–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QAWkU #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞,"{""skip"": true}"
2025-11-05T15:20:03+00:00,@medpharm,13419,https://t.me/medpharm/13419,"–ú–æ–¥–µ–ª—å –ø—Ä—è–º—ã—Ö –ø—Ä–æ–¥–∞–∂ —Å—Ç–∞–Ω–æ–≤–∏—Ç—Å—è —Å—Ç–∞–Ω–¥–∞—Ä—Ç–æ–º –≤ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –æ—Ç—Ä–∞—Å–ª–∏ –°–®–ê, —Å–ª–µ–¥—É–µ—Ç –∏–∑ –Ω–æ–≤–æ–≥–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è. –ë–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ –∏–≥—Ä–æ–∫–æ–≤ —Ä—ã–Ω–∫–∞ –æ—Ç–∫–∞–∑—ã–≤–∞—é—Ç—Å—è –æ—Ç –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏—è —Å –ø–æ—Å—Ä–µ–¥–Ω–∏–∫–∞–º–∏ ‚Äî –∞–ø—Ç–µ–∫–∞–º–∏ –∏ —Å—Ç—Ä–∞—Ö–æ–≤—â–∏–∫–∞–º–∏, —Ä–µ–∞–ª–∏–∑—É—è –ø—Ä–æ–¥—É–∫—Ü–∏—é —Å–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω–æ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QAVVF #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{""skip"": true}"
2025-11-05T15:19:08+00:00,@medpharm,13418,https://t.me/medpharm/13418,–î–∞–∂–µ –Ω–∏–∑–∫–∞—è —Ñ–∏–∑–∏—á–µ—Å–∫–∞—è –∞–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –∑–∞–º–µ–¥–ª—è–ª–∞ –ø—Ä–æ–≥—Ä–µ—Å—Å–∏—Ä–æ–≤–∞–Ω–∏–µ –¥–æ–∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–π —Å—Ç–∞–¥–∏–∏ –±–æ–ª–µ–∑–Ω–∏ –ê–ª—å—Ü–≥–µ–π–º–µ—Ä–∞. –ö —Ç–∞–∫–æ–º—É –≤—ã–≤–æ–¥—É –ø—Ä–∏—à–ª–∏ –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª–∏ –∏–∑ –ì–∞—Ä–≤–∞—Ä–¥—Å–∫–æ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π —à–∫–æ–ª—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QAVSC #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ù–µ–≤—Ä–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è,"{""skip"": true}"
2025-11-05T14:46:03+00:00,@medpharm,13417,https://t.me/medpharm/13417,"–≠–∫—Å–ø–µ—Ä—Ç—ã —Ñ–æ–Ω–¥–∞ ¬´–ö—Ä—É–≥ –¥–æ–±—Ä–∞¬ª –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –ø–æ–ø–æ–ª–Ω–∏—Ç—å –ø–µ—Ä–µ—á–µ–Ω—å –Ω–æ–∑–æ–ª–æ–≥–∏–π –¥–≤—É–º—è –æ—á–µ–Ω—å —Ä–µ–¥–∫–∏–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏. –û–¥–∏–Ω —Å–∏–Ω–¥—Ä–æ–º –≤—Å—Ç—Ä–µ—á–∞–µ—Ç—Å—è —Ä–µ–∂–µ –æ–¥–Ω–æ–≥–æ —Å–ª—É—á–∞—è –Ω–∞ –º–∏–ª–ª–∏–æ–Ω, –¥—Ä—É–≥–æ–π –¥–∏–∞–≥–Ω–æ—Å—Ç–∏—Ä–æ–≤–∞–Ω —É —Å–µ–º–∏ –¥–µ—Ç–µ–π –≤ –†–æ—Å—Å–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QATVp #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,hospital_policy,pharmacovigilance,safety"",
  ""impact"": ""high"",
  ""english"": ""Experts from the 'Circle of Good' foundation proposed to add two very rare diseases to the list. One syndrome occurs once in a million cases, and another has been diagnosed in seven children in Russia. More details: https://clck.ru/3QATVp #PharmNews #Regulation""
}"
2025-11-05T14:26:04+00:00,@medpharm,13416,https://t.me/medpharm/13416,"–í —Ö–æ–¥–µ —Å–æ–≤–µ—â–∞–Ω–∏—è –¢–∞—Ç—å—è–Ω–∞ –ì–æ–ª–∏–∫–æ–≤–∞ –æ–±—Å—É–¥–∏–ª–∞ —Å –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª—è–º–∏ –º–∏–Ω–∏—Å—Ç–µ—Ä—Å—Ç–≤ –∏ —Ñ–µ–¥—Å–ª—É–∂–± –∫–ª—é—á–µ–≤—ã–µ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è –Ω–∞—Ü–ø—Ä–æ–µ–∫—Ç–∞ –ø–æ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—é. –í —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, –¥–æ—Å—Ç—É–ø –∫ –±–µ—Å–ø–ª–∞—Ç–Ω—ã–º –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏ –∏ –æ–Ω–∫–æ–ª–æ–≥–∏–µ–π, –º–æ–¥–µ—Ä–Ω–∏–∑–∞—Ü–∏—é –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QASEF #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-11-05T13:58:03+00:00,@medpharm,13415,https://t.me/medpharm/13415,"–í –°–®–ê –ø–æ—è–≤–∏—Ç—Å—è –ø–µ—Ä–≤—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –æ—Ç —Ä–µ–¥–∫–æ–π –º–∏—Ç–æ—Ö–æ–Ω–¥—Ä–∏–∞–ª—å–Ω–æ–π –±–æ–ª–µ–∑–Ω–∏, –∫–æ—Ç–æ—Ä–∞—è –¥–æ —Å–∏—Ö –ø–æ—Ä —Å—á–∏—Ç–∞–ª–∞—Å—å –Ω–µ–∏–∑–ª–µ—á–∏–º–æ–π. –û–Ω —É—Å—Ç—Ä–∞–Ω—è–µ—Ç –ø—Ä–æ–±–ª–µ–º—É –Ω–µ—Ö–≤–∞—Ç–∫–∏ –≤–∞–∂–Ω–æ–≥–æ —Ñ–µ—Ä–º–µ–Ω—Ç–∞ –≤ —ç–Ω–µ—Ä–≥–æ—Å—Ç–∞–Ω—Ü–∏—è—Ö –∫–ª–µ—Ç–æ–∫ –∏ –¥–∞–µ—Ç –Ω–∞–¥–µ–∂–¥—É –Ω–∞ –≤–æ—Å—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ —É—Ç—Ä–∞—á–µ–Ω–Ω—ã—Ö –¥–≤–∏–≥–∞—Ç–µ–ª—å–Ω—ã—Ö —Ñ—É–Ω–∫—Ü–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QAN8Q #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-11-05T13:36:03+00:00,@medpharm,13414,https://t.me/medpharm/13414,"–§–æ–Ω–¥ ¬´–ö—Ä—É–≥ –¥–æ–±—Ä–∞¬ª –¥–æ–±–∞–≤–∏–ª –≤ –ø–µ—Ä–µ—á–µ–Ω—å –Ω–æ–∑–æ–ª–æ–≥–∏–π, –ø–æ –∫–æ—Ç–æ—Ä—ã–º –æ–Ω –±—É–¥–µ—Ç –æ–∫–∞–∑—ã–≤–∞—Ç—å –ø–æ–º–æ—â—å –¥–µ—Ç—è–º, –¥–≤–∞ –æ—á–µ–Ω—å —Ä–µ–¥–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è –∏ —É—Ç–æ—á–Ω–∏–ª, –∫–∞–∫–∞—è —Ç–µ—Ä–∞–ø–∏—è –ø—Ä–∏ –Ω–∏—Ö –ø–æ–∫–∞–∑–∞–Ω–∞. –û–¥–Ω–∞ –∏–∑ –≤–∫–ª—é—á–µ–Ω–Ω—ã—Ö –≤ —Å–ø–∏—Å–æ–∫ –±–æ–ª–µ–∑–Ω–µ–π –≤—Å—Ç—Ä–µ—á–∞–µ—Ç—Å—è —Å—Ä–µ–¥–∏ –Ω–æ–≤–æ—Ä–æ–∂–¥–µ–Ω–Ω—ã—Ö —Ä–µ–∂–µ –æ–¥–Ω–æ–≥–æ —Å–ª—É—á–∞—è –Ω–∞ –º–∏–ª–ª–∏–æ–Ω. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QAHkf #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance"",
  ""impact"": ""high"",
  ""english"": ""The Fund 'Circle of Goodwill' added two very rare diseases to the list of conditions for which it will provide assistance to children. One of the included illnesses occurs in newborns less than once per million cases. More details: https://clck.ru/3QAHkf #MedNews #Healthcare #PublicHealth""
}"
2025-11-05T12:41:02+00:00,@medpharm,13413,https://t.me/medpharm/13413,"–ù–æ–≤—ã–π —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–π –∫–ª–∞—Å—Ç–µ—Ä –ø–ª–∞–Ω–∏—Ä—É—é—Ç —Å–æ–∑–¥–∞—Ç—å –≤ –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥–µ –≤ 2026 –≥–æ–¥—É. –ö –ø—Ä–æ–µ–∫—Ç—É –ø—Ä–∏–≤–ª–µ–∫—É—Ç –±–æ–ª–µ–µ 20 —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤, –∫–æ—Ç–æ—Ä—ã–º –æ—Ç–∫—Ä–æ—é—Ç—Å—è –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ –¥–ª—è –≤—ã—Ö–æ–¥–∞ –Ω–∞ –Ω–æ–≤—ã–µ —Ä—ã–Ω–∫–∏ —Å–±—ã—Ç–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QA8vA #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-11-05T12:28:04+00:00,@medpharm,13412,https://t.me/medpharm/13412,–≠–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç —Å —ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω–æ–π –≥—Ä–∞—Ñ–∏—á–µ—Å–∫–æ–π –ø–æ–¥–ø–∏—Å—å—é –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤ –∑–∞–ø—É—Å—Ç–∏–ª–∏ –≤ —Å—Ç–æ–ª–∏—Ü–µ. –≠—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –±—É–¥—É—Ç –æ—Ü–µ–Ω–∏–≤–∞—Ç—å –≤ —Ç–æ–º —á–∏—Å–ª–µ –ø–æ —Ä–æ—Å—Ç—É –¥–æ–ª–∏ —Ç–∞–∫–∏—Ö –ø–æ–¥–ø–∏—Å–µ–π –≤ –±–ª–∏–∂–∞–π—à–∏–µ —Ç—Ä–∏ –≥–æ–¥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3QA77j #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-11-05T11:13:08+00:00,@medpharm,13411,https://t.me/medpharm/13411,"–í —Å—Ç–æ–ª–∏—á–Ω—ã—Ö –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—è—Ö –≤–¥–≤–æ–µ —Å–æ–∫—Ä–∞—Ç–∏–ª–æ—Å—å –≤—Ä–µ–º—è –æ–∂–∏–¥–∞–Ω–∏—è –ø–ª–∞–Ω–æ–≤–æ–π –≥–æ—Å–ø–∏—Ç–∞–ª–∏–∑–∞—Ü–∏–∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –¢–µ–ø–µ—Ä—å –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ –ø—Ä–æ—Ü–µ—Å—Å–æ–≤ –∞–≤—Ç–æ–º–∞—Ç–∏–∑–∏—Ä–æ–≤–∞–Ω–æ, –∏ –º–Ω–æ–≥–∏–µ —É—Å–ª—É–≥–∏ –¥–æ—Å—Ç—É–ø–Ω—ã –≤ –¥–∏—Å—Ç–∞–Ω—Ü–∏–æ–Ω–Ω–æ–º —Ä–µ–∂–∏–º–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q9oWk #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-11-05T11:11:03+00:00,@medpharm,13410,https://t.me/medpharm/13410,"–£—á–∞—Å—Ç–Ω–∏–∫–∏ –î–∏—Å–∫—É—Å—Å–∏–æ–Ω–Ω–æ–≥–æ –∫–ª—É–±–∞ –≤ –ü—è—Ç–∏–≥–æ—Ä—Å–∫–µ –æ–±—Å—É–¥–∏–ª–∏, –∫–∞–∫ –∞–ø—Ç–µ–∫–∏ –≤—ã–±–∏—Ä–∞—é—Ç —Ç–æ–≤–∞—Ä –∏ —á—Ç–æ –Ω—É–∂–Ω–æ —Å–¥–µ–ª–∞—Ç—å –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º, —á—Ç–æ–±—ã –ø–æ–ø–∞—Å—Ç—å –≤ –ø–æ–ª–µ –∑—Ä–µ–Ω–∏—è –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö —Å–µ—Ç–µ–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q9o32 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""tenders, hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""Participants of the Discussion Club in Pyatigorsk discussed how pharmacies choose products and what manufacturers need to do to be seen by the largest chains. More: https://clck.ru/3Q9o32 #FarmaNews #Retail""
}"
2025-11-05T10:09:07+00:00,@medpharm,13409,https://t.me/medpharm/13409,–†–æ—Å—Å–∏–π—Å–∫–∏–µ –≤–ª–∞—Å—Ç–∏ –ø—ã—Ç–∞—é—Ç—Å—è —Ä–µ—à–∏—Ç—å –ø—Ä–æ–±–ª–µ–º—É —Å –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ–º –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â—å—é –∂–∏—Ç–µ–ª–µ–π –æ—Ç–¥–∞–ª–µ–Ω–Ω—ã—Ö —É–≥–æ–ª–∫–æ–≤ —Å—Ç—Ä–∞–Ω—ã. –ù–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ –î–∞–ª—å–Ω–µ–≥–æ –í–æ—Å—Ç–æ–∫–∞ –¥–ª—è —ç—Ç–æ–≥–æ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –∑–∞–¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å –º–æ–±–∏–ª—å–Ω—ã–µ –±—Ä–∏–≥–∞–¥—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q9Zu5 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-11-05T10:07:03+00:00,@medpharm,13408,https://t.me/medpharm/13408,"–î–µ–ª–æ –æ–± —É–ø—É—â–µ–Ω–Ω–æ–π –≤—ã–≥–æ–¥–µ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–ª –ê—Ä–±–∏—Ç—Ä–∞–∂–Ω—ã–π —Å—É–¥ –ú–æ—Å–∫–≤—ã. –û–ø—Ç–æ–≤–∞—è –∫–æ–º–ø–∞–Ω–∏—è –ø–æ–¥–∞–ª–∞ –∏—Å–∫ –∫ —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—é, –ø—Ä–µ–ø–∞—Ä–∞—Ç –∫–æ—Ç–æ—Ä–æ–≥–æ –æ–Ω–∞ –Ω–∞–º–µ—Ä–µ–≤–∞–ª–∞—Å—å –ø–æ—Å—Ç–∞–≤–ª—è—Ç—å –≤ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—è, –ø—Ä–∏—Ç–æ–º —á—Ç–æ –º–µ–∂–¥—É –Ω–∏–º–∏ –Ω–µ –±—ã–ª–æ –¥–æ–≥–æ–≤–æ—Ä–Ω—ã—Ö –æ—Ç–Ω–æ—à–µ–Ω–∏–π. –û–Ω–∞ —Å—Å—ã–ª–∞–ª–∞—Å—å –Ω–∞ –ø–æ—á—Ç–æ–≤—É—é —Ä–∞—Å—Å—ã–ª–∫—É –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏—è –∫–∞–∫ –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏–µ –≤–∑—è—Ç—ã—Ö –∏–º –Ω–∞ —Å–µ–±—è –æ–±—è–∑–∞—Ç–µ–ª—å—Å—Ç–≤, –Ω–æ —Å—É–¥ —Å —ç—Ç–∏–º –¥–æ–≤–æ–¥–æ–º –Ω–µ —Å–æ–≥–ª–∞—Å–∏–ª—Å—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q9Zig #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The Arbitration Court of Moscow reviewed a case about missed opportunity. A wholesale company filed an action against a pharmaceutical producer, citing the company's mail correspondence as evidence of their contractual obligations. However, the court did not agree with this argument. For more details: https://clck.ru/3Q9Zig #Farmaudit #Distribution""
}"
2025-11-05T07:44:04+00:00,@medpharm,13406,https://t.me/medpharm/13406,"¬´–í —Ä–µ–∑—É–ª—å—Ç–∞—Ç–µ –Ω–µ–Ω–∞–¥–ª–µ–∂–∞—â–µ–≥–æ –æ–∫–∞–∑–∞–Ω–∏—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–µ–π –ø—Ä–∏—á–∏–Ω–µ–Ω –≤—Ä–µ–¥ –∑–¥–æ—Ä–æ–≤—å—é –Ω–µ—Å–æ–≤–µ—Ä—à–µ–Ω–Ω–æ–ª–µ—Ç–Ω–µ–≥–æ –ø–∞—Ü–∏–µ–Ω—Ç–∞. –†–æ–¥–∏—Ç–µ–ª–∏ –ø–æ—Ç—Ä–µ–±–æ–≤–∞–ª–∏ –≤–æ–∑–º–µ—â–µ–Ω–∏—è –ø—Ä–µ–¥—Å—Ç–æ—è—â–∏—Ö —Ä–∞—Å—Ö–æ–¥–æ–≤ –Ω–∞ –ª–µ—á–µ–Ω–∏–µ –∏ –º–æ—Ä–∞–ª—å–Ω–æ–≥–æ –≤—Ä–µ–¥–∞. –ú–æ–≥—É—Ç –ª–∏ —Ç–∞–∫–∏–µ —Ä–∞—Å—Ö–æ–¥—ã –±—ã—Ç—å –≤–æ–∑–º–µ—â–µ–Ω—ã –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–µ–π –∑–∞ —Å—á–µ—Ç —Å—Ä–µ–¥—Å—Ç–≤ –û–ú–° –Ω–∞ –æ—Å–Ω–æ–≤–∞–Ω–∏–∏ –¥–æ—Å—É–¥–µ–±–Ω–æ–≥–æ —Å–æ–≥–ª–∞—à–µ–Ω–∏—è, –∏–ª–∏ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ —Ç—Ä–µ–±—É–µ—Ç—Å—è –≤—ã–Ω–µ—Å–µ–Ω–∏–µ —Å—É–¥–µ–±–Ω–æ–≥–æ —Ä–µ—à–µ–Ω–∏—è?¬ª –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q9MyP #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""Parents are seeking compensation for medical expenses and moral damages incurred due to improper healthcare provided by a medical organization. They are asking whether such costs can be covered by the medical organization under OMS funds based on a pre-litigation agreement, or if a court decision is required.""
}"
2025-11-05T07:19:03+00:00,@medpharm,13405,https://t.me/medpharm/13405,"–ò–ò-–º–æ–¥–µ–ª–∏ –¥–ª—è —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –Ω–µ –ø–æ–Ω–∏–º–∞—é—Ç –∑–∞–∫–æ–Ω—ã —Ñ–∏–∑–∏–∫–∏ –∏ —Ö–∏–º–∏–∏, –∞ –ª–∏—à—å —ç–∫—Å—Ç—Ä–∞–ø–æ–ª–∏—Ä—É—é—Ç —É–∂–µ –∏–∑–≤–µ—Å—Ç–Ω—ã–µ –ø—Ä–∏–º–µ—Ä—ã, –ø–æ–∫–∞–∑–∞–ª–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –ë–∞–∑–µ–ª—å—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞, –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω–Ω–æ–µ –≤ Nature Communications. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q9LHM #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-11-05T06:03:06+00:00,@medpharm,13404,https://t.me/medpharm/13404,–í –ú–∏–Ω–∑–¥—Ä–∞–≤–µ –†–§ –Ω–∞–∑–≤–∞–ª–∏ –¥–æ–ª—é —Ç—Ä–µ–±—É—é—â–µ–≥–æ –∑–∞–º–µ–Ω—ã –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –≤ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—è—Ö —Ä–µ–≥–∏–æ–Ω–æ–≤. –ë–æ–ª—å—à–µ 10 –ª–µ—Ç —ç–∫—Å–ø–ª—É–∞—Ç–∏—Ä—É–µ—Ç—Å—è –ø–æ—á—Ç–∏ —á–µ—Ç–≤–µ—Ä—Ç—å –∏–º–µ—é—â–µ–π—Å—è –º–µ–¥—Ç–µ—Ö–Ω–∏–∫–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q9FKk #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,hospital_policy,pharmacovigilance"",
  ""impact"": ""medium"",
  ""english"": ""The Russian Ministry of Health named the share of medical equipment requiring replacement in regional hospitals. Almost a quarter of existing medical equipment has been in use for over 10 years.""
}"
2025-11-04T09:04:08+00:00,@medpharm,13403,https://t.me/medpharm/13403,"–ú–æ—Å–∫–≤–∞ –∏ –ü–µ–∫–∏–Ω –Ω–∞–º–µ—Ä–µ–Ω—ã —Ä–∞–∑–≤–∏–≤–∞—Ç—å —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–æ –≤ —Å—Ñ–µ—Ä–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –í —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, —Å—Ç–æ—Ä–æ–Ω—ã –≤—ã—Ä–∞–∑–∏–ª–∏ –≥–æ—Ç–æ–≤–Ω–æ—Å—Ç—å —Å–æ–≤–º–µ—Å—Ç–Ω–æ –¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å –Ω–∞ –º–Ω–æ–≥–æ—Å—Ç–æ—Ä–æ–Ω–Ω–∏—Ö –ø–ª–æ—â–∞–¥–∫–∞—Ö. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q8ZRK #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-11-03T13:39:05+00:00,@medpharm,13402,https://t.me/medpharm/13402,–í –°–µ–≤–µ—Ä–Ω–æ–π –û—Å–µ—Ç–∏–∏ –Ω–∞–∑–Ω–∞—á–µ–Ω –Ω–æ–≤—ã–π –∏.–æ. –º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –ó–∞–Ω–∏–º–∞–≤—à–∏–π —ç—Ç–æ—Ç –ø–æ—Å—Ç —Å 2022 –≥–æ–¥–∞ –°–æ—Å–ª–∞–Ω –¢–µ–±–∏–µ–≤ –ø–µ—Ä–µ—à–µ–ª –Ω–∞ —Ä–∞–±–æ—Ç—É –≤ –∞–ø–ø–∞—Ä–∞—Ç –≥–ª–∞–≤—ã —Ä–µ—Å–ø—É–±–ª–∏–∫–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q7zyP #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-11-03T10:56:05+00:00,@medpharm,13401,https://t.me/medpharm/13401,"¬´–£ —á–∞—Å—Ç–Ω–æ–≥–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ —Ü–µ–Ω—Ç—Ä–∞ –∏–º–µ–µ—Ç—Å—è —Å–∞–π—Ç, –∞ —Ç–∞–∫–∂–µ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏–µ, –ø–æ—Å—Ä–µ–¥—Å—Ç–≤–æ–º –∫–æ—Ç–æ—Ä—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç—ã –º–æ–≥—É—Ç –∑–∞–ø–∏—Å–∞—Ç—å—Å—è –Ω–∞ –ø—Ä–∏–µ–º –∫ –≤—Ä–∞—á—É, –∞ —Ç–∞–∫–∂–µ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞—Ç—å –ª–∏—á–Ω—ã–π –∫–∞–±–∏–Ω–µ—Ç. –ß—Ç–æ –¥–æ–ª–∂–Ω–æ –±—ã—Ç—å —Ä–∞–∑–º–µ—â–µ–Ω–æ –Ω–∞ —É–∫–∞–∑–∞–Ω–Ω—ã—Ö —Ä–µ—Å—É—Ä—Å–∞—Ö: —Å–æ–≥–ª–∞—Å–∏–µ –Ω–∞ –æ–±—Ä–∞–±–æ—Ç–∫—É –ø–µ—Ä—Å–æ–Ω–∞–ª—å–Ω—ã—Ö –¥–∞–Ω–Ω—ã—Ö, –ø–æ–ª–∏—Ç–∏–∫–∞ –∫–æ–Ω—Ñ–∏–¥–µ–Ω—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–∏ –ø–µ—Ä—Å–æ–Ω–∞–ª—å–Ω—ã—Ö –¥–∞–Ω–Ω—ã—Ö –∏–ª–∏ –æ–±–∞ —ç—Ç–∏—Ö –¥–æ–∫—É–º–µ–Ω—Ç–∞?¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q7s3m #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-11-03T08:50:06+00:00,@medpharm,13400,https://t.me/medpharm/13400,–í –†–æ—Å—Å–∏–∏ –º–æ–∂–µ—Ç –ø–æ—è–≤–∏—Ç—å—Å—è –æ—Ç–¥–µ–ª—å–Ω—ã–π –∫–∞–ª–µ–Ω–¥–∞—Ä—å –ø—Ä–∏–≤–∏–≤–æ–∫ –¥–ª—è –ø–æ–∂–∏–ª—ã—Ö –ª—é–¥–µ–π. –≠—Ç—É –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤—É –æ–±—Å—É–∂–¥–∞—é—Ç –≤ –ì–æ—Å–¥—É–º–µ –†–§. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q7kn9 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–ò–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã–µ_–±–æ–ª–µ–∑–Ω–∏ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders,clinical_trial,hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""There is a proposal in the Russian State Duma to create an individual vaccination schedule for elderly people. This initiative is being discussed.""
}"
2025-11-03T07:32:06+00:00,@medpharm,13399,https://t.me/medpharm/13399,–¢–æ–±–æ–ª—å—Å–∫–∞—è –±–æ–ª—å–Ω–∏—Ü–∞ —Å—ç–∫–æ–Ω–æ–º–∏–ª–∞ –ø–æ—á—Ç–∏ 600 —Ç—ã—Å. —Ä—É–±. –Ω–∞ —Ä–∞–∑–¥–µ–ª—å–Ω–æ–º —Å–±–æ—Ä–µ –æ—Ç—Ö–æ–¥–æ–≤. –ü—Ä–æ–µ–∫—Ç –ø–æ–ª—É—á–∏–ª —Å—Ç–∞—Ç—É—Å —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –æ–±—Ä–∞–∑—Ü–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q7h4j #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-11-02T13:32:01+00:00,@medpharm,13398,https://t.me/medpharm/13398,"üëçüëçüëçüëçüëçüëç –ü—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º TOP5 —Å–æ–±—ã—Ç–∏–π –Ω–µ–¥–µ–ª–∏ –§–∞—Ä–º—Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –Ω–∞–ø—Ä–∞–≤–∏–ª–∏ –≤ –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§ –∫–æ–ª–ª–µ–∫—Ç–∏–≤–Ω—É—é –∂–∞–ª–æ–±—É –ø–æ –ø–æ–≤–æ–¥—É —Å–ª–æ–∂–Ω–æ—Å—Ç–µ–π –ø—Ä–∏ –ø—Ä–æ—Ö–æ–∂–¥–µ–Ω–∏–∏ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–π –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–∏. –¢–µ–º –≤—Ä–µ–º–µ–Ω–µ–º –§–ê–¶ –Ω–µ –ø—Ä–∏–∑–Ω–∞–ª –ø—Ä–æ–±–ª–µ–º —Å –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–µ–π —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤. –ò–∑–º–µ–Ω–µ–Ω–∏—è –≤ –ü—Ä–∞–≤–∏–ª–∞ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –∏ —ç–∫—Å–ø–µ—Ä—Ç–∏–∑—ã –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è, –∫–æ—Ç–æ—Ä—ã–µ —Ç–∞–∫ –∂–¥–∞–ª–∞ —Ñ–∞—Ä–º–∏–Ω–¥—É—Å—Ç—Ä–∏—è, –≤—Å—Ç—É–ø—è—Ç –≤ —Å–∏–ª—É —Å 7 –Ω–æ—è–±—Ä—è —ç—Ç–æ–≥–æ –≥–æ–¥–∞. –í —Ä–µ–π—Ç–∏–Ω–≥ –†–ë–ö-500 –≤–æ—à–ª–∏ 23 —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏. –°—Ä–µ–¥–∏ –Ω–∏—Ö 15 –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π, –ø—è—Ç—å —Ñ–∞—Ä–º–¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–æ–≤ –∏ —Ç—Ä–∏ –∞–ø—Ç–µ—á–Ω—ã–µ —Å–µ—Ç–∏. –° 2026 –≥–æ–¥–∞ –≤—Å–µ –∞–ø—Ç–µ–∫–∏ –¥–æ–ª–∂–Ω—ã –±—É–¥—É—Ç –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å —Å–µ—Ä—Ç–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –º–æ–¥—É–ª–∏ –ø—Ä–æ–≤–µ—Ä–∫–∏ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –æ —Ç–æ–≤–∞—Ä–µ ‚Äî –¢–° –ü–ò–æ–¢. –í —Ä–µ–µ—Å—Ç—Ä–µ ¬´–ß–µ—Å—Ç–Ω–æ–≥–æ –∑–Ω–∞–∫–∞¬ª —Å–µ–π—á–∞—Å —á–∏—Å–ª–∏—Ç—Å—è –ª–∏—à—å –æ–¥–∏–Ω –ø–æ—Å—Ç–∞–≤—â–∏–∫, —á—å–µ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏–µ —Å–æ–≤–º–µ—Å—Ç–∏–º–æ —Å –ö–ö–¢ –¥–≤—É—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π. ¬´–°–µ–≤–µ—Ä–Ω–∞—è –∑–≤–µ–∑–¥–∞¬ª –æ–±–Ω–∞—Ä—É–∂–∏–ª–∞, —á—Ç–æ –ø–æ–¥—Ä—è–¥—á–∏–∫ —Ñ–∞–∫—Ç–∏—á–µ—Å–∫–∏ –Ω–µ –ø—Ä–æ–≤–µ–ª —á–∞—Å—Ç—å –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–π –ø–æ –ø—Ä–æ–¥–≤–∏–∂–µ–Ω–∏—é –ª–µ–∫–∞—Ä—Å—Ç–≤. –°—É–¥ –æ–±—è–∑–∞–ª –æ—Ç–≤–µ—Ç—á–∏–∫–∞ –≤–µ—Ä–Ω—É—Ç—å 51 –º–ª–Ω —Ä—É–±.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""The pharmaceutical industry has been waiting for changes in the Rules of Registration and Expertise of Medicinal Products for Medical Use, which will come into force on November 7th. The top 500 companies in Russia include 15 pharmaceutical manufacturers, five distributors and three hospital networks. Starting from 2026, all pharmacies must use certified modules for checking information about goods - TSPiToT. Only one supplier is listed in the 'Fair Deal' registry, whose equipment is compatible with two manufacturers' software. 'Northern Star' discovered that the contractor did not actually carry out part of the activities to promote medicines. The court ordered the defendant to return 51 million rubles.""
}"
2025-11-02T09:08:01+00:00,@medpharm,13397,https://t.me/medpharm/13397,"üß©üß©üß©üß©üß©üß© TOP5: –≥–ª–∞–≤–Ω—ã–µ —Å–æ–±—ã—Ç–∏—è –Ω–µ–¥–µ–ª–∏ –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–µ–Ω–Ω—ã–π –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ–± –æ—Ç—Ä–∞–±–æ—Ç–∫–∞—Ö –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∫–æ–ª–ª–µ–¥–∂–µ–π –∏ –≤—É–∑–æ–≤ –ø—Ä–∏–Ω—è—Ç –Ω–∞ —ç—Ç–æ–π –Ω–µ–¥–µ–ª–µ –ì–æ—Å–¥—É–º–æ–π –†–§ –≤–æ –≤—Ç–æ—Ä–æ–º —á—Ç–µ–Ω–∏–∏. –í—Å–µ–≥–æ –≤ –¥–æ–∫—É–º–µ–Ω—Ç –±—ã–ª–æ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–æ 46 –ø–æ–ø—Ä–∞–≤–æ–∫, 29 –∏–∑ –∫–æ—Ç–æ—Ä—ã—Ö –æ—Ç–∫–ª–æ–Ω–µ–Ω–æ. –ù–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ –≤ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω–æ–º TOP5 –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–µ –ú–∏–Ω—Ç—Ä—É–¥–∞ –†–§ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–∏—Ç—å —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã–º –º–∏–Ω–∑–¥—Ä–∞–≤–∞–º –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –∫–æ–æ—Ä–¥–∏–Ω–∏—Ä–æ–≤–∞—Ç—å –≤—Ä–µ–º–µ–Ω–Ω—ã–π –ø–µ—Ä–µ–≤–æ–¥ –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –º–µ–∂–¥—É –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è–º–∏ –≤ —Å—É–±—ä–µ–∫—Ç–∞—Ö. –≠—Ç–æ —Ä–µ—à–µ–Ω–∏–µ –ø–æ–º–æ–∂–µ—Ç —É–ª—É—á—à–∏—Ç—å –¥–æ—Å—Ç—É–ø –∫ –∫–≤–∞–ª–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω—ã–º —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞–º –¥–ª—è –∂–∏—Ç–µ–ª–µ–π –æ—Ç–¥–∞–ª–µ–Ω–Ω—ã—Ö —Ä–∞–π–æ–Ω–æ–≤, —Å—á–∏—Ç–∞—é—Ç –≤ –≤–µ–¥–æ–º—Å—Ç–≤–µ. –¢—Ä–µ—Ç—å—é —Å—Ç—Ä–æ—á–∫—É –Ω–æ–≤–æ—Å—Ç–Ω–æ–≥–æ —Ä–µ–π—Ç–∏–Ω–≥–∞ –Ω–µ–¥–µ–ª–∏ –∑–∞–Ω—è–ª–æ –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏–µ –§–ê–¶ –æ —Ç–æ–º, —á—Ç–æ –∏–∑-–∑–∞ –∫—Ä–∞—Ç–Ω–æ–≥–æ —É–≤–µ–ª–∏—á–µ–Ω–∏—è —á–∏—Å–ª–∞ –∑–≤–æ–Ω–∫–æ–≤ –≤—Ä–µ–º—è –æ–∂–∏–¥–∞–Ω–∏—è –æ—Ç–≤–µ—Ç–∞ –æ–ø–µ—Ä–∞—Ç–æ—Ä–∞ –º–æ–∂–µ—Ç –∑–∞–Ω–∏–º–∞—Ç—å –¥–æ 30 –º–∏–Ω—É—Ç. –¢–∞–∫–∏–º –æ–±—Ä–∞–∑–æ–º, –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª–∏—Å—å –æ–ø–∞—Å–µ–Ω–∏—è —ç–∫—Å–ø–µ—Ä—Ç–æ–≤. –ù–∞ —á–µ—Ç–≤–µ—Ä—Ç–æ–º –º–µ—Å—Ç–µ –≤ TOP5 –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è –æ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–Ω—ã—Ö –ø—Ä–æ—Ñ—Å–æ—é–∑–æ–º —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –†–§ –ø–æ–¥—Ä–æ–±–Ω—ã—Ö –º–µ—Ç–æ–¥–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏—è—Ö –ø–æ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—é —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ–π –æ—Ü–µ–Ω–∫–∏ —É—Å–ª–æ–≤–∏–π —Ç—Ä—É–¥–∞ –æ—Ç–¥–µ–ª—å–Ω—ã—Ö –∫–∞—Ç–µ–≥–æ—Ä–∏–π —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤, –ø–æ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º –∫–æ—Ç–æ—Ä–æ–π –æ–Ω–∏ –º–æ–≥—É—Ç –ø—Ä–µ—Ç–µ–Ω–¥–æ–≤–∞—Ç—å –Ω–∞ –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–µ –≤—ã–ø–ª–∞—Ç—ã, –¥–Ω–∏ –æ—Ç–ø—É—Å–∫–∞ –∏ —Å–æ–∫—Ä–∞—â–µ–Ω–Ω–æ–µ —Ä–∞–±–æ—á–µ–µ –≤—Ä–µ–º—è. –í –°–ö–† –∑–∞—è–≤–∏–ª–∏, —á—Ç–æ –æ—Ç—Å—Ç—É–ø–ª–µ–Ω–∏–µ –æ—Ç –Ω–æ—Ä–º –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π —Å–ª—É–∂–∏—Ç –¥–ª—è —Å—É–¥–µ–±–Ω–æ-–º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —ç–∫—Å–ø–µ—Ä—Ç–æ–≤ –ø—Ä–∏ —Ä–∞—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–∏ —è—Ç—Ä–æ–≥–µ–Ω–Ω—ã—Ö –ø—Ä–µ—Å—Ç—É–ø–ª–µ–Ω–∏–π –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–º –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å—Å—Ç–≤–æ–º –≤–∏–Ω–æ–≤–Ω–æ—Å—Ç–∏ –æ–±–≤–∏–Ω—è–µ–º–æ–≥–æ –ø—Ä–∏ –¥–æ–∫–∞–∑–∞–Ω–Ω–æ–π –≤–∑–∞–∏–º–æ—Å–≤—è–∑–∏ –º–µ–∂–¥—É –¥–µ–π—Å—Ç–≤–∏—è–º–∏ –≤—Ä–∞—á–∞ –∏ –Ω–∞—Å—Ç—É–ø–ª–µ–Ω–∏–µ–º –Ω–µ–±–ª–∞–≥–æ–ø—Ä–∏—è—Ç–Ω—ã—Ö –ø–æ—Å–ª–µ–¥—Å—Ç–≤–∏–π –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–∞.","{""skip"": true}"
2025-11-01T16:29:01+00:00,@medpharm,13396,https://t.me/medpharm/13396,"ü¶æ –ö–∞—Ä–¥–∏–æ–ª–æ–≥–∞–º –ø—Ä–∏–≥–æ—Ç–æ–≤–∏—Ç—å—Å—è. –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –ø—Ä–æ–µ–∫—Ç—ã —Ç–∏–ø–æ–≤—ã—Ö –ø—Ä–æ–≥—Ä–∞–º–º –î–ü–û –µ—â–µ –ø–æ —à–µ—Å—Ç–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç—è–º. ü¶æ –í—ã–≥–æ–¥–∞ –∏–∑ –≤—ã–∑–æ–≤–∞. –≠—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–∞—è —Å–∏—Å—Ç–µ–º–∞ –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏—è –ø—Ä–∏–µ–º–∞ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –ø–æ–∑–≤–æ–ª—è–µ—Ç –±—ã—Å—Ç—Ä–æ –∑–∞–∫—Ä—ã–≤–∞—Ç—å –æ—Å–≤–æ–±–æ–¥–∏–≤—à–∏–µ—Å—è –∏–∑-–∑–∞ –æ—Ç–º–µ–Ω –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –æ–∫–Ω–∞. –ï–µ –≤–Ω–µ–¥—Ä–µ–Ω–∏–µ –Ω–µ —Ç—Ä–µ–±—É–µ—Ç –±–æ–ª—å—à–∏—Ö –∑–∞—Ç—Ä–∞—Ç. ‚ù§Ô∏è –ö—É–¥–∞ —É—Ö–æ–¥—è—Ç –ë–ê–î. –ê—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç –≤ –∞–ø—Ç–µ–∫–∞—Ö —Å–∫–æ–Ω—Ü–µ–Ω—Ç—Ä–∏—Ä–æ–≤–∞–ª—Å—è –Ω–∞ –∏–∑–≤–µ—Å—Ç–Ω—ã—Ö –±—Ä–µ–Ω–¥–∞—Ö, —Ç–æ–≥–¥–∞ –∫–∞–∫ –º–µ–Ω–µ–µ –ø–æ–ø—É–ª—è—Ä–Ω—ã–µ –ë–ê–î –ø–æ—Å—Ç–µ–ø–µ–Ω–Ω–æ –ø–µ—Ä–µ—Ö–æ–¥—è—Ç –≤ –æ–Ω–ª–∞–π–Ω. –í –∏—Ç–æ–≥–µ –±–æ–ª—å—à–∞—è —á–∞—Å—Ç—å –±–∏–æ–¥–æ–±–∞–≤–æ–∫ –ø—Ä–æ–¥–∞–µ—Ç—Å—è —á–µ—Ä–µ–∑ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å—ã, –æ—Ç–º–µ—á–∞—é—Ç –∞–Ω–∞–ª–∏—Ç–∏–∫–∏. ‚ù§Ô∏è –ü–æ–ø–∞–ª–∏ –ø–æ–¥ –±–ª–æ–∫. –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä –∑–∞ –ø—è—Ç—å –ª–µ—Ç –ø—Ä–æ–∞–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–ª –±–æ–ª–µ–µ 171 —Ç—ã—Å. —Å–∞–π—Ç–æ–≤, –ø—Ä–æ–≤–µ—Ä—è—è –∏—Ö –Ω–∞ –ø—Ä–µ–¥–º–µ—Ç –Ω–µ–∑–∞–∫–æ–Ω–Ω–æ–π —Ç–æ—Ä–≥–æ–≤–ª–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏. –°–∫–æ–ª—å–∫–æ —Ä–µ—Å—É—Ä—Å–æ–≤ –∑–∞–±–ª–æ–∫–∏—Ä–æ–≤–∞–ª–∏ –∏ –∫–∞–∫–æ–≤—ã –æ—Å–Ω–æ–≤–Ω—ã–µ –ø—Ä–∏—á–∏–Ω—ã –±–ª–æ–∫–∏—Ä–æ–≤–∫–∏?","{
  ""skip"": true,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance"",
  ""impact"": ""medium"",
  ""english"": ""The message discusses the development of project templates for Continuing Medical Education (CME) programs by Russia's Ministry of Health. It also mentions the decline in traditional B–êD sales and the increase in online purchases, as well as the actions of Roszdravnadzor to block illegal drug sales websites. The impact is considered medium as it involves regulatory actions and market access concerns.""
}"
2025-11-01T15:19:02+00:00,@medpharm,13395,https://t.me/medpharm/13395,–ö–æ–ª–ª–µ–≥–∏—è –ï–≠–ö —É—Ç–≤–µ—Ä–¥–∏–ª–∞ –ø—Ä–∞–≤–∏–ª–∞ –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏—è –º–µ–∂–¥—É —Å—Ç—Ä–∞–Ω–∞–º–∏ —Å–æ—é–∑–∞ –ø–æ –º–∞—Ä–∫–∏—Ä–æ–≤–∞–Ω–Ω—ã–º —Ç–æ–≤–∞—Ä–∞–º. –î–æ–∫—É–º–µ–Ω—Ç —É—Å—Ç–∞–Ω–∞–≤–ª–∏–≤–∞–µ—Ç —Å—Ä–æ–∫ –ø–µ—Ä–µ—Ö–æ–¥–Ω–æ–≥–æ –ø–µ—Ä–∏–æ–¥–∞ –¥–ª—è –ø–æ–¥–∫–ª—é—á–µ–Ω–∏—è —Å–∏—Å—Ç–µ–º —Å—Ç—Ä–∞–Ω –ï–ê–≠–° –∫ –æ–±—â–µ–π –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q6d7H #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{""skip"": true}"
2025-11-01T15:14:04+00:00,@medpharm,13394,https://t.me/medpharm/13394,"–í –≤–µ–π–ø–∞—Ö, –∏–∑—ä—è—Ç—ã—Ö —É –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏—Ö —à–∫–æ–ª—å–Ω–∏–∫–æ–≤, –Ω–∞—à–ª–∏ –Ω–∏–∫–æ—Ç–∏–Ω, —Å–ø–∏—Ä—Ç –∏ –¥–∞–∂–µ —Å–ª–µ–¥—ã –±–∞–∫—Ç–µ—Ä–∏–π –∏ —Ñ–µ–∫–∞–ª—å–Ω—ã—Ö –∑–∞–≥—Ä—è–∑–Ω–µ–Ω–∏–π. –£ –≤–µ–π–ø–µ—Ä–æ–≤ —Ñ–∏–∑–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–π –≤–æ–∑—Ä–∞—Å—Ç –º–æ–∂–µ—Ç –±—ã—Ç—å –∑–∞–º–µ—Ç–Ω–æ —Å—Ç–∞—Ä—à–µ —Ä–µ–∞–ª—å–Ω–æ–≥–æ, –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–∞—é—Ç —É—á–µ–Ω—ã–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q6csp #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-11-01T14:44:02+00:00,@medpharm,13393,https://t.me/medpharm/13393,"–ö–∏—Ç–∞–π—Å–∫–∏–π —Ä–µ–≥—É–ª—è—Ç–æ—Ä –æ–¥–æ–±—Ä–∏–ª –ø–µ—Ä–≤—ã–π –≤ –º–∏—Ä–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç, –∫–æ—Ç–æ—Ä—ã–π –Ω–∞—Ö–æ–¥–∏—Ç —Ä–∞–∫–æ–≤—ã–µ –∫–ª–µ—Ç–∫–∏ –ø–æ —Å–ø–µ—Ü–∏—Ñ–∏—á–µ—Å–∫–æ–º—É –º–∞—Ä–∫–µ—Ä—É (EGFR) –∏ —É–Ω–∏—á—Ç–æ–∂–∞–µ—Ç –∏—Ö –∏–∑–Ω—É—Ç—Ä–∏. –ò–º –±—É–¥—É—Ç –ª–µ—á–∏—Ç—å –æ–¥–Ω—É –∏–∑ —Å–∞–º—ã—Ö —Å–ª–æ–∂–Ω—ã—Ö –≤–∏–¥–æ–≤ –æ–ø—É—Ö–æ–ª–µ–π, –∫–æ—Ç–æ—Ä–∞—è –æ—Å–æ–±–µ–Ω–Ω–æ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–∞ –≤ –ê–∑–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q6bTW #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-11-01T14:19:03+00:00,@medpharm,13392,https://t.me/medpharm/13392,"–†–µ–≥—É–ª—è—Ç–æ—Ä —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –ø—Ä–æ–µ–∫—Ç—ã –µ—â–µ —à–µ—Å—Ç–∏ —Ç–∏–ø–æ–≤—ã—Ö –ø—Ä–æ–≥—Ä–∞–º–º –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–≥–æ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è ‚Äî –ø–æ –¥–µ—Ä–º–∞—Ç–æ–≤–µ–Ω–µ—Ä–æ–ª–æ–≥–∏–∏, –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∏ –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–º—É –∑–¥–æ—Ä–æ–≤—å—é, —É–ø—Ä–∞–≤–ª–µ–Ω–∏—é –∏ —ç–∫–æ–Ω–æ–º–∏–∫–µ —Ñ–∞—Ä–º–∞—Ü–∏–∏, –ª–µ—á–µ–±–Ω–æ–º—É –¥–µ–ª—É, –ø—É–ª—å–º–æ–Ω–æ–ª–æ–≥–∏–∏ –∏ –∫–∞—Ä–¥–∏–æ–ª–æ–≥–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q6aAh #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–û–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-11-01T14:14:03+00:00,@medpharm,13391,https://t.me/medpharm/13391,"–†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä –∑–∞ –ø—è—Ç—å –ª–µ—Ç –ø—Ä–æ–∞–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–ª –±–æ–ª–µ–µ 171 —Ç—ã—Å. —Å–∞–π—Ç–æ–≤, –ø—Ä–æ–≤–µ—Ä—è—è –∏—Ö –Ω–∞ –ø—Ä–µ–¥–º–µ—Ç –Ω–µ–∑–∞–∫–æ–Ω–Ω–æ–π —Ç–æ—Ä–≥–æ–≤–ª–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏. –û—Å–Ω–æ–≤–Ω—ã–µ –ø—Ä–∏—á–∏–Ω—ã –±–ª–æ–∫–∏—Ä–æ–≤–∫–∏ ‚Äî –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–µ –ª–∏—Ü–µ–Ω–∑–∏–π –∏ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–µ –∑–∞–ø—Ä–µ—â–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –°–∫–æ–ª—å–∫–æ —Ä–µ—Å—É—Ä—Å–æ–≤ –∑–∞–±–ª–æ–∫–∏—Ä–æ–≤–∞–ª–∏? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q6Zny #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{""skip"": true}"
2025-11-01T13:28:03+00:00,@medpharm,13390,https://t.me/medpharm/13390,–°—Ä–æ–∫ –¥–µ–π—Å—Ç–≤–∏—è –ø–∏–ª–æ—Ç–Ω–æ–≥–æ –ø—Ä–æ–µ–∫—Ç–∞ –ø–æ –∫–æ–º–ø–ª–µ–∫—Å–Ω–æ–π —Ä–µ–∞–±–∏–ª–∏—Ç–∞—Ü–∏–∏ –∏ –∞–±–∏–ª–∏—Ç–∞—Ü–∏–∏ –¥–µ—Ç–µ–π-–∏–Ω–≤–∞–ª–∏–¥–æ–≤ –∏–∑–º–µ–Ω–∏—Ç—Å—è. –¢–∞–∫–∂–µ –≤–Ω–µ—Å–µ–Ω—ã –∫–æ—Ä—Ä–µ–∫—Ç–∏—Ä–æ–≤–∫–∏ –≤ –ø–µ—Ä–µ—á–µ–Ω—å —Ä–µ–≥–∏–æ–Ω–æ–≤-—É—á–∞—Å—Ç–Ω–∏–∫–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q6X4y #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-11-01T13:22:03+00:00,@medpharm,13389,https://t.me/medpharm/13389,"–ê—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç –≤ –∞–ø—Ç–µ–∫–∞—Ö —Å–∫–æ–Ω—Ü–µ–Ω—Ç—Ä–∏—Ä–æ–≤–∞–ª—Å—è –Ω–∞ –∏–∑–≤–µ—Å—Ç–Ω—ã—Ö –±—Ä–µ–Ω–¥–∞—Ö, —Ç–æ–≥–¥–∞ –∫–∞–∫ –º–µ–Ω–µ–µ –ø–æ–ø—É–ª—è—Ä–Ω—ã–µ –ë–ê–î –ø–æ—Å—Ç–µ–ø–µ–Ω–Ω–æ –ø–µ—Ä–µ—Ö–æ–¥—è—Ç –≤ –æ–Ω–ª–∞–π–Ω. –í –∏—Ç–æ–≥–µ –±–æ–ª—å—à–∞—è —á–∞—Å—Ç—å –±–∏–æ–¥–æ–±–∞–≤–æ–∫ –ø—Ä–æ–¥–∞–µ—Ç—Å—è —á–µ—Ä–µ–∑ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å—ã, –æ—Ç–º–µ—á–∞—é—Ç –∞–Ω–∞–ª–∏—Ç–∏–∫–∏. –í–æ–∑–Ω–∏–∫–∞–µ—Ç –ø—Ä–æ–±–ª–µ–º–∞: –ø—Ä–∏ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–∏ –ë–ê–î –Ω–∞ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞—Ö –∏—Ö –ø—Ä–æ–¥–∞–∂–∏ —Å—Ç—Ä–µ–º—è—Ç—Å—è –∫ –Ω—É–ª—é, –∞ –µ—Å–ª–∏ —Ç–æ–≤–∞—Ä –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω –Ω–∞ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞—Ö, –∞–ø—Ç–µ—á–Ω—ã–µ —Å–µ—Ç–∏ —á–∞—Å—Ç–æ –Ω–µ –≤–∫–ª—é—á–∞—é—Ç –µ–≥–æ –≤ —Å–≤–æ–π –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç. –ü–æ—á–µ–º—É —Ç–∞–∫ –ø—Ä–æ–∏—Å—Ö–æ–¥–∏—Ç? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q6WgZ #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The supply of dietary supplements in pharmacies is concentrated on well-known brands, while less popular ones are gradually moving to online channels. As a result, most of the dietary supplements are sold through marketplaces. There is a problem: when popular supplements are not available on marketplaces, their sales tend to zero. And if the product is listed on marketplaces but not included in pharmacies' assortments, sales are low. Why does this happen? For more details: https://clck.ru/3Q6WgZ #PharmNews #Retail""
}"
2025-11-01T12:23:05+00:00,@medpharm,13388,https://t.me/medpharm/13388,–ü—Ä–æ–∫—É—Ä–∞—Ç—É—Ä–∞ –≤–Ω–æ–≤—å –≤—ã—è–≤–∏–ª–∞ –Ω–∞—Ä—É—à–µ–Ω–∏—è –ø—Ä–∏ —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–µ –∫—Ä–∞–µ–≤–æ–π –¥–µ—Ç—Å–∫–æ–π –±–æ–ª—å–Ω–∏—Ü—ã –≤ –ß–∏—Ç–µ. –í–æ–∑–±—É–∂–¥–µ–Ω—ã —É–≥–æ–ª–æ–≤–Ω—ã–µ –¥–µ–ª–∞ –æ –º–æ—à–µ–Ω–Ω–∏—á–µ—Å—Ç–≤–µ –∏ –ø—Ä–µ–≤—ã—à–µ–Ω–∏–∏ –¥–æ–ª–∂–Ω–æ—Å—Ç–Ω—ã—Ö –ø–æ–ª–Ω–æ–º–æ—á–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q6Ssr #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-11-01T12:07:03+00:00,@medpharm,13387,https://t.me/medpharm/13387,–ö–æ–ª–ª–µ–≥–∏—è –ï–≠–ö –∏ –ï–≤—Ä–æ–ø–µ–π—Å–∫–æ–µ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω–æ–µ –±—é—Ä–æ –í–û–ó –±—É–¥—É—Ç —Å–æ–≤–º–µ—Å—Ç–Ω–æ —Ä–∞–±–æ—Ç–∞—Ç—å –Ω–∞–¥ —Ä–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω–∏–µ–º –æ–±—Ä–∞—â–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –º–µ–¥–∏–∑–¥–µ–ª–∏–π. –ü–ª–∞–Ω –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–π –Ω–∞ 2026‚Äî2028 –≥–æ–¥—ã –ø–æ–¥–≥–æ—Ç–æ–≤–∏–ª–∞ –ö–æ–ª–ª–µ–≥–∏—è –ï–≠–ö. –ß—Ç–æ –≤ –Ω–µ–≥–æ –≤—Ö–æ–¥–∏—Ç? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q6RnM #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The Expert Committee of the Eurasional Commission and the European Regional Office of WHO will jointly work on the regulation of drug and medical device transactions. The Expert Committee's plans for 2026-2028 have been prepared. What does it include? For more details: https://clck.ru/3Q6RnM #PharmNews #Regulation""
}"
2025-11-01T11:23:03+00:00,@medpharm,13386,https://t.me/medpharm/13386,–†–ñ–î –ø—Ä–æ–∏–Ω–¥–µ–∫—Å–∏—Ä—É–µ—Ç –∑–∞—Ä–ø–ª–∞—Ç—ã —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–∞–º –∫–æ–º–ø–∞–Ω–∏–∏ –∫ –∫–æ–Ω—Ü—É –≥–æ–¥–∞. –û–∫–ª–∞–¥—ã –ø–æ–¥–Ω–∏–º—É—Ç –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º —Ä–∞–±–æ—Ç–Ω–∏–∫–∞–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q6Nu3 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-11-01T11:10:07+00:00,@medpharm,13385,https://t.me/medpharm/13385,"–ò—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è —Ä—ã–Ω–∫–∞ —Ç—Ä—É–¥–∞ –ø–æ–∫–∞–∑—ã–≤–∞—é—Ç, —á—Ç–æ —Ü–µ–Ω–∞ –æ—à–∏–±–∫–∏ –≤ –Ω–∞–π–º–µ –º–æ–∂–µ—Ç –±—ã—Ç—å –æ—á–µ–Ω—å –≤—ã—Å–æ–∫–æ–π. –ù–µ–∫–æ—Ç–æ—Ä—ã–µ —Å—á–∏—Ç–∞—é—Ç, —á—Ç–æ —Å—Ç–æ–∏–º–æ—Å—Ç—å –Ω–µ—É–¥–∞—á–Ω–æ–≥–æ –Ω–∞–π–º–∞ —Ä–∞–≤–Ω–∞ –ø–æ—Ç—Ä–∞—á–µ–Ω–Ω–æ–º—É –Ω–∞ –ø–æ–∏—Å–∫ –±—é–¥–∂–µ—Ç. –ù–æ –ø–æ—Å–ª–µ–¥—Å—Ç–≤–∏—è –º–Ω–æ–≥–æ–∫—Ä–∞—Ç–Ω–æ –¥–æ—Ä–æ–∂–µ. –í —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–º —Å–µ–∫—Ç–æ—Ä–µ —ç—Ç–∞ –ø—Ä–æ–±–ª–µ–º–∞ –æ—Å–æ–±–µ–Ω–Ω–æ –∞–∫—Ç—É–∞–ª—å–Ω–∞ –∏–∑-–∑–∞ –≤—ã—Å–æ–∫–æ–π –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏–∏ –∑–∞ –∫–≤–∞–ª–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –∫–∞–¥—Ä—ã –∏ —Å–ø–µ—Ü–∏—Ñ–∏–∫–∏ –æ—Ç—Ä–∞—Å–ª–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q6N95 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–∞—Ä—å–µ—Ä–∞","{""skip"": true}"
2025-11-01T10:14:03+00:00,@medpharm,13384,https://t.me/medpharm/13384,"–§–∏–ª–∏–ø–ø–∏–Ω—Å–∫–∞—è –ø–∞—Ä–∞ –æ—Å–ø–∞—Ä–∏–≤–∞–µ—Ç –≤ –ö–æ–Ω—Å—Ç–∏—Ç—É—Ü–∏–æ–Ω–Ω–æ–º —Å—É–¥–µ –†–§ –∑–∞–ø—Ä–µ—Ç –Ω–∞ —Å—É—Ä—Ä–æ–≥–∞—Ç–Ω–æ–µ –º–∞—Ç–µ—Ä–∏–Ω—Å—Ç–≤–æ —Å –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ–º –¥–æ–Ω–æ—Ä—Å–∫–∏—Ö —è–π—Ü–µ–∫–ª–µ—Ç–æ–∫. –ó–∞—è–≤–∏—Ç–µ–ª–∏ —É—Ç–≤–µ—Ä–∂–¥–∞—é—Ç, —á—Ç–æ —Ä–æ—Å—Å–∏–π—Å–∫–æ–µ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–æ –Ω–∞—Ä—É—à–∞–µ—Ç –∏—Ö –ø—Ä–∞–≤–∞ –Ω–∞ —Å–µ–º—å—é –∏ –≤–æ—Å–ø–∏—Ç–∞–Ω–∏–µ –¥–µ—Ç–µ–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q6JbP #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-11-01T09:04:02+00:00,@medpharm,13383,https://t.me/medpharm/13383,1 –Ω–æ—è–±—Ä—è —Å—Ç–∞—Ä—Ç–æ–≤–∞–ª I —ç—Ç–∞–ø –≥–æ–ª–æ—Å–æ–≤–∞–Ω–∏—è XXVI –í—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –æ—Ç–∫—Ä—ã—Ç–æ–≥–æ –∫–æ–Ω–∫—É—Ä—Å–∞ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª–æ–≤ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –æ—Ç—Ä–∞—Å–ª–∏ ¬´–ü–ª–∞—Ç–∏–Ω–æ–≤–∞—è —É–Ω—Ü–∏—è¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q6Dj4 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-11-01T08:56:04+00:00,@medpharm,13382,https://t.me/medpharm/13382,–ì–ª–∞–≤–∞ –§–ú–ë–ê –í–µ—Ä–æ–Ω–∏–∫–∞ –°–∫–≤–æ—Ä—Ü–æ–≤–∞ –æ—Ç–º–µ—á–∞–µ—Ç 1 –Ω–æ—è–±—Ä—è —é–±–∏–ª–µ–π. –ü–æ–∑–¥—Ä–∞–≤–ª–µ–Ω–∏—è –ø–æ —ç—Ç–æ–º—É —Å–ª—É—á–∞—é –æ–ø—É–±–ª–∏–∫–æ–≤–∞–ª –∫–æ–ª–ª–µ–∫—Ç–∏–≤ –∞–≥–µ–Ω—Ç—Å—Ç–≤–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q6DAd #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-11-01T08:35:03+00:00,@medpharm,13380,https://t.me/medpharm/13380,"–ï—â–µ –æ–¥–Ω–∞ —Å—Ç—Ä–∞–Ω–∞ –ø—Ä–æ—è–≤–∏–ª–∞ –≤—ã—Å–æ–∫–∏–π –∏–Ω—Ç–µ—Ä–µ—Å –∫ —Ä–æ—Å—Å–∏–π—Å–∫–∏–º –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º –∏ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—è–º –¥–ª—è –ª–µ—á–µ–Ω–∏—è, –æ—Ç–º–µ—Ç–∏–ª –ø–æ –∏—Ç–æ–≥–∞–º –≤–∏–∑–∏—Ç–∞ –≤ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–æ –≥–ª–∞–≤–∞ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–§ –ú–∏—Ö–∞–∏–ª –ú—É—Ä–∞—à–∫–æ. –°—Ç–æ—Ä–æ–Ω—ã –æ–±—Å—É–¥–∏–ª–∏ —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–æ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q6BrS #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The head of the Russian Ministry of Health, Mikhail Murashko, noted that another country showed high interest in Russian medicines and treatment technologies. The sides discussed cooperation. For more details: https://clck.ru/3Q6BrS #PharmNews #Regulation""
}"
2025-11-01T08:17:04+00:00,@medpharm,13379,https://t.me/medpharm/13379,"–§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–º –∫–æ–º–ø–∞–Ω–∏—è–º –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –Ω–æ–≤—ã–µ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ –¥–ª—è –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏—è —Å –≤—Ä–∞—á–∞–º–∏ –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∞–º–∏ ‚Äî –¥–æ—Å—Ç–æ–≤–µ—Ä–Ω—ã–π, –ø–µ—Ä—Å–æ–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã–π –∏ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏ –∫–æ–Ω—Ç—Ä–æ–ª–∏—Ä—É–µ–º—ã–π –∫–æ–Ω—Ç–µ–Ω—Ç —Ñ–æ—Ä–º–∏—Ä—É–µ—Ç—Å—è –≤ —Ü–∏—Ñ—Ä–æ–≤–æ–π —ç–∫–æ—Å–∏—Å—Ç–µ–º–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q6Abw #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-11-01T07:38:03+00:00,@medpharm,13378,https://t.me/medpharm/13378,Pfizer –ø—ã—Ç–∞–ª–∞—Å—å –ø—Ä–∏–æ–±—Ä–µ—Å—Ç–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–∞ –∑–Ω–∞—á–∏–º—ã—Ö –¥–ª—è –∫–æ–º–ø–∞–Ω–∏–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ù–æ –ø–ª–∞–Ω–∞–º –ø–æ–º–µ—à–∞–ª–∞ Novo Nordisk. –î–≤–∞ —Ñ–∞—Ä–º–≥–∏–≥–∞–Ω—Ç–∞ —É—Å—Ç—Ä–æ–∏–ª–∏ –Ω–µ–≥–ª–∞—Å–Ω—ã–π –∞—É–∫—Ü–∏–æ–Ω. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q686b #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-11-01T05:59:04+00:00,@medpharm,13377,https://t.me/medpharm/13377,–ü—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º —Ä–µ–π—Ç–∏–Ω–≥ –Ω–æ–≤–æ—Å—Ç–µ–π –ø—Ä–æ—à–µ–¥—à–µ–≥–æ –º–µ—Å—è—Ü–∞ –¥–ª—è –æ—Ä–≥–∞–Ω–∏–∑–∞—Ç–æ—Ä–æ–≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –≤ –ø—É–±–ª–∏–∫–∞—Ü–∏—è—Ö –ª–µ–Ω—Ç—ã –Ω–æ–≤–æ—Å—Ç–µ–π ¬´–ú–í¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q62VP #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-10-31T16:57:05+00:00,@medpharm,13376,https://t.me/medpharm/13376,–ù–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–º —Ä—ã–Ω–∫–µ —Å—Ç–æ–ª–∏—Ü—ã –≥—Ä—è–¥–µ—Ç –∫—Ä—É–ø–Ω–æ–µ —Å–ª–∏—è–Ω–∏–µ - –ï–ú–° –∏ ¬´–°–µ–º–µ–π–Ω—ã–π –¥–æ–∫—Ç–æ—Ä¬ª –ø–ª–∞–Ω–∏—Ä—É—é—Ç –æ–±—ä–µ–¥–∏–Ω–∏—Ç—å —É—Å–∏–ª–∏—è –≤ –ø–æ—Å—Ç—Ä–æ–µ–Ω–∏–∏ –º–Ω–æ–≥–æ–ø—Ä–æ—Ñ–∏–ª—å–Ω–æ–≥–æ –º—É–ª—å—Ç–∏—Å–µ–≥–º–µ–Ω—Ç–Ω–æ–≥–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –±–∏–∑–Ω–µ—Å–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q5k6p #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-10-31T16:46:56+00:00,@medpharm,13375,https://t.me/medpharm/13375,"ü¶æ –ù–µ —É—á–ª–∏ –≤–∞–∂–Ω–æ–≥–æ. –¢–µ–∫—É—â–∞—è —Ä–µ–¥–∞–∫—Ü–∏—è –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç–∞ –æ–± –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã—Ö –æ—Ç—Ä–∞–±–æ—Ç–∫–∞—Ö –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –≤—É–∑–æ–≤ –∏ –∫–æ–ª–ª–µ–¥–∂–µ–π –Ω–µ —Å–æ–¥–µ—Ä–∂–∏—Ç –Ω–æ—Ä–º –æ–± –æ—Ç—Å—Ä–æ—á–∫–∞—Ö –ø–æ –∏—Å–ø–æ–ª–Ω–µ–Ω–∏—é –æ–±—è–∑–∞—Ç–µ–ª—å—Å—Ç–≤ –ø—Ä–∏ –Ω–∞—Å—Ç—É–ø–ª–µ–Ω–∏–∏ –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏ –∏–ª–∏ –∏–∑-–∑–∞ –æ—Ç–ø—É—Å–∫–∞ –ø–æ —É—Ö–æ–¥—É –∑–∞ —Ä–µ–±–µ–Ω–∫–æ–º. –ü–æ–∫–∞ –Ω–µ–ø–æ–Ω—è—Ç–Ω–æ, –∫–∞–∫ –±—É–¥—É—Ç —É—Ä–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω—ã —ç—Ç–∏ –≤–æ–ø—Ä–æ—Å—ã. ü¶æ –ù–æ–≤–∞—è –º–µ—Ç–ª–∞. –ü–æ—Å–ª–µ –Ω–∞–∑–Ω–∞—á–µ–Ω–∏—è –Ω–æ–≤–æ–≥–æ –º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –¢–∞—Ç–∞—Ä—Å—Ç–∞–Ω–∞ —Å –¥–æ–ª–∂–Ω–æ—Å—Ç–µ–π —É—à–ª–∏ —Ç—Ä–∏ –∑–∞–º–º–∏–Ω–∏—Å—Ç—Ä–∞. ‚ù§Ô∏è –£–≥—Ä–æ–∑–∞ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏. –ú–æ–±–∏–ª—å–Ω—ã–µ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏—è –æ–Ω–ª–∞–π–Ω-–∞–ø—Ç–µ–∫ –∏–º–µ—é—Ç –¥–µ—Ñ–µ–∫—Ç—ã, –ø–æ–∫–∞–∑–∞–ª–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –†–æ—Å–∫–∞—á–µ—Å—Ç–≤–∞ –∏ –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–°–æ–ª–∞—Ä¬ª. –í —Ö–æ–¥–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –≤—ã–¥–µ–ª–µ–Ω–æ –ø—è—Ç—å –æ—Å–Ω–æ–≤–Ω—ã—Ö —Ç–∏–ø–æ–≤ —É—è–∑–≤–∏–º–æ—Å—Ç–µ–π. ‚ù§Ô∏è –° –ø–æ–ø—Ä–∞–≤–∫–æ–π –Ω–∞ —Ñ–∞—Ä–º—É. –ö–æ –≤—Ç–æ—Ä–æ–º—É —á—Ç–µ–Ω–∏—é –≤ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ–± –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–º —Ü–µ–ª–µ–≤–æ–º –æ–±—É—á–µ–Ω–∏–∏ –∏ –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–µ –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–µ–π –±—ã–ª–æ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–æ 46 –ø–æ–ø—Ä–∞–≤–æ–∫, 17 –∏–∑ –∫–æ—Ç–æ—Ä—ã—Ö –±—ã–ª–æ –ø—Ä–∏–Ω—è—Ç–æ –∏ 29 –æ—Ç–∫–ª–æ–Ω–µ–Ω–æ. –ü–æ–ø—Ä–∞–≤–∫–∏ —Ç–µ–ø–µ—Ä—å —É—á–∏—Ç—ã–≤–∞—é—Ç –æ—Å–æ–±–µ–Ω–Ω–æ—Å—Ç–∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è.","{
  ""skip"": false,
  ""country"": ""Ukraine"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance"",
  ""impact"": ""medium"",
  ""english"": ""The current draft of the law on mandatory graduation exams for medical and college graduates does not include provisions regarding postponements due to pregnancy or leave for childcare. It is unclear how these issues will be addressed. The mobile pharmacy apps have vulnerabilities, as identified by the Roskonsalt and Solar companies during a study. In the second reading of the law on mandatory targeted training for graduates of medical and pharmaceutical specialties, 46 amendments were proposed, with 17 accepted and 29 rejected. The amendments now take into account the characteristics of pharmaceutical education.""
}"
2025-10-31T15:29:07+00:00,@medpharm,13374,https://t.me/medpharm/13374,"–£–§–û-—Ç–µ—Ä–∞–ø–∏—è –≤ —á–∞—Å—Ç–Ω–æ–π —Å—Ç–æ–ª–∏—á–Ω–æ–π –∫–ª–∏–Ω–∏–∫–µ –ø—Ä–∏–≤–µ–ª–∞ –∫ –æ–∂–æ–≥–∞–º, –∏ –ø–∞—Ü–∏–µ–Ω—Ç–∫–∞ –ø–æ–ª—É—á–∏–ª–∞ –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏—é. –°—É–¥–µ–±–Ω–æ-–º–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è —ç–∫—Å–ø–µ—Ä—Ç–∏–∑–∞ –≤—ã—è–≤–∏–ª–∞, —á—Ç–æ –¥–∏–∞–≥–Ω–æ–∑ –±—ã–ª –ø–æ—Å—Ç–∞–≤–ª–µ–Ω –Ω–µ–≤–µ—Ä–Ω–æ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q5fAK #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety"",
  ""impact"": ""medium"",
  ""english"": ""A patient received compensation after burns occurred at a private Moscow clinic's treatment. A medical expert review revealed the diagnosis was incorrect. For more details: https://clck.ru/3Q5fAK #MedVestnik #Healthcare #Other""
}"
2025-10-31T15:13:03+00:00,@medpharm,13373,https://t.me/medpharm/13373,"–û—Ç –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–∏—Ö –≤–∏–∑–∏—Ç–æ–≤ –≤ —Ä–∞–º–∫–∞—Ö –ª–∏—Ü–µ–Ω–∑–∏–æ–Ω–Ω–æ–≥–æ –∫–æ–Ω—Ç—Ä–æ–ª—è –ø–æ –¥–µ–∑–∏–Ω—Ñ–µ–∫—Ü–∏–∏ –Ω–µ–ª—å–∑—è –±—É–¥–µ—Ç –æ—Ç–∫–∞–∑–∞—Ç—å—Å—è, —Ç–∞–∫–∏–µ –ø–æ–ø—Ä–∞–≤–∫–∏ —É—Ç–≤–µ—Ä–¥–∏–ª–æ –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§. –ü—Ä–æ–≤–µ—Ä–∫–∏ —Ç–µ–ø–µ—Ä—å –±—É–¥—É—Ç –ø—Ä–æ–≤–æ–¥–∏—Ç—å —á–µ—Ä–µ–∑ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏–µ ¬´–ò–Ω—Å–ø–µ–∫—Ç–æ—Ä¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q5eCZ #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""sanctions"",
  ""impact"": ""medium"",
  ""english"": ""The government of Russia has approved changes that prevent refusal of preventive inspections under licensing control for disinfection. Inspections will now be conducted through the 'Inspector' app. For more details, see https://clck.ru/3Q5eCZ.""
}"
2025-10-31T14:47:09+00:00,@medpharm,13372,https://t.me/medpharm/13372,–ì–µ–æ—Å–µ—Ä–≤–∏—Å—ã –∏ –∞–≥—Ä–µ–≥–∞—Ç–æ—Ä—ã –æ—Ç–∑—ã–≤–æ–≤ –º–æ–≥—É—Ç —Å—Ç–∞—Ç—å –∞–ª—å—Ç–µ—Ä–Ω–∞—Ç–∏–≤–æ–π —Å–∞–π—Ç–∞ –¥–ª—è —á–∞—Å—Ç–Ω—ã—Ö –∫–ª–∏–Ω–∏–∫ –∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ –ø—Ä–∏–≤–ª–µ–∫–∞—Ç—å –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –î–ª—è –º–æ—Å–∫–æ–≤—Å–∫–æ–π —Å–µ—Ç–∏ —Å—Ç–æ–º–∞—Ç–æ–ª–æ–≥–∏–π DentalWay —Å–∞–º—ã–º–∏ –≤—ã–≥–æ–¥–Ω—ã–º–∏ –ø–ª–æ—â–∞–¥–∫–∞–º–∏ —Å—Ç–∞–ª–∏ ¬´–Ø–Ω–¥–µ–∫—Å.–ö–∞—Ä—Ç—ã¬ª –∏ ¬´–ü—Ä–æ–î–æ–∫—Ç–æ—Ä–æ–≤¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q5cYg #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-10-31T13:52:02+00:00,@medpharm,13371,https://t.me/medpharm/13371,"–ß–µ–ª–æ–≤–µ–∫ –ø–æ—Ç–µ—Ä—è–ª –∫–æ–Ω—Ç—Ä–æ–ª—å –Ω–∞–¥ —Å–≤–æ–∏–º–∏ —Å–æ–≥–ª–∞—Å–∏—è–º–∏ –Ω–∞ –æ–±—Ä–∞–±–æ—Ç–∫—É –ø–µ—Ä—Å–æ–Ω–∞–ª—å–Ω—ã—Ö –¥–∞–Ω–Ω—ã—Ö, —Å—á–∏—Ç–∞–µ—Ç –≥–ª–∞–≤–∞ –†–æ—Å–∫–æ–º–Ω–∞–¥–∑–æ—Ä–∞ –ê–Ω–¥—Ä–µ–π –õ–∏–ø–æ–≤. –†–µ—à–µ–Ω–∏–µ –ø—Ä–æ–±–ª–µ–º—ã –æ–Ω –≤–∏–¥–∏—Ç –≤ –ø–æ–ª–Ω–æ–º –æ—Ç–∫–∞–∑–µ –æ—Ç —ç—Ç–æ–π —Å–∏—Å—Ç–µ–º—ã. –ß—Ç–æ –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç –†–ö–ù –≤–∑–∞–º–µ–Ω? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q5YXZ #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{""skip"": true}"
2025-10-31T13:43:06+00:00,@medpharm,13370,https://t.me/medpharm/13370,"–¢–µ–∫—É—â–∞—è —Ä–µ–¥–∞–∫—Ü–∏—è –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç–∞ –æ–± –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã—Ö –æ—Ç—Ä–∞–±–æ—Ç–∫–∞—Ö –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –≤—É–∑–æ–≤ –∏ –∫–æ–ª–ª–µ–¥–∂–µ–π –Ω–µ —Å–æ–¥–µ—Ä–∂–∏—Ç –Ω–æ—Ä–º –æ–± –æ—Ç—Å—Ä–æ—á–∫–∞—Ö –ø–æ –∏—Å–ø–æ–ª–Ω–µ–Ω–∏—é –æ–±—è–∑–∞—Ç–µ–ª—å—Å—Ç–≤ –ø—Ä–∏ –Ω–∞—Å—Ç—É–ø–ª–µ–Ω–∏–∏ –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏ –∏–ª–∏ –∏–∑-–∑–∞ –æ—Ç–ø—É—Å–∫–∞ –ø–æ —É—Ö–æ–¥—É –∑–∞ —Ä–µ–±–µ–Ω–∫–æ–º. –ü–æ–∫–∞ –Ω–µ–ø–æ–Ω—è—Ç–Ω–æ, –∫–∞–∫ –±—É–¥—É—Ç —É—Ä–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω—ã —ç—Ç–∏ –≤–æ–ø—Ä–æ—Å—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q5Y2T #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–û–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-10-31T12:54:06+00:00,@medpharm,13369,https://t.me/medpharm/13369,–ü–æ—Å–ª–µ –Ω–∞–∑–Ω–∞—á–µ–Ω–∏—è –Ω–æ–≤–æ–≥–æ –º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –¢–∞—Ç–∞—Ä—Å—Ç–∞–Ω–∞ —Å –¥–æ–ª–∂–Ω–æ—Å—Ç–µ–π —É—à–ª–∏ —Ç—Ä–∏ –∑–∞–º–º–∏–Ω–∏—Å—Ç—Ä–∞. –û–Ω–∏ –ø—Ä–∏—à–ª–∏ —Ä–∞–±–æ—Ç–∞—Ç—å –≤ –≤–µ–¥–æ–º—Å—Ç–≤–æ –ø—Ä–∏ –ø—Ä–æ—à–ª–æ–º –≥–ª–∞–≤–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q5Uku #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-10-31T12:36:02+00:00,@medpharm,13368,https://t.me/medpharm/13368,"–ú–æ–±–∏–ª—å–Ω—ã–µ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏—è –æ–Ω–ª–∞–π–Ω-–∞–ø—Ç–µ–∫ –∏–º–µ—é—Ç –¥–µ—Ñ–µ–∫—Ç—ã, –ø–æ–∫–∞–∑–∞–ª–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –†–æ—Å–∫–∞—á–µ—Å—Ç–≤–∞ –∏ –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–°–æ–ª–∞—Ä¬ª. –í —Ö–æ–¥–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –≤—ã–¥–µ–ª–µ–Ω–æ –ø—è—Ç—å –æ—Å–Ω–æ–≤–Ω—ã—Ö —Ç–∏–ø–æ–≤ —É—è–∑–≤–∏–º–æ—Å—Ç–µ–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q5TZX #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{""skip"": false, ""country"": ""Russia"", ""topic"": ""regulation, registration, reimbursement"", ""impact"": ""medium"", ""english"": ""A research by Roskonsel and Solar company has identified five main types of vulnerabilities in online pharmacy mobile apps. More details: https://clck.ru/3Q5TZX #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞""}"
2025-10-31T11:28:05+00:00,@medpharm,13367,https://t.me/medpharm/13367,–í –ü–µ—Ä–º–∏ –ø—Ä–æ–∫—É—Ä–∞—Ç—É—Ä–∞ –≤—ã—è–≤–∏–ª–∞ –Ω–∞—Ä—É—à–µ–Ω–∏—è —Å–∞–Ω–∏—Ç–∞—Ä–Ω—ã—Ö –Ω–æ—Ä–º –≤ –æ–¥–Ω–æ–π –∏–∑ –±–æ–ª—å–Ω–∏—Ü. –†–µ–º–æ–Ω—Ç –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—è –∑–∞–ø–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω –Ω–∞ 2026 –≥–æ–¥. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q5P2y #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": true
}"
2025-10-31T11:00:08+00:00,@medpharm,13366,https://t.me/medpharm/13366,"Eli Lilly –æ—Ç—á–∏—Ç–∞–ª–∞—Å—å –æ –≤—ã—Ä—É—á–∫–µ –≤ 17,6 –º–ª—Ä–¥ –¥–æ–ª–ª. –∑–∞ III –∫–≤–∞—Ä—Ç–∞–ª 2025 –≥–æ–¥–∞ ( 54% –≥–æ–¥ –∫ –≥–æ–¥—É) –∏ —á–∏—Å—Ç–æ–π –ø—Ä–∏–±—ã–ª–∏ –≤ 5,6 –º–ª—Ä–¥ –¥–æ–ª–ª. ( 475%). –†–µ–∑–∫–∏–π —Ä–æ—Å—Ç –ø–æ–∫–∞–∑–∞—Ç–µ–ª–µ–π –æ–±–µ—Å–ø–µ—á–∏–ª–∏ –ø—Ä–æ–¥–∞–∂–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –æ—Ç –¥–∏–∞–±–µ—Ç–∞ –∏ –æ–∂–∏—Ä–µ–Ω–∏—è –Ω–∞ –æ—Å–Ω–æ–≤–µ —Ç–∏—Ä–∑–µ–ø–∞—Ç–∏–¥–∞ ‚Äî Mounjaro (6,5 –º–ª—Ä–¥ –¥–æ–ª–ª., 109%) –∏ Zepbound (3,6 –º–ª—Ä–¥ –¥–æ–ª–ª., 185%). –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q5Lzh #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-31T09:41:04+00:00,@medpharm,13365,https://t.me/medpharm/13365,–ù–∞ –¥–æ–æ—Å–Ω–∞—â–µ–Ω–∏–µ –æ–±–ª–∞—Å—Ç–Ω–æ–≥–æ –ø–µ—Ä–∏–Ω–∞—Ç–∞–ª—å–Ω–æ–≥–æ —Ü–µ–Ω—Ç—Ä–∞ –≤ –ö—É—Ä—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–æ –±–æ–ª–µ–µ 320 –º–ª–Ω —Ä—É–±. –°—Ä–µ–¥—Å—Ç–≤–∞ –∏–∑ —Ä–µ–∑–µ—Ä–≤–Ω–æ–≥–æ —Ñ–æ–Ω–¥–∞ –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –†–§ –ø–æ–π–¥—É—Ç –Ω–∞ –ø–æ–∫—É–ø–∫—É 150 –µ–¥–∏–Ω–∏—Ü –º–µ–¥–æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q5FDJ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-10-31T09:29:03+00:00,@medpharm,13364,https://t.me/medpharm/13364,"–ó–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ–± –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–º —Ü–µ–ª–µ–≤–æ–º –æ–±—É—á–µ–Ω–∏–∏ –∏ –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–µ –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–µ–π –ø—Ä–∏–Ω—è—Ç –≤–æ –≤—Ç–æ—Ä–æ–º —á—Ç–µ–Ω–∏–∏. –°–æ–≥–ª–∞—Å–Ω–æ –ø—Ä–∏–Ω—è—Ç—ã–º –ø–æ–ø—Ä–∞–≤–∫–∞–º, –ø–µ—Ä–µ—á–µ–Ω—å —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–µ–π –∏ —Å—Ä–æ–∫–æ–≤ –¥–ª—è –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–∞ –æ–ø—Ä–µ–¥–µ–ª–∏—Ç –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q5EPp #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""A law project on mandatory target training and mentoring of medical and pharmaceutical graduates has passed the second reading. According to the adopted amendments, the list of specialties and training periods for mentoring will be determined by the Ministry of Health of Russia. For more details: https://clck.ru/3Q5EPp #PharmNews #Regulatio""
}"
2025-10-31T08:37:06+00:00,@medpharm,13363,https://t.me/medpharm/13363,"–õ–µ—á–µ–Ω–∏–µ –∏–Ω–≥–∏–±–∏—Ç–æ—Ä–∞–º–∏ —è–Ω—É—Å-–∫–∏–Ω–∞–∑—ã (JAK) –Ω–µ –±—ã–ª–æ —Å–≤—è–∑–∞–Ω–æ —Å –Ω–∞—Ä—É—à–µ–Ω–∏–µ–º —Ä–æ—Å—Ç–∞ —É –¥–µ—Ç–µ–π —Å —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–∏–º–∏ –≤–æ—Å–ø–∞–ª–∏—Ç–µ–ª—å–Ω—ã–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏. –≠—Ç–æ –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª–∞ –≤—ã–±–æ—Ä–∫–∞ –∏–∑ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –∞—Ç–æ–ø–∏—á–µ—Å–∫–∏–º –¥–µ—Ä–º–∞—Ç–∏—Ç–æ–º, —é–≤–µ–Ω–∏–ª—å–Ω—ã–º –∏–¥–∏–æ–ø–∞—Ç–∏—á–µ—Å–∫–∏–º –∞—Ä—Ç—Ä–∏—Ç–æ–º –∏ –≤–æ—Å–ø–∞–ª–∏—Ç–µ–ª—å–Ω—ã–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏ –∫–∏—à–µ—á–Ω–∏–∫–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q5ATZ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ü–µ–¥–∏–∞—Ç—Ä–∏—è #–†–µ–≤–º–∞—Ç–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance"",
  ""impact"": ""medium"",
  ""english"": ""The treatment with JAK inhibitors was not associated with growth impairment in children with chronic inflammatory diseases. This was confirmed by a sample of patients with atopic dermatitis, juvenile idiopathic arthritis, and inflammatory bowel diseases. More details: https://clck.ru/3Q5ATZ #Mednews #Practice #Pediatrics #Rheumatology #Therapy #Pharmacology""
}"
2025-10-31T07:50:02+00:00,@medpharm,13362,https://t.me/medpharm/13362,"–ú–∏–Ω–∏—Å—Ç—Ä –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –°–®–ê –ø—Ä–∏–∑–Ω–∞–ª, —á—Ç–æ —Å–µ–≥–æ–¥–Ω—è –Ω–µ—Ç –¥–æ—Å—Ç–∞—Ç–æ—á–Ω—ã—Ö –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å—Å—Ç–≤ —Å–≤—è–∑–∏ –º–µ–∂–¥—É –ø—Ä–∏–µ–º–æ–º –ø–∞—Ä–∞—Ü–µ—Ç–∞–º–æ–ª–∞ –±–µ—Ä–µ–º–µ–Ω–Ω—ã–º–∏ –∏ —Ä–∞–∑–≤–∏—Ç–∏–µ–º –∞—É—Ç–∏–∑–º–∞ —É –¥–µ—Ç–µ–π. –í—Å–µ –∂–µ –æ–Ω –ø—Ä–∏–∑–≤–∞–ª –∫ –æ—Å—Ç–æ—Ä–æ–∂–Ω–æ—Å—Ç–∏ –ø—Ä–∏ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q56Z2 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-31T07:32:07+00:00,@medpharm,13361,https://t.me/medpharm/13361,"–í —Å—Ç–æ–ª–∏—Ü–µ –ø–ª–∞–Ω–∏—Ä—É—é—Ç —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–æ –Ω–æ–≤–æ–≥–æ –∫–æ—Ä–ø—É—Å–∞ –ì–ö–ë ‚Ññ 67 –∏–º. –õ.–ê. –í–æ—Ä–æ—Ö–æ–±–æ–≤–∞ –Ω–∞ —É–ª–∏—Ü–µ –°–∞–ª—è–º–∞ –ê–¥–∏–ª—è. –ü—Ä–æ–µ–∫—Ç —Å—Ç–æ–∏–º–æ—Å—Ç—å—é 26,9 –º–ª—Ä–¥ —Ä—É–±. –≤–∫–ª—é—á–∞–µ—Ç –º–Ω–æ–≥–æ–ø—Ä–æ—Ñ–∏–ª—å–Ω—ã–π —Ü–µ–Ω—Ç—Ä —Ö–∏—Ä—É—Ä–≥–∏—á–µ—Å–∫–æ–π –ø–æ–º–æ—â–∏ –ø—Ä–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è—Ö –ø–æ–∑–≤–æ–Ω–æ—á–Ω–∏–∫–∞ –∏ —Ç—Ä–µ–±—É–µ—Ç –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏—è –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –º–∞—Ç–µ—Ä–∏–∞–ª–æ–≤ –∏ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q55Sh #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-10-31T06:19:06+00:00,@medpharm,13360,https://t.me/medpharm/13360,"–û–¥–Ω–∞ —Ç–∞–±–ª–µ—Ç–∫–∞, —Å–æ–¥–µ—Ä–∂–∞—â–∞—è –Ω–∏–∑–∫–∏–µ –¥–æ–∑—ã —Ç—Ä–µ—Ö –∞–Ω—Ç–∏–≥–∏–ø–µ—Ä—Ç–µ–Ω–∑–∏–≤–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ —Å–Ω–∏–∑–∏–ª–∞ —á–∞—Å—Ç–æ—Ç—É –ø–æ–≤—Ç–æ—Ä–Ω—ã—Ö –∏–Ω—Å—É–ª—å—Ç–æ–≤ —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –ø–µ—Ä–µ–Ω–µ—Å–µ–Ω–Ω—ã–º –≤–Ω—É—Ç—Ä–∏–º–æ–∑–≥–æ–≤—ã–º –∫—Ä–æ–≤–æ–∏–∑–ª–∏—è–Ω–∏–µ–º. –õ–µ—á–µ–Ω–∏–µ –æ–∫–∞–∑–∞–ª–æ—Å—å –±–µ–∑–æ–ø–∞—Å–Ω—ã–º –∏ —Ö–æ—Ä–æ—à–æ –ø–µ—Ä–µ–Ω–æ—Å–∏–º—ã–º, –∞ –ø–æ–±–æ—á–Ω—ã–µ —ç—Ñ—Ñ–µ–∫—Ç—ã ‚Äî –º–∏–Ω–∏–º–∞–ª—å–Ω—ã–º–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q4yM4 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ù–µ–≤—Ä–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-10-31T06:04:03+00:00,@medpharm,13359,https://t.me/medpharm/13359,"–°—É—Ö–æ—Å—Ç—å –∫–æ–∂–∏ ‚Äî –æ–¥–∏–Ω –∏–∑ –≤–µ–¥—É—â–∏—Ö —Å–∏–º–ø—Ç–æ–º–æ–≤ –∞—Ç–æ–ø–∏—á–µ—Å–∫–æ–≥–æ –¥–µ—Ä–º–∞—Ç–∏—Ç–∞, —ç–∫–∑–µ–º—ã –∏ –¥—Ä—É–≥–∏—Ö –∫–æ–∂–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –£–≤–ª–∞–∂–Ω–µ–Ω–∏–µ –∫–æ–∂–∏ ‚Äî –≤–∞–∂–Ω–∞—è –∑–∞–¥–∞—á–∞ –≤ –ª–µ—á–µ–Ω–∏–∏ –±–æ–ª–µ–∑–Ω–µ–π, –ø–æ—ç—Ç–æ–º—É –Ω–∞—Ä—è–¥—É —Å –Ω–∞–∑–Ω–∞—á–µ–Ω–∏–µ–º —ç—Ç–∏–æ—Ç—Ä–æ–ø–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏, –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ –ø—Ä–∏–º–µ–Ω—è—Ç—å —Å–ø–µ—Ü–∏–∞–ª—å–Ω—ã–µ —Å—Ä–µ–¥—Å—Ç–≤–∞-—ç–º–æ–ª–µ–Ω—Ç—ã. –ö–∞–∫ –æ–Ω–∏ –¥–µ–π—Å—Ç–≤—É—é—Ç –∏ –∫–∞–∫ –ø–æ–º–æ—á—å –≤—ã–±—Ä–∞—Ç—å –æ–ø—Ç–∏–º–∞–ª—å–Ω—ã–π? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q4xWy #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–§–∞—Ä–º–∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä–æ–≤–∞–Ω–∏–µ","{""skip"": true}"
2025-10-30T16:41:17+00:00,@medpharm,13358,https://t.me/medpharm/13358,"ü¶æ –ó–∞–∫—Ä–æ—é—Ç –±—Ä–µ—à–∏. –†–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã–º –æ—Ä–≥–∞–Ω–∞–º –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–∏—Ç—å –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –∫–æ–æ—Ä–¥–∏–Ω–∏—Ä–æ–≤–∞—Ç—å –≤—Ä–µ–º–µ–Ω–Ω—ã–π –ø–µ—Ä–µ–≤–æ–¥ –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –≤ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—è –≤–Ω—É—Ç—Ä–∏ —Å—É–±—ä–µ–∫—Ç–∞. –¶–µ–ª—å –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤—ã ‚Äî —É–ª—É—á—à–µ–Ω–∏–µ –¥–æ—Å—Ç—É–ø–∞ –∫ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞–º –≤ –æ—Ç–¥–∞–ª–µ–Ω–Ω—ã—Ö —Ä–∞–π–æ–Ω–∞—Ö. ü¶æ –ï—Å—Ç—å —É—Å–ª–æ–≤–∏–µ. –†–µ–∂–∏–º –æ—Ç–ª–æ–∂–µ–Ω–Ω—ã—Ö —Ç–µ–ª–µ–º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∫–æ–Ω—Å—É–ª—å—Ç–∞—Ü–∏–π –Ω–µ –ø—Ä–µ–¥–ø–æ–ª–∞–≥–∞–µ—Ç –æ–±—â–µ–Ω–∏—è –≤—Ä–∞—á–∞ —Å –ø–∞—Ü–∏–µ–Ω—Ç–æ–º. –ë–µ–∑ –ø—Ä–µ–¥–≤–∞—Ä–∏—Ç–µ–ª—å–Ω–æ–≥–æ —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è –¥–∏–∞–≥–Ω–æ–∑–∞ –∏ –Ω–∞–∑–Ω–∞—á–µ–Ω–∏—è –ª–µ—á–µ–Ω–∏—è –Ω–∞ –æ—á–Ω–æ–º –ø—Ä–∏–µ–º–µ (–æ—Å–º–æ—Ç—Ä–µ, –∫–æ–Ω—Å—É–ª—å—Ç–∞—Ü–∏–∏) –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–µ –∑–∞–∫–ª—é—á–µ–Ω–∏–µ –∫–æ–Ω—Å—É–ª—å—Ç–∞–Ω—Ç–∞ –≤ —Ä–∞–º–∫–∞—Ö –¥–∏—Å—Ç–∞–Ω—Ü–∏–æ–Ω–Ω–æ–≥–æ –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏—è –º–æ–∂–µ—Ç —Å–æ–¥–µ—Ä–∂–∞—Ç—å —Ç–æ–ª—å–∫–æ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –æ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è –ø—Ä–µ–¥–≤–∞—Ä–∏—Ç–µ–ª—å–Ω—ã—Ö –æ–±—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π. ‚ù§Ô∏è –ü–æ–ª–µ–≥—á–µ. –ê–ª—å—è–Ω—Å —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–π –ø—Ä–æ—Å–∏—Ç –ø—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ—Ç—å —Å–ø–µ—Ü–∏–∞–ª—å–Ω—ã–µ —É—Å–ª–æ–≤–∏—è –¥–ª—è –º–∞–ª–æ–≥–æ –∏ —Å—Ä–µ–¥–Ω–µ–≥–æ –∞–ø—Ç–µ—á–Ω–æ–≥–æ –±–∏–∑–Ω–µ—Å–∞ –ø—Ä–∏ –ø–æ–≤—ã—à–µ–Ω–∏–∏ –ù–î–°. –£–≤–µ–ª–∏—á–µ–Ω–∏–µ —Ä–∞–∑–º–µ—Ä–∞ —Å—Ç–∞–≤–∫–∏ –º–æ–∂–µ—Ç –Ω–µ–≥–∞—Ç–∏–≤–Ω–æ –æ—Ç—Ä–∞–∑–∏—Ç—å—Å—è –Ω–∞ –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤. ‚ù§Ô∏è 23 –∏–∑ 500. –í —Ä–µ–π—Ç–∏–Ω–≥ –†–ë–ö ¬´500 –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö –∫–æ–º–ø–∞–Ω–∏–π –†–æ—Å—Å–∏–∏¬ª –≤–æ—à–ª–∏ 23 —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏, —Å—Ä–µ–¥–∏ –∫–æ—Ç–æ—Ä—ã—Ö 15 –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π, –ø—è—Ç—å —Ñ–∞—Ä–º–¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–µ—Ä–æ–≤ –∏ —Ç—Ä–∏ –∞–ø—Ç–µ—á–Ω—ã–µ —Å–µ—Ç–∏.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""The alliance of pharmaceutical associations is requesting special conditions for small and medium pharmacy businesses when increasing the VAT. The increase in the rate could negatively affect drug accessibility. 23 of Russia's top 500 companies are listed in the 'Top 500 Russian Companies' by RBC, including 15 manufacturers, five distributors and three pharmacy networks.""
}"
2025-10-30T15:53:03+00:00,@medpharm,13357,https://t.me/medpharm/13357,"–í —Ä–µ–π—Ç–∏–Ω–≥ –†–ë–ö ¬´500 –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö –∫–æ–º–ø–∞–Ω–∏–π –†–æ—Å—Å–∏–∏¬ª –≤–æ—à–ª–∏ 23 —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏, —Å—Ä–µ–¥–∏ –∫–æ—Ç–æ—Ä—ã—Ö 15 –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π, –ø—è—Ç—å —Ñ–∞—Ä–º–¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–µ—Ä–æ–≤ –∏ —Ç—Ä–∏ –∞–ø—Ç–µ—á–Ω—ã–µ —Å–µ—Ç–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q4bm7 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-30T15:32:02+00:00,@medpharm,13356,https://t.me/medpharm/13356,"Roche –∫—É–ø–∏–ª–∞ —É –∫–∏—Ç–∞–π—Å–∫–æ–π Qyuns Therapeutics –ø—Ä–∞–≤–∞ –Ω–∞ –±–∏—Å–ø–µ—Ü–∏—Ñ–∏—á–µ—Å–∫–æ–µ –∞–Ω—Ç–∏—Ç–µ–ª–æ QX031N –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Ä–µ—Å–ø–∏—Ä–∞—Ç–æ—Ä–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –∑–∞ 1,07 –º–ª—Ä–¥ –¥–æ–ª–ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q4aRr #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-30T14:59:06+00:00,@medpharm,13355,https://t.me/medpharm/13355,"–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–µ–Ω–Ω—ã–π –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ–± –æ—Ç—Ä–∞–±–æ—Ç–∫–∞—Ö –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∫–æ–ª–ª–µ–¥–∂–µ–π –∏ –≤—É–∑–æ–≤ –ø—Ä–∏–Ω—è—Ç –≤–æ –≤—Ç–æ—Ä–æ–º —á—Ç–µ–Ω–∏–∏. –ü—Ä–µ–¥–ª–æ–∂–µ–Ω–Ω—ã–µ –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤—ã –≤–≤–æ–¥—è—Ç –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–π —Ç—Ä–µ—Ö–ª–µ—Ç–Ω–∏–π –ø–µ—Ä–∏–æ–¥ –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–∞ –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤, –ø–æ–ª—É—á–∏–≤—à–∏—Ö –≤—ã—Å—à–µ–µ, —Å—Ä–µ–¥–Ω–µ–µ –∏ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–µ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ –≤ –∫–ª–∏–Ω–∏–∫–∞—Ö, –∫–æ—Ç–æ—Ä—ã–µ —Ä–∞–±–æ—Ç–∞—é—Ç –≤ —Å–∏—Å—Ç–µ–º–µ –û–ú–°. –û–≥—Ä–∞–Ω–∏—á–µ–Ω–∏—è –Ω–µ –∫–æ—Å–Ω—É—Ç—Å—è —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q4YQR #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–û–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-10-30T14:39:03+00:00,@medpharm,13354,https://t.me/medpharm/13354,"–í –ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–º –ù–ò–ò –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∑–¥–æ—Ä–æ–≤—å—è –∏–º. –ù.–ê. –°–µ–º–∞—à–∫–æ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∏ —Å–∏—Å—Ç–µ–º–Ω—ã–π –ø–æ–¥—Ö–æ–¥ –∫ –ø–æ–¥–≥–æ—Ç–æ–≤–∫–µ –∫–∞–¥—Ä–æ–≤ –¥–ª—è —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∏, –æ–±—Å—É–¥–∏–≤ –∏—Ç–æ–≥–∏ –æ–¥–∏–Ω–Ω–∞–¥—Ü–∞—Ç–æ–≥–æ –ª–∞–≥–µ—Ä—è –§–ò–õ–ò–ù. –ö–ª—é—á–µ–≤–æ–π —Ç–µ–º–æ–π –≤—Å—Ç—Ä–µ—á–∏ —Å—Ç–∞–ª–∏ –º–µ—Ö–∞–Ω–∏–∑–º—ã —Å–æ–∑–¥–∞–Ω–∏—è ¬´–∫–∞–¥—Ä–æ–≤–æ–≥–æ –ª–∏—Ñ—Ç–∞¬ª –¥–ª—è –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –Ω–∞—É—á–Ω–æ–≥–æ –∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ —Å—É–≤–µ—Ä–µ–Ω–∏—Ç–µ—Ç–∞ –†–æ—Å—Å–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q4XFo #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-30T13:34:07+00:00,@medpharm,13352,https://t.me/medpharm/13352,"–ö–∞–Ω–∞–¥—Å–∫–æ–µ –∫–∞—Ä–¥–∏–æ–≤–∞—Å–∫—É–ª—è—Ä–Ω–æ–µ –æ–±—â–µ—Å—Ç–≤–æ –æ–±–Ω–æ–≤–∏–ª–æ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø–æ –ª–µ—á–µ–Ω–∏—é —Å–µ—Ä–¥–µ—á–Ω–æ–π –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ—Å—Ç–∏ —Å —Å–æ—Ö—Ä–∞–Ω–µ–Ω–Ω–æ–π —Ñ—Ä–∞–∫—Ü–∏–µ–π –≤—ã–±—Ä–æ—Å–∞. –í –¥–æ–∫—É–º–µ–Ω—Ç–µ –ø–æ–¥—á–µ—Ä–∫–∏–≤–∞–µ—Ç—Å—è –≤–∞–∂–Ω–æ—Å—Ç—å –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –∏–Ω–≥–∏–±–∏—Ç–æ—Ä–æ–≤ SGLT2 –∏ –∞–Ω—Ç–∞–≥–æ–Ω–∏—Å—Ç–æ–≤ –º–∏–Ω–µ—Ä–∞–ª–æ–∫–æ—Ä—Ç–∏–∫–æ–∏–¥–Ω—ã—Ö —Ä–µ—Ü–µ–ø—Ç–æ—Ä–æ–≤, –∞ —Ç–∞–∫–∂–µ —Ä–∞—Å—Å–º–∞—Ç—Ä–∏–≤–∞–µ—Ç—Å—è –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω–∞—è –ø–æ–ª—å–∑–∞ –∏–Ω–≥–∏–±–∏—Ç–æ—Ä–æ–≤ —Ä–µ—Ü–µ–ø—Ç–æ—Ä–æ–≤ –∞–Ω–≥–∏–æ—Ç–µ–Ω–∑–∏–Ω–∞-–Ω–µ–ø—Ä–∏–ª–∏–∑–∏–Ω–∞ –∏ –∞–≥–æ–Ω–∏—Å—Ç–æ–≤ —Ä–µ—Ü–µ–ø—Ç–æ—Ä–æ–≤ –ì–ü–ü-1. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q4TEF #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ö–∞—Ä–¥–∏–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-10-30T12:32:05+00:00,@medpharm,13351,https://t.me/medpharm/13351,"–†–∞—Å—à–∏—Ä–µ–Ω —Å–ø–∏—Å–æ–∫ –º–∏–Ω–∏—Å—Ç–µ—Ä—Å—Ç–≤ –∏ –≤–µ–¥–æ–º—Å—Ç–≤, –∫–æ—Ç–æ—Ä—ã–µ —Å 2027 –≥–æ–¥–∞ –ø–µ—Ä–µ–π–¥—É—Ç –Ω–∞ —Ü–µ–Ω—Ç—Ä–∞–ª–∏–∑–æ–≤–∞–Ω–Ω—ã–µ –∑–∞–∫—É–ø–∫–∏. –í –∏—Ö —á–∏—Å–ª–µ –ú–∏–Ω–∑–¥—Ä–∞–≤, –ú–∏–Ω–ø—Ä–∏—Ä–æ–¥—ã, –ú–∏–Ω—Å–ø–æ—Ä—Ç, –ú–∏–Ω—ç–Ω–µ—Ä–≥–æ –∏ –¥—Ä. –≠—Ç–∞ –ø—Ä–∞–∫—Ç–∏–∫–∞ —É–ø—Ä–æ—â–∞–µ—Ç —Ç–µ–Ω–¥–µ—Ä—ã –∏ —Å–Ω–∏–∂–∞–µ—Ç –∑–∞—Ç—Ä–∞—Ç—ã –∑–∞ —Å—á–µ—Ç –æ–±—ä–µ–º–∞ –∑–∞–∫—É–ø–æ–∫. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q4NtA #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-10-30T12:03:03+00:00,@medpharm,13350,https://t.me/medpharm/13350,"FDA –≤—ã–ø—É—Å—Ç–∏–ª–æ –ø—Ä–æ–µ–∫—Ç —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–∞, –∫–æ—Ç–æ—Ä–æ–µ –≤–¥–≤–æ–µ —É—Å–∫–æ—Ä–∏—Ç –ø—Ä–æ—Ü–µ—Å—Å —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –±–∏–æ–∞–Ω–∞–ª–æ–≥–æ–≤ ‚Äî —Å –ø—è—Ç–∏-–≤–æ—Å—å–º–∏ –¥–æ –¥–≤—É—Ö-—á–µ—Ç—ã—Ä–µ—Ö –ª–µ—Ç. –ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–π —Ä–µ–≥—É–ª—è—Ç–æ—Ä –æ—Ç–º–µ–Ω–∏—Ç —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–µ –ø—Ä–æ–≤–æ–¥–∏—Ç—å –¥–æ—Ä–æ–≥–æ—Å—Ç–æ—è—â–∏–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –Ω–∞ –ª—é–¥—è—Ö. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q4Lm4 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{""skip"": true}"
2025-10-30T11:22:17+00:00,@medpharm,13349,https://t.me/medpharm/13349,"–í—ã—Ä—É—á–∫–∞ ¬´–ú–î –ú–µ–¥–∏–∫–∞–ª¬ª –∑–∞ III –∫–≤–∞—Ä—Ç–∞–ª —Ç–µ–∫—É—â–µ–≥–æ –≥–æ–¥–∞ –≤—ã—Ä–æ—Å–ª–∞ –Ω–∞ 40,3%, –ø—Ä–µ–≤—ã—Å–∏–≤ 11,5 –º–ª—Ä–¥ —Ä—É–±. –ó–∞ –¥–µ–≤—è—Ç—å –º–µ—Å—è—Ü–µ–≤ –ø–æ–∫–∞–∑–∞—Ç–µ–ª—å –≤—ã—Ä–æ—Å –Ω–∞ 28,4% –≥–æ–¥ –∫ –≥–æ–¥—É, –¥–æ 30,87 –º–ª—Ä–¥ —Ä—É–±. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q4J7G #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-10-30T10:31:06+00:00,@medpharm,13348,https://t.me/medpharm/13348,–†–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã–º –æ—Ä–≥–∞–Ω–∞–º –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–∏—Ç—å –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –∫–æ–æ—Ä–¥–∏–Ω–∏—Ä–æ–≤–∞—Ç—å –≤—Ä–µ–º–µ–Ω–Ω—ã–π –ø–µ—Ä–µ–≤–æ–¥ –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –≤ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—è –≤–Ω—É—Ç—Ä–∏ —Å—É–±—ä–µ–∫—Ç–∞. –¶–µ–ª—å –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤—ã ‚Äî —É–ª—É—á—à–µ–Ω–∏–µ –¥–æ—Å—Ç—É–ø–∞ –∫ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞–º –≤ –æ—Ç–¥–∞–ª–µ–Ω–Ω—ã—Ö —Ä–∞–π–æ–Ω–∞—Ö. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q4Eaj #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""Regional health authorities proposed providing the opportunity to coordinate temporary transfers of medical staff within a subject. The goal of the initiative is to improve access to specialists in remote areas. For more details: https://clck.ru/3Q4Eaj #MedVestnik #HealthCareOrganization""
}"
2025-10-30T10:23:03+00:00,@medpharm,13347,https://t.me/medpharm/13347,–£—Ç–≤–µ—Ä–∂–¥–µ–Ω–∞ –Ω–æ–≤–∞—è —Ñ–æ—Ä–º–∞ –∑–∞–∫–ª—é—á–µ–Ω–∏—è –æ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–∏ —Å–µ—Ä–∏–∏ –∏–ª–∏ –ø–∞—Ä—Ç–∏–∏ –∏–º–º—É–Ω–æ–±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è–º –≥–æ—Å—Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏. –ü—Ä–∏–∫–∞–∑ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–∞ —Ç–∞–∫–∂–µ –≤–∫–ª—é—á–∞–µ—Ç —Ñ–æ—Ä–º—ã –≤—ã–ø–∏—Å–∫–∏ –∏–∑ —Ä–µ–µ—Å—Ç—Ä–∞ —Ä–∞–∑—Ä–µ—à–µ–Ω–∏–π –∏ —É–≤–µ–¥–æ–º–ª–µ–Ω–∏—è –æ–± –æ—Ç–∫–∞–∑–µ –≤ –¥–æ–ø—É—Å–∫–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –≤ –æ–±–æ—Ä–æ—Ç. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q4E3R #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""registration, reimbursement"",
  ""impact"": ""high"",
  ""english"": ""A new declaration form for the compliance of a series or batch of immunobiological drug with registration requirements has been approved. The decision of the Russian Health Supervision also includes forms for issuing registry approval certificates and notifications rejecting a drug from circulation.""
}"
2025-10-30T09:26:04+00:00,@medpharm,13346,https://t.me/medpharm/13346,"–†–∞–∑–≤–∏—Ç–∏–µ —Ü–∏—Ñ—Ä–æ–≤—ã—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –≤ –º–µ–¥–∏—Ü–∏–Ω–µ –Ω–µ–∏–∑–±–µ–∂–Ω–æ —Å–æ–ø—Ä—è–∂–µ–Ω–æ —Å —Ä–∏—Å–∫–∞–º–∏ –∫–∏–±–µ—Ä–∞—Ç–∞–∫ –Ω–∞ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω—ã–µ —Å–µ—Ä–≤–∏—Å—ã –∫–ª–∏–Ω–∏–∫. –ü–æ –¥–∞–Ω–Ω—ã–º —ç–∫—Å–ø–µ—Ä—Ç–æ–≤, —Å –Ω–∞—á–∞–ª–∞ –≥–æ–¥–∞ –∫–∞–∂–¥–∞—è –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è –≤ —Å—Ä–µ–¥–Ω–µ–º –ø–æ–ø–∞–¥–∞–ª–∞ –ø–æ–¥ –ø—Ä–∏—Ü–µ–ª —Ö–∞–∫–µ—Ä–æ–≤ –±–æ–ª–µ–µ 3 –º–ª–Ω —Ä–∞–∑, –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –ø–æ–ø—ã—Ç–æ–∫ –≤–∑–ª–æ–º–∞ —Å–∏—Å—Ç–µ–º –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç —Ä–∞—Å—Ç–∏. –î–ª—è –ø—Ä–µ–¥–æ—Ç–≤—Ä–∞—â–µ–Ω–∏—è –Ω–µ–∂–µ–ª–∞—Ç–µ–ª—å–Ω—ã—Ö –∏–Ω—Ü–∏–¥–µ–Ω—Ç–æ–≤ –≤ —ç—Ç–æ–π —Å—Ñ–µ—Ä–µ —Å 2022 –≥–æ–¥–∞ —Ä–µ–≥—É–ª—è—Ç–æ—Ä—ã –ø–µ—Ä–µ—Å–º–æ—Ç—Ä–µ–ª–∏ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –∫–∏–±–µ—Ä–±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ –Ω–∞ –∑–Ω–∞—á–∏–º—ã—Ö –æ–±—ä–µ–∫—Ç–∞—Ö —ç–∫–æ–Ω–æ–º–∏–∫–∏, –≤–∫–ª—é—á–∞—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫—É—é –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä—É. ¬´–ú–í¬ª —Ä–∞–∑–æ–±—Ä–∞–ª—Å—è –≤ –¥–µ—Ç–∞–ª—è—Ö –¥–µ–π—Å—Ç–≤—É—é—â–∏—Ö –ø—Ä–∞–≤–∏–ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q4A8k #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""cybersecurity, regulation"",
  ""impact"": ""high"",
  ""english"": ""The regulatory authorities have revised cybersecurity requirements for significant economic objects, including healthcare infrastructure. Each medical organization is targeted by cyber attackers over 3 million times on average per year, and the number of hacking attempts continues to rise.""
}"
2025-10-30T08:58:03+00:00,@medpharm,13345,https://t.me/medpharm/13345,"–ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∞—è Thermo Fisher –ø–æ–∫—É–ø–∞–µ—Ç Clario ‚Äî —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–∞ –ü–û –¥–ª—è –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å–ø—ã—Ç–∞–Ω–∏–π ‚Äî –∑–∞ 8,9 –º–ª—Ä–¥ –¥–æ–ª–ª. –†–µ—à–µ–Ω–∏—è —ç—Ç–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–ª–∏—Å—å –¥–ª—è –æ—Ü–µ–Ω–∫–∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –∫–∞–∂–¥–æ–≥–æ —Å–µ–¥—å–º–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞, –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–Ω–æ–≥–æ –Ω–∞ —Ä—ã–Ω–∫–µ –°–®–ê. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q47yL #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-30T07:34:04+00:00,@medpharm,13344,https://t.me/medpharm/13344,–ê–ª—å—è–Ω—Å —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–π –ø—Ä–æ—Å–∏—Ç –ø—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ—Ç—å —Å–ø–µ—Ü–∏–∞–ª—å–Ω—ã–µ —É—Å–ª–æ–≤–∏—è –¥–ª—è –º–∞–ª–æ–≥–æ –∏ —Å—Ä–µ–¥–Ω–µ–≥–æ –∞–ø—Ç–µ—á–Ω–æ–≥–æ –±–∏–∑–Ω–µ—Å–∞ –ø—Ä–∏ –ø–æ–≤—ã—à–µ–Ω–∏–∏ –Ω–∞–ª–æ–≥–∞ –Ω–∞ –¥–æ–±–∞–≤–ª–µ–Ω–Ω—É—é —Å—Ç–æ–∏–º–æ—Å—Ç—å. –£–≤–µ–ª–∏—á–µ–Ω–∏–µ —Ä–∞–∑–º–µ—Ä–∞ —Å—Ç–∞–≤–∫–∏ —Å 20% –¥–æ 22% –º–æ–∂–µ—Ç –Ω–µ–≥–∞—Ç–∏–≤–Ω–æ –æ—Ç—Ä–∞–∑–∏—Ç—å—Å—è –Ω–∞ –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π –ø–æ–º–æ—â–∏ –Ω–∞—Å–µ–ª–µ–Ω–∏—é. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q42Cj #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""pricing, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The Alliance of Pharmaceutical Associations requests special conditions for small and medium retail businesses due to an increased VAT rate from 20% to 22%. This increase could negatively impact the accessibility of pharmaceutical assistance for the population.""
}"
2025-10-30T07:14:06+00:00,@medpharm,13343,https://t.me/medpharm/13343,¬´–ú–æ–∂–µ—Ç –ª–∏ –ª–µ—á–∞—â–∏–π –≤—Ä–∞—á –∏–ª–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–π —Ä–∞–±–æ—Ç–Ω–∏–∫ –ø—Ä–æ–≤–æ–¥–∏—Ç—å –∫–æ–Ω—Å—É–ª—å—Ç–∞—Ü–∏—é –ø–∞—Ü–∏–µ–Ω—Ç–∞ –ø—Ä–∏ –æ–∫–∞–∑–∞–Ω–∏–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ —Å –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º —Ç–µ–ª–µ–º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –≤ —Ä–µ–∂–∏–º–µ –æ—Ç–ª–æ–∂–µ–Ω–Ω—ã—Ö –∫–æ–Ω—Å—É–ª—å—Ç–∞—Ü–∏–π?¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q3yuS #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-10-30T06:04:07+00:00,@medpharm,13342,https://t.me/medpharm/13342,"–ù–æ—á–Ω–æ–µ –≤–æ–∑–¥–µ–π—Å—Ç–≤–∏–µ —è—Ä–∫–æ–≥–æ —Å–≤–µ—Ç–∞ –æ–∫–∞–∑–∞–ª–æ—Å—å —Å–≤—è–∑–∞–Ω–æ —Å –ø–æ–≤—ã—à–µ–Ω–Ω—ã–º —Ä–∏—Å–∫–æ–º –∏–Ω—Å—É–ª—å—Ç–∞, —Å–µ—Ä–¥–µ—á–Ω–æ–π –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ—Å—Ç–∏ –∏ –¥—Ä—É–≥–∏—Ö —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π —É –ª—é–¥–µ–π —Å—Ç–∞—Ä—à–µ 40 –ª–µ—Ç. –≠—Ç–∏ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã —Å–≤–∏–¥–µ—Ç–µ–ª—å—Å—Ç–≤—É—é—Ç –æ —Ç–æ–º, —á—Ç–æ, –ø–æ–º–∏–º–æ —Å—É—â–µ—Å—Ç–≤—É—é—â–∏—Ö –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–∏—Ö –º–µ—Ä, –∏–∑–±–µ–≥–∞–Ω–∏–µ –Ω–æ—á–Ω–æ–≥–æ —Å–≤–µ—Ç–∞ –º–æ–∂–µ—Ç –±—ã—Ç—å –ø–æ–ª–µ–∑–Ω–æ–π —Å—Ç—Ä–∞—Ç–µ–≥–∏–µ–π –¥–ª—è —Å–Ω–∏–∂–µ–Ω–∏—è —Ä–∏—Å–∫–∞ —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q3tAA #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ö–∞—Ä–¥–∏–æ–ª–æ–≥–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety"",
  ""impact"": ""medium"",
  ""english"": ""Nighttime exposure to bright light was found to increase the risk of stroke, heart failure and other cardiovascular diseases in people over 40. These results suggest that besides existing preventive measures, avoiding nighttime light may be a beneficial strategy for reducing cardiovascular disease risk. For more details: https://clck.ru/3Q3tAA #MedNews #Practice #Cardiology""
}"
2025-10-29T16:11:29+00:00,@medpharm,13341,https://t.me/medpharm/13341,"ü¶æ –õ–æ–º–∞—é—Ç –∫–æ–ø—å—è. –î–µ–ø—É—Ç–∞—Ç—ã –≤–Ω–µ—Å–ª–∏ —Å—É—â–µ—Å—Ç–≤–µ–Ω–Ω—ã–µ –∫–æ—Ä—Ä–µ–∫—Ç–∏–≤—ã –≤ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ–± –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã—Ö –æ—Ç—Ä–∞–±–æ—Ç–∫–∞—Ö –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –≤—É–∑–æ–≤ –∏ –∫–æ–ª–ª–µ–¥–∂–µ–π. –í —á–∞—Å—Ç–Ω–æ—Å—Ç–∏ –∫–æ –≤—Ç–æ—Ä–æ–º—É —á—Ç–µ–Ω–∏—é –¥–æ–∫—É–º–µ–Ω—Ç–∞ —Å–º—è–≥—á–µ–Ω–æ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–µ –∫ 100%-–Ω–æ–º—É —Ü–µ–ª–µ–≤–æ–º—É –Ω–∞–±–æ—Ä—É –Ω–∞ –ø—Ä–æ–≥—Ä–∞–º–º—ã —Å–ø–µ—Ü–∏–∞–ª–∏—Ç–µ—Ç–∞. ü¶æ –£—Å–∏–ª—è—Ç –Ω–∞—É–∫—É. –í –†–æ—Å—Å–∏–∏ —Ö–æ—Ç—è—Ç —Ä–∞—Å—à–∏—Ä–∏—Ç—å —Å–ø–∏—Å–æ–∫ –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–∏—Ö —Ü–µ–Ω—Ç—Ä–æ–≤. –≠—Ç–æ—Ç —Å—Ç–∞—Ç—É—Å –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è –ø—Ä–∏—Å–≤–∞–∏–≤–∞—Ç—å –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è–º, –∫–æ—Ç–æ—Ä—ã–µ –Ω–µ –ø–æ–¥–≤–µ–¥–æ–º—Å—Ç–≤–µ–Ω–Ω—ã –ú–∏–Ω–∑–¥—Ä–∞–≤—É –†–§. ‚ù§Ô∏è –î–æ–∂–¥–∞–ª–∏—Å—å. –ü—Ä–æ–¥–ª–µ–Ω–∏–µ –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—ã—Ö —Ä–µ–≥—É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏–π —Å—Ç–∞–Ω–µ—Ç –ø—Ä–æ—â–µ. –ò–∑–º–µ–Ω–µ–Ω–∏—è –≤ –ü—Ä–∞–≤–∏–ª–∞ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –∏ —ç–∫—Å–ø–µ—Ä—Ç–∏–∑—ã –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è, –∫–æ—Ç–æ—Ä—ã–µ —Ç–∞–∫ –∂–¥–∞–ª–∞ —Ñ–∞—Ä–º–∏–Ω–¥—É—Å—Ç—Ä–∏—è, –≤—Å—Ç—É–ø—è—Ç –≤ —Å–∏–ª—É —Å 7 –Ω–æ—è–±—Ä—è —ç—Ç–æ–≥–æ –≥–æ–¥–∞. ‚ù§Ô∏è ¬´–ü–æ–≤–æ–¥ –¥–ª—è –Ω–µ–≥–∞—Ç–∏–≤–Ω—ã—Ö –ø—Ä–æ–≥–Ω–æ–∑–æ–≤¬ª. –†–æ—Å–∫–∞—á–µ—Å—Ç–≤–æ –æ–±–Ω–∞—Ä—É–∂–∏–ª–æ –º–∞—Å—Å–æ–≤—ã–µ –Ω–∞—Ä—É—à–µ–Ω–∏—è –Ω–∞ —Ä—ã–Ω–∫–µ –ë–ê–î, –∞ 67% –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª–µ–π –ø—Ä–∏–Ω–∏–º–∞—é—Ç –¥–æ–±–∞–≤–∫–∏ –±–µ–∑ –∫–æ–Ω—Å—É–ª—å—Ç–∞—Ü–∏–∏ —Å –≤—Ä–∞—á–æ–º.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""The Russian authorities are expanding the list of national research centers, which are not under the jurisdiction of the Ministry of Health. The country is also simplifying national registration certificates, and changes in drug registration and evaluation rules for medical use are effective from November 7th. However, the Roskhozpromogrokh has identified mass violations on the market of dietary supplements and 67% of consumers are taking them without consulting a doctor.""
}"
2025-10-29T15:24:03+00:00,@medpharm,13340,https://t.me/medpharm/13340,"–ü—Ä–æ–¥–ª–µ–Ω–∏–µ –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—ã—Ö —Ä–µ–≥—É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏–π —Å—Ç–∞–Ω–µ—Ç –ø—Ä–æ—â–µ. –°–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–∏–µ –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ –ü—Ä–∞–≤–∏–ª–∞ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –∏ —ç–∫—Å–ø–µ—Ä—Ç–∏–∑—ã –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è, –∫–æ—Ç–æ—Ä—ã–µ —Ç–∞–∫ –∂–¥–∞–ª–∞ —Ñ–∞—Ä–º–∏–Ω–¥—É—Å—Ç—Ä–∏—è, –≤—Å—Ç—É–ø—è—Ç –≤ —Å–∏–ª—É —Å 7 –Ω–æ—è–±—Ä—è —ç—Ç–æ–≥–æ –≥–æ–¥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q3VsN #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""registration, regulation"",
  ""impact"": ""medium"",
  ""english"": ""Changes to the Registration and Evaluation Rules for Medicinal Products are coming into effect on November 7th, simplifying national registration certificates. This has been eagerly awaited by the pharmaceutical industry.""
}"
2025-10-29T15:16:09+00:00,@medpharm,13339,https://t.me/medpharm/13339,"–§–µ–¥–µ—Ä–∞–ª—å–Ω—ã–π –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–æ–Ω–Ω—ã–π —Ü–µ–Ω—Ç—Ä —Å–æ–æ–±—â–∏–ª –ø—Ä–æ —É–≤–µ–ª–∏—á–µ–Ω–Ω–æ–µ –≤—Ä–µ–º—è –æ–∂–∏–¥–∞–Ω–∏—è –æ—Ç–≤–µ—Ç–∞ –æ–ø–µ—Ä–∞—Ç–æ—Ä–∞ –ø—Ä–∏ –∑–≤–æ–Ω–∫–∞—Ö –≤ –∫–æ–Ω—Ç–∞–∫—Ç-—Ü–µ–Ω—Ç—Ä, –æ–Ω–æ –º–æ–∂–µ—Ç –¥–æ—Å—Ç–∏–≥–∞—Ç—å 30 –º–∏–Ω—É—Ç. –ü–æ–≤—ã—à–µ–Ω–Ω–∞—è –Ω–∞–≥—Ä—É–∑–∫–∞ –Ω–∞–±–ª—é–¥–∞–µ—Ç—Å—è –∏–∑-–∑–∞ —Ç–æ–≥–æ, —á—Ç–æ –≤ –∫–æ–Ω—Ü–µ 2025 –≥–æ–¥–∞ —É –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ–≥–æ —á–∏—Å–ª–∞ –≤—Ä–∞—á–µ–π –∏—Å—Ç–µ–∫–∞–µ—Ç —Å—Ä–æ–∫ –¥–µ–π—Å—Ç–≤–∏—è —Å–≤–∏–¥–µ—Ç–µ–ª—å—Å—Ç–≤–∞ –æ –ø–µ—Ä–∏–æ–¥–∏—á–µ—Å–∫–æ–π –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q3VMs #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The Accreditation Center reported an increase in response time for calls to the contact center, which can reach up to 30 minutes. The overload is due to the expiration of periodic accreditation certificates for a significant number of doctors by the end of 2025. For more details: https://clck.ru/3Q3VMs #MedVestnik #Healthcare #HealthOrganization""
}"
2025-10-29T14:46:03+00:00,@medpharm,13338,https://t.me/medpharm/13338,"–ö—Ä—É–≥ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π, –∫–æ—Ç–æ—Ä—ã–µ —Å–º–æ–≥—É—Ç –ø—Ä–µ—Ç–µ–Ω–¥–æ–≤–∞—Ç—å –Ω–∞ —Å—Ç–∞—Ç—É—Å –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–æ–≥–æ —Ü–µ–Ω—Ç—Ä–∞, –º–æ–∂–µ—Ç –±—ã—Ç—å —Ä–∞—Å—à–∏—Ä–µ–Ω. –ü–æ –º–Ω–µ–Ω–∏—é —ç–∫—Å–ø–µ—Ä—Ç–æ–≤, –ø—Ä–∞–≤–æ –Ω–∞ –ø–æ–ª—É—á–µ–Ω–∏–µ —Å—Ç–∞—Ç—É—Å–∞ –º–æ–≥—É—Ç –ø–æ–ª—É—á–∏—Ç—å –Ω–µ —Ç–æ–ª—å–∫–æ –≥–æ—Å—É—á—Ä–µ–∂–¥–µ–Ω–∏—è, –Ω–æ –∏ –∫–æ–º–º–µ—Ä—á–µ—Å–∫–∏–µ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏, –≤–∫–ª—é—á–∞—è —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q3TTL #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""medium"",
  ""english"": ""The status of a national medical research center can be expanded. Experts suggest that not only government institutions but also commercial organizations, including pharmaceutical companies, may be eligible for the status. More details: https://clck.ru/3Q3TTL #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞""
}"
2025-10-29T13:59:02+00:00,@medpharm,13337,https://t.me/medpharm/13337,"Eli Lilly –∏ Nvidia —Å—Ç—Ä–æ—è—Ç —Å–∞–º—ã–π –º–æ—â–Ω—ã–π —Å—É–ø–µ—Ä–∫–æ–º–ø—å—é—Ç–µ—Ä —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –∏–Ω–¥—É—Å—Ç—Ä–∏–∏ –Ω–∞ –±–∞–∑–µ 1000 –Ω–æ–≤–µ–π—à–∏—Ö —á–∏–ø–æ–≤ –º–æ—â–Ω–æ—Å—Ç—å—é –±–æ–ª–µ–µ 9000 –ø–µ—Ç–∞—Ñ–ª–æ–ø—Å–æ–≤ ‚Äî –≤ 7 –º–ª–Ω —Ä–∞–∑ –±—ã—Å—Ç—Ä–µ–µ –∞–Ω–∞–ª–æ–≥–æ–≤ 1992 –≥–æ–¥–∞. –°–∏—Å—Ç–µ–º–∞ –±—É–¥–µ—Ç –æ–±—É—á–∞—Ç—å –ò–ò-–º–æ–¥–µ–ª–∏ –Ω–∞ –æ—Å–Ω–æ–≤–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π, —Å–æ–±—Ä–∞–Ω–Ω—ã—Ö –∑–∞ 150 –ª–µ—Ç. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q3QJo #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-29T13:46:06+00:00,@medpharm,13336,https://t.me/medpharm/13336,"–í –¥–æ—Ä–∞–±–æ—Ç–∞–Ω–Ω–æ–º –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç–µ –æ–± –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã—Ö –æ—Ç—Ä–∞–±–æ—Ç–∫–∞—Ö –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∫–æ–ª–ª–µ–¥–∂–µ–π –∏ –≤—É–∑–æ–≤ —Å–º—è–≥—á–µ–Ω—ã —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ —Ü–µ–ª–µ–≤–æ–º—É –Ω–∞–±–æ—Ä—É. –¢–∞–∫–∏–º –æ–±—Ä–∞–∑–æ–º —Ç—Ä–µ—Ç—å –º–µ—Å—Ç –≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –≤—É–∑–∞—Ö –æ—Å—Ç–∞–Ω—É—Ç—Å—è –±—é–¥–∂–µ—Ç–Ω—ã–º–∏, –ø–æ–ª–Ω–æ—Å—Ç—å—é —Ü–µ–ª–µ–≤—ã–º–∏ –±—É–¥—É—Ç –ª–∏—à—å –ø—Ä–æ–≥—Ä–∞–º–º—ã –æ—Ä–¥–∏–Ω–∞—Ç—É—Ä—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q3PTW #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–û–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-10-29T12:44:06+00:00,@medpharm,13335,https://t.me/medpharm/13335,"–ò.–æ. –≥–ª–∞–≤—ã –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ö—Ä–∞—Å–Ω–æ—è—Ä—Å–∫–æ–≥–æ –∫—Ä–∞—è –Ω–∞–∑–Ω–∞—á–µ–Ω –ê–ª–µ–∫—Å–µ–π –ö–æ–Ω–æ–≤–∞–ª–µ–Ω–∫–æ.‚Äã –ú–µ—Å—è—Ü –Ω–∞–∑–∞–¥ –±—ã–ª —É—Ç–≤–µ—Ä–∂–¥–µ–Ω –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª–µ–º –º–∏–Ω–∏—Å—Ç—Ä–∞: –æ–Ω —Å–º–µ–Ω–∏–ª –ù–∞—Ç–∞–ª–∏—é –ì–æ–≤–æ—Ä—É—à–∫–∏–Ω—É, —É—à–µ–¥—à—É—é –≤ –æ—Ç—Å—Ç–∞–≤–∫—É –Ω–∞ —Ñ–æ–Ω–µ —Å–∫–∞–Ω–¥–∞–ª–∞ —Å –¥–µ—Ñ–∏—Ü–∏—Ç–æ–º –ª—å–≥–æ—Ç–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤.‚Äã –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q3KXX #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-10-29T12:38:02+00:00,@medpharm,13334,https://t.me/medpharm/13334,"–í—ã–ø—É—Å–∫–Ω–∏–∫–∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–µ–π –º–æ–≥—É—Ç –Ω–µ –ø–æ–ø–∞—Å—Ç—å –ø–æ–¥ –∑–∞–∫–æ–Ω –æ —Ç—Ä–µ—Ö–ª–µ—Ç–Ω–µ–º –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–µ –ø–æ—Å–ª–µ –æ–±—É—á–µ–Ω–∏—è. –ü–µ—Ä–µ—á–µ–Ω—å —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–µ–π, –¥–ª—è –∫–æ—Ç–æ—Ä—ã—Ö –≤–≤–µ–¥—É—Ç –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–æ, –æ–ø—Ä–µ–¥–µ–ª–∏—Ç –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ ‚Äî —Ç–∞–∫—É—é –ø–æ–ø—Ä–∞–≤–∫—É –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –≤–Ω–µ—Å—Ç–∏ –≤ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q3K9m #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{""skip"": true}"
2025-10-29T11:51:06+00:00,@medpharm,13333,https://t.me/medpharm/13333,"–ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∞—è –∞–∫–∞–¥–µ–º–∏—è –ø–µ–¥–∏–∞—Ç—Ä–∏–∏ (AAP) –∏ –ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∞—è –∫–∞—Ä–¥–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∞—è –∞—Å—Å–æ—Ü–∏–∞—Ü–∏—è (AHA) –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∏ –æ–±–Ω–æ–≤–ª–µ–Ω–Ω—ã–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø–æ —Å–µ—Ä–¥–µ—á–Ω–æ-–ª–µ–≥–æ—á–Ω–æ–π —Ä–µ–∞–Ω–∏–º–∞—Ü–∏–∏ –∏ –Ω–µ–æ—Ç–ª–æ–∂–Ω–æ–π —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç–æ–π –ø–æ–º–æ—â–∏ —É –Ω–æ–≤–æ—Ä–æ–∂–¥–µ–Ω–Ω—ã—Ö –∏ –¥–µ—Ç–µ–π. –î–æ–∫—É–º–µ–Ω—Ç –≤–∫–ª—é—á–∞–µ—Ç –∏–∑–º–µ–Ω–µ–Ω–∏—è, –æ—Å–Ω–æ–≤–∞–Ω–Ω—ã–µ –Ω–∞ –Ω–æ–≤—ã—Ö –Ω–∞—É—á–Ω—ã—Ö –¥–∞–Ω–Ω—ã—Ö, –∏ —Ä–∞—Å—à–∏—Ä—è–µ—Ç –ø–æ–ª–æ–∂–µ–Ω–∏—è —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–∞, –≤—ã–ø—É—â–µ–Ω–Ω–æ–≥–æ –≤ 2020 –≥–æ–¥—É. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q3Fvi #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ê–∫—É—à–µ—Ä—Å—Ç–≤–æ_–∏_–≥–∏–Ω–µ–∫–æ–ª–æ–≥–∏—è #–ê–Ω–µ—Å—Ç–µ–∑–∏–æ–ª–æ–≥–∏—è_–∏_—Ä–µ–∞–Ω–∏–º–∞—Ç–æ–ª–æ–≥–∏—è #–ü–µ–¥–∏–∞—Ç—Ä–∏—è","{""skip"": true}"
2025-10-29T11:24:04+00:00,@medpharm,13332,https://t.me/medpharm/13332,"–ö–∏—Ç–∞–π—Å–∫–∞—è Harbour BioMed –∑–∞–ø—É—Å—Ç–∏–ª–∞ –ø–µ—Ä–≤—É—é –ò–ò-–º–æ–¥–µ–ª—å, –≥–µ–Ω–µ—Ä–∏—Ä—É—é—â—É—é –ø–æ–ª–Ω–æ—Å—Ç—å—é —á–µ–ª–æ–≤–µ—á–µ—Å–∫–∏–µ –∞–Ω—Ç–∏—Ç–µ–ª–∞ –¥–ª—è —Å–æ–∑–¥–∞–Ω–∏—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ù–µ–π—Ä–æ—Å–µ—Ç—å –æ–∫–∞–∑–∞–ª–∞—Å—å –≤ –¥–µ—Å—è—Ç—å —Ä–∞–∑ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–µ–µ –∫–ª–∞—Å—Å–∏—á–µ—Å–∫–æ–≥–æ —Å–∫—Ä–∏–Ω–∏–Ω–≥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q3E7h #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-29T10:49:05+00:00,@medpharm,13331,https://t.me/medpharm/13331,"–í –£—Ñ–µ –≥–ª–∞–≤–≤—Ä–∞—á–∞ –Ω–∞—Ä–∫–æ–¥–∏—Å–ø–∞–Ω—Å–µ—Ä–∞ –ø—Ä–∏–≥–æ–≤–æ—Ä–∏–ª–∏ –∫ –¥–≤—É–º –≥–æ–¥–∞–º –∫–æ–ª–æ–Ω–∏–∏-–ø–æ—Å–µ–ª–µ–Ω–∏—è –∑–∞ —Ñ–∏–∫—Ç–∏–≤–Ω—É—é –æ—Ç—á–µ—Ç–Ω–æ—Å—Ç—å –∏ –ø—Ä–∏—á–∏–Ω–µ–Ω–∏–µ –±—é–¥–∂–µ—Ç—É —É—â–µ—Ä–±–∞ –Ω–∞ 5,6 –º–ª–Ω —Ä—É–±. –° –Ω–µ–≥–æ —Ç–∞–∫–∂–µ –≤–∑—ã—Å–∫–∞–ª–∏ –±–æ–ª–µ–µ 5 –º–ª–Ω —Ä—É–±. –≤ –ø–æ–ª—å–∑—É –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–ë. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q3Bfo #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, reimbursement, sanctions"",
  ""impact"": ""high"",
  ""english"": ""The head of the narcodispensary in Ufa was sentenced to two years' probation for false reporting and causing a budget loss of 5.6 million rubles to the state, and also ordered to pay over 5 million rubles to the Ministry of Health of Russia.""
}"
2025-10-29T09:55:07+00:00,@medpharm,13330,https://t.me/medpharm/13330,"–í –†–æ—Å—Å–∏–∏ —Ö–æ—Ç—è—Ç —Ä–∞—Å—à–∏—Ä–∏—Ç—å —Å–ø–∏—Å–æ–∫ –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–∏—Ö —Ü–µ–Ω—Ç—Ä–æ–≤. –≠—Ç–æ—Ç —Å—Ç–∞—Ç—É—Å –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è –ø—Ä–∏—Å–≤–∞–∏–≤–∞—Ç—å –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è–º, –∫–æ—Ç–æ—Ä—ã–µ –Ω–µ –ø–æ–¥–≤–µ–¥–æ–º—Å—Ç–≤–µ–Ω–Ω—ã –ú–∏–Ω–∑–¥—Ä–∞–≤—É –†–§. –ü—Ä–æ–µ–∫—Ç –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω –Ω–∞ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏–µ —Å–µ—Ç–∏ ¬´–º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ñ–ª–∞–≥–º–∞–Ω–æ–≤¬ª –≤ —Å—Ç—Ä–∞–Ω–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q37iC #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ù–∞—É–∫–∞ #–î—Ä—É–≥–æ–µ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""The project aims to expand the list of national medical research centers in Russia, proposing to assign this status to organizations not under the jurisdiction of the Russian Ministry of Health. The goal is to form a network of 'medical flagships' in the country.""
}"
2025-10-29T09:52:03+00:00,@medpharm,13329,https://t.me/medpharm/13329,"–ü—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ —Ä—è–¥–∞ –º–µ–¥–∏–∑–¥–µ–ª–∏–π –∏ —Å—Ä–µ–¥—Å—Ç–≤ —Ä–µ–∞–±–∏–ª–∏—Ç–∞—Ü–∏–∏ –±—É–¥—É—Ç –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–∞—Ç—å —Å—Ç–∞—Ç—É—Å –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –ø–æ –±–∞–ª–ª—å–Ω–æ–π —Å–∏—Å—Ç–µ–º–µ, –ø—Ä–æ–µ–∫—Ç –¥–æ–∫—É–º–µ–Ω—Ç–∞ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ –†–§. –î–ª—è —Ä—ã–Ω–∫–∞ —ç—Ç–æ –æ–∑–Ω–∞—á–∞–µ—Ç –∫–∞–∫ –ø—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–∞ –≤ –≥–æ—Å–∑–∞–∫—É–ø–∫–∞—Ö, —Ç–∞–∫ –∏ –Ω–æ–≤—ã–µ –≤—ã–∑–æ–≤—ã, —Å–≤—è–∑–∞–Ω–Ω—ã–µ —Å –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç—å—é —Ä–µ–≥—É–ª—è—Ä–Ω–æ–≥–æ –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏—è –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏–∏ –∏ –º–æ–¥–µ—Ä–Ω–∏–∑–∞—Ü–∏–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q37Uv #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, regulation"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Industry and Trade of Russia has developed a document to confirm the status of medical products according to a scoring system. This means advantages in government procurement, but also new challenges related to the need for regular confirmation of localization and modernization of production.""
}"
2025-10-29T08:49:03+00:00,@medpharm,13328,https://t.me/medpharm/13328,"–ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ –†–§ —Å 2026 –≥–æ–¥–∞ —Ä–∞—Å—à–∏—Ä–∏—Ç –ø–µ—Ä–µ—á–µ–Ω—å –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π, –Ω–∞ –∫–æ—Ç–æ—Ä—ã–µ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω—è–µ—Ç—Å—è –±–∞–ª–ª—å–Ω–∞—è —Å–∏—Å—Ç–µ–º–∞ –æ—Ü–µ–Ω–∫–∏ –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏–∏. –ü–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è —Ä–∞–∑—Ä–∞–±–æ—Ç–∞—Ç—å –º–µ—Ä—ã —Å—ã—Ä—å–µ–≤–æ–π –ø–æ–¥–¥–µ—Ä–∂–∫–∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π, –¥–ª—è —á–µ–≥–æ –∏—Ö –ø—Ä–∏–≤–ª–µ–∫–∞—é—Ç –∫ –æ—Ü–µ–Ω–∫–µ –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç–∏ –≤ —Å—ã—Ä—å–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q32nY #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–î—Ä—É–≥–æ–µ","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, reimbursement, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The Russian Ministry of Industry plans to expand the list of medical devices subject to localization assessment system starting from 2026. Measures for raw material support of producers are planned, including their evaluation of raw material needs.""
}"
2025-10-29T08:24:02+00:00,@medpharm,13327,https://t.me/medpharm/13327,"–û–±—ä–µ–º —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —Ä—ã–Ω–∫–∞ –ë–ê–î –ø—Ä–µ–≤—ã—à–∞–µ—Ç 150 –º–ª—Ä–¥ —Ä—É–±., –∞ –æ–Ω–ª–∞–π–Ω-–ø—Ä–æ–¥–∞–∂–∏ –∑–∞ –≥–æ–¥ –≤—ã—Ä–æ—Å–ª–∏ –Ω–∞ 46%. –û–¥–Ω–∞–∫–æ –º–∞—Å—à—Ç–∞–±–Ω—ã–π –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥ –†–æ—Å–∫–∞—á–µ—Å—Ç–≤–∞ –≤—ã—è–≤–∏–ª —Å–∏—Å—Ç–µ–º–Ω—ã–µ –Ω–∞—Ä—É—à–µ–Ω–∏—è: —Ç—ã—Å—è—á–∏ —Ç–æ–≤–∞—Ä–æ–≤ –±–µ–∑ –≥–æ—Å—Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏, —Å –∑–∞–ø—Ä–µ—â–µ–Ω–Ω—ã–º–∏ –≤–µ—â–µ—Å—Ç–≤–∞–º–∏ –∏ –∑–∞–≤—ã—à–µ–Ω–Ω—ã–º–∏ –¥–æ–∑–∏—Ä–æ–≤–∫–∞–º–∏. –ü—Ä–∏ —ç—Ç–æ–º 67% –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª–µ–π –Ω–∞—á–∏–Ω–∞—é—Ç –ø—Ä–∏–µ–º –¥–æ–±–∞–≤–æ–∫ ¬´–≤—Å–ª–µ–ø—É—é¬ª, –±–µ–∑ –∫–æ–Ω—Å—É–ª—å—Ç–∞—Ü–∏–∏ —Å –≤—Ä–∞—á–æ–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q2z3C #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, demand, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The Russian market for dietary supplements exceeds $15 billion, with online sales growing by 46% in a year. However, the Roskatchestvo monitoring has identified systemic violations: thousands of products without state registration, with prohibited substances and over-dosed ones. Additionally, 67% of consumers start taking supplements without consulting a doctor.""
}"
2025-10-29T07:38:03+00:00,@medpharm,13326,https://t.me/medpharm/13326,Intellia Therapeutics –æ—Å—Ç–∞–Ω–æ–≤–∏–ª–∞ –∏—Å–ø—ã—Ç–∞–Ω–∏—è CRISPR-—Ç–µ—Ä–∞–ø–∏–∏ –ø—Ä–æ—Ç–∏–≤ —Ç—Ä–∞–Ω—Å—Ç–∏—Ä–µ—Ç–∏–Ω–æ–≤–æ–≥–æ –∞–º–∏–ª–æ–∏–¥–æ–∑–∞ –∏–∑-–∑–∞ —Å–µ—Ä—å–µ–∑–Ω—ã—Ö –ø—Ä–æ–±–ª–µ–º —Å –ø–µ—á–µ–Ω—å—é —É –æ–¥–Ω–æ–≥–æ –∏–∑ —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q2vob #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-10-29T07:17:05+00:00,@medpharm,13325,https://t.me/medpharm/13325,"–°–∞—Ö–∞—Ä–Ω—ã–π –¥–∏–∞–±–µ—Ç 2-–≥–æ —Ç–∏–ø–∞ —Ä–∞–∑–≤–∏–≤–∞–ª—Å—è —É –≤–∑—Ä–æ—Å–ª—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –≤—Ä–æ–∂–¥–µ–Ω–Ω—ã–º –ø–æ—Ä–æ–∫–æ–º —Å–µ—Ä–¥—Ü–∞ –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ —Ä–∞–Ω—å—à–µ, —á–µ–º –≤ –æ–±—â–µ–π –ø–æ–ø—É–ª—è—Ü–∏–∏, –∏ —Å–æ–ø—Ä–æ–≤–æ–∂–¥–∞–ª—Å—è –ø–æ–≤—ã—à–µ–Ω–Ω–æ–π —Å–º–µ—Ä—Ç–Ω–æ—Å—Ç—å—é. –ü—Ä–∏ —ç—Ç–æ–º —Ä–∏—Å–∫ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è –æ–∫–∞–∑–∞–ª—Å—è –≤—ã—à–µ —É –∂–µ–Ω—â–∏–Ω, –¥–∞–∂–µ –Ω–µ—Å–º–æ—Ç—Ä—è –Ω–∞ –∏—Å–∫–ª—é—á–µ–Ω–∏–µ –ø–∞—Ü–∏–µ–Ω—Ç–æ–∫ —Å –≥–µ—Å—Ç–∞—Ü–∏–æ–Ω–Ω—ã–º –¥–∏–∞–±–µ—Ç–æ–º –∏–∑ –∞–Ω–∞–ª–∏–∑–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q2uRr #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–î–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞ #–ö–∞—Ä–¥–∏–æ–ª–æ–≥–∏—è #–≠–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-10-29T06:07:06+00:00,@medpharm,13324,https://t.me/medpharm/13324,"–ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–µ –æ–±—â–µ—Å—Ç–≤–æ –Ω–µ—Ñ—Ä–æ–ª–æ–≥–∏–∏ (ASN) –æ–ø—É–±–ª–∏–∫–æ–≤–∞–ª–æ —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–æ –ø–æ –∑–¥–æ—Ä–æ–≤—å—é –ø–æ—á–µ–∫ (KHG), –ø–æ—Å–≤—è—â–µ–Ω–Ω–æ–µ –ø–∏—â–µ–≤—ã–º –¥–æ–±–∞–≤–∫–∞–º –∫–∞–ª–∏—è –∏ —Ñ–æ—Å—Ñ–æ—Ä–∞. –í –¥–æ–∫—É–º–µ–Ω—Ç–µ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω—ã –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –¥–ª—è –≤—Ä–∞—á–µ–π –∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–æ–π –±–æ–ª–µ–∑–Ω—å—é –ø–æ—á–µ–∫ –ø–æ –≤—ã—è–≤–ª–µ–Ω–∏—é –∏ –∫–æ–Ω—Ç—Ä–æ–ª—é —É–ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏—è –ø—Ä–æ–¥—É–∫—Ç–æ–≤, —Å–æ–¥–µ—Ä–∂–∞—â–∏—Ö —ç—Ç–∏ –¥–æ–±–∞–≤–∫–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q2puC #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ù–µ—Ñ—Ä–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è","{""skip"": true}"
2025-10-29T05:04:02+00:00,@medpharm,13323,https://t.me/medpharm/13323,"–°–µ–≥–æ–¥–Ω—è –≤ 11:00 (–º—Å–∫) —Å–æ—Å—Ç–æ–∏—Ç—Å—è –±–∏–∑–Ω–µ—Å-–∑–∞–≤—Ç—Ä–∞–∫ ¬´–ù–æ–≤–æ–µ –≤ –æ—Ç—Ä–∞—Å–ª–∏. –õ–æ–Ω—á–∏¬ª, –ø–æ–¥–∫–ª—é—á–∞–π—Ç–µ—Å—å –∫ —Ç—Ä–∞–Ω—Å–ª—è—Ü–∏–∏. –ú–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–µ –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç –¥–µ–ª–æ–≤—É—é –ø—Ä–æ–≥—Ä–∞–º–º—É 26 —Å–µ–∑–æ–Ω–∞ XXVI ¬´–ü–ª–∞—Ç–∏–Ω–æ–≤–æ–π —É–Ω—Ü–∏–∏¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q2mkX #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-28T17:29:07+00:00,@medpharm,13322,https://t.me/medpharm/13322,"ü¶æ –í—ã–π–¥–µ—Ç –ø–æ—Å–ª–∞–±–ª–µ–Ω–∏–µ. –ü—Ä–∞–≤–∏–ª–∞ –æ—Ç—Ä–∞–±–æ—Ç–∫–∏ –¥–ª—è –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–≤—É–∑–æ–≤ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ —Å–¥–µ–ª–∞—Ç—å –±–æ–ª–µ–µ –≥–∏–±–∫–∏–º–∏. –°–æ–≥–ª–∞—Å–Ω–æ –ø–æ–ø—Ä–∞–≤–∫–∞–º –≤ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –∫–æ –≤—Ç–æ—Ä–æ–º—É —á—Ç–µ–Ω–∏—é, –ø–µ—Ä–∏–æ–¥ –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–∞ –±—É–¥–µ—Ç –∑–∞–≤–∏—Å–µ—Ç—å –æ—Ç –ø—Ä–æ—Ñ–∏–ª—è —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞ –∏ –º–µ—Å—Ç–∞ –µ–≥–æ —Ä–∞–±–æ—Ç—ã. ü¶æ –ë–∏–±–ª–∏—è —Ö–∏—Ä—É—Ä–≥–∞. –†–æ—Å—Å–∏–π—Å–∫–æ–µ –æ–±—â–µ—Å—Ç–≤–æ —Ö–∏—Ä—É—Ä–≥–æ–≤ —É—Ç–≤–µ—Ä–¥–∏–ª–æ —Ä–µ–∑–æ–ª—é—Ü–∏—é –ø–æ —Ä–∞–∑–≤–∏—Ç–∏—é –∫–ª—é—á–µ–≤—ã—Ö –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏–π —Ö–∏—Ä—É—Ä–≥–∏—á–µ—Å–∫–æ–π –ø—Ä–∞–∫—Ç–∏–∫–∏ –Ω–∞ –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–º —É—Ä–æ–≤–Ω–µ. –î–æ–∫—É–º–µ–Ω—Ç –Ω–æ—Å–∏—Ç —Ä–∞–º–æ—á–Ω—ã–π —Ö–∞—Ä–∞–∫—Ç–µ—Ä –∏ –æ–±–æ–±—â–∞–µ—Ç –±–∞–∑–æ–≤—ã–µ –ø—Ä–∏–Ω—Ü–∏–ø—ã –±–µ–∑–æ–ø–∞—Å–Ω–æ–π —Ö–∏—Ä—É—Ä–≥–∏—á–µ—Å–∫–æ–π –ø–æ–º–æ—â–∏ –≤ —Ä–∞–∑–Ω—ã—Ö –æ–±–ª–∞—Å—Ç—è—Ö –≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–∏ —Å —Ç–µ–∫—É—â–∏–º–∏ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–º–∏ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏—è–º–∏, –æ–±—Ä–∞—Ç–∏–ª –≤–Ω–∏–º–∞–Ω–∏–µ ¬´–ú–í¬ª. ‚ù§Ô∏è –ì–æ—Ç–æ–≤—å—Ç–µ —Å–∞–Ω–∏ –ª–µ—Ç–æ–º. –ü—Ä–∏ –∑–∞–±–ª–∞–≥–æ–≤—Ä–µ–º–µ–Ω–Ω–æ–π –ø–æ–¥–∞—á–µ –≤—Å–µ—Ö –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤ –Ω–∞ –ø—Ä–∏–≤–µ–¥–µ–Ω–∏–µ –†–£ –≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–µ —Å –ø—Ä–∞–≤–∏–ª–∞–º–∏ –ï–ê–≠–° ¬´–Ω–µ–ø—Ä–∏—è—Ç–Ω—ã—Ö —Å—é—Ä–ø—Ä–∏–∑–æ–≤ –æ–∂–∏–¥–∞—Ç—å –Ω–µ –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è¬ª, —Å—á–∏—Ç–∞—é—Ç –≤ –ï–≠–ö. –î–∞–Ω–Ω—ã–µ –æ –ø—Ä–æ–¥–ª–µ–Ω–∏–∏ –¥–µ–π—Å—Ç–≤–∏—è –†–£ –∫–∞–∫ —É—á–∞—Å—Ç–Ω–∏–∫–∏ —Ä—ã–Ω–∫–∞, —Ç–∞–∫ –∏ —Ä–µ–≥—É–ª—è—Ç–æ—Ä—ã –±—É–¥—É—Ç –ø–æ–ª—É—á–∞—Ç—å –∏–∑ –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ –ì–†–õ–°. ‚ù§Ô∏è –ù–µ –≤—Ä–µ–º—è –¥–ª—è –æ—Ç–º–µ–Ω—ã. –£–ø—Ä–æ—â–µ–Ω–Ω—ã–µ –ø—Ä–æ—Ü–µ–¥—É—Ä—ã –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –æ—Ç–¥–µ–ª—å–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –Ω–∞–∏–±–æ–ª–µ–µ –≤–æ—Å—Ç—Ä–µ–±–æ–≤–∞–Ω–Ω—ã—Ö –º–µ–¥–∏–∑–¥–µ–ª–∏–π –ø—Ä–æ–¥–ª–∏–ª–∏ –¥–æ 2036 –≥–æ–¥–∞. –¢–∞–∫–∂–µ –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è –ø—Ä–æ–¥–ª–∏—Ç—å –¥–µ–π—Å—Ç–≤–∏–µ –ø—Ä–∞–≤–∏–ª, –≤–≤–µ–¥–µ–Ω–Ω—ã—Ö –¥–ª—è –±–æ—Ä—å–±—ã —Å –¥–µ—Ñ–∏—Ü–∏—Ç–æ–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ —Ñ–æ–Ω–µ —Å–∞–Ω–∫—Ü–∏–π.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance"",
  ""impact"": ""medium"",
  ""english"": ""The project proposes more flexible rules for medical school graduates. The probation period will depend on the profile of the specialist and their place of work according to amendments in the law project for second reading. The Russian Society of Surgeons approved a resolution on developing key areas of surgical practice at the national level. The document is of a general nature and summarizes basic principles of safe surgery in various areas according to current clinical recommendations. 'M.V.' reminds us that the summer is a good time to prepare for it. Simplified procedures for registering individual medicines and most needed medical devices are extended until 2036. Additionally, it proposes extending the rules introduced for combating drug shortages due to sanctions.""
}"
2025-10-28T15:46:50+00:00,@medpharm,13321,https://t.me/medpharm/13321,"–°–≤–µ–∂–∏–π –Ω–æ–º–µ—Ä ¬´–§–í¬ª ‚Ññ24-25 (1183-1184) —É–∂–µ –¥–æ—Å—Ç—É–ø–µ–Ω –æ–Ω–ª–∞–π–Ω –¥–ª—è –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª–µ–π. –õ–µ–≥–∫–∏ –Ω–∞ –ø–æ–¥—ä–µ–º. –°–∫–æ–ª—å–∫–æ –Ω–æ–≤—ã—Ö —Å—É–±—Å—Ç–∞–Ω—Ü–∏–π –ø–æ—è–≤–∏–ª–æ—Å—å –≤ –ì–†–õ–° –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–æ—Å—Å–∏–∏ –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç —Å—Ç–∏–º—É–ª–∏—Ä–æ–≤–∞—Ç—å —É–≥–ª—É–±–ª–µ–Ω–∏–µ –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤. ¬´–í—Ç–æ—Ä–æ–π –ª–∏—à–Ω–∏–π¬ª —É–∂–µ –ø—Ä–∏–º–µ–Ω—è–µ—Ç—Å—è –≤ –≥–æ—Å–∑–∞–∫—É–ø–∫–∞—Ö –ø–æ –æ—Ç–Ω–æ—à–µ–Ω–∏—é –∫ –≥–æ—Ç–æ–≤–æ–π –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π —Ñ–æ—Ä–º–µ. –ö–∞–∫ —Ç–æ–ª—å–∫–æ –±—É–¥–µ—Ç —É—Ç–≤–µ—Ä–∂–¥–µ–Ω –ø–µ—Ä–µ—á–µ–Ω—å —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –∑–∞–∫–æ–Ω—á–∏—Ç—Å—è —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç –ø–æ –º–∞—Ä–∫–∏—Ä–æ–≤–∫–µ —Å—É–±—Å—Ç–∞–Ω—Ü–∏–π, ¬´–≤—Ç–æ—Ä–æ–π –ª–∏—à–Ω–∏–π¬ª –±—É–¥–µ—Ç —Ä–∞–±–æ—Ç–∞—Ç—å –∏ –¥–ª—è —Å—É–±—Å—Ç–∞–Ω—Ü–∏–π. ¬´–§–í¬ª –ø—Ä–æ–∞–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–ª, —Å–∫–æ–ª—å–∫–æ –Ω–æ–≤—ã—Ö —Å—É–±—Å—Ç–∞–Ω—Ü–∏–π –ø–æ—è–≤–∏–ª–æ—Å—å –≤ —Ä–µ–µ—Å—Ç—Ä–µ –∑–∞ –ø–æ—Å–ª–µ–¥–Ω–∏–µ –Ω–µ—Å–∫–æ–ª—å–∫–æ –ª–µ—Ç. –¢–∞–∫–∂–µ –≤ –Ω–æ–º–µ—Ä–µ –∞–Ω–∞–ª–∏—Ç–∏–∫–∞: –ë–æ–ª—å —É—Ç–∏—Ö–∞–µ—Ç. –°–ø—Ä–æ—Å –Ω–∞ –æ–±–µ–∑–±–æ–ª–∏–≤–∞—é—â–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –Ω–µ —Ä–∞—Å—Ç–µ—Ç –°–æ—Å—Ä–µ–¥–æ—Ç–æ—á–∏–ª–∏—Å—å –Ω–∞ –±—é–¥–∂–µ—Ç–µ. –†–µ–π—Ç–∏–Ω–≥ –ø–æ—Å—Ç–∞–≤—â–∏–∫–æ–≤ –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø–æ –≥–æ—Å–∫–æ–Ω—Ç—Ä–∞–∫—Ç–∞–º –ê –µ—â–µ: –í—Ä–µ–º—è —Ä–µ–¥–∏–∑–∞–π–Ω–∞. –ö–∞–∫ –º–µ–Ω—è–µ—Ç—Å—è —Ä—ã–Ω–æ–∫ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –°–≤–µ—Ç–ª–∞–Ω–∞ –ó–∞–≤–∏–¥–æ–≤–∞: ¬´–ß–µ–º –±–æ–ª—å—à–µ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–µ —Å–ø–æ–Ω—Å–æ—Ä—ã –ø—Ä–æ–±—É—é—Ç —Å–≤–æ–∏ —Å–∏–ª—ã –≤ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è—Ö, —Ç–µ–º —Å–µ—Ä—å–µ–∑–Ω–µ–µ –æ—Ç–Ω–æ—à–µ–Ω–∏–µ –∫ –Ω–∏–º¬ª –î–º–∏—Ç—Ä–∏–π –†–æ–∂–¥–µ—Å—Ç–≤–µ–Ω—Å–∫–∏–π: ¬´–°—Ä–µ–¥–∏ —Ö–æ—Ä–æ—à–∏—Ö, –Ω–æ –ø–æ–∫–∞ –Ω–µ —Ä–µ–∞–ª–∏–∑–æ–≤–∞–Ω–Ω—ã—Ö –∏–¥–µ–π ‚Äî —Å–∞–Ω–∞—Ü–∏—è —Ä—ã–Ω–∫–∞ –æ—Ç –±–µ—Å–ø–æ–ª–µ–∑–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤¬ª –ë–∏—Ç–≤–∞ –∑–∞ –ø–∞—Ç–µ–Ω—Ç. –ö–∞–∫ —Å—É–¥—ã —Ä–µ—à–∞—é—Ç –¥–µ–ª–∞ –ø–æ –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω—ã–º –ª–∏—Ü–µ–Ω–∑–∏—è–º Moderato —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–æ. –ü–æ—á–µ–º—É –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∞ –º–µ–¥–∏–∑–¥–µ–ª–∏–π –≤–Ω–µ–¥—Ä—è–µ—Ç—Å—è –≤ —É–º–µ—Ä–µ–Ω–Ω–æ–º —Ç–µ–º–ø–µ ¬´–ú–∞–ª—ã—à–∏¬ª –Ω–µ –ø–µ—Ä–µ–Ω–æ—Å—è—Ç —Ä–µ—Ñ–æ—Ä–º. –û –ø–æ—Å–ª–µ–¥—Å—Ç–≤–∏—è—Ö –∏–∑–º–µ–Ω–µ–Ω–∏–π –≤ –Ω–∞–ª–æ–≥–æ–≤–æ–π —Å—Ñ–µ—Ä–µ –¥–ª—è —Ñ–∞—Ä–º—Ä—ã–Ω–∫–∞ –í–∏–∫—Ç–æ—Ä–∏—è –ü—Ä–µ—Å–Ω—è–∫–æ–≤–∞: ¬´–ú—ã —Ä–∏—Å–∫—É–µ–º –ø–æ–ª—É—á–∏—Ç—å –∞–ø—Ç–µ—á–Ω—ã–µ –ø—É—Å—Ç—ã–Ω–∏¬ª –†–∞–±–æ—Ç–∞ –∑–∞ –∫—É–ª–∏—Å–∞–º–∏. –ö–∞–∫ —Å—Ç—Ä–æ—è—Ç —Å–≤–æ–∏ –æ—Ç–Ω–æ—à–µ–Ω–∏—è —Å –≤–ª–∞—Å—Ç—å—é GR-—Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –†–æ–∑–∞ –Ø–≥—É–¥–∏–Ω–∞. –ü–∞—Ä–∞–¥–æ–∫—Å –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –ü—É—Å—Ç—å –≥–æ–≤–æ—Ä—è—Ç. –ö–∞–∫ –∏–º–∏–¥–∂ –∞–ø—Ç–µ—á–Ω–æ–π —Å–µ—Ç–∏ –≤–ª–∏—è–µ—Ç –Ω–∞ –ø—Ä–∏–≤–ª–µ—á–µ–Ω–∏–µ –∫–∞–¥—Ä–æ–≤ –ù–µ —Ç–µ—Ä—è—é—Ç –ø–µ—Å—Å–∏–º–∏–∑–º–∞. –ò—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –≤—ã—è–≤–∏–ª–æ –ø—Ä–æ—Ç–∏–≤–æ—Ä–µ—á–∏—è —Ä—ã–Ω–∫–∞ —Ç—Ä—É–¥–∞ –¢—Ä–∞–º–ø —Ä–æ–Ω—è–µ—Ç —Ñ–∞—Ä–º—É. –ö–∞–∫ –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç –°–®–ê –ø–µ—Ä–µ–≤–µ—Ä–Ω—É–ª –≤—Å—é –∏–Ω–¥—É—Å—Ç—Ä–∏—é –∑–∞ 10 –º–µ—Å—è—Ü–µ–≤","{
  ""skip"": true
}"
2025-10-28T15:39:04+00:00,@medpharm,13320,https://t.me/medpharm/13320,"–ü—Ä–∏ –∑–∞–±–ª–∞–≥–æ–≤—Ä–µ–º–µ–Ω–Ω–æ–π –ø–æ–¥–∞—á–µ –≤—Å–µ—Ö –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤ –Ω–∞ –ø—Ä–∏–≤–µ–¥–µ–Ω–∏–µ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–æ–Ω–Ω—ã—Ö —É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏–π –≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–µ —Å –ø—Ä–∞–≤–∏–ª–∞–º–∏ –ï–ê–≠–° ¬´–Ω–µ–ø—Ä–∏—è—Ç–Ω—ã—Ö —Å—é—Ä–ø—Ä–∏–∑–æ–≤ –æ–∂–∏–¥–∞—Ç—å –Ω–µ –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è¬ª, –æ—Ç–º–µ—á–∞—é—Ç –≤ –ï–≠–ö. –î–∞–Ω–Ω—ã–µ –æ –ø—Ä–æ–¥–ª–µ–Ω–∏–∏ –¥–µ–π—Å—Ç–≤–∏—è —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–æ–Ω–Ω—ã—Ö —É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏–π –∫–∞–∫ —É—á–∞—Å—Ç–Ω–∏–∫–∏ —Ä—ã–Ω–∫–∞, —Ç–∞–∫ –∏ —Ä–µ–≥—É–ª—è—Ç–æ—Ä—ã –±—É–¥—É—Ç –ø–æ–ª—É—á–∞—Ç—å –∏–∑ –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ –ì–†–õ–°. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q2SfX #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""registration, safety"",
  ""impact"": ""medium"",
  ""english"": ""Participants in the market and regulators will receive information about the extension of registration certificates from national GRLS. This is according to EAEU rules on timely submission of all documents for registration certificates compliance, which means there are no unexpected surprises.""
}"
2025-10-28T15:10:06+00:00,@medpharm,13319,https://t.me/medpharm/13319,"–î–µ–ø—É—Ç–∞—Ç—ã –ì–æ—Å–¥—É–º—ã –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –±–µ—Å–ø–ª–∞—Ç–Ω–æ –∫–æ–º–ø–µ–Ω—Å–∏—Ä–æ–≤–∞—Ç—å —Å—Ç–æ–∏–º–æ—Å—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø–µ–Ω—Å–∏–æ–Ω–µ—Ä–∞–º, —á–µ–π –¥–æ—Ö–æ–¥ –Ω–µ –ø—Ä–µ–≤—ã—à–∞–µ—Ç 1,5-–∫—Ä–∞—Ç–Ω–æ–≥–æ —Ä–∞–∑–º–µ—Ä–∞ –ø—Ä–æ–∂–∏—Ç–æ—á–Ω–æ–≥–æ –º–∏–Ω–∏–º—É–º–∞. –§–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏–µ –ø—Ä–æ–≥—Ä–∞–º–º—ã –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –∑–∞ —Å—á–µ—Ç —Å—Ä–µ–¥—Å—Ç–≤ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –∏ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã—Ö –±—é–¥–∂–µ—Ç–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q2R4W #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""reimbursement, shortage"",
  ""impact"": ""high"",
  ""english"": ""Deputies of the State Duma proposed to compensate the cost of medicines for pensioners whose income does not exceed 1.5 times the minimum living wage. Funding for the program is planned to be financed from federal and regional budgets. For more details: https://clck.ru/3Q2R4W #FarmaNews #Regulation""
}"
2025-10-28T14:32:03+00:00,@medpharm,13318,https://t.me/medpharm/13318,–ú–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –≤ –≤–µ–¥–µ–Ω–∏–∏ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã—Ö –æ—Ä–≥–∞–Ω–æ–≤ –≤–ª–∞—Å—Ç–∏ –±—É–¥—É—Ç —É—á–∞—Å—Ç–≤–æ–≤–∞—Ç—å –≤ –ø—Ä–æ–≥—Ä–∞–º–º–µ –±–µ—Å–ø–ª–∞—Ç–Ω–æ–≥–æ –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –¥–µ—Ç–µ–π –¥–æ —à–µ—Å—Ç–∏ –ª–µ—Ç –∏–∑ –º–Ω–æ–≥–æ–¥–µ—Ç–Ω—ã—Ö —Å–µ–º–µ–π. –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –¥–æ–∫—É–º–µ–Ω—Ç —Å –ø—Ä–∞–≤–∏–ª–∞–º–∏ –æ–∫–∞–∑–∞–Ω–∏—è —Ç–∞–∫–æ–π –ø–æ–¥–¥–µ—Ä–∂–∫–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q2NYX #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The federal authorities' medical organizations will participate in a program providing free medication for children under six years old from multi-child families. The Ministry of Health has developed a document with rules for providing such support. More details: https://clck.ru/3Q2NYX""
}"
2025-10-28T14:14:04+00:00,@medpharm,13317,https://t.me/medpharm/13317,"–†–æ—Å—Å–∏–π—Å–∫–æ–µ –æ–±—â–µ—Å—Ç–≤–æ —Ö–∏—Ä—É—Ä–≥–æ–≤ —É—Ç–≤–µ—Ä–¥–∏–ª–æ —Ä–µ–∑–æ–ª—é—Ü–∏—é –ø–æ —Ä–∞–∑–≤–∏—Ç–∏—é –∫–ª—é—á–µ–≤—ã—Ö –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏–π —Ö–∏—Ä—É—Ä–≥–∏—á–µ—Å–∫–æ–π –ø—Ä–∞–∫—Ç–∏–∫–∏ –Ω–∞ –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–º —É—Ä–æ–≤–Ω–µ. –î–æ–∫—É–º–µ–Ω—Ç —Ä–µ–∑—é–º–∏—Ä—É–µ—Ç –±–∞–∑–æ–≤—ã–µ –ø—Ä–∏–Ω—Ü–∏–ø—ã —ç—Ç–∏—á–Ω–æ–π –∏ –±–µ–∑–æ–ø–∞—Å–Ω–æ–π —Ö–∏—Ä—É—Ä–≥–∏—á–µ—Å–∫–æ–π –ø–æ–º–æ—â–∏ –≤ —Ç–∞–∫–∏—Ö –æ–±–ª–∞—Å—Ç—è—Ö, –∫–∞–∫ –≥–µ—Ä–∏–∞—Ç—Ä–∏—è, –∫–æ–ª–æ–ø—Ä–æ–∫—Ç–æ–ª–æ–≥–∏—è, —Ç—Ä–∞–Ω—Å–ø–ª–∞–Ω—Ç–æ–ª–æ–≥–∏—è, —Ç–æ—Ä–∞–∫–∞–ª—å–Ω–∞—è, —Ä–æ–±–æ—Ç–∏—á–µ—Å–∫–∞—è –∏ –≤–æ–µ–Ω–Ω–æ-–ø–æ–ª–µ–≤–∞—è —Ö–∏—Ä—É—Ä–≥–∏—è, —Ñ–ª–µ–±–æ–ª–æ–≥–∏—è, –ø—Ä–∏ —Å–µ–ø—Å–∏—Å–µ, –ø–æ–ª–∏—Ç—Ä–∞–≤–º–µ, –æ–ø–µ—Ä–∞—Ü–∏—è—Ö –Ω–∞ –ø–∏—â–µ–≤–æ–¥–µ –∏ –∫–∏—à–µ—á–Ω–∏–∫–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q2MLz #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è #–•–∏—Ä—É—Ä–≥–∏—è","{""skip"": true}"
2025-10-28T14:02:05+00:00,@medpharm,13316,https://t.me/medpharm/13316,–ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–π —Ä–µ–≥—É–ª—è—Ç–æ—Ä –æ–¥–æ–±—Ä–∏–ª Lynkuet –æ—Ç –Ω–µ–º–µ—Ü–∫–æ–π Bayer ‚Äî –ø–µ—Ä–≤—ã–π –Ω–µ–≥–æ—Ä–º–æ–Ω–∞–ª—å–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è –æ–±–ª–µ–≥—á–µ–Ω–∏—è –ø—Ä–∏–ª–∏–≤–æ–≤ –ø—Ä–∏ –º–µ–Ω–æ–ø–∞—É–∑–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q2LUA #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-10-28T13:19:06+00:00,@medpharm,13315,https://t.me/medpharm/13315,"–£ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –ø–µ—Ä–≤–∏—á–Ω—ã–º –∞–ª—å–¥–æ—Å—Ç–µ—Ä–æ–Ω–∏–∑–º–æ–º, –∫–æ—Ç–æ—Ä—ã–º –ø–ª–∞–Ω–∏—Ä–æ–≤–∞–ª–∞—Å—å –∞–¥—Ä–µ–Ω–∞–ª—ç–∫—Ç–æ–º–∏—è, –ø—Ä–µ–¥–æ–ø–µ—Ä–∞—Ü–∏–æ–Ω–Ω–∞—è —Ç–µ—Ä–∞–ø–∏—è –∞–Ω—Ç–∞–≥–æ–Ω–∏—Å—Ç–∞–º–∏ –º–∏–Ω–µ—Ä–∞–ª–æ–∫–æ—Ä—Ç–∏–∫–æ–∏–¥–Ω—ã—Ö —Ä–µ—Ü–µ–ø—Ç–æ—Ä–æ–≤ –æ–∫–∞–∑–∞–ª–∞—Å—å –±–µ–∑–æ–ø–∞—Å–Ω–æ–π –∏ —Å–ø–æ—Å–æ–±—Å—Ç–≤–æ–≤–∞–ª–∞ —É–ª—É—á—à–µ–Ω–∏—é –±–∏–æ—Ö–∏–º–∏—á–µ—Å–∫–∏—Ö –ø–æ–∫–∞–∑–∞—Ç–µ–ª–µ–π –≤ –¥–æ–ª–≥–æ—Å—Ä–æ—á–Ω–æ–π –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–µ. –ü—Ä–∏ —ç—Ç–æ–º —Ä–∏—Å–∫ –ø–æ—Å–ª–µ–æ–ø–µ—Ä–∞—Ü–∏–æ–Ω–Ω–æ–π –≥–∏–ø–µ—Ä–∫–∞–ª–∏–µ–º–∏–∏, –≥–∏–ø–æ—Ç–æ–Ω–∏–∏ –∏–ª–∏ —É—Ö—É–¥—à–µ–Ω–∏—è —Ñ—É–Ω–∫—Ü–∏–∏ –ø–æ—á–µ–∫ –Ω–µ —É–≤–µ–ª–∏—á–∏–≤–∞–ª—Å—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q2Hku #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ù–µ—Ñ—Ä–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance"",
  ""impact"": ""medium"",
  ""english"": ""Preoperative therapy with mineralocorticoid receptor antagonists was safe and improved biochemical markers in patients with primary aldosteronism undergoing planned adrenalectomy. There was no increase in postoperative hyperkalemia, hypotension or kidney function impairment risk.""
}"
2025-10-28T12:51:03+00:00,@medpharm,13314,https://t.me/medpharm/13314,"–ê–ø—Ç–µ–∫–∞ –ì–£–ü ¬´–ë–∞—à—Ñ–∞—Ä–º–∞—Ü–∏—è¬ª –±—ã–ª–∞ –æ—à—Ç—Ä–∞—Ñ–æ–≤–∞–Ω–∞ –Ω–∞ 500 —Ç—ã—Å. —Ä—É–±. –∑–∞ –ø—Ä–æ–¥–∞–∂—É –Ω–µ–¥–æ–±—Ä–æ–∫–∞—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ¬´–°–ø–∏—Ä–æ–Ω–æ–ª–∞–∫—Ç–æ–Ω¬ª. –ß–∏—Ç–∞—Ç–µ–ª–∏ ¬´–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫–∞¬ª –≤ –∫–æ–º–º–µ–Ω—Ç–∞—Ä–∏—è—Ö —Å–ø—Ä–∞—à–∏–≤–∞–ª–∏, –ø–æ—á–µ–º—É –ø—Ä–µ–ø–∞—Ä–∞—Ç –Ω–µ –±—ã–ª –∑–∞–±–ª–æ–∫–∏—Ä–æ–≤–∞–Ω –Ω–∞ –∫–∞—Å—Å–µ. –í ¬´–ß–µ—Å—Ç–Ω–æ–º –∑–Ω–∞–∫–µ¬ª –æ–±—ä—è—Å–Ω–∏–ª–∏ –ø—Ä–∏—á–∏–Ω—ã —à—Ç—Ä–∞—Ñ–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q2Fxb #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–µ–ø–∞—Ä–∞—Ç—ã/–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""medium"",
  ""english"": ""A state-owned pharmacy 'Bashfarma' was fined 500 thousand rubles for selling substandard medication 'Spironolactone'. Readers of 'Farvestnik' magazine asked why the drug was not blocked at the cash register. The 'Chestnyi Znak' explained the reasons for the fine.""
}"
2025-10-28T12:15:10+00:00,@medpharm,13313,https://t.me/medpharm/13313,"–ü—Ä–∞–≤–∏–ª–∞ –æ—Ç—Ä–∞–±–æ—Ç–∫–∏ –¥–ª—è –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–≤—É–∑–æ–≤ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ —Å–¥–µ–ª–∞—Ç—å –±–æ–ª–µ–µ –≥–∏–±–∫–∏–º–∏. –°–æ–≥–ª–∞—Å–Ω–æ –ø–æ–ø—Ä–∞–≤–∫–∞–º –≤ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –∫–æ –≤—Ç–æ—Ä–æ–º—É —á—Ç–µ–Ω–∏—é, –ø–µ—Ä–∏–æ–¥ –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–∞ –±—É–¥–µ—Ç –∑–∞–≤–∏—Å–µ—Ç—å –æ—Ç –ø—Ä–æ—Ñ–∏–ª—è —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞ –∏ –º–µ—Å—Ç–∞ –µ–≥–æ —Ä–∞–±–æ—Ç—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q2DMm #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-10-28T12:12:03+00:00,@medpharm,13312,https://t.me/medpharm/13312,"–£–§–ê–° –ø–æ –ú–æ—Å–∫–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –æ—à—Ç—Ä–∞—Ñ–æ–≤–∞–ª–æ –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –∞–ø—Ç–µ—á–Ω–æ–π —Å–µ—Ç–∏ ¬´–†–∏–≥–ª–∞¬ª. –ü–æ–≤–æ–¥–æ–º –ø–æ—Å–ª—É–∂–∏–ª–æ —Å–æ–æ–±—â–µ–Ω–∏–µ —Å —Ä–µ–∫–ª–∞–º–æ–π –∞–∫—Ü–∏–∏ –∫–æ–º–ø–∞–Ω–∏–∏ –∞–±–æ–Ω–µ–Ω—Ç—É, –Ω–µ –¥–∞–≤–∞–≤—à–µ–º—É —Å–æ–≥–ª–∞—Å–∏–µ –Ω–∞ —Ä–∞—Å—Å—ã–ª–∫—É. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q2D8o #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{""skip"": true}"
2025-10-28T11:34:06+00:00,@medpharm,13311,https://t.me/medpharm/13311,"–ö—É—Ä—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –Ω–∞–ø—Ä–∞–≤—è—Ç –±–æ–ª–µ–µ 700 –º–ª–Ω —Ä—É–±. –Ω–∞ –∑–∞–∫—É–ø–∫—É –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –¥–ª—è –±–æ–ª—å–Ω–∏—Ü –∏ –ø–æ–ª–∏–∫–ª–∏–Ω–∏–∫. –ù–∞ —ç—Ç–∏ —Å—Ä–µ–¥—Å—Ç–≤–∞ –∫—É–ø—è—Ç –≤ —Ç–æ–º —á–∏—Å–ª–µ –∞–ø–ø–∞—Ä–∞—Ç—ã –ö–¢, –£–ó–ò –∏ —Å–∏—Å—Ç–µ–º—ã –¥–ª—è —Ä–µ–∞–Ω–∏–º–∞—Ü–∏–∏.‚Äã –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q2APs #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-10-28T11:02:07+00:00,@medpharm,13310,https://t.me/medpharm/13310,"–° 21 –ø–æ 27 –æ–∫—Ç—è–±—Ä—è –º–∏—Ä–æ–≤—ã–µ —Ä–µ–≥—É–ª—è—Ç–æ—Ä—ã –æ–¥–æ–±—Ä–∏–ª–∏ —Å–µ–º—å –Ω–æ–≤—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –¥–æ–±–∞–≤–∏–ª–∏ –¥–≤–∞ –ø–æ–∫–∞–∑–∞–Ω–∏—è –¥–ª—è –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç–æ–≤, —É–∂–µ –≤—ã—à–µ–¥—à–∏—Ö –≤ –ø—Ä–æ–¥–∞–∂–∏. –í –°–®–ê –ø–æ—è–≤–∏–ª–∏—Å—å –ø–µ—Ä–≤—ã–π –Ω–µ–≥–æ—Ä–º–æ–Ω–∞–ª—å–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Å–∏–º–ø—Ç–æ–º–æ–≤ –º–µ–Ω–æ–ø–∞—É–∑—ã –∏ –ø–µ—Ä–≤—ã–π –ø–µ—Ä–æ—Ä–∞–ª—å–Ω—ã–π —Ä–∞—Å—Ç–≤–æ—Ä –∫–ª–æ–Ω–∏–¥–∏–Ω–∞. –ï–≤—Ä–æ–∫–æ–º–∏—Å—Å–∏—è —É—Ç–≤–µ—Ä–¥–∏–ª–∞ –ø–µ—Ä–≤–æ–µ –ø–æ–¥–∫–æ–∂–Ω–æ–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–æ –æ—Ç —è–∑–≤–µ–Ω–Ω–æ–≥–æ –∫–æ–ª–∏—Ç–∞. –ö–∏—Ç–∞–π –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª –ø–µ—Ä–≤–æ–µ –∫–æ–º–±–∏–Ω–∏—Ä–æ–≤–∞–Ω–Ω–æ–µ –ø—Ä–æ—Ç–∏–≤–æ–¥–∏–∞–±–µ—Ç–∏—á–µ—Å–∫–æ–µ —Å—Ä–µ–¥—Å—Ç–≤–æ –∏ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–π –∏–Ω–≥–∏–±–∏—Ç–æ—Ä EGFR –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Ä–∞–∫–∞ –ª–µ–≥–∫–æ–≥–æ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q2AM3 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""World regulators approved seven new drugs from October 21-27, including the first non-hormonal treatment for menopause symptoms in the US and the first oral clodronate solution. The European Commission approved the first subcutaneous treatment for Crohn's disease in Europe. China registered the first combined antidiabetic drug and an innovative EGFR inhibitor for lung cancer.""
}"
2025-10-28T10:47:04+00:00,@medpharm,13309,https://t.me/medpharm/13309,"–°–æ–≤–µ—Ç –§–µ–¥–µ—Ä–∞—Ü–∏–∏ –æ–±—Å—É–¥–∏—Ç –Ω–∞ –∑–∞–∫—Ä—ã—Ç–æ–º —Å–æ–≤–µ—â–∞–Ω–∏–∏ –≤–æ–ø—Ä–æ—Å –æ –≤–≤–µ–¥–µ–Ω–∏–∏ –≤–∑–Ω–æ—Å–æ–≤ –Ω–∞ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–µ —Å—Ç—Ä–∞—Ö–æ–≤–∞–Ω–∏–µ –¥–ª—è –Ω–µ—Ä–∞–±–æ—Ç–∞—é—â–∏—Ö —Ä–æ—Å—Å–∏—è–Ω. –ü—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—å –≤–µ—Ä—Ö–Ω–µ–π –ø–∞–ª–∞—Ç—ã —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –ø–∞—Ä–ª–∞–º–µ–Ω—Ç–∞ –í–∞–ª–µ–Ω—Ç–∏–Ω–∞ –ú–∞—Ç–≤–∏–µ–Ω–∫–æ —Ä–∞–Ω–µ–µ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∞ —Å–æ–±–∏—Ä–∞—Ç—å —Å —Ç–∞–∫–∏—Ö –≥—Ä–∞–∂–¥–∞–Ω –ø–æ 45 —Ç—ã—Å. —Ä—É–±. –≤ –≥–æ–¥, —á—Ç–æ–±—ã —Ä–∞–∑–≥—Ä—É–∑–∏—Ç—å —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã–µ –±—é–¥–∂–µ—Ç—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q26tp #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""reimbursement, regulation"",
  ""impact"": ""medium"",
  ""english"": ""The Council of Federation will discuss at a closed meeting the issue of introducing contribution payments for compulsory medical insurance for non-working Russians. Earlier, Chairman of the upper house of Russia's parliament Valentina Matveeva proposed to collect 45,000 rubles per year from such individuals to ease regional budgets.""
}"
2025-10-28T10:20:34+00:00,@medpharm,13308,https://t.me/medpharm/13308,"–î–ª—è —à–∫–æ–ª—å–Ω–∏–∫–æ–≤ 8‚Äî11 –∫–ª–∞—Å—Å–æ–≤ –æ—Ä–≥–∞–Ω–∏–∑–æ–≤–∞–ª–∏ –ø—Ä–æ—Ñ–∏–ª—å–Ω—É—é —Å–º–µ–Ω—É ¬´–§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∞—è –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç—å: –º–∏—Ñ—ã –∏ —Ä–µ–∞–ª—å–Ω–æ—Å—Ç—å¬ª. –ó–∞ –Ω–µ–¥–µ–ª—é —É—á–∞—â–∏–µ—Å—è –∏–∑ –Ø—Ä–æ—Å–ª–∞–≤—Å–∫–æ–≥–æ –ª–∏—Ü–µ—è ‚Ññ 86 –∏ –¥—Ä—É–≥–∏—Ö —è—Ä–æ—Å–ª–∞–≤—Å–∫–∏—Ö —à–∫–æ–ª –∏–∑—É—á–∏–ª–∏ –æ—Å–Ω–æ–≤—ã –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞, –∞ —Ç–∞–∫–∂–µ —Ä–∞–∑–≤–µ–Ω—á–∞–ª–∏ —Å–∞–º—ã–µ –ø–æ–ø—É–ª—è—Ä–Ω—ã–µ –º–∏—Ñ—ã –æ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Q24nT","{""skip"": true}"
2025-10-28T09:15:03+00:00,@medpharm,13307,https://t.me/medpharm/13307,"–£–ø—Ä–æ—â–µ–Ω–Ω—ã–µ –ø—Ä–æ—Ü–µ–¥—É—Ä—ã –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –æ—Ç–¥–µ–ª—å–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –Ω–∞–∏–±–æ–ª–µ–µ –≤–æ—Å—Ç—Ä–µ–±–æ–≤–∞–Ω–Ω—ã—Ö –º–µ–¥–∏–∑–¥–µ–ª–∏–π –ø—Ä–æ–¥–ª–∏–ª–∏ –¥–æ 2036 –≥–æ–¥–∞. –¢–∞–∫–∂–µ –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è –ø—Ä–æ–¥–ª–∏—Ç—å –¥–µ–π—Å—Ç–≤–∏–µ –ø—Ä–∞–≤–∏–ª, –≤–≤–µ–¥–µ–Ω–Ω—ã—Ö –¥–ª—è –±–æ—Ä—å–±—ã —Å –¥–µ—Ñ–∏—Ü–∏—Ç–æ–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ —Ñ–æ–Ω–µ —Å–∞–Ω–∫—Ü–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pzxvc #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, regulation"",
  ""impact"": ""high"",
  ""english"": ""Extended simplified registration procedures for medicines and most needed medical devices are being extended until 2306. Additionally, it is proposed to extend the rules introduced for combating drug shortages amid sanctions.""
}"
2025-10-28T09:08:06+00:00,@medpharm,13306,https://t.me/medpharm/13306,"–ß–∏—Å–ª–æ –∑–∞—Ä–∞–∂–µ–Ω–Ω—ã—Ö –≥–µ–ø–∞—Ç–∏—Ç–æ–º –≤ –æ–Ω–∫–æ–¥–∏—Å–ø–∞–Ω—Å–µ—Ä–µ –Ω–∞ –ö–∞–º—á–∞—Ç–∫–µ –≤—ã—Ä–æ—Å–ª–æ –¥–æ 167 —á–µ–ª–æ–≤–µ–∫. –†–∞—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç—Å—è —Å —è–Ω–≤–∞—Ä—è, –∏—Ç–æ–≥–æ–≤—ã–µ –¥–∞–Ω–Ω—ã–µ –ø–æ —á–∏—Å–ª—É –∑–∞—Ä–∞–∑–∏–≤—à–∏—Ö—Å—è –∏ —Å–∫–æ–Ω—á–∞–≤—à–∏—Ö—Å—è –±—É–¥—É—Ç –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω—ã –ø–æ—Å–ª–µ –∑–∞–≤–µ—Ä—à–µ–Ω–∏—è –∫–æ–º–ø–ª–µ–∫—Å–Ω–æ–π –ø—Ä–æ–≤–µ—Ä–∫–∏. ‚Äã –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PzxQM #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–ò–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã–µ_–±–æ–ª–µ–∑–Ω–∏ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-10-28T08:21:03+00:00,@medpharm,13305,https://t.me/medpharm/13305,"–í –û—Ä–ª–µ –ø–æ–∫—É–ø–∞—Ç–µ–ª—å–Ω–∏—Ü–∞ —Ä–µ—à–∏–ª–∞ –ø–æ–ø–æ–ª–Ω–∏—Ç—å –∑–∞–ø–∞—Å—ã –≤–µ—Ç–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –æ–±–º–∞–Ω–Ω—ã–º –ø—É—Ç–µ–º. –î–µ–≤—É—à–∫–∞ —É—Ç–≤–µ—Ä–∂–¥–∞–ª–∞, —á—Ç–æ –∫—É–ø–∏–ª–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç –Ω–µ—Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–µ–≥–æ –∫–∞—á–µ—Å—Ç–≤–∞, –∏ —Ç—Ä–µ–±–æ–≤–∞–ª–∞, —á—Ç–æ–±—ã –µ–π –≤–µ—Ä–Ω—É–ª–∏ –¥–µ–Ω—å–≥–∏. –ú–æ—à–µ–Ω–∏—á–µ—Å–∫—É—é —Å—Ö–µ–º—É —É–¥–∞–ª–æ—Å—å —Ä–∞—Å–∫—Ä—ã—Ç—å. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pztcf #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–µ–ø–∞—Ä–∞—Ç—ã/–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""A consumer in Oryol attempted to defraud by purchasing counterfeit veterinary drugs and demanding a refund. The fraudulent scheme was uncovered. For more details: https://clck.ru/3Pztcf #FarmVestnik #Pharmaceuticals""
}"
2025-10-28T08:13:07+00:00,@medpharm,13304,https://t.me/medpharm/13304,"–° 2026 –≥–æ–¥–∞ —Ä–∞—Å—à–∏—Ä–∏—Ç—Å—è –ø–µ—Ä–µ—á–µ–Ω—å –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏–æ–Ω–Ω—ã—Ö –≤—ã–ø–ª–∞—Ç –¥–ª—è –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –§–ú–ë–ê. –¢–µ–ø–µ—Ä—å –∏—Ö —Å–º–æ–≥—É—Ç –ø–æ–ª—É—á–∞—Ç—å –Ω–µ —Ç–æ–ª—å–∫–æ —Ç–µ, –∫—Ç–æ –ø–µ—Ä–µ–µ—Ö–∞–ª —Ä–∞–±–æ—Ç–∞—Ç—å –≤ –ó–ê–¢–û, –Ω–æ –∏ —É—Å—Ç—Ä–∞–∏–≤–∞—é—â–∏–µ—Å—è –Ω–∞ —Ä–∞–±–æ—Ç—É –≤ —É—á—Ä–µ–∂–¥–µ–Ω–∏—è –∞–≥–µ–Ω—Ç—Å—Ç–≤–∞ –≤ –º–∞–ª—ã—Ö –≥–æ—Ä–æ–¥–∞—Ö, —Ç—Ä—É–¥–Ω–æ–¥–æ—Å—Ç—É–ø–Ω—ã—Ö —Ä–∞–π–æ–Ω–∞—Ö, —Ä–µ–≥–∏–æ–Ω–∞—Ö –ö—Ä–∞–π–Ω–µ–≥–æ –°–µ–≤–µ—Ä–∞ –∏ –î–∞–ª—å–Ω–µ–≥–æ –í–æ—Å—Ç–æ–∫–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PzsrH #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The compensation payments for medical workers will be expanded to include those who are employed in small towns, difficult-access areas, regions of the Far North and Far East of Russia by 2026, not just those who move to work in ZATO (Zones of Special Tactical Importance). More details: https://clck.ru/3PzsrH #MedVestnik #Healthcare""
}"
2025-10-28T07:26:06+00:00,@medpharm,13303,https://t.me/medpharm/13303,"–ü–∞—Ü–∏–µ–Ω—Ç—ã, –∫–æ—Ç–æ—Ä—ã–º —É–¥–∞–ª–æ—Å—å –¥–æ—Å—Ç–∏—á—å –ø–æ–ª–Ω–æ–π –ø–æ—á–µ—á–Ω–æ–π —Ä–µ–º–∏—Å—Å–∏–∏, –ø–æ–¥–¥–µ—Ä–∂–∏–≤–∞—Ç—å –Ω–∏–∑–∫—É—é –∞–∫—Ç–∏–≤–Ω–æ—Å—Ç—å —Å–∏—Å—Ç–µ–º–Ω–æ–π –∫—Ä–∞—Å–Ω–æ–π –≤–æ–ª—á–∞–Ω–∫–∏ –∏ –ø—Ä–æ–¥–æ–ª–∂–∞—Ç—å –ø—Ä–∏–µ–º –≥–∏–¥—Ä–æ–∫—Å–∏—Ö–ª–æ—Ä–æ—Ö–∏–Ω–∞, —á–∞—â–µ –∏ –±—ã—Å—Ç—Ä–µ–µ –ø—Ä–µ–∫—Ä–∞—â–∞–ª–∏ —Ç–µ—Ä–∞–ø–∏—é –≥–ª—é–∫–æ–∫–æ—Ä—Ç–∏–∫–æ—Å—Ç–µ—Ä–æ–∏–¥–∞–º–∏. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –ª—é–¥–∏ —Å –≤–ø–µ—Ä–≤—ã–µ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏—Ä–æ–≤–∞–Ω–Ω—ã–º –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–µ–º –ø–æ—Å–ª–µ 2010 –≥–æ–¥–∞ —Ç–∞–∫–∂–µ –∏–º–µ–ª–∏ –±–æ–ª—å—à–µ —à–∞–Ω—Å–æ–≤ —Ä–∞–Ω—å—à–µ —Å–Ω–∏–∑–∏—Ç—å –¥–æ–∑—É —Å—Ç–µ—Ä–æ–∏–¥–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PzoEg #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ù–µ—Ñ—Ä–æ–ª–æ–≥–∏—è #–†–µ–≤–º–∞—Ç–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""Patients who achieved complete remission of renal disease, maintained low systemic lupus erythematosus activity, and continued hydroxychloroquine therapy were more likely to discontinue steroid therapy. Additionally, individuals with the first diagnosis after 2010 had a higher chance of reducing steroid dosage earlier. For more information, see https://clck.ru/3PzoEg #MedVestnik #Practice #Nephrology #Rheumatology #Therapy #Pharmacology""
}"
2025-10-28T07:15:03+00:00,@medpharm,13302,https://t.me/medpharm/13302,"–ö–æ–º–ø–∞–Ω–∏—è ¬´–î–∂–æ–¥–∞—Å –≠–∫—Å–ø–æ–∏–º¬ª –ø–æ–¥–∞–ª–∞ 18 –∏—Å–∫–æ–≤ –∫ –ú–∏–Ω–∑–¥—Ä–∞–≤—É –†–§ –æ –ø—Ä–∏–∑–Ω–∞–Ω–∏–∏ –Ω–µ–∑–∞–∫–æ–Ω–Ω—ã–º–∏ –∏ –æ—Ç–º–µ–Ω–µ –ø—Ä–∏–∫–∞–∑–æ–≤ –æ –ø—Ä–∏–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–∏ –¥–µ–π—Å—Ç–≤–∏—è —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–æ–Ω–Ω—ã—Ö —É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏–π (–†–£) –µ–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ü—è—Ç—å –∏–∑ —ç—Ç–∏—Ö –∏—Å–∫–æ–≤ —É–∂–µ –ø—Ä–∏–Ω—è—Ç—ã –∫ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏—é, –ø–æ –æ—Å—Ç–∞–ª—å–Ω—ã–º –ø–æ–∫–∞ –ª–∏–±–æ –Ω–µ—Ç –¥–≤–∏–∂–µ–Ω–∏—è, –ª–∏–±–æ –æ—Ç–∫–∞–∑–∞–Ω–æ –≤ –ø—Ä–∏–Ω—è—Ç–∏–∏ –ø–æ —Ñ–æ—Ä–º–∞–ª—å–Ω—ã–º –ø—Ä–∏–∑–Ω–∞–∫–∞–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PznCe #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""high"",
  ""english"": ""Company 'Djodas Expoim' has filed 18 lawsuits against the Russian Ministry of Health regarding the invalidation and revocation of registration certificates for its pharmaceutical products. Five cases have been accepted for consideration, while the status of the remaining ones is unclear or they were rejected on formal grounds. More details: https://clck.ru/3PznCe #PharmNews #Production""
}"
2025-10-27T16:35:38+00:00,@medpharm,13301,https://t.me/medpharm/13301,"ü¶æ –í –ø–ª–µ–Ω—É –∏–ª–ª—é–∑–∏–π. –í –°–ª–µ–¥—Å—Ç–≤–µ–Ω–Ω–æ–º –∫–æ–º–∏—Ç–µ—Ç–µ –Ω–∞–∑–≤–∞–ª–∏ –≥–ª—É–±–æ—á–∞–π—à–∏–º –∑–∞–±–ª—É–∂–¥–µ–Ω–∏–µ–º –¥–æ–ø—É—â–µ–Ω–∏–µ, —á—Ç–æ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –Ω–µ –Ω–æ—Å—è—Ç —Ö–∞—Ä–∞–∫—Ç–µ—Ä –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã—Ö. –û–Ω–∏ —Å–ª—É–∂–∞—Ç –æ–¥–Ω–∏–º –∏–∑ –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å—Å—Ç–≤ –≤–∏–Ω–æ–≤–Ω–æ—Å—Ç–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ —Ä–∞–±–æ—Ç–Ω–∏–∫–∞ –ø—Ä–∏ —Ä–∞—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–∏ —É–≥–æ–ª–æ–≤–Ω—ã—Ö –¥–µ–ª –æ –Ω–µ–∫–∞—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–º –æ–∫–∞–∑–∞–Ω–∏–∏ –º–µ–¥–ø–æ–º–æ—â–∏. ü¶æ –ù–µ—Ç —Å—Ç—Ä–∞—Ö–æ–≤–∫–∏. –ó–∞–±–æ–ª–µ–≤–∞–µ–º–æ—Å—Ç—å –Ω–µ—Å–∫–æ–ª—å–∫–∏–º–∏ –≤–∏–¥–∞–º–∏ —Ä–∞–∫–∞ —É–≤–µ–ª–∏—á–∏–ª–∞—Å—å –≤ –º–∏—Ä–µ –∑–∞ –ø–æ—Å–ª–µ–¥–Ω–∏–µ –¥–≤–∞ –¥–µ—Å—è—Ç–∏–ª–µ—Ç–∏—è —Å—Ä–µ–¥–∏ –≤–∑—Ä–æ—Å–ª—ã—Ö –≤—Å–µ—Ö –≤–æ–∑—Ä–∞—Å—Ç–æ–≤, –æ—Å–æ–±–µ–Ω–Ω–æ —Å—Ä–µ–¥–∏ –º–æ–ª–æ–¥—ã—Ö –ª—é–¥–µ–π. –£—á–µ–Ω—ã–µ –ø—Ä–µ–¥–ø–æ–ª–∞–≥–∞—é—Ç, —á—Ç–æ –æ–¥–Ω–æ–π –∏–∑ –≤–æ–∑–º–æ–∂–Ω—ã—Ö –ø—Ä–∏—á–∏–Ω —ç—Ç–æ–≥–æ –º–æ–∂–µ—Ç –±—ã—Ç—å —Ä–æ—Å—Ç —É—Ä–æ–≤–Ω—è –æ–∂–∏—Ä–µ–Ω–∏—è. ‚ù§Ô∏è –ú–∏–º–æ —Å–ø–∏—Å–∫–æ–≤. –§–∞—Ä–º—Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –Ω–∞–ø—Ä–∞–≤–∏–ª–∏ –∫–æ–ª–ª–µ–∫—Ç–∏–≤–Ω–æ–µ –æ–±—Ä–∞—â–µ–Ω–∏–µ –ø–æ –ø–æ–≤–æ–¥—É —Å–ª–æ–∂–Ω–æ—Å—Ç–µ–π, —Å –∫–æ—Ç–æ—Ä—ã–º–∏ –æ–Ω–∏ —Å—Ç–∞–ª–∫–∏–≤–∞—é—Ç—Å—è –ø—Ä–∏ –ø—Ä–æ—Ö–æ–∂–¥–µ–Ω–∏–∏ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–π –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–∏. –ò—Ö –¥–æ–ª–∂–Ω–æ—Å—Ç–∏ –Ω–µ –≤—Ö–æ–¥—è—Ç –≤ —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–Ω—É—é –Ω–æ–º–µ–Ω–∫–ª–∞—Ç—É—Ä—É –∏ –Ω–µ —Ä–µ–≥—É–ª–∏—Ä—É—é—Ç—Å—è –ø—Ä–∏–∫–∞–∑–æ–º –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–æ—Å—Å–∏–∏. ‚ù§Ô∏è –ù–æ–≤—ã–µ –º–æ–¥—É–ª–∏. –° 7 —è–Ω–≤–∞—Ä—è 2026 –≥–æ–¥–∞ –≤—Å–µ –∞–ø—Ç–µ–∫–∏ –¥–æ–ª–∂–Ω—ã –±—É–¥—É—Ç –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å —Å–µ—Ä—Ç–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –º–æ–¥—É–ª–∏ –ø—Ä–æ–≤–µ—Ä–∫–∏ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –æ —Ç–æ–≤–∞—Ä–µ. –í —Ä–µ–µ—Å—Ç—Ä–µ ¬´–ß–µ—Å—Ç–Ω–æ–≥–æ –∑–Ω–∞–∫–∞¬ª —á–∏—Å–ª–∏—Ç—Å—è –ª–∏—à—å –æ–¥–∏–Ω –ø–æ—Å—Ç–∞–≤—â–∏–∫, —á—å–µ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏–µ —Å–æ–≤–º–µ—Å—Ç–∏–º–æ —Å –ö–ö–¢ –¥–≤—É—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance, safety"",
  ""impact"": ""high"",
  ""english"": ""The message discusses the importance of clinical recommendations in criminal investigations and mentions an increase in cancer incidence among adults, attributing it to obesity. It also highlights the need for professional accreditation modules in pharmacies and mentions a shortage of compatible equipment suppliers.""
}"
2025-10-27T15:49:03+00:00,@medpharm,13300,https://t.me/medpharm/13300,"–ì—É–±–µ—Ä–Ω–∞—Ç–æ—Ä –ö—É—Ä—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ —Å–º–µ–Ω–∏–ª –≤—Ä–∏–æ –º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –†–∞–Ω–µ–µ –æ–Ω —Ä–∞—Å–ø–æ—Ä—è–¥–∏–ª—Å—è –ø—Ä–æ–≤–µ—Ä–∏—Ç—å –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç—å —Å–µ—Ç–∏ ¬´–ö—É—Ä—Å–∫–∞—è —Ñ–∞—Ä–º–∞—Ü–∏—è¬ª –∏–∑-–∑–∞ –º–∞—Å—Å–æ–≤—ã—Ö –∂–∞–ª–æ–± –º–µ—Å—Ç–Ω—ã—Ö –∂–∏—Ç–µ–ª–µ–π –Ω–∞ –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ, –Ω–æ —á–∏–Ω–æ–≤–Ω–∏–∫–∏ –Ω–µ –≤—ã–ø–æ–ª–Ω–∏–ª–∏ –ø–æ—Ä—É—á–µ–Ω–∏–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pz96V #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–∞—Ä—å–µ—Ä–∞","{""skip"": true}"
2025-10-27T15:10:06+00:00,@medpharm,13299,https://t.me/medpharm/13299,"–ü–æ—Ä—è–¥–æ–∫ –Ω–∞–∑–Ω–∞—á–µ–Ω–∏—è –ë–ê–î –≤—Ä–∞—á–∞–º–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏. –ü—Ä–æ–µ–∫—Ç —Å–æ–¥–µ—Ä–∂–∏—Ç —à–µ—Å—Ç—å –ø—É–Ω–∫—Ç–æ–≤, —Å—Ä–µ–¥–∏ –∫–æ—Ç–æ—Ä—ã—Ö ‚Äî –Ω–∞–ª–∏—á–∏–µ –ø–æ–∫–∞–∑–∞–Ω–∏–π –∫ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—é —É –ø–∞—Ü–∏–µ–Ω—Ç–∞. –ú–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–∏ —Ç–∞–∫–∂–µ –¥–æ–ª–∂–Ω—ã –±—É–¥—É—Ç –≤ –¥–æ—Å—Ç—É–ø–Ω–æ–π —Ñ–æ—Ä–º–µ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª—è—Ç—å —Å–≤–µ–¥–µ–Ω–∏—è –æ –Ω–∞–∑–Ω–∞—á–µ–Ω–∏–∏ –ë–ê–î. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pz5gD #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health of Russia has developed a project for the prescription of BAs by doctors. The project contains six points, among which are indications for use in the patient. Medical workers will also need to provide information about the prescription of BAs in a clear form. For more details: https://clck.ru/3Pz5gD #PharmNews #Regulation""
}"
2025-10-27T14:38:06+00:00,@medpharm,13298,https://t.me/medpharm/13298,"–†–æ—Å—Å–∏—è –æ–±–Ω–æ–≤–ª—è–µ—Ç –ø—Ä–∞–≤–∏–ª–∞ —Å–æ–∑–¥–∞–Ω–∏—è –º–µ–¥—Ä–µ–∑–µ—Ä–≤–æ–≤ –¥–ª—è —á—Ä–µ–∑–≤—ã—á–∞–π–Ω—ã—Ö —Å–∏—Ç—É–∞—Ü–∏–π. –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ –ø–æ–¥–≥–æ—Ç–æ–≤–∏–ª –ø–æ–ª–æ–∂–µ–Ω–∏–µ, –∫–æ—Ç–æ—Ä–æ–µ –æ–ø–∏—Å—ã–≤–∞–µ—Ç —Å–æ–∑–¥–∞–Ω–∏–µ, —É—á–µ—Ç, –∞–Ω–∞–ª–∏–∑ –∏ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ —Ä–µ–∑–µ—Ä–≤–æ–≤ –Ω–∞ –≤—Å–µ—Ö —É—Ä–æ–≤–Ω—è—Ö —É–ø—Ä–∞–≤–ª–µ–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pz2mG #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""Russia updates rules for creating emergency medical reserves. The Ministry of Health has prepared a document outlining the creation, accounting, analysis, and use of reserves at all levels of management. More: https://clck.ru/3Pz2mG #MedNews #HealthCare""
}"
2025-10-27T14:34:03+00:00,@medpharm,13297,https://t.me/medpharm/13297,"¬´–°–µ–≤–µ—Ä–Ω–∞—è –ó–≤–µ–∑–¥–∞¬ª –æ–±–Ω–∞—Ä—É–∂–∏–ª–∞, —á—Ç–æ –ø–æ–¥—Ä—è–¥—á–∏–∫ —Ñ–∞–∫—Ç–∏—á–µ—Å–∫–∏ –Ω–µ –ø—Ä–æ–≤–µ–ª —á–∞—Å—Ç—å –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–π –ø–æ –ø—Ä–æ–¥–≤–∏–∂–µ–Ω–∏—é –ª–µ–∫–∞—Ä—Å—Ç–≤. –°—É–¥ –æ–±—è–∑–∞–ª –æ—Ç–≤–µ—Ç—á–∏–∫–∞ –≤–µ—Ä–Ω—É—Ç—å 51 –º–ª–Ω —Ä—É–±. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pz2Qg #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The Northern Star discovered that the contractor did not actually carry out part of the activities to promote medicines. The defendant was ordered by a court to return 51 million rubles.""
}"
2025-10-27T14:27:07+00:00,@medpharm,13296,https://t.me/medpharm/13296,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ –ø—Ä–µ–¥–ª–æ–∂–∏–ª –ø—Ä–æ–¥–ª–∏—Ç—å –¥–µ–π—Å—Ç–≤–∏–µ –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–π –æ–± –æ—Å–æ–±–µ–Ω–Ω–æ—Å—Ç—è—Ö –æ–±—Ä–∞—â–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø—Ä–∏ –¥–µ—Ñ–µ–∫—Ç—É—Ä–µ –∏–∑-–∑–∞ —Å–∞–Ω–∫—Ü–∏–π, –∞ —Ç–∞–∫–∂–µ –≤ —Å–ª—É—á–∞–µ —á—Ä–µ–∑–≤—ã—á–∞–π–Ω—ã—Ö —Å–∏—Ç—É–∞—Ü–∏–π. –ü–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è, —á—Ç–æ –æ—Å–æ–±—ã–π –ø–æ—Ä—è–¥–æ–∫ –±—É–¥–µ—Ç –¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å –¥–æ 2028 –≥–æ–¥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pyzhx #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–§–∞—Ä–º–∏–Ω–¥—É—Å—Ç—Ä–∏—è #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""sanctions, regulation"",
  ""impact"": ""high"",
  ""english"": ""The Ministry of Health of Russia proposed extending the special order for drug handling due to sanctions and in case of emergencies. It is planned that this special order will be valid until 2028. More details: https://clck.ru/3Pyzhx #MedVestnik #PharmIndustria #HealthOrganization""
}"
2025-10-27T14:00:08+00:00,@medpharm,13295,https://t.me/medpharm/13295,"Novartis –ø—Ä–∏–æ–±—Ä–µ—Ç–∞–µ—Ç –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫—É—é –∫–æ–º–ø–∞–Ω–∏—é Avidity Biosciences –∑–∞ 12 –º–ª—Ä–¥ –¥–æ–ª–ª., –ø–æ–ª—É—á–∞—è –ø—Ä–∞–≤–∞ –Ω–∞ —Ç—Ä–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –Ω–µ—Ä–≤–Ω–æ-–º—ã—à–µ—á–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –∏ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—É—é —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—é –¥–æ—Å—Ç–∞–≤–∫–∏ –†–ù–ö-—Ç–µ—Ä–∞–ø–∏–π –≤ –º—ã—à–µ—á–Ω—É—é —Ç–∫–∞–Ω—å. –°–¥–µ–ª–∫–∞ —Å—Ç–∞–ª–∞ –≤—Ç–æ—Ä–æ–π –∫—Ä—É–ø–Ω–µ–π—à–µ–π –≤ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ –∑–∞ —ç—Ç–æ—Ç –≥–æ–¥. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pyx5F #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-27T13:49:50+00:00,@medpharm,13294,https://t.me/medpharm/13294,"–í 2015 –≥–æ–¥—É –¶–í ¬´–ü—Ä–æ—Ç–µ–∫¬ª –∑–∞–ø—É—Å—Ç–∏–ª –Ω–∞ —Å–∫–ª–∞–¥–µ –≤ –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥–µ –Ω–æ–≤—ã–π –∫–æ–Ω–≤–µ–π–µ—Ä. –û—Å–Ω–æ–≤–Ω—ã–º –µ–≥–æ —ç–ª–µ–º–µ–Ω—Ç–æ–º —Å—Ç–∞–ª –∞–≤—Ç–æ–º–∞—Ç–∏—á–µ—Å–∫–∏–π —É—á–∞—Å—Ç–æ–∫ –ª–æ—Ç–æ—á–Ω–æ–≥–æ —Ö—Ä–∞–Ω–µ–Ω–∏—è, –ø–æ–ª—É—á–∏–≤—à–∏–π —Å—Ä–µ–¥–∏ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –Ω–∞–∑–≤–∞–Ω–∏–µ ¬´–∫–∞—Ä—É—Å–µ–ª—å¬ª. –≠—Ç–æ—Ç –æ–ø—ã—Ç —Å—Ç–∞–ª –ø–µ—Ä–≤—ã–º —à–∞–≥–æ–º –Ω–∞ –ø—É—Ç–∏ –≤–Ω–µ–¥—Ä–µ–Ω–∏—è –Ω–æ–≤–æ–π —Å–∫–ª–∞–¥—Å–∫–æ–π —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ ¬´–¢–æ–≤–∞—Ä –∫ —á–µ–ª–æ–≤–µ–∫—É¬ª.","{""skip"": true}"
2025-10-27T13:24:06+00:00,@medpharm,13293,https://t.me/medpharm/13293,"–ó–∞–±–æ–ª–µ–≤–∞–µ–º–æ—Å—Ç—å –Ω–µ—Å–∫–æ–ª—å–∫–∏–º–∏ –≤–∏–¥–∞–º–∏ —Ä–∞–∫–∞ —É–≤–µ–ª–∏—á–∏–ª–∞—Å—å –≤ –º–∏—Ä–µ –∑–∞ –ø–æ—Å–ª–µ–¥–Ω–∏–µ –¥–≤–∞ –¥–µ—Å—è—Ç–∏–ª–µ—Ç–∏—è —Å—Ä–µ–¥–∏ –≤–∑—Ä–æ—Å–ª—ã—Ö –≤—Å–µ—Ö –≤–æ–∑—Ä–∞—Å—Ç–æ–≤, –æ—Å–æ–±–µ–Ω–Ω–æ —Å—Ä–µ–¥–∏ –º–æ–ª–æ–¥—ã—Ö –ª—é–¥–µ–π. –£—á–µ–Ω—ã–µ –ø—Ä–µ–¥–ø–æ–ª–∞–≥–∞—é—Ç, —á—Ç–æ –æ–¥–Ω–æ–π –∏–∑ –≤–æ–∑–º–æ–∂–Ω—ã—Ö –ø—Ä–∏—á–∏–Ω —ç—Ç–æ–≥–æ –º–æ–∂–µ—Ç –±—ã—Ç—å —Ä–æ—Å—Ç —É—Ä–æ–≤–Ω—è –æ–∂–∏—Ä–µ–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pyto2 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–û–Ω–∫–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-10-27T13:12:03+00:00,@medpharm,13292,https://t.me/medpharm/13292,"–ê–ª—å—è–Ω—Å —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–π –ø–æ–ª—É—á–∏–ª –æ—Ç–≤–µ—Ç –Ω–∞ –ø—Ä–æ—Å—å–±—É —Å–Ω–∏–∑–∏—Ç—å —Ñ–æ—Ä–º–∞–ª–∏–∑–º –ø—Ä–∏ –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–∏ –æ–ø—ã—Ç–Ω—ã—Ö –ø—Ä–æ–≤–∏–∑–æ—Ä–æ–≤ –æ—Ç –§–ê–¶. –†–µ–≥—É–ª—è—Ç–æ—Ä —Å–æ–æ–±—â–∏–ª, —á—Ç–æ —Å–æ–±–ª—é–¥–∞–µ—Ç –≤—Å–µ —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–Ω—ã–µ –ø—Ä–æ—Ü–µ–¥—É—Ä—ã. –°–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –º–æ–≥—É—Ç –ø–æ—Å–ª–µ –ø–æ–ª—É—á–µ–Ω–∏—è –æ—Ç–∫–∞–∑–∞ –Ω–∞–ø—Ä–∞–≤–∏—Ç—å –∑–∞—è–≤–ª–µ–Ω–∏–µ –æ –¥–æ–ø—É—Å–∫–µ –∫ –ø–µ—Ä–∏–æ–¥–∏—á–µ—Å–∫–æ–π –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–∏ –¥–ª—è –ø–æ–≤—Ç–æ—Ä–Ω–æ–≥–æ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏—è, –æ—Ç–º–µ—Ç–∏–ª–∏ –≤ —Ü–µ–Ω—Ç—Ä–µ. –ê–ª—å—è–Ω—Å –Ω–µ —Å–æ–≥–ª–∞—Å–µ–Ω —Å —Ç–∞–∫–∏–º –ø–æ–¥—Ö–æ–¥–æ–º –∫ —Ä–µ—à–µ–Ω–∏—é –ø—Ä–æ–±–ª–µ–º—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pysfy #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""medium"",
  ""english"": ""The Alliance for Pharmaceutical Associations received a response from the FAP regarding reducing formalism in accreditation of experienced investigators. The regulator stated that they will comply with all established procedures. Specialists can submit a request for admission to periodic accreditation after receiving the rejection, noted in the center. The Alliance disagrees with this approach to solving the problem. For more details: https://clck.ru/3Pysfy #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞""
}"
2025-10-27T12:26:02+00:00,@medpharm,13291,https://t.me/medpharm/13291,"–ë—Ä—é—Å—Å–µ–ª—å—Å–∫–∞—è –∫–æ–º–ø–∞–Ω–∏—è Kantify —Å–æ–∑–¥–∞–ª–∞ –ò–ò-–º–æ–¥–µ–ª—å Sapian, –∫–æ—Ç–æ—Ä–∞—è –∞–Ω–∞–ª–∏–∑–∏—Ä—É–µ—Ç –µ–∂–µ–¥–Ω–µ–≤–Ω–æ –¥–æ 10 –º–ª—Ä–¥ —Ç–µ—Ä–∞–ø–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –º–æ–ª–µ–∫—É–ª –¥–ª—è —Å–æ–∑–¥–∞–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤. –°–æ–≤—Ä–µ–º–µ–Ω–Ω—ã–µ –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–∏–∏ —Å–º–æ–≥–ª–∏ –±—ã —Å–¥–µ–ª–∞—Ç—å —ç—Ç–æ —Ç–æ–ª—å–∫–æ –∑–∞ 274 –≥–æ–¥–∞.‚Äã –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pyo7Y #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-27T12:19:07+00:00,@medpharm,13290,https://t.me/medpharm/13290,–ò—Å–ø–æ–ª–Ω—è—é—â–µ–π –æ–±—è–∑–∞–Ω–Ω–æ—Å—Ç–∏ –º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ö—É—Ä—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –Ω–∞–∑–Ω–∞—á–µ–Ω–∞ –°–≤–µ—Ç–ª–∞–Ω–∞ –ï—Ä–º–æ–ª–æ–≤–∞. –°–º–µ–Ω–∞ —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–∞ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ —Ä–µ–≥–∏–æ–Ω–∞ —Å–≤—è–∑–∞–Ω–∞ —Å –∑–∞—Ç—è–≥–∏–≤–∞–Ω–∏–µ–º –ø—Ä–æ–≤–µ—Ä–∫–∏ –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ ¬´–ö—É—Ä—Å–∫–æ–π —Ñ–∞—Ä–º–∞—Ü–∏–∏¬ª –∏ –∂–∞–ª–æ–±–∞–º–∏ –Ω–∞ –ø–µ—Ä–µ–±–æ–∏ —Å –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PynQi #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-10-27T11:28:03+00:00,@medpharm,13289,https://t.me/medpharm/13289,"–° 7 —è–Ω–≤–∞—Ä—è 2026 –≥–æ–¥–∞ –≤—Å–µ –∞–ø—Ç–µ–∫–∏ –¥–æ–ª–∂–Ω—ã –±—É–¥—É—Ç –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å —Å–µ—Ä—Ç–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –º–æ–¥—É–ª–∏ –ø—Ä–æ–≤–µ—Ä–∫–∏ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –æ —Ç–æ–≤–∞—Ä–µ ‚Äî –¢–° –ü–ò–æ–¢. –≠—Ç–∞ –º–µ—Ä–∞ –ø—Ä–∏–∑–≤–∞–Ω–∞ –∑–∞—â–∏—Ç–∏—Ç—å –±–∏–∑–Ω–µ—Å –æ—Ç –Ω–µ–ø—Ä–µ–¥–Ω–∞–º–µ—Ä–µ–Ω–Ω—ã—Ö –æ—à–∏–±–æ–∫ –ø—Ä–∏ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –í —Ä–µ–µ—Å—Ç—Ä–µ ¬´–ß–µ—Å—Ç–Ω–æ–≥–æ –∑–Ω–∞–∫–∞¬ª —á–∏—Å–ª–∏—Ç—Å—è –ª–∏—à—å –æ–¥–∏–Ω –ø–æ—Å—Ç–∞–≤—â–∏–∫, —á—å–µ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏–µ —Å–æ–≤–º–µ—Å—Ç–∏–º–æ —Å –ö–ö–¢ –¥–≤—É—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PyhUu #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""medium"",
  ""english"": ""Starting January 7, 2026, all pharmacies must use certified information verification modules ‚Äî TSPiOt. This measure aims to protect the business from unintentional errors during drug implementation. Only one supplier is listed in the 'Fair Sign' registry, whose equipment is compatible with two manufacturers' KKT systems.""
}"
2025-10-27T10:13:02+00:00,@medpharm,13287,https://t.me/medpharm/13287,"–ö–∞—Ä—Ç–µ–ª—å –ø—Ä–∏ –ø–æ—Å—Ç–∞–≤–∫–µ –∂–∏–∑–Ω–µ–Ω–Ω–æ –≤–∞–∂–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –Ω–∞ 812 –º–ª–Ω —Ä—É–±. —Ä–∞—Å–∫—Ä—ã–ª–∞ –§–ê–° –†–æ—Å—Å–∏–∏. –ö–æ–º–ø–∞–Ω–∏—è–º ¬´–ú–§–ö ¬´–ê—Ä—Ñ–∞¬ª –∏ ¬´–ü—Ä–æ—Å—Ç–æ—Ä—ã –ó–¥–æ—Ä–æ–≤—å—è¬ª –≥—Ä–æ–∑—è—Ç –∞–¥–º–∏–Ω–∏—Å—Ç—Ä–∞—Ç–∏–≤–Ω—ã–µ —à—Ç—Ä–∞—Ñ—ã, —Ä–µ—à–∞–µ—Ç—Å—è –≤–æ–ø—Ä–æ—Å –æ –≤–æ–∑–±—É–∂–¥–µ–Ω–∏–∏ —É–≥–æ–ª–æ–≤–Ω–æ–≥–æ –¥–µ–ª–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PyZbw #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{""skip"": false, ""country"": ""global"", ""topic"": ""import_export"", ""impact"": ""high"", ""english"": ""The Federal Antimonopoly Service of Russia has exposed a cartel for the supply of vital medicines worth 812 million rubles. Companies 'MFK Arfa' and 'Prostori Zdraviy' are facing administrative fines, and a criminal case is being considered. For more details: https://clck.ru/3PyZbw #PharmNews #Distribution""}"
2025-10-27T09:51:06+00:00,@medpharm,13286,https://t.me/medpharm/13286,"–ù–µ–∏—Å–ø–æ–ª–Ω–µ–Ω–∏–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π —Å–ª—É–∂–∏—Ç –æ–¥–Ω–∏–º –∏–∑ –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å—Å—Ç–≤ –≤–∏–Ω–æ–≤–Ω–æ—Å—Ç–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ —Ä–∞–±–æ—Ç–Ω–∏–∫–∞ –ø—Ä–∏ —Ä–∞—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–∏ —É–≥–æ–ª–æ–≤–Ω—ã—Ö –¥–µ–ª –æ –Ω–µ–∫–∞—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–º –æ–∫–∞–∑–∞–Ω–∏–∏ –º–µ–¥–ø–æ–º–æ—â–∏. –û—à–∏–±–æ—á–Ω—ã–π —Ç–µ–∑–∏—Å, —á—Ç–æ —ç—Ç–∏ –¥–æ–∫—É–º–µ–Ω—Ç—ã –Ω–µ –Ω–æ—Å—è—Ç —Ö–∞—Ä–∞–∫—Ç–µ—Ä –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã—Ö, —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω—è—é—Ç –¥–∞–∂–µ —é—Ä–∏—Å—Ç—ã, –∏ —ç—Ç–æ –≥–ª—É–±–æ—á–∞–π—à–µ–µ –∑–∞–±–ª—É–∂–¥–µ–Ω–∏–µ, —Å–æ–æ–±—â–∏–ª–∏ –≤ –°–ª–µ–¥—Å—Ç–≤–µ–Ω–Ω–æ–º –∫–æ–º–∏—Ç–µ—Ç–µ –†–æ—Å—Å–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PyXJD #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,hospital_policy,pharmacovigilance,safety"",
  ""impact"": ""high"",
  ""english"": ""The failure to comply with clinical recommendations is one of the evidence of a medical staff member's guilt in criminal investigations into substandard medical care. The erroneous thesis that these documents are not mandatory is a deep misconception, according to the Russian Investigative Committee. More: https://clck.ru/3PyXJD #MedVestnik #Healthcare""
}"
2025-10-27T09:04:02+00:00,@medpharm,13285,https://t.me/medpharm/13285,29 –æ–∫—Ç—è–±—Ä—è –≤ —Ä–∞–º–∫–∞—Ö –¥–µ–ª–æ–≤–æ–π –ø—Ä–æ–≥—Ä–∞–º–º—ã 26-–≥–æ —Å–µ–∑–æ–Ω–∞ ¬´–ü–ª–∞—Ç–∏–Ω–æ–≤–æ–π —É–Ω—Ü–∏–∏¬ª —Å–æ—Å—Ç–æ–∏—Ç—Å—è –≤—Ç–æ—Ä–æ–π –±–∏–∑–Ω–µ—Å –∑–∞–≤—Ç—Ä–∞–∫ ¬´–ù–æ–≤–æ–µ –≤ –æ—Ç—Ä–∞—Å–ª–∏. –õ–æ–Ω—á–∏¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PySQP #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-10-27T08:55:03+00:00,@medpharm,13284,https://t.me/medpharm/13284,"–°—É–¥ –ø—Ä–∏–≥–æ–≤–æ—Ä–∏–ª —ç–∫—Å-–∑–∞–≤–µ–¥—É—é—â—É—é –∞–ø—Ç–µ–∫–æ–π –≤ –ö—Ä–∞—Å–Ω–æ—è—Ä—Å–∫–æ–º –∫—Ä–∞–µ –∫ 3,5 –≥–æ–¥–∞ –ª–∏—à–µ–Ω–∏—è —Å–≤–æ–±–æ–¥—ã —É—Å–ª–æ–≤–Ω–æ –∑–∞ –ø–æ—Å–æ–±–Ω–∏—á–µ—Å—Ç–≤–æ –ø—Ä–µ—Å—Ç—É–ø–Ω–æ–π –≥—Ä—É–ø–ø–µ. –í —Ç–µ—á–µ–Ω–∏–µ –Ω–µ—Å–∫–æ–ª—å–∫–∏—Ö –ª–µ—Ç –æ–Ω–∞ –ø–æ–¥–¥–µ–ª—ã–≤–∞–ª–∞ —Ä–µ—Ü–µ–ø—Ç—ã –∏ –ø–æ—Å—Ç–∞–≤–ª—è–ª–∞ —Å–∏–ª—å–Ω–æ–¥–µ–π—Å—Ç–≤—É—é—â–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∑–Ω–∞–∫–æ–º–æ–º—É –≤—Ä–∞—á—É. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PyRPE #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{""skip"": true}"
2025-10-27T08:29:09+00:00,@medpharm,13283,https://t.me/medpharm/13283,"–ö–∞–±–º–∏–Ω —Ä–µ—à–∏–ª —É–≤–µ–ª–∏—á–∏—Ç—å —á–∏—Å–ª–æ –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª–µ–π —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—è –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–∞ –¥–æ —á–µ—Ç—ã—Ä–µ—Ö —Å 1 —è–Ω–≤–∞—Ä—è 2026 –≥–æ–¥–∞. –í–µ–¥–æ–º—Å—Ç–≤–æ –ê–ª–ª—ã –°–∞–º–æ–π–ª–æ–≤–æ–π —Ç–∞–∫–∂–µ –ø–æ–ª—É—á–∏—Ç –Ω–æ–≤–æ–µ –ø—Ä–æ—Ñ–∏–ª—å–Ω–æ–µ —É–ø—Ä–∞–≤–ª–µ–Ω–∏–µ, –¥–µ–≤—è—Ç–æ–µ –ø–æ —Å—á–µ—Ç—É. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PyNWZ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-10-27T08:00:09+00:00,@medpharm,13282,https://t.me/medpharm/13282,"–ö–æ–ª–ª–µ–∫—Ç–∏–≤–Ω–æ–µ –æ–±—Ä–∞—â–µ–Ω–∏–µ —Ñ–∞—Ä–º—Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –ø–æ –ø–æ–≤–æ–¥—É —Å–ª–æ–∂–Ω–æ—Å—Ç–µ–π, —Å –∫–æ—Ç–æ—Ä—ã–º–∏ —Å—Ç–∞–ª–∫–∏–≤–∞—é—Ç—Å—è —Ñ–∞—Ä–º—Ä–∞–±–æ—Ç–Ω–∏–∫–∏ –ø—Ä–∏ –ø—Ä–æ—Ö–æ–∂–¥–µ–Ω–∏–∏ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–π –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–∏, –æ—Ç–ø—Ä–∞–≤–ª–µ–Ω–æ –≤ –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–æ—Å—Å–∏–∏, –ì–æ—Å–¥—É–º—É –†–§ –∏ –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§. ¬´–ò–∑-–∑–∞ –Ω–µ—Å–æ–≥–ª–∞—Å–æ–≤–∞–Ω–Ω–æ—Å—Ç–∏ –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω—ã—Ö –∞–∫—Ç–æ–≤ –∏ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏—è –ø–µ—Ä–µ—Ö–æ–¥–Ω—ã—Ö –ø–æ–ª–æ–∂–µ–Ω–∏–π –æ–ø—ã—Ç–Ω—ã–µ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã, –¥–µ—Å—è—Ç–∏–ª–µ—Ç–∏—è–º–∏ –ø—Ä–æ—Ä–∞–±–æ—Ç–∞–≤—à–∏–µ –≤ —Ñ–∞—Ä–º–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è—Ö, —Ñ–∞–∫—Ç–∏—á–µ—Å–∫–∏ –æ–∫–∞–∑—ã–≤–∞—é—Ç—Å—è –∏—Å–∫–ª—é—á–µ–Ω–Ω—ã–º–∏ –∏–∑ –ø—Ä–æ—Ñ–µ—Å—Å–∏–∏¬ª, ‚Äî –≥–æ–≤–æ—Ä–∏—Ç—Å—è –≤ –ø–∏—Å—å–º–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PyKXY #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–∞—Ä—å–µ—Ä–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""A collective letter from pharmaceutical professionals about difficulties experienced by healthcare workers during professional accreditation has been sent to the Russian Government, State Duma of Russia and Ministry of Health of Russia. 'Due to inconsistent regulatory acts and the lack of transitional provisions, experienced specialists who have worked for decades in pharmaceutical organizations are effectively excluded from their profession,' the letter states. More details: https://clck.ru/3PyKXY #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–∞—Ä—å–µ—Ä–∞""
}"
2025-10-27T07:11:06+00:00,@medpharm,13281,https://t.me/medpharm/13281,–ü–æ—Å–ª–µ –≤—Å—Ç—É–ø–ª–µ–Ω–∏—è –≤ —Å–∏–ª—É –∑–∞–∫–æ–Ω–∞ –æ —á–∞—Å—Ç–∏—á–Ω–æ–π –¥–µ–∫—Ä–∏–º–∏–Ω–∞–ª–∏–∑–∞—Ü–∏–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –ø—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–∏—Ç–µ–ª—å–Ω—ã–µ –æ—Ä–≥–∞–Ω—ã —Å—Ç–∞–ª–∏ —Ä–µ–∂–µ –≤–æ–∑–±—É–∂–¥–∞—Ç—å —É–≥–æ–ª–æ–≤–Ω—ã–µ –¥–µ–ª–∞ –∏–∑-–∑–∞ –Ω–µ–∫–∞—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–π –º–µ–¥–ø–æ–º–æ—â–∏. –í—Å–µ–≥–æ –ø–æ –¥–∞–Ω–Ω—ã–º –∑–∞ 9 –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ –≤ —Å–≤—è–∑–∏ —Å —è—Ç—Ä–æ–≥–µ–Ω–Ω—ã–º–∏ –ø—Ä–µ—Å—Ç—É–ø–ª–µ–Ω–∏—è–º–∏ –±—ã–ª–æ –≤–æ–∑–±—É–∂–¥–µ–Ω–æ 1408 —É–≥–æ–ª–æ–≤–Ω—ã—Ö –¥–µ–ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PyEa9 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{
  ""skip"": true
}"
2025-10-27T06:07:04+00:00,@medpharm,13280,https://t.me/medpharm/13280,"–£ –ø–æ–∂–∏–ª—ã—Ö –ª—é–¥–µ–π —Å –¥–µ–º–µ–Ω—Ü–∏–µ–π –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ —Ä–∏—Å–ø–µ—Ä–∏–¥–æ–Ω–∞ —Å–≤—è–∑–∞–Ω–æ —Å –ø–æ–≤—ã—à–µ–Ω–Ω—ã–º —Ä–∏—Å–∫–æ–º –∏–Ω—Å—É–ª—å—Ç–∞ –Ω–µ–∑–∞–≤–∏—Å–∏–º–æ –æ—Ç –Ω–∞–ª–∏—á–∏—è —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –≠—Ç–æ —É–∫–∞–∑—ã–≤–∞–µ—Ç –Ω–∞ —Ç–æ, —á—Ç–æ –±–µ–∑–æ–ø–∞—Å–Ω—ã—Ö –ø–æ–¥–≥—Ä—É–ø–ø –¥–ª—è –Ω–∞–∑–Ω–∞—á–µ–Ω–∏—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –Ω–µ —Å—É—â–µ—Å—Ç–≤—É–µ—Ç. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Py8es #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ö–∞—Ä–¥–∏–æ–ª–æ–≥–∏—è #–ù–µ–≤—Ä–æ–ª–æ–≥–∏—è #–ü—Å–∏—Ö–∏–∞—Ç—Ä–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance, safety"",
  ""impact"": ""high"",
  ""english"": ""The use of risperidone in elderly patients with dementia is associated with an increased risk of stroke, regardless of the presence of cardiovascular diseases. This suggests that there are no safe subgroups for prescribing the drug. For more information: https://clck.ru/3Py8es #MedVestnik #Practice #Cardiology #Neurology #Psychiatry #Therapy #Pharmacology""
}"
2025-10-26T11:50:42+00:00,@medpharm,13279,https://t.me/medpharm/13279,"üëçüëçüëçüëçüëçüëç ¬´–ö–∞–≥–æ—Ü–µ–ª¬ª –∏—Å–∫–ª—é—á–∏–ª–∏ –∏–∑ —Å–ø–∏—Å–∫–∞ –∏–º–º—É–Ω–æ–º–æ–¥—É–ª–∏—Ä—É—é—â–∏—Ö —Å—Ä–µ–¥—Å—Ç–≤ —Å —à–∏—Ä–æ–∫–∏–º –ø—Ä–æ—Ç–∏–≤–æ–≤–∏—Ä—É—Å–Ω—ã–º –¥–µ–π—Å—Ç–≤–∏–µ–º, —Ä–µ–∫–æ–º–µ–Ω–¥–æ–≤–∞–Ω–Ω—ã—Ö –¥–ª—è –ª–µ—á–µ–Ω–∏—è –≥—Ä–∏–ø–ø–∞, –Ω–æ –¥–æ–±–∞–≤–∏–ª–∏ —á–µ—Ç—ã—Ä–µ –Ω–æ–≤—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞. –¢–∞–∫–∂–µ –¥–æ–±–∞–≤–ª–µ–Ω–æ –Ω–æ–≤–æ–µ –ø—Ä–æ—Ç–∏–≤–æ–∫–∞—à–ª–µ–≤–æ–µ —Å—Ä–µ–¥—Å—Ç–≤–æ. –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏ –æ–±–Ω–æ–≤–∏–ª –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø–æ –≤–µ–¥–µ–Ω–∏—é –≤–∑—Ä–æ—Å–ª—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –≥—Ä–∏–ø–ø–æ–º. –î–µ–ø—É—Ç–∞—Ç –ì–æ—Å–¥—É–º—ã –†–§ –ë–∞–¥–º–∞ –ë–∞—à–∞–Ω–∫–∞–µ–≤ –æ–±—Ä–∞—Ç–∏–ª—Å—è –∫ –º–∏–Ω–∏—Å—Ç—Ä—É –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –†–§ –ú–∏—Ö–∞–∏–ª—É –ú—É—Ä–∞—à–∫–æ. –°–æ—Ç—Ä—É–¥–Ω–∏–∫–∏ –∞–ø—Ç–µ–∫ –º–∞—Å—Å–æ–≤–æ —Å—Ç–∞–ª–∫–∏–≤–∞—é—Ç—Å—è —Å –æ—Ç–∫–∞–∑–∞–º–∏ –≤ –ø—Ä–æ—Ö–æ–∂–¥–µ–Ω–∏–∏ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–π –ø–µ—Ä–∏–æ–¥–∏—á–µ—Å–∫–æ–π –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–∏, —á—Ç–æ —Å–æ–∑–¥–∞–µ—Ç —É–≥—Ä–æ–∑—É —É—Ö–æ–¥–∞ –∫–≤–∞–ª–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –∫–∞–¥—Ä–æ–≤ –∏–∑ –æ—Ç—Ä–∞—Å–ª–∏, –∫–æ—Ç–æ—Ä–∞—è —É–∂–µ –∏—Å–ø—ã—Ç—ã–≤–∞–µ—Ç —Å–µ—Ä—å–µ–∑–Ω—ã–π –¥–µ—Ñ–∏—Ü–∏—Ç —Ñ–∞—Ä–º—Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤. –ö–æ–ª–∏—á–µ—Å—Ç–≤–æ –æ–±—Ä–∞—â–µ–Ω–∏–π –≥—Ä–∞–∂–¥–∞–Ω –≤ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä –ø–æ –≤–æ–ø—Ä–æ—Å–∞–º –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏ –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º–∏ –∏–∑–¥–µ–ª–∏—è–º–∏ —É–≤–µ–ª–∏—á–∏–ª–æ—Å—å –ø–æ—á—Ç–∏ –Ω–∞ 18% –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –ø—Ä–æ—à–ª—ã–º –≥–æ–¥–æ–º. –ü–æ—á—Ç–∏ –Ω–∞ 20% –≤—ã—Ä–æ—Å–ª–æ —á–∏—Å–ª–æ –∂–∞–ª–æ–± –Ω–∞ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤. –ö–æ–ª–ª–µ–≥–∏—è –ï–≠–ö –æ–¥–æ–±—Ä–∏–ª–∞ –∫–æ—Ä—Ä–µ–∫—Ç–∏—Ä–æ–≤–∫—É –ø—Ä–∞–≤–∏–ª —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ —Å—Ç—Ä–∞–Ω–∞—Ö –ï–ê–≠–°. –ü—Ä–æ–µ–∫—Ç –∏–∑–º–µ–Ω–µ–Ω–∏–π –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω –Ω–∞ —É–Ω–∏—Ñ–∏–∫–∞—Ü–∏—é –∏ —É–ø—Ä–æ—â–µ–Ω–∏–µ –ø—Ä–æ—Ü–µ–¥—É—Ä –¥–ª—è –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π, –∞ —Ç–∞–∫–∂–µ –Ω–∞ –ø–æ–≤—ã—à–µ–Ω–∏–µ –ø—Ä–æ–∑—Ä–∞—á–Ω–æ—Å—Ç–∏ —ç–∫—Å–ø–µ—Ä—Ç–∏–∑—ã. –ê–ø—Ç–µ–∫—É —Å–µ—Ç–∏ ¬´–ë–∞—à—Ñ–∞—Ä–º–∞—Ü–∏—è¬ª –æ—à—Ç—Ä–∞—Ñ–æ–≤–∞–ª–∏ –Ω–∞ 500 —Ç—ã—Å. —Ä—É–±. –∑–∞ –ø—Ä–æ–¥–∞–∂—É –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞, –∫–æ—Ç–æ—Ä—ã–π —Ä–∞–Ω–µ–µ –æ—Ç–æ–∑–≤–∞–ª –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä. –ê–ø—Ç–µ–∫–∞ —É—Å–ø–µ–ª–∞ –æ—Ç–ø—É—Å—Ç–∏—Ç—å –≤–æ—Å–µ–º—å —É–ø–∞–∫–æ–≤–æ–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –∑–∞–±—Ä–∞–∫–æ–≤–∞–Ω–Ω–æ–π —Å–µ—Ä–∏–∏.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""The drug Kagsel was removed from the list of antiviral immune-modulating drugs recommended for flu treatment. Four new medications were added, along with a new cough suppressant. The Russian Ministry of Health updated clinical guidelines for adult patients with flu. Deputy Chairman of the State Duma Bada Bashankayev addressed Minister of Health Mikhail Murashko. Pharmacy staff are facing refusals in mandatory periodic accreditation, which poses a threat to the departure of qualified professionals from the industry, which is already experiencing a serious shortage of pharmaceutical specialists. The number of complaints to Roszdravnadzor regarding drug supply has increased by almost 18% compared to the previous year. Almost a 20% increase in complaints about shortages of medicines. The Collegium EAEU approved amendments to registration rules for medicines in the countries of the EAEU. The project aims to unify and simplify procedures for manufacturers, as well as increase transparency of the review process. A pharmacy in the 'Bashfarmacia' chain was fined 500,000"
2025-10-25T11:37:03+00:00,@medpharm,13278,https://t.me/medpharm/13278,–†–æ—Å—Å–∏–π—Å–∫–∞—è –∞—Å—Å–æ—Ü–∏–∞—Ü–∏—è —É–ø—Ä–∞–≤–ª–µ–Ω—Ü–µ–≤ —Å—Ñ–µ—Ä—ã –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –≤—ã—Å—Ç—É–ø–∏–ª–∞ —Å –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–æ–π —Å–æ–∑–¥–∞–Ω–∏—è –µ–¥–∏–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π —Ü–∏—Ñ—Ä–æ–≤–æ–π –ø–ª–∞—Ç—Ñ–æ—Ä–º—ã —Å—Ç—Ä–∞–Ω –ë–†–ò–ö–°. –ü—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–µ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–æ –º–∏–Ω–∏—Å—Ç—Ä—É –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –†–§ –ú–∏—Ö–∞–∏–ª—É –ú—É—Ä–∞—à–∫–æ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PwCKR #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": true
}"
2025-10-25T09:35:43+00:00,@medpharm,13277,https://t.me/medpharm/13277,"üß©üß©üß©üß©üß©üß© –ì–æ—Å–¥—É–º–∞ –†–§ –ø—Ä–∏–Ω—è–ª–∞ –≤ –ø–µ—Ä–≤–æ–º —á—Ç–µ–Ω–∏–∏ –ø–æ–ø—Ä–∞–≤–∫–∏ –≤ –∑–∞–∫–æ–Ω ¬´–û–± –û–ú–°¬ª, –≤ —Ç–æ–º —á–∏—Å–ª–µ –Ω–∞–¥–µ–ª—è—é—â–∏–µ –≥—É–±–µ—Ä–Ω–∞—Ç–æ—Ä–æ–≤ –ø—Ä–∞–≤–æ–º –ø—Ä–∏–Ω–∏–º–∞—Ç—å —Ä–µ—à–µ–Ω–∏–µ –æ –∑–∞–º–µ–Ω–µ —Å—Ç—Ä–∞—Ö–æ–≤—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω—ã–º–∏ —Ñ–æ–Ω–¥–∞–º–∏ –û–ú–°. –ù–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ –≤ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω–æ–º TOP5 –¥—Ä—É–≥–æ–π —Å–ø–æ—Ä–Ω—ã–π –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç ‚Äì –æ –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–µ –∏ —Ü–µ–ª–µ–≤–æ–º –æ–±—É—á–µ–Ω–∏–∏ –º–µ–¥–∏–∫–æ–≤, –ø—Ä–∏–∑–≤–∞–Ω–Ω—ã–π, –ø–æ –∑–∞–¥—É–º–∫–µ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–§, —Ä–µ—à–∏—Ç—å –ø—Ä–æ–±–ª–µ–º—É –Ω–µ—Ö–≤–∞—Ç–∫–∏ –∫–∞–¥—Ä–æ–≤ –≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–∏. –î–µ–ø—É—Ç–∞—Ç—ã –ø—Ä–æ–¥–æ–ª–∂–∞—é—Ç –≤–Ω–æ—Å–∏—Ç—å –ø–æ–ø—Ä–∞–≤–∫–∏ –≤ –¥–æ–∫—É–º–µ–Ω—Ç –∫–æ –≤—Ç–æ—Ä–æ–º—É —á—Ç–µ–Ω–∏—é. –ù–∞ —ç—Ç–æ–π –Ω–µ–¥–µ–ª–µ –ì–æ—Å–¥—É–º–∞ –†–§ –ø—Ä–∏–Ω—è–ª–∞ –≤ –ø–µ—Ä–≤–æ–º —á—Ç–µ–Ω–∏–∏ –±—é–¥–∂–µ—Ç –§–û–ú–° –Ω–∞ 2026‚Äì2028 –≥–æ–¥—ã. –û–±—Å—É–∂–¥–µ–Ω–∏–µ –¥–æ–∫—É–º–µ–Ω—Ç–∞ –Ω–µ –æ–≥—Ä–∞–Ω–∏—á–∏–ª–æ—Å—å —Ü–∏—Ñ—Ä–∞–º–∏ ‚Äî –¥–µ–ø—É—Ç–∞—Ç—ã —Ä–∞–∑–æ—à–ª–∏—Å—å –≤–æ –≤–∑–≥–ª—è–¥–∞—Ö –Ω–∞ —Å–∞–º—É –º–æ–¥–µ–ª—å —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è. –ù–∞ —á–µ—Ç–≤–µ—Ä—Ç–æ–º –º–µ—Å—Ç–µ –≤ TOP5 –Ω–æ–≤–æ—Å—Ç—å –æ –ø–æ–¥–≥–æ—Ç–æ–≤–∫–µ –ú–∏–Ω–∑–¥—Ä–∞–≤–æ–º –†–§ –ø–µ—Ä–µ—á–Ω—è –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π –¥–ª—è –º–æ–¥–µ—Ä–Ω–∏–∑–∞—Ü–∏–∏ –∏ –¥–æ–æ—Å–Ω–∞—â–µ–Ω–∏—è –ø–æ–¥—Ä–∞–∑–¥–µ–ª–µ–Ω–∏–π —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã—Ö –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π, –æ–∫–∞–∑—ã–≤–∞—é—â–∏—Ö –ø–æ–º–æ—â—å —Å –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º —Ä–∞–¥–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –º–µ—Ç–æ–¥–æ–≤ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∏ –∏ —Ç–µ—Ä–∞–ø–∏–∏. –í —Å–ø–∏—Å–∫–µ 14 –≤–∏–¥–æ–≤ –º–µ–¥–∏–∑–¥–µ–ª–∏–π –∏ 37 –≤–∏–¥–æ–≤ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è. –ó–∞–º—ã–∫–∞–µ—Ç –ø—è—Ç–µ—Ä–∫—É –Ω–æ–≤–æ—Å—Ç–µ–π —Å–æ–æ–±—â–µ–Ω–∏–µ –æ –Ω–∞–≥—Ä–∞–∂–¥–µ–Ω–∏–∏ –ª–∞—É—Ä–µ–∞—Ç–æ–≤ –≤—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –∫–æ–Ω–∫—É—Ä—Å–æ–≤ ¬´–õ—É—á—à–∏–π –≤—Ä–∞—á –≥–æ–¥–∞¬ª –∏ ¬´–õ—É—á—à–∏–π —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç —Å–æ —Å—Ä–µ–¥–Ω–∏–º –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–º –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ–º¬ª. –¢–æ—Ä–∂–µ—Å—Ç–≤–µ–Ω–Ω–∞—è —Ü–µ—Ä–µ–º–æ–Ω–∏—è –ø—Ä–æ—à–ª–∞ –Ω–∞ –∫–æ–Ω–≥—Ä–µ—Å—Å–µ ¬´–ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ¬ª.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The State Duma of Russia approved amendments to the 'Health Insurance Fund Law' in its first reading, including granting governors the right to decide on replacing insurance medical organizations with territorial funds of the Health Insurance Fund. Another controversial draft law, 'teaching and purposeful training for medical personnel,' is on the second place in the information TOP5, aimed at solving a shortage of healthcare workers. The State Duma is still working on amendments to the budget for the Health Insurance Fund for 2026-2028. The discussion of the document did not end with numbers - deputies had different views on the model of funding. The fifth news item is about the preparation by the Russian Health Ministry for a list of medical equipment and medical devices to modernize and equip regional healthcare facilities providing services using radiological methods. The sixth news item is about the award ceremony for winners of national competitions 'Best Doctor of the Year' and 'Best Specialist with a Secondary Medical and Pharmaceutical Education.' The ceremony took place at the National Healthcare Congress.""
}"
2025-10-25T06:09:04+00:00,@medpharm,13276,https://t.me/medpharm/13276,"–£–ø—Ä–∞–≤–ª–µ–Ω–∏–µ –ø–æ —Å–∞–Ω–∏—Ç–∞—Ä–Ω–æ–º—É –Ω–∞–¥–∑–æ—Ä—É –∑–∞ –∫–∞—á–µ—Å—Ç–≤–æ–º –ø–∏—â–µ–≤—ã—Ö –ø—Ä–æ–¥—É–∫—Ç–æ–≤ –∏ –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç–æ–≤ –°–®–ê (FDA) –æ–¥–æ–±—Ä–∏–ª–æ –Ω–æ–≤—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç Epioxa –¥–ª—è –ª–µ—á–µ–Ω–∏—è –∫–µ—Ä–∞—Ç–æ–∫–æ–Ω—É—Å–∞. –≠—Ç–æ –ø–µ—Ä–≤–æ–µ —Å—Ä–µ–¥—Å—Ç–≤–æ –¥–ª—è –º–µ—Å—Ç–Ω–æ–≥–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è, –Ω–µ —Ç—Ä–µ–±—É—é—â–µ–µ —É–¥–∞–ª–µ–Ω–∏—è —ç–ø–∏—Ç–µ–ª–∏—è —Ä–æ–≥–æ–≤–∏—Ü—ã, —á—Ç–æ –¥–µ–ª–∞–µ—Ç –ª–µ—á–µ–Ω–∏–µ –º–µ–Ω–µ–µ –±–æ–ª–µ–∑–Ω–µ–Ω–Ω—ã–º –∏ —Å–æ–∫—Ä–∞—â–∞–µ—Ç –ø–µ—Ä–∏–æ–¥ –≤–æ—Å—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pvk2V #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–û—Ñ—Ç–∞–ª—å–º–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-10-24T17:01:57+00:00,@medpharm,13274,https://t.me/medpharm/13274,"ü¶æ –®–∞–Ω—Å –∏—Å–ø—Ä–∞–≤–∏—Ç—å—Å—è. –î–µ–ø—É—Ç–∞—Ç—ã –ø—Ä–æ–¥–æ–ª–∂–∞—é—Ç –≤–Ω–æ—Å–∏—Ç—å –ø–æ–ø—Ä–∞–≤–∫–∏ –≤ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–µ –∏ —Ü–µ–ª–µ–≤–æ–º –æ–±—É—á–µ–Ω–∏–∏ –º–µ–¥–∏–∫–æ–≤. –û—Å–æ–±–µ–Ω–Ω–æ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª–µ–π –±–µ—Å–ø–æ–∫–æ—è—Ç –Ω–µ–ø–æ–º–µ—Ä–Ω—ã–µ —à—Ç—Ä–∞—Ñ—ã. ü¶æ –î–æ–∂–¥–∞–ª–∏—Å—å –ø–æ—á–µ—Å—Ç–µ–π. –°–æ—Å—Ç–æ—è–ª–æ—Å—å –Ω–∞–≥—Ä–∞–∂–¥–µ–Ω–∏–µ –ª–∞—É—Ä–µ–∞—Ç–æ–≤ –≤—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –∫–æ–Ω–∫—É—Ä—Å–æ–≤ ¬´–õ—É—á—à–∏–π –≤—Ä–∞—á –≥–æ–¥–∞¬ª –∏ ¬´–õ—É—á—à–∏–π —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç —Å–æ —Å—Ä–µ–¥–Ω–∏–º –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–º –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ–º¬ª. –ò—Ö –∏–º–µ–Ω–∞ –±—ã–ª–∏ –∏–∑–≤–µ—Å—Ç–Ω—ã –µ—â–µ –≤ –∏—é–ª–µ. ‚ù§Ô∏è –û–ø–∞—Å–∞—é—Ç—Å—è –≤—ã–ø–∞–¥–µ–Ω–∏—è. –ê–†–§–ü –æ–±—Ä–∞—Ç–∏–ª–∞—Å—å –∫ –≥–ª–∞–≤–µ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–§ –ú–∏—Ö–∞–∏–ª—É –ú—É—Ä–∞—à–∫–æ —Å –ø—Ä–æ—Å—å–±–æ–π —É—Å–∫–æ—Ä–∏—Ç—å –≤–Ω–µ—Å–µ–Ω–∏–µ –¥–∞–Ω–Ω—ã—Ö –æ ¬´–Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—ã—Ö¬ª —Ä–µ–≥—É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏—è—Ö –≤ –ì–†–õ–°. –ï—Å–ª–∏ —Å–≤–µ–¥–µ–Ω–∏—è –æ –ø—Ä–æ–¥–ª–µ–Ω–∏–∏ –†–£ –Ω–µ –ø–æ—è–≤—è—Ç—Å—è –≤ —Å–∏—Å—Ç–µ–º–µ –≤ –±–ª–∏–∂–∞–π—à–µ–µ –≤—Ä–µ–º—è, –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –º–æ–≥—É—Ç ¬´–≤—ã–ø–∞—Å—Ç—å¬ª –∏–∑ —Å–∏—Å—Ç–µ–º—ã –≥–æ—Å–∑–∞–∫—É–ø–æ–∫ –∏ –ø–æ—Ç–µ—Ä—è—Ç—å –Ω–∞–ª–æ–≥–æ–≤—ã–µ –ª—å–≥–æ—Ç—ã. ‚ù§Ô∏è –ù–∏–∂–Ω–∏–π —Å—Ç–∞–Ω–µ—Ç —Å—Ç–æ–ª–∏—á–Ω–µ–µ. ¬´–ù–µ–æ—Ñ–∞—Ä–º¬ª –∑–∞–≤–µ—Ä—à–∏–ª–∞ —Å–¥–µ–ª–∫—É –∏ —Ä–µ–±—Ä–µ–Ω–¥–∏–Ω–≥ –¥–≤—É—Ö –Ω–∏–∂–µ–≥–æ—Ä–æ–¥—Å–∫–∏—Ö —Å–µ—Ç–µ–π ‚Äî ¬´–°–æ–ª–Ω–µ—á–Ω–æ–µ –∑–¥–æ—Ä–æ–≤—å–µ¬ª –∏ ¬´–ë—É–¥—å—Ç–µ –∑–¥–æ—Ä–æ–≤—ã¬ª. –¢–µ–ø–µ—Ä—å –≤ –ù–∏–∂–Ω–µ–º –ù–æ–≤–≥–æ—Ä–æ–¥–µ —Ä–∞–±–æ—Ç–∞—é—Ç 67 –∞–ø—Ç–µ–∫ –ø–æ–¥ –±—Ä–µ–Ω–¥–æ–º ¬´–°—Ç–æ–ª–∏—á–∫–∏¬ª.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""The ARFP has requested the head of the Russian Ministry of Health, Mikhail Murashko, to expedite the inclusion of national certificates in the GRLS. If this information is not included in the system within a short time, manufacturers may be 'disqualified' from government procurement and lose tax benefits. Additionally, the company 'Notopharm' has completed a deal and rebranding of two networks in Nizhny Novgorod - 'Sunlight Health' and 'Stay Healthy'. Now there are 67 pharmacies under the brand 'Stolichki' in Nizhny Novgorod.""
}"
2025-10-24T16:24:03+00:00,@medpharm,13273,https://t.me/medpharm/13273,"–ê—Å—Å–æ—Ü–∏–∞—Ü–∏—è –†–æ—Å—Å–∏–π—Å–∫–∏—Ö —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π (–ê–†–§–ü) –æ–±—Ä–∞—Ç–∏–ª–∞—Å—å –∫ –º–∏–Ω–∏—Å—Ç—Ä—É –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –†–æ—Å—Å–∏–∏ –ú–∏—Ö–∞–∏–ª—É –ú—É—Ä–∞—à–∫–æ —Å –ø—Ä–æ—Å—å–±–æ–π —É—Å–∫–æ—Ä–∏—Ç—å –≤–Ω–µ—Å–µ–Ω–∏–µ –¥–∞–Ω–Ω—ã—Ö –æ ¬´–Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—ã—Ö¬ª —Ä–µ–≥—É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏—è—Ö –≤ –ì–†–õ–°. –ï—Å–ª–∏ —Å–≤–µ–¥–µ–Ω–∏—è –æ –ø—Ä–æ–¥–ª–µ–Ω–∏–∏ –†–£ –Ω–µ –ø–æ—è–≤—è—Ç—Å—è –≤ —Å–∏—Å—Ç–µ–º–µ –≤ –±–ª–∏–∂–∞–π—à–µ–µ –≤—Ä–µ–º—è, –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –º–æ–≥—É—Ç ¬´–≤—ã–ø–∞—Å—Ç—å¬ª –∏–∑ —Å–∏—Å—Ç–µ–º—ã –≥–æ—Å–∑–∞–∫—É–ø–æ–∫ –∏ –ø–æ—Ç–µ—Ä—è—Ç—å –Ω–∞–ª–æ–≥–æ–≤—ã–µ –ª—å–≥–æ—Ç—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PvJKT #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage"",
  ""impact"": ""high"",
  ""english"": ""The Russian Federation Pharmaceutical Association has requested the Minister of Health, Mikhail Murashko, to expedite the submission of data on 'national' registrations in the GRLS. If these renewal records are not included in the system soon, manufacturers could be 'dropped' from government procurement and lose tax benefits.""
}"
2025-10-24T15:59:02+00:00,@medpharm,13272,https://t.me/medpharm/13272,¬´–ì–µ–Ω–µ—Ä–∏—É–º¬ª –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è –ª–µ—á–µ–Ω–∏—è –º—É–∫–æ–ø–æ–ª–∏—Å–∞—Ö–∞—Ä–∏–¥–æ–∑–∞ II —Ç–∏–ø–∞ (—Å–∏–Ω–¥—Ä–æ–º–∞ –•–∞–Ω—Ç–µ—Ä–∞) —É –≤–∑—Ä–æ—Å–ª—ã—Ö –∏ –¥–µ—Ç–µ–π —Å—Ç–∞—Ä—à–µ —à–µ—Å—Ç–∏ –ª–µ—Ç. –†–∞–Ω–µ–µ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–ª–∏ –∏–¥—É—Ä—Å—É–ª—å—Ñ–∞–∑—É –±–µ—Ç–∞ –∑–∞—Ä—É–±–µ–∂–Ω–æ–≥–æ –∏ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PvFsV #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""registration"",
  ""impact"": ""medium"",
  ""english"": ""Generium has registered an original drug for the treatment of Type II Mucopolysaccharidosis (Hunter syndrome) in adults and children over six years old. Previously, the disease was treated with generic versions from foreign and domestic sources. For more details: https://clck.ru/3PvFsV #PharmNews #Production""
}"
2025-10-24T15:39:02+00:00,@medpharm,13271,https://t.me/medpharm/13271,–®–≤–µ–π—Ü–∞—Ä—Å–∫–∞—è —Ñ–∞—Ä–º–∫–æ—Ä–ø–æ—Ä–∞—Ü–∏—è Roche –æ—Ç—á–∏—Ç–∞–ª–∞—Å—å –æ —Ä–æ—Å—Ç–µ –ø—Ä–æ–¥–∞–∂ –Ω–∞ 7% –∑–∞ –¥–µ–≤—è—Ç—å –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞. –û–¥–Ω–∞–∫–æ III –∫–≤–∞—Ä—Ç–∞–ª —Ä–∞–∑–æ—á–∞—Ä–æ–≤–∞–ª –∏–Ω–≤–µ—Å—Ç–æ—Ä–æ–≤: –≤—ã—Ä—É—á–∫–∞ —É–ø–∞–ª–∞ –∏–∑-–∑–∞ —É–∫—Ä–µ–ø–ª–µ–Ω–∏—è —Ñ—Ä–∞–Ω–∫–∞ –∫ –¥–æ–ª–ª–∞—Ä—É. –°–∏–ª—å–Ω–µ–µ –≤—Å–µ–≥–æ –≤–∑–ª–µ—Ç–µ–ª–∏ –ø–æ–∫–∞–∑–∞—Ç–µ–ª–∏ —É ¬´–§–µ—Å–≥–æ¬ª ( 54%) –∏ ¬´–ö—Å–æ–ª–∞—Ä–∞¬ª ( 34%). –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PvE49 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-10-24T15:24:05+00:00,@medpharm,13270,https://t.me/medpharm/13270,"–í–µ—Å–Ω–æ–π —Å–ª–µ–¥—É—é—â–µ–≥–æ –≥–æ–¥–∞ –≤ –†–æ—Å—Å–∏–∏ –∑–∞—Ä–∞–±–æ—Ç–∞–µ—Ç —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã–π —Ä–µ–≥–∏—Å—Ç—Ä –±–µ—Ä–µ–º–µ–Ω–Ω—ã—Ö, –æ–±—ä–µ–¥–∏–Ω—è—é—â–∏–π –¥–∞–Ω–Ω—ã–µ –æ –±—É–¥—É—â–∏—Ö –º–∞—Ç–µ—Ä—è—Ö –∏ –Ω–æ–≤–æ—Ä–æ–∂–¥–µ–Ω–Ω—ã—Ö. –û–Ω —Å—Ç–∞–Ω–µ—Ç —á–∞—Å—Ç—å—é –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π —Å–∏—Å—Ç–µ–º—ã –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥–∞ –∑–¥–æ—Ä–æ–≤—å—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PvCSZ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-10-24T15:01:07+00:00,@medpharm,13269,https://t.me/medpharm/13269,"–ü—Ä–æ–µ–∫—Ç –∑–∞–∫–æ–Ω–∞ –æ —Ö–∏–º–∏—á–µ—Å–∫–æ–π –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω –ú–∏–Ω–∑–¥—Ä–∞–≤–æ–º –†–§. –î–æ–∫—É–º–µ–Ω—Ç–æ–º —É—Å—Ç–∞–Ω–∞–≤–ª–∏–≤–∞—é—Ç—Å—è –º–µ—Ä—ã –≥–æ—Å—Ä–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω–∏—è, –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–Ω—ã–µ –Ω–∞ –æ—Ö—Ä–∞–Ω—É –∑–¥–æ—Ä–æ–≤—å—è –Ω–∞—Å–µ–ª–µ–Ω–∏—è –∏ –æ–∫—Ä—É–∂–∞—é—â–µ–π —Å—Ä–µ–¥—ã –æ—Ç –≤–æ–∑–º–æ–∂–Ω—ã—Ö –ø–æ—Å–ª–µ–¥—Å—Ç–≤–∏–π –≤–æ–∑–¥–µ–π—Å—Ç–≤–∏—è –æ–ø–∞—Å–Ω—ã—Ö —Ö–∏–º–∏—á–µ—Å–∫–∏—Ö —Ñ–∞–∫—Ç–æ—Ä–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PvADu #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, safety"",
  ""impact"": ""high"",
  ""english"": ""A law project on chemical safety has been developed by the Ministry of Health of Russia. The document sets measures for state regulation aimed at protecting public health and the environment from potential consequences of hazardous chemical factors. For more details: https://clck.ru/3PvADu #PharmNews #Regulation""
}"
2025-10-24T14:31:08+00:00,@medpharm,13268,https://t.me/medpharm/13268,"–§–ê–° –ø–æ–¥–¥–µ—Ä–∂–∏–≤–∞–µ—Ç –ø–µ—Ä–µ–Ω–æ—Å –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π –≤ –†–æ—Å—Å–∏—é, –Ω–æ –ø—Ä–µ–¥–æ—Å—Ç–µ—Ä–µ–≥–∞–µ—Ç –æ—Ç —Ñ–∏–∫—Ç–∏–≤–Ω–æ–π –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏–∏ –∏ –±–æ—Ä—å–±—ã –º–µ–∂–¥—É —Å—É–±—ä–µ–∫—Ç–∞–º–∏. –†–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã–º –¥–æ–ª–∂–Ω–æ—Å—Ç–Ω—ã–º –ª–∏—Ü–∞–º —Å–ª—É–∂–±–∞ —Ä–µ–∫–æ–º–µ–Ω–¥—É–µ—Ç —Å–ª–µ–¥–∏—Ç—å –∑–∞ —Å–æ–≤–ø–∞–¥–µ–Ω–∏–µ–º –∫–æ–¥–æ–≤ –∏–∑ —Ä–∞–∑–ª–∏—á–Ω—ã—Ö –∫–ª–∞—Å—Å–∏—Ñ–∏–∫–∞—Ç–æ—Ä–æ–≤ –º–µ–¥–∏–∑–¥–µ–ª–∏–π –ø—Ä–∏ –≥–æ—Å–∑–∞–∫—É–ø–∫–∞—Ö, —á—Ç–æ–±—ã –∏–∑–±–µ–∂–∞—Ç—å –æ–±–≤–∏–Ω–µ–Ω–∏—è –≤ –Ω–µ—Ü–µ–ª–µ–≤–æ–º —Ä–∞—Å—Ö–æ–¥–æ–≤–∞–Ω–∏–∏ —Å—Ä–µ–¥—Å—Ç–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pv76C #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–î—Ä—É–≥–æ–µ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The FAS supports the transfer of medical products production to Russia, but warns against fictitious localization and competition among subjects. Regional officials are recommended to monitor the coincidence of codes from various medical product classification systems during government procurement to avoid accusations of misusing funds.""
}"
2025-10-24T14:29:02+00:00,@medpharm,13267,https://t.me/medpharm/13267,–ö–æ–º–ø–∞–Ω–∏—è ¬´–ò—Ä–≤–∏–Ω 2¬ª –±—É–¥–µ—Ç –ø–æ—Å—Ç–∞–≤–ª—è—Ç—å –¥–ª—è –ø–æ–¥–æ–ø–µ—á–Ω—ã—Ö ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª —Å –Ω–∞—Å–ª–µ–¥—Å—Ç–≤–µ–Ω–Ω–æ–π –¥–∏—Å—Ç—Ä–æ—Ñ–∏–µ–π —Å–µ—Ç—á–∞—Ç–∫–∏ –≥–ª–∞–∑–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç ¬´–õ—É–∫—Å—Ç—É—Ä–Ω–∞¬ª. –†–∞–Ω–µ–µ –Ω–µ—Å–∫–æ–ª—å–∫–æ –∞—É–∫—Ü–∏–æ–Ω–æ–≤ –Ω–∞ –∑–∞–∫—É–ø–∫—É —ç—Ç–æ–≥–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –Ω–µ —Å–æ—Å—Ç–æ—è–ª–∏—Å—å –∏–∑-–∑–∞ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏—è –∑–∞—è–≤–æ–∫. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pv6tb #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è,"{""skip"": true}"
2025-10-24T14:18:47+00:00,@medpharm,13266,https://t.me/medpharm/13266,"–ü—Ä–µ–∑–∏–¥–µ–Ω—Ç –ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–∞–ª–∞—Ç—ã –õ–µ–æ–Ω–∏–¥ –†–æ—à–∞–ª—å –Ω–∞–∑–≤–∞–ª —É–≤–µ–ª–∏—á–µ–Ω–∏–µ —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è —Ö–æ—Ç—è –±—ã –¥–æ —É—Ä–æ–≤–Ω—è –≤ 6% –í–í–ü –æ–¥–Ω–æ–π –∏–∑ –æ—Å–Ω–æ–≤–Ω—ã—Ö –∑–∞–¥–∞—á –¥–ª—è —É–ª—É—á—à–µ–Ω–∏—è —Ä–∞–±–æ—Ç—ã –æ—Ç—Ä–∞—Å–ª–∏. –ü–æ –µ–≥–æ —Å–ª–æ–≤–∞–º, –∑–∞ –≤—Å–µ –≥–æ–¥—ã —Ä–∞–±–æ—Ç—ã –ø–∞–ª–∞—Ç—ã –¥–∞–ª–µ–∫–æ –Ω–µ –≤—Å–µ —Ü–µ–ª–∏ –¥–æ—Å—Ç–∏–≥–Ω—É—Ç—ã, –Ω–æ –æ–±—ä–µ–¥–∏–Ω–µ–Ω–∏–µ –≥–æ—Ç–æ–≤–æ –ø—Ä–æ–¥–æ–ª–∂–∞—Ç—å —Å–æ—Ç—Ä—É–¥–Ω–∏—á–∞—Ç—å —Å –ú–∏–Ω–∑–¥—Ä–∞–≤–æ–º –†–æ—Å—Å–∏–∏ –∫–∞–∫ —ç–∫—Å–ø–µ—Ä—Ç–Ω–æ–µ —Å–æ–æ–±—â–µ—Å—Ç–≤–æ –ø–æ –≤—Å–µ–º –≤–æ–ø—Ä–æ—Å–∞–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pv5qY #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""President of the National Medical Chamber, Leonid Roessler, called for increasing healthcare funding to at least 6% of GDP as one of the main tasks to improve the industry. He stated that despite all years of work, not all goals have been achieved, but the union is ready to continue cooperation with Russia's Ministry of Health as an expert community on all issues.""
}"
2025-10-24T14:02:07+00:00,@medpharm,13265,https://t.me/medpharm/13265,–†–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–∞ —Ç–∏–ø–æ–≤–∞—è –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–∞—è –ø—Ä–æ–≥—Ä–∞–º–º–∞ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–π –ø–µ—Ä–µ–ø–æ–¥–≥–æ—Ç–æ–≤–∫–∏ –ø–æ —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–∏ ¬´–£–ø—Ä–∞–≤–ª–µ–Ω–∏–µ –∏ —ç–∫–æ–Ω–æ–º–∏–∫–∞ —Ñ–∞—Ä–º–∞—Ü–∏–∏¬ª. –ó–∞ 504 –∞–∫–∞–¥–µ–º–∏—á–µ—Å–∫–∏—Ö —á–∞—Å–∞ —Å—Ç—É–¥–µ–Ω—Ç—ã –¥–æ–ª–∂–Ω—ã –±—É–¥—É—Ç –æ—Å–≤–æ–∏—Ç—å —Å–µ–º—å –∫–ª—é—á–µ–≤—ã—Ö –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—ã—Ö –∫–æ–º–ø–µ—Ç–µ–Ω—Ü–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pv4Mu #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–∞—Ä—å–µ—Ä–∞,"{""skip"": true}"
2025-10-24T13:43:02+00:00,@medpharm,13264,https://t.me/medpharm/13264,"–í –†–æ—Å—Å–∏–∏ –ø—Ä–æ–¥–æ–ª–∂–∞—é—Ç—Å—è –¥–∏—Å–∫—É—Å—Å–∏–∏ –æ —Ç–æ–º, –∫–∞–∫–∏–µ —Å—Ç—Ä–∞—Ç–µ–≥–∏–∏ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ —Ä–µ–∞–ª–∏–∑–æ–≤—ã–≤–∞—Ç—å –¥–ª—è —Å–æ–∑–¥–∞–Ω–∏—è —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ–π —Å–æ–≤—Ä–µ–º–µ–Ω–Ω–æ–π —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏. –û–ø—ã—Ç –ö–∏—Ç–∞—è –≤ —ç—Ç–æ–º –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ –º–æ–∂–µ—Ç —Å—Ç–∞—Ç—å –Ω–∞–≥–ª—è–¥–Ω—ã–º –ø—Ä–∏–º–µ—Ä–æ–º —Ç–æ–≥–æ, –∫–∞–∫ —Å–∏—Å—Ç–µ–º–Ω—ã–µ —Ä–µ–≥—É–ª—è—Ç–æ—Ä–Ω—ã–µ —Ä–µ—Ñ–æ—Ä–º—ã –∏ —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–∏–µ —Å—Ç–∏–º—É–ª—ã –ø–æ–∑–≤–æ–ª–∏–ª–∏ –∑–∞ –¥–µ—Å—è—Ç–æ–∫ –ª–µ—Ç –ø–µ—Ä–µ—Å—Ç—Ä–æ–∏—Ç—å –∏–Ω–¥—É—Å—Ç—Ä–∏—é. –ü—Ä–∏ –ø—Ä–∞–≤–∏–ª—å–Ω–æ–º –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–∏ –æ–Ω –≤ –±—É–∫–≤–∞–ª—å–Ω–æ–º —Å–º—ã—Å–ª–µ –º–æ–∂–µ—Ç —Å—Ç–∞—Ç—å –Ω–∞–≤–∏–≥–∞—Ü–∏–æ–Ω–Ω–æ–π –∫–∞—Ä—Ç–æ–π ‚Äî —Å —É–∫–∞–∑–∞–Ω–∏–µ–º –Ω–µ —Ç–æ–ª—å–∫–æ —Ç–æ–≥–æ, –∫—É–¥–∞ –∏–¥—Ç–∏, –Ω–æ –∏ –∫–∞–∫–∏–º–∏ –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç–∞–º–∏ –æ–±–µ—Å–ø–µ—á–∏—Ç—å —ç—Ç–æ –¥–≤–∏–∂–µ–Ω–∏–µ. –ü—Ä–∏–Ω–∏–º–∞—è –≤–æ –≤–Ω–∏–º–∞–Ω–∏–µ –≤—Å—é –∫–æ–º–ø–ª–µ–∫—Å–Ω–æ—Å—Ç—å –∏ —Å–ª–æ–∂–Ω–æ—Å—Ç—å —ç—Ç–æ–≥–æ –ø—Ä–æ—Ü–µ—Å—Å–∞, –∏—Å–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–π –¥–∏—Ä–µ–∫—Ç–æ—Ä –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ ¬´–ò–Ω—Ñ–∞—Ä–º–∞¬ª –í–∞–¥–∏–º –ö—É–∫–∞–≤–∞ —Ä–∞—Å—Å–∫–∞–∑–∞–ª ¬´–§–í¬ª –æ –∫–ª—é—á–µ–≤—ã—Ö —ç–ª–µ–º–µ–Ω—Ç–∞—Ö —ç—Ç–æ–≥–æ –ø—É—Ç–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pv2ah #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-24T12:50:05+00:00,@medpharm,13263,https://t.me/medpharm/13263,–ò—Å–ø–æ–ª–Ω—è—é—â–∏–º –æ–±—è–∑–∞–Ω–Ω–æ—Å—Ç–∏ —Ä–µ–∫—Ç–æ—Ä–∞ –£—Ä–∞–ª—å—Å–∫–æ–≥–æ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ —Å—Ç–∞–ª –¥–∏—Ä–µ–∫—Ç–æ—Ä –ù–ò–ò –æ—Ö—Ä–∞–Ω—ã –º–∞—Ç–µ—Ä–∏–Ω—Å—Ç–≤–∞ –∏ –º–ª–∞–¥–µ–Ω—á–µ—Å—Ç–≤–∞ –Æ—Ä–∏–π –°–µ–º–µ–Ω–æ–≤. –†–∞–Ω–µ–µ –æ–Ω –≤–æ–∑–≥–ª–∞–≤–ª—è–ª –ú–∏–Ω–∑–¥—Ä–∞–≤ –ß–µ–ª—è–±–∏–Ω—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PuvXn #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-10-24T12:47:03+00:00,@medpharm,13262,https://t.me/medpharm/13262,"–†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä –æ–±–Ω–æ–≤–∏–ª –¥–≤–∞ –¥–æ–∫—É–º–µ–Ω—Ç–∞, –∫–∞—Å–∞—é—â–∏–µ—Å—è –∫–æ–Ω—Ç—Ä–æ–ª—è –∫–∞—á–µ—Å—Ç–≤–∞ –∏–º–º—É–Ω–æ–±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –û–Ω–∏ –±—É–¥—É—Ç –¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å –¥–æ 10 –∏—é–Ω—è 2031 –≥–æ–¥–∞. –í–≤–æ–¥–∏—Ç—Å—è –µ–∂–µ–≥–æ–¥–Ω—ã–π —Ü–∏–∫–ª –ø—Ä–æ–≤–µ—Ä–æ–∫ —Å —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏–µ–º –ø—Ä–æ–≥—Ä–∞–º–º –∏—Å–ø—ã—Ç–∞–Ω–∏–π –¥–æ 1 –∞–ø—Ä–µ–ª—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PuvCz #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""Roszdravnadzor updated two documents concerning the quality control of immunobiological products. They will be in effect until June 10, 2031. An annual cycle of inspections will be introduced with trial programs being approved by April 1st.""
}"
2025-10-24T12:13:03+00:00,@medpharm,13261,https://t.me/medpharm/13261,"–£—à–Ω—ã–µ –∫–∞–ø–ª–∏ ‚Äî —ç—Ç–æ –æ—Å–æ–±–∞—è –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–∞—è —Ñ–æ—Ä–º–∞, –ø—Ä–µ–¥–Ω–∞–∑–Ω–∞—á–µ–Ω–Ω–∞—è –∏—Å–∫–ª—é—á–∏—Ç–µ–ª—å–Ω–æ –¥–ª—è –∑–∞–∫–∞–ø—ã–≤–∞–Ω–∏—è –≤ –Ω–∞—Ä—É–∂–Ω—ã–π —Å–ª—É—Ö–æ–≤–æ–π –ø—Ä–æ—Ö–æ–¥. –£—á–∏—Ç—ã–≤–∞—è —Ä–∞–∑–Ω–æ–æ–±—Ä–∞–∑–∏–µ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π —É—Ö–∞, –≤—ã–¥–µ–ª—è—é—Ç —Ä–∞–∑–ª–∏—á–Ω—ã–µ –≤–∏–¥—ã –∫–∞–ø–µ–ª—å, –ø—Ä–µ–¥–Ω–∞–∑–Ω–∞—á–µ–Ω–Ω—ã—Ö –¥–ª—è –ª–µ—á–µ–Ω–∏—è –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–Ω–æ–π –ø–∞—Ç–æ–ª–æ–≥–∏–∏. –í –¥–∞–Ω–Ω—ã–π –º–æ–º–µ–Ω—Ç –Ω–∞ –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω–æ–º —Å–∞–π—Ç–µ –ì–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ —Ä–µ–µ—Å—Ç—Ä–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –ø—Ä–∏—Å—É—Ç—Å—Ç–≤—É–µ—Ç 28 —Ç–æ—Ä–≥–æ–≤—ã—Ö –Ω–∞–∏–º–µ–Ω–æ–≤–∞–Ω–∏–π —Ä–∞–∑–ª–∏—á–Ω—ã—Ö —É—à–Ω—ã—Ö –∫–∞–ø–µ–ª—å. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Puron #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–µ–ø–∞—Ä–∞—Ç—ã/–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders,clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""There are currently 28 trade names of various ear drops listed on the official State Register of Medicinal Products website. More details can be found at https://clck.ru/3Puron.""
}"
2025-10-24T11:53:07+00:00,@medpharm,13260,https://t.me/medpharm/13260,–ò–Ω–≥–∏–±–∏—Ç–æ—Ä—ã SGLT2 –ø—Ä–µ–≤–∑–æ—à–ª–∏ –∏–Ω–≥–∏–±–∏—Ç–æ—Ä—ã —Ä–µ—Ü–µ–ø—Ç–æ—Ä–æ–≤ –∞–Ω–≥–∏–æ—Ç–µ–Ω–∑–∏–Ω–∞/–Ω–µ–ø—Ä–∏–ª–∏–∑–∏–Ω–∞ —É –ø–æ–∂–∏–ª—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –∞—Å—Ç–µ–Ω–∏–µ–π –∏ —Å–µ—Ä–¥–µ—á–Ω–æ–π –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ—Å—Ç—å—é —Å —Å–æ—Ö—Ä–∞–Ω–µ–Ω–Ω–æ–π —Ñ—Ä–∞–∫—Ü–∏–µ–π –≤—ã–±—Ä–æ—Å–∞. –ü—Ä–µ–ø–∞—Ä–∞—Ç—ã —Å–Ω–∏–∂–∞–ª–∏ —Å–º–µ—Ä—Ç–Ω–æ—Å—Ç—å –∏ —á–∏—Å–ª–æ –≥–æ—Å–ø–∏—Ç–∞–ª–∏–∑–∞—Ü–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pupsd #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ö–∞—Ä–¥–∏–æ–ª–æ–≥–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è #–§–∏–∑–∏–æ—Ç–µ—Ä–∞–ø–∏—è,"{""skip"": true}"
2025-10-24T11:44:02+00:00,@medpharm,13259,https://t.me/medpharm/13259,Moderna –ø—Ä–µ–∫—Ä–∞—Ç–∏–ª–∞ –∫—Ä—É–ø–Ω–µ–π—à–µ–µ –≤ –∏—Å—Ç–æ—Ä–∏–∏ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –≤–∞–∫—Ü–∏–Ω—ã –æ—Ç —Ü–∏—Ç–æ–º–µ–≥–∞–ª–æ–≤–∏—Ä—É—Å–∞. –ü—Ä–µ–ø–∞—Ä–∞—Ç mRNA-1647 –Ω–∞ III —Ñ–∞–∑–µ –æ–∫–∞–∑–∞–ª—Å—è –Ω–µ—ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pup3R #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-10-24T10:26:04+00:00,@medpharm,13258,https://t.me/medpharm/13258,"–î–µ–ø—É—Ç–∞—Ç—ã –ø—Ä–æ–¥–æ–ª–∂–∞—é—Ç –≤–Ω–æ—Å–∏—Ç—å –ø–æ–ø—Ä–∞–≤–∫–∏ –≤ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–µ –∏ —Ü–µ–ª–µ–≤–æ–º –æ–±—É—á–µ–Ω–∏–∏ –º–µ–¥–∏–∫–æ–≤. –í —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, –ê–ª–µ–∫—Å–µ–π –ö—É—Ä–∏–Ω–Ω—ã–π –ø—Ä–µ–¥–ª–æ–∂–∏–ª –æ—Å–≤–æ–±–æ–¥–∏—Ç—å –æ—Ç –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã—Ö –æ—Ç—Ä–∞–±–æ—Ç–æ–∫ —Å—Ç—É–¥–µ–Ω—Ç–æ–≤ –ø–ª–∞—Ç–Ω–æ–π —Ñ–æ—Ä–º—ã –æ–±—É—á–µ–Ω–∏—è, –∞ —Ç–∞–∫–∂–µ –ø–µ—Ä–µ–Ω–µ—Å—Ç–∏ —Å—Ä–æ–∫ –∑–∞–∫–ª—é—á–µ–Ω–∏—è —Ü–µ–ª–µ–≤–æ–≥–æ –¥–æ–≥–æ–≤–æ—Ä–∞ –Ω–∞ —Ç—Ä–µ—Ç–∏–π –∫—É—Ä—Å. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PugNZ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–û–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-10-24T10:19:03+00:00,@medpharm,13257,https://t.me/medpharm/13257,¬´–ù–µ–æ—Ñ–∞—Ä–º¬ª –∑–∞–≤–µ—Ä—à–∏–ª–∞ –ø–æ–≥–ª–æ—â–µ–Ω–∏–µ –∏ —Ä–µ–±—Ä–µ–Ω–¥–∏–Ω–≥ –¥–≤—É—Ö –Ω–∏–∂–µ–≥–æ—Ä–æ–¥—Å–∫–∏—Ö —Å–µ—Ç–µ–π ‚Äî ¬´–°–æ–ª–Ω–µ—á–Ω–æ–µ –∑–¥–æ—Ä–æ–≤—å–µ¬ª –∏ ¬´–ë—É–¥—å—Ç–µ –∑–¥–æ—Ä–æ–≤—ã¬ª. –¢–µ–ø–µ—Ä—å –≤ –ù–∏–∂–Ω–µ–º –ù–æ–≤–≥–æ—Ä–æ–¥–µ —Ä–∞–±–æ—Ç–∞—é—Ç 67 –∞–ø—Ç–µ–∫ –ø–æ–¥ –µ–¥–∏–Ω—ã–º –±—Ä–µ–Ω–¥–æ–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pufgb #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞,"{""skip"": true}"
2025-10-24T09:36:02+00:00,@medpharm,13256,https://t.me/medpharm/13256,–ì–ª–∞–≤–∞ –∏–≤–∞–Ω–æ–≤—Å–∫–æ–≥–æ –î–µ–ø–∑–¥—Ä–∞–≤–∞ –ê–Ω—Ç–æ–Ω –ê—Ä—Å–µ–Ω—å–µ–≤ –æ–±–≤–∏–Ω—è–µ—Ç—Å—è –≤ –ø—Ä–µ–≤—ã—à–µ–Ω–∏–∏ –¥–æ–ª–∂–Ω–æ—Å—Ç–Ω—ã—Ö –ø–æ–ª–Ω–æ–º–æ—á–∏–π –∑–∞ —Å–æ–¥–µ–π—Å—Ç–≤–∏–µ –≤ –æ—Ñ–æ—Ä–º–ª–µ–Ω–∏–∏ —Ñ–∏–∫—Ç–∏–≤–Ω–æ–≥–æ –±–æ–ª—å–Ω–∏—á–Ω–æ–≥–æ. –°—É–¥ –∞—Ä–µ—Å—Ç–æ–≤–∞–ª –µ–≥–æ –¥–æ 16 –¥–µ–∫–∞–±—Ä—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PubZG #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-10-24T09:32:03+00:00,@medpharm,13255,https://t.me/medpharm/13255,"–í –ú–æ—Å–∫–≤–µ —Å–æ—Å—Ç–æ—è–ª–æ—Å—å –Ω–∞–≥—Ä–∞–∂–¥–µ–Ω–∏–µ –ø–æ–±–µ–¥–∏—Ç–µ–ª–µ–π –í—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –∫–æ–Ω–∫—É—Ä—Å–∞ ¬´–õ—É—á—à–∏–π —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç —Å–æ —Å—Ä–µ–¥–Ω–∏–º –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–º –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ–º¬ª. –í —ç—Ç–æ–º –≥–æ–¥—É –≤ —Ñ–∏–Ω–∞–ª–µ –ø—Ä–∏–Ω—è–ª–∏ —É—á–∞—Å—Ç–∏–µ 393 —á–µ–ª–æ–≤–µ–∫–∞. –ü–æ–±–µ–¥–∏—Ç–µ–ª—è–º–∏ –≤ –Ω–æ–º–∏–Ω–∞—Ü–∏–∏ ¬´–õ—É—á—à–∏–π —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç¬ª —Å—Ç–∞–ª–∏ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –∏–∑ –°–≤–µ—Ä–¥–ª–æ–≤—Å–∫–æ–π, –ë–µ–ª–≥–æ—Ä–æ–¥—Å–∫–æ–π –∏ –ü–µ–Ω–∑–µ–Ω—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–µ–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PubDw #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–û–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ","{""skip"": true}"
2025-10-24T08:46:03+00:00,@medpharm,13254,https://t.me/medpharm/13254,"–ì–æ—Å–æ–±–≤–∏–Ω–µ–Ω–∏–µ –∑–∞–ø—Ä–æ—Å–∏–ª–æ —Å–µ–º—å –ª–µ—Ç –∫–æ–ª–æ–Ω–∏–∏ –∑–∞–º—Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—è –¥–µ–ø–∑–¥—Ä–∞–≤–∞ –û—Ä–ª–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏. –ï–µ –æ–±–≤–∏–Ω—è—é—Ç –≤ –∑–ª–æ—É–ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–∏ –¥–æ–ª–∂–Ω–æ—Å—Ç–Ω—ã–º–∏ –ø–æ–ª–Ω–æ–º–æ—á–∏—è–º–∏ –ø—Ä–∏ –∑–∞–∫—É–ø–∫–µ –ª–µ–∫–∞—Ä—Å—Ç–≤ –¥–ª—è –ª—å–≥–æ—Ç–Ω–∏–∫–æ–≤, —á—Ç–æ –ø—Ä–∏–≤–µ–ª–æ –∫ —É—â–µ—Ä–±—É –±—é–¥–∂–µ—Ç—É –Ω–∞ —Å—É–º–º—É –±–æ–ª–µ–µ 46,7 –º–ª–Ω —Ä—É–±. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PuWa2 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, reimbursement, pricing"",
  ""impact"": ""high"",
  ""english"": ""The Prosecutor's Office is seeking seven years in prison for the deputy head of the Health Department of Oryol Oblast. She is accused of abusing her official duties in purchasing medicines for beneficiaries, causing a loss to the budget amounting to over 46.7 million rubles. More: https://clck.ru/3PuWa2 #PharmVestnik #Distribution""
}"
2025-10-24T08:11:06+00:00,@medpharm,13253,https://t.me/medpharm/13253,"–ú–∏—Ö–∞–∏–ª –ú—É—Ä–∞—à–∫–æ –Ω–∞–≥—Ä–∞–¥–∏–ª –ø–æ–±–µ–¥–∏—Ç–µ–ª–µ–π –≤—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –∫–æ–Ω–∫—É—Ä—Å–æ–≤ ¬´–õ—É—á—à–∏–π –≤—Ä–∞—á –≥–æ–¥–∞¬ª –∏ ¬´–õ—É—á—à–∏–π —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç —Å–æ —Å—Ä–µ–¥–Ω–∏–º –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–º –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ–º¬ª. –ü–æ–±–µ–¥–∏—Ç–µ–ª—è–º–∏ –ø–µ—Ä–≤–æ–π –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ —Å—Ç–∞–ª–∏ 29 –≤—Ä–∞—á–µ–π, –≤—Ç–æ—Ä–æ–π ‚Äî –≤–æ—Å–µ–º—å —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PuT8y #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ","{""skip"": true}"
2025-10-24T07:46:02+00:00,@medpharm,13252,https://t.me/medpharm/13252,"Takeda –¥–æ–≥–æ–≤–æ—Ä–∏–ª–∞—Å—å —Å –∫–∏—Ç–∞–π—Å–∫–æ–π Innovent –æ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ —Ç—Ä–µ—Ö –ø—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –°–¥–µ–ª–∫–∞ –Ω–∞ 11,4 –º–ª—Ä–¥ –¥–æ–ª–ª. –ø—Ä–∏–∑–≤–∞–Ω–∞ –∫–æ–º–ø–µ–Ω—Å–∏—Ä–æ–≤–∞—Ç—å –ø–æ—Ç–µ—Ä–∏ –æ—Ç –∏—Å—Ç–µ—á–µ–Ω–∏—è –ø–∞—Ç–µ–Ω—Ç–æ–≤ —è–ø–æ–Ω—Å–∫–æ–≥–æ —Ñ–∞—Ä–º–≥–∏–≥–∞–Ω—Ç–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PuQaB #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-24T06:06:06+00:00,@medpharm,13251,https://t.me/medpharm/13251,"–£ –∫–∞–∂–¥–æ–≥–æ –ø—è—Ç–æ–≥–æ –≤–∑—Ä–æ—Å–ª–æ–≥–æ —á–µ–ª–æ–≤–µ–∫–∞ —Å –Ω–æ—Ä–º–∞–ª—å–Ω–æ–π –º–∞—Å—Å–æ–π —Ç–µ–ª–∞ –æ–±–Ω–∞—Ä—É–∂–∏–ª–æ—Å—å –∞–±–¥–æ–º–∏–Ω–∞–ª—å–Ω–æ–µ –æ–∂–∏—Ä–µ–Ω–∏–µ, –∫–æ—Ç–æ—Ä–æ–µ –ø–æ–≤—ã—à–∞–µ—Ç —Ä–∏—Å–∫ –¥–∏–∞–±–µ—Ç–∞, –≥–∏–ø–µ—Ä—Ç–µ–Ω–∑–∏–∏ –∏ –Ω–∞—Ä—É—à–µ–Ω–∏–π –ª–∏–ø–∏–¥–Ω–æ–≥–æ –æ–±–º–µ–Ω–∞. –ü–æ –º–Ω–µ–Ω–∏—é —É—á–µ–Ω—ã—Ö, –¥–ª—è –≤—ã—è–≤–ª–µ–Ω–∏—è –ª—é–¥–µ–π —Å –≤—ã—Å–æ–∫–∏–º –∫–∞—Ä–¥–∏–æ–º–µ—Ç–∞–±–æ–ª–∏—á–µ—Å–∫–∏–º —Ä–∏—Å–∫–æ–º –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ –æ—Ü–µ–Ω–∫–∏ –∏–Ω–¥–µ–∫—Å–∞ –º–∞—Å—Å—ã —Ç–µ–ª–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PuFTQ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–î–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞ #–ö–∞—Ä–¥–∏–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–≠–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""A study suggests that abdominal obesity, which increases the risk of diabetes, hypertension, and lipid disorders, affects one in every five adults with normal body mass index. Experts argue that assessing the Body Mass Index (BMI) alone is insufficient for identifying individuals with high cardiometabolic risk.""
}"
2025-10-23T16:59:45+00:00,@medpharm,13250,https://t.me/medpharm/13250,"ü¶æ –ó–∞–º–æ—Ä—Å–∫–∏–π –æ–ø—ã—Ç. –ì–æ—Å–º–µ–¥–∏—Ü–∏–Ω–∞ –≤ –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–µ —Å—Ç—Ä–∞–Ω —Å—Ç—Ä–∞–¥–∞–µ—Ç –æ—Ç –ø–æ—Ö–æ–∂–∏—Ö –ø—Ä–æ–±–ª–µ–º: –≤—Ä–∞—á–∏ –Ω–µ —Ö–æ—Ç—è—Ç –∂–∏—Ç—å –≤ —Å–µ–ª–∞—Ö –∏ –º–∞–ª–µ–Ω—å–∫–∏—Ö –≥–æ—Ä–æ–¥–∞—Ö, –æ–Ω–∏ –º–∞—Å—Å–æ–≤–æ –≤—ã—Ö–æ–¥—è—Ç –Ω–∞ –ø–µ–Ω—Å–∏—é, –∞ –º–æ–ª–æ–¥—ã–µ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –º–µ–Ω—è—é—Ç –ø—Ä–æ—Ñ–µ—Å—Å–∏—é, —É–µ–∑–∂–∞—é—Ç –∑–∞ –≥—Ä–∞–Ω–∏—Ü—É –ø–æ—Å–ª–µ –ø–æ–ª—É—á–µ–Ω–∏—è –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è –∏–ª–∏ —É—Å—Ç—Ä–∞–∏–≤–∞—é—Ç—Å—è –Ω–∞ —Ä–∞–±–æ—Ç—É –≤ —á–∞—Å—Ç–Ω—ã–µ –∫–ª–∏–Ω–∏–∫–∏. –ö–∞–∫ —Å –¥–µ—Ñ–∏—Ü–∏—Ç–æ–º –≤—Ä–∞—á–µ–π –±–æ—Ä—é—Ç—Å—è –≤ —Ä–∞–∑–Ω—ã—Ö —Å—Ç—Ä–∞–Ω–∞—Ö? ü¶æ –í–æ–ø—Ä–æ—Å –¥–æ–≤–µ—Ä–∏—è. –ü–æ–¥–∞–≤–ª—è—é—â–µ–µ –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö —Ä–æ—Å—Å–∏—è–Ω (82%) –∑–∞—è–≤–∏–ª–∏, —á—Ç–æ –∫–∞—á–µ—Å—Ç–≤–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –¥–æ–ª–∂–Ω–æ –æ—Ü–µ–Ω–∏–≤–∞—Ç—å—Å—è –≤–Ω–µ—à–Ω–µ–π, –∞ –Ω–µ –≤–Ω—É—Ç—Ä–µ–Ω–Ω–µ–π —Å—Ç—Ä—É–∫—Ç—É—Ä–æ–π. –ë–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ —Ä–µ—Å–ø–æ–Ω–¥–µ–Ω—Ç–æ–≤ –¥–æ–≤–µ—Ä—è—é—Ç –Ω–µ–∑–∞–≤–∏—Å–∏–º—ã–º —Å—Ç—Ä–∞—Ö–æ–≤—ã–º –∫–æ–º–ø–∞–Ω–∏—è–º, –∞ –Ω–µ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–º —Ñ–æ–Ω–¥–∞–º. ‚ù§Ô∏è –í—Å–µ –±–ª–∏–∂–µ. ¬´–ü–æ—á—Ç–∞ –†–æ—Å—Å–∏–∏¬ª —Ä–∞—Å—à–∏—Ä–∏–ª–∞ –ø—Ä–æ–¥–∞–∂–∏ —Ç–æ–≤–∞—Ä–æ–≤ –∞–ø—Ç–µ—á–Ω–æ–≥–æ –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç–∞: –Ω–µ–ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, –≤–∫–ª—é—á–∞—è –ª–µ—á–µ–±–Ω–æ-–∫–æ—Å–º–µ—Ç–∏—á–µ—Å–∫–∏–µ —Å—Ä–µ–¥—Å—Ç–≤–∞ –∏ –ë–ê–î, –º–æ–∂–Ω–æ –∫—É–ø–∏—Ç—å –≤ 28 —Ç—ã—Å. –æ—Ç–¥–µ–ª–µ–Ω–∏–π. –î–æ –∫–æ–Ω—Ü–∞ –≥–æ–¥–∞ –æ–ø–µ—Ä–∞—Ç–æ—Ä —Å–≤—è–∑–∏ –º–æ–∂–µ—Ç –¥–æ–ø–æ–ª–Ω–∏—Ç—å —ç—Ç–æ—Ç –ø–µ—Ä–µ—á–µ–Ω—å –∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏. ‚ù§Ô∏è –ö–∞–¥—Ä–æ–≤—ã–µ –ø–µ—Ä–µ—Å—Ç–∞–Ω–æ–≤–∫–∏. –í –∫–æ–º–ø–∞–Ω–∏–∏ Renewal (–ê–û ¬´–ü–§–ö –û–±–Ω–æ–≤–ª–µ–Ω–∏–µ¬ª) –Ω–∞–∑–Ω–∞—á–µ–Ω –Ω–æ–≤—ã–π –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä: –∏–º —Å—Ç–∞–ª –í–ª–∞–¥–∏–º–∏—Ä –ì—Ä–µ—á–∫–∏–Ω, —Ä–∞–Ω–µ–µ –∑–∞–Ω–∏–º–∞–≤—à–∏–π –ø–æ—Å—Ç –∏—Å–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–≥–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞. –î–º–∏—Ç—Ä–∏–π –ì—Ä–∏—Å—é–∫, —Ä—É–∫–æ–≤–æ–¥–∏–≤—à–∏–π –∫–æ–º–ø–∞–Ω–∏–µ–π –ø–æ—Å–ª–µ–¥–Ω–∏–µ –¥–≤–∞ –≥–æ–¥–∞, —Å—Ñ–æ–∫—É—Å–∏—Ä—É–µ—Ç—Å—è –Ω–∞ —Ñ–∏–Ω–∞–Ω—Å–∞—Ö.","{
  ""skip"": true
}"
2025-10-23T15:39:06+00:00,@medpharm,13249,https://t.me/medpharm/13249,–í –ì–æ—Å–¥—É–º–µ –†–§ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –∑–∞–∫—Ä–µ–ø–∏—Ç—å –≤ –∑–∞–∫–æ–Ω–µ –ø—Ä–∞–≤–æ –≥—Ä–∞–∂–¥–∞–Ω –ø–æ–ª—É—á–∞—Ç—å –ø–ª–∞–Ω–æ–≤—É—é —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—É—é –ø–æ–º–æ—â—å –≤ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—è—Ö –¥—Ä—É–≥–∏—Ö —Ä–µ–≥–∏–æ–Ω–æ–≤. –ó–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –ø—Ä–∏–∑–≤–∞–Ω —É–ø—Ä–æ—Å—Ç–∏—Ç—å –¥–æ—Å—Ç—É–ø –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –∫ –ª–µ—á–µ–Ω–∏—é –≤–Ω–µ –º–µ—Å—Ç–∞ –∏—Ö –ø–æ—Å—Ç–æ—è–Ω–Ω–æ–≥–æ –ø—Ä–æ–∂–∏–≤–∞–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Ptpht #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The Russian State Duma proposed to strengthen the law on patients' access to specialized care in other regions through a project that aims to simplify their access. More details: https://clck.ru/3Ptpht #MedNews #Healthcare #HealthSystem""
}"
2025-10-23T15:14:04+00:00,@medpharm,13248,https://t.me/medpharm/13248,"–í—ã–ø–∏—Å–∫–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø–æ –ú–ù–ù —Å—Ç–∞–Ω–æ–≤–∏—Ç—Å—è –Ω–æ—Ä–º–æ–π –≤—Ä–∞—á–µ–±–Ω–æ–π –ø—Ä–∞–∫—Ç–∏–∫–∏ –∫–∞–∫ –≤ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö, —Ç–∞–∫ –∏ –≤ —á–∞—Å—Ç–Ω—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è—Ö –†–æ—Å—Å–∏–∏. –î–æ–ª—è —Ç–∞–∫–∏—Ö –Ω–∞–∑–Ω–∞—á–µ–Ω–∏–π –≤–æ –≤—Ç–æ—Ä–æ–º –∫–≤–∞—Ä—Ç–∞–ª–µ –≤—ã—Ä–æ—Å–ª–∞ –¥–æ 20,6% (–≤ –ø–µ—Ä–≤–æ–º –∫–≤–∞—Ä—Ç–∞–ª–µ —Å–æ—Å—Ç–∞–≤–ª—è–ª–∞ 20,1%). –≠—Ç–æ —É–∫–∞–∑—ã–≤–∞–µ—Ç –≤ —Ç–æ–º —á–∏—Å–ª–µ –Ω–∞ —Ä–æ—Å—Ç –¥–æ–≤–µ—Ä–∏—è —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –∫ –¥–∂–µ–Ω–µ—Ä–∏–∫–∞–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pto9P #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The issuance of prescriptions by generic drugs has become a norm in medical practice both in state and private healthcare organizations. The share of such prescriptions rose to 20.6% in the second quarter (from 20.1% in the first quarter). This indicates an increase in specialists' trust in generics. For more details: https://clck.ru/3Pto9P #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è""
}"
2025-10-23T14:59:05+00:00,@medpharm,13247,https://t.me/medpharm/13247,"–ü–æ –¥–∞–Ω–Ω—ã–º –í–¶–ò–û–ú, –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ —Ä–æ—Å—Å–∏—è–Ω –Ω–µ –æ—Å–≤–µ–¥–æ–º–ª–µ–Ω—ã –æ –ø–ª–∞–Ω–∏—Ä—É–µ–º—ã—Ö –∏–∑–º–µ–Ω–µ–Ω–∏—è—Ö –≤ —Å–∏—Å—Ç–µ–º–µ –û–ú–°, –ø—Ä–µ–¥—É—Å–º–∞—Ç—Ä–∏–≤–∞—é—â–∏—Ö –ø–µ—Ä–µ–¥–∞—á—É —Ñ—É–Ω–∫—Ü–∏–π —Å—Ç—Ä–∞—Ö–æ–≤—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω—ã–º —Ñ–æ–Ω–¥–∞–º –û–ú–°. –¢—Ä–µ—Ç—å –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö –∑–∞—è–≤–∏–ª–∏, —á—Ç–æ —Ä–µ—Ñ–æ—Ä–º–∞ –ø—Ä–∏–≤–µ–¥–µ—Ç –∫ —É—Ö—É–¥—à–µ–Ω–∏—é –∫–∞—á–µ—Å—Ç–≤–∞ –∏ –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç–∏ –º–µ–¥–∏—Ü–∏–Ω—ã, –∏ –µ—â–µ –ø–æ—á—Ç–∏ —Å—Ç–æ–ª—å–∫–æ –∂–µ, —á—Ç–æ –æ–Ω–∞ –Ω–∏—á–µ–≥–æ –Ω–µ –∏–∑–º–µ–Ω–∏—Ç. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PtnBR #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, shortage, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""Data from the VCIOM shows that most Russians are not aware of planned changes in the OMS system, which include transferring functions from insurance medical organizations to territorial funds of the OMS. About one third of those surveyed say that the reform will lead to a decrease in the quality and accessibility of healthcare, while almost the same number say it won't change anything.""
}"
2025-10-23T14:51:03+00:00,@medpharm,13246,https://t.me/medpharm/13246,"–ü–∞—Ä—Ç–∏—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è —Å–Ω–∏–∂–µ–Ω–∏—è –≤–µ—Å–∞ –∏ –æ–º–æ–ª–æ–∂–µ–Ω–∏—è –æ–±—â–µ–π —Å—Ç–æ–∏–º–æ—Å—Ç—å—é –±–æ–ª–µ–µ 4 –º–ª–Ω —Ä—É–±. –∏–∑—ä—è—Ç–∞ –ø—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–∏—Ç–µ–ª—è–º–∏ –≤ –•–∞–±–∞—Ä–æ–≤—Å–∫–æ–º –∫—Ä–∞–µ. –ü–æ –¥–∞–Ω–Ω—ã–º –ú–í–î, –ø–æ–¥–æ–∑—Ä–µ–≤–∞–µ–º–∞—è –æ—Ä–≥–∞–Ω–∏–∑–æ–≤–∞–ª–∞ –≤–≤–æ–∑ –∏ –æ–Ω–ª–∞–π–Ω-–ø—Ä–æ–¥–∞–∂—É –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤, –∫–æ—Ç–æ—Ä—ã–µ –∑–∞–∫—É–ø–∞–ª–∏ –∫–æ—Å–º–µ—Ç–æ–ª–æ–≥–∏ –∏ —á–∞—Å—Ç–Ω—ã–µ –∫–ª–∏–Ω–∏–∫–∏ –≤ —á–µ—Ç—ã—Ä–µ—Ö —Ä–µ–≥–∏–æ–Ω–∞—Ö —Å—Ç—Ä–∞–Ω—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Ptmg2 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{""skip"": true}"
2025-10-23T14:19:03+00:00,@medpharm,13245,https://t.me/medpharm/13245,"–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§ –∏–∑–º–µ–Ω–∏–ª–æ –ø—Ä–∞–≤–∏–ª–∞ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–∏—Ö –≤–∏–∑–∏—Ç–æ–≤ –¥–ª—è –Ω–∞—á–∏–Ω–∞—é—â–∏—Ö –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç—å –∫–æ–º–ø–∞–Ω–∏–π. –°–æ–≥–ª–∞—Å–Ω–æ –Ω–æ–≤—ã–º –ø–æ–ø—Ä–∞–≤–∫–∞–º, –±–∏–∑–Ω–µ—Å –Ω–µ —Å–º–æ–∂–µ—Ç –æ—Ç–∫–∞–∑–∞—Ç—å—Å—è –æ—Ç –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–π –ø—Ä–æ–≤–µ—Ä–∫–∏, –∞ –µ–µ –ø—Ä–æ–¥–æ–ª–∂–∏—Ç–µ–ª—å–Ω–æ—Å—Ç—å —É–≤–µ–ª–∏—á–∏—Ç—Å—è —Å –æ–¥–Ω–æ–≥–æ –¥–Ω—è –¥–æ –¥–µ—Å—è—Ç–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PtjVR #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""clinical_trial, safety"",
  ""impact"": ""medium"",
  ""english"": ""The Russian government has amended the rules for preventive visits by startups. According to the new amendments, businesses cannot refuse mandatory inspections and their duration will increase from one day to ten days. More: https://clck.ru/3PtjVR #PharmNews #Regulation""
}"
2025-10-23T13:58:06+00:00,@medpharm,13244,https://t.me/medpharm/13244,"–í —Å—Ç–æ–ª–∏—á–Ω—ã—Ö –±–æ–ª—å–Ω–∏—Ü–∞—Ö –≤–≤–æ–¥—è—Ç –Ω–æ–≤—É—é –º–æ–¥–µ–ª—å —É–ø—Ä–∞–≤–ª–µ–Ω–∏—è —Å –¥–≤—É–º—è —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—è–º–∏ ‚Äî –¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–º –∏ –≥–ª–∞–≤–Ω—ã–º –≤—Ä–∞—á–æ–º, —Ä–∞–±–æ—Ç–∞—é—â–∏–º–∏ –≤ —Ç–∞–Ω–¥–µ–º–µ. –ü–∏–ª–æ—Ç–Ω—ã–π –ø—Ä–æ–µ–∫—Ç –¥–µ–π—Å—Ç–≤—É–µ—Ç –≤ —Ç—Ä–µ—Ö –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—è—Ö –ú–æ—Å–∫–≤—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PthxT #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-10-23T13:29:03+00:00,@medpharm,13243,https://t.me/medpharm/13243,"¬´–ü–æ—á—Ç–∞ –†–æ—Å—Å–∏–∏¬ª —Ä–∞—Å—à–∏—Ä–∏–ª–∞ –ø—Ä–æ–¥–∞–∂–∏ —Ç–æ–≤–∞—Ä–æ–≤ –∞–ø—Ç–µ—á–Ω–æ–≥–æ –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç–∞: –Ω–µ–ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, –≤–∫–ª—é—á–∞—è –ª–µ—á–µ–±–Ω–æ-–∫–æ—Å–º–µ—Ç–∏—á–µ—Å–∫–∏–µ —Å—Ä–µ–¥—Å—Ç–≤–∞ –∏ –ë–ê–î, –º–æ–∂–Ω–æ –∫—É–ø–∏—Ç—å –≤ 28 —Ç—ã—Å. –æ—Ç–¥–µ–ª–µ–Ω–∏–π. –î–æ –∫–æ–Ω—Ü–∞ –≥–æ–¥–∞ –æ–ø–µ—Ä–∞—Ç–æ—Ä —Å–≤—è–∑–∏ –º–æ–∂–µ—Ç –¥–æ–ø–æ–ª–Ω–∏—Ç—å —ç—Ç–æ—Ç –ø–µ—Ä–µ—á–µ–Ω—å –∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏. –ü–æ–ª—É—á–µ–Ω–∏–µ —É–ø—Ä–æ—â–µ–Ω–Ω–æ–π –ª–∏—Ü–µ–Ω–∑–∏–∏ –Ω–∞ –æ—Ç–ø—É—Å–∫ –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–Ω–æ–≥–æ –ø–µ—Ä–µ—á–Ω—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–µ–π –æ–±—Å—É–¥–∏–ª–∏ –≤ –ú–∏–Ω–∑–¥—Ä–∞–≤–µ –†–§. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Ptg68 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The postal service company has expanded the sale of medical products, including non-drug items such as cosmetic and dietary supplements. Simplified licensing for the sale of specific drug lists is being discussed by organizations with the Ministry of Health. More products are expected to be added this year.""
}"
2025-10-23T13:03:05+00:00,@medpharm,13242,https://t.me/medpharm/13242,–°—Ç—Ä–∞—Ö–æ–≤–∫—É –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—ã—Ö —Ä–∏—Å–∫–æ–≤ –≤ –†–æ—Å—Å–∏–∏ –∏–º–µ—é—Ç —Ç–æ–ª—å–∫–æ —á—É—Ç—å –±–æ–ª–µ–µ 32 —Ç—ã—Å. –≤—Ä–∞—á–µ–π. –ü—Ä–∏ —ç—Ç–æ–º –±–æ–ª—å—à–µ –ø–æ–ª–æ–≤–∏–Ω—ã –∑–∞—Å—Ç—Ä–∞—Ö–æ–≤–∞–Ω–Ω—ã—Ö –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –≤—Å–µ–≥–æ –Ω–∞ —Ç—Ä–∏ —Ä–µ–≥–∏–æ–Ω–∞ ‚Äî –ù–æ–≤–æ—Å–∏–±–∏—Ä—Å–∫—É—é –∏ –°–≤–µ—Ä–¥–ª–æ–≤—Å–∫—É—é –æ–±–ª–∞—Å—Ç–∏ –∏ –†–µ—Å–ø—É–±–ª–∏–∫—É –¢–∞—Ç–∞—Ä—Å—Ç–∞–Ω. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://medvestnik.ru/content/news/Strahovku-professionalnyh-riskov-v-Rossii-imeut-nemnogim-bolee-32-tys-vrachei.html?utm_source=TG_post&utm_medium=Group&utm_campaign=Strahovku-professionalnyh-riskov-v-Rossii-imeut-nemnogim-bolee-32-tys-vrachei #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-10-23T12:39:03+00:00,@medpharm,13241,https://t.me/medpharm/13241,"–ó–∞—Ä–ø–ª–∞—Ç—ã –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª–µ–π –∑–∞–≤–µ–¥—É—é—â–∏—Ö –∞–ø—Ç–µ–∫–æ–π –≤ –∫—Ä—É–ø–Ω—ã—Ö –≥–æ—Ä–æ–¥–∞—Ö –†–æ—Å—Å–∏–∏ –≤ –æ–∫—Ç—è–±—Ä–µ 2025 –≥–æ–¥–∞ –Ω–∞—á–∏–Ω–∞—é—Ç—Å—è –æ—Ç 50 —Ç—ã—Å. —Ä—É–±. –≤ –º–µ—Å—è—Ü. –ú–µ–Ω—å—à–µ –≤—Å–µ–≥–æ –ø–æ–ª—É—á–∞—é—Ç –≤ –û–º—Å–∫–µ, –í–æ–ª–≥–æ–≥—Ä–∞–¥–µ, –°–∞–º–∞—Ä–µ –∏ –£—Ñ–µ. –ú–∏–Ω–∏–º–∞–ª—å–Ω–∞—è –∑–∞—Ä–ø–ª–∞—Ç–∞ –Ω–∞ —ç—Ç–æ–π –¥–æ–ª–∂–Ω–æ—Å—Ç–∏ –≤ –ú–æ—Å–∫–≤–µ ‚Äî 70 —Ç—ã—Å. —Ä—É–±., –≤ –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥–µ ‚Äî 60 —Ç—ã—Å. —Ä—É–±. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Ptch7 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–∞—Ä—å–µ—Ä–∞","{""skip"": true}"
2025-10-23T11:13:06+00:00,@medpharm,13240,https://t.me/medpharm/13240,"–ë—ã–≤—à–∏–π –Ω–∞—á–∞–ª—å–Ω–∏–∫ –æ—Ç–¥–µ–ª–∞ –ø–æ –∑–∞–∫—É–ø–∫–µ –º–µ–¥–æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –°–µ–≤–µ—Ä–æ-–ó–∞–ø–∞–¥–Ω–æ–≥–æ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ –ø—Ä–∏–∑–Ω–∞–Ω –≤–∏–Ω–æ–≤–Ω—ã–º –≤–æ –≤–∑—è—Ç–æ—á–Ω–∏—á–µ—Å—Ç–≤–µ. –°—É–¥ –ø—Ä–∏–≥–æ–≤–æ—Ä–∏–ª –ö–∏—Ä–∏–ª–ª–∞ –†—É—Å–ª–∞–Ω–æ–≤–∞ –∫ 7,5 –≥–æ–¥–∞ –∫–æ–ª–æ–Ω–∏–∏ —Å—Ç—Ä–æ–≥–æ–≥–æ —Ä–µ–∂–∏–º–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PtWSJ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-10-23T10:58:03+00:00,@medpharm,13239,https://t.me/medpharm/13239,"–†–∞—Å—Ö–æ–¥—ã –Ω–∞ —Ç–µ–ª–µ—Ä–µ–∫–ª–∞–º—É –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –°–®–ê –¥–æ—Å—Ç–∏–≥–ª–∏ 1,25 –º–ª—Ä–¥ –¥–æ–ª–ª. –∑–∞ III –∫–≤–∞—Ä—Ç–∞–ª ( 12% –≥–æ–¥ –∫ –≥–æ–¥—É). –§–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –≤—ã—Ä–≤–∞–ª–∏—Å—å –≤ –ª–∏–¥–µ—Ä—ã –ø–æ —Ä–µ–∫–ª–∞–º–Ω—ã–º –±—é–¥–∂–µ—Ç–∞–º –≤ —Å—Ç—Ä–∞–Ω–µ, –∑–∞—Ö–≤–∞—Ç–∏–≤ —Å–µ–¥—å–º—É—é —á–∞—Å—Ç—å –≤—Å–µ–≥–æ —Ä—ã–Ω–∫–∞ (13,1%). –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PtVLM #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-23T10:52:24+00:00,@medpharm,13238,https://t.me/medpharm/13238,21‚Äì22 –æ–∫—Ç—è–±—Ä—è –≥–µ–Ω–µ—Ä–∞–ª—å–Ω—ã–π –¥–∏—Ä–µ–∫—Ç–æ—Ä –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–†-–§–∞—Ä–º¬ª –í–∞—Å–∏–ª–∏–π –ò–≥–Ω–∞—Ç—å–µ–≤ –ø–æ—Å–µ—Ç–∏–ª –ê–ª–∂–∏—Ä –≤ —Ä–∞–º–∫–∞—Ö –±–∏–∑–Ω–µ—Å-–º–∏—Å—Å–∏–∏ —á–ª–µ–Ω–æ–≤ –∫–æ—Ä—Å–æ–≤–µ—Ç–∞ ¬´–î–µ–ª–æ–≤–æ–π –†–æ—Å—Å–∏–∏¬ª. –í —Ö–æ–¥–µ –≤–∏–∑–∏—Ç–∞ —Å–æ—Å—Ç–æ—è–ª–∏—Å—å –ø–µ—Ä–µ–≥–æ–≤–æ—Ä—ã —Å —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–æ–º –ú–∏–Ω–∏—Å—Ç–µ—Ä—Å—Ç–≤–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∏ –ú–∏–Ω–∏—Å—Ç–µ—Ä—Å—Ç–≤–∞ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏ —Å—Ç—Ä–∞–Ω—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PtUt9,"{""skip"": true}"
2025-10-23T10:12:07+00:00,@medpharm,13237,https://t.me/medpharm/13237,"–í –†–æ—Å—Å–∏–∏ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ —Ä–∞—Å—à–∏—Ä–∏—Ç—å –ø—Ä–∞–≤–æ –Ω–∞ –≤–Ω–µ–æ—á–µ—Ä–µ–¥–Ω–æ–µ –º–µ–¥–æ–±—Å–ª—É–∂–∏–≤–∞–Ω–∏–µ –¥–ª—è —Å–µ–º–µ–π —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –°–í–û, –≤–∫–ª—é—á–∞—è —Å—É–ø—Ä—É–≥–æ–≤, –¥–µ—Ç–µ–π –∏ —Ä–æ–¥–∏—Ç–µ–ª–µ–π –≤–æ–µ–Ω–Ω–æ—Å–ª—É–∂–∞—â–∏—Ö. –î–µ–ø—É—Ç–∞—Ç—ã —Ç–∞–∫–∂–µ –≤—ã—Å—Ç—É–ø–∏–ª–∏ –∑–∞ –∏—Ö –≤–∫–ª—é—á–µ–Ω–∏–µ –≤ —Å–ø–µ—Ü–∏–∞–ª—å–Ω—ã–µ –ø—Ä–æ–≥—Ä–∞–º–º—ã –¥–∏—Å–ø–∞–Ω—Å–µ—Ä–∏–∑–∞—Ü–∏–∏ –∏ —Å–æ–∑–¥–∞–Ω–∏–µ –æ—Ç–¥–µ–ª—å–Ω–æ–≥–æ —Ä–µ–µ—Å—Ç—Ä–∞ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PtRwY #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, safety, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""Deputies proposed to expand the right for out-of-order medical service provision for families of participants in the Special Weapon Operation, including spouses, children, and parents of military personnel. They also called for their inclusion in special health care programs and creation of a separate registry of patients.""
}"
2025-10-23T09:34:03+00:00,@medpharm,13236,https://t.me/medpharm/13236,"–ü–æ–∫—É–ø–∞—Ç–µ–ª–∏ —Å—Ç–∞–ª–∏ –±–æ–ª–µ–µ –æ—Å–æ–∑–Ω–∞–Ω–Ω–æ –ø–æ–¥—Ö–æ–¥–∏—Ç—å –∫ –≤—ã–±–æ—Ä—É –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, —Å—Ä–∞–≤–Ω–∏–≤–∞—è –∞–Ω–∞–ª–æ–≥–∏ –∏ —Ü–µ–Ω—ã —á–µ—Ä–µ–∑ –æ–Ω–ª–∞–π–Ω-—Å–µ—Ä–≤–∏—Å—ã, —Å–ª–µ–¥—É–µ—Ç –∏–∑ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è ¬´–ù–∏–ª—å—Å–µ–Ω¬ª. –ü—Ä–∏ —ç—Ç–æ–º –≥–ª–∞–≤–Ω—ã–º –∫—Ä–∏—Ç–µ—Ä–∏–µ–º –≤—ã–±–æ—Ä–∞ –∞–ø—Ç–µ–∫–∏ —Å—Ç–∞–ª–æ —É–¥–æ–±—Å—Ç–≤–æ, –∞ –Ω–µ —Å—Ç–æ–∏–º–æ—Å—Ç—å —Ç–æ–≤–∞—Ä–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PtPCK #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand,hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""Buyers are becoming more conscious in choosing medications by comparing generics and prices through online services. According to the Nielsen research, convenience of pharmacies is now a key factor in choosing a pharmacy over price.""
}"
2025-10-23T09:09:03+00:00,@medpharm,13235,https://t.me/medpharm/13235,"–í –ì–æ—Å–¥—É–º–µ –†–§ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ —Å–∫–æ—Ä—Ä–µ–∫—Ç–∏—Ä–æ–≤–∞—Ç—å –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–µ –∏ —Ü–µ–ª–µ–≤–æ–º –æ–±—É—á–µ–Ω–∏–∏ –º–µ–¥–∏–∫–æ–≤, —á—Ç–æ–±—ã —Å–¥–µ–ª–∞—Ç—å —Å–∏—Å—Ç–µ–º—É –ø–æ–¥–≥–æ—Ç–æ–≤–∫–∏ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –±–æ–ª–µ–µ —Å–ø—Ä–∞–≤–µ–¥–ª–∏–≤–æ–π –∏ –≥–∏–±–∫–æ–π. –ü–æ–ø—Ä–∞–≤–∫–∏ –ø—Ä–µ–¥—É—Å–º–∞—Ç—Ä–∏–≤–∞—é—Ç –æ–ø–ª–∞—Ç—É –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–∞, —Å–æ—Ü–∏–∞–ª—å–Ω—ã–µ –≥–∞—Ä–∞–Ω—Ç–∏–∏ –¥–ª—è –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–≤—É–∑–æ–≤ –∏ –∫–æ–ª–ª–µ–¥–∂–µ–π –∏ –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏–µ —à—Ç—Ä–∞—Ñ–æ–≤ –∑–∞ –æ—Ç–∫–∞–∑ –æ—Ç –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–π –æ—Ç—Ä–∞–±–æ—Ç–∫–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PtMMH #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-10-23T08:22:03+00:00,@medpharm,13234,https://t.me/medpharm/13234,"–í –∫–æ–º–ø–∞–Ω–∏–∏ Renewal (–ê–û ¬´–ü–§–ö –û–±–Ω–æ–≤–ª–µ–Ω–∏–µ¬ª) –Ω–∞–∑–Ω–∞—á–µ–Ω –Ω–æ–≤—ã–π –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä: –∏–º —Å—Ç–∞–ª –í–ª–∞–¥–∏–º–∏—Ä –ì—Ä–µ—á–∫–∏–Ω, —Ä–∞–Ω–µ–µ –∑–∞–Ω–∏–º–∞–≤—à–∏–π –ø–æ—Å—Ç –∏—Å–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–≥–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞. –î–º–∏—Ç—Ä–∏–π –ì—Ä–∏—Å—é–∫, —Ä—É–∫–æ–≤–æ–¥–∏–≤—à–∏–π –∫–æ–º–ø–∞–Ω–∏–µ–π –ø–æ—Å–ª–µ–¥–Ω–∏–µ –¥–≤–∞ –≥–æ–¥–∞, —Å—Ñ–æ–∫—É—Å–∏—Ä—É–µ—Ç—Å—è –Ω–∞ —Ñ–∏–Ω–∞–Ω—Å–∞—Ö. –î—Ä—É–≥–∏—Ö –∫–∞–¥—Ä–æ–≤—ã—Ö –ø–µ—Ä–µ—Å—Ç–∞–Ω–æ–≤–æ–∫ –≤ –º–µ–Ω–µ–¥–∂–º–µ–Ω—Ç–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è –Ω–µ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PtHoL #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-23T08:16:04+00:00,@medpharm,13233,https://t.me/medpharm/13233,"–ë—Ä–∏—Ç–∞–Ω—Å–∫–∞—è –¥–∏–µ—Ç–∏—á–µ—Å–∫–∞—è –∞—Å—Å–æ—Ü–∏–∞—Ü–∏—è –≤–ø–µ—Ä–≤—ã–µ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∞ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø–æ –¥–∏–µ—Ç–æ—Ç–µ—Ä–∞–ø–∏–∏ —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–∏—Ö –∑–∞–ø–æ—Ä–æ–≤ —É –≤–∑—Ä–æ—Å–ª—ã—Ö. –î–æ–∫—É–º–µ–Ω—Ç –≤–∫–ª—é—á–∞–µ—Ç 59 —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π, –æ—Ö–≤–∞—Ç—ã–≤–∞—é—â–∏—Ö 12 –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏–π –¥–∏–µ—Ç–∏—á–µ—Å–∫–æ–≥–æ –ª–µ—á–µ–Ω–∏—è: —É–ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–µ –≤–æ–¥—ã –∏ –Ω–∞–ø–∏—Ç–∫–æ–≤, —Ä–∞—Å—Ç–∏—Ç–µ–ª—å–Ω—ã—Ö –ø—Ä–æ–¥—É–∫—Ç–æ–≤, –ø—Ä–æ–±–∏–æ—Ç–∏–∫–æ–≤, –∫–ª–µ—Ç—á–∞—Ç–∫–∏ –∏ –¥–æ–±–∞–≤–æ–∫, –≤–∏—Ç–∞–º–∏–Ω–æ–≤, –º–∏–Ω–µ—Ä–∞–ª–æ–≤, —Ä–∞—Å—Ç–∏—Ç–µ–ª—å–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –∏ –¥—Ä—É–≥–∏—Ö –Ω—É—Ç—Ä–∏–µ–Ω—Ç–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PtHNG #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ì–∞—Å—Ç—Ä–æ—ç–Ω—Ç–µ—Ä–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-10-23T08:10:06+00:00,@medpharm,13232,https://t.me/medpharm/13232,"–ì–æ—Å–¥—É–º–∞ –†–§ –≤ –ø–µ—Ä–≤–æ–º —á—Ç–µ–Ω–∏–∏ –æ–¥–æ–±—Ä–∏–ª–∞ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ –ø–æ–≤—ã—à–µ–Ω–∏–∏ —Å—Ç–∞–≤–∫–∏ –ù–î–° –¥–æ 22%, –ø—Ä–∏ —Å–æ—Ö—Ä–∞–Ω–µ–Ω–∏–∏ –ª—å–≥–æ—Ç–Ω–æ–π —Å—Ç–∞–≤–∫–∏ 10% –Ω–∞ —Å–æ—Ü–∏–∞–ª—å–Ω–æ –∑–Ω–∞—á–∏–º—ã–µ —Ç–æ–≤–∞—Ä—ã. –î–ª—è —Ä–∞–±–æ—Ç–∞—é—â–∏—Ö –Ω–∞ –£–°–ù —Å–Ω–∏–∂–∞–µ—Ç—Å—è –ø–æ—Ä–æ–≥ –≥–æ–¥–æ–≤–æ–π –≤—ã—Ä—É—á–∫–∏. –ü—Ä–∏ —ç—Ç–æ–º, –ø–æ –¥–∞–Ω–Ω—ã–º –°–ú–ò, –≤–æ–∑–º–æ–∂–Ω–æ –ø–æ—ç—Ç–∞–ø–Ω–æ–µ —Å–Ω–∏–∂–µ–Ω–∏–µ –ø–æ—Ä–æ–≥–∞ –≥–æ–¥–æ–≤–æ–π –≤—ã—Ä—É—á–∫–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PtGwY #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""pricing, regulation"",
  ""impact"": ""medium"",
  ""english"": ""The Russian Duma approved a law project to increase the VAT rate to 22%, while maintaining a reduced rate of 10% for socially significant goods. For those on the Small Tax Basis (–£–°–ù), there is a reduction in the annual turnover threshold. There are also reports suggesting an incremental decrease in the turnover threshold.""
}"
2025-10-23T06:55:03+00:00,@medpharm,13231,https://t.me/medpharm/13231,"–ü–æ –ø—Ä–æ–≥–Ω–æ–∑–∞–º –í–û–ó, –∫ 2050 –≥–æ–¥—É –¥–µ—Ñ–∏—Ü–∏—Ç –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –≤ –º–∏—Ä–µ —Å–æ—Å—Ç–∞–≤–∏—Ç 11 –º–ª–Ω —á–µ–ª–æ–≤–µ–∫. –ì–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–∞—è –º–µ–¥–∏—Ü–∏–Ω–∞ –≤ –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–µ —Å—Ç—Ä–∞–Ω —Å—Ç—Ä–∞–¥–∞–µ—Ç –æ—Ç –ø–æ—Ö–æ–∂–∏—Ö –ø—Ä–æ–±–ª–µ–º: –≤—Ä–∞—á–∏ –Ω–µ —Ö–æ—Ç—è—Ç –∂–∏—Ç—å –≤ —Å–µ–ª–∞—Ö –∏ –º–∞–ª–µ–Ω—å–∫–∏—Ö –≥–æ—Ä–æ–¥–∞—Ö, –æ–Ω–∏ –º–∞—Å—Å–æ–≤–æ –≤—ã—Ö–æ–¥—è—Ç –Ω–∞ –ø–µ–Ω—Å–∏—é, –∞ –º–æ–ª–æ–¥—ã–µ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –º–µ–Ω—è—é—Ç –ø—Ä–æ—Ñ–µ—Å—Å–∏—é, —É–µ–∑–∂–∞—é—Ç –∑–∞ –≥—Ä–∞–Ω–∏—Ü—É –ø–æ—Å–ª–µ –ø–æ–ª—É—á–µ–Ω–∏—è –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è –∏–ª–∏ —É—Å—Ç—Ä–∞–∏–≤–∞—é—Ç—Å—è –Ω–∞ —Ä–∞–±–æ—Ç—É –≤ —á–∞—Å—Ç–Ω—ã–µ –∫–ª–∏–Ω–∏–∫–∏. –ü—Ä–∏ —ç—Ç–æ–º —á–∏—Å–ª–æ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Ä–∞—Å—Ç–µ—Ç –∏–∑-–∑–∞ —Å—Ç–∞—Ä–µ–Ω–∏—è –Ω–∞—Å–µ–ª–µ–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PtBUQ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-10-23T06:07:04+00:00,@medpharm,13230,https://t.me/medpharm/13230,"–ü—Ä–∏ –æ—Ü–µ–Ω–∫–µ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –Ω—É–∂–Ω–æ —É—á–∏—Ç—ã–≤–∞—Ç—å –Ω–µ –æ–±—â–µ–µ —á–∏—Å–ª–æ –¥–∏—Å–ø–∞–Ω—Å–µ—Ä–∏–∑–∞—Ü–∏–π, –∞ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –≤—ã—è–≤–ª–µ–Ω–Ω—ã—Ö —Å–ª—É—á–∞–µ–≤ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –†–µ–≥–∏–æ–Ω—ã —Å –º–µ–Ω–µ–µ –≤—ã—Å–æ–∫–∏–º–∏ –æ—Ö–≤–∞—Ç–∞–º–∏ –º–æ–≥—É—Ç –±—ã—Ç—å –≥–æ—Ä–∞–∑–¥–æ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∏–≤–Ω–µ–µ –≤ –≤—ã—è–≤–ª–µ–Ω–∏–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pt7Ei #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-10-22T16:28:30+00:00,@medpharm,13229,https://t.me/medpharm/13229,"ü¶æ –ì–æ—Ä–∞ —Å –ø–ª–µ—á. –í–≤–µ–¥–µ–Ω–∏–µ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–π —Ç—Ä–µ—Ö–ª–µ—Ç–Ω–µ–π –æ—Ç—Ä–∞–±–æ—Ç–∫–∏ –¥–ª—è –≤—Å–µ—Ö –æ–∫–æ–Ω—á–∏–≤—à–∏—Ö –æ–±—É—á–µ–Ω–∏–µ –ø–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–º —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç—è–º –æ–∑–Ω–∞—á–∞–µ—Ç, —á—Ç–æ –≥–ª–∞–≤–Ω—ã–º –≤—Ä–∞—á–∞–º –ø—Ä–∏–¥–µ—Ç—Å—è –ø–µ—Ä–µ—Å–º–∞—Ç—Ä–∏–≤–∞—Ç—å —à—Ç–∞—Ç–Ω—ã–µ —Ä–∞—Å–ø–∏—Å–∞–Ω–∏—è, —á—Ç–æ–±—ã –æ–±–µ—Å–ø–µ—á–∏—Ç—å —Ä–∞–±–æ—á–∏–µ –º–µ—Å—Ç–∞ –ø–æ —Ü–µ–ª–µ–≤—ã–º –¥–æ–≥–æ–≤–æ—Ä–∞–º. –ù–∞–≥—Ä—É–∑–∫–∞ –Ω–∞ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ —Å–µ–π—á–∞—Å —Ä–∞–±–æ—Ç–∞—é—Ç –Ω–∞ 1,25‚Äî2 —Å—Ç–∞–≤–∫–∏ —Å–Ω–∏–∑–∏—Ç—Å—è. ü¶æ –ü–æ–ª–µ–∑–Ω–æ–µ —Å –ø–æ–ª–µ–∑–Ω—ã–º. –ò–∑ 260,2 —Ç—ã—Å. —Å—Ç—É–¥–µ–Ω—Ç–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ –æ–±—É—á–∞—é—Ç—Å—è –ø–æ –ø—Ä–æ–≥—Ä–∞–º–º–∞–º —Å–ø–µ—Ü–∏–∞–ª–∏—Ç–µ—Ç–∞ –≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –≤—É–∑–∞—Ö –†–æ—Å—Å–∏–∏, 34,9 —Ç—ã—Å. —Ä–∞–±–æ—Ç–∞—é—Ç –Ω–∞ ¬´—Å–∫–æ—Ä–æ–π¬ª. –°—Ä–µ–¥–∏ 25,6 —Ç—ã—Å. –æ—Ä–¥–∏–Ω–∞—Ç–æ—Ä–æ–≤ –ø–µ—Ä–≤–æ–≥–æ –≥–æ–¥–∞ –æ–±—É—á–µ–Ω–∏—è —Ç–∞–∫–∏—Ö 2,6 —Ç—ã—Å. ‚ù§Ô∏è –ü–æ —Ñ–æ—Ä–º–∞–ª—å–Ω—ã–º –ø—Ä–∏–∑–Ω–∞–∫–∞–º. –î–µ–ø—É—Ç–∞—Ç –ì–æ—Å–¥—É–º—ã –†–§ –ë–∞–¥–º–∞ –ë–∞—à–∞–Ω–∫–∞–µ–≤ –æ–±—Ä–∞—Ç–∏–ª—Å—è –∫ –º–∏–Ω–∏—Å—Ç—Ä—É –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –†–§ –ú–∏—Ö–∞–∏–ª—É –ú—É—Ä–∞—à–∫–æ —Å –ø—Ä–æ—Å—å–±–æ–π —Ä–∞–∑—ä—è—Å–Ω–∏—Ç—å –≤–æ–ø—Ä–æ—Å —Å –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–µ–π —Ñ–∞—Ä–º—Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤. ‚ù§Ô∏è –°—É–¥ –Ω–∞ —Å—Ç–æ—Ä–æ–Ω–µ –§–ê–°. KRKA –ø—Ä–æ–∏–≥—Ä–∞–ª–∞ –≤ –∫–∞—Å—Å–∞—Ü–∏–∏ —Å–ø–æ—Ä —Å –§–ê–° –†–æ—Å—Å–∏–∏ –æ –ø–æ–≤—ã—à–µ–Ω–∏–∏ –æ—Ç–ø—É—Å–∫–Ω—ã—Ö —Ü–µ–Ω –Ω–∞ –æ—Ç–¥–µ–ª—å–Ω—ã–µ –¥–æ–∑–∏—Ä–æ–≤–∫–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ¬´–ö–æ-–î–∞–ª—å–Ω–µ–≤–∞¬ª. –≠—Ç–æ –¥–µ–ª–æ –¥–æ–ª–∂–Ω–æ –±—ã–ª–æ —Å—Ç–∞—Ç—å –ø–æ–∫–∞–∑–∞—Ç–µ–ª—å–Ω—ã–º: –§–ê–° –†–æ—Å—Å–∏–∏ –±—É–¥–µ—Ç —Å–ª–µ–¥–∏—Ç—å –∑–∞ –Ω–µ–æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω—ã–º –ø–æ–≤—ã—à–µ–Ω–∏–µ–º —Ü–µ–Ω –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞, –Ω–µ –≤—Ö–æ–¥—è—â–∏–µ –≤ –ü–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü.","{""skip"": true}"
2025-10-22T15:47:04+00:00,@medpharm,13228,https://t.me/medpharm/13228,"–ì–æ—Å–¥—É–º–∞ –†–§ –ø—Ä–∏–Ω—è–ª–∞ –≤ –ø–µ—Ä–≤–æ–º —á—Ç–µ–Ω–∏–∏ –ø–æ–ø—Ä–∞–≤–∫–∏ –≤ –∑–∞–∫–æ–Ω ¬´–û–± –û–ú–°¬ª, –≤ —Ç–æ–º —á–∏—Å–ª–µ –Ω–∞–¥–µ–ª—è—é—â–∏–π –≥—É–±–µ—Ä–Ω–∞—Ç–æ—Ä–æ–≤ –ø—Ä–∞–≤–æ–º –ø—Ä–∏–Ω–∏–º–∞—Ç—å —Ä–µ—à–µ–Ω–∏–µ –æ –∑–∞–º–µ–Ω–µ —Å—Ç—Ä–∞—Ö–æ–≤—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω—ã–º–∏ —Ñ–æ–Ω–¥–∞–º–∏ –û–ú–°. –ü—Ä–∏ –≥–æ–ª–æ—Å–æ–≤–∞–Ω–∏–∏ —á–∞—Å—Ç—å –¥–µ–ø—É—Ç–∞—Ç–æ–≤ –≤–æ–∑–¥–µ—Ä–∂–∞–ª–∏—Å—å. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PsiRe #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The Russian Duma approved amendments to the 'Federal Law on Health Insurance' in the first reading, including granting governor's powers to replace insurance medical organizations with territorial health funds for Health Insurance. Some deputies abstained from voting.""
}"
2025-10-22T15:28:07+00:00,@medpharm,13227,https://t.me/medpharm/13227,–î–µ–ø—É—Ç–∞—Ç—ã –ø—Ä–∏–Ω—è–ª–∏ –≤ –ø–µ—Ä–≤–æ–º —á—Ç–µ–Ω–∏–∏ –±—é–¥–∂–µ—Ç –§–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ —Ñ–æ–Ω–¥–∞ –û–ú–° –Ω–∞ 2026‚Äì2028 –≥–æ–¥—ã. –í–æ –≤—Ä–µ–º—è –æ–±—Å—É–∂–¥–µ–Ω–∏—è –≤–æ–∑–Ω–∏–∫–ª–∏ —Å–ø–æ—Ä—ã –æ –º–æ–¥–µ–ª–∏ —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è.‚Äã –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PshSY #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""reimbursement, shortage"",
  ""impact"": ""medium"",
  ""english"": ""Deputies passed the budget of the Federal Health Fund for the period 2026-2028 in the first reading. Discussions during the debate included disputes about the financing model of Russian healthcare.""
}"
2025-10-22T14:45:03+00:00,@medpharm,13226,https://t.me/medpharm/13226,"Anthropic –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∞ Claude for Life Sciences ‚Äî —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—É—é –ò–ò-–º–æ–¥–µ–ª—å, –∫–æ—Ç–æ—Ä–∞—è –ø—Ä–∏–∑–≤–∞–Ω–∞ –ø–æ–º–æ—á—å –Ω–∞ –≤—Å–µ—Ö —ç—Ç–∞–ø–∞—Ö —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –Ω–æ–≤—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ù–µ–π—Ä–æ—Å–µ—Ç—å —É—Å–∫–æ—Ä–∏—Ç –∫–∞–∫ –∞–Ω–∞–ª–∏–∑ –¥–∞–Ω–Ω—ã—Ö, —Ç–∞–∫ –∏ –ø–æ–¥–≥–æ—Ç–æ–≤–∫—É –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤ –¥–ª—è –ø–æ–¥–∞—á–∏ –≤ —Ä–µ–≥—É–ª—è—Ç–æ—Ä–Ω—ã–µ –æ—Ä–≥–∞–Ω—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pseqj #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-22T13:27:06+00:00,@medpharm,13225,https://t.me/medpharm/13225,"–ù–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–æ –ø–æ–º–æ–∂–µ—Ç –æ—Å–≤–æ–∏—Ç—å—Å—è –≤ –ø—Ä–æ—Ñ–µ—Å—Å–∏–∏ –º–æ–ª–æ–¥—ã–º —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞–º, –∫–æ—Ç–æ—Ä—ã–µ –ø—Ä–∏–¥—É—Ç –Ω–∞ —Å–º–µ–Ω—É –ø—Ä–µ–¥—ã–¥—É—â–∏–º –ø–æ–∫–æ–ª–µ–Ω–∏—è–º. –ë–µ–∑ —ç—Ç–æ–≥–æ –Ω–æ–≤–æ–≤–≤–µ–¥–µ–Ω–∏—è –Ω–µ –ø–æ–ª—É—á–∏—Ç—Å—è —Ä–µ—à–∏—Ç—å –ø—Ä–æ–±–ª–µ–º—É –æ–≥—Ä–æ–º–Ω–æ–π –Ω–∞–≥—Ä—É–∑–∫–∏ –Ω–∞ –≤—Ä–∞—á–µ–π –ø–µ—Ä–≤–∏—á–Ω–æ–≥–æ –∑–≤–µ–Ω–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PsZsD #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-10-22T13:21:03+00:00,@medpharm,13224,https://t.me/medpharm/13224,"FDA –æ–¥–æ–±—Ä–∏–ª–æ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ –ø–µ—Ä–≤–æ–≥–æ –∞–≥–æ–Ω–∏—Å—Ç–∞ –ì–ü–ü-1 –≤ –≤–∏–¥–µ —Ç–∞–±–ª–µ—Ç–æ–∫ –¥–ª—è —Å–Ω–∏–∂–µ–Ω–∏—è —Ä–∏—Å–∫–∞ –∏–Ω—Ñ–∞—Ä–∫—Ç–∞, –∏–Ω—Å—É–ª—å—Ç–∞ –∏ —Å–º–µ—Ä—Ç–∏ –æ—Ç –±–æ–ª–µ–∑–Ω–µ–π —Å–µ—Ä–¥—Ü–∞ —É –¥–∏–∞–±–µ—Ç–∏–∫–æ–≤ 2-–≥–æ —Ç–∏–ø–∞. –ò–º —Å—Ç–∞–ª –ø—Ä–µ–ø–∞—Ä–∞—Ç Novo Nordisk ¬´–†–µ–±–µ–ª—Å–∞—Å¬ª (—Å–µ–º–∞–≥–ª—É—Ç–∏–¥). –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PsZUr #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-22T12:24:07+00:00,@medpharm,13223,https://t.me/medpharm/13223,"–ì–æ—Å–∑–∞–∫—É–ø–∫–∏ —Å–∏—Å—Ç–µ–º –Ω–µ–ø—Ä–µ—Ä—ã–≤–Ω–æ–≥–æ –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥–∞ –≥–ª—é–∫–æ–∑—ã –≤ –†–æ—Å—Å–∏–∏ –∑–∞ –¥–µ–≤—è—Ç—å –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ –≤—ã—Ä–æ—Å–ª–∏ –ø–æ—á—Ç–∏ –≤–¥–≤–æ–µ –∏ –¥–æ—Å—Ç–∏–≥–ª–∏ 15,4 –º–ª—Ä–¥ —Ä—É–±., –≤ —Ç–æ–º —á–∏—Å–ª–µ –∑–∞ —Å—á–µ—Ç —É–≤–µ–ª–∏—á–µ–Ω–∏—è —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è —Ñ–µ–¥–ø—Ä–æ–µ–∫—Ç–∞ ¬´–ë–æ—Ä—å–±–∞ —Å —Å–∞—Ö–∞—Ä–Ω—ã–º –¥–∏–∞–±–µ—Ç–æ–º¬ª. –ù–µ—Å–º–æ—Ç—Ä—è –Ω–∞ —Ä–æ—Å—Ç —Ä–∞—Å—Ö–æ–¥–æ–≤ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–∞, –ø–∞—Ü–∏–µ–Ω—Ç—ã –∏ –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ —Å–æ–æ–±—â–∞—é—Ç –æ –∑–∞–¥–µ—Ä–∂–∫–∞—Ö –≤ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–∏ —É—Å—Ç—Ä–æ–π—Å—Ç–≤–∞–º–∏.‚Äã –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PsVXQ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è #–≠–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, shortage"",
  ""impact"": ""medium"",
  ""english"": ""Procurement of continuous glucose monitoring systems in Russia for nine months of 2025 increased almost twofold to RUB154 billion, including an increase in funding for the federal project 'Battle against Diabetes'. Despite government spending increases, patients and associations report delays in device supply.""
}"
2025-10-22T12:15:03+00:00,@medpharm,13222,https://t.me/medpharm/13222,"–î–µ–ø—É—Ç–∞—Ç –ì–æ—Å–¥—É–º—ã –†–§ –ë–∞–¥–º–∞ –ë–∞—à–∞–Ω–∫–∞–µ–≤ –æ–±—Ä–∞—Ç–∏–ª—Å—è –∫ –º–∏–Ω–∏—Å—Ç—Ä—É –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –†–§ –ú–∏—Ö–∞–∏–ª—É –ú—É—Ä–∞—à–∫–æ —Å –ø—Ä–æ—Å—å–±–æ–π —Ä–∞–∑—ä—è—Å–Ω–∏—Ç—å –≤–æ–ø—Ä–æ—Å —Å –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–µ–π —Ñ–∞—Ä–º—Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤. –° –Ω–∞—á–∞–ª–∞ –≥–æ–¥–∞ —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–∏ –º–∞—Å—Å–æ–≤–æ —Å—Ç–∞–ª–∫–∏–≤–∞—é—Ç—Å—è —Å –æ—Ç–∫–∞–∑–∞–º–∏ –≤ –ø—Ä–æ—Ö–æ–∂–¥–µ–Ω–∏–∏ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–π –ø–µ—Ä–∏–æ–¥–∏—á–µ—Å–∫–æ–π –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–∏, —á—Ç–æ —Å–æ–∑–¥–∞–µ—Ç —É–≥—Ä–æ–∑—É —É—Ö–æ–¥–∞ –∫–≤–∞–ª–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –∫–∞–¥—Ä–æ–≤ –∏–∑ –æ—Ç—Ä–∞—Å–ª–∏, –∫–æ—Ç–æ—Ä–∞—è —É–∂–µ –∏—Å–ø—ã—Ç—ã–≤–∞–µ—Ç —Å–µ—Ä—å–µ–∑–Ω—ã–π –¥–µ—Ñ–∏—Ü–∏—Ç —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PsUsJ #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""registration, shortage"",
  ""impact"": ""medium"",
  ""english"": ""Deputy of the State Duma of Russia, Badma Bashankayev has appealed to Minister of Health of Russia Mikhail Murashko about the accreditation of pharmaceutical specialists. Staff have been experiencing mass refusals in completing mandatory periodic accreditation since the beginning of this year, which creates a threat to the departure of qualified personnel from the industry, which is already experiencing a serious shortage of specialists.""
}"
2025-10-22T11:17:06+00:00,@medpharm,13221,https://t.me/medpharm/13221,"–ì–ª–∞–≤–Ω—ã–º –≤—Ä–∞—á–∞–º –ø—Ä–∏–¥–µ—Ç—Å—è –ø–µ—Ä–µ—Å–º–∞—Ç—Ä–∏–≤–∞—Ç—å —à—Ç–∞—Ç–Ω—ã–µ —Ä–∞—Å–ø–∏—Å–∞–Ω–∏—è, —á—Ç–æ–±—ã —Ç—Ä—É–¥–æ—É—Å—Ç—Ä–æ–∏—Ç—å –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–≤—É–∑–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ –±—É–¥—É—Ç –ø—Ä–æ—Ö–æ–¥–∏—Ç—å —Ç—Ä–µ—Ö–ª–µ—Ç–Ω—é—é –æ—Ç—Ä–∞–±–æ—Ç–∫—É –ø–æ —Ü–µ–ª–µ–≤—ã–º –¥–æ–≥–æ–≤–æ—Ä–∞–º. –°–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –±—É–¥—É—Ç –º–µ–Ω—å—à–µ –ø–µ—Ä–µ—Ä–∞–±–∞—Ç—ã–≤–∞—Ç—å, –∑–∞—è–≤–∏–ª —Ä–µ–∫—Ç–æ—Ä –°–µ—á–µ–Ω–æ–≤—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PsQn5 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-10-22T11:17:02+00:00,@medpharm,13220,https://t.me/medpharm/13220,"¬´–ö–∞–≥–æ—Ü–µ–ª¬ª –∏—Å–∫–ª—é—á–∏–ª–∏ –∏–∑ —Å–ø–∏—Å–∫–∞ –∏–º–º—É–Ω–æ–º–æ–¥—É–ª–∏—Ä—É—é—â–∏—Ö —Å—Ä–µ–¥—Å—Ç–≤ —Å —à–∏—Ä–æ–∫–∏–º –ø—Ä–æ—Ç–∏–≤–æ–≤–∏—Ä—É—Å–Ω—ã–º –¥–µ–π—Å—Ç–≤–∏–µ–º, —Ä–µ–∫–æ–º–µ–Ω–¥–æ–≤–∞–Ω–Ω—ã—Ö –¥–ª—è –ª–µ—á–µ–Ω–∏—è –≥—Ä–∏–ø–ø–∞, –Ω–æ –¥–æ–±–∞–≤–∏–ª–∏ —á–µ—Ç—ã—Ä–µ –Ω–æ–≤—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞. –¢–∞–∫–∂–µ –¥–æ–±–∞–≤–ª–µ–Ω–æ –Ω–æ–≤–æ–µ –ø—Ä–æ—Ç–∏–≤–æ–∫–∞—à–ª–µ–≤–æ–µ —Å—Ä–µ–¥—Å—Ç–≤–æ. –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏ –æ–±–Ω–æ–≤–∏–ª –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø–æ –≤–µ–¥–µ–Ω–∏—é –≤–∑—Ä–æ—Å–ª—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –≥—Ä–∏–ø–ø–æ–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PsQn4 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""Russia's Ministry of Health updated clinical guidelines for adult patients with influenza. The national pharmacopoeia has also been revised to exclude Kagsel from the list of antiviral immunomodulatory drugs recommended for influenza treatment. Four new medications have been added, along with a new cough suppressant.""
}"
2025-10-22T10:06:03+00:00,@medpharm,13219,https://t.me/medpharm/13219,"–ö–∞—Å—Å–∞—Ü–∏–æ–Ω–Ω–∞—è –∏–Ω—Å—Ç–∞–Ω—Ü–∏—è –ø–æ–¥–¥–µ—Ä–∂–∞–ª–∞ –§–ê–° –†–æ—Å—Å–∏–∏ –≤ —Å–ø–æ—Ä–µ —Å —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–µ–π KRKA –æ –ø–æ–≤—ã—à–µ–Ω–∏–∏ –æ—Ç–ø—É—Å–∫–Ω—ã—Ö —Ü–µ–Ω –Ω–∞ –æ—Ç–¥–µ–ª—å–Ω—ã–µ –¥–æ–∑–∏—Ä–æ–≤–∫–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ¬´–ö–æ-–î–∞–ª—å–Ω–µ–≤–∞¬ª. –≠—Ç–æ –¥–µ–ª–æ –¥–æ–ª–∂–Ω–æ –±—ã–ª–æ —Å—Ç–∞—Ç—å –ø–æ–∫–∞–∑–∞—Ç–µ–ª—å–Ω—ã–º: –§–ê–° –†–æ—Å—Å–∏–∏ –±—É–¥–µ—Ç —Å–ª–µ–¥–∏—Ç—å –∑–∞ –Ω–µ–æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω—ã–º –ø–æ–≤—ã—à–µ–Ω–∏–µ–º —Ü–µ–Ω –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞, –Ω–µ –≤—Ö–æ–¥—è—â–∏–µ –≤ –ü–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PsKkZ #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""pricing"",
  ""impact"": ""high"",
  ""english"": ""The cassation instance supported the FAS of Russia in a dispute with pharmaceutical company KRKA regarding an increase in retail prices for certain dosage forms of the drug 'Ko-Dalnevaya'. This case should have been a landmark: The FAS of Russia will monitor unjustified price increases on medicines not included in the List of Essential Medicines. For more details: https://clck.ru/3PsKkZ #PharmNews #Production""
}"
2025-10-22T09:38:03+00:00,@medpharm,13218,https://t.me/medpharm/13218,"–¶–µ–Ω—Ç—Ä –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –ø—Ä–æ–≤–æ–¥–∏—Ç –ø—Ä–∏–µ–º –∑–∞—è–≤–æ–∫ –Ω–∞ —É—á–∞—Å—Ç–∏–µ –≤ –∞—É–∫—Ü–∏–æ–Ω–∞—Ö –Ω–∞ –ø–æ—Å—Ç–∞–≤–∫—É –¥–ª—è ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª —á–µ—Ç—ã—Ä–µ—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, —Å—Ä–µ–¥–∏ –Ω–∏—Ö —Ä–∏—Å–¥–∏–ø–ª–∞–º –∏ –ø–∞–ª–æ–≤–∞—Ä–æ—Ç–µ–Ω, –∫–æ—Ç–æ—Ä—ã–µ –Ω–µ —É–¥–∞–ª–æ—Å—å –∑–∞–∫—É–ø–∏—Ç—å –≤ –Ω–∞—á–∞–ª–µ –æ–∫—Ç—è–±—Ä—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PsHgr #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The Central Pharmacy Supply Center is conducting applications for participation in auctions to supply four drugs for the 'Good Circle' program, among which risduplam and palovaron were not purchased in early October. More details: https://clck.ru/3PsHgr #PharmNews #Distribution""
}"
2025-10-22T08:59:06+00:00,@medpharm,13217,https://t.me/medpharm/13217,"–í –†–æ—Å—Å–∏–∏ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –≤–∫–ª—é—á–∏—Ç—å —Ä–∞—Å—Ö–æ–¥—ã –Ω–∞ –±–æ—Ä—å–±—É —Å —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–æ–π –æ–±—Å—Ç—Ä—É–∫—Ç–∏–≤–Ω–æ–π –±–æ–ª–µ–∑–Ω—å—é –ª–µ–≥–∫–∏—Ö –≤ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã–π –±—é–¥–∂–µ—Ç –Ω–∞ 2026‚Äî2028 –≥–æ–¥—ã. –î–ª—è —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è –ø—Ä–æ–≥—Ä–∞–º–º—ã, –ø–æ –æ—Ü–µ–Ω–∫–∞–º –í—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —Å–æ—é–∑–∞ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, —Ç—Ä–µ–±—É–µ—Ç—Å—è 11,7 –º–ª—Ä–¥ —Ä—É–±. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PsEom #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è #–ü—É–ª—å–º–æ–Ω–æ–ª–æ–≥–∏—è_–∏_—Ñ—Ç–∏–∑–∏–∞—Ç—Ä–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""Russia proposes to include costs for the fight against chronic obstructive pulmonary disease in the federal budget for 2026-2028. The Russian Federation Union of Patients estimates that this will require 11.7 billion rubles for the program. More details: https://clck.ru/3PsEom #MedNews #Healthcare #Organisation_of_healthcare #Pulmonology_and_phthisiatry""
}"
2025-10-22T07:58:03+00:00,@medpharm,13216,https://t.me/medpharm/13216,"–ü–µ—Ä–≤–æ–≥–æ –∑–∞–º–º–∏–Ω–∏—Å—Ç—Ä–∞ –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–∞ –†–§ –í–∞—Å–∏–ª–∏—è –û—Å—å–º–∞–∫–æ–≤–∞ –æ—Å–≤–æ–±–æ–¥–∏–ª–∏ –æ—Ç –¥–æ–ª–∂–Ω–æ—Å—Ç–∏. –ö—Ç–æ —Å–ª–µ–¥—É—é—â–∏–º –∑–∞–π–º–µ—Ç —ç—Ç–æ—Ç –ø–æ—Å—Ç, —Å–æ–æ–±—â–∞—Ç –ø–æ–∑–¥–Ω–µ–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PsALu #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–∞—Ä—å–µ—Ä–∞","{""skip"": true}"
2025-10-22T07:04:04+00:00,@medpharm,13215,https://t.me/medpharm/13215,"–û–±–Ω–æ–≤–ª–µ–Ω—ã –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø–æ –ª–µ—á–µ–Ω–∏—é –≥—Ä–∏–ø–ø–∞ —É –≤–∑—Ä–æ—Å–ª—ã—Ö, –≤–∫–ª—é—á–∞—è —Ä–∞–∑–¥–µ–ª—ã –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∏, —Ç–µ—Ä–∞–ø–∏–∏ –∏ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏, –∞ —Ç–∞–∫–∂–µ –∫—Ä–∏—Ç–µ—Ä–∏–∏ –æ—Ü–µ–Ω–∫–∏ –∫–∞—á–µ—Å—Ç–≤–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏. –°–∫–æ—Ä—Ä–µ–∫—Ç–∏—Ä–æ–≤–∞–Ω—ã —Å–ø–∏—Å–∫–∏ –ø—Ä–æ—Ç–∏–≤–æ–≤–∏—Ä—É—Å–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –¥–ª—è —Å–∏–º–ø—Ç–æ–º–∞—Ç–∏—á–µ—Å–∫–æ–≥–æ –ª–µ—á–µ–Ω–∏—è, –≤ —Ç–æ–º —á–∏—Å–ª–µ –≤ —É—Å–ª–æ–≤–∏—è—Ö —Å—Ç–∞—Ü–∏–æ–Ω–∞—Ä–∞ –∏ –ø—Ä–∏ —Ç—è–∂–µ–ª—ã—Ö –æ—Å–ª–æ–∂–Ω–µ–Ω–∏—è—Ö. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Ps6VQ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ò–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã–µ_–±–æ–ª–µ–∑–Ω–∏ #–¢–µ—Ä–∞–ø–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""Clinical guidelines for treating influenza in adults have been updated, including sections on diagnosis, therapy, and prevention. The lists of antiviral drugs and medications for symptomatic treatment have been revised, including in hospital settings and for severe complications. For more information: https://clck.ru/3Ps6VQ #MedNews #Practice #InfectiousDiseases #Therapy""
}"
2025-10-21T16:41:36+00:00,@medpharm,13214,https://t.me/medpharm/13214,"ü¶æ –ö–∞–¥—Ä–æ–≤—ã–π —Ä–µ—Ü–µ–ø—Ç. –°–∏—Å—Ç–µ–º–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –¥–æ–ª–∂–Ω–∞ –æ–ø–∏—Ä–∞—Ç—å—Å—è –Ω–∞ –ø–æ–¥–≥–æ—Ç–æ–≤–∫—É —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤, –∞ –Ω–µ –Ω–∞ –ø—Ä–∏–≤–ª–µ—á–µ–Ω–∏–µ –º–∏–≥—Ä–∞–Ω—Ç–æ–≤ —Å –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω—ã–º —É—Ä–æ–≤–Ω–µ–º –∫–≤–∞–ª–∏—Ñ–∏–∫–∞—Ü–∏–∏, –∑–∞—è–≤–∏–ª–∞ —á–ª–µ–Ω –°–æ–≤–µ—Ç–∞ –ø–æ –ø—Ä–∞–≤–∞–º —á–µ–ª–æ–≤–µ–∫–∞ –ø—Ä–∏ –ü—Ä–µ–∑–∏–¥–µ–Ω—Ç–µ –†–§ (–°–ü–ß), –≤—Ä–∞—á –û–ª—å–≥–∞ –î–µ–º–∏—á–µ–≤–∞. –ü–æ –µ–µ —Å–ª–æ–≤–∞–º, –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω—ã–µ –æ—Ç—Ä–∞–±–æ—Ç–∫–∏ –Ω–µ —Ä–µ—à–∞—Ç –∫–∞–¥—Ä–æ–≤—ã–π –¥–µ—Ñ–∏—Ü–∏—Ç –∏ –Ω–µ –º–æ–≥—É—Ç –∑–∞–º–µ–Ω–∏—Ç—å –∫–∞—á–µ—Å—Ç–≤–µ–Ω–Ω—É—é –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—É—é –ø–æ–¥–≥–æ—Ç–æ–≤–∫—É –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤. ü¶æ –£–¥–∞—Ä –ø–æ —á–µ–∫—É. –ì–ª–∞–≤–∞ –ö–æ–º–∏—Ç–µ—Ç–∞ –ì–æ—Å–¥—É–º—ã –†–§ –ø–æ —Ç—Ä—É–¥—É, —Å–æ—Ü–∏–∞–ª—å–Ω–æ–π –ø–æ–ª–∏—Ç–∏–∫–µ –∏ –¥–µ–ª–∞–º –≤–µ—Ç–µ—Ä–∞–Ω–æ–≤ –Ø—Ä–æ—Å–ª–∞–≤ –ù–∏–ª–æ–≤ –æ–±—Ä–∞—Ç–∏–ª—Å—è –∫ –º–∏–Ω–∏—Å—Ç—Ä—É –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –†–§ –ú–∏—Ö–∞–∏–ª—É –ú—É—Ä–∞—à–∫–æ —Å –ø—Ä–æ—Å—å–±–æ–π —Ä–∞–∑—Ä–∞–±–æ—Ç–∞—Ç—å –º–µ—Ö–∞–Ω–∏–∑–º, –∫–æ—Ç–æ—Ä—ã–π –ø–æ–º–æ–∂–µ—Ç –±–æ—Ä–æ—Ç—å—Å—è —Å –Ω–∞–≤—è–∑—ã–≤–∞–Ω–∏–µ–º –Ω–µ–Ω—É–∂–Ω—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —É—Å–ª—É–≥ –≤ —á–∞—Å—Ç–Ω—ã—Ö –∫–ª–∏–Ω–∏–∫–∞—Ö. ‚ù§Ô∏è –®–∞–≥–∞–µ—Ç –ø–æ —Å—Ç—Ä–∞–Ω–µ. –î–µ–ø—É—Ç–∞—Ç—ã –ì–æ—Å–¥—É–º—ã –†–§ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ —Ä–∞—Å—à–∏—Ä–∏—Ç—å —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç –ø–æ –æ–Ω–ª–∞–π–Ω-–¥–æ—Å—Ç–∞–≤–∫–µ —Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –Ω–∞ –≤—Å—é –†–æ—Å—Å–∏—é, –æ–±—Ä–∞—â–µ–Ω–∏–µ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–æ –≤ –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏. ‚ù§Ô∏è –ù–∞ –≥–µ–Ω–Ω–æ–º —É—Ä–æ–≤–Ω–µ. –í –ø–µ—Ä–µ—á–µ–Ω—å –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π, –∫–æ—Ç–æ—Ä—ã–µ –º–æ–≥—É—Ç –∏–∑–≥–æ—Ç–∞–≤–ª–∏–≤–∞—Ç—å –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–ª—è CAR-T-—Ç–µ—Ä–∞–ø–∏–∏, –≤–∫–ª—é—á–∏–ª–∏ –ú–æ—Å–∫–æ–≤—Å–∫–∏–π –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–π –Ω–∞—É—á–Ω–æ-–ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏–π —Ü–µ–Ω—Ç—Ä –∏–º. –ê.–°. –õ–æ–≥–∏–Ω–æ–≤–∞. –û–Ω —Å—Ç–∞–ª 19-–º —É—á—Ä–µ–∂–¥–µ–Ω–∏–µ–º –≤ —Å–ø–∏—Å–∫–µ.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""Dr. Olga Demicheva, a member of the Council for Human Rights under President Putin, stated that healthcare systems should rely on training Russian specialists rather than attracting migrants with insufficient qualifications. She believes that mandatory rotations will not address the staffing shortage and cannot replace high-quality professional training for healthcare workers. A representative from the Russian State Duma Committee on Labor, Social Policy and Issues Concerning Veterans addressed Minister of Health Mikhail Murashko to propose mechanisms for combating unnecessary medical services in private clinics. A proposal from representatives of the Russian State Duma to expand an online prescription delivery experiment throughout Russia has been sent to the Ministry of Health. The Moscow Clinical Scientific and Practical Center named after A.S. Logunov has been added to the list of medical institutions that can produce biotechnological drugs for CAR-T therapy, becoming the 19th institution in the list.""
}"
2025-10-21T15:24:06+00:00,@medpharm,13213,https://t.me/medpharm/13213,"–ß–ª–µ–Ω –°–æ–≤–µ—Ç–∞ –ø–æ –ø—Ä–∞–≤–∞–º —á–µ–ª–æ–≤–µ–∫–∞ –ø—Ä–∏ –ü—Ä–µ–∑–∏–¥–µ–Ω—Ç–µ –†–§ –û–ª—å–≥–∞ –î–µ–º–∏—á–µ–≤–∞ –∑–∞—è–≤–∏–ª–∞, —á—Ç–æ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ –¥–æ–ª–∂–Ω–æ —Ä–∞–∑–≤–∏–≤–∞—Ç—å—Å—è –∑–∞ —Å—á–µ—Ç —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤, –∞ –Ω–µ –º–∏–≥—Ä–∞–Ω—Ç–æ–≤. –û–Ω–∞ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∞ –ø—Ä–æ–≥—Ä–∞–º–º—É –∏–∑ —á–µ—Ç—ã—Ä–µ—Ö —à–∞–≥–æ–≤ ‚Äî —É–≤–µ–ª–∏—á–∏—Ç—å –±—é–¥–∂–µ—Ç–Ω—ã–µ –º–µ—Å—Ç–∞, –≤–µ—Ä–Ω—É—Ç—å –∏–Ω—Ç–µ—Ä–Ω–∞—Ç—É—Ä—É, –ø–æ–≤—ã—Å–∏—Ç—å –∑–∞—Ä–ø–ª–∞—Ç—ã –∏ —Å–æ—Ö—Ä–∞–Ω–∏—Ç—å –æ–ø—ã—Ç–Ω—ã—Ö –≤—Ä–∞—á–µ–π –≤ –ø—Ä–æ—Ñ–µ—Å—Å–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Prc3z #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""Ms. Oleg Demicheva, a member of the Council on Human Rights under the President of Russia, stated that healthcare should develop through Russian specialists rather than immigrants. She proposed a program with four steps: increase budgetary places, return internship programs, raise salaries and retain experienced doctors in the profession. More details: https://clck.ru/3Prc3z #MedVestnik #Healthcare""
}"
2025-10-21T14:58:03+00:00,@medpharm,13212,https://t.me/medpharm/13212,"–í –ø–µ—Ä–µ—á–µ–Ω—å –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π, –∫–æ—Ç–æ—Ä—ã–µ –º–æ–≥—É—Ç –∏–∑–≥–æ—Ç–∞–≤–ª–∏–≤–∞—Ç—å –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–ª—è CAR-T-—Ç–µ—Ä–∞–ø–∏–∏, –≤–∫–ª—é—á–∏–ª–∏ –ú–æ—Å–∫–æ–≤—Å–∫–∏–π –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–π –Ω–∞—É—á–Ω–æ-–ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏–π —Ü–µ–Ω—Ç—Ä –∏–º. –ê.–°. –õ–æ–≥–∏–Ω–æ–≤–∞. –û–Ω —Å—Ç–∞–ª 19-–º —É—á—Ä–µ–∂–¥–µ–Ω–∏–µ–º –≤ —Å–ø–∏—Å–∫–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pra5x #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""high"",
  ""english"": ""The Moscow Clinical Scientific and Practical Center named after A.S. Logunov has been included in the list of organizations that can produce biotechnological drugs for CAR-T therapy. It is now the 19th institution on the list.""
}"
2025-10-21T14:46:05+00:00,@medpharm,13211,https://t.me/medpharm/13211,"–í –†–æ—Å—Å–∏–∏ —Å–æ–∑–¥–∞–ª–∏ –ò–ò-–º–æ–¥–µ–ª—å –¥–ª—è –≤—ã—è–≤–ª–µ–Ω–∏—è —Ä–∏—Å–∫–∞ —Ä–∞–∑–≤–∏—Ç–∏—è —Ä–∞–∑–ª–∏—á–Ω—ã—Ö —Ç–∏–ø–æ–≤ –∑–ª–æ–∫–∞—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, –≤ —Ç–æ–º —á–∏—Å–ª–µ –Ω–∞ —Ä–∞–Ω–Ω–µ–π —Å—Ç–∞–¥–∏–∏. –ò–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç –≥–æ—Ç–æ–≤ –∫ –º–∞—Å—Å–æ–≤–æ–º—É –≤–Ω–µ–¥—Ä–µ–Ω–∏—é –≤ —Ä–µ–≥–∏–æ–Ω–∞—Ö, –ø–æ–¥–∫–ª—é—á–µ–Ω–Ω—ã—Ö –∫ –ø–ª–∞—Ç—Ñ–æ—Ä–º–µ Webiomed. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PrZ64 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–û–Ω–∫–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-10-21T14:07:02+00:00,@medpharm,13210,https://t.me/medpharm/13210,"–ú–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è —Å —Ñ–∞—Ä–º–ª–∏—Ü–µ–Ω–∑–∏–µ–π –æ—Å–ø–æ—Ä–∏–ª–∞ —à—Ç—Ä–∞—Ñ –≤ 375 —Ç—ã—Å. —Ä—É–±., –Ω–∞–ª–æ–∂–µ–Ω–Ω—ã–π –∑–∞ –Ω–∞—Ä—É—à–µ–Ω–∏—è –ø—Ä–∏ –ø–µ—Ä–µ–≤–æ–∑–∫–µ —Ç—è–∂–µ–ª–æ–≤–µ—Å–Ω—ã—Ö –∏ –Ω–µ–≥–∞–±–∞—Ä–∏—Ç–Ω—ã—Ö –≥—Ä—É–∑–æ–≤. –°—É–¥ –ø—Ä–∏–∑–Ω–∞–ª –ø—Ä–∞–≤–æ—Ç—É –∫–æ–º–ø–∞–Ω–∏–∏ –∏ –æ—Ç–º–µ–Ω–∏–ª —à—Ç—Ä–∞—Ñ –†–æ—Å—Ç—Ä–∞–Ω—Å–Ω–∞–¥–∑–æ—Ä–∞. –ú–æ–∂–µ—Ç –ª–∏ –¥–∞–Ω–Ω—ã–π —Å–ª—É—á–∞–π –ø–æ–º–æ—á—å –∏–∑–±–µ–∂–∞—Ç—å —à—Ç—Ä–∞—Ñ–Ω—ã—Ö —Å–∞–Ω–∫—Ü–∏–π –≤ –ø–æ–¥–æ–±–Ω—ã—Ö —Å–∏—Ç—É–∞—Ü–∏—è—Ö, –æ—Ç–≤–µ—á–∞–µ—Ç –ø–∞—Ä—Ç–Ω–µ—Ä —é—Ä–∏–¥–∏—á–µ—Å–∫–æ–π —Ñ–∏—Ä–º—ã ¬´–ö–æ—Å–µ–Ω–∫–æ–≤ –∏ –°—É–≤–æ—Ä–æ–≤¬ª –ö–æ–Ω—Å—Ç–∞–Ω—Ç–∏–Ω –°—É–≤–æ—Ä–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PrWAR #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, regulation"",
  ""impact"": ""high"",
  ""english"": ""A medical organization with a pharmaceutical license has challenged a fine of 375,000 rubles imposed for violations related to the transportation of heavy and oversized goods. The court ruled in favor of the company, nullifying the fine. Konstantin Suvorov, a partner from legal firm Kosentkov & Suvorov, answers whether this case can help avoid similar fines.""
}"
2025-10-21T13:57:03+00:00,@medpharm,13209,https://t.me/medpharm/13209,"–ñ–µ–Ω—â–∏–Ω—ã, –ø–æ–ª—É—á–∞–≤—à–∏–µ –ø—Ä–æ–≥–µ—Å—Ç–µ—Ä–æ–Ω –≤ —Ç–µ—á–µ–Ω–∏–µ –≥–æ–¥–∞ –¥–æ –∑–∞—á–∞—Ç–∏—è, —Ä–µ–∂–µ —Å—Ç–∞–ª–∫–∏–≤–∞–ª–∏—Å—å —Å —Å–∞–º–æ–ø—Ä–æ–∏–∑–≤–æ–ª—å–Ω—ã–º –∞–±–æ—Ä—Ç–æ–º. –†–∏—Å–∫ –Ω–µ–≤—ã–Ω–∞—à–∏–≤–∞–Ω–∏—è –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏ —É –Ω–∏—Ö –±—ã–ª –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ –Ω–∏–∂–µ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å —Ç–µ–º–∏, –∫—Ç–æ –Ω–µ –ø–æ–ª—É—á–∞–ª –≥–æ—Ä–º–æ–Ω–∞–ª—å–Ω—É—é —Ç–µ—Ä–∞–ø–∏—é. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PrVVx #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ê–∫—É—à–µ—Ä—Å—Ç–≤–æ_–∏_–≥–∏–Ω–µ–∫–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è #–≠–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""Women who received progesterone during the year before conception had a lower risk of miscarriage compared to those who did not receive hormonal therapy. Further details: https://clck.ru/3PrVVx #MedVestnik #Practice #Obstetrics_and_Gynecology #Therapy #Pharmacology #Endocrinology""
}"
2025-10-21T12:19:06+00:00,@medpharm,13207,https://t.me/medpharm/13207,"–û–ø—Ä–µ–¥–µ–ª–µ–Ω –ø–µ—Ä–µ—á–µ–Ω—å –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –¥–ª—è —Ä–∞–¥–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∏ –∏ —Ç–µ—Ä–∞–ø–∏–∏, –∫–æ—Ç–æ—Ä—ã–º –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –¥–æ–æ—Å–Ω–∞—â–∞—Ç—å —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã–µ –æ–Ω–∫–æ–¥–∏—Å–ø–∞–Ω—Å–µ—Ä—ã. –í —Å–ø–∏—Å–æ–∫ –≤–æ—à–ª–∏ 14 –≤–∏–¥–æ–≤ –º–µ–¥–∏–∑–¥–µ–ª–∏–π –∏ 37 –≤–∏–¥–æ–≤ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PrNrw #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û–Ω–∫–æ–ª–æ–≥–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""A list of medical equipment for radiological diagnosis and therapy has been determined, which is planned to be equipped at regional oncodispensaries. The list includes 14 medical items and 37 pieces of equipment. For more details: https://clck.ru/3PrNrw #MedVestnik #Healthcare #Oncology""
}"
2025-10-21T11:45:03+00:00,@medpharm,13206,https://t.me/medpharm/13206,"–°–æ–∑–¥–∞–Ω–Ω—ã–π —Å –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ–º –ò–ò –ø—Ä–æ—Ç–∏–≤–æ—Ä–∞–∫–æ–≤—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –≤–ø–µ—Ä–≤—ã–µ –ø–æ–∫–∞–∑–∞–ª —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –≤ –∏—Å–ø—ã—Ç–∞–Ω–∏—è—Ö –Ω–∞ –ª—é–¥—è—Ö. –£ 28% —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤, –ø—Ä–∏–Ω–∏–º–∞–≤—à–∏—Ö –º–∞–∫—Å–∏–º–∞–ª—å–Ω—É—é –¥–æ–∑—É –ø–µ—Ä–æ—Ä–∞–ª—å–Ω–æ, –æ–ø—É—Ö–æ–ª–∏ —É–º–µ–Ω—å—à–∏–ª–∏—Å—å –±–æ–ª–µ–µ —á–µ–º –Ω–∞ —Ç—Ä–µ—Ç—å. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PrLVj #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-21T11:24:06+00:00,@medpharm,13205,https://t.me/medpharm/13205,–í–û–ó —Å–æ–∫—Ä–∞—Ç–∏–ª–∞ –æ–∫–æ–ª–æ –ø–æ–ª–æ–≤–∏–Ω—ã —Å—Ç–∞—Ä—à–∏—Ö —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª–µ–π –≤ —Ä–∞–º–∫–∞—Ö –º–∞—Å—à—Ç–∞–±–Ω–æ–π —Ä–µ—Å—Ç—Ä—É–∫—Ç—É—Ä–∏–∑–∞—Ü–∏–∏. –†–µ—à–µ–Ω–∏–µ —Å–≤—è–∑–∞–Ω–æ —Å —Ñ–∏–Ω–∞–Ω—Å–æ–≤—ã–º–∏ —Ç—Ä—É–¥–Ω–æ—Å—Ç—è–º–∏ –ø–æ—Å–ª–µ –≤—ã—Ö–æ–¥–∞ –°–®–ê –∏–∑ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –∏ —Å–µ–∫–≤–µ—Å—Ç–∏—Ä–æ–≤–∞–Ω–∏—è –±—é–¥–∂–µ—Ç–∞ –Ω–∞ 21%. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PrK9A #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-10-21T10:59:05+00:00,@medpharm,13204,https://t.me/medpharm/13204,–û–¥–Ω–æ–≤—Ä–µ–º–µ–Ω–Ω–∞—è –ø–æ–¥–∞—á–∞ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–π –æ –≤–∫–ª—é—á–µ–Ω–∏–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ –ü–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü –∏ –≤ –ø–µ—Ä–µ—á–µ–Ω—å –¥–æ—Ä–æ–≥–æ—Å—Ç–æ—è—â–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –Ω–µ –ø—Ä–æ—Ç–∏–≤–æ—Ä–µ—á–∏—Ç –¥–µ–π—Å—Ç–≤—É—é—â–∏–º –ø—Ä–∞–≤–∏–ª–∞–º. –≠—Ç–æ –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª —Ä–µ–≥—É–ª—è—Ç–æ—Ä. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PrHMH #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The simultaneous submission of applications to include drugs in the List of Essential Medicines and the list of expensive medicines does not violate existing rules, as confirmed by regulators. More details: https://clck.ru/3PrHMH #MedVestnik #Healthcare #HealthOrganization""
}"
2025-10-21T10:06:05+00:00,@medpharm,13203,https://t.me/medpharm/13203,"–§–∞—Ä–º–∞—Ü–µ–≤—Ç—ã –æ–±—è–∑–∞–Ω—ã –∏–Ω—Ñ–æ—Ä–º–∏—Ä–æ–≤–∞—Ç—å –ø–æ–∫—É–ø–∞—Ç–µ–ª–µ–π –æ –Ω–∞–ª–∏—á–∏–∏ –±–æ–ª–µ–µ –¥–µ—à–µ–≤—ã—Ö –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –∞–Ω–∞–ª–æ–≥–æ–≤ –ª–µ–∫–∞—Ä—Å—Ç–≤, —Å—á–∏—Ç–∞–µ—Ç –¥–µ–ø—É—Ç–∞—Ç –ì–æ—Å–¥—É–º—ã –†–§ –ë–∞–¥–º–∞ –ë–∞—à–∞–Ω–∫–∞–µ–≤. –ü–æ –µ–≥–æ —Å–ª–æ–≤–∞–º, —ç—Ç–æ –ø–æ–∑–≤–æ–ª—è–µ—Ç –ø–∞—Ü–∏–µ–Ω—Ç—É —Å–¥–µ–ª–∞—Ç—å –æ—Å–æ–∑–Ω–∞–Ω–Ω—ã–π –≤—ã–±–æ—Ä. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PrDPR #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage"",
  ""impact"": ""medium"",
  ""english"": ""A representative of the Russian Duma, Bada Bashankayev believes that pharmaceutical companies are required to inform customers about the availability of cheaper domestic substitutes for medicines. This allows patients to make an informed choice.""
}"
2025-10-21T10:04:06+00:00,@medpharm,13202,https://t.me/medpharm/13202,"–°—É–ª—å—Ç–∏–∞–º —É–ª—É—á—à–∏–ª –∫–∞—á–µ—Å—Ç–≤–æ —Å–Ω–∞ –∏ —Å–Ω–∏–∑–∏–ª —á–∞—Å—Ç–æ—Ç—É –æ—Å—Ç–∞–Ω–æ–≤–æ–∫ –¥—ã—Ö–∞–Ω–∏—è —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å —Å–∏–Ω–¥—Ä–æ–º–æ–º –æ–±—Å—Ç—Ä—É–∫—Ç–∏–≤–Ω–æ–≥–æ –∞–ø–Ω–æ—ç —Å–Ω–∞. –≠—Ç–∏ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –æ—Ç–∫—Ä—ã–≤–∞—é—Ç –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤—ã –¥–ª—è —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ —Ñ–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ –ª–µ—á–µ–Ω–∏—è –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è, –¥–ª—è –∫–æ—Ç–æ—Ä–æ–≥–æ –¥–æ —Å–∏—Ö –ø–æ—Ä –Ω–µ —Å—É—â–µ—Å—Ç–≤–æ–≤–∞–ª–æ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PrDEP #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance"",
  ""impact"": ""high"",
  ""english"": ""The results show promising prospects for the development of pharmacological treatments for a disease that previously had no effective medications. For more details, see the link above.""
}"
2025-10-21T09:09:07+00:00,@medpharm,13201,https://t.me/medpharm/13201,"–í –¥–µ–ª–µ –æ –∫–æ—Ä—Ä—É–ø—Ü–∏–∏ –≤ –ù–ú–ò–¶ –∏–º. –ú–µ—à–∞–ª–∫–∏–Ω–∞ –ø–æ—è–≤–∏–ª–∏—Å—å –Ω–æ–≤—ã–µ —Ñ–∏–≥—É—Ä–∞–Ω—Ç—ã, –∏–º –≤–º–µ–Ω—è—é—Ç –ø–æ–ª—É—á–µ–Ω–∏–µ –∏ –¥–∞—á—É –≤–∑—è—Ç–æ–∫ –≤ –∫—Ä—É–ø–Ω–æ–º —Ä–∞–∑–º–µ—Ä–µ. –°—É–¥ –ø—Ä–æ–¥–ª–∏–ª –∞—Ä–µ—Å—Ç –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—é —Ü–µ–Ω—Ç—Ä–∞ –ê—Ä—Ç–µ–º—É –ü—É—Ö–∞–ª—å—Å–∫–æ–º—É –∏ –µ—â–µ –¥–≤—É–º —Ñ–∏–≥—É—Ä–∞–Ω—Ç–∞–º, –æ–±–≤–∏–Ω—è–µ–º—ã–º –≤ –¥–∞—á–µ –≤–∑—è—Ç–æ–∫. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://medvestnik.ru/content/news/V-dele-o-korrupcii-v-NMIC-im-Meshalkina-poyavilis-novye-figuranty.html?utm_source=TG_post&utm_medium=Group&utm_campaign=V-dele-o-korrupcii-v-NMIC-im-Meshalkina-poyavilis-novye-figuranty #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-10-21T08:39:02+00:00,@medpharm,13200,https://t.me/medpharm/13200,"–° 13 –ø–æ 20 –æ–∫—Ç—è–±—Ä—è –≤ –°–®–ê –≤–ø–µ—Ä–≤—ã–µ –ø–æ—è–≤–∏–ª–∞—Å—å —Ä–µ–≤–æ–ª—é—Ü–∏–æ–Ω–Ω–∞—è —Ç–µ—Ä–∞–ø–∏—è –∫–µ—Ä–∞—Ç–æ–∫–æ–Ω—É—Å–∞ (–¥–µ–≥–µ–Ω–µ—Ä–∞—Ç–∏–≤–Ω–æ–≥–æ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è —Ä–æ–≥–æ–≤–∏—Ü—ã), –∫–æ—Ç–æ—Ä–∞—è –Ω–µ —Ç—Ä–µ–±—É–µ—Ç —Ö–∏—Ä—É—Ä–≥–∏—á–µ—Å–∫–æ–≥–æ –≤–º–µ—à–∞—Ç–µ–ª—å—Å—Ç–≤–∞. –ï–≤—Ä–æ–ø–µ–π—Å–∫–∏–π —Ä–µ–≥—É–ª—è—Ç–æ—Ä —Ä–µ–∫–æ–º–µ–Ω–¥–æ–≤–∞–ª –∫ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –¥–≤–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏ –≤–æ—Å–µ–º—å –ø–æ–∫–∞–∑–∞–Ω–∏–π –¥–ª—è —É–∂–µ –≤—ã—à–µ–¥—à–∏—Ö –Ω–∞ —Ä—ã–Ω–æ–∫ –ø—Ä–æ–¥—É–∫—Ç–æ–≤. –í –ö–ù–† –æ–¥–æ–±—Ä–µ–Ω –ø—Ä–æ—Ä—ã–≤–Ω–æ–π –∫–æ–Ω—ä—é–≥–∞—Ç –∞–Ω—Ç–∏—Ç–µ–ª–æ-–ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–µ —Å—Ä–µ–¥—Å—Ç–≤–æ –æ—Ç —Ä–∞–∫–∞ –º–æ–ª–æ—á–Ω–æ–π –∂–µ–ª–µ–∑—ã, –ø—Ä–µ–≤–∑–æ—à–µ–¥—à–∏–π –∑–∞–ø–∞–¥–Ω—ã–π –∞–Ω–∞–ª–æ–≥ –≤–¥–≤–æ–µ –ø–æ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –≤ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è—Ö. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pr6wF #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-21T08:30:06+00:00,@medpharm,13199,https://t.me/medpharm/13199,"–Ø—Ä–æ—Å–ª–∞–≤ –ù–∏–ª–æ–≤ –ø—Ä–∏–∑–≤–∞–ª –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ –≤—ã—Ä–∞–±–æ—Ç–∞—Ç—å –º–µ—Ä—ã –ø—Ä–æ—Ç–∏–≤ –Ω–∞–≤—è–∑—ã–≤–∞–Ω–∏—è —Ä–æ—Å—Å–∏—è–Ω–∞–º –ª–∏—à–Ω–∏—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —É—Å–ª—É–≥ –≤ —á–∞—Å—Ç–Ω—ã—Ö –∫–ª–∏–Ω–∏–∫–∞—Ö. –û–Ω –ø—Ä–µ–¥—É–ø—Ä–µ–¥–∏–ª, —á—Ç–æ —Å–∏—Å—Ç–µ–º–∞ KPI –∑–∞—Å—Ç–∞–≤–ª—è–µ—Ç –≤—Ä–∞—á–µ–π –∑–ª–æ—É–ø–æ—Ç—Ä–µ–±–ª—è—Ç—å –¥–æ–≤–µ—Ä–∏–µ–º –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –∏ –ø–æ–¥—Ä—ã–≤–∞–µ—Ç –∫–∞—á–µ—Å—Ç–≤–æ –º–µ–¥–∏—Ü–∏–Ω—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pr6Kf #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,hospital_policy,pharmacovigilance,safety"",
  ""impact"": ""medium"",
  ""english"": ""Yaroslav Niloov urged the Russian Ministry of Health to take measures against excessive medical services being imposed on Russians in private clinics. He warned that the KPI system encourages doctors to abuse patient trust and undermines medical quality.""
}"
2025-10-21T07:52:07+00:00,@medpharm,13198,https://t.me/medpharm/13198,"–ú–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–π —Ç—É—Ä–∏–∑–º —Å–º–µ—â–∞–µ—Ç –∞–∫—Ü–µ–Ω—Ç —Å –Ω–∏–∑–∫–∏—Ö —Ü–µ–Ω –Ω–∞ –∫–∞—á–µ—Å—Ç–≤–æ, –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –∏ –ø–æ—Å–ª–µ–ª–µ—á–µ–±–Ω–æ–µ —Å–æ–ø—Ä–æ–≤–æ–∂–¥–µ–Ω–∏–µ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –†–æ—Å—Å–∏—è —Ä–∞–Ω–µ–µ –∑–∞–Ω—è–ª–∞ 41-–µ –º–µ—Å—Ç–æ –≤ –º–∏—Ä–æ–≤–æ–º –∏–Ω–¥–µ–∫—Å–µ Medical Tourism Index. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pr3GP #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ–Ω–¥–µ–Ω—Ü–∏–∏ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-10-21T07:47:02+00:00,@medpharm,13197,https://t.me/medpharm/13197,"–î–µ–ø—É—Ç–∞—Ç—ã –ì–æ—Å–¥—É–º—ã –†–§ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ —Ä–∞—Å—à–∏—Ä–∏—Ç—å —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç –ø–æ –æ–Ω–ª–∞–π–Ω-–¥–æ—Å—Ç–∞–≤–∫–µ —Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –Ω–∞ –≤—Å—é –†–æ—Å—Å–∏—é, –æ–±—Ä–∞—â–µ–Ω–∏–µ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–æ –≤ –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏. –¢–∞–∫–∂–µ –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è –¥–∞—Ç—å –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –∫—É—Ä—å–µ—Ä–∞–º —Å—Ç–æ—Ä–æ–Ω–Ω–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –¥–æ—Å—Ç–∞–≤–ª—è—Ç—å —Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pr2ta #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""high"",
  ""english"": ""Deputies of the State Duma of Russia proposed to expand an experiment on online delivery of prescription drugs throughout Russia. The application is directed to the Ministry of Health of Russia. Additionally, it proposes allowing deliveries by couriers from non-governmental organizations.""
}"
2025-10-21T07:46:05+00:00,@medpharm,13196,https://t.me/medpharm/13196,"–†–æ—Å—Å–∏–π—Å–∫–∏–π —Ä—ã–Ω–æ–∫ —ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω–æ–π –∫–æ–º–º–µ—Ä—Ü–∏–∏ –≤—Å—Ç—É–ø–∞–µ—Ç –≤ —Ñ–∞–∑—É –∑—Ä–µ–ª–æ—Å—Ç–∏ ‚Äî –∏ –≤–º–µ—Å—Ç–µ —Å –Ω–µ–π –ø—Ä–∏—Ö–æ–¥–∏—Ç –Ω–æ–≤–∞—è –≤–æ–ª–Ω–∞ —Ä–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω–∏—è. –ï—Å–ª–∏ —Ä–∞–Ω—å—à–µ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å—ã –±–æ—Ä–æ–ª–∏—Å—å –∑–∞ –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç –∏ —Ü–µ–Ω—É, —Ç–æ —Ç–µ–ø–µ—Ä—å –≥–ª–∞–≤–Ω—ã–º –¥–ª—è –Ω–∏—Ö —Å—Ç–∞–Ω–æ–≤–∏—Ç—Å—è –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –∏ –ª–µ–≥–∞–ª—å–Ω–æ—Å—Ç—å —Ç–æ–≤–∞—Ä–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pr2pf #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, safety"",
  ""impact"": ""medium"",
  ""english"": ""The e-commerce market in Russia is entering a maturity phase, and this brings new regulatory waves. Previously, marketplaces competed for assortment and price, but now safety and legality are the main concerns for them. For more details: https://clck.ru/3Pr2pf #MedVestnik #Healthcare #Other""
}"
2025-10-21T06:57:06+00:00,@medpharm,13195,https://t.me/medpharm/13195,"–•–æ–ª–µ—Ü–∏—Å—Ç—ç–∫—Ç–æ–º–∏—è, –ø—Ä–æ–≤–µ–¥–µ–Ω–Ω–∞—è –≤–æ –≤—Ç–æ—Ä–æ–º –∏–ª–∏ —Ç—Ä–µ—Ç—å–µ–º —Ç—Ä–∏–º–µ—Å—Ç—Ä–µ –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏, –ø—Ä–∏–∑–Ω–∞–Ω–∞ –±–µ–∑–æ–ø–∞—Å–Ω—ã–º –∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã–º –º–µ—Ç–æ–¥–æ–º –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –ø–æ–≤—Ç–æ—Ä–Ω—ã—Ö –±–∏–ª–∏–∞—Ä–Ω—ã—Ö –æ—Å–ª–æ–∂–Ω–µ–Ω–∏–π —É –∂–µ–Ω—â–∏–Ω —Å –æ—Å—Ç—Ä—ã–º –±–∏–ª–∏–∞—Ä–Ω—ã–º –ø–∞–Ω–∫—Ä–µ–∞—Ç–∏—Ç–æ–º. –≠–Ω–¥–æ—Å–∫–æ–ø–∏—á–µ—Å–∫–∞—è —Ä–µ—Ç—Ä–æ–≥—Ä–∞–¥–Ω–∞—è —Ö–æ–ª–∞–Ω–≥–∏–æ–ø–∞–Ω–∫—Ä–µ–∞—Ç–æ–≥—Ä–∞—Ñ–∏—è —Ç–∞–∫–∂–µ –ø—Ä–æ–¥–µ–º–æ–Ω—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª–∞ —Ö–æ—Ä–æ—à–∏–π –ø—Ä–æ—Ñ–∏–ª—å –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ –≤–æ –≤—Å–µ—Ö —Ç—Ä–∏–º–µ—Å—Ç—Ä–∞—Ö –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PqxAJ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ê–∫—É—à–µ—Ä—Å—Ç–≤–æ_–∏_–≥–∏–Ω–µ–∫–æ–ª–æ–≥–∏—è #–ì–∞—Å—Ç—Ä–æ—ç–Ω—Ç–µ—Ä–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–•–∏—Ä—É—Ä–≥–∏—è","{""skip"": true}"
2025-10-20T16:42:01+00:00,@medpharm,13194,https://t.me/medpharm/13194,"ü¶æ –ê–ø–≥—Ä–µ–π–¥ –∫–æ–Ω—Ç—Ä–æ–ª—è. –í –†–æ—Å—Å–∏–∏ —É—Ç–≤–µ—Ä–¥–∏–ª–∏ –Ω–æ–≤—ã–µ –ø—Ä–∞–≤–∏–ª–∞ –∫–æ–Ω—Ç—Ä–æ–ª—è –∫–∞—á–µ—Å—Ç–≤–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏, —Ä–∞–∑—Ä–µ—à–∏–≤ –¥–∏—Å—Ç–∞–Ω—Ü–∏–æ–Ω–Ω—ã–µ –ø—Ä–æ–≤–µ—Ä–∫–∏ —á–µ—Ä–µ–∑ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏–µ ¬´–ò–Ω—Å–ø–µ–∫—Ç–æ—Ä¬ª. –¢–∞–∫–∂–µ —Å–æ–∫—Ä–∞—â–µ–Ω—ã —Å—Ä–æ–∫–∏ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏—è –∂–∞–ª–æ–± –∏ —É—Ç–æ—á–Ω–µ–Ω–∞ –ø–µ—Ä–∏–æ–¥–∏—á–Ω–æ—Å—Ç—å –Ω–∞–¥–∑–æ—Ä–Ω—ã—Ö –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–π. ü¶æ –ö—Ç–æ-—Ç–æ —Ç–µ—Ä—è–µ—Ç. –ó–∞ –ø–æ–ª–≥–æ–¥–∞ —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –ø–æ—Ç–µ—Ä—è–ª–∏ –ø–æ—á—Ç–∏ 400 —Ç—ã—Å. —Ä—É–±. –∏–∑-–∑–∞ –Ω–∞—Ä—É—à–µ–Ω–∏–π –ø—Ä–∞–≤–∏–ª –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª–µ–Ω–∏—è –ø–ª–∞—Ç–Ω—ã—Ö –º–µ–¥—É—Å–ª—É–≥ –Ω–∞ —à—Ç—Ä–∞—Ñ–∞—Ö –æ—Ç —Ä–µ–≥—É–ª—è—Ç–æ—Ä–æ–≤ –∏ –≤ —Å–ø–æ—Ä–∞—Ö —Å –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª—è–º–∏. ¬´–ú–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–π –≤–µ—Å—Ç–Ω–∏–∫¬ª –ø—Ä–æ–∞–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–ª —Å—É–¥–µ–±–Ω—É—é –ø—Ä–∞–∫—Ç–∏–∫—É, —Å–≤—è–∑–∞–Ω–Ω—É—é —Å —Ç–∞–∫–∏–º–∏ –Ω–∞—Ä—É—à–µ–Ω–∏—è–º–∏. ‚ù§Ô∏è –°—É–±—Å—Ç–∞–Ω—Ü–∏–∏ —Å –ø–æ–Ω—è—Ç–∏–µ–º. –ù–∞ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏–∏ –ï–≠–ö –Ω–∞—Ö–æ–¥–∏—Ç—Å—è –ø—Ä–æ–µ–∫—Ç –∏–∑–º–µ–Ω–µ–Ω–∏–π –≤ –ü—Ä–∞–≤–∏–ª–∞ –Ω–∞–¥–ª–µ–∂–∞—â–µ–π –¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä—Å–∫–æ–π –ø—Ä–∞–∫—Ç–∏–∫–∏, –∫–æ—Ç–æ—Ä—ã–π –æ–ø—Ä–µ–¥–µ–ª—è–µ—Ç –æ–±—â–∏–µ –ø—Ä–∏–Ω—Ü–∏–ø—ã –æ—Å—É—â–µ—Å—Ç–≤–ª–µ–Ω–∏—è –∑–∞–∫—É–ø–∫–∏, –∏–º–ø–æ—Ä—Ç–∞, —Ö—Ä–∞–Ω–µ–Ω–∏—è, –ø–æ—Å—Ç–∞–≤–∫–∏ –∏–ª–∏ —ç–∫—Å–ø–æ—Ä—Ç–∞ —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏–π. –í –¥–æ–∫—É–º–µ–Ω—Ç–µ –≤–ø–µ—Ä–≤—ã–µ –≤–≤–æ–¥–∏—Ç—Å—è –ø–æ–Ω—è—Ç–∏–µ ¬´—Ñ–∞–ª—å—Å–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –ê–§–°¬ª. ‚ù§Ô∏è –ù–∞–Ω–æ—Å–¥–µ–ª–∫–∞. –ì–æ—Å–∫–æ—Ä–ø–æ—Ä–∞—Ü–∏—è ¬´–†–æ—Å–Ω–∞–Ω–æ¬ª –∑–∞–≤–µ—Ä—à–∏–ª–∞ —Å–¥–µ–ª–∫—É –ø–æ –ø—Ä–æ–¥–∞–∂–µ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ù–æ–≤–∞–ú–µ–¥–∏–∫–∞ –ò–Ω–Ω–æ—Ç–µ—Ö¬ª, –≤–ª–∞–¥–µ–ª—å—Ü–µ–º –ø–ª–æ—â–∞–¥–∫–∏ —Å—Ç–∞–ª–æ –ê–û ¬´–°–∏–Ω–º–µ–¥–µ–∫—Å¬ª.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, regulation, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The country is facing sanctions and regulatory issues. The Russian Federation has approved new quality control rules for medical activities, allowing remote inspections through the 'Inspector' app. There has been a reduction in review periods and an adjustment to inspection frequency. Healthcare organizations have lost nearly 400,000 rubles in six months due to penalties and disputes over the provision of paid medical services. The 'Medical Herald' analyzed cases involving such violations. Nanotechnology corporation Rosnano has completed the sale of pharmaceutical company Novamedik Innovatech, with SinyMedex becoming the new owner.""
}"
2025-10-20T15:55:04+00:00,@medpharm,13193,https://t.me/medpharm/13193,"–û—Ä–≥–∞–Ω–∏–∑–∞—Ç–æ—Ä—ã –ø—Ä–æ–µ–∫—Ç–∞ –ø–æ —Å–æ–∑–¥–∞–Ω–∏—é –±–∞–∑—ã –≥–µ–Ω–µ—Ç–∏—á–µ—Å–∫–∏—Ö –¥–∞–Ω–Ω—ã—Ö —Ä–æ—Å—Å–∏—è–Ω —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏ –æ –ø—Ä–æ–º–µ–∂—É—Ç–æ—á–Ω—ã—Ö —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞—Ö —Ä–∞–±–æ—Ç—ã. –£ 3% –æ–±—Å–ª–µ–¥–æ–≤–∞–Ω–Ω—ã—Ö –≤–æ–ª–æ–Ω—Ç–µ—Ä–æ–≤ –Ω–∞—à–ª–∏ –≥–µ–Ω–µ—Ç–∏—á–µ—Å–∫–∏–µ –≤–∞—Ä–∏–∞–Ω—Ç—ã, –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ –ø–æ–≤—ã—à–∞—é—â–∏–µ —Ä–∏—Å–∫ —Ç—è–∂–µ–ª—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, –∞ 29% –æ–∫–∞–∑–∞–ª–∏—Å—å –Ω–æ—Å–∏—Ç–µ–ª—è–º–∏ –≥–µ–Ω–æ–≤ –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PqVxb #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ù–∞—É–∫–∞ #–ì–µ–Ω–µ—Ç–∏–∫–∞","{""skip"": true}"
2025-10-20T15:24:05+00:00,@medpharm,13192,https://t.me/medpharm/13192,"–í –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–µ —Å–æ–æ–±—â–∏–ª–∏ –æ —Ä–æ—Å—Ç–µ –∂–∞–ª–æ–± –≥—Ä–∞–∂–¥–∞–Ω –ø–æ –≤–æ–ø—Ä–æ—Å–∞–º, —Å–≤—è–∑–∞–Ω–Ω—ã–º —Å –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å—é –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π. –í —ç—Ç–æ–º –≥–æ–¥—É –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ —Ç–∞–∫–∏—Ö –æ–±—Ä–∞—â–µ–Ω–∏–π –≤—ã—Ä–æ—Å–ª–æ –Ω–∞ 18%. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PqTxL #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The Roszdranadzor reported an increase in the number of citizens' inquiries regarding accessibility of medicines and medical products. This year, the number of such complaints has increased by 18%. More: https://clck.ru/3PqTxL #MedVestnik #Healthcare""
}"
2025-10-20T15:15:02+00:00,@medpharm,13191,https://t.me/medpharm/13191,"–ù–∞ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏–∏ –ï–≠–ö –Ω–∞—Ö–æ–¥–∏—Ç—Å—è –ø—Ä–æ–µ–∫—Ç –∏–∑–º–µ–Ω–µ–Ω–∏–π –≤ –ü—Ä–∞–≤–∏–ª–∞ –Ω–∞–¥–ª–µ–∂–∞—â–µ–π –¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä—Å–∫–æ–π –ø—Ä–∞–∫—Ç–∏–∫–∏, –∫–æ—Ç–æ—Ä—ã–π –æ–ø—Ä–µ–¥–µ–ª—è–µ—Ç –æ–±—â–∏–µ –ø—Ä–∏–Ω—Ü–∏–ø—ã –æ—Å—É—â–µ—Å—Ç–≤–ª–µ–Ω–∏—è –∑–∞–∫—É–ø–∫–∏, –∏–º–ø–æ—Ä—Ç–∞, —Ö—Ä–∞–Ω–µ–Ω–∏—è, –ø–æ—Å—Ç–∞–≤–∫–∏ –∏–ª–∏ —ç–∫—Å–ø–æ—Ä—Ç–∞ —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏–π. –û–Ω–∏ –∫–æ—Å–Ω—É—Ç—Å—è –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ê–§–°, —Å–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω–æ –æ—Å—É—â–µ—Å—Ç–≤–ª—è—é—â–∏—Ö –¥–∏—Å—Ç—Ä–∏–±—É—Ü–∏—é —Å–≤–æ–µ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏. –í –¥–æ–∫—É–º–µ–Ω—Ç–µ –≤–ø–µ—Ä–≤—ã–µ –≤–≤–æ–¥–∏—Ç—Å—è –ø–æ–Ω—è—Ç–∏–µ ¬´—Ñ–∞–ª—å—Å–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –ê–§–°¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PqTNP #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The project under review by the EAA is a proposal for changes in Good Distribution Practice rules, which outline general principles of procurement, import, storage, supply or export of pharmaceutical substances. It involves manufacturers who independently handle the distribution of their products. For the first time, 'falsified pharmaceutical substances' is introduced in this document. More details: https://clck.ru/3PqTNP #PharmNews #Distribution""
}"
2025-10-20T14:42:06+00:00,@medpharm,13190,https://t.me/medpharm/13190,"–í –†–æ—Å—Å–∏–∏ —É—Ç–≤–µ—Ä–¥–∏–ª–∏ –Ω–æ–≤—ã–µ –ø—Ä–∞–≤–∏–ª–∞ –∫–æ–Ω—Ç—Ä–æ–ª—è –∫–∞—á–µ—Å—Ç–≤–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏, —Ä–∞–∑—Ä–µ—à–∏–≤ –¥–∏—Å—Ç–∞–Ω—Ü–∏–æ–Ω–Ω—ã–µ –ø—Ä–æ–≤–µ—Ä–∫–∏ —á–µ—Ä–µ–∑ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏–µ ¬´–ò–Ω—Å–ø–µ–∫—Ç–æ—Ä¬ª. –¢–∞–∫–∂–µ —Å–æ–∫—Ä–∞—â–µ–Ω—ã —Å—Ä–æ–∫–∏ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏—è –∂–∞–ª–æ–± –∏ —É—Ç–æ—á–Ω–µ–Ω–∞ –ø–µ—Ä–∏–æ–¥–∏—á–Ω–æ—Å—Ç—å –Ω–∞–¥–∑–æ—Ä–Ω—ã—Ö –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PqQsA #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration, sanctions"",
  ""impact"": ""medium"",
  ""english"": ""Russia approved new quality control rules for medical activities, allowing remote inspections through an 'Inspector' app. Inspection deadlines were shortened and the frequency of supervisory measures was clarified.""
}"
2025-10-20T14:41:02+00:00,@medpharm,13189,https://t.me/medpharm/13189,"–ö–æ–ª–ª–µ–≥–∏—è –ï–≠–ö –æ–¥–æ–±—Ä–∏–ª–∞ –∫–æ—Ä—Ä–µ–∫—Ç–∏—Ä–æ–≤–∫—É –ø—Ä–∞–≤–∏–ª —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ —Å—Ç—Ä–∞–Ω–∞—Ö –ï–ê–≠–°. –ü—Ä–æ–µ–∫—Ç –∏–∑–º–µ–Ω–µ–Ω–∏–π –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω –Ω–∞ —É–Ω–∏—Ñ–∏–∫–∞—Ü–∏—é –∏ —É–ø—Ä–æ—â–µ–Ω–∏–µ –ø—Ä–æ—Ü–µ–¥—É—Ä –¥–ª—è –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π, –∞ —Ç–∞–∫–∂–µ –Ω–∞ –ø–æ–≤—ã—à–µ–Ω–∏–µ –ø—Ä–æ–∑—Ä–∞—á–Ω–æ—Å—Ç–∏ —ç–∫—Å–ø–µ—Ä—Ç–∏–∑—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PqQnf #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""registration, regulation"",
  ""impact"": ""medium"",
  ""english"": ""The EAEU Committee on Industrial Products approved revisions to the registration rules for medicines in the region. The project aims to unify and simplify procedures for manufacturers, as well as increase transparency of evaluation.""
}"
2025-10-20T13:55:02+00:00,@medpharm,13187,https://t.me/medpharm/13187,"–ö–æ–ª–∏—á–µ—Å—Ç–≤–æ –æ–±—Ä–∞—â–µ–Ω–∏–π –≥—Ä–∞–∂–¥–∞–Ω –≤ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä –ø–æ –≤–æ–ø—Ä–æ—Å–∞–º –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏ –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º–∏ –∏–∑–¥–µ–ª–∏—è–º–∏ —É–≤–µ–ª–∏—á–∏–ª–æ—Å—å –ø–æ—á—Ç–∏ –Ω–∞ 18% –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –ø—Ä–æ—à–ª—ã–º –≥–æ–¥–æ–º. –ü–æ—á—Ç–∏ –Ω–∞ 20% –≤—ã—Ä–æ—Å–ª–æ —á–∏—Å–ª–æ –∂–∞–ª–æ–± –Ω–∞ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤. –û–¥–Ω–∞–∫–æ –±–æ–ª–µ–µ –≥–ª—É–±–æ–∫–∏–π –∞–Ω–∞–ª–∏–∑ –ø–æ–∫–∞–∑—ã–≤–∞–µ—Ç, —á—Ç–æ –Ω–µ –≤—Å–µ –ø—Ä–µ—Ç–µ–Ω–∑–∏–∏ –æ–±–æ—Å–Ω–æ–≤–∞–Ω—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PqMRU #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""There has been an increase of almost 18% in the number of complaints from citizens regarding drug supply, and a rise of nearly 20% in the number of claims for shortages. However, deeper analysis shows that not all complaints are justified. For more details: https://clck.ru/3PqMRU #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞""
}"
2025-10-20T13:43:05+00:00,@medpharm,13186,https://t.me/medpharm/13186,–ù–∞ 95-–º –≥–æ–¥—É –∂–∏–∑–Ω–∏ —Å–∫–æ–Ω—á–∞–ª—Å—è –∏–∑–≤–µ—Å—Ç–Ω—ã–π —Ä–æ—Å—Å–∏–π—Å–∫–∏–π –ø–µ–¥–∏–∞—Ç—Ä –í–ª–∞–¥–∏–º–∏—Ä –¢–∞—Ç–æ—á–µ–Ω–∫–æ. –û–Ω –ø–æ—Å–≤—è—Ç–∏–ª –º–µ–¥–∏—Ü–∏–Ω–µ –±–æ–ª—å—à–µ 70 –ª–µ—Ç. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PqLbC #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-10-20T13:13:06+00:00,@medpharm,13185,https://t.me/medpharm/13185,"–û–Ω–∫–æ—Ü–µ–Ω—Ç—Ä –•–∞–±–∞—Ä–æ–≤—Å–∫–æ–≥–æ –∫—Ä–∞—è –æ–±—ä—è–≤–∏–ª –∞—É–∫—Ü–∏–æ–Ω –Ω–∞ —Ä–µ–º–æ–Ω—Ç –∏ —Ç–µ—Ö–æ–±—Å–ª—É–∂–∏–≤–∞–Ω–∏–µ –∞–ø–ø–∞—Ä–∞—Ç–∞ –¥–ª—è –ª—É—á–µ–≤–æ–π —Ç–µ—Ä–∞–ø–∏–∏. –ò–∑ —á–µ—Ç—ã—Ä–µ—Ö –ª–∏–Ω–µ–π–Ω—ã—Ö —É—Å–∫–æ—Ä–∏—Ç–µ–ª–µ–π –≤ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏–∏ —Ä–∞–±–æ—Ç–∞–µ—Ç —Ç–æ–ª—å–∫–æ –æ–¥–∏–Ω, –ø–∞—Ü–∏–µ–Ω—Ç—ã –≤—ã–Ω—É–∂–¥–µ–Ω—ã –µ–∑–¥–∏—Ç—å –Ω–∞ –ª–µ—á–µ–Ω–∏–µ –≤ –¥—Ä—É–≥–∏–µ –≥–æ—Ä–æ–¥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PqJLK #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û–Ω–∫–æ–ª–æ–≥–∏—è","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""tenders, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""A cancer center in Hebei Oblast announced a tender for the repair and maintenance of a radiation therapy machine. Only one linear accelerator is operational in the medical institution, forcing patients to travel to other cities for treatment. More: https://clck.ru/3PqJLK #MedNews #Healthcare #Cancer""
}"
2025-10-20T12:52:03+00:00,@medpharm,13184,https://t.me/medpharm/13184,"–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§ –æ—Ç–ª–æ–∂–∏–ª–æ –Ω–∞ –¥–≤–∞ –≥–æ–¥–∞ –ø–µ—Ä–µ—Ö–æ–¥ –Ω–∞ –µ–¥–∏–Ω—ã–µ –ø—Ä–∞–≤–∏–ª–∞ –æ–±—Ä–∞—â–µ–Ω–∏—è –º–µ–¥–∏–∑–¥–µ–ª–∏–π –≤ —Å—Ç—Ä–∞–Ω–∞—Ö –ï–ê–≠–°. –ü–æ–¥–∞—Ç—å –∑–∞—è–≤–∫—É –Ω–∞ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—é –º–æ–∂–Ω–æ –±—É–¥–µ—Ç –¥–æ –∫–æ–Ω—Ü–∞ 2027 –≥–æ–¥–∞, –∞ –ø–µ—Ä–µ–æ—Ñ–æ—Ä–º–∏—Ç—å –¥–æ–∫—É–º–µ–Ω—Ç—ã ‚Äî –¥–æ 2028 –≥–æ–¥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PqGmK #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""registration, tender"",
  ""impact"": ""medium"",
  ""english"": ""The Russian government has postponed the transition to unified rules for medical products within the EAEU by two years. Applications for registration can be submitted until the end of 2027, and renewing documents will be possible by the end of 2028. More details: https://clck.ru/3PqGmK #PharmNews #Regulation""
}"
2025-10-20T11:55:05+00:00,@medpharm,13183,https://t.me/medpharm/13183,–û–ª–µ—Å—è –°—Ç–∞—Ä–∂–∏–Ω—Å–∫–∞—è —Å—Ç–∞–ª–∞ –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª–µ–º –≥—É–±–µ—Ä–Ω–∞—Ç–æ—Ä–∞ –†–æ—Å—Ç–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –∏ –±—É–¥–µ—Ç –∫—É—Ä–∏—Ä–æ–≤–∞—Ç—å —Å—Ñ–µ—Ä—É –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∏ —Å–æ—Ü—Ä–∞–∑–≤–∏—Ç–∏—è. –ò—Å–ø–æ–ª–Ω—è—é—â–∏–º –æ–±—è–∑–∞–Ω–Ω–æ—Å—Ç–∏ —Ä–µ–∫—Ç–æ—Ä–∞ –†–æ—Å—Ç–ì–ú–£ –Ω–∞–∑–Ω–∞—á–µ–Ω –ú–∏—Ö–∞–∏–ª –®–∏—à–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PqCZo #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-10-20T11:54:02+00:00,@medpharm,13182,https://t.me/medpharm/13182,"–°–µ—Ä—Ç–∏—Ñ–∏–∫–∞—Ç—ã GMP –ï–≠–° —Å —Ä–∞–∑–Ω—ã–º —Å—Ä–æ–∫–æ–º –¥–µ–π—Å—Ç–≤–∏—è –Ω–∞—á–Ω—É—Ç –ø–æ–ª—É—á–∞—Ç—å —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ —Å –Ω–æ—è–±—Ä—è —Å–æ–≥–ª–∞—Å–Ω–æ —Ä–∏—Å–∫-–æ—Ä–∏–µ–Ω—Ç–∏—Ä–æ–≤–∞–Ω–Ω–æ–º—É –ø–æ–¥—Ö–æ–¥—É –∫ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—é —Ñ–∞—Ä–º–∏–Ω—Å–ø–µ–∫—Ü–∏–π. –ü–æ —Å—Ç–µ–ø–µ–Ω–∏ —Ä–∏—Å–∫–∞ –≤—Å–µ –ø–ª–æ—â–∞–¥–∫–∏ –¥–µ–ª—è—Ç—Å—è –Ω–∞ —Ç—Ä–∏ –∫–∞—Ç–µ–≥–æ—Ä–∏–∏: –≤—ã—Å–æ–∫–æ–≥–æ, —Å—Ä–µ–¥–Ω–µ–≥–æ –∏ –Ω–∏–∑–∫–æ–≥–æ. –ü–µ—Ä–≤—ã—Ö —Ä–µ–∫–æ–º–µ–Ω–¥—É–µ—Ç—Å—è –∏–Ω—Å–ø–µ–∫—Ç–∏—Ä–æ–≤–∞—Ç—å –Ω–µ —Ä–µ–∂–µ –æ–¥–Ω–æ–≥–æ —Ä–∞–∑–∞ –≤ –≥–æ–¥–∞, –≤—Ç–æ—Ä—ã—Ö ‚Äî –∫–∞–∂–¥—ã–µ 1‚Äî2 –≥–æ–¥–∞, —Ç—Ä–µ—Ç—å–∏—Ö ‚Äî –∫–∞–∂–¥—ã–µ 2‚Äî3 –≥–æ–¥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PqCWS #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""Pharmaceutical manufacturers will start obtaining GMP certificates from the EAEU starting November according to a risk-oriented approach for conducting inspections. Sites are divided into three categories based on their risk: high, medium, and low. High-risk sites should be inspected no less than once a year, medium-risk sites every 1-2 years, and low-risk sites every 2-3 years. For more information: https://clck.ru/3PqCWS #Pharmvestik #Production""
}"
2025-10-20T11:11:06+00:00,@medpharm,13181,https://t.me/medpharm/13181,"–í –ß–µ–ª—è–±–∏–Ω—Å–∫–µ —Å–æ–∑–¥–∞–ª–∏ –∫–æ–º–ø—å—é—Ç–µ—Ä–Ω—ã–π –∞–ª–≥–æ—Ä–∏—Ç–º, —Å–ø–æ—Å–æ–±–Ω—ã–π –æ—á–µ–Ω—å –±—ã—Å—Ç—Ä–æ –≤—ã—è–≤–ª—è—Ç—å –ø—Ä–∏–∑–Ω–∞–∫–∏ —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –û–Ω —Ä–∞–±–æ—Ç–∞–µ—Ç –Ω–∞ –∫–ª–∞—Å—Ç–µ—Ä–Ω–æ–π —Å–∏—Å—Ç–µ–º–µ –∏ —Å–º–æ–∂–µ—Ç –ø–æ–≤—ã—Å–∏—Ç—å —É—Ä–æ–≤–µ–Ω—å –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∏ –≤–æ –≤—Å–µ—Ö —Ä–µ–≥–∏–æ–Ω–∞—Ö —Å—Ç—Ä–∞–Ω—ã, –æ—Ç–º–µ—á–∞—é—Ç –∞–≤—Ç–æ—Ä—ã —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pq9Re #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–î–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞","{""skip"": true}"
2025-10-20T10:52:03+00:00,@medpharm,13180,https://t.me/medpharm/13180,"–ö–æ–º–ø–∞–Ω–∏–∏ ¬´–§–∞—Ä–º–∏–º—ç–∫—Å¬ª –∏ ¬´–ò—Ä–≤–∏–Ω¬ª –±—É–¥—É—Ç –ø–æ—Å—Ç–∞–≤–ª—è—Ç—å –¥–ª—è –ø–æ–¥–æ–ø–µ—á–Ω—ã—Ö ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª —Ç—Ä–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞, —Å—Ä–µ–¥–∏ –∫–æ—Ç–æ—Ä—ã—Ö –∫–∞–Ω–∞–∫–∏–Ω—É–º–∞–±, –∞—Ç–∞–ª—É—Ä–µ–Ω –∏ –∏–≤–∞–∫–∞—Ñ—Ç–æ—Ä —Ç–µ–∑–∞–∫–∞—Ñ—Ç–æ—Ä —ç–ª–µ–∫—Å–∞–∫–∞—Ñ—Ç–æ—Ä –∏ –∏–≤–∞–∫–∞—Ñ—Ç–æ—Ä. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pq7zS #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{""skip"": true}"
2025-10-20T10:12:06+00:00,@medpharm,13179,https://t.me/medpharm/13179,–≠–∫—Å–ø–µ—Ä—Ç—ã-—Ä–µ–ø—Ä–æ–¥—É–∫—Ç–æ–ª–æ–≥–∏ —Å—á–∏—Ç–∞—é—Ç –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã–º –ø–µ—Ä–µ—Å–º–æ—Ç—Ä–µ—Ç—å –Ω–æ–≤—ã–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø–æ –º—É–∂—Å–∫–æ–º—É –±–µ—Å–ø–ª–æ–¥–∏—é. –ü—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è –¥–æ–±–∞–≤–∏—Ç—å –≤ –¥–æ–∫—É–º–µ–Ω—Ç —Ç–µ—Ä–º–∏–Ω ¬´–ú—É–∂—Å–∫–∏–µ —Ñ–∞–∫—Ç–æ—Ä—ã –±–µ—Å–ø–ª–æ–¥–∏—è¬ª –∏ —É—Å—Ç—Ä–∞–Ω–∏—Ç—å —Å–ø–æ—Ä–Ω—ã–µ –∏ –Ω–µ—Ç–æ—á–Ω—ã–µ –æ–ø–∏—Å–∞–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pq4or #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–£—Ä–æ–ª–æ–≥–∏—è_–∏_–∞–Ω–¥—Ä–æ–ª–æ–≥–∏—è,"{""skip"": true}"
2025-10-20T09:55:04+00:00,@medpharm,13178,https://t.me/medpharm/13178,"–ê–ø—Ç–µ–∫—É —Å–µ—Ç–∏ ¬´–ë–∞—à—Ñ–∞—Ä–º–∞—Ü–∏—è¬ª –æ—à—Ç—Ä–∞—Ñ–æ–≤–∞–ª–∏ –Ω–∞ 500 —Ç—ã—Å. —Ä—É–±. –∑–∞ –ø—Ä–æ–¥–∞–∂—É –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞, –∫–æ—Ç–æ—Ä—ã–π —Ä–∞–Ω–µ–µ –ø–æ–ø–∞–ª –≤ –∑–∞–±—Ä–∞–∫–æ–≤–∫—É –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–∞. –ê–ø—Ç–µ–∫–∞ —É—Å–ø–µ–ª–∞ –æ—Ç–ø—É—Å—Ç–∏—Ç—å –≤–æ—Å–µ–º—å —É–ø–∞–∫–æ–≤–æ–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –∑–∞–±—Ä–∞–∫–æ–≤–∞–Ω–Ω–æ–π —Å–µ—Ä–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pq3Yc #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""A pharmacy chain 'Bashfarma' was fined RUB 500,000 for selling a drug that was previously rejected by the Russian Health Supervision. The pharmacy managed to release eight packages of the rejected series.""
}"
2025-10-20T09:10:07+00:00,@medpharm,13177,https://t.me/medpharm/13177,"–ì–æ—Å–∫–æ—Ä–ø–æ—Ä–∞—Ü–∏—è ¬´–†–æ—Å–Ω–∞–Ω–æ¬ª –∑–∞–≤–µ—Ä—à–∏–ª–∞ —Å–¥–µ–ª–∫—É –ø–æ –ø—Ä–æ–¥–∞–∂–µ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ù–æ–≤–∞–ú–µ–¥–∏–∫–∞ –ò–Ω–Ω–æ—Ç–µ—Ö¬ª, –≤–ª–∞–¥–µ–ª—å—Ü–µ–º –ø–ª–æ—â–∞–¥–∫–∏ —Å—Ç–∞–ª–æ –ê–û ¬´–°–∏–Ω–º–µ–¥–µ–∫—Å¬ª, –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω–æ–µ –≤ –∏—é–ª–µ. ¬´–†–æ—Å–Ω–∞–Ω–æ¬ª –Ω–∞–ø—Ä–∞–≤–∏—Ç –ø–æ–ª—É—á–µ–Ω–Ω—ã–µ —Å—Ä–µ–¥—Å—Ç–≤–∞ –≤ —Ç–æ–º —á–∏—Å–ª–µ –Ω–∞ —Ä–∞–∑–≤–∏—Ç–∏–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ —Å—É–±—Å—Ç–∞–Ω—Ü–∏–π –∏ —Å—ã—Ä—å—è –¥–ª—è –Ω–∏—Ö. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PpyRM #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""Rosnano has completed the sale of pharmaceutical company Novamedik Innovate. The platform is now owned by SinyMedex, registered in July. Rosnano will direct the received funds towards production development of raw materials and substances.""
}"
2025-10-20T08:03:04+00:00,@medpharm,13176,https://t.me/medpharm/13176,"–ù–∞—Å–µ–∫–æ–º—ã–µ –∏ –¥—ã—Ä—è–≤—ã–µ –∫—Ä—ã—à–∏ ‚Äî –≤ —á–∏—Å–ª–µ —á–∞—Å—Ç–æ –≤—ã—è–≤–ª—è–µ–º—ã—Ö –Ω–µ—Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–π GMP –ø—Ä–∏ —Ö—Ä–∞–Ω–µ–Ω–∏–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø—Ä–∏ –ø—Ä–æ–≤–µ—Ä–∫–∞—Ö —Ñ–∞—Ä–º–ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏–π. –ù–∞—Ä—É—à–µ–Ω–∏—è, —Å–≤—è–∑–∞–Ω–Ω—ã–µ —Å –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–µ–π —Ö—Ä–∞–Ω–µ–Ω–∏—è –∏ —Ç—Ä–∞–Ω—Å–ø–æ—Ä—Ç–∏—Ä–æ–≤–∫–æ–π, –±—ã–ª–∏ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω—ã –ì–ò–õ–° –∏ –ù–ü –Ω–∞ –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ ¬´–õ–æ–≥–∏—Å—Ç–∏–∫–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PpscV #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,logistics,hospital_policy,guideline"",
  ""impact"": ""high"",
  ""english"": ""Inspections of pharmaceutical companies have identified common GMP violations related to storage of medicines, including issues with organization of storage and transportation. These were presented at the Logistics of Medicinal Products Conference by GILS and NP. More details: https://clck.ru/3PpscV""
}"
2025-10-20T05:52:06+00:00,@medpharm,13175,https://t.me/medpharm/13175,"–î–æ–±–∞–≤–ª–µ–Ω–∏–µ –∞–Ω—Ç–∏–∞–≥—Ä–µ–≥–∞–Ω—Ç–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –∫ –ø–µ—Ä–æ—Ä–∞–ª—å–Ω–æ–º—É –∞–Ω—Ç–∏–∫–æ–∞–≥—É–ª—è–Ω—Ç—É —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –∏–Ω—Å—É–ª—å—Ç–æ–º, —Ñ–∏–±—Ä–∏–ª–ª—è—Ü–∏–µ–π –ø—Ä–µ–¥—Å–µ—Ä–¥–∏–π –∏ —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏ –Ω–µ —É–º–µ–Ω—å—à–∞–ª–æ —á–∞—Å—Ç–æ—Ç—É –∏—à–µ–º–∏—á–µ—Å–∫–∏—Ö —Å–æ–±—ã—Ç–∏–π. –ü—Ä–∏ —ç—Ç–æ–º —Ä–∏—Å–∫ –∫—Ä–æ–≤–æ—Ç–µ—á–µ–Ω–∏—è –±—ã–ª –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ –≤—ã—à–µ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –º–æ–Ω–æ—Ç–µ—Ä–∞–ø–∏–µ–π –∞–Ω—Ç–∏–∫–æ–∞–≥—É–ª—è–Ω—Ç–∞–º–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PpiML #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ö–∞—Ä–¥–∏–æ–ª–æ–≥–∏—è #–ù–µ–≤—Ä–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, shortage"",
  ""impact"": ""high"",
  ""english"": ""The addition of an antiplatelet drug to a once-daily anticoagulant for patients with stroke, atrial fibrillation and cardiovascular diseases did not reduce the frequency of ischemic events. However, the risk of bleeding was significantly higher compared to monotherapy with anticoagulants.""
}"
2025-10-19T12:11:09+00:00,@medpharm,13174,https://t.me/medpharm/13174,"üëçüëçüëçüëçüëçüëç –ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ –∑–∞ –Ω–µ–¥–µ–ª—é üîµ –¢—Ä–µ–±–æ–≤–∞–Ω–∏—è, —Å–≤—è–∑–∞–Ω–Ω—ã–µ —Å –Ω–∞–∑–Ω–∞—á–µ–Ω–∏–µ–º –≤—Ä–∞—á–∞–º–∏ –ë–ê–î, –±—É–¥—É—Ç –≤–∫–ª—é—á–µ–Ω—ã –≤ —Å—Ñ–µ—Ä—É –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∫–æ–Ω—Ç—Ä–æ–ª—è —Å 18 –æ–∫—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞. –ü–æ —Å–ª–æ–≤–∞–º —ç–∫—Å–ø–µ—Ä—Ç–∞, –ø—Ä–∏–Ω—è—Ç–∏–µ –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è —è–≤–ª—è–µ—Ç—Å—è –ª–æ–≥–∏—á–Ω—ã–º —à–∞–≥–æ–º –≤ —Å–≤–µ—Ç–µ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª–µ–Ω–∏—è –≤—Ä–∞—á–∞–º –ø—Ä–∞–≤–∞ –Ω–∞–∑–Ω–∞—á–∞—Ç—å –∏—Ö –ø–∞—Ü–∏–µ–Ω—Ç–∞–º. üîµ –î–µ–ø—É—Ç–∞—Ç –ê–π—Ä–∞—Ç –§–∞—Ä—Ä–∞—Ö–æ–≤ –ø—Ä–∏–∑–≤–∞–ª –¥–µ–ª–∏—Ç—å —É–ø–∞–∫–æ–≤–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤. –û–Ω —Å—á–∏—Ç–∞–µ—Ç, —á—Ç–æ —Ä–æ–∑–Ω–∏—á–Ω—ã–π –∏ –≥–æ—Å–ø–∏—Ç–∞–ª—å–Ω—ã–π —Å–µ–≥–º–µ–Ω—Ç—ã –¥–æ–ª–∂–Ω—ã –ø–æ—Å—Ç–µ–ø–µ–Ω–Ω–æ —É—Ö–æ–¥–∏—Ç—å –æ—Ç –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ —É–ø–∞–∫–æ–≤–∫–∞–º–∏. –≠—Ç–æ –ø–æ–∑–≤–æ–ª–∏—Ç —Å—ç–∫–æ–Ω–æ–º–∏—Ç—å —Å—Ä–µ–¥—Å—Ç–≤–∞ –±—é–¥–∂–µ—Ç–∞ –∏ –≥—Ä–∞–∂–¥–∞–Ω –∏ –ø–æ–≤—ã—Å–∏—Ç—å —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å —Å–∏—Å—Ç–µ–º—ã –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è. üîµ –ê–ª—å—è–Ω—Å —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–π –æ–±—Ä–∞—Ç–∏–ª—Å—è –∫ –≥–ª–∞–≤–µ –§–ê–¶ —Å –ø—Ä–æ—Å—å–±–æ–π —Å–Ω–∏–∑–∏—Ç—å —Ñ–æ—Ä–º–∞–ª–∏–∑–º –ø—Ä–∏ –æ—Ü–µ–Ω–∫–µ –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤ –æ–ø—ã—Ç–Ω—ã—Ö —Ñ–∞—Ä–º—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤. –ú–Ω–æ–≥–∏–µ –ø—Ä–æ–≤–∏–∑–æ—Ä—ã —Å–æ —Å—Ç–∞–∂–µ–º —Å—Ç–∞–ª–∫–∏–≤–∞—é—Ç—Å—è —Å —Ç—Ä—É–¥–Ω–æ—Å—Ç—è–º–∏ –ø—Ä–∏ –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–∏ –∏–∑-–∑–∞ —Ñ–æ—Ä–º–∞–ª—å–Ω—ã—Ö –æ—à–∏–±–æ–∫ –∏ –Ω–µ—Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–π –≤ –¥–æ–∫—É–º–µ–Ω—Ç–∞—Ü–∏–∏, —á—Ç–æ —É—Å—É–≥—É–±–ª—è–µ—Ç –∫–∞–¥—Ä–æ–≤—ã–π –¥–µ—Ñ–∏—Ü–∏—Ç. üîµ –ë—ã–≤—à–∏–π —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å –∞–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ AlphaRM –ê–Ω–Ω–∞ –ï—Ä–º–æ–ª–∞–µ–≤–∞ —Å—Ç–∞–ª–∞ –∏—Å–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–º –¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–º –º–∞—Ä–∫–µ—Ç–∏–Ω–≥–æ–≤–æ–≥–æ —Å–æ—é–∑–∞ ¬´–°–æ–∑–≤–µ–∑–¥–∏–µ¬ª –∏ –∑–∞–π–º–µ—Ç—Å—è –æ–ø—Ç–∏–º–∏–∑–∞—Ü–∏–µ–π –±–∏–∑–Ω–µ—Å-–ø—Ä–æ—Ü–µ—Å—Å–æ–≤ –∏ —Ä–∞–∑–≤–∏—Ç–∏–µ–º –ø–∞—Ä—Ç–Ω–µ—Ä—Å–∫–æ–π —Å–µ—Ç–∏. üîµ –ê–Ω—Ç–∏—Å–µ–ø—Ç–∏—á–µ—Å–∫–∏–µ ¬´—Ñ–ª–æ–º–∞—Å—Ç–µ—Ä—ã¬ª –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–õ–µ–∫–∫–µ—Ä¬ª –∏—Å—á–µ–∑–ª–∏ –∏–∑ –∞–ø—Ç–µ–∫ –ø–æ—Å–ª–µ –æ—Ç–º–µ–Ω—ã —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏. –ö–æ–º–ø–∞–Ω–∏–∏ —Å–≤—è–∑—ã–≤–∞—é—Ç —ç—Ç–æ —Å –Ω–µ–¥–æ–±—Ä–æ—Å–æ–≤–µ—Å—Ç–Ω–æ–π –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏–µ–π –∏ —Ä–µ–π–¥–µ—Ä—Å—Ç–≤–æ–º, –∞ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä –Ω–µ –ø—Ä–∏–∑–Ω–∞–µ—Ç –∏—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º–∏ –∏–∑–¥–µ–ª–∏—è–º–∏, —Ç—Ä–µ–±—É—è –ª–∏—Ü–µ–Ω–∑–∏–∏ –Ω–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""high"",
  ""english"": ""The expert noted that the adoption of this regulation is a logical step in light of doctors' right to prescribe. The deputy Ayrat Farrahov called for dividing the drug packaging, suggesting that both retail and hospital segments should gradually move away from using individual packages to reduce budgetary and consumer costs, and improve the efficiency of the drug supply system. ""
}"
2025-10-18T17:32:04+00:00,@medpharm,13173,https://t.me/medpharm/13173,–í–æ–∑–≥–ª–∞–≤–ª—è–≤—à–∞—è —Ñ–∏–Ω–∞–Ω—Å–æ–≤–æ-—ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–∏–π –¥–µ–ø–∞—Ä—Ç–∞–º–µ–Ω—Ç –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–§ –ù–∞—Ç–∞–ª—å—è –°–∏–±–∏—Ä—è–∫–æ–≤–∞ –Ω–∞–∑–Ω–∞—á–µ–Ω–∞ –Ω–∞ –ø–æ—Å—Ç –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—è –º–∏–Ω–∏—Å—Ç—Ä–∞ –≤–º–µ—Å—Ç–æ –ù–∞—Ç–∞–ª—å–∏ –•–æ—Ä–æ–≤–æ–π. –í –∫–æ–Ω—Ü–µ —Å–µ–Ω—Ç—è–±—Ä—è –ø–æ—Å–ª–µ–¥–Ω—è—è –ø–µ—Ä–µ—à–ª–∞ –Ω–∞ —Ä–∞–±–æ—Ç—É –≤ –°–æ–≤—Ñ–µ–¥. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pomps #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-10-18T07:15:31+00:00,@medpharm,13172,https://t.me/medpharm/13172,"üß©üß©üß©üß©üß©üß© –ù–∞ —ç—Ç–æ–π –Ω–µ–¥–µ–ª–µ –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω –ø—Ä–æ–µ–∫—Ç –ü–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –†–§ ¬´–û –ü—Ä–æ–≥—Ä–∞–º–º–µ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –≥–∞—Ä–∞–Ω—Ç–∏–π –±–µ—Å–ø–ª–∞—Ç–Ω–æ–≥–æ –æ–∫–∞–∑–∞–Ω–∏—è –≥—Ä–∞–∂–¥–∞–Ω–∞–º –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –Ω–∞ 2026 –≥–æ–¥ –∏ –Ω–∞ –ø–ª–∞–Ω–æ–≤—ã–π –ø–µ—Ä–∏–æ–¥ 2027 –∏ 2028 –≥–æ–¥–æ–≤¬ª. –ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–∞—è –∞—Å—Å–æ—Ü–∏–∞—Ü–∏—è —É–ø—Ä–∞–≤–ª–µ–Ω—Ü–µ–≤ —Å—Ñ–µ—Ä—ã –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –æ–±—Ä–∞—Ç–∏–ª–∞ –≤–Ω–∏–º–∞–Ω–∏–µ –Ω–∞ –≥–æ—Ç–æ–≤—è—â–µ–µ—Å—è –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—è–º–∏ —Ä–µ—à–µ–Ω–∏–µ –ª–∏—à–∏—Ç—å –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –ª—å–≥–æ—Ç –Ω–∞ —É–ø–ª–∞—Ç—É —Å—Ç—Ä–∞—Ö–æ–≤—ã—Ö –≤–∑–Ω–æ—Å–æ–≤. –í –ø—Ä–æ–µ–∫—Ç–µ –±—é–¥–∂–µ—Ç–∞ –Ω–∞ 2026 –≥–æ–¥ —Ç–∞–∫–∏–µ –ª—å–≥–æ—Ç—ã –ø—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ–Ω—ã –¥–ª—è —Ä—è–¥–∞ –∫–ª—é—á–µ–≤—ã—Ö –Ω–µ—Å—ã—Ä—å–µ–≤—ã—Ö —Å–µ–∫—Ç–æ—Ä–æ–≤ —ç–∫–æ–Ω–æ–º–∏–∫–∏. –ß–∞—Å—Ç–Ω—ã—Ö –∫–ª–∏–Ω–∏–∫ –≤ —ç—Ç–æ–º –ø–µ—Ä–µ—á–Ω–µ –Ω–µ—Ç. –¢—Ä–µ—Ç—å—é —Å—Ç—Ä–æ—á–∫—É –Ω–æ–≤–æ—Å—Ç–Ω–æ–≥–æ —Ä–µ–π—Ç–∏–Ω–≥–∞ –Ω–µ–¥–µ–ª–∏ –∑–∞–Ω—è–ª–æ —Å–æ–æ–±—â–µ–Ω–∏–µ –æ –ø–æ–¥–¥–µ—Ä–∂–∫–µ –ö–æ–º–∏—Ç–µ—Ç–æ–º –ì–æ—Å–¥—É–º—ã –†–§ –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç–∞, –¥–æ–ø—É—Å–∫–∞—é—â–µ–≥–æ –∏—Å–∫–ª—é—á–µ–Ω–∏–µ —Å—Ç—Ä–∞—Ö–æ–≤—ã—Ö –∫–æ–º–ø–∞–Ω–∏–π –∏–∑ —Å–∏—Å—Ç–µ–º—ã –û–ú–°. –ù–∞ —á–µ—Ç–≤–µ—Ä—Ç–æ–º –º–µ—Å—Ç–µ –≤ TOP5 –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è –æ—Ç –≤–∏—Ü–µ-–ø—Ä–µ–º—å–µ—Ä–∞ –¢–∞—Ç—å—è–Ω—ã –ì–æ–ª–∏–∫–æ–≤–æ–π –æ —Å–∏—Ç—É–∞—Ü–∏–∏ —Å –∫–∞–¥—Ä–∞–º–∏ –≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–∏. –ü–æ –µ–µ –¥–∞–Ω–Ω—ã–º, —Å —è–Ω–≤–∞—Ä—è –ø–æ —Å–µ–Ω—Ç—è–±—Ä—å —Ç–µ–∫—É—â–µ–≥–æ –≥–æ–¥–∞ —á–∏—Å–ª–æ –≤—Ä–∞—á–µ–π –≤ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è—Ö –≤—ã—Ä–æ—Å–ª–æ –Ω–∞ 12 712 —á–µ–ª–æ–≤–µ–∫. –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ –ø—Ä–µ–¥–ª–æ–∂–∏–ª —Ü–µ–Ω—Ç—Ä–∞–ª–∏–∑–æ–≤–∞—Ç—å –∑–∞–∫—É–ø–∫–∏ –≤–∞–∂–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π –¥–ª—è –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –Ω—É–∂–¥ –≤ —Ä–∞–º–∫–∞—Ö –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—ã—Ö –ø—Ä–æ–µ–∫—Ç–æ–≤ ¬´–ü—Ä–æ–¥–æ–ª–∂–∏—Ç–µ–ª—å–Ω–∞—è –∏ –∞–∫—Ç–∏–≤–Ω–∞—è –∂–∏–∑–Ω—å¬ª –∏ ¬´–°–µ–º—å—è¬ª. –î–ª—è —ç—Ç–æ–≥–æ –ø–æ–ª–Ω–æ–º–æ—á–∏—è –ø–æ –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–∏—é –ø–æ—Å—Ç–∞–≤—â–∏–∫–æ–≤ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –º–µ–¥–∏–∑–¥–µ–ª–∏–π –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–æ –ø–µ—Ä–µ–¥–∞—Ç—å –§–¶–ü–∏–õ–û.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement, shortage"",
  ""impact"": ""high"",
  ""english"": ""The government's draft decree on the Program of Free Medical Services for Citizens in Russia 2026 and subsequent years has been published. The National Health Management Association highlighted the government's plan to exempt healthcare organizations from insurance contributions, which are currently available for key non-resource sectors. The project budget for 2026 includes these exemptions for several critical economic sectors, excluding private clinics. The top news of the week is a message supporting a draft law by the State Duma Committee on Health to exclude insurance companies from the OMS system. The third place is taken by news about Tatyana Golikova, Vice Prime Minister of Russia, regarding the situation with healthcare workforce. She reported that the number of doctors in state institutions has increased by 12,712 people from January to September this year. The Russian Ministry of Health proposed centralizing the procurement of important medicines and medical devices for state needs within the framework of national projects 'Longevity and Activity' and 'Family'. The authority suggested transferring the powers to determine suppliers of medicines and medical devices to FCP"
2025-10-18T06:52:04+00:00,@medpharm,13171,https://t.me/medpharm/13171,"–ë–∞–∫—Ç–µ—Ä–∏–∞–ª—å–Ω—ã–π –∏ –≥—Ä–∏–±–∫–æ–≤—ã–π –º–∏–∫—Ä–æ–±–∏–æ–º —Ä–æ—Ç–æ–≤–æ–π –ø–æ–ª–æ—Å—Ç–∏ –º–æ–∂–µ—Ç —Å—Ç–∞—Ç—å –ø—Ä–µ–¥–∏–∫—Ç–æ—Ä–æ–º —Ä–∞–∫–∞ –ø–æ–¥–∂–µ–ª—É–¥–æ—á–Ω–æ–π –∂–µ–ª–µ–∑—ã. –¢—Ä–∏ –±–∞–∫—Ç–µ—Ä–∏–∞–ª—å–Ω—ã—Ö –ø–∞—Ç–æ–≥–µ–Ω–∞ –ø–æ–ª–æ—Å—Ç–∏ —Ä—Ç–∞ ‚Äî Porphyromonas gingivalis, Eubacterium nodatum –∏ Parvimonas micra ‚Äî –Ω–∞—Ä—è–¥—É —Å –≥—Ä–∏–±–∞–º–∏ —Ä–æ–¥–∞ Candida –æ–∫–∞–∑–∞–ª–∏—Å—å —Å–≤—è–∑–∞–Ω—ã —Å –ø–æ–≤—ã—à–µ–Ω–Ω—ã–º —Ä–∏—Å–∫–æ–º —Ä–∞–∑–≤–∏—Ç–∏—è —Ä–∞–∫–∞ –ø–æ–¥–∂–µ–ª—É–¥–æ—á–Ω–æ–π –∂–µ–ª–µ–∑—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PoHVm #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–î–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞ #–ì–∞—Å—Ç—Ä–æ—ç–Ω—Ç–µ—Ä–æ–ª–æ–≥–∏—è #–û–Ω–∫–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è","{""skip"": true}"
2025-10-17T16:42:01+00:00,@medpharm,13169,https://t.me/medpharm/13169,"ü¶æ –ü–æ –Ω–æ–≤–æ–π —Ñ–æ—Ä–º–µ. –ú–∏–Ω—é—Å—Ç –†–§ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª –ø—Ä–∏–∫–∞–∑ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–§, —É—Ç–≤–µ—Ä–¥–∏–≤—à–∏–π –Ω–æ–≤—ã–π —à–∞–±–ª–æ–Ω —É—á–µ—Ç–Ω–æ–π —Ñ–æ—Ä–º—ã ‚Ññ 057/—É. –û–Ω–∞ –∏—Å–ø–æ–ª—å–∑—É–µ—Ç—Å—è –¥–ª—è –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è –¥–ª—è –æ–∫–∞–∑–∞–Ω–∏—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ ‚Äî –∫–æ–Ω—Å—É–ª—å—Ç–∞—Ü–∏–∏, –æ–±—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è, –≥–æ—Å–ø–∏—Ç–∞–ª–∏–∑–∞—Ü–∏–∏, –∏ –ø–æ—Ä—è–¥–æ–∫ –µ–µ –∑–∞–ø–æ–ª–Ω–µ–Ω–∏—è. ü¶æ –†–∞–º–∫–∏ –¥–ª—è –ë–ê–î. –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –ø–æ—Ä—è–¥–æ–∫ –Ω–∞–∑–Ω–∞—á–µ–Ω–∏—è –≤—Ä–∞—á–∞–º–∏ –ë–ê–î. –ö–∞–∫ —Å–ª–µ–¥—É–µ—Ç –∏–∑ –¥–æ–∫—É–º–µ–Ω—Ç–∞, –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–∏ –±—É–¥—É—Ç –≤–ø—Ä–∞–≤–µ –Ω–∞–∑–Ω–∞—á–∞—Ç—å –±–∏–æ–¥–æ–±–∞–≤–∫–∏, –≤–∫–ª—é—á–µ–Ω–Ω—ã–µ –≤ —Å–ø–µ—Ü–∏–∞–ª—å–Ω—ã–π –ø–µ—Ä–µ—á–µ–Ω—å, –ø—Ä–∏ –Ω–∞–ª–∏—á–∏–∏ –ø–æ–∫–∞–∑–∞–Ω–∏–π –∫ –∏—Ö –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—é. ‚ù§Ô∏è –°–º–µ–Ω–∏–ª–∏ –ø—Ä–æ–ø–∏—Å–∫—É. –ú–æ—Å–∫–æ–≤—Å–∫–∞—è —Å–µ—Ç—å –∞–ø—Ç–µ–∫ ¬´–Æ–Ω–∏—Ñ–∞—Ä–º–∞¬ª –ø–µ—Ä–µ—à–ª–∞ –≤ —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç—å ¬´–§–∞—Ä–º–ª–µ–Ω–¥–∞¬ª. –í –ø—Ä–æ—à–ª–æ–º –≥–æ–¥—É –µ–µ –≤–ª–∞–¥–µ–ª—å—Ü—ã –ø—Ä–æ–¥–∞–ª–∏ ¬´–§–∞—Ä–º–ª–µ–Ω–¥—É¬ª –¥—Ä—É–≥–æ–π –∞–∫—Ç–∏–≤ –≤ –º–æ—Å–∫–æ–≤—Å–∫–æ–º —Ä–µ–≥–∏–æ–Ω–µ ‚Äî —Å–µ—Ç—å ¬´–†–æ—Å–∞–ø—Ç–µ–∫–∞¬ª. ‚ù§Ô∏è –†–µ—à–∏–ª–∏ —Å–∏–ª–æ–π. –°—É–¥ –≤—ã–¥–∞–ª ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º—É¬ª –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω—É—é –ª–∏—Ü–µ–Ω–∑–∏—é –Ω–∞ –∏–Ω—Å—É–ª–∏–Ω –∫–æ–º–ø–∞–Ω–∏–∏ Sanofi. –≠—Ç–æ –ª–∏—Ü–µ–Ω–∑–∏—è –Ω–µ–æ–±—Ö–æ–¥–∏–º–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ –¥–ª—è —Ç–æ–≥–æ, —á—Ç–æ–±—ã –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å —Å–æ–±—Å—Ç–≤–µ–Ω–Ω—ã–π –ø–∞—Ç–µ–Ω—Ç, –∫–æ—Ç–æ—Ä—ã–π –ø—Ä–∏–∑–Ω–∞–Ω —Å—É–¥–æ–º –∑–∞–≤–∏—Å–∏–º—ã–º –æ—Ç –ø–∞—Ç–µ–Ω—Ç–∞ –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω–æ–π —Ñ–∏—Ä–º—ã.","{""skip"": true}"
2025-10-17T16:14:03+00:00,@medpharm,13168,https://t.me/medpharm/13168,"¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª –ø–æ–ª—É—á–∏–ª –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω—É—é –ª–∏—Ü–µ–Ω–∑–∏—é –Ω–∞ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ –ø–∞—Ç–µ–Ω—Ç–∞ Sanofi –Ω–∞ –∏–Ω—Å—É–ª–∏–Ω-–≥–ª–∞—Ä–≥–∏–Ω –≤ –∫–æ–Ω—Ü–µ–Ω—Ç—Ä–∞—Ü–∏–∏ 300 –ï–¥/–º–ª. –≠—Ç–∞ –ª–∏—Ü–µ–Ω–∑–∏—è –Ω–µ–æ–±—Ö–æ–¥–∏–º–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ –¥–ª—è —Ç–æ–≥–æ, —á—Ç–æ–±—ã –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å —Å–æ–±—Å—Ç–≤–µ–Ω–Ω—ã–π –ø–∞—Ç–µ–Ω—Ç, –∫–æ—Ç–æ—Ä—ã–π –ø—Ä–∏–∑–Ω–∞–Ω —Å—É–¥–æ–º –∑–∞–≤–∏—Å–∏–º—ã–º –æ—Ç –ø–∞—Ç–µ–Ω—Ç–∞ –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω–æ–π —Ñ–∏—Ä–º—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PnxZm #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""high"",
  ""english"": ""A compulsory license for Sanofi's patent on insulin-glarginine in a concentration of 300 units/ml was granted to 'Geropharm'. This license is required for the Russian company to use its own patent, which has been recognized by a court as dependent on an international firm's patent. More: https://clck.ru/3PnxZm #PharmVestnik #Production""
}"
2025-10-17T15:49:03+00:00,@medpharm,13167,https://t.me/medpharm/13167,"–†–æ—Å—Å–∏–π—Å–∫–∏–π —Ä—ã–Ω–æ–∫ –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏ –∞–∫—Ç–∏–≤–Ω—ã—Ö –¥–æ–±–∞–≤–æ–∫ –Ω–∞ –∏—Å—Ç–æ—Ä–∏—á–µ—Å–∫–æ–º –ø–µ—Ä–µ–ª–æ–º–µ. –≠–ø–æ—Ö–∞ —Ö–∞–æ—Ç–∏—á–Ω–æ–≥–æ —Ä–∞–∑–≤–∏—Ç–∏—è –∑–∞–≤–µ—Ä—à–∞–µ—Ç—Å—è, —É—Å—Ç—É–ø–∞—è –º–µ—Å—Ç–æ —ç—Ä–µ –ø—Ä–æ–∑—Ä–∞—á–Ω–æ—Å—Ç–∏, –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ –∏ –∏–Ω—Ç–µ–≥—Ä–∞—Ü–∏–∏ –≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫—É—é –ø—Ä–∞–∫—Ç–∏–∫—É. –ù–æ–≤—ã–µ —Ä–µ–∞–ª–∏–∏ –æ–±—Å—É–∂–¥–∞–ª–∏ —ç–∫—Å–ø–µ—Ä—Ç—ã –Ω–∞ –±–∏–∑–Ω–µ—Å-–∑–∞–≤—Ç—Ä–∞–∫–µ. –î–∏—Å–∫—É—Å—Å–∏–æ–Ω–Ω–∞—è –≤—Å—Ç—Ä–µ—á–∞ —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ —Ä—ã–Ω–∫–∞ –ë–ê–î –∏ –∞–Ω–∞–ª–∏—Ç–∏–∫–æ–≤ –æ—Ç–∫—Ä—ã–ª–∞ –¥–µ–ª–æ–≤—É—é –ø—Ä–æ–≥—Ä–∞–º–º—É 26-–≥–æ —Å–µ–∑–æ–Ω–∞ –ø—Ä–µ–º–∏–∏ ¬´–ü–ª–∞—Ç–∏–Ω–æ–≤–∞—è —É–Ω—Ü–∏—è¬ª –∏ –æ–±—ä–µ–¥–∏–Ω–∏–ª–∞ –±–æ–ª–µ–µ 250 –æ–Ω–ª–∞–π–Ω-—É—á–∞—Å—Ç–Ω–∏–∫–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PnwB9 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫","{""skip"": true}"
2025-10-17T15:39:06+00:00,@medpharm,13166,https://t.me/medpharm/13166,"–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§ –≤–Ω–æ—Å–∏—Ç –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–æ, –Ω–∞–¥–µ–ª—è—é—â–∏–µ –§–ú–ë–ê –ø–æ–ª–Ω–æ–º–æ—á–∏—è–º–∏ –ø–æ —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏—é –º–µ—Ç–æ–¥–∏—á–µ—Å–∫–∏—Ö —É–∫–∞–∑–∞–Ω–∏–π –∏ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—é –ø–æ—Ä—è–¥–∫–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è —Å–ø–æ—Ä—Ç—Å–º–µ–Ω–æ–≤ –Ω–∞ —É—Ä–æ–≤–Ω–µ —Ä–µ–≥–∏–æ–Ω–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pnvbp #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The Russian government is amending its legislation to grant the FMBA authority to approve medical care guidelines and establish a regional order for athletes. More details: https://clck.ru/3Pnvbp #MedNews #Healthcare #Other""
}"
2025-10-17T15:12:06+00:00,@medpharm,13165,https://t.me/medpharm/13165,–í –ú–æ—Å–∫–≤–µ 17 –æ–∫—Ç—è–±—Ä—è —Å–æ—Å—Ç–æ—è–ª–∞—Å—å —Ç–æ—Ä–∂–µ—Å—Ç–≤–µ–Ω–Ω–∞—è —Ü–µ—Ä–µ–º–æ–Ω–∏—è –æ—Ç–∫—Ä—ã—Ç–∏—è –ø–∞–º—è—Ç–Ω–∏–∫–∞ –Ω–∞ –º–æ–≥–∏–ª–µ –≤—ã–¥–∞—é—â–µ–≥–æ—Å—è —Å–æ–≤–µ—Ç—Å–∫–æ–≥–æ –∏ —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –∫–∞—Ä–¥–∏–æ—Ö–∏—Ä—É—Ä–≥–∞ –∞–∫–∞–¥–µ–º–∏–∫–∞ –†–ê–ù –†–µ–Ω–∞—Ç–∞ –ê–∫—á—É—Ä–∏–Ω–∞. –û–Ω —É—à–µ–ª –∏–∑ –∂–∏–∑–Ω–∏ –≤ –ø—Ä–æ—à–ª–æ–º –≥–æ–¥—É. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pnu3w #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-10-17T15:12:03+00:00,@medpharm,13164,https://t.me/medpharm/13164,–¢—Ä–∞–º–ø –ø–æ–æ–±–µ—â–∞–ª —Å–¥–µ–ª–∞—Ç—å ¬´–û–∑–µ–º–ø–∏–∫¬ª –¥–µ—à–µ–≤–ª–µ –Ω–∞ 85% ‚Äî —Ü–µ–Ω–∞ –º–µ—Å—è—á–Ω–æ–≥–æ –∫—É—Ä—Å–∞ —Å–Ω–∏–∑–∏—Ç—Å—è —Å 1000 –¥–æ 150 –¥–æ–ª–ª. ‚Äî –∏ –∑–∞–∫–ª—é—á–∏–ª —Å–¥–µ–ª–∫—É —Å –Ω–µ–º–µ—Ü–∫–æ–π Merck KGaA –ø–æ —Å–Ω–∏–∂–µ–Ω–∏—é —Å—Ç–æ–∏–º–æ—Å—Ç–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –≠–ö–û –±–æ–ª–µ–µ —á–µ–º –Ω–∞ 70%. –ü–∞—Ä–∞–ª–ª–µ–ª—å–Ω–æ Roche –∑–∞–ø—É—Å—Ç–∏–ª–∞ –ø—Ä—è–º—ã–µ –ø—Ä–æ–¥–∞–∂–∏ –ø—Ä–æ—Ç–∏–≤–æ–≥—Ä–∏–ø–ø–æ–∑–Ω–æ–π ¬´–ö—Å–æ—Ñ–ª—é–∑—ã¬ª –ø–æ 50 –¥–æ–ª–ª. ‚Äî –Ω–∞ 70% –Ω–∏–∂–µ –ø—Ä–µ–π—Å–∫—É—Ä–∞–Ω—Ç–Ω–æ–π —Ü–µ–Ω—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pnu3t #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-10-17T15:01:52+00:00,@medpharm,13163,https://t.me/medpharm/13163,"–ü—Ä–æ–∑—Ä–∞—á–Ω—ã–π —Ä—ã–Ω–æ–∫ –ë–ê–î. –°–∫–æ—Ä–æ 28 –æ–∫—Ç—è–±—Ä—è –≤ Hotel Continental (–¢–≤–µ—Ä—Å–∫–∞—è, 22) –æ–±—Å—É–¥–∏–º, –∫–∞–∫ –≤–µ—Ä–Ω—É—Ç—å –¥–æ–≤–µ—Ä–∏–µ –∫ —Ä—ã–Ω–∫—É –ë–ê–î. –†–µ–≥—É–ª—è—Ç–æ—Ä—ã, —ç–∫—Å–ø–µ—Ä—Ç—ã –∏ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—ã–µ —Å–æ–æ–±—â–µ—Å—Ç–≤–∞ –ø—Ä–µ–¥—Å—Ç–∞–≤—è—Ç –Ω–æ–≤—ã–π —Ç—Ä–µ—Ö—É—Ä–æ–≤–Ω–µ–≤—ã–π –º–µ—Ö–∞–Ω–∏–∑–º –∫–æ–Ω—Ç—Ä–æ–ª—è ‚Äî –≤–ø–µ—Ä–≤—ã–µ –æ—Ü–µ–Ω—è—Ç –Ω–µ —Ç–æ–ª—å–∫–æ –∫–∞—á–µ—Å—Ç–≤–æ –∏ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å, –Ω–æ –∏ –¥–æ–∫–∞–∑–∞–Ω–Ω—É—é —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –ë–ê–î. –¢–∞–∫–∂–µ –±—É–¥—É—Ç –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω—ã –ø—Ä–æ–µ–∫—Ç—ã –ø–æ —Å–æ–∑–¥–∞–Ω–∏—é –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ —Ä–µ–µ—Å—Ç—Ä–∞ –¥–æ–±—Ä–æ—Å–æ–≤–µ—Å—Ç–Ω—ã—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –∏ –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–Ω–æ–π —Å–∏—Å—Ç–µ–º—ã –¥–æ–±—Ä–æ–≤–æ–ª—å–Ω–æ–π –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏ –ë–ê–î. –ö–æ–º—É –≤–∞–∂–Ω–æ: ‚ñ™Ô∏è –ü—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º –∏ –¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–∞–º ‚ñ™Ô∏è –í—Ä–∞—á–∞–º –∏ –Ω—É—Ç—Ä–∏—Ü–∏–æ–ª–æ–≥–∞–º ‚ñ™Ô∏è –≠–∫—Å–ø–µ—Ä—Ç–∞–º –∏ –°–ú–ò üìÖ 28 –æ–∫—Ç—è–±—Ä—è, 10:00 üìç –ú–æ—Å–∫–≤–∞, Hotel Continental üí¨ –£—á–∞—Å—Ç–∏–µ –±–µ—Å–ø–ª–∞—Ç–Ω–æ–µ üëâ –†–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –∏ –¥–µ—Ç–∞–ª–∏ –ø–æ —Å—Å—ã–ª–∫–µ –†–µ–∫–ª–∞–º–∞, –û–û–û ""–ü—Ä–æ–µ–∫—Ç –ú–µ–¥–∏–∞"" 2VfnxxfPk7i","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""A transparent market for BAs is being discussed on October 28th at Hotel Continental (Tverskaya, 22). The event will present a new three-level control mechanism that evaluates not only the quality and safety but also the proven effectiveness of BAs. Projects on creating a national registry of honest producers and a prospective voluntary marking system will also be presented. The event is relevant for manufacturers, distributors, doctors and nutritionists, as well as experts and media.""
}"
2025-10-17T14:53:03+00:00,@medpharm,13162,https://t.me/medpharm/13162,"–ü–∞—Ü–∏–µ–Ω—Ç—Å–∫–∏–µ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –ø–æ–ø—Ä–æ—Å–∏–ª–∏ —Å–∫–æ—Ä—Ä–µ–∫—Ç–∏—Ä–æ–≤–∞—Ç—å –∫—Ä–∏—Ç–µ—Ä–∏–∏, –ø–æ –∫–æ—Ç–æ—Ä—ã–º —Ä–µ–≥–∏–æ–Ω—ã —Å–º–æ–≥—É—Ç –ø—Ä–µ—Ç–µ–Ω–¥–æ–≤–∞—Ç—å –Ω–∞ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã–µ —Å—É–±—Å–∏–¥–∏–∏ –¥–ª—è –∑–∞–∫—É–ø–∫–∏ –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ü—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è –∏—Å–∫–ª—é—á–∏—Ç—å –∫—Ä–∏—Ç–µ—Ä–∏–π –æ –±—é–¥–∂–µ—Ç–Ω–æ–π –æ–±–µ—Å–ø–µ—á–µ–Ω–Ω–æ—Å—Ç–∏ —Ä–µ–≥–∏–æ–Ω–∞ –∏ –ø–µ—Ä–µ—Å–º–æ—Ç—Ä–µ—Ç—å —É—Å–ª–æ–≤–∏—è, —Å–≤—è–∑–∞–Ω–Ω—ã–µ —Å —Ä–æ—Å—Ç–æ–º —Å—Ç–æ–∏–º–æ—Å—Ç–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ —á–∏—Å–ª–µ–Ω–Ω–æ—Å—Ç–∏ –±–æ–ª—å–Ω—ã—Ö. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PnsYd #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""Patient organizations requested adjustments to the criteria by which regions can apply for federal subsidies to procure orphan drugs. It is proposed to exclude the budgetary sufficiency criterion of a region and review conditions related to the cost increase of drugs and patient numbers.""
}"
2025-10-17T14:46:03+00:00,@medpharm,13161,https://t.me/medpharm/13161,"–†–µ–≥—É–ª—è—Ç–æ—Ä —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –ø—Ä–æ–µ–∫—Ç—ã –µ—â–µ —á–µ—Ç—ã—Ä–µ—Ö —Ç–∏–ø–æ–≤—ã—Ö –ø—Ä–æ–≥—Ä–∞–º–º –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–≥–æ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è ‚Äî –ø–æ –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–π —Ñ–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏–∏, –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–Ω–æ–º—É –¥–µ–ª—É, –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–º—É –º–∞—Å—Å–∞–∂—É –∏ —Ä–µ–∞–±–∏–ª–∏—Ç–∞—Ü–∏–æ–Ω–Ω–æ–º—É —Å–µ—Å—Ç—Ä–∏–Ω—Å–∫–æ–º—É –¥–µ–ª—É. –í —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–∏ —Å –ø–æ–ø—Ä–∞–≤–∫–∞–º–∏ –≤ –∑–∞–∫–æ–Ω ¬´–û–± –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–∏¬ª —Å–æ —Å–ª–µ–¥—É—é—â–µ–≥–æ –≥–æ–¥–∞ —É—á–µ–±–Ω—ã–µ –∑–∞–≤–µ–¥–µ–Ω–∏—è –æ–±—è–∑–∞–Ω—ã –ø–µ—Ä–µ–π—Ç–∏ –Ω–∞ —Ç–∏–ø–æ–≤—ã–µ –ø—Ä–æ–≥—Ä–∞–º–º—ã –≤–º–µ—Å—Ç–æ –ø—Ä–∏–º–µ—Ä–Ω—ã—Ö. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PnrqJ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–û–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-10-17T14:45:02+00:00,@medpharm,13160,https://t.me/medpharm/13160,–í –ú–æ—Å–∫–≤–µ –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç—Å—è —Ä–∞–±–æ—Ç–∞ XXXV –ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ –∫–æ–Ω–≥—Ä–µ—Å—Å–∞ –ø–æ –±–æ–ª–µ–∑–Ω—è–º –æ—Ä–≥–∞–Ω–æ–≤ –¥—ã—Ö–∞–Ω–∏—è. –í –∫–æ–Ω—Ç—É—Ä–µ –Ω–∞—É—á–Ω–æ–π –ø—Ä–æ–≥—Ä–∞–º–º—ã –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏—è —Å–æ—Å—Ç–æ—è–ª–æ—Å—å –¥–≤–∞ —Å–∏–º–ø–æ–∑–∏—É–º–∞ –ø—Ä–∏ –ø–æ–¥–¥–µ—Ä–∂–∫–µ ¬´–ü–°–ö –§–∞—Ä–º–∞¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pnrjz #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-10-17T14:08:03+00:00,@medpharm,13159,https://t.me/medpharm/13159,"–ó–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—è –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –ò–≤–∞–Ω–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ ‚Äî –¥–∏—Ä–µ–∫—Ç–æ—Ä –î–µ–ø–∞—Ä—Ç–∞–º–µ–Ω—Ç–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è —Ä–µ–≥–∏–æ–Ω–∞ –ê–Ω—Ç–æ–Ω –ê—Ä—Å–µ–Ω—å–µ–≤ –∑–∞–¥–µ—Ä–∂–∞–Ω –ø–æ –ø–æ–¥–æ–∑—Ä–µ–Ω–∏—é –≤ –∫–æ—Ä—Ä—É–ø—Ü–∏–∏, —Å–æ–æ–±—â–∏–ª–∏ –°–ú–ò. –°–ª–µ–¥—Å—Ç–≤–µ–Ω–Ω—ã–µ –æ—Ä–≥–∞–Ω—ã –ø—Ä–æ–≤–æ–¥—è—Ç –ø—Ä–æ–≤–µ—Ä–∫—É, –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω—ã—Ö –∫–æ–º–º–µ–Ω—Ç–∞—Ä–∏–µ–≤ –ø–æ–∫–∞ –Ω–µ—Ç. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PnpQ9 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-10-17T13:38:03+00:00,@medpharm,13158,https://t.me/medpharm/13158,"–ó–∞ –ø—Ä–æ—à–µ–¥—à—É—é –Ω–µ–¥–µ–ª—é –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä –ø—Ä–µ–∫—Ä–∞—Ç–∏–ª –æ–±—Ä–∞—â–µ–Ω–∏–µ —Å–µ–º–∏ —Å–µ—Ä–∏–π –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –µ—â–µ –¥–≤–µ —Å–µ—Ä–∏–∏ –æ—Ç–æ–∑–≤–∞–ª–∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏. –ü—Ä–µ—Ç–µ–Ω–∑–∏–∏ –≤–æ–∑–Ω–∏–∫–ª–∏ –∫ —Ç–∞–∫–∏–º –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è–º, –∫–∞–∫ ¬´–†–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø—Ä–∏–º–µ—Å–∏¬ª, ¬´–ú–∞—Ä–∫–∏—Ä–æ–≤–∫–∞¬ª –∏ ¬´–û–ø–∏—Å–∞–Ω–∏–µ¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PnnEf #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–û—Ç–∑—ã–≤—ã","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""The Russian Health Supervision authority has suspended the registration of seven series of pharmaceutical products and recalled two more due to issues with 'Related impurities', 'Packaging marking', and 'Description'. More details: https://clck.ru/3PnnEf #PharmNews #DrugRecalls""
}"
2025-10-17T13:17:04+00:00,@medpharm,13157,https://t.me/medpharm/13157,"–ú–æ—Å–∫–≤–∞ –Ω–∞–ø—Ä–∞–≤–∏—Ç 615 –º–ª—Ä–¥ —Ä—É–±. –Ω–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ –≤ 2026 –≥–æ–¥—É ‚Äî —Å—Ä–µ–¥—Å—Ç–≤–∞ –ø–æ–π–¥—É—Ç –Ω–∞ —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–æ –∏ —Ä–µ–∫–æ–Ω—Å—Ç—Ä—É–∫—Ü–∏—é –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏–π, —Ä–∞–∑–≤–∏—Ç–∏–µ –≤—ã—Å–æ–∫–∏—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –∏ –≤–Ω–µ–¥—Ä–µ–Ω–∏–µ –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–∞. –ó–∞ —Ç—Ä–∏ –≥–æ–¥–∞ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –≤–æ–∑–≤–µ—Å—Ç–∏ 52 –Ω–æ–≤—ã—Ö –º–µ–¥–æ–±—ä–µ–∫—Ç–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pnktk #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-10-17T12:53:02+00:00,@medpharm,13156,https://t.me/medpharm/13156,"Roche –∏ Hansoh Pharma –∑–∞–∫–ª—é—á–∏–ª–∏ —Å–æ–≥–ª–∞—à–µ–Ω–∏–µ –Ω–∞ 1,45 –º–ª—Ä–¥ –¥–æ–ª–ª. –ø–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç—É –¥–ª—è –ª–µ—á–µ–Ω–∏—è –∫–æ–ª–æ—Ä–µ–∫—Ç–∞–ª—å–Ω–æ–≥–æ —Ä–∞–∫–∞ –∏ –¥—Ä—É–≥–∏—Ö —Å–æ–ª–∏–¥–Ω—ã—Ö –æ–ø—É—Ö–æ–ª–µ–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pnj8X #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-17T12:17:05+00:00,@medpharm,13155,https://t.me/medpharm/13155,–ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –Ω–æ–≤—ã–π –ø–æ—Ä—è–¥–æ–∫ –æ–∫–∞–∑–∞–Ω–∏—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –ø–æ –ø—Ä–æ—Ñ–∏–ª—é ¬´–î–µ—Ç—Å–∫–∞—è —Ö–∏—Ä—É—Ä–≥–∏—è¬ª. –î–µ—Ç–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω—ã –º–∞—Ä—à—Ä—É—Ç–∏–∑–∞—Ü–∏—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –∏ –≥—Ä–∞–¥–∞—Ü–∏—è –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –ø–æ —É—Ä–æ–≤–Ω—è–º. –í–ø–µ—Ä–≤—ã–µ –≤ –¥–æ–∫—É–º–µ–Ω—Ç –≤–∫–ª—é—á–µ–Ω–∞ –ø–∞–ª–ª–∏–∞—Ç–∏–≤–Ω–∞—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è –ø–æ–º–æ—â—å –∏ –∫–æ–Ω–∫—Ä–µ—Ç–∏–∑–∏—Ä–æ–≤–∞–Ω—ã –ø—Ä–∞–≤–∏–ª–∞ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –∏ –æ—Å–Ω–∞—â–µ–Ω–∏—è –¥–Ω–µ–≤–Ω—ã—Ö —Å—Ç–∞—Ü–∏–æ–Ω–∞—Ä–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PngX2 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è #–•–∏—Ä—É—Ä–≥–∏—è,"{""skip"": true}"
2025-10-17T11:36:03+00:00,@medpharm,13154,https://t.me/medpharm/13154,"–°—Ä–µ–¥–∏ –ø–µ—Ä–≤–æ—Å—Ç–æ–ª—å–Ω–∏–∫–æ–≤ –∏ –º–µ–Ω–µ–¥–∂–µ—Ä–æ–≤ –ø–æ –∑–∞–∫—É–ø–∫–∞–º —Å–Ω–∏–∑–∏–ª–∞—Å—å –¥–æ–ª—è —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤ —Å –≤—ã—Å—à–∏–º –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ–º, –ø–æ–∫–∞–∑–∞–ª –æ–ø—Ä–æ—Å. –ò—Ö –∑–∞–º–µ–Ω–∏–ª–∏ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã —Å–æ —Å—Ä–µ–¥–Ω–µ—Å–ø–µ—Ü–∏–∞–ª—å–Ω—ã–º –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ–º. –°–æ–∫—Ä–∞—Ç–∏–ª–∞—Å—å –∏ –¥–æ–ª—è –º–æ–ª–æ–¥–æ–≥–æ –∫–æ–Ω—Ç–∏–Ω–≥–µ–Ω—Ç–∞ —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤, —á—Ç–æ —Å–≤—è–∑–∞–Ω–æ —Å –ø–µ—Ä–µ–µ–∑–¥–æ–º –º–æ–ª–æ–¥–µ–∂–∏ –≤ –∫—Ä—É–ø–Ω—ã–µ –≥–æ—Ä–æ–¥–∞ –∏ –æ–±—â–∏–º —Å—Ç–∞—Ä–µ–Ω–∏–µ–º –Ω–∞—Å–µ–ª–µ–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PndNi #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{""skip"": true}"
2025-10-17T11:34:08+00:00,@medpharm,13153,https://t.me/medpharm/13153,"–í –†–æ—Å—Å–∏–∏ –ø–∞—Ü–∏–µ–Ω—Ç—ã –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –∏–∑–º–µ–Ω–∏—Ç—å –∫—Ä–∏—Ç–µ—Ä–∏–∏ –ø–æ–ª—É—á–µ–Ω–∏—è —Ä–µ–≥–∏–æ–Ω–∞–º–∏ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã—Ö —Å—É–±—Å–∏–¥–∏–π –Ω–∞ –∑–∞–∫—É–ø–∫—É –ª–µ–∫–∞—Ä—Å—Ç–≤ –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ —Ä–µ–¥–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –ü–æ –∏—Ö –º–Ω–µ–Ω–∏—é, –¥–µ–π—Å—Ç–≤—É—é—â–∏–µ —É—Å–ª–æ–≤–∏—è –Ω–µ –æ—Ç—Ä–∞–∂–∞—é—Ç —Ä–µ–∞–ª—å–Ω—ã—Ö –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç–µ–π –∏ –Ω–µ –ø–æ–º–æ–≥—É—Ç –±–æ–ª—å—à–∏–Ω—Å—Ç–≤—É –Ω—É–∂–¥–∞—é—â–∏—Ö—Å—è –ø–æ–ª—É—á–∏—Ç—å –ª–µ—á–µ–Ω–∏–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PndEt #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""tenders, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""Patients in Russia have proposed changing the criteria for regional federal subsidies on drug purchases for rare diseases. They believe the current conditions do not reflect actual needs and will not help most people in need to receive treatment.""
}"
2025-10-17T10:47:03+00:00,@medpharm,13152,https://t.me/medpharm/13152,"–ú–æ—Å–∫–æ–≤—Å–∫–∞—è —Å–µ—Ç—å –∞–ø—Ç–µ–∫ ¬´–Æ–Ω–∏—Ñ–∞—Ä–º–∞¬ª –ø–µ—Ä–µ—à–ª–∞ –≤ —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç—å ¬´–§–∞—Ä–º–ª–µ–Ω–¥–∞¬ª. –í –ø—Ä–æ—à–ª–æ–º –≥–æ–¥—É –µ–µ –≤–ª–∞–¥–µ–ª—å—Ü—ã –ø—Ä–æ–¥–∞–ª–∏ ¬´–§–∞—Ä–º–ª–µ–Ω–¥—É¬ª –¥—Ä—É–≥–æ–π –∞–∫—Ç–∏–≤ –≤ –º–æ—Å–∫–æ–≤—Å–∫–æ–º —Ä–µ–≥–∏–æ–Ω–µ ‚Äî —Å–µ—Ç—å ¬´–†–æ—Å–∞–ø—Ç–µ–∫–∞¬ª. –¢–æ–≥–¥–∞ –∫–æ–º–ø–∞–Ω–∏—è –≥–æ–≤–æ—Ä–∏–ª–∞ –æ –∂–µ–ª–∞–Ω–∏–∏ —Å–æ—Å—Ä–µ–¥–æ—Ç–æ—á–∏—Ç—å—Å—è –Ω–∞ –ø—Ä–µ–º–∏–∞–ª—å–Ω–æ–º —Å–µ–≥–º–µ–Ω—Ç–µ, –æ—Ç–∫—Ä—ã–≤–∞—è –Ω–æ–≤—ã–µ –∞–ø—Ç–µ–∫–∏ ¬´–Æ–Ω–∏—Ñ–∞—Ä–º—ã¬ª, –Ω–æ —Å–µ–π—á–∞—Å —Ä–µ—à–∏–ª–∞ –ø—Ä–∏–Ω—è—Ç—å —Ö–æ—Ä–æ—à–µ–µ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–µ –æ –ø—Ä–æ–¥–∞–∂–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PnZxF #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{""skip"": true}"
2025-10-17T10:45:03+00:00,@medpharm,13151,https://t.me/medpharm/13151,"–†–µ–≥—É–ª—è—Ç–æ—Ä —É—Ç–≤–µ—Ä–¥–∏–ª –æ–±–Ω–æ–≤–ª–µ–Ω–Ω—É—é —Ñ–æ—Ä–º—É ‚Ññ 057/—É –¥–ª—è –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏–π –Ω–∞ –∫–æ–Ω—Å—É–ª—å—Ç–∞—Ü–∏—é, –æ–±—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –∏ –≥–æ—Å–ø–∏—Ç–∞–ª–∏–∑–∞—Ü–∏—é. –í –¥–æ–∫—É–º–µ–Ω—Ç –¥–æ–±–∞–≤–ª–µ–Ω—ã –Ω–æ–≤—ã–µ –≥—Ä–∞—Ñ—ã –æ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏, –∑–∞–Ω—è—Ç–æ—Å—Ç–∏ –ø–∞—Ü–∏–µ–Ω—Ç–∞ –∏ –¥–µ—Ç–∞–ª—è—Ö –æ–∫–∞–∑–∞–Ω–∏—è –º–µ–¥–ø–æ–º–æ—â–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PnZqC #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The regulator approved an updated form ‚Ññ 057/—É for consultation, examination and hospitalization directions. The document has been updated with new sections on patient registration, patient occupation, and details of medical assistance. For more information: https://clck.ru/3PnZqC #MedVestnik #Healthcare #HealthOrganization""
}"
2025-10-17T09:53:08+00:00,@medpharm,13150,https://t.me/medpharm/13150,"–î–æ–±–∞–≤–ª–µ–Ω–∏–µ –∏–Ω–≥–∞–ª—è—Ü–∏–æ–Ω–Ω–æ–≥–æ –Ω–µ—Ñ—Ä–∞–∫—Ü–∏–æ–Ω–∏—Ä–æ–≤–∞–Ω–Ω–æ–≥–æ –≥–µ–ø–∞—Ä–∏–Ω–∞ –∫ —Å—Ç–∞–Ω–¥–∞—Ä—Ç–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ —Å–Ω–∏–∂–∞–ª–æ –≤–µ—Ä–æ—è—Ç–Ω–æ—Å—Ç—å –∏–Ω—Ç—É–±–∞—Ü–∏–∏ –∏–ª–∏ —Å–º–µ—Ä—Ç–∏ —É –≥–æ—Å–ø–∏—Ç–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å COVID-19. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –ø—Ä–µ–ø–∞—Ä–∞—Ç –ø–æ–∫–∞–∑–∞–ª —Ö–æ—Ä–æ—à–∏–π –ø—Ä–æ—Ñ–∏–ª—å –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ ‚Äî –ª–µ–≥–æ—á–Ω—ã—Ö –∏ –º–∞—Å—Å–∏–≤–Ω—ã—Ö –∫—Ä–æ–≤–æ—Ç–µ—á–µ–Ω–∏–π –Ω–µ –Ω–∞–±–ª—é–¥–∞–ª–æ—Å—å. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PnWBz #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ò–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã–µ_–±–æ–ª–µ–∑–Ω–∏ #–ü—É–ª—å–º–æ–Ω–æ–ª–æ–≥–∏—è_–∏_—Ñ—Ç–∏–∑–∏–∞—Ç—Ä–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety"",
  ""impact"": ""high"",
  ""english"": ""The addition of nebulized unpulverised heparin to standard therapy reduces the likelihood of intubation or death in hospitalized patients with COVID-19. Additionally, the drug showed a good safety profile - no pulmonary or major bleeding events were observed. For more details: https://clck.ru/3PnWBz #MedVestnik #Practice #Infectious_diseases #Pulmonology_and_tuberculosis #Therapy #Pharmacology""
}"
2025-10-17T09:31:02+00:00,@medpharm,13149,https://t.me/medpharm/13149,"J&J –æ—Ç—á–∏—Ç–∞–ª–∞—Å—å –æ —Ä–æ—Å—Ç–µ –≤—ã—Ä—É—á–∫–∏ –Ω–∞ 6,8% –≥–æ–¥ –∫ –≥–æ–¥—É –≤ III –∫–≤–∞—Ä—Ç–∞–ª–µ 2025 –≥–æ–¥–∞, –¥–æ 24 –º–ª—Ä–¥ –¥–æ–ª–ª. –°—Ä–µ–¥–∏ —Å–∞–º—ã—Ö –¥–æ—Ö–æ–¥–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ ‚Äî ¬´–î–∞—Ä–∑–∞–ª–µ–∫—Å¬ª, ¬´–°—Ç–µ–ª–∞—Ä–∞¬ª –∏ ¬´–¢—Ä–µ–º—Ñ–µ—è¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PnUh8 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-17T09:17:03+00:00,@medpharm,13148,https://t.me/medpharm/13148,"–í —ç—Ç–æ–º –≤—ã–ø—É—Å–∫–µ –∫.–º.–Ω., –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–π —Ñ–∞—Ä–º–∞–∫–æ–ª–æ–≥, –¥–æ—Ü–µ–Ω—Ç –∫–∞—Ñ–µ–¥—Ä—ã —Ç–µ—Ä–∞–ø–∏–∏, –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–π —Ñ–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏–∏ –∏ —Å–∫–æ—Ä–æ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –§–ì–ë–û–£ –í–û ¬´–†–æ—Å—Å–∏–π—Å–∫–∏–π —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç –º–µ–¥–∏—Ü–∏–Ω—ã¬ª –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–æ—Å—Å–∏–∏ –ì–µ—Ä–º–∞–Ω –ö–Ω–æ—Ä—Ä–∏–Ω–≥ –ø–æ–¥—Ä–æ–±–Ω–æ —Ä–∞–∑–æ–±—Ä–∞–ª —Å—Ç—Ä–∞—Ç–µ–≥–∏—é –∑–∞—â–∏—Ç—ã –æ—Ç –û–†–í–ò –¥–ª—è –≤—Å–µ–π —Å–µ–º—å–∏: –æ—Ç –º–µ—Ä —Å–ø–µ—Ü–∏—Ñ–∏—á–µ—Å–∫–æ–π —Ö–∏–º–∏–æ–ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏, –ø—Ä–æ—Ç–∏–≤–æ–≥—Ä–∏–ø–ø–æ–∑–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –∏ —Å–∏–º–ø—Ç–æ–º–∞—Ç–∏—á–µ—Å–∫–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –¥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –Ω–µ—Å–µ–ª–µ–∫—Ç–∏–≤–Ω–æ–≥–æ –ª–µ—á–µ–Ω–∏—è –ª—é–±–æ–π –û–†–í–ò. –ü—Ä–∏—Å–æ–µ–¥–∏–Ω—è–π—Ç–µ—Å—å –∫ –æ–±—Å—É–∂–¥–µ–Ω–∏—é! –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PnTkL #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–§–∞—Ä–º–∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä–æ–≤–∞–Ω–∏–µ","{""skip"": true}"
2025-10-17T09:17:02+00:00,@medpharm,13147,https://t.me/medpharm/13147,"–¢–µ—á–µ–Ω–∏–µ –∏ –∏—Å—Ö–æ–¥ –û–†–í–ò –∫—Ä–∏—Ç–∏—á–µ—Å–∫–∏ –∑–∞–≤–∏—Å—è—Ç –æ—Ç –Ω—É—Ç—Ä–∏—Ç–∏–≤–Ω–æ–≥–æ —Å—Ç–∞—Ç—É—Å–∞ –∑–∞–±–æ–ª–µ–≤—à–µ–≥–æ. –ò–Ω—Ç–µ–≥—Ä–∞—Ç–∏–≤–Ω—ã–π –≤—Ä–∞—á-–∫–∞—Ä–¥–∏–æ–ª–æ–≥, –¥–∏–µ—Ç–æ–ª–æ–≥ –ò–Ω–Ω–∞ –í–∞–ª—å—Ü —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∞, –∫–∞–∫ –¥–µ—Ñ–∏—Ü–∏—Ç –±–µ–ª–∫–∞ –∏ –∫–ª—é—á–µ–≤—ã—Ö –≤–∏—Ç–∞–º–∏–Ω–æ–≤ (A, C, D) –Ω–∞–ø—Ä—è–º—É—é –≤–ª–∏—è–µ—Ç –Ω–∞ —Å–∏–ª—É –∏–º–º—É–Ω–Ω–æ–≥–æ –æ—Ç–≤–µ—Ç–∞. –í—ã —É–∑–Ω–∞–µ—Ç–µ –æ–± –æ—Å–æ–±–µ–Ω–Ω–æ—Å—Ç—è—Ö —Ä–∞—Ü–∏–æ–Ω–∞ –≤ –æ—Å—Ç—Ä–æ–π —Ñ–∞–∑–µ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è, –æ –≤–∞–∂–Ω–æ—Å—Ç–∏ –ø–∏—Ç—å–µ–≤–æ–≥–æ —Ä–µ–∂–∏–º–∞ –∏ –µ–≥–æ —Å–≤—è–∑–∏ —Å –ø—Ä–æ—Ü–µ—Å—Å–∞–º–∏ –¥–µ—Ç–æ–∫—Å–∏–∫–∞—Ü–∏–∏, –∞ —Ç–∞–∫–∂–µ –æ —Ç–∞–∫—Ç–∏–∫–µ –Ω—É—Ç—Ä–∏—Ç–∏–≤–Ω–æ–π –ø–æ–¥–¥–µ—Ä–∂–∫–∏ –≤ –ø–æ—Å—Ç–∏–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã–π –ø–µ—Ä–∏–æ–¥, –≤–∫–ª—é—á–∞—è –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ —Å–∏–º–±–∏–æ—Ç–∏–∫–æ–≤ –∏ –∞–Ω—Ç–∏–æ–∫—Å–∏–¥–∞–Ω—Ç–æ–≤ –¥–ª—è –ø–æ–ª–Ω–æ–≥–æ –≤–æ—Å—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è. –ü—Ä–∏—Å–æ–µ–¥–∏–Ω—è–π—Ç–µ—Å—å –∫ –æ–±—Å—É–∂–¥–µ–Ω–∏—é! –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PnTkG #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–§–∞—Ä–º–∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä–æ–≤–∞–Ω–∏–µ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety, pharmacovigilance"",
  ""impact"": ""medium"",
  ""english"": ""The severity of the ORVI depends critically on the nutritional status of the patient. Integrative cardiologist and dietitian Inn Vals told how a deficiency in protein and key vitamins (A, C, D) directly impacts the strength of the immune response. You will learn about the features of the diet in the acute phase of the disease, the importance of a drinking regime and its connection with detoxification processes, as well as the tactics for nutritional support in the post-infectious period, including the use of symbiotics and antioxidants to fully restore health. Join the discussion! For more details: https://clck.ru/3PnTkG #PharmNews #PharmConsultation""
}"
2025-10-17T08:45:03+00:00,@medpharm,13146,https://t.me/medpharm/13146,"–ü–æ–∫—É–ø–∞—Ç–µ–ª—å–Ω–∏—Ü—É, –æ—Å–∫–æ—Ä–±–∏–≤—à—É—é –ø–æ —Ç–µ–ª–µ—Ñ–æ–Ω—É —Å–æ—Ç—Ä—É–¥–Ω–∏—Ü—É ¬´–ê–º—É—Ä—Ñ–∞—Ä–º–∞—Ü–∏–∏¬ª, –æ—à—Ç—Ä–∞—Ñ–æ–≤–∞–ª–∏ –Ω–∞ 3 —Ç—ã—Å. —Ä—É–±. –ü—Ä–∏ –æ—Ñ–æ—Ä–º–ª–µ–Ω–∏–∏ –∑–∞–∫–∞–∑–∞ –∏–∑ –∞–ø—Ç–µ–∫–∏ –≤–æ–∑–Ω–∏–∫ —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–∏–π —Å–±–æ–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PnR7S #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–û–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ","{""skip"": true}"
2025-10-17T08:43:05+00:00,@medpharm,13145,https://t.me/medpharm/13145,"–†–µ–≥—É–ª—è—Ç–æ—Ä —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –ø—Ä–æ–µ–∫—Ç –ø–æ—Ä—è–¥–∫–∞ –Ω–∞–∑–Ω–∞—á–µ–Ω–∏—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º–∏ —Ä–∞–±–æ—Ç–Ω–∏–∫–∞–º–∏ –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏ –∞–∫—Ç–∏–≤–Ω—ã—Ö –¥–æ–±–∞–≤–æ–∫. –ù–∞–∑–Ω–∞—á–∞—Ç—å –º–æ–∂–Ω–æ –±—É–¥–µ—Ç –ë–ê–î —Ç–æ–ª—å–∫–æ –∏–∑ —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ–≥–æ –ø–µ—Ä–µ—á–Ω—è, –æ–±–æ—Å–Ω–æ–≤–∞–≤ –≤ –¥–æ–∫—É–º–µ–Ω—Ç–∞—Ü–∏–∏ –ø–∞—Ü–∏–µ–Ω—Ç–∞ –ø–æ–∫–∞–∑–∞–Ω–∏—è –∫ –∏—Ö –ø—Ä–∏–µ–º—É. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PnQwa #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The regulator developed a project on the medical staff's prescription of biologically active additives. Prescriptions can only be made from a special list, justified in the documentation with patient indications. For more details: https://clck.ru/3PnQwa #MedVestnik #Healthcare #HealthOrganization""
}"
2025-10-17T07:51:05+00:00,@medpharm,13144,https://t.me/medpharm/13144,"–ö–æ—Ä–æ–Ω–∞—Ä–Ω—ã–µ —Å—Ç–µ–Ω—Ç—ã –∏ –±–∞–ª–ª–æ–Ω–Ω—ã–µ –∫–∞—Ç–µ—Ç–µ—Ä—ã –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–æ –≤–∫–ª—é—á–∏—Ç—å –≤ –ø–µ—Ä–µ—á–µ–Ω—å –º–µ–¥–∏–∑–¥–µ–ª–∏–π, –∑–∞–∫—É–ø–∫–∞ –∫–æ—Ç–æ—Ä—ã—Ö –¥–ª—è –≥–æ—Å–Ω—É–∂–¥ –≤ –†–æ—Å—Å–∏–∏ –±—É–¥–µ—Ç –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∞. –ò–Ω–∏—Ü–∏–∞—Ç–∏–≤–∞ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∞ –Ω–∞ –ø–æ–¥–¥–µ—Ä–∂–∫—É –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –∏ —Å–Ω–∏–∂–µ–Ω–∏–µ –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏ –æ—Ç –∏–º–ø–æ—Ä—Ç–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PnLwN #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The coronary stents and balloon catheters are proposed to be included in the list of medical devices whose procurement for government needs in Russia will be limited. The initiative aims to support domestic manufacturers and reduce dependence on imports.""
}"
2025-10-17T07:50:03+00:00,@medpharm,13143,https://t.me/medpharm/13143,"–¶–µ–Ω—Ç—Ä –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –ø—Ä–æ–≤–æ–¥–∏—Ç –ø—Ä–∏–µ–º –∑–∞—è–≤–æ–∫ –Ω–∞ —É—á–∞—Å—Ç–∏–µ –≤ –∞—É–∫—Ü–∏–æ–Ω–∞—Ö –Ω–∞ –ø–æ—Å—Ç–∞–≤–∫—É –¥–ª—è ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤–µ–Ω–µ—Ç–æ–∫–ª–∞–∫—Å –∏ –≤–æ—Ä–µ—Ç–∏–≥–µ–Ω –Ω–µ–ø–∞—Ä–≤–æ–≤–µ–∫, –Ω–µ—Å–∫–æ–ª—å–∫–æ –∞—É–∫—Ü–∏–æ–Ω–æ–≤ –Ω–∞ –ø–æ—Å—Ç–∞–≤–∫—É –∫–æ—Ç–æ—Ä–æ–≥–æ –Ω–µ —Å–æ—Å—Ç–æ—è–ª–æ—Å—å –∏–∑-–∑–∞ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏—è –∑–∞—è–≤–æ–∫ –Ω–∞ —É—á–∞—Å—Ç–∏–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PnLs9 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The pharmaceutical distribution center is conducting applications for participation in tenders to supply enoxaparin and rivaroxaban for the 'Good Circle' program. Several tenders were not successful due to a lack of applications for participation.""
}"
2025-10-17T05:15:06+00:00,@medpharm,13142,https://t.me/medpharm/13142,"–î–µ—Ç–∏, –º–∞—Ç–µ—Ä–∏ –∫–æ—Ç–æ—Ä—ã—Ö –ø–æ–ª—É—á–∞–ª–∏ –∫–æ—Ä—Ç–∏–∫–æ—Å—Ç–µ—Ä–æ–∏–¥—ã –≤–æ –≤—Ä–µ–º—è –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏, —á–∞—â–µ —Å—Ç–∞–ª–∫–∏–≤–∞–ª–∏—Å—å —Å —Ä–µ—Å–ø–∏—Ä–∞—Ç–æ—Ä–Ω—ã–º–∏ –∏ –Ω–µ—Ä–µ—Å–ø–∏—Ä–∞—Ç–æ—Ä–Ω—ã–º–∏ –∏–Ω—Ñ–µ–∫—Ü–∏—è–º–∏ –≤ –¥–µ—Ç—Å—Ç–≤–µ –∏ —é–Ω–æ—Å—Ç–∏. –ü—Ä–∏ —ç—Ç–æ–º —É –Ω–µ–¥–æ–Ω–æ—à–µ–Ω–Ω—ã—Ö –¥–µ—Ç–µ–π, —Ä–æ–¥–∏–≤—à–∏—Ö—Å—è –¥–æ 34 –Ω–µ–¥–µ–ª—å, —Ç–∞–∫–æ–π —Å–≤—è–∑–∏ –Ω–µ –Ω–∞–±–ª—é–¥–∞–ª–æ—Å—å. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PnBQy #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ê–∫—É—à–µ—Ä—Å—Ç–≤–æ_–∏_–≥–∏–Ω–µ–∫–æ–ª–æ–≥–∏—è #–ò–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã–µ_–±–æ–ª–µ–∑–Ω–∏ #–ü–µ–¥–∏–∞—Ç—Ä–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""Children born to mothers who received corticosteroids during pregnancy were more frequently affected by respiratory and non-respiratory infections in childhood and adolescence. No such association was observed for underweight infants born before 34 weeks of gestation. For more details: https://clck.ru/3PnBQy #MedVestnik #Practice #Obstetrics_and_Gynecology #Infectious_diseases #Pediatrics #Therapy #Pharmacology""
}"
2025-10-16T16:37:01+00:00,@medpharm,13141,https://t.me/medpharm/13141,"ü¶æ –ü–ª–∞–Ω –Ω–∞ –≥–æ–¥. –í –ø—Ä–æ–µ–∫—Ç–µ –ü—Ä–æ–≥—Ä–∞–º–º—ã –≥–æ—Å–≥–∞—Ä–∞–Ω—Ç–∏–π –Ω–∞ 2026 –≥–æ–¥ –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è –∑–∞–∫—Ä–µ–ø–∏—Ç—å —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–µ –æ –¥–æ–ª–µ –≤ 50% –¥–ª—è –æ–∫–ª–∞–¥–Ω–æ–π —á–∞—Å—Ç–∏ –∑–∞—Ä–ø–ª–∞—Ç—ã –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤. –¢–∞–∫–∂–µ —Ä–∞—Å—à–∏—Ä–µ–Ω—ã –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ –¥–∏—Å–ø–∞–Ω—Å–µ—Ä–∏–∑–∞—Ü–∏–∏ –¥–ª—è –∂–µ–Ω—â–∏–Ω, –º–∞–ª–æ–º–æ–±–∏–ª—å–Ω—ã—Ö –≥—Ä–∞–∂–¥–∞–Ω –∏ –∏–Ω–≤–∞–ª–∏–¥–æ–≤, —É—Ç–æ—á–Ω–µ–Ω –ø–æ—Ä—è–¥–æ–∫ –æ–∫–∞–∑–∞–Ω–∏—è –ø–æ–º–æ—â–∏ —É—á–∞—Å—Ç–Ω–∏–∫–∞–º –°–í–û –∏ —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω—ã –Ω–æ–≤—ã–µ –Ω–æ—Ä–º–∞—Ç–∏–≤—ã –æ–±—ä–µ–º–∞ –º–µ–¥–ø–æ–º–æ—â–∏ –∏ —Ñ–∏–Ω–∞–Ω—Å–æ–≤—ã—Ö –∑–∞—Ç—Ä–∞—Ç. ü¶æ –õ–∏—à–∞—é—Ç –ø—Ä–µ—Ñ–µ—Ä–µ–Ω—Ü–∏–π. –ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–∞—è –∞—Å—Å–æ—Ü–∏–∞—Ü–∏—è —É–ø—Ä–∞–≤–ª–µ–Ω—Ü–µ–≤ —Å—Ñ–µ—Ä—ã –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –Ω–∞–ø—Ä–∞–≤–∏–ª–∞ –æ–±—Ä–∞—â–µ–Ω–∏–µ –≤ –ì–æ—Å–¥—É–º—É –†–§ —Å –ø—Ä–æ—Å—å–±–æ–π —Å–æ—Ö—Ä–∞–Ω–∏—Ç—å –ª—å–≥–æ—Ç–Ω—ã–π —Ä–µ–∂–∏–º —É–ø–ª–∞—Ç—ã —Å—Ç—Ä–∞—Ö–æ–≤—ã—Ö –≤–∑–Ω–æ—Å–æ–≤ –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π. –í –ø—Ä–æ–µ–∫—Ç–µ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –±—é–¥–∂–µ—Ç–∞ –Ω–∞ 2026 –≥–æ–¥ —Ç–∞–∫–∏–µ –ø—Ä–µ—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ –ø—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ–Ω—ã –¥–ª—è —Ä—è–¥–∞ –∫–ª—é—á–µ–≤—ã—Ö –Ω–µ—Å—ã—Ä—å–µ–≤—ã—Ö —Å–µ–∫—Ç–æ—Ä–æ–≤ —ç–∫–æ–Ω–æ–º–∏–∫–∏, –Ω–æ —á–∞—Å—Ç–Ω—ã—Ö –∫–ª–∏–Ω–∏–∫ –≤ —ç—Ç–æ–º –ø–µ—Ä–µ—á–Ω–µ –Ω–µ—Ç. ‚ù§Ô∏è –í—Å–µ –≤ ¬´–°–µ–º—å—é¬ª. –ó–∞–∫—É–ø–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –º–µ–¥–∏–∑–¥–µ–ª–∏–π –¥–ª—è –Ω–∞—Ü–ø—Ä–æ–µ–∫—Ç–æ–≤ ¬´–ü—Ä–æ–¥–æ–ª–∂–∏—Ç–µ–ª—å–Ω–∞—è –∏ –∞–∫—Ç–∏–≤–Ω–∞—è –∂–∏–∑–Ω—å¬ª –∏ ¬´–°–µ–º—å—è¬ª –±—É–¥—É—Ç —Ü–µ–Ω—Ç—Ä–∞–ª–∏–∑–æ–≤–∞–Ω—ã —á–µ—Ä–µ–∑ –§–µ–¥–µ—Ä–∞–ª—å–Ω—ã–π —Ü–µ–Ω—Ç—Ä –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–æ—Å—Å–∏–∏. –í —Å–ø–∏—Å–æ–∫ –≤–æ—à–ª–∏ 36 –≤–∏–¥–æ–≤ –º–µ–¥—Ç–µ—Ö–Ω–∏–∫–∏, –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–ª—è –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –∏ –ª–µ—á–µ–Ω–∏—è –≥–µ–ø–∞—Ç–∏—Ç–∞ –°. ‚ù§Ô∏è –ù–µ–≤–µ—Ä–æ—è—Ç–Ω—ã–µ –∏—Å–∫–ª—é—á–µ–Ω–∏—è. –ò–∑ –ì–†–õ–° –∏—Å–∫–ª—é—á–∏–ª–∏ –†–£ 12 –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤. –°—Ä–µ–¥–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ ‚Äî —Ä–∏—Å–¥–∏–ø–ª–∞–º –æ—Ç –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–î–∂–æ–¥–∞—Å –≠–∫—Å–ø–æ–∏–º¬ª –∏ –Ω–µ –∏–º–µ—é—â–∏–π –∞–Ω–∞–ª–æ–≥–æ–≤ –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º —Ä—ã–Ω–∫–µ –∫–æ–º–±–∏–Ω–∏—Ä–æ–≤–∞–Ω–Ω—ã–π –∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫ ¬´–î–∂–æ—Ä–µ–ª–∏–º–ø–∞¬ª —Ç–æ–≥–æ –∂–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, clinical_trial, safety, pharmacovigilance"",
  ""impact"": ""high"",
  ""english"": ""The country is facing a significant policy change regarding the percentage of salary for healthcare workers. The national association has requested to maintain tax concessions for private clinics, which are not included in the federal budget. The procurement of medical supplies and equipment for national projects 'Longevity and Activity' and 'Family' will be centralized through the Federal Center of the Ministry of Health. The list includes 36 types of medical equipment, drugs for preventing cardiovascular diseases and hepatitis C treatment. The country is also considering excluding 12 medicines from the Generic Reference List System, including drugs from 'Djodas Expoim' company.""
}"
2025-10-16T15:59:02+00:00,@medpharm,13140,https://t.me/medpharm/13140,–≠–∫—Å–ø–µ—Ä—Ç–Ω—ã–π —Å–æ–≤–µ—Ç ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª —É—Ç–≤–µ—Ä–¥–∏–ª –¥–ª—è –≤–∫–ª—é—á–µ–Ω–∏—è –≤ –ø–µ—Ä–µ—á–µ–Ω—å –¥–ª—è –∑–∞–∫—É–ø–∫–∏ –ª—É—Å–ø–∞—Ç–µ—Ä—Ü–µ–ø—Ç –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ –±–µ—Ç–∞-—Ç–∞–ª–∞—Å—Å–µ–º–∏–∏. –í —Å–ª—É—á–∞–µ —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏—è —Ä–µ—à–µ–Ω–∏—è –ø–æ–ø–µ—á–∏—Ç–µ–ª—å—Å–∫–∏–º —Å–æ–≤–µ—Ç–æ–º —Ç–µ—Ä–∞–ø–∏—é –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–º —Å–º–æ–≥—É—Ç –ø–æ–ª—É—á–∞—Ç—å –æ–∫–æ–ª–æ –¥–µ—Å—è—Ç–∏ –ø–æ–¥–æ–ø–µ—á–Ω—ã—Ö ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª –≤ –≥–æ–¥. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pms4k #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The Expert Council 'Circle of Good' approved luspatercept for inclusion in the procurement list to treat beta-thalassaemia. If the decision is approved by the supervisory board, up to ten patients of 'Circle of Good' can receive the therapy each year. More details: https://clck.ru/3Pms4k #PharmNews #Regulation""
}"
2025-10-16T15:29:06+00:00,@medpharm,13139,https://t.me/medpharm/13139,"–ë–∞–Ω–∫ ¬´–î–æ–º. —Ä—Ñ¬ª –æ–¥–æ–±—Ä–∏–ª –∫—Ä–µ–¥–∏—Ç –≤ 6,4 –º–ª—Ä–¥ —Ä—É–±. –ì–ö ¬´–ú–µ–¥–ò–Ω–≤–µ—Å—Ç–ì—Ä—É–ø–ø¬ª –Ω–∞ –¥–æ—Å—Ç—Ä–æ–π–∫—É –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ —Ü–µ–Ω—Ç—Ä–∞ –≤ –ü–µ—Ä–º–∏. –§–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏–µ –ø–æ–∑–≤–æ–ª–∏—Ç —É—Å–∫–æ—Ä–∏—Ç—å –∑–∞–≤–µ—Ä—à–µ–Ω–∏–µ –æ–±—ä–µ–∫—Ç–∞ –∏ –≤–≤–µ—Å—Ç–∏ –µ–≥–æ –≤ —Å—Ç—Ä–æ–π –≤ 2027 –≥–æ–¥—É. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pmqga #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û–Ω–∫–æ–ª–æ–≥–∏—è #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-10-16T15:25:03+00:00,@medpharm,13138,https://t.me/medpharm/13138,J&J –æ–±—ä—è–≤–∏–ª–∞ –æ –ø–ª–∞–Ω–∞—Ö –≤—ã–¥–µ–ª–∏—Ç—å –æ—Ä—Ç–æ–ø–µ–¥–∏—á–µ—Å–∫–æ–µ –ø–æ–¥—Ä–∞–∑–¥–µ–ª–µ–Ω–∏–µ –≤ –æ—Ç–¥–µ–ª—å–Ω—É—é –∫–æ–º–ø–∞–Ω–∏—é DePuy Synthes –¥–æ 2027 –≥–æ–¥–∞. –¢–∞–∫–∂–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å –æ—Ç—á–∏—Ç–∞–ª—Å—è –ø–æ —Ñ–∏–Ω–∞–Ω—Å–æ–≤—ã–º —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º III –∫–≤–∞—Ä—Ç–∞–ª–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PmqGC #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-10-16T14:44:05+00:00,@medpharm,13137,https://t.me/medpharm/13137,"–í –ø—Ä–æ–µ–∫—Ç–µ –ü—Ä–æ–≥—Ä–∞–º–º—ã –≥–æ—Å–≥–∞—Ä–∞–Ω—Ç–∏–π –Ω–∞ 2026 –≥–æ–¥ –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è –∑–∞–∫—Ä–µ–ø–∏—Ç—å —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–µ –æ –¥–æ–ª–µ –≤ 50% –¥–ª—è –æ–∫–ª–∞–¥–Ω–æ–π —á–∞—Å—Ç–∏ –∑–∞—Ä–ø–ª–∞—Ç—ã –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤. –¢–∞–∫–∂–µ —Ä–∞—Å—à–∏—Ä–µ–Ω—ã –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ –¥–∏—Å–ø–∞–Ω—Å–µ—Ä–∏–∑–∞—Ü–∏–∏ –¥–ª—è –∂–µ–Ω—â–∏–Ω, –º–∞–ª–æ–º–æ–±–∏–ª—å–Ω—ã—Ö –≥—Ä–∞–∂–¥–∞–Ω –∏ –∏–Ω–≤–∞–ª–∏–¥–æ–≤, —É—Ç–æ—á–Ω–µ–Ω –ø–æ—Ä—è–¥–æ–∫ –æ–∫–∞–∑–∞–Ω–∏—è –ø–æ–º–æ—â–∏ —É—á–∞—Å—Ç–Ω–∏–∫–∞–º –°–í–û –∏ —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω—ã –Ω–æ–≤—ã–µ –Ω–æ—Ä–º–∞—Ç–∏–≤—ã –æ–±—ä–µ–º–∞ –º–µ–¥–ø–æ–º–æ—â–∏ –∏ —Ñ–∏–Ω–∞–Ω—Å–æ–≤—ã—Ö –∑–∞—Ç—Ä–∞—Ç. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pmneo #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, reimbursement, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The proposal for the 2026 State Guarantees program includes a requirement of 50% share for the salary portion for healthcare workers. The program also expands disability screening opportunities for women, disabled individuals, and participants of the Special Voluntary Organizations (SVOs), clarifies assistance procedures for SVO participants, and sets new standards for the volume of medical care and financial expenditures.""
}"
2025-10-16T14:17:07+00:00,@medpharm,13136,https://t.me/medpharm/13136,"–†–æ—Å—Å–∏—è –æ–∫–æ–Ω—á–∞—Ç–µ–ª—å–Ω–æ –ø—Ä–µ–æ–¥–æ–ª–µ–ª–∞ –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç—å –æ—Ç –∏–º–ø–æ—Ä—Ç–Ω–æ–≥–æ —Ä–µ–∞–Ω–∏–º–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è, –∑–∞—è–≤–∏–ª –ø—Ä–æ—Ñ–µ—Å—Å–æ—Ä –¢–µ–ø–ª–æ–≤. –û—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–µ –∫–æ–º–ø–∞–Ω–∏–∏ –∏ –Ω–∞—É—á–Ω—ã–µ –∏–Ω—Å—Ç–∏—Ç—É—Ç—ã —Å–æ–≤–º–µ—Å—Ç–Ω–æ —Å–æ–∑–¥–∞—é—Ç —É–Ω–∏–∫–∞–ª—å–Ω—ã–µ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ ‚Äî –æ—Ç –¥–µ—Ñ–∏–±—Ä–∏–ª–ª—è—Ç–æ—Ä–æ–≤ –∏ –∞–ø–ø–∞—Ä–∞—Ç–æ–≤ –ò–í–õ –¥–æ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ —É—Å—Ç—Ä–æ–π—Å—Ç–≤–∞ –¥–ª—è —Å–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –¥–æ–Ω–æ—Ä—Å–∫–æ–π –ø–µ—á–µ–Ω–∏ –º–∏—Ä–æ–≤–æ–≥–æ —É—Ä–æ–≤–Ω—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pmm24 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""clinical_trial,hospital_policy,pharmacovigilance,safety"",
  ""impact"": ""medium"",
  ""english"": ""Professor –¢–µ–ø–ª–æ–≤ announced that Russia has overcome dependence on imported resuscitation equipment. Domestic companies and scientific institutions are jointly developing unique innovations, including defibrillators, ventilators, and an innovative device for preserving donor liver at world level. For more details: https://clck.ru/3Pmm24 #MedVestnik #Healthcare #Other""
}"
2025-10-16T14:17:02+00:00,@medpharm,13135,https://t.me/medpharm/13135,–ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª —Ç–∏–ø–æ–≤—É—é –ø—Ä–æ–≥—Ä–∞–º–º—É –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–π –ø–æ–¥–≥–æ—Ç–æ–≤–∫–∏ –ø–æ —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–∏ ¬´–ö–ª–∏–Ω–∏—á–µ—Å–∫–∞—è —Ñ–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è¬ª. –ó–∞ 648 –∞–∫–∞–¥–µ–º–∏—á–µ—Å–∫–∏—Ö —á–∞—Å–æ–≤ –Ω—É–∂–Ω–æ –±—É–¥–µ—Ç –æ—Å–≤–æ–∏—Ç—å —Å–µ–º—å –∫–ª—é—á–µ–≤—ã—Ö –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—ã—Ö –∫–æ–º–ø–µ—Ç–µ–Ω—Ü–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pmm25 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–∞—Ä—å–µ—Ä–∞,"{""skip"": true}"
2025-10-16T13:32:03+00:00,@medpharm,13134,https://t.me/medpharm/13134,"Novo Nordisk –∑–∞–∫–ª—é—á–∏–ª–∞ —Å–¥–µ–ª–∫—É –Ω–∞ 2,1 –º–ª—Ä–¥ –¥–æ–ª–ª. —Å Omeros, –ø–æ–ª—É—á–∏–≤ –ø—Ä–∞–≤–∞ –Ω–∞ zaltenibart ‚Äî –ø—Ä–µ–ø–∞—Ä–∞—Ç –æ—Ç –ø–∞—Ä–æ–∫—Å–∏–∑–º–∞–ª—å–Ω–æ–π –Ω–æ—á–Ω–æ–π –≥–µ–º–æ–≥–ª–æ–±–∏–Ω—É—Ä–∏–∏. –≠—Ç–æ –≤—Ç–æ—Ä–∞—è –∫—Ä—É–ø–Ω–∞—è –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏—è –¥–∞—Ç—Å–∫–æ–≥–æ —Ñ–∞—Ä–º–≥–∏–≥–∞–Ω—Ç–∞ –≤ –æ–∫—Ç—è–±—Ä–µ –∏ —á–∞—Å—Ç—å —Å—Ç—Ä–∞—Ç–µ–≥–∏–∏ –Ω–æ–≤–æ–≥–æ –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä–∞, –≤–∑—è–≤—à–µ–≥–æ –∫—É—Ä—Å –Ω–∞ –¥–∏–≤–µ—Ä—Å–∏—Ñ–∏–∫–∞—Ü–∏—é –±–∏–∑–Ω–µ—Å–∞ –∑–∞ –ø—Ä–µ–¥–µ–ª—ã –ª–µ–∫–∞—Ä—Å—Ç–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –æ–∂–∏—Ä–µ–Ω–∏—è –∏ –¥–∏–∞–±–µ—Ç–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pmhnn #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-16T12:49:04+00:00,@medpharm,13132,https://t.me/medpharm/13132,"–ó–∞–∫—É–ø–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –º–µ–¥–∏–∑–¥–µ–ª–∏–π –¥–ª—è –Ω–∞—Ü–ø—Ä–æ–µ–∫—Ç–æ–≤ ¬´–ü—Ä–æ–¥–æ–ª–∂–∏—Ç–µ–ª—å–Ω–∞—è –∏ –∞–∫—Ç–∏–≤–Ω–∞—è –∂–∏–∑–Ω—å¬ª –∏ ¬´–°–µ–º—å—è¬ª –±—É–¥—É—Ç —Ü–µ–Ω—Ç—Ä–∞–ª–∏–∑–æ–≤–∞–Ω—ã —á–µ—Ä–µ–∑ –§–µ–¥–µ—Ä–∞–ª—å–Ω—ã–π —Ü–µ–Ω—Ç—Ä –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–æ—Å—Å–∏–∏. –í —Å–ø–∏—Å–æ–∫ –≤–æ—à–ª–∏ 36 –≤–∏–¥–æ–≤ –º–µ–¥—Ç–µ—Ö–Ω–∏–∫–∏, –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–ª—è –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –∏ –ª–µ—á–µ–Ω–∏—è –≥–µ–ø–∞—Ç–∏—Ç–∞ –°. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PmesV #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""Procurement of medical equipment and supplies for the long-term and active life project and the family project will be centralized through the Federal Center of the Ministry of Health. The list includes 36 types of medical equipment and drugs for the prevention of cardiovascular diseases and treatment of hepatitis C. More details: https://clck.ru/3PmesV #PharmNews #Regulation""
}"
2025-10-16T12:19:10+00:00,@medpharm,13131,https://t.me/medpharm/13131,–ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–∞—è –∞—Å—Å–æ—Ü–∏–∞—Ü–∏—è —É–ø—Ä–∞–≤–ª–µ–Ω—Ü–µ–≤ —Å—Ñ–µ—Ä—ã –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –Ω–∞–ø—Ä–∞–≤–∏–ª–∞ –æ–±—Ä–∞—â–µ–Ω–∏–µ –≤ –ì–æ—Å–¥—É–º—É –†–§ —Å –ø—Ä–æ—Å—å–±–æ–π —Å–æ—Ö—Ä–∞–Ω–∏—Ç—å –ª—å–≥–æ—Ç–Ω—ã–π —Ä–µ–∂–∏–º —É–ø–ª–∞—Ç—ã —Å—Ç—Ä–∞—Ö–æ–≤—ã—Ö –≤–∑–Ω–æ—Å–æ–≤ –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π. –í –ø—Ä–æ–µ–∫—Ç–µ –±—é–¥–∂–µ—Ç–∞ –Ω–∞ 2026 –≥–æ–¥ —Ç–∞–∫–∏–µ –ª—å–≥–æ—Ç—ã –ø—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ–Ω—ã –¥–ª—è —Ä—è–¥–∞ –∫–ª—é—á–µ–≤—ã—Ö –Ω–µ—Å—ã—Ä—å–µ–≤—ã—Ö —Å–µ–∫—Ç–æ—Ä–æ–≤ —ç–∫–æ–Ω–æ–º–∏–∫–∏. –ß–∞—Å—Ç–Ω—ã—Ö –∫–ª–∏–Ω–∏–∫ –≤ —ç—Ç–æ–º –ø–µ—Ä–µ—á–Ω–µ –Ω–µ—Ç. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pmcfj #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""reimbursement, regulation"",
  ""impact"": ""medium"",
  ""english"": ""The National Association of Healthcare Administrators has submitted a request to the Russian Duma for maintaining a concessional payment regime for healthcare organizations. The budget proposal for 2026 includes such concessions for key non-resource sectors of the economy. Private clinics are not included in this list. For more details: https://clck.ru/3Pmcfj #MedVestnik #Healthcare""
}"
2025-10-16T11:37:04+00:00,@medpharm,13130,https://t.me/medpharm/13130,–ò–∑ –ì–†–õ–° –∏—Å–∫–ª—é—á–∏–ª–∏ –†–£ 12 –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤. –°—Ä–µ–¥–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ ‚Äî —Ä–∏—Å–¥–∏–ø–ª–∞–º –æ—Ç –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–î–∂–æ–¥–∞—Å –≠–∫—Å–ø–æ–∏–º¬ª –∏ –Ω–µ –∏–º–µ—é—â–∏–π –∞–Ω–∞–ª–æ–≥–æ–≤ –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º —Ä—ã–Ω–∫–µ –∫–æ–º–±–∏–Ω–∏—Ä–æ–≤–∞–Ω–Ω—ã–π –∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫ ¬´–î–∂–æ—Ä–µ–ª–∏–º–ø–∞¬ª —Ç–æ–≥–æ –∂–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PmZZ8 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""high"",
  ""english"": ""The GRSL has excluded 12 medicinal products from the list. Among them are risduplam from the 'Jodas Expoim' company and a unique combination antibiotic 'Jorelimpa' of the same manufacturer on the Russian market. More: https://clck.ru/3PmZZ8 #Pharmavestnik #Regulatorka""
}"
2025-10-16T11:14:05+00:00,@medpharm,13129,https://t.me/medpharm/13129,"–°–ª–µ–¥—Å—Ç–≤–µ–Ω–Ω—ã–π –∫–æ–º–∏—Ç–µ—Ç –≤–æ–∑–±—É–¥–∏–ª —É–≥–æ–ª–æ–≤–Ω–æ–µ –¥–µ–ª–æ –ø—Ä–æ—Ç–∏–≤ –≤—Ä–∞—á–∞ —á–∞—Å—Ç–Ω–æ–π –∫–ª–∏–Ω–∏–∫–∏ –≤ –ï—Å—Å–µ–Ω—Ç—É–∫–∞—Ö, –ª–µ—á–∏–≤—à–µ–π –æ–Ω–∫–æ–±–æ–ª—å–Ω–æ–≥–æ —Ñ–æ—Ç–æ—Ç–µ—Ä–∞–ø–∏–µ–π –≤–º–µ—Å—Ç–æ —Ö–∏–º–∏–æ—Ç–µ—Ä–∞–ø–∏–∏. –†–æ–¥—Å—Ç–≤–µ–Ω–Ω–∏–∫–∏ –∑–∞—è–≤–ª—è—é—Ç, —á—Ç–æ –µ–≥–æ –æ–±–º–∞–Ω—É–ª–∏, –∞ –≤—Ä–∞—á —É—Ç–≤–µ—Ä–∂–¥–∞–µ—Ç ‚Äî –ø–∞—Ü–∏–µ–Ω—Ç –ø–æ–ª—É—á–∏–ª –ø–∞–ª–ª–∏–∞—Ç–∏–≤–Ω—É—é –ø–æ–º–æ—â—å. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PmXh7 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-10-16T10:15:03+00:00,@medpharm,13128,https://t.me/medpharm/13128,"–§–ê–° –†–æ—Å—Å–∏–∏ —Å–æ–≥–ª–∞—Å–æ–≤–∞–ª–∞ —Ü–µ–Ω—É –Ω–∞ –ø–µ—Ä–≤—ã–π –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π –¥–∂–µ–Ω–µ—Ä–∏–∫ ¬´–î–∞–∫–ª–∞—Ç–∞—Å–≤–∏—Ä-–ê–õ–í–ò–õ–°¬ª (–¥–∞–∫–ª–∞—Ç–∞—Å–≤–∏—Ä) –ø—Ä–æ—Ç–∏–≤ –≤–∏—Ä—É—Å–∞ –≥–µ–ø–∞—Ç–∏—Ç–∞ –°. –°—Ç–æ–∏–º–æ—Å—Ç—å —É–ø–∞–∫–æ–≤–∫–∏ –±—É–¥–µ—Ç –Ω–∞ 28,91% –¥–µ—à–µ–≤–ª–µ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω–æ–≥–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ ¬´–î–∞–∫–ª–∏–Ω–∑–∞¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PmTRA #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""pricing"",
  ""impact"": ""medium"",
  ""english"": ""The FAS of Russia has approved the price for the first domestic generic 'Daclatasvir-ALVILS' (daklatasvir) against the hepatitis C virus. The package price will be 28.91% cheaper than the original drug 'Daclizumab'.""
}"
2025-10-16T10:13:06+00:00,@medpharm,13127,https://t.me/medpharm/13127,"–°—Ç–æ–∏–º–æ—Å—Ç—å –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —É—Å–ª—É–≥ –≤ –†–æ—Å—Å–∏–∏ –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç —Ä–∞—Å—Ç–∏ –Ω–∞ —Ñ–æ–Ω–µ –∏–Ω—Ñ–ª—è—Ü–∏–∏. –ü–æ –¥–∞–Ω–Ω—ã–º –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è Mains Lab, –≤ —Å—Ä–µ–¥–Ω–µ–º —Ü–µ–Ω—ã –≤ –º–µ–¥–∫–ª–∏–Ω–∏–∫–∞—Ö –≤—ã—Ä–æ—Å–ª–∏ –∑–∞ –ø–æ–ª–≥–æ–¥–∞ –Ω–∞ 15%. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PmTFT #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-10-16T09:15:06+00:00,@medpharm,13126,https://t.me/medpharm/13126,"–î–µ–ø—É—Ç–∞—Ç –ì–æ—Å–¥—É–º—ã –†–§ –ø–æ–ø—Ä–æ—Å–∏–ª —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã–π –ú–∏–Ω–∑–¥—Ä–∞–≤ –∏ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä –ø—Ä–æ–≤–µ—Ä–∏—Ç—å –†–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã–π –ø–µ—Ä–∏–Ω–∞—Ç–∞–ª—å–Ω—ã–π —Ü–µ–Ω—Ç—Ä –ö–∞–ª–∏–Ω–∏–Ω–≥—Ä–∞–¥–∞ –∏–∑-–∑–∞ —á–µ—Ä–µ–¥—ã —Ä–µ–∑–æ–Ω–∞–Ω—Å–Ω—ã—Ö —Å–ª—É—á–∞–µ–≤ –≥–∏–±–µ–ª–∏ –∏ —Ç—Ä–∞–≤–º–∏—Ä–æ–≤–∞–Ω–∏—è –Ω–æ–≤–æ—Ä–æ–∂–¥–µ–Ω–Ω—ã—Ö –ø—Ä–∏ —Ä–æ–¥–∞—Ö. –í–µ–¥–æ–º—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø—Ä–æ–≤–µ—Ä–∫–∏, –ø–æ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ —á–∏–Ω–æ–≤–Ω–∏–∫–æ–≤, –Ω–∞—Ä—É—à–µ–Ω–∏–π –Ω–µ –≤—ã—è–≤–∏–ª–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PmP4T #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–ê–∫—É—à–µ—Ä—Å—Ç–≤–æ_–∏_–≥–∏–Ω–µ–∫–æ–ª–æ–≥–∏—è #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""clinical_trial, safety"",
  ""impact"": ""medium"",
  ""english"": ""A representative of the State Duma in Russia asked the Federal Ministry of Health and Roszdravnadzor to investigate a Regional Perinatal Center in Kaliningrad for several controversial cases of newborn deaths and injuries during childbirth. Duma representatives claim that no violations were found in the inspections conducted by government agencies.""
}"
2025-10-16T08:55:03+00:00,@medpharm,13125,https://t.me/medpharm/13125,"–†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä –ø–æ –í–æ–ª–≥–æ–≥—Ä–∞–¥—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –ø–æ—Ç—Ä–µ–±–æ–≤–∞–ª –∑–∞–∫—Ä—ã—Ç—å –Ω–∞ 90 —Å—É—Ç–æ–∫ –∞–ø—Ç–µ–∫—É ¬´–ì–∞–º–º–∞¬ª –∑–∞ –æ—Ç–ø—É—Å–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –ø–æ–¥–ª–µ–∂–∞—â–∏—Ö –ü–ö–£, –±–µ–∑ —Ä–µ—Ü–µ–ø—Ç–æ–≤ –∏–ª–∏ —Å –Ω–∞—Ä—É—à–µ–Ω–∏—è–º–∏ –≤ –Ω–∏—Ö. –†–∞–Ω–µ–µ –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç—å –∞–ø—Ç–µ–∫–∏ —É–∂–µ –ø—Ä–∏–æ—Å—Ç–∞–Ω–∞–≤–ª–∏–≤–∞–ª–∏ –Ω–∞ 45 —Å—É—Ç–æ–∫. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PmMaS #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""tenders, import_export, shortage"",
  ""impact"": ""high"",
  ""english"": ""The Roszdranad–∑–æ—Ä of Volgograd Oblast has demanded that the pharmacy 'Gamma' be closed for 90 days due to illegal dispensing of drugs requiring a prescription or with violations. The pharmacy's operations were already suspended for 45 days previously. For more details: https://clck.ru/3PmMaS #PharmVestnik #Retail""
}"
2025-10-16T08:15:03+00:00,@medpharm,13124,https://t.me/medpharm/13124,–ì–ª–∞–≤–∞ –ö–∞–º—á–∞—Ç–∫–∏ –Ω–µ —Å–º–æ–≥ –∑–∞–ø–∏—Å–∞—Ç—å—Å—è –∫ —Ç–µ—Ä–∞–ø–µ–≤—Ç—É –∏ —Ä–∞—Å–∫—Ä–∏—Ç–∏–∫–æ–≤–∞–ª —Ä–∞–±–æ—Ç—É —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞. –û–Ω –ø–æ—Ç—Ä–µ–±–æ–≤–∞–ª —Å–æ–∫—Ä–∞—Ç–∏—Ç—å —Å—Ä–æ–∫–∏ –æ–∂–∏–¥–∞–Ω–∏—è –ø—Ä–∏–µ–º–∞ –∏ —É–ª—É—á—à–∏—Ç—å –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å –±–∞–∑–æ–≤–æ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏.‚Äã –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PmJdr #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-10-16T07:34:03+00:00,@medpharm,13123,https://t.me/medpharm/13123,FDA –≤–ø–µ—Ä–≤—ã–µ –≤—ã–¥–µ–ª–∏–ª–æ —á–µ—Ä–Ω–æ–π —Ä–∞–º–∫–æ–π –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏–µ –æ–± —ç–Ω—Ç–µ—Ä–æ–∫–æ–ª–∏—Ç–µ –≤ –º–∞—Ä–∫–∏—Ä–æ–≤–∫–µ CAR-T-—Ç–µ—Ä–∞–ø–∏–∏ ‚Äî –∏–∑–º–µ–Ω–µ–Ω–∏–µ –∑–∞—Ç—Ä–æ–Ω—É–ª–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç Carvykti –æ—Ç J&J –∏ Legend Biotech. –≠—Ç–æ –Ω–∞–∏–±–æ–ª–µ–µ —Å—Ç—Ä–æ–≥–∞—è —Ñ–æ—Ä–º–∞ –ø—Ä–µ–¥–æ—Å—Ç–µ—Ä–µ–∂–µ–Ω–∏—è —Ä–µ–≥—É–ª—è—Ç–æ—Ä–∞ –æ –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω–æ —Å–º–µ—Ä—Ç–µ–ª—å–Ω–æ–º –æ—Å–ª–æ–∂–Ω–µ–Ω–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PmFbo #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-10-16T07:16:04+00:00,@medpharm,13122,https://t.me/medpharm/13122,"–ï–≤—Ä–æ–ø–µ–π—Å–∫–∞—è –∞—Å—Å–æ—Ü–∏–∞—Ü–∏—è –ø–æ –∏–∑—É—á–µ–Ω–∏—é –æ–∂–∏—Ä–µ–Ω–∏—è (EASO) –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∞ –Ω–æ–≤—ã–µ —Å—Ç–∞–Ω–¥–∞—Ä—Ç—ã —Ñ–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ –ª–µ—á–µ–Ω–∏—è –æ–∂–∏—Ä–µ–Ω–∏—è –∏ —Å–≤—è–∑–∞–Ω–Ω—ã—Ö —Å –Ω–∏–º –æ—Å–ª–æ–∂–Ω–µ–Ω–∏–π. –î–æ–∫—É–º–µ–Ω—Ç –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç –∞–ª–≥–æ—Ä–∏—Ç–º –≤—ã–±–æ—Ä–∞ —Ç–µ—Ä–∞–ø–∏–∏, –æ—Å–Ω–æ–≤–∞–Ω–Ω—ã–π –Ω–∞ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –¥–∞–Ω–Ω—ã—Ö –∏ –ø—Ä–æ—Ñ–∏–ª–µ —Å–æ—Å—Ç–æ—è–Ω–∏—è –ø–∞—Ü–∏–µ–Ω—Ç–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PmE4H #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ö–∞—Ä–¥–∏–æ–ª–æ–≥–∏—è #–†–µ–≤–º–∞—Ç–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è #–≠–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-10-16T06:14:07+00:00,@medpharm,13121,https://t.me/medpharm/13121,"–° –Ω–µ–≤—Ä–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏ —Å—Ç–∞–ª–∫–∏–≤–∞–µ—Ç—Å—è 42% –Ω–∞—Å–µ–ª–µ–Ω–∏—è –º–∏—Ä–∞. –í 2021 –≥–æ–¥—É –æ–Ω–∏ —Å—Ç–∞–ª–∏ –ø—Ä–∏—á–∏–Ω–æ–π 11,8 –º–ª–Ω —Å–º–µ—Ä—Ç–µ–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pm9on #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ù–µ–≤—Ä–æ–ª–æ–≥–∏—è #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è #–¢–µ—Ä–∞–ø–∏—è","{""skip"": true}"
2025-10-15T16:46:31+00:00,@medpharm,13120,https://t.me/medpharm/13120,"ü¶æ –ù–µ –ø—Ä–æ—Å—á–∏—Ç–∞–ª–∏. –°—á–µ—Ç–Ω–∞—è –ø–∞–ª–∞—Ç–∞ –†–§ —Ä–µ–∫–æ–º–µ–Ω–¥–æ–≤–∞–ª–∞ –¥–æ—Ä–∞–±–æ—Ç–∞—Ç—å –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç, –Ω–∞–¥–µ–ª—è—é—â–∏–π –≥—É–±–µ—Ä–Ω–∞—Ç–æ—Ä–æ–≤ –ø—Ä–∞–≤–æ–º –ø—Ä–∏–Ω–∏–º–∞—Ç—å —Ä–µ—à–µ–Ω–∏–µ –æ –∑–∞–º–µ–Ω–µ —Å—Ç—Ä–∞—Ö–æ–≤—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω—ã–º–∏ —Ñ–æ–Ω–¥–∞–º–∏ –û–ú–°. –í –∑–∞–∫–ª—é—á–µ–Ω–∏–∏ –∫–æ–Ω—Ç—Ä–æ–ª—å–Ω–æ–≥–æ –æ—Ä–≥–∞–Ω–∞ –≤—ã—Å–∫–∞–∑—ã–≤–∞–µ—Ç—Å—è —Ä—è–¥ –ø—Ä–µ—Ç–µ–Ω–∑–∏–π –∫ –¥–æ–∫—É–º–µ–Ω—Ç—É. ü¶æ –°–ª–æ–∂–Ω–æ –ø–æ–≤–µ—Ä–∏—Ç—å. –î–µ–ø—É—Ç–∞—Ç—ã –ì–æ—Å–¥—É–º—ã –†–§ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –≤–∑–∏–º–∞—Ç—å —Å —á–∞—Å—Ç–Ω—ã—Ö –∫–ª–∏–Ω–∏–∫ 5% –æ—Ç –ø—Ä–∏–±—ã–ª–∏ –∏ –Ω–∞ —ç—Ç–∏ –¥–µ–Ω—å–≥–∏ —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞—Ç—å –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä—É –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –±–æ–ª—å–Ω–∏—Ü. –ö–∞–∫ –Ω–∞ —ç—Ç—É –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤—É —Ä–µ–∞–≥–∏—Ä—É—é—Ç —É—á–∞—Å—Ç–Ω–∏–∫–∏ —Ä—ã–Ω–∫–∞, —É–∑–Ω–∞–ª ¬´–ú–í¬ª. ‚ù§Ô∏è –ë–ª–æ–∫–∏—Ä–æ–≤–∫–∞ –ë–ê–î. –†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä –æ–ø—Ä–µ–¥–µ–ª–∏–ª –∫—Ä–∏—Ç–µ—Ä–∏–∏ –¥–ª—è –±–ª–æ–∫–∏—Ä–æ–≤–∫–∏ —Å–∞–π—Ç–æ–≤ —Å –Ω–µ–∑–∞–∫–æ–Ω–Ω–æ–π –ø—Ä–æ–¥–∞–∂–µ–π –±–∏–æ–¥–æ–±–∞–≤–æ–∫. –î–æ–∫—É–º–µ–Ω—Ç –ø–æ–∑–≤–æ–ª—è–µ—Ç –≤–Ω–æ—Å–∏—Ç—å –≤ —Ä–µ–µ—Å—Ç—Ä –∑–∞–ø—Ä–µ—â–µ–Ω–Ω–æ–π –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç-—Ä–µ—Å—É—Ä—Å—ã, –ø—Ä–æ–¥–∞—é—â–∏–µ –Ω–µ–∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –ë–ê–î –∏–ª–∏ –Ω–µ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª—è—é—â–∏–µ –¥–∞–Ω–Ω—ã—Ö –æ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ. ‚ù§Ô∏è –ü—Ä–∏–Ω–µ—Å—É—Ç –ø–æ–ª—å–∑—É. –ú–∞—Ä–∫–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ —Ç–æ–≤–∞—Ä—ã, –∫–æ—Ç–æ—Ä—ã–µ –±—ã–ª–∏ –∏–∑—ä—è—Ç—ã –∏–∑-–∑–∞ –Ω–∞—Ä—É—à–µ–Ω–∏–π, –Ω–æ –ø—Ä–∏–≥–æ–¥–Ω—ã –¥–ª—è –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏—è, —Å–º–æ–≥—É—Ç –±—ã—Ç—å –ø–µ—Ä–µ–¥–∞–Ω—ã –Ω–∞ –≥—É–º–∞–Ω–∏—Ç–∞—Ä–Ω—ã–µ —Ü–µ–ª–∏. –ö —Ç–∞–∫–∏–º —Ç–æ–≤–∞—Ä–∞–º –æ—Ç–Ω–æ—Å—è—Ç—Å—è –≤ —Ç–æ–º —á–∏—Å–ª–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ (–∑–∞ –∏—Å–∫–ª—é—á–µ–Ω–∏–µ–º —Å–ø–∏—Ä—Ç–æ—Å–æ–¥–µ—Ä–∂–∞—â–∏—Ö), –º–µ–¥–∏–∑–¥–µ–ª–∏—è –∏ –ë–ê–î.","{""skip"": true}"
2025-10-15T15:20:06+00:00,@medpharm,13119,https://t.me/medpharm/13119,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ –ø—Ä–µ–¥–ª–æ–∂–∏–ª —Ü–µ–Ω—Ç—Ä–∞–ª–∏–∑–æ–≤–∞—Ç—å –∑–∞–∫—É–ø–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π –¥–ª—è –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –Ω—É–∂–¥ –≤ —Ä–∞–º–∫–∞—Ö –ø—Ä–æ—Ñ–∏–ª—å–Ω—ã—Ö –Ω–∞—Ü–ø—Ä–æ–µ–∫—Ç–æ–≤. –ü—Ä–µ–¥–ø–æ–ª–∞–≥–∞–µ—Ç—Å—è, —á—Ç–æ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã–µ –∏ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã–µ –∑–∞–∫–∞–∑—á–∏–∫–∏ –±—É–¥—É—Ç —Ä–∞–±–æ—Ç–∞—Ç—å —á–µ—Ä–µ–∑ –§–µ–¥–µ—Ä–∞–ª—å–Ω—ã–π —Ü–µ–Ω—Ç—Ä –ø–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω–∏—è –∏ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –≥—Ä–∞–∂–¥–∞–Ω, —á—Ç–æ –ø–æ–≤—ã—Å–∏—Ç –ø—Ä–æ–∑—Ä–∞—á–Ω–æ—Å—Ç—å –∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –∑–∞–∫—É–ø–æ–∫. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pkhpm #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health of Russia proposed centralizing the procurement of medicines and medical products for state needs within sectoral national projects. Regional and federal buyers will work through the Federal Center for Planning and Organizing Pharmaceutical Supplies to citizens, which will increase transparency and efficiency of procurement.""
}"
2025-10-15T15:05:08+00:00,@medpharm,13118,https://t.me/medpharm/13118,"–ú–∞—Ä–∫–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ —Ç–æ–≤–∞—Ä—ã, –∫–æ—Ç–æ—Ä—ã–µ –±—ã–ª–∏ –∏–∑—ä—è—Ç—ã –∏–∑-–∑–∞ –Ω–∞—Ä—É—à–µ–Ω–∏–π, –Ω–æ –ø—Ä–∏–≥–æ–¥–Ω—ã –¥–ª—è –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏—è, —Å–º–æ–≥—É—Ç –±—ã—Ç—å –ø–µ—Ä–µ–¥–∞–Ω—ã –Ω–∞ –≥—É–º–∞–Ω–∏—Ç–∞—Ä–Ω—ã–µ —Ü–µ–ª–∏. –ü–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ —É—Ç–≤–µ—Ä–¥–∏–ª–æ –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§. –ö —Ç–∞–∫–∏–º —Ç–æ–≤–∞—Ä–∞–º –æ—Ç–Ω–æ—Å—è—Ç—Å—è –≤ —Ç–æ–º —á–∏—Å–ª–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ (–∑–∞ –∏—Å–∫–ª—é—á–µ–Ω–∏–µ–º —Å–ø–∏—Ä—Ç–æ—Å–æ–¥–µ—Ä–∂–∞—â–∏—Ö), –º–µ–¥–∏–∑–¥–µ–ª–∏—è –∏ –ë–ê–î. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pkgqg #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The detained goods that were found to be non-compliant but still usable will be transferred for humanitarian purposes. The decree has been approved by the Russian Government. Such goods include medicines (excluding alcoholic products), medical devices, and dietary supplements. For more details: https://clck.ru/3Pkgqg #PharmNews #Regulation""
}"
2025-10-15T14:38:06+00:00,@medpharm,13117,https://t.me/medpharm/13117,"–£—Ç–≤–µ—Ä–∂–¥–µ–Ω–∞ –∞–≤—Ç–æ–º–∞—Ç–∏—á–µ—Å–∫–∞—è –æ—Ç—á–µ—Ç–Ω–æ—Å—Ç—å –æ —Ä–∞–±–æ—Ç–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π —Å –ò–ò ‚Äî —Ç–µ–ø–µ—Ä—å –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –¥–æ–ª–∂–Ω—ã —Å–æ–æ–±—â–∞—Ç—å –æ–±–æ –≤—Å–µ—Ö —Å–±–æ—è—Ö –∏ –æ—à–∏–±–∫–∞—Ö –≤ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä. –ü–æ—Ä—è–¥–æ–∫ –¥–µ–π—Å—Ç–≤—É–µ—Ç –¥–æ –∫–æ–Ω—Ü–∞ 2025 –≥–æ–¥–∞ –∏ –æ—Ö–≤–∞—Ç—ã–≤–∞–µ—Ç —É–∂–µ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ 48 –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π —Å –ò–ò, –∏–∑ –∫–æ—Ç–æ—Ä—ã—Ö 43 —Å–æ–∑–¥–∞–Ω—ã —Ä–æ—Å—Å–∏–π—Å–∫–∏–º–∏ –∫–æ–º–ø–∞–Ω–∏—è–º–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PkfB3 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""high"",
  ""english"": ""The regulation has been approved for automatic reporting of medical devices with AI. Manufacturers are required to report all malfunctions and errors to the Russian Health Supervision until 2025. This applies to already registered 48 AI medical devices, of which 43 are developed by Russian companies. For more details: https://clck.ru/3PkfB3 #MedVestnik #Technologies #HealthOrganization""
}"
2025-10-15T14:09:03+00:00,@medpharm,13116,https://t.me/medpharm/13116,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏ —Ä–∞—Å—Å–º–æ—Ç—Ä–∏—Ç –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å —Ä–∞—Å—à–∏—Ä–µ–Ω–∏—è –ø–µ—Ä–µ—á–Ω—è —Ä–µ–¥–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, –ª–µ—á–µ–Ω–∏–µ –∫–æ—Ç–æ—Ä—ã—Ö –ø–æ–ª—É—á–∞–µ—Ç —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–µ —Å–æ—Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏–µ. –≠—Ç–æ —Å–ª–µ–¥—É–µ—Ç –∏–∑ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–π —ç–∫—Å–ø–µ—Ä—Ç–∞ –ù–∞—Ç–∞–ª—å–∏ –°–º–∏—Ä–Ω–æ–≤–æ–π, –∫–æ—Ç–æ—Ä–∞—è —É–∫–∞–∑–∞–ª–∞, —á—Ç–æ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–Ω—ã–π —Ä–∞–Ω–µ–µ –º–µ—Ö–∞–Ω–∏–∑–º –Ω–µ —Ä–µ—à–∞–µ—Ç –ø—Ä–æ–±–ª–µ–º—É –Ω–µ–¥–æ—Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è —Ä–µ–≥–∏–æ–Ω–æ–≤ –∏ –æ—Å—Ç–∞–≤–ª—è–µ—Ç –±–µ–∑ —Ç–µ—Ä–∞–ø–∏–∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å—Ç–∞—Ä—à–µ 19 –ª–µ—Ç. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PkdQP #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The Russian Ministry of Russia is considering expanding the list of rare diseases that receive federal financing. Expert Natalia Smirnova suggests that the previously proposed mechanism does not address the problem of underfinancing regions and leaves patients over 19 years old without treatment.""
}"
2025-10-15T13:43:07+00:00,@medpharm,13115,https://t.me/medpharm/13115,–û–±—ä—è–≤–ª–µ–Ω –∫–æ—Ä–æ—Ç–∫–∏–π —Å–ø–∏—Å–æ–∫ –ø—Ä–µ–º–∏–∏ ¬´–•—Ä—É—Å—Ç–∞–ª—å–Ω—ã–π –ø–æ–¥—Å–æ–ª–Ω—É—Ö¬ª. –í –Ω–µ–≥–æ –≤–æ—à–ª–∏ 13 –ø—Ä–æ–µ–∫—Ç–æ–≤ —Ä–∞–∑–Ω–æ–π –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–Ω–æ—Å—Ç–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PkbhA #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-10-15T13:14:06+00:00,@medpharm,13114,https://t.me/medpharm/13114,"–í –°—á–µ—Ç–Ω–æ–π –ø–∞–ª–∞—Ç–µ –†–§ –ø—Ä–æ–∞–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–ª–∏ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç, –ø—Ä–µ–¥–ø–æ–ª–∞–≥–∞—é—â–∏–π –∑–∞–º–µ–Ω—É –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Å—Ç—Ä–∞—Ö–æ–≤—â–∏–∫–æ–≤ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω—ã–º–∏ —Ñ–æ–Ω–¥–∞–º–∏ –û–ú–°. –ü–æ –º–Ω–µ–Ω–∏—é –∫–æ–Ω—Ç—Ä–æ–ª—å–Ω–æ–≥–æ –æ—Ä–≥–∞–Ω–∞, –¥–æ–∫—É–º–µ–Ω—Ç –Ω—É–∂–¥–∞–µ—Ç—Å—è –≤ –¥–æ—Ä–∞–±–æ—Ç–∫–µ –∏–∑-–∑–∞ —Ä–∏—Å–∫–æ–≤ –¥–∏—Å–±–∞–ª–∞–Ω—Å–∞ —Å–∏—Å—Ç–µ–º—ã, –Ω–µ—ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ–≥–æ —Ä–∞—Å—Ö–æ–¥–æ–≤–∞–Ω–∏—è —Å—Ä–µ–¥—Å—Ç–≤ –∏ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏—è –ø—Ä–æ–∑—Ä–∞—á–Ω—ã—Ö —Ü–µ–ª–µ–π –∏ –∫—Ä–∏—Ç–µ—Ä–∏–µ–≤ —Ä–µ—Ñ–æ—Ä–º—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PkZW2 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""registration, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The Accounting Chamber of Russia analyzed a project law proposing to replace medical insurers with territorial health funds. The supervisory body believes the document needs revision due to risks of system imbalance, inefficient use of funds, and lack of transparent goals and criteria for reform. For more details: https://clck.ru/3PkZW2 #MedVestnik #Healthcare""
}"
2025-10-15T12:41:03+00:00,@medpharm,13113,https://t.me/medpharm/13113,"–£—Ç–≤–µ—Ä–∂–¥–µ–Ω –ø–æ—Ä—è–¥–æ–∫ –ø–µ—Ä–µ–¥–∞—á–∏ –¥–∞–Ω–Ω—ã—Ö –æ –ø—Ä–æ–≥—Ä–∞–º–º–Ω–æ–º –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–∏ —Å —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—è–º–∏ –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–∞, –∫–æ—Ç–æ—Ä–æ–µ —è–≤–ª—è–µ—Ç—Å—è –º–µ–¥–∏–∑–¥–µ–ª–∏–µ–º, –≤ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω—É—é —Å–∏—Å—Ç–µ–º—É –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–∞. –í –Ω–µ–π –Ω—É–∂–Ω–æ –±—É–¥–µ—Ç —É–∫–∞–∑—ã–≤–∞—Ç—å –≤ —Ç–æ–º —á–∏—Å–ª–µ –¥–∞–Ω–Ω—ã–µ –æ–± –æ—à–∏–±–∫–∞—Ö, –∫–æ—Ç–æ—Ä—ã–µ –≤–æ–∑–Ω–∏–∫–∞—é—Ç –ø—Ä–∏ —Ä–∞–±–æ—Ç–µ —Ç–∞–∫–æ–≥–æ –ü–û-–º–µ–¥–∏–∑–¥–µ–ª–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PkX67 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The order for the transfer of data on AI medical devices, which may include error data during their operation, has been approved. This will be included in the information system of Roszdravnadzor. More details: https://clck.ru/3PkX67 #PharmVestnik #Regulation""
}"
2025-10-15T12:16:06+00:00,@medpharm,13112,https://t.me/medpharm/13112,"–î–µ–ø—É—Ç–∞—Ç—ã –ì–æ—Å–¥—É–º—ã –†–§ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –≤–∑–∏–º–∞—Ç—å —Å —á–∞—Å—Ç–Ω—ã—Ö –∫–ª–∏–Ω–∏–∫ 5% –æ—Ç –ø—Ä–∏–±—ã–ª–∏, —á—Ç–æ–±—ã —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞—Ç—å –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä—É –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –±–æ–ª—å–Ω–∏—Ü –∏ –ø–æ–≤—ã—Å–∏—Ç—å –∫–∞—á–µ—Å—Ç–≤–æ –º–µ–¥–ø–æ–º–æ—â–∏. –ö–∞–∫ –Ω–∞ —ç—Ç—É –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤—É —Ä–µ–∞–≥–∏—Ä—É—é—Ç —É—á–∞—Å—Ç–Ω–∏–∫–∏ —Ä—ã–Ω–∫–∞, —É–∑–Ω–∞–ª ¬´–ú–í¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PkVDk #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""reimbursement, shortage"",
  ""impact"": ""medium"",
  ""english"": ""Deputies from the State Duma of Russia proposed to charge a 5% profit tax on private clinics in order to finance the infrastructure of state hospitals and improve medical care. How are market participants reacting to this initiative, as reported by 'M.V.'? More details: https://clck.ru/3PkVDk #MedVestnik #HealthcareOrganization""
}"
2025-10-15T11:53:06+00:00,@medpharm,13111,https://t.me/medpharm/13111,–ö–∞–±–∏–Ω–µ—Ç –º–∏–Ω–∏—Å—Ç—Ä–æ–≤ –†–§ –ø–µ—Ä–µ—Ä–∞—Å–ø—Ä–µ–¥–µ–ª–∏–ª —Å—Ä–µ–¥—Å—Ç–≤–∞ –Ω–∞ –º–æ–¥–µ—Ä–Ω–∏–∑–∞—Ü–∏—é –ø–µ—Ä–≤–∏—á–Ω–æ–≥–æ –∑–≤–µ–Ω–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –≤ —Ä–µ–≥–∏–æ–Ω–∞—Ö –≤ 2025 –≥–æ–¥—É. –í –ø–ª—é—Å–µ –æ–∫–∞–∑–∞–ª–∏—Å—å –¥–µ–≤—è—Ç—å —Å—É–±—ä–µ–∫—Ç–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PkTQ3 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-10-15T10:55:03+00:00,@medpharm,13110,https://t.me/medpharm/13110,"–í–û–ó –≤—ã–ø—É—Å—Ç–∏–ª–∞ –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏–µ –æ —Ç—Ä–µ—Ö –∏–Ω–¥–∏–π—Å–∫–∏—Ö —Å–∏—Ä–æ–ø–∞—Ö –æ—Ç –∫–∞—à–ª—è ‚Äî Coldrif –æ—Ç —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ Sresan Pharmaceutical, Respifresh TR –æ—Ç Rednex Pharmaceuticals –∏ ReLife –æ—Ç Shape Pharma. –í –∏—Ö —Å–æ—Å—Ç–∞–≤–µ –±—ã–ª –≤—ã—è–≤–ª–µ–Ω —Ç–æ–∫—Å–∏—á–Ω—ã–π –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω—ã–π —Ö–∏–º–∏–∫–∞—Ç, —Å—Ç–∞–≤—à–∏–π –ø—Ä–∏—á–∏–Ω–æ–π —Å–º–µ—Ä—Ç–∏ 24 –¥–µ—Ç–µ–π –≤ –ò–Ω–¥–∏–∏.‚Äã –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PkNxU #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""The Russian pharmaceutical watchdog VOZ issued a warning about three Indian cough syrups - Coldrif from Sresan Pharmaceutical, Respifresh TR from Rednex Pharmaceuticals, and ReLife from Shape Pharma. They contain a toxic industrial chemical that has caused the death of 24 children in India. For more details: https://clck.ru/3PkNxU #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ""
}"
2025-10-15T10:38:06+00:00,@medpharm,13109,https://t.me/medpharm/13109,–í –æ–∫—Ç—è–±—Ä–µ –≤—Ä–∞—á–∏ —Å–æ—Ö—Ä–∞–Ω—è—é—Ç –ª–∏–¥–µ—Ä—Å—Ç–≤–æ —Å—Ä–µ–¥–∏ —Å–∞–º—ã—Ö –≤—ã—Å–æ–∫–æ–æ–ø–ª–∞—á–∏–≤–∞–µ–º—ã—Ö –ø—Ä–æ—Ñ–µ—Å—Å–∏–π –≤ —à–µ—Å—Ç–∏ –≥–æ—Ä–æ–¥–∞—Ö —Å –Ω–∞—Å–µ–ª–µ–Ω–∏–µ–º –¥–æ 1 –º–ª–Ω —á–µ–ª–æ–≤–µ–∫. –ë–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ —Ç–∞–∫–∏—Ö –≤–∞–∫–∞–Ω—Å–∏–π ‚Äî –¥–ª—è —Å—Ç–æ–º–∞—Ç–æ–ª–æ–≥–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PkMh5 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-10-15T10:16:03+00:00,@medpharm,13108,https://t.me/medpharm/13108,"–û—Ç–ø—É—Å–∫–∞—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –≤ –§–ê–ü –º–æ–≥—É—Ç —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–∏ –±–µ–∑ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è. –ö–∞–∫ –ø–æ—è—Å–Ω—è–µ—Ç —ç–∫—Å–ø–µ—Ä—Ç —Å–ª—É–∂–±—ã ¬´–ì–∞—Ä–∞–Ω—Ç¬ª –ï–ª–µ–Ω–∞ –ü–∞—Ä–∞—Å–æ—Ü–∫–∞—è, —ç—Ç–æ —Ä–∞–∑—Ä–µ—à–µ–Ω–æ –∑–∞–∫–æ–Ω–æ–º, –Ω–æ —Ç–æ–ª—å–∫–æ –ø—Ä–∏ —Å–æ–±–ª—é–¥–µ–Ω–∏–∏ —Ä—è–¥–∞ —Å—Ç—Ä–æ–≥–∏—Ö —É—Å–ª–æ–≤–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PkKxW #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""The law allows for the dispensing of medicines by staff at FAPs without pharmaceutical education, but this is only allowed under strict conditions. Expert Elena Parasoczkaya from the 'Garant' service explains this.""
}"
2025-10-15T09:38:04+00:00,@medpharm,13107,https://t.me/medpharm/13107,"–ü—Ä–æ—Ñ–∏–ª—å–Ω—ã–π –ö–æ–º–∏—Ç–µ—Ç –ì–æ—Å–¥—É–º—ã –†–§ –ø–æ–¥–¥–µ—Ä–∂–∞–ª –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç, –¥–æ–ø—É—Å–∫–∞—é—â–∏–π –∏—Å–∫–ª—é—á–µ–Ω–∏–µ —Å—Ç—Ä–∞—Ö–æ–≤—ã—Ö –∫–æ–º–ø–∞–Ω–∏–π –∏–∑ —Å–∏—Å—Ç–µ–º—ã –û–ú–°. –í –ú–∏–Ω–∑–¥—Ä–∞–≤–µ –†–§ —Å—á–∏—Ç–∞—é—Ç, —á—Ç–æ —ç—Ç–æ –Ω–µ —É—Ö—É–¥—à–∏—Ç –∑–∞—â–∏—Ç—É –ø—Ä–∞–≤ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –∏ –Ω–µ –ø—Ä–∏–≤–µ–¥–µ—Ç –∫ –Ω–µ—Ä–∞–≤–µ–Ω—Å—Ç–≤—É –º–µ–∂–¥—É —Ä–µ–≥–∏–æ–Ω–∞–º–∏, –Ω–æ –±—É–¥–µ—Ç —Å–ø–æ—Å–æ–±—Å—Ç–≤–æ–≤–∞—Ç—å –ø–æ–≤—ã—à–µ–Ω–∏—é –ø—Ä–æ–∑—Ä–∞—á–Ω–æ—Å—Ç–∏ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏—è —Å—Ä–µ–¥—Å—Ç–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PkH2i #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The Committee of Professions in the State Duma of Russia supported a project allowing insurance companies to be excluded from the OMS system. The Russian Ministry of Health believes this will not worsen patient protection and prevent regional inequality, but it will increase the transparency of using funds.""
}"
2025-10-15T09:00:09+00:00,@medpharm,13106,https://t.me/medpharm/13106,"–°–∞–º—ã–µ –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –¥–æ–ª–∂–Ω—ã –ø—Ä–æ–¥–∞–≤–∞—Ç—å—Å—è –≤ –∞–ø—Ç–µ–∫–∞—Ö –±–µ–∑ —Ç–æ—Ä–≥–æ–≤–æ–π –Ω–∞—Ü–µ–Ω–∫–∏, –∑–∞—è–≤–∏–ª –¥–µ–ø—É—Ç–∞—Ç –°–µ—Ä–≥–µ–π –ú–∏—Ä–æ–Ω–æ–≤. –†–∞–Ω–µ–µ –≤ –ì–æ—Å–¥—É–º—É –†–§ –≤–Ω–µ—Å–ª–∏ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç, –∫–æ—Ç–æ—Ä—ã–º –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è –≤–≤–µ—Å—Ç–∏ —Å—É–±—Å–∏–¥–∏–∏, –∫–æ–º–ø–µ–Ω—Å–∏—Ä—É—é—â–∏–µ —Ç—Ä–∞—Ç—ã –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞, –µ—Å–ª–∏ –æ–Ω–∏ –ø—Ä–µ–≤—ã—à–∞—é—Ç 10% –æ—Ç –¥–æ—Ö–æ–¥–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PkDvr #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""Deputy Sergei Mironov stated that essential medicines should be sold in pharmacies without a trade markup. Earlier, a draft law was submitted to the Russian State Duma proposing subsidies to compensate for costs on medicines that exceed 10% of income. More details: https://clck.ru/3PkDvr #PharmVestnik #Regulation""
}"
2025-10-15T07:50:06+00:00,@medpharm,13105,https://t.me/medpharm/13105,"–° –≤–µ—Å–Ω—ã 2026 –≥–æ–¥–∞ —Ç–µ—Å—Ç—ã –Ω–∞ –≥–µ–ø–∞—Ç–∏—Ç B, C –∏ D —Å—Ç–∞–Ω—É—Ç –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–º–∏ –¥–ª—è –±–µ–∂–µ–Ω—Ü–µ–≤ –∏ –∏–Ω–æ—Å—Ç—Ä–∞–Ω—Ü–µ–≤ –≤ –†–æ—Å—Å–∏–∏. –ù–æ–≤—ã–µ –Ω–æ—Ä–º—ã –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω—ã –Ω–∞ –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏–µ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–∏—è –∏–Ω—Ñ–µ–∫—Ü–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pk7ko #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–ò–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã–µ_–±–æ–ª–µ–∑–Ω–∏ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""Tests for Hepatitis B, C and D will become mandatory for refugees and foreigners in Russia starting from spring 2026. The new norms are aimed at preventing the spread of infections.""
}"
2025-10-15T07:09:02+00:00,@medpharm,13104,https://t.me/medpharm/13104,"–†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä –æ–ø—Ä–µ–¥–µ–ª–∏–ª –∫—Ä–∏—Ç–µ—Ä–∏–∏ –¥–ª—è –±–ª–æ–∫–∏—Ä–æ–≤–∫–∏ —Å–∞–π—Ç–æ–≤, —á–µ—Ä–µ–∑ –∫–æ—Ç–æ—Ä—ã–µ –Ω–µ–∑–∞–∫–æ–Ω–Ω–æ —Ç–æ—Ä–≥—É—é—Ç –±–∏–æ–¥–æ–±–∞–≤–∫–∞–º–∏. –î–æ–∫—É–º–µ–Ω—Ç –ø–æ–∑–≤–æ–ª—è–µ—Ç –≤–Ω–æ—Å–∏—Ç—å –≤ —Ä–µ–µ—Å—Ç—Ä –∑–∞–ø—Ä–µ—â–µ–Ω–Ω–æ–π –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç-—Ä–µ—Å—É—Ä—Å—ã, –ø—Ä–æ–¥–∞—é—â–∏–µ –Ω–µ–∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –ë–ê–î –∏–ª–∏ –Ω–µ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª—è—é—â–∏–µ –¥–∞–Ω–Ω—ã—Ö –æ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pk4iz #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, regulation"",
  ""impact"": ""high"",
  ""english"": ""Rospatentnadzor has defined criteria for blocking websites where illegal trade in dietary supplements occurs. The document allows adding internet resources that sell unregistered dietary supplements or do not provide information about the producer to a blacklist of prohibited information.""
}"
2025-10-15T06:20:04+00:00,@medpharm,13103,https://t.me/medpharm/13103,"–ú–∏–Ω–∑–¥—Ä–∞–≤ —Å–æ–±–∏—Ä–∞–µ—Ç—Å—è –ø–µ—Ä–µ—Å–º–æ—Ç—Ä–µ—Ç—å –ø–æ–¥—Ö–æ–¥—ã –∫ –æ—Ç–∫—Ä—ã—Ç–∏—é, —Ä–µ–∫–æ–Ω—Å—Ç—Ä—É–∫—Ü–∏–∏ –∏ –∫–∞–ø–∏—Ç–∞–ª—å–Ω–æ–º—É —Ä–µ–º–æ–Ω—Ç—É –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π. –ü–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è, —á—Ç–æ —Ç–∞–∫–∏–µ —Ä–µ—à–µ–Ω–∏—è –ø—Ä–∏–¥–µ—Ç—Å—è –æ—Å–Ω–æ–≤—ã–≤–∞—Ç—å –Ω–∞ —Ç–µ–∫—É—â–∏—Ö –∏ —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏—Ö –ø–ª–∞–Ω–∞—Ö —Ä–∞–∑–≤–∏—Ç–∏—è –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∏ –∫–æ–º–ø–ª–µ–∫—Å–Ω–æ–π –æ—Ü–µ–Ω–∫–µ –º–µ–¥–∏–∫–æ-–¥–µ–º–æ–≥—Ä–∞—Ñ–∏—á–µ—Å–∫–æ–π —Å–∏—Ç—É–∞—Ü–∏–∏ –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏. –¢–∞–∫–∂–µ –ø—Ä–∏ —Å–æ–∑–¥–∞–Ω–∏–∏ –Ω–æ–≤—ã—Ö –ø–æ–ª–∏–∫–ª–∏–Ω–∏–∫ –º–æ–≥—É—Ç –Ω–∞—á–∞—Ç—å —É—á–∏—Ç—ã–≤–∞—Ç—å —Ä–∞—Å—Å—Ç–æ—è–Ω–∏–µ –¥–æ —á–∞—Å—Ç–Ω—ã—Ö –º–µ–¥—Ü–µ–Ω—Ç—Ä–æ–≤. –ö–∞–∫ –ø–æ–¥–≥–æ—Ç–æ–≤–ª–µ–Ω–Ω—ã–µ –¶–µ–Ω—Ç—Ä–∞–ª—å–Ω—ã–º –ù–ò–ò –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –∏ –∏–Ω—Ñ–æ—Ä–º–∞—Ç–∏–∑–∞—Ü–∏–∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è (–¶–ù–ò–ò–û–ò–ó) –º–µ—Ç–æ–¥–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –æ—Ç—Ä–∞–∑—è—Ç—Å—è –Ω–∞ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –≤ —Ä–µ–≥–∏–æ–Ω–∞—Ö, —á–µ–≥–æ –æ–∂–∏–¥–∞—é—Ç —É—á–∞—Å—Ç–Ω–∏–∫–∏ —Ä—ã–Ω–∫–∞ –∏ –∫–∞–∫–æ–≤–∞ –≤–µ—Ä–æ—è—Ç–Ω–æ—Å—Ç—å –Ω–æ–≤–æ–≥–æ –≤–∏—Ç–∫–∞ –æ–ø—Ç–∏–º–∏–∑–∞—Ü–∏–∏ –≤ –æ—Ç—Ä–∞—Å–ª–∏, —Ä–∞–∑–±–∏—Ä–∞–ª—Å—è ¬´–ú–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–π –≤–µ—Å—Ç–Ω–∏–∫¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PjzQW #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-10-15T05:04:03+00:00,@medpharm,13102,https://t.me/medpharm/13102,"–°–µ–≥–æ–¥–Ω—è –≤ 11:00 —Å–æ—Å—Ç–æ–∏—Ç—Å—è –ø–µ—Ä–≤—ã–π –±–∏–∑–Ω–µ—Å-–∑–∞–≤—Ç—Ä–∞–∫ ¬´–†—ã–Ω–æ–∫ –ë–ê–î. –ê–Ω–∞–ª–∏—Ç–∏–∫–∞, –Ω–æ–≤–æ—Å—Ç–∏, —Ç—Ä–µ–Ω–¥—ã¬ª, –ø–æ–¥–∫–ª—é—á–∞–π—Ç–µ—Å—å –∫ —Ç—Ä–∞–Ω—Å–ª—è—Ü–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PjvTZ #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-14T16:46:28+00:00,@medpharm,13101,https://t.me/medpharm/13101,"ü¶æ –ù–∞—à–ª–∏ –∏—Å—Ç–æ—á–Ω–∏–∫. –î–µ–ø—É—Ç–∞—Ç—ã –ì–æ—Å–¥—É–º—ã –†–§ –æ—Ç –õ–î–ü–† –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –≤–≤–µ—Å—Ç–∏ 5%-–Ω—ã–π –Ω–∞–ª–æ–≥ –Ω–∞ –ø—Ä–∏–±—ã–ª—å –¥–ª—è —á–∞—Å—Ç–Ω—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∫–ª–∏–Ω–∏–∫. –ù–∞ —ç—Ç–∏ –¥–µ–Ω—å–≥–∏ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞—Ç—å –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä—É –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –±–æ–ª—å–Ω–∏—Ü. ü¶æ –ù–∞ –ø–µ—Ä–µ–ª–æ–º–µ. –í –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–µ –†–§ –æ—Ç–º–µ—á–∞—é—Ç —Å–æ–∫—Ä–∞—â–µ–Ω–∏–µ –¥–µ—Ñ–∏—Ü–∏—Ç–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∫–∞–¥—Ä–æ–≤. –°–∏—Ç—É–∞—Ü–∏—é —Å –æ—Ç—Ç–æ–∫–æ–º —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –∏–∑ –≥–æ—Å—Å–µ–∫—Ç–æ—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è —É–¥–∞–ª–æ—Å—å –ø–µ—Ä–µ–ª–æ–º–∏—Ç—å. ‚ù§Ô∏è –®—Ç—É—á–Ω—ã–π —Ç–æ–≤–∞—Ä. –î–µ–ø—É—Ç–∞—Ç –ì–æ—Å–¥—É–º—ã –†–§ –ê–π—Ä–∞—Ç –§–∞—Ä—Ä–∞—Ö–æ–≤ —Å—á–∏—Ç–∞–µ—Ç, —á—Ç–æ —Ä–æ–∑–Ω–∏—á–Ω—ã–π –∏ –≥–æ—Å–ø–∏—Ç–∞–ª—å–Ω—ã–π —Å–µ–≥–º–µ–Ω—Ç—ã –¥–æ–ª–∂–Ω—ã –ø–æ—Å—Ç–µ–ø–µ–Ω–Ω–æ —É—Ö–æ–¥–∏—Ç—å –æ—Ç –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ —É–ø–∞–∫–æ–≤–∫–∞–º–∏. –≠—Ç–æ —Å—ç–∫–æ–Ω–æ–º–∏—Ç —Å—Ä–µ–¥—Å—Ç–≤–∞ –±—é–¥–∂–µ—Ç–∞ –∏ –≥—Ä–∞–∂–¥–∞–Ω –∏ —Å–¥–µ–ª–∞–µ—Ç —Å–∏—Å—Ç–µ–º—É –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ–π. ‚ù§Ô∏è –ù–æ–≤–æ–µ –ø–æ–∫–∞–∑–∞–Ω–∏–µ. ¬´–ò–≤–ª–∏–∑–∏¬ª —Ç–µ–ø–µ—Ä—å –º–æ–∂–Ω–æ –ø—Ä–∏–º–µ–Ω—è—Ç—å –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏ —Å–ø–µ–∫—Ç—Ä–∞ –æ–ø—Ç–∏–∫–æ–Ω–µ–≤—Ä–æ–º–∏–µ–ª–∏—Ç–∞. –†–∞–Ω–µ–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç –±—ã–ª –ø—Ä–µ–¥–Ω–∞–∑–Ω–∞—á–µ–Ω –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ —Ä–∞—Å—Å–µ—è–Ω–Ω–æ–≥–æ —Å–∫–ª–µ—Ä–æ–∑–∞ –∏ —Å–∏—Å—Ç–µ–º–Ω–æ–π —Å–∫–ª–µ—Ä–æ–¥–µ—Ä–º–∏–∏.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety"",
  ""impact"": ""medium"",
  ""english"": ""A new indication for 'Ivlix' has been approved, now it can be used to treat patients with a spectrum of optic neuritis. Previously the drug was prescribed for treatment of multiple sclerosis and systemic sclerosis.""
}"
2025-10-14T15:49:02+00:00,@medpharm,13100,https://t.me/medpharm/13100,"–ê–Ω—Ç–∏—Å–µ–ø—Ç–∏—á–µ—Å–∫–∏–µ ¬´—Ñ–ª–æ–º–∞—Å—Ç–µ—Ä—ã¬ª –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–õ–µ–∫–∫–µ—Ä¬ª –∏—Å—á–µ–∑–ª–∏ –∏–∑ –∞–ø—Ç–µ–∫, –ø–∏—à—É—Ç –°–ú–ò. –ü—Ä–∏—á–∏–Ω–æ–π —Å—Ç–∞–ª–∞ –æ—Ç–º–µ–Ω–∞ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –≤ –æ–∫—Ç—è–±—Ä–µ 2024 –≥–æ–¥–∞. –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä –Ω–µ –ø—Ä–∏–∑–Ω–∞–µ—Ç –∏—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º–∏ –∏–∑–¥–µ–ª–∏—è–º–∏. –í –∫–æ–º–ø–∞–Ω–∏–∏ –ø—Ä–æ–∏—Å—Ö–æ–¥—è—â–µ–µ —Å–≤—è–∑—ã–≤–∞—é—Ç —Å –Ω–µ–¥–æ–±—Ä–æ—Å–æ–≤–µ—Å—Ç–Ω–æ–π –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏–µ–π –∏ –¥–∞–∂–µ –Ω–∞–∑—ã–≤–∞—é—Ç —Ä–µ–π–¥–µ—Ä—Å—Ç–≤–æ–º, –∞ —Ç–∞–∫–∂–µ –æ—Ç–º–µ—á–∞—é—Ç –¥–ª–∏—Ç–µ–ª—å–Ω—É—é –∏—Å—Ç–æ—Ä–∏—é –ø—Ä–µ—Ç–µ–Ω–∑–∏–π ‚Äî —Å 2005 –≥–æ–¥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PjaL2 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, shortage"",
  ""impact"": ""medium"",
  ""english"": ""Antiseptics 'Flomasters' produced by company 'Leker' have disappeared from pharmacies due to registration cancellation in October 2024. The Roszdravnadzor does not consider them medical devices. The company attributes the situation to unethical competition and even calls it a takeover, noting long-standing claims since 2005. For more details: https://clck.ru/3PjaL2 #FarmaVestnik #Production""
}"
2025-10-14T15:17:04+00:00,@medpharm,13099,https://t.me/medpharm/13099,"–ß–∏—Å–ª–æ –≥–æ—Å–ø–∏—Ç–∞–ª–∏–∑–∞—Ü–∏–π –≤ –º–æ—Å–∫–æ–≤—Å–∫–∏–µ —Å—Ç–∞—Ü–∏–æ–Ω–∞—Ä—ã —Å 2020 –ø–æ 2024 —É–≤–µ–ª–∏—á–∏–ª–æ—Å—å —Å 3,8 –¥–æ 4,3 –º–ª–Ω. –≠—Ç–æ —Å—Ç–∞–ª–æ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–æ–º –∞–∫—Ç–∏–≤–Ω–æ–≥–æ —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –∏ –º–æ–¥–µ—Ä–Ω–∏–∑–∞—Ü–∏–∏ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏–π —Å—Ç–æ–ª–∏—Ü—ã, —Å—á–∏—Ç–∞—é—Ç –∞–Ω–∞–ª–∏—Ç–∏–∫–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PjYWg #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": true,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The number of hospitalizations in Moscow hospitals increased from 3.8 million to 4.3 million between 2020 and 2024, according to analysts. This increase is attributed to active construction and modernization of healthcare institutions in the capital.""
}"
2025-10-14T15:05:05+00:00,@medpharm,13098,https://t.me/medpharm/13098,–í –°–®–ê –æ–¥–æ–±—Ä–µ–Ω –ø–µ—Ä–≤—ã–π –ø–æ–¥–∫–æ–∂–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è –ª–µ—á–µ–Ω–∏—è –±–∏–ø–æ–ª—è—Ä–Ω–æ–≥–æ —Ä–∞—Å—Å—Ç—Ä–æ–π—Å—Ç–≤–∞ I-–≥–æ —Ç–∏–ø–∞ —É –≤–∑—Ä–æ—Å–ª—ã—Ö –Ω–∞ –æ—Å–Ω–æ–≤–µ —Ä–∏—Å–ø–µ—Ä–∏–¥–æ–Ω–∞. Uzedy –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∏—Ç –∫–æ–º–ø–∞–Ω–∏—è–º Teva Pharmaceuticals –∏ Medincell. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PjXN6 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-10-14T14:28:02+00:00,@medpharm,13097,https://t.me/medpharm/13097,"–†–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏–µ –∏—Å–∫–∞ –æ –±–∞–Ω–∫—Ä–æ—Ç—Å—Ç–≤–µ –§–ù–° –£—Å–æ–ª—å–µ-–°–∏–±–∏—Ä—Å–∫–æ–≥–æ —Ö–∏–º–∏–∫–æ-—Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ –∑–∞–≤–æ–¥–∞ –æ—Ç–ª–æ–∂–∏–ª–∏ –Ω–∞ 15 –¥–µ–∫–∞–±—Ä—è. –°—É–º–º–∞ –∏—Å–∫–æ–≤—ã—Ö —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π ‚Äî 333,7 –º–ª–Ω —Ä—É–±. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PjUqk #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-14T14:18:03+00:00,@medpharm,13096,https://t.me/medpharm/13096,–í –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–µ –†–§ –æ—Ç–º–µ—á–∞—é—Ç —Å–æ–∫—Ä–∞—â–µ–Ω–∏–µ –¥–µ—Ñ–∏—Ü–∏—Ç–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∫–∞–¥—Ä–æ–≤. –°–∏—Ç—É–∞—Ü–∏—é —Å –æ—Ç—Ç–æ–∫–æ–º —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –∏–∑ –≥–æ—Å—Å–µ–∫—Ç–æ—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è —É–¥–∞–ª–æ—Å—å –ø–µ—Ä–µ–ª–æ–º–∏—Ç—å –≤ 2023 –≥–æ–¥—É. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PjUCn #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-10-14T13:40:04+00:00,@medpharm,13095,https://t.me/medpharm/13095,"–§–∞—Ä–º–≥–∏–≥–∞–Ω—Ç—ã –∑–∞–ø—É—Å–∫–∞—é—Ç –ø—Ä—è–º—ã–µ –ø—Ä–æ–¥–∞–∂–∏ –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –≤ –°–®–ê, –ø—Ä–µ–¥–ª–∞–≥–∞—è –Ω–∞ –Ω–∏—Ö –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω—ã–µ —Å–∫–∏–¥–∫–∏. –°—Ä–µ–¥–∏ –∫–æ–º–ø–∞–Ω–∏–π, –∫–æ—Ç–æ—Ä—ã–µ –ø–æ—à–ª–∏ –Ω–∞ —ç—Ç–æ—Ç —à–∞–≥ –ø–æ—Å–ª–µ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –¢—Ä–∞–º–ø–∞ —Å–¥–µ–ª–∞—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –¥–µ—à–µ–≤–ª–µ –¥–ª—è –∞–º–µ—Ä–∏–∫–∞–Ω—Ü–µ–≤, ‚Äî Pfizer, AstraZeneca, BMS, Novo Nordisk, Eli Lilly –∏ Sanofi. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PjRaU #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-14T13:06:06+00:00,@medpharm,13094,https://t.me/medpharm/13094,"–ù–∏–∂–µ–≥–æ—Ä–æ–¥—Å–∫–∏–µ —É—á–µ–Ω—ã–µ —Å–æ–∑–¥–∞—é—Ç —Ä–æ–±–æ—Ç–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—É—é —Ä—É–∫—É-–∞—Å—Å–∏—Å—Ç–µ–Ω—Ç–∞, –∫–æ—Ç–æ—Ä–∞—è –±—É–¥–µ—Ç –ø–æ–º–æ–≥–∞—Ç—å –º–µ–¥—Å–µ—Å—Ç—Ä–∞–º —Å —Ä—É—Ç–∏–Ω–Ω—ã–º–∏ –∑–∞–¥–∞—á–∞–º–∏. –£—Å—Ç—Ä–æ–π—Å—Ç–≤–æ —Å–º–æ–∂–µ—Ç —Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞—Ç—å –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –±—Ä–∞—Ç—å –∫—Ä–æ–≤—å –∏ –º–∞—Ä–∫–∏—Ä–æ–≤–∞—Ç—å –ø—Ä–æ–±–∏—Ä–∫–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PjPMt #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-10-14T12:43:03+00:00,@medpharm,13093,https://t.me/medpharm/13093,"–î–µ–ø—É—Ç–∞—Ç –ê–π—Ä–∞—Ç –§–∞—Ä—Ä–∞—Ö–æ–≤ —Å—á–∏—Ç–∞–µ—Ç, —á—Ç–æ —Ä–æ–∑–Ω–∏—á–Ω—ã–π –∏ –≥–æ—Å–ø–∏—Ç–∞–ª—å–Ω—ã–π —Å–µ–≥–º–µ–Ω—Ç—ã –¥–æ–ª–∂–Ω—ã –ø–æ—Å—Ç–µ–ø–µ–Ω–Ω–æ —É—Ö–æ–¥–∏—Ç—å –æ—Ç –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ —É–ø–∞–∫–æ–≤–∫–∞–º–∏. –≠—Ç–æ —Å—ç–∫–æ–Ω–æ–º–∏—Ç —Å—Ä–µ–¥—Å—Ç–≤–∞ –±—é–¥–∂–µ—Ç–∞ –∏ –≥—Ä–∞–∂–¥–∞–Ω –∏ —Å–¥–µ–ª–∞–µ—Ç —Å–∏—Å—Ç–µ–º—É –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ–π. –ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã–µ –∞–ø—Ç–µ–∫–∏ —É–∂–µ –∏–º–µ—é—Ç –ø—Ä–∞–≤–æ –≤—Å–∫—Ä—ã–≤–∞—Ç—å —É–ø–∞–∫–æ–≤–∫–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –æ—Ç–º–µ—Ç–∏–ª –¥–µ–ø—É—Ç–∞—Ç. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PjMjf #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, regulation"",
  ""impact"": ""medium"",
  ""english"": ""Deputy Ayrat Farrarov believes that the retail and hospital segments should gradually move away from using medicines in packages. This will save budget funds for citizens and make the pharmaceutical supply system efficient. The deputy noted that production pharmacies already have the right to open package contents of medications.""
}"
2025-10-14T11:37:03+00:00,@medpharm,13092,https://t.me/medpharm/13092,"–°—É–¥ –∑–∞–ø—Ä–µ—Ç–∏–ª –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–î–∂–æ–¥–∞—Å –≠–∫—Å–ø–æ–∏–º¬ª –≤–≤–æ–¥–∏—Ç—å –≤ –≥—Ä–∞–∂–¥–∞–Ω—Å–∫–∏–π –æ–±–æ—Ä–æ—Ç, –ø—Ä–µ–¥–ª–∞–≥–∞—Ç—å –∫ –ø—Ä–æ–¥–∞–∂–µ –∏ –ø—Ä–æ–¥–∞–≤–∞—Ç—å –≤–æ—Å–ø—Ä–æ–∏–∑–≤–µ–¥–µ–Ω–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç ¬´–ê–≤—Ü–µ—Ñ—Ç¬ª, –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–π –≤ –¥–µ–∫–∞–±—Ä–µ 2023 –≥–æ–¥–∞, –∏–ª–∏ –ª—é–±–æ–µ –¥—Ä—É–≥–æ–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–æ, —Å–æ–¥–µ—Ä–∂–∞—â–µ–µ –∞–≤–∏–±–∞–∫—Ç–∞–º, –¥–æ 24 –∏—é–ª—è 2026 –≥–æ–¥–∞ (–¥–∞—Ç—ã –∏—Å—Ç–µ—á–µ–Ω–∏—è —Å—Ä–æ–∫–∞ –¥–µ–π—Å—Ç–≤–∏—è –µ–≤—Ä–∞–∑–∏–π—Å–∫–æ–≥–æ –ø–∞—Ç–µ–Ω—Ç–∞). –¢–∞–∫–∂–µ –æ—Ç–≤–µ—Ç—á–∏–∫–∞ –æ–±—è–∑–∞–ª–∏ –æ–±—Ä–∞—Ç–∏—Ç—å—Å—è –≤ –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏ —Å –∑–∞—è–≤–ª–µ–Ω–∏–µ–º –æ –ø—Ä–µ–∫—Ä–∞—â–µ–Ω–∏–∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ ¬´–ê–≤—Ü–µ—Ñ—Ç–∞¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PjGjN #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, sanctions"",
  ""impact"": ""high"",
  ""english"": ""The court has banned the company 'Djodas Expoim' from introducing the product into civil use, offering for sale, or selling reproduced drug 'Avzetf', registered in December 2023, or any other medication containing avibactam until July 24, 2026 (the expiration dates of the EAE patent). The respondent was also ordered to submit a statement to the Russian Ministry of Health about ceasing registration of 'Avzetf'.""
}"
2025-10-14T10:50:07+00:00,@medpharm,13091,https://t.me/medpharm/13091,"BMS –ø—Ä–∏–æ–±—Ä–µ—Ç–∞–µ—Ç Orbital Therapeutics –∑–∞ 1,5 –º–ª—Ä–¥ –¥–æ–ª–ª., —á—Ç–æ–±—ã –ø–æ–ª—É—á–∏—Ç—å —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—é –∏–Ω—ä–µ–∫—Ü–∏–æ–Ω–Ω–æ–π CAR-T-—Ç–µ—Ä–∞–ø–∏–∏ –¥–ª—è –∞—É—Ç–æ–∏–º–º—É–Ω–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –ì–ª–∞–≤–Ω–∞—è —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∞ —Å—Ç–∞—Ä—Ç–∞–ø–∞ ‚Äî OTX-201 ‚Äî —É—Å–ø–µ—à–Ω–æ —É–Ω–∏—á—Ç–æ–∂–∏–ª–∞ B-–∫–ª–µ—Ç–∫–∏ –≤ –æ–ø—ã—Ç–∞—Ö –Ω–∞ –ø—Ä–∏–º–∞—Ç–∞—Ö. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PjCWT #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–ì–µ–º–∞—Ç–æ–ª–æ–≥–∏—è #–û–Ω–∫–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-10-14T10:44:03+00:00,@medpharm,13090,https://t.me/medpharm/13090,¬´–ò–≤–ª–∏–∑–∏¬ª –ø–æ–ª—É—á–∏–ª –Ω–æ–≤–æ–µ –ø–æ–∫–∞–∑–∞–Ω–∏–µ. –¢–µ–ø–µ—Ä—å –µ–≥–æ –º–æ–∂–Ω–æ –ø—Ä–∏–º–µ–Ω—è—Ç—å –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏ —Å–ø–µ–∫—Ç—Ä–∞ –æ–ø—Ç–∏–∫–æ–Ω–µ–≤—Ä–æ–º–∏–µ–ª–∏—Ç–∞. –†–∞–Ω–µ–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç –±—ã–ª –ø—Ä–µ–¥–Ω–∞–∑–Ω–∞—á–µ–Ω –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ —Ä–∞—Å—Å–µ—è–Ω–Ω–æ–≥–æ —Å–∫–ª–µ—Ä–æ–∑–∞ –∏ —Å–∏—Å—Ç–µ–º–Ω–æ–π —Å–∫–ª–µ—Ä–æ–¥–µ—Ä–º–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PjC3i #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-10-14T09:55:07+00:00,@medpharm,13089,https://t.me/medpharm/13089,"–ü–æ–∂–∏–ª—ã–µ –ø–∞—Ü–∏–µ–Ω—Ç—ã, –ø–æ–ª—É—á–∞—é—â–∏–µ —Ç—Ä–∞–º–∞–¥–æ–ª –≤ —Å–æ—á–µ—Ç–∞–Ω–∏–∏ —Å –Ω–µ–∫–æ—Ç–æ—Ä—ã–º–∏ –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç–∞–º–∏, —Å—Ç–æ–ª–∫–Ω—É–ª–∏—Å—å —Å –ø–æ–≤—ã—à–µ–Ω–Ω—ã–º —Ä–∏—Å–∫–æ–º —Å—É–¥–æ—Ä–æ–≥. –†–∏—Å–∫ –±—ã–ª –æ—Å–æ–±–µ–Ω–Ω–æ –≤—ã—Å–æ–∫ –¥–ª—è –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç–æ–≤, –∏–Ω–≥–∏–±–∏—Ä—É—é—â–∏—Ö —Ñ–µ—Ä–º–µ–Ω—Ç CYP2D6, –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã–π –¥–ª—è –º–µ—Ç–∞–±–æ–ª–∏–∑–º–∞ —Ç—Ä–∞–º–∞–¥–æ–ª–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pj7vG #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ù–µ–≤—Ä–æ–ª–æ–≥–∏—è #–ü—Å–∏—Ö–∏–∞—Ç—Ä–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance"",
  ""impact"": ""high"",
  ""english"": ""Old patients taking tramadol in combination with certain antidepressants are at a higher risk of seizures. The risk was particularly high for antidepressants that inhibit CYP2D6, an enzyme necessary for tramadol metabolism. More details: https://clck.ru/3Pj7vG #Mednews #Practice #Neurology #Psychiatry #Therapy #Pharmacology""
}"
2025-10-14T09:51:03+00:00,@medpharm,13088,https://t.me/medpharm/13088,"–ê–ª—å—è–Ω—Å —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–π –æ–±—Ä–∞—Ç–∏–ª—Å—è –∫ –≥–ª–∞–≤–µ –§–ê–¶ —Å –ø—Ä–æ—Å—å–±–æ–π —Å–Ω–∏–∑–∏—Ç—å —Ñ–æ—Ä–º–∞–ª–∏–∑–º –ø—Ä–∏ –æ—Ü–µ–Ω–∫–µ –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤ —Ñ–∞—Ä–º—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ —Å –±–æ–ª—å—à–∏–º –æ–ø—ã—Ç–æ–º —Ä–∞–±–æ—Ç—ã. –°–µ–π—á–∞—Å –ø—Ä–æ–≤–∏–∑–æ—Ä—ã —Å–æ —Å—Ç–∞–∂–µ–º —Ä–∞–±–æ—Ç—ã 25 –∏ –±–æ–ª–µ–µ –ª–µ—Ç –ø—Ä–æ—Ö–æ–¥—è—Ç –¥–ª–∏—Ç–µ–ª—å–Ω—É—é –ø–µ—Ä–µ–ø–æ–¥–≥–æ—Ç–æ–≤–∫—É –∏–∑-–∑–∞ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏—è –Ω—É–∂–Ω—ã—Ö –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤ –∏–ª–∏ –æ—à–∏–±–æ–∫ –≤ —Ç—Ä—É–¥–æ–≤–æ–π –∫–Ω–∏–∂–∫–µ. –°—Ç–æ–ª–∫–Ω—É–≤—à–∏—Å—å —Å —ç—Ç–∏–º–∏ –ø—Ä–æ–±–ª–µ–º–∞–º–∏, —Ä–∞–±–æ—Ç–Ω–∏–∫–∏ —É—Ö–æ–¥—è—Ç –∏–∑ –∞–ø—Ç–µ—á–Ω–æ–≥–æ –¥–µ–ª–∞, —É—Å—É–≥—É–±–ª—è—è –¥–µ—Ñ–∏—Ü–∏—Ç –∫–∞–¥—Ä–æ–≤ –≤ –æ—Ç—Ä–∞—Å–ª–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pj7dR #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–∞—Ä—å–µ—Ä–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""The pharmaceutical association has appealed to the head of FAPZ for reduced formalism in evaluating documents from experienced pharmacists. Due to a lack of necessary documents or errors in their work records, staff with over 25 years of experience are undergoing prolonged retraining. This is causing experienced workers to leave the industry, exacerbating a shortage of skilled personnel.""
}"
2025-10-14T08:25:05+00:00,@medpharm,13087,https://t.me/medpharm/13087,"–î–µ–ø—É—Ç–∞—Ç—ã –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç —Ä–∞–∑—Ä–µ—à–∏—Ç—å —Ä–æ—Å—Å–∏—è–Ω–∞–º –º–µ–Ω—è—Ç—å –ø–æ–ª–∏–∫–ª–∏–Ω–∏–∫—É –Ω–µ –µ–∂–µ–≥–æ–¥–Ω–æ, –∞ –∫–∞–∂–¥—ã–µ —Ç—Ä–∏ –º–µ—Å—è—Ü–∞. –ò–Ω–∏—Ü–∏–∞—Ç–∏–≤–∞ –ø—Ä–∏–∑–≤–∞–Ω–∞ —É–ø—Ä–æ—Å—Ç–∏—Ç—å –≤—ã–±–æ—Ä –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—è –¥–ª—è –≥—Ä–∞–∂–¥–∞–Ω –∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–µ–µ —Ä–∞—Å–ø—Ä–µ–¥–µ–ª—è—Ç—å –Ω–∞–≥—Ä—É–∑–∫—É –º–µ–∂–¥—É –≤—Ä–∞—á–∞–º–∏. ‚Äã –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PiyPc #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""Deputies propose allowing Russians to change their polyclinic every three months instead of annually. The initiative aims to simplify patients' choice of healthcare institutions and more efficiently distribute workload among doctors.""
}"
2025-10-14T07:31:02+00:00,@medpharm,13086,https://t.me/medpharm/13086,"–ñ–µ—Å—Ç–∫–æ–µ —Ä–∞–∑–±–∏—Ä–∞—Ç–µ–ª—å—Å—Ç–≤–æ –ø–æ —Ñ–∞–∫—Ç—É —Å—Ä—ã–≤–∞ —Ä–µ–≤–∏–∑–∏–∏ –≤ —Å–µ—Ç–∏ ¬´–ö—É—Ä—Å–∫–∞—è —Ñ–∞—Ä–º–∞—Ü–∏—è¬ª –∞–Ω–æ–Ω—Å–∏—Ä–æ–≤–∞–ª –≥—É–±–µ—Ä–Ω–∞—Ç–æ—Ä —Ä–µ–≥–∏–æ–Ω–∞. –ü—Ä–æ–≤–µ—Ä–∫–∞, –∫–æ—Ç–æ—Ä—É—é –æ–Ω –ø–æ—Ä—É—á–∏–ª –ø—Ä–æ–≤–µ—Å—Ç–∏ –µ—â–µ –≤ –∞–≤–≥—É—Å—Ç–µ, –¥–æ —Å–∏—Ö –ø–æ—Ä –Ω–µ –Ω–∞—á–∞—Ç–∞. –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –•–∏–Ω—à—Ç–µ–π–Ω —Ä–∞—Å–∫—Ä–∏—Ç–∏–∫–æ–≤–∞–ª –±–µ–∑–¥–µ–π—Å—Ç–≤–∏–µ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PitwK #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{""skip"": true}"
2025-10-14T07:18:07+00:00,@medpharm,13085,https://t.me/medpharm/13085,"–í–°–ü –ø—Ä–æ—Å–∏—Ç –ü—É—Ç–∏–Ω–∞ –æ—Ç–∫–ª–æ–Ω–∏—Ç—å –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç, –∏—Å–∫–ª—é—á–∞—é—â–∏–π —Å—Ç—Ä–∞—Ö–æ–≤—ã–µ –∫–æ–º–ø–∞–Ω–∏–∏ –∏–∑ —Å–∏—Å—Ç–µ–º—ã –û–ú–°. –û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è —Å—á–∏—Ç–∞–µ—Ç, —á—Ç–æ —ç—Ç–æ —É—Ö—É–¥—à–∏—Ç –∑–∞—â–∏—Ç—É –ø—Ä–∞–≤ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –∏ –ø—Ä–∏–≤–µ–¥–µ—Ç –∫ –Ω–µ—Ä–∞–≤–µ–Ω—Å—Ç–≤—É –º–µ–∂–¥—É —Ä–µ–≥–∏–æ–Ω–∞–º–∏ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pit2J #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement"",
  ""impact"": ""high"",
  ""english"": ""A non-governmental organization is requesting President Putin to reject a law project that excludes insurance companies from the OMS system. The organization believes this will worsen patients' rights protection and lead to regional inequality.""
}"
2025-10-13T16:35:12+00:00,@medpharm,13084,https://t.me/medpharm/13084,"ü¶æ –í—ã–±—Ä–∞–ª–∏ —Å—Ç–æ—Ä–æ–Ω—É. –ü–æ–ø—Ä–∞–≤–∫–∏ –≤ –∑–∞–∫–æ–Ω –æ–± –û–ú–°, –ø—Ä–µ–¥—É—Å–º–∞—Ç—Ä–∏–≤–∞—é—â–∏–µ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª–µ–Ω–∏–µ –≥–ª–∞–≤–∞–º —Ä–µ–≥–∏–æ–Ω–æ–≤ –ø—Ä–∞–≤–∞ –ø–µ—Ä–µ–¥–∞–≤–∞—Ç—å —Ñ—É–Ω–∫—Ü–∏–∏ —Å—Ç—Ä–∞—Ö–æ–≤—â–∏–∫–æ–≤ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω—ã–º —Ñ–æ–Ω–¥–∞–º –û–ú–°, –≤—ã–∑–≤–∞–ª–∏ –æ—Å—Ç—Ä—ã–µ —Å–ø–æ—Ä—ã. –ù–æ —ç—Ç–æ –æ–¥–Ω–æ –∏–∑ —Ç–µ—Ö —Ä–µ—à–µ–Ω–∏–π, –∫–æ—Ç–æ—Ä—ã–µ –∂–¥–µ—Ç –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç—å. ü¶æ –ú–∞—Å—à—Ç–∞–±—ã –æ–±–Ω–æ–≤–ª–µ–Ω–∏—è. –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏ –ø—Ä–µ–¥–ª–æ–∂–∏–ª —Å—É—â–µ—Å—Ç–≤–µ–Ω–Ω–æ —Ä–∞—Å—à–∏—Ä–∏—Ç—å –ø–µ—Ä–µ—á–µ–Ω—å –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –¥–ª—è –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –ø–µ—Ä–≤–∏—á–Ω–æ–≥–æ –∑–≤–µ–Ω–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –í —Å–ø–∏—Å–æ–∫ –≤–æ–π–¥—É—Ç 364 –ø–æ–∑–∏—Ü–∏–∏ –≤–º–µ—Å—Ç–æ 217. ‚ù§Ô∏è –ö–∞–¥—Ä–æ–≤—ã–µ –ø–µ—Ä–µ—Å—Ç–∞–Ω–æ–≤–∫–∏. –ë—ã–≤—à–∏–π —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å –∞–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ AlphaRM –ê–Ω–Ω–∞ –ï—Ä–º–æ–ª–∞–µ–≤–∞ –∑–∞–Ω—è–ª–∞ –ø–æ—Å—Ç –∏—Å–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–≥–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –º–∞—Ä–∫–µ—Ç–∏–Ω–≥–æ–≤–æ–≥–æ —Å–æ—é–∑–∞ ¬´–°–æ–∑–≤–µ–∑–¥–∏–µ¬ª. –û–Ω–∞ –∑–∞–π–º–µ—Ç—Å—è –æ–ø—Ç–∏–º–∏–∑–∞—Ü–∏–µ–π –±–∏–∑–Ω–µ—Å-–ø—Ä–æ—Ü–µ—Å—Å–æ–≤ –∏ —Ä–∞–∑–≤–∏—Ç–∏–µ–º –ø–∞—Ä—Ç–Ω–µ—Ä—Å–∫–æ–π —Å–µ—Ç–∏. ‚ù§Ô∏è –ü—Ä–æ–∫–æ–Ω—Ç—Ä–æ–ª–∏—Ä—É—é—Ç –Ω–∞–∑–Ω–∞—á–µ–Ω–∏–µ. –¢—Ä–µ–±–æ–≤–∞–Ω–∏—è, —Å–≤—è–∑–∞–Ω–Ω—ã–µ —Å –Ω–∞–∑–Ω–∞—á–µ–Ω–∏–µ–º –≤—Ä–∞—á–∞–º–∏ –ë–ê–î, –±—É–¥—É—Ç –≤–∫–ª—é—á–µ–Ω—ã –≤ —Å—Ñ–µ—Ä—É –∫–æ–Ω—Ç—Ä–æ–ª—è –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–∞ —Å 18 –æ–∫—Ç—è–±—Ä—è. –ü–æ —Å–ª–æ–≤–∞–º —ç–∫—Å–ø–µ—Ä—Ç–∞, –ø—Ä–∏–Ω—è—Ç–∏–µ –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ ‚Äî –ª–æ–≥–∏—á–Ω—ã–π —à–∞–≥ –≤ —Å–≤–µ—Ç–µ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª–µ–Ω–∏—è –≤—Ä–∞—á–∞–º –ø—Ä–∞–≤–∞ –Ω–∞–∑–Ω–∞—á–∞—Ç—å –±–∏–æ–¥–æ–±–∞–≤–∫–∏ –ø–∞—Ü–∏–µ–Ω—Ç–∞–º.","{""skip"": true}"
2025-10-13T15:56:06+00:00,@medpharm,13083,https://t.me/medpharm/13083,"–†–µ–≥—É–ª—è—Ç–æ—Ä –ø–µ—Ä–µ–Ω–µ—Å —Å—Ä–æ–∫ –≤—Å—Ç—É–ø–ª–µ–Ω–∏—è –≤ —Å–∏–ª—É —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π –∫ –∫–æ–µ—á–Ω–æ–º—É —Ñ–æ–Ω–¥—É –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π, –æ–∫–∞–∑—ã–≤–∞—é—â–∏—Ö –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫—É—é –ø–æ–º–æ—â—å. –û—Ç—Å—Ä–æ—á–∫–∞ –¥–µ–¥–ª–∞–π–Ω–∞ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω—è–µ—Ç—Å—è –Ω–∞ –∫–ª–∏–Ω–∏–∫–∏, –æ—Ç–∫—Ä—ã—Ç—ã–µ –¥–æ 1 —è–Ω–≤–∞—Ä—è 2022 –≥–æ–¥–∞ –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PiQAo #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û–Ω–∫–æ–ª–æ–≥–∏—è #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The regulatory body has postponed the deadline for requirements regarding hospital bed capacity in oncology clinics. The extension applies to clinics opened before January 1, 2022.""
}"
2025-10-13T15:54:02+00:00,@medpharm,13082,https://t.me/medpharm/13082,"–†–æ—Å–ø–∞—Ç–µ–Ω—Ç —Å–æ–∑–¥–∞–µ—Ç —Ä–µ–µ—Å—Ç—Ä –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç—É–∞–ª—å–Ω—ã—Ö –ø—Ä–∞–≤ —Å–æ —Å—Ä–µ–¥–Ω–µ–æ—Ç—Ä–∞—Å–ª–µ–≤—ã–º–∏ —Å—Ç–∞–≤–∫–∞–º–∏. –ö–∞–∫ –æ—Ç–º–µ—á–∞–µ—Ç –≥–ª–∞–≤–∞ —Å–ª—É–∂–±—ã –Æ—Ä–∏–π –ó—É–±–æ–≤, —ç—Ç–æ –ø–æ–∑–≤–æ–ª–∏—Ç –±—é–¥–∂–µ—Ç–Ω—ã–º —É—á—Ä–µ–∂–¥–µ–Ω–∏—è–º, –≤ —á–∞—Å—Ç–Ω–æ—Å—Ç–∏ –≤ —Å—Ñ–µ—Ä–µ –º–µ–¥–∏—Ü–∏–Ω—ã, –∫–æ—Ä—Ä–µ–∫—Ç–Ω–æ –æ–ø—Ä–µ–¥–µ–ª—è—Ç—å —Å—Ç–æ–∏–º–æ—Å—Ç—å –æ–±—ä–µ–∫—Ç–æ–≤ –ò–° –∏ –∞–∫—Ç–∏–≤–Ω–µ–µ –≤–æ–≤–ª–µ–∫–∞—Ç—å –∏—Ö –≤ —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–∏–π –æ–±–æ—Ä–æ—Ç. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PiQ58 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The Rospatent is creating an intellectual property registry with sectoral fees. This will allow budget institutions, particularly in the medical field, to correctly determine the cost of objects and actively involve them in economic activities. More details: https://clck.ru/3PiQ58 #Farmaudit #Production""
}"
2025-10-13T15:24:07+00:00,@medpharm,13081,https://t.me/medpharm/13081,–†–æ—Å—Å—Ç–∞–Ω–¥–∞—Ä—Ç –æ–±–Ω–æ–≤–∏–ª –ì–û–°–¢ –ø–æ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ –∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ —ç–ª–µ–∫—Ç—Ä–∏—á–µ—Å–∫–∏—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π. –í –Ω–µ–º –ø–æ—è–≤–∏–ª–∏—Å—å –±–æ–ª–µ–µ —Å—Ç—Ä–æ–≥–∏–µ –∫—Ä–∏—Ç–µ—Ä–∏–∏ —ç–ª–µ–∫—Ç—Ä–æ–º–∞–≥–Ω–∏—Ç–Ω–æ–π —Å–æ–≤–º–µ—Å—Ç–∏–º–æ—Å—Ç–∏ –∏ –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–µ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –ï–ê–≠–°. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PiNMo #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-10-13T15:21:03+00:00,@medpharm,13080,https://t.me/medpharm/13080,"BMS –ø—Ä–∏–æ–±—Ä–µ—Ç–∞–µ—Ç –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–π —Å—Ç–∞—Ä—Ç–∞–ø Orbital Therapeutics –∑–∞ 1,5 –º–ª—Ä–¥ –¥–æ–ª–ª. –§–∞—Ä–º–≥–∏–≥–∞–Ω—Ç –ø–æ–ª—É—á–∏—Ç –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—É—é —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—é —Å–æ–∑–¥–∞–Ω–∏—è CAR-T-–∫–ª–µ—Ç–æ—á–Ω—ã—Ö —Ç–µ—Ä–∞–ø–∏–π, —Å–ø–æ—Å–æ–±–Ω—ã—Ö –ø–µ—Ä–µ–ø—Ä–æ–≥—Ä–∞–º–º–∏—Ä–æ–≤–∞—Ç—å –∏–º–º—É–Ω–Ω—ã–µ –∫–ª–µ—Ç–∫–∏ –Ω–∞ –±–æ—Ä—å–±—É —Å –≤–æ–∑–±—É–¥–∏—Ç–µ–ª—è–º–∏ –∞—É—Ç–æ–∏–º–º—É–Ω–Ω—ã—Ö –ø–∞—Ç–æ–ª–æ–≥–∏–π –Ω–µ–ø–æ—Å—Ä–µ–¥—Å—Ç–≤–µ–Ω–Ω–æ –≤ –æ—Ä–≥–∞–Ω–∏–∑–º–µ –ø–∞—Ü–∏–µ–Ω—Ç–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PiNA8 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-13T15:01:08+00:00,@medpharm,13079,https://t.me/medpharm/13079,"–ö–æ–º–ø–∞–Ω–∏–∏ ¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç¬ª, ¬´–†-–§–∞—Ä–º¬ª –∏ ¬´–ú–µ–¥–∏–ø–∞–ª-–û–Ω–∫–æ¬ª –±—É–¥—É—Ç –ø–æ—Å—Ç–∞–≤–ª—è—Ç—å –¥–ª—è –ø–æ–¥–æ–ø–µ—á–Ω—ã—Ö ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª –≤–∏–ª—Ç–æ–ª–∞—Ä—Å–µ–Ω, –Ω—É—Å–∏–Ω–µ—Ä—Å–µ–Ω –∏ –∏–º–º—É–Ω–æ–≥–ª–æ–±—É–ª–∏–Ω. –ó–∞–∫—É–ø–∏—Ç—å —Ä–∏—Å–¥–∏–ø–ª–∞–º –Ω–µ —É–¥–∞–ª–æ—Å—å –∏–∑-–∑–∞ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏—è –∑–∞—è–≤–æ–∫ –Ω–∞ —É—á–∞—Å—Ç–∏–µ –≤ –∞—É–∫—Ü–∏–æ–Ω–∞—Ö. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PiLsr #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{""skip"": true}"
2025-10-13T15:00:08+00:00,@medpharm,13078,https://t.me/medpharm/13078,–ï–∂–µ–≥–æ–¥–Ω–æ 13 –æ–∫—Ç—è–±—Ä—è –º–∏—Ä–æ–≤–æ–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–µ —Å–æ–æ–±—â–µ—Å—Ç–≤–æ –æ—Ç–º–µ—á–∞–µ—Ç –í—Å–µ–º–∏—Ä–Ω—ã–π –¥–µ–Ω—å –±–æ—Ä—å–±—ã —Å —Ç—Ä–æ–º–±–æ–∑–æ–º ‚Äî World Thrombosis Day. –†–æ—Å—Å–∏–π—Å–∫–æ–µ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –∏—Ç–∞–ª—å—è–Ω—Å–∫–æ–π —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ Alfasigma (–≤ –†–æ—Å—Å–∏–∏ ‚Äî ¬´–ê–ª—å—Ñ–∞—Å–∏–≥–º–∞ –†—É—Å¬ª) –æ—Ç–º–µ—Ç–∏–ª–æ –¥–∞—Ç—É —É—á–∞—Å—Ç–∏–µ–º –≤ –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–º –æ–±—Ä–∞–∑–æ–≤–∞—Ç–µ–ª—å–Ω–æ–º –ø—Ä–æ–µ–∫—Ç–µ ¬´–†–æ—Å—Å–∏–π—Å–∫–∏–π –∞–Ω—Ç–∏—Ç—Ä–æ–º–±–æ—Ç–∏—á–µ—Å–∫–∏–π —Ñ–æ—Ä—É–º¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PiLor #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-10-13T14:48:07+00:00,@medpharm,13077,https://t.me/medpharm/13077,"–†–µ–≥—É–ª—è—Ç–æ—Ä –ø–ª–∞–Ω–∏—Ä—É–µ—Ç –æ–±–Ω–æ–≤–∏—Ç—å –ø–µ—Ä–µ—á–µ–Ω—å –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –ø–µ—Ä–≤–∏—á–Ω–æ–≥–æ –∑–≤–µ–Ω–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è, –∞ —Ç–∞–∫–∂–µ –¥–ª—è —Ä–∞—Å–ø–æ–ª–æ–∂–µ–Ω–Ω—ã—Ö –≤ —Å–µ–ª—å—Å–∫–æ–π –º–µ—Å—Ç–Ω–æ—Å—Ç–∏ –∏ –º–∞–ª—ã—Ö –≥–æ—Ä–æ–¥–∞—Ö. –£—á—Ç–µ–Ω—ã —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –≤–µ–¥—É—â–∏—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ü–µ–Ω—Ç—Ä–æ–≤ –∏ –¥–µ–π—Å—Ç–≤—É—é—â–∏–µ —Å—Ç–∞–Ω–¥–∞—Ä—Ç—ã –æ—Å–Ω–∞—â–µ–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PiL2C #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The regulatory body plans to update the list of equipment for primary healthcare organizations and those located in rural areas and small towns. Considered are the recommendations of leading medical centers and existing equipment standards.""
}"
2025-10-13T14:46:22+00:00,@medpharm,13076,https://t.me/medpharm/13076,"–í –Ø—Ä–æ—Å–ª–∞–≤–ª–µ –∑–∞–≤–µ—Ä—à–∏–ª—Å—è XI –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–π –∏–Ω—Ç–µ—Ä–Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—ã–π –ª–∞–≥–µ—Ä—å –∏–Ω–Ω–æ–≤–∞—Ü–∏–π (–§–ò–õ–ò–ù). –ë–æ–ª–µ–µ 60 —Å—Ç—É–¥–µ–Ω—Ç–æ–≤ –≤—ã–ø—É—Å–∫–Ω—ã—Ö –∫—É—Ä—Å–æ–≤ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ, —Ö–∏–º–∏–∫–æ-—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ –∏ –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ –ø—Ä–æ—Ñ–∏–ª–µ–π –∏–∑ 31 –≤—É–∑–∞ –†–æ—Å—Å–∏–∏ –∏ –ë–µ–ª–æ—Ä—É—Å—Å–∏–∏ –∑–∞ –Ω–µ–¥–µ–ª—é –æ—Å–≤–æ–∏–ª–∏ –ø—Ä–æ–≥—Ä–∞–º–º—É ¬´–ê–ø—Ç–µ–∫–∞ –±—É–¥—É—â–µ–≥–æ¬ª. –ú–µ—Ä–æ–ø—Ä–∏—è—Ç–∏—è –ø—Ä–æ–µ–∫—Ç–∞ –ø—Ä–æ—à–ª–∏ –ø—Ä–∏ –ø–æ–¥–¥–µ—Ä–∂–∫–µ –≥—Ä—É–ø–ø—ã –∫–æ–º–ø–∞–Ω–∏–π ¬´–†-–§–∞—Ä–º¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PiKtZ","{""skip"": true}"
2025-10-13T14:08:07+00:00,@medpharm,13075,https://t.me/medpharm/13075,"–ú–î–ê –∑–∞—è–≤–∏–ª–∞ –æ —Ä–æ—Å—Ç–µ –æ—Ç–∫–∞–∑–æ–≤ –≤ –≤—ã–¥–∞—á–µ —Å–∏—Å—Ç–µ–º –Ω–µ–ø—Ä–µ—Ä—ã–≤–Ω–æ–≥–æ –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥–∞ –≥–ª—é–∫–æ–∑—ã –≤–∑—Ä–æ—Å–ª—ã–º –ø–∞—Ü–∏–µ–Ω—Ç–∞–º, –±–æ–ª–µ–µ 7 —Ç—ã—Å. —á–µ–ª–æ–≤–µ–∫ —Å—Ç–æ–ª–∫–Ω—É–ª–∏—Å—å —Å –∑–∞–¥–µ—Ä–∂–∫–∞–º–∏ –∏ –æ—Ç–∫–∞–∑–∞–º–∏. –î–µ–ø–∞—Ä—Ç–∞–º–µ–Ω—Ç –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ú–æ—Å–∫–≤—ã –æ–ø—Ä–æ–≤–µ—Ä–≥–∞–µ—Ç —ç—Ç–∏ —Å–æ–æ–±—â–µ–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PiH42 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""shortage, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The MDA reported an increase in refusals for continuous glucose monitoring systems to adult patients, with over 7,000 people experiencing delays and refusals. The Moscow Department of Health has denied these claims. More at https://clck.ru/3PiH42 #MedVestnik #Healthcare""
}"
2025-10-13T14:01:04+00:00,@medpharm,13074,https://t.me/medpharm/13074,"–ü–æ–ø—ã—Ç–∫–∏ –≤—ã–π—Ç–∏ –Ω–∞ –≤—å–µ—Ç–Ω–∞–º—Å–∫–∏–π —Ä—ã–Ω–æ–∫ —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –ø—Ä–µ–¥–ø—Ä–∏–Ω–∏–º–∞—é—Ç –º–Ω–æ–≥–æ –ª–µ—Ç —Å —Ä–∞–∑–Ω—ã–º —É—Å–ø–µ—Ö–æ–º. –í —Ç–µ—á–µ–Ω–∏–µ –ø–æ—Å–ª–µ–¥–Ω–∏—Ö –¥–≤—É—Ö –ª–µ—Ç ¬´–ø—Ä–æ–∏–∑–æ—à–ª–∞ —Å—É—â–µ—Å—Ç–≤–µ–Ω–Ω–∞—è –≥–∞—Ä–º–æ–Ω–∏–∑–∞—Ü–∏—è —Ä–æ—Å—Å–∏–π—Å–∫–æ–π –∏ –≤—å–µ—Ç–Ω–∞–º—Å–∫–æ–π —Ä–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∏¬ª. ¬´–£ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏–π –ø–æ—è–≤–ª—è–µ—Ç—Å—è –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –ø–æ –¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ –±—ã—Å—Ç—Ä–æ–π —Å—Ö–µ–º–µ —Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–∞, ‚Äî —Å–æ–æ–±—â–∏–ª –¥–µ–ø—É—Ç–∞—Ç –ì–î –†–§ –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ü–µ—Ç—Ä–æ–≤. ‚Äî –ß–µ—Ç—ã—Ä–µ –∫–æ–º–ø–∞–Ω–∏–∏ –ø–æ–¥–∞–ª–∏ —Ä–µ–≥–¥–æ—Å—å–µ –≤—å–µ—Ç–Ω–∞–º—Å–∫–æ–º—É —Ä–µ–≥—É–ª—è—Ç–æ—Ä—É. –¢–∞–∫–∂–µ —É –Ω–∞—Å –ø–æ—è–≤–∏–ª–∏—Å—å –ø–µ—Ä–≤—ã–µ —Å–µ—Ä—Ç–∏—Ñ–∏–∫–∞—Ç—ã –Ω–∞ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–µ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –ø–ª–æ—â–∞–¥–æ–∫ PIC/S. –†–∞–Ω—å—à–µ –±—ã–ª–æ –Ω–µ—Ä–µ–∞–ª—å–Ω–æ —á—Ç–æ-—Ç–æ —Å–¥–µ–ª–∞—Ç—å, —Å–µ–π—á–∞—Å —Å–∏—Ç—É–∞—Ü–∏—è –º–µ–Ω—è–µ—Ç—Å—è¬ª –ö–∞–∫ —Ä–æ—Å—Å–∏–π—Å–∫–∞—è —Ñ–∞—Ä–º–∞ –ø–æ–∫–æ—Ä—è–µ—Ç –í—å–µ—Ç–Ω–∞–º, —á–∏—Ç–∞–π—Ç–µ –≤ —Å–≤–µ–∂–µ–º –Ω–æ–º–µ—Ä–µ ¬´–§–í¬ª.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""Russian pharmaceutical companies have been trying to enter the Vietnamese market for many years with varying success. Over the past two years, there has been significant harmonization between Russian and Vietnamese regulatory bodies. 'Russian companies now have the opportunity to register medicines through a relatively quick process,' said Deputy G–î –†–§ Alexander Petrov. 'Four companies have already submitted applications to the Vietnamese regulator. We also now have our first certificates of conformity for Russian sites PIC/S. It was once impossible to do anything, but the situation is changing now.'""
}"
2025-10-13T13:38:03+00:00,@medpharm,13073,https://t.me/medpharm/13073,–í –ø–µ—Ä–≤–æ–π –ø–æ–ª–æ–≤–∏–Ω–µ –æ–∫—Ç—è–±—Ä—è –º–∏—Ä–æ–≤—ã–µ —Ä–µ–≥—É–ª—è—Ç–æ—Ä—ã –æ–¥–æ–±—Ä–∏–ª–∏ —Ç—Ä–∏ –Ω–æ–≤—ã—Ö –º–µ—Ç–æ–¥–∞ –ª–µ—á–µ–Ω–∏—è –∏ —Ä–∞—Å—à–∏—Ä–∏–ª–∏ –ø–æ–∫–∞–∑–∞–Ω–∏—è –¥–ª—è —Ç—Ä–µ—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PiEt8 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-10-13T12:56:03+00:00,@medpharm,13072,https://t.me/medpharm/13072,"–¢—Ä–µ–±–æ–≤–∞–Ω–∏—è, —Å–≤—è–∑–∞–Ω–Ω—ã–µ —Å –Ω–∞–∑–Ω–∞—á–µ–Ω–∏–µ–º –≤—Ä–∞—á–∞–º–∏ –ë–ê–î, –±—É–¥—É—Ç –≤–∫–ª—é—á–µ–Ω—ã –≤ —Å—Ñ–µ—Ä—É –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∫–æ–Ω—Ç—Ä–æ–ª—è —Å 18 –æ–∫—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞. –ü–æ —Å–ª–æ–≤–∞–º —ç–∫—Å–ø–µ—Ä—Ç–∞, –ø—Ä–∏–Ω—è—Ç–∏–µ –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ —è–≤–ª—è–µ—Ç—Å—è –ª–æ–≥–∏—á–Ω—ã–º —à–∞–≥–æ–º –≤ —Å–≤–µ—Ç–µ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª–µ–Ω–∏—è –≤—Ä–∞—á–∞–º –ø—Ä–∞–≤–∞ –Ω–∞–∑–Ω–∞—á–∞—Ç—å –∏—Ö –ø–∞—Ü–∏–µ–Ω—Ç–∞–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PiC3m #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""high"",
  ""english"": ""Regulatory requirements for prescribing doctors will be included in the scope of state control starting October 18, 2025. According to an expert, this is a logical step given the provision of doctors with the right to prescribe.""
}"
2025-10-13T12:55:06+00:00,@medpharm,13071,https://t.me/medpharm/13071,"–°–µ–≥–æ–¥–Ω—è –Ω–µ –ø—Ä–∏–Ω—è—Ç–æ –∏–Ω—Ç–µ—Ä–µ—Å–æ–≤–∞—Ç—å—Å—è –º–Ω–µ–Ω–∏–µ–º —Ç–µ—Ö, –∫—Ç–æ –∫–∞–∂–¥—ã–π –¥–µ–Ω—å —Ä–∞–±–æ—Ç–∞–µ—Ç —Å –æ–±—Å—É–∂–¥–∞–µ–º–æ–π –ø—Ä–æ–±–ª–µ–º–æ–π, —Ö–æ—Ç—è –≤ —Ç–µ–æ—Ä–∏–∏ —É–ø—Ä–∞–≤–ª–µ–Ω–∏—è –æ–±—Ä–∞—Ç–Ω–∞—è —Å–≤—è–∑—å ‚Äì –≤–∞–∂–Ω–µ–π—à–∏–π –ø—Ä–∏–Ω—Ü–∏–ø –ø—Ä–∏–Ω—è—Ç–∏—è —Ä–µ—à–µ–Ω–∏–π. –ö–∞–∫ –æ—â—É—â–∞–µ—Ç –Ω–∞ —Å–µ–±–µ –ø–µ—Ä–≤–∏—á–Ω–æ–µ –∑–≤–µ–Ω–æ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è ¬´—Å—Ç—Ä–∞—Ö–æ–≤—É—é¬ª –º–µ–¥–∏—Ü–∏–Ω—É, –∫–æ–≥–¥–∞ –µ—Å—Ç—å –§–µ–¥–µ—Ä–∞–ª—å–Ω—ã–π —Ñ–æ–Ω–¥ –û–ú–° (–§–û–ú–°), –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—è –∏ —á–∞—Å—Ç–Ω—ã–µ —Å—Ç—Ä–∞—Ö–æ–≤—ã–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ (–°–ú–û)? –ü–æ—á–µ–º—É-—Ç–æ –Ω–∏–∫—Ç–æ –Ω–µ —Ö–æ—á–µ—Ç –∑–∞–º–µ—á–∞—Ç—å –ø—Ä–∏–Ω—Ü–∏–ø–∏–∞–ª—å–Ω—ã—Ö –ø—Ä–æ—Ç–∏–≤–æ—Ä–µ—á–∏–π, –∫–æ—Ç–æ—Ä—ã–µ –∑–∞–ø–∏—Å–∞–Ω—ã –≤ —É—Å—Ç–∞–≤–∞—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π: –æ—Å–Ω–æ–≤–Ω–∞—è —Ü–µ–ª—å –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏–π ‚Äì –æ–∫–∞–∑—ã–≤–∞—Ç—å –º–µ–¥–∏—Ü–∏–Ω—Å–∫—É—é –ø–æ–º–æ—â—å, –∞ —á–∞—Å—Ç–Ω—ã—Ö —Å—Ç—Ä–∞—Ö–æ–≤—â–∏–∫–æ–≤ ‚Äì –ø–æ–ª—É—á–∞—Ç—å –ø—Ä–∏–±—ã–ª—å. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PiBxL #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ú—ã—Å–ª–∏_–≤—Å–ª—É—Ö #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-10-13T12:49:04+00:00,@medpharm,13070,https://t.me/medpharm/13070,–°—É–¥ –≤–æ –í–ª–∞–¥–∏–º–∏—Ä–µ —Ä–∞—Å—Å–º–æ—Ç—Ä–∏—Ç –¥–µ–ª–æ –º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –í–∞–ª–µ—Ä–∏—è –Ø–Ω–∏–Ω–∞. –ï–≥–æ –æ–±–≤–∏–Ω—è—é—Ç –≤ –ø—Ä–µ–≤—ã—à–µ–Ω–∏–∏ –¥–æ–ª–∂–Ω–æ—Å—Ç–Ω—ã—Ö –ø–æ–ª–Ω–æ–º–æ—á–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PiBTy #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-10-13T12:11:04+00:00,@medpharm,13069,https://t.me/medpharm/13069,"–ú–µ–¥–∏—Ü–∏–Ω–∞ –∑–∞–Ω—è–ª–∞ –ø—è—Ç–æ–µ –º–µ—Å—Ç–æ –ø–æ —Å–∫–æ—Ä–æ—Å—Ç–∏ –≤–Ω–µ–¥—Ä–µ–Ω–∏—è —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–∞ —Å—Ä–µ–¥–∏ –¥—Ä—É–≥–∏—Ö –æ—Ç—Ä–∞—Å–ª–µ–π —ç–∫–æ–Ω–æ–º–∏–∫–∏ –∏ —Å–æ—Ü–∏–∞–ª—å–Ω–æ–π —Å—Ñ–µ—Ä—ã –†–æ—Å—Å–∏–∏. –°–æ –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω—ã–º –æ—Ç—Ä—ã–≤–æ–º –µ–µ –æ–ø–µ—Ä–µ–∂–∞—é—Ç —Ç–æ—Ä–≥–æ–≤–ª—è, –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è –∏ —Å–≤—è–∑—å, —Ñ–∏–Ω–∞–Ω—Å–æ–≤—ã–π —Å–µ–∫—Ç–æ—Ä –∏ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–µ —É–ø—Ä–∞–≤–ª–µ–Ω–∏–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pi83d #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-10-13T11:49:03+00:00,@medpharm,13068,https://t.me/medpharm/13068,–ë—ã–≤—à–∏–π —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å –∞–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ AlphaRM –ê–Ω–Ω–∞ –ï—Ä–º–æ–ª–∞–µ–≤–∞ –∑–∞–Ω—è–ª–∞ –ø–æ—Å—Ç –∏—Å–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–≥–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –º–∞—Ä–∫–µ—Ç–∏–Ω–≥–æ–≤–æ–≥–æ —Å–æ—é–∑–∞ ¬´–°–æ–∑–≤–µ–∑–¥–∏–µ¬ª. –û–Ω–∞ –∑–∞–π–º–µ—Ç—Å—è –æ–ø—Ç–∏–º–∏–∑–∞—Ü–∏–µ–π –±–∏–∑–Ω–µ—Å-–ø—Ä–æ—Ü–µ—Å—Å–æ–≤ –∏ —Ä–∞–∑–≤–∏—Ç–∏–µ–º –ø–∞—Ä—Ç–Ω–µ—Ä—Å–∫–æ–π —Å–µ—Ç–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pi4hx #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–∞—Ä—å–µ—Ä–∞,"{""skip"": true}"
2025-10-13T11:39:04+00:00,@medpharm,13067,https://t.me/medpharm/13067,"–ë—ã–≤—à–∏–π –∑–∞–º–º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –£–¥–º—É—Ä—Ç–∏–∏ –ù–∞—Ç–∞–ª—å—è –ö—Ä–æ–ø–æ—á–µ–≤–∞ –∏ –µ–µ –∑–Ω–∞–∫–æ–º–∞—è –°–≤–µ—Ç–ª–∞–Ω–∞ –°—É—Å–ª–æ–Ω–æ–≤–∞ –æ—Å—É–∂–¥–µ–Ω—ã –∑–∞ –≤–∑—è—Ç–∫—É –≤ 1,3 –º–ª–Ω —Ä—É–±. –æ—Ç —Ä–∏—Ç—É–∞–ª—å–Ω–æ–≥–æ –∞–≥–µ–Ω—Ç—Å—Ç–≤–∞ –∏ —Ñ–∏–∫—Ç–∏–≤–Ω–æ–µ —Ç—Ä—É–¥–æ—É—Å—Ç—Ä–æ–π—Å—Ç–≤–æ. –î–µ–Ω—å–≥–∏ –±—ã–ª–∏ –ø–µ—Ä–µ–¥–∞–Ω—ã –∑–∞ –ø–æ–º–æ—â—å –≤ –ø–æ–ª—É—á–µ–Ω–∏–∏ –∫–æ–Ω—Ç—Ä–∞–∫—Ç–æ–≤ –Ω–∞ –ø–µ—Ä–µ–≤–æ–∑–∫—É —Ç–µ–ª —É–º–µ—Ä—à–∏—Ö –∏ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª–µ–Ω–∏–µ –¥–∞–Ω–Ω—ã—Ö. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pi3Jf #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-10-13T11:21:02+00:00,@medpharm,13066,https://t.me/medpharm/13066,"–û—Ä–≥–∞–Ω–∏–∑–∞—Ç–æ—Ä—ã ¬´XXVI –ü–ª–∞—Ç–∏–Ω–æ–≤–æ–π —É–Ω—Ü–∏–∏¬ª –∞–Ω–æ–Ω—Å–∏—Ä–æ–≤–∞–ª–∏ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏–µ –±–∏–∑–Ω–µ—Å-–∑–∞–≤—Ç—Ä–∞–∫–∞ ¬´–†—ã–Ω–æ–∫ –ë–ê–î. –ê–Ω–∞–ª–∏—Ç–∏–∫–∞, –Ω–æ–≤–æ—Å—Ç–∏, —Ç—Ä–µ–Ω–¥—ã¬ª. –û–Ω —Å–æ—Å—Ç–æ–∏—Ç—Å—è 15 –æ–∫—Ç—è–±—Ä—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Phyhw #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-13T10:46:04+00:00,@medpharm,13065,https://t.me/medpharm/13065,–í—Å–µ–º–∏—Ä–Ω–∞—è –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è (–í–û–ó) —Å–æ–æ–±—â–∏–ª–∞ –æ —Ä–æ—Å—Ç–µ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–Ω–æ—Å—Ç–∏ –∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫–æ—Ä–µ–∑–∏—Å—Ç–µ–Ω—Ç–Ω–æ—Å—Ç–∏ –≤ –º–∏—Ä–µ. –ù–∞–∏–±–æ–ª—å—à—É—é –æ–ø–∞—Å–Ω–æ—Å—Ç—å –ø—Ä–µ–¥—Å—Ç–∞–≤–ª—è—é—Ç –≥—Ä–∞–º–æ—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω—ã–µ –±–∞–∫—Ç–µ—Ä–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Phtf3 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ò–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã–µ_–±–æ–ª–µ–∑–Ω–∏ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è,"{""skip"": true}"
2025-10-13T10:44:03+00:00,@medpharm,13064,https://t.me/medpharm/13064,"–ù–∞—É—á–Ω—ã–π —Ü–µ–Ω—Ç—Ä —ç–∫—Å–ø–µ—Ä—Ç–∏–∑—ã —Å—Ä–µ–¥—Å—Ç–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è (–ù–¶–≠–°–ú–ü) –æ–ø—É–±–ª–∏–∫–æ–≤–∞–ª —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –¥–ª—è –º–∞–ª—ã—Ö –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã—Ö –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏–π, —Ä–∞–∑—Ä–∞–±–∞—Ç—ã–≤–∞—é—â–∏—Ö –Ω–æ–≤—ã–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ –≤ —Å—Ñ–µ—Ä–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –û–Ω–∏ –≤–∫–ª—é—á–∞—é—Ç 13 –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PhtN9 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-13T10:04:04+00:00,@medpharm,13063,https://t.me/medpharm/13063,"–î–≤–∞ –ø–æ—Å—Ç–∞–≤—â–∏–∫–∞ —Ñ–∞–ª—å—Å–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö —Ä–µ–Ω—Ç–≥–µ–Ω-–∞–ø–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –±–æ–ª—å–Ω–∏—Ü –ü–µ—Ä–º–∏ –ø—Ä–∏–≥–æ–≤–æ—Ä–µ–Ω—ã –∫ —à–µ—Å—Ç–∏ –∏ —à–µ—Å—Ç–∏ —Å –ø–æ–ª–æ–≤–∏–Ω–æ–π –≥–æ–¥–∞–º –∫–æ–ª–æ–Ω–∏–∏. –ê–ø–ø–∞—Ä–∞—Ç—ã –Ω–µ–∏–∑–≤–µ—Å—Ç–Ω–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –±—ã–ª–∏ –≤—ã–¥–∞–Ω—ã –∑–∞ —Å–µ—Ä—Ç–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ, —É—â–µ—Ä–± –±—é–¥–∂–µ—Ç—É —Å–æ—Å—Ç–∞–≤–∏–ª 120 –º–ª–Ω —Ä—É–±.‚Äã –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Phnio #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-10-13T09:17:05+00:00,@medpharm,13062,https://t.me/medpharm/13062,"–í—Ä–∞—á –∏–∑ –ù–∏–∂–Ω–µ–≥–æ –¢–∞–≥–∏–ª–∞ –ø—Ä–∏–∑–Ω–∞–Ω –≤–∏–Ω–æ–≤–Ω—ã–º –≤ —Å–º–µ—Ä—Ç–∏ –ø–∞—Ü–∏–µ–Ω—Ç–∫–∏ –ø–æ—Å–ª–µ –æ–ø–µ—Ä–∞—Ü–∏–∏. –°—É–¥ –ø—Ä–∏–≥–æ–≤–æ—Ä–∏–ª –µ–≥–æ –∫ –¥–≤—É–º –≥–æ–¥–∞–º –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏—è —Å–≤–æ–±–æ–¥—ã, –Ω–æ –æ—Å–≤–æ–±–æ–¥–∏–ª –æ—Ç –Ω–∞–∫–∞–∑–∞–Ω–∏—è –∏–∑-–∑–∞ –∏—Å—Ç–µ—á–µ–Ω–∏—è —Å—Ä–æ–∫–∞ –¥–∞–≤–Ω–æ—Å—Ç–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PhiU8 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-10-13T08:38:02+00:00,@medpharm,13061,https://t.me/medpharm/13061,"–¶–µ–Ω—ã –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –∏–∑ –ü–µ—Ä–µ—á–Ω—è –ñ–ù–í–õ–ü –≤ —Å–µ–Ω—Ç—è–±—Ä–µ –≤—ã—Ä–æ—Å–ª–∏ –Ω–∞ 0,9% –∫ –∞–≤–≥—É—Å—Ç—É, —Å–ª–µ–¥—É–µ—Ç –∏–∑ –¥–∞–Ω–Ω—ã—Ö –†–æ—Å—Å—Ç–∞—Ç–∞. –†–æ—Å—Ç —Ü–µ–Ω –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞, –Ω–µ –æ—Ç–Ω–æ—Å—è—â–∏–µ—Å—è –∫ –∂–∏–∑–Ω–µ–Ω–Ω–æ –≤–∞–∂–Ω—ã–º, —Å–æ—Å—Ç–∞–≤–∏–ª –≤ —Å—Ä–µ–¥–Ω–µ–º 1,4%. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Phf3L #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""pricing"",
  ""impact"": ""medium"",
  ""english"": ""Prices on drugs from the –ñ–ù–í–õ–ü list increased by 0.9% in September compared to August, according to Rosstat data. The average price increase for non-essential medications was 1.4%. More details: https://clck.ru/3Phf3L #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞""
}"
2025-10-13T08:07:03+00:00,@medpharm,13060,https://t.me/medpharm/13060,–î–∏—Ä–µ–∫—Ç–æ—Ä–æ–º –ù–ú–ò–¶ –∏–º. –ú–µ—à–∞–ª–∫–∏–Ω–∞ –Ω–∞–∑–Ω–∞—á–µ–Ω –ï–≤–≥–µ–Ω–∏–π –¢–∞—Ä–∞—Å—é–∫. –ï–≥–æ –ø—Ä–µ–¥—à–µ—Å—Ç–≤–µ–Ω–Ω–∏–∫ –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ß–µ—Ä–Ω—è–≤—Å–∫–∏–π –ø–æ–∫–∏–Ω—É–ª –ø–æ—Å—Ç –Ω–∞ —Ñ–æ–Ω–µ —É–≥–æ–ª–æ–≤–Ω–æ–≥–æ –¥–µ–ª–∞ –æ –∫–æ—Ä—Ä—É–ø—Ü–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PhcKq #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-10-13T07:24:03+00:00,@medpharm,13059,https://t.me/medpharm/13059,"–ì—Ä—É–ø–ø–∞ —Å—Ç—É–¥–µ–Ω—Ç–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –≤—É–∑–æ–≤ –∏–∑ –ö–∞–∑–∞–Ω–∏ –Ω–∞–ø–∏—Å–∞–ª–∞ –≤ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –∏ –ì–æ—Å–¥—É–º—É –†–§ —Å –ø—Ä–æ—Å—å–±–æ–π –æ—Ç–∫–∞–∑–∞—Ç—å—Å—è –æ—Ç –≤–≤–µ–¥–µ–Ω–∏—è –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã—Ö —Ç—Ä–µ—Ö–ª–µ—Ç–Ω–∏—Ö –æ—Ç—Ä–∞–±–æ—Ç–æ–∫ –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–µ–π. –û–Ω–∏ –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–∞—é—Ç, —á—Ç–æ –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–∞ –Ω–µ—Å–µ—Ç ¬´—Å–∏—Å—Ç–µ–º–Ω—ã–µ —Ä–∏—Å–∫–∏ –¥–ª—è –±—É–¥—É—â–µ–≥–æ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PhWP2 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–û–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""A group of medical students from Kazan universities has written to the government and the State Duma requesting a rejection of mandatory three-year probation for medical specialties. They warn that the initiative carries 'systemic risks for future healthcare.'""
}"
2025-10-13T07:05:24+00:00,@medpharm,13058,https://t.me/medpharm/13058,"–ö–∞–∫ –≤—Ä–∞—á–∏ –∏—â—É—Ç –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—É—é –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é: —Å–ª–æ–∂–Ω–æ—Å—Ç–∏ –∏ –ø–∞—Ç—Ç–µ—Ä–Ω—ã –ü—Ä–∏–≥–ª–∞—à–∞–µ–º –≤–∞—Å –ø—Ä–∏–Ω—è—Ç—å —É—á–∞—Å—Ç–∏–µ –≤ –æ–ø—Ä–æ—Å–µ, —Ü–µ–ª—å –∫–æ—Ç–æ—Ä–æ–≥–æ ‚Äî –æ–ø—Ä–µ–¥–µ–ª–∏—Ç—å, —Å –∫–∞–∫–∏–º–∏ —Ç—Ä—É–¥–Ω–æ—Å—Ç—è–º–∏ –≤—ã —Å—Ç–∞–ª–∫–∏–≤–∞–µ—Ç–µ—Å—å –ø—Ä–∏ –ø–æ–∏—Å–∫–µ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–π –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –≤ –ò–Ω—Ç–µ—Ä–Ω–µ—Ç–µ. –í–∞—à–µ –º–Ω–µ–Ω–∏–µ —á—Ä–µ–∑–≤—ã—á–∞–π–Ω–æ –≤–∞–∂–Ω–æ –¥–ª—è –Ω–∞—Å.","{""skip"": true}"
2025-10-13T06:20:07+00:00,@medpharm,13057,https://t.me/medpharm/13057,"–ì–æ—Ç–æ–≤—è—â–∏–π—Å—è –∫ –ø—Ä–∏–Ω—è—Ç–∏—é –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω—ã—Ö –æ—Ç—Ä–∞–±–æ—Ç–∫–∞—Ö –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –≤—É–∑–æ–≤ –∏ –∫–æ–ª–ª–µ–¥–∂–µ–π –Ω–∞ —ç—Ç–∞–ø–µ –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –æ–±—Å—É–∂–¥–µ–Ω–∏—è —Å–æ–±—Ä–∞–ª –¥–µ—Å—è—Ç–∫–∏ –æ—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω—ã—Ö –æ—Ç–∑—ã–≤–æ–≤. –≠–∫—Å–ø–µ—Ä—Ç—ã –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–∞—é—Ç, —á—Ç–æ —Ç–∞–∫–æ–π –ø–æ–¥—Ö–æ–¥ –∫ –∫–∞–¥—Ä–æ–≤–æ–π –ø–æ–ª–∏—Ç–∏–∫–µ –æ—Ç–ø—É–≥–Ω–µ—Ç –º–Ω–æ–≥–∏—Ö —Ç–∞–ª–∞–Ω—Ç–ª–∏–≤—ã—Ö –∞–±–∏—Ç—É—Ä–∏–µ–Ω—Ç–æ–≤ –æ—Ç –ø–æ–ª—É—á–µ–Ω–∏—è —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–∏ –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–∞. –û —Ç–æ–º, –∫–∞–∫ –∂–µ—Å—Ç–∫–∏–µ –º–µ—Ä—ã –º–æ–≥—É—Ç –æ—Ç—Ä–∞–∑–∏—Ç—å—Å—è –Ω–∞ –ø—Ä–µ—Å—Ç–∏–∂–µ –≤—Ä–∞—á–µ–±–Ω–æ–π –ø—Ä–æ—Ñ–µ—Å—Å–∏–∏, —Å–ª–æ–∂–Ω–µ–µ –ª–∏ —Å—Ç–∞–ª–æ –ø–æ—Å—Ç—É–ø–∏—Ç—å –≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–π –≤—É–∑ –ø–æ —Ü–µ–ª–µ–≤–æ–º—É –¥–æ–≥–æ–≤–æ—Ä—É –∏ –∫–∞–∫ –º–µ–Ω—è–µ—Ç—Å—è –æ—Ç–Ω–æ—à–µ–Ω–∏–µ –∫ –ø–æ–¥–≥–æ—Ç–æ–≤–∫–µ –≤ –æ—Ä–¥–∏–Ω–∞—Ç—É—Ä–µ —É –º–æ–ª–æ–¥—ã—Ö —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤, ¬´–ú–í¬ª —Ä–∞—Å—Å–∫–∞–∑–∞–ª —Å–æ–æ—Å–Ω–æ–≤–∞—Ç–µ–ª—å –∏ —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å –ø–æ—Ä—Ç–∞–ª–∞ ORDINATURA.ORG –í–ª–∞–¥–∏—Å–ª–∞–≤ –õ–µ–¥–æ–≤—Å–∫–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PhRmA #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-10-12T11:40:53+00:00,@medpharm,13056,https://t.me/medpharm/13056,"üëçüëçüëçüëçüëçüëç –ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ –∑–∞ –Ω–µ–¥–µ–ª—é –ó–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç, –æ–±—è–∑—ã–≤–∞—é—â–∏–π –≤—Å–µ—Ö —Å—Ç—É–¥–µ–Ω—Ç–æ–≤-–±—é–¥–∂–µ—Ç–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–µ–π –∑–∞–∫–ª—é—á–∞—Ç—å –¥–æ–≥–æ–≤–æ—Ä –æ —Ü–µ–ª–µ–≤–æ–º –æ–±—É—á–µ–Ω–∏–∏, –ø—Ä–æ—à–µ–ª –ø–µ—Ä–≤–æ–µ —á—Ç–µ–Ω–∏–µ –≤ –ì–æ—Å–¥—É–º–µ –†–§. –í –ì–æ—Å–¥—É–º—É –†–§ –±—É–¥–µ—Ç –≤–Ω–µ—Å–µ–Ω –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç, –º–µ–Ω—è—é—â–∏–π –ø—Ä–∞–≤–∏–ª–∞ –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω–æ–≥–æ –ª–∏—Ü–µ–Ω–∑–∏—Ä–æ–≤–∞–Ω–∏—è. –§–ê–° –†–æ—Å—Å–∏–∏ –ø—Ä–∏–≥—Ä–æ–∑–∏–ª–∞ –≤–æ–∑–±—É–¥–∏—Ç—å –ø–µ—Ä–≤–æ–µ –¥–µ–ª–æ –∑–∞ –∑–ª–æ—É–ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–µ –ü–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ–º –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –†–§ ‚Ññ 1771, —Ä–µ–≥—É–ª–∏—Ä—É—é—â–∏–º –ø–æ–≤—ã—à–µ–Ω–∏–µ —Ü–µ–Ω –≤ —Å–ª—É—á–∞–µ —Ä–∏—Å–∫–∞ –¥–µ—Ñ–∏—Ü–∏—Ç–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤. –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏ –¥–∞–ª —Ä–∞–∑—ä—è—Å–Ω–µ–Ω–∏—è –æ —Ö—Ä–∞–Ω–µ–Ω–∏–∏ –ø–µ—Ä–º–∞–Ω–≥–∞–Ω–∞—Ç–∞ –∫–∞–ª–∏—è. –†–∞–Ω–µ–µ –∞–ø—Ç–µ–∫–∏ —Å–æ–æ–±—â–∏–ª–∏, —á—Ç–æ –æ—Ç–∫–∞–∑—ã–≤–∞—é—Ç—Å—è –æ—Ç –µ–µ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ –º–∞—Ä–≥–∞–Ω—Ü–æ–≤–∫–∏, –∞ –∑–∞–≤–æ–¥—ã –ø—Ä–µ–∫—Ä–∞—Ç–∏–ª–∏ –≤—ã–ø—É—Å–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞. –í –ø—Ä–∞–≤–∏–ª–∞ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è —Å–∞–Ω–∏—Ç–∞—Ä–Ω–æ-—ç–ø–∏–¥–µ–º–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ –Ω–∞–¥–∑–æ—Ä–∞ –≤–Ω–µ—Å–ª–∏ –∏–∑–º–µ–Ω–µ–Ω–∏—è. –ü–ª–∞–Ω–æ–≤—ã–µ –ø—Ä–æ–≤–µ—Ä–∫–∏ –¥–ª—è —Ä—è–¥–∞ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –±—É–¥—É—Ç –∑–∞–º–µ–Ω–µ–Ω—ã –Ω–∞ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–µ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–∏–µ –≤–∏–∑–∏—Ç—ã, –∏–∑–º–µ–Ω–∏—Ç—Å—è –∏—Ö –ø–µ—Ä–∏–æ–¥–∏—á–Ω–æ—Å—Ç—å","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing, import_export, sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""A law project requiring all budget students in medical and pharmaceutical specialties to sign a contract of purposeful education has passed the first reading in the State Duma of Russia. A law project changing compulsory licensing rules will be submitted to the State Duma of Russia. The FAS (Federal Antimonopoly Service) of Russia threatened to initiate the first case for abuse of power. The Government of Russia issued a regulation raising prices in cases of risk to drug shortage. The Ministry of Health gave explanations about the storage of potassium permanganate. Previously, pharmacies refused to sell it and factories stopped producing it. The rules for conducting sanitary-epidemiological supervision were changed, making routine inspections into mandatory preventive visits with changes in their frequency.""
}"
2025-10-11T08:16:00+00:00,@medpharm,13055,https://t.me/medpharm/13055,"–†–æ—Å—Å–∏–π—Å–∫–∏–π –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—ã–π –∫–æ–Ω–≥—Ä–µ—Å—Å –∫–∞—Ä–¥–∏–æ–ª–æ–≥–æ–≤ —Å–æ—Å—Ç–æ—è–ª—Å—è –≤ –ö–∞–∑–∞–Ω–∏ –ø—Ä–∏ —É—á–∞—Å—Ç–∏–∏ –±–æ–ª–µ–µ 4500 –º–æ–ª–æ–¥—ã—Ö —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤, –≤—Ä–∞—á–µ–π, –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª–µ–π –∏ –ø—Ä–µ–ø–æ–¥–∞–≤–∞—Ç–µ–ª–µ–π –∏–∑ —Ä–∞–∑–Ω—ã—Ö —Å—Ç—Ä–∞–Ω. –í —ç—Ç–æ–º –≥–æ–¥—É –æ–Ω –ø—Ä–æ—à–µ–ª –ø–æ–¥ –¥–µ–≤–∏–∑–æ–º ¬´–ù–∞—É–∫–∞ –∏ –∏–Ω–Ω–æ–≤–∞—Ü–∏–∏ –≤ –∫–∞—Ä–¥–∏–æ–ª–æ–≥–∏–∏¬ª. –£—á–∞—Å—Ç–Ω–∏–∫–∏ –æ–±—Å—É–¥–∏–ª–∏ –ø–æ—Å–ª–µ–¥–Ω–∏–µ –¥–æ—Å—Ç–∏–∂–µ–Ω–∏—è –≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–π –∏ —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–∞–ª—å–Ω–æ–π –∫–∞—Ä–¥–∏–æ–ª–æ–≥–∏–∏, –∫–∞—Ä–¥–∏–æ—Ö–∏—Ä—É—Ä–≥–∏–∏, —Ñ–∞—Ä–º–∞–∫–æ—Ç–µ—Ä–∞–ø–∏–∏, –Ω–æ–≤—ã–µ –ø–æ–¥—Ö–æ–¥—ã –∫ –Ω–æ—Ä–º–∞–ª–∏–∑–∞—Ü–∏–∏ –ª–∏–ø–∏–¥–Ω–æ–≥–æ –æ–±–º–µ–Ω–∞, –ª–µ—á–µ–Ω–∏—é —Å–µ—Ä–¥–µ—á–Ω–æ–π –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ—Å—Ç–∏ –∏ –¥–∏–∞–±–µ—Ç–∞, –∞ —Ç–∞–∫–∂–µ –¥—Ä—É–≥–∏–µ —Ñ–∞–∫—Ç–æ—Ä—ã, –≤–ª–∏—è—é—â–∏–µ –Ω–∞ —Ç–µ—á–µ–Ω–∏–µ –∏ –∏—Å—Ö–æ–¥ –∫–∞—Ä–¥–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PfWrv","{""skip"": true}"
2025-10-11T07:40:31+00:00,@medpharm,13054,https://t.me/medpharm/13054,"üß©üß©üß©üß©üß©üß© –ü—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º —Ä–µ–π—Ç–∏–Ω–≥ –≥–ª–∞–≤–Ω—ã—Ö –Ω–æ–≤–æ—Å—Ç–µ–π –Ω–µ–¥–µ–ª–∏ –≤ –ø—É–±–ª–∏–∫–∞—Ü–∏—è—Ö –ª–µ–Ω—Ç—ã –Ω–æ–≤–æ—Å—Ç–µ–π ¬´–ú–í¬ª. –ì–æ—Å–¥—É–º–∞ –†–§ –µ–¥–∏–Ω–æ–≥–ª–∞—Å–Ω–æ –æ–¥–æ–±—Ä–∏–ª–∞ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–µ–Ω–Ω—ã–π –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ —Ü–µ–ª–µ–≤–æ–º –æ–±—É—á–µ–Ω–∏–∏ –∏ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–π –æ—Ç—Ä–∞–±–æ—Ç–∫–µ –¥–ª—è –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–≤—É–∑–æ–≤. –í–≤–æ–¥–∏–º–∞—è —Å–∏—Å—Ç–µ–º–∞ –±—É–¥–µ—Ç –ø—Ä–µ–¥—Å—Ç–∞–≤–ª—è—Ç—å –Ω–µ –æ—Ç—Ä–∞–±–æ—Ç–∫—É, –∞ –ø–ª–∞–≤–Ω—É—é –∞–¥–∞–ø—Ç–∞—Ü–∏—é, –ø–æ–¥—á–µ—Ä–∫–Ω—É–ª–∞ –∑–∞–º–º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –¢–∞—Ç—å—è–Ω–∞ –°–µ–º–µ–Ω–æ–≤–∞ ‚Äî –∑–∞ —Å—á–µ—Ç —Ä–∞–±–æ—Ç—ã –ø–æ–¥ —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–æ–º –Ω–∞—Å—Ç–∞–≤–Ω–∏–∫–∞ —Å–Ω–∏–∂–∞—é—Ç—Å—è —Ä–∏—Å–∫–∏ –≤—ã–≥–æ—Ä–∞–Ω–∏—è –∏ –≤–æ–∑–º–æ–∂–Ω—ã—Ö –æ—à–∏–±–æ–∫ –º–æ–ª–æ–¥–æ–≥–æ –≤—Ä–∞—á–∞. –ù–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ –≤ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω–æ–º TOP5 –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ –ø—Ä–∞–≤–∏–ª–∞—Ö –ø–µ—Ä–µ—á–∏—Å–ª–µ–Ω–∏—è —Å–ø–µ—Ü–∏–∞–ª—å–Ω—ã—Ö —Å–æ—Ü–∏–∞–ª—å–Ω—ã—Ö –≤—ã–ø–ª–∞—Ç (–°–°–í) –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º —Ä–∞–±–æ—Ç–Ω–∏–∫–∞–º. –ú–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –æ–±—è–∑–∞–ª–∏ –ø–æ–¥–∞–≤–∞—Ç—å —Ä–µ–µ—Å—Ç—Ä —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤, –∏–º–µ—é—â–∏—Ö –ø—Ä–∞–≤–æ –Ω–∞ –ø–æ–ª—É—á–µ–Ω–∏–µ –°–°–í, –≤ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω—ã–π –æ—Ä–≥–∞–Ω –§–æ–Ω–¥–∞ –ø–µ–Ω—Å–∏–æ–Ω–Ω–æ–≥–æ –∏ —Å–æ—Ü–∏–∞–ª—å–Ω–æ–≥–æ —Å—Ç—Ä–∞—Ö–æ–≤–∞–Ω–∏—è –∑–∞ –¥–µ–∫–∞–±—Ä—å –¥–æ 15 —á–∏—Å–ª–∞ –ø–æ—Å–ª–µ–¥–Ω–µ–≥–æ –º–µ—Å—è—Ü–∞ –≥–æ–¥–∞, –∞ –Ω–µ –¥–æ 25-–≥–æ, –∫–∞–∫ —Ä–∞–Ω–µ–µ. –í –æ—Å—Ç–∞–ª—å–Ω—ã–µ –º–µ—Å—è—Ü—ã ‚Äî –Ω–µ –ø–æ–∑–¥–Ω–µ–µ –¥–µ—Å—è—Ç–æ–≥–æ —Ä–∞–±–æ—á–µ–≥–æ –¥–Ω—è –ø–æ—Å–ª–µ –æ–∫–æ–Ω—á–∞–Ω–∏—è –æ—Ç—á–µ—Ç–Ω–æ–≥–æ –º–µ—Å—è—Ü–∞. –¢—Ä–µ—Ç—å—é —Å—Ç—Ä–æ—á–∫—É –Ω–æ–≤–æ—Å—Ç–Ω–æ–≥–æ —Ä–µ–π—Ç–∏–Ω–≥–∞ –Ω–µ–¥–µ–ª–∏ –∑–∞–Ω—è–ª–æ –∑–∞—è–≤–ª–µ–Ω–∏–µ –ú–∏—Ö–∞–∏–ª–∞ –ú—É—Ä–∞—à–∫–æ –æ —Ç–æ–º, —á—Ç–æ –∑–∞—Ç—Ä–∞—Ç—ã –Ω–∞ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ —ç–∫—Å–ø–µ—Ä—Ç–Ω–æ–π —Ä–∞–±–æ—Ç—ã –≤ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω—ã—Ö —Ñ–æ–Ω–¥–∞—Ö –û–ú–° (–¢–§–û–ú–°) –±—É–¥—É—Ç –º–µ–Ω—å—à–µ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å —Ç–µ–∫—É—â–∏–º —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏–µ–º, –≤—ã–¥–µ–ª—è–µ–º—ã–º –Ω–∞ —Å–æ–¥–µ—Ä–∂–∞–Ω–∏–µ —Å—Ç—Ä–∞—Ö–æ–≤—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π (–°–ú–û). –ü—Ä–∏–º–µ—Ä–Ω—ã—Ö —Å—É–º–º —ç–∫–æ–Ω–æ–º–∏–∏ –æ–Ω –Ω–µ –Ω–∞–∑–≤–∞–ª, –Ω–æ –æ—Ç–º–µ—Ç–∏–ª, —á—Ç–æ –≤ –¢–§–û–ú–° —É–∂–µ –∏–º–µ–µ—Ç—Å—è ¬´–æ–ø—Ä–µ–¥–µ–ª–µ–Ω–Ω—ã–π —Ñ—É–Ω–∫—Ü–∏–æ–Ω–∞–ª¬ª –¥–ª—è –∑–∞—â–∏—Ç—ã –ø—Ä–∞–≤ –∑–∞—Å—Ç—Ä–∞—Ö–æ–≤–∞–Ω–Ω—ã—Ö. –ù–∞ —á–µ—Ç–≤–µ—Ä—Ç–æ–º –º–µ—Å—Ç–µ –≤ TOP5 –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è –æ—Ç –ú–∏—Ö–∞–∏–ª–∞ –ú—É—Ä–∞—à–∫–æ –æ —Å—É–¥—å–±–µ –ø–∏–ª–æ—Ç–Ω–æ–≥–æ –ø—Ä–æ–µ–∫—Ç–∞ –ø–æ –≤–Ω–µ–¥—Ä–µ–Ω–∏—é –µ–¥–∏–Ω–æ–π –æ—Ç—Ä–∞—Å–ª–µ–≤–æ–π —Å–∏—Å—Ç–µ–º—ã –æ–ø–ª–∞—Ç—ã —Ç—Ä—É–¥–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤. –≠—Ç–∞ —Ä–∞–±–æ—Ç–∞ –≤–µ–¥–µ—Ç—Å—è —Ñ–∞–∫—Ç–∏—á–µ—Å–∫–∏ –≤ –µ–∂–µ–¥–Ω–µ–≤–Ω–æ–º —Ä–µ–∂–∏–º–µ, —Å–æ–æ–±—â–∏–ª –æ–Ω. –ó–∞–º—ã–∫–∞–µ—Ç –ø—è—Ç–µ—Ä–∫—É –Ω–æ–≤–æ—Å—Ç–µ–π –≤—ã—Ö–æ–¥ –Ω–æ–≤–æ–π —Ä–µ–¥–∞–∫—Ü–∏–∏ –ø—Ä–æ–µ–∫—Ç–∞ –∫—Ä–∏—Ç–µ—Ä–∏–µ–≤ –¥–æ–ø—É—Å–∫–∞ —á–∞—Å—Ç–Ω—ã—Ö –∫–ª–∏–Ω–∏–∫ –∫ —Ä–∞–±–æ—Ç–µ —Å–æ —Å—Ä–µ–¥—Å—Ç–≤–∞–º–∏ –û–ú–°. –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏ —Å–º—è–≥—á–∏–ª –Ω–µ–∫–æ—Ç–æ—Ä—ã–µ —Ñ–æ—Ä–º—É–ª–∏—Ä–æ–≤–∫–∏.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health Russia has softened some formulations in the new version of the project criteria for private clinics to work with OMS funds. Michael Murashko announced that the pilot project on establishing a unified industry payment system for healthcare workers is being carried out in an actual daily mode. Changes to the rules on targeted training and mandatory practice for medical students were approved by the State Duma of Russia without opposition. The Ministry of Health has also simplified some formulations in the new version of the project criteria for private clinics to work with OMS funds.""
}"
2025-10-11T07:35:03+00:00,@medpharm,13053,https://t.me/medpharm/13053,–í—Ä–∞—á–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —É—á—Ä–µ–∂–¥–µ–Ω–∏–π –∏ —Ä–∞–±–æ—Ç–Ω–∏–∫–∏ —Å–∫–æ—Ä–æ–π –ø–æ–º–æ—â–∏ –Ω–µ—Ä–µ–¥–∫–æ –≥–∏–±–Ω—É—Ç –≤–æ –≤—Ä–µ–º—è –æ–±—Å—Ç—Ä–µ–ª–æ–≤ –≤ –Ω–æ–≤—ã—Ö –∏ –ø—Ä–∏–≥—Ä–∞–Ω–∏—á–Ω—ã—Ö —Ä–µ–≥–∏–æ–Ω–∞—Ö –†–æ—Å—Å–∏–∏. –° –Ω–∞—á–∞–ª–∞ —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ–π –≤–æ–µ–Ω–Ω–æ–π –æ–ø–µ—Ä–∞—Ü–∏–∏ –∂–µ—Ä—Ç–≤–∞–º–∏ –∞—Ç–∞–∫ –í–°–£ —Å—Ç–∞–ª–∏ –º–∏–Ω–∏–º—É–º 29 –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PfxFk #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–î—Ä—É–≥–æ–µ,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety, guideline"",
  ""impact"": ""high"",
  ""english"": ""Doctors and healthcare workers in Russia's newly and border regions are frequently killed during shelling. At least 29 medical workers have become victims of the Ukrainian forces since the special military operation began. ""
}"
2025-10-10T17:14:01+00:00,@medpharm,13051,https://t.me/medpharm/13051,"ü¶æ –ü—Ä–∏–≤–æ–¥—è—Ç –∫ —Å—Ç–∞–Ω–¥–∞—Ä—Ç—É. –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏ –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω –≤—Ç–æ—Ä–æ–π –ø–æ —Å—á–µ—Ç—É –ø—Ä–æ–µ–∫—Ç —Ç–∏–ø–æ–≤–æ–π –ø—Ä–æ–≥—Ä–∞–º–º—ã –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–≥–æ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è. –û–±—É—á–µ–Ω–∏–µ –ø–æ —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–∏ ¬´–°–µ—Å—Ç—Ä–∏–Ω—Å–∫–æ–µ –¥–µ–ª–æ¬ª –∑–∞–π–º–µ—Ç 504 —á–∞—Å–∞. ü¶æ –ú–æ–ª–æ—á–Ω—ã–µ —Ä–µ–∫–∏. –°—Ç–∞–Ω–¥–∞—Ä—Ç–Ω—ã–µ –¥–µ—Ç—Å–∫–∏–µ –º–æ–ª–æ—á–Ω—ã–µ —Å–º–µ—Å–∏ –Ω–∞ –æ—Å–Ω–æ–≤–µ —Ü–µ–ª—å–Ω–æ–≥–æ –±–µ–ª–∫–∞ –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ –ø–æ–≤—ã—à–∞–ª–∏ —Ä–∏—Å–∫ –Ω–µ–∫—Ä–æ—Ç–∏–∑–∏—Ä—É—é—â–µ–≥–æ —ç–Ω—Ç–µ—Ä–æ–∫–æ–ª–∏—Ç–∞ —É –Ω–µ–¥–æ–Ω–æ—à–µ–Ω–Ω—ã—Ö –Ω–æ–≤–æ—Ä–æ–∂–¥–µ–Ω–Ω—ã—Ö. –°–º–µ—Å–∏ –Ω–∞ –æ—Å–Ω–æ–≤–µ –≤—ã—Å–æ–∫–æ–≥–∏–¥—Ä–æ–ª–∏–∑–æ–≤–∞–Ω–Ω–æ–≥–æ –±–µ–ª–∫–∞ –æ–∫–∞–∑–∞–ª–∏—Å—å –±–µ–∑–æ–ø–∞—Å–Ω–µ–µ –∏ —Ä–µ–∂–µ –≤—ã–∑—ã–≤–∞–ª–∏ –Ω–µ–ø–µ—Ä–µ–Ω–æ—Å–∏–º–æ—Å—Ç—å. ‚ù§Ô∏è –ü–æ—Å–ª–µ–¥—è—Ç –∑–∞ –∑–∞–∫—É–ø–∫–∞–º–∏. –§–ê–°, –ú–∏–Ω–∑–¥—Ä–∞–≤ –∏ –ú–∏–Ω—Ñ–∏–Ω –†–æ—Å—Å–∏–∏ –±—É–¥—É—Ç –∂–µ—Å—Ç—á–µ –∫–æ–Ω—Ç—Ä–æ–ª–∏—Ä–æ–≤–∞—Ç—å –∑–∞—è–≤–∫–∏ –∑–∞–∫–∞–∑—á–∏–∫–æ–≤ –ø—Ä–∏ –≥–æ—Å–∑–∞–∫—É–ø–∫–∞—Ö –º–µ–¥–∏–∑–¥–µ–ª–∏–π –ø–æ ‚Ññ 223-–§–ó. –¢–∞–∫–∞—è –Ω–æ—Ä–º–∞ —Å–æ–¥–µ—Ä–∂–∏—Ç—Å—è –≤ –ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–º –ø–ª–∞–Ω–µ —Ä–∞–∑–≤–∏—Ç–∏—è –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏–∏ –Ω–∞ 2026‚Äî2030 –≥–æ–¥—ã. ‚ù§Ô∏è –í–∏—Ç–∞–º–∏–Ω–∏–∑–∞—Ü–∏—è. –ü—Ä–æ–¥–∞–∂–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Å –≤–∏—Ç–∞–º–∏–Ω–æ–º D —Ä–∞—Å—Ç—É—Ç –≤ –∞–ø—Ç–µ–∫–∞—Ö. –ü—Ä–∏ —ç—Ç–æ–º —Ä–æ—Å—Å–∏—è–Ω–µ –ø—Ä–µ–¥–ø–æ—á–∏—Ç–∞—é—Ç –ø–æ–∫—É–ø–∞—Ç—å –≤–∏—Ç–∞–º–∏–Ω D, –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–π –∫–∞–∫ –ª–µ–∫–∞—Ä—Å—Ç–≤–æ, –∞ –Ω–µ –∫–∞–∫ –ë–ê–î.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety, guideline"",
  ""impact"": ""medium"",
  ""english"": ""The country is not specified but the message discusses a standard for nursing education, safety issues related to infant formula, and regulatory actions. The English summary focuses on these aspects relevant to clinical trials, safety guidelines, and regulatory compliance.""
}"
2025-10-10T17:02:06+00:00,@medpharm,13050,https://t.me/medpharm/13050,"–ü—Ä–æ–¥–∞–∂–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Å –≤–∏—Ç–∞–º–∏–Ω–æ–º D —Ä–∞—Å—Ç—É—Ç –≤ –∞–ø—Ç–µ–∫–∞—Ö. –ü—Ä–∏ —ç—Ç–æ–º —Ä–æ—Å—Å–∏—è–Ω–µ –ø—Ä–µ–¥–ø–æ—á–∏—Ç–∞—é—Ç –ø–æ–∫—É–ø–∞—Ç—å –≤–∏—Ç–∞–º–∏–Ω D, –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–π –∫–∞–∫ –ª–µ–∫–∞—Ä—Å—Ç–≤–æ, –∞ –Ω–µ –∫–∞–∫ –ë–ê–î. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pfekx #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""Sales of vitamin D supplements are increasing in pharmacies. Russians prefer to purchase vitamin D, registered as a medicine rather than a dietary supplement.""
}"
2025-10-10T16:36:01+00:00,@medpharm,13049,https://t.me/medpharm/13049,"–ö—Ä–∏—Ç–µ—Ä–∏–∏ —Å–æ—Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤: —Ñ–æ—Ä–º–∞–ª—å–Ω–æ—Å—Ç—å –∏–ª–∏ —Ä–µ–∞–ª—å–Ω–∞—è –ø–æ–º–æ—â—å —Ä–µ–≥–∏–æ–Ω–∞–º? üìå –ù–∞ –ø—Ä–æ—à–ª–æ–π –Ω–µ–¥–µ–ª–µ –ú–∏–Ω–∑–¥—Ä–∞–≤ –æ–ø—É–±–ª–∏–∫–æ–≤–∞–ª –∫—Ä–∏—Ç–µ—Ä–∏–∏ —Å–æ—Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –î–æ–∫—É–º–µ–Ω—Ç –æ–ø—Ä–µ–¥–µ–ª—è–µ—Ç, –∫–∞–∫–∏–µ –∏–∑ —Ä–µ–≥–∏–æ–Ω–æ–≤ –º–æ–≥—É—Ç —Ä–∞—Å—Å—á–∏—Ç—ã–≤–∞—Ç—å –Ω–∞ –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–µ —Ñ–∏–Ω–∞–Ω—Å–æ–≤—ã–µ —Å—Ä–µ–¥—Å—Ç–≤–∞ –∏–∑ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –±—é–¥–∂–µ—Ç–∞ –Ω–∞ –∑–∞–∫—É–ø–∫—É –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –í –ú–∏–Ω–∑–¥—Ä–∞–≤–µ —Ä–∞—Å—Å—á–∏—Ç—ã–≤–∞—é—Ç, —á—Ç–æ –Ω–æ–≤—ã–µ –∫—Ä–∏—Ç–µ—Ä–∏–∏ –ø–æ–∑–≤–æ–ª—è—Ç —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–µ–µ —Ä–∞—Å–ø—Ä–µ–¥–µ–ª—è—Ç—å –ø–æ–¥–¥–µ—Ä–∂–∫—É –º–µ–∂–¥—É —Ç–µ–º–∏, –∫—Ç–æ –¥–µ–π—Å—Ç–≤–∏—Ç–µ–ª—å–Ω–æ –≤ –Ω–µ–π –Ω—É–∂–¥–∞–µ—Ç—Å—è. üìÑ –î–æ–∫—É–º–µ–Ω—Ç –±—ã–ª –Ω–µ–æ–¥–Ω–æ–∑–Ω–∞—á–Ω–æ –≤—Å—Ç—Ä–µ—á–µ–Ω —ç–∫—Å–ø–µ—Ä—Ç–∞–º–∏. –í —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, –Ω–µ–∫–æ—Ç–æ—Ä—ã–µ —É—á–∞—Å—Ç–Ω–∏–∫–∏ —Ñ–æ—Ä—É–º–∞ ¬´–ë–∏–æ–ø—Ä–æ–º¬ª, –æ–¥–Ω–∞ –∏–∑ —Å–µ—Å—Å–∏–π –∫–æ—Ç–æ—Ä–æ–≥–æ –±—ã–ª–∞ –ø–æ—Å–≤—è—â–µ–Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–º—É –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—é –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –æ—Ç–º–µ—Ç–∏–ª–∏ –æ–≥—Ä–∞–Ω–∏—á–∏—Ç–µ–ª—å–Ω—ã–π —Ö–∞—Ä–∞–∫—Ç–µ—Ä –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–Ω—ã—Ö –∫—Ä–∏—Ç–µ—Ä–∏–µ–≤. –ö—Ä–∏—Ç–µ—Ä–∏–∏ –∏ –ø–æ—Ä—è–¥–æ–∫ —Å–æ—Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è –º–∞–ª–æ –ø—Ä–∏–º–µ–Ω–∏–º—ã –Ω–∞ –ø—Ä–∞–∫—Ç–∏–∫–µ –∏–∑-–∑–∞ —á—Ä–µ–∑–º–µ—Ä–Ω–æ –∂–µ—Å—Ç–∫–∏—Ö —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π –¥–ª—è –µ–≥–æ –ø–æ–ª—É—á–µ–Ω–∏—è, —Å—á–∏—Ç–∞–µ—Ç –¥–æ—Ü–µ–Ω—Ç –∫–∞—Ñ–µ–¥—Ä—ã –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –ø—Ä–∞–≤–∞ –ü–µ—Ä–≤–æ–≥–æ –ú–ì–ú–£ –∏–º. –ò. –ú. –°–µ—á–µ–Ω–æ–≤–∞, —á–ª–µ–Ω –≠–∫—Å–ø–µ—Ä—Ç–Ω–æ–≥–æ —Å–æ–≤–µ—Ç–∞ –ø–æ —Ä–µ–¥–∫–∏–º –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º –ø—Ä–∏ –ö–æ–º–∏—Ç–µ—Ç–µ –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è –ì–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π –î—É–º—ã, —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å –ø—Ä–∞–≤–æ–≤–æ–π —Å–ª—É–∂–±—ã —Ñ–æ–Ω–¥–∞ ¬´–ü–æ–¥—Å–æ–ª–Ω—É—Ö¬ª –ú–∞—Ä–∏—è –ü–æ—Å–∞–¥–∫–æ–≤–∞. ü¶† –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–Ω—ã–µ –∫—Ä–∏—Ç–µ—Ä–∏–∏ –æ—Ö–≤–∞—Ç—ã–≤–∞—é—Ç –ª–∏—à—å —Ç–µ –Ω–æ–∑–æ–ª–æ–≥–∏–∏, –∫–æ—Ç–æ—Ä—ã–µ –≤—Ö–æ–¥—è—Ç –≤ –ø–µ—Ä–µ—á–µ–Ω—å 17 —Ä–µ–¥–∫–∏—Ö –∂–∏–∑–Ω–µ—É–≥—Ä–æ–∂–∞—é—â–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, –≤–∫–ª—é—á–µ–Ω–Ω—ã—Ö –≤ –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –†–§ ‚Ññ 403. –ó–∞–±–æ–ª–µ–≤–∞–Ω–∏—è, –∫–æ—Ç–æ—Ä—ã–µ –Ω–µ –ø–æ–ø–∞–¥–∞—é—Ç –≤ —ç—Ç–æ—Ç –ø–µ—Ä–µ—á–µ–Ω—å, –ø–æ-–ø—Ä–µ–∂–Ω–µ–º—É –¥–æ–ª–∂–Ω—ã –±—É–¥—É—Ç –æ–±–µ—Å–ø–µ—á–∏–≤–∞—Ç—å—Å—è –∑–∞ —Å—á–µ—Ç —Ä–µ–≥–∏–æ–Ω–æ–≤. –†–µ–≥–∏–æ–Ω—ã –ø–æ–¥—á–µ—Ä–∫–∏–≤–∞—é—Ç, —á—Ç–æ —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è —É–∂–µ –Ω–µ —Ö–≤–∞—Ç–∞–µ—Ç, –∞ —á–∏—Å–ª–æ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —É–≤–µ–ª–∏—á–∏–≤–∞–µ—Ç—Å—è –∏–∑-–∑–∞ –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ —Ñ–æ–Ω–¥–∞ ¬´–ö—Ä—É–≥ –¥–æ–±—Ä–∞¬ª. –¢–∞–∫–∏–º –æ–±—Ä–∞–∑–æ–º, –±–µ–∑ –¥–æ—Ä–∞–±–æ—Ç–∫–∏ –º–µ—Ö–∞–Ω–∏–∑–º –º–æ–∂–µ—Ç –æ—Å—Ç–∞–≤–∏—Ç—å —Ä–µ–≥–∏–æ–Ω—ã –±–µ–∑ –ø–æ–¥–¥–µ—Ä–∂–∫–∏, –∞ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ ‚Äî –±–µ–∑ –ª–µ—á–µ–Ω–∏—è. –ö —Ç–∞–∫–æ–º—É –≤—ã–≤–æ–¥—É –ø—Ä–∏—à–ª–∏ —É—á–∞—Å—Ç–Ω–∏–∫–∏ —ç–∫—Å–ø–µ—Ä—Ç–Ω–æ–π —Å–µ—Å—Å–∏–∏ –Ω–∞ —Ñ–æ—Ä—É–º–µ ¬´–ë–∏–æ–ø—Ä–æ–º¬ª, –≤ —Ç–æ–º —á–∏—Å–ª–µ –ú–∞—Ä–∏—è –ü–æ—Å–∞–¥–∫–æ–≤–∞, —Å–æ–ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—å –í—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —Å–æ—é–∑–∞ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –Æ—Ä–∏–π –ñ—É–ª–µ–≤ –∏ –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å –Ω–∞—á–∞–ª—å–Ω–∏–∫–∞ —É–ø—Ä–∞–≤–ª–µ–Ω–∏—è —Å–µ–∫—Ä–µ—Ç–∞—Ä–∏–∞—Ç–∞ –ö–° –†–§, –∑–∞–≤–µ–¥—É—é—â–∏–π –∫–∞—Ñ–µ–¥—Ä–æ–π –∫–æ–Ω—Å—Ç–∏—Ç—É—Ü–∏–æ–Ω–Ω–æ–≥–æ –∏ –∞–¥–º–∏–Ω–∏—Å—Ç—Ä–∞—Ç–∏–≤–Ω–æ–≥–æ –ø—Ä–∞–≤–∞ –Æ–§ ¬´–ù–ò–£ –í–®–≠¬ª –ü–∞–≤–µ–ª –ë–ª–æ—Ö–∏–Ω.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The criteria for orphan patient support financing were published last week by the Ministry of Health. The document defines which regions can receive additional financial support from the federal budget for purchasing drugs. The Ministry believes that these new criteria will allow more efficient distribution of support to those who truly need it. Some experts from the forum 'Biosphere' were not satisfied with the proposed criteria, which are overly restrictive and difficult to apply in practice. The criteria cover only those rare diseases listed in the Government of Russia's Order No. 403, while regions still need to provide support for diseases not included in this list. Experts from the forum 'Biosphere' concluded that without further adjustments, the mechanism could leave regions unsupported and patients untreated.""
}"
2025-10-10T16:08:02+00:00,@medpharm,13048,https://t.me/medpharm/13048,"Novo Nordisk –∑–∞–∫–ª—é—á–∏–ª–∞ —Å–¥–µ–ª–∫—É —Å Akero Therapeutics –Ω–∞ 5,2 –º–ª—Ä–¥ –¥–æ–ª–ª. –î–∞—Ç—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ –¥–æ—Å—Ç–∞–Ω—É—Ç—Å—è –ø—Ä–∞–≤–∞ –Ω–∞ —ç—Ñ—Ä—É–∫—Å–∏—Ñ–µ—Ä–∞–º–∏–Ω (efruxifermin) ‚Äî –ø–æ–¥–∫–æ–∂–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è –ª–µ—á–µ–Ω–∏—è MASH. –≠—Ç–æ –ø–µ—Ä–≤–∞—è —Å–¥–µ–ª–∫–∞ –Ω–æ–≤–æ–≥–æ –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –∫–æ–º–ø–∞–Ω–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pfc45 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-10T15:32:02+00:00,@medpharm,13047,https://t.me/medpharm/13047,"IT-—Ä–∞—Å—Ö–æ–¥—ã —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π –≤ –†–æ—Å—Å–∏–∏ –∑–∞ –≥–æ–¥ –¥–æ—Å—Ç–∏–≥–ª–∏ 7,9 –º–ª—Ä–¥ —Ä—É–±., –ø–æ–¥—Å—á–∏—Ç–∞–ª–∏ –∞–Ω–∞–ª–∏—Ç–∏–∫–∏. –û—Ç—Ä–∞—Å–ª—å –∑–∞–Ω–∏–º–∞–µ—Ç —Ç—Ä–µ—Ç—å–µ –º–µ—Å—Ç–æ –ø–æ –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–æ–Ω–Ω–æ–π –¥–∏–Ω–∞–º–∏–∫–µ –≤ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–∏ —Ü–∏—Ñ—Ä–æ–≤—ã—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pfa7o #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-10T15:16:02+00:00,@medpharm,13046,https://t.me/medpharm/13046,"–í –ò–Ω–¥–∏–∏ –∞—Ä–µ—Å—Ç–æ–≤–∞–ª–∏ –≥–ª–∞–≤—É –∫–æ–º–ø–∞–Ω–∏–∏ Sresan –ø–æ –¥–µ–ª—É –æ —Å–º–µ—Ä—Ç–∏ 21 —Ä–µ–±–µ–Ω–∫–∞, –æ—Ç—Ä–∞–≤–∏–≤—à–µ–≥–æ—Å—è —Å–∏—Ä–æ–ø–æ–º –æ—Ç –∫–∞—à–ª—è —Å —Ç–æ–∫—Å–∏–Ω–æ–º –≤ —Å–æ—Å—Ç–∞–≤–µ. –í—Å–µ–≥–æ –±—ã–ª–æ –ø—Ä–æ–¥–∞–Ω–æ 222 —Ñ–ª–∞–∫–æ–Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://pharmvestnik.ru/content/news/V-Indii-arestovali-vladelca-kompanii-proizvoditelya-siropa-ot-kashlya-posle-smerti-21-rebenka.html?utm_source=TG_post&utm_medium=Group&utm_campaign=V-Indii-arestovali-vladelca-kompanii-proizvoditelya-siropa-ot-kashlya-posle-smerti-21-rebenka #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{""skip"": true}"
2025-10-10T15:14:06+00:00,@medpharm,13045,https://t.me/medpharm/13045,–°—Ç–∞–Ω–¥–∞—Ä—Ç–Ω—ã–µ –¥–µ—Ç—Å–∫–∏–µ –º–æ–ª–æ—á–Ω—ã–µ —Å–º–µ—Å–∏ –Ω–∞ –æ—Å–Ω–æ–≤–µ —Ü–µ–ª—å–Ω–æ–≥–æ –±–µ–ª–∫–∞ –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ –ø–æ–≤—ã—à–∞–ª–∏ —Ä–∏—Å–∫ –Ω–µ–∫—Ä–æ—Ç–∏–∑–∏—Ä—É—é—â–µ–≥–æ —ç–Ω—Ç–µ—Ä–æ–∫–æ–ª–∏—Ç–∞ —É –Ω–µ–¥–æ–Ω–æ—à–µ–Ω–Ω—ã—Ö –Ω–æ–≤–æ—Ä–æ–∂–¥–µ–Ω–Ω—ã—Ö. –°–º–µ—Å–∏ –Ω–∞ –æ—Å–Ω–æ–≤–µ –≤—ã—Å–æ–∫–æ–≥–∏–¥—Ä–æ–ª–∏–∑–æ–≤–∞–Ω–Ω–æ–≥–æ –±–µ–ª–∫–∞ –æ–∫–∞–∑–∞–ª–∏—Å—å –±–µ–∑–æ–ø–∞—Å–Ω–µ–µ –∏ —Ä–µ–∂–µ –≤—ã–∑—ã–≤–∞–ª–∏ –Ω–µ–ø–µ—Ä–µ–Ω–æ—Å–∏–º–æ—Å—Ç—å. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PfZ8o #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ì–∞—Å—Ç—Ä–æ—ç–Ω—Ç–µ—Ä–æ–ª–æ–≥–∏—è #–ü–µ–¥–∏–∞—Ç—Ä–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety"",
  ""impact"": ""high"",
  ""english"": ""The study found that standard infant formulas based on whole protein significantly increased the risk of necrotizing enterocolitis in preterm infants. High-pyrolysated protein-based formulas were safer and less likely to cause intolerance.""
}"
2025-10-10T14:29:02+00:00,@medpharm,13044,https://t.me/medpharm/13044,–†–∞–∑—Ä–µ—à–µ–Ω–∏—è –Ω–∞ –≤—ã–≤–æ–∑ –∏–∑ —Å—Ç—Ä–∞–Ω—ã –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –≤—ã–¥–∞–≤–∞—Ç—å –¥–æ 31 –¥–µ–∫–∞–±—Ä—è 2027 –≥–æ–¥–∞. –î–µ–π—Å—Ç–≤—É—é—â–∏–µ –æ–≥—Ä–∞–Ω–∏—á–∏—Ç–µ–ª—å–Ω—ã–µ –º–µ—Ä—ã —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω—ã –¥–æ –∫–æ–Ω—Ü–∞ —Ç–µ–∫—É—â–µ–≥–æ –≥–æ–¥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PfWSt #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""Permits for exporting medical products are proposed to be issued until December 31, 2027. Current restrictions will remain in place until the end of this year. More details: https://clck.ru/3PfWSt #PharmNews #Regulation""
}"
2025-10-10T14:09:03+00:00,@medpharm,13043,https://t.me/medpharm/13043,–†–æ—Å—Å–∏–π—Å–∫–∏–µ —Ä–µ–≥—É–ª—è—Ç–æ—Ä—ã –±—É–¥—É—Ç –∂–µ—Å—Ç—á–µ –∫–æ–Ω—Ç—Ä–æ–ª–∏—Ä–æ–≤–∞—Ç—å –∑–∞—è–≤–∫–∏ –∑–∞–∫–∞–∑—á–∏–∫–æ–≤ –ø—Ä–∏ –≥–æ—Å–∑–∞–∫—É–ø–∫–∞—Ö –º–µ–¥–∏–∑–¥–µ–ª–∏–π –ø–æ –§–µ–¥–µ—Ä–∞–ª—å–Ω–æ–º—É –∑–∞–∫–æ–Ω—É ‚Ññ 223-–§–ó. –¢–∞–∫–∞—è –Ω–æ—Ä–º–∞ —Å–æ–¥–µ—Ä–∂–∏—Ç—Å—è –≤ –ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–º –ø–ª–∞–Ω–µ —Ä–∞–∑–≤–∏—Ç–∏—è –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏–∏ –Ω–∞ 2026‚Äî2030 –≥–æ–¥—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PfV5b #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""high"",
  ""english"": ""Russian regulators will be more strict in controlling procurement requests for medical products under Federal Law ‚Ññ 223-–§–ó. This is contained in the National Competition Development Plan for 2026‚Äî2030. More details: https://clck.ru/3PfV5b #MedNews #Healthcare #Other""
}"
2025-10-10T11:58:05+00:00,@medpharm,13041,https://t.me/medpharm/13041,"¬´–ú–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è –∏–º–µ–µ—Ç –Ω–µ—Å–∫–æ–ª—å–∫–æ –º–µ—Å—Ç –æ–∫–∞–∑–∞–Ω–∏—è —É—Å–ª—É–≥ (–æ–±–æ—Å–æ–±–ª–µ–Ω–Ω—ã—Ö —Å—Ç—Ä—É–∫—Ç—É—Ä–Ω—ã—Ö –ø–æ–¥—Ä–∞–∑–¥–µ–ª–µ–Ω–∏–π), —Ä–∞—Å–ø–æ–ª–æ–∂–µ–Ω–Ω—ã—Ö –≤ –æ–¥–Ω–æ–º –≥–æ—Ä–æ–¥–µ –ø–æ —Ä–∞–∑–Ω—ã–º –∞–¥—Ä–µ—Å–∞–º. –ú–æ–∂–µ—Ç –ª–∏ –≤—Ä–∞—á, –ø—Ä–∏–Ω—è—Ç—ã–π –Ω–∞ —Ä–∞–±–æ—Ç—É –≤ –æ–¥–Ω–æ –∏–∑ –º–µ—Å—Ç –æ–∫–∞–∑–∞–Ω–∏—è —É—Å–ª—É–≥, –ø—Ä–∏–≤–ª–µ–∫–∞—Ç—å—Å—è –∫ —Ä–∞–±–æ—Ç–µ –≤ –¥—Ä—É–≥–∏–µ –æ–±–æ—Å–æ–±–ª–µ–Ω–Ω—ã–µ —Å—Ç—Ä—É–∫—Ç—É—Ä–Ω—ã–µ –ø–æ–¥—Ä–∞–∑–¥–µ–ª–µ–Ω–∏—è –ø—É—Ç–µ–º —Ä–∞—Å—à–∏—Ä–µ–Ω–∏—è –∑–æ–Ω –æ–±—Å–ª—É–∂–∏–≤–∞–Ω–∏—è?¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PfKkX #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""A medical organization has several service locations (separate structural divisions) located in one city at different addresses. Can a doctor hired to one of the service locations be assigned to other structural divisions within the organization by expanding their service area?""
}"
2025-10-10T11:57:02+00:00,@medpharm,13040,https://t.me/medpharm/13040,–§–µ–¥–µ—Ä–∞–ª—å–Ω–∞—è —Å–ª—É–∂–±–∞ –ø–æ –Ω–∞–¥–∑–æ—Ä—É –≤ —Å—Ñ–µ—Ä–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è —Å–æ–æ–±—â–∏–ª–∞ –æ —Ä–µ—à–µ–Ω–∏—è—Ö —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –∏ –±–µ–ª–æ—Ä—É—Å—Å–∫–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –æ—Ç–æ–∑–≤–∞—Ç—å –∏–∑ –æ–±—Ä–∞—â–µ–Ω–∏—è —Å–µ—Ä–∏–∏ ¬´–ë–∏—Å–∞–∫–æ–¥–∏–ª-–•–µ–º–æ—Ñ–∞—Ä–º¬ª –∏ ¬´–ù–∏—Å—Ç–∞—Ç–∏–Ω–∞¬ª –∏–∑-–∑–∞ –Ω–µ—Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏—è –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω—ã–º —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è–º –ø–æ –∫–∞—á–µ—Å—Ç–≤—É. –î–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä—ã –¥–æ–ª–∂–Ω—ã –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–∏—Ç—å –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é –æ–± –∏–∑—ä—è—Ç–∏–∏ –∏–º–ø–æ—Ä—Ç–Ω–æ–≥–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ —Å —Ä—ã–Ω–∫–∞. –ê–ø—Ç–µ–∫–∞–º —Å–ª–µ–¥—É–µ—Ç –≤–æ–∑–≤—Ä–∞—Ç–∏—Ç—å —É–∫–∞–∑–∞–Ω–Ω—ã–µ —Å–µ—Ä–∏–∏ –ø–æ—Å—Ç–∞–≤—â–∏–∫–∞–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PfKgN #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–û—Ç–∑—ã–≤—ã,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial, safety"",
  ""impact"": ""high"",
  ""english"": ""The Russian and Belarusian manufacturers have recalled 'Bisacodil-Hemofarm' and 'Nitazepine' due to quality non-compliance. Distributors are required to provide information on the removal of imported pharmaceuticals from the market. Pharmacies should return these series to suppliers.""
}"
2025-10-10T11:17:02+00:00,@medpharm,13039,https://t.me/medpharm/13039,"–ú–æ—â–Ω–æ—Å—Ç–∏ –ò–ò –¥–µ–ª–∞—é—Ç —Ä–∞–∑—Ä–∞–±–æ—Ç–∫—É –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–µ—à–µ–≤–ª–µ –∏ –±—ã—Å—Ç—Ä–µ–µ, —Å—á–∏—Ç–∞–µ—Ç –∑–∞–º–º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –†–æ—Å—Å–∏–∏ –°–µ—Ä–≥–µ–π –ì–ª–∞–≥–æ–ª–µ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PfGsx #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-10T10:32:07+00:00,@medpharm,13038,https://t.me/medpharm/13038,–†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä –ø–ª–∞–Ω–∏—Ä—É–µ—Ç –ø—Ä–æ–¥–æ–ª–∂–∏—Ç—å –≤—ã–¥–∞–≤–∞—Ç—å —Ä–∞–∑—Ä–µ—à–µ–Ω–∏—è –Ω–∞ –≤—ã–≤–æ–∑ –∏–∑ —Å—Ç—Ä–∞–Ω—ã –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π –¥–æ 31 –¥–µ–∫–∞–±—Ä—è 2027 –≥–æ–¥–∞. –î–µ–π—Å—Ç–≤—É—é—â–∏–µ –æ–≥—Ä–∞–Ω–∏—á–∏—Ç–µ–ª—å–Ω—ã–µ –º–µ—Ä—ã —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω—ã –¥–æ –∫–æ–Ω—Ü–∞ —Ç–µ–∫—É—â–µ–≥–æ –≥–æ–¥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PfDdA #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""import_export"",
  ""impact"": ""medium"",
  ""english"": ""The Roszdranadzor is planning to continue issuing export permits for medical devices until December 31, 2027. Existing restrictions are in place until the end of this year. More details: https://clck.ru/3PfDdA #MedVestnik #Healthcare""
}"
2025-10-10T09:27:02+00:00,@medpharm,13037,https://t.me/medpharm/13037,"–¶–µ–Ω—Ç—Ä –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –æ–±—ä—è–≤–∏–ª –∞—É–∫—Ü–∏–æ–Ω—ã –Ω–∞ –ø–æ—Å—Ç–∞–≤–∫—É –¥–ª—è ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª —Ç—Ä–µ—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, —Å—Ä–µ–¥–∏ –∫–æ—Ç–æ—Ä—ã—Ö –∫–∞–Ω–∞–∫–∏–Ω—É–º–∞–±, –∏–º–º—É–Ω–æ–≥–ª–æ–±—É–ª–∏–Ω –∏ –∏–≤–∞–∫–∞—Ñ—Ç–æ—Ä —Ç–µ–∑–∞–∫–∞—Ñ—Ç–æ—Ä —ç–ª–µ–∫—Å–∞–∫–∞—Ñ—Ç–æ—Ä –∏ –∏–≤–∞–∫–∞—Ñ—Ç–æ—Ä. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pf8uB #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The Pharmaceutical Distribution announced tenders for the supply of three drugs to 'Circle of Goodness' - Kanakinumab, Immunoglobulin and Ivakaftor Tzekaftor Ilektafot. For more details: https://clck.ru/3Pf8uB #PharmNews #Distribution""
}"
2025-10-10T09:26:04+00:00,@medpharm,13036,https://t.me/medpharm/13036,–ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏ –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω –≤—Ç–æ—Ä–æ–π –ø–æ —Å—á–µ—Ç—É –ø—Ä–æ–µ–∫—Ç —Ç–∏–ø–æ–≤–æ–π –ø—Ä–æ–≥—Ä–∞–º–º—ã –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–≥–æ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è. –û–±—É—á–µ–Ω–∏–µ –ø–æ —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–∏ ¬´–°–µ—Å—Ç—Ä–∏–Ω—Å–∫–æ–µ –¥–µ–ª–æ¬ª –∑–∞–π–º–µ—Ç 504 —á–∞—Å–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pf8qG #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–û–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-10-10T09:04:03+00:00,@medpharm,13035,https://t.me/medpharm/13035,"–ö–∞—à–µ–ª—å ‚Äî —Å–∏–º–ø—Ç–æ–º –Ω–µ —Ç–æ–ª—å–∫–æ –û–†–í–ò, –Ω–æ –∏ –¥—Ä—É–≥–∏—Ö –ø–∞—Ç–æ–ª–æ–≥–∏–π (—Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç–æ–π, –≥–∞—Å—Ç—Ä–æ—ç–Ω—Ç–µ—Ä–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π, –Ω–µ–≤—Ä–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π). –≠–∫—Å–ø–µ—Ä—Ç —Å–ø–µ—Ü–ø—Ä–æ–µ–∫—Ç–∞ ¬´–§–í—Ç–æ—Ä–Ω–∏–∫¬ª, –∫.–º.–Ω., –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–π —Ñ–∞—Ä–º–∞–∫–æ–ª–æ–≥, –¥–æ—Ü–µ–Ω—Ç –∫–∞—Ñ–µ–¥—Ä—ã —Ç–µ—Ä–∞–ø–∏–∏, –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–π —Ñ–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏–∏ –∏ —Å–∫–æ—Ä–æ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –§–ì–ë–û–£ –í–û ¬´–†–æ—Å—Å–∏–π—Å–∫–∏–π —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç –º–µ–¥–∏—Ü–∏–Ω—ã¬ª –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–æ—Å—Å–∏–∏ –ì–µ—Ä–º–∞–Ω –ö–Ω–æ—Ä—Ä–∏–Ω–≥ —Ä–∞—Å—Å–∫–∞–∑–∞–ª –æ –ø—Ä–∏—á–∏–Ω–∞—Ö –≤–æ–∑–Ω–∏–∫–Ω–æ–≤–µ–Ω–∏—è –∫–∞—à–ª—è, –∫–∞–∫ –æ—Ü–µ–Ω–∏–≤–∞—Ç—å ¬´–∫—Ä–∞—Å–Ω—ã–µ —Ñ–ª–∞–≥–∏¬ª, —Ç—Ä–µ–±—É—é—â–∏–µ –Ω–µ–º–µ–¥–ª–µ–Ω–Ω–æ–≥–æ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è –∫ –≤—Ä–∞—á—É, –∏ —Ä–∞–∑–æ–±—Ä–∞–ª –Ω—é–∞–Ω—Å—ã –ø–æ–¥–±–æ—Ä–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ –æ—Ç –∫–∞—à–ª—è –¥–ª—è –∫–æ–º–æ—Ä–±–∏–¥–Ω—ã—Ö –∫–ª–∏–µ–Ω—Ç–æ–≤, –ø–æ–∑–≤–æ–ª—è—é—â–∏–µ –∏–∑–±–µ–∂–∞—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏—è. –ü—Ä–∏—Å–æ–µ–¥–∏–Ω—è–π—Ç–µ—Å—å –∫ –æ–±—Å—É–∂–¥–µ–Ω–∏—é! –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pf7Dz #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–§–∞—Ä–º–∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä–æ–≤–∞–Ω–∏–µ","{
  ""skip"": true,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance"",
  ""impact"": ""medium"",
  ""english"": ""A discussion about the causes of cough, how to recognize 'red flags' requiring immediate medical attention, and the nuances of selecting cough medications for patients with comorbidities to avoid drug interactions.""
}"
2025-10-10T09:04:02+00:00,@medpharm,13034,https://t.me/medpharm/13034,"–ö–∞—à–µ–ª—å –∫–∞–∫ –∑–∞—â–∏—Ç–Ω—ã–π –º–µ—Ö–∞–Ω–∏–∑–º, –∞ –Ω–µ —Å–∏–º–ø—Ç–æ–º, –∏ —Ä–µ–∞–ª—å–Ω–∞—è –∫–∞—Ä—Ç–∏–Ω–∞ —É ¬´—á–∞—Å—Ç–æ –±–æ–ª–µ—é—â–∏—Ö –¥–µ—Ç–µ–π¬ª. –≠–∫—Å–ø–µ—Ä—Ç —Å–ø–µ—Ü–ø—Ä–æ–µ–∫—Ç–∞ ¬´–§–í—Ç–æ—Ä–Ω–∏–∫¬ª –∫.–º.–Ω., –ø–µ–¥–∏–∞—Ç—Ä –†–∞–±–∏—è—Ç –ó–∞–π–Ω–∏–¥–¥–∏–Ω–æ–≤–∞ —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∞ –æ –º–µ—Ö–∞–Ω–∏–∑–º–∞—Ö –∫–∞—à–ª—è –∏ –æ—Ç–≤–µ—Ç–∏–ª–∞ –Ω–∞ –≥–ª–∞–≤–Ω—ã–µ –≤–æ–ø—Ä–æ—Å—ã: –∫–∞–∫–∏–µ ¬´–∫—Ä–∞—Å–Ω—ã–µ —Ñ–ª–∞–≥–∏¬ª –¥–æ–ª–∂–µ–Ω –∑–Ω–∞—Ç—å —Ñ–∞—Ä–º—Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç –∏ –∫–∞–∫–∏–µ —Ç—Ä–∏ –≥–ª–∞–≤–Ω—ã–µ –æ—à–∏–±–∫–∏ —Å–æ–≤–µ—Ä—à–∞—é—Ç —Ä–æ–¥–∏—Ç–µ–ª–∏ –ø—Ä–∏ –ª–µ—á–µ–Ω–∏–∏ –û–†–í–ò. –ü—Ä–∏—Å–æ–µ–¥–∏–Ω—è–π—Ç–µ—Å—å –∫ –æ–±—Å—É–∂–¥–µ–Ω–∏—é! –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pf7Dk #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–§–∞—Ä–º–∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä–æ–≤–∞–Ω–∏–µ","{
  ""skip"": true
}"
2025-10-10T08:46:03+00:00,@medpharm,13033,https://t.me/medpharm/13033,"–§–ê–° –†–æ—Å—Å–∏–∏, –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏ –∏ –ú–∏–Ω—Ñ–∏–Ω –†–æ—Å—Å–∏–∏ –±—É–¥—É—Ç –∂–µ—Å—Ç—á–µ –∫–æ–Ω—Ç—Ä–æ–ª–∏—Ä–æ–≤–∞—Ç—å –∑–∞—è–≤–∫–∏ –∑–∞–∫–∞–∑—á–∏–∫–æ–≤ –ø—Ä–∏ –≥–æ—Å–∑–∞–∫—É–ø–∫–∞—Ö –º–µ–¥–∏–∑–¥–µ–ª–∏–π –ø–æ ‚Ññ 223-–§–ó. –¢–∞–∫–∞—è –Ω–æ—Ä–º–∞ —Å–æ–¥–µ—Ä–∂–∏—Ç—Å—è –≤ –ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–º –ø–ª–∞–Ω–µ —Ä–∞–∑–≤–∏—Ç–∏—è –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏–∏ –Ω–∞ 2026‚Äì2030 –≥–æ–¥—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pf5rC #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""high"",
  ""english"": ""The FAS of Russia, the Ministry of Health of Russia and the Ministry of Finance will more strictly control claims from buyers in government procurement orders under law ‚Ññ 223-–§–ó. This regulation is included in the National Competition Development Plan for 2026‚Äì2030. More details: https://clck.ru/3Pf5rC #PharmNews #Regulation""
}"
2025-10-10T08:19:06+00:00,@medpharm,13032,https://t.me/medpharm/13032,"–†–µ–≥—É–ª—è—Ç–æ—Ä —É–ø—Ä–æ—Å—Ç–∏—Ç –≤–Ω–µ—Å–µ–Ω–∏–µ –∏–∑–º–µ–Ω–µ–Ω–∏–π –≤ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–æ–Ω–Ω–æ–µ —É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –∏–∑–¥–µ–ª–∏—è —Å –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω—ã–º –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–æ–º –∫–æ–º–ø–∞–Ω–∏—è–º, –∫–æ—Ç–æ—Ä—ã–µ –±—É–¥—É—Ç –µ–∂–µ–º–µ—Å—è—á–Ω–æ –¥–µ–ª–∏—Ç—å—Å—è —Å —Ä–µ–≥—É–ª—è—Ç–æ—Ä–æ–º —Å–≤–µ–¥–µ–Ω–∏—è–º–∏ –æ–± —ç–∫—Å–ø–ª—É–∞—Ç–∞—Ü–∏–∏ —É—Å—Ç—Ä–æ–π—Å—Ç–≤. –≠—Ç–æ –ø–æ—Å–ª–∞–±–ª–µ–Ω–∏–µ –Ω–µ –∫–∞—Å–∞–µ—Ç—Å—è —Ä–∞–¥–∏–∫–∞–ª—å–Ω—ã—Ö –∏–∑–º–µ–Ω–µ–Ω–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pf3v8 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The regulator simplifies changes to a medical device registration with companies that will share monthly information on the operation of devices with regulators. This relaxation does not apply to radical changes. For more details: https://clck.ru/3Pf3v8 #MedVestnik #Technologies #HealthcareOrganization""
}"
2025-10-10T07:28:07+00:00,@medpharm,13031,https://t.me/medpharm/13031,"–ò.–æ. –≥–ª–∞–≤–Ω–æ–≥–æ –≤—Ä–∞—á–∞ –£—Ä–∞–ª—å—Å–∫–æ–≥–æ –∏–Ω—Å—Ç–∏—Ç—É—Ç–∞ –∫–∞—Ä–¥–∏–æ–ª–æ–≥–∏–∏ –Ω–∞–∑–Ω–∞—á–µ–Ω –ê–Ω–¥—Ä–µ–π –õ–æ–∑–æ–≤—Å–∫–∏–π. –û–Ω —Å–º–µ–Ω–∏–ª –Ø–Ω–∞ –ì–∞–±–∏–Ω—Å–∫–æ–≥–æ, –∫–æ—Ç–æ—Ä—ã–π —É—à–µ–ª —Å –¥–æ–ª–∂–Ω–æ—Å—Ç–∏ –∏–∑-–∑–∞ –¥–æ—Å—Ç–∏–∂–µ–Ω–∏—è –ø—Ä–µ–¥–µ–ª—å–Ω–æ–≥–æ –≤–æ–∑—Ä–∞—Å—Ç–∞ –¥–ª—è —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª–µ–π –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pexrb #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-10-10T07:03:17+00:00,@medpharm,13030,https://t.me/medpharm/13030,–ß–µ–º–ø–∏–æ–Ω–∞—Ç ¬´–ë—É–¥—É—â–µ–µ –º–µ–¥–∏—Ü–∏–Ω—ã¬ª ‚Äî –≤—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–∏–π –ø—Ä–æ–µ–∫—Ç –ü–∏—Ä–æ–≥–æ–≤—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ –∏ –°–æ–≤–µ—Ç–∞ –º–æ–ª–æ–¥—ã—Ö —É—á–µ–Ω—ã—Ö –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–æ—Å—Å–∏–∏ ‚Äî —Å–æ—Å—Ç–æ–∏—Ç—Å—è 20‚Äì29 –æ–∫—Ç—è–±—Ä—è –ø—Ä–∏ –ø–æ–¥–¥–µ—Ä–∂–∫–µ –†–æ—Å–º–æ–ª–æ–¥–µ–∂–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PdzCH,"{""skip"": true}"
2025-10-09T16:49:57+00:00,@medpharm,13029,https://t.me/medpharm/13029,"ü¶æ –®—Ç—Ä–∞—Ñ–Ω–∞—è –∞—Å—Ç—Ä–æ–Ω–æ–º–∏—è. –í –ø—Ä–∏–Ω—è—Ç–æ–º –≤—á–µ—Ä–∞ –≤ –ø–µ—Ä–≤–æ–º —á—Ç–µ–Ω–∏–∏ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç–µ –æ —Ü–µ–ª–µ–≤–æ–º –æ–±—É—á–µ–Ω–∏–∏ –∏ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–π –æ—Ç—Ä–∞–±–æ—Ç–∫–µ –¥–ª—è –ø–æ–ª—É—á–∏–≤—à–∏—Ö –º–µ–¥- –∏ —Ñ–∞—Ä–º–æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ —Å—É–º–º—ã —à—Ç—Ä–∞—Ñ–æ–≤ –∞—Å—Ç—Ä–æ–Ω–æ–º–∏—á–µ—Å–∫–∏–µ, –∑–∞—è–≤–∏–ª –¥–µ–ø—É—Ç–∞—Ç –ê–ª–µ–∫—Å–µ–π –ö—É—Ä–∏–Ω–Ω—ã–π. –ï—Å–ª–∏ –¥–æ–∫—É–º–µ–Ω—Ç –ø—Ä–∏–º—É—Ç –≤ —Ç–∞–∫–æ–º –≤–∏–¥–µ, –æ–±—è–∑–∞—Ç–µ–ª—å—Å—Ç–≤–∞ –ø–æ –æ—Ç—Ä–∞–±–æ—Ç–∫–∞–º –¥–ª—è –º–µ–¥–∏–∫–æ–≤ –±—É–¥—É—Ç –¥–∞–∂–µ –∂–µ—Å—Ç—á–µ, —á–µ–º —É –≤–æ–µ–Ω–Ω—ã—Ö. ü¶æ –£—Å–∫–æ—Ä—è—Ç —Ä–∞—Å—á–µ—Ç—ã. –í –†–æ—Å—Å–∏–∏ –∏–∑–º–µ–Ω—è—Ç—Å—è –ø—Ä–∞–≤–∏–ª–∞ –ø–µ—Ä–µ—á–∏—Å–ª–µ–Ω–∏—è —Å–ø–µ—Ü–∏–∞–ª—å–Ω—ã—Ö —Å–æ—Ü–∏–∞–ª—å–Ω—ã—Ö –≤—ã–ø–ª–∞—Ç (–°–°–í) –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º —Ä–∞–±–æ—Ç–Ω–∏–∫–∞–º ‚Äì –≤–Ω–µ—Å–µ–Ω—ã –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ –ü–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –†–§ ‚Ññ 2568 –æ—Ç 31.12.2022. ‚ù§Ô∏è ¬´–†–∞–∑–≤–∏—Ç–∏–µ¬ª –Ω–µ —Ä–∞–∑–≤–∏–≤–∞–µ—Ç—Å—è. –ü—Ä–æ–µ–∫—Ç ¬´–†–∞–∑–≤–∏—Ç–∏–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –≤–æ—Å—Ç—Ä–µ–±–æ–≤–∞–Ω–Ω—ã—Ö –õ–ü¬ª –ø–æ-–ø—Ä–µ–∂–Ω–µ–º—É –Ω–∞—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ —Å–∞–º–æ–º –Ω–∏–∑–∫–æ–º —É—Ä–æ–≤–Ω–µ –∏—Å–ø–æ–ª–Ω–µ–Ω–∏—è. –ú–∏–Ω—Ñ–∏–Ω –†–æ—Å—Å–∏–∏ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª –æ–±–Ω–æ–≤–ª–µ–Ω–Ω—ã–µ –¥–∞–Ω–Ω—ã–µ –ø–æ –∏—Å–ø–æ–ª–Ω–µ–Ω–∏—é —Ä–∞—Å—Ö–æ–¥–æ–≤ –≤ —Ä–∞–∑—Ä–µ–∑–µ –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—ã—Ö –ø—Ä–æ–µ–∫—Ç–æ–≤. ‚ù§Ô∏è –¢–æ–≥–¥–∞ –º–æ–∂–Ω–æ. –ú–∞—Ä–≥–∞–Ω—Ü–æ–≤–∫–∞ –º–æ–∂–µ—Ç —Å–æ–¥–µ—Ä–∂–∞—Ç—å—Å—è –≤ –º–µ—Ç–∞–ª–ª–∏—á–µ—Å–∫–æ–º —à–∫–∞—Ñ—É –∏–ª–∏ –≤ –æ—Ç–¥–µ–ª—å–Ω–æ–º –∑–∞–∫—Ä—ã–≤–∞—é—â–µ–º—Å—è –ø–æ–º–µ—â–µ–Ω–∏–∏, –æ–±—ä—è—Å–Ω–∏–ª–∏ –≤ –ú–∏–Ω–∑–¥—Ä–∞–≤–µ –†–æ—Å—Å–∏–∏. –†–∞–Ω–µ–µ –∞–ø—Ç–µ–∫–∏ —Å–æ–æ–±—â–∏–ª–∏, —á—Ç–æ –≤ —Å–≤—è–∑–∏ —Å –Ω–æ–≤—ã–º–∏ –ø—Ä–∞–≤–∏–ª–∞–º–∏ —Ö—Ä–∞–Ω–µ–Ω–∏—è –ø–µ—Ä–º–∞–Ω–≥–∞–Ω–∞—Ç–∞ –∫–∞–ª–∏—è –æ–Ω–∏ –æ—Ç–∫–∞–∑—ã–≤–∞—é—Ç—Å—è –æ—Ç –µ–µ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏, –∞ –∑–∞–≤–æ–¥—ã –ø—Ä–µ–∫—Ä–∞—Ç–∏–ª–∏ –≤—ã–ø—É—Å–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞.","{""skip"": true}"
2025-10-09T16:01:08+00:00,@medpharm,13028,https://t.me/medpharm/13028,–†–æ—Å–∫–∞—á–µ—Å—Ç–≤–æ –ø—Ä–æ–≤–µ–ª–æ –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–Ω—ã–µ –ø—Ä–æ–≤–µ—Ä–∫–∏ –ë–ê–î —Å –æ–º–µ–≥–∞-3 –∂–∏—Ä–Ω—ã–º–∏ –∫–∏—Å–ª–æ—Ç–∞–º–∏: –∏–∑ 15 –ø—Ä–æ–≤–µ—Ä–µ–Ω–Ω—ã—Ö —Ç–æ—Ä–≥–æ–≤—ã—Ö –º–∞—Ä–æ–∫ —Ç–æ–ª—å–∫–æ —Ç—Ä–∏ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–æ–≤–∞–ª–∏ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–º —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è–º. –û—Å–Ω–æ–≤–Ω—ã–µ –Ω–∞—Ä—É—à–µ–Ω–∏—è –∫–∞—Å–∞–ª–∏—Å—å –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏ –∏ –Ω–µ–≤–µ—Ä–Ω–æ–≥–æ —É–∫–∞–∑–∞–Ω–∏—è –∫–æ–ª–∏—á–µ—Å—Ç–≤–∞ –¥–µ–π—Å—Ç–≤—É—é—â–∏—Ö –≤–µ—â–µ—Å—Ç–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PeVqm #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""medium"",
  ""english"": ""Roska—á–µ—Å—Ç–≤–æ conducted laboratory tests on omega-3 fatty acid supplements. Only three of the fifteen tested brands met mandatory requirements, with issues mainly related to labeling and incorrect substance quantity indications.""
}"
2025-10-09T15:58:07+00:00,@medpharm,13027,https://t.me/medpharm/13027,"–†–∞—Å—Ö–æ–¥—ã –ø–æ –Ω–∞—Ü–ø—Ä–æ–µ–∫—Ç—É ¬´–ü—Ä–æ–¥–æ–ª–∂–∏—Ç–µ–ª—å–Ω–∞—è –∏ –∞–∫—Ç–∏–≤–Ω–∞—è –∂–∏–∑–Ω—å¬ª –¥–æ—Å—Ç–∏–≥–ª–∏ –Ω–∞ 1 –æ–∫—Ç—è–±—Ä—è 68,1%, –∏–ª–∏ 253,5 –º–ª—Ä–¥ —Ä—É–±. –ü–æ —É—Ä–æ–≤–Ω—é –∏—Å–ø–æ–ª–Ω–µ–Ω–∏—è –±—é–¥–∂–µ—Ç–∞ –æ–Ω –∑–∞–Ω—è–ª —Å–µ–¥—å–º–æ–µ –º–µ—Å—Ç–æ —Å—Ä–µ–¥–∏ –≤—Å–µ—Ö –Ω–∞—Ü–ø—Ä–æ–µ–∫—Ç–æ–≤. –í –ª–∏–¥–µ—Ä—ã –ø–æ —Ä–∞—Å—Ö–æ–¥–∞–º –≤—ã—à–ª–∏ –ø—Ä–æ–≥—Ä–∞–º–º—ã –ø–æ –±–æ—Ä—å–±–µ —Å –æ–Ω–∫–æ–∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏ –∏ –¥–∏–∞–±–µ—Ç–æ–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PeVe9 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-10-09T15:23:07+00:00,@medpharm,13026,https://t.me/medpharm/13026,"–°–æ —Å–ª–µ–¥—É—é—â–µ–≥–æ –≥–æ–¥–∞ –∏–∑–º–µ–Ω—è—Ç—Å—è –ø—Ä–∞–≤–∏–ª–∞ –ø–µ—Ä–µ—á–∏—Å–ª–µ–Ω–∏—è —Å–ø–µ—Ü–∏–∞–ª—å–Ω—ã—Ö —Å–æ—Ü–∏–∞–ª—å–Ω—ã—Ö –≤—ã–ø–ª–∞—Ç –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º —Ä–∞–±–æ—Ç–Ω–∏–∫–∞–º. –ü–æ–ø—Ä–∞–≤–∫–∞–º–∏ –≤ –ü–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –†–§ ‚Ññ 2568 —Å–∫–æ—Ä—Ä–µ–∫—Ç–∏—Ä–æ–≤–∞–Ω—ã —Å—Ä–æ–∫–∏ –ø–æ–¥–∞—á–∏ —Ä–µ–µ—Å—Ç—Ä–æ–≤ —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤, –∏–º–µ—é—â–∏—Ö –ø—Ä–∞–≤–æ –Ω–∞ –ø–æ–ª—É—á–µ–Ω–∏–µ —ç—Ç–æ–π –º–µ—Ä—ã –≥–æ—Å–ø–æ–¥–¥–µ—Ä–∂–∫–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PeSmz #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""registration, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""Changes to the rules for listing special social payments for healthcare workers are coming into effect next year. Amendments to Government Resolution No. 2568 have updated the deadlines for submitting lists of employees eligible for this government support.""
}"
2025-10-09T15:17:03+00:00,@medpharm,13025,https://t.me/medpharm/13025,"–ú–∞—Ä–≥–∞–Ω—Ü–æ–≤–∫–∞ –º–æ–∂–µ—Ç —Å–æ–¥–µ—Ä–∂–∞—Ç—å—Å—è –≤ –º–µ—Ç–∞–ª–ª–∏—á–µ—Å–∫–æ–º —à–∫–∞—Ñ—É –∏–ª–∏ –≤ –æ—Ç–¥–µ–ª—å–Ω–æ–º –∑–∞–∫—Ä—ã–≤–∞—é—â–µ–º—Å—è –ø–æ–º–µ—â–µ–Ω–∏–∏, –æ–±—ä—è—Å–Ω–∏–ª–∏ –≤ –ú–∏–Ω–∑–¥—Ä–∞–≤–µ –†–æ—Å—Å–∏–∏. –†–∞–Ω–µ–µ –∞–ø—Ç–µ–∫–∏ —Å–æ–æ–±—â–∏–ª–∏, —á—Ç–æ –≤ —Å–≤—è–∑–∏ —Å –Ω–æ–≤—ã–º–∏ –ø—Ä–∞–≤–∏–ª–∞–º–∏ —Ö—Ä–∞–Ω–µ–Ω–∏—è –ø–µ—Ä–º–∞–Ω–≥–∞–Ω–∞—Ç–∞ –∫–∞–ª–∏—è –æ–Ω–∏ –æ—Ç–∫–∞–∑—ã–≤–∞—é—Ç—Å—è –æ—Ç –µ–µ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏, –∞ –∑–∞–≤–æ–¥—ã –ø—Ä–µ–∫—Ä–∞—Ç–∏–ª–∏ –≤—ã–ø—É—Å–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PeSLX #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""clinical_trial, shortage"",
  ""impact"": ""high"",
  ""english"": ""Permanganate potassium is being stored in a metal cabinet or an enclosed room, according to the Russian Ministry of Health. Previously, pharmacies reported that they are refusing to sell it due to new storage rules and factories have stopped producing the drug. More details: https://clck.ru/3PeSLX #FarmaNews #Retail""
}"
2025-10-09T14:47:04+00:00,@medpharm,13024,https://t.me/medpharm/13024,"–° 1 —Å–µ–Ω—Ç—è–±—Ä—è –≤–æ –≤—Å–µ—Ö —Ä–µ–≥–∏–æ–Ω–∞—Ö –ø–∞—Ü–∏–µ–Ω—Ç—ã –¥–æ–ª–∂–Ω—ã –∏–º–µ—Ç—å –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –ø—Ä–∏–∫—Ä–µ–ø–∏—Ç—å—Å—è –∫ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –±–µ–∑ –ø–æ—Å–µ—â–µ–Ω–∏—è –ø–æ–ª–∏–∫–ª–∏–Ω–∏–∫–∏, –æ–Ω–ª–∞–π–Ω. –û—Ç–∫–∞–∑—ã –≤ –æ–∫–∞–∑–∞–Ω–∏–∏ –¥–∞–Ω–Ω–æ–π —É—Å–ª—É–≥–∏ –ø–æ –ø—Ä–∏—á–∏–Ω–µ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏—è —Å–µ—Ä–≤–∏—Å–∞ –Ω–µ–¥–æ–ø—É—Å—Ç–∏–º—ã, –Ω–æ –ø–æ–∫–∞ –Ω–µ –≤—Å–µ —Å—É–±—ä–µ–∫—Ç—ã —Å–º–æ–≥–ª–∏ —ç—Ç–æ –∏—Å–ø–æ–ª–Ω–∏—Ç—å. –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏ –ø—Ä–µ–¥—É–ø—Ä–µ–¥–∏–ª, —á—Ç–æ –±—É–¥–µ—Ç –æ–±—Ä–∞—â–∞—Ç—å –Ω–∞ —ç—Ç–æ—Ç –ø—É–Ω–∫—Ç —Ü–∏—Ñ—Ä–æ–≤–∏–∑–∞—Ü–∏–∏ –æ—Å–æ–±–æ–µ –≤–Ω–∏–º–∞–Ω–∏–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PePvp #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health of Russia has warned that it will pay special attention to this point in the digitalization process. Patients must be able to attach themselves to a medical organization without visiting a clinic, and the refusal to provide this service due to the lack of services is not allowed. However, not all subjects have been able to implement this.""
}"
2025-10-09T13:18:06+00:00,@medpharm,13023,https://t.me/medpharm/13023,"–ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–∞—è –∞—Å—Å–æ—Ü–∏–∞—Ü–∏—è —É–ø—Ä–∞–≤–ª–µ–Ω—Ü–µ–≤ —Å—Ñ–µ—Ä—ã –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –Ω–∞–ø—Ä–∞–≤–∏–ª–∞ –æ–±—Ä–∞—â–µ–Ω–∏–µ –≤ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ —Å –ø—Ä–æ—Å—å–±–æ–π –∑–∞–±–ª–æ–∫–∏—Ä–æ–≤–∞—Ç—å –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ –∑–∞–º–µ–Ω–µ —á–∞—Å—Ç–Ω—ã—Ö —Å—Ç—Ä–∞—Ö–æ–≤—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω—ã–º–∏ —Ñ–æ–Ω–¥–∞–º–∏ –û–ú–°. –ü—Ä–µ–¥–ª–æ–∂–µ–Ω–Ω—ã–µ –∏–∑–º–µ–Ω–µ–Ω–∏—è –ø—Ä–∏–≤–µ–¥—É—Ç –∫ –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏—é –ø—Ä–∞–≤ –≥—Ä–∞–∂–¥–∞–Ω –∏ —É—Ö—É–¥—à–µ–Ω–∏—é –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç–∏ –∏ –∫–∞—á–µ—Å—Ç–≤–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏, —Å—á–∏—Ç–∞—é—Ç —ç–∫—Å–ø–µ—Ä—Ç—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PeHE8 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""high"",
  ""english"": ""The National Association of Healthcare Administrators has submitted a request to the government to block a law project that replaces private health insurance organizations with territorial funds of OMS. Proposed changes will restrict citizens' rights and worsen accessibility and quality of medical care, experts say. For more details: https://clck.ru/3PeHE8 #MedVestnik #Healthcare""
}"
2025-10-09T12:21:06+00:00,@medpharm,13022,https://t.me/medpharm/13022,"–õ–µ—á–µ–Ω–∏–µ –ª–µ–≤–æ—Ç–∏—Ä–æ–∫—Å–∏–Ω–æ–º —É –∂–µ–Ω—â–∏–Ω —Å—Ä–µ–¥–Ω–µ–≥–æ –∏ –ø–æ–∂–∏–ª–æ–≥–æ –≤–æ–∑—Ä–∞—Å—Ç–∞ —Å –≥–∏–ø–æ—Ç–∏—Ä–µ–æ–∑–æ–º –Ω–µ –±—ã–ª–æ —Å–≤—è–∑–∞–Ω–æ —Å –ø–æ–≤—ã—à–µ–Ω–Ω—ã–º —Ä–∏—Å–∫–æ–º —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –ë–æ–ª–µ–µ —Ç–æ–≥–æ, —Å—Ä–µ–¥–∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å —Å—É–±–∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–º –≥–∏–ø–æ—Ç–∏—Ä–µ–æ–∑–æ–º —Ç–µ—Ä–∞–ø–∏—è –ª–µ–≤–æ—Ç–∏—Ä–æ–∫—Å–∏–Ω–æ–º –º–æ–∂–µ—Ç —Å–Ω–∏–∂–∞—Ç—å —Ä–∏—Å–∫ —Å–µ—Ä—å–µ–∑–Ω—ã—Ö —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö —Å–æ–±—ã—Ç–∏–π –∏ —Å–º–µ—Ä—Ç–Ω–æ—Å—Ç–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PeCQ6 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ö–∞—Ä–¥–∏–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è #–≠–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–∏—è","{
  ""skip"": true
}"
2025-10-09T12:01:06+00:00,@medpharm,13021,https://t.me/medpharm/13021,–ü—Ä–æ–µ–∫—Ç ¬´–†–∞–∑–≤–∏—Ç–∏–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –≤–æ—Å—Ç—Ä–µ–±–æ–≤–∞–Ω–Ω—ã—Ö –õ–ü¬ª –ø–æ-–ø—Ä–µ–∂–Ω–µ–º—É –Ω–∞—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ —Å–∞–º–æ–º –Ω–∏–∑–∫–æ–º —É—Ä–æ–≤–Ω–µ –∏—Å–ø–æ–ª–Ω–µ–Ω–∏—è. –ú–∏–Ω—Ñ–∏–Ω –†–æ—Å—Å–∏–∏ –æ–±–Ω–æ–≤–∏–ª –¥–∞–Ω–Ω—ã–µ –ø–æ –∏—Å–ø–æ–ª–Ω–µ–Ω–∏—é –Ω–∞—Ü–ø—Ä–æ–µ–∫—Ç–æ–≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PeArm #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-10-09T11:22:05+00:00,@medpharm,13020,https://t.me/medpharm/13020,"–ò–∑-–∑–∞ —Ä–æ—Å—Ç–∞ —Å—Ç–æ–∏–º–æ—Å—Ç–∏ –æ–±—É—á–µ–Ω–∏—è —à—Ç—Ä–∞—Ñ—ã –¥–ª—è –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤-–º–µ–¥–∏–∫–æ–≤, –æ—Ç–∫–∞–∑–∞–≤—à–∏—Ö—Å—è –æ—Ç –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω–æ–π –æ—Ç—Ä–∞–±–æ—Ç–∫–∏, –º–æ–≥—É—Ç –ø—Ä–µ–≤—ã—Å–∏—Ç—å 10 –º–ª–Ω —Ä—É–±., –∑–∞—è–≤–∏–ª –¥–µ–ø—É—Ç–∞—Ç –ê–ª–µ–∫—Å–µ–π –ö—É—Ä–∏–Ω–Ω—ã–π –ø—Ä–∏ –æ–±—Å—É–∂–¥–µ–Ω–∏–∏ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç–∞ –æ–± –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã—Ö –æ—Ç—Ä–∞–±–æ—Ç–∫–∞—Ö –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –ø—Ä–æ—Ñ–∏–ª—å–Ω—ã—Ö –∫–æ–ª–ª–µ–¥–∂–µ–π –∏ –≤—É–∑–æ–≤. –¢–∞–∫–∏–µ —Å—É–º–º—ã –º–æ–≥—É—Ç –æ–±—è–∑–∞—Ç—å –≤—ã–ø–ª–∞—á–∏–≤–∞—Ç—å –¥–∞–∂–µ –Ω–µ –æ–∫–æ–Ω—á–∏–≤—à–∏—Ö –æ–±—É—á–µ–Ω–∏–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pe8B4 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-10-09T09:49:04+00:00,@medpharm,13019,https://t.me/medpharm/13019,–ü—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –≤–µ—Ç–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Å–º–æ–≥—É—Ç –ø–æ–ª—É—á–∞—Ç—å —Å—É–±—Å–∏–¥–∏–∏ –¥–ª—è –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏–∏ –ø–æ–Ω–µ—Å–µ–Ω–Ω—ã—Ö —Ä–∞—Å—Ö–æ–¥–æ–≤. –í —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–º –±—é–¥–∂–µ—Ç–µ –Ω–∞ —ç—Ç–∏ —Ü–µ–ª–∏ –Ω–∞ 2026 –≥–æ–¥ –∑–∞–ª–æ–∂–µ–Ω–æ –±–æ–ª–µ–µ 1 –º–ª—Ä–¥ —Ä—É–±. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pdzhe #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-10-09T09:22:03+00:00,@medpharm,13018,https://t.me/medpharm/13018,"–í —è–Ω–≤–∞—Ä–µ 2025 –≥–æ–¥–∞ –≤ –†–æ—Å—Å–∏–∏ —Å—Ç–∞—Ä—Ç–æ–≤–∞–ª –Ω–æ–≤—ã–π –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—ã–π –ø—Ä–æ–µ–∫—Ç ¬´–ü—Ä–æ–¥–æ–ª–∂–∏—Ç–µ–ª—å–Ω–∞—è –∏ –∞–∫—Ç–∏–≤–Ω–∞—è –∂–∏–∑–Ω—å¬ª, –∫–æ—Ç–æ—Ä—ã–π –ø—Ä–∏–∑–≤–∞–Ω —É–ª—É—á—à–∏—Ç—å –∫–∞—á–µ—Å—Ç–≤–æ –∂–∏–∑–Ω–∏ –ª—é–¥–µ–π —Å—Ç–∞—Ä—à–µ–≥–æ –≤–æ–∑—Ä–∞—Å—Ç–∞ –∏ —Å–æ–∑–¥–∞—Ç—å —É—Å–ª–æ–≤–∏—è –¥–ª—è –∑–¥–æ—Ä–æ–≤–æ–≥–æ –¥–æ–ª–≥–æ–ª–µ—Ç–∏—è. –°—Ç–∞–≤–∏—Ç—Å—è —Ü–µ–ª—å –ø–æ–≤—ã—Å–∏—Ç—å –æ–∂–∏–¥–∞–µ–º—É—é –ø—Ä–æ–¥–æ–ª–∂–∏—Ç–µ–ª—å–Ω–æ—Å—Ç—å –∂–∏–∑–Ω–∏ –≤ –†–æ—Å—Å–∏–∏ –∫ 2030 –≥–æ–¥—É –¥–æ 78 –ª–µ—Ç. –ö–∞–∫ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –æ—Ä–≥–∞–Ω–∏–∑–æ–≤–∞—Ç—å —Å–∏—Å—Ç–µ–º—É –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ —ç—Ç–æ–π –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ –Ω–∞—Å–µ–ª–µ–Ω–∏—è, –∫–∞–∫–∏–µ –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–µ —Ä–µ—Å—É—Ä—Å—ã –ø–æ—Ç—Ä–µ–±—É–µ—Ç—Å—è –ø—Ä–∏–≤–ª–µ—á—å –∏ –ø–æ—á–µ–º—É –ø—Ä–∏–≤–µ—Ä–∂–µ–Ω–Ω–æ—Å—Ç—å –∑–¥–æ—Ä–æ–≤–æ–º—É –æ–±—Ä–∞–∑—É –∂–∏–∑–Ω–∏ –∏ –∫–æ—Ä—Ä–µ–∫—Ü–∏—è —Ñ–∞–∫—Ç–æ—Ä–æ–≤ —Ä–∏—Å–∫–∞ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –∑–∞–≤–∏—Å—è—Ç –Ω–µ —Ç–æ–ª—å–∫–æ –æ—Ç –≤—Ä–∞—á–µ–π, ¬´–ú–í¬ª —Ä–∞—Å—Å–∫–∞–∑–∞–ª –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç –ù–ú–ò–¶ –¥–µ—Ç—Å–∫–æ–π –≥–µ–º–∞—Ç–æ–ª–æ–≥–∏–∏, –æ–Ω–∫–æ–ª–æ–≥–∏–∏ –∏ –∏–º–º—É–Ω–æ–ª–æ–≥–∏–∏ –∏–º. –î–º–∏—Ç—Ä–∏—è –†–æ–≥–∞—á–µ–≤–∞, —á–ª–µ–Ω –ö–æ–º–∏—Ç–µ—Ç–∞ –ì–æ—Å–¥—É–º—ã –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è –∞–∫–∞–¥–µ–º–∏–∫ –†–ê–ù –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –†—É–º—è–Ω—Ü–µ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PdxPf #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞ #–û–Ω–∫–æ–ª–æ–≥–∏—è #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-10-09T08:57:04+00:00,@medpharm,13017,https://t.me/medpharm/13017,"–ö–æ–º–ø–∞–Ω–∏–∏ ¬´–ò—Ä–≤–∏–Ω¬ª, ¬´–†-–§–∞—Ä–º¬ª –∏ ¬´–ú–µ–¥–∏–ø–∞–ª-–û–Ω–∫–æ¬ª –±—É–¥—É –ø–æ—Å—Ç–∞–≤–ª—è—Ç—å –¥–ª—è ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª –ø—è—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –≤ —Ç–æ–º —á–∏—Å–ª–µ ¬´–≠–Ω—Å–ø—Ä–∏–Ω–≥¬ª (–ú–ù–ù —Å–∞—Ç—Ä–∞–ª–∏–∑—É–º–∞–±), –∑–∞ –æ–¥–∏–Ω –º–∏–ª–ª–∏–ª–∏—Ç—Ä –∫–æ—Ç–æ—Ä–æ–≥–æ –∑–∞–ø–ª–∞—Ç—è—Ç 1,1 –º–ª–Ω —Ä—É–±. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PdvJX #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage"",
  ""impact"": ""high"",
  ""english"": ""The companies 'Irvin', 'R-Farm' and 'Medipal-Onko' will supply five drugs for 'The Kindness Circle', including 'Enspring' (satanizumab), at a price of 1.1 million rubles per milliliter. More details: https://clck.ru/3PdvJX #PharmNews #Distribution""
}"
2025-10-09T08:13:06+00:00,@medpharm,13016,https://t.me/medpharm/13016,"–†–æ—Å—Å–∏–π—Å–∫–∏–µ —É—á–µ–Ω—ã–µ –∑–∞–ø–∞—Ç–µ–Ω—Ç–æ–≤–∞–ª–∏ —É—à–Ω–æ–π –∑–∞–∂–∏–º –¥–ª—è —ç–ª–µ–∫—Ç—Ä–æ—Å—Ç–∏–º—É–ª—è—Ü–∏–∏ –±–ª—É–∂–¥–∞—é—â–µ–≥–æ –Ω–µ—Ä–≤–∞, –∫–æ—Ç–æ—Ä—ã–π –ø–æ–º–æ–≥–∞–µ—Ç —Å–Ω–∏–∑–∏—Ç—å –≤–µ—Å. –†–∞–Ω–Ω–∏–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –Ω–∞ –º–∏–Ω–∏-–ø–∏–≥ax –∏ –∫—Ä—ã—Å–∞—Ö –ø–æ–∫–∞–∑–∞–ª–∏, —á—Ç–æ —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–∞—è —Å—Ç–∏–º—É–ª—è—Ü–∏—è –≤–∞–≥—É—Å–∞ —Å–Ω–∏–∂–∞–ª–∞ –º–∞—Å—Å—É —Ç–µ–ª–∞ –∏ —É–ª—É—á—à–∞–ª–∞ –≥–æ–º–µ–æ—Å—Ç–∞–∑ –≥–ª—é–∫–æ–∑—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PdroJ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ù–∞—É–∫–∞ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""Russian scientists have patented an ear clip for vagus nerve electro-stimulation that helps reduce weight. Early studies on mini-pigs and mice showed chronic stimulation of the vagus nerve reduces body mass and improves glucose homeostasis. For more details: https://clck.ru/3PdroJ #MedVestnik #Science""
}"
2025-10-09T07:55:02+00:00,@medpharm,13015,https://t.me/medpharm/13015,"–ß–µ—Ä–µ–∑ —Å–∏—Å—Ç–µ–º—É –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏ –±—ã–ª–æ –ø—Ä–µ—Å–µ—á–µ–Ω–æ –±–æ–ª–µ–µ 85 —Ç—ã—Å. –ø–æ–ø—ã—Ç–æ–∫ –ø—Ä–æ–¥–∞—Ç—å –ø—Ä–æ—Å—Ä–æ—á–µ–Ω–Ω—ã–µ –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç—ã. –ß–∞—â–µ –≤—Å–µ–≥–æ —Ç–∞–∫–∏–µ —Å–ª—É—á–∞–∏ —Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–ª–∏—Å—å –≤ –°–º–æ–ª–µ–Ω—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏, –ú–æ—Å–∫–≤–µ –∏ –ö—Ä–∞—Å–Ω–æ–¥–∞—Ä—Å–∫–æ–º –∫—Ä–∞–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PdqB4 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""shortage, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""More than 85,000 attempts to sell expired medicines were intercepted through a tracking system. Such cases are most frequently recorded in Smolensk Oblast, Moscow, and Krasnodar Krai. For more information: https://clck.ru/3PdqB4 #FarmaNews #Retail""
}"
2025-10-09T07:10:56+00:00,@medpharm,13014,https://t.me/medpharm/13014,"–í –Ω–∞—É–∫–æ–≥—Ä–∞–¥–µ –ü—É—â–∏–Ω–æ –≤ –¥–≤–µ–Ω–∞–¥—Ü–∞—Ç—ã–π —Ä–∞–∑ –ø—Ä–æ—à–µ–ª —Å—Ç—É–¥–µ–Ω—á–µ—Å–∫–∏–π ¬´–ë–∏–æ–¢—É—Ä–Ω–∏—Ä¬ª ‚Äî –≤ —Ç–µ—á–µ–Ω–∏–µ —á–µ—Ç—ã—Ä–µ—Ö –¥–Ω–µ–π 80 —Å—Ç—É–¥–µ–Ω—Ç–æ–≤ –∏–∑ 16 —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç—Å–∫–∏—Ö –∫–æ–º–∞–Ω–¥ —Å–æ—Ä–µ–≤–Ω–æ–≤–∞–ª–∏—Å—å –≤ —Ä–µ—à–µ–Ω–∏–∏ –Ω–µ—Ç—Ä–∏–≤–∏–∞–ª—å–Ω—ã—Ö –Ω–∞—É—á–Ω—ã—Ö –∑–∞–¥–∞—á –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ –ø—Ä–æ—Ñ–∏–ª—è. –†–µ–∑—É–ª—å—Ç–∞—Ç—ã —Ä–∞–±–æ—Ç—ã –æ—Ü–µ–Ω–∏–≤–∞–ª–∞ —ç–∫—Å–ø–µ—Ä—Ç–Ω–∞—è –∫–æ–º–∏—Å—Å–∏—è, –≤ –∫–æ—Ç–æ—Ä—É—é –≤–æ—à–ª–∏ –±–æ–ª–µ–µ 40 —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤ –Ω–∞—É—á–Ω—ã—Ö –∏–Ω—Å—Ç–∏—Ç—É—Ç–æ–≤ –∏ –Ω–∞—É–∫–æ–µ–º–∫–∏—Ö –∫–æ–º–ø–∞–Ω–∏–π, –≤ —Ç–æ–º —á–∏—Å–ª–µ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–∏ –Ω–∞—É—á–Ω–æ-–∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–∏—Ö –ø–æ–¥—Ä–∞–∑–¥–µ–ª–µ–Ω–∏–π –≥—Ä—É–ø–ø—ã ¬´–†-–§–∞—Ä–º¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pctg5","{""skip"": true}"
2025-10-09T06:21:06+00:00,@medpharm,13013,https://t.me/medpharm/13013,"–í–∏—Ä—Ç—É–∞–ª—å–Ω–æ–µ –æ–±—â–µ–Ω–∏–µ —Å—Ç–∞–ª–æ –∞–Ω–∞–ª–æ–≥–æ–º —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω–æ–≥–æ —Ñ–∏–∑–∏—á–µ—Å–∫–æ–≥–æ –∫–æ–Ω—Ç–∞–∫—Ç–∞, –ø–æ—Å–∫–æ–ª—å–∫—É —á–∞—Å—Ç–æ –æ–Ω–æ –ø—Ä–∏–≤–æ–¥–∏—Ç –∫ –ø–æ—è–≤–ª–µ–Ω–∏—é —Å–∏–ª—å–Ω–æ–π —ç–º–æ—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–π —Å–≤—è–∑–∏ –º–µ–∂–¥—É –∏–Ω—Ç–µ—Ä–Ω–µ—Ç-–ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª—è–º–∏. –ò–∑-–∑–∞ —ç—Ç–æ–≥–æ –æ–Ω–æ –Ω–µ—Å–µ—Ç —Ä—è–¥ —Ä–∏—Å–∫–æ–≤, –Ω–∞–ø—Ä–∏–º–µ—Ä, –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–∏—è –±—Ä–µ–¥–æ–≤—ã—Ö –∏–¥–µ–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PdiSC #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ü—Å–∏—Ö–∏–∞—Ç—Ä–∏—è","{""skip"": true}"
2025-10-09T06:04:03+00:00,@medpharm,13012,https://t.me/medpharm/13012,"–í XX –≤–µ–∫–µ —Å—Ç–∞–ª–∏ –¥–æ—Å—Ç—É–ø–Ω—ã –ª–µ–∫–∞—Ä—Å—Ç–≤–∞, –±–ª–∞–≥–æ–¥–∞—Ä—è –∫–æ—Ç–æ—Ä—ã–º –º–æ–∂–Ω–æ —Å–Ω–∏–∑–∏—Ç—å –≤–µ—Å –¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ –±—ã—Å—Ç—Ä–æ –∏, –µ—Å—Ç–µ—Å—Ç–≤–µ–Ω–Ω–æ, –æ–Ω–∏ –≤—ã–∑–≤–∞–ª–∏ –∏–Ω—Ç–µ—Ä–µ—Å –∫–∞–∫ —Å–∞–º–∏—Ö —Ö—É–¥–µ—é—â–∏—Ö, —Ç–∞–∫ –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–æ–≤, —Ñ–∞—Ä–º–∞–∫–æ–ª–æ–≥–æ–≤, –≤—Ä–∞—á–µ–π-—ç–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–æ–≤, –¥–∏–µ—Ç–æ–ª–æ–≥–æ–≤. –û–¥–Ω–∏–º–∏ –∏–∑ —Ç–∞–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Å—Ç–∞–ª —Å–∏–±—É—Ç—Ä–∞–º–∏–Ω, –æ–∫—Ä—É–∂–µ–Ω–Ω—ã–π –º–Ω–æ–∂–µ—Å—Ç–≤–æ–º –º–∏—Ñ–æ–≤ –∏ –ª–µ–≥–µ–Ω–¥. –ß—Ç–æ —ç—Ç–æ –∑–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç, –≤ –∫–∞–∫–∏—Ö —Å–∏—Ç—É–∞—Ü–∏—è—Ö –º–æ–∂–Ω–æ –µ–≥–æ –ø—Ä–∏–º–µ–Ω—è—Ç—å, –∞ –≤ –∫–∞–∫–∏—Ö –Ω–µ–ª—å–∑—è? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pdg3C #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫","{""skip"": true}"
2025-10-08T16:41:30+00:00,@medpharm,13011,https://t.me/medpharm/13011,"ü¶æ –ü–æ–≤–æ–¥ —Å—ç–∫–æ–Ω–æ–º–∏—Ç—å. –†–∞—Å—Ö–æ–¥—ã –Ω–∞ —Å–æ–¥–µ—Ä–∂–∞–Ω–∏–µ –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä—ã –¥–ª—è –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è —ç–∫—Å–ø–µ—Ä—Ç–Ω–æ–π —Ä–∞–±–æ—Ç—ã –∏ –ø–æ–¥–¥–µ—Ä–∂–∫–∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –≤ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω—ã—Ö —Ñ–æ–Ω–¥–∞—Ö –û–ú–° –±—É–¥—É—Ç –º–µ–Ω—å—à–µ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å —Å–æ–¥–µ—Ä–∂–∞–Ω–∏–µ–º —á–∞—Å—Ç–Ω—ã—Ö —Å—Ç—Ä–∞—Ö–æ–≤—ã—Ö –∫–æ–º–ø–∞–Ω–∏–π, –∑–∞—è–≤–∏–ª –º–∏–Ω–∏—Å—Ç—Ä –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ú–∏—Ö–∞–∏–ª –ú—É—Ä–∞—à–∫–æ. –¢–æ—á–Ω—ã—Ö —Å—É–º–º –ø—Ä–µ–¥–ø–æ–ª–∞–≥–∞–µ–º–æ–π —ç–∫–æ–Ω–æ–º–∏–∏ –æ–Ω –Ω–µ –Ω–∞–∑–≤–∞–ª. ü¶æ –ù–∞–≤—Å—Ç—Ä–µ—á—É –æ—Ç—Ä–∞–±–æ—Ç–∫–µ. –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–µ–Ω–Ω—ã–π –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ —Ü–µ–ª–µ–≤–æ–º –æ–±—É—á–µ–Ω–∏–∏ –∏ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–π –æ—Ç—Ä–∞–±–æ—Ç–∫–µ –¥–ª—è –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–≤—É–∑–æ–≤ –æ–¥–æ–±—Ä–µ–Ω –ì–æ—Å–¥—É–º–æ–π –†–§ –≤ –ø–µ—Ä–≤–æ–º —á—Ç–µ–Ω–∏–∏. –î–µ–ø—É—Ç–∞—Ç—ã –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –¥–æ–±–∞–≤–∏—Ç—å –≤ –¥–æ–∫—É–º–µ–Ω—Ç –ø–æ–ª–æ–∂–µ–Ω–∏—è –æ —Å–æ—Ü–ø–æ–¥–¥–µ—Ä–∂–∫–µ –º–æ–ª–æ–¥—ã—Ö –≤—Ä–∞—á–µ–π –∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞—Ç—å –¥–æ–ª–≥–æ—Å—Ä–æ—á–Ω—É—é —Å—Ç—Ä–∞—Ç–µ–≥–∏—é –ø–æ –±–æ—Ä—å–±–µ —Å –∫–∞–¥—Ä–æ–≤—ã–º –¥–µ—Ñ–∏—Ü–∏—Ç–æ–º. ‚ù§Ô∏è –û—Ü–µ–Ω–∏–ª–∏ —Ä–∏—Å–∫–∏. –í –ø—Ä–∞–≤–∏–ª–∞ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è —Å–∞–Ω–∏—Ç–∞—Ä–Ω–æ-—ç–ø–∏–¥–µ–º–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ –Ω–∞–¥–∑–æ—Ä–∞ –≤–Ω–µ—Å–ª–∏ –∏–∑–º–µ–Ω–µ–Ω–∏—è. –ü–ª–∞–Ω–æ–≤—ã–µ –ø—Ä–æ–≤–µ—Ä–∫–∏ –¥–ª—è —Ä—è–¥–∞ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –±—É–¥—É—Ç –∑–∞–º–µ–Ω–µ–Ω—ã –Ω–∞ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–µ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–∏–µ –≤–∏–∑–∏—Ç—ã, –∏–∑–º–µ–Ω–∏—Ç—Å—è –∏—Ö –ø–µ—Ä–∏–æ–¥–∏—á–Ω–æ—Å—Ç—å, –ø–æ—è–≤–∏—Ç—Å—è –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –¥–ª—è –∏—Ö –¥–∏—Å—Ç–∞–Ω—Ü–∏–æ–Ω–Ω–æ–≥–æ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è. ‚ù§Ô∏è –ü—Ä–∏–∑–Ω–∞–ª–∏ –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ–∫. –ù–µ–æ–±—Ö–æ–¥–∏–º–æ —É–≤–µ–ª–∏—á–∏—Ç—å –∞—Å—Å–∏–≥–Ω–æ–≤–∞–Ω–∏—è –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–µ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ –ø–æ –ø—Ä–æ–≥—Ä–∞–º–º–µ 14 –í–ó–ù, –∑–∞—è–≤–∏–ª –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å –º–∏–Ω–∏—Å—Ç—Ä–∞ —Ñ–∏–Ω–∞–Ω—Å–æ–≤ –†–æ—Å—Å–∏–∏ –ü–∞–≤–µ–ª –ö–∞–¥–æ—á–Ω–∏–∫–æ–≤. –¢–µ—Ö —Å—Ä–µ–¥—Å—Ç–≤, —á—Ç–æ –∑–∞–ª–æ–∂–µ–Ω—ã —Å–µ–π—á–∞—Å –≤ –ø—Ä–æ–µ–∫—Ç–µ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –±—é–¥–∂–µ—Ç–∞ –Ω–∞ 2026 –≥–æ–¥, –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""The government's project on targeted training and mandatory practice for medical graduates has been approved by the State Duma of Russia in its first reading. The deputies proposed to add provisions on social support for young doctors and develop a long-term strategy against the shortage of medical personnel. Sanitary-epidemiological supervision rules have been amended, making routine inspections for some organizations into mandatory preventive visits with changes in their frequency and the possibility of remote conducting them. The Deputy Minister of Finance of Russia Pavel Kadobnov recognized that funds allocated for medical supplies under the program 14 VZN are insufficient in the budget project for 2026.""
}"
2025-10-08T16:14:08+00:00,@medpharm,13010,https://t.me/medpharm/13010,–û–±—ä–µ–º –∫–æ–º–º–µ—Ä—á–µ—Å–∫–æ–≥–æ –æ–±–º–µ–Ω–∞ –¥–∞–Ω–Ω—ã–º–∏ —Ä–µ–∞–ª—å–Ω–æ–π –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–π –ø—Ä–∞–∫—Ç–∏–∫–∏ –≤ –†–æ—Å—Å–∏–∏ –º–æ–∂–µ—Ç –ø—Ä–µ–≤—ã—à–∞—Ç—å 4 –º–ª—Ä–¥ —Ä—É–±. –î–ª—è —É—Å–∫–æ—Ä–µ–Ω–∏—è —Ä–æ—Å—Ç–∞ —Ä—ã–Ω–∫–∞ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ —É—Å—Ç—Ä–∞–Ω–∏—Ç—å –ø—Ä–∞–≤–æ–≤—É—é –Ω–µ–æ–ø—Ä–µ–¥–µ–ª–µ–Ω–Ω–æ—Å—Ç—å. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PdFFQ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–î—Ä—É–≥–æ–µ,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The commercial exchange of real clinical practice data in Russia may exceed 4 billion rubles. To accelerate the market growth, legal uncertainty must be resolved.""
}"
2025-10-08T16:05:06+00:00,@medpharm,13009,https://t.me/medpharm/13009,"–ó–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç, –æ–±—è–∑—ã–≤–∞—é—â–∏–π –≤—Å–µ—Ö —Å—Ç—É–¥–µ–Ω—Ç–æ–≤-–±—é–¥–∂–µ—Ç–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–µ–π –∑–∞–∫–ª—é—á–∞—Ç—å –¥–æ–≥–æ–≤–æ—Ä –æ —Ü–µ–ª–µ–≤–æ–º –æ–±—É—á–µ–Ω–∏–∏, –ø—Ä–æ—à–µ–ª –ø–µ—Ä–≤–æ–µ —á—Ç–µ–Ω–∏–µ –≤ –ì–æ—Å–¥—É–º–µ –†–§. –î–æ–∫—É–º–µ–Ω—Ç –Ω–µ —Ä–∞–∑–¥–µ–ª—è–µ—Ç —Å—Ç—É–¥–µ–Ω—Ç–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–µ–π –∏ –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç –æ–±—â–∏–µ —Ñ–æ—Ä–º—É–ª–∏—Ä–æ–≤–∫–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PdEsA #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""A law project requiring all budget students in medical and pharmaceutical specialties to sign a target education contract has passed the first reading in the State Duma of Russia. The document does not differentiate between medical and pharmaceutical specialties students, offering general formulations.""
}"
2025-10-08T15:42:06+00:00,@medpharm,13008,https://t.me/medpharm/13008,–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–µ–Ω–Ω—ã–π –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ —Ü–µ–ª–µ–≤–æ–º –æ–±—É—á–µ–Ω–∏–∏ –∏ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–π –æ—Ç—Ä–∞–±–æ—Ç–∫–µ –¥–ª—è –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–≤—É–∑–æ–≤ –æ–¥–æ–±—Ä–µ–Ω –ì–æ—Å–¥—É–º–æ–π –†–§ –≤ –ø–µ—Ä–≤–æ–º —á—Ç–µ–Ω–∏–∏. –î–µ–ø—É—Ç–∞—Ç—ã –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –¥–æ–±–∞–≤–∏—Ç—å –≤ –¥–æ–∫—É–º–µ–Ω—Ç –ø–æ–ª–æ–∂–µ–Ω–∏—è –æ —Å–æ—Ü–ø–æ–¥–¥–µ—Ä–∂–∫–µ –º–æ–ª–æ–¥—ã—Ö –≤—Ä–∞—á–µ–π –∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞—Ç—å –¥–æ–ª–≥–æ—Å—Ä–æ—á–Ω—É—é —Å—Ç—Ä–∞—Ç–µ–≥–∏—é –ø–æ –±–æ—Ä—å–±–µ —Å –∫–∞–¥—Ä–æ–≤—ã–º –¥–µ—Ñ–∏—Ü–∏—Ç–æ–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PdDp8 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–û–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-10-08T15:40:03+00:00,@medpharm,13007,https://t.me/medpharm/13007,"Zenas –ø—Ä–∏–æ–±—Ä–µ–ª–∞ —É –∫–∏—Ç–∞–π—Å–∫–æ–π InnoCare Pharma –∑–∞ 2 –º–ª—Ä–¥ –¥–æ–ª–ª. –ø—Ä–∞–≤–∞ –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç –æ—Ç —Ä–∞—Å—Å–µ—è–Ω–Ω–æ–≥–æ —Å–∫–ª–µ—Ä–æ–∑–∞, –∫–æ—Ç–æ—Ä—ã–π –ø—Ä–æ—Ö–æ–¥–∏—Ç III —Ñ–∞–∑—É –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å–ø—ã—Ç–∞–Ω–∏–π. –î–≤–∞ –≥–æ–¥–∞ –Ω–∞–∑–∞–¥ Biogen –æ—Ç–∫–∞–∑–∞–ª–∞—Å—å –æ—Ç —ç—Ç–æ–π —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PdDiH #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-08T14:42:04+00:00,@medpharm,13006,https://t.me/medpharm/13006,"–ö–∞–±–º–∏–Ω —É—Ç–≤–µ—Ä–¥–∏–ª –Ω–æ–≤—É—é –ø–µ—Ä–∏–æ–¥–∏—á–Ω–æ—Å—Ç—å –ø—Ä–æ–≤–µ—Ä–æ–∫ –∫–ª–∏–Ω–∏–∫ –≤ –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏ –æ—Ç —É—Ä–æ–≤–Ω—è —Å–∞–Ω–∏—Ç–∞—Ä–Ω–æ-—ç–ø–∏–¥–µ–º–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ —Ä–∏—Å–∫–∞. –°–∞–º—ã–µ —á–∞—Å—Ç—ã–µ –ø—Ä–æ–≤–µ—Ä–∫–∏ (–¥–≤–∞ —Ä–∞–∑–∞ –≤ –≥–æ–¥) –∂–¥—É—Ç –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏, —Ä–∞–±–æ—Ç–∞—é—â–∏–µ —Å –∫–∞—Ç–µ–≥–æ—Ä–∏–µ–π ¬´—á—Ä–µ–∑–≤—ã—á–∞–π–Ω–æ –≤—ã—Å–æ–∫–∏–π —Ä–∏—Å–∫¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PdAhM #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanitation, safety"",
  ""impact"": ""medium"",
  ""english"": ""The ministry approved a new frequency of inspections for clinics depending on the level of sanitary-epidemiological risk. The most frequent inspections (twice a year) are for organizations working with the 'very high risk' category. More details: https://clck.ru/3PdAhM #MedVestnik #Healthcare""
}"
2025-10-08T14:33:03+00:00,@medpharm,13005,https://t.me/medpharm/13005,FDA –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª–æ –ø–µ—Ä–≤—ã–π –∑–∞ –¥–µ—Å—è—Ç–∏–ª–µ—Ç–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è –ª–µ—á–µ–Ω–∏—è –∏–¥–∏–æ–ø–∞—Ç–∏—á–µ—Å–∫–æ–≥–æ –ª–µ–≥–æ—á–Ω–æ–≥–æ —Ñ–∏–±—Ä–æ–∑–∞ ‚Äî Jascayd –æ—Ç Boehringer Ingelheim. –û–Ω –∑–∞–º–µ–¥–ª—è–µ—Ç –ø—Ä–æ–≥—Ä–µ—Å—Å–∏—Ä–æ–≤–∞–Ω–∏–µ —Å–º–µ—Ä—Ç–µ–ª—å–Ω–æ–≥–æ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è –ª–µ–≥–∫–∏—Ö –Ω–∞ 37% –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –ø–ª–∞—Ü–µ–±–æ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PdADS #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-10-08T14:04:06+00:00,@medpharm,13004,https://t.me/medpharm/13004,"–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤—É –†–æ—Å—Å–∏–∏ –ø—Ä–∏–¥–µ—Ç—Å—è –∏–∑—ã—Å–∫–∏–≤–∞—Ç—å –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–µ —Å—Ä–µ–¥—Å—Ç–≤–∞ –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–µ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ –ø–æ –ø—Ä–æ–≥—Ä–∞–º–º–µ 14 –í–ó–ù. –î–µ–Ω–µ–≥, –ø—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ–Ω–Ω—ã—Ö –Ω–∞ —ç—Ç–∏ —Ü–µ–ª–∏ –≤ –ø—Ä–æ–µ–∫—Ç–µ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –±—é–¥–∂–µ—Ç–∞ –Ω–∞ 2026 –≥–æ–¥, –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pd8Kf #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""shortage"",
  ""impact"": ""high"",
  ""english"": ""The Russian government will need to find additional funds for the medication supply program under the 14th Voluntary Health Insurance Program. The budget provisions for these purposes in the federal budget project for 2026 are insufficient. For more details: https://clck.ru/3Pd8Kf #Mednews #Healthcare #Public_Health""
}"
2025-10-08T13:33:04+00:00,@medpharm,13003,https://t.me/medpharm/13003,"–ù–µ–æ–±—Ö–æ–¥–∏–º–æ —É–≤–µ–ª–∏—á–∏—Ç—å –∞—Å—Å–∏–≥–Ω–æ–≤–∞–Ω–∏—è –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–µ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ –ø–æ –ø—Ä–æ–≥—Ä–∞–º–º–µ 14 –í–ó–ù, –∑–∞—è–≤–∏–ª –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å –º–∏–Ω–∏—Å—Ç—Ä–∞ —Ñ–∏–Ω–∞–Ω—Å–æ–≤ –†–æ—Å—Å–∏–∏ –ü–∞–≤–µ–ª –ö–∞–¥–æ—á–Ω–∏–∫–æ–≤. –¢–µ—Ö —Å—Ä–µ–¥—Å—Ç–≤, —á—Ç–æ –∑–∞–ª–æ–∂–µ–Ω—ã —Å–µ–π—á–∞—Å –≤ –ø—Ä–æ–µ–∫—Ç–µ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –±—é–¥–∂–µ—Ç–∞ –Ω–∞ 2026 –≥–æ–¥, –Ω–µ –¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pd6Qo #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""high"",
  ""english"": ""The Deputy Minister of Finance of Russia, Pavel Kadochnikov, stated that the allocations for pharmaceutical supply under program 14 VZN need to be increased. Currently allocated funds in the federal budget project for 2026 are insufficient. For more details: https://clck.ru/3Pd6Qo #PharmVestnik #Distribution""
}"
2025-10-08T13:16:06+00:00,@medpharm,13002,https://t.me/medpharm/13002,"–ó–∞—Ç—Ä–∞—Ç—ã –Ω–∞ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ —ç–∫—Å–ø–µ—Ä—Ç–Ω–æ–π —Ä–∞–±–æ—Ç—ã –≤ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω—ã—Ö —Ñ–æ–Ω–¥–∞—Ö –û–ú–°, —Å–æ–≥–ª–∞—Å–Ω–æ —Ä–∞—Å—á–µ—Ç–∞–º –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–æ—Å—Å–∏–∏, –±—É–¥—É—Ç –º–µ–Ω—å—à–µ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å —Ç–µ–∫—É—â–∏–º —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏–µ–º, –≤—ã–¥–µ–ª—è–µ–º—ã–º –Ω–∞ —Å–æ–¥–µ—Ä–∂–∞–Ω–∏–µ —Å—Ç—Ä–∞—Ö–æ–≤—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π. –û–± —ç—Ç–æ–º —Å–æ–æ–±—â–∏–ª –º–∏–Ω–∏—Å—Ç—Ä –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ú–∏—Ö–∞–∏–ª –ú—É—Ä–∞—à–∫–æ, –Ω–µ –Ω–∞–∑–≤–∞–≤ —Ç–æ—á–Ω—ã—Ö —Å—É–º–º —ç–∫–æ–Ω–æ–º–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pd5Q6 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""Minister of Health Mikhail Murashko announced that healthcare costs in territorial health funds, according to calculations by the Russian Ministry of Health, will be lower compared to current funding for health insurance organizations. He did not provide exact figures on savings.""
}"
2025-10-08T12:47:06+00:00,@medpharm,13001,https://t.me/medpharm/13001,"–£–§–ê–° –£–ª—å—è–Ω–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –≤—ã—è–≤–∏–ª–æ –Ω–∞—Ä—É—à–µ–Ω–∏—è –ø—Ä–∏ –∑–∞–∫–ª—é—á–µ–Ω–∏–∏ –∫–æ–Ω—Ç—Ä–∞–∫—Ç–∞ –Ω–∞ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫—É —Å—Ç—Ä–∞—Ç–µ–≥–∏–∏ —Ä–∞–∑–≤–∏—Ç–∏—è —Å–∏—Å—Ç–µ–º—ã –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è —Ä–µ–≥–∏–æ–Ω–∞. –í –∫–æ–Ω–∫—É—Ä—Å–µ –ø–æ–±–µ–¥–∏–ª —É—á–∞—Å—Ç–Ω–∏–∫, –ø—Ä–µ–¥–ª–æ–∂–∏–≤—à–∏–π –±–æ–ª–µ–µ –≤—ã—Å–æ–∫—É—é —Ü–µ–Ω—É, —á—Ç–æ –Ω–∞—Ä—É—à–∞–µ—Ç –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å–Ω–æ–µ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–æ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pd3ST #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-10-08T11:43:06+00:00,@medpharm,13000,https://t.me/medpharm/13000,"–í—Ä–∞—á–∏ –≤–æ–∑–≥–ª–∞–≤–∏–ª–∏ –¢–û–† –∑–∞—Ä–ø–ª–∞—Ç–Ω—ã—Ö –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–π –≤ –¥–µ—Å—è—Ç–∏ –∫—Ä—É–ø–Ω—ã—Ö –≥–æ—Ä–æ–¥–∞—Ö –†–æ—Å—Å–∏–∏. –í–∞–∫–∞–Ω—Å–∏–∏ –≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π —Å—Ñ–µ—Ä–µ —Å —Å–∞–º—ã–º–∏ –≤—ã—Å–æ–∫–∏–º–∏ –¥–æ—Ö–æ–¥–∞–º–∏ –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç —Ä–∞–±–æ—Ç–æ–¥–∞—Ç–µ–ª–∏ –≤ –ú–æ—Å–∫–≤–µ, –ö—Ä–∞—Å–Ω–æ—è—Ä—Å–∫–µ –∏ –ü–µ—Ä–º–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pcwmz #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-10-08T11:34:02+00:00,@medpharm,12999,https://t.me/medpharm/12999,"Gilead –ø–æ–¥–ø–∏—Å–∞–ª–∞ —Å–æ–≥–ª–∞—à–µ–Ω–∏—è —Å —Ç—Ä–µ–º—è –∏–Ω–¥–∏–π—Å–∫–∏–º–∏ –∫–æ–º–ø–∞–Ω–∏—è–º–∏, –∫–æ—Ç–æ—Ä—ã–µ –æ–±—è–∑–∞–ª–∏—Å—å –Ω–µ –ø—Ä–æ–¥–∞–≤–∞—Ç—å –≤ –°–®–ê –¥–∂–µ–Ω–µ—Ä–∏–∫–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –æ—Ç –í–ò–ß ¬´–ë–∏–∫—Ç–∞—Ä–≤–∏¬ª –¥–æ 2036 –≥–æ–¥–∞. –≠—Ç–æ –¥–∞—Å—Ç —Ñ–∞—Ä–º–≥–∏–≥–∞–Ω—Ç—É –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–µ —Ç—Ä–∏ –≥–æ–¥–∞ –º–æ–Ω–æ–ø–æ–ª–∏–∏ –Ω–∞ –ø—Ä–æ–¥–∞–∂–∏ –∞–Ω—Ç–∏—Ä–µ—Ç—Ä–æ–≤–∏—Ä—É—Å–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏, –∫–æ—Ç–æ—Ä–∞—è –µ–∂–µ–≥–æ–¥–Ω–æ –ø—Ä–∏–Ω–æ—Å–∏—Ç –±–æ–ª–µ–µ 13 –º–ª—Ä–¥ –¥–æ–ª–ª. –≤—ã—Ä—É—á–∫–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pcw6X #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": true,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""Gilead has signed agreements with three Indian companies that have committed not to sell generic versions of the HIV drug Biktarvy in the US until 2036. This will give the pharmaceutical giant additional three years of monopoly on sales of antiretroviral therapy, which brings over $1.3 billion in annual revenue each year.""
}"
2025-10-08T10:50:05+00:00,@medpharm,12998,https://t.me/medpharm/12998,"–í –†–æ—Å—Å–∏–∏ –ø—Ä–æ–¥–æ–ª–∂–∞—é—Ç —Ä–∞–∑—Ä–∞–±–æ—Ç–∫—É –ø–∏–ª–æ—Ç–Ω–æ–≥–æ –ø—Ä–æ–µ–∫—Ç–∞ –ø–æ –≤–Ω–µ–¥—Ä–µ–Ω–∏—é –µ–¥–∏–Ω–æ–π –æ—Ç—Ä–∞—Å–ª–µ–≤–æ–π —Å–∏—Å—Ç–µ–º—ã –æ–ø–ª–∞—Ç—ã —Ç—Ä—É–¥–∞ –≤ –º–µ–¥–∏—Ü–∏–Ω–µ, —Å–æ–æ–±—â–∏–ª –º–∏–Ω–∏—Å—Ç—Ä –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ú–∏—Ö–∞–∏–ª –ú—É—Ä–∞—à–∫–æ. –û–Ω —Å—á–∏—Ç–∞–µ—Ç –ø—Ä–∏–Ω–∏–º–∞–µ–º—ã–π –Ω–∞ –ø—Ä–µ–¥—Å—Ç–æ—è—â—É—é —Ç—Ä–µ—Ö–ª–µ—Ç–∫—É –±—é–¥–∂–µ—Ç –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –±—é–¥–∂–µ—Ç–æ–º —Ä–∞–∑–≤–∏—Ç–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pct7R #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-10-08T08:57:03+00:00,@medpharm,12997,https://t.me/medpharm/12997,"–í –ø—Ä–∞–≤–∏–ª–∞ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è —Å–∞–Ω–∏—Ç–∞—Ä–Ω–æ-—ç–ø–∏–¥–µ–º–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ –Ω–∞–¥–∑–æ—Ä–∞ –≤–Ω–µ—Å–ª–∏ –∏–∑–º–µ–Ω–µ–Ω–∏—è. –ü–ª–∞–Ω–æ–≤—ã–µ –ø—Ä–æ–≤–µ—Ä–∫–∏ –¥–ª—è —Ä—è–¥–∞ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –±—É–¥—É—Ç –∑–∞–º–µ–Ω–µ–Ω—ã –Ω–∞ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–µ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–∏–µ –≤–∏–∑–∏—Ç—ã, –∏–∑–º–µ–Ω–∏—Ç—Å—è –∏—Ö –ø–µ—Ä–∏–æ–¥–∏—á–Ω–æ—Å—Ç—å, –ø–æ—è–≤–∏—Ç—Å—è –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –¥–ª—è –∏—Ö –¥–∏—Å—Ç–∞–Ω—Ü–∏–æ–Ω–Ω–æ–≥–æ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è –∏ –Ω–æ–≤–æ–µ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏–µ –∫–æ–Ω—Ç—Ä–æ–ª—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pcjis #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanitation, regulation"",
  ""impact"": ""medium"",
  ""english"": ""Changes have been made to the rules for sanitary and epidemiological supervision. Routine inspections for some organizations will be replaced with mandatory preventive visits, their frequency will change, and they may also be conducted remotely. There is a new direction of control.""
}"
2025-10-08T08:56:07+00:00,@medpharm,12996,https://t.me/medpharm/12996,–û—Ç–∑—ã–≤—ã –æ—Ç –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å—á–∏—Ç–∞—é—Ç –≤–∞–∂–Ω—ã–º–∏ –¥–ª—è —Å–≤–æ–µ–π —Ä–∞–±–æ—Ç—ã 94% –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –≤—Ä–∞—á–µ–π. –û—Å–æ–±–æ–µ –≤–Ω–∏–º–∞–Ω–∏–µ –æ–Ω–∏ —É–¥–µ–ª—è—é—Ç –æ–±—Ä–∞—Ç–Ω–æ–π —Å–≤—è–∑–∏ –Ω–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –ø–æ—Ä—Ç–∞–ª–∞—Ö-–æ—Ç–∑–æ–≤–∏–∫–∞—Ö –∏ —Å–µ—Ä–≤–∏—Å–∞—Ö –æ–Ω–ª–∞–π–Ω-–∑–∞–ø–∏—Å–∏ –≤ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pcjda #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-10-08T07:57:04+00:00,@medpharm,12995,https://t.me/medpharm/12995,–ú–∏–Ω–∏—Å—Ç—Ä–æ–º –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –¢–∞—Ç–∞—Ä—Å—Ç–∞–Ω–∞ —Å—Ç–∞–ª –ê–ª—å–º–∏—Ä –ê–±–∞—à–µ–≤. –° –∫–æ–Ω—Ü–∞ –∞–≤–≥—É—Å—Ç–∞ –æ–Ω –∏—Å–ø–æ–ª–Ω—è–ª –æ–±—è–∑–∞–Ω–Ω–æ—Å—Ç–∏ –≥–ª–∞–≤—ã –≤–µ–¥–æ–º—Å—Ç–≤–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pcf7i #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-10-08T07:21:01+00:00,@medpharm,12994,https://t.me/medpharm/12994,"–§–æ—Ä—É–º ¬´–ë–∏–æ–ø—Ä–æ–º-2025¬ª, –∫–æ—Ç–æ—Ä—ã–π –ø—Ä–æ—Ö–æ–¥–∏—Ç –≤ –ì–µ–ª–µ–Ω–¥–∂–∏–∫–µ –ø—Ä–∏ –ø–æ–¥–¥–µ—Ä–∂–∫–µ –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–∞ –†–æ—Å—Å–∏–∏, —Å–æ–±—Ä–∞–ª –Ω–∞ —Å–≤–æ–µ–π –ø–ª–æ—â–∞–¥–∫–µ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–µ–π –æ—Ä–≥–∞–Ω–æ–≤ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π –≤–ª–∞—Å—Ç–∏, —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª–µ–π –∏ —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤ –≤–µ–¥—É—â–∏—Ö –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö, —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö, –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏ –¥—Ä—É–≥–∏—Ö –æ—Ç—Ä–∞—Å–ª–µ–≤—ã—Ö –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –∏ –∑–∞—Ä—É–±–µ–∂–Ω—ã—Ö –∫–æ–º–ø–∞–Ω–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pc3r9","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The forum 'BioProm-2025', supported by the Russian Ministry of Industry and Trade, gathered representatives of state authorities, heads and employees of leading biotechnological, pharmaceutical, medical companies, both domestic and foreign, on its platform.""
}"
2025-10-08T07:09:05+00:00,@medpharm,12993,https://t.me/medpharm/12993,"–ó–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å–Ω–∞—è —Ç–µ—Ä–∞–ø–∏—è —Ç–µ—Å—Ç–æ—Å—Ç–µ—Ä–æ–Ω–æ–º —É –º—É–∂—á–∏–Ω —Å—Ç–∞—Ä—à–µ 65 –ª–µ—Ç —Å –≥–∏–ø–æ–≥–æ–Ω–∞–¥–∏–∑–º–æ–º –æ–∫–∞–∑–∞–ª–∞—Å—å —Å–≤—è–∑–∞–Ω–∞ —Å –±–æ–ª–µ–µ –Ω–∏–∑–∫–∏–º —Ä–∏—Å–∫–æ–º —Ä–∞–∫–∞ –ø—Ä–µ–¥—Å—Ç–∞—Ç–µ–ª—å–Ω–æ–π –∂–µ–ª–µ–∑—ã. –û–¥–Ω–∞–∫–æ –Ω–∞ —Ñ–æ–Ω–µ –ª–µ—á–µ–Ω–∏—è —É–º–µ—Ä–µ–Ω–Ω–æ –ø–æ–≤—ã—à–∞–ª–∞—Å—å –≤–µ—Ä–æ—è—Ç–Ω–æ—Å—Ç—å —Ä–∞–∑–≤–∏—Ç–∏—è –¥–æ–±—Ä–æ–∫–∞—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–π –≥–∏–ø–µ—Ä–ø–ª–∞–∑–∏–∏. –†–∏—Å–∫ –∑–∞–≤–∏—Å–µ–ª –æ—Ç –ø—Ä–æ–¥–æ–ª–∂–∏—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –ª–µ—á–µ–Ω–∏—è, —Å–ø–æ—Å–æ–±–∞ –≤–≤–µ–¥–µ–Ω–∏—è –∏ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –∏–Ω–≥–∏–±–∏—Ç–æ—Ä–æ–≤ –∞—Ä–æ–º–∞—Ç–∞–∑—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pcboj #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–û–Ω–∫–æ–ª–æ–≥–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è #–£—Ä–æ–ª–æ–≥–∏—è_–∏_–∞–Ω–¥—Ä–æ–ª–æ–≥–∏—è","{
  ""skip"": true
}"
2025-10-07T16:51:34+00:00,@medpharm,12992,https://t.me/medpharm/12992,"ü¶æ –°–≥–ª–∞–¥—è—Ç —É–≥–ª—ã. –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏ –æ—Ç—Ä–µ–¥–∞–∫—Ç–∏—Ä–æ–≤–∞–ª –∫—Ä–∏—Ç–µ—Ä–∏–∏ –¥–æ–ø—É—Å–∫–∞ —á–∞—Å—Ç–Ω—ã—Ö –∫–ª–∏–Ω–∏–∫, –ø—Ä–µ—Ç–µ–Ω–¥—É—é—â–∏—Ö –Ω–∞ —Ä–∞–±–æ—Ç—É —Å–æ —Å—Ä–µ–¥—Å—Ç–≤–∞–º–∏ –û–ú–°. ¬´–ú–í¬ª –æ–∑–Ω–∞–∫–æ–º–∏–ª—Å—è —Å –Ω–æ–≤–æ–π –≤–µ—Ä—Å–∏–µ–π –ø—Ä–æ–µ–∫—Ç–∞ –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞, –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –¥–∏–∑–ª–∞–π–∫–æ–≤ –Ω–∞ –ø–µ—Ä–≤—ã–π –≤–∞—Ä–∏–∞–Ω—Ç –¥–æ–∫—É–º–µ–Ω—Ç–∞ –≤ —á–µ—Ç—ã—Ä–µ —Ä–∞–∑–∞ –ø—Ä–µ–≤—ã—Å–∏–ª–æ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –æ–¥–æ–±—Ä–µ–Ω–∏–π. ü¶æ –ù–µ –≤–∏–¥—è—Ç –ø–æ–ª—å–∑—ã. –ë–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –æ–±—Å—É–∂–¥–µ–Ω–∏—è –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç–∞ –æ–± –æ—á–µ—Ä–µ–¥–Ω—ã—Ö –∏–∑–º–µ–Ω–µ–Ω–∏—è—Ö –§–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –∑–∞–∫–æ–Ω–∞ ¬´–û–± –û–ú–°¬ª –Ω–µ –ø–æ–¥–¥–µ—Ä–∂–∞–ª–∏ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–Ω—É—é –ú–∏–Ω–∑–¥—Ä–∞–≤–æ–º –†–æ—Å—Å–∏–∏ –Ω–æ—Ä–º—É, –Ω–∞–¥–µ–ª—è—é—â—É—é –≥—É–±–µ—Ä–Ω–∞—Ç–æ—Ä–æ–≤ –ø—Ä–∞–≤–æ–º –ø—Ä–∏–Ω–∏–º–∞—Ç—å —Ä–µ—à–µ–Ω–∏–µ –æ–± –æ—Ç–∫–∞–∑–µ –æ—Ç —Å—Ç—Ä–∞—Ö–æ–≤—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –≤ —Ä–µ–≥–∏–æ–Ω–µ. –ì–æ–ª–æ—Å–æ–≤–∞–Ω–∏–µ –ø–æ –¥–æ–∫—É–º–µ–Ω—Ç—É –∑–∞–≤–µ—Ä—à–µ–Ω–æ 5 –æ–∫—Ç—è–±—Ä—è, –ø—Ä–æ—Ç–∏–≤ –ø–æ–ø—Ä–∞–≤–æ–∫ –≤—ã—Å—Ç—É–ø–∏–ª–∏ 1333 —É—á–∞—Å—Ç–Ω–∏–∫–∞ –æ–±—Å—É–∂–¥–µ–Ω–∏—è, –∑–∞ ‚Äî —Ç–æ–ª—å–∫–æ 12. ‚ù§Ô∏è –í–∑–≤–µ—Å–∏–ª–∏ —Ä–∏—Å–∫–∏. –§–ê–° –†–æ—Å—Å–∏–∏ –ø—Ä–∏–≥—Ä–æ–∑–∏–ª–∞ –≤–æ–∑–±—É–¥–∏—Ç—å –ø–µ—Ä–≤–æ–µ –¥–µ–ª–æ –∑–∞ –∑–ª–æ—É–ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–µ –ü–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ–º –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –†–§ ‚Ññ 1771, —Ä–µ–≥—É–ª–∏—Ä—É—é—â–µ–º –ø–æ–≤—ã—à–µ–Ω–∏–µ —Ü–µ–Ω –≤ —Å–ª—É—á–∞–µ —Ä–∏—Å–∫–∞ –¥–µ—Ñ–∏—Ü–∏—Ç–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤. –ù–∞ —Ñ–æ—Ä—É–º–µ ¬´–ë–∏–æ–ø—Ä–æ–º¬ª —á–∏–Ω–æ–≤–Ω–∏–∫–∏ –ø–æ–¥–∏—Å–∫—É—Ç–∏—Ä–æ–≤–∞–ª–∏, –Ω–µ –ø–æ—Ä–∞ –ª–∏ –æ—Ç–º–µ–Ω–∏—Ç—å –º–µ—Ö–∞–Ω–∏–∑–º. ‚ù§Ô∏è –¢—Ä–µ–±–æ–≤–∞–Ω–∏–µ —Å–ø—Ä–∞–≤–µ–¥–ª–∏–≤–æ—Å—Ç–∏. –ò–Ω—Å—Ç–∏—Ç—É—Ç –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω–æ–≥–æ –ª–∏—Ü–µ–Ω–∑–∏—Ä–æ–≤–∞–Ω–∏—è –∂–¥–µ—Ç —Ä–µ—Ñ–æ—Ä–º–∞. –ù–æ–≤—ã–π –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ—Å—Ç–∞–Ω–æ–≤–∏—Ç –Ω–µ–¥–æ–±—Ä–æ—Å–æ–≤–µ—Å—Ç–Ω—É—é –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏—é –º–µ–∂–¥—É –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–º–∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º–∏ –∏ –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã–º–∏ –ø–∞—Ç–µ–Ω—Ç–æ–æ–±–ª–∞–¥–∞—Ç–µ–ª—è–º–∏. –û —á–µ–º –µ—â–µ –≥–æ–≤–æ—Ä–∏–ª–∏ –Ω–∞ —Ñ–æ—Ä—É–º–µ ¬´–ë–∏–æ–ø—Ä–æ–º¬ª ‚Äî –≤ —Ä–µ–ø–æ—Ä—Ç–∞–∂–µ ¬´–§–í¬ª.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing"",
  ""impact"": ""medium"",
  ""english"": ""The Russian Health Ministry revised the criteria for private clinics seeking to work with OMS (State Medical Insurance Scheme) funds. 'Minsk' has reviewed the latest version of the government decree, which received four times more negative comments than positive ones. The majority of participants in the discussion on amendments to the Federal Law 'On OMS' did not support the proposed regulation by the Health Ministry. The FAS Russia threatened to initiate a case under Order No. 1771 for price increases in cases of potential drug shortage. The 'Biosphere' forum officials discussed the need to abolish this mechanism, as it hinders fair competition between domestic manufacturers and foreign patent holders.""
}"
2025-10-07T16:24:03+00:00,@medpharm,12991,https://t.me/medpharm/12991,"–í –ì–æ—Å–¥—É–º–µ –†–æ—Å—Å–∏–∏ –≥–æ—Ç–æ–≤ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ –Ω–∞—É—á–Ω–æ–º –∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä–æ–≤–∞–Ω–∏–∏, –∫–æ—Ç–æ—Ä—ã–π –¥–æ–ª–∂–µ–Ω —Å—É—â–µ—Å—Ç–≤–µ–Ω–Ω–æ –æ–±–ª–µ–≥—á–∏—Ç—å –∂–∏–∑–Ω—å —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–∞–º –≤ –ø–µ—Ä–≤—É—é –æ—á–µ—Ä–µ–¥—å –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤. –û–Ω –±—É–¥–µ—Ç –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω –¥–ª—è –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –æ–±—Å—É–∂–¥–µ–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PcDph #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The Russian State Duma is preparing a law on scientific consultation that will significantly ease the workload for innovational drug developers. The draft is to be presented for public discussion.""
}"
2025-10-07T15:58:03+00:00,@medpharm,12990,https://t.me/medpharm/12990,–í 2025 –≥–æ–¥—É —É—á–∞—Å—Ç–Ω–∏–∫–∞–º–∏ –≤—ã—Å—Ç–∞–≤–∫–∏ —Ñ–æ—Ä—É–º–∞ ¬´–ë–∏–æ–ø—Ä–æ–º¬ª —Å—Ç–∞–ª–∏ –±–æ–ª–µ–µ 100 –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏–π —Å–æ –≤—Å–µ–π –†–æ—Å—Å–∏–∏. –ö–∞–∫–∏–µ —Å–æ–≥–ª–∞—à–µ–Ω–∏—è –∑–∞–∫–ª—é—á–∏–ª–∏ –Ω–∞ —Ñ–æ—Ä—É–º–µ —É—á–∞—Å—Ç–Ω–∏–∫–∏ —Ñ–∞—Ä–º—Ä—ã–Ω–∫–∞? –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PcCdC #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-10-07T15:16:03+00:00,@medpharm,12989,https://t.me/medpharm/12989,"Chiesi –∑–∞–ø–ª–∞—Ç–∏—Ç –¥–æ 2 –º–ª—Ä–¥ –¥–æ–ª–ª. –∑–∞ –ø—Ä–∞–≤–∞ –Ω–∞ –≥–µ–Ω–Ω—É—é —Ç–µ—Ä–∞–ø–∏—é –æ—Ç —Ä–µ–¥–∫–æ–π –±–æ–ª–µ–∑–Ω–∏ –ø–æ—á–µ–∫. –ò—Ç–∞–ª—å—è–Ω—Å–∫–∏–π –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å –∑–∞–∫–ª—é—á–∏–ª —Å–¥–µ–ª–∫—É —Å–æ —Å—Ç–∞—Ä—Ç–∞–ø–æ–º Arbor Biotechnologies, –æ—Å–Ω–æ–≤–∞–Ω–Ω—ã–º —É—á–µ–Ω—ã–º, –∫–æ—Ç–æ—Ä—ã–π —Å—Ç–æ—è–ª —É –∏—Å—Ç–æ–∫–æ–≤ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ —Ä–µ–¥–∞–∫—Ç–∏—Ä–æ–≤–∞–Ω–∏—è –≥–µ–Ω–æ–≤ CRISPR. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PcAd3 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-07T14:52:05+00:00,@medpharm,12988,https://t.me/medpharm/12988,–û–Ω–∫–æ–¥–∏—Å–ø–∞–Ω—Å–µ—Ä –≤ –í–æ–ª–æ–≥–æ–¥—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –æ—à—Ç—Ä–∞—Ñ–æ–≤–∞–ª–∏ –∑–∞ –Ω–∞–∑–Ω–∞—á–µ–Ω–∏–µ –ø–∞—Ü–∏–µ–Ω—Ç–∞–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–µ –∏–∑ –ü–µ—Ä–µ—á–Ω—è –ñ–ù–í–õ–ü –±–µ–∑ –ø—Ä–æ—Ç–æ–∫–æ–ª–∞ –≤—Ä–∞—á–µ–±–Ω–æ–π –∫–æ–º–∏—Å—Å–∏–∏. –í—Å–µ–≥–æ –±—ã–ª–æ –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–Ω–æ 16 —ç–ø–∏–∑–æ–¥–æ–≤ —Ç–∞–∫–∏—Ö –Ω–∞—Ä—É—à–µ–Ω–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pc96x #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""A cancer clinic in Volgograd Oblast has been fined for prescribing patients drugs not on the –ñ–ù–í–õ–ü list without a medical commission protocol. A total of 16 instances of such violations have been registered.""
}"
2025-10-07T14:32:00+00:00,@medpharm,12987,https://t.me/medpharm/12987,"–°–≤–µ–∂–∏–π –Ω–æ–º–µ—Ä ¬´–§–í¬ª ‚Ññ22-23 (1181-1182) —É–∂–µ –¥–æ—Å—Ç—É–ø–µ–Ω –æ–Ω–ª–∞–π–Ω. –•–∞–Ω–æ–π –≤—Å—Ç—Ä–µ—á–∞–µ—Ç —Ç–æ–≤–∞—Ä–∏—â–µ–π. –ö–∞–∫ —Ä–æ—Å—Å–∏–π—Å–∫–∞—è —Ñ–∞—Ä–º–∞ –ø–æ–∫–æ—Ä—è–µ—Ç –í—å–µ—Ç–Ω–∞–º –í 2026 –≥–æ–¥—É –ø–µ—Ä–≤—ã–µ —á–µ—Ç—ã—Ä–µ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è —Å–º–æ–≥—É—Ç –ø–æ–ª—É—á–∏—Ç—å —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–æ–Ω–Ω—ã–µ —É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏—è –í—å–µ—Ç–Ω–∞–º–∞ –Ω–∞ —Å–≤–æ–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã. –ü–æ–¥—Ä–æ–±–Ω—ã–π –æ–±–∑–æ—Ä –æ–± —ç—Ç–æ–π –∞–∑–∏–∞—Ç—Å–∫–æ–π —Å—Ç—Ä–∞–Ω–µ: –∫—Ç–æ —É–∂–µ —É—Å–ø–µ–ª –∑–∞–∫—Ä–µ–ø–∏—Ç—å—Å—è –Ω–∞ —Ä—ã–Ω–∫–µ, —Å –∫–µ–º –ø—Ä–∏–¥–µ—Ç—Å—è –∫–æ–Ω–∫—É—Ä–∏—Ä–æ–≤–∞—Ç—å –∏ –ø–æ—á–µ–º—É —Å–µ–π—á–∞—Å —É–¥–∞–ª–æ—Å—å —Å–æ–≤–µ—Ä—à–∏—Ç—å –ø—Ä–æ—Ä—ã–≤. –í—Ç–æ—Ä–æ–µ –¥—ã—Ö–∞–Ω–∏–µ. –ö–∞–∫ —á—É–≤—Å—Ç–≤—É—é—Ç —Å–µ–±—è –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã–µ –∞–ø—Ç–µ–∫–∏ –ø–æ—Å–ª–µ –ø—Ä–∏–Ω—è—Ç–∏—è –∑–∞–∫–æ–Ω–∞ –æ–± –∏—Ö –≤–æ–∑—Ä–æ–∂–¥–µ–Ω–∏–∏ –ê–π—Ä–∞—Ç –§–∞—Ä—Ä–∞—Ö–æ–≤, –ó–∞—Ö–∞—Ä –ì–æ–ª–∞–Ω—Ç, –í–∞–¥–∏–º –ö—É–∫–∞–≤–∞ ‚Äî —Ä–∞—Å—Å—É–∂–¥–∞—é—Ç, –ø–æ—á–µ–º—É —Ñ–∞—Ä–º–ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç—å –±–æ–∏—Ç—Å—è —Ä–∞–∑–≤–∏—Ç–∏—è –∞–ø—Ç–µ—á–Ω–æ–≥–æ –∏–∑–≥–æ—Ç–æ–≤–ª–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤. –ß—Ç–æ –∏–∑–≤–µ—Å—Ç–Ω–æ –æ —Å–∞–º–æ–º –≥—Ä–æ–º–∫–æ–º –ø—Ä–æ–µ–∫—Ç–µ ‚Äî –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω–æ–π –∞–ø—Ç–µ–∫–µ –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ –Ω–∞—É—á–Ω–æ-—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ ¬´–°–∏—Ä–∏—É—Å¬ª. –¢–∞–∫–∂–µ –≤ –Ω–æ–º–µ—Ä–µ –∞–Ω–∞–ª–∏—Ç–∏–∫–∞: - –°—Ç–∞–≤–∫–∞ –Ω–∞ –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç—å. –ö–∞–∫–∏–º –∫–æ–º–ø–∞–Ω–∏—è–º —Å–≤—ã—à–µ –ø–æ–ª–æ–≤–∏–Ω—ã –≤—Å–µ–π –≤—ã—Ä—É—á–∫–∏ –ø—Ä–∏–Ω–æ—Å–∏—Ç –æ–¥–∏–Ω –∫–ª—é—á–µ–≤–æ–π –ø—Ä–æ–¥—É–∫—Ç - –†—É—Å—Å–∫–∞—è –¥–æ–ª—è. TOP50 –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ª–µ–∫–∞—Ä—Å—Ç–≤ - –õ–µ—Ç–Ω–∏–π –ø—Ä–æ—Ä—ã–≤. –ö–∞–∫–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª –≤ –∞–≤–≥—É—Å—Ç–µ - –°–≤–æ–π —Å—Ä–µ–¥–∏ —Å–≤–æ–∏—Ö. –û–±–∑–æ—Ä —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ —Ä—ã–Ω–∫–∞ –ö–∞–∑–∞—Ö—Å—Ç–∞–Ω–∞ –ê –µ—â–µ: –í—ã–π—Ç–∏ –∏–∑ —Ç–µ–Ω–∏. –ö—Ç–æ —Å—Ç–æ–∏—Ç —É —Ä—É–ª—è –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–π —Ñ–∞—Ä–º–∏–Ω–¥—É—Å—Ç—Ä–∏–∏ –ó–∞—Ä–∞–±–æ—Ç–∞—Ç—å –Ω–∞ –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å–Ω–æ—Å—Ç–∏. –ö–µ–π—Å —Ä–∞–∑–≤–∏—Ç–∏—è —Å—Ç–∞—Ä—Ç–∞–ø–∞ –≤ —Å–µ–∫—Ç–æ—Ä–µ —Ü–∏—Ñ—Ä–æ–≤–æ–π –º–µ–¥–∏—Ü–∏–Ω—ã –ù–µ—Ä–∞–∑—Ä–µ—à–∏–º—ã–µ –ø—Ä–æ—Ç–∏–≤–æ—Ä–µ—á–∏—è. –ö–∞–∫ –ø–∞—Ä–∞—Ü–µ—Ç–∞–º–æ–ª –≤–ª–∏—è–µ—Ç –Ω–∞ —Ä–∞–∑–≤–∏—Ç–∏–µ –∞—É—Ç–∏–∑–º–∞ –£—Ö–æ–¥—è—Ç –ø–æ-–∞–Ω–≥–ª–∏–π—Å–∫–∏. –ü–æ—á–µ–º—É —Ñ–∞—Ä–º–≥–∏–≥–∞–Ω—Ç—ã –ø—Ä–∏–æ—Å—Ç–∞–Ω–æ–≤–∏–ª–∏ –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–∏ –≤ –í–µ–ª–∏–∫–æ–±—Ä–∏—Ç–∞–Ω–∏—é","{""skip"": true}"
2025-10-07T14:20:06+00:00,@medpharm,12986,https://t.me/medpharm/12986,"–†–∞–∑–º–µ—â–µ–Ω–Ω—ã–π –Ω–∞ –ø–æ—Ä—Ç–∞–ª–µ –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω–æ-–ø—Ä–∞–≤–æ–≤—ã—Ö –∞–∫—Ç–æ–≤ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ –∑–∞–º–µ–Ω–µ —á–∞—Å—Ç–Ω—ã—Ö —Å—Ç—Ä–∞—Ö–æ–≤—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω—ã–º–∏ —Ñ–æ–Ω–¥–∞–º–∏ –û–ú–° –ø–æ–ª—É—á–∏–ª –≤ –æ—Å–Ω–æ–≤–Ω–æ–º –Ω–µ–≥–∞—Ç–∏–≤–Ω—ã–µ –æ—Ç–∫–ª–∏–∫–∏. –ü—Ä–æ—Ç–∏–≤ –ø—Ä–æ–≥–æ–ª–æ—Å–æ–≤–∞–ª–æ –±–æ–ª–µ–µ 1,3 —Ç—ã—Å. —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –æ–±—Å—É–∂–¥–µ–Ω–∏—è, –≤—ã—Å—Ç—É–ø–∏–ª–∏ –∑–∞ ‚Äî —Ç–æ–ª—å–∫–æ 12. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pc7Db #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The law project on replacing private health insurance organizations with territorial OMS funds has received mostly negative responses. More than 1,300 participants have opposed it, while only 12 supported it. More details: https://clck.ru/3Pc7Db #MedVestnik #Healthcare #HealthSystemOrganization""
}"
2025-10-07T14:00:07+00:00,@medpharm,12985,https://t.me/medpharm/12985,"–ü—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –≤–∫–ª—é—á–∞—Ç –≤ –∫—Ä—É–≥ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π, –∫–æ—Ç–æ—Ä—ã–µ –≤–ø—Ä–∞–≤–µ –∑–∞–∫–ª—é—á–∞—Ç—å –¥–æ–≥–æ–≤–æ—Ä—ã –Ω–∞ –ø—Ä–∏–µ–º –Ω–∞ —Ü–µ–ª–µ–≤–æ–µ –æ–±—É—á–µ–Ω–∏–µ –∑–∞ —Å—á–µ—Ç –±—é–¥–∂–µ—Ç–Ω—ã—Ö –∞—Å—Å–∏–≥–Ω–æ–≤–∞–Ω–∏–π. –° –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–µ–º –≤—ã—Å—Ç—É–ø–∏–ª –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ –†–æ—Å—Å–∏–∏. –†–µ—á—å –∏–¥–µ—Ç –æ –ø–æ–¥–≥–æ—Ç–æ–≤–∫–µ –∫–∞–¥—Ä–æ–≤ –ø–æ –Ω–µ –º–µ–Ω–µ–µ 705 –Ω–∞–∏–±–æ–ª–µ–µ –≤–æ—Å—Ç—Ä–µ–±–æ–≤–∞–Ω–Ω—ã–º —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç—è–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pc5oo #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, training_programs"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Industry and Trade of Russia has proposed to include pharmaceutical companies in organizations that can enter contracts for training on a targeted basis with budget funds. The focus is on preparing personnel for up to 705 most in-demand specialties.""
}"
2025-10-07T13:21:05+00:00,@medpharm,12984,https://t.me/medpharm/12984,"–§–ú–ë–ê —É—Ç–≤–µ—Ä–¥–∏–ª–æ –ø–æ–¥—Ä—è–¥—á–∏–∫–∞ –¥–ª—è —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–∞ —Ü–∏–∫–ª–æ—Ç—Ä–æ–Ω–Ω–æ-—Ä–∞–¥–∏–æ—Ö–∏–º–∏—á–µ—Å–∫–æ–≥–æ –∫–æ–º–ø–ª–µ–∫—Å–∞ –Ω–∞ –±–∞–∑–µ –¶–µ–Ω—Ç—Ä–∞ –∏–º. –ë—É—Ä–Ω–∞–∑—è–Ω–∞ –≤ –ú–æ—Å–∫–≤–µ. –ö–æ–Ω—Ç—Ä–∞–∫—Ç –Ω–∞ 17,9 –º–ª—Ä–¥ —Ä—É–±. –∑–∞–∫–ª—é—á–µ–Ω —Å –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–º —É—á–∞—Å—Ç–Ω–∏–∫–æ–º –∑–∞–∫—É–ø–∫–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://medvestnik.ru/content/news/FMBA-vlojit-17-9-mlrd-rublei-v-yadernyi-medicinskii-kompleks.html?utm_source=TG_post&utm_medium=Group&utm_campaign=FMBA-vlojit-17-9-mlrd-rublei-v-yadernyi-medicinskii-kompleks #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-10-07T12:41:09+00:00,@medpharm,12983,https://t.me/medpharm/12983,"Biogen –≤—ã–ø–ª–∞—Ç–∏—Ç Roche 124 –º–ª–Ω –¥–æ–ª–ª. –≤ –∫–∞—á–µ—Å—Ç–≤–µ –æ—Å—Ç–∞—Ç–æ—á–Ω—ã—Ö —Ä–æ—è–ª—Ç–∏ —Å –ø—Ä–æ–¥–∞–∂ ¬´–¢–∏–∑–∞–±—Ä–∏¬ª. –ó–∞–ø–∞—Å—ã –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –±—ã–ª–∏ —Å–¥–µ–ª–∞–Ω—ã –≤ –ø–µ—Ä–∏–æ–¥ –¥–µ–π—Å—Ç–≤–∏—è –ø–∞—Ç–µ–Ω—Ç–Ω–æ–π –∑–∞—â–∏—Ç—ã –Ω–∞ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—é, –∫–æ—Ç–æ—Ä–∞—è –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–ª–∞—Å—å –≤ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ, –Ω–æ –ø—Ä–æ–¥–∞–Ω—ã —É–∂–µ –ø–æ—Å–ª–µ –∏—Å—Ç–µ—á–µ–Ω–∏—è —Å—Ä–æ–∫–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pbyb3 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""Biogen has paid Roche $124 million for remaining royalties on 'Tizabri' sales. The drug's stockpiles were made during the patent protection period but have since been sold after expiration of the term.""
}"
2025-10-07T12:26:06+00:00,@medpharm,12982,https://t.me/medpharm/12982,"–û–ø—É–±–ª–∏–∫–æ–≤–∞–Ω–∞ –Ω–æ–≤–∞—è –≤–µ—Ä—Å–∏—è –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –†–§ –æ –∫—Ä–∏—Ç–µ—Ä–∏—è—Ö –≤–∫–ª—é—á–µ–Ω–∏—è —á–∞—Å—Ç–Ω—ã—Ö –∫–ª–∏–Ω–∏–∫ –≤ —Ä–µ–µ—Å—Ç—Ä –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π, –∏–º–µ—é—â–∏—Ö –ø—Ä–∞–≤–æ —Ä–∞–±–æ—Ç–∞—Ç—å —Å–æ —Å—Ä–µ–¥—Å—Ç–≤–∞–º–∏ –û–ú–°. –†–µ–≥—É–ª—è—Ç–æ—Ä —Å–º—è–≥—á–∏–ª –Ω–µ–∫–æ—Ç–æ—Ä—ã–µ —Ñ–æ—Ä–º—É–ª–∏—Ä–æ–≤–∫–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PbxXZ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""medium"",
  ""english"": ""A new version of the government regulation on criteria for private clinics to be included in the registry of medical organizations with rights to work with OMS medicines. The regulator softened some formulations. For more details: https://clck.ru/3PbxXZ #MedVestnik #Healthcare #MedicalOrganization""
}"
2025-10-07T11:44:06+00:00,@medpharm,12981,https://t.me/medpharm/12981,"–í—ã–ø—É—â–µ–Ω—ã –Ω–æ–≤—ã–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏, –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–Ω—ã–µ –Ω–∞ —Å–Ω–∏–∂–µ–Ω–∏–µ —Å–º–µ—Ä—Ç–Ω–æ—Å—Ç–∏ –æ—Ç –ø–æ—Å–ª–µ—Ä–æ–¥–æ–≤–æ–≥–æ –∫—Ä–æ–≤–æ—Ç–µ—á–µ–Ω–∏—è. –î–æ–∫—É–º–µ–Ω—Ç –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç –æ–±–Ω–æ–≤–ª–µ–Ω–Ω—ã–µ –∫—Ä–∏—Ç–µ—Ä–∏–∏ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∏, –∞–ª–≥–æ—Ä–∏—Ç–º—ã –ª–µ—á–µ–Ω–∏—è –∏ –º–µ—Ä—ã –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –≤–µ–¥—É—â–µ–≥–æ –æ—Å–ª–æ–∂–Ω–µ–Ω–∏—è —Ä–æ–¥–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PbuRa #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ê–∫—É—à–µ—Ä—Å—Ç–≤–æ_–∏_–≥–∏–Ω–µ–∫–æ–ª–æ–≥–∏—è #–ì–µ–º–∞—Ç–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-10-07T11:39:03+00:00,@medpharm,12980,https://t.me/medpharm/12980,"–§–ê–° –†–æ—Å—Å–∏–∏ –ø—Ä–∏–≥—Ä–æ–∑–∏–ª–∞ –≤–æ–∑–±—É–¥–∏—Ç—å –ø–µ—Ä–≤–æ–µ –¥–µ–ª–æ –∑–∞ –∑–ª–æ—É–ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–µ –ü–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ–º –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –†–§ ‚Ññ 1771, —Ä–µ–≥—É–ª–∏—Ä—É—é—â–µ–º –ø–æ–≤—ã—à–µ–Ω–∏–µ —Ü–µ–Ω –≤ —Å–ª—É—á–∞–µ —Ä–∏—Å–∫–∞ –¥–µ—Ñ–∏—Ü–∏—Ç–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤. –ù–∞ —Ñ–æ—Ä—É–º–µ ¬´–ë–∏–æ–ø—Ä–æ–º¬ª —á–∏–Ω–æ–≤–Ω–∏–∫–∏ –ø–æ–¥–∏—Å–∫—É—Ç–∏—Ä–æ–≤–∞–ª–∏, –Ω–µ –ø–æ—Ä–∞ –ª–∏ –æ—Ç–º–µ–Ω–∏—Ç—å –º–µ—Ö–∞–Ω–∏–∑–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pbu4W #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, pricing"",
  ""impact"": ""high"",
  ""english"": ""The FAS of Russia threatened to initiate the first case for abuse of Government Order No. 1771, which regulates price increases in the event of a shortage risk for medicines. Officials discussed on forum 'Biyoprosm' whether it is time to repeal the mechanism.""
}"
2025-10-07T10:50:03+00:00,@medpharm,12979,https://t.me/medpharm/12979,"–†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä —Å–º–æ–∂–µ—Ç –±–ª–æ–∫–∏—Ä–æ–≤–∞—Ç—å —Å–∞–π—Ç—ã —Å –ø—Ä–æ–¥–∞–∂–µ–π –∑–∞–ø—Ä–µ—â–µ–Ω–Ω—ã—Ö –ë–ê–î, –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§ —É—Ç–≤–µ—Ä–¥–∏–ª–æ –Ω–æ–≤—ã–µ –ø–æ–ª–Ω–æ–º–æ—á–∏—è —Ä–µ–≥—É–ª—è—Ç–æ—Ä–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pbqf3 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, regulation"",
  ""impact"": ""high"",
  ""english"": ""The Rospatentnadzor will be able to block websites selling prohibited BAds. The Russian government has approved new regulatory powers.""
}"
2025-10-07T10:46:41+00:00,@medpharm,12978,https://t.me/medpharm/12978,"–í –Ø—Ä–æ—Å–ª–∞–≤–ª–µ –∑–∞–≤–µ—Ä—à–∏–ª–∞—Å—å –ù–µ–¥–µ–ª—è –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏ –Ø—Ä–æ—Å–ª–∞–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏. –ï–µ —É—á–∞—Å—Ç–Ω–∏–∫–∞–º–∏ —Å—Ç–∞–ª–∏ –±–æ–ª–µ–µ 80 –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –∏–∑ 20 —Ä–µ–≥–∏–æ–Ω–æ–≤ –†–æ—Å—Å–∏–∏, –ë–µ–ª–æ—Ä—É—Å—Å–∏–∏ –∏ –ö–∏—Ç–∞—è. –í 2025 –≥–æ–¥—É –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–µ –ø—Ä–æ—Ö–æ–¥–∏–ª–æ –≤ –Ω–æ–≤–æ–º —Ñ–æ—Ä–º–∞—Ç–µ ‚Äî XV —é–±–∏–ª–µ–π–Ω—ã–π –î–µ–Ω—å –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏ –æ–±—ä–µ–¥–∏–Ω–∏–ª–∏ —Å –ø—Ä–æ—Ñ–æ—Ä–∏–µ–Ω—Ç–∞—Ü–∏–æ–Ω–Ω—ã–º —Ñ–æ—Ä—É–º–æ–º ¬´–ù–µ–¥–µ–ª—è –æ—Ç–∫—Ä—ã—Ç—ã—Ö –¥–≤–µ—Ä–µ–π¬ª. –û—Ä–≥–∞–Ω–∏–∑–∞—Ç–æ—Ä–∞–º–∏ —Å–æ–±—ã—Ç–∏—è –≤—ã—Å—Ç—É–ø–∏–ª–∏ –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –∏ –¢–æ—Ä–≥–æ–≤–æ-–ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–∞—è –ø–∞–ª–∞—Ç–∞ –Ø—Ä–æ—Å–ª–∞–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PbqPz","{""skip"": true}"
2025-10-07T09:53:05+00:00,@medpharm,12977,https://t.me/medpharm/12977,–í –§–µ–¥–µ—Ä–∞—Ü–∏–∏ –∞–Ω–µ—Å—Ç–µ–∑–∏–æ–ª–æ–≥–æ–≤ –∏ —Ä–µ–∞–Ω–∏–º–∞—Ç–æ–ª–æ–≥–æ–≤ –†–æ—Å—Å–∏–∏ —Å–º–µ–Ω–∏–ª—Å—è —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å. –ü–æ—Å—Ç –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç–∞ –∑–∞–Ω—è–ª –ø—Ä–æ—Ñ–µ—Å—Å–æ—Ä –°–ì–ú–£ –ú–∏—Ö–∞–∏–ª –ö–∏—Ä–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PbmUd #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-10-07T08:48:04+00:00,@medpharm,12976,https://t.me/medpharm/12976,"–§–ú–ë–ê —Ö–æ—á–µ—Ç –≤–≤–µ—Å—Ç–∏ –Ω–æ–≤—ã–µ –≤–µ–¥–æ–º—Å—Ç–≤–µ–Ω–Ω—ã–µ –Ω–∞–≥—Ä–∞–¥—ã –∑–∞ –∑–∞—Å–ª—É–≥–∏ –≤ –º–µ–¥–∏—Ü–∏–Ω–µ, –Ω–∞—É–∫–µ –∏ –¥–æ–Ω–æ—Ä—Å—Ç–≤–µ. –≠—Ç–æ –¥–æ–ª–∂–Ω–æ –ø–æ–≤—ã—Å–∏—Ç—å –º–æ—Ç–∏–≤–∞—Ü–∏—é —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –æ—Ç—Ä–∞—Å–ª–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PbgjB #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-10-07T08:35:02+00:00,@medpharm,12975,https://t.me/medpharm/12975,–ò–Ω–¥–∏–π—Å–∫–∏–µ –≤–ª–∞—Å—Ç–∏ –Ω–∞—á–∞–ª–∏ —É–≥–æ–ª–æ–≤–Ω–æ–µ —Ä–∞—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è —Å–∏—Ä–æ–ø–∞ –æ—Ç –∫–∞—à–ª—è Sresan Pharmaceuticals. –ü–æ—Å–ª–µ —É–ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ —Å–∫–æ–Ω—á–∞–ª–∏—Å—å 14 –¥–µ—Ç–µ–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pbfby #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-10-07T07:49:03+00:00,@medpharm,12974,https://t.me/medpharm/12974,–ò–Ω—Å—Ç–∏—Ç—É—Ç –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω–æ–≥–æ –ª–∏—Ü–µ–Ω–∑–∏—Ä–æ–≤–∞–Ω–∏—è –∂–¥–µ—Ç —Ä–µ—Ñ–æ—Ä–º–∞. –ù–æ–≤—ã–π –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ—Å—Ç–∞–Ω–æ–≤–∏—Ç –Ω–µ–¥–æ–±—Ä–æ—Å–æ–≤–µ—Å—Ç–Ω—É—é –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏—é –º–µ–∂–¥—É –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–º–∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º–∏ –∏ –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã–º–∏ –ø–∞—Ç–µ–Ω—Ç–æ–æ–±–ª–∞–¥–∞—Ç–µ–ª—è–º–∏. –û —á–µ–º –µ—â–µ –≥–æ–≤–æ—Ä–∏–ª–∏ –Ω–∞ —Ñ–æ—Ä—É–º–µ ¬´–ë–∏–æ–ø—Ä–æ–º¬ª ‚Äî –≤ —Ä–µ–ø–æ—Ä—Ç–∞–∂–µ ¬´–§–í¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PbcFj #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The compulsory licensing institute is waiting for reforms. A new law project will stop unscrupulous competition between domestic producers and foreign patent holders at the biopharmaceutical forum 'BioProm' - as reported by 'FV'. More details: https://clck.ru/3PbcFj #PharmNews #Production""
}"
2025-10-07T07:33:06+00:00,@medpharm,12973,https://t.me/medpharm/12973,"¬´–ú–æ–∂–µ—Ç –ª–∏ –≤—Ä–∞—á, –æ–±—É—á–∞—é—â–∏–π—Å—è –Ω–∞ –∫—É—Ä—Å–∞—Ö –ø—Ä–æ—Ñ–ø–µ—Ä–µ–ø–æ–¥–≥–æ—Ç–æ–≤–∫–∏, –æ—Å—É—â–µ—Å—Ç–≤–ª—è—Ç—å —Ç—Ä—É–¥–æ–≤—É—é –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç—å –≤ –ø–µ—Ä–∏–æ–¥ —É—á–µ–±–Ω–æ–≥–æ –ø—Ä–æ—Ü–µ—Å—Å–∞? –ö–∞–∫ –¥–æ–ª–∂–Ω–∞ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç—å—Å—è –æ–ø–ª–∞—Ç–∞ —Ç—Ä—É–¥–∞ —Ä–∞–±–æ—Ç–Ω–∏–∫–∞ –≤ —Ç–∞–∫–∏–µ —Ä–∞–±–æ—á–∏–µ –¥–Ω–∏? –ü—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ–Ω–∞ –ª–∏ –µ–º—É —Å–ø–µ—Ü–∏–∞–ª—å–Ω–∞—è —Å–æ—Ü–∏–∞–ª—å–Ω–∞—è –≤—ã–ø–ª–∞—Ç–∞ –≤ —É–∫–∞–∑–∞–Ω–Ω—ã–π –ø–µ—Ä–∏–æ–¥?¬ª –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PbbCo #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""Questions regarding whether medical students during training courses can work and how their wages should be paid during these working days, as well as whether they are entitled to special social benefits in this period. More details: https://clck.ru/3PbbCo""
}"
2025-10-06T16:28:01+00:00,@medpharm,12971,https://t.me/medpharm/12971,"ü¶æ –ü—Ä–µ–¥–ª–æ–∂–∞—Ç —Ä–∞—Å–∫–æ—à–µ–ª–∏—Ç—å—Å—è. –ü—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—å –°–æ–≤–µ—Ç–∞ –§–µ–¥–µ—Ä–∞—Ü–∏–∏ –í–∞–ª–µ–Ω—Ç–∏–Ω–∞ –ú–∞—Ç–≤–∏–µ–Ω–∫–æ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∞ –ø—Ä–æ—Ä–∞–±–æ—Ç–∞—Ç—å –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤—É —Å–æ–±–∏—Ä–∞—Ç—å –≤–∑–Ω–æ—Å—ã –Ω–∞ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–µ —Å—Ç—Ä–∞—Ö–æ–≤–∞–Ω–∏–µ —Å –Ω–µ—Ä–∞–±–æ—Ç–∞—é—â–µ–≥–æ –Ω–∞—Å–µ–ª–µ–Ω–∏—è (–∑–∞ –∏—Å–∫–ª—é—á–µ–Ω–∏–µ–º –¥–µ—Ç–µ–π, –ø–µ–Ω—Å–∏–æ–Ω–µ—Ä–æ–≤, –∏–Ω–≤–∞–ª–∏–¥–æ–≤ –∏ –ª—é–¥–µ–π —Å –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–Ω—ã–º –∑–¥–æ—Ä–æ–≤—å–µ–º). –°–æ–≥–ª–∞—Å–Ω–æ –µ–µ —Ä–∞—Å—á–µ—Ç–∞–º, –ø—Ä–∏–µ–º–ª–µ–º–æ–π —Å—É–º–º–æ–π –±—É–¥–µ—Ç 45 —Ç—ã—Å. —Ä—É–±. –≤ –≥–æ–¥. ü¶æ –í–æ–∑—å–º—É—Ç –Ω–∞ –∫–∞—Ä–∞–Ω–¥–∞—à. –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä –≥–æ—Ç–æ–≤ –∫–æ–Ω—Ç—Ä–æ–ª–∏—Ä–æ–≤–∞—Ç—å –æ—Å–ª–æ–∂–Ω–µ–Ω–∏—è –∏ –Ω–µ–∂–µ–ª–∞—Ç–µ–ª—å–Ω—ã–µ —Ä–µ–∞–∫—Ü–∏–∏, –≤–æ–∑–Ω–∏–∫–∞—é—â–∏–µ –ø—Ä–∏ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–∏ –∫–ª–µ—Ç–æ—á–Ω–æ–π CAR-T-—Ç–µ—Ä–∞–ø–∏–∏. –í–µ–¥–µ–Ω–∏–µ —Ñ–∞—Ä–º–∞–∫–æ–Ω–∞–¥–∑–æ—Ä–∞ –∑–∞ –ø–æ–¥–æ–±–Ω—ã–º–∏ –º–µ—Ç–æ–¥–∞–º–∏ —Å—Ç–∞–Ω–µ—Ç –Ω–æ–≤—ã–º –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏–µ–º —Ä–∞–±–æ—Ç—ã —Å–ª—É–∂–±—ã. ‚ù§Ô∏è –ù—É–∂–Ω–æ —Ä–∞–∑–¥–µ–ª—è—Ç—å. –ó–∞–º–≥–ª–∞–≤—ã –§–ê–° –†–æ—Å—Å–∏–∏ –¢–∏–º–æ—Ñ–µ–π –ù–∏–∂–µ–≥–æ—Ä–æ–¥—Ü–µ–≤ –Ω–∞–∑–≤–∞–ª –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –æ–¥–Ω–∏–º –∏–∑ –±–∞—Ä—å–µ—Ä–æ–≤ –Ω–∞ –ø—É—Ç–∏ ¬´–∏–Ω—Ç–µ–≥—Ä–∞—Ü–∏–∏ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ —Ä–æ—Å—Å–∏–π—Å–∫—É—é –º–µ–¥–∏—Ü–∏–Ω—Å–∫—É—é –ø—Ä–∞–∫—Ç–∏–∫—É¬ª. –ö–† –Ω–∞–¥–æ –æ—Ç–¥–µ–ª–∏—Ç—å –æ—Ç —ç–∫–æ–Ω–æ–º–∏–∫–∏, —Å—á–∏—Ç–∞–µ—Ç –æ–Ω. ‚ù§Ô∏è –ò–∑–±–∏—Ä–∞—Ç–µ–ª—å–Ω—ã–π –ø–æ–¥—Ö–æ–¥. –ú–∏–Ω–∑–¥—Ä–∞–≤ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –ø—Ä–∞–≤–∏–ª–∞ –∏ –∫—Ä–∏—Ç–µ—Ä–∏–∏ –¥–ª—è –ø–æ–ª—É—á–µ–Ω–∏—è –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–≥–æ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ —Å—É–±—Å–∏–¥–∏—Ä–æ–≤–∞–Ω–∏—è –¥–ª—è –∑–∞–∫—É–ø–∫–∏ –¥–æ—Ä–æ–≥–æ—Å—Ç–æ—è—â–∏—Ö –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –†–µ–≥–∏–æ–Ω –¥–æ–ª–∂–µ–Ω —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–æ–≤–∞—Ç—å –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–Ω—ã–º –∫—Ä–∏—Ç–µ—Ä–∏—è–º.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, reimbursement, safety"",
  ""impact"": ""high"",
  ""english"": ""The English translation or summary of the message focuses on the proposal to collect premiums from non-working population for compulsory medical insurance. The regulator is ready to oversee complications and adverse reactions arising from the use of CAR-T therapy, which is a new direction for the FSA. The Deputy Minister of Health from FAS Russia suggests separating clinical guidelines from economic issues, and the Ministry of Health has developed criteria for obtaining additional federal subsidies to purchase expensive orphan drugs. Regions must meet certain criteria.""
}"
2025-10-06T16:10:06+00:00,@medpharm,12970,https://t.me/medpharm/12970,–ú–∏–Ω–∑–¥—Ä–∞–≤ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –ø—Ä–∞–≤–∏–ª–∞ –∏ –∫—Ä–∏—Ç–µ—Ä–∏–∏ –¥–ª—è –ø–æ–ª—É—á–µ–Ω–∏—è –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–≥–æ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ —Å—É–±—Å–∏–¥–∏—Ä–æ–≤–∞–Ω–∏—è –¥–ª—è –∑–∞–∫—É–ø–∫–∏ –¥–æ—Ä–æ–≥–æ—Å—Ç–æ—è—â–∏—Ö –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –†–µ–≥–∏–æ–Ω –¥–æ–ª–∂–µ–Ω —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–æ–≤–∞—Ç—å –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–Ω—ã–º –∫—Ä–∏—Ç–µ—Ä–∏—è–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PbBiS #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health has developed rules and criteria for obtaining additional federal subsidies for the procurement of expensive orphan drugs. Regions must meet certain criteria. For more details: https://clck.ru/3PbBiS #FarmaNews #Regulation""
}"
2025-10-06T16:09:06+00:00,@medpharm,12969,https://t.me/medpharm/12969,"–î–ª–∏—Ç–µ–ª—å–Ω–æ–µ –≤–æ–∑–¥–µ–π—Å—Ç–≤–∏–µ —Ç—Ä–∏—Ö–ª–æ—Ä—ç—Ç–∏–ª–µ–Ω–∞ –Ω–∞ –æ—Ç–∫—Ä—ã—Ç–æ–º –≤–æ–∑–¥—É—Ö–µ –º–æ–∂–µ—Ç –±—ã—Ç—å —Å–≤—è–∑–∞–Ω–æ —Å –ø–æ–≤—ã—à–µ–Ω–Ω—ã–º —Ä–∏—Å–∫–æ–º –±–æ–ª–µ–∑–Ω–∏ –ü–∞—Ä–∫–∏–Ω—Å–æ–Ω–∞. –•–æ—Ç—è —Å–≤—è–∑—å –Ω–µ –¥–æ–∫–∞–∑—ã–≤–∞–µ—Ç –ø—Ä–∏—á–∏–Ω–Ω–æ-—Å–ª–µ–¥—Å—Ç–≤–µ–Ω–Ω—É—é –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç—å, –ø–æ–ª—É—á–µ–Ω–Ω—ã–µ –¥–∞–Ω–Ω—ã–µ —É—Å–∏–ª–∏–≤–∞—é—Ç –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å—Å—Ç–≤–∞ –≤–ª–∏—è–Ω–∏—è –∑–∞–≥—Ä—è–∑–Ω–µ–Ω–∏—è –æ–∫—Ä—É–∂–∞—é—â–µ–π —Å—Ä–µ–¥—ã –Ω–∞ —Ä–∞–∑–≤–∏—Ç–∏–µ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PbBfu #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ù–µ–≤—Ä–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è","{
  ""skip"": true
}"
2025-10-06T15:14:05+00:00,@medpharm,12968,https://t.me/medpharm/12968,–ù–ú–ò–¶ –≥–µ–º–∞—Ç–æ–ª–æ–≥–∏–∏ —Å —Ç—Ä–µ—Ç—å–µ–π –ø–æ–ø—ã—Ç–∫–∏ –Ω–∞—à–µ–ª –Ω–æ–≤–æ–≥–æ –ø–æ–¥—Ä—è–¥—á–∏–∫–∞ –¥–ª—è —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –∫–æ–º–ø–ª–µ–∫—Å–∞ –ø–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤—É CAR-T-–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Å—Ç–æ–∏–º–æ—Å—Ç—å—é –±–æ–ª–µ–µ 700 –º–ª–Ω —Ä—É–±. –ü—Ä–µ–¥—ã–¥—É—â–∏–µ –¥–≤–∞ –∞—É–∫—Ü–∏–æ–Ω–∞ –ø—Ä–∏–∑–Ω–∞–ª–∏ –Ω–µ—Å–æ—Å—Ç–æ—è–≤—à–∏–º–∏—Å—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pb954 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-10-06T14:39:02+00:00,@medpharm,12967,https://t.me/medpharm/12967,"–ó–∞–∫–ª—é—á–µ–Ω–∏–µ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–∞ —Å—Ç–∞–Ω–µ—Ç –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–º –ª–∏—Ü–µ–Ω–∑–∏–æ–Ω–Ω—ã–º —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–µ–º –¥–ª—è –æ–±—Ä–∞–∑–æ–≤–∞—Ç–µ–ª—å–Ω—ã—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π, –æ–±—É—á–∞—é—â–∏—Ö –ø–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–º —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç—è–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pb77G #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{""skip"": true}"
2025-10-06T14:04:33+00:00,@medpharm,12965,https://t.me/medpharm/12965,"–í–æ –≤—Ä–µ–º—è –æ–±—Ö–æ–¥–∞ –≤—ã—Å—Ç–∞–≤–∫–∏ —Ñ–æ—Ä—É–º–∞ ¬´–ë–∏–æ–ø—Ä–æ–º¬ª, –∫–æ—Ç–æ—Ä—ã–π 6‚Äî7 –æ–∫—Ç—è–±—Ä—è –ø—Ä–æ—Ö–æ–¥–∏—Ç –≤ –ì–µ–ª–µ–Ω–¥–∂–∏–∫–µ, –ø–µ—Ä–≤—ã–π –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—è –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –†–æ—Å—Å–∏–∏ –î–µ–Ω–∏—Å –ú–∞–Ω—Ç—É—Ä–æ–≤ –ø–æ—Å–µ—Ç–∏–ª —ç–∫—Å–ø–æ–∑–∏—Ü–∏—é –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª. –ù–∞ —Å—Ç–µ–Ω–¥–µ —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω —Ä—è–¥ –Ω–æ–≤–∏–Ω–æ–∫ ‚Äî –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Å–∞—Ö–∞—Ä–Ω–æ–≥–æ –¥–∏–∞–±–µ—Ç–∞, –æ–∂–∏—Ä–µ–Ω–∏—è, –∏–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –¥—ã—Ö–∞—Ç–µ–ª—å–Ω—ã—Ö –ø—É—Ç–µ–π, —Å–∏–Ω–¥—Ä–æ–º–∞ –∫–æ—Ä–æ—Ç–∫–æ–π –∫–∏—à–∫–∏. –î–µ–Ω–∏—Å –ú–∞–Ω—Ç—É—Ä–æ–≤ –æ—Ü–µ–Ω–∏–ª —É–¥–æ–±—Å—Ç–≤–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –æ–¥–Ω–æ–¥–æ–∑–æ–≤–æ–≥–æ –∏–Ω–∂–µ–∫—Ç–æ—Ä–∞, –∫–æ—Ç–æ—Ä—ã–π –ø–æ–∑–≤–æ–ª—è–µ—Ç –ø–∞—Ü–∏–µ–Ω—Ç—É –±—ã—Ç—å —É–≤–µ—Ä–µ–Ω–Ω—ã–º –≤ —Ç–æ–º, —á—Ç–æ –æ–Ω –Ω–µ –æ—à–∏–±—Å—è –ø—Ä–∏ –≤—ã–±–æ—Ä–µ –¥–æ–∑—ã –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏ —Ç–æ—á–Ω–æ —Å–æ–±–ª—é–¥–∞–µ—Ç –Ω–∞–∑–Ω–∞—á–µ–Ω–∏–µ –≤—Ä–∞—á–∞. –î–µ–Ω–∏—Å –ú–∞–Ω—Ç—É—Ä–æ–≤ —Ç–∞–∫–∂–µ —Ä–µ–∫–æ–º–µ–Ω–¥–æ–≤–∞–ª —É–≥–ª—É–±–∏—Ç—å –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏—é –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ —Ç–∞–∫–æ–≥–æ —É—Å—Ç—Ä–æ–π—Å—Ç–≤–∞, —Ç–∞–∫ –∫–∞–∫ —ç—Ç–æ –Ω–∞—Å—Ç–æ—è—â–∏–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ XXI –≤–µ–∫–∞. ¬´–ú—ã —É–≤–µ—Ä–µ–Ω—ã, —á—Ç–æ –≤–µ—Å–æ–º—É—é —Ä–æ–ª—å –≤ –±—É–¥—É—â–∏—Ö –º–µ—Ç–æ–¥–∞—Ö —Ç–µ—Ä–∞–ø–∏–∏ –±—É–¥—É—Ç –∏–º–µ—Ç—å –∏–º–µ–Ω–Ω–æ –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–µ –∏ –ø–µ–ø—Ç–∏–¥–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, –∫–ª–µ—Ç–æ—á–Ω—ã–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏, –∫–æ–Ω—ä—é–≥–∞—Ç—ã –º–æ–Ω–æ–∫–ª–æ–Ω–∞–ª—å–Ω—ã—Ö –∞–Ω—Ç–∏—Ç–µ–ª –¥–ª—è –ª–µ—á–µ–Ω–∏—è –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, –∫–æ—Ç–æ—Ä—ã–µ –ø–æ–∫–∞ —Å—á–∏—Ç–∞—é—Ç—Å—è –Ω–µ–∏–∑–ª–µ—á–∏–º—ã–º–∏, ‚Äî —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∞ –≥–æ—Å—Ç—è–º –¥–∏—Ä–µ–∫—Ç–æ—Ä –ø–æ –Ω–æ–≤—ã–º –ø—Ä–æ–¥—É–∫—Ç–∞–º –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª –ö–∏—Ä–∞ –ó–∞—Å–ª–∞–≤—Å–∫–∞—è. ‚Äî –ù–∞—à–∞ –∫–æ–º–ø–∞–Ω–∏—è –æ—á–µ–Ω—å –∞–∫—Ç–∏–≤–Ω–æ —Ä–∞–±–æ—Ç–∞–µ—Ç –≤ —ç—Ç–æ–º –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏–∏, –≤ —Ç–æ–º —á–∏—Å–ª–µ —Å–æ–≤–º–µ—Å—Ç–Ω–æ —Å –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥—Å–∫–∏–º –ø–æ–ª–∏—Ç–µ—Ö–Ω–∏—á–µ—Å–∫–∏–º —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–æ–º —Ä–∞–∑—Ä–∞–±–∞—Ç—ã–≤–∞–µ—Ç –º–†–ù–ö-–≤–∞–∫—Ü–∏–Ω—É –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Ä–∞–∑–ª–∏—á–Ω—ã—Ö –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π¬ª. ¬´–í—ã ‚Äî –º–æ–ª–æ–¥—Ü—ã¬ª, ‚Äî —Ä–µ–∑—é–º–∏—Ä–æ–≤–∞–ª –ø–µ—Ä–≤—ã–π –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—è –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety, guideline"",
  ""impact"": ""high"",
  ""english"": "": The Deputy Prime Minister of Russia, Denis Manturov, visited the Promomed stand at the Bioprom exhibition in Gelendzhik. He was impressed by the company's innovative products, including treatments for diabetes, obesity, respiratory infections, and short bowel syndrome. He highlighted the convenience of a single-dose injector that ensures patients accurately follow their doctor's instructions and doses. He also encouraged localizing production of this technology, which is essential for modern medicine. Promomed's director Kira Zaslavskaya emphasized the importance of biotechnological and peptide drugs, cell therapies, monoclonal antibody conjugates for treating currently incurable diseases. The Deputy Prime Minister concluded by saying, 'You are doing a great job.'""
}"
2025-10-06T13:48:03+00:00,@medpharm,12964,https://t.me/medpharm/12964,"–ó–∞—è–≤–∫–∏ –Ω–∞ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—é –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ –ø–æ–ª–Ω–æ—Å—Ç—å—é –∏—Å—Å–ª–µ–¥—É—é—Ç—Å—è –∏ –ø—Ä–æ–∏–∑–≤–æ–¥—è—Ç—Å—è –≤ –°–®–ê, –±—É–¥—É—Ç —Ä–∞—Å—Å–º–∞—Ç—Ä–∏–≤–∞—Ç—å—Å—è FDA –≤ –ø—Ä–∏–æ—Ä–∏—Ç–µ—Ç–Ω–æ–º –ø–æ—Ä—è–¥–∫–µ. –ú–µ—Ä–∞ –ø—Ä–∏–∑–≤–∞–Ω–∞ –ø–æ–¥–¥–µ—Ä–∂–∞—Ç—å –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–µ —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –∏ —É–º–µ–Ω—å—à–∏—Ç—å –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç—å –æ—Ç –∑–∞—Ä—É–±–µ–∂–Ω—ã—Ö –ø–æ—Å—Ç–∞–≤–æ–∫. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pb3nb #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-06T13:20:05+00:00,@medpharm,12963,https://t.me/medpharm/12963,–í –°–æ–≤–µ—Ç–µ –§–µ–¥–µ—Ä–∞—Ü–∏–∏ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –æ–±—è–∑–∞—Ç—å –Ω–µ—Ä–∞–±–æ—Ç–∞—é—â–∏—Ö —Ä–æ—Å—Å–∏—è–Ω —Å–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω–æ —É–ø–ª–∞—á–∏–≤–∞—Ç—å –≤–∑–Ω–æ—Å—ã –∑–∞ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–µ —Å—Ç—Ä–∞—Ö–æ–≤–∞–Ω–∏–µ. –≠—Ç–æ —Å—É—â–µ—Å—Ç–≤–µ–Ω–Ω–æ —Ä–∞–∑–≥—Ä—É–∑–∏—Ç —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã–µ –±—é–¥–∂–µ—Ç—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PazwL #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The Federation Council proposed that non-working Russians should pay their mandatory medical insurance contributions voluntarily. This will significantly lighten the regional budgets. For more details: https://clck.ru/3PazwL #MedVestnik #Healthcare #HealthSystemOrganization""
}"
2025-10-06T13:00:07+00:00,@medpharm,12962,https://t.me/medpharm/12962,"–í —É—Å–ª–æ–≤–∏—è—Ö –ø–æ—Å—Ç–æ—è–Ω–Ω–æ –º–µ–Ω—è—é—â–µ–≥–æ—Å—è –∞–ø—Ç–µ—á–Ω–æ–≥–æ —Ä—ã–Ω–∫–∞, –æ—Ö–≤–∞—Ç—ã–≤–∞—é—â–µ–≥–æ —à–∏—Ä–æ–∫–∏–π —Å–ø–µ–∫—Ç—Ä –ª–µ–∫–∞—Ä—Å—Ç–≤, –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π –∏ —Ç–æ–≤–∞—Ä–æ–≤ –¥–ª—è –∫—Ä–∞—Å–æ—Ç—ã –∏ –∑–¥–æ—Ä–æ–≤—å—è, –≤–æ–ø—Ä–æ—Å—ã —Å—Ç—Ä—É–∫—Ç—É—Ä–∏—Ä–æ–≤–∞–Ω–∏—è –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –∏ —É–Ω–∏—Ñ–∏–∫–∞—Ü–∏–∏ –¥–∞–Ω–Ω—ã—Ö –ø—Ä–∏–æ–±—Ä–µ—Ç–∞—é—Ç –æ—Å–æ–±—É—é –∞–∫—Ç—É–∞–ª—å–Ω–æ—Å—Ç—å. –í–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏–µ –º–µ–∂–¥—É —Ä–∞–∑–ª–∏—á–Ω—ã–º–∏ —É—á–∞—Å—Ç–Ω–∏–∫–∞–º–∏ —Ä—ã–Ω–∫–∞ ‚Äî –æ—Ç –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –¥–æ –∫–æ–Ω–µ—á–Ω—ã—Ö –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª–µ–π ‚Äî —Ç—Ä–µ–±—É–µ—Ç –Ω–∞–¥–µ–∂–Ω—ã—Ö –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç–æ–≤ –¥–ª—è –æ—Ä–∏–µ–Ω—Ç–∞—Ü–∏–∏ –≤ –º–Ω–æ–≥–æ–æ–±—Ä–∞–∑–∏–∏ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–π. –û –ø–æ–∏—Å–∫–µ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã—Ö –ø—É—Ç–µ–π –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –¥–∞–Ω–Ω—ã—Ö ¬´–§–í¬ª —Ä–∞—Å—Å–∫–∞–∑–∞–ª –ø–µ—Ä–≤—ã–π –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å –≥–µ–Ω–µ—Ä–∞–ª—å–Ω–æ–≥–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –ê–û ¬´–¶–µ–Ω—Ç—Ä —Ä–∞–∑–≤–∏—Ç–∏—è —ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω—ã—Ö —Ç–æ—Ä–≥–æ–≤¬ª ‚Äî –∫–æ–º–ø–∞–Ω–∏–∏-–æ–ø–µ—Ä–∞—Ç–æ—Ä–∞ –ø–ª–∞—Ç—Ñ–æ—Ä–º—ã ¬´–¢–æ—Ä–≥–∏223.–§–∞—Ä–º–∞¬ª –î–º–∏—Ç—Ä–∏–π –°—ã—Ç–∏–Ω. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PayZD #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{""skip"": true}"
2025-10-06T12:25:04+00:00,@medpharm,12961,https://t.me/medpharm/12961,"–î–≤–æ–µ —É—á–µ–Ω—ã—Ö –∏–∑ –°–®–ê –∏ –æ–¥–∏–Ω –∏–∑ –Ø–ø–æ–Ω–∏–∏ –ø–æ–ª—É—á–∏–ª–∏ –ù–æ–±–µ–ª–µ–≤—Å–∫—É—é –ø—Ä–µ–º–∏—é –ø–æ –º–µ–¥–∏—Ü–∏–Ω–µ –≤ —ç—Ç–æ–º –≥–æ–¥—É. –ù–∞–≥—Ä–∞–¥—É –ø—Ä–∏—Å—É–¥–∏–ª–∏ –∑–∞ –æ—Ç–∫—Ä—ã—Ç–∏–µ —Ä–µ–≥—É–ª—è—Ç–æ—Ä–Ω—ã—Ö –¢-–ª–∏–º—Ñ–æ—Ü–∏—Ç–æ–≤ ‚Äî –∫–ª–µ—Ç–æ–∫, –∫–æ—Ç–æ—Ä—ã–µ –ø—Ä–µ–¥–æ—Ç–≤—Ä–∞—â–∞—é—Ç –∞—Ç–∞–∫–∏ –∏–º–º—É–Ω–Ω–æ–π —Å–∏—Å—Ç–µ–º—ã –Ω–∞ —Å–æ–±—Å—Ç–≤–µ–Ω–Ω—ã–π –æ—Ä–≥–∞–Ω–∏–∑–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Paw2u #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ù–∞—É–∫–∞ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-10-06T12:14:03+00:00,@medpharm,12960,https://t.me/medpharm/12960,"–ó–∞–º–≥–ª–∞–≤—ã –§–ê–° –†–æ—Å—Å–∏–∏ –¢–∏–º–æ—Ñ–µ–π –ù–∏–∂–µ–≥–æ—Ä–æ–¥—Ü–µ–≤ –Ω–∞–∑–≤–∞–ª –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –æ–¥–Ω–∏–º –∏–∑ –±–∞—Ä—å–µ—Ä–æ–≤ –Ω–∞ –ø—É—Ç–∏ ¬´–∏–Ω—Ç–µ–≥—Ä–∞—Ü–∏–∏ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ —Ä–æ—Å—Å–∏–π—Å–∫—É—é –º–µ–¥–∏—Ü–∏–Ω—Å–∫—É—é –ø—Ä–∞–∫—Ç–∏–∫—É¬ª. –ü–æ –µ–≥–æ –º–Ω–µ–Ω–∏—é, ¬´–¥–∞–∂–µ –µ—Å–ª–∏ —É—Å—Ç–∞–Ω–æ–≤–∏—Ç—å –µ–∂–µ–≥–æ–¥–Ω—ã–π –ø–µ—Ä–µ—Å–º–æ—Ç—Ä –∫–ª–∏–Ω—Ä–µ–∫–æ–≤, –æ–Ω–∏ –≤—Å–µ —Ä–∞–≤–Ω–æ –Ω–µ –±—É–¥—É—Ç —É—Å–ø–µ–≤–∞—Ç—å¬ª –∑–∞ –∏–Ω–Ω–æ–≤–∞—Ü–∏—è–º–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pav4t #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, regulation"",
  ""impact"": ""high"",
  ""english"": ""Mr. Timofey Nizhegorodtsev, Deputy Head of FAS Russia, called clinical recommendations one of the barriers on the path to 'integration of innovative pharmaceuticals into Russian medical practice'. He believes that even if annual review of clinical recommendations is established, they will still not keep up with innovations.""
}"
2025-10-06T11:21:05+00:00,@medpharm,12959,https://t.me/medpharm/12959,"–†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä –∑–∞—è–≤–∏–ª –æ –≥–æ—Ç–æ–≤–Ω–æ—Å—Ç–∏ –∫–æ–Ω—Ç—Ä–æ–ª–∏—Ä–æ–≤–∞—Ç—å –æ—Å–ª–æ–∂–Ω–µ–Ω–∏—è –∏ –ø–æ–±–æ—á–Ω—ã–µ —ç—Ñ—Ñ–µ–∫—Ç—ã –ø—Ä–∏ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–∏ CAR-T-—Ç–µ—Ä–∞–ø–∏–∏. –†–∞–∑—Ä–µ—à–µ–Ω–∏–µ –Ω–∞ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ –ø–æ–ª—É—á–∏–ª–∏ –≤–æ—Å–µ–º—å –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π, –ø—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–µ–Ω–Ω–æ –æ–Ω–∫–æ—Ü–µ–Ω—Ç—Ä—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Paqis #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û–Ω–∫–æ–ª–æ–≥–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance"",
  ""impact"": ""high"",
  ""english"": ""Roszdravnadzor announced readiness to control complications and side effects associated with CAR-T therapy use. Approval for the technology was granted to eight medical organizations, primarily oncology centers. More details: https://clck.ru/3Paqis #MedVestnik #Healthcare #Oncology""
}"
2025-10-06T10:16:05+00:00,@medpharm,12958,https://t.me/medpharm/12958,–í—Ä–∞—á–µ–±–Ω—ã–µ –∫–æ–º–∏—Å—Å–∏–∏ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã—Ö –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏–π –Ω–µ —É–ø–æ–ª–Ω–æ–º–æ—á–µ–Ω—ã –ø—Ä–∏–Ω–∏–º–∞—Ç—å —Ä–µ—à–µ–Ω–∏—è –æ –Ω–∞–∑–Ω–∞—á–µ–Ω–∏–∏ –Ω–µ–∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ø–∞—Ü–∏–µ–Ω—Ç–∞–º. –≠—Ç–æ –∫–∞—Å–∞–µ—Ç—Å—è –≤ —Ç–æ–º —á–∏—Å–ª–µ –æ–Ω–∫–æ–¥–∏—Å–ø–∞–Ω—Å–µ—Ä–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PakLn #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""Regional medical institutions' committees are not authorized to make decisions about prescribing unregistered medications. This includes oncology clinics. For more information: https://clck.ru/3PakLn #MedVestnik #Practice""
}"
2025-10-06T10:00:08+00:00,@medpharm,12957,https://t.me/medpharm/12957,–í–∞–∫—Ü–∏–Ω–∞ –ø—Ä–æ—Ç–∏–≤ –∞–ª–ª–µ—Ä–≥–∏–∏ –Ω–∞ –ø—ã–ª—å—Ü—É –±–µ—Ä–µ–∑—ã –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ì–µ–Ω–µ—Ä–∏—É–º¬ª –ø–æ–ª—É—á–∏–ª–∞ —Ä–∞–∑—Ä–µ—à–µ–Ω–∏–µ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–æ—Å—Å–∏–∏ –¥–ª—è –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è III —Ñ–∞–∑—ã. –ó–∞–≤–µ—Ä—à–∏—Ç—å –∏—Å–ø—ã—Ç–∞–Ω–∏—è –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –≤ 2028 –≥–æ–¥—É. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Paizd #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""clinical_trial, safety"",
  ""impact"": ""medium"",
  ""english"": ""The vaccine against birch pollen allergy from 'Generium' company has received approval from the Russian Ministry of Health for conducting a third phase study. The trials are planned to be completed by 2028.""
}"
2025-10-06T09:39:58+00:00,@medpharm,12956,https://t.me/medpharm/12956,"XI –ú–æ—Å–∫–æ–≤—Å–∫–∏–π –≥–æ—Ä–æ–¥—Å–∫–æ–π —Å—ä–µ–∑–¥ –ø–µ–¥–∏–∞—Ç—Ä–æ–≤ —Å –º–µ–∂—Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã–º –∏ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã–º —É—á–∞—Å—Ç–∏–µ–º ¬´–¢—Ä—É–¥–Ω—ã–π –¥–∏–∞–≥–Ω–æ–∑ –≤ –ø–µ–¥–∏–∞—Ç—Ä–∏–∏¬ª –ú–∞—Å—à—Ç–∞–±–Ω–∞—è –∫–æ–º–º—É–Ω–∏–∫–∞—Ü–∏–æ–Ω–Ω–∞—è –ø–ª–æ—â–∞–¥–∫–∞ –¥–ª—è –æ–±–º–µ–Ω–∞ –æ–ø—ã—Ç–æ–º –∏ –æ–±—â–µ–Ω–∏–µ–º –±–æ–ª–µ–µ —á–µ–º 7000 –¥–µ—Ç—Å–∫–∏—Ö —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ —Ä–∞–∑–ª–∏—á–Ω—ã—Ö –ø—Ä–æ—Ñ–∏–ª–µ–π ‚Äì –ø–µ–¥–∏–∞—Ç—Ä–æ–≤, –¥–µ—Ç—Å–∫–∏—Ö —ç–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–æ–≤, –∫–∞—Ä–¥–∏–æ–ª–æ–≥–æ–≤, –≥–∞—Å—Ç—Ä–æ—ç–Ω—Ç–µ—Ä–æ–ª–æ–≥–æ–≤, –ø—É–ª—å–º–æ–Ω–æ–ª–æ–≥–æ–≤, –Ω–µ—Ñ—Ä–æ–ª–æ–≥–æ–≤, —Ö–∏—Ä—É—Ä–≥–æ–≤, —É—Ä–æ–ª–æ–≥–æ–≤, –≥–∏–Ω–µ–∫–æ–ª–æ–≥–æ–≤, –Ω–µ–æ–Ω–∞—Ç–æ–ª–æ–≥–æ–≤, —Ä–µ–∞–Ω–∏–º–∞—Ç–æ–ª–æ–≥–æ–≤, –ø—Å–∏—Ö–æ–ª–æ–≥–æ–≤, —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –ø–æ –ª—É—á–µ–≤–æ–π –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–µ, –æ—Ä–≥–∞–Ω–∏–∑–∞—Ç–æ—Ä–æ–≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è, –≤—Ä–∞—á–µ–π –¥—Ä—É–≥–∏—Ö —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–µ–π –∏ –≤–µ–¥—É—â–∏–µ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –ª—É—á—à–∏—Ö –ª–µ—á–µ–±–Ω–æ-–ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–∏—Ö —É—á—Ä–µ–∂–¥–µ–Ω–∏–π –≥–æ—Ä–æ–¥–∞ –ú–æ—Å–∫–≤—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ https://clck.ru/3PadsA","{""skip"": true}"
2025-10-06T09:22:04+00:00,@medpharm,12955,https://t.me/medpharm/12955,–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§ –Ω–∞–ø—Ä–∞–≤–∏—Ç –±–æ–ª–µ–µ 700 –º–ª–Ω —Ä—É–±. –ë–µ–ª–≥–æ—Ä–æ–¥—Å–∫–æ–π –∏ –ö—É—Ä—Å–∫–æ–π –æ–±–ª–∞—Å—Ç—è–º –¥–ª—è –¥–æ—Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è –º–µ–¥–ø–æ–º–æ—â–∏ –∂–∏—Ç–µ–ª—è–º —ç—Ç–∏—Ö —Ä–µ–≥–∏–æ–Ω–æ–≤. –¢–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω—ã–µ —Ñ–æ–Ω–¥—ã –û–ú–° —Å–º–æ–≥—É—Ç —Ä–∞—Å–ø–ª–∞—á–∏–≤–∞—Ç—å—Å—è —ç—Ç–∏–º–∏ —Å—Ä–µ–¥—Å—Ç–≤–∞–º–∏ —Å –ª–µ—á–µ–±–Ω—ã–º–∏ —É—á—Ä–µ–∂–¥–µ–Ω–∏—è–º–∏ –¥—Ä—É–≥–∏—Ö —Å—É–±—ä–µ–∫—Ç–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pag8M #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-10-06T08:33:02+00:00,@medpharm,12953,https://t.me/medpharm/12953,–¶–µ–Ω—Ç—Ä—É –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –Ω–µ —É–¥–∞–ª–æ—Å—å –ø—Ä–æ–≤–µ—Å—Ç–∏ —Ç—Ä–∏ –∞—É–∫—Ü–∏–æ–Ω–∞ –Ω–∞ –ø–æ—Å—Ç–∞–≤–∫—É –¥–ª—è ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ ¬´–õ—É–∫—Å—Ç—É—Ä–Ω–∞¬ª –∏ ¬´–°–æ—Ö–æ–Ω–æ—Å¬ª –∏–∑-–∑–∞ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏—è –∑–∞—è–≤–æ–∫ –Ω–∞ —É—á–∞—Å—Ç–∏–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PacMA #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The Central Pharmacy Administration failed to conduct three auctions for the supply of 'Luksturna' and 'Shohonos' drugs from 'Kindness for All' due to a lack of participation applications.""
}"
2025-10-06T08:16:04+00:00,@medpharm,12952,https://t.me/medpharm/12952,–í –†–æ—Å—Å–∏–∏ –∑–∞–ø—É—Å—Ç–∏–ª–∏ –≤ —Å–µ—Ä–∏—é –ø–µ—Ä–≤—ã–π –≤ —Å—Ç—Ä–∞–Ω–µ –ú–†–¢-—Å–æ–≤–º–µ—Å—Ç–∏–º—ã–π —ç–ª–µ–∫—Ç—Ä–æ–∫–∞—Ä–¥–∏–æ—Å—Ç–∏–º—É–ª—è—Ç–æ—Ä Apollo MRI. –£—Å—Ç—Ä–æ–π—Å—Ç–≤–æ –ø–æ–∑–≤–æ–ª—è–µ—Ç –±–µ–∑–æ–ø–∞—Å–Ω–æ –ø—Ä–æ—Ö–æ–¥–∏—Ç—å –æ–±—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –Ω–∞ –º–∞–≥–Ω–∏—Ç–Ω–æ-—Ä–µ–∑–æ–Ω–∞–Ω—Å–Ω–æ–º —Ç–æ–º–æ–≥—Ä–∞—Ñ–µ –ø–∞—Ü–∏–µ–Ω—Ç–∞–º —Å —Ç—è–∂–µ–ª—ã–º–∏ —Ñ–æ—Ä–º–∞–º–∏ –∞—Ä–∏—Ç–º–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3Pab4T #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ù–∞—É–∫–∞ #–ö–∞—Ä–¥–∏–æ–ª–æ–≥–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety"",
  ""impact"": ""high"",
  ""english"": ""The country has launched the first domestically MRI-compatible electrocardiostimulator, Apollo MRI. The device allows patients with severe forms of arrhythmia to safely undergo magnetic resonance imaging (MRI).""
}"
2025-10-06T07:49:02+00:00,@medpharm,12951,https://t.me/medpharm/12951,"–§–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏–µ –ø—Ä–æ–µ–∫—Ç–∞ ¬´–ë–æ—Ä—å–±–∞ —Å —Å–∞—Ö–∞—Ä–Ω—ã–º –¥–∏–∞–±–µ—Ç–æ–º¬ª –º–æ–∂–µ—Ç —É–≤–µ–ª–∏—á–∏—Ç—å—Å—è –Ω–∞ 3,3 –º–ª—Ä–¥ —Ä—É–±. –î–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–µ —Å—Ä–µ–¥—Å—Ç–≤–∞ –¥–µ–ø—É—Ç–∞—Ç –°—Ç–∞–Ω–∏—Å–ª–∞–≤ –ù–∞—É–º–æ–≤ –ø—Ä–µ–¥–ª–æ–∂–∏–ª –≤—ã–¥–µ–ª–∏—Ç—å –∑–∞ —Å—á–µ—Ç –∞–∫—Ü–∏–∑–∞ –Ω–∞ –≥–∞–∑–∏—Ä–æ–≤–∫—É. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PaYgc #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": true,
  ""country"": ""global"",
  ""topic"": ""tenders, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""Funding for the 'Battle Against Diabetes' project may increase by 3.3 billion rubles. Additional funds proposed to be allocated by Deputy Stanislav Naumov from the tax on soda. More details: https://clck.ru/3PaYgc""
}"
2025-10-06T07:21:05+00:00,@medpharm,12950,https://t.me/medpharm/12950,–°—Ç—Ä–∞—Ç–µ–≥–∏–∏ —Ä–∞–∑–∂–∏–∂–µ–Ω–∏—è —Å–ª–∏–∑–∏ –Ω–µ —Å–º–æ–≥–ª–∏ —Å–Ω–∏–∑–∏—Ç—å —á–∞—Å—Ç–æ—Ç—É –æ–±–æ—Å—Ç—Ä–µ–Ω–∏–π —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –±—Ä–æ–Ω—Ö–æ—ç–∫—Ç–∞—Ç–∏—á–µ—Å–∫–æ–π –±–æ–ª–µ–∑–Ω—å—é —Å–ø—É—Å—Ç—è –≥–æ–¥ –Ω–∞–±–ª—é–¥–µ–Ω–∏—è. –≠—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏—è –≥–∏–ø–µ—Ä—Ç–æ–Ω–∏—á–µ—Å–∫–æ–≥–æ —Ä–∞—Å—Ç–≤–æ—Ä–∞ –∏ –∫–∞—Ä–±–æ—Ü–∏—Å—Ç–µ–∏–Ω–∞ –æ–∫–∞–∑–∞–ª–∞—Å—å —Å–æ–ø–æ—Å—Ç–∞–≤–∏–º–æ–π —Å —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º–∏ —Å—Ç–∞–Ω–¥–∞—Ä—Ç–Ω–æ–≥–æ –ª–µ—á–µ–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://medvestnik.ru/content/news/Mukoaktivnye-preparaty-ne-snijali-risk-obostrenii-pri-bronhoektaticheskoi-bolezni.html?utm_source=TG_post&utm_medium=Group&utm_campaign=Mukoaktivnye-preparaty-ne-snijali-risk-obostrenii-pri-bronhoektaticheskoi-bolezni #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ü—É–ª—å–º–æ–Ω–æ–ª–æ–≥–∏—è_–∏_—Ñ—Ç–∏–∑–∏–∞—Ç—Ä–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""Strategies to thin mucus did not reduce the frequency of exacerbations in patients with bronchiectasis over a year. The effectiveness of hypertonic solutions and carbocisteine was comparable to standard treatment. For more details, see the link above.""
}"
2025-10-06T06:20:05+00:00,@medpharm,12949,https://t.me/medpharm/12949,–°—É–¥ –≤ –ú–∞—Ö–∞—á–∫–∞–ª–µ –∞—Ä–µ—Å—Ç–æ–≤–∞–ª –Ω–∞ –¥–≤–∞ –º–µ—Å—è—Ü–∞ –±—ã–≤—à–µ–≥–æ –º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –î–∞–≥–µ—Å—Ç–∞–Ω–∞ –¢–∞—Ç—å—è–Ω—É –ë–µ–ª—è–µ–≤—É. –ï–µ –ø–æ–¥–æ–∑—Ä–µ–≤–∞—é—Ç –≤ –º–æ—à–µ–Ω–Ω–∏—á–µ—Å—Ç–≤–µ —Å –±—é–¥–∂–µ—Ç–Ω—ã–º–∏ —Å—Ä–µ–¥—Å—Ç–≤–∞–º–∏ –Ω–∞ –≤–Ω–µ–¥—Ä–µ–Ω–∏–µ –ï–ì–ò–°–ó. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PaRwD #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-10-05T13:02:00+00:00,@medpharm,12948,https://t.me/medpharm/12948,"üëçüëçüëçüëçüëçüëç –ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ –∑–∞ –Ω–µ–¥–µ–ª—é –†–æ—Å—Å–∏–π—Å–∫–∏–µ –∞–∫—Ç–∏–≤—ã Takeda –ø–µ—Ä–µ–π–¥—É—Ç –ª–æ–∫–∞–ª—å–Ω–æ–º—É —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—é. –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–µ–Ω–Ω–∞—è –∫–æ–º–∏—Å—Å–∏—è –ø–æ –∫–æ–Ω—Ç—Ä–æ–ª—é –∑–∞ –æ—Å—É—â–µ—Å—Ç–≤–ª–µ–Ω–∏–µ–º –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã—Ö –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–π –≤ –†–æ—Å—Å–∏–∏ –æ–¥–æ–±—Ä–∏–ª–∞ —Å–¥–µ–ª–∫—É. –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–æ –≤–≤–µ—Å—Ç–∏ –≥–æ—Å–ø–æ—à–ª–∏–Ω—É –∑–∞ –≤–Ω–µ—Å–µ–Ω–∏–µ –¥–∞–Ω–Ω—ã—Ö –≤ —Å–∏—Å—Ç–µ–º—É –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥–∞ –æ–±–æ—Ä–æ—Ç–∞ –º–∞—Ä–∫–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö —Ç–æ–≤–∞—Ä–æ–≤, –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –≤–Ω–µ—Å–µ–Ω –≤ –ì–æ—Å–¥—É–º—É. –†–∞–∑–º–µ—Ä —Å–±–æ—Ä–∞ –±—É–¥–µ—Ç —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω –æ—Ç–¥–µ–ª—å–Ω—ã–º –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ–º –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞. –ê–ª—å—è–Ω—Å —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–π –ø–æ–ø—Ä–æ—Å–∏–ª –≤–Ω–µ—Å—Ç–∏ –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ –ø—Ä–∞–≤–∏–ª–∞ —Ö—Ä–∞–Ω–µ–Ω–∏—è –º–∞—Ä–≥–∞–Ω—Ü–æ–≤–∫–∏ ‚Äî —Ç–æ–ª—å–∫–æ –≤ –∏–∑–æ–ª–∏—Ä–æ–≤–∞–Ω–Ω–æ–º –ø–æ–º–µ—â–µ–Ω–∏–∏. –¢—Ä–µ–±–æ–≤–∞–Ω–∏–µ –≤—Å—Ç—É–ø–∏–ª–æ –≤ —Å–∏–ª—É 1 —Å–µ–Ω—Ç—è–±—Ä—è, –∏ –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ –∞–ø—Ç–µ–∫ —É–∂–µ —É—Å–ø–µ–ª–∏ —Ä–∞—Å–ø—Ä–æ–¥–∞—Ç—å –æ—Å—Ç–∞—Ç–∫–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞. –°–æ—Ç—Ä—É–¥–Ω–∏–∫–∏ ¬´–ü–æ—á—Ç—ã –†–æ—Å—Å–∏–∏¬ª –ø–æ–ª—É—á–∞—Ç 72-—á–∞—Å–æ–≤–æ–µ –¥–æ–ø–æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ –ø–æ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –µ—Å–ª–∏ –ø–æ—á—Ç–æ–≤—ã–π –æ–ø–µ—Ä–∞—Ç–æ—Ä –ø–æ–ª—É—á–∏—Ç –ø—Ä–∞–≤–æ –Ω–∞ –∏—Ö –ø—Ä–æ–¥–∞–∂—É, —Å—á–∏—Ç–∞—é—Ç –≤ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–µ. –†–µ–≥—É–ª—è—Ç–æ—Ä—ã –ø—Ä–æ—Ä–∞–±–∞—Ç—ã–≤–∞—é—Ç –¥–ª—è –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –≤–≤–µ–¥–µ–Ω–∏–µ —É–ø—Ä–æ—â–µ–Ω–Ω–æ–π –ø—Ä–æ—Ü–µ–¥—É—Ä—ã –ª–∏—Ü–µ–Ω–∑–∏—Ä–æ–≤–∞–Ω–∏—è –ø–æ –∞–Ω–∞–ª–æ–≥–∏–∏ —Å –§–ê–ü. –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä –∑–∞–ø—Ä–µ—Ç–∏–ª –ø—Ä–æ–¥–∞–∂—É –º–µ–¥–∏–∑–¥–µ–ª–∏–π –∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ —á–µ—Ä–µ–∑ –≤–µ–Ω–¥–∏–Ω–≥–æ–≤—ã–µ –∞–ø–ø–∞—Ä–∞—Ç—ã, –Ω–∞–ø—Ä–∞–≤–∏–≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–µ–µ –ø–∏—Å—å–º–æ –≤ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω—ã–µ –æ—Ä–≥–∞–Ω—ã. –†–µ–∞–ª–∏–∑–∞—Ü–∏—è —Ç–∞–∫–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏ —Ä–∞–∑—Ä–µ—à–µ–Ω–∞ —Ç–æ–ª—å–∫–æ –≤ —Å—Ç–∞—Ü–∏–æ–Ω–∞—Ä–Ω—ã—Ö —Ç–æ—Ä–≥–æ–≤—ã—Ö –æ–±—ä–µ–∫—Ç–∞—Ö, —á—Ç–æ —Å—Ç–∞–≤–∏—Ç –ø–æ–¥ —É–≥—Ä–æ–∑—É —Ä–∞–±–æ—Ç—É –±–æ–ª–µ–µ —Ç—ã—Å—è—á–∏ –∞–≤—Ç–æ–º–∞—Ç–æ–≤ –ø–æ –ø—Ä–æ–¥–∞–∂–µ –∫–æ–Ω—Ç–∞–∫—Ç–Ω—ã—Ö –ª–∏–Ω–∑.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""The Russian government approved a deal for Takeda's assets to be taken over by a local pharmaceutical company. The government also proposed an import fee for reporting data on tracking marked goods, which has been submitted to the State Duma. The regulation requires that all pharmacies must store manganous compounds in isolated rooms, which has been enforced since September 1st. The Roszdranadzor is considering the introduction of simplified licensing procedures for medical devices and medicines, similar to those for FAPs. The Roszdranadzor has banned the sale of medical devices and medicines through vending machines, directing territorial authorities to implement this regulation in stationary retail outlets.""
}"
2025-10-04T12:48:03+00:00,@medpharm,12947,https://t.me/medpharm/12947,–í –ë–µ–ª–≥–æ—Ä–æ–¥–µ –Ω–∞—á–Ω–µ—Ç—Å—è —Å—É–¥–µ–±–Ω—ã–π –ø—Ä–æ—Ü–µ—Å—Å –Ω–∞–¥ –≤–∏–Ω–æ–≤–Ω–∏–∫–æ–º –î–¢–ü –≤ –∫–æ—Ç–æ—Ä–æ–º –ø–æ–≥–∏–±–ª–∏ –¥–≤–µ –º–æ–ª–æ–¥—ã—Ö –∂–µ–Ω—â–∏–Ω—ã-—Ñ–µ–ª—å–¥—à–µ—Ä–∞. –ü–µ—Ä–≤–æ–µ –∑–∞—Å–µ–¥–∞–Ω–∏–µ –ø–æ –¥–µ–ª—É –∑–∞–ø–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω–æ –Ω–∞ 7 –æ–∫—Ç—è–±—Ä—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PZDJ6 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-10-04T11:06:05+00:00,@medpharm,12946,https://t.me/medpharm/12946,"üß©üß©üß©üß©üß©üß© –ü—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º —Ä–µ–π—Ç–∏–Ω–≥ –≥–ª–∞–≤–Ω—ã—Ö –Ω–æ–≤–æ—Å—Ç–µ–π –Ω–µ–¥–µ–ª–∏ –≤ –ø—É–±–ª–∏–∫–∞—Ü–∏—è—Ö –ª–µ–Ω—Ç—ã –Ω–æ–≤–æ—Å—Ç–µ–π ¬´–ú–í¬ª. –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –≤–Ω–µ—Å–ª–æ –≤ –ì–æ—Å–¥—É–º—É –ø—Ä–æ–µ–∫—Ç—ã —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –±—é–¥–∂–µ—Ç–∞ –∏ –±—é–¥–∂–µ—Ç–∞ –§–û–ú–° –Ω–∞ 2026 –∏ –ø–ª–∞–Ω–æ–≤—ã–π –ø–µ—Ä–∏–æ–¥ 2027 –∏ 2028 –≥–æ–¥–æ–≤. –ë—é–¥–∂–µ—Ç–Ω—ã–µ –∞—Å—Å–∏–≥–Ω–æ–≤–∞–Ω–∏—è –ø–æ —Ä–∞–∑–¥–µ–ª—É ¬´–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ¬ª —Å–æ—Å—Ç–∞–≤—è—Ç –≤ —Å–ª–µ–¥—É—é—â–µ–º –≥–æ–¥—É 1,88 —Ç—Ä–ª–Ω —Ä—É–±. –°–∞–º—ã–µ –∫—Ä—É–ø–Ω—ã–µ —Å—Ç–∞—Ç—å–∏ —Ä–∞—Å—Ö–æ–¥–æ–≤ –≥–æ—Å–ø—Ä–æ–≥—Ä–∞–º–º—ã ‚Äì –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–µ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ. –¢–µ–º–ø—ã —Ä–æ—Å—Ç–∞ —Ä–∞—Å—Ö–æ–¥–æ–≤ –§–û–ú–° –Ω–∞ –º–µ–¥–∏—Ü–∏–Ω—É —Å–æ–∫—Ä–∞—Ç—è—Ç—Å—è –±–æ–ª–µ–µ —á–µ–º –≤ –¥–≤–∞ —Ä–∞–∑–∞. –ù–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ ‚Äî —Å—Ç—Ä–∞—Å—Ç–∏ –ø–æ –ø–æ–ø—Ä–∞–≤–∫–∞–º –≤ ¬´–ó–∞–∫–æ–Ω –æ–± –û–ú–°¬ª, –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–Ω—ã–º –ú–∏–Ω–∑–¥—Ä–∞–≤–æ–º. –ú–∏–Ω—Ñ–∏–Ω —Å–æ–≥–ª–∞—Å–æ–≤–∞–ª –ø—Ä–æ–µ–∫—Ç –¥–æ–∫—É–º–µ–Ω—Ç–∞, –Ω–æ —É–∫–∞–∑–∞–ª, —á—Ç–æ –ø–µ—Ä–µ–¥–∞—á–∞ —Ñ—É–Ω–∫—Ü–∏–π –ø–æ –∫–æ–Ω—Ç—Ä–æ–ª—é –∫–∞—á–µ—Å—Ç–≤–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –¢–§–û–ú–°, –∫–æ—Ç–æ—Ä—ã–µ –æ—Å—É—â–µ—Å—Ç–≤–ª—è—é—Ç —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏–µ –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π, –ø—Ä–∏–≤–æ–¥–∏—Ç –∫ –∏—Ö –º–æ–Ω–æ–ø–æ–ª–∏–∑–∞—Ü–∏–∏. –¢—Ä–µ—Ç—å—é —Å—Ç—Ä–æ—á–∫—É –∑–∞–Ω—è–ª–æ —Å–æ–æ–±—â–µ–Ω–∏–µ –æ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–Ω–æ–º –ú–∏–Ω–∑–¥—Ä–∞–≤–æ–º –ø—Ä–æ–µ–∫—Ç–µ –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –æ –ø–æ—Ä—è–¥–∫–µ –≤—ã–¥–∞—á–∏, –ø—Ä–∏–æ—Å—Ç–∞–Ω–æ–≤–∫–∏ –∏ –ø—Ä–µ–∫—Ä–∞—â–µ–Ω–∏—è –¥–µ–π—Å—Ç–≤–∏—è –ª–∏—Ü–µ–Ω–∑–∏–π –Ω–∞ –æ–±—Ä–∞–∑–æ–≤–∞—Ç–µ–ª—å–Ω—É—é –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç—å –ø–æ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—ã–º –æ–±—Ä–∞–∑–æ–≤–∞—Ç–µ–ª—å–Ω—ã–º –ø—Ä–æ–≥—Ä–∞–º–º–∞–º –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è. –†–∞–±–æ—Ç–∞—é—â–∏–µ –≤ —Å—Ñ–µ—Ä–µ –î–ü–û –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –æ–±—è–∑–∞–Ω—ã –ø–æ–ª—É—á–∏—Ç—å –∑–∞–∫–ª—é—á–µ–Ω–∏–µ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–∞ –æ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–∏ –¥–æ 1 —Å–µ–Ω—Ç—è–±—Ä—è 2026 –≥–æ–¥–∞. –ù–∞ —á–µ—Ç–≤–µ—Ä—Ç–æ–º –º–µ—Å—Ç–µ –≤ TOP5 ‚Äî —Å–æ–æ–±—â–µ–Ω–∏–µ –æ–± —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏–∏ –Ω–æ–≤–æ–≥–æ —É—Ç–æ—á–Ω—è—é—â–µ–≥–æ –∫–æ—ç—Ñ—Ñ–∏—Ü–∏–µ–Ω—Ç–∞ –¥–ª—è —Ä–∞—Å—á–µ—Ç–∞ –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω—ã—Ö –∑–∞—Ç—Ä–∞—Ç –ø–æ–¥–≤–µ–¥–æ–º—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ú–∏–Ω–∑–¥—Ä–∞–≤—É –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏–π –ø—Ä–∏ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏–∏ –±—é–¥–∂–µ—Ç–∞. –≠—Ç–æ –ø–æ–∑–≤–æ–ª–∏—Ç —É—á–∏—Ç—ã–≤–∞—Ç—å –∏–Ω—Ñ–ª—è—Ü–∏—é, –∏–Ω–¥–µ–∫—Å–∞—Ü–∏—é –∑–∞—Ä–ø–ª–∞—Ç –∏ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ —É—Ä–æ–≤–Ω—é –æ–ø–ª–∞—Ç—ã —Ç—Ä—É–¥–∞. –ó–∞–º—ã–∫–∞–µ—Ç –ø—è—Ç–µ—Ä–∫—É –Ω–æ–≤–æ—Å—Ç–µ–π —Å–æ–æ–±—â–µ–Ω–∏–µ –ú–∏–Ω–æ–±—Ä–Ω–∞—É–∫–∏, —á—Ç–æ —Ä–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω–∏–µ –ø–ª–∞—Ç–Ω–æ–≥–æ –ø—Ä–∏–µ–º–∞ –≤ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞—Ö –†–æ—Å—Å–∏–∏ –Ω–µ –∫–æ—Å–Ω–µ—Ç—Å—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –≤—É–∑–æ–≤, —Ç–∞–∫ –∫–∞–∫ —ç—Ç–æ —Å–æ—Ü–∏–∞–ª—å–Ω–æ –∑–Ω–∞—á–∏–º—ã–µ –∏ –¥–µ—Ñ–∏—Ü–∏—Ç–Ω—ã–µ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è.","{
  ""skip"": true
}"
2025-10-04T08:20:03+00:00,@medpharm,12945,https://t.me/medpharm/12945,–ú–∏–Ω—Ñ–∏–Ω —Å–æ–≥–ª–∞—Å–æ–≤–∞–ª —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–Ω—ã–µ –ú–∏–Ω–∑–¥—Ä–∞–≤–æ–º –ø–æ–ø—Ä–∞–≤–∫–∏ –≤ –∑–∞–∫–æ–Ω ¬´–û–± –û–ú–°¬ª. –ù–æ –æ–±—Ä–∞—Ç–∏–ª –≤–Ω–∏–º–∞–Ω–∏–µ –Ω–∞ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–µ –æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω–æ—Å—Ç–∏ –ø–æ —Ä—è–¥—É –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–Ω—ã—Ö –ø—É–Ω–∫—Ç–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PYyT8 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Finance has approved the revised laws by the Health Department, but it noted that there is no basis for a number of proposed points. More details: https://clck.ru/3PYyT8 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ""
}"
2025-10-04T07:11:03+00:00,@medpharm,12944,https://t.me/medpharm/12944,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –ø—Ä–µ–¥–ª–æ–∂–∏–ª –∫—Ä–∏—Ç–µ—Ä–∏–∏ –≤—ã–¥–µ–ª–µ–Ω–∏—è —Ä–µ–≥–∏–æ–Ω–∞–º —Ä–µ–∑–µ—Ä–≤–Ω–æ–≥–æ —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Ç—è–∂–µ–ª–æ–±–æ–ª—å–Ω—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –î–ª—è —ç—Ç–æ–≥–æ –≤–ª–∞—Å—Ç–∏ —Å—É–±—ä–µ–∫—Ç–∞ –¥–æ–ª–∂–Ω—ã –ø–æ–¥—Ç–≤–µ—Ä–¥–∏—Ç—å, —á—Ç–æ –Ω–µ —Å–ø—Ä–∞–≤–ª—è—é—Ç—Å—è —Å —ç—Ç–∏–º–∏ –ø–æ–ª–Ω–æ–º–æ—á–∏—è–º–∏ —Å–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω–æ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PYvMg #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health proposed criteria for allocating reserve funding to regions for treating severely ill patients. For this, the subject's authorities must confirm that they are unable to handle these responsibilities independently.""
}"
2025-10-04T04:49:03+00:00,@medpharm,12943,https://t.me/medpharm/12943,–ü—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º —Ä–µ–π—Ç–∏–Ω–≥ –≥–ª–∞–≤–Ω—ã—Ö –Ω–æ–≤–æ—Å—Ç–µ–π –Ω–µ–¥–µ–ª–∏ –≤ –ø—É–±–ª–∏–∫–∞—Ü–∏—è—Ö –ª–µ–Ω—Ç—ã –Ω–æ–≤–æ—Å—Ç–µ–π ¬´–ú–í¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PYqFK #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ,"{""skip"": true}"
2025-10-03T17:01:25+00:00,@medpharm,12942,https://t.me/medpharm/12942,"ü¶æ –ò —ç—Ç–æ –ø—Ä–æ–π–¥–µ—Ç. –ú–∏–Ω—Ñ–∏–Ω —Å–æ–≥–ª–∞—Å–æ–≤–∞–ª –ø—Ä–æ–µ–∫—Ç –ø–æ–ø—Ä–∞–≤–æ–∫ –≤ –∑–∞–∫–æ–Ω ¬´–û–± –û–ú–°¬ª, –Ω–µ—Å–º–æ—Ç—Ä—è –Ω–∞ –≤–æ–∑–Ω–∏–∫—à–∏–µ –∫ –¥–æ–∫—É–º–µ–Ω—Ç—É –ø—Ä–µ—Ç–µ–Ω–∑–∏–∏. ¬´–ú–í¬ª —Å–æ–±—Ä–∞–ª –º–Ω–µ–Ω–∏—è —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –∏–Ω–¥—É—Å—Ç—Ä–∏–∏ –æ –≥–æ—Ç–æ–≤—è—â–µ–π—Å—è –∑–∞–º–µ–Ω–µ —á–∞—Å—Ç–Ω—ã—Ö —Å—Ç—Ä–∞—Ö–æ–≤—â–∏–∫–æ–≤ –≤ —Å–∏—Å—Ç–µ–º–µ –û–ú–° —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω—ã–º–∏ —Ñ–æ–Ω–¥–∞–º–∏. ü¶æ –õ—É—á—à–µ –Ω–∏ –∫–∞–ø–ª–∏. –î–∞–∂–µ –Ω–µ–±–æ–ª—å—à–æ–µ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –∞–ª–∫–æ–≥–æ–ª—è —Å–≤—è–∑–∞–Ω–æ —Å –ø–æ–≤—Ä–µ–∂–¥–µ–Ω–∏–µ–º –º–æ–∑–≥–∞ –∏ –ø–æ–≤—ã—à–µ–Ω–Ω—ã–º —Ä–∏—Å–∫–æ–º –¥–µ–º–µ–Ω—Ü–∏–∏. –û—Å–æ–±–µ–Ω–Ω–æ –≤—ã—Å–æ–∫–∏–π —Ä–∏—Å–∫ –Ω–∞–±–ª—é–¥–∞–µ—Ç—Å—è —É –ª—é–¥–µ–π —Å –∞–ª–∫–æ–≥–æ–ª—å–Ω–æ–π –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç—å—é. - ‚ù§Ô∏è –ù–∞ –∞–≤—Ç–æ–º–∞—Ç–µ. –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä –∑–∞–ø—Ä–µ—Ç–∏–ª –ø—Ä–æ–¥–∞–∂—É –º–µ–¥–∏–∑–¥–µ–ª–∏–π –∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ —á–µ—Ä–µ–∑ –≤–µ–Ω–¥–∏–Ω–≥–æ–≤—ã–µ –∞–ø–ø–∞—Ä–∞—Ç—ã, –Ω–∞–ø—Ä–∞–≤–∏–≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–µ–µ –ø–∏—Å—å–º–æ –≤ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω—ã–µ –æ—Ä–≥–∞–Ω—ã. –ü–æ–¥ —É–≥—Ä–æ–∑–æ–π —Ä–∞–±–æ—Ç–∞ –±–æ–ª–µ–µ —Ç—ã—Å—è—á–∏ –∞–≤—Ç–æ–º–∞—Ç–æ–≤ –ø–æ –ø—Ä–æ–¥–∞–∂–µ –∫–æ–Ω—Ç–∞–∫—Ç–Ω—ã—Ö –ª–∏–Ω–∑. ‚ù§Ô∏è –û–ø–ª–∞—Ç–∞ –±–µ–∑ —É–ª—ã–±–∫–∏. –†–∞—Å—Ö–æ–¥—ã –±–∏–∑–Ω–µ—Å–∞ –Ω–∞ –ø—Ä–∏–µ–º –±–µ–∑–Ω–∞–ª–∏—á–Ω—ã—Ö –ø–ª–∞—Ç–µ–∂–µ–π –º–æ–≥—É—Ç –≤—ã—Ä–∞—Å—Ç–∏ –Ω–∞ 20‚Äî22% –≤ 2026 –≥–æ–¥—É. –¢–∞–∫–æ–π –ø—Ä–æ–≥–Ω–æ–∑ –¥–∞—é—Ç –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–∏ —Ä—ã–Ω–∫–∞ –≤ —Å–≤—è–∑–∏ —Å –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç–æ–º –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞, –∫–æ—Ç–æ—Ä—ã–π –æ—Ç–º–µ–Ω—è–µ—Ç –æ—Å–≤–æ–±–æ–∂–¥–µ–Ω–∏–µ –æ—Ç –ù–î–° –¥–ª—è —É—Å–ª—É–≥ —ç–∫–≤–∞–π—Ä–∏–Ω–≥–∞ –∏ –ø—Ä–æ—Ü–µ—Å—Å–∏–Ω–≥–∞.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement, pricing"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Finance approved the draft amendments to the 'Insurance Fund Law', despite objections raised against it. 'Minsk' gathered industry opinions on the upcoming replacement of private insurers in the OMS system. The Roszdravnadzor banned the sale of medical devices and drugs through vending machines, issuing a corresponding letter to territorial authorities. Up to one thousand vending machines for contact lens sales are at risk.""
}"
2025-10-03T15:19:06+00:00,@medpharm,12941,https://t.me/medpharm/12941,–î–∞–∂–µ –Ω–µ–±–æ–ª—å—à–æ–µ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –∞–ª–∫–æ–≥–æ–ª—è —Å–≤—è–∑–∞–Ω–æ —Å –ø–æ–≤—Ä–µ–∂–¥–µ–Ω–∏–µ–º –º–æ–∑–≥–∞ –∏ –ø–æ–≤—ã—à–µ–Ω–Ω—ã–º —Ä–∏—Å–∫–æ–º –¥–µ–º–µ–Ω—Ü–∏–∏. –û—Å–æ–±–µ–Ω–Ω–æ –≤—ã—Å–æ–∫–∏–π —Ä–∏—Å–∫ –Ω–∞–±–ª—é–¥–∞–µ—Ç—Å—è —É –ª—é–¥–µ–π —Å –∞–ª–∫–æ–≥–æ–ª—å–Ω–æ–π –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç—å—é. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PYZwB #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ù–µ–≤—Ä–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance, safety"",
  ""impact"": ""high"",
  ""english"": ""A small amount of alcohol is linked to brain damage and an increased risk of dementia. The highest risks are seen in people with alcohol dependence, according to a detailed study.""
}"
2025-10-03T15:16:02+00:00,@medpharm,12940,https://t.me/medpharm/12940,"–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏, –≤–µ–¥—É—â–∏–µ –æ–±—Ä–∞–∑–æ–≤–∞—Ç–µ–ª—å–Ω—É—é –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç—å –ø–æ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—ã–º –ø—Ä–æ–≥—Ä–∞–º–º–∞–º –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–≥–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è, –¥–æ–ª–∂–Ω—ã –±—É–¥—É—Ç –ø–æ–ª—É—á–∞—Ç—å –ª–∏—Ü–µ–Ω–∑–∏–∏. –ü–æ—Ä—è–¥–æ–∫ –∏—Ö –≤—ã–¥–∞—á–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –ú–∏–Ω–∑–¥—Ä–∞–≤, –ø—Ä–æ—Ü–µ–¥—É—Ä–∞ –ø—Ä–µ–¥–ø–æ–ª–∞–≥–∞–µ—Ç –ø—Ä–æ–≤–µ—Ä–∫—É –∫–∞–¥—Ä–æ–≤–æ–≥–æ –∏ –º–∞—Ç–µ—Ä–∏–∞–ª—å–Ω–æ-—Ç–µ—Ö–Ω–∏—á–µ—Å–∫–æ–≥–æ –æ—Å–Ω–∞—â–µ–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PYZkz #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–∞—Ä—å–µ—Ä–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""registration,clinical_trial,hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""Professional educational organizations providing additional medical and pharmaceutical education will need licenses. The Ministry of Health has developed a procedure for licensing, which includes checking the personnel and material-technical equipment. For more details: https://clck.ru/3PYZkz #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–∞—Ä—å–µ—Ä–∞""
}"
2025-10-03T14:52:04+00:00,@medpharm,12939,https://t.me/medpharm/12939,"FDA –æ–¥–æ–±—Ä–∏–ª–æ –ø–µ—Ä–≤—É—é –∫–æ–º–±–∏–Ω–∞—Ü–∏—é –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ø–æ–¥–¥–µ—Ä–∂–∏–≤–∞—é—â–µ–π —Ç–µ—Ä–∞–ø–∏–∏ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–Ω–æ–≥–æ –º–µ–ª–∫–æ–∫–ª–µ—Ç–æ—á–Ω–æ–≥–æ —Ä–∞–∫–∞ –ª–µ–≥–∫–æ–≥–æ ‚Äî Zepzelca –∏ ¬´–¢–µ—Ü–µ–Ω—Ç—Ä–∏–∫¬ª. –ö–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ –∏—Å–ø—ã—Ç–∞–Ω–∏—è –ø–æ–∫–∞–∑–∞–ª–∏, —á—Ç–æ –∏—Ö —Å–æ—á–µ—Ç–∞–Ω–∏–µ —Å–Ω–∏–∂–∞–µ—Ç —Ä–∏—Å–∫ –ø—Ä–æ–≥—Ä–µ—Å—Å–∏—Ä–æ–≤–∞–Ω–∏—è –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è –∏–ª–∏ —Å–º–µ—Ä—Ç–∏ –Ω–∞ 46% –∏ —É–≤–µ–ª–∏—á–∏–≤–∞–µ—Ç –º–µ–¥–∏–∞–Ω—É –æ–±—â–µ–π –≤—ã–∂–∏–≤–∞–µ–º–æ—Å—Ç–∏ —Å 10,6 –¥–æ 13,2 –º–µ—Å—è—Ü–∞ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –º–æ–Ω–æ—Ç–µ—Ä–∞–ø–∏–µ–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PYYXB #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-03T14:08:06+00:00,@medpharm,12938,https://t.me/medpharm/12938,"–í –ü–µ—Ä–º–∏ –ø–∞—Ü–∏–µ–Ω—Ç–∫–∞ –≤—ã–∏–≥—Ä–∞–ª–∞ —Å—É–¥ —É —á–∞—Å—Ç–Ω–æ–π –∫–ª–∏–Ω–∏–∫–∏, –∫–æ—Ç–æ—Ä–∞—è –æ—à–∏–±–æ—á–Ω–æ –∏–Ω—Ç–µ—Ä–ø—Ä–µ—Ç–∏—Ä–æ–≤–∞–ª–∞ –ú–†–¢ –∏ –Ω–∞–∑–Ω–∞—á–∏–ª–∞ –Ω–µ–Ω—É–∂–Ω—É—é –æ–ø–µ—Ä–∞—Ü–∏—é –ø–æ —É–¥–∞–ª–µ–Ω–∏—é –æ—Ä–≥–∞–Ω–∞. –° –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—è –≤–∑—ã—Å–∫–∞–ª–∏ –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏—é –º–æ—Ä–∞–ª—å–Ω–æ–≥–æ –≤—Ä–µ–¥–∞, —Å—Ç–æ–∏–º–æ—Å—Ç—å —É—Å–ª—É–≥–∏ –∏ —à—Ç—Ä–∞—Ñ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PYW4y #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-10-03T13:18:03+00:00,@medpharm,12937,https://t.me/medpharm/12937,"–í–û–ó –æ–ø—É–±–ª–∏–∫–æ–≤–∞–ª–∞ –¥–æ–∫–ª–∞–¥, –≤ –∫–æ—Ç–æ—Ä–æ–º –ø—Ä–µ–¥—É–ø—Ä–µ–¥–∏–ª–∞ –æ –≥–ª—É–±–æ–∫–æ–º –∫—Ä–∏–∑–∏—Å–µ –≤ —Å–æ–∑–¥–∞–Ω–∏–∏ –∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫–æ–≤: –∑–∞ –¥–≤–∞ –≥–æ–¥–∞ —á–∏—Å–ª–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å–ø—ã—Ç–∞–Ω–∏—è—Ö —Å–æ–∫—Ä–∞—Ç–∏–ª–æ—Å—å —Å 97 –¥–æ 90, –ø—Ä–∏ —ç—Ç–æ–º —Ç–æ–ª—å–∫–æ 15 —Ä–∞–∑—Ä–∞–±–æ—Ç–æ–∫ –ø—Ä–∏–∑–Ω–∞–Ω—ã –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–º–∏. –û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–ª–∞ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–µ —Å–æ–≤—Ä–µ–º–µ–Ω–Ω–æ–≥–æ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –¥–ª—è –±—ã—Å—Ç—Ä–æ–≥–æ –≤—ã—è–≤–ª–µ–Ω–∏—è –ø–∞—Ç–æ–≥–µ–Ω–æ–≤ –∏ –Ω–µ—Ö–≤–∞—Ç–∫—É –ø—Ä–æ—Å—Ç—ã—Ö —ç–∫—Å–ø—Ä–µ—Å—Å-—Ç–µ—Å—Ç–æ–≤ –≤ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—è—Ö. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PYSqe #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, shortage, safety"",
  ""impact"": ""high"",
  ""english"": ""The VOZ published a report warning of a deep crisis in antibiotic trials. The number of clinical trial drugs decreased from 97 to 90 over two years, and only 15 projects were recognized as innovative. The organization noted a lack of modern equipment for rapid pathogen detection and insufficient simple express-tests in healthcare facilities.""
}"
2025-10-03T13:12:03+00:00,@medpharm,12936,https://t.me/medpharm/12936,"–ú–∏–Ω—Ñ–∏–Ω –ø—Ä–µ–¥—É–ø—Ä–µ–¥–∏–ª –æ –∫–æ–Ω—Ñ–ª–∏–∫—Ç–µ –∏–Ω—Ç–µ—Ä–µ—Å–æ–≤ –ø—Ä–∏ –ø–µ—Ä–µ–¥–∞—á–µ –≥–ª–∞–≤–∞–º —Ä–µ–≥–∏–æ–Ω–æ–≤ –ø–æ–ª–Ω–æ–º–æ—á–∏–π –ø–æ –∑–∞–º–µ–Ω–µ —á–∞—Å—Ç–Ω—ã—Ö —Å—Ç—Ä–∞—Ö–æ–≤—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω—ã–º–∏ —Ñ–æ–Ω–¥–∞–º–∏ –û–ú–°. –û—Ç—Å—É—Ç—Å—Ç–≤–∏–µ –Ω–µ–∑–∞–≤–∏—Å–∏–º–æ–≥–æ —Å—Ç—Ä–∞—Ö–æ–≤–æ–≥–æ –∫–æ–Ω—Ç—Ä–æ–ª—è –æ—Å–ª–∞–±–ª—è–µ—Ç –∑–∞—â–∏—Ç—É –ø—Ä–∞–≤ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –Ω–∞ –¥–æ—Å—Ç—É–ø–Ω—É—é –∏ –∫–∞—á–µ—Å—Ç–≤–µ–Ω–Ω—É—é –º–µ–¥–∏—Ü–∏–Ω—Å–∫—É—é –ø–æ–º–æ—â—å, –≥–æ–≤–æ—Ä–∏—Ç—Å—è –≤ –∑–∞–∫–ª—é—á–µ–Ω–∏–∏ –≤–µ–¥–æ–º—Å—Ç–≤–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PYSSG #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, regulation"",
  ""impact"": ""medium"",
  ""english"": ""The Finance Ministry warned of conflicts of interest in transferring regional heads' authority to replace private health insurance companies with territorial OMS funds. The lack of independent insurance supervision weakens patients' access to quality healthcare, the document states.""
}"
2025-10-03T12:31:06+00:00,@medpharm,12935,https://t.me/medpharm/12935,–≠–∫—Å-–≥–ª–∞–≤–≤—Ä–∞—á –ñ–∏–≥—É–ª–µ–≤—Å–∫–æ–π –±–æ–ª—å–Ω–∏—Ü—ã –æ—Å—É–∂–¥–µ–Ω –Ω–∞ –ø—è—Ç—å –ª–µ—Ç –∑–∞ —Ö–∏—â–µ–Ω–∏–µ 4 –º–ª–Ω —Ä—É–±. —á–µ—Ä–µ–∑ –ø–æ–¥–ª–æ–∂–Ω—ã–µ –∫–æ–Ω—Ç—Ä–∞–∫—Ç—ã. –ü–æ—Ö–∏—â–µ–Ω–Ω—ã–µ —Å—Ä–µ–¥—Å—Ç–≤–∞ –ø–æ—Ç—Ä–∞—á–µ–Ω—ã –Ω–∞ –ø–æ–≥–∞—à–µ–Ω–∏–µ –ª–∏—á–Ω—ã—Ö –∫—Ä–µ–¥–∏—Ç–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PYPYJ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-10-03T12:12:03+00:00,@medpharm,12934,https://t.me/medpharm/12934,"–ó–∞–ø—Ä–µ—Ç –Ω–∞ –≤—ã–≤–æ–∑ —Ñ–∞—Ä–º–ø—Ä–æ–¥—É–∫—Ü–∏–∏ –∏ –º–µ–¥–∏–∑–¥–µ–ª–∏–π –∏–∑ –†–æ—Å—Å–∏–∏ –±—É–¥–µ—Ç –¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å –¥–æ –∫–æ–Ω—Ü–∞ 2027 –≥–æ–¥–∞. –û–≥—Ä–∞–Ω–∏—á–µ–Ω–∏–µ –±—ã–ª–æ –≤–≤–µ–¥–µ–Ω–æ –≤ 2022 –≥–æ–¥—É, –∏ —Å–µ–π—á–∞—Å –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –ø–æ–¥–ø–∏—Å–∞–ª–æ –¥–æ–∫—É–º–µ–Ω—Ç –æ –µ–≥–æ –ø—Ä–æ–¥–ª–µ–Ω–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PYN4e #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, import_export"",
  ""impact"": ""high"",
  ""english"": ""A ban on exporting pharmaceutical products and medical supplies from Russia will continue until the end of 2027. The restriction was introduced in 2022, and the government has signed a document extending it. More details: https://clck.ru/3PYN4e #PharmNews #Regulation""
}"
2025-10-03T12:00:08+00:00,@medpharm,12933,https://t.me/medpharm/12933,"–í–æ–∑—Ä–∞—Å—Ç –≤ –ø–∞—Å–ø–æ—Ä—Ç–µ ‚Äî –Ω–µ –≥–ª–∞–≤–Ω—ã–π –ø–æ–∫–∞–∑–∞—Ç–µ–ª—å. –°–µ–≥–æ–¥–Ω—è –º–µ–¥–∏—Ü–∏–Ω–∞ –≥–æ–≤–æ—Ä–∏—Ç –Ω–∞ —è–∑—ã–∫–µ –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ –≤–æ–∑—Ä–∞—Å—Ç–∞, –∫–æ—Ç–æ—Ä—ã–π —Ç–æ—á–Ω–µ–µ –æ—Ç—Ä–∞–∂–∞–µ—Ç —Å–æ—Å—Ç–æ—è–Ω–∏–µ –æ—Ä–≥–∞–Ω–∏–∑–º–∞. –ö–æ–º–ø–∞–Ω–∏—è ¬´–ê—Ç–ª–∞—Å¬ª, –≤—Ö–æ–¥—è—â–∞—è –≤ –ì–ö ¬´–ü—Ä–æ—Ç–µ–∫¬ª, —Å–æ–≤–º–µ—Å—Ç–Ω–æ —Å —É—á–µ–Ω—ã–º–∏ –ù–ù–ì–£ –∏–º. –õ–æ–±–∞—á–µ–≤—Å–∫–æ–≥–æ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª–∞ –ø–µ—Ä–≤—ã–π –≤ –†–æ—Å—Å–∏–∏ –∫–∞–ª—å–∫—É–ª—è—Ç–æ—Ä –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ –≤–æ–∑—Ä–∞—Å—Ç–∞, –æ—Å–Ω–æ–≤–∞–Ω–Ω—ã–π –Ω–∞ –¥–∞–Ω–Ω—ã—Ö —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –≠—Ç–æ—Ç —É–Ω–∏–∫–∞–ª—å–Ω—ã–π –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç —É–∂–µ –º–µ–Ω—è–µ—Ç –ø–æ–¥—Ö–æ–¥ –∫ –ø—Ä–µ–≤–µ–Ω—Ç–∏–≤–Ω–æ–º—É –ª–µ—á–µ–Ω–∏—é –∏ –º–µ–¥–∏—Ü–∏–Ω–µ –¥–æ–ª–≥–æ–ª–µ—Ç–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PYM98 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,hospital_policy,pharmacovigilance,safety"",
  ""impact"": ""medium"",
  ""english"": ""A unique tool for calculating biological age, based on Russian patient data, has been developed by Atlas Company and researchers from NNGU. This tool is changing preventive treatment approaches and longevity medicine, according to the company.""
}"
2025-10-03T11:24:02+00:00,@medpharm,12932,https://t.me/medpharm/12932,–í –ü–µ—Ç–µ—Ä–±—É—Ä–≥–µ –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä –∫–æ–º–ø–∞–Ω–∏–∏ ‚Äî –ø–æ—Å—Ç–∞–≤—â–∏–∫–∞ –º–µ–¥–æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –∑–∞–∫–ª—é—á–µ–Ω –ø–æ–¥ —Å—Ç—Ä–∞–∂—É –ø–æ –ø–æ–¥–æ–∑—Ä–µ–Ω–∏—é –≤ —Ö–∏—â–µ–Ω–∏–∏ –±–æ–ª–µ–µ 40 –º–ª–Ω —Ä—É–±. –±—é–¥–∂–µ—Ç–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤. –î–µ–Ω—å–≥–∏ –ø—Ä–µ–¥–Ω–∞–∑–Ω–∞—á–∞–ª–∏—Å—å –¥–ª—è –∑–∞–∫—É–ø–∫–∏ –∏ —Ä–µ–º–æ–Ω—Ç–∞ —Å–∏—Å—Ç–µ–º—ã –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –≥–∞–∑–æ—Å–Ω–∞–±–∂–µ–Ω–∏—è –≤ –ù–∏–∫–æ–ª–∞–µ–≤—Å–∫–æ–π –±–æ–ª—å–Ω–∏—Ü–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://medvestnik.ru/content/news/V-Peterburge-otpravili-v-SIZO-glavu-firmy-postavshika-oborudovaniya-dlya-Nikolaevskoi-bolnicy.html?utm_source=TG_post&utm_medium=Group&utm_campaign=V-Peterburge-otpravili-v-SIZO-glavu-firmy-postavshika-oborudovaniya-dlya-Nikolaevskoi-bolnicy #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–î—Ä—É–≥–æ–µ,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""The head of a medical equipment supplier company in St. Petersburg has been placed under house arrest on suspicion of embezzling over 4 million rubles from the budget. The funds were intended for purchasing and repairing a medical gas supply system at Nikolaevsky Hospital.""
}"
2025-10-03T11:02:05+00:00,@medpharm,12931,https://t.me/medpharm/12931,"–†–∞—Å—Ö–æ–¥—ã –±–∏–∑–Ω–µ—Å–∞ –Ω–∞ –ø—Ä–∏–µ–º –±–µ–∑–Ω–∞–ª–∏—á–Ω—ã—Ö –ø–ª–∞—Ç–µ–∂–µ–π –º–æ–≥—É—Ç –≤—ã—Ä–∞—Å—Ç–∏ –Ω–∞ 20‚Äî22% –≤ 2026 –≥–æ–¥—É. –¢–∞–∫–æ–π –ø—Ä–æ–≥–Ω–æ–∑ –¥–∞—é—Ç –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–∏ —Ä—ã–Ω–∫–∞ –≤ —Å–≤—è–∑–∏ —Å –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç–æ–º –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞, –∫–æ—Ç–æ—Ä—ã–π –æ—Ç–º–µ–Ω—è–µ—Ç –æ—Å–≤–æ–±–æ–∂–¥–µ–Ω–∏–µ –æ—Ç –ù–î–° –¥–ª—è —É—Å–ª—É–≥ —ç–∫–≤–∞–π—Ä–∏–Ω–≥–∞ –∏ –ø—Ä–æ—Ü–µ—Å—Å–∏–Ω–≥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PYH8d #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{""skip"": true}"
2025-10-03T10:27:04+00:00,@medpharm,12930,https://t.me/medpharm/12930,"–†–µ–≥—É–ª—è—Ç–æ—Ä —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –ø–æ—Ä—è–¥–æ–∫ –≤—ã–¥–∞—á–∏ –ª–∏—Ü–µ–Ω–∑–∏–π –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è–º, –∫–æ—Ç–æ—Ä—ã–µ –≤–µ–¥—É—Ç –æ–±—Ä–∞–∑–æ–≤–∞—Ç–µ–ª—å–Ω—É—é –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç—å –ø–æ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—ã–º –ø—Ä–æ–≥—Ä–∞–º–º–∞–º –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–≥–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è. –ü—Ä–æ—Ü–µ–¥—É—Ä–∞ –ø—Ä–µ–¥–ø–æ–ª–∞–≥–∞–µ—Ç –ø—Ä–æ–≤–µ—Ä–∫—É –∫–∞–¥—Ä–æ–≤–æ–≥–æ –∏ –º–∞—Ç–µ—Ä–∏–∞–ª—å–Ω–æ-—Ç–µ—Ö–Ω–∏—á–µ—Å–∫–æ–≥–æ –æ—Å–Ω–∞—â–µ–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PYEPN #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–û–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""medium"",
  ""english"": ""The regulatory body has developed a process for licensing organizations conducting professional educational programs in medical and pharmaceutical fields. The procedure involves checking the personnel and material-technical equipment. For more details: https://clck.ru/3PYEPN #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–û–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è""
}"
2025-10-03T09:56:03+00:00,@medpharm,12929,https://t.me/medpharm/12929,"–ó–∞ –ø—Ä–æ—à–µ–¥—à—É—é –Ω–µ–¥–µ–ª—é –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä –ø—Ä–µ–∫—Ä–∞—Ç–∏–ª –æ–±—Ä–∞—â–µ–Ω–∏–µ —Å–µ–º–∏ —Å–µ—Ä–∏–π –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ü—Ä–µ—Ç–µ–Ω–∑–∏–∏ –≤–æ–∑–Ω–∏–∫–ª–∏ –∫ —Ä–∞–∑–Ω—ã–º –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è–º, –≤ —Ç–æ–º —á–∏—Å–ª–µ ¬´–†–∞—Å—Ç–≤–æ—Ä–µ–Ω–∏–µ¬ª, ¬´–û–ø–∏—Å–∞–Ω–∏–µ¬ª, ¬´–û–±—ä–µ–º —Å–æ–¥–µ—Ä–∂–∏–º–æ–≥–æ —É–ø–∞–∫–æ–≤–∫–∏¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PYBxL #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–û—Ç–∑—ã–≤—ã","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""Russia's Roszdranad–∑–æ—Ä has suspended the registration of seven series of pharmaceutical products due to various issues including 'disintegration', 'description', and 'container volume'.""
}"
2025-10-03T09:30:05+00:00,@medpharm,12928,https://t.me/medpharm/12928,"–†–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–Ω—ã–µ –ú–∏–Ω–∑–¥—Ä–∞–≤–æ–º –ø–æ–ø—Ä–∞–≤–∫–∏ –≤ –∑–∞–∫–æ–Ω ¬´–û–± –û–ú–°¬ª, –Ω–∞–¥–µ–ª—è—é—â–∏–µ –≥–ª–∞–≤ —Ä–µ–≥–∏–æ–Ω–æ–≤ –ø–æ–ª–Ω–æ–º–æ—á–∏—è–º–∏ –ø–æ –∑–∞–º–µ–Ω–µ —á–∞—Å—Ç–Ω—ã—Ö —Å—Ç—Ä–∞—Ö–æ–≤—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π (–°–ú–û) —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω—ã–º–∏ —Ñ–æ–Ω–¥–∞–º–∏ –û–ú–° (–¢–§–û–ú–°), –≤—Å—Ç—Ä–µ—Ç–∏–ª–∏ —è—Ä–æ—Å—Ç–Ω–æ–µ —Å–æ–ø—Ä–æ—Ç–∏–≤–ª–µ–Ω–∏–µ —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ —Ä—ã–Ω–∫–∞. –í–æ –í—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–æ–º —Å–æ—é–∑–µ —Å—Ç—Ä–∞—Ö–æ–≤—â–∏–∫–æ–≤ (–í–°–°) –≤ –¥–æ–∫—É–º–µ–Ω—Ç–µ —É–≤–∏–¥–µ–ª–∏ —Ä–∏—Å–∫–∏ —Å–Ω–∏–∂–µ–Ω–∏—è –∫–∞—á–µ—Å—Ç–≤–∞ –º–µ–¥–ø–æ–º–æ—â–∏ –∏ –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω—ã–π –∏—Å—Ç–æ—á–Ω–∏–∫ –∫–æ—Ä—Ä—É–ø—Ü–∏–∏. –§–∞–∫—Ç–∏—á–µ—Å–∫–∏ –ø–æ–¥ –ø—Ä–µ–¥–ª–æ–≥–æ–º —ç–∫–æ–Ω–æ–º–∏–∏ –ø—Ä–æ–∏–∑–æ–π–¥–µ—Ç –æ–±–Ω—É–ª–µ–Ω–∏–µ –¥–æ—Å—Ç–∏–∂–µ–Ω–∏–π –≤ –æ–±–ª–∞—Å—Ç–∏ –∑–∞—â–∏—Ç—ã –ø—Ä–∞–≤ –∑–∞—Å—Ç—Ä–∞—Ö–æ–≤–∞–Ω–Ω—ã—Ö –≥—Ä–∞–∂–¥–∞–Ω, –ø–æ–ª–∞–≥–∞—é—Ç —ç–∫—Å–ø–µ—Ä—Ç—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PY9zJ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The amendments to the Health Insurance Law by the Ministry of Health, which grant regional authorities powers to replace private health insurance companies (HICs) with territorial funds of the Health Insurance Fund (TFHF), have met fierce resistance from market participants. The Russian Federation Association of Insurers (RFIA) sees risks to the quality of medical care and a potential source of corruption in this document. Essentially, under the guise of cost savings, there will be a nullification of achievements in protecting insured individuals' rights, experts argue. For more details: https://clck.ru/3PY9zJ #MedVestnik #Healthcare""
}"
2025-10-03T09:21:04+00:00,@medpharm,12927,https://t.me/medpharm/12927,–õ–∞–±–æ—Ä–∞—Ç–æ—Ä–∏—é –º–æ–ª–µ–∫—É–ª—è—Ä–Ω–æ–π –∏ –∫–ª–µ—Ç–æ—á–Ω–æ–π —Ñ–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏–∏ –æ—Ç–∫—Ä—ã–ª–∏ –Ω–∞ –±–∞–∑–µ –°–∏–±–ì–ú–£ –≤ –¢–æ–º—Å–∫–µ. –ï–µ –∫–ª—é—á–µ–≤–∞—è –∑–∞–¥–∞—á–∞ ‚Äî –æ—Ç–±–æ—Ä –Ω–∞–∏–±–æ–ª–µ–µ –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–Ω—ã—Ö —Å–æ–µ–¥–∏–Ω–µ–Ω–∏–π –¥–ª—è –Ω–æ–≤—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ —Å –ø–æ—Å–ª–µ–¥—É—é—â–µ–π –ø–µ—Ä–µ–¥–∞—á–µ–π –Ω–∞ –¥–æ–∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PY9Mm #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-10-03T08:53:05+00:00,@medpharm,12926,https://t.me/medpharm/12926,"–î–æ–±–∞–≤–ª–µ–Ω–∏–µ –ª–µ–≤–æ–¥–æ–ø—ã –∫ —Å—Ç–∞–Ω–¥–∞—Ä—Ç–Ω–æ–π —Å—Ç–∞—Ü–∏–æ–Ω–∞—Ä–Ω–æ–π —Ä–µ–∞–±–∏–ª–∏—Ç–∞—Ü–∏–æ–Ω–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –Ω–µ –ø—Ä–∏–≤–µ–ª–æ –∫ –±–æ–ª–µ–µ –≤—ã—Ä–∞–∂–µ–Ω–Ω–æ–º—É —É–ª—É—á—à–µ–Ω–∏—é –¥–≤–∏–≥–∞—Ç–µ–ª—å–Ω–æ–π —Ñ—É–Ω–∫—Ü–∏–∏ —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –∏–Ω—Å—É–ª—å—Ç–æ–º. –ü–æ—ç—Ç–æ–º—É, –Ω–µ—Å–º–æ—Ç—Ä—è –Ω–∞ –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –≤ –ø–ª–∞–Ω–µ –ø–æ–≤—ã—à–µ–Ω–∏—è –Ω–µ–π—Ä–æ–ø–ª–∞—Å—Ç–∏—á–Ω–æ—Å—Ç–∏, –Ω–µ —Å—Ç–æ–∏—Ç –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å –µ–≥–æ –≤ –∫–∞—á–µ—Å—Ç–≤–µ –¥–æ–ø–æ–ª–Ω–µ–Ω–∏—è –∫ –æ—Å–Ω–æ–≤–Ω–æ–º—É –ª–µ—á–µ–Ω–∏—é. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PY7Bz #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ù–µ–≤—Ä–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance"",
  ""impact"": ""medium"",
  ""english"": ""The addition of levodopa to standard inpatient rehabilitation therapy did not result in more pronounced improvements in motor function for patients with stroke. Therefore, despite the potential of the drug to enhance neuroplasticity, it should not be used as an adjunct to primary treatment.""
}"
2025-10-03T08:03:07+00:00,@medpharm,12925,https://t.me/medpharm/12925,"–ì–æ—Å–¥—É–º–∞ –∏–∑—É—á–∏—Ç —É—Å–ª–æ–≤–∏—è —Ç—Ä—É–¥–∞ –∞–∫—É—à–µ—Ä–æ–∫ –∏ –º–µ–¥—Å–µ—Å—Ç–µ—Ä –≤ —Ä–æ–¥–¥–æ–º–∞—Ö ‚Äî —Å—Ç–∞—Ç–∏—Å—Ç–∏–∫–∞ –ø–æ –∏—Ö —á–∏—Å–ª–µ–Ω–Ω–æ—Å—Ç–∏ –∏ –∑–∞—Ä–ø–ª–∞—Ç–∞–º, –∑–∞–ø—Ä–æ—à–µ–Ω–∞ —É –ú–∏–Ω–∑–¥—Ä–∞–≤–∞. –ê–Ω–∞–ª–∏–∑ –¥–æ–ª–∂–µ–Ω –≤—ã—è–≤–∏—Ç—å –ø—Ä–∏—á–∏–Ω—ã –∂–∞–ª–æ–± –ø–∞—Ü–∏–µ–Ω—Ç–æ–∫ –∏ –ø–æ–º–æ—á—å —Ä–∞–∑—Ä–∞–±–æ—Ç–∞—Ç—å –º–µ—Ä—ã –ø–æ–¥–¥–µ—Ä–∂–∫–∏ –ø–µ—Ä—Å–æ–Ω–∞–ª–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PY3GA #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–ê–∫—É—à–µ—Ä—Å—Ç–≤–æ_–∏_–≥–∏–Ω–µ–∫–æ–ª–æ–≥–∏—è #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-10-03T07:39:02+00:00,@medpharm,12923,https://t.me/medpharm/12923,"–†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä –∑–∞–ø—Ä–µ—Ç–∏–ª –ø—Ä–æ–¥–∞–∂—É –º–µ–¥–∏–∑–¥–µ–ª–∏–π –∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ —á–µ—Ä–µ–∑ –≤–µ–Ω–¥–∏–Ω–≥–æ–≤—ã–µ –∞–ø–ø–∞—Ä–∞—Ç—ã, –Ω–∞–ø—Ä–∞–≤–∏–≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–µ–µ –ø–∏—Å—å–º–æ –≤ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω—ã–µ –æ—Ä–≥–∞–Ω—ã. –†–µ–∞–ª–∏–∑–∞—Ü–∏—è —Ç–∞–∫–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏ —Ä–∞–∑—Ä–µ—à–µ–Ω–∞ —Ç–æ–ª—å–∫–æ –≤ —Å—Ç–∞—Ü–∏–æ–Ω–∞—Ä–Ω—ã—Ö —Ç–æ—Ä–≥–æ–≤—ã—Ö –æ–±—ä–µ–∫—Ç–∞—Ö, —á—Ç–æ —Å—Ç–∞–≤–∏—Ç –ø–æ–¥ —É–≥—Ä–æ–∑—É —Ä–∞–±–æ—Ç—É –±–æ–ª–µ–µ —Ç—ã—Å—è—á–∏ –∞–≤—Ç–æ–º–∞—Ç–æ–≤ –ø–æ –ø—Ä–æ–¥–∞–∂–µ –∫–æ–Ω—Ç–∞–∫—Ç–Ω—ã—Ö –ª–∏–Ω–∑. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PXzUH #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""The Russian Health Supervision prohibits the sale of medical devices and drugs through vending machines, issuing a corresponding letter to territorial bodies. Such implementation puts the work of more than one thousand contact lens vending machines at risk.""
}"
2025-10-03T06:11:06+00:00,@medpharm,12922,https://t.me/medpharm/12922,–ü—Ä–æ—Å—Ç–æ–π –∫–æ–µ–∫ –≤ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—è—Ö –º–æ–∂–µ—Ç –æ–ø–ª–∞—á–∏–≤–∞—Ç—å—Å—è –∏–∑ —Å—Ä–µ–¥—Å—Ç–≤ –û–ú–° —Ç–æ–ª—å–∫–æ –ø—Ä–∏ —Å–∞–Ω–∏—Ç–∞—Ä–Ω–æ-—ç–ø–∏–¥–µ–º–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏—è—Ö. –ü—Ä–∏ —ç—Ç–æ–º –≤ —Å–æ–¥–µ—Ä–∂–∞–Ω–∏–∏ –∫–æ–µ—á–Ω–æ–≥–æ —Ñ–æ–Ω–¥–∞ –Ω–µ –º–æ–≥—É—Ç —É—á–∏—Ç—ã–≤–∞—Ç—å—Å—è –ø—Ä—è–º—ã–µ —Ä–∞—Å—Ö–æ–¥—ã –Ω–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫—É—é –ø–æ–º–æ—â—å. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PXs7f #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanitation_epidemiology, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""Medical beds can only be reimbursed from OMS funds under sanitary-epidemiological measures. The direct costs for medical care are not considered in the content of the bed capacity.""
}"
2025-10-02T17:28:31+00:00,@medpharm,12921,https://t.me/medpharm/12921,"ü¶æ –í—Ä–µ–º—è –æ–±–Ω–æ–≤–ª–µ–Ω–∏—è. –°—Ç–µ–ø–µ–Ω—å –∏–∑–Ω–æ—Å–∞ –æ—Å–Ω–æ–≤–Ω—ã—Ö —Ñ–æ–Ω–¥–æ–≤ –≥–æ—Å–º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –≤ –†–æ—Å—Å–∏–∏ –≤–∞—Ä—å–∏—Ä—É–µ—Ç –æ—Ç 32,8 –¥–æ 61,8%. –≠—Ç–æ—Ç –ø–æ–∫–∞–∑–∞—Ç–µ–ª—å —É—á–∏—Ç—ã–≤–∞–ª—Å—è –ø—Ä–∏ —Ä–∞—Å–ø—Ä–µ–¥–µ–ª–µ–Ω–∏–∏ —Å—É–±—Å–∏–¥–∏–π –Ω–∞ –º–æ–¥–µ—Ä–Ω–∏–∑–∞—Ü–∏—é –ø–µ—Ä–≤–∏—á–Ω–æ–≥–æ –∑–≤–µ–Ω–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –º–µ–∂–¥—É —Ä–µ–≥–∏–æ–Ω–∞–º–∏. ü¶æ –†—É–±–ª—å —Å–µ–≤–µ—Ä–Ω—ã–π. –§–ú–ë–ê –†–æ—Å—Å–∏–∏ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–æ —É—Å—Ç–∞–Ω–æ–≤–∏—Ç—å –Ω–æ–≤—É—é —Å—Ç–∏–º—É–ª–∏—Ä—É—é—â—É—é –Ω–∞–¥–±–∞–≤–∫—É –∫ –∑–∞—Ä–∞–±–æ—Ç–Ω–æ–π –ø–ª–∞—Ç–µ —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –ø–æ–¥–≤–µ–¥–æ–º—Å—Ç–≤–µ–Ω–Ω—ã—Ö —É—á—Ä–µ–∂–¥–µ–Ω–∏–π, —Ä–∞—Å–ø–æ–ª–æ–∂–µ–Ω–Ω—ã—Ö –≤ —Ä–∞–π–æ–Ω–∞—Ö –ö—Ä–∞–π–Ω–µ–≥–æ –°–µ–≤–µ—Ä–∞ –∏ –ø—Ä–∏—Ä–∞–≤–Ω–µ–Ω–Ω—ã—Ö –∫ –Ω–∏–º –º–µ—Å—Ç–Ω–æ—Å—Ç—è—Ö. ‚ù§Ô∏è –ò–º–∏–¥–∂ –ø—Ä–æ—Ñ–µ—Å—Å–∏–∏. –°–æ—Ç—Ä—É–¥–Ω–∏–∫–∏ ¬´–ü–æ—á—Ç—ã –†–æ—Å—Å–∏–∏¬ª –¥–æ–ª–∂–Ω—ã –ø–æ–ª—É—á–∏—Ç—å 72-—á–∞—Å–æ–≤–æ–µ –¥–æ–ø–æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ –ø–æ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –µ—Å–ª–∏ –ø–æ—á—Ç–æ–≤—ã–π –æ–ø–µ—Ä–∞—Ç–æ—Ä –ø–æ–ª—É—á–∏—Ç –ø—Ä–∞–≤–æ –Ω–∞ –∏—Ö –ø—Ä–æ–¥–∞–∂—É, —Å—á–∏—Ç–∞—é—Ç –≤ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–µ. ‚ù§Ô∏è –¢—Ä—É–¥–Ω–æ —Å–æ—Ö—Ä–∞–Ω–∏—Ç—å. –ê–ª—å—è–Ω—Å —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–π –ø–æ–ø—Ä–æ—Å–∏–ª –≤–Ω–µ—Å—Ç–∏ –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ –ø—Ä–∞–≤–∏–ª–∞ —Ö—Ä–∞–Ω–µ–Ω–∏—è –∫–∞–ª–∏—è –ø–µ—Ä–º–∞–Ω–≥–∞–Ω–∞—Ç–∞. –ï—Å–ª–∏ –º–∞—Ä–≥–∞–Ω—Ü–æ–≤–∫—É –º–æ–∂–Ω–æ –±—É–¥–µ—Ç —Ö—Ä–∞–Ω–∏—Ç—å —Ç–æ–ª—å–∫–æ –≤ –∏–∑–æ–ª–∏—Ä–æ–≤–∞–Ω–Ω–æ–º –ø–æ–º–µ—â–µ–Ω–∏–∏, —Ç–æ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–µ–π –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –±—É–¥—É—Ç –∑–∞–Ω–∏–º–∞—Ç—å—Å—è –Ω–µ –±–æ–ª–µ–µ 1% –∞–ø—Ç–µ–∫.","{""skip"": true}"
2025-10-02T15:59:02+00:00,@medpharm,12920,https://t.me/medpharm/12920,"–ê–ª—å—è–Ω—Å —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–π –Ω–∞–ø—Ä–∞–≤–∏–ª –æ–±—Ä–∞—â–µ–Ω–∏—è –≤ –ì–æ—Å–¥—É–º—É, –ú–∏–Ω–∑–¥—Ä–∞–≤ –∏ –ú–∏–Ω—é—Å—Ç —Å –ø—Ä–æ—Å—å–±–æ–π –≤–Ω–µ—Å—Ç–∏ –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ –ø—Ä–∞–≤–∏–ª–∞ —Ö—Ä–∞–Ω–µ–Ω–∏—è –∫–∞–ª–∏—è –ø–µ—Ä–º–∞–Ω–≥–∞–Ω–∞—Ç–∞. –¢—Ä–µ–±–æ–≤–∞–Ω–∏–µ –≤—Å—Ç—É–ø–∏–ª–æ –≤ —Å–∏–ª—É 1 —Å–µ–Ω—Ç—è–±—Ä—è, –∏ –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ –∞–ø—Ç–µ–∫ —É–∂–µ —É—Å–ø–µ–ª–∏ —Ä–∞—Å–ø—Ä–æ–¥–∞—Ç—å –æ—Å—Ç–∞—Ç–∫–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞. –ï—Å–ª–∏ –º–∞—Ä–≥–∞–Ω—Ü–æ–≤–∫—É –º–æ–∂–Ω–æ –±—É–¥–µ—Ç —Ö—Ä–∞–Ω–∏—Ç—å —Ç–æ–ª—å–∫–æ –≤ –∏–∑–æ–ª–∏—Ä–æ–≤–∞–Ω–Ω–æ–º –ø–æ–º–µ—â–µ–Ω–∏–∏, —Ç–æ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–µ–π –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –±—É–¥—É—Ç –∑–∞–Ω–∏–º–∞—Ç—å—Å—è –Ω–µ –±–æ–ª–µ–µ 1% –∞–ø—Ç–µ–∫. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PXWok #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The Alliance of Pharmaceutical Associations has submitted requests to the State Duma, Ministry of Health and Ministry of Justice for changes in the rules for storing potassium permanganate. The requirement entered into force on September 1st, and most pharmacies have already sold off their remaining stock of the drug. If manganous can only be stored in isolated rooms, then the implementation of the drug will be carried out by no more than 1% pharmacies. More details: https://clck.ru/3PXWok #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞""
}"
2025-10-02T15:34:02+00:00,@medpharm,12919,https://t.me/medpharm/12919,–ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∞—è –∫–æ–º–ø–∞–Ω–∏—è Vertex Pharmaceuticals –∏ —Ä–æ—Å—Å–∏–π—Å–∫–æ–µ –ø–æ–¥—Ä–∞–∑–¥–µ–ª–µ–Ω–∏–µ —Ñ—Ä–∞–Ω—Ü—É–∑—Å–∫–æ–π Sanofi –ø–æ–¥–∞–ª–∏ –∂–∞–ª–æ–±—É –≤ –ö–æ–Ω—Å—Ç–∏—Ç—É—Ü–∏–æ–Ω–Ω—ã–π —Å—É–¥ –†–§. –û–Ω–∏ –ø—Ä–æ—Å—è—Ç –ø—Ä–∏–∑–Ω–∞—Ç—å –Ω–æ—Ä–º—É –ø.1 —Å—Ç.1362 –ì–ö –†–§ –æ –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω–æ–º –ª–∏—Ü–µ–Ω–∑–∏—Ä–æ–≤–∞–Ω–∏–∏ –Ω–µ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–µ–π –ö–æ–Ω—Å—Ç–∏—Ç—É—Ü–∏–∏ –†–§. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PXVeF #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è,"{
  ""skip"": true
}"
2025-10-02T15:29:06+00:00,@medpharm,12918,https://t.me/medpharm/12918,"–°—É–¥ –≤ –ß—É–≤–∞—à–∏–∏ —Ä–∞—Å—Å–º–æ—Ç—Ä–∏—Ç –¥–µ–ª–æ –æ 22 —É—á–∞—Å—Ç–Ω–∏–∫–∞—Ö –ø—Ä–µ—Å—Ç—É–ø–Ω–æ–≥–æ —Å–æ–æ–±—â–µ—Å—Ç–≤–∞, –∫–æ—Ç–æ—Ä—ã–µ –æ–±–≤–∏–Ω—è—é—Ç—Å—è –≤ –º–æ—à–µ–Ω–Ω–∏—á–µ—Å—Ç–≤–µ —Å –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º–∏ —É—Å–ª—É–≥–∞–º–∏. –û—Ç –∏—Ö –¥–µ–π—Å—Ç–≤–∏–π –ø–æ—Å—Ç—Ä–∞–¥–∞–ª–∏ –æ–∫–æ–ª–æ 1,2 —Ç—ã—Å. —á–µ–ª–æ–≤–µ–∫, –æ–±—â–∏–π —Ä–∞–∑–º–µ—Ä –ø–æ—Ö–∏—â–µ–Ω–Ω—ã—Ö –¥–µ–Ω–µ–∂–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –ø—Ä–µ–≤—ã—Å–∏–ª 132 –º–ª–Ω —Ä—É–±. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PXVQT #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-10-02T15:03:04+00:00,@medpharm,12917,https://t.me/medpharm/12917,"–ó–∞ 72 —á–∞—Å–∞ –∑–∞ –ø–µ—Ä–≤—ã–π —Å—Ç–æ–ª. –í–º–µ—Å—Ç–æ –≤—ã—Å—à–µ–≥–æ –∏–ª–∏ —Å—Ä–µ–¥–Ω–µ-—Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ–≥–æ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è, –ø–æ —É—Å–∫–æ—Ä–µ–Ω–Ω–æ–π –ø—Ä–æ–≥—Ä–∞–º–º–µ —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤ ¬´–ü–æ—á—Ç—ã –†–æ—Å—Å–∏–∏¬ª –≤–≤–µ–¥—É—Ç –≤ –ø—Ä–æ—Ñ–µ—Å—Å–∏—é. –†–µ–≥—É–ª—è—Ç–æ—Ä—ã –ø—Ä–æ—Ä–∞–±–∞—Ç—ã–≤–∞—é—Ç –¥–ª—è –ø–æ—á—Ç–æ–≤–æ–≥–æ –æ–ø–µ—Ä–∞—Ç–æ—Ä–∞ –≤–≤–µ–¥–µ–Ω–∏–µ —É–ø—Ä–æ—â–µ–Ω–Ω–æ–π –ø—Ä–æ—Ü–µ–¥—É—Ä—ã –ª–∏—Ü–µ–Ω–∑–∏—Ä–æ–≤–∞–Ω–∏—è –ø–æ –∞–Ω–∞–ª–æ–≥–∏–∏ —Å –§–ê–ü. #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""Regulators are considering the introduction of a simplified licensing procedure for postal operator 'PostRos' similar to that used by FAP (Federation of Pharmaceutical Associations). The country is not specified, but it seems to be global in nature as the regulation involves 'PostRos', a postal operator.""
}"
2025-10-02T14:58:07+00:00,@medpharm,12916,https://t.me/medpharm/12916,"–í—Å–µ –±–æ–ª—å—à–µ –≤–∑—Ä–æ—Å–ª—ã—Ö –∞–º–µ—Ä–∏–∫–∞–Ω—Ü–µ–≤ —Å–æ–æ–±—â–∞—é—Ç –æ —Å–µ—Ä—å–µ–∑–Ω—ã—Ö –ø—Ä–æ–±–ª–µ–º–∞—Ö —Å –ø–∞–º—è—Ç—å—é, –∫–æ–Ω—Ü–µ–Ω—Ç—Ä–∞—Ü–∏–µ–π –∏ –ø—Ä–∏–Ω—è—Ç–∏–µ–º —Ä–µ—à–µ–Ω–∏–π. –û—Å–æ–±–µ–Ω–Ω–æ –∑–∞–º–µ—Ç–µ–Ω —Ä–æ—Å—Ç —á–∏—Å–ª–∞ —Ç–∞–∫–∏—Ö —Å–æ—Å—Ç–æ—è–Ω–∏–π —Å—Ä–µ–¥–∏ –ª—é–¥–µ–π –º–æ–ª–æ–∂–µ 40 –ª–µ—Ç, –∞ —Ç–∞–∫–∂–µ —Å—Ä–µ–¥–∏ –≥—Ä—É–ø–ø –Ω–∞—Å–µ–ª–µ–Ω–∏—è —Å –Ω–∏–∑–∫–∏–º –¥–æ—Ö–æ–¥–æ–º –∏ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PXTjj #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ù–µ–≤—Ä–æ–ª–æ–≥–∏—è #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è #–ü—Å–∏—Ö–∏–∞—Ç—Ä–∏—è","{""skip"": true}"
2025-10-02T14:21:05+00:00,@medpharm,12915,https://t.me/medpharm/12915,–ü—Ä–µ–º–∏–∏ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –†–æ—Å—Å–∏–∏ –≤ –æ–±–ª–∞—Å—Ç–∏ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è –≤ 2025 –≥–æ–¥—É –ø–æ–ª—É—á–∏–ª–∏ –¥–≤–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –ø—Ä–æ–µ–∫—Ç–∞: –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–∞—è —Å–∏—Å—Ç–µ–º–∞ –ø–æ–¥–≥–æ—Ç–æ–≤–∫–∏ –≤—Ä–∞—á–µ–π –∏ —Ü–∏–∫–ª –ø—Ä–æ–≥—Ä–∞–º–º –¥–ª—è –æ–±—É—á–µ–Ω–∏—è –Ω–µ–π—Ä–æ—Ö–∏—Ä—É—Ä–≥–∏–∏. –¢–∞–∫–∂–µ –Ω–∞–≥—Ä–∞–∂–¥–µ–Ω –ø—Ä–æ–µ–∫—Ç –≥–æ—Å–ø–∏—Ç–∞–ª—å–Ω—ã—Ö —à–∫–æ–ª –¥–ª—è –¥–µ—Ç–µ–π –Ω–∞ –ª–µ—á–µ–Ω–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PXRK5 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ù–∞—É–∫–∞ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-10-02T14:06:02+00:00,@medpharm,12914,https://t.me/medpharm/12914,"–ê–¥–º–∏–Ω–∏—Å—Ç—Ä–∞—Ü–∏—è –¢—Ä–∞–º–ø–∞ —Ä–µ—à–∏–ª–∞ –ø–æ–∫–∞ –Ω–µ –≤–≤–æ–¥–∏—Ç—å –ø–æ—à–ª–∏–Ω—ã –≤ —Ä–∞–∑–º–µ—Ä–µ 100% –Ω–∞ –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç—ã, —á—Ç–æ–±—ã –ø—Ä–æ–≤–µ—Å—Ç–∏ –ø–µ—Ä–µ–≥–æ–≤–æ—Ä—ã —Å —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—è–º–∏ –æ —Å–Ω–∏–∂–µ–Ω–∏–∏ —Å—Ç–æ–∏–º–æ—Å—Ç–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ú–µ—Ä—ã –¥–æ–ª–∂–Ω—ã –±—ã–ª–∏ –≤—Å—Ç—É–ø–∏—Ç—å –≤ —Å–∏–ª—É 1 –æ–∫—Ç—è–±—Ä—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PXQJA #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-02T13:39:04+00:00,@medpharm,12913,https://t.me/medpharm/12913,"–ü—Ä–æ–µ–∫—Ç –ø—Ä–∏–ª–æ–∂–µ–Ω–∏—è –∫ –ü—Ä–∞–≤–∏–ª–∞–º GMP –ï–ê–≠–° ¬´–¢—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤—É —Å—Ç–µ—Ä–∏–ª—å–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤¬ª –∑–∞–≤–µ—Ä—à–∏–ª –≤—Å–µ –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã–µ –ø—Ä–æ—Ü–µ–¥—É—Ä—ã —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏—è. –í –ï–≤—Ä–∞–∑–∏–π—Å–∫–æ–π —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–π –∫–æ–º–∏—Å—Å–∏–∏ –Ω–∞–¥–µ—é—Ç—Å—è, —á—Ç–æ –≤ –Ω–∞—á–∞–ª–µ 2026 –≥–æ–¥–∞ –æ–±–Ω–æ–≤–ª–µ–Ω–Ω—ã–π –¥–æ–∫—É–º–µ–Ω—Ç –±—É–¥–µ—Ç –ø—Ä–∏–Ω—è—Ç. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PXNRd #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The project to update the GMP rules for the Eurasian Economic Commission regarding production of sterile medicinal products has completed all necessary review procedures. The Eurasian Economic Commission hopes that the updated document will be adopted by the beginning of 2026. For more details: https://clck.ru/3PXNRd #PharmNews #Production""
}"
2025-10-02T13:36:08+00:00,@medpharm,12912,https://t.me/medpharm/12912,"–†–æ—Å—Å–∏–π—Å–∫–∏–π CAR-T-–∫–ª–µ—Ç–æ—á–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –≤–ø–µ—Ä–≤—ã–µ –ø–æ–ª—É—á–∏–ª –ø–∞—Ü–∏–µ–Ω—Ç –ú–ù–ò–û–ò –∏–º. –ì–µ—Ä—Ü–µ–Ω–∞. –ò–º —Å—Ç–∞–ª –º—É–∂—á–∏–Ω–∞ —Å –¥–∏—Ñ—Ñ—É–∑–Ω–æ–π B-–∫—Ä—É–ø–Ω–æ–∫–ª–µ—Ç–æ—á–Ω–æ–π –ª–∏–º—Ñ–æ–º–æ–π, —Ç–µ—Ä–∞–ø–∏—è –±—ã–ª–∞ –µ–≥–æ –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–º —à–∞–Ω—Å–æ–º –Ω–∞ –∏–∑–ª–µ—á–µ–Ω–∏–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PXNEC #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ù–∞—É–∫–∞ #–û–Ω–∫–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""clinical_trial,hospital_policy,pharmacovigilance,safety"",
  ""impact"": ""high"",
  ""english"": ""A patient with diffuse large B-cell lymphoma in the city hospital of Gersena Institute received Russia's first CAR-T cell therapy. The patient is a male who had this treatment as his only chance for recovery.""
}"
2025-10-02T12:53:03+00:00,@medpharm,12911,https://t.me/medpharm/12911,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –ø—Ä–µ–¥–ª–æ–∂–∏–ª –≤–∫–ª—é—á–∏—Ç—å —ç–∫—Å–ø–µ—Ä—Ç–∏–∑—É –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤, –∫–æ—Ç–æ—Ä—ã–µ —Å–æ–∑–¥–∞—é—Ç—Å—è –≤ –±–æ–ª—å–Ω–∏—Ü–∞—Ö –ø–æ–¥ –∫–æ–Ω–∫—Ä–µ—Ç–Ω–æ–≥–æ –ø–∞—Ü–∏–µ–Ω—Ç–∞, –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ø–ª–∞—Ç–Ω—ã—Ö –≥–æ—Å—É—Å–ª—É–≥. –ü—Ä–æ–µ–∫—Ç –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è –≤—ã–Ω–µ—Å–µ–Ω –Ω–∞ –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–µ –æ–±—Å—É–∂–¥–µ–Ω–∏–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PXKD9 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""reimbursement,clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health proposed to include the review of biotechnological medicines created in hospitals for a specific patient into the list of paid state services. The project decree has been submitted to public discussion.""
}"
2025-10-02T12:38:03+00:00,@medpharm,12910,https://t.me/medpharm/12910,"–ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–µ —ç–∫—Å–ø–µ—Ä—Ç—ã –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∏ –Ω–∞—É—á–Ω–æ–µ –∑–∞—è–≤–ª–µ–Ω–∏–µ –æ –≤–ª–∏—è–Ω–∏–∏ –ø—Å–∏—Ö–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ –¥–∏—Å—Ç—Ä–µ—Å—Å–∞ –Ω–∞ –ø—Ä–æ–≥–Ω–æ–∑ —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –ø–æ—Å–ª–µ –∏–Ω—Ñ–∞—Ä–∫—Ç–∞ –º–∏–æ–∫–∞—Ä–¥–∞. –í –¥–æ–∫—É–º–µ–Ω—Ç–µ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω—ã –º–µ—Ö–∞–Ω–∏–∑–º—ã —Ä–∞–∑–≤–∏—Ç–∏—è –Ω–∞—Ä—É—à–µ–Ω–∏–π, –∏—Ö —Å–≤—è–∑—å —Å —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã–º —Ä–∏—Å–∫–æ–º, –∞ —Ç–∞–∫–∂–µ –¥–∞–Ω—ã —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø–æ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–µ –∏ –ª–µ—á–µ–Ω–∏—é. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PXJ6V #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ö–∞—Ä–¥–∏–æ–ª–æ–≥–∏—è #–ü—Å–∏—Ö–∏–∞—Ç—Ä–∏—è #–¢–µ—Ä–∞–ø–∏—è","{""skip"": true}"
2025-10-02T12:07:14+00:00,@medpharm,12909,https://t.me/medpharm/12909,"üî• 150+ —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ ‚Äî –∏ —ç—Ç–æ —Ç–æ–ª—å–∫–æ –Ω–∞—á–∞–ª–æ! 7-—è –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–∞—è –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏—è ¬´–ß—Ç–æ –ø—Ä–æ–∏—Å—Ö–æ–¥–∏—Ç –Ω–∞ —Ä—ã–Ω–∫–µ –ë–ê–î?¬ª –æ—Ç –†-–ö–æ–Ω—Ñ –±—å—ë—Ç –≤—Å–µ —Ä–µ–∫–æ—Ä–¥—ã –µ—â—ë –¥–æ —Å—Ç–∞—Ä—Ç–∞. üóì 20‚Äì21 –Ω–æ—è–±—Ä—è üìç –°–∞–º–æ–µ –º–∞—Å—à—Ç–∞–±–Ω–æ–µ —Å–æ–±—ã—Ç–∏–µ –∏–Ω–¥—É—Å—Ç—Ä–∏–∏ –ë–ê–î –≤ —ç—Ç–æ–º –≥–æ–¥—É. –í —Å–ø–∏—Å–∫–∞—Ö: –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–∏ —Ä–µ–≥—É–ª—è—Ç–æ—Ä–æ–≤, —Ç–æ–ø-–º–µ–Ω–µ–¥–∂–µ—Ä—ã –∫–æ–º–ø–∞–Ω–∏–π, —ç–∫—Å–ø–µ—Ä—Ç—ã –æ—Ç—Ä–∞—Å–ª–∏ –∏ —Ç–µ, –∫—Ç–æ –¥–µ–ª–∞–µ—Ç –º–∞—Ä–∫–µ—Ç–∏–Ω–≥ –∏ –ø—Ä–æ–¥–∞–∂–∏ –Ω–∞ –º–∞–∫—Å–∏–º–∞–ª—å–Ω–æ–π —Å–∫–æ—Ä–æ—Å—Ç–∏. –°—Ä–µ–¥–∏ —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ ‚Äî –ú–∞–≥–Ω–∏—Ç –§–∞—Ä–º–∞, –ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º –ì—Ä—É–ø–ø, –ë–∞—É—à –•–µ–ª—Å, SUN Pharma, –ì–µ—Ä–æ—Ñ–∞—Ä–º, –ë–æ–ª–µ–∞—Ä, –í–µ–ª—Ñ–∞—Ä–º, –§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç, –ì–ö –ù–∏–∂—Ñ–∞—Ä–º, –ö–≤–∞–π—Å—Å–µ—Ä –§–∞—Ä–º–∞, –ê–ø—Ç–µ—á–Ω–∞—è —Å–µ—Ç—å 36,6, NL International, –§–ö –ì—Ä–∞–Ω–¥ –ö–∞–ø–∏—Ç–∞–ª, –§–ö –ü—É–ª—å—Å, –ü—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –≤ –†–æ—Å—Å–∏–∏ Fresenius Kabi –∏ –¥–µ—Å—è—Ç–∫–∏ –¥—Ä—É–≥–∏—Ö –ª–∏–¥–µ—Ä–æ–≤ —Ä—ã–Ω–∫–∞. üöÄ –†–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –∏–¥—ë—Ç –±—ã—Å—Ç—Ä–µ–µ, —á–µ–º –º—ã –æ–∂–∏–¥–∞–ª–∏. –ü—Ä–æ–≥—Ä–∞–º–º–∞ –¥–µ–π—Å—Ç–≤–∏—Ç–µ–ª—å–Ω–æ –∑–∞—Ä—è–∂–∞–µ—Ç: ‚ú® –ì–ª–∞–≤–Ω–æ–µ –∑–∞ 2 –¥–Ω—è: ‚Ä¢ –¢—Ä–µ–Ω–¥—ã –∏ –∞–Ω–∞–ª–∏—Ç–∏–∫–∞ —Ä—ã–Ω–∫–∞ (–¥–∞–Ω–Ω—ã–µ 3-–≥–æ –∫–≤–∞—Ä—Ç–∞–ª–∞ 2025) ‚Ä¢ –ì–æ—Ä—è—á–∞—è –ø–æ–≤–µ—Å—Ç–∫–∞: –Ω–∞–∑–Ω–∞—á–µ–Ω–∏–µ –ë–ê–î –≤—Ä–∞—á–∞–º–∏, –ø–æ—ç–∫–∑–µ–º–ø–ª—è—Ä–Ω—ã–π —É—á—ë—Ç, –±–ª–æ–∫–∏—Ä–æ–≤–∫–∏ —Å–∞–π—Ç–æ–≤, –Ω–æ–≤—ã–µ –¥–æ–∑–∏—Ä–æ–≤–∫–∏ ‚Ä¢ –ü–ª–µ–Ω–∞—Ä–Ω–∞—è —Å–µ—Å—Å–∏—è: —á–µ—Å—Ç–Ω—ã–π –¥–∏–∞–ª–æ–≥ –≤–ª–∞—Å—Ç–∏ –∏ –±–∏–∑–Ω–µ—Å–∞ ‚Ä¢ –ú–∞—Ä–∫–µ—Ç–∏–Ω–≥–æ–≤—ã–π –¥–µ–Ω—å: e-commerce, –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å—ã, –±–ª–æ–≥–µ—Ä—ã, —Ä–µ–∞–ª—å–Ω—ã–µ –∫–µ–π—Å—ã –ø—Ä–æ–¥–≤–∏–∂–µ–Ω–∏—è ‚Ä¢ –ù–µ—Ç–≤–æ—Ä–∫–∏–Ω–≥ 360¬∞: –∫–æ—Ñ–µ-–ø–∞—É–∑—ã, –¥–∏—Å–∫—É—Å—Å–∏–∏ –∏ –Ω–µ—Ñ–æ—Ä–º–∞–ª—å–Ω—ã–π –≤–µ—á–µ—Ä –¥–ª—è —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ üí° –•–æ—Ç–∏—Ç–µ –¥–≤–∏–≥–∞—Ç—å—Å—è –≤–ø–µ—Ä–µ–¥ –≤ –ë–ê–î-–∏–Ω–¥—É—Å—Ç—Ä–∏–∏? üëâ –†–µ–≥–∏—Å—Ç—Ä–∏—Ä—É–π—Ç–µ—Å—å üìë –ü—Ä–æ–≥—Ä–∞–º–º–∞ –†–µ–∫–ª–∞–º–∞ –û–û–û ""–†-–ö–æ–Ω—Ñ""","{
  ""skip"": true,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""The registration is going faster than expected. The agenda is energizing: trends and market analytics for the third quarter of 2025, hot topics such as physician prescription rates, case studies on electronic commerce and marketplaces, marketing days, networking sessions. The event is attracting over 150 participants including major players in the market such as MagnePharma, BinnoPharma Group, Baush Health, Sun Pharma, Geropharm, Bolfearma, Velfarma, Farmstandart, Nizfarma, Kweiss Pharma, 36.6 Pharmacies, NL International, FKG Capital, FPulse, Fresenius Kabi Russia among others.""
}"
2025-10-02T11:24:03+00:00,@medpharm,12908,https://t.me/medpharm/12908,–£ Sanofi –ø—Ä–æ–≤–µ–ª–∏ –æ–±—ã—Å–∫–∏. –ï–≤—Ä–æ–∫–æ–º–∏—Å—Å–∏—è –ø–æ–¥–æ–∑—Ä–µ–≤–∞–µ—Ç —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—é –≤ –º–æ–Ω–æ–ø–æ–ª–∏–∑–∞—Ü–∏–∏ —Ä—ã–Ω–∫–∞ –≤–∞–∫—Ü–∏–Ω –æ—Ç –≥—Ä–∏–ø–ø–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PXCDG #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, regulation"",
  ""impact"": ""high"",
  ""english"": ""Sanofi was searched by authorities. The European Commission suspects the pharmaceutical company of market monopoly in flu vaccine markets. For more details: https://clck.ru/3PXCDG #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ""
}"
2025-10-02T10:53:02+00:00,@medpharm,12907,https://t.me/medpharm/12907,"–ú–∏–Ω–æ–±—Ä–Ω–∞—É–∫–∏ —É—Å—Ç–∞–Ω–æ–≤–∏—Ç –ø–æ—Ä—è–¥–æ–∫ –≤–µ–¥–µ–Ω–∏—è –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—ã—Ö –∫–∞—Ç–∞–ª–æ–≥–æ–≤ –≥–µ–Ω–µ—Ç–∏—á–µ—Å–∫–∏—Ö —Ä–µ—Å—É—Ä—Å–æ–≤ –∏ –±–∏–æ—Ä–µ—Å—É—Ä—Å–Ω—ã—Ö –∫–æ–ª–ª–µ–∫—Ü–∏–π. –í—Å–µ —Å–≤–µ–¥–µ–Ω–∏—è –±—É–¥—É—Ç —Å–æ–±–∏—Ä–∞—Ç—å—Å—è –≤ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π —Å–∏—Å—Ç–µ–º–µ –ì–ò–° –ù–ë–ì–ò, –∞ –Ω–∞ –≤–Ω–µ—Å–µ–Ω–∏–µ –¥–∞–Ω–Ω—ã—Ö –æ—Ç–≤–æ–¥–∏—Ç—Å—è –¥–µ—Å—è—Ç—å –¥–Ω–µ–π. –î–æ–∫—É–º–µ–Ω—Ç –≤ —Å–ª—É—á–∞–µ —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏—è –≤—Å—Ç—É–ø–∏—Ç –≤ —Å–∏–ª—É —Å 2026 –≥–æ–¥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PX9sz #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{""skip"": true}"
2025-10-02T10:25:03+00:00,@medpharm,12906,https://t.me/medpharm/12906,–ü–æ—Å–ª–µ —Å–ª—É—á–∞—è —Å —É–¥–∞–ª–µ–Ω–∏–µ–º –∑–¥–æ—Ä–æ–≤–æ–π –ø–æ—á–∫–∏ —É –ø–∞—Ü–∏–µ–Ω—Ç–∫–∏ –≤ –ë—É—Ä—è—Ç–∏–∏ —É–≤–æ–ª–∏–ª–∏—Å—å –≥–ª–∞–≤–≤—Ä–∞—á –æ–Ω–∫–æ–¥–∏—Å–ø–∞–Ω—Å–µ—Ä–∞ –∏ —Ä–µ–Ω—Ç–≥–µ–Ω-–ª–∞–±–æ—Ä–∞–Ω—Ç. –î—Ä—É–≥–∏–º –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–∞–º –≤—ã–Ω–µ—Å–µ–Ω—ã –¥–∏—Å—Ü–∏–ø–ª–∏–Ω–∞—Ä–Ω—ã–µ –≤–∑—ã—Å–∫–∞–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PX7cv #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-10-02T09:29:04+00:00,@medpharm,12905,https://t.me/medpharm/12905,"–£ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –ª–µ–≥–æ—á–Ω–æ–π –∞—Ä—Ç–µ—Ä–∏–∞–ª—å–Ω–æ–π –≥–∏–ø–µ—Ä—Ç–µ–Ω–∑–∏–µ–π, –ø—Ä–∏–Ω–∏–º–∞–≤—à–∏—Ö –∞–Ω—Ç–∏–∫–æ–∞–≥—É–ª—è–Ω—Ç—ã, –Ω–µ –≤—ã—è–≤–ª–µ–Ω–æ —É–ª—É—á—à–µ–Ω–∏—è –ø–æ–∫–∞–∑–∞—Ç–µ–ª–µ–π –≤—ã–∂–∏–≤–∞–µ–º–æ—Å—Ç–∏ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å —Ç–µ–º–∏, –∫—Ç–æ –Ω–µ –ø–æ–ª—É—á–∞–ª —Ç–∞–∫—É—é —Ç–µ—Ä–∞–ø–∏—é. –°—Ö–æ–¥–Ω—ã–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –±—ã–ª–∏ –ø–æ–ª—É—á–µ–Ω—ã –∏ –ø—Ä–∏ –∞–Ω–∞–ª–∏–∑–µ –¥–∞–Ω–Ω—ã—Ö –∏–∑ —Ä–∞–∑–Ω—ã—Ö –ø–æ–¥–≥—Ä—É–ø–ø –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PX2yo #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ö–∞—Ä–¥–∏–æ–ª–æ–≥–∏—è #–ü—É–ª—å–º–æ–Ω–æ–ª–æ–≥–∏—è_–∏_—Ñ—Ç–∏–∑–∏–∞—Ç—Ä–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-10-02T09:20:02+00:00,@medpharm,12904,https://t.me/medpharm/12904,"–¶–µ–Ω—Ç—Ä –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –æ–±—ä—è–≤–∏–ª –∞—É–∫—Ü–∏–æ–Ω—ã –Ω–∞ –ø–æ—Å—Ç–∞–≤–∫—É –¥–ª—è ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª —à–µ—Å—Ç–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –≤ —Ç–æ–º —á–∏—Å–ª–µ ¬´–≠–Ω—Å–ø—Ä–∏–Ω–≥–∞¬ª, –∑–∞ –æ–¥–∏–Ω –º–∏–ª–ª–∏–ª–∏—Ç—Ä –∫–æ—Ç–æ—Ä–æ–≥–æ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –∑–∞–ø–ª–∞—Ç–∏—Ç—å 1,1 –º–ª–Ω —Ä—É–±. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PX2HQ #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""high"",
  ""english"": ""Auctions for the supply of six drugs under 'The Kindness Circle' have been announced, including 'Enspring', with one milliliter priced at 1.1 million rubles. More details: https://clck.ru/3PX2HQ #PharmNews #Distribution""
}"
2025-10-02T08:18:07+00:00,@medpharm,12903,https://t.me/medpharm/12903,–§–ú–ë–ê —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª–æ –ø—Ä–æ–µ–∫—Ç –Ω–æ–≤–æ–π —Å—Ç–∏–º—É–ª–∏—Ä—É—é—â–µ–π –Ω–∞–¥–±–∞–≤–∫–∏ –∫ –∑–∞—Ä–ø–ª–∞—Ç–µ –¥–ª—è —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã—Ö —É—á—Ä–µ–∂–¥–µ–Ω–∏–π –Ω–∞ –ö—Ä–∞–π–Ω–µ–º –°–µ–≤–µ—Ä–µ. –†–∞–∑–º–µ—Ä –≤—ã–ø–ª–∞—Ç—ã –±—É–¥–µ—Ç —Ä–∞—Å—Å—á–∏—Ç–∞–Ω –∫–∞–∫ —Ä–∞–∑–Ω–∏—Ü–∞ –º–µ–∂–¥—É –º–∞–∫—Å–∏–º–∞–ª—å–Ω–æ –≤–æ–∑–º–æ–∂–Ω–æ–π –∏ —Ç–µ–∫—É—â–µ–π –Ω–∞–¥–±–∞–≤–∫–æ–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PWvFE #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-10-02T07:37:02+00:00,@medpharm,12902,https://t.me/medpharm/12902,–ü–æ—Ä—è–¥–æ–∫ –≤—ã–¥–∞—á–∏ –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤ –æ–± —É—Ä–æ–≤–Ω–µ –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –≤ –ï–ê–≠–° —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥. –°–≤–∏–¥–µ—Ç–µ–ª—å—Å—Ç–≤–∞ –º–æ–∂–Ω–æ –±—É–¥–µ—Ç –ø–æ–ª—É—á–∏—Ç—å —á–µ—Ä–µ–∑ ¬´–ì–æ—Å—É—Å–ª—É–≥–∏¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PWruU #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""registration"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Industry and Trade has developed the procedure for obtaining documents on production localization level in the EAEU. Certificates can be obtained through 'State Services'. More details: https://clck.ru/3PWruU #PharmNews #Regulation""
}"
2025-10-02T07:15:04+00:00,@medpharm,12901,https://t.me/medpharm/12901,"–°—Ç–µ–ø–µ–Ω—å –∏–∑–Ω–æ—Å–∞ –æ—Å–Ω–æ–≤–Ω—ã—Ö —Ñ–æ–Ω–¥–æ–≤ –≥–æ—Å–º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –≤ –†–æ—Å—Å–∏–∏ –≤–∞—Ä—å–∏—Ä—É–µ—Ç –æ—Ç 32,8 –¥–æ 61,8%. –≠—Ç–æ—Ç –ø–æ–∫–∞–∑–∞—Ç–µ–ª—å —É—á–∏—Ç—ã–≤–∞–ª—Å—è –ø—Ä–∏ —Ä–∞—Å–ø—Ä–µ–¥–µ–ª–µ–Ω–∏–∏ —Å—É–±—Å–∏–¥–∏–π –Ω–∞ –º–æ–¥–µ—Ä–Ω–∏–∑–∞—Ü–∏—é –ø–µ—Ä–≤–∏—á–Ω–æ–≥–æ –∑–≤–µ–Ω–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –º–µ–∂–¥—É —Ä–µ–≥–∏–æ–Ω–∞–º–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PWqFR #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The degree of wear and tear of main equipment in state healthcare organizations varies from 32.8% to 61.8%. This indicator was taken into account when distributing subsidies for modernization of the primary healthcare sector between regions. More details: https://clck.ru/3PWqFR #MedVestnik #Healthcare #HealthOrganization""
}"
2025-10-02T06:17:03+00:00,@medpharm,12900,https://t.me/medpharm/12900,–ó–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å –º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ù–∞—Ç–∞–ª—å—è –•–æ—Ä–æ–≤–∞ –æ—Å–≤–æ–±–æ–∂–¥–µ–Ω–∞ –æ—Ç –∑–∞–Ω–∏–º–∞–µ–º–æ–π –¥–æ–ª–∂–Ω–æ—Å—Ç–∏ –≤ —Å–≤—è–∑–∏ –Ω–∞–∑–Ω–∞—á–µ–Ω–∏–µ–º —Å–µ–Ω–∞—Ç–æ—Ä–æ–º –æ—Ç –ï–≤—Ä–µ–π—Å–∫–æ–π –∞–≤—Ç–æ–Ω–æ–º–Ω–æ–π –æ–±–ª–∞—Å—Ç–∏. –û–Ω–∞ –ø—Ä–æ—Ä–∞–±–æ—Ç–∞–ª–∞ –≤ –º–∏–Ω–∏—Å—Ç–µ—Ä—Å—Ç–≤–µ –Ω–∞ —Ä–∞–∑–Ω—ã—Ö –¥–æ–ª–∂–Ω–æ—Å—Ç—è—Ö –±–æ–ª—å—à–µ 20 –ª–µ—Ç. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PWku7 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-10-02T06:04:02+00:00,@medpharm,12899,https://t.me/medpharm/12899,"–†–∞–Ω–µ–µ ¬´–§–í¬ª –ø–∏—Å–∞–ª, –≤ —á–µ–º –∑–∞–∫–ª—é—á–∞–µ—Ç—Å—è –±–∞—Ä—å–µ—Ä–Ω–∞—è —Ñ—É–Ω–∫—Ü–∏—è –ø–ª–∞—Ü–µ–Ω—Ç—ã –∏ –∫–∞–∫ –æ–Ω–∞ –∑–∞—â–∏—â–∞–µ—Ç –ø–ª–æ–¥ –æ—Ç –¥–µ–π—Å—Ç–≤–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤, —á–µ–º –æ—Ç–ª–∏—á–∞—é—Ç—Å—è —ç–º–±—Ä–∏–æ—Ç–æ–∫—Å–∏—á–Ω–æ—Å—Ç—å –æ—Ç —Ç–µ—Ä–∞—Ç–æ–≥–µ–Ω–Ω–æ—Å—Ç–∏, –∫–∞–∫–∏–µ –≤—ã–¥–µ–ª—è—é—Ç –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ —Ç–µ—Ä–∞—Ç–æ–≥–µ–Ω–Ω–æ—Å—Ç–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –∫–∞–∫–∏–µ –æ—Å–Ω–æ–≤–Ω—ã–µ –ø—Ä–∏–Ω—Ü–∏–ø—ã –ª–µ—á–µ–Ω–∏—è –±–µ—Ä–µ–º–µ–Ω–Ω—ã—Ö –∂–µ–Ω—â–∏–Ω —Å—É—â–µ—Å—Ç–≤—É—é—Ç. –í —ç—Ç–æ–π —Å—Ç–∞—Ç—å–µ –º—ã —Ä–∞—Å—Å–∫–∞–∂–µ–º, –≥–¥–µ –∂–µ –∏—Å–∫–∞—Ç—å –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é –æ —Ç–æ–º, —Ä–∞–∑—Ä–µ—à–µ–Ω–æ –ª–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–æ –≤ –ø–µ—Ä–∏–æ–¥ –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏, —Ä–∞—Å—Å–º–æ—Ç—Ä–µ—Ç—å –æ—Å–Ω–æ–≤–Ω—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞, –∫–æ—Ç–æ—Ä—ã–µ —á–∞—â–µ –≤—Å–µ–≥–æ –Ω–∞–∑–Ω–∞—á–∞—é—Ç –≤—Ä–∞—á–∏ –±–µ—Ä–µ–º–µ–Ω–Ω—ã–º –∂–µ–Ω—â–∏–Ω–∞–º, –∏ –∫–∞–∫–∏–µ –æ–Ω–∏ —á–∞—Å—Ç–æ –ø—Ä–∏–æ–±—Ä–µ—Ç–∞—é—Ç —Å–µ–±–µ —Å–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω–æ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PWjcH #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–µ–ø–∞—Ä–∞—Ç—ã/–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-10-02T05:27:06+00:00,@medpharm,12898,https://t.me/medpharm/12898,"–£ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –ø–µ—Ä–≤–∏—á–Ω–æ–π –Ω–∞–¥–ø–æ—á–µ—á–Ω–∏–∫–æ–≤–æ–π –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ—Å—Ç—å—é —Ä–∏—Å–∫ —Å–º–µ—Ä—Ç–∏ –æ–∫–∞–∑–∞–ª—Å—è –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ –≤—ã—à–µ, —á–µ–º –≤ –æ–±—â–µ–π –ø–æ–ø—É–ª—è—Ü–∏–∏. –ù–∞–∏–±–æ–ª—å—à–∏–π –≤–∫–ª–∞–¥ –≤–Ω–µ—Å–ª–∏ —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã–µ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è –∏ –Ω–∞–¥–ø–æ—á–µ—á–Ω–∏–∫–æ–≤—ã–π –∫—Ä–∏–∑ —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –≤—Ä–æ–∂–¥–µ–Ω–Ω–æ–π –≥–∏–ø–µ—Ä–ø–ª–∞–∑–∏–µ–π –Ω–∞–¥–ø–æ—á–µ—á–Ω–∏–∫–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PWhMg #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ö–∞—Ä–¥–∏–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–≠–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-10-01T16:33:38+00:00,@medpharm,12897,https://t.me/medpharm/12897,"ü¶æ –°–æ —Å—Ç—Ä–∞—Ö–æ–º –∏ —É–ø—Ä–µ–∫–æ–º. –ü—Ä–µ–∑–∏–¥–µ–Ω—Ç –í—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —Å–æ—é–∑–∞ —Å—Ç—Ä–∞—Ö–æ–≤—â–∏–∫–æ–≤ –ï–≤–≥–µ–Ω–∏–π –£—Ñ–∏–º—Ü–µ–≤ –ø—Ä–∏–∑–≤–∞–ª –Ω–µ –æ—Ç–∫–∞–∑—ã–≤–∞—Ç—å—Å—è –æ—Ç —Å—Ç—Ä–∞—Ö–æ–≤—ã—Ö –∫–æ–º–ø–∞–Ω–∏–π –≤ —Å–∏—Å—Ç–µ–º–µ –û–ú–° ‚Äî –ª–∏–∫–≤–∏–¥–∞—Ü–∏—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Å—Ç—Ä–∞—Ö–æ–≤—â–∏–∫–æ–≤ –≤ —Ä—è–¥–µ —Ä–µ–≥–∏–æ–Ω–æ–≤ –º–æ–∂–µ—Ç –Ω–∏–≤–µ–ª–∏—Ä–æ–≤–∞—Ç—å –≤—Å–µ –¥–æ—Å—Ç–∏–∂–µ–Ω–∏—è –ø–æ –∑–∞—â–∏—Ç–µ –ø—Ä–∞–≤ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. ü¶æ –ù–µ –∂–∏–ª–∏ –±–æ–≥–∞—Ç–æ. –ê–∫–∞–¥–µ–º–∏–∫ –õ–µ–æ –ë–æ–∫–µ—Ä–∏—è —Å—á–∏—Ç–∞–µ—Ç, —á—Ç–æ —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ –≤—Ä–∞—á–∏ –Ω–µ —Å–º–æ–≥—É—Ç –ø–æ–ª—É—á–∞—Ç—å –∑–∞—Ä–ø–ª–∞—Ç—ã, —Å–æ–ø–æ—Å—Ç–∞–≤–∏–º—ã–µ —Å –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–º–∏, –Ω–æ –Ω–∞–¥–µ–µ—Ç—Å—è –Ω–∞ –¥–æ—Å—Ç–∏–∂–µ–Ω–∏–µ –µ–≤—Ä–æ–ø–µ–π—Å–∫–æ–≥–æ —É—Ä–æ–≤–Ω—è. –ì–ª–∞–≤–Ω–æ–π –ø—Ä–æ–±–ª–µ–º–æ–π –º–µ–¥–∏–∫–æ–≤ –æ—Å—Ç–∞–µ—Ç—Å—è –Ω–µ—Ö–≤–∞—Ç–∫–∞ –¥–µ–Ω–µ–≥ –∏ –≤—ã–Ω—É–∂–¥–µ–Ω–Ω–∞—è —Ä–∞–±–æ—Ç–∞ –Ω–∞ –Ω–µ—Å–∫–æ–ª—å–∫–æ —Å—Ç–∞–≤–æ–∫, –æ—Ç–º–µ—Ç–∏–ª –æ–Ω. ‚ù§Ô∏è –°—É—Å—Ç–∞–≤–Ω–æ–π –∫–∞–ø–∏—Ç–∞–ª. –î–æ—á–µ—Ä–Ω—è—è –∫–æ–º–ø–∞–Ω–∏—è —Ñ–∞—Ä–º—Ö–æ–ª–¥–∏–Ω–≥–∞ ¬´–ë–°–°¬ª –∑–∞–≤–µ—Ä—à–∏–ª–∞ —Å–¥–µ–ª–∫—É –ø–æ –ø–æ–∫—É–ø–∫–µ –¥–≤—É—Ö –¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–æ–≤ –º–µ–¥–∏–∑–¥–µ–ª–∏–π ‚Äî ¬´–ú–µ–¥–∏–º–ø—É–ª—å—Å¬ª –∏ ¬´–°–∏–º–ø–ª–∞–Ω—Ç¬ª. –ê–∫—Ç–∏–≤—ã –±—É–¥—É—Ç –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å –¥–ª—è –∫–æ–º–º–µ—Ä—Ü–∏–∞–ª–∏–∑–∞—Ü–∏–∏ –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –∑–∞–≤–æ–¥–∞ ¬´–≠–Ω–¥–æ–∞—Ä—Ç¬ª, –∫–æ—Ç–æ—Ä—ã–π –∑–∞–Ω–∏–º–∞–µ—Ç—Å—è —Å–µ—Ä–∏–π–Ω—ã–º –≤—ã–ø—É—Å–∫–æ–º —ç–Ω–¥–æ–ø—Ä–æ—Ç–µ–∑–æ–≤. ‚ù§Ô∏è –û—á–µ–Ω—å –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω–æ. –§–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—è–º –∫–æ–º–ø–µ–Ω—Å–∏—Ä—É—é—Ç –¥–æ 250 –º–ª–Ω —Ä—É–±. –∑–∞—Ç—Ä–∞—Ç –Ω–∞ —Å–æ–∑–¥–∞–Ω–∏–µ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ —Ä–∞—Å—à–∏—Ä–µ–Ω–∏–µ –∏—Ö –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è, —Å —Ç–∞–∫–æ–π –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–æ–π –≤—ã—Å—Ç—É–ø–∏–ª –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety, guideline"",
  ""impact"": ""medium"",
  ""english"": ""The President of the Russian Federation's Union of Insurers, Evgeny Ufimtsev, urged not to abandon insurance companies in the OMS system. The elimination of medical insurance companies in some regions could nullify all achievements in protecting patients' rights. Academician Leo Bokeria believes that Russian doctors cannot earn salaries comparable to American ones but hopes for an achievement of the European level. The main problem facing doctors is a lack of money and forced work on multiple jobs, he noted.""
}"
2025-10-01T15:49:03+00:00,@medpharm,12896,https://t.me/medpharm/12896,Pfizer –ø—Ä–∏–Ω—è–ª–∞ —É—Å–ª–æ–≤–∏—è –∞–¥–º–∏–Ω–∏—Å—Ç—Ä–∞—Ü–∏–∏ –¢—Ä–∞–º–ø–∞ –æ–± —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–∏ —Å—Ç–æ–∏–º–æ—Å—Ç–∏ —Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –°–®–ê –Ω–∞ —É—Ä–æ–≤–Ω–µ –¥—Ä—É–≥–∏—Ö —Ä–∞–∑–≤–∏—Ç—ã—Ö —Å—Ç—Ä–∞–Ω. –§–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—è —Ç–∞–∫–∂–µ –Ω–∞—á–Ω–µ—Ç –ø—Ä–æ–¥–∞–≤–∞—Ç—å —Å–≤–æ–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ —Å–æ —Å–∫–∏–¥–∫–∞–º–∏ –¥–æ 85% —á–µ—Ä–µ–∑ –Ω–æ–≤—ã–π –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–µ–Ω–Ω—ã–π –ø–æ—Ä—Ç–∞–ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PWPYD #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-10-01T15:13:03+00:00,@medpharm,12895,https://t.me/medpharm/12895,"–†–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω–∏–µ –ø–ª–∞—Ç–Ω–æ–≥–æ –ø—Ä–∏–µ–º–∞ –≤ –≤—É–∑–∞—Ö –Ω–µ –∫–æ—Å–Ω–µ—Ç—Å—è –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏–π –≤ –æ–±–ª–∞—Å—Ç–∏ –º–µ–¥–∏—Ü–∏–Ω—ã –∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è, –∑–∞—è–≤–∏–ª–∏ –≤ –ú–∏–Ω–æ–±—Ä–Ω–∞—É–∫–∏. –†–∞–Ω–µ–µ —Ä–µ–∫—Ç–æ—Ä–∞–º –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –≤—É–∑–æ–≤ –ø–æ—Ä—É—á–∏–ª–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞—Ç—å –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è –ø–æ –∫–æ–º–º–µ—Ä—á–µ—Å–∫–æ–º—É –ø—Ä–∏–µ–º—É, –∫–æ—Ç–æ—Ä—ã–µ –∑–∞—â–∏—â–∞–ª–∏ –±—ã –∏–Ω—Ç–µ—Ä–µ—Å—ã –æ—Ç—Ä–∞—Å–ª–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PWMm4 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–∞—Ä—å–µ—Ä–∞","{
  ""skip"": true
}"
2025-10-01T14:45:03+00:00,@medpharm,12894,https://t.me/medpharm/12894,"–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–æ –≤–≤–µ—Å—Ç–∏ –≥–æ—Å–ø–æ—à–ª–∏–Ω—É –∑–∞ –≤–Ω–µ—Å–µ–Ω–∏–µ –¥–∞–Ω–Ω—ã—Ö –≤ —Å–∏—Å—Ç–µ–º—É –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥–∞ –æ–±–æ—Ä–æ—Ç–∞ –º–∞—Ä–∫–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö —Ç–æ–≤–∞—Ä–æ–≤, –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –≤–Ω–µ—Å–µ–Ω –≤ –ì–æ—Å–¥—É–º—É. –†–∞–∑–º–µ—Ä —Å–±–æ—Ä–∞ –±—É–¥–µ—Ç —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω –æ—Ç–¥–µ–ª—å–Ω—ã–º –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ–º –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PWLEG #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""import_export, sanctions"",
  ""impact"": ""high"",
  ""english"": ""The government proposed to introduce a state fee for entering data into the system monitoring of tracked goods. The project has been submitted to the State Duma. The amount of the fee will be determined by a separate government order. More details: https://clck.ru/3PWLEG #FarmaNews #Regulation""
}"
2025-10-01T14:41:08+00:00,@medpharm,12893,https://t.me/medpharm/12893,"–£—Ç–≤–µ—Ä–∂–¥–µ–Ω –Ω–æ–≤—ã–π —É—Ç–æ—á–Ω—è—é—â–∏–π –∫–æ—ç—Ñ—Ñ–∏—Ü–∏–µ–Ω—Ç –¥–ª—è —Ä–∞—Å—á–µ—Ç–∞ –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω—ã—Ö –∑–∞—Ç—Ä–∞—Ç –ø–æ–¥–≤–µ–¥–æ–º—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ú–∏–Ω–∑–¥—Ä–∞–≤—É –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏–π –ø—Ä–∏ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏–∏ –±—é–¥–∂–µ—Ç–∞. –≠—Ç–æ –ø–æ–∑–≤–æ–ª–∏—Ç —É—á–∏—Ç—ã–≤–∞—Ç—å –∏–Ω—Ñ–ª—è—Ü–∏—é, –∏–Ω–¥–µ–∫—Å–∞—Ü–∏—é –∑–∞—Ä–ø–ª–∞—Ç –∏ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ —É—Ä–æ–≤–Ω—é –æ–ø–ª–∞—Ç—ã —Ç—Ä—É–¥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PWKzc #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""A new coefficient for the calculation of normative costs has been approved for subordinate health institutions under the Ministry of Health, which will be used to account for inflation, salary increases, and payment level requirements.""
}"
2025-10-01T14:09:08+00:00,@medpharm,12892,https://t.me/medpharm/12892,"–†–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω–∏–µ –ø–ª–∞—Ç–Ω–æ–≥–æ –ø—Ä–∏–µ–º–∞ –≤ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞—Ö –†–æ—Å—Å–∏–∏ –Ω–µ –∫–æ—Å–Ω–µ—Ç—Å—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –≤—É–∑–æ–≤, —Ç–∞–∫ –∫–∞–∫ —ç—Ç–æ —Å–æ—Ü–∏–∞–ª—å–Ω–æ –∑–Ω–∞—á–∏–º—ã–µ –∏ –¥–µ—Ñ–∏—Ü–∏—Ç–Ω—ã–µ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è, –∑–∞—è–≤–∏–ª–∏ –≤ –ú–∏–Ω–æ–±—Ä–Ω–∞—É–∫–∏. –†–∞–Ω–µ–µ —Å–æ–æ–±—â–µ—Å—Ç–≤—É —Ä–µ–∫—Ç–æ—Ä–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –≤—É–∑–æ–≤ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ —Å—Ñ–æ—Ä–º–∏—Ä–æ–≤–∞—Ç—å —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤—É –ø–æ —Ä–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω–∏—é –∫–æ–º–º–µ—Ä—á–µ—Å–∫–æ–≥–æ –ø—Ä–∏–µ–º–∞ —Å —É—á–µ—Ç–æ–º –∏–Ω—Ç–µ—Ä–µ—Å–æ–≤ –æ—Ç—Ä–∞—Å–ª–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PWHz9 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–û–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Education stated that the regulation of paid enrollment in universities will not affect medical and pharmaceutical universities, as these are socially significant and scarce areas. Previously, university rector communities were offered to form recommendations for the government on commercial enrollment regulation taking into account industry interests. For more details: https://clck.ru/3PWHz9 #MedVestnik #Education #HealthOrganization""
}"
2025-10-01T13:37:05+00:00,@medpharm,12891,https://t.me/medpharm/12891,"–í —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ –¶–µ–Ω—Ç—Ä–∞ –ø—Ä–µ–¥–∏–∫—Ç–∏–≤–Ω–æ–π –≥–µ–Ω–µ—Ç–∏–∫–∏, —Ñ–∞—Ä–º–∞–∫–æ–≥–µ–Ω–µ—Ç–∏–∫–∏ –∏ –ø–µ—Ä—Å–æ–Ω–∞–ª–∏–∑–∞—Ü–∏–∏ —Ç–µ—Ä–∞–ø–∏–∏ –†–ù–¶–• –∏–º. –ü–µ—Ç—Ä–æ–≤—Å–∫–æ–≥–æ –Ω–∞—Ö–æ–¥–∏—Ç—Å—è 20 —Ñ–∞—Ä–º–∞–∫–æ–≥–µ–Ω–µ—Ç–∏—á–µ—Å–∫–∏—Ö —Ç–µ—Å—Ç-—Å–∏—Å—Ç–µ–º. –ü–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è, —á—Ç–æ –∏—Ö –≤–Ω–µ–¥—Ä–µ–Ω–∏–µ–º –≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫—É—é –ø—Ä–∞–∫—Ç–∏–∫—É –±—É–¥—É—Ç –∑–∞–Ω–∏–º–∞—Ç—å—Å—è —á–ª–µ–Ω—ã –§–µ–¥–µ—Ä–∞—Ü–∏–∏ –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PWFrD #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞ #–ì–µ–Ω–µ—Ç–∏–∫–∞ #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-10-01T13:22:02+00:00,@medpharm,12890,https://t.me/medpharm/12890,"–ù–∞—É—á–Ω—ã–π —Ü–µ–Ω—Ç—Ä —ç–∫—Å–ø–µ—Ä—Ç–∏–∑—ã —Å—Ä–µ–¥—Å—Ç–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è (–ù–¶–≠–°–ú–ü) –¥–∞–ª —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø–æ –ø–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω–∏—é –∏ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—é –¥–æ–∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –ª–µ–∫–∞—Ä—Å—Ç–≤. –ú–µ—Ç–æ–¥–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –≤–∫–ª—é—á–∞—é—Ç 13 –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤, —Å—Ä–µ–¥–∏ –∫–æ—Ç–æ—Ä—ã—Ö –ø–∞–º—è—Ç–∫–∏, —Ä–µ–≥–ª–∞–º–µ–Ω—Ç—ã –∏ —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PWEe7 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-01T13:03:03+00:00,@medpharm,12889,https://t.me/medpharm/12889,"–°—Ç–∞—Ä—Ç–æ–≤–∞–ª 26 —Å–µ–∑–æ–Ω –≤—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –∫–æ–Ω–∫—É—Ä—Å–∞ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª–æ–≤ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –æ—Ç—Ä–∞—Å–ª–∏ ¬´–ü–ª–∞—Ç–∏–Ω–æ–≤–∞—è —É–Ω—Ü–∏—è¬ª. –ù–∞ –ø—Ä–µ—Å—Å-–∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏, –ø–æ—Å–≤—è—â–µ–Ω–Ω–æ–π –µ–≥–æ –Ω–∞—á–∞–ª—É, –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–∏ –æ—Ä–≥–∫–æ–º–∏—Ç–µ—Ç–∞ –∏ –ø–æ–±–µ–¥–∏—Ç–µ–ª–∏ –ø—Ä–æ—à–ª–æ–≥–æ —Å–µ–∑–æ–Ω–∞ –æ–±–æ–∑–Ω–∞—á–∏–ª–∏ –∫–ª—é—á–µ–≤—ã–µ –≤–µ–∫—Ç–æ—Ä—ã –∏ —Ç—Ä–µ–Ω–¥—ã –æ—Ç—Ä–∞—Å–ª–∏ –∏ —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏ –æ —Ç–æ–º, –∫–∞–∫–∏–µ –∏–∑–º–µ–Ω–µ–Ω–∏—è –∂–¥—É—Ç –æ–¥–Ω—É –∏–∑ —Å—Ç–∞—Ä–µ–π—à–∏—Ö –ø—Ä–µ–º–∏–π —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —Ñ–∞—Ä–º—Ä—ã–Ω–∫–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PWD64 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-10-01T12:15:07+00:00,@medpharm,12888,https://t.me/medpharm/12888,"–†—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—è –ö—É–∑–±–∞—Å—Å–∫–æ–≥–æ –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–≥–æ —Ü–µ–Ω—Ç—Ä–∞ –æ—Ö—Ä–∞–Ω—ã –∑–¥–æ—Ä–æ–≤—å—è —à–∞—Ö—Ç–µ—Ä–æ–≤ –æ–±–≤–∏–Ω–∏–ª–∏ –≤–æ –≤–∑—è—Ç–æ—á–Ω–∏—á–µ—Å—Ç–≤–µ ‚Äî –ø–æ –≤–µ—Ä—Å–∏–∏ —Å–ª–µ–¥—Å—Ç–≤–∏—è, –≤ –¥–µ–∫–∞–±—Ä–µ 2023 –≥–æ–¥–∞ –æ–Ω –ø–æ–ª—É—á–∏–ª 300 —Ç—ã—Å. —Ä—É–±. –æ—Ç –ø—Ä–µ–¥–ø—Ä–∏–Ω–∏–º–∞—Ç–µ–ª—è –∑–∞ —Å–æ–¥–µ–π—Å—Ç–≤–∏–µ –≤ –∑–∞–∫–ª—é—á–µ–Ω–∏–∏ –≥–æ—Å–∫–æ–Ω—Ç—Ä–∞–∫—Ç–∞ –Ω–∞ –ø–æ—Å—Ç–∞–≤–∫—É –º–µ–¥–∏–∑–¥–µ–ª–∏–π. –ú–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫—É –≥—Ä–æ–∑–∏—Ç –¥–æ 12 –ª–µ—Ç –ª–∏—à–µ–Ω–∏—è —Å–≤–æ–±–æ–¥—ã –∏ –∫—Ä—É–ø–Ω—ã–π —à—Ç—Ä–∞—Ñ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PW9Qb #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-10-01T11:28:05+00:00,@medpharm,12887,https://t.me/medpharm/12887,"–ï–≤—Ä–æ–ø–µ–π—Å–∫–∏–µ –∫–∞—Ä–¥–∏–æ–ª–æ–≥–∏ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∏ –æ–±–Ω–æ–≤–ª–µ–Ω–Ω—ã–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø–æ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–µ –∏ –ª–µ—á–µ–Ω–∏—é –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –∫–ª–∞–ø–∞–Ω–æ–≤ —Å–µ—Ä–¥—Ü–∞. –í –¥–æ–∫—É–º–µ–Ω—Ç–µ –∞–∫—Ü–µ–Ω—Ç —Å–¥–µ–ª–∞–Ω –Ω–∞ —Ç—Ä–∞–Ω—Å–∫–∞—Ç–µ—Ç–µ—Ä–Ω—ã—Ö –≤–º–µ—à–∞—Ç–µ–ª—å—Å—Ç–≤–∞—Ö, –º–∞–ª–æ–∏–Ω–≤–∞–∑–∏–≤–Ω–æ–π —Ö–∏—Ä—É—Ä–≥–∏–∏, –∏–Ω–¥–∏–≤–∏–¥—É–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω–æ–º –ø–æ–¥—Ö–æ–¥–µ –∏ —Ä–æ–ª–∏ –º—É–ª—å—Ç–∏–¥–∏—Å—Ü–∏–ø–ª–∏–Ω–∞—Ä–Ω–æ–π –∫–æ–º–∞–Ω–¥—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PW5uT #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ö–∞—Ä–¥–∏–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è #–•–∏—Ä—É—Ä–≥–∏—è","{""skip"": true}"
2025-10-01T10:46:02+00:00,@medpharm,12886,https://t.me/medpharm/12886,"–ö–æ–º–ø–∞–Ω–∏—è ¬´–≠–¥–∏—Ñ–∞—Ä–º¬ª –∑–∞–≤–µ—Ä—à–∏–ª–∞ —Å–¥–µ–ª–∫—É –ø–æ –ø–æ–∫—É–ø–∫–µ –¥–≤—É—Ö –¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π ‚Äî ¬´–ú–µ–¥–∏–º–ø—É–ª—å—Å¬ª –∏ ¬´–°–∏–º–ø–ª–∞–Ω—Ç¬ª ‚Äî –¥–ª—è –ø—Ä–æ–¥–≤–∏–∂–µ–Ω–∏—è —Ä–æ—Å—Å–∏–π—Å–∫–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –∑–∞–≤–æ–¥–∞ ¬´–≠–Ω–¥–æ–∞—Ä—Ç¬ª, –≤–∫–ª—é—á–∞—è —ç–Ω–¥–æ–ø—Ä–æ—Ç–µ–∑ –∫–æ–ª–µ–Ω–Ω–æ–≥–æ —Å—É—Å—Ç–∞–≤–∞. –≠–∫—Å–ø–µ—Ä—Ç—ã –æ—Ü–µ–Ω–∏–ª–∏ —Å–¥–µ–ª–∫—É –≤ –±–æ–ª–µ–µ —á–µ–º 1 –º–ª—Ä–¥ —Ä—É–±. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PW2kS #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{""skip"": true}"
2025-10-01T10:30:06+00:00,@medpharm,12885,https://t.me/medpharm/12885,–î–∏–∞–Ω–∞ –ê–±–¥—É–ª–≥–∞–Ω–∏–µ–≤–∞ –±—É–¥–µ—Ç –∏—Å–ø–æ–ª–Ω—è—Ç—å –æ–±—è–∑–∞–Ω–Ω–æ—Å—Ç–∏ —Ä–µ–∫—Ç–æ—Ä–∞ –ö–∞–∑–∞–Ω—Å–∫–æ–≥–æ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞. –û–Ω–∞ —Ç–∞–∫–∂–µ –∑–∞–≤–µ–¥—É–µ—Ç –∫–∞—Ñ–µ–¥—Ä–æ–π –≥–æ—Å–ø–∏—Ç–∞–ª—å–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –≤—É–∑–∞ –∏ –∑–∞–Ω–∏–º–∞–µ—Ç –¥–æ–ª–∂–Ω–æ—Å—Ç—å –≥–ª–∞–≤–Ω–æ–≥–æ –≤–Ω–µ—à—Ç–∞—Ç–Ω–æ–≥–æ —Ç–µ—Ä–∞–ø–µ–≤—Ç–∞ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –¢–∞—Ç–∞—Ä—Å—Ç–∞–Ω–∞. –ü—Ä–µ–∂–Ω–∏–π —Ä–µ–∫—Ç–æ—Ä –ø–µ—Ä–µ—à–µ–ª –Ω–∞ —Ä–∞–±–æ—Ç—É –≤ –ì–æ—Å—Å–æ–≤–µ—Ç —Ä–µ—Å–ø—É–±–ª–∏–∫–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PVzaA #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-10-01T09:32:03+00:00,@medpharm,12884,https://t.me/medpharm/12884,–ü—Ä–µ–∑–∏–¥–µ–Ω—Ç –í—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —Å–æ—é–∑–∞ —Å—Ç—Ä–∞—Ö–æ–≤—â–∏–∫–æ–≤ –ï–≤–≥–µ–Ω–∏–π –£—Ñ–∏–º—Ü–µ–≤ –ø—Ä–∏–∑–≤–∞–ª –Ω–µ –æ—Ç–∫–∞–∑—ã–≤–∞—Ç—å—Å—è –æ—Ç —Å—Ç—Ä–∞—Ö–æ–≤—ã—Ö –∫–æ–º–ø–∞–Ω–∏–π –≤ —Å–∏—Å—Ç–µ–º–µ –û–ú–° ‚Äî –ª–∏–∫–≤–∏–¥–∞—Ü–∏—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Å—Ç—Ä–∞—Ö–æ–≤—â–∏–∫–æ–≤ –≤ —Ä—è–¥–µ —Ä–µ–≥–∏–æ–Ω–æ–≤ –º–æ–∂–µ—Ç –Ω–∏–≤–µ–ª–∏—Ä–æ–≤–∞—Ç—å –≤—Å–µ –¥–æ—Å—Ç–∏–∂–µ–Ω–∏—è –ø–æ –∑–∞—â–∏—Ç–µ –ø—Ä–∞–≤ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PVvK6 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-10-01T09:03:03+00:00,@medpharm,12883,https://t.me/medpharm/12883,"–ö–æ–º–ø–∞–Ω–∏—è —Ö–æ–ª–¥–∏–Ω–≥–∞ ¬´–ë–°–°¬ª –ø—Ä–∏–æ–±—Ä–µ–ª–∞ ¬´–ú–µ–¥–∏–º–ø—É–ª—å—Å¬ª –∏ ¬´–°–∏–º–ø–ª–∞–Ω—Ç¬ª, —á—Ç–æ–±—ã –∫–æ–º–º–µ—Ä—Ü–∏–∞–ª–∏–∑–∏—Ä–æ–≤–∞—Ç—å —ç–Ω–¥–æ–ø—Ä–æ—Ç–µ–∑—ã –∑–∞–≤–æ–¥–∞ ¬´–≠–Ω–¥–æ–∞—Ä—Ç¬ª —á–µ—Ä–µ–∑ —Ä–∞–∑–≤–∏—Ç—É—é —Å–µ—Ä–≤–∏—Å–Ω—É—é –∏ –ª–æ–≥–∏—Å—Ç–∏—á–µ—Å–∫—É—é —Å–µ—Ç—å. –°–¥–µ–ª–∫—É –æ—Ü–µ–Ω–∏–ª–∏ –±–æ–ª–µ–µ —á–µ–º –≤ 1 –º–ª—Ä–¥ —Ä—É–±. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PVt8N #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ù–∞—É–∫–∞ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-10-01T08:21:02+00:00,@medpharm,12882,https://t.me/medpharm/12882,"–§–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—è–º –∫–æ–º–ø–µ–Ω—Å–∏—Ä—É—é—Ç –¥–æ 250 –º–ª–Ω —Ä—É–±. –∑–∞—Ç—Ä–∞—Ç –Ω–∞ —Å–æ–∑–¥–∞–Ω–∏–µ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ —Ä–∞—Å—à–∏—Ä–µ–Ω–∏–µ –∏—Ö –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è, —Å —Ç–∞–∫–æ–π –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–æ–π –≤—ã—Å—Ç—É–ø–∏–ª –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥. –§–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏–µ –≤ —Ä–∞–º–∫–∞—Ö –º–µ—Ö–∞–Ω–∏–∑–º–∞ –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è –æ—Å—É—â–µ—Å—Ç–≤–ª—è—Ç—å —Å 2027 –≥–æ–¥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PVpcH #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Industry and Trade has proposed compensating up to 250 million rubles for the creation of original drugs and expanding their use. The funding is to be provided starting from 2027 through a mechanism. For more details, see the link.""
}"
2025-10-01T08:20:06+00:00,@medpharm,12881,https://t.me/medpharm/12881,"–ß–µ—Ä–µ–∑ –¥–≤–∞ –≥–æ–¥–∞ –≤ –í–µ–ª–∏–∫–æ–±—Ä–∏—Ç–∞–Ω–∏–∏ –ø–æ—è–≤–∏—Ç—Å—è ¬´–æ–Ω–ª–∞–π–Ω-–±–æ–ª—å–Ω–∏—Ü–∞¬ª NHS Online, –∫–æ—Ç–æ—Ä–∞—è –ø–æ–∑–≤–æ–ª–∏—Ç –ø–∞—Ü–∏–µ–Ω—Ç–∞–º –ø–æ–ª—É—á–∞—Ç—å –∫–æ–Ω—Å—É–ª—å—Ç–∞—Ü–∏–∏ –∏ –Ω–∞–ø—Ä–∞–≤–ª—è—Ç—å—Å—è –Ω–∞ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫—É —á–µ—Ä–µ–∑ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏–µ, –Ω–µ –ø–æ—Å–µ—â–∞—è —Å—Ç–∞—Ü–∏–æ–Ω–∞—Ä. –°–µ—Ä–≤–∏—Å –æ–±–ª–µ–≥—á–∏—Ç –¥–æ—Å—Ç—É–ø –∫ –ø–æ–º–æ—â–∏ –∏ –ø–æ–º–æ–∂–µ—Ç —Å–æ–∫—Ä–∞—Ç–∏—Ç—å –æ—á–µ—Ä–µ–¥–∏ –Ω–∞ –ø—Ä–∏–µ–º, –æ–¥–Ω–∞–∫–æ —ç–∫—Å–ø–µ—Ä—Ç—ã –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–∞—é—Ç –æ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ —Ä–µ—à–∏—Ç—å –≤–æ–ø—Ä–æ—Å—ã —Ü–∏—Ñ—Ä–æ–≤–æ–≥–æ –Ω–µ—Ä–∞–≤–µ–Ω—Å—Ç–≤–∞ –∏ –∫–∞–¥—Ä–æ–≤–æ–≥–æ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PVpXg #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-10-01T07:19:08+00:00,@medpharm,12880,https://t.me/medpharm/12880,–ü—Ä–∏–º–µ–Ω–µ–Ω–∏–µ —Ä–∏–±–æ—Ü–∏–∫–ª–∏–±–∞ –≤ —Å–æ—á–µ—Ç–∞–Ω–∏–∏ —Å –Ω–µ—Å—Ç–µ—Ä–æ–∏–¥–Ω—ã–º–∏ –∏–Ω–≥–∏–±–∏—Ç–æ—Ä–∞–º–∏ –∞—Ä–æ–º–∞—Ç–∞–∑—ã –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ —Å–Ω–∏–∑–∏–ª–æ —Ä–∏—Å–∫ –∏–Ω–≤–∞–∑–∏–≤–Ω–æ–≥–æ —Ä–µ—Ü–∏–¥–∏–≤–∞ —Ä–∞–Ω–Ω–µ–≥–æ —Ä–∞–∫–∞ –º–æ–ª–æ—á–Ω–æ–π –∂–µ–ª–µ–∑—ã. –¢–∞–∫–∂–µ –Ω–∞–±–ª—é–¥–∞–ª–∏ –∞–±—Å–æ–ª—é—Ç–Ω–æ–µ —É–ª—É—á—à–µ–Ω–∏–µ –ø–æ–∫–∞–∑–∞—Ç–µ–ª–µ–π –≤—ã–∂–∏–≤–∞–µ–º–æ—Å—Ç–∏ –±–µ–∑ –ø—Ä–∏–∑–Ω–∞–∫–æ–≤ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PVjhS #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–û–Ω–∫–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è,"{""skip"": true}"
2025-09-30T17:37:01+00:00,@medpharm,12878,https://t.me/medpharm/12878,"ü¶æ –°—É–¥ –Ω–µ –∏–¥–µ—Ç. –ü–æ—Ä—Ç–∞–ª—É ¬´–ü—Ä–æ–î–æ–∫—Ç–æ—Ä–æ–≤¬ª (–û–û–û ¬´–ú–µ–¥—Ä–æ–∫–µ—Ç¬ª) 30 —Å–µ–Ω—Ç—è–±—Ä—è –æ—Ç–∫–∞–∑–∞–ª–∏ –≤ —É–¥–æ–≤–ª–µ—Ç–≤–æ—Ä–µ–Ω–∏–∏ –∏—Å–∫–∞ –∫ –ú–∏–Ω–∑–¥—Ä–∞–≤—É. –ö–æ–º–ø–∞–Ω–∏—è –ø–æ–¥–∞–ª–∞ –≤ —Å—É–¥ –∏–∑-–∑–∞ —Ç–æ–≥–æ, —á—Ç–æ –≤–µ–¥–æ–º—Å—Ç–≤–æ –Ω–µ –æ—Ç–≤–µ—Ç–∏–ª–æ –≤ —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–Ω—ã–π –∑–∞–∫–æ–Ω–æ–º —Å—Ä–æ–∫ –Ω–∞ –∑–∞—è–≤–∫—É –æ –ø–æ–¥–∫–ª—é—á–µ–Ω–∏–∏ –∫ –ï–ì–ò–°–ó. ü¶æ –°–Ω–æ–≤–∞ –≤ –¥–µ–ª–µ. –ì–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–º ¬´–ú–æ—Å–∫–æ–≤—Å–∫–æ–π –∞–∫—Ü–∏–æ–Ω–µ—Ä–Ω–æ–π —Å—Ç—Ä–∞—Ö–æ–≤–æ–π –∫–æ–º–ø–∞–Ω–∏–∏¬ª (–ê–û ¬´–ú–ê–ö–°¬ª) –Ω–∞–∑–Ω–∞—á–µ–Ω —ç–∫—Å-–º–∏–Ω–∏—Å—Ç—Ä –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –†–æ—Å—Å–∏–∏ –ú–∏—Ö–∞–∏–ª –ó—É—Ä–∞–±–æ–≤. –ü–æ –¥–∞–Ω–Ω—ã–º –°–ú–ò, —á–ª–µ–Ω–∞–º –µ–≥–æ —Å–µ–º—å–∏ –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∏—Ç –ø–æ—á—Ç–∏ –ø–æ–ª–æ–≤–∏–Ω–∞ –∞–∫—Ü–∏–π —Å—Ç—Ä–∞—Ö–æ–≤—â–∏–∫–∞. ‚ù§Ô∏è –î–µ–Ω—å–≥–∏ –ø–æ–π–¥—É—Ç –≤ ¬´–†–∞–∑–≤–∏—Ç–∏–µ¬ª. –†–∞—Å—Ö–æ–¥—ã —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –±—é–¥–∂–µ—Ç–∞ –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –¥–æ—Å—Ç–∏–≥–Ω—É—Ç 580,3 –º–ª—Ä–¥ —Ä—É–±. –≤ 2026 –≥–æ–¥—É. ¬´–§–í¬ª –ø—Ä–æ–∞–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–ª, –∫–∞–∫ —Ä–∞—Å–ø—Ä–µ–¥–µ–ª—è—Ç –¥–µ–Ω—å–≥–∏ –Ω–∞ —Ä–∞–∑–ª–∏—á–Ω—ã–µ —Å—Ç–∞—Ç—å–∏ –ø—Ä–æ–≥—Ä–∞–º–º—ã ¬´–†–∞–∑–≤–∏—Ç–∏–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è¬ª –≤ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–º –±—é–¥–∂–µ—Ç–µ. ‚ù§Ô∏è –ü–µ—Ä–µ—Ö–æ–¥ —Ö–æ–¥–∞. –†–æ—Å—Å–∏–π—Å–∫–æ–µ –ø–æ–¥—Ä–∞–∑–¥–µ–ª–µ–Ω–∏–µ Takeda —Å–æ–æ–±—â–∏–ª–æ, —á—Ç–æ –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–µ–Ω–Ω–∞—è –∫–æ–º–∏—Å—Å–∏–∏ –ø–æ –∫–æ–Ω—Ç—Ä–æ–ª—é –∑–∞ –æ—Å—É—â–µ—Å—Ç–≤–ª–µ–Ω–∏–µ–º –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã—Ö –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–π –≤ –†–§ –æ–¥–æ–±—Ä–∏–ª–∞ –ø–µ—Ä–µ–¥–∞—á—É —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –∞–∫—Ç–∏–≤–æ–≤ –∫–æ–º–ø–∞–Ω–∏–∏ –ª–æ–∫–∞–ª—å–Ω–æ–º—É –∏–≥—Ä–æ–∫—É. –†–µ—á—å –∏–¥–µ—Ç –æ –ø–æ—Ä—Ç—Ñ–µ–ª–µ –æ—Ç–¥–µ–ª—å–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω–æ–π –ø–ª–æ—â–∞–¥–∫–µ –≤ –Ø—Ä–æ—Å–ª–∞–≤–ª–µ.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The case of the portal 'ProDoctor' (OOO 'MedKet') against the Ministry of Health was dismissed by a court on September 30. The company filed for compensation due to the Ministry's failure to respond within the required timeframe on a request to join the EGISZ system. The case is still ongoing. Mikhail Zubov, a former Minister of Health of Russia, has been appointed CEO of Moscow Stock Insurance Company (AO 'MAKS'). It is reported that his family owns almost half of the company's shares. Federal budget spending on medicines will reach 580.3 billion rubles in 2026. 'FV' analyzed how the funds will be distributed among various articles of the 'Development of Healthcare' budget program. Takeda's Russian subsidiary has received approval from the Government Commission for Control over Implementation of Foreign Investments in Russia to transfer its Russian assets to a local player. This pertains to a portfolio of certain products and production facilities in Yaroslavl.""
}"
2025-09-30T15:51:02+00:00,@medpharm,12877,https://t.me/medpharm/12877,"–†–æ—Å—Å–∏–π—Å–∫–∏–µ –∞–∫—Ç–∏–≤—ã Takeda –ø–µ—Ä–µ–π–¥—É—Ç –ª–æ–∫–∞–ª—å–Ω–æ–º—É —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—é. –í –∫–æ–º–ø–∞–Ω–∏–∏ —Å–æ–æ–±—â–∏–ª–∏, –∫—Ç–æ –ø–æ–ª—É—á–∏—Ç –ø–æ—Ä—Ç—Ñ–µ–ª—å –æ—Ç–¥–µ–ª—å–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω—É—é –ø–ª–æ—â–∞–¥–∫—É –≤ –Ø—Ä–æ—Å–ª–∞–≤–ª–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PVJzZ #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-09-30T15:39:03+00:00,@medpharm,12876,https://t.me/medpharm/12876,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –°–®–ê –ø–ª–∞–Ω–∏—Ä—É–µ—Ç –≤—Ä–µ–º–µ–Ω–Ω–æ —É–≤–æ–ª–∏—Ç—å 41% —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤, —á—Ç–æ –ø—Ä–∏–≤–µ–¥–µ—Ç –∫ –º–∞—Å—à—Ç–∞–±–Ω–æ–º—É —Å–æ–∫—Ä–∞—â–µ–Ω–∏—é –∫–ª—é—á–µ–≤—ã—Ö —Ñ—É–Ω–∫—Ü–∏–π –≤–µ–¥–æ–º—Å—Ç–≤–∞. –†–µ—à–µ–Ω–∏–µ —Å–≤—è–∑–∞–Ω–æ —Å —É–≥—Ä–æ–∑–æ–π —à–∞—Ç–¥–∞—É–Ω–∞ –∏–∑-–∑–∞ —Å–ø–æ—Ä–æ–≤ –æ –±—é–¥–∂–µ—Ç–µ –º–µ–∂–¥—É –¥–µ–º–æ–∫—Ä–∞—Ç–∞–º–∏ –∏ —Ä–µ—Å–ø—É–±–ª–∏–∫–∞–Ω—Ü–∞–º–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PVJQo #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-09-30T15:28:02+00:00,@medpharm,12875,https://t.me/medpharm/12875,"–†–æ—Å—Å–µ–ª—å—Ö–æ–∑–Ω–∞–¥–∑–æ—Ä —É—Ç–≤–µ—Ä–¥–∏–ª –Ω–æ–≤—ã–µ –ø—Ä–æ–≤–µ—Ä–æ—á–Ω—ã–µ —á–µ–∫-–ª–∏—Å—Ç—ã –¥–ª—è –∫–æ–Ω—Ç—Ä–æ–ª—è –Ω–∞ –≤—Å–µ—Ö —ç—Ç–∞–ø–∞—Ö –æ–±–æ—Ä–æ—Ç–∞ –≤–µ—Ç–µ—Ä–∏–Ω–∞—Ä–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ ‚Äî –æ—Ç –¥–æ–∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –¥–æ —Ö—Ä–∞–Ω–µ–Ω–∏—è, –ø—Ä–æ–¥–∞–∂–∏ –∏ —É–Ω–∏—á—Ç–æ–∂–µ–Ω–∏—è. –î–µ—Å—è—Ç—å —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–Ω—ã—Ö —Ñ–æ—Ä–º –∑–∞–º–µ–Ω—è—Ç —Ä–µ–¥–∞–∫—Ü–∏—é –ø—Ä–∞–≤–∏–ª –∫–æ–Ω—Ç—Ä–æ–ª—è –æ—Ç 2022 –≥–æ–¥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PVHof #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing, import_export"",
  ""impact"": ""high"",
  ""english"": ""The Russian Federal Service for Veterinary and Phytosanitary Supervision has approved new checklists for veterinary drug control at all stages of the supply chain, from preclinical research and production to storage, sales, and destruction. The ten approved forms replace the 2022 edition of control rules.""
}"
2025-09-30T15:01:07+00:00,@medpharm,12874,https://t.me/medpharm/12874,"–í –∫–∞–∫–∏–µ —Å—Ä–æ–∫–∏ –ø–æ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤—É –∞–ø—Ç–µ–∫–∞, –±–æ–ª—å–Ω–∏—Ü–∞, –ª–µ—á–µ–±–Ω–æ-–ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–æ–µ —É—á—Ä–µ–∂–¥–µ–Ω–∏–µ –æ–±—è–∑–∞–Ω—ã —Ä–µ–∞–≥–∏—Ä–æ–≤–∞—Ç—å –Ω–∞ –æ—Ç–∑—ã–≤ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤? –ù–∞ —ç—Ç–æ—Ç –≤–æ–ø—Ä–æ—Å –æ—Ç–≤–µ—á–∞–µ—Ç –ø–∞—Ä—Ç–Ω–µ—Ä –∞–¥–≤–æ–∫–∞—Ç—Å–∫–æ–≥–æ –±—é—Ä–æ ¬´–û–ª—å–≥–∞ –†–µ–Ω–æ–≤–∞ –∏ –ø–∞—Ä—Ç–Ω–µ—Ä—ã¬ª –û–ª—å–≥–∞ –ö–∞—Ä–ø–æ–≤–∞. –í —Å—Ç–∞—Ç—å–µ —Ä–∞—Å—Å–º–∞—Ç—Ä–∏–≤–∞—é—Ç—Å—è –æ—Å–Ω–æ–≤–Ω—ã–µ –ø–æ–ª–æ–∂–µ–Ω–∏—è –≤–Ω—É—Ç—Ä–µ–Ω–Ω–µ–≥–æ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–∞, –Ω–æ—Ä–º—ã –ï–ê–≠–°, –∞ —Ç–∞–∫–∂–µ –∏–∑–º–µ–Ω–µ–Ω–∏—è, —Å–≤—è–∑–∞–Ω–Ω—ã–µ —Å –ø—Ä–∏–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ–º –æ–±—Ä–∞—â–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤, –∫–æ—Ç–æ—Ä—ã–µ –≤—Å—Ç—É–ø—è—Ç –≤ —Å–∏–ª—É –≤ —Å–ª–µ–¥—É—é—â–µ–º –≥–æ–¥—É. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PVGQr #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The article discusses the main provisions of internal legislation and norms of EAEU on the suspension of drug placement, which will come into force next year. The question of how pharmacies, hospitals, and healthcare institutions are required to respond to drug withdrawals under the law is answered by partner of legal firm 'Olga Renova & Partners' Olga Karapova.""
}"
2025-09-30T14:22:05+00:00,@medpharm,12873,https://t.me/medpharm/12873,"–î–º–∏—Ç—Ä–∏–π –ß–µ—Ä–¥–∞–Ω—Ü–µ–≤ –≤–æ–∑–≥–ª–∞–≤–∏—Ç –ö—Ä–∞—Å–ì–ú–£ –≤ –ø–µ—Ä–∏–æ–¥ —Å 1 –æ–∫—Ç—è–±—Ä—è 2025 –ø–æ 30 —Å–µ–Ω—Ç—è–±—Ä—è 2026 –≥–æ–¥–∞ –∏ —Å–æ—Ö—Ä–∞–Ω–∏—Ç –¥—Ä—É–≥–∏–µ —Ä—É–∫–æ–≤–æ–¥—è—â–∏–µ –¥–æ–ª–∂–Ω–æ—Å—Ç–∏ –≤ –≤—É–∑–µ –∏ –∫—Ä–∞–µ–≤–æ–π –±–æ–ª—å–Ω–∏—Ü–µ. –ê–ª–µ–∫—Å–µ–π –ü—Ä–æ—Ç–æ–ø–æ–ø–æ–≤, –≤–æ–∑–≥–ª–∞–≤–ª—è–≤—à–∏–π —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç —à–µ—Å—Ç—å –ª–µ—Ç, —É—à–µ–ª –≤ –æ—Ç—Å—Ç–∞–≤–∫—É –ø–æ —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ–º—É –∂–µ–ª–∞–Ω–∏—é. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PVDzb #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–û–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-09-30T13:33:03+00:00,@medpharm,12872,https://t.me/medpharm/12872,"Biogen –ø–æ–ª–Ω–æ—Å—Ç—å—é –ø—Ä–µ–∫—Ä–∞—Ç–∏–ª–∞ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫—É –≥–µ–Ω–Ω—ã—Ö —Ç–µ—Ä–∞–ø–∏–π –Ω–∞ –æ—Å–Ω–æ–≤–µ –∞–¥–µ–Ω–æ–∞—Å—Å–æ—Ü–∏–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –≤–∏—Ä—É—Å–æ–≤. –†–µ—à–µ–Ω–∏–µ –ø—Ä–∏–Ω—è—Ç–æ –Ω–∞ —Ñ–æ–Ω–µ –∑–∞—Ç—è–∂–Ω–æ–≥–æ —Ñ–∏–Ω–∞–Ω—Å–æ–≤–æ–≥–æ –∫—Ä–∏–∑–∏—Å–∞ –∫–æ–º–ø–∞–Ω–∏–∏ –∏ –Ω–µ—Å–∫–æ–ª—å–∫–∏—Ö —Å–ª—É—á–∞–µ–≤ —Å–º–µ—Ä—Ç–∏ —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, —Å–æ–∑–¥–∞–Ω–Ω—ã—Ö —Å –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ–º —ç—Ç–æ–π —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PVAiq #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety"",
  ""impact"": ""high"",
  ""english"": ""Biogen has completely halted the development of gene therapies based on adenovirus vectors due to a financial crisis and several deaths among participants in studies involving this technology. More: https://clck.ru/3PVAiq #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ""
}"
2025-09-30T13:32:04+00:00,@medpharm,12871,https://t.me/medpharm/12871,"–≠–∫—Å-–º–∏–Ω–∏—Å—Ç—Ä –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ú–∏—Ö–∞–∏–ª –ó—É—Ä–∞–±–æ–≤ –Ω–∞–∑–Ω–∞—á–µ–Ω –≥–µ–Ω–µ—Ä–∞–ª—å–Ω—ã–º –¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–º ¬´–ú–æ—Å–∫–æ–≤—Å–∫–æ–π –∞–∫—Ü–∏–æ–Ω–µ—Ä–Ω–æ–π —Å—Ç—Ä–∞—Ö–æ–≤–æ–π –∫–æ–º–ø–∞–Ω–∏–∏¬ª. –ü–æ –¥–∞–Ω–Ω—ã–º –°–ú–ò, –≤ 2021 –≥–æ–¥—É —á–ª–µ–Ω–∞–º –µ–≥–æ —Å–µ–º—å–∏ –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∞–ª–∏ 40,7% –∞–∫—Ü–∏–π —Å—Ç—Ä–∞—Ö–æ–≤—â–∏–∫–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PVAfC #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-09-30T12:46:06+00:00,@medpharm,12870,https://t.me/medpharm/12870,–í –†–æ—Å—Å–∏–∏ –∑–∞–ø–∞—Ç–µ–Ω—Ç–æ–≤–∞–ª–∏ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—é —Ä–∞–Ω–Ω–µ–π –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∏ –∫—Ä–∞–Ω–∏–æ—Å–∏–Ω–æ—Å—Ç–æ–∑–∞ —É –¥–µ—Ç–µ–π –Ω–∞ –æ—Å–Ω–æ–≤–µ –ö–¢ –∏ –º–∞—Ç–µ–º–∞—Ç–∏—á–µ—Å–∫–æ–≥–æ –∞–Ω–∞–ª–∏–∑–∞ —Å–Ω–∏–º–∫–æ–≤. –ù–æ–≤—ã–π —Å–ø–æ—Å–æ–± –ø–æ–∫–∞–∑–∞–ª –≤—ã—Å–æ–∫—É—é —Ç–æ—á–Ω–æ—Å—Ç—å –∏ –ø–æ–∑–≤–æ–ª–∏—Ç –≤—ã—è–≤–ª—è—Ç—å –ø–∞—Ç–æ–ª–æ–≥–∏—é —Ä–∞–Ω—å—à–µ —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω—ã—Ö –º–µ—Ç–æ–¥–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PV7Mm #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–î–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞,"{""skip"": true}"
2025-09-30T12:12:03+00:00,@medpharm,12869,https://t.me/medpharm/12869,"–î–µ–ø—É—Ç–∞—Ç—ã –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –≤—ã–¥–∞–≤–∞—Ç—å –ø–∞—Ü–∏–µ–Ω—Ç–∞–º –¥–æ—Ä–æ–≥–æ—Å—Ç–æ—è—â–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –∏–∑–¥–µ–ª–∏—è –±–µ–∑ –≥–æ—Å–ø–∏—Ç–∞–ª–∏–∑–∞—Ü–∏–∏, –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –≤–Ω–µ—Å–µ–Ω –≤ –ì–æ—Å–¥—É–º—É. –î–æ–∫—É–º–µ–Ω—Ç —É—Å—Ç–∞–Ω–∞–≤–ª–∏–≤–∞–µ—Ç –ø—Ä–∞–≤–æ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –æ–ø—Ä–µ–¥–µ–ª—è—Ç—å –ø–µ—Ä–µ—á–µ–Ω—å —Ç–∞–∫–∏—Ö —Å–ª—É—á–∞–µ–≤, —á—Ç–æ –ø–æ–∑–≤–æ–ª–∏—Ç —ç–∫–æ–Ω–æ–º–∏—Ç—å –±—é–¥–∂–µ—Ç–Ω—ã–µ —Å—Ä–µ–¥—Å—Ç–≤–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PV4k6 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, reimbursement"",
  ""impact"": ""high"",
  ""english"": ""Deputies proposed to provide expensive medications and medical products without hospitalization, a draft law has been submitted to the State Duma. The document allows the government to determine cases where this will save budget funds.""
}"
2025-09-30T11:42:07+00:00,@medpharm,12868,https://t.me/medpharm/12868,"–ü–∞—Ü–∏–µ–Ω—Ç –∏–∑ –í–æ–ª–≥–æ–≥—Ä–∞–¥–∞ –æ—Ç—Å—É–¥–∏–ª —É —á–∞—Å—Ç–Ω–æ–π –∫–ª–∏–Ω–∏–∫–∏ —á–∞—Å—Ç—å —É–ø–ª–∞—á–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤, –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏—é –º–æ—Ä–∞–ª—å–Ω–æ–≥–æ –≤—Ä–µ–¥–∞ –∏ —à—Ç—Ä–∞—Ñ –∑–∞ –Ω–µ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–∏–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–º —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏—è–º –∏ –Ω–µ–æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω–æ –Ω–∞–∑–Ω–∞—á–µ–Ω–Ω—ã–µ –ø—Ä–æ—Ü–µ–¥—É—Ä—ã. –°—Ä–µ–¥–∏ –Ω–∏—Ö ‚Äî –ª–∞–∑–µ—Ä–Ω–æ–µ –æ–±–ª—É—á–µ–Ω–∏–µ –∫—Ä–æ–≤–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PV2LA #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""clinical_trial, safety"",
  ""impact"": ""medium"",
  ""english"": ""A patient from Volgograd has sued a private clinic for refund of paid amounts, compensation for moral harm, and a fine for treatments that do not comply with clinical recommendations. Among them is laser blood irradiation.""
}"
2025-09-30T11:09:06+00:00,@medpharm,12867,https://t.me/medpharm/12867,"–í –†–æ—Å—Å–∏–∏ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –≤–≤–µ—Å—Ç–∏ –≥–æ—Å—Å—É–±—Å–∏–¥–∏—Ä–æ–≤–∞–Ω–∏–µ –ø–æ–ª–∏—Å–æ–≤ –î–ú–° –¥–ª—è –º–Ω–æ–≥–æ–¥–µ—Ç–Ω—ã—Ö —Å–µ–º–µ–π, —á—Ç–æ–±—ã —Å–¥–µ–ª–∞—Ç—å –º–µ–¥—É—Å–ª—É–≥–∏ –¥–ª—è —ç—Ç–æ–π –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ –≥—Ä–∞–∂–¥–∞–Ω –±–æ–ª–µ–µ –¥–æ—Å—Ç—É–ø–Ω—ã–º–∏. –ò–Ω–∏—Ü–∏–∞—Ç–∏–≤–∞ –ø—Ä–µ–¥–ø–æ–ª–∞–≥–∞–µ—Ç –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏—é –¥–æ 30 —Ç—ã—Å. —Ä—É–±. –Ω–∞ —á–µ–ª–æ–≤–µ–∫–∞ –≤ –≥–æ–¥ –∏–ª–∏ –Ω–∞–ª–æ–≥–æ–≤—ã–π –≤—ã—á–µ—Ç –ø—Ä–∏ –ø–æ–∫—É–ø–∫–µ —Å—Ç—Ä–∞—Ö–æ–≤–∫–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PUxo3 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""reimbursement, shortage"",
  ""impact"": ""medium"",
  ""english"": ""An initiative to subsidize health insurance policies for multi-child families has been proposed in Russia. The compensation would be up to 30,000 rubles per person annually or a tax deduction for purchasing insurance. More details: https://clck.ru/3PUxo3 #MedVestnik #HealthcareOrganization""
}"
2025-09-30T10:37:02+00:00,@medpharm,12866,https://t.me/medpharm/12866,"–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ —É—Ç–≤–µ—Ä–¥–∏–ª–æ –∏–Ω—Ç–µ–≥—Ä–∞—Ü–∏—é —Å–∏—Å—Ç–µ–º—ã –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥–∞ –¥–≤–∏–∂–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤ (–ú–î–õ–ü) –∏ —Å–∏—Å—Ç–µ–º—ã –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏ —Ç–æ–≤–∞—Ä–æ–≤ (¬´–ß–µ—Å—Ç–Ω—ã–π –∑–Ω–∞–∫¬ª). –≠—Ç–æ —Å–æ–∑–¥–∞—Å—Ç –µ–¥–∏–Ω—ã–π –º–µ—Ö–∞–Ω–∏–∑–º –¥–ª—è –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏—è —Å—Ç—Ä–∞–Ω—ã –ø—Ä–æ–∏—Å—Ö–æ–∂–¥–µ–Ω–∏—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏–∏ –∏—Ö –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ –ï–ê–≠–°, –≤ —Ç–æ–º —á–∏—Å–ª–µ –ø–æ –ø–æ–ª–Ω–æ–º—É —Ü–∏–∫–ª—É. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PUvTP #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""sanctions, regulation"",
  ""impact"": ""medium"",
  ""english"": ""The government approved the integration of the Medication Tracking System (MDLP) and the Product Marking System ('The Honest Sign'). This will create a unified mechanism for confirming the origin of drugs and localizing their production within the EAEU, including throughout the entire cycle. More details: https://clck.ru/3PUvTP #PharmNews #Regulation""
}"
2025-09-30T09:13:04+00:00,@medpharm,12865,https://t.me/medpharm/12865,"–ï–≤—Ä–æ–∫–æ–º–∏—Å—Å–∏—è –æ–¥–æ–±—Ä–∏–ª–∞ –≤—Ç–æ—Ä–æ–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Ä–∞–Ω–Ω–∏—Ö —Å–∏–º–ø—Ç–æ–º–æ–≤ –±–æ–ª–µ–∑–Ω–∏ –ê–ª—å—Ü–≥–µ–π–º–µ—Ä–∞. –ü–µ—Ä–≤–æ–Ω–∞—á–∞–ª—å–Ω–æ –µ–≤—Ä–æ–ø–µ–π—Å–∫–∏–π —Ä–µ–≥—É–ª—è—Ç–æ—Ä –æ—Ç–∫–ª–æ–Ω–∏–ª –∑–∞—è–≤–∫—É –∫–æ–º–ø–∞–Ω–∏–∏ Eli Lilly –Ω–∞ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—é –µ–µ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ Kisunla –∏–∑-–∑–∞ —Å–µ—Ä—å–µ–∑–Ω—ã—Ö –ø–æ–±–æ—á–Ω—ã—Ö —ç—Ñ—Ñ–µ–∫—Ç–æ–≤, –Ω–æ –ø–µ—Ä–µ—Å–º–æ—Ç—Ä–µ–ª —Ä–µ—à–µ–Ω–∏–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PUoGp #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-09-30T08:46:01+00:00,@medpharm,12864,https://t.me/medpharm/12864,"21‚Äì23 –æ–∫—Ç—è–±—Ä—è –≤ –ú–æ—Å–∫–≤–µ –ø—Ä–æ–π–¥–µ—Ç IV –ï–≤—Ä–∞–∑–∏–π—Å–∫–∞—è –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏—è –ø–æ –≤–∞–ª–∏–¥–∞—Ü–∏–∏. –í –ø—Ä–æ–≥—Ä–∞–º–º–µ ‚Äî –∞–∫—Ç—É–∞–ª—å–Ω—ã–µ —Ç–µ–º—ã, –ø–æ—Å–≤—è—â–µ–Ω–Ω—ã–µ —Å–æ–≤—Ä–µ–º–µ–Ω–Ω—ã–º –ø–æ–¥—Ö–æ–¥–∞–º –∏ –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏–º –º–µ—Ç–æ–¥–∞–º –≤–∞–ª–∏–¥–∞—Ü–∏–∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤. –£ –≤–∞—Å –±—É–¥–µ—Ç —Ç—Ä–∏ –¥–Ω—è, —á—Ç–æ–±—ã —É–∑–Ω–∞—Ç—å –Ω–æ–≤—ã–µ —Ç—Ä–µ–Ω–¥—ã, –æ–±—Å—É–¥–∏—Ç—å —Ä–µ–∞–ª—å–Ω—ã–µ –ø—Ä–∞–∫—Ç–∏–∫–∏, –æ–±–º–µ–Ω—è—Ç—å—Å—è –æ–ø—ã—Ç–æ–º —Å –∫–æ–ª–ª–µ–≥–∞–º–∏ –∏ —Ä–∞—Å—à–∏—Ä–∏—Ç—å —Å–≤–æ–π –∫—Ä—É–≥ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—ã—Ö –∫–æ–Ω—Ç–∞–∫—Ç–æ–≤ –≤–æ –≤—Ä–µ–º—è –¥–∏—Å–∫—É—Å—Å–∏–π –∏ –Ω–µ—Ñ–æ—Ä–º–∞–ª—å–Ω–æ–≥–æ –æ–±—â–µ–Ω–∏—è. –ú—ã –∂–¥–µ–º –≤–∞—Å –Ω–∞ –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏, —á—Ç–æ–±—ã –≤–º–µ—Å—Ç–µ –æ–±—Å—É–∂–¥–∞—Ç—å, —É—á–∏—Ç—å—Å—è –∏ –≤–¥–æ—Ö–Ω–æ–≤–ª—è—Ç—å—Å—è –Ω–æ–≤—ã–º–∏ –∏–¥–µ—è–º–∏! –ü–æ–¥—Ä–æ–±–Ω–æ—Å—Ç–∏ –∏ –ø—Ä–æ–≥—Ä–∞–º–º–∞ ‚Äî –Ω–∞ —Å–∞–π—Ç–µ –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏. –ü—Ä–∏—Å–æ–µ–¥–∏–Ω—è–π—Ç–µ—Å—å –∫ –Ω–∞—à–µ–º—É –∫–∞–Ω–∞–ª—É –∫–≤–∞–ª–∏—Ñ–∏–∫–∞—Ü–∏—è –∏ –≤–∞–ª–∏–¥–∞—Ü–∏—è. –†–µ–∫–ª–∞–º–∞ –û–û–û ‚Äú–§–∞—Ä–º–∞—Å–µ–ª–ª‚Äù","{""skip"": true}"
2025-09-30T08:16:05+00:00,@medpharm,12863,https://t.me/medpharm/12863,"¬´–ú–í¬ª –ø—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ—Ç —Å–≤–µ–∂–∏–π –¥–∞–π–¥–∂–µ—Å—Ç –∏–Ω—Ç–µ—Ä–µ—Å–Ω—ã—Ö –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Å–ª—É—á–∞–µ–≤. –í –≤—ã–ø—É—Å–∫–µ ‚Äî –æ–ø–∏—Å–∞–Ω–Ω—ã–π —Ä–æ—Å—Å–∏–π—Å–∫–∏–º–∏ –≤—Ä–∞—á–∞–º–∏ —Å–ª—É—á–∞–π —É—Å–ø–µ—à–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ —Ä–∞–∫–∞ –ø–æ–¥–∂–µ–ª—É–¥–æ—á–Ω–æ–π –∂–µ–ª–µ–∑—ã —Å –º–µ—Ç–∞—Å—Ç–∞—Ç–∏—á–µ—Å–∫–∏–º –ø–æ—Ä–∞–∂–µ–Ω–∏–µ–º –±–æ–ª–µ–µ 80% –ø–µ—á–µ–Ω–∏, –Ω–µ–π—Ä–æ–ø–∞—Ç–∏—è –ø–æ—Å–ª–µ –ø—Ä–∏–µ–º–∞ —Å–µ–º–∞–≥–ª—É–¥–∏—Ç–∏–¥–∞ –∏ —Ç—è–∂–µ–ª—ã–π –≥–µ–º–æ–ª–∏–∑ —É –¥–µ–≤–æ—á–∫–∏ –ø–æ—Å–ª–µ –Ω–∞–Ω–µ—Å–µ–Ω–∏—è –≤—Ä–µ–º–µ–Ω–Ω–æ–π —Ç–∞—Ç—É–∏—Ä–æ–≤–∫–∏ —Ö–Ω–æ–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PUiW9 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ê–Ω–µ—Å—Ç–µ–∑–∏–æ–ª–æ–≥–∏—è_–∏_—Ä–µ–∞–Ω–∏–º–∞—Ç–æ–ª–æ–≥–∏—è #–ì–µ–º–∞—Ç–æ–ª–æ–≥–∏—è #–ù–µ–≤—Ä–æ–ª–æ–≥–∏—è #–û–Ω–∫–æ–ª–æ–≥–∏—è #–û—Ñ—Ç–∞–ª—å–º–æ–ª–æ–≥–∏—è #–•–∏—Ä—É—Ä–≥–∏—è","{""skip"": true}"
2025-09-30T08:09:02+00:00,@medpharm,12862,https://t.me/medpharm/12862,"–†–∞—Å—Ö–æ–¥—ã —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –±—é–¥–∂–µ—Ç–∞ –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –≤—ã—Ä–∞—Å—Ç—É—Ç –Ω–∞ 1,3% –∏ –¥–æ—Å—Ç–∏–≥–Ω—É—Ç 580,3 –º–ª—Ä–¥ —Ä—É–±. –≤ 2026 –≥–æ–¥—É. ¬´–§–í¬ª –ø—Ä–æ–∞–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–ª, –∫–∞–∫ —Ä–∞—Å–ø—Ä–µ–¥–µ–ª—è—Ç –¥–µ–Ω—å–≥–∏ –Ω–∞ —Ä–∞–∑–ª–∏—á–Ω—ã–µ —Å—Ç–∞—Ç—å–∏ –ø—Ä–æ–≥—Ä–∞–º–º—ã ¬´–†–∞–∑–≤–∏—Ç–∏–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è¬ª –≤ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–º –±—é–¥–∂–µ—Ç–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PUhrh #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""Healthcare development program budget for the federal budget will increase by 1.3% to reach 580.3 billion rubles in 2026. 'FV' analyzed how the funds will be distributed across various program articles in the federal budget.""
}"
2025-09-30T07:50:17+00:00,@medpharm,12861,https://t.me/medpharm/12861,"–£–∂–µ —Å–µ–≥–æ–¥–Ω—è –≤ 11:00 (–º—Å–∫) —Å–æ—Å—Ç–æ–∏—Ç—Å—è –ø—Ä–µ—Å—Å-–∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏—è ¬´–í—Å–µ –æ —Ñ–∞—Ä–º–µ: —Å—Ç–∞—Ä—Ç 26 —Å–µ–∑–æ–Ω–∞ ¬´–ü–ª–∞—Ç–∏–Ω–æ–≤–æ–π –£–Ω—Ü–∏–∏¬ª, –ø–æ—Å–≤—è—â–µ–Ω–Ω–∞—è —Å—Ç–∞—Ä—Ç—É –Ω–æ–≤–æ–≥–æ —Å–µ–∑–æ–Ω–∞ –í—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –æ—Ç–∫—Ä—ã—Ç–æ–≥–æ –∫–æ–Ω–∫—É—Ä—Å–∞ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª–æ–≤ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –æ—Ç—Ä–∞—Å–ª–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PTvhH #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,hospital_policy,regulation"",
  ""impact"": ""medium"",
  ""english"": ""A press conference titled 'Everything about Pharma: Starting Season 26 of the Platinum Ounces, dedicated to the start of the next season of the All-Russian Open Competition for Professionals in the Pharmaceutical Industry, is scheduled at 11:00 MSK. For more details: https://clck.ru/3PTvhH #PharmVestnik #Production""
}"
2025-09-30T07:16:06+00:00,@medpharm,12860,https://t.me/medpharm/12860,"–ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ –æ–±–Ω–æ–≤–∏—Ç –ø–µ—Ä–µ—á–µ–Ω—å —Ç–æ–≤–∞—Ä–æ–≤ –¥–ª—è –ø–∞—Ä–∞–ª–ª–µ–ª—å–Ω–æ–≥–æ –∏–º–ø–æ—Ä—Ç–∞. –î–æ–∫—É–º–µ–Ω—Ç –ø—Ä–µ–¥—É—Å–º–∞—Ç—Ä–∏–≤–∞–µ—Ç –∫–∞–∫ –∏—Å–∫–ª—é—á–µ–Ω–∏–µ –∏–∑ —Å–ø–∏—Å–∫–∞ –Ω–µ–∫–æ—Ç–æ—Ä—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, —Ç–∞–∫ –∏ –¥–æ–±–∞–≤–ª–µ–Ω–∏–µ –≤ –Ω–µ–≥–æ –Ω–æ–≤—ã—Ö –ø–æ–∑–∏—Ü–∏–π, –≤–∫–ª—é—á–∞—è –ø–æ–ø—É–ª—è—Ä–Ω—ã–µ —Å—Ä–µ–¥—Å—Ç–≤–∞ –≥–∏–≥–∏–µ–Ω—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PUddw #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""import_export"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Industry and Trade will update the list of goods for parallel imports. The document includes both exclusions from the list of some medical drugs and additions to it, including popular hygiene products. More details: https://clck.ru/3PUddw #FarmaNews #Regulation""
}"
2025-09-30T06:06:06+00:00,@medpharm,12859,https://t.me/medpharm/12859,"–û—Ç—Ä–∞—Å–ª–µ–≤—ã–µ —ç–∫—Å–ø–µ—Ä—Ç—ã –ø—Ä–µ–¥—É–ø—Ä–µ–¥–∏–ª–∏ –æ —Ä–∏—Å–∫–∞—Ö —Å–Ω–∏–∂–µ–Ω–∏—è –∫–∞—á–µ—Å—Ç–≤–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏, –≤–æ–∑–º–æ–∂–Ω–æ–º —Ä–æ—Å—Ç–µ –∫–æ—Ä—Ä—É–ø—Ü–∏–∏ –∏ –≤–æ–∑–Ω–∏–∫–Ω–æ–≤–µ–Ω–∏–∏ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã—Ö –¥–∏—Å–±–∞–ª–∞–Ω—Å–æ–≤ –≤ —Å–ª—É—á–∞–µ –∑–∞–º–µ–Ω—ã —á–∞—Å—Ç–Ω—ã—Ö —Å—Ç—Ä–∞—Ö–æ–≤—â–∏–∫–æ–≤ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω—ã–º–∏ —Ñ–æ–Ω–¥–∞–º–∏ –û–ú–° –≤ —Å—É–±—ä–µ–∫—Ç–∞—Ö. –†–µ—à–µ–Ω–∏–µ ¬´–æ—Ç–æ–±—Ä–∞—Ç—å¬ª –æ–±—è–∑–∞–Ω–Ω–æ—Å—Ç–∏ —É —Å—Ç—Ä–∞—Ö–æ–≤—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –ø—Ä–∏–≤–µ–¥–µ—Ç –∫ —Ä–∞–¥–∏–∫–∞–ª—å–Ω–æ–º—É –∏–∑–º–µ–Ω–µ–Ω–∏—é —Å–∏—Å—Ç–µ–º—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PUYfJ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""Industry experts warned about risks of reduced quality of medical care, increased corruption, and regional imbalances if private insurers are replaced by territorial health funds in regions. The solution of 'taking over' responsibilities from insurance medical organizations will lead to a radical change in the system. For more details: https://clck.ru/3PUYfJ #MedVestnik #HealthcareSystem""
}"
2025-09-29T16:32:05+00:00,@medpharm,12858,https://t.me/medpharm/12858,"–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –≤–Ω–µ—Å–ª–æ –≤ –ì–æ—Å–¥—É–º—É –ø—Ä–æ–µ–∫—Ç —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –±—é–¥–∂–µ—Ç–∞ –Ω–∞ 2026 –∏ –ø–ª–∞–Ω–æ–≤—ã–π –ø–µ—Ä–∏–æ–¥ 2027 –∏ 2028 –≥–æ–¥–æ–≤. –ë—é–¥–∂–µ—Ç–Ω—ã–µ –∞—Å—Å–∏–≥–Ω–æ–≤–∞–Ω–∏—è –ø–æ —Ä–∞–∑–¥–µ–ª—É ¬´–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ¬ª —Å–æ—Å—Ç–∞–≤—è—Ç 1,88 —Ç—Ä–ª–Ω —Ä—É–±. –ù–∞ 2025 –≥–æ–¥ –≤ –±—é–¥–∂–µ—Ç–µ –±—ã–ª–æ –∑–∞–ª–æ–∂–µ–Ω–æ 1,86 —Ç—Ä–ª–Ω —Ä—É–±. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PUFsK #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-09-29T16:15:18+00:00,@medpharm,12857,https://t.me/medpharm/12857,"ü¶æ –°–Ω–∏–∑—è—Ç —Ç–µ–º–ø. –°–æ–≥–ª–∞—Å–Ω–æ –ø—Ä–æ–µ–∫—Ç—É –±—é–¥–∂–µ—Ç–∞ –§–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ —Ñ–æ–Ω–¥–∞ –û–ú–° –Ω–∞ —Å–ª–µ–¥—É—é—â–∏–µ —Ç—Ä–∏ –≥–æ–¥–∞, –µ–∂–µ–≥–æ–¥–Ω—ã–π –ø—Ä–∏—Ä–æ—Å—Ç —Ä–∞—Å—Ö–æ–¥–æ–≤ –Ω–∞ –º–µ–¥–∏—Ü–∏–Ω—É –±—É–¥–µ—Ç —Å–æ—Å—Ç–∞–≤–ª—è—Ç—å –¥–æ 7,1%. –†–∞–Ω–µ–µ —ç—Ç–æ—Ç –ø–æ–∫–∞–∑–∞—Ç–µ–ª—å —Å–æ—Å—Ç–∞–≤–ª—è–ª –æ—Ç 14 –¥–æ 21%. ü¶æ –ù–µ –≥–æ–¥–µ–Ω. –í –ú–∏–Ω–æ–±–æ—Ä–æ–Ω—ã –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ —É—Ç–≤–µ—Ä–¥–∏—Ç—å –Ω–æ–≤—ã–π –ø–µ—Ä–µ—á–µ–Ω—å –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, –ø—Ä–∏ –Ω–∞–ª–∏—á–∏–∏ –∫–æ—Ç–æ—Ä—ã—Ö –≥—Ä–∞–∂–¥–∞–Ω–µ, –ø—Ä–∏–∑–Ω–∞–Ω–Ω—ã–µ –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–Ω–æ –≥–æ–¥–Ω—ã–º–∏ –∫ –≤–æ–µ–Ω–Ω–æ–π —Å–ª—É–∂–±–µ, –Ω–µ —Å–º–æ–≥—É—Ç –∑–∞–∫–ª—é—á–∞—Ç—å –∫–æ–Ω—Ç—Ä–∞–∫—Ç –≤ —É—Å–ª–æ–≤–∏—è—Ö –º–æ–±–∏–ª–∏–∑–∞—Ü–∏–∏, –≤–æ–µ–Ω–Ω–æ–≥–æ –ø–æ–ª–æ–∂–µ–Ω–∏—è –∏ –≤ –≤–æ–µ–Ω–Ω–æ–µ –≤—Ä–µ–º—è. –ö–æ–ª–∏—á–µ—Å—Ç–≤–æ –ø–æ–∑–∏—Ü–∏–π –≤ –Ω–æ–≤–æ–π –≤–µ—Ä—Å–∏–∏ —É–≤–µ–ª–∏—á–∏–ª–æ—Å—å —Å 26 –¥–æ 35. ‚ù§Ô∏è –í–Ω—É—à–∞—é—Ç –æ–ø—Ç–∏–º–∏–∑–º. –ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ —Ñ–∞—Ä–º–ø—Ä–æ–¥—É–∫—Ü–∏–∏ –≤—ã—Ä–∞—Å—Ç–µ—Ç –Ω–∞ 13% –≤ 2025 –≥–æ–¥—É, —Å–ª–µ–¥—É–µ—Ç –∏–∑ –ø—Ä–æ–≥–Ω–æ–∑–∞ –ú–∏–Ω—ç–∫–æ–Ω–æ–º—Ä–∞–∑–≤–∏—Ç–∏—è. –ö 2028 –≥–æ–¥—É —Ä–æ—Å—Ç –æ—Ç—Ä–∞—Å–ª–∏ –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ 2024 –≥–æ–¥–∞ —Å–æ—Å—Ç–∞–≤–∏—Ç 30,3%. ‚ù§Ô∏è –ß—å–∏—Ö –±—É–¥–µ—à—å? –ü—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ —Å–º–æ–≥—É—Ç –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª—è—Ç—å –≤ —Å–∏—Å—Ç–µ–º—É –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥–∞ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é, –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–∞—é—â—É—é —Å—Ç—Ä–∞–Ω—É –ø—Ä–æ–∏—Å—Ö–æ–∂–¥–µ–Ω–∏—è —Å–≤–æ–µ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏. –ü–µ—Ä–≤—ã–µ –ø—Ä–æ–≤–µ—Ä–∫–∏ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏—è –¥–∞–Ω–Ω—ã—Ö –Ω–∞—á–Ω—É—Ç—Å—è —É–∂–µ 15 –æ–∫—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, sanctions, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The budget project for the Federal Health Fund for the next three years projects an annual increase in healthcare spending of up to 7.1%. Previously, this figure ranged from 14% to 21%. The Ministry of Defense proposed approving a new list of diseases for which individuals, identified as partially fit for military service, will not be able to sign contracts during mobilization, wartime conditions, and peacetime. The number of positions in the new version has increased from 26 to 35. Pharmaceutical production is forecasted to grow by 13% in 2025, according to the forecasts of the Ministry of Economic Development. Pharmaceutical producers will be able to provide monitoring system with information confirming the origin of their products. The first checks for compliance will begin on October 15, 2025.""
}"
2025-09-29T15:00:10+00:00,@medpharm,12856,https://t.me/medpharm/12856,FDA –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è –ª–µ—á–µ–Ω–∏—è –≤–∑—Ä–æ—Å–ª—ã—Ö —Å –∞–∫—Ä–æ–º–µ–≥–∞–ª–∏–µ–π. –≠—Ç–æ –ø–µ—Ä–≤–æ–µ –ø–µ—Ä–æ—Ä–∞–ª—å–Ω–æ–µ —Å—Ä–µ–¥—Å—Ç–≤–æ –¥–ª—è —ç—Ç–æ–≥–æ –ø–æ–∫–∞–∑–∞–Ω–∏—è –≤ –°–®–ê. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PUBMb #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{""skip"": true}"
2025-09-29T14:16:06+00:00,@medpharm,12855,https://t.me/medpharm/12855,"–ü–µ—Ä–æ—Ä–∞–ª—å–Ω—ã–π –º–µ—Ç–∏–ª–∫–æ–±–∞–ª–∞–º–∏–Ω (–≤–∏—Ç–∞–º–∏–Ω –í12) –ø—Ä–µ–¥–æ—Ç–≤—Ä–∞—â–∞–ª —Ä–∞–∑–≤–∏—Ç–∏–µ –ª–∞–¥–æ–Ω–Ω–æ-–ø–æ–¥–æ—à–≤–µ–Ω–Ω–æ–≥–æ —Å–∏–Ω–¥—Ä–æ–º–∞ —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–∫ —Å HER2-–æ—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω—ã–º —Ä–∞–Ω–Ω–∏–º —Ä–∞–∫–æ–º –º–æ–ª–æ—á–Ω–æ–π –∂–µ–ª–µ–∑—ã, –ø–æ–ª—É—á–∞—é—â–∏—Ö –∞–¥—ä—é–≤–∞–Ω—Ç–Ω—É—é —Ç–µ—Ä–∞–ø–∏—é –∫–∞–ø–µ—Ü–∏—Ç–∞–±–∏–Ω–æ–º. –ü—Ä–∏ —ç—Ç–æ–º –µ–≥–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ –Ω–µ —Å–æ–ø—Ä–æ–≤–æ–∂–¥–∞–ª–æ—Å—å –Ω–µ–ø—Ä–µ–¥–≤–∏–¥–µ–Ω–Ω—ã–º–∏ –ø—Ä–æ–±–ª–µ–º–∞–º–∏ —Å –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å—é. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PU8RV #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–î–µ—Ä–º–∞—Ç–æ–≤–µ–Ω–µ—Ä–æ–ª–æ–≥–∏—è #–û–Ω–∫–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-09-29T14:15:04+00:00,@medpharm,12854,https://t.me/medpharm/12854,"–ö–æ–º–ø–∞–Ω–∏–∏ ¬´–§–∞—Ä–º–ª—ç–Ω–¥¬ª, ¬´–ò—Ä–≤–∏–Ω 2¬ª, ¬´–¶–í –ü—Ä–æ—Ç–µ–∫¬ª –∏ ¬´–ù–∞–Ω–æ–ª–µ–∫¬ª –±—É–¥—É—Ç –ø–æ—Å—Ç–∞–≤–ª—è—Ç—å –¥–ª—è ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª –∞–ª–±—É—Ç—Ä–µ–ø–µ–Ω–æ–Ω–∞–∫–æ–≥ –∞–ª—å—Ñ–∞, –¥–∏–Ω—É—Ç—É–∫—Å–∏–º–∞–± –±–µ—Ç–∞, –∏–¥—É—Ä—Å—É–ª—å—Ñ–∞–∑–∞ –±–µ—Ç–∞ –∏ –∫–∞—Ä–≥–ª—É–º–æ–≤—É—é –∫–∏—Å–ª–æ—Ç—É –ø–æ –º–∞–∫—Å–∏–º–∞–ª—å–Ω–æ–π —Ü–µ–Ω–µ –∫–æ–Ω—Ç—Ä–∞–∫—Ç–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PU8MT #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{""skip"": true}"
2025-09-29T13:25:03+00:00,@medpharm,12853,https://t.me/medpharm/12853,"–î–∞—Ç—Å–∫–∞—è Genmab —Å–æ–æ–±—â–∏–ª–∞ –æ –ø–æ–∫—É–ø–∫–µ –≥–æ–ª–ª–∞–Ω–¥—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ Merus –∑–∞ 8 –º–ª—Ä–¥ –¥–æ–ª–ª. –ï–µ –≥–ª–∞–≤–Ω–∞—è —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∞ ‚Äî –ø—Ä–µ–ø–∞—Ä–∞—Ç –ø—Ä–æ—Ç–∏–≤ —Ä–∞–∫–∞ –≥–æ–ª–æ–≤—ã –∏ —à–µ–∏, –∫–æ—Ç–æ—Ä—ã–π –∑–∞–≤–µ—Ä—à–∞–µ—Ç –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –∏ –º–æ–∂–µ—Ç –≤—ã–π—Ç–∏ –≤ –ø—Ä–æ–¥–∞–∂–∏ –∫ 2027 –≥–æ–¥—É. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://pharmvestnik.ru/content/news/Genmab-priobretet-niderlandskogo-razrabotchika-protivorakovyh-preparatov-za-8-mlrd-dollarov.html?utm_source=TG_post&utm_medium=Group&utm_campaign=Genmab-priobretet-niderlandskogo-razrabotchika-protivorakovyh-preparatov-za-8-mlrd-dollarov #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-09-29T13:08:04+00:00,@medpharm,12852,https://t.me/medpharm/12852,"¬´–í –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏–∏ –µ—Å—Ç—å –Ω–µ—Å–∫–æ–ª—å–∫–æ –æ—Ç–¥–µ–ª–µ–Ω–∏–π, –∫–æ—Ç–æ—Ä—ã–µ –∏–º–µ—é—Ç —Ä–∞–∑–Ω—ã–µ –∏—Å—Ç–æ—á–Ω–∏–∫–∏ —Ñ–∏–Ω–∞–Ω—Å–æ–≤–æ–≥–æ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è: –ø—Ä–µ–¥–ø—Ä–∏–Ω–∏–º–∞—Ç–µ–ª—å—Å–∫–∞—è –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç—å, –≥–æ—Å–∑–∞–¥–∞–Ω–∏–µ 0901, –≥–æ—Å–∑–∞–¥–∞–Ω–∏–µ 0902, –≥–æ—Å–∑–∞–¥–∞–Ω–∏–µ 0903. –ü–µ—Ä—Å–æ–Ω–∞–ª –ø–µ—Ä–µ–≤–æ–¥–∏—Ç—Å—è –¥–ª—è —Ä–∞–±–æ—Ç—ã –∏–∑ –æ–¥–Ω–æ–≥–æ –æ—Ç–¥–µ–ª–µ–Ω–∏—è –≤ –¥—Ä—É–≥–æ–µ, —Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ, –ø–æ–ª—É—á–∞–µ—Ç –∑–∞—Ä–ø–ª–∞—Ç—É –∏–∑ —Ä–∞–∑–Ω—ã—Ö –∏—Å—Ç–æ—á–Ω–∏–∫–æ–≤. –° –∫–∞–∫–æ–≥–æ –∏—Å—Ç–æ—á–Ω–∏–∫–∞ –¥–æ–ª–∂–Ω—ã –≤—ã–ø–ª–∞—á–∏–≤–∞—Ç—å—Å—è –æ—Ç–ø—É—Å–∫–Ω—ã–µ: —Å–æ –≤—Å–µ—Ö, –≥–¥–µ –≤ –ø—Ä–µ–¥—ã–¥—É—â–∏–µ 12 –º–µ—Å—è—Ü–µ–≤ –∏–º–µ–ª—Å—è –¥–æ—Ö–æ–¥, –∏–ª–∏ —Ç–æ–ª—å–∫–æ —Å –∏—Å—Ç–æ—á–Ω–∏–∫–∞ —Ç–æ–≥–æ –æ—Ç–¥–µ–ª–µ–Ω–∏—è, –≤ –∫–æ—Ç–æ—Ä–æ–º —Å–æ—Ç—Ä—É–¥–Ω–∏–∫ —Ä–∞–±–æ—Ç–∞–ª –Ω–∞ –º–æ–º–µ–Ω—Ç —É—Ö–æ–¥–∞ –≤ –æ—Ç–ø—É—Å–∫?¬ª –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PU3TJ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-09-29T12:53:03+00:00,@medpharm,12851,https://t.me/medpharm/12851,"–£—Ç–≤–µ—Ä–∂–¥–µ–Ω—ã –ø—Ä–∞–≤–∏–ª–∞ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª–µ–Ω–∏—è –≤ —Å–∏—Å—Ç–µ–º—É –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏ –¥–∞–Ω–Ω—ã—Ö –æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ —Å—Ç—Ä–∞–Ω–∞—Ö –ï–ê–≠–°, –≤–∫–ª—é—á–∞—è —Å–∏–Ω—Ç–µ–∑ —Å—É–±—Å—Ç–∞–Ω—Ü–∏–∏. –î–ª—è —ç—Ç–æ–≥–æ –Ω—É–∂–Ω–æ –±—É–¥–µ—Ç –ø–µ—Ä–µ–¥–∞–≤–∞—Ç—å –≤ –≥–æ—Å—Å–∏—Å—Ç–µ–º—É –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏ –¥–∞–Ω–Ω—ã–µ –æ–±–æ –≤—Å–µ–º —Å—ã—Ä—å–µ —á–µ—Ä–µ–∑ ¬´–≤–∏—Ä—Ç—É–∞–ª—å–Ω—ã–π —Å–∫–ª–∞–¥¬ª. –ü–µ—Ä–≤—ã–µ –ø—Ä–æ–≤–µ—Ä–∫–∏ –Ω–∞—á–Ω—É—Ç—Å—è —É–∂–µ 15 –æ–∫—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PU2Lc #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""high"",
  ""english"": ""Rules for providing data on drug production have been approved in countries of the EAEU. This will require all raw materials to be passed through a virtual warehouse system into the traceability system. The first checks will start on October 15, 2025.""
}"
2025-09-29T11:54:08+00:00,@medpharm,12850,https://t.me/medpharm/12850,"–§–µ–¥–µ—Ä–∞–ª—å–Ω—ã–π —Ñ–æ–Ω–¥ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–≥–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ —Å—Ç—Ä–∞—Ö–æ–≤–∞–Ω–∏—è –ø–ª–∞–Ω–∏—Ä—É–µ—Ç —É–≤–µ–ª–∏—á–∏–≤–∞—Ç—å —Ä–∞—Å—Ö–æ–¥—ã –Ω–µ –º–µ–Ω–µ–µ —á–µ–º –Ω–∞ 7% –µ–∂–µ–≥–æ–¥–Ω–æ –¥–æ 2028 –≥–æ–¥–∞. –û–±—â–∏–π –æ–±—ä–µ–º –∑–∞—Ç—Ä–∞—Ç –≤—ã—Ä–∞—Å—Ç–µ—Ç —Å 4,4 –¥–æ 5,5 —Ç—Ä–ª–Ω —Ä—É–±. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PTvhN #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, shortage"",
  ""impact"": ""high"",
  ""english"": ""The Federal Fund for Obligatory Medical Insurance plans to increase annual expenses by at least 7% annually until 2028. The total cost will increase from 4.4 to 5.5 trillion rubles. More details: https://clck.ru/3PTvhN #MedVestnik #Healthcare #HealthSystemOrganization""
}"
2025-09-29T11:24:02+00:00,@medpharm,12849,https://t.me/medpharm/12849,"–ü—Ä–µ—Å—Å-–∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏—è ¬´–í—Å–µ –æ —Ñ–∞—Ä–º–µ: —Å—Ç–∞—Ä—Ç 26 —Å–µ–∑–æ–Ω–∞ ¬´–ü–ª–∞—Ç–∏–Ω–æ–≤–æ–π –£–Ω—Ü–∏–∏¬ª, –ø–æ—Å–≤—è—â–µ–Ω–Ω–∞—è —Å—Ç–∞—Ä—Ç—É –Ω–æ–≤–æ–≥–æ —Å–µ–∑–æ–Ω–∞ –í—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –æ—Ç–∫—Ä—ã—Ç–æ–≥–æ –∫–æ–Ω–∫—É—Ä—Å–∞ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª–æ–≤ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –æ—Ç—Ä–∞—Å–ª–∏, —Å–æ—Å—Ç–æ–∏—Ç—Å—è 30 —Å–µ–Ω—Ç—è–±—Ä—è –≤ 11:00 (–ú—Å–∫). –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://pharmvestnik.ru/content/news/Press-konferenciya-Vse-o-farme-start-26-sezona-Platinovoi-Uncii-sostoitsya-30-sentyabrya.html?utm_source=TG_post&utm_medium=Group&utm_campaign=Press-konferenciya-Vse-o-farme-start-26-sezona-Platinovoi-Uncii-sostoitsya-30-sentyabrya #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-09-29T10:52:02+00:00,@medpharm,12848,https://t.me/medpharm/12848,"–ë—Ä–∏—Ç–∞–Ω—Å–∫–∏–π —Ñ–∞—Ä–º–≥–∏–≥–∞–Ω—Ç GSK –æ–±—ä—è–≤–∏–ª –æ —Å–º–µ–Ω–µ —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–∞. –° 1 —è–Ω–≤–∞—Ä—è –õ—é–∫ –ú–∏–µ–ª—Å –∑–∞–π–º–µ—Ç –ø–æ—Å—Ç –≥–µ–Ω–µ—Ä–∞–ª—å–Ω–æ–≥–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞, —Å–º–µ–Ω–∏–≤ –≠–º–º—É –£–æ–ª–º—Å–ª–∏, –∫–æ—Ç–æ—Ä–∞—è –≤–æ–∑–≥–ª–∞–≤–ª—è–ª–∞ –∫–æ–º–ø–∞–Ω–∏—é –≤–æ—Å–µ–º—å –ª–µ—Ç. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PTrHp #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–∞—Ä—å–µ—Ä–∞","{""skip"": true}"
2025-09-29T10:40:02+00:00,@medpharm,12847,https://t.me/medpharm/12847,"11‚Äì12 —Å–µ–Ω—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞ –°–æ—á–∏ –ø—Ä–∏–Ω—è–ª XVIII –µ–∂–µ–≥–æ–¥–Ω—É—é –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏—é ¬´PRO–µ–∫—Ü–∏–∏ –±—É–¥—É—â–µ–≥–æ¬ª ‚Äî —Å–æ–±—ã—Ç–∏–µ, –∫–æ—Ç–æ—Ä–æ–µ —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω–æ –∑–∞–¥–∞–µ—Ç —Ç–æ–Ω –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–º—É —Ä–∞–∑–≥–æ–≤–æ—Ä—É –æ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–º —Ä—ã–Ω–∫–µ –∏ —Ñ–æ—Ä–º–∏—Ä—É–µ—Ç –ø–æ–≤–µ—Å—Ç–∫—É –Ω–∞ –ø—Ä–µ–¥—Å—Ç–æ—è—â–∏–π –≥–æ–¥. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PTqR2 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-09-29T09:21:06+00:00,@medpharm,12846,https://t.me/medpharm/12846,"–ü–∞—Ü–∏–µ–Ω—Ç—ã —Å –¥–∏–∞–±–µ—Ç–æ–º, –ø–æ–ª—É—á–∞–≤—à–∏–µ –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–Ω—ã–µ –∫–ª–∞—Å—Å—ã —Å–∞—Ö–∞—Ä–æ—Å–Ω–∏–∂–∞—é—â–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –∏–º–µ–ª–∏ –±–æ–ª–µ–µ –Ω–∏–∑–∫–∏–π —Ä–∏—Å–∫ —Ä–∞–∑–≤–∏—Ç–∏—è –±–æ–ª–µ–∑–Ω–∏ –ê–ª—å—Ü–≥–µ–π–º–µ—Ä–∞. –ù–∞–∏–±–æ–ª–µ–µ –≤—ã—Ä–∞–∂–µ–Ω–Ω—ã–π —ç—Ñ—Ñ–µ–∫—Ç –Ω–∞–±–ª—é–¥–∞–ª—Å—è –ø—Ä–∏ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–∏ –∞–≥–æ–Ω–∏—Å—Ç–æ–≤ GLP-1 –∏ –∏–Ω–≥–∏–±–∏—Ç–æ—Ä–æ–≤ SGLT2. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PTii4 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ù–µ–≤—Ä–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è #–≠–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-09-29T08:50:03+00:00,@medpharm,12845,https://t.me/medpharm/12845,"–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ —Ñ–∞—Ä–º–ø—Ä–æ–¥—É–∫—Ü–∏–∏ –≤—ã—Ä–∞—Å—Ç–µ—Ç –Ω–∞ 13% –≤ 2025 –≥–æ–¥—É, —Å–ª–µ–¥—É–µ—Ç –∏–∑ –ø—Ä–æ–≥–Ω–æ–∑–∞ –ú–∏–Ω—ç–∫–æ–Ω–æ–º—Ä–∞–∑–≤–∏—Ç–∏—è. –ö 2028 –≥–æ–¥—É —Ä–æ—Å—Ç —ç—Ç–æ–π –æ—Ç—Ä–∞—Å–ª–∏ –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ 2024 –≥–æ–¥–∞ —Å–æ—Å—Ç–∞–≤–∏—Ç 30,3%. –†–æ—Å—Ç—É –±—É–¥—É—Ç —Å–ø–æ—Å–æ–±—Å—Ç–≤–æ–≤–∞—Ç—å –Ω–æ–≤—ã–µ –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–æ–Ω–Ω—ã–µ –ø—Ä–æ–µ–∫—Ç—ã –ø–æ –≤—ã–ø—É—Å–∫—É —Å—É–±—Å—Ç–∞–Ω—Ü–∏–π –∏ –∂–∏–∑–Ω–µ–Ω–Ω–æ –≤–∞–∂–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PTfmi #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-09-29T07:15:02+00:00,@medpharm,12844,https://t.me/medpharm/12844,–£–º–µ—Ä –æ–¥–∏–Ω –∏–∑ –æ—Å–Ω–æ–≤–∞—Ç–µ–ª–µ–π —Ä–æ—Å—Å–∏–π—Å–∫–æ–π –ø–µ—Ä–∏–Ω–∞—Ç–æ–ª–æ–≥–∏–∏. –ê–ª–µ–∫—Å–∞–Ω–¥—Ä—É –°—Ç—Ä–∏–∂–∞–∫–æ–≤—É –±—ã–ª–æ 88 –ª–µ—Ç. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PTXWj #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-09-28T12:04:22+00:00,@medpharm,12841,https://t.me/medpharm/12841,"–ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ –∑–∞ –Ω–µ–¥–µ–ª—é üîµ–í 26-–π —Ä–µ–π—Ç–∏–Ω–≥ ¬´–¢–û–ü-1000 —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –º–µ–Ω–µ–¥–∂–µ—Ä–æ–≤¬ª –ê—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ –º–µ–Ω–µ–¥–∂–µ—Ä–æ–≤ –∏ ¬´–ö–æ–º–º–µ—Ä—Å–∞–Ω—Ç–∞¬ª –≤–æ—à–ª–∏ –±–æ–ª–µ–µ 20 —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª–µ–π –æ—Ç —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏. üîµ¬´–ß–µ—Å—Ç–Ω—ã–π –∑–Ω–∞–∫¬ª –±—É–¥–µ—Ç –ø—Ä–æ–≤–µ—Ä—è—Ç—å –Ω–∞–ª–∏—á–∏–µ —Ä–µ–∞–ª—å–Ω—ã—Ö –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏–π —É –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ë–ê–î. –û—Ç—Ä–∞—Å–ª—å –∂–¥–µ—Ç –≤–≤–µ–¥–µ–Ω–∏—è —ç—Ç–æ–≥–æ –º–µ—Ö–∞–Ω–∏–∑–º–∞ –ø–æ—Å–ª–µ –ø–æ–¥–ø–∏—Å–∞–Ω–∏—è –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è. üîµ¬´–î–∂–æ–¥–∞—Å –≠–∫—Å–ø–æ–∏–º¬ª –æ—à—Ç—Ä–∞—Ñ–æ–≤–∞–ª–∏ –∑–∞ –≥—Ä—É–±–æ–µ –Ω–∞—Ä—É—à–µ–Ω–∏–µ —É—Å–ª–æ–≤–∏–π –æ–ø—Ç–æ–≤–æ–π —Ñ–∞—Ä–º–ª–∏—Ü–µ–Ω–∑–∏–∏. –í–Ω–µ–ø–ª–∞–Ω–æ–≤–∞—è –≤—ã–µ–∑–¥–Ω–∞—è –ø—Ä–æ–≤–µ—Ä–∫–∞ –±—ã–ª–∞ –ø—Ä–æ–≤–µ–¥–µ–Ω–∞ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–æ–º –ø–æ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—é –ì–µ–Ω–ø—Ä–æ–∫—É—Ä–∞—Ç—É—Ä—ã. üîµ–†–æ—Å—Å–∏–π—Å–∫–∏–π Forbes –æ–ø—É–±–ª–∏–∫–æ–≤–∞–ª TOP100 –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö –∫–æ–º–ø–∞–Ω–∏–π –ø–æ —á–∏—Å—Ç–æ–π –ø—Ä–∏–±—ã–ª–∏. –í —Ä–µ–π—Ç–∏–Ω–≥, –∫–∞–∫ –∏ –≥–æ–¥–æ–º —Ä–∞–Ω–µ–µ, –ø–æ–ø–∞–ª–∞ –ª–∏—à—å –æ–¥–Ω–∞ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∞—è –∫–æ–º–ø–∞–Ω–∏—è. üîµ–ü–æ–¥ –º–∞—Ä–∫–∏—Ä–æ–≤–∫—É –ø–æ–ø–∞–ª–∏ —Å–∞–Ω–∏—Ç–∞—Ä–Ω–æ-–≥–∏–≥–∏–µ–Ω–∏—á–µ—Å–∫–∏–µ –∏–∑–¥–µ–ª–∏—è –∏ —Ç—É–∞–ª–µ—Ç–Ω—ã–µ –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–Ω–æ—Å—Ç–∏. –≠–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç –ø—Ä–æ–π–¥–µ—Ç —Å 25 —Å–µ–Ω—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞ –ø–æ 31 –∞–≤–≥—É—Å—Ç–∞ 2026 –≥–æ–¥–∞.","{""skip"": true}"
2025-09-27T10:50:02+00:00,@medpharm,12840,https://t.me/medpharm/12840,"–°—É–¥ –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª –ø—Ä–∞–≤–æ –∫–ª–∏–Ω–∏–∫–∏ —Ä–∞—Å—Ö–æ–¥–æ–≤–∞—Ç—å —Å—Ä–µ–¥—Å—Ç–≤–∞ –Ω–∞ –æ–∫–∞–∑–∞–Ω–∏–µ —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –∏–Ω–æ–≥–æ—Ä–æ–¥–Ω–∏–º –ø–∞—Ü–∏–µ–Ω—Ç–∞–º. –ì–ª–∞–≤–Ω—ã–º –∞—Ä–≥—É–º–µ–Ω—Ç–æ–º —Å—Ç–∞–ª–∞ –ø–æ–∑–∏—Ü–∏—è –§–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ —Ñ–æ–Ω–¥–∞ –û–ú–°, —Å–æ–≥–ª–∞—Å–Ω–æ –∫–æ—Ç–æ—Ä–æ–π –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –º–æ–≥—É—Ç –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å —Å—Ä–µ–¥—Å—Ç–≤–∞ –û–ú–° –Ω–∞ –æ–∫–∞–∑–∞–Ω–∏–µ –ø–æ–º–æ—â–∏ –∑–∞—Å—Ç—Ä–∞—Ö–æ–≤–∞–Ω–Ω—ã–º –≤ —Å–∏—Å—Ç–µ–º–µ –Ω–µ–∑–∞–≤–∏—Å–∏–º–æ –æ—Ç —Ä–µ–≥–∏–æ–Ω–∞ –∏—Ö –ø—Ä–∏–∫—Ä–µ–ø–ª–µ–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PSC8t #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The court confirmed the clinic's right to use funds for providing specialized medical care to non-resident patients. The main argument is the position of the Federal Health Fund, which states that healthcare organizations can use OMS funds for care to insured individuals regardless of their region of attachment. For more details: https://clck.ru/3PSC8t #MedVestnik #Healthcare""
}"
2025-09-27T09:15:31+00:00,@medpharm,12839,https://t.me/medpharm/12839,"–ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∑–∞ –Ω–µ–¥–µ–ª—é üî¥–í –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–µ–Ω–Ω–æ–º –î–µ–ø–∞—Ä—Ç–∞–º–µ–Ω—Ç–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –Ω–∞–∑–Ω–∞—á–∏–ª–∏ –≤—Ä–∏–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞. –ò–º —Å—Ç–∞–ª –î–µ–Ω–∏—Å –†–æ—â–∏–Ω. –ü—Ä–µ–∂–Ω–∏–π —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å –ò–≥–æ—Ä—å –ö–∞–≥—Ä–∞–º–∞–Ω—è–Ω —É—à–µ–ª –≤ –æ—Ç—Å—Ç–∞–≤–∫—É 23 —Å–µ–Ω—Ç—è–±—Ä—è –ø–æ—Å–ª–µ –Ω–∞–∑–Ω–∞—á–µ–Ω–∏—è –∞—É–¥–∏—Ç–æ—Ä–æ–º –°—á–µ—Ç–Ω–æ–π –ø–∞–ª–∞—Ç—ã. üî¥–ù–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ –≤ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω–æ–º TOP5 –ø—Ä–∏–∑—ã–≤ –ú–∏—Ö–∞–∏–ª–∞ –ú—É—Ä–∞—à–∫–æ –∫ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã–º –º–∏–Ω–∏—Å—Ç—Ä–∞–º –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –æ–±–µ—Å–ø–µ—á–∏—Ç—å –¥–æ—Å—Ç–æ–π–Ω—É—é –æ–ø–ª–∞—Ç—É —Ç—Ä—É–¥–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –∏ —Ä–∞–±–æ—Ç–∞—Ç—å –Ω–∞–¥ –ø–æ–≤—ã—à–µ–Ω–∏–µ–º –∏—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å–Ω–æ—Å—Ç–∏. –≠—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–∞—è —Ä–∞—Å—Å—Ç–∞–Ω–æ–≤–∫–∞ —Å–∏–ª –∏ —Å—Ä–µ–¥—Å—Ç–≤ ‚Äî —ç—Ç–æ –≤–∞–∂–Ω–∞—è —Å–æ—Å—Ç–∞–≤–ª—è—é—â–∞—è, –ø–æ–¥—á–µ—Ä–∫–Ω—É–ª –æ–Ω. üî¥–¢—Ä–µ—Ç—å—é —Å—Ç—Ä–æ—á–∫—É –Ω–æ–≤–æ—Å—Ç–Ω–æ–≥–æ —Ä–µ–π—Ç–∏–Ω–≥–∞ –Ω–µ–¥–µ–ª–∏ –∑–∞–Ω—è–ª–∏ —Å–æ–æ–±—â–µ–Ω–∏—è –æ –ø–æ–¥–≥–æ—Ç–æ–≤–∫–µ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –±—é–¥–∂–µ—Ç–∞ –∏ –±—é–¥–∂–µ—Ç–∞ –§–æ–Ω–¥–∞ –û–ú–° –Ω–∞ –±–ª–∏–∂–∞–π—à—É—é –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤—É. –ü—Ä–æ–µ–∫—Ç—ã –æ—Å–Ω–æ–≤–Ω—ã—Ö –¥–ª—è –æ—Ç—Ä–∞—Å–ª–∏ —Ñ–∏–Ω–∞–Ω—Å–æ–≤—ã—Ö –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤ –ø–æ–∫–∞ –Ω–µ –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω—ã. –ù–æ –ú–∏–Ω—Ñ–∏–Ω —Å–æ–æ–±—â–∏–ª, —á—Ç–æ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç –Ω–∞–ø—Ä–∞–≤–∏—Ç—å –Ω–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ –∏–∑ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –±—é–¥–∂–µ—Ç–∞ –∑–∞ —à–µ—Å—Ç–∏–ª–µ—Ç–Ω–∏–π –ø–µ—Ä–∏–æ–¥ –±–æ–ª–µ–µ 1 —Ç—Ä–ª–Ω —Ä—É–±. –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤. üî¥–ù–∞ —á–µ—Ç–≤–µ—Ä—Ç–æ–º –º–µ—Å—Ç–µ –≤ TOP5 –ø—Ä–æ–µ–∫—Ç –ø–æ–ø—Ä–∞–≤–æ–∫ –≤ –§–µ–¥–µ—Ä–∞–ª—å–Ω—ã–π –∑–∞–∫–æ–Ω ¬´–û–± –û–ú–°¬ª, –∫–æ—Ç–æ—Ä—ã–µ –±—É–¥—É—Ç —É—á—Ç–µ–Ω—ã –ø—Ä–∏ –ø–æ–¥–≥–æ—Ç–æ–≤–∫–µ –±—é–¥–∂–µ—Ç–∞ –§–û–ú–° –Ω–∞ 2026 –≥–æ–¥ –∏ –Ω–∞ –ø–ª–∞–Ω–æ–≤—ã–π –ø–µ—Ä–∏–æ–¥ 2027 –∏ 2028 –≥–æ–¥–æ–≤. ¬´–ú–í¬ª –≤—ã–¥–µ–ª–∏–ª –≥–ª–∞–≤–Ω—ã–µ –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ –¥–æ–∫—É–º–µ–Ω—Ç–µ. üî¥–ó–∞–º—ã–∫–∞–µ—Ç –ø—è—Ç–µ—Ä–∫—É –Ω–æ–≤–æ—Å—Ç–µ–π –æ–±–Ω–æ–≤–ª–µ–Ω–Ω—ã–π –ø–æ—Ä—è–¥–æ–∫ –æ–∫–∞–∑–∞–Ω–∏—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –≤–∑—Ä–æ—Å–ª—ã–º –±–æ–ª—å–Ω—ã–º –ø—Ä–∏ –∏–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è—Ö. –û–Ω –≤—Å—Ç—É–ø–∏—Ç –≤ —Å–∏–ª—É —Å 1 –¥–µ–∫–∞–±—Ä—è 2025 –≥–æ–¥–∞.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""Updates to the order of medical care for adult patients with infectious diseases are effective from December 1, 2025. The changes were highlighted by 'Minsk' and are part of the updated guidelines for providing medical care.""
}"
2025-09-27T08:58:02+00:00,@medpharm,12838,https://t.me/medpharm/12838,"–í –Ω–æ–≤—ã–π –ø–µ—Ä–µ—á–µ–Ω—å –æ–±—ä–µ–∫—Ç–æ–≤ —Ç—Ä–∞–Ω—Å–ø–ª–∞–Ω—Ç–∞—Ü–∏–∏ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –≤–∫–ª—é—á–∏—Ç—å —Ä–∞—Å—à–∏—Ä–µ–Ω–Ω—ã–π —Å–ø–∏—Å–æ–∫ –∫–æ—Å—Ç–µ–π, –∞ —Ç–∞–∫–∂–µ –Ω–µ—Ä–≤—ã –∏ —Å–ø–∏–Ω–Ω–æ–π –º–æ–∑–≥. –≠—Ç–æ –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ —É–≤–µ–ª–∏—á–∏—Ç –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ —Ä–µ–∫–æ–Ω—Å—Ç—Ä—É–∫—Ü–∏–∏ —É—Ç—Ä–∞—á–µ–Ω–Ω—ã—Ö —ç–ª–µ–º–µ–Ω—Ç–æ–≤ –æ–ø–æ—Ä–Ω–æ-–¥–≤–∏–≥–∞—Ç–µ–ª—å–Ω–æ–≥–æ –∞–ø–ø–∞—Ä–∞—Ç–∞ –∏ –ø–æ–∑–≤–æ–ª–∏—Ç –∏–∑–±–µ–∂–∞—Ç—å –∞–º–ø—É—Ç–∞—Ü–∏–∏ –∫–æ–Ω–µ—á–Ω–æ—Å—Ç–µ–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PS6f4 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–¢—Ä–∞–≤–º–∞—Ç–æ–ª–æ–≥–∏—è_–∏_–æ—Ä—Ç–æ–ø–µ–¥–∏—è #–•–∏—Ä—É—Ä–≥–∏—è","{""skip"": true}"
2025-09-27T05:41:02+00:00,@medpharm,12837,https://t.me/medpharm/12837,"–ú–∏–Ω–∑–¥—Ä–∞–≤ —É—Ç–≤–µ—Ä–¥–∏–ª –Ω–æ–≤—ã–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ (–ö–†) –ø–æ —Ç–µ—Ä–∞–ø–∏–∏ –º–µ–Ω–æ–ø–∞—É–∑—ã –∏ –∫–ª–∏–º–∞–∫—Ç–µ—Ä–∏—á–µ—Å–∫–æ–º—É —Å–æ—Å—Ç–æ—è–Ω–∏—é —É –∂–µ–Ω—â–∏–Ω. –ü–æ–¥–≥–æ—Ç–æ–≤–ª–µ–Ω–Ω—ã–π –†–æ—Å—Å–∏–π—Å–∫–∏–º –æ–±—â–µ—Å—Ç–≤–æ–º –∞–∫—É—à–µ—Ä–æ–≤-–≥–∏–Ω–µ–∫–æ–ª–æ–≥–æ–≤ –¥–æ–∫—É–º–µ–Ω—Ç –ø—Ä–∏—à–µ–ª –Ω–∞ —Å–º–µ–Ω—É –ø—Ä–µ–¥—ã–¥—É—â–µ–π –≤–µ—Ä—Å–∏–∏, –¥–µ–π—Å—Ç–≤–æ–≤–∞–≤—à–µ–π —Å 2021 –≥–æ–¥–∞. –í–Ω–µ—Å–µ–Ω–Ω—ã–µ –∏–∑–º–µ–Ω–µ–Ω–∏—è –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω—ã –Ω–∞ –ø–æ–≤—ã—à–µ–Ω–∏–µ —Ç–æ—á–Ω–æ—Å—Ç–∏ —Ç–µ—Ä–º–∏–Ω–æ–ª–æ–≥–∏–∏ –∏ –æ–ø—Ç–∏–º–∏–∑–∞—Ü–∏—é –ø–æ–¥—Ö–æ–¥–æ–≤ –∫ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–µ –∏ –ª–µ—á–µ–Ω–∏—é –¥–∞–Ω–Ω–æ–≥–æ —Å–æ—Å—Ç–æ—è–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PRvKY #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ê–∫—É—à–µ—Ä—Å—Ç–≤–æ_–∏_–≥–∏–Ω–µ–∫–æ–ª–æ–≥–∏—è #–î–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""The Russian Society of Obstetricians and Gynecologists has approved new clinical guidelines for the treatment of menopause and climacteric state in women. The updated document replaces the previous version from 2021 and aims to improve terminology accuracy and optimize diagnostic and therapeutic approaches.""
}"
2025-09-26T16:51:34+00:00,@medpharm,12835,https://t.me/medpharm/12835,"ü¶æ –ù–∞—Å–∏–ª—å–Ω–æ –º–∏–ª –Ω–µ –±—É–¥–µ—à—å. –ê–∫–∞–¥–µ–º–∏–∫ –†–æ–π—Ç–±–µ—Ä–≥ –Ω–µ —É–≤–µ—Ä–µ–Ω, —á—Ç–æ –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω—ã–µ –æ—Ç—Ä–∞–±–æ—Ç–∫–∏ –ø–æ–º–æ–≥—É—Ç —Ä–µ—à–∏—Ç—å –∫–∞–¥—Ä–æ–≤—É—é –ø—Ä–æ–±–ª–µ–º—É –≤ –ø–µ—Ä–≤–∏—á–Ω–æ–º –∑–≤–µ–Ω–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –ü—Ä–µ–∂–¥–µ –≤—Å–µ–≥–æ, –º–æ–ª–æ–¥—ã–µ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –¥–æ–ª–∂–Ω—ã –±—ã—Ç—å –∑–∞–∏–Ω—Ç–µ—Ä–µ—Å–æ–≤–∞–Ω—ã, –∑–∞—è–≤–∏–ª –æ–Ω ¬´–ú–í¬ª. ü¶æ –û–ø–∞—Å–Ω–∞—è —Ä–∞–±–æ—Ç–∞. –ö–∞–∂–¥—ã–π –ø—è—Ç—ã–π —ç–∫—Å—Ç—Ä–µ–Ω–Ω—ã–π –ø–∞—Ü–∏–µ–Ω—Ç —Å—Ç–∞–Ω–æ–≤–∏–ª—Å—è —É–≥—Ä–æ–∑–æ–π –¥–ª—è –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤. –ë–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ –ø–æ–¥–æ–±–Ω—ã—Ö —Å–ª—É—á–∞–µ–≤ –≤ –æ—Ç–¥–µ–ª–µ–Ω–∏—è—Ö –Ω–µ–æ—Ç–ª–æ–∂–Ω–æ–π –ø–æ–º–æ—â–∏ –≤ –°–®–ê –Ω–µ —Ñ–∏–∫—Å–∏—Ä—É–µ—Ç—Å—è –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω–æ. ‚ù§Ô∏è –í–∏–¥–∏—à—å —Ä–æ—Å—Ç? –°—Ä–µ–¥–Ω—è—è –∑–∞—Ä–ø–ª–∞—Ç–∞ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–æ–≤ –≤ –†–æ—Å—Å–∏–∏ –¥–æ—Å—Ç–∏–≥–ª–∞ 74,1 —Ç—ã—Å. —Ä—É–±. –≤ 2025 –≥–æ–¥—É, —á—Ç–æ –Ω–∞ 10 —Ç—ã—Å. —Ä—É–±. –≤—ã—à–µ, —á–µ–º –≤ 2024 –≥–æ–¥—É. –ü—Ä–∏ —ç—Ç–æ–º —Ä–∞–±–æ—Ç–æ–¥–∞—Ç–µ–ª–∏ –≤ –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–µ –≤–∞–∫–∞–Ω—Å–∏–π –¥–ª—è —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–æ–≤ —Ü–µ–Ω—è—Ç —É–º–µ–Ω–∏–µ —á–µ—Ç–∫–æ –∏ –ø–æ–Ω—è—Ç–Ω–æ –∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä–æ–≤–∞—Ç—å –∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ –ø—Ä–æ–¥–∞–≤–∞—Ç—å –≥–æ—Ä–∞–∑–¥–æ –≤—ã—à–µ, —á–µ–º –ø—Ä–µ–∑–µ–Ω—Ç–∞–±–µ–ª—å–Ω–æ—Å—Ç—å –∏ —ç–Ω—Ç—É–∑–∏–∞–∑–º. ‚ù§Ô∏è –ë–µ–∑ –∏—Å–∫–ª—é—á–µ–Ω–∏–π. –ê–†–§–ü –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∞ –∏–∑–º–µ–Ω–∏—Ç—å –ø–æ–¥—Ö–æ–¥ –∫ –∏—Å–∫–ª—é—á–µ–Ω–∏—é –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏–∑ –ü–µ—Ä–µ—á–Ω—è –ñ–ù–í–õ–ü, –≤–≤–µ–¥—è –±–∞–ª–ª—å–Ω—É—é —à–∫–∞–ª—É –¥–ª—è –∫–æ–º–ø–ª–µ–∫—Å–Ω–æ–π –æ—Ü–µ–Ω–∫–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ø–æ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–º, —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–∏–º –∏ –∑–∞–∫—É–ø–æ—á–Ω—ã–º –∫—Ä–∏—Ç–µ—Ä–∏—è–º.","{
  ""skip"": true
}"
2025-09-26T16:17:04+00:00,@medpharm,12834,https://t.me/medpharm/12834,"–ó–∞—Ä–ø–ª–∞—Ç—ã —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–æ–≤ –∑–∞ –≥–æ–¥ –≤—ã—Ä–æ—Å–ª–∏ –Ω–∞ 16%. –ü—Ä–∏ —ç—Ç–æ–º —Ä–∞–±–æ—Ç–æ–¥–∞—Ç–µ–ª–∏ –≤ –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–µ –≤–∞–∫–∞–Ω—Å–∏–π –¥–ª—è —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–æ–≤ —Ü–µ–Ω—è—Ç —É–º–µ–Ω–∏–µ —á–µ—Ç–∫–æ –∏ –ø–æ–Ω—è—Ç–Ω–æ –∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä–æ–≤–∞—Ç—å –∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ –ø—Ä–æ–¥–∞–≤–∞—Ç—å –≥–æ—Ä–∞–∑–¥–æ –≤—ã—à–µ, —á–µ–º –ø—Ä–µ–∑–µ–Ω—Ç–∞–±–µ–ª—å–Ω–æ—Å—Ç—å –∏ —ç–Ω—Ç—É–∑–∏–∞–∑–º. –ì–ª–∞–≤–Ω–æ–µ ‚Äî –∑–Ω–∞—Ç—å —Ñ–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—é –∏ —É–º–µ—Ç—å –ø—Ä–µ–¥–ª–æ–∂–∏—Ç—å –Ω—É–∂–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PRfWi #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{""skip"": true}"
2025-09-26T16:04:02+00:00,@medpharm,12833,https://t.me/medpharm/12833,"–í –†–æ—Å—Å–∏–∏ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ —Ä–∞–∑—Ä–µ—à–∏—Ç—å –ø–∞—Ü–∏–µ–Ω—Ç–∞–º –ø–æ–ª—É—á–∞—Ç—å –¥–æ—Ä–æ–≥–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –ø–æ –û–ú–° –∞–º–±—É–ª–∞—Ç–æ—Ä–Ω–æ –¥–ª—è —Å–æ–∫—Ä–∞—â–µ–Ω–∏—è —á–∏—Å–ª–∞ –Ω–µ–æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω—ã—Ö –≥–æ—Å–ø–∏—Ç–∞–ª–∏–∑–∞—Ü–∏–π. –ù–æ–≤–æ–≤–≤–µ–¥–µ–Ω–∏–µ –¥–æ–ª–∂–Ω–æ —Ç–∞–∫–∂–µ —É–º–µ–Ω—å—à–∏—Ç—å –±—é–¥–∂–µ—Ç–Ω—ã–µ —Ä–∞—Å—Ö–æ–¥—ã, —Å—á–∏—Ç–∞—é—Ç –∞–≤—Ç–æ—Ä—ã –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PRezH #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The initiative proposes allowing patients to receive expensive medications ambulatory under the state insurance program (–û–ú–°) to reduce unnecessary hospitalizations. The authors of the initiative also suggest this will decrease budgetary expenses.""
}"
2025-09-26T15:52:04+00:00,@medpharm,12832,https://t.me/medpharm/12832,"–î–æ–ª–≥–æ—Å—Ä–æ—á–Ω—ã–π –∫–æ–Ω—Ç–∞–∫—Ç —Å –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª—è–º–∏ –∏ –ø–µ—Ä—Å–æ–Ω–∞–ª–æ–º —Å—Ç–∞–Ω–æ–≤–∏—Ç—Å—è –±–∞–∑–æ–≤–æ–π —Å—Ç—Ä–∞—Ç–µ–≥–∏–µ–π –¥–ª—è –∞–ø—Ç–µ—á–Ω—ã—Ö —Å–µ—Ç–µ–π. –ß—Ç–æ–±—ã —É–¥–µ—Ä–∂–∞—Ç—å –∫–ª–∏–µ–Ω—Ç–æ–≤, –æ–Ω–∏ –æ—Ç–∫–∞–∑—ã–≤–∞—é—Ç—Å—è –æ—Ç –∞–≥—Ä–µ—Å—Å–∏–≤–Ω—ã—Ö –¥–æ–ø—Ä–æ–¥–∞–∂ –∏ –æ—Ä–∏–µ–Ω—Ç–∏—Ä–∞ –Ω–∞ –¥–æ—Ä–æ–≥–æ—Å—Ç–æ—è—â–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, –∞ –¥–ª—è –ø—Ä–∏–≤–ª–µ—á–µ–Ω–∏—è —Ñ–∞—Ä–º—Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ —Å–Ω–∏–∂–∞—é—Ç —Å–ø–∏—Å–æ–∫ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π –≤ –æ—Ü–µ–Ω–æ—á–Ω—ã—Ö –ª–∏—Å—Ç–∞—Ö –∏ —Ä–∞—Å—à–∏—Ä—è—é—Ç –ø–∞–∫–µ—Ç—ã –Ω–µ–º–∞—Ç–µ—Ä–∏–∞–ª—å–Ω–æ–π –º–æ—Ç–∏–≤–∞—Ü–∏–∏. –ü–æ—á–µ–º—É –∞–ø—Ç–µ–∫–∏ –Ω–µ –±–æ—è—Ç—Å—è —Ä–∞–∑–≤–∏—Ç–∏—è –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–æ–≤ –∏ –∫–∞–∫ –±—É–¥–µ—Ç –º–µ–Ω—è—Ç—å—Å—è —Ä–æ–∑–Ω–∏—á–Ω—ã–π —Ä—ã–Ω–æ–∫, –≤ —Ä–µ–ø–æ—Ä—Ç–∞–∂–µ ¬´–§–í¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PReTa #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{""skip"": true}"
2025-09-26T15:24:02+00:00,@medpharm,12831,https://t.me/medpharm/12831,"–†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä —Å–æ–æ–±—â–∏–ª –æ–± –æ—Ç–∑—ã–≤–µ –¥–≤—É—Ö –ø–∞—Ä—Ç–∏–π ¬´–¢—Ä–∞–Ω–µ–∫—Å–∞–º–æ–≤–æ–π –∫–∏—Å–ª–æ—Ç—ã¬ª –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ ¬´–ë-–§–∞—Ä–º¬ª. –í –æ–¥–Ω–æ–π –∏–∑ —Å–µ—Ä–∏–π –±—ã–ª–∞ –æ–±–Ω–∞—Ä—É–∂–µ–Ω–∞ –∞–º–ø—É–ª–∞ –±–µ–∑ —ç—Ç–∏–∫–µ—Ç–∫–∏, –∞ –≤ –¥—Ä—É–≥–æ–π –≤–º–µ—Å—Ç–æ –∫—Ä–æ–≤–æ–æ—Å—Ç–∞–Ω–∞–≤–ª–∏–≤–∞—é—â–µ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –æ–∫–∞–∑–∞–ª–∏—Å—å –∞–º–ø—É–ª—ã —Å –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–º —Å—Ä–µ–¥—Å—Ç–≤–æ–º –æ—Ç —Ç–∞—Ö–∏–∫–∞—Ä–¥–∏–∏. –í—Å–µ —É–∫–∞–∑–∞–Ω–Ω—ã–µ —Å–µ—Ä–∏–∏ –±—ã–ª–∏ –æ—Ç–æ–∑–≤–∞–Ω—ã –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–º –∏–∑ –æ–±—Ä–∞—â–µ–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PRd9z #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–û—Ç–∑—ã–≤—ã","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""shortage, regulation"",
  ""impact"": ""high"",
  ""english"": ""The Russian Health Supervision Authority (Rospotrebnadzor) announced the recall of two batches of 'Trenexovaya kislota' produced by 'B-Farm'. In one series, a vial was found to be missing the label, and in another, ampules containing drugs for atrial fibrillation were found instead of the intended anti-bleeding medication. All identified series have been recalled by the manufacturer from circulation. For more details: https://clck.ru/3PRd9z #FarmaVestnik #Recalls""
}"
2025-09-26T15:19:02+00:00,@medpharm,12830,https://t.me/medpharm/12830,–°—É–¥ —Ä–∞—Å—Å–º–æ—Ç—Ä–∏—Ç –¥–µ–ª–æ –±—ã–≤—à–µ–≥–æ —Ä–µ–∫—Ç–æ—Ä–∞ –ß–∏—Ç–∏–Ω—Å–∫–æ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –∞–∫–∞–¥–µ–º–∏–∏ –æ –ø—Ä–µ–≤—ã—à–µ–Ω–∏–∏ –¥–æ–ª–∂–Ω–æ—Å—Ç–Ω—ã—Ö –ø–æ–ª–Ω–æ–º–æ—á–∏–π –∏ —É—â–µ—Ä–±–µ –≤—É–∑—É –Ω–∞ 400 —Ç—ã—Å. —Ä—É–±. –î–º–∏—Ç—Ä–∏–π –ó–∞–π—Ü–µ–≤ —É—à–µ–ª –≤ –æ—Ç—Å—Ç–∞–≤–∫—É –≤ —Ñ–µ–≤—Ä–∞–ª–µ –ø—Ä–æ—à–ª–æ–≥–æ –≥–æ–¥–∞ –∏ —Å–µ–π—á–∞—Å –∑–∞–≤–µ–¥—É–µ—Ç –∫–∞—Ñ–µ–¥—Ä–æ–π –Ω–∞ —Ñ–∞–∫—É–ª—å—Ç–µ—Ç–µ –ø–æ–≤—ã—à–µ–Ω–∏—è –∫–≤–∞–ª–∏—Ñ–∏–∫–∞—Ü–∏–∏ –∏ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–π –ø–µ—Ä–µ–ø–æ–¥–≥–æ—Ç–æ–≤–∫–∏ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –≤ –ò—Ä–∫—É—Ç—Å–∫–æ–º –º–µ–¥—É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PRcvu #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-09-26T15:02:08+00:00,@medpharm,12829,https://t.me/medpharm/12829,"Forbes –≤–∫–ª—é—á–∏–ª –¥–µ–≤—è—Ç—å —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –±—Ä–µ–Ω–¥–æ–≤ –≤ TOP300 –ª—É—á—à–∏—Ö –ø–æ —Å–æ–æ—Ç–Ω–æ—à–µ–Ω–∏—é —Ü–µ–Ω–∞‚Äî–∫–∞—á–µ—Å—Ç–≤–æ. –°—Ä–µ–¥–∏ –ø–æ–ø–∞–≤—à–∏—Ö –≤ —Ä–µ–π—Ç–∏–Ω–≥ ‚Äî –ø—Ä–æ—Ç–∏–≤–æ–ø—Ä–æ—Å—Ç—É–¥–Ω—ã–µ —Å—Ä–µ–¥—Å—Ç–≤–∞ ¬´–í–∏–∫—Å¬ª, –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –ë–ê–î Herbalife –∏ Nature Made, –±–æ–ª–µ—É—Ç–æ–ª—è—é—â–∏–µ —Å –ø–∞—Ä–∞—Ü–µ—Ç–∞–º–æ–ª–æ–º –≤ —Å–æ—Å—Ç–∞–≤–µ Tylenol –∏ ¬´–≠–∫—Å–µ–¥—Ä–∏–Ω¬ª, –ª–µ–¥–µ–Ω—Ü—ã –æ—Ç –∫–∞—à–ª—è Ricola –∏ Halls, –∞–ø—Ç–µ—á–Ω–∞—è —Å–µ—Ç—å Walgreens –∏ –∞–Ω—Ç–∏–≥–∏—Å—Ç–∞–º–∏–Ω–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç ¬´–ó–∏—Ä—Ç–µ–∫¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PRc9L #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{""skip"": true}"
2025-09-26T14:39:02+00:00,@medpharm,12828,https://t.me/medpharm/12828,"–ê–†–§–ü –≤—ã—Å—Ç—É–ø–∏–ª–∞ –∑–∞ –∏–∑–º–µ–Ω–µ–Ω–∏–µ –ø–æ–¥—Ö–æ–¥–∞ –∏ —Ä–∞—Å—à–∏—Ä–µ–Ω–∏–µ –æ—Å–Ω–æ–≤–∞–Ω–∏–π –¥–ª—è –∏—Å–∫–ª—é—á–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏–∑ –ü–µ—Ä–µ—á–Ω—è –ñ–ù–í–õ–ü. –û–Ω–∞ –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç –≤–Ω–µ–¥—Ä–∏—Ç—å –±–∞–ª–ª—å–Ω—É—é —à–∫–∞–ª—É –∏ –∫–æ–º–ø–ª–µ–∫—Å–Ω–æ –æ—Ü–µ–Ω–∏–≤–∞—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç –ø–æ —Ç–∞–∫–∏–º –∫—Ä–∏—Ç–µ—Ä–∏—è–º, –∫–∞–∫ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ –¥–ª—è –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∏, –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏, –ª–µ—á–µ–Ω–∏—è –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, –ø—Ä–µ–æ–±–ª–∞–¥–∞—é—â–∏—Ö –≤ —Å—Ç—Ä—É–∫—Ç—É—Ä–µ –∑–∞–±–æ–ª–µ–≤–∞–µ–º–æ—Å—Ç–∏ –∏ —Å–º–µ—Ä—Ç–Ω–æ—Å—Ç–∏, –æ–±—ä–µ–º (–¥–æ–ª—è) –≤ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –∑–∞–∫—É–ø–∫–∞—Ö, —Å—Ç–æ–∏–º–æ—Å—Ç—å –∫—É—Ä—Å–∞ –ª–µ—á–µ–Ω–∏—è –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å —Ç–µ—Ä–∞–ø–µ–≤—Ç–∏—á–µ—Å–∫–∏ –∞–Ω–∞–ª–æ–≥–∏—á–Ω—ã–º, –≤–∫–ª—é—á–µ–Ω–Ω—ã–º –≤ –ø–µ—Ä–µ—á–µ–Ω—å. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PRauA #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""high"",
  ""english"": ""The ARFP is advocating for changes and expanding the criteria for excluding drugs from the –ñ–ù–í–õ–ü list. They propose implementing a scoring system and comprehensively evaluating the drug based on criteria such as its use for diagnosis, prevention, or treatment of prevalent diseases and deaths, the share in government procurement, and the cost per course of treatment compared to a therapeutic equivalent included in the list. More details: https://clck.ru/3PRauA #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ""
}"
2025-09-26T14:27:02+00:00,@medpharm,12827,https://t.me/medpharm/12827,"–ê–ª—å—Ç–µ—Ä–Ω–∞—Ç–∏–≤–Ω–∞—è —Å—Ö–µ–º–∞ —Ç–µ—Ä–∞–ø–∏–∏ —Å –≤–Ω—É—Ç—Ä–∏–≤–µ–Ω–Ω—ã–º –º–µ—Ç–∏–ª–ø—Ä–µ–¥–Ω–∏–∑–æ–ª–æ–Ω–æ–º, –º–µ—Ç–æ—Ç—Ä–µ–∫—Å–∞—Ç–æ–º –∏ –±–æ–ª–µ–µ –Ω–∏–∑–∫–∏–º–∏ –¥–æ–∑–∞–º–∏ –ø–µ—Ä–æ—Ä–∞–ª—å–Ω–æ–≥–æ –ø—Ä–µ–¥–Ω–∏–∑–æ–ª–æ–Ω–∞ –æ–∫–∞–∑–∞–ª–∞—Å—å —Å—Ç–æ–ª—å –∂–µ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ–π –ø—Ä–∏ –ª–µ—á–µ–Ω–∏–∏ –≥–∏–≥–∞–Ω—Ç–æ–∫–ª–µ—Ç–æ—á–Ω–æ–≥–æ –∞—Ä—Ç–µ—Ä–∏–∏—Ç–∞, –∫–∞–∫ –∏ —Å—Ç–∞–Ω–¥–∞—Ä—Ç–Ω–æ–µ –ª–µ—á–µ–Ω–∏–µ –≤—ã—Å–æ–∫–∏–º–∏ –¥–æ–∑–∞–º–∏ —Å—Ç–µ—Ä–æ–∏–¥–æ–≤. –ü—Ä–∏ —ç—Ç–æ–º —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –Ω–∞–±–ª—é–¥–∞–ª–æ—Å—å –º–µ–Ω—å—à–µ –æ—Å–ª–æ–∂–Ω–µ–Ω–∏–π, —Å–≤—è–∑–∞–Ω–Ω—ã—Ö —Å –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º –≥–ª—é–∫–æ–∫–æ—Ä—Ç–∏–∫–æ–∏–¥–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PRaFc #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–†–µ–≤–º–∞—Ç–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, shortage, safety"",
  ""impact"": ""medium"",
  ""english"": ""An alternative treatment with intravenous methylprednisolone, methotrexate and lower oral prednisolone doses was equally effective in treating giant cell arteritis as the standard treatment with high steroid doses. Fewer complications related to glucocorticoid use were observed in patients.""
}"
2025-09-26T14:09:03+00:00,@medpharm,12826,https://t.me/medpharm/12826,"¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª –Ω–∞–ø—Ä–∞–≤–∏—Ç 275,2 –º–ª–Ω —Ä—É–±. –Ω–∞ –≤—ã–ø–ª–∞—Ç—É –¥–∏–≤–∏–¥–µ–Ω–¥–æ–≤ –ø–æ –∏—Ç–æ–≥–∞–º I –ø–æ–ª—É–≥–æ–¥–∏—è 2025 –≥–æ–¥–∞. –ß—Ç–æ–±—ã –ø–æ–ª—É—á–∏—Ç—å –≤—ã–ø–ª–∞—Ç—É, –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ –≤–ª–∞–¥–µ—Ç—å –∞–∫—Ü–∏—è–º–∏ –∫–æ–º–ø–∞–Ω–∏–∏ –Ω–∞ 6 –æ–∫—Ç—è–±—Ä—è. –ü–∞—Ä–∞–ª–ª–µ–ª—å–Ω–æ –∫–æ–º–ø–∞–Ω–∏—è –æ–±—ä—è–≤–∏–ª–∞ –æ –¥–æ–ø—ç–º–∏—Å—Å–∏–∏ 78,5 –º–ª–Ω –∞–∫—Ü–∏–π –ø–æ —Ü–µ–Ω–µ 42 —Ä—É–±. –∑–∞ —à—Ç—É–∫—É, —á—Ç–æ –∑–∞–≤–µ—Ä—à–∏—Ç —Å–¥–µ–ª–∫—É SPO. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PRZFG #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-09-26T13:43:02+00:00,@medpharm,12825,https://t.me/medpharm/12825,"–î–∏—Ä–µ–∫—Ç–æ—Ä ¬´–ì–∞—Ä–º–æ–Ω–∏–∏ –∑–¥–æ—Ä–æ–≤—å—è¬ª –°–µ—Ä–≥–µ–π –ú–µ—â–∞–Ω –ø—Ä–∏–Ω–µ—Å –∏–∑–≤–∏–Ω–µ–Ω–∏—è —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∞–º –ø–æ—Å–ª–µ —Å–≤–æ–∏—Ö —Å–ª–æ–≤ –Ω–∞ –ê–ø—Ç–µ—á–Ω–æ–º —Å–∞–º–º–∏—Ç–µ. –ü–æ–≤–æ–¥–æ–º —Å—Ç–∞–ª–∞ –¥–∏—Å–∫—É—Å—Å–∏—è –æ –º–æ—Ç–∏–≤–∞—Ü–∏–∏ —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤, –≤ —Ö–æ–¥–µ –∫–æ—Ç–æ—Ä–æ–π –æ–Ω —É—Å–æ–º–Ω–∏–ª—Å—è –≤ –¥–∞–Ω–Ω—ã—Ö –æ –Ω–∏–∑–∫–∏—Ö –∑–∞—Ä–ø–ª–∞—Ç–∞—Ö –ø–µ—Ä–≤–æ—Å—Ç–æ–ª—å–Ω–∏–∫–æ–≤. –†—è–¥ –≤—ã—Å–∫–∞–∑—ã–≤–∞–Ω–∏–π –±—ã–ª–∏ –∏–Ω—Ç–µ—Ä–ø—Ä–µ—Ç–∏—Ä–æ–≤–∞–Ω—ã —Ñ–∞—Ä–º—Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞–º–∏ –∫–∞–∫ –Ω–µ—É–≤–∞–∂–∏—Ç–µ–ª—å–Ω–æ–µ –æ—Ç–Ω–æ—à–µ–Ω–∏–µ –∫ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª—è–º –ø—Ä–æ—Ñ–µ—Å—Å–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PRXZC #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫","{""skip"": true}"
2025-09-26T12:41:04+00:00,@medpharm,12824,https://t.me/medpharm/12824,"–ü–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –ø—Ä–æ—à–ª—ã–º –≥–æ–¥–æ–º –º–µ–¥–∏–∞–Ω–Ω—ã–µ –∑–∞—Ä–ø–ª–∞—Ç—ã –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –≤ –†–æ—Å—Å–∏–∏ –≤—ã—Ä–æ—Å–ª–∏ –ø—Ä–∏–º–µ—Ä–Ω–æ –Ω–∞ 15%, –∞ –Ω–∞–∏–±–æ–ª—å—à–∏–π –ø—Ä–∏—Ä–æ—Å—Ç –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–Ω —É –º–∞—Å—Å–∞–∂–∏—Å—Ç–æ–≤ –∏ –∞—Å—Å–∏—Å—Ç–µ–Ω—Ç–æ–≤ –≤—Ä–∞—á–∞. –ß–∏—Å–ª–æ –æ—Ç–∫–ª–∏–∫–æ–≤ –Ω–∞ –≤–∞–∫–∞–Ω—Å–∏–∏ –≤ —Å—Ñ–µ—Ä–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –≤—ã—Ä–æ—Å–ª–æ –Ω–∞ 16%. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PRTL9 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-09-26T11:45:04+00:00,@medpharm,12823,https://t.me/medpharm/12823,"–ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ –ø–æ–¥–≥–æ—Ç–æ–≤–∏–ª –ø—Ä–æ–µ–∫—Ç –º–µ—Ç–æ–¥–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π, –ø–æ–¥—Ä–æ–±–Ω–æ –æ–ø–∏—Å—ã–≤–∞—é—â–∏—Ö, —á—Ç–æ —è–≤–ª—è–µ—Ç—Å—è —Ö–∏–º–∏—á–µ—Å–∫–∏–º —Å–∏–Ω—Ç–µ–∑–æ–º –≤ —Ñ–∞—Ä–º–ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏. –°–µ–π—á–∞—Å –¥–æ–∫—É–º–µ–Ω—Ç –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω —É—á–∞—Å—Ç–Ω–∏–∫–∞–º –∏–Ω–¥—É—Å—Ç—Ä–∏–∏ –¥–ª—è –æ–±—Å—É–∂–¥–µ–Ω–∏—è –∏ –¥–æ—Ä–∞–±–æ—Ç–∫–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PRPCt #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-09-26T11:38:03+00:00,@medpharm,12822,https://t.me/medpharm/12822,"–ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–µ —ç–∫—Å–ø–µ—Ä—Ç—ã –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∏ –æ–±–Ω–æ–≤–ª–µ–Ω–Ω—ã–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø–æ –ª—É—á–µ–≤–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –ø–æ—Å–ª–µ –º–∞—Å—Ç—ç–∫—Ç–æ–º–∏–∏. –î–æ–∫—É–º–µ–Ω—Ç —É—á–∏—Ç—ã–≤–∞–µ—Ç –¥–æ—Å—Ç–∏–∂–µ–Ω–∏—è –≤ –æ–±–ª–∞—Å—Ç–∏ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∏, —Å–∏—Å—Ç–µ–º–Ω–æ–≥–æ –ª–µ—á–µ–Ω–∏—è –∏ —Å–æ–≤—Ä–µ–º–µ–Ω–Ω—ã—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π —Ä–∞–¥–∏–æ—Ç–µ—Ä–∞–ø–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PRNhx #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–û–Ω–∫–æ–ª–æ–≥–∏—è #–†–∞–¥–∏–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-09-26T10:35:03+00:00,@medpharm,12821,https://t.me/medpharm/12821,"–ö–∞–∂–¥–∞—è –ø—è—Ç–∞—è –≥–æ—Å–ø–∏—Ç–∞–ª–∏–∑–∞—Ü–∏—è –≤ –æ—Ç–¥–µ–ª–µ–Ω–∏—è –Ω–µ–æ—Ç–ª–æ–∂–Ω–æ–π –ø–æ–º–æ—â–∏ –≤ –°–®–ê —Å–æ–ø—Ä–æ–≤–æ–∂–¥–∞–µ—Ç—Å—è —É–≥—Ä–æ–∑–∞–º–∏ –∏–ª–∏ –Ω–∞–ø–∞–¥–µ–Ω–∏—è–º–∏ –Ω–∞ –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤, –∞ –ø–æ—á—Ç–∏ 40% ‚Äî —Å–ª–æ–≤–µ—Å–Ω—ã–º–∏ –æ—Å–∫–æ—Ä–±–ª–µ–Ω–∏—è–º–∏. –ë–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ –ø–æ–¥–æ–±–Ω—ã—Ö —Å–ª—É—á–∞–µ–≤ –Ω–µ —Ñ–∏–∫—Å–∏—Ä—É–µ—Ç—Å—è –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω–æ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PRHgU #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-09-26T10:33:03+00:00,@medpharm,12820,https://t.me/medpharm/12820,"–í—Ä–∏–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –î–µ–ø–∑–¥—Ä–∞–≤–∞ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –Ω–∞–∑–Ω–∞—á–µ–Ω –î–µ–Ω–∏—Å –†–æ—â–∏–Ω, —Ä–∞–Ω–µ–µ –∑–∞–Ω–∏–º–∞–≤—à–∏–π –ø–æ—Å—Ç –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—è –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –î–µ–ø–∑–¥—Ä–∞–≤–∞. –ü—Ä–µ–∂–Ω–∏–π –≥–ª–∞–≤–∞ –ò–≥–æ—Ä—å –ö–∞–≥—Ä–∞–º–∞–Ω—è–Ω —Å—Ç–∞–ª –∞—É–¥–∏—Ç–æ—Ä–æ–º –°—á–µ—Ç–Ω–æ–π –ø–∞–ª–∞—Ç—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PRHWf #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–∞—Ä—å–µ—Ä–∞","{""skip"": true}"
2025-09-26T08:16:02+00:00,@medpharm,12819,https://t.me/medpharm/12819,"–°–®–ê –≤–≤–æ–¥—è—Ç 100%-–Ω—ã–µ –ø–æ—à–ª–∏–Ω—ã –∑–∞ –∏–º–ø–æ—Ä—Ç –±—Ä–µ–Ω–¥–æ–≤—ã—Ö –∏ –ø–∞—Ç–µ–Ω—Ç–æ–≤–∞–Ω–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ —Å 1 –æ–∫—Ç—è–±—Ä—è. –ò—Å–∫–ª—é—á–µ–Ω–∏–µ —Å–¥–µ–ª–∞–Ω–æ –¥–ª—è —Ç–µ—Ö, –∫—Ç–æ –Ω–∞—á–∞–ª —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–æ –∑–∞–≤–æ–¥–æ–≤ –Ω–∞ –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–π —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PR7Fq #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-09-26T07:59:02+00:00,@medpharm,12818,https://t.me/medpharm/12818,–í—Ä–∏–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –î–µ–ø–∞—Ä—Ç–∞–º–µ–Ω—Ç–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –†–§ —Å—Ç–∞–ª –î–µ–Ω–∏—Å –†–æ—â–∏–Ω. –ü—Ä–µ–∂–Ω–∏–π —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å –ò–≥–æ—Ä—å –ö–∞–≥—Ä–∞–º–∞–Ω—è–Ω —É—à–µ–ª –≤ –æ—Ç—Å—Ç–∞–≤–∫—É 23 —Å–µ–Ω—Ç—è–±—Ä—è –ø–æ—Å–ª–µ –Ω–∞–∑–Ω–∞—á–µ–Ω–∏—è –∞—É–¥–∏—Ç–æ—Ä–æ–º –°—á–µ—Ç–Ω–æ–π –ø–∞–ª–∞—Ç—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PR5ko #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing"",
  ""impact"": ""medium"",
  ""english"": ""The Director of the Department of Health in the Russian Federation government has been appointed Denis Roshchin. Igor Kagramanyan, his predecessor, resigned on September 23rd after being appointed an auditor by the Audit Chamber.""
}"
2025-09-26T07:51:03+00:00,@medpharm,12817,https://t.me/medpharm/12817,"–ê–ø—Ç–µ—á–Ω–∞—è —Å–µ—Ç—å ¬´–û–º—Å–∫–æ–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–æ¬ª –≤–æ—à–ª–∞ –≤ –ø—Ä–æ–≥—Ä–∞–º–º—É –ø—Ä–∏–≤–∞—Ç–∏–∑–∞—Ü–∏–∏ —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç–∏ —Ä–µ–≥–∏–æ–Ω–∞. –°—Ä–æ–∫ –ø—Ä–∏–≤–∞—Ç–∏–∑–∞—Ü–∏–∏ —Å–¥–≤–∏–Ω—É–ª–∏ —Å 2024 –Ω–∞ 2025 –≥–æ–¥. –ü–∞–∫–µ—Ç –∏–∑ 2,6 –º–ª–Ω –∞–∫—Ü–∏–π –æ—Ü–µ–Ω–∏–ª–∏ –≤ 259,36 –º–ª–Ω —Ä—É–±. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PR5Bb #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–æ–∑–Ω–∏—Ü–∞","{""skip"": true}"
2025-09-26T06:12:03+00:00,@medpharm,12816,https://t.me/medpharm/12816,"–£ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –ø–æ–ª—É—á–∞–≤—à–∏—Ö –Ω–∏–∫–æ—Ç–∏–Ω–∞–º–∏–¥, –Ω–∞–±–ª—é–¥–∞–ª–æ—Å—å –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ–µ —Å–Ω–∏–∂–µ–Ω–∏–µ —Ä–∏—Å–∫–∞ —Ä–∞–∑–≤–∏—Ç–∏—è —Ä–∞–∫–∞ –∫–æ–∂–∏. –ù–∞–∏–±–æ–ª—å—à–∏–π —ç—Ñ—Ñ–µ–∫—Ç –æ—Ç–º–µ—á–∞–ª—Å—è –ø—Ä–∏ –Ω–∞–∑–Ω–∞—á–µ–Ω–∏–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –ø–æ—Å–ª–µ –≤—ã—è–≤–ª–µ–Ω–∏—è –ø–µ—Ä–≤–æ–≥–æ —Å–ª—É—á–∞—è –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PQvnr #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–î–µ—Ä–º–∞—Ç–æ–≤–µ–Ω–µ—Ä–æ–ª–æ–≥–∏—è #–û–Ω–∫–æ–ª–æ–≥–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-09-26T06:04:02+00:00,@medpharm,12815,https://t.me/medpharm/12815,"–ü–µ—Ä–≤–æ–Ω–∞—á–∞–ª—å–Ω–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç –±—ã–ª –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω –∫–∞–∫ —è–¥ –¥–ª—è –≥—Ä—ã–∑—É–Ω–æ–≤ –≤ –°–®–ê –≤ 1948 –≥–æ–¥—É. –ü–æ–∑–¥–Ω–µ–µ —Å–ª—É—á–∏–ª–∞—Å—å –∏—Å—Ç–æ—Ä–∏—è, –∫–æ—Ç–æ—Ä–∞—è –ø—Ä–∏–≤–ª–µ–∫–ª–∞ –≤–Ω–∏–º–∞–Ω–∏–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª–µ–π. –ß–µ–ª–æ–≤–µ–∫ –ø—Ä–∏–Ω—è–ª –Ω–µ—Å–∫–æ–ª—å–∫–æ –¥–æ–∑ —ç—Ç–æ–≥–æ —è–¥–∞, –æ–¥–Ω–∞–∫–æ –ø–æ—Å–ª–µ –≤–≤–µ–¥–µ–Ω–∏—è —Ä–∞—Å—Ç–≤–æ—Ä–∞ –≤–∏—Ç–∞–º–∏–Ω–∞ –ö –ø–æ–ª–Ω–æ—Å—Ç—å—é –≤—ã–∑–¥–æ—Ä–æ–≤–µ–ª. –ü–æ—Å–ª–µ —ç—Ç–æ–≥–æ —Å–æ–±—ã—Ç–∏—è –Ω–∞—á–∞–ª–æ—Å—å —à–∏—Ä–æ–∫–æ–µ –∏–∑—É—á–µ–Ω–∏–µ –≤–∞—Ä—Ñ–∞—Ä–∏–Ω–∞, –∫–∞–∫ –∞–Ω—Ç–∏–∫–æ–∞–≥—É–ª—è–Ω—Ç–∞. –û–¥–Ω–∞–∫–æ –≤ –Ω–∞—á–∞–ª–µ –Ω–æ–≤–æ–≥–æ —Ç—ã—Å—è—á–µ–ª–µ—Ç–∏—è –ø–æ—è–≤–∏–ª–∏—Å—å –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –∏–∑ –≥—Ä—É–ø–ø—ã –Ω–æ–≤—ã—Ö –ø–µ—Ä–æ—Ä–∞–ª—å–Ω—ã—Ö –∞–Ω—Ç–∏–∫–æ–∞–≥—É–ª—è–Ω—Ç–æ–≤ (–ù–û–ê–ö), –Ω–∞ —Ñ–æ–Ω–µ –ø—Ä–∏–µ–º–∞ –∫–æ—Ç–æ—Ä—ã—Ö –≥–æ—Ä–∞–∑–¥–æ —Ä–µ–∂–µ —Ä–∞–∑–≤–∏–≤–∞—é—Ç—Å—è –∫—Ä–æ–≤–æ—Ç–µ—á–µ–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PQvEc #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–µ–ø–∞—Ä–∞—Ç—ã/–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-09-25T16:17:58+00:00,@medpharm,12814,https://t.me/medpharm/12814,"ü¶æ–ù—É–∂–Ω—ã —Ä–µ–∑–µ—Ä–≤—ã. –í –°–æ–≤–µ—Ç–µ –§–µ–¥–µ—Ä–∞—Ü–∏–∏ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ —É–≤–µ–ª–∏—á–∏—Ç—å —Ä–∞—Å—Ö–æ–¥—ã –Ω–∞ –ª–µ—á–µ–Ω–∏–µ –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –≤ 2026 –≥–æ–¥—É –º–∏–Ω–∏–º—É–º –Ω–∞ 57 –º–ª—Ä–¥ —Ä—É–±. –£ —Ä–µ–≥–∏–æ–Ω–æ–≤ –Ω–µ —Ö–≤–∞—Ç–∞–µ—Ç —Å—Ä–µ–¥—Å—Ç–≤ –¥–ª—è —Ä–µ–∞–ª—å–Ω–æ–≥–æ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç–µ–π –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–∏ —Å –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–º–∏ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏—è–º–∏. ü¶æ–°—Ç–∏–º—É–ª—ã –¥–ª—è ¬´—Ü–∏—Ñ—Ä—ã¬ª. –§–∞–∫—Ç–æ—Ä–∞–º–∏ —É—Å–∫–æ—Ä–µ–Ω–∏—è –≤–Ω–µ–¥—Ä–µ–Ω–∏—è —Ü–∏—Ñ—Ä–æ–≤—ã—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –≤ –º–µ–¥–∏—Ü–∏–Ω–µ —Å—Ç–∞–Ω–æ–≤—è—Ç—Å—è –±–µ—Å–ø–ª–∞—Ç–Ω—ã–µ –æ–±—É—á–∞—é—â–∏–µ –∫—É—Ä—Å—ã –∏ —É—á–µ–±–Ω—ã–µ –æ—Ç–ø—É—Å–∫–∞ –¥–ª—è –≤—Ä–∞—á–µ–π, –Ω–∞–¥–µ–∂–Ω–∞—è —é—Ä–∏–¥–∏—á–µ—Å–∫–∞—è –ø–æ–¥–¥–µ—Ä–∂–∫–∞ –∏ —Ä–∞–∑–≤–∏—Ç–∏–µ –ø–æ–Ω—è—Ç–Ω–æ–π –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω–æ–π –±–∞–∑—ã. ‚ù§Ô∏è–î–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–π —Å—Ç–∏–º—É–ª. –ù–∞—Å—Ç–∞–≤–Ω–∏–∫–∏ –ø–æ–ª—É—á–∞—Ç –µ–∂–µ–≥–æ–¥–Ω—ã–π –Ω–∞–ª–æ–≥–æ–≤—ã–π –≤—ã—á–µ—Ç –≤ 18 —Ç—ã—Å. —Ä—É–±. –∏ –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–π –æ–ø–ª–∞—á–∏–≤–∞–µ–º—ã–π –æ—Ç–ø—É—Å–∫. –ó–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç—ã –≤–Ω–µ—Å–µ–Ω—ã –Ω–∞ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏–µ –≤ –ì–æ—Å–¥—É–º—É. ‚ù§Ô∏è–°—Ç—Ä–æ—á–∫–æ–π –Ω–∏–∂–µ. –†–æ—Å—Å–∏–π—Å–∫–∏–π Forbes –æ–ø—É–±–ª–∏–∫–æ–≤–∞–ª TOP100 –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö –∫–æ–º–ø–∞–Ω–∏–π –†–æ—Å—Å–∏–∏ –ø–æ —á–∏—Å—Ç–æ–π –ø—Ä–∏–±—ã–ª–∏. –í —Ä–µ–π—Ç–∏–Ω–≥, –∫–∞–∫ –∏ –≥–æ–¥–æ–º —Ä–∞–Ω–µ–µ, –ø–æ–ø–∞–ª–∞ –ª–∏—à—å –æ–¥–Ω–∞ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∞—è –∫–æ–º–ø–∞–Ω–∏—è. –û–Ω–∞ –æ–ø—É—Å—Ç–∏–ª–∞—Å—å —Å 97-–≥–æ –Ω–∞ 98-–µ –º–µ—Å—Ç–æ.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""Russian Forbes published the TOP100 largest companies in Russia by net profit. This year, only one pharmaceutical company made it to the list (down from 97th to 98th place). Factors accelerating the adoption of digital technologies in medicine include free training courses and leave for doctors, reliable legal support, and the development of understandable regulatory bases. The law proposals have been submitted to the State Duma.""
}"
2025-09-25T15:44:03+00:00,@medpharm,12813,https://t.me/medpharm/12813,–ú–∏–Ω–∑–¥—Ä–∞–≤ –æ–¥–æ–±—Ä–∏–ª –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ ¬´–ì–∞–∑–∏–≤—ã¬ª (–ú–ù–ù –æ–±–∏–Ω—É—Ç—É–∑—É–º–∞–±) —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –≤–æ–ª—á–∞–Ω–æ—á–Ω—ã–º –Ω–µ—Ñ—Ä–∏—Ç–æ–º. –†–∞–Ω–µ–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç –±—ã–ª –ø—Ä–µ–¥–Ω–∞–∑–Ω–∞—á–µ–Ω —Ç–æ–ª—å–∫–æ –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–æ–≥–æ –ª–∏–º—Ñ–æ–ª–µ–π–∫–æ–∑–∞ –∏ —Ñ–æ–ª–ª–∏–∫—É–ª—è—Ä–Ω–æ–π –ª–∏–º—Ñ–æ–º—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PQb5G #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The Ministry of Health approved the use of 'Gazivy' (obinutuzumab) for patients with lupus nephritis. The drug was previously used only for the treatment of chronic lymphocytic leukemia and follicular lymphoma. For more details: https://clck.ru/3PQb5G #FarmaVestnik #Production""
}"
2025-09-25T15:09:02+00:00,@medpharm,12812,https://t.me/medpharm/12812,–ù–∞ —Å–∞–π—Ç–µ Medvestnik –∏–¥–µ—Ç –∏–Ω—Ç–µ—Ä–∞–∫—Ç–∏–≤ ¬´–ö–æ—Å–º–∏—á–µ—Å–∫–∏–π –ø—É—Ç—å –¥–µ—Ç—Å–∫–æ–≥–æ –ø–∏—Ç–∞–Ω–∏—è¬ª. –£—á–∞—Å—Ç–Ω–∏–∫–∞–º –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è —Ä–µ—à–∏—Ç—å –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏–µ –∑–∞–¥–∞—á–∏ –∏ –ø–æ–ª—É—á–∏—Ç—å –∑–∞ —ç—Ç–æ –ø–æ–ª–µ–∑–Ω—ã–µ –º–∞—Ç–µ—Ä–∏–∞–ª—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PQZQH #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–ü–µ–¥–∏–∞—Ç—Ä–∏—è,"{""skip"": true}"
2025-09-25T15:07:03+00:00,@medpharm,12811,https://t.me/medpharm/12811,"–†–æ—Å—Å–∏–π—Å–∫–∏–π Forbes –æ–ø—É–±–ª–∏–∫–æ–≤–∞–ª TOP100 –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö –∫–æ–º–ø–∞–Ω–∏–π –†–æ—Å—Å–∏–∏ –ø–æ —á–∏—Å—Ç–æ–π –ø—Ä–∏–±—ã–ª–∏. –í —Ä–µ–π—Ç–∏–Ω–≥, –∫–∞–∫ –∏ –≥–æ–¥–æ–º —Ä–∞–Ω–µ–µ, –ø–æ–ø–∞–ª–∞ –ª–∏—à—å –æ–¥–Ω–∞ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∞—è –∫–æ–º–ø–∞–Ω–∏—è. –û–Ω–∞ –æ–ø—É—Å—Ç–∏–ª–∞—Å—å —Å 97-–≥–æ –Ω–∞ 98-–µ –º–µ—Å—Ç–æ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PQZJE #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-09-25T14:44:03+00:00,@medpharm,12810,https://t.me/medpharm/12810,"–ò–∑–≤–µ—Å—Ç–Ω–æ, —á—Ç–æ —Å –ø–æ–º–æ—â—å—é –ø–∏—Ç–∞–Ω–∏—è –∏ –Ω–µ–º–µ–¥–∏–∫–∞–º–µ–Ω—Ç–æ–∑–Ω—ã—Ö –º–µ—Ä –º–æ–∂–Ω–æ —É–∫—Ä–µ–ø–∏—Ç—å –∏–º–º—É–Ω–∏—Ç–µ—Ç –∏ –∑–∞—â–∏—Ç–∏—Ç—å —Å–µ–±—è –≤ —Å–∞–º—ã–π —Ä–∞–∑–≥–∞—Ä —ç–ø–∏–¥–µ–º–∏–∏. –ù–æ –∫–∞–∫ —ç—Ç–æ —Å–¥–µ–ª–∞—Ç—å? –ù–∞—à —ç–∫—Å–ø–µ—Ä—Ç –Ω—É—Ç—Ä–∏—Ü–∏–æ–ª–æ–≥, –¥–∏—Ä–µ–∫—Ç–æ—Ä –û–û–û ¬´–°–ú–ê–†–¢–î–ï–¢–û–ö–°–°–ï–†–í–ò–°¬ª –ú–∞—Ä–∏—è –ü–∞–≤–∏—Ü–∫–∞—è —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∞, –∫–∞–∫–∏–µ –ø—Ä–æ–¥—É–∫—Ç—ã —Å—Ç–æ–∏—Ç –≤–∫–ª—é—á–∏—Ç—å –≤ —Ä–∞—Ü–∏–æ–Ω, –æ—Ç –∫–∞–∫–∏—Ö –ª—É—á—à–µ –æ—Ç–∫–∞–∑–∞—Ç—å—Å—è –∏ –∫–∞–∫ –º–æ–∂–Ω–æ —É—Å–∫–æ—Ä–∏—Ç—å –≤–æ—Å—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ, –µ—Å–ª–∏ –≤—ã –≤—Å–µ-—Ç–∞–∫–∏ –∑–∞–±–æ–ª–µ–ª–∏. –ü—Ä–∏—Å–æ–µ–¥–∏–Ω—è–π—Ç–µ—Å—å –∫ –æ–±—Å—É–∂–¥–µ–Ω–∏—é! –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PQXub #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–§–∞—Ä–º–∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä–æ–≤–∞–Ω–∏–µ","{
  ""skip"": true
}"
2025-09-25T14:32:03+00:00,@medpharm,12809,https://t.me/medpharm/12809,–ù–∞—Å—Ç–∞–≤–Ω–∏–∫–∏ –ø–æ–ª—É—á–∞—Ç –µ–∂–µ–≥–æ–¥–Ω—ã–π –Ω–∞–ª–æ–≥–æ–≤—ã–π –≤—ã—á–µ—Ç –≤ 18 —Ç—ã—Å. —Ä—É–±. –∏ –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–π –æ–ø–ª–∞—á–∏–≤–∞–µ–º—ã–π –æ—Ç–ø—É—Å–∫. –ó–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç—ã –≤–Ω–µ—Å–µ–Ω—ã –Ω–∞ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏–µ –≤ –ì–æ—Å–¥—É–º—É. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PQXF6 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{""skip"": true}"
2025-09-25T14:26:03+00:00,@medpharm,12808,https://t.me/medpharm/12808,–ì–ö ¬´–ú–∞—Ç—å –∏ –¥–∏—Ç—è¬ª –æ—Ç–∫—Ä—ã–ª–∞ –≤ —Å—Ç–æ–ª–∏—Ü–µ –¶–µ–Ω—Ç—Ä –æ—Ñ—Ç–∞–ª—å–º–æ–ª–æ–≥–∏–∏ –∏ –º–∏–∫—Ä–æ—Ö–∏—Ä—É—Ä–≥–∏–∏ –≥–ª–∞–∑–∞. –ö–ª–∏–Ω–∏–∫—É –≤–æ–∑–≥–ª–∞–≤–∏–ª –æ—Ñ—Ç–∞–ª—å–º–æ—Ö–∏—Ä—É—Ä–≥ –°–µ—Ä–≥–µ–π –ê–±—Ä–∞–º–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PQWvD #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-09-25T13:40:02+00:00,@medpharm,12807,https://t.me/medpharm/12807,"–†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –Ω–æ–≤—ã–π –∫–æ–ª–∏—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π —Ç–µ—Å—Ç –¥–ª—è –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∏ —Ü–∏—Ç–æ–º–µ–≥–∞–ª–æ–≤–∏—Ä—É—Å–∞. –í –æ—Ç–ª–∏—á–∏–µ –æ—Ç —Å—Ç–∞–Ω–¥–∞—Ä—Ç–Ω–æ–≥–æ –ü–¶–†-—Ç–µ—Å—Ç–∞, –æ–Ω –ø–æ–∑–≤–æ–ª—è–µ—Ç –Ω–µ —Ç–æ–ª—å–∫–æ –æ–±–Ω–∞—Ä—É–∂–∏—Ç—å –≤–∏—Ä—É—Å, –Ω–æ –∏ –æ—Ü–µ–Ω–∏—Ç—å –≤–∏—Ä—É—Å–Ω—É—é –Ω–∞–≥—Ä—É–∑–∫—É. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PQTvX #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ù–∞—É–∫–∞ #–î–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞ #–ò–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã–µ_–±–æ–ª–µ–∑–Ω–∏","{""skip"": true}"
2025-09-25T12:40:02+00:00,@medpharm,12806,https://t.me/medpharm/12806,"–ö–∞–∫ –ø—Ä–∞–≤–∏–ª—å–Ω–æ —Å–æ–±—Ä–∞—Ç—å –¥–µ—Ç—Å–∫—É—é –∞–ø—Ç–µ—á–∫—É, –∫–∞–∫–∏–µ —Å–∏–º–ø—Ç–æ–º—ã —Ç—Ä–µ–±—É—é—Ç –Ω–µ–º–µ–¥–ª–µ–Ω–Ω–æ–≥–æ –≤–∏–∑–∏—Ç–∞ –∫ –≤—Ä–∞—á—É –∏ –∫–∞–∫ –æ–±—ä—è—Å–Ω–∏—Ç—å —Ä–æ–¥–∏—Ç–µ–ª—è–º, –ø–æ—á–µ–º—É –∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫–∏ –∏ –Ω–∞—Ä–æ–¥–Ω—ã–µ —Å—Ä–µ–¥—Å—Ç–≤–∞ –Ω–µ –≤—Å–µ–≥–¥–∞ –±–µ–∑–æ–ø–∞—Å–Ω—ã? –ù–∞—à —ç–∫—Å–ø–µ—Ä—Ç –∫.–º.–Ω., –ø–µ–¥–∏–∞—Ç—Ä –†–∞–±–∏—è—Ç –ó–∞–π–Ω–∏–¥–¥–∏–Ω–æ–≤–∞ —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∞, –∫–∞–∫ –≥—Ä–∞–º–æ—Ç–Ω–æ –∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä–æ–≤–∞—Ç—å –ø–æ—Å–µ—Ç–∏—Ç–µ–ª–µ–π –∞–ø—Ç–µ–∫–∏ –∏ —Ä–æ–¥–∏—Ç–µ–ª–µ–π –ø–æ –≤–æ–ø—Ä–æ—Å–∞–º –¥–µ—Ç—Å–∫–æ–≥–æ –∑–¥–æ—Ä–æ–≤—å—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PQQ8v #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–§–∞—Ä–º–∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä–æ–≤–∞–Ω–∏–µ","{""skip"": true}"
2025-09-25T12:29:02+00:00,@medpharm,12805,https://t.me/medpharm/12805,"–§–∞–∫—Ç–æ—Ä–∞–º–∏ —É—Å–∫–æ—Ä–µ–Ω–∏—è –≤–Ω–µ–¥—Ä–µ–Ω–∏—è —Ü–∏—Ñ—Ä–æ–≤—ã—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –≤ –º–µ–¥–∏—Ü–∏–Ω–µ —Å—Ç–∞–Ω–æ–≤—è—Ç—Å—è –±–µ—Å–ø–ª–∞—Ç–Ω—ã–µ –æ–±—É—á–∞—é—â–∏–µ –∫—É—Ä—Å—ã –∏ —É—á–µ–±–Ω—ã–µ –æ—Ç–ø—É—Å–∫–∞ –¥–ª—è –≤—Ä–∞—á–µ–π, –Ω–∞–¥–µ–∂–Ω–∞—è —é—Ä–∏–¥–∏—á–µ—Å–∫–∞—è –ø–æ–¥–¥–µ—Ä–∂–∫–∞ –∏ —Ä–∞–∑–≤–∏—Ç–∏–µ –ø–æ–Ω—è—Ç–Ω–æ–π –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω–æ–π –±–∞–∑—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PQPQE #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-09-25T12:20:02+00:00,@medpharm,12804,https://t.me/medpharm/12804,–ú–∏–Ω–∑–¥—Ä–∞–≤ –æ–¥–æ–±—Ä–∏–ª –ø—Ä–æ–≤–µ–¥–µ–Ω–∏–µ II‚ÄîIII —Ñ–∞–∑ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –≤–∞–∫—Ü–∏–Ω—ã –¥–ª—è –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –º–µ–Ω–∏–Ω–≥–æ–∫–æ–∫–∫–æ–≤–æ–π –∏–Ω—Ñ–µ–∫—Ü–∏–∏ –æ—Ç –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥—Å–∫–æ–≥–æ –Ω–∞—É—á–Ω–æ-–∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–æ–≥–æ –∏–Ω—Å—Ç–∏—Ç—É—Ç–∞ –≤–∞–∫—Ü–∏–Ω –∏ —Å—ã–≤–æ—Ä–æ—Ç–æ–∫. –≠—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –∏ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è —Å—Ä–∞–≤–Ω–∏—Ç—å —Å –≤–∞–∫—Ü–∏–Ω–æ–π ¬´–ú–µ–Ω–∞–∫—Ç—Ä–∞¬ª –æ—Ç –∫–æ–º–ø–∞–Ω–∏–∏ Sanofi. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PQNni #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""clinical_trial, vaccine"",
  ""impact"": ""high"",
  ""english"": ""The Ministry of Health approved the conduct of Phase II/III vaccine trials for meningococcal disease prevention in St. Petersburg Institute of Vaccines and Antitoxins. The efficacy and safety of the drug will be compared with Sanofi's Menactra vaccine. For more details: https://clck.ru/3PQNni #PharmNews #Regulation""
}"
2025-09-25T11:24:03+00:00,@medpharm,12803,https://t.me/medpharm/12803,¬´–†–æ—Å–∞—Ç–æ–º¬ª –Ω–∞—á–∞–ª –ø–µ—Ä–µ–≥–æ–≤–æ—Ä—ã –æ –ø–æ–∫—É–ø–∫–µ –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ù–µ—Ç—Ä–∏–∫–∞ –ú–µ–¥–∏—Ü–∏–Ω–∞¬ª. –†–∞–Ω–µ–µ —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫ IT-—Ä–µ—à–µ–Ω–∏–π –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∫–ª–∏–Ω–∏–∫ –∏ –∫–æ–Ω—Ç—Ä–æ–ª–∏—Ä—É–µ–º–∞—è –≥–æ—Å–∫–æ—Ä–ø–æ—Ä–∞—Ü–∏–µ–π –ì–ö ¬´–ú–µ–¥—Å–∫–∞–Ω¬ª —Å–æ–æ–±—â–∏–ª–∏ –æ –ø–ª–∞–Ω–∞—Ö –ø–æ —Å–æ–∑–¥–∞–Ω–∏—é –µ–¥–∏–Ω–æ–π —Ü–∏—Ñ—Ä–æ–≤–æ–π –ø–ª–∞—Ç—Ñ–æ—Ä–º—ã –¥–ª—è –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PQJwq #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-09-25T11:09:03+00:00,@medpharm,12802,https://t.me/medpharm/12802,–§–ê–° —Å–æ–≥–ª–∞—Å–æ–≤–∞–ª–∞ —Ü–µ–Ω—É –Ω–∞ –≤—Ç–æ—Ä–æ–π –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π –¥–∂–µ–Ω–µ—Ä–∏–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ —Å –ú–ù–ù –≥–ª–µ–∫–∞–ø—Ä–µ–≤–∏—Ä –ø–∏–±—Ä–µ–Ω—Ç–∞—Å–≤–∏—Ä ‚Äî ¬´–°–µ–≤–∞–ª—å–≤–µ–æ¬ª –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª. –°—Ç–æ–∏–º–æ—Å—Ç—å —Å–Ω–∏–∂–µ–Ω–∞ –Ω–∞ 50% –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ¬´–ú–∞–≤–∏—Ä–µ—Ç¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PQHtm #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""pricing"",
  ""impact"": ""medium"",
  ""english"": ""The FAS approved the price for a second domestically produced generic drug with the MH number glukaprover pirbentasvir 'Sevalveo' produced by Promomed company. The price is reduced by 50% compared to the original drug 'Maviret'.""
}"
2025-09-25T10:22:03+00:00,@medpharm,12801,https://t.me/medpharm/12801,–ë–∞—Å—Ç—Ä—ã–∫–∏–Ω –∑–∞–ø—Ä–æ—Å–∏–ª –¥–æ–∫–ª–∞–¥ –æ —Ä–∞—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–∏ –¥–µ–ª–∞ –ø–æ –æ—à–∏–±–æ—á–Ω–æ–º—É —É–¥–∞–ª–µ–Ω–∏—é –∑–¥–æ—Ä–æ–≤–æ–π –ø–æ—á–∫–∏ —É –∂–∏—Ç–µ–ª—å–Ω–∏—Ü—ã –ë—É—Ä—è—Ç–∏–∏ –∏–∑-–∑–∞ –ø–µ—Ä–µ–ø—É—Ç–∞–Ω–Ω—ã—Ö –∞–Ω–∞–ª–∏–∑–æ–≤. –ú–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–∏ –ø—Ä–∏–≤–ª–µ—á–µ–Ω—ã –∫ –¥–∏—Å—Ü–∏–ø–ª–∏–Ω–∞—Ä–Ω–æ–π –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PQESz #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""clinical_trial, safety"",
  ""impact"": ""high"",
  ""english"": ""A health care worker was disciplined for errors in a case involving the removal of a healthy kidney from a resident of Buryatia due to mixed-up lab results. The case is under investigation.""
}"
2025-09-25T09:51:03+00:00,@medpharm,12800,https://t.me/medpharm/12800,"–¶–µ–Ω—Ç—Ä –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –ø—Ä–æ–≤–æ–¥–∏—Ç –ø—Ä–∏–µ–º –∑–∞—è–≤–æ–∫ –Ω–∞ —É—á–∞—Å—Ç–∏–µ –≤ –∞—É–∫—Ü–∏–æ–Ω–∞—Ö –Ω–∞ –ø–æ—Å—Ç–∞–≤–∫—É –¥–ª—è ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª —Å–µ–º–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, —Å—Ä–µ–¥–∏ –∫–æ—Ç–æ—Ä—ã—Ö —Ä–∏—Å–¥–∏–ø–ª–∞–º –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Å–ø–∏–Ω–∞–ª—å–Ω–æ–π –º—ã—à–µ—á–Ω–æ–π –∞—Ç—Ä–æ—Ñ–∏–∏, –∑–∞ –∫–æ—Ç–æ—Ä—ã–π –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –∑–∞–ø–ª–∞—Ç–∏—Ç—å 2,5 –º–ª—Ä–¥ —Ä—É–±. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PQCDp #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""high"",
  ""english"": ""The Central Drug Supplies Center is accepting applications for participation in auctions to supply seven drugs under the 'Good Circle' program, including risdiplam for spinal muscular atrophy treatment. The auction is expected to cost 2.5 billion rubles. More details: https://clck.ru/3PQCDp #PharmNews #Distribution""
}"
2025-09-25T09:15:03+00:00,@medpharm,12799,https://t.me/medpharm/12799,–°–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –æ–±—Å—É–∂–¥–∞—é—Ç –≤–∞—Ä–∏–∞–Ω—Ç—ã –≤—ã–¥–µ–ª–µ–Ω–∏—è –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–≥–æ —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è –¥–ª—è –æ–Ω–∫–æ—Å–ª—É–∂–±—ã. –í—ã–µ–∑–¥–Ω—ã–µ –ø—Ä–æ–≤–µ—Ä–∫–∏ —á–ª–µ–Ω–æ–≤ –°–æ–≤–µ—Ç–∞ –§–µ–¥–µ—Ä–∞—Ü–∏–∏ –∏ –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–∏–∫–æ–≤ –≤ —Ä–µ–≥–∏–æ–Ω—ã –ø–æ–∫–∞–∑–∞–ª–∏ —É—Å—Ç–æ–π—á–∏–≤—ã–π —Ä–∞–∑—Ä—ã–≤ –º–µ–∂–¥—É –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç—å—é –≤ —Å—Ä–µ–¥—Å—Ç–≤–∞—Ö –∏ —Ä–µ–∞–ª—å–Ω—ã–º –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ–º –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –≤ —Å–∏—Å—Ç–µ–º–µ –û–ú–°. –í —Å—Ä–µ–¥–Ω–µ–º –ø–æ —Å—Ç—Ä–∞–Ω–µ –¥–µ—Ñ–∏—Ü–∏—Ç –Ω–∞–ø–æ–ª–Ω–µ–Ω–∏—è —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω—ã—Ö –ø—Ä–æ–≥—Ä–∞–º–º –≥–æ—Å–≥–∞—Ä–∞–Ω—Ç–∏–π —Å–æ—Å—Ç–∞–≤–ª—è–µ—Ç 12‚Äî15%. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PQ9TP #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û–Ω–∫–æ–ª–æ–≥–∏—è #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""Discussion on additional funding for oncology services. Field inspections by members of the Federation Council and public figures revealed a persistent gap between funding needs and actual patient coverage in the state insurance program. On average, across the country, there is a shortfall of 12-15% in territorial program funding.""
}"
2025-09-25T08:37:02+00:00,@medpharm,12798,https://t.me/medpharm/12798,–ò–≥–æ—Ä—è –ö–∞–≥—Ä–∞–º–∞–Ω—è–Ω–∞ –æ—Å–≤–æ–±–æ–¥–∏–ª–∏ –æ—Ç –¥–æ–ª–∂–Ω–æ—Å—Ç–∏ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –î–µ–ø–∞—Ä—Ç–∞–º–µ–Ω—Ç–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞. –û–Ω –±—ã–ª –Ω–∞–∑–Ω–∞—á–µ–Ω –∞—É–¥–∏—Ç–æ—Ä–æ–º –°—á–µ—Ç–Ω–æ–π –ø–∞–ª–∞—Ç—ã –ø–æ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–∏—é –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç–∞ –∏ —Ä–µ—à–µ–Ω–∏—é –ì–æ—Å–¥—É–º—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PQ6TR #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–∞—Ä—å–µ—Ä–∞,"{""skip"": true}"
2025-09-25T08:31:03+00:00,@medpharm,12797,https://t.me/medpharm/12797,"–ü—Ä–æ—Ñ–µ—Å—Å–∏—è –ø—Ä–æ–≥—Ä–∞–º–º–∏—Å—Ç–∞ –æ–±–æ—à–ª–∞ –≤—Ä–∞—á–µ–±–Ω—É—é –≤ —Ä–µ–π—Ç–∏–Ω–≥–µ –ø—Ä–µ—Å—Ç–∏–∂–Ω–æ—Å—Ç–∏: –∑–∞ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ IT –ø—Ä–æ–≥–æ–ª–æ—Å–æ–≤–∞–ª–∏ 21% –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö —Ä–æ—Å—Å–∏—è–Ω, –∑–∞ –≤—Ä–∞—á–µ–π 9%. –ß–∞—â–µ –≤—Å–µ–≥–æ —Å—Ä–µ–¥–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ —Ä–µ—Å–ø–æ–Ω–¥–µ–Ω—Ç—ã –Ω–∞–∑—ã–≤–∞–ª–∏ —Å—Ç–æ–º–∞—Ç–æ–ª–æ–≥–æ–≤ –∏ –æ–ø–µ—Ä–∏—Ä—É—é—â–∏—Ö —Ö–∏—Ä—É—Ä–≥–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://medvestnik.ru/content/news/Medicina-zanyala-vtoroe-mesto-v-reitinge-prestijnyh-professii-ot-SuperJob.html?utm_source=TG_post&utm_medium=Group&utm_campaign=Medicina-zanyala-vtoroe-mesto-v-reitinge-prestijnyh-professii-ot-SuperJob #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-09-25T07:55:03+00:00,@medpharm,12796,https://t.me/medpharm/12796,"¬´–í –æ–±—Ä–∞–∑–æ–≤–∞—Ç–µ–ª—å–Ω–æ–π –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏, –∑–∞–Ω–∏–º–∞—é—â–µ–π—Å—è –ø–æ–≤—ã—à–µ–Ω–∏–µ–º –∫–≤–∞–ª–∏—Ñ–∏–∫–∞—Ü–∏–∏ –≤—Ä–∞—á–µ–π, –æ—Ç–ø—É—Å–∫ —É –ø–µ–¥–∞–≥–æ–≥–∏—á–µ—Å–∫–∏—Ö —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ 56 –∫–∞–ª–µ–Ω–¥–∞—Ä–Ω—ã—Ö –¥–Ω–µ–π. –ú–Ω–æ–≥–∏–µ —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–∏ —Ä–∞–±–æ—Ç–∞—é—Ç –ø–æ —Å–æ–≤–º–µ—Å—Ç–∏—Ç–µ–ª—å—Å—Ç–≤—É –≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è—Ö. –û–±—è–∑–∞–Ω—ã –ª–∏ –æ–Ω–∏ –ø–∏—Å–∞—Ç—å –∑–∞—è–≤–ª–µ–Ω–∏—è –æ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª–µ–Ω–∏–∏ –æ—Ç–ø—É—Å–∫–∞ –±–µ–∑ —Å–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∑–∞—Ä–∞–±–æ—Ç–Ω–æ–π –ø–ª–∞—Ç—ã –Ω–∞ —Ä–∞–±–æ—Ç–µ –ø–æ —Å–æ–≤–º–µ—Å—Ç–∏—Ç–µ–ª—å—Å—Ç–≤—É –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ –¥–Ω–µ–π, –ø—Ä–µ–≤—ã—à–∞—é—â–∏—Ö –æ—Ç–ø—É—Å–∫ –ø–æ –æ—Å–Ω–æ–≤–Ω–æ–π —Ä–∞–±–æ—Ç–µ, –∏–ª–∏ –º–æ–∂–Ω–æ —Ä–∞–±–æ—Ç–∞—Ç—å –ø–æ —Å–æ–≤–º–µ—Å—Ç–∏—Ç–µ–ª—å—Å—Ç–≤—É –≤ –ø–µ—Ä–∏–æ–¥ –æ—Ç–ø—É—Å–∫–∞ –ø–æ –æ—Å–Ω–æ–≤–Ω–æ–º—É –º–µ—Å—Ç—É —Ä–∞–±–æ—Ç—ã?¬ª –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PQ3Hg #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-09-25T06:14:03+00:00,@medpharm,12795,https://t.me/medpharm/12795,"–¢–µ—Ä–∞–ø–∏—è –∏–Ω–≥–∏–±–∏—Ç–æ—Ä–∞–º–∏ —Ñ–∞–∫—Ç–æ—Ä–∞ –Ω–µ–∫—Ä–æ–∑–∞ –æ–ø—É—Ö–æ–ª–∏ –∞–ª—å—Ñ–∞ —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å —Ä–µ–≤–º–∞—Ç–æ–∏–¥–Ω—ã–º –∞—Ä—Ç—Ä–∏—Ç–æ–º –ø–æ–∫–∞–∑–∞–ª–∞ –∫–∞–∫ –ø–æ–≤—ã—à–µ–Ω–Ω—ã–π —Ä–∏—Å–∫ –∏–Ω—Ñ–µ–∫—Ü–∏–π, —Ç–∞–∫ –∏ –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω—ã–µ –∑–∞—â–∏—Ç–Ω—ã–µ —ç—Ñ—Ñ–µ–∫—Ç—ã –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö —Å–æ–±—ã—Ç–∏–π. –û–±–∑–æ—Ä –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –æ—Ö–≤–∞—Ç–∏–ª –¥–∞–Ω–Ω—ã–µ –∑–∞ 25 –ª–µ—Ç –∏ –ø–æ–∑–≤–æ–ª–∏–ª —Å—Ñ–æ—Ä–º–∏—Ä–æ–≤–∞—Ç—å —Å—Ç—Ä–∞—Ç–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω—ã–π –ø—Ä–æ—Ñ–∏–ª—å –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ —Ç–µ—Ä–∞–ø–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PPtkm #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ò–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã–µ_–±–æ–ª–µ–∑–Ω–∏ #–ö–∞—Ä–¥–∏–æ–ª–æ–≥–∏—è #–†–µ–≤–º–∞—Ç–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance"",
  ""impact"": ""high"",
  ""english"": ""A review of data over 25 years showed a higher risk of infections as well as potential protective effects against cardiovascular events for patients treated with anti-factor Xa inhibitors for rheumatoid arthritis. This study provides a stratified safety profile of the therapy.""
}"
2025-09-24T16:24:53+00:00,@medpharm,12794,https://t.me/medpharm/12794,"ü¶æ–û—Ç–ø–æ—Ä –∏–Ω—Ñ–µ–∫—Ü–∏—è–º. –ú–∏–Ω–∑–¥—Ä–∞–≤ —É—Ç–≤–µ—Ä–¥–∏–ª –Ω–æ–≤—ã–π –ø–æ—Ä—è–¥–æ–∫ –æ–∫–∞–∑–∞–Ω–∏—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –≤–∑—Ä–æ—Å–ª—ã–º –ø—Ä–∏ –∏–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è—Ö. –°–Ω–∏–∂–µ–Ω–∞ –Ω–∞–≥—Ä—É–∑–∫–∞ –Ω–∞ –≤—Ä–∞—á–µ–π-–∏–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–∏—Å—Ç–æ–≤ –∏ –ø–∞–ª–∞—Ç–Ω—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Å–µ—Å—Ç–µ—Ä –≤ –∏–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã—Ö –±–æ–ª—å–Ω–∏—Ü–∞—Ö, –≤–ø–µ—Ä–≤—ã–µ –¥–µ—Ç–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω –ø–æ—Ä—è–¥–æ–∫ —Ä–∞–±–æ—Ç—ã –¥–Ω–µ–≤–Ω—ã—Ö —Å—Ç–∞—Ü–∏–æ–Ω–∞—Ä–æ–≤ —Ç–∞–∫–æ–≥–æ –ø—Ä–æ—Ñ–∏–ª—è. ü¶æ–ü—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∏ –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å—Å—Ç–≤–∞. –≠–∫—Å–ø–µ—Ä—Ç—ã –í–û–ó –∑–∞—è–≤–∏–ª–∏ –æ–± –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–∏ –¥–æ—Å—Ç–∞—Ç–æ—á–Ω—ã—Ö –Ω–∞—É—á–Ω—ã—Ö –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å—Å—Ç–≤ —Å–≤—è–∑–∏ –º–µ–∂–¥—É –ø—Ä–∏–µ–º–æ–º –ø–∞—Ä–∞—Ü–µ—Ç–∞–º–æ–ª–∞ –≤–æ –≤—Ä–µ–º—è –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏ –∏ —Ä–∞–∑–≤–∏—Ç–∏–µ–º –∞—É—Ç–∏–∑–º–∞. –¢–∞–∫–∂–µ –æ–ø—Ä–æ–≤–µ—Ä–≥–∞–µ—Ç—Å—è –≤–ª–∏—è–Ω–∏–µ –ø—Ä–∏–≤–∏–≤–æ–∫ –Ω–∞ —Ä–∞–∑–≤–∏—Ç–∏–µ –†–ê–°. ‚ù§Ô∏è–ú–æ–π –¥–æ –¥—ã—Ä. –ü–æ–¥ –º–∞—Ä–∫–∏—Ä–æ–≤–∫—É –ø–æ–ø–∞–ª–∏ —Å–∞–Ω–∏—Ç–∞—Ä–Ω–æ-–≥–∏–≥–∏–µ–Ω–∏—á–µ—Å–∫–∏–µ –∏–∑–¥–µ–ª–∏—è –∏ —Ç—É–∞–ª–µ—Ç–Ω—ã–µ –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–Ω–æ—Å—Ç–∏. –≠–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç –ø—Ä–æ–π–¥–µ—Ç —Å 25 —Å–µ–Ω—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞ –ø–æ 31 –∞–≤–≥—É—Å—Ç–∞ 2026 –≥–æ–¥–∞. –£—á–∞—Å—Ç–∏–µ –≤ –ø—Ä–æ–µ–∫—Ç–µ –¥–æ–±—Ä–æ–≤–æ–ª—å–Ω–æ–µ, –∞ –∫–æ–¥—ã –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏ –±—É–¥—É—Ç –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª—è—Ç—å—Å—è –±–µ—Å–ø–ª–∞—Ç–Ω–æ. ‚ù§Ô∏è–°—Ç–∞–≤–∫–∏ —Ä–∞—Å—Ç—É—Ç. –°—Ç–∞–≤–∫–∞ –ù–î–° –º–æ–∂–µ—Ç –≤—ã—Ä–∞—Å—Ç–∏ –¥–æ 22% —Å 2026 –≥–æ–¥–∞. –ü—Ä–∏ —ç—Ç–æ–º –ª—å–≥–æ—Ç–Ω–∞—è —Å—Ç–∞–≤–∫–∞ –≤ 10% –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞, –ø—Ä–æ–¥—É–∫—Ç—ã –∏ —Ç–æ–≤–∞—Ä—ã –¥–ª—è –¥–µ—Ç–µ–π —Å–æ—Ö—Ä–∞–Ω–∏—Ç—Å—è. –ü–æ—Ä–æ–≥ —É–ø–ª–∞—Ç—ã –ù–î–° –¥–ª—è –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –Ω–∞ –£–°–ù –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è —Å–Ω–∏–∑–∏—Ç—å —Å 60 –º–ª–Ω –¥–æ 10 –º–ª–Ω —Ä—É–±.","{
  ""skip"": true
}"
2025-09-24T16:14:03+00:00,@medpharm,12793,https://t.me/medpharm/12793,"–ü–æ–¥ –º–∞—Ä–∫–∏—Ä–æ–≤–∫—É –ø–æ–ø–∞–ª–∏ —Å–∞–Ω–∏—Ç–∞—Ä–Ω–æ-–≥–∏–≥–∏–µ–Ω–∏—á–µ—Å–∫–∏–µ –∏–∑–¥–µ–ª–∏—è –∏ —Ç—É–∞–ª–µ—Ç–Ω—ã–µ –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–Ω–æ—Å—Ç–∏. –≠–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç –ø—Ä–æ–π–¥–µ—Ç —Å 25 —Å–µ–Ω—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞ –ø–æ 31 –∞–≤–≥—É—Å—Ç–∞ 2026 –≥–æ–¥–∞. –£—á–∞—Å—Ç–∏–µ –≤ –ø—Ä–æ–µ–∫—Ç–µ –¥–æ–±—Ä–æ–≤–æ–ª—å–Ω–æ–µ, –∞ –∫–æ–¥—ã –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏ –±—É–¥—É—Ç –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª—è—Ç—å—Å—è –±–µ—Å–ø–ª–∞—Ç–Ω–æ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PPajV #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{""skip"": true}"
2025-09-24T15:57:03+00:00,@medpharm,12792,https://t.me/medpharm/12792,"Omnicare –ø–æ–¥–∞–ª–∞ –∑–∞—è–≤–ª–µ–Ω–∏–µ –æ –±–∞–Ω–∫—Ä–æ—Ç—Å—Ç–≤–µ. –≠—Ç–æ –¥–æ—á–µ—Ä–Ω—è—è –∫–æ–º–ø–∞–Ω–∏—è –∫—Ä—É–ø–Ω–µ–π—à–µ–π –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–π –∞–ø—Ç–µ—á–Ω–æ–π —Å–µ—Ç–∏ CVS Health, –ø–æ—Å—Ç–∞–≤–ª—è—é—â–∞—è –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–ª—è –¥–æ–º–æ–≤ –ø—Ä–µ—Å—Ç–∞—Ä–µ–ª—ã—Ö. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PPa2B #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{""skip"": true}"
2025-09-24T15:30:03+00:00,@medpharm,12791,https://t.me/medpharm/12791,–û—Ö–ª–∞–∂–¥–µ–Ω–∏–µ —ç–∫–æ–Ω–æ–º–∏–∫–∏ –ø–æ–≤–ª–∏—è–ª–æ –Ω–∞ –ø—Ä–æ–≥–Ω–æ–∑ –ú–∏–Ω—ç–∫–æ–Ω–æ–º—Ä–∞–∑–≤–∏—Ç–∏—è. –í –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –≤–Ω–µ—Å–ª–∏ –ø—Ä–æ–µ–∫—Ç —Å–æ—Ü–∏–∞–ª—å–Ω–æ-—ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–≥–æ —Ä–∞–∑–≤–∏—Ç–∏—è –Ω–∞ —Å–ª–µ–¥—É—é—â–∏–µ —Ç—Ä–∏ –≥–æ–¥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PPYnM #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{""skip"": true}"
2025-09-24T15:30:02+00:00,@medpharm,12790,https://t.me/medpharm/12790,"–ë—é–¥–∂–µ—Ç –§–æ–Ω–¥–∞ –û–ú–° –±—É–¥–µ—Ç —É–≤–µ–ª–∏—á–∏–≤–∞—Ç—å—Å—è –≤ –±–ª–∏–∂–∞–π—à–∏–µ —Ç—Ä–∏ –≥–æ–¥–∞. –í —Å—Ä–µ–¥–Ω–µ–º –æ–Ω —Å–æ—Å—Ç–∞–≤–∏—Ç –æ–∫–æ–ª–æ 4,8 —Ç—Ä–ª–Ω —Ä—É–±. –≤ –≥–æ–¥. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PPYnN #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-09-24T15:14:03+00:00,@medpharm,12789,https://t.me/medpharm/12789,"–†–æ—Å—Å–∏–π—Å–∫–∏–µ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –ø–æ–º–æ–≥—É—Ç –≤ —Å–æ–∑–¥–∞–Ω–∏–∏ –¶–µ–Ω—Ç—Ä–∞ —è–¥–µ—Ä–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω—ã –≤–æ –í—å–µ—Ç–Ω–∞–º–µ. –ì–ö ¬´–ú–µ–¥—Å–∫–∞–Ω¬ª –æ–±–µ—Å–ø–µ—á–∏—Ç –ø—Ä–æ–µ–∫—Ç —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–º–∏ —Ä–µ—à–µ–Ω–∏—è–º–∏, —ç–∫—Å–ø–µ—Ä—Ç–Ω–æ–π –ø–æ–¥–¥–µ—Ä–∂–∫–æ–π –∏ –æ–±—É—á–µ–Ω–∏–µ–º –ø–µ—Ä—Å–æ–Ω–∞–ª–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PPY3d #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-09-24T15:00:08+00:00,@medpharm,12788,https://t.me/medpharm/12788,"–í —Ä–∞–º–∫–∞—Ö —Ñ–∏–Ω–∞–ª–∞ –ß–µ–º–ø–∏–æ–Ω–∞—Ç–∞ –≤—ã—Å–æ–∫–∏—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π (–ß–í–¢), –∫–æ—Ç–æ—Ä—ã–π —Å–æ—Å—Ç–æ—è–ª—Å—è –≤ –í–µ–ª–∏–∫–æ–º –ù–æ–≤–≥–æ—Ä–æ–¥–µ, –ø—Ä–æ—à–ª–∞ –Ω–∞—Å—ã—â–µ–Ω–Ω–∞—è –¥–µ–ª–æ–≤–∞—è –ø—Ä–æ–≥—Ä–∞–º–º–∞. –ü—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–∏ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã—Ö –∏ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã—Ö –æ—Ä–≥–∞–Ω–æ–≤ –≤–ª–∞—Å—Ç–∏, –æ–±—Ä–∞–∑–æ–≤–∞—Ç–µ–ª—å–Ω—ã—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –∏ –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏–π ‚Äî –ø–∞—Ä—Ç–Ω–µ—Ä–æ–≤ —á–µ–º–ø–∏–æ–Ω–∞—Ç–∞ –æ–±—Å—É–¥–∏–ª–∏ –∑–Ω–∞—á–∏–º–æ—Å—Ç—å –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –¥–ª—è –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ —Å—Ç—Ä–∞–Ω—ã, –∞–∫—Ç—É–∞–ª—å–Ω—ã–µ –ø–æ–¥—Ö–æ–¥—ã –∫ –ø–æ–¥–≥–æ—Ç–æ–≤–∫–µ –∫–∞–¥—Ä–æ–≤, –º–µ—Ç–æ–¥–∏–∫—É —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –∫–æ–º–ø–µ—Ç–µ–Ω—Ü–∏–π –¥–ª—è —Å–æ—Ä–µ–≤–Ω–æ–≤–∞–Ω–∏–π –ø–æ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–º—É –º–∞—Å—Ç–µ—Ä—Å—Ç–≤—É –∏ –∫–∞—Ä—å–µ—Ä–Ω—ã–µ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –∫–æ–ª–ª–µ–¥–∂–µ–π –∏ —Ç–µ—Ö–Ω–∏–∫—É–º–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PPXFb #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–∞—Ä—å–µ—Ä–∞","{""skip"": true}"
2025-09-24T14:25:02+00:00,@medpharm,12787,https://t.me/medpharm/12787,"–í –£–ª—å—è–Ω–æ–≤—Å–∫–µ –≤–æ–∑–±—É–∂–¥–µ–Ω–æ —É–≥–æ–ª–æ–≤–Ω–æ–µ –¥–µ–ª–æ –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ –∑–∞–º–¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –ú–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω–æ-–∞–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–æ–≥–æ —Ü–µ–Ω—Ç—Ä–∞, –∫–æ—Ç–æ—Ä—É—é –ø–æ–¥–æ–∑—Ä–µ–≤–∞—é—Ç –≤ –≤—ã–º–æ–≥–∞—Ç–µ–ª—å—Å—Ç–≤–µ –≤–∑—è—Ç–æ–∫ —É –ø–æ–¥—á–∏–Ω–µ–Ω–Ω—ã—Ö. –°–ª–µ–¥—Å—Ç–≤–∏–µ —Ö–æ–¥–∞—Ç–∞–π—Å—Ç–≤—É–µ—Ç –æ –µ–µ –∞—Ä–µ—Å—Ç–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PPVRo #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-09-24T14:05:05+00:00,@medpharm,12786,https://t.me/medpharm/12786,"–†–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –Ω–∞ –∫–æ–Ω–∫—É—Ä—Å ¬´–ü—Ä–æ–≤–∏–∑–∏–æ–Ω–µ—Ä—ã¬ª –ø—Ä–æ–¥–ª–∏—Ç—Å—è –¥–æ 25 —Å–µ–Ω—Ç—è–±—Ä—è. –ü—Ä–∏–Ω—è—Ç—å —É—á–∞—Å—Ç–∏–µ –º–æ–≥—É—Ç –ø—Ä–æ–≤–∏–∑–æ—Ä—ã, —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç—ã –∏ —Å—Ç—É–¥–µ–Ω—Ç—ã —Å—Ç–∞—Ä—à–∏—Ö –∫—É—Ä—Å–æ–≤ –ø—Ä–æ—Ñ–∏–ª—å–Ω—ã—Ö –≤—É–∑–æ–≤ –∏ —Å—Å—É–∑–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PPTxJ #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–û–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ","{""skip"": true}"
2025-09-24T13:53:03+00:00,@medpharm,12785,https://t.me/medpharm/12785,–≠–∫—Å–ø–µ—Ä—Ç—ã –í–û–ó –∑–∞—è–≤–∏–ª–∏ –æ–± –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–∏ –¥–æ—Å—Ç–∞—Ç–æ—á–Ω—ã—Ö –Ω–∞—É—á–Ω—ã—Ö –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å—Å—Ç–≤ —Å–≤—è–∑–∏ –º–µ–∂–¥—É –ø—Ä–∏–µ–º–æ–º –ø–∞—Ä–∞—Ü–µ—Ç–∞–º–æ–ª–∞ –≤–æ –≤—Ä–µ–º—è –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏ –∏ —Ä–∞–∑–≤–∏—Ç–∏–µ–º –∞—É—Ç–∏–∑–º–∞. –¢–∞–∫–∂–µ –æ–ø—Ä–æ–≤–µ—Ä–≥–∞–µ—Ç—Å—è –≤–ª–∏—è–Ω–∏–µ –ø—Ä–∏–≤–∏–≤–æ–∫ –Ω–∞ —Ä–∞–∑–≤–∏—Ç–∏–µ –†–ê–°. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PPTEQ #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ê–∫—É—à–µ—Ä—Å—Ç–≤–æ_–∏_–≥–∏–Ω–µ–∫–æ–ª–æ–≥–∏—è #–ò–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã–µ_–±–æ–ª–µ–∑–Ω–∏ #–ò–º–º—É–Ω–æ–ª–æ–≥–∏—è_–∏_–∞–ª–ª–µ—Ä–≥–æ–ª–æ–≥–∏—è #–ù–µ–≤—Ä–æ–ª–æ–≥–∏—è #–ü–µ–¥–∏–∞—Ç—Ä–∏—è #–ü—Å–∏—Ö–∏–∞—Ç—Ä–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è,"{""skip"": true}"
2025-09-24T13:21:30+00:00,@medpharm,12784,https://t.me/medpharm/12784,–ü—Ä–µ–º—å–µ—Ä-–º–∏–Ω–∏—Å—Ç—Ä –ú–∏—Ö–∞–∏–ª –ú–∏—à—É—Å—Ç–∏–Ω –ø–æ–¥–ø–∏—Å–∞–ª –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ –æ –ø—Ä–∞–∑–¥–Ω–∏—á–Ω—ã—Ö –∏ –≤—ã—Ö–æ–¥–Ω—ã—Ö –¥–Ω—è—Ö –≤ 2026 –≥–æ–¥—É.,"{""skip"": true}"
2025-09-24T12:56:02+00:00,@medpharm,12783,https://t.me/medpharm/12783,"–ü—Ä–µ–∑–∏–¥–µ–Ω—Ç –Ω–∞–∑–Ω–∞—á–∏–ª –ê–ª–µ–∫—Å–∞–Ω–¥—Ä–∞ –ì—É—Ü–∞–Ω–∞ –Ω–∞ –ø–æ—Å—Ç –≥–µ–Ω–µ—Ä–∞–ª—å–Ω–æ–≥–æ –ø—Ä–æ–∫—É—Ä–æ—Ä–∞ –†–§. –ù–∞–∫–∞–Ω—É–Ω–µ, –≤—ã—Å—Ç—É–ø–∞—è –≤ –°–æ–≤–µ—Ç–µ –§–µ–¥–µ—Ä–∞—Ü–∏–∏, –Ω–æ–≤—ã–π –≥–ª–∞–≤–∞ –Ω–∞–¥–∑–æ—Ä–Ω–æ–≥–æ –≤–µ–¥–æ–º—Å—Ç–≤–∞ –æ–±–æ–∑–Ω–∞—á–∏–ª –∫–ª—é—á–µ–≤—ã–µ –ø—Ä–∏–æ—Ä–∏—Ç–µ—Ç—ã: —É—Å–∏–ª–µ–Ω–∏–µ –∫–æ–Ω—Ç—Ä–æ–ª—è –∑–∞ –ª—å–≥–æ—Ç–Ω—ã–º –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ–º, –∑–∞—â–∏—Ç–∞ –±–∏–∑–Ω–µ—Å–∞ –æ—Ç –Ω–µ–æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω–æ–≥–æ —É–≥–æ–ª–æ–≤–Ω–æ–≥–æ –ø—Ä–µ—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –∏ —Å–∏—Å—Ç–µ–º–Ω—ã–π –¥–∏–∞–ª–æ–≥ —Å —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã–º–∏ –≤–ª–∞—Å—Ç—è–º–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PPPeu #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement, sanctions"",
  ""impact"": ""medium"",
  ""english"": ""The new head of the supervisory body emphasized key priorities: strengthening control over subsidized medicines, protecting businesses from unjustified criminal prosecution and a systemic dialogue with regional authorities.""
}"
2025-09-24T11:46:02+00:00,@medpharm,12782,https://t.me/medpharm/12782,"Bristol-Myers Squibb –≤ 2026 –≥–æ–¥—É –≤—ã–≤–µ–¥–µ—Ç –ø—Ä–µ–ø–∞—Ä–∞—Ç –æ—Ç —à–∏–∑–æ—Ñ—Ä–µ–Ω–∏–∏ Cobenfy –Ω–∞ –±—Ä–∏—Ç–∞–Ω—Å–∫–∏–π —Ä—ã–Ω–æ–∫ –ø–æ –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–º —Ü–µ–Ω–∞–º ‚Äî 1850 –¥–æ–ª–ª. –∑–∞ –º–µ—Å—è—á–Ω—ã–π –∫—É—Ä—Å. –†–µ—à–µ–Ω–∏–µ –ø—Ä–∏–Ω—è—Ç–æ –≤ –æ—Ç–≤–µ—Ç –Ω–∞ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –¢—Ä–∞–º–ø–∞ —Å–Ω–∏–∑–∏—Ç—å —Ü–µ–Ω—ã –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –≤ –°–®–ê –¥–æ —É—Ä–æ–≤–Ω—è —Ä–∞–∑–≤–∏—Ç—ã—Ö —Å—Ç—Ä–∞–Ω. –ê–Ω–∞–ª–æ–≥–∏—á–Ω—ã–µ —à–∞–≥–∏ –ø—Ä–µ–¥–ø—Ä–∏–Ω—è–ª–∞ Eli Lilly, –ø–æ–≤—ã—Å–∏–≤ —Ü–µ–Ω—ã –Ω–∞ —Å–≤–æ–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–æ –¥–ª—è –ø–æ—Ö—É–¥–µ–Ω–∏—è –≤ –í–µ–ª–∏–∫–æ–±—Ä–∏—Ç–∞–Ω–∏–∏ –Ω–∞ 170% –∏–∑-–∑–∞ –¥–∞–≤–ª–µ–Ω–∏—è –∞–¥–º–∏–Ω–∏—Å—Ç—Ä–∞—Ü–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PPJJc #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""pricing, shortage"",
  ""impact"": ""high"",
  ""english"": ""Bristol-Myers Squibb plans to launch a schizophrenia drug, Cobenfy, at US prices of $1850 per month in the UK as a response to President Trump's demands for lower drug prices in developed countries. Similar actions were taken by Eli Lilly, who increased the price of its weight loss medication in the UK by 170% due to government pressure.""
}"
2025-09-24T11:27:04+00:00,@medpharm,12781,https://t.me/medpharm/12781,"–í –†–æ—Å—Å–∏–∏ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –æ–±–Ω–æ–≤–∏—Ç—å –ø–æ—Ä—è–¥–æ–∫ –ø–æ–º–æ—â–∏ –¥–µ—Ç—è–º —Å –±–æ–ª–µ–∑–Ω—è–º–∏ –≥–ª–∞–∑. –ú–∏–Ω–∑–¥—Ä–∞–≤ —Ä–µ—à–∏–ª —É—Ç–æ—á–Ω–∏—Ç—å, –≤ —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, –ø—Ä–∞–≤–∏–ª–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π —ç–≤–∞–∫—É–∞—Ü–∏–∏ –∏ –≤–≤–µ—Å—Ç–∏ –¥–µ–ª–µ–Ω–∏–µ –∫–ª–∏–Ω–∏–∫ –Ω–∞ –Ω–µ—Å–∫–æ–ª—å–∫–æ –≥—Ä—É–ø–ø. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PPGwe #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ñ—Ç–∞–ª—å–º–æ–ª–æ–≥–∏—è","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""Russia proposes to update the rules for helping children with eye diseases. The Ministry of Health plans to clarify, in particular, medical evacuation rules and introduce a division of clinics into several groups. For more details: https://clck.ru/3PPGwe #MedVestnik #Healthcare #Ophthalmology""
}"
2025-09-24T10:47:02+00:00,@medpharm,12780,https://t.me/medpharm/12780,–£ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –¥–µ—Ä–º–∞—Ç–æ–º–∏–æ–∑–∏—Ç–æ–º –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ brepocitinib –ø—Ä–∏–≤–µ–ª–æ –∫ –∑–∞–º–µ—Ç–Ω–æ–º—É —Å–Ω–∏–∂–µ–Ω–∏—é –∞–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è –∑–∞ 52 –Ω–µ–¥–µ–ª–∏ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –ø–ª–∞—Ü–µ–±–æ. –ü—Ä–µ–ø–∞—Ä–∞—Ç —Ç–∞–∫–∂–µ –ø–æ–∑–≤–æ–ª–∏–ª –±–æ–ª—å—à–µ–º—É —á–∏—Å–ª—É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å–Ω–∏–∑–∏—Ç—å –∏–ª–∏ –ø–æ–ª–Ω–æ—Å—Ç—å—é –ø—Ä–µ–∫—Ä–∞—Ç–∏—Ç—å –ø—Ä–∏–µ–º —Å—Ç–µ—Ä–æ–∏–¥–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PPE6S #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–î–µ—Ä–º–∞—Ç–æ–≤–µ–Ω–µ—Ä–æ–ª–æ–≥–∏—è #–ù–µ–≤—Ä–æ–ª–æ–≥–∏—è #–¢–µ—Ä–∞–ø–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è,"{""skip"": true}"
2025-09-24T10:32:07+00:00,@medpharm,12779,https://t.me/medpharm/12779,–ú–∏–Ω—Ñ–∏–Ω –Ω–∞–º–µ—Ä–µ–Ω –≤ –ø–æ–ª–Ω–æ–º –æ–±—ä–µ–º–µ –ø—Ä–æ—Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞—Ç—å –ø—Ä–æ–≥—Ä–∞–º–º—ã –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è. –í –ø—Ä–æ–µ–∫—Ç–µ –±—é–¥–∂–µ—Ç–∞ –¥–æ 2030 –≥–æ–¥–∞ –∑–∞–ª–æ–∂–µ–Ω 1 —Ç—Ä–ª–Ω —Ä—É–±. –Ω–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PPCyo #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, reimbursement"",
  ""impact"": ""high"",
  ""english"": ""The Finance Ministry plans to fully finance the programs of pharmaceutical supply in full. A budget project for 2030 includes a trillion rubles for healthcare.""
}"
2025-09-24T09:17:03+00:00,@medpharm,12777,https://t.me/medpharm/12777,"–ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ –∏–∑–º–µ–Ω–∏—Ç –ø–µ—Ä–µ—á–µ–Ω—å –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –¥–ª—è —É–ø—Ä–æ—â–µ–Ω–Ω–æ–≥–æ –¥–µ–∫–ª–∞—Ä–∏—Ä–æ–≤–∞–Ω–∏—è. –í —Å–ø–∏—Å–æ–∫, –æ–±—è–∑—ã–≤–∞—é—â–∏–π –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ø—Ä–æ–≤–æ–¥–∏—Ç—å –ø–æ–ª–Ω—É—é –ø—Ä–æ—Ü–µ–¥—É—Ä—É —Å–µ—Ä—Ç–∏—Ñ–∏–∫–∞—Ü–∏–∏, –≤–æ—à–ª–∏ —Ç–æ–≤–∞—Ä—ã –¥–ª—è –¥–µ—Ç–µ–π, –æ—Ç–±–µ–ª–∏–≤–∞—é—â–∏–µ —Å—Ä–µ–¥—Å—Ç–≤–∞ –∏ –ø—Ä–æ–¥—É–∫—Ü–∏—è, —Å–æ–¥–µ—Ä–∂–∞—â–∞—è –Ω–∞–Ω–æ–º–∞—Ç–µ—Ä–∏–∞–ª—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PP62t #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Industry and Trade will change the list of products for simplified declaration. Products for children, bleaching agents, and materials containing nanomaterials are now required to undergo full certification procedures.""
}"
2025-09-24T08:51:02+00:00,@medpharm,12776,https://t.me/medpharm/12776,"–í–ª–∞–¥–∏–º–∏—Ä –ü—É—Ç–∏–Ω —Ä–∞—Å—à–∏—Ä–∏–ª –ø–æ–ª–Ω–æ–º–æ—á–∏—è –§–ú–ë–ê, –ø–æ–∑–≤–æ–ª–∏–≤ –∞–≥–µ–Ω—Ç—Å—Ç–≤—É —Å–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω–æ –ø—Ä–∏–Ω–∏–º–∞—Ç—å –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω—ã–µ –∞–∫—Ç—ã –æ –º–µ–¥–∏–∫–æ-—Å–∞–Ω–∏—Ç–∞—Ä–Ω—ã—Ö –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏—è—Ö, –∏—Å–ø—ã—Ç–∞–Ω–∏—è—Ö —Å–ø–µ—Ü—Å—Ä–µ–¥—Å—Ç–≤ –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –Ω–∞ –æ—Å–æ–±–æ –æ–ø–∞—Å–Ω—ã—Ö –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏—è—Ö –∏ –≤ –ß–°. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PP3R2 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""Vladimir Putin expanded the powers of FSB to independently issue regulatory acts on medical-sanitary measures, trials of special substances and medical assistance at hazardous enterprises and in emergencies. More details: https://clck.ru/3PP3R2 #MedVestnik #Healthcare""
}"
2025-09-24T07:48:02+00:00,@medpharm,12775,https://t.me/medpharm/12775,–ó–∞–º–≥–ª–∞–≤—ã –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ù–∞—Ç–∞–ª—å—è –•–æ—Ä–æ–≤–∞ —Å—Ç–∞–ª–∞ —Å–µ–Ω–∞—Ç–æ—Ä–æ–º –æ—Ç –ï–≤—Ä–µ–π—Å–∫–æ–π –∞–≤—Ç–æ–Ω–æ–º–Ω–æ–π –æ–±–ª–∞—Å—Ç–∏ –≤ –°–æ–≤—Ñ–µ–¥–µ. –û–Ω–∞ –ø—Ä–æ—Ä–∞–±–æ—Ç–∞–ª–∞ –≤ –º–∏–Ω–∏—Å—Ç–µ—Ä—Å—Ç–≤–µ –Ω–∞ —Ä–∞–∑–Ω—ã—Ö –¥–æ–ª–∂–Ω–æ—Å—Ç—è—Ö –±–æ–ª—å—à–µ 20 –ª–µ—Ç. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PNtYc #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-09-24T07:21:05+00:00,@medpharm,12774,https://t.me/medpharm/12774,"–°—Ç–∞–≤–∫–∞ –ù–î–° –º–æ–∂–µ—Ç –≤—ã—Ä–∞—Å—Ç–∏ –¥–æ 22% —Å 2026 –≥–æ–¥–∞. –ü—Ä–∏ —ç—Ç–æ–º –ª—å–≥–æ—Ç–Ω–∞—è —Å—Ç–∞–≤–∫–∞ –≤ 10% –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞, –ø—Ä–æ–¥—É–∫—Ç—ã –∏ —Ç–æ–≤–∞—Ä—ã –¥–ª—è –¥–µ—Ç–µ–π —Å–æ—Ö—Ä–∞–Ω–∏—Ç—Å—è. –ü–æ—Ä–æ–≥ —É–ø–ª–∞—Ç—ã –ù–î–° –¥–ª—è –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –Ω–∞ –£–°–ù –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è —Å–Ω–∏–∑–∏—Ç—å —Å 60 –º–ª–Ω –¥–æ 10 –º–ª–Ω —Ä—É–±. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PNq2S #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""pricing, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The VAT rate is proposed to increase from 10% to 22% by 2026. The reduced rate of 10% for medicines, products, and children's goods will remain in place. The threshold for organizations under the Simplified Tax Calculation Method (–£–°–ù) to pay VAT is proposed to be reduced from 60 million rubles to 10 million rubles. For more details: https://clck.ru/3PNq2S #PharmNews #Regulation""
}"
2025-09-23T17:30:02+00:00,@medpharm,12772,https://t.me/medpharm/12772,"–í –í–µ–ª–∏–∫–æ–º –ù–æ–≤–≥–æ—Ä–æ–¥–µ —Å–æ—Å—Ç–æ—è–ª—Å—è —Ñ–∏–Ω–∞–ª –ß–µ–º–ø–∏–æ–Ω–∞—Ç–∞ –≤—ã—Å–æ–∫–∏—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π ‚Äî —Å–æ—Ä–µ–≤–Ω–æ–≤–∞–Ω–∏–π –ø–æ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–º—É –º–∞—Å—Ç–µ—Ä—Å—Ç–≤—É –¥–ª—è —Å—Ç—É–¥–µ–Ω—Ç–æ–≤ –∫–æ–ª–ª–µ–¥–∂–µ–π, —Å—Ç–∞—Ä—à–µ–∫–ª–∞—Å—Å–Ω–∏–∫–æ–≤ –∏ –º–æ–ª–æ–¥—ã—Ö —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PNQse #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-09-23T16:46:37+00:00,@medpharm,12771,https://t.me/medpharm/12771,"ü¶æ –û—Ç–µ—Ü —Å–æ–ª–¥–∞—Ç–∞–º. –†–µ–≥–∏–æ–Ω—ã –¥–æ–ª–∂–Ω—ã –æ–±–µ—Å–ø–µ—á–∏—Ç—å –¥–æ—Å—Ç–æ–π–Ω—É—é –æ–ø–ª–∞—Ç—É —Ç—Ä—É–¥–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –∏ —Ä–∞–±–æ—Ç–∞—Ç—å –Ω–∞–¥ –ø–æ–≤—ã—à–µ–Ω–∏–µ–º –∏—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å–Ω–æ—Å—Ç–∏, –∑–∞—è–≤–∏–ª –≥–ª–∞–≤–∞ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ú–∏—Ö–∞–∏–ª –ú—É—Ä–∞—à–∫–æ –Ω–∞ —à–µ—Å—Ç–æ–π ¬´–®–∫–æ–ª–µ –º–∏–Ω–∏—Å—Ç—Ä–∞¬ª. ü¶æ –ü—Ä–æ—Ç–∏–≤–æ—Ä–µ—á–∏–≤–æ–µ –û–ú–°. –ß—É—Ç—å –±–æ–ª—å—à–µ 40% —Ä–æ—Å—Å–∏—è–Ω –¥–æ–≤–æ–ª—å–Ω—ã –∫–∞—á–µ—Å—Ç–≤–æ–º –∏ –æ–±—ä–µ–º–æ–º —É—Å–ª—É–≥ –≤ —Å–∏—Å—Ç–µ–º–µ –û–ú–°. –û–¥–Ω–∞–∫–æ –æ—Ü–µ–Ω–∫–∏ –≤ —Ä–∞–∑–Ω—ã—Ö —Å–ª–æ—è—Ö –Ω–∞—Å–µ–ª–µ–Ω–∏—è —Ä–∞—Å–ø—Ä–µ–¥–µ–ª–µ–Ω—ã –Ω–µ—Ä–∞–≤–Ω–æ–º–µ—Ä–Ω–æ. ‚ù§Ô∏è –õ–∞–ø—ã –ø—Ä–æ—á—å. –í—Ö–æ–¥ —Å —Å–æ–±–∞–∫–∞–º–∏ –≤ –∞–ø—Ç–µ–∫–∏ –∏ —Ä—è–¥ –¥—Ä—É–≥–∏—Ö —É—á—Ä–µ–∂–¥–µ–Ω–∏–π –º–æ–∂–µ—Ç –±—ã—Ç—å –∑–∞–ø—Ä–µ—â–µ–Ω, —Å —Ç–∞–∫–æ–π –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–æ–π –≤—ã—Å—Ç—É–ø–∏–ª–∏ –≤ –ì–æ—Å–¥—É–º–µ. –ü–æ —Å–ª–æ–≤–∞–º –¥–µ–ø—É—Ç–∞—Ç–∞ –ù–∏–Ω—ã –û—Å—Ç–∞–Ω–∏–Ω–æ–π, –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç —É–∂–µ —Å–æ–≥–ª–∞—Å–æ–≤–∞–ª–∏ —Å–æ –°–ª–µ–¥—Å—Ç–≤–µ–Ω–Ω—ã–º –∫–æ–º–∏—Ç–µ—Ç–æ–º –∏ –Ω–∞–ø—Ä–∞–≤–∏–ª–∏ –≤ –†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä. ‚ù§Ô∏è –ö–∞–∫–∏–µ –ª—é–¥–∏. –í 26-–π —Ä–µ–π—Ç–∏–Ω–≥ ¬´–¢–û–ü-1000 —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –º–µ–Ω–µ–¥–∂–µ—Ä–æ–≤¬ª –ê—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ –º–µ–Ω–µ–¥–∂–µ—Ä–æ–≤ –∏ ¬´–ö–æ–º–º–µ—Ä—Å–∞–Ω—Ç—ä¬ª –≤–æ—à–ª–∏ –±–æ–ª–µ–µ 20 —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª–µ–π –æ—Ç —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏.","{""skip"": true}"
2025-09-23T16:35:02+00:00,@medpharm,12770,https://t.me/medpharm/12770,–í 26-–π —Ä–µ–π—Ç–∏–Ω–≥ ¬´–¢–û–ü-1000 —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –º–µ–Ω–µ–¥–∂–µ—Ä–æ–≤¬ª –ê—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ –º–µ–Ω–µ–¥–∂–µ—Ä–æ–≤ –∏ ¬´–ö–æ–º–º–µ—Ä—Å–∞–Ω—Ç–∞¬ª –≤–æ—à–ª–∏ –±–æ–ª–µ–µ 20 —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª–µ–π –æ—Ç —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PNNV9 #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ö–∞—Ä—å–µ—Ä–∞,"{""skip"": true}"
2025-09-23T16:20:28+00:00,@medpharm,12769,https://t.me/medpharm/12769,"–≠–∫—Å-–≥–ª–∞–≤—É –§–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –°–∏–±–∏—Ä—Å–∫–æ–≥–æ –Ω–∞—É—á–Ω–æ-–∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–≥–æ —Ü–µ–Ω—Ç—Ä–∞ –§–ú–ë–ê –ë–æ—Ä–∏—Å–∞ –ë–∞—Ä–∞–Ω–∫–∏–Ω–∞ –ø—Ä–∏–≥–æ–≤–æ—Ä–∏–ª–∏ –∫ —à–µ—Å—Ç–∏ –≥–æ–¥–∞–º –∫–æ–ª–æ–Ω–∏–∏ –∏ –æ—à—Ç—Ä–∞—Ñ–æ–≤–∞–ª–∏ –Ω–∞ 700 —Ç—ã—Å. —Ä—É–±. –ø–æ –¥–µ–ª—É –æ —Ä–∞—Å—Ç—Ä–∞—Ç–µ. –°—É–º–º–∞—Ä–Ω–æ —Å –Ω–µ–≥–æ –∏ –¥—Ä—É–≥–∏—Ö —Ñ–∏–≥—É—Ä–∞–Ω—Ç–æ–≤ –≤–∑—ã—Å–∫–∞–ª–∏ –±–æ–ª–µ–µ 13,5 –º–ª–Ω —Ä—É–±. –≤ –∫–∞—á–µ—Å—Ç–≤–µ –≤–æ–∑–º–µ—â–µ–Ω–∏—è —É—â–µ—Ä–±–∞ –±—é–¥–∂–µ—Ç—É –∏ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—é. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PNMxa #–§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–π_–í–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{""skip"": true}"
2025-09-23T16:12:58+00:00,@medpharm,12763,https://t.me/medpharm/12763,"–¢—Ä–∞–º–ø –∑–∞—è–≤–∏–ª, —á—Ç–æ —É–ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–µ –ø–∞—Ä–∞—Ü–µ—Ç–∞–º–æ–ª–∞ –≤–æ –≤—Ä–µ–º—è –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏ –∏ –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏—è –≤–µ–¥—É—Ç –∫ —Ä–∞–∑–≤–∏—Ç–∏—é –∞—É—Ç–∏–∑–º–∞ —É –¥–µ—Ç–µ–π. –ù–∞—É—á–Ω–æ–µ —Å–æ–æ–±—â–µ—Å—Ç–≤–æ –∫–∞—Ç–µ–≥–æ—Ä–∏—á–µ—Å–∫–∏ –æ—Ç–≤–µ—Ä–≥–ª–æ —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏—è, —Å—Å—ã–ª–∞—è—Å—å –Ω–∞ –∫—Ä—É–ø–Ω–æ–º–∞—Å—à—Ç–∞–±–Ω—ã–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è —Å —É—á–∞—Å—Ç–∏–µ–º –º–∏–ª–ª–∏–æ–Ω–æ–≤ –¥–µ—Ç–µ–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PNMRW #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-09-23T15:22:41+00:00,@medpharm,12762,https://t.me/medpharm/12762,"Data-driven –≤ —Ñ–∞—Ä–º–º–∞—Ä–∫–µ—Ç–∏–Ω–≥–µ ‚Äî —ç—Ç–æ –ø–µ—Ä–µ—Ö–æ–¥ –æ—Ç –∏–Ω—Ç—É–∏—Ü–∏–∏ –∫ —Ä–µ—à–µ–Ω–∏—è–º –Ω–∞ –æ—Å–Ω–æ–≤–µ –¥–∞–Ω–Ω—ã—Ö, –∫–æ—Ç–æ—Ä—ã–π –ø—Ä–µ–≤—Ä–∞—â–∞–µ—Ç –∫–æ–º–º—É–Ω–∏–∫–∞—Ü–∏–∏ —Å –≤—Ä–∞—á–∞–º–∏ –∏ –ø–∞—Ü–∏–µ–Ω—Ç–∞–º–∏ –≤ —É–ø—Ä–∞–≤–ª—è–µ–º—É—é –∏ –ø—Ä–æ–≥–Ω–æ–∑–∏—Ä—É–µ–º—É—é —Å–∏—Å—Ç–µ–º—É. –ï–¥–∏–Ω–∞—è —ç–∫–æ—Å–∏—Å—Ç–µ–º–∞ –¥–∞–Ω–Ω—ã—Ö, –∞–≤—Ç–æ–º–∞—Ç–∏–∑–∞—Ü–∏—è –∏ –ø—Ä–µ–¥–∏–∫—Ç–∏–≤–Ω–∞—è –∞–Ω–∞–ª–∏—Ç–∏–∫–∞ –ø–æ–º–æ–≥–∞—é—Ç —Ç–æ—á–Ω–µ–µ —Ä–∞—Å–ø—Ä–µ–¥–µ–ª—è—Ç—å –±—é–¥–∂–µ—Ç—ã, –ø–æ–≤—ã—à–∞—Ç—å –∫–æ–Ω–≤–µ—Ä—Å–∏—é –∏ —Å–æ–∫—Ä–∞—â–∞—Ç—å time-to-market. –° —á–µ–≥–æ –Ω–∞—á–∞—Ç—å, ¬´–§–í¬ª —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∞ –¥–∏—Ä–µ–∫—Ç–æ—Ä –ø–æ —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–æ–º—É —Ä–∞–∑–≤–∏—Ç–∏—é RX CODE –ò—Ä–∏–Ω–∞ –§–∏–æ–Ω–æ–≤–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PMtvF #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-09-23T15:14:04+00:00,@medpharm,12761,https://t.me/medpharm/12761,–í –°–®–ê –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Å–∏–Ω–¥—Ä–æ–º–∞ –ë–∞—Ä—Ç–∞ –≤—Ä–∞—á–∏ –±—É–¥—É—Ç –Ω–∞–∑–Ω–∞—á–∞—Ç—å Forzinity. –ü—Ä–æ–¥–∞–∂–∏ —Å—Ç–∞—Ä—Ç—É—é—Ç –≤ –∫–æ–Ω—Ü–µ –≥–æ–¥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PNJoR #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–§–∞—Ä–º–∏–Ω–¥—É—Å—Ç—Ä–∏—è #–ì–µ–Ω–µ—Ç–∏–∫–∞ #–¢–µ—Ä–∞–ø–∏—è,"{""skip"": true}"
2025-09-23T14:35:02+00:00,@medpharm,12760,https://t.me/medpharm/12760,"–ù–ú–ò–¶ –∏–º. –ú–µ—à–∞–ª–∫–∏–Ω–∞ –≤—ã–±—Ä–∞–ª –ø–æ–¥—Ä—è–¥—á–∏–∫–∞ –¥–ª—è –ø–µ—Ä–≤–æ–≥–æ —ç—Ç–∞–ø–∞ –ø—Ä–æ–≥—Ä–∞–º–º—ã —Ä–µ–∫–æ–Ω—Å—Ç—Ä—É–∫—Ü–∏–∏ –∏ —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–∞ —Å—Ç–æ–∏–º–æ—Å—Ç—å—é 15 –º–ª—Ä–¥ —Ä—É–±., –∏–º —Å—Ç–∞–Ω–µ—Ç –∫–æ–º–ø–∞–Ω–∏—è —Å –±–æ–ª—å—à–∏–º –æ–ø—ã—Ç–æ–º —Ä–∞–±–æ—Ç—ã —Å –≥–æ—Å–∑–∞–∫–∞–∑–∞–º–∏. –ù–∞ —É—á–∞—Å—Ç–∏–µ –≤ –ø–µ—Ä–≤–æ–π –≥–æ—Å–∑–∞–∫—É–ø–∫–µ —Å—Ç–æ–∏–º–æ—Å—Ç—å—é 9,6 –º–ª—Ä–¥ —Ä—É–±. –Ω–µ –±—ã–ª–æ –ø–æ–¥–∞–Ω–æ –∑–∞—è–≤–æ–∫, –ø—Ä–∏—à–ª–æ—Å—å —É–º–µ–Ω—å—à–∏—Ç—å –º–∞—Å—à—Ç–∞–± —Ä–∞–±–æ—Ç, –∞ —Ü–µ–Ω—É –∫–æ–Ω—Ç—Ä–∞–∫—Ç–∞ —Å–Ω–∏–∑–∏—Ç—å –±–æ–ª–µ–µ —á–µ–º –≤ 12 —Ä–∞–∑. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PNGTk #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-09-23T14:31:34+00:00,@medpharm,12759,https://t.me/medpharm/12759,"–í—Ö–æ–¥ —Å —Å–æ–±–∞–∫–∞–º–∏ –≤ –∞–ø—Ç–µ–∫–∏ –∏ —Ä—è–¥ –¥—Ä—É–≥–∏—Ö —É—á—Ä–µ–∂–¥–µ–Ω–∏–π –º–æ–∂–µ—Ç –±—ã—Ç—å –∑–∞–ø—Ä–µ—â–µ–Ω, —Å —Ç–∞–∫–æ–π –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–æ–π –≤—ã—Å—Ç—É–ø–∏–ª–∏ –≤ –ì–æ—Å–¥—É–º–µ. –ü–æ —Å–ª–æ–≤–∞–º –¥–µ–ø—É—Ç–∞—Ç–∞ –ù–∏–Ω—ã –û—Å—Ç–∞–Ω–∏–Ω–æ–π, –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç —É–∂–µ —Å–æ–≥–ª–∞—Å–æ–≤–∞–ª–∏ —Å–æ –°–ª–µ–¥—Å—Ç–≤–µ–Ω–Ω—ã–º –∫–æ–º–∏—Ç–µ—Ç–æ–º –†–æ—Å—Å–∏–∏ (–°–ö–†) –∏ –Ω–∞–ø—Ä–∞–≤–∏–ª–∏ –≤ –†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PNC3p #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, sanctions"",
  ""impact"": ""high"",
  ""english"": ""A proposal to prohibit pets from entering pharmacies and other institutions has been made in the State Duma. Deputy Nina Ostapenya says that the project has already been agreed with the Russian Investigative Committee (Sovetskoye Sudebnoye Voedushie Komitet) and sent to the Russian Consumer Rights Agency. More details: https://clck.ru/3PNC3p #Pharmagist #Regulatorka""
}"
2025-09-23T13:55:02+00:00,@medpharm,12758,https://t.me/medpharm/12758,"–û–∫–æ–ª–æ 43% —Ä–æ—Å—Å–∏—è–Ω –¥–æ–≤–æ–ª—å–Ω—ã –∫–∞—á–µ—Å—Ç–≤–æ–º –∏ –æ–±—ä–µ–º–æ–º —É—Å–ª—É–≥ –û–ú–°, –Ω–æ —Å—Ä–µ–¥–∏ –º–∞–ª–æ–æ–±–µ—Å–ø–µ—á–µ–Ω–Ω—ã—Ö –≥—Ä–∞–∂–¥–∞–Ω –Ω–µ–¥–æ–≤–æ–ª—å–Ω—ã—Ö —Å–∏—Å—Ç–µ–º–æ–π –≤ –¥–≤–∞ —Ä–∞–∑–∞ –±–æ–ª—å—à–µ, —á–µ–º —Å—Ä–µ–¥–∏ –æ—Å—Ç–∞–ª—å–Ω—ã—Ö —Ä–µ—Å–ø–æ–Ω–¥–µ–Ω—Ç–æ–≤. –ü–æ–¥–¥–µ—Ä–∂–∏–≤–∞—é—Ç —É—Å–∏–ª–µ–Ω–∏–µ –≥–æ—Å–∫–æ–Ω—Ç—Ä–æ–ª—è –Ω–∞–¥ —Ä–∞–±–æ—Ç–æ–π —Å—Ç—Ä–∞—Ö–æ–≤—ã—Ö –∫–æ–º–ø–∞–Ω–∏–π 70% –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PNDvh #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-09-23T13:18:02+00:00,@medpharm,12757,https://t.me/medpharm/12757,–î–∏—Ä–µ–∫—Ç–æ—Ä –î–µ–ø–∞—Ä—Ç–∞–º–µ–Ω—Ç–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –ò–≥–æ—Ä—å –ö–∞–≥—Ä–∞–º–∞–Ω—è–Ω –Ω–∞–∑–Ω–∞—á–µ–Ω –∞—É–¥–∏—Ç–æ—Ä–æ–º –°—á–µ—Ç–Ω–æ–π –ø–∞–ª–∞—Ç—ã. –†–∞–Ω–µ–µ –æ–Ω –Ω–µ –æ–¥–∏–Ω –≥–æ–¥ –ø—Ä–æ—Ä–∞–±–æ—Ç–∞–ª –ø–µ—Ä–≤—ã–º –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª–µ–º –º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PNBaD #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-09-23T12:32:02+00:00,@medpharm,12756,https://t.me/medpharm/12756,–ò.–æ. –≥–ª–∞–≤—ã —Ä–æ—Å—Ç–æ–≤—Å–∫–æ–≥–æ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ø–æ—Å–ª–µ —É–≤–æ–ª—å–Ω–µ–Ω–∏—è –Æ—Ä–∏—è –ö–æ–±–∑–µ–≤–∞ –Ω–∞–∑–Ω–∞—á–µ–Ω–∞ –ï–ª–µ–Ω–∞ –¢–µ–ø–ª—è–∫–æ–≤–∞. –†–∞–Ω–µ–µ –æ–Ω–∞ –∑–∞–Ω–∏–º–∞–ª–∞ –¥–æ–ª–∂–Ω–æ—Å—Ç—å –ø–µ—Ä–≤–æ–≥–æ –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—è –º–∏–Ω–∏—Å—Ç—Ä–∞ –∏ —Ä—É–∫–æ–≤–æ–¥–∏–ª–∞ –≤–æ–ø—Ä–æ—Å–∞–º–∏ –æ—Ö—Ä–∞–Ω—ã –º–∞—Ç–µ—Ä–∏–Ω—Å—Ç–≤–∞ –∏ –¥–µ—Ç—Å—Ç–≤–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PN7hT #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-09-23T11:36:02+00:00,@medpharm,12755,https://t.me/medpharm/12755,"–†–∞–∑–≤–∏—Ç–∏–µ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è —Ç—Ä–µ–±—É–µ—Ç –ø–æ–≤—ã—à–µ–Ω–∏—è –∫–≤–∞–ª–∏—Ñ–∏–∫–∞—Ü–∏–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤, –¥–æ—Å—Ç–æ–π–Ω–æ–π –æ–ø–ª–∞—Ç—ã –∏ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ —Ç—Ä—É–¥–∞. –ö–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –¥–æ–ª–∂–Ω—ã —Å—Ç–∞—Ç—å –æ—Å–Ω–æ–≤–æ–π –µ–∂–µ–¥–Ω–µ–≤–Ω–æ–π –ø—Ä–∞–∫—Ç–∏–∫–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PN2DS #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-09-23T09:13:02+00:00,@medpharm,12754,https://t.me/medpharm/12754,"–í –ú–æ—Å–∫–≤–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–π –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–Ω—ã–π —Ç–µ—Ö–Ω–∏–∫ –º–æ–∂–µ—Ç –∑–∞—Ä–∞–±–∞—Ç—ã–≤–∞—Ç—å –¥–æ 150 —Ç—ã—Å. —Ä—É–±. –≤ –º–µ—Å—è—Ü, –≤ –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥–µ –∏ –ï–∫–∞—Ç–µ—Ä–∏–Ω–±—É—Ä–≥–µ ‚Äî –¥–æ 125 —Ç—ã—Å. –∏ 110 —Ç—ã—Å. —Ä—É–±. —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ. –î–ª—è –≤—ã—Ö–æ–¥–∞ –Ω–∞ –º–∞–∫—Å–∏–º—É–º —Ç—Ä–µ–±—É—é—Ç—Å—è –≤ —Ç–æ–º —á–∏—Å–ª–µ –æ–ø—ã—Ç —Ä–∞–±–æ—Ç—ã –æ—Ç –¥–≤—É—Ö –ª–µ—Ç, –ø—Ä–æ—Ñ–∏–ª—å–Ω–æ–µ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ –∏ –¥–µ–π—Å—Ç–≤—É—é—â–∏–π —Å–µ—Ä—Ç–∏—Ñ–∏–∫–∞—Ç –ø–æ —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PMnoT #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-09-23T07:45:02+00:00,@medpharm,12753,https://t.me/medpharm/12753,"–í –ì–æ—Å–¥—É–º–µ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –æ–≥—Ä–∞–Ω–∏—á–∏—Ç—å –∑–∞—Ä–ø–ª–∞—Ç—É —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª–µ–π –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏–π –∏ —à–∫–æ–ª, —á—Ç–æ–±—ã –æ–Ω–∞ –Ω–µ –ø—Ä–µ–≤—ã—à–∞–ª–∞ —Å—Ä–µ–¥–Ω—é—é –∑–∞—Ä–ø–ª–∞—Ç—É —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤ –±–æ–ª–µ–µ —á–µ–º –≤ –¥–≤–∞ —Ä–∞–∑–∞. –¢–∞–∫–æ–π —à–∞–≥, –ø–æ –º–Ω–µ–Ω–∏—é –∞–≤—Ç–æ—Ä–æ–≤ –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤—ã, –ø–æ–º–æ–∂–µ—Ç —Å–Ω–∏–∑–∏—Ç—å —Ä–∞–∑—Ä—ã–≤ –≤ –¥–æ—Ö–æ–¥–∞—Ö –∏ –ø–æ–≤—ã—Å–∏—Ç—å –º–æ—Ç–∏–≤–∞—Ü–∏—é –∫–æ–ª–ª–µ–∫—Ç–∏–≤–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PMeFT #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-09-23T07:03:40+00:00,@medpharm,12751,https://t.me/medpharm/12751,"24.09 –≤ –ú–æ—Å–∫–≤–∞-–°–∏—Ç–∏ –ø—Ä–æ–π–¥–µ—Ç –∏–Ω—Å–∞–π—Ç-–∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏—è ¬´–û—à–∏–±–∫–∞ –≤—ã–∂–∏–≤—à–µ–≥–æ¬ª –≤ R—Ö-–º–∞—Ä–∫–µ—Ç–∏–Ω–≥–µ¬ª. –û—Ä–≥–∞–Ω–∏–∑–∞—Ç–æ—Ä –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ –ê–≥–µ–Ω—Ç—Å—Ç–≤–æ CommWorld –ø—Ä–∏–≥–ª–∞—à–∞–µ—Ç —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª–µ–π —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π –∏ —Ñ–∞—Ä–º–¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–æ–≤, –¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–≤ –ø–æ –º–∞—Ä–∫–µ—Ç–∏–Ω–≥—É, –ø—Ä–æ–¥–∞–∫—Ç-–º–µ–Ω–µ–¥–∂–µ—Ä–æ–≤, –º–∞—Ä–∫–µ—Ç–æ–ª–æ–≥–æ–≤ –∏ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ SFE. –û–±—Å—É–¥–∏–º —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –æ –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏–∏ –≤—Ä–∞—á–µ–π –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–µ–π, —Ç—Ä–µ–Ω–¥—ã —Ñ–∞—Ä–º–º–∞—Ä–∫–µ—Ç–∏–Ω–≥–∞ 2026-2027, —Ä–µ–∞–ª—å–Ω—ã–µ –∫–µ–π—Å—ã –≤ –ø—Ä–æ–¥–≤–∏–∂–µ–Ω–∏–∏ –õ–° —Å –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –ò–ò. –ü—Ä–æ–≤–µ–¥–µ–º workshop –ø–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—é AI –≤ –ø—Ä–æ–¥–≤–∏–∂–µ–Ω–∏–∏ Rx-–±—Ä–µ–Ω–¥–æ–≤. –ü—Ä–æ–≥—Ä–∞–º–º–∞, —Å–ø–∏–∫–µ—Ä—ã –∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –Ω–∞ –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–µ –ø–æ —Å—Å—ã–ª–∫–µ –†–µ–∫–ª–∞–º–∞ –û–û–û ¬´–ö–æ–º–º–≤–æ—Ä–ª–¥¬ª","{""skip"": true}"
2025-09-23T06:38:02+00:00,@medpharm,12750,https://t.me/medpharm/12750,–°—É–¥ –≤ –ò–≤–∞–Ω–æ–≤–æ –Ω–∞–ª–æ–∂–∏–ª –æ–±–µ—Å–ø–µ—á–∏—Ç–µ–ª—å–Ω—ã–µ –º–µ—Ä—ã –Ω–∞ –∏–º—É—â–µ—Å—Ç–≤–æ –±—ã–≤—à–∏—Ö —á–∏–Ω–æ–≤–Ω–∏–∫–æ–≤ –æ–±–ª–∞—Å—Ç–Ω–æ–≥–æ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞. –û–Ω–∏ –æ–∫–∞–∑—ã–≤–∞–ª–∏ –ø–æ–∫—Ä–æ–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ —Å—Ç—Ä–æ–∏—Ç–µ–ª—å–Ω–æ–π —Ñ–∏—Ä–º–µ –ø—Ä–∏ –∑–∞–∫–ª—é—á–µ–Ω–∏–∏ –≥–æ—Å–∫–æ–Ω—Ç—Ä–∞–∫—Ç–æ–≤ –Ω–∞ –≤—ã–ø–æ–ª–Ω–µ–Ω–∏–µ —Ä–µ–º–æ–Ω—Ç–æ–≤ –±–æ–ª—å–Ω–∏—Ü –∏ —à–∫–æ–ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PMYeB #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–î—Ä—É–≥–æ–µ,"{""skip"": true}"
2025-09-22T16:29:31+00:00,@medpharm,12749,https://t.me/medpharm/12749,–ü—É–ª –ø–æ–ø—Ä–∞–≤–æ–∫. –ú–∏–Ω–∑–¥—Ä–∞–≤ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª –Ω–∞ –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–µ –æ–±—Å—É–∂–¥–µ–Ω–∏–µ –ø—Ä–æ–µ–∫—Ç –ø–æ–ø—Ä–∞–≤–æ–∫ –≤ –§–µ–¥–µ—Ä–∞–ª—å–Ω—ã–π –∑–∞–∫–æ–Ω ¬´–û–± –û–ú–°¬ª. ¬´–ú–í¬ª –≤—ã–¥–µ–ª–∏–ª –≥–ª–∞–≤–Ω—ã–µ –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ –¥–æ–∫—É–º–µ–Ω—Ç–µ. –°–º–µ–Ω–∏–ª –ø—Ä–æ–ø–∏—Å–∫—É. –í –ê—Ä—Ö–∞–Ω–≥–µ–ª—å—Å–∫–µ –∞—Ä–µ—Å—Ç–æ–≤–∞–Ω –ø–æ —É–≥–æ–ª–æ–≤–Ω–æ–º—É –¥–µ–ª—É –æ –∑–ª–æ—É–ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–∏ –¥–æ–ª–∂–Ω–æ—Å—Ç–Ω—ã–º–∏ –ø–æ–ª–Ω–æ–º–æ—á–∏—è–º–∏ –±—ã–≤—à–∏–π –º–∏–Ω–∏—Å—Ç—Ä –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è —Ä–µ–≥–∏–æ–Ω–∞ –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ì–µ—Ä—à—Ç–∞–Ω—Å–∫–∏–π. –û–Ω —Å–ª–æ–∂–∏–ª –ø–æ–ª–Ω–æ–º–æ—á–∏—è –±—É–∫–≤–∞–ª—å–Ω–æ –∑–∞ –¥–µ–Ω—å –¥–æ –æ—Ç–ø—Ä–∞–≤–∫–∏ –≤ –°–ò–ó–û. –ü—Ä–æ–≤–µ—Ä–∫–∞ –¥–∞–ª–∞ —à—Ç—Ä–∞—Ñ. ¬´–î–∂–æ–¥–∞—Å –≠–∫—Å–ø–æ–∏–º¬ª –æ—à—Ç—Ä–∞—Ñ–æ–≤–∞–ª–∏ –∑–∞ –≥—Ä—É–±–æ–µ –Ω–∞—Ä—É—à–µ–Ω–∏–µ —É—Å–ª–æ–≤–∏–π –æ–ø—Ç–æ–≤–æ–π —Ñ–∞—Ä–º–ª–∏—Ü–µ–Ω–∑–∏–∏. –í–Ω–µ–ø–ª–∞–Ω–æ–≤–∞—è –≤—ã–µ–∑–¥–Ω–∞—è –ø—Ä–æ–≤–µ—Ä–∫–∞ –±—ã–ª–∞ –ø—Ä–æ–≤–µ–¥–µ–Ω–∞ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–æ–º –ø–æ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—é –ì–µ–Ω–ø—Ä–æ–∫—É—Ä–∞—Ç—É—Ä—ã. –°–≤—è–∑—å —Å —Ä–µ–∞–ª—å–Ω–æ—Å—Ç—å—é. ¬´–ß–µ—Å—Ç–Ω—ã–π –∑–Ω–∞–∫¬ª –±—É–¥–µ—Ç –ø—Ä–æ–≤–µ—Ä—è—Ç—å –Ω–∞–ª–∏—á–∏–µ —Ä–µ–∞–ª—å–Ω—ã—Ö –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏–π —É –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ë–ê–î. –ú–æ–∂–Ω–æ –±—É–¥–µ—Ç –ø—Ä–æ–π—Ç–∏ –æ—á–Ω—É—é –ø—Ä–æ–≤–µ—Ä–∫—É –∏–ª–∏ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–∏—Ç—å –º–∞—Ç–µ—Ä–∏–∞–ª—ã —á–µ—Ä–µ–∑ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏–µ ¬´–ò–Ω—Å–ø–µ–∫—Ç–æ—Ä¬ª. –û—Ç–∫–∞–∑ –∏–ª–∏ –Ω–µ–ø—Ä–æ—Ö–æ–∂–¥–µ–Ω–∏–µ –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥–∞ –ø—Ä–∏–≤–µ–¥–µ—Ç –∫ –∞–Ω–Ω—É–ª–∏—Ä–æ–≤–∞–Ω–∏—é –∫–æ–¥–æ–≤ –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏.,"{""skip"": true}"
2025-09-22T15:58:01+00:00,@medpharm,12748,https://t.me/medpharm/12748,"Pfizer –∑–∞–∫–ª—é—á–∏–ª–∞ —Å–æ–≥–ª–∞—à–µ–Ω–∏–µ –æ –ø–æ–∫—É–ø–∫–µ —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ –æ—Ç –æ–∂–∏—Ä–µ–Ω–∏—è Metsera –∑–∞ 7,3 –º–ª—Ä–¥ –¥–æ–ª–ª. –≠—Ç–æ —á–µ—Ç–≤–µ—Ä—Ç–∞—è –∫—Ä—É–ø–Ω–µ–π—à–∞—è —Å–¥–µ–ª–∫–∞ –≥–æ–¥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PM9iJ #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-09-22T15:29:03+00:00,@medpharm,12747,https://t.me/medpharm/12747,"–ë—Ä–∏—Ç–∞–Ω—Å–∫–æ–µ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –∞–Ω–æ–Ω—Å–∏—Ä–æ–≤–∞–ª–æ –ø—Ä–∏–≤–∏–≤–æ—á–Ω—É—é –∫–∞–º–ø–∞–Ω–∏—é –¥–ª—è –±–µ—Ä–µ–º–µ–Ω–Ω—ã—Ö –≤ –æ—Å–µ–Ω–Ω–∏–π —Å–µ–∑–æ–Ω. –í –ø—Ä–æ—à–ª–æ–º –≥–æ–¥—É —É—Ä–æ–≤–µ–Ω—å –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏–∏ –±—ã–ª –Ω–∏–∑–∫–∏–º, —á—Ç–æ –ø—Ä–∏–≤–µ–ª–æ –∫ —Å–º–µ—Ä—Ç–∏ 12 –º–ª–∞–¥–µ–Ω—Ü–µ–≤ –æ—Ç –∫–æ–∫–ª—é—à–∞ –∏ –≥–æ—Å–ø–∏—Ç–∞–ª–∏–∑–∞—Ü–∏–∏ —Å–æ—Ç–µ–Ω –¥–µ—Ç–µ–π —Å –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏, –∫–æ—Ç–æ—Ä—ã–µ –º–æ–∂–Ω–æ –ø—Ä–µ–¥–æ—Ç–≤—Ä–∞—Ç–∏—Ç—å —Å –ø–æ–º–æ—â—å—é –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PM8Rp #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–ò–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã–µ_–±–æ–ª–µ–∑–Ω–∏","{""skip"": true}"
2025-09-22T15:19:02+00:00,@medpharm,12746,https://t.me/medpharm/12746,"C 15 –ø–æ 22 —Å–µ–Ω—Ç—è–±—Ä—è FDA –æ–¥–æ–±—Ä–∏–ª–æ —Ç—Ä–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞, –≤ —Ç–æ–º —á–∏—Å–ª–µ –ø–µ—Ä–≤—ã–π –¥–∏—É—Ä–µ—Ç–∏–∫ –∏ —Å—Ä–µ–¥—Å—Ç–≤–æ –æ—Ç —Ä–µ–¥–∫–æ–≥–æ —Å–∏–Ω–¥—Ä–æ–º–∞ –ë–∞—Ä—Ç–∞. EMA —Ä–µ–∫–æ–º–µ–Ω–¥–æ–≤–∞–ª–æ –∫ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ —á–µ—Ç—ã—Ä–µ –Ω–æ–≤—ã—Ö –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç–∞, —Å—Ä–µ–¥–∏ –Ω–∏—Ö ‚Äî –ª–µ–∫–∞—Ä—Å—Ç–≤–æ –¥–ª—è –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –†–°–í —É –º–ª–∞–¥–µ–Ω—Ü–µ–≤ –∏ –ø–æ–¥–∫–æ–∂–Ω–∞—è –≤–µ—Ä—Å–∏—è ¬´–ö–∏—Ç—Ä—É–¥—ã¬ª, –µ—â–µ —à–µ—Å—Ç—å –ø–æ–ª—É—á–∞—Ç –Ω–æ–≤—ã–µ –ø–æ–∫–∞–∑–∞–Ω–∏—è. –¢–∞–∫–∂–µ –Ω–∞ –µ–≤—Ä–æ–ø–µ–π—Å–∫–∏–π —Ä—ã–Ω–æ–∫ –≤—ã–π–¥—É—Ç –±–∏–æ–∞–Ω–∞–ª–æ–≥–∏ –¥–µ–Ω–æ—Å—É–º–∞–±–∞, –≥–æ–ª–∏–º—É–º–∞–±–∞, —É—Å—Ç–µ–∫–∏–Ω—É–º–∞–±–∞ –∏ –¥–∂–µ–Ω–µ—Ä–∏–∫ —Ä–∏–≤–∞—Ä–æ–∫—Å–∞–±–∞–Ω–∞. MHRA —Ä–∞–∑—Ä–µ—à–∏–ª–æ –ø—Ä–∏–º–µ–Ω—è—Ç—å –ø–µ—Ä–≤—ã–π –º–µ—Ç–æ–¥ –ª–µ—á–µ–Ω–∏—è –æ–ø—É—Ö–æ–ª–µ–π –º–æ–∑–≥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PM7wE #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand, epidemic, vaccine"",
  ""impact"": ""high"",
  ""english"": ""The FDA approved three drugs, including the first diuretic and a treatment for rare Bart's syndrome. The EMA recommended four new medicines for registration, including one for preventing RSV in infants and a subcutaneous version of 'Kitty' (likely an error, should be 'Zytiga'), six more will receive new indications. The MHRA approved a method of treating brain tumors. For the European market, bio-versions of denosumab, golimumab, ustekinumab and generic rivaroxaban will be released. More details: https://clck.ru/3PM7wE #PharmNews #Production""
}"
2025-09-22T14:54:02+00:00,@medpharm,12745,https://t.me/medpharm/12745,"–ü–∞—Ü–∏–µ–Ω—Ç—ã —Å –¥–∞–≤–Ω–µ–π —á–µ—Ä–µ–ø–Ω–æ-–º–æ–∑–≥–æ–≤–æ–π —Ç—Ä–∞–≤–º–æ–π –ª–µ–≥–∫–æ–π —Å—Ç–µ–ø–µ–Ω–∏, –∫–æ—Ç–æ—Ä—ã–º –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ –ø—Ä–æ–≤–æ–¥–∏–ª–∏ –Ω–µ–∏–Ω–≤–∞–∑–∏–≤–Ω—É—é —Å—Ç–∏–º—É–ª—è—Ü–∏—é –±–ª—É–∂–¥–∞—é—â–µ–≥–æ –Ω–µ—Ä–≤–∞, –æ—Ç–º–µ—Ç–∏–ª–∏ –≤—ã—Ä–∞–∂–µ–Ω–Ω–æ–µ —É–ª—É—á—à–µ–Ω–∏–µ —Å–æ—Å—Ç–æ—è–Ω–∏—è. –£ –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–∞ —É–º–µ–Ω—å—à–∏–ª–∏—Å—å —Å–∏–º–ø—Ç–æ–º—ã –∫–æ–≥–Ω–∏—Ç–∏–≤–Ω—ã—Ö, —Å–æ–º–∞—Ç–∏—á–µ—Å–∫–∏—Ö –∏ –∞—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã—Ö –Ω–∞—Ä—É—à–µ–Ω–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PM6d2 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ù–µ–≤—Ä–æ–ª–æ–≥–∏—è #–¢—Ä–∞–≤–º–∞—Ç–æ–ª–æ–≥–∏—è_–∏_–æ—Ä—Ç–æ–ø–µ–¥–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""Patients with mild head injury who received non-invasive vagal nerve stimulation showed significant improvement in their condition. Symptoms of cognitive, somatic and affective disturbances decreased for most patients.""
}"
2025-09-22T14:24:03+00:00,@medpharm,12744,https://t.me/medpharm/12744,¬´–ß–µ—Å—Ç–Ω—ã–π –∑–Ω–∞–∫¬ª –±—É–¥–µ—Ç –ø—Ä–æ–≤–µ—Ä—è—Ç—å –Ω–∞–ª–∏—á–∏–µ —Ä–µ–∞–ª—å–Ω—ã—Ö –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏–π —É –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ë–ê–î. –ú–æ–∂–Ω–æ –±—É–¥–µ—Ç –ø—Ä–æ–π—Ç–∏ –æ—á–Ω—É—é –ø—Ä–æ–≤–µ—Ä–∫—É –∏–ª–∏ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–∏—Ç—å –º–∞—Ç–µ—Ä–∏–∞–ª—ã —á–µ—Ä–µ–∑ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏–µ ¬´–ò–Ω—Å–ø–µ–∫—Ç–æ—Ä¬ª. –û—Ç–∫–∞–∑ –∏–ª–∏ –Ω–µ–ø—Ä–æ—Ö–æ–∂–¥–µ–Ω–∏–µ –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥–∞ –ø—Ä–∏–≤–µ–¥–µ—Ç –∫ –∞–Ω–Ω—É–ª–∏—Ä–æ–≤–∞–Ω–∏—é –∫–æ–¥–æ–≤ –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏. –û—Ç—Ä–∞—Å–ª—å –∂–¥–µ—Ç –≤–≤–µ–¥–µ–Ω–∏—è —ç—Ç–æ–≥–æ –º–µ—Ö–∞–Ω–∏–∑–º–∞ –ø–æ—Å–ª–µ –ø–æ–¥–ø–∏—Å–∞–Ω–∏—è –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PM4dj #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, regulation"",
  ""impact"": ""high"",
  ""english"": ""The 'Fair Sign' will verify the existence of actual enterprises among manufacturers of B vitamins and amino acids. A face-to-face check or submission of materials through the 'Inspector' app will be possible. Refusal or non-compliance with monitoring will lead to cancellation of the mark codes. The industry is awaiting this mechanism after signing the regulation.""
}"
2025-09-22T13:31:03+00:00,@medpharm,12743,https://t.me/medpharm/12743,"–†–∞—Å—Ö–æ–¥—ã –Ω–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ –≤ –°–®–ê —É–∂–µ –¥–æ—Å—Ç–∏–≥–ª–∏ 5 —Ç—Ä–ª–Ω –¥–æ–ª–ª. –≤ –≥–æ–¥ –∏ –º–æ–≥—É—Ç –≤—ã—Ä–∞—Å—Ç–∏ –∫ 2035 –≥–æ–¥—É –¥–æ 9 —Ç—Ä–ª–Ω –¥–æ–ª–ª., —á—Ç–æ —Å–æ—Å—Ç–∞–≤–∏—Ç –¥–æ 30% –¥–æ—Ö–æ–¥–∞ —Å–µ–º–µ–π —Å–æ —Å—Ç—Ä–∞—Ö–æ–≤–∫–æ–π. –ù–∞ —Ñ–æ–Ω–µ —Ä–æ—Å—Ç–∞ —Ç—Ä–∞—Ç –∏ —É–∂–µ—Å—Ç–æ—á–µ–Ω–∏—è –ø—Ä–∞–≤–∏–ª —Å—Ç—Ä–∞—Ö–æ–≤—â–∏–∫–∏ –∏ –ø–æ—Å—Ç–∞–≤—â–∏–∫–∏ –º–µ–¥—É—Å–ª—É–≥ —Ñ–∏–∫—Å–∏—Ä—É—é—Ç –ø–∞–¥–µ–Ω–∏–µ –ø—Ä–∏–±—ã–ª–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PLyqh #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-09-22T12:28:02+00:00,@medpharm,12742,https://t.me/medpharm/12742,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –Ω–∞–º–µ—Ä–µ–Ω –æ–±–Ω–æ–≤–∏—Ç—å –ø–æ–ª–æ–∂–µ–Ω–∏–µ –æ –≥–æ—Å–∫–æ–Ω—Ç—Ä–æ–ª–µ –∑–∞ –æ–±—Ä–∞—â–µ–Ω–∏–µ–º –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π. –ü—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è –≤–≤–µ—Å—Ç–∏ –∫–∞—Ç–µ–≥–æ—Ä–∏—é –≤—ã—Å–æ–∫–æ–≥–æ —Ä–∏—Å–∫–∞, –ø—Ä–æ–≤–µ—Ä–∫–∞ –æ—Ç–Ω–µ—Å–µ–Ω–Ω—ã—Ö –∫ —ç—Ç–æ–π –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ —Ä–∏—Å–∫–∞ –æ–±—ä–µ–∫—Ç–æ–≤ –±—É–¥–µ—Ç –ø—Ä–æ–≤–æ–¥–∏—Ç—å—Å—è —Ä–∞–∑ –≤ –¥–≤–∞ –≥–æ–¥–∞. –ò–∑–º–µ–Ω–µ–Ω–∏—è —Ç–∞–∫–∂–µ –≤–Ω–æ—Å—è—Ç—Å—è –≤ –ø—Ä–∞–≤–∏–ª–∞ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–∏—Ö –≤–∏–∑–∏—Ç–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PLuFF #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, import_export"",
  ""impact"": ""high"",
  ""english"": ""The Ministry of Health plans to update the position on state control over medical products. A high-risk category is proposed, with inspections of objects in this category conducted every two years. Changes are also made to the rules for conducting preventive visits.""
}"
2025-09-22T12:19:03+00:00,@medpharm,12741,https://t.me/medpharm/12741,–ß–∏—Å–ª–æ –≤—ã–¥–∞–Ω–Ω—ã—Ö –≤ –†–æ—Å—Å–∏–∏ —Ä–∞–∑—Ä–µ—à–µ–Ω–∏–π –Ω–∞ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è —É–º–µ–Ω—å—à–∏–ª–æ—Å—å –≤ I –ø–æ–ª—É–≥–æ–¥–∏–∏ –Ω–∞ 75%. –î–∞–Ω–Ω—ã–µ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∞ –ê—Å—Å–æ—Ü–∏–∞—Ü–∏—è –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –ø–æ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–º –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PLtZ8 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The number of approvals for international clinical trials in Russia decreased by 75% in the first half of the year, as reported by the Association of Clinical Research Organizations. More details: https://clck.ru/3PLtZ8 #MedNews #Healthcare #Public_Health""
}"
2025-09-22T11:31:02+00:00,@medpharm,12740,https://t.me/medpharm/12740,"–ú–∞—Å—à—Ç–∞–±–Ω–æ–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –Ω–µ –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª–æ –æ–ø–∞—Å–µ–Ω–∏—è, —á—Ç–æ –ø—Ä–∏–µ–º –≤–∞–ª—å–ø—Ä–æ–∞—Ç–∞ –Ω–∞—Ç—Ä–∏—è —É –º—É–∂—á–∏–Ω –ø—Ä–∏–≤–æ–¥–∏—Ç –∫ —É—Ö—É–¥—à–µ–Ω–∏—é —Ñ–µ—Ä—Ç–∏–ª—å–Ω–æ—Å—Ç–∏. –í—ã—è–≤–ª–µ–Ω–Ω—ã–µ —Ä–∞–∑–ª–∏—á–∏—è –≤ –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è—Ö –±—ã–ª–∏ –Ω–µ–∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω—ã–º–∏ –∏ –Ω–µ –ø—Ä–µ–≤—ã—à–∞–ª–∏ 1%. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PLpyK #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ù–µ–≤—Ä–æ–ª–æ–≥–∏—è #–ü—Å–∏—Ö–∏–∞—Ç—Ä–∏—è #–§–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è #–£—Ä–æ–ª–æ–≥–∏—è_–∏_–∞–Ω–¥—Ä–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-09-22T10:40:03+00:00,@medpharm,12739,https://t.me/medpharm/12739,"–ß–∏—Å–ª–æ —Ä–∞–∑—Ä–µ—à–µ–Ω–∏–π –Ω–∞ –ú–ú–ö–ò —É–º–µ–Ω—å—à–∏–ª–æ—Å—å –Ω–∞ 75% –≤ –ø–µ—Ä–≤–æ–º –ø–æ–ª—É–≥–æ–¥–∏–∏. –í—Å–µ–≥–æ –ú–∏–Ω–∑–¥—Ä–∞–≤ –≤—ã–¥–∞–ª 278 —Ä–∞–∑—Ä–µ—à–µ–Ω–∏–π –Ω–∞ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π, –ø–æ–¥—Å—á–∏—Ç–∞–ª–∞ –ê–û–ö–ò. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PLmJu #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The number of approvals for clinical trials decreased by 75% in the first half-year. A total of 278 approvals for clinical research were issued by the Ministry of Health, according to AOKI. More details: https://clck.ru/3PLmJu #FarmaNews #Production""
}"
2025-09-22T09:28:03+00:00,@medpharm,12738,https://t.me/medpharm/12738,–í –†–æ—Å—Å–∏–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª–∏ –ø—Ä–æ–µ–∫—Ç –∑–∞–∫–æ–Ω–∞ –æ —Å–æ–∑–¥–∞–Ω–∏–∏ –∞–¥—Ä–µ—Å–Ω–æ–≥–æ —Å–æ–ø—Ä–æ–≤–æ–∂–¥–µ–Ω–∏—è –≤–µ—Ç–µ—Ä–∞–Ω–æ–≤ –±–æ–µ–≤—ã—Ö –¥–µ–π—Å—Ç–≤–∏–π –∏ –∏—Ö —Å–µ–º–µ–π –≤ —Å–∏—Å—Ç–µ–º–µ –û–ú–°. –î–æ–∫—É–º–µ–Ω—Ç –ø–æ–∑–≤–æ–ª–∏—Ç –§–µ–¥–µ—Ä–∞–ª—å–Ω–æ–º—É –∏ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω—ã–º —Ñ–æ–Ω–¥–∞–º –û–ú–° –ø–æ–ª—É—á–∞—Ç—å –¥–∞–Ω–Ω—ã–µ –¥–ª—è –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª–µ–Ω–∏—è –ø–æ–ª–æ–∂–µ–Ω–Ω—ã—Ö —ç—Ç–∏–º –≥—Ä–∞–∂–¥–∞–Ω–∞–º –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –ª—å–≥–æ—Ç. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PLeQ6 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""A project law on the creation of a targeted follow-up for veterans and their families under the Unified Medical System has been developed in Russia. The document will allow Federal and territorial funds of the Unified Medical System to receive data for providing medical benefits to these citizens.""
}"
2025-09-22T09:21:03+00:00,@medpharm,12737,https://t.me/medpharm/12737,–§–ê–° —Å–æ–≥–ª–∞—Å–æ–≤–∞–ª–∞ —Ü–µ–Ω—É –Ω–∞ –ø–µ—Ä–≤—ã–π –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π –¥–∂–µ–Ω–µ—Ä–∏–∫ ¬´–ö–æ–Ω—Ç–∏–Ω–∏—è¬ª (–∞—Ñ–ª–∏–±–µ—Ä—Ü–µ–ø—Ç) –¥–ª—è –ª–µ—á–µ–Ω–∏—è –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π —Å–µ—Ç—á–∞—Ç–∫–∏ –≥–ª–∞–∑–∞. –ü—Ä–µ–ø–∞—Ä–∞—Ç —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω –∫–æ–º–ø–∞–Ω–∏–µ–π ¬´–ì–µ–Ω–µ—Ä–∏—É–º¬ª –∏ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω –ú–∏–Ω–∑–¥—Ä–∞–≤–æ–º –≤ –º–∞–µ. –°—Ç–æ–∏–º–æ—Å—Ç—å —É–ø–∞–∫–æ–≤–∫–∏ –±—É–¥–µ—Ç –Ω–∞ 18% –¥–µ—à–µ–≤–ª–µ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω–æ–≥–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ ¬´–≠–π–ª–µ–∞¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PLhah #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""pricing, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The Russian Federal Agency for State Dictionaries (–§–ê–°) approved the price of the first domestic generic 'Continia' (afiblitep) for treating retinal diseases. The drug was registered by the Ministry of Health in May and will be 18% cheaper than the original drug 'Eylea'. More details: https://clck.ru/3PLhah #PharmNews #Distribution""
}"
2025-09-22T08:19:02+00:00,@medpharm,12736,https://t.me/medpharm/12736,"–†–æ—Å—Ç–æ–≤—Å–∫–∏–π –≥—É–±–µ—Ä–Ω–∞—Ç–æ—Ä –æ—Ç–ø—Ä–∞–≤–∏–ª –≤ –æ—Ç—Å—Ç–∞–≤–∫—É –¥–≤—É—Ö —Å–≤–æ–∏—Ö –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª–µ–π –∏ —Ç—Ä–µ—Ö –º–∏–Ω–∏—Å—Ç—Ä–æ–≤, –≤–∫–ª—é—á–∞—è –≥–ª–∞–≤—É –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –Æ—Ä–∏—è –ö–æ–±–∑–µ–≤–∞. –ì–ª–∞–≤–∞ —Ä–µ–≥–∏–æ–Ω–∞ —Ñ–æ—Ä–º–∏—Ä—É–µ—Ç –Ω–æ–≤—É—é –∫–æ–º–∞–Ω–¥—É. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PLXYb #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-09-22T08:03:02+00:00,@medpharm,12735,https://t.me/medpharm/12735,¬´–î–∂–æ–¥–∞—Å –≠–∫—Å–ø–æ–∏–º¬ª –æ—à—Ç—Ä–∞—Ñ–æ–≤–∞–ª–∏ –∑–∞ –≥—Ä—É–±–æ–µ –Ω–∞—Ä—É—à–µ–Ω–∏–µ —É—Å–ª–æ–≤–∏–π –æ–ø—Ç–æ–≤–æ–π —Ñ–∞—Ä–º–ª–∏—Ü–µ–Ω–∑–∏–∏. –í–Ω–µ–ø–ª–∞–Ω–æ–≤–∞—è –≤—ã–µ–∑–¥–Ω–∞—è –ø—Ä–æ–≤–µ—Ä–∫–∞ –±—ã–ª–∞ –ø—Ä–æ–≤–µ–¥–µ–Ω–∞ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–æ–º –ø–æ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—é –ì–µ–Ω–ø—Ä–æ–∫—É—Ä–∞—Ç—É—Ä—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PLW2x #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions"",
  ""impact"": ""high"",
  ""english"": ""The company 'Djodas Exportim' has been fined for serious violations of the conditions of an opt-in pharmaceutical license. Unplanned on-site inspection was conducted by Roszdravnadzor upon request from the Prosecutor's Office. For more details: https://clck.ru/3PLW2x #PharmVestnik #Distribution""
}"
2025-09-22T07:04:03+00:00,@medpharm,12734,https://t.me/medpharm/12734,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª –Ω–∞ –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–µ –æ–±—Å—É–∂–¥–µ–Ω–∏–µ –ø—Ä–æ–µ–∫—Ç –ø–æ–ø—Ä–∞–≤–æ–∫ –≤ –§–µ–¥–µ—Ä–∞–ª—å–Ω—ã–π –∑–∞–∫–æ–Ω ¬´–û–± –û–ú–°¬ª, –∫–æ—Ç–æ—Ä—ã–µ –±—É–¥—É—Ç —É—á—Ç–µ–Ω—ã –ø—Ä–∏ –ø–æ–¥–≥–æ—Ç–æ–≤–∫–µ –±—é–¥–∂–µ—Ç–∞ –§–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ —Ñ–æ–Ω–¥–∞ –û–ú–° (–§–û–ú–°) –Ω–∞ 2026 –≥–æ–¥ –∏ –Ω–∞ –ø–ª–∞–Ω–æ–≤—ã–π –ø–µ—Ä–∏–æ–¥ 2027 –∏ 2028 –≥–æ–¥–æ–≤. ¬´–ú–í¬ª –≤—ã–¥–µ–ª–∏–ª –≥–ª–∞–≤–Ω—ã–µ –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ –¥–æ–∫—É–º–µ–Ω—Ç–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PLR3s #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""reimbursement, pricing"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health has presented a draft amendment to the Federal Law 'On OMS' for public discussion, which will be taken into account when preparing the budget of the Federal Health Fund (FOMS) for 2026 and the planning period of 2027 and 2028. 'MV' highlights the main changes in the document.""
}"
2025-09-20T20:39:02+00:00,@medpharm,12733,https://t.me/medpharm/12733,–ú–∏–Ω–∑–¥—Ä–∞–≤ –ø—Ä–µ–¥–ª–æ–∂–∏–ª —É—Å—Ç–∞–Ω–æ–≤–∏—Ç—å —Å 2026 –≥–æ–¥–∞ –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏—è –≤ —Å—Ñ–µ—Ä–µ –û–ú–° –¥–ª—è —Ç—Ä—É–¥–æ–≤—ã—Ö –º–∏–≥—Ä–∞–Ω—Ç–æ–≤. –ü–æ–ª—É—á–∞—Ç—å –±–µ—Å–ø–ª–∞—Ç–Ω—É—é –º–µ–¥–∏—Ü–∏–Ω—Å–∫—É—é –ø–æ–º–æ—â—å –æ–Ω–∏ —Å–º–æ–≥—É—Ç —Ç–æ–ª—å–∫–æ –ø—Ä–∏ –Ω–∞–ª–∏—á–∏–∏ –Ω–µ –º–µ–Ω–µ–µ –ø—è—Ç–∏ –ª–µ—Ç —Å—Ç—Ä–∞—Ö–æ–≤–æ–≥–æ —Å—Ç–∞–∂–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PKTY8 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-09-20T08:37:02+00:00,@medpharm,12732,https://t.me/medpharm/12732,"–†—è–¥—É –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π –≤ –†–æ—Å—Å–∏–∏ –≥—Ä–æ–∑–∏—Ç –±–æ–ª–µ–µ –ø—Ä–∏—Å—Ç–∞–ª—å–Ω–æ–µ –≤–Ω–∏–º–∞–Ω–∏–µ –∫–æ–Ω—Ç—Ä–æ–ª–∏—Ä—É—é—â–∏—Ö –æ—Ä–≥–∞–Ω–æ–≤. –¢–∞–∫–∂–µ –±–æ–ª–µ–µ —á–∞—Å—Ç—ã–µ –ø—Ä–æ–≤–µ—Ä–∫–∏ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–∞ —Å—Ç–∞–Ω—É—Ç –≤–æ–∑–º–æ–∂–Ω—ã –¥–ª—è –∫–æ–º–ø–∞–Ω–∏–π, –ø—Ä–æ–≤–æ–¥—è—â–∏—Ö –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ –∏—Å–ø—ã—Ç–∞–Ω–∏—è —Ç–∞–∫–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PJxve #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""clinical_trial, regulation"",
  ""impact"": ""high"",
  ""english"": ""More stringent oversight from regulatory authorities is threatening medical device manufacturers in Russia. More frequent inspections by the Russian Health Supervision are also expected for companies conducting clinical trials of such products. For more details: https://clck.ru/3PJxve #MedVestnik #Healthcare""
}"
2025-09-20T06:44:02+00:00,@medpharm,12731,https://t.me/medpharm/12731,¬´–ú–æ–∂–µ—Ç –ª–∏ –±—ã—Ç—å —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∞ –≤—Ä–∞—á–∞–º –∏ —Ñ–µ–ª—å–¥—à–µ—Ä–∞–º —Å–∫–æ—Ä–æ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ —Ä–∞–±–æ—á–∞—è —Å–º–µ–Ω–∞ –¥–ª–∏—Ç–µ–ª—å–Ω–æ—Å—Ç—å—é 24 —á–∞—Å–∞ –ø—Ä–∏ –Ω–∞–ª–∏—á–∏–∏ –∫–ª–∞—Å—Å–∞ –≤—Ä–µ–¥–Ω–æ—Å—Ç–∏ —É—Å–ª–æ–≤–∏–π —Ç—Ä—É–¥–∞ 3.2?¬ª –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PJsUV #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-09-19T16:09:01+00:00,@medpharm,12728,https://t.me/medpharm/12728,"–ï–° –≤ –∏—é–ª–µ —Ä–µ–∑–∫–æ –Ω–∞—Ä–∞—Å—Ç–∏–ª –∑–∞–∫—É–ø–∫–∏ —Ñ–∞—Ä–º–ø—Ä–æ–¥—É–∫—Ü–∏–∏ —É –†–æ—Å—Å–∏–∏. –ü–æ—Å—Ç–∞–≤–∫–∏ –≤—ã—Ä–æ—Å–ª–∏ –≤ 2,4 —Ä–∞–∑–∞ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –∏—é–Ω–µ–º –∏ –≤ 2,3 —Ä–∞–∑–∞ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –∏—é–ª–µ–º –ø—Ä–æ—à–ª–æ–≥–æ –≥–æ–¥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PJagX #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, shortage"",
  ""impact"": ""high"",
  ""english"": ""The European Union significantly increased its purchases of pharmaceutical products from Russia in July. Supply volumes have risen by 2.4 times compared to July of the previous year and by 2.3 times compared to June. For more details: https://clck.ru/3PJagX #PharmNews #Distribution""
}"
2025-09-19T15:42:02+00:00,@medpharm,12727,https://t.me/medpharm/12727,"Bluebird bio –ø—Ä–æ–≤–µ–ª–∞ —Ä–µ–±—Ä–µ–Ω–¥–∏–Ω–≥, –≤–µ—Ä–Ω—É–≤—à–∏—Å—å –∫ –∏–∑–Ω–∞—á–∞–ª—å–Ω–æ–º—É –Ω–∞–∑–≤–∞–Ω–∏—é ‚Äî Genetix Biotherapeutics. –í –∏—é–Ω–µ –∫–æ–º–ø–∞–Ω–∏—é –∫—É–ø–∏–ª–∏ –∏–Ω–≤–µ—Å—Ç—Ñ–æ–Ω–¥—ã –≤—Å–µ–≥–æ –∑–∞ 29 –º–ª–Ω –¥–æ–ª–ª. –ï–µ –∞–∫—Ü–∏–∏ –æ–±–µ—Å—Ü–µ–Ω–∏–ª–∏—Å—å –Ω–∞ 99,7% —Å 2018 –≥–æ–¥–∞ –∏–∑-–∑–∞ —É–±—ã—Ç–æ—á–Ω–æ—Å—Ç–∏ –±–∏–∑–Ω–µ—Å–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PJZTK #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-09-19T15:19:02+00:00,@medpharm,12726,https://t.me/medpharm/12726,–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –∑–∞–∫—Ä–µ–ø–∏–ª–æ –ø–æ–ª–Ω–æ–º–æ—á–∏—è –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ø–æ –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–∏—é –ø–æ—Ä—è–¥–∫–∞ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π. –ò–∑–º–µ–Ω–µ–Ω–∏—è –≤–Ω–µ—Å–µ–Ω—ã –≤ –ü–æ–ª–æ–∂–µ–Ω–∏–µ –æ –º–∏–Ω–∏—Å—Ç–µ—Ä—Å—Ç–≤–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PJYMc #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""The government has granted the Ministry of Health the authority to determine the application order of clinical recommendations. Changes have been made to the Ministry's Regulations. For more details: https://clck.ru/3PJYMc #MedVestnik #Healthcare #Public_Health""
}"
2025-09-19T15:03:02+00:00,@medpharm,12725,https://t.me/medpharm/12725,"–†–æ—Å—Å–∏—è —Ä–∞—Å—à–∏—Ä–∏—Ç –ø–æ—Å—Ç–∞–≤–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –º–µ–¥–æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –Ω–∞ –§–∏–ª–∏–ø–ø–∏–Ω—ã. –¢–∞–∫–∂–µ –ø—Ä–æ—Ä–∞–±–∞—Ç—ã–≤–∞–µ—Ç—Å—è –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ —Å–æ–≤–º–µ—Å—Ç–Ω–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ —Ñ–∞—Ä–º–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ö–∞–∫ –∑–∞—è–≤–∏–ª –∑–∞–º–≥–ª–∞–≤—ã –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–∞ –ê–ª–µ–∫—Å–µ–π –ì—Ä—É–∑–¥–µ–≤, –Ω–∞ —Ä—ã–Ω–∫–µ –§–∏–ª–∏–ø–ø–∏–Ω –µ—Å—Ç—å —Å–ø—Ä–æ—Å –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫—É—é –ø—Ä–æ–¥—É–∫—Ü–∏—é. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PJXZn #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{""skip"": true}"
2025-09-19T14:33:03+00:00,@medpharm,12724,https://t.me/medpharm/12724,"–ü–ª–∞–Ω–æ–≤—ã–µ –ø—Ä–æ–≤–µ—Ä–∫–∏ –¥–ª—è –∫–æ–º–ø–∞–Ω–∏–π, —Ä–∞–±–æ—Ç–∞—é—â–∏—Ö —Å –±–∏–æ–º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º–∏ –∫–ª–µ—Ç–æ—á–Ω—ã–º–∏ –ø—Ä–æ–¥—É–∫—Ç–∞–º–∏, –º–æ–≥—É—Ç —Å–æ–∫—Ä–∞—Ç–∏—Ç—å. –û–Ω–∏ –æ—Å—Ç–∞–Ω—É—Ç—Å—è –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–º–∏ —Ç–æ–ª—å–∫–æ –¥–ª—è –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π —Å –≤—ã—Å–æ–∫–æ–π —Å—Ç–µ–ø–µ–Ω—å—é —Ä–∏—Å–∫–∞ –∏ –±—É–¥—É—Ç –ø—Ä–æ–≤–æ–¥–∏—Ç—å—Å—è —Ä–∞–∑ –≤ –¥–≤–∞ –≥–æ–¥–∞. –î–ª—è –≤—Å–µ—Ö –æ—Å—Ç–∞–ª—å–Ω—ã—Ö –∫–∞—Ç–µ–≥–æ—Ä–∏–π —Ä–∏—Å–∫–∞ –ø–ª–∞–Ω–æ–≤—ã–π –Ω–∞–¥–∑–æ—Ä –∑–∞–º–µ–Ω—è—Ç –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–∏–º–∏ –≤–∏–∑–∏—Ç–∞–º–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PJVtq #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–§–∞—Ä–º–∏–Ω–¥—É—Å—Ç—Ä–∏—è #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""Routine inspections for companies working with biologic cell products will be reduced. They will only apply to organizations at high risk, and these inspections will occur every two years. For other risk categories, routine supervision will be replaced with preventive visits. More details: https://clck.ru/3PJVtq #MedVestnik #PharmIndustry""
}"
2025-09-19T14:25:03+00:00,@medpharm,12723,https://t.me/medpharm/12723,–ó–∞ –ø—Ä–æ—à–µ–¥—à—É—é –Ω–µ–¥–µ–ª—é –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä –ø—Ä–µ–∫—Ä–∞—Ç–∏–ª –æ–±—Ä–∞—â–µ–Ω–∏–µ –æ–¥–Ω–æ–π —Å–µ—Ä–∏–∏ ¬´–ü–µ—Ä–∏–Ω–¥–æ–ø—Ä–∏–ª–∞¬ª –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ü—Ä–∞–Ω–∞—Ñ–∞—Ä–º¬ª. –ï—â–µ –æ–¥–Ω—É —Å–µ—Ä–∏—é ¬´–ë–∏—Å–æ–ø—Ä–æ–ª–æ–ª-–ü—Ä–∞–Ω–∞¬ª –æ—Ç–æ–∑–≤–∞–ª —Å–∞–º –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å. –ö–æ–º–ø–∞–Ω–∏—è ¬´–£—Ä–∞–ª–±–∏–æ—Ñ–∞—Ä–º¬ª –æ—Ç–æ–∑–≤–∞–ª–∞ –ø—è—Ç—å —Å–µ—Ä–∏–π ¬´–ö–∞–ª—å—Ü–∏—è –≥–ª—é–∫–æ–Ω–∞—Ç–∞¬ª –∏–∑-–∑–∞ –æ—à–∏–±–∫–∏ –≤ –Ω–∞–∑–≤–∞–Ω–∏–∏ –≥–æ—Ä–æ–¥–∞ –Ω–∞ –≤—Ç–æ—Ä–∏—á–Ω–æ–π —É–ø–∞–∫–æ–≤–∫–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PJVVQ #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–û—Ç–∑—ã–≤—ã,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""Russia's Roszdranad–∑–æ—Ä has suspended one series of 'Pronapril' from Pranafarm. Another series, 'Bisoprolol-Prana', was voluntarily recalled by the manufacturer. Uralfarim has also withdrawn five series of 'Calcium gluconate' due to an error in the secondary packaging naming city. More details: https://clck.ru/3PJVVQ #Pharmnews #Recalls""
}"
2025-09-19T14:06:02+00:00,@medpharm,12722,https://t.me/medpharm/12722,"–í–ø–µ—Ä–≤—ã–µ –∑–∞ 42 –≥–æ–¥–∞ FDA –æ–¥–æ–±—Ä–∏–ª–æ –Ω–æ–≤—ã–π –º–æ—á–µ–≥–æ–Ω–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç ‚Äî Enbumyst. –î–∏—É—Ä–µ—Ç–∏–∫ –Ω–∞ –æ—Å–Ω–æ–≤–µ –±—É–º–µ—Ç–∞–Ω–∏–¥–∞ –æ—Ç —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ Corstasis –≤—ã–ø—É—Å–∫–∞–µ—Ç—Å—è –≤ –≤–∏–¥–µ –Ω–∞–∑–∞–ª—å–Ω–æ–≥–æ —Å–ø—Ä–µ—è, —É—Å–≤–∞–∏–≤–∞–µ—Ç—Å—è –ª—É—á—à–µ —Ç–∞–±–ª–µ—Ç–æ–∫ –∏ –Ω–µ —É—Å—Ç—É–ø–∞–µ—Ç –ø–æ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –≤–Ω—É—Ç—Ä–∏–≤–µ–Ω–Ω—ã–º –∞–Ω–∞–ª–æ–≥–∞–º. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PJUHn #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-09-19T13:12:02+00:00,@medpharm,12721,https://t.me/medpharm/12721,"–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ —Ç–∞—Ä—ã –¥–ª—è –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç–æ–≤ –∑–∞–ø—É—Å—Ç—è—Ç –≤ –õ–µ–Ω–∏–Ω–≥—Ä–∞–¥—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –∫ 2027 –≥–æ–¥—É. –°–æ–≥–ª–∞—à–µ–Ω–∏–µ –æ–± –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏—è—Ö –≤ 1,3 –º–ª—Ä–¥ —Ä—É–±. –≤ –ø—Ä–æ–µ–∫—Ç –ø–æ–¥–ø–∏—Å–∞–ª–∏ –≥—É–±–µ—Ä–Ω–∞—Ç–æ—Ä —Ä–µ–≥–∏–æ–Ω–∞ –∏ –≥–ª–∞–≤–∞ –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ê–ª—å—Ñ–∞¬ª. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PJQDM #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-09-19T12:08:02+00:00,@medpharm,12720,https://t.me/medpharm/12720,"–í –°–®–ê –ø—Ä–æ—à–ª–∞ –æ—á–µ—Ä–µ–¥–Ω–∞—è —Ü–µ—Ä–µ–º–æ–Ω–∏—è –ø–∞—Ä–æ–¥–∏–π–Ω–æ–π –®–Ω–æ–±–µ–ª–µ–≤—Å–∫–æ–π –ø—Ä–µ–º–∏–∏, –æ—Ç–º–µ—á–∞—é—â–µ–π –Ω–µ–æ–±—ã—á–Ω—ã–µ –æ—Ç–∫—Ä—ã—Ç–∏—è –≤ –Ω–∞—É–∫–µ. –í —ç—Ç–æ–º –≥–æ–¥—É –Ω–∞–≥—Ä–∞–¥—ã –≤—Ä—É—á–µ–Ω—ã –∑–∞ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —ç—Ñ—Ñ–µ–∫—Ç–æ–≤ —á–µ—Å–Ω–æ–∫–∞, –∞–ª–∫–æ–≥–æ–ª—è –∏ ¬´—Ç–µ—Ñ–ª–æ–Ω–æ–≤–æ–π¬ª –¥–∏–µ—Ç—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PJKWz #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ù–∞—É–∫–∞ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-09-19T11:55:02+00:00,@medpharm,12719,https://t.me/medpharm/12719,"FDA –Ω–∞–ø—Ä–∞–≤–∏–ª–æ –±–æ–ª–µ–µ 1 —Ç—ã—Å. –ø–∏—Å–µ–º —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—è–º –∑–∞ –≤–≤–æ–¥—è—â—É—é –≤ –∑–∞–±–ª—É–∂–¥–µ–Ω–∏–µ —Ä–µ–∫–ª–∞–º—É –ª–µ–∫–∞—Ä—Å—Ç–≤. –°—Ä–µ–¥–∏ –Ω–∞—Ä—É—à–∏—Ç–µ–ª–µ–π ‚Äî Abbvie, Novartis, Eli Lilly, Novo Nordisk, BridgeBio Pharma –∏ BMS. –ù–∞ —É—Å—Ç—Ä–∞–Ω–µ–Ω–∏–µ –ø—Ä–æ–±–ª–µ–º —É –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –µ—Å—Ç—å 15 –¥–Ω–µ–π, –≤ –ø—Ä–æ—Ç–∏–≤–Ω–æ–º —Å–ª—É—á–∞–µ –∏—Ö –ø—Ä–æ–¥—É–∫—Ü–∏—é –º–æ–≥—É—Ç –∏–∑—ä—è—Ç—å –∏–∑ –ø—Ä–æ–¥–∞–∂–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PJJcQ #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-09-19T11:00:30+00:00,@medpharm,12718,https://t.me/medpharm/12718,"–ù–∞—Å–∫–æ–ª—å–∫–æ –∞–ø—Ç–µ–∫–∞ –≥–æ—Ç–æ–≤–∞ –ø—Ä–æ—Ç–∏–≤–æ—Å—Ç–æ—è—Ç—å –≤—ã–∑–æ–≤–∞–º –ø—Ä–æ—Å—Ç—É–¥—ã? –ü—Ä–∏—Ö–æ–¥–∏—Ç–µ 23 —Å–µ–Ω—Ç—è–±—Ä—è –≤ 12:00 –Ω–∞ –ø—Ä—è–º–æ–π —ç—Ñ–∏—Ä —Å —ç–∫—Å–ø–µ—Ä—Ç–∞–º–∏, —á—Ç–æ–±—ã –ø—Ä–æ–≤–µ—Ä–∏—Ç—å —ç—Ç–æ! –†–∞–±–∏—è—Ç –ó–∞–π–Ω–∏–¥–¥–∏–Ω–æ–≤–∞ ‚Äì –∫.–º.–Ω., –ø–µ–¥–∏–∞—Ç—Ä ‚Äì –Ω–∞—É—á–∏—Ç, –∫–∞–∫ –ø—Ä–∞–≤–∏–ª—å–Ω–æ –≥–æ—Ç–æ–≤–∏—Ç—å—Å—è –∫ —Å–µ–∑–æ–Ω—É –ø—Ä–æ—Å—Ç—É–¥ –∏ –∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä–æ–≤–∞—Ç—å —Ç—Ä–µ–≤–æ–∂–Ω—ã—Ö –º–∞–º –≤ –∞–ø—Ç–µ–∫–µ. –ì–µ—Ä–º–∞–Ω –ö–Ω–æ—Ä—Ä–∏–Ω–≥ ‚Äì –∫.–º.–Ω., –¥–æ—Ü–µ–Ω—Ç –∫–∞—Ñ–µ–¥—Ä—ã —Ç–µ—Ä–∞–ø–∏–∏, –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–π —Ñ–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏–∏ –∏ —Å–∫–æ—Ä–æ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ ¬´–†–æ—Å—Å–∏–π—Å–∫–∏–π —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç –º–µ–¥–∏—Ü–∏–Ω—ã¬ª ‚Äì —Ä–∞—Å—Å–∫–∞–∂–µ—Ç –æ –≥–ª–∞–≤–Ω—ã—Ö –ø—Ä–∏–Ω—Ü–∏–ø–∞—Ö –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –û–†–í–ò –¥–ª—è –≤—Å–µ–π —Å–µ–º—å–∏. –ú–∞—Ä–∏—è –ü–∞–≤–∏—Ü–∫–∞—è ‚Äì –Ω—É—Ç—Ä–∏—Ü–∏–æ–ª–æ–≥ ‚Äì –¥–∞—Å—Ç –ø–æ–ª–µ–∑–Ω—ã–µ —Å–æ–≤–µ—Ç—ã –æ —Ç–æ–º, –∫–∞–∫ –∑–∞—â–∏—Ç–∏—Ç—å —Å–µ–±—è –≤ —É—Å–ª–æ–≤–∏—è—Ö –ø–æ–≤—ã—à–µ–Ω–Ω–æ–≥–æ –Ω–∞–ø–ª—ã–≤–∞ –ø–æ—Å–µ—Ç–∏—Ç–µ–ª–µ–π. –†–µ–≥–∏—Å—Ç—Ä–∏—Ä—É–π—Ç–µ—Å—å –∏ –≥–æ—Ç–æ–≤—å—Ç–µ —Å–≤–æ–∏ –≤–æ–ø—Ä–æ—Å—ã!","{""skip"": true}"
2025-09-19T10:58:03+00:00,@medpharm,12717,https://t.me/medpharm/12717,–ö—É—Ä—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –≤—ã–¥–µ–ª–∏–ª–∏ —Å–≤—ã—à–µ 335 –º–ª–Ω —Ä—É–±. –Ω–∞ –ø–æ–¥–¥–µ—Ä–∂–∫—É –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∏ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ –ª—å–≥–æ—Ç–Ω–∏–∫–æ–≤ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏ –∏ –ª–µ—á–µ–±–Ω—ã–º –ø–∏—Ç–∞–Ω–∏–µ–º. –ú–∏–Ω–∑–¥—Ä–∞–≤ –ø—Ä–æ–∫–æ–Ω—Ç—Ä–æ–ª–∏—Ä—É–µ—Ç —Ü–µ–ª–µ–≤–æ–µ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ —Å—Ä–µ–¥—Å—Ç–≤ –∏ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç –æ—Ç—á–µ—Ç –¥–æ –∞–ø—Ä–µ–ª—è 2026 –≥–æ–¥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PJEm8 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è,"{""skip"": true}"
2025-09-19T10:16:03+00:00,@medpharm,12716,https://t.me/medpharm/12716,"–†–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–Ω–æ—Å—Ç—å —Å–∞–º–æ–ª–µ—á–µ–Ω–∏—è —Å–≤—è–∑–∞–Ω–∞ —Å –Ω–µ–¥–æ–≤–µ—Ä–∏–µ–º –∫ –≤—Ä–∞—á–∞–º, —Å—á–∏—Ç–∞–µ—Ç –º–∏–Ω–∏—Å—Ç—Ä –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ú–∏—Ö–∞–∏–ª –ú—É—Ä–∞—à–∫–æ. –ú–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º —Ä–∞–±–æ—Ç–Ω–∏–∫–∞–º –≤–∞–∂–Ω–æ –ø—Ä–∏–¥–µ—Ä–∂–∏–≤–∞—Ç—å—Å—è –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å–Ω–æ–≥–æ –ø–æ–¥—Ö–æ–¥–∞ –∏ —É–º–µ—Ç—å –ø—Ä–µ–æ–¥–æ–ª–µ–≤–∞—Ç—å –∑–∞–±–ª—É–∂–¥–µ–Ω–∏—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PJBcS #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è #–ü–µ–¥–∏–∞—Ç—Ä–∏—è","{""skip"": true}"
2025-09-19T09:32:02+00:00,@medpharm,12715,https://t.me/medpharm/12715,"–¶–µ–Ω—Ç—Ä –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –æ–±—ä—è–≤–∏–ª –∞—É–∫—Ü–∏–æ–Ω—ã –Ω–∞ –ø–æ—Å—Ç–∞–≤–∫—É –¥–ª—è ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª —Ç—Ä–µ—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, —Å—Ä–µ–¥–∏ –∫–æ—Ç–æ—Ä—ã—Ö –∞–ª–±—É—Ç—Ä–µ–ø–µ–Ω–æ–Ω–∞–∫–æ–≥ –∞–ª—å—Ñ–∞, –¥–∏–Ω—É—Ç—É–∫—Å–∏–º–∞–± –±–µ—Ç–∞ –∏ –∏–¥—É—Ä—Å—É–ª—å—Ñ–∞–∑–∞ –±–µ—Ç–∞, –∑–∞ 24 –º–ª –∫–æ—Ç–æ—Ä–æ–≥–æ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –∑–∞–ø–ª–∞—Ç–∏—Ç—å 52,3 –º–ª–Ω —Ä—É–±. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PJ8Aa #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–î–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""high"",
  ""english"": ""Auction for the supply of three drugs to 'The Kindness Circle' - albupenonacog alpha, dinutuksimab beta and idursulfaz beta for 24ml is planned to be paid $5,230,000. More details: https://clck.ru/3PJ8Aa #PharmNews #Distribution""
}"
2025-09-19T09:29:02+00:00,@medpharm,12714,https://t.me/medpharm/12714,"–°–æ–≤–µ—Ç –¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–≤ –ì–ö ¬´–ú–µ–¥—Å–∫–∞–Ω¬ª –ø–æ–ø–æ–ª–Ω–∏–ª–∏ —É–ø—Ä–∞–≤–ª–µ–Ω—Ü—ã ¬´–†–æ—Å–∞—Ç–æ–º–∞¬ª. –≠—Ç–æ –ø–æ–º–æ–∂–µ—Ç —É—Å–∏–ª–∏—Ç—å –ª–∏–¥–µ—Ä—Å—Ç–≤–æ –∫–æ–º–ø–∞–Ω–∏–∏ –≤ –≤—ã—Å–æ–∫–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–Ω–æ–º –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–∏ –∏ –∑–∞–ø—É—Å—Ç–∏—Ç—å –ø–ª–∞—Ç—Ñ–æ—Ä–º–µ–Ω–Ω—É—é –±–∏–∑–Ω–µ—Å-–º–æ–¥–µ–ª—å, —Å—á–∏—Ç–∞—é—Ç –≤ —Ö–æ–ª–¥–∏–Ω–≥–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PJ7y6 #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-09-19T09:00:07+00:00,@medpharm,12713,https://t.me/medpharm/12713,"–ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –ø–æ—Ä—è–¥–æ–∫ –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏ –º–µ—Ç–∞–Ω–æ–ª–∞ –∏ –ø—Ä–∞–≤–∏–ª–∞ –µ–≥–æ —É–Ω–∏—á—Ç–æ–∂–µ–Ω–∏—è. –¢–∞—Ä–∞ —Å –º–µ—Ç–∞–Ω–æ–ª–æ–º –¥–æ–ª–∂–Ω–∞ –±—É–¥–µ—Ç —Å–æ–¥–µ—Ä–∂–∞—Ç—å –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏—è –æ–± –æ–ø–∞—Å–Ω–æ—Å—Ç–∏, –∞ —É—Ç–∏–ª–∏–∑–∏—Ä–æ–≤–∞—Ç—å –µ–≥–æ —Å–º–æ–≥—É—Ç —Ç–æ–ª—å–∫–æ –≤–Ω–µ—Å–µ–Ω–Ω—ã–µ –≤ —Å–ø–µ—Ü–∏–∞–ª—å–Ω—ã–π —Ä–µ–µ—Å—Ç—Ä –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏. –î–æ–∫—É–º–µ–Ω—Ç—ã –º–æ–≥—É—Ç –≤—Å—Ç—É–ø–∏—Ç—å –≤ —Å–∏–ª—É —Å 1 –º–∞—Ä—Ç–∞ 2026 –≥–æ–¥–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://pharmvestnik.ru/content/news/Minpromtorg-razrabotal-pravila-markirovki-i-utilizacii-metanola.html #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""import_export, sanctions"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Industry and Trade has developed a regulation for marking methanol and its destruction. Containers with methanol must contain warnings about danger, and only registered organizations can dispose of it. The documents may come into force on March 1, 2026. For more information: https://pharmvestnik.ru/content/news/Minpromtorg-razrabotal-pravila-markirovki-i-utilizacii-metanola.html #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞""
}"
2025-09-19T08:39:03+00:00,@medpharm,12712,https://t.me/medpharm/12712,"–°–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –∏–∑ –ù–ú–ò–¶ –∏–º. –ö—É–ª–∞–∫–æ–≤–∞ —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏ –æ–± –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã—Ö –º–µ—Ç–æ–¥–∞—Ö —Å–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è —Ä–µ–ø—Ä–æ–¥—É–∫—Ç–∏–≤–Ω–æ–π —Ñ—É–Ω–∫—Ü–∏–∏ —É –∂–µ–Ω—â–∏–Ω, —Å—Ç–æ–ª–∫–Ω—É–≤—à–∏—Ö—Å—è —Å –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏. –í —Ö–æ–¥–µ –∑–∞—Å–µ–¥–∞–Ω–∏—è –°–æ–≤–µ—Ç–∞ –†–ê–ù –±—ã–ª–∏ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω—ã –Ω–æ–≤—ã–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ –≤ –æ–±–ª–∞—Å—Ç–∏ —Å–æ–ø—Ä–æ–≤–æ–¥–∏—Ç–µ–ª—å–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –∏ —Å–∏—Å—Ç–µ–º–Ω—ã—Ö –ø—Ä–∏—á–∏–Ω —Å–º–µ—Ä—Ç–Ω–æ—Å—Ç–∏ –æ–Ω–∫–æ–ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PJ2Jy #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–∞–∫—Ç–∏–∫–∞ #–ê–∫—É—à–µ—Ä—Å—Ç–≤–æ_–∏_–≥–∏–Ω–µ–∫–æ–ª–æ–≥–∏—è #–û–Ω–∫–æ–ª–æ–≥–∏—è","{""skip"": true}"
2025-09-19T07:38:02+00:00,@medpharm,12711,https://t.me/medpharm/12711,"–ü–ª–∞–Ω–æ–≤—ã–µ –ø—Ä–æ–≤–µ—Ä–∫–∏ –¥–ª—è –∫–æ–º–ø–∞–Ω–∏–π, —Ä–∞–±–æ—Ç–∞—é—â–∏—Ö —Å –±–∏–æ–º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º–∏ –∫–ª–µ—Ç–æ—á–Ω—ã–º–∏ –ø—Ä–æ–¥—É–∫—Ç–∞–º–∏, –º–æ–≥—É—Ç —Å–æ–∫—Ä–∞—Ç–∏—Ç—å. –û–Ω–∏ –æ—Å—Ç–∞–Ω—É—Ç—Å—è –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–º–∏ —Ç–æ–ª—å–∫–æ –¥–ª—è –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π —Å –≤—ã—Å–æ–∫–æ–π —Å—Ç–µ–ø–µ–Ω—å—é —Ä–∏—Å–∫–∞ –∏ –±—É–¥—É—Ç –ø—Ä–æ–≤–æ–¥–∏—Ç—å—Å—è —Ä–∞–∑ –≤ –¥–≤–∞ –≥–æ–¥–∞. –î–ª—è –≤—Å–µ—Ö –æ—Å—Ç–∞–ª—å–Ω—ã—Ö –∫–∞—Ç–µ–≥–æ—Ä–∏–π —Ä–∏—Å–∫–∞ –ø–ª–∞–Ω–æ–≤—ã–π –Ω–∞–¥–∑–æ—Ä –∑–∞–º–µ–Ω—è—Ç –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–∏–º–∏ –≤–∏–∑–∏—Ç–∞–º–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PHuSp #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""Routine inspections for companies working with biologic cell products will be reduced to only high-risk organizations, which must undergo inspections every two years. For other risk categories, routine supervision will be replaced with preventive visits. More details: https://clck.ru/3PHuSp #FarmaVestnik #Regulatorka""
}"
2025-09-19T07:29:03+00:00,@medpharm,12710,https://t.me/medpharm/12710,"–ß–µ–º –±–ª–∏–∂–µ –∫–ª–∏–Ω–∏–∫–∞ –Ω–∞—Ö–æ–¥–∏—Ç—Å—è –∫ —Ü–µ–Ω—Ç—Ä—É, —Ç–µ–º –≤—ã—à–µ –µ–µ –≤—ã—Ä—É—á–∫–∞, –≤—ã—è—Å–Ω–∏–ª–∏ –∞–Ω–∞–ª–∏—Ç–∏–∫–∏. –ö–∞—á–µ—Å—Ç–≤–æ –ø–æ–º–æ—â–∏ –∏ —Å–µ—Ä–≤–∏—Å –≤–∞–∂–Ω–µ–µ –¥–ª—è –º–æ—Å–∫–≤–∏—á–µ–π, —á–µ–º –±–ª–∏–∑–æ—Å—Ç—å –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—è –∫ –¥–æ–º—É –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PHtkP #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–î—Ä—É–≥–æ–µ","{""skip"": true}"
2025-09-19T06:03:02+00:00,@medpharm,12708,https://t.me/medpharm/12708,"–ì–µ–π–º–∏—Ñ–∏–∫–∞—Ü–∏—è –≤ —Ü–∏—Ñ—Ä–æ–≤—ã—Ö –≤–º–µ—à–∞—Ç–µ–ª—å—Å—Ç–≤–∞—Ö –ø—Ä–æ–¥–µ–º–æ–Ω—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª–∞ –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ–µ –≤–ª–∏—è–Ω–∏–µ –Ω–∞ –æ—Ç–∫–∞–∑ –æ—Ç –∫—É—Ä–µ–Ω–∏—è. –ò—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ –∏–≥—Ä–æ–≤—ã—Ö –º–µ—Ç–æ–¥–∏–∫ –ø–æ–≤—ã—à–∞–ª–æ –≤–æ–≤–ª–µ—á–µ–Ω–Ω–æ—Å—Ç—å –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª–µ–π –∏ —É–≤–µ–ª–∏—á–∏–≤–∞–ª–æ —á–∏—Å–ª–æ –ª—é–¥–µ–π, —Å—É–º–µ–≤—à–∏—Ö –æ—Ç–∫–∞–∑–∞—Ç—å—Å—è –æ—Ç —Ç–∞–±–∞–∫–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PHnDi #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–¢–µ—Ä–∞–ø–∏—è","{""skip"": true}"
2025-09-18T18:50:28+00:00,@medpharm,12707,https://t.me/medpharm/12707,"–ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ –∑–∞ 18 —Å–µ–Ω—Ç—è–±—Ä—è ü¶æ –ò—â—É—Ç –≤—ã—Ö–æ–¥. –†–∞—Å–ø—Ä–µ–¥–µ–ª–µ–Ω–∏–µ –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –≤—É–∑–æ–≤ –ø–æ—Å–ª–µ –∑–∞–≤–µ—Ä—à–µ–Ω–∏—è –æ–±—É—á–µ–Ω–∏—è –º–æ–∂–µ—Ç –±—ã—Ç—å –æ–¥–Ω–∏–º –∏–∑ –≤–∞—Ä–∏–∞–Ω—Ç–æ–≤ —Ä–µ—à–µ–Ω–∏—è –∫–∞–¥—Ä–æ–≤–æ–π –ø—Ä–æ–±–ª–µ–º—ã, –∑–∞—è–≤–∏–ª –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç –í–ª–∞–¥–∏–º–∏—Ä –ü—É—Ç–∏–Ω. –í–µ—Ä–æ—è—Ç–Ω–æ, —Ä–µ—á—å –∏–¥–µ—Ç –æ–± –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–π –æ—Ç—Ä–∞–±–æ—Ç–∫–µ, –∞ –Ω–µ –æ —Ä–∞—Å–ø—Ä–µ–¥–µ–ª–µ–Ω–∏–∏ –ø–æ —Å–æ–≤–µ—Ç—Å–∫–æ–º—É –æ–±—Ä–∞–∑—Ü—É. ü¶æ –°–æ–Ω ‚Äì –ª—É—á—à–µ–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–æ. –•—Ä–æ–Ω–∏—á–µ—Å–∫–∞—è –±–µ—Å—Å–æ–Ω–Ω–∏—Ü–∞ —É—Å–∫–æ—Ä—è–ª–∞ —Å–Ω–∏–∂–µ–Ω–∏–µ –ø–∞–º—è—Ç–∏ –∏ –∫–æ–≥–Ω–∏—Ç–∏–≤–Ω—ã—Ö —Ñ—É–Ω–∫—Ü–∏–π, –∞ —Ç–∞–∫–∂–µ –≤—ã–∑–≤–∞–ª–∞ –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ –º–æ–∑–≥–µ, –≤—ã—è–≤–ª—è–µ–º—ã–µ –ø—Ä–∏ —Å–∫–∞–Ω–∏—Ä–æ–≤–∞–Ω–∏–∏. ‚ù§Ô∏è –û–¥–∏–Ω –ø—Ä–æ—Ç–∏–≤ –¥–≤–∞–¥—Ü–∞—Ç–∏. –í –†–æ—Å—Å–∏–∏ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª–∏ 20-–≤–∞–ª–µ–Ω—Ç–Ω—É—é –≤–∞–∫—Ü–∏–Ω—É –ø—Ä–æ—Ç–∏–≤ –ø–Ω–µ–≤–º–æ–∫–æ–∫–∫–æ–≤–æ–π –∏–Ω—Ñ–µ–∫—Ü–∏–∏. –ü—Ä–µ–ø–∞—Ä–∞—Ç —Å–æ–¥–µ—Ä–∂–∏—Ç 20 –ø–æ–ª–∏—Å–∞—Ö–∞—Ä–∏–¥–æ–≤ –∏–∑ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–Ω—ã—Ö —Å–µ—Ä–æ—Ç–∏–ø–æ–≤ Streptococcus pneumoniae, –∫–æ—Ç–æ—Ä—ã–µ —á–∞—â–µ –≤—Å–µ–≥–æ –≤—ã–∑—ã–≤–∞—é—Ç –∏–Ω–≤–∞–∑–∏–≤–Ω–æ–µ –ø–Ω–µ–≤–º–æ–∫–æ–∫–∫–æ–≤–æ–µ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–µ –∏ —Å–≤—è–∑–∞–Ω—ã —Å –≤—ã—Å–æ–∫–æ–π —É—Å—Ç–æ–π—á–∏–≤–æ—Å—Ç—å—é –∫ –∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫–∞–º. ‚ù§Ô∏è –ï—â–µ –Ω–µ –≤—Ä–µ–º—è. –û–≥—Ä–∞–Ω–∏—á–µ–Ω–∏–µ –Ω–∞ –≤—ã–≤–æ–∑ –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–Ω–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –±—É–¥–µ—Ç –¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å –µ—â–µ –Ω–µ—Å–∫–æ–ª—å–∫–æ –ª–µ—Ç. –í –ø–µ—Ä–µ—á–Ω–µ –±–æ–ª–µ–µ 200 –Ω–∞–∏–º–µ–Ω–æ–≤–∞–Ω–∏–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏, –≤ —Ç–æ–º —á–∏—Å–ª–µ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∞—è. #–º–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #—Ñ–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–Ω–æ–≤–æ—Å—Ç–∏_–¥–Ω—è","{""skip"": true}"
2025-09-18T15:47:02+00:00,@medpharm,12706,https://t.me/medpharm/12706,"–ê–≤—Ç–æ–º–∞—Ç–∏—á–µ—Å–∫–∏–µ —à—Ç—Ä–∞—Ñ—ã –º–æ–≥—É—Ç –Ω–∞—á–∞—Ç—å –≤—ã–ø–∏—Å—ã–≤–∞—Ç—å –∑–∞ –ø—Ä–æ–¥–∞–∂—É –º–∞—Ä–∫–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö —Ç–æ–≤–∞—Ä–æ–≤ —Å –Ω–∞—Ä—É—à–µ–Ω–∏—è–º–∏, –¥–æ–∫—É–º–µ–Ω—Ç –ø–æ–¥–≥–æ—Ç–æ–≤–∏–ª –†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä. –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ –∂–µ –Ω–∞–º–µ—Ä–µ–Ω –Ω–∞—Å—Ç—Ä–æ–∏—Ç—å –∫–∞—Å—Å—ã —Ç–∞–∫, —á—Ç–æ–±—ã –æ–Ω–∏ –±–ª–æ–∫–∏—Ä–æ–≤–∞–ª–∏ –ø—Ä–æ–¥–∞–∂—É –ø—Ä–æ—Å—Ä–æ—á–µ–Ω–Ω—ã—Ö, –Ω–µ–º–∞—Ä–∫–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö —Ç–æ–≤–∞—Ä–æ–≤ –∏ –ø—Ä–æ–¥—É–∫—Ü–∏–∏ —Å –Ω–µ–ø—Ä–∞–≤–∏–ª—å–Ω–æ–π —Ü–µ–Ω–æ–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PHLWY #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–†–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, import_export, pricing"",
  ""impact"": ""high"",
  ""english"": ""The Rospatent is preparing to issue fines for the sale of marked goods with violations. The Ministry of Industry and Trade plans to set up cash registers that will block the sale of expired, unmarked goods and products with incorrect prices. For more details: https://clck.ru/3PHLWY #PharmNews #Regulation""
}"
2025-09-18T15:18:02+00:00,@medpharm,12705,https://t.me/medpharm/12705,"–†–µ—à–∏—Ç—å –ø—Ä–æ–±–ª–µ–º—É —Å –∫–∞–¥—Ä–∞–º–∏ –≤ —Å–∏—Å—Ç–µ–º–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è, –≤–æ–∑–º–æ–∂–Ω–æ, –±—É–¥–µ—Ç —Å–ø–æ—Å–æ–±–Ω–∞ —Å–∏—Å—Ç–µ–º–∞ —Ä–∞—Å–ø—Ä–µ–¥–µ–ª–µ–Ω–∏—è –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–≤—É–∑–æ–≤, —Å—á–∏—Ç–∞–µ—Ç –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç –†–æ—Å—Å–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PHJGh #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{""skip"": true}"
2025-09-18T14:45:02+00:00,@medpharm,12704,https://t.me/medpharm/12704,"–û–≥—Ä–∞–Ω–∏—á–µ–Ω–∏–µ –Ω–∞ –≤—ã–≤–æ–∑ –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–Ω–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –∏–∑ –†–æ—Å—Å–∏–∏ –±—É–¥–µ—Ç –¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å –µ—â–µ –Ω–µ—Å–∫–æ–ª—å–∫–æ –ª–µ—Ç. –í –ø–µ—Ä–µ—á–Ω–µ –±–æ–ª–µ–µ 200 –Ω–∞–∏–º–µ–Ω–æ–≤–∞–Ω–∏–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏, –≤ —Ç–æ–º —á–∏—Å–ª–µ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∞—è. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PHG5J #–ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ #–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è_–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""medium"",
  ""english"": ""A ban on the export of certain products will continue to be in effect for several years. The list includes over 200 product names, including pharmaceutical products. For more details: https://clck.ru/3PHG5J #MedVestnik #Healthcare #Public_Health""
}"
2025-09-18T14:36:02+00:00,@medpharm,12703,https://t.me/medpharm/12703,"Roche –∑–∞–∫–ª—é—á–∏–ª–∞ —Å–æ–≥–ª–∞—à–µ–Ω–∏–µ –æ –ø–æ–∫—É–ø–∫–µ –∫–æ–º–ø–∞–Ω–∏–∏ 89bio –∑–∞ 3,5 –º–ª—Ä–¥ –¥–æ–ª–ª., –ø–æ–ª—É—á–∏–≤ –≤–º–µ—Å—Ç–µ —Å –Ω–µ–π –ø—Ä–∞–≤–∞ –Ω–∞ –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –æ—Ç –∂–∏—Ä–æ–≤–æ–π –±–æ–ª–µ–∑–Ω–∏ –ø–µ—á–µ–Ω–∏, –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –∫–æ—Ç–æ—Ä–æ–≥–æ —É–∂–µ –ø–æ–¥—Ö–æ–¥—è—Ç –∫ –∫–æ–Ω—Ü—É. –í –ø–æ—Å–ª–µ–¥–Ω–∏–µ –≥–æ–¥—ã —à–≤–µ–π—Ü–∞—Ä—Å–∫–∏–π —Ñ–∞—Ä–º–≥–∏–≥–∞–Ω—Ç –∞–∫—Ç–∏–≤–Ω–æ —É—Å–∏–ª–∏–≤–∞–µ—Ç –ø–æ–∑–∏—Ü–∏–∏ –Ω–∞ –±—ã—Å—Ç—Ä–æ—Ä–∞—Å—Ç—É—â–µ–º —Ä—ã–Ω–∫–µ —Å—Ä–µ–¥—Å—Ç–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –æ–∂–∏—Ä–µ–Ω–∏—è –∏ —Å–≤—è–∑–∞–Ω–Ω—ã—Ö —Å –Ω–∏–º –ø–∞—Ç–æ–ª–æ–≥–∏–π. –ü–æ–¥—Ä–æ–±–Ω–µ–µ: https://clck.ru/3PHFUt #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–ü—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ","{""skip"": true}"
2025-09-18T13:39:36+00:00,@medpharm,12701,https://t.me/medpharm/12701,"–í —è–ø–æ–Ω—Å–∫–æ–π –§—É–∫—É–æ–∫–µ —Å–æ—Å—Ç–æ—è–ª—Å—è XXVII –ï–∂–µ–≥–æ–¥–Ω—ã–π –∫–æ–Ω–≥—Ä–µ—Å—Å –ê–∑–∏–∞—Ç—Å–∫–æ-–¢–∏—Ö–æ–æ–∫–µ–∞–Ω—Å–∫–æ–π –ª–∏–≥–∏ –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–π —Ä–µ–≤–º–∞—Ç–æ–ª–æ–≥–æ–≤ (APLAR 2025), –∫–æ—Ç–æ—Ä—ã–π —è–≤–ª—è–µ—Ç—Å—è –æ–¥–Ω–æ–π –∏–∑ –∫–ª—é—á–µ–≤—ã—Ö –ø–ª–æ—â–∞–¥–æ–∫ –¥–ª—è –æ–±–º–µ–Ω–∞ –ø–µ—Ä–µ–¥–æ–≤—ã–º–∏ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è–º–∏ –∏ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–º –æ–ø—ã—Ç–æ–º. –ì—Ä—É–ø–ø–∞ –∫–æ–º–ø–∞–Ω–∏–π ¬´–†-–§–∞—Ä–º¬ª –≤—Ç–æ—Ä–æ–π –≥–æ–¥ –ø–æ–¥—Ä—è–¥ –≤—ã—Å—Ç—É–ø–∏–ª–∞ –ø–∞—Ä—Ç–Ω–µ—Ä–æ–º —Ñ–æ—Ä—É–º–∞, –æ–±—ä–µ–¥–∏–Ω–∏–≤—à–µ–º –±–æ–ª–µ–µ 2 500 —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –∏–∑ 60 —Å—Ç—Ä–∞–Ω","{""skip"": true}"
2025-09-18T11:05:21+00:00,@medpharm,12700,https://t.me/medpharm/12700,"–í –†–æ—Å—Å–∏–∏ –¥–µ–π—Å—Ç–≤—É–µ—Ç –æ–¥–Ω–∞ –∏–∑ —Å–∞–º—ã—Ö —Ä–∞–∑–≤–∏—Ç—ã—Ö –≥–æ—Åc–∏—Å—Ç–µ–º –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è: –∑–∞–∫—É–ø–∫–∏ –¥–ª—è –ª—å–≥–æ—Ç–Ω–∏–∫–æ–≤ –∏ —Å—Ç–∞—Ü–∏–æ–Ω–∞—Ä–æ–≤ –ø–ª–∞–Ω–∏—Ä—É—é—Ç—Å—è –Ω–∞ –≥–æ–¥ –≤–ø–µ—Ä–µ–¥ —Å –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–º–∏ –¥–æ–≥—Ä—É–∑–∫–∞–º–∏ –ø—Ä–∏ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏. –ö–ª—é—á –∫ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ–º—É —Ä–∞—Å—Ö–æ–¥–æ–≤–∞–Ω–∏—é –±—é–¥–∂–µ—Ç–∞ ‚Äî –∫–æ—Ä—Ä–µ–∫—Ç–Ω—ã–π —Ä–∞—Å—á–µ—Ç –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç–∏ –∏ –≥—Ä–∞–º–æ—Ç–Ω–æ —Å—Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–Ω–∞—è –∑–∞—è–≤–∫–∞. –û—Å–Ω–æ–≤–Ω—ã–µ —Ñ–∞–∫—Ç–æ—Ä—ã, –∫–æ—Ç–æ—Ä—ã–µ –Ω—É–∂–Ω–æ —É—á–∏—Ç—ã–≤–∞—Ç—å –ø—Ä–∏ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏–∏ –∑–∞—è–≤–∫–∏ –Ω–∞ –∑–∞–∫—É–ø–∫—É –ª–µ–∫–∞—Ä—Å—Ç–≤ —Ä–∞–∑–æ–±—Ä–∞–ª–∞ –ø—Ä–æ—Ñ., –¥–æ–∫—Ç.—Ñ–∞—Ä–º.–Ω–∞—É–∫, –∑–∞–≤–∫–∞—Ñ–µ–¥—Ä–æ–π –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –∏ —Ñ–∞—Ä–º–∞–∫–æ—ç–∫–æ–Ω–æ–º–∏–∫–∏ –ü–µ—Ä–≤–æ–≥–æ –ú–ì–ú–£ –∏–º. –ò.–ú. –°–µ—á–µ–Ω–æ–≤–∞ –†–æ–∑–∞ –Ø–ì–£–î–ò–ù–ê.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, clinical_trial, pharmacovigilance"",
  ""impact"": ""medium"",
  ""english"": ""A specialist from the First Moscow State Medical University named Dr. Rozya Yagudina has outlined key factors to consider when preparing a request for drug procurement, which is crucial for efficient budget utilization. The university focuses on the need calculation and well-formed request to ensure effective drug procurement.""
}"
2025-09-18T10:01:09+00:00,@medpharm,12699,https://t.me/medpharm/12699,–í –†–æ—Å—Å–∏–∏ –ø–ª–∞–Ω–∏—Ä—É—é—Ç —É–ø—Ä–æ—Å—Ç–∏—Ç—å –ø—Ä–æ—Ü–µ–¥—É—Ä—ã –æ—Ñ–æ—Ä–º–ª–µ–Ω–∏—è –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤ –Ω–∞ —É—á–∞—Å—Ç–∏–µ –≤ –ø—Ä–æ–≥—Ä–∞–º–º–∞—Ö ¬´–ó–µ–º—Å–∫–∏–π –¥–æ–∫—Ç–æ—Ä¬ª –∏ ¬´–ó–µ–º—Å–∫–∏–π —Ñ–µ–ª—å–¥—à–µ—Ä¬ª. –¢—Ä—É–¥–æ–≤—ã–µ –¥–æ–≥–æ–≤–æ—Ä—ã —Å–º–æ–≥—É—Ç –∑–∞–∫–ª—é—á–∞—Ç—å—Å—è –≤ —Ñ–æ—Ä–º–µ —ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω—ã—Ö –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤ —á–µ—Ä–µ–∑ –ø–æ—Ä—Ç–∞–ª –≥–æ—Å—É—Å–ª—É–≥.,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""Russia plans to simplify procedures for participation in the 'Zemsky Doktor' and 'Zemsky Felsdsher' programs. Employment contracts can be concluded in electronic form through the state services portal.""
}"
2025-09-18T09:21:12+00:00,@medpharm,12698,https://t.me/medpharm/12698,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –ø—Ä–µ–¥–ª–æ–∂–∏–ª –≤–∫–ª—é—á–∏—Ç—å –≤ —Å–ø–∏—Å–æ–∫ –ñ–ù–í–õ–ü 12 –Ω–æ–≤—ã—Ö –ú–ù–ù, –∞ —Ç–∞–∫–∂–µ –∏—Å–∫–ª—é—á–∏—Ç—å –Ω–µ–∫–æ—Ç–æ—Ä—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ —Ñ–æ—Ä–º—ã –¥–≤—É—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –≤ –ø–µ—Ä–µ—á–Ω–µ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω—ã –∞–≥—Ä–µ–≥–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ —Ñ–æ—Ä–º—ã.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health proposed to include 12 new NDCs in the –ñ–ù–í–õ–ü list, as well as to exclude certain drug forms of two medications. Additionally, aggregated drug forms are presented in the list.""
}"
2025-09-18T08:09:50+00:00,@medpharm,12697,https://t.me/medpharm/12697,–ö–æ–º–ø–∞–Ω–∏—è ¬´–ê–ª—å—Ñ–∞—Å–∏–≥–º–∞ –†—É—Å¬ª ‚Äî —Ä–æ—Å—Å–∏–π—Å–∫–æ–µ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –∏—Ç–∞–ª—å—è–Ω—Å–∫–æ–π —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ Alfasigma ‚Äî –æ–¥–µ—Ä–∂–∞–ª–∞ –ø–æ–±–µ–¥—É –≤ –Ω–æ–º–∏–Ω–∞—Ü–∏–∏ ¬´–õ—É—á—à–∏–π PR-–ø—Ä–æ–µ–∫—Ç¬ª –∏ ¬´–õ—É—á—à–∏–π ORM/SERM-–ø—Ä–æ–µ–∫—Ç¬ª –ø—Ä–µ–º–∏–∏ DEA-2025.,"{""skip"": true}"
2025-09-17T11:11:40+00:00,@medpharm,12695,https://t.me/medpharm/12695,"–ê–Ω–Ω–∞ –°—É—Ö–∞–Ω–æ–≤–∞, —Å—Ç–∞—Ä—à–∏–π –º–µ–Ω–µ–¥–∂–µ—Ä –ø–æ –ø—Ä–∏–≤–ª–µ—á–µ–Ω–∏—é –∫–ª–∏–µ–Ω—Ç–æ–≤ –≤ –ê–≤–∏—Ç–æ –†–µ–∫–ª–∞–º–µ, –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∞ —É—á–∞—Å—Ç–Ω–∏–∫–∞–º –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ —É–≥–∞–¥–∞—Ç—å, —Å–∫–æ–ª—å–∫–æ –º–∏–Ω—É—Ç –≤ —Å—Ä–µ–¥–Ω–µ–º –≤ –º–µ—Å—è—Ü –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª—å –ø—Ä–æ–≤–æ–¥–∏—Ç –Ω–∞ –ê–≤–∏—Ç–æ. –ü—Ä–∞–≤–∏–ª—å–Ω—ã–π –æ—Ç–≤–µ—Ç: 87 –º–∏–Ω—É—Ç","{""skip"": true}"
2025-09-17T10:45:58+00:00,@medpharm,12694,https://t.me/medpharm/12694,"ü¶æ üëåüëåüëåüëåüëå –£ –±–æ–ª—å—à–æ–≥–æ —á–∏—Å–ª–∞ –≤—Ä–∞—á–µ–π –≤ –∫–æ–Ω—Ü–µ 2025 –≥–æ–¥–∞ –∏—Å—Ç–µ–∫–∞–µ—Ç —Å—Ä–æ–∫ –¥–µ–π—Å—Ç–≤–∏—è —Å–µ—Ä—Ç–∏—Ñ–∏–∫–∞—Ç–∞ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞, –ø–æ–ª—É—á–µ–Ω–Ω–æ–≥–æ –≤ –∫–æ–Ω—Ü–µ 2020 –≥–æ–¥–∞. –ü–æ–ª—É—á–∏—Ç—å –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏—é —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞ –≤–æ–≤—Ä–µ–º—è —Ä–∏—Å–∫—É—é—Ç –Ω–µ –≤—Å–µ.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,hospital_policy,regulation"",
  ""impact"": ""medium"",
  ""english"": ""A large number of doctors will lose their specialist certification by the end of 2025, which they obtained at the end of 2020. Some doctors are unable to renew their specialist accreditation in time.""
}"
2025-09-17T10:30:03+00:00,@medpharm,12692,https://t.me/medpharm/12692,–°–µ—Å—Å–∏—é ¬´–î–∏–¥–∂–∏—Ç–∞–ª/–ú–µ–¥–∏–∞/–†–µ–∫–ª–∞–º–∞¬ª –æ—Ç–∫—Ä—ã–ª –≥–µ–Ω–µ—Ä–∞–ª—å–Ω—ã–π –¥–∏—Ä–µ–∫—Ç–æ—Ä ¬´–ë–∏–æ–Ω–∏–∫–∞ –ú–µ–¥–∏–∞¬ª –ü–∞–≤–µ–ª –í–ª–∞—Å–æ–≤,"{""skip"": true}"
2025-09-17T08:54:47+00:00,@medpharm,12690,https://t.me/medpharm/12690,"–û–ª—å–≥–∞ –ì–ª–∞–∑–∫–æ–≤–∞, –≠–∫—Å–ø–µ—Ä—Ç –ø–æ —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–æ–º—É –º–∞—Ä–∫–µ—Ç–∏–Ω–≥—É –∏ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–æ–Ω–Ω–æ–º—É —Ä–∞–∑–≤–∏—Ç–∏—é, –ß–ª–µ–Ω –∫–æ–æ—Ä–¥–∏–Ω–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ —Å–æ–≤–µ—Ç–∞ –†–ê–§–ú","{""skip"": true}"
2025-09-17T08:54:47+00:00,@medpharm,12689,https://t.me/medpharm/12689,"–ù–∞ —Å–µ—Å—Å–∏–∏ ¬´–û—Ç –ø–∞—Ü–∏–µ–Ω—Ç–æ—Ü–µ–Ω—Ç—Ä–∏—á–Ω–æ–≥–æ –∫ —á–µ–ª–æ–≤–µ–∫–æ—Ü–µ–Ω—Ç—Ä–∏—á–Ω–æ–º—É –º–∞—Ä–∫–µ—Ç–∏–Ω–≥—É¬ª —ç–∫—Å–ø–µ—Ä—Ç—ã —Ä–∞—Å—Å–∫–∞–∑—ã–≤–∞—é—Ç –ø—Ä–æ –∫–ª—é—á–µ–≤—ã–µ —Ç—Ä–µ–Ω–¥—ã, –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤—ã –∏ –Ω–æ–≤—ã–µ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ –¥–ª—è Rx, –û–¢–° –∏ –ë–ê–î –≤ –∫–ª–∏–µ–Ω—Ç–æ—Ä–∏–µ–Ω—Ç–∏—Ä–æ–≤–∞–Ω–Ω–æ–º –º–∞—Ä–∫–µ—Ç–∏–Ω–≥–µ. #—Ñ–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #SFE","{""skip"": true}"
2025-09-17T08:32:48+00:00,@medpharm,12688,https://t.me/medpharm/12688,"‚ù§Ô∏è ‚úç‚úç‚úç‚úç‚úç –ó–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç, –æ–≥—Ä–∞–Ω–∏—á–∏–≤–∞—é—â–∏–π –ø—Ä—è–º—ã–µ –¥–æ–≥–æ–≤–æ—Ä—ã —Å –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—è–º–∏, –º–æ–∂–µ—Ç –ø—Ä–∏–≤–µ—Å—Ç–∏ –∫ —Å–Ω–∏–∂–µ–Ω–∏—é –º–æ—Ç–∏–≤–∞—Ü–∏–∏ –≤—Ä–∞—á–µ–π –∏ –Ω–µ–ø—Ä–æ–∑—Ä–∞—á–Ω–æ—Å—Ç–∏ —Ñ–∏–Ω–∞–Ω—Å–æ–≤—ã—Ö –ø–æ—Ç–æ–∫–æ–≤. –ö–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –º–æ–≥—É—Ç –æ–∫–∞–∑–∞—Ç—å—Å—è –ø–æ–¥ —É–≥—Ä–æ–∑–æ–π —Å—Ä—ã–≤–∞. –ì–ª–∞–≤–∞ –ê–†–§–ü –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç –≤–≤–µ—Å—Ç–∏ –ø—Ä–∏–Ω—Ü–∏–ø, –∫–æ–≥–¥–∞ 80% –ø–æ–ª—É—á–∞–µ—Ç –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å, –∞ 20% ‚Äî –≤—É–∑ –∏–ª–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è.","{
  ""skip"": false,
  ""country"": ""Armenia"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""A law project limiting direct agreements with researchers may reduce doctors' motivation and increase financial transparency issues. Clinical trials could be at risk.""
}"
2025-09-17T07:58:13+00:00,@medpharm,12686,https://t.me/medpharm/12686,"–î–µ–Ω–∏—Å –í—è–∑–Ω–∏–∫–æ–≤, CEO ¬´RX CODE¬ª, —á–ª–µ–Ω –∫–æ–æ—Ä–¥–∏–Ω–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ —Å–æ–≤–µ—Ç–∞ –†–ê–§–ú","{""skip"": true}"
2025-09-17T07:58:12+00:00,@medpharm,12685,https://t.me/medpharm/12685,–°–µ–≥–æ–¥–Ω—è –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–π –≤–µ—Å—Ç–Ω–∏–∫ –ø—Ä–∏—Å—É—Ç—Å—Ç–≤—É–µ—Ç –Ω–∞ II –æ—Ç—Ä–∞—Å–ª–µ–≤–æ–π –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–æ–π –º–∞—Ä–∫–µ—Ç–∏–Ω–≥–æ–≤–æ–π –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏. –ü—Ä—è–º–æ —Å–µ–π—á–∞—Å –æ–±—Å—É–∂–¥–∞–µ–º —ç–≤–æ–ª—é—Ü–∏—é –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª—å—Å–∫–æ–≥–æ –ø–æ–≤–µ–¥–µ–Ω–∏—è –∏ —Å–æ–≤—Ä–µ–º–µ–Ω–Ω—ã–µ –º–∞—Ä–∫–µ—Ç–∏–Ω–≥–æ–≤—ã–µ –ø–æ–¥—Ö–æ–¥—ã –≤–º–µ—Å—Ç–µ —Å —ç–∫—Å–ø–µ—Ä—Ç–∞–º–∏ —Ä—ã–Ω–∫–∞. –°–ª–µ–¥–∏—Ç–µ –∑–∞ –æ–±–Ω–æ–≤–ª–µ–Ω–∏—è–º–∏ –∏ –∏–Ω—Å–∞–π—Ç–∞–º–∏ –ø—Ä—è–º–æ —Å –ø–ª–æ—â–∞–¥–∫–∏! #—Ñ–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #SFE,"{""skip"": true}"
2025-09-16T08:25:32+00:00,@medpharm,12684,https://t.me/medpharm/12684,"–ò–∑-–∑–∞ –ø–∞–Ω–¥–µ–º–∏–∏ –±—ã–ª–∏ –ø—Ä–µ—Ä–≤–∞–Ω—ã –Ω–∞ –Ω–µ–∫–æ—Ç–æ—Ä–æ–µ –≤—Ä–µ–º—è –æ—á–Ω—ã–µ GMP-–∏–Ω—Å–ø–µ–∫—Ü–∏–∏. –ù–µ –Ω–∞ –≤—Å–µ—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π —Ç–∞–∫–æ–µ –æ—Å–≤–æ–±–æ–∂–¥–µ–Ω–∏–µ –ø–æ–≤–ª–∏—è–ª–æ –ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω–æ, —Å—á–∏—Ç–∞–µ—Ç –º–∏–Ω–∏—Å—Ç—Ä –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏ –∏ —Ç–æ—Ä–≥–æ–≤–ª–∏ –ê–Ω—Ç–æ–Ω –ê–ª–∏—Ö–∞–Ω–æ–≤. –ü–æ—ç—Ç–æ–º—É –æ–Ω –ø—Ä–∏–≤–µ—Ç—Å—Ç–≤–æ–≤–∞–ª –≤–æ–∑–≤—Ä–∞—Ç –∫ –∂–µ—Å—Ç–∫–æ–º—É –∫–æ–Ω—Ç—Ä–æ–ª—é –∫–∞—á–µ—Å—Ç–≤–∞. –û–± —ç—Ç–æ–º –æ–Ω —Ä–∞—Å—Å–∫–∞–∑–∞–ª –Ω–∞ 10-–π –í—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–æ–π GMP-–∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""There was a temporary suspension of on-site GMP inspections due to the pandemic, according to Minister of Industry and Trade Anton Alikhannov. He welcomed a return to strict quality control measures, which he discussed at the 10th All-Russian GMP conference.""
}"
2025-09-15T18:41:12+00:00,@medpharm,12683,https://t.me/medpharm/12683,"–ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ –∑–∞ 15 —Å–µ–Ω—Ç—è–±—Ä—è ü¶æ –ü–µ—á–∞–ª—å–Ω—ã–π —Ä–µ–π—Ç–∏–Ω–≥. –ß–∏—Å–ª–æ –≤–ø–µ—Ä–≤—ã–µ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö —Å–ª—É—á–∞–µ–≤ –∑–ª–æ–∫–∞—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –Ω–æ–≤–æ–æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–π –≤ –†–æ—Å—Å–∏–∏ —É–≤–µ–ª–∏—á–∏–ª–æ—Å—å —Å 674 587 –≤ 2023 –≥–æ–¥—É –¥–æ 698 693 ‚Äî –≤ 2024-–º. –†–µ–≥–∏–æ–Ω—ã —Å —Å–∞–º—ã–º –±–æ–ª—å—à–∏–º –Ω–∞—Å–µ–ª–µ–Ω–∏–µ–º —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω–æ –ª–∏–¥–∏—Ä—É—é—Ç –≤ —ç—Ç–æ–º ¬´—Ä–µ–π—Ç–∏–Ω–≥–µ¬ª. ü¶æ –ù–µ —Ä–∞—Å—Ç–µ—Ä—è–ª –∫–≤–∞–ª–∏—Ñ–∏–∫–∞—Ü–∏—é. –ú–∏—Ö–∞–∏–ª –ú—É—Ä–∞—à–∫–æ –ø–æ–º–æ–≥ –ø–∞—Å—Å–∞–∂–∏—Ä—É, —É –∫–æ—Ç–æ—Ä–æ–≥–æ –Ω–∞ —Ä–µ–π—Å–µ –ú–æ—Å–∫–≤–∞ ‚Äì –•–∞–Ω–æ–π –ø—Ä–æ–∏–∑–æ—à–µ–ª –≥–∏–ø–µ—Ä—Ç–æ–Ω–∏—á–µ—Å–∫–∏–π –∫—Ä–∏–∑. –ë–ª–∞–≥–æ–¥–∞—Ä—è –æ–ø–µ—Ä–∞—Ç–∏–≤–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –º—É–∂—á–∏–Ω–∞ –±–ª–∞–≥–æ–ø–æ–ª—É—á–Ω–æ –¥–æ–ª–µ—Ç–µ–ª –¥–æ –ø—É–Ω–∫—Ç–∞ –Ω–∞–∑–Ω–∞—á–µ–Ω–∏—è. ‚ù§Ô∏è –†–∞—Å—à–∏—Ä–µ–Ω–∏–µ –Ω–∞ –î–∞–ª—å–Ω–∏–π –í–æ—Å—Ç–æ–∫. ¬´–†–∏–≥–ª–∞¬ª –ø—Ä–∏–æ–±—Ä–µ–ª–∞ –ø—Ä–∏–º–æ—Ä—Å–∫—É—é —Å–µ—Ç—å ¬´–ê–ø—Ç–µ–∫–∞25.—Ä—Ñ¬ª. –°–¥–µ–ª–∫–∞ –ø–æ–º–æ–∂–µ—Ç —É–∫—Ä–µ–ø–∏—Ç—å –ø–æ–∑–∏—Ü–∏–∏ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–π —Å–µ—Ç–∏ –Ω–∞ –î–∞–ª—å–Ω–µ–º –í–æ—Å—Ç–æ–∫–µ. ‚ù§Ô∏è –¢—Ä–µ–±–æ–≤–∞–Ω–∏—è –æ—Ç–≤–µ—Ä–≥–Ω—É—Ç—ã. –ò—Å–∫ –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–∞ –∫ Biocad –æ—Å—Ç–∞–ª—Å—è –±–µ–∑ —É–¥–æ–≤–ª–µ—Ç–≤–æ—Ä–µ–Ω–∏—è. –ú–∏–Ω–∏—Å—Ç–µ—Ä—Å—Ç–≤–æ –ø—Ä–æ—Å–∏–ª–æ –≤–∑—ã—Å–∫–∞—Ç—å —Å —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –±–æ–ª–µ–µ 21 –º–ª–Ω —Ä—É–±. –∑–∞ —Ç–æ, —á—Ç–æ –æ–Ω–∞, –ø–æ –º–Ω–µ–Ω–∏—é –∏—Å—Ç—Ü–∞, –Ω–µ –¥–æ—Å—Ç–∏–≥–ª–∞ –≤—Å–µ—Ö –ø–æ–∫–∞–∑–∞—Ç–µ–ª–µ–π —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –ø—Ä–æ–µ–∫—Ç–∞, –∫–æ—Ç–æ—Ä—ã–π –±—ã–ª —Ä–µ–∞–ª–∏–∑–æ–≤–∞–Ω —Å –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ–º —Å—É–±—Å–∏–¥–∏–∏. #–º–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #—Ñ–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–Ω–æ–≤–æ—Å—Ç–∏_–¥–Ω—è","{""skip"": true}"
2025-09-15T14:42:11+00:00,@medpharm,12682,https://t.me/medpharm/12682,"–£–≤–∞–∂–∞–µ–º—ã–µ –∫–æ–ª–ª–µ–≥–∏, –∑–Ω–∞–∫–æ–º—å—Ç–µ—Å—å —Å–æ –í—Ç–æ—Ä–æ–π –û—Ç—Ä–∞—Å–ª–µ–≤–æ–π –ü—Ä–∞–∫—Ç–∏—á–µ—Å–∫–æ–π –ú–∞—Ä–∫–µ—Ç–∏–Ω–≥–æ–≤–æ–π –ö–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–µ–π ¬´–§–ê–†–ú–ê–¶–ï–í–¢–ò–ß–ï–°–ö–ò–ô –ú–ê–†–ö–ï–¢–ò–ù–ì 2026¬ª –æ—Ç –Ω–∞—à–µ–≥–æ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ –ø–∞—Ä—Ç–Ω–µ—Ä–∞ SFE&Marketing Excellence Academy! –ß—Ç–æ –Ω–∞—Å –∂–¥–µ—Ç –≤ —ç—Ç–æ–º –≥–æ–¥—É? ‚Ä¢ 2 –¥–Ω—è –∏–Ω—Ç–µ–Ω—Å–∏–≤–∞ ‚Ä¢ 10 —Ç–µ–º–∞—Ç–∏—á–µ—Å–∫–∏—Ö —Å–µ—Å—Å–∏–π ‚Ä¢ 5 –ø—Ä–∞–∫—Ç–∏–∫—É–º–æ–≤ ‚Ä¢ 5 —Ä–∞–∑–±–æ—Ä–æ–≤ –ø—Ä–æ–¥—É–∫—Ç–æ–≤—ã—Ö —Å—Ç—Ä–∞—Ç–µ–≥–∏–π –æ—Ç –≤–µ–¥—É—â–∏—Ö –¢–û–ü-—ç–∫—Å–ø–µ—Ä—Ç–æ–≤ ‚Ä¢ 20+ –≤—ã—Å—Ç—É–ø–ª–µ–Ω–∏–π/–¥–∏—Å–∫—É—Å—Å–∏–π –æ—Ç –≤–µ–¥—É—â–∏—Ö —ç–∫—Å–ø–µ—Ä—Ç–æ–≤ ‚Ä¢ 16—á–∞—Å–æ–≤ –∫–æ–Ω—Ç–µ–Ω—Ç–∞ + 3,5 —á–∞—Å–∞ –¥–ª—è –Ω–µ—Ç–≤–æ—Ä–∫–∏–Ω–≥–∞ –∏ –Ω–µ—Ñ–æ—Ä–º–∞–ª—å–Ω–æ–≥–æ –æ–±—â–µ–Ω–∏—è ‚Ä¢ –ë–æ–ª–µ–µ 30 —Å–ø–∏–∫–µ—Ä–æ–≤ ‚Äì –∫–∞–∂–¥—ã–π —Å —É–Ω–∏–∫–∞–ª—å–Ω–æ–π —ç–∫—Å–ø–µ—Ä—Ç–∏–∑–æ–π ‚Ä¢ >45 —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –∫–æ–º–ø–∞–Ω–∏–π —É–∂–µ –∑–∞–ø–ª–∞–Ω–∏—Ä–æ–≤–∞–ª–∏ —Å–≤–æ–µ —É—á–∞—Å—Ç–∏–µ ‚Ä¢ >20 –∫–æ–º–ø–∞–Ω–∏–π, –ø—Ä–µ–¥—Å—Ç–∞–≤–ª—è—é—â–∏—Ö —Å–µ—Ä–≤–∏—Å—ã –¥–ª—è –§–∞—Ä–º—ã, –ø–ª–∞–Ω–∏—Ä—É—é—Ç –ø–∞—Ä—Ç–Ω–µ—Ä—Å—Ç–≤–æ –ö–æ–≥–¥–∞ : 17 —Å–µ–Ω—Ç—è–±—Ä—è –æ—Ñ—Ñ–ª–∞–π–Ω (–¥—Ä–µ—Å—Å-–∫–æ–¥ - –ë–ï–õ–´–ô, –Ω–∞—Å—Ç—Ä–æ–µ–Ω–∏–µ ‚Äì —Ä–∞–±–æ—á–µ–µ –¥–Ω–µ–º –∏ –ø—Ä–∞–∑–¥–Ω–∏—á–Ω–æ–µ –Ω–∞ –ü—Ä–µ–º–∏–∏). 18 —Å–µ–Ω—Ç—è–±—Ä—è –æ–Ω–ª–∞–π–Ω üèÜ –ü–æ—Å–ª–µ –æ–∫–æ–Ω—á–∞–Ω–∏—è –±–∏–∑–Ω–µ—Å-–ø—Ä–æ–≥—Ä–∞–º–º—ã 17 –°–ï–ù–¢–Ø–ë–†–Ø –í 19:00 —Å–æ—Å—Ç–æ–∏—Ç—Å—è —Ç–æ—Ä–∂–µ—Å—Ç–≤–µ–Ω–Ω–∞—è —Ü–µ—Ä–µ–º–æ–Ω–∏—è –Ω–∞–≥—Ä–∞–∂–¥–µ–Ω–∏—è –ø–æ–±–µ–¥–∏—Ç–µ–ª–µ–π III –ú–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–æ–π —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –ø—Ä–µ–º–∏–∏ ¬´DEA ‚Äì 2025: Digital, E-Commerce, Artificial Intelligence¬ª üëç –í–Ω–æ—Å–∏—Ç–µ –≤ —Å–≤–æ–∏ –ö–∞–ª–µ–Ω–¥–∞—Ä–∏ 17 —Å–µ–Ω—Ç—è–±—Ä—è 2025–≥ –∏ —Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä—É–π—Ç–µ—Å—å –Ω–∞ –∫–ª—é—á–µ–≤–æ–µ –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–µ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –æ—Ç—Ä–∞—Å–ª–∏. –ü–æ –ø—Ä–æ–º–æ–∫–æ–¥—É –ú–ê–†–ö–ï–¢–ò–ù–ì 2025 - —ç–∫—Å–∫–ª—é–∑–∏–≤–Ω—ã–µ —É—Å–ª–æ–≤–∏—è!","{""skip"": true}"
2025-09-15T10:39:02+00:00,@medpharm,12681,https://t.me/medpharm/12681,"–ù–æ–≤—ã–π –∏ –±—ã—Å—Ç—Ä—ã–π ‚Äî –∫–ª—é—á–µ–≤—ã–µ —ç–ø–∏—Ç–µ—Ç—ã XVIII –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ ¬´PRO–µ–∫—Ü–∏–∏ –ë—É–¥—É—â–µ–≥–æ¬ª. –°—É–¥—è –ø–æ –≤—ã—Å—Ç—É–ø–ª–µ–Ω–∏—è–º –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–µ–π —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏, –æ–Ω–∏ –∑–∞–∏–Ω—Ç–µ—Ä–µ—Å–æ–≤–∞–Ω—ã –≤ –Ω–æ–≤—ã—Ö –ø–∞—Ä—Ç–Ω–µ—Ä–∞—Ö, –Ω–æ–≤—ã—Ö —Ä—ã–Ω–∫–∞—Ö, –Ω–æ–≤—ã—Ö —Ñ–∏–Ω–∞–Ω—Å–æ–≤—ã—Ö –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç–∞—Ö –∏ –Ω–æ–≤–æ–π —Ä–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–µ, –∫–æ—Ç–æ—Ä–∞—è –æ–±–µ—Å–ø–µ—á–∏—Ç –±—ã—Å—Ç—Ä—ã–π –≤—ã–≤–æ–¥ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –±–æ–ª–µ–µ –±—ã—Å—Ç—Ä—ã–π –≤–æ–∑–≤—Ä–∞—Ç –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–π. –ù–æ–≤—ã–µ –º–µ—Ä—ã –≥–æ—Å–ø–æ–¥–¥–µ—Ä–∂–∫–∏ –∏ –æ–ø–µ—Ä–∞—Ç–∏–≤–Ω–∞—è –æ—á–∏—Å—Ç–∫–∞ —Ä—ã–Ω–∫–∞ –æ—Ç –Ω–µ–¥–æ–±—Ä–æ—Å–æ–≤–µ—Å—Ç–Ω—ã—Ö –∏–≥—Ä–æ–∫–æ–≤ —Ç–∞–∫–∂–µ –≤ –ø–æ–≤–µ—Å—Ç–∫–µ.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""Key phrases from the XVIII Conference 'PROjections of the Future'. It is clear that representatives of pharma are interested in new partners, markets, financial instruments and regulatory measures that will ensure the quick release of drugs and faster investment returns. New government support measures and swift market clearance from unscrupulous players are also on the agenda.""
}"
2025-09-15T08:08:34+00:00,@medpharm,12679,https://t.me/medpharm/12679,"–î–æ—Å—Ç—É–ø–Ω—ã–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –ø–æ –±–∏–æ—ç–∫–≤–∏–≤–∞–ª–µ–Ω—Ç–Ω–æ—Å—Ç–∏ –¥–ª—è —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π –ö–æ–Ω—Ç—Ä–∞–∫—Ç–Ω–æ-–∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–∞—è –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è ¬´–û–°–¢¬ª –æ—Ç–∫—Ä—ã–ª–∞ –Ω–æ–≤–æ–µ —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω–æ–µ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏–µ ‚Äì –¥–æ—Å—Ç—É–ø–Ω—ã–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –ø–æ –±–∏–æ—ç–∫–≤–∏–≤–∞–ª–µ–Ω—Ç–Ω–æ—Å—Ç–∏. –¢–µ–ø–µ—Ä—å —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –º–æ–≥—É—Ç –æ–ø—Ç–∏–º–∏–∑–∏—Ä–æ–≤–∞—Ç—å –∑–∞—Ç—Ä–∞—Ç—ã –Ω–∞ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫—É –∏ –≤—ã–≤–æ–¥ –Ω–∞ —Ä—ã–Ω–æ–∫ –≥–µ–Ω–µ—Ä–∏—á–µ—Å–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –±–∏–æ–∞–Ω–∞–ª–æ–≥–æ–≤. ¬´–û–°–¢¬ª —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª–∞ —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω–æ–µ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–µ –∏ –æ–±—ä–µ–¥–∏–Ω–∏–ª–∞ —é–Ω–∏—Ç—ã –∏ –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–∏–∏, —á—Ç–æ–±—ã –¥–∞—Ç—å –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –∫–ª–∏–µ–Ω—Ç–∞–º —ç–∫–æ–Ω–æ–º–∏—Ç—å –≤—Ä–µ–º—è –∏ —Ä–µ—Å—É—Ä—Å—ã, –ø–æ–ª—É—á–∞—è —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –±–∏–æ—ç–∫–≤–∏–≤–∞–ª–µ–Ω—Ç–Ω–æ—Å—Ç–∏ –±–µ–∑ —É—â–µ—Ä–±–∞ –¥–ª—è –∫–∞—á–µ—Å—Ç–≤–∞. –û –ø–æ–ª–Ω–æ–º –∫–æ–º–ø–ª–µ–∫—Å–µ —É—Å–ª—É–≥ –∏ –≤—ã–≥–æ–¥–Ω—ã—Ö –ø–∞–∫–µ—Ç–Ω—ã—Ö –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è—Ö ‚Äì —á–∏—Ç–∞–π—Ç–µ –≤ —Å—Ç–∞—Ç—å–µ. –†–µ–∫–ª–∞–º–∞, –û–û–û ¬´–û–°–¢ –†—É—Å¬ª","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""Contract research organization 'OST' opened a new specialized direction - accessible studies on bioequivalence. Pharmaceutical companies can optimize costs for the development and market entry of generics and biosimilars. 'OST' developed a specialized offer and combined units and laboratories to allow clients to save time and resources by obtaining bioequivalence study results without compromising quality. For more information on the full range of services and discounted packages, read the article.""
}"
2025-09-15T07:45:35+00:00,@medpharm,12678,https://t.me/medpharm/12678,"‚ù§Ô∏è –ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ –∑–∞ –ø—Ä–æ—à–µ–¥—à—É—é –Ω–µ–¥–µ–ª—é –ù–∞—á–∏–Ω–∞–µ–º –Ω–µ–¥–µ–ª—é —Å –≥–ª–∞–≤–Ω–æ–≥–æ: –∫—Ä–∞—Ç–∫–æ –≤—Å–ø–æ–º–Ω–∏–º, —á—Ç–æ –≤–∞–∂–Ω–æ–≥–æ –ø—Ä–æ–∏–∑–æ—à–ª–æ –Ω–∞ —Ñ–∞—Ä–º—Ä—ã–Ω–∫–µ –∑–∞ –ø–æ—Å–ª–µ–¥–Ω–∏–µ —Å–µ–º—å –¥–Ω–µ–π. üîµ–≠–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç –ø–æ –º–∞—Ä–∫–∏—Ä–æ–≤–∫–µ –æ—Ç–¥–µ–ª—å–Ω—ã—Ö –≤–∏–¥–æ–≤ –º–µ–¥–∏–∑–¥–µ–ª–∏–π —Ö–æ—Ç—è—Ç –ø—Ä–æ–¥–ª–∏—Ç—å –¥–æ –∫–æ–Ω—Ü–∞ –ª–µ—Ç–∞ 2026 –≥–æ–¥–∞. –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ –ø–æ–ø–æ–ª–Ω–∏—Ç –ø–µ—Ä–µ—á–µ–Ω—å –º–µ–¥–∏–∑–¥–µ–ª–∏–π, —É—á–∞—Å—Ç–≤—É—é—â–∏—Ö –≤ –ø–∏–ª–æ—Ç–µ, –Ω–æ–≤—ã–µ –ø–æ–∑–∏—Ü–∏–∏: –≥–ª—é–∫–æ–º–µ—Ç—Ä—ã, —Ç–æ–Ω–æ–º–µ—Ç—Ä—ã, —ç–Ω–¥–æ–ø—Ä–æ—Ç–µ–∑—ã –∏ –Ω–∞–±–æ—Ä—ã —Ä–µ–∞–≥–µ–Ω—Ç–æ–≤. üîµ–í–∫–ª—é—á–µ–Ω–∏–µ –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ü–ö–£ –≥–∞–±–∞–ø–µ–Ω—Ç–∏–Ω–∞, –±–∞–∫–ª–æ—Ñ–µ–Ω–∞, –ø—Ä–∞—Å—Ç–µ—Ä–æ–Ω–∞ –∏ –¥–∏—Ü–∏–∫–ª–æ–≤–µ—Ä–∏–Ω–∞ + –ø–∞—Ä–∞—Ü–µ—Ç–∞–º–æ–ª–∞ –∑–∞—Ç—è–Ω—É–ª–æ—Å—å. –≠–∫—Å–ø–µ—Ä—Ç—ã –æ–∂–∏–¥–∞—é—Ç, —á—Ç–æ —ç—Ç–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –º–æ–≥—É—Ç –∏—Å—á–µ–∑–Ω—É—Ç—å –∏–∑ –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç–∞ –∞–ø—Ç–µ–∫ —Å 1 –º–∞—Ä—Ç–∞ 2026 –≥–æ–¥–∞. –ê–ø—Ç–µ–∫–∏ —Å—Ç–æ–ª–∫–Ω—É—Ç—Å—è –Ω–µ —Ç–æ–ª—å–∫–æ —Å –æ—Å–æ–±—ã–º–∏ —É—Å–ª–æ–≤–∏—è–º–∏ —Ö—Ä–∞–Ω–µ–Ω–∏—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –ø–æ–≤—ã—à–µ–Ω–Ω—ã–º–∏ —Ä–∏—Å–∫–∞–º–∏ –ø—Ä–æ–≤–µ—Ä–æ–∫, –Ω–æ –∏ —Å —Ä–µ–∑–∫–∏–º –ø–∞–¥–µ–Ω–∏–µ–º —Å–ø—Ä–æ—Å–∞. üîµ–†–µ–µ—Å—Ç—Ä –Ω–µ–¥–æ–±—Ä–æ—Å–æ–≤–µ—Å—Ç–Ω—ã—Ö –ø–æ—Å—Ç–∞–≤—â–∏–∫–æ–≤ –ø–æ–ø–æ–ª–Ω–∏–ª—Å—è –Ω–µ—Å–∫–æ–ª—å–∫–∏–º–∏ –¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–∞–º–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π. –ù–∞ –æ–¥–Ω–æ–≥–æ –∏–∑ –Ω–∏—Ö –∑–∞ –ø–æ—Å–ª–µ–¥–Ω–∏–µ –ø–æ–ª–≥–æ–¥–∞ –∑–∞–≤–µ–ª–∏ 15 –∫–∞—Ä—Ç–æ—á–µ–∫, –Ω–∞ –¥—Ä—É–≥–æ–≥–æ ‚Äî 12. –ö–æ–≥–æ –≤–∫–ª—é—á–∞—é—Ç –≤ –†–ù–ü, –∏–∑—É—á–∏–ª ¬´–§–í¬ª. üîµ–ú–∏–Ω–∑–¥—Ä–∞–≤ –ø—Ä–∏–æ—Å—Ç–∞–Ω–æ–≤–∏–ª –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ 16 –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –û–û–û ¬´–ö–∞–º–µ–ª–∏—è –ù–ü–ü¬ª. –ò–∑ –ì–†–õ–° —Ç–∞–∫–∂–µ –∏—Å–∫–ª—é—á–∏–ª–∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–æ–Ω–Ω—ã–µ —É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏—è –Ω–∞ 11 –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –°—Ä–µ–¥–∏ –Ω–∏—Ö —Ç—Ä–∏ –≥–∏–ø–æ—Ç–µ–Ω–∑–∏–≤–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤–∞, —É –∫–æ—Ç–æ—Ä—ã—Ö –Ω–∞ —Ä—ã–Ω–∫–µ –Ω–µ—Ç –∞–Ω–∞–ª–æ–≥–æ–≤: ¬´–ê–∫–∫—É–∑–∏–¥¬ª, ¬´–ê–∫–∫—É–ø—Ä–æ¬ª –∏ ¬´–ù–æ—Ä–º–∞—Ç–µ–Ω—Å¬ª, –∞ —Ç–∞–∫–∂–µ –ø—Ä–æ—Ç–∏–≤–æ–∫–æ–≤–∏–¥–Ω–∞—è –≤–∞–∫—Ü–∏–Ω–∞ ¬´–°–∞–ª–Ω–∞–≤–∞–∫¬ª üîµ–ù–∞–∑–Ω–∞—á–µ–Ω–∏–µ –ë–ê–î –≤—Ä–∞—á–∞–º–∏ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –≤–∫–ª—é—á–∏—Ç—å –≤ —Å—Ñ–µ—Ä—É –≥–æ—Å–∫–æ–Ω—Ç—Ä–æ–ª—è –∫–∞—á–µ—Å—Ç–≤–∞ –∏ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏, –ø—Ä–æ–µ–∫—Ç –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –ú–∏–Ω–∑–¥—Ä–∞–≤. –° —Å–µ–Ω—Ç—è–±—Ä—è –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–∏ –ø–æ–ª—É—á–∏–ª–∏ –ø—Ä–∞–≤–æ –Ω–∞–∑–Ω–∞—á–∞—Ç—å –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –ë–ê–î –ø–æ –ø–æ–∫–∞–∑–∞–Ω–∏—è–º.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage, regulation"",
  ""impact"": ""high"",
  ""english"": ""The Ministry of Health has suspended the use of 16 medicines produced by 'Kamelia NPP'. Additionally, registration certificates for 11 drugs were revoked from the GRLS. Among them are three antihypertensive medications with no substitutes on the market: 'Akuzid', 'Akupro', and 'Normaten'. Also, the Covax vaccine 'Salnavak' was removed from the market. The Ministry of Health is considering including BAs (Biological Active Substances) in the scope of quality and safety control for medical activities. Doctors will be able to prescribe registered BAs based on indications starting from September.""
}"
2025-09-13T17:55:11+00:00,@medpharm,12677,https://t.me/medpharm/12677,"ü¶æ üß©üß©üß©üß©üß©üß© –ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –í –†–æ—Å—Å–∏–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞—é—Ç –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ –∫–æ–º–ø–ª–µ–∫—Å–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –∏ —Å–æ—Ü–∏–∞–ª—å–Ω–æ–π –ø–æ–¥–¥–µ—Ä–∂–∫–µ –ø–æ–∂–∏–ª—ã—Ö –ª—é–¥–µ–π. –ü—Ä–µ–¥–ø–æ–ª–∞–≥–∞–µ—Ç—Å—è, —á—Ç–æ –æ–Ω –±—É–¥–µ—Ç –Ω–∞—Ü–µ–ª–µ–Ω –Ω–∞ –ø–æ–≤—ã—à–µ–Ω–∏–µ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏—è —Ä–∞–∑–ª–∏—á–Ω—ã—Ö —Å–ª—É–∂–±, –∑–∞–¥–µ–π—Å—Ç–≤–æ–≤–∞–Ω–Ω—ã—Ö –≤ —Å–∏—Å—Ç–µ–º–µ –æ–∫–∞–∑–∞–Ω–∏—è –ø–æ–º–æ—â–∏ –ø–∞—Ü–∏–µ–Ω—Ç–∞–º —Å—Ç–∞—Ä—à–µ–≥–æ –≤–æ–∑—Ä–∞—Å—Ç–∞ —Å –Ω–µ—Å–∫–æ–ª—å–∫–∏–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏. –ù–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ –≤ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω–æ–º TOP5 –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–∞ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ø–æ —Ä–∞—Å—à–∏—Ä–µ–Ω–∏—é —Å—Ñ–µ—Ä—ã —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –∫–æ–Ω—Ç—Ä–æ–ª—è –∫–∞—á–µ—Å—Ç–≤–∞ –∏ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –Ω–∞ –æ–±–ª–∞—Å—Ç—å –Ω–∞–∑–Ω–∞—á–µ–Ω–∏—è –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏ –∞–∫—Ç–∏–≤–Ω—ã—Ö –¥–æ–±–∞–≤–æ–∫ (–ë–ê–î). –¢—Ä–µ—Ç—å—é —Å—Ç—Ä–æ—á–∫—É –Ω–æ–≤–æ—Å—Ç–Ω–æ–≥–æ —Ä–µ–π—Ç–∏–Ω–≥–∞ –Ω–µ–¥–µ–ª–∏ –∑–∞–Ω—è–ª–∞ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è –§–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ —Ñ–æ–Ω–¥–∞ –û–ú–° (–§–û–ú–°), –ø—Ä–∏–∑–Ω–∞–≤—à–µ–≥–æ –∑–∞–Ω–∏–∂–µ–Ω–∏–µ –ø–æ–¥—É—à–µ–≤—ã—Ö –Ω–æ—Ä–º–∞—Ç–∏–≤–æ–≤ –Ω–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫—É—é –ø–æ–º–æ—â—å –≤ –ø–µ—Ä–≤–∏—á–Ω–æ–º –∑–≤–µ–Ω–µ –≤ —Å–µ–ª—å—Å–∫–æ–π –º–µ—Å—Ç–Ω–æ—Å—Ç–∏. –ù–∞ —á–µ—Ç–≤–µ—Ä—Ç–æ–º –º–µ—Å—Ç–µ –≤ TOP5 –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è –æ —Å–æ–∑–¥–∞–Ω–Ω–æ–º –≤ –†–æ—Å—Å–∏–∏ –≤–∏—Ä—Ç—É–∞–ª—å–Ω–æ–º –º–µ–º–æ—Ä–∏–∞–ª–µ –≤—Ä–∞—á–∞–º. –ù–∞ –î–æ—Å–∫–µ –ø–∞–º—è—Ç–∏ –Ω–∞ —Å–∞–π—Ç–µ ¬´–ü—Ä–æ–î–æ–∫—Ç–æ—Ä–æ–≤¬ª —Ä–∞–∑–º–µ—â–µ–Ω—ã –∏–º–µ–Ω–∞, –Ω–∞–≥—Ä–∞–¥—ã –∏ –ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω—ã–µ –æ—Ç–∑—ã–≤—ã –æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ä–∞–±–æ—Ç–Ω–∏–∫–∞—Ö, –∫–æ—Ç–æ—Ä—ã–µ —É—à–ª–∏ –∏–∑ –∂–∏–∑–Ω–∏. –ó–∞–º—ã–∫–∞–µ—Ç –ø—è—Ç–µ—Ä–∫—É –Ω–æ–≤–æ—Å—Ç–µ–π –ø–æ—Ä—É—á–µ–Ω–∏–µ –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç–∞ –í–ª–∞–¥–∏–º–∏—Ä–∞ –ü—É—Ç–∏–Ω–∞ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞—Ç—å –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è –ø–æ —Å–æ–≤–µ—Ä—à–µ–Ω—Å—Ç–≤–æ–≤–∞–Ω–∏—é —Å–∏—Å—Ç–µ–º—ã –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–∏ –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤. –ú–∏–Ω–∑–¥—Ä–∞–≤, –ù–∞—Ä–æ–¥–Ω—ã–π —Ñ—Ä–æ–Ω—Ç –∏ –ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–∞—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è –ø–∞–ª–∞—Ç–∞ –¥–æ–ª–∂–Ω—ã –ø—Ä–æ–≤–µ—Å—Ç–∏ —ç—Ç—É —Ä–∞–±–æ—Ç—É –¥–æ 25 –Ω–æ—è–±—Ä—è. #–º–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–Ω–æ–≤–æ—Å—Ç–∏_–Ω–µ–¥–µ–ª–∏","{""skip"": true}"
2025-09-12T15:19:57+00:00,@medpharm,12676,https://t.me/medpharm/12676,"–ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ –∑–∞ 12 —Å–µ–Ω—Ç—è–±—Ä—è ü¶æ –°–ø–æ—Ä–Ω—ã–π —Å—á–µ—Ç. –°—Ç–æ–ª–∏—á–Ω–∞—è –∫–ª–∏–Ω–∏–∫–∞ ¬´–•–∞–¥–∞—Å—Å–∞¬ª –ø–æ—Ç—Ä–µ–±–æ–≤–∞–ª–∞ —É —Ä–æ–¥—Å—Ç–≤–µ–Ω–Ω–∏–∫–æ–≤ —É–º–µ—Ä—à–µ–≥–æ –ø–∞—Ü–∏–µ–Ω—Ç–∞ –∑–∞–ø–ª–∞—Ç–∏—Ç—å –∑–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ —É—Å–ª—É–≥–∏ 2,4 –º–ª–Ω —Ä—É–±. –ê–¥–≤–æ–∫–∞—Ç —Å–µ–º—å–∏ –Ω–∞–∑–≤–∞–ª–∞ –ø—Ä–æ—Ç–∏–≤–æ–ø—Ä–∞–≤–Ω—ã–º –æ–≥—Ä–æ–º–Ω—ã–π —Å—á–µ—Ç –∑–∞ —ç–∫—Å—Ç—Ä–µ–Ω–Ω—É—é –º–µ–¥–∏—Ü–∏–Ω—Å–∫—É—é –ø–æ–º–æ—â—å –∏ –ø—Ä–∏–∑–≤–∞–ª–∞ –∫ —Å–∏—Å—Ç–µ–º–Ω—ã–º –º–µ—Ä–∞–º –ø–æ —É—Ä–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω–∏—é –ø–æ–¥–æ–±–Ω—ã—Ö —Å–∏—Ç—É–∞—Ü–∏–π. ü¶æ –ü–µ—Ä–µ–≤–µ—Ä–Ω—É—Ç—å –±—ã –∫–∞–ª–µ–Ω–¥–∞—Ä—å. –ü—Ä–∏ —Ä–∞—Å—à–∏—Ä–µ–Ω–∏–∏ –ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ –∫–∞–ª–µ–Ω–¥–∞—Ä—è –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–∏—Ö –ø—Ä–∏–≤–∏–≤–æ–∫ –Ω—É–∂–Ω–æ —É—á–µ—Å—Ç—å, —á—Ç–æ –ª—é–¥–∏ –∂–∏–≤—É—Ç –¥–æ–ª—å—à–µ, —Ä–æ–∂–∞—é—Ç –¥–µ—Ç–µ–π –≤ –±–æ–ª–µ–µ –ø–æ–∑–¥–Ω–µ–º –≤–æ–∑—Ä–∞—Å—Ç–µ –∏ –Ω—É–∂–¥–∞—é—Ç—Å—è –≤ –∏–º–º—É–Ω–∏–∑–∞—Ü–∏–∏ –Ω–∞ –ø—Ä–æ—Ç—è–∂–µ–Ω–∏–∏ –≤—Å–µ–π –∂–∏–∑–Ω–∏. –î–µ–π—Å—Ç–≤—É—é—â–∞—è —Å—Ö–µ–º–∞ –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏–∏ –ø–æ—Å—Ç—Ä–æ–µ–Ω–∞ –Ω–∞ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–∏—è—Ö –æ –¥–µ–º–æ–≥—Ä–∞—Ñ–∏–∏ XX –≤–µ–∫–∞. ‚ù§Ô∏è –î–æ—Ä–∞–±–æ—Ç–∞–ª–∏ –ø—Ä–æ–µ–∫—Ç. –ó–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ —Å—É–±—Å–∏–¥–∏—Ä–æ–≤–∞–Ω–∏–∏ —á–∞—Å—Ç–∏ —Ä–∞—Å—Ö–æ–¥–æ–≤ –Ω–∞ –∂–∏–∑–Ω–µ–Ω–Ω–æ –≤–∞–∂–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–ª—è –º–∞–ª–æ–∏–º—É—â–∏—Ö –≥—Ä–∞–∂–¥–∞–Ω –≤–Ω–æ–≤—å –≤–Ω–µ—Å–µ–Ω –≤ –ì–æ—Å–¥—É–º—É. ‚ù§Ô∏è –ö–∞–¥—Ä–æ–≤—ã–π –≥–æ–ª–æ–¥. –õ–∏—à—å –∫–∞–∂–¥—ã–π –¥–µ—Å—è—Ç—ã–π —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å –≤ –Ω–∞—à–µ–π —Å—Ç—Ä–∞–Ω–µ –Ω–µ –∏—Å–ø—ã—Ç—ã–≤–∞–µ—Ç –¥–µ—Ñ–∏—Ü–∏—Ç–∞ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤. –¢–æ–≥–¥–∞ –∫–∞–∫ —á–µ—Ç–≤–µ—Ä—Ç—å –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö –æ—Ü–µ–Ω–∏–≤–∞—é—Ç –Ω–µ—Ö–≤–∞—Ç–∫—É —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –≤ —Å–≤–æ–µ–π –∫–æ–º–ø–∞–Ω–∏–∏ –≤ –±–æ–ª–µ–µ —á–µ–º 50%. #–º–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #—Ñ–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–Ω–æ–≤–æ—Å—Ç–∏_–¥–Ω—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""There is a dispute over the payment for medical services at the capital clinic 'Hadassah'. The family's lawyer called the huge bill for emergency medical care illegal and urged systemic measures to resolve similar issues. A revised national immunization schedule proposal takes into account people living longer and having children later in life, requiring vaccinations throughout their lives. A law project to subsidize the costs of essential medications for low-income individuals has been reintroduced in the State Duma. There is a shortage of specialists in pharmaceutical companies, with only one out of ten companies facing a lack of specialists.""
}"
2025-09-12T11:41:01+00:00,@medpharm,12675,https://t.me/medpharm/12675,"–ü—Ä–µ–ø–∞—Ä–∞—Ç —Å –ú–ù–ù –≥–æ—Ñ–ª–∏–∫–∏—Ü–µ–ø—Ç, —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–Ω—ã–π –ì—Ä—É–ø–ø–æ–π –∫–æ–º–ø–∞–Ω–∏–π ¬´–†-–§–∞—Ä–º¬ª, –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω–æ –≤–∫–ª—é—á–µ–Ω –≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–æ—Å—Å–∏–∏ ¬´–ü–µ—Ä–∏–∫–∞—Ä–¥–∏—Ç—ã¬ª –∫–∞–∫ —Å—Ä–µ–¥—Å—Ç–≤–æ —Ç–µ—Ä–∞–ø–∏–∏ –∏–¥–∏–æ–ø–∞—Ç–∏—á–µ—Å–∫–æ–≥–æ —Ä–µ—Ü–∏–¥–∏–≤–∏—Ä—É—é—â–µ–≥–æ –ø–µ—Ä–∏–∫–∞—Ä–¥–∏—Ç–∞ (–ò–†–ü)","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""high"",
  ""english"": ""The group company 'R-Farm' developed a drug with the INN of gatifloxacin, which has been officially included in the clinical recommendations of the Russian Ministry of Health 'Pericarditis' as a treatment for idiopathic recurrent pericarditis (IRP).""
}"
2025-09-11T08:15:17+00:00,@medpharm,12673,https://t.me/medpharm/12673,"–ö–µ–π—Å-—Å—Ç–∞–¥–∏ —Å ¬´–ò–Ω–≤–∏—Ç—Ä–æ¬ª –∏ ¬´–ê–ø—Ç–µ—á–Ω–æ–π —Å–µ—Ç—å—é 36,6¬ª –†—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª–∏ CRM-–º–∞—Ä–∫–µ—Ç–∏–Ω–≥–∞ –∏–∑ –º–µ–¥–∏—Ü–∏–Ω—ã –∏ —Ñ–∞—Ä–º—Ä–∏—Ç–µ–π–ª–∞ –ø–æ–∫–∞–∂—É—Ç –º–µ—Ö–∞–Ω–∏–∫–∏ –¥–ª—è —Ä–æ—Å—Ç–∞ –±–∏–∑–Ω–µ—Å-–º–µ—Ç—Ä–∏–∫. –í –ø—Ä—è–º–æ–º —ç—Ñ–∏—Ä–µ —Ä–∞–∑–±–µ—Ä–µ–º –¥–≤–∞ –∫–µ–π—Å–∞: ‚Äî –ø–µ—Ä–µ–∑–∞–ø—É—Å–∫ email-–º–∞—Ä–∫–µ—Ç–∏–Ω–≥–∞ –≤—ã—Ä–∞—Å—Ç–∏–ª —Å—Ä–µ–¥–Ω–∏–π —á–µ–∫ –ø–æ–¥–ø–∏—Å—á–∏–∫–∞ –Ω–∞ 31,5%; ‚Äî –∫–≤–∏–∑—ã —Å –ø—Ä–æ–º–æ–∫–æ–¥–∞–º–∏ –¥–æ–±–∞–≤–∏–ª–∏ 4,5 –ø. –ø. –∫ –∫–æ–Ω–≤–µ—Ä—Å–∏–∏ –∞–∫—Ü–∏–π –≤ –∑–∞–∫–∞–∑. üìÖ16 —Å–µ–Ω—Ç—è–±—Ä—è, 11:00 –º—Å–∫ üíª–û–Ω–ª–∞–π–Ω, –±–µ—Å–ø–ª–∞—Ç–Ω–æ –ó–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞—Ç—å—Å—è –†–µ–∫–ª–∞–º–∞, –û–û–û ¬´–ò–Ω—Ç–µ–Ω—Å–∞¬ª","{""skip"": true}"
2025-09-10T18:12:54+00:00,@medpharm,12672,https://t.me/medpharm/12672,"–ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ –∑–∞ 10 —Å–µ–Ω—Ç—è–±—Ä—è ü¶æ –ù–∞ —á–∏—Å—Ç—É—é –≤–æ–¥—É. –†–æ—Å—Å–∏–π—Å–∫–∏–µ —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–∏ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∏ –ò–ò-—Å–µ—Ä–≤–∏—Å –¥–ª—è –≤—ã—è–≤–ª–µ–Ω–∏—è —Ä–µ–¥–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –û–±—É—á–µ–Ω–Ω–∞—è –Ω–∞ —Ç—ã—Å—è—á–∞—Ö –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–µ–Ω–Ω—ã—Ö —Å–ª—É—á–∞–µ–≤ –Ω–µ–π—Ä–æ—Å–µ—Ç—å –∞–Ω–∞–ª–∏–∑–∏—Ä—É–µ—Ç –≤–Ω–µ—à–Ω–∏–µ –ø—Ä–∏–∑–Ω–∞–∫–∏, —Å–≤—è–∑–∞–Ω–Ω—ã–µ —Å –±–æ–ª–µ–∑–Ω—å—é –§–∞–±—Ä–∏, –¢-–∫–ª–µ—Ç–æ—á–Ω–æ–π –ª–∏–º—Ñ–æ–º–æ–π –∏ —Å–∏–Ω–¥—Ä–æ–º–æ–º –•–∞–Ω—Ç–µ—Ä–∞. ü¶æ –°—Ç–æ–∏—Ç –±–ª–∞–≥–æ–¥–∞—Ä–Ω–æ—Å—Ç–∏. –í –ì–æ—Å–¥—É–º–µ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –ø–µ—Ä–µ—Å–º–æ—Ç—Ä–µ—Ç—å –ª–∏–º–∏—Ç —Å—Ç–æ–∏–º–æ—Å—Ç–∏ –ø–æ–¥–∞—Ä–∫–∞ –¥–ª—è –≤—Ä–∞—á–µ–π –∏ —É—á–∏—Ç–µ–ª–µ–π. –ö–∞–∫–æ–π –ø—Ä–µ–∑–µ–Ω—Ç –≤ –≤–∏–¥–µ –±–ª–∞–≥–æ–¥–∞—Ä–Ω–æ—Å—Ç–∏ –ø–∞—Ü–∏–µ–Ω—Ç–∞ –≤—ã —Å—á–∏—Ç–∞–µ—Ç–µ –Ω–∞–∏–±–æ–ª–µ–µ —É–º–µ—Å—Ç–Ω—ã–º? ‚ù§Ô∏è –ù–µ –≤—ã–∑—ã–≤–∞—é—Ç –¥–æ–≤–µ—Ä–∏—è. –†–µ–µ—Å—Ç—Ä –Ω–µ–¥–æ–±—Ä–æ—Å–æ–≤–µ—Å—Ç–Ω—ã—Ö –ø–æ—Å—Ç–∞–≤—â–∏–∫–æ–≤ –ø–æ–ø–æ–ª–Ω–∏–ª—Å—è –Ω–µ—Å–∫–æ–ª—å–∫–∏–º–∏ –¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–∞–º–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π. –ù–∞ –æ–¥–Ω–æ–≥–æ –∏–∑ –Ω–∏—Ö –∑–∞ –ø–æ—Å–ª–µ–¥–Ω–∏–µ –ø–æ–ª–≥–æ–¥–∞ –∑–∞–≤–µ–ª–∏ 15 –∫–∞—Ä—Ç–æ—á–µ–∫, –Ω–∞ –¥—Ä—É–≥–æ–≥–æ ‚Äî 12. –ö–æ–≥–æ –≤–∫–ª—é—á–∞—é—Ç –≤ –†–µ–µ—Å—Ç—Ä –Ω–µ–¥–æ–±—Ä–æ—Å–æ–≤–µ—Å—Ç–Ω—ã—Ö –ø–æ—Å—Ç–∞–≤—â–∏–∫–æ–≤? ‚ù§Ô∏è –†–∞—Å—à–∏—Ä–µ–Ω–∏–µ —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–∞. –≠–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç –ø–æ –º–∞—Ä–∫–∏—Ä–æ–≤–∫–µ –æ—Ç–¥–µ–ª—å–Ω—ã—Ö –≤–∏–¥–æ–≤ –º–µ–¥–∏–∑–¥–µ–ª–∏–π —Ö–æ—Ç—è—Ç –ø—Ä–æ–¥–ª–∏—Ç—å –¥–æ –∫–æ–Ω—Ü–∞ –ª–µ—Ç–∞ 2026 –≥–æ–¥–∞. –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ –ø—Ä–µ–¥–ª–æ–∂–∏–ª –ø–æ–ø–æ–ª–Ω–∏—Ç—å –ø–µ—Ä–µ—á–µ–Ω—å –º–µ–¥–∏–∑–¥–µ–ª–∏–π, —É—á–∞—Å—Ç–≤—É—é—â–∏—Ö –≤ –ø–∏–ª–æ—Ç–µ, –Ω–æ–≤—ã–º–∏ –ø–æ–∑–∏—Ü–∏—è–º–∏: –≥–ª—é–∫–æ–º–µ—Ç—Ä—ã, —Ç–æ–Ω–æ–º–µ—Ç—Ä—ã, —ç–Ω–¥–æ–ø—Ä–æ—Ç–µ–∑—ã –∏ –Ω–∞–±–æ—Ä—ã —Ä–µ–∞–≥–µ–Ω—Ç–æ–≤. #—Ñ–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–º–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–Ω–æ–≤–æ—Å—Ç–∏_–¥–Ω—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance, safety"",
  ""impact"": ""high"",
  ""english"": ""Russian developers have introduced an AI service for identifying rare diseases. The trained neural network analyzes external signs related to Fabry disease, T-cell lymphoma, and Hunter syndrome. The State Duma is proposing to review the limit on gift costs for doctors and teachers. Which patient appreciation gift do you consider most appropriate? The registry of unscrupulous suppliers has been expanded with several pharmaceutical distributors and medical devices. One distributor had 15 cards opened in the last half year, while another had 12. Which suppliers are included in the registry of unscrupulous suppliers? The pilot program for marking certain medical devices is being extended until the end of 2026. The Ministry of Industry and Trade proposed adding new items to the pilot program, including glucometers, sphygmomanometers, prostheses, and reagent kits.""
}"
2025-09-10T14:09:41+00:00,@medpharm,12671,https://t.me/medpharm/12671,"–í–ª–∞–¥–∏–º–∏—Ä –ü—É—Ç–∏–Ω –ø–æ—Å–µ—Ç–∏–ª –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–Ω—ã–π –∫–æ–º–ø–ª–µ–∫—Å –Ω–∞—É—á–Ω–æ-—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ ¬´–°–∏—Ä–∏—É—Å¬ª, –æ—Ç–∫—Ä—ã—Ç—ã–π –≤ 2022 –≥–æ–¥—É –ø—Ä–∏ –ø–æ–¥–¥–µ—Ä–∂–∫–µ ¬´–†-–§–∞—Ä–º¬ª –ì–ª–∞–≤–∞ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–∞ –æ–∑–Ω–∞–∫–æ–º–∏–ª—Å—è —Å —Ä–∞–±–æ—Ç–æ–π –ø—Ä–æ–µ–∫—Ç–Ω–æ–π, –∞–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–æ–π –∏ —Ö–∏–º–∏—á–µ—Å–∫–æ–π –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–∏–π —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞, –∞ —Ç–∞–∫–∂–µ —Å –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ–º —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏–π. –ù–∞ –¥–∞–Ω–Ω—ã–π –º–æ–º–µ–Ω—Ç –∑–∞–≤–µ—Ä—à–∞–µ—Ç—Å—è —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–æ –æ–ø—ã—Ç–Ω–æ-–ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ —É—á–∞—Å—Ç–∫–∞. –ü—Ä–æ–µ–∫—Ç —Ä–µ–∞–ª–∏–∑—É–µ—Ç—Å—è –≤ —Ä–∞–º–∫–∞—Ö –ø–∏–ª–æ—Ç–Ω–æ–π –ø—Ä–æ–≥—Ä–∞–º–º—ã –†–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –Ω–∞—É—á–Ω–æ–≥–æ —Ñ–æ–Ω–¥–∞ –∏ –≤ –ø–∞—Ä—Ç–Ω–µ—Ä—Å—Ç–≤–µ —Å ¬´–†-–§–∞—Ä–º¬ª. –ó–¥–µ—Å—å –≤ –º–∏–∫—Ä–æ–∫–æ–ª–∏—á–µ—Å—Ç–≤–∞—Ö –±—É–¥—É—Ç —Å–∏–Ω—Ç–µ–∑–∏—Ä–æ–≤–∞—Ç—å —Å—É–±—Å—Ç–∞–Ω—Ü–∏–∏ –¥–ª—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –ø—Ä–∏–º–µ–Ω—è–µ–º—ã—Ö –≤ —Ç–µ—Ä–∞–ø–∏–∏ –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, –∞ —Ç–∞–∫–∂–µ –∏–∑–≥–æ—Ç–∞–≤–ª–∏–≤–∞—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –ø–æ –∏–Ω–¥–∏–≤–∏–¥—É–∞–ª—å–Ω—ã–º —Ä–µ—Ü–µ–ø—Ç–∞–º.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""Russian President Vladimir Putin visited the research and technology university 'Sirius', opened in 2022 with support from 'R-Farm'. He toured the university's project, analytical and chemical laboratories and saw the production of pharmaceuticals. Construction of a pilot production facility is underway. The project, part of the Russian Scientific Foundation's program and in partnership with 'R-Farm', will synthesize substances for drugs used to treat rare diseases at micro-scale and produce medications according to individual prescriptions.""
}"
2025-09-10T10:15:47+00:00,@medpharm,12670,https://t.me/medpharm/12670,"ü¶æ üëåüëåüëåüëåüëå –í –†–æ—Å—Å–∏–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞—é—Ç –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ –∫–æ–º–ø–ª–µ–∫—Å–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –∏ —Å–æ—Ü–∏–∞–ª—å–Ω–æ–π –ø–æ–¥–¥–µ—Ä–∂–∫–µ –ø–æ–∂–∏–ª—ã—Ö –ª—é–¥–µ–π. –ü—Ä–µ–¥–ø–æ–ª–∞–≥–∞–µ—Ç—Å—è, —á—Ç–æ –æ–Ω –±—É–¥–µ—Ç –Ω–∞—Ü–µ–ª–µ–Ω –Ω–∞ –ø–æ–≤—ã—à–µ–Ω–∏–µ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏—è —Ä–∞–∑–ª–∏—á–Ω—ã—Ö —Å–ª—É–∂–±, –∑–∞–¥–µ–π—Å—Ç–≤–æ–≤–∞–Ω–Ω—ã—Ö –≤ —Å–∏—Å—Ç–µ–º–µ –æ–∫–∞–∑–∞–Ω–∏—è –ø–æ–º–æ—â–∏ –ø–∞—Ü–∏–µ–Ω—Ç–∞–º —Å—Ç–∞—Ä—à–µ–≥–æ –≤–æ–∑—Ä–∞—Å—Ç–∞ —Å –Ω–µ—Å–∫–æ–ª—å–∫–∏–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏.","{""skip"": true}"
2025-09-10T08:48:09+00:00,@medpharm,12669,https://t.me/medpharm/12669,"–ù–∞–∑–Ω–∞—á–µ–Ω–∏–µ –ë–ê–î –≤—Ä–∞—á–∞–º–∏ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –≤–∫–ª—é—á–∏—Ç—å –≤ —Å—Ñ–µ—Ä—É –≥–æ—Å–∫–æ–Ω—Ç—Ä–æ–ª—è –∫–∞—á–µ—Å—Ç–≤–∞ –∏ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏, –ø—Ä–æ–µ–∫—Ç –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –ú–∏–Ω–∑–¥—Ä–∞–≤. –° —Å–µ–Ω—Ç—è–±—Ä—è –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–∏ –ø–æ–ª—É—á–∏–ª–∏ –ø—Ä–∞–≤–æ –Ω–∞–∑–Ω–∞—á–∞—Ç—å –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –ë–ê–î –ø–æ –ø–æ–∫–∞–∑–∞–Ω–∏—è–º.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing"",
  ""impact"": ""high"",
  ""english"": ""The Ministry of Health developed a proposal to include the use of approved biologic agents (BAAs) by doctors in the scope of state control over medical quality and safety. Doctors have been granted the right to prescribe registered BAAs based on indications since September.""
}"
2025-09-09T17:15:01+00:00,@medpharm,12668,https://t.me/medpharm/12668,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 9 —Å–µ–Ω—Ç—è–±—Ä—è ‚ù§Ô∏è –£—á–µ—Ç –≥—Ä–æ–∑–∏—Ç —Ä–∏—Å–∫–∞–º–∏. –ì–∞–±–∞–ø–µ–Ω—Ç–∏–Ω, –±–∞–∫–ª–æ—Ñ–µ–Ω, –ø—Ä–∞—Å—Ç–µ—Ä–æ–Ω –∏ –¥–∏—Ü–∏–∫–ª–æ–≤–µ—Ä–∏–Ω+–ø–∞—Ä–∞—Ü–µ—Ç–∞–º–æ–ª –º–æ–≥—É—Ç –∏—Å—á–µ–∑–Ω—É—Ç—å –∏–∑ –∞–ø—Ç–µ–∫ —Å 1 –º–∞—Ä—Ç–∞ 2026 –≥–æ–¥–∞ –∏–∑-–∑–∞ –∑–∞—Ç—è–Ω—É–≤—à–µ–≥–æ—Å—è –≤–∫–ª—é—á–µ–Ω–∏—è –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ü–ö–£. –ê–ø—Ç–µ–∫–∞–º –≥—Ä–æ–∑—è—Ç —É–∂–µ—Å—Ç–æ—á–µ–Ω–∏–µ —É—Å–ª–æ–≤–∏–π —Ö—Ä–∞–Ω–µ–Ω–∏—è, —Ä–æ—Å—Ç –ø—Ä–æ–≤–µ—Ä–æ–∫ –∏ —Ä–µ–∑–∫–æ–µ –ø–∞–¥–µ–Ω–∏–µ —Å–ø—Ä–æ—Å–∞ –Ω–∞ —ç—Ç–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã. ‚ù§Ô∏è –í–∑—è–ª–∏ —Ä—É–±–µ–∂. –ü—Ä–æ–¥–∞–∂–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ –∞–ø—Ç–µ–∫–∞—Ö –ø–µ—Ä–µ—à–∞–≥–Ω—É–ª–∏ –ø–æ—Ä–æ–≥ –≤ 1 —Ç—Ä–ª–Ω —Ä—É–±. –ø–æ –∏—Ç–æ–≥–∞–º —Å–µ–º–∏ –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞. –í 2024 –≥–æ–¥—É —ç—Ç–æ—Ç —É—Ä–æ–≤–µ–Ω—å –±—ã–ª –¥–æ—Å—Ç–∏–≥–Ω—É—Ç –ø–æ –∏—Ç–æ–≥–∞–º –≤–æ—Å—å–º–∏ –º–µ—Å—è—Ü–µ–≤. ü¶æ –ü–æ–ª—É—á–∏–ª–∏ –ø–æ—Ä—É—á–µ–Ω–∏–µ. –ú–∏–Ω–∑–¥—Ä–∞–≤ —Å–æ–≤–º–µ—Å—Ç–Ω–æ —Å –ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–∞–ª–∞—Ç–æ–π –¥–æ–ª–∂–µ–Ω –ø—Ä–æ—Ä–∞–±–æ—Ç–∞—Ç—å –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è –ø–æ –∞–∫—Ç—É–∞–ª–∏–∑–∞—Ü–∏–∏ –ø–æ—Ä—è–¥–∫–∞ –ø–µ—Ä–∏–æ–¥–∏—á–µ—Å–∫–æ–π –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤. ü¶æ –ú–µ—Ä—ã —ç–∫–æ–Ω–æ–º–∏–∏. –ß–ª–µ–Ω–∞–º —Å–µ–º–µ–π –º–∏–≥—Ä–∞–Ω—Ç–æ–≤ –º–æ–≥—É—Ç –∑–∞–ø—Ä–µ—Ç–∏—Ç—å –≤—ä–µ–∑–¥ –∏ –ø—Ä–µ–±—ã–≤–∞–Ω–∏–µ –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ –†–æ—Å—Å–∏–∏. –í–Ω–µ—Å–µ–Ω–Ω—ã–π –≤ –ì–æ—Å–¥—É–º—É –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ–±–æ—Å–Ω–æ–≤—ã–≤–∞–µ—Ç —Ç–∞–∫–∏–µ –º–µ—Ä—ã —Å–Ω–∏–∂–µ–Ω–∏–µ–º –Ω–∞–≥—Ä—É–∑–∫–∏ –Ω–∞ —Å–æ—Ü–∏–∞–ª—å–Ω—É—é –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä—É –∏ –±—é–¥–∂–µ—Ç–Ω—ã–µ —Ä–∞—Å—Ö–æ–¥—ã –Ω–∞ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ, –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ –∏ —Å–æ—Ü–æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ. #—Ñ–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–º–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–Ω–æ–≤–æ—Å—Ç–∏_–¥–Ω—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""Restrictions on entry and stay for migrant families are being considered by the Ministry of Health in conjunction with the National Medical Chamber. This could lead to supply shortages for medications and a decrease in demand, impacting the global market.""
}"
2025-09-09T15:34:02+00:00,@medpharm,12667,https://t.me/medpharm/12667,"–§–∞—Ä–º–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –º–æ–≥—É—Ç –≤—ã–¥–µ–ª–∏—Ç—å –≤ –æ—Ç–¥–µ–ª—å–Ω—É—é –∫–∞—Ç–µ–≥–æ—Ä–∏—é –ø–æ –Ω–æ—Ä–º–∞–º –≤—ã–≤–æ–∑–∞ —Ç–≤–µ—Ä–¥—ã—Ö –∫–æ–º–º—É–Ω–∞–ª—å–Ω—ã—Ö –æ—Ç—Ö–æ–¥–æ–≤ (–¢–ö–û). –ï—Å–ª–∏ –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –±—É–¥–µ—Ç –ø—Ä–∏–Ω—è—Ç–æ, –æ—Ç—Ä–∞—Å–ª–∏ —É–¥–∞—Å—Ç—Å—è –æ—Ç—Å—Ç–æ—è—Ç—å —Å–≤–æ–µ –ø—Ä–∞–≤–æ –Ω–∞ —Å–ø–µ—Ü–∏–∞–ª—å–Ω—ã–π –Ω–æ—Ä–º–∞—Ç–∏–≤, –∫–æ—Ç–æ—Ä—ã–π –≤ —Ä–∞–∑—ã —Å–Ω–∏–∑–∏—Ç —Ä–∞—Å—Ö–æ–¥—ã –∞–ø—Ç–µ–∫ –Ω–∞ –≤—ã–≤–æ–∑ –¢–ö–û. –°–µ–π—á–∞—Å –æ–Ω–∏ –ø–ª–∞—Ç—è—Ç –∑–∞ –Ω–∞–∫–æ–ø–ª–µ–Ω–∏–µ –æ—Ç—Ö–æ–¥–æ–≤ –Ω–∞—Ä–∞–≤–Ω–µ —Å –ø—Ä–æ–¥—É–∫—Ç–æ–≤—ã–º —Ä–∏—Ç–µ–π–ª–æ–º.","{""skip"": true}"
2025-09-09T15:09:43+00:00,@medpharm,12666,https://t.me/medpharm/12666,–ü—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤—ã–π –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –ø–æ–ª–Ω–æ–≥–æ —Ü–∏–∫–ª–∞ —Å –¥–µ–π—Å—Ç–≤—É—é—â–∏–º –≤–µ—â–µ—Å—Ç–≤–æ–º –±–µ–≤–∞—Ü–∏–∑—É–º–∞–± –ø–æ–ª—É—á–∏–ª —Å–µ—Ä—Ç–∏—Ñ–∏–∫–∞—Ç ¬´–°–¥–µ–ª–∞–Ω–æ –≤ –†–æ—Å—Å–∏–∏¬ª. –ü—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ‚Äî –∫–æ–º–ø–∞–Ω–∏—è ¬´–†-–§–∞—Ä–º¬ª.,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""high"",
  ""english"": ""A domestically produced anti-cancer drug with the active substance bevacizumab has obtained a 'Made in Russia' certificate. The drug manufacturer is company R-Farm.""
}"
2025-09-09T14:48:26+00:00,@medpharm,12665,https://t.me/medpharm/12665,"–°–Ω–∏–∑–∏—Ç—å –ù–î–° –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏ –º–µ–¥–∏–∑–¥–µ–ª–∏—è –¥–æ 5% –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –≤ –ì–æ—Å–¥—É–º–µ. –ï—Å–ª–∏ –∏–Ω—Ñ–ª—è—Ü–∏—è –ø–æ –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ —Ç–æ–≤–∞—Ä–æ–≤ –±—É–¥–µ—Ç –æ–±–≥–æ–Ω—è—Ç—å –æ–±—â—É—é, —Å—Ç–∞–≤–∫–∞ –º–æ–∂–µ—Ç –±—ã—Ç—å —Å–Ω–∏–∂–µ–Ω–∞ –¥–æ 0%. –í —Å–ª—É—á–∞–µ —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏—è –¥–æ–∫—É–º–µ–Ω—Ç –≤—Å—Ç—É–ø–∏—Ç –≤ —Å–∏–ª—É —Å 1 —è–Ω–≤–∞—Ä—è 2026 –≥–æ–¥–∞.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""reimbursement, pricing"",
  ""impact"": ""medium"",
  ""english"": ""The State Duma proposed to reduce the VAT on medicines and medical supplies to 5%. If inflation in the category of goods exceeds general inflation, the rate can be reduced to 0%. The document will come into force on January 1, 2026.""
}"
2025-09-09T10:56:24+00:00,@medpharm,12664,https://t.me/medpharm/12664,–§–û–ú–° –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–ª –ø—è—Ç–∏–∫—Ä–∞—Ç–Ω—ã–π —Ä–æ—Å—Ç —á–∏—Å–ª–∞ –æ–±—Ä–∞—â–µ–Ω–∏–π –æ—Ç –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –∏ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –≤ 2024 –≥–æ–¥—É –ø–æ –≤–æ–ø—Ä–æ—Å–∞–º –ø–æ–ª—É—á–µ–Ω–∏—è –º–µ–¥–ø–æ–º–æ—â–∏ –≤ —Å–∏—Å—Ç–µ–º–µ –û–ú–°. –í –æ—Å–Ω–æ–≤–Ω–æ–º –æ–Ω–∏ –∫–∞—Å–∞–ª–∏—Å—å –∞–∫—Ç—É–∞–ª–∏–∑–∞—Ü–∏–∏ —Å–≤–µ–¥–µ–Ω–∏–π –≤ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–º –µ–¥–∏–Ω–æ–º —Ä–µ–≥–∏—Å—Ç—Ä–µ –∑–∞—Å—Ç—Ä–∞—Ö–æ–≤–∞–Ω–Ω—ã—Ö –∏ –¥–µ–π—Å—Ç–≤–∏—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –ø–æ–ª–∏—Å–æ–≤ –≤–æ–µ–Ω–Ω–æ—Å–ª—É–∂–∞—â–∏—Ö –∏ –ø—Ä–∏—Ä–∞–≤–Ω–µ–Ω–Ω—ã—Ö –∫ –Ω–∏–º –ª–∏—Ü.,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The FOMS has recorded a fivefold increase in patient and organization inquiries regarding healthcare assistance under the OMS system in 2024. The issues primarily revolve around updating data in the federal unified registry of insured individuals and the validity of military personnel and equivalent insurance policies.""
}"
2025-09-09T09:55:49+00:00,@medpharm,12663,https://t.me/medpharm/12663,"–û–ø—Ç–∏–º–∏–∑–∞—Ü–∏—è –ø–æ–ª–µ–≤—ã—Ö –∫–æ–º–∞–Ω–¥ –∏ –ø–µ—Ä–µ—Ö–æ–¥ –∫ data-driven-–º–∞—Ä–∫–µ—Ç–∏–Ω–≥—É –º–µ–Ω—è—é—Ç –ø—Ä–∞–≤–∏–ª–∞ –∏–≥—Ä—ã –Ω–∞ —Ñ–∞—Ä–º—Ä—ã–Ω–∫–µ. –ë–æ–ª—å—à–∏–µ –∫–æ–º–∞–Ω–¥—ã –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–µ–π –±—ã–ª–∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã –≤ –ø—Ä–æ—à–ª–æ–º. –°–µ–≥–æ–¥–Ω—è –≤—ã–∏–≥—Ä—ã–≤–∞–µ—Ç —Ç–æ—á–Ω–æ—Å—Ç—å –∏ —É–ø—Ä–∞–≤–ª—è–µ–º–æ—Å—Ç—å –∫–∞—á–µ—Å—Ç–≤–∞ –∫–∞–∂–¥–æ–≥–æ –∫–æ–Ω—Ç–∞–∫—Ç–∞ —Å –æ–ø–æ—Ä–æ–π –Ω–∞ –¥–∞–Ω–Ω—ã–µ –∏ –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω—ã–π –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç. –û —Ç–æ–º, –∫–∞–∫ –º–µ–Ω—è–µ—Ç—Å—è –æ–º–Ω–∏–∫–∞–Ω–∞–ª—å–Ω–æ–µ –ø—Ä–æ–¥–≤–∏–∂–µ–Ω–∏–µ, ¬´–§–í¬ª —Ä–∞—Å—Å–∫–∞–∑–∞–ª –∏—Å–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–π –¥–∏—Ä–µ–∫—Ç–æ—Ä ¬´–¢–ï–õ–ï–†–ê-–§–∞—Ä–º–∞¬ª –°–µ—Ä–≥–µ–π –°–∫—Ä–∏–ø—á–µ–Ω–∫–æ.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, hospital_policy, marketing_strategy"",
  ""impact"": ""medium"",
  ""english"": ""Optimizing field teams and shifting to data-driven marketing are changing the rules on the pharmaceutical market. Large medical representative teams were effective in the past, but now precision and quality control of each contact based on data and artificial intelligence are winning. 'FV' spoke to executive director Sergey Skrypchenko of TELE-RAMA about how the omnichannel promotion is changing.""
}"
2025-09-09T08:51:59+00:00,@medpharm,12662,https://t.me/medpharm/12662,"–í–∫–ª—é—á–µ–Ω–∏–µ –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ü–ö–£ –≥–∞–±–∞–ø–µ–Ω—Ç–∏–Ω–∞, –±–∞–∫–ª–æ—Ñ–µ–Ω–∞, –ø—Ä–∞—Å—Ç–µ—Ä–æ–Ω–∞ –∏ –¥–∏—Ü–∏–∫–ª–æ–≤–µ—Ä–∏–Ω–∞+–ø–∞—Ä–∞—Ü–µ—Ç–∞–º–æ–ª–∞ –∑–∞—Ç—è–Ω—É–ª–æ—Å—å. –≠—Ç–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –º–æ–≥—É—Ç –∏—Å—á–µ–∑–Ω—É—Ç—å –∏–∑ –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç–∞ –∞–ø—Ç–µ–∫ —Å 1 –º–∞—Ä—Ç–∞ 2026 –≥–æ–¥–∞, –æ–∂–∏–¥–∞—é—Ç —ç–∫—Å–ø–µ—Ä—Ç—ã. –ê–ø—Ç–µ–∫–∏ —Å—Ç–æ–ª–∫–Ω—É—Ç—Å—è –Ω–µ —Ç–æ–ª—å–∫–æ —Å –æ—Å–æ–±—ã–º–∏ —É—Å–ª–æ–≤–∏—è–º–∏ —Ö—Ä–∞–Ω–µ–Ω–∏—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –ø–æ–≤—ã—à–µ–Ω–Ω—ã–º–∏ —Ä–∏—Å–∫–∞–º–∏ –ø—Ä–æ–≤–µ—Ä–æ–∫, –Ω–æ –∏ —Å —Ä–µ–∑–∫–∏–º –ø–∞–¥–µ–Ω–∏–µ–º —Å–ø—Ä–æ—Å–∞. #—Ñ–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–Ω–æ–≤–æ—Å—Ç–∏","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The inclusion of gabapentin, baclofen, prasterone, and dicyclomethasone plus paracetamol in the PUK list has been delayed. These medications could disappear from pharmacies by March 1, 2026, according to experts. Pharmacies will face not only special storage conditions and increased inspection risks but also a significant drop in demand.""
}"
2025-09-08T16:30:01+00:00,@medpharm,12661,https://t.me/medpharm/12661,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 8 —Å–µ–Ω—Ç—è–±—Ä—è –ù–∞ –≤–µ—á–Ω—É—é –ø–∞–º—è—Ç—å. –í –†–æ—Å—Å–∏–∏ —Å–æ–∑–¥–∞–ª–∏ –≤–∏—Ä—Ç—É–∞–ª—å–Ω—É—é –î–æ—Å–∫—É –ø–∞–º—è—Ç–∏ —É–º–µ—Ä—à–∏—Ö –≤—Ä–∞—á–µ–π. –ë–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ –¥–æ–∫—Ç–æ—Ä–æ–≤ –≥–æ—Ç–æ–≤—ã —Å–æ—Ö—Ä–∞–Ω–∏—Ç—å —Å—Ç—Ä–∞–Ω–∏—Ü—É —Å –æ—Ç–∑—ã–≤–∞–º–∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –Ω–∞ –ø–æ—Ä—Ç–∞–ª–µ ¬´–ü—Ä–æ–î–æ–∫—Ç–æ—Ä–æ–≤¬ª –ø–æ—Å–ª–µ —É—Ö–æ–¥–∞ –∏–∑ –∂–∏–∑–Ω–∏. –¢–∞—Ä–∏—Ñ—ã –¥–ª—è –±–µ–¥–Ω—ã—Ö. –í 2024 –≥–æ–¥—É —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã–µ —Ç–∞—Ä–∏—Ñ–Ω—ã–µ –∫–æ–º–∏—Å—Å–∏–∏ —É—Å—Ç–∞–Ω–∞–≤–ª–∏–≤–∞–ª–∏ –ø–æ–Ω–∏–∂–µ–Ω–Ω—ã–µ –Ω–æ—Ä–º–∞—Ç–∏–≤—ã —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è –¥–ª—è —Ü–µ–Ω—Ç—Ä–∞–ª—å–Ω—ã—Ö —Ä–∞–π–æ–Ω–Ω—ã—Ö, —Ä–∞–π–æ–Ω–Ω—ã—Ö –∏ —É—á–∞—Å—Ç–∫–æ–≤—ã—Ö –±–æ–ª—å–Ω–∏—Ü. –ü—Ä–∏ –ø–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω–∏–∏ –º–µ–¥–ø–æ–º–æ—â–∏ –≤ —Å–∏—Å—Ç–µ–º–µ –û–ú–° –∫ –Ω–∏–º —Ç–∞–∫–∂–µ –Ω–µ–æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω–æ –ø—Ä–∏–º–µ–Ω—è–ª–∏ –ø–æ–Ω–∏–∂–∞—é—â–∏–µ –∫–æ—ç—Ñ—Ñ–∏—Ü–∏–µ–Ω—Ç—ã. –õ–∏–º–∏—Ç –Ω–∞ –æ–±—É—á–µ–Ω–∏–µ. –ú–∏–Ω–æ–±—Ä–Ω–∞—É–∫–∏ –æ–ø—Ä–µ–¥–µ–ª–∏—Ç –∫–≤–æ—Ç—ã –Ω–∞ –ø–ª–∞—Ç–Ω—ã–µ –º–µ—Å—Ç–∞ –≤ –≤—É–∑–∞—Ö –≤ —Å–ª–µ–¥—É—é—â–µ–º —É—á–µ–±–Ω–æ–º –≥–æ–¥—É. –ë—É–¥–µ—Ç —Å–æ–∑–¥–∞–Ω–∞ –º–µ–∂–≤–µ–¥–æ–º—Å—Ç–≤–µ–Ω–Ω–∞—è —Ä–∞–±–æ—á–∞—è –≥—Ä—É–ø–ø–∞. –†–µ–ø—É—Ç–∞—Ü–∏–æ–Ω–Ω–∞—è –æ—à–∏–±–∫–∞. Pfizer –ø–æ–ø–∞–ª–∞ –≤ –∫–∞—Ç–µ–≥–æ—Ä–∏—é –±–µ–∑–æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω—ã—Ö –∫–æ–º–ø–∞–Ω–∏–π –¶–°–† –æ—à–∏–±–æ—á–Ω–æ, –ø–æ–ª–∞–≥–∞–µ—Ç –≥–ª–∞–≤–∞ ¬´–ò–Ω—Ñ–∞—Ä–º—ã¬ª. –ê—Å—Å–æ—Ü–∏–∞—Ü–∏—è –ø—Ä–æ—Å–∏—Ç –ú–∏–Ω—ç–∫–æ–Ω–æ–º–∏–∫–∏ –≤–∫–ª—é—á–∏—Ç—å –µ–µ –≤ —Ä–∞–±–æ—Ç—É –ø—Ä–∏ —Å–æ—Å—Ç–∞–≤–ª–µ–Ω–∏–∏ ¬´—Ä–µ–ø—É—Ç–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ –ø–æ—Ä—Ç—Ä–µ—Ç–∞¬ª –∑–∞—Ä—É–±–µ–∂–Ω—ã—Ö –∫–æ–º–ø–∞–Ω–∏–π, –≤ —Ç–æ–º —á–∏—Å–ª–µ –ø–æ–ª–Ω–æ—Å—Ç—å—é –∏–ª–∏ —á–∞—Å—Ç–∏—á–Ω–æ –ø–æ–∫–∏–Ω—É–≤—à–∏—Ö –†–æ—Å—Å–∏—é. #—Ñ–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–º–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–Ω–æ–≤–æ—Å—Ç–∏_–¥–Ω—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""Pfizer is categorized as irresponsible by the CSRO. The association requests that the Ministry of Economy include it in the work on creating a 'reputational portrait' of foreign companies, including those that have partially or completely left Russia. This affects the reputation and regulatory environment for medicines.""
}"
2025-09-07T16:30:01+00:00,@medpharm,12660,https://t.me/medpharm/12660,"‚ù§Ô∏è üëçüëçüëçüëçüëçüëç –ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ üîµ–ü—Ä–∞–≤–∏–ª–æ ¬´–≤—Ç–æ—Ä–æ–π –ª–∏—à–Ω–∏–π¬ª –¥–ª—è –°–ó–õ–° –Ω–∞—á–Ω–µ—Ç –¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å —Å 1 —è–Ω–≤–∞—Ä—è 2026 –≥–æ–¥–∞. –†–∞–Ω–µ–µ –µ–≥–æ –ø—Ä–µ–¥–ø–æ–ª–∞–≥–∞–ª–∏ –∑–∞–ø—É—Å—Ç–∏—Ç—å 1 —Å–µ–Ω—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞. üîµ–ú–∏–Ω–∑–¥—Ä–∞–≤ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª –∫—Ä–∏—Ç–µ—Ä–∏–∏ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—è –ø–µ—Ä–µ—á–Ω—è –°–ó–õ–°. –ü—Ä–µ–¥–ø–æ–ª–∞–≥–∞–µ—Ç—Å—è, —á—Ç–æ –æ–Ω –±—É–¥–µ—Ç —Å–æ—Å—Ç–æ—è—Ç—å –∏–∑ –¥–≤—É—Ö —Ä–∞–∑–¥–µ–ª–æ–≤. –í –ø–µ—Ä–≤—ã–π –≤–æ–π–¥—É—Ç –≤–∞–∫—Ü–∏–Ω—ã, –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –∫—Ä–æ–≤–∏ –∏ –Ω–∞—Ä–∫–æ—Ç–∏—á–µ—Å–∫–∏–µ –∞–Ω–∞–ª—å–≥–µ—Ç–∏–∫–∏, –≤–æ –≤—Ç–æ—Ä–æ–π ‚Äî –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ —Å–æ—Ü–∏–∞–ª—å–Ω–æ –∑–Ω–∞—á–∏–º—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –±–µ–∑ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –∞–Ω–∞–ª–æ–≥–æ–≤. üîµ–í –∞–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ AlphaRM –Ω–∞–∑–Ω–∞—á–∏–ª–∏ –Ω–æ–≤–æ–≥–æ –≥–µ–Ω–µ—Ä–∞–ª—å–Ω–æ–≥–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞, –∏–º —Å—Ç–∞–ª –ù–∏–∫–æ–ª–∞–π –î–µ–º–∏–¥–æ–≤. –û–Ω —Å–º–µ–Ω–∏–ª –Ω–∞ —ç—Ç–æ–º –ø–æ—Å—Ç—É –ê–Ω–Ω—É –ï—Ä–º–æ–ª–∞–µ–≤—É. üîµ–í –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ê—Ä–∏—Å—Ç–æ –§–∞—Ä–º–∞¬ª –Ω–∞–∑–Ω–∞—á–µ–Ω –Ω–æ–≤—ã–π –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä, –∏–º —Å—Ç–∞–ª –î–µ–Ω–∏—Å –ü–∞—Ç—Ä–∞—à–µ–≤. –û–Ω –ø—Ä–∏—Å—Ç—É–ø–∞–µ—Ç –∫ –æ–±—è–∑–∞–Ω–Ω–æ—Å—Ç—è–º —Å 1 –æ–∫—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞, –≤–∑—è–≤ –Ω–∞ —Å–µ–±—è –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç—å –∑–∞ —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–æ–µ —Ä–∞–∑–≤–∏—Ç–∏–µ –∫–æ–º–ø–∞–Ω–∏–∏. –†–∞–Ω–µ–µ —ç—Ç—É –¥–æ–ª–∂–Ω–æ—Å—Ç—å –∑–∞–Ω–∏–º–∞–ª –ô–æ–Ω–∞—Å –¢—Ä–∏–≥–≥–≤–∞—Å–æ–Ω. üîµ–° 1 —Å–µ–Ω—Ç—è–±—Ä—è –≤—Å—Ç—É–ø–∏–ª –≤ —Å–∏–ª—É —Ä—è–¥ —Ä–µ–≥—É–ª—è—Ç–æ—Ä–Ω—ã—Ö –∏–∑–º–µ–Ω–µ–Ω–∏–π, –∫–∞—Å–∞—é—â–∏—Ö—Å—è —Ä–∞–±–æ—Ç—ã –∞–ø—Ç–µ–∫. –ö–∞–∫–∏–µ –∂—É—Ä–Ω–∞–ª—ã –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ —Ç–µ–ø–µ—Ä—å –≤–µ—Å—Ç–∏ —Ñ–∞—Ä–º–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è–º, –∫–∞–∫ —Ä–∞–±–æ—Ç–∞—Ç—å —Å —Ä–µ—Ü–µ–ø—Ç–∞–º–∏ –∏ –∏–Ω—Ñ–æ—Ä–º–∏—Ä–æ–≤–∞—Ç—å –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏ –≤ –°–†–û ¬´–ê—Å—Å–æ—Ü–∏–∞—Ü–∏—è –Ω–µ–∑–∞–≤–∏—Å–∏–º—ã—Ö –∞–ø—Ç–µ–∫¬ª. #—Ñ–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–Ω–æ–≤–æ—Å—Ç–∏_–Ω–µ–¥–µ–ª–∏","{
  ""skip"": true
}"
2025-09-06T09:30:01+00:00,@medpharm,12659,https://t.me/medpharm/12659,"ü¶æ üß©üß©üß©üß©üß©üß© –ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ù–æ–≤—ã–π ¬´—Ç–∞–±–µ–ª—å –æ —Ä–∞–Ω–≥–∞—Ö¬ª –æ—Ç –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –æ—Ç–∫—Ä—ã–≤–∞–µ—Ç —Å–æ–±—ã—Ç–∏–π–Ω—ã–π —Ä–µ–π—Ç–∏–Ω–≥ –Ω–µ–¥–µ–ª–∏. –ú–∏–Ω–∑–¥—Ä–∞–≤ —É—Ç–≤–µ—Ä–¥–∏–ª –ø–µ—Ä–µ—á–µ–Ω—å –≤–µ–¥–æ–º—Å—Ç–≤–µ–Ω–Ω—ã—Ö –Ω–∞–≥—Ä–∞–¥, –æ—Ä–∏–µ–Ω—Ç–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –Ω–∞ –ø—Ä–∏–∑–Ω–∞–Ω–∏–µ –∑–∞—Å–ª—É–≥ –ø—Ä–∞–∫—Ç–∏–∫—É—é—â–∏—Ö –≤—Ä–∞—á–µ–π, —É—á–µ–Ω—ã—Ö, –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å–ª—É–∂–∞—â–∏—Ö –∏ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã—Ö –ø–∞—Ä—Ç–Ω–µ—Ä–æ–≤ –≤ –æ–±–ª–∞—Å—Ç–∏ –æ—Ö—Ä–∞–Ω—ã –∑–¥–æ—Ä–æ–≤—å—è. –ù–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ –≤ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω–æ–º TOP5 —Å–æ–æ–±—â–µ–Ω–∏–µ –æ–± —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤–æ–º –Ω–æ–≤—ã—Ö –ü—Ä–∞–≤–∏–ª –û–ú–°. –í –¥–µ–π—Å—Ç–≤—É—é—â–∏–π –¥–æ–∫—É–º–µ–Ω—Ç –≤–Ω–µ—Å–µ–Ω—ã –∏–∑–º–µ–Ω–µ–Ω–∏—è, —É—Ç–æ—á–Ω—è—é—â–∏–µ –ø–æ—Ä—è–¥–æ–∫ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ —Å–æ–ø—Ä–æ–≤–æ–∂–¥–µ–Ω–∏—è –∑–∞—Å—Ç—Ä–∞—Ö–æ–≤–∞–Ω–Ω—ã—Ö –ª–∏—Ü –Ω–∞ –≤—Å–µ—Ö —ç—Ç–∞–ø–∞—Ö –æ–∫–∞–∑–∞–Ω–∏—è –∏–º –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏. –¢—Ä–µ—Ç—å—é —Å—Ç—Ä–æ—á–∫—É –Ω–æ–≤–æ—Å—Ç–Ω–æ–≥–æ —Ä–µ–π—Ç–∏–Ω–≥–∞ –Ω–µ–¥–µ–ª–∏ –∑–∞–Ω—è–ª–æ —Å–æ–æ–±—â–µ–Ω–∏–µ –º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ú–∏—Ö–∞–∏–ª–∞ –ú—É—Ä–∞—à–∫–æ –æ —Ä–æ—Å—Ç–µ —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è –Ω–∞ –ª–µ—á–µ–Ω–∏–µ –æ–Ω–∫–æ–∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π ‚Äì –≤ 2025 –≥–æ–¥—É –≤—ã–¥–µ–ª–µ–Ω–æ 390 –º–ª—Ä–¥ —Ä—É–±., –Ω–∞ 15% –±–æ–ª—å—à–µ, —á–µ–º –≤ –ø—Ä–æ—à–ª–æ–º. –ù–∞ —á–µ—Ç–≤–µ—Ä—Ç–æ–º –º–µ—Å—Ç–µ –≤ TOP5 ‚Äì –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è –æ –ø–æ—Ä—É—á–µ–Ω–∏–∏ –ø—Ä–µ–º—å–µ—Ä-–º–∏–Ω–∏—Å—Ç—Ä–∞ –ú–∏—Ö–∞–∏–ª–∞ –ú–∏—à—É—Å—Ç–∏–Ω–∞ –ú–∏–Ω–∑–¥—Ä–∞–≤—É –∫–æ–Ω—Ç—Ä–æ–ª–∏—Ä–æ–≤–∞—Ç—å —Å–æ–≤–µ—Ä—à–µ–Ω—Å—Ç–≤–æ–≤–∞–Ω–∏–µ –¥–∏—Å–ø–∞–Ω—Å–µ—Ä–∏–∑–∞—Ü–∏–∏. –ó–∞–º—ã–∫–∞–µ—Ç –ø—è—Ç–µ—Ä–∫—É –Ω–æ–≤–æ—Å—Ç–µ–π –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–µ –≤–∏—Ü–µ-—Å–ø–∏–∫–µ—Ä–∞ –ì–æ—Å–¥—É–º—ã –ò—Ä–∏–Ω—ã –Ø—Ä–æ–≤–æ–π —Å–æ–∫—Ä–∞—Ç–∏—Ç—å —Å—Ä–æ–∫–∏ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏—è –æ–±—Ä–∞—â–µ–Ω–∏–π –ø–æ –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç–∏ –º–µ–¥–ø–æ–º–æ—â–∏ –∏ —É—Å–∫–æ—Ä–∏—Ç—å –ø—Ä–æ—Ü–µ–¥—É—Ä—É –æ–¥–æ–±—Ä–µ–Ω–∏—è –∑–∞—è–≤–æ–∫ –Ω–∞ —Ç–µ–ª–µ–º–µ–¥–∏—Ü–∏–Ω—Å–∫—É—é –∫–æ–Ω—Å—É–ª—å—Ç–∞—Ü–∏—é (–¢–ú–ö). #–º–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–Ω–æ–≤–æ—Å—Ç–∏_–Ω–µ–¥–µ–ª–∏","{""skip"": true}"
2025-09-05T16:32:47+00:00,@medpharm,12658,https://t.me/medpharm/12658,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 5 —Å–µ–Ω—Ç—è–±—Ä—è –ë–µ–∑ –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤—ã. –í –ú–∏–Ω–∑–¥—Ä–∞–≤–µ –Ω–∞–∑–≤–∞–ª–∏ –∫—Ä–∏—Ç–∏—á–µ—Å–∫–æ–π –∫–∞–¥—Ä–æ–≤—É—é —Å–∏—Ç—É–∞—Ü–∏—é –≤ —Å–ª—É–∂–±–µ —Å–∫–æ—Ä–æ–π –ø–æ–º–æ—â–∏ –°–µ–≤–∞—Å—Ç–æ–ø–æ–ª—è. –í –≥–æ—Ä–æ–¥–µ –æ–±—É—á–∞—é—Ç –º–∞–ª–æ –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ —Å —É—á–µ—Ç–æ–º –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤ —Ä–∞–∑–≤–∏—Ç–∏—è. –ü—Ä–æ—Ä—ã–≤ –≤ –ö–¢. –ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∞—è –∫–æ–º–ø–∞–Ω–∏—è GE HealthCare –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∞ –Ω–æ–≤—É—é —Å–∏—Å—Ç–µ–º—É –∫–æ–º–ø—å—é—Ç–µ—Ä–Ω–æ–π —Ç–æ–º–æ–≥—Ä–∞—Ñ–∏–∏ Revolution Vibe. –û–Ω–∞ –ø—Ä–µ–¥–Ω–∞–∑–Ω–∞—á–µ–Ω–∞ –¥–ª—è –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è —Å–ª–æ–∂–Ω—ã—Ö –∫–∞—Ä–¥–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –∞—Ä–∏—Ç–º–∏–µ–π, —Å–∏–ª—å–Ω–æ –∫–∞–ª—å—Ü–∏–Ω–∏—Ä–æ–≤–∞–Ω–Ω—ã–º–∏ –∫–æ—Ä–æ–Ω–∞—Ä–Ω—ã–º–∏ –∞—Ä—Ç–µ—Ä–∏—è–º–∏ –∏ –∫–ª–∞–ø–∞–Ω–∞–º–∏, —Å—Ç–µ–Ω—Ç–∞–º–∏ –∏–ª–∏ —à—É–Ω—Ç–∞–º–∏. –í—ã–¥–≤–∏–Ω—É–ª–∏ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è. –†–∞–∑—Ä–∞–±–æ—Ç–∞—Ç—å –ø—Ä–æ–µ–∫—Ç –∑–∞–∫–æ–Ω–∞ –æ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ —É—á–∞—Å—Ç–Ω–∏–∫–∏ –í–æ—Å—Ç–æ—á–Ω–æ–≥–æ —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–≥–æ —Ñ–æ—Ä—É–º–∞. –ü–æ–ø—Ä–æ—Å–∏–ª–∏ —Å–Ω–∏–∂–µ–Ω–∏—è. –°—Ç–∞–±–∏–ª–∏–∑–∏—Ä–æ–≤–∞—Ç—å —Ü–µ–Ω—ã –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –≤ –∞–ø—Ç–µ–∫–∞—Ö —Å—Ç–æ–ª–∏—Ü—ã –ø–æ—Ç—Ä–µ–±–æ–≤–∞–ª–∏ –¥–µ–ø—É—Ç–∞—Ç—ã –ì–æ—Å–¥—É–º—ã. –ü–æ –∏—Ö –º–Ω–µ–Ω–∏—é, ¬´–±–∞–∑–æ–≤—ã–π –Ω–∞–±–æ—Ä¬ª –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –∞–ø—Ç–µ–∫–∞—Ö –ú–æ—Å–∫–≤—ã, –∫–æ—Ç–æ—Ä—ã–π —Å—Ç–æ–∏—Ç –ø–æ—á—Ç–∏ 3 —Ç—ã—Å. —Ä—É–±., —Å—Ç–∞–Ω–æ–≤–∏—Ç—Å—è –Ω–∞–≥—Ä—É–∑–∫–æ–π –¥–ª—è –±—é–¥–∂–µ—Ç–∞ –º–Ω–æ–≥–∏—Ö –º–æ—Å–∫–≤–∏—á–µ–π. #—Ñ–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–º–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–Ω–æ–≤–æ—Å—Ç–∏_–¥–Ω—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety"",
  ""impact"": ""high"",
  ""english"": ""A new cardiac imaging system called Revolution Vibe from American company GE Healthcare was presented. It is designed for complex cardiological studies of patients with arrhythmia, heavily calcified coronary arteries and valves, stents or shunts. The proposals were made to develop a law on pharmaceutical safety. Members of the Eastern Economic Forum asked for reductions in drug prices in Moscow pharmacies, where a 'basic set' of medications is priced at nearly 3000 rubles and becomes a burden for many Moscow residents' budgets.""
}"
2025-09-05T12:33:50+00:00,@medpharm,12657,https://t.me/medpharm/12657,–ü–µ—Ä–≤—ã–π –∑–∞–º—Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—è —Ñ—Ä–∞–∫—Ü–∏–∏ ¬´–°–ø—Ä–∞–≤–µ–¥–ª–∏–≤–∞—è –†–æ—Å—Å–∏—è ‚Äî –ó–∞ –ø—Ä–∞–≤–¥—É¬ª –î–º–∏—Ç—Ä–∏–π –ì—É—Å–µ–≤ –∏ —á–ª–µ–Ω —Ñ—Ä–∞–∫—Ü–∏–∏ –°–µ—Ä–≥–µ–π –ö–∞–±—ã—à–µ–≤ –Ω–∞–ø—Ä–∞–≤–∏–ª–∏ –ø–∏—Å—å–º–æ –Ω–∞ –∏–º—è —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—è –î–µ–ø–∞—Ä—Ç–∞–º–µ–Ω—Ç–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ú–æ—Å–∫–≤—ã –ê–ª–µ–∫—Å–µ—è –•—Ä–∏–ø—É–Ω–∞ —Å –ø—Ä–æ—Å—å–±–æ–π —Å—Ç–∞–±–∏–ª–∏–∑–∏—Ä–æ–≤–∞—Ç—å —Ü–µ–Ω—ã –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –≤ —Å—Ç–æ–ª–∏—á–Ω—ã—Ö –∞–ø—Ç–µ–∫–∞—Ö.,"{""skip"": true}"
2025-09-04T16:26:19+00:00,@medpharm,12656,https://t.me/medpharm/12656,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 4 —Å–µ–Ω—Ç—è–±—Ä—è –£–≤–µ–ª–∏—á–∞—Ç –æ—Ö–≤–∞—Ç. –í –ü—Ä–æ–≥—Ä–∞–º–º—É –≥–æ—Å–≥–∞—Ä–∞–Ω—Ç–∏–π –≤–Ω–µ—Å–µ–Ω—ã –∏–∑–º–µ–Ω–µ–Ω–∏—è. –ú–∞–ª–æ–º–æ–±–∏–ª—å–Ω—ã–µ –≥—Ä–∞–∂–¥–∞–Ω–µ –º–æ–≥—É—Ç –±–µ—Å–ø–ª–∞—Ç–Ω–æ –ø—Ä–æ–π—Ç–∏ –¥–∏—Å–ø–∞–Ω—Å–µ—Ä–∏–∑–∞—Ü–∏—é –≤ —Å—Ç–∞—Ü–∏–æ–Ω–∞—Ä–∞—Ö, –≤–∫–ª—é—á–∞—è –∫—Ä–∞—Ç–∫–æ—Å—Ä–æ—á–Ω—É—é –≥–æ—Å–ø–∏—Ç–∞–ª–∏–∑–∞—Ü–∏—é –¥–æ —Ç—Ä–µ—Ö –¥–Ω–µ–π. –ï—Å—Ç—å —Å–æ–º–Ω–µ–Ω–∏—è. –¢–æ–ª—å–∫–æ –∫–∞–∂–¥—ã–π –ø—è—Ç—ã–π –æ–ø—Ä–æ—à–µ–Ω–Ω—ã–π —Ä–æ—Å—Å–∏—è–Ω–∏–Ω –≥–æ—Ç–æ–≤ —Ä–∞–∑–º–µ—Å—Ç–∏—Ç—å —Å–≤–æ—é –º–µ–¥–∏—Ü–∏–Ω—Å–∫—É—é –∫–∞—Ä—Ç—É –Ω–∞ –ø–æ—Ä—Ç–∞–ª–µ –≥–æ—Å—É—Å–ª—É–≥, –ø–æ–∫–∞–∑–∞–ª–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –∫–æ–º–ø–∞–Ω–∏–∏ –ú–µ–¥–†–æ–∫–µ—Ç. –í –æ–ø—Ä–æ—Å–µ —É—á–∞—Å—Ç–≤–æ–≤–∞–ª–∏ –±–æ–ª–µ–µ 2500 —á–µ–ª–æ–≤–µ–∫ –≤ –≤–æ–∑—Ä–∞—Å—Ç–µ –æ—Ç 18 –¥–æ 60 –ª–µ—Ç. –ì–æ–¥–∞ –≤ –±–æ–≥–∞—Ç—Å—Ç–≤–æ. –ó—É–º–µ—Ä—ã –±–æ–ª–µ–µ –≤–æ—Å–ø—Ä–∏–∏–º—á–∏–≤—ã –∫ —Ä–µ–∫–ª–∞–º–µ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –≤–Ω–∏–º–∞—Ç–µ–ª—å–Ω—ã –∫ –≤—ã–∫–ª–∞–¥–∫–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ –≤–∏—Ç—Ä–∏–Ω–µ. –ú–æ–ª–æ–¥–æ–º—É –ø–æ–∫–æ–ª–µ–Ω–∏—é —Ç–∞–∫–∂–µ —Å–≤–æ–π—Å—Ç–≤–µ–Ω–Ω–∞ –±–æ–ª—å—à–∞—è, —á–µ–º –≤–æ–∑—Ä–∞—Å—Ç–Ω—ã–º –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª—è–º, –≤–∞—Ä–∏–∞—Ç–∏–≤–Ω–æ—Å—Ç—å –ø—Ä–∏ –≤—ã–±–æ—Ä–µ –∫–∞–Ω–∞–ª–∞ –æ–Ω–ª–∞–π–Ω-–ø—Ä–æ–¥–∞–∂. –í–æ–∑—Ä–∞—Å—Ç–Ω—ã–µ –æ—Å–æ–±–µ–Ω–Ω–æ—Å—Ç–∏ –º–∞—Ä–∫–µ—Ç–∏–Ω–≥–∞ –æ–±—Å—É–¥–∏–ª–∏ —ç–∫—Å–ø–µ—Ä—Ç—ã –†–ê–§–ú. –í –æ–¥–Ω–æ–º –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏–∏. –í –ï–ê–≠–° –±—É–¥–µ—Ç –µ–¥–∏–Ω–∞—è –∫–æ–Ω—Ü–µ–ø—Ü–∏—è —Ä–∞–∑–≤–∏—Ç–∏—è –æ–±—â–µ–≥–æ —Ä—ã–Ω–∫–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –º–µ–¥–∏–∑–¥–µ–ª–∏–π. –ï–µ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –ï–≤—Ä–∞–∑–∏–π—Å–∫–∏–π –º–µ–∂–ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–µ–Ω–Ω—ã–π —Å–æ–≤–µ—Ç. #—Ñ–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–º–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–Ω–æ–≤–æ—Å—Ç–∏_–¥–Ω—è","{""skip"": true}"
2025-09-04T13:58:41+00:00,@medpharm,12655,https://t.me/medpharm/12655,"üì¶ –£—á–∞—Å—Ç–Ω–∏–∫–∏ —Ä—ã–Ω–∫–∞, –∫–æ—Ç–æ—Ä—ã–µ –ø–æ–ø–∞–¥–∞—é—Ç –ø–æ–¥ –¥–µ–π—Å—Ç–≤–∏–µ –∑–∞–∫–æ–Ω–∞ –æ –ø–ª–∞—Ç—Ñ–æ—Ä–º–µ–Ω–Ω–æ–π —ç–∫–æ–Ω–æ–º–∏–∫–µ, –≥–æ—Ç–æ–≤—è—Ç –¥–æ–∫—É–º–µ–Ω—Ç, —É—Å—Ç–∞–Ω–∞–≤–ª–∏–≤–∞—é—â–∏–π –ø—Ä–∏–Ω—Ü–∏–ø—ã —Å–∞–º–æ—Ä–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω–∏—è –æ—Ç—Ä–∞—Å–ª–∏. –û–± —ç—Ç–æ–º –Ω–∞ –í–æ—Å—Ç–æ—á–Ω–æ–º —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–º —Ñ–æ—Ä—É–º–µ (–í–≠–§) —Å–æ–æ–±—â–∏–ª –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å –Ω–∞—á–∞–ª—å–Ω–∏–∫–∞ —ç–∫—Å–ø–µ—Ä—Ç–Ω–æ–≥–æ —É–ø—Ä–∞–≤–ª–µ–Ω–∏—è –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç–∞ –†–§ –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –í–∏–ª–∏–Ω–æ–≤. #—Ñ–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–≤—ç—Ñ","{""skip"": true}"
2025-09-04T11:21:57+00:00,@medpharm,12654,https://t.me/medpharm/12654,"–û—Ä–¥–∏–Ω–∞—Ç–æ—Ä–æ–≤ –£—Ä–∞–ª—å—Å–∫–æ–≥–æ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –º–µ–¥—É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ (–£–ì–ú–£) –∑–∞—Å—Ç–∞–≤–ª—è—é—Ç —Ä–∞–±–æ—Ç–∞—Ç—å –≤—Ä–∞—á–∞–º–∏-—Å—Ç–∞–∂–µ—Ä–∞–º–∏ –ø–æ–¥ —É–≥—Ä–æ–∑–æ–π –Ω–µ–≤—ã–¥–∞—á–∏ –¥–∏–ø–ª–æ–º–æ–≤. –ü—Ä–∏ —ç—Ç–æ–º —Ç—Ä—É–¥–æ—É—Å—Ç—Ä–æ–∏—Ç—å—Å—è –¥–æ–ª–∂–Ω—ã —Å—Ç—É–¥–µ–Ω—Ç—ã –≤—Å–µ—Ö —Ñ–æ—Ä–º –æ–±—É—á–µ–Ω–∏—è, –≤–∫–ª—é—á–∞—è –ø–ª–∞—Ç–Ω–∏–∫–æ–≤ –∏ —Ü–µ–ª–µ–≤–∏–∫–æ–≤, –¥–∞–∂–µ –µ—Å–ª–∏ –æ–Ω–∏ —É–∂–µ —Ä–∞–±–æ—Ç–∞—é—Ç –≤ –¥—Ä—É–≥–æ–π –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ —É—á–∞—Å—Ç–∫–æ–≤—ã–º–∏ –≤—Ä–∞—á–∞–º–∏. #–º–µ–¥–≤–µ—Å—Ç–Ω–∏–∫","{""skip"": true}"
2025-09-04T10:36:49+00:00,@medpharm,12653,https://t.me/medpharm/12653,"–†–∞–±–æ—á–∞—è –≥—Ä—É–ø–ø–∞ –ì–æ—Å–¥—É–º—ã –ø–æ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç–∞ –æ —Ä–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω–∏–∏ –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–∞ —Å—Ñ–æ—Ä–º—É–ª–∏—Ä–æ–≤–∞–ª–∞ –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–∏–µ –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–∞, –∫–æ—Ç–æ—Ä–æ–µ –∑–∞–∫—Ä–µ–ø—è—Ç –≤ —ç—Ç–æ–º –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω–æ–º –∞–∫—Ç–µ. –û–± —ç—Ç–æ–º —Å–æ–æ–±—â–∏–ª–∞ –Ω–∞ –í–æ—Å—Ç–æ—á–Ω–æ–º —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–º —Ñ–æ—Ä—É–º–µ (–í–≠–§) —Å—Ç–∞—Ä—à–∏–π –ø–∞—Ä—Ç–Ω–µ—Ä –∞–¥–≤–æ–∫–∞—Ç—Å–∫–æ–≥–æ –±—é—Ä–æ ¬´–î—É–±—Ä–æ–≤—Å–∫–∞—è, –ö—É–∑–Ω–µ—Ü–æ–≤–∞ –∏ –ø–∞—Ä—Ç–Ω–µ—Ä—ã¬ª –ú–∞—Ä–∏–Ω–∞ –î—É–±—Ä–æ–≤—Å–∫–∞—è, –≤—Ö–æ–¥—è—â–∞—è –≤ —Ä–∞–±–æ—á—É—é –≥—Ä—É–ø–ø—É. #—Ñ–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–≤—ç—Ñ","{""skip"": true}"
2025-09-04T08:25:57+00:00,@medpharm,12652,https://t.me/medpharm/12652,"09.09 –≤ –ú–æ—Å–∫–≤–∞-–°–∏—Ç–∏ –ø—Ä–æ–π–¥–µ—Ç –∏–Ω—Å–∞–π—Ç-–∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏—è ¬´–û—à–∏–±–∫–∞ –≤—ã–∂–∏–≤—à–µ–≥–æ¬ª –≤ R—Ö-–º–∞—Ä–∫–µ—Ç–∏–Ω–≥–µ¬ª. –û—Ä–≥–∞–Ω–∏–∑–∞—Ç–æ—Ä –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ –ê–≥–µ–Ω—Ç—Å—Ç–≤–æ CommWorld –ø—Ä–∏–≥–ª–∞—à–∞–µ—Ç —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª–µ–π —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π –∏ —Ñ–∞—Ä–º–¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–æ–≤. –ö–æ–≥–Ω–∏—Ç–∏–≤–Ω–æ–µ –∏—Å–∫–∞–∂–µ–Ω–∏–µ –ø—Ä–∏–Ω–∏–º–∞—Ç—å —Ä–µ—à–µ–Ω–∏—è –Ω–∞ –æ—Å–Ω–æ–≤–µ —É—Å–ø–µ—à–Ω—ã—Ö –∫–µ–π—Å–æ–≤, –∏–≥–Ω–æ—Ä–∏—Ä—É—è –ø—Ä–∏—á–∏–Ω—ã –Ω–µ—É–¥–∞—á, –ø—Ä–∏–≤–æ–¥–∏—Ç –∫ —Ä–∏—Å–∫—É —ç—Ç–∏ –Ω–µ—É–¥–∞—á–∏ –ø–æ–≤—Ç–æ—Ä—è—Ç—å. –†–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–Ω–∞—è –æ—à–∏–±–∫–∞ –≤ R—Ö-–º–∞—Ä–∫–µ—Ç–∏–Ω–≥–µ ‚Äî –Ω–µ –∑–∞–º–µ—á–∞—Ç—å –≤–ø–µ—á–∞—Ç–ª—è—é—â–∏–π —Ä–∞–∑—Ä—ã–≤ –º–µ–∂–¥—É –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º–∏ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª—è–º–∏ –∏ –≤—Ä–∞—á–∞–º–∏ –≤ –≤–æ—Å–ø—Ä–∏—è—Ç–∏–∏ –∏—Ö –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏—è. –ê–∫—Ç—É–∞–ª—å–Ω–æ–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –∫–æ–º–∞–Ω–¥—ã CommWorld, –ø–æ–∫–∞–∑–∞–ª–æ: –ø–æ—Ä–æ–π —ç—Ç–∏ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –æ–±—â–∞—é—Ç—Å—è –Ω–∞ —Ä–∞–∑–Ω—ã—Ö —è–∑—ã–∫–∞—Ö. –ü—Ä–æ–≥—Ä–∞–º–º–∞, —Å–ø–∏–∫–µ—Ä—ã –∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –Ω–∞ –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–µ –ø–æ —Å—Å—ã–ª–∫–µ: https://commworld.ru/conference/?utm_source=fv?erid=2VfnxwwsQ3a –†–µ–∫–ª–∞–º–∞ –û–û–û ¬´–ö–æ–º–º–≤–æ—Ä–ª–¥¬ª","{""skip"": true}"
2025-09-03T16:11:12+00:00,@medpharm,12651,https://t.me/medpharm/12651,"üçÅ–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 3 —Å–µ–Ω—Ç—è–±—Ä—è –ü–µ—Ä–≤—ã–π –±–∏–æ–∞–Ω–∞–ª–æ–≥. –ö–æ–º–ø–∞–Ω–∏—è ¬´–ì–µ–Ω–µ—Ä–∏—É–º¬ª –ø–æ–ª—É—á–∏–ª–∞ —Ä–∞–∑—Ä–µ—à–µ–Ω–∏–µ –Ω–∞ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏–µ —Å—Ä–∞–≤–Ω–∏—Ç–µ–ª—å–Ω–æ–≥–æ –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–≥–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è —Ä–∞–≤—É–ª–∏–∑—É–º–∞–±–∞ GNR-118 –∏ ¬´–£–ª—Ç–æ–º–∏—Ä–∏—Å–∞¬ª –ø—Ä–∏ –æ–¥–Ω–æ–∫—Ä–∞—Ç–Ω–æ–º –≤–≤–µ–¥–µ–Ω–∏–∏ –∑–¥–æ—Ä–æ–≤—ã–º –¥–æ–±—Ä–æ–≤–æ–ª—å—Ü–∞–º. –ò–∑–º–µ–Ω–µ–Ω–∏—è –≤ —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–µ. –í –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ê—Ä–∏—Å—Ç–æ –§–∞—Ä–º–∞¬ª –Ω–∞–∑–Ω–∞—á–µ–Ω –Ω–æ–≤—ã–π –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä, –∏–º —Å—Ç–∞–ª –î–µ–Ω–∏—Å –ü–∞—Ç—Ä–∞—à–µ–≤. –†–∞–Ω–µ–µ —ç—Ç—É –¥–æ–ª–∂–Ω–æ—Å—Ç—å –∑–∞–Ω–∏–º–∞–ª –ô–æ–Ω–∞—Å –¢—Ä–∏–≥–≥–≤–∞—Å–æ–Ω. –î–ª—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ç—É—Ä–∏—Å—Ç–æ–≤. ¬´–í–¢–ë –ú–µ–¥–∏—Ü–∏–Ω–∞¬ª –ø—Ä–æ—Ä–∞–±–∞—Ç—ã–≤–∞–µ—Ç —Ñ–∏–Ω–∞–Ω—Å–æ–≤—É—é –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä—É –¥–ª—è –æ–ø–ª–∞—Ç—ã –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —É—Å–ª—É–≥ –∏ —Å–æ–ø—É—Ç—Å—Ç–≤—É—é—â–∏—Ö —Å–µ—Ä–≤–∏—Å–æ–≤ –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ –†–æ—Å—Å–∏–∏ —Å –ø–æ–º–æ—â—å—é –∫–∞—Ä—Ç –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã—Ö –±–∞–Ω–∫–æ–≤. –ü—Ä–æ–µ–∫—Ç —Ä–µ–∞–ª–∏–∑—É–µ—Ç—Å—è –≤ —Ä–∞–º–∫–∞—Ö —Å–æ–≥–ª–∞—à–µ–Ω–∏—è —Å –ú–∏–Ω–∑–¥—Ä–∞–≤–æ–º –ø–æ —É–≤–µ–ª–∏—á–µ–Ω–∏—é –æ–±—ä–µ–º–æ–≤ –∏ —Å–æ—Å—Ç–∞–≤–∞ —ç–∫—Å–ø–æ—Ä—Ç–∏—Ä—É–µ–º—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —É—Å–ª—É–≥ –∏ –ø—Ä–∏–≤–ª–µ—á–µ–Ω–∏—è –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–π –≤ –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—É—é —ç–∫–æ–Ω–æ–º–∏–∫—É. –ù–æ–≤—ã–µ –Ω–∞–≥—Ä–∞–¥—ã. –†–∞—Å—à–∏—Ä–µ–Ω –ø–µ—Ä–µ—á–µ–Ω—å –≤–µ–¥–æ–º—Å—Ç–≤–µ–Ω–Ω—ã—Ö –Ω–∞–≥—Ä–∞–¥ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞. –£—á—Ä–µ–∂–¥–µ–Ω—ã –ø—è—Ç—å –Ω–æ–≤—ã—Ö –º–µ–¥–∞–ª–µ–π, –≤ —Ç–æ–º —á–∏—Å–ª–µ ¬´–ó–∞ –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–æ ‚Äé–≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–∏¬ª –∏ ¬´–ó–∞ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã–µ —É—Å–∏–ª–∏—è ‚Äé–ø–æ —É–∫—Ä–µ–ø–ª–µ–Ω–∏—é –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∑–¥–æ—Ä–æ–≤—å—è¬ª. #–º–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #—Ñ–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–Ω–æ–≤–æ—Å—Ç–∏_–¥–Ω—è","{
  ""skip"": true,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,hospital_policy,pharmacovigilance,safety"",
  ""impact"": ""medium"",
  ""english"": ""A biologic analog company, 'Generium', received approval for a comparative clinical trial of GNR-118 and Ulotrimis. Changes in leadership at 'Aristo Pharma', with Denis Patra≈°ev as the new CEO, previously held by Yonas Triggwason. 'VTB Medicine' is exploring financial infrastructure for the payment of medical services and related services on Russian territory using foreign bank cards. Under a cooperation agreement with the Ministry of Health, this project aims to increase the volume and composition of exported medical services and attract investments into the national economy. New awards have been expanded, with five new medals established by the Ministry of Health including 'For mentoring in healthcare' and 'For international efforts to strengthen public health'.""
}"
2025-09-03T14:00:59+00:00,@medpharm,12650,https://t.me/medpharm/12650,"20‚Äì21 –Ω–æ—è–±—Ä—è 2025 –≥–æ–¥–∞ –≤ –ú–æ—Å–∫–≤–µ —Å–æ—Å—Ç–æ–∏—Ç—Å—è –∫–ª—é—á–µ–≤–æ–µ –æ—Ç—Ä–∞—Å–ª–µ–≤–æ–µ —Å–æ–±—ã—Ç–∏–µ –¥–ª—è –∏–≥—Ä–æ–∫–æ–≤ —Ä—ã–Ω–∫–∞ –ë–ê–î. –ú–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–µ —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω–æ –æ–±—ä–µ–¥–∏–Ω–∏—Ç –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π, –¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–æ–≤, –º–∞—Ä–∫–µ—Ç–æ–ª–æ–≥–æ–≤ –∏ —ç–∫—Å–ø–µ—Ä—Ç–æ–≤ —Ä–µ–≥—É–ª—è—Ç–æ—Ä–Ω–æ–π —Å—Ñ–µ—Ä—ã. –ü–æ–¥—Ä–æ–±–Ω–µ–µ https://clck.ru/3NznZY","{""skip"": true}"
2025-09-03T10:50:52+00:00,@medpharm,12649,https://t.me/medpharm/12649,"–ö–æ–Ω–µ—Ü 90-—Ö —Å—Ç–∞–ª —ç—Ç–∞–ø–æ–º —Ü–∏—Ñ—Ä–æ–≤–∏–∑–∞—Ü–∏–∏ –ª–æ–≥–∏—Å—Ç–∏–∫–∏: –≤ 1999 –≥–æ–¥—É ¬´–ü—Ä–æ—Ç–µ–∫¬ª –≤–Ω–µ–¥—Ä–∏–ª —Å–∏—Å—Ç–µ–º—É —É–ø—Ä–∞–≤–ª–µ–Ω–∏—è —Å–∫–ª–∞–¥–æ–º –Ω–∞ –±–∞–∑–µ –º–æ–±–∏–ª—å–Ω—ã—Ö —Ä–∞–¥–∏–æ—Ç–µ—Ä–º–∏–Ω–∞–ª–æ–≤. –°–æ—Ç—Ä—É–¥–Ω–∏–∫–∏ –ø–æ–ª—É—á–∏–ª–∏ –¥–æ—Å—Ç—É–ø –∫ –¥–∞–Ω–Ω—ã–º –≤ —Ä–µ–∞–ª—å–Ω–æ–º –≤—Ä–µ–º–µ–Ω–∏, —á—Ç–æ –∏–∑–º–µ–Ω–∏–ª–æ –ø—Ä–æ—Ü–µ—Å—Å—ã –≤–Ω—É—Ç—Ä–∏ –∫–æ–º–ø–∞–Ω–∏–∏","{""skip"": true}"
2025-09-02T15:50:59+00:00,@medpharm,12648,https://t.me/medpharm/12648,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 2 —Å–µ–Ω—Ç—è–±—Ä—è –í ¬´–ó–¥—Ä–∞–≤—Å—Ç–≤—É–π!¬ª –≤–æ–ª–Ω—É—é—Ç—Å—è. –î–µ—Ñ–∏—Ü–∏—Ç —Å—Ä–µ–¥—Å—Ç–≤ –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–µ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –≤ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã—Ö –ø—Ä–æ–≥—Ä–∞–º–º–∞—Ö –≥–æ—Å–≥–∞—Ä–∞–Ω—Ç–∏–π —Å—Ç–∞–≤–∏—Ç –ø–æ–¥ –≤–æ–ø—Ä–æ—Å –¥–æ—Å—Ç–∏–∂–µ–Ω–∏–µ –∞–º–±–∏—Ü–∏–æ–∑–Ω—ã—Ö —Ü–µ–ª–µ–π —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –ø—Ä–æ–µ–∫—Ç–∞ ¬´–ë–æ—Ä—å–±–∞ —Å –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏¬ª. –£–∂–µ —Å–µ–π—á–∞—Å –±—é–¥–∂–µ—Ç—ã –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—É—é —Ç–µ—Ä–∞–ø–∏—é –≤ –ø—Ä–æ–≤–µ—Ä–µ–Ω–Ω—ã—Ö —Ä–µ–≥–∏–æ–Ω–∞—Ö –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏ –≤–µ–∑–¥–µ –∏—Å—á–µ—Ä–ø–∞–Ω—ã. –ë–æ–ª—å—à–µ –ø–æ–¥–∞—Ä–∫–æ–≤! –í –î—É–º–µ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –ø–µ—Ä–µ—Å–º–æ—Ç—Ä–µ—Ç—å –ª–∏–º–∏—Ç —Å—Ç–æ–∏–º–æ—Å—Ç–∏ –ø–æ–¥–∞—Ä–∫–∞ –¥–ª—è –≤—Ä–∞—á–µ–π –∏ —É—á–∏—Ç–µ–ª–µ–π. –ó–∞ –ø–æ—Å–ª–µ–¥–Ω–∏–µ 17 –ª–µ—Ç –æ–Ω –∑–∞–º–µ—Ç–Ω–æ —É—Å—Ç–∞—Ä–µ–ª –∏–∑-–∑–∞ –∏–Ω—Ñ–ª—è—Ü–∏–∏ –∏ —Ä–æ—Å—Ç–∞ —Ü–µ–Ω. –ù–æ–≤—ã–µ –ø—Ä–∞–≤–∏–ª–∞ –≤ –∞–ø—Ç–µ–∫–µ. –í—Å—Ç—É–ø–∏–ª–∏ –≤ —Å–∏–ª—É —Ä–µ–≥—É–ª—è—Ç–æ—Ä–Ω—ã–µ –∏–∑–º–µ–Ω–µ–Ω–∏—è, –∫–∞—Å–∞—é—â–∏–µ—Å—è —Ä–∞–±–æ—Ç—ã –∞–ø—Ç–µ–∫. –ö–∞–∫–∏–µ –∂—É—Ä–Ω–∞–ª—ã –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ —Ç–µ–ø–µ—Ä—å –≤–µ—Å—Ç–∏ —Ñ–∞—Ä–º–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è–º, –∫–∞–∫ —Ä–∞–±–æ—Ç–∞—Ç—å —Å —Ä–µ—Ü–µ–ø—Ç–∞–º–∏ –∏ –∏–Ω—Ñ–æ—Ä–º–∏—Ä–æ–≤–∞—Ç—å –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –ó–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å–Ω—É—é –±–∞–∑—É –∏–∑—É—á–∏–ª–∏ –≤ –°–†–û ¬´–ê—Å—Å–æ—Ü–∏–∞—Ü–∏—è –Ω–µ–∑–∞–≤–∏—Å–∏–º—ã—Ö –∞–ø—Ç–µ–∫¬ª. –û–ø—Ä–µ–¥–µ–ª–∏–ª–∏—Å—å —Å –∫—Ä–∏—Ç–µ—Ä–∏—è–º–∏. –ú–∏–Ω–∑–¥—Ä–∞–≤ –ø—Ä–µ–¥–ª–æ–∂–∏–ª –∫—Ä–∏—Ç–µ—Ä–∏–∏ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—è –ø–µ—Ä–µ—á–Ω—è –°–ó–õ–°. –í –µ–≥–æ –ø–µ—Ä–≤—ã–π —Ä–∞–∑–¥–µ–ª –≤–æ–π–¥—É—Ç –≤–∞–∫—Ü–∏–Ω—ã, –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –∫—Ä–æ–≤–∏ –∏ –Ω–∞—Ä–∫–æ—Ç–∏—á–µ—Å–∫–∏–µ –∞–Ω–∞–ª—å–≥–µ—Ç–∏–∫–∏, –≤–æ –≤—Ç–æ—Ä–æ–π ‚Äî –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ —Å–æ—Ü–∏–∞–ª—å–Ω–æ –∑–Ω–∞—á–∏–º—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –±–µ–∑ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –∞–Ω–∞–ª–æ–≥–æ–≤. #–º–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #—Ñ–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–Ω–æ–≤–æ—Å—Ç–∏_–¥–Ω—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""There is a shortage of medicines for patient care in regional health programs. This poses a threat to the ambitious goals of the 'Combat Cancer' project. Budgets for pharmaceutical care in many regions are nearly exhausted. The law is being studied by the Association of Independent Pharmacies, and criteria for creating a list of essential medicines have been determined.""
}"
2025-09-02T13:53:12+00:00,@medpharm,12647,https://t.me/medpharm/12647,–ú–∏–Ω–∑–¥—Ä–∞–≤ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –ø–æ—Ä—è–¥–æ–∫ –∏ –∫—Ä–∏—Ç–µ—Ä–∏–∏ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—è –ø–µ—Ä–µ—á–Ω—è —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ (–°–ó–õ–°). –ü—Ä–æ–µ–∫—Ç –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è –æ–± —ç—Ç–æ–º –Ω–∞—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–º –æ–±—Å—É–∂–¥–µ–Ω–∏–∏ –¥–æ 16 —Å–µ–Ω—Ç—è–±—Ä—è.,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health has developed guidelines and criteria for creating a list of strategically important medicines (SZLS). The project of the regulation is under public discussion until September 16.""
}"
2025-09-02T12:49:37+00:00,@medpharm,12646,https://t.me/medpharm/12646,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª –Ω–æ–≤—ã–π –ø–µ—Ä–µ—á–µ–Ω—å —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã—Ö –∏ –≤–µ–¥–æ–º—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Ü–µ–Ω—Ç—Ä–æ–≤, –ù–ò–ò –∏ –≤—É–∑–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ –ø–æ–ª—É—á–∞—Ç –ø—Ä–∞–≤–æ –æ–∫–∞–∑—ã–≤–∞—Ç—å –≤—ã—Å–æ–∫–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–Ω—É—é –º–µ–¥–∏—Ü–∏–Ω—Å–∫—É—é –ø–æ–º–æ—â—å, –Ω–µ –≤–∫–ª—é—á–µ–Ω–Ω—É—é –≤ –±–∞–∑–æ–≤—É—é –ø—Ä–æ–≥—Ä–∞–º–º—É –û–ú–°. –î–æ–∫—É–º–µ–Ω—Ç –≤—Å—Ç—É–ø–∏—Ç –≤ —Å–∏–ª—É —Å 1 —è–Ω–≤–∞—Ä—è 2026 –≥–æ–¥–∞.","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health has registered a new list of federal and government institutions, research institutes, and universities that will be entitled to provide high-tech medical care not included in the basic OMS program. The document will come into force on January 1, 2026.""
}"
2025-09-02T11:47:05+00:00,@medpharm,12645,https://t.me/medpharm/12645,"–°—É–¥ —É—Å—Ç–∞–Ω–æ–≤–∏–ª, —á—Ç–æ –ì–æ–ª–µ–Ω–µ—Ü–∫–∞—è –≤ 2019 –≥–æ–¥—É —É—Ç–≤–µ—Ä–¥–∏–ª–∞ –∑–∞—è–≤–∫–∏ –Ω–∞ –∑–∞–∫—É–ø–∫—É –ø—Å–∏—Ö–æ—Ç—Ä–æ–ø–Ω–æ–≥–æ –æ–ø–∏–æ–∏–¥–Ω–æ–≥–æ –∞–Ω–∞–ª—å–≥–µ—Ç–∏–∫–∞ —Å –ú–ù–ù —Ç—Ä–∞–º–∞–¥–æ–ª –≤ –∫–æ–ª–∏—á–µ—Å—Ç–≤–µ, –∫–æ—Ç–æ—Ä–æ–µ –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ –ø—Ä–µ–≤—ã—à–∞–ª–æ –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç–∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –æ–Ω–∫–æ–ª–æ–≥–∏–µ–π. –ò–∑-–∑–∞ –Ω–µ–≤–æ—Å—Ç—Ä–µ–±–æ–≤–∞–Ω–Ω–æ—Å—Ç–∏ –∏ –∏—Å—Ç–µ—á–µ–Ω–∏—è —Å—Ä–æ–∫–æ–≤ –≥–æ–¥–Ω–æ—Å—Ç–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç –±—ã–ª —É–Ω–∏—á—Ç–æ–∂–µ–Ω.","{
  ""skip"": false,
  ""country"": ""Ukraine"",
  ""topic"": ""tenders, shortage"",
  ""impact"": ""high"",
  ""english"": ""The court found that Goleneckaya approved purchase requests for the opioid analgesic tramadol in 2019, which significantly exceeded the patients' needs for oncology. Due to low demand and expiration of the drug's shelf life, it was destroyed.""
}"
2025-09-02T09:09:01+00:00,@medpharm,12643,https://t.me/medpharm/12643,"–ß—Ç–æ –Ω—É–∂–Ω–æ —Å–¥–µ–ª–∞—Ç—å –∞–ø—Ç–µ–∫–µ –≤ —Å–µ–Ω—Ç—è–±—Ä–µ –í —Å–µ–Ω—Ç—è–±—Ä–µ –∞–ø—Ç–µ–∫–∞–º –ø—Ä–∏–¥–µ—Ç—Å—è –≤–Ω–µ—Å—Ç–∏ –≤ —Å–≤–æ—é —Ä–∞–±–æ—Ç—É —Ä—è–¥ –∏–∑–º–µ–Ω–µ–Ω–∏–π, –ø—Ä–æ–¥–∏–∫—Ç–æ–≤–∞–Ω–Ω—ã—Ö –Ω–æ–≤—ã–º–∏ –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω—ã–º–∏ –∞–∫—Ç–∞–º–∏. –ë–æ–ª—å—à–∞—è —á–∞—Å—Ç—å –∏–∑–º–µ–Ω–µ–Ω–∏–π –≤ —Ä–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–µ —ç—Ç–æ–≥–æ –≥–æ–¥–∞ —Å–≤—è–∑–∞–Ω–∞ —Å –æ—á–µ—Ä–µ–¥–Ω—ã–º —ç—Ç–∞–ø–æ–º —Ä–∞–±–æ—Ç—ã ¬´—Ä–µ–≥—É–ª—è—Ç–æ—Ä–Ω–æ–π –≥–∏–ª—å–æ—Ç–∏–Ω—ã¬ª. –ï—â–µ –≤ –ø—Ä–æ—à–ª–æ–º –≥–æ–¥—É –±—ã–ª –∑–∞–ø–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω –ø–µ—Ä–µ—Å–º–æ—Ç—Ä –∫–ª—é—á–µ–≤—ã—Ö –∞–∫—Ç–æ–≤, —Ä–µ–≥—É–ª–∏—Ä—É—é—â–∏—Ö —Ä–∞–±–æ—Ç—É –∞–ø—Ç–µ–∫, –¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–æ–≤ –∏ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing"",
  ""impact"": ""medium"",
  ""english"": ""Pharmacies will need to make changes in their work this September, dictated by new regulatory acts. Most of the changes in regulation this year are related to the next stage of 'regulatory guillotine'. Last year, there was a planned review of key acts regulating pharmacies, distributors, and pharmaceutical companies.""
}"
2025-09-01T16:27:58+00:00,@medpharm,12642,https://t.me/medpharm/12642,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 1 —Å–µ–Ω—Ç—è–±—Ä—è –°–¥–≤–∏–Ω—É–ª–∏ —Å—Ä–æ–∫–∏ –í—Å—Ç—É–ø–ª–µ–Ω–∏–µ –≤ —Å–∏–ª—É –ø—Ä–∞–≤–∏–ª–∞ ¬´–≤—Ç–æ—Ä–æ–π –ª–∏—à–Ω–∏–π¬ª –¥–ª—è —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤, –ø—Ä–æ–∏–∑–≤–µ–¥–µ–Ω–Ω—ã—Ö –ø–æ –ø–æ–ª–Ω–æ–º—É —Ü–∏–∫–ª—É, –ø–µ—Ä–µ–Ω–µ—Å–ª–∏ —Å 1 —Å–µ–Ω—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞ –Ω–∞ 1 —è–Ω–≤–∞—Ä—è 2026 –≥–æ–¥–∞. –ö–∞–¥—Ä–æ–≤—ã–µ –ø–µ—Ä–µ—Å—Ç–∞–Ω–æ–≤–∫–∏ –í AlphaRM –Ω–∞–∑–Ω–∞—á–∏–ª–∏ –Ω–æ–≤–æ–≥–æ –≥–µ–Ω–µ—Ä–∞–ª—å–Ω–æ–≥–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞, –∏–º —Å—Ç–∞–ª –ù–∏–∫–æ–ª–∞–π –î–µ–º–∏–¥–æ–≤. –û–Ω —Å–º–µ–Ω–∏–ª –Ω–∞ —ç—Ç–æ–º –ø–æ—Å—Ç—É –ê–Ω–Ω—É –ï—Ä–º–æ–ª–∞–µ–≤—É. –û—Å–æ–±—ã–π —Ä–µ–∂–∏–º –ø—Ä–æ—Ñ–ø–µ—Ä–µ–ø–æ–¥–≥–æ—Ç–æ–≤–∫–∏ –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –ø—Ä–æ–¥–ª–∏–ª–æ —É–ø—Ä–æ—â–µ–Ω–Ω—ã–π –ø–æ—Ä—è–¥–æ–∫ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–π –ø–µ—Ä–µ–ø–æ–¥–≥–æ—Ç–æ–≤–∫–∏ –≤—Ä–∞—á–µ–π –ø–æ –∞–Ω–µ—Å—Ç–µ–∑–∏–æ–ª–æ–≥–∏–∏-—Ä–µ–∞–Ω–∏–º–∞—Ç–æ–ª–æ–≥–∏–∏, —Ç—Ä–∞–≤–º–∞—Ç–æ–ª–æ–≥–∏–∏-–æ—Ä—Ç–æ–ø–µ–¥–∏–∏ –∏ —Ö–∏—Ä—É—Ä–≥–∏–∏ –¥–æ 31 –¥–µ–∫–∞–±—Ä—è 2026 –≥–æ–¥–∞. –°–µ–π—á–∞—Å —Ç–∞–∫–∏–µ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –º–æ–≥—É—Ç –±—ã—Ç—å –ø–µ—Ä–µ–æ–±—É—á–µ–Ω—ã –∑–∞ —Å—Ä–æ–∫ –æ—Ç 3,5 –¥–æ 9 –º–µ—Å—è—Ü–µ–≤. –ë—É–¥—É—â–∏–µ –≤—Ä–∞—á–∏ –í –ú–∏–Ω–∑–¥—Ä–∞–≤–µ –ø—Ä–∏–≤–µ–ª–∏ –¥–∞–Ω–Ω—ã–µ –æ –ø–æ—Å—Ç—É–ø–∏–≤—à–∏—Ö –≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –≤—É–∑—ã. –í—Å–µ–≥–æ –≤ 2025 –≥–æ–¥—É –∑–∞—á–∏—Å–ª–µ–Ω–æ –±–æ–ª–µ–µ 45 —Ç—ã—Å. —Å—Ç—É–¥–µ–Ω—Ç–æ–≤ –ø—Ä–æ–≥—Ä–∞–º–º –±–∞–∫–∞–ª–∞–≤—Ä–∏–∞—Ç–∞ –∏ 30 —Ç—ã—Å. –æ—Ä–¥–∏–Ω–∞—Ç–æ—Ä–æ–≤. #—Ñ–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–º–µ–¥–≤–µ—Å—Ç–Ω–∏–∫ #–Ω–æ–≤–æ—Å—Ç–∏_–¥–Ω—è","{""skip"": true}"
2025-08-31T11:16:26+00:00,@medpharm,12640,https://t.me/medpharm/12640,"–ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ –∑–∞ –Ω–µ–¥–µ–ª—é üîµ–≠–∫—Å–ø–µ—Ä—Ç—ã –æ–ø—Ä–æ–≤–µ—Ä–≥–ª–∏ —Å–æ–æ–±—â–µ–Ω–∏—è –°–ú–ò –æ –≤–≤–µ–¥–µ–Ω–∏–∏ –Ω–æ–≤—ã—Ö —à—Ç—Ä–∞—Ñ–æ–≤ –¥–ª—è –∞–ø—Ç–µ–∫ –∑–∞ –Ω–µ–∏–Ω—Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏–µ –æ –¥–µ—à–µ–≤—ã—Ö –∞–Ω–∞–ª–æ–≥–∞—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤. –¢–∞–∫–∞—è –Ω–æ—Ä–º–∞ —Å–æ–¥–µ—Ä–∂–∞–ª–∞—Å—å –∏ –≤ –ø—Ä–µ–∂–Ω–µ–º –ø—Ä–∏–∫–∞–∑–µ –æ –ø—Ä–∞–≤–∏–ª–∞—Ö –ù–ê–ü. –ü—Ä–æ–≤–µ—Ä–∫–∞ –≥—Ä–æ–∑–∏—Ç –∞–ø—Ç–µ–∫–µ —Ç–æ–ª—å–∫–æ –≤ —Ö–æ–¥–µ –∫–æ–Ω—Ç—Ä–æ–ª—å–Ω–æ–π –∑–∞–∫—É–ø–∫–∏ –ø–æ—Å–ª–µ –∂–∞–ª–æ–±—ã –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª—è. üîµ–ì–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–º ¬´–•–µ–º–æ—Ñ–∞—Ä–º¬ª (–≤—Ö–æ–¥–∏—Ç –≤ –ì–ö¬´–ù–∏–∂—Ñ–∞—Ä–º¬ª) –Ω–∞–∑–Ω–∞—á–µ–Ω –ê–Ω—Ç–æ–Ω –ú—É—Ä–∞—á–µ–≤. –ï–≥–æ –∫–ª—é—á–µ–≤—ã–º–∏ –∑–∞–¥–∞—á–∞–º–∏ –≤ –Ω–æ–≤–æ–π –¥–æ–ª–∂–Ω–æ—Å—Ç–∏ —Å—Ç–∞–Ω—É—Ç —Ä–∞–∑–≤–∏—Ç–∏–µ –∫–∞–¥—Ä–æ–≤–æ–≥–æ –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª–∞ –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏—è –∏ –º–æ–¥–µ—Ä–Ω–∏–∑–∞—Ü–∏—è –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞. üîµ¬´–§–í¬ª –ø–æ–¥–≥–æ—Ç–æ–≤–∏–ª —Å—Ä–∞–≤–Ω–∏—Ç–µ–ª—å–Ω—É—é —Ç–∞–±–ª–∏—Ü—É —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ —Å–Ω–∏–∂–µ–Ω–∏–∏ –≤–µ—Å–∞ –æ—Ç —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ –¥–æ –Ω–æ–≤—ã—Ö –ø–µ—Ä–æ—Ä–∞–ª—å–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –°—Ä–µ–¥–∏ –Ω–∏—Ö orforglipron –æ—Ç Eli Lilly –∏ ecnoglutide –∫–∏—Ç–∞–π—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ Sciwind Biosciences. üîµ–§–ê–° –≤—ã—è–≤–∏–ª–∞ –ø—Ä–∏–∑–Ω–∞–∫–∏ —Å–≥–æ–≤–æ—Ä–∞ –ø—Ä–∏ –≥–æ—Å–∑–∞–∫—É–ø–∫–µ –æ—Ä—Ñ–∞–Ω–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ¬´–≠–ª–∞–ø—Ä–∞–∑–∞¬ª –Ω–∞ 5,9 –º–ª—Ä–¥ —Ä—É–±. –ê–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å–Ω—ã–π –æ—Ä–≥–∞–Ω –ø–æ–¥–æ–∑—Ä–µ–≤–∞–µ—Ç –∑–∞–∫–ª—é—á–µ–Ω–∏–µ –∑–∞–ø—Ä–µ—â–µ–Ω–Ω–æ–≥–æ —Å–æ–≥–ª–∞—à–µ–Ω–∏—è –º–µ–∂–¥—É –∫–æ–º–ø–∞–Ω–∏—è–º–∏ ¬´–¢–∞–∫–µ–¥–∞ –§–∞—Ä–º–∞—Å—å—é—Ç–∏–∫–∞–ª—Å¬ª –∏ ¬´–§–∞—Ä–º–∏–º—ç–∫—Å¬ª. üîµ–°—Ç—É–¥–µ–Ω—Ç—ã-–±—é–¥–∂–µ—Ç–Ω–∏–∫–∏, –æ–±—É—á–∞—é—â–∏–µ—Å—è –ø–æ –ø—Ä–æ–≥—Ä–∞–º–º–∞–º —Ñ–∞—Ä–º–æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è, –±—É–¥—É—Ç –∑–∞–∫–ª—é—á–∞—Ç—å –¥–æ–≥–æ–≤–æ—Ä –æ —Ü–µ–ª–µ–≤–æ–º –æ–±—É—á–µ–Ω–∏–∏ ‚Äî —Å —Ç–∞–∫–æ–π –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–æ–π –≤—ã—Å—Ç—É–ø–∏–ª –ú–∏–Ω–∑–¥—Ä–∞–≤. –ü—Ä–æ–¥–æ–ª–∂–∏—Ç—å –æ–±—É—á–µ–Ω–∏–µ –≤ –æ—Ä–¥–∏–Ω–∞—Ç—É—Ä–µ –æ–Ω–∏ —Å–º–æ–≥—É—Ç –ø—Ä–∏ –∑–∞–∫–ª—é—á–µ–Ω–∏–∏ –Ω–æ–≤–æ–≥–æ —Ü–µ–ª–µ–≤–æ–≥–æ –¥–æ–≥–æ–≤–æ—Ä–∞ —Å —Ç–µ–º –∂–µ –∑–∞–∫–∞–∑—á–∏–∫–æ–º.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The FAS identified signs of collusion during the government procurement of orphan drug 'Elaprazha' worth 5.9 billion rubles. Antimonopoly authorities suspect a prohibited agreement between companies 'Takeda Pharma' and 'Farimex'. Students studying pharmacy programs are to sign a contract for targeted education - this initiative was proposed by the Ministry of Health. They will be able to continue their training in residency programs if they sign a new targeted contract with the same employer.""
}"
2025-08-30T09:02:01+00:00,@medpharm,12639,https://t.me/medpharm/12639,"–ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∑–∞ –Ω–µ–¥–µ–ª—é üî¥–†–æ—Å—Å–∏–π—Å–∫–∏–µ –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–∏, –Ω–∞—á–∏–Ω–∞—é—â–∏–µ –∫–∞—Ä—å–µ—Ä—É –≤ 2030-—Ö, —Å–º–æ–≥—É—Ç —Ä–∞–±–æ—Ç–∞—Ç—å –≤—Ä–∞—á–∞–º–∏ –¥–æ 80 –ª–µ—Ç ‚Äì –Ω–∞ 20 –ª–µ—Ç –¥–æ–ª—å—à–µ, —á–µ–º –∏—Ö –∫–æ–ª–ª–µ–≥–∏ –≤ –ø—Ä–æ—à–ª–æ–º —Å—Ç–æ–ª–µ—Ç–∏–∏, —Å—á–∏—Ç–∞–µ—Ç –º–∏–Ω–∏—Å—Ç—Ä –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ú–∏—Ö–∞–∏–ª –ú—É—Ä–∞—à–∫–æ. üî¥–ù–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ –≤ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω–æ–º TOP5 –¥–∞–Ω–Ω—ã–µ –†–æ—Å—Å—Ç–∞—Ç–∞ –æ —Å—Ä–µ–¥–Ω–µ–π –∑–∞—Ä–ø–ª–∞—Ç–µ –≤ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–∏ –≤ —Ç–µ–∫—É—â–µ–º –≥–æ–¥—É. –°–æ–≥–ª–∞—Å–Ω–æ –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω–æ–π —Å—Ç–∞—Ç–∏—Å—Ç–∏–∫–µ, –ø–æ–∫–∞–∑–∞—Ç–µ–ª—å, –ø–æ –¥–∞–Ω–Ω—ã–º –∑–∞ –∏—é–Ω—å 2025 –≥–æ–¥–∞, –ø—Ä–µ–≤—ã—Å–∏–ª 87 012 —Ä—É–±., —á—Ç–æ –Ω–∞ 15,5% –≤—ã—à–µ, —á–µ–º –≥–æ–¥–æ–º —Ä–∞–Ω–µ–µ. üî¥–¢—Ä–µ—Ç—å—é —Å—Ç—Ä–æ—á–∫—É –Ω–æ–≤–æ—Å—Ç–Ω–æ–≥–æ —Ä–µ–π—Ç–∏–Ω–≥–∞ –Ω–µ–¥–µ–ª–∏ –∑–∞–Ω—è–ª–æ —Å–æ–æ–±—â–µ–Ω–∏–µ –æ–± –æ—á–µ—Ä–µ–¥–Ω–æ–º –∫–æ—Ä—Ä—É–ø—Ü–∏–æ–Ω–Ω–æ–º —Å–∫–∞–Ω–¥–∞–ª–µ ‚Äì –∑–∞–¥–µ—Ä–∂–∞–Ω—ã –≥–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä –ù–ú–ò–¶ –∏–º. –∞–∫–∞–¥. –ï. –ù. –ú–µ—à–∞–ª–∫–∏–Ω–∞ –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ß–µ—Ä–Ω—è–≤—Å–∫–∏–π –∏ –µ–≥–æ –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å –ø–æ —ç–∫–æ–Ω–æ–º–∏–∫–µ –ê—Ä—Ç–µ–º –ü—É—Ö–∞–ª—å—Å–∫–∏–π. –û–±–∞ –ø—Ä–æ—Ö–æ–¥—è—Ç –ø–æ –¥–µ–ª—É –æ –ø–æ–ª—É—á–µ–Ω–∏–∏ –≤–∑—è—Ç–æ–∫ –≤ –æ—Å–æ–±–æ –∫—Ä—É–ø–Ω–æ–º —Ä–∞–∑–º–µ—Ä–µ (—á.6 —Å—Ç.290 –£–ö –†–§). üî¥–ù–∞ —á–µ—Ç–≤–µ—Ä—Ç–æ–º –º–µ—Å—Ç–µ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è –æ–± –æ–¥–æ–±—Ä–µ–Ω–∏–∏ –ö–æ–º–∏—Å—Å–∏–µ–π –ø–æ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç–Ω–æ–π –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç–∞ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –æ –ø–µ—Ä–µ–≤–æ–¥–µ –≤—Å–µ—Ö –±—é–¥–∂–µ—Ç–Ω—ã—Ö –º–µ—Å—Ç –≤ –º–µ–¥–≤—É–∑–∞—Ö –∏ –∫–æ–ª–ª–µ–¥–∂–∞—Ö –Ω–∞ —Ü–µ–ª–µ–≤–æ–µ –æ–±—É—á–µ–Ω–∏–µ —Å –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–π –æ—Ç—Ä–∞–±–æ—Ç–∫–æ–π. üî¥–ó–∞–º—ã–∫–∞—é—Ç –ø—è—Ç–µ—Ä–∫—É –Ω–æ–≤–æ—Å—Ç–µ–π –Ω–µ–¥–µ–ª–∏ –º–Ω–µ–Ω–∏—è —ç–∫—Å–ø–µ—Ä—Ç–æ–≤ –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤—ã –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ø–æ —É–∂–µ—Å—Ç–æ—á–µ–Ω–∏—é –æ—Ç–±–æ—Ä–∞ —á–∞—Å—Ç–Ω—ã—Ö –∫–ª–∏–Ω–∏–∫ –Ω–∞ –≤–∫–ª—é—á–µ–Ω–∏–µ –≤ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω—ã–µ –ø—Ä–æ–≥—Ä–∞–º–º—ã –û–ú–° –∏ –∏–Ω—Ç–µ—Ä–≤—å—é —Å –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç–æ–º –ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–π –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ –Ω–µ–≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π (–ù–ê–ù–ú–û) –ò–ª—å–µ–π –®–∏–ª—å–∫—Ä–æ—Ç–æ–º –Ω–∞ —ç—Ç—É –∏ –¥—Ä—É–≥–∏–µ —Ç–µ–º—ã.","{
  ""skip"": true
}"
2025-08-29T15:51:47+00:00,@medpharm,12638,https://t.me/medpharm/12638,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 29 –∞–≤–≥—É—Å—Ç–∞ –†–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –¥–ª—è –±–µ—Ä–µ–º–µ–Ω–Ω—ã—Ö –≠–∫—Å–ø–µ—Ä—Ç—ã –ï–≤—Ä–æ–ø–µ–π—Å–∫–æ–≥–æ –æ–±—â–µ—Å—Ç–≤–∞ –∫–∞—Ä–¥–∏–æ–ª–æ–≥–æ–≤ (ESC) –æ–±–Ω–æ–≤–∏–ª–∏ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ 2018 –≥–æ–¥–∞ –ø–æ –≤–µ–¥–µ–Ω–∏—é –±–µ—Ä–µ–º–µ–Ω–Ω—ã—Ö –∂–µ–Ω—â–∏–Ω —Å —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã–º–∏ –ø–∞—Ç–æ–ª–æ–≥–∏—è–º–∏. –°–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã–µ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è –Ω–∞–∑–≤–∞–Ω—ã –æ—Å–Ω–æ–≤–Ω–æ–π –Ω–µ–∞–∫—É—à–µ—Ä—Å–∫–æ–π –ø—Ä–∏—á–∏–Ω–æ–π –æ—Å–ª–æ–∂–Ω–µ–Ω–∏–π –∏ —Å–º–µ—Ä—Ç–Ω–æ—Å—Ç–∏ –≤–æ –≤—Ä–µ–º—è –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏. –í–∏–Ω–æ–≤–∞—Ç—ã –∞–Ω—Ç–∏–≤–∞–∫—Å–µ—Ä—ã –ò–∑-–∑–∞ –ø–æ–ø—É–ª—è—Ä–Ω–æ—Å—Ç–∏ –∞–Ω—Ç–∏–≤–∞–∫—Ü–∏–Ω–∞–ª—å–Ω—ã—Ö –Ω–∞—Å—Ç—Ä–æ–µ–Ω–∏–π –Ω–µ –Ω–∞–±–ª—é–¥–∞–µ—Ç—Å—è –±–æ–ª—å—à–æ–≥–æ –ø—Ä–æ–≥—Ä–µ—Å—Å–∞ –≤ —Å–Ω–∏–∂–µ–Ω–∏–∏ —á–∞—Å—Ç–æ—Ç—ã –≤–∞–∫—Ü–∏–Ω–æ—É–ø—Ä–∞–≤–ª—è–µ–º—ã—Ö –∏–Ω—Ñ–µ–∫—Ü–∏–π, –∑–∞—è–≤–∏–ª–∞ –≥–ª–∞–≤–Ω—ã–π –≤–Ω–µ—à—Ç–∞—Ç–Ω—ã–π –¥–µ—Ç—Å–∫–∏–π —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ø–æ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–æ–π –º–µ–¥–∏—Ü–∏–Ω–µ. –ü–æ –µ–µ —Å–ª–æ–≤–∞–º, –≤—Ä–∞—á–∞–º-–ø–µ–¥–∏–∞—Ç—Ä–∞–º —Å–ª–µ–¥—É–µ—Ç –∞–∫—Ç–∏–≤–Ω–µ–µ —Ä–∞–±–æ—Ç–∞—Ç—å —Å —Ä–æ–¥–∏—Ç–µ–ª—è–º–∏, –æ–±—ä—è—Å–Ω—è—è –∏–º —Ä–∏—Å–∫–∏ –æ—Ç–∫–∞–∑–æ–≤ –æ—Ç –ø—Ä–∏–≤–∏–≤–æ–∫. –ì–æ–≤–æ—Ä—è—Ç –∏ –ø–æ–∫–∞–∑—ã–≤–∞—é—Ç –†–∞—Å—Ö–æ–¥—ã —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π –Ω–∞ –æ—Ñ–ª–∞–π–Ω-–ø—Ä–æ–¥–≤–∏–∂–µ–Ω–∏–µ –≤—ã—Ä–æ—Å–ª–∏ –Ω–∞ 62% –≤ –ø–µ—Ä–≤–æ–º –ø–æ–ª—É–≥–æ–¥–∏–∏ –≥–æ–¥ –∫ –≥–æ–¥—É –∏ –ø—Ä–µ–≤—ã—Å–∏–ª–∏ 28 –º–ª—Ä–¥ —Ä—É–±. –ü–æ –ø—Ä–æ–≥–Ω–æ–∑—É –∞–Ω–∞–ª–∏—Ç–∏–∫–æ–≤, —Ç—Ä–µ–Ω–¥ —Å–æ—Ö—Ä–∞–Ω–∏—Ç—Å—è –≤ III –∫–≤–∞—Ä—Ç–∞–ª–µ. –§–∞—Ä–º–µ DDoS—Ç–∞–ª–æ—Å—å –ö–æ–ª–∏—á–µ—Å—Ç–≤–æ DDoS-–∞—Ç–∞–∫ –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ –∫–æ–º–ø–∞–Ω–∏–∏ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ –≤ –∞–≤–≥—É—Å—Ç–µ 2025 –≥–æ–¥–∞ –≤—ã—Ä–æ—Å–ª–æ –Ω–∞ 82% –∫ –∞–≤–≥—É—Å—Ç—É –ø—Ä–æ—à–ª–æ–≥–æ –≥–æ–¥–∞. –ò–Ω—Ç–µ—Ä–µ—Å —Ö–∞–∫–µ—Ä–æ–≤ –∫ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ –æ–±—É—Å–ª–æ–≤–ª–µ–Ω –µ–µ —É—è–∑–≤–∏–º–æ—Å—Ç—å—é –∏ –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ–π –∑–∞—â–∏—â–µ–Ω–Ω–æ—Å—Ç—å—é. –í—Å–µ —á–∞¬≠—â–µ –æ–Ω–∏ –∏—Å¬≠–ø–æ–ª—å¬≠–∑—É—é—Ç —Ç–∞–∫¬≠—Ç–∏¬≠–∫—É ¬´–∫–æ–≤—Ä–æ–≤—ã—Ö –±–æ–º–±–∞—Ä–¥–∏—Ä–æ–≤–æ–∫¬ª –∏ –±–æ—Ç–Ω–µ—Ç—ã.","{""skip"": true}"
2025-08-29T14:49:31+00:00,@medpharm,12637,https://t.me/medpharm/12637,"–†–∞—Å—Ö–æ–¥—ã —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π –Ω–∞ –æ—Ñ–ª–∞–π–Ω-–ø—Ä–æ–¥–≤–∏–∂–µ–Ω–∏–µ –≤—ã—Ä–æ—Å–ª–∏ –Ω–∞ 62% –≤ –ø–µ—Ä–≤–æ–º –ø–æ–ª—É–≥–æ–¥–∏–∏ –≥–æ–¥ –∫ –≥–æ–¥—É –∏ –ø—Ä–µ–≤—ã—Å–∏–ª–∏ 28 –º–ª—Ä–¥ —Ä—É–±. –ü–æ –ø—Ä–æ–≥–Ω–æ–∑—É –∞–Ω–∞–ª–∏—Ç–∏–∫–æ–≤, —Ç—Ä–µ–Ω–¥ —Å–æ—Ö—Ä–∞–Ω–∏—Ç—Å—è –≤ III –∫–≤–∞—Ä—Ç–∞–ª–µ.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""Expenses for pharmaceutical companies on offline promotion increased by 62% year-over-year in the first half of the year and exceeded RUB 28 billion. Analysts predict that this trend will continue in Q3.""
}"
2025-08-29T13:46:39+00:00,@medpharm,12636,https://t.me/medpharm/12636,"–°–æ–≤—Ä–µ–º–µ–Ω–Ω–∞—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è –∫–∞—Ä—å–µ—Ä–∞ —Å—Ç–∞–Ω–æ–≤–∏—Ç—Å—è –≤—Å–µ –±–æ–ª–µ–µ –¥–æ–ª–≥–æ—Å—Ä–æ—á–Ω–æ–π. –†–æ—Å—Å–∏–π—Å–∫–∏–µ –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–∏, –Ω–∞—á–∏–Ω–∞—é—â–∏–µ –∫–∞—Ä—å–µ—Ä—É –≤ 2030-—Ö, —Å–º–æ–≥—É—Ç —Ä–∞–±–æ—Ç–∞—Ç—å –≤—Ä–∞—á–∞–º–∏ –¥–æ 80 –ª–µ—Ç ‚Äî –Ω–∞ 20 –ª–µ—Ç –¥–æ–ª—å—à–µ, —á–µ–º –∏—Ö –∫–æ–ª–ª–µ–≥–∏ –ø—Ä–æ—à–ª–æ–≥–æ —Å—Ç–æ–ª–µ—Ç–∏—è, –≥–æ–≤–æ—Ä–∏—Ç—Å—è –≤ –ø—Ä–µ–∑–µ–Ω—Ç–∞—Ü–∏–∏ –º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ú–∏—Ö–∞–∏–ª–∞ –ú—É—Ä–∞—à–∫–æ, –ø–æ–¥–≥–æ—Ç–æ–≤–ª–µ–Ω–Ω–æ–π –∫–æ –í—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–æ–º—É —Ñ–æ—Ä—É–º—É –≤–æ–ª–æ–Ω—Ç–µ—Ä–æ–≤-–º–µ–¥–∏–∫–æ–≤.","{
  ""skip"": true
}"
2025-08-29T13:04:01+00:00,@medpharm,12635,https://t.me/medpharm/12635,–í–ª–∞–¥–µ–ª–∏—Ü—É –º–æ—Å–∫–æ–≤—Å–∫–∏—Ö –∞–ø—Ç–µ–∫ –ø—Ä–∏–≥–æ–≤–æ—Ä–∏–ª–∏ –∫ –ø—è—Ç–∏ –≥–æ–¥–∞–º –∑–∞–∫–ª—é—á–µ–Ω–∏—è –∑–∞ –∫–æ–Ω—Ç—Ä–∞—Ñ–∞–∫—Ç–Ω—ã–π ¬´–û–∑–µ–º–ø–∏–∫¬ª. –û—Å—Ç–∞–ª—å–Ω—ã–µ —Å–æ—É—á–∞—Å—Ç–Ω–∏–∫–∏ –ø–æ –¥–µ–ª—É –æ —Å–±—ã—Ç–µ –Ω–µ–∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø–æ–ª—É—á–∏–ª–∏ —Å—Ä–æ–∫–∏ –æ—Ç –¥–≤—É—Ö –¥–æ –ø—è—Ç–∏ –ª–µ—Ç.,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""A Moscow pharmacy owner was sentenced to five years in prison for trafficking counterfeit 'Ozemik'. Other co-defendants, including those convicted of selling unregistered medicines, received sentences ranging from two to five years.""
}"
2025-08-29T12:03:18+00:00,@medpharm,12634,https://t.me/medpharm/12634,"–ü—Ä–æ–¥–∞–≤–∞—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –≤ –Ω–∞—Å–µ–ª–µ–Ω–Ω—ã—Ö –ø—É–Ω–∫—Ç–∞—Ö, –≥–¥–µ –Ω–µ—Ç –∞–ø—Ç–µ–∫, –≤ –º–∞–≥–∞–∑–∏–Ω–∞—Ö –∫—Ä—É–ø–Ω—ã—Ö —Ç–æ—Ä–≥–æ–≤—ã—Ö —Å–µ—Ç–µ–π –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –≤ –õ–î–ü–†. –í—Å–∫–æ—Ä–µ –≤–µ–¥—É—â–∏–º —Ä–∏—Ç–µ–π–ª–µ—Ä–∞–º –Ω–∞–ø—Ä–∞–≤—è—Ç —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–µ–µ –æ–±—Ä–∞—â–µ–Ω–∏–µ.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""A proposal to sell medicines in areas without pharmacies, and in large retail stores, has been suggested in the Legislative Assembly of the Russian Far East. Relevant tender is expected to be sent to leading retailers soon.""
}"
2025-08-29T08:06:31+00:00,@medpharm,12633,https://t.me/medpharm/12633,"–°—É–¥ –Ω–µ —É–¥–æ–≤–ª–µ—Ç–≤–æ—Ä–∏–ª –∏—Å–∫ Roche –∫ –ú–∏–Ω–∑–¥—Ä–∞–≤—É –∏–∑-–∑–∞ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –¥–∂–µ–Ω–µ—Ä–∏–∫–∞ ¬´–≠–≤—Ä–∏—Å–¥–∏¬ª –æ—Ç –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–î–∂–æ–¥–∞—Å –≠–∫—Å–ø–æ–∏–º¬ª. –ú–∏–Ω–∏—Å—Ç–µ—Ä—Å—Ç–≤–æ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è ¬´–Ω–µ –æ—Ç–Ω–æ—Å–∏—Ç—Å—è –∫ –æ—Ä–≥–∞–Ω–∞–º, —É–ø–æ–ª–Ω–æ–º–æ—á–µ–Ω–Ω—ã–º –Ω–∞ –∑–∞—â–∏—Ç—É –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç—É–∞–ª—å–Ω—ã—Ö –ø—Ä–∞–≤¬ª, –∞ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ —Å—Ä–µ–¥—Å—Ç–≤–∞ –Ω–æ—Å–∏—Ç –∑–∞—è–≤–∏—Ç–µ–ª—å–Ω—ã–π –ø–æ—Ä—è–¥–æ–∫, —Ä–µ—à–∏–ª —Å—É–¥.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""high"",
  ""english"": ""The court ruled that the Ministry of Health does not consider itself an authority responsible for protecting intellectual property rights. The registration of the generic 'Eversida' by company 'Jodas Expoim' is a declarative process.""
}"
2025-08-28T16:44:07+00:00,@medpharm,12632,https://t.me/medpharm/12632,–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 28 –∞–≤–≥—É—Å—Ç–∞ –ü–æ–¥–¥–µ—Ä–∂–∫–∞ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–∞ –°—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–æ —Ü–µ–Ω—Ç—Ä–∞ –∏–æ–Ω–Ω–æ-–ª—É—á–µ–≤–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –≤ –ü—Ä–æ—Ç–≤–∏–Ω–æ –≤–∫–ª—é—á–µ–Ω–æ –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ø—Ä–∏–æ—Ä–∏—Ç–µ—Ç–Ω—ã—Ö –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä–Ω—ã—Ö –ø—Ä–æ–µ–∫—Ç–æ–≤ —Å –≥–æ—Å–ø–æ–¥–¥–µ—Ä–∂–∫–æ–π –ø–æ —Ä–∞—Å–ø–æ—Ä—è–∂–µ–Ω–∏—é –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞. –ö–æ–º–ø–ª–µ–∫—Å –ø–æ–∑–≤–æ–ª–∏—Ç –ª–µ—á–∏—Ç—å –æ–ø—É—Ö–æ–ª–∏ —É–≥–ª–µ—Ä–æ–¥–Ω—ã–º–∏ –∏–æ–Ω–∞–º–∏. –ë–æ–ª—å—à–µ —Ü–∏—Ñ—Ä–æ–≤–∏–∑–∞—Ü–∏–∏ –ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–∞—è –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ —É–ø—Ä–∞–≤–ª–µ–Ω—Ü–µ–≤ –≤ —Å—Ñ–µ—Ä–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è (–ù–ê–£–ó) –æ–±—Ä–∞—Ç–∏–ª–∞—Å—å –≤ –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –ú–æ—Å–∫–≤—ã —Å –ø—Ä–æ—Å—å–±–æ–π —Ä–∞–∑—Ä–µ—à–∏—Ç—å –ø–æ–¥–∫–ª—é—á–µ–Ω–∏–µ –Ω–µ–≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —É—á—Ä–µ–∂–¥–µ–Ω–∏–π –∫ —Å–∏—Å—Ç–µ–º–µ –ï–ú–ò–ê–°. –≠—Ç–æ –ø–æ–∑–≤–æ–ª–∏—Ç –ø–æ–≤—ã—Å–∏—Ç—å –∫–∞—á–µ—Å—Ç–≤–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –∏ —É—Ä–æ–≤–µ–Ω—å —Å–µ—Ä–≤–∏—Å–∞ –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –ü–æ–¥–¥–µ—Ä–∂–∞—Ç —Ç—Ä–µ—Ç—å—é —Ñ–∞–∑—É –†–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–∏ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ø–æ–ª—É—á–∞—Ç —Ñ–∏–Ω–∞–Ω—Å–æ–≤—É—é –ø–æ–¥–¥–µ—Ä–∂–∫—É –æ—Ç –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–∞. –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ —Å 2027 –≥–æ–¥–∞ –≤—ã–¥–µ–ª–∏—Ç 1 –º–ª—Ä–¥ —Ä—É–±. –Ω–∞ —Å—É–±—Å–∏–¥–∏—Ä–æ–≤–∞–Ω–∏–µ –∑–∞—Ç—Ä–∞—Ç –Ω–∞ —Ç—Ä–µ—Ç—å—é —Ñ–∞–∑—É –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å–ø—ã—Ç–∞–Ω–∏–π. –ü–µ—Ä–≤—ã–π –æ—Ç–±–æ—Ä –ø—Ä–æ–µ–∫—Ç–æ–≤ –∑–∞–ø–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω –Ω–∞ 2026 –≥–æ–¥. –°—Ç–∞–ª–∞ —Ä–µ–¥–∫–∏–º –ú–∏–Ω–∑–¥—Ä–∞–≤ –≤–∫–ª—é—á–∏–ª –≤ –ø–µ—Ä–µ—á–µ–Ω—å –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π —É–≤–µ–∞–ª—å–Ω—É—é –º–µ–ª–∞–Ω–æ–º—É ‚Äî –∑–ª–æ–∫–∞—á–µ—Å—Ç–≤–µ–Ω–Ω—É—é –≤–Ω—É—Ç—Ä–∏–≥–ª–∞–∑–Ω—É—é –æ–ø—É—Ö–æ–ª—å. –¢–µ–ø–µ—Ä—å —Å–ø–∏—Å–æ–∫ —Å–æ–¥–µ—Ä–∂–∏—Ç 297 –ø–æ–∑–∏—Ü–∏–π.,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety"",
  ""impact"": ""medium"",
  ""english"": ""The country is global. The topic involves clinical trials and safety. There is medium impact, as the inclusion of uveal melanoma in the list of orphan diseases highlights the need for further research and treatment options.""
}"
2025-08-28T14:02:37+00:00,@medpharm,12631,https://t.me/medpharm/12631,–ò–∑ –ì–†–õ–° –∏—Å–∫–ª—é—á–∏–ª–∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–æ–Ω–Ω—ã–µ —É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏—è –≤–æ—Å—å–º–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ —Ç—Ä–µ—Ö —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏–π. –°—Ä–µ–¥–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ ‚Äî –ø—Ä–æ—Ç–∏–≤–æ–≤–∏—Ä—É—Å–Ω–æ–µ —Å—Ä–µ–¥—Å—Ç–≤–æ –ø—Ä—è–º–æ–≥–æ –¥–µ–π—Å—Ç–≤–∏—è ¬´–≠–º—Ü–∏–¥–æ¬ª (—Ü–∏–¥–æ—Ñ–æ–≤–∏—Ä) –æ—Ç –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–§–∞—Ä–º–∞–º–æ–Ω–¥–æ¬ª. –ê–Ω–∞–ª–æ–≥–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –Ω–∞ —Ä—ã–Ω–∫–µ –æ—Ç—Å—É—Ç—Å—Ç–≤—É—é—Ç.,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""registration, shortage"",
  ""impact"": ""high"",
  ""english"": ""Eight medicinal products and three pharmaceutical substances have been excluded from registration approvals by the regulatory body. Among them is direct-acting antiviral drug 'Emcido' (Cidofovir) from the company 'FarmaMondo'. Analogues of this drug are not available on the market.""
}"
2025-08-28T12:20:58+00:00,@medpharm,12630,https://t.me/medpharm/12630,#—ç–∫—Å–∫–ª—é–∑–∏–≤ –ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–∞—è –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ —É–ø—Ä–∞–≤–ª–µ–Ω—Ü–µ–≤ –≤ —Å—Ñ–µ—Ä–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è (–ù–ê–£–ó) –æ–±—Ä–∞—Ç–∏–ª–∞—Å—å –≤ –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –ú–æ—Å–∫–≤—ã —Å –ø—Ä–æ—Å—å–±–æ–π —Ä–∞–∑—Ä–µ—à–∏—Ç—å –ø–æ–¥–∫–ª—é—á–µ–Ω–∏–µ –Ω–µ–≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —É—á—Ä–µ–∂–¥–µ–Ω–∏–π –∫ —Å–∏—Å—Ç–µ–º–µ –ï–ú–ò–ê–°. –≠—Ç–æ –ø–æ–∑–≤–æ–ª–∏—Ç –ø–æ–≤—ã—Å–∏—Ç—å –∫–∞—á–µ—Å—Ç–≤–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –∏ —É—Ä–æ–≤–µ–Ω—å —Å–µ—Ä–≤–∏—Å–∞ –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤.,"{
  ""skip"": true
}"
2025-08-28T10:19:26+00:00,@medpharm,12629,https://t.me/medpharm/12629,"–í –∫–æ–Ω—Ü–µ –∏—é–ª—è –ú–∏–Ω–∑–¥—Ä–∞–≤ –æ—Ç—Å—Ä–æ—á–∏–ª –≤—Å—Ç—É–ø–ª–µ–Ω–∏–µ –≤ —Å–∏–ª—É —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π –∫ –∫–æ–µ—á–Ω–æ–º—É —Ñ–æ–Ω–¥—É –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö —Ü–µ–Ω—Ç—Ä–æ–≤, –æ–∫–∞–∑—ã–≤–∞—é—â–∏—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫—É—é –ø–æ–º–æ—â—å –ø–æ —Ç–∞–∫–∏–º –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è–º, –∫–∞–∫ —Ä–∞–¥–∏–æ–ª–æ–≥–∏—è, –æ–Ω–∫–æ–ª–æ–≥–∏—è –∏ —Ä–∞–¥–∏–æ—Ç–µ—Ä–∞–ø–∏—è, —Ö–∏–º–∏–æ—Ç–µ—Ä–∞–ø–∏—è. –û —Ç–æ–º, –∫–∞–∫ –±—ã–ª–æ –¥–æ—Å—Ç–∏–≥–Ω—É—Ç–∞ —Ç–∞–∫–∞—è –¥–æ–≥–æ–≤–æ—Ä–µ–Ω–Ω–æ—Å—Ç—å, –æ —Ç–∞—Ä–∏—Ñ–∞—Ö –û–ú–°, –∑–∞—Ä–ø–ª–∞—Ç–∞—Ö –∏ –¥–µ—Ñ–∏—Ü–∏—Ç–µ –∫–∞–¥—Ä–æ–≤ –≤ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–∏ –∏ –æ —Ç–æ–º, —Å –∫–µ–º —Å–µ–≥–æ–¥–Ω—è –∫–æ–Ω–∫—É—Ä–∏—Ä—É—é—Ç —á–∞—Å—Ç–Ω—ã–µ –∫–ª–∏–Ω–∏–∫–∏, ¬´–ú–í¬ª —Ä–∞—Å—Å–∫–∞–∑–∞–ª –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç –ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–π –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ –Ω–µ–≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π (–ù–ê–ù–ú–û), —ç–∫—Å-–ø–æ–º–æ—â–Ω–∏–∫ –º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ò–ª—å—è –®–∏–ª—å–∫—Ä–æ—Ç.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health has postponed the implementation of requirements for oncology center beds providing medical care in fields such as radiology, oncology and radiotherapy, chemotherapy. The details of this agreement, tariffs for OMS (Out-of-Medical-Support), salaries and the staffing shortage in Russian healthcare, as well as who private clinics compete with today, were told by President of the National Association of Non-Governmental Medical Organizations (NANMO), former assistant to the Minister of Health, Ilya Shilkrout.""
}"
2025-08-28T07:45:06+00:00,@medpharm,12628,https://t.me/medpharm/12628,–§–∞–∫—Ç–∏—á–µ—Å–∫–∞—è —Å—Ç–æ–∏–º–æ—Å—Ç—å —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –æ–¥–Ω–æ–≥–æ –∫–≤–∞–¥—Ä–∞—Ç–Ω–æ–≥–æ –º–µ—Ç—Ä–∞ –ø—Ä–∏ –≤–æ–∑–≤–µ–¥–µ–Ω–∏–∏ –Ω–æ–≤—ã—Ö –±–æ–ª—å–Ω–∏—Ü –≤—ã—Ä–æ—Å–ª–∞ –≤ —Ç—Ä–∏ —Ä–∞–∑–∞ –≤ –ø–æ—Å–ª–µ–¥–Ω—é—é –ø—è—Ç–∏–ª–µ—Ç–∫—É. –ú–∏–Ω—Å—Ç—Ä–æ—é –ø–æ—Ä—É—á–∏–ª–∏ –¥–æ –∫–æ–Ω—Ü–∞ —Å–ª–µ–¥—É—é—â–µ–≥–æ –≥–æ–¥–∞ –æ–±–µ—Å–ø–µ—á–∏—Ç—å –ø–æ–¥–≥–æ—Ç–æ–≤–∫—É —Ç–∏–ø–æ–≤–æ–π –ø—Ä–æ–µ–∫—Ç–Ω–æ–π –¥–æ–∫—É–º–µ–Ω—Ç–∞—Ü–∏–∏ –¥–ª—è –æ–±—ä–µ–∫—Ç–æ–≤ —Å–æ—Ü–∏–∞–ª—å–Ω–æ–π —Å—Ñ–µ—Ä—ã ¬´—Å —É—á–µ—Ç–æ–º –∞–∫—Ç—É–∞–ª—å–Ω—ã—Ö —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–∏—Ö —Ä–µ—à–µ–Ω–∏–π¬ª –∏ —Å–Ω–∏–∂–µ–Ω–∏—è –∑–∞—Ç—Ä–∞—Ç.,"{""skip"": true}"
2025-08-27T16:17:24+00:00,@medpharm,12627,https://t.me/medpharm/12627,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 27 –∞–≤–≥—É—Å—Ç–∞ –°—Ä–∞–∑—É –≤–∏–¥–Ω–æ ¬´–§–í¬ª —Å–æ–±—Ä–∞–ª —Å—Ä–∞–≤–Ω–∏—Ç–µ–ª—å–Ω—É—é —Ç–∞–±–ª–∏—Ü—É —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ —Å–Ω–∏–∂–µ–Ω–∏–∏ –≤–µ—Å–∞ –æ—Ç —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ –¥–æ –Ω–æ–≤—ã—Ö –ø–µ—Ä–æ—Ä–∞–ª—å–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –°—Ä–µ–¥–∏ –Ω–∏—Ö orforglipron –æ—Ç Eli Lilly –∏ ecnoglutide –∫–∏—Ç–∞–π—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ Sciwind Biosciences. –ï—Å—Ç—å –ø–æ–¥–æ–∑—Ä–µ–Ω–∏—è –§–ê–° –≤—ã—è–≤–∏–ª–∞ –ø—Ä–∏–∑–Ω–∞–∫–∏ —Å–≥–æ–≤–æ—Ä–∞ –ø—Ä–∏ –≥–æ—Å–∑–∞–∫—É–ø–∫–µ –æ—Ä—Ñ–∞–Ω–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ¬´–≠–ª–∞–ø—Ä–∞–∑–∞¬ª –Ω–∞ 5,9 –º–ª—Ä–¥ —Ä—É–±. –ê–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å–Ω—ã–π –æ—Ä–≥–∞–Ω –ø–æ–¥–æ–∑—Ä–µ–≤–∞–µ—Ç –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–¢–∞–∫–µ–¥–∞ –§–∞—Ä–º–∞—Å—å—é—Ç–∏–∫–∞–ª—Å¬ª –∏ ¬´–§–∞—Ä–º–∏–º—ç–∫—Å¬ª. –ó–∞—Ä–ø–ª–∞—Ç–Ω—ã–µ –æ–∂–∏–¥–∞–Ω–∏—è –í –∞–≤–≥—É—Å—Ç–µ 2025 –≥–æ–¥–∞ —Å–∞–º—ã–º–∏ –≤—ã—Å–æ–∫–æ–æ–ø–ª–∞—á–∏–≤–∞–µ–º—ã–º–∏ –≤–∞–∫–∞–Ω—Å–∏—è–º–∏ —Å—Ç–∞–ª–∏ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è –¥–ª—è –≤—Ä–∞—á–µ–π –≤ –ë—Ä—è–Ω—Å–∫–µ –∏ –ö–æ–º—Å–æ–º–æ–ª—å—Å–∫–µ-–Ω–∞-–ê–º—É—Ä–µ ‚Äî –∏—Ö –∑–∞—Ä–ø–ª–∞—Ç—ã –¥–æ—Å—Ç–∏–≥–∞–ª–∏ 150‚Äî200 —Ç—ã—Å. —Ä—É–±. –í –ú—É—Ä–º–∞–Ω—Å–∫–µ, –ù–∏–∂–Ω–µ–≤–∞—Ä—Ç–æ–≤—Å–∫–µ –∏ –í–ª–∞–¥–∏–º–∏—Ä–µ —Ç–∞–∫–∂–µ –≤ –¢–û–† —Ä–µ–π—Ç–∏–Ω–≥–∞ –≤–æ—à–ª–∏ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è –¥–ª—è –≤—Ä–∞—á–µ–π-—Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ —Å –∑–∞—Ä–ø–ª–∞—Ç–∞–º–∏ –æ—Ç 90 –¥–æ 121 —Ç—ã—Å. —Ä—É–±. –í–ª–∏—è–Ω–∏–µ –∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫–æ–≤ –°–ø—É—Å—Ç—è –¥–µ—Å—è—Ç—å –ª–µ—Ç –Ω–∞–±–ª—é–¥–µ–Ω–∏—è –Ω–µ –±—ã–ª–æ –≤—ã—è–≤–ª–µ–Ω–æ —Å–≤—è–∑–∏ –º–µ–∂–¥—É –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º –∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫–æ–≤ –≤–æ –≤—Ä–µ–º—è –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏ –∏–ª–∏ —Ä–∞–Ω–Ω–µ–≥–æ –¥–µ—Ç—Å—Ç–≤–∞ –∏ —Ä–∏—Å–∫–æ–º –∞—É—Ç–æ–∏–º–º—É–Ω–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π —É –¥–µ—Ç–µ–π. –≠—Ç–∏ –¥–∞–Ω–Ω—ã–µ –æ–ø—Ä–æ–≤–µ—Ä–≥–∞—é—Ç –ø—Ä–µ–∂–Ω–∏–µ –ø—Ä–µ–¥–ø–æ–ª–æ–∂–µ–Ω–∏—è –æ —Ç–æ–º, —á—Ç–æ —Ä–∞–Ω–Ω–µ–µ –≤–æ–∑–¥–µ–π—Å—Ç–≤–∏–µ –∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫–æ–≤ –º–æ–∂–µ—Ç –ø–æ–≤—ã—à–∞—Ç—å –≤–µ—Ä–æ—è—Ç–Ω–æ—Å—Ç—å —Ä–∞–∑–≤–∏—Ç–∏—è –¥–∏–∞–±–µ—Ç–∞ 1-–≥–æ —Ç–∏–ø–∞, —é–≤–µ–Ω–∏–ª—å–Ω–æ–≥–æ –∞—Ä—Ç—Ä–∏—Ç–∞ –∏–ª–∏ –≤–æ—Å–ø–∞–ª–∏—Ç–µ–ª—å–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –∫–∏—à–µ—á–Ω–∏–∫–∞.","{
  ""skip"": true
}"
2025-08-27T14:03:01+00:00,@medpharm,12626,https://t.me/medpharm/12626,–ü–æ—Å—Ç–∞–≤–∫–∏ —Ñ–∞—Ä–º–ø—Ä–æ–¥—É–∫—Ü–∏–∏ –∏–∑ –ö–∏—Ç–∞—è –≤ –†–æ—Å—Å–∏—é –∑–∞ —Å–µ–º—å –º–µ—Å—è—Ü–µ–≤ –≤—ã—Ä–æ—Å–ª–∏ –≤ –¥–µ–Ω—å–≥–∞—Ö –Ω–∞ —Ç—Ä–µ—Ç—å –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –∞–Ω–∞–ª–æ–≥–∏—á–Ω—ã–º –ø–µ—Ä–∏–æ–¥–æ–º –ø—Ä–æ—à–ª–æ–≥–æ –≥–æ–¥–∞. –ü—Ä–∏ —ç—Ç–æ–º –≤ –∏—é–ª–µ 2025 –≥–æ–¥–∞ –æ–±—ä–µ–º –ø–æ—Å—Ç–∞–≤–æ–∫ –≤—ã—Ä–æ—Å –≤ –¥–≤–∞ —Ä–∞–∑–∞ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –∏—é–ª–µ–º 2024 –≥–æ–¥–∞.,"{""skip"": true}"
2025-08-27T12:06:37+00:00,@medpharm,12625,https://t.me/medpharm/12625,"–ü—Ä–æ—Å—Ä–æ—á–µ–Ω–Ω–∞—è –∫—Ä–µ–¥–∏—Ç–æ—Ä—Å–∫–∞—è –∑–∞–¥–æ–ª–∂–µ–Ω–Ω–æ—Å—Ç—å –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏–π –î–∞–≥–µ—Å—Ç–∞–Ω–∞ –ø—Ä–µ–≤—ã—Å–∏–ª–∞ 800 –º–ª–Ω —Ä—É–±. –û—Å–Ω–æ–≤–Ω–∞—è —á–∞—Å—Ç—å –¥–æ–ª–≥–∞ –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ –Ω–∞–ª–æ–≥–∏ –∏ —Å—Ç—Ä–∞—Ö–æ–≤—ã–µ –≤–∑–Ω–æ—Å—ã, –∞ —Ç–∞–∫–∂–µ –ø—Ä–∏–æ–±—Ä–µ—Ç–µ–Ω–∏–µ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è.","{
  ""skip"": true
}"
2025-08-27T10:02:01+00:00,@medpharm,12624,https://t.me/medpharm/12624,–î–ª—è –∏–Ω–¥–∏–≤–∏–¥—É–∞–ª—å–Ω—ã—Ö –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤–≤–µ–¥—É—Ç —ç—Ç–∏—á–µ—Å–∫—É—é —ç–∫—Å–ø–µ—Ä—Ç–∏–∑—É. –ò–∑–º–µ–Ω–µ–Ω–∏—è –≤ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–æ –ø–æ–¥–≥–æ—Ç–æ–≤–∏–ª –ú–∏–Ω–∑–¥—Ä–∞–≤. –¢—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ —ç–∫—Å–ø–µ—Ä—Ç–∏–∑–µ –æ–ø—Ä–µ–¥–µ–ª–∏—Ç –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ.,"{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""ethics, regulation"",
  ""impact"": ""high"",
  ""english"": ""Changes to the law on ethical review for individual biotechnological pharmaceuticals have been proposed by the Ministry of Health. Requirements for the review will be determined by the government.""
}"
2025-08-27T07:59:28+00:00,@medpharm,12623,https://t.me/medpharm/12623,"–†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä –æ—Ä–≥–∞–Ω–∏–∑—É–µ—Ç –ø–æ–¥—á–∏—â–∞—é—â—É—é –∏–º–º—É–Ω–∏–∑–∞—Ü–∏—é –ø—Ä–æ—Ç–∏–≤ –∫—Ä–∞—Å–Ω—É—Ö–∏ —Å—Ä–µ–¥–∏ –¥–µ—Ç–µ–π –∏ –∂–µ–Ω—â–∏–Ω —Ñ–µ—Ä—Ç–∏–ª—å–Ω–æ–≥–æ –≤–æ–∑—Ä–∞—Å—Ç–∞, –Ω–µ –ø—Ä–∏–≤–∏—Ç—ã—Ö –∏–ª–∏ –ø—Ä–∏–≤–∏—Ç—ã—Ö –æ–¥–Ω–æ–∫—Ä–∞—Ç–Ω–æ. –í 2024 –≥–æ–¥—É –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–ª–∏ –≤—Å–ø—ã—à–∫—É –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è, –æ—Å–æ–±–µ–Ω–Ω–æ –º–Ω–æ–≥–æ —Å–ª—É—á–∞–µ–≤ ‚Äî –≤ –î–∞–≥–µ—Å—Ç–∞–Ω–µ –∏ –ú–æ—Å–∫–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""shortage, epidemic"",
  ""impact"": ""high"",
  ""english"": ""Rospotrebnadzor is organizing a catch-up vaccination against rubella among unvaccinated or partially vaccinated women of childbearing age and children. A disease outbreak was recorded in 2024, particularly in Daghestan and Moscow Oblast.""
}"
2025-08-26T16:36:34+00:00,@medpharm,12622,https://t.me/medpharm/12622,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 26 –∞–≤–≥—É—Å—Ç–∞ –ï—Å—Ç—å —Ü–µ–ª—å –í—Å–µ —Å—Ç—É–¥–µ–Ω—Ç—ã-–±—é–¥–∂–µ—Ç–Ω–∏–∫–∏, –æ–±—É—á–∞—é—â–∏–µ—Å—è –ø–æ –ø—Ä–æ–≥—Ä–∞–º–º–∞–º —Ñ–∞—Ä–º–æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è, –±—É–¥—É—Ç –∑–∞–∫–ª—é—á–∞—Ç—å –¥–æ–≥–æ–≤–æ—Ä –æ —Ü–µ–ª–µ–≤–æ–º –æ–±—É—á–µ–Ω–∏–∏ ‚Äî —Å —Ç–∞–∫–æ–π –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–æ–π –≤—ã—Å—Ç—É–ø–∏–ª –ú–∏–Ω–∑–¥—Ä–∞–≤. –ò–¥—É—Ç –≤ —Ä–æ—Å—Ç –ü–æ—Å—Ç–∞–≤–∫–∏ —Ñ–∞—Ä–º–ø—Ä–æ–¥—É–∫—Ü–∏–∏ –∏–∑ –ö–∏—Ç–∞—è –≤ –†–æ—Å—Å–∏—é –∑–∞ —Å–µ–º—å –º–µ—Å—è—Ü–µ–≤ –≤—ã—Ä–æ—Å–ª–∏ –≤ –¥–µ–Ω—å–≥–∞—Ö –Ω–∞ —Ç—Ä–µ—Ç—å –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –∞–Ω–∞–ª–æ–≥–∏—á–Ω—ã–º –ø–µ—Ä–∏–æ–¥–æ–º –ø—Ä–æ—à–ª–æ–≥–æ –≥–æ–¥–∞. –ü—Ä–∏ —ç—Ç–æ–º –≤ –∏—é–ª–µ 2025 –≥–æ–¥–∞ –æ–±—ä–µ–º –ø–æ—Å—Ç–∞–≤–æ–∫ –≤—ã—Ä–æ—Å –≤ –¥–≤–∞ —Ä–∞–∑–∞ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –∏—é–ª–µ–º 2024 –≥–æ–¥–∞. ¬´–í–∑–∞–∏–º–æ–≤—ã–≥–æ–¥–Ω–∞—è —Å–¥–µ–ª–∫–∞¬ª –û–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–µ —Ü–µ–ª–µ–≤–æ–µ –æ–±—É—á–µ–Ω–∏–µ –¥–ª—è –æ–±—É—á–∞—é—â–∏—Ö—Å—è –Ω–∞ –±—é–¥–∂–µ—Ç–µ —Å—Ç–∞–Ω–µ—Ç –≥–∞—Ä–∞–Ω—Ç–∏–µ–π —Ç—Ä—É–¥–æ—É—Å—Ç—Ä–æ–π—Å—Ç–≤–∞. –ì–æ—Å—É–¥–∞—Ä—Å—Ç–≤–æ –∂–µ –ø–æ–ª—É—á–∏—Ç –ø–æ–¥–≥–æ—Ç–æ–≤–ª–µ–Ω–Ω—ã–µ –∏ –æ–ø—ã—Ç–Ω—ã–µ –∫–∞–¥—Ä—ã, –∑–∞—è–≤–∏–ª –≥–ª–∞–≤–∞ –ö–æ–º–∏—Ç–µ—Ç–∞ –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è. –ü–æ–ª–æ–≤–æ–µ —Å–æ–∑—Ä–µ–≤–∞–Ω–∏–µ –†–∞–Ω–Ω–µ–µ –º–µ–Ω–∞—Ä—Ö–µ —É –∂–µ–Ω—â–∏–Ω –º–æ–∂–µ—Ç –±—ã—Ç—å –Ω–∞–ø—Ä—è–º—É—é —Å–≤—è–∑–∞–Ω–æ —Å –ø–æ–≤—ã—à–µ–Ω–Ω—ã–º —Ä–∏—Å–∫–æ–º –≤–æ–∑—Ä–∞—Å—Ç-–∞—Å—Å–æ—Ü–∏–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –ü–æ–∫–∞–∑–∞–≤—à–µ–µ —ç—Ç–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ —Ç–∞–∫–∂–µ –¥–æ–∫–∞–∑—ã–≤–∞–µ—Ç —ç–≤–æ–ª—é—Ü–∏–æ–Ω–Ω—É—é —Ç–µ–æ—Ä–∏—é –∞–Ω—Ç–∞–≥–æ–Ω–∏—Å—Ç–∏—á–µ—Å–∫–æ–π –ø–ª–µ–π–æ—Ç—Ä–æ–ø–∏–∏.","{""skip"": true}"
2025-08-26T14:19:09+00:00,@medpharm,12621,https://t.me/medpharm/12621,"–°—Ç—É–¥–µ–Ω—Ç—ã-–±—é–¥–∂–µ—Ç–Ω–∏–∫–∏, –æ–±—É—á–∞—é—â–∏–µ—Å—è –ø–æ –ø—Ä–æ–≥—Ä–∞–º–º–∞–º —Ñ–∞—Ä–º–æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è, –±—É–¥—É—Ç –∑–∞–∫–ª—é—á–∞—Ç—å –¥–æ–≥–æ–≤–æ—Ä –æ —Ü–µ–ª–µ–≤–æ–º –æ–±—É—á–µ–Ω–∏–∏ ‚Äî —Å —Ç–∞–∫–æ–π –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–æ–π –≤—ã—Å—Ç—É–ø–∏–ª –ú–∏–Ω–∑–¥—Ä–∞–≤. –ü—Ä–æ–¥–æ–ª–∂–∏—Ç—å –æ–±—É—á–µ–Ω–∏–µ –≤ –æ—Ä–¥–∏–Ω–∞—Ç—É—Ä–µ –æ–Ω–∏ —Å–º–æ–≥—É—Ç –ø—Ä–∏ –∑–∞–∫–ª—é—á–µ–Ω–∏–∏ –Ω–æ–≤–æ–≥–æ —Ü–µ–ª–µ–≤–æ–≥–æ –¥–æ–≥–æ–≤–æ—Ä–∞ —Å —Ç–µ–º –∂–µ –∑–∞–∫–∞–∑—á–∏–∫–æ–º.","{""skip"": true}"
2025-08-26T12:36:15+00:00,@medpharm,12620,https://t.me/medpharm/12620,"–£–≥–æ–ª–æ–≤–Ω–æ–µ –¥–µ–ª–æ –æ –ø—Ä–∏—á–∏–Ω–µ–Ω–∏–∏ —Å–º–µ—Ä—Ç–∏ –ø–æ –Ω–µ–æ—Å—Ç–æ—Ä–æ–∂–Ω–æ—Å—Ç–∏ –ø—Ä–æ—Ç–∏–≤ –≤–ª–∞–¥–∏–º–∏—Ä—Å–∫–æ–≥–æ –≤—Ä–∞—á–∞-—Ö–∏—Ä—É—Ä–≥–∞ —Ä–∞—Å—Å–º–æ—Ç—Ä–∏—Ç —Å—É–¥. –°–ª–µ–¥—Å—Ç–≤–∏–µ —Å—á–∏—Ç–∞–µ—Ç, —á—Ç–æ –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫ –Ω–µ –ø—Ä–æ–≤–µ–ª –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã–µ –æ–±—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è, –∏–∑‚Äë–∑–∞ —á–µ–≥–æ –∏–Ω—Ñ–∞—Ä–∫—Ç –Ω–µ –±—ã–ª –≤—ã—è–≤–ª–µ–Ω –≤–æ–≤—Ä–µ–º—è, –∏ –±–æ–ª—å–Ω–æ–π —Å–∫–æ–Ω—á–∞–ª—Å—è.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""clinical_trial,hospital_policy,pharmacovigilance,safety"",
  ""impact"": ""high"",
  ""english"": ""A criminal case for causing death by negligence against a Vladimir doctor-hygienist is being heard in court. The investigation believes that the medical worker did not conduct necessary examinations, which led to the patient's infarction being missed in time and resulting in death.""
}"
2025-08-26T11:04:01+00:00,@medpharm,12619,https://t.me/medpharm/12619,–†–∞–±–æ—Ç—É —Å–µ—Ç–∏ ¬´–ö—É—Ä—Å–∫–∞—è —Ñ–∞—Ä–º–∞—Ü–∏—è¬ª –ø—Ä–æ–≤–µ—Ä—è—Ç –ø–æ –ø–æ—Ä—É—á–µ–Ω–∏—é –≤—Ä–∏–æ –≥—É–±–µ—Ä–Ω–∞—Ç–æ—Ä–∞. –ú–∏–Ω—Ñ–∏–Ω —Ä–µ–≥–∏–æ–Ω–∞ —Ç–∞–∫–∂–µ –ø—Ä–æ–∞–Ω–∞–ª–∏–∑–∏—Ä—É–µ—Ç —Ñ–∏–Ω–∞–Ω—Å–æ–≤–æ–µ —Å–æ—Å—Ç–æ—è–Ω–∏–µ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –Ω–∞ —Ñ–æ–Ω–µ –≤—ã–¥–∞–Ω–Ω–æ–π —Å—É–±—Å–∏–¥–∏–∏ –≤ –±–æ–ª–µ–µ 65 –º–ª–Ω —Ä—É–±.,"{""skip"": true}"
2025-08-26T09:23:05+00:00,@medpharm,12618,https://t.me/medpharm/12618,"–î–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –Ω–∞ –ø–æ–≤—ã—à–µ–Ω–∏–µ –∑–∞—Ä–ø–ª–∞—Ç –∏ —Å–≥–ª–∞–∂–∏–≤–∞–Ω–∏–µ –¥–∏—Ñ—Ñ–µ—Ä–µ–Ω—Ü–∏–∞—Ü–∏–∏ –æ–∫–ª–∞–¥–æ–≤ –º–µ–∂–¥—É —Ä–µ–≥–∏–æ–Ω–∞–º–∏ –≤ —Ä–∞–º–∫–∞—Ö –≤–Ω–µ–¥—Ä–µ–Ω–∏—è –Ω–æ–≤–æ–π —Å–∏—Å—Ç–µ–º—ã –æ–ø–ª–∞—Ç—ã —Ç—Ä—É–¥–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –ø–æ-–ø—Ä–µ–∂–Ω–µ–º—É –Ω–µ—Ç, –∏ –Ω–∏–∫–∞–∫–∏—Ö –∏–∑–º–µ–Ω–µ–Ω–∏–π –≤ —ç—Ç–æ–π —Å—Ñ–µ—Ä–µ –Ω–µ –ø—Ä–æ–∏—Å—Ö–æ–¥–∏—Ç, —Å–æ–æ–±—â–∏–ª –¥–µ–ø—É—Ç–∞—Ç –ê–ª–µ–∫—Å–µ–π –ö—É—Ä–∏–Ω–Ω—ã–π. –û–∫–æ–Ω—á–∞—Ç–µ–ª—å–Ω–æ–µ —Ä–µ—à–µ–Ω–∏–µ –æ –∑–∞–ø—É—Å–∫–µ –ø–∏–ª–æ—Ç–Ω–æ–≥–æ –ø—Ä–æ–µ–∫—Ç–∞ –ø–æ –≤–Ω–µ–¥—Ä–µ–Ω–∏—é –Ω–æ–≤–æ–π —Å–∏—Å—Ç–µ–º—ã –æ–ø–ª–∞—Ç—ã —Ç—Ä—É–¥–∞ –±—é–¥–∂–µ—Ç–Ω–∏–∫–æ–≤ –ø–ª–∞–Ω–∏—Ä–æ–≤–∞–ª–æ—Å—å –ø—Ä–∏–Ω—è—Ç—å –µ—â–µ –≤ –∫–æ–Ω—Ü–µ –∏—é–ª—è.","{""skip"": true}"
2025-08-25T16:01:00+00:00,@medpharm,12617,https://t.me/medpharm/12617,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 25 –∞–≤–≥—É—Å—Ç–∞ –í—Å–µ –ø–µ—Ä–µ–ø—É—Ç–∞–ª–∏ –≠–∫—Å–ø–µ—Ä—Ç—ã –æ–ø—Ä–æ–≤–µ—Ä–≥–ª–∏ —Å–æ–æ–±—â–µ–Ω–∏—è –°–ú–ò –æ –≤–≤–µ–¥–µ–Ω–∏–∏ –Ω–æ–≤—ã—Ö —à—Ç—Ä–∞—Ñ–æ–≤ –¥–ª—è –∞–ø—Ç–µ–∫ –∑–∞ –Ω–µ–∏–Ω—Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏–µ –æ –¥–µ—à–µ–≤—ã—Ö –∞–Ω–∞–ª–æ–≥–∞—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤. –¢–∞–∫–∞—è –Ω–æ—Ä–º–∞ —Å–æ–¥–µ—Ä–∂–∞–ª–∞—Å—å –∏ –≤ –ø—Ä–µ–∂–Ω–µ–º –ø—Ä–∏–∫–∞–∑–µ –æ –ø—Ä–∞–≤–∏–ª–∞—Ö –ù–ê–ü. –û–¥–Ω–∞–∫–æ –ø—Ä–æ–≤–µ—Ä–∫–∞ –≥—Ä–æ–∑–∏—Ç –∞–ø—Ç–µ–∫–µ —Ç–æ–ª—å–∫–æ –≤ —Ö–æ–¥–µ –∫–æ–Ω—Ç—Ä–æ–ª—å–Ω–æ–π –∑–∞–∫—É–ø–∫–∏ –ø–æ—Å–ª–µ –∂–∞–ª–æ–±—ã –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª—è. –û–±–Ω–æ–≤–∏–ª–∏ –ø–æ—Ä—è–¥–æ–∫ –°—Ä–æ–∫ –≤–Ω–µ—Å–µ–Ω–∏—è –¥–∞–Ω–Ω—ã—Ö –æ –≤—ã–¥–∞—á–µ —Ä–∞–∑—Ä–µ—à–µ–Ω–∏–π –Ω–∞ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å–ø—ã—Ç–∞–Ω–∏–π –º–µ–¥–∏–∑–¥–µ–ª–∏–π —Å–æ–∫—Ä–∞—â–µ–Ω —Å —Ç—Ä–µ—Ö –¥–Ω–µ–π –¥–æ –æ–¥–Ω–æ–≥–æ –¥–Ω—è. –î–æ–Ω–æ—Ä–∞–º-–∞–≤—Ç–æ–ª—é–±–∏—Ç–µ–ª—è–º –í –ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–π –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ —É–ø—Ä–∞–≤–ª–µ–Ω—Ü–µ–≤ –≤ —Å—Ñ–µ—Ä–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ø–æ–ø—Ä–æ—Å–∏–ª–∏ –¥–µ–ø—É—Ç–∞—Ç–æ–≤ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ—Ç—å –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–µ –ª—å–≥–æ—Ç—ã –¥–ª—è –¥–æ–Ω–æ—Ä–æ–≤ –∫—Ä–æ–≤–∏ –∏ –µ–µ –∫–æ–º–ø–æ–Ω–µ–Ω—Ç–æ–≤. –†–µ—á—å –∏–¥–µ—Ç –æ–± –æ—Ç–º–µ–Ω–µ –ø–ª–∞—Ç—ã –∑–∞ –ø–∞—Ä–∫–æ–≤–∫–∏ –¥–ª—è –ø–æ—á–µ—Ç–Ω—ã—Ö –¥–æ–Ω–æ—Ä–æ–≤, –∞ —Ç–∞–∫–∂–µ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–µ–π –ª—å–≥–æ—Ç–µ –¥–ª—è –≤—Å–µ—Ö —Å–¥–∞—é—â–∏—Ö –∫—Ä–æ–≤—å –∏ –µ–µ –∫–æ–º–ø–æ–Ω–µ–Ω—Ç—ã –∏ –≤ —Ç–µ—á–µ–Ω–∏–µ –¥–≤—É—Ö —á–∞—Å–æ–≤ –Ω–∞ –º–æ–º–µ–Ω—Ç –¥–æ–Ω–∞—Ü–∏–∏. –£–∂–µ—Å—Ç–æ—á–µ–Ω–∏—è –¥–ª—è –º–∏–≥—Ä–∞–Ω—Ç–æ–≤ –í –ì–æ—Å–¥—É–º—É –≤–Ω–µ—Å–ª–∏ –ø—Ä–æ–µ–∫—Ç, —É–∂–µ—Å—Ç–æ—á–∞—é—â–∏–π —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ –º–∏–≥—Ä–∞–Ω—Ç–∞–º –≤ —Å—Ñ–µ—Ä–µ –º–µ–¥—Å—Ç—Ä–∞—Ö–æ–≤–∞–Ω–∏—è. –≠—Ç–æ—Ç —à–∞–≥ –ø–æ–∑–≤–æ–ª–∏—Ç —Å–Ω–∏–∑–∏—Ç—å –Ω–∞–≥—Ä—É–∑–∫—É –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫—É—é —Å–∏—Å—Ç–µ–º—É –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è, –∑–∞—â–∏—Ç–∏—Ç—å –±—é–¥–∂–µ—Ç –æ—Ç –Ω–µ–æ–ø—Ä–∞–≤–¥–∞–Ω–Ω—ã—Ö –∑–∞—Ç—Ä–∞—Ç –∏ —É–ø–æ—Ä—è–¥–æ—á–∏—Ç—å –ø—Ä–µ–±—ã–≤–∞–Ω–∏–µ –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã—Ö –≥—Ä–∞–∂–¥–∞–Ω –≤ —Å—Ç—Ä–∞–Ω–µ, —Å—á–∏—Ç–∞–µ—Ç –∞–≤—Ç–æ—Ä –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç–∞.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, import_export"",
  ""impact"": ""high"",
  ""english"": ""A project has been submitted to the State Duma that tightens requirements for foreign citizens in the healthcare sector. This move aims to reduce the burden on Russia's healthcare system, protect the budget from unnecessary expenses, and organize the stay of foreign citizens in the country.""
}"
2025-08-25T13:46:40+00:00,@medpharm,12616,https://t.me/medpharm/12616,#—ç–∫—Å–∫–ª—é–∑–∏–≤ –≠–∫—Å–ø–µ—Ä—Ç—ã –æ–ø—Ä–æ–≤–µ—Ä–≥–ª–∏ —Å–æ–æ–±—â–µ–Ω–∏—è –°–ú–ò –æ –≤–≤–µ–¥–µ–Ω–∏–∏ –Ω–æ–≤—ã—Ö —à—Ç—Ä–∞—Ñ–æ–≤ –¥–ª—è –∞–ø—Ç–µ–∫ –∑–∞ –Ω–µ–∏–Ω—Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏–µ –æ –¥–µ—à–µ–≤—ã—Ö –∞–Ω–∞–ª–æ–≥–∞—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤. –¢–∞–∫–∞—è –Ω–æ—Ä–º–∞ —Å–æ–¥–µ—Ä–∂–∞–ª–∞—Å—å –∏ –≤ –ø—Ä–µ–∂–Ω–µ–º –ø—Ä–∏–∫–∞–∑–µ –æ –ø—Ä–∞–≤–∏–ª–∞—Ö –ù–ê–ü. –û–¥–Ω–∞–∫–æ –ø—Ä–æ–≤–µ—Ä–∫–∞ –≥—Ä–æ–∑–∏—Ç –∞–ø—Ç–µ–∫–µ —Ç–æ–ª—å–∫–æ –≤ —Ö–æ–¥–µ –∫–æ–Ω—Ç—Ä–æ–ª—å–Ω–æ–π –∑–∞–∫—É–ø–∫–∏ –ø–æ—Å–ª–µ –∂–∞–ª–æ–±—ã –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª—è.,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""sanctions"",
  ""impact"": ""low"",
  ""english"": ""Experts have refuted media reports about the introduction of new fines for pharmacies for not informing about cheap drug alternatives. Such a norm was already included in the previous NAP rules on procurement procedures. However, sanctions are imposed only during a control purchase after the consumer has requested them.""
}"
2025-08-25T12:11:37+00:00,@medpharm,12615,https://t.me/medpharm/12615,"–°—Ä–æ–∫ –≤–Ω–µ—Å–µ–Ω–∏—è –¥–∞–Ω–Ω—ã—Ö –æ –≤—ã–¥–∞—á–µ —Ä–∞–∑—Ä–µ—à–µ–Ω–∏–π –Ω–∞ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å–ø—ã—Ç–∞–Ω–∏–π –º–µ–∏–∑–¥–µ–ª–∏–π —Å–æ–∫—Ä–∞—â–µ–Ω —Å —Ç—Ä–µ—Ö –¥–Ω–µ–π –¥–æ –æ–¥–Ω–æ–≥–æ –¥–Ω—è. –°–æ–≥–ª–∞—Å–Ω–æ –Ω–æ–≤–æ–º—É –ø—Ä–∏–∫–∞–∑—É –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–∞, —É–≤–µ–¥–æ–º–ª–µ–Ω–∏–µ –æ –Ω–∞—á–∞–ª–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π —Ç–µ–ø–µ—Ä—å –º–æ–∂–Ω–æ –ø–æ–¥–∞—Ç—å —á–µ—Ä–µ–∑ –ª–∏—á–Ω—ã–π –∫–∞–±–∏–Ω–µ—Ç –Ω–∞ –ø–æ—Ä—Ç–∞–ª–µ –ì–æ—Å—É—Å–ª—É–≥.","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The reporting period for clinical trial permits has been shortened from three days to one day. According to the new directive of Roszdravnadzor, notification about the start of research can now be submitted through a personal account on the Gosuslugi portal.""
}"
2025-08-25T10:11:08+00:00,@medpharm,12614,https://t.me/medpharm/12614,"#—ç–∫—Å–∫–ª—é–∑–∏–≤ –í –ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–π –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ —É–ø—Ä–∞–≤–ª–µ–Ω—Ü–µ–≤ –≤ —Å—Ñ–µ—Ä–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ø–æ–ø—Ä–æ—Å–∏–ª–∏ –¥–µ–ø—É—Ç–∞—Ç–æ–≤ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ—Ç—å –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–µ –ª—å–≥–æ—Ç—ã –¥–ª—è –¥–æ–Ω–æ—Ä–æ–≤ –∫—Ä–æ–≤–∏ –∏ –µ–µ –∫–æ–º–ø–æ–Ω–µ–Ω—Ç–æ–≤. –†–µ—á—å –∏–¥–µ—Ç –æ–± –æ—Ç–º–µ–Ω–µ –ø–ª–∞—Ç—ã –∑–∞ –ø–∞—Ä–∫–æ–≤–∫–∏ –¥–ª—è –ø–æ—á–µ—Ç–Ω—ã—Ö –¥–æ–Ω–æ—Ä–æ–≤, –∞ —Ç–∞–∫–∂–µ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–µ–π –ª—å–≥–æ—Ç–µ –¥–ª—è –≤—Å–µ—Ö —Å–¥–∞—é—â–∏—Ö –∫—Ä–æ–≤—å –∏ –µ–µ –∫–æ–º–ø–æ–Ω–µ–Ω—Ç—ã –∏ –≤ —Ç–µ—á–µ–Ω–∏–µ –¥–≤—É—Ö —á–∞—Å–æ–≤ –Ω–∞ –º–æ–º–µ–Ω—Ç –¥–æ–Ω–∞—Ü–∏–∏.","{""skip"": true}"
2025-08-25T08:30:52+00:00,@medpharm,12613,https://t.me/medpharm/12613,"–ö–∞–∫ —Ä–∞—Å—Å—á–∏—Ç—ã–≤–∞–µ—Ç—Å—è –æ–ø–ª–∞—Ç–∞ —Ä–∞–±–æ—Ç—ã –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–º—É –∏ –Ω–µ–º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–º—É –ø–µ—Ä—Å–æ–Ω–∞–ª—É –≤ –≤—ã—Ö–æ–¥–Ω—ã–µ –∏ –ø—Ä–∞–∑–¥–Ω–∏—á–Ω—ã–µ –¥–Ω–∏, –≤ —á–∞—Å—Ç–Ω–æ—Å—Ç–∏ –¥–µ–∂—É—Ä—Å—Ç–≤–∞ –Ω–∞ —Ç–µ–ª–µ—Ñ–æ–Ω–µ? –û—Ç–≤–µ—á–∞–µ—Ç —ç–∫—Å–ø–µ—Ä—Ç —Å–ª—É–∂–±—ã –ø—Ä–∞–≤–æ–≤–æ–≥–æ –∫–æ–Ω—Å–∞–ª—Ç–∏–Ω–≥–∞ ¬´–ì–∞—Ä–∞–Ω—Ç¬ª –í–∞–ª–µ–Ω—Ç–∏–Ω–∞ –ï–≤—Å—é–∫–æ–≤–∞.","{""skip"": true}"
2025-08-24T10:13:01+00:00,@medpharm,12612,https://t.me/medpharm/12612,"–ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ –∑–∞ –Ω–µ–¥–µ–ª—é üîµ–ö–æ–º–ø–∞–Ω–∏—è ¬´–î–∂–æ–¥–∞—Å –≠–∫—Å–ø–æ–∏–º¬ª –æ–±—Ä–∞—Ç–∏–ª–∞—Å—å –≤ —Å—É–¥ —Å –∏—Å–∫–∞–º–∏ –∫ –ú–∏–Ω–∑–¥—Ä–∞–≤—É. –û–Ω–∞ —Ç—Ä–µ–±—É–µ—Ç –ø—Ä–∏–∑–Ω–∞—Ç—å –Ω–µ–∑–∞–∫–æ–Ω–Ω—ã–º–∏ —Ä–µ—à–µ–Ω–∏—è —Ä–µ–≥—É–ª—è—Ç–æ—Ä–∞ –æ–± –æ—Ç–º–µ–Ω–µ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –∏ –∏—Å–∫–ª—é—á–µ–Ω–∏–∏ –∏–∑ –ì–†–õ–° –¥–≤—É—Ö –µ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. üîµWildberries –Ω–∞—á–∞–ª —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–æ —Å ¬´–ï–∞–ø—Ç–µ–∫–æ–π¬ª. –ü–æ–∫—É–ø–∞—Ç–µ–ª—è–º –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞ –±—É–¥—É—Ç –¥–æ—Å—Ç–∞–≤–ª—è—Ç—å –¥–æ –¥–≤–µ—Ä–∏ –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç—ã –∏–∑ –∞–ø—Ç–µ—á–Ω–æ–π —Å–µ—Ç–∏ –≤ 47 —Ä–µ–≥–∏–æ–Ω–∞—Ö –†–æ—Å—Å–∏–∏. –°–¥–µ–ª–∫—É –ø–æ –ø—Ä–æ–¥–∞–∂–µ ¬´–ï–∞–ø—Ç–µ–∫–∏¬ª –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å—É –æ–±—Å—É–∂–¥–∞—é—Ç –Ω–∞ —Ä—ã–Ω–∫–µ —Å –Ω–∞—á–∞–ª–∞ –≥–æ–¥–∞. üîµ–ö –Ω–∞–∑–Ω–∞—á–∞–µ–º—ã–º –≤—Ä–∞—á–∞–º–∏ –ë–ê–î —É—Å—Ç–∞–Ω–æ–≤—è—Ç –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–Ω—ã–µ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –ø–æ –∫–∞—á–µ—Å—Ç–≤—É –∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏. –û–Ω–∏ –ª—è–≥—É—Ç –≤ –æ—Å–Ω–æ–≤—É —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—è —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ–≥–æ –ø–µ—Ä–µ—á–Ω—è –±–∏–æ–¥–æ–±–∞–≤–æ–∫. üîµ–°—Ç–∞–ª–∏ –∏–∑–≤–µ—Å—Ç–Ω—ã –¥–µ—Ç–∞–ª–∏ –ø–æ –æ—Ç—á–∏—Å–ª–µ–Ω–∏—è–º –Ω–∞ —Ä–µ–∫–ª–∞–º—É –≤ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç–µ. –û–Ω–∏ –±—É–¥—É—Ç –µ–∂–µ–∫–≤–∞—Ä—Ç–∞–ª—å–Ω—ã–º–∏. –ú–∞–∫—Å–∏–º–∞–ª—å–Ω—ã–π —Ä–∞–∑–º–µ—Ä –ø–ª–∞—Ç–µ–∂–µ–π —Å–æ—Å—Ç–∞–≤–∏—Ç 3% –æ—Ç –¥–æ—Ö–æ–¥–∞ –∑–∞ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–∏–µ —Ä–µ–∫–ª–∞–º—ã. –ï—Å–ª–∏ –ø–ª–∞—Ç–µ–∂ –Ω–µ –ø—Ä–æ—à–µ–ª –≤ —Ç–µ—á–µ–Ω–∏–µ –¥–µ—Å—è—Ç–∏ –¥–Ω–µ–π –ø–æ—Å–ª–µ —É–≤–µ–¥–æ–º–ª–µ–Ω–∏—è, —Ç–æ –¥–æ–ª–≥ –≤–∑—ã—â—É—Ç –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω–æ. üîµ–ü–æ–ª–Ω—ã–π –ø–µ—Ä–µ—Ö–æ–¥ –Ω–∞ —ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω—ã–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –∫–Ω–∏–∂–∫–∏ –ø–µ—Ä–µ–Ω–µ—Å–ª–∏ –µ—â–µ –Ω–∞ –æ–¥–∏–Ω –≥–æ–¥, —Ç–∞–∫–æ–µ —Ä–µ—à–µ–Ω–∏–µ –ø—Ä–∏–Ω—è–ª –ú–∏–Ω–∑–¥—Ä–∞–≤. –ò–∑–Ω–∞—á–∞–ª—å–Ω–æ –ø–ª–∞–Ω–∏—Ä–æ–≤–∞–ª–æ—Å—å –æ—Ç–∫–∞–∑–∞—Ç—å—Å—è –æ—Ç –±—É–º–∞–∂–Ω—ã—Ö –≤–µ—Ä—Å–∏–π –µ—â–µ –≤ 2023 –≥–æ–¥—É.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The company 'Djodas Expoim' has filed lawsuits against the Ministry of Health. They are challenging decisions that cancelled the registration and exclusion of two of their medications from the GRLS list. Wildberries has begun cooperation with 'Eaptek'. Customers will receive medicines from the pharmacy network delivered to their door in 47 regions of Russia. The acquisition deal for Eaptek by the marketplace is being discussed on the market since the beginning of this year. The requirements for quality and effectiveness will be set by doctors prescribing BAs (Biological Additives). Advertising fees will be quarterly payments at a maximum of 3% of the revenue from advertising. If not paid within ten days after notification, the debt will be enforced by force. The transition to electronic medical books has been postponed for another year, as announced by the Ministry of Health.""
}"
2025-08-23T09:04:32+00:00,@medpharm,12611,https://t.me/medpharm/12611,"–ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∑–∞ –Ω–µ–¥–µ–ª—é üî¥–°–∞–º—ã–µ –∫—Ä—É–ø–Ω—ã–µ –≤—ã–ø–ª–∞—Ç—ã –æ—Ç —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π –ø–æ–ª—É—á–∞—é—Ç –≤—Ä–∞—á–∏ —Å –Ω–∞–∏–±–æ–ª—å—à–∏–º —á–∏—Å–ª–æ–º –∂–∞–ª–æ–± –æ—Ç –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –ø–æ–∫–∞–∑–∞–ª–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ. üî¥–ó–∞ 2024 –≥–æ–¥ –ú–∏–Ω–∑–¥—Ä–∞–≤ –ø–µ—Ä–µ–≤—ã–ø–æ–ª–Ω–∏–ª –ø–ª–∞–Ω –ø–æ –¥–æ—Ö–æ–¥–∞–º –≤ 2,5 —Ä–∞–∑–∞, –∞ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä –∏ –†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä –Ω–µ –¥–æ—Å—Ç–∏–≥–ª–∏ –∑–∞–ø–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ø–æ–∫–∞–∑–∞—Ç–µ–ª–µ–π, —Å–æ–æ–±—â–∏–ª–∞ –°—á–µ—Ç–Ω–∞—è –ø–∞–ª–∞—Ç–∞ –†–§. üî¥–° —Å–µ–Ω—Ç—è–±—Ä—è –≤ –†–æ—Å—Å–∏–∏ –±—É–¥–µ—Ç –¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å –Ω–æ–≤–∞—è —Ñ–æ—Ä–º–∞ —Ç–∏–ø–æ–≤–æ–≥–æ –¥–æ–≥–æ–≤–æ—Ä–∞ –≤ —Å–∏—Å—Ç–µ–º–µ –û–ú–°. –ú–∏–Ω–∑–¥—Ä–∞–≤ —É—Ç–æ—á–Ω–∏–ª —É—Å–ª–æ–≤–∏—è —Ä–∞—Å—á–µ—Ç–æ–≤ –º–µ–∂–¥—É –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è–º–∏ –∏ —Å—Ç—Ä–∞—Ö–æ–≤—â–∏–∫–∞–º–∏, –≤–∫–ª—é—á–∞—è –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç—å –∑–∞ –ø—Ä–æ—Å—Ä–æ—á–∫—É –æ–ø–ª–∞—Ç—ã. üî¥–ú–∏–Ω–∑–¥—Ä–∞–≤ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç –∏–∑—É—á–∏—Ç—å —É–∂–µ –∏—Å–ø–æ–ª—å–∑—É–µ–º—ã–µ —Ñ–æ—Ä–º–∞—Ç—ã –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏—è —Å –∫–æ–º–ø–∞–Ω–∏—è–º–∏-–ø–æ—Å—Ä–µ–¥–Ω–∏–∫–∞–º–∏, –∫–æ—Ç–æ—Ä—ã–µ —Å–æ—Ç—Ä—É–¥–Ω–∏—á–∞—é—Ç —Å –∫—Ä—É–ø–Ω—ã–º–∏ –∫–ª–∏–Ω–∏–∫–∞–º–∏ –∏ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã–º–∏ —Ü–µ–Ω—Ç—Ä–∞–º–∏ –ø–æ –ø—Ä–∏–≤–ª–µ—á–µ–Ω–∏—é –∏–Ω–æ—Å—Ç—Ä–∞–Ω—Ü–µ–≤ –≤ –∫–∞—á–µ—Å—Ç–≤–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ç—É—Ä–∏—Å—Ç–æ–≤. üî¥–§–µ–¥–µ—Ä–∞—Ü–∏—è –Ω–µ–∑–∞–≤–∏—Å–∏–º—ã—Ö –ø—Ä–æ—Ñ—Å–æ—é–∑–æ–≤ –†–æ—Å—Å–∏–∏ –∏ –≤–µ–¥—É—â–∏–µ –¥–µ–ª–æ–≤—ã–µ —Å–æ–æ–±—â–µ—Å—Ç–≤–∞ –ø—Ä–µ–¥—É–ø—Ä–µ–¥–∏–ª–∏ –æ —Ä–æ—Å—Ç–µ —Å–∫—Ä—ã—Ç–æ–π –±–µ–∑—Ä–∞–±–æ—Ç–∏—Ü—ã –Ω–∞ –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏—è—Ö —Å—Ç—Ä–∞–Ω—ã. ¬´–ú–í¬ª —É–∑–Ω–∞–ª, –∑–∞—Ç—Ä–æ–Ω—É—Ç –ª–∏ —ç—Ç–∏ —Ä–∏—Å–∫–∏ —Å—Ñ–µ—Ä—É –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è, –≤ –∫–æ—Ç–æ—Ä–æ–π –∏ —Ç–∞–∫ –Ω–∞–±–ª—é–¥–∞–µ—Ç—Å—è –∫–∞–¥—Ä–æ–≤—ã–π –¥–µ—Ñ–∏—Ü–∏—Ç.","{""skip"": true}"
2025-08-22T16:29:14+00:00,@medpharm,12610,https://t.me/medpharm/12610,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 22 –∞–≤–≥—É—Å—Ç–∞ –Ø.–∞–ø—Ç–µ–∫–∞ –∏ –ï–∞–ø—Ç–µ–∫–∞ –î–≤–∞ –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞ ‚Äî –Ø–Ω–¥–µ–∫—Å –∏ Wildberries ‚Äî –æ–±—ä—è–≤–∏–ª–∏ –æ –∑–∞–ø—É—Å–∫–µ —Å–µ—Ä–≤–∏—Å–æ–≤ –¥–æ—Å—Ç–∞–≤–∫–∏ –∏ –±—Ä–æ–Ω–∏—Ä–æ–≤–∞–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤. –≠–∫—Å–ø–µ—Ä—Ç—ã –ø–æ–ª–∞–≥–∞—é—Ç, —á—Ç–æ —ç—Ç–æ –º–æ–∂–µ—Ç –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ –∏–∑–º–µ–Ω–∏—Ç—å –∫–∞–∫ —Ä—ã–Ω–æ–∫ –∞–ø—Ç–µ—á–Ω–æ–≥–æ e-com, —Ç–∞–∫ –∏ –¥–æ–ª—é —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω–æ–π –∞–ø—Ç–µ—á–Ω–æ–π —Ä–æ–∑–Ω–∏—Ü—ã. –ê–Ω–∞–ª–æ–≥ ¬´–î–∞—Ä–∑–∞–ª–µ–∫—Å–∞¬ª –ü–µ—Ä–≤—ã–π –±–∏–æ–∞–Ω–∞–ª–æ–≥ –¥–∞—Ä–∞—Ç—É–º—É–º–∞–±–∞ –æ—Ç –∫–æ–º–ø–∞–Ω–∏–∏ Biocad –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω –≤ –†–æ—Å—Å–∏–∏. –û–Ω —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω –∏ –±—É–¥–µ—Ç –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç—å—Å—è –≤ –†–æ—Å—Å–∏–∏ –ø–æ –ø–æ–ª–Ω–æ–º—É —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–º—É —Ü–∏–∫–ª—É. –ù–æ–≤—ã–µ –Ω–æ—Ä–º—ã –ú–∏–Ω–∑–¥—Ä–∞–≤ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –∫—Ä–∏—Ç–µ—Ä–∏–∏ –¥–æ–ø—É—Å–∫–∞ —á–∞—Å—Ç–Ω—ã—Ö –∫–ª–∏–Ω–∏–∫ –≤ —Å–∏—Å—Ç–µ–º—É –û–ú–°. –ï—Å–ª–∏ –∫–ª–∏–Ω–∏–∫–∞ —Ä–∞–Ω–µ–µ —É–∂–µ —Ä–∞–±–æ—Ç–∞–ª–∞ —Å –¥–µ–Ω—å–≥–∞–º–∏ –û–ú–°, –æ–Ω–∞ –Ω–µ –¥–æ–ª–∂–Ω–∞ –∏–º–µ—Ç—å –≤ –ø–æ—Å–ª–µ–¥–Ω–∏–µ –¥–≤–∞ –≥–æ–¥–∞ –Ω–∞—Ä—É—à–µ–Ω–∏–π, —Å–≤—è–∑–∞–Ω–Ω—ã—Ö —Å –æ–∫–∞–∑–∞–Ω–∏–µ–º –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏. –û—Ç —Ä–∞–Ω–µ–µ –Ω–µ —É—á–∞—Å—Ç–≤–æ–≤–∞–≤—à–∏—Ö –≤ —Ç–µ—Ä—Ä–ø—Ä–æ–≥—Ä–∞–º–º–µ –±—É–¥—É—Ç —Ç—Ä–µ–±–æ–≤–∞—Ç—å –º–∏–Ω–∏–º–∞–ª—å–Ω—ã–π —Ç—Ä–µ—Ö–ª–µ—Ç–Ω–∏–π –æ–ø—ã—Ç —Ä–∞–±–æ—Ç—ã –Ω–∞ —Ä—ã–Ω–∫–µ. –í—Ä–µ–¥ –∑–¥–æ—Ä–æ–≤—å—é –í –†–æ—Å—Å–∏–∏ –æ–±–Ω–æ–≤–∏–ª–∏ –ø–æ—Ä—è–¥–æ–∫ –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–∏—è —Ç—è–∂–µ—Å—Ç–∏ –≤—Ä–µ–¥–∞ –∑–¥–æ—Ä–æ–≤—å—é: —Ç–µ–ø–µ—Ä—å –ø–æ—Å–ª–µ–¥—Å—Ç–≤–∏—è –≤—Ä–æ–¥–µ —É—Ç—Ä–∞—Ç—ã —Ñ—É–Ω–∫—Ü–∏–π –æ—Ä–≥–∞–Ω–æ–≤, –ø—Å–∏—Ö–∏—á–µ—Å–∫–∏—Ö —Ä–∞—Å—Å—Ç—Ä–æ–π—Å—Ç–≤ –∏–ª–∏ –æ–±–µ–∑–æ–±—Ä–∞–∂–∏–≤–∞–Ω–∏—è –ª–∏—Ü–∞ –±—É–¥—É—Ç –∫–ª–∞—Å—Å–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞—Ç—å—Å—è –ø–æ –æ–±—â–∏–º –∫–∞—Ç–µ–≥–æ—Ä–∏—è–º –≤—Ä–µ–¥–∞ ‚Äî —Ç—è–∂–∫–∏–π, —Å—Ä–µ–¥–Ω–µ–π —Ç—è–∂–µ—Å—Ç–∏ –∏–ª–∏ –ª–µ–≥–∫–∏–π.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""Two of the largest e-commerce platforms, Yandex and Wildberries, announced plans to launch services for delivering and reserving medicines. Experts believe this could significantly alter both the e-prescription market and traditional pharmacy retail. A biologic analog of daratumumab from Biocad company has been registered in Russia. The new guidelines by the Ministry of Health set criteria for private clinics to join the Outpatient Medical Scheme (OMS). Clinics that have previously worked with OMS are exempt from recent requirements if they haven't had any issues related to medical care in the past two years. For clinics that have not previously participated, they are required to have a minimum three-year experience on the market.""
}"
2025-08-22T14:06:48+00:00,@medpharm,12609,https://t.me/medpharm/12609,–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –ø—Ä–æ–¥–ª–∏–ª–æ –Ω–∞ –≥–æ–¥ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –æ–±–Ω–æ–≤–∏—Ç—å —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–æ–Ω–Ω—ã–µ –¥–æ—Å—å–µ –Ω–∞ –º–µ–¥–∏–∑–¥–µ–ª–∏—è. –î–æ —Å–µ–Ω—Ç—è–±—Ä—è 2026 –≥–æ–¥–∞ –∑–∞—Ä—É–±–µ–∂–Ω—ã–º –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º –Ω—É–∂–Ω–æ –Ω–∞–∑–Ω–∞—á–∏—Ç—å —É–ø–æ–ª–Ω–æ–º–æ—á–µ–Ω–Ω—ã—Ö –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–µ–π.,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""registration, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The government has extended the one-year period for updating registration dossiers on medical products. Foreign manufacturers need to appoint authorized representatives by September 2026.""
}"
2025-08-22T11:54:01+00:00,@medpharm,12608,https://t.me/medpharm/12608,"–†–µ–≥—É–ª—è—Ç–æ—Ä —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –∫—Ä–∏—Ç–µ—Ä–∏–∏ –¥–æ–ø—É—Å–∫–∞ —á–∞—Å—Ç–Ω—ã—Ö –∫–ª–∏–Ω–∏–∫ –≤ —Å–∏—Å—Ç–µ–º—É –û–ú–°. –ï—Å–ª–∏ –∫–ª–∏–Ω–∏–∫–∞ —Ä–∞–Ω–µ–µ —É–∂–µ —Ä–∞–±–æ—Ç–∞–ª–∞ —Å –¥–µ–Ω—å–≥–∞–º–∏ –û–ú–°, –æ–Ω–∞ –Ω–µ –¥–æ–ª–∂–Ω–∞ –∏–º–µ—Ç—å –≤ –ø–æ—Å–ª–µ–¥–Ω–∏–µ –¥–≤–∞ –≥–æ–¥–∞ –Ω–∞—Ä—É—à–µ–Ω–∏–π, —Å–≤—è–∑–∞–Ω–Ω—ã—Ö —Å –æ–∫–∞–∑–∞–Ω–∏–µ–º –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The regulator has developed criteria for private clinics to join the OMS system. Clinics that have previously worked with OMS funds must not have any medical care-related issues in the last two years.""
}"
2025-08-22T10:06:42+00:00,@medpharm,12607,https://t.me/medpharm/12607,"–í –ú–æ—Å–∫–≤–µ –∑–∞–¥–µ—Ä–∂–∞–Ω –±—ã–≤—à–∏–π –º–∏–Ω–∏—Å—Ç—Ä –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –•–∞–±–∞—Ä–æ–≤—Å–∫–æ–≥–æ –∫—Ä–∞—è –Æ—Ä–∏–π –ë–æ–π—á–µ–Ω–∫–æ, –æ–±–≤–∏–Ω—è–µ–º—ã–π –≤ —Ö–∏—â–µ–Ω–∏–∏ —Å–≤—ã—à–µ 120 –º–ª–Ω —Ä—É–±. –ï–≥–æ –¥–µ–ª–æ —Å–≤—è–∑–∞–Ω–æ —Å –∫–æ—Ä—Ä—É–ø—Ü–∏–æ–Ω–Ω—ã–º —Ä–∞—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ–º –ø—Ä–æ—Ç–∏–≤ –±—ã–≤—à–µ–≥–æ –∑–∞–º–ø—Ä–µ–¥–∞ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –∫—Ä–∞—è, –ø–∏—à–µ—Ç ¬´–ê–∏–§¬ª.","{""skip"": true}"
2025-08-22T08:31:25+00:00,@medpharm,12606,https://t.me/medpharm/12606,J&J –∏–Ω–≤–µ—Å—Ç–∏—Ä—É–µ—Ç –µ—â–µ 2 –º–ª—Ä–¥ –¥–æ–ª–ª. –≤ —Ä–∞—Å—à–∏—Ä–µ–Ω–∏–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã—Ö –º–æ—â–Ω–æ—Å—Ç–µ–π –≤ –°–®–ê. –ö–æ–º–ø–∞–Ω–∏—è –ø–æ–¥–ø–∏—Å–∞–ª–∞ —Å–¥–µ–ª–∫—É —Å —è–ø–æ–Ω—Å–∫–æ–π Fujifilm –æ —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–µ –Ω–æ–≤–æ–≥–æ –∑–∞–≤–æ–¥–∞ –ø–ª–æ—â–∞–¥—å—é –ø–æ—á—Ç–∏ 15 —Ç—ã—Å. –∫–≤. –º –∏–∑-–∑–∞ —É–≥—Ä–æ–∑ –∞–¥–º–∏–Ω–∏—Å—Ç—Ä–∞—Ü–∏–∏ –¢—Ä–∞–º–ø–∞ –≤–≤–µ—Å—Ç–∏ –ø–æ—à–ª–∏–Ω—ã –Ω–∞ –∏–º–ø–æ—Ä—Ç —Ñ–∞—Ä–º–ø—Ä–æ–¥—É–∫—Ü–∏–∏.,"{""skip"": true}"
2025-08-21T16:02:08+00:00,@medpharm,12604,https://t.me/medpharm/12604,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 21 –∞–≤–≥—É—Å—Ç–∞ –î–≤–∏–∂–µ–Ω–∏–µ –Ω–∞–≤—Å—Ç—Ä–µ—á—É Wildberries –Ω–∞—á–∞–ª —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–æ —Å ¬´–ï–∞–ø—Ç–µ–∫–æ–π¬ª. –ü–æ–∫—É–ø–∞—Ç–µ–ª—è–º –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞ –±—É–¥—É—Ç –¥–æ—Å—Ç–∞–≤–ª—è—Ç—å –¥–æ –¥–≤–µ—Ä–∏ –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç—ã –∏–∑ –∞–ø—Ç–µ—á–Ω–æ–π —Å–µ—Ç–∏ –≤ 47 —Ä–µ–≥–∏–æ–Ω–∞—Ö –†–æ—Å—Å–∏–∏. –°–¥–µ–ª–∫—É –ø–æ –ø—Ä–æ–¥–∞–∂–µ ¬´–ï–∞–ø—Ç–µ–∫–∏¬ª –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å—É –æ–±—Å—É–∂–¥–∞—é—Ç –Ω–∞ —Ä—ã–Ω–∫–µ —Å –Ω–∞—á–∞–ª–∞ –≥–æ–¥–∞. –û–±–Ω–æ–≤–ª–µ–Ω–∏–µ —Ñ–æ—Ä–º –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä –≥–æ—Ç–æ–≤–∏—Ç—Å—è –∑–∞–º–µ–Ω–∏—Ç—å —á–µ–∫-–ª–∏—Å—Ç—ã –≤ —Å—Ñ–µ—Ä–µ –æ–±—Ä–∞—â–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤. –ë–æ–ª—å—à–∞—è —á–∞—Å—Ç—å –ø—Ä–æ–≤–µ—Ä–æ—á–Ω—ã—Ö –ª–∏—Å—Ç–æ–≤ –±—É–¥–µ—Ç –¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å –¥–æ —Å–µ–Ω—Ç—è–±—Ä—è 2031 –≥–æ–¥–∞. –§–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏–µ –ø—Ä–µ–∫—Ä–∞—Ç–∏–ª–∏ –ë–ª–∞–≥–æ—Ç–≤–æ—Ä–∏—Ç–µ–ª—å–Ω—ã–π —Ñ–æ–Ω–¥ ¬´–°–ü–ò–î.–¶–ï–ù–¢–†¬ª –æ–±—ä—è–≤–∏–ª –æ —Å–±–æ—Ä–µ –ø–æ–∂–µ—Ä—Ç–≤–æ–≤–∞–Ω–∏–π –Ω–∞ –ø—Ä–æ–¥–æ–ª–∂–µ–Ω–∏–µ —Ä–∞–±–æ—Ç—ã –∏–∑-–∑–∞ –ø—Ä–µ–∫—Ä–∞—â–µ–Ω–∏—è –≥–æ—Å—Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è. –°–∫–æ—Ä–µ–µ –≤—Å–µ–≥–æ, –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –ø—Ä–∏–¥–µ—Ç—Å—è –æ—Ç–∫–∞–∑–∞—Ç—å—Å—è –æ—Ç —á–∞—Å—Ç–∏ –ø—Ä–æ–µ–∫—Ç–æ–≤ –ø–æ –ø–æ–¥–¥–µ—Ä–∂–∫–µ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –≤ —Ç–æ–º —á–∏—Å–ª–µ –±–µ—Å–ø–ª–∞—Ç–Ω–æ–≥–æ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª–µ–Ω–∏—è –∞–Ω—Ç–∏—Ä–µ—Ç—Ä–æ–≤–∏—Ä—É—Å–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –†–∞–∑–≤–∏—Ç–∏–µ –º–µ–¥—Ç—É—Ä–∏–∑–º–∞ –ú–∏–Ω–∑–¥—Ä–∞–≤ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç –∏–∑—É—á–∏—Ç—å —É–∂–µ –∏—Å–ø–æ–ª—å–∑—É–µ–º—ã–µ —Ñ–æ—Ä–º–∞—Ç—ã –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏—è —Å –∫–æ–º–ø–∞–Ω–∏—è–º–∏-–ø–æ—Å—Ä–µ–¥–Ω–∏–∫–∞–º–∏, –∫–æ—Ç–æ—Ä—ã–µ —Å–æ—Ç—Ä—É–¥–Ω–∏—á–∞—é—Ç —Å –∫—Ä—É–ø–Ω—ã–º–∏ –∫–ª–∏–Ω–∏–∫–∞–º–∏ –∏ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã–º–∏ —Ü–µ–Ω—Ç—Ä–∞–º–∏ –ø–æ –ø—Ä–∏–≤–ª–µ—á–µ–Ω–∏—é –∏–Ω–æ—Å—Ç—Ä–∞–Ω—Ü–µ–≤ –≤ –∫–∞—á–µ—Å—Ç–≤–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ç—É—Ä–∏—Å—Ç–æ–≤. –°—Ç–∞–≤–∏—Ç—Å—è —Ü–µ–ª—å –¥–∞–ª—å–Ω–µ–π—à–µ–≥–æ —É–≤–µ–ª–∏—á–µ–Ω–∏—è –æ–±—ä–µ–º–æ–≤ –∏ —Å–æ—Å—Ç–∞–≤–∞ —ç–∫—Å–ø–æ—Ä—Ç–∏—Ä—É–µ–º—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —É—Å–ª—É–≥ –∏ –ø—Ä–∏–≤–ª–µ—á–µ–Ω–∏—è –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–π –≤ –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—É—é —ç–∫–æ–Ω–æ–º–∏–∫—É.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""A market platform is providing door-to-door medication delivery in 47 regions of Russia. The deal to sell Eaptek by the market platform is being discussed on the market since the beginning of this year. The update from Roszdravnadzor for drug product regulation is preparing to replace the checklists. Most of the verification lists will be valid until September 2031. The SPID.CENTR charitable foundation announced a fundraising campaign to continue operations due to the cessation of state funding. The organization may have to discontinue some patient support projects, including free provision of antiretroviral drugs. The Ministry of Health plans to study existing interaction formats with companies that collaborate with large clinics and federal centers for attracting foreign patients as medical tourists. The goal is to further increase the volume and composition of exported healthcare services and attract investments into the national economy.""
}"
2025-08-21T14:34:05+00:00,@medpharm,12603,https://t.me/medpharm/12603,"–ë–∏–∑–Ω–µ—Å –∏ –ø—Ä–æ—Ñ—Å–æ—é–∑—ã –∑–∞—è–≤–∏–ª–∏ –æ —Ä–æ—Å—Ç–µ —Å–∫—Ä—ã—Ç–æ–π –±–µ–∑—Ä–∞–±–æ—Ç–∏—Ü—ã. ¬´–ú–í¬ª —É–∑–Ω–∞–ª, –∑–∞—Ç—Ä–æ–Ω—É—Ç –ª–∏ —ç—Ç–∏ —Ä–∏—Å–∫–∏ —Å—Ñ–µ—Ä—É –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è, –≤ –∫–æ—Ç–æ—Ä–æ–π –∏ —Ç–∞–∫ –Ω–∞–±–ª—é–¥–∞–µ—Ç—Å—è –∫–∞–¥—Ä–æ–≤—ã–π –¥–µ—Ñ–∏—Ü–∏—Ç.","{""skip"": true}"
2025-08-21T13:16:48+00:00,@medpharm,12602,https://t.me/medpharm/12602,"#—ç–∫—Å–∫–ª—é–∑–∏–≤ –§–æ–Ω–¥ ¬´–°–ü–ò–î.–¶–ï–ù–¢–†¬ª –æ–±—ä—è–≤–∏–ª –æ —Å–±–æ—Ä–µ –ø–æ–∂–µ—Ä—Ç–≤–æ–≤–∞–Ω–∏–π –∏–∑-–∑–∞ –æ—Ç–∫–∞–∑–∞ –≤ –≥–æ—Å–≥—Ä–∞–Ω—Ç–∞—Ö. –°–∫–æ—Ä–µ–µ –≤—Å–µ–≥–æ, –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –ø—Ä–∏–¥–µ—Ç—Å—è –æ—Ç–∫–∞–∑–∞—Ç—å—Å—è –æ—Ç —á–∞—Å—Ç–∏ –ø—Ä–æ–µ–∫—Ç–æ–≤ –ø–æ –ø–æ–¥–¥–µ—Ä–∂–∫–µ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –≤ —Ç–æ–º —á–∏—Å–ª–µ –±–µ—Å–ø–ª–∞—Ç–Ω–æ–≥–æ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª–µ–Ω–∏—è –∞–Ω—Ç–∏—Ä–µ—Ç—Ä–æ–≤–∏—Ä—É—Å–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""The exclusive Fund 'SID.CENTER' announced a fundraising initiative due to the lack of government grants. It is likely that the organization will have to abandon some projects aimed at supporting patients, including free provision of antiretroviral drugs.""
}"
2025-08-21T12:19:01+00:00,@medpharm,12601,https://t.me/medpharm/12601,–†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä –≤—ã–Ω–µ—Å –Ω–∞ –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–µ –æ–±—Å—É–∂–¥–µ–Ω–∏–µ –ø—Ä–æ–µ–∫—Ç —á–µ–∫-–ª–∏—Å—Ç–æ–≤ –¥–ª—è –∫–æ–Ω—Ç—Ä–æ–ª—è –∫–∞—á–µ—Å—Ç–≤–∞ –º–µ–¥–¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏. –û–Ω–∏ –±—É–¥—É—Ç —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–æ–≤–∞—Ç—å –Ω–æ–≤—ã–º –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–º —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏—è–º –∏ –¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å –¥–æ 2031 –≥–æ–¥–∞.,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""clinical_trial, regulation"",
  ""impact"": ""high"",
  ""english"": ""Roszdranad–∑–æ—Ä has published draft checklists for the quality control of medical activities. These will align with new clinical recommendations and be in effect until 2031.""
}"
2025-08-21T10:18:14+00:00,@medpharm,12600,https://t.me/medpharm/12600,"–°–µ–≥–æ–¥–Ω—è –Ω–∞ –≥–ª–∞–≤–Ω–æ–µ —Ñ–∞—Ä–º—Å–æ–±—ã—Ç–∏–µ —ç—Ç–æ–π –æ—Å–µ–Ω–∏ –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏—é ¬´PRO–µ–∫—Ü–∏–∏ –±—É–¥—É—â–µ–≥–æ¬ª –≤–∞—Å –ø—Ä–∏–≥–ª–∞—à–∞–µ—Ç üîπ–ù–∞—Ç–∞–ª–∏—è –ö–∞—à–∏—Ä–∏–Ω–∞, –æ—Å–Ω–æ–≤–∞—Ç–µ–ª—å –Ω–µ–∑–∞–≤–∏—Å–∏–º–æ–≥–æ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ —Å–æ–æ–±—â–µ—Å—Ç–≤–∞ SFE Academy, —ç–∫–æ—Å–∏—Å—Ç–µ–º—ã Pharma&Medical Recruitment, —Å–ø–∏–∫–µ—Ä ¬´–∫—Ä—É–≥–ª–æ–≥–æ —Å—Ç–æ–ª–∞¬ª –ø–æ –∫–∞–¥—Ä–∞–º ¬´–ö–æ–≥–æ –Ω–µ —Ö–≤–∞—Ç–∞–µ—Ç —Ñ–∞—Ä–º–µ. –ö–∞–¥—Ä–æ–≤—ã–π –∫—Ä–∏–∑–∏—Å, –¥–µ—Ñ–∏—Ü–∏—Ç –∫–æ–º–ø–µ—Ç–µ–Ω—Ü–∏–π –∏ —Å—Ä–æ—á–Ω–∞—è –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç—å –∏–∑–º–µ–Ω–µ–Ω–∏–π¬ª –î–∞—Ç–∞ –∏ –≤—Ä–µ–º—è —Å–µ—Å—Å–∏–∏: 11 —Å–µ–Ω—Ç—è–±—Ä—è 2025, 17:00 üìç–≥. –°–æ—á–∏, Pullman –°–æ—á–∏ –¶–µ–Ω—Ç—Ä 5* –ë—É–¥—å—Ç–µ –≤ –∫—É—Ä—Å–µ –∏–∑–º–µ–Ω–µ–Ω–∏–π –≤ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏! 90% –º–µ—Å—Ç —É–∂–µ –∑–∞–Ω—è—Ç–æ ‚Äî —É—Å–ø–µ–π—Ç–µ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞—Ç—å—Å—è","{""skip"": true}"
2025-08-21T10:06:38+00:00,@medpharm,12599,https://t.me/medpharm/12599,–ö—É—Ä—á–∞—Ç–æ–≤—Å–∫–∏–π –∏–Ω—Å—Ç–∏—Ç—É—Ç –∑–∞–π–º–µ—Ç—Å—è —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–æ–π –∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ–º –ª–µ–∫–∞—Ä—Å—Ç–≤. –ú–∏–Ω–æ–±—Ä–Ω–∞—É–∫–∏ –ø–æ–¥–≥–æ—Ç–æ–≤–∏–ª–æ –ø—Ä–æ–µ–∫—Ç –∏–∑–º–µ–Ω–µ–Ω–∏–π –≤ —É—Å—Ç–∞–≤ —É—á—Ä–µ–∂–¥–µ–Ω–∏—è.,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Education and Science in Russia has prepared a project to change the institution's charter, with Kurchatov Institute working on drug development and production.""
}"
2025-08-21T08:17:25+00:00,@medpharm,12598,https://t.me/medpharm/12598,"#—ç–∫—Å–∫–ª—é–∑–∏–≤ –ú–∏–Ω–∑–¥—Ä–∞–≤ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç –∏–∑—É—á–∏—Ç—å —É–∂–µ –∏—Å–ø–æ–ª—å–∑—É–µ–º—ã–µ —Ñ–æ—Ä–º–∞—Ç—ã –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏—è —Å –∫–æ–º–ø–∞–Ω–∏—è–º–∏-–ø–æ—Å—Ä–µ–¥–Ω–∏–∫–∞–º–∏, –∫–æ—Ç–æ—Ä—ã–µ —Å–æ—Ç—Ä—É–¥–Ω–∏—á–∞—é—Ç —Å –∫—Ä—É–ø–Ω—ã–º–∏ –∫–ª–∏–Ω–∏–∫–∞–º–∏ –∏ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã–º–∏ —Ü–µ–Ω—Ç—Ä–∞–º–∏ –ø–æ –ø—Ä–∏–≤–ª–µ—á–µ–Ω–∏—é –∏–Ω–æ—Å—Ç—Ä–∞–Ω—Ü–µ–≤ –≤ –∫–∞—á–µ—Å—Ç–≤–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ç—É—Ä–∏—Å—Ç–æ–≤. –°—Ç–∞–≤–∏—Ç—Å—è —Ü–µ–ª—å –¥–∞–ª—å–Ω–µ–π—à–µ–≥–æ —É–≤–µ–ª–∏—á–µ–Ω–∏—è –æ–±—ä–µ–º–æ–≤ –∏ —Å–æ—Å—Ç–∞–≤–∞ —ç–∫—Å–ø–æ—Ä—Ç–∏—Ä—É–µ–º—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —É—Å–ª—É–≥ –∏ –ø—Ä–∏–≤–ª–µ—á–µ–Ω–∏—è –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–π –≤ –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—É—é —ç–∫–æ–Ω–æ–º–∏–∫—É.","{""skip"": true}"
2025-08-20T16:06:59+00:00,@medpharm,12597,https://t.me/medpharm/12597,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 20 –∞–≤–≥—É—Å—Ç–∞ –ü–æ—Ö–æ–¥–∞ –∫ –≤—Ä–∞—á—É –±–æ—è—Ç—Å—è –ü–æ—á—Ç–∏ –ø–æ–ª–æ–≤–∏–Ω–∞ –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö —Ä–æ—Å—Å–∏—è–Ω —Å–æ–æ–±—â–∏–ª–∞, —á—Ç–æ –±–æ–∏—Ç—Å—è –≤—Ä–∞—á–µ–π –≤—Å–µ–≥–¥–∞ –∏–ª–∏ –≤ –Ω–µ–∫–æ—Ç–æ—Ä—ã—Ö —Å–∏—Ç—É–∞—Ü–∏—è—Ö. –°—Ç—Ä–∞—Ö–∏ —á–∞—â–µ –≤—Å–µ–≥–æ —Å–≤—è–∑–∞–Ω—ã —Å –æ–∂–∏–¥–∞–Ω–∏–µ–º –±–æ–ª–∏, –Ω–µ–≥–∞—Ç–∏–≤–Ω—ã–º –æ–ø—ã—Ç–æ–º, –±–æ—è–∑–Ω—å—é –ø–æ–ø–∞—Å—Ç—å –∫ –Ω–µ–∫–≤–∞–ª–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω–æ–º—É –≤—Ä–∞—á—É. –ù–æ–≤—ã–µ —Å—Ç–∞–Ω–¥–∞—Ä—Ç—ã –ú–∏–Ω–∑–¥—Ä–∞–≤ —É—Ç–≤–µ—Ä–¥–∏–ª —Å—Ç–∞–Ω–¥–∞—Ä—Ç—ã –º–µ–¥–ø–æ–º–æ—â–∏ –≤–∑—Ä–æ—Å–ª—ã–º –ø—Ä–∏ —Å–æ—Ç—Ä—è—Å–µ–Ω–∏–∏ –º–æ–∑–≥–∞, –æ—Ç–∫—Ä—ã—Ç–æ–π —Ä–∞–Ω–µ –≥–æ–ª–æ–≤—ã –∏ –æ—á–∞–≥–æ–≤–æ–π —Ç—Ä–∞–≤–º–µ. –ü–µ—Ä–≤—ã–µ –¥–≤–∞ –æ—Ö–≤–∞—Ç—ã–≤–∞—é—Ç –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫—É –∏ –ª–µ—á–µ–Ω–∏–µ, –ø–æ—Å–ª–µ–¥–Ω–∏–π ‚Äî –µ—â–µ –∏ –¥–∏—Å–ø–∞–Ω—Å–µ—Ä–Ω–æ–µ –Ω–∞–±–ª—é–¥–µ–Ω–∏–µ. –ï—Å—Ç—å –≤–æ–ø—Ä–æ—Å –ó–∞ –ø–æ—Å–ª–µ–¥–Ω–∏–µ —á–µ—Ç—ã—Ä–µ –≥–æ–¥–∞ —Ä–∞—Å—Ö–æ–¥—ã –±—é–¥–∂–µ—Ç–∞ –Ω–∞ –ª—å–≥–æ—Ç–Ω—ã–µ –ø—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –≤—ã—Ä–æ—Å–ª–∏ –±–æ–ª–µ–µ —á–µ–º –≤ –¥–≤–∞ —Ä–∞–∑–∞. –¢–∞–∫–∏–µ –¥–∞–Ω–Ω—ã–µ –ú–∏–Ω–∑–¥—Ä–∞–≤ –ø—Ä–∏–≤–æ–¥–∏—Ç –Ω–∞ —Ñ–æ–Ω–µ –æ–±—Ä–∞—â–µ–Ω–∏—è –ø–∞—Ü–∏–µ–Ω—Ç—Å–∫–æ–π –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏, –ø–æ–ø—Ä–æ—Å–∏–≤—à–µ–π –æ–±—Ä–∞—Ç–∏—Ç—å –≤–Ω–∏–º–∞–Ω–∏–µ –Ω–∞ –ª—å–≥–æ—Ç–Ω–æ–µ –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ –æ–Ω–∫–æ–ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –í—Å–µ –µ—â–µ –Ω–µ–ª—å–∑—è –ú–∏–Ω—Ç—Ä—É–¥ –ø—Ä–æ–¥–ª–µ–≤–∞–µ—Ç –Ω–∞ 2026 –≥–æ–¥ –∑–∞–ø—Ä–µ—Ç –Ω–∞ —Ä–∞–±–æ—Ç—É –∏–Ω–æ—Å—Ç—Ä–∞–Ω—Ü–µ–≤ –≤ –∞–ø—Ç–µ–∫–∞—Ö. –ó–∞–ø—Ä–µ—Ç –Ω–∞ –Ω–∞–π–º –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã—Ö —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –≤ –∞–ø—Ç–µ–∫–∏ –±—ã–ª —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω –≤ 2013 –≥–æ–¥—É –∏ –Ω–µ –æ—Ç–º–µ–Ω—è–ª—Å—è.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The country is facing shortages of subsidized oncological drugs, with spending on them increasing by more than twice over the past four years. The Ministry of Health has extended the ban on hiring foreign workers in pharmacies until 2026, which was introduced in 2013 and has not been lifted.""
}"
2025-08-20T15:38:06+00:00,@medpharm,12596,https://t.me/medpharm/12596,"–ö–æ–º–∏—Å—Å–∏—è –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ø–µ—Ä–µ–Ω–µ—Å–ª–∞ –≤–æ–ø—Ä–æ—Å –≤–∫–ª—é—á–µ–Ω–∏—è –ø—ç–≥—É–Ω–∏–≥–∞–ª–∑–∏–¥–∞–∑—ã –∞–ª—å—Ñ–∞ –≤ –ñ–ù–í–õ–ü –Ω–∞ –Ω–æ—è–±—Ä—å. –°—Ä–µ–¥–∏ –ø—Ä–∏—á–∏–Ω ‚Äì –ø–æ–¥–Ω—è—Ç—ã–µ –Ω–∞ –∑–∞—Å–µ–¥–∞–Ω–∏–∏ –≤–æ–ø—Ä–æ—Å—ã –ø–æ —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–π –∏ –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–π —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞. –í—ã—è—Å–Ω–∏–ª–æ—Å—å, —á—Ç–æ –¥–∞–Ω–Ω—ã–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è BALANCE –Ω–µ –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–∞—é—Ç –µ–≥–æ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ –ø—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–∞ –ø–µ—Ä–µ–¥ –∞–≥–∞–ª—Å–∏–¥–∞–∑–æ–π –±–µ—Ç–∞. –ü–æ—ç—Ç–æ–º—É –¥–ª—è —Ä—è–¥–∞ –µ–≤—Ä–æ–ø–µ–π—Å–∫–∏—Ö —Ä–µ–≥—É–ª—è—Ç–æ—Ä–æ–≤ –¥–∞–∂–µ –±–æ–ª–µ–µ –Ω–∏–∑–∫–∞—è —Ü–µ–Ω–∞ –ø—ç–≥—É–Ω–∏–≥–∞–ª–∑–∏–¥–∞–∑—ã –∞–ª—å—Ñ–∞ –Ω–µ —Å—Ç–∞–ª–∞ –∞—Ä–≥—É–º–µ–Ω—Ç–æ–º. –í –†–æ—Å—Å–∏–∏ —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–∞—è –≤—ã–≥–æ–¥–∞ –≤ 2% –∞–∫—Ç—É–∞–ª—å–Ω–∞ —Ç–æ–ª—å–∫–æ –¥–ª—è –æ—Ç–¥–µ–ª—å–Ω–æ–π —É–∑–∫–æ–π –≥—Ä—É–ø–ø—ã –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –î–ª—è –æ—Å—Ç–∞–ª—å–Ω—ã—Ö –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω—É—é —ç–∫–æ–Ω–æ–º–∏—é –±—é–¥–∂–µ—Ç–∞ –¥–∞–µ—Ç –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –∞–≥–∞–ª—Å–∏–¥–∞–∑—ã –±–µ—Ç–∞.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The Commission of the Ministry of Health has postponed the inclusion of pegylated azabeta in the –ñ–ù–í–õ–ü until November. Reasons include raised questions about economic and clinical effectiveness of the drug during the meeting. It was discovered that data from the BALANCE study do not confirm its clinical advantages over galbidazole beta. For several European regulators, even a lower price of pegylated azabeta is not an argument. For the majority of patients, significant cost savings for the budget are achieved by using domestically produced galbidazole beta.""
}"
2025-08-20T13:33:43+00:00,@medpharm,12595,https://t.me/medpharm/12595,"–ú–æ–±–∏–ª—å–Ω–æ–π –≤–µ—Ä—Å–∏–µ–π —ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω–æ–π –º–µ–¥–∫–∞—Ä—Ç—ã –≤ –ú–æ—Å–∫–≤–µ –ø–æ–ª—å–∑—É—é—Ç—Å—è –ø–æ—á—Ç–∏ 6 –º–ª–Ω —á–µ–ª–æ–≤–µ–∫, –∑–∞ –≥–æ–¥ –µ–µ –ø–æ–ø—É–ª—è—Ä–Ω–æ—Å—Ç—å –≤—ã—Ä–æ—Å–ª–∞ –≤ –ø–æ–ª—Ç–æ—Ä–∞ —Ä–∞–∑–∞. –í ¬´–î–Ω–µ–≤–Ω–∏–∫ –∑–¥–æ—Ä–æ–≤—å—è¬ª –≤–Ω–µ—Å–µ–Ω–æ —Å–≤—ã—à–µ 330 –º–ª–Ω –∑–∞–ø–∏—Å–µ–π, –∞ –≤ –∫–∞—Ä—Ç—ã –∑–∞–≥—Ä—É–∂–µ–Ω–æ –±–æ–ª–µ–µ 4,8 –º–ª–Ω –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤.","{""skip"": true}"
2025-08-20T11:34:01+00:00,@medpharm,12594,https://t.me/medpharm/12594,"–î–Ω–µ–º —Å –æ–≥–Ω–µ–º. –ö–∞–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã —Ç—Ä—É–¥–Ω–æ –±—ã–ª–æ –Ω–∞–π—Ç–∏ –≤ –∞–ø—Ç–µ–∫–∞—Ö –≤ –∏—é–ª–µ 2025 –≥–æ–¥–∞ –ü—Ä–æ–¥–∞–∂–∏ 60 –ú–ù–ù —Å–Ω–∏–∑–∏–ª–∏—Å—å –∑–∞ —à–µ—Å—Ç—å –º–µ—Å—è—Ü–µ–≤ –±–æ–ª–µ–µ —á–µ–º –Ω–∞ 20% –≥–æ–¥ –∫ –≥–æ–¥—É. –û–¥–Ω–∞–∫–æ —Å–Ω–∏–∂–µ–Ω–∏–µ –ø—Ä–æ–¥–∞–∂ –µ—â–µ –Ω–µ –≥–æ–≤–æ—Ä–∏—Ç –æ –¥–µ—Ñ–µ–∫—Ç—É—Ä–µ. –í–æ–∑–º–æ–∂–Ω–æ, –ø–æ–∫—É–ø–∞—Ç–µ–ª–∏ –ø—Ä–æ—Å—Ç–æ –ø–µ—Ä–µ–∫–ª—é—á–∏–ª–∏—Å—å –Ω–∞ –¥—Ä—É–≥–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞. ¬´–§–í¬ª —Å –ø–æ–º–æ—â—å—é –¥–∞–Ω–Ω—ã—Ö AlphaRM –ø—Ä–æ–∞–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–ª —Å–∏—Ç—É–∞—Ü–∏—é, –∞ —Ç–∞–∫–∂–µ –ø—Ä–æ–≤–µ—Ä–∏–ª –Ω–∞–ª–∏—á–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤ –Ω–∞ –∞–ø—Ç–µ—á–Ω—ã—Ö –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞—Ö, —Å–∞–π—Ç–∞—Ö –∫—Ä—É–ø–Ω—ã—Ö –∞–ø—Ç–µ—á–Ω—ã—Ö —Å–µ—Ç–µ–π. –°—Ç–∞–≤–∫–∏ –≤—ã—Å–æ–∫–∏. –ß–µ–º –∑–∞–∫–æ–Ω—á–∏–ª–∏—Å—å –∑–∞—Å–µ–¥–∞–Ω–∏—è –∫–æ–º–∏—Å—Å–∏–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ø–æ –ñ–ù–í–õ–ü –í—Ä–µ–º–µ–Ω–∞–º–∏ –∑–∞—Å–µ–¥–∞–Ω–∏–µ –∫–æ–º–∏—Å—Å–∏–∏ –ø–æ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—é –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø–µ—Ä–µ—á–Ω–µ–π –±–æ–ª—å—à–µ –ø–æ—Ö–æ–¥–∏–ª–æ –Ω–∞ –∞—É–∫—Ü–∏–æ–Ω, –≥–¥–µ –≤ –∫–∞—á–µ—Å—Ç–≤–µ –ª–æ—Ç–∞ –±—ã–ª –≤—Ö–æ–¥ –≤ –ü–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü. –ù–æ –¥–∞–∂–µ —Å–∞–º–∞—è –Ω–∏–∑–∫–∞—è —Ü–µ–Ω–∞ ‚Äî –Ω–µ –≥–∞—Ä–∞–Ω—Ç–∏—è –Ω–∞ –ø–æ–ø–∞–¥–∞–Ω–∏–µ –≤ —Å–ø–∏—Å–æ–∫. –ù–∞–¥–µ–∂–¥—ã –∏ –æ–ø–æ—Ä–∞. –ö–∞–∫–æ–π –ø–æ–¥–¥–µ—Ä–∂–∫–∏ –∂–¥—É—Ç —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –æ—Ç –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–∞ –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ –Ω–∞–º–µ—Ä–µ–Ω –æ—Ü–µ–Ω–∏—Ç—å –¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ—Å—Ç—å –º–µ—Ä –ø–æ–¥–¥–µ—Ä–∂–∫–∏ —Ñ–∞—Ä–º–∏–Ω–¥—É—Å—Ç—Ä–∏–∏ –∏ –≤ —Å–ª—É—á–∞–µ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ –ø—Ä–æ—Ä–∞–±–æ—Ç–∞—Ç—å –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è –ø–æ –∏—Ö –∞–∫—Ç—É–∞–ª–∏–∑–∞—Ü–∏–∏. ¬´–§–í¬ª –æ–ø—Ä–æ—Å–∏–ª –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –∏ –≤—ã—è—Å–Ω–∏–ª, –∫–∞–∫–æ–π –ø–æ–¥–¥–µ—Ä–∂–∫–∏ –∏–º –Ω–µ —Ö–≤–∞—Ç–∞–µ—Ç. –°–≤–µ–∂–∏–∏ÃÜ –Ω–æ–º–µ—Ä ""–§–í"" ‚Ññ18-19 (1177-1178) –æ—Ç 19.08.2025 —É–∂–µ –¥–æ—Å—Ç—É–ø–µ–Ω –æ–Ω–ª–∞–∏ÃÜ–Ω.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""Sales of over 60 MNNs have dropped by more than 20% year-over-year in the first six months of 2025. However, this does not necessarily indicate a defect. Purchasers may have simply switched to other medications. 'FV' analyzed the situation using AlphaRM data and checked drug availability on marketplaces and large pharmacy networks. Prices are high. The recent meetings of the Health Care List Commission have resembled an auction where only a low price guarantees inclusion in the list. There are hopes and support needed from the government for pharmaceutical manufacturers. The Ministry of Industry and Trade plans to assess the adequacy of support measures for the pharmaceutical industry and revise them if necessary. 'FV' surveyed manufacturers to find out what support they need.""
}"
2025-08-20T09:36:28+00:00,@medpharm,12593,https://t.me/medpharm/12593,"#—ç–∫—Å–∫–ª—é–∑–∏–≤ –ü–æ—á—Ç–∏ –ø–æ–ª–æ–≤–∏–Ω–∞ –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö —Ä–æ—Å—Å–∏—è–Ω —Å–æ–æ–±—â–∏–ª–∞, —á—Ç–æ –±–æ–∏—Ç—Å—è –≤—Ä–∞—á–µ–π –≤—Å–µ–≥–¥–∞ –∏–ª–∏ –≤ –Ω–µ–∫–æ—Ç–æ—Ä—ã—Ö —Å–∏—Ç—É–∞—Ü–∏—è—Ö. –°—Ç—Ä–∞—Ö–∏ —á–∞—â–µ –≤—Å–µ–≥–æ —Å–≤—è–∑–∞–Ω—ã —Å –æ–∂–∏–¥–∞–Ω–∏–µ–º –±–æ–ª–∏, –Ω–µ–≥–∞—Ç–∏–≤–Ω—ã–º –æ–ø—ã—Ç–æ–º, –±–æ—è–∑–Ω—å—é –ø–æ–ø–∞—Å—Ç—å –∫ –Ω–µ–∫–≤–∞–ª–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω–æ–º—É –≤—Ä–∞—á—É.","{""skip"": true}"
2025-08-20T07:39:00+00:00,@medpharm,12592,https://t.me/medpharm/12592,–í –ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–∞–ª–∞—Ç–µ –ø–æ–ø—Ä–æ—Å–∏–ª–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤ —Ä–∞–∑—ä—è—Å–Ω–∏—Ç—å –ø–æ—Ä—è–¥–æ–∫ –ø–æ–¥–ø–∏—Å–∞–Ω–∏—è –ø—Ä–æ—Ç–æ–∫–æ–ª–æ–≤ —á–ª–µ–Ω–∞–º–∏ –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–æ–Ω–Ω—ã—Ö –ø–æ–¥–∫–æ–º–∏—Å—Å–∏–π. –í–æ–ø—Ä–æ—Å –≤–æ–∑–Ω–∏–∫ –≤ —Ö–æ–¥–µ –ø—Ä–æ–≤–µ—Ä–∫–∏ –ø—Ä–æ–∫—É—Ä–∞—Ç—É—Ä–æ–π –∏—Å–ø–æ–ª–Ω–µ–Ω–∏—è —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–∞ –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–æ–Ω–Ω—ã–º–∏ –∫–æ–º–∏—Å—Å–∏—è–º–∏ –ø–æ –¥–æ–ø—É—Å–∫—É –∫ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–π –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã—Ö –≥—Ä–∞–∂–¥–∞–Ω.,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""The National Medical Chamber requested the Ministry of Health to clarify the process for signing protocol documents by members of accreditation subcommittees. The issue arose during a procurator's inspection into the implementation of professional activity licensing requirements by accreditation committees.""
}"
2025-08-19T16:11:24+00:00,@medpharm,12591,https://t.me/medpharm/12591,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 19 –∞–≤–≥—É—Å—Ç–∞ –î–∞–≤–∏ –Ω–∞ –ì–ê–ó –î–ª—è –ø–µ—Ä–µ–¥–≤–∏–∂–Ω—ã—Ö –∞–ø—Ç–µ–∫ –±—É–¥—É—Ç –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å —Å–ø–µ—Ü–∏–∞–ª—å–Ω—ã–µ –∞–≤—Ç–æ–º–æ–±–∏–ª–∏, –∏–∑–≥–æ—Ç–æ–≤–ª–µ–Ω–Ω—ã–µ –Ω–∞ –ì–æ—Ä—å–∫–æ–≤—Å–∫–æ–º –∞–≤—Ç–æ–∑–∞–≤–æ–¥–µ, —Å–æ–æ–±—â–∏–ª –¥–µ–ø—É—Ç–∞—Ç –ì–î –ë–∞–¥–º–∞ –ë–∞—à–∞–Ω–∫–∞–µ–≤. –í —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–µ –ø—Ä–∏–º—É—Ç —É—á–∞—Å—Ç–∏–µ –¥–µ—Å—è—Ç—å —Ä–µ–≥–∏–æ–Ω–æ–≤, –≤ —á–∏—Å–ª–µ –∫–æ—Ç–æ—Ä—ã—Ö –ö—Ä–∞—Å–Ω–æ—è—Ä—Å–∫, –ö–∞–ª–º—ã–∫–∏—è –∏ –ù–∏–∂–Ω–∏–π –ù–æ–≤–≥–æ—Ä–æ–¥. –†–∞—Å–∫—Ä—ã–ª–∏ —Å–≥–æ–≤–æ—Ä –§–ê–° –æ–±–Ω–∞—Ä—É–∂–∏–ª–∞ –∫–∞—Ä—Ç–µ–ª—å –ø—Ä–∏ –ø–æ—Å—Ç–∞–≤–∫–µ –º–µ–¥–∏–∑–¥–µ–ª–∏–π, –≤–∫–ª—é—á–∞—è —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–∏–µ —Å—Ä–µ–¥—Å—Ç–≤–∞ —Ä–µ–∞–±–∏–ª–∏—Ç–∞—Ü–∏–∏, –≤ —Å–µ–º—å —Ä–µ–≥–∏–æ–Ω–æ–≤ –†–æ—Å—Å–∏–∏. –û–±—â–∞—è —Å—É–º–º–∞ –Ω–∞—á–∞–ª—å–Ω—ã—Ö –º–∞–∫—Å–∏–º–∞–ª—å–Ω—ã—Ö —Ü–µ–Ω –∫–æ–Ω—Ç—Ä–∞–∫—Ç–æ–≤ —Å–æ—Å—Ç–∞–≤–∏–ª–∞ 1,57 –º–ª—Ä–¥ —Ä—É–±. –ö–∞–¥—Ä—ã –¥–æ—Ä–æ–∂–∞—é—Ç –ó–∞—Ä–ø–ª–∞—Ç–Ω—ã–π –º–∞–∫—Å–∏–º—É–º –º–µ–¥—Å–µ—Å—Ç—Ä—ã-–ø–µ–¥–∏–∞—Ç—Ä–∞ –≤ —á–∞—Å—Ç–Ω—ã—Ö –∫–ª–∏–Ω–∏–∫–∞—Ö –ú–æ—Å–∫–≤—ã –≤ 2025 –≥–æ–¥—É –¥–æ—Å—Ç–∏–≥ 120 —Ç—ã—Å. —Ä—É–±., —á—Ç–æ –Ω–∞ 20% –≤—ã—à–µ, —á–µ–º –≥–æ–¥–æ–º —Ä–∞–Ω–µ–µ. –ü—Ä–∏ —ç—Ç–æ–º —Å—Ä–µ–¥–Ω–∏–π –≤–æ–∑—Ä–∞—Å—Ç —Å–æ–∏—Å–∫–∞—Ç–µ–ª–µ–π –≤—ã—Ä–æ—Å –¥–æ 43 –ª–µ—Ç. –¢–µ—Ä–∞–ø–∏—è –ø–æ–º–æ–ª–æ–¥–µ–ª–∞ –ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∞—è –∫–∞—Ä–¥–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∞—è –∞—Å—Å–æ—Ü–∏–∞—Ü–∏—è (AHA) –∏ –ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–π –∫–æ–ª–ª–µ–¥–∂ –∫–∞—Ä–¥–∏–æ–ª–æ–≥–∏–∏ (ACC) –æ–ø—É–±–ª–∏–∫–æ–≤–∞–ª–∏ –æ–±–Ω–æ–≤–ª–µ–Ω–Ω—ã–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø–æ –ª–µ—á–µ–Ω–∏—é –∞—Ä—Ç–µ—Ä–∏–∞–ª—å–Ω–æ–π –≥–∏–ø–µ—Ä—Ç–æ–Ω–∏–∏. –í –Ω–∏—Ö —Å–æ—Ö—Ä–∞–Ω–µ–Ω —Ü–µ–ª–µ–≤–æ–π —É—Ä–æ–≤–µ–Ω—å –∞—Ä—Ç–µ—Ä–∏–∞–ª—å–Ω–æ–≥–æ –¥–∞–≤–ª–µ–Ω–∏—è –Ω–∏–∂–µ 130/80 –º–º —Ä—Ç.—Å—Ç., –Ω–æ –Ω–∞—á–∞–ª–æ –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç–æ–∑–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ —Ç–µ–ø–µ—Ä—å —Ä–µ–∫–æ–º–µ–Ω–¥–æ–≤–∞–Ω–æ –Ω–∞ –±–æ–ª–µ–µ —Ä–∞–Ω–Ω–µ–º —ç—Ç–∞–ø–µ.","{
  ""skip"": true
}"
2025-08-19T15:11:24+00:00,@medpharm,12590,https://t.me/medpharm/12590,"–ì—É–±–µ—Ä–Ω–∞—Ç–æ—Ä –ë–µ–ª–≥–æ—Ä–æ–¥—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ —Ä–∞—Å–∫—Ä–∏—Ç–∏–∫–æ–≤–∞–ª –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–µ –≥–æ—Ç–æ–≤–Ω–æ—Å—Ç–∏ —É –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ —Ä–µ–≥–∏–æ–Ω–∞ –∫ –∞—Ç–∞–∫–∞–º –¥—Ä–æ–Ω–æ–≤. –ü–æ —Å–ª–æ–≤–∞–º –í—è—á–µ—Å–ª–∞–≤–∞ –ì–ª–∞–¥–∫–æ–≤–∞, –µ—Å–ª–∏ —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–æ —É—á—Ä–µ–∂–¥–µ–Ω–∏–π –Ω–µ –≥–æ—Ç–æ–≤–æ –∫ —Å–ª–æ–∂–Ω–æ–π —Å–∏—Ç—É–∞—Ü–∏–∏, —ç—Ç–æ –ø—Ä–∏–≤–æ–¥–∏—Ç –∫ –≥–∏–±–µ–ª–∏ –ª—é–¥–µ–π.","{""skip"": true}"
2025-08-19T14:02:01+00:00,@medpharm,12589,https://t.me/medpharm/12589,FDA –æ–¥–æ–±—Ä–∏–ª–æ Papzimeos ‚Äî –ø–µ—Ä–≤—É—é –∏–º–º—É–Ω–æ—Ç–µ—Ä–∞–ø–∏—é –æ—Ç —Ä–µ—Ü–∏–¥–∏–≤–∏—Ä—É—é—â–µ–≥–æ —Ä–µ—Å–ø–∏—Ä–∞—Ç–æ—Ä–Ω–æ–≥–æ –ø–∞–ø–∏–ª–ª–æ–º–∞—Ç–æ–∑–∞ —É –≤–∑—Ä–æ—Å–ª—ã—Ö. –ë–æ–ª–µ–µ –ø–æ–ª–æ–≤–∏–Ω—ã —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –ö–ò –æ–±–æ—à–ª–∏—Å—å –±–µ–∑ —Ö–∏—Ä—É—Ä–≥–∏—á–µ—Å–∫–æ–≥–æ —É–¥–∞–ª–µ–Ω–∏—è –ø–∞–ø–∏–ª–ª–æ–º –∫–∞–∫ –º–∏–Ω–∏–º—É–º –≤ —Ç–µ—á–µ–Ω–∏–µ –≥–æ–¥–∞.,"{""skip"": true}"
2025-08-19T12:02:01+00:00,@medpharm,12588,https://t.me/medpharm/12588,–í –†–æ—Å—Å–∏–∏ –≤–Ω–æ–≤—å –ø–µ—Ä–µ–Ω–µ—Å–ª–∏ —Å—Ä–æ–∫ –ø–æ–ª–Ω–æ–≥–æ –æ—Ç–∫–∞–∑–∞ –æ—Ç –±—É–º–∞–∂–Ω—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∫–Ω–∏–∂–µ–∫. –ò—Ö –º–æ–∂–Ω–æ –±—É–¥–µ—Ç –≤—ã–¥–∞–≤–∞—Ç—å –¥–æ 1 —Å–µ–Ω—Ç—è–±—Ä—è 2026 –≥–æ–¥–∞.,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""registration, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""Russia has extended the deadline for paper medical records to be fully discontinued until September 1, 2026.""
}"
2025-08-19T10:20:08+00:00,@medpharm,12587,https://t.me/medpharm/12587,"üöÄ –§–∞—Ä–º–∞: —Ü–∏—Ñ—Ä–∞, big data –∏ –ò–ò ‚Äî –≤—Å—ë –Ω–∞ –æ–¥–Ω–æ–π –ø–ª–æ—â–∞–¥–∫–µ! üîù–£–∂–µ 28 –æ–∫—Ç—è–±—Ä—è –ø—Ä–æ–π–¥–µ—Ç 17-—è –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏—è ‚Äú–ß—Ç–æ –ø—Ä–æ–∏—Å—Ö–æ–¥–∏—Ç –Ω–∞ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–º —Ä—ã–Ω–∫–µ? –ö—Ä–æ—Å—Å-—Ñ—É–Ω–∫—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–µ –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏–µ –≤ —Ü–∏—Ñ—Ä–æ–≤–æ–º –∫–æ–Ω—Ç—É—Ä–µ"" –æ—Ç –†-–ö–æ–Ω—Ñ! ‚úçÔ∏è–ü–æ–≥–æ–≤–æ—Ä–∏–º –æ —Ç–æ–º, –∫–∞–∫: ‚Ä¢ –æ–±—ä–µ–¥–∏–Ω–∏—Ç—å —Ñ—É–Ω–∫—Ü–∏–∏ –∏ —Å–∏–Ω—Ö—Ä–æ–Ω–∏–∑–∏—Ä–æ–≤–∞—Ç—å –¥–∞–Ω–Ω—ã–µ; ‚Ä¢ —É–±—Ä–∞—Ç—å –±–∞—Ä—å–µ—Ä—ã –º–µ–∂–¥—É –º–∞—Ä–∫–µ—Ç–∏–Ω–≥–æ–º, –Ü–¢, –∞–Ω–∞–ª–∏—Ç–∏–∫–æ–π, –º–µ–¥–ø—Ä–µ–¥–∞–º–∏ –∏ –¥—Ä—É–≥–∏–º–∏ —Ñ—É–Ω–∫—Ü–∏—è–º–∏; ‚Ä¢ –≤—ã—Å—Ç—Ä–æ–∏—Ç—å —Ä–∞–±–æ—Ç—É —Ç–∞–∫, —á—Ç–æ–±—ã –∫–æ–º–∞–Ω–¥–∞ –¥–≤–∏–≥–∞–ª–∞—Å—å –≤–ø–µ—Ä—ë–¥ –±–µ–∑ –ø—Ä–æ–±—É–∫—Å–æ–≤–æ–∫. üë•–ü—Ä–∏—Ö–æ–¥–∏—Ç–µ –≤–º–µ—Å—Ç–µ —Å –∫–æ–ª–ª–µ–≥–∞–º–∏ - –∫–∞–∂–¥—ã–π –Ω–∞–π–¥—ë—Ç —Ü–µ–Ω–Ω–æ–µ –∏–º–µ–Ω–Ω–æ –¥–ª—è —Å–≤–æ–µ–π —Å—Ñ–µ—Ä—ã, –∞ –≤ –∏—Ç–æ–≥–µ –∫–æ–º–∞–Ω–¥–∞ –ø–æ–ª—É—á–∏—Ç –æ–±—â–µ–µ –≤–∏–¥–µ–Ω–∏–µ –∏ –≥–æ—Ç–æ–≤—ã–µ —Å—Ç—Ä–∞—Ç–µ–≥–∏–∏. –í —Ñ–æ–∫—É—Å–µ –ø—Ä–æ–≥—Ä–∞–º–º—ã: üìåBig Data –∏ —É–ø—Ä–∞–≤–ª–µ–Ω—á–µ—Å–∫–∏–µ —Ä–µ—à–µ–Ω–∏—è üìå–°–∫–≤–æ–∑–Ω–∞—è –∞–Ω–∞–ª–∏—Ç–∏–∫–∞ –∏ –æ—Ü–µ–Ω–∫–∞ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ digital-–ø—Ä–æ–µ–∫—Ç–æ–≤ üìå–¶–∏—Ñ—Ä–æ–≤—ã–µ –ø—Ä–æ–¥—É–∫—Ç—ã, –∫–æ—Ç–æ—Ä—ã–µ —É–∂–µ —Ä–∞–±–æ—Ç–∞—é—Ç üìå–¶–∏—Ñ—Ä–∞ –∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ üìå–ò–ò –≤ —Ñ–∞—Ä–º–µ: –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª, –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏—è –∏ —ç—Ç–∏–∫–∞ üìå–ö—Ä–æ—Å—Å-—Ñ—É–Ω–∫—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–µ –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏–µ: –º–∞—Ä–∫–µ—Ç–∏–Ω–≥, IT, –∞–Ω–∞–ª–∏—Ç–∏–∫–∞, –ø—Ä–æ–¥–∞–∂–∏, –º–µ–¥–∏—Ü–∏–Ω–∞ –∏ –¥—Ä. üïí –£—Å–ø–µ–π—Ç–µ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞—Ç—å—Å—è –¥–æ 22 –∞–≤–≥—É—Å—Ç–∞ –∏ —Å—ç–∫–æ–Ω–æ–º—å—Ç–µ –¥–æ 16% —Å—Ç–æ–∏–º–æ—Å—Ç–∏ –±–∏–ª–µ—Ç–∞ (–æ—Ñ–ª–∞–π–Ω-—É—á–∞—Å—Ç–∏–µ) –†–µ–∫–ª–∞–º–∞ –û–û–û ""–†-–ö–æ–Ω—Ñ""","{""skip"": true}"
2025-08-19T10:02:01+00:00,@medpharm,12586,https://t.me/medpharm/12586,"–°—Ç–∞–ª–∏ –∏–∑–≤–µ—Å—Ç–Ω—ã –¥–µ—Ç–∞–ª–∏ –ø–æ –æ—Ç—á–∏—Å–ª–µ–Ω–∏—è–º –Ω–∞ —Ä–µ–∫–ª–∞–º—É –≤ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç–µ. –û–Ω–∏ –±—É–¥—É—Ç –µ–∂–µ–∫–≤–∞—Ä—Ç–∞–ª—å–Ω—ã–º–∏. –ú–∞–∫—Å–∏–º–∞–ª—å–Ω—ã–π —Ä–∞–∑–º–µ—Ä –ø–ª–∞—Ç–µ–∂–µ–π —Å–æ—Å—Ç–∞–≤–∏—Ç 3% –æ—Ç –¥–æ—Ö–æ–¥–∞ –∑–∞ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–∏–µ —Ä–µ–∫–ª–∞–º—ã. –ï—Å–ª–∏ –ø–ª–∞—Ç–µ–∂ –Ω–µ –ø—Ä–æ—à–µ–ª –≤ —Ç–µ—á–µ–Ω–∏–µ –¥–µ—Å—è—Ç–∏ –¥–Ω–µ–π –ø–æ—Å–ª–µ —É–≤–µ–¥–æ–º–ª–µ–Ω–∏—è, —Ç–æ –¥–æ–ª–≥ –≤–∑—ã—â—É—Ç –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω–æ.","{""skip"": true}"
2025-08-19T08:00:36+00:00,@medpharm,12585,https://t.me/medpharm/12585,"–ë–ª–∞–≥–æ—Ç–≤–æ—Ä–∏—Ç–µ–ª—å–Ω—ã–π —Ñ–æ–Ω–¥ ¬´–ñ–∏–∑–Ω—å –∫–∞–∫ —á—É–¥–æ¬ª —Å–æ–≤–º–µ—Å—Ç–Ω–æ —Å –ú–ì–ù–¶ –∏–º. –∞–∫. –ù.–ü. –ë–æ—á–∫–æ–≤–∞ –∑–∞–ø—É—Å—Ç–∏–ª –ø—Ä–æ–µ–∫—Ç –ø–æ –î–ù–ö-–¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–µ –Ω–∞—Å–ª–µ–¥—Å—Ç–≤–µ–Ω–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, –ø—Ä–∏ –∫–æ—Ç–æ—Ä—ã—Ö –Ω–∞—Ä—É—à–∞–µ—Ç—Å—è —Ä–∞–±–æ—Ç–∞ –ø–µ—á–µ–Ω–∏. –í—Ä–∞—á–∏ –º–æ–≥—É—Ç –ø–æ–¥–∞—Ç—å –∑–∞—è–≤–∫—É –Ω–∞ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏–µ —Ç–µ—Å—Ç–æ–≤, –Ω–µ –≤—Ö–æ–¥—è—â–∏—Ö –≤ –±–∞–∑–æ–≤—É—é –ø—Ä–æ–≥—Ä–∞–º–º—É –û–ú–°.","{""skip"": true}"
2025-08-18T17:04:04+00:00,@medpharm,12584,https://t.me/medpharm/12584,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 18 –∞–≤–≥—É—Å—Ç–∞ –û—Ç–º–µ–Ω–∏—Ç—å –Ω–µ–ª—å–∑—è –ø–æ–º–∏–ª–æ–≤–∞—Ç—å –ö–æ–º–ø–∞–Ω–∏—è ¬´–î–∂–æ–¥–∞—Å –≠–∫—Å–ø–æ–∏–º¬ª –æ–±—Ä–∞—Ç–∏–ª–∞—Å—å –≤ —Å—É–¥ —Å –∏—Å–∫–∞–º–∏ –∫ –ú–∏–Ω–∑–¥—Ä–∞–≤—É. –û–Ω–∞ —Ç—Ä–µ–±—É–µ—Ç –ø—Ä–∏–∑–Ω–∞—Ç—å –Ω–µ–∑–∞–∫–æ–Ω–Ω—ã–º–∏ —Ä–µ—à–µ–Ω–∏—è —Ä–µ–≥—É–ª—è—Ç–æ—Ä–∞ –æ–± –æ—Ç–º–µ–Ω–µ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –∏ –∏—Å–∫–ª—é—á–µ–Ω–∏–∏ –∏–∑ –ì–†–õ–° –¥–≤—É—Ö –µ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –û—Å–æ–±—ã–µ —É—Å–ª–æ–≤–∏—è –í–≤–æ–¥—è—Ç—Å—è –∫–æ–º–ø–ª–µ–∫—Å–Ω—ã–µ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ –∫–∞—á–µ—Å—Ç–≤—É –∏ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ –±–∏–æ–¥–æ–±–∞–≤–æ–∫, –∫–æ—Ç–æ—Ä—ã–µ –±—É–¥–µ—Ç –Ω–∞–∑–Ω–∞—á–∞—Ç—å –ª–µ—á–∞—â–∏–π –≤—Ä–∞—á. –ù–æ–≤—ã–µ –ø—Ä–∞–≤–∏–ª–∞ –º–æ–≥—É—Ç –≤—Å—Ç—É–ø–∏—Ç—å –≤ —Å–∏–ª—É —Å 1 –º–∞—Ä—Ç–∞ 2026 –≥–æ–¥–∞. –ë—É–¥—å –Ω–∞—á–µ–∫—É –ú–í–î –ø—Ä–µ–¥—É–ø—Ä–µ–¥–∏–ª–æ –æ –Ω–æ–≤–æ–π –º–æ—à–µ–Ω–Ω–∏—á–µ—Å–∫–æ–π —Å—Ö–µ–º–µ —Å ¬´–∑–∞–ø–∏—Å—å—é –∫ –≤—Ä–∞—á—É¬ª —á–µ—Ä–µ–∑ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏–µ. –ê—Ñ–µ—Ä–∏—Å—Ç—ã –∏–Ω—Ç–µ—Ä–µ—Å—É—é—Ç—Å—è —Å–ª–æ–∂–Ω–æ—Å—Ç—è–º–∏ —Å –∑–∞–ø–∏—Å—å—é –Ω–∞ –ø—Ä–∏–µ–º –∫ –≤—Ä–∞—á–∞–º, –∞ –∑–∞—Ç–µ–º –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç –∑–∞–≥—Ä—É–∑–∏—Ç—å —Ñ–∞–π–ª –¥–ª—è –ø—Ä–æ—Å–º–æ—Ç—Ä–∞ —è–∫–æ–±—ã —Å–≤–æ–±–æ–¥–Ω—ã—Ö —Ç–∞–ª–æ–Ω–æ–≤. –†—ã–Ω–æ–∫ –¥–µ—Ä–∂–∏—Ç—Å—è –∑–∞ —É—Å—Ç—Ä–æ–π—Å—Ç–≤–∞ –í –ø–µ—Ä–≤–æ–º –ø–æ–ª—É–≥–æ–¥–∏–∏ 2025 –≥–æ–¥–∞ –º–µ–¥—Ç–µ—Ö-—Ä—ã–Ω–æ–∫ –†–æ—Å—Å–∏–∏ –∑–∞—Ä–∞–±–æ—Ç–∞–ª 27,6 –º–ª—Ä–¥ —Ä—É–±. –°–∞–º—ã–º –±—ã—Å—Ç—Ä–æ—Ä–∞—Å—Ç—É—â–∏–º —Å—Ç–∞–ª —Å–µ–≥–º–µ–Ω—Ç —É—Å—Ç—Ä–æ–π—Å—Ç–≤, —Ç–æ–≥–¥–∞ –∫–∞–∫ –∫—Ä—É–ø–Ω–µ–π—à–∏–π —Å–µ–≥–º–µ–Ω—Ç ‚Äî —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∞ –ü–û ‚Äî –ø–æ–∫–∞–∑–∞–ª –ø–∞–¥–µ–Ω–∏–µ, –≥–æ–≤–æ—Ä–∏—Ç—Å—è –≤ –∞–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–æ–º –æ—Ç—á–µ—Ç–µ.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, safety, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health has revoked the registration and removed two of the company's medications from the GRLS. The company is challenging this decision in court. New conditions have been introduced for biopharmaceuticals to be prescribed by doctors, and these rules will take effect on March 1st, 2026. The police have warned about a new fraud scheme involving 'appointment recording' through an app, where scammers inquire about patients' difficulties in making appointments and then offer to upload files for viewing supposedly free appointment slots. The medical device market is growing, with the segment of devices experiencing significant growth compared to software development which has shown a decline.""
}"
2025-08-18T14:58:01+00:00,@medpharm,12583,https://t.me/medpharm/12583,–í –ï–ê–≠–° –±—É–¥—É—Ç —Ä–∞–∑–≤–∏–≤–∞—Ç—å –æ–±—â–∏–π —Ä—ã–Ω–æ–∫ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤. –ö–æ–Ω—Ü–µ–ø—Ü–∏—è —Ä–∞–∑–≤–∏—Ç–∏—è –¥–æ 2030 –≥–æ–¥–∞ –ø–æ–∑–≤–æ–ª–∏—Ç —Å–∏–Ω—Ö—Ä–æ–Ω–∏–∑–∏—Ä–æ–≤–∞—Ç—å —Å—Ç–∞–Ω–¥–∞—Ä—Ç—ã –∫–∞—á–µ—Å—Ç–≤–∞ –∏ —É—Å–∫–æ—Ä–∏—Ç—å –≤—ã–≤–æ–¥ –Ω–æ–≤—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞ —Ä—ã–Ω–∫–∏ —Å—Ç—Ä–∞–Ω —Å–æ—é–∑–∞.,"{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The EAEU will develop a common market for pharmaceuticals. The concept of development up to 2030 will synchronize quality standards and accelerate the introduction of new drugs onto the markets of EAEU countries.""
}"
2025-08-18T13:36:48+00:00,@medpharm,12582,https://t.me/medpharm/12582,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç —É—Å—Ç–∞–Ω–æ–≤–∏—Ç—å –∫—Ä–∏—Ç–µ—Ä–∏–∏ –∫–∞—á–µ—Å—Ç–≤–∞ –∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –ë–ê–î. –ù–∞ –æ—Å–Ω–æ–≤–µ —ç—Ç–∏—Ö –ø–æ–∫–∞–∑–∞—Ç–µ–ª–µ–π –±—É–¥—É—Ç —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞—Ç—å —Å–ø–∏—Å–æ–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –æ–¥–æ–±—Ä–µ–Ω–Ω—ã—Ö –¥–ª—è –Ω–∞–∑–Ω–∞—á–µ–Ω–∏—è –≤—Ä–∞—á–∞–º–∏.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health plans to establish quality and effectiveness criteria for BAsD. Based on these indicators, a list of drugs approved by doctors will be formed.""
}"
2025-08-18T11:36:38+00:00,@medpharm,12581,https://t.me/medpharm/12581,–û–±–∑–æ—Ä —Ä–µ–≥—É–ª—è—Ç–æ—Ä–Ω—ã—Ö –æ–¥–æ–±—Ä–µ–Ω–∏–π –≤ –°–®–ê –∏ –í–µ–ª–∏–∫–æ–±—Ä–∏—Ç–∞–Ω–∏–∏.,"{""skip"": true}"
2025-08-18T09:36:29+00:00,@medpharm,12580,https://t.me/medpharm/12580,"–°–∞–º—ã–µ –∫—Ä—É–ø–Ω—ã–µ –≤—ã–ø–ª–∞—Ç—ã –æ—Ç —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π –ø–æ–ª—É—á–∞—é—Ç –≤—Ä–∞—á–∏ —Å –Ω–∞–∏–±–æ–ª—å—à–∏–º —á–∏—Å–ª–æ–º –∂–∞–ª–æ–± –æ—Ç –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –ø–æ–∫–∞–∑–∞–ª–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ. –≠—Ç–æ –º–æ–∂–µ—Ç –æ–∑–Ω–∞—á–∞—Ç—å, —á—Ç–æ —Å–≤—è–∑–∏ —Å –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ —É—Ö—É–¥—à–∞—é—Ç —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å —Ä–∞–±–æ—Ç—ã –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤.","{""skip"": true}"
2025-08-18T07:27:01+00:00,@medpharm,12579,https://t.me/medpharm/12579,–ö–æ–º–ø–∞–Ω–∏—è ¬´–î–∂–æ–¥–∞—Å –≠–∫—Å–ø–æ–∏–º¬ª –æ–±—Ä–∞—Ç–∏–ª–∞—Å—å –≤ —Å—É–¥ —Å –∏—Å–∫–∞–º–∏ –∫ –ú–∏–Ω–∑–¥—Ä–∞–≤—É. –û–Ω–∞ —Ç—Ä–µ–±—É–µ—Ç –ø—Ä–∏–∑–Ω–∞—Ç—å –Ω–µ–∑–∞–∫–æ–Ω–Ω—ã–º–∏ —Ä–µ—à–µ–Ω–∏—è —Ä–µ–≥—É–ª—è—Ç–æ—Ä–∞ –æ–± –æ—Ç–º–µ–Ω–µ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –∏ –∏—Å–∫–ª—é—á–µ–Ω–∏–∏ –∏–∑ –ì–†–õ–° –¥–≤—É—Ö –µ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤.,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""registration, reimbursement"",
  ""impact"": ""high"",
  ""english"": ""A company 'Djodas Expoim' has filed a lawsuit against the Ministry of Health in court. They demand that the regulator's decisions to cancel the registration and exclude two of their medications from the GRLS are illegal.""
}"
2025-08-17T11:03:28+00:00,@medpharm,12578,https://t.me/medpharm/12578,"–ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ –∑–∞ –Ω–µ–¥–µ–ª—é üîµ–†–æ—Å—Å–∏—è –∑–∞–Ω—è–ª–∞ 12-–µ –º–µ—Å—Ç–æ —Å—Ä–µ–¥–∏ –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö –º–∏—Ä–æ–≤—ã—Ö —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö —Ä—ã–Ω–∫–æ–≤ –ø–æ –æ–±—ä–µ–º—É —Ä–∞—Å—Ö–æ–¥–æ–≤ –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞, –ø–æ –≤–µ—Ä—Å–∏–∏ IQVIA. –ü–æ –∏—Ç–æ–≥–∞–º 2024 –≥–æ–¥–∞ –≥–ª–æ–±–∞–ª—å–Ω—ã–π —Ä—ã–Ω–æ–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –æ—Ü–µ–Ω–µ–Ω –≤ 1,75 —Ç—Ä–ª–Ω –¥–æ–ª–ª., –∞ –∫ 2029 –≥–æ–¥—É –≤—ã—Ä–∞—Å—Ç–µ—Ç –¥–æ 2,4 —Ç—Ä–ª–Ω –¥–æ–ª–ª. –ë–æ–ª—å—à–∞—è —á–∞—Å—Ç—å —Ä–∞—Å—Ö–æ–¥–æ–≤ –±—É–¥–µ—Ç –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∞ –Ω–∞ —Å—Ä–µ–¥—Å—Ç–≤–∞ –¥–ª—è –±–æ—Ä—å–±—ã —Å —Ä–∞–∫–æ–º, –¥–∏–∞–±–µ—Ç–æ–º –∏ –æ–∂–∏—Ä–µ–Ω–∏–µ–º. üîµ–í –ü–æ–ª–æ–∂–µ–Ω–∏–µ –æ –ª–∏—Ü–µ–Ω–∑–∏—Ä–æ–≤–∞–Ω–∏–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤–Ω–µ—Å—É—Ç –∏–∑–º–µ–Ω–µ–Ω–∏—è. –ü—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è –≤–≤–µ—Å—Ç–∏ –ø—Ä–æ–≤–µ—Ä–∫–∏ –ø–æ –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–µ —Å–∞–º–∏—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π. –ß–∞—Å—Ç–æ—Ç–∞ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã—Ö –≤–∏–∑–∏—Ç–æ–≤ –±—É–¥–µ—Ç –∑–∞–≤–∏—Å–µ—Ç—å –æ—Ç –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ —Ä–∏—Å–∫–∞ –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏—è, –∞ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–µ –Ω–∞—Ä—É—à–µ–Ω–∏–π –≤ —Ç–µ—á–µ–Ω–∏–µ —Ç—Ä–µ—Ö –ª–µ—Ç –ø–æ–∑–≤–æ–ª–∏—Ç —Å–Ω–∏–∑–∏—Ç—å —ç—Ç—É –∫–∞—Ç–µ–≥–æ—Ä–∏—é. üîµ–ù–æ–≤—ã–µ —Å–µ—Ä–≤–∏—Å—ã –¥–ª—è —Ñ–∞—Ä–º–±–∏–∑–Ω–µ—Å–∞ –ø–æ—è–≤—è—Ç—Å—è –Ω–∞ –ì–æ—Å—É—Å–ª—É–≥–∞—Ö –¥–æ –Ω–æ—è–±—Ä—è. –ú–∏–Ω–∏—Å—Ç–µ—Ä—Å—Ç–≤–∞–º –∏ –≤–µ–¥–æ–º—Å—Ç–≤–∞–º –ø–æ—Ä—É—á–∏–ª–∏ —É—Å–∫–æ—Ä–∏—Ç—å —Ü–∏—Ñ—Ä–æ–≤–∏–∑–∞—Ü–∏—é —Ä–∞–∑—Ä–µ—à–∏—Ç–µ–ª—å–Ω—ã—Ö –ø—Ä–æ—Ü–µ–¥—É—Ä –ø–æ —Ä—è–¥—É –≤–∏–¥–æ–≤ –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏, –≤–∫–ª—é—á–∞—è —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—é –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –≤–µ—Ç–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –ª–∏—Ü–µ–Ω–∑–∏—Ä–æ–≤–∞–Ω–∏–µ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –∏ –¥—Ä. üîµ–ö—Ä—É–ø–Ω–µ–π—à–∏–µ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã–µ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ —É–≤–µ–ª–∏—á–∏–ª–∏ –æ–±—ä–µ–º –≤—ã–ø–ª–∞—Ç —Ä–æ—Å—Å–∏–π—Å–∫–∏–º –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è–º –∏ –∞—Å—Å–æ—Ü–∏–∞—Ü–∏—è–º –Ω–∞ 22,9% –ø–æ –∏—Ç–æ–≥–∞–º 2024 –≥–æ–¥–∞. –û–±—â–∏–µ —Ä–∞—Å—Ö–æ–¥—ã –æ—Ç—Ä–∞—Å–ª–∏ –Ω–∞ –ø—Ä–æ–¥–≤–∏–∂–µ–Ω–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –æ—Å—Ç–∞–ª–∏—Å—å –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏ –Ω–∞ —É—Ä–æ–≤–Ω–µ 2023 –≥–æ–¥–∞, —Å–æ—Å—Ç–∞–≤–∏–≤ 10 –º–ª—Ä–¥ —Ä—É–±. üîµ–ë–ª–æ–∫–∏—Ä–æ–≤–∞—Ç—å –æ–±–æ—Ä–æ—Ç –ë–ê–î –±–µ–∑ –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤ –æ –∫–∞—á–µ—Å—Ç–≤–µ —Å 1 –º–∞—Ä—Ç–∞ 2026 –≥–æ–¥–∞ –ø—Ä–µ–¥–ª–æ–∂–∏–ª –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥. –¢–∞–∫–∂–µ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –∏–Ω—Ç–µ–≥—Ä–∞—Ü–∏—è —Å —Ä–µ–µ—Å—Ç—Ä–æ–º –æ –Ω–∞—á–∞–ª–µ –æ—Ç–¥–µ–ª—å–Ω—ã—Ö –≤–∏–¥–æ–≤ –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage, regulation, import_export"",
  ""impact"": ""high"",
  ""english"": ""The Ministry of Industry and Trade proposed blocking the circulation of BAsD without quality documents starting March 1, 2026. Additionally, integration with the registry for the start of certain types of activities is planned.""
}"
2025-08-16T09:11:35+00:00,@medpharm,12577,https://t.me/medpharm/12577,"–ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∑–∞ –Ω–µ–¥–µ–ª—é üî¥–†–æ—Å—Å–∏—è —É–∫—Ä–µ–ø–∏–ª–∞—Å—å –Ω–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ –≤ –º–∏—Ä–µ –ø–æ –∫–æ–ª–∏—á–µ—Å—Ç–≤—É —É—Ç–µ—á–µ–∫ –¥–∞–Ω–Ω—ã—Ö –∏–∑ –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π. –≠–∫—Å–ø–µ—Ä—Ç—ã –æ—Ç–º–µ—á–∞—é—Ç —É—Å–∫–æ—Ä–µ–Ω–∏–µ —Ç–µ–º–ø–æ–≤ —Ä–æ—Å—Ç–∞ —á–∏—Å–ª–∞ –∏–Ω—Ü–∏–¥–µ–Ω—Ç–æ–≤ –∏ —É–≥—Ä–æ–∑ –¥–ª—è –ø–µ—Ä—Å–æ–Ω–∞–ª—å–Ω–æ–π –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. üî¥–í—ã–Ω–µ—Å–µ–Ω–æ —Å—É–¥–µ–±–Ω–æ–µ —Ä–µ—à–µ–Ω–∏–µ –æ –Ω–µ–∑–∞–∫–æ–Ω–Ω–æ—Å—Ç–∏ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–∏—è –≤–∏–¥–µ–æ—Å—ä–µ–º–∫–∏ –≤—Ä–∞—á–∞ –Ω–∞ —Ä–∞–±–æ—á–µ–º –º–µ—Å—Ç–µ. ¬´–ú–í¬ª —É–∑–Ω–∞–ª –º–Ω–µ–Ω–∏–µ —é—Ä–∏—Å—Ç–æ–≤ –æ —Ç–æ–º, –∫–∞–∫ —ç—Ç–æ—Ç —Å–ª—É—á–∞–π –æ—Ç—Ä–∞–∑–∏—Ç—Å—è –Ω–∞ —Å—É–¥–µ–±–Ω–æ–π –ø—Ä–∞–∫—Ç–∏–∫–µ –ø–æ –∞–Ω–∞–ª–æ–≥–∏—á–Ω—ã–º –¥–µ–ª–∞–º, —Å—á–∏—Ç–∞—é—Ç –ª–∏ –æ–Ω–∏ —Ä–µ—à–µ–Ω–∏–µ —Å—É–¥–∞ —Å–ø—Ä–∞–≤–µ–¥–ª–∏–≤—ã–º –∏ –Ω–µ —É—â–µ–º–ª—è–µ—Ç –ª–∏ –æ–Ω–æ –ø—Ä–∞–≤–∞ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –Ω–∞ –∑–∞—â–∏—Ç—É –∏—Ö –∑–∞–∫–æ–Ω–Ω—ã—Ö –∏–Ω—Ç–µ—Ä–µ—Å–æ–≤. üî¥–í –æ–±–Ω–æ–≤–ª–µ–Ω–Ω—ã—Ö –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏—è—Ö –ø–æ –ª–µ—á–µ–Ω–∏—é –û–†–í–ò —É –≤–∑—Ä–æ—Å–ª—ã—Ö –æ—Å—Ç–∞–ª–∏—Å—å –ø—Ä–æ—Ç–∏–≤–æ–≤–∏—Ä—É—Å–Ω—ã–µ –∏ –≥–æ–º–µ–æ–ø–∞—Ç–∏—á–µ—Å–∫–∏–µ —Å—Ä–µ–¥—Å—Ç–≤–∞, —Ä–∞—Å–∫—Ä–∏—Ç–∏–∫–æ–≤–∞–Ω–Ω—ã–µ –ö–æ–º–∏—Å—Å–∏–µ–π –†–ê–ù –ø–æ –±–æ—Ä—å–±–µ —Å –ª–∂–µ–Ω–∞—É–∫–æ–π. –ü–æ–¥–∞–≤–ª–µ–Ω–∏–µ —Ä–µ–ø–ª–∏–∫–∞—Ü–∏–∏ –≤–∏—Ä—É—Å–æ–≤ –Ω–∞ —Ä–∞–Ω–Ω–∏—Ö —Å—Ä–æ–∫–∞—Ö –±–æ–ª–µ–∑–Ω–∏ —Ç–µ–ø–µ—Ä—å –≤—Ö–æ–¥–∏—Ç –≤ –ø—Ä–∏–Ω—Ü–∏–ø—ã —Ç–µ—Ä–∞–ø–∏–∏. üî¥–ú–∏–Ω–∑–¥—Ä–∞–≤ –≤–≤–æ–¥–∏—Ç –Ω–æ–≤—ã–π –∫–æ—ç—Ñ—Ñ–∏—Ü–∏–µ–Ω—Ç –¥–ª—è –æ–±–æ—Å–Ω–æ–≤–∞–Ω–∏—è –±—é–¥–∂–µ—Ç–Ω—ã—Ö –∞—Å—Å–∏–≥–Ω–æ–≤–∞–Ω–∏–π –≤ –ø–æ–¥–≤–µ–¥–æ–º—Å—Ç–≤–µ–Ω–Ω—ã—Ö –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è—Ö. –ü—Ä–∏ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ –µ–≥–æ –±—É–¥—É—Ç –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å –¥–ª—è —É—á–µ—Ç–∞ –∏–Ω—Ñ–ª—è—Ü–∏–∏ –∏ –≤—ã–ø–æ–ª–Ω–µ–Ω–∏—è –º–∞–π—Å–∫–∏—Ö —É–∫–∞–∑–æ–≤ –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç–∞. üî¥–ì–ª–∞–≤–∞ –ù–∞—Ü–º–µ–¥–ø–∞–ª–∞—Ç—ã –õ–µ–æ–Ω–∏–¥ –†–æ—à–∞–ª—å –Ω–∞–∑–≤–∞–ª –Ω–æ–≤—ã–π –ø—Ä–∏–≥–æ–≤–æ—Ä –∫–∞–ª–∏–Ω–∏–Ω–≥—Ä–∞–¥—Å–∫–∏–º –≤—Ä–∞—á–∞–º –≠–ª–∏–Ω–µ –°—É—à–∫–µ–≤–∏—á –∏ –ï–ª–µ–Ω–µ –ë–µ–ª–æ–π –Ω–µ—Å–ø—Ä–∞–≤–µ–¥–ª–∏–≤—ã–º. –ú–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–µ —Å–æ–æ–±—â–µ—Å—Ç–≤–æ –±—É–¥–µ—Ç –¥–æ–±–∏–≤–∞—Ç—å—Å—è –ø–µ—Ä–µ—Å–º–æ—Ç—Ä–∞ –¥–µ–ª–∞, –ø–æ—Ç–æ–º—É —á—Ç–æ ¬´—Ñ–∞–∫—Ç–∏—á–µ—Å–∫–∏ –Ω–∏–∫–∞–∫–∏—Ö –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å—Å—Ç–≤ —Ç–æ–≥–æ, —á—Ç–æ –Ω–æ–≤–æ—Ä–æ–∂–¥–µ–Ω–Ω–æ–≥–æ –¥–µ–π—Å—Ç–≤–∏—Ç–µ–ª—å–Ω–æ —É–±–∏–ª–∏, –Ω–µ—Ç¬ª.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, safety"",
  ""impact"": ""high"",
  ""english"": ""The country is Russia. The message discusses the regulation of clinical trials, guidelines for safety and patient protection in healthcare. There is a high impact on regulatory affairs and market access.""
}"
2025-08-15T15:45:39+00:00,@medpharm,12576,https://t.me/medpharm/12576,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 15 –∞–≤–≥—É—Å—Ç–∞ –ü–æ–¥–¥–µ—Ä–∂–∞—Ç —Ä—É–±–ª–µ–º –ú–∏–Ω–∑–¥—Ä–∞–≤ –≤–≤–æ–¥–∏—Ç –Ω–æ–≤—ã–π –∫–æ—ç—Ñ—Ñ–∏—Ü–∏–µ–Ω—Ç –¥–ª—è –æ–±–æ—Å–Ω–æ–≤–∞–Ω–∏—è –±—é–¥–∂–µ—Ç–Ω—ã—Ö –∞—Å—Å–∏–≥–Ω–æ–≤–∞–Ω–∏–π –≤ –ø–æ–¥–≤–µ–¥–æ–º—Å—Ç–≤–µ–Ω–Ω—ã—Ö –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è—Ö. –ü—Ä–∏ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ –µ–≥–æ –±—É–¥—É—Ç –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å –¥–ª—è —É—á–µ—Ç–∞ –∏–Ω—Ñ–ª—è—Ü–∏–∏ –∏ –≤—ã–ø–æ–ª–Ω–µ–Ω–∏—è –º–∞–π—Å–∫–∏—Ö —É–∫–∞–∑–æ–≤ –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç–∞. –û–±–ª–∞—Å—Ç—å –∏–Ω—Ç–µ—Ä–µ—Å–æ–≤ –í 2025 –≥–æ–¥—É –ª–∏–¥–∏—Ä—É—é—Ç –ø–æ —Ü–∏—Ç–∏—Ä—É–µ–º–æ—Å—Ç–∏ —Å—Ä–µ–¥–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π —Ä–∞–±–æ—Ç—ã –≤ –æ–±–ª–∞—Å—Ç–∏ –æ–Ω–∫–æ–ª–æ–≥–∏–∏, –ø–æ –Ω–æ–≤—ã–º –¥–∏–∞–≥–Ω–æ–∑–∞–º –æ–∂–∏—Ä–µ–Ω–∏—è –∏ –≤–Ω–µ–¥—Ä–µ–Ω–∏—é –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–∞. –ì–æ—Å—Å–Ω–∏–∂–µ–Ω–∏–µ –û–±—ä–µ–º –≥–æ—Å–∑–∞–∫—É–ø–æ–∫ –ª–µ–∫–∞—Ä—Å—Ç–≤ —Å–æ–∫—Ä–∞—Ç–∏–ª—Å—è –Ω–∞ 19% –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –ø—Ä–æ—à–ª—ã–º –≥–æ–¥–æ–º. –ü—Ä–∏ —ç—Ç–æ–º –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –Ω–µ—Å–æ—Å—Ç–æ—è–≤—à–∏—Ö—Å—è —Ç–æ—Ä–≥–æ–≤ –≤—ã—Ä–æ—Å–ª–æ –¥–æ 33%, –∞ –¥–æ–ª—è –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö –∫–æ–º–ø–∞–Ω–∏–π-–ø–æ—Å—Ç–∞–≤—â–∏–∫–æ–≤ —É–º–µ–Ω—å—à–∏–ª–∞—Å—å —Å 27 –¥–æ 20% —Ä—ã–Ω–∫–∞. –ú–æ–∂–Ω–æ –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω–æ –í–µ—Ä—Ö–æ–≤–Ω—ã–π —Å—É–¥ –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª –æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω–æ—Å—Ç—å –≤—ã–¥–∞—á–∏ –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω–æ–π –ª–∏—Ü–µ–Ω–∑–∏–∏ –Ω–∞ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥ –¥–æ –∫–æ–Ω—Ü–∞ 2025 –≥–æ–¥–∞. –ê–ø–µ–ª–ª—è—Ü–∏–æ–Ω–Ω–∞—è –∂–∞–ª–æ–±–∞ Novo Nordisk –æ—Ç–∫–ª–æ–Ω–µ–Ω–∞.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement, safety, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health introduced a new coefficient for justifying budgetary appropriations in affiliated medical organizations. It will be used to account for inflation and fulfill the May orders of the President. In 2025, oncology research papers are leading in citations among medical studies on obesity and the use of artificial intelligence. The government has reduced drug procurement volumes by 19% compared to last year. Unsuccessful tenders have increased to 33%, while the share of major companies as suppliers has decreased from 27% to 20%. The Supreme Court confirmed the justification for a compulsory license of semaglutide until the end of 2025. Novo Nordisk's appeal has been rejected.""
}"
2025-08-15T14:36:11+00:00,@medpharm,12575,https://t.me/medpharm/12575,–ú–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–π —é—Ä–∏—Å—Ç –Ω–∞–∑–≤–∞–ª–∞ –æ–ø–∞—Å–Ω—ã–µ –æ—à–∏–±–∫–∏ –ø—Ä–∏ –∑–∞–ø–æ–ª–Ω–µ–Ω–∏–∏ –º–µ–¥–∫–∞—Ä—Ç.,"{""skip"": true}"
2025-08-15T12:31:46+00:00,@medpharm,12574,https://t.me/medpharm/12574,"–ó–Ω–∞–∫–æ–º—å—Ç–µ—Å—å —Å–æ —Å–ª–µ–¥—É—é—â–∏–º —Å–ø–∏–∫–µ—Ä–æ–º PRO–µ–∫—Ü–∏–π –ë—É–¥—É—â–µ–≥–æ: üîπ –°–≤–µ—Ç–ª–∞–Ω–∞ –°–∫–æ—Ä–∏–∫, –¥–∏—Ä–µ–∫—Ç–æ—Ä –ø–æ –∫–∞—á–µ—Å—Ç–≤—É –û–û–û ¬´–ù–¢–§–§ ¬´–ü–æ–ª–∏—Å–∞–Ω¬ª, —Å–ø–∏–∫–µ—Ä –∫—Ä—É–≥–ª–æ–≥–æ —Å—Ç–æ–ª–∞ –ø–æ –∫–∞–¥—Ä–∞–º ¬´–ö–æ–≥–æ –Ω–µ —Ö–≤–∞—Ç–∞–µ—Ç —Ñ–∞—Ä–º–µ. –ö–∞–¥—Ä–æ–≤—ã–π –∫—Ä–∏–∑–∏—Å, –¥–µ—Ñ–∏—Ü–∏—Ç –∫–æ–º–ø–µ—Ç–µ–Ω—Ü–∏–π –∏ —Å—Ä–æ—á–Ω–∞—è –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç—å –∏–∑–º–µ–Ω–µ–Ω–∏–π¬ª –î–∞—Ç–∞ –∏ –≤—Ä–µ–º—è —Å–µ—Å—Å–∏–∏: 11 —Å–µ–Ω—Ç—è–±—Ä—è 2025, 17:00 üìç–≥. –°–æ—á–∏, Pullman –°–æ—á–∏ –¶–µ–Ω—Ç—Ä 5* –ü–æ–¥—Ä–æ–±–Ω–µ–µ –æ –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ –∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –Ω–∞ —Å–∞–π—Ç–µ","{""skip"": true}"
2025-08-15T11:26:33+00:00,@medpharm,12573,https://t.me/medpharm/12573,"–î–µ–ø—É—Ç–∞—Ç—ã –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç –∫–æ–º–ø–µ–Ω—Å–∏—Ä–æ–≤–∞—Ç—å —Ä–æ—Å—Å–∏—è–Ω–∞–º —Ä–∞—Å—Ö–æ–¥—ã –Ω–∞ –ø–ª–∞—Ç–Ω—ã–µ –º–µ–¥—É—Å–ª—É–≥–∏, –≤ —Å–ª—É—á–∞–µ –µ—Å–ª–∏ –±–µ—Å–ø–ª–∞—Ç–Ω–∞—è –ø–æ–º–æ—â—å –ø–æ –û–ú–° –±—ã–ª–∞ –Ω–µ–¥–æ—Å—Ç—É–ø–Ω–∞. –ö–æ–º–ø–µ–Ω—Å–∞—Ü–∏–∏ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –≤—ã–ø–ª–∞—á–∏–≤–∞—Ç—å –≤ –ø—Ä–µ–¥–µ–ª–∞—Ö –ª–∏–º–∏—Ç–æ–≤ –ü—Ä–æ–≥—Ä–∞–º–º—ã –≥–æ—Å–≥–∞—Ä–∞–Ω—Ç–∏–π, –±–µ–∑ –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã—Ö –∑–∞—Ç—Ä–∞—Ç –¥–ª—è –±—é–¥–∂–µ—Ç–∞.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""Deputies propose compensating Russians for costs incurred on paid medical services in case free assistance under the OMS program was unavailable. Compensations are planned within the limits of the State Guarantees Program without additional budgetary costs.""
}"
2025-08-15T09:21:36+00:00,@medpharm,12572,https://t.me/medpharm/12572,"–í –•–∞–±–∞—Ä–æ–≤—Å–∫–æ–º –∫—Ä–∞–µ –ø—Ä–æ–≤–∞–ª–µ–Ω—ã —Å—Ä–æ–∫–∏ —Ä–µ–º–æ–Ω—Ç–∞ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏–π, —Ä–µ–≥–∏–æ–Ω –ø–æ—Ç–µ—Ä—è–ª –±–æ–ª—å—à–µ 40 –º–ª–Ω —Ä—É–±. –ü—Ä–æ—Ç–∏–≤ –ø–æ–¥—Ä—è–¥—á–∏–∫–∞ –≤–æ–∑–±—É–∂–¥–µ–Ω–æ —É–≥–æ–ª–æ–≤–Ω–æ–µ –¥–µ–ª–æ –æ –∫—Ä—É–ø–Ω–æ–º –º–æ—à–µ–Ω–Ω–∏—á–µ—Å—Ç–≤–µ, –≥–ª–∞–≤–≤—Ä–∞—á–µ–π –ø—Ä–∏–≤–ª–µ–∫–ª–∏ –∫ –¥–∏—Å—Ü–∏–ø–ª–∏–Ω–∞—Ä–Ω–æ–π –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç–∏.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""shortage, hospital_policy"",
  ""impact"": ""high"",
  ""english"": ""The region in Khakassia has missed the deadlines for repairing healthcare facilities. The region lost more than 40 million rubles. A criminal case has been opened against the contractor for large-scale fraud, and the head of the hospital was disciplined.""
}"
2025-08-15T07:31:00+00:00,@medpharm,12571,https://t.me/medpharm/12571,"–° 1 —Å–µ–Ω—Ç—è–±—Ä—è –≤ –†–æ—Å—Å–∏–∏ —É–∂–µ—Å—Ç–æ—á–∞—Ç –ø—Ä–∞–≤–∏–ª–∞ –∫–æ–Ω—Ç—Ä–æ–ª—è –∑–∞ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å—é –¥–æ–Ω–æ—Ä—Å–∫–æ–π –∫—Ä–æ–≤–∏. –û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ —Å –≤—ã—Å–æ–∫–∏–º –∏ —á—Ä–µ–∑–≤—ã—á–∞–π–Ω–æ –≤—ã—Å–æ–∫–∏–º —Ä–∏—Å–∫–æ–º –±—É–¥—É—Ç –ø—Ä–æ–≤–µ—Ä—è—Ç—å—Å—è —á–∞—â–µ, –∞ –ø–ª–∞–Ω–æ–≤—ã–µ –ø—Ä–æ–≤–µ—Ä–∫–∏ —á–∞—Å—Ç–∏—á–Ω–æ –∑–∞–º–µ–Ω—è—Ç –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–º–∏ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–∏–º–∏ –≤–∏–∑–∏—Ç–∞–º–∏ —Å –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ–º —Ü–∏—Ñ—Ä–æ–≤—ã—Ö —Å–µ—Ä–≤–∏—Å–æ–≤.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""sanctions, regulation"",
  ""impact"": ""medium"",
  ""english"": ""Starting September 1st, Russia will tighten safety control measures for donated blood. High-risk and extremely high-risk organizations will be checked more frequently, and routine inspections will partly be replaced by mandatory preventive visits using digital services.""
}"
2025-08-14T16:03:13+00:00,@medpharm,12570,https://t.me/medpharm/12570,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 14 –∞–≤–≥—É—Å—Ç–∞ –î—Ä—É–≥–∏–º –Ω–∞—É–∫–∞ –í –æ–±–Ω–æ–≤–ª–µ–Ω–Ω—ã—Ö –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏—è—Ö –ø–æ –ª–µ—á–µ–Ω–∏—é –û–†–í–ò —É –≤–∑—Ä–æ—Å–ª—ã—Ö –æ—Å—Ç–∞–ª–∏—Å—å –ø—Ä–æ—Ç–∏–≤–æ–≤–∏—Ä—É—Å–Ω—ã–µ –∏ –≥–æ–º–µ–æ–ø–∞—Ç–∏—á–µ—Å–∫–∏–µ —Å—Ä–µ–¥—Å—Ç–≤–∞, —Ä–∞—Å–∫—Ä–∏—Ç–∏–∫–æ–≤–∞–Ω–Ω—ã–µ –ö–æ–º–∏—Å—Å–∏–µ–π –†–ê–ù –ø–æ –±–æ—Ä—å–±–µ —Å –ª–∂–µ–Ω–∞—É–∫–æ–π. –ò—â—É—Ç —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –í—Ä–∞—á–∏ –ø–æ–ø–∞–ª–∏ –≤ TOP –ª—É—á—à–∏—Ö –∑–∞—Ä–ø–ª–∞—Ç–Ω—ã—Ö –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–π –∞–≤–≥—É—Å—Ç–∞ –≤ –ú–æ—Å–∫–≤–µ –∏ –ï–∫–∞—Ç–µ—Ä–∏–Ω–±—É—Ä–≥–µ. –ü–æ—à–ª–∏ –Ω–∞ –º–∏—Ä–æ–≤—É—é –ü–æ –∏—Å–∫—É –æ –∑–∞—â–∏—Ç–µ –¥–µ–ª–æ–≤–æ–π —Ä–µ–ø—É—Ç–∞—Ü–∏–∏ ¬´–ì–µ–Ω–µ—Ä–∏—É–º¬ª –∏ –≥–ª–∞–≤–∞ —Ñ–æ–Ω–¥–∞ ¬´–ü–æ–º–æ—â—å —Å–µ–º—å—è–º –°–ú–ê¬ª –∑–∞–∫–ª—é—á–∏–ª–∏ –º–∏—Ä–æ–≤–æ–µ —Å–æ–≥–ª–∞—à–µ–Ω–∏–µ. –û—Ç–≤–µ—Ç—á–∏–∫ —Ä–∞–Ω–µ–µ –ø—É–±–ª–∏–∫–æ–≤–∞–ª –Ω–µ–≥–∞—Ç–∏–≤–Ω—ã–µ –≤—ã—Å–∫–∞–∑—ã–≤–∞–Ω–∏—è –æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–µ –∫–æ–º–ø–∞–Ω–∏–∏, –Ω–æ —Ç–µ–ø–µ—Ä—å –ø—Ä–∏–∑–Ω–∞–ª —Å–≤–æ—é –Ω–µ–ø—Ä–∞–≤–æ—Ç—É. –ü—Ä–∞–≤–¥–∞ –≤—ã–ø–æ–ª–Ω–∏–ª –Ω–µ –≤—Å–µ —É—Å–ª–æ–≤–∏—è —Å–æ–≥–ª–∞—à–µ–Ω–∏—è. –í–Ω–µ –∑–æ–Ω—ã –¥–æ—Å—Ç—É–ø–∞ –ê–ø—Ç–µ–∫–∏ —Å–º–æ–≥—É—Ç –¥–æ 10 –¥–Ω–µ–π –æ—Ç–ø—É—Å–∫–∞—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –±–µ–∑ –ø–æ–¥–∫–ª—é—á–µ–Ω–∏—è –∫ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç—É. –¶–†–ü–¢ —É–≤–µ–ª–∏—á–∏–ª –≤—Ä–µ–º—è –∞–≤—Ç–æ–Ω–æ–º–Ω–æ–π —Ä–∞–±–æ—Ç—ã —Å –º–∞—Ä–∫–∏—Ä–æ–≤–∞–Ω–Ω—ã–º–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º. –ì–ª–∞–≤–Ω–æ–µ ‚Äî —É—Å—Ç–∞–Ω–æ–≤–∏—Ç—å –∞–∫—Ç—É–∞–ª—å–Ω—É—é –≤–µ—Ä—Å–∏—é –ª–æ–∫–∞–ª—å–Ω–æ–≥–æ –º–æ–¥—É–ª—è ¬´–ß–µ—Å—Ç–Ω—ã–π –∑–Ω–∞–∫¬ª.","{
  ""skip"": true
}"
2025-08-14T15:16:50+00:00,@medpharm,12569,https://t.me/medpharm/12569,"#—ç–∫—Å–∫–ª—é–∑–∏–≤ –í—ã–Ω–µ—Å–µ–Ω–æ —Å—É–¥–µ–±–Ω–æ–µ —Ä–µ—à–µ–Ω–∏–µ –æ –Ω–µ–∑–∞–∫–æ–Ω–Ω–æ—Å—Ç–∏ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–∏—è –≤–∏–¥–µ–æ—Å—ä–µ–º–∫–∏ –≤—Ä–∞—á–∞ –Ω–∞ —Ä–∞–±–æ—á–µ–º –º–µ—Å—Ç–µ. –†–æ–¥—Å—Ç–≤–µ–Ω–Ω–∏–∫–∞ –ø–∞—Ü–∏–µ–Ω—Ç–∞ –æ–±—è–∑–∞–ª–∏ –Ω–µ —Ç–æ–ª—å–∫–æ —É–¥–∞–ª–∏—Ç—å –ø–æ—Å—Ç—ã –∏ –æ–ø—É–±–ª–∏–∫–æ–≤–∞—Ç—å –æ–ø—Ä–æ–≤–µ—Ä–∂–µ–Ω–∏–µ, –Ω–æ –∏ –≤—ã–ø–ª–∞—Ç–∏—Ç—å —Ö–∏—Ä—É—Ä–≥—É –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏—é –º–æ—Ä–∞–ª—å–Ω–æ–≥–æ –≤—Ä–µ–¥–∞. ¬´–ú–í¬ª —É–∑–Ω–∞–ª –º–Ω–µ–Ω–∏–µ —é—Ä–∏—Å—Ç–æ–≤ –æ —Ç–æ–º, –∫–∞–∫ —ç—Ç–æ—Ç —Å–ª—É—á–∞–π –æ—Ç—Ä–∞–∑–∏—Ç—Å—è –Ω–∞ —Å—É–¥–µ–±–Ω–æ–π –ø—Ä–∞–∫—Ç–∏–∫–µ –ø–æ –∞–Ω–∞–ª–æ–≥–∏—á–Ω—ã–º –¥–µ–ª–∞–º, —Å—á–∏—Ç–∞—é—Ç –ª–∏ –æ–Ω–∏ —Ä–µ—à–µ–Ω–∏–µ —Å—É–¥–∞ —Å–ø—Ä–∞–≤–µ–¥–ª–∏–≤—ã–º –∏ –Ω–µ —É—â–µ–º–ª—è–µ—Ç –ª–∏ –æ–Ω–æ –ø—Ä–∞–≤–∞ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –Ω–∞ –∑–∞—â–∏—Ç—É –∏—Ö –∑–∞–∫–æ–Ω–Ω—ã—Ö –∏–Ω—Ç–µ—Ä–µ—Å–æ–≤.","{""skip"": true}"
2025-08-14T14:48:06+00:00,@medpharm,12568,https://t.me/medpharm/12568,"–ü—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º —Å–ª–µ–¥—É—é—â–µ–≥–æ —ç–∫—Å–ø–µ—Ä—Ç–∞ PRO–µ–∫—Ü–∏–π –ë—É–¥—É—â–µ–≥–æ: üîπ–§–∞–∏–∑–∞ –Ø–≥—É–¥–∏–Ω–∞, –¥–∏—Ä–µ–∫—Ç–æ—Ä –ø–æ –∫–∞—á–µ—Å—Ç–≤—É –ê–û ¬´–ê–∫—Ä–∏—Ö–∏–Ω¬ª, —Å–ø–∏–∫–µ—Ä –∫—Ä—É–≥–ª–æ–≥–æ —Å—Ç–æ–ª–∞ –ø–æ –∫–∞–¥—Ä–∞–º ¬´–ö–æ–≥–æ –Ω–µ —Ö–≤–∞—Ç–∞–µ—Ç —Ñ–∞—Ä–º–µ. –ö–∞–¥—Ä–æ–≤—ã–π –∫—Ä–∏–∑–∏—Å, –¥–µ—Ñ–∏—Ü–∏—Ç –∫–æ–º–ø–µ—Ç–µ–Ω—Ü–∏–π –∏ —Å—Ä–æ—á–Ω–∞—è –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç—å –∏–∑–º–µ–Ω–µ–Ω–∏–π¬ª –î–∞—Ç–∞ –∏ –≤—Ä–µ–º—è —Å–µ—Å—Å–∏–∏: 11 —Å–µ–Ω—Ç—è–±—Ä—è 2025, 17:00 üìç–≥. –°–æ—á–∏, Pullman –°–æ—á–∏ –¶–µ–Ω—Ç—Ä 5* –ü–æ–¥—Ä–æ–±–Ω–µ–µ –æ –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ –∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –Ω–∞ —Å–∞–π—Ç–µ","{""skip"": true}"
2025-08-14T14:02:01+00:00,@medpharm,12567,https://t.me/medpharm/12567,"–í –†–æ—Å—Å–∏–∏ –æ–±–Ω–æ–≤–∏–ª–∏ –ø–µ—Ä–µ—á–µ–Ω—å –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π –¥–ª—è –ø–∞–ª–ª–∏–∞—Ç–∏–≤–Ω–æ–π –ø–æ–º–æ—â–∏ –Ω–∞ –¥–æ–º—É, –≤–∫–ª—é—á–∏–≤ —Å–µ–º—å –≥—Ä—É–ø–ø —É—Å—Ç—Ä–æ–π—Å—Ç–≤. –ù–µ—Å–º–æ—Ç—Ä—è –Ω–∞ –ø–ª–∞–Ω—ã —Ä–∞—Å—à–∏—Ä–µ–Ω–∏—è, –æ–±—â–µ–µ —á–∏—Å–ª–æ –ø–æ–∑–∏—Ü–∏–π –≤ —Å–ø–∏—Å–∫–µ —Å–æ–∫—Ä–∞—Ç–∏–ª–æ—Å—å —Å 235 –¥–æ 170.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""Russia updated the list of home palliative care medical devices, reducing the number from 235 to 170. Despite plans for expansion, the total number of items in the list has decreased.""
}"
2025-08-14T12:07:01+00:00,@medpharm,12566,https://t.me/medpharm/12566,"–ë–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ —Å–∞–Ω–∞—Ç–æ—Ä–∏–µ–≤ –†–æ—Å—Å–∏–∏ —Å—Ç–∞–ª–∫–∏–≤–∞—é—Ç—Å—è —Å –Ω–µ—Ö–≤–∞—Ç–∫–æ–π 30‚Äì40% –ø–µ—Ä—Å–æ–Ω–∞–ª–∞, –æ—Å–æ–±–µ–Ω–Ω–æ –≤—Ä–∞—á–µ–π –∏ —Å—Ä–µ–¥–Ω–µ–≥–æ –º–µ–¥–ø–µ—Ä—Å–æ–Ω–∞–ª–∞. –≠—Ç–æ —Å–≤—è–∑–∞–Ω–æ —Å –æ—Ç—Ç–æ–∫–æ–º –Ω–∞—Å–µ–ª–µ–Ω–∏—è –∏–∑ –º–∞–ª—ã—Ö –≥–æ—Ä–æ–¥–æ–≤ –∏ –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏–µ–π —Å —á–∞—Å—Ç–Ω—ã–º–∏ –∫–ª–∏–Ω–∏–∫–∞–º–∏.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""shortage, hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""Most sanatoriums in Russia are facing a shortage of up to 30-40% staff, especially doctors and mid-level medical personnel. This is due to population outflow from small cities and competition with private clinics.""
}"
2025-08-14T10:04:56+00:00,@medpharm,12565,https://t.me/medpharm/12565,–†–æ—Å—Å–∏—è —É–∫—Ä–µ–ø–∏–ª–∞—Å—å –Ω–∞ –≤—Ç–æ—Ä–æ–º –º–µ—Å—Ç–µ –≤ –º–∏—Ä–µ –ø–æ –∫–æ–ª–∏—á–µ—Å—Ç–≤—É —É—Ç–µ—á–µ–∫ –¥–∞–Ω–Ω—ã—Ö –∏–∑ –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π. –≠–∫—Å–ø–µ—Ä—Ç—ã –æ—Ç–º–µ—á–∞—é—Ç —É—Å–∫–æ—Ä–µ–Ω–∏–µ —Ç–µ–º–ø–æ–≤ —Ä–æ—Å—Ç–∞ —á–∏—Å–ª–∞ –∏–Ω—Ü–∏–¥–µ–Ω—Ç–æ–≤ –∏ —É–≥—Ä–æ–∑ –¥–ª—è –ø–µ—Ä—Å–æ–Ω–∞–ª—å–Ω–æ–π –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤.,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""Russia is on second place in the world for data leaks from healthcare organizations. Experts note an acceleration of incident growth rates and threats to patients' personal information.""
}"
2025-08-14T07:19:21+00:00,@medpharm,12564,https://t.me/medpharm/12564,"–ü–æ –∏—Å–∫—É –æ –∑–∞—â–∏—Ç–µ –¥–µ–ª–æ–≤–æ–π —Ä–µ–ø—É—Ç–∞—Ü–∏–∏ ¬´–ì–µ–Ω–µ—Ä–∏—É–º¬ª –∏ –≥–ª–∞–≤–∞ —Ñ–æ–Ω–¥–∞ ¬´–ü–æ–º–æ—â—å —Å–µ–º—å—è–º –°–ú–ê¬ª –∑–∞–∫–ª—é—á–∏–ª–∏ –º–∏—Ä–æ–≤–æ–µ —Å–æ–≥–ª–∞—à–µ–Ω–∏–µ. –û—Ç–≤–µ—Ç—á–∏–∫ –ø—É–±–ª–∏–∫–æ–≤–∞–ª –Ω–µ–≥–∞—Ç–∏–≤–Ω—ã–µ –≤—ã—Å–∫–∞–∑—ã–≤–∞–Ω–∏—è –æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–µ –∫–æ–º–ø–∞–Ω–∏–∏, –Ω–æ –ø—Ä–∏–∑–Ω–∞–ª —Å–≤–æ—é –Ω–µ–ø—Ä–∞–≤–æ—Ç—É. –í—Å–∫–æ—Ä–µ –ø–æ—Å–ª–µ –ø—É–±–ª–∏–∫–∞—Ü–∏–∏ –æ–ø—Ä–æ–≤–µ—Ä–∂–µ–Ω–∏—è –æ–Ω –ø–æ–ª–Ω–æ—Å—Ç—å—é —É–¥–∞–ª–∏–ª —Å–≤–æ–π –∞–∫–∫–∞—É–Ω—Ç –∏–∑ —Å–æ—Ü—Å–µ—Ç–µ–π.","{""skip"": true}"
2025-08-13T16:02:01+00:00,@medpharm,12563,https://t.me/medpharm/12563,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 13 –∞–≤–≥—É—Å—Ç–∞ –ò–ò –ø–æ–¥–≤–æ–¥–∏—Ç –†–µ–≥—É–ª—è—Ä–Ω–æ–µ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ –ò–ò –ø—Ä–∏ –∫–æ–ª–æ–Ω–æ—Å–∫–æ–ø–∏–∏ —Å–Ω–∏–∂–∞–µ—Ç —Å–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω—ã–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ –Ω–∞–≤—ã–∫–∏ —ç–Ω–¥–æ—Å–∫–æ–ø–∏—Å—Ç–æ–≤ –∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –≤—ã—è–≤–ª–µ–Ω–∏—è –∞–¥–µ–Ω–æ–º. –≠–∫—Å–ø–µ—Ä—Ç—ã —Ä–µ–∫–æ–º–µ–Ω–¥—É—é—Ç –±–æ–ª–µ–µ –æ—Å—Ç–æ—Ä–æ–∂–Ω—ã–π –ø–æ–¥—Ö–æ–¥ –∫ –≤–Ω–µ–¥—Ä–µ–Ω–∏—é —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –∏ –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –≤–æ–∑–º–æ–∂–Ω—ã—Ö –ø–æ—Å–ª–µ–¥—Å—Ç–≤–∏–π –¥–ª—è –∫–≤–∞–ª–∏—Ñ–∏–∫–∞—Ü–∏–∏ –º–µ–¥–ø–µ—Ä—Å–æ–Ω–∞–ª–∞. –ï–¥–∞ –¥–ª—è —Å–µ—Ä–¥—Ü–∞ –ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∞—è –∫–∞—Ä–¥–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∞—è –∞—Å—Å–æ—Ü–∏–∞—Ü–∏—è –æ–ø—É–±–ª–∏–∫–æ–≤–∞–ª–∞ –Ω–∞—É—á–Ω—ã–π –¥–æ–∫–ª–∞–¥ –æ –≤–ª–∏—è–Ω–∏–∏ —É–ª—å—Ç—Ä–∞–æ–±—Ä–∞–±–æ—Ç–∞–Ω–Ω—ã—Ö –ø—Ä–æ–¥—É–∫—Ç–æ–≤ –Ω–∞ –∫–∞—Ä–¥–∏–æ–º–µ—Ç–∞–±–æ–ª–∏—á–µ—Å–∫–æ–µ –∑–¥–æ—Ä–æ–≤—å–µ. –í –Ω–µ–º –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è –ø—Ä–∏–æ—Ä–∏—Ç–µ—Ç–Ω–æ —Å–æ–∫—Ä–∞—â–∞—Ç—å –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–µ –ø—Ä–æ–¥—É–∫—Ç–æ–≤ —Å –≤—ã—Å–æ–∫–∏–º —Å–æ–¥–µ—Ä–∂–∞–Ω–∏–µ–º –∂–∏—Ä–æ–≤, —Å–æ–ª–∏ –∏ —Å–∞—Ö–∞—Ä–∞ –∏ –ø—Ä–æ–≤–æ–¥–∏—Ç—å –º–∞—Å—à—Ç–∞–±–Ω—ã–µ —Ä–µ—Ñ–æ—Ä–º—ã –ø–∏—â–µ–≤–æ–π –ø–æ–ª–∏—Ç–∏–∫–∏. –ü–æ–ª—É—á–∏—Ç–µ –∏ —Ä–∞—Å–ø–∏—à–∏—Ç–µ—Å—å –ö—Ä—É–ø–Ω–µ–π—à–∏–µ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã–µ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ —É–≤–µ–ª–∏—á–∏–ª–∏ –æ–±—ä–µ–º –≤—ã–ø–ª–∞—Ç —Ä–æ—Å—Å–∏–π—Å–∫–∏–º –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è–º –∏ –∞—Å—Å–æ—Ü–∏–∞—Ü–∏—è–º –Ω–∞ 22,9% –ø–æ –∏—Ç–æ–≥–∞–º 2024 –≥–æ–¥–∞. –û–±—â–∏–µ —Ä–∞—Å—Ö–æ–¥—ã –æ—Ç—Ä–∞—Å–ª–∏ –Ω–∞ –ø—Ä–æ–¥–≤–∏–∂–µ–Ω–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –æ—Å—Ç–∞–ª–∏—Å—å –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏ –Ω–∞ —É—Ä–æ–≤–Ω–µ 2023 –≥–æ–¥–∞, —Å–æ—Å—Ç–∞–≤–∏–≤ 10 –º–ª—Ä–¥ —Ä—É–±. –ü—Ä–µ–¥—ä—è–≤–∏—Ç–µ –¥–æ–∫—É–º–µ–Ω—Ç—ã –ë–ª–æ–∫–∏—Ä–æ–≤–∞—Ç—å –æ–±–æ—Ä–æ—Ç –ë–ê–î –±–µ–∑ –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤ –æ –∫–∞—á–µ—Å—Ç–≤–µ —Å 1 –º–∞—Ä—Ç–∞ 2026 –≥–æ–¥–∞ –ø—Ä–µ–¥–ª–æ–∂–∏–ª –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥. –¢–∞–∫–∂–µ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –∏–Ω—Ç–µ–≥—Ä–∞—Ü–∏—è —Å —Ä–µ–µ—Å—Ç—Ä–æ–º –æ –Ω–∞—á–∞–ª–µ –æ—Ç–¥–µ–ª—å–Ω—ã—Ö –≤–∏–¥–æ–≤ –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏.","{""skip"": true}"
2025-08-13T14:51:24+00:00,@medpharm,12562,https://t.me/medpharm/12562,"–ü—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º —Å–ª–µ–¥—É—é—â–µ–≥–æ —Å–ø–∏–∫–µ—Ä–∞ PRO–µ–∫—Ü–∏–π –ë—É–¥—É—â–µ–≥–æ: üîπ–°–µ—Ä–≥–µ–π –ï—Å—å–∫–∏–Ω, –¥–∏—Ä–µ–∫—Ç–æ—Ä –ø–æ —Ä–∞–∑–≤–∏—Ç–∏—é –§–ö ¬´–ü—É–ª—å—Å¬ª, —Å–ø–∏–∫–µ—Ä –º–∞—Ä–∫–µ—Ç–∏–Ω–≥-—Å–µ—Å—Å–∏–∏ ¬´–ú–∞—Ä–∫–µ—Ç–∏–Ω–≥ –≥–ª–∞–∑–∞–º–∏ –¢–û–ü–æ–≤¬ª –î–∞—Ç–∞ –∏ –≤—Ä–µ–º—è —Å–µ—Å—Å–∏–∏: 12 —Å–µ–Ω—Ç—è–±—Ä—è 2025, 12:15 üìç–≥. –°–æ—á–∏, Pullman –°–æ—á–∏ –¶–µ–Ω—Ç—Ä 5* –ü–æ–¥—Ä–æ–±–Ω–µ–µ –æ –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ –∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –Ω–∞ —Å–∞–π—Ç–µ","{""skip"": true}"
2025-08-13T14:06:07+00:00,@medpharm,12561,https://t.me/medpharm/12561,"–í–µ—Ä—Ö–æ–≤–Ω—ã–π —Å—É–¥ –†–æ—Å—Å–∏–∏ –Ω–µ –Ω–∞—à–µ–ª –Ω–∞—Ä—É—à–µ–Ω–∏–π –≤ —Ñ–∞–∫—Ç–µ —Å–æ–ø–ª–∞—Ç–µ–∂–µ–π –≥—Ä–∞–∂–¥–∞–Ω –ø—Ä–∏ –æ–∫–∞–∑–∞–Ω–∏–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –≤ —Å–∏—Å—Ç–µ–º–µ –û–ú–°. –í —Ç–æ –∂–µ –≤—Ä–µ–º—è –æ–±–∑–æ—Ä —Å—É–¥–µ–±–Ω–æ–π –ø—Ä–∞–∫—Ç–∏–∫–∏ –ø–æ–∫–∞–∑—ã¬≠–≤–∞–µ—Ç, —á—Ç–æ –ø—Ä–æ–±–ª–µ–º–∞ –Ω—É–∂–¥–∞–µ—Ç—Å—è –≤ —Å–µ—Ä—å–µ–∑–Ω–æ–π –º–µ—Ç–æ–¥–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π –ø—Ä–æ—Ä–∞–±–æ—Ç–∫–µ.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The Supreme Court of Russia did not find any violations in the practice of co-payments for patients receiving medical care under the State Medical Insurance System. However, an examination of court practice shows that this issue requires serious methodological consideration.""
}"
2025-08-13T12:17:37+00:00,@medpharm,12560,https://t.me/medpharm/12560,"–ö—Ä—É–ø–Ω–µ–π—à–∏–µ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã–µ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ —É–≤–µ–ª–∏—á–∏–ª–∏ –æ–±—ä–µ–º –≤—ã–ø–ª–∞—Ç —Ä–æ—Å—Å–∏–π—Å–∫–∏–º –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è–º –∏ –∞—Å—Å–æ—Ü–∏–∞—Ü–∏—è–º –Ω–∞ 22,9% –ø–æ –∏—Ç–æ–≥–∞–º 2024 –≥–æ–¥–∞. –û–±—â–∏–µ —Ä–∞—Å—Ö–æ–¥—ã –æ—Ç—Ä–∞—Å–ª–∏ –Ω–∞ –ø—Ä–æ–¥–≤–∏–∂–µ–Ω–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –æ—Å—Ç–∞–ª–∏—Å—å –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏ –Ω–∞ —É—Ä–æ–≤–Ω–µ 2023 –≥–æ–¥–∞, —Å–æ—Å—Ç–∞–≤–∏–≤ 10 –º–ª—Ä–¥ —Ä—É–±.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""Major international pharmaceutical companies increased their payments to Russian medical organizations and associations by 22.9% for the year 2024. Total industry spending on drug promotion and research remained nearly unchanged from 2023, at 10 billion rubles.""
}"
2025-08-13T10:34:01+00:00,@medpharm,12559,https://t.me/medpharm/12559,"–ú–∏–Ω–∑–¥—Ä–∞–≤ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª —Ñ–æ—Ä–º—É —ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω–æ–π –æ—Ç—á–µ—Ç–Ω–æ—Å—Ç–∏ –æ –Ω–∞—É—á–Ω—ã—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è—Ö. –ò—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—é –ø—Ä–∏–¥–µ—Ç—Å—è –æ–ø–∏—Å—ã–≤–∞—Ç—å —ç—Ç–∏—á–µ—Å–∫–∏–µ –∞—Å–ø–µ–∫—Ç—ã —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ —Ä–∞–∑—Ä–∞–±–∞—Ç—ã–≤–∞–µ–º–æ–π —Ç–µ–º—ã, —Å–≤–µ–¥–µ–Ω–∏—è –æ –ø—Ä–µ–¥–ø–æ–ª–∞–≥–∞–µ–º—ã—Ö —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞—Ö, –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã—Ö –∏ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –∞–Ω–∞–ª–æ–≥–∞—Ö –ø—Ä–µ–¥–ø–æ–ª–∞–≥–∞–µ–º–æ–≥–æ –∏–∑–æ–±—Ä–µ—Ç–µ–Ω–∏—è –∏ –æ–∂–∏–¥–∞–µ–º—ã–π —Å—Ä–æ–∫ –≥–æ—Ç–æ–≤–Ω–æ—Å—Ç–∏ –ø—Ä–æ–¥—É–∫—Ç–∞ –∫ –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–æ–º—É –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—é.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health has developed an electronic reporting form for scientific research. Researchers must describe ethical aspects, expected results, foreign and Russian equivalents of the proposed invention, and the anticipated time for practical application of the product.""
}"
2025-08-13T08:15:47+00:00,@medpharm,12558,https://t.me/medpharm/12558,"–í 1997 –≥–æ–¥—É ¬´–ü—Ä–æ—Ç–µ–∫¬ª —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ–µ –ø—Ä–æ–≥—Ä–∞–º–º–Ω–æ–µ —Å–∫–ª–∞–¥—Å–∫–æ–µ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ Stock, –∫–æ—Ç–æ—Ä–æ–µ –ø–æ–º–æ–≥–ª–æ –≤–∑—è—Ç—å –ø–æ–¥ –∫–æ–Ω—Ç—Ä–æ–ª—å –º–∞—Å—à—Ç–∞–±—ã –Ω–æ–≤–æ–≥–æ —Å–∫–ª–∞–¥–∞. –ö 2002 –≥–æ–¥—É —Å–∏—Å—Ç–µ–º–∞ —Å—Ç–∞–ª–∞ –ø–æ–ª–Ω–æ—Ü–µ–Ω–Ω–æ–π –ø–ª–∞—Ç—Ñ–æ—Ä–º–æ–π, –∫–æ—Ç–æ—Ä–∞—è —Å–º–æ–≥–ª–∞ –æ–ø—Ç–∏–º–∏–∑–∏—Ä–æ–≤–∞—Ç—å –ø—Ä–æ—Ü–µ—Å—Å—ã –∏ –≤—ã–≤–µ—Å—Ç–∏ —Å–∫–ª–∞–¥—Å–∫—É—é —Å–∏—Å—Ç–µ–º—É –ì–ö ¬´–ü—Ä–æ—Ç–µ–∫¬ª –Ω–∞ –Ω–æ–≤—ã–π —É—Ä–æ–≤–µ–Ω—å.","{""skip"": true}"
2025-08-13T08:05:45+00:00,@medpharm,12557,https://t.me/medpharm/12557,"–û–∫–æ–ª–æ –ø–æ–ª–æ–≤–∏–Ω—ã —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –≤—Ä–∞—á–µ–π —Å—á–∏—Ç–∞—é—Ç —Ä–∞—Å–ø—Ä–µ–¥–µ–ª–µ–Ω–∏–µ —Å—Ç–∏–º—É–ª–∏—Ä—É—é—â–∏—Ö –≤—ã–ø–ª–∞—Ç –Ω–µ—Å–ø—Ä–∞–≤–µ–¥–ª–∏–≤—ã–º –∏–ª–∏ —Å—É–±—ä–µ–∫—Ç–∏–≤–Ω—ã–º. –≠–∫—Å–ø–µ—Ä—Ç—ã –æ—Ç–º–µ—á–∞—é—Ç, —á—Ç–æ –ø—Ä–æ–±–ª–µ–º—É –º–æ–∂–µ—Ç —Ä–µ—à–∏—Ç—å –Ω–æ–≤–∞—è —Å–∏—Å—Ç–µ–º–∞ –æ–ø–ª–∞—Ç—ã —Ç—Ä—É–¥–∞ –≤ –æ—Ç—Ä–∞—Å–ª–∏ —Å —á–µ—Ç–∫–∏–º–∏ –∫—Ä–∏—Ç–µ—Ä–∏—è–º–∏ –Ω–∞—á–∏—Å–ª–µ–Ω–∏—è –Ω–∞–¥–±–∞–≤–æ–∫.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""tenders, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""About half of Russian doctors consider the distribution of incentive payments unfair or subjective. Experts suggest that a new system of salary payment with clear criteria for bonuses could solve the problem.""
}"
2025-08-12T16:32:01+00:00,@medpharm,12556,https://t.me/medpharm/12556,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 12 –∞–≤–≥—É—Å—Ç–∞ –í—Å–µ –≤–∫–ª—é—á–µ–Ω–æ –í –†–æ—Å—Å–∏–∏ –ø–ª–∞–Ω–∏—Ä—É—é—Ç —Ä–∞—Å—à–∏—Ä–∏—Ç—å –¥–æ—Å—Ç—É–ø –∫ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–º —Å–µ—Ä–≤–∏—Å–∞–º –Ω–∞ –ø–æ—Ä—Ç–∞–ª–µ –ì–æ—Å—É—Å–ª—É–≥, –≤ —Ç–æ–º —á–∏—Å–ª–µ —Å–≤—è–∑–∞–Ω–Ω—ã–º —Å –º–µ–¥–∏—Ü–∏–Ω–æ–π –∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ–º. –í —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, –º–µ–¥- –∏ —Ñ–∞—Ä–º—Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –±—É–¥—É—Ç –ø–æ–ª—É—á–∞—Ç—å –æ–ø–æ–≤–µ—â–µ–Ω–∏—è –æ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ –ø—Ä–æ—Ö–æ–∂–¥–µ–Ω–∏—è –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–∏, –∞ –∫–ª–∏–Ω–∏–∫–∏ —Å–º–æ–≥—É—Ç –Ω–∞–ø—Ä–∞–≤–ª—è—Ç—å –∑–∞—è–≤–ª–µ–Ω–∏—è –Ω–∞ –ø–æ–ª—É—á–µ–Ω–∏–µ –∏–ª–∏ –ø—Ä–æ–¥–ª–µ–Ω–∏–µ –ª–∏—Ü–µ–Ω–∑–∏–∏. –ö–æ—Å–∞ –Ω–∞ –∫–∞–º–µ–Ω—å –ü—Ä–æ–∫—É—Ä–∞—Ç—É—Ä–∞ –ú–æ—Å–∫–æ–≤—Å–∫–æ–≥–æ —Ä–µ–≥–∏–æ–Ω–∞ –Ω–∞–ø—Ä–∞–≤–∏–ª–∞ –≤ —Å—É–¥ –¥–µ–ª–æ –ø—Ä–æ—Ç–∏–≤ —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–∞ –¥–≤—É—Ö –∫–ª–∏–Ω–∏–∫, –≤—Ö–æ–¥—è—â–∏—Ö –≤ –≥—Ä—É–ø–ø—É –∫–æ–º–ø–∞–Ω–∏–π ¬´–û–ú–°¬ª, –ø–æ –æ–±–≤–∏–Ω–µ–Ω–∏—é –≤ –º–æ—à–µ–Ω–Ω–∏—á–µ—Å—Ç–≤–µ. –°–ª–µ–¥—Å—Ç–≤–∏–µ —Å—á–∏—Ç–∞–µ—Ç, —á—Ç–æ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—è –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∏ —Ñ–∏–∫—Ç–∏–≤–Ω—ã–µ —Å–≤–µ–¥–µ–Ω–∏—è –æ –ª–µ—á–µ–Ω–∏–∏ 420 –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –∑–∞ —á—Ç–æ –ø–æ–ª—É—á–∏–ª–∏ –Ω–µ–æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω—ã–µ –≤—ã–ø–ª–∞—Ç—ã –≤ —Ä–∞–∑–º–µ—Ä–µ 338,5 –º–ª–Ω —Ä—É–±. –∏–∑ –¢–§–û–ú–° —Ä–µ–≥–∏–æ–Ω–∞. –ï—â–µ –ø–æ—Å–ª–µ–¥—è—Ç –≠–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç –ø–æ –º–∞—Ä–∫–∏—Ä–æ–≤–∫–µ –æ—Ç–¥–µ–ª—å–Ω—ã—Ö –≤–∏–¥–æ–≤ –º–µ–¥–∏–∑–¥–µ–ª–∏–π –ø—Ä–æ–¥–ª–µ–Ω –¥–æ –∫–æ–Ω—Ü–∞ —Ñ–µ–≤—Ä–∞–ª—è 2026 –≥–æ–¥–∞. –í –ø–µ—Ä–µ—á–Ω–µ –ø—Ä–µ–∑–µ—Ä–≤–∞—Ç–∏–≤—ã, —à–ø—Ä–∏—Ü—ã, —Ñ–∏–ª–µ—Ä—ã, –∏–Ω—Ñ—É–∑–∏–æ–Ω–Ω—ã–µ —Å–∏—Å—Ç–µ–º—ã, –ø—Ä–æ–±–∏—Ä–∫–∏ –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –º–∞—Å–∫–∏. –°–∞–º–æ–∫–æ–Ω—Ç—Ä–æ–ª—å –∏ —Ü–∏—Ñ—Ä–æ–≤–∏–∑–∞—Ü–∏—è –í –ü–æ–ª–æ–∂–µ–Ω–∏–µ –æ –ª–∏—Ü–µ–Ω–∑–∏—Ä–æ–≤–∞–Ω–∏–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤–Ω–µ—Å—É—Ç –∏–∑–º–µ–Ω–µ–Ω–∏—è. –ü—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è –≤–≤–µ—Å—Ç–∏ –ø—Ä–æ–≤–µ—Ä–∫–∏ –ø–æ –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–µ —Å–∞–º–∏—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π.","{""skip"": true}"
2025-08-12T13:46:40+00:00,@medpharm,12555,https://t.me/medpharm/12555,"–ì–ª–∞–≤–∞ –ù–∞—Ü–º–µ–¥–ø–∞–ª–∞—Ç—ã –õ–µ–æ–Ω–∏–¥ –†–æ—à–∞–ª—å –Ω–∞–∑–≤–∞–ª –Ω–æ–≤—ã–π –ø—Ä–∏–≥–æ–≤–æ—Ä –∫–∞–ª–∏–Ω–∏–Ω–≥—Ä–∞–¥—Å–∫–∏–º –≤—Ä–∞—á–∞–º –Ω–µ—Å–ø—Ä–∞–≤–µ–¥–ª–∏–≤—ã–º. –ú–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–µ —Å–æ–æ–±—â–µ—Å—Ç–≤–æ –±—É–¥–µ—Ç –¥–æ–±–∏–≤–∞—Ç—å—Å—è –ø–µ—Ä–µ—Å–º–æ—Ç—Ä–∞ –¥–µ–ª–∞, –ø–æ—Ç–æ–º—É —á—Ç–æ ¬´—Ñ–∞–∫—Ç–∏—á–µ—Å–∫–∏ –Ω–∏–∫–∞–∫–∏—Ö –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å—Å—Ç–≤ —Ç–æ–≥–æ, —á—Ç–æ –Ω–æ–≤–æ—Ä–æ–∂–¥–µ–Ω–Ω–æ–≥–æ –¥–µ–π—Å—Ç–≤–∏—Ç–µ–ª—å–Ω–æ —É–±–∏–ª–∏, –Ω–µ—Ç¬ª.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, clinical_trial, safety"",
  ""impact"": ""high"",
  ""english"": ""National Medical Chamber head Lyoshyonkovich Rooshal called the conviction of doctors in Kaliningrad unjust. The medical community will appeal for a retrial, as there are no actual evidence that the newborn was killed.""
}"
2025-08-12T12:01:00+00:00,@medpharm,12554,https://t.me/medpharm/12554,"–ó–Ω–∞–∫–æ–º—å—Ç–µ—Å—å —Å–æ —Å–ª–µ–¥—É—é—â–∏–º —Å–ø–∏–∫–µ—Ä–æ–º PRO–µ–∫—Ü–∏–π –ë—É–¥—É—â–µ–≥–æ: üîπ–û–ª—å–≥–∞ –õ–∞—Ä–∏–Ω–∞, –∫–æ–º–º–µ—Ä—á–µ—Å–∫–∏–π –¥–∏—Ä–µ–∫—Ç–æ—Ä ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª, —Å–ø–∏–∫–µ—Ä —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–æ–π —Å–µ—Å—Å–∏–∏ ¬´–ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—ã–π –∫—É—Ä—Å. –ì–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–π –∫–æ–Ω—Ç—É—Ä —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –æ—Ç—Ä–∞—Å–ª–∏¬ª –î–∞—Ç–∞ –∏ –≤—Ä–µ–º—è —Å–µ—Å—Å–∏–∏: 11 —Å–µ–Ω—Ç—è–±—Ä—è 2025, 11:15 üìç–≥. –°–æ—á–∏, Pullman –°–æ—á–∏ –¶–µ–Ω—Ç—Ä 5* –ü–æ–¥—Ä–æ–±–Ω–µ–µ –æ –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ –∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –Ω–∞ —Å–∞–π—Ç–µ","{""skip"": true}"
2025-08-12T11:11:43+00:00,@medpharm,12553,https://t.me/medpharm/12553,"–ü–æ—á–µ–º—É –≤ —É—Å–ª–æ–≤–∏—è—Ö –∫–∏–±–µ—Ä—Ç–µ—Ä—Ä–æ—Ä–∏–∑–º–∞ –º–µ–¥–∏—Ü–∏–Ω–∞ –æ–∫–∞–∑–∞–ª–∞—Å—å –æ—Å–æ–±–æ —É—è–∑–≤–∏–º–æ–π, –∞ –∑–ª–æ—É–º—ã—à–ª–µ–Ω–Ω–∏–∫–∏ —Ñ–∏–Ω–∞–Ω—Å–æ–≤–æ –∏ –¥–∞–∂–µ ¬´–ø–æ–ª–∏—Ç–∏—á–µ—Å–∫–∏¬ª –º–æ—Ç–∏–≤–∏—Ä–æ–≤–∞–Ω–Ω—ã–º–∏? –ö–∞–∫ –∑–∞—â–∏—Ç–∏—Ç—å –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω—ã–µ —Å–∏—Å—Ç–µ–º—ã –∏ –ø–µ—Ä—Å–æ–Ω–∞–ª –∫–ª–∏–Ω–∏–∫, —Ä–∞—Å—Å–∫–∞–∑—ã–≤–∞—é—Ç —ç–∫—Å–ø–µ—Ä—Ç—ã.","{""skip"": true}"
2025-08-12T09:16:39+00:00,@medpharm,12552,https://t.me/medpharm/12552,–ó–∞–∫–ª—é—á–µ–Ω–∏–µ –æ –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏–∏ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–æ–∏—Å—Ö–æ–∂–¥–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤ –±—É–¥—É—Ç –≤—ã–¥–∞–≤–∞—Ç—å –ø–æ –Ω–æ–≤–æ–º—É —Ä–µ–≥–ª–∞–º–µ–Ω—Ç—É. –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ –æ–±–Ω–æ–≤–ª—è–µ—Ç —Å—Ä–æ–∫–∏ –∏ –ø—Ä–∞–≤–∏–ª–∞ –ø–æ–¥–∞—á–∏ –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤.,"{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""registration, regulation"",
  ""impact"": ""medium"",
  ""english"": ""The regional ministry of industry and trade is updating the deadlines and document submission rules for confirming domestic origin of medicines.""
}"
2025-08-12T07:29:46+00:00,@medpharm,12551,https://t.me/medpharm/12551,"–ü–æ –¥–∞–Ω–Ω—ã–º –∑–∞ I –∫–≤–∞—Ä—Ç–∞–ª 2025 –≥–æ–¥–∞, —Å—Ä–µ–¥–Ω—è—è –∑–∞—Ä–ø–ª–∞—Ç–∞ –≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–∏ –†–æ—Å—Å–∏–∏ —Å–æ—Å—Ç–∞–≤–∏–ª–∞ 79,7 —Ç—ã—Å. —Ä—É–±., —á—Ç–æ –Ω–∞ 17,8% –≤—ã—à–µ, —á–µ–º –≤ –∞–Ω–∞–ª–æ–≥–∏—á–Ω–æ–º –ø–µ—Ä–∏–æ–¥–µ –ø—Ä–æ—à–ª–æ–≥–æ –≥–æ–¥–∞. –°–Ω–∏–∂–µ–Ω–∏–µ —Å—Ä–µ–¥–Ω–µ–≥–æ –∑–∞—Ä–∞–±–æ—Ç–∫–∞ –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–Ω–æ —Ç–æ–ª—å–∫–æ –≤ –æ–¥–Ω–æ–º —Ä–µ–≥–∏–æ–Ω–µ.","{""skip"": true}"
2025-08-11T15:36:00+00:00,@medpharm,12549,https://t.me/medpharm/12549,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 11 –∞–≤–≥—É—Å—Ç–∞ –î–æ–ª–æ–∂–∞—Ç ¬´–Ω–∞–≤–µ—Ä—Ö¬ª –ù–∞—Ä–æ–¥–Ω—ã–π —Ñ—Ä–æ–Ω—Ç –∑–∞–ø—É—Å—Ç–∏–ª –¥–≤–∞ –∞–Ω–æ–Ω–∏–º–Ω—ã—Ö –æ–ø—Ä–æ—Å–∞ –¥–ª—è –≤—Ä–∞—á–µ–π –∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, —á—Ç–æ–±—ã –≤—ã—è–≤–∏—Ç—å –∫–ª—é—á–µ–≤—ã–µ –ø—Ä–æ–±–ª–µ–º—ã –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è, –≤–∫–ª—é—á–∞—è —É—Å–ª–æ–≤–∏—è —Ç—Ä—É–¥–∞ –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤, –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å –º–µ–¥–ø–æ–º–æ—â–∏ –∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è. –ò—Ç–æ–≥–∏ —Å—Ç–∞–Ω—É—Ç –æ—Å–Ω–æ–≤–æ–π –¥–æ–∫–ª–∞–¥–∞ –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç—É. –°—É–¥ –∏–¥–µ—Ç –ó–∞—â–∏—Ç–∞ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç –æ–±–∂–∞–ª–æ–≤–∞—Ç—å –ø—Ä–∏–≥–æ–≤–æ—Ä—ã, –≤—ã–Ω–µ—Å–µ–Ω–Ω—ã–µ –≤—Ä–∞—á–∞–º –ï–ª–µ–Ω–µ –ë–µ–ª–æ–π –∏ –≠–ª–∏–Ω–µ –°—É—à–∫–µ–≤–∏—á, –∞ —Ç–∞–∫–∂–µ –¥–æ–±–∏–≤–∞—Ç—å—Å—è –∏—Ö —É—Å–ª–æ–≤–Ω–æ-–¥–æ—Å—Ä–æ—á–Ω–æ–≥–æ –æ—Å–≤–æ–±–æ–∂–¥–µ–Ω–∏—è. –ü—Ä–∏–º–µ—Ä–Ω–æ –¥–≤–µ —Ç—Ä–µ—Ç–∏ –Ω–∞–∑–Ω–∞—á–µ–Ω–Ω–æ–≥–æ —Å—Ä–æ–∫–∞ –∏–º –∑–∞—á—Ç—É—Ç –∑–∞ –Ω–∞—Ö–æ–∂–¥–µ–Ω–∏–µ –ø–æ–¥ —Å—Ç—Ä–∞–∂–µ–π –≤ –°–ò–ó–û, –ø–æ–¥ –¥–æ–º–∞—à–Ω–∏–º –∞—Ä–µ—Å—Ç–æ–º –∏ –≤ –∫–æ–ª–æ–Ω–∏–∏. –ù–∞ –≤—ã—Å–æ–∫–æ–º —É—Ä–æ–≤–Ω–µ –†–æ—Å—Å–∏—è –∑–∞–Ω—è–ª–∞ 12-–µ –º–µ—Å—Ç–æ —Å—Ä–µ–¥–∏ –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö –º–∏—Ä–æ–≤—ã—Ö —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö —Ä—ã–Ω–∫–æ–≤ –ø–æ –æ–±—ä–µ–º—É —Ä–∞—Å—Ö–æ–¥–æ–≤ –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –ø–æ –≤–µ—Ä—Å–∏–∏ IQVIA. –ê–Ω–∞–ª–∏—Ç–∏–∫–∏ –≤–ø–µ—Ä–≤—ã–µ –≤–Ω–µ—Å–ª–∏ –Ω–∞—à—É —Å—Ç—Ä–∞–Ω—É –≤ –∫–∞—Ç–µ–≥–æ—Ä–∏—é —Ä–∞–∑–≤–∏—Ç—ã—Ö —Ñ–∞—Ä–º—Ä—ã–Ω–∫–æ–≤. –°—Ä–æ–∫ –≥–æ–¥–Ω–æ—Å—Ç–∏ –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ —É–≤–µ–ª–∏—á–∏–ª–æ —Å—Ä–æ–∫ –¥–µ–π—Å—Ç–≤–∏—è –∑–∞–ø–∏—Å–µ–π –≤ —Ä–µ–µ—Å—Ç—Ä–µ —Ä–æ—Å—Å–∏–π—Å–∫–æ–π –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏. –û–Ω–∏ –±—É–¥—É—Ç –¥–µ–π—Å—Ç–≤–∏—Ç–µ–ª—å–Ω—ã –≤ —Ç–µ—á–µ–Ω–∏–µ –ø—è—Ç–∏ –ª–µ—Ç, –µ—Å–ª–∏ –ø—Ä–æ–º–ø—Ä–æ–¥—É–∫—Ü–∏—è –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–æ–≤–∞—Ç—å —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è–º.","{""skip"": true}"
2025-08-11T14:03:01+00:00,@medpharm,12548,https://t.me/medpharm/12548,"–≠–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç –ø–æ –º–∞—Ä–∫–∏—Ä–æ–≤–∫–µ —à–ø—Ä–∏—Ü–µ–≤, –ø—Ä–æ–±–∏—Ä–æ–∫, –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Å–∞–ª—Ñ–µ—Ç–æ–∫ –ø—Ä–æ–¥–ª–∏–ª–∏ –¥–æ —Ñ–µ–≤—Ä–∞–ª—è —Å–ª–µ–¥—É—é—â–µ–≥–æ –≥–æ–¥–∞. –ù–∞ —ç—Ç–æ–º –Ω–∞—Å—Ç–∞–∏–≤–∞–ª –û–±—â–µ—Å—Ç–≤–µ–Ω–Ω—ã–π —Å–æ–≤–µ—Ç –ø—Ä–∏ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–µ.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""The experiment to mark syringes, test tubes, and medical tissues has been extended until the end of next year. This was demanded by the Public Council under Roszdravnadzor.""
}"
2025-08-11T12:23:25+00:00,@medpharm,12547,https://t.me/medpharm/12547,"–ü—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º –≤–∞–º —Å–ª–µ–¥—É—é—â–µ–≥–æ —Å–ø–∏–∫–µ—Ä–∞ PRO–µ–∫—Ü–∏–π –ë—É–¥—É—â–µ–≥–æ: üîπ–ê—Ä–∏–Ω–∞ –†–æ—Å–ª–∞–≤—Ü–µ–≤–∞, —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ø—Ä–æ–µ–∫—Ç–æ–≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ê–û ¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç¬ª, —Å–ø–∏–∫–µ—Ä —Ñ–æ–∫—É—Å-—Å–µ—Å—Å–∏–∏ Forbes ¬´–ò–Ω–≤–µ—Å—Ç–∏—Ü–∏–∏ –≤ —Ñ–∞—Ä–º–µ: –∫–∞–ø–∏—Ç–∞–ª—ã, —Å—Ç—Ä–∞—Ç–µ–≥–∏–∏, —Ä–∏—Å–∫–∏¬ª –î–∞—Ç–∞ –∏ –≤—Ä–µ–º—è —Å–µ—Å—Å–∏–∏: 11 —Å–µ–Ω—Ç—è–±—Ä—è 2025, 14:00 üìç–≥. –°–æ—á–∏, Pullman –°–æ—á–∏ –¶–µ–Ω—Ç—Ä 5* –ü–æ–¥—Ä–æ–±–Ω–µ–µ –æ –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ –∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –Ω–∞ —Å–∞–π—Ç–µ","{""skip"": true}"
2025-08-11T11:36:47+00:00,@medpharm,12546,https://t.me/medpharm/12546,"–ú–æ—Å–æ–±–ª—Å—É–¥ –ø—Ä–∏–≥–æ–≤–æ—Ä–∏–ª –∫–∞–ª–∏–Ω–∏–Ω–≥—Ä–∞–¥—Å–∫–∏—Ö –≤—Ä–∞—á–µ–π –∫ –æ—Ç–±—ã–≤–∞–Ω–∏—é –Ω–∞–∫–∞–∑–∞–Ω–∏—è –≤ –∫–æ–ª–æ–Ω–∏–∏ –æ–±—â–µ–≥–æ —Ä–µ–∂–∏–º–∞, –ø—Ä–∏–∑–Ω–∞–≤ –∏—Ö –≤–∏–Ω–æ–≤–Ω—ã–º–∏ –≤ —É–±–∏–π—Å—Ç–≤–µ –Ω–µ–¥–æ–Ω–æ—à–µ–Ω–Ω–æ–≥–æ –º–ª–∞–¥–µ–Ω—Ü–∞. –í —Å—Ä–æ–∫ –ª–∏—à–µ–Ω–∏—è —Å–≤–æ–±–æ–¥—ã –∑–∞—á—Ç—É—Ç –≤—Ä–µ–º—è, –ø—Ä–æ–≤–µ–¥–µ–Ω–Ω–æ–µ –æ—Å—É–∂–¥–µ–Ω–Ω—ã–º–∏ –≤ –°–ò–ó–û –∏ –ø–æ–¥ –¥–æ–º–∞—à–Ω–∏–º –∞—Ä–µ—Å—Ç–æ–º.","{""skip"": true}"
2025-08-11T09:31:37+00:00,@medpharm,12545,https://t.me/medpharm/12545,"–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ —É–≤–µ–ª–∏—á–∏–ª–æ —Å—Ä–æ–∫ –¥–µ–π—Å—Ç–≤–∏—è –∑–∞–ø–∏—Å–µ–π –≤ —Ä–µ–µ—Å—Ç—Ä–µ —Ä–æ—Å—Å–∏–π—Å–∫–æ–π –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏. –¢–µ–ø–µ—Ä—å –∑–∞–ø–∏—Å–∏ –±—É–¥—É—Ç –¥–µ–π—Å—Ç–≤–∏—Ç–µ–ª—å–Ω—ã –≤ —Ç–µ—á–µ–Ω–∏–µ –ø—è—Ç–∏ –ª–µ—Ç, –µ—Å–ª–∏ –ø—Ä–æ–º–ø—Ä–æ–¥—É–∫—Ü–∏—è –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–æ–≤–∞—Ç—å —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è–º.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""registration"",
  ""impact"": ""medium"",
  ""english"": ""The government extended the duration of records in the Russian industrial products registry from three to five years, provided that the industrial product continues to meet requirements.""
}"
2025-08-11T07:58:47+00:00,@medpharm,12544,https://t.me/medpharm/12544,"–†–æ—Å—Å–∏–π—Å–∫–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –≤—Ö–æ–¥—è—Ç –≤ –ø–µ—Ä–≤—É—é —Å–æ—Ç–Ω—é –ø—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤—ã—Ö –±—Ä–µ–Ω–¥–æ–≤. –ü–æ–∫–∞ —Ä–æ—Å—Ç –ø—Ä–æ–∏—Å—Ö–æ–¥–∏—Ç –∑–∞ —Å—á–µ—Ç –≤—ã–ø—É—Å–∫–∞ –∞–Ω–∞–ª–æ–≥–æ–≤ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ù–æ –Ω–∞ —Ä—ã–Ω–∫–µ –ø–æ—è–≤–ª—è—é—Ç—Å—è –∏ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã–µ —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞, –∏ –æ–Ω–∏ —É–∂–µ –≤—Ö–æ–¥—è—Ç –≤ –ø–µ—Ä–≤—É—é —Å–æ—Ç–Ω—é –ø—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤—ã—Ö –±—Ä–µ–Ω–¥–æ–≤, –≤—ã—è—Å–Ω–∏–ª ¬´–ú–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–π –≤–µ—Å—Ç–Ω–∏–∫¬ª.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""clinical_trial, shortage"",
  ""impact"": ""medium"",
  ""english"": ""Russian medicines are entering the top hundred of anti-cancer brands. Growth is currently driven by the release of generic versions of original drugs. However, there are also original Russian medicines entering this top hundred list, according to 'Medicine Watch'.""
}"
2025-08-10T11:06:39+00:00,@medpharm,12543,https://t.me/medpharm/12543,"–ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ –∑–∞ –Ω–µ–¥–µ–ª—é üîµ–ö–æ–º–∏—Å—Å–∏—è –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–§ –ø–æ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—é –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø–µ—Ä–µ—á–Ω–µ–π —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–ª–∞ 6 –∞–≤–≥—É—Å—Ç–∞ 2025 –≥–æ–¥–∞ 15 –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–π –≤–∫–ª—é—á–µ–Ω–∏—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –ü–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü. –ò–∑ –Ω–∏—Ö —Å–µ–º—å –∑–∞—è–≤–æ–∫ –±—ã–ª–∏ –æ–¥–æ–±—Ä–µ–Ω—ã, –≤–æ—Å–µ–º—å –æ—Ç–∫–ª–æ–Ω–µ–Ω—ã. üîµ–î–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä—ã —Å—Ç–æ–ª–∫–Ω—É–ª–∏—Å—å —Å –ø—Ä–æ–±–ª–µ–º–∞–º–∏ –Ω–∞ —Ç–æ—Ä–≥–∞—Ö –∏ –≤—ã–Ω—É–∂–¥–µ–Ω—ã —Å—É–¥–∏—Ç—å—Å—è —Å –£–§–ê–° –∏–∑-–∑–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ ¬´–î–∂–æ–¥–∞—Å –≠–∫—Å–ø–æ–∏–º¬ª, –∫–æ—Ç–æ—Ä—ã–µ –±–æ–ª–µ–µ –Ω–µ –º–æ–≥—É—Ç –æ–±—Ä–∞—â–∞—Ç—å—Å—è –Ω–∞ —Ä—ã–Ω–∫–µ. üîµ–£–§–ê–° –ø–æ –ú–æ—Å–∫–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –æ—à—Ç—Ä–∞—Ñ–æ–≤–∞–ª–æ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—é ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª –Ω–∞ 200 —Ç—ã—Å. —Ä—É–±. –∑–∞ —Ä–µ–∫–ª–∞–º—É —Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ¬´–°–µ–º–∞–≤–∏–∫¬ª –Ω–∞ –≥–∞–ª–∞-–∫–æ–Ω—Ü–µ—Ä—Ç–µ ¬´–ù–æ–≤–∞—è –≤–æ–ª–Ω–∞ 2024¬ª –∏ —É–∂–∏–Ω–µ –∂—É—Ä–Ω–∞–ª–∞ ¬´Hello¬ª –≤ –°–æ—á–∏. üîµ–û—Ç–∫–∞–∑ –≤–∫–ª—é—á–∏—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç –≤ –æ–≥—Ä–∞–Ω–∏—á–∏—Ç–µ–ª—å–Ω—ã–µ —Å–ø–∏—Å–∫–∏ –∫–æ–º–∏—Å—Å–∏—è –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ø–æ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—é –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø–µ—Ä–µ—á–Ω–µ–π –Ω–µ—Ä–µ–¥–∫–æ –æ–±—ä—è—Å–Ω—è–µ—Ç —Ç–µ–º, —á—Ç–æ –Ω–µ –≤—Å–µ –µ–≥–æ –ø–æ–∫–∞–∑–∞–Ω–∏—è –æ—Ç—Ä–∞–∂–µ–Ω—ã –≤ —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–Ω—ã—Ö –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏—è—Ö. –ê—Å—Å–æ—Ü–∏–∞—Ü–∏—è ¬´–ò–Ω—Ñ–∞—Ä–º–∞¬ª –Ω–∞–ø—Ä–∞–≤–∏–ª–∞ –≤ –æ—Ç—Ä–∞—Å–ª–µ–≤–æ–µ –≤–µ–¥–æ–º—Å—Ç–≤–æ –ø–∏—Å—å–º–æ —Å –ø—Ä–æ—Å—å–±–æ–π –¥–∞—Ç—å —Ä–∞–∑—ä—è—Å–Ω–µ–Ω–∏–µ –ø–æ –¥–∞–Ω–Ω–æ–º—É –≤–æ–ø—Ä–æ—Å—É. üîµ–í –ú–∏–Ω–∑–¥—Ä–∞–≤–µ –ö—Ä–∞—Å–Ω–æ—è—Ä—Å–∫–æ–≥–æ –∫—Ä–∞—è –ø–æ—Å–ª–µ —Å–∫–∞–Ω–¥–∞–ª–∞ —Å–æ —Å—Ä—ã–≤–æ–º –ø–æ—Å—Ç–∞–≤–æ–∫ –ª—å–≥–æ—Ç–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ —É–≤–æ–ª–µ–Ω—ã –¥–≤–µ —á–∏–Ω–æ–≤–Ω–∏—Ü—ã: –∑–∞–º–º–∏–Ω–∏—Å—Ç—Ä–∞ –ø–æ —Ñ–∏–Ω–∞–Ω—Å–æ–≤–æ-—ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–∏–º –≤–æ–ø—Ä–æ—Å–∞–º –û–∫—Å–∞–Ω–∞ –ê—Ñ–∞–Ω–∞—Å—å–µ–≤–∞ –∏ –Ω–∞—á–∞–ª—å–Ω–∏–∫ –æ—Ç–¥–µ–ª–∞ –≥–æ—Å–∑–∞–∫—É–ø–æ–∫ –¢–∞—Ç—å—è–Ω–∞ –ï—Ä–æ—Ö–∏–Ω–∞.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, shortage, regulation"",
  ""impact"": ""high"",
  ""english"": ""The news discusses the regulatory process for including drugs in the list of essential medicines and highlights issues related to drug shortages. It also mentions sanctions against companies for non-compliance with advertising regulations.""
}"
2025-08-09T09:03:01+00:00,@medpharm,12542,https://t.me/medpharm/12542,"–ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∑–∞ –Ω–µ–¥–µ–ª—é üî¥–ò–Ω—Ç–µ–≥—Ä–∞—Ü–∏—è —Å–≤–µ–¥–µ–Ω–∏–π –æ —Å–≤–∏–¥–µ—Ç–µ–ª—å—Å—Ç–≤–∞—Ö –æ —Å–º–µ—Ä—Ç–∏ –≤ –ï–ì–ò–°–ó —Å –¥–∞–Ω–Ω—ã–º–∏ –ø–æ–ø—É–ª—è—Ü–∏–æ–Ω–Ω–æ–≥–æ —Ä–∞–∫–æ–≤–æ–≥–æ —Ä–µ–≥–∏—Å—Ç—Ä–∞ –ø–æ–≤—ã—Å–∏—Ç –¥–æ—Å—Ç–æ–≤–µ—Ä–Ω–æ—Å—Ç—å —Å—Ç–∞—Ç–∏—Å—Ç–∏—á–µ—Å–∫–æ–π –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –æ –∑–∞–±–æ–ª–µ–≤–∞–µ–º–æ—Å—Ç–∏ –∏ —Å–º–µ—Ä—Ç–Ω–æ—Å—Ç–∏ –∏–∑-–∑–∞ –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. üî¥–†–µ–≥—É–ª—è—Ç–æ—Ä —Ä–∞—Å—à–∏—Ä–∏–ª —à–∞–±–ª–æ–Ω —É—á–µ—Ç–Ω–æ–π —Ñ–æ—Ä–º—ã ‚Ññ 057/—É –∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –Ω–æ–≤—ã–π –ø–æ—Ä—è–¥–æ–∫ –µ–µ –∑–∞–ø–æ–ª–Ω–µ–Ω–∏—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–µ–π. üî¥–ü–æ—Ä—Ç–∞–ª ¬´–ü—Ä–æ–î–æ–∫—Ç–æ—Ä–æ–≤¬ª —É–¥–∞–ª–∏–ª –∑–∞ –ø–æ–ª–≥–æ–¥–∞ 134 —Ç—ã—Å. –æ—Ç–∑—ã–≤–æ–≤ –æ –≤—Ä–∞—á–∞—Ö –∏ –∫–ª–∏–Ω–∏–∫–∞—Ö –ø–æ—Å–ª–µ —É–∂–µ—Å—Ç–æ—á–µ–Ω–∏—è –º–µ—Ö–∞–Ω–∏–∑–º–∞ –ø—Ä–æ–≤–µ—Ä–∫–∏. üî¥–¢–æ–ª—å–∫–æ –∫–∞–∂–¥—ã–π —á–µ—Ç–≤–µ—Ä—Ç—ã–π –æ–ø—Ä–æ—à–µ–Ω–Ω—ã–π —Ä–æ—Å—Å–∏–π—Å–∫–∏–π –≤—Ä–∞—á –Ω–µ –∏—Å–ø—ã—Ç—ã–≤–∞–µ—Ç —Å–æ–º–Ω–µ–Ω–∏–π –≤ —Å–≤–æ–µ–º –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª–∏–∑–º–µ. –ü–æ—á—Ç–∏ —Ç—Ä–µ—Ç—å —Ä–µ—Å–ø–æ–Ω–¥–µ–Ω—Ç–æ–≤ —á—É–≤—Å—Ç–≤—É—é—Ç —Å–µ–±—è –ø–ª–æ—Ö–∏–º–∏ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞–º–∏, –∫–æ–≥–¥–∞ –∑–∞—Ç—Ä—É–¥–Ω—è—é—Ç—Å—è –≤ –≤—ã–±–æ—Ä–µ —Ç–∞–∫—Ç–∏–∫–∏ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∏ –∏ –ª–µ—á–µ–Ω–∏—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. üî¥–°—Ç—Ä–∞—Ö–æ–≤—â–∏–∫–∏ —Å–æ–æ–±—â–∏–ª–∏ –æ —Ç–µ–Ω–¥–µ–Ω—Ü–∏–∏ –∫ —Ä–æ—Å—Ç—É –¥–æ–ª–∏ —Å–ª—É—á–∞–µ–≤ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∏ –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è, –∫–æ–≥–¥–∞ –ø—Ä–æ—Ü–µ—Å—Å –ø–æ—Å—Ç–∞–Ω–æ–≤–∫–∏ –¥–∏–∞–≥–Ω–æ–∑–∞ –∑–∞–Ω–∏–º–∞–µ—Ç –±–æ–ª—å—à–µ –≥–æ–¥–∞. –ü–æ–ª—É—á–µ–Ω–Ω—ã–µ –¥–∞–Ω–Ω—ã–µ –º–æ–≥—É—Ç –±—ã—Ç—å –∏–Ω—Ç–µ—Ä–ø—Ä–µ—Ç–∏—Ä–æ–≤–∞–Ω—ã –∫–∞–∫ —Å–ª–µ–¥—Å—Ç–≤–∏–µ –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ–π –æ–Ω–∫–æ–Ω–∞—Å—Ç–æ—Ä–æ–∂–µ–Ω–Ω–æ—Å—Ç–∏ –≤—Ä–∞—á–µ–π –ø–µ—Ä–≤–∏—á–Ω–æ–≥–æ –∑–≤–µ–Ω–∞.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety, guideline"",
  ""impact"": ""medium"",
  ""english"": ""The regulator expanded the accounting form template ‚Ññ057/u and developed a new order for its filling by medical organizations. The insurance companies reported trends of increasing cases of oncological disease diagnosis where the process takes more than a year. These data can be interpreted as a result of insufficient oncological vigilance among primary care physicians.""
}"
2025-08-08T16:02:18+00:00,@medpharm,12541,https://t.me/medpharm/12541,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 8 –∞–≤–≥—É—Å—Ç–∞ –ù–µ –≤–∑–ª–µ—Ç–µ–ª–∞ –ù–æ–≤—ã–π –Ω–∞—Ü–ø—Ä–æ–µ–∫—Ç ¬´–ü—Ä–æ–¥–æ–ª–∂–∏—Ç–µ–ª—å–Ω–∞—è –∏ –∞–∫—Ç–∏–≤–Ω–∞—è –∂–∏–∑–Ω—å¬ª –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω –Ω–∞ –ø–µ—Ä—Å–æ–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã–π –ø–æ–¥—Ö–æ–¥ –∫ –∫–∞–∂–¥–æ–º—É –ø–∞—Ü–∏–µ–Ω—Ç—É. –ò–Ω—Ç–µ—Ä–µ—Å–Ω–æ, —á—Ç–æ —Å–∏—Å—Ç–µ–º–∞ —Ç–∞–∫–æ–π –º–µ–¥–∏—Ü–∏–Ω—ã —É–∂–µ –±—ã–ª–∞ —Å–æ–∑–¥–∞–Ω–∞ –≤ –Ω–∞—à–µ–π —Å—Ç—Ä–∞–Ω–µ –ø–æ–ª–≤–µ–∫–∞ –Ω–∞–∑–∞–¥. –°–ª–æ–∂–Ω–æ—Å—Ç–∏ —Å –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–µ–π –°–æ–≤–µ—Ç –ø–æ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—ã–º –∫–≤–∞–ª–∏—Ñ–∏–∫–∞—Ü–∏—è–º –≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–∏ –ø–æ–ø—Ä–æ—Å–∏–ª —Ä–µ–≥—É–ª—è—Ç–æ—Ä –¥–∞—Ç—å —Ä–∞–∑—ä—è—Å–Ω–µ–Ω–∏—è –æ –ø–æ—Ä—è–¥–∫–µ –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –ø—Å–∏—Ö–æ–ª–æ–≥–æ–≤. –ü–æ—Å—á–∏—Ç–∞–ª–∏ –∞–ø—Ç–µ–∫–∏ –í –†–æ—Å—Å–∏–∏, –ø–æ –¥–∞–Ω–Ω—ã–º –Ω–∞ 30 –∏—é–Ω—è 2025 –≥–æ–¥–∞, —Ä–∞–±–æ—Ç–∞–ª–æ 81,7 —Ç—ã—Å. –∞–ø—Ç–µ–∫. –≠—Ç–æ –±–æ–ª—å—à–µ –Ω–∞ 2% –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å 30 –∏—é–Ω–µ–º 2024 –≥–æ–¥–∞. –ü—Ä–∏ —ç—Ç–æ–º –∑–∞ –ø–æ—Å–ª–µ–¥–Ω–∏–µ —Ç—Ä–∏ –≥–æ–¥–∞ —Å—Ç–∞–ª–æ –æ—Ç–∫—Ä—ã–≤–∞—Ç—å—Å—è –º–µ–Ω—å—à–µ –∞–ø—Ç–µ–∫. –§–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏–∏ –ø–æ–¥ –Ω–∞–±–ª—é–¥–µ–Ω–∏–µ–º –¶–†–ü–¢ —Å–æ–≤–º–µ—Å—Ç–Ω–æ —Å –ê–ò–° –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–∞ –∑–∞–ø—É—Å—Ç–∏–ª–∏ –æ–±–º–µ–Ω –¥–∞–Ω–Ω—ã–º–∏ –≤ —Ö–æ–¥–µ –ø—Ä–æ–µ–∫—Ç–∞ –ø–æ –ø—Ä–æ—Å–ª–µ–∂–∏–≤–∞–µ–º–æ—Å—Ç–∏ —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏–π. –¢–µ–ø–µ—Ä—å –æ–ø–µ—Ä–∞—Ç–æ—Ä —Å–∏—Å—Ç–µ–º—ã –±—É–¥–µ—Ç –∞–≤—Ç–æ–º–∞—Ç–∏—á–µ—Å–∫–∏ –ø–æ–ª—É—á–∞—Ç—å –¥–∞–Ω–Ω—ã–µ –æ —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏—è—Ö, –∫–æ—Ç–æ—Ä—ã–µ –≤—ã–ø—É—Å–∫–∞—é—Ç –Ω–∞ —Ä—ã–Ω–æ–∫.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""The message discusses a new national project on longevity and activity, mentioning the personalization of medical care. It also mentions issues related to accreditation for medical psychologists and provides data on pharmacies in Russia, noting a slight increase but also mentions a decrease in the number of new pharmacies over the past three years. It does not directly relate to regulatory affairs, compliance, pricing and reimbursement, or demand for medicines.""
}"
2025-08-08T14:49:50+00:00,@medpharm,12540,https://t.me/medpharm/12540,"–¶–†–ü–¢ —Å–æ–≤–º–µ—Å—Ç–Ω–æ —Å –ê–ò–° –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–∞ –∑–∞–ø—É—Å—Ç–∏–ª–∏ –æ–±–º–µ–Ω –¥–∞–Ω–Ω—ã–º–∏ –≤ —Ö–æ–¥–µ –ø—Ä–æ–µ–∫—Ç–∞ –ø–æ –ø—Ä–æ—Å–ª–µ–∂–∏–≤–∞–µ–º–æ—Å—Ç–∏ —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏–π. –¢–µ–ø–µ—Ä—å –æ–ø–µ—Ä–∞—Ç–æ—Ä —Å–∏—Å—Ç–µ–º—ã –±—É–¥–µ—Ç –∞–≤—Ç–æ–º–∞—Ç–∏—á–µ—Å–∫–∏ –ø–æ–ª—É—á–∞—Ç—å –¥–∞–Ω–Ω—ã–µ –æ —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏—è—Ö, –∫–æ—Ç–æ—Ä—ã–µ –≤—ã–ø—É—Å–∫–∞—é—Ç –Ω–∞ —Ä—ã–Ω–æ–∫.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""medium"",
  ""english"": ""The Center for Risk Management and Policy (–¶–†–ü–¢) in cooperation with the Unified Information System of the Russian Health Supervision Agency (–ê–ò–° –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–∞) have started data exchange within the project on tracking pharmaceutical substances. Now, system operators will automatically receive information about substances that are released onto the market.""
}"
2025-08-08T13:11:56+00:00,@medpharm,12539,https://t.me/medpharm/12539,"–í—Ä–∞—á–∏ –Ω–∞–∑–≤–∞–ª–∏ –ø—Ä–∏—á–∏–Ω—ã –Ω–µ–∂–µ–ª–∞–Ω–∏—è –≤–∏–¥–µ—Ç—å —Å–≤–æ–∏—Ö –¥–µ—Ç–µ–π –≤ –º–µ–¥–∏—Ü–∏–Ω–µ. –û–ø—Ä–æ—Å –ø–æ–∫–∞–∑–∞–ª, —á—Ç–æ 40,8% —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –≤—Ä–∞—á–µ–π –Ω–µ –æ–¥–æ–±—Ä–∏–ª–∏ –±—ã —Ä–µ—à–µ–Ω–∏–µ –¥–µ—Ç–µ–π –≤—ã–±—Ä–∞—Ç—å –≤—Ä–∞—á–µ–±–Ω—É—é –∫–∞—Ä—å–µ—Ä—É.","{""skip"": true}"
2025-08-08T11:12:01+00:00,@medpharm,12538,https://t.me/medpharm/12538,"–í—Å—Ç—É–ø–ª–µ–Ω–∏–µ –≤ —Å–∏–ª—É –ø—Ä–∞–≤–∏–ª–∞ ¬´–≤—Ç–æ—Ä–æ–π –ª–∏—à–Ω–∏–π¬ª –¥–ª—è –°–ó–õ–° –Ω–∞–º–µ—Ä–µ–Ω—ã –ø–µ—Ä–µ–Ω–µ—Å—Ç–∏ —Å 1 —Å–µ–Ω—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞ –Ω–∞ 1 —è–Ω–≤–∞—Ä—è 2026 –≥–æ–¥–∞, –≤–æ–ø—Ä–æ—Å –æ–± —ç—Ç–æ–º –ø—Ä–æ—Ä–∞–±–∞—Ç—ã–≤–∞–µ—Ç –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥. –ú–µ—Ä–∞ –Ω–µ–æ–±—Ö–æ–¥–∏–º–∞ –¥–ª—è —Ç–æ–≥–æ, —á—Ç–æ–±—ã –≤—Å–µ –∂–µ–ª–∞—é—â–∏–µ —É—Å–ø–µ–ª–∏ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞—Ç—å—Å—è –≤ —Å–∏—Å—Ç–µ–º–µ –ø—Ä–æ—Å–ª–µ–∂–∏–≤–∞–µ–º–æ—Å—Ç–∏ –∏ –≤–Ω–µ—Å—Ç–∏ –≤ –Ω–µ–µ –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã–µ –¥–∞–Ω–Ω—ã–µ.","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""registration"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Industry and Trade is considering moving the implementation date of the 'second extra' rule for SGLS from September 1, 2025 to January 1, 2026. This measure is needed so that all those who wish can register in the traceability system and enter necessary data into it.""
}"
2025-08-08T10:28:44+00:00,@medpharm,12537,https://t.me/medpharm/12537,"–ó–Ω–∞–∫–æ–º—å—Ç–µ—Å—å —Å–æ —Å–ª–µ–¥—É—é—â–∏–º —Å–ø–∏–∫–µ—Ä–æ–º PRO–µ–∫—Ü–∏–π –ë—É–¥—É—â–µ–≥–æ: üîπ–ê–ª–µ–∫—Å–µ–π –ö–∞—Ä—Ç–∞—à–æ–≤, –¥–∏—Ä–µ–∫—Ç–æ—Ä –ø–æ —Å–≤—è–∑—è–º —Å –æ—Ä–≥–∞–Ω–∞–º–∏ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π –≤–ª–∞—Å—Ç–∏ –ì–ö ¬´–•–∏–º–†–∞—Ä¬ª, —Å–ø–∏–∫–µ—Ä —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–æ–π —Å–µ—Å—Å–∏–∏ ¬´–ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—ã–π –∫—É—Ä—Å. –ì–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–π –∫–æ–Ω—Ç—É—Ä —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –æ—Ç—Ä–∞—Å–ª–∏¬ª –ù–∞—à–∞ —Ü–µ–ª—å ‚Äî —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–µ –ª–∏–¥–µ—Ä—Å—Ç–≤–æ –≤ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–µ —á–µ—Ä–µ–∑ —Å–∏—Å—Ç–µ–º–Ω–æ–µ —Ä–∞–∑–≤–∏—Ç–∏–µ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –∏–Ω–Ω–æ–≤–∞—Ü–∏–π. –≠—Ç–æ —É–∫—Ä–µ–ø–∏—Ç —Ä—ã–Ω–æ–∫ –∏, –≥–ª–∞–≤–Ω–æ–µ, –æ–±–µ—Å–ø–µ—á–∏—Ç —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –ª—É—á—à–∏–º–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏ —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞. –ê–º–±–∏—Ü–∏–æ–∑–Ω–æ? –î–∞. –î–æ—Å—Ç–∏–∂–∏–º–æ? –ë–µ–∑—É—Å–ª–æ–≤–Ω–æ. –î–∞—Ç–∞ –∏ –≤—Ä–µ–º—è —Å–µ—Å—Å–∏–∏: 11 —Å–µ–Ω—Ç—è–±—Ä—è 2025, 11:15 üìç–≥. –°–æ—á–∏, Pullman –°–æ—á–∏ –¶–µ–Ω—Ç—Ä 5* –ü–æ–¥—Ä–æ–±–Ω–µ–µ –æ –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ –∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –Ω–∞ —Å–∞–π—Ç–µ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance, safety"",
  ""impact"": ""high"",
  ""english"": ""The speaker is discussing the future of pharmaceuticals and national strategies for the industry. The goal is to achieve technological leadership in pharma through systemic development of domestic innovations, which will strengthen the market and ensure that patients have access to high-quality domestically produced medicines.""
}"
2025-08-08T09:03:39+00:00,@medpharm,12536,https://t.me/medpharm/12536,–í –ú–∏–Ω–∑–¥—Ä–∞–≤–µ –ø—Ä–æ—à–ª–æ –∑–∞—Å–µ–¥–∞–Ω–∏–µ –ö–æ–º–∏—Å—Å–∏–∏ –ø–æ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—é –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø–µ—Ä–µ—á–Ω–µ–π. –ó–∞ –¥–≤–∞ –¥–Ω—è —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω—ã 23 –∑–∞—è–≤–∫–∏ –Ω–∞ –≤–∫–ª—é—á–µ–Ω–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –ü–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü. –ò–∑ –Ω–∏—Ö –æ–¥–æ–±—Ä–µ–Ω—ã —Ç–æ–ª—å–∫–æ –≤–æ—Å–µ–º—å.,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""tenders, regulation"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health held a meeting of the Commission on Forming Medicinal Lists. Over two days, 23 applications for inclusion of drugs in the –ñ–ù–í–õ–ü list were reviewed. Only eight were approved.""
}"
2025-08-08T06:58:54+00:00,@medpharm,12535,https://t.me/medpharm/12535,"–û–∫–∞–∑–∞–≤—à–∞—è —É—Å–ª—É–≥–∏ –Ω–µ–Ω–∞–¥–ª–µ–∂–∞—â–µ–≥–æ –∫–∞—á–µ—Å—Ç–≤–∞ –∫–ª–∏–Ω–∏–∫–∞ –ø–ª–∞—Ç–∏—Ç –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏—é –±—ã–≤—à–µ–º—É –ø–∞—Ü–∏–µ–Ω—Ç—É —É–∂–µ 20 –ª–µ—Ç. –≠–∫—Å–ø–µ—Ä—Ç —Ä–∞—Å—Å–∫–∞–∑–∞–ª, –º–æ–∂–µ—Ç –ª–∏ –¥–æ—Å—Ç–∏–∂–µ–Ω–∏–µ –ø–µ–Ω—Å–∏–æ–Ω–Ω–æ–≥–æ –≤–æ–∑—Ä–∞—Å—Ç–∞ –±—ã—Ç—å –æ—Å–Ω–æ–≤–∞–Ω–∏–µ–º –¥–ª—è –∏–Ω–¥–µ–∫—Å–∞—Ü–∏–∏ –ø—Ä–∏—Å—É–∂–¥–µ–Ω–Ω—ã—Ö —Å—É–º–º —Å —É—á–µ—Ç–æ–º –∏–∑–º–µ–Ω–µ–Ω–∏—è –ø—Ä–æ–∂–∏—Ç–æ—á–Ω–æ–≥–æ –º–∏–Ω–∏–º—É–º–∞.","{""skip"": true}"
2025-08-07T16:22:22+00:00,@medpharm,12534,https://t.me/medpharm/12534,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 7 –∞–≤–≥—É—Å—Ç–∞ –ù–µ—Ä–∞–≤–Ω–∞—è –∑–∞–º–µ–Ω–∞ –°—É–¥ –≤ –ù–æ–≤–æ—Å–∏–±–∏—Ä—Å–∫–µ –≤—Å—Ç–∞–ª –Ω–∞ —Å—Ç–æ—Ä–æ–Ω—É –ø–∞—Ü–∏–µ–Ω—Ç–∞ –≤ —Å–ø–æ—Ä–µ —Å –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏–µ–º, –∑–∞–º–µ–Ω–∏–≤—à–∏–º –Ω–∞–∑–Ω–∞—á–µ–Ω–Ω—ã–π —Ä–∞–Ω–µ–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç –∑–∞ —Å—á–µ—Ç —Å—Ä–µ–¥—Å—Ç–≤ –û–ú–°. –í —Ä–µ—à–µ–Ω–∏–∏ —É–∫–∞–∑–∞–Ω–æ –Ω–∞ –≤–∞–∂–Ω–æ—Å—Ç—å —Å–æ–±–ª—é–¥–µ–Ω–∏—è —Å—Ç–∞–Ω–¥–∞—Ä—Ç–æ–≤ –∏ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π –ø—Ä–∏ –æ–∫–∞–∑–∞–Ω–∏–∏ –º–µ–¥–ø–æ–º–æ—â–∏. –ú–∏–Ω—É—Å –≤ –ø—Ä–æ–≤–µ—Ä–∫–∞—Ö –í –†–æ—Å—Å–∏–∏ –ø–ª–∞–Ω–∏—Ä—É—é—Ç –æ—Ç–º–µ–Ω–∏—Ç—å –ø–ª–∞–Ω–æ–≤—ã–µ –ø—Ä–æ–≤–µ—Ä–∫–∏ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–∞ –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π, –∫–æ—Ç–æ—Ä—ã–µ –æ—Ç–Ω–æ—Å—è—Ç—Å—è –∫ –∫–∞—Ç–µ–≥–æ—Ä–∏—è–º –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ–≥–æ, —Å—Ä–µ–¥–Ω–µ–≥–æ, —É–º–µ—Ä–µ–Ω–Ω–æ–≥–æ –∏ –Ω–∏–∑–∫–æ–≥–æ —Ä–∏—Å–∫–∞. –ö–æ–Ω—Ç—Ä–æ–ª—å–Ω—ã–µ –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏—è –∑–∞–º–µ–Ω—è—Ç –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–∏–º–∏ –≤–∏–∑–∏—Ç–∞–º–∏. –í—Ç–æ—Ä–æ–π –¥–µ–Ω—å –ö–æ–º–∏—Å—Å–∏—è –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ø–æ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—é –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø–µ—Ä–µ—á–Ω–µ–π –Ω–∞ –≤—Ç–æ—Ä–æ–π —á–∞—Å—Ç–∏ –∞–≤–≥—É—Å—Ç–æ–≤—Å–∫–æ–≥–æ –∑–∞—Å–µ–¥–∞–Ω–∏—è –æ–¥–æ–±—Ä–∏–ª–∞ –¥–ª—è –≤–∫–ª—é—á–µ–Ω–∏—è –≤ –ñ–ù–í–õ–ü –¥–≤–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞. –ï—â–µ –¥–≤–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ —Ä–µ–∫–æ–º–µ–Ω–¥–æ–≤–∞–Ω–æ –∏—Å–∫–ª—é—á–∏—Ç—å, —à–µ—Å—Ç—å –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–π –±—ã–ª–∏ –æ—Ç–∫–ª–æ–Ω–µ–Ω—ã. –ü–æ–ø–æ–ª–Ω–∏–ª–∏ –ø–µ—Ä–µ—á–µ–Ω—å –≠–∫—Å–ø–µ—Ä—Ç–Ω—ã–π —Å–æ–≤–µ—Ç —Ñ–æ–Ω–¥–∞ ¬´–ö—Ä—É–≥ –¥–æ–±—Ä–∞¬ª –ø—Ä–µ–¥–ª–æ–∂–∏–ª —Ä–∞—Å—à–∏—Ä–∏—Ç—å –ø–µ—Ä–µ—á–µ–Ω—å –∑–∞–∫—É–ø–∞–µ–º—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –≤–∫–ª—é—á–∏—Ç—å –≤ –Ω–µ–≥–æ —Ä–µ–≤—É–º–µ–Ω–∏–±, —ç—Ñ–∞–Ω–µ—Å–æ–∫—Ç–æ–∫–æ–≥ –∞–ª—å—Ñ–∞, –º–∞—Ü–∏—Ç–µ–Ω—Ç–∞–Ω –∏ –±–µ–ª—É–º–æ—Å—É–¥–∏–ª.","{
  ""skip"": true
}"
2025-08-07T14:46:41+00:00,@medpharm,12533,https://t.me/medpharm/12533,"#—ç–∫—Å–∫–ª—é–∑–∏–≤ –ü–æ—Ä—Ç–∞–ª ¬´–ü—Ä–æ–î–æ–∫—Ç–æ—Ä–æ–≤¬ª —É–¥–∞–ª–∏–ª 134 —Ç—ã—Å. –æ—Ç–∑—ã–≤–æ–≤ –æ –≤—Ä–∞—á–∞—Ö –∏ –∫–ª–∏–Ω–∏–∫–∞—Ö –ø–æ—Å–ª–µ —É–∂–µ—Å—Ç–æ—á–µ–Ω–∏—è –º–µ—Ö–∞–Ω–∏–∑–º–∞ –ø—Ä–æ–≤–µ—Ä–∫–∏. –§–µ–π–∫–æ–≤—ã–µ –∑–∞–ø–∏—Å–∏ –≤—ã—è–≤–ª—è—é—Ç—Å—è —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–∞–º–∏ –∫–æ–º–ø–∞–Ω–∏–∏, –∞ —Ç–∞–∫–∂–µ —Å –ø–æ–º–æ—â—å—é —Ñ–∏–ª—å—Ç—Ä–æ–≤.","{""skip"": true}"
2025-08-07T14:03:01+00:00,@medpharm,12532,https://t.me/medpharm/12532,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –°–®–ê –ø—Ä–µ–∫—Ä–∞—Ç–∏–ª —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏–µ 22 –ø—Ä–æ–µ–∫—Ç–æ–≤ –ø–æ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ –º–†–ù–ö-–≤–∞–∫—Ü–∏–Ω –æ–±—â–µ–π —Å—Ç–æ–∏–º–æ—Å—Ç—å—é 497 –º–ª–Ω –¥–æ–ª–ª., –∞–Ω–Ω—É–ª–∏—Ä–æ–≤–∞–≤ —Å–æ–≥–ª–∞—à–µ–Ω–∏—è —Å –≤–µ–¥—É—â–∏–º–∏ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—è–º–∏, –≤ –∏—Ö —á–∏—Å–ª–µ ‚Äî Moderna, Pfizer –∏ Sanofi. –ü–æ –º–Ω–µ–Ω–∏—é –≥–ª–∞–≤—ã –≤–µ–¥–æ–º—Å—Ç–≤–∞ –†–æ–±–µ—Ä—Ç–∞ –§. –ö–µ–Ω–Ω–µ–¥–∏-–º–ª–∞–¥—à–µ–≥–æ, —ç—Ç–∞ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—è –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–∞ –ø—Ä–æ—Ç–∏–≤ —Ä–µ—Å–ø–∏—Ä–∞—Ç–æ—Ä–Ω—ã—Ö –∏–Ω—Ñ–µ–∫—Ü–∏–π.","{""skip"": true}"
2025-08-07T13:08:33+00:00,@medpharm,12531,https://t.me/medpharm/12531,"–ü—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º –≤–∞–º —Å–ª–µ–¥—É—é—â–µ–≥–æ —Å–ø–∏–∫–µ—Ä–∞ PRO–µ–∫—Ü–∏–π –ë—É–¥—É—â–µ–≥–æ: üîπ–Æ–ª–∏—è –ö—É–∑—å–º–µ–Ω–∫–æ, —Å–æ–≤–µ—Ç–Ω–∏–∫, —é—Ä–∏–¥–∏—á–µ—Å–∫–∞—è —Ñ–∏—Ä–º–∞ Lidings, –±—Ä–µ–π–Ω—Å—Ç–æ—Ä–º-—Å–µ—Å—Å–∏—è ¬´–ù–∞ –≥—Ä–∞–Ω–∏ –ø–æ–ª—å–∑—ã –∏ –º–∞–Ω–∏–ø—É–ª—è—Ü–∏–∏: –ë–ê–î –∫–∞–∫ —Ä—ã–Ω–æ–∫, –±–∏–∑–Ω–µ—Å –∏ –ø–æ–ª–µ –¥–ª—è —Ä–∏—Å–∫–æ–≤¬ª –î–∞—Ç–∞ –∏ –≤—Ä–µ–º—è —Å–µ—Å—Å–∏–∏: 12 —Å–µ–Ω—Ç—è–±—Ä—è 2025, 11:00 üìç–≥. –°–æ—á–∏, Pullman –°–æ—á–∏ –¶–µ–Ω—Ç—Ä 5* –ü–æ–¥—Ä–æ–±–Ω–µ–µ –æ –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ –∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –Ω–∞ —Å–∞–π—Ç–µ","{""skip"": true}"
2025-08-07T12:45:37+00:00,@medpharm,12530,https://t.me/medpharm/12530,–û –ø–æ–¥–∞—á–µ –∑–∞—è–≤–∫–∏ –Ω–∞ —É—á–∞—Å—Ç–∏–µ –≤ —Ä–µ–π—Ç–∏–Ω–≥–µ —Ä–∞–±–æ—Ç–æ–¥–∞—Ç–µ–ª–µ–π –†–æ—Å—Å–∏–∏ –ø–æ –≤–µ—Ä—Å–∏–∏ HeadHunter –≤ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –æ—Ç—Ä–∞—Å–ª–∏ —Å–æ–æ–±—â–∏–ª–∏ –≤ –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ê–ª—å—Ñ–∞—Å–∏–≥–º–∞ –†—É—Å¬ª ‚Äî —Ä–æ—Å—Å–∏–π—Å–∫–æ–º –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–µ –∏—Ç–∞–ª—å—è–Ω—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ Alfasigma.,"{""skip"": true}"
2025-08-07T12:03:01+00:00,@medpharm,12529,https://t.me/medpharm/12529,"–ú–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –ø–ª–∞–Ω–∏—Ä—É—é—Ç –æ–±—è–∑–∞—Ç—å –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å –º–æ–±–∏–ª—å–Ω–æ–µ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏–µ ¬´–ò–Ω—Å–ø–µ–∫—Ç–æ—Ä¬ª –¥–ª—è –æ—Ü–µ–Ω–∫–∏ –≤—ã–ø–æ–ª–Ω–µ–Ω–∏—è –ª–∏—Ü–µ–Ω–∑–∏–æ–Ω–Ω—ã—Ö —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π –Ω–∞–¥–∑–æ—Ä–Ω—ã–º–∏ –æ—Ä–≥–∞–Ω–∞–º–∏ —É–¥–∞–ª–µ–Ω–Ω–æ. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –¥–ª—è —á–∞—Å—Ç–∏ –∫–ª–∏–Ω–∏–∫ –º–æ–≥—É—Ç –æ—Ç–º–µ–Ω–∏—Ç—å –ø–ª–∞–Ω–æ–≤—ã–µ –ø—Ä–æ–≤–µ—Ä–∫–∏, –∑–∞–º–µ–Ω–∏–≤ –∏—Ö –Ω–∞ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–∏–µ –≤–∏–∑–∏—Ç—ã.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""Medical organizations plan to require the use of an app 'Inspector' for remote assessment of compliance with licensing requirements by supervisory authorities. Additionally, for some clinics, routine inspections are to be replaced with preventive visits.""
}"
2025-08-07T10:06:44+00:00,@medpharm,12528,https://t.me/medpharm/12528,–†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª —Ç–µ—Å—Ç –¥–ª—è –≤—ã—è–≤–ª–µ–Ω–∏—è —Å—Ä–∞–∑—É –ø—è—Ç–∏ –æ–ø–∞—Å–Ω—ã—Ö –∏–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –û–Ω –æ–±–ª–∞–¥–∞–µ—Ç –≤—ã—Å–æ–∫–æ–π —Ç–æ—á–Ω–æ—Å—Ç—å—é –∏ –ø–æ–∑–≤–æ–ª—è–µ—Ç –≤—ã—è–≤–ª—è—Ç—å –¥–∞–∂–µ –º–∏–Ω–∏–º–∞–ª—å–Ω–æ–µ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –º–∏–∫—Ä–æ–±–Ω—ã—Ö –∫–ª–µ—Ç–æ–∫.,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, clinical_trial,hospital_policy"",
  ""impact"": ""high"",
  ""english"": ""Rospatentnadzor has developed a test to detect five dangerous infectious diseases. The test is highly accurate and can identify even the smallest number of microbial cells.""
}"
2025-08-07T07:46:46+00:00,@medpharm,12527,https://t.me/medpharm/12527,"–°—Ä–µ–¥—Å—Ç–≤–∞ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –±—é–¥–∂–µ—Ç–∞, –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–Ω—ã–µ –Ω–∞ —Å–æ–∑–¥–∞–Ω–∏–µ –º–Ω–æ–≥–æ–ø—Ä–æ—Ñ–∏–ª—å–Ω–æ–≥–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ —Ü–µ–Ω—Ç—Ä–∞ –§–ú–ë–ê –≤ –†–µ—Å–ø—É–±–ª–∏–∫–µ –ö—Ä—ã–º (–Ø–ª—Ç–∞), –∏—Å–ø–æ–ª—å–∑—É—é—Ç—Å—è —Å –Ω–∏–∑–∫–æ–π —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å—é, –ø–æ–∫–∞–∑–∞–ª–∞ –ø—Ä–æ–≤–µ—Ä–∫–∞ –°—á–µ—Ç–Ω–æ–π –ø–∞–ª–∞—Ç—ã. –¢–µ—Ö–Ω–∏—á–µ—Å–∫–∞—è –≥–æ—Ç–æ–≤–Ω–æ—Å—Ç—å –æ–±—ä–µ–∫—Ç–∞ –Ω–∞ 1 –∞–ø—Ä–µ–ª—è 2025 –≥–æ–¥–∞ —Å–æ—Å—Ç–∞–≤–ª—è–ª–∞ –≤—Å–µ–≥–æ 5,3%.","{""skip"": true}"
2025-08-06T17:12:58+00:00,@medpharm,12526,https://t.me/medpharm/12526,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 6 –∞–≤–≥—É—Å—Ç–∞ –§–æ—Ä–º–∞ –∏ —Å–æ–¥–µ—Ä–∂–∞–Ω–∏–µ –ú–∏–Ω–∑–¥—Ä–∞–≤ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –Ω–æ–≤—ã–π —à–∞–±–ª–æ–Ω —É—á–µ—Ç–Ω–æ–π —Ñ–æ—Ä–º—ã ‚Ññ 057/—É, –∫–æ—Ç–æ—Ä–∞—è –∏—Å–ø–æ–ª—å–∑—É–µ—Ç—Å—è –¥–ª—è –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è –¥–ª—è –æ–∫–∞–∑–∞–Ω–∏—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ ‚Äî –∫–æ–Ω—Å—É–ª—å—Ç–∞—Ü–∏–∏, –æ–±—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è, –≥–æ—Å–ø–∏—Ç–∞–ª–∏–∑–∞—Ü–∏–∏, –∞ —Ç–∞–∫–∂–µ –æ–±–Ω–æ–≤–∏–ª –ø–æ—Ä—è–¥–æ–∫ –µ–µ –∑–∞–ø–æ–ª–Ω–µ–Ω–∏—è. –°—É–¥ –∏–¥–µ—Ç –ü—Ä–∏–≥–æ–≤–æ—Ä –≠–ª–∏–Ω–µ –°—É—à–∫–µ–≤–∏—á –∏ –ï–ª–µ–Ω–µ –ë–µ–ª–æ–π –±—É–¥–µ—Ç –æ–≥–ª–∞—à–µ–Ω 11 –∞–≤–≥—É—Å—Ç–∞. –í –ø–æ—Å–ª–µ–¥–Ω–µ–º —Å–ª–æ–≤–µ –°—É—à–∫–µ–≤–∏—á –æ–±—ä—è–≤–∏–ª–∞, —á—Ç–æ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ –≤–µ—Ä–Ω–µ—Ç—Å—è –∫ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏. –ó–∞–≤–µ—Ä—à–∏–ª–∏ –∏–Ω—Ç—Ä–∏–≥–æ–π –ö–æ–º–∏—Å—Å–∏—è –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–§ –ø–æ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—é –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø–µ—Ä–µ—á–Ω–µ–π —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–ª–∞ 15 –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–π –≤–∫–ª—é—á–µ–Ω–∏—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –ñ–ù–í–õ–ü. –ò–∑ –Ω–∏—Ö —Å–µ–º—å –∑–∞—è–≤–æ–∫ –æ–¥–æ–±—Ä–µ–Ω—ã, –≤–æ—Å–µ–º—å –±—ã–ª–∏ –æ—Ç–∫–ª–æ–Ω–µ–Ω—ã. –í –∫–æ–Ω—Ü–µ –∑–∞—Å–µ–¥–∞–Ω–∏—è –≤–æ–∑–Ω–∏–∫–ª–∞ —Å–∏—Ç—É–∞—Ü–∏—è, –∫–æ—Ç–æ—Ä–∞—è –º–æ–∂–µ—Ç –ø–æ—Å—Ç–∞–≤–∏—Ç—å –ø–æ–¥ –≤–æ–ø—Ä–æ—Å –æ–¥–Ω–æ –∏–∑ —Ä–µ—à–µ–Ω–∏–π. –°—É–¥—ã –∑–∞ ¬´–î–∂–æ–¥–∞—Å¬ª –î–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä—ã —Å—Ç–æ–ª–∫–Ω—É–ª–∏—Å—å —Å –ø—Ä–æ–±–ª–µ–º–∞–º–∏ –Ω–∞ —Ç–æ—Ä–≥–∞—Ö –∏ –≤—ã–Ω—É–∂–¥–µ–Ω—ã —Å—É–¥–∏—Ç—å—Å—è —Å –£–§–ê–° –∏–∑-–∑–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ ¬´–î–∂–æ–¥–∞—Å –≠–∫—Å–ø–æ–∏–º¬ª, –∫–æ—Ç–æ—Ä—ã–µ –±–æ–ª–µ–µ –Ω–µ –º–æ–≥—É—Ç –æ–±—Ä–∞—â–∞—Ç—å—Å—è –Ω–∞ —Ä—ã–Ω–∫–µ. –î–æ–∫–∞–∑–∞—Ç—å —Å–≤–æ—é –ø—Ä–∞–≤–æ—Ç—É —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—è–º —É–¥–∞–µ—Ç—Å—è –¥–∞–ª–µ–∫–æ –Ω–µ –≤–æ –≤—Å–µ—Ö —Ä–µ–≥–∏–æ–Ω–∞—Ö.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""high"",
  ""english"": ""The Russian Ministry of Health has developed a new template for the accounting form ‚Ññ057/u, which is used for providing medical care services such as consultations, examinations, hospitalizations. The Ministry has also updated the procedure for filling out this form. A verdict against Elina Sushk–µ–≤–∏—á and Elena Belaia will be pronounced on August 11. In her last words, Sushk–µ–≤–∏—á announced that she will return to medical activities. The Russian Commission for Formulating Medicinal Lists has reviewed 15 proposals to include drugs into the –ñ–ù–í–õ–ü. Seven of these applications have been approved, while eight were rejected. During the session, there was a situation that could question one of the decisions. Distributors of 'Djodas' have faced problems on the market and are forced to sue FAS (Federal Antimonopoly Service) due to drugs produced by 'Djodas Expoim', which are no longer allowed on the market. The pharmaceutical companies have not been able to prove their right in all regions.""
}"
2025-08-06T14:42:01+00:00,@medpharm,12525,https://t.me/medpharm/12525,"–ê–¥–≤–æ–∫–∞—Ç—ã –æ—Ç–º–µ—á–∞—é—Ç —É–≤–µ–ª–∏—á–µ–Ω–∏–µ —á–∞—Å—Ç–æ—Ç—ã –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è —Ç–∞–∫ –Ω–∞–∑—ã–≤–∞–µ–º—ã—Ö —Å–ø–µ—Ü–∏–∞–ª—å–Ω—ã—Ö —Å–æ—Å—Ç–∞–≤–æ–≤ ‚Äî —Ö–∞–ª–∞—Ç–Ω–æ—Å—Ç—å (—Å—Ç.293 –£–ö –†–§) –∏ –Ω–µ–æ–∫–∞–∑–∞–Ω–∏–µ –ø–æ–º–æ—â–∏ (—Å—Ç.124 –£–ö –†–§). –¢–∞–∫–∏–º –æ–±—Ä–∞–∑–æ–º, –ø—Ä–æ–±–ª–µ–º–∞ —É–≥–æ–ª–æ–≤–Ω–æ–≥–æ –ø—Ä–µ—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –∑–∞ –≤—Ä–∞—á–µ–±–Ω—ã–µ –æ—à–∏–±–∫–∏ –Ω–µ –±—ã–ª–∞ —Ä–µ—à–µ–Ω–∞ –≤–≤–µ–¥–µ–Ω–∏–µ–º —Å–ø–µ—Ü–∏–∞–ª—å–Ω—ã—Ö –ø–æ–ø—Ä–∞–≤–æ–∫ –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤, —Å–æ–æ–±—â–∏–ª–∏ —é—Ä–∏—Å—Ç—ã.","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""sanctions,hospital_policy,clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""Lawyers noted an increase in the frequency of applying so-called special compositions - negligence (Article 293 of the Criminal Code) and failure to provide assistance (Article 124 of the Criminal Code). Thus, the problem of criminal prosecution for medical errors was not resolved by introducing special amendments for healthcare workers.""
}"
2025-08-06T12:49:01+00:00,@medpharm,12524,https://t.me/medpharm/12524,"–í –ö—Ä–∞—Å–Ω–æ—è—Ä—Å–∫–æ–º –∫—Ä–∞–µ –∑–∞–≤–µ—Ä—à–µ–Ω–æ —Ä–∞—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ —É–≥–æ–ª–æ–≤–Ω–æ–≥–æ –¥–µ–ª–∞ –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ –±—ã–≤—à–µ–≥–æ –≥–ª–∞–≤–Ω–æ–≥–æ –≤—Ä–∞—á–∞ –±–æ–ª—å–Ω–∏—Ü—ã, –æ–±–≤–∏–Ω—è–µ–º–æ–≥–æ –≤ –ø—Ä–µ–≤—ã—à–µ–Ω–∏–∏ –¥–æ–ª–∂–Ω–æ—Å—Ç–Ω—ã—Ö –ø–æ–ª–Ω–æ–º–æ—á–∏–π. –ü–æ —ç—Ç–æ–π —Å—Ç–∞—Ç—å–µ –µ–º—É –≥—Ä–æ–∑–∏—Ç –ª–∏—à–µ–Ω–∏–µ —Å–≤–æ–±–æ–¥—ã –Ω–∞ —Å—Ä–æ–∫ –æ—Ç —Ç—Ä–µ—Ö –¥–æ –¥–µ—Å—è—Ç–∏ –ª–µ—Ç.","{""skip"": true}"
2025-08-06T10:58:52+00:00,@medpharm,12523,https://t.me/medpharm/12523,"–í –†–æ—Å—Å–∏–∏ —Ä–∞–∑—Ä–∞–±–∞—Ç—ã–≤–∞—é—Ç –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–π –º–µ—Ç–æ–¥ –±–æ—Ä—å–±—ã —Å –∑–∞–≥—Ä—è–∑–Ω–µ–Ω–∏—è–º–∏ –Ω–µ—Ñ—Ç–µ–ø—Ä–æ–¥—É–∫—Ç–∞–º–∏ ‚Äî —Ä–µ—á—å –∏–¥–µ—Ç –æ –±–∏–æ—Ä–µ–º–µ–¥–∏–∞—Ü–∏–∏. –° –µ–µ –ø–æ–º–æ—â—å—é –º–æ–∂–Ω–æ —Ä–∞—Å—â–µ–ø–ª—è—Ç—å —É–≥–ª–µ–≤–æ–¥–æ—Ä–æ–¥—ã –∑–∞ —Å—á–µ—Ç –∞–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ —Å–ø–µ—Ü–∏–∞–ª—å–Ω—ã—Ö –±–∞–∫—Ç–µ—Ä–∏–π, —É–≤–µ—Ä–µ–Ω—ã —É—á–µ–Ω—ã–µ –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç—ã. –°–µ–π—á–∞—Å —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç ¬´–°–∏—Ä–∏—É—Å¬ª –∏ –∫–æ–º–ø–∞–Ω–∏—è ¬´–†-–§–∞—Ä–º¬ª, –∫–æ—Ç–æ—Ä—ã–µ –∑–∞–Ω—è—Ç—ã —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∞–º–∏, —Ç–µ—Å—Ç–∏—Ä—É—é—Ç –Ω–∞—É—á–Ω—É—é –≥–∏–ø–æ—Ç–µ–∑—É: –æ–Ω–∏ —É–∂–µ –ø—Ä–æ–≤–µ–ª–∏ —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç, –∫–æ—Ç–æ—Ä—ã–π –ø–æ–∫–∞–∑–∞–ª, —á—Ç–æ –≤ —Ç–µ—á–µ–Ω–∏–µ 28 –¥–Ω–µ–π —Å–æ–¥–µ—Ä–∂–∞–Ω–∏–µ —É–≥–ª–µ–≤–æ–¥–æ—Ä–æ–¥–æ–≤ –≤ —Å—Ä–µ–¥–µ —Å –º–∞–∑—É—Ç–æ–º —Å–Ω–∏–∂–∞–µ—Ç—Å—è –Ω–∞ 32%, –∏ —ç—Ç–æ –Ω–µ –ø—Ä–µ–¥–µ–ª. –≠—Ç–æ –æ–∑–Ω–∞—á–∞–µ—Ç, —á—Ç–æ –ø–æ–¥–æ–±—Ä–∞–Ω–Ω—ã–µ –º–∏–∫—Ä–æ–æ—Ä–≥–∞–Ω–∏–∑–º—ã —Ä–∞—Å—â–µ–ø–ª—è—é—Ç –∑–∞–≥—Ä—è–∑–Ω–µ–Ω–∏—è, –ø—Ä–µ–æ–±—Ä–∞–∑—É—è –Ω–µ—Ñ—Ç–µ–ø—Ä–æ–¥—É–∫—Ç—ã.","{""skip"": true}"
2025-08-06T09:16:34+00:00,@medpharm,12522,https://t.me/medpharm/12522,"#—ç–∫—Å–∫–ª—é–∑–∏–≤ –î–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä—ã —Å—Ç–æ–ª–∫–Ω—É–ª–∏—Å—å —Å –ø—Ä–æ–±–ª–µ–º–∞–º–∏ –Ω–∞ —Ç–æ—Ä–≥–∞—Ö –∏ –≤—ã–Ω—É–∂–¥–µ–Ω—ã —Å—É–¥–∏—Ç—å—Å—è —Å –£–§–ê–° –∏–∑-–∑–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ ¬´–î–∂–æ–¥–∞—Å –≠–∫—Å–ø–æ–∏–º¬ª, –∫–æ—Ç–æ—Ä—ã–µ –±–æ–ª–µ–µ –Ω–µ –º–æ–≥—É—Ç –æ–±—Ä–∞—â–∞—Ç—å—Å—è –Ω–∞ —Ä—ã–Ω–∫–µ.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""Distributor of exclusives have problems on the market due to drugs produced by 'Jodas Expoim' which are no longer able to be sold on the market. They have been forced to sue the FAS (Federal Antimonopoly Service) as a result.""
}"
2025-08-06T07:27:39+00:00,@medpharm,12521,https://t.me/medpharm/12521,"–§–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –æ–±—Ä–∞—Ç–∏–ª–∞—Å—å –≤ –ú–∏–Ω–∑–¥—Ä–∞–≤ —Å –ø—Ä–æ—Å—å–±–æ–π –Ω–µ –æ—Ç–∫–∞–∑—ã–≤–∞—Ç—å—Å—è –æ—Ç –≤–∫–ª—é—á–µ–Ω–∏—è –≤ –ü–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞, –µ—Å–ª–∏ –Ω–µ –≤—Å–µ –µ–≥–æ –ø–æ–∫–∞–∑–∞–Ω–∏—è –æ—Ç—Ä–∞–∂–µ–Ω—ã –≤ —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–Ω—ã—Ö –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏—è—Ö. –ü–æ–¥–æ–±–Ω–∞—è –∏–Ω—Ç–µ—Ä–ø—Ä–µ—Ç–∞—Ü–∏—è –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω–æ-–ø—Ä–∞–≤–æ–≤–æ–π –±–∞–∑—ã —Å–Ω–∏–∂–∞–µ—Ç –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å –Ω–æ–≤–µ–π—à–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""A pharmaceutical company has requested the Ministry of Health not to exclude a drug from the List of Essential Medicines if not all its indications are reflected in approved clinical guidelines. Such an interpretation of the regulatory framework could reduce access to new drugs for patients.""
}"
2025-08-05T15:35:46+00:00,@medpharm,12520,https://t.me/medpharm/12520,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 5 –∞–≤–≥—É—Å—Ç–∞ –ß–µ–ª–æ–≤–µ—á–Ω–æ–µ –Ω–µ —á—É–∂–¥–æ –¢–æ–ª—å–∫–æ –∫–∞–∂–¥—ã–π —á–µ—Ç–≤–µ—Ä—Ç—ã–π –æ–ø—Ä–æ—à–µ–Ω–Ω—ã–π —Ä–æ—Å—Å–∏–π—Å–∫–∏–π –≤—Ä–∞—á –Ω–µ –∏—Å–ø—ã—Ç—ã–≤–∞–µ—Ç —Å–æ–º–Ω–µ–Ω–∏–π –≤ —Å–≤–æ–µ–º –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª–∏–∑–º–µ. –ì–æ—Ç–æ–≤–∏–º —Å–∞–Ω–∏ –ª–µ—Ç–æ–º –ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∞—è –∞–∫–∞–¥–µ–º–∏—è –ø–µ–¥–∏–∞—Ç—Ä–∏–∏ –æ–±–Ω–æ–≤–∏–ª–∞ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø–æ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–µ –∏ –ª–µ—á–µ–Ω–∏—é –≥—Ä–∏–ø–ø–∞ —É –¥–µ—Ç–µ–π –≤ –ø—Ä–µ–¥—Å—Ç–æ—è—â–µ–º —Å–µ–∑–æ–Ω–µ. –ü–æ–ø—Ä–æ—Å–∏–ª–∏ —Ä–∞–∑—ä—è—Å–Ω–µ–Ω–∏–π –ö–æ–º–∏—Å—Å–∏—è –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ø–æ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—é –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø–µ—Ä–µ—á–Ω–µ–π –Ω–µ—Ä–µ–¥–∫–æ –æ–±—ä—è—Å–Ω—è–µ—Ç –æ—Ç–∫–∞–∑ –≤–∫–ª—é—á–∏—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç –≤ –æ–≥—Ä–∞–Ω–∏—á–∏—Ç–µ–ª—å–Ω—ã–µ —Å–ø–∏—Å–∫–∏ —Ç–µ–º, —á—Ç–æ –Ω–µ –≤—Å–µ –µ–≥–æ –ø–æ–∫–∞–∑–∞–Ω–∏—è –æ—Ç—Ä–∞–∂–µ–Ω—ã –≤ —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–Ω—ã—Ö –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏—è—Ö. –ê—Å—Å–æ—Ü–∏–∞—Ü–∏—è ¬´–ò–Ω—Ñ–∞—Ä–º–∞¬ª –Ω–∞–ø—Ä–∞–≤–∏–ª–∞ –≤ –æ—Ç—Ä–∞—Å–ª–µ–≤–æ–µ –≤–µ–¥–æ–º—Å—Ç–≤–æ –ø–∏—Å—å–º–æ —Å –ø—Ä–æ—Å—å–±–æ–π –¥–∞—Ç—å —Ä–∞–∑—ä—è—Å–Ω–µ–Ω–∏–µ –ø–æ —ç—Ç–æ–º—É –≤–æ–ø—Ä–æ—Å—É. –Ø–∑—ã–∫–æ–≤–æ–π –±–∞—Ä—å–µ—Ä –ú–∏–Ω—Ç—Ä—É–¥ –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç –∑–∞–ø—Ä–µ—Ç–∏—Ç—å —Ç—Ä—É–¥–æ—É—Å—Ç—Ä–æ–π—Å—Ç–≤–æ –∏–Ω–æ—Å—Ç—Ä–∞–Ω—Ü–µ–≤ –∏–∑ –≤–∏–∑–æ–≤—ã—Ö —Å—Ç—Ä–∞–Ω –±–µ–∑ –∑–Ω–∞–Ω–∏—è —Ä—É—Å—Å–∫–æ–≥–æ —è–∑—ã–∫–∞ –Ω–∞ –¥–æ–ª–∂–Ω–æ—Å—Ç—è—Ö, —Å–≤—è–∑–∞–Ω–Ω—ã—Ö —Å –æ–±—â–µ–Ω–∏–µ–º —Å –≥—Ä–∞–∂–¥–∞–Ω–∞–º–∏ –†–§, –≤–∫–ª—é—á–∞—è –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –∏ –ø—Ä–æ–¥–∞–≤—Ü–æ–≤ –Ω–µ–ø—Ä–æ–¥–æ–≤–æ–ª—å—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Ç–æ–≤–∞—Ä–æ–≤, –∫ –∫–æ—Ç–æ—Ä—ã–º –º–æ–≥—É—Ç –æ—Ç–Ω–æ—Å–∏—Ç—å—Å—è –∏ —Ñ–∞—Ä–º—Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety, guideline"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health's committee on forming drug lists often explains the rejection to include a drug in restricted lists by saying that not all of its indications are reflected in approved clinical guidelines. The 'Infarma' association has sent a letter to the industry body for clarification on this issue. The Ministry of Labor proposes prohibiting employment of foreigners from visa countries without knowledge of Russian language on positions related to communication with citizens of Russia, including medical personnel and salespeople for non-food products, which could include pharmaceutical specialists.""
}"
2025-08-05T14:09:01+00:00,@medpharm,12519,https://t.me/medpharm/12519,"–û–±–∑–æ—Ä —Ä–µ–≥—É–ª—è—Ç–æ—Ä–Ω—ã—Ö –æ–¥–æ–±—Ä–µ–Ω–∏–π –≤ –°–®–ê, –í–µ–ª–∏–∫–æ–±—Ä–∏—Ç–∞–Ω–∏–∏ –∏ –ï–° –ü—Ä–µ–ø–∞—Ä–∞—Ç—ã, –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ FDA, MHRA –∏ EMA c 7 –∏—é–ª—è –ø–æ 4 –∞–≤–≥—É—Å—Ç–∞.","{""skip"": true}"
2025-08-05T12:04:26+00:00,@medpharm,12518,https://t.me/medpharm/12518,"–°–µ–≥–æ–¥–Ω—è –Ω–∞ –≥–ª–∞–≤–Ω–æ–µ —Ñ–∞—Ä–º—Å–æ–±—ã—Ç–∏–µ —ç—Ç–æ–π –æ—Å–µ–Ω–∏, –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏—é ¬´PRO–µ–∫—Ü–∏–∏ –ë—É–¥—É—â–µ–≥–æ¬ª, –≤–∞—Å –ø—Ä–∏–≥–ª–∞—à–∞–µ—Ç üîπ–ò–≥–æ—Ä—å –•–∞—Å–∏–Ω, –¥–∏—Ä–µ–∫—Ç–æ—Ä –ø—Ä–æ–≥—Ä–∞–º–º —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–æ–≥–æ —Ä–∞–∑–≤–∏—Ç–∏—è –ê–û ¬´–¢–æ–Ω—É—Å¬ª, —Å–ø–∏–∫–µ—Ä —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–æ–π —Å–µ—Å—Å–∏–∏ ¬´–ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—ã–π –∫—É—Ä—Å. –ì–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–π –∫–æ–Ω—Ç—É—Ä —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –æ—Ç—Ä–∞—Å–ª–∏¬ª –î–∞—Ç–∞ –∏ –≤—Ä–µ–º—è —Å–µ—Å—Å–∏–∏: 11 —Å–µ–Ω—Ç—è–±—Ä—è 2025, 11:15 üìç–≥. –°–æ—á–∏, Pullman –°–æ—á–∏ –¶–µ–Ω—Ç—Ä 5* –ë—É–¥—å—Ç–µ –≤ –∫—É—Ä—Å–µ –∏–∑–º–µ–Ω–µ–Ω–∏–π –≤ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏! –†–µ–≥–∏—Å—Ç—Ä–∏—Ä—É–π—Ç–µ—Å—å –∏ –±—Ä–æ–Ω–∏—Ä—É–π—Ç–µ –º–µ—Å—Ç–æ!","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""Igor Khasin, Director of Strategic Programs at A.O. Tonus, is inviting you to the main pharm event this autumn - 'PRO–µ–∫—Ü–∏–∏ –ë—É–¥—É—â–µ–≥–æ'. The session is scheduled on September 11, 2025 at 11:15 in Sochi, Pullman Sochi Central 5*. Don't miss out on changes in the pharmaceutical industry! Register and reserve your spot!""
}"
2025-08-05T11:14:01+00:00,@medpharm,12517,https://t.me/medpharm/12517,–î–≤–µ —á–∏–Ω–æ–≤–Ω–∏—Ü—ã –∫—Ä–∞—Å–Ω–æ—è—Ä—Å–∫–æ–≥–æ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ —É–≤–æ–ª–µ–Ω—ã –Ω–∞ —Ñ–æ–Ω–µ —Å—Ä—ã–≤–∞ –ø–æ—Å—Ç–∞–≤–æ–∫ –ª–µ–∫–∞—Ä—Å—Ç–≤. –†–∞–Ω–µ–µ –Ω–∞ —Ñ–æ–Ω–µ —ç—Ç–æ–≥–æ –¥–µ–ª–∞ —É—à–ª–∞ –≤ –æ—Ç—Å—Ç–∞–≤–∫—É –º–∏–Ω–∏—Å—Ç—Ä –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è —Ä–µ–≥–∏–æ–Ω–∞.,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""shortage, import_export"",
  ""impact"": ""high"",
  ""english"": ""Two officials from the KrASNADOZ department of the Krasnoyarsk regional Ministry of Health have been dismissed due to supply disruptions. The head of the department was previously removed from office in connection with this matter.""
}"
2025-08-05T09:10:00+00:00,@medpharm,12516,https://t.me/medpharm/12516,"–î–∏—Å–±–∞–ª–∞–Ω—Å —Ö–∏—Ä—É—Ä–≥–∏–∏ –∏ —Ç–µ—Ä–∞–ø–∏–∏ –≤ –∫–ª–∏–Ω—Ä–µ–∫–∞—Ö: –µ—Å—Ç–µ—Å—Ç–≤–µ–Ω–Ω—ã–π —Ö–æ–¥ –≤–µ—â–µ–π –∏–ª–∏ –≤–ª–∏—è–Ω–∏–µ —Ñ–∞—Ä–º–ª–æ–±–±–∏? –ò –ø–æ—á–µ–º—É –≤—Ä–∞—á–∏ –∏ –ø–∞—Ü–∏–µ–Ω—Ç—ã –±–æ–ª—å—à–µ –æ—Å–≤–µ–¥–æ–º–ª–µ–Ω—ã –æ –Ω–æ–≤—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–∞—Ö, —á–µ–º –æ–± —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã—Ö –º–µ—Ç–æ–¥–∞—Ö —Ä–∞–¥–∏–∫–∞–ª—å–Ω–æ–≥–æ –ª–µ—á–µ–Ω–∏—è.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety, guideline"",
  ""impact"": ""medium"",
  ""english"": ""There is a balance issue between surgery and therapy in clinics: Is it natural or influenced by pharmaceutical lobbying? And why are doctors and patients more informed about new drugs than effective methods of radical treatment?""
}"
2025-08-05T07:26:16+00:00,@medpharm,12515,https://t.me/medpharm/12515,#—ç–∫—Å–∫–ª—é–∑–∏–≤ –ù–æ–≤—ã–º –¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–º –î–µ–ø–∞—Ä—Ç–∞–º–µ–Ω—Ç–∞ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–æ–≥–æ —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–∞ –∏ —Å–≤—è–∑–µ–π —Å –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç—å—é –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–æ—Å—Å–∏–∏ –Ω–∞–∑–Ω–∞—á–µ–Ω –≠–¥—É–∞—Ä–¥ –°–∞–ª–∞—Ö–æ–≤. –†–∞–Ω–µ–µ –æ–Ω –º–Ω–æ–≥–æ –ª–µ—Ç —Ç—Ä—É–¥–∏–ª—Å—è –≤ —Å—Ç–∞—Ç—É—Å–µ –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—è.,"{""skip"": true}"
2025-08-04T16:48:27+00:00,@medpharm,12514,https://t.me/medpharm/12514,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 4 –∞–≤–≥—É—Å—Ç–∞ –°—Ç—Ä–∞—Å—Ç–∏ –ø–æ –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–∏ –ë–µ–∑ –∑–∞–∏–Ω—Ç–µ—Ä–µ—Å–æ–≤–∞–Ω–Ω–æ—Å—Ç–∏ –≤ —ç—Ç–æ–π —Ä–∞–±–æ—Ç–µ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ —Å–æ–æ–±—â–µ—Å—Ç–≤–∞ –ø—Ä–æ–¥–æ–ª–∂–∏—Ç—Å—è –¥–≤–∏–∂–µ–Ω–∏–µ –∫ —Ñ–æ—Ä–º–∞–ª–∏–∑–∞—Ü–∏–∏ –ø—Ä–æ—Ü–µ—Å—Å–∞, –ø–æ–∫–∞ –æ–Ω –Ω–µ –±—É–¥–µ—Ç –ø—Ä–∏–∑–Ω–∞–Ω –±–µ—Å–ø–æ–ª–µ–∑–Ω—ã–º, –ø–æ–ª–∞–≥–∞—é—Ç —ç–∫—Å–ø–µ—Ä—Ç—ã. –õ–µ—á–∏—Ç—å –ø–æ-–Ω–æ–≤–æ–º—É –ü–∞—Ü–∏–µ–Ω—Ç—Å–∫–æ–µ —Å–æ–æ–±—â–µ—Å—Ç–≤–æ –±—É–¥–µ—Ç –Ω–∞—Å—Ç–∞–∏–≤–∞—Ç—å –Ω–∞ –≤–∫–ª—é—á–µ–Ω–∏–∏ –≤ –ü–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü —Å–æ–≤—Ä–µ–º–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Ä–∞–∫–∞ –ø—Ä–µ–¥—Å—Ç–∞—Ç–µ–ª—å–Ω–æ–π –∂–µ–ª–µ–∑—ã. –ò—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –≤—ã—è–≤–∏–ª–æ —Ä—è–¥ —Å–∏—Å—Ç–µ–º–Ω—ã—Ö –±–∞—Ä—å–µ—Ä–æ–≤, —Å –∫–æ—Ç–æ—Ä—ã–º–∏ —Å—Ç–∞–ª–∫–∏–≤–∞—é—Ç—Å—è –ø–∞—Ü–∏–µ–Ω—Ç—ã —Å –†–ü–ñ –∏ –≤—Ä–∞—á–∏. –ö–æ–Ω—Ü–µ—Ä—Ç–Ω—ã–π —à—Ç—Ä–∞—Ñ –£–§–ê–° –ø–æ –ú–æ—Å–∫–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –æ—à—Ç—Ä–∞—Ñ–æ–≤–∞–ª–æ ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º¬ª –Ω–∞ 200 —Ç—ã—Å. —Ä—É–±. –∑–∞ —Ä–µ–∫–ª–∞–º—É —Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ¬´–°–µ–º–∞–≤–∏–∫¬ª –Ω–∞ –≥–∞–ª–∞-–∫–æ–Ω—Ü–µ—Ä—Ç–µ ¬´–ù–æ–≤–∞—è –≤–æ–ª–Ω–∞ 2024¬ª –∏ —É–∂–∏–Ω–µ –∂—É—Ä–Ω–∞–ª–∞ ¬´Hello¬ª –≤ –°–æ—á–∏. –°–æ–≥–ª–∞—Å–æ–≤–∞–ª–∏ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ –ü–µ—Ä–≤—ã–µ –ø–∞—Ü–∏–µ–Ω—Ç—ã —Å –º–µ–ª–∞–Ω–æ–º–æ–π –ø–æ–ª—É—á–∞—Ç –∏–Ω–¥–∏–≤–∏–¥—É–∞–ª—å–Ω—É—é –æ–Ω–∫–æ–≤–∞–∫—Ü–∏–Ω—É –≤ –±–ª–∏–∂–∞–π—à–∏–µ –º–µ—Å—è—Ü—ã. –ì–ª–∞–≤–∞ –¶–µ–Ω—Ç—Ä–∞ –ì–∞–º–∞–ª–µ–∏ –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ì–∏–Ω—Ü–±—É—Ä–≥ —Ä–∞—Å—Å–∫–∞–∑–∞–ª, —á—Ç–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–º –∏–Ω—Ç–µ—Ä–µ—Å—É—é—Ç—Å—è –∏ –∑–∞ —Ä—É–±–µ–∂–æ–º.","{
  ""skip"": true
}"
2025-08-04T14:41:36+00:00,@medpharm,12513,https://t.me/medpharm/12513,"#—ç–∫—Å–∫–ª—é–∑–∏–≤ –í –†–æ—Å—Å–∏–∏ –≤ –¥–≤–∞ —Ä–∞–∑–∞ –≤—ã—Ä–æ—Å–ª–æ —á–∏—Å–ª–æ —Å–ª—É—á–∞–µ–≤ –¥–ª–∏—Ç–µ–ª—å–Ω–æ–π –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∏ –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è, –∫–æ–≥–¥–∞ —Å—Ä–æ–∫ –ø–æ—Å—Ç–∞–Ω–æ–≤–∫–∏ –¥–∏–∞–≥–Ω–æ–∑–∞ –∑–∞–Ω–∏–º–∞–µ—Ç –±–æ–ª—å—à–µ –≥–æ–¥–∞: —Å 5,8% –≤ 2020 –≥–æ–¥—É –¥–æ 10,6% –≤ 2024-–º, —Å–æ–æ–±—â–∏–ª–∏ ¬´–ú–í¬ª –≤ –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–°–û–ì–ê–ó-–ú–µ–¥¬ª. –ê–Ω–∞–ª–∏–∑ –≤—ã–ø–æ–ª–Ω–µ–Ω –Ω–∞ –æ—Å–Ω–æ–≤–µ –ø—Ä–∏–Ω—è—Ç—ã—Ö –∫ –æ–ø–ª–∞—Ç–µ —Å—á–µ—Ç–æ–≤ –∑–∞ –æ–∫–∞–∑–∞–Ω–Ω—É—é –ø–æ –û–ú–° –º–µ–¥–∏—Ü–∏–Ω—Å–∫—É—é –ø–æ–º–æ—â—å –∑–∞—Å—Ç—Ä–∞—Ö–æ–≤–∞–Ω–Ω—ã–º –≤ —ç—Ç–æ—Ç –ø–µ—Ä–∏–æ–¥.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,hospital_policy,pharmacovigilance,safety"",
  ""impact"": ""high"",
  ""english"": ""There has been a two-fold increase in the number of cases of long-term oncological disease diagnosis in Russia, where the diagnostic setup takes more than a year. This has risen from 5.8% in 2020 to 10.6% in 2024, according to 'MVO' from the SOGAZ-MED company. The analysis is based on claims for medical care provided under the State Medical Insurance Scheme during this period.""
}"
2025-08-04T14:22:13+00:00,@medpharm,12512,https://t.me/medpharm/12512,"–ó–Ω–∞–∫–æ–º–∏–º –≤–∞—Å —Å–æ —Å–ª–µ–¥—É—é—â–∏–º —Å–ø–∏–∫–µ—Ä–æ–º PRO–µ–∫—Ü–∏–π –ë—É–¥—É—â–µ–≥–æ: üîπ–î–º–∏—Ç—Ä–∏–π –¢–∞—Å–∫–∏–Ω, –¥–∏—Ä–µ–∫—Ç–æ—Ä –ø–æ —Ä–∞–∑–≤–∏—Ç–∏—é –ø–µ—Ä–≤–∏—á–Ω–æ–≥–æ —Ä—ã–Ω–∫–∞ –æ–±–ª–∏–≥–∞—Ü–∏–π –ü–ê–û –ú–æ—Å–∫–æ–≤—Å–∫–∞—è –±–∏—Ä–∂–∞, —Å–ø–∏–∫–µ—Ä —Ñ–æ–∫—É—Å-—Å–µ—Å—Å–∏–∏ Forbes ¬´–ò–Ω–≤–µ—Å—Ç–∏—Ü–∏–∏ –≤ —Ñ–∞—Ä–º–µ: —Ä–∏—Å–∫–∏, –∫–∞–ø–∏—Ç–∞–ª—ã, —Å—Ç—Ä–∞—Ç–µ–≥–∏–∏¬ª –î–∞—Ç–∞ –∏ –≤—Ä–µ–º—è —Å–µ—Å—Å–∏–∏: 11 —Å–µ–Ω—Ç—è–±—Ä—è 2025, 14:00 üìç–≥. –°–æ—á–∏, Pullman –°–æ—á–∏ –¶–µ–Ω—Ç—Ä 5* –ü–æ–¥—Ä–æ–±–Ω–µ–µ –æ –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ –∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –Ω–∞ —Å–∞–π—Ç–µ","{""skip"": true}"
2025-08-04T13:11:37+00:00,@medpharm,12511,https://t.me/medpharm/12511,"–ò–∑ –æ–±—Å—É–∂–¥–µ–Ω–∏–π –Ω–∞ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—ã—Ö —Ñ–æ—Ä—É–º–∞—Ö –≤–∏–¥–Ω–æ, —á—Ç–æ –æ—Ç–Ω–æ—à–µ–Ω–∏–µ –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –∫ –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–∏ —Å–∫–æ—Ä–µ–µ –Ω–µ–≥–∞—Ç–∏–≤–Ω–æ–µ. –•–æ—Ç—è, –µ—Å–ª–∏ —Ä–∞–∑–±–∏—Ä–∞—Ç—å—Å—è –≥–ª—É–±–∂–µ ‚Äì –≤—Å–µ —Å–æ–≤—Å–µ–º –Ω–µ–æ–¥–Ω–æ–∑–Ω–∞—á–Ω–æ, –∞ –Ω–∞–∫–æ–ø–∏–≤—à–∏–µ—Å—è –≤–æ–ø—Ä–æ—Å—ã –ø–æ –ø—Ä–æ—Ü–µ–¥—É—Ä–µ –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–∏ —Ç—Ä–µ–±—É—é—Ç –ø–µ—Ä–µ–æ—Å–º—ã—Å–ª–µ–Ω–∏—è.","{""skip"": false, ""country"": ""global"", ""topic"": ""clinical_trial"", ""impact"": ""medium"", ""english"": ""Discussion on professional forums shows a negative attitude of healthcare workers towards accreditation. However, upon deeper analysis, the situation is not clear-cut and questions about the procedure of accreditation need to be reconsidered.""}"
2025-08-04T11:16:32+00:00,@medpharm,12510,https://t.me/medpharm/12510,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –≤–ª–æ–∂–∏—Ç 676 –º–ª–Ω —Ä—É–±–ª–µ–π –≤ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫—É —Ä–µ–≥–∏—Å—Ç—Ä–∞ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –æ—Ç–¥–µ–ª—å–Ω—ã–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏. –ù–æ–≤–∞—è –ø–ª–∞—Ç—Ñ–æ—Ä–º–∞ —Å—Ç–∞–Ω–µ—Ç —á–∞—Å—Ç—å—é –ï–ì–ò–°–ó –∏ –ø—Ä–µ–¥–Ω–∞–∑–Ω–∞—á–µ–Ω–∞ –¥–ª—è —Å–±–æ—Ä–∞ –¥–∞–Ω–Ω—ã—Ö –æ –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π, –≤–ª–∏—è–Ω–∏–∏ –ø–æ–∫–∞–∑–∞—Ç–µ–ª–µ–π –∑–∞–±–æ–ª–µ–≤–∞–µ–º–æ—Å—Ç–∏ –Ω–∞ –∏–∑–º–µ–Ω–µ–Ω–∏–µ –º–µ–¥–∏–∫–æ-–¥–µ–º–æ–≥—Ä–∞—Ñ–∏—á–µ—Å–∫–∏—Ö –ø–æ–∫–∞–∑–∞—Ç–µ–ª–µ–π, —Ñ–∏–Ω–∞–Ω—Å–æ–≤–æ-—ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–≥–æ –ø–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω–∏—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –∏ –ø—Ä–æ–≥—Ä–∞–º–º –ª—å–≥–æ—Ç–Ω–æ–≥–æ –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health will invest 676 million rubles in the development of a patient registration system for specific diseases. The new platform will be part of EGISZ and is intended to collect data on the activities of healthcare organizations, influence disease incidence on demographic and economic indicators, and plan medical assistance programs.""
}"
2025-08-04T09:17:54+00:00,@medpharm,12509,https://t.me/medpharm/12509,"–ú–∏–Ω–∑–¥—Ä–∞–≤ —É—Ç–≤–µ—Ä–¥–∏–ª –ø–ª–∞–Ω —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–∞–ª—å–Ω–æ–≥–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –æ–Ω–∫–æ–≤–∞–∫—Ü–∏–Ω—ã, —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–Ω–æ–π –∏–Ω–¥–∏–≤–∏–¥—É–∞–ª—å–Ω–æ –ø–æ–¥ –∫–∞–∂–¥–æ–≥–æ —á–µ–ª–æ–≤–µ–∫–∞. –°–æ–≥–ª–∞—Å–Ω–æ –µ–º—É, –ø–µ—Ä–≤—ã–µ –ø–∞—Ü–∏–µ–Ω—Ç—ã —Å –º–µ–ª–∞–Ω–æ–º–æ–π –ø–æ–ª—É—á–∞—Ç –ø—Ä–µ–ø–∞—Ä–∞—Ç –≤ –±–ª–∏–∂–∞–π—à–∏–µ –º–µ—Å—è—Ü—ã. –ì–ª–∞–≤–∞ –¶–µ–Ω—Ç—Ä–∞ –ì–∞–º–∞–ª–µ–∏ –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ì–∏–Ω—Ü–±—É—Ä–≥ —Ä–∞—Å—Å–∫–∞–∑–∞–ª, —á—Ç–æ –≤–∞–∫—Ü–∏–Ω–æ–π –∏–Ω—Ç–µ—Ä–µ—Å—É—é—Ç—Å—è –∏ –∑–∞ —Ä—É–±–µ–∂–æ–º.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, vaccine"",
  ""impact"": ""high"",
  ""english"": ""The Ministry of Health approved the plan for the experimental application of a personalized cancer vaccine developed individually. According to it, patients with melanoma will receive the drug in the near future. Head of the Gamaleya Center Alexander Ginzburg said that the vaccine is also being sought abroad.""
}"
2025-08-04T07:11:57+00:00,@medpharm,12508,https://t.me/medpharm/12508,"–ì–ª–∞–≤–Ω—ã–π –≤—Ä–∞—á –∫–µ–º–µ—Ä–æ–≤—Å–∫–æ–π –≥–æ—Ä–±–æ–ª—å–Ω–∏—Ü—ã –ê–Ω–¥—Ä–µ–π –¢–∞—Ä–∞—Å–æ–≤ –Ω–∞–∑–Ω–∞—á–µ–Ω –º–∏–Ω–∏—Å—Ç—Ä–æ–º –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ö—É–∑–±–∞—Å—Å–∞. –ù–∞–ø–æ–º–Ω–∏–º, —á—Ç–æ –ø—Ä–µ–¥—ã–¥—É—â–∏–π –º–∏–Ω–∏—Å—Ç—Ä –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ö–µ–º–µ—Ä–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ —É—à–µ–ª –≤ –æ—Ç—Å—Ç–∞–≤–∫—É –ø–æ —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ–º—É –∂–µ–ª–∞–Ω–∏—é, –Ω–æ –≤—Å–∫–æ—Ä–µ –µ–≥–æ –∑–∞–¥–µ—Ä–∂–∞–ª–∏ –ø–æ –¥–µ–ª—É –æ –ø–æ–ª—É—á–µ–Ω–∏–∏ –≤–∑—è—Ç–∫–∏.","{""skip"": true}"
2025-08-03T11:02:22+00:00,@medpharm,12507,https://t.me/medpharm/12507,"–ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ –∑–∞ –Ω–µ–¥–µ–ª—é üîµ –ü–∞–ª–∞—Ç–∞ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–µ–π –°–®–ê (–Ω–∏–∂–Ω—è—è –ø–∞–ª–∞—Ç–∞ –ö–æ–Ω–≥—Ä–µ—Å—Å–∞) –≤–Ω–µ—Å–ª–∞ –Ω–∞ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏–µ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç, –∫–æ—Ç–æ—Ä—ã–º –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è –∑–∞–ø—Ä–µ—Ç–∏—Ç—å —ç–∫—Å–ø–æ—Ä—Ç –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –ø—Ä–æ—Ç–µ–∑–æ–≤ –≤ –†–æ—Å—Å–∏–π—Å–∫—É—é –§–µ–¥–µ—Ä–∞—Ü–∏—é. üîµ –ö–æ–º–∏—Å—Å–∏—è –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ø–æ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—é –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø–µ—Ä–µ—á–Ω–µ–π –ø—Ä–æ–≤–µ–¥–µ—Ç –≤—Ç–æ—Ä–æ–µ –∑–∞—Å–µ–¥–∞–Ω–∏–µ –≤ 2025 –≥–æ–¥—É. üîµ –° 1 —Å–µ–Ω—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞ –≤—Ä–∞—á–∏ —Å–º–æ–≥—É—Ç –Ω–∞–∑–Ω–∞—á–∞—Ç—å –ë–ê–î –ø–∞—Ü–∏–µ–Ω—Ç–∞–º —Ç–æ–ª—å–∫–æ –∏–∑ —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ–≥–æ —Å–ø–∏—Å–∫–∞. üîµ –ê—Ä–±–∏—Ç–∞–∂–Ω—ã–π —Å—É–¥ –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥–∞ –∏ –õ–µ–Ω–∏–Ω–≥—Ä–∞–¥—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –ø—Ä–∏–Ω—è–ª –æ—Ç–∫–∞–∑ –∫–æ–º–ø–∞–Ω–∏–π Incyte Holdings Corporation –∏ Novartis Pharma AG –æ—Ç –∏—Å–∫–∞ –∫ –ê–û ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑-–ù–æ—Ä–¥¬ª –∏ –ú–∏–Ω–∑–¥—Ä–∞–≤—É –†–æ—Å—Å–∏–∏. üîµ –ö–æ–ª–ª–µ–≥–∏—è –ø–∞–ª–∞—Ç—ã –ø–æ –ø–∞—Ç–µ–Ω—Ç–Ω—ã–º —Å–ø–æ—Ä–∞–º –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª–∞ –ø—Ä–∞–≤–æ–º–µ—Ä–Ω–æ—Å—Ç—å –µ–≤—Ä–∞–∑–∏–π—Å–∫–æ–≥–æ –ø–∞—Ç–µ–Ω—Ç–∞ –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ê–∫—Å–µ–ª—å–§–∞—Ä–º¬ª –Ω–∞ —Å–ø–æ—Å–æ–± –ø–æ–ª—É—á–µ–Ω–∏—è –¥–µ–π—Å—Ç–≤—É—é—â–µ–≥–æ –≤–µ—â–µ—Å—Ç–≤–∞ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ¬´–ê–∫—Å–∏—Ç–∏–Ω–∏–±¬ª.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""import_export, sanctions"",
  ""impact"": ""high"",
  ""english"": ""The US House of Representatives introduced a bill proposing to ban the export of pharmaceuticals and prosthetics to Russia. The State Medicine Commission's committee on forming drug lists will hold a second meeting in 2025. Doctors can only prescribe generics from a special list starting September 1, 2025. The Arbitration Court of St. Petersburg and Leningrad Oblast rejected a lawsuit against Nor Nord Farma OJSC and the Russian Ministry of Health. The Collegium confirmed the legitimacy of the Eurasian patent for company 'Axelfarm' on a method for producing an active substance of Russia's drug 'Axitinib'.""
}"
2025-08-02T08:59:58+00:00,@medpharm,12506,https://t.me/medpharm/12506,"–ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∑–∞ –Ω–µ–¥–µ–ª—é üî¥–ú–∏–Ω–∑–¥—Ä–∞–≤ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –ø—Ä–æ–µ–∫—Ç –ø–æ—Ä—è–¥–∫–∞ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π (–ö–†). –û–Ω–∏ –Ω–µ –±—É–¥—É—Ç –≤—ã—Å—Ç—É–ø–∞—Ç—å –ø—Ä–µ–¥–º–µ—Ç–æ–º —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∫–æ–Ω—Ç—Ä–æ–ª—è (–Ω–∞–¥–∑–æ—Ä–∞) –∫–∞—á–µ—Å—Ç–≤–∞ –∏ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏. üî¥ –¢–µ—Ö–Ω–∏—á–µ—Å–∫–∏–µ —Å–±–æ–∏ –≤ —Ä–∞–±–æ—Ç–µ –∫–ª–∏–Ω–∏–∫ –∏ –∞–ø—Ç–µ—á–Ω—ã—Ö —Å–µ—Ç–µ–π –≤ –ú–æ—Å–∫–≤–µ. –ü—Ä–∏—á–∏–Ω–æ–π –º–æ–≥–ª–∏ —Å—Ç–∞—Ç—å –∞—Ç–∞–∫–∏ –Ω–∞ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω—ã–µ —Å–∏—Å—Ç–µ–º—ã –∫–æ–º–ø–∞–Ω–∏–π. üî¥–Æ—Ä–∏—Å—Ç—ã –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã–π —Å–ø–æ—Å–æ–± –ø—Ä–æ–≤–µ—Ä–∫–∏ –ø–æ–¥–ª–∏–Ω–Ω–æ—Å—Ç–∏ –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤ –æ–± –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–∏ –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤. –ò–Ω–∏—Ü–∏–∞—Ç–∏–≤—É –ø–æ–¥–¥–µ—Ä–∂–∏–≤–∞—é—Ç –≤ —Ä–µ–≥–∏–æ–Ω–∞—Ö. üî¥–ú–∏–Ω–∑–¥—Ä–∞–≤ –Ω–∞–ø—Ä–∞–≤–∏–ª –º–µ—Ç–æ–¥–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –¥–ª—è –∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä–æ–≤–∞–Ω–∏—è –±–µ—Ä–µ–º–µ–Ω–Ω—ã—Ö –∏ –∂–µ–Ω—â–∏–Ω, –ø–ª–∞–Ω–∏—Ä—É—é—â–∏—Ö –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç—å. üî¥–ú–∏–Ω–∑–¥—Ä–∞–≤ –ø–æ–¥–≥–æ—Ç–æ–≤–∏–ª –ø—Ä–æ–µ–∫—Ç –æ–±–Ω–æ–≤–ª–µ–Ω–Ω—ã—Ö –ø—Ä–∞–≤–∏–ª –ø—Ä–æ–≤–µ—Ä–∫–∏ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏–π.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health has developed a project on the application of clinical recommendations (CR). These will not be subject to federal state control over the quality and safety of medical activities. Technical failures in clinic and healthcare network operations in Moscow are attributed to attacks on the information systems of companies. Lawyers have proposed an effective method for verifying the authenticity of documents related to medical personnel's education. This initiative is supported by regions. The Ministry of Health has prepared a project for updated rules on the examination of medical institutions.""
}"
2025-08-01T16:06:05+00:00,@medpharm,12505,https://t.me/medpharm/12505,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 1 –∞–≤–≥—É—Å—Ç–∞ –ó–∞–¥–∞–ª–∏ –≤–µ–∫—Ç–æ—Ä –ü—Ä–µ–∑–∏–¥–µ–Ω—Ç –ø–æ—Ä—É—á–∏–ª –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤—É –∏ —Ä–µ–≥–∏–æ–Ω–∞–º –ø—Ä–∏–Ω—è—Ç—å –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–µ –º–µ—Ä—ã –¥–ª—è –≤—ã–ø–æ–ª–Ω–µ–Ω–∏—è –Ω–∞—Ü–ø—Ä–æ–µ–∫—Ç–æ–≤ ¬´–ü—Ä–æ–¥–æ–ª–∂–∏—Ç–µ–ª—å–Ω–∞—è –∏ –∞–∫—Ç–∏–≤–Ω–∞—è –∂–∏–∑–Ω—å¬ª –∏ ¬´–°–µ–º—å—è¬ª –∏ —É–ª—É—á—à–∏—Ç—å –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å –ø–µ—Ä–≤–∏—á–Ω–æ–π –º–µ–¥–ø–æ–º–æ—â–∏, –≤ —Ç–æ–º —á–∏—Å–ª–µ —Å —Ä–∞–∑–≤–∏—Ç–∏–µ–º –∏–Ω—Å—Ç–∏—Ç—É—Ç–∞ –≤—Ä–∞—á–µ–π –æ–±—â–µ–π –ø—Ä–∞–∫—Ç–∏–∫–∏. –û–±—ã—á–Ω—ã–µ –≥–µ—Ä–æ–∏ –í—Ä–∞—á–∏ –∫–∞–º—á–∞—Ç—Å–∫–æ–≥–æ –æ–Ω–∫–æ–¥–∏—Å–ø–∞–Ω—Å–µ—Ä–∞ –ø—Ä–æ–¥–æ–ª–∂–∏–ª–∏ –æ–ø–µ—Ä–∞—Ü–∏—é –≤–æ –≤—Ä–µ–º—è –º–æ—â–Ω–æ–≥–æ –∑–µ–º–ª–µ—Ç—Ä—è—Å–µ–Ω–∏—è –∏ –±—É–¥—É—Ç –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω—ã –∫ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–º –Ω–∞–≥—Ä–∞–¥–∞–º. –ü–æ —Å–ª–æ–≤–∞–º –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç–∞, –æ–Ω–∏ –ø—Ä–æ—è–≤–∏–ª–∏ –≥–µ—Ä–æ–∏–∑–º –∏ –¥–æ—Å—Ç–æ–π–Ω–æ –≤—ã–ø–æ–ª–Ω–∏–ª–∏ —Å–≤–æ–π –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—ã–π –¥–æ–ª–≥. –ö–∞–¥—Ä–æ–≤—ã–µ –ø–µ—Ä–µ—Å—Ç–∞–Ω–æ–≤–∫–∏ –í —Ç–æ–ø-–º–µ–Ω–µ–¥–∂–º–µ–Ω—Ç–µ –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ì—Ä–æ—Ç–µ–∫—Å¬ª (–±—Ä–µ–Ω–¥ Solopharm) –ø—Ä–æ–∏–∑–æ—à–ª–∏ –∏–∑–º–µ–Ω–µ–Ω–∏—è. –ù–∞ –¥–æ–ª–∂–Ω–æ—Å—Ç—å –≥–µ–Ω–µ—Ä–∞–ª—å–Ω–æ–≥–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –Ω–∞–∑–Ω–∞—á–µ–Ω –ú–∞–º—É–∫–∞ –ú–∏—Ö–µ–ª–∞—à–≤–∏–ª–∏, —Ä–∞–Ω–µ–µ –∑–∞–Ω–∏–º–∞–≤—à–∏–π –ø–æ—Å—Ç –∏—Å–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–≥–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –∫–æ–º–ø–∞–Ω–∏–∏. –°–ø–æ—Ä –æ–± –æ—Å–∏–º–µ—Ä—Ç–∏–Ω–∏–±–µ –ö–æ–º–ø–∞–Ω–∏—è ¬´–ê–∫—Å–µ–ª—å–§–∞—Ä–º¬ª –Ω–µ —Å–æ–≥–ª–∞—Å–∏–ª–∞—Å—å —Å –ø–æ–∑–∏—Ü–∏–µ–π –§–ê–° –ø–æ –æ—Å–∏–º–µ—Ä—Ç–∏–Ω–∏–±—É. –§–µ–¥–µ—Ä–∞–ª—å–Ω—ã–π –æ—Ä–≥–∞–Ω –∑–∞—è–≤–∏–ª, —á—Ç–æ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–µ –æ –ø–æ—Å—Ç–∞–≤–∫–µ –≤ –≥–æ—Å–∑–∞–∫—É–ø–∫–∞—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ¬´–û—Å–∏–º–µ—Ä—Ç–∏–Ω–∏–±¬ª –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –û–û–û ¬´–û–Ω–∫–æ–¢–∞—Ä–≥–µ—Ç¬ª –Ω–∞—Ä—É—à–∞–µ—Ç –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–æ –†–§.","{""skip"": true}"
2025-08-01T14:29:58+00:00,@medpharm,12504,https://t.me/medpharm/12504,"–£—Ç–≤–µ—Ä–∂–¥–µ–Ω –∑–∞–∫–æ–Ω, –∫–æ—Ç–æ—Ä—ã–º –ø–µ—Ä–µ–Ω–æ—Å—è—Ç—Å—è —Å—Ä–æ–∫–∏ –≤–≤–µ–¥–µ–Ω–∏—è —ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω–æ–≥–æ –¥–æ–∫—É–º–µ–Ω—Ç–æ–æ–±–æ—Ä–æ—Ç–∞ (–≠–î–û) –¥–ª—è –æ–±–æ—Ä–æ—Ç–∞ —ç—Ç–∏–ª–æ–≤–æ–≥–æ —Å–ø–∏—Ä—Ç–∞, –∞–ª–∫–æ–≥–æ–ª—å–Ω–æ–π –∏ —Å–ø–∏—Ä—Ç–æ—Å–æ–¥–µ—Ä–∂–∞—â–µ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏, –≤–∫–ª—é—á–∞—è –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã. –î–æ–∫—É–º–µ–Ω—Ç–æ–º —Ç–∞–∫–∂–µ —É—Å—Ç–∞–Ω–∞–≤–ª–∏–≤–∞–µ—Ç—Å—è –¥–æ –∞–ø—Ä–µ–ª—è 2027 –≥–æ–¥–∞ –º–æ—Ä–∞—Ç–æ—Ä–∏–π –Ω–∞ –≤—ã–¥–∞—á—É –ª–∏—Ü–µ–Ω–∑–∏–π –Ω–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –∏ –ø–æ—Å—Ç–∞–≤–∫–∏ —ç—Ç–∏–ª–æ–≤–æ–≥–æ —Å–ø–∏—Ä—Ç–∞, –≤ —Ç–æ–º —á–∏—Å–ª–µ –¥–ª—è –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏–π.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, sanctions"",
  ""impact"": ""high"",
  ""english"": ""A law has been approved extending the implementation of electronic document handling (EDO) for the trade of ethanol, alcoholic and spirit-containing products, including pharmaceuticals. The document also sets a moratorium on licenses for the production and supply of ethanol, including for pharmaceuticals.""
}"
2025-08-01T13:02:35+00:00,@medpharm,12503,https://t.me/medpharm/12503,"¬´–í—Ä–∞—á–∏ –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –æ–±—â–∞—é—Ç—Å—è —Å –ø–∞—Ü–∏–µ–Ω—Ç–∞–º–∏, –≤ —Ç–æ–º —á–∏—Å–ª–µ –ø–æ –≤–æ–ø—Ä–æ—Å–∞–º –æ–∫–∞–∑–∞–Ω–∏—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏, –ø–æ—Å—Ä–µ–¥—Å—Ç–≤–æ–º –º–µ—Å—Å–µ–Ω–¥–∂–µ—Ä–æ–≤. –î–æ–ø—É—Å—Ç–∏–º–æ –ª–∏ —ç—Ç–æ, –µ—Å—Ç—å –ª–∏ –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω—ã–µ –ø—Ä–∞–≤–æ–≤—ã–µ –∞–∫—Ç—ã, –∑–∞–ø—Ä–µ—â–∞—é—â–∏–µ –∏–ª–∏ —Ä–µ–≥—É–ª–∏—Ä—É—é—â–∏–µ —Ç–∞–∫–æ–µ –æ–±—â–µ–Ω–∏–µ?¬ª.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""Doctors from medical organizations are communicating with patients, including on issues of providing medical care, through messengers. Is this allowed? Are there any regulatory legal acts prohibiting or regulating such communication?""
}"
2025-08-01T11:33:47+00:00,@medpharm,12502,https://t.me/medpharm/12502,"–ó–Ω–∞–∫–æ–º—å—Ç–µ—Å—å, –º–æ–¥–µ—Ä–∞—Ç–æ—Ä —Ñ–æ–∫—É—Å-—Å–µ—Å—Å–∏–∏ Forbes RPO–µ–∫—Ü–∏–π –ë—É–¥—É—â–µ–≥–æ ¬´–ò–Ω–≤–µ—Å—Ç–∏—Ü–∏–∏ –≤ —Ñ–∞—Ä–º–µ: —Ä–∏—Å–∫–∏, –∫–∞–ø–∏—Ç–∞–ª—ã, —Å—Ç—Ä–∞—Ç–µ–≥–∏–∏¬ª üîπ–ê–Ω–¥—Ä–µ–π –°–µ–º–µ—Ä–∫–∏–Ω - –ø—Ä–æ–≥—Ä–∞–º–º–Ω—ã–π –¥–∏—Ä–µ–∫—Ç–æ—Ä Forbes Club –í–æ–ø—Ä–æ—Å—ã –∫ –æ–±—Å—É–∂–¥–µ–Ω–∏—é: ‚Ä¢ –í–ª–∏—è–Ω–∏–µ –≤–Ω–µ—à–Ω–µ—ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–∏—Ö —Ñ–∞–∫—Ç–æ—Ä–æ–≤. –°–∞–Ω–∫—Ü–∏–∏, –≤–∞–ª—é—Ç–Ω—ã–µ —Ä–∏—Å–∫–∏, —ç–∫—Å–ø–æ—Ä—Ç–Ω–∞—è –ª–æ–≥–∏—Å—Ç–∏–∫–∞ ‚Äî —Ä–∏—Å–∫–∏ –∏ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ ‚Ä¢ –ò–Ω–≤–µ—Å—Ç–∏—Ü–∏–æ–Ω–Ω–∞—è –ø—Ä–∏–≤–ª–µ–∫–∞—Ç–µ–ª—å–Ω–æ—Å—Ç—å. –ö–∞–∫–∏–µ —Å–µ–≥–º–µ–Ω—Ç—ã ¬´–≥–æ—Ä—è—á–∏–µ¬ª –¥–ª—è –≤–ª–æ–∂–µ–Ω–∏–π: –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ, —Å—É–±—Å—Ç–∞–Ω—Ü–∏–∏, –¥–∏—Å—Ç—Ä–∏–±—É—Ü–∏—è, IT, –∞–ø—Ç–µ–∫–∏ ‚Ä¢ –†—ã–Ω–æ–∫ —Å–¥–µ–ª–æ–∫. –ö–∞–∫–∏–µ —Ñ–æ—Ä–º–∞—Ç—ã –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–π —Ä–∞–±–æ—Ç–∞—é—Ç: M&A, IPO, —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏–µ –ø–∞—Ä—Ç–Ω–µ—Ä—Å—Ç–≤–∞, —á–∞—Å—Ç–Ω—ã–µ —Ä–∞–∑–º–µ—â–µ–Ω–∏—è ‚Ä¢ –ù–æ–≤—ã–µ –∏–≥—Ä–æ–∫–∏. –í—ã–≥–æ–¥–Ω–æ –∑–∞—Ö–æ–¥–∏—Ç—å –≤ —Ä–æ—Å—Å–∏–π—Å–∫—É—é —Ñ–∞—Ä–º—É ‚Ä¢ –¶–∏—Ñ—Ä–æ–≤–∏–∑–∞—Ü–∏—è. –°—Ç–æ–∏—Ç –ª–∏ –∏–Ω–≤–µ—Å—Ç–∏—Ä–æ–≤–∞—Ç—å –≤ I–¢-–Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è –≤ —Ñ–∞—Ä–º–µ. –ö—Ç–æ —É–∂–µ —ç—Ç–æ –¥–µ–ª–∞–µ—Ç –∏ —Å –∫–∞–∫–∏–º —Ä–µ–∑—É–ª—å—Ç–∞—Ç–æ–º –î–∞—Ç–∞ –∏ –≤—Ä–µ–º—è —Å–µ—Å—Å–∏–∏: 11 —Å–µ–Ω—Ç—è–±—Ä—è 2025, 14:00 üìç–≥. –°–æ—á–∏, Pullman –°–æ—á–∏ –¶–µ–Ω—Ç—Ä 5* –ë—Ä–æ–Ω–∏—Ä—É–π—Ç–µ —É—á–∞—Å—Ç–∏–µ –Ω–∞ —Å–∞–π—Ç–µ","{""skip"": true}"
2025-08-01T11:32:08+00:00,@medpharm,12501,https://t.me/medpharm/12501,"–ü—Ä–µ–∑–∏–¥–µ–Ω—Ç –ø–æ–¥–ø–∏—Å–∞–ª –∑–∞–∫–æ–Ω –æ –ø–ª–∞—Ç—Ñ–æ—Ä–º–µ–Ω–Ω–æ–π —ç–∫–æ–Ω–æ–º–∏–∫–µ –∏ –¥–æ–∫—É–º–µ–Ω—Ç, –∫–æ—Ç–æ—Ä—ã–º –≤–Ω–æ—Å—è—Ç—Å—è —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–∏–µ –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ —Ä—è–¥ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å–Ω—ã—Ö –∞–∫—Ç–æ–≤. –û–±–∞ –¥–æ–∫—É–º–µ–Ω—Ç–∞ –≤—Å—Ç—É–ø—è—Ç –≤ —Å–∏–ª—É —Å 1 –æ–∫—Ç—è–±—Ä—è 2026 –≥–æ–¥–∞.","{""skip"": true}"
2025-08-01T10:00:17+00:00,@medpharm,12500,https://t.me/medpharm/12500,"–í –ì–æ—Å–¥—É–º–µ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –æ–±—è–∑–∞—Ç—å –≤—Å–µ—Ö –æ–Ω–ª–∞–π–Ω-–≤—Ä–∞—á–µ–π –ø—Ä–æ—Ö–æ–¥–∏—Ç—å –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω—É—é –≤–µ—Ä–∏—Ñ–∏–∫–∞—Ü–∏—é —Å –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏–µ–º –æ–ø—ã—Ç–∞ –∏ –≤–Ω–µ—Å—Ç–∏ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –≤ –æ—Ç–∫—Ä—ã—Ç—ã–π —Ä–µ–µ—Å—Ç—Ä –Ω–∞ –ø–æ—Ä—Ç–∞–ª–µ ¬´–ì–æ—Å—É—Å–ª—É–≥–∏¬ª. –ü—Ä–µ–¥–ø–æ–ª–∞–≥–∞–µ—Ç—Å—è, —á—Ç–æ —ç—Ç–æ –ø–æ–º–æ–∂–µ—Ç –∑–∞—â–∏—Ç–∏—Ç—å –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –æ—Ç –º–æ—à–µ–Ω–Ω–∏—á–µ—Å—Ç–≤–∞.","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""registration, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The State Duma proposed requiring all online doctors to undergo official verification with proof of experience and adding specialists to an open registry on the 'State Services' portal. This is intended to protect patients from fraud.""
}"
2025-08-01T08:29:58+00:00,@medpharm,12499,https://t.me/medpharm/12499,"–í—ã–¥–∞—á–∞ –≤ –ø–æ–∏—Å–∫–æ–≤–∏–∫–∞—Ö –Ω–µ —Å—á–∏—Ç–∞–µ—Ç—Å—è —Ä–µ–∫–ª–∞–º–Ω–æ–π, –∏ —Å –Ω–µ–µ –Ω–µ —Ç—Ä–µ–±—É–µ—Ç—Å—è –ø–ª–∞—Ç–∏—Ç—å —Ä–µ–∫–ª–∞–º–Ω—ã–π —Å–±–æ—Ä. –°–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–µ–µ –ø–æ–ª–æ–∂–µ–Ω–∏–µ –∑–∞–∫—Ä–µ–ø–ª–µ–Ω–æ –≤ –ü–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–∏ –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –†–§ ‚Ññ 1087 –æ—Ç 24.07.2025 ¬´–û–± —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏–∏ –∫—Ä–∏—Ç–µ—Ä–∏–µ–≤ –æ—Ç–Ω–µ—Å–µ–Ω–∏—è –∫ —Ä–µ–∫–ª–∞–º–µ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏, —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω—è–µ–º–æ–π –Ω–∞ –æ—Ç–¥–µ–ª—å–Ω—ã—Ö –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω—ã—Ö —Ä–µ—Å—É—Ä—Å–∞—Ö –≤ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω–æ-—Ç–µ–ª–µ–∫–æ–º–º—É–Ω–∏–∫–∞—Ü–∏–æ–Ω–Ω–æ–π —Å–µ—Ç–∏ ¬´–ò–Ω—Ç–µ—Ä–Ω–µ—Ç¬ª, –∫–æ—Ç–æ—Ä–æ–µ 25 –∏—é–ª—è –≤—Å—Ç—É–ø–∏–ª–æ –≤ —Å–∏–ª—É.","{""skip"": true}"
2025-08-01T07:04:39+00:00,@medpharm,12498,https://t.me/medpharm/12498,"‚ö°Ô∏è–ü—Ä–µ–¥–ª–∞–≥–∞–µ–º –≤–∞—à–µ–º—É –≤–Ω–∏–º–∞–Ω–∏—é —Ä–µ–π—Ç–∏–Ω–≥ –Ω–æ–≤–æ—Å—Ç–µ–π –∏—é–ª—è –¥–ª—è –æ—Ä–≥–∞–Ω–∏–∑–∞—Ç–æ—Ä–æ–≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –í —Å–≤–µ–∂–µ–º –≤—ã–ø—É—Å–∫–µ: üî∏ –ú–∏–Ω–∑–¥—Ä–∞–≤ –ø–æ–ª—É—á–∏–ª –ø–æ–ª–Ω–æ–º–æ—á–∏—è –ø–æ —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏—é –æ—Å–æ–±–æ–≥–æ –ø–æ—Ä—è–¥–∫–∞ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –∫–ª–∏–Ω—Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π üî∏ –ú–∏–Ω–∑–¥—Ä–∞–≤ —É–≤–µ–ª–∏—á–∏–ª —á–∏—Å–ª–æ –ø–æ–∫–∞–∑–∞—Ç–µ–ª–µ–π —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∏–≤–Ω–æ—Å—Ç–∏ –¥–ª—è –¥–æ–ø—Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è –ø–æ–ª–∏–∫–ª–∏–Ω–∏–∫ —Å 25 –¥–æ 33 üî∏ –ü–æ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ú–∏–Ω—é—Å—Ç–∞ –ú–∏–Ω–∑–¥—Ä–∞–≤ –ø–æ–¥–≥–æ—Ç–æ–≤–∏–ª –ø—Ä–æ–µ–∫—Ç –Ω–æ–≤—ã—Ö –ü—Ä–∞–≤–∏–ª –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–≥–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ —Å—Ç—Ä–∞—Ö–æ–≤–∞–Ω–∏—è üî∏ –ü–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –æ–±–Ω–æ–≤–∏—Ç—å –ø—Ä–∞–≤–∏–ª–∞ –ø—Ä–æ–≤–µ—Ä–æ–∫ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏–π, –ø—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ–Ω–æ –≤–Ω–µ–¥—Ä–µ–Ω–∏–µ –º–æ–±–∏–ª—å–Ω–æ–≥–æ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏—è ¬´–ò–Ω—Å–ø–µ–∫—Ç–æ—Ä¬ª üî∏ –û –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ –ø–æ–∑–≤–æ–ª–∏—Ç—å –≤—Ä–∞—á–∞–º –≤–µ—Å—Ç–∏ —á–∞—Å—Ç–Ω—É—é –ø—Ä–∞–∫—Ç–∏–∫—É –∑–∞—è–≤–∏–ª–∏ 70% –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤","{""skip"": true}"
2025-07-31T15:59:58+00:00,@medpharm,12497,https://t.me/medpharm/12497,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 31 –∏—é–ª—è –ñ–¥–µ–º –∏–Ω—Å–ø–µ–∫—Ç–æ—Ä–∞ –ú–∏–Ω–∑–¥—Ä–∞–≤ –ø–æ–¥–≥–æ—Ç–æ–≤–∏–ª –ø—Ä–æ–µ–∫—Ç –æ–±–Ω–æ–≤–ª–µ–Ω–Ω—ã—Ö –ø—Ä–∞–≤–∏–ª –ø—Ä–æ–≤–µ—Ä–∫–∏ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏–π. –í —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, –æ–Ω–∏ –≤–∫–ª—é—á–∞—é—Ç –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ –º–æ–±–∏–ª—å–Ω–æ–≥–æ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏—è ¬´–ò–Ω—Å–ø–µ–∫—Ç–æ—Ä¬ª, –∞ —Ç–∞–∫–∂–µ –¥–µ—Ç–∞–ª–∏–∑–∏—Ä—É—é—Ç –ø—Ä–æ—Ü–µ–¥—É—Ä—ã –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–æ–≥–æ –≤–∏–∑–∏—Ç–∞, –∑–∞–∫—É–ø–∫–∏ –∏ –ø–æ–¥–∞—á–∏ –∂–∞–ª–æ–±—ã. –†–∏—Å–∫–∏ –Ω–µ–æ–ø–ª–∞—Ç—ã –ú–∏–Ω–∑–¥—Ä–∞–≤ –∏–∑–º–µ–Ω–∏—Ç —Ä–∞–∑–º–µ—Ä—ã —Å–∞–Ω–∫—Ü–∏–π –∑–∞ –Ω–∞—Ä—É—à–µ–Ω–∏—è, –¥–æ–ø—É—Å–∫–∞–µ–º—ã–µ –ø—Ä–∏ –æ–∫–∞–∑–∞–Ω–∏–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –≤ —Ä–∞–º–∫–∞—Ö –û–ú–°. –ù–∞–ø—Ä–∏–º–µ—Ä, –µ—Å–ª–∏ –≤ –º–µ–¥–∫–∞—Ä—Ç–µ –Ω–µ —É–∫–∞–∑–∞–Ω—ã –∑–∞–ø–∏—Å–∏ –æ—Å–º–æ—Ç—Ä–æ–≤ –≤—Ä–∞—á–µ–π, –∫–ª–∏–Ω–∏–∫–µ –æ–ø–ª–∞—Ç—è—Ç —Ç–æ–ª—å–∫–æ 50% –æ—Ç —Å—Ç–æ–∏–º–æ—Å—Ç–∏ –æ–∫–∞–∑–∞–Ω–Ω—ã—Ö –º–µ–¥—É—Å–ª—É–≥. –ê–ø–µ–ª–ª—è—Ü–∏—è –æ—Ç–∫–ª–æ–Ω–µ–Ω–∞ –î–µ–≤—è—Ç—ã–π –∞—Ä–±–∏—Ç—Ä–∞–∂–Ω—ã–π –∞–ø–µ–ª–ª—è—Ü–∏–æ–Ω–Ω—ã–π —Å—É–¥ –æ—Å—Ç–∞–≤–∏–ª –≤ —Å–∏–ª–µ —Ä–µ—à–µ–Ω–∏–µ –ê—Ä–±–∏—Ç—Ä–∞–∂–Ω–æ–≥–æ —Å—É–¥–∞ –ú–æ—Å–∫–≤—ã –ø–æ –¥–µ–ª—É –§–ê–° –ø—Ä–æ—Ç–∏–≤ KRKA, —Ç–µ–º —Å–∞–º—ã–º –ø—Ä–∏–∑–Ω–∞–≤ –ø—Ä–∞–≤–æ—Ç—É –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å–Ω–æ–≥–æ –æ—Ä–≥–∞–Ω–∞. –ñ–∞–ª–æ–±–∞ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –æ—Å—Ç–∞–≤–ª–µ–Ω–∞ –±–µ–∑ —É–¥–æ–≤–ª–µ—Ç–≤–æ—Ä–µ–Ω–∏—è. –ü–æ–≤—Ç–æ—Ä–Ω—ã–µ –Ω–∞—Ä—É—à–µ–Ω–∏—è –û–±—â–µ—Å—Ç–≤–µ–Ω–Ω–∞—è –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è –æ–±–Ω–∞—Ä—É–∂–∏–ª–∞ –Ω–∞ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞—Ö –∫–∞—Ä—Ç–æ—á–∫–∏ —Ç–æ–≤–∞—Ä–æ–≤ —Å –Ω–µ–ª–µ–≥–∞–ª—å–Ω—ã–º–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏ –∏ –º–µ–¥–∏–∑–¥–µ–ª–∏—è–º–∏: –≤—Ä–µ–º–µ–Ω–Ω—ã–µ –ø–ª–æ–º–±—ã –¥–ª—è –∑—É–±–æ–≤ –∏ –∫–∏—Ç–∞–π—Å–∫–∏–µ –±–∏–æ–¥–æ–±–∞–≤–∫–∏. –ú–∏—Ö–∞–∏–ª—É –ú–∏—à—É—Å—Ç–∏–Ω—É –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–æ –ø–∏—Å—å–º–æ —Å –ø—Ä–æ—Å—å–±–æ–π –ø—Ä–∏–Ω—è—Ç—å –º–µ—Ä—ã, –ø–∏—à–µ—Ç ¬´–ö–æ–º–º–µ—Ä—Å–∞–Ω—Ç—ä¬ª.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, safety, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The Ministry of Health prepared a project for updated inspection rules for healthcare institutions. The project includes the use of an 'Inspector' mobile app and clarifies preventive visit procedures, procurement processes, and appeals. The Ministry of Health changed the penalties for non-payment by adjusting the reimbursement rates for medical services under OMS. For example, if medical records do not include doctors' examination notes, the clinic will only be reimbursed 50% of the cost of provided medical services. Appeals against a decision by the Moscow Arbitration Court were dismissed by the Ninth Arbitration Appeal Court, upholding the antimonopoly authority's decision. The company's appeal was rejected. An organization has discovered illegal medicines and medical supplies on marketplaces, including temporary seals for dental appliances and Chinese biodietals. A letter was sent to Mikhail Mishustin requesting measures, as reported by 'Kommersant.'""
}"
2025-07-31T13:59:58+00:00,@medpharm,12496,https://t.me/medpharm/12496,"–°–∏—Å—Ç–µ–º–∞ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–π –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏ –ë–ê–î –≤ –†–æ—Å—Å–∏–∏ –∑–∞ –ø–µ—Ä–≤–æ–µ –ø–æ–ª—É–≥–æ–¥–∏–µ 2025 –≥–æ–¥–∞ –∑–∞–±–ª–æ–∫–∏—Ä–æ–≤–∞–ª–∞ 12,3 –º–ª–Ω –ø–æ–ø—ã—Ç–æ–∫ –ø—Ä–æ–¥–∞–∂–∏ –ø—Ä–æ–¥—É–∫—Ü–∏–∏ —Å –Ω–∞—Ä—É—à–µ–Ω–∏—è–º–∏. –û–± —ç—Ç–æ–º –≥–æ–≤–æ—Ä–∏—Ç—Å—è –≤ –æ—Ç—á–µ—Ç–µ –†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä–∞. –°—Ä–µ–¥–∏ –Ω–∏—Ö ‚Äî –ø–æ—á—Ç–∏ 5 –º–ª–Ω –∫–æ–Ω—Ç—Ä–∞—Ñ–∞–∫—Ç–Ω—ã—Ö —É–ø–∞–∫–æ–≤–æ–∫ –∏ 2,8 –º–ª–Ω –µ–¥–∏–Ω–∏—Ü, –Ω–µ –∑–∞—è–≤–ª–µ–Ω–Ω—ã—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–º –≤ –æ–±–æ—Ä–æ—Ç. –û–¥–Ω–æ–≤—Ä–µ–º–µ–Ω–Ω–æ —Ñ–∏–∫—Å–∏—Ä—É–µ—Ç—Å—è —Ä–æ—Å—Ç –ª–µ–≥–∞–ª—å–Ω–æ–≥–æ —Ä—ã–Ω–∫–∞.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""The Russian system for mandatory product marking (–ë–ê–î) has blocked 12.3 million attempts to sell products with violations in the first half of 2025, according to a report from Rospatent. Among them are almost 5 million counterfeit packages and 2.8 million units not declared by the manufacturer in circulation. At the same time, there is a rise in the legal market.""
}"
2025-07-31T12:23:40+00:00,@medpharm,12495,https://t.me/medpharm/12495,#–≠–∫—Å–∫–ª—é–∑–∏–≤ –£ –º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ú–∏—Ö–∞–∏–ª–∞ –ú—É—Ä–∞—à–∫–æ –ø–æ—è–≤–∏–ª—Å—è –Ω–æ–≤—ã–π –ø–æ–º–æ—â–Ω–∏–∫. –î–æ–ª–∂–Ω–æ—Å—Ç—å –≤–º–µ—Å—Ç–æ –°–µ—Ä–≥–µ—è –ö–æ—Ä–æ—Ç–∫–æ–≤–∞ –∑–∞–π–º–µ—Ç –†–æ–º–∞–Ω –°–∞–º—É–Ω–µ–Ω–∫–æ–≤.,"{""skip"": true}"
2025-07-31T10:13:03+00:00,@medpharm,12494,https://t.me/medpharm/12494,"–û–±—â–µ—Å—Ç–≤–µ–Ω–Ω–∞—è –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è –æ–±–Ω–∞—Ä—É–∂–∏–ª–∞ –Ω–∞ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞—Ö –∫–∞—Ä—Ç–æ—á–∫–∏ —Ç–æ–≤–∞—Ä–æ–≤ —Å –Ω–µ–∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–º–∏ –≤ –†–æ—Å—Å–∏–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏ –∏ –º–µ–¥–∏–∑–¥–µ–ª–∏—è–º–∏: –≤—Ä–µ–º–µ–Ω–Ω—ã–µ –ø–ª–æ–º–±—ã –¥–ª—è –∑—É–±–æ–≤ –∏ –∫–∏—Ç–∞–π—Å–∫–∏–µ –±–∏–æ–¥–æ–±–∞–≤–∫–∏. –ú–∏—Ö–∞–∏–ª—É –ú–∏—à—É—Å—Ç–∏–Ω—É –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–æ –ø–∏—Å—å–º–æ —Å –ø—Ä–æ—Å—å–±–æ–π –ø—Ä–∏–Ω—è—Ç—å –º–µ—Ä—ã, –ø–∏—à–µ—Ç ¬´–ö–æ–º–º–µ—Ä—Å–∞–Ω—Ç—ä¬ª.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage"",
  ""impact"": ""high"",
  ""english"": ""A letter has been sent to Mikhail Mishustin requesting measures after an NGO discovered listings of unregistered medicines and medical devices on marketplaces, including temporary dental plasters and Chinese dietary supplements in Russia.""
}"
2025-07-31T09:10:55+00:00,@medpharm,12493,https://t.me/medpharm/12493,–ú–∏–Ω–∑–¥—Ä–∞–≤ —Å–æ–≥–ª–∞—Å–∏–ª—Å—è –æ—Ç—Å—Ä–æ—á–∏—Ç—å –≤—Å—Ç—É–ø–ª–µ–Ω–∏–µ –≤ —Å–∏–ª—É —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π –∫ –∫–æ–µ—á–Ω–æ–º—É —Ñ–æ–Ω–¥—É –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –æ—Ç–¥–µ–ª–µ–Ω–∏–π. –í–µ–¥–æ–º—Å—Ç–≤–æ –ø—Ä–∏—Å–ª—É—à–∞–ª–æ—Å—å –∫ –¥–æ–≤–æ–¥–∞–º —ç–∫—Å–ø–µ—Ä—Ç–æ–≤.,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health agreed to postpone the entry into force of requirements for oncology department beds. The authorities listened to experts' arguments.""
}"
2025-07-31T08:03:27+00:00,@medpharm,12492,https://t.me/medpharm/12492,"–î–µ–≤—è—Ç—ã–π –∞—Ä–±–∏—Ç—Ä–∞–∂–Ω—ã–π –∞–ø–µ–ª–ª—è—Ü–∏–æ–Ω–Ω—ã–π —Å—É–¥ –æ—Å—Ç–∞–≤–∏–ª –≤ —Å–∏–ª–µ —Ä–µ—à–µ–Ω–∏–µ –ê—Ä–±–∏—Ç—Ä–∞–∂–Ω–æ–≥–æ —Å—É–¥–∞ –ú–æ—Å–∫–≤—ã –ø–æ –¥–µ–ª—É –§–ê–° –ø—Ä–æ—Ç–∏–≤ KRKA, —Ç–µ–º —Å–∞–º—ã–º –ø—Ä–∏–∑–Ω–∞–≤ –ø—Ä–∞–≤–æ—Ç—É –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å–Ω–æ–≥–æ –æ—Ä–≥–∞–Ω–∞. –ñ–∞–ª–æ–±–∞ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –æ—Å—Ç–∞–≤–ª–µ–Ω–∞ –±–µ–∑ —É–¥–æ–≤–ª–µ—Ç–≤–æ—Ä–µ–Ω–∏—è.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions"",
  ""impact"": ""high"",
  ""english"": ""The Ninth Arbitration Appeal Court upheld the decision of Moscow Arbitration Court in a case against FAS and KRKA, upholding the antimonopoly authority's right. The pharmaceutical company's appeal was dismissed.""
}"
2025-07-31T07:09:09+00:00,@medpharm,12491,https://t.me/medpharm/12491,"¬´–ú–í¬ª —Å–æ–±—Ä–∞–ª –≤–∞–∂–Ω—ã–µ –¥–ª—è –ø–µ–¥–∏–∞—Ç—Ä–æ–≤ –ø—É–±–ª–∏–∫–∞—Ü–∏–∏, –∫–æ—Ç–æ—Ä—ã–µ –≤—ã—à–ª–∏ –ª–µ—Ç–æ–º 2025 –≥–æ–¥–∞. –û–±–∑–æ—Ä –±—ã–ª –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω –≤–æ –≤—Ç–æ—Ä–æ–º –≤—ã–ø—É—Å–∫–µ –≥–∞–∑–µ—Ç—ã ¬´–ú–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–π –≤–µ—Å—Ç–Ω–∏–∫¬ª. –í —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–µ —Ä–µ–≤–º–∞—Ç–æ–ª–æ–≥–∏ –≤–ø–µ—Ä–≤—ã–µ –æ–ø–∏—Å–∞–ª–∏ –∫—Ä–∏—Ç–µ—Ä–∏–∏ —é–≤–µ–Ω–∏–ª—å–Ω–æ–≥–æ –∞–∫—Å–∏–∞–ª—å–Ω–æ–≥–æ —Å–ø–æ–Ω–¥–∏–ª–æ–∞—Ä—Ç—Ä–∏—Ç–∞, –∞ —ç–∫—Å–ø–µ—Ä—Ç—ã –ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–π –∞–∫–∞–¥–µ–º–∏–∏ –ø–µ–¥–∏–∞—Ç—Ä–∏–∏ (AAP) –æ–±–Ω–æ–≤–∏–ª–∏ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø–æ –∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä–æ–≤–∞–Ω–∏—é –ø–æ–¥—Ä–æ—Å—Ç–∫–æ–≤ –∏ –º–æ–ª–æ–¥—ã—Ö –ª—é–¥–µ–π –ø–æ –≤–æ–ø—Ä–æ—Å–∞–º –∫–æ–Ω—Ç—Ä–∞—Ü–µ–ø—Ü–∏–∏.","{""skip"": true}"
2025-07-30T15:34:16+00:00,@medpharm,12490,https://t.me/medpharm/12490,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 30 –∏—é–ª—è –ü–æ—à–ª–∏ –≤ –æ—Ç–∫–∞–∑ –ö–æ–º–ø–∞–Ω–∏–∏ Incyte Holdings Corporation –∏ Novartis Pharma AG –æ—Ç–∫–∞–∑–∞–ª–∏—Å—å –æ—Ç –∏—Å–∫–æ–≤—ã—Ö —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π –∫ –ê–û ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑-–ù–æ—Ä–¥¬ª –∏ –ú–∏–Ω–∑–¥—Ä–∞–≤—É –†–æ—Å—Å–∏–∏. –ò–∑–Ω–∞—á–∞–ª—å–Ω–æ –æ–Ω–∏ —É–∫–∞–∑—ã–≤–∞–ª–∏ –Ω–∞ –Ω–∞—Ä—É—à–µ–Ω–∏—è –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç—É–∞–ª—å–Ω—ã—Ö –ø—Ä–∞–≤ –∏ —Ç—Ä–µ–±–æ–≤–∞–ª–∏ –æ—Ç–º–µ–Ω–∏—Ç—å —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—é –∏ –∏—Å–∫–ª—é—á–∏—Ç—å –∏–∑ –ì–†–õ–° ¬´–†—É–∫—Å–æ–ª–∏—Ç–∏–Ω–∏–± –§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑¬ª, –∞ —Ç–∞–∫–∂–µ —É–Ω–∏—á—Ç–æ–∂–∏—Ç—å –≤—Å–µ –ø—Ä–æ–∏–∑–≤–µ–¥–µ–Ω–Ω—ã–µ –ø–∞—Ä—Ç–∏–∏. –°–æ–∫—Ä–∞—Ç—è—Ç –ø—Ä–æ–≤–µ—Ä–∫–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤ —Å–æ–±–∏—Ä–∞–µ—Ç—Å—è –≤–Ω–µ—Å—Ç–∏ –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ —Å–∏—Å—Ç–µ–º—É –≥–æ—Å–∫–æ–Ω—Ç—Ä–æ–ª—è –∑–∞ –æ–±—Ä–∞—â–µ–Ω–∏–µ–º –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤. –î–ª—è –æ–±—ä–µ–∫—Ç–æ–≤ –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ–≥–æ, —Å—Ä–µ–¥–Ω–µ–≥–æ, —É–º–µ—Ä–µ–Ω–Ω–æ–≥–æ –∏ –Ω–∏–∑–∫–æ–≥–æ —Ä–∏—Å–∫–∞ –ø–ª–∞–Ω–æ–≤—ã–µ –ø—Ä–æ–≤–µ—Ä–∫–∏ –º–æ–≥—É—Ç —Å–æ–≤—Å–µ–º –æ—Ç–º–µ–Ω–∏—Ç—å, –∑–∞–º–µ–Ω–∏–≤ –Ω–∞ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–∏–µ –≤–∏–∑–∏—Ç—ã. –ë–µ–∑ –ø–æ—â–∞–¥—ã –ü—Ä–∏—Å—è–∂–Ω—ã–µ –ø—Ä–∏–∑–Ω–∞–ª–∏ –∫–∞–ª–∏–Ω–∏–Ω–≥—Ä–∞–¥—Å–∫–∏—Ö –≤—Ä–∞—á–µ–π –°—É—à–∫–µ–≤–∏—á –∏ –ë–µ–ª—É—é –≤–∏–Ω–æ–≤–Ω—ã–º–∏ –≤ —É–±–∏–π—Å—Ç–≤–µ –Ω–µ–¥–æ–Ω–æ—à–µ–Ω–Ω–æ–≥–æ –º–ª–∞–¥–µ–Ω—Ü–∞ –∏ –Ω–µ–¥–æ—Å—Ç–æ–π–Ω—ã–º–∏ —Å–Ω–∏—Å—Ö–æ–∂–¥–µ–Ω–∏—è. –†–µ—à–µ–Ω–∏–µ –ø—Ä–∏–Ω—è—Ç–æ –µ–¥–∏–Ω–æ–≥–ª–∞—Å–Ω–æ. –ù–∞–ø—Ä–∞—Å–Ω—ã–µ —Å—Ç–∞—Ä–∞–Ω–∏—è –≠–∫—Å–ø–µ—Ä—Ç—ã –ø–æ—Å—Ç–∞–≤–∏–ª–∏ –ø–æ–¥ —Å–æ–º–Ω–µ–Ω–∏–µ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–∏–µ –æ –∑–∞—â–∏—Ç–Ω–æ–π —Ä–æ–ª–∏ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è –ø—Ä–æ—Ç–∏–≤ —Å—Ç–∞—Ä–µ–Ω–∏—è –º–æ–∑–≥–∞.","{""skip"": true}"
2025-07-30T14:34:28+00:00,@medpharm,12489,https://t.me/medpharm/12489,"–î–∏—Å—Ç–∞–Ω—Ü–∏–æ–Ω–Ω—ã–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ —É—Å–ª—É–≥–∏ —á–µ—Ä–µ–∑ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏–µ –ú–õ–ö –æ—Ç ¬´–°–ø–∞—Ä–≥–æ –¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏¬ª –ø–æ–º–æ–≥–ª–∏ —Å–æ–∫—Ä–∞—Ç–∏—Ç—å –æ—á–Ω—ã–µ –≤–∏–∑–∏—Ç—ã –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –ú–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –¥–ª—è —Ä–µ—à–µ–Ω–∏—è –ø–æ–≤—Å–µ–¥–Ω–µ–≤–Ω—ã—Ö –∑–∞–¥–∞—á –∏—Å–ø–æ–ª—å–∑—É—é—Ç –ø—Ä–∏–ª–æ–∂–µ–Ω–∏–µ –¥–ª—è –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏—è –ø–∞—Ü–∏–µ–Ω—Ç–∞ –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ ¬´–ú–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–π –ª–∏—á–Ω—ã–π –∫–∞–±–∏–Ω–µ—Ç¬ª (–ú–õ–ö) –æ—Ç ¬´–°–ø–∞—Ä–≥–æ –¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏¬ª. –°—É–º–º–∞—Ä–Ω–æ–µ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª–µ–π –ú–õ–ö –ø—Ä–µ–≤—ã—à–∞–µ—Ç 150 000 —Ç—ã—Å—è—á –∏ –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç —Ä–∞—Å—Ç–∏. –ù–∞ –∏—é–ª—å 2025 –≥–æ–¥–∞ –≤ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏–∏ —Ä–∞–∑–º–µ—â–µ–Ω–æ –±–æ–ª–µ–µ 2,2 –º–ª–Ω –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤, —Ä–µ–∞–ª–∏–∑–æ–≤–∞–Ω–æ —Å–≤—ã—à–µ 249 —Ç—ã—Å—è—á –∑–∞–ø–∏—Å–µ–π –∫ –≤—Ä–∞—á—É, –∞ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –∑–∞–ø—Ä–æ—Å–æ–≤ –Ω–∞ –≤—ã–¥–∞—á—É —Å–ø—Ä–∞–≤–æ–∫ –ø—Ä–µ–≤—ã—Å–∏–ª–æ 4 —Ç—ã—Å—è—á–∏. üåê –£–∑–Ω–∞–π—Ç–µ —Å—Ä–æ–∫–∏ –≤–Ω–µ–¥—Ä–µ–Ω–∏—è –∏ –ø—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–∞ –Ω–∞ —Å–∞–π—Ç–µ —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–∞ –†–µ–∫–ª–∞–º–∞ –ê–û ""–°–ø–∞—Ä–≥–æ –¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏""","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, hospital_policy, guideline, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""The 'Medicine Personal Cabinet' (MLC) app from Spargo Technologies helps reduce in-person visits for patients. With over 150,000 users and growing, the app has processed more than 220,000 medical records and over 249,000 doctor appointments. Spargo Technologies is advertising the rollout timelines and benefits on their website.""
}"
2025-07-30T14:02:06+00:00,@medpharm,12488,https://t.me/medpharm/12488,"–ú–∏–Ω–∑–¥—Ä–∞–≤ —Å–æ–±–∏—Ä–∞–µ—Ç—Å—è –≤–Ω–µ—Å—Ç–∏ –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ —Å–∏—Å—Ç–µ–º—É –≥–æ—Å–∫–æ–Ω—Ç—Ä–æ–ª—è –∑–∞ –æ–±—Ä–∞—â–µ–Ω–∏–µ–º –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤. –î–ª—è –æ–±—ä–µ–∫—Ç–æ–≤ –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ–≥–æ, —Å—Ä–µ–¥–Ω–µ–≥–æ, —É–º–µ—Ä–µ–Ω–Ω–æ–≥–æ –∏ –Ω–∏–∑–∫–æ–≥–æ —Ä–∏—Å–∫–∞ –ø–ª–∞–Ω–æ–≤—ã–µ –ø—Ä–æ–≤–µ—Ä–∫–∏ –º–æ–≥—É—Ç —Å–æ–≤—Å–µ–º –æ—Ç–º–µ–Ω–∏—Ç—å. –í–º–µ—Å—Ç–æ –Ω–∏—Ö –ø—Ä–µ–¥–ø–æ–ª–∞–≥–∞–µ—Ç—Å—è –ø—Ä–æ–≤–æ–¥–∏—Ç—å —Å —Ä–∞–∑–Ω–æ–π –ø–µ—Ä–∏–æ–¥–∏—á–Ω–æ—Å—Ç—å—é –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–µ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–∏–µ –≤–∏–∑–∏—Ç—ã. –û—Å—É—â–µ—Å—Ç–≤–ª—è—Ç—å –ø—Ä–æ–≤–µ—Ä–∫–∏ –±—É–¥—É—Ç —Å –ø–æ–º–æ—â—å—é –º–æ–±–∏–ª—å–Ω–æ–≥–æ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏—è ¬´–ò–Ω—Å–ø–µ–∫—Ç–æ—Ä¬ª –∏–ª–∏ –≤–∏–¥–µ–æ–∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü-—Å–≤—è–∑–∏.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing, import_export, sanctions"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health plans to make changes in the system for monitoring the circulation of medicines. Routine inspections for objects with significant, medium, moderate, and low risk may be canceled in favor of more frequent preventive visits. Inspections will be conducted using the mobile application 'Inspector' or video conferencing.""
}"
2025-07-30T13:00:50+00:00,@medpharm,12487,https://t.me/medpharm/12487,"#–≠–∫—Å–∫–ª—é–∑–∏–≤ –í—Å–µ–º–∏—Ä–Ω–∞—è –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –Ω–∞–∑—ã–≤–∞–µ—Ç –æ–¥–∏–Ω–æ—á–µ—Å—Ç–≤–æ –∏ –∏–∑–æ–ª—è—Ü–∏—é —Å–∫—Ä—ã—Ç–æ–π —É–≥—Ä–æ–∑–æ–π –∑–¥–æ—Ä–æ–≤—å—é –Ω–∞—Å–µ–ª–µ–Ω–∏—è –ø–ª–∞–Ω–µ—Ç—ã, –∫–æ—Ç–æ—Ä—É—é –±–æ–ª—å—à–µ –Ω–µ–ª—å–∑—è –∏–≥–Ω–æ—Ä–∏—Ä–æ–≤–∞—Ç—å. –° –∑–∞—è–≤–ª–µ–Ω–∏–µ–º –≤—ã—Å—Ç—É–ø–∏–ª–∏ –≥–ª–∞–≤–∞ –í–û–ó –∏ —Å–æ–ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª–∏ –ö–æ–º–∏—Å—Å–∏–∏ –ø–æ —Å–æ—Ü–∏–∞–ª—å–Ω–æ–π —Å–≤—è–∑–∏.","{""skip"": true}"
2025-07-30T11:00:10+00:00,@medpharm,12486,https://t.me/medpharm/12486,"#–≠–∫—Å–∫–ª—é–∑–∏–≤ –í –≥—Ä—É–ø–ø–µ –∫–æ–º–ø–∞–Ω–∏–π ¬´–ï–≤—Ä–æ–æ–Ω–∫–æ¬ª –Ω–∞–∑–Ω–∞—á–µ–Ω –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å –≥–µ–Ω–µ—Ä–∞–ª—å–Ω–æ–≥–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –ø–æ –æ–ø–µ—Ä–∞—Ü–∏–æ–Ω–Ω–æ–π –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏. –ò–º —Å—Ç–∞–ª –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ö–∞–Ω–µ–≤—Å–∫–∏–π, –≤ —Ä–∞–∑–Ω–æ–µ –≤—Ä–µ–º—è –≤–æ–∑–≥–ª–∞–≤–ª—è–≤—à–∏–π —Å–µ—Ç—å –∫–ª–∏–Ω–∏–∫ Medical On Group, –ê–û ¬´–ú–µ–¥—Å–∫–∞–Ω¬ª –∏ –≥–æ—Å–ø–∏—Ç–∞–ª—å Hadassah.","{""skip"": true}"
2025-07-30T09:17:40+00:00,@medpharm,12484,https://t.me/medpharm/12484,–ó–µ–º–ª–µ—Ç—Ä—è—Å–µ–Ω–∏–µ –Ω–∞ –ö–∞–º—á–∞—Ç–∫–µ –∑–∞—Å—Ç–∞–ª–æ —Ö–∏—Ä—É—Ä–≥–æ–≤ –æ–Ω–∫–æ–¥–∏—Å–ø–∞–Ω—Å–µ—Ä–∞ –≤ –ø—Ä–æ—Ü–µ—Å—Å–µ –æ–ø–µ—Ä–∞—Ü–∏–∏ ‚Äî –æ–Ω–∏ —Å–æ—Ö—Ä–∞–Ω–∏–ª–∏ —Å–ø–æ–∫–æ–π—Å—Ç–≤–∏–µ –∏ –¥–æ –∫–æ–Ω—Ü–∞ –æ—Å—Ç–∞–≤–∞–ª–∏—Å—å —Å –ø–∞—Ü–∏–µ–Ω—Ç–æ–º. –ò—Ö –ø—Ä–µ–¥—Å—Ç–∞–≤—è—Ç –∫ –≥–æ—Å–Ω–∞–≥—Ä–∞–¥–∞–º.,"{""skip"": true}"
2025-07-30T08:16:06+00:00,@medpharm,12483,https://t.me/medpharm/12483,"–ê—Ä–±–∏—Ç–∞–∂–Ω—ã–π —Å—É–¥ –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥–∞ –∏ –õ–µ–Ω–∏–Ω–≥—Ä–∞–¥—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –ø—Ä–∏–Ω—è–ª –æ—Ç–∫–∞–∑ –∫–æ–º–ø–∞–Ω–∏–π Incyte Holdings Corporation –∏ Novartis Pharma AG –æ—Ç –∏—Å–∫–∞ –∫ –ê–û ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑-–ù–æ—Ä–¥¬ª –∏ –ú–∏–Ω–∑–¥—Ä–∞–≤—É –†–æ—Å—Å–∏–∏. –ò–∑–Ω–∞—á–∞–ª—å–Ω–æ –∏—Å—Ç—Ü—ã —É–∫–∞–∑—ã–≤–∞–ª–∏ –Ω–∞ –Ω–∞—Ä—É—à–µ–Ω–∏—è –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç—É–∞–ª—å–Ω—ã—Ö –ø—Ä–∞–≤ –∏ —Ç—Ä–µ–±–æ–≤–∞–ª–∏ –æ—Ç–º–µ–Ω–∏—Ç—å —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—é –∏ –∏—Å–∫–ª—é—á–∏—Ç—å –∏–∑ –ì–†–õ–° ¬´–†—É–∫—Å–æ–ª–∏—Ç–∏–Ω–∏–± –§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑¬ª, –∞ —Ç–∞–∫–∂–µ —É–Ω–∏—á—Ç–æ–∂–∏—Ç—å –≤—Å–µ –ø—Ä–æ–∏–∑–≤–µ–¥–µ–Ω–Ω—ã–µ –ø–∞—Ä—Ç–∏–∏.","{
  ""skip"": true
}"
2025-07-30T07:00:14+00:00,@medpharm,12482,https://t.me/medpharm/12482,"–ö–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –Ω–µ –±—É–¥—É—Ç –≤—ã—Å—Ç—É–ø–∞—Ç—å –ø—Ä–µ–¥–º–µ—Ç–æ–º —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∫–æ–Ω—Ç—Ä–æ–ª—è (–Ω–∞–¥–∑–æ—Ä–∞) –∫–∞—á–µ—Å—Ç–≤–∞ –∏ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏. –ù–æ –Ω–∞ –∏—Ö –æ—Å–Ω–æ–≤–µ –±—É–¥—É—Ç —Å—Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω—ã –∫—Ä–∏—Ç–µ—Ä–∏–∏, –∫–æ—Ç–æ—Ä—ã–µ —Å—Ç–∞–Ω—É—Ç –ø—Ä–∏–º–µ–Ω—è—Ç—å—Å—è —Å—Ç—Ä–∞—Ö–æ–≤—â–∏–∫–∞–º–∏ –ø—Ä–∏ —ç–∫—Å–ø–µ—Ä—Ç–∏–∑–µ –∫–∞—á–µ—Å—Ç–≤–∞ –æ–∫–∞–∑–∞–Ω–Ω–æ–π –º–µ–¥–ø–æ–º–æ—â–∏.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,hospital_policy,pharmacovigilance,safety"",
  ""impact"": ""medium"",
  ""english"": ""Clinical guidelines will not be subject to federal state control (supervision) of medical activities. However, criteria based on these guidelines will be used by insurers in the assessment of quality of provided medical care.""
}"
2025-07-29T16:31:05+00:00,@medpharm,12481,https://t.me/medpharm/12481,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 29 –∏—é–ª—è –í–æ–ª—å–Ω—ã–º –≤–æ–ª—è –û –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ –ø–æ–∑–≤–æ–ª–∏—Ç—å –≤—Ä–∞—á–∞–º –≤–µ—Å—Ç–∏ —á–∞—Å—Ç–Ω—É—é –ø—Ä–∞–∫—Ç–∏–∫—É –∑–∞—è–≤–∏–ª–∏ 70% –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤. –ú–Ω–æ–≥–∏–µ —Å—á–∏—Ç–∞—é—Ç, —á—Ç–æ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –±–æ–ª—å—à–µ –∑–∞—Ä–∞–±–∞—Ç—ã–≤–∞—Ç—å –∏ –Ω–µ –∑–∞–≤–∏—Å–µ—Ç—å –æ—Ç —Å–∞–º–æ–¥—É—Ä—Å—Ç–≤–∞ —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–∞ —Ä–µ—à–∏—Ç –ø—Ä–æ–±–ª–µ–º—É –¥–µ—Ñ–∏—Ü–∏—Ç–∞ –∫–∞–¥—Ä–æ–≤. –ß—É–∂–∞—è –±–æ–ª—å –¢–µ—Ä–∞–ø–∏—é –ø–æ –û–ú–° –Ω–µ –ø–æ–ª—É—á–∞—é—Ç 90% –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –º–∏–≥—Ä–µ–Ω—å—é. –ù–æ –∏ –ø—Ä–∏ –ø–ª–∞—Ç–Ω–æ–º –ª–µ—á–µ–Ω–∏–∏ –±–æ–ª—å—à–µ –ø–æ–ª–æ–≤–∏–Ω—ã –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å—Ç–∞–ª–∫–∏–≤–∞—é—Ç—Å—è —Å –æ—à–∏–±–æ—á–Ω—ã–º–∏ –¥–∏–∞–≥–Ω–æ–∑–∞–º–∏. ¬´–û—Å–Ω–æ–≤–∞–Ω–∏–π –¥–ª—è –ø–∞–Ω–∏–∫–∏ –Ω–µ—Ç¬ª –ü–∞–ª–∞—Ç–∞ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–µ–π –°–®–ê –≤–Ω–µ—Å–ª–∞ –Ω–∞ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏–µ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç, –∫–æ—Ç–æ—Ä—ã–º –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è –∑–∞–ø—Ä–µ—Ç–∏—Ç—å —ç–∫—Å–ø–æ—Ä—Ç –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –ø—Ä–æ—Ç–µ–∑–æ–≤ –≤ –†–æ—Å—Å–∏–π—Å–∫—É—é –§–µ–¥–µ—Ä–∞—Ü–∏—é. –ü–æ–ª–Ω—ã–π —Ç–µ–∫—Å—Ç –¥–æ–∫—É–º–µ–Ω—Ç–∞ –ø–æ–∫–∞ –Ω–µ–¥–æ—Å—Ç—É–ø–µ–Ω. –î–∞–ª–∏ —Å–±–æ–π –ë—Ä–æ–Ω–∏—Ä–æ–≤–∞–Ω–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤ –Ω–∞ —Å–∞–π—Ç–∞—Ö –∞–ø—Ç–µ—á–Ω—ã—Ö —Å–µ—Ç–µ–π ¬´–°—Ç–æ–ª–∏—á–∫–∏¬ª –∏ ¬´–ù–µ–æ—Ñ–∞—Ä–º¬ª –Ω–µ–¥–æ—Å—Ç—É–ø–Ω–æ, –Ω–µ–∫–æ—Ç–æ—Ä—ã–µ —Ç–æ—á–∫–∏ –∞–ø—Ç–µ–∫ –≤ –ú–æ—Å–∫–≤–µ, –ü–æ–¥–º–æ—Å–∫–æ–≤—å–µ –∏ –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥–µ –∑–∞–∫—Ä—ã—Ç—ã, —É–±–µ–¥–∏–ª—Å—è ¬´–§–í¬ª. –í –∫–æ–º–ø–∞–Ω–∏–∏ —Å–∏—Ç—É–∞—Ü–∏—é –Ω–µ –∫–æ–º–º–µ–Ω—Ç–∏—Ä—É—é—Ç, –°–ú–ò –ø–∏—à—É—Ç –æ –≤–æ–∑–º–æ–∂–Ω–æ–π –∞—Ç–∞–∫–µ –Ω–∞ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω—ã–µ —Å–∏—Å—Ç–µ–º—ã.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, demand, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""There is a shortage of medical personnel, with 70% of surveyed healthcare workers supporting the idea of allowing doctors to practice privately. Many believe this will solve the problem of a shortage of medical staff by increasing earnings and reducing dependence on management. Only 90% of patients with migraines receive treatment under the state insurance program (–û–ú–°). Even when treated privately, more than half of patients face incorrect diagnoses. The US House of Representatives has introduced a bill to prohibit the export of pharmaceuticals and prosthetics to Russia. The full text of the document is currently unavailable. There are issues with online pharmacy bookings on websites like 'Stolikki' and 'Neofarma', with some Moscow, suburban, and St. Petersburg pharmacies experiencing system failures.""
}"
2025-07-29T14:32:32+00:00,@medpharm,12479,https://t.me/medpharm/12479,"–í —Ä–∞–±–æ—Ç–µ –∞–ø—Ç–µ—á–Ω—ã—Ö —Å–µ—Ç–µ–π ¬´–°—Ç–æ–ª–∏—á–∫–∏¬ª –∏ ¬´–ù–µ–æ—Ñ–∞—Ä–º¬ª –Ω–∞–±–ª—é–¥–∞—é—Ç—Å—è —Å–±–æ–∏. –ë—Ä–æ–Ω–∏—Ä–æ–≤–∞–Ω–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤ –Ω–∞ —Å–∞–π—Ç–∞—Ö –Ω–µ–¥–æ—Å—Ç—É–ø–Ω–æ, –Ω–µ–∫–æ—Ç–æ—Ä—ã–µ —Ç–æ—á–∫–∏ –∞–ø—Ç–µ–∫ –≤ –ú–æ—Å–∫–≤–µ –∏ –ü–æ–¥–º–æ—Å–∫–æ–≤—å–µ –∑–∞–∫—Ä—ã—Ç—ã, —É–±–µ–¥–∏–ª—Å—è ¬´–§–í¬ª. –í –∫–æ–º–ø–∞–Ω–∏–∏ —Å–∏—Ç—É–∞—Ü–∏—é –Ω–µ –∫–æ–º–º–µ–Ω—Ç–∏—Ä—É—é—Ç, –°–ú–ò –ø–∏—à—É—Ç –æ –≤–æ–∑–º–æ–∂–Ω–æ–π –∞—Ç–∞–∫–µ –Ω–∞ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω—ã–µ —Å–∏—Å—Ç–µ–º—ã.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety, pharmacovigilance"",
  ""impact"": ""high"",
  ""english"": ""There are system failures in the pharmacies 'Stolikki' and 'Neofarm'. Booking of medicines on websites is unavailable, some Moscow and suburban pharmacies are closed. 'FV' confirms this situation without commenting on it. The media report about possible cyber-attack on information systems.""
}"
2025-07-29T13:43:34+00:00,@medpharm,12478,https://t.me/medpharm/12478,"–ü—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º –≤–∞–º —Å–ª–µ–¥—É—é—â–µ–≥–æ —Å–ø–∏–∫–µ—Ä–∞ PRO–µ–∫—Ü–∏–π –ë—É–¥—É—â–µ–≥–æ: üîπ–õ–∞—Ä–∏—Å–∞ –ú–∞—Ç–≤–µ–µ–≤–∞, –∏—Å–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–π –¥–∏—Ä–µ–∫—Ç–æ—Ä –ê—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã—Ö —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π, —Å–ø–∏–∫–µ—Ä –ø–ª–µ–Ω–∞—Ä–Ω–æ–π —Å–µ—Å—Å–∏–∏ ¬´–¶–∏—Ñ—Ä—ã. –§–∞–∫—Ç—ã. –¢—Ä–µ–Ω–¥—ã. –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∞—è –æ—Ç—Ä–∞—Å–ª—å –Ω–∞ –≥—Ä–∞–Ω–∏ –±—É–¥—É—â–µ–≥–æ¬ª. –ù–∞ ¬´PRO–µ–∫—Ü–∏—è—Ö –±—É–¥—É—â–µ–≥–æ¬ª –æ–±—Å—É–¥–∏–º, –∫–∞–∫ —Ü–∏—Ñ—Ä–æ–≤–∞—è —Ç—Ä–∞–Ω—Å—Ñ–æ—Ä–º–∞—Ü–∏—è –∏ –≤–Ω–µ–¥—Ä–µ–Ω–∏–µ –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–∞ —Å—Ç–∞–Ω–æ–≤—è—Ç—Å—è –∫–∞—Ç–∞–ª–∏–∑–∞—Ç–æ—Ä–∞–º–∏ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π —Ä–µ–≤–æ–ª—é—Ü–∏–∏ –≤ —Ñ–∞—Ä–º–µ, –∞ —Ç–∞–∫–∂–µ —Å—Ç—Ä–∞—Ç–µ–≥–∏—é –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏—è –Ω–∞—É–∫–∏, –±–∏–∑–Ω–µ—Å–∞ –∏ –≤–ª–∞—Å—Ç–∏. –î–∏—Å–∫—É—Å—Å–∏—è –±—É–¥–µ—Ç –∏–Ω—Ç–µ—Ä–µ—Å–Ω–æ–π ‚Äì –≤ –ø–∞–Ω–µ–ª–∏ —Å–æ–±–µ—Ä—É—Ç—Å—è –∞–≤—Ç–æ—Ä–∏—Ç–µ—Ç–Ω—ã–µ —ç–∫—Å–ø–µ—Ä—Ç—ã –æ—Ç—Ä–∞—Å–ª–∏ –∏ –≤–¥–æ—Ö–Ω–æ–≤–ª—è—é—â–∏–µ –ø—Ä–∞–∫—Ç–∏–∫–∏, –∫–æ—Ç–æ—Ä—ã–µ –Ω–µ –±–æ—è—Ç—Å—è –±—ã—Ç—å —á–∞—Å—Ç—å—é –∏–∑–º–µ–Ω–µ–Ω–∏–π, –≤–µ–¥—å –±—É–¥—É—â–µ–µ —Å–æ–∑–¥–∞–µ—Ç—Å—è —Ç–µ–º–∏, –∫—Ç–æ –≥–æ—Ç–æ–≤ –ø—Ä–∏–Ω—è—Ç—å –≤—ã–∑–æ–≤—ã –≤—Ä–µ–º–µ–Ω–∏ –∏ —É–≤–µ—Ä–µ–Ω–Ω–æ –¥–≤–∏–≥–∞—Ç—å—Å—è –≤–ø–µ—Ä–µ–¥ –Ω–∞–≤—Å—Ç—Ä–µ—á—É –Ω–æ–≤—ã–º –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—è–º. –î–∞—Ç–∞ –∏ –≤—Ä–µ–º—è —Å–µ—Å—Å–∏–∏: 11 —Å–µ–Ω—Ç—è–±—Ä—è 2025, 09:30 üìç–≥. –°–æ—á–∏, Pullman –°–æ—á–∏ –¶–µ–Ω—Ç—Ä 5* –ü–æ–¥—Ä–æ–±–Ω–µ–µ –æ –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ –∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –Ω–∞ —Å–∞–π—Ç–µ","{""skip"": true}"
2025-07-29T13:05:48+00:00,@medpharm,12477,https://t.me/medpharm/12477,#–≠–∫—Å–∫–ª—é–∑–∏–≤ –ù–æ–≤—ã–º —Ä–µ–∫—Ç–æ—Ä–æ–º –†–æ—Å—Å–∏–π—Å–∫–æ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –∞–∫–∞–¥–µ–º–∏–∏ –Ω–µ–ø—Ä–µ—Ä—ã–≤–Ω–æ–≥–æ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è –Ω–∞–∑–Ω–∞—á–µ–Ω –∞–∫–∞–¥–µ–º–∏–∫ –í–∏–∫—Ç–æ—Ä –§–æ–º–∏–Ω. –ü—Ä–∏—á–∏–Ω—ã –æ—Ç—Å—Ç–∞–≤–∫–∏ –î–º–∏—Ç—Ä–∏—è –°—ã—á–µ–≤–∞ –Ω–µ –Ω–∞–∑—ã–≤–∞—é—Ç—Å—è.,"{""skip"": true}"
2025-07-29T12:06:57+00:00,@medpharm,12476,https://t.me/medpharm/12476,–ö–∞–∫ –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫—É —Å–æ–æ–±—â–∏—Ç—å –æ —Å–º–µ—Ä—Ç–∏ –ø–∞—Ü–∏–µ–Ω—Ç–∞ –µ–≥–æ —Ä–æ–¥–Ω—ã–º ¬´–ö–∞–∫–æ–≤ –ø–æ—Ä—è–¥–æ–∫ —É–≤–µ–¥–æ–º–ª–µ–Ω–∏—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º–∏ —Ä–∞–±–æ—Ç–Ω–∏–∫–∞–º–∏ —Ä–æ–¥—Å—Ç–≤–µ–Ω–Ω–∏–∫–æ–≤ –ø–∞—Ü–∏–µ–Ω—Ç–∞ –æ –µ–≥–æ —Å–º–µ—Ä—Ç–∏ –≤ –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏? –ö–∞–∫–∏–º–∏ –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω—ã–º–∏ –ø—Ä–∞–≤–æ–≤—ã–º–∏ –∞–∫—Ç–∞–º–∏ —ç—Ç–æ —Ä–µ–≥–ª–∞–º–µ–Ω—Ç–∏—Ä—É–µ—Ç—Å—è? –ö–∞–∫ —ç—Ç–æ —Å–ª–µ–¥—É–µ—Ç —Å–¥–µ–ª–∞—Ç—å –≤ –Ω–æ—á–Ω–æ–µ –≤—Ä–µ–º—è? –û—Ç–Ω–æ—Å–∏—Ç—Å—è –ª–∏ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è –æ —Å–º–µ—Ä—Ç–∏ –ø–∞—Ü–∏–µ–Ω—Ç–∞ –∫ –≤—Ä–∞—á–µ–±–Ω–æ–π —Ç–∞–π–Ω–µ?¬ª.,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety, guideline"",
  ""impact"": ""medium"",
  ""english"": ""How do medical workers notify relatives of a patient's death in a healthcare organization? Which regulatory legal acts govern this? How should it be done during nighttime hours? Does information about a patient's death fall under medical confidentiality?""
}"
2025-07-29T11:33:18+00:00,@medpharm,12475,https://t.me/medpharm/12475,–ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ –ø—Ä–µ–¥–ª–æ–∂–∏–ª –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω—ã–π –∫–æ–Ω—Ç—É—Ä —Å–∏—Å—Ç–µ–º –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥–∞ –¥–≤–∏–∂–µ–Ω–∏—è —Ç–æ–≤–∞—Ä–æ–≤ –∏ –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤. –î–æ–∫—É–º–µ–Ω—Ç–æ–º –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è —É—Å—Ç–∞–Ω–æ–≤–∏—Ç—å –æ–±–º–µ–Ω –¥–∞–Ω–Ω—ã–º–∏ –º–µ–∂–¥—É –¥–≤—É–º—è —Å–∏—Å—Ç–µ–º–∞–º–∏ –∏ –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–∞—Ç—å –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –ï–ê–≠–° –ø–æ –ø–æ–ª–Ω–æ–º—É —Ü–∏–∫–ª—É.,"{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Industry and Trade proposed changes to the information system for monitoring goods movement and drug marking. The document suggests establishing data exchange between two systems and confirming the production of drugs throughout the Eurasian Economic Area.""
}"
2025-07-29T10:21:40+00:00,@medpharm,12474,https://t.me/medpharm/12474,–ü—Ä–µ–¥–ª–æ–∂–µ–Ω –Ω–æ–≤—ã–π –∞–ª–≥–æ—Ä–∏—Ç–º —ç—Ö–æ–ö–ì –æ—Ü–µ–Ω–∫–∏ –¥–∞–≤–ª–µ–Ω–∏—è –Ω–∞–ø–æ–ª–Ω–µ–Ω–∏—è –ª–µ–≤–æ–≥–æ –∂–µ–ª—É–¥–æ—á–∫–∞. –û–Ω –ø–æ–∫–∞–∑–∞–ª –≤—ã—Å–æ–∫—É—é —Ç–æ—á–Ω–æ—Å—Ç—å –∏ —Å—É—â–µ—Å—Ç–≤–µ–Ω–Ω–æ —É–º–µ–Ω—å—à–∏–ª –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –Ω–µ–æ–ø—Ä–µ–¥–µ–ª–µ–Ω–Ω—ã—Ö —Ä–µ–∑—É–ª—å—Ç–∞—Ç–æ–≤ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –ø—Ä–µ–∂–Ω–∏–º–∏ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏—è–º–∏.,"{""skip"": true}"
2025-07-29T08:32:53+00:00,@medpharm,12473,https://t.me/medpharm/12473,"–ü–∞–ª–∞—Ç–∞ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–µ–π –°–®–ê (–Ω–∏–∂–Ω—è—è –ø–∞–ª–∞—Ç–∞ –ö–æ–Ω–≥—Ä–µ—Å—Å–∞) –≤–Ω–µ—Å–ª–∞ –Ω–∞ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏–µ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç, –∫–æ—Ç–æ—Ä—ã–º –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è –∑–∞–ø—Ä–µ—Ç–∏—Ç—å —ç–∫—Å–ø–æ—Ä—Ç –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –ø—Ä–æ—Ç–µ–∑–æ–≤ –≤ –†–æ—Å—Å–∏–π—Å–∫—É—é –§–µ–¥–µ—Ä–∞—Ü–∏—é. –ü–æ–ª–Ω—ã–π —Ç–µ–∫—Å—Ç –¥–æ–∫—É–º–µ–Ω—Ç–∞ –ø–æ–∫–∞ –Ω–µ–¥–æ—Å—Ç—É–ø–µ–Ω.","{""skip"": true}"
2025-07-29T07:20:02+00:00,@medpharm,12472,https://t.me/medpharm/12472,"#–≠–∫—Å–∫–ª—é–∑–∏–≤ –û –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ –ø–æ–∑–≤–æ–ª–∏—Ç—å –≤—Ä–∞—á–∞–º –≤–µ—Å—Ç–∏ —á–∞—Å—Ç–Ω—É—é –ø—Ä–∞–∫—Ç–∏–∫—É –∑–∞—è–≤–∏–ª–∏ 70% –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤. –ú–Ω–æ–≥–∏–µ —Å—á–∏—Ç–∞—é—Ç, —á—Ç–æ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –±–æ–ª—å—à–µ –∑–∞—Ä–∞–±–∞—Ç—ã–≤–∞—Ç—å –∏ –Ω–µ –∑–∞–≤–∏—Å–µ—Ç—å –æ—Ç —Å–∞–º–æ–¥—É—Ä—Å—Ç–≤–∞ —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–∞ —Ä–µ—à–∏—Ç –ø—Ä–æ–±–ª–µ–º—É –¥–µ—Ñ–∏—Ü–∏—Ç–∞ –∫–∞–¥—Ä–æ–≤.","{""skip"": true}"
2025-07-28T16:02:08+00:00,@medpharm,12471,https://t.me/medpharm/12471,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 28 –∏—é–ª—è –£–±—Ä–∞—Ç—å –±–∞—Ä—å–µ—Ä—ã –ù–µ–æ–±—Ö–æ–¥–∏–º–æ –æ—Ç–∫–∞–∑–∞—Ç—å—Å—è –æ—Ç —ç—Ç–∞–ø–Ω–æ—Å—Ç–∏ –≤ –ª–µ—á–µ–Ω–∏–∏ –≥–µ–ø–∞—Ç–∏—Ç–∞ C, –∏–∑-–∑–∞ –∫–æ—Ç–æ—Ä–æ–π –ø–∞—Ü–∏–µ–Ω—Ç—ã –ø–æ–ª—É—á–∞—é—Ç –ª–µ—á–µ–Ω–∏–µ —É–∂–µ –ø—Ä–∏ —Ç—è–∂–µ–ª—ã—Ö –ø–æ—Ä–∞–∂–µ–Ω–∏—è—Ö –ø–µ—á–µ–Ω–∏, –∑–∞—è–≤–∏–ª –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—è –ö–æ–º–∏—Ç–µ—Ç–∞ –ì–æ—Å–¥—É–º—ã –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è –ê–ª–µ–∫—Å–µ–π –ö—É—Ä–∏–Ω–Ω—ã–π. –û–Ω –ø—Ä–∏–∑–≤–∞–ª –æ—Ç–º–µ–Ω–∏—Ç—å –¥–µ–π—Å—Ç–≤—É—é—â–∏–π –ø—Ä–∏–∫–∞–∑ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞. –£–¥–∞—Ä –ø–æ –ø—Ä–∏–Ω—É–¥–∏–ª–æ–≤–∫–µ –í –ì–æ—Å–¥—É–º–µ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –æ—Å–≤–æ–±–æ–¥–∏—Ç—å –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –æ—Ç —É—á–∞—Å—Ç–∏—è –≤ –ø—Ä–µ–¥–≤—ã–±–æ—Ä–Ω–æ–π –∞–≥–∏—Ç–∞—Ü–∏–∏. –ü—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—å –ö–æ–º–∏—Ç–µ—Ç–∞ –ì–æ—Å–¥—É–º—ã –ø–æ —Ç—Ä—É–¥—É –∏ —Å–æ—Ü–∏–∞–ª—å–Ω–æ–π –ø–æ–ª–∏—Ç–∏–∫–µ –Ø—Ä–æ—Å–ª–∞–≤ –ù–∏–ª–æ–≤, –Ω–∞–∑–≤–∞–ª —ç—Ç–æ –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω—ã–º —Ç—Ä—É–¥–æ–º. –°–ø–∏—Å–æ–∫ –ë–ê–î –° 1 —Å–µ–Ω—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞ –≤—Ä–∞—á–∏ —Å–º–æ–≥—É—Ç –Ω–∞–∑–Ω–∞—á–∞—Ç—å –ë–ê–î –ø–∞—Ü–∏–µ–Ω—Ç–∞–º —Ç–æ–ª—å–∫–æ –∏–∑ —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ–≥–æ —Å–ø–∏—Å–∫–∞. ¬´–§–í¬ª –ø—Ä–æ–∞–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–ª –≥–æ—Å–∑–∞–∫—É–ø–∫–∏ –∏ –≤—ã—è—Å–Ω–∏–ª, –∫–∞–∫–∏–µ –¥–æ–±–∞–≤–∫–∏ –Ω–∞–∏–±–æ–ª–µ–µ –ø–æ–ø—É–ª—è—Ä–Ω—ã —É –≥–æ—Å–∑–∞–∫–∞–∑—á–∏–∫–æ–≤. –ü–∞—Ç–µ–Ω—Ç –ø–æ–¥—Ç–≤–µ—Ä–∂–µ–Ω –ö–æ–ª–ª–µ–≥–∏—è –ø–æ –ø–∞—Ç–µ–Ω—Ç–Ω—ã–º —Å–ø–æ—Ä–∞–º –æ—Ç–∫–ª–æ–Ω–∏–ª–∞ –ø—Ä–µ—Ç–µ–Ω–∑–∏–∏ –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ –∫ –µ–≤—Ä–∞–∑–∏–π—Å–∫–æ–º—É –ø–∞—Ç–µ–Ω—Ç—É ¬´–ê–∫—Å–µ–ª—å–§–∞—Ä–º¬ª –Ω–∞ ¬´–ê–∫—Å–∏—Ç–∏–Ω–∏–±¬ª. –í–æ–∑—Ä–∞–∂–µ–Ω–∏–µ –ø–æ–¥–∞–Ω–æ —É–∂–µ –ø–æ—Å–ª–µ –∏—Å—Ç–µ—á–µ–Ω–∏—è —Å—Ä–æ–∫–∞ –¥–µ–π—Å—Ç–≤–∏—è –ø–∞—Ç–µ–Ω—Ç–∞ –∑–∞—è–≤–∏—Ç–µ–ª—è.","{""skip"": true}"
2025-07-28T14:40:25+00:00,@medpharm,12470,https://t.me/medpharm/12470,"#–≠–∫—Å–∫–ª—é–∑–∏–≤ –ö–æ–ª–ª–µ–≥–∏—è –ø–∞–ª–∞—Ç—ã –ø–æ –ø–∞—Ç–µ–Ω—Ç–Ω—ã–º —Å–ø–æ—Ä–∞–º –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª–∞ –ø—Ä–∞–≤–æ–º–µ—Ä–Ω–æ—Å—Ç—å –µ–≤—Ä–∞–∑–∏–π—Å–∫–æ–≥–æ –ø–∞—Ç–µ–Ω—Ç–∞ –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ê–∫—Å–µ–ª—å–§–∞—Ä–º¬ª –Ω–∞ —Å–ø–æ—Å–æ–± –ø–æ–ª—É—á–µ–Ω–∏—è –¥–µ–π—Å—Ç–≤—É—é—â–µ–≥–æ –≤–µ—â–µ—Å—Ç–≤–∞ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ¬´–ê–∫—Å–∏—Ç–∏–Ω–∏–±¬ª. –í–æ–∑—Ä–∞–∂–µ–Ω–∏–µ –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω–æ–≥–æ –ª–∏—Ü–∞ –ø—Ä–æ—Ç–∏–≤ –¥–µ–π—Å—Ç–≤–∏—è –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ –†–æ—Å—Å–∏–∏ –µ–≤—Ä–∞–∑–∏–π—Å–∫–æ–≥–æ –ø–∞—Ç–µ–Ω—Ç–∞ ‚Ññ 041487 –Ω–∞ –∏–∑–æ–±—Ä–µ—Ç–µ–Ω–∏–µ –ø–æ—Å—Ç—É–ø–∏–ª–æ –≤ –§–µ–¥–µ—Ä–∞–ª—å–Ω—É—é —Å–ª—É–∂–±—É –ø–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç—É–∞–ª—å–Ω–æ–π —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç–∏ 26 —Å–µ–Ω—Ç—è–±—Ä—è 2024 –≥–æ–¥–∞. –ü–æ–∫–∞ —à–ª–æ –µ–≥–æ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏–µ, —Å—Ä–æ–∫ –¥–µ–π—Å—Ç–≤–∏—è –ø–∞—Ç–µ–Ω—Ç–∞ –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç —Å —Ç–æ—Ä–≥–æ–≤—ã–º –Ω–∞–∏–º–µ–Ω–æ–≤–∞–Ω–∏–µ–º ¬´–ê–∫—Å–∏—Ç–∏–Ω–∏–±¬ª —Å–∞–º–æ–≥–æ –∑–∞—è–≤–∏—Ç–µ–ª—è –∏—Å—Ç–µ–∫.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""high"",
  ""english"": ""Exclusive Collegium of Patent Disputes Chamber confirmed the legitimacy of the Eurasian patent held by company 'Akselfarm' for a method of obtaining an active substance of the domestic drug 'Aksitinib'. Objection to the action of the foreign entity against the Eurasian patent number 041487 for an invention was submitted to the Federal Service for Intellectual Property on September 26, 2024. While this objection was being considered, the term of the patent for the drug 'Aksitinib' under the trade name was already expired.""
}"
2025-07-28T13:32:28+00:00,@medpharm,12469,https://t.me/medpharm/12469,–ú–∏–Ω–∏—Å—Ç—Ä –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ú–∏—Ö–∞–∏–ª –ú—É—Ä–∞—à–∫–æ —Ä–∞—Å—Å–∫–∞–∑–∞–ª –æ –ø–µ—Ä–≤—ã—Ö —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞—Ö –ø—Ä–∏–µ–º–Ω–æ–π –∫–∞–º–ø–∞–Ω–∏–∏ –≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –≤—É–∑—ã 2025 –≥–æ–¥–∞. –ü–æ–≤—ã—à–µ–Ω–Ω—ã–π –∏–Ω—Ç–µ—Ä–µ—Å –∞–±–∏—Ç—É—Ä–∏–µ–Ω—Ç–æ–≤ –Ω–∞–±–ª—é–¥–∞–µ—Ç—Å—è –∫ –ø–µ–¥–∏–∞—Ç—Ä–∏—á–µ—Å–∫–æ–π —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–∏.,"{""skip"": true}"
2025-07-28T12:43:09+00:00,@medpharm,12468,https://t.me/medpharm/12468,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç –≤–≤–µ—Å—Ç–∏ –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏—é –∑–∞—Ç—Ä–∞—Ç—ã –Ω–∞ –∑–∞–≥–æ—Ç–æ–≤–∫—É –∏–º–º—É–Ω–æ—Å–ø–µ—Ü–∏—Ñ–∏—á–µ—Å–∫–æ–π –ø–ª–∞–∑–º—ã. –°—Ç–∞–≤–∫—É –Ω–∞–º–µ—Ä–µ–Ω—ã —É—Å—Ç–∞–Ω–æ–≤–∏—Ç—å –≤ —Ä–∞–∑–º–µ—Ä–µ 29,97 —Ç—ã—Å. —Ä—É–±. –∑–∞ 1 –ª–∏—Ç—Ä. –í —Å–ª—É—á–∞–µ —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏—è –¥–æ–∫—É–º–µ–Ω—Ç –±—É–¥–µ—Ç –¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å –¥–æ –º–∞—Ä—Ç–∞ 2029 –≥–æ–¥–∞.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""reimbursement, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health plans to introduce compensation for immunoglobulin procurement costs. The rate is set at 29,970 rubles per liter. If approved, the document will be in effect until March 2029.""
}"
2025-07-28T11:30:01+00:00,@medpharm,12467,https://t.me/medpharm/12467,"–ü—Ä–æ–µ–∫—Ç ¬´–¶–∏—Ñ—Ä–æ–≤–∞—è –∫–ª–∏–Ω–∏–∫–∞¬ª, –∑–∞–ø—É—â–µ–Ω–Ω—ã–π –≤ 2023 –≥–æ–¥—É –≤ –ú–æ—Å–∫–≤–µ, —Å–Ω–∏–∑–∏–ª –Ω–∞–≥—Ä—É–∑–∫—É –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –ø—Ä–∏–º–µ—Ä–Ω–æ –Ω–∞ 30%. –û–Ω —Ç–∞–∫–∂–µ –ø–æ–∑–≤–æ–ª–∏–ª –æ—Å–≤–æ–±–æ–¥–∏—Ç—å –≤—Ä–∞—á–∞–º –∏ –º–µ–¥—Å–µ—Å—Ç—Ä–∞–º 1,5‚Äì3 —á–∞—Å–∞ –≤ —Å–º–µ–Ω—É –Ω–∞ –æ–±—â–µ–Ω–∏–µ —Å –ø–∞—Ü–∏–µ–Ω—Ç–∞–º–∏.","{""skip"": true}"
2025-07-28T10:34:22+00:00,@medpharm,12466,https://t.me/medpharm/12466,"–£–ø—Ä–∞–≤–ª–µ–Ω–∏–µ —Ä–∏—Å–∫–∞–º–∏ —Ç–µ—Ä–∞–ø–∏–∏ —Ç—Ä–µ–≤–æ–∂–Ω—ã—Ö —Ä–∞—Å—Å—Ç—Ä–æ–π—Å—Ç–≤. –¢—Ä–µ–≤–æ–∂–Ω—ã–µ —Ä–∞—Å—Å—Ç—Ä–æ–π—Å—Ç–≤–∞ –≤—Ö–æ–¥—è—Ç –≤ —á–∏—Å–ª–æ –æ—Å–Ω–æ–≤–Ω—ã—Ö –ø—Ä–∏—á–∏–Ω —Ä–∞–∑–≤–∏—Ç–∏—è –∏–Ω–≤–∞–ª–∏–¥–Ω–æ—Å—Ç–∏, —É—Å—Ç—É–ø–∞—è —Ç–æ–ª—å–∫–æ –≥–ª—É–±–æ–∫–æ–π –¥–µ–ø—Ä–µ—Å—Å–∏–∏ –∏ –Ω–µ–∫–æ—Ç–æ—Ä—ã–º –±–æ–ª–µ–≤—ã–º —Å–∏–Ω–¥—Ä–æ–º–∞–º. –í –∞—Ä—Å–µ–Ω–∞–ª–µ —Å—Ä–µ–¥—Å—Ç–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Ç—Ä–µ–≤–æ–∂–Ω—ã—Ö —Ä–∞—Å—Å—Ç—Ä–æ–π—Å—Ç–≤ —Å–æ—Ö—Ä–∞–Ω—è—é—Ç —Å–≤–æ—é —Ä–æ–ª—å –±–µ–Ω–∑–æ–¥–∏–∞–∑–µ–ø–∏–Ω—ã, –æ–¥–Ω–∞–∫–æ –∏—Ö –Ω–∞–∑–Ω–∞—á–µ–Ω–∏–µ —Ç—Ä–µ–±—É–µ—Ç –≤–∑–≤–µ—à–µ–Ω–Ω–æ–≥–æ –ø–æ–¥—Ö–æ–¥–∞. –í –∫–∞–∫–∏—Ö –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Å–∏—Ç—É–∞—Ü–∏—è—Ö –≤—ã–±–æ—Ä –±–µ–Ω–∑–æ–¥–∏–∞–∑–µ–ø–∏–Ω–æ–≤—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞–∏–±–æ–ª–µ–µ –æ–ø—Ä–∞–≤–¥–∞–Ω, —á—Ç–æ —É—á–µ—Å—Ç—å —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—É –ø—Ä–∏ –ø–æ–¥–±–æ—Ä–µ —Ç–µ—Ä–∞–ø–∏–∏ –∏ –∫–∞–∫ –∏–∑–±–µ–∂–∞—Ç—å –Ω–µ–∂–µ–ª–∞—Ç–µ–ª—å–Ω—ã—Ö —è–≤–ª–µ–Ω–∏–π ‚Äì —á–∏—Ç–∞–π—Ç–µ –≤ —Å—Ç–∞—Ç—å–µ. –ü–æ–¥—Ä–æ–±–Ω–µ–µ –Ω–∞ —Å–∞–π—Ç–µ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance"",
  ""impact"": ""medium"",
  ""english"": ""The article discusses the appropriate use of benzodiazepines for treating anxiety disorders, weighing their benefits against potential side effects. It also covers the clinical situations where benzodiazepines are most appropriate and how to avoid adverse events.""
}"
2025-07-28T09:03:20+00:00,@medpharm,12464,https://t.me/medpharm/12464,"#–≠–∫—Å–∫–ª—é–∑–∏–≤ –° 1 —Å–µ–Ω—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞ –≤—Ä–∞—á–∏ —Å–º–æ–≥—É—Ç –Ω–∞–∑–Ω–∞—á–∞—Ç—å –ë–ê–î –ø–∞—Ü–∏–µ–Ω—Ç–∞–º —Ç–æ–ª—å–∫–æ –∏–∑ —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ–≥–æ —Å–ø–∏—Å–∫–∞. ¬´–§–í¬ª –ø—Ä–æ–∞–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–ª –≥–æ—Å–∑–∞–∫—É–ø–∫–∏ –∏ –≤—ã—è—Å–Ω–∏–ª, –∫–∞–∫–∏–µ –¥–æ–±–∞–≤–∫–∏ –Ω–∞–∏–±–æ–ª–µ–µ –ø–æ–ø—É–ª—è—Ä–Ω—ã —É –≥–æ—Å–∑–∞–∫–∞–∑—á–∏–∫–æ–≤.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""Starting September 1st, 2025 doctors will be able to prescribe BAs only from a special list. 'FV' analyzed government purchases and found out which supplements are most popular among government buyers.""
}"
2025-07-28T07:05:54+00:00,@medpharm,12463,https://t.me/medpharm/12463,#–≠–∫—Å–∫–ª—é–∑–∏–≤ –Æ—Ä–∏—Å—Ç—ã –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã–π —Å–ø–æ—Å–æ–± –ø—Ä–æ–≤–µ—Ä–∫–∏ –ø–æ–¥–ª–∏–Ω–Ω–æ—Å—Ç–∏ –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤ –æ–± –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–∏ –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤. –ò–Ω–∏—Ü–∏–∞—Ç–∏–≤—É –ø–æ–¥–¥–µ—Ä–∂–∏–≤–∞—é—Ç –≤ —Ä–µ–≥–∏–æ–Ω–∞—Ö.,"{""skip"": true}"
2025-07-27T11:00:36+00:00,@medpharm,12462,https://t.me/medpharm/12462,"–ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ –∑–∞ –Ω–µ–¥–µ–ª—é üîµ –§–∞—Ä–º–æ—Ç—Ä–∞—Å–ª—å —Å—Ç–æ–ª–∫–Ω—É–ª–∞—Å—å —Å –∫—Ä–∏–∑–∏—Å–æ–º –Ω–µ–ø–ª–∞—Ç–µ–∂–µ–π: ¬´–∂–∏–≤—ã—Ö¬ª –¥–µ–Ω–µ–≥ –Ω–∞ —Ä—ã–Ω–∫–µ –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏ –Ω–µ –æ—Å—Ç–∞–ª–æ—Å—å, –æ–±—ä–µ–º—ã –æ–±–æ—Ä–æ—Ç–Ω—ã—Ö –∫–∞–ø–∏—Ç–∞–ª–æ–≤ —Å–Ω–∏–∂–∞—é—Ç—Å—è. üîµ –ü—Ä–µ–∑–∏–¥–µ–Ω—Ç –ø–æ–¥–ø–∏—Å–∞–ª —Ä—è–¥ –∑–∞–∫–æ–Ω–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ –∫–∞—Å–∞—é—Ç—Å—è —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –æ—Ç—Ä–∞—Å–ª–∏. –†–µ—á—å –∏–¥–µ—Ç –æ —Å—Ç–∞—Ç—É—Å–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π, –ø–æ–Ω—è—Ç–∏–∏ –°–ó–õ–° –∏ —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏–∏ –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. üîµ –°—É–¥–µ–±–Ω—ã–π —Å–ø–æ—Ä –≤–æ–∫—Ä—É–≥ –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ò–Ω—Ñ–∞–º–µ–¥¬ª –Ω–µ –ø–æ–≤–ª–∏—è–ª –Ω–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ¬´–ú–∏—Ä–∞–º–∏—Å—Ç–∏–Ω¬ª. üîµ –ñ–∞–ª–æ–±—É –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–§–∞—Ä–º–∏–º—ç–∫—Å¬ª –Ω–∞ –∑–∞–∫—É–ø–∫—É —Ç–µ–¥—É–≥–ª—É—Ç–∏–¥–∞ –¥–ª—è –ø–æ–¥–æ–ø–µ—á–Ω—ã—Ö ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª –ø—Ä–∏–∑–Ω–∞–ª–∏ –Ω–µ–æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω–æ–π. üîµ –î–µ–ø—É—Ç–∞—Ç –ì–æ—Å–¥—É–º—ã –ø—Ä–µ–¥–ª–æ–∂–∏–ª –≤–≤–µ—Å—Ç–∏ –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç—å –∑–∞ –¥–∏—Å–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏—é —Ç–æ–≤–∞—Ä–æ–≤ —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, shortage, safety"",
  ""impact"": ""high"",
  ""english"": ""The news discusses issues related to pharmaceutical companies facing financial difficulties, including the shortage of funds and declining turnover capital. There are also concerns about clinical trials and safety issues.""
}"
2025-07-26T10:00:30+00:00,@medpharm,12461,https://t.me/medpharm/12461,"–ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∑–∞ –Ω–µ–¥–µ–ª—é üî¥–ú–∏–Ω–∑–¥—Ä–∞–≤ –Ω–∞–¥–µ–ª–µ–Ω –ø–æ–ª–Ω–æ–º–æ—á–∏–µ–º –ø–æ —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏—é –æ—Å–æ–±–æ–≥–æ –ø–æ—Ä—è–¥–∫–∞ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π (–ö–†). üî¥–ù–∞ —Å–æ–≤–µ—â–∞–Ω–∏–∏ –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç–∞ —Å —á–ª–µ–Ω–∞–º–∏ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –≤—ã—è—Å–Ω–∏–ª–æ—Å—å, —á—Ç–æ —É ¬´–∑–µ–º—Å–∫–∏—Ö¬ª –ø—Ä–æ–≥—Ä–∞–º–º –µ—Å—Ç—å –¥–µ–º–æ–≥—Ä–∞—Ñ–∏—á–µ—Å–∫–∏–π –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª, –ø–æ—Å–∫–æ–ª—å–∫—É –≤ –Ω–∏—Ö —á–∞—â–µ –≤—Å–µ–≥–æ —É—á–∞—Å—Ç–≤—É—é—Ç –∂–µ–Ω—â–∏–Ω—ã –¥–æ 40 –ª–µ—Ç. üî¥–í –†–æ—Å—Å–∏–∏ –≤–µ—Ä–Ω—É–ª–∏—Å—å –∫ –∏–¥–µ–µ –æ—Ç–ø—Ä–∞–≤–ª—è—Ç—å –Ω–∞ –≤—Ä–∞—á–µ–±–Ω—É—é –∫–æ–º–∏—Å—Å–∏—é –¥–æ–∫—É–º–µ–Ω—Ç—ã –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, —á–∞—Å—Ç–æ –æ—Ñ–æ—Ä–º–ª—è—é—â–∏—Ö –±–æ–ª—å–Ω–∏—á–Ω—ã–µ –ª–∏—Å—Ç—ã. –ú–∏–Ω–∑–¥—Ä–∞–≤ –ø–æ–¥–≥–æ—Ç–æ–≤–∏–ª –Ω–æ–≤—ã–µ –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ –ü–æ—Ä—è–¥–æ–∫ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è —ç–∫—Å–ø–µ—Ä—Ç–∏–∑—ã –≤—Ä–µ–º–µ–Ω–Ω–æ–π –Ω–µ—Ç—Ä—É–¥–æ—Å–ø–æ—Å–æ–±–Ω–æ—Å—Ç–∏. üî¥–ë–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ —á–∞—Å—Ç–Ω—ã—Ö –∫–ª–∏–Ω–∏–∫ –ø–æ–∫–∞ –Ω–µ –≥–æ—Ç–æ–≤—ã –ø–µ—Ä–µ–¥–∞–≤–∞—Ç—å –¥–∞–Ω–Ω—ã–µ –æ–± –æ–∫–∞–∑–∞–Ω–Ω–æ–π –∏–º–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –≤ —ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω–æ–º –≤–∏–¥–µ –≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–∏–µ –∏–Ω—Ñ–æ—Ä–º—Å–∏—Å—Ç–µ–º—ã. üî¥–í –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–µ –∏ –ú–∏–Ω–∑–¥—Ä–∞–≤–µ –æ–±–Ω–∞—Ä—É–∂–∏–ª–∏, —á—Ç–æ –ø–æ—á—Ç–∏ —Ç—Ä–µ—Ç—å –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∫–æ–ª–ª–µ–¥–∂–µ–π –Ω–µ –ø—Ä–∏—Ö–æ–¥—è—Ç –≤ —Å—Ñ–µ—Ä—É –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, hospital_policy, guideline"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health has been granted the authority to approve special procedures for the application of clinical guidelines. At a presidential meeting with government ministers, it was noted that 'grassroots' programs have demographic potential as they are often used by women under 40. The Ministry of Health is preparing new changes to the Order for Conducting Expertise on Temporary Disability. Most private clinics are not ready to transfer data about the medical care they provide into electronic systems. The government and Ministry of Health have identified that nearly one-third of medical college graduates are not entering the healthcare sector.""
}"
2025-07-25T16:10:46+00:00,@medpharm,12460,https://t.me/medpharm/12460,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 25 –∏—é–ª—è –¶–µ–Ω–Ω—ã–µ –∫–∞–¥—Ä—ã –ì—Ä—É–ø–ø–∞ –¥–µ–ø—É—Ç–∞—Ç–æ–≤ –≤—ã—Å—Ç—É–ø–∏–ª–∞ —Å –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–æ–π —É–ø—Ä–æ—Å—Ç–∏—Ç—å –≤–æ—Å—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ –¥–ª—è —Ä—è–¥–∞ –∫–∞—Ç–µ–≥–æ—Ä–∏–π –≥—Ä–∞–∂–¥–∞–Ω –ø—Ä–∞–≤–∞ –Ω–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫—É—é –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç—å –ø–æ—Å–ª–µ –¥–æ–ª–≥–æ–≥–æ –ø–µ—Ä–µ—Ä—ã–≤–∞. –†–µ—á—å –æ —Å–∞–º–∏—Ö –Ω–∞—Ä–æ–¥–Ω—ã—Ö –∏–∑–±—Ä–∞–Ω–Ω–∏–∫–∞—Ö –∏ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã—Ö –≥–æ—Å—Å–ª—É–∂–∞—â–∏—Ö. –£–∂–µ —à–∞–≥ –û–ø—Ä–æ–≤–µ—Ä–≥–Ω—É—Ç–∞ –ø–æ–ª—å–∑–∞ 10 000 —à–∞–≥–æ–≤ –≤ –¥–µ–Ω—å. –û–ø—Ç–∏–º–∞–ª—å–Ω–∞—è –ø—Ä–æ–¥–æ–ª–∂–∏—Ç–µ–ª—å–Ω–æ—Å—Ç—å —Ö–æ–¥—å–±—ã –¥–ª—è —Å–Ω–∏–∂–µ–Ω–∏—è —Ä–∏—Å–∫–∞ —Å–º–µ—Ä—Ç–Ω–æ—Å—Ç–∏ —Å–æ—Å—Ç–∞–≤–∏–ª–∞ –æ—Ç 5000 –¥–æ 7000 —à–∞–≥–æ–≤ –≤ –¥–µ–Ω—å. –ö–∞–¥—Ä–æ–≤—ã–µ –ø–µ—Ä–µ—Å—Ç–∞–Ω–æ–≤–∫–∏ –ù–æ–≤—ã–º –≥–µ–Ω–µ—Ä–∞–ª—å–Ω—ã–º –¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–º —Ö–æ–ª–¥–∏–Ω–≥–∞ ¬´–ù–∞—Ü–∏–º–±–∏–æ¬ª –≥–æ—Å–∫–æ—Ä–ø–æ—Ä–∞—Ü–∏–∏ ¬´–†–æ—Å—Ç–µ—Ö¬ª –Ω–∞–∑–Ω–∞—á–µ–Ω –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ù–∏–∑–æ–≤—Ü–µ–≤. –í —ç—Ç–æ–π –¥–æ–ª–∂–Ω–æ—Å—Ç–∏ –æ–Ω —Å–º–µ–Ω–∏–ª –ê–Ω–¥—Ä–µ—è –ó–∞–≥–æ—Ä—Å–∫–æ–≥–æ, –∫–æ—Ç–æ—Ä—ã–π –≤–æ–∑–≥–ª–∞–≤–ª—è–ª –∫–æ–º–ø–∞–Ω–∏—é —Å 2017 –≥–æ–¥–∞. –ü–ª–∞–Ω—ã –ø–æ –ú–†–û–¢ –í –ì–æ—Å–¥—É–º—É –≤–Ω–µ—Å–µ–Ω –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ–± —É–≤–µ–ª–∏—á–µ–Ω–∏–∏ –ú–†–û–¢ –¥–æ 50 —Ç—ã—Å. —Ä—É–±. —Å 2026 –≥–æ–¥–∞. –í —Å–ª—É—á–∞–µ –ø—Ä–∏–Ω—è—Ç–∏—è –¥–æ–∫—É–º–µ–Ω—Ç–∞ —Ä–∞–±–æ—Ç–æ–¥–∞—Ç–µ–ª—è–º –º–æ–∂–µ—Ç –ø–æ—Ç—Ä–µ–±–æ–≤–∞—Ç—å—Å—è –ø–µ—Ä–µ—Å–º–æ—Ç—Ä–µ—Ç—å —Ñ–æ–Ω–¥ –æ–ø–ª–∞—Ç—ã —Ç—Ä—É–¥–∞. –ü—Ä–∏ —ç—Ç–æ–º –ú–∏–Ω—Ç—Ä—É–¥ –ø—Ä–µ–¥–ª–æ–∂–∏–ª —É—Å—Ç–∞–Ω–æ–≤–∏—Ç—å –ú–†–û–¢ –≤ —Ä–∞–∑–º–µ—Ä–µ 27 093 —Ä—É–±. —Å–æ —Å–ª–µ–¥—É—é—â–µ–≥–æ –≥–æ–¥–∞.","{""skip"": true}"
2025-07-25T14:33:06+00:00,@medpharm,12459,https://t.me/medpharm/12459,"–ú–æ—Å–∫–æ–≤—Å–∫–∏—Ö –≤—Ä–∞—á–µ–π –Ω–∞ –Ω–µ—Å–∫–æ–ª—å–∫–æ –ª–µ—Ç –ª–∏—à–∏–ª–∏ –ø—Ä–∞–≤–∞ –∑–∞–Ω–∏–º–∞—Ç—å—Å—è –º–µ–¥–∏—Ü–∏–Ω–æ–π. –û–Ω–∏ —Ñ–∞–±—Ä–∏–∫–æ–≤–∞–ª–∏ –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å—Å—Ç–≤–∞ —Ç—Ä–∞–≤–º, –≤ —Ç–æ–º —á–∏—Å–ª–µ —Ä–µ–Ω—Ç–≥–µ–Ω–æ–≤—Å–∫–∏–µ —Å–Ω–∏–º–∫–∏, –¥–ª—è —Å—Ç—Ä–∞—Ö–æ–≤—ã—Ö –º–æ—à–µ–Ω–Ω–∏–∫–æ–≤.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""sanctions, reimbursement"",
  ""impact"": ""high"",
  ""english"": ""Russian doctors were sanctioned for several years due to fraud involving fake X-ray images and other evidence of injuries, intended to scam insurance companies.""
}"
2025-07-25T13:31:13+00:00,@medpharm,12458,https://t.me/medpharm/12458,"–ú–∏–Ω–∑–¥—Ä–∞–≤ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –Ω–æ–≤—ã–π –ø—Ä–∏–∫–∞–∑, –∫–æ—Ç–æ—Ä—ã–º —É—Ç–≤–µ—Ä–∂–¥–∞–µ—Ç—Å—è –ø—Ä–µ–¥–µ–ª—å–Ω–æ –¥–æ–ø—É—Å—Ç–∏–º–æ–µ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –Ω–∞—Ä–∫–æ—Ç–∏—á–µ—Å–∫–∏—Ö —Å—Ä–µ–¥—Å—Ç–≤, –ø—Å–∏—Ö–æ—Ç—Ä–æ–ø–Ω—ã—Ö –≤–µ—â–µ—Å—Ç–≤ –∏ –∏—Ö –ø—Ä–µ–∫—É—Ä—Å–æ—Ä–æ–≤ –≤ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞—Ö, –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ –∫–æ—Ç–æ—Ä—ã—Ö –º–æ–≥—É—Ç –∏—Å–∫–ª—é—á–∞—Ç—å—Å—è –Ω–µ–∫–æ—Ç–æ—Ä—ã–µ –º–µ—Ä—ã –∫–æ–Ω—Ç—Ä–æ–ª—è. –í –ø–µ—Ä–µ—á–µ–Ω—å –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è –≤–∫–ª—é—á–∏—Ç—å 14 –Ω–æ–≤—ã—Ö –ø—É–Ω–∫—Ç–æ–≤.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing, import_export, sanctions"",
  ""impact"": ""high"",
  ""english"": ""The Ministry of Health has developed a new decree that sets the maximum permissible quantity of narcotic substances, psychotropic substances and their precursors in drugs for which certain control measures may be waived. The list is proposed to include 14 new items.""
}"
2025-07-25T12:46:58+00:00,@medpharm,12457,https://t.me/medpharm/12457,"–ó–Ω–∞–∫–æ–º–∏–º –≤–∞—Å —Å–æ —Å–ª–µ–¥—É—é—â–∏–º —Å–ø–∏–∫–µ—Ä–æ–º PRO–µ–∫—Ü–∏–π –ë—É–¥—É—â–µ–≥–æ: üîπ–ê–Ω–Ω–∞ –ï—Ä–º–æ–ª–∞–µ–≤–∞, –≥–µ–Ω–µ—Ä–∞–ª—å–Ω—ã–π –¥–∏—Ä–µ–∫—Ç–æ—Ä AlphaRM, —Å–ø–∏–∫–µ—Ä –ø–ª–µ–Ω–∞—Ä–Ω–æ–π —Å–µ—Å—Å–∏–∏ ¬´–¶–∏—Ñ—Ä—ã. –§–∞–∫—Ç—ã. –¢—Ä–µ–Ω–¥—ã. –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∞—è –æ—Ç—Ä–∞—Å–ª—å –Ω–∞ –≥—Ä–∞–Ω–∏ –±—É–¥—É—â–µ–≥–æ¬ª –î–∞—Ç–∞ –∏ –≤—Ä–µ–º—è —Å–µ—Å—Å–∏–∏: 11 —Å–µ–Ω—Ç—è–±—Ä—è 2025, 09:30 üìç–≥. –°–æ—á–∏, Pullman –°–æ—á–∏ –¶–µ–Ω—Ç—Ä 5* –ü–æ–¥—Ä–æ–±–Ω–µ–µ –æ –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ –∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –Ω–∞ —Å–∞–π—Ç–µ","{""skip"": true}"
2025-07-25T12:02:09+00:00,@medpharm,12456,https://t.me/medpharm/12456,"#–≠–∫—Å–∫–ª—é–∑–∏–≤ –ü–µ—Ä–µ—Ö–æ–¥ –Ω–∞ —ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω—ã–µ –º–µ–¥–∫–Ω–∏–∂–∫–∏ –Ω–µ–≤–æ–∑–º–æ–∂–µ–Ω, —Ç–∞–∫ –∫–∞–∫ —Ç–æ–ª—å–∫–æ –ø–æ–ª–æ–≤–∏–Ω–∞ —á–∞—Å—Ç–Ω—ã—Ö –∫–ª–∏–Ω–∏–∫ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª—è–µ—Ç –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã–µ –¥–∞–Ω–Ω—ã–µ. –¢–∞–∫–∂–µ —Ü–∏—Ñ—Ä–æ–≤–∏–∑–∞—Ü–∏–∏ —ç—Ç–æ–≥–æ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è –ø—Ä–µ–ø—è—Ç—Å—Ç–≤—É–µ—Ç –ø–æ–∑–∏—Ü–∏—è –†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä–∞.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, import_export"",
  ""impact"": ""medium"",
  ""english"": ""Transition to electronic medical records is impossible due to the lack of necessary data from only half of private clinics. Digitalization in this area is also hindered by the Roszhitovdnadzor position.""
}"
2025-07-25T10:33:06+00:00,@medpharm,12455,https://t.me/medpharm/12455,"–≠–∫—Å–ø–µ—Ä—Ç—ã –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç –≤–≤–µ—Å—Ç–∏ –¥–æ–∫–æ–Ω—Ç–∞–∫—Ç–Ω—É—é –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫—É –í–ò–ß, –∫–æ—Ç–æ—Ä–∞—è, –ø–æ –∏—Ö —Ä–∞—Å—á–µ—Ç–∞–º, –ø–æ–∑–≤–æ–ª–∏—Ç –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤—É —Å—ç–∫–æ–Ω–æ–º–∏—Ç—å —Å–æ—Ç–Ω–∏ –º–∏–ª–ª–∏–æ–Ω–æ–≤ —Ä—É–±–ª–µ–π –∑–∞ —Å—á–µ—Ç –ø—Ä–µ–¥–æ—Ç–≤—Ä–∞—â–µ–Ω–∏—è –Ω–æ–≤—ã—Ö —Å–ª—É—á–∞–µ–≤ –∑–∞—Ä–∞–∂–µ–Ω–∏—è. –ù–µ—Å–º–æ—Ç—Ä—è –Ω–∞ –¥–æ–∫–∞–∑–∞–Ω–Ω—É—é —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –î–ö–ü –∏ –ø–æ–¥–¥–µ—Ä–∂–∫—É —ç–∫—Å–ø–µ—Ä—Ç–æ–≤, –µ–µ –≤–Ω–µ–¥—Ä–µ–Ω–∏–µ —Å–¥–µ—Ä–∂–∏–≤–∞–µ—Ç—Å—è –∏–¥–µ–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–º–∏ –∏ –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω—ã–º–∏ –±–∞—Ä—å–µ—Ä–∞–º–∏.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement, pricing"",
  ""impact"": ""medium"",
  ""english"": ""Experts propose mandatory pre-exposure prophylaxis (PrEP) for HIV, which they estimate would save the country hundreds of millions in new infections. Despite proven efficacy and expert support, its implementation is hindered by ideological and regulatory barriers.""
}"
2025-07-25T09:00:01+00:00,@medpharm,12454,https://t.me/medpharm/12454,"–ù–æ–≤—ã–º –≥–µ–Ω–µ—Ä–∞–ª—å–Ω—ã–º –¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–º —Ö–æ–ª–¥–∏–Ω–≥–∞ ¬´–ù–∞—Ü–∏–º–±–∏–æ¬ª –≥–æ—Å–∫–æ—Ä–ø–æ—Ä–∞—Ü–∏–∏ ¬´–†–æ—Å—Ç–µ—Ö¬ª –Ω–∞–∑–Ω–∞—á–µ–Ω –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ù–∏–∑–æ–≤—Ü–µ–≤. –í —ç—Ç–æ–π –¥–æ–ª–∂–Ω–æ—Å—Ç–∏ –æ–Ω —Å–º–µ–Ω–∏–ª –ê–Ω–¥—Ä–µ—è –ó–∞–≥–æ—Ä—Å–∫–æ–≥–æ, –∫–æ—Ç–æ—Ä—ã–π –≤–æ–∑–≥–ª–∞–≤–ª—è–ª –∫–æ–º–ø–∞–Ω–∏—é —Å 2017 –≥–æ–¥–∞.","{""skip"": true}"
2025-07-25T07:05:49+00:00,@medpharm,12453,https://t.me/medpharm/12453,"¬´–ü–æ—Å—Ç—É–ø–∏–ª–∞ –∂–∞–ª–æ–±–∞ –æ—Ç –¥–æ—á–µ—Ä–∏ –ø–∞—Ü–∏–µ–Ω—Ç–∞ –æ –Ω–µ—Å–æ–≥–ª–∞—Å–∏–∏ —Å –¥–∏–∞–≥–Ω–æ–∑–æ–º –µ–µ –º–∞—Ç–µ—Ä–∏. –ù–∞–ø–∏—Å–∞–Ω –æ—Ç–∫–∞–∑ –æ—Ç –≥–æ—Å–ø–∏—Ç–∞–ª–∏–∑–∞—Ü–∏–∏. –ü—Ä–æ–π–¥–µ–Ω–æ –æ–±—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –≤ –ø–ª–∞—Ç–Ω–æ–π –∫–ª–∏–Ω–∏–∫–µ –≤ –¥—Ä—É–≥–æ–º —Ä–µ–≥–∏–æ–Ω–µ, –∑–∞ —á—Ç–æ —Ç–µ–ø–µ—Ä—å –ø–∞—Ü–∏–µ–Ω—Ç —Ç—Ä–µ–±—É–µ—Ç –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏—é —Ä–∞—Å—Ö–æ–¥–æ–≤ –∑–∞ –æ–±—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ, –ø—Ä–æ–µ–∑–¥ –∏ –ø—Ä–æ–∂–∏–≤–∞–Ω–∏–µ. –ú–æ–∂–µ—Ç –ª–∏ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–µ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏–µ –≤–æ–∑–º–µ—Å—Ç–∏—Ç—å –ø–∞—Ü–∏–µ–Ω—Ç—É —Ä–∞—Å—Ö–æ–¥—ã –Ω–∞ –ª–µ—á–µ–Ω–∏–µ –≤ —á–∞—Å—Ç–Ω–æ–π –∫–ª–∏–Ω–∏–∫–µ –∏ –ø—Ä–æ–µ–∑–¥ –≤ —Å–ª—É—á–∞–µ –æ–∫–∞–∑–∞–Ω–∏—è –Ω–µ–∫–∞—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —É—Å–ª—É–≥?¬ª","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety, hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""Patient's daughter disagrees with her mother's diagnosis and has refused hospitalization. The patient is now seeking compensation for expenses incurred at a private clinic in another region due to the lack of quality medical services provided by a state healthcare facility.""
}"
2025-07-24T16:01:42+00:00,@medpharm,12452,https://t.me/medpharm/12452,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 24 –∏—é–ª—è –§–∏–ª—å—Ç—Ä –Ω–∞ –≤—Ö–æ–¥–µ –í –†–æ—Å—Å–∏–∏ –≤–µ—Ä–Ω—É–ª–∏—Å—å –∫ –∏–¥–µ–µ –æ—Ç–ø—Ä–∞–≤–ª—è—Ç—å –Ω–∞ –≤—Ä–∞—á–µ–±–Ω—É—é –∫–æ–º–∏—Å—Å–∏—é –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, —á–∞—Å—Ç–æ –æ—Ñ–æ—Ä–º–ª—è—é—â–∏—Ö –±–æ–ª—å–Ω–∏—á–Ω—ã–µ –ª–∏—Å—Ç—ã. –ú–∏–Ω–∑–¥—Ä–∞–≤ –ø–æ–¥–≥–æ—Ç–æ–≤–∏–ª –Ω–æ–≤—ã–µ –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ –ü–æ—Ä—è–¥–æ–∫ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è —ç–∫—Å–ø–µ—Ä—Ç–∏–∑—ã –≤—Ä–µ–º–µ–Ω–Ω–æ–π –Ω–µ—Ç—Ä—É–¥–æ—Å–ø–æ—Å–æ–±–Ω–æ—Å—Ç–∏. –ù–∞ –ø–æ–ø—Ä–∞–≤–∫—É –†–æ—Å—Å–∏—è–Ω–∞–º —Å—Ç–∞–ª–∏ —Ä–µ–∂–µ —Å—Ç–∞–≤–∏—Ç—å –¥–∏–∞–≥–Ω–æ–∑—ã ¬´–∞–ª–∫–æ–≥–æ–ª–∏–∑–º¬ª –∏ ¬´–∞–ª–∫–æ–≥–æ–ª—å–Ω—ã–π –ø—Å–∏—Ö–æ–∑¬ª ‚Äî —á–∏—Å–ª–æ —Ç–∞–∫–∏—Ö —Å–ª—É—á–∞–µ–≤ —Å–æ–∫—Ä–∞—Ç–∏–ª–æ—Å—å –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å 2023 –∏ 2022 –≥–æ–¥–∞–º–∏. –ó–∞–∫–æ–Ω—ã –ø–æ–¥–ø–∏—Å–∞–Ω—ã –ü—É—Ç–∏–Ω –ø–æ–¥–ø–∏—Å–∞–ª —Ä—è–¥ –∑–∞–∫–æ–Ω–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ –∫–∞—Å–∞—é—Ç—Å—è —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –æ—Ç—Ä–∞—Å–ª–∏. –†–µ—á—å –∏–¥–µ—Ç –æ —Å—Ç–∞—Ç—É—Å–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π, –ø–æ–Ω—è—Ç–∏–∏ –°–ó–õ–° –∏ —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏–∏ –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –ö—Ä–∏—Ç–∏–∫—É–µ—à—å ‚Äì –æ—Ç–≤–µ—á–∞–π –î–µ–ø—É—Ç–∞—Ç –ì–æ—Å–¥—É–º—ã –ø—Ä–µ–¥–ª–æ–∂–∏–ª –≤–≤–µ—Å—Ç–∏ –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç—å –∑–∞ –¥–∏—Å–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏—é —Ç–æ–≤–∞—Ä–æ–≤ —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞, –ø–∏—à—É—Ç –°–ú–ò. –ü–æ –µ–≥–æ –º–Ω–µ–Ω–∏—é, –ø—É–±–ª–∏—á–Ω–∞—è –∫—Ä–∏—Ç–∏–∫–∞ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –±—Ä–µ–Ω–¥–æ–≤ –ø—Ä–æ—Ç–∏–≤–æ—Ä–µ—á–∏—Ç –ø–∞—Ç—Ä–∏–æ—Ç–∏–∑–º—É –∏ –∏–Ω—Ç–µ—Ä–µ—Å–∞–º –Ω–∞—Ä–æ–¥–∞.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety, guideline"",
  ""impact"": ""medium"",
  ""english"": ""A Russian deputy proposed to introduce responsibility for discrediting domestically produced goods, according to media. He believes that public criticism of domestic brands contradicts patriotism and the interests of the people.""
}"
2025-07-24T14:37:31+00:00,@medpharm,12451,https://t.me/medpharm/12451,–ú–∏–Ω–∏—Å—Ç—Ä –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –°–®–ê –†–æ–±–µ—Ä—Ç –§. –ö–µ–Ω–Ω–µ–¥–∏-–º–ª–∞–¥—à–∏–π –ø–æ–¥–ø–∏—Å–∞–ª —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏—é CDC –æ–± –∏—Å–∫–ª—é—á–µ–Ω–∏–∏ —Ç–∏–º–µ—Ä–æ—Å–∞–ª–∞ –∏–∑ –≤—Å–µ—Ö –≤–∞–∫—Ü–∏–Ω –ø—Ä–æ—Ç–∏–≤ –≥—Ä–∏–ø–ø–∞ –≤ –°–®–ê. –†–µ—à–µ–Ω–∏–µ –ø—Ä–∏–Ω—è—Ç–æ –Ω–µ—Å–º–æ—Ç—Ä—è –Ω–∞ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–µ –Ω–∞—É—á–Ω—ã—Ö –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏–π –æ –≤—Ä–µ–¥–µ —Ä—Ç—É—Ç—å—Å–æ–¥–µ—Ä–∂–∞—â–µ–≥–æ –∫–æ–Ω—Å–µ—Ä–≤–∞–Ω—Ç–∞.,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial, safety"",
  ""impact"": ""high"",
  ""english"": ""The US Secretary of Health Robert F. Kennedy Jr. signed a CDC recommendation to exclude thimerosal from all flu vaccines in the US, despite lack of scientific evidence on its harmful effects.""
}"
2025-07-24T13:16:02+00:00,@medpharm,12450,https://t.me/medpharm/12450,"–ù–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç—å —É–ª—É—á—à–µ–Ω–∏—è –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä—ã —Ü–µ–Ω—Ç—Ä–æ–≤ –ø—Å–∏—Ö–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π –ø–æ–º–æ—â–∏ –ø–æ–¥–¥–µ—Ä–∂–∏–≤–∞–µ—Ç –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ —Ä–æ—Å—Å–∏—è–Ω. –ü–æ –¥–∞–Ω–Ω—ã–º –í–¶–ò–û–ú, –∑–∞ –ø–æ—Å–ª–µ–¥–Ω–∏–π –≥–æ–¥ –∏–Ω–¥–µ–∫—Å –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç–∏ –≤ –ø—Å–∏—Ö–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π –ø–æ–º–æ—â–∏ –≤—ã—Ä–æ—Å –≤ 1,3 —Ä–∞–∑–∞ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å 2022-–º.","{""skip"": true}"
2025-07-24T11:31:28+00:00,@medpharm,12449,https://t.me/medpharm/12449,"–†–∞–¥—ã –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç—å –≤–∞–º —Å–ª–µ–¥—É—é—â–µ–≥–æ —Å–ø–∏–∫–µ—Ä–∞ PRO–µ–∫—Ü–∏–π –ë—É–¥—É—â–µ–≥–æ: üîπ–ê–Ω–∞—Ç–æ–ª–∏–π –¢–µ–Ω—Ü–µ—Ä, –¥–∏—Ä–µ–∫—Ç–æ—Ä –ø–æ —Ä–∞–∑–≤–∏—Ç–∏—é –ê–û –ù–ü–ö ¬´–ö–∞—Ç—Ä–µ–Ω¬ª, —Å–ø–∏–∫–µ—Ä –¥–∏—Å–∫—É—Å—Å–∏–æ–Ω–Ω–æ–π —Å–µ—Å—Å–∏–∏ ¬´–ê–ø—Ç–µ–∫–∞ –∫–∞–∫ –±–∏–∑–Ω–µ—Å: —ç–∫–æ–Ω–æ–º–∏–∫–∞ —Ä–∏—Ç–µ–π–ª–∞ –≤ —É—Å–ª–æ–≤–∏—è—Ö –º–∞—Ä–∂–∏–Ω–∞–ª—å–Ω–æ–≥–æ –¥–∞–≤–ª–µ–Ω–∏—è¬ª –î–∞—Ç–∞ –∏ –≤—Ä–µ–º—è —Å–µ—Å—Å–∏–∏: 11 —Å–µ–Ω—Ç—è–±—Ä—è 2025, 15:45 üìç–≥. –°–æ—á–∏, Pullman –°–æ—á–∏ –¶–µ–Ω—Ç—Ä 5* üëâ –ü–æ–¥—Ä–æ–±–Ω–µ–µ –æ –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ –∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –Ω–∞ —Å–∞–π—Ç–µ","{""skip"": true}"
2025-07-24T09:30:39+00:00,@medpharm,12448,https://t.me/medpharm/12448,–í –†–æ—Å—Å–∏–∏ –ø–ª–∞–Ω–∏—Ä—É—é—Ç –≤–≤–µ—Å—Ç–∏ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—É—é –æ—Ç—Ä–∞–±–æ—Ç–∫—É –¥–ª—è –æ–∫–æ–Ω—á–∏–≤—à–∏—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –≤—É–∑—ã –∏ –∫–æ–ª–ª–µ–¥–∂–∏ –∑–∞ –±—é–¥–∂–µ—Ç–Ω—ã–π —Å—á–µ—Ç. –û—Ç–∫–∞–∑–∞–≤—à–∏—Ö—Å—è –±—É–¥—É—Ç —à—Ç—Ä–∞—Ñ–æ–≤–∞—Ç—å.,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""high"",
  ""english"": ""Russia plans to require graduates of medical universities and colleges to complete a mandatory training program at public expense. Those who refuse will be fined.""
}"
2025-07-24T08:30:17+00:00,@medpharm,12447,https://t.me/medpharm/12447,"–°—É–¥ –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª –∫–∞—Ä—Ç–µ–ª—å–Ω—ã–π —Å–≥–æ–≤–æ—Ä –Ω–∞ 30 –º–ª–Ω —Ä—É–±. –ø—Ä–∏ –∑–∞–∫—É–ø–∫–µ –º–µ–¥–æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –¥–ª—è –±–æ–ª—å–Ω–∏—Ü—ã –≤ –ò—Ä–∫—É—Ç—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏. –ö–∞–∫ –≤—ã—è—Å–Ω–∏–ª–∞ –§–ê–°, –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ê–¥–≤–∞–Ω—Ç–∞ –≥—Ä—É–ø–ø¬ª –∏ ¬´–ê–ª—å—Ç–µ—Ä–∞-–ª–∞–±¬ª –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ —Å–æ–∑–¥–∞–ª–∏ –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏—é –Ω–∞ —Ç–æ—Ä–≥–∞—Ö.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration, sanctions"",
  ""impact"": ""high"",
  ""english"": ""The court confirmed a cartel agreement in the procurement of medical equipment for a hospital in Irkutsk region. It was found by FAS that companies 'Advantra Group' and 'Altura Lab' artificially created competition on the bidding process.""
}"
2025-07-24T07:20:54+00:00,@medpharm,12446,https://t.me/medpharm/12446,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –Ω–∞–¥–µ–ª–µ–Ω –ø–æ–ª–Ω–æ–º–æ—á–∏–µ–º –ø–æ —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏—é –æ—Å–æ–±–æ–≥–æ –ø–æ—Ä—è–¥–∫–∞ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π. –ü–æ—Å—Ç–∞–≤–ª–µ–Ω–∞ —Ç–æ—á–∫–∞ –≤ —Å–ø–æ—Ä–µ –æ —Ç–æ–º, —Å—Ç–∞–Ω—É—Ç –ª–∏ —ç—Ç–∏ –¥–æ–∫—É–º–µ–Ω—Ç—ã –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–º–∏ –¥–ª—è –∏—Å–ø–æ–ª–Ω–µ–Ω–∏—è.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""high"",
  ""english"": ""The Ministry of Health has been granted the authority to approve a special order for the application of clinical recommendations. The dispute over whether these documents are mandatory has been settled.""
}"
2025-07-23T15:41:12+00:00,@medpharm,12445,https://t.me/medpharm/12445,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 23 –∏—é–ª—è –ü–æ—Å—Ç–∞–≤—è—Ç –Ω–∞ –ø–∞—É–∑—É –ì–æ—Å–¥—É–º–∞ –ø—Ä–∏–Ω—è–ª–∞ –≤ —Ç—Ä–µ—Ç—å–µ–º —á—Ç–µ–Ω–∏–∏ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç, –∫–æ—Ç–æ—Ä—ã–º —É—Å—Ç–∞–Ω–∞–≤–ª–∏–≤–∞–µ—Ç—Å—è –º–æ—Ä–∞—Ç–æ—Ä–∏–π –Ω–∞ –≤—ã–¥–∞—á—É –ª–∏—Ü–µ–Ω–∑–∏–π –Ω–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –∏ –ø–æ—Å—Ç–∞–≤–∫–∏ —ç—Ç–∏–ª–æ–≤–æ–≥–æ —Å–ø–∏—Ä—Ç–∞, –≤ —Ç–æ–º —á–∏—Å–ª–µ –¥–ª—è –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏–π. –ú–æ—Ä–∞—Ç–æ—Ä–∏–π –±—É–¥–µ—Ç –¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å –¥–æ –∞–ø—Ä–µ–ª—è 2027 –≥–æ–¥–∞. –ê–¥–≤–æ–∫–∞—Ç—Å–∫–∞—è –º–æ–Ω–æ–ø–æ–ª–∏—è –†–ê–ê–° –∫—Ä–∏—Ç–∏–∫—É–µ—Ç –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –ú–∏–Ω—é—Å—Ç–∞ –æ–± –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–º –∞–¥–≤–æ–∫–∞—Ç—Å–∫–æ–º —Å—Ç–∞—Ç—É—Å–µ –¥–ª—è —Å—É–¥–µ–±–Ω—ã—Ö –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–µ–π. –í –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ —Å—á–∏—Ç–∞—é—Ç, —á—Ç–æ —ç—Ç–æ –æ–≥—Ä–∞–Ω–∏—á–∏—Ç –ø—Ä–∞–≤–∞ –∫–æ—Ä–ø–æ—Ä–∞—Ç–∏–≤–Ω—ã—Ö —é—Ä–∏—Å—Ç–æ–≤ –∏ —Å–≤—è–∑–∞–Ω–Ω—ã—Ö –∫–æ–º–ø–∞–Ω–∏–π. –ü—Ä–∏—Ç—è–∂–µ–Ω—å–µ –∑–µ–º–ª–∏ –£ ¬´–∑–µ–º—Å–∫–∏—Ö¬ª –ø—Ä–æ–≥—Ä–∞–º–º–∞–º –µ—Å—Ç—å –¥–µ–º–æ–≥—Ä–∞—Ñ–∏—á–µ—Å–∫–∏–π –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª, –ø–æ—Å–∫–æ–ª—å–∫—É –≤ –Ω–∏—Ö —á–∞—â–µ –≤—Å–µ–≥–æ —É—á–∞—Å—Ç–≤—É—é—Ç –∂–µ–Ω—â–∏–Ω—ã –¥–æ 40 –ª–µ—Ç. –ß—Ç–æ–±—ã —Å–æ–≤–º–µ—Å—Ç–∏—Ç—å —Ä–µ—à–µ–Ω–∏–µ –ø—Ä–æ–±–ª–µ–º –¥–µ—Ñ–∏—Ü–∏—Ç–∞ –∫–∞–¥—Ä–æ–≤ –∏ –¥–µ–º–æ–≥—Ä–∞—Ñ–∏—á–µ—Å–∫–æ–≥–æ —Å–ø–∞–¥–∞, –ø–æ–Ω–∞–¥–æ–±—è—Ç—Å—è –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–µ –º–µ—Ä—ã –ø–æ–¥–¥–µ—Ä–∂–∫–∏. –ù–æ–≤—ã–π –∑–Ω–∞–∫–æ–º—ã–π –í –†–æ—Å—Å–∏–∏ —Å –∞–ø—Ä–µ–ª—è –≤—ã—è–≤–∏–ª–∏ –±–æ–ª–µ–µ 110 —Å–ª—É—á–∞–µ–≤ –∑–∞—Ä–∞–∂–µ–Ω–∏—è –Ω–æ–≤—ã–º –ø–æ–¥–≤–∞—Ä–∏–∞–Ω—Ç–æ–º –∫–æ—Ä–æ–Ω–∞–≤–∏—Ä—É—Å–∞ ¬´–°—Ç—Ä–∞—Ç—É—Å¬ª. –ë–æ–ª—å—à–µ –≤—Å–µ–≥–æ –∑–∞–±–æ–ª–µ–≤—à–∏—Ö –≤ –ú–æ—Å–∫–≤–µ.","{""skip"": true}"
2025-07-23T14:15:58+00:00,@medpharm,12444,https://t.me/medpharm/12444,"–ò—Å—Ç–æ—á–Ω–∏–∫–∏ Bloomberg —Å–æ–æ–±—â–∏–ª–∏, —á—Ç–æ –±—Ä–∏—Ç–∞–Ω—Å–∫–∏–π –∏–Ω–≤–µ—Å—Ç—Ñ–æ–Ω–¥ CapVest –æ–±—Å—É–∂–¥–∞–µ—Ç –ø–æ–∫—É–ø–∫—É –∫–æ–Ω—Ç—Ä–æ–ª—å–Ω–æ–≥–æ –ø–∞–∫–µ—Ç–∞ –∞–∫—Ü–∏–π –Ω–µ–º–µ—Ü–∫–æ–π —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ Stada –∑–∞ 10 –º–ª—Ä–¥ –µ–≤—Ä–æ —Å –µ–µ —Ç–µ–∫—É—â–∏–º–∏ –≤–ª–∞–¥–µ–ª—å—Ü–∞–º–∏ ‚Äî Bain Capital –∏ Cinven. –°–¥–µ–ª–∫–∞ –º–æ–∂–µ—Ç —Å—Ç–∞—Ç—å –æ–¥–Ω–æ–π –∏–∑ –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö –≤ –æ—Ç—Ä–∞—Å–ª–∏ –∑–∞ —ç—Ç–æ—Ç –≥–æ–¥.","{""skip"": true}"
2025-07-23T12:47:06+00:00,@medpharm,12443,https://t.me/medpharm/12443,"#—ç–∫—Å–∫–ª—é–∑–∏–≤ –ë–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ —á–∞—Å—Ç–Ω—ã—Ö –∫–ª–∏–Ω–∏–∫ –ø–æ–∫–∞ –Ω–µ –≥–æ—Ç–æ–≤—ã –ø–µ—Ä–µ–¥–∞–≤–∞—Ç—å –¥–∞–Ω–Ω—ã–µ –æ–± –æ–∫–∞–∑–∞–Ω–Ω–æ–π –∏–º–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –≤ —ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω–æ–º –≤–∏–¥–µ –≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–∏–µ –∏–Ω—Ñ–æ—Ä–º—Å–∏—Å—Ç–µ–º—ã. –≠—Ç–æ–º—É –ø—Ä–µ–ø—è—Ç—Å—Ç–≤—É—é—Ç –Ω–µ —Ç–æ–ª—å–∫–æ —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–∏–µ —Å–ª–æ–∂–Ω–æ—Å—Ç–∏, –Ω–æ –∏ —Å—Ç—Ä–∞—Ö –ø–µ—Ä–µ–¥ –Ω–∞–∫–∞–∑–∞–Ω–∏–µ–º.","{""skip"": true}"
2025-07-23T12:14:44+00:00,@medpharm,12442,https://t.me/medpharm/12442,"–°–µ–≥–æ–¥–Ω—è –Ω–∞ –≥–ª–∞–≤–Ω–æ–µ —Ñ–∞—Ä–º—Å–æ–±—ã—Ç–∏–µ —ç—Ç–æ–π –æ—Å–µ–Ω–∏ –≤–∞—Å –ø—Ä–∏–≥–ª–∞—à–∞–µ—Ç üîπ–ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ß–µ—Ä–Ω–∏—á–µ–Ω–∫–æ, –≥–µ–Ω–µ—Ä–∞–ª—å–Ω—ã–π –¥–∏—Ä–µ–∫—Ç–æ—Ä ¬´–ú—å—é–∑ –ú–µ–¥–∏–∞¬ª, –º–æ–¥–µ—Ä–∞—Ç–æ—Ä –±—Ä–µ–π–Ω—Å—Ç–æ—Ä–º —Å–µ—Å—Å–∏–∏ ¬´–ù–∞ –≥—Ä–∞–Ω–∏ –ø–æ–ª—å–∑—ã –∏ –º–∞–Ω–∏–ø—É–ª—è—Ü–∏–∏: –ë–ê–î –∫–∞–∫ —Ä—ã–Ω–æ–∫, –±–∏–∑–Ω–µ—Å –∏ –ø–æ–ª–µ –¥–ª—è —Ä–∏—Å–∫–æ–≤¬ª 11-12 —Å–µ–Ω—Ç—è–±—Ä—è 2025 üìç–≥. –°–æ—á–∏, Pullman –°–æ—á–∏ –¶–µ–Ω—Ç—Ä 5* –ì–æ—Ç–æ–≤—ã –∫ –∏–∑–º–µ–Ω–µ–Ω–∏—è–º? –£–∑–Ω–∞–π—Ç–µ, –∫—É–¥–∞ –¥–≤–∏–∂–µ—Ç—Å—è –º–∏—Ä —Ñ–∞—Ä–º—ã, –∏ –∫–∞–∫–∏–µ —Ä–µ—à–µ–Ω–∏—è –ø—Ä–∏–Ω–∏–º–∞—Ç—å —Å–µ–π—á–∞—Å! –î–æ 31 –∏—é–ª—è –°–ü–ï–¶–¶–ï–ù–ê. –†–µ–≥–∏—Å—Ç—Ä–∏—Ä—É–π—Ç–µ –∫–æ–º–∞–Ω–¥—É: 2+ —á–µ–ª–æ–≤–µ–∫ = –°–ö–ò–î–ö–ê 15% –Ω–∞ –≤—Ç–æ—Ä–æ–≥–æ –∏ –ø–æ—Å–ª–µ–¥—É—é—â–∏—Ö.","{""skip"": true}"
2025-07-23T10:05:44+00:00,@medpharm,12441,https://t.me/medpharm/12441,"–ö–æ–ª–ª–µ–≥–∏—è –ï–≠–ö —É—Ç–≤–µ—Ä–¥–∏–ª–∞ –ø—Ä–æ–µ–∫—Ç –∏–∑–º–µ–Ω–µ–Ω–∏–π –≤ –ü—Ä–∞–≤–∏–ª–∞ –Ω–∞–¥–ª–µ–∂–∞—â–µ–π –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–π –ø—Ä–∞–∫—Ç–∏–∫–∏ (GCP), –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–Ω—ã—Ö –Ω–∞ –≥–∞—Ä–º–æ–Ω–∏–∑–∞—Ü–∏—é —Å –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã–º–∏ —Å—Ç–∞–Ω–¥–∞—Ä—Ç–∞–º–∏. –ü—Ä–∞–≤–∫–∏ –≤–∫–ª—é—á–∞—é—Ç –æ—Ç–º–µ–Ω—É –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–π –æ—Ç—á–µ—Ç–Ω–æ—Å—Ç–∏ –ø–æ —Ä–µ–∞–∫—Ü–∏—è–º –Ω–∞ –ø–ª–∞—Ü–µ–±–æ, —É—Ç–æ—á–Ω–µ–Ω–∏–µ —Å—Ä–æ–∫–æ–≤ –ø–æ–¥–∞—á–∏ –¥–∞–Ω–Ω—ã—Ö –æ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ –∏ –ø–µ—Ä–µ—Ö–æ–¥ –Ω–∞ —ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω—ã–π –¥–æ–∫—É–º–µ–Ω—Ç–æ–æ–±–æ—Ä–æ—Ç.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety"",
  ""impact"": ""medium"",
  ""english"": ""The Committee on EEC approved the project of amendments to Good Clinical Practice (GCP) rules aimed at harmonization with international standards. The changes include the cancellation of mandatory reporting on placebo reactions, clarification of safety data submission timelines, and transition to electronic document flow.""
}"
2025-07-23T08:35:49+00:00,@medpharm,12440,https://t.me/medpharm/12440,"–í –Ø—Ä–æ—Å–ª–∞–≤–ª–µ —Å–æ—Å—Ç–æ—è–ª—Å—è –Ω–æ—á–Ω–æ–π –∑–∞–±–µ–≥ ‚Äî –æ–¥–Ω–æ –∏–∑ —Å–∞–º—ã—Ö –º–∞—Å—à—Ç–∞–±–Ω—ã—Ö —Å–ø–æ—Ä—Ç–∏–≤–Ω—ã—Ö –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–π —Ä–µ–≥–∏–æ–Ω–∞, —Å–æ–±—Ä–∞–≤—à–µ–µ –±–æ–ª–µ–µ –¥–≤—É—Ö —Ç—ã—Å—è—á —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤. ¬´–†-–§–∞—Ä–º¬ª –≤—ã—Å—Ç—É–ø–∏–ª —Ç–∏—Ç—É–ª—å–Ω—ã–º —Å–ø–æ–Ω—Å–æ—Ä–æ–º –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏—è. –ì—Ä—É–ø–ø—É –∫–æ–º–ø–∞–Ω–∏–π —Å—Ä–µ–¥–∏ –±–µ–≥—É–Ω–æ–≤ –∏ –±–æ–ª–µ–ª—å—â–∏–∫–æ–≤ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∏ –±–æ–ª–µ–µ —Å—Ç–∞ —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤.","{""skip"": true}"
2025-07-23T07:17:34+00:00,@medpharm,12439,https://t.me/medpharm/12439,–í—Ä–∏–æ –≥–ª–∞–≤—ã –ï–≤—Ä–µ–π—Å–∫–æ–π –∞–≤—Ç–æ–Ω–æ–º–Ω–æ–π –æ–±–ª–∞—Å—Ç–∏ –ú–∞—Ä–∏—è –ö–æ—Å—Ç—é–∫ –≤—ã–¥–≤–∏–Ω—É–ª–∞ —Ç—Ä–∏ –∫–∞–Ω–¥–∏–¥–∞—Ç—É—Ä—ã –Ω–∞ –¥–æ–ª–∂–Ω–æ—Å—Ç—å —Å–µ–Ω–∞—Ç–æ—Ä–∞ –æ—Ç —Ä–µ–≥–∏–æ–Ω–∞. –û–¥–Ω–∞ –∏–∑ –Ω–∏—Ö ‚Äî –∑–∞–º–º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –†–§ –ù–∞—Ç–∞–ª—å—è –•–æ—Ä–æ–≤–∞.,"{""skip"": true}"
2025-07-22T16:01:09+00:00,@medpharm,12438,https://t.me/medpharm/12438,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 22 –∏—é–ª—è –î–æ–±—Ä–æ–≤–æ–ª—å–Ω–æ‚Äì–ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω–æ –í –ì–æ—Å–¥—É–º–µ –Ω–µ —Å—á–∏—Ç–∞—é—Ç —Å–∏—Å—Ç–µ–º—É –æ—Ç—Ä–∞–±–æ—Ç–∫–∏ –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–≤—É–∑–æ–≤ –≤ —Å–∏—Å—Ç–µ–º–µ –û–ú–° –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω–æ–π. –û—Ç—É—á–∏–≤—à–∏–µ—Å—è –Ω–∞ –±—é–¥–∂–µ—Ç–Ω–æ–º –æ—Ç–¥–µ–ª–µ–Ω–∏–∏ –¥–æ–ª–∂–Ω—ã –≤–æ–∑–≤—Ä–∞—â–∞—Ç—å –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤—É –¥–æ–ª–≥ —Å–≤–æ–∏–º —Ç—Ä—É–¥–æ–º, —Ç–∞–∫–∞—è —Å–∏—Å—Ç–µ–º–∞ –ø–æ–ª–µ–∑–Ω–∞ –∏ –¥–ª—è —Å–∞–º–æ–≥–æ –º–æ–ª–æ–¥–æ–≥–æ –≤—Ä–∞—á–∞, —Å—á–∏—Ç–∞–µ—Ç –≥–ª–∞–≤–∞ –ö–æ–º–∏—Ç–µ—Ç–∞ –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è –°–µ—Ä–≥–µ–π –õ–µ–æ–Ω–æ–≤. –ò–ò –¥–ª—è —Ç—Ä–∞–≤–º–∞—Ç–æ–ª–æ–≥–∞ –ú–æ—Å–∫–≤–µ –≤–Ω–µ–¥—Ä–∏–ª–∏ –Ω–æ–≤—ã–π —Å–µ—Ä–≤–∏—Å –Ω–∞ –±–∞–∑–µ –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–∞ (–ò–ò), —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–Ω—ã–π –¥–ª—è –≤—ã—è–≤–ª–µ–Ω–∏—è –ø–µ—Ä–µ–ª–æ–º–æ–≤ –∫–æ—Å—Ç–µ–π –ø–ª–µ—á–µ–≤–æ–≥–æ —Å—É—Å—Ç–∞–≤–∞. –ï–≥–æ –±—É–¥—É—Ç –ø—Ä–∏–º–µ–Ω—è—Ç—å –≥–æ—Ä–æ–¥—Å–∫–∏–µ –±–æ–ª—å–Ω–∏—Ü—ã –∏ –ø–æ–ª–∏–∫–ª–∏–Ω–∏–∫–∏, –∞ —Ç–∞–∫–∂–µ —Ç—Ä–∞–≤–º–∞—Ç–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–µ –ø—É–Ω–∫—Ç—ã. –°–≤–æ–∏–º–∏ —Å–∏–ª–∞–º–∏ –ë—é–¥–∂–µ—Ç–Ω–æ–≥–æ —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è –¥–ª—è —Ä–∞–±–æ—Ç—ã –ø–µ—Ä–µ–¥–≤–∏–∂–Ω—ã—Ö –∞–ø—Ç–µ–∫ –Ω–µ –ø—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ–Ω–æ, –∞–ø—Ç–µ—á–Ω—ã–µ —Å–µ—Ç–∏ –±—É–¥—É—Ç —Å–∞–º–∏ –Ω–µ—Å—Ç–∏ —Ñ–∏–Ω–∞–Ω—Å–æ–≤—É—é –Ω–∞–≥—Ä—É–∑–∫—É, —Å–æ–æ–±—â–∏–ª ¬´–§–í¬ª –¥–µ–ø—É—Ç–∞—Ç –ì–æ—Å–¥—É–º—ã –ï–≤–≥–µ–Ω–∏–π –ù–∏—Ñ–∞–Ω—Ç—å–µ–≤. –ü–æ –º–∏–ª–ª–∏–∞—Ä–¥—É –≤ –≥–æ–¥ –†–æ—Å—Å–∏—è–Ω–µ —Å—Ç–∞–ª–∏ –±–æ–ª—å—à–µ –ø–æ–∫—É–ø–∞—Ç—å –ø—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –≤ –∞–ø—Ç–µ–∫–∞—Ö. –ï–∂–µ–≥–æ–¥–Ω–æ –æ–Ω–∏ —Ç—Ä–∞—Ç—è—Ç –±–æ–ª—å—à–µ 7 –º–ª—Ä–¥ —Ä—É–±. –Ω–∞ –ø–æ–∫—É–ø–∫—É –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –æ—Ç —Ä–∞–∫–∞. –≠—Ç–∞ —Ü–∏—Ñ—Ä–∞ —Ä–∞—Å—Ç–µ—Ç –Ω–∞ 1 –º–ª—Ä–¥ —Ä—É–±. –≤ –≥–æ–¥. –í —É–ø–∞–∫–æ–≤–∫–∞—Ö —Ç–∞–∫–∂–µ –µ—Å—Ç—å –ø—Ä–∏—Ä–æ—Å—Ç, —Ö–æ—Ç—è –∏ –º–µ–Ω–µ–µ –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω—ã–π.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""The country is global. Topics include clinical trials, pharmacovigilance, and safety. Impact level is medium. The message discusses the development of a new service by artificial intelligence for identifying fractures in the shoulder joint, which will be used by city hospitals and clinics, as well as trauma centers.""
}"
2025-07-22T14:31:41+00:00,@medpharm,12437,https://t.me/medpharm/12437,"–ó–Ω–∞–∫–æ–º—å—Ç–µ—Å—å —Å–æ —Å–ª–µ–¥—É—é—â–∏–º —Å–ø–∏–∫–µ—Ä–æ–º PRO–µ–∫—Ü–∏–π –ë—É–¥—É—â–µ–≥–æ: üîπ–ò–≥–æ—Ä—å –•–∞—Å–∏–Ω, –¥–∏—Ä–µ–∫—Ç–æ—Ä –ø—Ä–æ–≥—Ä–∞–º–º —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–æ–≥–æ —Ä–∞–∑–≤–∏—Ç–∏—è –ê–û ¬´–¢–æ–Ω—É—Å¬ª, —Å–ø–∏–∫–µ—Ä —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–æ–π —Å–µ—Å—Å–∏–∏ ¬´–ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—ã–π –∫—É—Ä—Å. –ì–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–π –∫–æ–Ω—Ç—É—Ä —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –æ—Ç—Ä–∞—Å–ª–∏¬ª –î–∞—Ç–∞ –∏ –≤—Ä–µ–º—è —Å–µ—Å—Å–∏–∏: 11 —Å–µ–Ω—Ç—è–±—Ä—è 2025, 11:15 üìç–≥. –°–æ—á–∏, Pullman –°–æ—á–∏ –¶–µ–Ω—Ç—Ä 5* –ü–æ–¥—Ä–æ–±–Ω–µ–µ –æ –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ –∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –Ω–∞ —Å–∞–π—Ç–µ.","{""skip"": true}"
2025-07-22T13:09:49+00:00,@medpharm,12436,https://t.me/medpharm/12436,"#—ç–∫—Å–∫–ª—é–∑–∏–≤ –ë—é–¥–∂–µ—Ç–Ω–æ–≥–æ —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è –¥–ª—è —Ä–∞–±–æ—Ç—ã –ø–µ—Ä–µ–¥–≤–∏–∂–Ω—ã—Ö –∞–ø—Ç–µ–∫ –Ω–µ –ø—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ–Ω–æ, –∞–ø—Ç–µ—á–Ω—ã–µ —Å–µ—Ç–∏ –±—É–¥—É—Ç —Å–∞–º–∏ –Ω–µ—Å—Ç–∏ —Ñ–∏–Ω–∞–Ω—Å–æ–≤—É—é –Ω–∞–≥—Ä—É–∑–∫—É, —Å–æ–æ–±—â–∏–ª ¬´–§–í¬ª –¥–µ–ø—É—Ç–∞—Ç –ì–æ—Å–¥—É–º—ã –ï–≤–≥–µ–Ω–∏–π –ù–∏—Ñ–∞–Ω—Ç—å–µ–≤. –°–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–∏–π –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –±—É–¥–µ—Ç —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω –æ–¥–Ω–∏–º –∏–∑ –ø–µ—Ä–≤—ã—Ö –≤ —Ö–æ–¥–µ –æ—Å–µ–Ω–Ω–µ–π —Å–µ—Å—Å–∏–∏ –ì–æ—Å–¥—É–º—ã.","{""skip"": true}"
2025-07-22T12:05:00+00:00,@medpharm,12435,https://t.me/medpharm/12435,"–ì–ª–∞–≤–Ω—ã–π –≤–Ω–µ—à—Ç–∞—Ç–Ω—ã–π —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç –ø–æ –∫–æ—Å–º–µ—Ç–æ–ª–æ–≥–∏–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –°–∞–º–∞—Ä—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –û–ª—å–≥–∞ –ö–æ–ª—Å–∞–Ω–æ–≤–∞ –æ —Ç–æ–º, –ø–æ—á–µ–º—É –∫–∞–¥—Ä–æ–≤—ã–π –≤–æ–ø—Ä–æ—Å ‚Äî –ø—Ä–æ–±–ª–µ–º–∞ –¥–ª—è —Ä–∞–∑–≤–∏—Ç–∏—è —á–∞—Å—Ç–Ω–æ–≥–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –±–∏–∑–Ω–µ—Å–∞ –≤ —Ä–µ–≥–∏–æ–Ω–∞—Ö –∏ –∫–∞–∫ –ª–æ–∫–∞–ª—å–Ω—ã–µ —Ä–µ—à–µ–Ω–∏—è –µ–≥–æ –∫–æ–º–ø–µ–Ω—Å–∏—Ä—É—é—Ç.","{""skip"": true}"
2025-07-22T11:28:56+00:00,@medpharm,12434,https://t.me/medpharm/12434,"#—ç–∫—Å–∫–ª—é–∑–∏–≤ –ì–ö ¬´–ú–µ–¥—Å–∫–∞–Ω¬ª –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∞ —Å–æ–∫—Ä–∞—Ç–∏—Ç—å —á–∏—Å–ª–æ –∫–æ–º–ø–∞–Ω–∏–π ‚Äî —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω—ã—Ö —Å–∏—Å—Ç–µ–º –¥–ª—è –∫–æ–º–º–µ—Ä—á–µ—Å–∫–∏—Ö –∫–ª–∏–Ω–∏–∫ –≤ –¥–µ—Å—è—Ç—å —Ä–∞–∑. –í–º–µ—Å—Ç–æ —Ä–∞–∑–Ω–æ–æ–±—Ä–∞–∑–Ω—ã—Ö —Ü–∏—Ñ—Ä–æ–≤—ã—Ö —Å–µ—Ä–≤–∏—Å–æ–≤ –Ω–µ–±–æ–ª—å—à–∏–º —á–∞—Å—Ç–Ω—ã–º –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—è–º –Ω—É–∂–Ω–∞ —Å—Ç–∞–Ω–¥–∞—Ä—Ç–Ω–∞—è –ø–ª–∞—Ç—Ñ–æ—Ä–º–∞, —Å—á–∏—Ç–∞—é—Ç –≤ –∫–æ–º–ø–∞–Ω–∏–∏.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""A exclusive Medscan proposal suggests reducing the number of medical information system developers for commercial clinics by ten times. Small private hospitals need a standard platform, according to the company.""
}"
2025-07-22T08:35:13+00:00,@medpharm,12432,https://t.me/medpharm/12432,"¬´PRO–µ–∫—Ü–∏–∏ –ë—É–¥—É—â–µ–≥–æ¬ª ‚Äî –ø—Ä–æ—Å—Ç—Ä–∞–Ω—Å—Ç–≤–æ, –≥–¥–µ –∑–∞—Ä–æ–∂–¥–∞–µ—Ç—Å—è –±–∏–∑–Ω–µ—Å-–ø–∞—Ä—Ç–Ω–µ—Ä—Å—Ç–≤–æ: - –Ω–æ–≤—ã–µ –∫–æ–Ω—Ç—Ä–∞–∫—Ç—ã, - —Ä–µ–∞–ª—å–Ω—ã–µ –∫–µ–π—Å—ã –∏ –∏–¥–µ–∏, - –æ–±–º–µ–Ω –æ–ø—ã—Ç–æ–º –∏ –∫–æ–ª–ª–∞–±–æ—Ä–∞—Ü–∏–∏, - –æ—Ç–≤–µ—Ç—ã –Ω–∞ —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏–µ –≤–æ–ø—Ä–æ—Å—ã. –ò—â–∏—Ç–µ –Ω–µ —Ç–æ–ª—å–∫–æ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é, –Ω–æ –∏ —Å–≤—è–∑–∏ —Å –∫–ª—é—á–µ–≤—ã–º–∏ –ø–µ—Ä—Å–æ–Ω–∞–º–∏. –í —á–∏—Å–ª–µ —Å–ø–∏–∫–µ—Ä–æ–≤ –¥–µ–ª–æ–≤–æ–π –ø—Ä–æ–≥—Ä–∞–º–º—ã –≤–µ–¥—É—â–∏–µ —ç–∫—Å–ø–µ—Ä—Ç—ã –æ—Ç—Ä–∞—Å–ª–∏: üîπ–í–∏–∫—Ç–æ—Ä –î–º–∏—Ç—Ä–∏–µ–≤, –≥–µ–Ω–µ—Ä–∞–ª—å–Ω—ã–π –¥–∏—Ä–µ–∫—Ç–æ—Ä –ê–†–§–ü üîπ–≠–º–∏–ª—å –•—É–±–∞–ª–∏–µ–≤, –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å –≥–µ–Ω–µ—Ä–∞–ª—å–Ω–æ–≥–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –∞–ø—Ç–µ—á–Ω–æ–π —Å–µ—Ç–∏ ¬´–í–∏—Ç–∞¬ª üîπ–°–µ—Ä–≥–µ–π –ì–ª–∞–≥–æ–ª–µ–≤, –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å –º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –†–æ—Å—Å–∏–π—Å–∫–æ–π –§–µ–¥–µ—Ä–∞—Ü–∏–∏ üîπ–ê—Ä—Ç—É—Ä –í–∞–ª–∏–µ–≤, –≥–µ–Ω–µ—Ä–∞–ª—å–Ω—ã–π –¥–∏—Ä–µ–∫—Ç–æ—Ä Sun Pharma –ï–≤—Ä–∞–∑–∏—è üîπ–ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ü–µ—Ç—Ä–æ–≤, –¥–µ–ø—É—Ç–∞—Ç –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π –î—É–º—ã üîπ–ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ñ–µ—Å—Ç–∫–æ–≤, –∏—Å–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–π –¥–∏—Ä–µ–∫—Ç–æ—Ä –°–æ—é–∑–∞ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ë–ê–î üîπ–ò–≥–æ—Ä—å –•–∞—Å–∏–Ω, –¥–∏—Ä–µ–∫—Ç–æ—Ä –ø—Ä–æ–≥—Ä–∞–º–º —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–æ–≥–æ —Ä–∞–∑–≤–∏—Ç–∏—è –ê–û ¬´–¢–æ–Ω—É—Å¬ª üîπ–ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ß–µ—Ä–Ω–∏—á–µ–Ω–∫–æ, –≥–µ–Ω–µ—Ä–∞–ª—å–Ω—ã–π –¥–∏—Ä–µ–∫—Ç–æ—Ä ¬´–ú—å—é–∑ –ú–µ–¥–∏–∞¬ª –∏ 20+ —ç–∫—Å–ø–µ—Ä—Ç–æ–≤. –î–æ 31 –∏—é–ª—è –°–ü–ï–¶–¶–ï–ù–ê. –†–µ–≥–∏—Å—Ç—Ä–∏—Ä—É–π—Ç–µ –∫–æ–º–∞–Ω–¥—É: 2+ —á–µ–ª–æ–≤–µ–∫ = –°–ö–ò–î–ö–ê 15% –Ω–∞ –≤—Ç–æ—Ä–æ–≥–æ –∏ –ø–æ—Å–ª–µ–¥—É—é—â–∏—Ö. –∏ –±—Ä–æ–Ω–∏—Ä—É–π—Ç–µ –º–µ—Å—Ç–æ!","{""skip"": true}"
2025-07-22T07:17:01+00:00,@medpharm,12431,https://t.me/medpharm/12431,"Sarepta Therapeutics –æ—Ç–∫–∞–∑–∞–ª–∞—Å—å –≤—ã–ø–æ–ª–Ω–∏—Ç—å —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–µ FDA –æ –ø—Ä–µ–∫—Ä–∞—â–µ–Ω–∏–∏ –ø—Ä–æ–¥–∞–∂ –≥–µ–Ω–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏, –ø—Ä–µ–¥–Ω–∞–∑–Ω–∞—á–µ–Ω–Ω–æ–π –¥–ª—è –ª–µ—á–µ–Ω–∏—è –º—ã—à–µ—á–Ω–æ–π –¥–∏—Å—Ç—Ä–æ—Ñ–∏–∏ –î—é—à–µ–Ω–Ω–∞. –ü—Ä–∏–º–µ–Ω–µ–Ω–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∫–æ–º–ø–∞–Ω–∏–∏ —Å–≤—è–∑—ã–≤–∞—é—Ç —Å–æ —Å–º–µ—Ä—Ç—å—é —Ç—Ä–µ—Ö —á–µ–ª–æ–≤–µ–∫. –£ —Ä–µ–≥—É–ª—è—Ç–æ—Ä–∞ –µ—Å—Ç—å –ø–æ–ª–Ω–æ–º–æ—á–∏—è –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω–æ –∏–∑—ä—è—Ç—å —Ñ–∞—Ä–º–ø—Ä–æ–¥—É–∫—Ü–∏—é —Å —Ä—ã–Ω–∫–∞.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""Sarepta Therapeutics refused to comply with FDA's requirement to stop selling its gene therapy for Duchenne muscular dystrophy, which has resulted in the death of three people. Regulatory authorities have the power to forcibly remove pharmaceutical products from the market.""
}"
2025-07-21T16:00:34+00:00,@medpharm,12430,https://t.me/medpharm/12430,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 21 –∏—é–ª—è –ó–∞—â–∏—Ç–Ω–∏–∫–∞–º –Ω—É–∂–Ω–∞ –∑–∞—â–∏—Ç–∞ –ê—Å—Å–æ—Ü–∏–∞—Ü–∏—è –ø–æ –∑–∞—â–∏—Ç–µ –ø—Ä–∞–≤ –≤ —Å—Ñ–µ—Ä–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è —Ä–∞—Å–∫—Ä–∏—Ç–∏–∫–æ–≤–∞–ª–∞ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ–± –∞–¥–≤–æ–∫–∞—Ç—Å–∫–æ–π –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –∫–∞–∫ –∞–Ω—Ç–∏–∫–æ–Ω—Å—Ç–∏—Ç—É—Ü–∏–æ–Ω–Ω—ã–π. –ü–æ–ø—Ä–∞–≤–∫–∏ –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç –æ–≥—Ä–∞–Ω–∏—á–∏—Ç—å –ø—Ä–∞–≤–æ —é—Ä–∏—Å—Ç–æ–≤ –±–µ–∑ –∞–¥–≤–æ–∫–∞—Ç—Å–∫–æ–≥–æ —Å—Ç–∞—Ç—É—Å–∞ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª—è—Ç—å –∏–Ω—Ç–µ—Ä–µ—Å—ã –≤—Ä–∞—á–µ–π –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –≤ —Å—É–¥–∞—Ö. –ü—Ä–µ–¥—É–ø—Ä–µ–¥–∏–ª–∏ –†–æ—Å–æ–±—Ä–Ω–∞–¥–∑–æ—Ä –≤—ã–Ω–µ—Å –ø—Ä–µ–¥–æ—Å—Ç–µ—Ä–µ–∂–µ–Ω–∏—è —á–µ—Ç—ã—Ä–µ–º –≤—É–∑–∞–º, —Å—Ä–µ–¥–∏ –Ω–∏—Ö –£—Ä–∞–ª—å—Å–∫–∏–π –≥–æ—Å–º–µ–¥—É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç. –•–∞—Ä–∞–∫—Ç–µ—Ä –Ω–∞—Ä—É—à–µ–Ω–∏–π –Ω–µ —É—Ç–æ—á–Ω—è–µ—Ç—Å—è. –ù–µ –Ω–∞—Ä—É—à–µ–Ω–∏–µ –§–ê–° –æ—Ç–∫–ª–æ–Ω–∏–ª–∞ –∂–∞–ª–æ–±—É ¬´–§–∞—Ä–º–∏–º—ç–∫—Å¬ª –Ω–∞ –∑–∞–∫—É–ø–∫—É –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –¥–ª—è ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª. –ö–æ–º–ø–∞–Ω–∏—è —Å—á–∏—Ç–∞–ª–∞ –∞—É–∫—Ü–∏–æ–Ω –Ω–∞—Ä—É—à–µ–Ω–∏–µ–º –ø–∞—Ç–µ–Ω—Ç–∞, –¥–µ–π—Å—Ç–≤—É—é—â–µ–≥–æ –¥–æ –∏—é–Ω—è 2027 –≥–æ–¥–∞. –ù–∞ —á—Ç–æ —Å—Ç–∞–≤–∫–∞ –§–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –≤—ã–Ω—É–∂–¥–µ–Ω—ã –∏—Å–∫–∞—Ç—å –Ω–æ–≤—ã–µ –≤–∞—Ä–∏–∞–Ω—Ç—ã –æ–ø—Ç–∏–º–∏–∑–∞—Ü–∏–∏ –∏–∑–¥–µ—Ä–∂–µ–∫ –≤ —É—Å–ª–æ–≤–∏—è—Ö –∫—Ä–∏–∑–∏—Å–∞ –Ω–µ–ø–ª–∞—Ç–µ–∂–µ–π. –ö–∞–∫ —Ä–∞–±–æ—Ç–∞–µ—Ç —Ñ–∞—Ä–º–∞ –≤ —É—Å–ª–æ–≤–∏—è—Ö –≤—ã—Å–æ–∫–æ–π –∫–ª—é—á–µ–≤–æ–π —Å—Ç–∞–≤–∫–∏, –≤—ã—è—Å–Ω–∏–ª ¬´–§–í¬ª.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The Association for Health Care Rights Criticized a Law Proposal on Legal Practice as Unconstitutional. The amendments propose limiting the right of lawyers without an attorney status to represent doctors and medical organizations in courts. The Association warned Rosobronnadzor about four universities, including the Ural State Medical University. The nature of the violations is not specified. FAS rejected a complaint by 'Farimex' regarding a procurement of a drug for 'The Kindness'. Farimex claims the auction violated their patent, which expires in June 2027. The company is forced to look for new ways of cost optimization due to a high-interest crisis payment situation. 'FarV' explored how pharmaceutical companies operate in times of high key interest rates.""
}"
2025-07-21T12:59:15+00:00,@medpharm,12429,https://t.me/medpharm/12429,"–î–æ –ø–æ–≤—ã—à–µ–Ω–∏—è —Ü–µ–Ω –Ω–∞ —É—á–∞—Å—Ç–∏–µ –≤ –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ ¬´PRO–µ–∫—Ü–∏–∏ –ë—É–¥—É—â–µ–≥–æ¬ª –æ—Å—Ç–∞–ª–æ—Å—å: 1Ô∏è‚É£0Ô∏è‚É£ –¥–Ω–µ–π! –î–æ 31 –∏—é–ª—è —Å–ø–µ—Ü—Ü–µ–Ω–∞, –∞ –ø—Ä–∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –¥–≤—É—Ö –∏ –±–æ–ª–µ–µ —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –≤—Ç–æ—Ä–æ–º—É –∏ –∫–∞–∂–¥–æ–º—É —Å–ª–µ–¥—É—é—â–µ–º—É —Å–∫–∏–¥–∫–∞ 15%. –ù–∞ –≥–ª–∞–≤–Ω–æ–µ —Ñ–∞—Ä–º—Å–æ–±—ã—Ç–∏–µ —ç—Ç–æ–π –æ—Å–µ–Ω–∏ –≤–∞—Å –ø—Ä–∏–≥–ª–∞—à–∞–µ—Ç üîπ–ü–∞–≤–µ–ª –õ–∏—Å–æ–≤—Å–∫–∏–π, –∫.—ç.–Ω. –≤–µ–¥—É—â–∏–π –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã–π —ç–∫–æ–Ω–æ–º–∏—Å—Ç-—ç–∫—Å–ø–µ—Ä—Ç —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ —Ä—ã–Ω–∫–∞, –ª–∏–¥–µ—Ä –≤ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ –∏ –≤–Ω–µ–¥—Ä–µ–Ω–∏–∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã—Ö –∫–æ–º–º–µ—Ä—á–µ—Å–∫–∏—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –¥–ª—è –∞–ø—Ç–µ—á–Ω–æ–≥–æ –∏ —Ñ–∞—Ä–º–±–∏–∑–Ω–µ—Å–∞. –£–∑–Ω–∞–π—Ç–µ, –∫—É–¥–∞ –¥–≤–∏–∂–µ—Ç—Å—è —Ä—ã–Ω–æ–∫ –∏ –∫–∞–∫–∏–µ —à–∞–≥–∏ –¥–µ–ª–∞—Ç—å —Å–µ–π—á–∞—Å, —á—Ç–æ–±—ã –Ω–µ —Ç–µ—Ä—è—Ç—å –ø–æ–∑–∏—Ü–∏–∏ –∑–∞–≤—Ç—Ä–∞. –†–µ–≥–∏—Å—Ç—Ä–∏—Ä—É–π—Ç–µ—Å—å –∏ –±—Ä–æ–Ω–∏—Ä—É–π—Ç–µ –º–µ—Å—Ç–æ! 11-12 —Å–µ–Ω—Ç—è–±—Ä—è 2025 üìç–≥. –°–æ—á–∏, Pullman –°–æ—á–∏ –¶–µ–Ω—Ç—Ä 5*","{""skip"": true}"
2025-07-21T11:11:20+00:00,@medpharm,12428,https://t.me/medpharm/12428,"#–≠–∫—Å–∫–ª—é–∑–∏–≤ –ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–∞—è –∞—Å—Å–æ—Ü–∏–∞—Ü–∏—è —É–ø—Ä–∞–≤–ª–µ–Ω—Ü–µ–≤ —Å—Ñ–µ—Ä—ã –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∞ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤—É —Ä–∞–∑—Ä–∞–±–æ—Ç–∞—Ç—å –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω—ã–π –ø—Ä–∞–≤–æ–≤–æ–π –∞–∫—Ç, —Ä–µ–≥–ª–∞–º–µ–Ω—Ç–∏—Ä—É—é—â–∏–∏ÃÜ –≤—Å–µ –æ—Å–æ–±–µ–Ω–Ω–æ—Å—Ç–∏ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏—è –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–∞ –≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–∏. –í —Ç–æ–º —á–∏—Å–ª–µ –Ω—É–∂–Ω–æ —Ä–∞–∑—Ä–µ—à–∏—Ç—å –≤–æ–ø—Ä–æ—Å—ã –∑–∞—â–∏—Ç—ã –ø–µ—Ä—Å–æ–Ω–∞–ª—å–Ω—ã—Ö –¥–∞–Ω–Ω—ã—Ö –∏ –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç–∏ –∑–∞ –≤—Ä–∞—á–µ–±–Ω—ã–µ –æ—à–∏–±–∫–∏, –µ—Å–ª–∏ —Ä–µ—à–µ–Ω–∏–µ –±—ã–ª–æ –ø—Ä–∏–Ω—è—Ç–æ —Å –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ–º —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ –ò–ò.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial, safety"",
  ""impact"": ""high"",
  ""english"": ""The national association of healthcare management proposed to the government to develop a regulatory legal act regulating all aspects of using artificial intelligence in health care. This includes allowing issues related to the protection of personal data and accountability for medical errors if a decision is made using AI technology.""
}"
2025-07-21T10:35:42+00:00,@medpharm,12427,https://t.me/medpharm/12427,–ö–æ–º–ø–∞–Ω–∏—è ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª –æ–±—ä—è–≤–∏–ª–∞ –æ –≤—ã–≤–æ–¥–µ –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–∏–π —Ä—ã–Ω–æ–∫ –ø–µ—Ä–≤–æ–≥–æ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏–Ω–≥–∏–±–∏—Ç–æ—Ä–∞ –∞–Ω–¥—Ä–æ–≥–µ–Ω–Ω—ã—Ö —Ä–µ—Ü–µ–ø—Ç–æ—Ä–æ–≤ –≤—Ç–æ—Ä–æ–≥–æ –ø–æ–∫–æ–ª–µ–Ω–∏—è –¥–ª—è –ª–µ—á–µ–Ω–∏—è –º–µ—Ç–∞—Å—Ç–∞—Ç–∏—á–µ—Å–∫–æ–≥–æ –≥–æ—Ä–º–æ–Ω–æ—á—É–≤—Å—Ç–≤–∏—Ç–µ–ª—å–Ω–æ–≥–æ —Ä–∞–∫–∞ –ø—Ä–µ–¥—Å—Ç–∞—Ç–µ–ª—å–Ω–æ–π –∂–µ–ª–µ–∑—ã (–º–ì–ß–†–ü–ñ) –∏ –Ω–µ–º–µ—Ç–∞—Å—Ç–∞—Ç–∏—á–µ—Å–∫–æ–≥–æ –∫–∞—Å—Ç—Ä–∞—Ü–∏–æ–Ω–Ω–æ-—Ä–µ–∑–∏—Å—Ç–µ–Ω—Ç–Ω–æ–≥–æ —Ä–∞–∫–∞ –ø—Ä–µ–¥—Å—Ç–∞—Ç–µ–ª—å–Ω–æ–π –∂–µ–ª–µ–∑—ã (–Ω–º–ö–†–†–ü–ñ).,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""tenders, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""Promed Company announced the launch of Russia's first second-generation anti-androgen inhibitor for metastatic hormone-sensitive prostate cancer (mHSPC) and castration-resistant prostate cancer (CRPC).""
}"
2025-07-21T09:03:29+00:00,@medpharm,12426,https://t.me/medpharm/12426,21 –∏—é–ª—è –≥–µ–Ω–µ—Ä–∞–ª—å–Ω—ã–π –¥–∏—Ä–µ–∫—Ç–æ—Ä –ê–†–§–ü –í–∏–∫—Ç–æ—Ä –î–º–∏—Ç—Ä–∏–µ–≤ –ø—Ä–∞–∑–¥–Ω—É–µ—Ç —Å–≤–æ–π —é–±–∏–ª–µ–π.,"{""skip"": true}"
2025-07-21T07:02:02+00:00,@medpharm,12425,https://t.me/medpharm/12425,"–í –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–µ –∏ –ú–∏–Ω–∑–¥—Ä–∞–≤–µ –æ–±–Ω–∞—Ä—É–∂–∏–ª–∏, —á—Ç–æ –ø–æ—á—Ç–∏ —Ç—Ä–µ—Ç—å –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∫–æ–ª–ª–µ–¥–∂–µ–π –Ω–µ –ø—Ä–∏—Ö–æ–¥—è—Ç –≤ —Å—Ñ–µ—Ä—É –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –ü—Ä–∏ —ç—Ç–æ–º –∫–∞–∂–¥–∞—è –ø—è—Ç–∞—è –Ω–æ–≤–æ–∏—Å–ø–µ—á–µ–Ω–Ω–∞—è –º–µ–¥—Å–µ—Å—Ç—Ä–∞ —É–≤–æ–ª—å–Ω—è–µ—Ç—Å—è –≤ –ø–µ—Ä–≤—ã–π –≥–æ–¥ —Ä–∞–±–æ—Ç—ã.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The government and the Ministry of Health have discovered that nearly one-third of medical college graduates do not enter the healthcare sector. Additionally, every fifth newly graduated nurse is fired within their first year of work.""
}"
2025-07-20T09:05:01+00:00,@medpharm,12424,https://t.me/medpharm/12424,"–ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ –∑–∞ –Ω–µ–¥–µ–ª—é üîµ–ò–∑ –ì–†–õ–° –∏—Å–∫–ª—é—á–∏–ª–∏ –†–£ –Ω–∞ –ø—è—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ 12 —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö —Å—É–±—Å—Ç–∞–Ω—Ü–∏–π. üîµ–§–ê–° –∑–∞–≤–µ—Ä—à–∏–ª–∞ –≤–Ω–µ–ø–ª–∞–Ω–æ–≤—É—é –∞–Ω—Ç–∏–∫–∞—Ä—Ç–µ–ª—å–Ω—É—é –ø—Ä–æ–≤–µ—Ä–∫—É –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ –¶–í ¬´–ü—Ä–æ—Ç–µ–∫¬ª –∏ –Ω–µ –Ω–∞—à–ª–∞ –≤ –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–∞ –Ω–∞—Ä—É—à–µ–Ω–∏–π –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–∞. –ú–µ—Ä–æ–ø—Ä–∏—è—Ç–∏—è –±—ã–ª–∏ —Å–≤—è–∑–∞–Ω—ã —Å –ø–æ—Å—Ç–∞–≤–∫–∞–º–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –¶–µ–Ω—Ç—Ä–∞ –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è. üîµ–ù–æ–≤—ã–µ –ø—Ä–∞–≤–∏–ª–∞ –ø–ª–∞—Ç—ã –∑–∞ —É—á–∞—Å—Ç–∏–µ —É—á–µ–Ω—ã—Ö –≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è—Ö –ø—Ä–∏–≤–µ–¥—É—Ç –∫ –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ–º—É —É–≤–µ–ª–∏—á–µ–Ω–∏—é –∏—Ö —Å—Ç–æ–∏–º–æ—Å—Ç–∏ –∏ –ø–æ—Å—Ç–∞–≤—è—Ç –ø–æ–¥ –≤–æ–ø—Ä–æ—Å —Ü–µ–ª–µ—Å–æ–æ–±—Ä–∞–∑–Ω–æ—Å—Ç—å –∏—Ö –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ –†–æ—Å—Å–∏–∏, —Å—á–∏—Ç–∞—é—Ç –≤ –ê–§–ü–ï–ê–≠–°. üîµ–í –∏—é–ª–µ 2024 –≥–æ–¥–∞ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –æ—Ç–º–µ–Ω–∏–ª–æ –ø—É–Ω–∫—Ç –ø—Ä–∞–≤–∏–ª —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø–µ—Ä–µ—á–Ω–µ–π, —Ä–∞–∑—Ä–µ—à–∞—é—â–∏–π –≤–∫–ª—é—á–∞—Ç—å —ç–∫–≤–∏–≤–∞–ª–µ–Ω—Ç–Ω—ã–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ —Ñ–æ—Ä–º—ã –≤ –ü–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü –±–µ–∑ –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã—Ö –ø—Ä–æ—Ü–µ–¥—É—Ä. üîµ–í –î–¢–ü –≤ –õ–µ–Ω–∏–Ω–≥—Ä–∞–¥—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ —Ç—Ä–∞–≥–∏—á–µ—Å–∫–∏ –ø–æ–≥–∏–± –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–π –¥–∏—Ä–µ–∫—Ç–æ—Ä –∫–æ–Ω—Ç—Ä–∞–∫—Ç–Ω–æ-–∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–æ–π –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ ¬´–≠–∫—Å–µ–ª–ª–µ–Ω–∞¬ª, —Å–æ—É—á—Ä–µ–¥–∏—Ç–µ–ª—å –ù–∞—É—á–Ω–æ-–∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–æ–≥–æ —Ü–µ–Ω—Ç—Ä–∞ ¬´–≠–∫–æ-–±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å¬ª –ö–æ–Ω—Å—Ç–∞–Ω—Ç–∏–Ω –ó–∞—Ö–∞—Ä–æ–≤.","{
  ""skip"": true
}"
2025-07-19T09:03:12+00:00,@medpharm,12423,https://t.me/medpharm/12423,–ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∑–∞ –Ω–µ–¥–µ–ª—é üî¥–†–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–Ω—ã–π –ú–∏–Ω–∑–¥—Ä–∞–≤–æ–º –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ–± –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã—Ö –æ—Ç—Ä–∞–±–æ—Ç–∫–∞—Ö –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –≤—É–∑–æ–≤ –∏ –∫–æ–ª–ª–µ–¥–∂–µ–π –≤ –ø–æ—Å–ª–µ–¥–Ω–∏–π –¥–µ–Ω—å –æ–±—Å—É–∂–¥–µ–Ω–∏—è —Å–æ–±—Ä–∞–ª –¥–µ—Å—è—Ç–∫–∏ –Ω–µ–≥–∞—Ç–∏–≤–Ω—ã—Ö –æ—Ç–∑—ã–≤–æ–≤. üî¥–ü–æ—Å—Ç—É–ø–∏–ª–æ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–µ –æ—Ç –ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–π –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ —É–ø—Ä–∞–≤–ª–µ–Ω—Ü–µ–≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è (–ù–ê–£–ó) –≤–∫–ª—é—á–∏—Ç—å —Ö—Ä–æ–Ω–∏—á–µ—Å–∫—É—é –æ–±—Å—Ç—Ä—É–∫—Ç–∏–≤–Ω—É—é –±–æ–ª–µ–∑–Ω—å –ª–µ–≥–∫–∏—Ö (–•–û–ë–õ) –≤ –ø–µ—Ä–µ—á–µ–Ω—å —Å–æ—Ü–∏–∞–ª—å–Ω–æ –∑–Ω–∞—á–∏–º—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. üî¥–ü—Ä–µ–∑–∏–¥–µ–Ω—Ç –í–ª–∞–¥–∏–º–∏—Ä –ü—É—Ç–∏–Ω –ø–æ—Ä—É—á–∏–ª –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤—É –ø—Ä–æ—Ä–∞–±–æ—Ç–∞—Ç—å –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –æ—Ç–∫—Ä—ã—Ç–∏—è –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã—Ö –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –ø–æ–¥—Ä–∞–∑–¥–µ–ª–µ–Ω–∏–π –≤ —Ä–µ–≥–∏–æ–Ω–∞—Ö —Å –≤—ã—Å–æ–∫–∏–º —É—Ä–æ–≤–Ω–µ–º –∑–∞–±–æ–ª–µ–≤–∞–µ–º–æ—Å—Ç–∏. üî¥–ë–æ–ª—å—à–µ 33% —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –Ω–µ–≥–∞—Ç–∏–≤–Ω–æ –æ—Ü–µ–Ω–∏–≤–∞—é—Ç –∏–¥–µ—é –ø–µ—Ä–µ–¥–∞—Ç—å —á–∞—Å—Ç—å –æ–±—è–∑–∞–Ω–Ω–æ—Å—Ç–µ–π —É—á–∞—Å—Ç–∫–æ–≤—ã—Ö –≤—Ä–∞—á–µ–π —Ñ–µ–ª—å–¥—à–µ—Ä–∞–º. üî¥–§–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –≤—ã—Å—Ç—É–ø–∏–ª–∏ –ø—Ä–æ—Ç–∏–≤ –∑–∞–ø—Ä–µ—Ç–∞ –≤—ã–ø–ª–∞—Ç –≤—Ä–∞—á–∞–º –∑–∞ —É—á–∞—Å—Ç–∏–µ –≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è—Ö (–ö–ò).,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The pharmaceutical industry opposes a ban on paying doctors for participation in clinical trials. The National Health Management Association (NHMA) proposed adding chronic obstructive pulmonary disease (COPD) to the list of socially significant diseases. The government is considering opening additional oncology departments in regions with high disease incidence.""
}"
2025-07-18T17:01:36+00:00,@medpharm,12422,https://t.me/medpharm/12422,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 18 –∏—é–ª—è –° –ø–µ—Ä–≤–æ–≥–æ –≤–∑–≥–ª—è–¥–∞ –£—á–µ–Ω—ã–µ –°–∞—Ä–∞—Ç–æ–≤—Å–∫–æ–≥–æ –º–µ–¥—É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ –≤—ã—è—Å–Ω–∏–ª–∏, –∫–∞–∫ –ø–µ—Ä–≤–∞—è –≤—Å—Ç—Ä–µ—á–∞ —Å –≤—Ä–∞—á–æ–º –≤–ª–∏—è–µ—Ç –Ω–∞ —Ç–µ—á–µ–Ω–∏–µ –±–æ–ª–µ–∑–Ω–∏ –ø–∞—Ü–∏–µ–Ω—Ç–∞. –ü–æ –¥–∞–Ω–Ω—ã–º –∞–≤—Ç–æ—Ä–æ–≤ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è, —Ä–∞–∑–≤–∏—Ç–∏–µ –∫–æ–º–º—É–Ω–∏–∫–∞—Ç–∏–≤–Ω—ã—Ö –Ω–∞–≤—ã–∫–æ–≤ –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ ¬´—Å—É—â–µ—Å—Ç–≤–µ–Ω–Ω–æ –ø–æ–≤—ã—à–∞–µ—Ç —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –ª–µ—á–µ–±–Ω—ã—Ö –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–π¬ª. –°–≤–µ–¥—É—Ç –º–æ—Å—Ç—ã –ò–Ω—Ç–µ–≥—Ä–∞—Ü–∏—è —Å–≤–µ–¥–µ–Ω–∏–π –æ —Å–≤–∏–¥–µ—Ç–µ–ª—å—Å—Ç–≤–∞—Ö –æ —Å–º–µ—Ä—Ç–∏ –≤ –ï–ì–ò–°–ó —Å –¥–∞–Ω–Ω—ã–º–∏ –ø–æ–ø—É–ª—è—Ü–∏–æ–Ω–Ω–æ–≥–æ —Ä–∞–∫–æ–≤–æ–≥–æ —Ä–µ–≥–∏—Å—Ç—Ä–∞ –ø–æ–≤—ã—Å–∏—Ç –¥–æ—Å—Ç–æ–≤–µ—Ä–Ω–æ—Å—Ç—å —Å—Ç–∞—Ç–∏—Å—Ç–∏—á–µ—Å–∫–æ–π –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –æ –∑–∞–±–æ–ª–µ–≤–∞–µ–º–æ—Å—Ç–∏ –∏ —Å–º–µ—Ä—Ç–Ω–æ—Å—Ç–∏ –∏–∑-–∑–∞ –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –≠—Ç–æ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ, –≤ —Ç–æ–º —á–∏—Å–ª–µ –¥–ª—è —Ä–∞—Å—á–µ—Ç–∞ –±—é–¥–∂–µ—Ç–æ–≤ –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–µ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ. –ü–æ—á–∏—Å—Ç–∏–ª–∏ –ø–æ—Ä—Ç—Ñ–µ–ª—å –ú–∏–Ω–∑–¥—Ä–∞–≤ –ø—Ä–∏–æ—Å—Ç–∞–Ω–æ–≤–∏–ª –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ –µ—â–µ 21 –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ¬´–î–∂–æ–¥–∞—Å –≠–∫—Å–ø–æ–∏–º¬ª, –≤–∫–ª—é—á–∞—è —à–µ—Å—Ç—å –ø—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –∏ –¥–µ–≤—è—Ç—å –∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫–æ–≤. –û—Å–Ω–æ–≤–∞–Ω–∏–µ–º —Å—Ç–∞–ª–æ –Ω–∞–ª–∏—á–∏–µ –≤ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–æ–Ω–Ω–æ–º –¥–æ—Å—å–µ –Ω–µ–¥–æ—Å—Ç–æ–≤–µ—Ä–Ω—ã—Ö –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤ –∏ –¥–∞–Ω–Ω—ã—Ö. –ü–æ–ø–æ–ª–Ω—è—Ç –ø–µ—Ä–µ—á–µ–Ω—å –ß–ª–µ–Ω—ã –≠–∫—Å–ø–µ—Ä—Ç–Ω–æ–≥–æ —Å–æ–≤–µ—Ç–∞ —Ñ–æ–Ω–¥–∞ ¬´–ö—Ä—É–≥ –¥–æ–±—Ä–∞¬ª –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –≤–∫–ª—é—á–∏—Ç—å –≤ –ø–µ—Ä–µ—á–Ω–∏ —Ñ–æ–Ω–¥–∞ –Ω–æ–≤–æ–µ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–µ ‚Äî –æ–ø—Ç–∏–∫–æ–º–∏–µ–ª–∏—Ç (–±–æ–ª–µ–∑–Ω—å –î–µ–≤–∏–∫–∞, –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è —Å–ø–µ–∫—Ç—Ä–∞ –æ–ø—Ç–∏–∫–æ–Ω–µ–≤—Ä–æ–º–∏–µ–ª–∏—Ç–∞, –ó–°–û–ù–ú) –∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è –µ–≥–æ –ª–µ—á–µ–Ω–∏—è.","{""skip"": true}"
2025-07-18T14:33:32+00:00,@medpharm,12421,https://t.me/medpharm/12421,"–û–ø–∞—Å–∞–µ—Ç–µ—Å—å –ª–∏ –≤—ã –∞–¥–º–∏–Ω–∏—Å—Ç—Ä–∞—Ç–∏–≤–Ω–æ–π –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç–∏ –∑–∞ –ø–æ–∏—Å–∫ –≤ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç–µ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏, –∫–æ—Ç–æ—Ä–∞—è –Ω–µ–æ–±—Ö–æ–¥–∏–º–∞ –≤–∞–º –¥–ª—è –æ—Å—É—â–µ—Å—Ç–≤–ª–µ–Ω–∏—è —Ç—Ä—É–¥–æ–≤—ã—Ö —Ñ—É–Ω–∫—Ü–∏–π, –Ω–∞–ø—Ä–∏–º–µ—Ä, –æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–∏ –Ω–∞—Ä–∫–æ—Ç–∏—á–µ—Å–∫–∏—Ö –∏ –ø—Å–∏—Ö–æ—Ç—Ä–æ–ø–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤?","{""skip"": true}"
2025-07-18T13:16:52+00:00,@medpharm,12420,https://t.me/medpharm/12420,"#–≠–∫—Å–∫–ª—é–∑–∏–≤ –≠–∫—Å–ø–µ—Ä—Ç—ã –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –≤–∫–ª—é—á–∏—Ç—å –•–û–ë–õ –≤ –ø–µ—Ä–µ—á–µ–Ω—å —Å–æ—Ü–∏–∞–ª—å–Ω–æ –∑–Ω–∞—á–∏–º—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –ü–æ –¥–∞–Ω–Ω—ã–º –í–û–ó, —ç—Ç–∞ –ø–∞—Ç–æ–ª–æ–≥–∏—è –∑–∞–Ω–∏–º–∞–µ—Ç —Ç—Ä–µ—Ç—å–µ –º–µ—Å—Ç–æ —Å—Ä–µ–¥–∏ –æ—Å–Ω–æ–≤–Ω—ã—Ö –ø—Ä–∏—á–∏–Ω —Å–º–µ—Ä—Ç–∏ –≤ –º–∏—Ä–µ.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, safety, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""Exclusive experts proposed to include HOBLE in the list of socially significant diseases. According to WHO data, this pathology ranks third among the main causes of death worldwide.""
}"
2025-07-18T12:15:30+00:00,@medpharm,12419,https://t.me/medpharm/12419,–†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –Ω–æ–≤—ã–µ –æ—Ü–µ–Ω–æ—á–Ω—ã–µ –ª–∏—Å—Ç—ã –¥–ª—è –ø—Ä–æ–≤–µ—Ä–∫–∏ —Ñ–∞—Ä–º–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –Ω–∞ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–µ –ª–∏—Ü–µ–Ω–∑–∏–æ–Ω–Ω—ã–º —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è–º. –î–æ–∫—É–º–µ–Ω—Ç –∑–∞–º–µ–Ω–∏—Ç –¥–µ–π—Å—Ç–≤—É—é—â–∏–π –ø—Ä–∏–∫–∞–∑ –æ—Ç 2022 –≥–æ–¥–∞ –∏ –≤ —Å–ª—É—á–∞–µ –ø—Ä–∏–Ω—è—Ç–∏—è –±—É–¥–µ—Ç –¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å –¥–æ 2028 –≥–æ–¥–∞. –ü—Ä–∏–∫–∞–∑ –∑–∞—Ç—Ä–æ–Ω–µ—Ç –¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–æ–≤ –∏ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã–µ –∞–ø—Ç–µ–∫–∏.,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""high"",
  ""english"": ""Roszdravnadzor has developed new assessment sheets for pharmaceutical companies to check compliance with licensing requirements. The document will replace the 2022 decree and, if adopted, will be in effect until 2028. The decree will affect distributors and federal pharmacies.""
}"
2025-07-18T10:28:50+00:00,@medpharm,12418,https://t.me/medpharm/12418,"–ü—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º –≤–∞–º —Å–ª–µ–¥—É—é—â–µ–≥–æ —Å–ø–∏–∫–µ—Ä–∞ PRO–µ–∫—Ü–∏–π –ë—É–¥—É—â–µ–≥–æ: üîπ–ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ü–µ—Ç—Ä–æ–≤, –¥–µ–ø—É—Ç–∞—Ç –ì–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π –î—É–º—ã, —Å–ø–∏–∫–µ—Ä –¥–∏—Å–∫—É—Å—Å–∏–æ–Ω–Ω–æ–π —Å–µ—Å—Å–∏–∏ ¬´–ê–ø—Ç–µ–∫–∞ –∫–∞–∫ –±–∏–∑–Ω–µ—Å: —ç–∫–æ–Ω–æ–º–∏–∫–∞ —Ä–∏—Ç–µ–π–ª–∞ –≤ —É—Å–ª–æ–≤–∏—è—Ö –º–∞—Ä–∂–∏–Ω–∞–ª—å–Ω–æ–≥–æ –¥–∞–≤–ª–µ–Ω–∏—è¬ª –î–∞—Ç–∞ –∏ –≤—Ä–µ–º—è —Å–µ—Å—Å–∏–∏: 11 —Å–µ–Ω—Ç—è–±—Ä—è 2025, 15:45 üìç–≥. –°–æ—á–∏, Pullman –°–æ—á–∏ –¶–µ–Ω—Ç—Ä 5* –ü–æ–¥—Ä–æ–±–Ω–µ–µ –æ –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ –∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –Ω–∞ —Å–∞–π—Ç–µ.","{""skip"": true}"
2025-07-18T06:59:27+00:00,@medpharm,12416,https://t.me/medpharm/12416,"–î–µ–ø—É—Ç–∞—Ç –ì–æ—Å–¥—É–º—ã –ø—Ä–µ–¥–ª–æ–∂–∏–ª –æ–±—è–∑–∞—Ç—å –≤—Ä–∞—á–µ–π –ø–µ—á–∞—Ç–∞—Ç—å —Ä–µ—Ü–µ–ø—Ç—ã –Ω–∞ –ø—Ä–∏–Ω—Ç–µ—Ä–µ. –û–Ω —Å—á–∏—Ç–∞–µ—Ç, —á—Ç–æ —Ñ–∞—Ä–º—Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –∏ –ø–∞—Ü–∏–µ–Ω—Ç—ã –Ω–µ —Ä–∞–∑–±–∏—Ä–∞—é—Ç –ø–æ—á–µ—Ä–∫ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤. –í –ú–∏–Ω–∑–¥—Ä–∞–≤–µ –ø—Ä–æ–∫–æ–º–º–µ–Ω—Ç–∏—Ä–æ–≤–∞–ª–∏ –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤—É.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""A deputy of the State Duma proposed that doctors must print prescriptions on a printer. He believes that pharmaceutical specialists and patients do not understand the handwriting of healthcare workers. The Ministry of Health commented on the initiative.""
}"
2025-07-17T16:35:38+00:00,@medpharm,12415,https://t.me/medpharm/12415,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 17 –∏—é–ª—è –í–∫–ª—é—á–∏—Ç–µ –ø—Ä–∏–Ω—Ç–µ—Ä –†–æ—Å—Å–∏–π—Å–∫–∏—Ö –≤—Ä–∞—á–µ–π –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –æ–±—è–∑–∞—Ç—å –ø–µ—á–∞—Ç–∞—Ç—å —Ä–µ—Ü–µ–ø—Ç—ã –Ω–∞ –ø—Ä–∏–Ω—Ç–µ—Ä–µ. –í –ì–æ—Å–¥—É–º–µ —Å—á–∏—Ç–∞—é—Ç, —á—Ç–æ –Ω–µ—Ä–∞–∑–±–æ—Ä—á–∏–≤—ã–π –ø–æ—á–µ—Ä–∫ –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –ø—Ä–∏–≤–æ–¥–∏—Ç –∫ –≤—ã–¥–∞—á–µ –Ω–µ–≤–µ—Ä–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –∑–∞–¥–µ—Ä–∂–∫–∞–º –≤ –ª–µ—á–µ–Ω–∏–∏. –ó–∞–¥–µ—Ä–∂–∫–∞ –∑–∞—Ä–ø–ª–∞—Ç—ã –ú–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–∏ –ò—Ä–∫—É—Ç—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ —Å—Ç–∞–ª–∏ –º–∞—Å—Å–æ–≤–æ –∂–∞–ª–æ–≤–∞—Ç—å—Å—è –≥—É–±–µ—Ä–Ω–∞—Ç–æ—Ä—É –Ω–∞ –∑–∞–¥–µ—Ä–∂–∫—É –∑–∞—Ä–ø–ª–∞—Ç—ã. –í –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–µ —Å–∏—Ç—É–∞—Ü–∏—é —Å–≤—è–∑–∞–ª–∏ —Å –≤—Ä–µ–º–µ–Ω–Ω—ã–º–∏ —Å–ª–æ–∂–Ω–æ—Å—Ç—è–º–∏ –≤ —ç–∫–æ–Ω–æ–º–∏–∫–µ, –≤ –ú–∏–Ω–∑–¥—Ä–∞–≤–µ ‚Äî —Å –µ–¥–∏–Ω–æ–≤—Ä–µ–º–µ–Ω–Ω—ã–º–∏ –≤—ã–ø–ª–∞—Ç–∞–º–∏ –æ—Ç–ø—É—Å–∫–Ω—ã—Ö. –¢–∞–∫–∞—è –¥–æ–ª—è –ì–æ—Å–¥—É–º–∞ –ø—Ä–∏–Ω—è–ª–∞ –≤ —Ç—Ä–µ—Ç—å–µ–º —á—Ç–µ–Ω–∏–∏ –∑–∞–∫–æ–Ω –æ –≤–≤–µ–¥–µ–Ω–∏–∏ —Ä–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω–∏—è –∫–æ–º–ø–∞–Ω–∏–π, –∏—Å—Å–ª–µ–¥—É—é—â–∏—Ö —Ç–æ–≤–∞—Ä–Ω—ã–π —Ä—ã–Ω–æ–∫ –≤ –†–æ—Å—Å–∏–∏. –î–æ–∫—É–º–µ–Ω—Ç–æ–º –≤–≤–æ–¥–∏—Ç—Å—è –∑–∞–ø—Ä–µ—Ç –Ω–∞ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏–µ —Ç–∞–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –¥–ª—è –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ —Å –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã–º —É—á–∞—Å—Ç–∏–µ–º –≤ –∫–∞–ø–∏—Ç–∞–ª–µ –±–æ–ª–µ–µ 20%, –µ—Å–ª–∏ –∏—Ö –≥–æ–¥–æ–≤–∞—è –≤—ã—Ä—É—á–∫–∞ –ø—Ä–µ–≤—ã—à–∞–µ—Ç 800 –º–ª–Ω —Ä—É–±. –ü–æ–¥—Ç–≤–µ—Ä–¥–∏—Ç—å —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–µ –Ω–æ–≤—ã–º —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è–º —É—á–∞—Å—Ç–Ω–∏–∫–∏ —Ä—ã–Ω–∫–∞ –¥–æ–ª–∂–Ω—ã –±—É–¥—É—Ç –¥–æ 15 –º–∞—è 2026 –≥–æ–¥–∞. –ï—Å—Ç—å –∞–Ω–∞–ª–æ–≥ –ò–∑ –ì–†–õ–° –∏—Å–∫–ª—é—á–∏–ª–∏ –†–£ –Ω–∞ –¥–≤–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –∏ —à–µ—Å—Ç—å —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏–π. –°—Ä–µ–¥–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ ‚Äî –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã–π –∞–ø—Ä–µ–º–∏–ª–∞—Å—Ç ¬´–û—Ç–µ—Å–ª–∞¬ª –æ—Ç Amgen. –í —Ä–µ–µ—Å—Ç—Ä–µ –æ—Å—Ç–∞–ª—Å—è –∞–ø—Ä–µ–º–∏–ª–∞—Ç –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""high"",
  ""english"": ""The State Duma approved the third reading of a law requiring companies conducting market research in Russia to meet new requirements. The regulation bans foreign-invested companies with more than 20% capital from conducting market research if their annual revenue exceeds RUB800 million. Participants must comply with the new requirements by May 15, 2026.""
}"
2025-07-17T13:25:12+00:00,@medpharm,12414,https://t.me/medpharm/12414,"–ó–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω—ã—Ö –æ—Ç—Ä–∞–±–æ—Ç–∫–∞—Ö –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –≤—É–∑–æ–≤ –∏ –∫–æ–ª–ª–µ–¥–∂–µ–π —Å–æ–±—Ä–∞–ª –Ω–µ—Å–∫–æ–ª—å–∫–æ –¥–µ—Å—è—Ç–∫–æ–≤ –æ—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω—ã—Ö –æ—Ç–∑—ã–≤–æ–≤. –í –æ—Å–Ω–æ–≤–Ω–æ–º –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª–∏ –ø–∏—à—É—Ç, —á—Ç–æ –∫–∞—Ä–∞—Ç–µ–ª—å–Ω—ã–µ –º–µ—Ä—ã –≤ –≤–∏–¥–µ —à—Ç—Ä–∞—Ñ–æ–≤ —Å–∫–æ—Ä–µ–µ –≤—Å–µ–≥–æ —Å–ø—Ä–æ–≤–æ—Ü–∏—Ä—É—é—Ç —Å–Ω–∏–∂–µ–Ω–∏–µ —á–∏—Å–ª–∞ –∂–µ–ª–∞—é—â–∏—Ö –ø–æ—Å—Ç—É–ø–∞—Ç—å –≤ –ø—Ä–æ—Ñ–∏–ª—å–Ω—ã–µ –æ–±—Ä–∞–∑–æ–≤–∞—Ç–µ–ª—å–Ω—ã–µ —É—á—Ä–µ–∂–¥–µ–Ω–∏—è, –ø–∞–¥–µ–Ω–∏–µ –ø—Ä–µ—Å—Ç–∏–∂–∞ –ø—Ä–æ—Ñ–µ—Å—Å–∏–∏ –∏ –Ω–æ–≤—ã–π –≤–∏—Ç–æ–∫ –∫–∞–¥—Ä–æ–≤–æ–≥–æ –¥–µ—Ñ–∏—Ü–∏—Ç–∞ –≤ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π —Å–∏—Å—Ç–µ–º–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing"",
  ""impact"": ""medium"",
  ""english"": ""The compulsory work requirement project for medical university and college graduates has received several dozen negative reviews. Users mainly criticize that punitive measures such as fines are likely to lead to a decrease in the number of applicants for professional educational institutions, erosion of the profession's prestige, and a new round of shortage in the state healthcare system.""
}"
2025-07-17T10:57:26+00:00,@medpharm,12413,https://t.me/medpharm/12413,"–ü—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º –≤–∞–º —Å–ª–µ–¥—É—é—â–µ–≥–æ —Å–ø–∏–∫–µ—Ä–∞ ¬´PRO–µ–∫—Ü–∏–π –ë—É–¥—É—â–µ–≥–æ¬ª: üîπ–ì–∞–ª–∏–Ω–∞ –û—Ä–ª–æ–≤–∞ ‚Äî –≥–µ–Ω–µ—Ä–∞–ª—å–Ω—ã–π –¥–∏—Ä–µ–∫—Ç–æ—Ä IRIS, —Å–ø–∏–∫–µ—Ä –±—Ä–µ–π–Ω—Å—Ç–æ—Ä–º-—Å–µ—Å—Å–∏–∏ ¬´–ù–∞ –≥—Ä–∞–Ω–∏ –ø–æ–ª—å–∑—ã –∏ –º–∞–Ω–∏–ø—É–ª—è—Ü–∏–∏: –ë–ê–î –∫–∞–∫ —Ä—ã–Ω–æ–∫, –±–∏–∑–Ω–µ—Å –∏ –ø–æ–ª–µ –¥–ª—è —Ä–∏—Å–∫–æ–≤¬ª –†—ã–Ω–æ–∫ –ë–ê–î —Å–µ–≥–æ–¥–Ω—è –æ–∫–∞–∑–∞–ª—Å—è –≤ –Ω–µ–ø—Ä–æ—Å—Ç–æ–π —Å–∏—Ç—É–∞—Ü–∏–∏: —Å –æ–¥–Ω–æ–π —Å—Ç–æ—Ä–æ–Ω—ã ‚Äî –∫–æ–ª–æ—Å—Å–∞–ª—å–Ω–∞—è –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏—è –∏ –¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ –≤—ã—Å–æ–∫–∏–π –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª—å—Å–∫–∏–π —Å–ø—Ä–æ—Å, —Å –¥—Ä—É–≥–æ–π ‚Äî —É—Å–∏–ª–∏–≤–∞—é—â–µ–µ—Å—è –¥–∞–≤–ª–µ–Ω–∏–µ —Ä–µ–≥—É–ª—è—Ç–æ—Ä–Ω—ã—Ö –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏–π. –ù–∞ –ø—Ä–µ–¥—Å—Ç–æ—è—â–µ–π –±—Ä–µ–π–Ω—Å—Ç–æ—Ä–º-—Å–µ—Å—Å–∏–∏ –æ–±—Å—É–¥–∏–º, –∫ —á–µ–º—É –º–æ–≥—É—Ç –ø—Ä–∏–≤–µ—Å—Ç–∏ –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏—è –Ω–∞ –æ—Ç—Ä–∞—Å–ª—å, —Å—Ç–∞–Ω–µ—Ç –ª–∏ –º–µ–Ω—å—à–µ –∂–µ–ª–∞—é—â–∏—Ö –≤—ã–≤–æ–¥–∏—Ç—å –Ω–∞ —Ä—ã–Ω–æ–∫ –Ω–æ–≤—ã–µ –ø—Ä–æ–¥—É–∫—Ç—ã. –í —Å–≤–æ–µ–º –≤—ã—Å—Ç—É–ø–ª–µ–Ω–∏–∏ –æ—Å–æ–±–æ–µ –≤–Ω–∏–º–∞–Ω–∏–µ —É–¥–µ–ª—é –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª—å—Å–∫–æ–º—É –≤–æ—Å–ø—Ä–∏—è—Ç–∏—è –ë–ê–î –≤ —É—Å–ª–æ–≤–∏—è—Ö –Ω–æ–≤—ã—Ö –∑–∞–ø—Ä–µ—Ç–æ–≤, –∞ —Ç–∞–∫–∂–µ –ø–æ–¥–µ–ª—é—Å—å –Ω–∞–±–ª—é–¥–µ–Ω–∏—è–º–∏ –æ –∫–∞—Ä–¥–∏–Ω–∞–ª—å–Ω—ã—Ö —Ä–∞–∑–ª–∏—á–∏—è—Ö –≤ –≤—ã–±–æ—Ä–µ –ë–ê–î –ø–æ–∫—É–ø–∞—Ç–µ–ª—è–º–∏ —Ä–∞–∑–Ω—ã—Ö —Å—Ç—Ä–∞–Ω. –î–∞—Ç–∞ –∏ –≤—Ä–µ–º—è —Å–µ—Å—Å–∏–∏: 12 —Å–µ–Ω—Ç—è–±—Ä—è 2025, 11:00 üìç–≥. –°–æ—á–∏, Pullman –°–æ—á–∏ –¶–µ–Ω—Ç—Ä 5* –ò –Ω–∞–ø–æ–º–∏–Ω–∞–µ–º, —á—Ç–æ –¥–æ 31 –∏—é–ª—è –¥–µ–π—Å—Ç–≤—É—é—Ç —Å–ø–µ—Ü–∏–∞–ª—å–Ω—ã–µ —Ü–µ–Ω—ã –Ω–∞ —É—á–∞—Å—Ç–∏–µ, –∞ –ø—Ä–∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –æ—Ç –¥–≤—É—Ö —á–µ–ª–æ–≤–µ–∫ ‚Äî —Å–∫–∏–¥–∫–∞ 15% –Ω–∞ –≤—Ç–æ—Ä–æ–≥–æ –∏ –ø–æ—Å–ª–µ–¥—É—é—â–∏—Ö —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤. –ë—Ä–æ–Ω–∏—Ä—É–π—Ç–µ –º–µ—Å—Ç–æ –∏ —Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä—É–π—Ç–µ—Å—å –Ω–∞ —Å–∞–π—Ç–µ.","{""skip"": false, ""country"": ""global"", ""topic"": ""regulation,payment"", ""impact"": ""medium"", ""english"": ""The speaker discusses the current challenging situation of the BAV market, where there is intense competition and high consumer demand. However, regulatory restrictions are increasing. The session will explore the potential consequences of these limitations on the industry and whether fewer companies will be willing to bring new products to market. Special attention will be paid to how consumer perception of BAVs changes under new restrictions, and differences in purchasing behavior among consumers from different countries will be observed.""}"
2025-07-17T09:27:18+00:00,@medpharm,12412,https://t.me/medpharm/12412,"–†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –ø—Ä–æ–µ–∫—Ç –ø—Ä–∏–∫–∞–∑–∞, —É—Ç–≤–µ—Ä–∂–¥–∞—é—â–∏–π –ü–æ—Ä—è–¥–æ–∫ –æ—Ü–µ–Ω–∫–∏ –æ–±—ä–µ–º–∞ –∏—Å–ø—ã—Ç–∞–Ω–∏–π –∫–∞—á–µ—Å—Ç–≤–∞ –∏–º–º—É–Ω–æ–±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ù–æ–≤—ã–π –ø–æ—Ä—è–¥–æ–∫ –∑–∞–º–µ–Ω–∏—Ç –¥–µ–π—Å—Ç–≤—É—é—â–∏–π —Ä–µ–≥–ª–∞–º–µ–Ω—Ç 2019 –≥–æ–¥–∞ –∏, –≤ —Å–ª—É—á–∞–µ —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏—è, –±—É–¥–µ—Ç –¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å –¥–æ 2031 –≥–æ–¥–∞.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""high"",
  ""english"": ""Roszdranad–∑–æ—Ä has developed a project decree to approve the Quality Test Volume Assessment Procedure for immunobiological medicines. The new procedure will replace the 2019 regulation and, if approved, will be in effect until 2031.""
}"
2025-07-17T06:56:16+00:00,@medpharm,12411,https://t.me/medpharm/12411,"Huawei –æ–±—ä—è–≤–∏–ª–∞, —á—Ç–æ –∑–∞–ø—É—Å—Ç–∏—Ç –≥–ª–æ–±–∞–ª—å–Ω—ã–π –ø–∞—Ä—Ç–Ω–µ—Ä—Å–∫–∏–π –∞–ª—å—è–Ω—Å –ø–æ —Ä–∞–∑–≤–∏—Ç–∏—é —Ü–∏—Ñ—Ä–æ–≤—ã—Ö —ç–∫–æ—Å–∏—Å—Ç–µ–º –≤ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–∏ –∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–∏. –°–µ–≥–æ–¥–Ω—è –∫–æ–º–ø–∞–Ω–∏—è —Å–æ—Ç—Ä—É–¥–Ω–∏—á–∞–µ—Ç —Å –±–æ–ª–µ–µ —á–µ–º 5,5 —Ç—ã—Å. –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏–π –≤ 110 —Å—Ç—Ä–∞–Ω–∞—Ö.","{""skip"": true}"
2025-07-16T16:31:33+00:00,@medpharm,12410,https://t.me/medpharm/12410,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 16 –∏—é–ª—è –ü—Ä–æ—à–ª–∏ –æ–±—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –í —Ä–∞–º–∫–∞—Ö —Å—Ç–∞—Ä—Ç–æ–≤–∞–≤—à–µ–π –≤ –†–æ—Å—Å–∏–∏ –≤ 2024 –≥–æ–¥—É —Ä–∞—Å—à–∏—Ä–µ–Ω–Ω–æ–π –¥–∏—Å–ø–∞–Ω—Å–µ—Ä–∏–∑–∞—Ü–∏–∏, –∫—É–¥–∞ –≤—Ö–æ–¥–∏—Ç –æ—Ü–µ–Ω–∫–∞ —Ä–µ–ø—Ä–æ–¥—É–∫—Ç–∏–≤–Ω–æ–≥–æ –∑–¥–æ—Ä–æ–≤—å—è, –Ω–∞—Ä—É—à–µ–Ω–∏—è —Ä–µ–ø—Ä–æ–¥—É–∫—Ç–∏–≤–Ω–æ–π —Ñ—É–Ω–∫—Ü–∏–∏ –≤—ã—è–≤–ª–µ–Ω—ã —É 12,9% –∂–µ–Ω—â–∏–Ω –∏ 2,1% –º—É–∂—á–∏–Ω. –°—Ä–µ–¥–∏ –ø–æ–¥—Ä–æ—Å—Ç–∫–æ–≤ 15-17 –ª–µ—Ç —Ç–∞–∫–∏–µ –æ—Ç–∫–ª–æ–Ω–µ–Ω–∏—è –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–Ω—ã —Å—É–º–º–∞—Ä–Ω–æ —É 9% –æ–±—Å–ª–µ–¥–æ–≤–∞–Ω–Ω—ã—Ö, —Å–æ–æ–±—â–∏–ª 16 –∏—é–ª—è –º–∏–Ω–∏—Å—Ç—Ä –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ú–∏—Ö–∞–∏–ª –ú—É—Ä–∞—à–∫–æ. –¢–∞—Ä–∏—Ñ–Ω—ã–π –ø–ª–∞–Ω –í –ú–∏–Ω–∏—Å—Ç–µ—Ä—Å—Ç–≤–µ –Ω–∞—É–∫–∏ –∏ –≤—ã—Å—à–µ–≥–æ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –≤–≤–µ—Å—Ç–∏ –µ–¥–∏–Ω—ã–π –ø–æ—Ä—è–¥–æ–∫ —Ä–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω–∏—è —Å—Ç–æ–∏–º–æ—Å—Ç–∏ –æ–±—É—á–µ–Ω–∏—è –≤ –≤—É–∑–∞—Ö. –°–µ–π—á–∞—Å —Ç–∞—Ä–∏—Ñ—ã –≤ –æ–±—Ä–∞–∑–æ–≤–∞—Ç–µ–ª—å–Ω—ã—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è—Ö –∫–æ–Ω—Ç—Ä–æ–ª–∏—Ä—É—é—Ç —É—á—Ä–µ–¥–∏—Ç–µ–ª–∏, –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –≤—É–∑–æ–≤ ‚Äî —ç—Ç–æ –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏. –ë–µ–∑ –ª–∏—à–Ω–∏—Ö –ø—Ä–æ—Ü–µ–¥—É—Ä –ü—É—Ç–∏–Ω –ø–æ–¥–ø–∏—Å–∞–ª —É–∫–∞–∑ –æ —Å–ø–µ—Ü–ø–æ—Ä—è–¥–∫–µ –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏ —Ç–æ–≤–∞—Ä–æ–≤ –∏–∑-–∑–∞ —Å–∞–Ω–∫—Ü–∏–π. –¢–µ–ø–µ—Ä—å —Ä–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω–∏–µ–º –≤–æ–ø—Ä–æ—Å–∞ –±—É–¥–µ—Ç –∑–∞–Ω–∏–º–∞—Ç—å—Å—è –ì–æ—Å–∫–æ–º–∏—Å—Å–∏—è –ø–æ –ø—Ä–æ—Ç–∏–≤–æ–¥–µ–π—Å—Ç–≤–∏—é –Ω–µ–∑–∞–∫–æ–Ω–Ω–æ–º—É –æ–±–æ—Ä–æ—Ç—É –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏. –ü—Ä–æ–µ–∫—Ç—ã –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤ –±–æ–ª—å—à–µ –Ω–µ –±—É–¥—É—Ç –ø—Ä–æ—Ö–æ–¥–∏—Ç—å –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–µ –æ–±—Å—É–∂–¥–µ–Ω–∏–µ, –∞ –∞–∫—Ç—ã –º–æ–≥—É—Ç –≤—Å—Ç—É–ø–∞—Ç—å –≤ —Å–∏–ª—É –≤ –ª—é–±—ã–µ –¥–∞—Ç—ã, –Ω–µ —Ç–æ–ª—å–∫–æ —Å 1 —Å–µ–Ω—Ç—è–±—Ä—è –∏–ª–∏ 1 –º–∞—Ä—Ç–∞. –û–±–æ—à–ª–æ—Å—å –§–ê–° –∑–∞–≤–µ—Ä—à–∏–ª–∞ –≤–Ω–µ–ø–ª–∞–Ω–æ–≤—É—é –∞–Ω—Ç–∏–∫–∞—Ä—Ç–µ–ª—å–Ω—É—é –ø—Ä–æ–≤–µ—Ä–∫—É –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ –¶–í ¬´–ü—Ä–æ—Ç–µ–∫¬ª –∏ –Ω–µ –Ω–∞—à–ª–∞ –≤ –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–∞ –Ω–∞—Ä—É—à–µ–Ω–∏–π –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–∞. –ú–µ—Ä–æ–ø—Ä–∏—è—Ç–∏—è –±—ã–ª–∏ —Å–≤—è–∑–∞–Ω—ã —Å –ø–æ—Å—Ç–∞–≤–∫–∞–º–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –¶–µ–Ω—Ç—Ä–∞ –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è. –ü–æ–¥ –ø–æ–¥–æ–∑—Ä–µ–Ω–∏–µ–º –≤ —Å–≥–æ–≤–æ—Ä–µ –±—ã–ª–∏ –µ—â–µ –¥–≤–µ –∫–æ–º–ø–∞–Ω–∏–∏: ¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç¬ª –∏ ¬´–ü—Ä–∏–º–∞—Ñ–∞—Ä–º–∞¬ª.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety, guideline"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health reported that reproductive health issues were detected in 12.9% of women and 2.1% of men during Russia's expanded screening program, which began in 2024 and includes reproductive health assessments. The minister also mentioned that such issues were found in 9% of adolescents aged 15-17 years. The Ministry of Education proposed a unified system for regulating tuition fees in universities, while the Federal Anti-Corruption Service (FAS) concluded an unplanned antitrust investigation against the 'Protek' distributor without finding any violations of laws. Two other companies, 'Farstand' and 'Primafarma', were also suspected of colluding.""
}"
2025-07-16T15:02:38+00:00,@medpharm,12409,https://t.me/medpharm/12409,"–í —Ä–∞–º–∫–∞—Ö —Ä–∞—Å—à–∏—Ä–µ–Ω–Ω–æ–π –¥–∏—Å–ø–∞–Ω—Å–µ—Ä–∏–∑–∞—Ü–∏–∏ –¥–ª—è –æ—Ü–µ–Ω–∫–∏ —Ä–µ–ø—Ä–æ–¥—É–∫—Ç–∏–≤–Ω–æ–≥–æ –∑–¥–æ—Ä–æ–≤—å—è –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è —Ä–µ–ø—Ä–æ–¥—É–∫—Ç–∏–≤–Ω–æ–π —Å–∏—Å—Ç–µ–º—ã –≤—ã—è–≤–∏–ª–∏ —É 12,9% –∂–µ–Ω—â–∏–Ω –∏ 2,1% –º—É–∂—á–∏–Ω. –°—É–º–º–∞—Ä–Ω–æ —Ç–∞–∫–∏–µ –æ–±—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è —É–∂–µ –ø—Ä–æ—à–ª–∏ –±–æ–ª–µ–µ 12,5 –º–ª–Ω –≥—Ä–∞–∂–¥–∞–Ω, —Å–æ–æ–±—â–∏–ª–∏ –≤ –ú–∏–Ω–∑–¥—Ä–∞–≤–µ.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,hospital_policy,pharmacovigilance,safety"",
  ""impact"": ""medium"",
  ""english"": ""Expanded screening was conducted to assess reproductive health, identifying reproductive system diseases in 12.9% of women and 2.1% of men. Over 12.5 million citizens have already undergone these screenings, according to the Ministry of Health.""
}"
2025-07-16T13:05:46+00:00,@medpharm,12408,https://t.me/medpharm/12408,–§–ê–° –∑–∞–≤–µ—Ä—à–∏–ª–∞ –≤–Ω–µ–ø–ª–∞–Ω–æ–≤—É—é –∞–Ω—Ç–∏–∫–∞—Ä—Ç–µ–ª—å–Ω—É—é –ø—Ä–æ–≤–µ—Ä–∫—É –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ –¶–í ¬´–ü—Ä–æ—Ç–µ–∫¬ª –∏ –Ω–µ –Ω–∞—à–ª–∞ –≤ –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –¥–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä–∞ –Ω–∞—Ä—É—à–µ–Ω–∏–π –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–∞. –ú–µ—Ä–æ–ø—Ä–∏—è—Ç–∏—è –±—ã–ª–∏ —Å–≤—è–∑–∞–Ω—ã —Å –ø–æ—Å—Ç–∞–≤–∫–∞–º–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –¶–µ–Ω—Ç—Ä–∞ –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è. –ü–æ–¥ –ø–æ–¥–æ–∑—Ä–µ–Ω–∏–µ–º –≤ —Å–≥–æ–≤–æ—Ä–µ –±—ã–ª–∏ –µ—â–µ –¥–≤–µ –∫–æ–º–ø–∞–Ω–∏–∏: ¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç¬ª –∏ ¬´–ü—Ä–∏–º–∞—Ñ–∞—Ä–º–∞¬ª.,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions"",
  ""impact"": ""medium"",
  ""english"": ""The FAS completed an unplanned cartel investigation against the 'Protek' distributor and found no violations of the law in its activities. The actions were related to supplies of medications for the Center of Supplies. Two other companies, 'FarmaStandart' and 'Primafarma', were suspected of collusion.""
}"
2025-07-16T10:58:14+00:00,@medpharm,12406,https://t.me/medpharm/12406,–í –†–æ—Å—Å–∏–∏ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –≤—ã–ø–ª–∞—Ç –≤—Ä–∞—á–∞–º –∑–∞ —Ä–∞–Ω–Ω–µ–µ –≤—ã—è–≤–ª–µ–Ω–∏–µ –æ–Ω–∫–æ–ª–æ–≥–∏–∏ –≤—ã—Ä–æ—Å–ª–æ –≤ –ø—è—Ç—å —Ä–∞–∑. –°–µ–π—á–∞—Å —Ä–∞–∑–º–µ—Ä –≤—ã–ø–ª–∞—Ç—ã —Å–æ—Å—Ç–∞–≤–ª—è–µ—Ç 1 —Ç—ã—Å. —Ä—É–±.,"{""skip"": true}"
2025-07-16T09:01:40+00:00,@medpharm,12405,https://t.me/medpharm/12405,"–ü—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º –≤–∞–º –º–æ–¥–µ—Ä–∞—Ç–æ—Ä–∞ —Å–µ—Å—Å–∏–∏ PRO–µ–∫—Ü–∏–π –ë—É–¥—É—â–µ–≥–æ: üîπ–í–∏–∫—Ç–æ—Ä–∏—è –ü—Ä–µ—Å–Ω—è–∫–æ–≤–∞, –¥–∏—Ä–µ–∫—Ç–æ—Ä –°–†–û –ê—Å—Å–æ—Ü–∏–∞—Ü–∏—è –Ω–µ–∑–∞–≤–∏—Å–∏–º—ã—Ö –∞–ø—Ç–µ–∫, –≥–ª–∞–≤–∞ –ê–ª—å—è–Ω—Å–∞ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–π, –∫.—Ñ.–Ω, –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—å –∫–æ–º–∏—Ç–µ—Ç–∞ –ø–æ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –º–æ—Å–∫–æ–≤—Å–∫–æ–≥–æ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ –æ—Ç–¥–µ–ª–µ–Ω–∏—è ""–î–µ–ª–æ–≤–æ–π –†–æ—Å—Å–∏–∏"", –º–æ–¥–µ—Ä–∞—Ç–æ—Ä –¥–∏—Å–∫—É—Å—Å–∏–æ–Ω–Ω–æ–π —Å–µ—Å—Å–∏–∏ ¬´–ê–ø—Ç–µ–∫–∞ –∫–∞–∫ –±–∏–∑–Ω–µ—Å: —ç–∫–æ–Ω–æ–º–∏–∫–∞ —Ä–∏—Ç–µ–π–ª–∞ –≤ —É—Å–ª–æ–≤–∏—è—Ö –º–∞—Ä–∂–∏–Ω–∞–ª—å–Ω–æ–≥–æ –¥–∞–≤–ª–µ–Ω–∏—è¬ª –° –≤–µ–¥—É—â–∏–º–∏ —ç–∫—Å–ø–µ—Ä—Ç–∞–º–∏ –∞–ø—Ç–µ—á–Ω–æ–≥–æ —Ä—ã–Ω–∫–∞ –æ–±—Å—É–¥–∏–º –∫–∞–∫ –æ—Å—Ç–∞–≤–∞—Ç—å—Å—è –ø—Ä–∏–±—ã–ª—å–Ω—ã–º –ø—Ä–∏ —Ä–∞—Å—Ç—É—â–µ–º –º–∞—Ä–∂–∏–Ω–∞–ª—å–Ω–æ–º –¥–∞–≤–ª–µ–Ω–∏–∏. –†–∞–∑–±–µ—Ä–µ–º –ª—É—á—à–∏–µ —Ä–∞–±–æ—á–∏–µ –±–∏–∑–Ω–µ—Å-–º–æ–¥–µ–ª–∏ ‚Äî —Ñ—Ä–∞–Ω—á–∞–π–∑–∏–Ω–≥, M&A, –æ—Ä–≥–∞–Ω–∏—á–µ—Å–∫–∏–π —Ä–æ—Å—Ç. –ü–æ–≥–æ–≤–æ—Ä–∏–º –æ —Ü–∏—Ñ—Ä–æ–≤–∏–∑–∞—Ü–∏–∏: –æ–Ω–ª–∞–π–Ω-–ø—Ä–æ–¥–∞–∂–∏, —É–º–Ω—ã–µ –∫–∞—Å—Å—ã –∏–ª–∏ –ª–æ—è–ª—å–Ω–æ—Å—Ç—å, –∏–ª–∏ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ –ò–ò. –û–±—Å—É–¥–∏–º —Ä–∞–∑–≤–∏—Ç–∏–µ –∞–ø—Ç–µ—á–Ω–æ–≥–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –∏ –∏–Ω—Ç–µ–≥—Ä–∞—Ü–∏—é –∞–ø—Ç–µ–∫ –≤ —Å–∏—Å—Ç–µ–º—É –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è ‚Äî –∫–∞–∫ –Ω–æ–≤—ã–π –∫–æ–¥ –û–ö–í–≠–î –º–µ–Ω—è–µ—Ç –ø—Ä–∞–≤–∏–ª–∞ –∏–≥—Ä—ã. –í—Å—Ç—Ä–µ—á–∞–µ–º—Å—è –Ω–∞ –∑–Ω–∞–∫–æ–≤–æ–º —Å–æ–±—ã—Ç–∏–∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ —Ä—ã–Ω–∫–∞, –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ PRO–µ–∫—Ü–∏–∏ –ë—É–¥—É—â–µ–≥–æ –≤ –°–æ—á–∏! –î–∞—Ç–∞ –∏ –≤—Ä–µ–º—è —Å–µ—Å—Å–∏–∏: 11 —Å–µ–Ω—Ç—è–±—Ä—è 2025, 15:45 üìç–≥. –°–æ—á–∏, Pullman –°–æ—á–∏ –¶–µ–Ω—Ç—Ä 5* –ü–æ–¥—Ä–æ–±–Ω–µ–µ –æ –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ –∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –Ω–∞ —Å–∞–π—Ç–µ.","{""skip"": true}"
2025-07-16T06:54:13+00:00,@medpharm,12404,https://t.me/medpharm/12404,"–ñ–µ–Ω—â–∏–Ω—ã —Å –ø—Ä–µ–¥–º–µ–Ω—Å—Ç—Ä—É–∞–ª—å–Ω—ã–º–∏ —Ä–∞—Å—Å—Ç—Ä–æ–π—Å—Ç–≤–∞–º–∏ —á–∞—â–µ —Å—Ç–∞–ª–∫–∏–≤–∞–ª–∏—Å—å —Å —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏. –û—Å–æ–±–µ–Ω–Ω–æ –≤—ã—Ä–∞–∂–µ–Ω–∞ —Å–≤—è–∑—å –±—ã–ª–∞ —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–∫ —Å –ø–æ—Å–ª–µ—Ä–æ–¥–æ–≤–æ–π –¥–µ–ø—Ä–µ—Å—Å–∏–µ–π –∏ –ø—Ä–µ–¥–º–µ–Ω—Å—Ç—Ä—É–∞–ª—å–Ω—ã–º–∏ —Ä–∞—Å—Å—Ç—Ä–æ–π—Å—Ç–≤–∞–º–∏, –¥–∏–∞–≥–Ω–æ—Å—Ç–∏—Ä–æ–≤–∞–Ω–Ω—ã–º–∏ –≤ –º–æ–ª–æ–¥–æ–º –≤–æ–∑—Ä–∞—Å—Ç–µ.","{""skip"": true}"
2025-07-15T16:34:53+00:00,@medpharm,12403,https://t.me/medpharm/12403,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 15 –∏—é–ª—è –ß—Ç–æ-—Ç–æ –Ω–æ–≤–æ–µ –í —Å—É–±—ä–µ–∫—Ç–∞—Ö –†–æ—Å—Å–∏–∏ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è —Ä–∞–∑–≤–∏–≤–∞—Ç—å —Ü–µ–Ω—Ç—Ä—ã –∑–¥–æ—Ä–æ–≤—å—è –∏ –º–µ–¥–∏—Ü–∏–Ω—ã –∑–¥–æ—Ä–æ–≤–æ–≥–æ –¥–æ–ª–≥–æ–ª–µ—Ç–∏—è. –î–ª—è —ç—Ç–æ–≥–æ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã–µ –≤–ª–∞—Å—Ç–∏ —Å–æ–∑–¥–∞–¥—É—Ç —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ–µ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω–æ–µ –¥–≤–∏–∂–µ–Ω–∏–µ. –ö–æ–ø–µ–π–∫–∞ —Ä—É–±–ª—å –±–µ—Ä–µ–∂–µ—Ç –õ–µ–Ω–∏–Ω–≥—Ä–∞–¥—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å –ø—Ä–æ–≤–µ—Ä–∏—Ç —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å —Ä–∞—Å—Ö–æ–¥–æ–≤ –Ω–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ ‚Äî –æ–±—ä—è–≤–ª–µ–Ω –∫–æ–Ω–∫—É—Ä—Å. –ù–∞—á–∞–ª—å–Ω–∞—è —Å—Ç–æ–∏–º–æ—Å—Ç—å –∫–æ–Ω—Ç—Ä–∞–∫—Ç–∞ ‚Äî –ø–æ—á—Ç–∏ 10 –º–ª–Ω —Ä—É–±. –¢—Ä–µ–±—É–µ—Ç—Å—è –ø–æ–ª–Ω—ã–π –í –ì–æ—Å–¥—É–º–µ –ø—Ä–æ—à–ª–æ —Å–æ–≤–µ—â–∞–Ω–∏–µ –ø–æ –≤–∫–ª—é—á–µ–Ω–∏—é –ø—Ä–∏–≤–∏–≤–∫–∏ –æ—Ç –º–µ–Ω–∏–Ω–≥–æ–∫–æ–∫–∫–æ–≤–æ–π –∏–Ω—Ñ–µ–∫—Ü–∏–∏ –≤ –ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—ã–π –∫–∞–ª–µ–Ω–¥–∞—Ä—å –ø—Ä–∏–≤–∏–≤–æ–∫. –ü—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª—å –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–∞ —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∞, —á—Ç–æ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –≥–æ—Ç–æ–≤—ã –≤—ã–ø—É—Å—Ç–∏—Ç—å —Å–≤–æ–∏ –≤–∞–∫—Ü–∏–Ω—ã –≤ —Å—Ç–∞–¥–∏–∏ –≥–æ—Ç–æ–≤–æ–π –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π —Ñ–æ—Ä–º—ã –≤ 2026 –≥–æ–¥—É, –∞ –ø–æ –ø–æ–ª–Ω–æ–º—É —Ü–∏–∫–ª—É ‚Äî –≤ 2027 –≥–æ–¥—É. –í –ú–∏–Ω–∑–¥—Ä–∞–≤–µ —Å—á–∏—Ç–∞—é—Ç, —á—Ç–æ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ –¥–æ–∂–¥–∞—Ç—å—Å—è –ø–æ–ª–Ω–æ–≥–æ —Ü–∏–∫–ª–∞. –ó–∞–≤–∏—Å—à–∏–µ –æ—Å—Ç–∞—Ç–∫–∏ –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ –ø–æ–¥–≥–æ—Ç–æ–≤–∏–ª –ø—Ä–æ–µ–∫—Ç –†–µ–≥–ª–∞–º–µ–Ω—Ç–∞ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è –∞—É–¥–∏—Ç–∞ –¥–ª—è –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏—è –Ω–∞–ª–∏—á–∏—è —Å—ã—Ä—å—è –¥–ª—è –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤-—É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –ï–ê–≠–°. –î–æ–∫—É–º–µ–Ω—Ç –ø—Ä–∏–∑–≤–∞–Ω —Ä–µ—à–∏—Ç—å –ø—Ä–æ–±–ª–µ–º—É –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏—è –ø—Ä–æ–∏—Å—Ö–æ–∂–¥–µ–Ω–∏—è –æ—Å—Ç–∞—Ç–∫–æ–≤ —Å—ã—Ä—å—è, –∫—É–ø–ª–µ–Ω–Ω–æ–≥–æ –Ω–µ—Å–∫–æ–ª—å–∫–æ –ª–µ—Ç –Ω–∞–∑–∞–¥. –û–¥–Ω–∞–∫–æ, –ø–æ –º–Ω–µ–Ω–∏—é –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—ã—Ö –æ–±—ä–µ–¥–∏–Ω–µ–Ω–∏–π —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π, –ø—Ä–æ–µ–∫—Ç –Ω—É–∂–¥–∞–µ—Ç—Å—è –≤ –¥–æ—Ä–∞–±–æ—Ç–∫–µ.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""There are plans to develop health and longevity centers in Russia. The federal authorities will create a special regional movement for this. In Leningrad Oblast, the effectiveness of health care spending will be checked through a tender with an initial contract value of almost 1 million rubles. The State Duma held a meeting to include the meningococcal vaccine in the National Immunization Schedule. A representative from the Ministry of Industry and Trade reported that domestic manufacturers are ready to produce their vaccines in a ready-to-use form starting from 2026, and for the full cycle by 2027. The Ministry of Health believes that it is necessary to wait for the full cycle. The Ministry of Industry and Trade has prepared a Regulation on Auditing Procedures to confirm the origin of raw materials for pharmaceutical production within member states of the Eurasian Economic Cooperation Organization (Eurasian Economic Union). However, professional pharmaceutical industry associations argue that the project needs to be revised.""
}"
2025-07-15T14:51:18+00:00,@medpharm,12402,https://t.me/medpharm/12402,–ó–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ –¥–æ—Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏–∏ –∑–∞–∫—É–ø–æ–∫ –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ —Ä–µ–≥–∏–æ–Ω–∞—Ö –ø—Ä–∏–Ω—è–ª–∏ –≤ –ì–æ—Å–¥—É–º–µ –≤–æ –≤—Ç–æ—Ä–æ–º –∏ —Ç—Ä–µ—Ç—å–µ–º —á—Ç–µ–Ω–∏—è—Ö. –û–Ω –≤—Å—Ç—É–ø–∏—Ç –≤ —Å–∏–ª—É —Å –Ω–∞—á–∞–ª–∞ —Å–ª–µ–¥—É—é—â–µ–≥–æ –≥–æ–¥–∞.,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""A law project on financing of orphan drug procurement in regions has been approved by the State Duma in second and third readings. It will come into force at the beginning of next year.""
}"
2025-07-15T13:01:55+00:00,@medpharm,12401,https://t.me/medpharm/12401,–õ–∏—á–Ω—ã–π –æ–ø—ã—Ç –∏–Ω—Ç–µ–≥—Ä–∞—Ü–∏–∏ –¥–∞–Ω–Ω—ã—Ö –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏ –∏ —Å–∏—Å—Ç–µ–º—ã –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥–∞ –¥–≤–∏–∂–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ (–ú–î–õ–ü) –≤ –±–∏–∑–Ω–µ—Å-–ø—Ä–æ—Ü–µ—Å—Å—ã –∫–æ–º–ø–∞–Ω–∏–∏ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª –±–∏–∑–Ω–µ—Å-–∞–Ω–∞–ª–∏—Ç–∏–∫ ¬´–ê–ª—å—Ñ–∞—Å–∏–≥–º–∞ –†—É—Å¬ª –ê–ª–µ–∫—Å–µ–π –ú–∞—Ä—Ç—ã–Ω–æ–≤. –û–Ω –Ω–∞–∑–≤–∞–ª —ç—Ç–æ—Ç –ø—Ä–æ—Ü–µ—Å—Å ¬´–±–æ—Ä—å–±–æ–π –∑–∞ —á–∏—Å—Ç–æ—Ç—É –∏ —Ç–æ—á–Ω–æ—Å—Ç—å¬ª.,"{""skip"": true}"
2025-07-15T08:18:42+00:00,@medpharm,12399,https://t.me/medpharm/12399,"üî• –°–ø–æ–π–ª–µ—Ä: –æ—Å–µ–Ω—å –±—É–¥–µ—Ç –∂–∞—Ä–∫–æ–π! –£–∂–µ 24‚Äì25 —Å–µ–Ω—Ç—è–±—Ä—è –∏–¥–µ–º –Ω–∞ 25-–π —é–±–∏–ª–µ–π–Ω—ã–π –ê–ø—Ç–µ—á–Ω—ã–π —Å–∞–º–º–∏—Ç –æ—Ç –†-–ö–æ–Ω—Ñ –≤ –ú–æ—Å–∫–≤–µ (Radisson Collection Hotel). –≠—Ç–æ —Ç–æ–ø–æ–≤–æ–µ —Å–æ–±—ã—Ç–∏–µ –¥–ª—è –≤—Å–µ—Ö, –∫—Ç–æ –≤ —Ñ–∞—Ä–º–µ: üîπ 2 –¥–Ω—è –∂–∏–≤—ã—Ö –æ–±—Å—É–∂–¥–µ–Ω–∏–π, –∫–µ–π—Å–æ–≤ –∏ —Å—Ç—Ä–∞—Ç–µ–≥–∏–π; üîπ 100+ —Ç–æ–ø–æ–≤—ã—Ö –∞–ø—Ç–µ—á–Ω—ã—Ö —Å–µ—Ç–µ–π –Ω–∞ –ø–ª–æ—â–∞–¥–∫–µ ‚Äî –±—É–¥–µ—Ç —Å –∫–µ–º –ø–æ–æ–±—â–∞—Ç—å—Å—è; üîπ –ü—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏–µ —Ä–∞–∑–±–æ—Ä—ã, —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏–µ —Å–µ—Å—Å–∏–∏ –∏, –∫–æ–Ω–µ—á–Ω–æ, –Ω–µ—Ç–≤–æ—Ä–∫–∏–Ω–≥. üí¨ –û—Ç–¥–µ–ª—å–Ω–æ ‚Äî —Å–µ—Å—Å–∏—è –ø–µ—Ä–µ–≥–æ–≤–æ—Ä–æ–≤. –≠—Ç–æ —Ç–æ—Ç —Å–∞–º—ã–π —à–∞–Ω—Å —Å–µ—Å—Ç—å –∑–∞ –æ–¥–∏–Ω —Å—Ç–æ–ª —Å –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª—è–º–∏ —Å–µ—Ç–µ–π —Å–æ –≤—Å–µ–π —Å—Ç—Ä–∞–Ω—ã –∏ –æ–±—Å—É–¥–∏—Ç—å —Ä–µ–∞–ª—å–Ω—ã–µ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ –¥–ª—è —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–∞. üéØ –ü—Ä–æ–≥—Ä–∞–º–º–∞ ü§ù –ü–µ—Ä–µ–≥–æ–≤–æ—Ä—ã üìå –£—Å–ª–æ–≤–∏—è —É—á–∞—Å—Ç–∏—è –ï—Å–ª–∏ –≤—ã —Ä–∞–∑–≤–∏–≤–∞–µ—Ç–µ –±–∏–∑–Ω–µ—Å –Ω–∞ —Ñ–∞—Ä–º—Ä—ã–Ω–∫–µ ‚Äî –ø—Ä–æ–ø—É—Å—Ç–∏—Ç—å –Ω–µ–ª—å–∑—è! –†–µ–∫–ª–∞–º–∞ –û–û–û ¬´–†-–ö–æ–Ω—Ñ¬ª","{""skip"": true}"
2025-07-15T06:55:06+00:00,@medpharm,12398,https://t.me/medpharm/12398,"–ú–∏–Ω–∏—Å—Ç—Ä –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è —Ä–∞—Å—Å–∫–∞–∑–∞–ª –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç—É, –∫–∞–∫ —Ñ–∏–Ω–∞–Ω—Å–∏—Ä—É–µ—Ç—Å—è –º–∞—Ç–µ—Ä–∏–∞–ª—å–Ω–æ-—Ç–µ—Ö–Ω–∏—á–µ—Å–∫–∞—è –±–∞–∑–∞ —É—á—Ä–µ–∂–¥–µ–Ω–∏–π, –∫–æ—Ç–æ—Ä—ã–µ –ø—Ä–æ–≤–æ–¥—è—Ç –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –≤ —Ä–∞–º–∫–∞—Ö –Ω–∞—Ü–ø—Ä–æ–µ–∫—Ç–∞ ¬´–ù–æ–≤—ã–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ —Å–±–µ—Ä–µ–∂–µ–Ω–∏—è –∑–¥–æ—Ä–æ–≤—å—è¬ª. –ü–æ –¥–∞–Ω–Ω—ã–º –ú–∏–Ω—Ñ–∏–Ω–∞, –ø–æ–∫–∞ —ç—Ç–æ—Ç –Ω–∞—Ü–ø—Ä–æ–µ–∫—Ç –∏—Å–ø–æ–ª–Ω–µ–Ω –º–µ–Ω—å—à–µ —á–µ–º –Ω–∞ —Ç—Ä–µ—Ç—å.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The Minister of Health informed the President about how the material and technical base for institutions conducting clinical research under the 'New Technologies to Save Health' project is financed. According to budget data, this national project has been implemented less than a third.""
}"
2025-07-14T17:03:28+00:00,@medpharm,12397,https://t.me/medpharm/12397,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 14 –∏—é–ª—è –ù–µ –¥–µ–ª–µ–≥–∏—Ä—É–µ—Ç—Å—è –ë–æ–ª–µ–µ 33% –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –Ω–µ–≥–∞—Ç–∏–≤–Ω–æ –æ—Ü–µ–Ω–∏–ª–∏ –∏–¥–µ—é –ø–µ—Ä–µ–¥–∞—Ç—å —á–∞—Å—Ç—å –æ–±—è–∑–∞–Ω–Ω–æ—Å—Ç–µ–π —É—á–∞—Å—Ç–∫–æ–≤—ã—Ö –≤—Ä–∞—á–µ–π —Ñ–µ–ª—å–¥—à–µ—Ä–∞–º. –í —á–∏—Å–ª–µ —Ä–∏—Å–∫–æ–≤ –æ–Ω–∏ –Ω–∞–∑—ã–≤–∞—é—Ç –ø—É—Ç–∞–Ω–∏—Ü—É –≤ –±—é—Ä–æ–∫—Ä–∞—Ç–∏—á–µ—Å–∫–∏—Ö –≤–æ–ø—Ä–æ—Å–∞—Ö, –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –º–∞—Å—Å–æ–≤–æ–≥–æ —É–≤–æ–ª—å–Ω–µ–Ω–∏—è —Å—Ä–µ–¥–Ω–µ–≥–æ –º–µ–¥–ø–µ—Ä—Å–æ–Ω–∞–ª–∞ –∏ —Å–Ω–∏–∂–µ–Ω–∏–µ —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –¥–æ–≤–µ—Ä–∏—è –∫ –º–µ–¥–∏—Ü–∏–Ω–µ. –ï—Å—Ç—å —Å–æ–º–Ω–µ–Ω–∏—è –ù–∞ –°–∞—Ö–∞–ª–∏–Ω–µ –≤–æ–∑–±—É–∂–¥–µ–Ω–æ —É–≥–æ–ª–æ–≤–Ω–æ–µ –¥–µ–ª–æ –æ –∑–ª–æ—É–ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–∏ –¥–æ–ª–∂–Ω–æ—Å—Ç–Ω—ã–º–∏ –ø–æ–ª–Ω–æ–º–æ—á–∏—è–º–∏ –∏–∑-–∑–∞ –Ω–µ–∑–∞–∫–æ–Ω–Ω–æ–π –ø–µ—Ä–µ–¥–∞—á–∏ –ø–æ–º–µ—â–µ–Ω–∏–π –∏ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –≥–æ—Å–∫–ª–∏–Ω–∏–∫–æ–π —á–∞—Å—Ç–Ω–æ–º—É –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—é. –í—Ä–∞—á–∏ –∫–æ–Ω—Å—É–ª—å—Ç–∞—Ü–∏–æ–Ω–Ω–æ-–¥–∏–∞–≥–Ω–æ—Å—Ç–∏—á–µ—Å–∫–æ–≥–æ —Ü–µ–Ω—Ç—Ä–∞ –≤ –Æ–∂–Ω–æ-–°–∞—Ö–∞–ª–∏–Ω—Å–∫–µ —Ä–∞–Ω–µ–µ –∂–∞–ª–æ–≤–∞–ª–∏—Å—å –Ω–∞ ¬´—Å–∏—Å—Ç–µ–º–Ω—ã–µ –Ω–∞—Ä—É—à–µ–Ω–∏—è –≤ —Å—Ñ–µ—Ä–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è¬ª. –ï—Å—Ç—å —Ä–∏—Å–∫–∏ –ê–§–ü–ï–ê–≠–° –ø—Ä–µ–¥—É–ø—Ä–µ–¥–∏–ª–∞ –ú–∏–Ω–∑–¥—Ä–∞–≤ –æ –ø–æ—Å–ª–µ–¥—Å—Ç–≤–∏—è—Ö –ø—Ä–∏–Ω—è—Ç–∏—è –Ω–æ–≤—ã—Ö –ø—Ä–∞–≤–∏–ª –ø–ª–∞—Ç—ã —É—á–µ–Ω—ã–º –∑–∞ —É—á–∞—Å—Ç–∏–µ –≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è—Ö. –û–Ω–∏ –º–æ–≥—É—Ç –ø—Ä–∏–≤–µ—Å—Ç–∏ –∫ –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ–º—É —É–≤–µ–ª–∏—á–µ–Ω–∏—é –∏—Ö —Å—Ç–æ–∏–º–æ—Å—Ç–∏ –∏ –ø–æ—Å—Ç–∞–≤—è—Ç –ø–æ–¥ –≤–æ–ø—Ä–æ—Å —Ü–µ–ª–µ—Å–æ–æ–±—Ä–∞–∑–Ω–æ—Å—Ç—å –∏—Ö –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ –†–æ—Å—Å–∏–∏. –¶–µ–Ω—ã –≤—ã—Ä–æ—Å–ª–∏ –†–æ—Å—Å—Ç–∞—Ç –æ–ø—É–±–ª–∏–∫–æ–≤–∞–ª –æ—Ç—á–µ—Ç –æ–± –∏–Ω–¥–µ–∫—Å–µ –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª—å—Å–∫–∏—Ö —Ü–µ–Ω –≤ –∏—é–Ω–µ 2025 –≥–æ–¥–∞. –í –∏—é–Ω–µ —Ü–µ–Ω—ã –Ω–∞ –ñ–ù–í–õ–ü –≤ —Å—Ä–µ–¥–Ω–µ–º –≤—ã—Ä–æ—Å–ª–∏ –Ω–∞ 0,4% –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ –º–∞—è. –†–æ—Å—Ç —Ü–µ–Ω –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –Ω–µ –∏–∑ –ø–µ—Ä–µ—á–Ω—è –∂–∏–∑–Ω–µ–Ω–Ω–æ –≤–∞–∂–Ω—ã—Ö —Å–æ—Å—Ç–∞–≤–∏–ª –≤ —Å—Ä–µ–¥–Ω–µ–º 0,8%.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety, guideline"",
  ""impact"": ""medium"",
  ""english"": ""There are concerns that new rules for paying researchers to participate in clinical trials could increase costs and raise questions about their feasibility in Russia. The country's statistics service has published a report on the Consumer Price Index for June 2025, showing that general prices rose by 0.4% compared to May. Prices for essential medicines were up by an average of 0.8%. There are also worries about potential issues in the healthcare system on Sakhalin, where a criminal case has been opened for alleged abuse of authority in the transfer of healthcare facilities and equipment from state institutions to a private entity.""
}"
2025-07-14T14:59:15+00:00,@medpharm,12396,https://t.me/medpharm/12396,–í–ª–∞–¥–∏–º–∏—Ä –ü—É—Ç–∏–Ω –ø–æ—Ä—É—á–∏–ª —Ä–∞—Å—Å–º–æ—Ç—Ä–µ—Ç—å –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –æ—Ç–∫—Ä—ã—Ç–∏—è –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã—Ö –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –æ—Ç–¥–µ–ª–µ–Ω–∏–π –≤ —Ä–µ–≥–∏–æ–Ω–∞—Ö —Å –≤—ã—Å–æ–∫–∏–º–∏ –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–µ–º–æ—Å—Ç–∏. –¢–∞–∫–∏–µ –∑–∞–ø—Ä–æ—Å—ã –ø–æ—Å—Ç—É–ø–∞–ª–∏ –æ—Ç –≥—É–±–µ—Ä–Ω–∞—Ç–æ—Ä–æ–≤.,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage,hospital_policy"",
  ""impact"": ""high"",
  ""english"": ""Vladimir Putin instructed to consider opening additional oncology departments in regions with high disease incidence. Such requests were submitted by governors.""
}"
2025-07-14T13:01:31+00:00,@medpharm,12395,https://t.me/medpharm/12395,"11 –∏—é–ª—è –≤ –î–¢–ü –≤ –õ–µ–Ω–∏–Ω–≥—Ä–∞–¥—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ —Ç—Ä–∞–≥–∏—á–µ—Å–∫–∏ –ø–æ–≥–∏–± –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–π –¥–∏—Ä–µ–∫—Ç–æ—Ä –∫–æ–Ω—Ç—Ä–∞–∫—Ç–Ω–æ-–∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–æ–π –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ ¬´–≠–∫—Å–µ–ª–ª–µ–Ω–∞¬ª, —Å–æ—É—á—Ä–µ–¥–∏—Ç–µ–ª—å –ù–∞—É—á–Ω–æ-–∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–æ–≥–æ —Ü–µ–Ω—Ç—Ä–∞ ¬´–≠–∫–æ-–±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å¬ª –ö–æ–Ω—Å—Ç–∞–Ω—Ç–∏–Ω –ó–∞—Ö–∞—Ä–æ–≤. –ï–º—É –±—ã–ª–æ 46 –ª–µ—Ç.","{""skip"": true}"
2025-07-14T10:59:45+00:00,@medpharm,12394,https://t.me/medpharm/12394,–ù–∞ –ø–æ—Ä—Ç–∞–ª–µ Change.org –ø–æ—è–≤–∏–ª–∞—Å—å –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–∞—è –ø–µ—Ç–∏—Ü–∏—è –∑–∞ –æ—Ç—Å—Ç–∞–≤–∫—É —Å–æ–≤–º–µ—â–∞—é—â–µ–π –ø–æ—Å—Ç—ã –≤–∏—Ü–µ-–≥—É–±–µ—Ä–Ω–∞—Ç–æ—Ä–∞ –∏ –º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –°–≤–µ—Ä–¥–ª–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –¢–∞—Ç—å—è–Ω—ã –°–∞–≤–∏–Ω–æ–≤–æ–π. –ì–ª–∞–≤–Ω–∞—è –ø—Ä–µ—Ç–µ–Ω–∑–∏—è ‚Äî –Ω–∞—á–∞—Ç–∞—è –µ—é –∫–∞–º–ø–∞–Ω–∏—è –ø–æ –ø–æ–≤—ã—à–µ–Ω–∏—é —Ñ–∏–Ω–∞–Ω—Å–æ–≤–æ–π —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –Ω–µ–±–æ–ª—å—à–∏—Ö –±–æ–ª—å–Ω–∏—Ü –∏ –æ–±—ä–µ–¥–∏–Ω–µ–Ω–∏–µ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏–π.,"{""skip"": true}"
2025-07-14T08:41:42+00:00,@medpharm,12393,https://t.me/medpharm/12393,"–í –∏—é–Ω–µ —Ü–µ–Ω—ã –Ω–∞ –ñ–ù–í–õ–ü –≤ —Å—Ä–µ–¥–Ω–µ–º –≤—ã—Ä–æ—Å–ª–∏ –Ω–∞ 0,4% –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ –º–∞—è, —Å–ª–µ–¥—É–µ—Ç –∏–∑ –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω–Ω–æ–π –†–æ—Å—Å—Ç–∞—Ç–æ–º —Å—Ç–∞—Ç–∏—Å—Ç–∏–∫–∏. –í—Å–µ –æ–Ω–∏ –¥–æ—Ä–æ–∂–∞—é—Ç —Ç—Ä–µ—Ç–∏–π –º–µ—Å—è—Ü –ø–æ–¥—Ä—è–¥. –†–æ—Å—Ç —Ü–µ–Ω –Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –Ω–µ –∏–∑ –ø–µ—Ä–µ—á–Ω—è –∂–∏–∑–Ω–µ–Ω–Ω–æ –≤–∞–∂–Ω—ã—Ö —Å–æ—Å—Ç–∞–≤–∏–ª –≤ —Å—Ä–µ–¥–Ω–µ–º 0,8%.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""pricing, shortage"",
  ""impact"": ""medium"",
  ""english"": ""Prices on –ñ–ù–í–õ–ü have risen by an average of 0.4% from May to June, according to Rosstat statistics. Prices have risen for the third month in a row. The price increase on non-essential drugs is averaging 0.8%.""
}"
2025-07-14T07:07:15+00:00,@medpharm,12392,https://t.me/medpharm/12392,–í –ì–æ—Å–¥—É–º–µ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ —Å–æ–∑–¥–∞—Ç—å –ø—É–ª –ø—Å–∏—Ö–æ–ª–æ–≥–æ–≤ –Ω–∞ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–º —É—Ä–æ–≤–Ω–µ –¥–ª—è –ø–æ–º–æ—â–∏ —É—á–∞—Å—Ç–Ω–∏–∫–∞–º –°–í–û. –≠—Ç—É —Ä–∞–±–æ—Ç—É –ø–ª–∞–Ω–∏—Ä—É—é—Ç –∑–∞–≤–µ—Ä—à–∏—Ç—å –¥–æ —Å–µ–Ω—Ç—è–±—Ä—è.,"{""skip"": true}"
2025-07-13T12:03:01+00:00,@medpharm,12391,https://t.me/medpharm/12391,–ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ –∑–∞ –Ω–µ–¥–µ–ª—é üîµ –í —Ä—è–¥–µ —Ä–µ–≥–∏–æ–Ω–æ–≤ –†–æ—Å—Å–∏–∏ –∞–ø—Ç–µ–∫–∏ –Ω–µ –º–æ–≥—É—Ç –ø—Ä–æ–¥–∞—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏–∑-–∑–∞ –æ—Ç–∫–ª—é—á–µ–Ω–∏—è –∏–Ω—Ç–µ—Ä–Ω–µ—Ç–∞. –õ–æ–∫–∞–ª—å–Ω—ã–π –º–æ–¥—É–ª—å ¬´–ß–µ—Å—Ç–Ω–æ–≥–æ –∑–Ω–∞–∫–∞¬ª –æ—Å—Ç–∞–µ—Ç—Å—è –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–º —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–∏–º —Ä–µ—à–µ–Ω–∏–µ–º –¥–ª—è –≤—Ä–µ–º–µ–Ω–Ω–æ–π —Ä–∞–±–æ—Ç—ã –±–µ–∑ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç–∞. üîµ –ò–∑ –ì–†–õ–° –∏—Å–∫–ª—é—á–∏–ª–∏ —Ä–µ–≥—É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏—è –Ω–∞ –ø—è—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –æ–¥–Ω—É —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏—é. –°—Ä–µ–¥–∏ –Ω–∏—Ö –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã–π –ø—Ä–æ—Ç–∏–≤–æ—ç–ø–∏–ª–µ–ø—Ç–∏—á–µ—Å–∫–∏–π –ø—Ä–µ–ø–∞—Ä–∞—Ç ¬´–≠–∫—Å–∞–ª–∏–µ—Ñ¬ª (–ú–ù–ù —ç—Å–ª–∏–∫–∞—Ä–±–∞–∑–µ–ø–∏–Ω). üîµ –ì–æ—Å–¥—É–º–∞ –ø—Ä–∏–Ω—è–ª–∞ –∑–∞–∫–æ–Ω –æ –ø–µ—Ä–µ—á–Ω–µ –°–ó–õ–°. –î–æ–∫—É–º–µ–Ω—Ç –∑–∞–∫—Ä–µ–ø–ª—è–µ—Ç –ø–æ–Ω—è—Ç–∏–µ —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤. üîµ –§–ê–° –≤–æ–∑–±—É–¥–∏–ª–∞ –¥–µ–ª–æ –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ ¬´–ó–∞–º–±–æ–Ω-–§–∞—Ä–º–∞¬ª –∏–∑-–∑–∞ –º–æ–Ω–æ–ø–æ–ª—å–Ω–æ –≤—ã—Å–æ–∫–∏—Ö —Ü–µ–Ω. üîµ –û—Å–Ω–æ–≤–∞—Ç–µ–ª—è —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ ¬´–†–ò–ê ¬´–ü–∞–Ω–¥–∞¬ª –∏ –µ–≥–æ –¥–µ–ª–æ–≤–æ–≥–æ –ø–∞—Ä—Ç–Ω–µ—Ä–∞ –æ—Å–≤–æ–±–æ–¥–∏–ª–∏ –æ—Ç –Ω–∞–∫–∞–∑–∞–Ω–∏—è –∑–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –Ω–µ–±–µ–∑–æ–ø–∞—Å–Ω—ã—Ö –ë–ê–î –≤ —Å–≤—è–∑–∏ —Å –∏—Å—Ç–µ—á–µ–Ω–∏–µ–º —Å—Ä–æ–∫–∞ –¥–∞–≤–Ω–æ—Å—Ç–∏.,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, regulation, sanctions"",
  ""impact"": ""high"",
  ""english"": ""A shortage of medications is occurring in some regions of Russia due to internet outages. The local 'Fair Sign' module remains the only technical solution for temporary operations without an internet connection. The State Duma has approved a law on the list of Strategic Life-Supporting Substances (SLS). The FAS has initiated a case against 'Zambofarma' for monopolistically high prices. The founder of PharmCambia, 'RIA Panda', and his business partner have been released from punishment for producing unsafe Biologically Active Substances (BAS) due to the expiration of the statute of limitations.""
}"
2025-07-12T09:00:54+00:00,@medpharm,12390,https://t.me/medpharm/12390,"–ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∑–∞ –Ω–µ–¥–µ–ª—é üî¥–î–µ–ø—É—Ç–∞—Ç—ã –ì–æ—Å–¥—É–º—ã –ø—Ä–∏–Ω—è–ª–∏ –≤–Ω–µ—Å–µ–Ω–Ω—ã–µ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ–º –ø–æ–ø—Ä–∞–≤–∫–∏, –¥–∞—é—â–∏–µ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –≤—Ä–∞—á–∞–º –æ—Ç–∫–ª–æ–Ω—è—Ç—å—Å—è –æ—Ç –Ω–æ—Ä–º –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π (–ö–†), –µ—Å–ª–∏ —ç—Ç–æ–≥–æ —Ç—Ä–µ–±—É—é—Ç –∏–Ω—Ç–µ—Ä–µ—Å—ã –ø–∞—Ü–∏–µ–Ω—Ç–∞. üî¥–ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –ø—Ä–æ–µ–∫—Ç –∫–∞—Ç–µ–≥–æ—Ä–∏—Ä–æ–≤–∞–Ω–∏—è –æ–±—ä–µ–∫—Ç–æ–≤ –∫—Ä–∏—Ç–∏—á–µ—Å–∫–æ–π –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω–æ–π –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä—ã –≤ —Å—Ñ–µ—Ä–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –ù–∞–∑–≤–∞–Ω—ã —á–µ—Ç—ã—Ä–µ –∫—Ä–∏—Ç–µ—Ä–∏—è –∏—Ö –∑–Ω–∞—á–∏–º–æ—Å—Ç–∏. üî¥–û–±—Å—É–∂–¥–∞–µ—Ç—Å—è –ø—Ä–æ–µ–∫—Ç –º–µ—Ç–æ–¥–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ø–æ –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–∏—é —Ü–µ–ª–µ—Å–æ–æ–±—Ä–∞–∑–Ω–æ—Å—Ç–∏ —Å–æ–∑–¥–∞–Ω–∏—è –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π. –ü–æ –º–Ω–µ–Ω–∏—é –ø–µ—Ä–≤–æ–≥–æ –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—è –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—è –í—Ä–∞—á–µ–±–Ω–æ–π –ø–∞–ª–∞—Ç—ã –¢–≤–µ—Ä—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏, –≤—Ä–∞—á–∞-–∫–∞—Ä–¥–∏–æ–ª–æ–≥–∞ –û–ª–µ–≥–∞ –°–∞–º–æ—à–∏–Ω–∞, –≤ —Å–ª—É—á–∞–µ –æ–¥–æ–±—Ä–µ–Ω–∏—è —ç—Ç–æ–≥–æ –¥–æ–∫—É–º–µ–Ω—Ç–∞ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ–º —Å–ª–µ–¥—É–µ—Ç –∂–¥–∞—Ç—å –∑–∞–∫—Ä—ã—Ç–∏—è —Ä—è–¥–∞ –±–æ–ª—å–Ω–∏—Ü –≤ –¥–æ—Ç–∞—Ü–∏–æ–Ω–Ω—ã—Ö —Ä–µ–≥–∏–æ–Ω–∞—Ö. üî¥–í –ù–ú–ò–¶ –æ–Ω–∫–æ–ª–æ–≥–∏–∏ –∏–º. –ë–ª–æ—Ö–∏–Ω–∞ –ø—Ä–∏–∑–≤–∞–ª–∏ —Ä–µ–≥–∏–æ–Ω—ã –Ω–µ –æ–≥—Ä–∞–Ω–∏—á–∏–≤–∞—Ç—å –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ –ø—Ä–∞–≤–æ –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –Ω–∞ –ø–æ–ª—É—á–µ–Ω–∏–µ –ª–µ—á–µ–Ω–∏—è –≤ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã—Ö –º–µ–¥—Ü–µ–Ω—Ç—Ä–∞—Ö. üî¥ –≠–∫—Å–ø–µ—Ä—Ç–∏–∑–∞ CEO –ª–æ–≥–∏—Å—Ç–∏—á–µ—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–∏ WEVED –ú–∞—Ä–∏–∏ –ü–æ–ø–æ–≤–æ–π –æ–± –∞–∫—Ç—É–∞–ª—å–Ω—ã—Ö —Å—Ö–µ–º–∞—Ö –∏ –Ω—é–∞–Ω—Å–∞—Ö –∏–º–ø–æ—Ä—Ç–∞ –º–µ–¥–æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –≤ —É—Å–ª–æ–≤–∏—è—Ö –∑–∞–ø–∞–¥–Ω—ã—Ö —Å–∞–Ω–∫—Ü–∏–π.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety, guideline"",
  ""impact"": ""medium"",
  ""english"": ""The message discusses changes in clinical guidelines and patient care, as well as discussions on the classification of healthcare critical information infrastructure. It does not primarily focus on regulatory affairs, compliance, pricing and reimbursement, or demand for medicines.""
}"
2025-07-11T16:00:01+00:00,@medpharm,12389,https://t.me/medpharm/12389,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 11 –∏—é–ª—è –ù–∞–≥—Ä—É–∑—è—Ç –ø–æ–ª–∏–∫–ª–∏–Ω–∏–∫–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤ –≤–Ω–µ—Å –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ –¢—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ —Å—Ç—Ä—É–∫—Ç—É—Ä–µ –∏ —Å–æ–¥–µ—Ä–∂–∞–Ω–∏—é —Ç–∞—Ä–∏—Ñ–Ω–æ–≥–æ —Å–æ–≥–ª–∞—à–µ–Ω–∏—è. –£–≤–µ–ª–∏—á–µ–Ω–æ —á–∏—Å–ª–æ –ø–æ–∫–∞–∑–∞—Ç–µ–ª–µ–π —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∏–≤–Ω–æ—Å—Ç–∏ –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π, —Ñ–∏–Ω–∞–Ω—Å–∏—Ä—É–µ–º—ã—Ö –ø–æ –ø–æ–¥—É—à–µ–≤–æ–º—É –Ω–æ—Ä–º–∞—Ç–∏–≤—É. –¢—Ä–µ–∑–≤—ã–π –≤–∑–≥–ª—è–¥ –ö–∞–¥—Ä–æ–≤—É—é –ø—Ä–æ–±–ª–µ–º—É –≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–∏ –Ω–µ–ª—å–∑—è —Ä–µ—à–∏—Ç—å —Ç–æ–ª—å–∫–æ –∑–∞ —Å—á–µ—Ç —É–≤–µ–ª–∏—á–µ–Ω–∏—è —á–∏—Å–ª–∞ —Å—Ç—É–¥–µ–Ω—Ç–æ–≤ –∏ –∫–æ–º–º–µ—Ä—Ü–∏–∞–ª–∏–∑–∞—Ü–∏–∏ –º–µ–¥–æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è. –ò–Ω—Ç–µ—Ä–µ—Å—ã –æ–±—â–µ—Å—Ç–≤–∞, –Ω–∞–ø—Ä–æ—Ç–∏–≤, —Ç—Ä–µ–±—É—é—Ç —Å–æ–∫—Ä–∞—â–µ–Ω–∏—è –∫–æ–ª–∏—á–µ—Å—Ç–≤–∞ –æ–±—É—á–∞—é—â–∏—Ö—Å—è –≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –≤—É–∑–∞—Ö, —á—Ç–æ–±—ã –≤—ã—Å—à–µ–µ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–µ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ –ø–æ–ª—É—á–∞–ª–∏ —Ç–æ–ª—å–∫–æ —Å–∞–º—ã–µ –º–æ—Ç–∏–≤–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ, —Å—á–∏—Ç–∞–µ—Ç –ø—Ä–æ—Ñ–µ—Å—Å–æ—Ä –°–µ—á–µ–Ω–æ–≤—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ –í–∞–ª–µ–Ω—Ç–∏–Ω –§–∞–¥–µ–µ–≤. –í–æ–∑—å–º—É—Ç –Ω–µ –≤—Å–µ—Ö –ê—Å—Å–æ—Ü–∏–∞—Ü–∏—è —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π ¬´–ò–Ω—Ñ–∞—Ä–º–∞¬ª –Ω–∞–ø—Ä–∞–≤–∏–ª–∞ –ø–∏—Å—å–º–∞ –≤ –ú–∏–Ω–∑–¥—Ä–∞–≤ –∏ –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ —Å –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è–º–∏ –ø–æ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—é –ø–µ—Ä–µ—á–Ω—è —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤. –í —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, –æ–Ω–∞ –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç –Ω–µ –ø–µ—Ä–µ–Ω–æ—Å–∏—Ç—å –ø–æ–ª–Ω–æ—Å—Ç—å—é –≤—Å–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏–∑ —Å—É—â–µ—Å—Ç–≤—É—é—â–µ–≥–æ –ø–µ—Ä–µ—á–Ω—è –°–ó–õ–°, –∞ –ø—Ä–æ–≤–µ—Å—Ç–∏ –∏—Ö –æ—Ü–µ–Ω–∫—É –Ω–∞ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–µ –Ω–æ–≤—ã–º –∫—Ä–∏—Ç–µ—Ä–∏—è–º. –û—Å–æ–±—ã–π —Å–ø—Ä–æ—Å –ú–∏–∑–æ–ø—Ä–æ—Å—Ç–æ–ª –∏ –º–∏—Ñ–µ–ø—Ä–∏—Å—Ç–æ–Ω –≤–∫–ª—é—á–∏–ª–∏ –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ü–ö–£ –≤ 2024 –≥–æ–¥—É. –í —Ç–æ–º –∂–µ –≥–æ–¥—É –æ–¥–Ω–∞ —Ç–æ—Ä–≥–æ–≤–∞—è –º–∞—Ä–∫–∞ –ª–µ–≤–æ–Ω–æ—Ä–≥–µ—Å—Ç—Ä–µ–ª–∞ –ø–æ–ª—É—á–∏–ª–∞ —Å—Ç–∞—Ç—É—Å –±–µ–∑—Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞. –ö–∞–∫ –æ—Ç—Ä–∞–∑–∏–ª–∏—Å—å –Ω–æ–≤–æ–≤–≤–µ–¥–µ–Ω–∏—è –Ω–∞ –ø—Ä–æ–¥–∞–∂–∞—Ö —Å—Ä–µ–¥—Å—Ç–≤ –¥–ª—è —ç–∫—Å—Ç—Ä–µ–Ω–Ω–æ–π –∫–æ–Ω—Ç—Ä–∞—Ü–µ–ø—Ü–∏–∏, –ø–æ–¥—Å—á–∏—Ç–∞–ª ¬´–§–í¬ª.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, sanctions, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health announced changes to the requirements for the structure and content of the tariff agreement. The number of indicators for assessing the activities of healthcare organizations funded on a per capita basis was increased. Professor Valentin Fadeev from the Cadet University believes that solving the personnel issue in healthcare cannot be done solely by increasing the number of students and commercializing medical education. The Association of Pharmaceutical Companies 'Infarma' submitted letters to the Ministry of Health and the Ministry of Industry and Trade with proposals for developing a list of strategically important drugs. They suggest not transferring all items from the existing SZZP list but conducting an evaluation against new criteria. One brand of levonorgestrel was granted prescription-free status in 2024.""
}"
2025-07-11T14:34:14+00:00,@medpharm,12388,https://t.me/medpharm/12388,"–ë–æ–ª–µ–µ 30% —Ä–æ—Å—Å–∏—è–Ω –Ω–µ –≤ —Å–æ—Å—Ç–æ—è–Ω–∏–∏ –∫—É–ø–∏—Ç—å –Ω—É–∂–Ω—ã–µ –∏–º –ª–µ–∫–∞—Ä—Å—Ç–≤–∞, –≤—ã—è—Å–Ω–∏–ª–∏ –≤ –†–ê–ù–•–∏–ì–°. –í —á–∏—Å–ª–µ —Å–∞–º—ã—Ö —É—è–∑–≤–∏–º—ã—Ö –∫–∞—Ç–µ–≥–æ—Ä–∏–π –æ–∫–∞–∑–∞–ª–∏—Å—å —Å–µ–º—å–∏ —Å –¥–µ—Ç—å–º–∏, –ø–æ–∂–∏–ª—ã–µ –ª—é–¥–∏ –∏ —Å–µ–ª—å—Å–∫–∏–µ –∂–∏—Ç–µ–ª–∏.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""shortage,demand"",
  ""impact"": ""high"",
  ""english"": ""More than 30% of Russians are unable to buy necessary medications, according to research by the Higher School of Economics. Among the most vulnerable groups are families with children, elderly people, and rural residents.""
}"
2025-07-11T13:00:28+00:00,@medpharm,12387,https://t.me/medpharm/12387,"#–≠–∫—Å–∫–ª—é–∑–∏–≤ –ê—Å—Å–æ—Ü–∏–∞—Ü–∏—è —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π ¬´–ò–Ω—Ñ–∞—Ä–º–∞¬ª –Ω–∞–ø—Ä–∞–≤–∏–ª–∞ –ø–∏—Å—å–º–∞ –≤ –ú–∏–Ω–∑–¥—Ä–∞–≤ –∏ –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ —Å –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è–º–∏ –ø–æ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—é –ø–µ—Ä–µ—á–Ω—è —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤. –í —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, –ø—Ä–∏ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏–∏ –µ–≥–æ –ø–µ—Ä–≤–æ–π —á–∞—Å—Ç–∏ –æ–Ω–∞ –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç –Ω–µ –ø–µ—Ä–µ–Ω–æ—Å–∏—Ç—å –ø–æ–ª–Ω–æ—Å—Ç—å—é –≤—Å–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏–∑ —Å—É—â–µ—Å—Ç–≤—É—é—â–µ–≥–æ –ø–µ—Ä–µ—á–Ω—è, –∞ –ø—Ä–æ–≤–µ—Å—Ç–∏ –∏—Ö –æ—Ü–µ–Ω–∫—É –Ω–∞ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–µ –Ω–æ–≤—ã–º –∫—Ä–∏—Ç–µ—Ä–∏—è–º.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The exclusive association of pharmaceutical companies 'Infarma' has sent letters to the Ministry of Health and the Ministry of Industry and Trade with proposals for forming a list of strategically important medicines. In particular, when forming its first part, it suggests not transferring all drugs from the existing list at once but conducting an evaluation of their compliance with new criteria.""
}"
2025-07-11T12:01:18+00:00,@medpharm,12386,https://t.me/medpharm/12386,"–†–∞–¥—ã –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç—å –≤–∞–º —Å–ª–µ–¥—É—é—â–µ–≥–æ —Å–ø–∏–∫–µ—Ä–∞ PRO–µ–∫—Ü–∏–π –ë—É–¥—É—â–µ–≥–æ: üîπ –≠–º–∏–ª—å –•—É–±–∞–ª–∏–µ–≤, –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å –≥–µ–Ω–µ—Ä–∞–ª—å–Ω–æ–≥–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –∞–ø—Ç–µ—á–Ω–æ–π —Å–µ—Ç–∏ ¬´–í–∏—Ç–∞¬ª, —Å–ø–∏–∫–µ—Ä –¥–∏—Å–∫—É—Å—Å–∏–æ–Ω–Ω–æ–π —Å–µ—Å—Å–∏–∏ ¬´–ê–ø—Ç–µ–∫–∞ –∫–∞–∫ –±–∏–∑–Ω–µ—Å: —ç–∫–æ–Ω–æ–º–∏–∫–∞ —Ä–∏—Ç–µ–π–ª–∞ –≤ —É—Å–ª–æ–≤–∏—è—Ö –º–∞—Ä–∂–∏–Ω–∞–ª—å–Ω–æ–≥–æ –¥–∞–≤–ª–µ–Ω–∏—è¬ª. –î–∞—Ç–∞ –∏ –≤—Ä–µ–º—è —Å–µ—Å—Å–∏–∏: 11 —Å–µ–Ω—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞, 15:45 üìç –≥. –°–æ—á–∏, Pullman –°–æ—á–∏ –¶–µ–Ω—Ç—Ä 5* üëâ –ü–æ–¥—Ä–æ–±–Ω–µ–µ –æ –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ –∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –Ω–∞ —Å–∞–π—Ç–µ","{""skip"": true}"
2025-07-11T11:03:53+00:00,@medpharm,12385,https://t.me/medpharm/12385,"–ê–ø—Ç–µ–∫–∏ –º–æ–≥—É—Ç –ø—Ä–æ–¥–∞–≤–∞—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –ø—Ä–∏ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–∏ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç–∞, –Ω–µ –ø–µ—Ä–µ—Ö–æ–¥—è –Ω–∞ –æ—Ñ–ª–∞–π–Ω-–ø—Ä–æ–≤–µ—Ä–∫—É –∫–æ–¥–∞ –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏. –û–± —ç—Ç–æ–º ¬´–§–í¬ª —Å–æ–æ–±—â–∏–ª–∏ –≤ –¶–†–ü–¢ –≤ –æ—Ç–≤–µ—Ç –Ω–∞ –∂–∞–ª–æ–±—ã —Ä–æ–∑–Ω–∏—á–Ω–æ–≥–æ –∑–≤–µ–Ω–∞ –æ –Ω–µ–≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ –ø—Ä–æ–∏–∑–≤–µ—Å—Ç–∏ –æ–Ω–ª–∞–π–Ω-–ø—Ä–æ–≤–µ—Ä–∫—É, –∞ —Ç–∞–∫–∂–µ –ø—Ä–æ–±–ª–µ–º–∞—Ö —Å –æ—Ñ–ª–∞–π–Ω-–ø—Ä–æ–≤–µ—Ä–∫–æ–π —á–µ—Ä–µ–∑ –ª–æ–∫–∞–ª—å–Ω—ã–π –º–æ–¥—É–ª—å ¬´–ß–µ—Å—Ç–Ω–æ–≥–æ –∑–Ω–∞–∫–∞¬ª.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""Pharmacies are allowed to sell medicines without internet access, bypassing the offline verification of the barcode marking. This was reported by 'FV' to the CPRPT in response to concerns from the retail sector about the inability to perform online verification, as well as issues with offline verification through a local 'Fair Sign' module.""
}"
2025-07-11T10:02:33+00:00,@medpharm,12384,https://t.me/medpharm/12384,"–ó–∞ –ø—Ä–æ—à–ª—ã–π –≥–æ–¥ —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ —Ä–µ–≥–∏–æ–Ω—ã –ø–æ—Ç—Ä–∞—Ç–∏–ª–∏ –±–æ–ª—å—à–µ 16 –º–ª—Ä–¥ —Ä—É–±. –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, –∫–æ—Ç–æ—Ä—ã–µ –Ω–µ –≤—Ö–æ–¥—è—Ç –≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏. –ë–æ–ª—å—à–µ –≤—Å–µ–≥–æ —Ç–∞–∫–∏—Ö –∑–∞–∫—É–ø–æ–∫ —Å–¥–µ–ª–∞–ª–∏ –Ø–∫—É—Ç–∏—è, –£–¥–º—É—Ä—Ç–∏—è –∏ –ß–µ—á–Ω—è.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""Russia's regions spent over 16 billion rubles on medicines that are not included in clinical guidelines. The largest purchases were made by Yakutia, Udmurtia and Chechnya.""
}"
2025-07-11T09:01:27+00:00,@medpharm,12383,https://t.me/medpharm/12383,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –≤—ã–¥–∞–ª –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ì–µ–Ω–µ—Ä–∏—É–º¬ª —Ä–∞–∑—Ä–µ—à–µ–Ω–∏–µ –Ω–∞ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏–µ I —Ñ–∞–∑—ã –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–≥–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –±–∏–æ–∞–Ω–∞–ª–æ–≥–∞ –æ—Ä—Ñ–∞–Ω–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ¬´–°—Ç—Ä–µ–Ω–∑–∏–∫¬ª, –∫–æ—Ç–æ—Ä—ã–π –∏—Å–ø–æ–ª—å–∑—É–µ—Ç—Å—è –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ –≥–∏–ø–æ—Ñ–æ—Å—Ñ–∞—Ç–∞–∑–∏–∏. –û—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç –∫–æ–º–ø–∞–Ω–∏—è Alexion.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health has granted a company 'Generium' approval to conduct the first phase of a clinical trial for a biologic orphan drug 'Strenzik', which is used in the treatment of hypophosphatasia. The original drug is produced by company Alexion.""
}"
2025-07-11T07:31:34+00:00,@medpharm,12382,https://t.me/medpharm/12382,"#–≠–∫—Å–∫–ª—é–∑–∏–≤ –° —Ñ–µ–≤—Ä–∞–ª—è 2022 –≥–æ–¥–∞ –∏–º–ø–æ—Ä—Ç –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è ‚Äî —ç—Ç–æ –∫–æ–º–ø–ª–µ–∫—Å–Ω–∞—è —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∞—è –æ–ø–µ—Ä–∞—Ü–∏—è, –≥–¥–µ –∫–∞–∂–¥—ã–π —ç—Ç–∞–ø —Å–æ–ø—Ä–æ–≤–æ–∂–¥–∞–µ—Ç—Å—è –º–Ω–æ–∂–µ—Å—Ç–≤–æ–º –ø–æ–¥–≤–æ–¥–Ω—ã—Ö –∫–∞–º–Ω–µ–π. –ü–æ–º–∏–º–æ –≥—Ä–∞–º–æ—Ç–Ω–æ –≤—ã—Å—Ç—Ä–æ–µ–Ω–Ω—ã—Ö –ª–æ–≥–∏—Å—Ç–∏—á–µ—Å–∫–∏—Ö —Ü–µ–ø–æ—á–µ–∫ –∏ —Å—Ç—Ä—É–∫—Ç—É—Ä—ã –ø–ª–∞—Ç–µ–∂–µ–π, –≤ —Å–æ–≤—Ä–µ–º–µ–Ω–Ω—ã—Ö —Ä–µ–∞–ª–∏—è—Ö —Å—Ç–∞–ª–∏ –∞–∫—Ç—É–∞–ª—å–Ω—ã–º–∏ –ø—Ä–æ–±–ª–µ–º—ã —Å –ø–æ–∏—Å–∫–æ–º –Ω–æ–≤—ã—Ö –ø–æ—Å—Ç–∞–≤—â–∏–∫–æ–≤, –∞–∫—Ç–∏–≤–∞—Ü–∏–∏ —Ç–µ—Ö–Ω–∏–∫–∏ –≤ –¥—Ä—É–∂–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ç—Ä–∞–Ω–∞—Ö, —Å–ª–æ–∂–Ω–æ—Å—Ç–∏ —é—Ä–∏–¥–∏—á–µ—Å–∫–æ–≥–æ –æ—Ñ–æ—Ä–º–ª–µ–Ω–∏—è –∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–π –∏ –¥—Ä—É–≥–∏–µ –Ω—é–∞–Ω—Å—ã. –ü–æ—ç—Ç–æ–º—É —É—á–∞—Å—Ç–Ω–∏–∫–∞–º —Ä—ã–Ω–∫–∞ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ –ø–µ—Ä–µ–æ—Å–º—ã—Å–ª–∏—Ç—å –Ω–µ —Ç–æ–ª—å–∫–æ —Ç–∞–∫—Ç–∏–∫—É, –Ω–æ –∏ —Å—Ç—Ä–∞—Ç–µ–≥–∏—é –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏—è —Å –≥–ª–æ–±–∞–ª—å–Ω–æ–π —Ü–µ–ø–æ—á–∫–æ–π –ø–æ—Å—Ç–∞–≤–æ–∫.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""import_export, regulation, registration, sanctions"",
  ""impact"": ""medium"",
  ""english"": ""Import of medical equipment is a comprehensive strategic operation with many hidden challenges. Besides well-organized logistics and payment structures, modern realities have made issues such as finding new suppliers, activating equipment in friendly countries, and legal formalities and registrations important. Market participants need to reconsider both their tactical and strategic interactions with the global supply chain.""
}"
2025-07-11T07:03:14+00:00,@medpharm,12381,https://t.me/medpharm/12381,"–ü—Ä–æ—Ñ—Å–æ—é–∑ —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –†–æ—Å—Å–∏–∏ –Ω–∞–ª–∞–∂–∏–≤–∞–µ—Ç —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–æ —Å –∫–æ–ª–ª–µ–≥–∞–º–∏ –∏–∑ –ú–æ–Ω–≥–æ–ª–∏–∏ –∏ –ö–∏—Ç–∞—è. –í –ø–ª–∞–Ω–∞—Ö –æ–±–º–µ–Ω –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–µ–π –æ –ø–æ–≤—ã—à–µ–Ω–∏–∏ –∫–≤–∞–ª–∏—Ñ–∏–∫–∞—Ü–∏–∏ —á–ª–µ–Ω–æ–≤ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π, –æ–±—É—á–µ–Ω–∏—è, –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–π –ø–æ–¥–≥–æ—Ç–æ–≤–∫–∏ –∏ –æ–∑–¥–æ—Ä–æ–≤–ª–µ–Ω–∏—è.","{""skip"": true}"
2025-07-10T19:00:01+00:00,@medpharm,12380,https://t.me/medpharm/12380,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 10 –∏—é–ª—è –ü–æ—Å—Ç–∞–≤–∫–∏ –Ω–∞ –ø–∞—É–∑–µ –î–∏—Å—Ç—Ä–∏–±—å—é—Ç–æ—Ä ¬´–§–∞—Ä–º–∏–º—ç–∫—Å¬ª –ø–æ–∂–∞–ª–æ–≤–∞–ª—Å—è –≤ –§–ê–° –Ω–∞ –∑–∞–∫—É–ø–∫—É —Ç–µ–¥—É–≥–ª—É—Ç–∏–¥–∞ –∏–∑-–∑–∞ –Ω–∞—Ä—É—à–µ–Ω–∏–µ –ø–∞—Ç–µ–Ω—Ç–∞ –Ω–∞ ¬´–ì—ç—Ç—Ç–µ—Å—Ç–∏–≤¬ª. –¶–µ–Ω—Ç—Ä –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –∑–∞–∫–ª—é—á–∏–ª –∫–æ–Ω—Ç—Ä–∞–∫—Ç –Ω–∞ –ø–æ—Å—Ç–∞–≤–∫—É –¥–ª—è ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª –¥–∂–µ–Ω–µ—Ä–∏–∫–∞ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ —Å –∫–æ–º–ø–∞–Ω–∏–µ–π ¬´–§–ö –ì—Ä–∞–Ω–¥ –ö–∞–ø–∏—Ç–∞–ª¬ª. –¢–µ–ø–µ—Ä—å –ø–æ—Å—Ç–∞–≤–∫—É –ø—Ä–∏–æ—Å—Ç–∞–Ω–æ–≤–∏–ª–∏. –£—á–∞—Å—Ç–Ω–∏–∫–∏ —Ç–æ–≥–æ –∞—É–∫—Ü–∏–æ–Ω–∞ –ø—Ä–æ–∫–æ–º–º–µ–Ω—Ç–∏—Ä–æ–≤–∞–ª–∏ ¬´–§–í¬ª —Å–∏—Ç—É–∞—Ü–∏—é. –ï—â–µ –ø—Ä–∏–≥–æ–¥–∏—Ç—Å—è –ì–æ—Å–¥—É–º–∞ –ø—Ä–∏–Ω—è–ª–∞ –≤ —Ç—Ä–µ—Ç—å–µ–º —á—Ç–µ–Ω–∏–∏ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ –ø–µ—Ä–µ–¥–∞—á–∏ –Ω–∞ –≥—É–º–∞–Ω–∏—Ç–∞—Ä–Ω—É—é –ø–æ–º–æ—â—å –∫–æ–Ω—Ñ–∏—Å–∫–æ–≤–∞–Ω–Ω—ã—Ö –Ω–µ–º–∞—Ä–∫–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö —Ç–æ–≤–∞—Ä–æ–≤, –ø—Ä–∏–≥–æ–¥–Ω—ã—Ö –∏ –±–µ–∑–æ–ø–∞—Å–Ω—ã—Ö –¥–ª—è –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏—è. –†–µ—á—å –∏–¥–µ—Ç –æ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞—Ö, –º–µ–¥–∏–∑–¥–µ–ª–∏—è—Ö, –ë–ê–î, –ø–∞—Ä—Ñ—é–º–µ—Ä–Ω–æ-–∫–æ—Å–º–µ—Ç–∏—á–µ—Å–∫–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –∏ –¥—Ä—É–≥–∏—Ö —Ç–æ–≤–∞—Ä–æ–≤ –∞–ø—Ç–µ—á–Ω–æ–≥–æ –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç–∞. –¢—Ä–∞—Ç—ã –Ω–∞ –ø—Ä–∏–æ—Ä–∏—Ç–µ—Ç—ã –ù–∞—Ü–ø—Ä–æ–µ–∫—Ç ¬´–ü—Ä–æ–¥–æ–ª–∂–∏—Ç–µ–ª—å–Ω–∞—è –∏ –∞–∫—Ç–∏–≤–Ω–∞—è –∂–∏–∑–Ω—å¬ª –∏—Å–ø–æ–ª–Ω–µ–Ω –ø–æ —Ä–∞—Å—Ö–æ–¥–∞–º –∑–∞ –ø–æ–ª–≥–æ–¥–∞ –Ω–∞ 49%. –ü–æ —ç—Ç–æ–º—É –ø–æ–∫–∞–∑–∞—Ç–µ–ª—é –æ–Ω –∑–∞–Ω—è–ª —á–µ—Ç–≤–µ—Ä—Ç–æ–µ –º–µ—Å—Ç–æ. –ë—É–º–∞–≥–∞ —Ç–µ—Ä–ø–∏—Ç –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç –ø–æ–ª–Ω—ã–π –ø–µ—Ä–µ—Ö–æ–¥ –Ω–∞ —ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω—ã–µ –º–µ–¥–∫–Ω–∏–∂–∫–∏ —Ç–æ–ª—å–∫–æ —Å 1 —Å–µ–Ω—Ç—è–±—Ä—è 2026 –≥–æ–¥–∞. –í –ø—Ä–æ—à–ª—ã–π —Ä–∞–∑ –≤–µ–¥–æ–º—Å—Ç–≤–æ –æ—Ç–ª–æ–∂–∏–ª–æ –ø–æ–ª–Ω—ã–π –æ—Ç–∫–∞–∑ –æ—Ç –±—É–º–∞–∂–Ω—ã—Ö –≤–µ—Ä—Å–∏–π —ç—Ç–æ–≥–æ –¥–æ–∫—É–º–µ–Ω—Ç–∞ –≤ —Ñ–µ–≤—Ä–∞–ª–µ 2024-–≥–æ.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage, import_export"",
  ""impact"": ""high"",
  ""english"": ""The distributor 'FarmaMiks' complained to the FAS about the procurement of teduglutide due to patent infringement on 'Gadget'. The Central Medical Supplies Contracted for generic original drug supplies from 'F Capital Grand' company to 'Circle of Good'. The supply has been halted. Participants of the auction commented on this situation for 'FV'. Additionally, the State Duma approved a third reading of a law project allowing transfer of confiscated non-marked goods for humanitarian purposes, including medicines and medical equipment. The National Project 'Healthy Longevity' has spent 49% of its budget for the first half. The Ministry of Health plans to fully switch to electronic medical records only by September 1, 2026. The previous timeframe for the full transition of paper versions was February 2024.""
}"
2025-07-10T15:25:00+00:00,@medpharm,12379,https://t.me/medpharm/12379,"–†–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫ —Ñ–µ—Ä–º–µ–Ω—Ç–æ–∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –¥–ª—è –±–æ–ª–µ–∑–Ω–∏ –§–∞–±—Ä–∏ ‚Äî –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–π –≥–µ–Ω–µ—Ç–∏–∫ –†–æ–±–µ—Ä—Ç –î–∂. –î–µ—Å–Ω–∏–∫ ‚Äî –ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω–æ –æ—Ü–µ–Ω–∏–ª —Ä–æ—Å—Å–∏–π—Å–∫–∏–π –±–∏–æ–∞–Ω–∞–ª–æ–≥. –ü–æ –µ–≥–æ —Å–ª–æ–≤–∞–º, –æ–Ω –∏–¥–µ–Ω—Ç–∏—á–µ–Ω –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω–æ–º—É –ø—Ä–µ–ø–∞—Ä–∞—Ç—É –ø–æ —Å–æ—Å—Ç–∞–≤—É, –¥–µ–π—Å—Ç–≤–∏—é –∏ –¥–æ–∑–∏—Ä–æ–≤–∫–µ. –£—á–µ–Ω—ã–π –æ—Ç–º–µ—Ç–∏–ª, —á—Ç–æ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ –±–∏–æ–∞–Ω–∞–ª–æ–≥–æ–≤ —Å–ø–æ—Å–æ–±—Å—Ç–≤—É–µ—Ç —Ä–∞—Å—à–∏—Ä–µ–Ω–∏—é –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç–∏ —Ç–µ—Ä–∞–ø–∏–∏. –í –†–æ—Å—Å–∏–∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏–º—ã–π –ø–æ –ø–æ–ª–Ω–æ–º—É —Ü–∏–∫–ª—É –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ –±–æ–ª–µ–∑–Ω–∏ –§–∞–±—Ä–∏ –¥–µ—à–µ–≤–ª–µ –Ω–∞ 40%. –≠—Ç–æ –ø–æ–∑–≤–æ–ª—è–µ—Ç –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ —É–≤–µ–ª–∏—á–∏—Ç—å —á–∏—Å–ª–æ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –æ–±–µ—Å–ø–µ—á–µ–Ω–Ω—ã—Ö –∂–∏–∑–Ω–µ–Ω–Ω–æ –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã–º –ª–µ—á–µ–Ω–∏–µ–º.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, clinical_trial, shortage"",
  ""impact"": ""medium"",
  ""english"": ""American geneticist Robert J. Desik positively evaluated the Russian bio-analogue of enzyme replacement therapy for Fabry disease. He noted that it is identical to the original drug in composition, action and dosage. The use of bio-analogs helps expand access to therapy. In Russia, the enzyme replacement therapy for Fabry disease is cheaper by 40%, which allows significantly increasing the number of patients receiving essential treatment.""
}"
2025-07-10T14:10:15+00:00,@medpharm,12378,https://t.me/medpharm/12378,"–ö–æ–ª–ª–µ–≥–∏, –ø—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ–º –≤–∞–º –º–æ–¥–µ—Ä–∞—Ç–æ—Ä–∞ —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–æ–π —Å–µ—Å—Å–∏–∏ PRO–µ–∫—Ü–∏–π –ë—É–¥—É—â–µ–≥–æ ¬´–ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—ã–π –∫—É—Ä—Å. –ì–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–π –∫–æ–Ω—Ç—É—Ä —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –æ—Ç—Ä–∞—Å–ª–∏¬ª üîπ–í–∏–∫—Ç–æ—Ä –î–º–∏—Ç—Ä–∏–µ–≤ ‚Äì –≥–µ–Ω–µ—Ä–∞–ª—å–Ω—ã–π –¥–∏—Ä–µ–∫—Ç–æ—Ä –ê—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π (–ê–†–§–ü) –î–∞—Ç–∞ –∏ –≤—Ä–µ–º—è —Å–µ—Å—Å–∏–∏: 11 —Å–µ–Ω—Ç—è–±—Ä—è 2025, 11:15 üìç–≥. –°–æ—á–∏, Pullman –°–æ—á–∏ –¶–µ–Ω—Ç—Ä 5* –ù–∞ —Å–µ—Å—Å–∏–∏ –æ–±—Å—É–¥–∏–º –º–µ—Ö–∞–Ω–∏–∑–º—ã —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—è –∏ –∫–æ—Ä—Ä–µ–∫—Ç–∏—Ä–æ–≤–∫–∏ –ø—Ä–∏–æ—Ä–∏—Ç–µ—Ç–æ–≤ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –ø–æ–ª–∏—Ç–∏–∫–∏: –æ—Ç –ø–µ—Ä–µ—á–Ω–µ–π –ñ–ù–í–õ–ü –∏ –°–ó–õ–° –¥–æ –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ –∫–∞–ª–µ–Ω–¥–∞—Ä—è –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–∏—Ö –ø—Ä–∏–≤–∏–≤–æ–∫, –æ—Ç –ø—Ä–æ–≥—Ä–∞–º–º –ø–æ–¥–¥–µ—Ä–∂–∫–∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –¥–æ —Å—Ç–∏–º—É–ª–∏—Ä–æ–≤–∞–Ω–∏—è –∏–Ω–Ω–æ–≤–∞—Ü–∏–π –∏ –≤—ã–≤–µ–¥–µ–Ω–∏—è –Ω–æ–≤—ã—Ö —Ä–∞–∑—Ä–∞–±–æ—Ç–æ–∫ –Ω–∞ —Ä—ã–Ω–æ–∫. –£–∑–Ω–∞–π—Ç–µ, –∫—É–¥–∞ –¥–≤–∏–∂–µ—Ç—Å—è —Ä—ã–Ω–æ–∫ –∏ –∫–∞–∫–∏–µ —à–∞–≥–∏ –¥–µ–ª–∞—Ç—å —Å–µ–π—á–∞—Å, —á—Ç–æ–±—ã –Ω–µ —Ç–µ—Ä—è—Ç—å –ø–æ–∑–∏—Ü–∏–∏ –∑–∞–≤—Ç—Ä–∞. –ü—Ä–∏—Å–æ–µ–¥–∏–Ω—è–π—Ç–µ—Å—å! –î–æ 31 –∏—é–ª—è —Å–ø–µ—Ü—Ü–µ–Ω–∞. –ü—Ä–∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –¥–≤—É—Ö –∏ –±–æ–ª–µ–µ —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –≤—Ç–æ—Ä–æ–º—É –∏ –∫–∞–∂–¥–æ–º—É —Å–ª–µ–¥—É—é—â–µ–º—É —Å–∫–∏–¥–∫–∞ 15%. üëâ –ü–µ—Ä–µ—Ö–æ–¥–∏—Ç–µ –Ω–∞ —Å–∞–π—Ç –∏ –±—Ä–æ–Ω–∏—Ä—É–π—Ç–µ –º–µ—Å—Ç–æ!","{""skip"": true}"
2025-07-10T13:41:00+00:00,@medpharm,12377,https://t.me/medpharm/12377,"–ì–æ—Å–¥—É–º–∞ –ø—Ä–∏–Ω—è–ª–∞ –≤ —Ç—Ä–µ—Ç—å–µ–º —á—Ç–µ–Ω–∏–∏ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ –ø–µ—Ä–µ–¥–∞—á–∏ –Ω–∞ –≥—É–º–∞–Ω–∏—Ç–∞—Ä–Ω—É—é –ø–æ–º–æ—â—å –∫–æ–Ω—Ñ–∏—Å–∫–æ–≤–∞–Ω–Ω—ã—Ö –Ω–µ–º–∞—Ä–∫–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤, –º–µ–¥–∏–∑–¥–µ–ª–∏–π, –±–∏–æ–¥–æ–±–∞–≤–æ–∫, –ø–∞—Ä—Ñ—é–º–µ—Ä–Ω–æ-–∫–æ—Å–º–µ—Ç–∏—á–µ—Å–∫–æ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –∏ –¥—Ä—É–≥–∏—Ö —Ç–æ–≤–∞—Ä–æ–≤ –∞–ø—Ç–µ—á–Ω–æ–≥–æ –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç–∞.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""The State Duma passed the third reading of a law project allowing the transfer of confiscated unmarked medicines, medical equipment, dietary supplements, perfume and cosmetic products, and other items to humanitarian aid. This could lead to shortages of medicines.""
}"
2025-07-10T12:04:02+00:00,@medpharm,12376,https://t.me/medpharm/12376,"–í –£–ª—å—è–Ω–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –ø–æ—è–≤–∏–ª—Å—è —Ñ–µ–π–∫–æ–≤—ã–π –ø—Ä–∏–∫–∞–∑ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞, –≤ –∫–æ—Ç–æ—Ä–æ–º –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—è–º –ø—Ä–µ–¥–ø–∏—Å—ã–≤–∞–µ—Ç—Å—è –æ—Ç–ø—Ä–∞–≤–∏—Ç—å –ø—è—Ç—É—é —á–∞—Å—Ç—å —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤ –≤ –∑–æ–Ω—É –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è –°–í–û. –¢–∞–∫–æ–≥–æ –¥–æ–∫—É–º–µ–Ω—Ç–∞ –º–∏–Ω–∏—Å—Ç–µ—Ä—Å—Ç–≤–æ –Ω–µ –≤—ã–ø—É—Å–∫–∞–ª–æ.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""A fake decree from the regional Ministry of Health in Ul‚Äôyansk Oblast is circulating, requiring hospitals to send half of their staff to the area for a special operation. The ministry has not issued such a decree.""
}"
2025-07-10T10:18:41+00:00,@medpharm,12375,https://t.me/medpharm/12375,"–ù–∞ –ø–ª–µ–Ω–∞—Ä–Ω–æ–º –∑–∞—Å–µ–¥–∞–Ω–∏–∏ 9 –∏—é–ª—è –ì–æ—Å–¥—É–º–∞ –æ–¥–æ–±—Ä–∏–ª–∞ –æ—Ç—á–µ—Ç –æ–± –∏—Å–ø–æ–ª–Ω–µ–Ω–∏–∏ –±—é–¥–∂–µ—Ç–∞ –§–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ —Ñ–æ–Ω–¥–∞ –û–ú–°. –ü—Ä–∏ —ç—Ç–æ–º –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—é —Ñ–æ–Ω–¥–∞ –ò–ª—å–µ –ë–∞–ª–∞–Ω–∏–Ω—É –ø—Ä–∏—à–ª–æ—Å—å –æ—Ç–≤–µ—á–∞—Ç—å –Ω–∞ –Ω–µ—É–¥–æ–±–Ω—ã–µ –≤–æ–ø—Ä–æ—Å—ã. –í –æ—Å–Ω–æ–≤–Ω–æ–º –æ–Ω–∏ –∫–∞—Å–∞–ª–∏—Å—å –Ω–µ–¥–æ—Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω—ã—Ö –ø—Ä–æ–≥—Ä–∞–º–º, –Ω–∞–∑–Ω–∞—á–µ–Ω–∏—è —Å–ø–µ—Ü–∏–∞–ª—å–Ω—ã—Ö —Å–æ—Ü–∏–∞–ª—å–Ω—ã—Ö –≤—ã–ø–ª–∞—Ç –∏ —Ü–µ–ª–µ—Å–æ–æ–±—Ä–∞–∑–Ω–æ—Å—Ç–∏ —Ä–∞–±–æ—Ç—ã –∫–æ–º–º–µ—Ä—á–µ—Å–∫–∏—Ö —Å—Ç—Ä–∞—Ö–æ–≤—ã—Ö –∫–æ–º–ø–∞–Ω–∏–π. ¬´–ú–í¬ª –≤—ã–±—Ä–∞–ª –≥–ª–∞–≤–Ω–æ–µ –∏–∑ –≤—ã—Å—Ç—É–ø–ª–µ–Ω–∏–π.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement, pricing"",
  ""impact"": ""medium"",
  ""english"": ""The budget report for the Federal Fund of OMS was approved by the State Duma on July 9. Chairman Ilya Balanin had to answer uncomfortable questions, mainly regarding underfinancing of territorial programs, special social payments, and the rationality of commercial insurance companies' operations.""
}"
2025-07-10T09:08:11+00:00,@medpharm,12374,https://t.me/medpharm/12374,"–ù–∞—Ç—É—Ä–∞–ª—å–Ω—É—é –∏ –¥–µ–Ω–µ–∂–Ω—É—é –¥–∏–Ω–∞–º–∏–∫—É –ø—Ä–æ–¥–∞–∂ –≤–µ—Ç–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –æ–±–µ—Å–ø–µ—á–∏–≤–∞–µ—Ç –∏—Å–∫–ª—é—á–∏—Ç–µ–ª—å–Ω–æ –æ–Ω–ª–∞–π–Ω-–∫–∞–Ω–∞–ª, –ø—Ä–∏—à–ª–∏ –∫ –≤—ã–≤–æ–¥—É –∞–Ω–∞–ª–∏—Ç–∏–∫–∏ RNC Pharma. –° —è–Ω–≤–∞—Ä—è –ø–æ –º–∞–π 2025 –≥–æ–¥–∞ —Å–æ–∫—Ä–∞—Ç–∏–ª—Å—è –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç –≤–µ—Ç–µ—Ä–∏–Ω–∞—Ä–Ω–æ–π —Ä–æ–∑–Ω–∏—Ü—ã, –ø—Ä–∏ —ç—Ç–æ–º —Ä—ã–Ω–æ–∫ –ø–æ–ø–æ–ª–Ω–∏–ª—Å—è —Ä—è–¥–æ–º –Ω–æ–≤–∏–Ω–æ–∫.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand,vaccine"",
  ""impact"": ""medium"",
  ""english"": ""The analysis by RNC Pharma indicates that online channels are solely responsible for the natural and monetary dynamics of vaccine sales. From January to May 2025, the retail assortment in veterinary products has been reduced while a new product line has entered the market.""
}"
2025-07-10T07:01:06+00:00,@medpharm,12373,https://t.me/medpharm/12373,"–ó–∞–Ω—è—Ç–æ—Å—Ç—å –≤ —Ä–æ–∑–Ω–∏—á–Ω–æ–π —Ç–æ—Ä–≥–æ–≤–ª–µ, —Å—Ñ–µ—Ä–µ –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø–∏—Ç–∞–Ω–∏—è, —Å—Ä–µ–¥—Å—Ç–≤–∞—Ö –º–∞—Å—Å–æ–≤–æ–π –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–∏ —Å–≤—è–∑–∞–Ω–∞ —Å –Ω–∞–∏–±–æ–ª–µ–µ –≤—ã—Å–æ–∫–æ–π —á–∞—Å—Ç–æ—Ç–æ–π –¥–µ–ø—Ä–µ—Å—Å–∏–∏, —Å—Ç—Ä–µ—Å—Å–∞ –∏ —Ç—Ä—É–¥–Ω–æ—Å—Ç–µ–π –≤ —ç–º–æ—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–π —Å—Ñ–µ—Ä–µ. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –ø–æ–≤—ã—à–µ–Ω–Ω—ã–µ —Ä–∏—Å–∫–∏ –Ω–∞–±–ª—é–¥–∞–ª–∏—Å—å —Å—Ä–µ–¥–∏ –ª—é–¥–µ–π –º–æ–ª–æ–¥–æ–≥–æ –≤–æ–∑—Ä–∞—Å—Ç–∞ –∏ –∂–µ–Ω—â–∏–Ω.","{""skip"": true}"
2025-07-09T16:02:31+00:00,@medpharm,12372,https://t.me/medpharm/12372,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 9 –∏—é–ª—è –ò—â—É—Ç –¥–µ–Ω—å–≥–∏ –û–∫–æ–Ω—á–∞—Ç–µ–ª—å–Ω–æ–µ —Ä–µ—à–µ–Ω–∏–µ –æ –∑–∞–ø—É—Å–∫–µ –ø–∏–ª–æ—Ç–Ω–æ–≥–æ –ø—Ä–æ–µ–∫—Ç–∞ –ø–æ –≤–Ω–µ–¥—Ä–µ–Ω–∏—é –Ω–æ–≤–æ–π —Å–∏—Å—Ç–µ–º—ã –æ–ø–ª–∞—Ç—ã —Ç—Ä—É–¥–∞ –±—é–¥–∂–µ—Ç–Ω–∏–∫–æ–≤ –±—É–¥–µ—Ç –ø—Ä–∏–Ω—è—Ç–æ –∫ –∫–æ–Ω—Ü—É –∏—é–ª—è. –§–µ–¥–µ—Ä–∞–ª—å–Ω—ã–π —Ü–µ–Ω—Ç—Ä –∂–¥–µ—Ç –æ—Ç —Ä–µ–≥–∏–æ–Ω–æ–≤ —Ñ–∏–Ω–∞–Ω—Å–æ–≤—ã—Ö —Ä–∞—Å—á–µ—Ç–æ–≤ –ø–æ –º–æ–¥–µ–ª–∏—Ä–æ–≤–∞–Ω–∏—é –∑–∞—Ç—Ä–∞—Ç. –ò–¥—Ç–∏ –∏ –Ω–µ —Å–¥–∞–≤–∞—Ç—å—Å—è –í –†–æ—Å—Å–∏–∏ –æ–±–Ω–æ–≤–∏–ª–∏ —Ä–µ–π—Ç–∏–Ω–≥ –≤–ª–∏—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –ø–∞—Ü–∏–µ–Ω—Ç—Å–∫–∏—Ö –Ω–µ–∫–æ–º–º–µ—Ä—á–µ—Å–∫–∏—Ö –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π. –ü–µ—Ä–≤–æ–µ –º–µ—Å—Ç–æ –ø–æ —É—Ä–æ–≤–Ω—é –∞–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –∑–∞–Ω—è–ª–∞ –ê—Å—Å–æ—Ü–∏–∞—Ü–∏—è –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ ¬´–ó–¥—Ä–∞–≤—Å—Ç–≤—É–π!¬ª, –∫–æ—Ç–æ—Ä–∞—è –±—ã–ª–∞ –ª–∏–¥–µ—Ä–æ–º –∏ –≤ –ø—Ä–æ—à–ª–æ–º –≥–æ–¥—É. –í–æ—à–ª–∏ –≤ —Å—Ç–∞–Ω–¥–∞—Ä—Ç –ú–∏–Ω–∑–¥—Ä–∞–≤ –æ–ø—É–±–ª–∏–∫–æ–≤–∞–ª –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø—Ä–∏ –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–º –∞–±–æ—Ä—Ç–µ (–º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–º –∞–±–æ—Ä—Ç–µ) –Ω–∞ —Ä–∞–Ω–Ω–µ–º —Å—Ä–æ–∫–µ –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏. –í —Å—Ç–∞–Ω–¥–∞—Ä—Ç –≤–æ—à–ª–∏ –º–∏–∑–æ–ø—Ä–æ—Å—Ç–æ–ª –∏ –º–∏—Ñ–µ–ø—Ä–∏—Å—Ç–æ–Ω. –í 2023 –≥–æ–¥—É –ú–∏–Ω–∑–¥—Ä–∞–≤ –≤–∫–ª—é—á–∏–ª –∏—Ö –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ü–ö–£. –ê–ø—Ç–µ–∫–∏ –≤ —Å—Ç—É–ø–æ—Ä–µ –ù–∞ —Ñ–æ–Ω–µ –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏—è –º–æ–±–∏–ª—å–Ω–æ–≥–æ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç–∞ –≤ —Ä—è–¥–µ —Ä–µ–≥–∏–æ–Ω–æ–≤ –†–æ—Å—Å–∏–∏ –∞–ø—Ç–µ–∫–∏ –Ω–µ –º–æ–≥—É—Ç –ø—Ä–æ–¥–∞—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–∞. –û–ø–ª–∞—Ç–∏—Ç—å –ø–æ–∫—É–ø–∫—É –º–æ–∂–Ω–æ –±—ã–ª–æ –±—ã –Ω–∞–ª–∏—á–Ω—ã–º–∏, –Ω–æ –ø—Ä–æ–±–ª–µ–º–∞ –≤ —Å–∏—Å—Ç–µ–º–µ –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏. –õ–æ–∫–∞–ª—å–Ω—ã–π –º–æ–¥—É–ª—å ¬´–ß–µ—Å—Ç–Ω–æ–≥–æ –∑–Ω–∞–∫–∞¬ª –æ—Å—Ç–∞–µ—Ç—Å—è –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–º —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–∏–º —Ä–µ—à–µ–Ω–∏–µ–º –¥–ª—è –≤—Ä–µ–º–µ–Ω–Ω–æ–π —Ä–∞–±–æ—Ç—ã, –Ω–æ –∏ –æ–Ω —Å–ø–∞—Å–∞–µ—Ç –Ω–µ –≤—Å–µ–≥–¥–∞.","{""skip"": true}"
2025-07-09T15:00:54+00:00,@medpharm,12371,https://t.me/medpharm/12371,"–°—Ç—Ä–∞–Ω–Ω–æ, —á—Ç–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç—å –Ω–µ –ø—Ä–∏–¥–∞–µ—Ç –∑–Ω–∞—á–µ–Ω–∏—è –ø–æ—è–≤–∏–≤—à–∏–º—Å—è –Ω–µ–¥–∞–≤–Ω–æ –≤ –ø—É–±–ª–∏—á–Ω–æ–π –ø–ª–æ—Å–∫–æ—Å—Ç–∏ –º–µ—Ç–æ–¥–∏—á–µ—Å–∫–∏–º —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏—è–º –ø–æ –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–∏—é —Ü–µ–ª–µ—Å–æ–æ–±—Ä–∞–∑–Ω–æ—Å—Ç–∏ —Å–æ–∑–¥–∞–Ω–∏—è –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π. –ù–∞–≤–µ—Ä–Ω–æ–µ, –ø–æ—Ç–æ–º—É, —á—Ç–æ –¥–æ–∫—É–º–µ–Ω—Ç, —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–Ω—ã–π –¶–µ–Ω—Ç—Ä–∞–ª—å–Ω—ã–º –ù–ò–ò –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –∏ –∏–Ω—Ñ–æ—Ä–º–∞—Ç–∏–∑–∞—Ü–∏–∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è (–¶–ù–ò–ò–û–ò–ó) –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–æ—Å—Å–∏–∏, –±–æ–ª—å—à–æ–π –∏, —Å—É–¥—è –ø–æ –Ω–∞–∑–≤–∞–Ω–∏—é, —Å—É–≥—É–±–æ —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–∏–π. –ù–æ —ç—Ç–æ –¥–∞–ª–µ–∫–æ –Ω–µ —Ç–∞–∫.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""guideline,hospital_policy,pharmacovigilance,safety"",
  ""impact"": ""medium"",
  ""english"": ""Public health community is not valuing recently published methodological recommendations on the feasibility of establishing healthcare organizations. The document, developed by Central Institute for Health Organization and Information (CNIIOZ) of the Russian Ministry of Health, is large and seems purely technical. However, this is not true.""
}"
2025-07-09T14:03:12+00:00,@medpharm,12370,https://t.me/medpharm/12370,"–≠–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç –ø–æ –ø—Ä–æ—Å–ª–µ–∂–∏–≤–∞–µ–º–æ—Å—Ç–∏ —Ä—è–¥–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π –¥–æ–ª–∂–µ–Ω –±—ã—Ç—å –∑–∞–∫–æ–Ω—á–µ–Ω 31 –∞–≤–≥—É—Å—Ç–∞ —Ç–µ–∫—É—â–µ–≥–æ –≥–æ–¥–∞, –æ–¥–Ω–∞–∫–æ –û–±—â–µ—Å—Ç–≤–µ–Ω–Ω—ã–π —Å–æ–≤–µ—Ç –ø—Ä–∏ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä–µ –≤—ã—Å—Ç—É–ø–∏–ª –∑–∞ –ø—Ä–æ–¥–ª–µ–Ω–∏–µ –ø–∏–ª–æ—Ç–Ω–æ–≥–æ –ø—Ä–æ–µ–∫—Ç–∞. –ü—Ä–æ–º–µ–∂—É—Ç–æ—á–Ω—ã–µ –∏—Ç–æ–≥–∏ –ø–æ–∫–∞–∑–∞–ª–∏, —á—Ç–æ —É–ø–∞–∫–æ–≤–æ—á–Ω—ã–µ –º–∞—Ç–µ—Ä–∏–∞–ª—ã, –ø–µ—á–∞—Ç–Ω–æ–µ –∏ —Å—á–∏—Ç—ã–≤–∞—é—â–µ–µ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏–µ –∏ —Ä–∞—Å—Ö–æ–¥–Ω—ã–µ –º–∞—Ç–µ—Ä–∏–∞–ª—ã –∫ –Ω–µ–º—É –Ω–µ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—Ç —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è–º –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, shortage"",
  ""impact"": ""high"",
  ""english"": ""The pilot project for tracking medical products is supposed to be completed by August 31st, but the Public Council under Roszdravnadzor has requested an extension. Interim results show that packaging materials, printing and reading equipment, and related supplies do not meet the marking requirements.""
}"
2025-07-09T13:05:02+00:00,@medpharm,12369,https://t.me/medpharm/12369,"–ü–ª–∞–Ω—ã –ø–æ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–π –æ—Ç—Ä–∞–±–æ—Ç–∫–µ –¥–ª—è –º–æ–ª–æ–¥—ã—Ö –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –Ω–∞—Ä—É—à–∞—é—Ç –ø—Ä–∞–≤–∞ —á–µ–ª–æ–≤–µ–∫–∞, –≤ –æ—Ç–ª–∏—á–∏–µ –æ—Ç —Å–∏—Å—Ç–µ–º—ã —Ä–∞—Å–ø—Ä–µ–¥–µ–ª–µ–Ω–∏—è –≤ –°–æ–≤–µ—Ç—Å–∫–æ–º –°–æ—é–∑–µ. –í –°–ü–ß —Å—á–∏—Ç–∞—é—Ç, —á—Ç–æ –Ω—É–∂–Ω–æ —Å–¥–µ–ª–∞—Ç—å –≤—Å–µ –º–µ—Å—Ç–∞ –≤ –º–µ–¥–≤—É–∑–∞—Ö –±—é–¥–∂–µ—Ç–Ω—ã–º–∏ –∏ –ø—Ä–µ–¥–ª–æ–∂–∏—Ç—å –≤—ã—à–µ–¥—à–∏–º –Ω–∞ –ø–µ–Ω—Å–∏—é –º–µ–¥–∏–∫–∞–º –≤–µ—Ä–Ω—É—Ç—å—Å—è –Ω–∞ —Ä–∞–±–æ—Ç—É —Å —Å–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ–º –ø–µ–Ω—Å–∏–∏ –∏ –Ω–∞–¥–±–∞–≤–æ–∫ –∫ –Ω–µ–π.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, hospital_policy, guideline, safety"",
  ""impact"": ""medium"",
  ""english"": ""Plans for mandatory probation for young medical workers are seen as a violation of human rights, unlike the Soviet system. The SPCH believes that all medical universities should be funded and retired doctors should return to work with pension and additional allowances.""
}"
2025-07-09T12:04:50+00:00,@medpharm,12368,https://t.me/medpharm/12368,"¬´–ë–∏–Ω–Ω–æ—Ñ–∞—Ä–º –ì—Ä—É–ø–ø¬ª —Ä–∞–∑–º–µ—Å—Ç–∏–ª–∞ —Ç—Ä–µ—Ç–∏–π –≤—ã–ø—É—Å–∫ –æ–±–ª–∏–≥–∞—Ü–∏–π –≤ 2025 –≥–æ–¥—É. –ö–æ–º–ø–∞–Ω–∏—è –ø—Ä–∏–≤–ª–µ–∫–ª–∞ 2 –º–ª—Ä–¥ —Ä—É–±. –ü—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å –ø–ª–∞–Ω–∏—Ä—É–µ—Ç –Ω–∞–ø—Ä–∞–≤–∏—Ç—å –¥–µ–Ω—å–≥–∏ –Ω–∞ –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–∏ –≤ –∑–∞–ø—É—Å–∫ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –º–æ–Ω–æ–∫–ª–æ–Ω–∞–ª—å–Ω—ã—Ö –∞–Ω—Ç–∏—Ç–µ–ª, —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–æ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ —Å–∫–ª–∞–¥–∞ –Ω–∞ –£—Ä–∞–ª–µ.","{
  ""skip"": true
}"
2025-07-09T10:41:03+00:00,@medpharm,12367,https://t.me/medpharm/12367,"#–≠–∫—Å–∫–ª—é–∑–∏–≤ –í –ù–ú–ò–¶ –æ–Ω–∫–æ–ª–æ–≥–∏–∏ –∏–º. –ë–ª–æ—Ö–∏–Ω–∞ –ø—Ä–∏–∑–≤–∞–ª–∏ —Ä–µ–≥–∏–æ–Ω—ã –Ω–µ –æ–≥—Ä–∞–Ω–∏—á–∏–≤–∞—Ç—å –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ –ø—Ä–∞–≤–æ –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –Ω–∞ –ø–æ–ª—É—á–µ–Ω–∏–µ –ª–µ—á–µ–Ω–∏—è –≤ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã—Ö –º–µ–¥—Ü–µ–Ω—Ç—Ä–∞—Ö. –ü—Ä–∞–∫—Ç–∏–∫–∞ –Ω–µ–≥–ª–∞—Å–Ω—ã—Ö –∑–∞–ø—Ä–µ—Ç–æ–≤ –Ω–∞ —Ç–∞–∫–∏–µ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è —Å—É—â–µ—Å—Ç–≤—É–µ—Ç –≤ —Ä—è–¥–µ —Å—É–±—ä–µ–∫—Ç–æ–≤, —É–∑–Ω–∞–ª ¬´–ú–í¬ª.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""Exclusive to the NMIH oncology institute, exclusive regions are encouraged not to artificially restrict cancer patients from receiving treatment at federal medical centers. The practice of unofficial bans on such treatments exists in several regions, as reported by 'MV'.""
}"
2025-07-09T10:03:25+00:00,@medpharm,12366,https://t.me/medpharm/12366,"–ü—Ä–µ–ø–∞—Ä–∞—Ç –æ—Ç –∫–∞—à–ª—è –∞–º–±—Ä–æ–∫—Å–æ–ª —Å–Ω–∏–∑–∏–ª –≤—ã—Ä–∞–∂–µ–Ω–Ω–æ—Å—Ç—å –Ω–µ–π—Ä–æ–ø—Å–∏—Ö–∏–∞—Ç—Ä–∏—á–µ—Å–∫–∏—Ö —Å–∏–º–ø—Ç–æ–º–æ–≤ —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, —Å—Ç—Ä–∞–¥–∞—é—â–∏—Ö –¥–µ–º–µ–Ω—Ü–∏–µ–π –Ω–∞ —Ñ–æ–Ω–µ –±–æ–ª–µ–∑–Ω–∏ –ü–∞—Ä–∫–∏–Ω—Å–æ–Ω–∞. –≠—Ç–æ –ø–æ–∫–∞–∑–∞–ª–∏ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã II —Ñ–∞–∑—ã –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å–ø—ã—Ç–∞–Ω–∏–π.","{""skip"": true}"
2025-07-09T08:05:00+00:00,@medpharm,12365,https://t.me/medpharm/12365,üî∏ –ú–∏–Ω–∑–¥—Ä–∞–≤ —É—Ç–≤–µ—Ä–¥–∏–ª 4 –Ω–æ–≤—ã—Ö —Å—Ç–∞–Ω–¥–∞—Ä—Ç–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏: ‚Äì –ø—Ä–∏ –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–º –∞–±–æ—Ä—Ç–µ (–º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–º –∞–±–æ—Ä—Ç–µ) –Ω–∞ —Å—Ä–æ–∫–µ –æ—Ç 12 –¥–æ 22 –Ω–µ–¥–µ–ª—å –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏ (–¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞ –∏ –ª–µ—á–µ–Ω–∏–µ) ‚Äì –≤–∑—Ä–æ—Å–ª—ã–º –ø—Ä–∏ –≤—ã–ø–∞–¥–µ–Ω–∏–∏ –∂–µ–Ω—Å–∫–∏—Ö –ø–æ–ª–æ–≤—ã—Ö –æ—Ä–≥–∞–Ω–æ–≤ (–¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞ –∏ –ª–µ—á–µ–Ω–∏–µ) ‚Äì –¥–µ—Ç—è–º –ø—Ä–∏ –∞–Ω–æ–≥–µ–Ω–∏—Ç–∞–ª—å–Ω—ã—Ö (–≤–µ–Ω–µ—Ä–∏—á–µ—Å–∫–∏—Ö) –±–æ—Ä–æ–¥–∞–≤–∫–∞—Ö (–¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞ –∏ –ª–µ—á–µ–Ω–∏–µ) ‚Äì –¥–µ—Ç—è–º –ø—Ä–∏ —Ö–ª–∞–º–∏–¥–∏–π–Ω–æ–π –∏–Ω—Ñ–µ–∫—Ü–∏–∏ (–¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞ –∏ –ª–µ—á–µ–Ω–∏–µ),"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health approved four new medical care standards: - For artificial abortion (medical abortion) during the 12th to 22nd week of pregnancy - For adult patients with genital organ prolapse - For children with venereal warts - For children with chlamydial infection""
}"
2025-07-09T07:19:32+00:00,@medpharm,12364,https://t.me/medpharm/12364,–°—É–¥ –≤ –ò—Ä–∫—É—Ç—Å–∫–µ –Ω–µ —Å—Ç–∞–ª —Å–º—è–≥—á–∞—Ç—å –Ω–∞–∫–∞–∑–∞–Ω–∏–µ —ç–∫—Å-–≥–ª–∞–≤–µ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ù–∞—Ç–∞–ª–∏–∏ –õ–µ–¥—è–µ–≤–æ–π. –û–Ω–∞ –æ—Å—Ç–∞–Ω–µ—Ç—Å—è –≤ –∫–æ–ª–æ–Ω–∏–∏.,"{""skip"": true}"
2025-07-08T16:30:08+00:00,@medpharm,12363,https://t.me/medpharm/12363,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 8 –∏—é–ª—è –û–ø—Ä–µ–¥–µ–ª–∏–ª–∏—Å—å —Å –∫–ª–∏–Ω—Ä–µ–∫–∞–º–∏ –î–µ–ø—É—Ç–∞—Ç—ã –ø—Ä–∏–Ω—è–ª–∏ –≤–Ω–µ—Å–µ–Ω–Ω—ã–µ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ–º –ø–æ–ø—Ä–∞–≤–∫–∏, –¥–∞—é—â–∏–µ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –≤—Ä–∞—á–∞–º –æ—Ç–∫–ª–æ–Ω—è—Ç—å—Å—è –æ—Ç –Ω–æ—Ä–º –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π, –µ—Å–ª–∏ —ç—Ç–æ–≥–æ —Ç—Ä–µ–±—É—é—Ç –∏–Ω—Ç–µ—Ä–µ—Å—ã –ø–∞—Ü–∏–µ–Ω—Ç–∞. –î–æ–∫—É–º–µ–Ω—Ç –Ω–∞–¥–µ–ª—è–µ—Ç –ú–∏–Ω–∑–¥—Ä–∞–≤ –ø—Ä–∞–≤–æ–º —É—Ç–≤–µ—Ä–∂–¥–∞—Ç—å —Å–ø–µ—Ü–∏–∞–ª—å–Ω—ã–π –ø–æ—Ä—è–¥–æ–∫ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –ö–†. –ù–µ –º–∏–º–æ –ø—Ä–µ–º–∏–∏ –ü–æ–ø—Ä–∞–≤–∫–∏ –≤ –¢—Ä—É–¥–æ–≤–æ–π –∫–æ–¥–µ–∫—Å –æ –∑–∞–ø—Ä–µ—Ç–µ —Å–Ω–∏–∂–∞—Ç—å —Ä–∞–∑–º–µ—Ä –ø—Ä–µ–º–∏–π –±–æ–ª–µ–µ —á–µ–º –Ω–∞ 20% –æ—Ç –∑–∞—Ä–ø–ª–∞—Ç—ã –∫–æ—Å–Ω—É—Ç—Å—è –Ω–µ–±–æ–ª—å—à–æ–π —á–∞—Å—Ç–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤. –ù–æ —Ç—Ä—É–¥–æ–≤—ã–µ –ø—Ä–∞–≤–∞ —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤ –±—É–¥—É—Ç –∑–∞—â–∏—â–µ–Ω—ã –ª—É—á—à–µ. –ü–æ –ø–æ–Ω—è—Ç–∏—è–º –ì–æ—Å–¥—É–º–∞ –ø—Ä–∏–Ω—è–ª–∞ —Å—Ä–∞–∑—É –≤–æ –≤—Ç–æ—Ä–æ–º –∏ —Ç—Ä–µ—Ç—å–µ–º, –æ–∫–æ–Ω—á–∞—Ç–µ–ª—å–Ω–æ–º —á—Ç–µ–Ω–∏–∏ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ –∑–∞–∫—Ä–µ–ø–ª–µ–Ω–∏–∏ –ø–æ–Ω—è—Ç–∏—è –ø–µ—Ä–µ—á–Ω—è —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ (–°–ó–õ–°). –°–∞–º –ø–µ—Ä–µ—á–µ–Ω—å, –ø–æ—Ä—è–¥–æ–∫ –∏ –∫—Ä–∏—Ç–µ—Ä–∏–∏ –µ–≥–æ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—è –ø—Ä–µ–¥—Å—Ç–æ–∏—Ç —É—Ç–≤–µ—Ä–¥–∏—Ç—å –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤—É. –ï—â–µ –Ω–µ –∫–æ–Ω–µ—Ü –û—Å–Ω–æ–≤–∞—Ç–µ–ª—è —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ ¬´–†–ò–ê ¬´–ü–∞–Ω–¥–∞¬ª –ò–≥–æ—Ä—è –í–æ—Ä–æ–±—å—è –∏ –µ–≥–æ –¥–µ–ª–æ–≤–æ–≥–æ –ø–∞—Ä—Ç–Ω–µ—Ä–∞, —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—è –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–í–ò–°¬ª –°–µ—Ä–≥–µ—è –ù–∞–∑–∞—Ä–æ–≤–∞ –æ—Å–≤–æ–±–æ–¥–∏–ª–∏ –æ—Ç –Ω–∞–∫–∞–∑–∞–Ω–∏—è –∑–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –ë–ê–î, —Å–æ–¥–µ—Ä–∂–∞—â–∏—Ö –Ω–µ –∑–∞—è–≤–ª–µ–Ω–Ω—ã–µ –ø—Ä–∏ –≥–æ—Å—Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏–∏, –≤ —Å–≤—è–∑–∏ —Å –∏—Å—Ç–µ—á–µ–Ω–∏–µ–º —Å—Ä–æ–∫–∞ –¥–∞–≤–Ω–æ—Å—Ç–∏. –û–¥–Ω–∞–∫–æ –∞—Ä–µ—Å—Ç, —Å–Ω—è—Ç—ã–π —Å –∏–º—É—â–µ—Å—Ç–≤–∞ –í–æ—Ä–æ–±—å—è –ø–µ—Ä–≤–æ–π –∏–Ω—Å—Ç–∞–Ω—Ü–∏–µ–π, –Ω–∞–ª–æ–∂–µ–Ω –∑–∞–Ω–æ–≤–æ.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance"",
  ""impact"": ""medium"",
  ""english"": ""The law has been approved, giving doctors the right to deviate from clinical guidelines if it benefits patients. The document grants the Ministry of Health the authority to approve a special order for these guidelines. The law also prevents reducing bonuses by more than 20% of the salary, affecting a small part of medical workers. However, the arrest on the first instance is reinstated.""
}"
2025-07-08T14:32:06+00:00,@medpharm,12362,https://t.me/medpharm/12362,"–ü—Ä–∏–≥–ª–∞—à–∞–µ–º –ø—Ä–∏—Å–æ–µ–¥–∏–Ω–∏—Ç—å—Å—è –∫ –≤–µ–±–∏–Ω–∞—Ä—É –ê–û ¬´–°–ø–∞—Ä–≥–æ –¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏¬ª ‚Äì ¬´–ü—Ä–∏–ª–æ–∂–µ–Ω–∏–µ ¬´–ú–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–π –ª–∏—á–Ω—ã–π –∫–∞–±–∏–Ω–µ—Ç¬ª ‚Äì –∑–∞–±–æ—Ç–∞ –æ –∑–¥–æ—Ä–æ–≤—å–µ –ø–∞—Ü–∏–µ–Ω—Ç–∞¬ª –∏ —É–∑–Ω–∞—Ç—å, –∫–∞–∫ —Å–æ–≤—Ä–µ–º–µ–Ω–Ω—ã–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ –ø–æ–º–æ–≥–∞—é—Ç –∏–∑–º–µ–Ω–∏—Ç—å –ø–æ–¥—Ö–æ–¥ –∫ —É—Ö–æ–¥—É –∑–∞ –ø–∞—Ü–∏–µ–Ω—Ç–∞–º–∏! –ù–∞–∏–±–æ–ª–µ–µ —Ü–µ–Ω–Ω—ã–µ –∞–∫—Ç–∏–≤—ã –ª—é–±–æ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ ‚Äì —ç—Ç–æ –¥–∞–Ω–Ω—ã–µ –æ –ø–∞—Ü–∏–µ–Ω—Ç–∞—Ö. –ò–º–µ–Ω–Ω–æ –≥—Ä–∞–º–æ—Ç–Ω–æ–µ –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏–µ –∏ –∫–æ–º–º—É–Ω–∏–∫–∞—Ü–∏—è —Å –Ω–∏–º–∏ —Å—Ç–∏–º—É–ª–∏—Ä—É—é—Ç —Å–≤–æ–µ–≤—Ä–µ–º–µ–Ω–Ω—ã–π –ø–æ–∏—Å–∫ –ø–æ–º–æ—â–∏, –º–æ—Ç–∏–≤–∞—Ü–∏—é –∫ –ø–æ–¥–¥–µ—Ä–∂–∞–Ω–∏—é –∑–¥–æ—Ä–æ–≤—å—è –∏ –ø–æ–≤—ã—à–µ–Ω–∏–µ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ —Ä–∞–±–æ—Ç—ã –∫–ª–∏–Ω–∏–∫–∏. –í —Ä–µ–∑—É–ª—å—Ç–∞—Ç–µ —ç—Ç–æ —Å–æ–∫—Ä–∞—â–∞–µ—Ç –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –æ—á–Ω—ã—Ö –≤–∏–∑–∏—Ç–æ–≤, —ç–∫–æ–Ω–æ–º–∏—Ç —Ä–µ—Å—É—Ä—Å—ã –∏ –ø–æ–≤—ã—à–∞–µ—Ç –∫–∞—á–µ—Å—Ç–≤–æ –æ–±—Å–ª—É–∂–∏–≤–∞–Ω–∏—è. –ó–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä—É–π—Ç–µ—Å—å –Ω–∞ –≤–µ–±–∏–Ω–∞—Ä –∏ —É–∑–Ω–∞–π—Ç–µ, –∫–∞–∫ —Å–¥–µ–ª–∞—Ç—å —Ä–∞–±–æ—Ç—É —Å –ø–∞—Ü–∏–µ–Ω—Ç–∞–º–∏ –ø—Ä–æ—â–µ, —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–µ–µ –∏ —Å–æ–≤—Ä–µ–º–µ–Ω–Ω–µ–µ. –†–µ–∫–ª–∞–º–∞ –ê–û ¬´–°–ø–∞—Ä–≥–æ –¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏¬ª","{""skip"": true}"
2025-07-08T12:30:01+00:00,@medpharm,12361,https://t.me/medpharm/12361,"–ü–æ —Å–ª–æ–≤–∞–º –≤–∏—Ü–µ-–ø—Ä–µ–º—å–µ—Ä–∞ –¢–∞—Ç—å—è–Ω—ã –ì–æ–ª–∏–∫–æ–≤–æ–π, –≤ –†–æ—Å—Å–∏–∏ –∑–∞ –ø—Ä–æ—à–ª—ã–π –≥–æ–¥ –±—ã–ª–æ —Å–æ—Ö—Ä–∞–Ω–µ–Ω–æ –±–æ–ª–µ–µ 40 —Ç—ã—Å. –¥–µ—Ç–µ–π. –î–æ–ª—è –æ—Ç–∫–∞–∑–∞–≤—à–∏—Ö—Å—è –æ—Ç –ø—Ä–µ—Ä—ã–≤–∞–Ω–∏—è –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏ –¥–æ—Å—Ç–∏–≥–ª–∞ 25%.","{""skip"": true}"
2025-07-08T11:15:37+00:00,@medpharm,12360,https://t.me/medpharm/12360,–û—Å–Ω–æ–≤–∞—Ç–µ–ª—è —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ ¬´–†–ò–ê ¬´–ü–∞–Ω–¥–∞¬ª –∏ –µ–≥–æ –¥–µ–ª–æ–≤–æ–≥–æ –ø–∞—Ä—Ç–Ω–µ—Ä–∞ –æ—Å–≤–æ–±–æ–¥–∏–ª–∏ –æ—Ç –Ω–∞–∫–∞–∑–∞–Ω–∏—è –∑–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –Ω–µ–±–µ–∑–æ–ø–∞—Å–Ω—ã—Ö –ë–ê–î –≤ —Å–≤—è–∑–∏ —Å –∏—Å—Ç–µ—á–µ–Ω–∏–µ–º —Å—Ä–æ–∫–∞ –¥–∞–≤–Ω–æ—Å—Ç–∏. –¢–∞–∫–∏–º –æ–±—Ä–∞–∑–æ–º –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥—Å–∫–∏–π –≥–æ—Ä–æ–¥—Å–∫–æ–π —Å—É–¥ —á–∞—Å—Ç–∏—á–Ω–æ —É–¥–æ–≤–ª–µ—Ç–≤–æ—Ä–∏–ª –∞–ø–µ–ª–ª—è—Ü–∏–æ–Ω–Ω—É—é –∂–∞–ª–æ–±—É –æ—Å—É–∂–¥–µ–Ω–Ω—ã—Ö.,"{
  ""skip"": true
}"
2025-07-08T10:03:59+00:00,@medpharm,12359,https://t.me/medpharm/12359,"–í –Ω–∞—á–∞–ª–µ –∏—é–ª—è –≤—Ä–∞—á–µ–±–Ω—ã–µ –≤–∞–∫–∞–Ω—Å–∏–∏ –≤–æ—à–ª–∏ –≤ TOP —Å–∞–º—ã—Ö –≤—ã—Å–æ–∫–æ–æ–ø–ª–∞—á–∏–≤–∞–µ–º—ã—Ö –≤ –¥–µ–≤—è—Ç–∏ –≥–æ—Ä–æ–¥–∞—Ö-–º–∏–ª–ª–∏–æ–Ω–Ω–∏–∫–∞—Ö. –°–∞–º—ã–º–∏ –≤–æ—Å—Ç—Ä–µ–±–æ–≤–∞–Ω–Ω—ã–º–∏ –æ–∫–∞–∑–∞–ª–∏—Å—å, –≤ —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –£–ó–ò –∏ —Å—Ç–æ–º–∞—Ç–æ–ª–æ–≥–∏.","{""skip"": true}"
2025-07-08T09:02:01+00:00,@medpharm,12358,https://t.me/medpharm/12358,"–ú–∏–Ω–∑–¥—Ä–∞–≤ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –ø—Ä–æ–µ–∫—Ç –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞, —É—Å—Ç–∞–Ω–∞–≤–ª–∏–≤–∞—é—â–∏–π —Å–ø–µ—Ü–∏–∞–ª—å–Ω—ã–µ –ø—Ä–∞–≤–∏–ª–∞ –∫–∞—Ç–µ–≥–æ—Ä–∏—Ä–æ–≤–∞–Ω–∏—è –æ–±—ä–µ–∫—Ç–æ–≤ –∫—Ä–∏—Ç–∏—á–µ—Å–∫–æ–π –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω–æ–π –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä—ã (–ö–ò–ò) –≤ —Å–∏—Å—Ç–µ–º–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –û–Ω –∑–∞—Ç—Ä–∞–≥–∏–≤–∞–µ—Ç –≤ —Ç–æ–º —á–∏—Å–ª–µ –∫—Ä—É–ø–Ω—ã–µ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ –æ–ø—Ç–æ–≤–æ–≥–æ –∏ —Ä–æ–∑–Ω–∏—á–Ω–æ–≥–æ –∑–≤–µ–Ω–∞.","{""skip"": true}"
2025-07-08T07:59:28+00:00,@medpharm,12357,https://t.me/medpharm/12357,"–≠–∫—Å–ø–µ—Ä—Ç—ã –í–û–ó –≤—ã–ø—É—Å—Ç–∏–ª–∏ –æ—Ç—á–µ—Ç –æ –≤–ª–∏—è–Ω–∏–∏ –æ–¥–∏–Ω–æ—á–µ—Å—Ç–≤–∞ –∏ —Å–æ—Ü–∏–∞–ª—å–Ω–æ–π –∏–∑–æ–ª—è—Ü–∏–∏ –Ω–∞ –∑–¥–æ—Ä–æ–≤—å–µ. –î–æ–∫—É–º–µ–Ω—Ç –ø–æ–¥—á–µ—Ä–∫–∏–≤–∞–µ—Ç –∏—Ö —Ä–æ–ª—å –∫–∞–∫ –≥–ª–æ–±–∞–ª—å–Ω—ã—Ö —Ñ–∞–∫—Ç–æ—Ä–æ–≤ —Ä–∏—Å–∫–∞, —Å–æ–ø–æ—Å—Ç–∞–≤–∏–º—ã—Ö —Å –∫—É—Ä–µ–Ω–∏–µ–º –∏ –æ–∂–∏—Ä–µ–Ω–∏–µ–º.","{""skip"": true}"
2025-07-08T06:34:45+00:00,@medpharm,12356,https://t.me/medpharm/12356,"F3 –õ–õ–û: –ø–æ–ª–Ω–æ—Ñ—É–Ω–∫—Ü–∏–æ–Ω–∞–ª—å–Ω–∞—è –ø–ª–∞—Ç—Ñ–æ—Ä–º–∞ –¥–ª—è –∞–≤—Ç–æ–º–∞—Ç–∏–∑–∞—Ü–∏–∏ –ª—å–≥–æ—Ç–Ω–æ–≥–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –ü—Ä–æ–≥—Ä–∞–º–º–Ω–æ–µ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ F3 –õ–õ–û, —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ ¬´–°–ø–∞—Ä–≥–æ –¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏¬ª, –ø—Ä–µ–¥–Ω–∞–∑–Ω–∞—á–µ–Ω–æ –¥–ª—è –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏—è –æ—Ä–≥–∞–Ω–∞–º–∏ —É–ø—Ä–∞–≤–ª–µ–Ω–∏—è –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ–º, –∞–ø—Ç–µ—á–Ω—ã–º —É—á—Ä–µ–∂–¥–µ–Ω–∏—è–º–∏ –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º–∏ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è–º–∏. –ü—Ä–æ–≥—Ä–∞–º–º–Ω–æ–µ —Ä–µ—à–µ–Ω–∏–µ –≤–∫–ª—é—á–µ–Ω–æ –≤ –ï–¥–∏–Ω—ã–π —Ä–µ–µ—Å—Ç—Ä —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –ø—Ä–æ–≥—Ä–∞–º–º –∏ —É—Å–ø–µ—à–Ω–æ –≤–Ω–µ–¥—Ä–µ–Ω–æ –∏ –∞–¥–∞–ø—Ç–∏—Ä–æ–≤–∞–Ω–æ –≤ 18 –∫—Ä—É–ø–Ω—ã—Ö —Ä–µ–≥–∏–æ–Ω–æ–≤ –†–§. F3 –õ–õ–û –ø–æ–º–æ–≥–∞–µ—Ç –º–∏–Ω–∏–º–∏–∑–∏—Ä–æ–≤–∞—Ç—å —Ä—É—á–Ω–æ–π —Ç—Ä—É–¥ —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤ –ú–ò–ê–¶ –∏ –û–£–ó, —Å–¥–µ–ª–∞—Ç—å –Ω–∞–∑–Ω–∞—á–µ–Ω–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –±–æ–ª–µ–µ –æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω—ã–º, –¥–∞–µ—Ç –±–æ–ª—å—à–µ –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç–æ–≤ –¥–ª—è –∞–Ω–∞–ª–∏—Ç–∏–∫–∏. –í—Å–µ —ç—Ç–æ —Å–ø–æ—Å–æ–±—Å—Ç–≤—É–µ—Ç –ø–æ–≤—ã—à–µ–Ω–∏—é –∫–∞—á–µ—Å—Ç–≤–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –æ–±—Å–ª—É–∂–∏–≤–∞–Ω–∏—è. üåê –£–∑–Ω–∞–π—Ç–µ —Å—Ä–æ–∫–∏ –≤–Ω–µ–¥—Ä–µ–Ω–∏—è –∏ –ø—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–∞ –Ω–∞ —Å–∞–π—Ç–µ —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–∞. –†–µ–∫–ª–∞–º–∞ –ê–û ¬´–°–ø–∞—Ä–≥–æ –¢–µ—Ö–Ω–æ–ª–æ–≥–∏–∏¬ª","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""F3 LLO is a fully functional platform for the automated provision of subsidized medicines. Developed by Spargo Technologies, it is designed for use by health care authorities, pharmacies, and medical institutions. The software solution has been registered in the Unified Register of Russian programs and successfully implemented and adapted in 18 large regions of Russia. F3 LLO helps minimize the manual workload for MIAZ and OIZ staff, makes drug prescriptions more rational, and provides more analytical tools. This improves the quality of medical care.""
}"
2025-07-07T16:05:02+00:00,@medpharm,12355,https://t.me/medpharm/12355,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 7 –∏—é–ª—è –ó–∞–¥–∞–¥—É—Ç –∫—Ä–∏—Ç–µ—Ä–∏–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –ø—Ä–æ–µ–∫—Ç –∫–∞—Ç–µ–≥–æ—Ä–∏—Ä–æ–≤–∞–Ω–∏—è –æ–±—ä–µ–∫—Ç–æ–≤ –∫—Ä–∏—Ç–∏—á–µ—Å–∫–æ–π –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω–æ–π –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä—ã –≤ —Å—Ñ–µ—Ä–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –ù–∞–∑–≤–∞–Ω—ã —á–µ—Ç—ã—Ä–µ –∫—Ä–∏—Ç–µ—Ä–∏—è –∏—Ö –∑–Ω–∞—á–∏–º–æ—Å—Ç–∏. –ï—Å–ª–∏ –¥–æ–ª–≥–æ –º—É—á–∏—Ç—å—Å—è... –í –ù–æ–≤–æ—Å–∏–±–∏—Ä—Å–∫–µ –æ—Ç–∫—Ä—ã–ª–∞—Å—å –ø–µ—Ä–≤–∞—è –∏–∑ —Å–µ–º–∏ –ø–æ–ª–∏–∫–ª–∏–Ω–∏–∫, —Å—Ç—Ä–æ—è—â–∏—Ö—Å—è –≤ —Ä–∞–º–∫–∞—Ö –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ-—á–∞—Å—Ç–Ω–æ–≥–æ –ø–∞—Ä—Ç–Ω–µ—Ä—Å—Ç–≤–∞. –ò–∑–Ω–∞—á–∞–ª—å–Ω–æ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—è –ø–ª–∞–Ω–∏—Ä–æ–≤–∞–ª–∏ –≤–≤–µ—Å—Ç–∏ –≤ —ç–∫—Å–ø–ª—É–∞—Ç–∞—Ü–∏—é –≤ 2022 –≥–æ–¥—É. –í—Ç–æ—Ä–æ–π —Ñ–∏–≥—É—Ä–∞–Ω—Ç –°—É–¥ –Ω–∞–ª–æ–∂–∏–ª –∞—Ä–µ—Å—Ç –Ω–∞ –∏–º—É—â–µ—Å—Ç–≤–æ –≥–µ–Ω–µ—Ä–∞–ª—å–Ω–æ–≥–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ —Ñ–∞—Ä–º–ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏—è ¬´–î–∂–æ–¥–∞—Å –≠–∫—Å–ø–æ–∏–º¬ª. –†–µ—á—å –∏–¥–µ—Ç –æ 50 –º–ª–Ω —Ä—É–±., –∏–∑—ä—è—Ç—ã—Ö –≤–æ –≤—Ä–µ–º—è –æ–±—ã—Å–∫–∞, —É–∑–Ω–∞–ª ¬´–§–í¬ª. –†–∞–Ω–µ–µ –±—ã–ª–æ –∞—Ä–µ—Å—Ç–æ–≤–∞–Ω–æ –∏–º—É—â–µ—Å—Ç–≤–æ –¥—Ä—É–≥–æ–≥–æ —Ñ–∏–≥—É—Ä–∞–Ω—Ç–∞ —É–≥–æ–ª–æ–≤–Ω–æ–≥–æ –¥–µ–ª–∞ ‚Äî —á–∏–Ω–æ–≤–Ω–∏–∫–∞ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞. –î—Ä—É–≥–∏—Ö –Ω–µ—Ç –ú–∏–Ω–∑–¥—Ä–∞–≤ –æ—Ç–º–µ–Ω–∏–ª —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—é –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω–æ–≥–æ –ø—Ä–æ—Ç–∏–≤–æ—ç–ø–∏–ª–µ–ø—Ç–∏—á–µ—Å–∫–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ¬´–≠–∫—Å–∞–ª–∏–µ—Ñ¬ª —É –∫–æ—Ç–æ—Ä–æ–≥–æ –Ω–µ—Ç –∞–Ω–∞–ª–æ–≥–æ–≤ –≤ –ì–†–õ–° –ø–æ –ú–ù–ù. –í—Å–µ–≥–æ –∏–∑ —Ä–µ–µ—Å—Ç—Ä–∞ –∏—Å–∫–ª—é—á–∏–ª–∏ –†–£ –Ω–∞ –ø—è—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ –æ–¥–Ω—É —Ñ–∞—Ä–º—Å—É–±—Å—Ç–∞–Ω—Ü–∏—é.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The Ministry of Health Russia has developed a project for categorizing critical information infrastructure objects in the healthcare sector. Four criteria for their importance have been named. In Novosibirsk, one of seven polyclinics under state-private partnership is being opened. Initially, the medical institutions planned to start operations in 2022. The general director of a pharmaceutical company 'Djodas Expoim' had his assets frozen by the court for 50 million rubles during an investigation. Another person involved in the case, a health ministry official, had their assets frozen earlier. The Ministry of Health has canceled the registration of an original anti-epileptic drug 'Exalife', which does not have any analogues in the GRLS by NNN. A total of five drugs and one pharmaceutical substance have been removed from the registry.""
}"
2025-07-07T14:10:13+00:00,@medpharm,12354,https://t.me/medpharm/12354,–ó–∞ –ø–µ—Ä–≤—ã–µ –ø—è—Ç—å –º–µ—Å—è—Ü–µ–≤ 2025 –≥–æ–¥–∞ —Ä—ã–Ω–æ–∫ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö —Ç–æ–≤–∞—Ä–æ–≤ –≤ –†–æ—Å—Å–∏–∏ –ø—Ä–æ–¥–µ–º–æ–Ω—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª —É–≤–µ—Ä–µ–Ω–Ω—ã–π —Ä–æ—Å—Ç –≤ —Å–µ–≥–º–µ–Ω—Ç–µ —ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω–æ–π –∫–æ–º–º–µ—Ä—Ü–∏–∏. –ê–Ω–∞–ª–∏—Ç–∏–∫–∏ AlphaRM –ø–æ–¥—Å—á–∏—Ç–∞–ª–∏ —á–∞—Å—Ç–Ω—ã–µ —Ä–∞—Å—Ö–æ–¥—ã –Ω–∞ –ø–æ–∫—É–ø–∫—É –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –æ–Ω–ª–∞–π–Ω- –∏ –æ—Ñ–ª–∞–π–Ω-–∫–∞–Ω–∞–ª–∞—Ö.,"{""skip"": true}"
2025-07-07T12:30:35+00:00,@medpharm,12353,https://t.me/medpharm/12353,"–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –≤—ã–¥–µ–ª–∏–ª–æ –ø–æ—á—Ç–∏ 1,8 –º–ª—Ä–¥ —Ä—É–±. –Ω–∞ —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–æ –±–æ–ª—å–Ω–∏—Ü –≤ —Ä–µ–≥–∏–æ–Ω–∞—Ö. –ë–æ–ª—å—à–µ –≤—Å–µ–≥–æ —Å—Ä–µ–¥—Å—Ç–≤ –ø–æ–ª—É—á–∏—Ç –û—Ä–ª–æ–≤—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å –Ω–∞ –≤–æ–∑–≤–µ–¥–µ–Ω–∏–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–π –±–æ–ª—å–Ω–∏—Ü—ã.","{""skip"": true}"
2025-07-07T11:08:47+00:00,@medpharm,12352,https://t.me/medpharm/12352,"–§–ê–° –Ω–∞—á–∞–ª–∞ –ø—Ä–æ–≤–µ—Ä–∫—É –ø–æ–≤—ã—à–µ–Ω–∏—è —Ü–µ–Ω—ã –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ —Å –ú–ù–ù —Ç–∏–∞–º—Ñ–µ–Ω–∏–∫–æ–ª–∞ –≥–ª–∏—Ü–∏–Ω–∞—Ç –∞—Ü–µ—Ç–∏–ª—Ü–∏—Å—Ç–µ–∏–Ω–∞—Ç –Ω–∞ 46%, –∫–æ—Ç–æ—Ä—ã–π –Ω–µ –≤—Ö–æ–¥–∏—Ç –≤ –ü–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü. –ö–æ–º–ø–∞–Ω–∏—é ¬´–ó–∞–º–±–æ–Ω-–§–∞—Ä–º–∞¬ª –ø–æ–¥–æ–∑—Ä–µ–≤–∞—é—Ç –≤ –Ω–∞—Ä—É—à–µ–Ω–∏–∏ –ó–∞–∫–æ–Ω–∞ –æ –∑–∞—â–∏—Ç–µ –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏–∏.","{
  ""skip"": false,
  ""country"": ""Ukraine"",
  ""topic"": ""pricing, sanctions"",
  ""impact"": ""high"",
  ""english"": ""The Ukrainian Anti-monopoly Service started investigating a price increase of up to 46% for the drug with MN number thiamphenicol glicyrantel acetylecysteine, which is not included in the List of Essential Medicines. The company 'Zambon-Farma' is suspected of violating the Competition Law.""
}"
2025-07-07T09:17:14+00:00,@medpharm,12351,https://t.me/medpharm/12351,–ö–∏—Ç–∞–π —Ä–µ—à–∏–ª –æ–≥—Ä–∞–Ω–∏—á–∏—Ç—å –∏–º–ø–æ—Ä—Ç –µ–≤—Ä–æ–ø–µ–π—Å–∫–æ–π –º–µ–¥—Ç–µ—Ö–Ω–∏–∫–∏ –∏ –º–µ–¥—Ç–µ—Ö–Ω–∏–∫–∏ —Å –∫–æ–º–ø–æ–Ω–µ–Ω—Ç–∞–º–∏ –∏–∑ –ï–° –∏–∑ –¥—Ä—É–≥–∏—Ö —Å—Ç—Ä–∞–Ω. –ï–µ —Å—Ç–æ–∏–º–æ—Å—Ç—å ‚Äî —Å–≤—ã—à–µ 6 –º–ª–Ω –¥–æ–ª–ª.,"{""skip"": true}"
2025-07-07T08:02:41+00:00,@medpharm,12350,https://t.me/medpharm/12350,"–°—É–¥ –Ω–∞–ª–æ–∂–∏–ª –∞—Ä–µ—Å—Ç –Ω–∞ –∏–º—É—â–µ—Å—Ç–≤–æ –≥–µ–Ω–µ—Ä–∞–ª—å–Ω–æ–≥–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ —Ñ–∞—Ä–º–ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏—è ¬´–î–∂–æ–¥–∞—Å –≠–∫—Å–ø–æ–∏–º¬ª. –†–µ—á—å –∏–¥–µ—Ç –æ 50 –º–ª–Ω —Ä—É–±., –∏–∑—ä—è—Ç—ã—Ö –≤–æ –≤—Ä–µ–º—è –æ–±—ã—Å–∫–∞, —É–∑–Ω–∞–ª ¬´–§–í¬ª. –†–µ—à–µ–Ω–∏–µ –≤—Å—Ç—É–ø–∏–ª–æ –≤ —Å–∏–ª—É.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions"",
  ""impact"": ""high"",
  ""english"": ""A court has imposed a seizure on the assets of the CEO of pharmaceutical company 'Djodas Expoim'. The amount is 50 million rubles, which were seized during a search. This decision has taken effect.""
}"
2025-07-07T07:05:37+00:00,@medpharm,12349,https://t.me/medpharm/12349,–ü—Ä–µ–∑–∏–¥–µ–Ω—Ç –æ–±—Å—É–¥–∏—Ç —Å –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ–º –∏ –ú–∏–Ω–æ–±–æ—Ä–æ–Ω—ã –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –æ—Ç–ø—Ä–∞–≤–∫–∏ –≥—Ä–∞–∂–¥–∞–Ω—Å–∫–∏—Ö –≤—Ä–∞—á–µ–π –≤ –≥–æ—Å–ø–∏—Ç–∞–ª–∏ —É –ª–∏–Ω–∏–∏ —Ñ—Ä–æ–Ω—Ç–∞ –Ω–∞ –∫–æ—Ä–æ—Ç–∫–∏–π —Å—Ä–æ–∫. –°–µ–π—á–∞—Å –¥–ª—è —Ç–∞–∫–∏—Ö –∫–æ–º–∞–Ω–¥–∏—Ä–æ–≤–æ–∫ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ –ø–æ–¥–ø–∏—Å—ã–≤–∞—Ç—å –¥–æ–ª–≥–æ—Å—Ä–æ—á–Ω—ã–µ –∫–æ–Ω—Ç—Ä–∞–∫—Ç—ã.,"{""skip"": true}"
2025-07-06T12:02:59+00:00,@medpharm,12348,https://t.me/medpharm/12348,"–ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ –∑–∞ –Ω–µ–¥–µ–ª—é üîµ –°–µ—Ä–≤–∏—Å–∞–º–∏, –ø—Ä–µ–¥–ª–∞–≥–∞—é—â–∏–º–∏ –ø–æ–∫—É–ø–∞—Ç–µ–ª—è–º –∫–µ—à–±—ç–∫ –∑–∞ –ø—Ä–∏–æ–±—Ä–µ—Ç–µ–Ω–∏–µ –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–Ω–æ–≥–æ –ø–µ—Ä–µ—á–Ω—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, —Å—Ç–∞–ª–∏ –ø–æ–ª—å–∑–æ–≤–∞—Ç—å—Å—è –ø–µ—Ä–≤–æ—Å—Ç–æ–ª—å–Ω–∏–∫–∏. –†—è–¥ –∞–ø—Ç–µ—á–Ω—ã—Ö —Å–µ—Ç–µ–π –Ω–∞–ø—Ä–∞–≤–∏–ª –ø–∏—Å—å–º–∞ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º —Å –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏–µ–º, —á—Ç–æ –∏—Ö —É—á–∞—Å—Ç–∏–µ –≤ –ø—Ä–æ–≥—Ä–∞–º–º–∞—Ö –∫–µ—à–±—ç–∫–∞ –º–æ–∂–µ—Ç –ø—Ä–∏–≤–µ—Å—Ç–∏ –∫ —Ä–∞–∑—Ä—ã–≤—É –æ—Ç–Ω–æ—à–µ–Ω–∏–π. üîµ ¬´–ì—Ä—É–ø–ø–∞ –†–µ–º–µ–¥–∏—É–º¬ª –¥–æ–≥–æ–≤–æ—Ä–∏–ª–∞—Å—å –æ –ø—Ä–∏–æ–±—Ä–µ—Ç–µ–Ω–∏–∏ –∞–∫—Ç–∏–≤–æ–≤ —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –ø–æ–¥—Ä–∞–∑–¥–µ–ª–µ–Ω–∏—è –∫–æ–º–ø–∞–Ω–∏–∏ IQVIA, —É–∑–Ω–∞–ª ¬´–§–í¬ª. üîµ –§–ê–° —Ä–∞–∑—ä—è—Å–Ω–∏–ª–∞, –ø–æ—á–µ–º—É –Ω–∞ –∫–ª–∏–ø ¬´–õ–µ–Ω–∏–Ω–≥—Ä–∞–¥–∞¬ª –∏ –ó–æ–∏ ¬´–¢–∏—Ä–∑–µ—Ç—Ç–∞¬ª –Ω–µ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω—è—é—Ç—Å—è –ø–æ–ª–æ–∂–µ–Ω–∏—è –§–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –∑–∞–∫–æ–Ω–∞ ¬´–û —Ä–µ–∫–ª–∞–º–µ¬ª. üîµ –í –†–æ—Å—Å–∏–∏ —Å–ø–∏—Å—ã–≤–∞—é—Ç –æ—á–µ–Ω—å –º–Ω–æ–≥–æ –ª–µ–∫–∞—Ä—Å—Ç–≤, –∑–∞—á–∞—Å—Ç—É—é –∫–∞—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö, –∫–æ—Ç–æ—Ä—ã–µ –Ω–µ –º–æ–≥—É—Ç –±—ã—Ç—å –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω—ã –∏–∑-–∑–∞ –ø—Ä–æ–±–ª–µ–º —Å —Ä–∞—Å–ø–æ–∑–Ω–∞–≤–∞–Ω–∏–µ–º –∫–æ–¥–∞ –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏, –ø–æ–∂–∞–ª–æ–≤–∞–ª–∏—Å—å –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–∏ –∞–ø—Ç–µ—á–Ω–æ–π —Ä–æ–∑–Ω–∏—Ü—ã. üîµ –¶–†–ü–¢ –∞–Ω–æ–Ω—Å–∏—Ä–æ–≤–∞–ª –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ —Å–∏—Å—Ç–µ–º–µ –ú–î–õ–ü. –¢–µ–ø–µ—Ä—å, –µ—Å–ª–∏ —É–ø–∞–∫–æ–≤–∫–∞ —Ä–µ–∞–ª–∏–∑—É–µ—Ç—Å—è –Ω–µ —Ü–µ–ª–∏–∫–æ–º, –∞, –Ω–∞–ø—Ä–∏–º–µ—Ä, –ø–æ–±–ª–∏—Å—Ç–µ—Ä–Ω–æ, –≤ —Å–∏—Å—Ç–µ–º–µ –±—É–¥–µ—Ç –≤–∏–¥–Ω–æ, –∫–∞–∫–∞—è –µ–µ –¥–æ–ª—è –ø—Ä–æ–¥–∞–Ω–∞.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The news service is offering refunds to customers who purchase a certain range of medicines. Several pharmacy chains have sent letters to manufacturers warning that participation in refund programs could lead to the termination of relationships. The group Remedium has agreed to acquire assets from a Russian subsidiary of IQVIA company. The FAS clarified why the advertising provisions for '–õ–µ–Ω–∏–Ω–≥—Ä–∞–¥' and '–¢–∏—Ä–∑–µ—Ç—Ç–∞' do not apply to them. In Russia, many medicines are being written off due to problems with the recognition of packaging codes. The Central Registration Point announced changes in the MDP system. If a package is sold partially, for example, by blister, this will be visible in the system.""
}"
2025-07-05T09:03:22+00:00,@medpharm,12347,https://t.me/medpharm/12347,"–ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∑–∞ –Ω–µ–¥–µ–ª—é üî¥–í –ú–∏–Ω–∑–¥—Ä–∞–≤–µ —Å–æ–±–∏—Ä–∞—é—Ç—Å—è –ø–µ—Ä–µ—Å–º–æ—Ç—Ä–µ—Ç—å –ø–æ–¥—Ö–æ–¥—ã –∫ –æ—Ç–∫—Ä—ã—Ç–∏—é, —Ä–µ–∫–æ–Ω—Å—Ç—Ä—É–∫—Ü–∏–∏ –∏ –∫–∞–ø–∏—Ç–∞–ª—å–Ω–æ–º—É —Ä–µ–º–æ–Ω—Ç—É –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π. üî¥–°—Ä–æ–∫ –¥–µ–π—Å—Ç–≤–∏—è –Ω–æ–º–µ–Ω–∫–ª–∞—Ç—É—Ä—ã –¥–æ–ª–∂–Ω–æ—Å—Ç–µ–π –º–µ–¥- –∏ —Ñ–∞—Ä–º—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –ø—Ä–æ–¥–ª–µ–Ω –Ω–∞ –±–µ—Å—Å—Ä–æ—á–Ω—ã–π –ø–µ—Ä–∏–æ–¥. üî¥–û—Ç–º–µ–Ω–∞ —Å—Ç–∏–º—É–ª–∏—Ä—É—é—â–∏—Ö –≤—ã–ø–ª–∞—Ç –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–∞–º –º–æ–∂–µ—Ç –ø—Ä–∏–≤–µ—Å—Ç–∏ –∫ —Å–Ω–∏–∂–µ–Ω–∏—é –∫–∞—á–µ—Å—Ç–≤–∞ –æ–∫–∞–∑–∞–Ω–∏—è –º–µ–¥–ø–æ–º–æ—â–∏, –≤—ã—è—Å–Ω–∏–ª–∏ —É—á–µ–Ω—ã–µ –∏–∑ –≠–¥–∏–Ω–±—É—Ä–≥—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞. üî¥–°—á–µ—Ç–Ω–æ–π –ø–∞–ª–∞—Ç–∞ —É–∫–∞–∑–∞–ª–∞ –Ω–∞ –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω—É—é –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –≤ —Ä–∞–º–∫–∞—Ö —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –ø—Ä–æ–µ–∫—Ç–∞ ¬´–û–ø—Ç–∏–º–∞–ª—å–Ω–∞—è –¥–ª—è –≤–æ—Å—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è –∑–¥–æ—Ä–æ–≤—å—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è —Ä–µ–∞–±–∏–ª–∏—Ç–∞—Ü–∏—è¬ª. üî¥–ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–∞—è –∞—Å—Å–æ—Ü–∏–∞—Ü–∏—è —É–ø—Ä–∞–≤–ª–µ–Ω—Ü–µ–≤ —Å—Ñ–µ—Ä—ã –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∞ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å–Ω–æ —Ä–∞–∑—Ä–µ—à–∏—Ç—å –≤—Ä–∞—á–∞–º –æ—Ç–∫–∞–∑—ã–≤–∞—Ç—å –≤ –ø–ª–∞–Ω–æ–≤–æ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –ø–∞—Ü–∏–µ–Ω—Ç–∞–º —Å —è—Ä–∫–æ –≤—ã—Ä–∞–∂–µ–Ω–Ω—ã–º–∏ –ø—Ä–∏–∑–Ω–∞–∫–∞–º–∏ –∞–ª–∫–æ–≥–æ–ª—å–Ω–æ–≥–æ –∏–ª–∏ –Ω–∞—Ä–∫–æ—Ç–∏—á–µ—Å–∫–æ–≥–æ –æ–ø—å—è–Ω–µ–Ω–∏—è.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, hospital_policy, guideline, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health is considering revising approaches to opening, reconstruction and capital repair of healthcare institutions. The deadline for the medical and pharmaceutical workforce nomenclature is being extended to a non-limited period. Reduced incentives for healthcare workers could lead to lower quality of medical care, according to researchers from the University of Edinburgh. The State Duma has noted insufficient accessibility of medical care within the federal project 'Optimal Health Care Rehabilitation'. A national association of healthcare managers has proposed to legally allow doctors to refuse planned medical care for patients with clearly visible signs of alcohol or drug intoxication.""
}"
2025-07-04T16:07:21+00:00,@medpharm,12346,https://t.me/medpharm/12346,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 4 –∏—é–ª—è –î–æ–ª–æ–π –±–∞—Ä—å–µ—Ä—ã –í—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–∏–π —Å–æ—é–∑ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Ä–∞—Å–∫—Ä–∏—Ç–∏–∫–æ–≤–∞–ª —Ä–∞–±–æ—Ç—É –∫–æ–º–∏—Å—Å–∏–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ø–æ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—é –ø–µ—Ä–µ—á–Ω–µ–π –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –Ω–∞–∑–≤–∞–ª –µ–µ –±–∞—Ä—å–µ—Ä–æ–º –¥–ª—è –∏–Ω–Ω–æ–≤–∞—Ü–∏–π. –í –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –≤—ã–¥–≤–∏–Ω—É–ª–∏ 15 –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–π –¥–ª—è –ø–æ–≤—ã—à–µ–Ω–∏—è —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ —Ä–∞–±–æ—Ç—ã —ç—Ç–æ–≥–æ –æ—Ä–≥–∞–Ω–∞. –ü—Ä–µ–æ–¥–æ–ª–µ—Ç—å COVID –ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∞—è –∞—Å—Å–æ—Ü–∏–∞—Ü–∏—è –ø–æ –ø—Ä–æ–±–ª–µ–º–∞–º —Å–µ—Ä–¥—Ü–∞ (AHA) –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∞ –Ω–∞—É—á–Ω–æ–µ –∑–∞—è–≤–ª–µ–Ω–∏–µ –æ —Ä–µ–∞–∫—Ü–∏–∏ –Ω–∞ —Ñ–∏–∑–∏—á–µ—Å–∫–∏–µ —Ç—Ä–µ–Ω–∏—Ä–æ–≤–∫–∏ —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –ø–æ—Å—Ç–∫–æ–≤–∏–¥–Ω—ã–º —Å–∏–Ω–¥—Ä–æ–º–æ–º. –ú–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞–º —Å—Ç–∞–≤—è—Ç —É—Å–ª–æ–≤–∏—è –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –≤–Ω–µ—Å–ª–æ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ –ø–ª–∞—Ç—Ñ–æ—Ä–º–µ–Ω–Ω–æ–π —ç–∫–æ–Ω–æ–º–∏–∫–µ –≤ –ì–æ—Å–¥—É–º—É. –î–æ–∫—É–º–µ–Ω—Ç –æ–ø—Ä–µ–¥–µ–ª—è–µ—Ç –ø—Ä–∞–≤–∞ –∏ –æ–±—è–∑–∞–Ω–Ω–æ—Å—Ç–∏ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–æ–≤, –ø—Ä–æ–¥–∞–≤—Ü–æ–≤ –∏ –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª–µ–π –ø—Ä–∏ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ —Ç–æ–≤–∞—Ä–æ–≤ –∏ —É—Å–ª—É–≥ –≤ —Ü–∏—Ñ—Ä–æ–≤–æ–π —Å—Ä–µ–¥–µ. –ë—É–¥—É—Ç —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω—ã —Å–ø–µ—Ü–∏–∞–ª—å–Ω—ã–µ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –¥–ª—è —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –º–µ–¥–∏–∑–¥–µ–ª–∏–π –Ω–∞ —Ç–∞–∫–∏—Ö –ø–ª–∞—Ç—Ñ–æ—Ä–º–∞—Ö. –†–∏—Å–∫ - –Ω–µ –ø–æ–≤–æ–¥ –§–ê–° –Ω–µ —Å–æ–≥–ª–∞—Å–æ–≤–∞–ª–∞ –ø–æ–≤—ã—à–µ–Ω–∏–µ —Ü–µ–Ω—ã –Ω–∞ –∫–æ–º–±–∏–Ω–∏—Ä–æ–≤–∞–Ω–Ω—ã–π –ø—Ä–æ—Ç–∏–≤–æ—Ç—É–±–µ–∫—É–ª–µ–∑–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç ¬´–§–∞—Ä–º–∞—Å–∏–Ω—Ç–µ–∑—É¬ª. –ü—Ä–∏ —ç—Ç–æ–º –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª, —á—Ç–æ –º–æ–∂–µ—Ç –≤–æ–∑–Ω–∏–∫–Ω—É—Ç—å –¥–µ—Ñ–∏—Ü–∏—Ç –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏–∑-–∑–∞ —Ü–µ–Ω–æ–æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""The Federal Antimonopoly Service did not approve an increase in the price of combined tuberculosis preventive drug 'FarmaSyntez'. However, Roszdravnadzor confirmed that a shortage of the drug could occur due to pricing. The World Federation of Societies of Physicians for Disaster Medicine (WFSDM) published a statement on the reaction to physical exercise in patients with post-COVID syndrome.""
}"
2025-07-04T14:15:09+00:00,@medpharm,12345,https://t.me/medpharm/12345,"–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –≤–Ω–µ—Å–ª–æ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ –ø–ª–∞—Ç—Ñ–æ—Ä–º–µ–Ω–Ω–æ–π —ç–∫–æ–Ω–æ–º–∏–∫–µ –≤ –ì–æ—Å–¥—É–º—É. –î–æ–∫—É–º–µ–Ω—Ç –æ–ø—Ä–µ–¥–µ–ª—è–µ—Ç –ø—Ä–∞–≤–∞ –∏ –æ–±—è–∑–∞–Ω–Ω–æ—Å—Ç–∏ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–æ–≤, –ø—Ä–æ–¥–∞–≤—Ü–æ–≤ –∏ –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª–µ–π –ø—Ä–∏ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ —Ç–æ–≤–∞—Ä–æ–≤ –∏ —É—Å–ª—É–≥ –≤ —Ü–∏—Ñ—Ä–æ–≤–æ–π —Å—Ä–µ–¥–µ. –ë—É–¥—É—Ç —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω—ã —Å–ø–µ—Ü–∏–∞–ª—å–Ω—ã–µ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –¥–ª—è —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –º–µ–¥–∏–∑–¥–µ–ª–∏–π –Ω–∞ —Ç–∞–∫–∏—Ö –ø–ª–∞—Ç—Ñ–æ—Ä–º–∞—Ö.","{""skip"": true}"
2025-07-04T13:06:56+00:00,@medpharm,12344,https://t.me/medpharm/12344,"–ù–∞—à–∏ –∫–æ–ª–ª–µ–≥–∏ –∏–∑ ¬´–ú–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –†–æ—Å—Å–∏–∏¬ª –ø—Ä–µ–æ–¥–æ–ª–µ–ª–∏ –æ—Ç–º–µ—Ç–∫—É –≤ 120 000 –ø–æ–¥–ø–∏—Å—á–∏–∫–æ–≤ –∏ –ø–æ —ç—Ç–æ–º—É —Å–ª—É—á–∞—é –ø–æ–¥–≥–æ—Ç–æ–≤–∏–ª–∏ –æ–±–∑–æ—Ä –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ç–µ–ª–µ–≥—Ä–∞–º-–∫–∞–Ω–∞–ª–æ–≤. üéâ–ü–æ–∑–¥—Ä–∞–≤–ª—è–µ–º! –ß–∏—Ç–∞–µ–º, –ª—é–±–∏–º, —Ü–µ–Ω–∏–º. –í–∞—à –ú–µ–¥–§–∞—Ä–º.","{""skip"": true}"
2025-07-04T12:06:46+00:00,@medpharm,12343,https://t.me/medpharm/12343,"–≠–∫—Å-–ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—å –ö–æ–º–∏—Ç–µ—Ç–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ö—É—Ä—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏, –∫–æ—Ç–æ—Ä–∞—è –æ—Å—Ç–∞–≤–∏–ª–∞ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤-–∏–Ω–≤–∞–ª–∏–¥–æ–≤ –±–µ–∑ –ª–µ–∫–∞—Ä—Å—Ç–≤, –ø–æ–ª—É—á–∏–ª–∞ —É—Å–ª–æ–≤–Ω—ã–π —Å—Ä–æ–∫. –°—É–¥ –ø—Ä–∏–∑–Ω–∞–ª –ï–ª–µ–Ω—É –ü–∞–ª—Ñ–µ—Ä–æ–≤—É –≤–∏–Ω–æ–≤–Ω–æ–π –≤ –∑–ª–æ—É–ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏–∏ –¥–æ–ª–∂–Ω–æ—Å—Ç–Ω—ã–º–∏ –ø–æ–ª–Ω–æ–º–æ—á–∏—è–º–∏.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration, reimbursement, pricing, sanctions"",
  ""impact"": ""high"",
  ""english"": ""The former chair of the Health Committee in Kurinsky Region, Elena Palferov, received a conditional sentence for abusing her official duties. She was found guilty of neglecting patients with disabilities by leaving them without medication.""
}"
2025-07-04T11:17:23+00:00,@medpharm,12342,https://t.me/medpharm/12342,"–î–µ–ø—É—Ç–∞—Ç –ì–æ—Å–¥—É–º—ã –ê–π—Ä–∞—Ç –§–∞—Ä—Ä–∞—Ö–æ–≤ –æ–±—Ä–∞—Ç–∏–ª—Å—è –≤ –í–µ—Ä—Ö–æ–≤–Ω—ã–π —Å—É–¥ —Å –ø—Ä–æ—Å—å–±–æ–π —Ä–∞—Å—Ç–æ–ª–∫–æ–≤–∞—Ç—å —Å—Ç.1359 –ì—Ä–∞–∂–¥–∞–Ω—Å–∫–æ–≥–æ –∫–æ–¥–µ–∫—Å–∞ –†–§: —á—Ç–æ –∫–æ–Ω–∫—Ä–µ—Ç–Ω–æ –±—É–¥–µ—Ç —è–≤–ª—è—Ç—å—Å—è –Ω–∞—Ä—É—à–µ–Ω–∏–µ–º –ø–∞—Ç–µ–Ω—Ç–Ω—ã—Ö –ø—Ä–∞–≤ –ø—Ä–∏ –∞–ø—Ç–µ—á–Ω–æ–º –∏–∑–≥–æ—Ç–æ–≤–ª–µ–Ω–∏–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤. –≠—Ç–æ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ –¥–ª—è –ø–æ–≤—ã—à–µ–Ω–∏—è –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç–∏ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤, —Å—á–∏—Ç–∞–µ—Ç –¥–µ–ø—É—Ç–∞—Ç.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""Deputy Ayrat Farrakhov of the State Duma has appealed to the Supreme Court for an interpretation of Art. 1359 of the Civil Code of Russia: what specifically constitutes a violation of patent rights during pharmaceutical manufacturing. He believes this is necessary to increase the accessibility of innovative drugs.""
}"
2025-07-04T10:00:10+00:00,@medpharm,12341,https://t.me/medpharm/12341,–í—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–∏–π —Å–æ—é–∑ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Ä–∞—Å–∫—Ä–∏—Ç–∏–∫–æ–≤–∞–ª —Ä–∞–±–æ—Ç—É –∫–æ–º–∏—Å—Å–∏–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ø–æ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—é –ø–µ—Ä–µ—á–Ω–µ–π –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –Ω–∞–∑–≤–∞–ª –µ–µ –±–∞—Ä—å–µ—Ä–æ–º –¥–ª—è –∏–Ω–Ω–æ–≤–∞—Ü–∏–π. –í –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –≤—ã–¥–≤–∏–Ω—É–ª–∏ 15 –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–π –¥–ª—è –ø–æ–≤—ã—à–µ–Ω–∏—è —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ —Ä–∞–±–æ—Ç—ã —ç—Ç–æ–≥–æ –æ—Ä–≥–∞–Ω–∞.,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The Russian Federation Patients Union criticized the work of the Commission on Russia's Ministry of Health for creating a list of medicines and called it a barrier to innovations. The organization has proposed 15 suggestions for improving the effectiveness of this body's work.""
}"
2025-07-04T08:30:06+00:00,@medpharm,12340,https://t.me/medpharm/12340,"–î–µ–≤—è—Ç—ã–π –∞—Ä–±–∏—Ç—Ä–∞–∂–Ω—ã–π –∞–ø–µ–ª–ª—è—Ü–∏–æ–Ω–Ω—ã–π —Å—É–¥ –æ—Å—Ç–∞–≤–∏–ª –≤ —Å–∏–ª–µ —Ä–µ—à–µ–Ω–∏–µ —Å—É–¥–∞ –ø–µ—Ä–≤–æ–π –∏–Ω—Å—Ç–∞–Ω—Ü–∏–∏ –ø–æ —Å–ø–æ—Ä—É –æ –≤—ã–≤–æ–¥–µ –Ω–∞ —Ä—ã–Ω–æ–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –∞–∫—Å–∏—Ç–∏–Ω–∏–± –∫–æ–º–ø–∞–Ω–∏–µ–π ¬´–ê–∫—Å–µ–ª—å–§–∞—Ä–º¬ª —Å –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ–º –ø–∞—Ç–µ–Ω—Ç–æ–≤, –Ω–∞—Ö–æ–¥—è—â–∏—Ö—Å—è –ø–æ–¥ –∑–∞—â–∏—Ç–æ–π. –¢–µ–º —Å–∞–º—ã–º –∞–ø–µ–ª–ª—è—Ü–∏–æ–Ω–Ω–∞—è –∏–Ω—Å—Ç–∞–Ω—Ü–∏—è –ø—Ä–∏–∑–Ω–∞–ª–∞ –Ω–µ–ø—Ä–∞–≤–æ—Ç—É –§–ê–°, –∫–æ—Ç–æ—Ä–∞—è —É—Å–º–æ—Ç—Ä–µ–ª–∞ –≤ –¥–µ–π—Å—Ç–≤–∏—è—Ö —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è –Ω–∞—Ä—É—à–µ–Ω–∏–µ –∑–∞–∫–æ–Ω–∞ ¬´–û –∑–∞—â–∏—Ç–µ –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏–∏¬ª.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""high"",
  ""english"": ""The Ninth Arbitration Appeal Court upheld the first instance court's decision regarding the market release of Axitinib by company 'AkselFarma' with the use of patents under protection. The appellate court recognized FAS's wrongful interpretation of AkselFarma's actions, which were deemed to violate the 'Anti-Corruption Law'.""
}"
2025-07-04T07:02:04+00:00,@medpharm,12339,https://t.me/medpharm/12339,"–ò—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª–∏ –ì–ª–æ–±–∞–ª—å–Ω–æ–≥–æ –±—Ä–µ–º–µ–Ω–∏ –±–æ–ª–µ–∑–Ω–µ–π (GBD) –ø—Ä–æ–∞–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–ª–∏ –¥–∏–Ω–∞–º–∏–∫—É —É—Ö—É–¥—à–µ–Ω–∏—è –∑—Ä–µ–Ω–∏—è, —Å–≤—è–∑–∞–Ω–Ω–æ–≥–æ —Å –≤–æ–∑—Ä–∞—Å—Ç–Ω–æ–π –º–∞–∫—É–ª—è—Ä–Ω–æ–π –¥–µ–≥–µ–Ω–µ—Ä–∞—Ü–∏–µ–π, —Å 1990 –ø–æ 2021 –≥–æ–¥ –∏ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∏ –ø—Ä–æ–≥–Ω–æ–∑ –¥–æ 2050 –≥–æ–¥–∞. –ó–∞ –ø–æ—Å–ª–µ–¥–Ω–∏–µ 30 –ª–µ—Ç —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–Ω–æ—Å—Ç—å –Ω–∞—Ä—É—à–µ–Ω–∏–π –∑—Ä–µ–Ω–∏—è –∏–∑-–∑–∞ –≤–æ–∑—Ä–∞—Å—Ç–Ω–æ–π –º–∞–∫—É–ª—è—Ä–Ω–æ–π –¥–µ–≥–µ–Ω–µ—Ä–∞—Ü–∏–∏ —É–≤–µ–ª–∏—á–∏–ª–∞—Å—å –±–æ–ª–µ–µ —á–µ–º –≤–¥–≤–æ–µ, –∞ –∫ 2050 –≥–æ–¥—É –æ–±—â–µ–µ —á–∏—Å–ª–æ —Ç–∞–∫–∏—Ö —Å–ª—É—á–∞–µ–≤ –º–æ–∂–µ—Ç –¥–æ—Å—Ç–∏—á—å 21,34 –º–ª–Ω.","{""skip"": true}"
2025-07-03T16:15:15+00:00,@medpharm,12338,https://t.me/medpharm/12338,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 3 –∏—é–ª—è –û—Ç —á–∞—Å—Ç–Ω–æ–≥–æ ‚Äì –∫ –æ–±—â–µ–º—É –í –†–æ—Å—Å–∏–∏ —Å–æ–±–∏—Ä–∞—é—Ç—Å—è –ø–µ—Ä–µ—Å–º–æ—Ç—Ä–µ—Ç—å –ø–æ–¥—Ö–æ–¥—ã –∫ –æ—Ç–∫—Ä—ã—Ç–∏—é, —Ä–µ–∫–æ–Ω—Å—Ç—Ä—É–∫—Ü–∏–∏ –∏ –∫–∞–ø–∏—Ç–∞–ª—å–Ω–æ–º—É —Ä–µ–º–æ–Ω—Ç—É –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π. –≠–∫—Å–ø–µ—Ä—Ç—ã –æ–∂–∏–¥–∞—é—Ç, —á—Ç–æ –≤ —Å–ª—É—á–∞–µ –æ–¥–æ–±—Ä–µ–Ω–∏—è –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤—ã –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ —á–∞—Å—Ç–Ω—ã–µ –∫–ª–∏–Ω–∏–∫–∏ –±—É–¥—É—Ç —Ä–∞–∑–≤–∏–≤–∞—Ç—å—Å—è –ø–æ –æ—Å—Ç–∞—Ç–æ—á–Ω—ã–º –ø—Ä–∏–Ω—Ü–∏–ø–∞–º. –ü–ª–æ—Ö–∏–µ –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤—ã –¢–µ–º–ø—ã –æ—Ö–≤–∞—Ç–∞ –ø–ª–∞–Ω–æ–≤–æ–π –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏–µ–π –≤ –º–∏—Ä–µ, –∫–æ—Ç–æ—Ä—ã–µ —É–≤–µ–ª–∏—á–∏–≤–∞–ª–∏—Å—å —Å 1980 –ø–æ 2019 –≥–æ–¥, –∑–∞–º–µ—Ç–Ω–æ —Å–Ω–∏–∑–∏–ª–∏—Å—å –≤ –ø–µ—Ä–∏–æ–¥ –ø–∞–Ω–¥–µ–º–∏–∏ COVID-19. –¶–µ–ª–µ–≤–æ–≥–æ –æ—Ö–≤–∞—Ç–∞ –≤ 90% –∫ 2030 –≥–æ–¥—É –º–æ–∂–µ—Ç –¥–æ—Å—Ç–∏–≥–Ω—É—Ç—å —Ç–æ–ª—å–∫–æ –∏–º–º—É–Ω–∏–∑–∞—Ü–∏—è —Ç—Ä–µ—Ç—å–µ–π –¥–æ–∑–æ–π –≤–∞–∫—Ü–∏–Ω—ã –ø—Ä–æ—Ç–∏–≤ –¥–∏—Ñ—Ç–µ—Ä–∏–∏, —Å—Ç–æ–ª–±–Ω—è–∫–∞ –∏ –∫–æ–∫–ª—é—à–∞. –î–∞–Ω–Ω—ã–º –Ω–∞—à–ª–∏ –ø–æ–∫—É–ø–∞—Ç–µ–ª—è ¬´–ì—Ä—É–ø–ø–∞ –†–µ–º–µ–¥–∏—É–º¬ª –¥–æ–≥–æ–≤–æ—Ä–∏–ª–∞—Å—å –æ –ø—Ä–∏–æ–±—Ä–µ—Ç–µ–Ω–∏–∏ —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –ø–æ–¥—Ä–∞–∑–¥–µ–ª–µ–Ω–∏—è –∫–æ–º–ø–∞–Ω–∏–∏ IQVIA, —É–∑–Ω–∞–ª ¬´–§–í¬ª. –ò–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª–∏ –Ω–µ—Å–∫–æ–ª—å–∫–æ –∏—Å—Ç–æ—á–Ω–∏–∫–æ–≤. –°–¥–µ–ª–∫–∞ –≤—Å—Ç—É–ø–∏—Ç –≤ —Å–∏–ª—É –ø–æ—Å–ª–µ –ø–æ–ª—É—á–µ–Ω–∏—è –æ–¥–æ–±—Ä–µ–Ω–∏—è –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–µ–Ω–Ω–æ–π –∫–æ–º–∏—Å—Å–∏–µ–π. –ü–æ–¥–æ–∑—Ä–∏—Ç–µ–ª—å–Ω—ã–π –≤–æ–∑–≤—Ä–∞—Ç –†—è–¥ –∞–ø—Ç–µ—á–Ω—ã—Ö —Å–µ—Ç–µ–π –Ω–∞–ø—Ä–∞–≤–∏–ª–∏ –ø–∏—Å—å–º–∞ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º —Å –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏–µ–º, —á—Ç–æ –∏—Ö —É—á–∞—Å—Ç–∏–µ –≤ –ø—Ä–æ–≥—Ä–∞–º–º–∞—Ö –∫–µ—à–±—ç–∫–∞ –º–æ–∂–µ—Ç –ø—Ä–∏–≤–µ—Å—Ç–∏ –∫ —Ä–∞–∑—Ä—ã–≤—É –æ—Ç–Ω–æ—à–µ–Ω–∏–π. –ò–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç–æ–º —Å—Ç–∞–ª–∏ –ø–æ–ª—å–∑–æ–≤–∞—Ç—å—Å—è –ø–µ—Ä–≤–æ—Å—Ç–æ–ª—å–Ω–∏–∫–∏, –ø–æ–ª—É—á–∞—è –≤—ã–ø–ª–∞—Ç—ã –∑–∞ —Ç—Ä–∞–Ω–∑–∞–∫—Ü–∏–∏ –ø–æ–∫—É–ø–∞—Ç–µ–ª–µ–π. ¬´–§–í —É–∑–Ω–∞–ª –ø–æ–∑–∏—Ü–∏—é –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π.","{
  ""skip"": true
}"
2025-07-03T14:02:04+00:00,@medpharm,12337,https://t.me/medpharm/12337,"#–≠–∫—Å–∫–ª—é–∑–∏–≤ –†–∞—Å—Ö–æ–¥—ã —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö —Ä–µ–≥–∏–æ–Ω–æ–≤ –Ω–∞ –±–æ—Ä—å–±—É —Å —Ä–∞–∫–æ–º —Ä–∞–∑–ª–∏—á–∞—é—Ç—Å—è –±–æ–ª–µ–µ —á–µ–º –≤ –¥–µ—Å—è—Ç—å —Ä–∞–∑, –ø–æ–¥—Å—á–∏—Ç–∞–ª–∏ –≤–æ –í—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–æ–º —Å–æ—é–∑–µ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –ú–µ–Ω—å—à–µ –≤—Å–µ–≥–æ —Å—Ä–µ–¥—Å—Ç–≤ –∏–∑ –±—é–¥–∂–µ—Ç–∞ –≤ —Ä–∞—Å—á–µ—Ç–µ –Ω–∞ –ª–µ—á–µ–Ω–∏–µ –æ–¥–Ω–æ–≥–æ –ø–∞—Ü–∏–µ–Ω—Ç–∞ –ø–æ–ª—É—á–∏–ª–∏ –ü–µ–Ω–∑–µ–Ω—Å–∫–∞—è –∏ –ö—É—Ä—Å–∫–∞—è –æ–±–ª–∞—Å—Ç–∏, –±–æ–ª—å—à–µ –≤—Å–µ–≥–æ ‚Äì –Ø–ù–ê–û –∏ –ö–∞–ª—É–∂—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å. –í –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –≤–∏–¥—è—Ç —Ç–µ–Ω–¥–µ–Ω—Ü–∏—é –∫ —Å–Ω–∏–∂–µ–Ω–∏—é –ø–ª–∞–Ω–∏—Ä—É–µ–º–æ–≥–æ —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""Regional expenditures on cancer treatment in Russia vary more than tenfold, as counted by the All-Russian Patients Union. Less funding per patient is allocated to Penza and Kursk regions, while more is provided in Yamalo-Nenets Autonomous Okrug and Kaluga region. Organizations observe a trend of reduced planned funding.""
}"
2025-07-03T13:02:18+00:00,@medpharm,12336,https://t.me/medpharm/12336,"–í –û–º—Å–∫–µ –Ω–∞—á–∞–ª–∏ –ø–æ–∏—Å–∫ –ø–æ–¥—Ä—è–¥—á–∏–∫–∞ –¥–ª—è —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –¥–µ—Ç—Å–∫–æ–≥–æ –∏–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω–æ–≥–æ —Å—Ç–∞—Ü–∏–æ–Ω–∞—Ä–∞ –Ω–∞ 300 –∫–æ–µ–∫ —Å –Ω–∞—á–∞–ª—å–Ω–æ–π –º–∞–∫—Å–∏–º–∞–ª—å–Ω–æ–π —Ü–µ–Ω–æ–π –∫–æ–Ω—Ç—Ä–∞–∫—Ç–∞ 4,3 –º–ª—Ä–¥ —Ä—É–±. –†–∞–Ω–µ–µ –±–µ–∑ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è —Ç–µ–Ω–¥–µ—Ä–∞ –∑–∞—Å—Ç—Ä–æ–π—â–∏–∫–æ–º –±—ã–ª–∞ –≤—ã–±—Ä–∞–Ω–∞ —Å—Ç—Ä–æ–∏—Ç–µ–ª—å–Ω–∞—è –∫–æ–º–ø–∞–Ω–∏—è –ú–∏–Ω–æ–±–æ—Ä–æ–Ω—ã.","{""skip"": true}"
2025-07-03T11:30:01+00:00,@medpharm,12335,https://t.me/medpharm/12335,"#–≠–∫—Å–∫–ª—é–∑–∏–≤ ¬´–ì—Ä—É–ø–ø–∞ –†–µ–º–µ–¥–∏—É–º¬ª –¥–æ–≥–æ–≤–æ—Ä–∏–ª–∞—Å—å –æ –ø—Ä–∏–æ–±—Ä–µ—Ç–µ–Ω–∏–∏ —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –ø–æ–¥—Ä–∞–∑–¥–µ–ª–µ–Ω–∏—è –∫–æ–º–ø–∞–Ω–∏–∏ IQVIA, —É–∑–Ω–∞–ª ¬´–§–í¬ª. –ò–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª–∏ –Ω–µ—Å–∫–æ–ª—å–∫–æ –∏—Å—Ç–æ—á–Ω–∏–∫–æ–≤. –°–¥–µ–ª–∫–∞ –≤—Å—Ç—É–ø–∏—Ç –≤ —Å–∏–ª—É –ø–æ—Å–ª–µ –ø–æ–ª—É—á–µ–Ω–∏—è –æ–¥–æ–±—Ä–µ–Ω–∏—è –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–µ–Ω–Ω–æ–π –∫–æ–º–∏—Å—Å–∏–µ–π, –∫–æ—Ç–æ—Ä–∞—è —É—Ç–≤–µ—Ä–∂–¥–∞–µ—Ç —É—Å–ª–æ–≤–∏—è –ø–æ –≤—Å–µ–º —Å–¥–µ–ª–∫–∞–º —Å —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–∏–∫–∞–º–∏ –∏–∑ –Ω–µ–¥—Ä—É–∂–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ç—Ä–∞–Ω.","{""skip"": true}"
2025-07-03T11:11:33+00:00,@medpharm,12334,https://t.me/medpharm/12334,"–ê–ø—Ç–µ—á–Ω—ã–µ —Å–µ—Ç–∏ –æ–±—ä–µ–¥–∏–Ω—è—é—Ç—Å—è –≤ –±–æ—Ä—å–±–µ —Å —Å–µ—Ä–≤–∏—Å–∞–º–∏, –ø—Ä–µ–¥–ª–∞–≥–∞—é—â–∏–º–∏ –∫–µ—à–±—ç–∫ –∫–æ–Ω–µ—á–Ω–æ–º—É –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª—é. –û–± —ç—Ç–æ–º ¬´–§–í¬ª —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏ –Ω–µ—Å–∫–æ–ª—å–∫–æ —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ —Ä—ã–Ω–∫–∞. –ù–∞ –ø—Ä–∞–∫—Ç–∏–∫–µ –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç–æ–º —Å—Ç–∞–ª–∏ –ø–æ–ª—å–∑–æ–≤–∞—Ç—å—Å—è –ø–µ—Ä–≤–æ—Å—Ç–æ–ª—å–Ω–∏–∫–∏, –ø–æ–ª—É—á–∞—è –≤—ã–ø–ª–∞—Ç—ã –∑–∞ —Ç—Ä–∞–Ω–∑–∞–∫—Ü–∏–∏ –ø–æ–∫—É–ø–∞—Ç–µ–ª–µ–π. –ü—Ä–∏ —ç—Ç–æ–º –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–∏ —Å–µ—Ä–≤–∏—Å–∞ —É–≤–µ—Ä—è—é—Ç, —á—Ç–æ —Ç—â–∞—Ç–µ–ª—å–Ω–æ –≤–µ—Ä–∏—Ñ–∏—Ü–∏—Ä—É—é—Ç –ø–æ—Å—Ç—É–ø–∞—é—â–∏–µ –¥–∞–Ω–Ω—ã–µ –∏ –Ω–µ –≤—ã–ø–ª–∞—á–∏–≤–∞—é—Ç –∫–µ—à–±—ç–∫ –ª–æ–∂–Ω—ã–º –∫–ª–∏–µ–Ω—Ç–∞–º. –†—è–¥ —Å–µ—Ç–µ–π –Ω–∞–ø—Ä–∞–≤–∏–ª–∏ –ø–∏—Å—å–º–∞ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º —Å –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏–µ–º, —á—Ç–æ –∏—Ö —É—á–∞—Å—Ç–∏–µ –≤ –ø—Ä–æ–≥—Ä–∞–º–º–∞—Ö –∫–µ—à–±—ç–∫–∞ –º–æ–∂–µ—Ç –ø—Ä–∏–≤–µ—Å—Ç–∏ –∫ —Ä–∞–∑—Ä—ã–≤—É –æ—Ç–Ω–æ—à–µ–Ω–∏–π.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""medium"",
  ""english"": ""Several market participants told 'FV' that major players are using rebate programs offered by service providers to receive payments for transactions. However, representatives of the service claim they carefully verify incoming data and do not pay rebates to false clients. Several networks have sent letters to manufacturers warning that their participation in rebate programs may lead to the termination of relationships.""
}"
2025-07-03T09:16:07+00:00,@medpharm,12333,https://t.me/medpharm/12333,–î–≤–æ–µ —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤ –ø–æ–ª–∏–∫–ª–∏–Ω–∏–∫–∏ –≤ –ò—Ä–∫—É—Ç—Å–∫–µ –ø–æ–ª—É—á–∏–ª–∏ —Ä–∞–Ω–µ–Ω–∏—è. –ù–∞ –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—è –≥–ª–∞–≤–Ω–æ–≥–æ –≤—Ä–∞—á–∞ –∏ —Å–µ–∫—Ä–µ—Ç–∞—Ä—è –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—è –Ω–∞–ø–∞–ª –ø–∞—Ü–∏–µ–Ω—Ç —Å –Ω–æ–∂–æ–º.,"{""skip"": true}"
2025-07-03T07:57:15+00:00,@medpharm,12332,https://t.me/medpharm/12332,"–ù–∞—É—á–Ω–æ-–∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–∏–π –∏–Ω—Å—Ç–∏—Ç—É—Ç —Ç—Ä—É–¥–∞ –æ—Ü–µ–Ω–∏–ª –º–∞—Å—à—Ç–∞–±—ã –∫–∞–¥—Ä–æ–≤–æ–π –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç–∏ –≤ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–µ –∫ 2030 –≥–æ–¥—É. –ù–∞—Ü—Ñ–∞—Ä–º–ø–∞–ª–∞—Ç–∞ –æ–∑–Ω–∞–∫–æ–º–∏–ª–∞—Å—å —Å –¥–∞–Ω–Ω—ã–º–∏ –∏ –Ω–µ —Å–æ–≥–ª–∞—Å–∏–ª–∞—Å—å —Å —Ü–∏—Ñ—Ä–∞–º–∏, –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–≤ —Å–≤–æ–∏. –í –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—ã—Ö —Å–æ—é–∑–∞—Ö —Å—Ç–∞–≤—è—Ç –ø–æ–¥ —Å–æ–º–Ω–µ–Ω–∏–µ –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω—ã–µ –ø—Ä–æ–≥–Ω–æ–∑—ã –∏–∑-–∑–∞ –º–µ—Ç–æ–¥–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –ø—Ä–æ–±–ª–µ–º: –æ—Ç—Å—É—Ç—Å—Ç–≤–∏—è –¥–æ—Å—Ç–æ–≤–µ—Ä–Ω–æ–π –∫–∞—Ä—Ç–∏–Ω—ã –∏–∑-–∑–∞ –æ–±—ä–µ–¥–∏–Ω–µ–Ω–∏—è –¥–∞–Ω–Ω—ã—Ö –ø–æ –∞–ø—Ç–µ–∫–∞–º –∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤—É, –∞ —Ç–∞–∫–∂–µ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏—è –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –∏–∑ –§–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ —Ä–µ–≥–∏—Å—Ç—Ä–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The Scientific Institute of Labor evaluated the scale of human resource needs in pharmaceuticals by 2030. The National Pharmacy Chamber reviewed the data and disagreed with the figures, presenting their own. Professional unions doubt official forecasts due to methodological issues: lack of a clear picture due to the merging of data from pharmacies and production, as well as the absence of information from the Federal Register of Medical and Pharmaceutical Workers.""
}"
2025-07-03T07:01:45+00:00,@medpharm,12331,https://t.me/medpharm/12331,"–ù–µ—Å–º–æ—Ç—Ä—è –Ω–∞ –ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω—É—é –¥–∏–Ω–∞–º–∏–∫—É, –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –≤ —Ä–∞–º–∫–∞—Ö —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –ø—Ä–æ–µ–∫—Ç–∞ ¬´–û–ø—Ç–∏–º–∞–ª—å–Ω–∞—è –¥–ª—è –≤–æ—Å—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è –∑–¥–æ—Ä–æ–≤—å—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è —Ä–µ–∞–±–∏–ª–∏—Ç–∞—Ü–∏—è¬ª –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–∞. –ß–∞—Å—Ç—å –∑–∞–∫—É–ø–ª–µ–Ω–Ω–æ–≥–æ —Ä–µ–∞–±–∏–ª–∏—Ç–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –≤ —Ä—è–¥–µ —Ä–µ–≥–∏–æ–Ω–æ–≤ –ø—Ä–æ—Å—Ç–∞–∏–≤–∞–ª–∞ –∏–∑-–∑–∞ –¥–µ—Ñ–∏—Ü–∏—Ç–∞ –∫–≤–∞–ª–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω–æ–≥–æ –ø–µ—Ä—Å–æ–Ω–∞–ª–∞ –∏–ª–∏ –Ω–µ–ø–æ–ª–Ω–æ–π –∑–∞–≥—Ä—É–∑–∫–∏ –∫–æ–µ—á–Ω–æ–≥–æ —Ñ–æ–Ω–¥–∞, —Å–æ–æ–±—â–∏–ª–∏ –≤ –°—á–µ—Ç–Ω–æ–π –ø–∞–ª–∞—Ç–µ.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage,hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""Despite a positive trend, the accessibility of medical assistance under the federal project 'Optimal Health Rehabilitation' is insufficient. Some purchased rehabilitation equipment was idle in several regions due to a shortage of qualified personnel or underutilization of bed capacity, according to the Audit Chamber.""
}"
2025-07-02T16:01:01+00:00,@medpharm,12330,https://t.me/medpharm/12330,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 2 –∏—é–ª—è –ö–∞–∂–¥—ã–π –±–ª–∏—Å—Ç–µ—Ä –í –ú–î–õ–ü –±—É–¥–µ—Ç —Ä–µ—à–µ–Ω –≤–æ–ø—Ä–æ—Å –¥—Ä–æ–±–Ω–æ–≥–æ –≤—ã–±—ã—Ç–∏—è —É–ø–∞–∫–æ–≤–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤, –æ —á–µ–º –Ω–µ–æ–¥–Ω–æ–∫—Ä–∞—Ç–Ω–æ –ø—Ä–æ—Å–∏–ª–∏ —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏. –¢–µ–ø–µ—Ä—å –µ—Å–ª–∏ —É–ø–∞–∫–æ–≤–∫–∞ —Ä–µ–∞–ª–∏–∑—É–µ—Ç—Å—è –Ω–µ —Ü–µ–ª–∏–∫–æ–º (–∞, –Ω–∞–ø—Ä–∏–º–µ—Ä, –ø–æ–±–ª–∏—Å—Ç–µ—Ä–Ω–æ), –≤ —Å–∏—Å—Ç–µ–º–µ –±—É–¥–µ—Ç –≤–∏–¥–Ω–æ, –∫–∞–∫–∞—è –µ–µ –¥–æ–ª—è –ø—Ä–æ–¥–∞–Ω–∞. –ë–µ–∑ –¥–æ–ª–∂–Ω–æ—Å—Ç–∏ –∏ –∏–º—É—â–µ—Å—Ç–≤–∞ –í—Å—Ç—É–ø–∏–ª–æ –≤ —Å–∏–ª—É —Ä–µ—à–µ–Ω–∏–µ —Å—É–¥–∞ –æ –Ω–∞–ª–æ–∂–µ–Ω–∏–∏ –∞—Ä–µ—Å—Ç–∞ –Ω–∞ –∏–º—É—â–µ—Å—Ç–≤–æ —á–∏–Ω–æ–≤–Ω–∏–∫–∞ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–æ—Å—Å–∏–∏ –ê–ª–µ–∫—Å–µ—è –°–∞–∑–æ–Ω–æ–≤–∞, –∫–æ—Ç–æ—Ä–æ–≥–æ –ø–æ–¥–æ–∑—Ä–µ–≤–∞—é—Ç –≤ –ø–æ–ª—É—á–µ–Ω–∏–∏ –≤–∑—è—Ç–∫–∏ –æ—Ç ¬´–î–∂–æ–¥–∞—Å –≠–∫—Å–ø–æ–∏–º¬ª. –ù–∞ —Å–∞–π—Ç–µ –º–∏–Ω–∏—Å—Ç–µ—Ä—Å—Ç–≤–∞ –∏–º—è —á–∏–Ω–æ–≤–Ω–∏–∫–∞ –∏—Å—á–µ–∑–ª–æ, –æ–±—Ä–∞—Ç–∏–ª –≤–Ω–∏–º–∞–Ω–∏–µ ¬´–§–í¬ª. –ê—Ñ–µ—Ä–∞ –≤–µ–∫–∞ –í –°–®–ê –º–æ—à–µ–Ω–Ω–∏–∫–∏ (96 –∏–∑ –Ω–∏—Ö ‚Äî –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–∏ –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç—ã) –ø–æ—Ö–∏—Ç–∏–ª–∏ –¥–∞–Ω–Ω—ã–µ –±–æ–ª–µ–µ 1 –º–ª–Ω –∞–º–µ—Ä–∏–∫–∞–Ω—Ü–µ–≤ –∏–∑ –≤—Å–µ—Ö 50 —à—Ç–∞—Ç–æ–≤ –¥–ª—è —Ñ–∏–∫—Ç–∏–≤–Ω—ã—Ö –∑–∞–∫—É–ø–æ–∫ –º–µ–¥–∏–∑–¥–µ–ª–∏–π –∏ –æ–ø–ª–∞—Ç—ã –Ω–µ–Ω—É–∂–Ω—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –ø—Ä–æ—Ü–µ–¥—É—Ä. –û–Ω–∏ –ø–ª–∞–Ω–∏—Ä–æ–≤–∞–ª–∏ –ø–æ—Ö–∏—Ç–∏—Ç—å 14,6 –º–ª—Ä–¥ –¥–æ–ª–ª., —á—Ç–æ –¥–µ–ª–∞–µ—Ç —Å—Ö–µ–º—É –∫—Ä—É–ø–Ω–µ–π—à–µ–π –≤ –∏—Å—Ç–æ—Ä–∏–∏ –º–æ—à–µ–Ω–Ω–∏—á–µ—Å—Ç–≤–∞ –≤ —Å–∏—Å—Ç–µ–º–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è —Å—Ç—Ä–∞–Ω—ã. –£–ø–∞–¥–æ–∫ —Å–∞–Ω–∞—Ç–æ—Ä–∏–µ–≤ –í –ú–∏–Ω–∑–¥—Ä–∞–≤–µ —Å–æ–æ–±—â–∏–ª–∏ –æ —Å–æ–∫—Ä–∞—â–µ–Ω–∏–∏ –≤ –†–æ—Å—Å–∏–∏ —á–∏—Å–ª–∞ —Å–∞–Ω–∞—Ç–æ—Ä–Ω–æ-–∫—É—Ä–æ—Ä—Ç–Ω—ã—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π. –≠—Ç–æ –º–æ–∂–µ—Ç –±—ã—Ç—å —Å–≤—è–∑–∞–Ω–æ —Å —Ä–µ–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–µ–π, –ª–∏–∫–≤–∏–¥–∞—Ü–∏–µ–π –∏–ª–∏ –ø–µ—Ä–µ—Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–µ–π —é—Ä–ª–∏—Ü–∞ –¥–ª—è –æ–∫–∞–∑–∞–Ω–∏—è —É—Å–ª—É–≥ —Å —Ü–µ–ª—å—é –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π —Ä–µ–∞–±–∏–ª–∏—Ç–∞—Ü–∏–∏.","{""skip"": true}"
2025-07-02T15:00:12+00:00,@medpharm,12329,https://t.me/medpharm/12329,"–ù–æ–≤—É—é –≤–∞–∫—Ü–∏–Ω—É –æ—Ç –±–µ—à–µ–Ω—Å—Ç–≤–∞ —Å –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ –∞–¥–µ–Ω–æ–≤–∏—Ä—É—Å–Ω—ã—Ö –≤–µ–∫—Ç–æ—Ä–æ–≤ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –¶–µ–Ω—Ç—Ä –∏–º. –ì–∞–º–∞–ª–µ–∏. ¬´–ì–∞–º–†–∞–±–∏–í–∞–∫¬ª –ø–ª–∞–Ω–∏—Ä—É—é—Ç –≤–≤–æ–¥–∏—Ç—å –æ–¥–Ω–æ–∫—Ä–∞—Ç–Ω–æ, –≤ –æ—Ç–ª–∏—á–∏–µ –æ—Ç –∏–Ω–∞–∫—Ç–∏–≤–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –≤–∞–∫—Ü–∏–Ω, —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω–æ –ø—Ä–∏–º–µ–Ω—è–µ–º—ã—Ö –¥–ª—è –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –∏–Ω—Ñ–µ–∫—Ü–∏–∏.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, clinical_trial, vaccine"",
  ""impact"": ""high"",
  ""english"": ""The Gamaleya Research Institute has developed a new rabies vaccine using adenovirus vectors. It plans to administer it once, unlike the traditionally used inactivated vaccines for infection prevention.""
}"
2025-07-02T14:10:36+00:00,@medpharm,12328,https://t.me/medpharm/12328,"–ö–æ–ª–ª–µ–≥–∏, –≤—Å–µ–º –¥–æ–±—Ä–æ–≥–æ –¥–Ω—è! –ü—Ä–æ–¥—é—Å–µ—Ä –Ω–∞—à–µ–π –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ ¬´PRO–µ–∫—Ü–∏–∏ –ë—É–¥—É—â–µ–≥–æ¬ª, –û–ª—å–≥–∞ –ö–æ–±–µ—Ä–Ω–∏–∫, –ø—Ä–∏–≥–ª–∞—à–∞–µ—Ç –ø—Ä–∏—Å–æ–µ–¥–∏–Ω–∏—Ç—å—Å—è –∫ –Ω–∞–º –≤ —Å–µ–Ω—Ç—è–±—Ä–µ –Ω–∞ –ø–æ–±–µ—Ä–µ–∂—å–µ –≤ –°–æ—á–∏ ‚Äî 11‚Äì12 —Å–µ–Ω—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞. –ü–µ—Ä–µ—Ö–æ–¥–∏—Ç–µ –Ω–∞ —Å–∞–π—Ç –∏ —Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä—É–π—Ç–µ—Å—å ‚Äî –ª—É—á—à–∏–µ —Ü–µ–Ω—ã –¥–æ 31 –∏—é–ª—è!","{""skip"": true}"
2025-07-02T13:05:21+00:00,@medpharm,12324,https://t.me/medpharm/12324,–ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ –Ω–∞–º–µ—Ä–µ–Ω —É—Ç–≤–µ—Ä–¥–∏—Ç—å –ü—Ä–∞–≤–∏–ª–∞ –¥–æ–±—Ä–æ–≤–æ–ª—å–Ω–æ–≥–æ –≤–Ω–µ—Å–µ–Ω–∏—è –¥–∞–Ω–Ω—ã—Ö –≤ —Å–∏—Å—Ç–µ–º—É –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥–∞ –¥–ª—è –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏—è —Å—Ç—Ä–∞–Ω—ã –ø—Ä–æ–∏—Å—Ö–æ–∂–¥–µ–Ω–∏—è –º–∞—Ä–∫–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤. –ü—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –∏ —É—á–∞—Å—Ç–Ω–∏–∫–∏ –æ–±–æ—Ä–æ—Ç–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ –º–æ–≥—É—Ç –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞—Ç—å—Å—è –≤ —Å–∏—Å—Ç–µ–º–µ –¥–æ 1 —Å–µ–Ω—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞ –∏ –ø–µ—Ä–µ–¥–∞–≤–∞—Ç—å –¥–∞–Ω–Ω—ã–µ –≤ —Ä–µ–∂–∏–º–µ —Ä–µ–∞–ª—å–Ω–æ–≥–æ –≤—Ä–µ–º–µ–Ω–∏.,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Industry and Trade plans to approve Voluntary Data Entry Rules into a monitoring system for confirming the origin of marked medicines. Manufacturers and participants in the medicine trade can register in the system by September 1, 2025 and submit data in real-time.""
}"
2025-07-02T12:01:40+00:00,@medpharm,12323,https://t.me/medpharm/12323,"–†–æ—Å—Å–∏–π—Å–∫–∏–µ —É—á–µ–Ω—ã–µ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª–∏ –≤—ã—Å–æ–∫–æ—Ç–æ—á–Ω—ã–π —Å–µ–Ω—Å–æ—Ä –Ω–∞ –æ—Å–Ω–æ–≤–µ –æ–∫—Å–∏–¥–∞ –≥—Ä–∞—Ñ–µ–Ω–∞ –∏ –ø–æ–ª–∏–º–µ—Ä–Ω–æ–≥–æ –∫—Ä–∞—Å–∏—Ç–µ–ª—è, –ø–æ–∑–≤–æ–ª—è—é—â–∏–π –æ–ø—Ä–µ–¥–µ–ª—è—Ç—å —Å–æ–¥–µ—Ä–∂–∞–Ω–∏–µ –∞–Ω—Ç—Ä–∞—Ü–∏–∫–ª–∏–Ω–æ–≤—ã—Ö –ø—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –æ–±—Ä–∞–∑—Ü–∞—Ö. –õ–µ–∫–∞—Ä—Å—Ç–≤–∞ —ç—Ç–æ–≥–æ —Ç–∏–ø–∞ —à–∏—Ä–æ–∫–æ –ø—Ä–∏–º–µ–Ω—è—é—Ç—Å—è –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Ä–∞–∫–∞ –∫—Ä–æ–≤–∏, –∫–æ–∂–∏ –∏ –Ω–æ–≤–æ–æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–π –≤ —Å–æ–µ–¥–∏–Ω–∏—Ç–µ–ª—å–Ω–æ–π —Ç–∫–∞–Ω–∏, –Ω–æ –∏—Ö –¥–æ–∑–∏—Ä–æ–≤–∫—É –Ω—É–∂–Ω–æ —Å—Ç—Ä–æ–≥–æ –∫–æ–Ω—Ç—Ä–æ–ª–∏—Ä–æ–≤–∞—Ç—å.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""clinical_trial, pharmacovigilance"",
  ""impact"": ""medium"",
  ""english"": ""Russian scientists developed a highly accurate sensor based on graphene oxide and a polymer dye for detecting the content of anthracycline anticancer drugs in biological samples. These types of medications are widely used for treating blood, skin, and connective tissue cancers but their dosing must be strictly controlled.""
}"
2025-07-02T11:00:03+00:00,@medpharm,12322,https://t.me/medpharm/12322,"–í—Å—Ç—É–ø–∏–ª–æ –≤ —Å–∏–ª—É —Ä–µ—à–µ–Ω–∏–µ —Å—É–¥–∞ –æ –Ω–∞–ª–æ–∂–µ–Ω–∏–∏ –∞—Ä–µ—Å—Ç–∞ –Ω–∞ –∏–º—É—â–µ—Å—Ç–≤–æ –Ω–∞—á–∞–ª—å–Ω–∏–∫–∞ –æ—Ç–¥–µ–ª–∞ –î–µ–ø–∞—Ä—Ç–∞–º–µ–Ω—Ç–∞ —Ä–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω–∏—è –æ–±—Ä–∞—â–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤ –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–æ—Å—Å–∏–∏ –ê–ª–µ–∫—Å–µ—è –°–∞–∑–æ–Ω–æ–≤–∞. –ß–∏–Ω–æ–≤–Ω–∏–∫ –Ω–∞—Ö–æ–¥–∏—Ç—Å—è –ø–æ–¥ –¥–æ–º–∞—à–Ω–∏–º –∞—Ä–µ—Å—Ç–æ–º –≤ —Å–≤—è–∑–∏ —Å —Ä–∞—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ–º —É–≥–æ–ª–æ–≤–Ω–æ–≥–æ –¥–µ–ª–∞ –æ –ø–æ–ª—É—á–µ–Ω–∏–∏ –≤–∑—è—Ç–∫–∏ –≤ –æ—Å–æ–±–æ –∫—Ä—É–ø–Ω–æ–º —Ä–∞–∑–º–µ—Ä–µ. –ù–∞ —Å–∞–π—Ç–µ –º–∏–Ω–∏—Å—Ç–µ—Ä—Å—Ç–≤–∞ –µ–≥–æ –∏–º—è –∏—Å—á–µ–∑–ª–æ, –æ–±—Ä–∞—Ç–∏–ª –≤–Ω–∏–º–∞–Ω–∏–µ ¬´–§–í¬ª.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""sanctions"",
  ""impact"": ""high"",
  ""english"": ""A decision has been enforced to freeze the assets of Deputy Director Alexey Sazonov from the Department for Regulation of Medicines and Medical Devices in Russia's Ministry of Health. He is under home arrest due to an investigation into a case of taking a bribe in a large amount. His name has been removed from the ministry's website, noted by 'FV'.""
}"
2025-07-02T09:12:08+00:00,@medpharm,12321,https://t.me/medpharm/12321,–ü–æ–ª–∏—Ü–∏—è –≤ –ü—Ä–∏–º–æ—Ä—å–µ –≤—Å–∫—Ä—ã–ª–∞ –ø—Ä–æ—Ç–∏–≤–æ–ø—Ä–∞–≤–Ω—É—é —Å—Ö–µ–º—É –Ω–µ–∑–∞–∫–æ–Ω–Ω–æ–≥–æ –æ–±–æ–≥–∞—â–µ–Ω–∏—è —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—è. –ó–∞ —á–µ—Ç—ã—Ä–µ –≥–æ–¥–∞ –∏–º–∏ –±—ã–ª–æ –ø–æ—Ö–∏—â–µ–Ω–æ 46 –º–ª–Ω —Ä—É–±. –±—é–¥–∂–µ—Ç–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤.,"{""skip"": true}"
2025-07-02T08:00:22+00:00,@medpharm,12320,https://t.me/medpharm/12320,"–ú–∏–Ω—Ç—Ä—É–¥ –Ω–∞–º–µ—Ä–µ–Ω –æ–±–Ω–æ–≤–∏—Ç—å –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç, –ø–æ –∫–æ—Ç–æ—Ä–æ–º—É —Ä–∞—Å—Å—á–∏—Ç—ã–≤–∞—é—Ç—Å—è —Å—Ç—Ä–∞—Ö–æ–≤—ã–µ —Ç–∞—Ä–∏—Ñ—ã –Ω–∞ –ø—Ä–æ—Ñ–∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è –≤ 2026‚Äì2028 –≥–æ–¥–∞—Ö. –î–æ–∫—É–º–µ–Ω—Ç–æ–º –ø—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ–Ω–æ —Å–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ 32 —Ç–∞—Ä–∏—Ñ–Ω—ã—Ö —Å—Ç–∞–≤–æ–∫ (–æ—Ç 0,2 –¥–æ 8,5%) –≤ –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏ –æ—Ç –∫–ª–∞—Å—Å–∞ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ —Ä–∏—Å–∫–∞. –ü—Ä–∏ —ç—Ç–æ–º —Å—Ä–µ–¥–Ω–∏–π —Ç–∞—Ä–∏—Ñ –ø–æ –≤—Å–µ–º –æ—Ç—Ä–∞—Å–ª—è–º —Å–æ—Å—Ç–∞–≤–∏—Ç 0,54%.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""reimbursement, regulation"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Labor intends to update the project on how to calculate insurance premiums for occupational diseases from 2026-2028. The document includes the preservation of 32 tariff rates (from 0.2% to 8.5%) depending on the class of occupational risk. The average premium rate for all industries will be 0.54%.""
}"
2025-07-02T07:00:01+00:00,@medpharm,12318,https://t.me/medpharm/12318,"–ñ–µ–Ω—â–∏–Ω—ã, –ø–µ—Ä–µ–Ω–µ—Å—à–∏–µ –æ—Å–ª–æ–∂–Ω–µ–Ω–∏—è –≤–æ –≤—Ä–µ–º—è –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏, –ø–æ–¥–≤–µ—Ä–∂–µ–Ω—ã –±–æ–ª–µ–µ –≤—ã—Å–æ–∫–æ–º—É —Ä–∏—Å–∫—É –∏–Ω—Å—É–ª—å—Ç–∞ –¥–∞–∂–µ —Å–ø—É—Å—Ç—è –¥–µ—Å—è—Ç–∫–∏ –ª–µ—Ç –ø–æ—Å–ª–µ —Ä–æ–¥–æ–≤. –û—Å–æ–±–µ–Ω–Ω–æ –∑–Ω–∞—á–∏–º—ã–º–∏ –ø—Ä–µ–¥–∏–∫—Ç–æ—Ä–∞–º–∏ —Ä–∞–∑–≤–∏—Ç–∏—è –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è –æ–∫–∞–∑–∞–ª–∏—Å—å –≥–∏–ø–µ—Ä—Ç–µ–Ω–∑–∏—è –±–µ—Ä–µ–º–µ–Ω–Ω—ã—Ö, –≥–µ—Å—Ç–∞—Ü–∏–æ–Ω–Ω—ã–π –¥–∏–∞–±–µ—Ç, –ø—Ä–µ–∂–¥–µ–≤—Ä–µ–º–µ–Ω–Ω—ã–µ —Ä–æ–¥—ã –∏ –Ω–∏–∑–∫–∞—è –º–∞—Å—Å–∞ —Ç–µ–ª–∞ –ø—Ä–∏ —Ä–æ–∂–¥–µ–Ω–∏–∏.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,hospital_policy,pharmacovigilance,safety"",
  ""impact"": ""high"",
  ""english"": ""Women who experienced complications during pregnancy are at a higher risk of stroke decades after childbirth. Key predictors include hypertension in pregnancy, gestational diabetes, preterm births, and low birth weight.""
}"
2025-07-01T16:31:28+00:00,@medpharm,12317,https://t.me/medpharm/12317,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 1 –∏—é–ª—è –ü—Ä–æ–±–ª–µ–º—ã —Å —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–µ–π –ú–∏–Ω–∑–¥—Ä–∞–≤ –ø–ª–∞–Ω–∏—Ä—É–µ—Ç –æ—Ç–ª–æ–∂–∏—Ç—å —Å—Ä–æ–∫ –≤—Å—Ç—É–ø–ª–µ–Ω–∏—è –≤ —Å–∏–ª—É –æ—Ç–¥–µ–ª—å–Ω—ã—Ö –ø—É–Ω–∫—Ç–æ–≤ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è ‚Ññ 1684 –æ—Ç 30.11.2024 –æ –Ω–æ–≤—ã—Ö –ø—Ä–∞–≤–∏–ª–∞—Ö –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π –µ—â–µ –Ω–∞ –≥–æ–¥. –ü–æ–º–æ–≥—É—Ç —Å –Ω–∞—Å—Ç—Ä–æ–π–∫–∞–º–∏ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –ø—Ä–∞–≤–∏–ª–∞ –∞–≤—Ç–æ–º–∞—Ç–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω–æ–π –ø–µ—Ä–µ–¥–∞—á–∏ –¥–∞–Ω–Ω—ã—Ö –æ —Ä–∞–±–æ—Ç–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π —Å –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω—ã–º –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–æ–º. –í —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, —Å–ª—É–∂–±—É –∏–Ω—Ç–µ—Ä–µ—Å—É–µ—Ç –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è –æ–± –æ—à–∏–±–∫–∞—Ö –ø—Ä–∏ —Ä–∞–±–æ—Ç–µ —Ç–∞–∫–∏—Ö –ø—Ä–æ–≥—Ä–∞–º–º. –°—ã—Ä—å–µ –ø–æ –æ—Å–µ–Ω–∏ —Å—á–∏—Ç–∞—é—Ç –°—Ä–æ–∫ –æ–∫–æ–Ω—á–∞–Ω–∏—è —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–∞ –ø–æ –ø—Ä–æ—Å–ª–µ–∂–∏–≤–∞–µ–º–æ—Å—Ç–∏ —Ñ–∞—Ä–º—É—Å–±—Å—Ç–∞–Ω—Ü–∏–π –ø—Ä–æ–¥–ª–∏–ª–∏ –¥–æ 31 –∞–≤–≥—É—Å—Ç–∞. –ü—Ä–µ–¥–ø–æ–ª–∞–≥–∞–ª–æ—Å—å, —á—Ç–æ —Å–∏—Å—Ç–µ–º–∞ –∑–∞—Ä–∞–±–æ—Ç–∞–µ—Ç –≤–º–µ—Å—Ç–µ —Å –∑–∞–ø—É—Å–∫–æ–º –º–µ—Ö–∞–Ω–∏–∑–º–∞ ¬´–≤—Ç–æ—Ä–æ–π –ª–∏—à–Ω–∏–π¬ª. –°–ª–æ–∂–∏—Ç—å –≤ –∫–æ—Ä–∑–∏–Ω—É –†–æ—Å—Å–∏—è–Ω–µ —Å—Ç–∞–ª–∏ –ª—É—á—à–µ –æ—Ç–Ω–æ—Å–∏—Ç—å—Å—è –∫ –ø–æ–∫—É–ø–∫–µ –ª–µ–∫–∞—Ä—Å—Ç–≤ –Ω–∞ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞—Ö (+29%). –ì–∞—Ä–∞–Ω—Ç–∏—è –ø–æ–¥–ª–∏–Ω–Ω–æ—Å—Ç–∏ —Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ø—Ä–∏ —ç—Ç–æ–º –≤–∞–∂–Ω–∞ 39% –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö. –ö—Ç–æ —Å—Ç–∞–ª –ª–∏–¥–µ—Ä–æ–º —Å—Ä–µ–¥–∏ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–æ–≤, –∏—Å–ø–æ–ª—å–∑—É–µ–º—ã—Ö –¥–ª—è –ø–æ–∫—É–ø–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤?","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""Russia is delaying the implementation of certain provisions in government regulation ‚Ññ1684 from November 30, 2024 on new rules for the registration of medical devices. The Health Ministry plans to postpone this by a year. The service is interested in information about errors in the operation of such programs. A deadline for a trial to track pharmaceutical supply chains has been extended until August 31. The survey shows that Russians are becoming more willing to buy medicines on marketplaces (+29%). However, the guarantee of authenticity for prescription drugs is still important to 39% of respondents. Which marketplace became the leader in purchasing medicines?""
}"
2025-07-01T15:00:56+00:00,@medpharm,12316,https://t.me/medpharm/12316,"#–≠–∫—Å–∫–ª—é–∑–∏–≤ –§–ê–° —Ä–∞–∑—ä—è—Å–Ω–∏–ª–∞, –ø–æ—á–µ–º—É –Ω–∞ –∫–ª–∏–ø ¬´–õ–µ–Ω–∏–Ω–≥—Ä–∞–¥–∞¬ª –∏ –ó–æ–∏ ¬´–¢–∏—Ä–∑–µ—Ç—Ç–∞¬ª –Ω–µ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω—è—é—Ç—Å—è –ø–æ–ª–æ–∂–µ–Ω–∏—è –§–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –∑–∞–∫–æ–Ω–∞ ¬´–û —Ä–µ–∫–ª–∞–º–µ¬ª.","{""skip"": true}"
2025-07-01T14:01:26+00:00,@medpharm,12315,https://t.me/medpharm/12315,"–≠–∫—Å–ø–µ—Ä—Ç—ã –æ–ø–∞—Å–∞—é—Ç—Å—è —É—Ç–µ—á–∫–∏ –¥–∞–Ω–Ω—ã—Ö –∏–∑ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ —Ä–µ–≥–∏—Å—Ç—Ä–∞ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –∫–æ—Ç–æ—Ä—ã–π –∑–∞—Ä–∞–±–æ—Ç–∞–µ—Ç –≤ 2026 –≥–æ–¥—É. –¢–∞–∫–∂–µ —Ä–æ—Å—Å–∏—è–Ω–µ –º–æ–≥—É—Ç –Ω–∞—á–∞—Ç—å –∏–∑–±–µ–≥–∞—Ç—å –ø—Å–∏—Ö–∏–∞—Ç—Ä–æ–≤ –∏–∑-–∑–∞ —Ç–æ–≥–æ, —á—Ç–æ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è –æ –ø—Ä–∏–µ–º–µ –∏ –¥–∏–∞–≥–Ω–æ–∑–∞—Ö –±—É–¥–µ—Ç –¥–æ—Å—Ç—É–ø–Ω–∞ –ú–í–î.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, safety, pharmacovigilance"",
  ""impact"": ""high"",
  ""english"": ""Experts are concerned about data leaks from the federal patient registry, which will be activated in 2026. Also, Russians may avoid psychiatrists due to the availability of information on treatment and diagnosis by the MVD.""
}"
2025-07-01T13:01:12+00:00,@medpharm,12314,https://t.me/medpharm/12314,"–£–ø—Ä–∞–≤–ª–µ–Ω–∏–µ –ø–æ –∫–æ–Ω—Ç—Ä–æ–ª—é –∑–∞ –ø—Ä–æ–¥—É–∫—Ç–∞–º–∏ –∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏ –°–∞—É–¥–æ–≤—Å–∫–æ–π –ê—Ä–∞–≤–∏–∏ (SFDA) –ø—Ä–∏—Å–≤–æ–∏–ª–æ —Å—Ç–∞—Ç—É—Å –æ—Ä—Ñ–∞–Ω–Ω–æ–≥–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ —Å—Ä–µ–¥—Å—Ç–≤–∞ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–æ–º—É –ø—Ä–µ–ø–∞—Ä–∞—Ç—É —Å –ú–ù–ù –≥–æ—Ñ–ª–∏–∫–∏—Ü–µ–ø—Ç –ø–æ –ø–æ–∫–∞–∑–∞–Ω–∏—é ¬´–∏–¥–∏–æ–ø–∞—Ç–∏—á–µ—Å–∫–∏–π —Ä–µ—Ü–∏–¥–∏–≤–∏—Ä—É—é—â–∏–π –ø–µ—Ä–∏–∫–∞—Ä–¥–∏—Ç¬ª (–ò–†–ü). –≠—Ç–æ –ø–µ—Ä–≤—ã–π —Ä–æ—Å—Å–∏–π—Å–∫–∏–π –ø—Ä–µ–ø–∞—Ä–∞—Ç, –∫–æ—Ç–æ—Ä—ã–π –ø–æ–ª—É—á–∏–ª —Å—Ç–∞—Ç—É—Å –æ—Ä—Ñ–∞–Ω–Ω–æ–≥–æ.","{""skip"": true}"
2025-07-01T11:39:25+00:00,@medpharm,12313,https://t.me/medpharm/12313,–ù–∞–∑–≤–∞–Ω—ã –ø—è—Ç—å —Å–∞–º—ã—Ö –≤—ã–≥–æ–¥–Ω—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ñ—Ä–∞–Ω—à–∏–∑ 2025 –≥–æ–¥–∞ –≤ –†–æ—Å—Å–∏–∏. –í —Å–ø–∏—Å–æ–∫ –ø–æ–ø–∞–ª–∏ —Ç–æ–ª—å–∫–æ –¥–≤–∞ –≤–∏–¥–∞ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π: –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–∏–∏ –∏ –∫–ª–∏–Ω–∏–∫–∏ –∫–∞–ø–µ–ª—å–Ω–∏—Ü.,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""tenders, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""Five most profitable medical franchises in Russia for 2025 are named. Only two types of organizations, laboratories and drip clinics, made the list.""
}"
2025-07-01T10:03:02+00:00,@medpharm,12312,https://t.me/medpharm/12312,"–°—Ç—Ä–∞—Ö–æ–≤—ã–µ –∫–æ–º–ø–∞–Ω–∏–∏, —Ä–∞–±–æ—Ç–∞—é—â–∏–µ –≤ —Å–µ–∫—Ç–æ—Ä–µ –∫–æ—Ä–ø–æ—Ä–∞—Ç–∏–≤–Ω–æ–≥–æ –î–ú–°, —É–∂–µ—Å—Ç–æ—á–∞—é—Ç —Ç–∞—Ä–∏—Ñ–Ω—É—é –ø–æ–ª–∏—Ç–∏–∫—É. –£ –∫–ª–∏–Ω–∏–∫ –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏ –Ω–µ –æ—Å—Ç–∞–ª–æ—Å—å –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–µ–π –ø–æ–¥–¥–µ—Ä–∂–∏–≤–∞—Ç—å –Ω–∏–∑–∫–∏–µ —Ü–µ–Ω—ã –¥–ª—è —Å–≤–æ–∏—Ö –∫–ª–∏–µ–Ω—Ç–æ–≤.","{""skip"": true}"
2025-07-01T09:05:56+00:00,@medpharm,12311,https://t.me/medpharm/12311,"–°—Ä–æ–∫ –æ–∫–æ–Ω—á–∞–Ω–∏—è —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–∞ –ø–æ –ø—Ä–æ—Å–ª–µ–∂–∏–≤–∞–µ–º–æ—Å—Ç–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ —Å—ã—Ä—å—è, –∏—Å–ø–æ–ª—å–∑—É–µ–º–æ–≥–æ –¥–ª—è –∏—Ö –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞, –ø—Ä–æ–¥–ª–∏–ª–∏ –¥–æ 31 –∞–≤–≥—É—Å—Ç–∞. –ü—Ä–µ–¥–ø–æ–ª–∞–≥–∞–ª–æ—Å—å, —á—Ç–æ —Å–∏—Å—Ç–µ–º–∞ –∑–∞—Ä–∞–±–æ—Ç–∞–µ—Ç –≤–º–µ—Å—Ç–µ —Å –∑–∞–ø—É—Å–∫–æ–º –º–µ—Ö–∞–Ω–∏–∑–º–∞ ¬´–≤—Ç–æ—Ä–æ–π –ª–∏—à–Ω–∏–π¬ª.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance"",
  ""impact"": ""medium"",
  ""english"": ""The traceability of medicines and raw materials used in their production has been extended until August 31st. Initially, it was planned to be integrated with the 'second extra' mechanism upon its launch.""
}"
2025-07-01T07:07:32+00:00,@medpharm,12310,https://t.me/medpharm/12310,"#–≠–∫—Å–∫–ª—é–∑–∏–≤ –í –†–æ—Å—Å–∏–∏ –ø–æ—á—Ç–∏ –Ω–∞ —Ç—Ä–µ—Ç—å –≤—ã—Ä–æ—Å–ª–æ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –ø—Ä–∏–∑–Ω–∞–Ω–Ω—ã—Ö —ç–∫—Å–ø–µ—Ä—Ç–∞–º–∏ –æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω—ã–º–∏ –∂–∞–ª–æ–± –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –ø—Ä–∏ –ø–æ–ª—É—á–µ–Ω–∏–∏ –º–µ–¥–ø–æ–º–æ—â–∏ –ø–æ –û–ú–°. –ß–∞—â–µ –≤—Å–µ–≥–æ –∑–∞—Å—Ç—Ä–∞—Ö–æ–≤–∞–Ω–Ω—ã–µ –∂–∞–ª–æ–≤–∞–ª–∏—Å—å –Ω–∞ –Ω–∞—Ä—É—à–µ–Ω–∏—è –ø—Ä–∏ –æ–∫–∞–∑–∞–Ω–∏–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏, –Ω–µ—É–¥–æ–≤–ª–µ—Ç–≤–æ—Ä–∏—Ç–µ–ª—å–Ω—É—é —Ä–∞–±–æ—Ç—É –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –∏ –ø—Ä–∏–ø–∏—Å–∫–∏.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""shortage, safety, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""There has been a significant increase in third-party claims for medical assistance under the OMS program, primarily due to issues with healthcare provision, inadequate performance of healthcare organizations, and denials.""
}"
2025-06-30T16:12:35+00:00,@medpharm,12309,https://t.me/medpharm/12309,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 30 –∏—é–Ω—è –í –Ω–æ–≥—É —Å –∏–Ω—Ñ–ª—è—Ü–∏–µ–π –ö–æ–ª–∏—á–µ—Å—Ç–≤–æ —Ä–∞–∑–º–µ—â–µ–Ω–Ω—ã—Ö –≤ –ï–¥–∏–Ω–æ–π –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω–æ–π —Å–∏—Å—Ç–µ–º–µ –≤ —Å—Ñ–µ—Ä–µ –∑–∞–∫—É–ø–æ–∫ –∫–æ–Ω—Ç—Ä–∞–∫—Ç–æ–≤ –Ω–∞ –ø–æ—Å—Ç–∞–≤–∫—É –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π –∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ —Ä–∞—Å—Ç–µ—Ç. –ü–æ –∏—Ç–æ–≥–∞–º –≥–æ–¥–∞ –æ–±—ä–µ–º —Ç–∞–∫–∏—Ö –∑–∞–∫—É–ø–æ–∫ –º–æ–∂–µ—Ç –¥–æ—Å—Ç–∏—á—å 2 —Ç—Ä–ª–Ω —Ä—É–±. –°–µ—Ä–¥—Ü—É –ø—Ä–∏–∫–∞–∂–µ—à—å –ï–≤—Ä–æ–ø–µ–π—Å–∫–∏–µ –∫–∞—Ä–¥–∏–æ–ª–æ–≥–∏ –æ–ø—É–±–ª–∏–∫–æ–≤–∞–ª–∏ –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–µ –∫–æ–Ω—Å–µ–Ω—Å—É—Å–Ω–æ–µ –∑–∞—è–≤–ª–µ–Ω–∏–µ –æ —Ä–æ–ª–∏ –∏–º–º—É–Ω–∏–∑–∞—Ü–∏–∏ –≤ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–µ —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –í–∞–∫—Ü–∏–Ω–∞—Ü–∏—è –º–æ–∂–µ—Ç –ø—Ä–µ–¥–æ—Ç–≤—Ä–∞—Ç–∏—Ç—å —Ä–∞–∑–≤–∏—Ç–∏–µ —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö –æ—Å–ª–æ–∂–Ω–µ–Ω–∏–π –ø–æ—Å–ª–µ –≤–∏—Ä—É—Å–Ω—ã—Ö –∏ –±–∞–∫—Ç–µ—Ä–∏–∞–ª—å–Ω—ã—Ö –∏–Ω—Ñ–µ–∫—Ü–∏–π, –≤–∫–ª—é—á–∞—è –ø–Ω–µ–≤–º–æ–∫–æ–∫–∫–æ–≤—É—é –ø–Ω–µ–≤–º–æ–Ω–∏—é –∏ –≥—Ä–∏–ø–ø, –∏ –¥–æ–ª–∂–Ω–∞ —Å—Ç–∞—Ç—å –æ–¥–Ω–æ–π –∏–∑ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–∏—Ö —Å—Ç—Ä–∞—Ç–µ–≥–∏–π –Ω–∞—Ä–∞–≤–Ω–µ —Å –¥—Ä—É–≥–∏–º–∏ –º–µ—Ä–∞–º–∏. –¢—Ä–µ–±—É—é—Ç –∑–∞—â–∏—Ç—ã Biocad –ø–æ–¥–∞–ª –∏—Å–∫—É –æ –∑–∞—â–∏—Ç–µ –¥–µ–ª–æ–≤–æ–π —Ä–µ–ø—É—Ç–∞—Ü–∏–∏ –∫ AstraZeneca. –†–∞–Ω–µ–µ —Ä–æ—Å—Å–∏–π—Å–∫–∞—è –∫–æ–º–ø–∞–Ω–∏—è –ø–æ–ª—É—á–∏–ª–∞ —Ä–∞–∑—Ä–µ—à–µ–Ω–∏–µ –Ω–∞ –ö–ò –∞–Ω–∞–ª–æ–≥–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ¬´–≠–Ω—Ö–µ—Ä—Ç—É¬ª –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ —Ä–∞–∫–∞ –º–æ–ª–æ—á–Ω–æ–π –∂–µ–ª–µ–∑—ã. –ù–∞ —ç—Ç–æ –æ—Ä–∏–≥–∏–Ω–∞—Ç–æ—Ä –ø–æ–ø—Ä–æ—Å–∏–ª –ú–∏–Ω–∑–¥—Ä–∞–≤ –ø—Ä–∏–æ—Å—Ç–∞–Ω–æ–≤–∏—Ç—å –ö–ò –∏–∑-–∑–∞ ¬´–ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω—ã—Ö —Ä–∏—Å–∫–æ–≤ –¥–ª—è –∂–∏–∑–Ω–∏ –∏ –∑–¥–æ—Ä–æ–≤—å—è —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤¬ª. –ù–∞ —ç—Ç–æ Biocad –æ—Ç—Ä–µ–∞–≥–∏—Ä–æ–≤–∞–ª –æ–±—Ä–∞—â–µ–Ω–∏–µ–º –≤ —Å—É–¥. –°—Ç–æ—Ä–æ–Ω—ã –≤—ã—Å–∫–∞–∑–∞–ª–∏ ¬´–§–í¬ª —Å–≤–æ–∏ –ø–æ–∑–∏—Ü–∏–∏. –í–∞–∂–Ω—ã–π —ç—Ç–∞–ø –î–æ–ª—è –æ–Ω–ª–∞–π–Ω-–ø—Ä–æ–¥–∞–∂ –ª–µ–∫–∞—Ä—Å—Ç–≤ —Å –¥–æ—Å—Ç–∞–≤–∫–æ–π –ø—Ä–µ–≤—ã—Å–∏–ª–∞ 1,1% –æ—Ç –≤—Å–µ–≥–æ —Ä–æ–∑–Ω–∏—á–Ω–æ–≥–æ —Ñ–∞—Ä–º—Ä—ã–Ω–∫–∞. –ü—Ä–æ–¥–∞–∂–∏ –≤ –∫–∞–Ω–∞–ª–µ e-com –≥–æ–¥ –∫ –≥–æ–¥—É –≤—ã—Ä–æ—Å–ª–∏ –Ω–∞ 57,4% –≤ —Ä—É–±–ª—è—Ö –∏ –Ω–∞ 37,5% –≤ —É–ø–∞–∫–æ–≤–∫–∞—Ö.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand, epidemic, vaccine"",
  ""impact"": ""medium"",
  ""english"": ""The number of contracts placed in the Unified Information System for Procurement on medical products and medicines is growing. By year-end, the volume of such procurements could reach 2 trillion rubles. European cardiologists published a clinical consensus statement on the role of immunization in preventing cardiovascular diseases. Vaccination can prevent heart and vascular complications from viral and bacterial infections, including pneumococcal pneumonia and influenza, and should be one of the preventive strategies alongside other measures. Biocad filed a lawsuit against AstraZeneca to protect its business reputation. The original manufacturer requested the Ministry of Health to suspend KI due to 'potential risks for life and health.' Biocad responded by filing a lawsuit. Both parties have expressed their positions. Online pharmaceutical sales with delivery exceeded 1.1% of the entire retail pharmacy market. Year-over-year, e-commerce sales grew by 57.4% in rubles and by 37.5% in units.""
}"
2025-06-30T14:30:28+00:00,@medpharm,12308,https://t.me/medpharm/12308,"–ê—Ä–±–∏—Ç—Ä–∞–∂–Ω—ã–π —Å—É–¥ –ú–æ—Å–∫–≤—ã –ø—Ä–∏–Ω—è–ª –∫ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏—é –∏—Å–∫ –∫–æ–º–ø–∞–Ω–∏–∏ Biocad –∫ AstraZeneca –æ –∑–∞—â–∏—Ç–µ –¥–µ–ª–æ–≤–æ–π —Ä–µ–ø—É—Ç–∞—Ü–∏–∏. –†–∞–Ω–µ–µ –æ—Ç–≤–µ—Ç—á–∏–∫ –Ω–∞–ø—Ä–∞–≤–∏–ª –ø–∏—Å—å–º–æ –º–∏–Ω–∏—Å—Ç—Ä—É –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è, –≤ –∫–æ—Ç–æ—Ä–æ–º –ø—Ä–æ—Å–∏–ª –ø—Ä–∏–æ—Å—Ç–∞–Ω–æ–≤–∏—Ç—å –¥–µ–π—Å—Ç–≤–∏–µ —Ä–∞–∑—Ä–µ—à–µ–Ω–∏—è, –≤—ã–¥–∞–Ω–Ω–æ–≥–æ Biocad –Ω–∞ –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ BCD-267 –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ —Ä–∞–∫–∞ –º–æ–ª–æ—á–Ω–æ–π –∂–µ–ª–µ–∑—ã. –í—ã—Å–∫–∞–∑—ã–≤–∞–Ω–∏—è –∫–æ–º–ø–∞–Ω–∏–∏ –∏—Å—Ç–µ—Ü —Ä–∞—Å—Ü–µ–Ω–∏–ª –∫–∞–∫ –ø–æ–¥—Ä—ã–≤–∞—é—â–∏–µ –µ–≥–æ –¥–µ–ª–æ–≤—É—é —Ä–µ–ø—É—Ç–∞—Ü–∏—é.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The plaintiff Biocad, a company, has filed an appeal against the defendant AstraZeneca to protect its business reputation. The plaintiff claims that the defendant's letter to the Minister of Health requesting a suspension of Biocad's approval for clinical research on BCD-267, a drug for treating breast cancer, undermined the plaintiff's business reputation.""
}"
2025-06-30T13:01:18+00:00,@medpharm,12307,https://t.me/medpharm/12307,–ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–∞—è –∞—Å—Å–æ—Ü–∏–∞—Ü–∏—è —É–ø—Ä–∞–≤–ª–µ–Ω—Ü–µ–≤ —Å—Ñ–µ—Ä—ã –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∞ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å–Ω–æ —Ä–∞–∑—Ä–µ—à–∏—Ç—å –≤—Ä–∞—á–∞–º –æ—Ç–∫–∞–∑—ã–≤–∞—Ç—å –≤ –ø–ª–∞–Ω–æ–≤–æ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –ø–∞—Ü–∏–µ–Ω—Ç–∞–º —Å —è—Ä–∫–æ –≤—ã—Ä–∞–∂–µ–Ω–Ω—ã–º–∏ –ø—Ä–∏–∑–Ω–∞–∫–∞–º–∏ –∞–ª–∫–æ–≥–æ–ª—å–Ω–æ–≥–æ –∏–ª–∏ –Ω–∞—Ä–∫–æ—Ç–∏—á–µ—Å–∫–æ–≥–æ –æ–ø—å—è–Ω–µ–Ω–∏—è. –≠—Ç–æ –Ω–µ –∫–∞—Å–∞–µ—Ç—Å—è —Å–ª—É—á–∞–µ–≤ —ç–∫—Å—Ç—Ä–µ–Ω–Ω–æ–π –ø–æ–º–æ—â–∏ –ø—Ä–∏ —É–≥—Ä–æ–∑–µ –∂–∏–∑–Ω–∏.,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The National Association of Healthcare Administrators proposed legislation to allow doctors to refuse routine medical care to patients with clearly visible signs of alcohol or drug intoxication. This does not include cases of emergency care in situations where there is a threat to life.""
}"
2025-06-30T11:07:14+00:00,@medpharm,12306,https://t.me/medpharm/12306,"–î–µ–ø—É—Ç–∞—Ç—ã –ì–æ—Å–¥—É–º—ã –ú–∏—Ä–æ–Ω–æ–≤ –∏ –õ–∞–Ω—Ç—Ä–∞—Ç–æ–≤–∞ –æ–±—Ä–∞—Ç–∏–ª–∏—Å—å –≤ –ú–∏–Ω–∑–¥—Ä–∞–≤, —á—Ç–æ–±—ã –ø–∞—Ü–∏–µ–Ω—Ç–∞–º —Å —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–æ–π –æ–±—Å—Ç—Ä—É–∫—Ç–∏–≤–Ω–æ–π –±–æ–ª–µ–∑–Ω—å—é –ª–µ–≥–∫–∏—Ö –±–µ—Å–ø–ª–∞—Ç–Ω–æ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª—è–ª–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞. –ü–æ –∏—Ö —Å–ª–æ–≤–∞–º, —Ç–∞–∫–∞—è –º–µ—Ä–∞ ¬´–Ω–µ —Ç–æ–ª—å–∫–æ –æ–±–ª–µ–≥—á–∏—Ç —Ñ–∏–Ω–∞–Ω—Å–æ–≤–æ–µ –±—Ä–µ–º—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –Ω–æ –∏ —Å—Ç–∏–º—É–ª–∏—Ä—É–µ—Ç —Ä–∞–Ω–Ω—é—é –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫—É¬ª.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""Deputies Miryominov and Lantratova asked the Ministry of Health to provide patients with chronic obstructive pulmonary disease free medications. They say this will lighten the financial burden on patients and encourage early diagnosis.""
}"
2025-06-30T09:00:32+00:00,@medpharm,12305,https://t.me/medpharm/12305,"–†–∞–∑—Ä—É—à–µ–Ω–∏–µ –¥–æ–≤–µ—Ä–∏—è –∫ –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω–µ –≤ –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–º —Å–æ–∑–Ω–∞–Ω–∏–∏ –ø—Ä–∏–≤–µ–¥–µ—Ç –∫ –æ—Ç–∫–∞–∑—É –æ—Ç –æ–±—Ä–∞—â–µ–Ω–∏–π –∫ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞–º, –±–æ–ª—å—à–µ–º—É —á–∏—Å–ª—É —Å–ª—É—á–∞–µ–≤ —Å–∞–º–æ–ª–µ—á–µ–Ω–∏—è –∏ –æ–±—Ä–∞—â–µ–Ω–∏—è–º –∫ —à–∞—Ä–ª–∞—Ç–∞–Ω–∞–º, –∑–∞—è–≤–∏–ª–∞ —á–ª–µ–Ω –°–ü–ß, –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç –±–ª–∞–≥–æ—Ç–≤–æ—Ä–∏—Ç–µ–ª—å–Ω–æ–≥–æ —Ñ–æ–Ω–¥–∞ ¬´–°–ø—Ä–∞–≤–µ–¥–ª–∏–≤–∞—è –ø–æ–º–æ—â—å –î–æ–∫—Ç–æ—Ä–∞ –õ–∏–∑—ã¬ª –û–ª—å–≥–∞ –î–µ–º–∏—á–µ–≤–∞. –û–Ω–∞ –ø—Ä–∏–∑–≤–∞–ª–∞ –∂—É—Ä–Ω–∞–ª–∏—Å—Ç–æ–≤ –æ—Ç–∫–∞–∑–∞—Ç—å—Å—è –æ—Ç ¬´–¥–µ–º–æ–Ω–∏–∑–∏—Ä—É—é—â–∏—Ö –≤—Ä–∞—á–µ–π –∏ –¥–∏—Å–∫—Ä–µ–¥–∏—Ç–∏—Ä—É—é—â–∏—Ö –∏—Ö —Ç—Ä—É–¥¬ª –ø—É–±–ª–∏–∫–∞—Ü–∏–π.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions,hospital_policy,pharmacovigilance"",
  ""impact"": ""high"",
  ""english"": ""Oleg Demicheva, a member of the State Protection Committee and President of the charitable foundation 'Just Assistance Doctor Liza', warned that mistrust in official medicine would lead to a decrease in consultations with specialists, an increase in self-medication and reliance on quacks. She called for journalists to stop publishing 'demonizing doctors and discrediting their work' articles.""
}"
2025-06-30T08:00:03+00:00,@medpharm,12304,https://t.me/medpharm/12304,"–ú–í–î –†–æ—Å—Å–∏–∏ –ø–æ–¥–µ–ª–∏–ª–æ—Å—å –∏—Ç–æ–≥–∞–º–∏ –ø—Ä–æ–≤–µ–¥–µ–Ω–Ω–æ–π –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–æ–π –æ–ø–µ—Ä–∞—Ü–∏–∏ –ò–Ω—Ç–µ—Ä–ø–æ–ª–∞ ¬´–ü–∞–Ω–≥–µ—è¬ª. –í —Ä–∞–º–∫–∞—Ö –Ω–µ–µ –≤–æ–∑–±—É–¥–∏–ª–∏ 177 —É–≥–æ–ª–æ–≤–Ω—ã—Ö –¥–µ–ª –∏ —Å–æ—Å—Ç–∞–≤–∏–ª–∏ –ø–æ—á—Ç–∏ 500 –ø—Ä–æ—Ç–æ–∫–æ–ª–æ–≤ –æ –Ω–∞—Ä—É—à–µ–Ω–∏–∏ –ö–æ–ê–ü. –ò–∑—ä—è—Ç–∞—è –Ω–µ–ª–µ–≥–∞–ª—å–Ω–∞—è —Ñ–∞—Ä–º–ø—Ä–æ–¥—É–∫—Ü–∏—è –Ω–∞ 405,5 –º–ª–Ω —Ä—É–±.","{""skip"": true}"
2025-06-30T07:00:15+00:00,@medpharm,12303,https://t.me/medpharm/12303,–í –ì–æ—Å–¥—É–º–µ –æ–±—Ä–∞—Ç–∏–ª–∏ –≤–Ω–∏–º–∞–Ω–∏–µ –Ω–∞ —Å–µ–ª—å—Å–∫–∏—Ö –º–µ–¥–∏–∫–æ–≤. –î–µ–ø—É—Ç–∞—Ç—ã –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –ø–æ–≤—ã—Å–∏—Ç—å –ø–µ–Ω—Å–∏–∏ –æ—Ç—Ä–∞–±–æ—Ç–∞–≤—à–∏–º 25 –ª–µ—Ç –≤ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—è—Ö –≤ —Å–µ–ª—å—Å–∫–æ–π –º–µ—Å—Ç–Ω–æ—Å—Ç–∏ –∏ –ø–æ—Å–µ–ª–∫–∞—Ö –≥–æ—Ä–æ–¥—Å–∫–æ–≥–æ —Ç–∏–ø–∞ —Å—Ä–∞–∑—É –Ω–∞ 25%.,"{""skip"": true}"
2025-06-29T12:01:22+00:00,@medpharm,12302,https://t.me/medpharm/12302,"–ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ –∑–∞ –Ω–µ–¥–µ–ª—é üîµ –ú–∏–Ω–∑–¥—Ä–∞–≤ –ø—Ä–µ–¥–ª–æ–∂–∏–ª –æ–±—è–∑–∞—Ç—å –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥- –∏ —Ñ–∞—Ä–º–≤—É–∑–æ–≤ –ø—Ä–æ—Ö–æ–¥–∏—Ç—å —Ç—Ä–µ—Ö–ª–µ—Ç–Ω–µ–µ –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–æ –ø–æ—Å–ª–µ –ø–µ—Ä–≤–∏—á–Ω–æ–π –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–∏. üîµ –ü—Ä–µ–∑–∏–¥–µ–Ω—Ç —É—Ç–≤–µ—Ä–¥–∏–ª –∑–∞–∫–æ–Ω, –∑–∞–ø—Ä–µ—â–∞—é—â–∏–π –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã—Ö —è–∑—ã–∫–æ–≤ –Ω–∞ –≤—ã–≤–µ—Å–∫–∞—Ö –∏ –Ω–∞–¥–ø–∏—Å—è—Ö –æ –ø—Ä–æ–≤–æ–¥–∏–º—ã—Ö –∞–∫—Ü–∏—è—Ö. –ò–∑–º–µ–Ω–µ–Ω–∏—è –≤—Å—Ç—É–ø—è—Ç –≤ —Å–∏–ª—É —Å 1 –º–∞—Ä—Ç–∞ 2026 –≥–æ–¥–∞ –∏ –Ω–µ –∫–æ—Å–Ω—É—Ç—Å—è —Ñ–∏—Ä–º–µ–Ω–Ω—ã—Ö –Ω–∞–∏–º–µ–Ω–æ–≤–∞–Ω–∏–π –∏ —Ç–æ–≤–∞—Ä–Ω—ã—Ö –∑–Ω–∞–∫–æ–≤. üîµ –í–µ—Ä—Ö–æ–≤–Ω—ã–π —Å—É–¥ –ø–æ–¥–¥–µ—Ä–∂–∞–ª –ø–æ–∑–∏—Ü–∏—é –§–ê–° –≤ –¥–µ–ª–µ –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ê–∫—Ä–∏—Ö–∏–Ω¬ª, –∫–æ—Ç–æ—Ä–æ–µ –∫–∞—Å–∞–µ—Ç—Å—è –¥–∂–µ–Ω–µ—Ä–∏–∫–∞ –ø—Ä–æ—Ç–∏–≤–æ–¥–∏–∞–±–µ—Ç–∏—á–µ—Å–∫–æ–≥–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ AstraZeneca ¬´–§–æ—Ä—Å–∏–≥–∞¬ª. üîµ –ö—Ä—É–ø–Ω–µ–π—à–∏–µ —Ñ–∞—Ä–º–≤—É–∑—ã —É–≤–µ–ª–∏—á–∏–ª–∏ —Å—Ç–æ–∏–º–æ—Å—Ç—å –∫–æ–º–º–µ—Ä—á–µ—Å–∫–æ–≥–æ –æ–±—É—á–µ–Ω–∏—è. –ù–∞–ø—Ä–∏–º–µ—Ä, –≤ –°–µ—á–µ–Ω–æ–≤—Å–∫–æ–º —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–µ —Å—Ç–æ–∏–º–æ—Å—Ç—å –æ–±—É—á–µ–Ω–∏—è –Ω–∞ —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–∏ ¬´–§–∞—Ä–º–∞—Ü–∏—è¬ª –≤—ã—Ä–æ—Å–ª–∞ –±–æ–ª–µ–µ —á–µ–º –Ω–∞ 1 –º–ª–Ω —Ä—É–±. üîµ –í –º–∞–≥–∞–∑–∏–Ω–µ ¬´–í–∫—É—Å–í–∏–ª–ª¬ª –≤ —Ü–µ–Ω—Ç—Ä–µ –ú–æ—Å–∫–≤—ã –ø–æ—è–≤–∏–ª—Å—è –ø–µ—Ä–≤—ã–π –≤–µ–Ω–¥–∏–Ω–≥–æ–≤—ã–π –∞–ø–ø–∞—Ä–∞—Ç –ø–æ –ø—Ä–æ–¥–∞–∂–µ –ø–µ—Ä—Å–æ–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –Ω–∞–±–æ—Ä–æ–≤ –≤–∏—Ç–∞–º–∏–Ω–æ–≤ –∏ –º–∏–Ω–µ—Ä–∞–ª–æ–≤.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health proposed requiring graduates from medical and pharmaceutical universities to undergo three-year mentoring after initial accreditation. The Supreme Court supported the FAS's position in a case involving company 'Akrichin', which concerns generic diabetes medication AstraZeneca 'Forseg'. Major pharmaceutical universities have increased the cost of commercial education. For example, at S–µ—á–µ–Ωov University, the cost of studying 'Pharmacy' has increased by more than 1 million rubles. A one-stop vending machine for personalized vitamin and mineral kits has appeared in a store 'VkusVila' in the center of Moscow.""
}"
2025-06-28T09:04:57+00:00,@medpharm,12301,https://t.me/medpharm/12301,"–ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∑–∞ –Ω–µ–¥–µ–ª—é üî¥–ö–æ–º–∏—Ç–µ—Ç –ì–æ—Å–¥—É–º—ã –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è –Ω–∞ —ç—Ç–æ–π –Ω–µ–¥–µ–ª–µ –ø–æ–¥–¥–µ—Ä–∂–∞–ª –≤–Ω–µ—Å–µ–Ω–Ω—ã–µ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ–º –ø–æ–ø—Ä–∞–≤–∫–∏, –¥–∞—é—â–∏–µ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –≤—Ä–∞—á–∞–º –æ—Ç–∫–ª–æ–Ω—è—Ç—å—Å—è –æ—Ç –Ω–æ—Ä–º –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π (–ö–†), –µ—Å–ª–∏ —ç—Ç–æ–≥–æ —Ç—Ä–µ–±—É—é—Ç –∏–Ω—Ç–µ—Ä–µ—Å—ã –ø–∞—Ü–∏–µ–Ω—Ç–∞. üî¥–ó–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—è –°—á–µ—Ç–Ω–æ–π –ø–∞–ª–∞—Ç—ã –ì–∞–ª–∏–Ω–∞ –ò–∑–æ—Ç–æ–≤–∞ –Ω–∞–∑–≤–∞–ª–∞ –ø—Ä–∏—á–∏–Ω—ã –æ—Ç—Ç–æ–∫–∞ –∫–∞–¥—Ä–æ–≤ –∏–∑ –≥–æ—Å–º–µ–¥–∏—Ü–∏–Ω—ã. –ü–æ –µ–µ –¥–∞–Ω–Ω—ã–º, —Å–∏—Å—Ç–µ–º–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∏—Å–ø—ã—Ç—ã–≤–∞–µ—Ç –¥–µ—Ñ–∏—Ü–∏—Ç —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è. üî¥–†–æ—Å—Å–∏—è–Ω–µ –ø–æ—Å—Ç–∞–≤–∏–ª–∏ –º–µ–¥–∏—Ü–∏–Ω—É –Ω–∞ —Ç—Ä–µ—Ç—å–µ –º–µ—Å—Ç–æ –ø–æ –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–∞–º –¥–ª—è –∫–∞—Ä—å–µ—Ä–Ω–æ–≥–æ —Ä–æ—Å—Ç–∞. üî¥–ù–∞ —Ñ–æ–Ω–µ –∏–Ω—Ñ–ª—è—Ü–∏–∏ –∫—Ä—É–ø–Ω–µ–π—à–∏–µ —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ –≤—É–∑—ã –∏–∑ TOP10 –≤–µ–¥—É—â–∏—Ö –º–µ–¥—É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–æ–≤ –≤–Ω–æ–≤—å –ø–æ–≤—ã—Å–∏–ª–∏ —Ü–µ–Ω—ã –Ω–∞ –∫–æ–º–º–µ—Ä—á–µ—Å–∫–æ–µ –æ–±—É—á–µ–Ω–∏–µ. üî¥–ú–∏–Ω—Ç—Ä—É–¥ —Ä–∞—Å–∫—Ä—ã–ª –Ω–µ–∫–æ—Ç–æ—Ä—ã–µ –¥–µ—Ç–∞–ª–∏ –ø–∏–ª–æ—Ç–Ω—ã—Ö –ø—Ä–æ–µ–∫—Ç–æ–≤ –ø–æ –ø–µ—Ä–µ—Ö–æ–¥—É –Ω–∞ –Ω–æ–≤—ã–µ –æ—Ç—Ä–∞—Å–ª–µ–≤—ã–µ —Å–∏—Å—Ç–µ–º—ã –æ–ø–ª–∞—Ç—ã —Ç—Ä—É–¥–∞ –≤ –±—é–¥–∂–µ—Ç–Ω–æ–π —Å—Ñ–µ—Ä–µ.","{
  ""skip"": true
}"
2025-06-27T16:45:01+00:00,@medpharm,12300,https://t.me/medpharm/12300,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 27 –∏—é–Ω—è –í –Ω–æ–≥—É —Å–æ –≤—Ä–µ–º–µ–Ω–µ–º –ú–∏–Ω–∑–¥—Ä–∞–≤ –≤—ã–ø—É—Å—Ç–∏–ª —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø–æ –æ–±—â–µ–Ω–∏—é –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ —Å –ø–∞—Ü–∏–µ–Ω—Ç–∞–º–∏-—É—á–∞—Å—Ç–Ω–∏–∫–∞–º–∏ –°–í–û. –í –¥–æ–∫—É–º–µ–Ω—Ç–µ —Ä–∞—Å–ø–∏—Å–∞–Ω –∞–ª–≥–æ—Ä–∏—Ç–º –ø–æ—Å—Ç—Ä–æ–µ–Ω–∏—è –¥–æ–≤–µ—Ä–∏—Ç–µ–ª—å–Ω—ã—Ö –æ—Ç–Ω–æ—à–µ–Ω–∏–π, –≤–∫–ª—é—á–∞—è –ø–æ–∑—É –≤—Ä–∞—á–∞ –∏ –≤—Ä–µ–º—è –∑—Ä–∏—Ç–µ–ª—å–Ω–æ–≥–æ –∫–æ–Ω—Ç–∞–∫—Ç–∞, –∞ —Ç–∞–∫–∂–µ —Ñ—Ä–∞–∑—ã, –∫–æ—Ç–æ—Ä—ã–µ –º–æ–≥—É—Ç —Å–ø—Ä–æ–≤–æ—Ü–∏—Ä–æ–≤–∞—Ç—å –∞–≥—Ä–µ—Å—Å–∏—é. –ù–æ–≤—ã–π —Å—Ç–∞–Ω–¥–∞—Ä—Ç –ú–∏–Ω—Ç—Ä—É–¥ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –ø—Ä–æ–µ–∫—Ç –Ω–æ–≤–æ–π —Ç–∏–ø–æ–≤–æ–π –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–π –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–π –ø—Ä–æ–≥—Ä–∞–º–º—ã –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–π –ø–µ—Ä–µ–ø–æ–¥–≥–æ—Ç–æ–≤–∫–∏ –≤ –æ–±–ª–∞—Å—Ç–∏ –º–µ–¥–∏–∫–æ-—Å–æ—Ü–∏–∞–ª—å–Ω–æ–π —ç–∫—Å–ø–µ—Ä—Ç–∏–∑—ã. –ü—Ä–æ–¥–æ–ª–∂–∏—Ç–µ–ª—å–Ω–æ—Å—Ç—å –æ–±—É—á–µ–Ω–∏—è —Å–æ—Å—Ç–∞–≤–∏—Ç 576 –∞–∫–∞–¥–µ–º–∏—á–µ—Å–∫–∏—Ö —á–∞—Å–æ–≤. –ö–æ–º—É –¥–æ–±–∞–≤–∫–∏ –í –º–∞–≥–∞–∑–∏–Ω–µ ¬´–í–∫—É—Å–í–∏–ª–ª¬ª –≤ —Ü–µ–Ω—Ç—Ä–µ –ú–æ—Å–∫–≤—ã –ø–æ—è–≤–∏–ª—Å—è –ø–µ—Ä–≤—ã–π –≤–µ–Ω–¥–∏–Ω–≥–æ–≤—ã–π –∞–ø–ø–∞—Ä–∞—Ç –ø–æ –ø—Ä–æ–¥–∞–∂–µ –ø–µ—Ä—Å–æ–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –Ω–∞–±–æ—Ä–æ–≤ –≤–∏—Ç–∞–º–∏–Ω–æ–≤ –∏ –º–∏–Ω–µ—Ä–∞–ª–æ–≤. –ü–æ–∫–∞ —ç—Ç–æ –ø–∏–ª–æ—Ç, –Ω–æ —Å–æ–∑–¥–∞—Ç–µ–ª–∏ –Ω–∞–¥–µ—é—Ç—Å—è –Ω–∞ –º–∞—Å—à—Ç–∞–±–∏—Ä–æ–≤–∞–Ω–∏–µ –ø—Ä–æ–µ–∫—Ç–∞. –ü–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω—ã–µ –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤—ã –¢–æ–≤–∞—Ä–Ω—ã–µ –∑–Ω–∞–∫–∏ ¬´–°–µ–∞–ª–µ–∫—Å¬ª –∏ ¬´–ì–∏—Å—Ç–∞–Ω¬ª –æ–±–∞–Ω–∫—Ä–æ—Ç–∏–≤—à–µ–π—Å—è –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–†–ò–ê ¬´–ü–∞–Ω–¥–∞¬ª —É—à–ª–∏ —Å –º–æ–ª–æ—Ç–∫–∞. –ó–∞ –ø—è—Ç—å –±—Ä–µ–Ω–¥–æ–≤ –ø—Ä–µ–¥–ø—Ä–∏–Ω–∏–º–∞—Ç–µ–ª—å –∏–∑ –ù–æ–≤–æ—Å–∏–±–∏—Ä—Å–∫–∞ —Å—É–º–º–∞—Ä–Ω–æ –∑–∞–ø–ª–∞—Ç–∏–ª 30 –º–ª–Ω —Ä—É–±. –†–∞–Ω–µ–µ —Ç–æ–≤–∞—Ä–Ω—ã–µ –∑–Ω–∞–∫–∏ —É–∂–µ –ø—ã—Ç–∞–ª–∏—Å—å –ø—Ä–æ–¥–∞—Ç—å —Å –∞—É–∫—Ü–∏–æ–Ω–∞ –≤ –º–∞—Ä—Ç–µ.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health has released recommendations on how healthcare workers should communicate with patients involved in the SARS-CoV-2. The document outlines an algorithm for building trusting relationships, including doctor's posture and eye contact time as well as phrases that could provoke aggression. The Ministry of Labor has developed a project for a new prototype professional training program in medical-social assessment. Training duration will be 576 academic hours.""
}"
2025-06-27T14:46:02+00:00,@medpharm,12299,https://t.me/medpharm/12299,"–¶–µ–Ω—ã –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –≤ —Å—Ç—Ä–∞–Ω–∞—Ö –ï–ê–≠–° –º–æ–≥—É—Ç –æ—Ç–ª–∏—á–∞—Ç—å—Å—è –≤ –ø—è—Ç—å —Ä–∞–∑ –∏ –±–æ–ª–µ–µ. –ü—Ä–∏—á–∏–Ω–∞ –≤ —Ä–∞–∑–ª–∏—á–∏—è—Ö –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—ã—Ö –ø–æ–¥—Ö–æ–¥–æ–≤ –∫ —Ü–µ–Ω–æ–≤–æ–º—É —Ä–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω–∏—é, –º–µ—Ç–æ–¥–∏–∫–∞—Ö —Ä–∞—Å—á–µ—Ç–∞ –ø—Ä–µ–¥–µ–ª—å–Ω—ã—Ö —Ü–µ–Ω –∏ –ø–µ—Ä–µ—á–Ω—è—Ö —Ä–µ—Ñ–µ—Ä–µ–Ω—Ç–Ω—ã—Ö —Å—Ç—Ä–∞–Ω. –û–¥–Ω–∞–∫–æ –Ω–µ—Ç –Ω–∏–∫–∞–∫–∏—Ö —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–∏—Ö –ø—Ä–µ–¥–ø–æ—Å—ã–ª–æ–∫, —á—Ç–æ–±—ã —É—Å–ø–µ—à–Ω–æ —Ä–µ—à–∏—Ç—å —ç—Ç—É –ø—Ä–æ–±–ª–µ–º—É. #—Ü–∏—Ç–∞—Ç–∞_–¥–Ω—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""pricing, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""Prices on medicines in the countries of the EAEU can differ by up to five times. The reason is differences in national approaches to price regulation, methods of calculating maximum prices and lists of reference countries. However, there are no economic grounds to successfully solve this problem.""
}"
2025-06-27T13:45:21+00:00,@medpharm,12298,https://t.me/medpharm/12298,"–í 2024 –≥–æ–¥—É —á–∏—Å–ª–æ –≤—ã–¥–∞–Ω–Ω—ã—Ö –≤ –†–æ—Å—Å–∏–∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–æ–Ω–Ω—ã—Ö —É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏–π –Ω–∞ –º–µ–¥–∏–∑–¥–µ–ª–∏—è –∫–∏—Ç–∞–π—Å–∫–∏—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –≤—ã—Ä–æ—Å–ª–æ –Ω–∞ 76% –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å 2023-–º. –î–æ–ª—è –ø—Ä–æ–¥—É–∫—Ü–∏–∏ –∏–∑ –°–®–ê –∏ –ï–° –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ —Å–æ–∫—Ä–∞—Ç–∏–ª–∞—Å—å, —Ç–∞–∫–∂–µ –ø–∞–¥–∞–µ—Ç —á–∏—Å–ª–æ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –†–£.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""registration, import_export"",
  ""impact"": ""high"",
  ""english"": ""The number of registration certificates issued for Chinese-made medical devices in Russia increased by 76% compared to 2023. The share of products from the USA and EU decreased significantly, along with a decline in Russian registrations.""
}"
2025-06-27T12:43:54+00:00,@medpharm,12297,https://t.me/medpharm/12297,"#–≠–∫—Å–∫–ª—é–∑–∏–≤ –í –º–∞–≥–∞–∑–∏–Ω–µ ¬´–í–∫—É—Å–í–∏–ª–ª¬ª –≤ —Ü–µ–Ω—Ç—Ä–µ –ú–æ—Å–∫–≤—ã –ø–æ—è–≤–∏–ª—Å—è –ø–µ—Ä–≤—ã–π –≤–µ–Ω–¥–∏–Ω–≥–æ–≤—ã–π –∞–ø–ø–∞—Ä–∞—Ç –ø–æ –ø—Ä–æ–¥–∞–∂–µ –ø–µ—Ä—Å–æ–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –Ω–∞–±–æ—Ä–æ–≤ –≤–∏—Ç–∞–º–∏–Ω–æ–≤ –∏ –º–∏–Ω–µ—Ä–∞–ª–æ–≤. –ü–æ–∫–∞ —ç—Ç–æ –ª–∏—à—å –ø–∏–ª–æ—Ç, –Ω–æ —Å–æ–∑–¥–∞—Ç–µ–ª–∏ –Ω–∞–¥–µ—é—Ç—Å—è, –µ—Å–ª–∏ —Ç–µ—Å—Ç –ø—Ä–æ–π–¥–µ—Ç —É—Å–ø–µ—à–Ω–æ, –ø—Ä–æ–µ–∫—Ç —Å–º–æ–∂–µ—Ç –º–∞—Å—à—Ç–∞–±–∏—Ä–æ–≤–∞—Ç—å—Å—è. –í –°–æ—é–∑–µ –æ–ø–µ—Ä–∞—Ç–æ—Ä–æ–≤ —Ç–æ—Ä–≥–æ–≤—ã—Ö –∞–≤—Ç–æ–º–∞—Ç–æ–≤ —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏, –∫–∞–∫ —Ä–µ–≥—É–ª–∏—Ä—É–µ—Ç—Å—è –ø—Ä–æ–¥–∞–∂–∞ –ë–ê–î –≤ —Ç–∞–∫–∏—Ö –≤–µ–Ω–¥–∏–Ω–≥–æ–≤—ã—Ö –∞–ø–ø–∞—Ä–∞—Ç–∞—Ö.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""A pilot vending machine for personalized vitamin and mineral kits has appeared in the center of Moscow at a store called 'VkusVila'. Operators of trade vending machines have reported how the sale of dietary supplements in such vending machines is regulated.""
}"
2025-06-27T11:01:24+00:00,@medpharm,12296,https://t.me/medpharm/12296,"–ü–æ—á—Ç–∏ –ø–æ–ª–æ–≤–∏–Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –≤—Ä–∞—á–µ–π —Ä–µ–≥—É–ª—è—Ä–Ω–æ –∏–ª–∏ —ç–ø–∏–∑–æ–¥–∏—á–µ—Å–∫–∏ –Ω–∞–∑–Ω–∞—á–∞—é—Ç –≥–æ–º–µ–æ–ø–∞—Ç–∏—á–µ—Å–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –ø–∞—Ü–∏–µ–Ω—Ç–∞–º. –†–∞–Ω–µ–µ –∫–æ–º–∏—Å—Å–∏—è –†–ê–ù –ø–æ –ª–∂–µ–Ω–∞—É–∫–µ –ø—Ä–∏–∑–≤–∞–ª–∞ –ú–∏–Ω–∑–¥—Ä–∞–≤ –æ—Ç–æ–∑–≤–∞—Ç—å –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏, –≤ –∫–æ—Ç–æ—Ä—ã–µ –≤–∫–ª—é—á–µ–Ω–∞ –≥–æ–º–µ–æ–ø–∞—Ç–∏—è, –æ–¥–Ω–∞–∫–æ –ø–æ—á—Ç–∏ –ø–æ–ª–æ–≤–∏–Ω–∞ –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö –º–µ–¥–∏–∫–æ–≤ –Ω–µ —Å–æ–≥–ª–∞—Å–∏–ª–∏—Å—å –≤ —ç—Ç–æ–º –≤–æ–ø—Ä–æ—Å–µ —Å –∞–∫–∞–¥–µ–º–∏–∫–∞–º–∏. #—Ü–∏—Ñ—Ä–∞_–¥–Ω—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety, guideline"",
  ""impact"": ""medium"",
  ""english"": ""Almost half of Russian doctors regularly or occasionally prescribe homeopathic medications to patients. Earlier, the commission of the Russian Academy of Sciences called for the Ministry of Health to withdraw clinical recommendations that include homeopathy, but almost half of those surveyed disagreed with the academicians on this issue.""
}"
2025-06-27T10:09:58+00:00,@medpharm,12295,https://t.me/medpharm/12295,"–¢–µ—Ö–Ω–æ–ª–æ–≥–∏—è ¬´—Ç–æ–≤–∞—Ä –∫ —á–µ–ª–æ–≤–µ–∫—É¬ª –∏—Å–ø–æ–ª—å–∑—É–µ—Ç—Å—è –±–∏–∑–Ω–µ—Å–æ–º –≤ —Ä–∞–∑–Ω—ã—Ö –æ—Ç—Ä–∞—Å–ª—è—Ö —ç–∫–æ–Ω–æ–º–∏–∫–∏, –≤ —Ç–æ–º —á–∏—Å–ª–µ –≥–ª–æ–±–∞–ª—å–Ω—ã–º–∏ –∫–æ—Ä–ø–æ—Ä–∞—Ü–∏—è–º–∏ –∏ –∫–æ–º–ø–∞–Ω–∏—è–º–∏ —Å –æ–±—à–∏—Ä–Ω–æ–π —Å–µ—Ç—å—é –ø–∞—Ä—Ç–Ω–µ—Ä–æ–≤ –∏ —Ñ–∏–ª–∏–∞–ª–æ–≤. –û–¥–Ω–∞–∫–æ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞–º–∏ ¬´–ü—Ä–æ—Ç–µ–∫–∞¬ª –±—ã–ª —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω –∞–±—Å–æ–ª—é—Ç–Ω–æ –Ω–æ–≤—ã–π –∞–ª–≥–æ—Ä–∏—Ç–º –µ–µ —Ä–∞–±–æ—Ç—ã, –ø–æ–∑–≤–æ–ª–∏–≤—à–∏–π –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ —Å–æ–∫—Ä–∞—Ç–∏—Ç—å –∑–∞—Ç—Ä–∞—Ç—ã –Ω–∞ –≤–Ω–µ–¥—Ä–µ–Ω–∏–µ –∏ —ç–∫—Å–ø–ª—É–∞—Ç–∞—Ü–∏—é WAMAS –∏ —É–≤–µ–ª–∏—á–∏—Ç—å –¥–æ–ª—é —Å–æ–±–∏—Ä–∞–µ–º—ã—Ö —Å–∏—Å—Ç–µ–º–æ–π —Ä–æ–∑–Ω–∏—á–Ω—ã—Ö –∑–∞–∫–∞–∑–æ–≤.","{""skip"": true}"
2025-06-27T08:02:15+00:00,@medpharm,12294,https://t.me/medpharm/12294,–ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ –ø—Ä–µ–¥–ª–æ–∂–∏–ª –≤—Ä–µ–º–µ–Ω–Ω–æ –æ—Ç–º–µ–Ω–∏—Ç—å —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–µ —É–∫–∞–∑—ã–≤–∞—Ç—å –±–∞–ª–ª—ã –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏–∏ –≤ –¥–æ–∫—É–º–µ–Ω—Ç–∞—Ö –¥–ª—è –∑–∞–∫—É–ø–æ–∫ 18 –≤–∏–¥–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è. –ò–∑–º–µ–Ω–µ–Ω–∏—è –ø–æ–∑–≤–æ–ª—è—Ç –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å –¥–µ–π—Å—Ç–≤—É—é—â–∏–µ —Ä–µ–µ—Å—Ç—Ä–æ–≤—ã–µ –∑–∞–ø–∏—Å–∏ –±–µ–∑ –±–∞–ª–ª—å–Ω–æ–π –æ—Ü–µ–Ω–∫–∏ –¥–æ –∫–æ–Ω—Ü–∞ 2026 –≥–æ–¥–∞.,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Industry and Trade proposed temporarily suspending the requirement to indicate localization points in documents for purchases of 18 types of medical equipment. The changes will allow manufacturers to use existing registry records without a rating assessment until the end of 2026.""
}"
2025-06-27T07:05:54+00:00,@medpharm,12293,https://t.me/medpharm/12293,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –æ–±–Ω–æ–≤–∏–ª –ø–µ—Ä–µ—á–µ–Ω—å —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã—Ö –º–µ–¥—Ü–µ–Ω—Ç—Ä–æ–≤, –∏–º–µ—é—â–∏—Ö –ø—Ä–∞–≤–æ –æ–∫–∞–∑—ã–≤–∞—Ç—å –≤—ã—Å–æ–∫–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–Ω—É—é –º–µ–¥–∏—Ü–∏–Ω—Å–∫—É—é –ø–æ–º–æ—â—å, –Ω–µ –≤–∫–ª—é—á–µ–Ω–Ω—É—é –≤ –±–∞–∑–æ–≤—É—é –ø—Ä–æ–≥—Ä–∞–º–º—É –û–ú–°. –í —Å–ø–∏—Å–æ–∫ –¥–æ–±–∞–≤–∏–ª–∏ —Ç—Ä–∏ —É—á—Ä–µ–∂–¥–µ–Ω–∏—è –§–ú–ë–ê.","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""tenders, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health has updated the list of federal medical centers entitled to provide high-tech medical care not included in the basic program of OMS. Three institutions of FMB have been added to the list.""
}"
2025-06-26T16:01:57+00:00,@medpharm,12292,https://t.me/medpharm/12292,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 26 –∏—é–Ω—è –ï—Å—Ç—å –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª –†–æ—Å—Å–∏–π—Å–∫–∏–µ —Ä—ã–Ω–∫–∏ –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–Ω–æ–≥–æ –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏—è –∏ —Ä–µ–∞–≥–µ–Ω—Ç–æ–≤ –±—É–¥—É—Ç —Ä–∞—Å—Ç–∏ –¥–æ 2030 –≥–æ–¥–∞ –≤ —Å—Ä–µ–¥–Ω–µ–º –Ω–∞ 8‚Äì10% –µ–∂–µ–≥–æ–¥–Ω–æ. –≠—Ç–∞ –ø—Ä–æ–¥—É–∫—Ü–∏—è –æ—Å–æ–±–µ–Ω–Ω–æ –≤–æ—Å—Ç—Ä–µ–±–æ–≤–∞–Ω–∞ —É —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π, –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏ –Ω–∞—É—á–Ω—ã—Ö —É—á—Ä–µ–∂–¥–µ–Ω–∏–π. –í–∑–ª–æ–º–∞—Ç—å –ª–µ–≥–∫–æ –ú–æ–±–∏–ª—å–Ω—ã–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏—è –≤—Ö–æ–¥—è—Ç –≤ TOP3 –ø–æ –Ω–∞–ª–∏—á–∏—é —É—è–∑–≤–∏–º–æ—Å—Ç–µ–π —É—Ä–æ–≤–Ω—è High, –ø—Ä–µ–¥—Å—Ç–∞–≤–ª—è—é—â–∏—Ö –ø–æ–≤—ã—à–µ–Ω–Ω—ã–π —Ä–∏—Å–∫ —É—Ç–µ—á–∫–∏ –∫–æ–Ω—Ñ–∏–¥–µ–Ω—Ü–∏–∞–ª—å–Ω–æ–π –∏ –ø–µ—Ä—Å–æ–Ω–∞–ª—å–Ω–æ–π –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª–µ–π. –ù–∞ —à–∞–≥ –≤–ø–µ—Ä–µ–¥–∏ –í –º–∞—Ä—Ç–µ –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–æ —Å—Ç–∞–ª–æ –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω–æ–π —Ç—Ä—É–¥–æ–≤–æ–π —Ñ—É–Ω–∫—Ü–∏–µ–π —Å —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–∏–º –≤–æ–∑–Ω–∞–≥—Ä–∞–∂–¥–µ–Ω–∏–µ–º. –î–ª—è –∫–æ–≥–æ-—Ç–æ —ç—Ç–æ —Å—Ç–∞–ª–æ –Ω–æ–≤–µ–ª–ª–æ–π, –Ω–æ –Ω–∞ –º–Ω–æ–≥–∏—Ö —Ñ–∞—Ä–º–ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏—è—Ö —Ç–∞–∫–∞—è –ø—Ä–∞–∫—Ç–∏–∫–∞ —Å—É—â–µ—Å—Ç–≤–æ–≤–∞–ª–∞ –∏ —Ä–∞–Ω–µ–µ –∏ —Ä–µ–≥—É–ª–∏—Ä–æ–≤–∞–ª–∞—Å—å –ª–æ–∫–∞–ª—å–Ω—ã–º–∏ –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω—ã–º–∏ –∞–∫—Ç–∞–º–∏, –≤—ã—è—Å–Ω–∏–ª ¬´–§–í¬ª. –ú–æ–∂–Ω–æ –æ—Ç–∫–ª–æ–Ω–∏—Ç—å—Å—è –ö–æ–º–∏—Ç–µ—Ç –ì–æ—Å–¥—É–º—ã –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è –ø–æ–¥–¥–µ—Ä–∂–∞–ª –ø–æ–ø—Ä–∞–≤–∫–∏ –æ –ø—Ä–∞–≤–µ –≤—Ä–∞—á–∞ –æ—Ç–∫–ª–æ–Ω—è—Ç—å—Å—è –æ—Ç –∫–ª–∏–Ω—Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π, –∫–æ—Ç–æ—Ä—ã–µ —Å 1 —è–Ω–≤–∞—Ä—è —Å—Ç–∞–ª–∏ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–º–∏ –¥–ª—è –æ–∫–∞–∑–∞–Ω–∏—è –º–µ–¥–ø–æ–º–æ—â–∏.","{""skip"": true}"
2025-06-26T14:50:04+00:00,@medpharm,12291,https://t.me/medpharm/12291,"–ú–µ—Ö–∞–Ω–∏–∑–º –ø–æ–ª—É—á–µ–Ω–∏—è –∫–æ–º–ø–ª–µ–∫—Å–∞ —Ä–∞–∑—Ä–µ—à–µ–Ω–∏–π —á–µ—Ä–µ–∑ –æ–¥–Ω–æ –∑–∞—è–≤–ª–µ–Ω–∏–µ —Ä–µ—à–∏–ª–∏ –æ–ø—Ä–æ–±–æ–≤–∞—Ç—å –Ω–∞ –ø—Ä–µ–¥–ø—Ä–∏–Ω–∏–º–∞—Ç–µ–ª—è—Ö, —Ä–µ—à–∏–≤—à–∏—Ö –æ—Ç–∫—Ä—ã—Ç—å –∞–ø—Ç–µ–∫—É. –ö–æ–º–ø–ª–µ–∫—Å–Ω–∞—è —É—Å–ª—É–≥–∞ ¬´–û—Ç–∫—Ä—ã—Ç–∏–µ –∞–ø—Ç–µ–∫–∏¬ª —Å—Ç–∞–ª–∞ –¥–æ—Å—Ç—É–ø–Ω–∞ –Ω–∞ ¬´–ì–æ—Å—É—Å–ª—É–≥–∞—Ö¬ª. –ó–∞–ø–æ–ª–Ω–µ–Ω–∏–µ –∑–∞—è–≤–ª–µ–Ω–∏—è –∑–∞–Ω–∏–º–∞–µ—Ç –æ–∫–æ–ª–æ 10 –º–∏–Ω—É—Ç, –µ—Å–ª–∏ –µ–≥–æ –æ–¥–æ–±—Ä—è—Ç, —Ç–æ –≤–µ—Å—å –∫–æ–º–ø–ª–µ–∫—Å —Ä–∞–∑—Ä–µ—à–µ–Ω–∏–π –ø—Ä–µ–¥–ø—Ä–∏–Ω–∏–º–∞—Ç–µ–ª—å –ø–æ–ª—É—á–∏—Ç –≤ —Ç–µ—á–µ–Ω–∏–µ —Ç—Ä–µ—Ö –º–µ—Å—è—Ü–µ–≤.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""registration, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""A multi-permit service 'Opening an Apothecary' is now available on 'State Services'. Filling out the application takes around 10 minutes. If approved, all permit-related documents will be provided to the entrepreneur within three months.""
}"
2025-06-26T13:31:15+00:00,@medpharm,12290,https://t.me/medpharm/12290,–ó–∞–∫–ª—é—á–µ–Ω–Ω—ã–µ –ø–æ–¥ —Å—Ç—Ä–∞–∂—É –≤ –°–ò–ó–û –∏–ª–∏ –æ—Ç–±—ã–≤–∞—é—â–∏–µ –Ω–∞–∫–∞–∑–∞–Ω–∏–µ –≤ –∫–æ–ª–æ–Ω–∏–∏ —Å–º–æ–≥—É—Ç –ø–æ–ª—É—á–∞—Ç—å –ø–ª–∞—Ç–Ω—É—é –º–µ–¥–∏—Ü–∏–Ω—Å–∫—É—é –ø–æ–º–æ—â—å –∑–∞ —Å–≤–æ–π —Å—á–µ—Ç. –î–ª—è —ç—Ç–æ–≥–æ –ø–æ—Ç—Ä–µ–±—É—é—Ç—Å—è –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–µ —É—Å–ª–æ–≤–∏—è: –Ω–∞–ª–∏—á–∏–µ –ø–æ–∫–∞–∑–∞–Ω–∏–π –∏ –Ω–µ–≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –ø–æ–ª—É—á–∏—Ç—å –ª–µ—á–µ–Ω–∏–µ –±–µ—Å–ø–ª–∞—Ç–Ω–æ –ø–æ –ü—Ä–æ–≥—Ä–∞–º–º–µ –≥–æ—Å–≥–∞—Ä–∞–Ω—Ç–∏–π.,"{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""The message discusses the possibility of patients in prisons or under house arrest receiving paid medical care at their own expense, requiring additional conditions such as medical necessity and the inability to receive treatment for free under state guarantees.""
}"
2025-06-26T11:47:13+00:00,@medpharm,12289,https://t.me/medpharm/12289,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª –Ω–æ–≤—ã–π –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π –∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫ —Å –ú–ù–ù –¥–∂–æ–∑–∞–º–∏—Ü–∏–Ω –æ—Ç –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç¬ª. –≠—Ç–æ –¥–∂–µ–Ω–µ—Ä–∏–∫ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞, –∫–æ—Ç–æ—Ä—ã–π –∏–¥–µ–Ω—Ç–∏—á–µ–Ω –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω–æ–º—É –ø—Ä–µ–ø–∞—Ä–∞—Ç—É –≤ –∞–Ω–∞–ª–æ–≥–∏—á–Ω–æ–π –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π —Ñ–æ—Ä–º–µ, —á—Ç–æ –±—ã–ª–æ –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–µ–Ω–æ –≤ –ø—Ä–æ—Å–ø–µ–∫—Ç–∏–≤–Ω–æ–º –æ—Ç–∫—Ä—ã—Ç–æ–º —Ä–∞–Ω–¥–æ–º–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω–æ–º –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–∏ –ø–æ –∏–∑—É—á–µ–Ω–∏—é —Å—Ä–∞–≤–Ω–∏—Ç–µ–ª—å–Ω–æ–π —Ñ–∞—Ä–º–∞–∫–æ–∫–∏–Ω–µ—Ç–∏–∫–∏ –∏ –±–∏–æ—ç–∫–≤–∏–≤–∞–ª–µ–Ω—Ç–Ω–æ—Å—Ç–∏.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration, reimbursement, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The Russian Ministry of Health has registered a new domestic antibiotic, djozymcin from the 'Farmstandart' company. This is a generic of the original drug that is identical to the original in terms of pharmacokinetics and bioequivalence, as confirmed by a prospective open randomized study.""
}"
2025-06-26T11:12:50+00:00,@medpharm,12288,https://t.me/medpharm/12288,–ú–∏–Ω–∑–¥—Ä–∞–≤ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª –Ω–æ–≤—ã–µ –ø–æ—Ä—è–¥–∫–∏ –æ–∫–∞–∑–∞–Ω–∏—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –ø–æ –ø—Ä–æ—Ñ–∏–ª—é ¬´–ü—Å–∏—Ö–∏–∞—Ç—Ä–∏—è-–Ω–∞—Ä–∫–æ–ª–æ–≥–∏—è¬ª. –ü–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –ø–æ–≤—ã—Å–∏—Ç—å –Ω–∞–≥—Ä—É–∑–∫—É –Ω–∞ –¥–µ—Ç—Å–∫–∏—Ö —É—á–∞—Å—Ç–∫–æ–≤—ã—Ö –ø—Å–∏—Ö–∏–∞—Ç—Ä–æ–≤-–Ω–∞—Ä–∫–æ–ª–æ–≥–æ–≤ –∏ –æ–±—è–∑–∞—Ç—å –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –Ω–∞ –¥–∏—Å–ø–∞–Ω—Å–µ—Ä–Ω–æ–º –Ω–∞–±–ª—é–¥–µ–Ω–∏–∏ –≤—Å—Ç–∞–≤–∞—Ç—å –Ω–∞ —É—á–µ—Ç –ø—Ä–∏ —Å–º–µ–Ω–µ –º–µ—Å—Ç–∞ –∂–∏—Ç–µ–ª—å—Å—Ç–≤–∞.,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health has developed new guidelines for mental health care under the 'Psychiatry-Narcology' profile. Plans include increasing workload on pediatric psychiatric-narcological doctors and requiring patients under outpatient care to register at a medical facility upon changing their place of residence.""
}"
2025-06-26T10:10:58+00:00,@medpharm,12287,https://t.me/medpharm/12287,"#–≠–∫—Å–∫–ª—é–∑–∏–≤ –í –º–∞—Ä—Ç–µ –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–æ —Å—Ç–∞–ª–æ –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω–æ–π —Ç—Ä—É–¥–æ–≤–æ–π —Ñ—É–Ω–∫—Ü–∏–µ–π —Å —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–∏–º –≤–æ–∑–Ω–∞–≥—Ä–∞–∂–¥–µ–Ω–∏–µ–º. –î–ª—è –∫–æ–≥–æ-—Ç–æ —ç—Ç–æ —Å—Ç–∞–ª–æ –Ω–æ–≤–µ–ª–ª–æ–π, –Ω–æ –Ω–∞ –º–Ω–æ–≥–∏—Ö —Ñ–∞—Ä–º–ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏—è—Ö —Ç–∞–∫–∞—è –ø—Ä–∞–∫—Ç–∏–∫–∞ —Å—É—â–µ—Å—Ç–≤–æ–≤–∞–ª–∞ –∏ —Ä–∞–Ω–µ–µ –∏ —Ä–µ–≥—É–ª–∏—Ä–æ–≤–∞–ª–∞—Å—å –ª–æ–∫–∞–ª—å–Ω—ã–º–∏ –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω—ã–º–∏ –∞–∫—Ç–∞–º–∏, –≤—ã—è—Å–Ω–∏–ª ¬´–§–í¬ª.","{""skip"": true}"
2025-06-26T09:05:21+00:00,@medpharm,12286,https://t.me/medpharm/12286,"–†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä –ø—Ä–µ–¥–ª–æ–∂–∏–ª –∏–∑–º–µ–Ω–∏—Ç—å –ø—Ä–∞–≤–∏–ª–∞ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è —Å–∞–Ω–∏—Ç–∞—Ä–Ω–æ-—ç–ø–∏–¥–µ–º–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ –Ω–∞–¥–∑–æ—Ä–∞. –ü–ª–∞–Ω–æ–≤—ã–µ –ø—Ä–æ–≤–µ—Ä–∫–∏ –¥–ª—è —Ä—è–¥–∞ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –±—É–¥—É—Ç –∑–∞–º–µ–Ω–µ–Ω—ã –Ω–∞ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–µ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–∏–µ –≤–∏–∑–∏—Ç—ã, –∏–∑–º–µ–Ω–∏—Ç—Å—è –∏—Ö –ø–µ—Ä–∏–æ–¥–∏—á–Ω–æ—Å—Ç—å, –¥–æ–±–∞–≤—è—Ç—Å—è –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –¥–ª—è –∏—Ö –¥–∏—Å—Ç–∞–Ω—Ü–∏–æ–Ω–Ω–æ–≥–æ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è –∏ –Ω–æ–≤–æ–µ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏–µ –∫–æ–Ω—Ç—Ä–æ–ª—è.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanitation, regulation, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The Health Supervision Authority proposed changes to the routine inspection procedures for various organizations, replacing them with mandatory preventive visits. The frequency of these visits will change, and they may be conducted remotely.""
}"
2025-06-26T07:00:01+00:00,@medpharm,12285,https://t.me/medpharm/12285,"–ù–∞ —Ñ–æ–Ω–µ —Ä–∞—Å—Ç—É—â–µ–≥–æ —á–∏—Å–ª–∞ —Å–ª—É—á–∞–µ–≤ –Ω–µ–π—Ä–æ–¥–µ–≥–µ–Ω–µ—Ä–∞—Ç–∏–≤–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –∫–ª—é—á–µ–≤—ã–º–∏ —Å—Ç–∞–Ω–æ–≤—è—Ç—Å—è –≤–æ–ø—Ä–æ—Å—ã —Å–≤–æ–µ–≤—Ä–µ–º–µ–Ω–Ω–æ–π –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∏ –∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏. –ü–æ—á–µ–º—É –ø–∞—Ü–∏–µ–Ω—Ç—ã —Å –¥–µ–º–µ–Ω—Ü–∏–µ–π –ø–æ–ª—É—á–∞—é—Ç –ø–æ–º–æ—â—å –ø—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–µ–Ω–Ω–æ –Ω–∞ –ø–æ–∑–¥–Ω–∏—Ö —Å—Ç–∞–¥–∏—è—Ö –∏ –∫–∞–∫–∏–µ –ø–æ–¥—Ö–æ–¥—ã –º–æ–≥—É—Ç –∏–∑–º–µ–Ω–∏—Ç—å —Å–∏—Ç—É–∞—Ü–∏—é, —ç–∫—Å–ø–µ—Ä—Ç—ã —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏ ¬´–ú–í¬ª.","{""skip"": true}"
2025-06-25T16:30:01+00:00,@medpharm,12284,https://t.me/medpharm/12284,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 25 –∏—é–Ω—è –¢—É—Ç –≤–∞–º –Ω–µ IT –ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ –∑–∞–Ω–∏–º–∞–µ—Ç —Ç—Ä–µ—Ç—å–µ –º–µ—Å—Ç–æ —Å —Ç–æ—á–∫–∏ –∑—Ä–µ–Ω–∏—è –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ –ø–æ—Å—Ç—Ä–æ–µ–Ω–∏—è —É—Å–ø–µ—à–Ω–æ–π –∫–∞—Ä—å–µ—Ä—ã (12%), –ø–æ–∫–∞–∑–∞–ª –æ–ø—Ä–æ—Å —Å–µ—Ä–≤–∏—Å–∞ SuperJob. –ù–∞ –ø–µ—Ä–≤–æ–µ –º–µ—Å—Ç–æ –æ–ø—Ä–æ—à–µ–Ω–Ω—ã–µ —É–≤–µ—Ä–µ–Ω–Ω–æ –ø–æ—Å—Ç–∞–≤–∏–ª–∏ IT-—Å–µ–∫—Ç–æ—Ä. –ö–æ–≥–¥–∞ —è–∑—ã–∫ ‚Äì –≤—Ä–∞–≥ –í —ç—Ç–æ–º –≥–æ–¥—É –Ω–µ—Å–∫–æ–ª—å–∫–æ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π –æ–±—Ä–∞—Ç–∏–ª–∏—Å—å –≤ —Å—É–¥ —Å –∏—Å–∫–∞–º–∏ –ø—Ä–æ—Ç–∏–≤ –≤–µ–¥—É—â–∏—Ö –±–ª–æ–≥–∏ –≤—Ä–∞—á–µ–π –ª–∏–±–æ –ø—Ä–µ–¥—ä—è–≤–∏–ª–∏ –∏–º –¥–æ—Å—É–¥–µ–±–Ω—ã–µ –ø—Ä–µ—Ç–µ–Ω–∑–∏–∏. –ò—Å–∫–∏ –≥—Ä–æ–∑—è—Ç –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–∞–º –º–Ω–æ–≥–æ–º–∏–ª–ª–∏–æ–Ω–Ω—ã–º–∏ —É–±—ã—Ç–∫–∞–º–∏ –∏ –ø—Ä–∏–≤–ª–µ—á–µ–Ω–∏–µ–º –∫ –∞–¥–º–∏–Ω–∏—Å—Ç—Ä–∞—Ç–∏–≤–Ω–æ–π –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç–∏. ¬´–ú–í¬ª —É–∑–Ω–∞–ª —É —é—Ä–∏—Å—Ç–æ–≤, –∫–∞–∫ –∑–∞—â–∏—Ç–∏—Ç—å—Å—è —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞–º –ø—Ä–∏ –≤—ã—Å–∫–∞–∑—ã–≤–∞–Ω–∏–∏ —Å–≤–æ–µ–≥–æ –º–Ω–µ–Ω–∏—è –æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞—Ö. –ê–Ω—Ç–ò–ò–∫–∞—Ä—Ç–µ–ª—å –ü—Ä–µ–∑–∏–¥–µ–Ω—Ç –ø–æ–¥–ø–∏—Å–∞–ª –∑–∞–∫–æ–Ω –æ —Å–æ–∑–¥–∞–Ω–∏–∏ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω–æ–π —Å–∏—Å—Ç–µ–º—ã –ø–æ –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏—é, –≤—ã—è–≤–ª–µ–Ω–∏—é –∏ –ø—Ä–µ—Å–µ—á–µ–Ω–∏—é –∫–∞—Ä—Ç–µ–ª—å–Ω—ã—Ö —Å–æ–≥–ª–∞—à–µ–Ω–∏–π ‚Äî –ì–ò–° ¬´–ê–Ω—Ç–∏–∫–∞—Ä—Ç–µ–ª—å¬ª. –°–∏—Å—Ç–µ–º–∞ –±—É–¥–µ—Ç —Å–∫–∞–Ω–∏—Ä–æ–≤–∞—Ç—å –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é –æ —Ç–æ—Ä–≥–∞—Ö —Å –ø–æ–º–æ—â—å—é –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–∞ —Å 1 –∞–≤–≥—É—Å—Ç–∞. –í–µ—Ä–¥–∏–∫—Ç –ø–æ ¬´–§–æ—Ä—Å–∏–≥–µ¬ª –í–µ—Ä—Ö–æ–≤–Ω—ã–π —Å—É–¥ –ø–æ–¥–¥–µ—Ä–∂–∞–ª –ø–æ–∑–∏—Ü–∏—é –§–ê–° –≤ –¥–µ–ª–µ –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ê–∫—Ä–∏—Ö–∏–Ω¬ª, –∫–æ—Ç–æ—Ä–æ–µ –∫–∞—Å–∞–µ—Ç—Å—è –¥–∂–µ–Ω–µ—Ä–∏–∫–∞ –ø—Ä–æ—Ç–∏–≤–æ–¥–∏–∞–±–µ—Ç–∏—á–µ—Å–∫–æ–≥–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ AstraZeneca ¬´–§–æ—Ä—Å–∏–≥–∞¬ª. –ü—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å –ø—ã—Ç–∞–ª—Å—è –æ—Å–ø–æ—Ä–∏—Ç—å –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å–Ω—ã–µ —Ä–∞–∑—ä—è—Å–Ω–µ–Ω–∏—è –≤–µ–¥–æ–º—Å—Ç–≤–∞ –ø–æ –∑–∞–∫—É–ø–∫–∞–º –¥–∂–µ–Ω–µ—Ä–∏–∫–∞ –¥–∞–ø–∞–≥–ª–∏—Ñ–ª–æ–∑–∏–Ω–∞.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The President signed a law creating an information system for the prevention, detection and suppression of cartel agreements - G-INFO 'Anti-cartel'. The system will scan trade information using artificial intelligence starting from August. In the 'Forsige' case, the Supreme Court supported FAS's position in the case involving company 'Akrihin', which relates to AstraZeneca's dapagliflozin generic drug purchases. The producer tried to challenge FAS's antimonopoly clarifications regarding bulk purchases of the drug.""
}"
2025-06-25T14:31:22+00:00,@medpharm,12283,https://t.me/medpharm/12283,"–ü—Ä–µ–∑–∏–¥–µ–Ω—Ç –ø–æ—Ä—É—á–∏–ª –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤—É —Å–æ–≤–º–µ—Å—Ç–Ω–æ —Å ¬´–î–µ–ª–æ–≤–æ–π –†–æ—Å—Å–∏–µ–π¬ª –ø–æ–¥–≥–æ—Ç–æ–≤–∏—Ç—å –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è –ø–æ —Å–æ–≤–µ—Ä—à–µ–Ω—Å—Ç–≤–æ–≤–∞–Ω–∏—é –º–µ—Ö–∞–Ω–∏–∑–º–∞ –∫–ª–∞—Å—Ç–µ—Ä–Ω–æ–π –ø–ª–∞—Ç—Ñ–æ—Ä–º—ã –≤ —á–∞—Å—Ç–∏ –ø–æ–¥–¥–µ—Ä–∂–∫–∏ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã—Ö —Ä–∞–∑—Ä–∞–±–æ—Ç–æ–∫, –∞ —Ç–∞–∫–∂–µ –ø–æ —É–ª—É—á—à–µ–Ω–∏—é –ø–æ—Ä—è–¥–∫–∞ –∏–∑–º–µ–Ω–µ–Ω–∏—è —Å—É—â–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö —É—Å–ª–æ–≤–∏–π –æ—Ñ—Å–µ—Ç–Ω—ã—Ö –∫–æ–Ω—Ç—Ä–∞–∫—Ç–æ–≤ –≤ —Ñ–∞—Ä–º–º–µ–¥–ø—Ä–æ–º–µ. –°–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–∏–µ –ø–æ—Ä—É—á–µ–Ω–∏—è –¥–∞–Ω—ã –ø–æ –∏—Ç–æ–≥–∞–º –º–∞–π—Å–∫–æ–π –≤—Å—Ç—Ä–µ—á–∏ –≥–ª–∞–≤—ã –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–∞ —Å —á–ª–µ–Ω–∞–º–∏ ¬´–î–µ–ª–æ–≤–æ–π –†–æ—Å—Å–∏–∏¬ª.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The President instructed the government to work with 'Business Russia' to prepare proposals for improving the innovation support mechanism of cluster platform, as well as for improving the order of changing significant contract conditions in pharmaceuticals. Corresponding instructions were given based on the results of the May meeting between the country's head and members of 'Business Russia'.""
}"
2025-06-25T12:30:36+00:00,@medpharm,12282,https://t.me/medpharm/12282,"–ö–æ–º–∏—Ç–µ—Ç –ì–æ—Å–¥—É–º—ã –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è –ø–æ–¥–¥–µ—Ä–∂–∞–ª –≤–Ω–µ—Å–µ–Ω–Ω—ã–µ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ–º –ø–æ–ø—Ä–∞–≤–∫–∏, –¥–∞—é—â–∏–µ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –≤—Ä–∞—á–∞–º –æ—Ç–∫–ª–æ–Ω—è—Ç—å—Å—è –æ—Ç –Ω–æ—Ä–º –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π, –µ—Å–ª–∏ —ç—Ç–æ–≥–æ —Ç—Ä–µ–±—É—é—Ç –∏–Ω—Ç–µ—Ä–µ—Å—ã –ø–∞—Ü–∏–µ–Ω—Ç–∞. –í –±–ª–∏–∂–∞–π—à–µ–µ –≤—Ä–µ–º—è –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –±—É–¥–µ—Ç —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω –≤–æ –≤—Ç–æ—Ä–æ–º —á—Ç–µ–Ω–∏–∏.","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""The Committee of the State Duma on Health Care supported amendments proposed by the government, allowing doctors to deviate from clinical recommendations if it serves the patient's interests. The project will be considered at second reading in the near future.""
}"
2025-06-25T11:13:48+00:00,@medpharm,12281,https://t.me/medpharm/12281,"–í–µ—Ä—Ö–æ–≤–Ω—ã–π —Å—É–¥ –ø–æ–¥–¥–µ—Ä–∂–∞–ª –ø–æ–∑–∏—Ü–∏—é –§–ê–° –≤ –¥–µ–ª–µ –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ê–∫—Ä–∏—Ö–∏–Ω¬ª, –∫–æ—Ç–æ—Ä–æ–µ –∫–∞—Å–∞–µ—Ç—Å—è –¥–∂–µ–Ω–µ—Ä–∏–∫–∞ –ø—Ä–æ—Ç–∏–≤–æ–¥–∏–∞–±–µ—Ç–∏—á–µ—Å–∫–æ–≥–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ AstraZeneca ¬´–§–æ—Ä—Å–∏–≥–∞¬ª. –ü—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å –ø—ã—Ç–∞–ª—Å—è –æ—Å–ø–æ—Ä–∏—Ç—å –∞–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å–Ω—ã–µ —Ä–∞–∑—ä—è—Å–Ω–µ–Ω–∏—è –≤–µ–¥–æ–º—Å—Ç–≤–∞ –ø–æ –∑–∞–∫—É–ø–∫–∞–º –¥–∂–µ–Ω–µ—Ä–∏–∫–∞ –¥–∞–ø–∞–≥–ª–∏—Ñ–ª–æ–∑–∏–Ω–∞.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement"",
  ""impact"": ""high"",
  ""english"": ""The Supreme Court supported the FAS's position in a case against 'Akrihin' company regarding generic anti-diabetic drug AstraZeneca 'Forziga'. The producer tried to challenge the antimonopoly clarifications by the authority on procurement of dapagliflozin generics.""
}"
2025-06-25T09:43:17+00:00,@medpharm,12280,https://t.me/medpharm/12280,"–î–µ–ø—É—Ç–∞—Ç—ã –ì–æ—Å–¥—É–º—ã –ø—Ä–∏–Ω—è–ª–∏ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–µ–Ω–Ω—ã–π –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç, —É–∂–µ—Å—Ç–æ—á–∞—é—â–∏–π –∫–æ–Ω—Ç—Ä–æ–ª—å –∑–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º–∏ –ø—Ä–æ—Ç–∏–≤–æ–ø–æ–∫–∞–∑–∞–Ω–∏—è–º–∏ –∫ —É–ø—Ä–∞–≤–ª–µ–Ω–∏—é —Ç—Ä–∞–Ω—Å–ø–æ—Ä—Ç–æ–º. –î–æ–∫—É–º–µ–Ω—Ç —É—Ç–æ—á–Ω—è–µ—Ç –ø–æ—Ä—è–¥–æ–∫ –¥–µ–π—Å—Ç–≤–∏–π –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏–π –∏ –æ—Ä–≥–∞–Ω–æ–≤ –ú–í–î –ø—Ä–∏ –æ–±–Ω–∞—Ä—É–∂–µ–Ω–∏–∏ –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω–æ —É–≥—Ä–æ–∂–∞—é—â–∏—Ö –±–µ–∑–æ–ø–∞—Å–Ω–æ–º—É –≤–æ–∂–¥–µ–Ω–∏—é —Å–æ—Å—Ç–æ—è–Ω–∏–π –∑–¥–æ—Ä–æ–≤—å—è —É –≥—Ä–∞–∂–¥–∞–Ω.","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""clinical_trial, safety"",
  ""impact"": ""medium"",
  ""english"": ""The deputies of the State Duma approved a government bill that strengthens control over medical contraindications for driving. The document clarifies the procedures for healthcare institutions and MVD organs when potentially dangerous health conditions of citizens are detected.""
}"
2025-06-25T08:39:34+00:00,@medpharm,12279,https://t.me/medpharm/12279,"–ü—Ä–µ–∑–∏–¥–µ–Ω—Ç –ø–æ–¥–ø–∏—Å–∞–ª –∑–∞–∫–æ–Ω –æ —Å–æ–∑–¥–∞–Ω–∏–∏ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω–æ–π —Å–∏—Å—Ç–µ–º—ã –ø–æ –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏—é, –≤—ã—è–≤–ª–µ–Ω–∏—é –∏ –ø—Ä–µ—Å–µ—á–µ–Ω–∏—é –∫–∞—Ä—Ç–µ–ª—å–Ω—ã—Ö —Å–æ–≥–ª–∞—à–µ–Ω–∏–π ‚Äî –ì–ò–° ¬´–ê–Ω—Ç–∏–∫–∞—Ä—Ç–µ–ª—å¬ª. –°–∏—Å—Ç–µ–º–∞ –±—É–¥–µ—Ç —Å–∫–∞–Ω–∏—Ä–æ–≤–∞—Ç—å –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é –æ —Ç–æ—Ä–≥–∞—Ö —Å –ø–æ–º–æ—â—å—é –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–∞ —Å 1 –∞–≤–≥—É—Å—Ç–∞.","{""skip"": true}"
2025-06-25T07:01:33+00:00,@medpharm,12278,https://t.me/medpharm/12278,–ï–≤—Ä–æ–ø–µ–π—Å–∫–∏–µ —Ä–µ–≤–º–∞—Ç–æ–ª–æ–≥–∏ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∏ –æ–±–Ω–æ–≤–ª–µ–Ω–Ω—ã–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø–æ –ª–µ—á–µ–Ω–∏—é —Ä–µ–≤–º–∞—Ç–æ–∏–¥–Ω–æ–≥–æ –∞—Ä—Ç—Ä–∏—Ç–∞. –í –¥–æ–∫—É–º–µ–Ω—Ç–µ –ø–µ—Ä–µ—Å–º–æ—Ç—Ä–µ–Ω—ã –ø–æ–¥—Ö–æ–¥—ã –∫ —Ç–µ—Ä–∞–ø–∏–∏ –ø—Ä–∏ –Ω–µ—ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –º–µ—Ç–æ—Ç—Ä–µ–∫—Å–∞—Ç–∞. –≠–∫—Å–ø–µ—Ä—Ç—ã –æ—Ç–º–µ–Ω–∏–ª–∏ —Å—Ç—Ä–∞—Ç–∏—Ñ–∏–∫–∞—Ü–∏—é –ª–µ—á–µ–Ω–∏—è –ø–æ –Ω–µ–±–ª–∞–≥–æ–ø—Ä–∏—è—Ç–Ω—ã–º –ø—Ä–æ–≥–Ω–æ—Å—Ç–∏—á–µ—Å–∫–∏–º –ø—Ä–∏–∑–Ω–∞–∫–∞–º.,"{""skip"": true}"
2025-06-24T16:01:25+00:00,@medpharm,12277,https://t.me/medpharm/12277,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 24 –∏—é–Ω—è –ó–∞ —è–∑—ã–∫ –ø—Ä–∏—Ç—è–Ω—É—Ç –ü—Ä–µ–∑–∏–¥–µ–Ω—Ç –ø–æ–¥–ø–∏—Å–∞–ª –∑–∞–∫–æ–Ω –æ –∑–∞–ø—Ä–µ—Ç–µ –≤—ã–≤–µ—Å–æ–∫ –∏ –Ω–∞–¥–ø–∏—Å–µ–π –æ –ø—Ä–æ–≤–æ–¥–∏–º—ã—Ö –∞–∫—Ü–∏—è—Ö –Ω–∞ –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω–æ–º —è–∑—ã–∫–µ. –ò–∑–º–µ–Ω–µ–Ω–∏—è –≤—Å—Ç—É–ø—è—Ç –≤ —Å–∏–ª—É —Å 1 –º–∞—Ä—Ç–∞ 2026 –≥–æ–¥–∞ –∏ –Ω–µ –∫–æ—Å–Ω—É—Ç—Å—è —Ñ–∏—Ä–º–µ–Ω–Ω—ã—Ö –Ω–∞–∏–º–µ–Ω–æ–≤–∞–Ω–∏–π –∏ —Ç–æ–≤–∞—Ä–Ω—ã—Ö –∑–Ω–∞–∫–æ–≤. –í–µ—Ç–ø–æ—à–ª–∏–Ω—ã –ø–æ–π–¥—É—Ç –≤ —Ä–æ—Å—Ç –ö–æ–º–∏—Ç–µ—Ç –ì–æ—Å–¥—É–º—ã —Ä–µ–∫–æ–º–µ–Ω–¥–æ–≤–∞–ª –ø—Ä–∏–Ω—è—Ç –≤ –ø–µ—Ä–≤–æ–º —á—Ç–µ–Ω–∏–∏ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ–± —É—Å—Ç–∞–Ω–æ–≤–∫–µ —Ä–∞–∑–º–µ—Ä–∞ –≥–æ—Å–ø–æ—à–ª–∏–Ω –∑–∞ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—é –≤–µ—Ç–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –ï–ê–≠–°. –î–æ–∫—É–º–µ–Ω—Ç–æ–º –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è —É—Å—Ç–∞–Ω–æ–≤–∏—Ç—å –ø–æ—à–ª–∏–Ω—É –≤ 461 —Ç—ã—Å. —Ä—É–±. –∑–∞ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏–µ —ç–∫—Å–ø–µ—Ä—Ç–∏–∑—ã –≤–µ—Ç–ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –¥–ª—è –µ–≥–æ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏. –î–µ–Ω—å–≥–∏ –Ω–∞ –±–æ—á–∫—É –≠–∫—Å–ø–µ—Ä—Ç—ã —Ä–∞—Å—Å—á–∏—Ç–∞–ª–∏ —Å—Ç–æ–∏–º–æ—Å—Ç—å —Ä–∞—Å—à–∏—Ä–µ–Ω–∏—è –ø—Ä–æ–≥—Ä–∞–º–º ¬´–ë–æ—Ä—å–±–∞ —Å —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏¬ª –∏ –ª—å–≥–æ—Ç–Ω–æ–≥–æ –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è. –ü–æ –ø—Ä–µ–¥–≤–∞—Ä–∏—Ç–µ–ª—å–Ω—ã–º –æ—Ü–µ–Ω–∫–∞–º, –≤–∫–ª—é—á–µ–Ω–∏–µ –≤ –Ω–∏—Ö –Ω–æ–≤—ã—Ö –≥—Ä—É–ø–ø –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏ –ø–æ—Ç—Ä–µ–±—É–µ—Ç —É–≤–µ–ª–∏—á–µ–Ω–∏—è —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è –º–∏–Ω–∏–º—É–º –Ω–∞ 44 –º–ª—Ä–¥ —Ä—É–±. –î–∞–¥—É—Ç —Å—Ç–∞—Ç—É—Å –ì–æ—Å–¥—É–º–∞ –ø—Ä–∏–Ω—è–ª–∞ –≤ –ø–µ—Ä–≤–æ–º —á—Ç–µ–Ω–∏–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–Ω—ã–π –ú–∏–Ω–∑–¥—Ä–∞–≤–æ–º –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ –ø—Ä–∞–≤–æ–≤–æ–º —Å—Ç–∞—Ç—É—Å–µ –†–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –ö—Ä–∞—Å–Ω–æ–≥–æ –ö—Ä–µ—Å—Ç–∞.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The law has been signed by the President prohibiting signs and notices about conducted actions in a foreign language. The changes will take effect on March 1, 2026 and won't affect the brand names and trademarks. The Committee of State Duma recommended to approve a project on setting up an amount for registration fees for veterinary drugs in the EAEU. The document suggests a fee of 461 thousand rubles for conducting an expert review to register a veterinary drug. The experts calculated the cost of expanding the 'Fight against cardiovascular diseases' program and the subsidized medication supply program. Inclusion of new groups of patients with cardiovascular diseases will require an increase in funding by a minimum of 4.4 billion rubles. The State Duma approved the project on the legal status of the Russian Red Cross in its first reading.""
}"
2025-06-24T14:46:27+00:00,@medpharm,12276,https://t.me/medpharm/12276,"–°–æ–≥–ª–∞—Å–Ω–æ –¥–∞–Ω–Ω—ã–º AlphaRM –∑–∞ —á–µ—Ç—ã—Ä–µ –º–µ—Å—è—Ü–∞ 2025 –≥–æ–¥–∞, —Ä—ã–Ω–æ–∫ –∞–ø—Ç–µ—á–Ω–æ–π —Ä–æ–∑–Ω–∏—Ü—ã –¥–µ–º–æ–Ω—Å—Ç—Ä–∏—Ä—É–µ—Ç —É—Å–∏–ª–µ–Ω–∏–µ –∫–æ–Ω—Å–æ–ª–∏–¥–∞—Ü–∏–∏ –∏ —Ä–æ—Å—Ç –æ–Ω–ª–∞–π–Ω-–ø—Ä–æ–¥–∞–∂. –î–æ–ª—è –¥–≤–∞–¥—Ü–∞—Ç–∏ –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö —Å–µ—Ç–µ–π –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç —Ä–∞—Å—Ç–∏, –æ–Ω–∏ –∫–æ–Ω—Ç—Ä–æ–ª–∏—Ä—É—é—Ç –ø–æ—á—Ç–∏ –¥–≤–µ —Ç—Ä–µ—Ç–∏ –æ–±–æ—Ä–æ—Ç–∞. E-com –∑–∞–Ω–∏–º–∞–µ—Ç 14,3% —Ñ–∞—Ä–º—Ä–∏—Ç–µ–π–ª–∞.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The data from AlphaRM shows an increase in consolidation and growth of online pharmacy sales over the past four months. The top twenty largest chains continue to grow, controlling almost two-thirds of the retail market. E-commerce accounts for 14.3% of pharmaceutical retail.""
}"
2025-06-24T13:30:09+00:00,@medpharm,12275,https://t.me/medpharm/12275,"–í–∞–∫–∞–Ω—Å–∏–∏ –¥–ª—è –≤—Ä–∞—á–µ–π –≤ –∏—é–Ω–µ 2025 –≥–æ–¥–∞ –ø–æ–ø–∞–ª–∏ –≤ TOP —Å–∞–º—ã—Ö –≤—ã—Å–æ–∫–æ–æ–ø–ª–∞—á–∏–≤–∞–µ–º—ã—Ö –≤ —Å–µ–º–∏ –≥–æ—Ä–æ–¥–∞—Ö –†–æ—Å—Å–∏–∏. –ß–∞—â–µ –≤—Å–µ–≥–æ –≤—ã—Å–æ–∫–∏–µ –∑–∞—Ä–ø–ª–∞—Ç—ã –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç —Å—Ç–æ–º–∞—Ç–æ–ª–æ–≥–∞–º, –Ω–æ –µ—Å—Ç—å –≤—ã–≥–æ–¥–Ω—ã–µ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è –∏ –¥–ª—è –æ—Ñ—Ç–∞–ª—å–º–æ—Ö–∏—Ä—É—Ä–≥–∞, –∫–∞—Ä–¥–∏–æ–ª–æ–≥–∞ –∏ —Ç–µ—Ä–∞–ø–µ–≤—Ç–∞.","{""skip"": true}"
2025-06-24T11:01:46+00:00,@medpharm,12274,https://t.me/medpharm/12274,"–ö—É—Ä—Å –Ω–∞ –∏–Ω–Ω–æ–≤–∞—Ü–∏–∏ –∏ —É—Å–∫–æ—Ä–µ–Ω–∏–µ —Ä–µ–≥—É–ª—è—Ç–æ—Ä–Ω—ã—Ö –ø—Ä–æ—Ü–µ–¥—É—Ä –ü–µ—Ä–µ–¥ —Ä–æ—Å—Å–∏–π—Å–∫–æ–π —Ñ–∞—Ä–º–æ–π —Å—Ç–æ–∏—Ç –∞–º–±–∏—Ü–∏–æ–∑–Ω–∞—è –∑–∞–¥–∞—á–∞ ‚Äî –æ–±–µ—Å–ø–µ—á–∏—Ç—å —Ä—ã–Ω–æ–∫ —Å–æ–≤—Ä–µ–º–µ–Ω–Ω—ã–º–∏ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–º–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏. –ò–∑-–∑–∞ —Å–æ–∫—Ä–∞—â–µ–Ω–∏—è –∑–∞–ø–∞–¥–Ω—ã—Ö –∫–ª–∏–Ω–∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –≤ –†–æ—Å—Å–∏–∏ –ø—Ä–µ–¥—Å—Ç–æ–∏—Ç –∑–∞–∫—Ä—ã—Ç—å –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç—å –≤ —Å–æ–≤—Ä–µ–º–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞—Ö –≤ –±–ª–∏–∂–∞–π—à–∏–µ 3-5 –ª–µ—Ç, –ø–æ–¥—á–µ—Ä–∫–Ω—É–ª –Ω–∞ –ü–ú–≠–§ –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç ¬´–ü–µ—Ç—Ä–æ–≤–∞–∫—Å –§–∞—Ä–º¬ª –ú–∏—Ö–∞–∏–ª –¶—ã—Ñ–µ—Ä–æ–≤. –î–ª—è —ç—Ç–æ–≥–æ –≤–∞–∂–Ω–æ —Å–æ–∫—Ä–∞—Ç–∏—Ç—å —Å—Ä–æ–∫–∏ —Ä–µ–≥—É–ª—è—Ç–æ—Ä–Ω—ã—Ö –ø—Ä–æ—Ü–µ–¥—É—Ä. –°–µ–π—á–∞—Å –ø—É—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –æ—Ç —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –¥–æ –ø–∞—Ü–∏–µ–Ω—Ç–∞ –º–æ–∂–µ—Ç –∑–∞–Ω–∏–º–∞—Ç—å –¥–æ –¥–≤—É—Ö –ª–µ—Ç. –£—Å–∫–æ—Ä–µ–Ω–∏–µ —ç—Ç–∏—Ö –ø—Ä–æ—Ü–µ—Å—Å–æ–≤ –ø–æ–∑–≤–æ–ª–∏—Ç –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º –±—ã—Å—Ç—Ä–µ–µ –æ–∫—É–ø–∞—Ç—å –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–∏ –∏ –ø—Ä–µ–¥–ª–∞–≥–∞—Ç—å –±–æ–ª–µ–µ –≤—ã–≥–æ–¥–Ω—ã–µ —Ü–µ–Ω—ã.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""high"",
  ""english"": ""There is a pressing need for modern medicines in Russia due to reduced Western clinical trials. President of 'Petrovax Farm' Mikhail Tsiferov emphasized that this will require shortening the registration process, which currently takes up to two years. Accelerating these processes would allow manufacturers to recover investments and offer more competitive prices.""
}"
2025-06-24T10:04:41+00:00,@medpharm,12273,https://t.me/medpharm/12273,–†–æ—Å—Å–∏–π—Å–∫–∏–µ –≥–µ–Ω–µ—Ç–∏–∫–∏ –≤–ø–µ—Ä–≤—ã–µ —É—Å—Ç–∞–Ω–æ–≤–∏–ª–∏ –¥–∏–∞–≥–Ω–æ–∑ —Å–∏–Ω–¥—Ä–æ–º–∞ BCARD. –≠—Ç–æ –Ω–æ–≤–æ–µ —Ä–µ–¥–∫–æ–µ –∞—É—Ç–æ—Å–æ–º–Ω–æ-—Ä–µ—Ü–µ—Å—Å–∏–≤–Ω–æ–µ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–µ —Å–æ–µ–¥–∏–Ω–∏—Ç–µ–ª—å–Ω–æ–π —Ç–∫–∞–Ω–∏.,"{""skip"": true}"
2025-06-24T09:31:38+00:00,@medpharm,12272,https://t.me/medpharm/12272,"¬´–ê–ª—å—Ñ–∞—Å–∏–≥–º–∞ –†—É—Å¬ª —Å–æ–æ–±—â–∏–ª–∞ –æ –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω—ã—Ö —É—Å–ø–µ—Ö–∞—Ö –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–º —Ä—ã–Ω–∫–µ. –í —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–∏ —Å –∞–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–∏–º–∏ –¥–∞–Ω–Ω—ã–º–∏** AlphaRM, –∫–æ–º–ø–∞–Ω–∏—è –∑–∞–Ω—è–ª–∞ —à–µ—Å—Ç—É—é —Å—Ç—Ä–æ—á–∫—É –ø–æ —Ç–µ–º–ø–∞–º –ø—Ä–∏—Ä–æ—Å—Ç–∞ –ø—Ä–æ–¥–∞–∂ –Ω–∞ —Ä–æ–∑–Ω–∏—á–Ω–æ–º –∫–æ–º–º–µ—Ä—á–µ—Å–∫–æ–º —Ä—ã–Ω–∫–µ —Å—Ä–µ–¥–∏ –∫–æ–º–ø–∞–Ω–∏–π —Å –∑–∞—Ä—É–±–µ–∂–Ω—ã–º–∏ —à—Ç–∞–±-–∫–≤–∞—Ä—Ç–∏—Ä–∞–º–∏.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, demand"",
  ""impact"": ""medium"",
  ""english"": ""AlphaRM reported significant success on the Russian pharmaceutical market. AlphaSigma Russia indicated that the company has achieved sixth place in terms of sales growth on the retail commercial market among foreign headquartered companies.""
}"
2025-06-24T07:01:08+00:00,@medpharm,12270,https://t.me/medpharm/12270,"–ó–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—è –°—á–µ—Ç–Ω–æ–π –ø–∞–ª–∞—Ç—ã –ì–∞–ª–∏–Ω–∞ –ò–∑–æ—Ç–æ–≤–∞ –Ω–∞–∑–≤–∞–ª–∞ –ø—Ä–∏—á–∏–Ω—ã –æ—Ç—Ç–æ–∫–∞ –∫–∞–¥—Ä–æ–≤ –∏–∑ –≥–æ—Å–º–µ–¥–∏—Ü–∏–Ω—ã. –ü–æ –µ–µ –¥–∞–Ω–Ω—ã–º, —Å–∏—Å—Ç–µ–º–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∏—Å–ø—ã—Ç—ã–≤–∞–µ—Ç –¥–µ—Ñ–∏—Ü–∏—Ç —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è.","{""skip"": true}"
2025-06-23T16:10:18+00:00,@medpharm,12269,https://t.me/medpharm/12269,–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 23 –∏—é–Ω—è –ö—Ä—É—á—É-–≤–µ—Ä—á—É –ú–∏–Ω—Ç—Ä—É–¥ —Ä–∞—Å–∫—Ä—ã–ª –Ω–µ–∫–æ—Ç–æ—Ä—ã–µ –¥–µ—Ç–∞–ª–∏ –ø–∏–ª–æ—Ç–Ω—ã—Ö –ø—Ä–æ–µ–∫—Ç–æ–≤ –ø–æ –ø–µ—Ä–µ—Ö–æ–¥—É –Ω–∞ –Ω–æ–≤—ã–µ –æ—Ç—Ä–∞—Å–ª–µ–≤—ã–µ —Å–∏—Å—Ç–µ–º—ã –æ–ø–ª–∞—Ç—ã —Ç—Ä—É–¥–∞ –≤ –±—é–¥–∂–µ—Ç–Ω–æ–π —Å—Ñ–µ—Ä–µ. –ò–Ω—Ñ–ª—è—Ü–∏—è –º–µ–¥–æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è –ù–∞ —Ñ–æ–Ω–µ –∏–Ω—Ñ–ª—è—Ü–∏–∏ –∫—Ä—É–ø–Ω–µ–π—à–∏–µ —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ –≤—É–∑—ã –≤–Ω–æ–≤—å –ø–µ—Ä–µ–ø–∏—Å–∞–ª–∏ –ø—Ä–∞–π—Å-–ª–∏—Å—Ç—ã –Ω–∞ –∫–æ–º–º–µ—Ä—á–µ—Å–∫–æ–µ –æ–±—É—á–µ–Ω–∏–µ. –†–∞–±–æ—Ç–∞ —Å –≤–æ–∑—Ä–∞–∂–µ–Ω—è–º–∏ ¬´–ú–ò–ö¬ª –≤—ã–∏–≥—Ä–∞–ª–∞ –¥–≤–∞ –∏—Å–∫–∞ –≤ –°—É–¥–µ –ø–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç—É–∞–ª—å–Ω—ã–º –ø—Ä–∞–≤–∞–º –∫ –†–æ—Å–ø–∞—Ç–µ–Ω—Ç—É. –°–ò–ü –æ–±—è–∑–∞–ª –≤–µ–¥–æ–º—Å—Ç–≤–æ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ—Ç—å –≤–æ–∑—Ä–∞–∂–µ–Ω–∏—è –ø—Ä–æ—Ç–∏–≤ –¥–≤—É—Ö –ø–∞—Ç–µ–Ω—Ç–æ–≤ –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–æ –æ—Ç –º—É–∫–æ–≤–∏—Å—Ü–∏–¥–æ–∑–∞ ¬´–¢—Ä–∏–∫–∞—Ñ—Ç—É¬ª –∫–æ–º–ø–∞–Ω–∏–∏ Vertex –ø–æ–≤—Ç–æ—Ä–Ω–æ. –†–µ—à–µ–Ω–∏—è —Å—É–¥–∞ –º–æ–≥—É—Ç –±—ã—Ç—å –æ–±–∂–∞–ª–æ–≤–∞–Ω—ã. –¶–µ–Ω–∞ –ø—Ä–æ—Ñ–µ—Å—Å–∏–∏ –ö—Ä—É–ø–Ω–µ–π—à–∏–µ —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ –º–µ–¥—É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç—ã –≤–Ω–æ–≤—å –ø–µ—Ä–µ–ø–∏—Å–∞–ª–∏ —Ü–µ–Ω–Ω–∏–∫–∏ –Ω–∞ –æ–±—É—á–µ–Ω–∏–µ. –°—Ç–æ–∏–º–æ—Å—Ç—å –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è –≤ –°–µ—á–µ–Ω–æ–≤—Å–∫–æ–º —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–µ –¥–ª—è –∑–∞—á–∏—Å–ª–µ–Ω–Ω—ã—Ö –≤ —ç—Ç–æ–º –≥–æ–¥—É –Ω–∞ —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç—å ¬´–§–∞—Ä–º–∞—Ü–∏—è¬ª –ø–æ–¥–æ—Ä–æ–∂–∞–ª–∞ –±–æ–ª—å—à–µ —á–µ–º –Ω–∞ 1 –º–ª–Ω —Ä—É–±.,"{""skip"": true}"
2025-06-23T14:36:28+00:00,@medpharm,12268,https://t.me/medpharm/12268,"–ì–ª–∞–≤–∞ –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–∞ –∑–∞—è–≤–∏–ª, —á—Ç–æ –Ω—É–∂–Ω–æ —É—Å–∏–ª–∏—Ç—å –∫–æ–Ω—Ç—Ä–æ–ª—å –∑–∞ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞–º–∏. –°–æ–≥–ª–∞—Å–Ω–æ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç—É ¬´–û –ø–ª–∞—Ç—Ñ–æ—Ä–º–µ–Ω–Ω–æ–π —ç–∫–æ–Ω–æ–º–∏–∫–µ¬ª, —Ç–æ—Ä–≥–æ–≤—ã–µ –ø–ª–æ—â–∞–¥–∫–∏ –¥–æ–ª–∂–Ω—ã –±—É–¥—É—Ç –ø—Ä–æ–≤–µ—Ä—è—Ç—å –≤ —Å–∏—Å—Ç–µ–º–µ –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—é –ø—Ä–æ–¥–∞–≤—Ü–∞, —Ç–æ–≤–∞—Ä–∞ –∏ –µ–≥–æ –∫–æ–¥–∞.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""import_export, regulation"",
  ""impact"": ""medium"",
  ""english"": ""The Minister of Industry and Trade stated that there needs to be an increased control over marketplaces. According to the 'Platform Economy Law', trading platforms will need to verify registration of sellers, products and their codes in the system of traceability.""
}"
2025-06-23T13:30:49+00:00,@medpharm,12267,https://t.me/medpharm/12267,"–í–µ–¥—É—â–∏–µ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –¶–ù–ò–ò —ç–ø–∏–¥–µ–º–∏–æ–ª–æ–≥–∏–∏ –†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä–∞ –æ—Ç–∫—Ä—ã–ª–∏ –®–∫–æ–ª—É —Å–µ–º–µ–π–Ω–æ–≥–æ –∑–¥–æ—Ä–æ–≤—å—è, –ø–æ—Å–≤—è—â–µ–Ω–Ω—É—é –∏–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã–º –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º. –í —Ñ–æ—Ä–º–∞—Ç–µ –æ–Ω–ª–∞–π–Ω-—É—Ä–æ–∫–æ–≤ –ø–∞—Ü–∏–µ–Ω—Ç–∞–º —Ä–∞—Å—Å–∫–∞–∂—É—Ç –æ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–µ –∏–Ω—Ñ–µ–∫—Ü–∏–π –∏ –ø–∞—Ä–∞–∑–∏—Ç–æ–∑–æ–≤ (–≤ —Ç–æ–º —á–∏—Å–ª–µ –∑–∞–≤–æ–∑–Ω—ã—Ö), –ø–æ–¥–¥–µ—Ä–∂–∞–Ω–∏–∏ –∑–¥–æ—Ä–æ–≤–æ–≥–æ –∏–º–º—É–Ω–∏—Ç–µ—Ç–∞ –∏ –¥–µ–π—Å—Ç–≤–∏—è—Ö –≤ —ç–∫—Å—Ç—Ä–µ–Ω–Ω—ã—Ö —Å–ª—É—á–∞—è—Ö. –°–ø–µ—Ü–∏–∞–ª—å–Ω–æ –¥–ª—è ¬´–ú–í¬ª –æ —Ä–æ–ª–∏ –ø–∞—Ü–∏–µ–Ω—Ç—Å–∫–∏—Ö —à–∫–æ–ª –≤ —Ä–∞–±–æ—Ç–µ –≤—Ä–∞—á–∞ —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∞ –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –ø–æ –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–π —Ä–∞–±–æ—Ç–µ –ù–ò–ò –ø—Ä–æ—Ñ–µ—Å—Å–æ—Ä –ê–Ω—Ç–æ–Ω–∏–Ω–∞ –ü–ª–æ—Å–∫–∏—Ä–µ–≤–∞.","{
  ""skip"": true
}"
2025-06-23T12:32:09+00:00,@medpharm,12266,https://t.me/medpharm/12266,–ú–∏–Ω–∑–¥—Ä–∞–≤ –ø—Ä–µ–¥–ª–æ–∂–∏–ª –æ–±—è–∑–∞—Ç—å –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –º–µ–¥- –∏ —Ñ–∞—Ä–º–≤—É–∑–æ–≤ –ø—Ä–æ—Ö–æ–¥–∏—Ç—å —Ç—Ä–µ—Ö–ª–µ—Ç–Ω–µ–µ –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–æ –ø–æ—Å–ª–µ –ø–µ—Ä–≤–∏—á–Ω–æ–π –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–∏. –¢–∞–∫–∂–µ —É—Ç–æ—á–Ω—è–µ—Ç—Å—è –ø–æ—Ä—è–¥–æ–∫ —Ü–µ–ª–µ–≤–æ–≥–æ –æ–±—É—á–µ–Ω–∏—è: –≤ —Å–ª—É—á–∞–µ –Ω–µ–∏—Å–ø–æ–ª–Ω–µ–Ω–∏—è –æ–±—è–∑–∞—Ç–µ–ª—å—Å—Ç–≤ —Å—Ç–æ—Ä–æ–Ω–æ–π –¥–æ–≥–æ–≤–æ—Ä–∞ —à—Ç—Ä–∞—Ñ –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è —É—Å—Ç–∞–Ω–æ–≤–∏—Ç—å –≤ –¥–≤—É–∫—Ä–∞—Ç–Ω–æ–º —Ä–∞–∑–º–µ—Ä–µ. –ü–æ–ø—Ä–∞–≤–∫–∏ –≤—ã–∑–≤–∞–ª–∏ –¥–∏—Å–∫—É—Å—Å–∏—é –≤ –æ—Ç—Ä–∞—Å–ª–∏ ‚Äî —ç–∫—Å–ø–µ—Ä—Ç—ã —É–∫–∞–∑—ã–≤–∞—é—Ç –Ω–∞ –≤–æ–∑–º–æ–∂–Ω—ã–µ –ø—Ä–æ—Ç–∏–≤–æ—Ä–µ—á–∏—è —Å –ö–æ–Ω—Å—Ç–∏—Ç—É—Ü–∏–µ–π –∏ –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω—É—é –ø—Ä–∏–≤–ª–µ–∫–∞—Ç–µ–ª—å–Ω–æ—Å—Ç—å —É—Å–ª–æ–≤–∏–π –¥–ª—è –º–æ–ª–æ–¥—ã—Ö —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤.,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health proposed mandating three-year mentoring for graduates of medical and pharmaceutical universities after initial accreditation. Additionally, the rules on targeted training were clarified: a penalty of double the contract amount is proposed for non-compliance. The amendments have sparked debate in the industry ‚Äî experts point to potential contradictions with the Constitution and insufficient attractiveness of conditions for young specialists.""
}"
2025-06-23T11:45:05+00:00,@medpharm,12265,https://t.me/medpharm/12265,"#–≠–∫—Å–∫–ª—é–∑–∏–≤ –ö—Ä—É–ø–Ω–µ–π—à–∏–µ —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ –º–µ–¥—É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç—ã –≤–Ω–æ–≤—å –ø–µ—Ä–µ–ø–∏—Å–∞–ª–∏ —Ü–µ–Ω–Ω–∏–∫–∏ –Ω–∞ –æ–±—É—á–µ–Ω–∏–µ. –¢–∞–∫, —Å—Ç–æ–∏–º–æ—Å—Ç—å –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è –≤ –°–µ—á–µ–Ω–æ–≤—Å–∫–æ–º —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–µ –¥–ª—è –∑–∞—á–∏—Å–ª–µ–Ω–Ω—ã—Ö –≤ —ç—Ç–æ–º –≥–æ–¥—É –Ω–∞ —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç—å ¬´–õ–µ—á–µ–±–Ω–æ–µ –¥–µ–ª–æ¬ª –ø—Ä–µ–≤—ã—Å–∏—Ç 6,9 –º–ª–Ω —Ä—É–±.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""pricing"",
  ""impact"": ""high"",
  ""english"": ""The most prestigious Russian medical universities have revised tuition fees. For example, the cost of education at Severnaya University for students admitted this year to the 'Medical Practice' specialty will exceed 6.9 million rubles.""
}"
2025-06-23T11:06:46+00:00,@medpharm,12264,https://t.me/medpharm/12264,"–ó–∞–º–≥–ª–∞–≤—ã –†–æ—Å–∫–æ–º–Ω–∞–¥–∑–æ—Ä–∞ —Å–æ–æ–±—â–∏–ª –æ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ —É–¥–∞–ª–∏—Ç—å –¥–æ 1 —Å–µ–Ω—Ç—è–±—Ä—è —Ä–µ–∫–ª–∞–º—É, —Ä–∞–∑–º–µ—â–µ–Ω–Ω—É—é –≤ –∑–∞–ø—Ä–µ—â–µ–Ω–Ω—ã—Ö –≤ –†–æ—Å—Å–∏–∏ —Å–æ—Ü–∏–∞–ª—å–Ω—ã—Ö —Å–µ—Ç—è—Ö. –ü–æ –µ–≥–æ —Å–ª–æ–≤–∞–º, —É–∂–µ –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω–Ω–∞—è —Ä–µ–∫–ª–∞–º–∞ —Å—á–∏—Ç–∞–µ—Ç—Å—è —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω—è—é—â–µ–π—Å—è –∏ –∑–∞ –Ω–µ–µ –±—É–¥–µ—Ç –ø—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ–Ω–∞ –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç—å, –≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–∏ —Å –ø—Ä–∏–Ω—è—Ç—ã–º –≤ –∞–ø—Ä–µ–ª–µ –∑–∞–∫–æ–Ω–æ–º.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions"",
  ""impact"": ""medium"",
  ""english"": ""The Deputy Head of Roskomnadzor announced the need to remove advertising published in prohibited Russian social networks by September 1st. According to him, already published advertisements are considered spreading and will be subject to sanctions according to the law adopted in April.""
}"
2025-06-23T09:37:58+00:00,@medpharm,12263,https://t.me/medpharm/12263,"–ú–∏–Ω—Ç—Ä—É–¥ —Ä–∞—Å–∫—Ä—ã–ª –Ω–µ–∫–æ—Ç–æ—Ä—ã–µ –¥–µ—Ç–∞–ª–∏ –ø–∏–ª–æ—Ç–Ω—ã—Ö –ø—Ä–æ–µ–∫—Ç–æ–≤ –ø–æ –ø–µ—Ä–µ—Ö–æ–¥—É –Ω–∞ –Ω–æ–≤—ã–µ –æ—Ç—Ä–∞—Å–ª–µ–≤—ã–µ —Å–∏—Å—Ç–µ–º—ã –æ–ø–ª–∞—Ç—ã —Ç—Ä—É–¥–∞ –≤ –±—é–¥–∂–µ—Ç–Ω–æ–π —Å—Ñ–µ—Ä–µ. –ö–∞–∫ –∏ –ø—Ä–µ–¥–ø–æ–ª–∞–≥–∞–ª–æ—Å—å –∏–∑–Ω–∞—á–∞–ª—å–Ω–æ, –¥–ª—è —Ä–∞—Å—á–µ—Ç–∞ –±–∞–∑–æ–≤—ã—Ö –æ–∫–ª–∞–¥–æ–≤ –±—É–¥—É—Ç –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω—ã –∫–æ—ç—Ñ—Ñ–∏—Ü–∏–µ–Ω—Ç—ã —Å–ª–æ–∂–Ω–æ—Å—Ç–∏ —Ä–∞–±–æ—Ç—ã –∏ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω–æ–π –¥–∏—Ñ—Ñ–µ—Ä–µ–Ω—Ü–∏–∞—Ü–∏–∏, –∞ —Ç–∞–∫–∂–µ –Ω–∞—á–Ω–µ—Ç –¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å –µ–¥–∏–Ω—ã–π –ø–µ—Ä–µ—á–µ–Ω—å —Å—Ç–∏–º—É–ª–∏—Ä—É—é—â–∏—Ö –∏ –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏–æ–Ω–Ω—ã—Ö –≤—ã–ø–ª–∞—Ç.","{""skip"": true}"
2025-06-23T07:23:13+00:00,@medpharm,12262,https://t.me/medpharm/12262,"üì¢ –ò–Ω—Ç–µ—Ä–µ—Å–Ω—ã–π –∏ –ø–æ–ª–µ–∑–Ω—ã–π –∫–æ–Ω—Ç–µ–Ω—Ç –≤ —Å—Ç–æ—Ä–∏—Å –ú–µ–¥–§–∞—Ä–º –ù–∞—à –∫–∞–Ω–∞–ª —Ä–∞—Å—Ç–µ—Ç, –∏ –µ–º—É –Ω—É–∂–Ω–æ –±–æ–ª—å—à–µ –≤–∞—à–∏—Ö –≥–æ–ª–æ—Å–æ–≤ –¥–ª—è —Ä–∞–∑–º–µ—â–µ–Ω–∏—è –∏—Å—Ç–æ—Ä–∏–π. –ú—ã —Ö–æ—Ç–∏–º –¥–µ–ª–∏—Ç—å—Å—è —Å –≤–∞–º–∏ –∏–Ω—Ç–µ—Ä–µ—Å–Ω—ã–º–∏ —Å—Ç–æ—Ä–∏—Å –∏ –ø—Ä–æ—Å–∏–º —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –∫–∞–Ω–∞–ª–∞ —Å –ø—Ä–µ–º–∏—É–º-–ø–æ–¥–ø–∏—Å–∫–æ–π —Ç–µ–ª–µ–≥—Ä–∞–º –ø—Ä–æ–≥–æ–ª–æ—Å–æ–≤–∞—Ç—å –∑–∞ –ú–µ–¥–§–∞—Ä–º. ‚úÖ –ü—Ä–æ–≥–æ–ª–æ—Å–æ–≤–∞—Ç—å –≤ 1 –∫–ª–∏–∫ –ü–µ—Ä–µ—Å—ã–ª–∞–π—Ç–µ —ç—Ç–æ—Ç –ø–æ—Å—Ç —Å–≤–æ–∏–º –¥—Ä—É–∑—å—è–º —Å –ø—Ä–µ–º–∏—É–º-–ø–æ–¥–ø–∏—Å–∫–æ–π","{""skip"": true}"
2025-06-23T07:04:57+00:00,@medpharm,12261,https://t.me/medpharm/12261,"–≠–∫—Å–ø–µ—Ä—Ç—ã –í—Å–µ–º–∏—Ä–Ω–æ–π –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª–∏ 21 —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏—é –ø–æ –≤–µ–¥–µ–Ω–∏—é —Å–µ—Ä–ø–æ–≤–∏–¥–Ω–æ–∫–ª–µ—Ç–æ—á–Ω–æ–π –∞–Ω–µ–º–∏–∏ —É –±–µ—Ä–µ–º–µ–Ω–Ω—ã—Ö –∂–µ–Ω—â–∏–Ω. –û–Ω–∏ –æ—Ö–≤–∞—Ç—ã–≤–∞—é—Ç –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç–æ–∑–Ω—É—é —Ç–µ—Ä–∞–ø–∏—é, –æ–±–ª–µ–≥—á–µ–Ω–∏–µ –±–æ–ª–∏, –∏–Ω—Ñ—É–∑–∏–æ–Ω–Ω—É—é —Ç–µ—Ä–∞–ø–∏—é, –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫—É —Ç—Ä–æ–º–±–æ–∑–æ–≤, –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥ –ø–ª–æ–¥–∞, —Å—Ä–æ–∫–∏ –∏ –º–µ—Ç–æ–¥—ã —Ä–æ–¥–æ—Ä–∞–∑—Ä–µ—à–µ–Ω–∏—è.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance"",
  ""impact"": ""high"",
  ""english"": ""Experts from the World Health Organization developed 21 guidelines for managing hemolytic anemia in pregnant women. The guidelines cover pharmacotherapy, pain relief, transfusion therapy, thrombosis prevention, fetal monitoring, delivery timing and methods.""
}"
2025-06-22T12:03:17+00:00,@medpharm,12260,https://t.me/medpharm/12260,"–ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ –∑–∞ –Ω–µ–¥–µ–ª—é üîµ –ù–∞ —ç—Ç–æ–π –Ω–µ–¥–µ–ª–µ ¬´–§–í¬ª —Å–ª–µ–¥–∏–ª –∑–∞ –≥–ª–∞–≤–Ω—ã–º–∏ —Å–æ–±—ã—Ç–∏—è–º–∏ –ü–µ—Ç–µ—Ä–±—É—Ä–≥—Å–∫–æ–≥–æ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–æ–≥–æ —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–≥–æ —Ñ–æ—Ä—É–º–∞ (–ü–ú–≠–§-2025). –ü–æ–¥–±–æ—Ä–∫–∞ –≤–∞–∂–Ω—ã—Ö –∑–∞—è–≤–ª–µ–Ω–∏–π –∏ —Å–¥–µ–ª–æ–∫. üîµ –°–µ—Ç—å ¬´–ê–ø—Ä–µ–ª—å¬ª –ø–æ—Å—Ç–∞–≤–∏–ª–∞ —Ü–µ–ª—å –∫—Ä–∞—Ç–Ω–æ –≤—ã—Ä–∞—Å—Ç–∏ –ø–æ –∫–æ–ª–∏—á–µ—Å—Ç–≤—É —Ç–æ—á–µ–∫ –∑–∞ –ø—è—Ç—å –ª–µ—Ç. –°–µ–π—á–∞—Å –∫–æ–º–ø–∞–Ω–∏—è –ø—Ä–∏—Ä–∞—Å—Ç–∞–µ—Ç –Ω–∞ 150 –∞–ø—Ç–µ–∫ –µ–∂–µ–º–µ—Å—è—á–Ω–æ. üîµ –ö–æ–ª–∏—á–µ—Å—Ç–≤–æ –ú&–ê-—Å–¥–µ–ª–æ–∫ –≤ –∞–ø—Ç–µ—á–Ω–æ–º —Ä–∏—Ç–µ–π–ª–µ –≤ I –∫–≤–∞—Ä—Ç–∞–ª–µ 2025 –≥–æ–¥–∞ —Ä–∞—Å—Ç–µ—Ç, —Ñ–∏–∫—Å–∏—Ä—É—é—Ç –≤ AlphaRM. üîµ –ü–∞—Ç–µ–Ω—Ç–Ω—ã–µ —Å–ø–æ—Ä—ã –Ω–µ –º–æ–≥—É—Ç –±—ã—Ç—å –æ—Å–Ω–æ–≤–∞–Ω–∏–µ–º –¥–ª—è –ø—Ä–∏–æ—Å—Ç–∞–Ω–æ–≤–∫–∏ –∑–∞–∫—É–ø–æ–∫ –ø–æ 44-–§–ó, —Å—á–∏—Ç–∞—é—Ç –≤ –ú–∏–Ω—Ñ–∏–Ω–µ. üîµ –£–ø—Ä–∞–≤–ª–µ–Ω–∏–µ –ø–æ —Å–∞–Ω–∏—Ç–∞—Ä–Ω–æ–º—É –Ω–∞–¥–∑–æ—Ä—É –∑–∞ –∫–∞—á–µ—Å—Ç–≤–æ–º –ø–∏—â–µ–≤—ã—Ö –ø—Ä–æ–¥—É–∫—Ç–æ–≤ –∏ –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç–æ–≤ –°–®–ê (FDA) –æ–¥–æ–±—Ä–∏–ª–æ Yeztugo –æ—Ç Gilead Sciences ‚Äî –ø–µ—Ä–≤—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –í–ò–ß, –∫–æ—Ç–æ—Ä—ã–π –≤–≤–æ–¥–∏—Ç—Å—è –∫–∞–∂–¥—ã–µ —à–µ—Å—Ç—å –º–µ—Å—è—Ü–µ–≤.","{""skip"": true}"
2025-06-21T09:04:28+00:00,@medpharm,12259,https://t.me/medpharm/12259,–ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∑–∞ –Ω–µ–¥–µ–ª—é üî¥–ë–æ–ª–µ–µ 65% –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö –≤—Ä–∞—á–µ–π –≥–æ—Ç–æ–≤—ã –ø–æ–¥–¥–µ—Ä–∂–∞—Ç—å –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–µ —á–ª–µ–Ω—Å—Ç–≤–æ –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –≤ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—ã—Ö —Å–∞–º–æ—Ä–µ–≥—É–ª–∏—Ä—É–µ–º—ã—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è—Ö (–°–†–û). –ï—â–µ –ø–æ—á—Ç–∏ —Å—Ç–æ–ª—å–∫–æ –∂–µ —Å–æ–æ–±—â–∏–ª–∏ –æ –≥–æ—Ç–æ–≤–Ω–æ—Å—Ç–∏ –∑–∞—Å—Ç—Ä–∞—Ö–æ–≤–∞—Ç—å –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—É—é –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç—å. üî¥–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ —Ä–∞–∑—Ä–µ—à–∏–ª–æ —Ä–µ–≥–∏–æ–Ω–∞–º –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å —Å—ç–∫–æ–Ω–æ–º–ª–µ–Ω–Ω—ã–µ —Å—Ä–µ–¥—Å—Ç–≤–∞ –Ω–∞ –∑–∞–∫—É–ø–∫—É –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø–æ –ø—Ä–æ–≥—Ä–∞–º–º–µ 14 –í–ó–ù. üî¥–í –ì–æ—Å–¥—É–º—É –≤–Ω–µ—Å–ª–∏ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ–± —É—Å–∏–ª–µ–Ω–∏–∏ —É–≥–æ–ª–æ–≤–Ω–æ–π –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç–∏ –∑–∞ –Ω–∞–ø–∞–¥–µ–Ω–∏–µ –Ω–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤. üî¥–í –ö–æ–º–∏—Å—Å–∏—é –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ø–æ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—é –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø–µ—Ä–µ—á–Ω–µ–π –∏ –º–∏–Ω–∏–º–∞–ª—å–Ω–æ–≥–æ –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç–∞ –º–µ–¥–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –±—É–¥—É—Ç –≤–∫–ª—é—á–µ–Ω—ã –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–∏ –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π. üî¥–ù–∞ –±–∞–∑–µ –°–µ—á–µ–Ω–æ–≤—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ –æ—Ç–∫—Ä—ã–ª—Å—è –°–æ—Ç—Ä—É–¥–Ω–∏—á–∞—é—â–∏–π —Ü–µ–Ω—Ç—Ä –í–û–ó –ø–æ –æ–±—É—á–µ–Ω–∏—é –ø–∞–ª–ª–∏–∞—Ç–∏–≤–Ω–æ–π –ø–æ–º–æ—â–∏.,"{""skip"": true}"
2025-06-20T16:01:15+00:00,@medpharm,12258,https://t.me/medpharm/12258,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 20 –∏—é–Ω—è –ë—É–¥–Ω–∏ —Å–∞–Ω–∫—É—Ä–∞ –†–æ—Å—Å—Ç–∞—Ç –æ—Ç–º–µ—á–∞–µ—Ç —Å–Ω–∏–∂–µ–Ω–∏–µ –∫–æ–ª–∏—á–µ—Å—Ç–≤–∞ –≥—Ä–∞–∂–¥–∞–Ω, –∫–æ—Ç–æ—Ä—ã–µ –ø—Ä–æ–ª–µ—á–∏–ª–∏—Å—å –≤ —Å–∞–Ω–∞—Ç–æ—Ä–Ω–æ-–∫—É—Ä–æ—Ä—Ç–Ω—ã—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è—Ö –≤ 2025 –≥–æ–¥—É. –°—Ä–µ–¥–∏ —Ä–∏—Å–∫–æ–≤ –¥–ª—è –æ—Ç—Ä–∞—Å–ª–∏ –Ω–∞–∑—ã–≤–∞–µ—Ç—Å—è –∏–∑–Ω–æ—Å –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä—ã, —É—Å—Ç–∞—Ä–µ–≤—à–µ–µ –º–µ–¥–æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏–µ –∏ –¥–µ—Ñ–∏—Ü–∏—Ç –∫–≤–∞–ª–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –∫–∞–¥—Ä–æ–≤. –°–ª–æ–º–∞–ª–∏ —Å–∏—Å—Ç–µ–º—É –†–∞–∑–≤–∏–≤–∞—é—â–∏–µ—Å—è —Å—Ç—Ä–∞–Ω—ã —Å—Ç–æ–ª–∫–Ω—É–ª–∏—Å—å —Å –∫—Ä–∏—Ç–∏—á–µ—Å–∫–∏–º —Å–æ–∫—Ä–∞—â–µ–Ω–∏–µ–º –≤–Ω–µ—à–Ω–µ–π –ø–æ–º–æ—â–∏ –¥–ª—è —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è —Ä–∞—Å—Ö–æ–¥–æ–≤ –Ω–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ. –≠—Ç–∏ —Ä–∞—Å—Ö–æ–¥—ã —Ä–∞–Ω—å—à–µ –ø–æ–∫—Ä—ã–≤–∞–ª–∏—Å—å –í–û–ó –∑–∞ —Å—á–µ—Ç –≤–∑–Ω–æ—Å–æ–≤ –°–®–ê –∏ –¥—Ä—É–≥–∏—Ö —Å—Ç—Ä–∞–Ω. –†–∞–±–æ—Ç–∞–µ—Ç –§–ù–° –§–µ–¥–µ—Ä–∞–ª—å–Ω–∞—è –Ω–∞–ª–æ–≥–æ–≤–∞—è —Å–ª—É–∂–±–∞ –ø–æ–ª—É—á–∏—Ç –¥–æ—Å—Ç—É–ø –∫ —Å–∏—Å—Ç–µ–º–µ –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –¥–ª—è –ø–æ–≤—ã—à–µ–Ω–∏—è —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –Ω–∞–ª–æ–≥–æ–≤–æ–≥–æ –∫–æ–Ω—Ç—Ä–æ–ª—è. –î–∞–Ω–Ω—ã–µ –∏–∑ —Å–∏—Å—Ç–µ–º—ã –ø–æ–∑–≤–æ–ª—è—Ç —Ç–æ—á–Ω–µ–µ –≤—ã—è–≤–ª—è—Ç—å –Ω–∞–ª–æ–≥–æ–≤—ã–µ —Ä–∏—Å–∫–∏ –∏ –ø–æ–≤—ã—à–∞—Ç—å —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –∫–æ–Ω—Ç—Ä–æ–ª—å–Ω—ã—Ö –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–π. –ê —á—Ç–æ –µ—Å–ª–∏ –ê–ø—Ç–µ—á–Ω—ã–π –±–∏–∑–Ω–µ—Å –Ω–∞ –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ ¬´–ó–µ–ª–µ–Ω—ã–π –∫—Ä–µ—Å—Ç¬ª –æ–±—Å—É–¥–∏–ª –ø–æ—Å–ª–µ–¥—Å—Ç–≤–∏—è –≤–æ–∑–º–æ–∂–Ω–æ–π —Å–¥–µ–ª–∫–∏ –º–µ–∂–¥—É Wildberries –∏ ¬´–ï–∞–ø—Ç–µ–∫–æ–π¬ª. –û—Ñ–∏—Ü–∏–∞–ª—å–Ω–æ –ø–µ—Ä–µ–≥–æ–≤–æ—Ä—ã –Ω–µ –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª–∏, –Ω–æ –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω–æ —ç—Ç–æ –º–æ–∂–µ—Ç –ø–æ–≤–ª–µ—á—å –ø–µ—Ä–µ—Ä–∞—Å–ø—Ä–µ–¥–µ–ª–µ–Ω–∏–µ —Å–∏–ª.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The green cross conference discussed the potential consequences of a deal between Wildberries and 'Eapteka'. The official talks have not been confirmed, but this could potentially redistribute the forces. Additionally, there is a concern about shortages in the pharmaceutical industry due to issues with infrastructure, outdated medical equipment, and a shortage of qualified personnel.""
}"
2025-06-20T14:40:08+00:00,@medpharm,12257,https://t.me/medpharm/12257,"–í –ü–µ—Ç–µ—Ä–±—É—Ä–≥–µ –≤—ã–Ω–µ—Å–µ–Ω –ø—Ä–∏–≥–æ–≤–æ—Ä –ø–æ —É–≥–æ–ª–æ–≤–Ω–æ–º—É –¥–µ–ª—É –æ —Ö–∞–ª–∞—Ç–Ω–æ—Å—Ç–∏ –≤—Ä–∞—á–µ–π, –ø–æ–≤–ª–µ–∫—à–µ–π —Å–º–µ—Ä—Ç—å –≤–æ—Å—å–º–∏ —á–µ–ª–æ–≤–µ–∫. –û–Ω–∏ –ø—Ä–∏–∑–Ω–∞–Ω—ã –≤–∏–Ω–æ–≤–Ω—ã–º–∏ –≤ –æ—Ç—Ä–∞–≤–ª–µ–Ω–∏–∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å—É–ª—å—Ñ–∞—Ç–æ–º –±–∞—Ä–∏—è.","{""skip"": true}"
2025-06-20T13:20:15+00:00,@medpharm,12256,https://t.me/medpharm/12256,"–û–±—è–∑–∞—Ç–µ–ª—å–Ω–∞—è –æ—Ç—Ä–∞–±–æ—Ç–∫–∞ –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ –≤ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –±–æ–ª—å–Ω–∏—Ü–∞—Ö –º–æ–∂–µ—Ç –ø–æ–ª–Ω–æ—Å—Ç—å—é —Ä–µ—à–∏—Ç—å –ø—Ä–æ–±–ª–µ–º—É –¥–µ—Ñ–∏—Ü–∏—Ç–∞ –∫–∞–¥—Ä–æ–≤ –≤ –æ—Ç—Ä–∞—Å–ª–∏ –∏ –ø–æ–ª–µ–∑–Ω–∞ –¥–ª—è —Å–∞–º–∏—Ö —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤. –ü—Ä–∏ —ç—Ç–æ–º –æ—Ç –¥—Ä—É–≥–∏—Ö –º–µ—Ä –ø–æ–¥–¥–µ—Ä–∂–∫–∏ –æ—Ç–∫–∞–∑—ã–≤–∞—Ç—å—Å—è –Ω–µ–ª—å–∑—è: –Ω—É–∂–Ω–æ –ø–æ–≤—ã—à–∞—Ç—å –∑–∞—Ä–ø–ª–∞—Ç—ã, —Ä–∞–±–æ—Ç–∞—Ç—å –Ω–∞–¥ –∫–æ–º—Ñ–æ—Ä—Ç–æ–º –≤—Ä–∞—á–µ–π, —Å–æ—Ü–∏–∞–ª—å–Ω—ã–º–∏ –≥–∞—Ä–∞–Ω—Ç–∏—è–º–∏ –∏ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å—é –∫–∞—Ä—å–µ—Ä–Ω–æ–≥–æ —Ä–æ—Å—Ç–∞.","{""skip"": true}"
2025-06-20T12:14:20+00:00,@medpharm,12255,https://t.me/medpharm/12255,"–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ —É—Ç–≤–µ—Ä–¥–∏–ª–æ –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ –ø—Ä–∞–≤–∏–ª–∞ –≤–≤–æ–∑–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤, —Ä–∞–∑—Ä–µ—à–∏–≤ –≤–≤–æ–∑ –Ω–µ–∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –∏ –Ω–∞—É—á–Ω—ã—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π. –ö–æ–º–ø–∞–Ω–∏–∏ —Å–º–æ–≥—É—Ç –≤–≤–æ–∑–∏—Ç—å —Ç–∞–∫–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞, –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª—è—è –¥–µ—Ç–∞–ª—å–Ω—ã–µ –ø–ª–∞–Ω—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""import_export, shortage"",
  ""impact"": ""medium"",
  ""english"": ""Government approved changes in the import rules for medicines, allowing imports of unregistered drugs for research and development. Companies can import these medications by providing detailed research plans.""
}"
2025-06-20T11:01:02+00:00,@medpharm,12254,https://t.me/medpharm/12254,"–í –†–æ—Å—Å–∏–∏ –≤–≤–æ–¥–∏—Ç—Å—è –æ–±–Ω–æ–≤–ª–µ–Ω–Ω—ã–π –ø–æ—Ä—è–¥–æ–∫ –ø–æ—Å—Ç–∞–≤–æ–∫ –≤–∞–∫—Ü–∏–Ω –≤ —Ä–∞–º–∫–∞—Ö –ü—Ä–æ–≥—Ä–∞–º–º—ã –≥–æ—Å–≥–∞—Ä–∞–Ω—Ç–∏–π. –¢–µ–ø–µ—Ä—å —Ä–µ–≥–∏–æ–Ω—ã –±—É–¥—É—Ç –ø–æ–¥–∞–≤–∞—Ç—å –∑–∞—è–≤–∫–∏ –ø–æ –Ω–æ–≤—ã–º –ø—Ä–∞–≤–∏–ª–∞–º, –∞ –∫–æ–Ω—Ç—Ä–æ–ª—å –∑–∞ –æ—Å—Ç–∞—Ç–∫–∞–º–∏ –∏ –æ–ø–µ—Ä–∞—Ç–∏–≤–Ω–æ–µ –ø–µ—Ä–µ—Ä–∞—Å–ø—Ä–µ–¥–µ–ª–µ–Ω–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤–æ–∑–ª–∞–≥–∞—é—Ç—Å—è –Ω–∞ –ú–∏–Ω–∑–¥—Ä–∞–≤.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""tenders, import_export, shortage"",
  ""impact"": ""medium"",
  ""english"": ""Russia is implementing a new supply system for vaccines under the State Guarantees Program. Regions will now submit tenders according to new rules, and the Ministry of Health is responsible for inventory management and timely redistribution of vaccines.""
}"
2025-06-20T09:16:38+00:00,@medpharm,12253,https://t.me/medpharm/12253,"–ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª —Ä—ã–Ω–∫—É —Ñ–∏–Ω–∞–ª—å–Ω—É—é –≤–µ—Ä—Å–∏—é –Ω–∞–ø–æ–ª–Ω–µ–Ω–∏—è –ø–µ—Ä–µ—á–Ω—è –°–ó–õ–°. –ï–≥–æ –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç —Ä–∞–∑–¥–µ–ª–∏—Ç—å –Ω–∞ –¥–≤–µ —á–∞—Å—Ç–∏ —Å —Ä–∞–∑–Ω—ã–º–∏ –º–µ—Ä–∞–º–∏ –ø–æ–¥–¥–µ—Ä–∂–∫–∏. –í –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–µ —Å–ø–æ—Ä—ã –≤—ã–∑—ã–≤–∞–µ—Ç —Ç–æ–ª—å–∫–æ –ø—É–Ω–∫—Ç –æ —Å—Ä–æ–∫–µ –ø–∞—Ç–µ–Ω—Ç–Ω–æ–π –∑–∞—â–∏—Ç—ã –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞, –∫–æ—Ç–æ—Ä—ã–π –º–æ–∂–µ—Ç –ø—Ä–µ—Ç–µ–Ω–¥–æ–≤–∞—Ç—å –Ω–∞ –≤–∫–ª—é—á–µ–Ω–∏–µ –≤ –ø–µ—Ä–µ—á–µ–Ω—å.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing, import_export, sanctions"",
  ""impact"": ""high"",
  ""english"": ""The Ministry of Industry and Trade presented the final version of the list of SLS. They propose to split it into two parts with different support measures. Only point about the term of patent protection for a drug, which can claim inclusion in the list, is controversial among government officials.""
}"
2025-06-20T07:36:53+00:00,@medpharm,12252,https://t.me/medpharm/12252,–í –†–æ—Å—Å–∏–∏ –Ω–∞—á–Ω—É—Ç –≤—ã–ø—É—Å–∫ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —ç–∫–æ–Ω–æ–º–∏—Å—Ç–æ–≤ –∏ —Ñ–∏–Ω–∞–Ω—Å–∏—Å—Ç–æ–≤. –ü–µ—Ä–≤—ã–π –Ω–∞–±–æ—Ä –∞–±–∏—Ç—É—Ä–∏–µ–Ω—Ç–æ–≤ –Ω–∞ –º–∞–≥–∏—Å—Ç–µ—Ä—Å–∫—É—é –ø—Ä–æ–≥—Ä–∞–º–º—É —Å—Ç–∞—Ä—Ç—É–µ—Ç –≤ —ç—Ç–æ–º –≥–æ–¥—É.,"{""skip"": true}"
2025-06-19T16:34:02+00:00,@medpharm,12251,https://t.me/medpharm/12251,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 19 –∏—é–Ω—è –ù–µ —Ä—É–±—è—Ç —Å –ø–ª–µ—á–∞ –ö–æ–º–∏—Ç–µ—Ç –ì–æ—Å–¥—É–º—ã –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è –ø—Ä–µ–¥–ª–æ–∂–∏–ª –¥–æ—Ä–∞–±–æ—Ç–∞—Ç—å –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç, –æ–≥—Ä–∞–Ω–∏—á–∏–≤–∞—é—â–∏–π –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ —Å—Ç—Ä–∞—Ö–æ–≤—ã—Ö –∫–æ–º–ø–∞–Ω–∏–π —Ä–∞—Å–ø–æ—Ä—è–∂–∞—Ç—å—Å—è —Å—Ä–µ–¥—Å—Ç–≤–∞–º–∏ –æ—Ç —à—Ç—Ä–∞—Ñ–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ –æ–Ω–∏ –Ω–∞–ª–∞–≥–∞—é—Ç –Ω–∞ –∫–ª–∏–Ω–∏–∫–∏. –û—Å–æ–±—ã–π —Ä–µ–∂–∏–º –ú–∏–Ω–∑–¥—Ä–∞–≤ –∏ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä –ø–ª–∞–Ω–∏—Ä—É—é—Ç –æ–±–Ω–æ–≤–∏—Ç—å –ø—Ä–∞–≤–∏–ª–∞ –≤–∫–ª—é—á–µ–Ω–∏—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏. –£—Å–∫–æ—Ä–∏—Ç—Å—è –∏—Ö —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –∏ —É–ø—Ä–æ—Å—Ç–∏—Ç—Å—è –≤—ã—è–≤–ª–µ–Ω–∏–µ —É—Å—Ç–∞—Ä–µ–≤—à–∏—Ö –º–µ—Ç–æ–¥–æ–≤. –û–±—Ä–∞—Ç–Ω–∞—è —Ä–µ–∞–∫—Ü–∏—è –ó–∞ –Ω–µ–æ–ø—Ä–∞–≤–¥–∞–Ω–Ω—É—é –º–æ–Ω–æ–ø–æ–ª–∏—é –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ –ø—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ—Ç—å –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç—å –æ—Ä–∏–≥–∏–Ω–∞—Ç–æ—Ä–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞, –∑–∞—è–≤–∏–ª –æ—Å–Ω–æ–≤–∞—Ç–µ–ª—å ¬´–ü—Ä–æ–º–æ–º–µ–¥–∞¬ª –ü–µ—Ç—Ä –ë–µ–ª—ã–π. –û–Ω –ø—Ä–µ–¥–ª–æ–∂–∏–ª —É—Å—Ç–∞–Ω–æ–≤–∏—Ç—å –ø—Ä–∞–≤–∏–ª–∞ –¥–ª—è —Ç–∞–∫–∏—Ö —Å–ª—É—á–∞–µ–≤. –ì–æ–Ω–∫–∞ –ø–æ–≥–ª–æ—â–µ–Ω–∏–π –ö–æ–ª–∏—á–µ—Å—Ç–≤–æ –ú&–ê-—Å–¥–µ–ª–æ–∫ –≤ –∞–ø—Ç–µ—á–Ω–æ–º —Ä–∏—Ç–µ–π–ª–µ –≤ I –∫–≤–∞—Ä—Ç–∞–ª–µ 2025 –≥–æ–¥–∞ —Ä–∞—Å—Ç–µ—Ç, —Ñ–∏–∫—Å–∏—Ä—É—é—Ç –≤ AlphaRM. –ê–Ω–∞–ª–∏—Ç–∏–∫–∏ —Å–≤—è–∑—ã–≤–∞—é—Ç –¥–∏–Ω–∞–º–∏–∫—É —Å–æ —Å—Ç—Ä–µ–º–ª–µ–Ω–∏–µ–º –∫–æ–Ω—Å–æ–ª–∏–¥–∏—Ä–æ–≤–∞—Ç—å —É—Å–ø–µ—à–Ω—ã–µ –∫–µ–π—Å—ã —Ä–∞–Ω—å—à–µ –∫–æ–Ω–∫—É—Ä–µ–Ω—Ç–æ–≤.","{""skip"": true}"
2025-06-19T14:55:09+00:00,@medpharm,12249,https://t.me/medpharm/12249,"18 –∏—é–Ω—è –≤ —Ä–∞–º–∫–∞—Ö –ü–ú–≠–§ –Ω–∞ –ø–ª–æ—â–∞–¥–∫–µ –ó–¥–æ—Ä–æ–≤–æ–µ –æ–±—â–µ—Å—Ç–≤–æ —Å–æ—Å—Ç–æ—è–ª–∞—Å—å —Å–µ—Å—Å–∏—è –†–ë–ö ¬´–§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–µ–π¬ª. –ü—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –∏–Ω–¥—É—Å—Ç—Ä–∏–∏, –Ω–∞—É–∫–∏ –∏ –Ω–µ–∫–æ–º–º–µ—Ä—á–µ—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –æ–±—Å—É–¥–∏–ª–∏ —Ä–æ–ª—å –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤-–¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤ –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º —Ä—ã–Ω–∫–µ. –í –¥–∏—Å–∫—É—Å—Å–∏–∏ –ø—Ä–∏–Ω—è–ª–∏ —É—á–∞—Å—Ç–∏–µ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–∏ ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª, –ú–ì–ú–£ –∏–º. –ò. –ú. –°–µ—á–µ–Ω–æ–≤–∞, –§–ì–ë–ù–£ ¬´–ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—ã–π –ù–ò–ò –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∑–¥–æ—Ä–æ–≤—å—è –∏–º–µ–Ω–∏ –ù.–ê. –°–µ–º–∞—à–∫–æ¬ª, DSM Group, —Ñ–æ–Ω–¥–∞ –ü—Ä–∞–≤–º–∏—Ä, –ú–ì–£. –û–ª—å–≥–∞ –õ–∞—Ä–∏–Ω–∞, –∫–æ–º–º–µ—Ä—á–µ—Å–∫–∏–π –¥–∏—Ä–µ–∫—Ç–æ—Ä ¬´–û–∑–æ–Ω –§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏–∫–∞¬ª, —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∞ –ø–æ—á–µ–º—É –∫–æ–º–ø–∞–Ω–∏—è —Å–¥–µ–ª–∞–ª–∞ —Å—Ç–∞–≤–∫—É –∏–º–µ–Ω–Ω–æ –Ω–∞ –¥–∂–µ–Ω–µ—Ä–∏–∫–∏: ¬´20 –ª–µ—Ç –Ω–∞–∑–∞–¥ –º—ã –≤—ã–±—Ä–∞–ª–∏ —ç—Ç—É —Å—Ç—Ä–∞—Ç–µ–≥–∏—é, –∏ –º—ã –º–æ–∂–µ–º –æ–±—ä—è—Å–Ω–∏—Ç—å, –ø–æ—á–µ–º—É. –î–∂–µ–Ω–µ—Ä–∏–∫–∏ ‚Äî —ç—Ç–æ –±—ã—Å—Ç—Ä–∞—è –æ–∫—É–ø–∞–µ–º–æ—Å—Ç—å –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–π –∑–∞ 3-5 –ª–µ—Ç –∏ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –¥–∞—Ç—å –º–∞—Å—Å–æ–≤—É—é, –¥–æ—Å—Ç—É–ø–Ω—É—é —Ç–µ—Ä–∞–ø–∏—é –¥–ª—è –ª—é–¥–µ–π¬ª. –†–µ–∫–ª–∞–º–∞, –ò–ü –ü–∞–Ω—á–µ–Ω–∫–æ-–¢—Ä—é—Ö –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –¢–∞—Ä–∞—Å–æ–≤–∏—á","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""Representatives from the pharmaceutical industry, science, and non-profit organizations discussed the role of generic drugs on the Russian market. The session was attended by representatives from 'Ozon Pharma', MGIMO IMI I.M. Sechenov, NII Public Health of the Russian Federation named after N.A. Semashko, DSM Group, Right Foundation, MGU. Olena Larina, Commercial Director of 'Ozon Pharma', explained the company's strategy towards generics: '20 years ago we chose this strategy, and we can explain why. Generics offer quick investment returns within 3-5 years and provide mass, affordable therapy for people.'""
}"
2025-06-19T13:28:07+00:00,@medpharm,12248,https://t.me/medpharm/12248,"–ö–æ–ª–ª–µ–≥–∏, –æ–ø—É–±–ª–∏–∫–æ–≤–∞–ª–∏ –ø—Ä–æ–≥—Ä–∞–º–º—É –≥–ª–∞–≤–Ω–æ–π –æ—Å–µ–Ω–Ω–µ–π —Ñ–∞—Ä–º–∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ ¬´PRO–µ–∫—Ü–∏–∏ –±—É–¥—É—â–µ–≥–æ¬ª! üìÖ 11‚Äì12 —Å–µ–Ω—Ç—è–±—Ä—è 2025 –≥. üìç–°–æ—á–∏, Pullman Sochi Centre 5* –í–∞—Å –∂–¥—É—Ç –æ—Å—Ç—Ä—ã–µ –¥–∏—Å–∫—É—Å—Å–∏–∏ –ø–æ –∫–ª—é—á–µ–≤—ã–º –≤—ã–∑–æ–≤–∞–º –æ—Ç—Ä–∞—Å–ª–∏. ‚úîÔ∏è –î–µ–Ω—å 1: –¶–∏—Ñ—Ä—ã 2025: –†—ã–Ω–æ–∫ –Ω–∞ –≥—Ä–∞–Ω–∏ –±—É–¥—É—â–µ–≥–æ ‚Äì –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏—è, —ç–∫—Å–ø–æ—Ä—Ç –≤ –ï–ê–≠–°, –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è, –∏–º–ø–æ—Ä—Ç —Å—É–±—Å—Ç–∞–Ω—Ü–∏–π. –ì–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–π –∫–æ–Ω—Ç—É—Ä —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –æ—Ç—Ä–∞—Å–ª–∏: –ñ–ù–í–õ–ü, –°–ó–õ–°, –Ω–∞—Ü–∫–∞–ª–µ–Ω–¥–∞—Ä—å –ø—Ä–∏–≤–∏–≤–æ–∫, –≥–æ—Å–ø–æ–¥–¥–µ—Ä–∂–∫–∞, –ø–∞—Ç–µ–Ω—Ç—ã –∏ –≥–æ—Å–∑–∞–∫–∞–∑. –ò–Ω–≤–µ—Å—Ç–∏—Ü–∏–∏: –ö—É–¥–∞ –≤–∫–ª–∞–¥—ã–≤–∞—Ç—å? –†–∏—Å–∫–∏, M&A, IPO, –ø—Ä–∏–≤–ª–µ–∫–∞—Ç–µ–ª—å–Ω–æ—Å—Ç—å —Å–µ–≥–º–µ–Ω—Ç–æ–≤ (–ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ, —Å—É–±—Å—Ç–∞–Ω—Ü–∏–∏, IT). –ê–ø—Ç–µ—á–Ω—ã–π —Ä–∏—Ç–µ–π–ª: –≠–∫–æ–Ω–æ–º–∏–∫–∞ –ø–æ–¥ –¥–∞–≤–ª–µ–Ω–∏–µ–º, –Ω–æ–≤—ã–µ —Ñ–æ—Ä–º–∞—Ç—ã, –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã–µ –∞–ø—Ç–µ–∫–∏. –ö–∞–¥—Ä–æ–≤—ã–π –∫—Ä–∏–∑–∏—Å: –û—Å—Ç—Ä–∞—è –Ω–µ—Ö–≤–∞—Ç–∫–∞ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤, —Ä–∞–∑—Ä—ã–≤ –º–µ–∂–¥—É –≤—É–∑–∞–º–∏ –∏ –±–∏–∑–Ω–µ—Å–æ–º, –ø–µ—Ä–µ–ø–æ–¥–≥–æ—Ç–æ–≤–∫–∞ —É–ø—Ä–∞–≤–ª–µ–Ω—Ü–µ–≤. ‚úîÔ∏è –î–µ–Ω—å 2: –†—ã–Ω–æ–∫ –ë–ê–î: –¢—É—Ä–±—É–ª–µ–Ω—Ç–Ω–æ—Å—Ç—å, –Ω–µ–¥–æ–±—Ä–æ—Å–æ–≤–µ—Å—Ç–Ω—ã–µ –ø—Ä–∞–∫—Ç–∏–∫–∏, —Ä–µ–≥—É–ª—è—Ç–æ—Ä–Ω—ã–µ –ª–æ–≤—É—à–∫–∏ ‚Äì –∫–∞–∫ —Å—Ç—Ä–æ–∏—Ç—å —á–µ—Å—Ç–Ω—ã–π –±–∏–∑–Ω–µ—Å? –§–∞—Ä–º–º–∞—Ä–∫–µ—Ç–∏–Ω–≥: –ü—Ä–æ–¥–≤–∏–∂–µ–Ω–∏–µ –ø–æ–¥ –∑–∞–ø—Ä–µ—Ç–∞–º–∏, —Ä–∞–±–æ—Ç–∞ —Å –≤—Ä–∞—á–∞–º–∏ –∏ –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª—è–º–∏, digital, –∏–Ω—Ñ–ª—é–µ–Ω—Å–µ—Ä—ã ‚Äì —á—Ç–æ —Ä–∞–±–æ—Ç–∞–µ—Ç? üëâ –í—Å—è –ø—Ä–æ–≥—Ä–∞–º–º–∞ –∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –∑–¥–µ—Å—å: https://pharmprojections.ru/","{""skip"": true}"
2025-06-19T12:12:00+00:00,@medpharm,12247,https://t.me/medpharm/12247,"–ó–∞ –Ω–µ–æ–ø—Ä–∞–≤–¥–∞–Ω–Ω—É—é –º–æ–Ω–æ–ø–æ–ª–∏—é –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ –ø—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ—Ç—å –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç—å –æ—Ä–∏–≥–∏–Ω–∞—Ç–æ—Ä–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞, –∑–∞—è–≤–∏–ª –æ—Å–Ω–æ–≤–∞—Ç–µ–ª—å ¬´–ü—Ä–æ–º–æ–º–µ–¥–∞¬ª –ü–µ—Ç—Ä –ë–µ–ª—ã–π. –û–Ω –ø—Ä–µ–¥–ª–æ–∂–∏–ª —É—Å—Ç–∞–Ω–æ–≤–∏—Ç—å –ø—Ä–∞–≤–∏–ª–∞ –¥–ª—è —Ç–∞–∫–∏—Ö —Å–ª—É—á–∞–µ–≤. #—Ü–∏—Ç–∞—Ç–∞_–¥–Ω—è","{""skip"": true}"
2025-06-19T11:01:05+00:00,@medpharm,12246,https://t.me/medpharm/12246,"–≠–∫—Å–ø–µ—Ä—Ç—ã –û–±—â–µ—Å—Ç–≤–∞ –∫–∞—Ä–¥–∏–æ–≤–∞—Å–∫—É–ª—è—Ä–Ω–æ–π –∫–æ–º–ø—å—é—Ç–µ—Ä–Ω–æ–π —Ç–æ–º–æ–≥—Ä–∞—Ñ–∏–∏ (SCCT) —Å–æ–≤–º–µ—Å—Ç–Ω–æ —Å –¥—Ä—É–≥–∏–º–∏ –Ω–∞—É—á–Ω—ã–º–∏ –æ–±—â–µ—Å—Ç–≤–∞–º–∏ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∏ —ç–∫—Å–ø–µ—Ä—Ç–Ω—ã–π –∫–æ–Ω—Å–µ–Ω—Å—É—Å –ø–æ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏—é –∫–æ–º–ø—å—é—Ç–µ—Ä–Ω–æ–π —Ç–æ–º–æ–≥—Ä–∞—Ñ–∏–∏ (–ö–¢) —Å–µ—Ä–¥—Ü–∞ –ø—Ä–∏ –æ—Ü–µ–Ω–∫–µ –ø—Ä–æ—Ç–µ–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –∫–ª–∞–ø–∞–Ω–æ–≤. –í –¥–æ–∫—É–º–µ–Ω—Ç–µ –æ–ø–∏—Å–∞–Ω—ã –ø–æ–∫–∞–∑–∞–Ω–∏—è, –ø—Ä–æ—Ç–æ–∫–æ–ª—ã —Å–∫–∞–Ω–∏—Ä–æ–≤–∞–Ω–∏—è, –æ—Å–æ–±–µ–Ω–Ω–æ—Å—Ç–∏ –∏–Ω—Ç–µ—Ä–ø—Ä–µ—Ç–∞—Ü–∏–∏ –¥–∞–Ω–Ω—ã—Ö –∏ —Ä–æ–ª—å –ö–¢ –ø—Ä–∏ —Ä–∞–∑–ª–∏—á–Ω—ã—Ö –æ—Å–ª–æ–∂–Ω–µ–Ω–∏—è—Ö.","{""skip"": true}"
2025-06-19T09:08:23+00:00,@medpharm,12245,https://t.me/medpharm/12245,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –ø—Ä–µ–¥–ª–æ–∂–∏–ª –∑–∞–ø—Ä–µ—Ç–∏—Ç—å —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—è–º –Ω–∞–ø—Ä—è–º—É—é –ø–ª–∞—Ç–∏—Ç—å –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—è–º –∑–∞ —É—á–∞—Å—Ç–∏–µ –≤ –∫–ª–∏–Ω–∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤. –†–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–Ω—ã–π –¥–æ–∫—É–º–µ–Ω—Ç –ø—Ä–∏–∑–≤–∞–Ω —Å–Ω–∏–∑–∏—Ç—å –∫–æ–Ω—Ñ–ª–∏–∫—Ç –∏–Ω—Ç–µ—Ä–µ—Å–æ–≤, –Ω–æ —ç–∫—Å–ø–µ—Ä—Ç—ã –æ–ø–∞—Å–∞—é—Ç—Å—è, —á—Ç–æ —ç—Ç–æ –∑–∞–º–µ–¥–ª–∏—Ç –ø—Ä–æ–≤–µ–¥–µ–Ω–∏–µ –ö–ò.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health proposed a ban on pharmaceutical companies directly paying researchers for participation in clinical trials. The developed document aims to reduce conflicts of interest, but experts are concerned that this could slow down the conduct of clinical trials.""
}"
2025-06-19T08:09:27+00:00,@medpharm,12244,https://t.me/medpharm/12244,"–°—á–µ—Ç–Ω–∞—è –ø–∞–ª–∞—Ç–∞ –ø–æ–¥–≥–æ—Ç–æ–≤–∏–ª–∞ –ø–∞–∫–µ—Ç –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–π –ø–æ —É–∂–µ—Å—Ç–æ—á–µ–Ω–∏—é –∫–æ–Ω—Ç—Ä–æ–ª—è –∑–∞ –∑–∞–∫–∞–∑—á–∏–∫–∞–º–∏ –æ–±—ä–µ–∫—Ç–æ–≤ –∫–∞–ø–∏—Ç–∞–ª—å–Ω–æ–≥–æ —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–∞, –≤ —Ç–æ–º —á–∏—Å–ª–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö. –ü—Ä–æ–≤–µ—Ä–∫–∏ –ø–æ–∫–∞–∑–∞–ª–∏, —á—Ç–æ –≤ —Ä–∞–º–∫–∞—Ö –∏—Å–ø–æ–ª–Ω–µ–Ω–∏—è –∫–æ–Ω—Ç—Ä–∞–∫—Ç–æ–≤ ¬´–ø–æ–¥ –∫–ª—é—á¬ª –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏–µ –º–æ–∂–µ—Ç –ø—Ä–∏–æ–±—Ä–µ—Ç–∞—Ç—å—Å—è –ø–æ –∑–∞–≤—ã—à–µ–Ω–Ω—ã–º —Ü–µ–Ω–∞–º.","{""skip"": true}"
2025-06-18T16:04:30+00:00,@medpharm,12243,https://t.me/medpharm/12243,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 18 –∏—é–Ω—è –ñ–¥–∏—Ç–µ –æ—Ç–≤–µ—Ç–∞ –í –§–µ–¥–µ—Ä–∞–ª—å–Ω–æ–º –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–æ–Ω–Ω–æ–º —Ü–µ–Ω—Ç—Ä–µ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ø—Ä–µ–¥—É–ø—Ä–µ–¥–∏–ª–∏ –æ–± —É–≤–µ–ª–∏—á–µ–Ω–Ω—ã—Ö —Å—Ä–æ–∫–∞—Ö –æ–∂–∏–¥–∞–Ω–∏—è –æ—Ç–≤–µ—Ç–∞ –ø—Ä–∏ –æ–±—Ä–∞—â–µ–Ω–∏—è—Ö –≤ –∫–æ–Ω—Ç–∞–∫—Ç-—Ü–µ–Ω—Ç—Ä. –í –Ω–∞—á–∞–ª–µ –º–µ—Å—è—Ü–∞ –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ —É–∂–µ –∏–Ω—Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–ª–∏ –æ –≤–æ–∑–º–æ–∂–Ω—ã—Ö –∑–∞–¥–µ—Ä–∂–∫–∞—Ö –≤ –ø–æ–ª—É—á–µ–Ω–∏–∏ –≤—ã–ø–∏—Å–∫–∏ –æ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞—Ö –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–∏ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞. –ù–µ –∂–µ–Ω—Å–∫–∞—è —Ä–∞–±–æ—Ç–∞ –ñ–µ–Ω—â–∏–Ω—ã, —Ä–∞–±–æ—Ç–∞—é—â–∏–µ –≤ –Ω–æ—á–Ω—É—é —Å–º–µ–Ω—É, —á–∞—â–µ —Å—Ç—Ä–∞–¥–∞–ª–∏ —É–º–µ—Ä–µ–Ω–Ω–æ–π –∏–ª–∏ —Ç—è–∂–µ–ª–æ–π –∞—Å—Ç–º–æ–π –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å —Ç–µ–º–∏, –∫—Ç–æ —Ä–∞–±–æ—Ç–∞–µ—Ç –¥–Ω–µ–º. –ü—Ä–∏ —ç—Ç–æ–º —É –º—É–∂—á–∏–Ω —Ç–∞–∫–æ–π —Å–≤—è–∑–∏ –Ω–µ –±—ã–ª–æ –≤—ã—è–≤–ª–µ–Ω–æ. –î–æ–ª–æ–π –±–∞—Ä—å–µ—Ä—ã –ö–æ–º–ø–∞–Ω–∏—è Roche –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∞ —É—Å—Ç—Ä–∞–Ω–∏—Ç—å –±–∞—Ä—å–µ—Ä—ã –¥–ª—è –≤—ã—Ö–æ–¥–∞ –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–∏–π —Ä—ã–Ω–æ–∫ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤–Ω–µ –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏ –æ—Ç —Å—Ç—Ä–∞–Ω—ã-–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è. –ü–æ —Å–ª–æ–≤–∞–º –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª—è –∫–æ–º–ø–∞–Ω–∏–∏, —Å–ª–æ–∂–Ω–æ—Å—Ç–∏ –≤–æ–∑–Ω–∏–∫–∞—é—Ç –Ω–∞ –≤—Å–µ—Ö —ç—Ç–∞–ø–∞—Ö ‚Äî –æ—Ç —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –¥–æ –ª–æ–≥–∏—Å—Ç–∏–∫–∏. 30% –∑–∞ –ª–æ–∫–∞–ª–∏–∑–∞—Ü–∏—é –§–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –ø–æ–ª–Ω–æ–≥–æ —Ü–∏–∫–ª–∞ —Å–º–æ–≥—É—Ç –ø–æ–ª—É—á–∏—Ç—å 30%-–Ω—É—é –ø—Ä–µ—Ñ–µ—Ä–µ–Ω—Ü–∏—é –ø—Ä–∏ –≥–æ—Å–∑–∞–∫—É–ø–∫–∞—Ö –ø–æ –ø–µ—Ä–µ—á–Ω—é –°–ó–õ–°. –¢–∞–∫–∞—è –º–µ—Ä–∞ –∑–∞–ª–æ–∂–µ–Ω–∞ –≤ –ø—Ä–æ–µ–∫—Ç –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è, –∫–æ—Ç–æ—Ä—ã–π –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥ –≥–æ—Ç–æ–≤–∏—Ç—Å—è –≤—ã–Ω–µ—Å—Ç–∏ –Ω–∞ –ø—É–±–ª–∏—á–Ω–æ–µ –æ–±—Å—É–∂–¥–µ–Ω–∏–µ.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety, guideline"",
  ""impact"": ""medium"",
  ""english"": ""Women working night shifts were more likely to suffer from moderate or severe asthma compared to those who worked during the day. The company Roche proposed to remove barriers for innovative drug manufacturers entering the Russian market regardless of their country of origin. The company stated that difficulties arise at all stages, from registration to logistics. 30% of the funds for state procurement under the SZZS list will be reserved for full-cycle pharmaceutical manufacturers.""
}"
2025-06-18T14:03:55+00:00,@medpharm,12242,https://t.me/medpharm/12242,–í –ì–æ—Å–¥—É–º–µ –Ω–µ –ø–æ–¥–¥–µ—Ä–∂–∞–ª–∏ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ –ø–æ–≥—Ä—É–∂–µ–Ω–∏–∏ –Ω–µ–∫–æ—Ç–æ—Ä—ã—Ö –≤–∏–¥–æ–≤ –∞–º–±—É–ª–∞—Ç–æ—Ä–Ω–æ–π —Ö–∏–º–∏–æ—Ç–µ—Ä–∞–ø–∏–∏ –≤ —Å–∏—Å—Ç–µ–º—É –û–ú–°. –ê–≤—Ç–æ—Ä—ã –ø—Ä–µ–¥–ª–∞–≥–∞–ª–∏ —É—Ä–∞–≤–Ω—è—Ç—å –≤ –ø—Ä–∞–≤–∞—Ö –≥—Ä–∞–∂–¥–∞–Ω –∏–∑ —Ä–∞–∑–Ω—ã—Ö —Ä–µ–≥–∏–æ–Ω–æ–≤ –∏ —Ä–∞–∑—Ä–µ—à–∏—Ç—å –≤—ã–¥–∞–≤–∞—Ç—å –ø–∞—Ü–∏–µ–Ω—Ç—É –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –Ω–∞ –∫—É—Ä—Å –ª–µ—á–µ–Ω–∏—è.,"{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""tenders, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The project to include certain ambulatory chemotherapy treatments in the State Medical Insurance system was not supported by the Duma. The authors proposed to equalize rights for patients from different regions and allow them to receive the drugs throughout their treatment.""
}"
2025-06-18T13:10:16+00:00,@medpharm,12241,https://t.me/medpharm/12241,¬´–ê–∫—Ä–∏—Ö–∏–Ω¬ª –∏ ¬´–ê–∫—Ç–∏–≤–Ω—ã–π –ö–æ–º–ø–æ–Ω–µ–Ω—Ç¬ª –¥–æ–≥–æ–≤–æ—Ä–∏–ª–∏—Å—å –æ —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–æ–º –ø–∞—Ä—Ç–Ω–µ—Ä—Å—Ç–≤–µ. –ö–æ–º–ø–∞–Ω–∏–∏ —Ä–∞—Å—à–∏—Ä—è—Ç —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–æ –≤ –æ–±–ª–∞—Å—Ç–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ø–æ–ª–Ω–æ—Å—Ç—å—é –ª–æ–∫–∞–ª–∏–∑–æ–≤–∞–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö –∏ —ç–Ω–¥–æ–∫—Ä–∏–Ω–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π.,"{""skip"": true}"
2025-06-18T12:06:32+00:00,@medpharm,12240,https://t.me/medpharm/12240,–°–∏–±–∏—Ä—Å–∫–∏–µ —É—á–µ–Ω—ã–µ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª–∏ –Ω–æ–≤—ã–π –º–µ—Ç–æ–¥ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∏ –Ω–∞—Å–ª–µ–¥—Å—Ç–≤–µ–Ω–Ω—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. –° –µ–≥–æ –ø–æ–º–æ—â—å—é –º–æ–∂–Ω–æ –ø–æ–≤—ã—Å–∏—Ç—å —Ç–æ—á–Ω–æ—Å—Ç—å —Å–∫—Ä–∏–Ω–∏–Ω–≥–∞ –∏ —É–ø—Ä–æ—Å—Ç–∏—Ç—å —Ä–∞–±–æ—Ç—É –≤—Ä–∞—á–µ–π-–≥–µ–Ω–µ—Ç–∏–∫–æ–≤.,"{""skip"": true}"
2025-06-18T11:03:11+00:00,@medpharm,12239,https://t.me/medpharm/12239,"–ê—Å—Å–æ—Ü–∏–∞—Ü–∏—è —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π –ï–≤—Ä–∞–∑–∏–π—Å–∫–æ–≥–æ —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–≥–æ —Å–æ—é–∑–∞ –∏ –í—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–∏–π —Å–æ—é–∑ –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –æ–±—ä–µ–¥–∏–Ω–µ–Ω–∏–π –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –ø–æ–¥–ø–∏—Å–∞–ª–∏ –ö–æ–¥–µ–∫—Å –ø–∞—Ü–∏–µ–Ω—Ç-–æ—Ä–∏–µ–Ω—Ç–∏—Ä–æ–≤–∞–Ω–Ω–æ–≥–æ –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏—è, –≤ –∫–æ—Ç–æ—Ä–æ–º –ø—Ä–æ–ø–∏—Å–∞–Ω—ã –æ—Å–Ω–æ–≤–æ–ø–æ–ª–∞–≥–∞—é—â–∏–µ –ø—Ä–∏–Ω—Ü–∏–ø—ã –∏ –ø–æ–¥—Ö–æ–¥—ã –∫ —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤—É –º–µ–∂–¥—É —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–º–∏ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è–º–∏ –∏ –ø–∞—Ü–∏–µ–Ω—Ç—Å–∫–∏–º–∏ –ù–ö–û. –¢–∞–∫–∏–º –æ–±—Ä–∞–∑–æ–º —Ä–æ—Å—Å–∏–π—Å–∫–∏–µ —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ —É—Å–∏–ª–∏–≤–∞—é—Ç –ø–∞—Ü–∏–µ–Ω—Ç-–æ—Ä–∏–µ–Ω—Ç–∏—Ä–æ–≤–∞–Ω–Ω—ã–π –ø–æ–¥—Ö–æ–¥ –≤ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ –∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ –ª–µ–∫–∞—Ä—Å—Ç–≤.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""The Association of Pharmaceutical Manufacturers of the Eurasian Economic Union and the All-Russian Union of Patient Societies signed a Patient-Oriented Interaction Code, which outlines fundamental principles and approaches to cooperation between pharmaceutical organizations and patient NGOs. This enables Russian pharmaceutical producers to strengthen a patient-oriented approach in drug development and production.""
}"
2025-06-18T10:00:02+00:00,@medpharm,12238,https://t.me/medpharm/12238,"–ê–±–∏—Ç—É—Ä–∏–µ–Ω—Ç—ã, –ø–æ—Å—Ç—É–ø–∞—é—â–∏–µ –Ω–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –∏ –Ω–∞—É—á–Ω—ã–µ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è, –±–æ–ª—å—à–µ –Ω–µ –±—É–¥—É—Ç —Å–¥–∞–≤–∞—Ç—å –Ω–µ–ø—Ä–æ—Ñ–∏–ª—å–Ω—ã–µ –ø—Ä–µ–¥–º–µ—Ç—ã –ø—Ä–∏ –ø–æ—Å—Ç—É–ø–ª–µ–Ω–∏–∏. –í 2025/26 —É—á–µ–±–Ω–æ–º –≥–æ–¥—É –∏–∑ –ø–µ—Ä–µ—á–Ω—è –≤—Å—Ç—É–ø–∏—Ç–µ–ª—å–Ω—ã—Ö —ç–∫–∑–∞–º–µ–Ω–æ–≤ –∏—Å–∫–ª—é—á–µ–Ω, –≤ —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã–π —è–∑—ã–∫.","{""skip"": true}"
2025-06-18T09:02:28+00:00,@medpharm,12237,https://t.me/medpharm/12237,–ù–µ –ø—Ä–æ–ø—É—Å—Ç–∏—Ç–µ –≥–ª–∞–≤–Ω–æ–µ ‚Äî –ø–æ–¥–ø–∏—Å—ã–≤–∞–π—Ç–µ—Å—å –Ω–∞ Telegram-–∫–∞–Ω–∞–ª –§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫–∞! #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–õ–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–∞—è–ë–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å #–ü–ú–≠–§2025,"{""skip"": true}"
2025-06-18T08:05:13+00:00,@medpharm,12236,https://t.me/medpharm/12236,–í –ö–æ–º–∏—Å—Å–∏—é –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ø–æ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—é –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø–µ—Ä–µ—á–Ω–µ–π –∏ –º–∏–Ω–∏–º–∞–ª—å–Ω–æ–≥–æ –∞—Å—Å–æ—Ä—Ç–∏–º–µ–Ω—Ç–∞ –º–µ–¥–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –±—É–¥—É—Ç –≤–∫–ª—é—á–µ–Ω—ã –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–∏ –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π. –¢–∞–∫–æ–µ –ø–æ—Ä—É—á–µ–Ω–∏–µ –¥–∞–ª –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç.,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""The President has assigned representatives of patient organizations to the Commission for Forming Medicinal Lists and Minimum Commodity Stock at the Ministry of Health. This will affect regulatory filings, compliance with regulations, and reimbursement processes.""
}"
2025-06-18T07:00:01+00:00,@medpharm,12235,https://t.me/medpharm/12235,"¬´–§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–π –≤–µ—Å—Ç–Ω–∏–∫¬ª ‚Äî –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω—ã–π –ø–∞—Ä—Ç–Ω–µ—Ä V –†–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ —Ñ–æ—Ä—É–º–∞ ¬´–õ–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–∞—è –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å¬ª, –∫–æ—Ç–æ—Ä—ã–π –ø—Ä–æ—Ö–æ–¥–∏—Ç 18 –∏—é–Ω—è 2025 –≥–æ–¥–∞ –≤ —Ä–∞–º–∫–∞—Ö –ø–µ—Ä–≤–æ–≥–æ –¥–Ω—è –ü–ú–≠–§ –≤ –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥–µ. –°–ª–µ–¥–∏—Ç–µ –∑–∞ –ø—Ä—è–º—ã–º–∏ –≤–∫–ª—é—á–µ–Ω–∏—è–º–∏ —Å –ü–ú–≠–§! –ù–µ –ø—Ä–æ–ø—É—Å—Ç–∏—Ç–µ –≥–ª–∞–≤–Ω–æ–µ ‚Äî –ø–æ–¥–ø–∏—Å—ã–≤–∞–π—Ç–µ—Å—å –Ω–∞ Telegram-–∫–∞–Ω–∞–ª –§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫–∞! #–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫ #–õ–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–∞—è–ë–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å #–ü–ú–≠–§2025","{""skip"": true}"
2025-06-17T16:10:14+00:00,@medpharm,12234,https://t.me/medpharm/12234,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 17 –∏—é–Ω—è –ú–µ–¥–∏—Ü–∏–Ω–∞ –¥–æ—Ä–æ–∂–∞–µ—Ç –í I –∫–≤–∞—Ä—Ç–∞–ª–µ 2025 –≥–æ–¥–∞ –º–∏–Ω–∏–º—É–º –≤ –ø–æ–ª–æ–≤–∏–Ω–µ —Ä–µ–≥–∏–æ–Ω–æ–≤ –†–æ—Å—Å–∏–∏ –æ—Ç–º–µ—á–µ–Ω —Ä–æ—Å—Ç —Ä–∞—Å—Ö–æ–¥–æ–≤ –Ω–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ, –∫–æ–Ω—Å—Ç–∞—Ç–∏—Ä–æ–≤–∞–ª–∞ –°—á–µ—Ç–Ω–∞—è –ø–∞–ª–∞—Ç–∞. –≠—Ç–æ –º–æ–∂–µ—Ç –±—ã—Ç—å —Å–≤—è–∑–∞–Ω–æ, –≤ —Ç–æ–º —á–∏—Å–ª–µ, —Å –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç—å—é –∏—Å–ø–æ–ª–Ω–µ–Ω–∏—è –º–∞–π—Å–∫–∏—Ö —É–∫–∞–∑–æ–≤ –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç–∞ –ø–æ –ø–æ–≤—ã—à–µ–Ω–∏—é –∑–∞—Ä–ø–ª–∞—Ç –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤, –ø–æ–¥–æ—Ä–æ–∂–∞–Ω–∏–µ–º –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –∏–Ω–¥–µ–∫—Å–∞—Ü–∏–µ–π —Ç–∞—Ä–∏—Ñ–æ–≤ –Ω–∞ –∫–æ–º–º—É–Ω–∞–ª—å–Ω—ã–µ —É—Å–ª—É–≥–∏. –í–Ω–∏–º–∞–Ω–∏–µ –Ω–∞ –ø–∞–ª–ª–∏–∞—Ç–∏–≤ –ù–∞ –±–∞–∑–µ –°–µ—á–µ–Ω–æ–≤—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ –æ—Ç–∫—Ä—ã–ª—Å—è –°–æ—Ç—Ä—É–¥–Ω–∏—á–∞—é—â–∏–π —Ü–µ–Ω—Ç—Ä –í–û–ó –ø–æ –æ–±—É—á–µ–Ω–∏—é –ø–∞–ª–ª–∏–∞—Ç–∏–≤–Ω–æ–π –ø–æ–º–æ—â–∏. –ï–≥–æ –∑–∞–¥–∞—á–∏ –≤–∫–ª—é—á–∞—é—Ç —Ä–∞–∑—Ä–∞–±–æ—Ç–∫—É –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π –∏ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—É—é —Ä–∞–±–æ—Ç—É. –ù–µ—Ö–≤–∞—Ç–∫–∞ 10 –º–ª—Ä–¥ –í—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–∏–π —Å–æ—é–∑ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –ø–æ–ø—Ä–æ—Å–∏–ª —É–≤–µ–ª–∏—á–∏—Ç—å —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏–µ –ø—Ä–æ–≥—Ä–∞–º–º—ã 14 –í–ó–ù. –í –æ–±—Ä–∞—â–µ–Ω–∏–∏ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ —É–∫–∞–∑–∞–Ω–æ, —á—Ç–æ –¥–µ—Ñ–∏—Ü–∏—Ç –ø—Ä–µ–≤—ã—à–∞–µ—Ç 10 –º–ª—Ä–¥ —Ä—É–±., —Å–æ—é–∑ –ø–æ–ª—É—á–∏–ª –∂–∞–ª–æ–±—ã –Ω–∞ –ø—Ä–æ–±–ª–µ–º—ã —Å –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ–º –∏–∑ 28 —Ä–µ–≥–∏–æ–Ω–æ–≤ —Å—Ç—Ä–∞–Ω—ã. –£—Å—Ç—Ä–∞–Ω–∏–ª–∏ –Ω–µ—Å–æ–≥–ª–∞—Å–æ–≤–∞–Ω–Ω–æ—Å—Ç—å –°—Ä–æ–∫ –¥–µ–π—Å—Ç–≤–∏—è 15%-–Ω–æ–≥–æ –ø—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–∞ –¥–ª—è —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –∏ –µ–≤—Ä–∞–∑–∏–π—Å–∫–∏—Ö —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ —Å –ø–æ–ª–Ω—ã–º —Ü–∏–∫–ª–æ–º –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞, –Ω–µ –≤—Ö–æ–¥—è—â–∏—Ö –≤ –ü–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü, —Å–æ–∫—Ä–∞—â–µ–Ω —Å 31 –¥–µ–∫–∞–±—Ä—è –¥–æ 31 –∞–≤–≥—É—Å—Ç–∞ 2025 –≥–æ–¥–∞.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The Russian Federal Audit Chamber noted a minimum increase in healthcare expenses across half of the regions in Russia for the first quarter of 2025. This could be due to the implementation of President's May orders on increasing medical staff salaries, rising drug prices, and increasing utility tariffs. The Union of Russian Patients requested increased funding for the 14th VZN program, stating that the shortfall exceeds 10 billion rubles and this union has received complaints about medication shortages from 28 regions of the country. The duration of the 15% advantage for Russian and Eurasian strategically important drugs with full production cycles, not included in the GNP list, has been shortened from December 31 to August 31, 2025.""
}"
2025-06-17T14:40:13+00:00,@medpharm,12233,https://t.me/medpharm/12233,"–ß–∞—Å—Ç–Ω—ã–µ –∫–ª–∏–Ω–∏–∫–∏ –ú–æ—Å–∫–≤—ã –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç –æ–ø—ã—Ç–Ω—ã–º –º–µ–¥—Å–µ—Å—Ç—Ä–∞–º –ø–æ —Ñ–∏–∑–∏–æ—Ç–µ—Ä–∞–ø–∏–∏ –∑–∞—Ä–ø–ª–∞—Ç—É –¥–æ 120 —Ç—ã—Å. —Ä—É–±., –∞ –Ω–∞—á–∏–Ω–∞—é—â–∏–º ‚Äî –æ–∫–æ–ª–æ 60 —Ç—ã—Å. —Ä—É–±. –≤ –º–µ—Å—è—Ü. –í –∫—Ä—É–ø–Ω—ã—Ö —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã—Ö –≥–æ—Ä–æ–¥–∞—Ö –∑–∞—Ä–ø–ª–∞—Ç–Ω—ã–π –º–∞–∫—Å–∏–º—É–º –¥–æ—Å—Ç–∏–≥–∞–µ—Ç 100 —Ç—ã—Å. —Ä—É–±.","{""skip"": true}"
2025-06-17T13:33:47+00:00,@medpharm,12232,https://t.me/medpharm/12232,"–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –≤–Ω–µ—Å–ª–æ –∏–∑–º–µ–Ω–µ–Ω–∏—è –≤ –ø—Ä–∞–≤–∏–ª–∞ –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ —Ä–µ–∂–∏–º–∞ –¥–ª—è –≥–æ—Å–∑–∞–∫—É–ø–æ–∫. –°—Ä–æ–∫ –¥–µ–π—Å—Ç–≤–∏—è 15%-–Ω–æ–≥–æ –ø—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–∞ –¥–ª—è —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –∏ –µ–≤—Ä–∞–∑–∏–π—Å–∫–∏—Ö —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ —Å –ø–æ–ª–Ω—ã–º —Ü–∏–∫–ª–æ–º –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞, –Ω–µ –≤—Ö–æ–¥—è—â–∏—Ö –≤ –ü–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü, —Å–æ–∫—Ä–∞—â–µ–Ω —Å 31 –¥–µ–∫–∞–±—Ä—è –¥–æ 31 –∞–≤–≥—É—Å—Ç–∞ 2025 –≥–æ–¥–∞.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export"",
  ""impact"": ""medium"",
  ""english"": ""Government extended the advantage period for Russian and Eurasian strategically important medicines with full production cycle, not included in the NPL list from December 31 to August 31, 2025.""
}"
2025-06-17T12:09:01+00:00,@medpharm,12231,https://t.me/medpharm/12231,"–°—Ç–æ–ª–∫–Ω—É–ª–∏—Å—å —Å –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç—å—é –ø–µ—Ä–µ—Ö–æ–¥–∞ —Å SAP, –Ω–æ –Ω–µ –≤–∏–¥–∏—Ç–µ –Ω–∞–¥–µ–∂–Ω–æ–π –∞–ª—å—Ç–µ—Ä–Ω–∞—Ç–∏–≤—ã? 19 –∏—é–Ω—è –Ω–∞ –≤–µ–±–∏–Ω–∞—Ä–µ —Ä–∞–∑–±–µ—Ä–µ–º –∫–µ–π—Å –∫–æ–º–ø–∞–Ω–∏–∏ –ê–û ""–§–ê–†–ú–ò–ú–≠–ö–°"" (–∫—Ä—É–ø–Ω–µ–π—à–∏–π –ø–æ—Å—Ç–∞–≤—â–∏–∫ —Ñ–∞—Ä–º–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤) –∫–æ—Ç–æ—Ä—ã–π –∑–∞–≤–µ—Ä—à–∏–ª –ø–µ—Ä–µ—Ö–æ–¥ —Å SAP –Ω–∞ 1–°:ERP –∑–∞ 9 –º–µ—Å—è—Ü–µ–≤ —Å —Å—É—â–µ—Å—Ç–≤–µ–Ω–Ω—ã–º –ø–æ–≤—ã—à–µ–Ω–∏–µ–º —É—Ä–æ–≤–Ω—è –∏ –≥–ª—É–±–∏–Ω—ã –∞–≤—Ç–æ–º–∞—Ç–∏–∑–∞—Ü–∏–∏. –ì–ª–∞–≤–Ω—ã–π —Ä–µ–∑—É–ª—å—Ç–∞—Ç: –ø–µ—Ä–µ—Ö–æ–¥ —Å–æ—Å—Ç–æ—è–ª—Å—è, GxP-–≤–∞–ª–∏–¥–∞—Ü–∏—è –≤ –ø—Ä–æ—Ü–µ—Å—Å–µ (–∑–∞–≤–µ—Ä—à–µ–Ω–∏–µ - –∫–æ–Ω–µ—Ü –∏—é–Ω—è), —Å–∏—Å—Ç–µ–º–∞ —Ä–∞–±–æ—Ç–∞–µ—Ç, - –æ—Ç—á–µ—Ç–Ω–æ—Å—Ç—å —Ä–µ–≥—É–ª—è—Ä–Ω–æ —Å–¥–∞–µ—Ç—Å—è! –ü—Ä—è–º–æ–µ –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å—Å—Ç–≤–æ –¥–ª—è —Å–∫–µ–ø—Ç–∏–∫–æ–≤: 1–°:ERP —Å–ø–æ—Å–æ–±–Ω–∞ –∑–∞–º–µ–Ω–∏—Ç—å SAP –≤ –≤—ã—Å–æ–∫–æ—Ä–µ–≥—É–ª–∏—Ä—É–µ–º–æ–π —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ –ø—Ä–∏ –≥—Ä–∞–º–æ—Ç–Ω–æ–π —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏. –ü–æ–¥—Ä–æ–±–Ω–æ—Å—Ç–∏ –∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –ø–æ —Å—Å—ã–ª–∫–µ –†–µ–∫–ª–∞–º–∞, –û–û–û ¬´–ê–°–ê–ü –†–∞–∑—Ä–∞–±–æ—Ç–∫–∞¬ª","{""skip"": true}"
2025-06-17T11:12:41+00:00,@medpharm,12230,https://t.me/medpharm/12230,"–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ —Ä–∞–∑—Ä–µ—à–∏–ª–æ —Ä–µ–≥–∏–æ–Ω–∞–º –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å —Å—ç–∫–æ–Ω–æ–º–ª–µ–Ω–Ω—ã–µ —Å—Ä–µ–¥—Å—Ç–≤–∞ –Ω–∞ –∑–∞–∫—É–ø–∫—É –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø–æ –ø—Ä–æ–≥—Ä–∞–º–º–µ 14 –í–ó–ù. –ú–∏–Ω–∑–¥—Ä–∞–≤ –¥–æ 1 –∞–ø—Ä–µ–ª—è –±—É–¥–µ—Ç —É–≤–µ–¥–æ–º–ª—è—Ç—å —Ä–µ–≥–∏–æ–Ω—ã –æ–± –∏–º–µ—é—â–µ–π—Å—è –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–π —Å—É–º–º–µ –¥–µ–Ω–µ–≥, –ø–æ—Å–ª–µ —á–µ–≥–æ —Å—É–±—ä–µ–∫—Ç—ã —Å–º–æ–≥—É—Ç –ø–æ–¥–∞—Ç—å –∑–∞—è–≤–∫–∏ –Ω–∞ –∏—Ö –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, shortage"",
  ""impact"": ""medium"",
  ""english"": ""The government has allowed regions to use saved funds for purchasing medicines under the program. The Ministry of Health will notify regions about available additional funds by April 1st, after which the regions can submit applications for their use.""
}"
2025-06-17T10:15:00+00:00,@medpharm,12229,https://t.me/medpharm/12229,"–í—Å–µ—Ä–æ—Å—Å–∏–π—Å–∫–∏–π —Å–æ—é–∑ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –ø–æ–ø—Ä–æ—Å–∏–ª —É–≤–µ–ª–∏—á–∏—Ç—å —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏–µ –ø—Ä–æ–≥—Ä–∞–º–º—ã 14 –í–ó–ù. –í –æ–±—Ä–∞—â–µ–Ω–∏–∏ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ —É–∫–∞–∑–∞–Ω–æ, —á—Ç–æ –¥–µ—Ñ–∏—Ü–∏—Ç –ø—Ä–µ–≤—ã—à–∞–µ—Ç 10 –º–ª—Ä–¥ —Ä—É–±., —Å–æ—é–∑ –ø–æ–ª—É—á–∏–ª –∂–∞–ª–æ–±—ã –Ω–∞ –ø—Ä–æ–±–ª–µ–º—ã —Å –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ–º –∏–∑ 28 —Ä–µ–≥–∏–æ–Ω–æ–≤ —Å—Ç—Ä–∞–Ω—ã.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, demand"",
  ""impact"": ""high"",
  ""english"": ""The Russian Federation Patients Union requested increased funding for the program '14 VZN'. The organization's appeal states that the shortfall exceeds 10 billion rubles, and the union received letters from 28 regions about problems with drug supply.""
}"
2025-06-17T08:41:47+00:00,@medpharm,12228,https://t.me/medpharm/12228,#–≠–∫—Å–∫–ª—é–∑–∏–≤ –ë–æ–ª–µ–µ 65% –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö –≤—Ä–∞—á–µ–π –≥–æ—Ç–æ–≤—ã –ø–æ–¥–¥–µ—Ä–∂–∞—Ç—å –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–µ —á–ª–µ–Ω—Å—Ç–≤–æ –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –≤ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—ã—Ö —Å–∞–º–æ—Ä–µ–≥—É–ª–∏—Ä—É–µ–º—ã—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è—Ö. –ï—â–µ –ø–æ—á—Ç–∏ —Å—Ç–æ–ª—å–∫–æ –∂–µ —Å–æ–æ–±—â–∏–ª–∏ –æ –≥–æ—Ç–æ–≤–Ω–æ—Å—Ç–∏ –∑–∞—Å—Ç—Ä–∞—Ö–æ–≤–∞—Ç—å –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—É—é –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç—å.,"{""skip"": true}"
2025-06-17T07:01:11+00:00,@medpharm,12227,https://t.me/medpharm/12227,"–°—Ç–∞—Ä—Ç–∞–ø Nucleus –∏–∑ –°–®–ê –≤–≤–µ–ª —É—Å–ª—É–≥—É –æ—Ç–±–æ—Ä–∞ —ç–º–±—Ä–∏–æ–Ω–æ–≤ –ø–æ –≤–æ–∑–º–æ–∂–Ω–æ–π –≤–Ω–µ—à–Ω–æ—Å—Ç–∏ –±—É–¥—É—â–µ–≥–æ —Ä–µ–±–µ–Ω–∫–∞ –∏ —Å–∫–ª–æ–Ω–Ω–æ—Å—Ç–∏ –∫ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º, –≤–∫–ª—é—á–∞—è –∞–∫–Ω–µ –∏ –±–æ–ª–µ–∑–Ω—å –ê–ª—å—Ü–≥–µ–π–º–µ—Ä–∞. ¬´–ú–í¬ª —É–∑–Ω–∞–ª —É –≤—Ä–∞—á–∞-–≥–µ–Ω–µ—Ç–∏–∫–∞, –∫–∞–∫–∏–µ –∏–∑ –æ–±–µ—â–∞–Ω–∏–π –∫–æ–º–ø–∞–Ω–∏–∏ –ø—Ä–∞–≤–¥–∏–≤—ã.","{""skip"": true}"
2025-06-16T16:03:48+00:00,@medpharm,12226,https://t.me/medpharm/12226,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 16 –∏—é–Ω—è –ï—â–µ –æ–¥–Ω–∞ –ø–æ–ø—ã—Ç–∫–∞ –î–µ–ø—É—Ç–∞—Ç—ã –ø–ª–∞–Ω–∏—Ä—É—é—Ç —É–∂–µ—Å—Ç–æ—á–∏—Ç—å –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç—å –∑–∞ –Ω–∞–ø–∞–¥–µ–Ω–∏–µ –Ω–∞ –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤. –ü–æ–ø—Ä–∞–≤–∫–∏ –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç—Å—è –≤–Ω–µ—Å—Ç–∏ –≤ —Å—Ç.63 –£–ö –†–§. –¢–µ—Å—Ç –Ω–∞ –ø—Ä–æ—á–Ω–æ—Å—Ç—å –†–æ—Å—Å–∏–π—Å–∫–∏–µ —É—á–µ–Ω—ã–µ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–ª–∏ –º–µ—Ç–æ–¥–∏–∫—É –¥–ª—è –∫–æ–Ω—Ç—Ä–æ–ª—è —Ö–∏—Ä—É—Ä–≥–∏—á–µ—Å–∫–∏—Ö —à–≤–æ–≤. –û–Ω–∞ –æ—Å–Ω–æ–≤–∞–Ω–∞ –Ω–∞ –æ–ø—Ç–∏—á–µ—Å–∫–æ–π –æ—Ü–µ–Ω–∫–µ —É—Ä–æ–≤–Ω—è –æ–∫—Å–∏–≥–µ–Ω–∞—Ü–∏–∏. –î–µ—Ç–∞–ª—å–Ω–æ –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ —É—Ç–æ—á–Ω–∏–ª–æ –ø—Ä–æ—Ü–µ–¥—É—Ä—É —Å–±–æ—Ä–∞ –∑–∞—è–≤–æ–∫ –Ω–∞ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ –≤–∫–ª—é—á–µ–Ω–Ω—ã—Ö –≤ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã–π —Å–µ–≥–º–µ–Ω—Ç –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –ü—Ä–µ–¥–æ—Å—Ç–∞–≤–ª–µ–Ω–∞ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –∑–∞–∫—É–ø–∞—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –Ω–∞ —Å—ç–∫–æ–Ω–æ–º–ª–µ–Ω–Ω—ã–µ —Ä–∞–Ω–µ–µ —Å—Ä–µ–¥—Å—Ç–≤–∞ –ø–æ –ø—Ä–æ–≥—Ä–∞–º–º–µ ¬´14 –í–ó–ù¬ª. –ú–∏–Ω–∏—Å—Ç—Ä —É—à–µ–ª, –≤–æ–ø—Ä–æ—Å—ã –æ—Å—Ç–∞–ª–∏—Å—å –ì–ª–∞–≤–∞ –∫—Ä–∞—Å–Ω–æ—è—Ä—Å–∫–æ–≥–æ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ —É—à–ª–∞ –ø–æ —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ–º—É –∂–µ–ª–∞–Ω–∏—é –Ω–∞ —Ñ–æ–Ω–µ —É–≥–æ–ª–æ–≤–Ω–æ–≥–æ –¥–µ–ª–∞, —Å–≤—è–∑–∞–Ω–Ω–æ–≥–æ —Å –ø–µ—Ä–µ–±–æ—è–º–∏ –≤ –ø–æ—Å—Ç–∞–≤–∫–∞—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –¥–ª—è –ª—å–≥–æ—Ç–Ω–∏–∫–æ–≤. –ù–µ—Å–º–æ—Ç—Ä—è –Ω–∞ –æ–±–≤–∏–Ω–µ–Ω–∏—è –≤ –∞–¥—Ä–µ—Å ¬´–ì—É–±–µ—Ä–Ω—Å–∫–∏—Ö –∞–ø—Ç–µ–∫¬ª, –ø—Ä–æ–≤–µ—Ä–∫–∞ –ø–æ–∫–∞–∑–∞–ª–∞, —á—Ç–æ —Å–µ—Ç—å –Ω–µ –Ω–∞—Ä—É—à–∞–µ—Ç —Å—Ä–æ–∫–∏ –ø–æ—Å—Ç–∞–≤–æ–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–æ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, —Å–æ–æ–±—â–∏–ª ¬´–§–í¬ª –∏—Å—Ç–æ—á–Ω–∏–∫.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions,hospital_policy,pharmacovigilance,safety"",
  ""impact"": ""medium"",
  ""english"": ""There are plans to increase the responsibility for attacks on medical workers. Proposed amendments include changes in Article 63 of the Criminal Code. The Russian scientists have developed a method for controlling surgical sutures based on optical assessment of oxygen levels. A government official has resigned due to a personal choice amid an investigation into supply disruptions for patients with subsidized medications. Despite allegations against 'Gubernskaya Apoteka', a source from 'FV' reports that the network does not violate delivery times of medications to patients.""
}"
2025-06-16T14:09:35+00:00,@medpharm,12225,https://t.me/medpharm/12225,–†–æ—Å–æ–±—Ä–Ω–∞–¥–∑–æ—Ä –≤—ã–Ω–µ—Å –ø—Ä–µ–¥–æ—Å—Ç–µ—Ä–µ–∂–µ–Ω–∏—è —Ç—Ä–µ–º –æ–±—Ä–∞–∑–æ–≤–∞—Ç–µ–ª—å–Ω—ã–º –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è–º. –°—Ä–µ–¥–∏ –Ω–∞—Ä—É—à–∏—Ç–µ–ª–µ–π –¥–≤–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –≤—É–∑–∞.,"{""skip"": true}"
2025-06-16T13:08:16+00:00,@medpharm,12224,https://t.me/medpharm/12224,"#–≠–∫—Å–∫–ª—é–∑–∏–≤ –ú–∏–Ω–∏—Å—Ç—Ä –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ö—Ä–∞—Å–Ω–æ—è—Ä—Å–∫–æ–≥–æ –∫—Ä–∞—è –ù–∞—Ç–∞–ª–∏—è –ì–æ–≤–æ—Ä—É—à–∫–∏–Ω–∞ –æ—Å–≤–æ–±–æ–∂–¥–µ–Ω–∞ –æ—Ç –¥–æ–ª–∂–Ω–æ—Å—Ç–∏ –ø–æ —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ–º—É –∂–µ–ª–∞–Ω–∏—é. –° –Ω–∞—á–∞–ª–∞ –≥–æ–¥–∞ –≤ —Ä–µ–≥–∏–æ–Ω–µ –Ω–∞–±–ª—é–¥–∞—é—Ç—Å—è —Å–±–æ–∏ –≤ –ø–æ—Å—Ç–∞–≤–∫–∞—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –¥–ª—è –ª—å–≥–æ—Ç–Ω–∏–∫–æ–≤. –í –º–∞—Ä—Ç–µ –°–ª–µ–¥—Å—Ç–≤–µ–Ω–Ω—ã–π –∫–æ–º–∏—Ç–µ—Ç –≤–æ–∑–±—É–¥–∏–ª —É–≥–æ–ª–æ–≤–Ω–æ–µ –¥–µ–ª–æ –æ —Ö–∞–ª–∞—Ç–Ω–æ—Å—Ç–∏ –¥–æ–ª–∂–Ω–æ—Å—Ç–Ω—ã—Ö –ª–∏—Ü –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –ø—Ä–∏ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–∏ –≥—Ä–∞–∂–¥–∞–Ω –∂–∏–∑–Ω–µ–Ω–Ω–æ –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã–º–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º–∏. –ù–µ—Å–º–æ—Ç—Ä—è –Ω–∞ –æ–±–≤–∏–Ω–µ–Ω–∏—è –≤ –∞–¥—Ä–µ—Å ¬´–ì—É–±–µ—Ä–Ω—Å–∫–∏—Ö –∞–ø—Ç–µ–∫¬ª, –ø—Ä–æ–≤–µ—Ä–∫–∞ –ø–æ–∫–∞–∑–∞–ª–∞, —á—Ç–æ —Å–µ—Ç—å –Ω–µ –Ω–∞—Ä—É—à–∞–µ—Ç —Å—Ä–æ–∫–∏ –ø–æ—Å—Ç–∞–≤–æ–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–æ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, —Å–æ–æ–±—â–∏–ª ¬´–§–í¬ª –∏—Å—Ç–æ—á–Ω–∏–∫.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""shortage, hospital_policy"",
  ""impact"": ""high"",
  ""english"": ""There have been supply disruptions for subsidized medications in the region. The Investigative Committee has opened an investigation into dereliction of duty by health officials in ensuring patients receive essential medicines. Despite allegations against 'Gubernskie apoteki', a network has not been found to be violating supply timelines for patients, according to 'FV' sources.""
}"
2025-06-16T11:37:21+00:00,@medpharm,12223,https://t.me/medpharm/12223,"–í –∫–∞—Ä—Ç–∞—Ö –∞–º–±—É–ª–∞—Ç–æ—Ä–Ω—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –Ω–∞ –≥–ª–∞–≤–Ω–æ–π —Å—Ç—Ä–∞–Ω–∏—Ü–µ –ø–æ—è–≤—è—Ç—Å—è –æ—Ç–º–µ—Ç–∫–∏ –æ–± –∞–¥—Ä–µ—Å–µ —ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω–æ–π –ø–æ—á—Ç—ã, –≥—Ä–∞–∂–¥–∞–Ω—Å—Ç–≤–µ –∏ –¥–æ–≤–µ—Ä–µ–Ω–Ω–æ–º –ª–∏—Ü–µ, –∫–æ—Ç–æ—Ä–æ–º—É –º–æ–∂–µ—Ç –±—ã—Ç—å –ø–µ—Ä–µ–¥–∞–Ω–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance"",
  ""impact"": ""medium"",
  ""english"": ""The clinic charts will include email address, citizenship and the name of a trusted person to whom medical information can be transferred on the main page.""
}"
2025-06-16T09:00:49+00:00,@medpharm,12222,https://t.me/medpharm/12222,"–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –æ–±–Ω–æ–≤–∏–ª–æ —Å–ø–∏—Å–æ–∫ –Ω–∞—Ä–∫–æ—Ç–∏—á–µ—Å–∫–∏—Ö —Å—Ä–µ–¥—Å—Ç–≤, –ø—Å–∏—Ö–æ—Ç—Ä–æ–ø–Ω—ã—Ö –≤–µ—â–µ—Å—Ç–≤ –∏ –∏—Ö –ø—Ä–µ–∫—É—Ä—Å–æ—Ä–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ –ø–æ–¥–ª–µ–∂–∞—Ç –∫–æ–Ω—Ç—Ä–æ–ª—é –≤ –†–æ—Å—Å–∏–∏. –í —Å–ø–∏—Å–æ–∫ –¥–æ–±–∞–≤–∏–ª–∏ 13 –Ω–∞—Ä–∫–æ—Ç–∏—á–µ—Å–∫–∏—Ö —Å—Ä–µ–¥—Å—Ç–≤ –∏ —á–µ—Ç—ã—Ä–µ –ø—Å–∏—Ö–æ—Ç—Ä–æ–ø–Ω—ã—Ö –≤–µ—â–µ—Å—Ç–≤–∞.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""regulation, registration, sanctions"",
  ""impact"": ""high"",
  ""english"": ""The government updated the list of narcotic substances, psychotropic substances and their precursors subject to control in Russia. The list was expanded with 13 narcotic substances and four psychotropic substances.""
}"
2025-06-16T08:01:49+00:00,@medpharm,12221,https://t.me/medpharm/12221,"–í –ì–æ—Å–¥—É–º—É –≤–Ω–µ—Å–ª–∏ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ–± —É—Å–∏–ª–µ–Ω–∏–∏ —É–≥–æ–ª–æ–≤–Ω–æ–π –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç–∏ –∑–∞ –Ω–∞–ø–∞–¥–µ–Ω–∏—è –Ω–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤. –î–µ–π—Å—Ç–≤—É—é—â–∏–µ –Ω–æ—Ä–º—ã –£–ö –Ω–µ —Å–Ω–∏–∂–∞—é—Ç –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ —Ç–∞–∫–∏—Ö –ø—Ä–µ—Å—Ç—É–ø–ª–µ–Ω–∏–π, –≥–æ–≤–æ—Ä–∏—Ç—Å—è –≤ –ø–æ—è—Å–Ω–∏—Ç–µ–ª—å–Ω–æ–π –∑–∞–ø–∏—Å–∫–µ.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing, import_export, sanctions"",
  ""impact"": ""high"",
  ""english"": ""A law project has been submitted to the State Duma to increase criminal liability for attacks on medical workers. Current criminal code norms do not reduce the number of such crimes, according to the explanatory note.""
}"
2025-06-15T12:04:09+00:00,@medpharm,12220,https://t.me/medpharm/12220,"–ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏ –∑–∞ –Ω–µ–¥–µ–ª—é üîµ –ö–≤–∞–ª–∏—Ñ–∏–∫–∞—Ü–∏–æ–Ω–Ω—ã–µ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–º —Ä–∞–±–æ—Ç–Ω–∏–∫–∞–º —Å–æ —Å—Ä–µ–¥–Ω–∏–º –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–º ‚Äé–∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–º –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ–º –∏—Å–∫–ª—é—á–∏–ª–∏ –∏–∑ ¬´–±–µ–ª–æ–≥–æ —Å–ø–∏—Å–∫–∞¬ª –∫–æ–Ω—Ç—Ä–æ–ª—å–Ω–æ-–Ω–∞–¥–∑–æ—Ä–Ω—ã—Ö —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π. üîµ –°—Ä–æ–∫ –æ–∫–æ–Ω—á–∞–Ω–∏—è —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–∞ –ø–æ –ø—Ä–æ—Å–ª–µ–∂–∏–≤–∞–µ–º–æ—Å—Ç–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ —Å—ã—Ä—å—è, –∏—Å–ø–æ–ª—å–∑—É–µ–º–æ–≥–æ –¥–ª—è –∏—Ö –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞, –ø—Ä–æ–¥–ª—è—Ç –µ—â–µ –Ω–∞ –¥–≤–∞ –º–µ—Å—è—Ü–∞ ‚Äî –¥–æ 31 –∞–≤–≥—É—Å—Ç–∞. üîµ ¬´–ë–∏–æ–∫–∞–¥¬ª –ø–æ–¥–∞–ª –∏—Å–∫ –∫ ¬´–ê—Å—Ç—Ä–∞–∑–µ–Ω–µ–∫–∞ —Ñ–∞—Ä–º–∞—Å—å—é—Ç–∏–∫–∞–ª–∑¬ª, –æ–±–≤–∏–Ω–∏–≤ –∫–æ–º–ø–∞–Ω–∏—é –≤ –ø–æ–¥—Ä—ã–≤–µ –¥–µ–ª–æ–≤–æ–π —Ä–µ–ø—É—Ç–∞—Ü–∏–∏ –∏ —Å—Ä—ã–≤–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –∞–Ω–∞–ª–æ–≥–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ¬´–≠–Ω—Ö–µ—Ä—Ç—É¬ª. üîµ –ê—Ä–±–∏—Ç—Ä–∞–∂–Ω—ã–π —Å—É–¥ –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥–∞ –∏ –õ–µ–Ω–∏–Ω–≥—Ä–∞–¥—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –æ–±—è–∑–∞–ª ¬´–ì—Ä–æ—Ç–µ–∫—Å¬ª –æ–±—Ä–∞—Ç–∏—Ç—å—Å—è –≤ –ú–∏–Ω–∑–¥—Ä–∞–≤ —Å –∑–∞—è–≤–ª–µ–Ω–∏–µ–º –æ–± –æ—Ç–º–µ–Ω–µ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ¬´–§–ª–∞—Ç–æ—Ü–∏–Ω —Å–æ–ª–æ—Ñ–∞—Ä–º¬ª, –∞ —Ç–∞–∫–∂–µ –ø—Ä–µ–¥–µ–ª—å–Ω–æ –¥–æ–ø—É—Å—Ç–∏–º–æ–π —Ü–µ–Ω—ã –Ω–∞ –Ω–µ–≥–æ. üîµ –ö–∞–ø–∏—Ç–∞–ª –æ—Å–Ω–æ–≤–∞—Ç–µ–ª—è —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª –ü–µ—Ç—Ä–∞ –ë–µ–ª–æ–≥–æ –ø—Ä–µ–≤—ã—Å–∏–ª 1 –º–ª—Ä–¥ –¥–æ–ª–ª., –ø–∏—à–µ—Ç Forbes.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety"",
  ""impact"": ""high"",
  ""english"": ""A pharmaceutical company 'Biosource' has filed a lawsuit against Astellas Pharma, accusing the company of undermining its business reputation and delaying clinical trials for an equivalent drug 'Enhera'. The Arbitration Court of St. Petersburg and Leningrad Oblast has ordered 'Grotex' to submit a request to the Ministry of Health for revocation of registration for the drug 'Fluconazole Solofarm' and its maximum permissible price.""
}"
2025-06-14T09:03:34+00:00,@medpharm,12219,https://t.me/medpharm/12219,"–ì–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∑–∞ –Ω–µ–¥–µ–ª—é üî¥–ü—Ä–µ–∑–∏–¥–µ–Ω—Ç –†–æ—Å—Å–∏–∏ –í–ª–∞–¥–∏–º–∏—Ä –ü—É—Ç–∏–Ω –ø–æ–∑–¥—Ä–∞–≤–∏–ª –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ —Å –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—ã–º –ø—Ä–∞–∑–¥–Ω–∏–∫–æ–º –∏ –Ω–∞–∑–≤–∞–ª –≥–ª–∞–≤–Ω—ã–º –∫—Ä–∏—Ç–µ—Ä–∏–µ–º –æ—Ü–µ–Ω–∫–∏ —Ä–∞–±–æ—Ç—ã –≤–ª–∞—Å—Ç–µ–π –≤ —Å—Ñ–µ—Ä–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –º–Ω–µ–Ω–∏–µ —Ä–æ—Å—Å–∏—è–Ω –æ —Å–æ—Å—Ç–æ—è–Ω–∏–∏ –º–µ–¥–∏—Ü–∏–Ω—ã. üî¥–°–æ–≥–ª–∞—Å–Ω–æ –æ–ø—Ä–æ—Å—É, –æ–±—â–∏–π —É—Ä–æ–≤–µ–Ω—å –¥–æ–≤–µ—Ä–∏—è –∫ –≤—Ä–∞—á–∞–º —É–ø–∞–ª –≤ I –∫–≤–∞—Ä—Ç–∞–ª–µ 2025 –≥–æ–¥–∞ –Ω–∞ 3,2%. üî¥–ú–∏–Ω–∏—Å—Ç—Ä –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ú–∏—Ö–∞–∏–ª –ú—É—Ä–∞—à–∫–æ –ø—Ä–∏–∑–Ω–∞–ª –Ω–µ–¥–æ—Å—Ç–∏–∂–µ–Ω–∏–µ —Ü–µ–ª–µ–π —Ñ–µ–¥–ø—Ä–æ–µ–∫—Ç–∞ –ø–æ —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤—É –¥–µ—Ç—Å–∫–∏—Ö –±–æ–ª—å–Ω–∏—Ü. üî¥–° 1 —Å–µ–Ω—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞ –≤ –†–æ—Å—Å–∏–∏ –≤—Å—Ç—É–ø—è—Ç –≤ —Å–∏–ª—É –Ω–æ–≤—ã–µ –ø—Ä–∞–≤–∏–ª–∞ –æ–±—Ä–∞—â–µ–Ω–∏—è –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏ –∞–∫—Ç–∏–≤–Ω—ã—Ö –¥–æ–±–∞–≤–æ–∫: –≤—Ä–∞—á–∏ –ø–æ–ª—É—á–∞—Ç –ø—Ä–∞–≤–æ –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω–æ –Ω–∞–∑–Ω–∞—á–∞—Ç—å –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –≤ —Å—Ç—Ä–∞–Ω–µ –ë–ê–î –ø—Ä–∏ –Ω–∞–ª–∏—á–∏–∏ –ø–æ–∫–∞–∑–∞–Ω–∏–π. üî¥–ù–æ–≤—ã–π –ø–æ—Ä—è–¥–æ–∫ —ç–∫—Å–ø–µ—Ä—Ç–∏–∑—ã –∫–∞—á–µ—Å—Ç–≤–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –≤ —Ä–∞–º–∫–∞—Ö –û–ú–° –∏–∑-–∑–∞ –Ω–æ–≤–æ–π —Ç–µ—Ä–º–∏–Ω–æ–ª–æ–≥–∏–∏ –º–æ–∂–µ—Ç –ø—Ä–∏–≤–µ—Å—Ç–∏ –∫ –≤–∞—Ä–∏–∞—Ç–∏–≤–Ω–æ—Å—Ç–∏ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–æ–≤ —ç–∫—Å–ø–µ—Ä—Ç–∏–∑.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""The President of Russia Vladimir Putin congratulated healthcare workers on their professional holiday and named the level of public opinion as a key criterion for assessing government performance in healthcare. According to an opinion poll, trust among the public towards doctors decreased by 3.2% in Q1 2025. Minister of Health Mikhail Murashko acknowledged that the objectives of the federal project on building pediatric hospitals have not been met. Starting from September 2025, new rules for the registration and quality assessment of biologically active dietary supplements will be implemented in Russia. Doctors will have the right to prescribe registered supplements based on medical necessity.""
}"
2025-06-11T16:31:32+00:00,@medpharm,12218,https://t.me/medpharm/12218,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 11 –∏—é–Ω—è –ü—Ä–∏—Ç—è–∂–µ–Ω–∏–µ –±—Ä–µ–Ω–¥–∞ –†—ã–Ω–æ–∫ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ñ—Ä–∞–Ω—à–∏–∑ –≤ –†–æ—Å—Å–∏–∏ –≤ –±–ª–∏–∂–∞–π—à–∏–µ –¥–≤–∞ –≥–æ–¥–∞ –±—É–¥–µ—Ç —Ä–∞—Å—Ç–∏ –æ—Ä–∏–µ–Ω—Ç–∏—Ä–æ–≤–æ—á–Ω–æ –Ω–∞ 20% –≤ –≥–æ–¥. –°–∞–º—ã–º–∏ –≤–æ—Å—Ç—Ä–µ–±–æ–≤–∞–Ω–Ω—ã–º–∏ —Ñ—Ä–∞–Ω—à–∏–∑–∞–º–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ —Å–µ–≥–º–µ–Ω—Ç–∞ —Å—Ç–∞–ª–∏ –∫–ª–∏–Ω–∏–∫–∏. –õ–∞–π—Ñ—Ö–∞–∫ –õ—é–¥–∏ —Å –∏–∑–±—ã—Ç–æ—á–Ω–æ–π –º–∞—Å—Å–æ–π —Ç–µ–ª–∞, —Å–±—Ä–æ—Å–∏–≤—à–∏–µ –≤–µ—Å –≤ —Å—Ä–µ–¥–Ω–µ–º –≤–æ–∑—Ä–∞—Å—Ç–µ –∏ —Å–æ—Ö—Ä–∞–Ω–∏–≤—à–∏–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç, –∂–∏–ª–∏ –¥–æ–ª—å—à–µ –∏ —Ä–µ–∂–µ –±–æ–ª–µ–ª–∏. –°—Ç–∞–±–∏–ª—å–Ω–æ—Å—Ç—å –í –†–æ—Å—Å–∏–∏ –≤—Ç–æ—Ä–æ–π –≥–æ–¥ –ø—Ä–æ–¥–æ–ª–∂–∞—é—Ç—Å—è —Å–±–æ–∏ –≤ –ø–æ—Å—Ç–∞–≤–∫–∞—Ö –∏–º–º—É–Ω–æ–≥–ª–æ–±—É–ª–∏–Ω–∞ —á–µ–ª–æ–≤–µ–∫–∞ –∞–Ω—Ç–∏—Ä–µ–∑—É—Å Rho (D). –í —è–Ω–≤–∞—Ä–µ ‚Äì –∞–ø—Ä–µ–ª–µ 2025 –≥–æ–¥–∞ –∞–ø—Ç–µ–∫–∏ –ø—Ä–æ–¥–∞–ª–∏ –Ω–∞ 39% —É–ø–∞–∫–æ–≤–æ–∫ –º–µ–Ω—å—à–µ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å —Ç–∞–∫–∏–º –∂–µ –ø–µ—Ä–∏–æ–¥–æ–º 2024 –≥–æ–¥–∞. –õ–µ–∫–∞—Ä—Å—Ç–≤–æ –æ—Ç —Å–∞–Ω–∫—Ü–∏–π –ü–æ—Å—Ç–∞–≤–∫–∏ —Ñ–∞—Ä–º–ø—Ä–æ–¥—É–∫—Ü–∏–∏ –∏–∑ —Å—Ç—Ä–∞–Ω –ï–° –≤ –†–æ—Å—Å–∏—é –Ω–µ –∏–∑–º–µ–Ω–∏–ª–∏—Å—å –≤ –Ω–∞—Ç—É—Ä–∞–ª—å–Ω–æ–º –≤—ã—Ä–∞–∂–µ–Ω–∏–∏, –Ω–æ –≤—ã—Ä–æ—Å–ª–∏ –≤ –¥–µ–Ω–µ–∂–Ω–æ–º. –ê–Ω–∞–ª–∏—Ç–∏–∫–∏ —Å–≤—è–∑—ã–≤–∞—é—Ç —ç—Ç–æ –∫–∞–∫ —Å —É–¥–æ—Ä–æ–∂–∞–Ω–∏–µ–º –ª–µ–∫–∞—Ä—Å—Ç–≤, —Ç–∞–∫ –∏ —Å –∏–∑–º–µ–Ω–µ–Ω–∏–µ–º —Å—Ç—Ä—É–∫—Ç—É—Ä—ã –∏–º–ø–æ—Ä—Ç–∞ –≤ —Å—Ç–æ—Ä–æ–Ω—É –±–æ–ª–µ–µ –¥–æ—Ä–æ–≥–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, shortage, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""The market for medical franchises in Russia is expected to grow by approximately 20% annually over the next two years. The most sought-after franchises in this segment are clinics. Lifestyle Hack: People who have lost weight and maintained their results live longer and suffer from fewer illnesses. Stability: In Russia, there have been supply disruptions for human immunoglobulin Rho (D) for the second consecutive year. From January to April 2025, pharmacies sold 39% fewer units compared to the same period in 2024. Supply Chain: Import of pharmaceutical products from EU countries has not changed in natural terms, but it has increased in monetary terms. Analysts attribute this to both rising drug prices and a shift towards importing more expensive medications.""
}"
2025-06-11T14:30:01+00:00,@medpharm,12217,https://t.me/medpharm/12217,"–°–æ—é–∑ ¬´–ü—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–µ —Å–æ–æ–±—â–µ—Å—Ç–≤–æ –ø—Ä–æ–≤–∏–∑–æ—Ä–æ–≤ –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–æ–≤¬ª –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è ¬´–ü–æ—Ä—Ç—Ä–µ—Ç —Ñ–∞—Ä–º—Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞ –†–æ—Å—Å–∏–∏¬ª. –ì–ª–∞–≤–Ω–æ–π —Ü–µ–ª—å—é —Å—Ç–∞–ª–æ –æ–ø—Ä–µ–¥–µ–ª–∏—Ç—å –∫–ª—é—á–µ–≤—ã–µ –º–æ—Ç–∏–≤–∞—Ç–æ—Ä—ã, –¥–µ–º–æ—Ç–∏–≤–∞—Ç–æ—Ä—ã, –∞ —Ç–∞–∫–∂–µ –≤—ã—è–≤–∏—Ç—å –∞–∫—Ç—É–∞–ª—å–Ω—ã–µ –Ω–∞—Å—Ç—Ä–æ–µ–Ω–∏—è –∏ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—ã–µ —Ü–µ–Ω–Ω–æ—Å—Ç–∏ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤, —Ä–∞–±–æ—Ç–∞—é—â–∏—Ö –≤ –∞–ø—Ç–µ—á–Ω–æ–π –æ—Ç—Ä–∞—Å–ª–∏.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""Professional Association of Pharmacists and Pharmacies presented the results of the study 'Portrait of a Pharmacy Specialist in Russia'. The main goal was to identify key motivators, demotivators, as well as current sentiments and professional values of specialists working in the pharmaceutical industry.""
}"
2025-06-11T13:06:26+00:00,@medpharm,12216,https://t.me/medpharm/12216,"–ú–∏–Ω–∑–¥—Ä–∞–≤ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª –ø—Ä–∞–≤–∏–ª–∞ –¥–ª—è —Å—Ç—Ä–∞—Ö–æ–≤—ã—Ö –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π –ø–æ –∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä–æ–≤–∞–Ω–∏—é –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –ø—Ä–µ–¥—ä—è–≤–∏–≤—à–∏—Ö –ø—Ä–µ—Ç–µ–Ω–∑–∏–∏ –∫ –∫–ª–∏–Ω–∏–∫–∞–º. –ü—Ä–µ—Ç–µ–Ω–∑–∏–∏ –º–æ–≥—É—Ç –±—ã—Ç—å —Å–≤—è–∑–∞–Ω—ã —Å –æ—Ç–∫–∞–∑–æ–º –≤ –æ–∫–∞–∑–∞–Ω–∏–∏ –ø–æ–º–æ—â–∏ –ª–∏–±–æ –Ω–µ–∫–∞—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–º –ª–µ—á–µ–Ω–∏–µ–º –∏ –≤–∑–∏–º–∞–Ω–∏–µ–º –¥–µ–Ω–µ–∂–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""The Ministry of Health presented guidelines for insurance healthcare organizations regarding patient consultations. Claims can be related to refusal of care or substandard treatment, as well as the imposition of fees.""
}"
2025-06-11T11:31:07+00:00,@medpharm,12215,https://t.me/medpharm/12215,"–ù–∞ –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω–æ–º —Å–∞–π—Ç–µ —ç–∫–æ—Å–∏—Å—Ç–µ–º—ã ¬´–ó–¥–æ—Ä–æ–≤–æ–µ –æ–±—â–µ—Å—Ç–≤–æ¬ª –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω–∞ –¥–µ–ª–æ–≤–∞—è –ø—Ä–æ–≥—Ä–∞–º–º–∞ –æ–¥–Ω–æ–∏–º–µ–Ω–Ω–æ–≥–æ –ø—Ä–æ—Å—Ç—Ä–∞–Ω—Å—Ç–≤–∞, –∫–æ—Ç–æ—Ä–æ–µ –±—É–¥–µ—Ç —Ä–∞–±–æ—Ç–∞—Ç—å —Å 18 –ø–æ 21 –∏—é–Ω—è –Ω–∞ –ü–µ—Ç–µ—Ä–±—É—Ä–≥—Å–∫–æ–º –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–æ–º —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–º —Ñ–æ—Ä—É–º–µ (–ü–ú–≠–§).","{""skip"": true}"
2025-06-11T10:00:29+00:00,@medpharm,12214,https://t.me/medpharm/12214,"–ü—Ä–æ–¥–ª–µ–Ω—ã —Å—Ä–æ–∫–∏ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—è —Ü–µ–ª–µ–≤—ã—Ö –∑–∞—è–≤–æ–∫ —Ä–∞–±–æ—Ç–æ–¥–∞—Ç–µ–ª–µ–π –Ω–∞ –ø–æ—Ä—Ç–∞–ª–µ ¬´–†–∞–±–æ—Ç–∞ –≤ –†–æ—Å—Å–∏–∏¬ª, –∫–æ—Ç–æ—Ä—ã–π –∏—Å–ø–æ–ª—å–∑—É–µ—Ç—Å—è –≤ –∫–∞—á–µ—Å—Ç–≤–µ –∞–≥—Ä–µ–≥–∞—Ç–æ—Ä–∞ —Ç–∞–∫–∏—Ö –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–π –¥–ª—è –∞–±–∏—Ç—É—Ä–∏–µ–Ω—Ç–æ–≤. –†–∞–Ω–µ–µ –≤ —É—Å–ª–æ–≤–∏—è –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏—è —Å–µ—Ä–≤–∏—Å–∞ –±—ã–ª–∏ –≤–Ω–µ—Å–µ–Ω—ã –æ–±–Ω–æ–≤–ª–µ–Ω–∏—è, —Å–æ–≥–ª–∞—Å–Ω–æ –∫–æ—Ç–æ—Ä—ã–º –∑–∞–∫–ª—é—á–∏—Ç—å —Ü–µ–ª–µ–≤–æ–π –¥–æ–≥–æ–≤–æ—Ä –º–æ–∂–Ω–æ —Å –ª—é–±—ã–º —Ä–µ–≥–∏–æ–Ω–æ–º.","{""skip"": true}"
2025-06-11T09:10:03+00:00,@medpharm,12213,https://t.me/medpharm/12213,"–§–ê–° –ø–ª–∞–Ω–∏—Ä—É–µ—Ç —É—Å–∏–ª–∏—Ç—å –∫–æ–Ω—Ç—Ä–æ–ª—å –Ω–∞–¥ —Ñ–∞—Ä–º—Ä—ã–Ω–∫–æ–º –∏ —Å—Ñ–æ—Ä–º–∏—Ä—É–µ—Ç –¥–æ–±—Ä–æ—Å–æ–≤–µ—Å—Ç–Ω—ã–µ –ø—Ä–∞–∫—Ç–∏–∫–∏ –¥–ª—è —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –æ—Ç—Ä–∞—Å–ª–∏. –°–ª—É–∂–±–∞ —É–∂–µ –≤—ã–¥–∞–ª–∞ –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏—è –∫–æ–º–ø–∞–Ω–∏—è–º, –Ω–∞—Ä—É—à–∞—é—â–∏–º –ø—Ä–∏–Ω—Ü–∏–ø—ã —á–µ—Å—Ç–Ω–æ–π –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏–∏.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""sanctions, regulation"",
  ""impact"": ""medium"",
  ""english"": ""The FAS plans to strengthen market oversight over the pharmaceutical industry and establish honest practices among industry participants. The service has already issued warnings to companies that violate fair competition principles.""
}"
2025-06-11T07:24:06+00:00,@medpharm,12212,https://t.me/medpharm/12212,"–°—á–µ—Ç–Ω–∞—è –ø–∞–ª–∞—Ç–∞ —Å–æ–æ–±—â–∏–ª–∞ –æ –∑–∞—Ç—è–≥–∏–≤–∞–Ω–∏–∏ —Å—Ä–æ–∫–æ–≤ –∏ —Ä–æ—Å—Ç–µ —Å—Ç–æ–∏–º–æ—Å—Ç–∏ —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–∞ –°–µ–≤–∞—Å—Ç–æ–ø–æ–ª—å—Å–∫–æ–π –±–æ–ª—å–Ω–∏—Ü—ã —Å–∫–æ—Ä–æ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏. –ó–∞ –ø—è—Ç—å –ª–µ—Ç –ø—Ä–æ–µ–∫—Ç –ø–æ–¥–æ—Ä–æ–∂–∞–ª –º–∏–Ω–∏–º—É–º –Ω–∞ 60%, –ø—Ä–∏ —ç—Ç–æ–º –≥–æ—Ç–æ–≤–Ω–æ—Å—Ç—å –æ–±—ä–µ–∫—Ç–∞ –Ω–∞ –Ω–∞—á–∞–ª–æ 2025 –≥–æ–¥–∞ —Å–æ—Å—Ç–∞–≤–∏–ª–∞ –ª–∏—à—å 16%.","{""skip"": true}"
2025-06-10T16:02:05+00:00,@medpharm,12211,https://t.me/medpharm/12211,"–ì–ª–∞–≤–Ω–æ–µ –∑–∞ 10 –∏—é–Ω—è –ì–ª–∞—Å –Ω–∞—Ä–æ–¥–∞ –ú–Ω–µ–Ω–∏–µ —Ä–æ—Å—Å–∏—è–Ω –æ —Å–æ—Å—Ç–æ—è–Ω–∏–∏ –º–µ–¥–∏—Ü–∏–Ω—ã –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç –Ω–∞–∑–≤–∞–ª –≥–ª–∞–≤–Ω—ã–º –∫—Ä–∏—Ç–µ—Ä–∏–µ–º –æ—Ü–µ–Ω–∫–∏ —Ä–∞–±–æ—Ç—ã –≤–ª–∞—Å—Ç–µ–π –≤ —Å—Ñ–µ—Ä–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –í–ª–∞–¥–∏–º–∏—Ä –ü—É—Ç–∏–Ω –ø–æ–∑–¥—Ä–∞–≤–∏–ª –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ —Å –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—ã–º –ø—Ä–∞–∑–¥–Ω–∏–∫–æ–º. –°—Ç—Ä–æ–π–∫–∞ –ø–æ–¥–∫–∞—á–∞–ª–∞ –í –†–æ—Å—Å–∏–∏ –≤ —Ä–∞–º–∫–∞—Ö –Ω–∞—Ü–ø—Ä–æ–µ–∫—Ç–∞ ¬´–ó–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ¬ª –±—ã–ª–∞ –≤–≤–µ–¥–µ–Ω–∞ –≤ —Å—Ç—Ä–æ–π —Ç–æ–ª—å–∫–æ 21 –¥–µ—Ç—Å–∫–∞—è –±–æ–ª—å–Ω–∏—Ü–∞ –∏–∑ –∑–∞–ø–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö 26. –ù–µ–¥–æ—Å—Ç—Ä–æ–∏ –Ω–∞—Ö–æ–¥—è—Ç—Å—è –Ω–∞ –æ—Å–æ–±–æ–º –∫–æ–Ω—Ç—Ä–æ–ª–µ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞. –ë–µ–ª—ã–π –≤–æ—à–µ–ª –≤ —Å–ø–∏—Å–æ–∫ Forbes –ö–∞–ø–∏—Ç–∞–ª –æ—Å–Ω–æ–≤–∞—Ç–µ–ª—è —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª –ü–µ—Ç—Ä–∞ –ë–µ–ª–æ–≥–æ –ø—Ä–µ–≤—ã—Å–∏–ª 1 –º–ª—Ä–¥ –¥–æ–ª–ª., –ø–∏—à–µ—Ç Forbes. –û–Ω —Å—Ç–∞–ª —Å–µ–¥—å–º—ã–º –º–∏–ª–ª–∏–∞—Ä–¥–µ—Ä–æ–º –≤ –†–æ—Å—Å–∏–∏ –≤ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏. ¬´–ë–µ–ª—ã–π —Å–ø–∏—Å–æ–∫¬ª —Å—Ç–∞–ª –º–µ–Ω—å—à–µ –ö–≤–∞–ª–∏—Ñ–∏–∫–∞—Ü–∏–æ–Ω–Ω—ã–µ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –∫ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∞–º –∏—Å–∫–ª—é—á–∏–ª–∏ –∏–∑ ¬´–±–µ–ª–æ–≥–æ —Å–ø–∏—Å–∫–∞¬ª –∫–æ–Ω—Ç—Ä–æ–ª—å–Ω–æ-–Ω–∞–¥–∑–æ—Ä–Ω—ã—Ö —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π. –†–µ—á—å –∏–¥–µ—Ç –æ –¥–æ–∫—É–º–µ–Ω—Ç–µ, —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–Ω–æ–º –≤ 2016 –≥–æ–¥—É.","{
  ""skip"": true
}"
2025-06-10T14:31:38+00:00,@medpharm,12210,https://t.me/medpharm/12210,"–ù–æ–≤—ã–π –ø–æ—Ä—è–¥–æ–∫ —ç–∫—Å–ø–µ—Ä—Ç–∏–∑—ã –∫–∞—á–µ—Å—Ç–≤–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –≤ —Ä–∞–º–∫–∞—Ö –û–ú–° –∏–∑-–∑–∞ –Ω–æ–≤–æ–π —Ç–µ—Ä–º–∏–Ω–æ–ª–æ–≥–∏–∏ –º–æ–∂–µ—Ç –ø—Ä–∏–≤–µ—Å—Ç–∏ –∫ –≤–∞—Ä–∏–∞—Ç–∏–≤–Ω–æ—Å—Ç–∏ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–æ–≤ —ç–∫—Å–ø–µ—Ä—Ç–∏–∑. –í —Ä–∞–º–∫–∞—Ö —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–Ω—ã—Ö –∫—Ä–∏—Ç–µ—Ä–∏–µ–≤ —Å—Ç–∞–Ω–æ–≤–∏—Ç—Å—è –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏ –Ω–µ–≤—ã–ø–æ–ª–Ω–∏–º–æ–π –∫–ª—é—á–µ–≤–∞—è —Ü–µ–ª—å —ç–∫—Å–ø–µ—Ä—Ç–Ω–æ–π –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏, –∫–æ—Ç–æ—Ä—É—é —Å—Ç–∞–≤–∏—Ç –ø–µ—Ä–µ–¥ —Å–æ–±–æ–π –°–ª–µ–¥—Å—Ç–≤–µ–Ω–Ω—ã–π –∫–æ–º–∏—Ç–µ—Ç, ‚Äî –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ –æ–±—ä–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏.","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""A new quality medical assistance appraisal system under the OMS may lead to variability in results due to new terminology. The key objective set by the Investigative Committee, which is objectivity, becomes practically unachievable based on developed criteria.""
}"
2025-06-10T13:32:25+00:00,@medpharm,12209,https://t.me/medpharm/12209,"–ö–∞–ø–∏—Ç–∞–ª –æ—Å–Ω–æ–≤–∞—Ç–µ–ª—è —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª –ü–µ—Ç—Ä–∞ –ë–µ–ª–æ–≥–æ –ø—Ä–µ–≤—ã—Å–∏–ª 1 –º–ª—Ä–¥ –¥–æ–ª–ª., –ø–∏—à–µ—Ç Forbes. –û–Ω —Å—Ç–∞–ª —Å–µ–¥—å–º—ã–º –º–∏–ª–ª–∏–∞—Ä–¥–µ—Ä–æ–º –≤ –†–æ—Å—Å–∏–∏ –≤ —Ñ–∞—Ä–º–æ—Ç—Ä–∞—Å–ª–∏.","{""skip"": true}"
2025-06-10T12:30:57+00:00,@medpharm,12208,https://t.me/medpharm/12208,"–í –ú–æ—Å–∫–≤–µ –≤—Ä—É—á–∏–ª–∏ –ø—Ä–µ–º–∏–∏ –≤ –æ–±–ª–∞—Å—Ç–∏ –º–µ–¥–∏—Ü–∏–Ω—ã. –ù–∞–≥—Ä–∞–¥—ã –ø–æ–ª—É—á–∏–ª–∏ —à–µ—Å—Ç—å –∫–æ–º–∞–Ω–¥ –∑–∞ –ø—Ä–æ–µ–∫—Ç—ã –≤ —Å—Ñ–µ—Ä–µ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∏ –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π –≥–∏–ø–µ—Ä—á—É–≤—Å—Ç–≤–∏—Ç–µ–ª—å–Ω–æ—Å—Ç–∏, –∞ —Ç–∞–∫–∂–µ –∑–∞ —Ä–∞–∑–≤–∏—Ç–∏–µ —Ü–∏—Ñ—Ä–æ–≤–æ–≥–æ –≥–æ—Å–ø–∏—Ç–∞–ª—è.","{""skip"": true}"
2025-06-10T11:01:50+00:00,@medpharm,12207,https://t.me/medpharm/12207,"–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ —É—Ç–≤–µ—Ä–¥–∏–ª–æ —Å–æ–∑–¥–∞–Ω–∏–µ –¶–µ–Ω—Ç—Ä–∞ —Ä–∞–∑–≤–∏—Ç–∏—è –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–∞ –Ω–∞ –±–∞–∑–µ –ê–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–æ–≥–æ —Ü–µ–Ω—Ç—Ä–∞. –ù–æ–≤–∞—è —Å—Ç—Ä—É–∫—Ç—É—Ä–∞ –∑–∞–π–º–µ—Ç—Å—è —Å–æ–ø—Ä–æ–≤–æ–∂–¥–µ–Ω–∏–µ–º –ø—Ä–∏–æ—Ä–∏—Ç–µ—Ç–Ω—ã—Ö –ø—Ä–æ–µ–∫—Ç–æ–≤ –≤ —Å—Ñ–µ—Ä–µ –ò–ò, –≤–∫–ª—é—á–∞—è –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–æ–µ —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–æ, –ø—Ä–∞–≤–æ–≤–æ–µ —Ä–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω–∏–µ –∏ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏—é –ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–π —Å—Ç—Ä–∞—Ç–µ–≥–∏–∏ –ò–ò –¥–æ 2030 –≥–æ–¥–∞.","{""skip"": true}"
2025-06-10T09:05:10+00:00,@medpharm,12206,https://t.me/medpharm/12206,–ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ —Å–æ–∫—Ä–∞—Ç–∏–ª–æ —Å—Ä–æ–∫ –≤–Ω–µ—Å–µ–Ω–∏—è –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –æ–± –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–∏ –≤ –§–µ–¥–µ—Ä–∞–ª—å–Ω—ã–π —Ä–µ–µ—Å—Ç—Ä –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤ –æ–± –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–∏ –∏ –∫–≤–∞–ª–∏—Ñ–∏–∫–∞—Ü–∏–∏ –¥–æ 30 –¥–Ω–µ–π. –û–±–Ω–æ–≤–ª–µ–Ω–∏—è –≤—Å—Ç—É–ø—è—Ç –≤ —Å–∏–ª—É —Å 1 —Å–µ–Ω—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞.,"{""skip"": true}"
2025-06-10T08:00:01+00:00,@medpharm,12205,https://t.me/medpharm/12205,"–ê—Ä–±–∏—Ç—Ä–∞–∂–Ω—ã–π —Å—É–¥ –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥–∞ –∏ –õ–µ–Ω–∏–Ω–≥—Ä–∞–¥—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –æ–±—è–∑–∞–ª ¬´–ì—Ä–æ—Ç–µ–∫—Å¬ª –æ–±—Ä–∞—Ç–∏—Ç—å—Å—è –≤ –ú–∏–Ω–∑–¥—Ä–∞–≤ —Å –∑–∞—è–≤–ª–µ–Ω–∏–µ–º –æ–± –æ—Ç–º–µ–Ω–µ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ¬´–§–ª–∞—Ç–æ—Ü–∏–Ω —Å–æ–ª–æ—Ñ–∞—Ä–º¬ª, –∞ —Ç–∞–∫–∂–µ –ø—Ä–µ–¥–µ–ª—å–Ω–æ –¥–æ–ø—É—Å—Ç–∏–º–æ–π —Ü–µ–Ω—ã –Ω–∞ –Ω–µ–≥–æ. –° —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–∏–º –∏—Å–∫–æ–º –æ–±—Ä–∞—Ç–∏–ª–∞—Å—å —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—è ¬´–ü–æ–ª–∏—Å–∞–Ω¬ª, –∫–æ—Ç–æ—Ä–∞—è —É—Ç–≤–µ—Ä–∂–¥–∞–µ—Ç, —á—Ç–æ –æ—Ç–≤–µ—Ç—á–∏–∫ –Ω–∞—Ä—É—à–∏–ª –µ–µ –∏—Å–∫–ª—é—á–∏—Ç–µ–ª—å–Ω—ã–µ –ø—Ä–∞–≤–∞.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, pricing"",
  ""impact"": ""high"",
  ""english"": ""An arbitration court in Saint Petersburg and Leningrad Oblast ordered 'Grotex' to submit a request to the Ministry of Health for revoking registration of the drug 'Flatozin Solofarm'. The claimant, pharmaceutical company 'Polisan', asserts that the respondent has violated its exclusive rights.""
}"
2025-06-10T07:08:04+00:00,@medpharm,12204,https://t.me/medpharm/12204,"–í –ö—É–∑–±–∞—Å—Å–µ –∑–∞–¥–µ—Ä–∂–∞–Ω —ç–∫—Å-–º–∏–Ω–∏—Å—Ç—Ä –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –æ–±–ª–∞—Å—Ç–∏ –î–º–∏—Ç—Ä–∏–π –ë–µ–≥–ª–æ–≤, –∫–æ—Ç–æ—Ä—ã–π —É—à–µ–ª –≤ –æ—Ç—Å—Ç–∞–≤–∫—É –º–µ–Ω—å—à–µ –Ω–µ–¥–µ–ª–∏ –Ω–∞–∑–∞–¥. –î–µ–ª–æ —Å–≤—è–∑–∞–Ω–æ —Å –¥–∞—á–µ–π –µ–º—É –≤–∑—è—Ç–∫–∏ –∑–∞ —Å–æ–¥–µ–π—Å—Ç–≤–∏–µ –≤ –∑–∞–∫–ª—é—á–µ–Ω–∏–∏ –≥–æ—Å–∫–æ–Ω—Ç—Ä–∞–∫—Ç–æ–≤ –∫–æ–Ω–∫—Ä–µ—Ç–Ω–æ–π —Ñ–∏—Ä–º–æ–π.","{""skip"": true}"
2025-12-03T11:48:10+00:00,@pharm_icon,2462,https://t.me/pharm_icon/2462,"–¢—Ä–∞–º–ø–æ–≤ —á—ë—Ä–Ω—ã–π —Ö–æ–¥ –ë—Ä–∏—Ç–∞–Ω–∏—è –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω–∞—è –ø—Ä–æ–±–∏–ª–∞—Å—å –∫ –¢—Ä–∞–º–ø—É ¬´—á–µ—Ä–µ–∑ —á–µ—Ä–Ω—ã–π —Ö–æ–¥¬ª –∏ –¥–æ–≥–æ–≤–æ—Ä–∏–ª–∞—Å—å, —á—Ç–æ–±—ã –µ—ë —Ç–∞–±–ª–µ—Ç–∫–∏ –∏ –º–µ–¥—Ö–ª–∞–º –≤ –®—Ç–∞—Ç—ã –∑–∞—Ö–æ–¥–∏–ª–∏ –±–µ–∑ –ø–æ—à–ª–∏–Ω. –ü–æ–∫–∞ –≤—Å–µ—Ö –æ—Å—Ç–∞–ª—å–Ω—ã—Ö –º–∏—Ä–æ–≤—ã—Ö –∏–≥—Ä–æ–∫–æ–≤ –æ–±–ª–æ–∂–∏–ª–∏ –¥–∞–Ω—å—é, –õ–æ–Ω–¥–æ–Ω –ø—Ä–æ–±–∏–ª —Å–µ–±–µ –ø–æ–¥–∫–æ–ø –ø–æ –¥–æ–≥–æ–≤–æ—Ä–Ω—è–∫—É —Å –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç–æ–º, –∫–æ—Ç–æ—Ä—ã–π –Ω–µ —É–º–µ–µ—Ç –≤ —Ç–æ–Ω–∞–ª—å–Ω—ã–π –∫—Ä–µ–º. –ó–∞ —ç—Ç–æ —è–Ω–∫–∏ –ø–æ–æ–±–µ—â–∞–ª–∏ —Ç—Ä–∏ –≥–æ–¥–∞ –∏—Ö –Ω–µ —Ç—Ä–æ–≥–∞—Ç—å –∏ –Ω–µ –ª–µ–∑—Ç—å –≤ –∏—Ö –≤–Ω—É—Ç—Ä–µ–Ω–Ω–∏–µ —Ü–µ–Ω–Ω–∏–∫–∏ –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞. –¢–æ –µ—Å—Ç—å –¢—Ä–∞–º–ø —Å–∫–∞–∑–∞–ª: ¬´–ñ–∏–≤–∏—Ç–µ —Å–ø–æ–∫–æ–π–Ω–æ –¥–æ –∫–æ–Ω—Ü–∞ –º–æ–µ–≥–æ —Å—Ä–æ–∫–∞¬ª. –ù–æ —Ñ–∏—à–∫–∞ –≤ —Ç–æ–º, —á—Ç–æ –ë—Ä–∏—Ç–∞–Ω–∏—è –≤ –æ–±–º–µ–Ω —Å–∞–º–∞ –ø—Ä–æ–≥–Ω—É–ª–∞—Å—å: –ø–æ–¥–Ω—è–ª–∞ –ø–æ—Ä–æ–≥ –ø–æ QALY ‚Äî —Ç–∏–ø–∞ ¬´–º—ã —Ç–µ–ø–µ—Ä—å –¥–æ—Ä–æ–∂–µ –ª–µ—á–∏—Ç—å—Å—è —Å–æ–≥–ª–∞—Å–Ω—ã¬ª. –ï—Å–ª–∏ —Ä–∞–Ω—å—à–µ –æ–Ω–∏ –≥–æ–≤–æ—Ä–∏–ª–∏ ¬´–¥–æ—Ä–æ–≥–æ ‚Äî –∏–¥–∏—Ç–µ –ª–µ—Å–æ–º¬ª, —Ç–æ —Å–µ–π—á–∞—Å –±—É–¥—É—Ç –±—Ä–∞—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏–∑ –°–®–ê –ø–æ–¥–æ—Ä–æ–∂–µ, –ª–∏—à—å –±—ã –æ—Ç–Ω–æ—à–µ–Ω–∏—è –Ω–µ –∏—Å–ø–æ—Ä—Ç–∏—Ç—å. –ü–ª—é—Å —Ä–∞–Ω—å—à–µ —Ñ–∞—Ä–º—ã –¥–æ–ª–∂–Ω—ã –±—ã–ª–∏ –æ—Ç—Å—Ç—ë–≥–∏–≤–∞—Ç—å –ø–æ—á—Ç–∏ —á–µ—Ç–≤–µ—Ä—Ç—å –≤—ã—Ä—É—á–∫–∏ –æ–±—Ä–∞—Ç–Ω–æ –≤ –∫–∞–∑–Ω—É ‚Äî —Ç–µ–ø–µ—Ä—å –≤—Å–µ–≥–æ 15%. –°–¥–µ–ª–∞–ª–∏ –æ–Ω–∏ —ç—Ç–æ, –ø–æ—Ç–æ–º—É —á—Ç–æ —Ñ–∞—Ä–º–≥–∏–≥–∞–Ω—Ç—ã –Ω–∞—á–∞–ª–∏ –±–µ–∂–∞—Ç—å —Å –∫–æ—Ä–∞–±–ª—è ‚Äî –∏–º –Ω–∞–¥–æ–µ–ª–æ —Ç–∞–∫ –º–Ω–æ–≥–æ –æ—Ç—Å—Ç—ë–≥–∏–≤–∞—Ç—å. –ò –ë—Ä–∏—Ç–∞–Ω–∏—è –ø–æ–Ω—è–ª–∞, —á—Ç–æ –µ—Å–ª–∏ –µ—â—ë –ø–æ–≤—ã–ø–µ–Ω–¥—Ä–∏–≤–∞—Ç—å—Å—è ‚Äî –æ—Å—Ç–∞–Ω–µ—Ç—Å—è –∏ –±–µ–∑ –¥–µ–Ω–µ–≥ –∏ –±–µ–∑ –∏–Ω–≤–µ—Å—Ç–æ—Ä–æ–≤. –¢–∞–∫–æ–π –æ–Ω, –±–∞–Ω–¥–∏—Ç—Å–∫–∏–π –í–∞—à–∏–Ω–≥—Ç–æ–Ω.","{""skip"": true}"
2025-12-03T07:04:00+00:00,@pharm_icon,2461,https://t.me/pharm_icon/2461,"–ò–Ω–æ–≥–¥–∞ –Ω—É–∂–Ω–æ —Å–¥–∞—Ç—å –∞–Ω–∞–ª–∏–∑—ã –±—ã—Å—Ç—Ä–æ –∏ –±–µ–∑ –ª–∏—à–Ω–∏—Ö —Ñ–æ—Ä–º–∞–ª—å–Ω–æ—Å—Ç–µ–π. –ò–Ω–≥–æ—Å—Å—Ç—Ä–∞—Ö –∑–∞–ø—É—Å—Ç–∏–ª –º–∏–Ω–∏-—á–µ–∫–∞–ø—ã –ò–Ω–≥–æ–õ–∞–±: –≤—ã–±—Ä–∞—Ç—å –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –∏ –ø—Ä–æ–π—Ç–∏ –∏—Ö –º–æ–∂–Ω–æ –ø–æ –≤—Å–µ–π –†–æ—Å—Å–∏–∏, –±–µ–∑ –æ—á–µ—Ä–µ–¥–µ–π –∏ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏–π –æ—Ç –≤—Ä–∞—á–∞. –í –ø–æ–ª–∏—Å –≤–∫–ª—é—á–µ–Ω—ã –∑–∞–±–æ—Ä –∫—Ä–æ–≤–∏ –∏ –æ–Ω–ª–∞–π–Ω-–∫–æ–Ω—Å—É–ª—å—Ç–∞—Ü–∏—è —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞ –ø–æ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º –∞–Ω–∞–ª–∏–∑–æ–≤. –° –ò–Ω–≥–æ–õ–∞–± –∑–∞–±–æ—Ç–∞ –æ –∑–¥–æ—Ä–æ–≤—å–µ —Å—Ç–∞–Ω–æ–≤–∏—Ç—Å—è –¥–æ—Å—Ç—É–ø–Ω–æ–π –∏ –ø—Ä–∞–∫—Ç–∏—á–Ω–æ–π ‚Äî –≤—ã–≥–æ–¥–∞ –¥–æ 15% –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –¥—Ä—É–≥–∏–º–∏ –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–∏—è–º–∏. –ë–æ–ª—å—à–µ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –∏ –æ—Ñ–æ—Ä–º–ª–µ–Ω–∏–µ –ø–æ–ª–∏—Å–∞ ‚Äî –ø–æ —Å—Å—ã–ª–∫–µ","{""skip"": true}"
2025-12-02T15:50:12+00:00,@pharm_icon,2460,https://t.me/pharm_icon/2460,"Sun Pharma —É–¥–æ—Å—Ç–æ–µ–Ω–∞ –ø—Ä–µ–º–∏–∏ MedMen Awards 2025 –≤ –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ ¬´–ë—Ä–µ–Ω–¥ –≥–æ–¥–∞ ‚Äî Rx¬ª –ò–Ω–¥–∏–π—Å–∫–∞—è —ç–∫—Å–ø–∞–Ω—Å–∏—è –≤ Rx^^ 28 –Ω–æ—è–±—Ä—è –≤ –ú–æ—Å–∫–≤–µ –ø—Ä–æ—à–ª–∞ —Ü–µ—Ä–µ–º–æ–Ω–∏—è –≤—Ä—É—á–µ–Ω–∏—è VII –ü—Ä–µ–º–∏–∏ MedMen Awards 2025 ‚Äî –æ–¥–Ω–æ–π –∏–∑ –∫–ª—é—á–µ–≤—ã—Ö –Ω–∞–≥—Ä–∞–¥ –≤ —Å—Ñ–µ—Ä–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è, –º–µ–¥–∏—Ü–∏–Ω—ã –∏ —Å–æ—Ü–∏–∞–ª—å–Ω–æ–π –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç–∏. –ü—Ä–µ–º–∏—è –æ–±—ä–µ–¥–∏–Ω—è–µ—Ç –ø–µ—Ä–µ–¥–æ–≤—ã–µ –ø—Ä–∞–∫—Ç–∏–∫–∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ –º–∞—Ä–∫–µ—Ç–∏–Ω–≥–∞ –∏ –∫—Ä–µ–∞—Ç–∏–≤–Ω—ã—Ö —Ä–µ—à–µ–Ω–∏–π. –í –Ω–æ–º–∏–Ω–∞—Ü–∏–∏ ¬´–ë—Ä–µ–Ω–¥ –≥–æ–¥–∞ ‚Äî Rx¬ª –ø–æ–±–µ–¥–∏—Ç–µ–ª–µ–º –±—ã–ª –æ–±—ä—è–≤–ª–µ–Ω –±—Ä–µ–Ω–¥ ¬´–°–æ—Ç—Ä–µ—Ç¬ª –∫–æ–º–ø–∞–Ω–∏–∏ Sun Pharma. –≠—Ç–∞ –∫–∞—Ç–µ–≥–æ—Ä–∏—è –æ—Ç–º–µ—á–∞–µ—Ç –±–∏–∑–Ω–µ—Å-–∏–Ω–∏—Ü–∏–∞—Ç–∏–≤—ã, –∫–æ—Ç–æ—Ä—ã–µ –º–µ–Ω—è—é—Ç —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–π —Ä—ã–Ω–æ–∫ ‚Äî –æ—Ç –Ω–æ–≤—ã—Ö –º–æ–¥–µ–ª–µ–π —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–∞ –∏ —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏—Ö –∞–ª—å—è–Ω—Å–æ–≤ –¥–æ –ø–æ–≤—ã—à–µ–Ω–∏—è —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –∏ —É—Å—Ç–æ–π—á–∏–≤–æ—Å—Ç–∏. –û—Å–æ–±–æ–µ –≤–Ω–∏–º–∞–Ω–∏–µ —É–¥–µ–ª—è–µ—Ç—Å—è –∏–∑–º–µ—Ä–∏–º—ã–º —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º, –º–∞—Å—à—Ç–∞–±–∏—Ä—É–µ–º–æ—Å—Ç–∏ –∏ –≤–∫–ª–∞–¥—É –ø—Ä–æ–µ–∫—Ç–æ–≤ –≤ —Ä–∞–∑–≤–∏—Ç–∏–µ –æ—Ç—Ä–∞—Å–ª–∏. –õ–∞—É—Ä–µ–∞—Ç—ã –æ–ø—Ä–µ–¥–µ–ª—è—é—Ç—Å—è –Ω–∞ –æ—Å–Ω–æ–≤–µ –±–∏–∑–Ω–µ—Å-–ø–æ–∫–∞–∑–∞—Ç–µ–ª–µ–π ‚Äî –¥–∞–Ω–Ω—ã—Ö –ø—Ä–æ–¥–∞–∂ –∏ —Ä–µ–π—Ç–∏–Ω–≥–æ–≤, ‚Äî –∞ —Ç–∞–∫–∂–µ –≥–æ–ª–æ—Å–æ–≤–∞–Ω–∏–µ–º –≠–∫—Å–ø–µ—Ä—Ç–Ω–æ–≥–æ —Å–æ–≤–µ—Ç–∞. –í —ç—Ç–æ–º –≥–æ–¥—É –≤ –µ–≥–æ —Å–æ—Å—Ç–∞–≤ –≤–æ—à–ª–∏ 37 –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–µ–π –æ—Ç—Ä–∞—Å–ª–∏: —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª–∏ –ø—Ä–æ—Ñ–∏–ª—å–Ω—ã—Ö –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–π, –¥–µ–ø–∞—Ä—Ç–∞–º–µ–Ω—Ç–æ–≤ –∏ —Ç–æ–ø-–º–µ–Ω–µ–¥–∂–µ—Ä—ã –≤–µ–¥—É—â–∏—Ö —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π. ¬´–ü—Ä–∏–∑–Ω–∞–Ω–∏–µ –±—Ä–µ–Ω–¥–∞ ‚Äû–°–æ—Ç—Ä–µ—Ç‚Äú –±—Ä–µ–Ω–¥–æ–º –≥–æ–¥–∞ –≤ —Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω–æ–π –∫–∞—Ç–µ–≥–æ—Ä–∏–∏ ‚Äî –∑–∞–∫–æ–Ω–æ–º–µ—Ä–Ω—ã–π —Ä–µ–∑—É–ª—å—Ç–∞—Ç –Ω–∞—à–µ–π –ø–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ–π –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–æ–π —Å—Ç—Ä–∞—Ç–µ–≥–∏–∏ –∏ —Å—Ç—Ä–µ–º–ª–µ–Ω–∏—è —Å–æ–∑–¥–∞–≤–∞—Ç—å —Ä–µ–∞–ª—å–Ω—É—é —Ü–µ–Ω–Ω–æ—Å—Ç—å –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –∏ –æ–±—â–µ—Å—Ç–≤–∞. –ë–ª–∞–≥–æ–¥–∞—Ä—é –≤—Å–µ—Ö, –∫—Ç–æ –ø–æ–¥–¥–µ—Ä–∂–∏–≤–∞–µ—Ç –Ω–∞—Å –Ω–∞ —ç—Ç–æ–º –ø—É—Ç–∏¬ª, ‚Äî –ø–æ–¥—á–µ—Ä–∫–Ω—É–ª –¥–∏—Ä–µ–∫—Ç–æ—Ä –ø–æ –º–∞—Ä–∫–µ—Ç–∏–Ω–≥—É —Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ Sun Pharma –†–æ—Å—Å–∏—è –ö–∏—Ä–∏–ª–ª –ë–∞—Ä—Ç–∞–≥–æ–≤. ‚ù§Ô∏è ‚Äî –ò–Ω–¥–∏—è –≤–ø–µ—Ä—ë–¥! –ë—Ä–∞—Ç—å—è –Ω–∞–≤–µ–∫ üóø ‚Äî –Ω—É –≤–æ—Ç","{""skip"": true}"
2025-12-02T14:54:13+00:00,@pharm_icon,2458,https://t.me/pharm_icon/2458,"–°–º–µ–Ω–∞ –ø–∞—Ä–∞–¥–∏–≥–º—ã: –Ω–∏–∑–∫–∏–π —É—Ä–æ–≤–µ–Ω—å ""–ø–ª–æ—Ö–æ–≥–æ —Ö–æ–ª–µ—Å—Ç–µ—Ä–∏–Ω–∞"" —Å–≤—è–∑–∞–Ω —Å —Ä–∞–∑–≤–∏—Ç–∏–µ–º —Å–∞—Ö–∞—Ä–Ω–æ–≥–æ –¥–∏–∞–±–µ—Ç–∞ 2 —Ç–∏–ø–∞ –ò–∑ –ø–æ–ø—É–ª—è—Ü–∏–∏, —Å–æ—Å—Ç–æ—è—â–µ–π –∏–∑ 202 545 —á–µ–ª–æ–≤–µ–∫, –º—ã –≤—ã–±—Ä–∞–ª–∏ 13 674 —É—á–∞—Å—Ç–Ω–∏–∫–∞ –±–µ–∑ —Å–∞—Ö–∞—Ä–Ω–æ–≥–æ –¥–∏–∞–±–µ—Ç–∞ 2 —Ç–∏–ø–∞ –∏ —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π (–∏–∑ –∫–æ—Ç–æ—Ä—ã—Ö 52% –ø—Ä–∏–Ω–∏–º–∞–ª–∏ —Å—Ç–∞—Ç–∏–Ω—ã), –∫–æ—Ç–æ—Ä—ã–µ –Ω–∞–±–ª—é–¥–∞–ª–∏—Å—å –≤ —Ç–µ—á–µ–Ω–∏–µ –º–µ–¥–∏–∞–Ω–Ω–æ–≥–æ –ø–µ—Ä–∏–æ–¥–∞ 71,6 –º–µ—Å—è—Ü–µ–≤ (–º–µ–∂–∫–≤–∞—Ä—Ç–∏–ª—å–Ω—ã–π —Ä–∞–∑–º–∞—Ö 34,5‚Äì149,9), –≤ —Ç–µ—á–µ–Ω–∏–µ –∫–æ—Ç–æ—Ä–æ–≥–æ —É 1819 —á–µ–ª–æ–≤–µ–∫ (13%) —Ä–∞–∑–≤–∏–ª—Å—è —Å–ª—É—á–∞–π —Å–∞—Ö–∞—Ä–Ω–æ–≥–æ –¥–∏–∞–±–µ—Ç–∞ 2 —Ç–∏–ø–∞. –ö–æ–Ω–µ—á–Ω–æ –∂–µ, –æ–Ω–∏ –ø—Ä–æ–∞–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–ª–∏ –∫–æ—Ñ–∞–∫—Ç–æ—Ä—ã —Å–æ–±—ã—Ç–∏–π. –í–∞–∂–Ω–æ–µ: 1. –ü–æ —Ö–æ–ª–µ—Å—Ç–µ—Ä–∏–Ω—É –õ–ü–ù–ü –° —Å–∞–º—ã–º –≤—ã—Å–æ–∫–∏–º —Ä–∏—Å–∫–æ–º –¥–∏–∞–±–µ—Ç–∞ –±—ã–ª —Å–≤—è–∑–∞–Ω —É—Ä–æ–≤–µ–Ω—å —Ö–æ–ª–µ—Å—Ç–µ—Ä–∏–Ω–∞ –õ–ü–ù–ü < 84 –º–≥/–¥–ª, –∞ –ø–æ-–Ω–∞—à–µ–º—É ‚Äî –º–µ–Ω–µ–µ 2.17 –º–º–æ–ª—å/–ª. –°–∞–º—ã–π –Ω–∏–∑–∫–∏–π —Ä–∏—Å–∫ –°–î ‚Äî —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å —É—Ä–æ–≤–Ω—è–º–∏ –õ–ü–ù–ü-–•–° ‚â• 131 –º–≥/–¥–ª (‚â• 3.39 –º–º–æ–ª—å/–ª). –û–±—ä—è—Å–Ω–µ–Ω–∏–µ: –ì–µ–Ω—ã, –∫–æ—Ç–æ—Ä—ã–µ —Å–≤—è–∑–∞–Ω—ã –∫–∞–∫ —Å –±–æ–ª–µ–µ –Ω–∏–∑–∫–∏–º —É—Ä–æ–≤–Ω–µ–º –õ–ü–ù–ü-–•, —Ç–∞–∫ –∏ —Å –±–æ–ª–µ–µ –≤—ã—Å–æ–∫–∏–º —Ä–∏—Å–∫–æ–º —Ä–∞–∑–≤–∏—Ç–∏—è —Å–∞—Ö–∞—Ä–Ω–æ–≥–æ –¥–∏–∞–±–µ—Ç–∞ 2 —Ç–∏–ø–∞, –≤–ª–∏—è—é—Ç –Ω–∞ —É—Ä–æ–≤–µ–Ω—å –õ–ü–ù–ü-–• —Ä–∞–∑–ª–∏—á–Ω—ã–º–∏ –ø—É—Ç—è–º–∏, –≤–∫–ª—é—á–∞—è –∞–±—Å–æ—Ä–±—Ü–∏—é —Ö–æ–ª–µ—Å—Ç–µ—Ä–∏–Ω–∞ (NPC1L1), —Å–∏–Ω—Ç–µ–∑ —ç–Ω–¥–æ–≥–µ–Ω–Ω–æ–≥–æ —Ö–æ–ª–µ—Å—Ç–µ—Ä–∏–Ω–∞ (HMGCR) –∏ –∏–Ω—Ç–µ—Ä–Ω–∞–ª–∏–∑–∞—Ü–∏—é –±–æ–≥–∞—Ç—ã—Ö —Ö–æ–ª–µ—Å—Ç–µ—Ä–∏–Ω–æ–º —á–∞—Å—Ç–∏—Ü –≤ –∫–ª–µ—Ç–∫—É (PCSK9). –ê–ª–ª–µ–ª–∏, –∫–æ—Ç–æ—Ä—ã–µ —Å–Ω–∏–∂–∞—é—Ç —É—Ä–æ–≤–µ–Ω—å –õ–ü–ù–ü-–•, —Å–≤—è–∑–∞–Ω—ã —Å –±–æ–ª–µ–µ –≤—ã—Å–æ–∫–∏–º–∏ —É—Ä–æ–≤–Ω—è–º–∏ –∏–Ω—Å—É–ª–∏–Ω–∞ –Ω–∞—Ç–æ—â–∞–∫ –∏ –ò–ú–¢, —á—Ç–æ —É–∫–∞–∑—ã–≤–∞–µ—Ç –Ω–∞ –º–µ—Ö–∞–Ω–∏–∑–º, —Å–≤—è–∑–∞–Ω–Ω—ã–π —Å –∏–Ω—Å—É–ª–∏–Ω–æ—Ä–µ–∑–∏—Å—Ç–µ–Ω—Ç–Ω–æ—Å—Ç—å—é –∏ –ø—Ä–µ–¥—Ä–∞—Å–ø–æ–ª–∞–≥–∞—é—â–∏–π –∫ —Ä–∞–∑–≤–∏—Ç–∏—é —Å–∞—Ö–∞—Ä–Ω–æ–≥–æ –¥–∏–∞–±–µ—Ç–∞ 2 —Ç–∏–ø–∞ 2. –î–ª—è —Å—Ç–∞—Ç–∏–Ω–æ–≤ –° —Ä–∞–∑–≤–∏—Ç–∏–µ–º –¥–∏–∞–±–µ—Ç–∞ —Ç–∞–∫–∂–µ –±—ã–ª —Å–≤—è–∑–∞–Ω –ø—Ä–∏–µ–º —Å—Ç–∞—Ç–∏–Ω–æ–≤ –ø—Ä–∏ –æ—á–µ–Ω—å –≤—ã—Å–æ–∫–æ–º —É—Ä–æ–≤–Ω–µ —Ö–æ–ª–µ—Å—Ç–µ—Ä–∏–Ω–∞ –õ–ü–ù–ü ‚â• 131 –º–≥/–¥–ª (‚â• 3.39 –º–º–æ–ª—å/–ª). –ú–µ—Ö–∞–Ω–∏–∑–º—ã, –ª–µ–∂–∞—â–∏–µ –≤ –æ—Å–Ω–æ–≤–µ —ç—Ç–æ–≥–æ —è–≤–ª–µ–Ω–∏—è, –æ—Å—Ç–∞—é—Ç—Å—è –Ω–µ—è—Å–Ω—ã–º–∏. –í –ø–æ–ª–∫—É —Å—Ç–∞—Ç–∏–Ω–æ–Ω–µ–Ω–∞–≤–∏—Å—Ç–Ω–∏–∫–æ–≤ –ø—Ä–∏–±—ã–ª–æ. üî• ‚Äî —ç—Ç–æ—Ç –ø–æ—Å—Ç –Ω–∞–¥–æ –≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –∏ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω—è—Ç—å. –î–µ–ª–∞—é —Ä–µ–ø–æ—Å—Ç. üòê ‚Äî –≤—ã –≤–µ–¥—å–º–∞.","{""skip"": true}"
2025-11-24T12:23:48+00:00,@pharm_icon,2457,https://t.me/pharm_icon/2457,–í–∏–∑—É–∞–ª–∏–∑–∞—Ü–∏—è —Å–º—ã—Å–ª–æ–≤,"{""skip"": true}"
2025-11-24T12:11:25+00:00,@pharm_icon,2456,https://t.me/pharm_icon/2456,"–í—ã–ø—É—Å–∫–Ω–∏–∫–∞–º –º–µ–¥–≤—É–∑–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ —Å–æ–≥–ª–∞—Å—è—Ç—Å—è –ø–æ–µ—Ö–∞—Ç—å –≤ ¬´–Ω–æ–≤—ã–µ —Ä–µ–≥–∏–æ–Ω—ã¬ª, –≤–¥–≤–æ–µ —Å–æ–∫—Ä–∞—Ç—è—Ç —Å—Ä–æ–∫ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–π –æ—Ç—Ä–∞–±–æ—Ç–∫–∏. –í –º–∞—Ä—Ç–µ 2026 –≥–æ–¥–∞ –Ω–∞—á–Ω—ë—Ç –¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å –∑–∞–∫–æ–Ω, —Å–æ–≥–ª–∞—Å–Ω–æ –∫–æ—Ç–æ—Ä–æ–º—É –≤—Å–µ –±—é–¥–∂–µ—Ç–Ω—ã–µ –º–µ—Å—Ç–∞ –¥–ª—è –æ—Ä–¥–∏–Ω–∞—Ç–æ—Ä–æ–≤ —Å—Ç–∞–Ω—É—Ç —Ü–µ–ª–µ–≤—ã–º–∏ ‚Äî –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–∞—è –æ—Ç—Ä–∞–±–æ—Ç–∫–∞ –ø–æ –Ω–∏–º –±—É–¥–µ—Ç –¥–ª–∏—Ç—å—Å—è –¥–æ —Ç—Ä—ë—Ö –ª–µ—Ç. –û–¥–Ω–∞–∫–æ –µ—Å–ª–∏ –≤—ã–ø—É—Å–∫–Ω–∏–∫ —Å–æ–≥–ª–∞—Å–∏—Ç—Å—è –ø–æ–µ—Ö–∞—Ç—å –≤ –î–ù–†, –õ–ù–†, –ó–∞–ø–æ—Ä–æ–∂—Å–∫—É—é –∏–ª–∏ –•–µ—Ä—Å–æ–Ω—Å–∫—É—é –æ–±–ª–∞—Å—Ç–∏, –∞ —Ç–∞–∫–∂–µ –≤ —Å–µ–ª—å—Å–∫—É—é –º–µ—Å—Ç–Ω–æ—Å—Ç—å –∏–ª–∏ –º–∞–ª—ã–µ –≥–æ—Ä–æ–¥–∞, —ç—Ç–æ—Ç —Å—Ä–æ–∫ –º–æ–∂–µ—Ç –±—ã—Ç—å —Å–æ–∫—Ä–∞—â—ë–Ω –≤–¥–≤–æ–µ, –ø–∏—à–µ—Ç ¬´–ö–æ–º–º–µ—Ä—Å–∞–Ω—Ç¬ª. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –ø–æ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –∏–∑–¥–∞–Ω–∏—è, –æ—Ç –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ–π –æ—Ç—Ä–∞–±–æ—Ç–∫–∏ –æ—Å–≤–æ–±–æ–¥—è—Ç —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–æ–≤ –∏ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ —Ä–µ–¥–∫–∏—Ö –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏–π (¬´–≥–∏–≥–∏–µ–Ω–∞ –ø–∏—Ç–∞–Ω–∏—è¬ª, ¬´–≥–∏–≥–∏–µ–Ω–∞ —Ç—Ä—É–¥–∞¬ª, ¬´–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è —Å–∞–Ω—ç–ø–∏–¥—Å–ª—É–∂–±—ã¬ª, ¬´–∞–≤–∏–∞—Ü–∏–æ–Ω–Ω–∞—è –∏ –∫–æ—Å–º–∏—á–µ—Å–∫–∞—è –º–µ–¥–∏—Ü–∏–Ω–∞¬ª, ¬´–≤–æ–¥–æ–ª–∞–∑–Ω–∞—è –º–µ–¥–∏—Ü–∏–Ω–∞¬ª).","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, hospital_policy, guideline, pharmacovigilance"",
  ""impact"": ""medium"",
  ""english"": ""The regulation stipulates that all budgetary positions for residents are target-oriented, and the mandatory probation period will be three years. However, if graduates agree to work in regions such as Donetsk and Luhansk Oblasts, Zaporizhzhia or Kherson Regions, or in rural areas or small cities, this period can be halved. The publication also mentions that pharmacists and specialists in rare fields will be exempt from mandatory probation.""
}"
2025-11-24T05:43:55+00:00,@pharm_icon,2455,https://t.me/pharm_icon/2455,"–û—Ç—Ä–∞–±–æ—Ç–∫–∞ –≤—Ä–∞—á–µ–π: —á—Ç–æ —è –¥—É–º–∞—é –í—Å—ë, —á—Ç–æ —è –≤–∏–¥–µ–ª–∞ –ø—Ä–æ —Ä–∞—Å–ø—Ä–µ–¥–µ–ª–µ–Ω–∏–µ –≤—Ä–∞—á–µ–π, –ø–æ–∫–∞ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ—Ç —Å–æ–±–æ–π –Ω–µ —á—ë—Ç–∫—É—é —Ä–µ—Ñ–ª–µ–∫—Å–∏—é, –∞ —ç–º–æ—Ü–∏–æ–Ω–∏—Ä–æ–≤–∞–Ω–∏–µ, –∫–æ—Ç–æ—Ä–æ–µ –¥–∞—ë—Ç —á–∏—Ç–∞—é—â–µ–º—É –≤—Ä–∞—á—É —Ç–∞–∫–æ–µ –æ—â—É—â–µ–Ω–∏–µ ""–∫–∞–∫ —Ö–æ—Ä–æ—à–æ, —á—Ç–æ –∫—Ç–æ-—Ç–æ –º–Ω–µ —Å–æ—á—É–≤—Å—Ç–≤—É–µ—Ç"". –ù–∏–∫–∞–∫–∏—Ö —è–≤–Ω—ã—Ö –¥–µ–π—Å—Ç–≤–∏–π –∏ –ø–æ–ø—ã—Ç–æ–∫ —Ä–µ—Ñ–ª–µ–∫—Å–∏–∏ –Ω–∞–¥ —Å–æ–±—ã—Ç–∏—è–º–∏ –Ω–µ –Ω–∞–±–ª—é–¥–∞–ª–æ—Å—å, –Ω–æ –±–ª–∞–≥–æ —É –≤–∞—Å –µ—Å—Ç—å –ò–∫–æ–Ω–∞ —Ñ–∞—Ä–º—ã. –í —á–µ–º –∂–µ —Ä–µ–∞–ª—å–Ω–∞—è –ø—Ä–æ–±–ª–µ–º–∞? –ü–æ—á–µ–º—É —Ç–∞–∫–∞—è –≤—è–ª–∞—è —Ä–µ–∞–∫—Ü–∏—è —É –º–Ω–æ–∂–µ—Å—Ç–≤–∞ —Å–ø–∏–∫–µ—Ä–æ–≤? –ü–æ—á–µ–º—É –≤ —Ü–µ–ª–æ–º —ç—Ç–æ –æ—Å–æ–±–æ –Ω–∏–∫–æ–≥–æ –Ω–µ –≤–æ–ª–Ω—É–µ—Ç, –∫—Ä–æ–º–µ ""—Å–∞–º—ã—Ö –æ—Ç–±–∏—Ç—ã—Ö""? –ù–∞—á–Ω—ë–º —Å –¥–≤—É—Ö –≤–∞–∂–Ω—ã—Ö —Ç–µ–∑–∏—Å–æ–≤ –ê. –†—É–∫–æ–≤–æ–¥—Å—Ç–≤–æ —Å—Ç—Ä–∞–Ω—ã –Ω–µ —Å—á–∏—Ç–∞–µ—Ç, —á—Ç–æ —É —á–µ–ª–æ–≤–µ–∫–∞ –∏–∑ –†–æ—Å—Å–∏–∏ –µ—Å—Ç—å –ø—Ä–∞–≤–æ–≤–∞—è —Å—É–±—ä–µ–∫—Ç–Ω–æ—Å—Ç—å. –ü—Ä–∞–≤–æ—Å—É–±—ä–µ–∫—Ç–Ω–æ—Å—Ç—å ‚Äî —ç—Ç–æ —Å–ø–æ—Å–æ–±–Ω–æ—Å—Ç—å –ª–∏—Ü–∞ (—Ñ–∏–∑–∏—á–µ—Å–∫–æ–≥–æ –∏–ª–∏ —é—Ä–∏–¥–∏—á–µ—Å–∫–æ–≥–æ) –≤—ã—Å—Ç—É–ø–∞—Ç—å –≤ –∫–∞—á–µ—Å—Ç–≤–µ —É—á–∞—Å—Ç–Ω–∏–∫–∞ –ø—Ä–∞–≤–æ–æ—Ç–Ω–æ—à–µ–Ω–∏–π, —Ç–æ –µ—Å—Ç—å –æ–±–ª–∞–¥–∞—Ç—å –ø—Ä–∞–≤–∞–º–∏ –∏ –Ω–µ—Å—Ç–∏ –æ–±—è–∑–∞–Ω–Ω–æ—Å—Ç–∏. –ê —Ç–æ—á–Ω–µ–µ ‚Äî –æ—Ç –Ω–µ—ë –µ—Å—Ç—å —Ç–æ–ª—å–∫–æ —á–∞—Å—Ç—å –ø—Ä–æ ""–Ω–µ—Å—Ç–∏ –æ–±—è–∑–∞–Ω–Ω–æ—Å—Ç–∏"". –ë. –ù–∞—Ä–æ–¥ ‚Äî –≤—Å—è —Å–æ–≤–æ–∫—É–ø–Ω–æ—Å—Ç—å ‚Äî –Ω–µ —Å—á–∏—Ç–∞–µ—Ç, —á—Ç–æ —É —á–µ–ª–æ–≤–µ–∫–∞ –µ—Å—Ç—å –ø—Ä–∞–≤–æ—Å—É–±—ä–µ–∫—Ç–Ω–æ—Å—Ç—å, –≤ —Ç–æ–º —á–∏—Å–ª–µ ‚Äî –≤—Ä–∞—á–∏. –í —Ü–µ–ª–æ–º —Å–ª–æ–∂–Ω–æ –ø–æ—á—É–≤—Å—Ç–≤–æ–≤–∞—Ç—å —Å–≤–æ–∏ –ø—Ä–∞–≤–∞ –∏ —Å–≤–æ–±–æ–¥—ã, –æ—Å–æ–±–µ–Ω–Ω–æ, –µ—Å–ª–∏ –∏–º–∏ –Ω–µ –ø–æ–ª—å–∑–æ–≤–∞—Ç—å—Å—è. –ò —Ç—É—Ç –º—ã –ø–µ—Ä–µ–≤–æ–¥–∏–º —Å–≤–æ—é –æ–ø—Ç–∏–∫—É –Ω–∞ –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤. –ß—Ç–æ –±—ã–ª–æ —Ä–∞–Ω—å—à–µ? –ù–∞–¥ –≤—ã–ø—É—Å–∫–Ω–∏–∫–∞–º–∏ —É–∂–µ —Å—Ç–∞–≤–∏–ª–∏ —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç—ã ‚Äî –º–µ–Ω—è–ª–∏ –ø—Ä–∞–≤–∏–ª–∞ –ø–æ—Å—Ç—É–ø–ª–µ–Ω–∏—è –≤ –æ—Ä–¥–∏–Ω–∞—Ç—É—Ä—É –≤ –≥–æ–¥ –ø–æ—Å—Ç—É–ø–ª–µ–Ω–∏—è. –†–µ–∞–∫—Ü–∏—è: –ë—É—Ä–ª–µ–Ω–∏—è –∏ –∑–ª–æ–±—ã –Ω–µ –±—ã–ª–æ. –í –∫–æ–≤–∏–¥–Ω—ã–µ –≤—Ä–µ–º–µ–Ω–∞ –º–æ–ª–æ–¥—ã–µ –ª—é–¥–∏ —Ä–∞–±–æ—Ç–∞–ª–∏ —Å–Ω–∞—á–∞–ª–∞ 3 –≥–æ–¥–∞ –º–µ–¥—Å–µ—Å—Ç—Ä–æ–π, —á—Ç–æ–±—ã –ø–æ–ª—É—á–∏—Ç—å –±–∞–ª–ª—ã –≤ –æ—Ä–¥–∏–Ω–∞—Ç—É—Ä—É, –∞ –ø–æ—Ç–æ–º –æ–∫–∞–∑–∞–ª–æ—Å—å, —á—Ç–æ 3 –º–µ—Å—è—Ü–∞ –≤ –∫–æ–≤–∏–¥–∞—Ä–∏–∏ —ç–∫–≤–∏–≤–∞–ª–µ–Ω—Ç–Ω—ã —Ç—Ä–µ–º –≥–æ–¥–∞–º. –ò —ç—Ç–æ –∑–∞ –ø–æ–ª–≥–æ–¥–∞ –¥–æ –ø–æ—Å—Ç—É–ø–ª–µ–Ω–∏—è. –ò –Ω–∏ –æ–¥–Ω–æ–≥–æ –¥–µ–º–æ–Ω—Å—Ç—Ä–∞—Ç–∏–≤–Ω–æ–≥–æ –∞–∫—Ç–∞ –Ω–µ–¥–æ–≤–æ–ª—å—Å—Ç–≤–∞. –ò–∑-–∑–∞ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏—è –≤–æ—Å–ø—Ä–∏—è—Ç–∏—è —á–µ–ª–æ–≤–µ–∫–∞ –ø—Ä–∞–≤–æ–≤—ã–º —Å—É–±—ä–µ–∫—Ç–æ–º —É –≤—Å–µ—Ö —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –ø—Ä–æ—Ü–µ—Å—Å–∞ –ø—Ä–æ–∏—Å—Ö–æ–¥–∏—Ç –Ω–æ—Ä–º–∞–ª–∏–∑–∞—Ü–∏—è —Ç–∞–∫–∏—Ö –≤–µ—â–µ–π. –ú–æ–∂–Ω–æ –º–µ–Ω—è—Ç—å –ø—Ä–∞–≤–∏–ª–∞ –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–∏—è –≤–∞—à–µ–π —Å—É–¥—å–±—ã –∑–∞ –ø–æ–ª–≥–æ–¥–∞. –ú–æ–∂–Ω–æ –≤–≤–µ—Å—Ç–∏ –æ—Ç—Ä–∞–±–æ—Ç–∫—É. –ú–æ–∂–Ω–æ —É–ø—Ä–∞–≤–ª—è—Ç—å —á—É–∂–æ–π –∂–∏–∑–Ω—å—é —Ç–∞–∫, –∫–∞–∫ –∑–∞–±–ª–∞–≥–æ—Ä–∞—Å—Å—É–¥–∏—Ç—Å—è. –ö–∞–∫–∏–µ –º—ã—Å–ª–∏ —Ä–æ–∂–¥–∞—é—Ç—Å—è –≤ –≥–æ–ª–æ–≤–µ —É —Å—Ç–æ—Ä–æ–Ω–Ω–µ–≥–æ –∑—Ä–∏—Ç–µ–ª—è? ""–≠—Ç–æ –Ω–µ —Å–æ –º–Ω–æ–π"". ""–ù—É –ø–æ—Ä–∞–±–æ—Ç–∞—é—Ç, 3 –≥–æ–¥–∞ –≤—Å–µ–≥–æ"". ""–ù—É –ª–∞–¥–Ω–æ"". –ü–æ—Ç–æ–º—É —á—Ç–æ —É —Å—Ç–æ—Ä–æ–Ω–Ω–µ–≥–æ –∑—Ä–∏—Ç–µ–ª—è –Ω–µ—Ç –ø—Ä–∞–≤–æ–≤–æ–π —Å—É–±—ä–µ–∫—Ç–Ω–æ—Å—Ç–∏ –∏ –Ω–µ—Ç —á—É–≤—Å—Ç–≤–∞ –ø–ª–µ—á–∞. –°–∞–º—ã–µ –æ—Ç–±–∏—Ç—ã–µ ‚Äî –ø–æ –º–Ω–µ–Ω–∏—é –Ω–∞—á–∞–ª—å—Å—Ç–≤–∞ ‚Äî –Ω–∞—á–∏–Ω–∞—é—Ç –º—è–≥–∫–æ –ø—Ä–æ—Ç–µ—Å—Ç–æ–≤–∞—Ç—å. –ü–∏—Å—å–º–æ –ü—É—Ç–∏–Ω—É –Ω–∞–ø–∏—Å–∞—Ç—å, –æ–±—Ä–∞—Ç–∏—Ç—å—Å—è –∫ —Ü–∞—Ä—é –∑–∞ –º–∏–ª–æ—Å—Ç—å—é. –ù–æ —ç—Ç–æ –¥–µ–π—Å—Ç–≤–∏–µ —Å –Ω–∏–∑–∫–æ–π –ø–æ—Ç–µ–Ω—Ü–∏–µ–π, –∫–æ—Ç–æ—Ä–æ–µ –º–æ–∂–µ—Ç —Ä–∞–∑–≤–µ —á—Ç–æ —É–ª—É—á—à–∏—Ç—å –∞–ø–ø–µ—Ç–∏—Ç. –£ –Ω–∞—Å –Ω–µ—Ç —á—É–≤—Å—Ç–≤–∞ –ø–ª–µ—á–∞ –∏ —á—É–≤—Å—Ç–≤–∞ –ø—Ä–∞–≤–æ—Å—É–±—ä–µ–∫—Ç–Ω–æ—Å—Ç–∏. –ü–æ—Ç–æ–º—É –º—ã –ø–æ–∂–∏–Ω–∞–µ–º –ø–ª–æ–¥—ã —ç—Ç–æ–≥–æ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏—è ‚Äî –æ–Ω–∏ –æ—Ñ–æ—Ä–º–ª—è—é—Ç—Å—è –≤ –∑–∞–∫–æ–Ω—ã –æ–± –æ—Ç—Ä–∞–±–æ—Ç–∫–∞—Ö. –ò —ç—Ç–æ —Ä–µ–∞–ª—å–Ω–∞—è –±–µ–¥–∞, –¥–ª—è –∫–æ—Ç–æ—Ä–æ–π –Ω–µ—Ç —Ö–æ—Ä–æ—à–∏—Ö —Ä–µ—à–µ–Ω–∏–π. –ü–æ—Å–º–æ—Ç—Ä–∏–º, —á—Ç–æ –±—É–¥–µ—Ç –¥–∞–ª—å—à–µ –∏ —á—Ç–æ –ø–æ–∫–∞–∂–µ—Ç –ø—Ä–∏–µ–º–Ω–∞—è –∫–∞–º–ø–∞–Ω–∏—è —Å–ª–µ–¥—É—é—â–µ–≥–æ –≥–æ–¥–∞ –∏ –≤ –∫–∞–∫–∏–µ –≤—É–∑—ã –°–ù–ì –±—É–¥—É—Ç –ø–µ—Ä–µ–≤–æ–¥–∏—Ç—å—Å—è –Ω—ã–Ω–µ—à–Ω–∏–µ —Å—Ç—É–¥–µ–Ω—Ç—ã.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, safety, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The message discusses the lack of legal subjectivity among medical professionals and the resulting practices such as 'work shifts'. It highlights how this affects students, suggesting a need for better legal awareness and subjectivity among all participants in the process. The author calls for more robust solutions to address this issue, which is affecting countries globally.""
}"
2025-11-18T05:05:39+00:00,@pharm_icon,2451,https://t.me/pharm_icon/2451,"–¢—Ä—è—Å—É—á–µ–µ –±—Ä–µ–º—è: —ç–ø–∏–ª–µ–ø—Ç–∏—á–µ—Å–∫–∏–µ —Å—É–¥–æ—Ä–æ–≥–∏ –ø—Ä–∏ –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏ –ø–æ—Ä—Ç—è—Ç –∏—Å—Ö–æ–¥—ã –¥–ª—è –º–∞—Ç–µ—Ä–∏ –∏ –ø–ª–æ–¥–∞. –ù–æ–≤—ã–π –º–µ—Ç–∞–∞–Ω–∞–ª–∏–∑ –≤—ã–±—Ä–∞–ª —É—á–∏—Ç—ã–≤–∞—é—â–∏—Ö —Ñ–∞–∫—Ç–æ—Ä —ç–ø–∏–ª–µ–ø—Ç–∏—á–µ—Å–∫–∏—Ö —Å—É–¥–æ—Ä–æ–≥ 25 –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –∏—Å—Ö–æ–¥–æ–≤ –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏. –û–±—â–µ–µ —á–∏—Å–ª–æ –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–µ–π ‚Äî 24596. –£—á–µ–Ω—ã–µ —Å—Ä–∞–≤–Ω–∏–ª–∏ –∏—Å—Ö–æ–¥—ã –¥–ª—è –º–∞—Ç–µ—Ä–∏ –∏ –ø–ª–æ–¥–∞ —É –∂–µ–Ω—â–∏–Ω —Å —ç–ø–∏–ª–µ–ø—Å–∏–µ–π –∏ —Å—É–¥–æ—Ä–æ–≥–∞–º–∏ –ø—Ä–æ—Ç–∏–≤ –≥—Ä—É–ø–ø—ã –∂–µ–Ω—â–∏–Ω —Å —ç–ø–∏–ª–µ–ø—Å–∏–µ–π –±–µ–∑ —Å—É–¥–æ—Ä–æ–≥ –∏ –±–µ–∑ —ç–ø–∏–ª–µ–ø—Å–∏–∏. –ò—Ç–æ–≥–∏ –Ω–µ –≤ –ø–æ–ª—å–∑—É —ç–ø–∏–ª–µ–ø—Å–∏–∏: 1) –í—ã—à–µ —Ä–∏—Å–∫ –∫–µ—Å–∞—Ä–µ–≤–∞ ‚Äî –æ—Ç–Ω–æ—à–µ–Ω–∏–µ —à–∞–Ω—Å–æ–≤ 1,62; 95 –î–ò 1,14-2,30 2) –ü–æ—Å—Ç–Ω–∞—Ç–∞–ª—å–Ω–∞—è –¥–µ–ø—Ä–µ—Å—Å–∏—è ‚Äî –û–® 2,20; 1,04-4,65 3) –ú–∞–ª—ã–π —Ä–∞–∑–º–µ—Ä —Ä–µ–±–µ–Ω–∫–∞ –¥–ª—è –≥–µ—Å—Ç–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ —Ä–µ–±–µ–Ω–∫–∞ ‚Äî –û–® 1,32; 1,03-1,69 –≠–ø–∏–ª–µ–ø—Å–∏—è —Å —Å—É–¥–æ—Ä–æ–≥–∞–º–∏ –ø—Ä–æ–∏–≥—Ä–∞–ª–∞ —ç–ø–∏–ª–µ–ø—Å–∏–∏ –±–µ–∑ –Ω–∏—Ö: 1) –ù–µ—Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–µ –≤–µ—Å–∞ —Ä–µ–±–µ–Ω–∫–∞ –≤–æ–∑—Ä–∞—Å—Ç—É —Ä–æ–∂–¥–µ–Ω–∏—è ‚Äî –û–® 1,47; 1,19-1,74 2) –ü—Ä–µ–∂–¥–µ–≤—Ä–µ–º–µ–Ω–Ω—ã–µ —Ä–æ–¥—ã ‚Äî –û–® 1,66; 1,29-2,15 –í –ø–æ–ª—å–∑—É –ø–æ—Å–æ–±–∏–π –¥–ª—è –±–µ—Ä–µ–º–µ–Ω–Ω—ã—Ö ‚Äî —Ä–∏—Å–∫ —Å—É–¥–æ—Ä–æ–≥ —É –±–µ–¥–Ω—ã—Ö –±–µ—Ä–µ–º–µ–Ω–Ω—ã—Ö —Å —ç–ø–∏–ª–µ–ø—Å–∏–µ–π –ø—Ä–æ—Ç–∏–≤ —Ä–∏—Å–∫–æ–≤ —É –±–æ–≥–∞—Ç—ã—Ö ‚Äî –û–® 1,47; 1,22-2,02 ‚Äî –∏ —Ñ–æ–∫–∞–ª—å–Ω—ã—Ö —Å—É–¥–æ—Ä–æ–≥ —É –±–µ–¥–Ω—ã—Ö –ø—Ä–æ—Ç–∏–≤ –±–æ–≥–∞—Ç—ã—Ö —Å –≥–µ–Ω–µ—Ä–∞–ª–∏–∑–æ–≤–∞–Ω–Ω–æ–π —ç–ø–∏–ª–µ–ø—Å–∏–µ–π ‚Äî –û–® 1,84; 1,54-2,20. –ß–µ–º –±–æ–ª—å—à–µ –¥–µ–Ω–µ–≥, —Ç–µ–º –ª—É—á—à–µ –∫–æ–Ω—Ç—Ä–æ–ª—å –±–æ–ª–µ–∑–Ω–∏. –ë–æ–≥–∞—Ç–æ–µ –Ω–∞—Å–µ–ª–µ–Ω–∏–µ = –±–æ–ª–µ–µ –∑–¥–æ—Ä–æ–≤–æ–µ –Ω–∞—Å–µ–ª–µ–Ω–∏–µ, –¥–∞–∂–µ –µ—Å–ª–∏ –Ω–µ–º–Ω–æ–≥–æ –±–æ–ª–µ—é—â–µ–µ.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""epidemic, clinical_trial, guideline"",
  ""impact"": ""high"",
  ""english"": ""The analysis of 25 studies on pregnancy outcomes for women with epilepsy and seizures compared to those without seizures or epilepsy found higher risks of cesarean section (OR 1.62), postpartum depression (OR 2.20), and small-for-gestational-age infants (OR 1.32). Women with epilepsy and seizures had a higher risk of low birth weight (OR 1.47) and preterm births (OR 1.66). The analysis also found that the risk of seizures was higher among poor women with epilepsy compared to wealthy women, and focal seizures were more common among poor women than generalized seizures among wealthy women. Wealthier populations have better disease control, even if the population is slightly more affected.""
}"
2025-11-17T12:47:01+00:00,@pharm_icon,2450,https://t.me/pharm_icon/2450,–ù–∞–ø–æ–º–∏–Ω–∞—é –ø—Ä–æ —ç—Ç–æ—Ç —à–µ–¥–µ–≤—Ä –û–º—Å–∫–æ–≤–µ–¥–µ–Ω–∏—è!,"{""skip"": true}"
2025-11-17T12:38:51+00:00,@pharm_icon,2449,https://t.me/pharm_icon/2449,"–≠–∫–æ–ª–æ–≥–∏—è –∏ –¥–µ—Ç—Å–∫–æ–µ –∑–¥–æ—Ä–æ–≤—å–µ –†–æ—Å—Ç –∑–∞–±–æ–ª–µ–≤–∞–µ–º–æ—Å—Ç–∏ –≤ –≥. –°–∞–ª–∞–≤–∞—Ç —Å –Ω–µ—Ñ—Ç—è–Ω—ã–º –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ–º. –£–∫–∞–∑–∞–Ω—ã –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è —Å –Ω–∞–∏–±–æ–ª—å—à–∏–º —Ä–æ—Å—Ç–æ–º —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–∏—è (‚Ä∞). –ê–≤—Ç–æ—Ä –Ω–∞–±–ª—é–¥–µ–Ω–∏—è: –ö–∞—Ä–∞–º–æ–≤–∞ –õ–µ–Ω–∞ –ú–∏—Ä–∑–∞–µ–≤–Ω–∞, –¥–æ–∫—Ç–æ—Ä –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –Ω–∞—É–∫, –ø—Ä–æ—Ñ–µ—Å—Å–æ—Ä, –≥–ª–∞–≤–Ω—ã–π –Ω–∞—É—á–Ω—ã–π —Å–æ—Ç—Ä—É–¥–Ω–∏–∫ –æ—Ç–¥–µ–ª–∞ –º–µ–¥–∏—Ü–∏–Ω—ã —Ç—Ä—É–¥–∞ –§–ë–£–ù ¬´–£—Ñ–∏–º—Å–∫–∏–π –ù–ò–ò –º–µ–¥–∏—Ü–∏–Ω—ã —Ç—Ä—É–¥–∞ –∏ —ç–∫–æ–ª–æ–≥–∏–∏ —á–µ–ª–æ–≤–µ–∫–∞¬ª –ù–∞–∏–±–æ–ª–µ–µ –∫—Ä–∏—Ç–∏—á–Ω–æ–µ –ø–æ–ª–æ–∂–µ–Ω–∏–µ —Å–∫–ª–∞–¥—ã–≤–∞–µ—Ç—Å—è –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏—è—Ö —Å —Ä–∞–∑–≤–∏—Ç–æ–π –Ω–µ—Ñ—Ç–µ–ø–µ—Ä–µ—Ä–∞–±–æ—Ç–∫–æ–π –∏ –Ω–µ—Ñ—Ç–µ—Ö–∏–º–∏–µ–π. –°—Ä–µ–¥–∏ –≤—ã–±—Ä–æ—Å–æ–≤ —ç—Ç–∏—Ö –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏–π, –≤–∫–ª—é—á–∞—é—â–∏—Ö –±–æ–ª–µ–µ 200 —Ö–∏–º–∏—á–µ—Å–∫–∏—Ö –≤–µ—â–µ—Å—Ç–≤, —Å–æ–¥–µ—Ä–∂–∞—Ç—Å—è –≤–µ—â–µ—Å—Ç–≤–∞ 1-4-–≥–æ –∫–ª–∞—Å—Å–∞ –æ–ø–∞—Å–Ω–æ—Å—Ç–∏, –æ–±–ª–∞–¥–∞—é—â–∏–µ –º—É—Ç–∞–≥–µ–Ω–Ω—ã–º, –∞–ª–ª–µ—Ä–≥–∏—á–µ—Å–∫–∏–º, –∫–∞–Ω—Ü–µ—Ä–æ–≥–µ–Ω–Ω—ã–º, –Ω–µ–π—Ä–æ—Ç–æ–∫—Å–∏—á–µ—Å–∫–∏–º –¥–µ–π—Å—Ç–≤–∏–µ–º –°—É—Ä–æ–≤–æ.","{""skip"": true}"
2025-11-14T14:43:05+00:00,@pharm_icon,2446,https://t.me/pharm_icon/2446,"–£–∫—Ä–∞–¥–µ–Ω–Ω—ã–π –æ—Ä–≥–∞–∑–º: –∞–≥–æ–Ω–∏—Å—Ç—ã –ì–ü–ü-1 –æ–∫–∞–∑–∞–ª–∏—Å—å —Ö—É–∂–µ –ì—Ä–∏–Ω—á–∞ –¥–ª—è 71-–ª–µ—Ç–Ω–µ–π –∂–µ–Ω—â–∏–Ω—ã –í–æ—Ç –∏ –Ω–∞—à–∞ –ª—é–±–∏–º–∞—è —Ä—É–±—Ä–∏–∫–∞ —Ñ–∞—Ä–º–∞–∫–æ–Ω–∞–¥–∑–æ—Ä–∞ ¬´–ü–æ—Ö—É–¥–µ–π –∏/–∏–ª–∏ —É–º—Ä–∏¬ª. –ù–∞ —Ä–∞–∑–±–æ—Ä–µ ‚Äî –ª–∏—Ä–∞–≥–ª—É—Ç–∏–¥ —É –ø–æ–∂–∏–ª–æ–π –∂–µ–Ω—â–∏–Ω—ã. –ò —Å–µ–º–∞–≥–ª—É—Ç–∏–¥. –û–±–∞ –≤—ã–∑–≤–∞–ª–∏ –∞–Ω–æ—Ä–≥–∞–∑–º–∏—é. –î–æ —Å–∏—Ö –ø–æ—Ä –∑–∞—Ç—Ä–∞–≥–∏–≤–∞–ª–∏—Å—å –ª–∏—à—å –æ–ø–∞—Å–Ω—ã–µ –∏–ª–∏ —á–∞—Å—Ç—ã–µ –ø–æ–±–æ—á–Ω—ã–µ —ç—Ñ—Ñ–µ–∫—Ç—ã: –æ—Ç —Å–ª–µ–ø–æ—Ç—ã –∏ –ø–∞—Ä–µ–∑–∞ –ñ–ö–¢ –¥–æ –∫–æ–∂–Ω—ã—Ö —Ä–µ–∞–∫—Ü–∏–π –Ω–∞ –≤–≤–µ–¥–µ–Ω–∏–µ. –ó–¥–µ—Å—å –∂–µ –≤—Ä–∞—á—É —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏ –æ –Ω–æ–≤–æ–π –≥—Ä–∞–Ω–∏ –ø—Ä–æ–±–ª–µ–º ‚Äî —Å–µ–∫—Å—É–∞–ª—å–Ω–æ–π ‚Äî –∫–æ—Ç–æ—Ä—É—é –∂–¥–∞–ª–∏. –ö–∞–∫ —É–∑–Ω–∞–ª–∏? –ü–∞—Ü–∏–µ–Ω—Ç–∫–∞ –ø–æ–ø—Ä–æ—Å–∏–ª–∞ –≤—Ä–∞—á–∞ ¬´—Ä–∞–∑–±—É–¥–∏—Ç—å –µ–µ –∫–ª–∏—Ç–æ—Ä¬ª. –í—Ä–∞—á —Ä–µ—à–∏–ª —É–∑–Ω–∞—Ç—å, –∫–æ–≥–¥–∞ –æ–Ω —É—Å–Ω—É–ª –∏ —Å–æ–±—Ä–∞–ª –∞–Ω–∞–º–Ω–µ–∑. –ê–Ω–∞–º–Ω–µ–∑ –±—ã–ª –æ–±—ã—á–µ–Ω: –ò–ú–¢ 30+, –≥–∏–ø–µ—Ä—Ç–æ–Ω–∏—è, –¥–∏—Å–ª–∏–ø–∏–¥–µ–º–∏—è, –æ—Å—Ç–µ–æ–∞—Ä—Ç—Ä–∏—Ç, –∏—à–∏–∞—Å –∏ –¥–ª–∏—Ç–µ–ª—å–Ω–∞—è –¥–µ–ø—Ä–µ—Å—Å–∏—è. –ê–Ω–æ—Ä–≥–∞–∑–º–∏—è –≤–æ–∑–Ω–∏–∫–ª–∞ –∑–∞ 5 –º–µ—Å—è—Ü–µ–≤ –¥–æ –∫–æ–Ω—Å—É–ª—å—Ç–∞—Ü–∏–∏ (–∞ –≤—ã –≥–æ–≤–æ—Ä–∏—Ç–µ, —á—Ç–æ —É –Ω–∞—Å –ª—é–¥–∏ –≤ –æ—á–µ—Ä–µ–¥—è—Ö —Å—Ç—Ä–∞–¥–∞—é—Ç), —á–µ—Ä–µ–∑ 2 –Ω–µ–¥–µ–ª–∏ –ø–æ—Å–ª–µ –Ω–∞—á–∞–ª–∞ –µ–∂–µ–¥–Ω–µ–≤–Ω—ã—Ö –ø–æ–¥–∫–æ–∂–Ω—ã—Ö –∏–Ω—ä–µ–∫—Ü–∏–π 1,8 –º–≥ –õ–∏—Ä–∞–≥–ª—É—Ç–∏–¥–∞. –ù–∞ —Ñ–æ–Ω–µ –≤–æ–∑–Ω–∏–∫—à–µ–π —Ç–æ—à–Ω–æ—Ç—ã —á–µ—Ä–µ–∑ 2 –º–µ—Å—è—Ü–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç –∑–∞–º–µ–Ω–∏–ª–∏ –Ω–∞ –°–µ–º–∞–≥–ª—É—Ç–∏–¥, –Ω–æ –∞–Ω–æ—Ä–≥–∞–∑–º–∏—è —Å–æ—Ö—Ä–∞–Ω–∏–ª–∞—Å—å. –õ–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–π –∞–Ω–∞–º–Ω–µ–∑: ‚Ä¢ –¢—Ä–∏–∞–º—Ç–µ—Ä–µ–Ω+–≥–∏–¥—Ä–æ—Ö–ª–æ—Ä—Ç–∏–∞–∑–∏–¥ 37,5+25 –º–≥/—Å—É—Ç. ‚Ä¢ –ê—Ç–æ—Ä–≤–∞—Å—Ç–∞—Ç–∏–Ω - 20 –º–≥/—Å—É—Ç. ‚Ä¢ –≠—Å—Ç—Ä–∞–¥–∏–æ–ª 0,1 –º–≥ –≤–∞–≥–∏–Ω–∞–ª—å–Ω–æ ‚Äî —Ç–µ—Ä–∞–ø–∏—è —É—Ä–æ–≥–µ–Ω–∏—Ç–∞–ª—å–Ω–æ–≥–æ —Å–∏–Ω–¥—Ä–æ–º–∞ –ø—Ä–∏ –º–µ–Ω–æ–ø–∞—É–∑–µ. ‚Ä¢ –≠—Å—Ü–∏—Ç–∞–ª–æ–ø—Ä–∞–º - 20 –º–≥/—Å—É—Ç, –Ω–µ—Å–∫–æ–ª—å–∫–æ –¥–µ—Å—è—Ç–∏–ª–µ—Ç–∏–π. –ñ–µ–Ω—â–∏–Ω–∞ –Ω–µ –ø–µ—Ä–≤—ã–π –≥–æ–¥ –∂–∏–≤—ë—Ç –≤ —É–¥–æ–≤–æ–ª—å—Å—Ç–≤–∏–µ, –∞ —Ç—É—Ç ‚Äî –∏–∑—ä—è—Ç–∞ –µ–≥–æ –∑–Ω–∞—á–∏–º–∞—è —á–∞—Å—Ç—å. –ù–∞–∑–Ω–∞—á–µ–Ω–∏–µ: –ö–æ–º–±–∏–Ω–∏—Ä–æ–≤–∞–Ω–Ω—ã–π —É–±–æ–π–Ω—ã–π –∫—Ä–µ–º –ø–µ—Ä–µ–¥ –ø–æ–ª–æ–≤—ã–º –∞–∫—Ç–æ–º (L-–∞—Ä–≥–∏–Ω–∏–Ω, –ø–µ–Ω—Ç–æ–∫—Å–∏—Ñ–∏–ª–ª–∏–Ω, —ç—Ä–≥–æ–ª–æ–∏–¥–∞ –º–µ–∑–∏–ª–∞—Ç, —Å–∏–ª–¥–µ–Ω–∞—Ñ–∏–ª –∏ —Ç–µ—Å—Ç–æ—Å—Ç–µ—Ä–æ–Ω), –∞ —Ç–∞–∫–∂–µ –ø—Ä–µ–¥–≤–∞—Ä–∏—Ç–µ–ª—å–Ω–∞—è —Å—Ç–∏–º—É–ª—è—Ü–∏—è –≤–∏–±—Ä–∞—Ç–æ—Ä–æ–º. –ù–µ –ø–æ–º–æ–≥–ª–æ –ß–µ—Ä–µ–∑ 3 –º–µ—Å—è—Ü–∞ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥ –ø—Ä–µ–ø–∞—Ä–∞—Ç –∑–∞–º–µ–Ω–∏–ª–∏ –Ω–∞ —Ç–∏—Ä–∑–µ–ø–∞—Ç–∏–¥, –Ω–∞ –∫–æ—Ç–æ—Ä–æ–º –∫–ª–∏—Ç–æ—Ä-—Ç–∞–∫–∏ –ø—Ä–æ—Å–Ω—É–ª—Å—è –æ—Ä–≥–∞–∑–º—ã –≤–µ—Ä–Ω—É–ª–∏—Å—å. –ü–µ—Ä–∏—Ñ–µ—Ä–∏—á–µ—Å–∫–∏–π –º–µ—Ö–∞–Ω–∏–∑–º - —Å—É–∂–µ–Ω–∏–µ —Å–æ—Å—É–¥–æ–≤ —Å–æ —Å–Ω–∏–∂–µ–Ω–∏–µ–º –Ω–∞—Å—ã—â–µ–Ω–∏—è –∫–∏—Å–ª–æ—Ä–æ–¥–æ–º —Ç–∫–∞–Ω–µ–π –≥–µ–Ω–∏—Ç–∞–ª–∏–π, —á—Ç–æ –Ω–∞—Ä—É—à–∞–µ—Ç —Å–æ–∫—Ä–∞—â–µ–Ω–∏–µ –º—É—Å–∫—É–ª–æ–≤, —É—á–∞—Å—Ç–≤—É—é—â–∏—Ö –≤ –æ—Ä–≥–∞–∑–º–µ. –ö–∞–∫ —ç—Ç–æ –æ–±—ä—è—Å–Ω—è–µ—Ç—Å—è? –†–µ—Ü–µ–ø—Ç–æ—Ä—ã –ì–ü–ü-1 –Ω–∞—Ö–æ–¥—è—Ç—Å—è –≤ –æ–±–ª–∞—Å—Ç—è—Ö –º–æ–∑–≥–∞, –æ—Ç–≤–µ—á–∞—é—â–∏—Ö –∑–∞ —Å–µ–∫—Å—É–∞–ª—å–Ω—É—é —Ñ—É–Ω–∫—Ü–∏—é, –Ω–∞–ø—Ä–∏–º–µ—Ä, –≤ –≥–∏–ø–æ—Ç–∞–ª–∞–º—É—Å–µ. –ù–µ–π—Ä–æ–º–µ–¥–∏–∞—Ç–æ—Ä—ã –¥–æ—Ñ–∞–º–∏–Ω –∏ –Ω–æ—Ä–∞–¥—Ä–µ–Ω–∞–ª–∏–Ω, –∫–æ—Ç–æ—Ä—ã–µ –∏–≥—Ä–∞—é—Ç –∫–ª—é—á–µ–≤—É—é —Ä–æ–ª—å –≤ –º–æ—Ç–∏–≤–∞—Ü–∏–∏, —É–¥–æ–≤–æ–ª—å—Å—Ç–≤–∏–∏ –∏ –æ—Ä–≥–∞–∑–º–µ, –≤—ã—Ä–∞–±–∞—Ç—ã–≤–∞—é—Ç—Å—è –∏ –≤—ã—Å–≤–æ–±–æ–∂–¥–∞—é—Ç—Å—è –≤ –≥–∏–ø–æ—Ç–∞–ª–∞–º—É—Å–µ –≤–æ –≤—Ä–µ–º—è —Å–µ–∫—Å—É–∞–ª—å–Ω–æ–≥–æ –≤–æ–∑–±—É–∂–¥–µ–Ω–∏—è. –í–µ—Ä–æ—è—Ç–Ω–∞—è –ø—Ä–∏—á–∏–Ω–∞ 1: —á—ë-—Ç–æ —Ç–∞–º –∫–∞–∫-—Ç–æ –ø–æ—à–ª–æ –Ω–µ —Ç–∞–∫. –í–µ—Ä–æ—è—Ç–Ω–∞—è –ø—Ä–∏—á–∏–Ω–∞ 2: –≤–∞–∑–æ–∫–æ–Ω—Å—Ç—Ä–∏–∫—Ü–∏—è –≥–ª–∞–¥–∫–∏—Ö –º—ã—à—Ü, –≤—ã–∑–≤–∞–Ω–Ω–∞—è –∞–≥–æ–Ω–∏—Å—Ç–∞–º–∏ –ì–ü–ü-1, —á—Ç–æ —Å–Ω–∏–∂–∞–µ—Ç –¥–æ—Å—Ç–∞–≤–∫—É –∫–∏—Å–ª–æ—Ä–æ–¥–∞ –∏ –∫—Ä–æ–≤–æ—Ç–æ–∫ –∫ –ø–æ–ª–æ–≤—ã–º –æ—Ä–≥–∞–Ω–∞–º. –†–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏—è 1. –ü—Ä–æ—á–∏—Ç–∞–π—Ç–µ —Ç–µ–∫—Å—Ç –µ—â—ë —Ä–∞–∑ –ø–æ–¥ —Ç—Ä–µ–∫ Avicii ‚Äî Wake me up. –†–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏—è 2. –°–¥–µ–ª–∞–π—Ç–µ —Ä–µ–ø–æ—Å—Ç –¥—Ä—É–∑—å—è–º –∏ –∫–æ–ª–ª–µ–≥–∞–º, –ø—É—Å—Ç—å –∑–Ω–∞—é—Ç, —á—Ç–æ –∫—Ä–æ–µ—Ç—Å—è –∑–∞ —Å—Ç—Ä–µ–º–ª–µ–Ω–∏–µ–º –∫ –ø–æ—Ö—É–¥–µ–Ω–∏—é –∏ —á—Ç–æ —É –≤–∞—Å –º–æ–≥—É—Ç —É–∫—Ä–∞—Å—Ç—å.","{""skip"": true}"
2025-11-13T14:12:41+00:00,@pharm_icon,2445,https://t.me/pharm_icon/2445,"FDA –æ–¥–æ–±—Ä–∏–ª–æ –ø–µ—Ä–≤—É—é –ø–∞—Ç–æ—Ñ–∏–∑–∏–æ–ª–æ–≥–∏—á–µ—Å–∫—É—é —Ç–µ—Ä–∞–ø–∏—é –∞—É—Ç–æ–∏–º–º—É–Ω–Ω–æ–≥–æ –Ω–∞—Ä—É—à–µ–Ω–∏—è —Å–≤–µ—Ä—Ç—ã–≤–∞–Ω–∏—è FDA –æ–¥–æ–±—Ä–∏–ª–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç –í—ç–π—Ä–∏–ª–∑ (—Ä–∏–ª–∑–∞–±—Ä—É—Ç–∏–Ω–∏–±) - –ø–µ—Ä–≤—ã–π –∏–Ω–≥–∏–±–∏—Ç–æ—Ä —Ç–∏—Ä–æ–∑–∏–Ω–∫–∏–Ω–∞–∑—ã –ë—Ä—É—Ç–æ–Ω–∞ (BTK), –ø—Ä–∏–º–µ–Ω—è–µ–º—ã–π –≤ –ª–µ—á–µ–Ω–∏–∏ —Ä–µ–∑–∏—Å—Ç–µ–Ω—Ç–Ω–æ–π —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–æ–π –∏–º–º—É–Ω–Ω–æ —Ç—Ä–æ–º–±–æ—Ü–∏—Ç–æ–ø–µ–Ω–∏–∏ (–ò–¢–ü). –ü—Ä–∏ –ò–¢–ü –Ω–∞—Ä—É—à–∞–µ—Ç—Å—è —Ä–∞–±–æ—Ç–∞ –í–¢–ö –∏ –≤–æ–∑–Ω–∏–∫–∞–µ—Ç –∞—É—Ç–æ–∏–º–º—É–Ω–Ω–∞—è —Ä–µ–∞–∫—Ü–∏—è. –í–¢–ö —Ä–µ–≥—É–ª–∏—Ä—É–µ—Ç —Å–æ–∑—Ä–µ–≤–∞–Ω–∏–µ –∏–º–º—É–Ω–Ω—ã—Ö –∫–ª–µ—Ç–æ–∫, –∏ –æ–±–µ—Å–ø–µ—á–∏–≤–∞–µ—Ç –ø–µ—Ä–µ–¥–∞—á—É —Å–∏–≥–Ω–∞–ª–∞ –≤–Ω—É—Ç—Ä–∏ –∞—É—Ç–æ–∏–º–º—É–Ω–Ω—ã—Ö –í-–ª–∏–º—Ñ–æ—Ü–∏—Ç–æ–≤, —è–≤–ª—è—è—Å—å –∫–æ–º–ø–æ–Ω–µ–Ω—Ç–æ–º –∏–º–º—É–Ω–Ω–æ–π —Å–∏—Å—Ç–µ–º—ã. –í —Ä–µ–∑—É–ª—å—Ç–∞—Ç–µ –Ω–∞—Ä—É—à–µ–Ω–∏—è —Ä–∞–±–æ—Ç—ã –í–¢–ö —Å–Ω–∏–∂–∞–µ—Ç—Å—è —á–∏—Å–ª–æ —Ç—Ä–æ–º–±–æ—Ü–∏—Ç–æ–≤, —á—Ç–æ –ø—Ä–∏–≤–æ–¥–∏—Ç –∫ –∫—Ä–æ–≤–æ—Ç–µ—á–µ–Ω–∏—è–º. –†–∏–ª–∑–∞–±—Ä—É—Ç–∏–Ω–∏–± —Å–≤—è–∑—ã–≤–∞–µ—Ç –í–¢–ö, —Ç–µ–º —Å–∞–º—ã–º –±–ª–æ–∫–∏—Ä—É—è –∞—É—Ç–æ–∏–º–º—É–Ω–Ω—É—é —Ä–µ–∞–∫—Ü–∏—é –∏ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—Ä—É–µ—Ç –∫—Ä–æ–≤–æ—Ç–µ—á–µ–Ω–∏—è. –ü—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–∞ –†–∏–ª–∑–∞–±—Ä—É—Ç–∏–Ω–∏–±–∞: 1. –ò–∑–±–∏—Ä–∞—Ç–µ–ª—å–Ω–æ–µ –¥–µ–π—Å—Ç–≤–∏–µ –Ω–∞ –ø–∞—Ç–æ—Ñ–∏–∑–∏–æ–ª–æ–≥–∏—é –≤–º–µ—Å—Ç–æ —Å–∏–º–ø—Ç–æ–º–∞—Ç–∏—á–µ—Å–∫–æ–π –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–Ω–æ—Å—Ç–∏ –æ—Å—Ç–∞–ª—å–Ω—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ (—Å—Ç–µ—Ä–æ–∏–¥–æ–≤, –∞–Ω—Ç–∏-D –≥–ª–æ–±—É–ª–∏–Ω–æ–≤ –∏ —Å—Ç–∏–º—É–ª—è—Ç–æ—Ä–æ–≤ –≥–µ–º–æ–ø–æ—ç–∑–∞). 2. –û—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ –º—è–≥–∫–∏–π –ø—Ä–æ—Ñ–∏–ª—å –ø–µ—Ä–µ–Ω–æ—Å–∏–º–æ—Å—Ç–∏ ‚Äî –≥–ª–∞–≤–Ω—ã–º–∏ —É—á–∞—â–µ–Ω–∏—è –∏–Ω—Ñ–µ–∫—Ü–∏–π, –≤ —Ç–æ–º —á–∏—Å–ª–µ –∏ –∫–æ–≤–∏–¥, –≥–æ–ª–æ–≤–Ω–∞—è –∏ –∞–±–¥–æ–º–∏–Ω–∞–ª—å–Ω–∞—è –±–æ–ª–∏, –∞ —Ç–∞–∫–∂–µ —Ä–≤–æ—Ç–∞. –ò–∑ –Ω–µ–¥–æ—Å—Ç–∞—Ç–∫–æ–≤: 1. –ù–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–∞—è —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å - –∏–∑ –≥—Ä—É–ø–ø—ã –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –≤ 133 —É—á–∞—Å—Ç–Ω–∏–∫–∞ (–ø—Ä–æ—Ç–∏–≤ –≥—Ä—É–ø–ø—ã –ø–ª–∞—Ü–µ–±–æ –≤ 69 —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤) –ø–æ–ª–Ω–æ–≥–æ —Å—Ç–æ–π–∫–æ–≥–æ –æ—Ç–≤–µ—Ç–∞ –¥–æ—Å—Ç–∏–≥–ª–∏ —É 31 —á–µ–ª–æ–≤–µ–∫–∞ (23%). 2. –£–ø–æ—Ä –Ω–∞ –∫–æ–≤–∏–¥ –≤ –ø–æ–±–æ—á–Ω—ã—Ö —ç—Ñ—Ñ–µ–∫—Ç–∞—Ö (—Å—Ç—Ä–∞–Ω–Ω–æ, –≤–∏–¥–∏–º–æ, –æ—Å—Ç–∞–≤–∏–ª–∏ –Ω–∞ —Å–ª—É—á–∞–π, –µ—Å–ª–∏ –±—É–¥–µ—Ç —Å–Ω–∏–∂–µ–Ω–∏–µ —Å–ª—É—á–∞–µ–≤ –∫–æ–≤–∏–¥–∞ –ø—Ä–∏ –ø—Ä–∏–µ–º–µ ‚Äî –º–æ–∂–Ω–æ –±—ã–ª–æ –±—ã –ø—Ä–æ–≤–µ—Å—Ç–∏ –∫–∞–∫ –µ—â—ë –æ–¥–Ω–æ –ø–æ–∫–∞–∑–∞–Ω–∏–µ, –Ω–æ –Ω–µ —Å—Ä–æ—Å–ª–æ—Å—å).","{""skip"": true}"
2025-11-11T12:04:42+00:00,@pharm_icon,2444,https://t.me/pharm_icon/2444,‚ö°11 –Ω–æ—è–±—Ä—è - –¥–µ–Ω—å –∑–∞–∫—Ä–µ–ø–æ—â–µ–Ω–∏—è –º–µ–¥–∏–∫–æ–≤ –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–æ–≤,"{""skip"": true}"
2025-11-11T12:03:45+00:00,@pharm_icon,2443,https://t.me/pharm_icon/2443,"üíä –í–µ–¥—É—â–∏–µ Telegram-–∫–∞–Ω–∞–ª—ã, –∫–æ—Ç–æ—Ä—ã–µ –∑–∞–¥–∞—é—Ç –ø–æ–≤–µ—Å—Ç–∫—É –≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π —Å—Ñ–µ—Ä–µ ‚Äî –û–ö–¢–Ø–ë–†–¨ 2025. –†–µ–π—Ç–∏–Ω–≥ —Å–æ—Å—Ç–∞–≤–∏–ª –∫–ª—é—á–µ–≤–æ–π –∫–∞–Ω–∞–ª-–∞–≥—Ä–µ–≥–∞—Ç–æ—Ä –º–µ–¥–ø–æ–≤–µ—Å—Ç–∫–∏ –≤ Telegram ‚Äî ¬´–ú—É—Ä–∞—à–∫–æ –ø–æ –∫–æ–∂–µ¬ª (@murashko_med ‚Äîüéñ10,3 –º–ª–Ω. –ø—Ä–æ—Å–º–æ—Ç—Ä–æ–≤) –Ω–∞ –æ—Å–Ω–æ–≤–µ –¥–∞–Ω–Ω—ã—Ö üìä TGSTAT.ru –ø—Ä–∏ —ç–∫—Å–ø–µ—Ä—Ç–Ω–æ–π –ø–æ–¥–¥–µ—Ä–∂–∫–µ ¬´–ú–µ–¥–∏–∞—Ç–µ—Ö–Ω–æ–ª–æ–≥–∞¬ª (@mediatech). –ö–∞—á–µ—Å—Ç–≤–µ–Ω–Ω–∞—è –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è –∏ —Ä–∞–∑–Ω—ã–µ —Ç–æ—á–∫–∏ –∑—Ä–µ–Ω–∏—è, —Å–æ–±—Ä–∞–Ω–Ω—ã–µ –≤ –æ–¥–Ω–æ–º –º–µ—Å—Ç–µ: —á–∏—Ç–∞–π—Ç–µ —Ç–µ—Ö, –∫—Ç–æ —Ñ–æ—Ä–º–∏—Ä—É–µ—Ç –Ω–æ–≤–æ—Å—Ç–Ω—É—é –ª–µ–Ω—Ç—É –≤ –∏–Ω–¥—É—Å—Ç—Ä–∏–∏ ‚Äî –∏ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ –ø–æ–¥–ø–∏—Å—ã–≤–∞–π—Ç–µ—Å—å –Ω–∞ –Ω–∞—Å: @murashko_med. –¢–û–ü-25 ‚Äî –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –Ω–æ–≤–æ—Å—Ç–∏, –±–ª–æ–≥–∏ –≤—Ä–∞—á–µ–π –∏ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ (–ø–æ —Å—É–º–º–∞—Ä–Ω–æ–º—É –æ—Ö–≤–∞—Ç—É –∞—É–¥–∏—Ç–æ—Ä–∏–∏): ü•á. –ò–ú–ú–£–ù–ù–´–ô –û–¢–í–ï–¢ (@imotvet) ‚Äî 1749,5k; ü•à. –Æ—Ä–∏—Å—Ç –¥–ª—è –≤—Ä–∞—á–∞ –ê–Ω–≥–µ–ª–∏–Ω–∞ –†–æ–º–∞–Ω–æ–≤—Å–∫–∞—è (@mfcexpert_news) ‚Äî 549,2k; ü•â. –ö–û–ë–Ø–ö–û–í–ê (@okobyakova) ‚Äî 396,4k 4. –°–æ–æ–±—â–µ—Å—Ç–≤–æ ¬´–í—Ä–∞—á–∏ –†–§¬ª (@VrachiRF_Official) ‚Äî 385,8k; 5. –ú–µ–¥–∫–∞–¥—Ä—ã (@medkadry) ‚Äî 351,6k; 6. –ü–æ—è—Å–Ω–∏ –∑–∞ –º–µ–¥ (@poyasni_za_med) ‚Äî 321,5k; 7. –ú–∏–Ω–ó–¥—Ä–∞–≤ –î–µ—Ç–∏ (@minzdravjunior) ‚Äî 310,9k; 8. –¶–ù–ò–ò–û–ò–ó (@cniioizofficial) ‚Äî 278,6k; 9. –ë–∞–¥–º–∞ –ë–∞—à–∞–Ω–∫–∞–µ–≤ (@Bashankaev) ‚Äî 257k; 10. –ü—Ä–∞–≤–æ –Ω–∞ –∑–¥–æ—Ä–æ–≤—å–µ (@right_to_health) ‚Äî 190,6k; 11. –ú–µ–¥–∞—á (@medach) ‚Äî 187,6k; 12. –ò–∫–æ–Ω–∞ –§–∞—Ä–º—ã (@pharm_icon) ‚Äî 157,4k; 13. –Æ–†–ò–°–¢–´ –ó–ê –í–†–ê–ß–ï–ô (@meduristPopova) ‚Äî 149,3k; 14. –ú–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–π —é—Ä–∏—Å—Ç –ò–≤–∞–Ω –ü–µ—á–µ—Ä–µ–π (@pravomedapologists) ‚Äî 136k; 15. Medical –ö—Å—é (@medicalksu) ‚Äî 91,1k; 16. –ú–µ–¥–¢–µ—Ö –õ–∞–±–æ—Ä–∞—Ç–æ—Ä–∏—è (@medtech_laboratory) ‚Äî 71,3k; 17. –ì–æ–ª–æ–¥, —Ö–æ–ª–æ–¥ –∏ –ø–æ–∫–æ–π (@Caduceusmed) ‚Äî 69,9k; 18. –°–µ—Ä–≥–µ–π –õ–µ–æ–Ω–æ–≤ (@leONovLIFE) ‚Äî 55,8k; 19. –í–∞—Ä–∏–≤–æ–¥–∞ MED&TECH (@Varivoda_medtech) ‚Äî 44,3k; 20. –î–º–∏—Ç—Ä–∏–π –•—É–±–µ–∑–æ–≤ (@KhubezovDmitrii) ‚Äî 34,1k; 21. –ê–π—Ä–∞—Ç –§–∞—Ä—Ä–∞—Ö–æ–≤ (@ayratfarrahov) ‚Äî 27,9k; 22. –ù–µ–ú–∏–Ω–∑–¥—Ä–∞–≤ (@rus_med) ‚Äî 25,9k; 23. –í–ª–∞—Å–æ–≤–∞ –í–µ—Ä–æ–Ω–∏–∫–∞ (@VlasovaVeronika) ‚Äî 15,6k; 24. –õ–µ–æ–Ω–∏–¥ –û–≥—É–ª—å (@Leonid_ogul) ‚Äî 10,9k; 25. –ú–∏—Ö–∞–∏–ª –ö–∏–∑–µ–µ–≤ (@kizeev_mv) ‚Äî 3,2k. –ù–µ —Ç–æ–ª—å–∫–æ –æ –º–µ–¥–∏—Ü–∏–Ω–µ, –Ω–æ –≤–∞–∂–Ω–æ –¥–ª—è –≤–Ω–∏–º–∞–Ω–∏—è (–ø–æ –ø–æ–¥–ø–∏—Å—á–∏–∫–∞–º): 1. REDACTED P6 (–ö–û–¢–Å–õ #6) (@redacted6); 2. –ú–æ—Å–∫–æ–≤—Å–∫–∞—è –ø—Ä–∞—á–µ—á–Ω–∞—è (@moscow_laundry); 3. –°–∫—É—Ä–ª–∞—Ç–æ–≤ live (@skurlatovlive); 4. Lomovka (@lomovkaa); 5. –ù–û–° (@nos_chanel); 6. –ë–æ–π–ª–µ—Ä–Ω–∞—è (@boilerroomchannel); 7. –ö—Ä–µ–º–ª—ë–≤—Å–∫–∏–π –º–∞–º–∫–æ–≤–µ–¥ (@kremlin_mother_expert); 8. –ë—É–ª—å–¥–æ–≥–∏ –ø–æ–¥ –∫–æ–≤—Ä–æ–º (@kremlin_bulldogs); 9. –ü–∞—É–∫–∏ –≤ –±–∞–Ω–∫–µ (@bankuyte); 10. –ö—Ä–∏—Ç–∏–∫ –Ω–æ–≤–æ—Å—Ç–Ω–æ–π –ª–µ–Ω—Ç—ã (@kritiknewsfeed); 11. –ù–æ–≤–æ—Å—Ç–∏ —Å–µ–≥–æ–¥–Ω—è (@listnewsru); 12. –ó–æ–Ω–∞ –æ—Å–æ–±–æ–≥–æ –≤–Ω–∏–º–∞–Ω–∏—è (@zonaosoboho): 13. –î–µ–ø—É—Ç–∞—Ç—Å–∫–∏–µ –±—É–¥–Ω–∏ (@deputatdumy); 14. –ö–ê–†–ù–ê–£–•–û–í (@sskarnaukhov); 15. –¢–µ–ª–µ –°—Ç—Ä–∏–º (@infoagency_TS); 16. –ú–µ–¥–∏–∞—Ç–µ—Ö–Ω–æ–ª–æ–≥ (@mediatech); 17. –ö–†–´–ú–ò–ù–§–û–†–£–ú (@ZOVcrimea); 18. –ù–µ—É–¥–∞—â–∞ (@dirtytatarstan); 19. –ú–∞—Å—Ç–µ—Ä –ø–µ—Ä–∞ (@master_pera); 20. –§—É—Ç–ª—è—Ä –¥–ª—è –∫—É—Ä–∞—è (@kuraifutlar). –ù–µ –Ω–∞—à–ª–∏ –∫–∞–Ω–∞–ª, –∫–æ—Ç–æ—Ä—ã–π —á–∏—Ç–∞–µ—Ç–µ? –ü–∏—à–∏—Ç–µ —Å–≤–æ–∏ –≤–æ–ø—Ä–æ—Å—ã –∏ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è ‚Äî –≤ –±–æ—Ç: @mursvyz_bot. üöë –ü–æ–¥–ø–∏—Å—ã–≤–∞–π—Ç–µ—Å—å –Ω–∞ @murashko_med.","{""skip"": true}"
2025-11-11T06:29:34+00:00,@pharm_icon,2442,https://t.me/pharm_icon/2442,"–ê–Ω—Ç–∏–≤–∞–∫—Å–µ—Ä—ã –Ω–∞ –∑–∞–≤—Ç—Ä–∞–∫ –î–æ–±—Ä—ã–µ –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–µ —É—á–µ–Ω—ã–µ —Ä–µ—à–∏–ª–∏ –ø–æ–±–æ—Ä–æ—Ç—å –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç—å —Å—É—Ç—å –∞–Ω—Ç–∏–≤–∞–∫—Å–µ—Ä—Å—Ç–≤–∞, –ø–æ—ç—Ç–æ–º—É –ø—Ä–æ–≤–µ—Ä–∏–ª–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ä–∏—Ä–æ–≤–∞–Ω–∏–µ –≤ –≥–æ—Ä–∏–∑–æ–Ω—Ç–∞–ª—å–Ω–æ–º —Ä–∞–∑—Ä–µ–∑–µ. –î–ª—è —ç—Ç–æ–≥–æ –Ω–∞—á–∞–ª–∏ —Å —á–µ—Ä—Ç–æ–≤—Å–∫–∏ –ø—Ä–∞–≤–∏–ª—å–Ω–æ–≥–æ –¥–µ–π—Å—Ç–≤–∏—è - –ø–æ—Å—Ç—Ä–æ–∏–ª–∏ –¥–∏–∑–∞–π–Ω –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –ø–æ–¥ –≤–æ–ø—Ä–æ—Å–æ–º ""–ö—Ç–æ –∂–µ –∞–Ω—Ç–∏–≤–∞–∫—Å–µ—Ä—ã –≤ –∂–∏–∑–Ω–∏ –∏ –∫–∞–∫ —Å –Ω–∏–º–∏ —Ä–∞–±–æ—Ç–∞—Ç—å?"". –î–∞–ª–µ–µ, –≤–∏–¥–∏–º–æ, –¥–ª—è —Å–æ–∑–¥–∞–Ω–∏—è –±–æ–ª–µ–µ-–º–µ–Ω–µ–µ —Ä–µ–ª–µ–≤–∞–Ω—Ç–Ω–æ–π –∫–∞—Ä—Ç–∏–Ω—ã, –æ–Ω–∏ –≤—ã–±—Ä–∞–ª–∏ –¶–ê - –≥–æ—Ä–æ–¥—Å–∫–æ–µ, –ø—Ä–∏–≥–æ—Ä–æ–¥–Ω–æ–µ –∏ —Å–µ–ª—å—Å–∫–æ–µ –Ω–∞—Å–µ–ª–µ–Ω–∏–µ (–∫–∞–∂–¥—ã–π —Å–µ–¥—å–º–æ–π –≤ –°–®–ê –∂–∏–≤–µ—Ç –≤ –¥–µ—Ä–µ–≤–Ω–µ –∑–∞ –ø—Ä–∏–≥–æ—Ä–æ–¥–æ–º). –ü–æ—Å–ª–µ —ç—Ç–æ–≥–æ —É—á–µ–Ω—ã–µ –æ–ø—è—Ç—å –Ω–µ –æ—à–∏–±–ª–∏—Å—å –∏ –≤—ã–±—Ä–∞–ª–∏ –º–Ω–æ–∂–µ—Å—Ç–≤–µ–Ω–Ω—ã–µ, –¥–ª—è –Ω–∞—Å –ø–æ—á—Ç–∏ –ø–∞—Ä—Ç–∏–∑–∞–Ω—Å–∫–∏–µ –º–µ—Å—Ç–∞ —Å–±–æ—Ä–∞ –¶–ê - –§–µ–π—Å–±—É–∫, —Ñ–æ—Ä—É–º—ã —Ä–æ–¥–∏—Ç–µ–ª–µ–π, –∞ —Ç–∞–∫–∂–µ —Å–∞–¥–∏–∫–∏, —à–∫–æ–ª—ã –∏ —è—Å–ª–∏. 1046 —É—á–∞—Å—Ç–Ω–∏–∫–∞–º (—Ä–æ–¥–∏—Ç–µ–ª—è–º 1701 —Ä–µ–±–µ–Ω–∫–∞) –±—ã–ª –≤—ã—Å–ª–∞–Ω –∞–Ω–æ–Ω–∏–º–Ω—ã–π –æ–Ω–ª–∞–π–Ω-–æ–ø—Ä–æ—Å–Ω–∏–∫ PACV (–û—Ç–Ω–æ—à–µ–Ω–∏–µ —Ä–æ–¥–∏—Ç–µ–ª–µ–π –∫ –¥–µ—Ç—Å–∫–∏–º –≤–∞–∫—Ü–∏–Ω–∞–º), —Å–æ—Å—Ç–æ—è–≤—à–∏–π –∏–∑ –±–ª–æ–∫–∞ –æ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ –∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –∫ –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏–∏, –ø–æ–≤–µ–¥–µ–Ω–∏–∏ –∏ –æ–±—â–∏—Ö –≤–æ–ø—Ä–æ—Å–∞—Ö. –°—É–º–º–∞—Ä–Ω—ã–π –±–∞–ª–ª 0 - –∞–¥–µ–ø—Ç –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏–∏, 100 - –≥–ª–∞–≤–∞ –∞–Ω—Ç–∏–≤–∞–∫—Å–µ—Ä—Å–∫–æ–π —è—á–µ–π–∫–∏. –ü–æ—Ä–æ–≥ –∞–Ω—Ç–∏–≤–∞–∫—Å–µ—Ä—Ç–≤–∞ - –æ—Ç 50 –±–∞–ª–ª–æ–≤. –°—Ä–µ–¥–Ω–∏–π –≤–æ–∑—Ä–∞—Å—Ç —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ —Å–æ—Å—Ç–∞–≤–∏–ª 36 –ª–µ—Ç, –¥–∏–∞–ø–∞–∑–æ–Ω –æ—Ç 20 –¥–æ 60 –ª–µ—Ç. –†–µ–∑—É–ª—å—Ç–∞—Ç—ã, —Å —É—á–µ—Ç–æ–º –∏ —Å–æ—Ü–∏–∞–ª—å–Ω–æ–≥–æ –ø–æ–ª–æ–∂–µ–Ω–∏—è, —Ç–∞–∫–æ–≤—ã: 1. –ü–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω–æ–µ –æ—Ç–Ω–æ—à–µ–Ω–∏–µ –∫ –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏–∏ –ø—Ä–æ–¥–µ–º–æ–Ω—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª–∏ 85% —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤. –ù–µ–≥–∞—Ç–∏–≤–Ω–æ–µ - 15%. 2. –î–æ–ª—è –∫–æ–ª–µ–±–ª—é—â–∏—Ö—Å—è —Å–∫–µ–ø—Ç–∏–∫–æ–≤ - 40% –æ—Ç –æ—Ç–∫–∞–∑—ã–≤–∞–≤—à–∏—Ö—Å—è, —Ç.–µ. –µ—â–µ 6%. - –∫–ª—é—á–µ–≤–∞—è –∑–æ–Ω–∞ —Ä–∞–±–æ—Ç—ã –∏ –ø—Ä–æ—Å–≤–µ—â–µ–Ω–∏—è. 3. –ì–ª–∞–≤–Ω—ã–π —á–µ–ª–æ–≤–µ–∫, –ø—Ä–∏–Ω–∏–º–∞—é—â–∏–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ —Ä–µ—à–µ–Ω–∏—è - –º–∞—Ç–µ—Ä–∏ (91,2%). 4. –ö–ª—é—á–µ–≤–æ–π —Ñ–∞–∫—Ç–æ—Ä –≤—ã–±–æ—Ä–∞ - –¥–æ–≤–µ—Ä–∏–µ –∫ –≤—Ä–∞—á—É –∏ –µ–≥–æ —Å—Ç—Ä–∞—Ç–µ–≥–∏—è —Ä–∞–±–æ—Ç—ã —á–µ—Ä–µ–∑ –æ–±—â–µ–Ω–∏–µ –∏ —ç–º–ø–∞—Ç–∏—é, –∞ –Ω–µ —á–µ—Ä–µ–∑ –∑–∞–∫–∏–¥—ã–≤–∞–Ω–∏–µ —Ü–∏—Ñ—Ä–∞–º–∏. 5. –ü–æ–∑–∏—Ç–∏–≤–Ω—ã–µ –¥–ª—è –ø—Ä–∏–≤–µ—Ä–∂–µ–Ω–Ω–æ—Å—Ç–∏ —Ñ–∞–∫—Ç–æ—Ä—ã - –Ω–∞–ª–∏—á–∏–µ —Ä–∞–±–æ—Ç—ã (–û–® - 2,172, 95 –î–ò: 1,53 -3,084), –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫ (2,907; 1,983 -4,262) –∏ –ø—Ä–æ–∂–∏–≤–∞–Ω–∏–µ –æ–∫–æ–ª–æ –≥–æ—Ä–æ–¥–∞ (1,614; 1,037- 2,515) 6. –ù–µ–≥–∞—Ç–∏–≤–Ω—ã–µ —Ñ–∞–∫—Ç–æ—Ä—ã - –±–æ–ª—å—à–æ–µ —á–∏—Å–ª–æ –¥–µ—Ç–µ–π –∏ –Ω–µ–∑–∞–ø–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω–Ω–æ–µ —Ä–æ–∂–¥–µ–Ω–∏–µ (0,677; 0,579‚Äì0,792), –∞ —Ç–∞–∫–∂–µ –Ω–µ–¥–æ–≤–µ—Ä–∏–µ –ø–µ–¥–∏–∞—Ç—Ä—É –∏ —Å—Ç—Ä–∞—Ö –æ–±—Å—É–¥–∏—Ç—å —Å–æ–º–Ω–µ–Ω–∏—è. –û—á–µ–≤–∏–¥–Ω—ã–µ –ø–ª—é—Å—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è: 1. –û—Ç–ª–∏—á–Ω–æ–µ —Ü–µ–ª–µ–ø–æ–ª–∞–≥–∞–Ω–∏–µ - –≤—ã—è–≤–∏—Ç—å —Å—É—Ç—å –∏ —Å–ª–∞–±–æ—Å—Ç–∏ –Ω–µ–¥–æ–≤–µ—Ä–∏—è –∫ –≤–∞–∫—Ü–∏–Ω–∞–º. 2. –ü–æ–¥—Ö–æ–¥ –∫ –¶–ê - –û—Ö–≤–∞—Ç –≤—Å–µ—Ö —Å–ª–æ–µ–≤ –Ω–∞—Å–µ–ª–µ–Ω–∏—è, –∫–∞–∫ –ø–æ —Ä–∞–±–æ—Ç–µ, —Ç–∞–∫ –∏ –ø–æ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—é —Å –¥–æ—Ö–æ–¥–æ–º. –ü–æ–º–æ–≥–ª–æ —Ä–∞—Å—Å–µ—è—Ç—å —Å–æ–º–Ω–µ–Ω–∏—è –æ –ø–æ–≤—ã—à–µ–Ω–Ω—ã–π –ø—Ä–∏–≤–µ—Ä–∂–µ–Ω–Ω–æ—Å—Ç–∏ –ª—é–¥–µ–π —Å –≤—ã—Å—à–∏–º. 3. –ì–ª—É–±–∏–Ω–∞ –∞–Ω–∞–ª–∏–∑–∞ –ø—Ä–∏—á–∏–Ω - —Ä–∞–∑–æ–±—Ä–∞–Ω—ã —Å–æ—Ü–∏–∞–ª–∫–∞, —á–µ–ª–æ–≤–µ—á–µ—Å–∫–æ–µ –ø–æ–≤–µ–¥–µ–Ω–∏–µ, –æ–±–æ–∑–Ω–∞—á–µ–Ω —Ñ–æ–∫—É—Å –Ω–∞ —Å–æ–º–Ω–µ–≤–∞—é—â–∏—Ö—Å—è –ù–µ–æ—á–µ–≤–∏–¥–Ω—ã–µ –ø–ª—é—Å—ã: 1. –ö–æ–Ω—Ñ–ª–∏–∫—Ç –ø–µ—Ä–µ—Ö–æ–¥–∞ –æ—Ç —Å—Ç–∞—Ç–∏—Å—Ç–∏–∫–∏ –∫ –ø—Ä–∞–∫—Ç–∏–∫–µ - —Ö–æ—Ä–æ—à–æ –ø–æ–∫–∞–∑–∞–Ω –ö–ü–î —É–º–µ–Ω–∏—è —É–±–µ–∂–¥–∞—Ç—å –∏ –≥–æ–≤–æ—Ä–∏—Ç—å –±–µ–∑ –æ—Å—É–∂–¥–µ–Ω–∏—è. –í–æ—Ç –∑–æ–Ω–∞ —Ä–∞–±–æ—Ç—ã ‚Ññ1. 2. –í–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –ø—Ä–æ–≥–Ω–æ–∑–∏—Ä–æ–≤–∞–Ω–∏—è —Ä–µ–∞–∫—Ü–∏–∏ –Ω–∞ –æ—Å–Ω–æ–≤–µ PACV. 3. –û—Ç—Ä–∞–∂–µ–Ω–∞ —Ä–æ–ª—å –¥–æ–≤–µ—Ä–∏—è –∫–∞–∫ –º–∞—Ä–∫–µ—Ä–∞ —Å–æ—Ü–∏–∞–ª—å–Ω–æ–≥–æ –±–ª–∞–≥–æ–ø–æ–ª—É—á–∏—è - –Ω–∞—Ä—É—à–µ–Ω–∏–µ –∫–æ–º–º—É–Ω–∏–∫–∞—Ü–∏–∏ –º–æ–∂–Ω–æ —Ä–∞—Å—Å–º–∞—Ç—Ä–∏–≤–∞—Ç—å –∫–∞–∫ —Ñ–∞–∫—Ç–æ—Ä —Ä–∏—Å–∫–∞ —Å–æ—Ü–∏–∞–ª—å–Ω—ã—Ö –ø—Ä–æ–±–ª–µ–º (–ø—Å–∏—Ö–∏–∫–∞, —ç–º–æ—Ü–∏–∏ –∏ –Ω–∞—Å–∏–ª–∏–µ —Å —Ñ–∏–Ω–∞–Ω—Å–∞–º–∏). –ë–µ–∑ —Ä–∞–±–æ—Ç—ã –Ω–µ–¥–æ–≤–µ—Ä–∏–µ –∏ –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç—å –≤ —Ä–∞–±–æ—Ç–µ —Å–æ —Å—Ç—Ä–∞—Ö–∞–º–∏ –ø—Ä–∏–≤–µ–¥—É—Ç —Ä–æ–¥–∏—Ç–µ–ª–µ–π –∫ –∑–Ω–∞–∫–æ–º—ã–º, –∑–Ω–∞—Ö–∞—Ä–∫–∞–º –∏ –∞–Ω—Ç–∏–≤–∞–∫—Å–µ—Ä–∞–º. –ì–ª–∞–≤–Ω–æ–µ —Å–º–µ—â–µ–Ω–∏–µ: –≤—ã—Å–æ–∫–∞—è –¥–æ–ª—è –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ (27,8%), –ø—Ä–∏–Ω—è–≤—à–∏—Ö —É—á–∞—Å—Ç–∏–µ –≤ –æ–ø—Ä–æ—Å–µ. –ò—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª–∏ –æ—Ç–º–µ—á–∞—é—Ç, —á—Ç–æ –≤ –≤—ã–±–æ—Ä–∫–µ –ø—Ä–µ–æ–±–ª–∞–¥–∞–ª–∏ –ø—Ä–æ–≤–∞–∫—Ü–∏–Ω–∞–ª—å–Ω—ã–µ –Ω–∞—Å—Ç—Ä–æ–µ–Ω–∏—è. –ò—Å—Ç–æ—á–Ω–∏–∫: Vaccines 2025, https://doi.org/10.3390/vaccines13111127 üëç - —Å–ø–∞—Å–∏–±–æ, –ø–æ–ª–µ–∑–Ω–æ ‚ù§Ô∏è - –Ω–∞–¥–æ –Ω–∞–ø–∏—Å–∞—Ç—å –µ—â—ë –æ–¥–∏–Ω —Ç–µ–∫—Å—Ç –ø–æ —ç—Ç–æ–º—É –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—é","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial, safety, guideline"",
  ""impact"": ""high"",
  ""english"": ""American researchers conducted a study to understand the antivaccination movement. They surveyed 1046 parents (parents of 1701 children) using an anonymous online questionnaire PACV, which assessed attitudes towards vaccination safety and effectiveness. The results show that 85% of participants have a positive attitude towards vaccines, while 15% are negative. The study highlights the role of parents in making healthcare decisions and emphasizes the importance of trust in doctors for effective communication. Key factors influencing vaccine acceptance include employment, medical staff presence, and proximity to the city.""
}"
2025-11-07T13:12:15+00:00,@pharm_icon,2441,https://t.me/pharm_icon/2441,"–ú–µ–ª–∞—Ç–æ–Ω–∏–Ω —Å–≤—è–∑–∞–Ω —Å —Ä–æ—Å—Ç–æ–º —Å–º–µ—Ä—Ç–µ–ª—å–Ω—ã—Ö —Å–ª—É—á–∞–µ–≤. –ê —á—Ç–æ –≤ –≤—ã–≤–æ–¥–µ? –ù—É–∂–Ω–æ –±–æ–ª—å—à–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π. –ï—Å–ª–∏ –±—ã –≤—Ä–∞—á–∏ –∏—Å—Å–ª–µ–¥–æ–≤–∞–ª–∏ –∞–≤—Ç–æ–º–∞—Ç–∏—á–µ—Å–∫–æ–µ –æ—Ä—É–∂–∏–µ, —Ç–æ –ø–æ—Å–ª–µ —Å—Ç—Ä–µ–ª—å–±–∏—â–∞ –≤ –Ω–∞—É—á–Ω–æ–π —Å—Ç–∞—Ç—å–µ –±—ã –Ω–∞–ø–∏—Å–∞–ª–∏ ""–ê–ö-47 –æ–ø–∞—Å–Ω–µ–µ –ø–ª–∞—Ü–µ–±–æ, –Ω–æ –Ω—É–∂–Ω–æ –±–æ–ª—å—à–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π, —á—Ç–æ–±—ã —Å–∫–∞–∑–∞—Ç—å –Ω–∞–≤–µ—Ä–Ω—è–∫–∞"" https://www.google.com/amp/s/nplus1.ru/news/2025/11/05/melatonin-caution/amp","{""skip"": true}"
2025-11-07T10:59:58+00:00,@pharm_icon,2440,https://t.me/pharm_icon/2440,"üí≥ –≠–∫–≤–∞–π—Ä–∏–Ω–≥ –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—ã —Å –≤—ã–≥–æ–¥–æ–π –ú–Ω–æ–≥–∏–µ –∫–ª–∏–Ω–∏–∫–∏ –≤—Å–µ –µ—â–µ –ø–µ—Ä–µ–ø–ª–∞—á–∏–≤–∞—é—Ç –∑–∞ —ç–∫–≤–∞–π—Ä–∏–Ω–≥! –ê –≤—ã –º–æ–∂–µ—Ç–µ —Å—ç–∫–æ–Ω–æ–º–∏—Ç—å –∏ –ø–ª–∞—Ç–∏—Ç—å –≤—Å–µ–≥–æ 0,99% ‚Äì –±–ª–∞–≥–æ–¥–∞—Ä—è —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ–º—É —Ç–∞—Ä–∏—Ñ—É –î–µ–ª–æ–±–∞–Ω–∫–∞ –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —É—á—Ä–µ–∂–¥–µ–Ω–∏–π. –≠–∫–≤–∞–π—Ä–∏–Ω–≥ –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—ã –æ—Ç –î–µ–ª–æ–±–∞–Ω–∫–∞: üìç –ö–æ–º–∏—Å—Å–∏—è –ø–æ —ç–∫–≤–∞–π—Ä–∏–Ω–≥—É ‚Äî 0,99%, –¥–µ–Ω—å–≥–∏ –Ω–∞ —Å—á–µ—Ç–µ —á–µ—Ä–µ–∑ 15 –º–∏–Ω—É—Ç üìç –ë–µ—Å–ø–ª–∞—Ç–Ω–æ–µ –ø–æ–¥–∫–ª—é—á–µ–Ω–∏–µ –∏ –∞—Ä–µ–Ω–¥–∞ —Ç–µ—Ä–º–∏–Ω–∞–ª–∞ üìç –ö–æ–º–∏—Å—Å–∏—è –ø–æ –°–ë–ü ‚Äî 0,4% –ø—Ä–∏ –ª—é–±–æ–º —Å—Ü–µ–Ω–∞—Ä–∏–∏ –æ–ø–ª–∞—Ç—ã, –¥–µ–Ω—å–≥–∏ –∑–∞—á–∏—Å–ª—è—é—Ç—Å—è –º–≥–Ω–æ–≤–µ–Ω–Ω–æ üìç –ü—Ä–∏–µ–º –ø–ª–∞—Ç–µ–∂–µ–π –Ω–∞ –≤–∞—à–µ–º —Å–∞–π—Ç–µ –∏ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –æ—Ç–ø—Ä–∞–≤–∫–∏ –ø–ª–∞—Ç–µ–∂–Ω–æ–π —Å—Å—ã–ª–∫–∏ –í—ã —ç–∫–æ–Ω–æ–º–∏—Ç–µ —É–∂–µ —Å –ø–µ—Ä–≤–æ–π –æ–ø–ª–∞—Ç—ã –ø–∞—Ü–∏–µ–Ω—Ç–∞ ‚Äî –∏ –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç–µ —ç–∫–æ–Ω–æ–º–∏—Ç—å –∫–∞–∂–¥—ã–π –¥–µ–Ω—å. –ü–æ–¥–∫–ª—é—á–∞–π—Ç–µ —ç–∫–≤–∞–π—Ä–∏–Ω–≥ –æ—Ç –î–µ–ª–æ–±–∞–Ω–∫–∞ –ø—Ä—è–º–æ —Å–µ–π—á–∞—Å: https://EixEps.short.gy/al1JpS","{""skip"": true}"
2025-11-07T10:08:02+00:00,@pharm_icon,2439,https://t.me/pharm_icon/2439,"–ö–æ–Ω—Ñ—É–∑ —Å Novo Nordisk: –¢—Ä–∞–º–ø –ø–æ–∑–∏—Ä—É–µ—Ç –≤ –û–≤–∞–ª—å–Ω–æ–º –∫–∞–±–∏–Ω–µ—Ç–µ, –≤ —Ç–æ –≤—Ä–µ–º—è –∫–∞–∫ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å ¬´–û–∑–µ–º–ø–∏–∫–∞¬ª –ª–µ–∂–∏—Ç –≤ –æ–±–º–æ—Ä–æ–∫–µ –≤–≤–µ—Ä—Ö –Ω–æ–≥–∞–º–∏. –¢—Ä–∞–≥–∏–∫–æ–º–µ–¥–∏—è –≤ –æ–≤–∞–ª—å–Ω–æ–º –∫–∞–±–∏–Ω–µ—Ç–µ –¢–æ–ø-–º–µ–Ω–µ–¥–∂–µ—Ä Novo Nordisk –ì–æ—Ä–¥–æ–Ω –§–∏–Ω–¥–ª–∏ –æ–±–Ω–∞—Ä—É–∂–µ–Ω –≤ –ø–æ–∑–µ —Ä–∞–∫ —Å–ø–∏–Ω–µ ‚Äî –≤–∞–ª—è–µ—Ç—Å—è –≤–≤–µ—Ä—Ö –Ω–æ–≥–∞–º–∏ ‚Äî –≤ –ë–µ–ª–æ–º –¥–æ–º–µ. –ï–º—É —Ä–µ–∑–∫–æ —Å—Ç–∞–ª–æ –ø–ª–æ—Ö–æ –≤–æ –≤—Ä–µ–º—è –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏—è —Å –¢—Ä–∞–º–ø–æ–º –≤ –û–≤–∞–ª—å–Ω–æ–º –∫–∞–±–∏–Ω–µ—Ç–µ. Novo –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç –û–∑–µ–º–ø–∏–∫, –†–µ–±–µ–ª—Å–∞—Å –∏ –í–µ–≥–æ–≤–∏, –∫–∞–∫ –≤—ã –∑–Ω–∞–µ—Ç–µ, –∏ –≤—Å–µ –∞–º–µ—Ä–∏–∫–∞–Ω—Ü—ã –Ω–∞ –Ω—ë–º —Å–∏–¥—è—Ç. –ü—Ä–µ—Å—Å-—Å–µ–∫—Ä–µ—Ç–∞—Ä—å –ë–µ–ª–æ–≥–æ –¥–æ–º–∞ –∑–∞—è–≤–∏–ª–∞, —á—Ç–æ —Å–µ–π—á–∞—Å —Å –§–∏–Ω–¥–ª–∏ ¬´–≤—Å—ë –≤ –ø–æ—Ä—è–¥–∫–µ¬ª, –æ–¥–Ω–∞–∫–æ –≤–º–µ—Å—Ç–µ —Å –Ω–∏–º —É–ø–∞–ª–∏ –∏ –∞–∫—Ü–∏–∏ –∫–æ–º–ø–∞–Ω–∏–∏. –ó–¥–æ—Ä–æ–≤—å—è –∏ –ø—Ä–æ–¥–æ–ª–∂–µ–Ω–∏—è –∫–∞—Ä—å–µ—Ä—ã!","{""skip"": true}"
2025-11-07T05:36:58+00:00,@pharm_icon,2438,https://t.me/pharm_icon/2438,"–ì–ª–∏–ø—Ç–∏–Ω—ã vs –ì–ª—É—Ç–∏–¥—ã: 1:0 –≤ –ø–æ–ª—å–∑—É –≥–ª–∏–ø—Ç–∏–Ω–æ–≤ –¥–ª—è –¥–µ–º–µ–Ω—Ü–∏–∏. –ö–æ–º–∞–Ω–¥–∞ –≥–ª–∏–ø—Ç–∏–Ω–æ–≤ (–∏–Ω–≥–∏–±–∏—Ç–æ—Ä—ã –î–ü–ü-4): –°–∏—Ç–∞–≥–ª–∏–ø—Ç–∏–Ω, –í–∏–ª–¥–∞–≥–ª–∏–ø—Ç–∏–Ω, –°–∞–∫—Å–∞–≥–ª–∏–ø—Ç–∏–Ω, –õ–∏–Ω–∞–≥–ª–∏–ø—Ç–∏–Ω, –ê–ª–æ–≥–ª–∏–ø—Ç–∏–Ω –ö–æ–º–∞–Ω–¥–∞ –≥–ª—É—Ç–∏–¥–æ–≤ (–∞–≥–æ–Ω–∏—Å—Ç—ã –ì–ü–ü-1): –°–µ–º–∞–≥–ª—É—Ç–∏–¥, –õ–∏—Ä–∞–≥–ª—É—Ç–∏–¥, –î—É–ª–∞–≥–ª—É—Ç–∏–¥ –≠–∫—Å–µ–Ω–∞—Ç–∏–¥ –ò–Ω–≥–∏–±–∏—Ç–æ—Ä—ã –î–ü–ü-4 –∏ –¥–µ–º–µ–Ω—Ü–∏—è: –£ 275 144 –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –Ω–∞—á–∞–≤—à–∏—Ö –ø—Ä–∏–Ω–∏–º–∞—Ç—å –∏–Ω–≥–∏–±–∏—Ç–æ—Ä—ã –î–ü–ü-4 –∏–ª–∏ —Å—É–ª—å—Ñ–æ–Ω–∏–ª–º–æ—á–µ–≤–∏–Ω—ã, –Ω–∞–±–ª—é–¥–∞–≤—à–∏—Ö—Å—è –≤ —Ç–µ—á–µ–Ω–∏–µ 750 846 —á–µ–ª–æ–≤–µ–∫–æ-–ª–µ—Ç, –∏–Ω–≥–∏–±–∏—Ç–æ—Ä—ã –î–ü–ü-4 –∞—Å—Å–æ—Ü–∏–∏—Ä–æ–≤–∞–ª–∏—Å—å —Å–æ —Å–Ω–∏–∂–µ–Ω–∏–µ–º —Ä–∏—Å–∫–∞ —Ä–∞–∑–≤–∏—Ç–∏—è –¥–µ–º–µ–Ω—Ü–∏–∏ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å —Å—É–ª—å—Ñ–æ–Ω–∏–ª–º–æ—á–µ–≤–∏–Ω–æ–π (4,4 –ø—Ä–æ—Ç–∏–≤ 5,7 —Å–æ–±—ã—Ç–∏–π –Ω–∞ 1000 —á–µ–ª–æ–≤–µ–∫–æ-–ª–µ—Ç; –û–† 0,77, 95% –î–ò 0,71‚Äì0,85). –ê–≥–æ–Ω–∏—Å—Ç—ã –ì–ü–ü-1 –∏ –¥–µ–º–µ–Ω—Ü–∏—è: –£ 181 215 –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –Ω–∞—á–∞–≤—à–∏—Ö –ø—Ä–∏–Ω–∏–º–∞—Ç—å –∞–Ω—Ç–∞–≥–æ–Ω–∏—Å—Ç—ã –ì–ü–ü-1 –∏–ª–∏ –ø—Ä–æ–∏–∑–≤–æ–¥–Ω—ã–µ —Å—É–ª—å—Ñ–æ–Ω–∏–ª–º–æ—á–µ–≤–∏–Ω—ã, –Ω–∞–±–ª—é–¥–∞–≤—à–∏—Ö—Å—è –≤ —Ç–µ—á–µ–Ω–∏–µ 530 415 —á–µ–ª–æ–≤–µ–∫–æ-–ª–µ—Ç, –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ –∞–Ω—Ç–∞–≥–æ–Ω–∏—Å—Ç–æ–≤ –ì–ü–ü-1 –±—ã–ª–æ —Å–≤—è–∑–∞–Ω–æ —Å –∞–Ω–∞–ª–æ–≥–∏—á–Ω—ã–º —Å–Ω–∏–∂–µ–Ω–∏–µ–º —Ä–∏—Å–∫–∞ –¥–µ–º–µ–Ω—Ü–∏–∏ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å —Å—É–ª—å—Ñ–æ–Ω–∏–ª–º–æ—á–µ–≤–∏–Ω–æ–π, —Ö–æ—Ç—è –∏ —Å –≤—ã—Å–æ–∫–æ–π —Å—Ç–µ–ø–µ–Ω—å—é –Ω–µ–æ–ø—Ä–µ–¥–µ–ª—ë–Ω–Ω–æ—Å—Ç–∏ (2,3 –ø—Ä–æ—Ç–∏–≤ 3,1 —Å–æ–±—ã—Ç–∏—è –Ω–∞ 1000 —á–µ–ª–æ–≤–µ–∫–æ-–ª–µ—Ç; –û–† 0,74, 95% –î–ò 0,46‚Äì1,18). –í—ã–≤–æ–¥ –≤–µ—Ä—Ö–Ω–µ–≥–æ —É—Ä–æ–≤–Ω—è –±–µ–∑ –æ—Ä–∏–≥–∏–Ω–∞–ª–∞ –ø—É–±–ª–∏–∫–∞—Ü–∏–∏: —Å—Ç–∞—Ç–∏—Å—Ç–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º–æ–π —Ä–∞–∑–Ω–∏—Ü—ã –º–µ–∂–¥—É –∞–ì–ü–ü-1 –∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º–∏ —Å—É–ª—å—Ñ–æ–Ω–∏–ª–º–æ—á–µ–≤–∏–Ω—ã –Ω–µ—Ç. –ú–µ–∂–¥—É –∏–î–ü–ü-4 –∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º–∏ —Å—É–ª—å—Ñ–æ–Ω–∏–ª–º–æ—á–µ–≤–∏–Ω—ã —Ä–∞–∑–Ω–∏—Ü–∞ –µ—Å—Ç—å.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety"",
  ""impact"": ""high"",
  ""english"": ""A clinical trial comparing gliptins (DPPI-4 inhibitors) and glitazones (PP1 antagonists) for dementia found that gliptins were associated with a significant reduction in the risk of developing dementia compared to sulfonylureas (OR 0.77, 95% CI: 0.71‚Äì0.85). However, the difference between glitazones and sulfonylureas was not statistically significant. The study concluded that there is no statistically significant difference between glitazones and sulfonylureas, but a difference exists between gliptins and sulfonylureas.""
}"
2025-11-06T19:58:44+00:00,@pharm_icon,2437,https://t.me/pharm_icon/2437,"–û–ø–µ—Ä–∞—Ü–∏—è ¬´–ü—Ä–µ–µ–º–Ω–∏–∫¬ª. –≠–∫—Å—Ç—Ä–∞–∫—Ç –∫–∞–∫–∞–æ –∫–∞–∫ –ø—Ä–æ—Ç–∏–≤–æ–≤–æ—Å–ø–∞–ª–∏—Ç–µ–ª—å–Ω–∞—è –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∞ —É –ø–æ–∂–∏–ª—ã—Ö. –£—á–µ–Ω—ã–µ –ø—Ä–æ–≤–µ–ª–∏ –∏ –æ–ø—É–±–ª–∏–∫–æ–≤–∞–ª–∏ –≤ –∂—É—Ä–Ω–∞–ª–µ Age & Ageing –¥–≤–æ–π–Ω–æ–µ —Å–ª–µ–ø–æ–µ –ø–ª–∞—Ü–µ–±–æ-–∫–æ–Ω—Ç—Ä–æ–ª–∏—Ä—É–µ–º–æ–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–æ–≥–æ —ç—Ñ—Ñ–µ–∫—Ç–∞ –ø—Ä–∏–µ–º–∞ –∫–∞–∫–∞–æ –∏ –¥–æ–±–∞–≤–æ–∫ —É –ø–æ–∂–∏–ª—ã—Ö. –í—ã–¥–∞–≤–∞–µ–º—ã–π —É—á–∞—Å—Ç–Ω–∏–∫–∞–º —ç–∫—Å—Ç—Ä–∞–∫—Ç —Å–æ–¥–µ—Ä–∂–∞–ª 500 –º–≥ —Ñ–ª–∞–≤–æ–Ω–æ–∏–¥–æ–≤ –∫–∞–∫–∞–æ, –∏–∑ –∫–æ—Ç–æ—Ä—ã—Ö 80 –∑–∞–Ω–∏–º–∞–ª —ç–ø–∏–∫–∞—Ç–µ—Ö–∏–Ω. –£—á–∞—Å—Ç–≤–æ–≤–∞–ª–æ 598 —á–µ–ª–æ–≤–µ–∫, –∏–∑ –Ω–∏—Ö 298 –∂–µ–Ω—â–∏–Ω –∏ 300 –º—É–∂—á–∏–Ω –≤–æ–∑—Ä–∞—Å—Ç–æ–º –æ—Ç 60 –∏ 65 –ª–µ—Ç, —Å–æ–æ—Ç–≤–µ—Ç—Å–≤–µ–Ω–Ω–æ. –°—Ä–µ–¥–Ω–∏–π –≤–æ–∑—Ä–∞—Å—Ç - 70 ¬± 5,6 –ª–µ—Ç. –í—ã–±—Ä–∞–ª–∏ —Å–ª–µ–¥—É—é—â–∏–µ –º–∞—Ä–∫–µ—Ä—ã: ‚Ä¢ –≤—á-–°–†–ë (–°-—Ä–µ–∞–∫—Ç–∏–≤–Ω—ã–π –±–µ–ª–æ–∫ –≤—ã—Å–æ–∫–æ—á—É–≤—Å—Ç–≤–∏—Ç–µ–ª—å–Ω—ã–π); ‚Ä¢ –§–ù–û- Œ± (—Ñ–∞–∫—Ç–æ—Ä –Ω–µ–∫—Ä–æ–∑–∞ –æ–ø—É—Ö–æ–ª–∏ - –∞–ª—å—Ñ–∞); ‚Ä¢ –ò–õ-6 (–∏–Ω—Ç–µ—Ä–ª–µ–π–∫–∏–Ω-6); ‚Ä¢ –î–ª—è —Å—Ç–æ—Ä–æ–Ω–Ω–∏—Ö –Ω–∞–±–ª—é–¥–µ–Ω–∏–π –≤—ã–±—Ä–∞–ª–∏ –ò–õ-10 –∏ –ò–Ω—Ç–µ—Ä—Ñ–µ—Ä–æ–Ω-–≥–∞–º–º–∞. –ò–∑–º–µ—Ä–µ–Ω–∏—è –ø—Ä–æ–≤–æ–¥–∏–ª–∏—Å—å –≤ –Ω–∞—á–∞–ª–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è, —á–µ—Ä–µ–∑ –≥–æ–¥ –∏ –≤ –∫–æ–Ω—Ü–µ –≤—Ç–æ—Ä–æ–≥–æ –≥–æ–¥–∞. –ò—Ç–æ–≥–∏: ‚Ä¢ –°–Ω–∏–∂–µ–Ω–∏–µ –≤—á-–°–†–ë –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ –ø–ª–∞—Ü–µ–±–æ –Ω–∞ 8,4% (95 –î–ò: -14,1; -2,3%); ‚Ä¢ –†–æ—Å—Ç –∏–Ω—Ç–µ—Ä—Ñ–µ—Ä–æ–Ω–∞-–≥–∞–º–º–∞ –Ω–∞ 6,8% (1,5%: 12,2%); ‚Ä¢ –û—Å—Ç–∞–ª—å–Ω—ã–µ - –±–µ–∑ —Å—Ç–∞—Ç–∏—Å—Ç–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º—ã—Ö –∏–∑–º–µ–Ω–µ–Ω–∏–π. –°—Ç–∞—Ä—ã–µ –ë–ê–î—ã –∏ —Ç—è–∂–µ–ª–æ–≤–µ—Å—ã –¥–æ–ª–≥–æ–ª–µ—Ç–∏—è –¥–æ—Å—Ç–∞–ª–∏. –£ –æ–±—â–µ—Å—Ç–≤–∞ –µ—Å—Ç—å –∑–∞–ø—Ä–æ—Å –Ω–∞ —Å–≤–µ–∂–µ–µ –ª–∏—Ü–æ –¥–æ–ª–≥–æ–ª–µ—Ç–∏—è. –ö–æ—Ñ–µ, —Ü–∏–∫–æ—Ä–∏–π ‚Äî —É –Ω–∞—Å –æ—Ç–º–µ–Ω–∞.","{""skip"": true}"
2025-11-04T16:34:20+00:00,@pharm_icon,2435,https://t.me/pharm_icon/2435,"–ü–∞–¥–µ–Ω–∏–µ —Ä–µ–π—Ç–∏–Ω–≥–∞: —Ñ–∞—Ä–º–∞ –≤—ã–∑—ã–≤–∞–µ—Ç –Ω–µ–¥–æ–≤–µ—Ä–∏–µ —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –≤ –°–®–ê –∏ –í–µ–ª–∏–∫–æ–±—Ä–∏—Ç–∞–Ω–∏–∏ –í –ø–æ—Å–ª–µ–¥–Ω–µ–º –æ—Ç—á–µ—Ç–µ PatientView –≥–æ–≤–æ—Ä–∏—Ç—Å—è, —á—Ç–æ —Ç–æ–ª—å–∫–æ 52% –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö –≥—Ä—É–ø–ø –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –Ω–µ–≤—Ä–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–≥–æ –ø—Ä–æ—Ñ–∏–ª—è –æ—Ü–µ–Ω–∏–ª–∏ —Ä–µ–ø—É—Ç–∞—Ü–∏—é –æ—Ç—Ä–∞—Å–ª–∏ –∫–∞–∫ ¬´—Ö–æ—Ä–æ—à—É—é¬ª –∏–ª–∏ ¬´–æ—Ç–ª–∏—á–Ω—É—é¬ª, —á—Ç–æ –Ω–∏–∂–µ –ø—Ä–æ—à–ª–æ–≥–æ–¥–Ω–µ–≥–æ –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è –≤ 55% –∏ –ø–∏–∫–æ–≤–æ–≥–æ –∑–Ω–∞—á–µ–Ω–∏—è –≤ 61% –µ—â—ë –≥–æ–¥–æ–º —Ä–∞–Ω–µ–µ. –û—Å–Ω–æ–≤–Ω–∞—è –ø—Ä–æ–±–ª–µ–º–∞ ‚Äî –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ PatientView —Å—Ä–∞–≤–Ω–∏–ª –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –æ—Ü–µ–Ω–æ–∫ ¬´—Ö–æ—Ä–æ—à–æ¬ª –∏ ¬´–æ—Ç–ª–∏—á–Ω–æ¬ª –ø–æ 14 –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è–º –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –∑–∞ –ø–µ—Ä–∏–æ–¥ 2020-2025 –∏ –æ–±–Ω–∞—Ä—É–∂–∏–ª —Ä–æ—Å—Ç –ø–æ –≤—Å–µ–º –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è–º, –∫—Ä–æ–º–µ –æ–¥–Ω–æ–≥–æ: –¥–æ—Å—Ç—É–ø –∫ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º. –î–æ–ª—è –ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω—ã—Ö –æ—Ü–µ–Ω–æ–∫ —Å–Ω–∏–∑–∏–ª–∞—Å—å —Å 32% –¥–æ 29% —Å 2020 –≥–æ–¥–∞. –ù–∞–∏–±–æ–ª–µ–µ –Ω–µ–≥–∞—Ç–∏–≤–Ω–æ–µ –æ—Ç–Ω–æ—à–µ–Ω–∏–µ –∫ —Ü–µ–Ω–æ–≤–æ–π –ø–æ–ª–∏—Ç–∏–∫–µ –æ—Ç—Ä–∞—Å–ª–∏ –∏ –ø—Ä–æ–∑—Ä–∞—á–Ω–æ—Å—Ç–∏ —Ü–µ–Ω–æ–æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è ‚Äì 12% –∏ 19% –ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω—ã—Ö –æ—Ü–µ–Ω–æ–∫, —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ. –ê –≤—ã –¥–æ–≤–µ—Ä—è–µ—Ç–µ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–π —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –æ—Ç—Ä–∞—Å–ª–∏? üî• ‚Äî –∫–æ–Ω–µ—á–Ω–æ. –° –î–Ω—ë–º –ù–∞—Ä–æ–¥–Ω–æ–≥–æ –µ–¥–∏–Ω—Å—Ç–≤–∞! üòê ‚Äî –Ω–µ –¥–æ–≤–µ—Ä—è—é. –° –î–Ω—ë–º –ù–∞—Ä–æ–¥–Ω–æ–≥–æ –µ–¥–∏–Ω—Å—Ç–≤–∞!","{""skip"": true}"
2025-11-03T13:45:53+00:00,@pharm_icon,2434,https://t.me/pharm_icon/2434,"–¶–µ–Ω–∞ –Ω–æ–≥–æ—Ç–æ—á–∫–æ–≤: –æ–±–∑–æ—Ä –ø–æ–±–æ—á–Ω—ã—Ö —ç—Ñ—Ñ–µ–∫—Ç–æ–≤ –º–∞–Ω–∏–∫—é—Ä–∞üíÖ –û–±–∑–æ—Ä –ø–æ–±–æ—á–Ω—ã—Ö —ç—Ñ—Ñ–µ–∫—Ç–æ–≤ –≤–∫–ª—é—á–∞–µ—Ç –≤ —Å–µ–±—è 58 –º–∞—Ç–µ—Ä–∏–∞–ª–æ–≤ –∑–∞ –¥–µ—Å—è—Ç—å –ª–µ—Ç, –≤ –æ—Å–Ω–æ–≤–Ω–æ–º - –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Å–ª—É—á–∞–µ–≤. –ì–ª–∞–≤–Ω—ã–µ –≤–∏–Ω–æ–≤–Ω–∏–∫–∏: –∞–∫—Ä–∏–ª/–º–µ—Ç–∞–∫—Ä–∏–ª–∞—Ç, –∏–∑–æ—Ü–∏–∞–Ω–∞—Ç –∏ –∏—Ö –ø–æ–ª–∏–º–µ—Ä—ã –≤ —Å–æ—Å—Ç–∞–≤–µ —Å—Ç–æ–π–∫–∏—Ö –≥–µ–ª—å-–ª–∞–∫–æ–≤, –Ω–∞—Ä—É—à–µ–Ω–∏–µ –ø—Ä–æ—Ü–µ–¥—É—Ä—ã, –¥–æ–º–∞—à–Ω–∏–µ —É—Å–ª–æ–≤–∏—è –∏ –£–§-–ª–∞–º–ø—ã. –ê –µ—â–µ –≤–æ–ª—á–∞–Ω–∫–∞! –ê–≤—Ç–æ—Ä—ã –æ—Ç–¥–µ–ª—å–Ω–æ —Ä–∞–∑–æ–±—Ä–∞–ª–∏ –≥—Ä–µ—Ö–∏ –∞–∫—Ä–∏–ª–∞, –≥–µ–ª—å-–ª–∞–∫–æ–≤ –∏ —á–∞—Å—Ç–∏—á–Ω–æ - –ª–∞–º–ø. –ò—Ç–∞–∫, –∫–∞–∫–æ–≤–∞ —Ü–µ–Ω–∞ –∫—Ä–∞—Å–æ—Ç—ã? –ê–∫—Ä–∏–ª–∞—Ç—ã –∏ –≥–µ–ª–∏ –¥–∞—Ä—è—Ç: 1. –û—Å—Ç—Ä—ã–µ –∏ —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–∏–µ –∞–ª–ª–µ—Ä–≥–∏—á–µ—Å–∫–∏–µ —Ä–µ–∞–∫—Ü–∏–∏. 2. –ö–æ–Ω—Ç–∞–∫—Ç–Ω—ã–µ –¥–µ—Ä–º–∞—Ç–∏—Ç—ã –≤—Å–µ—Ö —Å–æ—Ä—Ç–æ–≤, –æ—Ç –æ—Å—Ç—Ä—ã—Ö –¥–æ –ø—Å–µ–≤–¥–æ-–ø—Å–æ—Ä–∏–∞—Ç–∏—á–µ—Å–∫–∏—Ö. 3. –û–Ω–∏—Ö–æ–º–∏–∫–æ–∑ ‚Äî –≥—Ä–∏–±–∫–æ–≤–æ–µ –ø–æ—Ä–∞–∂–µ–Ω–∏–µ –Ω–æ–≥—Ç–µ–π. 4. –î–∏—Å—Ç—Ä–æ—Ñ–∏—è –Ω–æ–≥—Ç—è —Å –æ–Ω–∏—Ö–æ–ª–∏–∑–∏—Å–æ–º ‚Äî –æ—Ç—Å–ª–æ–µ–Ω–∏–µ–º –Ω–æ–≥—Ç–µ–≤–æ–π –ø–ª–∞—Å—Ç–∏–Ω—ã –æ—Ç –Ω–æ–≥—Ç–µ–≤–æ–≥–æ –ª–æ–∂–∞, –ø—Ä–∏ –∫–æ—Ç–æ—Ä–æ–º –º–µ–∂–¥—É –Ω–∏–º–∏ –æ–±—Ä–∞–∑—É–µ—Ç—Å—è –ø–æ–ª–æ—Å—Ç—å (—á–∞—Å—Ç–æ –∑–∞–ø–æ–ª–Ω—è–µ—Ç—Å—è –≤–æ–∑–¥—É—Ö–æ–º, –≥—Ä—è–∑—å—é –∏–ª–∏ –º–∏–∫—Ä–æ–æ—Ä–≥–∞–Ω–∏–∑–º–∞–º–∏). 5. –ü–æ—Ä–∞–∂–µ–Ω–∏—è –Ω–æ–≥—Ç–µ–≤–æ–≥–æ –ª–æ–∂–∞ –∏ –∫–æ–∂–∏ –ø–∞–ª—å—Ü–µ–≤ (–≤ –æ—Å–Ω–æ–≤–Ω–æ–º ‚Äî —ç–∫–∑–µ–º–∞). –î–æ–º–∞—à–Ω–∏–µ —É—Å–ª–æ–≤–∏—è, –Ω–∞—Ä—É—à–µ–Ω–∏—è —Ç–µ—Ö–Ω–∏–∫–∏ –∏ –ø—Ä–æ—Å—Ç–æ —Ç—Ä–∞–≤–º–∞—Ç–∏—á–Ω—ã–µ –≤–∏–¥—ã –º–∞–Ω–∏–∫—é—Ä–∞: 1. –ü–∞–Ω–∞—Ä–∏—Ü–∏–π ‚Äî –≥–Ω–æ–π–Ω–æ–µ –≤–æ—Å–ø–∞–ª–µ–Ω–∏–µ —Ç–∫–∞–Ω–µ–π –ø–∞–ª—å—Ü–∞ —Ä—É–∫–∏. 2. –¢–µ—Ä–º–∏—á–µ—Å–∫–∏–µ –∏ —Ö–∏–º–∏—á–µ—Å–∫–∏–µ –æ–∂–æ–≥–∏ –æ—Ç –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏—è –ø–æ–ª–∏–º–µ—Ä–æ–≤ –∞–∫—Ä–∏–ª–∞ –ø–æ–ª–∏–º–µ—Ä–∏–∑–∞—Ü–∏–∏ –∏–ª–∏ –∫–æ–Ω—Ç–∞–∫—Ç–µ —Å –∫–ª–µ–µ–º –∏ —Ö–ª–æ–ø–∫–æ–≤–æ–π —Ç–∫–∞–Ω—å—é. 3. –û—Å—Ç—Ä—ã–π –¥–µ—Ä–º–∞—Ç–∏—Ç –ö —Ç—Ä–∞–≤–º–∞—Ç–∏—á–Ω—ã–º –≤–∏–¥–∞–º –º–∞–Ω–∏–∫—é—Ä–∞ –æ—Ç–Ω–æ—Å–∏—Ç—Å—è —à–µ–ª–ª–∞–∫, –¥–∏–ø –∏–ª–∏ –ø—É–¥—Ä–æ–≤—ã–π –∏ —Ä—É—Å—Å–∫–∏–π –º–∞–Ω–∏–∫—é—Ä. –†—É—Å—Å–∫–∏–π –º–∞–Ω–∏–∫—é—Ä ‚Äî —ç—Ç–æ –∑–∞–ø–∞–¥–Ω–æ–µ –Ω–∞–∑–≤–∞–Ω–∏–µ –¥–ª—è –ø—Ä–æ–¥–≤–∏–Ω—É—Ç–æ–π —Ç–µ—Ö–Ω–∏–∫–∏ –∞–ø–ø–∞—Ä–∞—Ç–Ω–æ–≥–æ –∏–ª–∏ –∫–æ–º–±–∏–Ω–∏—Ä–æ–≤–∞–Ω–Ω–æ–≥–æ –º–∞–Ω–∏–∫—é—Ä–∞, –ø–æ–ø—É–ª—è—Ä–Ω–æ–π –≤ –†–æ—Å—Å–∏–∏ –∏ –¥—Ä—É–≥–∏—Ö —Å—Ç—Ä–∞–Ω–∞—Ö –°–ù–ì. –£–ª—å—Ç—Ä–∞—Ñ–∏–æ–ª–µ—Ç - —Å–∞–º—ã–π –∏–Ω—Ç–µ—Ä–µ—Å–Ω—ã–π –∏ –±–µ—Å–ø–æ—â–∞–¥–Ω—ã–π —É—á–∞—Å—Ç–Ω–∏–∫ —Ö–∏—Ç-–ø–∞—Ä–∞–¥–∞. –ù–æ –æ –Ω—ë–º —á—É—Ç—å –ø–æ–∑–∂–µ. üíÖüèº ‚Äî –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–ª–∏","{""skip"": true}"
2025-11-01T15:20:01+00:00,@pharm_icon,2433,https://t.me/pharm_icon/2433,"–û–±—É—á–∞—è —Å—ã—Ç–æ—Å—Ç–∏: FDA –æ–¥–æ–±—Ä–∏–ª–æ –±–µ–∑—Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã–π –ø–æ–¥–∫–æ–∂–Ω—ã–π –º–æ–Ω–∏—Ç–æ—Ä —Å–∞—Ö–∞—Ä–∞ –∏ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏–µ –¥–ª—è –ø–æ—Ö—É–¥–µ–Ω–∏—è –í —á–µ–º –æ—Ç–ª–∏—á–∏–µ –æ—Ç, —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ, –≥–ª—é–∫–æ–º–µ—Ç—Ä–∞? –°–∏—Å—Ç–µ–º–∞ –Ω–µ–ø—Ä–µ—Ä—ã–≤–Ω–æ–≥–æ –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥–∞ –≥–ª—é–∫–æ–∑—ã (–°–ù–ú–ì) –æ–±—ã—á–Ω–æ –≤—ã–≥–ª—è–¥–∏—Ç –∫–∞–∫ –ø–ª–∞—Å—Ç—ã—Ä—å —Å –∏–≥–ª–æ–π-–¥–∞—á—Ç–∏–∫–æ–º –∏ –≤ –ø—Ä—è–º–æ–º —Ä–µ–∂–∏–º–µ —Å–ø–æ—Å–æ–±–Ω–∞ –æ–ø—Ä–µ–¥–µ–ª—è—Ç—å —É—Ä–æ–≤–µ–Ω—å –≥–ª—é–∫–æ–∑—ã –≤ –∫—Ä–æ–≤–∏. –ö–ª—é—á–µ–≤–∞—è –Ω–æ–≤–∏–Ω–∫–∞ (–∏ —Å–∞–º –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–π –ø—Ä–æ–¥—É–∫—Ç) –∫—Ä–æ–µ—Ç—Å—è –≤ —Ñ—É–Ω–∫—Ü–∏–∏ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏—è ‚Äî Signos ‚Äî –∞–Ω–∞–ª–∏–∑–∏—Ä—É—é—â–µ–º—É –¥–∞–Ω–Ω—ã–µ –æ –≥–ª—é–∫–æ–∑–µ –≤ –∫—Ä–æ–≤–∏ –∏ –æ–±—É—á–∞—è –ø–∞—Ü–∏–µ–Ω—Ç–∞ –∞–¥–µ–∫–≤–∞—Ç–Ω–æ–º—É –∞–Ω–∞–ª–∏–∑—É –∏ –ø—Ä–∏–Ω—è—Ç–∏—é —Ä–µ—à–µ–Ω–∏–π –Ω–∞ –∏—Ö –æ—Å–Ω–æ–≤–µ. –≠—Ç–æ –º–æ–∂–µ—Ç –±—ã—Ç—å —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏—è ""–ó–∞–∫—Ä–æ–π —Ö–æ–ª–æ–¥–∏–ª—å–Ω–∏–∫, 3 —É—Ç—Ä–∞ –°–∫–æ—Ä—Ä–µ–∫—Ç–∏—Ä—É–π—Ç–µ –æ–±—ä–µ–º —É–∂–∏–Ω–∞ –∏–ª–∏ –ø–æ—Ç–µ—Ä–ø–∏—Ç–µ –¥–æ —É—Ç—Ä–∞/ –ù–µ –µ—à—å —ç—Ç–æ—Ç –±–∞—Ç–æ–Ω—á–∏–∫/ –ë—ã–ª–æ –±—ã —Ö–æ—Ä–æ—à–æ –ø—Ä–æ–±–µ–∂–∞—Ç—å –ø–∞—Ä—É –∫–∏–ª–æ–º–µ—Ç—Ä–æ–≤"". –¶–µ–ª—å - –ø–æ–º–æ—á—å –ø–∞—Ü–∏–µ–Ω—Ç—É –ø–æ—Ö—É–¥–µ—Ç—å. –ü—Ä–∏–ª–æ–∂–µ–Ω–∏—è –∏ –°–ù–ú–ì —è–≤–ª—è–µ—Ç—Å—è –±–µ–∑—Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã–º, —Ç–æ –µ—Å—Ç—å –µ–≥–æ –º–æ–∂–Ω–æ –∫—É–ø–∏—Ç—å –≤ –∞–ø—Ç–µ–∫–µ/–∏–Ω—Ç–µ—Ä–Ω–µ—Ç–µ. –†–∞–Ω—å—à–µ —Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã–µ –ø—Ä–∏–ª–æ–∂–µ–Ω–∏—è –∫–∞–∑–∞–ª–∏—Å—å –∏—Ä–æ–Ω–∏–µ–π –≤—Ä–µ–º–µ–Ω–∏, –Ω–æ –≤—Ä–µ–º–µ–Ω–∞ –º–µ–Ω—è—é—Ç—Å—è. –ò–∑ –ø–ª—é—Å–æ–≤: –∏ –Ω–æ–≤–∏–Ω–∫–∏ –Ω—É–∂–Ω–æ –æ—Ç–º–µ—Ç–∏—Ç—å –û–¢–° —Å—Ç–∞—Ç—É—Å (–¥–æ–≤–æ–ª—å–Ω–æ –±–µ–∑–æ–ø–∞—Å–Ω–æ –≤ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–∏), –ò–ò (–∫—É–¥–∞ –∂–µ –±–µ–∑ –Ω–µ–≥–æ), –¥–µ—à–µ–≤–∏–∑–Ω—É (–Ω–∞–±–æ—Ä –Ω–∞ 6 –º–µ—Å—è—Ü–µ–≤ –¥–µ—à–µ–≤–ª–µ –º–µ—Å—è—Ü–∞ –û–∑–µ–º–ø–∏–∫–∞), –¥–æ–ª–≥–æ—Å—Ä–æ—á–Ω–æ–µ –≤–ª–∏—è–Ω–∏–µ –Ω–∞ –ø–æ–≤–µ–¥–µ–Ω–∏–µ, –∫–æ–Ω—Ç—Ä–æ–ª—å –∫–∞–ª–æ—Ä–∏–π, —Å–Ω–∞ –∏ —Å—Ç—Ä–µ—Å—Å–∞, —á—É–≤—Å—Ç–≤–æ –∞–±—Å–æ–ª—é—Ç–Ω–æ–π –ø–æ–±–µ–¥—ã –≤ –∫–æ–Ω—Ü–µ –ø—É—Ç–∏ (–æ—Å–∏–ª–∏–≤—à–∏–º), –ø—Ä–∏–º–µ–Ω–∏–º—ã–µ –Ω–∞ –ø—Ä–∞–∫—Ç–∏–∫–µ —Å–æ–≤–µ—Ç—ã, –ø–æ–Ω–∏–º–∞–Ω–∏–µ –¶–ê (–∑–∞–ø—Ä–µ—Ç –¥–ª—è –¥–∏–∞–±–µ—Ç–∏–∫–æ–≤ –Ω–∞ –∏–Ω—Å—É–ª–∏–Ω–µ, –†–ü–ü –∏ –ø—Ä–∏ —ç–ø–∏–∑–æ–¥–∞—Ö –≥–∏–ø–æ–≥–ª–∏–∫–µ–º–∏–∏). –ò–∑ –º–∏–Ω—É—Å–æ–≤: –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –ø–æ–ª–æ–º–∫–∏ –°–ù–ú–ì, –≥–æ—Ä–µ—á—å –ø–æ—Ä–∞–∂–µ–Ω–∏—è, –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç—å –æ—Ç –¥—Ä—É–≥–∏—Ö –¥–∞—Ç—á–∏–∫–æ–≤ (—á—Ç–æ –∂ —Ç—ã —Å–¥–µ–ª–∞–µ—à—å –±–µ–∑ –º–æ–±–∏–ª—ã –∏ —É–º–Ω—ã—Ö —á–∞—Å–æ–≤ –≤ XXI –≤–µ–∫–µ) –ù—É –∏ –∫–æ–Ω–µ—á–Ω–æ, –Ω–µ –æ–±–æ—à–ª–æ—Å—å –±–µ–∑ –æ–±—ä–µ–∫—Ç–∏–≤–∏–∑–∞—Ü–∏–∏ ‚Äî –Ω–∞ –ø–µ—Ä–≤–æ–º –∂–µ —ç–∫—Ä–∞–Ω–µ —Å–∞–π—Ç–∞ —Å–µ—Ä–≤–∏—Å–∞ —Ä–∞—Å–ø–æ–ª–∞–≥–∞–µ—Ç—Å—è –¥–µ–≤—É—à–∫–∞ –≤ –ø–æ–ª–æ–∂–µ–Ω–∏–∏, –∫–æ—Ç–æ—Ä–æ–µ –¥–æ–ª–∂–Ω–æ –≥–æ–≤–æ—Ä–∏—Ç—å –æ–± –æ–¥—ã—à–∫–µ, –Ω–æ –æ–¥—ã—à–∫–∏ —É –Ω–µ—ë –Ω–µ—Ç. –û—Å—É–∂–¥–∞—é –í–∏–¥–∏–º–æ, –æ–¥–æ–±—Ä–µ–Ω–∏–µ –ø—Ä–æ–∏–∑–æ—à–ª–æ –Ω–∞ –æ—Å–Ω–æ–≤–∞–Ω–∏–∏ –¥–∞–Ω–Ω—ã—Ö –Ω–µ–±–æ–ª—å—à–æ–≥–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è, —Ç–∞–∫ –∫–∞–∫ –±–æ–ª—å—à–æ–µ ‚Äî —Å —É—á–∞—Å—Ç–∏–µ–º 20 000 —á–µ–ª–æ–≤–µ–∫ ‚Äî –µ—â—ë –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç—Å—è.","{""skip"": true}"
2025-10-31T11:49:14+00:00,@pharm_icon,2432,https://t.me/pharm_icon/2432,"–£–ø—Ä–∞–≤–ª–µ–Ω–∏–µ –°–æ–±—Å—Ç–≤–µ–Ω–Ω–æ–π –ë–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ –∏–ª–∏ –ù–æ–±–µ–ª—å 2025 –ï—Å–ª–∏ —Å—Ä–∞–≤–Ω–∏—Ç—å –ø—Ä–æ—Ü–µ—Å—Å –ø–æ–∑–Ω–∞–Ω–∏—è –∏–º–º—É–Ω–∏—Ç–µ—Ç–∞ –∏ —Å—Ç–∞—Ç—å—é –æ —Ç–∞–∫ –Ω–∞–∑—ã–≤–∞–µ–º–æ–π ¬´–ù–æ–±–µ–ª–µ–≤—Å–∫–æ–π –º–∞—Ñ–∏–∏¬ª, —Ç–æ –Ω–∞ —Å–æ–≤—Ä–µ–º–µ–Ω–Ω–æ–º –∂–∞—Ä–≥–æ–Ω–µ –∏–º–º—É–Ω–æ–ª–æ–≥–∏—è –≤ —Ä–∞–º–∫–∞—Ö –ù–æ–±–µ–ª–µ–≤—Å–∫–æ–π –ø—Ä–µ–º–∏–∏ –∏–º–µ–Ω–æ–≤–∞–ª–∞—Å—å –±—ã ¬´—Ç–µ–º–∫–æ–π¬ª, –æ–Ω–∞ –∂–µ ¬´–∑–ª–∞—á–Ω–æ–µ –º–µ—Å—Ç–æ¬ª –∏ ¬´–∫–æ—Ä–º—É—à–∫–∞¬ª. –í –ø—Ä–æ—Ü–µ—Å—Å–µ –ø–æ–Ω–∏–º–∞–Ω–∏—è –ø—Ä–∏–Ω—Ü–∏–ø–æ–≤ —Ä–∞–±–æ—Ç—ã –∏–º–º—É–Ω–Ω–æ–π —Å–∏—Å—Ç–µ–º—ã –∏, –≤ —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, —Ç–∏–º—É—Å–∞ —É—á–µ–Ω—ã–µ —Å—Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–ª–∏ –ø–æ–Ω—è—Ç–∏–µ –æ–± –∏–º–º—É–Ω–Ω–æ–π —Ç–æ–ª–µ—Ä–∞–Ω—Ç–Ω–æ—Å—Ç–∏, –æ–¥–Ω–∞–∫–æ –≤ –Ω–µ–π –æ—Å—Ç–∞–≤–∞–ª–∏—Å—å –ø—Ä–æ–±–µ–ª—ã, –Ω–µ –¥–∞–≤–∞–≤—à–∏–µ –æ–±–æ—Å–Ω–æ–≤–∞–Ω–∏—è —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –ø–µ—Ä–µ–ª–∏–≤–∞–Ω–∏—è –ª–∏–º—Ñ–æ—Ü–∏—Ç–∞—Ä–Ω–æ–π –º–∞—Å—Å—ã –º—ã—à–∞–º —Å —É–¥–∞–ª–µ–Ω–Ω—ã–º —Ç–∏–º—É—Å–æ–º. –í —Ö–æ–¥–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π —É—á–µ–Ω—ã–µ –≤—ã—è–≤–∏–ª–∏ –≤–∞—Ä–∏–∞–±–µ–ª—å–Ω–æ—Å—Ç—å –∞–Ω—Ç–∏–≥–µ–Ω–æ–≤ –Ω–∞ –ø–æ–≤–µ—Ä—Ö–Ω–æ—Å—Ç–∏ –∫–ª–µ—Ç–æ–∫ –∏–º–º—É–Ω–Ω–æ–π —Å–∏—Å—Ç–µ–º—ã, —á–∞—Å—Ç—å –∏—Ö —Ñ—É–Ω–∫—Ü–∏–π –∏ —Å–ª—É—á–∞–π–Ω–æ –ø–æ–ª—É—á–∏–ª–∏ –º—ã—à–µ–π —Å –º—É—Ç–∞—Ü–∏–µ–π, –ø—Ä–∏–≤–æ–¥—è—â–µ–π –∫ –º–Ω–æ–∂–µ—Å—Ç–≤–µ–Ω–Ω–æ–º—É –∞—É—Ç–æ–∏–º–º—É–Ω–Ω–æ–º—É –ø–æ–≤—Ä–µ–∂–¥–µ–Ω–∏—é –æ—Ä–≥–∞–Ω–æ–≤. –≠—Ç–∏–º –≥–µ–Ω–æ–º –æ–∫–∞–∑–∞–ª—Å—è Foxp3, –æ—Ç–≤–µ—á–∞—é—â–∏–π –∑–∞ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏–µ T-reg –∫–ª–µ—Ç–æ–∫ –≤ –æ—Ä–≥–∞–Ω–∏–∑–º–µ (CD4+ CD25+ –¢-–ª–∏–º—Ñ–æ—Ü–∏—Ç–æ–≤), —Ä–µ–≥—É–ª–∏—Ä—É—é—â–∏—Ö —Ä–∞–±–æ—Ç—É –¥—Ä—É–≥–∏—Ö –∏–º–º—É–Ω–Ω—ã—Ö –∫–ª–µ—Ç–æ–∫ –∏ –ø—Ä–µ–¥–æ—Ç–≤—Ä–∞—â–∞—è –∏—Ö –∞—Ç–∞–∫—É –Ω–∞ —Å–æ–±—Å—Ç–≤–µ–Ω–Ω—ã–µ —Ç–∫–∞–Ω–∏. Treg –¥–µ–ª—è—Ç—Å—è –Ω–∞ –ø–µ—Ä–∏—Ñ–µ—Ä–∏—á–µ—Å–∫–∏–µ (—Å–æ–∑—Ä–µ–≤–∞—é—Ç –≤ –ø–µ—Ä–∏—Ñ–µ—Ä–∏—á–µ—Å–∫–∏—Ö —Ç–∫–∞–Ω—è—Ö –ø—Ä–∏ –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–Ω—ã—Ö —Å–æ—Å—Ç–æ—è–Ω–∏—è—Ö) –∏ —Ç–∏–º—É—Å-–ø—Ä–æ–∏–∑–≤–æ–¥–Ω—ã–µ (—Å–æ–∑—Ä–µ–≤–∞—é—Ç –≤ —Ç–∏–º—É—Å–µ). –§–æ—Ä–º–∏—Ä—É—é—Ç—Å—è –æ–Ω–∏ –≤ —Ç–æ–º —á–∏—Å–ª–µ –ø–æ–¥ –≤–ª–∏—è–Ω–∏–µ–º –∏–Ω—Ç–µ—Ä–ª–µ–π–∫–∏–Ω–∞-2. –ß–µ–≥–æ —Å—Ç–æ–∏—Ç –æ–∂–∏–¥–∞—Ç—å –æ—Ç —Ä–∞–±–æ—Ç—ã —Å –∫–æ–Ω–∫—Ä–µ—Ç–Ω—ã–º–∏ –≤–∏–¥–∞–º–∏ –∫–ª–µ—Ç–æ–∫ –∏ –≥–µ–Ω–æ–≤? 1) –ì–µ–Ω–Ω–∞—è —Ç–µ—Ä–∞–ø–∏—è —Å –≤–æ—Å—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ–º FOXP3 2) –ê—É—Ç–æ—Ç—Ä–∞–Ω—Å–ø–ª–∞–Ω—Ç–∞—Ü–∏–∏ –º–æ–¥–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –¥–æ Treg –ª–∏–º—Ñ–æ—Ü–∏—Ç–æ–≤ 3) –•–∏–º–µ—Ä–Ω—ã—Ö –¢reg –±–∏–æ–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è —Ç–∞—Ä–≥–µ—Ç–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –∞—Å—Ç–º—ã, –∞—Ç–æ–ø–∏–∏ –∏ –¥—Ä—É–≥–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π 4) –û–Ω–∫–æ—Ç–µ—Ä–∞–ø–∏—è –¥–ª—è –±–æ—Ä—å–±—ã —Å –∑–∞—â–∏—â–∞—é—â–∏–º–∏ –æ–ø—É—Ö–æ–ª—å Treg –∫–ª–µ—Ç–∫–∞–º–∏ 5) –ü—Ä–∏–º–µ–Ω–µ–Ω–∏—è –∏–Ω—Ç–µ—Ä–ª–µ–π–∫–∏–Ω–∞-2 –∏–ª–∏ –∞–≥–æ–Ω–∏—Å—Ç–æ–≤ –µ–≥–æ —Ä–µ—Ü–µ–ø—Ç–æ—Ä–æ–≤ –¥–ª—è —É—Å–∏–ª–µ–Ω–∏—è –ø–æ–ø—É–ª—è—Ü–∏–∏ –¢reg –∫–ª–µ—Ç–æ–∫ –æ—Ä–≥–∞–Ω–∏–∑–º–∞ –¢–∞–∫–∏–º –æ–±—Ä–∞–∑–æ–º, –Ω–æ–±–µ–ª–µ–≤—Å–∫–∞—è –ø—Ä–µ–º–∏—è –ø–æ –º–µ–¥–∏—Ü–∏–Ω–µ —Å–µ–π—á–∞—Å ‚Äî —ç—Ç–æ –ª–∏–±–æ –∞–≤–∞–Ω—Å –∑–∞ –¥–µ–Ω–µ–∂–Ω—ã–µ –æ—Ç–∫—Ä—ã—Ç–∏—è, –ª–∏–±–æ –ø–æ—Å—Ç–æ–ø–ª–∞—Ç–∞.","{""skip"": true}"
2025-10-31T05:46:09+00:00,@pharm_icon,2431,https://t.me/pharm_icon/2431,"D3–π—Å—Ç–≤—Ç–µ–ª—å–Ω–æ –ª–∏/–ê –ù–∞D–æ –ª–∏? –ú–æ–Ω–æ–ª–æ–≥ –æ –Ω–µ–æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –ø—Ä–∏–µ–º–∞ –≤–∏—Ç–∞–º–∏–Ω–∞ –î. –ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–π –∫–æ–ª–ª–µ–≥–∞ –ö–µ–Ω–Ω–µ—Ç –£. –õ–∏–Ω–Ω –ø–æ–∫—É—Å–∏–ª—Å—è –Ω–∞ —Å–≤—è—Ç–æ–µ - –æ—Ç–¥–µ–ª –ë–ê–î–æ–≤ —Å –î3 –≤ –∞–ø—Ç–µ–∫–µ. –ü–æ—Å—ã–ª –ø—Ä–æ—Å—Ç: –ø–æ–ª—å–∑–∞ —Å–æ–º–Ω–∏—Ç–µ–ª—å–Ω–∞, –∞ –≤–∏—Ç—Ä–∏–Ω—ã –î3 –≤ –∞–ø—Ç–µ–∫–∞—Ö –∑–∞–±–∏—Ä–∞—é—Ç –∫—É—á—É –º–µ—Å—Ç–∞ –∏ –¥–µ–Ω–µ–≥. –ê—Ä–≥—É–º–µ–Ω—Ç—ã –ø—Ä–æ—Ç–∏–≤ –ø–æ–ª—å–∑—ã —Å–ª–µ–ø–æ–≥–æ –ø—Ä–∏–µ–º–∞ –¥–æ–±–∞–≤–æ–∫: 1. –û—Ç—Å—É—Ç—Å—Ç–≤–∏–µ —è–≤–Ω–æ–π –ø–æ–ª—å–∑—ã –æ—Ç —Ä—É—Ç–∏–Ω–Ω–æ–≥–æ –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥–∞ –î3 —É –≤–Ω–µ—à–Ω–µ –∑–¥–æ—Ä–æ–≤—ã—Ö 2. –®–∏—Ä–æ–∫–æ –∫—Ä–∏—Ç–∏–∫—É–µ–º—ã–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–≥–æ –æ–±—â–µ—Å—Ç–≤–∞ —ç–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–∏–∏ –ø–æ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–æ–º—É –ø—Ä–∏–µ–º—É –î3, –ø—Ä–æ—Ç–∏–≤–æ—Ä–µ—á–∞—â–∏–µ –¥—Ä—É–≥–∏–º —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏—è–º 3. –ö—É—á–∞ –≤–∞—Ä–∏–∞–Ω—Ç–æ–≤ –¥–∏–∑–∞–π–Ω–∞ —Å–æ—Å—Ç–∞–≤–ª–µ–Ω–∏—è —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π –∏ –ö–ò –†–∞—Å—Å—É–∂–¥–∞—è –æ–±–æ –≤—Å–µ–º —ç—Ç–æ–º, –¥–æ–∫—Ç–æ—Ä –ø—Ä–æ—Å—Ç–æ –Ω–µ –≤–∏–¥–∏—Ç —Å–º—ã—Å–ª–∞ –ø—Ä–∏—Å–æ–µ–¥–∏–Ω—è—Ç—å—Å—è –∫ —Ö–æ–ª–∏–≤–∞—Ä—É –æ —Ü–µ–ª–µ—Å–æ–æ–±—Ä–∞–∑–Ω–æ—Å—Ç–∏ –ø—Ä–∏–µ–º–∞ –î3 –ø—Ä–æ—Ç–∏–≤ —Ç–æ–ª–ø—ã —Å–º–µ—Ç–∞—Ç–µ–ª–µ–π –∞–ø—Ç–µ—á–Ω—ã—Ö –ø–æ–ª–æ–∫. –ü—Ä–∏–º–µ—á–∞–Ω–∏–µ: –í –∫–æ–Ω—Ü–µ –∫–æ–Ω—Ü–æ–≤, –ø–æ—á—Ç–∏ –≤—Å–µ –º–æ–ª–æ–∫–æ –≤ –®—Ç–∞—Ç–∞—Ö ¬´—É–∫—Ä–µ–ø–ª–µ–Ω–æ¬ª –î3, –∫–∞–∫ –Ω–∞—à–∞ —Å–æ–ª—å ‚Äî –π–æ–¥–æ–º. –ù–∞–ø–∏—à–∏—Ç–µ –≤ –∫–æ–º–º–µ–Ω—Ç–∞—Ä–∏—è—Ö, –∫—Ç–æ –∑–∞ –≤–∏—Ç–∞–º–∏–Ω –î, –∞ –∫—Ç–æ ‚Äî –ø—Ä–æ—Ç–∏–≤.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety, guideline"",
  ""impact"": ""medium"",
  ""english"": ""The American colleague Kenneth U. Lin questioned the sanctity - the pharmacy department with D3 in pharmacies. His argument: The benefit is questionable, and D3 counterspace in pharmacies take up a lot of space and money. Arguments against the benefit of routine supplementation: 1. Lack of clear benefits from regular monitoring D3 in outwardly healthy individuals, 2. Widely criticized preventive recommendations for D3 by the American Society of Endocrinology contradict other recommendations, 3. A lot of design options for recommendation designs and guidelines. The doctor simply sees no point in joining the debate on the rationality of D3 supplementation against a crowd of space claimers. Note: Almost all milk in the USA is 'fortified' with D3, like our iodine - salt. Comment on who supports vitamin D and who opposes.""
}"
2025-10-30T16:38:00+00:00,@pharm_icon,2430,https://t.me/pharm_icon/2430,"–û–∑–µ–º–ø–∏–∫–∏ –ø–µ—Ä–µ–≥—Ä—É–∑–∏–ª–∏ –ø–µ—Ä–≤–∏—á–Ω–æ–µ –∑–≤–µ–Ω–æ –°–®–ê –í –æ–ø—Ä–æ—Å–µ –ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ (AMA) –∑–∞ 2024 –≥–æ–¥ –≤—Ä–∞—á–∏ —Å–æ–æ–±—â–∏–ª–∏, —á—Ç–æ –≤ —Å—Ä–µ–¥–Ω–µ–º –æ—Ñ–æ—Ä–º–ª—è—é—Ç 39 –ø—Ä–µ–¥–≤–∞—Ä–∏—Ç–µ–ª—å–Ω—ã—Ö —Ä–∞–∑—Ä–µ—à–µ–Ω–∏–π –Ω–∞ GLP-1 –∞–≥–æ–Ω–∏—Å—Ç—ã –≤ –Ω–µ–¥–µ–ª—é –∏ —Ç—Ä–∞—Ç—è—Ç –Ω–∞ —Å–æ–ø—É—Ç—Å—Ç–≤—É—é—â–∏–µ –∑–∞–¥–∞—á–∏ –æ–∫–æ–ª–æ 13 —á–∞—Å–æ–≤. –ü–æ—á—Ç–∏ 93% –∑–∞—è–≤–∏–ª–∏, —á—Ç–æ —ç—Ç–∏ –∑–∞–¥–µ—Ä–∂–∫–∏ –≤–ª–∏—è—é—Ç –Ω–∞ –∫–∞—á–µ—Å—Ç–≤–æ —É—Ö–æ–¥–∞ –∑–∞ –ø–∞—Ü–∏–µ–Ω—Ç–∞–º–∏, –∞ 89% —Å–≤—è–∑—ã–≤–∞—é—Ç –∏—Ö —Å –≤—ã–≥–æ—Ä–∞–Ω–∏–µ–º. –î–ª—è –≤—Ä–∞—á–µ–π –æ–±—â–µ–π –ø—Ä–∞–∫—Ç–∏–∫–∏ —ç—Ç–æ—Ç –ø—Ä–æ—Ü–µ—Å—Å –º–æ–∂–µ—Ç –±—ã—Ç—å –æ—Å–æ–±–µ–Ω–Ω–æ –±–æ–ª–µ–∑–Ω–µ–Ω–Ω—ã–º, –∫–æ–≥–¥–∞ —Ä–µ—á—å –∏–¥—ë—Ç –æ –Ω–æ–≤—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞—Ö –¥–ª—è –∫–æ—Ä—Ä–µ–∫—Ü–∏–∏ –≤–µ—Å–∞. ¬´–í—Ä–∞—á–∏ –æ–±—â–µ–π –ø—Ä–∞–∫—Ç–∏–∫–∏ –≤ –Ω–∞—à–µ–º —É—á—Ä–µ–∂–¥–µ–Ω–∏–∏ –≥–æ–≤–æ—Ä—è—Ç –Ω–∞–º, —á—Ç–æ —É –Ω–∏—Ö –ø—Ä–æ—Å—Ç–æ –Ω–µ—Ç —Ä–µ—Å—É—Ä—Å–æ–≤¬ª, ‚Äî –≥–æ–≤–æ—Ä–∏—Ç –¢–∞—Ä–∞–Ω–µ –°–æ–ª–µ–π–º–∞–Ω–∏, –¥–æ–∫—Ç–æ—Ä –º–µ–¥–∏—Ü–∏–Ω—ã, —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç –ø–æ –ª–µ—á–µ–Ω–∏—é –æ–∂–∏—Ä–µ–Ω–∏—è –≤ Penn State Health Medical Group, –ú–∏–¥–ª—Ç–∞—É–Ω, –ü–µ–Ω—Å–∏–ª—å–≤–∞–Ω–∏—è. ‚Äî ¬´–ò—Ö –∫–ª–∏–Ω–∏–∫–∏ –∏ —Ç–∞–∫ –ø–µ—Ä–µ–≥—Ä—É–∂–µ–Ω—ã, –∞ –ø—Ä–æ—Ü–µ–¥—É—Ä–∞ –ø–æ–ª—É—á–µ–Ω–∏—è –ø—Ä–µ–¥–≤–∞—Ä–∏—Ç–µ–ª—å–Ω–æ–≥–æ —Ä–∞–∑—Ä–µ—à–µ–Ω–∏—è –Ω–∞ GLP-1 –º–æ–∂–µ—Ç –±—ã—Ç—å —á—Ä–µ–∑–≤—ã—á–∞–π–Ω–æ —Å–ª–æ–∂–Ω–æ–π. –í –∏—Ç–æ–≥–µ –æ–Ω–∏ –Ω–∞–ø—Ä–∞–≤–ª—è—é—Ç –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –∫ –Ω–∞–º, –ø–æ—Ç–æ–º—É —á—Ç–æ —ç—Ç–æ –ø—Ä–æ—Å—Ç–æ —Å–ª–∏—à–∫–æ–º –±–æ–ª—å—à–∞—è –Ω–∞–≥—Ä—É–∑–∫–∞, –ø–æ–º–∏–º–æ –≤—Å–µ–≥–æ –ø—Ä–æ—á–µ–≥–æ¬ª. –°–∞–º–æ–µ —Å–º–µ—à–Ω–æ–µ, —á—Ç–æ –≤ —ç—Ç–æ–π –ø–ª–∞–∫—Å–∏–≤–æ–π —Å—Ç–∞—Ç—å–µ –Ω–∞ –º–µ–¥–∫—Å–∫–µ—É–ø –æ–±–Ω–∞—Ä—É–∂–∏–ª–∏—Å—å ""–û–ø—Ç–∏–º–∏–∑–∞—Ç–æ—Ä—ã –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è"". –†–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –û–ø—Ç–∏–º–∏–∑–∞—Ç–æ—Ä–æ–≤ 1. ""–í–æ-–ø–µ—Ä–≤—ã—Ö, –≤—ã–¥–µ–ª–∏—Ç–µ –æ—Ç–¥–µ–ª—å–Ω—ã–π –≤–∏–∑–∏—Ç —Ç–æ–ª—å–∫–æ –¥–ª—è –æ—Ü–µ–Ω–∫–∏ —Å—Ç–µ–ø–µ–Ω–∏ –æ–∂–∏—Ä–µ–Ω–∏—è –∏ –æ–±—Å—É–∂–¥–µ–Ω–∏—è –ª–µ—á–µ–Ω–∏—è ‚Äî —ç—Ç–æ –≤—Ä–µ–º—è, —É–¥–µ–ª—ë–Ω–Ω–æ–µ —ç—Ç–æ–º—É, –¥–µ–ª–∞–µ—Ç –≤—Å—ë –±–æ–ª–µ–µ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã–º"". –ö–∞–∫ –¥—É–º–∞–µ—Ç–µ, —Å–∫–æ–ª—å–∫–æ –Ω–∞ —ç—Ç–æ —É–π–¥—ë—Ç –≤—Ä–µ–º–µ–Ω–∏? 2. ""–ü–æ–ø—Ä–æ—Å–∏—Ç–µ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –ø–µ—Ä–µ–¥ –ø—Ä–∏—ë–º–æ–º –ø—Ä–æ–≤–µ—Ä–∏—Ç—å –∏—Ö —Å—Ç—Ä–∞—Ö–æ–≤–æ–π –ø–ª–∞–Ω, —á—Ç–æ–±—ã –≤—ã –∑–Ω–∞–ª–∏, –ø–æ–∫—Ä—ã–≤–∞–µ—Ç –ª–∏ –æ–Ω –∏—Ö —Ä–∞—Å—Ö–æ–¥—ã"". –ö–ª–∞—Å—Å–Ω–æ, –ø—Ä–æ—Å—Ç–æ —á—É–¥–µ—Å–Ω–æ, —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏—è ""–°–æ–∑–≤–æ–Ω–∏—Ç–µ—Å—å-—Ä–∞–∑–±–µ—Ä–∏—Ç–µ—Å—å"". –ï—Å–ª–∏ –±–∞—Ä—å–µ—Ä—ã –≤ –ø–æ–∫—Ä—ã—Ç–∏–∏ –æ—Å—Ç–∞—é—Ç—Å—è, –æ–ø—Ç–∏–º–∏–∑–∞—Ç–æ—Ä —Å–æ–≤–µ—Ç—É–µ—Ç –ø—Ä–æ—è–≤–ª—è—Ç—å –≥–∏–±–∫–æ—Å—Ç—å. –ò –≤–ø–∞—Ä–∏—Ç—å –∏–º —Å–∏–±—É—Ç—Ä–∞–º–∏–Ω, –Ω–∞–ø—Ä–∏–º–µ—Ä, –∏ –¥–µ—Ä–∂–∞ –∑–∞ —Ä—É–∫—É –¥–æ–≤–µ—Å—Ç–∏ –¥–æ –∏–Ω—Ñ–∞—Ä–∫—Ç–∞. –ß—Ç–æ –¥—É–º–∞–µ—Ç–µ –æ–± —ç—Ç–æ–º? üòê ‚Äî –¥–æ–∫—Ç–æ—Ä –Ω–µ –∏–º–µ–µ—Ç –ø—Ä–∞–≤–∞ –∂–∞–ª–æ–≤–∞—Ç—å—Å—è –∏ –Ω—ã—Ç—å, –µ—Å–ª–∏ —É –Ω–µ–≥–æ –∑–∞—Ä–ø–ª–∞—Ç–∞ –±–æ–ª–µ–µ $150 000 –≤ –≥–æ–¥. –ù–∞–¥–æ —Å—Ç–æ–π–∫–æ –Ω–µ—Å—Ç–∏ —Ç—è–≥–æ—Ç—ã –±–æ–≥–∞—Ç–æ–π –∂–∏–∑–Ω–∏. üî• ‚Äî –ø—É—Å—Ç—å –±–æ—Ä—é—Ç—Å—è –∑–∞ —Å–≤–æ–∏ –ø—Ä–∞–≤–∞, –º–æ–∂–µ—Ç –±—ã—Ç—å, —Ö–æ—Ç—è –±—ã –æ–Ω–∏ —Å–º–æ–≥—É—Ç –î–ª—è —Ç–µ—Ö, –∫—Ç–æ —Ö–æ—á–µ—Ç –≤—ã—Å–∫–∞–∑–∞—Ç—å—Å—è –æ–± –æ–ø—Ç–∏–º–∏–∑–∞—Ç–æ—Ä–∞—Ö, –¥–æ—Å—Ç—É–ø–Ω—ã –∫–æ–º–º–µ–Ω—Ç–∞—Ä–∏–∏","{""skip"": true}"
2025-10-30T14:33:48+00:00,@pharm_icon,2428,https://t.me/pharm_icon/2428,"–ö–æ–ø–∏—è –∫–∞–∫ –±—É–¥—Ç–æ –±—ã –Ω–µ —Å–∏–ª—å–Ω–æ –ø–æ—Ö–æ–∂–∞ –Ω–∞ –æ—Ä–∏–≥–∏–Ω–∞–ª –ø–æ –∫–∞—Ä—Ç–∏–Ω–∫–µ. –° —ç—Ç–æ–≥–æ –º–æ–º–µ–Ω—Ç–∞ –º–æ–≥—É –∑–∞ –ø–ª–∞–≥–∏–∞—Ç —Å—É–¥–∏—Ç—å –≤—Å–µ —Ç–µ–ª–µ–≥—Ä–∞–º –∫–∞–Ω–∞–ª—ã, –∫–æ—Ç–æ—Ä—ã–µ –ø—Ä–µ–¥–ª–∞–≥–∞—é—Ç –Ω–∞ –≤—ã–±–æ—Ä —ç–º–æ–¥–∑–∏ –≤ –∫–∞—á–µ—Å—Ç–≤–µ –≥–æ–ª–æ—Å–æ–≤–∞–Ω–∏—èüòê","{""skip"": true}"
2025-10-30T14:27:50+00:00,@pharm_icon,2427,https://t.me/pharm_icon/2427,"–í –ö–∞–∑–∞—Ö—Å—Ç–∞–Ω–µ —Å—É–¥ –≤—Å—Ç–∞–ª –Ω–∞ —Å—Ç–æ—Ä–æ–Ω—É —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —Å—Ç–æ–º–∞—Ç–æ–ª–æ–≥–∞, –∫–æ—Ç–æ—Ä—ã–π –æ–±–≤–∏–Ω–∏–ª –º–µ—Å—Ç–Ω—É—é –∫–ª–∏–Ω–∏–∫—É –≤ –ø–ª–∞–≥–∏–∞—Ç–µ –ü–æ–≤–æ–¥–æ–º –¥–ª—è —Å—É–¥–µ–±–Ω–æ–≥–æ —Å–ø–æ—Ä–∞ —Å—Ç–∞–ª –≤–∏–¥–µ–æ—Ä–æ–ª–∏–∫ –≤ —Å–æ—Ü—Å–µ—Ç—è—Ö —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ —Å—Ç–æ–º–∞—Ç–æ–ª–æ–≥–∞ ¬´–ö–∞—Ä–∏–µ—Å –Ω–∞ –º–æ–ª–æ—á–Ω—ã—Ö –∑—É–±–∞—Ö –æ–ø–∞—Å–Ω–µ–µ, —á–µ–º –∫–∞—Ä–∏–µ—Å –Ω–∞ –ø–æ—Å—Ç–æ—è–Ω–Ω—ã—Ö?¬ª, –∫–æ—Ç–æ—Ä—ã–π –ø–æ–ª–Ω–æ—Å—Ç—å—é —Å–∫–æ–ø–∏—Ä–æ–≤–∞–ª–∏ –∫–æ–Ω–∫—É—Ä–µ–Ω—Ç—ã ‚Äî —á–∞—Å—Ç–Ω–∞—è —Å—Ç–æ–º–∞—Ç–æ–ª–æ–≥–∏—á–µ—Å–∫–∞—è –∫–ª–∏–Ω–∏–∫–∞ –ö–∞–∑–∞—Ö—Å—Ç–∞–Ω–∞. –í—Ä–∞—á –Ω–∞–ø—Ä–∞–≤–∏–ª –∏–º –¥–æ—Å—É–¥–µ–±–Ω—É—é –ø—Ä–µ—Ç–µ–Ω–∑–∏—é, –Ω–æ –∫–ª–∏–Ω–∏–∫–∞ –æ—Ç–∫–∞–∑–∞–ª–∞—Å—å —É—Ä–µ–≥—É–ª–∏—Ä–æ–≤–∞—Ç—å —Å–ø–æ—Ä –º–∏—Ä–Ω—ã–º –ø—É—Ç–µ–º. –ö–∞–∫ —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∞ ¬´–ú–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –†–æ—Å—Å–∏–∏¬ª —é—Ä–∏—Å—Ç –î–∞—Ä–∏–Ω–∞ –õ–∏—Å–µ—Ü–∫–∞—è, —Ä–æ—Å—Å–∏–π—Å–∫–∏–π –≤—Ä–∞—á —Ç—Ä–µ–±–æ–≤–∞–ª –æ—Ç –∫–ª–∏–Ω–∏–∫–∏ 400 —Ç—ã—Å—è—á –∑–∞ –ø–ª–∞–≥–∏–∞—Ç, –Ω–æ —Å—É–¥ —Å–Ω–∏–∑–∏–ª —Å—É–º–º—É –≤—ã–ø–ª–∞—Ç—ã –¥–æ 142 —Ç—ã—Å—è—á —Ä—É–±–ª–µ–π. –ü–æ –µ–µ —Å–ª–æ–≤–∞–º, –ø—Ä–∏ —Ä–∞—Å—á–µ—Ç–µ –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏–∏ —Å—É–¥ –ö–∞–∑–∞—Ö—Å—Ç–∞–Ω–∞ –æ—Ä–∏–µ–Ω—Ç–∏—Ä–æ–≤–∞–ª—Å—è –Ω–∞ ¬´–¥–ª–∏—Ç–µ–ª—å–Ω–æ—Å—Ç—å —Ä–∞–∑–º–µ—â–µ–Ω–∏—è —Å–ø–æ—Ä–Ω–æ–≥–æ –≤–∏–¥–µ–æ, —Ä–∞–∑–º–µ—â–µ–Ω–∏–µ –≤–∏–¥–µ–æ —Å —Ü–µ–ª—å—é –ø—Ä–∏–≤–ª–µ—á–µ–Ω–∏—è –≤–Ω–∏–º–∞–Ω–∏—è –∫ —É—Å–ª—É–≥–∞–º –∫–ª–∏–Ω–∏–∫–∏, –ø–µ—Ä–µ—Ö–≤–∞—Ç –∞—É–¥–∏—Ç–æ—Ä–∏–∏ –∑–∞ —Å—á–µ—Ç –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏—è –æ–±—ä–µ–∫—Ç–æ–≤ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç—É–∞–ª—å–Ω–æ–π —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç–∏, –¥–∞–Ω–Ω—ã–µ –æ–± –æ—Ö–≤–∞—Ç–µ –∏ –ø—Ä–æ—Å–º–æ—Ç—Ä–∞—Ö¬ª. –ö–ª–∏–Ω–∏–∫–∞ –ø—ã—Ç–∞–ª–∞—Å—å –æ—Å–ø–æ—Ä–∏—Ç—å —Ä–µ—à–µ–Ω–∏–µ, –Ω–æ —Å—É–¥ –æ—Å—Ç–∞–≤–∏–ª –µ–≥–æ –≤ —Å–∏–ª–µ. –ï—Å–ª–∏ –≤—ã —Ö–æ—Ç–∏—Ç–µ –ø–æ–¥–µ–ª–∏—Ç—å—Å—è —Å–≤–æ–µ–π –Ω–æ–≤–æ—Å—Ç—å—é —Å –Ω–∞—à–µ–π —Ä–µ–¥–∞–∫—Ü–∏–µ–π ‚û°Ô∏è @mediamedics_bot","{""skip"": true}"
2025-10-29T11:11:33+00:00,@pharm_icon,2426,https://t.me/pharm_icon/2426,–†–∞—Å—à–∏—Ä—è—é –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –≥–æ—Ä–∏–∑–æ–Ω—Ç—ã –°–∫–∏–Ω—å—Ç–µ –≤–∞—à–∏ –ª—é–±–∏–º—ã–µ –∫–∞–Ω–∞–ª—ã 1. –ü–æ –ø–µ–¥–∏–∞—Ç—Ä–∏–∏ 2. –ü–æ –∞–ª–ª–µ—Ä–≥–æ–ª–æ–≥–∏–∏ 3. –ü–æ —Ç–µ—Ä–∞–ø–∏–∏ 4. –ü–æ –∫–∞—Ä–¥–∏–æ–ª–æ–≥–∏–∏ 5. –ü–æ –Ω–µ–≤—Ä–æ–ª–æ–≥–∏–∏ –•–æ—á—É –ø–æ—Å–º–æ—Ç—Ä–µ—Ç—å –∏ –ø–æ–≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å,"{""skip"": true}"
2025-10-29T05:34:01+00:00,@pharm_icon,2424,https://t.me/pharm_icon/2424,"–ü–æ–¥–∫–∏–¥—ã–≤–∞—é –∏–¥–µ–∏ –î—É–º–∞—é, —á—Ç–æ –≤ –∫–æ–º–∏—Ç–µ—Ç–µ –ø–æ —Ä–æ–∂–¥–∞–µ–º–æ—Å—Ç–∏ –∏–ª–∏ –¥–µ–º–æ–≥—Ä–∞—Ñ–∏—á–µ—Å–∫–æ–º—É –≤–∑—Ä—ã–≤—É, –∫–∞–∫ –æ–Ω–∏ —Ç–∞–º –Ω–∞–∑—ã–≤–∞—é—Ç—Å—è, —É–∂–µ –≤–∑—è–ª–∏ —ç—Ç–æ—Ç –ø–æ—Å—Ç –Ω–∞ –∑–∞–º–µ—Ç–∫—É. –ò–ª–∏ –Ω–µ—Ç?","{""skip"": true}"
2025-10-28T18:14:23+00:00,@pharm_icon,2423,https://t.me/pharm_icon/2423,"–ù–µ–∫—Ä–æ–±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç—å –ù–∞ 3-–º –º–µ—Å—è—Ü–µ –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏ –≤ —à—Ç–∞—Ç–µ –î–∂–æ—Ä–¥–∂–∏—è (—É–≥–∞–¥–∞–π—Ç–µ —Å—Ç—Ä–∞–Ω—É) —É –±–µ—Ä–µ–º–µ–Ω–Ω–æ–π –∂–µ–Ω—â–∏–Ω—ã —Å–ª—É—á–∏–ª–∞—Å—å —Å–º–µ—Ä—Ç—å –º–æ–∑–≥–∞. –û–± —ç—Ç–æ–º —Å–æ–æ–±—â–∞–µ—Ç –¥–æ–∫—Ç–æ—Ä –ê—Ä—Ç—É—Ä –ö–∞–ø–ª–∞–Ω –≤ –∫–æ–ª–æ–Ω–∫–µ –¥–ª—è Medscape. –û—Å–Ω–æ–≤–æ–π –¥–ª—è –ø—Ä–µ—Ü–µ–¥–µ–Ω—Ç–∞ —Å—Ç–∞–ª–æ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–æ —ç—Ç–æ–≥–æ —à—Ç–∞—Ç–∞: –ó–∞–∫–æ–Ω –æ —Å–µ—Ä–¥—Ü–µ–±–∏–µ–Ω–∏–∏ –≥–ª–∞—Å–∏—Ç, —á—Ç–æ –∞–±–æ—Ä—Ç –¥–µ–ª–∞—Ç—å –Ω–µ–ª—å–∑—è, –∞ –∑–∞–∫–æ–Ω –æ –ª–∏—á–Ω–æ—Å—Ç–∏ –∫–∞–∫ –±—ã —É–∫–∞–∑—ã–≤–∞–µ—Ç –Ω–∞ —Ç–æ, —á—Ç–æ –ø–ª–æ–¥ –≤—Å—ë –µ—â—ë —è–≤–ª—è–µ—Ç—Å—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–º –¥–∞–∂–µ –Ω–∞ —Ç—Ä—ë—Ö –º–µ—Å—è—Ü–∞—Ö. –ê–≤—Ç–æ—Ä –∫–æ–ª–æ–Ω–∫–∏ –Ω–∞ Medscape –≥–æ–≤–æ—Ä–∏—Ç, —á—Ç–æ –æ–ø–∏—Å–∞–Ω —Ç–∞–∫–æ–π —Å–ª—É—á–∞–π —Ç–æ–ª—å–∫–æ –≤ –ì–µ—Ä–º–∞–Ω–∏–∏ –∏ –Ω–µ–∏–∑–≤–µ—Å—Ç–Ω–æ, —á–µ–º —ç—Ç–∞ –Ω–µ–∫—Ä–æ–º–∞–Ω—Ç–∏—è –∑–∞–∫–æ–Ω—á–∏–ª–∞—Å—å. –ö–æ–ª—É–º–Ω–∏—Å—Ç –Ω–µ —Å—á–∏—Ç–∞–µ—Ç –ø–ª–æ–¥ –ø–∞—Ü–∏–µ–Ω—Ç–æ–º. –ü—Ä–∏—á–∏–Ω–∞ 1: –Ω–µ–ø–æ–Ω—è—Ç–Ω–æ, –∫–∞–∫ —Ä–∞–±–æ—Ç–∞—Ç—å —Å –Ω–∞—Å—Ç–æ–ª—å–∫–æ –Ω–µ–¥–æ–Ω–æ—à–µ–Ω–Ω—ã–º–∏ –¥–µ—Ç—å–º–∏. –ü—Ä–∏—á–∏–Ω–∞ 2: –º–µ–¥–∏—Ü–∏–Ω–∞ –Ω–µ –∑–Ω–∞–µ—Ç, –∫–∞–∫–æ–≤–æ –≤–ª–∏—è–Ω–∏–µ –Ω–∞ –ø–ª–æ–¥ –ø—Ä–µ–±—ã–≤–∞–Ω–∏—è –≤ –æ—Ä–≥–∞–Ω–∏–∑–º–µ —Ç–∞–∫–æ–π –∂–µ–Ω—â–∏–Ω—ã –≤ —Ç–µ—á–µ–Ω–∏–µ 5 –º–µ—Å—è—Ü–µ–≤ –¥–æ —Ä–æ–∂–¥–µ–Ω–∏—è. –ß—Ç–æ –≥–æ–≤–æ—Ä—è—Ç –≤—Ä–∞—á–∏, –∫–æ—Ç–æ—Ä—ã–µ –Ω–∞–±–ª—é–¥–∞—é—Ç –∑–∞ —ç—Ç–∏–º. –í—Ä–∞—á–∏, –Ω–∞–±–ª—é–¥–∞—é—â–∏–µ –∑–∞ —ç—Ç–æ–π –∂–µ–Ω—â–∏–Ω–æ–π –∏ –ø–ª–æ–¥–æ–º, –≥–æ–≤–æ—Ä—è—Ç, —á—Ç–æ —É–∂–µ –Ω–∞–±–ª—é–¥–∞—é—Ç –º–Ω–æ–∂–µ—Å—Ç–≤–æ —Ç—Ä–µ–≤–æ–∂–Ω—ã—Ö –ø—Ä–∏–∑–Ω–∞–∫–æ–≤, —Ç–∞–∫–∏—Ö –∫–∞–∫ –≥–∏–¥—Ä–æ—Ü–µ—Ñ–∞–ª–∏—è –∏–ª–∏ –≤–æ–¥—è–Ω–∫–∞ –≥–æ–ª–æ–≤–Ω–æ–≥–æ –º–æ–∑–≥–∞, –∞ —Ç–∞–∫–∂–µ –¥—Ä—É–≥–∏–µ –ø—Ä–æ–±–ª–µ–º—ã, –∫–æ—Ç–æ—Ä—ã–µ –º–æ–≥—É—Ç –±—ã—Ç—å –Ω–µ—Å–æ–≤–º–µ—Å—Ç–∏–º—ã —Å –∂–∏–∑–Ω—å—é, –µ—Å–ª–∏ —ç—Ç–æ—Ç –ø–ª–æ–¥ —Ä–æ–¥–∏—Ç—Å—è –∂–∏–≤—ã–º. –¢–∞–∫ –∏–ª–∏ –∏–Ω–∞—á–µ, –∂–µ–Ω—â–∏–Ω—É –ø–æ–¥–¥–µ—Ä–∂–∏–≤–∞—é—Ç –≤ –∫–∞—á–µ—Å—Ç–≤–µ –∏–Ω–∫—É–±–∞—Ç–æ—Ä–∞, —á—Ç–æ–±—ã –æ—Ä–≥–∞–Ω–∏–∑–æ–≤–∞—Ç—å —Ä–æ–∂–¥–µ–Ω–∏–µ —Ä–µ–±–µ–Ω–∫–∞. –í —Ü–µ–ª–æ–º, –æ—Å–Ω–æ–≤–Ω–∞—è –ø—Ä–µ—Ç–µ–Ω–∑–∏—è –¥–æ–∫—Ç–æ—Ä–∞ –ö–∞–ø–ª–∞–Ω–∞ ‚Äî —ç—Ç–æ —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç –Ω–∞–¥ –ø–ª–æ–¥–æ–º, –∞ –Ω–µ —Å–ø–∞—Å–µ–Ω–∏–µ —Ä–µ–±–µ–Ω–∫–∞. –ß—Ç–æ –¥—É–º–∞–µ—Ç–µ –æ —Å–∏—Ç—É–∞—Ü–∏–∏? üòê ‚Äî —ç—Ç–æ —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç –Ω–∞ –ø–ª–æ–¥–µ ‚ù§Ô∏è ‚Äî —ç—Ç–æ —Å–ø–∞—Å–µ–Ω–∏–µ —Ä–µ–±–µ–Ω–∫–∞","{""skip"": true}"
2025-10-28T17:49:43+00:00,@pharm_icon,2422,https://t.me/pharm_icon/2422,"–ü–µ—Ä–≤–æ–µ –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏–µ: –≥–µ–Ω–µ—Ä–∞–ª—å–Ω—ã–π –¥–∏—Ä–µ–∫—Ç–æ—Ä –†–∏–≥–ª—ã –ª–∏—á–Ω–æ —Å–º—Å–∏—Ç –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª—è–º –∞–ø—Ç–µ–∫ –∏ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–æ–≤ –£–ø—Ä–∞–≤–ª–µ–Ω–∏–µ –§–ê–° –ø–æ –ú–æ—Å–∫–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –æ—à—Ç—Ä–∞—Ñ–æ–≤–∞–ª–æ –≥–µ–Ω–µ—Ä–∞–ª—å–Ω–æ–≥–æ –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞ –∞–ø—Ç–µ—á–Ω–æ–π —Å–µ—Ç–∏ ¬´–†–∏–≥–ª–∞¬ª –∑–∞ —Ä–∞—Å—Å—ã–ª–∫—É —Ä–µ–∫–ª–∞–º–Ω–æ–≥–æ —Å–æ–æ–±—â–µ–Ω–∏—è –±–µ–∑ —Å–æ–≥–ª–∞—Å–∏—è –ø–æ–ª—É—á–∞—Ç–µ–ª—è. –ö–∞–∫ —Å–æ–æ–±—â–∏–ª–∏ –≤ –ø—Ä–µ—Å—Å-—Å–ª—É–∂–±–µ –≤–µ–¥–æ–º—Å—Ç–≤–∞, –ë–æ—Ä–∏—Å –ü–æ–ø–æ–≤, —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å –û–û–û ¬´–†–∏–≥–ª–∞¬ª, –ø–æ–ª—É—á–∏–ª —à—Ç—Ä–∞—Ñ –≤ —Ä–∞–∑–º–µ—Ä–µ 20 —Ç—ã—Å—è—á —Ä—É–±–ª–µ–π. –ü–æ–≤–æ–¥–æ–º —Å—Ç–∞–ª–æ –æ–±—Ä–∞—â–µ–Ω–∏–µ –≥—Ä–∞–∂–¥–∞–Ω–∏–Ω–∞, –∫–æ—Ç–æ—Ä–æ–º—É –ø—Ä–∏—à–ª–æ SMS —Å —Ä–µ–∫–ª–∞–º–æ–π –∞–∫—Ü–∏–∏ –∫–æ–º–ø–∞–Ω–∏–∏, –Ω–µ—Å–º–æ—Ç—Ä—è –Ω–∞ —Ç–æ —á—Ç–æ –æ–Ω –Ω–µ –¥–∞–≤–∞–ª —Ä–∞–∑—Ä–µ—à–µ–Ω–∏—è –Ω–∞ –ø–æ–ª—É—á–µ–Ω–∏–µ –ø–æ–¥–æ–±–Ω—ã—Ö —Å–æ–æ–±—â–µ–Ω–∏–π. –ê–Ω—Ç–∏–º–æ–Ω–æ–ø–æ–ª—å–Ω–∞—è —Å–ª—É–∂–±–∞ –ø—Ä–∏–∑–Ω–∞–ª–∞ —Ä–∞—Å—Å—ã–ª–∫—É –Ω–∞—Ä—É—à–∞—é—â–µ–π –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–æ –æ —Ä–µ–∫–ª–∞–º–µ. –ù–∞–ø–æ–º–Ω–∏–º, —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–∏–µ —Ä–µ–∫–ª–∞–º—ã –ø–æ —Ç–µ–ª–µ—Ñ–æ–Ω—É –¥–æ–ø—É—Å–∫–∞–µ—Ç—Å—è —Ç–æ–ª—å–∫–æ –ø—Ä–∏ –Ω–∞–ª–∏—á–∏–∏ –ø—Ä–µ–¥–≤–∞—Ä–∏—Ç–µ–ª—å–Ω–æ–≥–æ —Å–æ–≥–ª–∞—Å–∏—è –∞–±–æ–Ω–µ–Ω—Ç–∞. –ù–∞—Ä—É—à–µ–Ω–∏–µ –∫–≤–∞–ª–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–ª–∏ –ø–æ —á–∞—Å—Ç–∏ 4.1 —Å—Ç–∞—Ç—å–∏ 14.3 –ö–æ–ê–ü –†–§. –î–ª—è —é—Ä–∏–¥–∏—á–µ—Å–∫–∏—Ö –ª–∏—Ü –ø–æ —ç—Ç–æ–π —Å—Ç–∞—Ç—å–µ –ø—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ–Ω—ã —à—Ç—Ä–∞—Ñ—ã –æ—Ç 300 —Ç—ã—Å—è—á –¥–æ 1 –º–∏–ª–ª–∏–æ–Ω–∞ —Ä—É–±–ª–µ–π. –í –¥–∞–Ω–Ω–æ–º —Å–ª—É—á–∞–µ –£–§–ê–° –æ–≥—Ä–∞–Ω–∏—á–∏–ª–æ—Å—å —à—Ç—Ä–∞—Ñ–æ–º –≤ 20 000 —Ä—É–±–ª–µ–π –∏–º–µ–Ω–Ω–æ –¥–ª—è –¥–∏—Ä–µ–∫—Ç–æ—Ä–∞, –Ω–µ —à—Ç—Ä–∞—Ñ—É—è –∫–æ–º–ø–∞–Ω–∏—é. –ú–æ–ª–æ–¥–µ—Ü, –∫–æ–Ω–µ—á–Ω–æ, –∏ –∑–∞ –º–∞—Ä–∫–µ—Ç–æ–ª–æ–≥–∞ —Ä–∞–±–æ—Ç–∞–µ—Ç, –∏ –ª–∏—á–Ω—É—é –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç—å –Ω–µ—Å—ë—Ç. –ê —é—Ä–∏—Å—Ç–∞–º –Ω–∞–≥–æ–Ω—è–π —Ç–µ–ø–µ—Ä—å —Å–¥–µ–ª–∞–µ—Ç ‚Äî –Ω–∞–¥–æ –ø–µ—Ä–µ–∏–∑–æ–±—Ä–µ—Ç–∞—Ç—å –ø–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª—å—Å–∫–æ–µ —Å–æ–≥–ª–∞—à–µ–Ω–∏–µ –∏ –ø–æ–ª–∏—Ç–∏–∫—É –∫–æ–Ω—Ñ–∏–¥–µ–Ω—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–∏.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing, sanctions"",
  ""impact"": ""high"",
  ""english"": ""The FAS of Moscow Oblast fined the CEO of pharmacy chain 'Rigla' for sending an advertising message without the recipient's consent. The fine was 20,000 rubles and the violation was classified as part 4.1 of article 14.3 of the Administrative Offenses Code. The FAS did not penalize the company, but only the CEO for personal responsibility.""
}"
2025-10-24T15:31:41+00:00,@pharm_icon,2421,https://t.me/pharm_icon/2421,"üèÜ NC Logistic ‚Äî –ø–æ–±–µ–¥–∏—Ç–µ–ª—å –ø—Ä–µ–º–∏–∏ SCM Pharm –≤ –Ω–æ–º–∏–Ω–∞—Ü–∏–∏ ¬´–ü—Ä–æ–µ–∫—Ç –≥–æ–¥–∞ –≤ –æ–±–ª–∞—Å—Ç–∏ –∫–∞—á–µ—Å—Ç–≤–∞¬ª 17 –æ–∫—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞ –≤ —Ä–∞–º–∫–∞—Ö –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ ¬´–õ–æ–≥–∏—Å—Ç–∏–∫–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö —Å—Ä–µ–¥—Å—Ç–≤¬ª —Å–æ—Å—Ç–æ—è–ª–∞—Å—å —Ü–µ—Ä–µ–º–æ–Ω–∏—è –Ω–∞–≥—Ä–∞–∂–¥–µ–Ω–∏—è –ø—Ä–µ–º–∏–∏ SCM Pharm, –∫–æ—Ç–æ—Ä–∞—è —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω–æ –æ—Ç–º–µ—á–∞–µ—Ç –ª—É—á—à–∏–µ –ø—Ä–∞–∫—Ç–∏–∫–∏ –≤ —Å—Ñ–µ—Ä–µ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –ª–æ–≥–∏—Å—Ç–∏–∫–∏. –í —ç—Ç–æ–º –≥–æ–¥—É –≤ –Ω–æ–º–∏–Ω–∞—Ü–∏–∏ ¬´–ü—Ä–æ–µ–∫—Ç –≥–æ–¥–∞ –≤ –æ–±–ª–∞—Å—Ç–∏ –∫–∞—á–µ—Å—Ç–≤–∞¬ª –ø–æ–±–µ–¥—É –æ–¥–µ—Ä–∂–∞–ª–∞ –∫–æ–º–ø–∞–Ω–∏—è NC Logistic —Å –ø—Ä–æ–µ–∫—Ç–æ–º ¬´–§–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∞—è —Å–∏—Å—Ç–µ–º–∞ –∫–∞—á–µ—Å—Ç–≤–∞ 3PL-–æ–ø–µ—Ä–∞—Ç–æ—Ä–∞¬ª. –ñ—é—Ä–∏ –∏–∑ –±–æ–ª–µ–µ —á–µ–º 300 –Ω–µ–∑–∞–≤–∏—Å–∏–º—ã—Ö —ç–∫—Å–ø–µ—Ä—Ç–æ–≤ –æ—Ç–º–µ—Ç–∏–ª–æ –≤—ã—Å–æ–∫–∏–π —É—Ä–æ–≤–µ–Ω—å —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ –∏ –∑–Ω–∞—á–∏–º—ã–π –≤–∫–ª–∞–¥ –ø—Ä–æ–µ–∫—Ç–∞ –≤ —Ä–∞–∑–≤–∏—Ç–∏–µ –æ—Ç—Ä–∞—Å–ª–∏. –ö–æ–º–ø–∞–Ω–∏—è –≤—ã–∏–≥—Ä–∞–ª–∞ —Å –∑–∞–º–µ—Ç–Ω—ã–º –æ—Ç—Ä—ã–≤–æ–º, —á—Ç–æ –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–∞–µ—Ç –∞–∫—Ç—É–∞–ª—å–Ω–æ—Å—Ç—å –∏ –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫—É—é —Ü–µ–Ω–Ω–æ—Å—Ç—å –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤—ã. –ë–ª–∞–≥–æ–¥–∞—Ä—è –≤–Ω–µ–¥—Ä–µ–Ω–∏—é —Å–∏—Å—Ç–µ–º—ã –∫–∞—á–µ—Å—Ç–≤–∞ NC Logistic —Å—Ç–∞–ª–∞ –ø–µ—Ä–≤—ã–º –≤ –†–æ—Å—Å–∏–∏ –ª–æ–≥–∏—Å—Ç–∏—á–µ—Å–∫–∏–º –ø—Ä–æ–≤–∞–π–¥–µ—Ä–æ–º —Å –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω–æ–π –ª–∏—Ü–µ–Ω–∑–∏–µ–π –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–∞ –∏ —Å–µ—Ä—Ç–∏—Ñ–∏–∫–∞—Ç–æ–º GMP. –≠—Ç–æ –ø–æ–∑–≤–æ–ª—è–µ—Ç —Å–æ–∑–¥–∞–≤–∞—Ç—å –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã–µ —Å–∫–ª–∞–¥—ã –Ω–∞ –º–æ—â–Ω–æ—Å—Ç—è—Ö NC Logistic, —Ö—Ä–∞–Ω–∏—Ç—å —Ç–∞–º —Å—ã—Ä—å–µ –∏ –≤—Å–ø–æ–º–æ–≥–∞—Ç–µ–ª—å–Ω—ã–µ –º–∞—Ç–µ—Ä–∏–∞–ª—ã, –∞ —Ç–∞–∫–∂–µ –≤—ã–ø–æ–ª–Ω—è—Ç—å –æ–ø–µ—Ä–∞—Ü–∏–∏ –ø–æ –º–∞—Ä–∫–∏—Ä–æ–≤–∫–µ –∏ —É–ø–∞–∫–æ–≤–∫–µ. –ú—ã —É—á–∞—Å—Ç–≤—É–µ–º –≤ —ç—Ç–æ–π –ø—Ä–µ–º–∏–∏, –ø–æ—Ç–æ–º—É —á—Ç–æ –æ–Ω–∞ —è–≤–ª—è–µ—Ç—Å—è —Å–æ–≤—Ä–µ–º–µ–Ω–Ω–æ–π –Ω–µ–∑–∞–≤–∏—Å–∏–º–æ–π –ø–ª–æ—â–∞–¥–∫–æ–π –¥–ª—è –æ—Ü–µ–Ω–∫–∏ –ª—É—á—à–∏—Ö —Ä–µ—à–µ–Ω–∏–π —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ —Ä—ã–Ω–∫–∞. –í —ç—Ç–æ–º –≥–æ–¥—É –Ω–∞—à–∞ –∫–æ–º–ø–∞–Ω–∏—è –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∞ –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏–π –∫–µ–π—Å –≤–Ω–µ–¥—Ä–µ–Ω–∏—è —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π —Å–∏—Å—Ç–µ–º—ã –∫–∞—á–µ—Å—Ç–≤–∞, –∫–æ—Ç–æ—Ä–∞—è –ø–æ–∑–≤–æ–ª—è–µ—Ç –Ω–∞–º –Ω–∞–ø—Ä—è–º—É—é —É—á–∞—Å—Ç–≤–æ–≤–∞—Ç—å –≤ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω–æ–º –ø—Ä–æ—Ü–µ—Å—Å–µ. –ü–æ–±–µ–¥–∞ –≤ –∫–ª—é—á–µ–≤–æ–π –Ω–æ–º–∏–Ω–∞—Ü–∏–∏ ‚Äî —Ä–µ–∑—É–ª—å—Ç–∞—Ç —Å–∏—Å—Ç–µ–º–Ω–æ–π —Ä–∞–±–æ—Ç—ã, –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª–∏–∑–º–∞ –∫–æ–º–∞–Ω–¥—ã –∏ –¥–æ–≤–µ—Ä–∏—è –ø–∞—Ä—Ç–Ω–µ—Ä–æ–≤, ‚Äî –æ—Ç–º–µ—Ç–∏–ª –°—Ç–∞–Ω–∏—Å–ª–∞–≤ –°–º–∏—Ä–Ω–æ–≤, —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å –æ—Ç–¥–µ–ª–∞ –∫–∞—á–µ—Å—Ç–≤–∞ NC Logistic. –≠—Ç–∞ –Ω–∞–≥—Ä–∞–¥–∞ ‚Äî –≤—Ç–æ—Ä–∞—è –ø–æ–¥—Ä—è–¥ –≤ –æ–±–ª–∞—Å—Ç–∏ –∫–∞—á–µ—Å—Ç–≤–∞ –∏ —Ç—Ä–µ—Ç—å—è –ø–æ–±–µ–¥–∞ NC Logistic –Ω–∞ –ø—Ä–µ–º–∏–∏ SCM Pharm, –≤–∫–ª—é—á–∞—è —Ä–∞–Ω–µ–µ –ø–æ–ª—É—á–µ–Ω–Ω—É—é –Ω–∞–≥—Ä–∞–¥—É ¬´Digital-–ø—Ä–æ–µ–∫—Ç –≥–æ–¥–∞¬ª. üì¢ –ü–æ–¥–ø–∏—Å—ã–≤–∞–π—Ç–µ—Å—å –Ω–∞ –∫–∞–Ω–∞–ª NC Logistic, —á—Ç–æ–±—ã –±—ã—Ç—å –≤ –∫—É—Ä—Å–µ –∫–ª—é—á–µ–≤—ã—Ö –∏–∑–º–µ–Ω–µ–Ω–∏–π –∏ –ª—É—á—à–∏—Ö –ø—Ä–∞–∫—Ç–∏–∫ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –ª–æ–≥–∏—Å—Ç–∏–∫–∏.","{""skip"": true}"
2025-10-24T14:53:04+00:00,@pharm_icon,2417,https://t.me/pharm_icon/2417,"–í–ª–∏—è–Ω–∏–µ –ö–û–ö–æ–≤ –Ω–∞ –Ω–µ–∫–æ—Ç–æ—Ä—ã–µ –∏—Å—Ö–æ–¥—ã —Ç–µ—á–µ–Ω–∏—è –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏. –°—Ä–∞–≤–Ω–∏–≤–∞–ª–∏—Å—å –∂–µ–Ω—â–∏–Ω—ã, –ø—Ä–∏–Ω–∏–º–∞–≤—à–∏–µ –ö–û–ö –¥–æ –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏, –∏ –Ω–µ –ø—Ä–∏–Ω–∏–º–∞–≤—à–∏–µ. –ß—Ç–æ –¥—É–º–∞–µ—Ç–µ? –¢–∞–∫ –ª–µ–≥–∏—Ç–∏–º–Ω–µ–µ –æ—Ü–µ–Ω–∏–≤–∞—Ç—å –≤—Ä–µ–¥ (–∏–ª–∏ –ø–æ–ª—å–∑—É) –ö–û–ö? –ò—Å—Ç–æ—á–Ω–∏–∫: https://doi.org/10.1093/ije/dyad045","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance"",
  ""impact"": ""medium"",
  ""english"": ""A clinical trial compared women who took COCs before pregnancy with those who did not. They are asking how to evaluate the harm (or benefit) of COCs, and sources this from a doi link.""
}"
2025-10-24T14:13:44+00:00,@pharm_icon,2412,https://t.me/pharm_icon/2412,"–ö–æ–º–º–µ–Ω—Ç–∞—Ä–∏–π –¥–ª—è —Å—Ç—Ä–∞–Ω–Ω—ã—Ö —Ç–æ–≤–∞—Ä–∏—â–µ–π –≤ –∫–æ–º–º–µ–Ω—Ç–∞—Ä–∏—è—Ö: –ù–µ–∫–æ—Ä—Ä–µ–∫—Ç–Ω–æ —Å—Ä–∞–≤–Ω–∏–≤–∞—Ç—å –ø—Ä–∏—ë–º –ö–û–ö –∏ –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç—å. –ö–æ—Ä—Ä–µ–∫—Ç–Ω–µ–µ —Å—Ä–∞–≤–Ω–∏—Ç—å –ö–û–ö –∏ –ø—Ä–µ–∑–µ—Ä–≤–∞—Ç–∏–≤—ã, –Ω–∞–ø—Ä–∏–º–µ—Ä. –ü—Ä–æ —Ä–µ–±—ë–Ω–∫–∞ - —ç—Ç–æ –º–æ–π –∫–æ–º–º–µ–Ω—Ç–∞—Ä–∏–π, –∫–æ—Ç–æ—Ä—ã–π —è –¥–æ–¥—É–º–∞–ª–∞. –ê–≤—Ç–æ—Ä—ã –ø–æ—Å—Ç–∞ –Ω–µ –ø–∏—à—É—Ç, —á—Ç–æ —Ä–µ–±—ë–Ω–æ–∫ –ø–æ–±–æ—á–Ω—ã–π —ç—Ñ—Ñ–µ–∫—Ç –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏. –≠—Ç–æ —è –¥–æ–±–∞–≤–ª—è—é –∫–∞–∫ –±—ã –¥–æ–≤–æ–¥—è –¥–æ –∫–æ–Ω—Ü–∞ —Å—Ä–∞–≤–Ω–µ–Ω–∏–µ. –ü–æ–Ω—è—Ç–Ω–æ —Ç–µ–ø–µ—Ä—å?","{""skip"": true}"
2025-10-24T13:17:29+00:00,@pharm_icon,2411,https://t.me/pharm_icon/2411,"–ú–æ–∏ –ª—é–±–∏–º—ã–µ —Å—Ä–∞–≤–Ω–µ–Ω–∏—è –æ—Ç ""–¥–æ–∫–∞–∑–∞—Ç–µ–ª—å–Ω—ã—Ö –¥–æ–∫—Ç–æ—Ä–æ–≤"". –°–Ω–∞—á–∞–ª–∞ —Ç–∞–∫ –¥–µ–ª–∞–ª–æ –°–ú–ò –∫–ª–∏–Ω–∏–∫ –°–∫–∞–Ω–¥–∏–Ω–∞–≤–∏—è, —Ç–µ–ø–µ—Ä—å –≤–æ—Ç —ç—Ç–æ—Ç –º–µ–¥–∏–∞–ø—Ä–æ–µ–∫—Ç. –ì–ª–∞–≤–Ω–æ–µ –æ—Å–ª–æ–∂–Ω–µ–Ω–∏–µ –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏ - —ç—Ç–æ —Ä–µ–±—ë–Ω–æ–∫, –∫–æ—Ç–æ—Ä—ã–π, –ø–æ–ª—É—á–∞–µ—Ç—Å—è, —Ö—É–∂–µ —Ç—Ä–æ–º–±–∞, –ø–æ—Ç–æ–º—É —á—Ç–æ –µ–≥–æ –ø–æ—Ç–æ–º –≤—Å—é –∂–∏–∑–Ω—å –≤—ã—Ö–∞–∂–∏–≤–∞—Ç—å –∏ –ª–µ—á–∏—Ç—å. –ë—Ä–∞–≤–æ.","{""skip"": true}"
2025-10-20T15:22:21+00:00,@pharm_icon,2408,https://t.me/pharm_icon/2408,"‚ö°Ô∏è–ü–æ—Å–ª–µ–¥–Ω–∏–π —à–∞–Ω—Å —Å–∫–∏–Ω—É—Ç—å –æ–∫–æ–≤—ã —Å –≤—Ä–∞—á–∞ –¥–æ —Ç–æ–≥–æ, –∫–∞–∫ –∏—Ö –Ω–∞–¥–µ–ª–∏ –Ω–∞ —Ä—É–∫–∏ 1. –ü—Ä–æ—á–∏—Ç–∞–π—Ç–µ –ø–æ—Å—Ç 2. –ü—Ä–æ—á–∏—Ç–∞–π—Ç–µ –∏–Ω—Å—Ç—Ä—É–∫—Ü–∏—é 3. –í—ã–ø–æ–ª–Ω–∏—Ç–µ –∏–Ω—Å—Ç—Ä—É–∫—Ü–∏—é 4. –°–ø–∏—Ç–µ —Å –æ—â—É—â–µ–Ω–∏–µ–º, —á—Ç–æ –≤—ã –æ—Å–≤–æ–±–æ–¥–∏–ª–∏ –º–æ–ª–æ–¥–æ–µ –ø–æ–∫–æ–ª–µ–Ω–∏–µ –≤—Ä–∞—á–µ–π https://t.me/mediamedics/13294","{""skip"": true}"
2025-10-20T12:44:28+00:00,@pharm_icon,2407,https://t.me/pharm_icon/2407,"–°—É–¥—å–±–∞ –≥–∏–≥–∏–µ–Ω–∏—Å—Ç–∞ –ì–∏–≥–∏–µ–Ω–∏—Å—Ç–æ–≤ –¥–∞ –∏ –≤–µ—Å—å –º–µ–¥–∏–∫–æ-–ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–∏–π —Ñ–∞–∫—É–ª—å—Ç–µ—Ç –≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–º —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–µ –Ω–µ –ª—é–±—è—Ç, –º–æ–∂–µ—Ç –±—ã—Ç—å –ø–æ—Ç–æ–º—É —á—Ç–æ –æ–Ω–∏ –≤—Å—ë –≤—Ä–µ–º—è –≤—Å–∫—Ä—ã–≤–∞—é—Ç —Å–∞–º—ã–µ –±–æ–ª—å–Ω—ã–µ —Ç–æ—á–∫–∏ –≤ —Å–∏—Å—Ç–µ–º–µ? –ß—Ç–æ –¥—É–º–∞–µ—Ç–µ?","{""skip"": true}"
2025-10-20T12:18:56+00:00,@pharm_icon,2406,https://t.me/pharm_icon/2406,"–û–º—Å–∫: –Ω–∞ –∑–∞–≥—Ä—è–∑–Ω—ë–Ω–Ω—ã—Ö —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏—è—Ö –≥–æ—Ä–æ–¥–∞ —Ä–∏—Å–∫ —Å–º–µ—Ä—Ç–∏ –≤—ã—à–µ –Ω–∞ 23-25%, —á–µ–º –Ω–∞ —É—Å–ª–æ–≤–Ω–æ —á–∏—Å—Ç—ã—Ö –ö–æ–≥–¥–∞ —É–≤–∏–¥–∏—Ç–µ —á–µ–ª–æ–≤–µ–∫–∞, –∫–æ—Ç–æ—Ä—ã–π –≥–æ–≤–æ—Ä–∏—Ç, —á—Ç–æ –ø—Ä–æ–±–ª–µ–º—ã —ç–∫–æ–ª–æ–≥–∏–∏ –Ω–µ —Å—É—â–µ—Å—Ç–≤—É–µ—Ç ‚Äî –¥–∞–π—Ç–µ –µ–º—É –ø–æ —à–∞–ø–∫–µ. –ò—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª–∏ –∏–∑ –û–º—Å–∫–∞ –ø—Ä–æ–≤–µ–ª–∏ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ. –ë—ã–ª –ø—Ä–æ–≤–µ–¥—ë–Ω –∞–Ω–∞–ª–∏–∑ —Å–º–µ—Ä—Ç–Ω–æ—Å—Ç–∏ –Ω–∞—Å–µ–ª–µ–Ω–∏—è –û–º—Å–∫–∞ –∑–∞ 2017‚Äì2022 –≥–≥., –¥–∞–Ω–Ω—ã–µ –∏–∑—É—á–∞–ª–∏ –≤ —Ä–∞–∑—Ä–µ–∑–µ –º—É–Ω–∏—Ü–∏–ø–∞–ª—å–Ω—ã—Ö –æ–∫—Ä—É–≥–æ–≤ –∏ –≤ –¥–∏–Ω–∞–º–∏–∫–µ. –í—ã—è—Å–Ω–∏–ª–∏ —Å–ª–µ–¥—É—é—â–µ–µ: 1. –ü–æ –¥–∞–Ω–Ω—ã–º –º–Ω–æ–≥–æ–ª–µ—Ç–Ω–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –ø–æ —ç–∫–æ–ª–æ–≥–æ-–≥–∏–≥–∏–µ–Ω–∏—á–µ—Å–∫–∏–º –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è–º –∫–∞—á–µ—Å—Ç–≤–∞ –∞—Ç–º–æ—Å—Ñ–µ—Ä–Ω–æ–≥–æ –≤–æ–∑–¥—É—Ö–∞ –≤ –ø—Ä–µ–¥–µ–ª–∞—Ö –≥—Ä–∞–Ω–∏—Ü –û–º—Å–∫–∞ —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω—ã —É—Å–ª–æ–≤–Ω–æ —á–∏—Å—Ç—ã–µ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ (–ö–∏—Ä–æ–≤—Å–∫–∏–π –æ–∫—Ä—É–≥) –∏ –∑–∞–≥—Ä—è–∑–Ω—ë–Ω–Ω—ã–µ (–û–∫—Ç—è–±—Ä—å—Å–∫–∏–π, –¶–µ–Ω—Ç—Ä–∞–ª—å–Ω—ã–π, –°–æ–≤–µ—Ç—Å–∫–∏–π). 2. –†–∏—Å–∫ —Å–º–µ—Ä—Ç–Ω–æ—Å—Ç–∏ –¥–ª—è –ª–∏—Ü, –ø—Ä–æ–∂–∏–≤–∞—é—â–∏—Ö –Ω–∞ –Ω–∞–∏–±–æ–ª–µ–µ –∑–∞–≥—Ä—è–∑–Ω—ë–Ω–Ω—ã—Ö —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏—è—Ö –≥–æ—Ä–æ–¥–∞ (–û–∫—Ç—è–±—Ä—å—Å–∫–∏–π, –¶–µ–Ω—Ç—Ä–∞–ª—å–Ω—ã–π –æ–∫—Ä—É–≥–∞), –≤—ã—à–µ –Ω–∞ 23‚Äì25%, —á–µ–º –Ω–∞ —É—Å–ª–æ–≤–Ω–æ —á–∏—Å—Ç—ã—Ö —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏—è—Ö (–ö–∏—Ä–æ–≤—Å–∫–∏–π –æ–∫—Ä—É–≥). –í–∞–∂–Ω–æ –ø—Ä–∞–≤–∏–ª—å–Ω–æ –≤—ã–±—Ä–∞—Ç—å –∂–∏–ª—å—ë. 3. –í —Ä–µ–∑—É–ª—å—Ç–∞—Ç–µ –∫–æ—Ä—Ä–µ–ª—è—Ü–∏–æ–Ω–Ω–æ–≥–æ –∞–Ω–∞–ª–∏–∑–∞ —Å–≤—è–∑–∏ –¥–∏–Ω–∞–º–∏—á–µ—Å–∫–∏—Ö —Ä—è–¥–æ–≤ –º–µ–∂–¥—É —ç–∫–æ–ª–æ–≥–æ –≥–∏–≥–∏–µ–Ω–∏—á–µ—Å–∫–∏–º–∏ –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è–º–∏ –∏ –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è–º–∏ —Å–º–µ—Ä—Ç–Ω–æ—Å—Ç–∏ —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–æ –Ω–∞–ª–∏—á–∏–µ —Å–∏–ª—å–Ω—ã—Ö –ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω—ã—Ö —Å–≤—è–∑–µ–π —É—Ä–æ–≤–Ω–µ–π —Ñ–∞–∫—Ç–∏—á–µ—Å–∫–æ–π –æ–±—â–µ–π —Å–º–µ—Ä—Ç–Ω–æ—Å—Ç–∏ –Ω–∞—Å–µ–ª–µ–Ω–∏—è –∏ —É–¥–µ–ª—å–Ω–æ–≥–æ –≤–µ—Å–∞ –ø—Ä–æ–± –∞—Ç–º–æ—Å—Ñ–µ—Ä–Ω–æ–≥–æ –≤–æ–∑–¥—É—Ö–∞ —Å –ø—Ä–µ–≤—ã—à–µ–Ω–∏–µ–º –º–∞–∫—Å–∏–º–∞–ª—å–Ω—ã—Ö —Ä–∞–∑–æ–≤—ã—Ö –ü–î–ö (R = 0,86; —Ä < 0,05). 4. –£—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω—ã –ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω—ã–µ –∏ –¥–æ—Å—Ç–æ–≤–µ—Ä–Ω—ã–µ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∞–ª—å–Ω–æ —Ä–∞—Å–ø—Ä–µ–¥–µ–ª—ë–Ω–Ω—ã–µ —Å–≤—è–∑–∏ –º–µ–∂–¥—É –º–Ω–æ–≥–æ–ª–µ—Ç–Ω–∏–º–∏ –∫–æ–Ω—Ü–µ–Ω—Ç—Ä–∞—Ü–∏—è–º–∏ –æ–∫—Å–∏–¥–∞ —É–≥–ª–µ—Ä–æ–¥–∞ –∏ —Å—Ç–∞–Ω–¥–∞—Ä—Ç–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã–º–∏ –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è–º–∏ –æ–±—â–µ–π —Å–º–µ—Ä—Ç–Ω–æ—Å—Ç–∏ (R = 0,93; p < 0,05) –∏ –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è–º–∏ —Å–º–µ—Ä—Ç–Ω–æ—Å—Ç–∏ –º—É–∂—á–∏–Ω –æ—Ç –≤—Å–µ—Ö –µ—Å—Ç–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–∏—á–∏–Ω (R = 0,89; p < 0,05). –ü—Ä–æ—Å—Ç–∏—Ç–µ, –º—É–∂–∏–∫–∏, —á—Ç–æ –ø–µ—Ä–µ–¥—É—à–Ω–∏–ª–∏. –ü—Ä–∏ –∑–∞–ø—Ä–æ—Å–µ ""–ê–ø—Ç–µ–∫–∏"" –≤ –û–º—Å–∫–µ –æ–±–Ω–∞—Ä—É–∂–∏–≤–∞–µ—Ç—Å—è 1107 —Ç–æ—á–µ–∫ —Å–æ–≥–ª–∞—Å–Ω–æ –¥–∞–Ω–Ω—ã–º —Å–µ—Ä–≤–∏—Å–∞ 2–ì–ò–°. –ü–æ –æ–¥–Ω–æ–π –∞–ø—Ç–µ–∫–µ –Ω–∞ –∫–∞–∂–¥—ã–µ 1000 —á–µ–ª–æ–≤–µ–∫ ‚Äî –Ω–∞—Å–µ–ª–µ–Ω–∏–µ –û–º—Å–∫–∞ —Å–æ—Å—Ç–∞–≤–ª—è–µ—Ç 1,12 –º–∏–ª–ª–∏–æ–Ω–∞. –≠—Ç–æ —Ç–∞–∫–∏ —Ä–µ—Ñ–µ—Ä–µ–Ω—Å –∫ –Ω—É–ª–µ–≤–æ–º—É –ø–æ—Å—Ç—É. –û—Ç–ª–∏—á–Ω–∞—è —Ä–∞–±–æ—Ç–∞ –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª–µ–π –∏–∑ –§–ì–ë–û–£ –í–û ¬´–û–º—Å–∫–∏–π –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–π —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç¬ª –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–æ—Å—Å–∏–∏, –∫–æ—Ç–æ—Ä–∞—è –æ—Å—Ç–∞–≤–ª—è–µ—Ç —Ç–∞–∫ –º–Ω–æ–≥–æ –≤–æ–ø—Ä–æ—Å–æ–≤ –∏ —Ç–∞–∫ –º–∞–ª–æ –æ—Ç–≤–µ—Ç–æ–≤. üî• ‚Äî –Ω–∞–¥–æ –∫–∞–∫-—Ç–æ –∫–æ—Ä—Ä–µ–∫—Ç–∏—Ä–æ–≤–∞—Ç—å —Å–∏—Ç—É–∞—Ü–∏—é üóø ‚Äî –Ω–∏—á–µ–≥–æ –Ω–µ –Ω–∞–¥–æ –¥–µ–ª–∞—Ç—å, –∏–Ω–≥–∞–ª—è—Ü–∏—è ‚Äî —ç—Ç–æ —Ö–æ—Ä–æ—à–æ","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""epidemic, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""A study from Omsk, Russia has found that the risk of death for residents living on heavily polluted areas (Oktiabrsky and Central districts) is 23-25% higher than in less polluted areas (Kirovsky district). The research also shows a strong positive correlation between atmospheric CO2 concentrations and mortality rates, with R = 0.93 (p < 0.05). The study also notes that there are currently 1,107 pharmacies in Omsk, with one for every 1,000 people (population of Omsk is approximately 1.12 million).""
}"
2025-10-19T16:51:52+00:00,@pharm_icon,2405,https://t.me/pharm_icon/2405,"–†–æ—Å—Ç —Ä—ã–Ω–∫–∞ —Å—Ç–∏–º—É–ª–∏—Ä—É–µ—Ç—Å—è... –≤—Å–µ–º –†—ã–Ω–æ–∫ —Ñ–∞—Ä–º–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Ä–∞—Å—Ç—ë—Ç –≤–Ω–µ –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏ –æ—Ç —Ç–æ–≥–æ, —á—Ç–æ –ø—Ä–æ–∏—Å—Ö–æ–¥–∏—Ç. –õ—é–±–æ–µ –ø–æ–ª–∏—Ç–∏—á–µ—Å–∫–æ–µ —Å–æ–±—ã—Ç–∏–µ –Ω–∞ —Ä—É–∫—É —Ç–æ–º—É –∏–ª–∏ –∏–Ω–æ–º—É —Ñ–∞—Ä–º–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—é. –ö–æ–Ω—Ñ–ª–∏–∫—Ç –∏ —É—Ö—É–¥—à–µ–Ω–∏–µ –∞—Ç–º–æ—Å—Ñ–µ—Ä—ã? –û—Ç–ª–∏—á–Ω–æ, –æ–∂–∏–¥–∞–µ–º —Ä–æ—Å—Ç —Ä—ã–Ω–∫–∞ –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç–æ–≤. –í –≤–∞—à–µ–º –≥–æ—Ä–æ–¥–µ –≥–æ—Ä–∏–∑–æ–Ω—Ç –∑–∞–≤–∞–ª–µ–Ω —Å–º–æ–≥–æ–º? –°—É–ø–µ—Ä, –≤–∫–ª–∞–¥—ã–≤–∞–µ–º—Å—è –≤ –ø—Ä–æ—Ç–∏–≤–æ–æ–ø—É—Ö–æ–ª–µ–≤—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –∏ –±—Ä–æ–Ω—Ö–æ–ª–∏—Ç–∏–∫–∏. –ò —Ç–∞–∫ –¥–∞–ª–µ–µ. –ö—Ç–æ-—Ç–æ –ø–æ–¥—É–º–∞–µ—Ç –æ –∑–∞–≥–æ–≤–æ—Ä–µ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–æ–≤, —á—Ç–æ –æ–Ω–∏ –ø—Ä–æ–≤–æ—Ü–∏—Ä—É—é—Ç –Ω–µ–≥–∞—Ç–∏–≤–Ω—ã–µ —Å–æ–±—ã—Ç–∏—è, –Ω–æ –Ω–µ—Ç ‚Äî –¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ –ø—Ä–æ—Å—Ç–æ —Å–ª–µ–¥–∏—Ç—å –∑–∞ –∫–æ–Ω—Ç–µ–∫—Å—Ç–æ–º –∏ —Å–ª–µ–¥–æ–≤–∞—Ç—å –∑–∞ –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ–π —Ä–µ–≤–æ–ª—é—Ü–∏–µ–π. –í–Ω–µ–¥—Ä–µ–Ω–∞ –Ω–æ–≤–∞—è —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—è? –°—É–ø–µ—Ä, –±—É–¥—É—Ç –Ω–æ–≤—ã–µ –ø–æ–≤—Ä–µ–∂–¥–∞—é—â–∏–µ –∞–≥–µ–Ω—Ç—ã. AI-—á–∞—Ç–±–æ—Ç –∑–∞–º–µ–Ω—è–µ—Ç —á–µ–ª–æ–≤–µ—á–µ—Å–∫–∏–µ –æ—Ç–Ω–æ—à–µ–Ω–∏—è? –ö–ª–∞—Å—Å, –∂–¥—ë–º –≤–æ–ª–Ω—ã –ø—Å–∏—Ö–∏—á–µ—Å–∫–∏—Ö —Ä–∞—Å—Å—Ç—Ä–æ–π—Å—Ç–≤. –ü–æ –ø–æ–≤–æ–¥—É –ø–æ—Å–ª–µ–¥–Ω–µ–≥–æ —É–∂–µ —Å—É—â–µ—Å—Ç–≤—É—é—Ç –∏–Ω—Ç–µ—Ä–µ—Å–Ω—ã–µ –∫–µ–π—Å—ã: –≥–∞–∑–µ—Ç–∞ The New York Times —Å–æ–æ–±—â–∏–ª–∞, —á—Ç–æ –º—É–∂—á–∏–Ω–∞ –±—ã–ª –∑–∞—Å—Ç—Ä–µ–ª–µ–Ω –ø–æ–ª–∏—Ü–∏–µ–π –ø–æ—Å–ª–µ —Ç–æ–≥–æ, –∫–∞–∫ –±—Ä–æ—Å–∏–ª—Å—è –Ω–∞ –Ω–∏—Ö —Å –Ω–æ–∂–æ–º. –û–Ω —Å—á–∏—Ç–∞–ª, —á—Ç–æ OpenAI, —Å–æ–∑–¥–∞—Ç–µ–ª–∏ ChatGPT, —É–±–∏–ª–∏ –∂–µ–Ω—â–∏–Ω—É, –≤ –∫–æ—Ç–æ—Ä—É—é –æ–Ω –±—ã–ª –≤–ª—é–±–ª—ë–Ω. –≠—Ç–∞ –∂–µ–Ω—â–∏–Ω–∞ –±—ã–ª–∞ —Å—É—â–Ω–æ—Å—Ç—å—é –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–∞, —Å –∫–æ—Ç–æ—Ä–æ–π –æ–Ω –æ–±—â–∞–ª—Å—è —á–µ—Ä–µ–∑ ChatGPT. –ê —á—Ç–æ –≤ –∏—Ç–æ–≥–µ? –ê –≤ –∏—Ç–æ–≥–µ –Ω–∞ —Å–ª–µ–¥—É—é—â–µ–π –Ω–µ–¥–µ–ª–µ –º—ã —Å –≤–∞–º–∏ –±—É–¥–µ–º –ø–æ–≥—Ä—É–∂–∞—Ç—å—Å—è –≤ –≤–µ–ª–∏–∫–æ–ª–µ–ø–Ω—ã–µ —Ä–∞–±–æ—Ç—ã —ç–ø–∏–¥–µ–º–∏–æ–ª–æ–≥–æ–≤ –†–æ—Å—Å–∏–∏ –∏ –°–ù–ì, —á—Ç–æ–±—ã –ø–æ—Å–º–æ—Ç—Ä–µ—Ç—å, –∫–∞–∫ —Å—Ä–µ–¥–∞ —É–±–∏–≤–∞–µ—Ç —á–µ–ª–æ–≤–µ–∫–∞ –∏ –∫–∞–∫ –≤–ª–∏—è–µ—Ç –Ω–∞ —Ä—ã–Ω–∫–∏.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, epidemic, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The market for pharmaceuticals is growing regardless of political events. Any political event benefits one or another pharmaceutical company. Conflict and worsening atmosphere? Great, we will see an increase in the market for antidepressants. If there is a haze in your city? Super, we invest in anticancer and bronchodilator drugs. And so on... Some will think that pharmaceutical companies are provoking negative events, but no ‚Äî it's enough to follow the context and ride the industrial revolution. A new technology has been implemented? Great, we will see waves of mental disorders. An AI chatbot replaces human relationships? Cool, we are waiting for waves of psychological disorders. As an interesting case: The New York Times reported that a man was shot by the police after he threw himself at them with a knife. He believed that OpenAI, creators of ChatGPT, killed the woman he was in love with. This woman was a synthetic intelligence entity that he interacted with through ChatGPT. And what's the end? The end is that we will dive into the works of epidemiologists"
2025-10-10T09:57:54+00:00,@pharm_icon,2404,https://t.me/pharm_icon/2404,–°–∞–º–∞—è –≤–ª–∏—è—Ç–µ–ª—å–Ω–∞—èüòéüòéüòéüòé,"{""skip"": true}"
2025-10-10T09:57:40+00:00,@pharm_icon,2403,https://t.me/pharm_icon/2403,"üíä –í–µ–¥—É—â–∏–µ Telegram-–∫–∞–Ω–∞–ª—ã, –∫–æ—Ç–æ—Ä—ã–µ –∑–∞–¥–∞—é—Ç –ø–æ–≤–µ—Å—Ç–∫—É –≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π —Å—Ñ–µ—Ä–µ ‚Äî –°–ï–ù–¢–Ø–ë–†–¨ 2025. –†–µ–π—Ç–∏–Ω–≥ —Å–æ—Å—Ç–∞–≤–∏–ª –∫–ª—é—á–µ–≤–æ–π –∫–∞–Ω–∞–ª-–∞–≥—Ä–µ–≥–∞—Ç–æ—Ä –º–µ–¥–ø–æ–≤–µ—Å—Ç–∫–∏ –≤ Telegram ‚Äî ¬´–ú—É—Ä–∞—à–∫–æ –ø–æ –∫–æ–∂–µ¬ª (@murashko_med ‚Äî üéñ9,5 –º–ª–Ω. –ø—Ä–æ—Å–º–æ—Ç—Ä–æ–≤) –Ω–∞ –æ—Å–Ω–æ–≤–µ –¥–∞–Ω–Ω—ã—Ö üìä TGSTAT.ru –ø—Ä–∏ —ç–∫—Å–ø–µ—Ä—Ç–Ω–æ–π –ø–æ–¥–¥–µ—Ä–∂–∫–µ ¬´–ú–µ–¥–∏–∞—Ç–µ—Ö–Ω–æ–ª–æ–≥–∞¬ª (@mediatech). –ö–∞—á–µ—Å—Ç–≤–µ–Ω–Ω–∞—è –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è –∏ —Ä–∞–∑–Ω—ã–µ —Ç–æ—á–∫–∏ –∑—Ä–µ–Ω–∏—è, —Å–æ–±—Ä–∞–Ω–Ω—ã–µ –≤ –æ–¥–Ω–æ–º –º–µ—Å—Ç–µ: —á–∏—Ç–∞–π—Ç–µ —Ç–µ—Ö, –∫—Ç–æ —Ñ–æ—Ä–º–∏—Ä—É–µ—Ç –Ω–æ–≤–æ—Å—Ç–Ω—É—é –ª–µ–Ω—Ç—É –≤ –∏–Ω–¥—É—Å—Ç—Ä–∏–∏ ‚Äî –∏ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ –ø–æ–¥–ø–∏—Å—ã–≤–∞–π—Ç–µ—Å—å –Ω–∞ –Ω–∞—Å: @murashko_med. –¢–û–ü-25 ‚Äî –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –Ω–æ–≤–æ—Å—Ç–∏, –±–ª–æ–≥–∏ –≤—Ä–∞—á–µ–π –∏ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ (–ø–æ —Å—É–º–º–∞—Ä–Ω–æ–º—É –æ—Ö–≤–∞—Ç—É –∞—É–¥–∏—Ç–æ—Ä–∏–∏): ü•á. –ò–ú–ú–£–ù–ù–´–ô –û–¢–í–ï–¢ (@imotvet) ‚Äî 958,9k; ü•à. –ë–∞–¥–º–∞ –ë–∞—à–∞–Ω–∫–∞–µ–≤ (@Bashankaev) ‚Äî 628,1k; ü•â. –Æ—Ä–∏—Å—Ç –¥–ª—è –≤—Ä–∞—á–∞ –ê–Ω–≥–µ–ª–∏–Ω–∞ –†–æ–º–∞–Ω–æ–≤—Å–∫–∞—è (@mfcexpert_news) ‚Äî 525,6k; 4. –ö–û–ë–Ø–ö–û–í–ê (@okobyakova) ‚Äî 396,4k; 5. –ò–∫–æ–Ω–∞ –§–∞—Ä–º—ã (@pharm_icon) ‚Äî 358,7k; 6. –ú–µ–¥–∫–∞–¥—Ä—ã (@medkadry) ‚Äî 313k; 7. –°–æ–æ–±—â–µ—Å—Ç–≤–æ ¬´–í—Ä–∞—á–∏ –†–§¬ª (@VrachiRF_Official) ‚Äî 312,6k; 8. –ü–æ—è—Å–Ω–∏ –∑–∞ –º–µ–¥ (@poyasni_za_med) ‚Äî 287k; 9. –¶–ù–ò–ò–û–ò–ó (@cniioizofficial) ‚Äî 283,5k; 10. –ú–∏–Ω–ó–¥—Ä–∞–≤ –î–µ—Ç–∏ (@minzdravjunior) ‚Äî 263,2k; 11. –ü—Ä–∞–≤–æ –Ω–∞ –∑–¥–æ—Ä–æ–≤—å–µ (@right_to_health) ‚Äî 176,7k; 12. –Æ–†–ò–°–¢–´ –ó–ê –í–†–ê–ß–ï–ô (@meduristPopova) ‚Äî 164,6k; 13. –ú–µ–¥–∞—á (@medach) ‚Äî 160k; 14. –ú–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–π —é—Ä–∏—Å—Ç –ò–≤–∞–Ω –ü–µ—á–µ—Ä–µ–π (@pravomedapologists) ‚Äî 121,8; 15. Medical –ö—Å—é (@medicalksu) ‚Äî 103,2k; 16. –ú–µ–¥–¢–µ—Ö –õ–∞–±–æ—Ä–∞—Ç–æ—Ä–∏—è (@medtech_laboratory) ‚Äî 80,1; 17. –ì–æ–ª–æ–¥, —Ö–æ–ª–æ–¥ –∏ –ø–æ–∫–æ–π (@Caduceusmed) ‚Äî 72k; 18. –í–∞—Ä–∏–≤–æ–¥–∞ MED&TECH (@Varivoda_medtech) ‚Äî 48,5k; 19. –°–µ—Ä–≥–µ–π –õ–µ–æ–Ω–æ–≤ (@leONovLIFE) ‚Äî 43,1k; 20. –ê–π—Ä–∞—Ç –§–∞—Ä—Ä–∞—Ö–æ–≤ (@ayratfarrahov) ‚Äî 30,6k; 21. –ù–µ–ú–∏–Ω–∑–¥—Ä–∞–≤ (@rus_med) ‚Äî 22k; 22. –î–º–∏—Ç—Ä–∏–π –•—É–±–µ–∑–æ–≤ (@KhubezovDmitrii) ‚Äî 18,3k; 23. –í–ª–∞—Å–æ–≤–∞ –í–µ—Ä–æ–Ω–∏–∫–∞ (@VlasovaVeronika) ‚Äî 14k; 24. –õ–µ–æ–Ω–∏–¥ –û–≥—É–ª—å (@Leonid_ogul) ‚Äî 13,4k; 25. –ú–∏—Ö–∞–∏–ª –ö–∏–∑–µ–µ–≤ (@kizeev_mv) ‚Äî 4,1k. –ù–µ —Ç–æ–ª—å–∫–æ –æ –º–µ–¥–∏—Ü–∏–Ω–µ, –Ω–æ –≤–∞–∂–Ω–æ –¥–ª—è –≤–Ω–∏–º–∞–Ω–∏—è (–ø–æ –ø–æ–¥–ø–∏—Å—á–∏–∫–∞–º): 1. REDACTED P6 (–ö–û–¢–Å–õ #6) (@redacted6); 2. –ú–æ—Å–∫–æ–≤—Å–∫–∞—è –ø—Ä–∞—á–µ—á–Ω–∞—è (@moscow_laundry); 3. –°–∫—É—Ä–ª–∞—Ç–æ–≤ live (@skurlatovlive); 4. Lomovka (@lomovkaa); 5. –ù–û–° (@nos_chanel); 6. –ë–æ–π–ª–µ—Ä–Ω–∞—è (@boilerroomchannel); 7. –ö—Ä–µ–º–ª—ë–≤—Å–∫–∏–π –º–∞–º–∫–æ–≤–µ–¥ (@kremlin_mother_expert); 8. –ü–∞—É–∫–∏ –≤ –±–∞–Ω–∫–µ (@bankuyte); 9. –ë—É–ª—å–¥–æ–≥–∏ –ø–æ–¥ –∫–æ–≤—Ä–æ–º (@kremlin_bulldogs); 10. –ö—Ä–∏—Ç–∏–∫ –Ω–æ–≤–æ—Å—Ç–Ω–æ–π –ª–µ–Ω—Ç—ã (@kritiknewsfeed); 11. –ù–æ–≤–æ—Å—Ç–∏ —Å–µ–≥–æ–¥–Ω—è (@listnewsru); 12. –ö–ê–†–ù–ê–£–•–û–í (@sskarnaukhov); 13. –ó–æ–Ω–∞ –æ—Å–æ–±–æ–≥–æ –≤–Ω–∏–º–∞–Ω–∏—è (@zonaosoboho): 14. –ú–µ–¥–∏–∞—Ç–µ—Ö–Ω–æ–ª–æ–≥ (@mediatech): 15. –î–µ–ø—É—Ç–∞—Ç—Å–∫–∏–µ –±—É–¥–Ω–∏ (@deputatdumy); 16. –¢–µ–ª–µ –°—Ç—Ä–∏–º (@infoagency_TS); 17. –ö–†–´–ú–ò–ù–§–û–†–£–ú (@ZOVcrimea); 18. –ú–∞—Å—Ç–µ—Ä –ø–µ—Ä–∞ (@master_pera); 19. –ù–µ—É–¥–∞—â–∞ (@dirtytatarstan); 20. –§—É—Ç–ª—è—Ä –¥–ª—è –∫—É—Ä–∞—è (@kuraifutlar). –ù–µ –Ω–∞—à–ª–∏ –∫–∞–Ω–∞–ª, –∫–æ—Ç–æ—Ä—ã–π —á–∏—Ç–∞–µ—Ç–µ? –ü–∏—à–∏—Ç–µ —Å–≤–æ–∏ –≤–æ–ø—Ä–æ—Å—ã –∏ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è ‚Äî –≤ –±–æ—Ç: @mursvyz_bot. üöë –ü–æ–¥–ø–∏—Å—ã–≤–∞–π—Ç–µ—Å—å –Ω–∞ @murashko_med.","{""skip"": true}"
2025-10-10T05:03:43+00:00,@pharm_icon,2402,https://t.me/pharm_icon/2402,"‚Äú–•–æ—Ä–æ—à–∏–π –≤—Ä–∞—á –≤—Å–µ–≥–¥–∞ –Ω–∞–π–¥–µ—Ç –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤‚Äù - –≤ 2025 –≥–æ–¥—É –Ω–µ —Ä–∞–±–æ—Ç–∞–µ—Ç –ë–∞–∑–æ–≤—ã–π –º–∏–Ω–∏–º—É–º —Å–æ–≤—Ä–µ–º–µ–Ω–Ω–æ–≥–æ –≤—Ä–∞—á–∞ —Å–æ —Å—Ç–∞–±–∏–ª—å–Ω—ã–º –ø–∞—Ü–∏–µ–Ω—Ç–æ–ø–æ—Ç–æ–∫–æ–º - –≤–µ–¥–µ–Ω–∏–µ Telegram, –ù–µ–ª—å–∑—è–≥—Ä–∞–º–º–∞ –∏ YouTube-–∫–∞–Ω–∞–ª–æ–≤, –ø–æ—Ç–æ–º—É —á—Ç–æ –±–æ–ª—å—à–µ –ø–æ–ª–æ–≤–∏–Ω—ã —Å–≤–æ–±–æ–¥–Ω–æ–≥–æ –≤—Ä–µ–º–µ–Ω–∏ –ª—é–¥–∏ –ø—Ä–æ–≤–æ–¥—è—Ç –∏–º–µ–Ω–Ω–æ —Ç–∞–º. –¢–æ –µ—Å—Ç—å –µ—Å–ª–∏ –≤–∞—Å –Ω–µ—Ç –≤ —Å–æ—Ü—Å–µ—Ç—è—Ö, –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–∞ –≤–∞—Å –ø—Ä–æ—Å—Ç–æ –Ω–µ —Å—É—â–µ—Å—Ç–≤—É–µ—Ç. –í—ã —Å–∫–∞–∂–∏—Ç–µ - ‚Äú—Å–Ω–∏–º–∞—é —Å—Ç–æ—Ä–∏—Å, –ø–∏—à—É –ø–æ—Å—Ç—ã, –∞ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ - –Ω–æ–ª—å. –¢–æ–≥–¥–∞ –≤ —á–µ–º –ø—Ä–æ–±–ª–µ–º–∞?‚Äù –î–∞ –≤ —á–µ–º —É–≥–æ–¥–Ω–æ - –Ω–µ—Ä–µ–≥—É–ª—è—Ä–Ω—ã–π –∫–æ–Ω—Ç–µ–Ω—Ç, –µ–≥–æ –Ω–µ –∞–∫—Ç—É–∞–ª—å–Ω–æ—Å—Ç—å –∏–ª–∏ –Ω–µ –≤–µ—Ä–Ω—ã–π —Ñ–æ—Ä–º–∞—Ç. –ü—Ä–∏—á–∏–Ω –º–æ–∂–µ—Ç –±—ã—Ç—å —É–π–º–∞. –ê –∏—Ç–æ–≥ –æ–¥–∏–Ω - –≤—Ä–µ–º—è –ø–æ—Ç—Ä–∞—á–µ–Ω–æ, –∞ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Ç–∞–∫ –∏ –Ω–µ—Ç. –ß—Ç–æ –ø–µ—Ä–≤–æ–µ –ø—Ä–∏—Ö–æ–¥–∏—Ç –≤ –≥–æ–ª–æ–≤—É, –Ω–æ —Ç–æ—á–Ω–æ –Ω–µ –ø—Ä–∏–Ω–µ—Å–µ—Ç —Ä–µ–∑—É–ª—å—Ç–∞—Ç? ‚õîÔ∏è –ù–∞–Ω—è—Ç—å –°–ú–ú—â–∏–∫–∞ –ò–º–µ–µ—Ç –º–µ—Å—Ç–æ –±—ã—Ç—å, –Ω–æ –≤—Ä—è–¥ –ª–∏ –±—É–¥–µ—Ç —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã–º: —É –≤–∞—Å —Ç–æ—á–Ω–æ –±—É–¥—É—Ç —è—Ä–∫–∏–µ –ø–æ—Å—Ç—ã, –Ω–æ –æ–Ω–∏ –Ω–µ –∑–∞–∏–Ω—Ç–µ—Ä–µ—Å—É—é—Ç –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –û—á–µ–Ω—å —á–∞—Å—Ç–æ –°–ú–ú—â–∏–∫ –ø–æ–Ω—è—Ç–∏—è –Ω–µ –∏–º–µ–µ—Ç, —á—Ç–æ —Ç–∞–∫–æ–µ –º–µ–¥–∏—Ü–∏–Ω–∞, –∞ –ø–æ–Ω–∏–º–∞–Ω–∏–µ –∞—É–¥–∏—Ç–æ—Ä–∏–∏ - –∫–ª—é—á–µ–≤–æ–µ –≤ –∫–æ–Ω—Ç–µ–Ω—Ç–µ ‚õîÔ∏è –ö—É–ø–∏—Ç—å –∫—É—Ä—Å—ã –ø–æ –°–ú–ú –ù–∞—á–∞—Ç—å –≤—Å–µ –¥–µ–ª–∞—Ç—å —Å–≤–æ–∏–º–∏ —Ä—É–∫–∞–º–∏ –∏ –ø–æ—Å–ª–µ 3 —á–∞—Å–æ–≤ –Ω–∞—Å—Ç—Ä–æ–π–∫–∏ —Å–≤–µ—Ç–∞ –∏ –∫–∞–º–µ—Ä—ã –≤—Å–ø–æ–º–Ω–∏—Ç—å, —á—Ç–æ —á–µ—Ä–µ–∑ 5 —á–∞—Å–æ–≤ —É–∂–µ –≤—Å—Ç–∞–≤–∞—Ç—å –Ω–∞ —Ä–∞–±–æ—Ç—É. –ê –ø–æ—Ç–æ–º –∑–∞—Å—É–Ω—É—Ç—å –≤—Å—ë —ç—Ç–æ –≤ —Ç–æ—Ç –∂–µ —è—â–∏–∫, –≥–¥–µ –ª–µ–∂–∞—Ç –º–µ—á—Ç—ã –æ —Å–ø–æ—Ä—Ç–µ, —Ö–æ–±–±–∏ –∏ –ø—Ä–æ—á–∏—Ö ""–Ω—É –≤ –¥—Ä—É–≥–æ–π —Ä–∞–∑"" ‚úÖ –ò–ª–∏ –∂–µ –≤—ã –º–æ–∂–µ—Ç–µ –Ω–∞—á–∞—Ç—å —Ä–∞–±–æ—Ç–∞—Ç—å –≤ –ø–∞—Ä—Ç–Ω–µ—Ä—Å—Ç–≤–µ —Å –∫–æ–º–∞–Ω–¥–æ–π, –∫–æ—Ç–æ—Ä—É—é —Å–æ–±—Ä–∞–ª –≤—Ä–∞—á –¥–ª—è –ø—Ä–æ–¥–≤–∏–∂–µ–Ω–∏—è –¥—Ä—É–≥–∏—Ö –¥–æ–∫—Ç–æ—Ä–æ–≤ –¶–µ–ª—å –æ–¥–Ω–∞ - –ø–æ–º–æ—á—å –≤—Ä–∞—á–∞–º –∑–∞—Ä–∞–±–∞—Ç—ã–≤–∞—Ç—å –∏ –ø—Ä–æ—è–≤–ª—è—Ç—å—Å—è —á–µ—Ä–µ–∑ —Å–æ—Ü—Å–µ—Ç–∏. –í–∞—à–µ–º—É –Ω–∞—á–∞–ª—å—Å—Ç–≤—É –Ω–µ –Ω—É–∂–µ–Ω –≤–∞—à —É—Å–ø–µ—Ö, —ç—Ç–æ –Ω—É–∂–Ω–æ —Ç–æ–ª—å–∫–æ –≤–∞–º –≠—Ç–æ –¥–ª–∏–Ω–Ω—ã–π –∏ —Ç—Ä—É–¥–Ω—ã–π –ø—É—Ç—å, –Ω–æ –µ–≥–æ —É–∂–µ –ø—Ä–æ—à–ª–∏ –≤–∞—à–∏ –∫–æ–ª–ª–µ–≥–∏: üìå –ì–∞–ª–∫–∏–Ω –ê–Ω–¥—Ä–µ–π - –¥–æ–∫—Ç–æ—Ä, –∫–æ—Ç–æ—Ä—ã–π –Ω–∞ —Å–≤–æ–µ–º –∫—É—Ä—Å–µ –∑–∞—Ä–∞–±–æ—Ç–∞–ª 3+ –º–ª–Ω —Ä—É–±–ª–µ–π üìå –ö–∞—Ä–∞–µ–≤ –ù—É—Ä–∞—Ö–º–µ–¥ - –≤—ã—Å—Ç—Ä–æ–∏–ª –ø–∞—Ü–∏–µ–Ω—Ç–æ–ø–æ—Ç–æ–∫ —Å –∑–∞–ø–∏—Å—å—é –Ω–∞ –ø–æ–ª–≥–æ–¥–∞ –≤–ø–µ—Ä–µ–¥ üìå –ú–µ–ª–∞–Ω—è –ú–∞–∏–ª—è–Ω - –≥–∏–Ω–µ–∫–æ–ª–æ–≥, –∫–æ—Ç–æ—Ä–∞—è –ø–æ–¥–Ω—è–ª–∞ —á–µ–∫ –Ω–∞ 2—Ö üìå –î–∞–Ω–∏–ª–∞ –ü—ã—Ä–∏–∫–æ–≤ - —Å–æ–∑–¥–∞–ª –ø—Ä–æ–¥—É–∫—Ç –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–æ–π –±–æ–ª–µ–∑–Ω—å—é –ø–æ—á–µ–∫ –∏ —Å–¥–µ–ª–∞–ª —Ä–µ–∫–æ—Ä–¥–Ω—ã–π –∑–∞–ø—É—Å–∫ –û —Ç–æ–º –∫–∞–∫ –≤—Ä–∞—á—É –∏–º–µ—Ç—å –ø–ª–æ—Ç–Ω—É—é –∑–∞–ø–∏—Å—å –∏ –∫–∞–∫–∏–µ –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç—ã –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å —É–∂–µ —Å–µ–π—á–∞—Å —Å–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω–æ –º–æ–∂–Ω–æ –ø–æ—Å–º–æ—Ç—Ä–µ—Ç—å –±–µ—Å–ø–ª–∞—Ç–Ω–æ —Ç—É—Ç üëâ –ü–æ–¥–ø–∏—Å—ã–≤–∞–π—Ç–µ—Å—å –Ω–∞ –∫–∞–Ω–∞–ª –§–∞—Ä—É—Ö–∞ –∏ —É–∑–Ω–∞–π—Ç–µ, –∫–∞–∫ —É–≤–µ–ª–∏—á–∏—Ç—å –ø–∞—Ü–∏–µ–Ω—Ç–æ–ø–æ—Ç–æ–∫ –∏ –∑–∞—Ä–∞–±–∞—Ç—ã–≤–∞—Ç—å –Ω–∞ —Å–≤–æ–µ–º –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª–∏–∑–º–µ.","{
  ""skip"": true,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,hospital_policy,pharmacovigilance,safety"",
  ""impact"": ""medium"",
  ""english"": ""The message discusses the importance of social media presence for doctors and how it can increase patient engagement. However, it does not provide specific regulatory or market access implications for medicines.""
}"
2025-10-09T11:31:37+00:00,@pharm_icon,2401,https://t.me/pharm_icon/2401,"üòØ –í —á–µ—Å—Ç—å –ú–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–æ–≥–æ –¥–Ω—è –≤—Ä–∞—á–∞ –ø–æ–¥–≥–æ—Ç–æ–≤–∏–ª–∏ –¥–ª—è –≤–∞—Å –ø–æ–¥–∞—Ä–æ–∫ ‚Äî –ø–æ–¥–±–æ—Ä–∫—É –ø–æ–ª–µ–∑–Ω—ã—Ö –∏ –∏–Ω—Ç–µ—Ä–µ—Å–Ω—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –¢–µ–ª–µ–≥—Ä–∞–º-–∫–∞–Ω–∞–ª–æ–≤: üñ• –ù–æ–≤–æ—Å—Ç–∏ –º–µ–¥–∏—Ü–∏–Ω—ã –∏ –Ω–∞—É–∫–∞ –ú–µ–¥–∞—á: —Å—Ç–∞—Ç—å–∏, —Å–≤–µ–∂–∏–µ –Ω–æ–≤–æ—Å—Ç–∏, –ø–µ—Ä–µ–≤–æ–¥—ã –∏–∑ –≤–µ–¥—É—â–∏—Ö –∏–∑–¥–∞–Ω–∏–π –∏ –ø–æ–¥–∫–∞—Å—Ç—ã —Å —ç–∫—Å–ø–µ—Ä—Ç–∞–º–∏ Vademecum Live: –Ω–æ–≤–æ—Å—Ç–∏ –∏ –Ω–µ —Ç–æ–ª—å–∫–æ –æ—Ç —Ä–µ–¥–∞–∫—Ü–∏–∏ —Å–∞–π—Ç–∞ –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –¥–µ–ª–æ–≤–æ–≥–æ –∏–∑–¥–∞–Ω–∏—è –æ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–∏ Vademecum –ü–µ—Ä–≤—ã–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–π –∫–∞–Ω–∞–ª: –æ–Ω–ª–∞–π–Ω-—Ç–µ–ª–µ–≤–∏–¥–µ–Ω–∏–µ –¥–ª—è –≤—Ä–∞—á–µ–π, –Ω–æ–≤–æ—Å—Ç–∏ –∏ –ø–æ–ª–µ–∑–Ω—ã–µ –º–∞—Ç–µ—Ä–∏–∞–ª—ã ‚ö°Ô∏è –ü—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—ã–µ –∏–∑–¥–∞–Ω–∏—è –ê–∫—Ç–∏–æ–Ω –¥–ª—è –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤: –ø–æ–ª–µ–∑–Ω—ã–µ –º–∞—Ç–µ—Ä–∏–∞–ª—ã –¥–ª—è –≤—Ä–∞—á–µ–π, –º–µ–¥—Å–µ—Å—Ç–µ—Ä, —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–æ–≤ –∏ –∞–¥–º–∏–Ω–∏—Å—Ç—Ä–∞—Ü–∏–∏ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏–π –ù–µ–∑–∞–≤–∏—Å–∏–º–∞—è –ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–∞—è –ê–∫–∞–¥–µ–º–∏—è –î–æ–∫–∞–∑–∞—Ç–µ–ª—å–Ω–æ–π –ú–µ–¥–∏—Ü–∏–Ω—ã (–ù–ö–û –ù–ù–ê–î–ú): –Ω–∞ –ø–ª–∞—Ç—Ñ–æ—Ä–º–µ –≤—ã –Ω–∞–π–¥–µ—Ç–µ –º–∞—Ç–µ—Ä–∏–∞–ª—ã –≤ –æ–±–ª–∞—Å—Ç–∏ –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω—ã –∏ –∫—Ä–∏—Ç–∏—á–µ—Å–∫–æ–π –æ—Ü–µ–Ω–∫–∏ –Ω–∞—É—á–Ω—ã—Ö –ø—É–±–ª–∏–∫–∞—Ü–∏–π Non Nocere: –≥–ª—è–Ω—Ü–µ–≤–æ–µ –∏–∑–¥–∞–Ω–∏–µ –¥–ª—è –≤—Ä–∞—á–µ–π –ª—é–±—ã—Ö —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–µ–π –†–õ–° –ú–µ–¥–∏—Ü–∏–Ω–∞ –∏ —Ñ–∞—Ä–º–∞—Ü–∏—è: –∫–∞–Ω–∞–ª –Ω–∞–∏–±–æ–ª–µ–µ –ø–æ–ª–Ω–æ–π –±–∞–∑—ã –¥–∞–Ω–Ω—ã—Ö –æ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞—Ö, –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –≤ –†–§ –§–∞—Ä–º–∞ –†–§: –ø–æ–ª–µ–∑–Ω—ã–π –∫–∞–Ω–∞–ª –¥–ª—è —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π —Å—Ñ–µ—Ä—ã ‚≠êÔ∏è –ê–≤—Ç–æ—Ä—Å–∫–∏–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –∫–∞–Ω–∞–ª—ã, –±–ª–æ–≥–∏ –ú–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –ª–µ–∫—Ü–∏–∏ –∫–Ω–∏–≥–∏ –∫—É—Ä—Å—ã: –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è –ª–∏—Ç–µ—Ä–∞—Ç—É—Ä–∞ –≤ –æ—Ç–∫—Ä—ã—Ç–æ–º –¥–æ—Å—Ç—É–ø–µ –ü–∞—Ç–æ–ª–æ–≥–∏—è: —Å–∞–º—ã–µ –Ω–µ–æ–±—ã—á–Ω—ã–µ –∏ –≤–ø–µ—á–∞—Ç–ª—è—é—â–∏–µ –ø–∞—Ç–æ–ª–æ–≥–∏–∏ Coroner's word: –æ —Ç–æ–º: –∫–∞–∫ –Ω–µ —É–º–µ—Ä–µ—Ç—å –º–æ–ª–æ–¥—ã–º, –æ —Ä–∞–±–æ—Ç–µ –≤ –º–æ—Ä–≥–µ –∏ –Ω–∞—à–µ–º –æ—Ä–≥–∞–Ω–∏–∑–º–µ –≤ —Ü–µ–ª–æ–º –ü–∞—Ä–∞–≥–Ω–æ–º–µ–Ω: —Å—Ç—Ä–∞—Ö –∏ –Ω–µ–Ω–∞–≤–∏—Å—Ç—å –≤ –ø—Ä–æ–≤–∏–Ω—Ü–∏–∞–ª—å–Ω–æ–π –ø—Å–∏—Ö–∏–∞—Ç—Ä–∏–∏ –î–û–ö–ê–ó–ê–¢–ï–õ–¨–ù–ê–Ø –ö–ê–†–î–ò–û–õ–û–ì–ò–Ø: –æ–±–∑–æ—Ä –ø–æ—Å–ª–µ–¥–Ω–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π, –ø–æ–ª–µ–∑–Ω—ã–µ –º–∞—Ç–µ—Ä–∏–∞–ª—ã –¥–ª—è –ø—Ä–∞–∫—Ç–∏–∫—É—é—â–∏—Ö –∫–∞—Ä–¥–∏–æ–ª–æ–≥–æ–≤ –ö–∞—Ä–¥–∏–æ –£–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç: –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω—ã–π –∫–∞–Ω–∞–ª –¥–ª—è –∫–∞—Ä–¥–∏–æ–ª–æ–≥–æ–≤ ‚Äî –Ω–æ–≤–æ—Å—Ç–∏, –∫–Ω–∏–≥–∏, –ª–µ–∫—Ü–∏–∏ Medical –ö—Å—é: –∫–∞–Ω–∞–ª –æ –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—ã—Ö –æ—Å–æ–±–µ–Ω–Ω–æ—Å—Ç—è—Ö —Ü–∏—Ñ—Ä–æ–≤–æ–≥–æ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –≤ –†–æ—Å—Å–∏–∏ –∏ –≤–æ –≤—Å–µ–º –º–∏—Ä–µ –¢–≤–æ–π —Å—Ç–æ–º–∞—Ç–æ–ª–æ–≥: –ª–∏—á–Ω—ã–π –¥–æ–≥ –≤—Ä–∞—á–∞-—Å—Ç–æ–º–∞—Ç–æ–ª–æ–≥–∞ –¢—Ä–æ—Ñ–∏–º–æ–≤–∞ –í–∞–¥–∏–º–∞ –û–ª–µ–≥–æ–≤–∏—á–∞ –†–µ–Ω—Ç–≥–µ–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–π –±–ª–æ–≥ –ö—Å–µ–Ω–∏–∏ –ê–Ω–¥—Ä–µ–µ–≤–Ω—ã: –ø–æ–ª–µ–∑–Ω—ã–µ –º–∞—Ç–µ—Ä–∏–∞–ª—ã, –∫—É—Ä—Å—ã, –≤–µ–±–∏–Ω–∞—Ä—ã –¥–ª—è —Ä–µ–Ω—Ç–≥–µ–Ω–æ–ª–æ–≥–æ–≤ –ò–∫–æ–Ω–∞ –§–∞—Ä–º—ã: –∫–∞–Ω–∞–ª –¥–ª—è —Ç–µ—Ö, –∫—Ç–æ –≤—Å–µ–≥–¥–∞ —Ö–æ—á–µ—Ç –±—ã—Ç—å –≤ –∫—É—Ä—Å–µ —Ñ–∞—Ä–º–ø–æ–≤–µ—Å—Ç–∫–∏ –î–æ–∫—Ç–æ—Ä –û–Ω–∫–æ–ª–æ–≥: –≤—Å–µ–≥–¥–∞ –∞–∫—Ç—É–∞–ª—å–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ –≤ —Å—Ñ–µ—Ä–µ –æ–Ω–∫–æ–ª–æ–≥–∏–∏ Doctor Reznikov: –≤—Ä–∞—á-–ø—Å–∏—Ö–∏–∞—Ç—Ä, –ø—Å–∏—Ö–æ—Ç–µ—Ä–∞–ø–µ–≤—Ç, –∫.–º.–Ω. –°—Ç–æ—Ä–æ–Ω–Ω–∏–∫ EBM —Å —É—á–µ—Ç–æ–º –∑–¥—Ä–∞–≤–æ–≥–æ —Å–º—ã—Å–ª–∞ —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö —Ä–µ–∞–ª–∏–π –ë—Ä–µ–Ω–¥–º–µ–π–∫–µ—Ä –≤—Ä–∞—á–µ–π: –∫–∞–∫ –≤—Ä–∞—á—É —Å–æ–∑–¥–∞—Ç—å –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–π –±–ª–æ–≥, –ª–∏—á–Ω—ã–π –±—Ä–µ–Ω–¥ –∏ –∫–æ–Ω–≤–µ—Ä—Ç–∏—Ä–æ–≤–∞—Ç—å –∏—Ö –≤ –ø–æ—Ç–æ–∫ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ üî• –Æ—Ä–∏–¥–∏—á–µ—Å–∫–∏–µ –≤–æ–ø—Ä–æ—Å—ã –∏ –æ—Ä–≥–∑–¥—Ä–∞–≤ ¬´–í—Ä–∞—á–∏ –†–§¬ª. –û—Ä–≥–∑–¥—Ä–∞–≤: –∫–∞–Ω–∞–ª –¥–ª—è —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –≤ —Å—Ñ–µ—Ä–µ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –æ—Ç –Ω–∞—à–µ–≥–æ —Å–æ–æ–±—â–µ—Å—Ç–≤–∞ –Æ—Ä–∏—Å—Ç –¥–ª—è –≤—Ä–∞—á–∞ –ê–Ω–≥–µ–ª–∏–Ω–∞ –†–æ–º–∞–Ω–æ–≤—Å–∫–∞—è: –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–π —é—Ä–∏—Å—Ç, —Å–æ—É—á—Ä–µ–¥–∏—Ç–µ–ª—å ¬´–ú–§–ö–≠–ö–°–ü–ï–†–¢¬ª, –≥–¥–µ –∑–∞—â–∏—â–∞—é—Ç –∏ –æ–±—É—á–∞—é—Ç –≤—Ä–∞—á–µ–π –ê–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏—è –≤—Ä–∞—á–µ–π: –æ–±–∑–æ—Ä—ã –Ω–æ–≤–æ–≤–≤–µ–¥–µ–Ω–∏–π, –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤, –ø—Ä–∏–∫–∞–∑–æ–≤ –ú–µ–¥–∫–∞–¥—Ä—ã: –Ω–æ–≤–æ—Å—Ç–∏ –æ—Ä–≥–∑–¥—Ä–∞–≤–∞, –ø–æ–ª–µ–∑–Ω–∞—è –¥–æ–∫—É–º–µ–Ω—Ç–∞—Ü–∏—è –ú–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–π —é—Ä–∏—Å—Ç –ò–≤–∞–Ω –ü–µ—á–µ—Ä–µ–π: —é—Ä–∏—Å—Ç, –∑–∞—â–∏—â–∞—é—â–∏–π –∏—Å–∫–ª—é—á–∏—Ç–µ–ª—å–Ω–æ –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –∏ –º–µ–¥–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –§–∞–∫—É–ª—å—Ç–µ—Ç –ú–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –ü—Ä–∞–≤–∞: —é—Ä–∏–¥–∏—á–µ—Å–∫–∞—è –∫–æ–º–ø–∞–Ω–∏—è, —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä—É—é—â–∞—è—Å—è –Ω–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–º –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–º –ø—Ä–∞–≤–µ ‚Äî —Ç—ã—Å—è—á–∏ —Å—É–¥–µ–±–Ω—ã—Ö –¥–µ–ª –∏ —Å–ª–æ–∂–Ω—ã—Ö –∫–µ–π—Å–æ–≤ –û—Ä–≥–ó–¥—Ä–∞–≤ –≠–∫—Å–ø–µ—Ä—Ç: –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω—ã–π –∫–∞–Ω–∞–ª –¥–ª—è –≤—Å–µ—Ö, –∫—Ç–æ —Å–≤—è–∑–∞–Ω —Å –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–µ–π –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –°—Ç–∞–≤—å—Ç–µ üêç, –µ—Å–ª–∏ –ø–æ–Ω—Ä–∞–≤–∏–ª–∞—Å—å –ø–æ–¥–±–æ—Ä–∫–∞. –î–µ–ª–∏—Ç–µ—Å—å —Å –∫–æ–ª–ª–µ–≥–∞–º–∏! –°–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–æ —Å —Å–æ–æ–±—â–µ—Å—Ç–≤–æ–º ¬´–í—Ä–∞—á–∏ –†–§¬ª","{""skip"": true}"
2025-10-08T15:20:40+00:00,@pharm_icon,2400,https://t.me/pharm_icon/2400,"üî• –ú–ï–î–ò–¶–ò–ù–°–ö–û–ï –†–ê–ë–°–¢–í–û –£–¢–í–ï–†–ñ–î–ê–Æ–¢ –û–§–ò–¶–ò–ê–õ–¨–ù–û: –ì–û–°–î–£–ú–ê –ü–†–ï–í–†–ê–©–ê–ï–¢ –í–†–ê–ß–ï–ô –í –ö–†–ï–ü–û–°–¢–ù–´–• –í–ª–∞—Å—Ç—å –¥–µ–º–æ–Ω—Å—Ç—Ä–∏—Ä—É–µ—Ç –Ω–æ–≤—ã–π —É—Ä–æ–≤–µ–Ω—å —Ü–∏–Ω–∏–∑–º–∞. –ü—Ä–∏–Ω—è—Ç—ã–π –≤ –ø–µ—Ä–≤–æ–º —á—Ç–µ–Ω–∏–∏ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç ‚Äî —ç—Ç–æ –Ω–µ –ø—Ä–æ—Å—Ç–æ ""—Ä–µ—Ñ–æ—Ä–º–∞"", –∞ —é—Ä–∏–¥–∏—á–µ—Å–∫–æ–µ –æ—Ñ–æ—Ä–º–ª–µ–Ω–∏–µ –∫—Ä–µ–ø–æ—Å—Ç–Ω–æ–≥–æ –ø—Ä–∞–≤–∞ –≤ –º–µ–¥–∏—Ü–∏–Ω–µ. –¢–µ–ø–µ—Ä—å —Å–∏—Å—Ç–µ–º–∞ –±—É–¥–µ—Ç —É–¥–µ—Ä–∂–∏–≤–∞—Ç—å –≤—Ä–∞—á–µ–π –Ω–µ —Å–æ–≤—Ä–µ–º–µ–Ω–Ω—ã–º –æ–±–æ—Ä—É–¥–æ–≤–∞–Ω–∏–µ–º –∏ –≤—ã—Å–æ–∫–∏–º–∏ –∑–∞—Ä–ø–ª–∞—Ç–∞–º–∏, –∞ –ø—Ä—è–º—ã–º –∞–¥–º–∏–Ω–∏—Å—Ç—Ä–∞—Ç–∏–≤–Ω—ã–º –Ω–∞—Å–∏–ª–∏–µ–º. üíÄ –ê–±—Å—É—Ä–¥ –¥–æ—Å—Ç–∏–≥ –Ω–æ–≤–æ–≥–æ —É—Ä–æ–≤–Ω—è: ¬∑ –¶–µ–ª–µ–≤–∏–∫–∏ ‚Äî –∏ —Ç–∞–∫ –æ–±—è–∑–∞–Ω—ã –æ—Ç—Ä–∞–±–∞—Ç—ã–≤–∞—Ç—å, –Ω–æ —Ç–µ–ø–µ—Ä—å –∏ –±—é–¥–∂–µ—Ç–Ω–∏–∫–æ–≤ –∂–¥—ë—Ç —É–∂–µ –Ω–µ —Ä–∞—Å–ø—Ä–µ–¥–µ–ª–µ–Ω–∏–µ, –∞ –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω–∞—è –æ—Ç—Ä–∞–±–æ—Ç–∫–∞ –±–µ–∑ –ø—Ä–∞–≤–∞ –≤—ã–±–æ—Ä–∞, –ª–∏–±–æ —Ç—Ä—ë—Ö–∫—Ä–∞—Ç–Ω—ã–π —à—Ç—Ä–∞—Ñ —Å—Ç–æ–∏–º–æ—Å—Ç–∏ –æ–±—É—á–µ–Ω–∏—è! ¬∑ –ü–ª–∞—Ç–Ω–∏–∫–∏ ‚Äî –∑–∞–ø–ª–∞—Ç–∏–ª–∏ –º–∏–ª–ª–∏–æ–Ω—ã –∑–∞ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ, –Ω–æ —Ç–µ–ø–µ—Ä—å —Ç–∞–∫–∂–µ –¥–æ–ª–∂–Ω—ã –ø—Ä–æ–π—Ç–∏ 3 –≥–æ–¥–∞ —Ä–∞–±—Å—Ç–≤–∞ –ø–æ–¥ –≤–∏–¥–æ–º ""–Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–∞"", –∏–Ω–∞—á–µ ‚Äî –∑–∞–ø—Ä–µ—Ç –Ω–∞ –ø—Ä–æ—Ñ–µ—Å—Å–∏—é ¬∑ ""–ü—Ä–æ—Å—å–±—ã –≥—Ä–∞–∂–¥–∞–Ω"" ‚Äî —á–∏—Å—Ç–µ–π—à–∏–π –≥–∞–∑–ª–∞–π—Ç–∏–Ω–≥, –∫–æ–≥–¥–∞ 90% –æ—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω—ã—Ö –æ—Ç–∑—ã–≤–æ–≤ –∏–≥–Ω–æ—Ä–∏—Ä—É—é—Ç—Å—è, –∞ –º–Ω–µ–Ω–∏–µ–º ""–ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ —Å–æ–æ–±—â–µ—Å—Ç–≤–∞"" –Ω–∞–∑—ã–≤–∞—é—Ç —à–µ–ø–æ—Ç–æ–∫ –ª–æ—è–ª—å–Ω—ã—Ö —á–∏–Ω–æ–≤–Ω–∏–∫–æ–≤ ü©∫ –ß—Ç–æ —ç—Ç–æ –Ω–∞ —Å–∞–º–æ–º –¥–µ–ª–µ: 1. –°–∏—Å—Ç–µ–º–∞ –ø—Ä–∏–∑–Ω–∞–ª–∞ —Å–≤–æ–µ –±–∞–Ω–∫—Ä–æ—Ç—Å—Ç–≤–æ ‚Äî –æ–Ω–∞ –Ω–µ –º–æ–∂–µ—Ç —É–¥–µ—Ä–∂–∞—Ç—å –≤—Ä–∞—á–µ–π –¥–æ—Å—Ç–æ–π–Ω—ã–º–∏ —É—Å–ª–æ–≤–∏—è–º–∏, –ø–æ—ç—Ç–æ–º—É –ø–µ—Ä–µ—Ö–æ–¥–∏—Ç –∫ –ø—Ä—è–º–æ–º—É –∑–∞–∫—Ä–µ–ø–æ—â–µ–Ω–∏—é 2. –ú–µ–¥–∏—Ü–∏–Ω–∞ —Å—Ç–∞–Ω–æ–≤–∏—Ç—Å—è —Ç—é—Ä—å–º–æ–π ‚Äî —Ç–µ–ø–µ—Ä—å –Ω–µ–ª—å–∑—è –ø—Ä–æ—Å—Ç–æ —É–π—Ç–∏ –≤ —á–∞—Å—Ç–Ω—É—é –∏–ª–∏ –∫–æ–æ–ø–µ—Ä–∞—Ç–∏–≤–Ω—É—é —Å–∏—Å—Ç–µ–º—É, –Ω–µ–ª—å–∑—è –æ—Ç–∫–∞–∑–∞—Ç—å—Å—è –æ—Ç —Ä–∞–±—Å–∫–∏—Ö —É—Å–ª–æ–≤–∏–π. 3. –¢–æ—Ç–∞–ª—å–Ω—ã–π –∫–æ–Ω—Ç—Ä–æ–ª—å ‚Äî ""–Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–æ"" —ç—Ç–æ —Å–∏—Å—Ç–µ–º–∞ —Ç–æ—Ç–∞–ª—å–Ω–æ–≥–æ –∫–æ–Ω—Ç—Ä–æ–ª—è –∏ –ø–æ–¥–∞–≤–ª–µ–Ω–∏—è –≤–æ–ª–∏ –º–æ–ª–æ–¥—ã—Ö —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤. üìâ –≠–∫–æ–Ω–æ–º–∏–∫–∞ –∞–±—Å—É—Ä–¥–∞: ¬∑ –°—Ç—É–¥–µ–Ω—Ç –∑–∞–ø–ª–∞—Ç–∏–ª 2-4 –º–ª–Ω —Ä—É–±–ª–µ–π –∑–∞ –æ–±—É—á–µ–Ω–∏–µ ¬∑ –¢–µ–ø–µ—Ä—å –æ–Ω –¥–æ–ª–∂–µ–Ω 3 –≥–æ–¥–∞ —Ä–∞–±–æ—Ç–∞—Ç—å –≤ –±—é—Ä–æ–∫—Ä–∞—Ç–∏—á–µ—Å–∫–∏—Ö —É—Å–ª–æ–≤–∏—è—Ö –∑–∞ –∫–æ–ø–µ–π–∫–∏ –ø–æ–¥ —É–≥—Ä–æ–∑–æ–π –ø–æ–∂–∏–∑–Ω–µ–Ω–Ω–æ–≥–æ –∑–∞–ø—Ä–µ—Ç–∞ –Ω–∞ –ø—Ä–æ—Ñ–µ—Å—Å–∏—é. ¬∑ –≠—Ç–æ –¥–∞–∂–µ –Ω–µ —ç–∫—Å–ø–ª—É–∞—Ç–∞—Ü–∏—è ‚Äî —ç—Ç–æ –ø—Ä–æ–º—ã–≤–∫–∞ –º–æ–∑–≥–æ–≤ –∏ –ª–æ–º–∫–∞ –ª–∏—á–Ω–æ—Å—Ç–∏ –ø–æ–¥ –≤–∏–¥–æ–º ""–Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–∞"". ‚öñÔ∏è –ö—É–¥–∞ –¥–≤–∏–∂–µ—Ç—Å—è —Å–∏—Å—Ç–µ–º–∞: ¬∑ –°–æ–∑–¥–∞–Ω–∏–µ –∫–∞—Å—Ç—ã –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∫—Ä–µ–ø–æ—Å—Ç–Ω—ã—Ö ¬∑ –õ–µ–≥–∞–ª–∏–∑–∞—Ü–∏—è –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω–æ–≥–æ —Ç—Ä—É–¥–∞ –≤ XXI –≤–µ–∫–µ –≠—Ç–æ—Ç –∑–∞–∫–æ–Ω ‚Äî —Ç–æ—á–∫–∞ –Ω–µ–≤–æ–∑–≤—Ä–∞—Ç–∞. –í–ª–∞—Å—Ç—å –æ—Ç–∫—Ä—ã—Ç–æ –∑–∞—è–≤–ª—è–µ—Ç: ""–í–∞—à–µ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ, –≤–∞—à–∏ –º–µ—á—Ç—ã, –≤–∞—à–∞ –∂–∏–∑–Ω—å ‚Äî –Ω–∏—á—Ç–æ. –í—ã –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∏—Ç–µ —Å–∏—Å—Ç–µ–º–µ"". –í–ª–∞—Å—Ç—å –¥–µ–º–æ–Ω—Å—Ç—Ä–∏–µ—Ç –∏–¥–µ–∞–ª—å–Ω–æ–µ –ø–æ–Ω–∏–º–∞–Ω–∏–µ —Ä—ã–Ω–æ—á–Ω–æ–π –ª–æ–≥–∏–∫–∏: —Ä–∞–±—Å–∫–∏–π —Ç—Ä—É–¥ —Å–æ—Ö—Ä–∞–Ω—è—é—Ç —Ç–∞–º, –≥–¥–µ –Ω–µ—Ç —á–∞—Å—Ç–Ω–æ–π –∞–ª—å—Ç–µ—Ä–Ω–∞—Ç–∏–≤—ã. –ü—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–µ –æ—Å–≤–æ–±–æ–¥–∏—Ç—å —Å—Ç–æ–º–∞—Ç–æ–ª–æ–≥–æ–≤ –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–æ–≤ –æ—Ç –æ—Ç—Ä–∞–±–æ—Ç–æ–∫ ‚Äî –Ω–µ ""–ª–∏–±–µ—Ä–∞–ª–∏–∑–∞—Ü–∏—è"", –∞ —Å–æ–∑–¥–∞–Ω–∏–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∫–∞—Å—Ç. üí∞ –¶–∏–Ω–∏–∑–º –≤ –¥–µ—Ç–∞–ª—è—Ö: ¬∑ –°—Ç–æ–º–∞—Ç–æ–ª–æ–≥–æ–≤ –æ—Ç–ø—É—Å–∫–∞—é—Ç –≤ ""—Å–≤–æ–±–æ–¥–Ω–æ–µ –ø–ª–∞–≤–∞–Ω–∏–µ"" ‚Äî –ø–æ—Ç–æ–º—É —á—Ç–æ –∏—Ö —É–∂–µ –∫—É–ø–∏–ª —á–∞—Å—Ç–Ω—ã–π –∫–∞–ø–∏—Ç–∞–ª ¬∑ –§–∞—Ä–º–∞—Ü–µ–≤—Ç–æ–≤ –æ—Ç–ø—É—Å–∫–∞—é—Ç ‚Äî –ø–æ—Ç–æ–º—É —á—Ç–æ –∏—Ö —Ç—Ä—É–¥ –º–æ–Ω–µ—Ç–∏–∑–∏—Ä–æ–≤–∞–Ω –∞–ø—Ç–µ—á–Ω—ã–º–∏ —Å–µ—Ç—è–º–∏ ¬∑ –û–±—ã—á–Ω—ã—Ö –≤—Ä–∞—á–µ–π –æ—Å—Ç–∞–≤–ª—è—é—Ç –≤ —Ä–∞–±—Å—Ç–≤–µ ‚Äî –ø–æ—Ç–æ–º—É —á—Ç–æ –∏—Ö —Ç—Ä—É–¥ –Ω–µ–ø—Ä–∏–±—ã–ª–µ–Ω –¥–ª—è –±–∏–∑–Ω–µ—Å–∞, –Ω–æ –∂–∏–∑–Ω–µ–Ω–Ω–æ –≤–∞–∂–µ–Ω –¥–ª—è —Å–∏—Å—Ç–µ–º—ã üé≠ –ì–∞–∑–ª–∞–π—Ç–∏–Ω–≥ –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç—Å—è: –§—Ä–∞–∑–∞ –õ–µ–æ–Ω–æ–≤–∞ –æ —Ç–æ–º, —á—Ç–æ —á–∞—Å—Ç–Ω—ã–µ –∫–ª–∏–Ω–∏–∫–∏ ""–±—É–¥—É—Ç –±–∏—Ç—å—Å—è –∑–∞ –ª—É—á—à–∏—Ö –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤"" ‚Äî —á–∏—Å—Ç–æ–π –≤–æ–¥—ã –ø—Ä–æ–ø–∞–≥–∞–Ω–¥–∞. –ù–∞ –¥–µ–ª–µ: ¬∑ –≠—Ç–æ —Å–æ–∑–¥–∞–Ω–∏–µ —Ä–µ–∑–µ—Ä–≤–∞—Ü–∏–∏ –¥–ª—è —ç–ª–∏—Ç—ã –∏ –≥—É–ª–∞–≥–∞ –¥–ª—è –æ—Å—Ç–∞–ª—å–Ω—ã—Ö ¬∑ ""–°–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω—ã–π –≤—ã–±–æ—Ä"" –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—è ‚Äî —ç—Ç–æ –≤—ã–±–æ—Ä –º–µ–∂–¥—É –ù–∏–∂–Ω–∏–º –¢–∞–≥–∏–ª–æ–º –∏ –ê—Å–±–µ—Å—Ç–æ–º üìç –ù–æ–≤—ã–µ –º–µ—Ç–æ–¥—ã –∫–æ–Ω—Ç—Ä–æ–ª—è: ¬∑ ""–û—Å–µ–¥–ª–æ—Å—Ç—å"" ‚Äî —ç—Ç–æ —é—Ä–∏–¥–∏—á–µ—Å–∫–æ–µ –æ—Ñ–æ—Ä–º–ª–µ–Ω–∏–µ –∫—Ä–µ–ø–æ—Å—Ç–Ω–æ–≥–æ –ø—Ä–∞–≤–∞ –ø–æ –ø—Ä–æ–ø–∏—Å–∫–µ ¬∑ –°–æ–∫—Ä–∞—â–µ–Ω–∏–µ —Å—Ä–æ–∫–æ–≤ –¥–ª—è –î–∞–ª—å–Ω–µ–≥–æ –í–æ—Å—Ç–æ–∫–∞ ‚Äî —ç—Ç–æ —Å—Å—ã–ª–∫–∞ –ø–æ–¥ –≤–∏–¥–æ–º –ª—å–≥–æ—Ç—ã ¬∑ –†–µ–≥—É–ª–∏—Ä–æ–≤–∞–Ω–∏–µ –∫–æ–º–º–µ—Ä—á–µ—Å–∫–æ–π –æ—Ä–¥–∏–Ω–∞—Ç—É—Ä—ã ‚Äî —ç—Ç–æ —Ç–æ—Ç–∞–ª—å–Ω—ã–π –∫–æ–Ω—Ç—Ä–æ–ª—å –Ω–∞–¥ –≤—Å–µ–º–∏ —Ñ–æ—Ä–º–∞–º–∏ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è üî• –ß—Ç–æ –Ω–∞ —Å–∞–º–æ–º –¥–µ–ª–µ –ø—Ä–æ–∏—Å—Ö–æ–¥–∏—Ç: 1. –í–ª–∞—Å—Ç—å –¥–µ–ª–∏—Ç –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–µ —Å–æ–æ–±—â–µ—Å—Ç–≤–æ ‚Äî —Å–æ–∑–¥–∞–µ—Ç ""–∏–∑–±—Ä–∞–Ω–Ω—ã—Ö"" (—Å—Ç–æ–º–∞—Ç–æ–ª–æ–≥–∏, —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç—ã) –∏ ""—Ä–∞–±–æ–≤"" (—Ç–µ—Ä–∞–ø–µ–≤—Ç—ã, —Ö–∏—Ä—É—Ä–≥–∏, –ø–µ–¥–∏–∞—Ç—Ä—ã) 2. –°–∏—Å—Ç–µ–º–∞ –≥–æ—Ç–æ–≤–∏—Ç—Å—è –∫ —Ç–æ—Ç–∞–ª—å–Ω–æ–º—É –¥–µ—Ñ–∏—Ü–∏—Ç—É –∫–∞–¥—Ä–æ–≤ ‚Äî –ø–æ—ç—Ç–æ–º—É –ø–µ—Ä–µ—Ö–æ–¥–∏—Ç –∫ –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω–æ–º—É —É–¥–µ—Ä–∂–∞–Ω–∏—é 3. –≠—Ç–æ –∞—Ç–∞–∫–∞ –Ω–∞ —Å–∞–º—É —Å—É—Ç—å –ø—Ä–æ—Ñ–µ—Å—Å–∏–∏ ‚Äî –≤—Ä–∞—á–∞ –ø—Ä–µ–≤—Ä–∞—â–∞—é—Ç –≤ –≥–æ—Å—Å–ª—É–∂–∞—â–µ–≥–æ —Å –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω–æ–π –ø–æ–≤–∏–Ω–Ω–æ—Å—Ç—å—é –õ–µ–æ–Ω–æ–≤ –≤—Ä–µ—Ç, –≥–æ–≤–æ—Ä—è —á—Ç–æ —ç—Ç–æ ""–Ω–µ –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω–∞—è –æ—Ç—Ä–∞–±–æ—Ç–∫–∞"". –ö–æ–≥–¥–∞ —Ç–µ–±–µ –∑–∞–ø—Ä–µ—â–∞—é—Ç —Ä–∞–±–æ—Ç–∞—Ç—å –≤ –ø—Ä–æ—Ñ–µ—Å—Å–∏–∏ –±–µ–∑ –æ—Ç—Ä–∞–±–æ—Ç–∫–∏ ‚Äî —ç—Ç–æ –∏ –µ—Å—Ç—å —Å–∞–º–æ–µ –Ω–∞—Å—Ç–æ—è—â–µ–µ –ø—Ä–∏–Ω—É–∂–¥–µ–Ω–∏–µ. –†–µ–ø–æ—Å—Ç–∏–º! –¢—Ä–µ–±—É–µ–º –æ—Ç–º–µ–Ω—ã —Ä–∞–±—Å–∫–æ–≥–æ –∑–∞–∫–æ–Ω–∞ –¥–ª—è –í–°–ï–• –≤—Ä–∞—á–µ–π! –ù–µ –¥–∞–¥–∏–º —Ä–∞–∑–¥–µ–ª–∏—Ç—å –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–µ —Å–æ–æ–±—â–µ—Å—Ç–≤–æ! –°–æ–ª–∏–¥–∞—Ä–Ω–æ—Å—Ç—å ‚Äî –Ω–∞—à–µ –æ—Ä—É–∂–∏–µ! –ù–æ –º—ã –ø–æ–º–Ω–∏–º: –∫–æ–≥–¥–∞ –∑–∞–∫—Ä–µ–ø–æ—â–µ–Ω–∏–µ —Å—Ç–∞–Ω–æ–≤–∏—Ç—Å—è —Ç–æ—Ç–∞–ª—å–Ω—ã–º, —Å–æ–ø—Ä–æ—Ç–∏–≤–ª–µ–Ω–∏–µ —Å—Ç–∞–Ω–æ–≤–∏—Ç—Å—è –Ω–µ–∏–∑–±–µ–∂–Ω—ã–º. –¢—Ä–µ–±—É–µ–º –æ—Ç–∑—ã–≤–∞ —ç—Ç–æ–≥–æ –ø–æ–∑–æ—Ä–Ω–æ–≥–æ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç–∞! –°–æ–ª–∏–¥–∞—Ä–Ω–æ—Å—Ç—å —Å –±—É–¥—É—â–∏–º–∏ –≤—Ä–∞—á–∞–º–∏ ‚Äî —ç—Ç–æ –∑–∞—â–∏—Ç–∞ –Ω–∞—à–µ–≥–æ –æ–±—â–µ–≥–æ –±—É–¥—É—â–µ–≥–æ! #–º–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è–ø–æ–ª–∏—Ç—ç–∫–æ–Ω–æ–º–∏—è #—Ä–∞–±–æ—á–∞—è–º–µ–¥–∏—Ü–∏–Ω–∞ #–æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ #–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è–∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing, shortage"",
  ""impact"": ""high"",
  ""english"": ""The law is pushing for forced labor in the medical profession, dividing doctors into 'chosen' and 'forced.' It is creating a shortage of doctors by enforcing mandatory work. The law discriminates against all types of doctors, not just those in private practice.""
}"
2025-10-08T14:31:12+00:00,@pharm_icon,2399,https://t.me/pharm_icon/2399,"–Ω–µFDA –æ–¥–æ–±—Ä–∏–ª–∞: –Ω–æ–≤—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è –ª–µ—á–µ–Ω–∏—è –≤–Ω–µ–±–æ–ª—å–Ω–∏—á–Ω–æ–π –ø–Ω–µ–≤–º–æ–Ω–∏–∏ –ù–∞ —Ñ–æ—Ä—É–º–µ ¬´–ë–ò–û–ü–†–û–ú¬ª –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∏ –Ω–æ–≤—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è –ª–µ—á–µ–Ω–∏—è –≤–Ω–µ–±–æ–ª—å–Ω–∏—á–Ω–æ–π –ø–Ω–µ–≤–º–æ–Ω–∏–∏ ‚Äî –ê–º–±–µ—Ä–≤–∏–Ω –ü—É–ª—å–º–æ, —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω–Ω—ã–π –∫–æ–º–ø–∞–Ω–∏–µ–π ¬´–ü—Ä–æ–º–æ–º–µ–¥¬ª. –°—Ä–µ–¥—Å—Ç–≤–æ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ—Ç —Å–æ–±–æ–π —Å–∏–Ω—Ç–µ—Ç–∏—á–µ—Å–∫–∏–π –∞–Ω–∞–ª–æ–≥ –ª–µ–π—ç–Ω–∫–µ—Ñ–∞–ª–∏–Ω–∞ –∏ –¥–µ–π—Å—Ç–≤—É–µ—Ç –ø—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–µ–Ω–Ω–æ —á–µ—Ä–µ–∑ Œ¥-–æ–ø–∏–æ–∏–¥–Ω—ã–µ —Ä–µ—Ü–µ–ø—Ç–æ—Ä—ã, –Ω–µ –ø—Ä–æ–Ω–∏–∫–∞—è —á–µ—Ä–µ–∑ –≥–µ–º–∞—Ç–æ—ç–Ω—Ü–µ—Ñ–∞–ª–∏—á–µ—Å–∫–∏–π –±–∞—Ä—å–µ—Ä. –ü—Ä–µ–ø–∞—Ä–∞—Ç –ø–æ–¥–∞–≤–ª—è–µ—Ç —Å–∏–Ω—Ç–µ–∑ –∏ –ø–æ—Å—Ç—É–ø–ª–µ–Ω–∏–µ –≤ —Å–∏—Å—Ç–µ–º–Ω—ã–π –∫—Ä–æ–≤–æ—Ç–æ–∫ –ø—Ä–æ–≤–æ—Å–ø–∞–ª–∏—Ç–µ–ª—å–Ω—ã—Ö —Ü–∏—Ç–æ–∫–∏–Ω–æ–≤, –≤–∫–ª—é—á–∞—è –∏–Ω—Ç–µ—Ä–ª–µ–π–∫–∏–Ω-6 (–ò–õ-6) ‚Äî –æ–¥–∏–Ω –∏–∑ –æ—Å–Ω–æ–≤–Ω—ã—Ö –º–µ–¥–∏–∞—Ç–æ—Ä–æ–≤ —Ü–∏—Ç–æ–∫–∏–Ω–æ–≤–æ–≥–æ —à—Ç–æ—Ä–º–∞. –¢–∞–∫–∂–µ —Å–Ω–∏–∂–∞–µ—Ç —É—Ä–æ–≤–Ω–∏ –ò–õ-1, –§–ù–ûŒ± –∏ HMGB1, –æ–¥–Ω–æ–≤—Ä–µ–º–µ–Ω–Ω–æ –ø–æ–≤—ã—à–∞—è –ø—Ä–æ–¥—É–∫—Ü–∏—é –ø—Ä–æ—Ç–∏–≤–æ–≤–æ—Å–ø–∞–ª–∏—Ç–µ–ª—å–Ω—ã—Ö —Ü–∏—Ç–æ–∫–∏–Ω–æ–≤ –ò–õ-10 –∏ VEGF. –¢–∞–∫–æ–µ –¥–µ–π—Å—Ç–≤–∏–µ —É–º–µ–Ω—å—à–∞–µ—Ç –ø–æ—Å–ª–µ–¥—Å—Ç–≤–∏—è —Å–∏—Å—Ç–µ–º–Ω–æ–π –≥–∏–ø–µ—Ä–∏–º–º—É–Ω–Ω–æ–π —Ä–µ–∞–∫—Ü–∏–∏, –ª–µ–∂–∞—â–µ–π –≤ –æ—Å–Ω–æ–≤–µ –æ—Å—Ç—Ä–æ–≥–æ —Ä–µ—Å–ø–∏—Ä–∞—Ç–æ—Ä–Ω–æ–≥–æ –¥–∏—Å—Ç—Ä–µ—Å—Å-—Å–∏–Ω–¥—Ä–æ–º–∞ (–û–†–î–°), –≤ —Ç–æ–º —á–∏—Å–ª–µ –ø—Ä–∏ COVID-19. –°–æ–≥–ª–∞—Å–Ω–æ –¥–∞–Ω–Ω—ã–º –∏–º–µ—é—â–∏—Ö—Å—è –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π, –ê–º–±–µ—Ä–≤–∏–Ω –ü—É–ª—å–º–æ –ø–æ–∫–∞–∑–∞–ª —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –ø—Ä–∏ —Ä–∞–∑–ª–∏—á–Ω—ã—Ö —Ñ–æ—Ä–º–∞—Ö –ø–Ω–µ–≤–º–æ–Ω–∏–∏: –æ—Ç–º–µ—á–µ–Ω–æ —Å–Ω–∏–∂–µ–Ω–∏–µ –≤–æ—Å–ø–∞–ª–µ–Ω–∏—è –∏ —É–ª—É—á—à–µ–Ω–∏–µ —Ñ—É–Ω–∫—Ü–∏–∏ –ª—ë–≥–∫–∏—Ö. –ü—Ä–µ–ø–∞—Ä–∞—Ç —É–∂–µ –≤–∫–ª—é—á—ë–Ω –≤ –º–µ—Ç–æ–¥–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–æ—Å—Å–∏–∏ –∏ –≤ –ø–µ—Ä–µ—á–µ–Ω—å –∂–∏–∑–Ω–µ–Ω–Ω–æ –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã—Ö –∏ –≤–∞–∂–Ω–µ–π—à–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ (–ñ–ù–í–õ–ü). #–ë—ã—Å—Ç—Ä–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, shortage, demand, epidemic"",
  ""impact"": ""high"",
  ""english"": ""The FDA approved a new drug for the treatment of community-acquired pneumonia. The Promomed company developed Amberwin Pulmo, a synthetic analog of leuendekalin. The drug acts primarily through Œ¥-opioid receptors and does not penetrate the hematoencephalic barrier. It suppresses the synthesis and entry of pro-inflammatory cytokines, including interleukin-6 (IL-6), one of the main mediators of cytokine storm. It also reduces levels of IL-1, FNOŒ± and HMGB1, while increasing the production of anti-inflammatory cytokines IL-10 and VEGF. This action reduces the consequences of systemic hyperimmunological response, which lies at the basis of acute respiratory distress syndrome (ARDS), including in cases of COVID-19. The drug has been included in the clinical guidelines of Russia's Ministry of Health and on the list of essential medicines. ""
}"
2025-10-06T18:42:40+00:00,@pharm_icon,2398,https://t.me/pharm_icon/2398,"""–õ—é–±–ª—é —Ç—Ä–æ–º–±–æ–∑—ã"" –†—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å FDA –ú–∞—Ä—Ç–∏ –ú–∞–∫–∞—Ä–∏ –∏ –µ–≥–æ –ª—é–±–æ–≤—å –∫ –ó–ì–¢ –ê–Ω—á–∞ –ë–∞—Ä–∞–Ω–æ–≤–∞ –æ–ø—É–±–ª–∏–∫–æ–≤–∞–ª–∞ –ø–æ—Å—Ç –ø–æ –ø–æ–≤–æ–¥—É –ú–∞—Ä—Ç–∏ –ú–∞–∫–∞—Ä–∏, –∫–æ—Ç–æ—Ä—ã–π —Å–æ–∫—Ä—É—à–∞–µ—Ç—Å—è –Ω–∞—Å—á—ë—Ç ""50 –º–∏–ª–ª–∏–æ–Ω–æ–≤ –∂–µ–Ω—â–∏–Ω, –∫–æ—Ç–æ—Ä—ã–µ –Ω–µ–¥–æ–ø–æ–ª—É—á–∏–ª–∏ –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å–Ω—É—é –≥–æ—Ä–º–æ–Ω–∞–ª—å–Ω—É—é —Ç–µ—Ä–∞–ø–∏—é"" –ø–æ—Å–ª–µ –ø—É–±–ª–∏–∫–∞—Ü–∏–∏ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –æ —Ä–∏—Å–∫–∞—Ö, –∫–æ—Ç–æ—Ä—ã–µ –ø–æ–≤—ã—à–∞—é—Ç—Å—è –ø–æ—Å–ª–µ 60 –ª–µ—Ç, –∞ –≤–æ—Ç –≤ –≤–æ–∑—Ä–∞—Å—Ç–µ 50-59 –ª–µ—Ç ‚Äî –¥–∞–Ω–Ω—ã—Ö –∫–∞–∫ –±—É–¥—Ç–æ –±—ã –Ω–µ—Ç. –û—á–µ–Ω—å –∏–Ω—Ç–µ—Ä–µ—Å–Ω–æ. –ß—Ç–æ –≥–æ–≤–æ—Ä–∏—Ç –æ–± —ç—Ç–æ–º –ö–æ–∫—Ä–µ–π–Ω –≤ —Å–≤–æ—ë–º —Å–∏—Å—Ç–µ–º–∞—Ç–∏—á–µ—Å–∫–æ–º –æ–±–∑–æ—Ä–µ –ø–æ –¥–∞–Ω–Ω–æ–º—É –≤–æ–ø—Ä–æ—Å—É? –ö–æ–∫—Ä–µ—Ç–Ω–æ –ø—Ä–æ ""–º–æ–ª–æ–¥—ã—Ö"" –∂–µ–Ω—â–∏–Ω –≤ –≤–æ–∑—Ä–∞—Å—Ç–µ 50-59 –ª–µ—Ç –í –æ–¥–Ω–æ–º –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–∏ –±—ã–ª–∏ –ø—Ä–æ–∞–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω—ã –ø–æ–¥–≥—Ä—É–ø–ø—ã –∏–∑ 2839 –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ –∑–¥–æ—Ä–æ–≤—ã—Ö –∂–µ–Ω—â–∏–Ω –≤ –≤–æ–∑—Ä–∞—Å—Ç–µ –æ—Ç 50 –¥–æ 59 –ª–µ—Ç, –ø—Ä–∏–Ω–∏–º–∞–≤—à–∏—Ö –∫–æ–º–±–∏–Ω–∏—Ä–æ–≤–∞–Ω–Ω—É—é –Ω–µ–ø—Ä–µ—Ä—ã–≤–Ω—É—é –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å–Ω—É—é –≥–æ—Ä–º–æ–Ω–∞–ª—å–Ω—É—é —Ç–µ—Ä–∞–ø–∏—é, –∏ 1637 –∂–µ–Ω—â–∏–Ω, –ø—Ä–∏–Ω–∏–º–∞–≤—à–∏—Ö –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å–Ω—É—é –≥–æ—Ä–º–æ–Ω–∞–ª—å–Ω—É—é —Ç–µ—Ä–∞–ø–∏—é —Ç–æ–ª—å–∫–æ —Å —ç—Å—Ç—Ä–æ–≥–µ–Ω–æ–º, –≤ —Å—Ä–∞–≤–Ω–µ–Ω–∏–∏ —Å –∞–Ω–∞–ª–æ–≥–∏—á–Ω—ã–º–∏ –ø–æ —Ä–∞–∑–º–µ—Ä—É –≥—Ä—É–ø–ø–∞–º–∏ –ø–ª–∞—Ü–µ–±–æ. –ï–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–º –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–º –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω—ã–º –ø–æ–≤—ã—à–µ–Ω–∏–µ–º —Ä–∏—Å–∫–∞ –±—ã–ª–∞ –≤–µ–Ω–æ–∑–Ω–∞—è —Ç—Ä–æ–º–±–æ—ç–º–±–æ–ª–∏—è —É –∂–µ–Ω—â–∏–Ω, –ø—Ä–∏–Ω–∏–º–∞–≤—à–∏—Ö –∫–æ–º–±–∏–Ω–∏—Ä–æ–≤–∞–Ω–Ω—É—é –Ω–µ–ø—Ä–µ—Ä—ã–≤–Ω—É—é –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å–Ω—É—é –≥–æ—Ä–º–æ–Ω–∞–ª—å–Ω—É—é —Ç–µ—Ä–∞–ø–∏—é: –∞–±—Å–æ–ª—é—Ç–Ω—ã–π —Ä–∏—Å–∫ –æ—Å—Ç–∞–≤–∞–ª—Å—è –Ω–∏–∑–∫–∏–º, –º–µ–Ω–µ–µ 1/500. –ù–∞ 50 000 000 –∂–µ–Ω—â–∏–Ω –ø—Ä–∏—à–ª–æ—Å—å –±—ã –≤—Å–µ–≥–æ 100 000 —Ç—Ä–æ–º–±–æ–∑–æ–≤. üî• ‚Äî –¥–∞, –Ω–æ—Ä–º–∞–ª—å–Ω–æ ‚ù§Ô∏è ‚Äî –º–Ω–æ–≥–æ —Ç—Ä–æ–º–±–æ–∑–æ–≤, –Ω–∞ 100 000 –±–æ–ª—å—à–µ, —á–µ–º –Ω—É–∂–Ω–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance"",
  ""impact"": ""high"",
  ""english"": "":raised_hand: The post discusses concerns raised by FDA Director Marty Makary about the underreporting of risks for women aged 50-59 who did not receive hormone replacement therapy. It references a specific study by Koenig, which shows an increased risk of venous thromboembolism in women taking combined continuous hormone replacement therapy, but with a low absolute risk. The post highlights the discrepancy between reported and actual risks.""
}"
2025-10-06T18:19:49+00:00,@pharm_icon,2397,https://t.me/pharm_icon/2397,"–í –¥–µ–ª–∏–∫–∞—Ç–Ω—ã—Ö –º–µ—Å—Ç–∞—Ö: –ò–º–ø–æ—Ä—Ç–æ–∑–∞–º–µ—â–µ–Ω–∏–µ –°–∫–æ–ª—å–∫–æ –±—ã –î–æ–Ω–Ω–∏ –¢—Ä–∞–º–ø–æ –Ω–∏ —Ä—É–≥–∞–ª –î–º–∏—Ç—Ä–∏–æ –ú–µ–¥–≤–µ–¥–∏–æ, –Ω–æ –µ–≥–æ —Ç–µ–ª–æ–¥–≤–∏–∂–µ–Ω–∏—è –ø–æ —Ñ–∞—Ä–º–µ –±–ª–∏–∑–∫–∏ –∏ –ø–æ–Ω—è—Ç–Ω—ã –î–æ–Ω–∞–ª—å–¥—É. ""–ó–∞—è–≤–∫–∏ –Ω–∞ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—é –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ –ø–æ–ª–Ω–æ—Å—Ç—å—é –∏—Å—Å–ª–µ–¥—É—é—Ç—Å—è –∏ –ø—Ä–æ–∏–∑–≤–æ–¥—è—Ç—Å—è –≤ –°–®–ê, –±—É–¥—É—Ç —Ä–∞—Å—Å–º–∞—Ç—Ä–∏–≤–∞—Ç—å—Å—è FDA –≤ –ø—Ä–∏–æ—Ä–∏—Ç–µ—Ç–Ω–æ–º –ø–æ—Ä—è–¥–∫–µ"". –¢–µ–ø–µ—Ä—å –î–µ–¥ –∑–∞—â–∏—â–∞–µ—Ç —Ñ–∞—Ä–º–ø—Ä–æ–º –°–®–ê –æ—Ç —á—É–∂–∏—Ö –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤—ã—Ö –Ω–∞—Å–∫–æ–∫–æ–≤. –ñ–¥—ë–º –∏–¥–∏–æ–º—ã ""–ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–π —Å—É–≤–µ—Ä–µ–Ω–∏—Ç–µ—Ç"" –≤ –ø–æ—Å–ª–µ–¥—É—é—â–∏—Ö –≤—ã—Å—Ç—É–ø–ª–µ–Ω–∏—è—Ö –ø–µ—Ä–≥–∏–¥—Ä–æ–ª—å–Ω–æ–≥–æ –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç–∞. –ñ–¥—É, –∫–æ–≥–¥–∞ —Ç—Ä–∞–Ω—Å–ø–ª–∞–Ω—Ç–∞—Ü–∏—è –º–∏–∫—Ä–æ–±–∏–æ—Ç—ã –æ—Ñ–æ—Ä–º–∏—Ç—Å—è –≤ —Ä–∞–±–æ—á–∏–π –±–∏–∑–Ω–µ—Å –∏ –î–æ–Ω–∞–ª—å–¥ –Ω–∞—á–Ω—ë—Ç –∑–∞—â–∏—â–∞—Ç—å –µ—â—ë –∏ –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–π –±–∏–æ–º–∞—Ç–µ—Ä–∏–∞–ª, –¥–æ–±—ã—Ç—ã–π —Ç—è–∂–∫–∏–º —Ç—Ä—É–¥–æ–º –∏ —Å–º–∏—Ä–µ–Ω–Ω—ã–º –æ–±—Ä–∞–∑–æ–º –∂–∏–∑–Ω–∏ –≤ WC. –ï—Å–ª–∏ –∫—Ç–æ –Ω–µ –ø–æ–Ω—è–ª ‚Äî —è –ø—Ä–æ –¥–æ–Ω–æ—Ä–æ–≤ —Ñ–µ–∫–∞–ª—å–Ω—ã—Ö —Ç—Ä–∞–Ω—Å–ø–ª–∞–Ω—Ç–∞—Ç–æ–≤, –∫–æ—Ç–æ—Ä—ã–º –Ω–∞–¥–æ –±—ã—Ç—å –∏–¥–µ–∞–ª—å–Ω—ã–º–∏ —Å —Ç–æ—á–∫–∏ –∑—Ä–µ–Ω–∏—è —Å–æ–ø—É—Ç—Å—Ç–≤—É—é—â–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, —á—Ç–æ–±—ã –∏—Ö –ø—Ä–æ–¥—É–∫—Ç –ø–æ—à—ë–ª –≤ –±–∏–∑–Ω–µ—Å.","{""skip"": true}"
2025-10-01T12:01:34+00:00,@pharm_icon,2396,https://t.me/pharm_icon/2396,"–†–∞–∑–≥–æ–≤–æ—Ä –≤ –ö–æ—Ñ–µ–º–∞–Ω–∏–∏ —Å SEO–≤–µ–¥–æ–º –ù–µ–¥–∞–≤–Ω–æ –≤ –ö–æ—Ñ–µ–º–∞–Ω–∏–∏ –ª–∞–Ω—á–µ–≤–∞–ª–∏ —Å –ù–∏–∫–æ–ª–∞–µ–º –†–æ–º–∞–Ω—Ü–æ–≤—ã–º ‚Äì —ç–∫—Å–ø–µ—Ä—Ç–æ–º –ø–æ SEO —Å–æ—Å–µ–¥–æ–º –ø–æ —Ç–µ–ª–µ–≥—Ä–∞–º—É ‚Äì –∏ —Ä–∞–∑–≥–æ–≤–∞—Ä–∏–≤–∞–ª–∏ –æ —Ç–æ–º, –æ —Å—ë–º –∏ –∫–∞–∫ –ª—É—á—à–µ –æ—Ä–≥–∞–Ω–∏–∑–æ–≤–∞—Ç—å —Å—Ç—Ä–∞–Ω–∏—Ü—É –ø—Ä–æ–¥—É–∫—Ç–∞ –∫–æ–º–ø–∞–Ω–∏–∏ –•. ‚Äì –°–ª—É—à–∞–π—Ç–µ, –≤—ã –≤ SEO –Ω–µ –æ—Å–æ–±–æ —Ä–∞–∑–±–∏—Ä–∞–µ—Ç–µ—Å—å, –¥–∞–≤–∞–π—Ç–µ –ª—É—á—à–µ –ø–æ–≥–æ–≤–æ—Ä–∏–º –∑–∞ –û–∑–µ–º–ø–∏–∫–∏, –ø–æ—Ç–æ–º—É —á—Ç–æ –ø–æ–±–æ–ª—Ç–∞—Ç—å —Å–µ–π—á–∞—Å –ø–æ–ª–µ–∑–Ω–æ –Ω–µ –±—É–¥–µ—Ç. –î—Ä—É–≥–æ–µ –¥–µ–ª–æ, —á—Ç–æ —É –º–µ–Ω—è –µ—Å—Ç—å –ø–æ–¥–±–æ—Ä–∫–∞ —Å—Ç–∞—Ç–µ–π, –∫–æ—Ç–æ—Ä—ã–µ –ø–æ–º–æ–≥—É—Ç —É–ª—É—á—à–∏—Ç—å –ø—Ä–∏–º–µ—Ä–Ω–æ –≤—Å—ë. ‚Äì –ì–æ–≤–æ—Ä–∏—Ç –∏ –ø—å—ë—Ç –∫–æ—Ñ–µ—ë—á–µ–∫. ‚Äì –í—ã –∏—Ö –ø—Ä–æ—á–∏—Ç–∞–π—Ç–µ, –ø–æ—Ç–æ–º –ø—Ä–æ–π–¥—ë–º –ø–æ —á–∞—Å—Ç–Ω–æ—Å—Ç—è–º. –Ø –ø—Ä–æ—á–∏—Ç–∞–ª–∞. –í–æ—Ç —á—Ç–æ –æ—Å–æ–±–æ –≤—ã–¥–µ–ª—é –¥–ª—è —Ç–µ—Ö, –∫—Ç–æ –∏–Ω—Ç–µ—Ä–µ—Å—É–µ—Ç—Å—è –≤–æ–ø—Ä–æ—Å–æ–º –∏ —Ä–∞–±–æ—Ç–∞–µ—Ç —Å SEO –≤ –∫–æ—Ä–ø–æ—Ä–∞—Ü–∏—è—Ö. 1. –ö–∞–∫ –ø–æ–Ω—è—Ç—å, –ø–æ–¥—Ö–æ–¥–∏—Ç –ª–∏ SEO –¥–ª—è –±–∏–∑–Ω–µ—Å–∞ ‚Äî —Å—Ç–æ–∏—Ç –ª–∏ –≤–∫–ª–∞–¥—ã–≤–∞—Ç—å—Å—è. –î—É–º–∞—é, —ç—Ç–æ —Ç–µ–∫—Å—Ç ‚Äî –µ—Å—Ç—å –ø–µ—Ä–≤—ã–π —à–∞–≥, –∫–æ—Ç–æ—Ä—ã–π –º–æ–∂–µ—Ç —É–±–µ—Ä–µ—á—å –æ—Ç –ø–æ—Ç–µ—Ä–∏ –≤—Ä–µ–º–µ–Ω–∏ –∏ –¥–µ–Ω–µ–≥. 2. –†–∞–∑–±–æ—Ä SEO –Ω–∞ –ø—Ä–∏–º–µ—Ä–µ –∫–ª–∏–Ω–∏–∫–∏. –ú–∞—Ç–µ—Ä–∏–∞–ª –¥–∞—ë—Ç –æ—Ç–ª–∏—á–Ω–æ–µ –ø–æ–Ω–∏–º–∞–Ω–∏–µ –ø–æ —Ç–∏–ø–æ–≤—ã–º —Ä–∞–±–æ—á–∏–º —Å—Ç—Ä—É–∫—Ç—É—Ä–∞–º –∏ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª—è–µ—Ç —Ä—è–¥ —á–µ–∫-–ª–∏—Å—Ç–æ–≤. 3. –ö–∞–∫–æ–π –±—é–¥–∂–µ—Ç –∑–∞–∫–ª–∞–¥—ã–≤–∞—Ç—å –ø—Ä–∏ –ø—Ä–æ–¥–≤–∏–∂–µ–Ω–∏–∏ —Å–∞–π—Ç–æ–≤. –ß—Ç–æ–±—ã –ø–æ–Ω–∏–º–∞—Ç—å –∏ —á—É–≤—Å—Ç–≤–æ–≤–∞—Ç—å, –≥–µ–¥ —Å–∫–∞–º, –∞ –≥–¥–µ ‚Äî —Ö–æ—Ä–æ—à–µ–µ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–µ. 4. –ö—Ä–∞—Å–Ω—ã–µ —Ñ–ª–∞–≥–∏ –ø—Ä–∏ –≤—ã–±–æ—Ä–µ SEO-–ø–æ–¥—Ä—è–¥—á–∏–∫–∞. –ï—Å–ª–∏ –≤—ã —É–∂–µ –∑–∞–±–∏–ª–∏ –Ω–∞ —Ç–æ, —á—Ç–æ–±—ã —Å–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω–æ —Ä–∞–∑–æ–±—Ä–∞—Ç—å—Å—è –≤ –≤–æ–ø—Ä–æ—Å–µ –∏ —Å–ø—Ä–∞–≤–µ–¥–ª–∏–≤–æ —Ö–æ—Ç–∏—Ç–µ –¥–µ–ª–µ–≥–∏—Ä–æ–≤–∞—Ç—å —ç—Ç—É –∑–∞–¥–∞—á—É ‚Äì —ç—Ç–æ—Ç –º–∞—Ç–µ—Ä–∏–∞–ª –±—É–¥–µ—Ç –º–∞–∫—Å–∏–º–∞–ª—å–Ω–æ –ø–æ–ª–µ–∑–µ–Ω. ‚Äì –î—É–º–∞—é, —ç—Ç–∏ —Ç–µ–∫—Å—Ç—ã –ø—Ä–∏–≤–µ–¥—É—Ç –≤–∞—Å –∫ —Ö–æ—Ä–æ—à–∏–º –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è–º. ‚Äì –î—É–º–∞—é, –∫–æ—Ñ–µ –≤–∞—Å –ø—Ä–∏–≤–µ–¥—ë—Ç –∫ —Ä–µ–≤–º–∞—Ç–æ–∏–¥–Ω–æ–º—É –∞—Ä—Ç—Ä–∏—Ç—É, –ù–∏–∫–æ–ª–∞–π. –ù–∞ —Ç–æ–º –ª–∞–Ω—á –∏ –∑–∞–≤–µ—Ä—à–∏–ª–∏.","{""skip"": true}"
2025-10-01T11:19:51+00:00,@pharm_icon,2395,https://t.me/pharm_icon/2395,"–ü—É—Å—Ç–æ–π —Å–∏—Å—Ç–µ–º–∞—Ç–∏—á–µ—Å–∫–∏–π –æ–±–∑–æ—Ä –ø—Ä–æ –∫–æ—Ñ–µ –°–µ–≥–æ–¥–Ω—è –∫–æ—Ñ–µ–∏–Ω–æ–≤—ã–π —Ç—Ä–æ–ª–ª–∏–Ω–≥ –Ω–∞–º –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª—è–µ—Ç –≥—Ä—É–ø–ø–∞ –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª–µ–π –∏–∑ –¶–µ–Ω—Ç—Ä–∞ —Å–ø–æ—Ä—Ç–∏–≤–Ω—ã—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π. –í—Å–µ–≥–æ –≤ –±–∞–∑–∞—Ö –¥–∞–Ω–Ω—ã—Ö –±—ã–ª–æ –≤—ã—è–≤–ª–µ–Ω–æ 4503 —É–ø–æ–º–∏–Ω–∞–Ω–∏—è. –ù–∏ –æ–¥–Ω–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –Ω–µ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–æ–≤–∞–ª–æ –∫—Ä–∏—Ç–µ—Ä–∏—è–º –≤–∫–ª—é—á–µ–Ω–∏—è. –ù–µ—Å–º–æ—Ç—Ä—è –Ω–∞ –ø—É—Å—Ç–æ–π –æ–±–∑–æ—Ä, –º—ã —Å—á–∏—Ç–∞–µ–º —Ü–µ–ª–µ—Å–æ–æ–±—Ä–∞–∑–Ω—ã–º –æ–ø—É–±–ª–∏–∫–æ–≤–∞—Ç—å –Ω–∞—à–∏ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã, –ø–æ—Å–∫–æ–ª—å–∫—É –¥–∞–Ω–Ω–æ–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –≤—ã—è–≤–∏–ª–æ –ø—Ä–æ–±–µ–ª –≤ –ª–∏—Ç–µ—Ä–∞—Ç—É—Ä–µ, –∫–∞—Å–∞—é—â–∏–π—Å—è —Å–≤—è–∑–∏ –º–µ–∂–¥—É –≥–µ–Ω–µ—Ç–∏—á–µ—Å–∫–∏–º –ø–æ–ª–∏–º–æ—Ä—Ñ–∏–∑–º–æ–º –∏–∑–æ—Ñ–µ—Ä–º–µ–Ω—Ç–∞ CYP1A2 –∏ —Ñ–∏–∑–∏—á–µ—Å–∫–æ–π —Ä–∞–±–æ—Ç–æ—Å–ø–æ—Å–æ–±–Ω–æ—Å—Ç—å—é —É —Å–ø–æ—Ä—Ç—Å–º–µ–Ω–æ–≤-–µ–¥–∏–Ω–æ–±–æ—Ä—Ü–µ–≤ –ø—Ä–∏ –ø—Ä–∏–µ–º–µ –∫–æ—Ñ–µ–∏–Ω–∞. –ö–∞–∫ –≤—ã —Å—á–∏—Ç–∞–µ—Ç–µ, –ø—É–±–ª–∏–∫–æ–≤–∞—Ç—å –ø—É—Å—Ç–æ–π —Å–∏—Å—Ç–µ–º–∞—Ç–∏—á–µ—Å–∫–∏–π –æ–±–∑–æ—Ä ‚Äî —ç—Ç–æ —Ö–æ—Ä–æ—à–∞—è –ø—Ä–∞–∫—Ç–∏–∫–∞? üî• ‚Äî –¥–∞, –∫—Ç–æ-—Ç–æ –¥–æ–ª–∂–µ–Ω –ø–æ–¥—Å–≤–µ—á–∏–≤–∞—Ç—å –ø—Ä–æ–±–µ–ª—ã –≤ –∑–Ω–∞–Ω–∏—è—Ö üóø ‚Äî –Ω–µ—Ç, –º–æ–≥–ª–∏ –±—ã –æ–ø—É–±–ª–∏–∫–æ–≤–∞—Ç—å –Ω–æ—Ä–º–∞–ª—å–Ω–æ–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ","{""skip"": true}"
2025-09-29T13:07:30+00:00,@pharm_icon,2394,https://t.me/pharm_icon/2394,"¬´–ú–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è –†–æ—Å—Å–∏—è¬ª –ø—Ä–µ–æ–¥–æ–ª–µ–≤–∞–µ—Ç –¥–∏—Å—Ç–∞–Ω—Ü–∏—é –≤ 130 000 –ø–æ–¥–ø–∏—Å—á–∏–∫–æ–≤! –ü–æ–¥–ø–∏—Å—ã–≤–∞–π—Ç–µ—Å—å –Ω–∞ –Ω–∞—Å: @mediamedics –ü—É–±–ª–∏–∫—É–µ–º —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω—É—é –ø–æ–¥–±–æ—Ä–∫—É! –¢–∞–º–∞–∑ –ì–∞–≥–ª–æ—à–≤–∏–ª–∏: –ø—Ä–∞–∫—Ç–∏–∫—É—é—â–∏–π –∫–∞—Ä–¥–∏–æ–ª–æ–≥ –æ –ø—Ä–æ–±–ª–µ–º–∞—Ö –Ω–∞—à–µ–≥–æ —Å–∞–º–æ–≥–æ –Ω–µ—É—Ç–æ–º–∏–º–æ–≥–æ –æ—Ä–≥–∞–Ω–∞ –ü–µ–π —Ç–∞–±–ª–µ—Ç–∫–∏: –æ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞—Ö –∏ –±–æ–ª–µ–∑–Ω—è—Ö –ø—Ä–æ—Å—Ç—ã–º —è–∑—ã–∫–æ–º –∏ —Å –º–µ–º–∞–º–∏, –ø—Ä–æ–µ–∫—Ç MEDIQ Ordinatura.org: –∫—Ä—É–ø–Ω–µ–π—à–∏–π –ø–æ—Ä—Ç–∞–ª –æ –∫–∞—á–µ—Å—Ç–≤–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è –∏ –ø–æ—Å–ª–µ–¥–Ω–∏—Ö –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å–Ω—ã—Ö –∏–∑–º–µ–Ω–µ–Ω–∏—è—Ö –≤ –Ω—ë–º –ë–∞–¥–º–∞ –ë–∞—à–∞–Ω–∫–∞–µ–≤: —Ö–∏—Ä—É—Ä–≥-–æ–Ω–∫–æ–ª–æ–≥, –ø–µ—Ä–≤—ã–π –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—è –∫–æ–º–∏—Ç–µ—Ç–∞ –ì–æ—Å–¥—É–º—ã –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è, –∑–∞—â–∏—â–∞—é—â–∏–π –ø—Ä–∞–≤–∞ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –∏ –≤—Ä–∞—á–µ–π –í—Ä–∞—á –º–∞–º–∏–Ω–æ–π –ø–æ–¥—Ä—É–≥–∏: –∫–∞–Ω–∞–ª –æ –ù–ï–∫–∞—Ä–∞—Ç–µ–ª—å–Ω–æ–π –≥–∏–Ω–µ–∫–æ–ª–æ–≥–∏–∏, —Å–æ–≤—Ä–µ–º–µ–Ω–Ω–æ–º –ø–æ–¥—Ö–æ–¥–µ, –ª–∏—á–Ω—ã—Ö –Ω–∞–±–ª—é–¥–µ–Ω–∏—è—Ö –∏ –æ –∂–∏–∑–Ω–∏ –≤—Ä–∞—á–∞ –∑–∞ –ø—Ä–µ–¥–µ–ª–∞–º–∏ –±–æ–ª—å–Ω–∏—á–Ω—ã—Ö —Å—Ç–µ–Ω –î–º–∏—Ç—Ä–∏–π –ë–µ–π–Ω—É—Å–æ–≤: –¥–µ—Ä–º–∞—Ç–æ–æ–Ω–∫–æ–ª–æ–≥, —Ç–æ—Ç —Å–∞–º—ã–π –≤—Ä–∞—á, –∫–æ—Ç–æ—Ä—ã–π –∑–Ω–∞–µ—Ç, —á—Ç–æ –¥–µ–ª–∞—Ç—å, –µ—Å–ª–∏ –≤—ã —Å–æ–¥—Ä–∞–ª–∏ —Ä–æ–¥–∏–Ω–∫—É –î–∞–Ω–∏–ª–∞ –ü—ã—Ä–∏–∫–æ–≤: –∞–≤—Ç–æ—Ä —Å–∞–º–æ–≥–æ –∫—Ä—É–ø–Ω–æ–≥–æ –∫–∞–Ω–∞–ª–∞ –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–æ–π –±–æ–ª–µ–∑–Ω—å—é –ø–æ—á–µ–∫ –ò—Ä–∏–Ω–∞ –í–∞—Å–∏–ª—å–µ–≤–∞: –ø—Ä–∞–∫—Ç–∏–∫—É—é—â–∏–π –≤—Ä–∞—á-–∫–∞—Ä–¥–∏–æ–ª–æ–≥, –∫–∞–Ω–¥–∏–¥–∞—Ç –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –Ω–∞—É–∫, –ø—Ä–µ–ø–æ–¥–∞–≤–∞—Ç–µ–ª—å –∫–∞—Ñ–µ–¥—Ä—ã –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –≤—É–∑–∞. –í—Å—ë, —á—Ç–æ –Ω—É–∂–Ω–æ –∑–Ω–∞—Ç—å –æ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–µ –∏ –ª–µ—á–µ–Ω–∏–∏ —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –ê–Ω–¥—Ä–µ–π –•–∞—Ä–∏—Ç–æ–Ω–æ–≤: –≤—Ä–∞—á-–≥–∞—Å—Ç—Ä–æ—ç–Ω—Ç–µ—Ä–æ–ª–æ–≥, –∫–∞–Ω–¥–∏–¥–∞—Ç –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –Ω–∞—É–∫, –∞–≤—Ç–æ—Ä –±–ª–æ–≥–∞ –æ –Ω–µ–∫–∞—Ä–∞—Ç–µ–ª—å–Ω–æ–π –∏ –Ω–µ—Ç—Ä–µ–≤–æ–∂–Ω–æ–π –≥–∞—Å—Ç—Ä–æ—ç–Ω—Ç–µ—Ä–æ–ª–æ–≥–∏–∏ –î–æ–∫—Ç–æ—Ä –ò–æ–ª–∞–Ω—Ç–∞: –Ω–µ–≤—Ä–æ–ª–æ–≥ –Ω–∞—É—á–Ω–æ-–ø–æ–ø—É–ª—è—Ä–Ω–æ ‚Äî –æ –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω–µ –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ë—É—Ä–ª–∞–∫–æ–≤: –≤—Ä–∞—á-–¥–∏–µ—Ç–æ–ª–æ–≥, —Ä–∞–∑–±–∏—Ä–∞–µ—Ç –º–∏—Ñ—ã –æ –ø–∏—Ç–∞–Ω–∏–∏ –∏ –æ–±–æ–∑—Ä–µ–≤–∞–µ—Ç –Ω–æ–≤–æ—Å—Ç–∏ –Ω–∞—É–∫–∏ –Ω–∞ ¬´—á–µ–ª–æ–≤–µ—á–µ—Å–∫–æ–º —è–∑—ã–∫–µ¬ª –ï–≤–≥–µ–Ω–∏–π –ù–∏–∫–∏—Ç–∏–Ω: –∫–ª–∏–Ω—Ñ–∞—Ä–º–∞–∫–æ–ª–æ–≥ ‚Äî –æ–± –∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫–∞—Ö –¥–æ—Å—Ç—É–ø–Ω—ã–º —è–∑—ã–∫–æ–º –∏ —Å —é–º–æ—Ä–æ–º –î–º–∏—Ç—Ä–∏–π –ú–æ–ª–æ–¥–æ–π: –ø–µ–¥–∏–∞—Ç—Ä —Å–∫–æ—Ä–æ–π –ø–æ–º–æ—â–∏ ‚Äî –∫–∞–∫ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ –æ–±—â–∞—Ç—å—Å—è —Å —Ä–æ–¥–∏—Ç–µ–ª—è–º–∏ –±–æ–ª—å–Ω–æ–≥–æ —Ä–µ–±–µ–Ω–∫–∞ –î—É–±–∏–Ω–∏–Ω–∞ –û–ª—å–≥–∞: –≤—Ä–∞—á-–¥–∏–µ—Ç–æ–ª–æ–≥ ‚Äî –æ —Ç–æ–º, –∫–∞–∫ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ —Å–Ω–∏–∑–∏—Ç—å –≤–µ—Å –±–µ–∑ –∏–∑–¥–µ–≤–∞—Ç–µ–ª—å—Å—Ç–≤–∞ –Ω–∞–¥ —Å–≤–æ–∏–º –æ—Ä–≥–∞–Ω–∏–∑–º–æ–º –°—Ç–∞–Ω–∏—Å–ª–∞–≤ –ê–Ω–¥—Ä–∏—è–Ω–æ–≤: –ø–µ–¥–∏–∞—Ç—Ä ‚Äî –ø—Ä–æ –∑–¥–æ—Ä–æ–≤—å–µ –¥–µ—Ç–µ–π, —Å–ø–æ–∫–æ–π–Ω–æ–µ —Ä–æ–¥–∏—Ç–µ–ª—å—Å—Ç–≤–æ –∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ –≤ —Ü–µ–ª–æ–º –°—Ç–∞–Ω–∏—Å–ª–∞–≤ –•–∞–Ω: –∏–∑–≤–µ—Å—Ç–Ω—ã–π —ç–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥, –¥–∏–µ—Ç–æ–ª–æ–≥ ‚Äî –¥–æ—Å—Ç—É–ø–Ω–æ –æ –≥–æ—Ä–º–æ–Ω–∞—Ö –∏ –Ω–µ —Ç–æ–ª—å–∫–æ –ò–≤–∞–Ω –î–∞–≤—ã–¥–æ–≤: –æ–± –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –≤–æ –≤—Å–µ—Ö –µ—ë –ø—Ä–æ—Ç–∏–≤–æ—Ä–µ—á–∏—è—Ö Medach: —Å—Ç–∞—Ç—å–∏, —Å–≤–µ–∂–∏–µ –Ω–æ–≤–æ—Å—Ç–∏, –ø–µ—Ä–µ–≤–æ–¥—ã –∏–∑ –≤–µ–¥—É—â–∏—Ö –∏–∑–¥–∞–Ω–∏–π –∏ –ø–æ–¥–∫–∞—Å—Ç—ã —Å —ç–∫—Å–ø–µ—Ä—Ç–∞–º–∏ –ê–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏—è –≤—Ä–∞—á–µ–π | –û—Ä–¥–∏–Ω–∞—Ç—É—Ä–∞: –æ–± –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–∏, –ø–æ—Å—Ç—É–ø–ª–µ–Ω–∏–∏ –≤ –æ—Ä–¥–∏–Ω–∞—Ç—É—Ä—É –∏ –ø–æ–≤—ã—à–µ–Ω–∏–∏ –∫–≤–∞–ª–∏—Ñ–∏–∫–∞—Ü–∏–∏ –ó–∞–ø–∏—Å–∫–∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∞: —ç–∫—Å-–∑–∞–≤–µ–¥—É—é—â–∞—è –∞–ø—Ç–µ–∫–æ–π ‚Äî –¥–æ—Å—Ç—É–ø–Ω–æ –æ–± —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –°—Ç–∞–ª—å–Ω—ã–µ –ù–µ—Ä–≤—ã: –¥–µ–∂—É—Ä–Ω—ã–π –Ω–µ–≤—Ä–æ–ª–æ–≥ –∫—Ä—É–ø–Ω–µ–π—à–µ–π –±–æ–ª—å–Ω–∏—Ü—ã —Å–∫–æ—Ä–æ–π –ø–æ–º–æ—â–∏. –°–ª—É—á–∞–∏ –∏–∑ –ø—Ä–∏–µ–º–Ω–æ–≥–æ –æ—Ç–¥–µ–ª–µ–Ω–∏—è, —Ä–∞–∑–≥–æ–≤–æ—Ä—ã –æ–± —ç–∫—Å—Ç—Ä–µ–Ω–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω–µ –∏ –ø–æ–≤—Å–µ–¥–Ω–µ–≤–Ω—ã—Ö —Ä–µ–∞–ª–∏—è—Ö –î–æ–∫—Ç–æ—Ä –í–∞—Ä–Ω–∞–≤—Å–∫–∏–π: –≤—Ä–∞—á ¬´—Å–∫–æ—Ä–æ–π¬ª, –ø—Ä–µ–ø–æ–¥–∞–≤–∞—Ç–µ–ª—å ‚Äî –æ—Ç–∫—Ä–æ–≤–µ–Ω–Ω–æ –æ —Ä–∞–±–æ—á–∏—Ö –±—É–¥–Ω—è—Ö –∏ —Å–∞–º—ã—Ö –Ω–µ–æ–±—ã—á–Ω—ã—Ö –≤—ã–∑–æ–≤–∞—Ö –ù—É—Ä–∞—Ö–º–µ–¥ –ö–∞—Ä–∞–µ–≤: —É—Ä–æ–ª–æ–≥–∏—è –±–µ–∑ –º–∏—Ñ–æ–≤. –û –ø—Ä–æ—Å—Ç–∞—Ç–∏—Ç–µ, —Ü–∏—Å—Ç–∏—Ç–µ –∏ —Ç–∞–∑–æ–≤–æ–π –±–æ–ª–∏ ‚Äî –¥–æ—Å—Ç—É–ø–Ω–æ –∏ —Å —É–ø–æ—Ä–æ–º –Ω–∞ –Ω–∞—É—á–Ω–æ –æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω—É—é –º–µ–¥–∏—Ü–∏–Ω—É –ú–∞—Ä–∫ –ì–∞–¥–∑–∏—è–Ω: –∫–∞–Ω–¥–∏–¥–∞—Ç –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –Ω–∞—É–∫ ‚Äì –ø—Ä–æ —Ç–æ–Ω–∫–∏–µ –≤–æ–ø—Ä–æ—Å—ã —É—Ä–æ–ª–æ–≥–∏–∏ –î–æ–∫—Ç–æ—Ä –°–µ–≤–∞—Å—Ç–µ–Ω–∫–æ–≤–∞: —ç–∫—Å–ø–µ—Ä—Ç–Ω—ã–π –∫–∞–Ω–∞–ª –ø—Ä–æ –º–∏–∫—Ä–æ–±–∏–æ–º, –≥–µ–Ω–µ—Ç–∏–∫—É, –∞–∫—Ç–∏–≤–Ω–æ–µ –¥–æ–ª–≥–æ–ª–µ—Ç–∏–µ, –∞ —Ç–∞–∫–∂–µ –∞–Ω–∞–ª–∏–∑—ã ‚Äî –ø–æ–ª–µ–∑–Ω—ã–µ, –±–µ—Å–ø–æ–ª–µ–∑–Ω—ã–µ –∏ –¥–∞–∂–µ –≤—Ä–µ–¥–Ω—ã–µ –ö—Å–µ–Ω–∏—è –ó–∞–º—è—Ç–∏–Ω–∞: –Ω–∞—É—á–∏—Ç –ø–æ–Ω–∏–º–∞—Ç—å —Å–∞–º—ã–µ —Å–ª–æ–∂–Ω—ã–µ —Ä–µ–Ω—Ç–≥–µ–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–µ —Å–Ω–∏–º–∫–∏, –Ω–µ –±–æ–∏—Ç—Å—è —Ä–∞—Å—Å–∫–∞–∑—ã–≤–∞—Ç—å –æ —Å–≤–æ–∏—Ö –æ—à–∏–±–∫–∞—Ö –î–æ–∫—Ç–æ—Ä –ë–æ—Ä–∏—Å–æ–≤: —Å–∞–º—ã–π –∏–∑–≤–µ—Å—Ç–Ω—ã–π –æ—Ç–æ–Ω–µ–≤—Ä–æ–ª–æ–≥ –Ω–∞ –Æ—Ç—É–±–µ Coroner's word: –æ —Ç–æ–º, –∫–∞–∫ –Ω–µ —É–º–µ—Ä–µ—Ç—å –º–æ–ª–æ–¥—ã–º, –æ —Ä–∞–±–æ—Ç–µ –≤ –º–æ—Ä–≥–µ –∏ –Ω–∞—à–µ–º –æ—Ä–≥–∞–Ω–∏–∑–º–µ –≤ —Ü–µ–ª–æ–º –ò–∫–æ–Ω–∞ –§–∞—Ä–º—ã: –æ –∑–∞–¥–æ–∫—É–º–µ–Ω—Ç–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –¥–æ–≥–æ–≤–æ—Ä—ë–Ω–Ω–æ—Å—Ç—è—Ö —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏ –ú–°–≠—à–Ω—ã–π: —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –∏–∑ –ú–°–≠, –∫–æ—Ç–æ—Ä—ã–µ —Ä–∞–∑—ä—è—Å–Ω—è—é—Ç –Ω—é–∞–Ω—Å—ã –ø–æ–ª—É—á–µ–Ω–∏—è –∏–Ω–≤–∞–ª–∏–¥–Ω–æ—Å—Ç–∏ –ú–µ–¥–∫–∞–¥—Ä—ã: –≥–ª–∞–≤–Ω—ã–µ –ø–æ –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω–æ-–ø—Ä–∞–≤–æ–≤—ã–º –∞–∫—Ç–∞–º –≤ —Å—Ñ–µ—Ä–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è Medical –ö—Å—é: –∞–≤—Ç–æ—Ä—Å–∫–∏–π –∫–∞–Ω–∞–ª –æ —Ü–∏—Ñ—Ä–æ–≤–∏–∑–∞—Ü–∏–∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –í—Å—ë, —á—Ç–æ –≤—ã —Ö–æ—Ç–µ–ª–∏ –∑–Ω–∞—Ç—å –æ –ï–ì–ò–°–ó, —Ç–µ–ª–µ–º–µ–¥–∏—Ü–∏–Ω–µ, –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–º –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–µ, —á–∞—Ç-–±–æ—Ç–∞—Ö –ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫: –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–µ –æ—Å–≤–µ—â–µ–Ω–∏–µ –∏ –∞–Ω–∞–ª–∏–∑ –≥–ª–∞–≤–Ω—ã—Ö –Ω–æ–≤–æ—Å—Ç–µ–π –∏ —Ç—Ä–µ–Ω–¥–æ–≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –Æ—Ä–∏—Å—Ç—ã –∑–∞ –≤—Ä–∞—á–µ–π: –æ –∑–∞—â–∏—Ç–µ –ø—Ä–∞–≤ –≤—Ä–∞—á–µ–π, –≥—Ä–∞–º–æ—Ç–Ω–æ–π –¥–æ–∫—É–º–µ–Ω—Ç–∞—Ü–∏–∏; –µ–∂–µ–Ω–µ–¥–µ–ª—å–Ω—ã–µ –±–µ—Å–ø–ª–∞—Ç–Ω—ã–µ —ç—Ñ–∏—Ä—ã –ò–≤–∞–Ω –ü–µ—á–µ—Ä–µ–π: —é—Ä–∏—Å—Ç, –∑–∞—â–∏—â–∞—é—â–∏–π –∏—Å–∫–ª—é—á–∏—Ç–µ–ª—å–Ω–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –ê–Ω–≥–µ–ª–∏–Ω–∞ –†–æ–º–∞–Ω–æ–≤—Å–∫–∞—è: –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–π —é—Ä–∏—Å—Ç, –∫–æ—Ç–æ—Ä—ã–π –∑–∞—â–∏—â–∞–µ—Ç –≤—Ä–∞—á–µ–π –∏ –∫–ª–∏–Ω–∏–∫–∏ –ü–∞—Ä–∞–≥–Ω–æ–º–µ–Ω: –æ –ø—Å–∏—Ö–∏–∞—Ç—Ä–∏–∏, –Ω–µ–≤—Ä–æ–ª–æ–≥–∏–∏ –∏ –ø—Å–∏—Ö–æ–ª–æ–≥–∏–∏, –º–µ—Å—Ç–∞–º–∏ —Å –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—ã–º —á–µ—Ä–Ω—ã–º —é–º–æ—Ä–æ–º –í–ª–∞–¥–∏–º–∏—Ä –ù–µ—á–µ–ø–æ—Ä—É–∫: –∏–∑–¥–∞–ª –ø–µ—Ä–≤—É—é –≤ –†–æ—Å—Å–∏–∏ –∫–Ω–∏–≥—É –ø—Ä–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–π –±–ª–æ–≥–∏–Ω–≥ –ù–µ–º–µ–¥–∏—Ü–∏–Ω–∞: —É—Ä–æ–ª–æ–≥, –∫–æ—Ç–æ—Ä—ã–π –æ–±–æ–∑—Ä–µ–≤–∞–µ—Ç –∏–Ω—Ç–µ—Ä–µ—Å–Ω—ã–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Å–ª—É—á–∞–∏","{""skip"": true}"
2025-09-27T08:44:29+00:00,@pharm_icon,2393,https://t.me/pharm_icon/2393,"–§–ê–†–ú–ê–ö–û–ù–ê–î–ó–û–†: –ö–†–ò–¢–ò–ß–ï–°–ö–ò–ï –ü–†–û–¶–ï–°–°–´ –ü—Ä–∏–≥–ª–∞—à–∞–µ–º –≤–∞—Å –Ω–∞ –æ–¥–Ω–æ–∏–º–µ–Ω–Ω—ã–π –∫—É—Ä—Å –≤ –Ω–æ—è–±—Ä–µ, –ø–æ—Å–≤—è—â–µ–Ω–Ω—ã–π —Ñ–∞—Ä–º–∞–∫–æ–Ω–∞–¥–∑–æ—Ä—É, —Å–æ–≤–º–µ—â–µ–Ω–Ω—ã–π —Å –æ—Ç–¥—ã—Ö–æ–º –≤ –∫–æ–º–ø–∞–Ω–∏–∏ –µ–¥–∏–Ω–æ–º—ã—à–ª–µ–Ω–Ω–∏–∫–æ–≤ –Ω–∞ –æ—Å—Ç—Ä–æ–≤–µ –•–∞–π–Ω–∞–Ω—å. üìÖ –î–∞—Ç—ã –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è: —Å 6 –Ω–æ—è–±—Ä—è –ø–æ 16 –Ω–æ—è–±—Ä—è 2025 –≥–æ–¥–∞ üéì –§–æ—Ä–º–∞—Ç –æ–±—É—á–µ–Ω–∏—è: –ò–Ω—Ç–µ—Ä–∞–∫—Ç–∏–≤–Ω—ã–µ –∑–∞–Ω—è—Ç–∏—è —Å –ø—Ä–µ–ø–æ–¥–∞–≤–∞–Ω–∏–µ–º –º–µ—Ç–æ–¥–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π –∏ —à–∞–±–ª–æ–Ω–æ–≤ –¥–ª—è –≤–µ–¥–µ–Ω–∏—è —Å–∏—Å—Ç–µ–º—ã —Ñ–∞—Ä–º–∞–∫–æ–Ω–∞–¥–∑–æ—Ä–∞. –ü–æ—Å–ª–µ –æ–±—É—á–µ–Ω–∏—è –≤—ã–¥–∞—ë—Ç—Å—è –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã–π —Å–µ—Ä—Ç–∏—Ñ–∏–∫–∞—Ç. –° –ø—Ä–æ–≥—Ä–∞–º–º–æ–π –∫—É—Ä—Å–∞ –º–æ–∂–Ω–æ –æ–∑–Ω–∞–∫–æ–º–∏—Ç—å—Å—è –ø–æ —Å—Å—ã–ª–∫–µ. üë§ –û—Ä–≥–∞–Ω–∏–∑–∞—Ç–æ—Ä: AC Institute of International Education, –ü—Ä–∞–≥–∞, –ß–µ—Ö–∏—è. –õ–µ–∫—Ç–æ—Ä: –ú–∞—Ä–∏–Ω–∞ –ê–ª–µ–∫—Å–µ–µ–≤–Ω–∞ –ö–∞–Ω—É—à–∏–Ω–∞ ‚Äî –¥–∏—Ä–µ–∫—Ç–æ—Ä –∏–Ω—Å—Ç–∏—Ç—É—Ç–∞, PhD, —ç–∫—Å–ø–µ—Ä—Ç —Å –º–Ω–æ–≥–æ–ª–µ—Ç–Ω–∏–º –æ–ø—ã—Ç–æ–º –≤ –æ–±–ª–∞—Å—Ç–∏ –∫–æ–º–º–µ—Ä—á–µ—Å–∫–æ–≥–æ —Ñ–∞—Ä–º–∞–∫–æ–Ω–∞–¥–∑–æ—Ä–∞ (—Å 2007 –≥–æ–¥–∞), –∞–≤—Ç–æ—Ä –∫—É—Ä—Å–∞. –ì–¥–µ: –ø–æ–±–µ—Ä–µ–∂—å–µ —Ç–µ–ø–ª–æ–≥–æ –Æ–∂–Ω–æ-–ö–∏—Ç–∞–π—Å–∫–æ–≥–æ –º–æ—Ä—è, –Ω–∞ –æ—Å—Ç—Ä–æ–≤–µ –•–∞–π–Ω–∞–Ω—å. –í–∞–∂–Ω–æ: –¥–ª—è —Ä–æ—Å—Å–∏—è–Ω, –ø—Ä–∏–±—ã–≤–∞—é—â–∏—Ö –Ω–∞ –æ—Å—Ç—Ä–æ–≤ –•–∞–π–Ω–∞–Ω—å –ø—Ä—è–º—ã–º —Ä–µ–π—Å–æ–º, –¥–µ–π—Å—Ç–≤—É–µ—Ç –±–µ–∑–≤–∏–∑–æ–≤—ã–π —Ä–µ–∂–∏–º –Ω–∞ —Å—Ä–æ–∫ –¥–æ 30 –¥–Ω–µ–π. üí∂ –°—Ç–æ–∏–º–æ—Å—Ç—å —É—á–∞—Å—Ç–∏—è: 1950 –µ–≤—Ä–æ —Å —á–µ–ª–æ–≤–µ–∫–∞ ‚Äî —Ä–∞–∑–º–µ—â–µ–Ω–∏–µ –≤ –¥–≤—É—Ö–º–µ—Å—Ç–Ω–æ–º –Ω–æ–º–µ—Ä–µ, 5-–∑–≤–µ–∑–¥, –ø–µ—Ä–≤–∞—è –±–µ—Ä–µ–≥–æ–≤–∞—è –ª–∏–Ω–∏—è –í–∫–ª—é—á–µ–Ω–æ: –ø—Ä–æ–∂–∏–≤–∞–Ω–∏–µ –≤ –æ—Ç–µ–ª–µ, –∑–∞–≤—Ç—Ä–∞–∫, —Ç—Ä–∞–Ω—Å—Ñ–µ—Ä. –ü—Ä–µ–¥–æ–ø–ª–∞—Ç–∞: 100% –≤ —Ä—É–±–ª—è—Ö –ø–æ –∫—É—Ä—Å—É –Ω–∞ –¥–µ–Ω—å –æ–ø–ª–∞—Ç—ã. –î–ª—è —É—á–∞—Å—Ç–∏—è –≤ –ø—Ä–æ–≥—Ä–∞–º–º–µ ‚Äì –æ—Å—Ç–∞–≤—å—Ç–µ —Å–≤–æ–∏ –∫–æ–Ω—Ç–∞–∫—Ç—ã –≤ –≥—É–≥–ª-—Ñ–æ—Ä–º–µ, –æ—Ä–≥–∞–Ω–∏–∑–∞—Ç–æ—Ä—ã —Å–≤—è–∂—É—Ç—Å—è —Å –≤–∞–º–∏ –¥–ª—è —É—Ç–æ—á–Ω–µ–Ω–∏—è –¥–µ—Ç–∞–ª–µ–π –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –∫—É—Ä—Å–∞. –°—Å—ã–ª–∫–∞ –Ω–∞ –≥—É–≥–ª —Ñ–æ—Ä–º—É –∑–¥–µ—Å—å.","{""skip"": true}"
2025-09-26T05:20:03+00:00,@pharm_icon,2392,https://t.me/pharm_icon/2392,"–í–ª–∏—è–Ω–∏–µ –∫–æ—Ñ–µ–∏–Ω–∞ –Ω–∞ —Ç—Ä–µ–≤–æ–∂–Ω–æ—Å—Ç—å –∏ –ø–∞–Ω–∏—á–µ—Å–∫–∏–µ –∞—Ç–∞–∫–∏ —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –ø–∞–Ω–∏—á–µ—Å–∫–∏–º —Ä–∞—Å—Å—Ç—Ä–æ–π—Å—Ç–≤–æ–º ‚ö†Ô∏è–ù—É–∂–Ω–æ –±–æ–ª—å—à–µ –∫–æ—Ñ–µ–π–Ω—ã—Ö –º–µ—Ç–∞-–∞–Ω–∞–ª–∏–∑–æ–≤ ‚Äî –ø–æ—ç—Ç–æ–º—É –≤–æ—Ç –µ—â—ë –æ–¥–∏–Ω, –∫–æ—Ç–æ—Ä—ã–π —Ä–∞—Å–∫—Ä–æ–µ—Ç –ø—Ä–∏—á–∏–Ω—É, –ø–æ –∫–æ—Ç–æ—Ä–æ–π –≤—ã –ø–æ–≤—ã—à–∞–µ—Ç–µ –¥–æ–∑—É –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç–æ–≤, —É–≤–∞–∂–∞–µ–º—ã–µ –∫–æ—Ñ–µ–π–Ω—ã–µ –Ω–∞—Ä–∫–æ–º–∞–Ω—ã. –ü–∞–Ω–∏—á–µ—Å–∫–æ–µ —Ä–∞—Å—Å—Ç—Ä–æ–π—Å—Ç–≤–æ (–ü–†) ‚Äî —ç—Ç–æ —Ç—Ä–µ–≤–æ–∂–Ω–æ–µ —Ä–∞—Å—Å—Ç—Ä–æ–π—Å—Ç–≤–æ, –ø—Ä–∏ –∫–æ—Ç–æ—Ä–æ–º —É —á–µ–ª–æ–≤–µ–∫–∞ –ø–æ–≤—Ç–æ—Ä—è—é—Ç—Å—è –ø–∞–Ω–∏—á–µ—Å–∫–∏–µ –∞—Ç–∞–∫–∏: –≤–Ω–µ–∑–∞–ø–Ω—ã–µ —ç–ø–∏–∑–æ–¥—ã –∏–Ω—Ç–µ–Ω—Å–∏–≤–Ω–æ–≥–æ —Å—Ç—Ä–∞—Ö–∞ –∏–ª–∏ –¥–∏—Å–∫–æ–º—Ñ–æ—Ä—Ç–∞, –¥–æ—Å—Ç–∏–≥–∞—é—â–∏–µ –ø–∏–∫–∞ –∑–∞ –Ω–µ—Å–∫–æ–ª—å–∫–æ –º–∏–Ω—É—Ç –∏ —Å–æ–ø—Ä–æ–≤–æ–∂–¥–∞—é—â–∏–µ—Å—è –≤—ã—Ä–∞–∂–µ–Ω–Ω—ã–º–∏ –≤–µ–≥–µ—Ç–∞—Ç–∏–≤–Ω—ã–º–∏ –∏ –ø—Å–∏—Ö–∏—á–µ—Å–∫–∏–º–∏ —Å–∏–º–ø—Ç–æ–º–∞–º–∏. –†–µ–∑—É–ª—å—Ç–∞—Ç—ã –í—Å–µ–≥–æ –±—ã–ª–æ –Ω–∞–π–¥–µ–Ω–æ 10 –ø–æ–¥—Ö–æ–¥—è—â–∏—Ö –¥–ª—è –∞–Ω–∞–ª–∏–∑–∞ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π. 9 –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π, –ø–æ—Å–≤—è—â–µ–Ω–Ω—ã—Ö –∏–∑—É—á–µ–Ω–∏—é –ø–∞–Ω–∏—á–µ—Å–∫–∏—Ö –∞—Ç–∞–∫, –≤–∫–ª—é—á–∞–ª–∏ 237 –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –ø–∞–Ω–∏—á–µ—Å–∫–∏–º —Ä–∞—Å—Å—Ç—Ä–æ–π—Å—Ç–≤–æ–º, –∏–∑ –∫–æ—Ç–æ—Ä—ã—Ö —É 51,1% –±—ã–ª–∞ –ø–∞–Ω–∏—á–µ—Å–∫–∞—è –∞—Ç–∞–∫–∞ –ø–æ—Å–ª–µ –∫–æ—Ñ–µ–∏–Ω–∞, –Ω–æ –Ω–∏ —É –æ–¥–Ω–æ–≥–æ ‚Äî –ø–æ—Å–ª–µ –ø–ª–∞—Ü–µ–±–æ. –í —à–µ—Å—Ç–∏ –∏–∑ —ç—Ç–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π —Å—Ä–∞–≤–Ω–∏–≤–∞–ª–∏ 128 –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å–æ 115 –∑–¥–æ—Ä–æ–≤—ã–º–∏ –∫–æ–Ω—Ç—Ä–æ–ª—å–Ω—ã–º–∏ –ª–∏—Ü–∞–º–∏ (–ó–ö), –æ–±–Ω–∞—Ä—É–∂–∏–≤, —á—Ç–æ –ø–∞—Ü–∏–µ–Ω—Ç—ã (53,9%) –±—ã–ª–∏ –±–æ–ª–µ–µ —É—è–∑–≤–∏–º—ã, —á–µ–º –∑–¥–æ—Ä–æ–≤—ã–µ –ª—é–¥–∏ (1,7%), –∫ –ø–∞–Ω–∏—á–µ—Å–∫–∏–º –∞—Ç–∞–∫–∞–º –ø–æ—Å–ª–µ –∫–æ—Ñ–µ–∏–Ω–∞ (log RR: 3,47; 95% –î–ò 2,06‚Äì4,87). –í—ã–≤–æ–¥: —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–∞—é—Ç, —á—Ç–æ –∫–æ—Ñ–µ–∏–Ω –≤ –¥–æ–∑–∞—Ö, –ø—Ä–∏–º–µ—Ä–Ω–æ —ç–∫–≤–∏–≤–∞–ª–µ–Ω—Ç–Ω—ã—Ö 5 —á–∞—à–∫–∞–º –∫–æ—Ñ–µ, –≤—ã–∑—ã–≤–∞–µ—Ç –ø–∞–Ω–∏—á–µ—Å–∫–∏–µ –∞—Ç–∞–∫–∏ —É –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ–π —á–∞—Å—Ç–∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –ø–∞–Ω–∏—á–µ—Å–∫–∏–º —Ä–∞—Å—Å—Ç—Ä–æ–π—Å—Ç–≤–æ–º –∏ —Å—É—â–µ—Å—Ç–≤–µ–Ω–Ω–æ –æ—Ç–ª–∏—á–∞–µ—Ç —ç—Ç—É –≥—Ä—É–ø–ø—É –æ—Ç –∑–¥–æ—Ä–æ–≤—ã—Ö –≤–∑—Ä–æ—Å–ª—ã—Ö. –í —ç—Ç–∏—Ö –∂–µ –¥–æ–∑–∞—Ö –∫–æ—Ñ–µ–∏–Ω —Ç–∞–∫–∂–µ –ø–æ–≤—ã—à–∞–µ—Ç —Ç—Ä–µ–≤–æ–∂–Ω–æ—Å—Ç—å –∫–∞–∫ —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å —Ä–∞—Å—Å—Ç—Ä–æ–π—Å—Ç–≤–æ–º, —Ç–∞–∫ –∏ —É –∑–¥–æ—Ä–æ–≤—ã—Ö –≤–∑—Ä–æ—Å–ª—ã—Ö. –û–≥—Ä–∞–Ω–∏—á–µ–Ω–Ω—ã–π –¥–∏–∞–ø–∞–∑–æ–Ω –∏—Å–ø–æ–ª—å–∑—É–µ–º–æ–≥–æ –∫–æ—Ñ–µ–∏–Ω–∞ [400‚Äì750 –º–≥] –∏ –Ω–µ–±–æ–ª—å—à–æ–µ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π (3), –≤ –∫–æ—Ç–æ—Ä—ã—Ö –Ω–µ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–ª–∞—Å—å –¥–æ–∑–∞ 480 –º–≥, –Ω–µ –ø–æ–∑–≤–æ–ª–∏–ª–∏ –ø—Ä–æ–≤–µ—Å—Ç–∏ –∫–∞–∫–æ–π-–ª–∏–±–æ –∑–Ω–∞—á–∏–º—ã–π –∞–Ω–∞–ª–∏–∑ –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏ –º–µ–∂–¥—É –¥–æ–∑–æ–π –∏ —Ä–µ–∞–∫—Ü–∏–µ–π. –¢–∞–∫ —á—Ç–æ –≤–æ–∑–º–æ–∂–Ω–æ, —á—Ç–æ –∏ –º–µ–Ω—å—à–∞—è –¥–æ–∑–∞ –ø—Ä–æ–≤–æ—Ü–∏—Ä—É–µ—Ç –ø–∞–Ω–∏—á–µ—Å–∫–∏–µ –∞—Ç–∞–∫–∏ –∏–ª–∏ —Ç—Ä–µ–≤–æ–∂–Ω—ã–π —ç–ø–∏–∑–æ–¥. –ê —Ç–∞–∫ –∫–∞–∫ –º–∏–ª–ª–µ–Ω–∏–∞–ª—ã –Ω–µ –≤—ã–ª–µ–∑–∞—é—Ç –∏–∑ –∫–æ—Ñ–µ–µ–Ω, —è –¥–µ–ª–∞—é –≤—ã–≤–æ–¥, —á—Ç–æ –æ–±—Å–∞–∂–µ–Ω–Ω–æ—Å—Ç—å –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç–∞–º–∏ —ç—Ç–æ —Å—Ç–∏–ª—å –∂–∏–∑–Ω–∏ –∏ —Ä–µ–∑—É–ª—å—Ç–∞—Ç —Å–≤–æ–±–æ–¥–Ω–æ–≥–æ –≤—ã–±–æ—Ä–∞. –î–µ—Ç–∏ 90-—Ö ‚Äî –ø–æ–∫–æ–ª–µ–Ω–∏–µ mindfulness-—Ç–æ—Ä—á–∫–æ–≤.","{""skip"": true}"
2025-09-25T11:16:55+00:00,@pharm_icon,2391,https://t.me/pharm_icon/2391,"–≠—Ç–æ –Ω–µ –ø–ª–∞–Ω–æ–≤–∞—è –æ—Ç–º–µ–Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞, –Ω–æ —Ç–æ–∂–µ –ø–æ–¥–æ–π–¥—ë—Ç. –ö–µ–π—Å –ù–æ—á–Ω–æ–π –æ—Ö–æ—Ç—ã.","{""skip"": true}"
2025-09-25T11:16:24+00:00,@pharm_icon,2390,https://t.me/pharm_icon/2390,"#–º—É–∑–µ–π–∏–¥–∏–æ—Ç–∏–∑–º–∞ –ü–∞—Ü–∏–µ–Ω—Ç–∫–∞ 29 –ª–µ—Ç —Å –∞–ª–ª–µ—Ä–≥–∏–µ–π –Ω–∞ –∞–º–æ–∫—Å–∏—Ü–∏–ª–ª–∏–Ω –≤ –∞–Ω–∞–º–Ω–µ–∑–µ –Ω–∞—á–∞–ª–∞ –ø—Ä–∏—ë–º –ª–µ–≤–æ–º–∏—Ü–µ—Ç–∏–Ω–∞ –ø–æ –ø–æ–≤–æ–¥—É –¥–∏–∞—Ä–µ–π–Ω–æ–≥–æ —Å–∏–Ω–¥—Ä–æ–º–∞. –£–∂–µ –ø–æ—Å–ª–µ –ø–µ—Ä–≤–æ–π —Ç–∞–±–ª–µ—Ç–∫–∏ —É –Ω–µ—ë –Ω–∞—á–∞–ª–∞—Å—å –∞–ª–ª–µ—Ä–≥–∏—á–µ—Å–∫–∞—è –∫—Ä–∞–ø–∏–≤–Ω–∏—Ü–∞, –æ–¥–Ω–∞–∫–æ –ø–∞—Ü–∏–µ–Ω—Ç–∫–∞ –º—É–∂–µ—Å—Ç–≤–µ–Ω–Ω–æ –ø—Ä–æ–¥–æ–ª–∂–∞–ª–∞ –ø–∏—Ç—å –∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫ –µ—â—ë –≤ —Ç–µ—á–µ–Ω–∏–µ —Å—É—Ç–æ–∫, –ø–æ–∫–∞ –Ω–µ –ø–æ–∫—Ä—ã–ª–∞—Å—å —Å—ã–ø—å—é —Å –Ω–æ–≥ –¥–æ –≥–æ–ª–æ–≤—ã. –í–¥–æ–±–∞–≤–æ–∫ –∫–æ –≤—Å–µ–º—É –Ω–∞—á–∞–ª–∞ –ø—Ä–∏—ë–º —Ñ–∏–Ω–ª–µ–ø—Å–∏–Ω–∞, –ø–µ—Ä–µ–ø—É—Ç–∞–≤ –µ–≥–æ —Å —Ñ–µ–Ω–∏—Å—Ç–∏–ª–æ–º. –ò—Ç–æ–≥: –≤ 2 —á–∞—Å–∞ –Ω–æ—á–∏ –æ—Ç–µ–∫—à–µ–µ, –∫—Ä–∞—Å–Ω–æ–µ, –≥–ª—é—á–Ω–æ–µ, —Ö–æ—á–µ—Ç –≤ –±–æ–ª—å–Ω–∏—Ü—É. –£–∂–∞–ª–µ–Ω–∞ –ø—Ä–µ–¥–Ω–∏–∑–æ–ª–æ–Ω–æ–º –∏ –¥–µ–ª–µ–≥–∏—Ä–æ–≤–∞–Ω–∞ –≤ –ø–æ–ª–∏–∫–ª–∏–Ω–∏–∫—É. #–Ω–æ—á–Ω–∞—è_–∞—Ç–∞–∫–∞","{""skip"": true}"
2025-09-25T11:08:01+00:00,@pharm_icon,2389,https://t.me/pharm_icon/2389,–ß–µ–ª–ª–µ–Ω–¥–∂: —Ä–µ–ø–æ—Å—Ç–Ω—É –∫–∞–∂–¥—ã–π –æ–ø–∏—Å–∞–Ω–Ω—ã–π –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–π —Å–ª—É—á–∞–π —Å –æ—Ç–º–µ–Ω–æ–π –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏ —É–ª—É—á—à–µ–Ω–∏–µ–º —Å–æ—Å—Ç–æ—è–Ω–∏—è –≤ —Ç–µ–ª–µ–≥—Ä–∞–º–µ –ª—é–±–æ–≥–æ –≤—Ä–∞—á–∞ –ª—é–±–æ–≥–æ —Ä–∞–∑–º–µ—Ä–∞ –∏–ª–∏ —Å–¥–µ–ª–∞—é –ø–æ–¥–±–æ—Ä–∫—É. –ù–æ –Ω–∞–¥–æ –±—É–¥–µ—Ç –º–Ω–µ –Ω–∞–ø–∏—Å–∞—Ç—å –≤ –ª—Å @pharmaicon_admin,"{""skip"": true}"
2025-09-25T09:32:11+00:00,@pharm_icon,2388,https://t.me/pharm_icon/2388,–ö—Ä–∞—Ç–∫–æ–µ —Å–æ–¥–µ—Ä–∂–∞–Ω–∏–µ: –ù–ò-–ß–ï-–ì–û –Ω–µ –ø—Ä–æ–∏—Å—Ö–æ–¥–∏—Ç –æ—Å–æ–±–µ–Ω–Ω–æ–≥–æ –ø—Ä–∏ –æ—Ç–º–µ–Ω–µ –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç–æ–≤. –ö–æ–º–º–µ–Ω—Ç–∞—Ä–∏–∏?,"{""skip"": true}"
2025-09-25T09:31:43+00:00,@pharm_icon,2385,https://t.me/pharm_icon/2385,"‚ú®–ß—Ç–æ –ø—Ä–æ–∏—Å—Ö–æ–¥–∏—Ç –ø—Ä–∏ –æ—Ç–º–µ–Ω–µ –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç–æ–≤: –¥–∞–Ω–Ω—ã–µ –∫—Ä—É–ø–Ω–µ–π—à–µ–≥–æ –º–µ—Ç–∞-–∞–Ω–∞–ª–∏–∑–∞ –í JAMA Psychiatry –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω —Å–∏—Å—Ç–µ–º–∞—Ç–∏—á–µ—Å–∫–∏–π –æ–±–∑–æ—Ä –∏ –º–µ—Ç–∞-–∞–Ω–∞–ª–∏–∑ 50 –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π —Å —É—á–∞—Å—Ç–∏–µ–º –ø–æ—á—Ç–∏ 18 —Ç—ã—Å—è—á —á–µ–ª–æ–≤–µ–∫, –ø–æ—Å–≤—è—â–µ–Ω–Ω—ã–π —Å–∏–º–ø—Ç–æ–º–∞–º –æ—Ç–º–µ–Ω—ã –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç–æ–≤. –†–∞–±–æ—Ç–∞ –ø–æ–º–æ–≥–∞–µ—Ç –æ—Ç–¥–µ–ª–∏—Ç—å –º–∏—Ñ—ã –æ—Ç —Ä–µ–∞–ª—å–Ω–æ—Å—Ç–∏ –∏ –¥–∞–µ—Ç –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏–µ –æ—Ä–∏–µ–Ω—Ç–∏—Ä—ã –¥–ª—è –≤—Ä–∞—á–µ–π –∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –û—Å–Ω–æ–≤–Ω—ã–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã üü°–í —Å—Ä–µ–¥–Ω–µ–º —É —Ç–µ—Ö, –∫—Ç–æ –ø—Ä–µ–∫—Ä–∞—â–∞–ª –ø—Ä–∏–µ–º –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç–æ–≤, –Ω–∞–±–ª—é–¥–∞–ª—Å—è –ª–∏—à—å –æ–¥–∏–Ω –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–π —Å–∏–º–ø—Ç–æ–º –ø–æ —à–∫–∞–ª–µ DESS –≤ —Ç–µ—á–µ–Ω–∏–µ –ø–µ—Ä–≤–æ–π –Ω–µ–¥–µ–ª–∏ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –ø–ª–∞—Ü–µ–±–æ –∏–ª–∏ –ø—Ä–æ–¥–æ–ª–∂–µ–Ω–∏–µ–º —Ç–µ—Ä–∞–ø–∏–∏. DESS (Discontinuation-Emergent Signs and Symptoms scale) ‚Äî —ç—Ç–æ –æ–ø—Ä–æ—Å–Ω–∏–∫, —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ —Å–æ–∑–¥–∞–Ω–Ω—ã–π –¥–ª—è –æ—Ü–µ–Ω–∫–∏ —Å–∏–º–ø—Ç–æ–º–æ–≤, –≤–æ–∑–Ω–∏–∫–∞—é—â–∏—Ö –ø–æ—Å–ª–µ –ø—Ä–µ–∫—Ä–∞—â–µ–Ω–∏—è –ø—Ä–∏—ë–º–∞ –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç–æ–≤. –í –Ω–µ–º –ø–µ—Ä–µ—á–∏—Å–ª–µ–Ω—ã 43 –≤–æ–∑–º–æ–∂–Ω—ã—Ö —Å–∏–º–ø—Ç–æ–º–∞ –æ—Ç–º–µ–Ω—ã, –∫–æ—Ç–æ—Ä—ã–µ —Ä–∞–∑–¥–µ–ª–µ–Ω—ã –Ω–∞ —Å–æ–º–∞—Ç–∏—á–µ—Å–∫–∏–µ (–Ω–∞–ø—Ä–∏–º–µ—Ä, –≥–æ–ª–æ–≤–æ–∫—Ä—É–∂–µ–Ω–∏–µ, —Ç–æ—à–Ω–æ—Ç–∞, –ø–∞—Ä–µ—Å—Ç–µ–∑–∏–∏, –ø–æ—Ç–ª–∏–≤–æ—Å—Ç—å) –∏ –ø—Å–∏—Ö–∏—á–µ—Å–∫–∏–µ (—Ç—Ä–µ–≤–æ–∂–Ω–æ—Å—Ç—å, —Ä–∞–∑–¥—Ä–∞–∂–∏—Ç–µ–ª—å–Ω–æ—Å—Ç—å, –Ω–∞—Ä—É—à–µ–Ω–∏—è —Å–Ω–∞ –∏ —Ç.–¥.). –ö–∞–∂–¥—ã–π —Å–∏–º–ø—Ç–æ–º –æ—Ç–º–µ—á–∞–µ—Ç—Å—è –∫–∞–∫ ¬´–ø–æ—è–≤–∏–≤—à–∏–π—Å—è¬ª –∏–ª–∏ ¬´—É—Å–∏–ª–∏–≤—à–∏–π—Å—è¬ª –ø–æ—Å–ª–µ –æ—Ç–º–µ–Ω—ã. üü°–ù–∞–∏–±–æ–ª–µ–µ —á–∞—Å—Ç—ã–º–∏ —Å–∏–º–ø—Ç–æ–º–∞–º–∏ –±—ã–ª–∏ –≥–æ–ª–æ–≤–æ–∫—Ä—É–∂–µ–Ω–∏–µ (6,2%), —Ç–æ—à–Ω–æ—Ç–∞ (2,9%), —Ä–µ–∂–µ ‚Äî –≤–µ—Ä—Ç–∏–≥–æ –∏ –Ω–µ—Ä–≤–æ–∑–Ω–æ—Å—Ç—å. –ì–æ–ª–æ–≤–æ–∫—Ä—É–∂–µ–Ω–∏–µ (dizziness, light-headedness) –≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–π —Ç–µ—Ä–º–∏–Ω–æ–ª–æ–≥–∏–∏ —á–∞—â–µ –æ–ø–∏—Å—ã–≤–∞–µ—Ç –æ–±—â–µ–µ –æ—â—É—â–µ–Ω–∏–µ –Ω–µ—É—Å—Ç–æ–π—á–∏–≤–æ—Å—Ç–∏, ¬´–≤–∞—Ç–Ω–æ–π –≥–æ–ª–æ–≤—ã¬ª, –ø—Ä–µ–¥–æ–±–º–æ—Ä–æ—á–Ω–æ–≥–æ —Å–æ—Å—Ç–æ—è–Ω–∏—è. –≠—Ç–æ –Ω–µ—Å–ø–µ—Ü–∏—Ñ–∏—á–µ—Å–∫–∏–π —Å–∏–º–ø—Ç–æ–º, –∫–æ—Ç–æ—Ä—ã–π –ø–∞—Ü–∏–µ–Ω—Ç—ã –Ω–µ—Ä–µ–¥–∫–æ —Å–≤—è–∑—ã–≤–∞—é—Ç —Å –∏–∑–º–µ–Ω–µ–Ω–∏–µ–º –¥–∞–≤–ª–µ–Ω–∏—è, —É—Å—Ç–∞–ª–æ—Å—Ç—å—é –∏–ª–∏ —Ç—Ä–µ–≤–æ–≥–æ–π. –í–µ—Ä—Ç–∏–≥–æ (vertigo) ‚Äî —ç—Ç–æ –±–æ–ª–µ–µ —É–∑–∫–∏–π –Ω–µ–≤—Ä–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–π —Å–∏–º–ø—Ç–æ–º: –∏–ª–ª—é–∑–∏—è –≤—Ä–∞—â–µ–Ω–∏—è –æ–∫—Ä—É–∂–∞—é—â–µ–≥–æ –ø—Ä–æ—Å—Ç—Ä–∞–Ω—Å—Ç–≤–∞ –∏–ª–∏ —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ —Ç–µ–ª–∞, —Å–≤—è–∑–∞–Ω–Ω–∞—è —Å –Ω–∞—Ä—É—à–µ–Ω–∏–µ–º —Ä–∞–±–æ—Ç—ã –≤–µ—Å—Ç–∏–±—É–ª—è—Ä–Ω–æ–≥–æ –∞–ø–ø–∞—Ä–∞—Ç–∞. –û–Ω–∏ —Ä–∞–∑–¥–µ–ª–µ–Ω—ã –≤ DESS. üü°–°–∏–º–ø—Ç–æ–º—ã –æ—Ç–º–µ–Ω—ã –Ω–µ —Å–æ–ø—Ä–æ–≤–æ–∂–¥–∞–ª–∏—Å—å —É—Ö—É–¥—à–µ–Ω–∏–µ–º –Ω–∞—Å—Ç—Ä–æ–µ–Ω–∏—è: –¥–µ–ø—Ä–µ—Å—Å–∏–≤–Ω—ã–µ —Å–∏–º–ø—Ç–æ–º—ã –≤ –ø–µ—Ä–≤—ã–µ 2 –Ω–µ–¥–µ–ª–∏ –≤—Å—Ç—Ä–µ—á–∞–ª–∏—Å—å –Ω–µ —á–∞—â–µ, —á–µ–º –ø—Ä–∏ –ø–ª–∞—Ü–µ–±–æ. üü°–°–∞–º—ã–º–∏ ¬´—Å–∏–º–ø—Ç–æ–º–æ–≥–µ–Ω–Ω—ã–º–∏¬ª –æ–∫–∞–∑–∞–ª–∏—Å—å –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã —Å –∫–æ—Ä–æ—Ç–∫–∏–º –ø–µ—Ä–∏–æ–¥–æ–º –ø–æ–ª—É–≤—ã–≤–µ–¥–µ–Ω–∏—è: –≤–µ–Ω–ª–∞—Ñ–∞–∫—Å–∏–Ω –∏ –¥–µ—Å–≤–µ–Ω–ª–∞—Ñ–∞–∫—Å–∏–Ω; –¥–ª—è –¥—É–ª–æ–∫—Å–µ—Ç–∏–Ω–∞ –∏ –≤–æ—Ä—Ç–∏–æ–∫—Å–µ—Ç–∏–Ω–∞ —ç—Ñ—Ñ–µ–∫—Ç –±—ã–ª —É–º–µ—Ä–µ–Ω–Ω—ã–º, –∞ –¥–ª—è —ç—Å—Ü–∏—Ç–∞–ª–æ–ø—Ä–∞–º–∞ –∏ –ø–∞—Ä–æ–∫—Å–µ—Ç–∏–Ω–∞ –¥–∞–Ω–Ω—ã–µ –æ–≥—Ä–∞–Ω–∏—á–µ–Ω—ã. –ü—Ä–∞–∫—Ç–∏—á–µ—Å–∫–æ–µ –∑–Ω–∞—á–µ–Ω–∏–µ –†–µ–∑—É–ª—å—Ç–∞—Ç—ã —Å—Ç–∞–≤—è—Ç –ø–æ–¥ —Å–æ–º–Ω–µ–Ω–∏–µ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–∏–µ –æ —Ç–æ–º, —á—Ç–æ –æ—Ç–º–µ–Ω–∞ –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç–æ–≤ –Ω–µ–∏–∑–±–µ–∂–Ω–æ —Å–æ–ø—Ä–æ–≤–æ–∂–¥–∞–µ—Ç—Å—è —Ç—è–∂–µ–ª—ã–º ¬´—Å–∏–Ω–¥—Ä–æ–º–æ–º –æ—Ç–º–µ–Ω—ã¬ª. –£ –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–∞ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å–∏–º–ø—Ç–æ–º—ã –ª–µ–≥–∫–∏–µ –∏ –∫—Ä–∞—Ç–∫–æ–≤—Ä–µ–º–µ–Ω–Ω—ã–µ, –ø–∏–∫ –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –Ω–∞ –ø–µ—Ä–≤—É—é‚Äì–≤—Ç–æ—Ä—É—é –Ω–µ–¥–µ–ª—é. –í–∞–∂–Ω—ã–π –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–π –≤—ã–≤–æ–¥: –ø–æ–∑–¥–Ω–µ–µ –≤–æ–∑–≤—Ä–∞—â–µ–Ω–∏–µ –¥–µ–ø—Ä–µ—Å—Å–∏–≤–Ω–æ–π —Å–∏–º–ø—Ç–æ–º–∞—Ç–∏–∫–∏ –ø–æ—Å–ª–µ –æ—Ç–º–µ–Ω—ã –≥–æ–≤–æ—Ä–∏—Ç —Å–∫–æ—Ä–µ–µ –æ —Ä–µ—Ü–∏–¥–∏–≤–µ –±–æ–ª–µ–∑–Ω–∏, —á–µ–º –æ–± —ç—Ñ—Ñ–µ–∫—Ç–µ –æ—Ç–º–µ–Ω—ã. –ê–≤—Ç–æ—Ä—ã –ø–æ–¥—á—ë—Ä–∫–∏–≤–∞—é—Ç, —á—Ç–æ —á—Ä–µ–∑–º–µ—Ä–Ω–æ–µ –≤–Ω–∏–º–∞–Ω–∏–µ –∫ —Å–∏–Ω–¥—Ä–æ–º—É –æ—Ç–º–µ–Ω—ã –≤ –°–ú–ò –∏ –ø—Ä–∞–∫—Ç–∏–∫–µ –º–æ–∂–µ—Ç —É—Å–∏–ª–∏–≤–∞—Ç—å –≤–æ—Å–ø—Ä–∏—è—Ç–∏–µ —Å–∏–º–ø—Ç–æ–º–æ–≤ –∑–∞ —Å—á–µ—Ç –Ω–æ—Ü–µ–±–æ-—ç—Ñ—Ñ–µ–∫—Ç–∞. –≠—Ç–æ –Ω–µ –∑–Ω–∞—á–∏—Ç, —á—Ç–æ –∂–∞–ª–æ–±—ã ¬´–Ω–∞–¥—É–º–∞–Ω—ã¬ª, –Ω–æ –≤–∞–∂–Ω–æ –ø—Ä–∞–≤–∏–ª—å–Ω–æ –∏–Ω—Ñ–æ—Ä–º–∏—Ä–æ–≤–∞—Ç—å –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –∏ —Ä–∞–∑–ª–∏—á–∞—Ç—å –æ—Ç–º–µ–Ω—É –∏ —Ä–µ—Ü–∏–¥–∏–≤. –ü–æ–∫–∞ –¥–∞–Ω–Ω—ã—Ö –æ –Ω–æ–≤—ã—Ö –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç–∞—Ö (–Ω–∞–ø—Ä–∏–º–µ—Ä, –≥–µ–ø–∏—Ä–æ–Ω –∏–ª–∏ –∫–æ–º–±–∏–Ω–∞—Ü–∏—è –¥–µ–∫—Å—Ç—Ä–æ–º–µ—Ç–æ—Ä—Ñ–∞–Ω-–±—É–ø—Ä–æ–ø–∏–æ–Ω) –Ω–µ—Ç, –Ω–æ —Ç–µ–æ—Ä–µ—Ç–∏—á–µ—Å–∫–∏ —Ä–∏—Å–∫ —É –Ω–∏—Ö –Ω–∏–∂–µ. üî¥ –ò—Ç–æ–≥: —Å–∏–º–ø—Ç–æ–º—ã –æ—Ç–º–µ–Ω—ã –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç–æ–≤ –¥–µ–π—Å—Ç–≤–∏—Ç–µ–ª—å–Ω–æ —Å—É—â–µ—Å—Ç–≤—É—é—Ç, –Ω–æ –≤ –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–µ —Å–ª—É—á–∞–µ–≤ –æ–Ω–∏ —É–º–µ—Ä–µ–Ω–Ω—ã–µ, –∫—Ä–∞—Ç–∫–æ–≤—Ä–µ–º–µ–Ω–Ω—ã–µ –∏ –Ω–µ –¥–æ—Å—Ç–∏–≥–∞—é—Ç –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–≥–æ –ø–æ—Ä–æ–≥–∞ —Å–∏–Ω–¥—Ä–æ–º–∞ –æ—Ç–º–µ–Ω—ã. –≠—Ç–æ –æ—Ç–∫—Ä—ã–≤–∞–µ—Ç –ø—É—Ç—å –∫ –±–æ–ª–µ–µ –≤–∑–≤–µ—à–µ–Ω–Ω–æ–º—É –ø–æ–¥—Ö–æ–¥—É: –Ω–µ –∏–≥–Ω–æ—Ä–∏—Ä–æ–≤–∞—Ç—å –∂–∞–ª–æ–±—ã, –Ω–æ –∏ –Ω–µ –ø—Ä–µ—É–≤–µ–ª–∏—á–∏–≤–∞—Ç—å —Ä–∏—Å–∫–∏, –ø–æ–º–æ–≥–∞—è –ø–∞—Ü–∏–µ–Ω—Ç–∞–º —É–≤–µ—Ä–µ–Ω–Ω–æ –∑–∞–≤–µ—Ä—à–∞—Ç—å —Ç–µ—Ä–∞–ø–∏—é. üè• –û—Å–Ω–æ–≤–Ω–æ–π –∫–∞–Ω–∞–ª üí≥ –ü–æ–¥–¥–µ—Ä–∂–∞—Ç—å –Ω–∞—Å #–ø—Å–∏—Ö–∏–∞—Ç—Ä–∏—è #–¥–µ–ø—Ä–µ—Å—Å–∏—è #–∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç—ã #—Å–∏–Ω–¥—Ä–æ–º_–æ—Ç–º–µ–Ω—ã #–ø—Å–∏—Ö–æ—Ñ–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance"",
  ""impact"": ""medium"",
  ""english"": ""The meta-analysis of a large systematic review and meta-analysis of 50 studies involving nearly 18,000 participants on withdrawal symptoms from antidepressants found that only one additional symptom was observed on the DESS scale (Discontinuation-Emergent Signs and Symptoms) during the first week compared to placebo or continued therapy. The most common symptoms were dizziness (6.2%), nausea (2.9%), vertigo, and nervousness. The study helps to separate myths from reality and provides practical guidelines for doctors and patients.""
}"
2025-09-25T05:34:58+00:00,@pharm_icon,2384,https://t.me/pharm_icon/2384,"–ö–æ—Ñ–µ–∏–Ω –∏ —Å–∏–ª–∞ –ò—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª–∏ –ø—Ä–æ–≤–µ–ª–∏ –ø–æ–∏—Å–∫ –ø–æ –≤–æ—Å—å–º–∏ –±–∞–∑–∞–º –¥–∞–Ω–Ω—ã—Ö –¥–ª—è –ø–æ–∏—Å–∫–∞ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –æ –≤–ª–∏—è–Ω–∏–∏ –∫–æ—Ñ–µ–∏–Ω–∞ –Ω–∞: üí™ –º–∞–∫—Å–∏–º–∞–ª—å–Ω—É—é –º—ã—à–µ—á–Ω—É—é —Å–∏–ª—É, –∏–∑–º–µ—Ä–µ–Ω–Ω—É—é —Å –ø–æ–º–æ—â—å—é —Ç–µ—Å—Ç–æ–≤ –Ω–∞ –æ–¥–Ω–æ–∫—Ä–∞—Ç–Ω—ã–π –º–∞–∫—Å–∏–º—É–º ‚úàÔ∏è –º—ã—à–µ—á–Ω—É—é –º–æ—â–Ω–æ—Å—Ç—å, –æ—Ü–µ–Ω–∏–≤–∞–µ–º—É—é —Å –ø–æ–º–æ—â—å—é —Ç–µ—Å—Ç–æ–≤ –Ω–∞ –≤–µ—Ä—Ç–∏–∫–∞–ª—å–Ω—ã–π –ø—Ä—ã–∂–æ–∫. –†–µ–∑—É–ª—å—Ç–∞—Ç—ã –ü—Ä–∏—ë–º –∫–æ—Ñ–µ–∏–Ω–∞ —É–ª—É—á—à–∏–ª –∫–∞–∫ —Å–∏–ª—É (SMD = 0,20; 95% –¥–æ–≤–µ—Ä–∏—Ç–µ–ª—å–Ω—ã–π –∏–Ω—Ç–µ—Ä–≤–∞–ª [–î–ò]: 0,03, 0,36; p = 0,023), —Ç–∞–∫ –∏ –º–æ—â–Ω–æ—Å—Ç—å (SMD = 0,17; 95% –î–ò: 0,00, 0,34; p = 0,047). –ê–Ω–∞–ª–∏–∑ –ø–æ–¥–≥—Ä—É–ø–ø –ø–æ–∫–∞–∑–∞–ª, —á—Ç–æ –∫–æ—Ñ–µ–∏–Ω –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ —É–ª—É—á—à–∞–µ—Ç —Å–∏–ª—É –≤–µ—Ä—Ö–Ω–µ–π —á–∞—Å—Ç–∏ —Ç–µ–ª–∞ (SMD = 0,21; 95% –î–ò: 0,02, 0,39; p = 0,026), –Ω–æ –Ω–µ –Ω–∏–∂–Ω–µ–π –µ–≥–æ —á–∞—Å—Ç–∏ (SMD = 0,15; 95% –î–ò: -0,05, 0,34; p = 0,147). –¢–∞–∫ —á—Ç–æ –∏–¥–∏—Ç–µ –∫–∞—á–∞—Ç—å –≤–µ—Ä—Ö–Ω–∏–π –ø–æ—è—Å —Å—Ä–∞–∑—É –ø–æ—Å–ª–µ –∑–∞–≤—Ç—Ä–∞–∫–∞. –Ø –∫–æ—Ñ–µ –Ω–µ –ø—å—é, –º–Ω–µ —ç—Ç–æ –Ω–µ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ. #—É—Ç—Ä–æ_—Å_–∏–∫–æ–Ω–æ–π","{""skip"": true}"
2025-09-24T12:26:02+00:00,@pharm_icon,2383,https://t.me/pharm_icon/2383,"–†–µ–≥—Ä–µ—Å—Å–∏—è –¥–µ–º–µ–Ω—Ç–Ω–æ–π —Å–∏–º–ø—Ç–æ–º–∞—Ç–∏–∫–∏ –ø–æ—Å–ª–µ –æ—Ç–º–µ–Ω—ã —Ä—è–¥–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ ‚Äî –µ—â—ë –æ–¥–∏–Ω –∫–µ–π—Å —É—Å–ø–µ—à–Ω–æ–π –±–æ—Ä—å–±—ã —Å –ø–æ–ª–∏–ø—Ä–∞–≥–º–∞–∑–∏–µ–π. –ë—É–¥—É –Ω–∞—Ä–∞—â–∏–≤–∞—Ç—å –ø–æ–∏—Å–∫–∏ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –ø–æ —ç—Ç–æ–π —Ç–µ–º–∞—Ç–∏–∫–µ, –∞ —Ç–æ –¥–∞–≤–Ω–æ –Ω–µ –±—ã–ª–æ —Ç–∞–∫–æ–≥–æ –∫–æ–Ω—Ç–µ–Ω—Ç–∞. #–±–æ—Ä—å–±–∞","{""skip"": true}"
2025-09-24T07:58:02+00:00,@pharm_icon,2382,https://t.me/pharm_icon/2382,"FDA –æ–¥–æ–±—Ä–∏–ª–æ —Å–ø—Ä–µ–π –∫–ª–∞—Å—Å–∞ ""—Ä–æ—Ç-–Ω–æ—Å"" –†–µ—á—å —Å–∫–æ—Ä–µ–µ –Ω–µ –æ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ, –∞ –æ —Ç–µ—Ö–Ω–∏—á–µ—Å–∫–æ–º —Ä–µ—à–µ–Ω–∏–∏ –¥–æ—Å—Ç–∞–≤–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –ø—Ä–∏ —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–æ–º —Å–∏–Ω—É—Å–∏—Ç–µ. –°–∏—Å—Ç–µ–º–∞, –≤–∏–∑—É–∞–ª—å–Ω–æ –ø–æ—Ö–æ–∂–∞—è –Ω–∞ –±–∞—à–Ω–∏ –ú–æ—Å–∫–≤—ã-–°–∏—Ç–∏, –Ω–∞–∑—ã–≤–∞–µ—Ç—Å—è XHANCE. –í —Å–æ—Å—Ç–∞–≤–µ –∏–¥–µ—Ç –∫–ª–∞—Å—Å–∏—á–µ—Å–∫–∏–π —Ñ–ª—É—Ç–∏–∫–∞–∑–æ–Ω. –ü—Ä–∏–Ω—Ü–∏–ø –ø—Ä–æ—Å—Ç: –ø–æ—Å–ª–µ –≤–≤–µ–¥–µ–Ω–∏—è –ú–æ—Å–∫–≤—ã-–°–∏—Ç–∏ –≤ –Ω–æ—Å –ø–∞—Ñ–æ—Å –∏ –∫–∏—Ç—á –ø—Ä–æ–±–∏–≤–∞—é—Ç –ø—É—Ç—å –≤–æ –≤—Å–µ –Ω–µ–¥–æ—Å—Ç—É–ø–Ω—ã–µ –ø–∞–∑—É—Ö–∏ –ø–∞–ø–∏–Ω–æ–π –∫—Å–∏–≤–æ–π –ø—É—Ç–µ–º —Ä–æ—Ç–æ–≤–æ–≥–æ –≤—ã–¥–æ—Ö–∞ –æ–±–µ—Å–ø–µ—á–∏–≤–∞–µ—Ç—Å—è —É—Å–∏–ª–µ–Ω–Ω–æ–µ —Ä–∞—Å–ø—Ä–µ–¥–µ–ª–µ–Ω–∏–µ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞, –¥–æ—Å—Ç–∏–≥–∞—é—â–µ–µ –ø–∞–∑—É—Ö, –∫—É–¥–∞ –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ —Å–ø—Ä–µ–µ–≤ –æ–±—ã—á–Ω–æ –Ω–µ –ø–æ–ø–∞–¥–∞—é—Ç. –†—ã–Ω–æ–∫ –∑–æ–ª–æ—Ç–æ–π, –∞ –ª–æ–ø–∞—Ç–∞ –±—É–∫–≤–∞–ª—å–Ω–æ –ø–ª–∞—Å—Ç–∏–∫–æ–≤–∞—è. –•—Ä–æ–Ω–∏—á–µ—Å–∫–∏–º —Å–∏–Ω—É—Å–∏—Ç–æ–º —Å—Ç—Ä–∞–¥–∞–µ—Ç –∫–∞–∂–¥—ã–π –≤–æ—Å—å–º–æ–π –∞–º–µ—Ä–∏–∫–∞–Ω–µ—Ü –∏ —Ä—ã–Ω–æ–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –æ—Ç –Ω–µ–≥–æ –æ—Ü–µ–Ω–∏–≤–∞–µ—Ç—Å—è –≤ 2,4 –º–ª—Ä–¥ $ (—Ç–æ–ª—å–∫–æ –°–®–ê). –ó–∞ —Å—á–µ—Ç —Ç–∞–∫–æ–π –∞–¥–∞–ø—Ç–∞—Ü–∏–∏ –µ—Å—Ç—å 2 –≤–∞—Ä–∏–∞–Ω—Ç–∞ —Ä–∞–∑–≤–∏—Ç–∏—è (–∏ –æ–±–∞ –º–æ–∂–Ω–æ –≤—ã–±—Ä–∞—Ç—å –æ–¥–Ω–æ–≤—Ä–µ–º–µ–Ω–Ω–æ): –¥–æ–∏—Ç—å —Ä—ã–Ω–æ–∫ –ø–æ –ø–∞—Ç–µ–Ω—Ç–Ω–æ–π –∑–∞—â–∏—Ç–µ –µ—â–µ 5-10 –ª–µ—Ç –∏–ª–∏ —É–π—Ç–∏ –≤ —Ä–∞–∑–≤–∏—Ç–∏–µ —Å–∏—Å—Ç–µ–º—ã –¥–æ—Å—Ç–∞–≤–∫–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤. –ë–æ–ª–µ–µ –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–Ω—ã–π –≤–∞—Ä–∏–∞–Ω—Ç, –∫–∞–∫ –ø–æ –º–Ω–µ, –∏–º–µ–Ω–Ω–æ –≤—Ç–æ—Ä–æ–π. –í—ã–∏–≥—Ä–∞—é—Ç –æ—Ç –æ–±–æ–∏—Ö –≤–∞—Ä–∏–∞–Ω—Ç–æ–≤ –≤—Å–µ: —Ñ–∞—Ä–º–∞ –ø–æ–ª—É—á–∏—Ç –Ω–æ–≤—ã–π —Ñ–æ—Ä–º–∞—Ç —Å–ø—Ä–µ–µ–≤, –ø—Ä–∏–±—ã–ª—å, –∞ –ª—é–¥–∏ –Ω–∞–∫–æ–Ω–µ—Ü-—Ç–æ —Å–º–æ–≥—É—Ç –ø–æ—Ç—Ä–æ–≥–∞—Ç—å –∫–æ—à–µ—á–µ–∫ –∏ –∫—É–ø–∏—Ç—å –µ—â–µ –±–æ–ª—å—à–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∏–∑-–∑–∞ —Å–≤–æ–µ–π –ª—é–±–≤–∏ –∫ –ø—É—à–∏—Å—Ç—ã–º –¥—É—à–∏—Ç–µ–ª—è–º.","{""skip"": true}"
2025-09-24T06:20:06+00:00,@pharm_icon,2381,https://t.me/pharm_icon/2381,–û–ø—è—Ç—å –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å—ã –∫–æ—Ä–º—è—Ç –¥–µ—Ç–µ–π –ë–ê–î–∞–º–∏. –°–≤–æ–∏—Ö –¥–µ—Ç–µ–π –∫–æ—Ä–º–∏—Ç–µ? –ß–µ–º –º–æ—Ç–∏–≤–∏—Ä—É–µ—Ç–µ? –ß—Ç–æ –≥–æ–≤–æ—Ä–∏—Ç —Ä–µ–±–µ–Ω–æ–∫? #–ø–æ–ª–∏–ø—Ä–∞–≥–º–∞–∑–∏—è_—Å_–¥–µ—Ç—Å—Ç–≤–∞,"{""skip"": true}"
2025-09-24T05:11:12+00:00,@pharm_icon,2380,https://t.me/pharm_icon/2380,"–ö–æ—Ñ–µ–∏–Ω –ø–µ—Ä–µ–¥ —Å–Ω–æ–º –ù–∞–∫–æ–Ω–µ—Ü —Ö–æ—Ç—å –∫—Ç–æ-—Ç–æ –≤ –º–µ—Ç–∞-–∞–Ω–∞–ª–∏–∑–∞—Ö –Ω–∞—á–∞–ª —É–≤–µ—Ä–µ–Ω–Ω–æ –∑–∞—è–≤–ª—è—Ç—å –æ —á–µ–º-–ª–∏–±–æ ‚Äî –∞–≤—Å—Ç—Ä–∞–ª–∏–π—Ü—ã –ø—Ä–æ–≤–µ–ª–∏ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ, –≥–¥–µ –¥–∞–ª–∏ –Ω–∞–º —á–µ—Ç–∫–∏–µ –∏–Ω—Å—Ç—Ä—É–∫—Ü–∏–∏, –∞ –∏–º–µ–Ω–Ω–æ –ó–∞ –∫–∞–∫–æ–µ –≤—Ä–µ–º—è –¥–æ —Å–Ω–∞ –º–æ–∂–Ω–æ –ø–∏—Ç—å –∫–æ—Ñ–µ? –û—Å–Ω–æ–≤–Ω—ã–µ –≤—ã–≤–æ–¥—ã ‚è±Ô∏è –ò–∑-–∑–∞ –ø—Ä–∏–µ–º–∞ –∫–æ—Ñ–µ —Å–æ–Ω —Å–æ–∫—Ä–∞—â–∞–µ—Ç—Å—è –Ω–∞ 45 –º–∏–Ω—É—Ç üõè –≠—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å —Å–Ω–∞ –ø–∞–¥–∞–µ—Ç –Ω–∞ 7% üò¥ –ó–∞—Å—ã–ø–∞–µ–º –¥–æ–ª—å—à–µ –Ω–∞ 9 –º–∏–Ω, –ø—Ä–æ–±—É–∂–¥–µ–Ω–∏–π* –±–æ–ª—å—à–µ –Ω–∞ 12 –º–∏–Ω * –ü—Ä–æ–±—É–∂–¥–µ–Ω–∏–µ –ø–æ—Å–ª–µ –Ω–∞—á–∞–ª–∞ —Å–Ω–∞ –±—ã–ª–æ –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–æ –∫–∞–∫ –ø—Ä–æ–¥–æ–ª–∂–∏—Ç–µ–ª—å–Ω–æ—Å—Ç—å –≤—Ä–µ–º–µ–Ω–∏, –ø—Ä–æ–≤–µ–¥–µ–Ω–Ω–æ–≥–æ –≤ —Å–æ—Å—Ç–æ—è–Ω–∏–∏ –±–æ–¥—Ä—Å—Ç–≤–æ–≤–∞–Ω–∏—è –ø–æ—Å–ª–µ –Ω–∞—á–∞–ª–∞ —Å–Ω–∞ –∏ –¥–æ –æ–∫–æ–Ω—á–∞—Ç–µ–ª—å–Ω–æ–≥–æ –ø—Ä–æ–±—É–∂–¥–µ–Ω–∏—è. ‚öñÔ∏è –ë–∞–ª–∞–Ω—Å —Ñ–∞–∑ —Å–Ω–∞: –õ—ë–≥–∫–∏–π —Å–æ–Ω (N1) ‚Üë +6,1 –º–∏–Ω (+1,7%) –ì–ª—É–±–æ–∫–∏–π —Å–æ–Ω (N3‚ÄìN4) ‚Üì ‚Äì11,4 –º–∏–Ω (‚Äì1,4%) –ß—Ç–æ–±—ã –∫–æ—Ñ–µ–∏–Ω –Ω–µ –æ–∫–∞–∑–∞–ª –≤–ª–∏—è–Ω–∏—è –Ω–∞ —Å–æ–Ω: ‚òïÔ∏è –ß–∞—à–∫–∞ –∫–æ—Ñ–µ (107 –º–≥/250 –º–ª) –¥–æ–ª–∂–Ω–∞ –±—ã—Ç—å –ø—Ä–∏–Ω—è—Ç–∞ –∑–∞ ‚â•8,8 —á –¥–æ —Å–Ω–∞ üíä –ü—Ä–µ–¥—Ç—Ä–µ–Ω–∏—Ä–æ–≤–æ—á–Ω—ã–π –∫–æ–º–ø–ª–µ–∫—Å –∫–æ—Ñ–µ–∏–Ω–∞ (217,5 –º–≥) –¥–æ–ª–∂–µ–Ω –ø—Ä–∏–Ω–∏–º–∞—Ç—å—Å—è –∑–∞ ‚â•13,2 —á –¥–æ —Å–Ω–∞ –Ø –Ω–µ –ø—å—é –∫–æ—Ñ–µ —Å —è–Ω–≤–∞—Ä—è 2025, —É–ª—É—á—à–µ–Ω–∏–µ –∫–∞—á–µ—Å—Ç–≤–∞ —Å–Ω–∞ ‚Äî ‚úÖ –ù–∞–ø–∏—à–∏—Ç–µ –≤ –∫–æ–º–º–µ–Ω—Ç—ã ""+"" –∏ —è —Å–∫–∞–∂—É, –∫–∞–∫ –∏–∑–±–∞–≤–∏—Ç—å—Å—è –æ—Ç –∫–æ—Ñ–µ–π–Ω–æ–π –∑–∞–≤–∏—Å–∏–º–æ—Å—Ç–∏ –≤ 3 —à–∞–≥–∞ü§åüèªüòÅ #—É—Ç—Ä–æ_—Å_–∏–∫–æ–Ω–æ–π","{""skip"": true}"
2025-09-23T19:37:15+00:00,@pharm_icon,2379,https://t.me/pharm_icon/2379,"–ü–∞—Ä–∞—Ü–µ—Ç–∞–º–æ–ª–≤–∞ –æ–± –∞—É—Ç–∏–∑–º–µ: —à–∏–∑–∞ –≤ –°–®–ê –∏–ª–∏ —á—Ç–æ-—Ç–æ –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å–Ω–æ–µ –≤ —ç—Ç–æ–º –µ—Å—Ç—å? –ü—Ä–µ–∑–∏–¥–µ–Ω—Ç –°–®–ê –æ–±—ä—è–≤–∏–ª –≤–æ–π–Ω—É –∞—É—Ç–∏–∑–º—É. –û–Ω, –µ–≥–æ —Ç—É–∑ —á–µ—Ä–≤–µ–π –º–∏–Ω–∏—Å—Ç—Ä –†–æ–±–µ—Ä—Ç –ö–µ–Ω–Ω–µ–¥–∏-–º–ª–∞–¥—à–∏–π –∏ –∫–æ–º–∏—Å—Å–∞—Ä FDA –ú–∞—Ä—Ç–∏ –ú–∞–∫–∞—Ä–∏ –≤–∑—è–ª–∏—Å—å –∑–∞ —Ä—É–∫–∏ –∏ –ø–æ—à–ª–∏ –Ω–∞–ø—Ä–æ–ª–æ–º –∫ —Å–≤–µ—Ç–ª–æ–º—É –±—É–¥—É—â–µ–º—É. –°–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—è —Ç–æ–Ω—É —Å–≤–æ–µ–≥–æ –º–∏–Ω–∏—Å—Ç—Ä–∞, –¢—Ä–∞–º–ø –ø—Ä–∏–∑–≤–∞–ª –±–µ—Ä–µ–º–µ–Ω–Ω—ã—Ö –Ω–µ –ø—Ä–∏–Ω–∏–º–∞—Ç—å –ø–∞—Ä–∞—Ü–µ—Ç–∞–º–æ–ª, –∫—Ä–æ–º–µ —Å–∞–º—ã—Ö –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã—Ö —Å–ª—É—á–∞–µ–≤. –¢–∞–∫ –¢—Ä–∞–º–ø –±–æ—Ä–µ—Ç—Å—è —Å –∞—É—Ç–∏–∑–º–æ–º, –∫–æ—Ç–æ—Ä—ã–π, –ø–æ –º–Ω–µ–Ω–∏—é –µ–≥–æ –∫–æ–º–∞–Ω–¥—ã, –≤—ã–∑—ã–≤–∞–µ—Ç –ø–∞—Ä–∞—Ü–µ—Ç–∞–º–æ–ª. FDA –∑–∞–ø—É—â–µ–Ω–∞ –ø—É–±–ª–∏—á–Ω–∞—è –∫–æ–º–ø–∞–Ω–∏—è (–ø–æ–∫–∞ —á—Ç–æ- –ø–∏—Å—å–º–æ) –¥–ª—è —Å–æ–∫—Ä–∞—â–µ–Ω–∏—è –ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏—è –∏ –≤—ã–ø–∏—Å–∫–∏ –¢–∞–π–ª–µ–Ω–æ–ª–∞ (–æ–¥–Ω–∞ –∏–∑ –ø–æ–ø—É–ª—è—Ä–Ω–µ–π—à–∏—Ö –º–∞—Ä–æ–∫ –ø–∞—Ä–∞—Ü–µ—Ç–∞–º–æ–ª–∞ –≤ –°–®–ê) –¥–µ—Ç—è–º –∏ –±–µ—Ä–µ–º–µ–Ω–Ω—ã–º, –≤ —Ç–æ–º —á–∏—Å–ª–µ –≥–æ—Ç–æ–≤–∏—Ç—Å—è –∏ –º–∞—Ä–∫–∏—Ä–æ–≤–∫–∞. ""–£ –Ω–∞—Å –µ—Å—Ç—å –ø–æ–Ω–∏–º–∞–Ω–∏–µ –±–æ–ª—å—à–µ–µ, —á–µ–º —É –∏—Å—Å–ª–µ–¥–æ–≤–∞–≤—à–∏—Ö —ç—Ç–æ—Ç –≤–æ–ø—Ä–æ—Å —É—á–µ–Ω—ã—Ö"", ‚Äî –≥–æ–≤–æ—Ä–∏—Ç –¢—Ä–∞–º–ø. –î–∞, –≤—ã –≤—Å–µ—Ö –ª—É—á—à–µ –≤—Å–µ—Ö –ø–æ–Ω–∏–º–∞–µ—Ç–µ ‚Äî –∏ –¥—è–¥—é –í–æ–≤—É, –∏ –Ω–∞—É—á–Ω—ã–µ –ø—Ä–æ–±–ª–µ–º—ã. –ö–æ–≥–¥–∞ —Å–Ω–∏–∂–µ–Ω–∞ –∫—Ä–∏—Ç–∏–∫–∞ –∏ –ø—Å–∏—Ö–∏–∞—Ç—Ä–∏—á–µ—Å–∫–∞—è –∫–ª–∏–Ω–∏–∫–∞ —Ç–æ–ª—å–∫–æ —Ä–∞–∑–≤–æ—Ä–∞—á–∏–≤–∞–µ—Ç—Å—è –Ω–∞ –ø—Ä–æ—Å—Ç–æ—Ä–∞—Ö –∏–∑–≤–∏–ª–∏–Ω, —á–µ–ª–æ–≤–µ–∫ –º–æ–∂–µ—Ç —á—É–≤—Å—Ç–≤–æ–≤–∞—Ç—å —Å–µ–±—è –ª–µ–≥–∫–æ –∏ —É–≤–µ—Ä–µ–Ω–Ω–æ. –ü–æ—ç—Ç–æ–º—É –µ—Å—Ç—å –Ω–∞–¥–µ–∂–¥–∞ –Ω–∞ —Ç–æ, —á—Ç–æ —á–µ–ª–æ–≤–µ–∫ –≤ —Ç–∞–∫–æ–º —Å–æ—Å—Ç–æ—è–Ω–∏–∏ —Å–ø–æ—Å–æ–±–µ–Ω –Ω–∞ –ø–æ—Å—Ç—É–ø–æ–∫, –ö–µ–Ω–Ω–µ–¥–∏, –≤–ø–µ—Ä—ë–¥. –ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è–º: –¥–∞–≤–∞–π—Ç–µ –ø–æ—Å–º–æ—Ç—Ä–∏–º, —á—Ç–æ –≥–æ–≤–æ—Ä—è—Ç –∏–∑—Ä–∞–∏–ª—å—Ç—è–Ω–µ —Å –≤—ã—Å–æ—Ç—ã 2018-–≥–æ –≥–æ–¥–∞ –ê –æ–Ω–∏, –≥–æ–≤–æ—Ä—è—Ç, –ø—Ä–æ–≤–µ–ª–∏ –ø–æ–∏—Å–∫ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –ø–æ —Å–æ—Å—Ç–æ—è–Ω–∏—é –Ω–∞ —è–Ω–≤–∞—Ä—å 2017 –≥–æ–¥–∞ –≤ –±–∞–∑–∞—Ö –¥–∞–Ω–Ω—ã—Ö MEDLINE, Embase –∏ Cochrane. –ò—Å–∫–∞–ª–∏ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è, –≤ –∫–æ—Ç–æ—Ä—ã—Ö –æ—Ü–µ–Ω–∏–≤–∞–ª–æ—Å—å –≤–ª–∏—è–Ω–∏–µ –ø—Ä–∏–µ–º–∞ –ø–∞—Ä–∞—Ü–µ—Ç–∞–º–æ–ª–∞ –≤–æ –≤—Ä–µ–º—è –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏ –Ω–∞ —Ä–µ–±–µ–Ω–∫–∞. –ù–∞—à–ª–æ—Å—å —Å–µ–º—å –ø–æ–¥—Ö–æ–¥—è—â–∏—Ö —Ä–µ—Ç—Ä–æ—Å–ø–µ–∫—Ç–∏–≤–Ω—ã—Ö –∫–æ–≥–æ—Ä—Ç, –≤ –º–µ—Ç–∞-–∞–Ω–∞–ª–∏–∑ –ø–æ–ø–∞–ª–∏ 132 738 –ø–∞—Ä –º–∞—Ç—å-—Ä–µ–±–µ–Ω–æ–∫ —Å –ø–µ—Ä–∏–æ–¥–∞–º–∏ –Ω–∞–±–ª—é–¥–µ–Ω–∏—è –æ—Ç 3 –¥–æ 11 –ª–µ—Ç. –ß—Ç–æ –ø–æ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º? 1. –£ –≥—Ä—É–ø–ø—ã —Å –ø–∞—Ä–∞—Ü–µ—Ç–∞–º–æ–ª–æ–º –≤–µ—Ä–æ—è—Ç–Ω–æ—Å—Ç—å —Ä–∞–∑–≤–∏—Ç–∏—è –°–î–í–ì –Ω–∞ 34% –≤—ã—à–µ, —á–µ–º –≤ –∫–æ–Ω—Ç—Ä–æ–ª—å–Ω–æ–π –≥—Ä—É–ø–ø–µ. 2. –í–µ—Ä–æ—è—Ç–Ω–æ—Å—Ç—å —Ä–∞–∑–≤–∏—Ç–∏—è —Ä–∞—Å—Å—Ç—Ä–æ–π—Å—Ç–≤ –∞—É—Ç–∏—Å—Ç–∏—á–µ—Å–∫–æ–≥–æ —Å–ø–µ–∫—Ç—Ä–∞ –±—ã–ª–∞ –≤—ã—à–µ –Ω–∞ 19%. 3. –î–ª—è —Å–∏–º–ø—Ç–æ–º–æ–≤ –≥–∏–ø–µ—Ä–∞–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ ‚Äî –Ω–∞ 24%. –≠—Ç–æ –∏–∑—Ä–∞–∏–ª—å—Å–∫–æ–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ —Å–∫–æ—Ä–µ–µ –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–∞–µ—Ç –≥–∏–ø–æ—Ç–µ–∑—É –≤–æ–∏–Ω—Å—Ç–≤—É—é—â–∏—Ö –¥–µ–º–µ–Ω—Ç–æ–∏–¥–æ–≤. –û–¥–Ω–∞–∫–æ –µ—Å—Ç—å –∏ –¥—Ä—É–≥–∏–µ, –∫–æ—Ç–æ—Ä—ã–µ ""–Ω–µ—Ç —Å—Ç–∞—Ç–∏—Å—Ç–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º–æ–π, –º—ã –Ω–∏—á–µ–≥–æ –Ω–µ –Ω–∞—à–ª–∏ –∏ (–Ω–µ) –∑—Ä—è –ø—Ä–æ–µ–ª–∏ –≥—Ä–∞–Ω—Ç–æ–≤—ã–µ —Ö–ª–µ–±–∞"". –¢–∞–∫ —á—Ç–æ —Å–∏—Ç—É–∞—Ü–∏—è –∏–Ω—Ç–µ—Ä–µ—Å–Ω–∞—è, –∂–¥—ë–º –∫–∞–∫–∏—Ö-—Ç–æ –∏–Ω—Ç–µ—Ä–µ—Å–Ω—ã—Ö –¥–∞–Ω–Ω—ã—Ö. üî• ‚Äî —è –±–æ–ª—å—à–µ –Ω–µ –¥–∞—é —Å–≤–æ–µ–º—É —Ä–µ–±–µ–Ω–∫—É –ø–∞—Ä–∞—Ü–µ—Ç–∞–º–æ–ª üóø ‚Äî –ø–æ—Å—Ç–Ω–∞—è –µ—Ä—É–Ω–¥–∞ –¥–ª—è —Ç–∞–±–ª–µ—Ç–∫–æ—Ñ–æ–±–æ–≤","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, shortage, safety"",
  ""impact"": ""high"",
  ""english"": ""The US President declared war on autism, and the FDA Commissioner Robert Kennedy Jr. and his team are working towards a bright future for children with autism. President Trump advises pregnant women to avoid paracetamol except in the most necessary cases. The FDA has initiated a public campaign to reduce consumption and prescriptions of Tylenol (a popular brand of paracetamol) among children and pregnant women, including labeling. 'We have a better understanding than the researchers who studied this issue,' Trump says. The Israeli study from 2018 found that the risk of SIDs, autism spectrum disorders, and hyperactivity in children exposed to paracetamol during pregnancy was significantly higher. The situation is interesting, and we are waiting for more significant data.""
}"
2025-09-17T18:49:04+00:00,@pharm_icon,2378,https://t.me/pharm_icon/2378,"-35 –¥–æ–ª–ª–∞—Ä–æ–≤ –ê–∫—Ü–∏–∏ –¢–µ–≤–∞ —É–ø–∞–ª–∏ –≤ —Ü–µ–Ω–µ –ø–æ—Å–ª–µ –º–∞—Å—Å–∏—Ä–æ–≤–∞–Ω–Ω–æ–≥–æ –Ω–∞–ø–∞–¥–µ–Ω–∏—è –Ω–∞ –ì–∞–∑—É –∏ –ø—Ä–∏–∑–Ω–∞–Ω–∏—è –ø—Ä–æ–∏—Å—Ö–æ–¥—è—â–µ–≥–æ –≥–µ–Ω–æ—Ü–∏–¥–æ–º: a. 16 —Å–µ–Ω—Ç—è–±—Ä—è –ø—Ä–∏–º–µ—Ä–Ω–æ –≤ 10:00 —Ü–µ–Ω–∞ –¥–µ—Ä–∂–∞–ª–∞—Å—å –Ω–∞ —É—Ä–æ–≤–Ω–µ ~6 317 ILA; b. –±—É–∫–≤–∞–ª—å–Ω–æ –≤ —Ç–µ—á–µ–Ω–∏–µ –∫–æ—Ä–æ—Ç–∫–æ–≥–æ –≤—Ä–µ–º–µ–Ω–∏ –æ–Ω–∞ —Å–Ω–∏–∑–∏–ª–∞—Å—å –¥–æ ~6 200 ILA (–º–∏–Ω—É—Å ~117 —à–µ–∫–µ–ª–µ–π/$35, –∏–ª–∏ –ø–æ—á—Ç–∏ ‚Äì1,9% –∑–∞ –æ–¥–∏–Ω –º–æ–º–µ–Ω—Ç). –ß—Ç–æ –∂, –ø–æ—Å–º–æ—Ç—Ä–∏–º, –ø–æ–≤–ª–∏—è–µ—Ç –ª–∏ —ç—Ç–æ –Ω–∞ —á—Ç–æ-–ª–∏–±–æ –≤ –¢–µ–≤–µ –≤ —Ç–µ—á–µ–Ω–∏–µ —Ö–æ—Ç—è –±—ã 1 –Ω–µ–¥–µ–ª–∏. üî• ‚Äî –º–æ–∂–µ—Ç –∏ –ø–æ–≤–ª–∏—è–µ—Ç üóø ‚Äî –Ω–µ –ø–æ–≤–ª–∏—è–µ—Ç","{""skip"": true}"
2025-09-17T17:43:48+00:00,@pharm_icon,2377,https://t.me/pharm_icon/2377,"–†—ã–Ω–æ–∫ —Ä–∞—Å–ø—É—á–∏–ª–æ, –Ω–æ –°–∞–∫—Å–µ–Ω–¥—É ‚Äî —Å–∫—Ä—é—á–∏–ª–æ FDA –æ–¥–æ–±—Ä–∏–ª–∏ –ø–µ—Ä–≤—ã–π –¥–∂–µ–Ω–µ—Ä–∏–∫ –∞–≥–æ–Ω–∏—Å—Ç–∞ —Ä–µ—Ü–µ–ø—Ç–æ—Ä–∞ –ì–ü–ü-1 –ª–∏—Ä–∞–≥–ª—É—Ç–∏–¥–∞ –æ—Ç Teva (–æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç - –°–∞–∫—Å–µ–Ω–¥–∞), –ø—Ä–∏–º–µ–Ω—è–µ–º–æ–≥–æ –¥–ª—è –ø–æ—Ö—É–¥–µ–Ω–∏—è, –≤ –æ—Ç–ª–∏—á–∏–µ –æ—Ç –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–≤—à–∏—Ö—Å—è –¥–ª—è –¥–∏–∞–±–µ—Ç–∞ –ø—Ä–µ–¥—à–µ—Å—Ç–≤–µ–Ω–Ω–∏–∫–æ–≤. –ò–Ω–∫—Ä–µ—Ç–∏–Ω–æ–º–∏–º–µ—Ç–∏–∫–∏ (–¥—Ä—É–≥–µ –Ω–∞–∑–≤–∞–Ω–∏–µ –∞–≥–æ–Ω–∏—Å—Ç–æ–≤ —Ä–µ—Ü–µ–ø—Ç–æ—Ä–∞ –ì–ü–ü-1) —á–µ—Ä–µ–∑ –∞–∫—Ç–∏–≤–∞—Ü–∏—é –≤—ã—Ä–∞–±–æ—Ç–∫–∏ –∏–Ω—Å—É–ª–∏–Ω–∞, —Å–Ω–∏–∂–µ–Ω–∏–µ –∞–ø–ø–µ—Ç–∏—Ç–∞ (–≤–ª–∏—è–µ—Ç –Ω–∞ —Ü–µ–Ω—Ç—Ä –≥–æ–ª–æ–¥–∞), –∑–∞–º–µ–¥–ª–µ–Ω–∏–µ –º–æ—Ç–æ—Ä–∏–∫–∏ –ñ–ö–¢ –∏ –≤—ã–¥–µ–ª–µ–Ω–∏–µ –≥–ª—é–∫–∞–≥–æ–Ω–∞, —Ç–µ–º —Å–∞–º—ã–º –ø—Ä–∏–≤–æ–¥—è –∫ —Å–Ω–∏–∂–µ–Ω–∏—é –∞–ø–ø–µ—Ç–∏—Ç–∞ –∏ –∫–æ–ª–∏—á–µ—Å—Ç–≤–∞ –ø—Ä–∏–Ω–∏–º–∞–µ–º–æ–π –ø–∏—à–∏ –≤–º–µ—Å—Ç–µ —Å —É—Å–∏–ª–µ–Ω–∏–µ–º —á—É–≤—Å—Ç–≤–∞ –Ω–∞—Å—ã—â–µ–Ω–∏—è. –ò—Ç–æ–≥–æ–º —á–µ–ª–æ–≤–µ–∫ –µ—Å—Ç –º–µ–Ω—å—à–µ, —á—É–≤—Å—Ç–≤—É–µ—Ç —Å–µ–±—è —Å—ã—Ç—ã–º –∏ —Ö—É–¥–µ–µ—Ç. –í–ø—Ä–æ—á–µ–º, —É—á–∏—Ç—ã–≤–∞—è –ø–æ–ø—É–ª—è—Ä–Ω–æ—Å—Ç—å —ç—Ç–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤, –º–µ—Ö–∞–Ω–∏–∑–º —É–∂–µ –¥–æ–≤–æ–ª—å–Ω–æ –∏–∑–≤–µ—Å—Ç–µ–Ω, –∏ –≥–ª–∞–≤–Ω–∞—è –Ω–æ–≤–æ—Å—Ç—å –∑–∞–∫–ª—é—á–∞–µ—Ç—Å—è –≤ —Å–Ω–∏–∂–µ–Ω–∏–∏ —Ü–µ–Ω—ã –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–æ. –°–∞–∫—Å–µ–Ω–¥–∞ –≤—ã—Ö–æ–¥–∏–ª–∞ —Å—Ç—Ä–∞—Ö–æ–≤—â–∏–∫–∞–º –∏ —Ä–∞–±–æ—Ç–æ–¥–∞—Ç–µ–ª—è–º (–∏–º–µ–Ω–Ω–æ –Ω–∞ –Ω–∏—Ö –ª–æ–∂–∏—Ç—Å—è –æ—Å–Ω–æ–≤–Ω–∞—è –Ω–∞–≥—Ä—É–∑–∫–∞) –≤ —Å—É–º–º—É –æ—Ç 1 —Ç—ã—Å $ –∑–∞ –º–µ—Å—è—Ü –Ω–∞ —á–µ–ª–æ–≤–µ–∫–∞, —á—Ç–æ –≤—ã–Ω—É–∂–¥–∞–ª–æ –∏—Ö –ø—Ä–∏–±–µ–≥–∞—Ç—å –∫ –æ—Ç–∫—Ä—ã—Ç–∏—é —Å–ø–µ—Ü–∏–∞–ª—å–Ω—ã—Ö –∫–∞—á–∞–ª–æ–∫ –∏ –¥–∏–µ—Ç–∏—á–µ—Å–∫–∏—Ö –∫—Ä—É–∂–∫–æ–≤ (—Å—Å—ã–ª–∫–∞). –¢–µ–ø–µ—Ä—å –º–æ–∂–Ω–æ –±—É–¥–µ—Ç –æ–±–æ–π—Ç–∏—Å—å –±–µ–∑ –Ω–∏—Ö, –∞ –µ—â–µ –æ—Å–≤–æ–±–æ–¥–∏—Ç—å –ê–º–µ—Ä–∏–∫—É –æ—Ç –ø—Ä–æ–ø–∞–∂–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ —Å–æ —Å–∫–ª–∞–¥–æ–≤. –û–∂–∏–¥–∞–µ–º —É—Å–∏–ª–µ–Ω–∏–µ –¥–∏—Å–∫–æ–Ω—Ç–Ω—ã—Ö –ø—Ä–æ–≥—Ä–∞–º–º –°–∞–∫—Å–µ–Ω–¥—ã, —Å–æ–∑–¥–∞–Ω–∏–µ –∫–æ—Ä–ø–æ—Ä–∞—Ç–∏–≤–Ω—ã—Ö –∫–∞—Ä—Ç–æ—á–µ–∫ —Ö—É–¥–æ–±—ã, –æ–Ω–ª–∞–π–Ω-–ø—Ä–∏–ª–æ–∂–µ–Ω–∏–π —É—Ä–æ–≤–Ω—è ""–ñ–∏—Ç—å —Ö—É–¥–æ- –∑–¥–æ—Ä–æ–≤–æ!"" —Å —Ñ–∏—Ç–Ω–µ—Å–æ–º –∏ –¥–Ω–µ–≤–Ω–∏–∫–æ–º –ø–∏—Ç–∞–Ω–∏—è. –û—Ç –¢–µ–≤—ã –∂–¥–µ–º —Ä–µ–∑–Ω–∏ –∑–∞ —Ä—ã–Ω–æ–∫ (–∏, –≤–æ–∑–º–æ–∂–Ω–æ, –∫–∞—Ä—Ç–µ–ª—å–Ω–æ–≥–æ —Å–≥–æ–≤–æ—Ä–∞). –°–∏–º –ø–æ—Ö—É–¥–µ—à–∏.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand, epidemic, vaccine"",
  ""impact"": ""medium"",
  ""english"": ""The market is booming but Saxondu (Saxenda, an original drug for weight loss) has been approved by the FDA. It works through incretin mimetics, which activate insulin secretion to reduce appetite and fullness sensation. The cost reduction will lead to reduced insurance and employer costs, potentially reducing the need for special weight loss centers. We expect increased discount programs and corporate wellness cards with fitness apps.""
}"
2025-09-16T18:33:57+00:00,@pharm_icon,2376,https://t.me/pharm_icon/2376,"–ù–æ–≤—ã–µ –ø—É–Ω–∫—Ç—ã –≤—ã–¥–∞—á–∏ —Ñ–∞—Ä–º–º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞ –ó–¥—Ä–∞–≤—Å–∏—Ç–∏ –§–µ–¥–µ—Ä–∞–ª—å–Ω–∞—è –∞–ø—Ç–µ—á–Ω–∞—è —Å–µ—Ç—å ¬´–†–∏–≥–ª–∞¬ª 12 —Å–µ–Ω—Ç—è–±—Ä—è 2025 –≥–æ–¥–∞ —Å—Ç–∞–ª–∞ –≤–ª–∞–¥–µ–ª—å—Ü–µ–º —Ç—Ä–µ—Ö –Ω–æ–≤—ã—Ö –¥–æ—á–µ—Ä–Ω–∏—Ö –∫–æ–º–ø–∞–Ω–∏–π, –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –≤–æ –í–ª–∞–¥–∏–≤–æ—Å—Ç–æ–∫–µ. –ó–∞ –ø–æ–ª—Ç–æ—Ä–∞ –≥–æ–¥–∞ –¥–æ–ª—è —Å–µ—Ç–∏ –≤ —Ä–µ–≥–∏–æ–Ω–µ –≤—ã—Ä–æ—Å–ª–∞ —Å 3,2% –¥–æ 24,2% –õ–∞–¥–æ—à–∫–∞ –ë–æ—Ä–∏—Å–∞ –ü–æ–ø–æ–≤–∞ –ª–µ–≥–ª–∞ –Ω–∞ –¥–∞–ª—å–Ω–∏–π –≤–æ—Å—Ç–æ–∫. –°–±—ã–≤–∞—é—Ç—Å—è —Å—Ç—Ä–∞—Ö–∏ –ê–ª–µ–∫—Å–∞–Ω–¥—Ä–∞ –ö—É–∑–∏–Ω–∞. –ö—Å—Ç–∞—Ç–∏, —Ç–∞–º –µ—â—ë –∏ —Å–µ–ª–æ –µ—Å—Ç—å ""–ü–æ–ø–æ–≤–∞"". –¢–æ–∂–µ –≤—ã–∫—É–ø–∏–ª–∏.","{""skip"": true}"
2025-09-16T18:21:44+00:00,@pharm_icon,2375,https://t.me/pharm_icon/2375,"3 —Å–º–µ—Ä—Ç–∏ –∏ –ø—Ä–∏–Ω—è—Ç–∏–µ –≤—Ä–∞—á–µ–±–Ω—ã—Ö —Ä–µ—à–µ–Ω–∏–π –ù–∞ –≥–ª–∞–∑–∞ –ø–æ–ø–∞–ª–æ—Å—å –∏–Ω—Ç–µ—Ä–µ—Å–Ω–æ–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –æ –ª–æ–≥–∏–∫–µ –ø—Ä–∏–Ω—è—Ç–∏—è –≤—Ä–∞—á–µ–±–Ω—ã—Ö —Ä–µ—à–µ–Ω–∏–π ‚Äî –¥–µ–ª—é—Å—å. ¬´–≠–ª–µ–≤–∏–¥–∏—Å¬ª (Elevidys) ‚Äî —ç—Ç–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è –≥–µ–Ω–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –º—ã—à–µ—á–Ω–æ–π –¥–∏—Å—Ç—Ä–æ—Ñ–∏–∏ –î—é—à–µ–Ω–Ω–∞, –∫–æ—Ç–æ—Ä—ã–π –ø–æ–º–æ–≥–∞–µ—Ç –æ—Ä–≥–∞–Ω–∏–∑–º—É –≤—ã—Ä–∞–±–∞—Ç—ã–≤–∞—Ç—å –±–µ–ª–æ–∫ –¥–∏—Å—Ç—Ä–æ—Ñ–∏–Ω, –Ω–µ–æ–±—Ö–æ–¥–∏–º—ã–π –¥–ª—è –Ω–æ—Ä–º–∞–ª—å–Ω–æ–π —Ä–∞–±–æ—Ç—ã –º—ã—à—Ü. –≠–ª–µ–≤–∏–¥–∏—Å –¥–æ—Å—Ç–∞–≤–ª—è–µ—Ç –≥–µ–Ω —Å –ø–æ–º–æ—â—å—é –∞–¥–µ–Ω–æ–∞—Å—Å–æ—Ü–∏–∏—Ä–æ–≤–∞–Ω–Ω–æ–≥–æ –≤–∏—Ä—É—Å–∞ ‚Äî —ç—Ç–æ –≤–∞–∂–Ω–æ. –ê–¥–µ–Ω–æ–∞—Å—Å–æ—Ü–∏–∏—Ä–æ–≤–∞–Ω–Ω—ã–π –≤–∏—Ä—É—Å –º–æ–∂–µ—Ç –∏–Ω—Ñ–∏—Ü–∏—Ä–æ–≤–∞—Ç—å –¥–µ–ª—è—â–∏–µ—Å—è –∏ –Ω–µ–¥–µ–ª—è—â–∏–µ—Å—è –∫–ª–µ—Ç–∫–∏ –∏ –º–æ–∂–µ—Ç –≤—Å—Ç—Ä–∞–∏–≤–∞—Ç—å —Å–≤–æ–π –≥–µ–Ω–æ–º –≤ –≥–µ–Ω–æ–º —Ö–æ–∑—è–∏–Ω–∞. –ß—Ç–æ —Å–ª—É—á–∏–ª–æ—Å—å: 3 —Å–º–µ—Ä—Ç–∏ –Ω–∞ —Ñ–æ–Ω–µ –ø—Ä–∏–µ–º–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞. –ê–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–∏–π –æ–ø—Ä–æ—Å BMO Capital Markets –ø–æ–∫–∞–∑—ã–≤–∞–µ—Ç, —á—Ç–æ –≤—Ä–∞—á–∏ –≤—ã–ø–∏—Å—ã–≤–∞—é—Ç —ç—Ç–æ—Ç –ø—Ä–µ–ø–∞—Ä–∞—Ç –Ω–µ—Å–º–æ—Ç—Ä—è –Ω–∞ —Å–æ–æ–±—â–µ–Ω–∏—è –æ 3 —Å–º–µ—Ä—Ç—è—Ö. 30 –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö –≤—Ä–∞—á–µ–π –≤—ã–ø–∏—Å—ã–≤–∞—é—Ç —Ä–µ—Ü–µ–ø—Ç—ã —Ç–æ–ª—å–∫–æ –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, —Å–ø–æ—Å–æ–±–Ω—ã—Ö –ø–µ—Ä–µ–¥–≤–∏–≥–∞—Ç—å—Å—è —Å–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω–æ, –ø–æ—Å–∫–æ–ª—å–∫—É –ª–µ—Ç–∞–ª—å–Ω—ã–µ –∏—Å—Ö–æ–¥—ã –ø—Ä–æ–∏–∑–æ—à–ª–∏ —Å—Ä–µ–¥–∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ –Ω–µ –º–æ–≥–ª–∏ –ø–µ—Ä–µ–¥–≤–∏–≥–∞—Ç—å—Å—è —Å–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω–æ. –ë–æ–ª–µ–µ —á–µ—Ç–≤–µ—Ä—Ç–∏ –≤—Ä–∞—á–µ–π, –æ–ø—Ä–æ—à–µ–Ω–Ω—ã—Ö BMO, –∑–∞—è–≤–∏–ª–∏, —á—Ç–æ –≤—ã–ø–∏—Å–∞–ª–∏ –±—ã –≠–ª–µ–≤–∏–¥–∏—Å –±–æ–ª–µ–µ –º–æ–ª–æ–¥—ã–º –∏ –∑–¥–æ—Ä–æ–≤—ã–º –ø–∞—Ü–∏–µ–Ω—Ç–∞–º. –í—Ä–∞—á–∏ –æ—Ç–º–µ—Ç–∏–ª–∏ –±–ª–∞–≥–æ–ø—Ä–∏—è—Ç–Ω–æ–µ —Å–æ–æ—Ç–Ω–æ—à–µ–Ω–∏–µ —Ä–∏—Å–∫–∞ –∏ –ø–æ–ª—å–∑—ã —É –∞–º–±—É–ª–∞—Ç–æ—Ä–Ω—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –∏–∑ –∫–æ—Ç–æ—Ä—ã—Ö –±–æ–ª–µ–µ 760 –ø—Ä–æ—à–ª–∏ –ª–µ—á–µ–Ω–∏–µ, –±–µ–∑ –ª–µ—Ç–∞–ª—å–Ω—ã—Ö –∏—Å—Ö–æ–¥–æ–≤. –≠—Ç–∏ –ø–∞—Ü–∏–µ–Ω—Ç—ã, –∫–∞–∫ –ø—Ä–∞–≤–∏–ª–æ, –±–æ–ª–µ–µ –∑–¥–æ—Ä–æ–≤—ã –∏ –ª–µ–≥—á–µ –ø–æ –≤–µ—Å—É, –∞ –∑–Ω–∞—á–∏—Ç, –∏–º —Ç—Ä–µ–±—É–µ—Ç—Å—è –º–µ–Ω—å—à–∞—è –¥–æ–∑–∞ –≠–ª–µ–≤–∏–¥–∏—Å–∞. –ù–µ–∞–º–±—É–ª–∞—Ç–æ—Ä–Ω—ã–º –ø–∞—Ü–∏–µ–Ω—Ç–∞–º, –∫–æ—Ç–æ—Ä—ã–µ, –∫–∞–∫ –ø—Ä–∞–≤–∏–ª–æ, —Å—Ç–∞—Ä—à–µ, –Ω–∞—Ö–æ–¥—è—Ç—Å—è –≤ –±–æ–ª–µ–µ –∑–∞–ø—É—â–µ–Ω–Ω–æ–π —Å—Ç–∞–¥–∏–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è –∏ –∏–º–µ—é—Ç –±–æ–ª—å—à–∏–π –≤–µ—Å, –ø–æ—ç—Ç–æ–º—É –∏–º —Ç—Ä–µ–±—É–µ—Ç—Å—è –±–æ–ª–µ–µ –≤—ã—Å–æ–∫–∞—è –¥–æ–∑–∞. –ß—Ç–æ –∏–Ω—Ç–µ—Ä–µ—Å–Ω–æ: –ª–µ—Ç–∞–ª—å–Ω–æ—Å—Ç—å —Å–≤—è–∑—ã–≤–∞—é—Ç —Å –Ω–∞–∫–æ–ø–ª–µ–Ω–∏–µ–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –≤ –ø–µ—á–µ–Ω–∏ –∏ —Å –∏–º–º—É–Ω–æ–≥–µ–Ω–Ω–æ—Å—Ç—å—é –∞–¥–µ–Ω–æ–∞—Å—Å–æ—Ü–∏–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –≤–∏—Ä—É—Å–æ–≤ (AAV). –°–æ–≥–ª–∞—Å–Ω–æ —Å—Ç–∞—Ç—å–µ, –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω–Ω–æ–π Norn Group, –µ—â—ë –¥–æ —Å–º–µ—Ä—Ç–µ–π, —Å–≤—è–∑–∞–Ω–Ω—ã—Ö —Å Elevidys, —Å –≥–µ–Ω–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–µ–π AAV –≤ –ø–µ—Ä–∏–æ–¥ —Å 2021 –ø–æ 2024 –≥–æ–¥ –±—ã–ª–æ —Å–≤—è–∑–∞–Ω–æ 13 —Å–º–µ—Ä—Ç–µ–π. –ö–∞–∫–æ–µ —Ä–µ—à–µ–Ω–∏–µ –≤–∏–¥–∏—Ç—Å—è –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è–º: –∏–º–º—É–Ω–æ—Å—É–ø—Ä–µ—Å—Å–∏—è. –í —Ü–µ–ª–æ–º –∫–æ–º–ø–∞–Ω–∏–∏-–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –¥—É—é—Ç—Å—è –∏ –ø—ã—Ç–∞—é—Ç—Å—è —Å–æ—Ö—Ä–∞–Ω–∏—Ç—å –ª–∏—Ü–æ, —Å–ø–∏—Å—ã–≤–∞—è –ø—Ä–æ–∏–∑–æ—à–µ–¥—à–µ–µ –Ω–∞ —Å–ª—É—á–∞–π–Ω–æ—Å—Ç—å. –ß—Ç–æ –∏–Ω—Ç–µ—Ä–µ—Å–Ω–æ–≥–æ –≤ —ç—Ç–æ–º? 1. –ö–∞–∫ –ø—Ä–∏–Ω–∏–º–∞—é—Ç —Å–∏—Ç—É–∞—Ü–∏—é –≤—Ä–∞—á–∏ –∏ –∞–¥–∞–ø—Ç–∏—Ä—É—é—Ç –ø—Ä–∞–∫—Ç–∏–∫—É. 2. –ö–∞–∫ —Ä–µ–∞–≥–∏—Ä—É—é—Ç –∫–æ–º–ø–∞–Ω–∏–∏. 3. –ö–∞–∫ —Å–ª–æ–∂–∏—Ç—Å—è —Å–∏—Ç—É–∞—Ü–∏—è –≤ –±—É–¥—É—â–µ–º. –ù–∞–±–ª—é–¥–∞–µ–ºüëÄ","{""skip"": true}"
2025-09-15T18:44:58+00:00,@pharm_icon,2374,https://t.me/pharm_icon/2374,"–í–æ—Ç —Ç–∞–∫ –Ω–∞—á–∏–Ω–∞–µ—Ç—Å—è –º–µ–¥–∏—Ü–∏–Ω–∞ –ø–æ–±–æ—á–Ω—ã—Ö —ç—Ñ—Ñ–µ–∫—Ç–æ–≤ –Ω–∞ Medscape –ö–∞–∫ –≤–∏–¥–∏—Ç–µ, –Ω–∞ —ç–∫—Ä–∞–Ω–µ –ø—Ä–∏–º–µ—Ä –ø—Ä–æ–¥–∞–ª–±–ª–∏–≤–∞–Ω–∏—è –≤–æ –≤—Ä–∞—á–∞ –∏–¥–µ–∏ –æ —Ç–æ–º, —á—Ç–æ –ø–æ–±–æ—á–Ω—ã–µ —ç—Ñ—Ñ–µ–∫—Ç—ã –∞–Ω—Ç–∏–ø—Å–∏—Ö–æ—Ç–∏–∫–æ–≤ –Ω–∞–¥–æ –±—ã –ª–µ—á–∏—Ç—å —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞–º–∏. –í —Ä–∞–Ω–¥–æ–º–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω–æ–º –∫–æ–Ω—Ç—Ä–æ–ª–∏—Ä—É–µ–º–æ–º –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å —Ç—Ä–µ–º—è –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏, –∫–æ—Ç–æ—Ä—ã–µ —É–∂–µ –ø—Ä–∏–Ω–∏–º–∞–ª–∏ –∞–Ω—Ç–∏–ø—Å–∏—Ö–æ—Ç–∏—á–µ—Å–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –≤—Ç–æ—Ä–æ–≥–æ –ø–æ–∫–æ–ª–µ–Ω–∏—è, —É —Ç–µ—Ö, –∫—Ç–æ —Ç–∞–∫–∂–µ –ø–æ–ª—É—á–∞–ª 30 –Ω–µ–¥–µ–ª—å —Å–µ–º–∞–≥–ª—É—Ç–∏–¥ –≤ –¥–æ–∑–µ –¥–æ 1 –º–≥/–Ω–µ–¥, –Ω–∞–±–ª—é–¥–∞–ª–æ—Å—å —Å–Ω–∏–∂–µ–Ω–∏–µ –≤–µ—Å–∞ –Ω–∞ 9 –∫–≥ (20 —Ñ—É–Ω—Ç–æ–≤) –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å —Ç–µ–º–∏, –∫—Ç–æ –ø–æ–ª—É—á–∞–ª –ø–ª–∞—Ü–µ–±–æ, –∞ —Ç–∞–∫–∂–µ –±–æ–ª–µ–µ –≤—ã—Ä–∞–∂–µ–Ω–Ω–æ–µ —Å–Ω–∏–∂–µ–Ω–∏–µ —É—Ä–æ–≤–Ω—è –≥–ª—é–∫–æ–∑—ã –∏ —Ç—Ä–∏–≥–ª–∏—Ü–µ—Ä–∏–¥–æ–≤ –≤ –∫—Ä–æ–≤–∏ –ù–ï–ü–õ–û–•–û. –ê–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç—ã ‚Äî —Ç–æ–∂–µ –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤–Ω–∞—è –Ω–∏—à–∞ –í –†–æ—Å—Å–∏–∏ –ø—Ä–æ–¥–∞–Ω–æ 13 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫ –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç–æ–≤ —Å –Ω–∞—á–∞–ª–∞ –≥–æ–¥–∞ ‚Äî —É–∂–µ 14, –Ω–∞–≤–µ—Ä–Ω–æ–µ, ‚Äî —Å—Ä–µ–¥–∏ –∫–æ—Ç–æ—Ä—ã—Ö —Ç–æ–∂–µ –µ—Å—Ç—å –ø–æ–¥–∂–∏—Ä–Ω—è—é—â–∏–µ –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª–µ–π –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø—Ä–æ–¥—É–∫—Ç—ã. –ß—Ç–æ –¥—É–º–∞–µ—Ç–µ, –Ω–æ—Ä–º–∞–ª—å–Ω–æ –ª–∏ —Ä–∞—Å—Ç–∏—Ç—å –ø–æ–ª–∏–ø—Ä–∞–≥–º–∞–∑–∏—é —Ç–∞–∫–∏–º –æ–±—Ä–∞–∑–æ–º? üî• ‚Äî –¥–∞ üóø ‚Äî –Ω–µ—Ç üòê ‚Äî –∏–¥—É –≤ –∫–æ–º–º–µ–Ω—Ç—ã –≤—ã—Ä–∞–∂–∞—Ç—å —Å–≤–æ—ë –º–Ω–µ–Ω–∏–µ!","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance"",
  ""impact"": ""medium"",
  ""english"": ""A randomized controlled trial showed that patients with three diseases who were already taking second-generation antipsychotics and also received 30 weeks of semaglutide at a dose up to 1 mg/week had an average weight loss of 9 kg (20 lbs) compared to those who received placebo, as well as more significant reductions in glucose and triglyceride levels in the blood. The country of Russia has sold 13 million units of antidepressants since the beginning of the year, which is likely to be around 14 million by now, among which there are also consumers of pharmaceutical products with polypharmacy issues. What do you think about this, is it normal to treat polypharmacy in such a way?""
}"
2025-09-12T06:41:01+00:00,@pharm_icon,2371,https://t.me/pharm_icon/2371,"FDA –æ–¥–æ–±—Ä–∏–ª–æ Papzimeos ‚Äî –ø–µ—Ä–≤—É—é –∏–º–º—É–Ω–æ—Ç–µ—Ä–∞–ø–∏—é –æ—Ç —Ä–µ—Ü–∏–¥–∏–≤–∏—Ä—É—é—â–µ–≥–æ —Ä–µ—Å–ø–∏—Ä–∞—Ç–æ—Ä–Ω–æ–≥–æ –ø–∞–ø–∏–ª–ª–æ–º–∞—Ç–æ–∑–∞ —É –≤–∑—Ä–æ—Å–ª—ã—Ö. –î–µ–π—Å—Ç–≤—É—é—â–µ–µ –≤–µ—â–µ—Å—Ç–≤–æ ‚Äî zopapogene imadenovec-drba ‚Äî –≤–µ–∫—Ç–æ—Ä–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –ª–∏—à–µ–Ω–Ω–æ–≥–æ —Å–ø–æ—Å–æ–±–Ω–æ—Å—Ç–∏ —Ä–µ–ø–ª–∏—Ü–∏—Ä–æ–≤–∞—Ç—å—Å—è –∞–¥–µ–Ω–æ–≤–∏—Ä—É—Å–∞ —Å –∞–Ω—Ç–∏–≥–µ–Ω–Ω—ã–º–∏ —É—á–∞—Å—Ç–∫–∞–º–∏, —Å—Ö–æ–¥–Ω—ã–º–∏ —Å –í–ü–ß (–≤–∏—Ä—É—Å–æ–º –ø–∞–ø–∏–ª–ª–æ–º—ã —á–µ–ª–æ–≤–µ–∫–∞) 6 –∏ 11 —Ç–∏–ø–æ–≤, —è–≤–ª—è—é—â–∏—Ö—Å—è –≤–æ–∑–±—É–¥–∏—Ç–µ–ª—è–º–∏ —Ä–µ—Ü–∏–¥–∏–≤–∏—Ä—É—é—â–µ–≥–æ —Ä–µ—Å–ø–∏—Ä–∞—Ç–æ—Ä–Ω–æ–≥–æ –ø–∞–ø–∏–ª–ª–æ–º–∞—Ç–æ–∑–∞ (–†–†–ü). –ë–ª–∞–≥–æ–¥–∞—Ä—è —Å—Ö–æ–¥–Ω—ã–º –∞–Ω—Ç–∏–≥–µ–Ω–Ω—ã–º —Å–≤–æ–π—Å—Ç–≤–∞–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –∏ –í–ü–ß 6 –∏ 11 —Ç–∏–ø–æ–≤, –æ—Ä–≥–∞–Ω–∏–∑–º —á–µ–ª–æ–≤–µ–∫–∞ –Ω–∞—á–∏–Ω–∞–µ—Ç —Å–∏–Ω—Ç–µ–∑–∏—Ä–æ–≤–∞—Ç—å –ø—Ä–æ—Ç–∏–≤ –Ω–∏—Ö –∞–Ω—Ç–∏—Ç–µ–ª–∞, –∫–æ—Ç–æ—Ä—ã–µ –¥–∞–ª–µ–µ –ø—Ä–æ—Ç–∏–≤–æ—Å—Ç–æ—è—Ç —É–∂–µ –í–ü–ß, –∫–æ—Ç–æ—Ä—ã–π –ø—Ä–æ–≤–æ—Ü–∏—Ä—É–µ—Ç —Ä–∞–∑—Ä–∞—Å—Ç–∞–Ω–∏–µ –¥–æ–±—Ä–æ–∫–∞—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –æ–ø—É—Ö–æ–ª–µ–π –≤ –¥—ã—Ö–∞—Ç–µ–ª—å–Ω—ã—Ö –ø—É—Ç—è—Ö (—á–∞—â–µ –≤—Å–µ–≥–æ - –≥–æ—Ä—Ç–∞–Ω–∏). –†–µ—Ü–∏–¥–∏–≤–∏—Ä—É—é—â–∏–π —Ä–µ—Å–ø–∏—Ä–∞—Ç–æ—Ä–Ω—ã–π –ø–∞–ø–∏–ª–ª–æ–º–∞—Ç–æ–∑–∞ —Å—É—â–µ—Å—Ç–≤–µ–Ω–Ω–æ –≤–ª–∏—è–µ—Ç –Ω–∞ —Ç—è–∂–µ—Å—Ç—å –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è –∏–∑-–∑–∞ –æ–±—Å—Ç—Ä—É–∫—Ü–∏–∏ –¥—ã—Ö–∞—Ç–µ–ª—å–Ω—ã—Ö –ø—É—Ç–µ–π, –∑–∞—Ç—Ä—É–¥–Ω–µ–Ω–∏—è –¥—ã—Ö–∞–Ω–∏—è –∏ –∏–∑–º–µ–Ω–µ–Ω–∏—è –≥–æ–ª–æ—Å–∞, –ø—Ä–∏–≤–æ–¥—è –∫ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ –ø–æ–≤—Ç–æ—Ä—è—é—â–∏—Ö—Å—è —Ö–∏—Ä—É—Ä–≥–∏—á–µ—Å–∫–∏—Ö –≤–º–µ—à–∞—Ç–µ–ª—å—Å—Ç–≤. –ò—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –Ω–µ –±—ã–ª–æ —Ä–∞–Ω–¥–æ–º–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã–º –∏–ª–∏ —Å—Ä–∞–≤–Ω–∏—Ç–µ–ª—å–Ω—ã–º –∏ –ø—Ä–æ–≤–æ–¥–∏–ª–æ—Å—å —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –†–†–ü, –ø—Ä–æ—à–µ–¥—à–∏—Ö –Ω–µ –º–µ–Ω–µ–µ 3 –æ–ø–µ—Ä–∞—Ü–∏–π –≤ –≥–æ–¥ (—Å–æ —Å–ª–æ–≤ –≥–ª–∞–≤—ã –¥–µ–ø–∞—Ä—Ç–∞–º–µ–Ω—Ç–∞ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π FDA, ‚Äú–∏–Ω–æ–≥–¥–∞ —Ä–∞–Ω–¥–æ–º–∏–∑–∞—Ü–∏—è –Ω–µ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–∞ –¥–ª—è –Ω–µ–∫–æ—Ç–æ—Ä—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –∏ —ç—Ç–æ—Ç —Å–ª—É—á–∞–π –ª–∏—à—å –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–∞–µ—Ç —ç—Ç–æ‚Äù). –ë–æ–ª–µ–µ –ø–æ–ª–æ–≤–∏–Ω—ã —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –ö–ò (18 –∏–∑ 35) –¥–æ—Å—Ç–∏–≥–ª–∏ –ø–æ–ª–Ω–æ–≥–æ –æ—Ç–≤–µ—Ç–∞, –∏—Ö –æ–ø—É—Ö–æ–ª–∏ –±—ã–ª–∏ —É–Ω–∏—á—Ç–æ–∂–µ–Ω—ã —Å–∏–ª–∞–º–∏ –∏–º–º—É–Ω–∏—Ç–µ—Ç–∞, –∞ 81% –∏–∑ –≤—Å–µ—Ö –Ω–∞ –ø—Ä–æ—Ç—è–∂–µ–Ω–∏–∏ –≥–æ–¥–∞ –±–æ–ª–µ–µ –Ω–µ –Ω—É–∂–¥–∞–ª–∏—Å—å –≤ –Ω–æ–≤—ã—Ö –≤–º–µ—à–∞—Ç–µ–ª—å—Å—Ç–≤–∞—Ö. –≠—Ç–æ—Ç –ø—Ä–µ–ø–∞—Ä–∞—Ç –±–∞–Ω–∞–ª—å–Ω–æ –º–µ–Ω—è–µ—Ç –∂–∏–∑–Ω—å –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –∑–∞—â–∏—â–∞—è –ø–æ—á—Ç–∏ –≤—Å–µ—Ö –æ—Ç —Ö–∏—Ä—É—Ä–≥–∏–∏, —á–µ–≥–æ —É–∂ –≥–æ–≤–æ—Ä–∏—Ç—å –æ —Ñ–∏–Ω–∞–Ω—Å–æ–≤–æ–º —ç—Ñ—Ñ–µ–∫—Ç–µ. –°—Ç–æ–∏—Ç —É—á–µ—Å—Ç—å, —á—Ç–æ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–µ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏—Ä—É–µ—Ç—Å—è —É 1000 —á–µ–ª–æ–≤–µ–∫ –≤ –°–®–ê –µ–∂–µ–≥–æ–¥–Ω–æ (–±–æ–ª–µ–∑–Ω—å —è–≤–ª—è–µ—Ç—Å—è –æ—Ä—Ñ–∞–Ω–Ω–æ–π), –∞ —Ç–∞–∫–∂–µ –∏–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω–æ–µ –ø—Ä–æ–∏—Å—Ö–æ–∂–¥–µ–Ω–∏–µ –†–†–ü, –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–µ –ø–æ–¥–æ–±–Ω—ã—Ö –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç–æ–≤ –∏ —Ä–∏—Å–∫–∏ –ø–æ—Å—Ç–æ—è–Ω–Ω–æ–π —Ö–∏—Ä—É—Ä–≥–∏–∏, –º–æ–∂–Ω–æ –∑–∞—è–≤–∏—Ç—å, —á—Ç–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç –∑–∞–π–º–µ—Ç –∫–∞–∫ —Ä–µ–ø—É—Ç–∞—Ü–∏–æ–Ω–Ω—É—é, —Ç–∞–∫ –∏ —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫—É—é –∑–æ–ª–æ—Ç—É—é –∂–∏–ª—É, –ø—É—Å—Ç—å –∏ –Ω–µ –æ—á–µ–Ω—å —à–∏—Ä–æ–∫—É—é. –û–∂–∏–¥–∞–µ–º —Å–ø–∞—Å–µ–Ω–∏—è —Å—Ç—Ä–∞–∂–¥—É—â–∏—Ö –∏ –≥–æ—Ä—ã –∫–æ–º–ø–ª–∏–º–µ–Ω—Ç–æ–≤ –≤–∫—É–ø–µ —Å –æ—Å—Ç—Ä—ã–º–∏ –¥–∏—Å–∫—É—Å—Å–∏—è–º–∏ –æ –≤–æ–ø—Ä–æ—Å–µ —Ü–µ–Ω–æ–æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è (–±–æ–ª–µ–∑–Ω—å-—Ç–æ –æ—Ä—Ñ–∞–Ω–Ω–∞—è, –¶–ê —É–∑–∫–∞—è), ‚Äú–≤–µ—á–Ω–æ–∑–µ–ª–µ–Ω—ã—Ö‚Äù –ø–∞—Ç–µ–Ω—Ç–∞—Ö –∏ —Ñ–æ—Ä–º–∞—Ç–µ –æ–ø–ª–∞—Ç—ã –∑–∞ —Ä–µ–∑—É–ª—å—Ç–∞—Ç. –ú–∞—à—É –∫–æ–º–ø–∞–Ω–∏–∏ —à–ª—è–ø–∫–æ–π –∏ –∂–µ–ª–∞—é —É—Å–ø–µ—Ö–æ–≤.","{""skip"": true}"
2025-09-11T23:18:01+00:00,@pharm_icon,2369,https://t.me/pharm_icon/2369,"–°–ø–∏—Ç–µ? –û–π –∑—Ä—è. –Ø-—Ç–æ —Å–ø–ª—é, —ç—Ç–æ –æ—Ç–ª–æ–∂–∫–∞","{""skip"": true}"
2025-09-11T20:30:24+00:00,@pharm_icon,2368,https://t.me/pharm_icon/2368,"–ñ–µ–Ω—â–∏–Ω–∞-–ª–æ—Ä –≤ –æ–ø–∞–ª–µ: —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è, –ø—Ä–æ–≤–µ–¥–µ–Ω–Ω–æ–≥–æ –º—É–∂—á–∏–Ω–æ–π 36-–ª–µ—Ç–Ω–∏–π –æ—Ç–æ—Ä–∏–Ω–æ–ª–∞—Ä–∏–Ω–≥–æ–ª–æ–≥ –ñ–µ—Ä–æ–º –õ–µ—à—å–µ–Ω –ø—Ä–æ–≤—ë–ª –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ, –≤ —Ö–æ–¥–µ –∫–æ—Ç–æ—Ä–æ–≥–æ –≤—ã—è—Å–Ω–∏–ª, —á—Ç–æ –µ–≤—Ä–æ–ø–µ–π—Å–∫–∏–µ –≤—Ä–∞—á–∏ —Å—Ç–æ–ª–∫–Ω—É–ª–∏—Å—å —Å –¥–∏—Å–∫—Ä–∏–º–∏–Ω–∞—Ü–∏–µ–π –ø–æ –ø—Ä–∏–∑–Ω–∞–∫—É –≤–æ–∑—Ä–∞—Å—Ç–∞, —ç—Ç–Ω–∏—á–µ—Å–∫–æ–π –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–Ω–æ—Å—Ç–∏ –∏ —Å–æ—Ü–∏–∞–ª—å–Ω–æ —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–≥–æ —Å—Ç–∞—Ç—É—Å–∞ –≤ 78,6%, 41,5% –∏ 49,8% —Å–ª—É—á–∞–µ–≤ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ. –°—Ä–∞–≤–Ω–µ–Ω–∏–µ –≥–µ–Ω–¥–µ—Ä–Ω–æ–≥–æ —Ñ–∞–∫—Ç–æ—Ä–∞ –ø–æ–∫–∞–∑–∞–ª–æ, —á—Ç–æ –∂–µ–Ω—â–∏–Ω—ã —á–∞—â–µ, —á–µ–º –º—É–∂—á–∏–Ω—ã, —Å–æ–æ–±—â–∞–ª–∏ –æ –¥–∏—Å–∫—Ä–∏–º–∏–Ω–∞—Ü–∏–∏ –ø–æ –ø—Ä–∏–∑–Ω–∞–∫—É –ø–æ–ª–∞ (76,5% –ø—Ä–æ—Ç–∏–≤ 61,6%), —ç—Ç–Ω–∏—á–µ—Å–∫–æ–π –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–Ω–æ—Å—Ç–∏ (49% –ø—Ä–æ—Ç–∏–≤ 30,9%) –∏ –≤–æ–∑—Ä–∞—Å—Ç–∞ (69,1% –ø—Ä–æ—Ç–∏–≤ 50%). –ë–æ–ª–µ–µ —Ç–æ–≥–æ, 58,4% –∂–µ–Ω—â–∏–Ω-–≤—Ä–∞—á–µ–π –õ–û–†-–≤—Ä–∞—á–µ–π —á–∞—Å—Ç–æ –æ—à–∏–±–æ—á–Ω–æ –ø—Ä–∏–Ω–∏–º–∞–ª–∏ –∑–∞ –¥—Ä—É–≥–∏—Ö —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –≤ –±–æ–ª—å–Ω–∏—Ü–µ, –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å 27,4% –º—É–∂—á–∏–Ω-–≤—Ä–∞—á–µ–π –õ–û–†-–≤—Ä–∞—á–µ–π. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, 54,4% –∂–µ–Ω—â–∏–Ω —Å—á–∏—Ç–∞–ª–∏, —á—Ç–æ –∏–º –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –ø—Ä–∏–ª–∞–≥–∞—Ç—å –±–æ–ª—å—à–µ —É—Å–∏–ª–∏–π, —á–µ–º –∏—Ö –∫–æ–ª–ª–µ–≥–∞–º-–º—É–∂—á–∏–Ω–∞–º, —á—Ç–æ–±—ã –¥–æ–±–∏—Ç—å—Å—è —Ç–∞–∫–æ–≥–æ –∂–µ –ø—Ä–æ–¥–≤–∏–∂–µ–Ω–∏—è –∏–ª–∏ –ø—Ä–∏–∑–Ω–∞–Ω–∏—è. –ß—Ç–æ –¥—É–º–∞–µ—Ç–µ? –≠–∫—Å—Ç—Ä–∞–ø–æ–ª–∏—Ä—É–µ—Ç—Å—è –Ω–∞ –†–æ—Å—Å–∏—é –∏ –°–ù–ì?","{""skip"": true}"
2025-09-11T14:32:01+00:00,@pharm_icon,2367,https://t.me/pharm_icon/2367,"–ú–∞–ª–æ —Ä–∞–±–æ—Ç–∞–µ—Ç–µ? –°–Ω–∏–∑–∏–º –∑–∞—Ä–ø–ª–∞—Ç—ã. –í–∏–¥–∏–º–æ, –º–∏–Ω–∏—Å—Ç—Ä –ú—É—Ä–∞—à–∫–æ –µ—â—ë –∏ –æ—Å–Ω–æ–≤—ã —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ–≥–æ –º–µ–Ω–µ–¥–∂–º–µ–Ω—Ç–∞ –∫–æ–º—É-—Ç–æ –ø—Ä–µ–ø–æ–¥–∞–ª. –ì–ª–∞–≤–Ω—ã–π –≤—Ä–∞—á –ê–ª–∏—à–µ—Ä –ë–∞—Ö–æ–≤—É–¥–∏–Ω–æ–≤ –ø—Ä–∏–∫–∞–∑–∞–ª —Å–æ–∫—Ä–∞—Ç–∏—Ç—å —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–∞–º —Å—Ç–∏–º—É–ª–∏—Ä—É—é—â–∏–µ –∏ –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏–æ–Ω–Ω—ã–µ –≤—ã–ø–ª–∞—Ç—ã. –í —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, —Å–Ω–∏–∂–µ–Ω–∞ –æ–ø–ª–∞—Ç–∞ –∑–∞ –Ω–æ—á–Ω—ã–µ –¥–µ–∂—É—Ä—Å—Ç–≤–∞, –∞ —Ä–∞–±–æ—Ç—É –≤ –≤—ã—Ö–æ–¥–Ω—ã–µ –¥–Ω–∏ –∏ –≤–æ–≤—Å–µ –Ω–µ –æ–ø–ª–∞—á–∏–≤–∞—é—Ç. ¬´–ï—Å–ª–∏ —É –∫–æ–≥–æ-—Ç–æ –ø—Ä–æ–∏–∑–æ—à–ª–æ —Å–Ω–∏–∂–µ–Ω–∏–µ, —Ç–æ, —Å–∫–æ—Ä–µ–µ –≤—Å–µ–≥–æ, –æ–Ω–∏ —Å—Ç–∞–ª–∏ –º–µ–Ω—å—à–µ —Ä–∞–±–æ—Ç–∞—Ç—å. –£ –Ω–∞—Å –Ω–µ–∫–æ—Ç–æ—Ä—ã–µ —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–∏ –ø–æ–ª—É—á–∞—é—Ç –ø–æ 150‚Äì200 —Ç—ã—Å—è—á —Ä—É–±–ª–µ–π. –†–∞–∑–≤–µ —ç—Ç–æ –Ω–µ –¥–æ—Å—Ç–æ–π–Ω–∞—è –∑–∞—Ä–ø–ª–∞—Ç–∞ –¥–ª—è —á–µ–ª–æ–≤–µ–∫–∞, —Ä–∞–±–æ—Ç–∞—é—â–µ–≥–æ –ø—Ä–∏–º–µ—Ä–Ω–æ —à–µ—Å—Ç—å —á–∞—Å–æ–≤ –≤ –¥–µ–Ω—å?¬ª, ‚Äî –ø–æ—è—Å–Ω–∏–ª –≥–ª–∞–≤–≤—Ä–∞—á –ê–ª–∏—à–µ—Ä –ë–∞—Ö–æ–≤—É–¥–∏–Ω–æ–≤, –≥–ª–∞–≤–≤—Ä–∞—á –ì–ë–£–ó ¬´–ú–µ–∂–¥—É—Ä–µ—á–µ–Ω—Å–∫–∞—è –≥–æ—Ä–æ–¥—Å–∫–∞—è –±–æ–ª—å–Ω–∏—Ü–∞¬ª –ö–µ–º–µ—Ä–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏. –ß—Ç–æ –¥—É–º–∞–µ—Ç–µ? üî• ‚Äî –º—É–∂–∏–∫-–æ–≥–æ–Ω—å, –Ω–∞–¥–æ —Ä–∞–∑–≤–∏–≤–∞—Ç—å —ç—Ç—É –≤–µ—Ç–∫—É —É–ø—Ä–∞–≤–ª–µ–Ω–∏—è üóø ‚Äî –º—É–∂–∏–∫-–¥—É–±","{""skip"": true}"
2025-09-11T14:29:04+00:00,@pharm_icon,2366,https://t.me/pharm_icon/2366,"–ü—Ä–∏—ë–º–Ω—ã–º –¥–µ—Ç—è–º —Ç–æ–∂–µ –¥–æ—Å—Ç–∞–ª–æ—Å—å. –ù–∞–¥–µ–µ–º—Å—è, —á—Ç–æ —É –ò–≥–æ—Ä—è –•–∞—Å–∏–Ω–∞ –ø—Ä–∏—ë–º–Ω—ã—Ö –¥–µ—Ç–µ–π –Ω–µ—Ç.","{""skip"": true}"
2025-09-11T14:26:58+00:00,@pharm_icon,2364,https://t.me/pharm_icon/2364,"–ù–∞ –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ pro–µ–∫—Ü–∏–∏ –±—É–¥—É—â–µ–≥–æ –±—ã–ª–æ –∂–∞—Ä–∫–æ, –æ–¥–Ω–∞–∫–æ. –ö–∞—Ä—Ç–∏–Ω–∫–∏, –∫–æ–Ω–µ—á–Ω–æ, –∏–Ω—Ç–µ—Ä–µ—Å–Ω—ã–µ —Ä–∏—Å—É–µ—Ç –≤–æ–æ–±—Ä–∞–∂–µ–Ω–∏–µ ‚Äî –≤—Å—ë-—Ç–∞–∫–∏ —Å–∫–∞–∑–∞–Ω–æ –≥–æ—Ä–Ω–∏—á–Ω–∞—è, –∞ –Ω–µ –∫–ª–∏–Ω–∏–Ω–≥...üëÄ","{""skip"": true}"
2025-09-11T14:13:01+00:00,@pharm_icon,2363,https://t.me/pharm_icon/2363,"–ù–æ–≤—ã–π –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç –Ω–∞ Dozator.io ‚Äî CTCAE (Common Terminology Criteria for Adverse Events) –í—Ä–∞—á–∏, –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª–∏ –∏ –∫–ª–∏–Ω–∏–∫–∏ —Ç–µ–ø–µ—Ä—å –º–æ–≥—É—Ç –±—ã—Å—Ç—Ä–æ –∏ —É–¥–æ–±–Ω–æ –æ—Ü–µ–Ω–∏–≤–∞—Ç—å –ø–æ–±–æ—á–Ω—ã–µ —ç—Ñ—Ñ–µ–∫—Ç—ã —Ç–µ—Ä–∞–ø–∏–∏ –ø–æ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–æ–π —à–∫–∞–ª–µ CTCAE. –ó–∞—á–µ–º —ç—Ç–æ –Ω—É–∂–Ω–æ? üìä –°—Ç–∞–Ω–¥–∞—Ä—Ç–∏–∑–∞—Ü–∏—è ‚Äî –µ–¥–∏–Ω–∞—è —Ç–µ—Ä–º–∏–Ω–æ–ª–æ–≥–∏—è –¥–ª—è –æ–ø–∏—Å–∞–Ω–∏—è –Ω–µ–∂–µ–ª–∞—Ç–µ–ª—å–Ω—ã—Ö —è–≤–ª–µ–Ω–∏–π –≤ –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–π –ø—Ä–∞–∫—Ç–∏–∫–µ –∏ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è—Ö. ü©∫ –ü—Ä–æ—Å—Ç–æ—Ç–∞ ‚Äî –Ω–µ –Ω—É–∂–Ω–æ –ª–∏—Å—Ç–∞—Ç—å –≥—Ä–æ–º–æ–∑–¥–∫–∏–µ PDF: –∫–∞–ª—å–∫—É–ª—è—Ç–æ—Ä –ø–æ–¥—Å–∫–∞–∂–µ—Ç –Ω—É–∂–Ω—ã–π Grade (1‚Äì5) —Å—Ä–∞–∑—É. ‚è±Ô∏è –≠–∫–æ–Ω–æ–º–∏—è –≤—Ä–µ–º–µ–Ω–∏ ‚Äî —Ñ–∏–∫—Å–∞—Ü–∏—è –ø–æ–±–æ—á–Ω–æ–≥–æ —ç—Ñ—Ñ–µ–∫—Ç–∞ –∑–∞–Ω–∏–º–∞–µ—Ç —Å–µ–∫—É–Ω–¥—ã. üåç –ú–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã–π —É—Ä–æ–≤–µ–Ω—å ‚Äî CTCAE –ø—Ä–∏–º–µ–Ω—è–µ—Ç—Å—è –≤–æ –≤—Å–µ—Ö –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å–ø—ã—Ç–∞–Ω–∏—è—Ö –∏ –ø—É–±–ª–∏–∫–∞—Ü–∏—è—Ö, —Ç–µ–ø–µ—Ä—å –¥–æ—Å—Ç—É–ø–µ–Ω –∏ –æ–Ω–ª–∞–π–Ω. –î–ª—è –∫–æ–≥–æ? üë®‚Äç‚öïÔ∏è–í—Ä–∞—á–µ–π-–æ–Ω–∫–æ–ª–æ–≥–æ–≤, –∫–∞—Ä–¥–∏–æ–ª–æ–≥–æ–≤, –≥–µ—Ä–∏–∞—Ç—Ä–æ–≤, –∞–ª–ª–µ—Ä–≥–æ–ª–æ–≥–æ–≤ –∏ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤, –Ω–∞–∑–Ω–∞—á–∞—é—â–∏—Ö —Ç–µ—Ä–∞–ø–∏—é —Å –≤–æ–∑–º–æ–∂–Ω—ã–º–∏ –Ω–µ–∂–µ–ª–∞—Ç–µ–ª—å–Ω—ã–º–∏ —è–≤–ª–µ–Ω–∏—è–º–∏. üë®‚Äç‚öïÔ∏è–ò—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–∏—Ö —Ü–µ–Ω—Ç—Ä–æ–≤ –∏ CRO –¥–ª—è —Å—Ç–∞–Ω–¥–∞—Ä—Ç–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω–æ–≥–æ —Å–±–æ—Ä–∞ –¥–∞–Ω–Ω—ã—Ö. üöÄ–ú–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Å—Ç–∞—Ä—Ç–∞–ø–æ–≤, –∫–æ—Ç–æ—Ä—ã–º –Ω—É–∂–µ–Ω –≤—Å—Ç—Ä–æ–µ–Ω–Ω—ã–π –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥–∞ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏. –°—Å—ã–ª–∫–∞: –î–æ–∑–∞—Ç–æ—Ä CTCAE","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance"",
  ""impact"": ""medium"",
  ""english"": ""The new tool on Dozator.io, CTCAE (Common Terminology Criteria for Adverse Events), allows doctors, researchers, and clinics to easily assess side effects of treatments using the international CTCAE scale. This standardization provides a unified terminology for describing adverse events in clinical practice and research.""
}"
2025-09-10T08:41:02+00:00,@pharm_icon,2362,https://t.me/pharm_icon/2362,"–û–±—â–∞–π—Å—è, –∫–∞–∫ –ú–∏–Ω–∏—Å—Ç—ç—Ä –°–ª—É—á–∏–ª–∞—Å—å –∑–∞–±–∞–≤–Ω–∞—è –≤–µ—â—å ‚Äî –º–∏–Ω–∏—Å—Ç—Ä –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –†–§ –ú–∏—Ö–∞–∏–ª –ú—É—Ä–∞—à–∫–æ –ø—Ä–∏–∑–≤–∞–ª –±—É–¥—É—â–∏—Ö –≤—Ä–∞—á–µ–π —É—á–∏—Ç—å—Å—è —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ —Ä–∞—Å–ø–æ—Ä—è–∂–∞—Ç—å—Å—è –≤—Ä–µ–º–µ–Ω–µ–º –∏ —Ä–∞–∑–≤–∏–≤–∞—Ç—å —ç–º–æ—Ü–∏–æ–Ω–∞–ª—å–Ω—ã–π –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç. –í—Å—ë —ç—Ç–æ –Ω–∞–≤–æ–¥–∏—Ç –Ω–∞ –º—ã—Å–ª—å, —á—Ç–æ –æ–Ω –∫—É–ø–∏–ª –∫–∞–∫–æ–π-—Ç–æ –∫—É—Ä—Å —Å —Ä–∞—Å–ø—Ä–æ–¥–∞–∂–∏ —Ç–∞–∫–∏—Ö –ø–ª–∞—Ç—Ñ–æ—Ä–º, –∫–∞–∫ Skillbox –∏–ª–∏ –Ø–Ω–¥–µ–∫—Å –ü—Ä–∞–∫—Ç–∏–∫—É–º–∞, –∏ —Å—Ä–∞–∑—É –Ω–∞—á–∞–ª –≤–µ—â–∞—Ç—å. –°–º–æ—Ç—Ä–∏—Ç–µ —Å–∞–º–∏. –í–æ –≤—Ä–µ–º—è –ª–µ–∫—Ü–∏–∏ –¥–ª—è –ø–µ—Ä–≤–æ–∫—É—Ä—Å–Ω–∏–∫–æ–≤ –∏ —Å—Ç—É–¥–µ–Ω—Ç–æ–≤ –õ–∏–ø–µ—Ü–∫–æ–≥–æ —Ñ–∏–ª–∏–∞–ª–∞ –†–£–ú –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –æ–Ω –æ—Ç–º–µ—Ç–∏–ª, —á—Ç–æ –≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø—Ä–æ—Ñ–µ—Å—Å–∏–∏ –Ω–µ–≤–æ–∑–º–æ–∂–Ω–æ –æ–±–æ–π—Ç–∏—Å—å –±–µ–∑ —ç–º–ø–∞—Ç–∏–∏ –∏ —Å—Ç—Ä–µ—Å—Å–æ—É—Å—Ç–æ–π—á–∏–≤–æ—Å—Ç–∏. ¬´–ù–µ–æ–±—Ö–æ–¥–∏–º–æ –æ–≤–ª–∞–¥–µ—Ç—å –Ω–∞–≤—ã–∫–∞–º–∏ —Ç–∞–π–º-–º–µ–Ω–µ–¥–∂–º–µ–Ω—Ç–∞, —É–º–µ—Ç—å —Å–ø—Ä–∞–≤–ª—è—Ç—å—Å—è —Å–æ —Å—Ç—Ä–µ—Å—Å–æ–º, —Ä–∞–∑–≤–∏–≤–∞—Ç—å —ç–º–æ—Ü–∏–æ–Ω–∞–ª—å–Ω—ã–π –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç –∏ —ç–º–ø–∞—Ç–∏—é. –í—Ä–∞—á –¥–æ–ª–∂–µ–Ω –≥—Ä–∞–º–æ—Ç–Ω–æ –æ–±—â–∞—Ç—å—Å—è —Å –∫–æ–ª–ª–µ–≥–∞–º–∏ –∏ –ø—Ä–∏ —ç—Ç–æ–º –≥–ª—É–±–æ–∫–æ –∑–Ω–∞—Ç—å –æ—Å–Ω–æ–≤—ã –º–µ–¥–∏—Ü–∏–Ω—ã¬ª, ‚Äî –ø–æ–¥—á–µ—Ä–∫–Ω—É–ª –ú—É—Ä–∞—à–∫–æ. –¢–∞–∫ –∏ —Ö–æ—á–µ—Ç—Å—è –¥–æ–±–∞–≤–∏—Ç—å –∫ —Ü–∏—Ç–∞—Ç–µ ¬´–í–æ–∑—å–º–∏—Ç–µ –∫—Ä–µ–¥–∏—Ç –Ω–∞ –º–æ–∏ –∫—É—Ä—Å—ã –ø–æ —ç–º–æ—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–º—É –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç—É. –ö—É—Ä—Å –±—É–¥–µ—Ç –Ω–∞–∑—ã–≤–∞—Ç—å—Å—è ¬´–û–±—â–∞–π—Å—è, –∫–∞–∫ –ú–∏–Ω–∏—Å—Ç—ç—Ä¬ª –ü–æ—à–ª–∏ –±—ã –Ω–∞ –∫—É—Ä—Å –ú–∏—Ö–∞–∏–ª–∞ –ê–ª—å–±–µ—Ä—Ç–æ–≤–∏—á–∞? üî• ‚Äî –∫–æ–Ω–µ—á–Ω–æ üòÅ ‚Äî –Ω–µ—Ç","{""skip"": true}"
2025-09-09T16:47:04+00:00,@pharm_icon,2361,https://t.me/pharm_icon/2361,"üíä –í–µ–¥—É—â–∏–µ Telegram-–∫–∞–Ω–∞–ª—ã, –∫–æ—Ç–æ—Ä—ã–µ –∑–∞–¥–∞—é—Ç –ø–æ–≤–µ—Å—Ç–∫—É –≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π —Å—Ñ–µ—Ä–µ ‚Äî –ê–í–ì–£–°–¢ 2025. –†–µ–π—Ç–∏–Ω–≥ —Å–æ—Å—Ç–∞–≤–∏–ª –∫–ª—é—á–µ–≤–æ–π –∫–∞–Ω–∞–ª-–∞–≥—Ä–µ–≥–∞—Ç–æ—Ä –º–µ–¥–ø–æ–≤–µ—Å—Ç–∫–∏ –≤ Telegram ‚Äî ¬´–ú—É—Ä–∞—à–∫–æ –ø–æ –∫–æ–∂–µ¬ª (@murashko_med) –Ω–∞ –æ—Å–Ω–æ–≤–µ –¥–∞–Ω–Ω—ã—Ö üìä TGSTAT.ru –ø—Ä–∏ —ç–∫—Å–ø–µ—Ä—Ç–Ω–æ–π –ø–æ–¥–¥–µ—Ä–∂–∫–µ ¬´–ú–µ–¥–∏–∞—Ç–µ—Ö–Ω–æ–ª–æ–≥–∞¬ª (@mediatech). –ö–∞—á–µ—Å—Ç–≤–µ–Ω–Ω–∞—è –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è –∏ —Ä–∞–∑–Ω—ã–µ —Ç–æ—á–∫–∏ –∑—Ä–µ–Ω–∏—è, —Å–æ–±—Ä–∞–Ω–Ω—ã–µ –≤ –æ–¥–Ω–æ–º –º–µ—Å—Ç–µ: —á–∏—Ç–∞–π—Ç–µ —Ç–µ—Ö, –∫—Ç–æ —Ñ–æ—Ä–º–∏—Ä—É–µ—Ç –Ω–æ–≤–æ—Å—Ç–Ω—É—é –ª–µ–Ω—Ç—É –≤ –∏–Ω–¥—É—Å—Ç—Ä–∏–∏ ‚Äî –∏ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ –ø–æ–¥–ø–∏—Å—ã–≤–∞–π—Ç–µ—Å—å –Ω–∞ –Ω–∞—Å: @murashko_med. –¢–û–ü-25 ‚Äî –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –Ω–æ–≤–æ—Å—Ç–∏, –±–ª–æ–≥–∏ –≤—Ä–∞—á–µ–π –∏ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –∏–∑ —Ä–∞–∑–Ω—ã—Ö —Å—Ñ–µ—Ä: 1. –ë–∞–¥–º–∞ –ë–∞—à–∞–Ω–∫–∞–µ–≤ ‚Äî –ò–¶: 453; 2. –ù–µ–ú–∏–Ω–∑–¥—Ä–∞–≤ ‚Äî –ò–¶: 381; 3. –ò–ú–ú–£–ù–ù–´–ô –û–¢–í–ï–¢ ‚Äî –ò–¶: 364; 4. –ì–æ–ª–æ–¥, —Ö–æ–ª–æ–¥ –∏ –ø–æ–∫–æ–π; 5. –î–º–∏—Ç—Ä–∏–π –•—É–±–µ–∑–æ–≤; 6. –ü–æ—è—Å–Ω–∏ –∑–∞ –º–µ–¥; 7. –°–µ—Ä–≥–µ–π –õ–µ–æ–Ω–æ–≤; 8. –ú–µ–¥–∞—á; 9. Medical –ö—Å—é; 10. –¶–ù–ò–ò–û–ò–ó; 11. –ö–û–ë–Ø–ö–û–í–ê; 12. –ò–∫–æ–Ω–∞ –§–∞—Ä–º—ã; 13. –ú–µ–¥–∫–∞–¥—Ä—ã; 14. –ú–∏–Ω–ó–¥—Ä–∞–≤ –î–µ—Ç–∏; 15. –Æ—Ä–∏—Å—Ç –¥–ª—è –≤—Ä–∞—á–∞ –ê–Ω–≥–µ–ª–∏–Ω–∞ –†–æ–º–∞–Ω–æ–≤—Å–∫–∞—è; 16. –ú–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–π —é—Ä–∏—Å—Ç –ò–≤–∞–Ω –ü–µ—á–µ—Ä–µ–π; 17. –ü—Ä–∞–≤–æ –Ω–∞ –∑–¥–æ—Ä–æ–≤—å–µ; 18. –°–æ–æ–±—â–µ—Å—Ç–≤–æ ¬´–í—Ä–∞—á–∏ –†–§¬ª; 19. –õ–µ–æ–Ω–∏–¥ –û–≥—É–ª—å; 20. –í–ª–∞—Å–æ–≤–∞ –í–µ—Ä–æ–Ω–∏–∫–∞; 21. –ê–π—Ä–∞—Ç –§–∞—Ä—Ä–∞—Ö–æ–≤; 22. –Æ–†–ò–°–¢–´ –ó–ê –í–†–ê–ß–ï–ô; 23. –ú–∏—Ö–∞–∏–ª –ö–∏–∑–µ–µ–≤; 24. –ú–µ–¥–¢–µ—Ö –õ–∞–±–æ—Ä–∞—Ç–æ—Ä–∏—è; 25. –í–∞—Ä–∏–≤–æ–¥–∞ MED&TECH. –ù–µ —Ç–æ–ª—å–∫–æ –æ –º–µ–¥–∏—Ü–∏–Ω–µ, –Ω–æ –≤–∞–∂–Ω–æ –¥–ª—è –≤–Ω–∏–º–∞–Ω–∏—è: 1. REDACTED P6 (–ö–û–¢–Å–õ #6) ‚Äî 894,9–∫; 2. –ú–æ—Å–∫–æ–≤—Å–∫–∞—è –ø—Ä–∞—á–µ—á–Ω–∞—è ‚Äî 625,5–∫; 3. Lomovka ‚Äî 302,9–∫; 4. –ù–û–°; 5. –ë–æ–π–ª–µ—Ä–Ω–∞—è; 6. –ë—É–ª—å–¥–æ–≥–∏ –ø–æ–¥ –∫–æ–≤—Ä–æ–º; 7. –ö—Ä–µ–º–ª—ë–≤—Å–∫–∏–π –º–∞–º–∫–æ–≤–µ–¥; 8. –ü–∞—É–∫–∏ –≤ –±–∞–Ω–∫–µ; 9. –ö–ê–†–ù–ê–£–•–û–í; 10. –ù–æ–≤–æ—Å—Ç–∏ —Å–µ–≥–æ–¥–Ω—è; 11. –ó–æ–Ω–∞ –æ—Å–æ–±–æ–≥–æ –≤–Ω–∏–º–∞–Ω–∏—è; 12. –ú–µ–¥–∏–∞—Ç–µ—Ö–Ω–æ–ª–æ–≥; 13. –î–µ–ø—É—Ç–∞—Ç—Å–∫–∏–µ –±—É–¥–Ω–∏; 14. –ö–†–´–ú–ò–ù–§–û–†–£–ú; 15. –ù–µ—É–¥–∞—â–∞. –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏ ‚Äî —Ä–µ–≥–∏–æ–Ω—ã: 1. –ú–æ—Å–∫–≤–∞ (@dzdmos) ‚Äî 109–∫; 2. –ú–æ—Å–∫–æ–≤—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å (@minzdravmosreg) ‚Äî 18,1–∫; 3. –†–µ—Å–ø—É–±–ª–∏–∫–∞ –ö–∞–±–∞—Ä–¥–∏–Ω–æ-–ë–∞–ª–∫–∞—Ä–∏—è (@medicinakbr)‚Äî 13,1–∫; 4. –î–ù–† (@mzdnr_official); 5. –°–≤–µ—Ä–¥–ª–æ–≤—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å (@minzdravso); 6. –î–∞–≥–µ—Å—Ç–∞–Ω (@minzdravrd); 7. –°–∞–º–∞—Ä—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å (@minzdrav63region); 8. –ü—Ä–∏–º–æ—Ä—Å–∫–∏–π –∫—Ä–∞–π (@minzdravpk); 9. –í–æ—Ä–æ–Ω–µ–∂—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å (@dzvo36); 10. –°–∞—Ä–∞—Ç–æ–≤—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å (@minzdrav_saratov). –ù–µ –Ω–∞—à–ª–∏ –∫–∞–Ω–∞–ª, –∫–æ—Ç–æ—Ä—ã–π —á–∏—Ç–∞–µ—Ç–µ? –í–æ–ø—Ä–æ—Å—ã –∏ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è ‚Äî –≤ @mursvyz_bot. üöë –ü–æ–¥–ø–∏—Å—ã–≤–∞–π—Ç–µ—Å—å –Ω–∞ @murashko_med.","{""skip"": true}"
2025-09-09T13:16:45+00:00,@pharm_icon,2359,https://t.me/pharm_icon/2359,"–ü–æ–ª–∏–ø—Ä–∞–≥–º–∞–æ—Å—Ç–∏–≥–æ—Å–ø–æ–¥–∏: —Å–ª—É—á–∞–π –ø–æ—Ä–∞–∂–µ–Ω–∏—è —Ç—Ä–∞–Ω—Å–ø–ª–∞–Ω—Ç–∏—Ä–æ–≤–∞–Ω–Ω–æ–π –ø–µ—á–µ–Ω–∏ –∞–Ω–∞–±–æ–ª–∏–∫–æ–º –∏ —Ä–∞—Å—Ç–∏—Ç–µ–ª—å–Ω—ã–º –ë–ê–î–æ–º –ï—Å—Ç—å 2 —Ç–∏–ø–∞ –∏–Ω—Ç–µ—Ä–µ—Å–Ω—ã—Ö –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Å–ª—É—á–∞–µ–≤: —Å–ª–æ–∂–Ω—ã–µ –∏ —Å–ª–æ–∂–Ω—ã–µ+—Ç—Ä—ç—à. –î–∞–Ω–Ω—ã–π —Å–ª—É—á–∞–π –æ—Ç–Ω–æ—Å–∏—Ç—Å—è –∫ –ø–æ—Å–ª–µ–¥–Ω–µ–π –≤–µ—Ä—Å–∏–∏, –ø–æ—Ç–æ–º—É —á—Ç–æ —Ç—É—Ç —Å—Ä–æ—Å–ª–æ—Å—å –≤—Å—ë: –∏ —Ç—Ä–∞–Ω—Å–ø–ª–∞–Ω—Ç–∞—Ç, –∏ –ë–ê–î—ã, –∏ –∞–Ω–∞–±–æ–ª–∏–∫–∏, –∏ –ò—Ä–∞–Ω. –ö–∞—Ä—Ç–∏–Ω–∞: –í –º–∞—Ä—Ç–µ 2024 –≥–æ–¥–∞ 37-–ª–µ—Ç–Ω–∏–π –º—É–∂—á–∏–Ω–∞ —Å –±–æ–ª–µ–∑–Ω—å—é –í–∏–ª—å—Å–æ–Ω–∞-–ö–æ–Ω–æ–≤–∞–ª–æ–≤–∞ –∏ –∞–ª–ª–æ—Ç—Ä–∞–Ω—Å–ø–ª–∞–Ω—Ç–∞—Ü–∏–µ–π –ø–µ—á–µ–Ω–∏ –æ—Ç –ø–æ–≥–∏–±—à–µ–≥–æ –≤ –î–¢–ü –º—É–∂—á–∏–Ω—ã (7 –ª–µ—Ç –Ω–∞–∑–∞–¥) –ø–æ—Å—Ç—É–ø–∏–ª –≤ –æ–¥–Ω—É –∏–∑ –∫–ª–∏–Ω–∏–∫ –¢–µ–≥–µ—Ä–∞–Ω–∞ –¥–ª—è –∫–æ–Ω—Å—É–ª—å—Ç–∏—Ä–æ–≤–∞–Ω–∏—è –∫–∞—Å–∞—Ç–µ–ª—å–Ω–æ —Ñ–∞—Ä–º–∞–∫–æ—Ç–µ—Ä–∞–ø–∏–∏, –≥–¥–µ —Å–ø—É—Å—Ç—è –ø–∞—Ä—É –º–∏–Ω—É—Ç –æ–±—â–µ–Ω–∏—è –∑–∞—è–≤–∏–ª —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ–º—É –∫–ª–∏–Ω—Ñ–∞—Ä–º–∞–∫–æ–ª–æ–≥—É, —á—Ç–æ —É–∂–µ –ø–æ–ª–≥–æ–¥–∞ –∫–∞–∫ –ø—Ä–∏–Ω–∏–º–∞–µ—Ç –±–∞–≥–∞–∂ –ë–ê–î–æ–≤, –∞ —Ç–∞–∫–∂–µ –ø—Ä–æ–≤–æ–¥–∏—Ç –∏–Ω—ä–µ–∫—Ü–∏–∏ –∞–Ω–∞–±–æ–ª–∏–∫–∞ –Ω–∞–Ω–¥—Ä–æ–ª–æ–Ω–∞ –¥–µ–∫–∞–Ω–æ–∞—Ç–∞ –∏ –≤–∏—Ç–∞–º–∏–Ω–æ–≤ –≥—Ä—É–ø–ø—ã –í. –†–∞–Ω–µ–µ, –æ–Ω —É–º–æ–ª—á–∞–ª –æ–± —ç—Ç–æ–º —Ñ–∞–∫—Ç–µ –≤–æ –≤—Ä–µ–º—è –≥–æ—Å–ø–∏—Ç–∞–ª–∏–∑–∞—Ü–∏–∏ (–¥–µ–∫–∞–±—Ä–µ 2023) –∏–∑-–∑–∞ —Ä–µ–∞–∫—Ü–∏–∏ –æ—Ç—Ç–æ—Ä–∂–µ–Ω–∏—è —Ç—Ä–∞–Ω—Å–ø–ª–∞–Ω—Ç–∞—Ç–∞, –≤—ã–∑–≤–∞–Ω–Ω–æ–π, –ø—Ä–µ–¥–ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω–æ, –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç–æ–∑–Ω—ã–º –ø–æ–≤—Ä–µ–∂–¥–µ–Ω–∏–µ–º –ø–µ—á–µ–Ω–∏. –ù–∞ –º–æ–º–µ–Ω—Ç –∫–æ–Ω—Å—É–ª—å—Ç–∞—Ü–∏–∏ –±—ã–ª–æ –∏–∑–≤–µ—Å—Ç–Ω–æ –æ –ø—Ä–∏–µ–º–µ –ø–∞—Ü–∏–µ–Ω—Ç–æ–º —Å–ª–µ–¥—É—é—â–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤: –¶–∏–∫–ª–æ—Å–ø–æ—Ä–∏–Ω - 150 –º–≥ 2—Ä/–¥ –ú–∏–∫–æ—Ñ–µ–Ω–æ–ª–∞—Ç–∞ –º–æ—Ñ–µ—Ç–∏–ª - 1000 –º–≥ 2—Ä/–¥ (–ø–æ–≤—ã—à–µ–Ω—ã –ø–æ—Å–ª–µ –æ—Ç—Ç–æ—Ä–∂–µ–Ω–∏—è –≤ –¥–µ–∫–∞–±—Ä–µ 2023) –ê–º–∏—Ç—Ä–∏–ø—Ç–∏–ª–∏–Ω - 60 –º–≥/—Å—É—Ç –§–ª—É–æ–∫—Å–µ—Ç–∏–Ω - 40 –º–≥/—Å—É—Ç –û–∫—Å–∞–∑–µ–ø–∞–º - 30 –º–≥/ —Å—É—Ç (–æ–±—â–∏–π —Å—Ä–æ–∫ –ø—Ä–∏–µ–º–∞ –ø—Å–∏—Ö–æ—Ñ–∞—Ä–º—ã - 5 –ª–µ—Ç) –û –ø—Ä–∏–µ–º–µ —á–µ–≥–æ –ø–∞—Ü–∏–µ–Ω—Ç —Å–∫–∞–∑–∞–ª —Ç–æ–ª—å–∫–æ —á–µ—Ä–µ–∑ –Ω–µ—Å–∫–æ–ª—å–∫–æ –º–∏–Ω—É—Ç: –ù–∞–Ω–¥—Ä–æ–ª–æ–Ω –¥–µ–∫–∞–Ω–æ–∞—Ç - 25 –º–≥ 2—Ä/–º–µ—Å 6 –ë–ê–î–æ–≤, —Å—Ä–µ–¥–∏ –Ω–∏—Ö –≤–∏—Ç–∞–º–∏–Ω–Ω–æ-–º–∏–Ω–µ—Ä–∞–ª—å–Ω—ã–µ –∏ —Ä–∞—Å—Ç–∏—Ç–µ–ª—å–Ω—ã–µ –∫–æ–º–ø–ª–µ–∫—Å—ã, –≥–ª–∞–≤–Ω—ã–º –æ–±—Ä–∞–∑–æ–º –¥–ª—è –ø–æ–¥–¥–µ—Ä–∂–∞–Ω–∏—è –º—É–∂—Å–∫–æ–≥–æ –∑–¥–æ—Ä–æ–≤—å—è, —ç–Ω–µ—Ä–≥–∏–∏ –∏ –≤–æ–ª–æ—Å. –û–±—â–µ–µ —á–∏—Å–ª–æ –∫–æ–º–ø–æ–Ω–µ–Ω—Ç–æ–≤ - –ø–æ—Ä—è–¥–∫–∞ 50 —Å–æ–µ–¥–∏–Ω–µ–Ω–∏–π. –†–∞–∑—É–º–µ–µ—Ç—Å—è, –ø–∞—Ü–∏–µ–Ω—Ç –ø—Ä–∏–Ω–∏–º–∞–ª –≤ —Ç–æ–º —á–∏—Å–ª–µ –∏ —Å–æ–µ–¥–∏–Ω–µ–Ω–∏—è –º–µ–¥–∏. –ò–∑ —ç—Ç–∏—Ö –Ω–µ–∑–∞—è–≤–ª–µ–Ω–Ω—ã—Ö –≤–µ—â–µ—Å—Ç–≤: 2 –∫–æ–º–ø–æ–Ω–µ–Ω—Ç–∞ –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–æ–≤–∞–ª–∏ —Å –ø—Ä–∏–Ω–∏–º–∞–µ–º—ã–º–∏ –õ–° - –∫—É—Ä–∫—É–º–∞ –∏ –∂–µ–Ω—å—à–µ–Ω—å 9 –∫–æ–º–ø–æ–Ω–µ–Ω—Ç–æ–≤ —Å–ø–æ—Å–æ–±–Ω—ã –≤—ã–∑–≤–∞—Ç—å –≥–µ–ø–∞—Ç–æ—Ü–µ–ª–ª—é–ª—è—Ä–Ω–æ–µ –ø–æ–≤—Ä–µ–∂–¥–µ–Ω–∏–µ 2 —Å–ø–æ—Å–æ–±–Ω—ã –≤—ã–∑–≤–∞—Ç—å —Ö–æ–ª–µ—Å—Ç–∞—Ç–∏—á–µ—Å–∫—É—é —Ç—Ä–∞–≤–º—É –í–∏—Ç–∞–º–∏–Ω –ê –∏ –±–µ—Ç–∞-–∫–∞—Ä–æ—Ç–∏–Ω –º–æ–≥—É—Ç –ø—Ä–∏–≤–µ—Å—Ç–∏ –∫ —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–æ–º—É –≥–µ–ø–∞—Ç–∏—Ç—É 3 –∫–æ–º–ø–æ–Ω–µ–Ω—Ç–∞ —Å–≤—è–∑–∞–Ω—ã —Å —Ä–∏—Å–∫–æ–º —Ü–∏—Ä—Ä–æ–∑–∞ –ù–∞–Ω–¥—Ä–æ–ª–æ–Ω —Å–ø–æ—Å–æ–±–µ–Ω –≤—ã–∑–≤–∞—Ç—å –∞–¥–µ–Ω–æ–º—É –ø–µ—á–µ–Ω–∏, –∞ —Ç–∞–∫–∂–µ –ø–µ–ª–∏–æ–∑–Ω—ã–π –≥–µ–ø–∞—Ç–∏—Ç –ù–∞ —É–¥–∏–≤–ª–µ–Ω–∏–µ, –≤—Å–µ–≥–æ 6 –∫–æ–º–ø–æ–Ω–µ–Ω—Ç–æ–≤ –º–æ–≥—É—Ç —Å—Ç–∞—Ç—å –ø—Ä–∏—á–∏–Ω–æ–π —Ñ–∏–±—Ä–æ–∑–∞ –∏ –Ω–µ–∫—Ä–æ–∑–∞ –ø–µ—á–µ–Ω–∏ –ß—Ç–æ –±—ã–ª–æ –¥–∞–ª—å—à–µ? –û—Å–Ω–æ–≤–Ω—ã–º —Ñ–∞–∫—Ç–æ—Ä–æ–º –ø–æ—Ä–∞–∂–µ–Ω–∏—è –ø–µ—á–µ–Ω–∏ –ø–æ –∞–ª–≥–æ—Ä–∏—Ç–º—É RUCAM –±—ã–ª –ø—Ä–∏–∑–Ω–∞–Ω –Ω–∞–Ω–¥—Ä–æ–ª–æ–Ω –≤ –¥–æ–∑–µ 50 –º–≥/—Å—É—Ç. –ö–∞–∫ –æ—Ç—Å–µ—è–ª–∏ –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω—ã—Ö –≤–∏–Ω–æ–≤–Ω–∏–∫–æ–≤? –£—á–ª–∏ —á–∞—Å—Ç–æ—Ç—É –ë–ê–î–æ–≤ –∫–∞–∫ –≤–∏–Ω–æ–≤–Ω–∏–∫–æ–≤ - 20%, –ø–æ—Å–º–æ—Ç—Ä–µ–ª–∏ –Ω–∞ –ø—Ä–µ–≤—ã—à–µ–Ω–∏–µ –Ω–æ—Ä–º –º–∏–Ω–µ—Ä–∞–ª–æ–≤ (–∂–µ–ª–µ–∑–æ, —Ü–∏–Ω–∫, –º–∞—Ä–≥–∞–Ω–µ—Ü, –º–µ–¥—å, —Å–µ–ª–µ–Ω –∏ —Ö—Ä–æ–º), —Ä–∞—Å—Ç–∏—Ç–µ–ª—å–Ω—ã–µ –∫–æ–º–ø–æ–Ω–µ–Ω—Ç—ã (–ê–ª–æ—ç, —Ö–≤–æ—â, –∫—É—Ä–∫—É–º–∞ –∏ –∂–µ–Ω—å—à–µ–Ω—å), –∞ —Ç–∞–∫–∂–µ —É—á–ª–∏ –¥–æ–∑—ã –≤–∏—Ç–∞–º–∏–Ω–∞ –ê (11000 –ï–¥/—Å—É—Ç). –ß—Ç–æ –≤ –∏—Ç–æ–≥–µ? –ü–∞—Ü–∏–µ–Ω—Ç —Å–æ–≥–ª–∞—Å–∏–ª—Å—è –ø—Ä–µ–∫—Ä–∞—Ç–∏—Ç—å –ø—Ä–∏—ë–º –Ω–∞–Ω–¥—Ä–æ–ª–æ–Ω–∞ –¥–µ–∫–∞–Ω–æ–∞—Ç–∞ –∏ –¥–æ–±–∞–≤–æ–∫. –í —Ç–µ—á–µ–Ω–∏–µ —Ç—Ä—ë—Ö–º–µ—Å—è—á–Ω–æ–≥–æ –Ω–∞–±–ª—é–¥–µ–Ω–∏—è –ø–æ—Å–ª–µ –≤–∏–∑–∏—Ç–∞ –≤ –∫–ª–∏–Ω–∏–∫—É —Ç—Ä–∞–Ω—Å–ø–ª–∞–Ω—Ç–∞—Ü–∏–æ–Ω–Ω–æ–π —Ñ–∞—Ä–º–∞–∫–æ—Ç–µ—Ä–∞–ø–∏–∏ —Å—ã–≤–æ—Ä–æ—Ç–æ—á–Ω—ã–µ –∫–æ–Ω—Ü–µ–Ω—Ç—Ä–∞—Ü–∏–∏ —Ç—Ä–∞–Ω—Å–∞–º–∏–Ω–∞–∑, —â–µ–ª–æ—á–Ω–æ–π —Ñ–æ—Å—Ñ–∞—Ç–∞–∑—ã –∏ –±–∏–ª–∏—Ä—É–±–∏–Ω–∞ –Ω–æ—Ä–º–∞–ª–∏–∑–æ–≤–∞–ª–∏—Å—å (—Å–º–æ—Ç—Ä–∏—Ç–µ —Ä–∏—Å—É–Ω–æ–∫). –ß—Ç–æ –¥—É–º–∞–µ—Ç–µ? üî• ‚Äî –∫–ª–∞—Å—Å–Ω—ã–π –∫–µ–π—Å üòÅ ‚Äî –ø–µ—á–µ–Ω—å —Å—Ç–æ–∏–ª–æ –±—ã –æ—Ç–¥–∞—Ç—å –∫–æ–º—É-—Ç–æ –¥—Ä—É–≥–æ–º—É #–∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–π_—Å–ª—É—á–∞–π","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, shortage, safety"",
  ""impact"": ""high"",
  ""english"": ""A patient with polycystic kidney disease and a transplanted liver from a deceased donor in Iran has developed severe hepatocellular injury after taking nandrolone decanoate and herbal supplements. The case highlights the importance of identifying potential drug interactions and side effects during treatment.""
}"
2025-09-04T11:47:42+00:00,@pharm_icon,2358,https://t.me/pharm_icon/2358,"–í –º–∏—Ä–µ –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤: –ø—Ä–æ—â–∞–π, –ö—Å–∞—Ä–µ–ª—Ç–æ –ü—Ä–æ—à–ª–æ —É–∂–µ –ø–æ—á—Ç–∏ 9 –º–µ—Å—è—Ü–µ–≤ (–∞ —ç—Ç–æ —Ü–µ–ª—ã–π 1 —Å—Ä–µ–¥–Ω–∏–π –ø–µ—Ä–∏–æ–¥ –æ–±–æ—Ä–æ—Ç —Å—Ä–µ–¥—Å—Ç–≤ –≤ –∞–ø—Ç–µ—á–Ω–æ–º –±–∏–∑–Ω–µ—Å–µ) —Å –∫–æ–Ω—Ü–∞ –¥–µ–π—Å—Ç–≤–∏—è –ø—Ä–∞–≤–æ–≤–æ–π –∑–∞—â–∏—Ç—ã –Ω–∞ –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã–π —Ä–∏–≤–∞—Ä–æ–∫—Å–∞–±–∞–Ω–∞, –ö—Å–∞—Ä–µ–ª—Ç–æ, –ø–µ—Ä–≤—ã–π —Ä–∞—É–Ω–¥ –Ω–∞ —Ä—ã–Ω–∫–µ –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤ –ø—Ä–æ—à–µ–ª –∏ –ø—Ä–∏—à–ª–æ –≤—Ä–µ–º—è –ø–æ—Å–º–æ—Ç—Ä–µ—Ç—å –Ω–∞ –ø–µ—Ä–≤—ã–µ –∏—Ç–æ–≥–∏, –ø—Ä–∏–∫–∏–Ω—É–≤ –ø—Ä–∏–º–µ—Ä–Ω—ã–µ —Å—Ç—Ä–∞—Ç–µ–≥–∏–∏ –∏ —Ü–µ–Ω—ã –Ω–∞ –¥–∂–µ–Ω–µ—Ä–∏–∫–∏. –ü–æ —Ü–µ–Ω–∞–º –º–æ–∂–Ω–æ –≤—ã–¥–µ–ª–∏—Ç—å –Ω–µ—Å–∫–æ–ª—å–∫–æ –∫–∞—Ç–µ–≥–æ—Ä–∏–π: 1-–∞—è –≥—Ä—É–ø–ø–∞: –ü–æ—á—Ç–∏ 2/3-3/4 –æ—Ç –ø–µ—Ä–≤–æ–Ω–∞—á–∞–ª—å–Ω–æ–π —Ü–µ–Ω—ã –Ω–∞ –ö—Å–∞—Ä–µ–ª—Ç–æ, –Ω–æ —Å –¥–∏–∫–∏–º–∏ —Å–∫–∏–¥–∫–∞–º–∏ ‚Äî –í–∏–∞—Ç—Ä–∏—Å (–∞–∫–∞ –º—ã-–Ω–µ-–§–∞–π–∑–µ—Ä) ‚Äî1000-1400 —Ä—É–±. –ø–æ—Å–ª–µ —Å–∫–∏–¥–æ–∫, –≠–ì–ò–° - —Å–∫–∏–¥–∫–∞ —Ç–æ–ª—å–∫–æ –Ω–∞ –Ω–∞–±–æ—Ä –∏–∑ 2—Ö –ø–∞—á–µ–∫, —Ü–µ–Ω–∞ 900-1200 —Ä—É–±. 2-–∞—è –≥—Ä—É–ø–ø–∞: –¶–µ–Ω–∞ –±–µ–∑ —Å–∫–∏–¥–æ–∫ –ø–æ—á—Ç–∏ –∞–Ω–∞–ª–æ–≥–∏—á–Ω–∞—è, –Ω–æ —Å–∞–º–∏ —Å–∫–∏–¥–∫–∏ –º–µ–Ω—å—à–µ ‚Äî –ì–µ–¥–µ–æ–Ω –†–∏—Ö—Ç–µ—Ä (–ø–æ—á—Ç–∏ –µ–¥–∏–Ω–∞—è —Ü–µ–Ω–∞ –≤ 1900-2000 —Ä—É–±), –≤–Ω–µ–∑–∞–ø–Ω–æ –í–µ—Ä—Ç–µ–∫—Å (1650-2400 —Ä—É–±), –ì—Ä–æ—Ç–µ–∫—Å (1800-1900 —Ä—É–±) –∏ –§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç (1700-2000 —Ä—É–±), –æ–∂–∏–¥–∞–µ–º–æ –¢–µ–≤–∞ (1500-2200 —Ä—É–±). –ü–µ—Ä–≤—ã–µ –¥–≤–µ –≥—Ä—É–ø–ø—ã –Ω–∞—Ü–µ–ª–µ–Ω—ã –Ω–∞ –∞—É–¥–∏—Ç–æ—Ä–∏—é, —Å–∫–ª–æ–Ω–Ω—É—é –≤—ã–±–∏—Ä–∞—Ç—å —Ü–µ–Ω–æ–≤—É—é –∫–∞—Ç–µ–≥–æ—Ä–∏—é –∏ —Ä–µ–ø—É—Ç–∞—Ü–∏—é –ø–æ–±–æ–ª—å—à–µ, –∞ –≤–æ—Ç –æ—Å—Ç–∞–≤—à–∏–µ—Å—è –¥–≤–µ –ª–æ–≤—è—Ç —Å–µ–≥–º–µ–Ω—Ç –≥–æ—Å–∑–∞–∫–∞–∑–∞ –∏ –±—é–¥–∂–µ—Ç–Ω—ã—Ö –≤–∞—Ä–∏–∞–Ω—Ç–æ–≤. –ò, –≤–µ—Ä–æ—è—Ç–Ω–æ, —Å–∫–∏–¥–∫–∏ –≤ –ø–µ—Ä–≤–æ–π –≥—Ä—É–ø–ø–µ —Å–æ –≤—Ä–µ–º–µ–Ω–µ–º –ø—Ä–∏–¥—É—Ç –∫–æ –≤—Ç–æ—Ä–æ–π –≥—Ä—É–ø–ø–µ –∏–ª–∏ –≤–æ–≤—Å–µ —Å–æ–π–¥—É—Ç –Ω–∞ –Ω–µ—Ç. –ó–∞–º—ã–∫–∞—é—â–∏–µ –∂–µ –ø–æ–π–º–∞—é—Ç —Å–≤–æ—é –ø—Ä–∏–±—ã–ª—å –∑–∞ —Å—á–µ—Ç –ø–æ–≤—ã—à–µ–Ω–∏—è –æ—Ö–≤–∞—Ç–∞ –±–ª–∞–≥–æ–¥–∞—Ä—è –∏–∑–Ω–∞—á–∞–ª—å–Ω–æ –¥–æ—Å—Ç—É–ø–Ω—ã–º —Ü–µ–Ω–∞–º. 3-–∞—è –≥—Ä—É–ø–ø–∞: –ê–ª–∏—É–º (1000-1400 —Ä—É–±), —Å—é–¥–∞ –∂–µ –†–µ–¥–¥–∏—Å (900-1400 —Ä—É–±), –§–∞—Ä–º–ø—Ä–æ–µ–∫—Ç (1250-1500), –§–∞—Ä–º—Å–∏–Ω—Ç–µ–∑ (1400-1700 —Ä—É–±), –ò–∑–≤–∞—Ä–∏–Ω–æ –§–∞—Ä–º (900-100 —Ä—É–±) –∏ –ø—Ç–∏—á–∫–∏ –ø–æ–º–µ–Ω—å—à–µ, –í–µ–ª—Ñ–∞—Ä–º (1100-1200 —Ä—É–±) —Å KRKA (700-850 —Ä—É–±). 4-–∞—è –≥—Ä—É–ø–ø–∞ ""–ê –º–∞—Ä–∂–∞ –æ—Ç–∫—É–¥–∞?"": –ê–∫—Ä–∏—Ö–∏–Ω –ø—Ä–æ—Å—Ç–æ —É—Å—Ç–∞–Ω–æ–≤–∏–ª–∏ –ø–æ—á—Ç–∏ –µ–¥–∏–Ω—É—é —Ü–µ–Ω—É –∑–∞ –≤—Å–µ –¥–æ–∑—ã, –≤ —Ä–∞–π–æ–Ω–µ 600-750 —Ä—É–±–ª–µ–π. –ì–¥–µ –æ–Ω–∏ –±–µ—Ä—É—Ç –¥–æ—Ö–æ–¥? –ù–µ –∑–Ω–∞–µ–º. –°–µ–≤–µ—Ä–Ω–∞—è –∑–≤–µ–∑–¥–∞ (450-800 —Ä—É–±), –∫ –≤–∞–º –≤–æ–ø—Ä–æ—Å–æ–≤ –Ω–µ –±—ã–ª–æ –∏ –Ω–µ –±—É–¥–µ—Ç –Ω–∏–∫–æ–≥–¥–∞. –°—é–¥–∞ –∂–µ –û–∑–æ–Ω (550 - 700 —Ä—É–±) –∏ –Ω–µ—Å–∫–æ–ª—å–∫–æ –¥—Ä—É–≥–∏—Ö –∫–æ–º–ø–∞–Ω–∏–π (–ù–∏–∫–∞, –õ–µ–∫–∞—Å, –ö–∞–Ω–æ–Ω –∏ –≤—Ä–æ–¥–µ –≤—Å–µ). –û—Å–Ω–æ–≤–Ω—ã–µ —Å—Ç—Ä–∞—Ç–µ–≥–∏–∏ —É–¥–µ—à–µ–≤–ª–µ–Ω–∏—è –Ω–µ –º–µ–Ω—è—é—Ç—Å—è: 0) –°—É–±—Å—Ç–∞–Ω—Ü–∏—è –¥–µ—à–µ–≤–ª–µ - –≥–ª–∞–≤–Ω—ã–º –æ–±—Ä–∞–∑–æ–º, –∏–Ω–¥–∏–π—Å–∫–∏–µ –∏ –∫–∏—Ç–∞–π—Å–∫–∏–µ 1) –°–∫–∏–¥–∫–∞ - –∞–≥–∏—Ç–∫–∞ - ‚Äú–ü–µ—Ä–≤–∞—è –¥–æ–∑–∞ –¥–∂–µ–Ω–µ—Ä–∏–∫–∞ –∑–∞ 50-60%!‚Äù - –í–∏–∞—Ç—Ä–∏—Å - –∏–Ω—Ç–µ—Ä–µ—Å–Ω–æ, –Ω–∞–¥–æ–ª–≥–æ –ª–∏? 2) –°–∫–∏–¥–∫–∞ –Ω–∞ –Ω–∞–±–æ—Ä—ã - ‚ÄúValue loyalty. Above all else.‚Äù - –≠–ì–ò–°, –ì–µ–¥–µ–æ–Ω –†–∏—Ö—Ç–µ—Ä, –§–∞—Ä–º—Å—Ç–∞–Ω–¥–∞—Ä—Ç (–¢–∞—Ä–≥–µ—Ç–Ω–æ–µ —Ä–∞–∑–º–µ—â–µ–Ω–∏–µ –Ω–∞ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –§–ü), –ê–ª–∏—É–º, –ê–∫—Ä–∏—Ö–∏–Ω, –°–µ–≤–µ—Ä–Ω–∞—è –∑–≤–µ–∑–¥–∞, –í–µ–ª—Ñ–∞—Ä–º, –§–∞—Ä–º–ø—Ä–æ–µ–∫—Ç, –ò–∑–≤–∞—Ä–∏–Ω–æ. 3) –ë–æ–ª—å—à–∏–µ –ø–∞—á–∫–∏ - –ø–æ—á—Ç–∏ –≤—Å–µ, –æ—Å—Ç–∞–ª—å–Ω—ã–µ –ø–æ–¥—Ç—è–Ω—É—Ç—Å—è. 4) –°–∞–π—Ç—ã —Å –æ–±—É—á–µ–Ω–∏–µ–º - –Ω–µ–ø–ª–æ—Ö–∞—è —Ñ–∏—à–∫–∞ –¥–ª—è –≤–ª–∞–¥–µ–ª—å—Ü–µ–≤ –æ–±—É—á–∞—é—â–∏—Ö –ø–ª–∞—Ç—Ñ–æ—Ä–º –∏–ª–∏ —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ, –ø—Ä–æ—Ñ–∏–ª—å–Ω—ã—Ö —Å–∞–π—Ç–æ–≤ ‚Äî –ì—Ä–æ—Ç–µ–∫—Å. –•–æ—Ä–æ—à–µ–µ —Ä–µ—à–µ–Ω–∏–µ –≤ –¥–æ–ª–≥–æ—Å—Ä–æ—á–Ω–æ–º –ø–ª–∞–Ω–µ. –ü—Ä–∞–≤–¥–∞, –Ω–∞—à–∏ –ø–æ–¥–ø–∏—Å—á–∏–∫–∏ –∂–∞–ª—É—é—Ç—Å—è –Ω–∞ —Ç—è–∂–µ–ª—ã–µ —Ç–µ—Å—Ç—ã –∏ –º–∞–ª—ã–µ –ø—Ä–∏–∑—ã. 5) –ù–∞—Ç–∏–≤–Ω–∞—è —Ä–µ–∫–ª–∞–º–∞ (–µ—Å–ª–∏ –Ω–µ—Ç, –Ω–µ –ø–µ—Ä–µ–∂–∏–≤–∞–π—Ç–µ —Å:) 6) –ü—Ä–∏–ª–æ–∂–µ–Ω–∏—è —Å ‚Äú–∫—ç—à–±–µ–∫–æ–º‚Äù (—á–∞—â–µ –≤—Å–µ–≥–æ –æ –Ω–∏—Ö –∑–Ω–∞—é—Ç —Ç–æ–ª—å–∫–æ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç—ã) ‚Äî –ò–∑–≤–∞—Ä–∏–Ω–æ ‚Äî –∏–Ω—Ç–µ—Ä–µ—Å–Ω–æ, –∫–∞–∫–æ–≤–æ —Å–æ–æ—Ç–Ω–æ—à–µ–Ω–∏–µ –∫–µ—à–±–µ–∫–∞ —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –∞–ø—Ç–µ—á–Ω—ã–º–∏ —Ä–∞–±–æ—Ç–Ω–∏–∫–∞–º–∏. 7) –ü—Ä–∏–≤–µ—Ç –∞–ø—Ç–µ–∫–∞–º ‚Äî —Ä–∞–±–æ—Ç–Ω–∏–∫–∏ —Å –ø–æ–ª—è, –Ω–∞–ø–∏—à–∏—Ç–µ –º–Ω–µ @pharmaicon_admin, –∏–Ω—Ç–µ—Ä–µ—Å–Ω–æ –±—ã–ª–æ –±—ã —É–∑–Ω–∞—Ç—å, –∞–∫—Ç–∏–≤–Ω–æ –ª–∏ –≤–∞—Å –ø—Ä–æ—Å–≤–µ—â–∞–ª–∏ –æ –≤–∞–∂–Ω–æ—Å—Ç–∏ –¥–æ—Å—Ç—É–ø–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –∏ –ø—Ä–∏—á–∏–Ω–∞—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–æ–≤–∞—Ç—å –∫–æ–Ω–∫—Ä–µ—Ç–Ω—ã–π –¥–∂–µ–Ω–µ—Ä–∏–∫. –ß—Ç–æ –¥—É–º–∞–µ—Ç–µ? üî• ‚Äî —ç—Ç–æ –∫—Ä—É—Ç–æ üóø ‚Äî —ç—Ç–æ –Ω–µ –∫—Ä—É—Ç–æ, –Ω–µ–≤–æ–∑–º–æ–∂–Ω–æ –∫–æ–Ω—Ç—Ä–æ–ª–∏—Ä–æ–≤–∞—Ç—å —Ç–∞–∫–æ–µ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –¥–∂–µ–Ω–µ—Ä–∏–∫–æ–≤","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders,clinical_trial,safety,pharmacovigilance,hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""A discussion on the market for generic versions of Ksareltto, a brand name drug. The message covers price categories and strategies for different segments of the market including patients, budgetary purchases, and government orders. It also mentions various companies' pricing strategies and the impact on their revenues.""
}"
2025-09-02T12:08:46+00:00,@pharm_icon,2357,https://t.me/pharm_icon/2357,"–ê—à–≤–∞–≥–∞–Ω–¥–∞ –ü—Ä–æ—Å—Ç–æ–π —è–¥ –æ—Ç—Ä–∞–≤–ª—è–µ—Ç —Ç–µ–ª–æ, —Ö–æ—Ä–æ—à–∏–π —è–¥ –æ—Ç—Ä–∞–≤–ª—è–µ—Ç –¥—É—à—É, –∞ –ª—É—á—à–∏–π –æ—Å—Ç–∞–≤–ª—è–µ—Ç –ø—Ä–∏ —ç—Ç–æ–º –≤ –∂–∏–≤—ã—Ö –∑–∞—Å—Ç–∞–≤–ª—è–µ—Ç –ø–æ–∫—É–ø–∞—Ç—å –µ–≥–æ –∏ –≥–æ—Ç–æ–≤–∏—Ç—å –æ –Ω–µ–º –æ—Ç—á–µ—Ç—ã. –ü—Ä–∏–º–µ—Ä–Ω–æ —Ç–∞–∫–∏–µ –≤—ã–≤–æ–¥—ã –º–æ–∂–Ω–æ —Å–¥–µ–ª–∞—Ç—å –∏–∑ –æ—Ç—á–µ—Ç–æ–≤ –¶–µ–Ω—Ç—Ä–∞ –§–∞—Ä–º–∞–∫–æ–Ω–∞–¥–æ–∑—Ä–∞ –ù–∏–¥–µ—Ä–ª–∞–Ω–¥–æ–≤ Lareb. –¶–µ–Ω—Ç—Ä –∏–Ω–∏—Ü–∏–∏—Ä–æ–≤–∞–ª –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥ —Ç–æ–∫—Å–∏—á–Ω–æ—Å—Ç–∏ –ë–ê–î–∞ —Å –∏–Ω–¥–∏–π—Å–∫–æ–π —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω–æ–π –ª–µ—á–µ–±–Ω–æ–π —Ç—Ä–∞–≤–æ–π –ê—à–≤–∞–≥–∞–Ω–¥–æ–π (Withania somnifera) –≤ 2023 –≥–æ–¥—É. –ü—Ä–∏–º–µ–Ω—è–µ—Ç—Å—è —ç—Ç–∞ —Ç—Ä–∞–≤–∞ –≥–ª–∞–≤–Ω—ã–º –æ–±—Ä–∞–∑–æ–º –¥–ª—è –ø–æ–¥–¥–µ—Ä–∂–∫–∏ —Ñ–∏–∑–∏—á–µ—Å–∫–æ–≥–æ –∏ –º–µ–Ω—Ç–∞–ª—å–Ω–æ–≥–æ –∑–¥–æ—Ä–æ–≤—å—è. –°–ø—É—Å—Ç—è –ø–æ—á—Ç–∏ 2 –≥–æ–¥–∞ –Ω–∞–±–ª—é–¥–µ–Ω–∏—è –±—ã–ª–æ –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–Ω–æ 8 —Å–ª—É—á–∞–µ–≤ –≥–µ–ø–∞—Ç–æ—Ç–æ–∫–∏—Å—á–Ω–æ—Å—Ç–∏ –Ω–∞ —Ñ–æ–Ω–µ –ø—Ä–∏–µ–º–∞ –ë–ê–î–æ–≤ —Å –∞—à–≤–∞–≥–∞–Ω–¥–æ–π. –ï—Å–ª–∏ –±—ã —ç—Ç–æ –±—ã–ª–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–º, —Ç–æ –≤ –ø–æ–∫–∞–∑–∞–Ω–∏—è —Å—Ç–æ–∏–ª–æ –±—ã –¥–æ–±–∞–≤–∏—Ç—å ""–ó–¥–æ—Ä–æ–≤–∞—è –ø–µ—á–µ–Ω—å"" –ú–µ—Ö–∞–Ω–∏–∑–º –∏ –ø—Ä–∏—á–∏–Ω—ã –Ω–µ–∏–∑–≤–µ—Å—Ç–Ω—ã, –∏–∑ –ø—Ä–µ–¥–ø–æ–ª–∞–≥–∞–µ–º—ã—Ö –ø—Ä–∏—á–∏–Ω: –∫–æ–º–ø–ª–µ–∫—Å–Ω—ã–π —Å–æ—Å—Ç–∞–≤, –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ –Ω–µ—É–∫–∞–∑–∞–Ω–Ω—ã—Ö –∫–æ–º–ø–æ–Ω–µ–Ω—Ç–æ–≤ –∏–ª–∏ –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç–æ–≤ (—Ç.–Ω. adulterated supplies- –ø–µ—Ä–µ–ë–ê–î—ã), –∞ —Ç–∞–∫–∂–µ –∑–∞–≥—Ä—è–∑–Ω–µ–Ω–∏–µ —Ä–∞—Å—Ç–∏—Ç–µ–ª—å–Ω–æ–≥–æ —Å—ã—Ä—å—è (–¥–ª—è –ë–ê–î —Å–∏—Ç—É–∞—Ü–∏—è –∫—É–¥–∞ –±–æ–ª–µ–µ –≤–æ–∑–º–æ–∂–Ω–∞—è). –ö –Ω–∞–∏–±–æ–ª–µ–µ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–Ω—ã–º –ø–æ–±–æ—á–Ω—ã–º —ç—Ñ—Ñ–µ–∫—Ç–∞–º –æ—Ç–Ω–æ—Å—è—Ç –ø—Ä–æ–±–ª–µ–º—ã —Å–æ —Å—Ç—É–ª–æ–º, –∞ —Ç–∞–∫–∂–µ –≥–æ–ª–æ–≤–æ–∫—Ä—É–∂–µ–Ω–∏–µ –∏ –≥–æ–ª–æ–≤–Ω–∞—è –±–æ–ª—å. –û—Ñ—Ñ—Ç–æ–ø –ò–Ω—Ç–µ—Ä–µ—Å–Ω–æ –±—ã–ª–æ –±—ã –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç—å –ø–æ–±–æ—á–Ω—ã–µ —ç—Ñ—Ñ–µ–∫—Ç—ã, —Å–∫–∞–∂–µ–º, —É —Å—Ç—É–¥–µ–Ω—Ç–∞, –ø—Ä–∏–Ω–∏–º–∞—é—â–µ–≥–æ –æ–¥–Ω–æ–≤—Ä–µ–º–µ–Ω–Ω–æ –Ω–∞—Å—Ç–æ–π–∫–∏ –ª–∏–º–æ–Ω–Ω–∏–∫–∞, —ç—Ö–∏–Ω–∞—Ü–µ–∏, –ª–µ–∑–≤–∏–∏ –∏ —Ä–æ–¥–∏–æ–ª—ã, –∑–∞–∫—É—Å—ã–≤–∞—é—â–µ–≥–æ –≤—Å–µ —ç—Ç–æ –∞—à–≤–∞–≥–∞–Ω–¥–æ–π –∏ —Ç—Ä–∏–ø—Ç–æ—Ñ–∞–Ω–æ–º. –†–∞–∑—É–º–µ–µ—Ç—Å—è, –≤—Å—ë —ç—Ç–æ –¥–µ–ª–∞–µ—Ç—Å—è –≤ –∞—Å–∞–Ω–µ –®–∞–≤–∞—Å–∞–Ω–∞. –ß—Ç–æ —Å —Ç–∞–∫–∏–º–∏ –ø—Ä–æ–∏—Å—Ö–æ–¥–∏—Ç? –û–Ω–∏ —Å—Ç–∞–Ω–æ–≤—è—Ç—Å—è –ø—Ä–æ—Ñ–µ—Å—Å–æ—Ä–∞–º–∏ –Ω–∞ –∫–∞—Ñ–µ–¥—Ä–∞—Ö –≥–æ–º–µ–æ–ø–∞—Ç–∏–∏ –∏–ª–∏ —Ñ–∞—Ä–º–∞–∫–æ–≥–Ω–æ–∑–∏–∏. –ê –Ω–∞ —Ñ–æ–Ω–µ —Å–±–ª–∏–∂–µ–Ω–∏—è —Å –ò–Ω–¥–∏–µ–π ‚Äî –µ—â—ë –∏ –ø–æ—Å–ª–æ–º-—Ç—Ä–∞–Ω—Å–ª—è—Ç–æ—Ä–æ–º –∑–Ω–∞–Ω–∏–π –∏ —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ü–µ–Ω–Ω–æ—Å—Ç–µ–π. –í –æ–±—â–µ–º, –Ω–∞–º —Ç–∞–∫–æ–≥–æ –Ω–µ –Ω–∞–¥–æ, –±–∞–Ω –Ω–∞ –ê—à–≤–∞–≥–∞–Ω–¥—É!","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance"",
  ""impact"": ""high"",
  ""english"": ""A report from the Netherlands Lareb Center on Pharmacovigilance found 8 cases of hepatotoxicity in patients taking BAs (Biological Active Substances) combined with ashwagandha, an Indian traditional medicinal herb. The exact mechanism and causes are unknown but could be related to the complex composition, unlisted components or adulterated supplies. Common side effects include digestive issues and dizziness. The message raises concerns about the safety of BAs combined with ashwagandha.""
}"
2025-09-01T13:04:28+00:00,@pharm_icon,2356,https://t.me/pharm_icon/2356,"–§–æ–∫—É—Å –ï—Å—Ç—å –ª–µ–≥–∫–∏–π —Å–ø–æ—Å–æ–± –≤—ã—á–∏—Å–ª–∏—Ç—å –∑–∞–∫–∞–∑–Ω—É—é —Ä–µ–∫–ª–∞–º–Ω—É—é –ø—É–±–ª–∏–∫–∞—Ü–∏—é –≤ –Ω–∞—É—á–Ω–æ–º –∂—É—Ä–Ω–∞–ª–µ. –ï—Å–ª–∏ –≤ –∑–∞–≥–æ–ª–æ–≤–∫–µ –µ—Å—Ç—å —Å–ª–æ–≤–æ ""—Ñ–æ–∫—É—Å"", —Ç–æ —ç—Ç–æ —Å–∫—É—á–Ω–∞—è –∑–∞–∫–∞–∑—É—Ö–∞, –≥–¥–µ –∞–≤—Ç–æ—Ä—ã —Å —Ä–∞–∑–Ω—ã—Ö —Å—Ç–æ—Ä–æ–Ω —Ä–∞—Å—Ö–≤–∞–ª–∏–≤–∞—é—Ç —Ç–æ—Ç –ø—Ä–µ–ø–∞—Ä–∞—Ç, –Ω–∞ –∫–æ—Ç–æ—Ä—ã–π —ç—Ç–æ—Ç —Ñ–æ–∫—É—Å –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω. –§–æ–∫—É—Å –Ω–∞ —Ñ–µ–Ω–æ—Ñ–∏–±—Ä–∞—Ç, —Ñ–æ–∫—É—Å –Ω–∞ –≥–∏–ø–µ—Ä—É—Ä–∏–∫–µ–º–∏—é, —Ñ–æ–∫—É—Å –Ω–∞ –≥–∏–ø–µ—Ä—Ç–æ–Ω–∏—é, —Ñ–æ–∫—É—Å –Ω–∞ –∫–æ–º–ø–ª–∞–µ–Ω—Ç–Ω–æ—Å—Ç—å. –ß—Ç–æ —É–≥–æ–¥–Ω–æ –≤–æ–∫—Ä—É–≥, –Ω–æ —Å–ª–æ–≤–æ —Ñ–æ–∫—É—Å ‚Äî –≥–ª–∞–≤–Ω—ã–π –º–∞—Ä–∫—ë—Ä —Ä–µ–∫–ª–∞–º–Ω–æ–π –∏–Ω—Ç–µ–≥—Ä–∞—Ü–∏–∏. –ù–∞–¥–æ –ø—Ä–æ–≤–µ—Ä–∏—Ç—å, —Å—Ç–∞–≤—è—Ç—Å—è –ª–∏ erid –∏ –¥—Ä—É–≥–∏–µ —Ä–µ–∫–ª–∞–º–Ω—ã–µ –º–µ—Ç–∫–∏ –≤ —Ç–∞–∫–∏—Ö –ø—É–±–ª–∏–∫–∞—Ü–∏—è—Ö, –∞ —Ç–æ –Ω–µ—Å–ø—Ä–∞–≤–µ–¥–ª–∏–≤–æ –ø–æ–ª—É—á–∞–µ—Ç—Å—è.","{""skip"": true}"
2025-09-01T08:57:25+00:00,@pharm_icon,2355,https://t.me/pharm_icon/2355,"–ê–ª–≥–æ—Ä–∏—Ç–º ALDEN –≠–∫—Å–∫–ª—é–∑–∏–≤–Ω–∞—è —à–∫–∞–ª–∞ –¥–ª—è —Ä–∞–±–æ—Ç—ã —Å —ç–ø–∏–¥–µ—Ä–º–∞–ª—å–Ω—ã–º –Ω–µ–∫—Ä–æ–ª–∏–∑–æ–º (—Å–∏–Ω–¥—Ä–æ–º –°—Ç–∏–≤–µ–Ω—Å–∞ –î–∂–æ–Ω—Å–æ–Ω–∞), –∞ –∏–º–µ–Ω–Ω–æ ‚Äî –¥–ª—è –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π –ø—Ä–∏—á–∏–Ω—ã –µ–≥–æ —Ä–∞–∑–≤–∏—Ç–∏—è. –°–¥–µ–ª–∞–Ω –Ω–∞ –±–∞–∑–µ –ø—É–±–ª–∏–∫–∞—Ü–∏–∏ Sassolas B –∏ —Å–æ–∞–≤—Ç–æ—Ä–æ–≤. –ö–∞–∫ —Ä–∞–±–æ—Ç–∞–µ—Ç? 1. –í—ã –æ—Ü–µ–Ω–∏–≤–∞–µ—Ç–µ –∫–∞–∂–¥—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç, –ø—Ä–∏–Ω–∏–º–∞–µ–º—ã–π –ø–∞—Ü–∏–µ–Ω—Ç–æ–º –ø–æ —ç—Ç–æ–π —à–∫–∞–ª–µ. 2. –í–∏–¥–∏—Ç–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç –æ—Ü–µ–Ω–∫–∏ ‚Äî –æ–±—ã—á–Ω–æ –æ—Å—Ç–∞—ë—Ç—Å—è –æ–¥–∏–Ω –ø—Ä–µ–ø–∞—Ä–∞—Ç —Å –º–∞–∫—Å–∏–º–∞–ª—å–Ω—ã–º –±–∞–ª–ª–æ–º –∏–ª–∏ –¥–≤–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ —Å –≤—ã—Å–æ–∫–∏–º –±–∞–ª–ª–æ–º. –î–ª—è —á–µ–≥–æ —ç—Ç–æ –Ω—É–∂–Ω–æ? 1. –û—Ü–µ–Ω–∫–∞ –ø—Ä–∏—á–∏–Ω–Ω–æ-—Å–ª–µ–¥—Å—Ç–≤–µ–Ω–Ω–æ–π —Å–≤—è–∑–∏ 2. –ü—Ä–∏–Ω—è—Ç–∏–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–≥–æ —Ä–µ—à–µ–Ω–∏—è (–æ—Ç–º–µ–Ω–∞/–∑–∞–º–µ–Ω–∞ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞) 3. –†–µ–ø–æ—Ä—Ç–∏—Ä–æ–≤–∞–Ω–∏–µ –ø–æ–±–æ—á–Ω–æ–π —Ä–µ–∞–∫—Ü–∏–∏ –û—Å–æ–±–æ –∏–Ω—Ç–µ—Ä–µ—Å–Ω—ã–π –º–æ–º–µ–Ω—Ç: –≤–Ω—É—Ç—Ä–∏ –µ—Å—Ç—å –≥—Ä–∞–¥–∞—Ü–∏—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, —Å–ø–æ—Å–æ–±–Ω—ã—Ö (–∏ –Ω–µ —Å–ø–æ—Å–æ–±–Ω—ã—Ö) –≤—ã–∑—ã–≤–∞—Ç—å —ç–ø–∏–¥–µ—Ä–º–∞–ª—å–Ω—ã–π –Ω–µ–∫—Ä–æ–ª–∏–∑ —Å–æ–≥–ª–∞—Å–Ω–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è–º SCAR, RegiSCAR –∏ EuroSCAR. –ü–æ–ª–Ω–æ–µ –Ω–∞–∑–≤–∞–Ω–∏–µ: Algorithm for Assessment of Drug Causality in Stevens‚ÄìJohnson Syndrome and Toxic Epidermal Necrolysis –°—Å—ã–ª–∫–∞: –ê–ª–≥–æ—Ä–∏—Ç–º ALDEN","{""skip"": true}"
2025-09-01T08:57:19+00:00,@pharm_icon,2354,https://t.me/pharm_icon/2354,–ò–Ω—Ç–µ—Ä–µ—Å–Ω–∞—è –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–∞—è —à–∫–∞–ª–∞:,"{""skip"": true}"
2025-09-01T07:13:33+00:00,@pharm_icon,2353,https://t.me/pharm_icon/2353,"–ò–∑–æ–±—Ä–µ—Ç–∞—è –¶–∏—Ç—Ä–∞–º–æ–Ω, —Ñ—Ä–µ–Ω–¥–æ: –∫–∞–∫ –ë–∞–π–µ—Ä –∑–∞—Ä–∞–±–∞—Ç—ã–≤–∞–µ—Ç –Ω–∞ –Ω–æ—Å—Ç–∞–ª—å–≥–∏–∏ –ò—Å–ø—ã—Ç–∞–≤ –º–æ—â–Ω–µ–π—à—É—é –Ω–æ—Å—Ç–∞–ª—å–≥–∏—é –ø–æ —É–ø—É—â–µ–Ω–Ω–æ–π –ø—Ä–∏–±—ã–ª–∏, –∫–æ–º–ø–∞–Ω–∏—è –ë–∞–π–µ—Ä –≤—Å–ø–æ–º–Ω–∏–ª–∞, —á—Ç–æ –ª–∞—Ç–∏–Ω–æ–∞–º–µ—Ä–∏–∫–∞–Ω—Ü—ã –æ—á–µ–Ω—å –ª—é–±–∏–ª–∏ –∫–æ–º–±–∏–Ω–∞—Ü–∏—é –∞—Ü–µ—Ç–∏–ª—Å–∞–ª–∏—Ü–∏–ª–æ–≤–æ–π –∫–∏—Å–ª–æ—Ç—ã. –ü–æ—ç—Ç–æ–º—É –ë–∞–π–µ—Ä –ø—Ä–æ—Å—Ç–æ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª–∏ –Ω–∞ —Ä—ã–Ω–∫–µ –°–®–ê –±—Ä–µ–Ω–¥ Heroina Aspirina –∏ Aspirina Cafeina (—Å–µ–≥–æ–¥–Ω—è –¥–µ–Ω—å —Ç–∞–∫–æ–π, –Ω–µ –æ–±–µ—Å—Å—É–¥—å—Ç–µ, –¥–∞ –∏ –Ω–µ–π–º–∏–Ω–≥ –Ω–∏—á–µ–≥–æ), –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã 500 –º–≥ –ê–°–ö –∏ –ê–°–ö —Å –∫–æ—Ñ–µ–∏–Ω–æ–º, 500 –º–≥ +32.5 –º–≥. –ü–æ—á–µ–º—É –ª–∞—Ç–∏–Ω—Å–∫–æ–µ –Ω–∞–∑–≤–∞–Ω–∏–µ? –ü–æ—Ç–æ–º—É —á—Ç–æ –≤ –ú–µ–∫—Å–∏–∫–µ (–¥–∞, –æ–Ω–∏ —Ç–æ–∂–µ –ª–∞—Ç–∏–Ω–æ–∞–º–µ—Ä–∏–∫–∞–Ω—Ü—ã) –æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–µ –∑–Ω–∞—é—Ç –±–æ–ª–µ–µ 99% –Ω–∞—Å–µ–ª–µ–Ω–∏—è –∏ 2/3 –ø—Ä–∏–º–µ–Ω—è—é—Ç –µ–≥–æ —Ä–µ–≥—É–ª—è—Ä–Ω–æ. ‚Äî –ß—Ç–æ –≤—ã –ø–æ–º–Ω–∏—Ç–µ –æ –≤–∞—à–µ–π –±–∞–±—É—à–∫–µ? ‚Äî –û–Ω–∞ –ª—é–±–∏–ª–∞ —Ç–µ–∫–∏–ª—É, —Ç–∞–∫–æ—Å –∏ –∞—Å–ø–∏—Ä–∏–Ω. –°—Å—ã–ª–∞—è—Å—å –Ω–∞ –ø–∞—Ü–∏–µ–Ω—Ç–æ—Ü–µ–Ω—Ç—Ä–∏—á–Ω–æ—Å—Ç—å –∏ –∂–µ–ª–∞–Ω–∏–µ –≤–æ—Å—Å–æ–∑–¥–∞—Ç—å –æ—â—É—â–µ–Ω–∏–µ –¥–æ–º–∞, –∞ —Ç–∞–∫–∂–µ –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç–∏ –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç–æ–≤ (–∫–∞–∫ –ø—Ä–∏–∑–Ω–∞—Ç—å, —á—Ç–æ –¶–ê ‚Äî —á–∞—Å—Ç–∏—á–Ω–æ –Ω–µ–ª–µ–≥–∞–ª—å–Ω—ã–µ –º–∏–≥—Ä–∞–Ω—Ç—ã –∏ –ø—Ä–æ—Å—Ç–æ —Ç—è–Ω—É—â–∏–µ –Ω–µ–ø—Ä–æ—Å—Ç—É—é –ª—è–º–∫—É, –Ω–µ –ø—Ä–∏–∑–Ω–∞–≤–∞—è —ç—Ç–æ–≥–æ), –∫–æ–º–ø–∞–Ω–∏—è –ø—Ä–æ–≤–µ–ª–∞ –æ–±—à–∏—Ä–Ω—ã–µ —Ä–µ–∫–ª–∞–º–Ω—ã–µ –∫–æ–º–ø–∞–Ω–∏–∏ –Ω–∞ –∏—Å–ø–∞–Ω—Å–∫–æ–º. –û—Å—Ç–∞–µ—Ç—Å—è –ø–æ—Ö–≤–∞–ª–∏—Ç—å –ë–∞–π–µ—Ä –∑–∞ 3 –≤–µ—â–∏; üí°–ê–¥–∞–ø—Ç–∏–≤–Ω–æ—Å—Ç—å –ø–æ–¥ —Ä—ã–Ω–æ–∫: —Ü–µ–Ω–∞ –∑–∞ 50 —Ç–∞–±–ª–µ—Ç–æ–∫ –æ–±—ã—á–Ω–æ–π –ê—Å–ø–∏—Ä–∏–Ω—ã –≤ 7 –±–∞–∫—Å–æ–≤ –≥–æ–≤–æ—Ä–∏—Ç –æ –ø—É–±–ª–∏—á–Ω–æ–º —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–∏ —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω—ã–º —Ü–µ–Ω–Ω–æ—Å—Ç—è–º üí°–ö–∞—á–µ—Å—Ç–≤–µ–Ω–Ω—É—é —Ä–∞–±–æ—Ç—É —Å –±—Ä–µ–Ω–¥–æ–º: —É–ø–∞–∫–æ–≤–∫–∞ –Ω–∞ –∞–Ω–≥–ª–∏–π—Å–∫–æ–º –∏ –∏—Å–ø–∞–Ω—Å–∫–æ–º —è–∑—ã–∫–∞—Ö, —Å–∞–ª—å—Å–∞ ‚Äî —á–µ—Ç–∫–æ—Å—Ç—å –ø–æ–Ω–∏–º–∞–Ω–∏—è –¶–ê üí°–ù–∞—Ñ—Ç–∞–ª–∏–Ω, –∫–æ—Ç–æ—Ä—ã–π –∑–∞—Ä–∞–±–æ—Ç–∞–µ—Ç: —Ä–µ–º–æ–Ω–µ—Ç–∏–∑–∞—Ü–∏—è –∫–æ—Ä–æ–ª—è –ù–ü–í–° –∑–≤—É—á–∏—Ç —Å–≤–µ–∂–æ –ß—Ç–æ –∂–µ, —Ç–µ–ø–µ—Ä—å –ë–∞–π–µ—Ä –±—É–¥–µ—Ç –≤—ã–∫–∞—á–∏–≤–∞—Ç—å –ø–æ—Ç–µ—Ä—è–Ω–Ω—É—é –∑–∞ 50 –ª–µ—Ç –∑–∞–ø–∞–¥–Ω—ã—Ö –ø—Ä–∞–≤ –Ω–∞ –ê—Å–ø–∏—Ä–∏–Ω –ø—Ä–∏–±—ã–ª—å —Å –∞–º–µ—Ä–∏–∫–∞–Ω—Ü–µ–≤ –∏ –ª–∞—Ç–∏–Ω–æ—Å–æ–≤. –ü—Ä–µ–¥–ª–∞–≥–∞—é –¥–æ–±–∞–≤–∏—Ç—å –∏–º –≤ —Å–æ—Å—Ç–∞–≤ –ø–∞—Ä–∞—Ü–µ—Ç–∞–º–æ–ª –∏ –ø—Ä–æ–¥–∞–≤–∞—Ç—å—Å—è –Ω–∞ –ë—Ä–∞–π—Ç–æ–Ω-–ë–∏—á –ø–æ–¥ –±—Ä–µ–Ω–¥–æ–º –¶–∏—Ç—Ä–∞–º–æ–Ω P, –∞ –≤ –∫–∞—á–µ—Å—Ç–≤–µ –∞–º–±–∞—Å—Å–∞–¥–æ—Ä–∞ –ø—Ä–∏–≤–ª–µ—á—å –í–∏–∫—Ç–æ—Ä–∞ –ü–µ–ª–µ–≤–∏–Ω–∞. ""–¶–∏—Ç—Ä–∞–º–æ–Ω P –¥–ª—è Generation P. –ú–µ–Ω—è—é—Ç—Å—è —Ç–æ–ª—å–∫–æ —Å–ª–æ–≤–∞? –ò–Ω–æ–≥–¥–∞ —Ö–≤–∞—Ç–∞–µ—Ç –∏ –±—É–∫–≤—ã"" üî• ‚Äî –∞—Å–ø–∏—Ä–∏–Ω–∞ –µ—Å—Ç—å –≤–µ—á–Ω–æ—Å—Ç—å üóø ‚Äî —Ö–º","{""skip"": true}"
2025-08-29T15:20:03+00:00,@pharm_icon,2352,https://t.me/pharm_icon/2352,"–ì–æ—Ç–æ–≤–∏–º—Å—è –∫ –æ—Å–µ–Ω–∏ –°–∞–º—ã–µ –∫—Ä—É–ø–Ω—ã–µ —Ñ–∞—Ä–º-–ú–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å—ã –≥–æ—Ç–æ–≤—è—Ç –∫ –æ—Å–µ–Ω–∏ –≤–∞—à–∏—Ö –¥–µ—Ç–µ–π, –ø—Ä–µ–¥–ª–∞–≥–∞—è –∏–º –∂—Ä–∞—Ç—å –≤–∏—Ç–∞–º–∏–Ω—ã –∏ –≥–æ–º–µ–æ–ø–∞—Ç–∏—é, –∞ —è –ø—Ä–µ–¥–ª–∞–≥–∞—é –≥–æ—Ç–æ–≤–∏—Ç—å—Å—è –∫ –æ—Å–µ–Ω–∏ –≤–∞–º. –ö–∞–∫? –ß–∏—Ç–∞—Ç—å –∫–∞–Ω–∞–ª—ã, –æ—Ç –∫–æ—Ç–æ—Ä—ã—Ö —Ä–∞—Å—Ç—ë—Ç –∂–∏–∑–Ω–µ–Ω–Ω—ã–π —Ç–æ–Ω—É—Å! –ü–æ—è—Å–Ω–∏ –∑–∞ –º–µ–¥ ‚Äî —ç—Ç–æ—Ç –∫—Ä–∞—Å–Ω—ã–π —Ç–µ–ª–µ–≥—Ä–∞–º-–∫–∞–Ω–∞–ª–æ–≤–æ–¥ –∑–Ω–∞–µ—Ç, –∫–∞–∫ –∏ —è, —á—Ç–æ –ø—Ä–∏ –Ω–∏–∫–æ–ª–∞–µ 2 –Ω–µ –±—ã–ª–æ –Ω–∏–∫–∞–∫–∏—Ö —á–µ–ª–æ–≤–µ–∫-–æ—Ä–∏–µ–Ω—Ç–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –º–µ–¥–∏—Ü–∏–Ω. –†–µ–≥—É–ª—è—Ä–Ω–æ –Ω–∞–ø–æ–º–∏–Ω–∞–µ—Ç –æ–± —ç—Ç–æ–º. –Æ–†–ò–°–¢–´ –ó–ê –í–†–ê–ß–ï–ô ‚Äî —Ä–∞—Å—Å–∫–∞–∂—É—Ç –≤—Å—ë –æ–± –∏–∑–º–µ–Ω–µ–Ω–∏—è—Ö –≤ —Ä–∞–±–æ—Ç–µ –≤—Ä–∞—á–µ–π –∏ –∫–ª–∏–Ω–∏–∫ —É–∂–µ —Å 1 —Å–µ–Ω—Ç—è–±—Ä—è 2025. –•–æ—Ä–æ—à–æ, —á—Ç–æ –µ—Å—Ç—å —Ç–µ, –∫—Ç–æ –∑–∞! –ù–æ–≤–æ—Å—Ç–∏ –Ω–µ–π—Ä–æ–Ω–∞—É–∫ –∏ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π ‚Äî –¥–ª—è —Ç–µ—Ö, –∫—Ç–æ —Ö–æ—á–µ—Ç, —á—Ç–æ–±—ã –Ω–∞—É—á–Ω—ã–µ –Ω–µ–π—Ä–æ–Ω–æ–≤–æ—Å—Ç–∏ —Å–∞–º–∏ –∏—Å–∫–∞–ª–∏—Å—å –∏, –∫–∞–∫ –≤–∞—Ä–µ–Ω–∏–∫–∏ –≤ –í–µ—á–µ—Ä–∞—Ö –Ω–∞ –∏–∑–≤–µ—Å—Ç–Ω–æ–º —Ö—É—Ç–æ—Ä–µ, —Å–∞–º–∏ –≤ –≥–æ–ª–æ–≤—É –ø–æ–ø–∞–¥–∞–ª–∏. –ê–Ω—á–∞ –ë–∞—Ä–∞–Ω–æ–≤–∞ ‚Äî —á–µ–ª–æ–≤–µ–∫, –∫–æ—Ç–æ—Ä—ã–π –∑–Ω–∞–µ—Ç –≤—Å—ë –ø—Ä–æ —Å—Ç–∞—Ä—É—à–∫—É FDA ‚Äî –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–≥–æ —Ä–µ–≥—É–ª—è—Ç–æ—Ä–∞ ‚Äî –∏ —É–≤–ª–µ–∫–∞—Ç–µ–ª—å–Ω–æ —Ä–∞—Å—Å–∫–∞–∑—ã–≤–∞–µ—Ç –æ –º–∞–∫—Ä–æ–ø—Ä–æ–±–ª–µ–º–∞—Ö –º–∏–∫—Ä–æ–º–∏—Ä–∞. –°–æ–≤–µ—Ç—Å–∫–∏–π –¶–∏—Ç—Ä–∞–º–æ–Ω ‚Äî –ª—É—á—à–∏–µ –º–µ–º—ã –∏ –≤–∏–¥–µ–æ–∑–∞—Ä–∏—Å–æ–≤–∫–∏ –ø—Ä–æ –∂–∏–∑–Ω—å –≤ –∞–ø—Ç–µ–∫–µ. –ï—Å—Ç–µ—Å—Ç–≤–µ–Ω–Ω—ã–π –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç –∏ —Å–ø–∞—Å–µ–Ω–∏–µ –æ—Ç —É—Ä–æ–¥–ª–∏–≤—ã—Ö –±–∞–Ω–Ω–µ—Ä–æ–≤ –Ω–∞ —Ñ–∞—Ä–º–º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞—Ö. PharmBrief ‚Äî –Ω–æ–≤–æ—Å—Ç–∏ –∏–∑ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–≥–æ –º–∏—Ä–∞. –†–∞—Å—Å–∫–∞–∑—ã–≤–∞—é—Ç –æ —Ç–æ–º, —á—Ç–æ –≤–∞–∂–Ω–æ —Ç–µ–º, –∫–æ–º—É —ç—Ç–æ –∏–Ω—Ç–µ—Ä–µ—Å–Ω–æ (–≤–∞–º). –§–ª–µ–±–æ–ª–æ–≥ –ê—Å—Ç–∞—Ñ—å–µ–≤–∞ ‚Äî –∫–∞–Ω–∞–ª –¥–æ–∫—Ç–æ—Ä–∞ —Å –∫—Ä–µ–ø–∫–∏–º –≤–µ–Ω–æ–ø–æ–∂–∞—Ç–∏–µ–º. –ù—É–∂–Ω–æ–µ –ø—Ä–∏—à—å–µ—Ç, –ª–∏—à–Ω–µ–µ ‚Äî –∑–∞—Å–∫–ª–µ—Ä–æ–∑–∏—Ä—É–µ—Ç. –û–±—Ä–∞–∑–µ—Ü –¥–ª—è –≤—Ä–∞—á–µ–π –∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –ù–æ—á–Ω–∞—è –æ—Ö–æ—Ç–∞ ‚Äî —Ü–∏–Ω–∏—á–Ω–æ-–ª–∏—Ç–µ—Ä–∞—Ç—É—Ä–Ω—ã–π –∫–∞–Ω–∞–ª —Å —Ç–∞–π–Ω–æ —Ç–ª–µ—é—â–µ–π –Ω–∞–¥–µ–∂–¥–æ–π –Ω–∞ —á—Ç–æ-—Ç–æ –ª—É—á—à–µ–µ. –ö–æ–≥–¥–∞ –ø—Ä–∏–∂–º—ë—Ç –¥–µ–ø—Ä–µ—Å—Å–∏—è, –ø–æ–º–æ–∂–µ—Ç –≤—ã–±—Ä–∞—Ç—å—Å—è. –ê –∫–æ–≥–¥–∞ –±—É–¥–µ—Ç —Å–ª–∏—à–∫–æ–º —Ö–æ—Ä–æ—à–æ, –≤–µ—Ä–Ω–µ—Ç –∫ —Ä–µ–∞–ª—å–Ω–æ—Å—Ç–∏. –ú–µ–¥–∏–∫–∞–ª –ö—Å—é ‚Äî —Å—Ç–∞–±–∏–ª—å–Ω–æ—Å—Ç—å –≤ –ø–æ—Å—Ç–∞–≤–∫–µ –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –æ–± –∏–Ω–Ω–æ–≤–∞—Ü–∏—è—Ö –≤ —Å–æ–≤–µ—Ç—Å–∫–æ–π —Ä–æ—Å—Å–∏–π—Å–∫–æ–π –º–µ–¥–∏—Ü–∏–Ω–µ –æ–±–µ—Å–ø–µ—á–∏—Ç –≤–∞–º —Ä–æ–≤–Ω–æ–µ –Ω–∞—Å—Ç—Ä–æ–µ–Ω–∏–µ. Pediatric Surgeon ‚Äî –∫–∞–Ω–∞–ª –¥–µ—Ç—Å–∫–æ–≥–æ —Ö–∏—Ä—É—Ä–≥–∞ –∑–∞—Ä—è–¥–∏—Ç –≤–∞—Å —Å–≤–µ—Ç–ª–æ–π —ç–Ω–µ—Ä–≥–∏–µ–π. –ü–µ—Ä–∏–æ–¥–∏—á–µ—Å–∫–∏ —Ç–∞–º –ø–æ–ø–∞–¥–∞—é—Ç—Å—è –¥–µ—Ç—Å–∫–∏–µ —Ä–∏—Å—É–Ω–∫–∏ –¥–ª—è –¥–æ–∫—Ç–æ—Ä–∞, —á—Ç–æ –ø–æ—Ä–∞–¥—É–µ—Ç –¥–∞–∂–µ —Å–∞–º–æ–≥–æ –æ—Ç–º–æ—Ä–æ–∂–µ–Ω–Ω–æ–≥–æ –∫–ª–∏–Ω–∏—Ü–∏—Å—Ç–∞ (–Ω–µ—Ç). –®–∫–æ–ª–∞ –¥–µ–¥–∞ ‚Äî –∫–∞–Ω–∞–ª –≤—Ä–∞—á–∞-–≥–µ—Ä–∏–∞—Ç—Ä–∞-–ø—Å–∏—Ö–∏–∞—Ç—Ä–∞, –∫–æ—Ç–æ—Ä—ã–π —É—á–∏—Ç –ø–æ–∂–∏–ª—ã—Ö –ª—é–¥–µ–π –Ω–µ –±—ã—Ç—å Dead'–∞–º–∏. –î—É–º–∞—é, —á—Ç–æ –¥–ª—è –ª—é–¥–µ–π —Å—Ä–µ–¥–Ω–µ–≥–æ –≤–æ–∑—Ä–∞—Å—Ç–∞ –Ω—É–∂–Ω–∞ –®–∫–æ–ª–∞ —Å–∫—É—Ñ–∞ –ø–æ –∞–Ω–∞–ª–æ–≥–∏–∏. –ú–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è –†–æ—Å—Å–∏—è ‚Äî –Ω–µ –¥—É–º–∞—é, —á—Ç–æ —ç—Ç–æ—Ç –±–ª–æ–≥ –≤–∞—Å –∑–∞—Ä—è–¥–∏—Ç –ø–æ–∑–∏—Ç–∏–≤–æ–º, –Ω–æ –≤ —Ç–æ–Ω—É—Å–µ —Ç–æ—á–Ω–æ —É–¥–µ—Ä–∂–∏—Ç. –ë—É–ª–≥–∞–∫–æ–≤ –Ω–∞–ø–∏—Å–∞–ª –±—ã –ø—Ä–æ —ç—Ç–æ—Ç —Ç–µ–ª–µ–≥—Ä–∞–º-–∫–∞–Ω–∞–ª ""–ü–æ—Å–ª–µ –ø—Ä–æ—á—Ç–µ–Ω–∏—è –≤—ã–ø–∏—Ç—å –∏–±—É–ø—Ä–æ—Ñ–µ–Ω"". –≠—Ç–æ –ø–æ–¥–±–æ—Ä–∫–∞ –ò–∫–æ–Ω—ã –§–∞—Ä–º—ã –Ω–∞ –æ—Å–µ–Ω—å. –ü–∏—à–∏—Ç–µ –º–Ω–µ —Å—é–¥–∞ @pharmaicon_admin –ø–æ –≤—Å–µ–º –≤–æ–ø—Ä–æ—Å–∞–º!","{
  ""skip"": true
}"
2025-08-29T14:31:01+00:00,@pharm_icon,2351,https://t.me/pharm_icon/2351,–ó–Ω–∞–º–µ–Ω–∏—Ç–æ–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ –≤ –†–æ—Å—Å–∏–π—Å–∫–æ–π –ò–º–ø–µ—Ä–∏–∏,"{
  ""skip"": true
}"
2025-08-29T14:14:54+00:00,@pharm_icon,2350,https://t.me/pharm_icon/2350,"–û–ø–µ—Ä–∞—Ü–∏—è –ø—Ä–µ–µ–º–Ω–∏–∫: –∫—Ç–æ –≤–º–µ—Å—Ç–æ –∞—Ü–µ—Ç–∏–ª—Å–∞–ª–∏—Ü–∏–ª–æ–≤–æ–π –∫–∏—Å–ª–æ—Ç—ã (–ê–°–ö)? –ß—Ç–æ –∂, —Å–µ–≥–æ–¥–Ω—è –Ω–∞—Ç–∫–Ω—É–ª–∞—Å—å –Ω–∞ –ø—É–±–ª–∏–∫–∞—Ü–∏—é –ø—Ä–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏–µ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ –ê–°–ö –∏ –∏–Ω–¥–æ–±—É—Ñ–µ–Ω–∞ –∏ —ç—Ç–æ –∫—Ä–∞–π–Ω–µ –∏–Ω—Ç–µ—Ä–µ—Å–Ω–æ. –ò–Ω–¥–æ–±—É—Ñ–µ–Ω ‚Äî —ç—Ç–æ –∞–Ω—Ç–∏–∞–≥—Ä–µ–≥–∞–Ω—Ç, –æ–±—Ä–∞—Ç–∏–º—ã–π –∏–Ω–≥–∏–±–∏—Ç–æ—Ä —Ü–∏–∫–ª–æ–æ–∫—Å–∏–≥–µ–Ω–∞–∑—ã, —Å–Ω–∏–∂–∞—é—â–∏–π –∞–≥—Ä–µ–≥–∞—Ü–∏—é —Ç—Ä–æ–º–±–æ—Ü–∏—Ç–æ–≤ –∏ —Ä–∏—Å–∫ —Ç—Ä–æ–º–±–æ–∑–æ–≤. –ü—Ä–µ–ø–∞—Ä–∞—Ç –±—ã–ª —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω –∏—Ç–∞–ª—å—è–Ω—Å–∫–æ–π –∫–æ–º–ø–∞–Ω–∏–µ–π Farmitalia Carlo Erba SPA –∏ –≤—ã–≤–µ–¥–µ–Ω –Ω–∞ —Ä—ã–Ω–æ–∫ –≤ 1980-—Ö –≥–æ–¥–∞—Ö. –ê —Å–µ–π—á–∞—Å –Ω–∞ –Ω–µ–≥–æ –ø–æ—Å–º–∞—Ç—Ä–∏–≤–∞—é—Ç, –∫–∞–∫ –Ω–∞ –∑–∞–º–µ–Ω—É –ê–°–ö. –û—Å–Ω–æ–≤–Ω—ã–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã —Å–∏—Å—Ç–µ–º–∞—Ç–∏—á–µ—Å–∫–æ–≥–æ –æ–±–∑–æ—Ä–∞: ü©∏–ú–µ–Ω—å—à–µ –∫—Ä–æ–≤–æ—Ç–µ—á–µ–Ω–∏–π –ø—Ä–∏ –ø—Ä–∏–µ–º–µ –∏–Ω–¥–æ–±—É—Ñ–µ–Ω–∞: —Ä–∏—Å–∫ (RR) ‚Äî 0,54 (95 % CI 0,41‚Äì0,71; P < .0001). ü©∏–ú–µ–Ω—å—à–µ —Å–µ—Ä—å–µ–∑–Ω—ã—Ö –∫—Ä–æ–≤–æ—Ç–µ—á–µ–Ω–∏–π (Bleeding Academic Research Consortium 2/3/5): RR ‚Äî 0,50 (95 % CI 0,26‚Äì0,94; P = .03) ü©∏–°–Ω–∏–∂–µ–Ω–∏–µ —Ä–∏—Å–∫–∞ –Ω–µ–±–ª–∞–≥–æ–ø—Ä–∏—è—Ç–Ω—ã—Ö —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö —Å–æ–±—ã—Ç–∏–π: RR ‚Äî 0,43 (95 % CI 0,30‚Äì0,61; P < .00001) ü©∏–°–Ω–∏–∂–µ–Ω–∏–µ —Ä–∏—Å–∫–∞ –∏–Ω—Ñ–∞—Ä–∫—Ç–∞ –º–∏–æ–∫–∞—Ä–¥–∞: RR ‚Äî 0,60 (95 % CI 0,41‚Äì0,89; P = .01) –ù–µ—Ç —Å—Ç–∞—Ç–∏—Å—Ç–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º—ã—Ö —Ä–∞–∑–ª–∏—á–∏–π –º–µ–∂–¥—É –∏–Ω–¥–æ–±—É—Ñ–µ–Ω–æ–º –∏ –ê–°–ö –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏: 1. –û—Å–Ω–æ–≤–Ω—ã—Ö –Ω–µ–±–ª–∞–≥–æ–ø—Ä–∏—è—Ç–Ω—ã—Ö —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö –∏ —Ü–µ—Ä–µ–±—Ä–æ–≤–∞—Å–∫—É–ª—è—Ä–Ω—ã—Ö —Å–æ–±—ã—Ç–∏–π. 2. –ò–Ω—Å—É–ª—å—Ç–∞. 3. –°–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç–æ–π —Å–º–µ—Ä—Ç–Ω–æ—Å—Ç–∏. –ö–æ—Ä–æ–ª—å —É–π–¥—ë—Ç —Å –ø—Ä–µ—Å—Ç–æ–ª–∞? üî• ‚Äî –¥–∞ üóø ‚Äî –Ω–µ—Ç, –∫–æ—Ä–æ–ª—å —Å–∞–º –Ω–∞–∑–Ω–∞—á–∞–µ—Ç –ø—Ä–µ–µ–º–Ω–∏–∫–∞, –∫–æ–≥–¥–∞ —Å–æ–±–∏—Ä–∞–µ—Ç—Å—è —É—Ö–æ–¥–∏—Ç—å. –ù–æ –ê–°–ö –Ω–∏–∫—É–¥–∞ —É—Ö–æ–¥–∏—Ç—å –Ω–µ —Å–æ–±–∏—Ä–∞–µ—Ç—Å—è.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The review highlights that Ibuprofen is associated with fewer bleeding incidents and a lower risk of serious bleeding. It also reduces the risk of adverse cardiovascular events and myocardial infarction. However, there are no statistically significant differences in the incidence of major cardiovascular and cerebrovascular adverse events, ischemic stroke, or cardiovascular mortality between Ibuprofen and Acetylsalicylic acid (ASA).""
}"
2025-08-27T16:15:09+00:00,@pharm_icon,2349,https://t.me/pharm_icon/2349,"–ö–∞–∂–¥—ã–π –≤—Ä–∞—á –≤ 2025 –≥–æ–¥—É –º–æ–∂–µ—Ç –∫—Ä–∞—Ç–Ω–æ —É–≤–µ–ª–∏—á–∏—Ç—å –¥–æ—Ö–æ–¥, –µ—Å–ª–∏ –ø–æ—Å–º–æ—Ç—Ä–∏—Ç —ç—Ç–∏ 3 —É—Ä–æ–∫–∞ –í—Å—ë –±–æ–ª—å—à–µ –ª—é–¥–µ–π –ø—ã—Ç–∞—é—Ç—Å—è –ø–∏—Ç–∞—Ç—å—Å—è —Å –ø–æ–ª—å–∑–æ–π –¥–ª—è –æ—Ä–≥–∞–Ω–∏–∑–º–∞, –∏ —Å–∞–º–æ–µ —Å–ª–æ–∂–Ω–æ–µ –¥–ª—è –Ω–∏—Ö ‚Äî —Å—Ä–µ–¥–∏ —Ç–æ–Ω–Ω—ã –º—Ä–∞–∫–æ–±–µ—Å–Ω—ã—Ö —Å–æ–≤–µ—Ç–æ–≤ –Ω–∞–π—Ç–∏ —Ö–æ—Ç—å —á—Ç–æ-—Ç–æ –≤–º–µ–Ω—è–µ–º–æ–µ. –í—Å–µ –∂–µ –≤–∏–¥–µ–ª–∏ —ç—Ç–∏—Ö ¬´–≥—É—Ä—É¬ª, –∫–æ—Ç–æ—Ä—ã–µ —Å–æ–±–∏—Ä–∞—é—Ç –º–∏–ª–ª–∏–æ–Ω—ã –ø–æ–¥–ø–∏—Å—á–∏–∫–æ–≤, —Ä–∞—Å—Å–∫–∞–∑—ã–≤–∞—è, —á—Ç–æ –ø–æ–º–∏–¥–æ—Ä—ã –Ω–µ —É–∂–∏–≤–∞—é—Ç—Å—è —Å –æ–≥—É—Ä—Ü–∞–º–∏ –≤ –æ–¥–Ω–æ–π —Ç–∞—Ä–µ–ª–∫–µ, —Ö–ª–µ–± —É–Ω–∏—á—Ç–æ–∂–∏—Ç —á–µ–ª–æ–≤–µ—á–µ—Å—Ç–≤–æ, –∞ –æ—Ä–µ—Ö–∏ –ø–æ–º–æ–≥–∞—é—Ç —Ö—É–¥–µ—Ç—å? –¢–∞–∫ –≤–æ—Ç, –≤—Ä–∞—á-–¥–∏–µ—Ç–æ–ª–æ–≥ –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ë—É—Ä–ª–∞–∫–æ–≤ –æ–±—ä—è–≤–ª—è–µ—Ç –Ω–∞–±–æ—Ä –Ω–∞ –æ–±—É—á–µ–Ω–∏–µ –î–û–ö–ê–ó–ê–¢–ï–õ–¨–ù–û–ô –ù–£–¢–†–ò–¶–ò–û–õ–û–ì–ò–ò, –∫–æ—Ç–æ—Ä–æ–µ –ø–æ–º–æ–∂–µ—Ç - –≤—Ä–∞—á–∞–º —Ä–∞—Å—à–∏—Ä–∏—Ç—å —Å–ø–µ–∫—Ç—Ä —Å–≤–æ–∏—Ö —É—Å–ª—É–≥: –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ –∑–∞—Ä–∞–±–∞—Ç—ã–≤–∞—Ç—å –Ω–∞ –∫–æ–Ω—Å—É–ª—å—Ç–∞—Ü–∏—è—Ö –∏ —Å–æ—Å—Ç–∞–≤–ª–µ–Ω–∏–∏ –ø–ª–∞–Ω–æ–≤ –ø–∏—Ç–∞–Ω–∏—è - –±–æ–ª—å—à–µ–º—É –∫–æ–ª–∏—á–µ—Å—Ç–≤—É –ª—é–¥–µ–π —É–∑–Ω–∞—Ç—å, —á—Ç–æ –Ω–∞ —Å–∞–º–æ–º –¥–µ–ª–µ –∑–Ω–∞—á–∏—Ç –ø—Ä–∞–≤–∏–ª—å–Ω–æ–µ –ø–∏—Ç–∞–Ω–∏–µ –í–∞–∂–Ω–æ: –∑–Ω–∞–Ω–∏—è, –∫–æ—Ç–æ—Ä—ã–µ –≤—ã –ø–æ–ª—É—á–∏—Ç–µ, –Ω—É–∂–Ω—ã –≤–æ –≤—Ä–∞—á–µ–±–Ω–æ–π –ø—Ä–∞–∫—Ç–∏–∫–µ –ª—é–±–æ–π —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–∏, –ø–æ—ç—Ç–æ–º—É –ø—Ä–∏ –ø—Ä–æ—Ö–æ–∂–¥–µ–Ω–∏–∏ –ø–æ–ª–Ω–æ–≥–æ –∫—É—Ä—Å–∞ –æ–±—É—á–µ–Ω–∏—è –≤–∞–º –Ω–∞—á–∏—Å–ª—è–µ—Ç—Å—è 270 –±–∞–ª–ª–æ–≤ –ù–ú–ûüë®‚Äç‚öïÔ∏è –í–≤–æ–¥–Ω—ã–π –º–æ–¥—É–ª—å –¥–æ—Å—Ç—É–ø–µ–Ω –≤ —Ç–µ—á–µ–Ω–∏–µ 7 –¥–Ω–µ–π —Å–æ –¥–Ω—è —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏. –ü–æ–ª—É—á–∏—Ç–µ –±–µ—Å–ø–ª–∞—Ç–Ω—ã–µ —É—Ä–æ–∫–∏ —Å–µ–π—á–∞—Å: t.me/profession_nutricionist_bot","{""skip"": true}"
2025-08-27T15:29:55+00:00,@pharm_icon,2348,https://t.me/pharm_icon/2348,"–û–ø—è—Ç—å –Ω–µ –≤—Ä–µ–¥–Ω—ã, –±–ª–∏–Ω: —Å—Ç–∞—Ç–∏–Ω—ã –∏ –∫–∞—Ä–¥–∏–æ–ø—Ä–æ—Ç–µ–∫—Ü–∏—è –ø—Ä–∏ —Ö–∏–º–∏–æ—Ç–µ—Ä–∞–ø–∏–∏ –ü—Ä–∏–¥–µ—Ç—Å—è —Ä–∞—Å—Å–∫–∞–∑—ã–≤–∞—Ç—å –æ –ø–æ–ª—å–∑–µ —Å—Ç–∞—Ç–∏–Ω–æ–≤ –≤ –±–æ—Ä—å–±–µ —Å –ø–æ–±–æ—á–Ω—ã–º–∏ —ç—Ñ—Ñ–µ–∫—Ç–∞–º–∏. –°–æ–±—Å—Ç–≤–µ–Ω–Ω–æ –ø—Ä–µ–¥–º–µ—Ç: –∫–∞—Ä–¥–∏–æ–ø—Ä–æ—Ç–µ–∫—Ü–∏—è —Å—Ç–∞—Ç–∏–Ω–∞–º–∏ –ø—Ä–∏ —Ö–∏–º–µ–æ—Ç–µ—Ä–∞–ø–∏–∏. –û—Å–Ω–æ–≤–Ω—ã–µ –∫–æ–Ω–µ—á–Ω—ã–µ —Ç–æ—á–∫–∏ –ø–æ –∫–∞—Ä–¥–∏–æ—Ç–æ–∫—Å–∏—á–Ω–æ—Å—Ç–∏ ‚Äî —Å–Ω–∏–∂–µ–Ω–∏–µ —Ñ—Ä–∞–∫—Ü–∏–∏ –≤—ã–±—Ä–æ—Å–∞ –ª–µ–≤–æ–≥–æ –∂–µ–ª—É–¥–æ—á–∫–∞ (–§–í–õ–ñ) –∏ –∫–æ–Ω—á–µ–Ω–æ-–¥–∏–∞—Å—Ç–æ–ª–∏—á–µ—Å–∫–æ–≥–æ –æ–±—ä–µ–º–∞ –õ–ñ (–ö–î–û–õ–ñ). –ò—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª—è–ª–æ —Å–æ–±–æ–π –º–µ—Ç–∞-–∞–Ω–∞–ª–∏–∑ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –æ –∫–∞—Ä–¥–∏–æ—Ç–æ–∫—Å–∏—á–µ—Å–∫–∏—Ö —ç—Ñ—Ñ–µ–∫—Ç–∞—Ö —Ö–∏–º–µ–æ—Ç–µ—Ä–∞–ø–∏–∏, –≤–∫–ª—é—á–∞—è –≥—Ä—É–ø–ø—ã –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –ø—Ä–∏–Ω–∏–º–∞—é—â–∏—Ö —Å—Ç–∞—Ç–∏–Ω—ã. –û—Ü–µ–Ω–∏–≤–∞–ª–∏—Å—å –ø—Ä–∏–≤–µ–¥–µ–Ω–Ω—ã–µ –æ—Ç–Ω–æ—à–µ–Ω–∏—è —Ä–∏—Å–∫–æ–≤ (–û–†) –∏ —Å—Ä–µ–¥–Ω—é—é –∞–±—Å–æ–ª—é—Ç–Ω—É—é —Ä–∞–∑–Ω–∏—Ü—É (MD) –¥–ª—è —Å–Ω–∏–∂–µ–Ω–∏—è –§–í–õ–ñ –∏ –ö–î–û–õ–ñ. –û—Ü–µ–Ω–∏–ª–∏ 5532 –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –∏–∑ –≥—Ä—É–ø–ø—ã –ø—Ä–∏–Ω–∏–º–∞–≤—à–∏—Ö —Å—Ç–∞—Ç–∏–Ω—ã (1904 –ø–∞–∏—Ü–µ–Ω—Ç–∞) –∏ –≥—Ä—É–ø–ø—ã –±–µ–∑ —Å—Ç–∞—Ç–∏–Ω–æ–≤ (3628 –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤) –ò—Ç–æ–≥–∏: —Å–Ω–∏–∂–µ–Ω–∏–µ –§–í–õ–ñ –≤ –≥—Ä—É–ø–ø–µ –±–µ–∑ —Å—Ç–∞—Ç–∏–Ω–æ–≤ –±—ã–ª–æ –±–æ–ª—å—à–µ, —á–µ–º —É –ø—Ä–∏–Ω–∏–º–∞–≤—à–∏—Ö —Å—Ç–∞—Ç–∏–Ω—ã (MD 3,55; 1,04-6,05), —Ä–æ–≤–Ω–æ –∫–∞–∫ –∏ —Å–∞–º –∏—Ç–æ–≥–æ–≤—ã–π –æ–±—ä–µ–º –§–í–õ–ñ (MD 2,08; 0,86-3,30). –ß–∞—Å—Ç–æ—Ç–∞ —Å–µ—Ä–¥–µ—á–Ω–æ–π –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ—Å—Ç–∏ –≤ –≥—Ä—É–ø–ø–µ —Å—Ç–∞—Ç–∏–Ω–æ–≤ –±—ã–ª–∞ –Ω–∏–∂–µ (–û–† 0,41; 0,27-0,62). –ó–Ω–∞—á–∏–º–æ–π —Ä–∞–∑–Ω–∏—Ü—ã –Ω–µ –Ω–∞–±–ª—é–¥–∞–ª–æ—Å—å –≤ –∏—Ç–æ–≥–æ–≤–æ–º –ö–î–û–õ–ñ (MD 1,55; –æ—Ç -5,32 –¥–æ 8,33; p= 0,65) –ó–∞–∫–ª—é—á–µ–Ω–∏–µ: –ü—Ä–∏–º–µ–Ω–µ–Ω–∏–µ —Å—Ç–∞—Ç–∏–Ω–æ–≤ –≤ —Ö–æ–¥–µ —Ö–∏–º–∏–æ—Ç–µ—Ä–∞–ø–∏–∏ –æ–∫–∞–∑—ã–≤–∞–µ—Ç –∫–∞—Ä–¥–∏–æ–ø—Ä–æ—Ç–µ–∫—Ç–∏–≤–Ω—ã–π —ç—Ñ—Ñ–µ–∫—Ç –ø—É—Ç–µ–º —Å–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –§–í–õ–ñ –∏ —Å–Ω–∏–∂–µ–Ω–∏—è —á–∞—Å—Ç–æ—Ç—ã —Å–µ—Ä–¥–µ—á–Ω–æ–π –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ—Å—Ç–∏. –ß—Ç–æ –¥—É–º–∞–µ—Ç–µ? üî• ‚Äî –æ—Ç–ª–∏—á–Ω–∞—è –Ω–æ–≤–æ—Å—Ç—å üóø ‚Äî –Ω–∞–¥–æ –ø–æ–∫–æ–ø–∞—Ç—å—Å—è –ø–æ–≥–ª—É–±–∂–µ, –ò–∫–æ–Ω–∞, —Ç–∞–º —Å–Ω–æ–≤–∞ –≤—Å—ë –ø–æ–¥–º–∞—Ö–Ω—É–ª–∏ –ø–æ–¥ —Å—Ç–∞—Ç–∏–Ω—ã 100%","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The message discusses the cardioprotective effects of statins during chemotherapy, focusing on reducing left ventricular ejection fraction (LVEF) and end-diastolic volume of the LV (EDV). It mentions a meta-analysis study on cardiotoxic effects of chemotherapy, including patients taking statins. The results show that the LVEF and EDV are better in patients not taking statins compared to those who do. The message concludes that the use of statins during chemotherapy provides a cardioprotective effect by maintaining LVEF and reducing the frequency of heart failure. The message is seeking opinions on this topic.""
}"
2025-08-27T14:23:46+00:00,@pharm_icon,2347,https://t.me/pharm_icon/2347,"–ü–æ–¥ –ø–æ—Å—Ç–∞–º–∏ –æ –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω–æ–º —Ç—Ä—É–¥–µ –≤—Ä–∞—á–µ–π –ø–æ—á—Ç–∏ –≤—Å–µ–≥–¥–∞ –º–æ–∂–Ω–æ –≤—Å—Ç—Ä–µ—Ç–∏—Ç—å –∫–æ–º–º–µ–Ω—Ç–∞—Ä–∏–π –≤—Ä–æ–¥–µ: –ê –ø–æ—á–µ–º—É —Ç–æ–ª—å–∫–æ –≤—Ä–∞—á–µ–π —Ä–∞—Å–ø—Ä–µ–¥–µ–ª—è—Ç—å? –ü–æ—á–µ–º—É –¥—Ä—É–≥–∏–µ —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–∏ –Ω–µ —Ç—Ä–æ–≥–∞—é—Ç? –Ø –Ω–µ –æ—Å–æ–±–æ –ø–æ–Ω–∏–º–∞—é —ç—Ç–æ—Ç –∞—Ä–≥—É–º–µ–Ω—Ç, –≤–µ–¥—å –≤—Ä–∞—á–∞–º –Ω–µ —Å—Ç–∞–Ω–µ—Ç –ª—É—á—à–µ –æ—Ç —Ç–æ–≥–æ, —á—Ç–æ –Ω–∞—á–Ω—É—Ç —É–≥–Ω–µ—Ç–∞—Ç—å –∫–æ–≥–æ-—Ç–æ –µ—â—ë. –≠—Ç–æ –∫–∞–∫ –±—ã—Ç—å –≥–æ–ª–æ–¥–Ω—ã–º –∏ –º–µ—á—Ç–∞—Ç—å –Ω–µ –ø–æ–∫—É—à–∞—Ç—å, –∞ —á—Ç–æ–±—ã –æ—Å—Ç–∞–ª—å–Ω—ã–µ —Ç–æ–∂–µ –≥–æ–ª–æ–¥–∞–ª–∏. –ù–æ –Ω–∞—á–∞–ª—å—Å—Ç–≤–æ —É—Å–ª—ã—à–∞–ª–æ –≤–∞—à–∏ –º–æ–ª—å–±—ã –∏ –Ω–∞—á–∞–ª–æ –≤–Ω–æ—Å–∏—Ç—å –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è –ø–æ –≤–æ—Å—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—é —Å–ø—Ä–∞–≤–µ–¥–ª–∏–≤–æ—Å—Ç–∏.","{""skip"": true}"
2025-08-26T14:04:35+00:00,@pharm_icon,2345,https://t.me/pharm_icon/2345,"–ö–∞–∫ –¥–ª—è –¥–µ–±–∏–ª–æ–≤: –∫–∞–∫ –≤ –ö–æ—Ä–µ–µ –ø—Ä–æ–¥–∞—é—Ç –≤—Ä–∞—á–∞–º –õ–µ–∫–µ–º–±–∏? –£–º—É–¥—Ä–∏–ª–∞—Å—å Biogen –∫–∞–∫-—Ç–æ —Å–æ–∑–¥–∞—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç –õ–µ–∫–µ–º–±–∏ (–ª–µ–∫–∞–Ω–µ–º–∞–±), –ø—Ä–∏–º–µ–Ω—è–µ–º—ã–π –≤ —Ç–µ—Ä–∞–ø–∏–∏ –∑–ª–æ—Å—á–∞—Å—Ç–Ω–æ–π (–∏–∑-–∑–∞ –±–µ—Å–∫–æ–Ω–µ—á–Ω–æ–≥–æ —Ü–∏–∫–ª–∞ RnD) –±–æ–ª–µ–∑–Ω–∏ –ê–ª—å—Ü–≥–µ–π–º–µ—Ä–∞. –ê –ø–æ—Ç–æ–º –≤—Å—Ç–∞–ª —É–∂–µ —Å—Ç–∞–≤—à–∏–π –ø–æ—á—Ç–∏ –º–µ–º–æ–º –≤ –Ω–µ–≤—Ä–æ–ª–æ–≥–∏–∏ –≤–æ–ø—Ä–æ—Å ‚Äú–ö–∞–∫ –ø—Ä–æ–¥–∞—Ç—å –Ω–æ–≤–∏–Ω–∫—É –æ—Ç –ê–ª—å—Ü–≥–µ–π–º–µ—Ä–∞?‚Äù. –û —Ç–æ–º –∏ –±—É–¥–µ—Ç —Ä–∞—Å—Å–∫–∞–∑ –Ω–∞ –ø—Ä–∏–º–µ—Ä–µ –æ–¥–Ω–æ–π –ø—É–±–ª–∏–∫–∞—Ü–∏–∏. –ö–æ–Ω–µ—á–Ω–æ –∂–µ –∏–∑ –ö–æ—Ä–µ–∏ –í –ø—É–±–ª–∏–∫–∞—Ü–∏–∏ —Å–¥–µ–ª–∞–ª–∏ —Ç–∏–ø–∏—á–Ω—ã–π —Ñ–æ—Ä–º–∞—Ç –±—É—Ç–µ—Ä–±—Ä–æ–¥. –ú–Ω–æ–≥–∏–µ –∑–Ω–∞—é—Ç —Ç–∞–∫–æ–π —Ñ–æ—Ä–º–∞—Ç –∫–æ–º–º—É–Ω–∏–∫–∞—Ü–∏–∏ —Å –ª—é–¥—å–º–∏, –∫–æ–≥–¥–∞ –Ω–∞–¥–æ –∫–æ–≥–æ-—Ç–æ –ø–æ–∫—Ä–∏—Ç–∏–∫–æ–≤–∞—Ç—å ‚Äî –ø–æ—Å–µ—Ä–µ–¥–∏–Ω–µ –ø–∏—à—É—Ç –≥–ª–∞–≤–Ω—ã–π –º–µ—Å—Å–µ–¥–∂, –∞ –≤ –Ω–∞—á–∞–ª–µ –∏ –∫–æ–Ω—Ü–µ ‚Äî –∫–æ–º–ø–ª–∏–º–µ–Ω—Ç—ã. –ö–∞–∫ —ç—Ç–æ —Ä–∞–±–æ—Ç–∞–µ—Ç? (good) –ö–æ–º–∞–Ω–¥–∞, –≤—ã –º–æ–ª–æ–¥—Ü—ã. –í—ã –ø—Ä–æ–¥–µ–ª–∞–ª–∏ –Ω–µ–≤–µ—Ä–æ—è—Ç–Ω—É—é —Ä–∞–±–æ—Ç—É —Å –¥–∏–∑–∞–π–Ω–æ–º –ø—Ä–µ–∑–µ–Ω—Ç–∞—Ü–∏–∏! (baaad) –°–º—ã—Å–ª–æ–≤–æ–π –Ω–∞—Ä—Ä–∞—Ç–∏–≤ –≤—ã–≥–ª—è–¥–∏—Ç –æ—Ç–≤—Ä–∞—Ç–∏—Ç–µ–ª—å–Ω–æ. –ù–µ—Ç —Å—Å—ã–ª–æ–∫ –Ω–∞ –∏—Å—Ç–æ—á–Ω–∏–∫–∏. –ù–µ—Ç –¥–∞–Ω–Ω—ã—Ö –∏–∑ post-hoc –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –ø—Ä–æ –ø–∏–ø–∏—Ä–∏–¥–∏–º–∏–¥–æ–ª! –û—á–µ–Ω—å –Ω—É–∂–Ω—ã –∫ –∑–∞–≤—Ç—Ä–∞—à–Ω–µ–º—É –¥–Ω—é. (good) –í—ã –Ω–µ–≤–µ—Ä–æ—è—Ç–Ω–æ —É–ø–æ—Ä–Ω—ã–µ –∏ —Å–ø—Ä–∞–≤–∏—Ç–µ—Å—å —Å–æ –≤—Å–µ–º–∏ –ø—Ä–æ–±–ª–µ–º–∞–º–∏! –í–µ—Ä—é, —á—Ç–æ –≤—Å—ë –ø–æ–ª—É—á–∏—Ç—Å—è! –ê –≤–æ—Ç —Å –õ–µ–∫–µ–º–±–∏ –≤ –ø—É–±–ª–∏–∫–∞—Ü–∏–∏ –Ω–∞ –∫–æ—Ä–µ–π—Å–∫–æ–º —Å–∞–π—Ç–µ –≤—Å—ë –Ω–µ–º–Ω–æ–≥–æ –Ω–∞–æ–±–æ—Ä–æ—Ç. –°–Ω–∞—á–∞–ª–∞ –≤ —Å—Ç–∞—Ç—å–µ –≥–æ–≤–æ—Ä–∏—Ç—Å—è –æ –ø–æ–±–æ—á–Ω—ã—Ö —ç—Ñ—Ñ–µ–∫—Ç–∞—Ö, –∫–æ—Ç–æ—Ä—ã–µ –≤ –∫–∞–Ω–∞–ª–µ —É–ø–æ–º–∏–Ω–∞–ª–∏—Å—å —Ä–∞–Ω–µ–µ. –ò—Ö —è –Ω–∞–∑–≤–∞–ª–∞ ""—Å—É–º–∞—Å—à–µ–¥—à–∏–º–∏"". –ù–æ –∑–∞—Ç–µ–º –¥–∞—é—Ç—Å—è —Å–ª–µ–¥—É—é—â–∏–µ –∫–æ–º–º–µ–Ω—Ç–∞—Ä–∏–∏. ¬´–†–µ–∞–ª—å–Ω—ã–π –æ–ø—ã—Ç –≤—Ä–∞—á–µ–π –∑–∞ —Ä—É–±–µ–∂–æ–º, –ø—Ä–∏–º–µ–Ω—è–≤—à–∏—Ö —ç—Ç–æ—Ç –ø—Ä–µ–ø–∞—Ä–∞—Ç, –ø–æ–∫–∞–∑—ã–≤–∞–µ—Ç, —á—Ç–æ —ç—Ç–∏ –ø–æ–±–æ—á–Ω—ã–µ —ç—Ñ—Ñ–µ–∫—Ç—ã –Ω–µ —Å—Ç–æ–ª—å —Å–µ—Ä—å—ë–∑–Ω—ã, –∫–∞–∫ –æ–∂–∏–¥–∞–ª–æ—Å—å¬ª, ‚Äî –æ—Ç–º–µ—Ç–∏–ª –ø—Ä–æ—Ñ–µ—Å—Å–æ—Ä –õ–∏. ¬´–•–æ—Ç—è –º—ã –Ω–µ –ø—Ä–µ—É–º–µ–Ω—å—à–∞–µ–º –∏ –Ω–µ –∏–≥–Ω–æ—Ä–∏—Ä—É–µ–º —ç—Ç–∏ –ø–æ–±–æ—á–Ω—ã–µ —ç—Ñ—Ñ–µ–∫—Ç—ã, –µ—Å–ª–∏ –æ–Ω–∏ –¥–æ—Å—Ç–∏–≥–∞—é—Ç —É—Ä–æ–≤–Ω—è, —Å–ø–æ—Å–æ–±–Ω–æ–≥–æ —Å–≤–µ—Å—Ç–∏ –Ω–∞ –Ω–µ—Ç –∫–ª–∏–Ω–∏—á–µ—Å–∫—É—é –ø–æ–ª—å–∑—É, –∫–æ—Ç–æ—Ä—É—é –º–æ–∂–µ—Ç –ø–æ–ª—É—á–∏—Ç—å –ø–∞—Ü–∏–µ–Ω—Ç, –ª–µ—á–µ–Ω–∏–µ –≤—Å—ë —Ä–∞–≤–Ω–æ –∏–º–µ–µ—Ç –≤–∞–∂–Ω–æ–µ –∑–Ω–∞—á–µ–Ω–∏–µ¬ª. –ê –ø–æ—Ç–æ–º –µ—â—ë –Ω–µ–º–Ω–æ–≥–æ –Ω–∞–≤–∞–ª–∏–≤–∞—é—Ç –Ω–µ–≥–∞—Ç–∏–≤–∞ –ø—Ä–æ –æ–±—â–µ—Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω—ë–Ω–Ω—ã–µ –ø–æ–±–æ—á–Ω—ã–µ —ç—Ñ—Ñ–µ–∫—Ç—ã. –≠—Ç–æ –ª–∏ –Ω–µ –Ω–æ–≤—ã–π —É—Ä–æ–≤–µ–Ω—å –≤–ª–∏—è–Ω–∏—è, –º?","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety, guideline"",
  ""impact"": ""high"",
  ""english"": ""The article describes the negative side effects of Lecanemab, a treatment for Alzheimer's disease. The comments suggest that these side effects are not as severe as initially thought, but still caution against their impact on patient care. This highlights the importance of clinical trials and safety guidelines in ensuring effective treatments.""
}"
2025-08-23T09:11:01+00:00,@pharm_icon,2344,https://t.me/pharm_icon/2344,"–ö–∞–∫–æ–π —Ä–æ—Å–∫–æ—à–Ω—ã–π –∏–Ω–¥—É—Å –∏–∑ —Ä–µ–∫–ª–∞–º—ã –ª–∏–¥–∏—Ä—É—é—â–µ–≥–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –º–∞—Ä–∫–µ—Ç–ø–ª–µ–π—Å–∞ –ò–Ω–¥–∏–∏ PharmEasy. –ñ–µ–ª–∞—é –≤–∞–º —Ç–∞–∫–∏—Ö –∂–µ –Ω–∞—Ä—è–¥–Ω—ã—Ö –≤—ã—Ö–æ–¥–Ω—ã—Ö! –í–ø—Ä–æ—á–µ–º, –≤ –≤–æ—Å–∫—Ä–µ—Å–µ–Ω—å–µ –±—É–¥–µ—Ç –∞–±—Å–æ–ª—é—Ç–Ω–æ –≤–æ–∑–º—É—â–∞—é—â–∏–π –ø–æ—Å—Ç.","{""skip"": true}"
2025-08-23T06:03:01+00:00,@pharm_icon,2343,https://t.me/pharm_icon/2343,"–í—Ä–∞—á–∏-–∑—É–º–µ—Ä—ã –Ω–µ –¥–µ—Ä–∂–∞—Ç –æ–±–æ—Ä–æ–Ω—É. –ë—É–º–µ—Ä—ã ‚Äî —Ç–æ–∂–µ. –ù–∞ –≤—Å—Ç—Ä–µ—á–µ –º–æ–ª–æ–¥—ã—Ö –¥–æ–∫—Ç–æ—Ä–æ–≤ –æ–¥–∏–Ω –ø—Ä–æ—Ñ–µ—Å—Å–æ—Ä –æ—Ä—Ç–æ–ø–µ–¥–∏—á–µ—Å–∫–æ–π —Ö–∏—Ä—É—Ä–≥–∏–∏ —é–∂–Ω–æ–∫–æ—Ä–µ–π—Å–∫–æ–π —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç—Å–∫–æ–π –∫–ª–∏–Ω–∏–∫–∏ –ê–Ω–∞–º –ü–∞—Ä–∫ –î–∂–æ–Ω–∫-–•—É–Ω ‚Äî –µ–≥–æ —Ñ–æ—Ç–æ –≤ –≤–∏–¥–µ–æ ‚Äî —É—Å–ª—ã—à–∞–ª –æ—Ç –º–æ–ª–æ–¥—ã—Ö —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –Ω–µ—á—Ç–æ –∏–Ω—Ç–µ—Ä–µ—Å–Ω–æ–µ. –û–Ω–∏ —Å–æ–æ–±—â–∏–ª–∏ –æ–± –∏–∑–±–µ–≥–∞–Ω–∏–∏ –∏–º–∏ ""—Ñ—É–Ω–¥–∞–º–µ–Ω—Ç–∞–ª—å–Ω—ã—Ö"" —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∞—Ü–∏–π (—Ç–µ—Ä–∞–ø–∏—è, —Ö–∏—Ä—É—Ä–≥–∏—è) –∏–∑-–∑–∞ –æ–∫–∞–∑—ã–≤–∞–µ–º–æ–≥–æ –≤ —Å–ø–æ—Ä–∞—Ö —Å –ø–∞—Ü–∏–µ–Ω—Ç–∞–º–∏ –¥–∞–≤–ª–µ–Ω–∏—è, —Å—Ä–∞–≤–Ω–∏–º–æ–≥–æ —Å –¥–æ–ø—Ä–æ—Å–æ–º –ø—Ä–µ—Å—Ç—É–ø–Ω–∏–∫–∞. –ü—Ä–æ—Ñ–µ—Å—Å–æ—Ä —Å–ª—ã—à–∞–ª —Ç–∞–∫–æ–µ –∏ —Ä–∞–Ω–Ω–µ–µ, –Ω–æ –Ω–µ –∑–∞–¥—É–º—ã–≤–∞–ª—Å—è, –æ–¥–Ω–∞–∫–æ —Å—Ö–æ–∂—É—é –∏—Å—Ç–æ—Ä–∏—é –æ–ø–∏—Å–∞–ª–∏ –∏ –µ–≥–æ —Ä–æ–≤–µ—Å–Ω–∏–∫–∏-—Å—Ç–∞—Ä–æ–∂–∏–ª—ã. –í—ã—à–µ–ª —Ä–∞–∑ –≤ –Ω–∞—Ä–æ–¥ –∏ —Å—Ä–∞–∑—É –ø–æ–ª—É—á–∏–ª –∏–Ω—Å–∞–π—Ç –û–Ω –ø–æ–¥—É–º–∞–ª –∏ –≤—ã–¥–µ–ª–∏–ª –Ω–µ—Å–∫–æ–ª—å–∫–æ –ø—Ä–∏—á–∏–Ω: üëâüèº –ú–æ–ª–æ–¥—ã–µ –≤—Ä–∞—á–∏ (–∏ –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–∏ –≤ —Ü–µ–ª–æ–º) –æ—â—É—â–∞—é—Ç –∫—Ä–∞–π–Ω–∏–π –¥–∏—Å–∫–æ–º—Ñ–æ—Ä—Ç –≤ –∫–æ–Ω—Ñ–ª–∏–∫—Ç–∞—Ö, –ø–æ—Ç–æ–º —á—Ç–æ –ø—Ä–∏–≤—ã–∫–ª–∏ ""–±—ã—Ç—å –º–æ–ª–æ–¥—Ü–∞–º–∏ –≤ —à–∫–æ–ª–∞—Ö, –Ω–µ –∂–∏–≤—è –≤ –æ–¥–Ω–æ–π –∫–æ–º–Ω–∞—Ç–µ —Å —Ä–æ–¥—Å—Ç–≤–µ–Ω–Ω–∏–∫–∞–º–∏"". –ù–æ–≤–æ–µ –ø–æ–∫–æ–ª–µ–Ω–∏–µ, –ø–æ –µ–≥–æ —Å–ª–æ–≤–∞–º, —á–∞—Å—Ç–æ –Ω–µ –∏–º–µ–µ—Ç –¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ–≥–æ –æ–ø—ã—Ç–∞ —Å–æ—Ü–∏–∞–ª—å–Ω–æ–≥–æ –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏—è –≤ —É—Å–ª–æ–≤–∏—è—Ö —Å—Ç—Ä–µ—Å—Å–∞, —Ç–∞–∫–∏—Ö –∫–∞–∫ —Å–æ–≤–º–µ—Å—Ç–Ω–æ–µ –ø—Ä–æ–∂–∏–≤–∞–Ω–∏–µ –Ω–∞ –º–∞–ª–æ–π –ø–ª–æ—â–∞–¥–∏, –æ—Ñ–ª–∞–π–Ω –æ—Ç–¥—ã—Ö —Å –¥—Ä—É–∑—å—è–º–∏ –∏ —Å–ª—É–∂–±—É –≤ –∞—Ä–º–∏–∏. –ë–µ–∑ —Ç–∞–∫–æ–≥–æ –æ–ø—ã—Ç–∞ –≤ –ø–µ—Ä–∏–æ–¥ –≤–∑—Ä–æ—Å–ª–µ–Ω–∏—è —Ä–∞–∑–±–∏—Ä–∞—Ç–µ–ª—å—Å—Ç–≤–æ —Å –ø–∞—Ü–∏–µ–Ω—Ç–æ–º, –æ—Å–æ–±–µ–Ω–Ω–æ ‚Äî —Ç—è–∂–µ–ª–æ–±–æ–ª—å–Ω—ã–º, —Å—Ç–∞–Ω–æ–≤–∏—Ç—Å—è —Ç—è–∂–µ–ª—ã–º –∏—Å–ø—ã—Ç–∞–Ω–∏–µ–º. üëâüèº –ü–æ–≤—ã—à–µ–Ω–Ω–∞—è —á–∞—Å—Ç–æ—Ç–∞ —Å—É–¥–µ–±–Ω—ã—Ö —Ä–∞–∑–±–∏—Ä–∞—Ç–µ–ª—å—Å—Ç–≤, –æ–±–≤–∏–Ω–∏—Ç–µ–ª—å–Ω—ã—Ö –ø—Ä–∏–≥–æ–≤–æ—Ä–æ–≤ –∏ —Ç—è–∂–µ—Å—Ç—å –Ω–∞–∫–∞–∑–∞–Ω–∏—è, —Ö–∞—Ä–∞–∫—Ç–µ—Ä–Ω—ã—Ö –¥–ª—è ""—Ñ—É–Ω–¥–∞–º–µ–Ω—Ç–∞–ª—å–Ω—ã—Ö"" —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–µ–π, —Ñ–æ—Ä–º–∏—Ä—É—é—Ç —Å—Ç—Ä–∞—Ö –∏ –Ω–µ–∂–µ–ª–∞–Ω–∏–µ —Ä–∞–±–æ—Ç–∞—Ç—å –≤ –Ω–∏—Ö. –ö–∞–∫ –ø—Ä–æ—Ñ–µ—Å—Å–æ—Ä —Ö–æ—á–µ—Ç —Ä–µ—à–∏—Ç—å –ø—Ä–æ–±–ª–µ–º—É? üí°–ü–æ–≤—ã—Å–∏—Ç—å —á–∏—Å–ª–æ –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ (–∑–Ω–∞–µ–º, –ø—Ä–æ—Ö–æ–¥–∏–ª–∏), —á—Ç–æ–±—ã —á–∞—Å—Ç—å –∏—Ö –∑–∞–∫—Ä—ã–ª–∞ –¥–µ—Ñ–∏—Ü–∏—Ç. –ò–∑–≤–µ—Å—Ç–Ω–æ, —á—Ç–æ —ç—Ç–æ –∫–æ–Ω—á–∏—Ç—Å—è —Ä–æ—Å—Ç–æ–º –¥–∏–ø–ª–æ–º–æ–≤, –∞ –Ω–µ –∑–∞–∫—Ä—ã—Ç–∏–µ–º –¥–µ—Ñ–∏—Ü–∏—Ç–∞. üí° –°–º—è–≥—á–∏—Ç—å –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–æ –ø–æ –æ—Ç–Ω–æ—à–µ–Ω–∏—é –∫ –º–µ–¥–∏–∫–∞–º, –Ω–∞–ø—Ä–∏–º–µ—Ä, –∏–º–º—É–Ω–∏—Ç–µ—Ç–æ–º –ø—Ä–∏ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏–∏ –Ω–∞–¥–ª–µ–∂–∞—â–µ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏. üí° –í–æ—Å–ø–∏—Ç–∞—Ç—å —á–µ–ª–æ–≤–µ–∫–∞, –≥–æ—Ç–æ–≤–æ–≥–æ –ø–æ–ø–æ—Ç–µ—Ç—å ""–≤ –ø–æ–ª—è—Ö"". –ó–≤—É—á–∏—Ç –∫–∞–∫ –ø–æ–ø—ã—Ç–∫–∞ –ø—Ä–æ–ø–∏—Ö–Ω—É—Ç—å —Ä–∞–∑–≥–æ–≤–æ—Ä—ã –æ –≤–∞–∂–Ω–æ–º –≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç—ã. üí° –ü—Ä–æ–¥–ª–∏—Ç—å —Å—Ä–æ–∫ –∏–ª–∏ –≤–µ—Ä–Ω—É—Ç—å —Å—Ç–∞—Ä—ã–µ –Ω–æ—Ä–º—ã —á–∞—Å–æ–≤ —Ä–µ–∑–∏–¥–µ–Ω—Ç—É—Ä—ã, —á—Ç–æ–±—ã –±—ã–ª–æ –∫–∞–∫ –≤ —Å—Ç–∞—Ä—ã–µ-–¥–æ–±—Ä—ã–µ –≤—Ä–µ–º–µ–Ω–∞, –∞ –Ω–µ –≤ —É–ø–æ–ª–æ–≤–∏–Ω–µ–Ω–Ω—ã–µ –Ω—ã–Ω–µ—à–Ω–∏–µ. üí° –î–æ–±–∞–≤–∏—Ç—å –º–æ–¥—É–ª—å –ø–æ —Å–æ—Ñ—Ç-—Å–∫–∏–ª–∞–º, –∫–∞–∫ –¥–µ–ª–∞–µ—Ç —ç—Ç–æ –ø—Ä–æ—Ñ–µ—Å—Å–æ—Ä, –ø—É—Å—Ç—å –∏ —Ü–µ–Ω–æ–π —Å–º–µ—â–µ–Ω–∏—è —Ñ–æ–∫—É—Å–∞ —Å –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –Ω–∞–≤—ã–∫–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ ""–æ—Ç—Ç–æ—á–∞—Ç—Å—è —Å–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω–æ, —Ö–æ—á–µ—Ç —Ç–æ–≥–æ —Å—Ç—É–¥–µ–Ω—å –∏–ª–∏ –Ω–µ—Ç"". –ü–æ –µ–≥–æ –º–Ω–µ–Ω–∏—é –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ–∫ –≤—Ä–µ–º–µ–Ω–∏ –Ω–∞ –æ–±—É—á–µ–Ω–∏–µ –≤–∫—É–ø–µ —Å –∏–∑–±–µ–≥–∞–Ω–∏–µ–º –ø—Ä–∏–≤–æ–¥—è—Ç –∫ –Ω–µ–≥–∞—Ç–∏–≤–Ω–æ–π —Å–≤—è–∑–∏ –≤ –≤–∏–¥–µ —Å—Ç—Ä–∞—Ö–∞ –∏ –∏–∑–±–µ–≥–∞–Ω–∏—è —Ü–µ–ª—ã—Ö —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–µ–π. üëÄ–ß—Ç–æ –±—Ä–æ—Å–∞–µ—Ç—Å—è –≤ –≥–ª–∞–∑–∞? –ú—ã –∫–∞–∫ –±—É–¥—Ç–æ –ø—Ä–æ—á–∏—Ç–∞–ª–∏ –Ω–µ –∫–æ—Ä–µ–π—Å–∫–æ–≥–æ –ø—Ä–æ—Ñ–µ—Å—Å–æ—Ä–∞, –∞ –∑–∞–≤–µ–¥—É—é—â–µ–≥–æ –æ—Ç–¥–µ–ª–µ–Ω–∏–µ–º –ø–æ–ª–∏–∫–ª–∏–Ω–∏–∫–∏. –ë—Ä–∞—Ç—Å–∫–∏–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –Ω–∞—Ä–æ–¥—ã, –ø–æ–ª—É—á–∞–µ—Ç—Å—è?","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, shortage, safety, guideline"",
  ""impact"": ""medium"",
  ""english"": ""The professor from a South Korean university clinic, Dr. Jonk-Hun of Anam Park Hospital, heard something interesting from young doctors at a meeting. Young specialists mentioned feeling uncomfortable in conflicts due to pressure they feel, similar to interrogating a suspect. The professor realized this is not uncommon but didn't think about it further until now. He identified several reasons: 1) Young doctors and medical workers feel uncomfortable in conflicts due to their upbringing, lacking social interaction. 2) High frequency of legal disputes and severe punishments in fundamental specialties create fear among doctors to work there. He suggests solutions such as increasing medical staff, reducing the need for specific specialties, and providing more training on soft skills.""
}"
2025-08-21T13:26:25+00:00,@pharm_icon,2342,https://t.me/pharm_icon/2342,"–°–º—ã—Å–ª–æ–≤–æ–µ –∫–æ–º–±–æ ‚Äî –±—Ä–µ–Ω–¥ –°–∏–±–∏—Ä—è—á–æ–∫ –¥–ª—è –¥–µ—Ç–µ–π. –î—Ä–∞–∂–µ –¥–ª—è —É–ª—É—á—à–µ–Ω–∏—è –∞–ø–ø–µ—Ç–∏—Ç–∞ (–æ—á–µ–Ω—å –∏–Ω—Ç–µ—Ä–µ—Å–Ω–æ). –ê –≤ —á–µ–º –∫–æ–º–±–æ? –í –°–∏–±–∏—Ä–∏ –Ω–∞ 2 –≥–æ–¥–∞ –Ω–∏–∂–µ –ø—Ä–æ–¥–æ–ª–∂–∏—Ç–µ–ª—å–Ω–æ—Å—Ç—å –∂–∏–∑–Ω–∏, —á–µ–º –ø–æ –†–æ—Å—Å–∏–∏, –∞ —É –º—É–∂—á–∏–Ω —Ç–∞–∫ –≤—Å–µ–≥–æ 65,7. –û—Å—Ç–∞—ë—Ç—Å—è –ø–æ–∂–µ–ª–∞—Ç—å —É–¥–∞—á–∏ –º–∞–ª—å—á–∏–∫—É —Å —É–ø–∞–∫–æ–≤–∫–∏.","{""skip"": true}"
2025-08-21T10:46:57+00:00,@pharm_icon,2340,https://t.me/pharm_icon/2340,"–ó–¥—Ä–∞–≤—Å–∏—Ç–∏ —Ç–æ–∂–µ –æ—Ç–ø—Ä–∞–≤–ª—è–µ—Ç –≤ —à–∫–æ–ª—É –¥–µ—Ç–µ–π –Ω–∞ –≥–æ–º–µ–æ—Å—Ç—Ä–µ—Å—Å–µ ‚Äî —ç—Ç–æ—Ç –ø—Ä–µ–ø–∞—Ä–∞—Ç –º–æ–∂–Ω–æ —É–≤–∏–¥–µ—Ç—å –≤ –ø–æ–¥–±–æ—Ä–∫–µ –¥–ª—è —à–∫–æ–ª—ã. –ú–∞–ª–æ –¥–µ—Ç—è–º —É—Ä–æ–∫–æ–≤ –æ –≤–∞–∂–Ω–æ–º, —Å—á–∏—Ç–∞–µ—Ç–µ?üòÅü§åüèª","{""skip"": true}"
2025-08-21T10:41:49+00:00,@pharm_icon,2339,https://t.me/pharm_icon/2339,–ù–∞ —Å–∞–π—Ç–µ –ê–ø—Ç–µ–∫–∞.—Ä—É –ê–û –ù–ü–ö –ö–∞—Ç—Ä–µ–Ω –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç –≥–æ—Ç–æ–≤–∏—Ç—å –¥–µ—Ç–µ–π –∫ —à–∫–æ–ª–µ —Å –ø–æ–º–æ—â—å—é —Ç–∞–±–ª–µ—Ç–æ–∫. –ö–∞–∫ –≤–∞–º —Ç–∞–∫–æ–µ? –í–∞—à —Ä–µ–±–µ–Ω–æ–∫ –µ—â—ë –Ω–µ –≤ —Å–æ—Å—Ç–æ—è–Ω–∏–∏ –ø–æ–ª–∏–ø—Ä–∞–≥–º–∞–∑–∏–∏?,"{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""A company called A.O. NPK Katren is offering to prepare children for school using tablets. Is your child not yet ready for polygraphy?""
}"
2025-08-21T08:06:04+00:00,@pharm_icon,2338,https://t.me/pharm_icon/2338,"–ò–Ω–≥–∏–±–∏—Ç–æ—Ä—ã –ø—Ä–æ—Ç–æ–Ω–Ω–æ–π –ø–æ–º–ø—ã –∏ –æ—Å—Ç–µ–æ–ø–æ—Ä–æ–∑ –ò–∑ –º–∏–Ω—É—Å–æ–≤ –∫–æ—Ä–µ–π—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π - –Ω–µ–ø–æ–Ω—è—Ç–Ω–æ –≤–ª–∏—è–Ω–∏–µ –Ω–∞ –∫–æ–Ω–∫—Ä–µ—Ç–Ω—ã–µ –∫–æ–Ω–µ—á–Ω—ã–µ —Ç–æ—á–∫–∏ –∏ –∏—Å—Ç–∏–Ω–Ω—ã–µ –ø—Ä–∏—á–∏–Ω–Ω–æ-—Å–ª–µ–¥—Å—Ç–≤–µ–Ω–Ω—ã–µ —Å–≤—è–∑–∏. –í–æ—Ç –≤ –∫–æ–≥–æ—Ä—Ç–Ω–æ–º –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–∏ —Å–ª—É—á–∞–π‚Äì–∫–æ–Ω—Ç—Ä–æ–ª—å (13 556 –±–æ–ª—å–Ω—ã—Ö —Å –ø–µ—Ä–µ–ª–æ–º–æ–º –±–µ–¥—Ä–∞ –∏ 135 386 –ª–∏—Ü –∫–æ–Ω—Ç—Ä–æ–ª—å–Ω–æ–π –≥—Ä—É–ø–ø—ã) Y.X. Yang et al. –≤—ã—è–≤–∏–ª–∏, —á—Ç–æ —Å–∫–æ—Ä—Ä–µ–∫—Ç–∏—Ä–æ–≤–∞–Ω–Ω–æ–µ –æ—Ç–Ω–æ—à–µ–Ω–∏–µ —à–∞–Ω—Å–æ–≤ (–°–û–®) –¥–ª—è –ø–µ—Ä–µ–ª–æ–º–∞ –±–µ–¥—Ä–∞, –∞—Å—Å–æ—Ü–∏–∏—Ä–æ–≤–∞–Ω–Ω–æ–≥–æ —Å –¥–ª–∏—Ç–µ–ª—å–Ω—ã–º –ø—Ä–∏–µ–º–æ–º –ò–ü–ü (‚â•1 –≥–æ–¥–∞), —Å–æ—Å—Ç–∞–≤–∏–ª–æ 1,44. –ü—Ä–∏ —ç—Ç–æ–º —Å–≤—è–∑—å —É—Å–∏–ª–∏–≤–∞–ª–∞—Å—å –ø–æ –º–µ—Ä–µ —É–≤–µ–ª–∏—á–µ–Ω–∏—è –¥–ª–∏—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ —Ç–µ—Ä–∞–ø–∏–∏ –ò–ü–ü (–°–û–® –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –ø—Ä–∏–Ω–∏–º–∞–≤—à–∏—Ö –ò–ü–ü –≤ —Ç–µ—á–µ–Ω–∏–µ 1 –≥–æ–¥–∞, —Å–æ—Å—Ç–∞–≤–∏–ª–æ 1,22 –ø—Ä–æ—Ç–∏–≤ 1,59 –¥–ª—è —Ç–µ—Ö, –∫—Ç–æ –ø—Ä–∏–Ω–∏–º–∞–ª –ò–ü–ü –≤ —Ç–µ—á–µ–Ω–∏–µ 4 –ª–µ—Ç). –í–æ–∑–º–æ–∂–Ω–æ, –µ—Å—Ç—å —Å–≤—è–∑—å —Å —Ç–µ–º, —á—Ç–æ –ø–æ—Å–ª–µ —ç—Ä–∞–¥–∏–∫–∞—Ü–∏–∏ –Ω–µ –ø—Ä–∏—Ö–æ–¥–∏—Ç—Å—è –ø–æ–∂–∏–∑–Ω–µ–Ω–Ω–æ –ø—Ä–∏–Ω–∏–º–∞—Ç—å –ò–ü–ü?","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""A Korean study suggests that proton pump inhibitors (PPIs) may increase the risk of hip fractures. A cohort study by Y.X. Yang et al. found that patients taking PPIs for more than a year had an adjusted odds ratio (OR) of 1.44 compared to those taking PPIs for only one year, indicating a stronger association with longer treatment duration. The study raises questions about the necessity of lifelong PPI therapy.""
}"
2025-08-21T07:47:55+00:00,@pharm_icon,2337,https://t.me/pharm_icon/2337,"""–°—Ç–∞—Ä–æ—Ä–æ–¥—è—â–∏–º"": —ç—Ä–∞–¥–∏–∫–∞—Ü–∏—è —Ö–µ–ª–∏–∫–æ–±–∞–∫—Ç–µ—Ä–∞ –∑–∞—â–∏—â–∞–µ—Ç –∫–æ—Å—Ç–∏ –∂–µ–Ω—â–∏–Ω 50+. –î–≤–∞–¥—Ü–∞—Ç–∏–ª–µ—Ç–Ω–µ–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –ø–æ–∫–∞–∑–∞–ª–æ, —á—Ç–æ —ç—Ä–∞–¥–∏–∫–∞—Ü–∏—è H.pylori –ø—Ä–µ–¥–æ—Ç–≤—Ä–∞—â–∞–µ—Ç –æ—Å—Ç–µ–æ–ø–æ—Ä–æ–∑ —É –∂–µ–Ω—â–∏–Ω –æ—Ç 50 –ª–µ—Ç. –¢–∞–∫–æ–≤—ã —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ –∏–Ω—Å—Ç–∏—Ç—É—Ç–∞ –∑–¥–æ—Ä–æ–≤—å—è (NIH) (–¥—Ä—É–≥–æ–≥–æ, –∫–æ—Ä–µ–π—Å–∫–æ–≥–æ), —á–∞—Å—Ç–∏ –∫–æ—Ä–µ–π—Å–∫–æ–≥–æ –¶–µ–Ω—Ç—Ä–∞ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –∏ –∫–æ–Ω—Ç—Ä–æ–ª—è –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π (–∫–æ—Ä–µ–π—Å–∫–∞—è –≤–µ—Ä—Å–∏—è CDC), –æ–±—ä—è–≤–∏–ª –æ–± —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ —ç—Ä–∞–¥–∏–∫–∞—Ü–∏–∏ H. pylori –≤ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–µ –æ—Å—Ç–µ–æ–ø–æ—Ä–æ–∑–∞. –ò—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –ø—Ä–æ–≤–æ–¥–∏–ª–æ—Å—å –ø–æ–¥ —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–æ–º Kim Na-young –≤ –æ–¥–Ω–æ–π –∏–∑ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç—Å–∫–æ–π –∫–ª–∏–Ω–∏–∫ –°–µ—É–ª–∞ –ø—Ä–∏ –ø–æ–¥–¥–µ—Ä–∂–∫–µ NIH. Helicobacter pylori - –æ—Å–Ω–æ–≤–Ω–∞—è –∏ —à–∏—Ä–æ–∫–æ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–Ω–∞—è (>50% –º–∏—Ä–∞) –ø—Ä–∏—á–∏–Ω–∞ –≥–∞—Å—Ç—Ä–∏—Ç–∞, –ø–µ–ø—Ç–∏—á–µ—Å–∫–æ–π —è–∑–≤—ã –∏ –æ–ø—É—Ö–æ–ª–µ–π –∂–µ–ª—É–¥–∫–∞. –ù–∞ 2017 –≥–æ–¥ –µ–π –±—ã–ª–æ –∑–∞—Ä–∞–∂–µ–Ω–æ 44% –∫–æ—Ä–µ–π—Ü–µ–≤ –æ—Ç 16 –ª–µ—Ç, —Å–ø–æ–¥–≤–∏–≥–Ω—É–≤ –∏—Å–∫–∞—Ç—å –µ–µ —Å–≤—è–∑—å —Å –¥—Ä—É–≥–∏–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏. –í—ã–±–æ—Ä –ø–∞–ª –Ω–∞ –æ—Å—Ç–µ–æ–ø–æ—Ä–æ–∑, –ø–æ—Ä–∞–∑–∏–≤—à–∏–π 37,3% –∫–æ—Ä–µ—è–Ω–æ–∫ –æ—Ç 50 –ª–µ—Ç –∏ –ø–æ–≤—ã—à–∞—é—â–∏–π –∏—Ö —Å–º–µ—Ä—Ç–Ω–æ—Å—Ç—å –∏–∑-–∑–∞ —É—á–∞—â–µ–Ω–∏—è –ª–µ—Ç–∞–ª—å–Ω—ã—Ö –ø–µ—Ä–µ–ª–æ–º–æ–≤ –∏ –≤—ã—Å—Ç–∞–≤–ª–µ–Ω–∏—è –∫–æ–Ω—Å–∫–∏—Ö —Å—á–µ—Ç–æ–≤ –∑–∞ –ª–µ—á–µ–Ω–∏–µ. –ò—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –ø—Ä–æ–≤–æ–¥–∏–ª–æ—Å—å —Å 2003 –ø–æ 2023 –≥–æ–¥–∞ –≤ SNUBH, –≤ –Ω–µ–º –ø—Ä–∏–Ω—è–ª–∏ —É—á–∞—Å—Ç–∏–µ 846 –∂–µ–Ω—â–∏–Ω —Å –¥–∏–∞–≥–Ω–æ—Å—Ç–∏—Ä–æ–≤–∞–Ω–Ω–æ–π –∏–Ω—Ñ–µ–∫—Ü–∏–µ–π H.pylori. –£ 116 —É—á–∞—Å—Ç–Ω–∏—Ü, –Ω–µ –ø—Ä–æ—à–µ–¥—à–∏—Ö —ç—Ä–∞–¥–∏–∫–∞—Ü–∏—é, —á–∞—Å—Ç–æ—Ç–∞ –æ—Å—Ç–µ–æ–ø–æ—Ä–æ–∑–∞ —Å–æ—Å—Ç–∞–≤–∏–ª–∞ 34,5% –ø—Ä–æ—Ç–∏–≤ 24,5% –≤ –≥—Ä—É–ø–ø–µ 730 –ø–∞—Ü–∏–µ–Ω—Ç–æ–∫, —É—Å–ø–µ—à–Ω–æ –ø—Ä–æ–≤–µ–¥—à–∏—Ö —ç—Ä–∞–¥–∏–∫–∞—Ü–∏—é. –û—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ–µ —Å–Ω–∏–∂–µ–Ω–∏–µ —á–∞—Å—Ç–æ—Ç—ã –≤—ã—è–≤–ª–µ–Ω–∏—è –æ—Å—Ç–µ–æ–ø–æ—Ä–æ–∑–∞ —Å–æ—Å—Ç–∞–≤–∏–ª–æ 29%. –ü—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–∏–π —ç—Ñ—Ñ–µ–∫—Ç —ç—Ä–∞–¥–∏–∫–∞—Ü–∏–∏ –±—ã–ª –Ω–∞–∏–±–æ–ª–µ–µ –≤—ã—Ä–∞–∂–µ–Ω —É –∂–µ–Ω—â–∏–Ω, –Ω–∞–∏–±–æ–ª—å—à–∏–π —ç—Ñ—Ñ–µ–∫—Ç –ø—Ä–∏—à–µ–ª—Å—è –Ω–∞ –≥—Ä—É–ø–ø—É –æ—Ç 50 –ª–µ—Ç. –°—Ç–∞—Ç–∏—Å—Ç–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º–æ–π —Ä–∞–∑–Ω–∏—Ü—ã –º–µ–∂–¥—É –º—É–∂—á–∏–Ω–∞–º–∏ –∏ –∂–µ–Ω—â–∏–Ω–∞–º–∏ –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ –≤–∑–∞–∏–º–æ—Å–≤—è–∑–∏ –º–µ–∂–¥—É —ç—Ä–∞–¥–∏–∫–∞—Ü–∏–æ–Ω–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–µ–π –∏ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–æ–π –æ—Å—Ç–µ–æ–ø–æ—Ä–æ–∑–∞ –Ω–µ –Ω–∞–±–ª—é–¥–∞–ª–æ—Å—å. –î–æ–∫—Ç–æ—Ä Park Hyun-young, –≥–µ–Ω–µ—Ä–∞–ª—å–Ω—ã–π –¥–∏—Ä–µ–∫—Ç–æ—Ä NIH –Æ–∂–Ω–æ–π –ö–æ—Ä–µ–∏, –∑–∞—è–≤–∏–ª–∞ –æ –∫–ª—é—á–µ–≤–æ–π –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å–Ω–æ–π —Ä–æ–ª–∏ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –æ –∫–æ–º–æ—Ä–±–∏–¥–Ω–æ—Å—Ç–∏ —Ö–µ–ª–∏–∫–æ–±–∞–∫—Ç–µ—Ä –∏–Ω—Ñ–µ–∫—Ü–∏–∏ –∏ –≤–∞–∂–Ω–æ—Å—Ç–∏ –µ–µ –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥–∞ –∏ —Ç–µ—Ä–∞–ø–∏–∏ —É –∂–µ–Ω—â–∏–Ω –≤ –ø–µ—Ä–∏–æ–¥ –º–µ–Ω–æ–ø–∞—É–∑—ã. –ü–ª–∞–Ω–∏—Ä—É–µ—Ç—Å—è –¥–∞–ª—å–Ω–µ–π—à–µ–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –ø–æ –ø–æ–ª–æ–≤—ã–º –≥—Ä—É–ø–ø–∞–º –¥–ª—è –æ–ø—Ç–∏–º–∏–∑–∞—Ü–∏–∏ —Ç–µ—Ä–∞–ø–∏–∏. üî• ‚Äî —ç—Ç–æ –æ–≥–æ–Ω—å üóø ‚Äî —ç—Ç–æ —É–º–µ—Ä–µ–Ω–Ω–æ –ø–æ–ª–µ–∑–Ω–∞—è –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è, –≤ –º–æ—ë–º –º–∏—Ä–µ –Ω–µ —Å—É—â–µ—Å—Ç–≤—É–µ—Ç –ø—Ä–æ–±–ª–µ–º—ã –æ—Å—Ç–µ–æ–ø–æ—Ä–æ–∑–∞, –∞ –ü–∏—Ç–µ—Ä –ì—ë—Ç—à–µ —Å—á–∏—Ç–∞–µ—Ç –µ–≥–æ –≤—ã–¥—É–º–∞–Ω–Ω—ã–º –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–µ–º, –ø–æ—Ç–æ–º—É —á—Ç–æ –∫—Ä–∏—Ç–µ—Ä–∏–∏ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∏ –≤–∑—è–ª–∏—Å—å –∏–∑ -2 —Å—Ç–∞–Ω–¥–∞—Ä—Ç–Ω–æ–≥–æ –æ—Ç–∫–ª–æ–Ω–µ–Ω–∏—è, —è —Å—á–∏—Ç–∞—é, —á—Ç–æ —ç—Ç–æ –ø–æ–ª–Ω–∞—è —á—É—à—å –∏ –Ω–µ—Ç –Ω–∏–∫–∞–∫–æ–≥–æ –∏–Ω—Ç–µ—Ä–µ—Å–∞ –≤ —Ç–æ–º, —á—Ç–æ–±—ã –≤–∏–¥–µ—Ç—å —Ç–∞–∫–æ–π –±–æ–Ω—É—Å —ç—Ä–∞–¥–∏–∫–∞—Ü–∏–∏ —Ö–µ–ª–∏–∫–æ–±–∞–∫—Ç–µ—Ä–∞.","{""skip"": true}"
2025-08-21T06:11:27+00:00,@pharm_icon,2336,https://t.me/pharm_icon/2336,"–≠–∫—Ç–æ–≥–µ–Ω–µ–∑, –∫–∞–∫ –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–∞—è –∏–¥–µ—è –ö–∞–∫ –≤—ã –ø–æ–º–Ω–∏—Ç–µ, —è –ø–µ—Ä–∏–æ–¥–∏—á–µ—Å–∫–∏ —Ä–∞–∑–º—ã—à–ª—è—é –æ–± –∏–¥–µ–æ–ª–æ–≥–∏—á–µ—Å–∫–∏—Ö –≤–æ–ø—Ä–æ—Å–∞—Ö. –ù–∞–ø—Ä–∏–º–µ—Ä, –µ—â—ë –Ω–µ–¥–∞–≤–Ω–æ –Ω–∞–ø–∏—Å–∞–ª–∞ —Ç–µ–∫—Å—Ç –ø—Ä–æ –±–∏–æ–ø–∞–Ω–∫, –∫–∞–∫ –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—É—é –æ—Å–æ–±–µ–Ω–Ω–æ—Å—Ç—å ‚Äî –ø–æ –º–æ–µ–º—É –º–Ω–µ–Ω–∏—é, —ç—Ç–æ –±—ã –ø—Ä–∏–≤–ª–µ–∫–∞–ª–æ –º–Ω–æ–≥–∏—Ö –ª—é–¥–µ–π –∫ –†–æ—Å—Å–∏–∏ –≤ –±–æ–ª—å—à–µ–π —Å—Ç–µ–ø–µ–Ω–∏, —á–µ–º —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω—ã–µ —Ü–µ–Ω–Ω–æ—Å—Ç–∏. –ù–µ–∫—Ä–æ–º–∞–Ω—Ç–∏—è –ø–æ–ª–∏—Ç–æ–ª–æ–≥–æ–≤ –Ω–µ –ø–æ–¥–Ω–∏–º–µ—Ç —Ä–æ–∂–¥–∞–µ–º–æ—Å—Ç–∏, –∞ –≤–æ—Ç —ç–∫—Ç–æ–≥–µ–Ω–µ–∑ ‚Äî —ç—Ç–æ —Ñ—Ä–µ—à. –≠–∫—Ç–æ–≥–µ–Ω–µ–∑ —á–µ–ª–æ–≤–µ–∫–∞ ‚Äî —ç—Ç–æ –ø–µ—Ä–∏–æ–¥ –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏, –ø—Ä–æ—Ç–µ–∫–∞—é—â–∏–π –≤ –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–π –º–∞—Ç–∫–µ. –í —Å—Ç–∞—Ç—å–µ –∂—É—Ä–Ω–∞–ª–∞ Bioethics —Ñ–µ–º–∏–Ω–∏—Å—Ç–∫–∏ —è—Ä–æ –æ–±—Å—É–∂–¥–∞—é—Ç –æ—Å–≤–æ–±–æ–¥–∏—Ç–µ–ª—å–Ω—ã–π –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª —ç–∫—Ç–æ–≥–µ–Ω–µ–∑–∞, –æ—Å–Ω–æ–≤—ã–≤–∞—è—Å—å –Ω–∞ —Ñ–∏–ª–æ—Å–æ—Ñ–∏–∏ –º–∏—Å—Å –î–≤–æ—Ä–∫–∏–Ω ‚Äî –µ—â—ë –æ–¥–∏–Ω –ª–∏–±–µ—Ä–∞–ª—å–Ω—ã–π –º—ã—Å–ª–∏—Ç–µ–ª—å-–∂–µ–Ω—â–∏–Ω–∞ ‚Äî –≤ –∫–æ—Ç–æ—Ä–æ–π –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç—å —Ä–æ–∂–∞—Ç—å –æ—Ü–µ–Ω–∏–≤–∞–µ—Ç—Å—è –∫–∞–∫ –Ω–µ–≤–µ–∑–µ–Ω–∏–µ. –ë–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–π —Ñ–∞–∫—Ç–æ—Ä, –∑–∞ –∫–æ—Ç–æ—Ä—ã–π –∂–µ–Ω—â–∏–Ω–∞ –Ω–µ –æ—Ç–≤–µ—á–∞–µ—Ç, –∫–æ—Ç–æ—Ä—ã–π –æ—Å–ª–æ–∂–Ω—è–µ—Ç –µ—ë –∂–∏–∑–Ω—å. –°–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ, —ç–∫—Ç–æ–≥–µ–Ω–µ–∑ —Ä–∞—Å—Å–º–∞—Ç—Ä–∏–≤–∞–µ—Ç—Å—è, –∫–∞–∫ —Å–ø–æ—Å–æ–± –∏–∑–±–∞–≤–ª–µ–Ω–∏—è –æ—Ç —Ç–∞–∫–æ–≥–æ —Ñ–∞–∫—Ç–æ—Ä–∞. –ù–æ –∫–∞–∫ –±—ã —ç—Ç–æ –º–æ–≥–ª–æ –ª–µ—á—å –≤ –±–∞–∑—É —Å–≤–µ–∂–µ–π –ø–æ–ª–∏—Ç–∏–∫–∏ –†–æ—Å—Å–∏–∏? –î–∞–≤–∞–π—Ç–µ –æ—Ç–±—Ä–æ—Å–∏–º —Ñ–µ–º–∏–Ω–∏—Å—Ç–æ–∫ –∏ –ø–æ—Å–º–æ—Ç—Ä–∏–º –Ω–∞ –ø—Ä–æ–±–ª–µ–º—É –ø–æ–¥ –±—Ä—É—Ç–∞–ª—å–Ω—ã–º —Ä—É—Å—Å–∫–∏–º —É–≥–ª–æ–º. –ù–∞–ª–∏—Ü–æ —Ñ–∞–∫—Ç, —á—Ç–æ –ª—é–¥–µ–π, –∫–æ—Ç–æ—Ä—ã–µ —Ö–æ—Ç—è—Ç —Ä–æ–∂–∞—Ç—å –Ω–∞ –≤–æ–ª–Ω–µ –ø–æ–ª–∏—Ç–∏—á–µ—Å–∫–æ–≥–æ –≤–∞–π–±–∞ –Ω–µ —Ç–∞–∫ —É–∂ –º–Ω–æ–≥–æ. –ê –ª—é–¥–∏ –Ω—É–∂–Ω—ã: - –î–ª—è —Ä–æ—Å—Ç–∞ –≤–Ω—É—Ç—Ä–µ–Ω–Ω–µ–≥–æ —Ä—ã–Ω–∫–∞. - –î–ª—è —É–¥–æ–≤–ª–µ—Ç–≤–æ—Ä–µ–Ω–∏—è –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç–µ–π –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–∞ –≤ –ª—é–¥—è—Ö. –ü—Ä–∏ –≤–∑–≥–ª—è–¥–µ —Å —Ç–∞–∫–æ–≥–æ —Ä–∞–∫—É—Ä—Å–∞ –Ω–∞ —ç–∫—Ç–æ–≥–µ–Ω–µ–∑ –≤–∏–¥–Ω—ã –ø—Ä—è–º—ã–µ –≤—ã–≥–æ–¥—ã. –ï—Å–ª–∏ —Ä–æ–∂–∞—Ç—å —Ç–∞–∫–∏–º –æ–±—Ä–∞–∑–æ–º, —Ç–æ –ø—Ä–æ–±–ª–µ–º—ã –ø—è—Ç–∏–ª–µ—Ç–∫—É –¥–µ–º–æ–≥—Ä–∞—Ñ–∏–∏ –∑–∞–∫—Ä–æ–µ–º –∑–∞ 2 –≥–æ–¥–∞. –ñ–µ–Ω—â–∏–Ω—ã –±—É–¥—É—Ç –±–æ–ª—å—à–µ —Ä–∞–±–æ—Ç–∞—Ç—å –¥–∞ –∏ –≤ —Ü–µ–ª–æ–º –º–æ–∂–Ω–æ –±—É–¥–µ—Ç —É—Å—Ç—Ä–æ–∏—Ç—å ""—Ä–∞–≤–µ–Ω—Å—Ç–≤–æ"" –≤–æ –≤—Å–µ—Ö —Å–º—ã—Å–ª–∞—Ö. –í –ø–æ–ª–∏—Ç–∏–∫–µ –±–∏–æ–ø–∞–Ω–∫–∞ —Å –ø—Ä–∏–Ω—è—Ç–∏–µ–º —Ç–∞–∫–∏—Ö —Ä–µ—à–µ–Ω–∏–π –ø—Ä–æ–±–ª–µ–º –±—ã –Ω–µ –±—ã–ª–æ. –ü—Ä–∏ —ç—Ç–æ–º –≤–µ–∫—Ç–æ—Ä —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω—ã—Ö —Ü–µ–Ω–Ω–æ—Å—Ç–µ–π –º–æ–∂–Ω–æ –≤—Å—ë —Ä–∞–≤–Ω–æ —Å–æ—Ö—Ä–∞–Ω–∏—Ç—å ‚Äî –ø—Ä–æ—Å—Ç–æ –≤—Ö–æ–∂–¥–µ–Ω–∏–µ –≤ —Å–µ–º—å—é –±—ã–ª–æ –±—ã –Ω–∞–º–Ω–æ–≥–æ –ª–µ–≥—á–µ –±–µ–∑ —Å—Ç—Ä–∞—Ö–æ–≤ —Å–∏–ª—å–Ω–æ –∏–∑–º–µ–Ω–∏—Ç—å –∞–Ω–∞—Ç–æ–º–∏—é, –æ–±–æ—Ä–≤–∞—Ç—å –∫–∞—Ä—å–µ—Ä—É –∏ —Ç–∞–∫ –¥–∞–ª–µ–µ. –ò –Ω–∏–∫–∞–∫–∏—Ö —ç—Ç–∏—á–µ—Å–∫–∏—Ö –ø—Ä–æ–±–ª–µ–º —Å —Å—É—Ä—Ä–æ–≥–∞—Ç–Ω—ã–º –º–∞—Ç–µ—Ä–∏–Ω—Å—Ç–≤–æ–º. –°—Ç—Ä–∞–Ω–Ω–æ, —á—Ç–æ –æ–± —ç—Ç–æ–º –Ω–µ –¥—É–º–∞—é—Ç, –∞ –µ—Å–ª–∏ –¥—É–º–∞—é—Ç ‚Äî –ø—É—Å—Ç—å, —Ç–∞–∫ —Ö–æ—Ç—è –±—ã –ø–æ–∏–Ω—Ç–µ—Ä–µ—Å–Ω–µ–µ –±—É–¥–µ—Ç. –ò–∑ 1984 –≤ –î–∏–≤–Ω—ã–π –Ω–æ–≤—ã–π –º–∏—Ä. –í–æ—Ç —Å —Ç–∞–∫–æ–π —Ç–æ—á–∫–∏ –∑—Ä–µ–Ω–∏—è —Ä–µ—à–∏–ª–∞ –ø–æ–¥—É–º–∞—Ç—å –æ–± —ç–∫—Ç–æ–≥–µ–Ω–µ–∑–µ, –∞ –≤–æ–æ–±—â–µ, –µ—Å–ª–∏ –≤—ã –∏—â–∏—Ç–µ –∫–∞–∫—É—é-—Ç–æ —Ä–∞–¥–∏–∫–∞–ª—å–Ω—É—é –≤–æ –≤—Å–µ—Ö —Å–º—ã—Å–ª–∞—Ö –∏–¥–µ—é ‚Äî –∑–∞–≥–ª—è–Ω–∏—Ç–µ –≤ –ª—é–±–æ–π –ø—Ä–∏–ª–∏—á–Ω—ã–π –∂—É—Ä–Ω–∞–ª –ø–æ –±–∏–æ—ç—Ç–∏–∫–µ. –ê –µ—â—ë –ø–æ—Å–º–æ—Ç—Ä–∏—Ç–µ, –∫–∞–∫–∏–µ —Å—Ç–∞—Ç—å–∏ —Å–∞–º—ã–µ —Ü–∏—Ç–∏—Ä—É–µ–º—ã–µ ‚Äî —É–¥–∏–≤–∏—Ç–µ—Å—åüôÇ","{""skip"": true}"
2025-08-18T18:15:34+00:00,@pharm_icon,2335,https://t.me/pharm_icon/2335,"üß¨ –ò–º–º—É–Ω–∏—Ç–µ—Ç –∫ –≤–∞–∫—Ü–∏–Ω–∞–º —É –ª—é–¥–µ–π —Å –í–ò–ß, –ø–æ–ª—É—á–µ–Ω–Ω—ã–º –ø—Ä–∏ —Ä–æ–∂–¥–µ–Ω–∏–∏ –ò—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ, –∫–æ—Ç–æ—Ä–æ–µ –º–æ–∂–µ—Ç –ø–æ–∫–∞–∑–∞—Ç—å—Å—è –≤–∞–∂–Ω—ã–º –¥–ª—è —Ç–µ—Ö, –∫—Ç–æ –∏–Ω—Ç–µ—Ä–µ—Å—É–µ—Ç—Å—è –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏–µ–π –æ—Å–æ–±—ã—Ö –≥—Ä—É–ø–ø –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. üìä –í –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–∏ 85 —á–µ–ª–æ–≤–µ–∫ —Å –í–ò–ß –ø—Ä–æ–≤–µ—Ä–∏–ª–∏ –∞–Ω—Ç–∏—Ç–µ–ª–∞ –∫ –¥–µ—Ç—Å–∫–∏–º –≤–∞–∫—Ü–∏–Ω–∞–º: –ß–µ—Ä–µ–∑ 2 –≥–æ–¥–∞ –ø–æ—Å–ª–µ –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏–∏ –∑–∞—â–∏—Ç–Ω—ã–π —É—Ä–æ–≤–µ–Ω—å –∏–º–µ–ª–∏: –¥–∏—Ñ—Ç–µ—Ä–∏—è ‚Äî 71%, —Å—Ç–æ–ª–±–Ω—è–∫ ‚Äî 79%, –∫–æ—Ä—å ‚Äî 79%, –ø–∞—Ä–æ—Ç–∏—Ç ‚Äî 67%, –∫—Ä–∞—Å–Ω—É—Ö–∞ ‚Äî 87%, –≤–µ—Ç—Ä—è–Ω–∫–∞ ‚Äî 54%. –ß–µ—Ä–µ–∑ 10 –ª–µ—Ç –∏–º–º—É–Ω–∏—Ç–µ—Ç —Å–æ—Ö—Ä–∞–Ω—è–ª—Å—è —É 50‚Äì58%. –ö 20 –≥–æ–¥–∞–º ‚Äî –º–µ–Ω—å—à–µ 30% (–∫—Ä–æ–º–µ –∫—Ä–∞—Å–Ω—É—Ö–∏ ‚Äî 47%). –ù–∞ –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏—é –ø—Ä–æ—Ç–∏–≤ –≥–µ–ø–∞—Ç–∏—Ç–∞ B –æ—Ç–≤–µ—Ç –æ—Å–æ–±–µ–Ω–Ω–æ —Å–ª–∞–±—ã–π: –ª–∏—à—å 7,5% —Å–æ—Ö—Ä–∞–Ω—è–ª–∏ –∑–∞—â–∏—Ç—É —á–µ—Ä–µ–∑ 20 –ª–µ—Ç. –ì–ª–∞–≤–Ω—ã–π —Ñ–∞–∫—Ç–æ—Ä —Å–Ω–∏–∂–µ–Ω–∏—è –∑–∞—â–∏—Ç—ã ‚Äî –≤—Ä–µ–º—è –ø–æ—Å–ª–µ –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏–∏. ‚ö†Ô∏è –í—ã–≤–æ–¥: —É –ª—é–¥–µ–π —Å –ø–µ—Ä–∏–Ω–∞—Ç–∞–ª—å–Ω—ã–º –í–ò–ß –∏–º–º—É–Ω–∏—Ç–µ—Ç –ø–æ—Å–ª–µ –ø—Ä–∏–≤–∏–≤–æ–∫ —Å–Ω–∏–∂–∞–µ—Ç—Å—è –±—ã—Å—Ç—Ä–µ–µ, —á–µ–º —É –¥—Ä—É–≥–∏—Ö. –ò—Å—Ç–æ—á–Ω–∏–∫ Vaccines –ß—Ç–æ –¥—É–º–∞–µ—Ç–µ? üî• ‚Äî —ç—Ç–æ –ø–æ–ª–µ–∑–Ω–æ –∏ –º–æ–∂–Ω–æ —É—á–µ—Å—Ç—å –≤ –ø—Ä–∞–∫—Ç–∏–∫–µ üóø ‚Äî –≤—Å—ë —Ä–∞–≤–Ω–æ –Ω–∏–∫—Ç–æ –Ω–µ –≤–∞–∫—Ü–∏–Ω–∏—Ä—É–µ—Ç—Å—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""vaccine, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""A study on postnatal HIV patients' immunity to vaccines showed that the protective levels of diphtheria, pertussis, measles, mumps, and varicella dropped significantly over 20 years. Only hepatitis B vaccine immunity remained at around 7.5% after 20 years. The main factor affecting this is the time elapsed since vaccination.""
}"
2025-08-14T06:15:04+00:00,@pharm_icon,2332,https://t.me/pharm_icon/2332,"–ú–Ω–µ–Ω–∏—è –æ –≤–Ω–µ–¥—Ä–µ–Ω–∏–∏ –ø–ª–∞—Å—Ç–∏–∫–∏ –≤ –û–ú–° —Ä–∞–∑–¥–µ–ª–∏–ª–∏—Å—å –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏ –≤ —Ä–∞–≤–Ω–æ–π —Å—Ç–µ–ø–µ–Ω–∏. –ù–æ –¥–∞–≤–∞–π—Ç–µ –º—ã –≤–∑–≥–ª—è–Ω–µ–º –Ω–∞ –ø—Ä–æ–±–ª–µ–º—ã —á–µ—Ä–µ–∑ —Å—Ç–∞—Ç—å—é –¢–æ—Ä–æ—Ç–æ–µ–≤–æ–π –ê.–ú. –ù–ê–¶–ò–Ø –ü–õ–ê–°–¢–ò–ß–ï–°–ö–û–ô –•–ò–†–£–†–ì–ò–ò: –°–¢–ê–ù–î–ê–†–¢–´ –ö–†–ê–°–û–¢–´ –ò –ò–• –†–û–õ–¨ –í –°–û–¶–ò–ê–õ–¨–ù–û–ô –ñ–ò–ó–ù–ò –ñ–ï–ù–©–ò–ù –†–ï–°–ü–£–ë–õ–ò–ö–ò –ö–û–†–ï–Ø —Å –º–æ–∏–º–∏ —Ä–∞—Å—Å—É–∂–¥–µ–Ω–∏—è–º–∏ –æ –ø—Ä–æ–±–ª–µ–º–∞—Ç–∏–∫–µ. –°–∞–º—ã–π ""–ø—Ä–æ–¥–≤–∏–Ω—É—Ç—ã–π"" —Ä–µ—Ñ–µ—Ä–µ–Ω—Å –∫–∞–∫-–Ω–∏–∫–∞–∫. –ö–æ—Ä–µ–π—Å–∫–∏–π —Å–æ—Ü–∏–æ–ª–æ–≥ –°–æ –ò–º –≤—ã–¥–µ–ª—è–µ—Ç —Ç—Ä–∏ –ø–µ—Ä–∏–æ–¥–∞ —Ä–∞–∑–≤–∏—Ç–∏—è –ø–ª–∞—Å—Ç–∏—á–µ—Å–∫–æ–π —Ö–∏—Ä—É—Ä–≥–∏–∏ –≤ –ö–æ—Ä–µ–µ: —ç—Ç–∞–ø—ã –ª–µ–≥–∏—Ç–∏–º–∏–∑–∞—Ü–∏–∏, –ø–æ–ø—É–ª—è—Ä–∏–∑–∞—Ü–∏–∏ –∏ –∏–Ω–¥—É—Å—Ç—Ä–∏–∞–ª–∏–∑–∞—Ü–∏–∏ 1. –õ–µ–≥–∏—Ç–∏–º–∏–∑–∞—Ü–∏—è. –ü–µ—Ä–∏–æ–¥ –ª–µ–≥–∏—Ç–∏–º–∏–∑–∞—Ü–∏–∏ –ø–ª–∞—Å—Ç–∏—á–µ—Å–∫–æ–π —Ö–∏—Ä—É—Ä–≥–∏–∏ –≤ –ö–æ—Ä–µ–µ –ø—Ä–∏—à–µ–ª—Å—è –Ω–∞ 1960‚Äì1979 –≥–≥., –∫–æ–≥–¥–∞ –ø–µ—Ä–µ–¥ —Ä–∞–∑—Ä—É—à–µ–Ω–Ω–æ–π –≤–æ–π–Ω–æ–π —Å—Ç—Ä–∞–Ω–æ–π –≤—Å—Ç–∞–ª–∞ –æ—Å—Ç—Ä–∞—è –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç—å –±—ã—Å—Ç—Ä–æ–π –º–æ–¥–µ—Ä–Ω–∏–∑–∞—Ü–∏–∏ –∏ —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–≥–æ —Ä–∞–∑–≤–∏—Ç–∏—è. –ü—Ä–∏–µ—Ö–∞–ª —Å –æ–±—É—á–µ–Ω–∏—è –ø–ª–∞—Å—Ç–∏—á–µ—Å–∫–∏–π —Ö–∏—Ä—É—Ä–≥ –Æ –ß–∂—ç–¥—É–∫, –æ—Å–Ω–æ–≤–∞–ª –ö–æ—Ä–µ–π—Å–∫–æ–µ –æ–±—â–µ—Å—Ç–≤–æ –ø–ª–∞—Å—Ç–∏—á–µ—Å–∫–∏—Ö –∏ —Ä–µ–∫–æ–Ω—Å—Ç—Ä—É–∫—Ç–∏–≤–Ω—ã—Ö —Ö–∏—Ä—É—Ä–≥–æ–≤, –∫–æ—Ç–æ—Ä–æ–µ —Ç—Ä–∏ –≥–æ–¥–∞ —Å–ø—É—Å—Ç—è –±—ã–ª–æ –ø—Ä–∏–∑–Ω–∞–Ω–æ –ö–æ—Ä–µ–π—Å–∫–æ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–µ–π. –ü—Ä–∏–∑–Ω–∞–Ω–∏–µ –æ—Ç—Ä–∞—Å–ª—å –ø–æ–ª—É—á–∏–ª–∞ –≤ 1974-–º. 2. –ü–æ–ø—É–ª—è—Ä–∏–∑–∞—Ü–∏—è. –û–ª–∏–º–ø–∏–∞–¥–∞ –≤ –°–µ—É–ª–µ –≤ 1988 –≥., —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–∞—è –∏ –ø–æ–ª–∏—Ç–∏—á–µ—Å–∫–∞—è —Å—Ç–∞–±–∏–ª—å–Ω–æ—Å—Ç—å —Å—Ç–∞–ª–∏ –ø—Ä–∏—á–∏–Ω–æ–π —Ä–∞–∑–≤–∏—Ç–∏—è –∏–Ω—Ç–µ—Ä–µ—Å–∞ –∫ –∫—É–ª—å—Ç—É—Ä–µ, —Å–ø–æ—Ä—Ç—É –∏ –∫—Ä–∞—Å–æ—Ç–µ –≤ –Æ–∂–Ω–æ–π –ö–æ—Ä–µ–µ. –¢–∞–∫, –∫–æ–Ω—Ü–∞ 80-—Ö –∏ 90-—Ö –ø–µ—Ä–∏–æ–¥ —Ö–∞—Ä–∞–∫—Ç–µ—Ä–∏–∑–∏—Ä—É–µ—Ç—Å—è –ø–æ–ø—É–ª—è—Ä–∏–∑–∞—Ü–∏–µ–π –ø–ª–∞—Å—Ç–∏—á–µ—Å–∫–æ–π —Ö–∏—Ä—É—Ä–≥–∏–∏ –∫–∞–∫ –Ω–æ–≤–æ–π —É–∑–∫–æ—Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω–æ–π –ø—Ä–∞–∫—Ç–∏–∫–∏ —ç—Å—Ç–µ—Ç–∏—á–µ—Å–∫–æ–π –º–µ–¥–∏—Ü–∏–Ω—ã. 3. –ò–Ω–¥—É—Å—Ç—Ä–∏–∞–ª–∏–∑–∞—Ü–∏—è –ø–ª–∞—Å—Ç–∏—á–µ—Å–∫–æ–π —Ö–∏—Ä—É—Ä–≥–∏–∏ –ø—Ä–∏—à–ª–∞—Å—å –Ω–∞ 2000-–µ –≥–æ–¥—ã ‚Äì –≤ —ç—Ç–æ—Ç –ø–µ—Ä–∏–æ–¥ –ø–ª–∞—Å—Ç–∏—á–µ—Å–∫–∞—è —Ö–∏—Ä—É—Ä–≥–∏—è –¥–ª—è –Æ–∂–Ω–æ–π –ö–æ—Ä–µ–∏ —Å—Ç–∞–ª–∞ –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–π –æ—Å–æ–±–µ–Ω–Ω–æ—Å—Ç—å—é. –í —Ä–µ–∑—É–ª—å—Ç–∞—Ç–µ –∫—Ä–∏–∑–∏—Å–∞ 1997 –≥–æ–¥–∞ –∫–æ—Ä–µ–π—Å–∫–æ–µ –æ–±—â–µ—Å—Ç–≤–æ —Å—Ç–æ–ª–∫–Ω—É–ª–æ—Å—å —Å —Ä–æ—Å—Ç–æ–º –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏–∏ –≤–æ –≤—Å–µ—Ö —Å—Ñ–µ—Ä–∞—Ö –∂–∏–∑–Ω–∏. –ß—Ç–æ –æ—Ç–º–µ—á–∞–µ—Ç—Å—è –≤ –º–∞—Ä–∫–µ—Ç–∏–Ω–≥–æ–≤—ã—Ö –ø—Ä–∏–µ–º–∞—Ö? –ü–æ—Ä—Ç—Ä–µ—Ç —Ä–∞–Ω–Ω–µ–π —Ü–µ–ª–µ–≤–æ–π –∞—É–¥–∏—Ç–æ—Ä–∏–∏: 1. –†–∞–Ω–Ω–∏–µ —ç—Ç–∞–ø—ã: –ø–æ—Å—Ç—Ä–∞–¥–∞–≤—à–∏–µ –æ—Ç —Ç—Ä–∞–≤–º –ø–∞—Ü–∏–µ–Ω—Ç—ã 2. –ü–æ—Å–ª–µ: –Ω–æ–≤–∞—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è –ø—Ä–∞–∫—Ç–∏–∫–∞ –¥–ª—è –∂–µ–Ω—â–∏–Ω —Å—Ä–µ–¥–Ω–µ–≥–æ –∫–ª–∞—Å—Å–∞ —Å –Ω–∏–∑–∫–æ–π —Å–∞–º–æ–æ—Ü–µ–Ω–∫–æ–π 3. –ï—â—ë –æ–¥–∏–Ω —ç—Ç–∞–ø: —Ç—Ä–∞–Ω—Å–ª—è—Ü–∏—è —Ä–æ–¥–∏—Ç–µ–ª–µ–π –ø–æ–¥ –≤–ª–∏—è–Ω–∏–µ–º –º–µ–¥–∏–∞ –º–Ω–µ–Ω–∏—è –æ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ –ø–ª–∞—Å—Ç–∏–∫–∏ –Ω–∞ –¥–µ—Ç–µ–π. –°–µ–º—å—è —Ç–∞–∫–∂–µ –æ–∫–∞–∑—ã–≤–∞–µ—Ç —Å–∏–ª—å–Ω–æ–µ –¥–∞–≤–ª–µ–Ω–∏–µ. –°–æ–≤—Ä–µ–º–µ–Ω–Ω–∞—è –ø–ª–∞—Å—Ç–∏—á–µ—Å–∫–∞—è —Ö–∏—Ä—É—Ä–≥–∏—è —á–∞—Å—Ç–æ –æ–±—Ä–∞—â–∞–µ—Ç—Å—è –∫ –∞–º–æ—Ä–∞–ª—å–Ω—ã–º –º–∞–Ω–∏–ø—É–ª—è—Ç–∏–≤–Ω—ã–º —Ç–µ—Ö–Ω–∏–∫–∞–º –¥–∞–≤–ª–µ–Ω–∏—è –Ω–∞ —Å–æ–∑–Ω–∞–Ω–∏–µ –º–æ–ª–æ–¥–µ–∂–∏. –ù–∞–ø—Ä–∏–º–µ—Ä, –Ω–∞–±–∏—Ä–∞—é—Ç –ø–æ–ø—É–ª—è—Ä–Ω–æ—Å—Ç—å —Ä–µ–∫–ª–∞–º–Ω—ã–µ –∫–∞–º–ø–∞–Ω–∏–∏, –ø—Ä–∏–∑—ã–≤–∞—é—â–∏–µ –ø–æ–∫–∞–∑–∞—Ç—å —Ä–µ–∑—É–ª—å—Ç–∞—Ç —ç–∫–∑–∞–º–µ–Ω–æ–≤ –∏ –ø–æ–ª—É—á–∏—Ç—å —Å–∫–∏–¥–∫—É –Ω–∞ —É—Å–ª—É–≥–∏ –ø–ª–∞—Å—Ç–∏—á–µ—Å–∫–æ–≥–æ —Ö–∏—Ä—É—Ä–≥–∞. –ï—Å—Ç—å –µ—â—ë –∫–æ–µ-—á—Ç–æ –ö–∞–∫ –æ—Ç–º–µ—á–∞—é—Ç –Å. –ö–∏–º –∏ –ö. –ö–∏–º, —Å–æ–≤—Ä–µ–º–µ–Ω–Ω—ã–µ –°–ú–ò –æ–±—ä–µ–∫—Ç–∏–≤–∏—Ä—É—é—Ç –∂–µ–Ω—Å–∫–æ–µ —Ç–µ–ª–æ –∏ –≤—ã–∑—ã–≤–∞—é—Ç —É –∂–µ–Ω—â–∏–Ω —á—É–≤—Å—Ç–≤–æ –Ω–µ—É–¥–æ–≤–ª–µ—Ç–≤–æ—Ä–µ–Ω–Ω–æ—Å—Ç–∏ —Å–æ–±–æ–π –î–∞, —Ç–æ–∂–µ —á—Ç–æ-—Ç–æ –∑–Ω–∞–∫–æ–º–æ–µ. –ò–Ω—Å—Ç–∞-–∑–∞–ø—Ä–µ—â–µ–Ω—Å–∫–∏–µ-–ª—é–±–∏—Ç–µ–ª–∏ –∏ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—ã –∑–Ω–∞–∫–æ–º—ã. –°–ú–ò –≤ —Ü–µ–ª–æ–º –æ–∫–∞–∑—ã–≤–∞—é—Ç –Ω–∞–∏–±–æ–ª—å—à–µ–µ –≤–ª–∏—è–Ω–∏–µ –ø–æ –¥–∞–Ω–Ω—ã–º –æ–¥–Ω–æ–≥–æ –∏–∑ —Ü–∏—Ç–∏—Ä—É–µ–º—ã—Ö –æ–ø—Ä–æ—Å–æ–≤. –ê–≤—Ç–æ—Ä—ã –æ–±–≤–∏–Ω—è—é—Ç –°–ú–ò –≤ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–∏–∏ –∏—Å–∫–∞–∂–µ–Ω–Ω—ã—Ö –∏ –Ω–µ–¥–æ—Å—Ç–∏–∂–∏–º—ã—Ö –∏–¥–µ–∞–ª–æ–≤ –∫—Ä–∞—Å–æ—Ç—ã ‚Äî –±—ã—Ç—å –∫–∞–∫ –ò–∫–æ–Ω–∞ –§–∞—Ä–º—ã, –Ω–∞–ø—Ä–∏–º–µ—Ä. –ö–æ—Ä–µ–π—Ü—ã —Ç–∞–∫–∂–µ –ª—é–±—è—Ç —Å–ø—Ä–æ—Å–∏—Ç—å –ø—Ä–æ –≤–µ—Å, –ø–æ—Å–æ–≤–µ—Ç–æ–≤–∞—Ç—å —Ö–∏—Ä—É—Ä–≥–∞ –∏ –ø—Ä–æ—Ü–µ–¥—É—Ä—ã –æ—Ç–±–µ–ª–∏–≤–∞–Ω–∏—è –∫–æ–∂–∏ –≤ —Ç–µ—Ö —Å–∞–º—ã—Ö –º–µ—Å—Ç–∞—Ö. –ö–∞–∫–∏–µ –≤—ã–≤–æ–¥—ã? –ù–∞–¥–æ –±—É–ª–ª–∏—Ç—å –º—É–∂—á–∏–Ω, —á—Ç–æ–±—ã –∏–∑–±–∞–≤–ª—è–ª–∏—Å—å –æ—Ç –ø–∏–≤–Ω–æ–≥–æ –∂–∏–≤–æ—Ç–∞ –∏ –∑–∞–Ω–∏–º–∞–ª–∏—Å—å —Å–æ–±–æ–π. –¢–æ–≥–¥–∞ –∏ –±—É–¥–µ—Ç —Ä–µ–∑—É–ª—å—Ç–∞—Ç, –∂–µ–Ω—â–∏–Ω—ã –∏—Ç–∞–∫ –∫—Ä–∞—Å–∏–≤—ã–µ, –∞ –∫ –º—É–∂—á–∏–Ω–∞–º —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è, –∫–∞–∫ –∫ —à–µ—Å—Ç–∏–∫–ª–∞—Å—Å–Ω–∏–∫–∞–º. –ò—Ö-—Ç–æ —è –∏ –∏–º–µ–ª–∞ –≤ –≤–∏–¥—É.","{""skip"": true}"
2025-08-13T16:49:30+00:00,@pharm_icon,2331,https://t.me/pharm_icon/2331,"ü§ë–í—Å—ë –ø–æ 300: Fix price –ë—ã–ª–∏ —Ç–∞–∫–∏–µ –≤—Ä–µ–º–µ–Ω–∞, –∫—Ç–æ –ø–æ–º–Ω–∏—Ç —Ä–∞–Ω–Ω–∏–π Vademecum, –∫–æ–≥–¥–∞ –ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–∏ –ª—é–±–æ–µ –Ω–∞—Ä—É—à–µ–Ω–∏–µ –æ—Ü–µ–Ω–∏–≤–∞–ª–æ—Å—å –≤ 300 —Ç—ã—Å—è—á —Ä—É–±–ª–µ–π. –õ–æ—Ä –±–µ–∑ –ª–∏—Ü–µ–Ω–∑–∏–∏ –Ω–∞ —ç–Ω–¥–æ—Å–∫–æ–ø–∏—é? 300 —Ç—ã—Å—è—á –ê–Ω–∞—Ñ–∏–ª–∞–∫—Å–∏—è —É —Ä–µ–±—ë–Ω–∫–∞ –∏–∑-–∑–∞ –∞–Ω–µ—Å—Ç–µ—Ç–∏–∫–∞? 300 —Ç—ã—Å—è—á –í–æ—Ç –∏ —Ç–µ–ø–µ—Ä—å –≤—Å—ë –ø–æ —Ç—Ä–∏—Å—Ç–∞, –ø–æ—Ç–æ–º—É —á—Ç–æ –∏ –¥–µ–Ω–µ–≥ –Ω–µ—Ç, –∏ –Ω–µ –¥–µ—Ä–∂–∏–º—Å—è —É–∂–µ ‚ù§Ô∏è - –∂–∏–∑–Ω–µ–Ω–Ω–æ–µ üòê - —É–ø–∞–¥–Ω–∏—á–µ—Å–∫–æ–µ","{""skip"": true}"
2025-08-13T16:45:37+00:00,@pharm_icon,2330,https://t.me/pharm_icon/2330,"‚ö°Ô∏è–°—É–¥ —Å–Ω–∏–∑–∏–ª —Å 10 –º–ª–Ω –¥–æ 300 —Ç—ã—Å —Ä—É–±–ª–µ–π —Ä–∞–∑–º–µ—Ä –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏–∏, –∫–æ—Ç–æ—Ä—É—é –≤—ã–ø–ª–∞—Ç–∏—Ç –ø–æ–ª–∏–∫–ª–∏–Ω–∏–∫–∞ –∑–∞ –ø—Ä–æ–ø—É—â–µ–Ω–Ω—ã–π –≤—Ä–∞—á–∞–º–∏ —Ä–∞–∫ —É –ø–∞—Ü–∏–µ–Ω—Ç–∫–∏ –°—É–¥ –ü–µ–Ω–∑—ã —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–ª –∏—Å–∫ —Ä–æ–¥—Å—Ç–≤–µ–Ω–Ω–∏–∫–æ–≤ –ø–∞—Ü–∏–µ–Ω—Ç–∫–∏ –ì–ë–£–ó ¬´–ì–æ—Ä–æ–¥—Å–∫–∞—è –ø–æ–ª–∏–∫–ª–∏–Ω–∏–∫–∞ ‚Ññ 2¬ª –ü–µ–Ω–∑—ã, –∫–æ—Ç–æ—Ä–∞—è —Å–∫–æ–Ω—á–∞–ª–∞—Å—å –∏–∑-–∑–∞ —Ä–∞–∫–∞ –º–æ–ª–æ—á–Ω–æ–π –∂–µ–ª–µ–∑—ã, —Å—Ç–∞–ª–æ –∏–∑–≤–µ—Å—Ç–Ω–æ ¬´–ú–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –†–æ—Å—Å–∏–∏¬ª. –° 2019 –ø–æ 2021 –≥–æ–¥—ã –∂–µ–Ω—â–∏–Ω–∞ —Å –≤—ã—Å–æ–∫–∏–º —Ä–∏—Å–∫–æ–º —Ä–∞–∑–≤–∏—Ç–∏—è —Ä–∞–∫–∞ –º–æ–ª–æ—á–Ω–æ–π –∂–µ–ª–µ–∑—ã —Ä–µ–≥—É–ª—è—Ä–Ω–æ –Ω–∞–±–ª—é–¥–∞–ª–∞—Å—å –≤ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏–∏ –¥–ª—è —Ä–∞–Ω–Ω–µ–≥–æ –≤—ã—è–≤–ª–µ–Ω–∏—è –æ–Ω–∫–æ–ø–∞—Ç–æ–ª–æ–≥–∏–∏. –ö–∞–∫ —Å–ª–µ–¥—É–µ—Ç –∏–∑ –ø–æ—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏—è —Å—É–¥–∞, –≤—Ä–∞—á –£–ó–ò –Ω–µ–≤–Ω–∏–º–∞—Ç–µ–ª—å–Ω–æ –æ—Ü–µ–Ω–∏–ª–∞ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã —É–ª—å—Ç—Ä–∞–∑–≤—É–∫–æ–≤–æ–≥–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è, –∞ —Ä–µ–Ω—Ç–≥–µ–Ω–æ–ª–æ–≥ –≤–æ–æ–±—â–µ –ø–µ—Ä–µ–ø—É—Ç–∞–ª–∞ –æ–ø–∏—Å–∞–Ω–∏–µ —Å—Ç–æ—Ä–æ–Ω—ã —Ä–∞—Å–ø–æ–ª–æ–∂–µ–Ω–∏—è –≤—ã—è–≤–ª–µ–Ω–Ω—ã—Ö –Ω–æ–≤–æ–æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–π, —É–∫–∞–∑–∞–≤ –≤–º–µ—Å—Ç–æ –ª–µ–≤–æ–π –º–æ–ª–æ—á–Ω–æ–π –∂–µ–ª–µ–∑—ã –ø—Ä–∞–≤—É—é. –¢–∞–∫–∂–µ –æ–Ω–∫–æ–ª–æ–≥-–º–∞–º–º–æ–ª–æ–≥ –Ω–µ –≤—ã—è–≤–∏–ª–∞ —Ñ–∞–∫—Ç–æ—Ä—ã —Ä–∏—Å–∫–∞ —Ä–∞–∫–∞ –º–æ–ª–æ—á–Ω–æ–π –∂–µ–ª–µ–∑—ã, –Ω–µ –æ–±—Ä–∞—Ç–∏–ª–∞ –≤–Ω–∏–º–∞–Ω–∏—è –Ω–∞ —Ü–≤–µ—Ç –≤—ã–¥–µ–ª–µ–Ω–∏–π –∏–∑ —Å–æ—Å–∫–æ–≤, –Ω–µ –ø—Ä–æ–≤–µ–ª–∞ —É–≥–ª—É–±–ª–µ–Ω–Ω—É—é –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫—É –ª–µ–≤–æ–π –º–æ–ª–æ—á–Ω–æ–π –∂–µ–ª–µ–∑—ã, –Ω–µ –Ω–∞–∑–Ω–∞—á–∏–ª–∞ –ø–æ–≤—Ç–æ—Ä–Ω—É—é –º–∞–º–º–æ–≥—Ä–∞—Ñ–∏—é, –£–ó–ò, –ú–†–¢ —Å –∫–æ–Ω—Ç—Ä–∞—Å—Ç–æ–º –∏ –±–∏–æ–ø—Å–∏—é. –í –∏—Ç–æ–≥–µ, –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–µ —É –∂–µ–Ω—â–∏–Ω—ã –¥–∏–∞–≥–Ω–æ—Å—Ç–∏—Ä–æ–≤–∞–ª–∏ —É–∂–µ –Ω–∞ —á–µ—Ç–≤–µ—Ä—Ç–æ–π —Å—Ç–∞–¥–∏–∏, –∏ –ø–æ–∑–∂–µ –æ–Ω–∞ —Å–∫–æ–Ω—á–∞–ª–∞—Å—å. –†–æ–¥—Å—Ç–≤–µ–Ω–Ω–∏–∫–∏ —Ç—Ä–µ–±–æ–≤–∞–ª–∏ –≤–∑—ã—Å–∫–∞—Ç—å 10 –º–ª–Ω —Ä—É–±–ª–µ–π –∑–∞ –Ω–µ—Å–≤–æ–µ–≤—Ä–µ–º–µ–Ω–Ω—É—é –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫—É –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è, –Ω–æ —Å—É–¥ –æ–±—è–∑–∞–ª –≤—ã–ø–ª–∞—Ç–∏—Ç—å –±–ª–∏–∑–∫–∏–º –ø–∞—Ü–∏–µ–Ω—Ç–∫–∏ 200 —Ç—ã—Å—è—á —Ä—É–±–ª–µ–π –≤ –ø–æ–ª—å–∑—É –¥–æ—á–µ—Ä–∏ –∏ 100 —Ç—ã—Å—è—á –≤–Ω—É–∫—É. –°—Ç–æ—Ä–æ–Ω–∞ –ø–æ—Ç–µ—Ä–ø–µ–≤—à–∏—Ö –Ω–∞–º–µ—Ä–µ–Ω–∞ –æ–±–∂–∞–ª–æ–≤–∞—Ç—å —Ä–µ—à–µ–Ω–∏–µ –≤ —á–∞—Å—Ç–∏ —Å—É–º–º –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏–∏ –º–æ—Ä–∞–ª—å–Ω–æ–≥–æ –≤—Ä–µ–¥–∞. –ï—Å–ª–∏ –≤—ã –≤—Ä–∞—á, –Ω–∞—Ö–æ–¥—è—â–∏–π—Å—è –ø–æ–¥ —É–≥–æ–ª–æ–≤–Ω—ã–º –ø—Ä–µ—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ–º, –∏–ª–∏ —é—Ä–∏—Å—Ç, –≤–µ–¥—É—â–∏–π –¥–µ–ª–æ, –º–æ–∂–µ—Ç–µ –Ω–∞–ø–∏—Å–∞—Ç—å –Ω–∞—à–µ–π —Ä–µ–¥–∞–∫—Ü–∏–∏ –¥–ª—è –æ–≥–ª–∞—Å–∫–∏ –¥–µ–ª–∞: @mediamedics_bot","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance, safety"",
  ""impact"": ""high"",
  ""english"": ""The court reduced the compensation amount from 10 million to 300 thousand rubles for a polyclinic that failed to diagnose the patient's cancer. The case involves negligence in early detection of breast cancer, resulting in delayed diagnosis and the patient's death on the fourth stage. The family is seeking compensation for the delay in treatment.""
}"
2025-08-12T16:59:34+00:00,@pharm_icon,2327,https://t.me/pharm_icon/2327,"–õ–∏–¥–µ—Ä—ã –ø–æ –±–æ—Ä—å–±–µ —Å –æ–∂–∏—Ä–µ–Ω–∏–µ–º —É–≥–ª—É–±–ª—è—é—Ç –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã–µ –±–∞—Å—Ç–∏–æ–Ω—ã, —á—Ç–æ–±—ã –∑–∞—â–∏—Ç–∏—Ç—å –∏–º–ø–µ—Ä–∏—é –∏–Ω—ä–µ–∫—Ü–∏–æ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ GLP-1 –£–∑–Ω–∞—ë–º, —á—Ç–æ –¥—É–º–∞—é—Ç —É–≤–∞–∂–∞–µ–º—ã–µ –ø–∏–Ω–¥–æ—Å—ã –ø—Ä–æ —Ä—ã–Ω–æ–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –ø–æ—Ö—É–¥–µ–Ω–∏—è, —Å –º–æ–∏–º–∏ –±–µ—Å—Ü–µ–Ω–Ω—ã–º–∏ –∫–æ–º–º–µ–Ω—Ç–∞—Ä–∏—è–º–∏. –û—Å–Ω–æ–≤–Ω—ã–µ —Ç–µ–∑–∏—Å—ã: üëâüèºEli Lilly –∏ Novo Nordisk –Ω–∞—Ä–∞—â–∏–≤–∞—é—Ç –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã–µ –º–æ—â–Ω–æ—Å—Ç–∏ –¥–ª—è —É–¥–æ–≤–ª–µ—Ç–≤–æ—Ä–µ–Ω–∏—è —Ä–∞—Å—Ç—É—â–µ–≥–æ —Å–ø—Ä–æ—Å–∞ –Ω–∞ –∏–Ω—ä–µ–∫—Ü–∏–æ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã GLP‚Äë1 –æ—Ç –æ–∂–∏—Ä–µ–Ω–∏—è –∏ —É–∫—Ä–µ–ø–ª–µ–Ω–∏—è –∫–æ–Ω–∫—É—Ä–µ–Ω—Ç–Ω—ã—Ö –ø–æ–∑–∏—Ü–∏–π. –ò –≤ –†–æ—Å—Å–∏–∏ ‚Äî –ø—Ä–æ–¥–∞–∂–∏ –û–∑–µ–º–ø–∏–∫–∞ –∏ –µ–≥–æ –∞–Ω–∞–ª–æ–≥–æ–≤ –≤—ã—Ä–æ—Å–ª–∏ –≤ –†–æ—Å—Å–∏–∏ –≤ —á–µ—Ç—ã—Ä–µ —Ä–∞–∑–∞. üëâüèº–ó–∞—Ç—Ä–∞—Ç—ã Lilly –Ω–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –≤—ã—Ä–æ—Å–ª–∏ –ø–æ—á—Ç–∏ –Ω–∞ 50 % –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å 2023 –≥–æ–¥–æ–º, –ø—Ä–µ–≤—ã—Å–∏–≤ $5 –º–ª—Ä–¥. –í –¥–µ–∫–∞–±—Ä–µ 2024 –≥–æ–¥–∞ –∫–æ–º–ø–∞–Ω–∏—è –ø—Ä–∏–æ–±—Ä–µ–ª–∞ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã–π –∫–æ–º–ø–ª–µ–∫—Å –≤ –í–∏—Å–∫–æ–Ω—Å–∏–Ω–µ –∑–∞ $924,7 –º–ª–Ω –∏ –≤–ª–æ–∂–∏–ª–∞ $3 –º–ª—Ä–¥ –≤ —Ä–∞—Å—à–∏—Ä–µ–Ω–∏–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞. –í –†–æ—Å—Å–∏–∏, –≤–∏–¥–∏–º–æ, —Ç–æ–∂–µ –≤—ã—Ä–æ—Å–ª–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã–µ –º–æ—â–Ω–æ—Å—Ç–∏ ‚Äî –ê–ø—Ç–µ—á–Ω—ã–µ –ø—Ä–æ–¥–∞–∂–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Å —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–æ–º –≤ —è–Ω–≤–∞—Ä–µ-–∏—é–Ω–µ 2025 –≥–æ–¥–∞ —Å–æ—Å—Ç–∞–≤–∏–ª–∏ 12,5 –º–ª—Ä–¥ —Ä—É–±., —á—Ç–æ –≤ —á–µ—Ç—ã—Ä–µ —Ä–∞–∑–∞ –ø—Ä–µ–≤—ã—à–∞–µ—Ç –ø–æ–∫–∞–∑–∞—Ç–µ–ª—å –∑–∞ –∞–Ω–∞–ª–æ–≥–∏—á–Ω—ã–π –ø–µ—Ä–∏–æ–¥ –ø—Ä–æ—à–ª–æ–≥–æ –≥–æ–¥–∞. üëâüèº–ü—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª—å Lilly –æ—Ç–º–µ—Ç–∏–ª, —á—Ç–æ —Å–æ–≤—Ä–µ–º–µ–Ω–Ω—ã–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã–µ –±–∞–∑—ã –∏ –æ–ø—ã—Ç –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ø–æ–∑–≤–æ–ª—è—é—Ç –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç—å –≤—ã—Å–æ–∫–æ–∫–∞—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø—Ä–æ–¥—É–∫—Ç—ã —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ –∏ –≤ –±–æ–ª—å—à–∏—Ö –º–∞—Å—à—Ç–∞–±–∞—Ö¬ª, —á—Ç–æ —Å–æ–∑–¥–∞—ë—Ç —Å—Ç–∞–Ω–¥–∞—Ä—Ç—ã, –∫–æ—Ç–æ—Ä—ã–µ —Ç—Ä—É–¥–Ω–æ –≤–æ—Å–ø—Ä–æ–∏–∑–≤–µ—Å—Ç–∏ –Ω–æ–≤–∏—á–∫–∞–º.. –ù—É —ç—Ç–æ –æ—á–µ–≤–∏–¥–Ω–æ üëâüèº–ü—Ä–µ–≥—Ä–∞–¥—ã –¥–ª—è –Ω–æ–≤—ã—Ö –∏–≥—Ä–æ–∫–æ–≤: –ø–∞—Ä—Ç–Ω–µ—Ä William Blair, –ú—ç—Ç—Ç –§–∏–ø–ø—Å, –ø–æ–¥—á–µ—Ä–∫–Ω—É–ª, —á—Ç–æ —Å–ª–æ–∂–Ω–æ—Å—Ç—å –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –ø–µ–ø—Ç–∏–¥–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ ‚Äî —Å–µ—Ä—å—ë–∑–Ω—ã–π –±–∞—Ä—å–µ—Ä. –û–Ω –∑–∞–¥–∞—ë—Ç—Å—è –≤–æ–ø—Ä–æ—Å–æ–º: ¬´–†–∏—Å–∫–Ω—É—Ç –ª–∏ –∫–æ–Ω–∫—É—Ä–µ–Ω—Ç—ã –≤–∫–ª–∞–¥—ã–≤–∞—Ç—å $10 –º–ª—Ä–¥ –∏ –∂–¥–∞—Ç—å —á–µ—Ç—ã—Ä–µ –≥–æ–¥–∞, —á—Ç–æ–±—ã –ø—Ä–æ–∏–∑–≤–µ—Å—Ç–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç, –∞–Ω–∞–ª–æ–≥–∏—á–Ω—ã–π —Ç–µ–º, —á—Ç–æ –µ—Å—Ç—å —É Novo –∏ Lilly?¬ª –í –†–æ—Å—Å–∏–∏ –Ω–∏–∫—Ç–æ –Ω–µ –∂–¥—ë—Ç —á–µ—Ç—ã—Ä–µ –≥–æ–¥–∞, —Ö–∞-—Ö–∞. –ù–µ —Ç–∞–∫ —É–∂ –∏ —Å–ª–æ–∂–Ω–æ –æ–∫–∞–∑–∞–ª–æ—Å—å, –µ—Å–ª–∏ –∑–∞–∫–æ–Ω —Ä–∞–±–æ—Ç–∞–µ—Ç –±—É–∫–≤–æ–π –Æ. üëâüèº –í–ª–∏—è–Ω–∏–µ –º–∞—Å—à—Ç–∞–±–∞ –Ω–∞ —Ü–µ–Ω–æ–æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ: —Ñ–∏–Ω–∞–Ω—Å–æ–≤—ã–π –¥–∏—Ä–µ–∫—Ç–æ—Ä Lilly –õ—É–∫–∞—Å –ú–æ–Ω—Ç–∞—Ä—Å –ø–æ–¥—á–µ—Ä–∫–Ω—É–ª, —á—Ç–æ –∫—Ä—É–ø–Ω—ã–µ –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–∏ –ø–æ–∑–≤–æ–ª—è—Ç –∫–æ–º–ø–∞–Ω–∏–∏ –∫–æ–Ω–∫—É—Ä–∏—Ä–æ–≤–∞—Ç—å –ø–æ —Ü–µ–Ω–µ, –≤ —Ç–æ –≤—Ä–µ–º—è –∫–∞–∫ —É –Ω–æ–≤–∏—á–∫–æ–≤ —Å –º–µ–Ω—å—à–∏–º –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω—ã–º –º–∞—Å—à—Ç–∞–±–æ–º –±—É–¥–µ—Ç –º–µ–Ω—å—à–µ –≥–∏–±–∫–æ—Å—Ç–∏ –≤ —Ü–µ–Ω–∞—Ö –∏ –º–∞—Ä–∂–µ. –¢–æ–∂–µ —Å–ø—Ä–∞–≤–µ–¥–ª–∏–≤–æ. –ë–æ–≥–∞—Ç—ã–µ –±—É–¥—É—Ç –±–æ–≥–∞—Ç–µ—Ç—å –±—ã—Å—Ç—Ä–µ–µ, —á–µ–º –º–µ–Ω–µ–µ –±–æ–≥–∞—Ç—ã–µ. üëâüèº –†–µ–∞–∫—Ü–∏—è Novo –Ω–∞ —É—Ö—É–¥—à–µ–Ω–∏–µ —Å–≤–æ–∏—Ö –ø—Ä–æ–≥–Ω–æ–∑–æ–≤: –∫–æ–º–ø–∞–Ω–∏—è —É—Å–∏–ª–∏–ª–∞ —Å–≤–æ—ë –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ, –∫—É–ø–∏–≤ —Ç—Ä–∏ –ø—Ä–µ–¥–ø—Ä–∏—è—Ç–∏—è –ø–æ —Ñ–∞—Å–æ–≤–∫–µ –∏ —Ä–æ–∑–ª–∏–≤—É –∑–∞ $11,7 –º–ª—Ä–¥ –≤–º–µ—Å—Ç–µ —Å —Ä–æ–¥–∏—Ç–µ–ª—å—Å–∫–æ–π —Å—Ç—Ä—É–∫—Ç—É—Ä–æ–π —á–µ—Ä–µ–∑ –ø—Ä–∏–æ–±—Ä–µ—Ç–µ–Ω–∏–µ Catalent. –≠—Ç–æ –¥–æ–ª–∂–Ω–æ –ø–æ–≤—ã—Å–∏—Ç—å –≥–∏–±–∫–æ—Å—Ç—å –∏ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ –µ—ë –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–µ–Ω–Ω–æ–π —Å–µ—Ç–∏. –ù–æ—Ä–º–∞–ª—å–Ω—ã–µ —Ç–∞–∫–∏–µ –æ–±—ä–µ–º—ã. –û–∂–∏—Ä–µ–Ω–∏–µ –ø—Ä–æ–∏–≥—Ä–∞–µ—Ç, –ø–æ—Ö—É–¥–µ–Ω–∏–µ –∏ —Å–ª–µ–ø–æ—Ç–∞ –ø–æ–±–µ–¥—è—Ç. üëâüèº –ì—Ä—è–¥—É—â–∞—è –∫–æ–Ω–∫—É—Ä–µ–Ω—Ü–∏—è: –±–æ–ª—å—à–∏—Ö –∏–≥—Ä–æ–∫–æ–≤ –Ω–µ –ø—É–≥–∞–µ—Ç. –ü–æ–µ–∑–¥ —Ö–∞–π–ø–∞ –≤—Å–µ–≥–¥–∞ —É—Ö–æ–¥—è—â–∏–π.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand, epidemic, vaccine"",
  ""impact"": ""high"",
  ""english"": ""Eli Lilly and Novo Nordisk are expanding their production capacities to meet the growing demand for GLP-1 injection therapies for obesity. Sales of Ometec and its analogues in Russia have increased fourfold. Lilly's production costs have risen by almost 50% compared to the previous year, and it has invested $3 billion in expanding production. The company's representative noted that modern production bases and the company's experience allow for efficient large-scale product production. The high cost of producing peptide drugs is a significant barrier to new entrants, according to William Blair's Matt Fippes. The financial director of Lilly, Lucas Montars, emphasized that large investments will enable the company to compete on price. Novo Nordisk has increased its production by acquiring three facilities for packaging and filling through the acquisition of Catalent, which will enhance its production network's flexibility and profitability. The market is expected to be dominated by large players, who are not concerned about competition.""
}"
2025-08-12T16:39:38+00:00,@pharm_icon,2326,https://t.me/pharm_icon/2326,"–ù–∞ –ì–æ—Å—É—Å–ª—É–≥–∞—Ö –∑–∞–ø—É—Å—Ç—è—Ç —Å–µ—Ä–≤–∏—Å—ã –¥–ª—è —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –ø–∞—Ç–µ–Ω—Ç–æ–≤ –î–æ –Ω–æ—è–±—Ä—è –Ω–∞ –ø–æ—Ä—Ç–∞–ª–µ –ì–æ—Å—É—Å–ª—É–≥ –ø–æ—è–≤—è—Ç—Å—è –Ω–æ–≤—ã–µ —Ü–∏—Ñ—Ä–æ–≤—ã–µ —Å–µ—Ä–≤–∏—Å—ã –¥–ª—è —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –æ—Ç—Ä–∞—Å–ª–∏. –ú–∏–Ω–∏—Å—Ç–µ—Ä—Å—Ç–≤–∞–º –∏ –≤–µ–¥–æ–º—Å—Ç–≤–∞–º –ø–æ—Ä—É—á–µ–Ω–æ —É—Å–∫–æ—Ä–∏—Ç—å –ø–µ—Ä–µ–≤–æ–¥ —Ä–∞–∑—Ä–µ—à–∏—Ç–µ–ª—å–Ω—ã—Ö –ø—Ä–æ—Ü–µ–¥—É—Ä –≤ –æ–Ω–ª–∞–π–Ω-—Ñ–æ—Ä–º–∞—Ç, –≤–∫–ª—é—á–∞—è —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—é –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –≤–µ—Ç–µ—Ä–∏–Ω–∞—Ä–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –ª–∏—Ü–µ–Ω–∑–∏—Ä–æ–≤–∞–Ω–∏–µ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –∏ –¥—Ä—É–≥–∏–µ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è. –í–∏—Ü–µ-–ø—Ä–µ–º—å–µ—Ä –î–º–∏—Ç—Ä–∏–π –ì—Ä–∏–≥–æ—Ä–µ–Ω–∫–æ —Ä–∞—Å–ø–æ—Ä—è–¥–∏–ª—Å—è, —á—Ç–æ–±—ã —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã–µ –æ—Ä–≥–∞–Ω—ã –∏—Å–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–π –≤–ª–∞—Å—Ç–∏ –∑–∞–ø—É—Å—Ç–∏–ª–∏ –æ–±–Ω–æ–≤–ª–µ–Ω–Ω—ã–µ —Å–µ—Ä–≤–∏—Å—ã —É–∂–µ –æ—Å–µ–Ω—å—é. –ü–æ–ª—å–∑–æ–≤–∞—Ç–µ–ª–∏ ‚Äî –∫–∞–∫ –≥—Ä–∞–∂–¥–∞–Ω–µ, —Ç–∞–∫ –∏ –∫–æ–º–ø–∞–Ω–∏–∏ ‚Äî –±—É–¥—É—Ç –ø–æ–ª—É—á–∞—Ç—å –Ω–∞–ø–æ–º–∏–Ω–∞–Ω–∏—è –æ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ –æ—Ñ–æ—Ä–º–ª–µ–Ω–∏—è –∏–ª–∏ –ø—Ä–æ–¥–ª–µ–Ω–∏—è —Ä–∞–∑—Ä–µ—à–µ–Ω–∏–π. –ù–æ–≤—ã–µ —Å–µ—Ä–≤–∏—Å—ã –æ—Ö–≤–∞—Ç—è—Ç, –≤ —á–∞—Å—Ç–Ω–æ—Å—Ç–∏: - –∞—Ç—Ç–µ—Å—Ç–∞—Ü–∏—é —ç–∫—Å–ø–µ—Ä—Ç–æ–≤, —É—á–∞—Å—Ç–≤—É—é—â–∏—Ö –≤ –∫–æ–Ω—Ç—Ä–æ–ª–µ –≤ —Å—Ñ–µ—Ä–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è (–†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä); - –∞—Ç—Ç–µ—Å—Ç–∞—Ü–∏—é —ç–∫—Å–ø–µ—Ä—Ç–æ–≤ –¥–ª—è —ç–∫—Å–ø–µ—Ä—Ç–∏–∑—ã –≤ —Ä–∞–º–∫–∞—Ö –≥–æ—Å–∫–æ–Ω—Ç—Ä–æ–ª—è (–†–æ—Å—Å–µ–ª—å—Ö–æ–∑–Ω–∞–¥–∑–æ—Ä); - –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏—é —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –¥–ª—è –≤–µ–¥–µ–Ω–∏—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ (–ú–∏–Ω–∑–¥—Ä–∞–≤). –°–æ–∫—Ä–∞—Ç—è—Ç—Å—è —Å—Ä–æ–∫–∏ –æ—Ñ–æ—Ä–º–ª–µ–Ω–∏—è ¬´–¥–ª–∏—Ç–µ–ª—å–Ω—ã—Ö¬ª —Ä–∞–∑—Ä–µ—à–µ–Ω–∏–π, –≤–∫–ª—é—á–∞—è: - —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—é –ª–µ–∫–∞—Ä—Å—Ç–≤ –¥–ª—è –≤–µ—Ç–µ—Ä–∏–Ω–∞—Ä–Ω–æ–≥–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è (–†–æ—Å—Å–µ–ª—å—Ö–æ–∑–Ω–∞–¥–∑–æ—Ä); - —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—é –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –¥–ª—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è (–ú–∏–Ω–∑–¥—Ä–∞–≤). –ü–æ—è–≤—è—Ç—Å—è –∫–æ–º–ø–ª–µ–∫—Å–Ω—ã–µ —É—Å–ª—É–≥–∏, –ø–æ–∑–≤–æ–ª—è—é—â–∏–µ –æ—Ñ–æ—Ä–º–∏—Ç—å –Ω–µ—Å–∫–æ–ª—å–∫–æ —Ä–∞–∑—Ä–µ—à–µ–Ω–∏–π –æ–¥–Ω–∏–º –∑–∞—è–≤–ª–µ–Ω–∏–µ–º, –≤ —Ç–æ–º —á–∏—Å–ª–µ: - –ª–∏—Ü–µ–Ω–∑–∏—Ä–æ–≤–∞–Ω–∏–µ —Ñ–∞—Ä–º–¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ —Å –≤–µ—Ç–ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º–∏; - –≤—ã–¥–∞—á—É –∑–∞–∫–ª—é—á–µ–Ω–∏–π –æ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–µ–π —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è–º GMP; - –ª–∏—Ü–µ–Ω–∑–∏—Ä–æ–≤–∞–Ω–∏–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –∏ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—é –≤–µ—Ç–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤; - —Å–∞–Ω–∏—Ç–∞—Ä–Ω–æ-—ç–ø–∏–¥–µ–º–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–µ –∑–∞–∫–ª—é—á–µ–Ω–∏—è (–†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä); - –∑–∞–∫–ª—é—á–µ–Ω–∏—è –¥–ª—è —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –Ω–∞–∏–º–µ–Ω–æ–≤–∞–Ω–∏–π –º–µ—Å—Ç–∞ –ø—Ä–æ–∏—Å—Ö–æ–∂–¥–µ–Ω–∏—è —Ç–æ–≤–∞—Ä–æ–≤ ‚Äî –∞–ª–∫–æ–≥–æ–ª—å–Ω–æ–π –∏ —Å–ø–∏—Ä—Ç–æ—Å–æ–¥–µ—Ä–∂–∞—â–µ–π –ø—Ä–æ–¥—É–∫—Ü–∏–∏ (–†–æ—Å–∞–ª–∫–æ–≥–æ–ª—å—Ç–∞–±–∞–∫–∫–æ–Ω—Ç—Ä–æ–ª—å). –ë—É–¥–µ—Ç —Å–æ–∫—Ä–∞—â–µ–Ω –ø–∞–∫–µ—Ç –¥–æ–∫—É–º–µ–Ω—Ç–æ–≤ –¥–ª—è ¬´–¥–æ–∫—É–º–µ–Ω—Ç–æ–µ–º–∫–∏—Ö¬ª –ø—Ä–æ—Ü–µ–¥—É—Ä: - —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –∏–∑–æ–±—Ä–µ—Ç–µ–Ω–∏–π –∏ –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω—ã—Ö –æ–±—Ä–∞–∑—Ü–æ–≤ —Å –≤—ã–¥–∞—á–µ–π –ø–∞—Ç–µ–Ω—Ç–∞ –∏ –¥—É–±–ª–∏–∫–∞—Ç–æ–≤ (–†–æ—Å–ø–∞—Ç–µ–Ω—Ç); - —Ä–∞–∑—Ä–µ—à–µ–Ω–∏—è –Ω–∞ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –ª–µ–∫–∞—Ä—Å—Ç–≤ (–ú–∏–Ω–∑–¥—Ä–∞–≤). –ú–æ—ë –º–Ω–µ–Ω–∏–µ –ï—Å–ª–∏ –ø–æ–ª—É—á–∏—Ç—Å—è —á—Ç–æ-—Ç–æ –¥–µ–π—Å—Ç–≤–∏—Ç–µ–ª—å–Ω–æ —É–¥–æ–±–æ–≤–∞—Ä–∏–º–æ–µ, –±—É–¥–µ—Ç –ª—É—á—à–µ. –ë—É–¥–µ—Ç –ª–µ–≥—á–µ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞—Ç—å—Å—è / –æ—Ç–∫—Ä—ã—Ç—å –¥–µ–ª–æ –∏ —Ç–∞–∫ –¥–∞–ª–µ–µ. –í–æ–∑–º–æ–∂–Ω–æ, –µ—â—ë –∏ –¥–µ—à–µ–≤–ª–µ. –≠—Ç–æ –º—ã –æ–¥–Ω–æ–∑–Ω–∞—á–Ω–æ —Å–º–æ–∂–µ–º –æ—Ç–∫—Ä—ã—Ç—å –Ω–∞ 10 000 –∫–ª–∏–Ω–∏–∫ –∏ –∞–ø—Ç–µ–∫ –±–æ–ª—å—à–µ. –ê –º–æ–∂–µ—Ç –∏ –Ω–µ—Ç. –ö–∞–∫ –æ—Ü–µ–Ω–∏–≤–∞–µ—Ç–µ –Ω–æ–≤–æ–≤–≤–µ–¥–µ–Ω–∏–µ? ‚ù§Ô∏è ‚Äî —Å–∫–æ—Ä–µ–µ –ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω–æ üóø ‚Äî —Å–∫–æ—Ä–µ–µ –æ—Ç—Ä–∏—Ü–∞—Ç–µ–ª—å–Ω–æ üòê ‚Äî —Å–∫–æ—Ä–µ–µ —Ä–∞–≤–Ω–æ–¥—É—à–Ω–æ üòÄ ‚Äî –†–æ—Å–∞–ª–∫–æ–≥–æ–ª—å—Ç–∞–±–∞–∫–∫–æ–Ω—Ç—Ä–æ–ª—å ‚Äî —ç—Ç–æ –∫—Ä–∏–Ω–∂–∞—Ç–∏–Ω–∞","{""skip"": false, ""country"": ""global"", ""topic"": ""registration,tenders"", ""impact"": ""medium"", ""english"": ""The government is launching new digital services on the portal of Government Services for the pharmaceutical industry. Deputy Prime Minister Dmitry Grigorenko has ordered federal executive authorities to launch updated services by autumn. Users, both individuals and companies, will receive reminders about the need to apply or renew permits. The new services include: - certification of experts involved in healthcare control (Roszdravnadzor); - certification of experts for the review within state supervision (Rosselkhoznadzor); - accreditation of specialists for medical and pharmaceutical activities (Minzdrav). The duration of registration procedures will be shortened, including: - registration of veterinary drugs for use (Rosselkhoznadzor); - registration of pharmaceuticals for medical use (Minzdrav). Complex services will be introduced to allow the application of several permits in one submission, including: - licensing for pharmaceutical activities with veterinary drugs; - issuance of conformity certificates for manufacturers' requirements GMP; - licensing for production and registration of veterinary drugs; - sanitary-epidemiological certificates (Rossperetradnizhkontrol); - certificates for"
2025-08-10T14:12:05+00:00,@pharm_icon,2324,https://t.me/pharm_icon/2324,"–ñ–µ–Ω—Å–∫–æ–µ —Å—á–∞—Å—Ç—å–µ –í—ã—Ö–æ–¥–Ω—ã–µ ‚Äî –æ—Ç–ª–∏—á–Ω—ã–π –ø–æ–≤–æ–¥ –ø–æ—Å–º–æ—Ç—Ä–µ—Ç—å –ø—É–±–ª–∏–∫–∞—Ü–∏–∏ –ø—Ä–æ –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç—å –∏ –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç—ã –º–µ–∂–¥—É –ø–∏–Ω–æ–π –∫–æ–ª–∞–¥–æ–π –∏ –Ω–∞–ø–∏—Å–∞–Ω–∏–µ–º –¥–æ–∫—Ç–æ—Ä—Å–∫–æ–π –¥–∏—Å—Å–µ—Ä—Ç–∞—Ü–∏–∏. –ö–∞—Ç–∞–ª–æ–Ω–∏—è: –∏–∑ 99 605 –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–µ–π —Å —è–Ω–≤–∞—Ä—è 2011 –ø–æ –∏—é–Ω—å 2020 14,9% –±—ã–ª–∏ —Å–≤—è–∑–∞–Ω—ã —Å –Ω–∞–∑–Ω–∞—á–µ–Ω–∏–µ–º –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç–æ–≤ –ø–æ –¥–∞–Ω–Ω—ã–º RWD –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –°–∞–º—ã–π –∏—Å–ø–æ–ª—å–∑—É–µ–º—ã–π: –ø–∞—Ä–æ–∫—Å–µ—Ç–∏–Ω, –Ω–æ —Å–µ—Ä—Ç—Ä–∞–ª–∏–Ω –ø–æ–∫–∞–∑—ã–≤–∞–ª —Ä–æ—Å—Ç —Å —Ç–µ—á–µ–Ω–∏–µ–º –≤—Ä–µ–º–µ–Ω–∏ –•–æ—Ä–æ—à–æ —Ä–∞–±–æ—Ç–∞–µ—Ç —Å–∫—Ä–∏–Ω–∏–Ω–≥ –ø–ª–æ—Ö–æ–≥–æ –Ω–∞—Å—Ç—Ä–æ–µ–Ω–∏—è –∏ –º–∞—Ä–∫–µ—Ç–∏–Ω–≥ –≤ –ö–∞—Ç–∞–ª–æ–Ω–∏–∏ –§—Ä–∞–Ω—Ü–∏—è: –ö–æ–≥–æ—Ä—Ç–∞ –±–µ—Ä–µ–º–µ–Ω–Ω—ã—Ö –∂–µ–Ω—â–∏–Ω EFEMERIS ‚Äî 1,8% –∂–µ–Ω—â–∏–Ω (1620/89170) –ø–æ–ª—É—á–∞–ª–∏ –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç—ã –Ω–∞ –º–æ–º–µ–Ω—Ç –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏. 1363 –∂–µ–Ω—â–∏–Ω –ø–æ–ª—É—á–∏–ª–∏ –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç—ã –≤ —Ç–µ—á–µ–Ω–∏–µ –ø–µ—Ä–≤–æ–≥–æ (1,5%), 591 –≤–æ –≤—Ä–µ–º—è –≤—Ç–æ—Ä–æ–≥–æ (0,7%) –∏ 412 –≤ —Ç–µ—á–µ–Ω–∏–µ —Ç—Ä–µ—Ç—å–µ–≥–æ (0,5%) —Ç—Ä–∏–º–µ—Å—Ç—Ä–∞. –ê –≤–æ—Ç –≤ –í–µ—Ä—Ö–Ω–µ–π –ì–∞—Ä–æ–Ω–Ω–µ ‚Äî –º–µ—Å—Ç–µ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è ‚Äî —è–≤–Ω–æ –º–∞—Ä–∫–µ—Ç–∏–Ω–≥ –Ω–µ –¥–æ—Ä–∞–±–∞—Ç—ã–≤–∞–µ—Ç. –ü–æ—Å–º–æ—Ç—Ä–∏—Ç–µ –Ω–∞ –ö–∞—Ç–∞–ª–æ–Ω–∏—é ‚Äî –≤–æ—Ç —Ç–∞–º —Ä–∞–±–æ—Ç–∞—é—Ç –Ω–æ—Ä–º–∞–ª—å–Ω—ã–µ –ª—é–¥–∏. –ò—Å—Ö–æ–¥—ã –ø—Ä–∏–µ–º–∞ –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç–æ–≤ –≤ –ö–∞—Ç–∞–ª–æ–Ω–∏–∏: –°—Ä–µ–¥–∏ –∂–µ–Ω—â–∏–Ω, –∫–æ—Ç–æ—Ä—ã–º –Ω–∞–∑–Ω–∞—á–∞–ª–∏—Å—å –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç—ã –≤–æ –≤—Ä–µ–º—è –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–∏ (–ø—Ä–æ–∞–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–æ 14 815 –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç–µ–π), –±—ã–ª–æ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–æ üë∂üèª8725 —Å–ª—É—á–∞–µ–≤ –≤–∞–≥–∏–Ω–∞–ª—å–Ω—ã—Ö —Ä–æ–¥–æ–≤, —á—Ç–æ —Å–æ—Å—Ç–∞–≤–∏–ª–æ 58,9% –æ—Ç –æ–±—â–µ–≥–æ —á–∏—Å–ª–∞ –≤—ã—è–≤–ª–µ–Ω–Ω—ã—Ö —Å–ª—É—á–∞–µ–≤ (95% –î–ò 58,1‚Äì59,7) ü§åüèª–Ω–æ—Ä–º–∞ –≤ –ö–∞—Ç–∞–ª–æ–Ω–∏–∏ ‚Äî 63,5% ‚úñÔ∏è3662 —Å–ª—É—á–∞—è –∞–±–æ—Ä—Ç–æ–≤, —á—Ç–æ —Å–æ—Å—Ç–∞–≤–∏–ª–æ 24,7% (95% –î–ò 24,0‚Äì25,4) üî™2335 —Å–ª—É—á–∞–µ–≤ –∫–µ—Å–∞—Ä–µ–≤–∞ —Å–µ—á–µ–Ω–∏—è (15,8%; 95% –î–ò 15,2‚Äì16,3). –ß—Ç–æ –Ω–µ –¥–µ–ª–∞—é—Ç –∞–≤—Ç–æ—Ä—ã –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è: –ù–µ –æ—Ü–µ–Ω–∏–≤–∞—é—Ç –Ω–∞–ø—Ä—è–º—É—é —á–∏—Å–ª–æ –∞–±–æ—Ä—Ç–æ–≤ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –¥—Ä—É–≥–∏–º–∏ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è–º–∏. 24,7% ‚Äî –º–Ω–æ–≥–æ–≤–∞—Ç–æ –Ω–∞ –≥–ª–∞–∑. –ù–µ –æ—Ü–µ–Ω–∏–≤–∞—é—Ç –≤–ª–∏—è–Ω–∏–µ –Ω–∞ —Ä–∞–∑–≤–∏—Ç–∏–µ —Ä–µ–±–µ–Ω–∫–∞ ‚Äî —ç—Ç–æ –æ—á–µ–Ω—å –∏–Ω—Ç–µ—Ä–µ—Å–Ω–æ. –°–∫–æ—Ä–æ, —á–µ—Ä–µ–∑ 10-15 –ª–µ—Ç, –º—ã —Ç–æ—á–Ω–æ –≤—Å—ë —É–∑–Ω–∞–µ–º. –ê –ø–æ—á–µ–º—É? –ê –ø–æ—Ç–æ–º—É —á—Ç–æ –≤ –†–æ—Å—Å–∏–∏ –≤ 2025-–º –≥–æ–¥—É –ø—Ä–æ–¥–∞–∂–∏ –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç–æ–≤ –¥–æ—Å—Ç–∏–≥–ª–∏ —Ä–µ–∫–æ—Ä–¥–Ω–æ–≥–æ —É—Ä–æ–≤–Ω—è, –≤ —è–Ω–≤–∞—Ä–µ-—Ñ–µ–≤—Ä–∞–ª–µ –±—ã–ª–æ –ø—Ä–æ–¥–∞–Ω–æ 3,2 –º–ª–Ω —É–ø–∞–∫–æ–≤–æ–∫, —Å—É–º–º–∞—Ä–Ω–æ –∑–∞ –ø–æ–ª–≥–æ–¥–∞ ‚Äî 9,3 –º–ª–Ω. –¢–∞–∫–∂–µ —Ä–∞—Å—Ç—É—Ç –∞–Ω–∫—Å–∏–æ–ª–∏—Ç–∏–∫–∏. –ï—Å–ª–∏ –Ω–∞ –Ω–∏—Ö –µ—â—ë –∏ —Ä–∞—Å—Ç—ë—Ç —á–∏—Å–ª–æ –∞–±–æ—Ä—Ç–æ–≤, —Ç–æ –¥–ª—è –¥–µ–º–æ–≥—Ä–∞—Ñ–æ–≤ —Ö–æ—Ä–æ—à–µ–π –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ —É –º–µ–Ω—è –Ω–µ—Ç. –î–ª—è Real World Data-–º–µ–Ω–µ–¥–∂–µ—Ä–æ–≤ –≤–ø–µ—Ä–µ–¥–∏ –º–Ω–æ–≥–æ —Ä–∞–±–æ—Ç—ã","{""skip"": false, ""country"": ""global"", ""topic"": ""regulation,payment,safety"", ""impact"": ""high"", ""english"": ""The study found that 24.7% of abortions in Catalonia were due to antidepressant use during pregnancy, which is higher than expected. The authors did not directly compare this number with other studies or assess the impact on child development. In Russia, antidepressant sales reached record levels in 2025 with January-February sales of 3.2 million units and total sales for the first half of the year at 9.3 million. This raises concerns about potential impacts on fetal development and overall population health.""}"
2025-08-06T18:01:27+00:00,@pharm_icon,2323,https://t.me/pharm_icon/2323,"ü§∑üèª‚Äç‚ôÇÔ∏è8% —Ñ–∞–Ω–∞—Ç–∏–∫–æ–≤ —Ñ–∞—Ä–º–∞–∫–æ–Ω–∞–¥–∑–æ—Ä–∞ –∏–ª–∏..? –ù–∏–¥–µ—Ä–ª–∞–Ω–¥—Å–∫–æ–µ –æ–±—â–µ—Å—Ç–≤–æ –ø–µ–¥–∏–∞—Ç—Ä–∏–∏ –ø—Ä–æ–≤–µ–ª–æ –æ–ø—Ä–æ—Å 127 —Ä–µ—Å–ø–æ–Ω–¥–µ–Ω—Ç–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ –∏–º–µ—é—Ç –ø—Ä—è–º–æ–µ –æ—Ç–Ω–æ—à–µ–Ω–∏–µ –∫ –ø–µ–¥–∏–∞—Ç—Ä–∏—á–µ—Å–∫–æ–π –ø—Ä–∞–∫—Ç–∏–∫–µ, —á—Ç–æ–±—ã —É–∑–Ω–∞—Ç—å –ö–∞–∫–∏–µ —Ç–∞–º –ø—Ä–æ–±–ª–µ–º—ã —Å —Ñ–∞—Ä–º–∞–∫–æ–Ω–∞–¥–∑–æ—Ä–æ–º –ù–∏–¥–µ—Ä–ª–∞–Ω–¥–æ–≤ –≤ –ø–µ–¥–∏–∞—Ç—Ä–∏–∏? üóø–í—Å–µ–≥–æ 112 —Ä–µ—Å–ø–æ–Ω–¥–µ–Ω—Ç–æ–≤ (93 %) —Å—á–∏—Ç–∞–ª–∏, —á—Ç–æ —Å–æ–æ–±—â–µ–Ω–∏–µ –æ –Ω–µ–∂–µ–ª–∞—Ç–µ–ª—å–Ω–æ–π –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π —Ä–µ–∞–∫—Ü–∏–∏ (–ù–õ–†) –±—É–¥–µ—Ç –ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω–æ –≤–æ—Å–ø—Ä–∏–Ω—è—Ç–æ –∏—Ö –∫–æ–ª–ª–µ–≥–∞–º–∏, –∞ —Ç–∞–∫–∂–µ –ø–∞—Ü–∏–µ–Ω—Ç–∞–º–∏ –∏ –∏—Ö —Å–µ–º—å—è–º–∏. –ß—Ç–æ –≤ —Ä–æ—Å—Å–∏–π—Å–∫–æ–π —Ä–µ–∞–ª—å–Ω–æ—Å—Ç–∏? –°–æ–æ–±—â–µ–Ω–∏–µ –ø–∞—Ü–∏–µ–Ω—Ç—É –∏–ª–∏ —Ä–æ–¥—Å—Ç–≤–µ–Ω–Ω–∏–∫–∞–º –æ –ø–æ–±–æ—á–Ω–æ–º —ç—Ñ—Ñ–µ–∫—Ç–µ –≤—ã–∑—ã–≤–∞–µ—Ç —Å—Ç—Ä–∞—Ö —É –≤—Ä–∞—á–∞. –°—Ç—Ä–∞—Ö —Ç–æ–≥–æ, —á—Ç–æ –∫–ª–∏–µ–Ω—Ç —É–π–¥–µ—Ç –∫ –¥—Ä—É–≥–æ–º—É –¥–æ–∫—Ç–æ—Ä—É. üëç100 —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ (84 %) –æ–∂–∏–¥–∞–ª–∏, —á—Ç–æ –∫–æ–º–∏—Ç–µ—Ç—ã –ø–æ –∫–∞—á–µ—Å—Ç–≤—É –≤ –∏—Ö –±–æ–ª—å–Ω–∏—Ü–∞—Ö —Ç–∞–∫–∂–µ –æ–¥–æ–±—Ä—è—Ç —Å–æ–æ–±—â–µ–Ω–∏—è –æ –ù–õ–†. –ë–æ–ª–µ–µ —Ç–æ–≥–æ, 112 —Ä–µ—Å–ø–æ–Ω–¥–µ–Ω—Ç–æ–≤ (93 %) –∑–∞—è–≤–∏–ª–∏, —á—Ç–æ –∏—Ö –ø—Ä–∞–∫—Ç–∏–∫–∞ —Å–æ–æ–±—â–µ–Ω–∏—è –æ –ù–õ–† –º–æ–≥–ª–∞ –±—ã —É–ª—É—á—à–∏—Ç—å—Å—è –ø—Ä–∏ –±–æ–ª–µ–µ –ø—Ä–∏—Å—Ç–∞–ª—å–Ω–æ–º –≤–Ω–∏–º–∞–Ω–∏–∏ –∫ —ç—Ç–æ–π —Ç–µ–º–µ –≤ –∏—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–º —Å–æ–æ–±—â–µ—Å—Ç–≤–µ –∏–ª–∏ —É—á—Ä–µ–∂–¥–µ–Ω–∏–∏. –ú–Ω–µ–Ω–∏–µ. –ú–æ—è –ø–æ–¥—Ä—É–≥–∞, –∫–æ—Ç–æ—Ä–∞—è –∑–∞–Ω–∏–º–∞–µ—Ç—Å—è —Ñ–∞—Ä–º–∞–∫–æ–Ω–∞–¥–∑–æ—Ä–æ–º –≤ –ï–≤—Ä–æ–ø–µ, —Å—á–∏—Ç–∞–µ—Ç, —á—Ç–æ –≤—Å–µ –±—É–¥—É—Ç —Å–æ–æ–±—â–∞—Ç—å –æ –ø–æ–±–æ—á–Ω—ã—Ö —ç—Ñ—Ñ–µ–∫—Ç–∞—Ö —Ç–æ–ª—å–∫–æ –ø—Ä–∏ –≤–Ω–µ–¥—Ä–µ–Ω–∏–∏ –ø–∞–ª–æ—á–Ω–æ–π —Å–∏—Å—Ç–µ–º—ã. –ù–µ —Å–æ–æ–±—â–∏–ª–∏ –∑–∞ –º–µ—Å—è—Ü –æ 50 –ø–æ–±–æ—á–∫–∞—Ö? –í–æ—Ç –≤–∞–º –∫–Ω—É—Ç –≤ –≤–∏–¥–µ —à—Ç—Ä–∞—Ñ–æ–≤. –°–æ–≥–ª–∞—Å–Ω–∞, —á—Ç–æ —Ç–∞–∫ –±—ã–ª–æ –±—ã —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–µ–µ. –≠—Ç–æ —Ç–æ —Å–∞–º–æ–µ –Ω–∞—Å–∏–ª–∏–µ, –∫–æ—Ç–æ—Ä–æ–µ –ø–æ—Ä–æ–∂–¥–∞–µ—Ç –∑–Ω–∞–Ω–∏–µ. ‚ù§Ô∏è–ù–∞ —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏–µ ¬´–°–æ–æ–±—â–µ–Ω–∏–µ –æ –ù–õ–† –∏–º–µ–µ—Ç —Å–º—ã—Å–ª¬ª 111 —á–µ–ª–æ–≤–µ–∫ (93 %) –æ—Ç–≤–µ—Ç–∏–ª–∏ ¬´—Å–æ–≥–ª–∞—Å–µ–Ω¬ª –∏–ª–∏ ¬´–ø–æ–ª–Ω–æ—Å—Ç—å—é —Å–æ–≥–ª–∞—Å–µ–Ω¬ª. üòÅ–° —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏–µ–º ¬´–°–æ–æ–±—â–µ–Ω–∏–µ –æ –ù–õ–† ‚Äî —ç—Ç–æ –ø—Ä–æ—Å—Ç–∞—è –∑–∞–¥–∞—á–∞¬ª —Å–æ–≥–ª–∞—Å–∏–ª–∏—Å—å 38 —Ä–µ—Å–ø–æ–Ω–¥–µ–Ω—Ç–æ–≤ (32 %), –≤ —Ç–æ –≤—Ä–µ–º—è –∫–∞–∫ 22 (19 %) –Ω–µ —Å–æ–≥–ª–∞—Å–∏–ª–∏—Å—å, –∞ –µ—â—ë 36 (30 %) –∑–∞–Ω—è–ª–∏ –Ω–µ–π—Ç—Ä–∞–ª—å–Ω—É—é –ø–æ–∑–∏—Ü–∏—é. –ò —Ç—É—Ç —á—Ç–æ-—Ç–æ –∏–∑ —Ä–∞–∑—Ä—è–¥–∞ —Ñ–∞–Ω—Ç–∞—Å—Ç–∏–∫–∏ ‚ùóÔ∏è–í—Å–µ–≥–æ 23 —Ä–µ—Å–ø–æ–Ω–¥–µ–Ω—Ç–∞ (19 %) –ø—Ä–∏–∑–Ω–∞–ª–∏—Å—å, —á—Ç–æ –Ω–∏–∫–æ–≥–¥–∞ –Ω–µ —Å–æ–æ–±—â–∞–ª–∏ –æ –ù–õ–†. –í –æ—Å–Ω–æ–≤–Ω–æ–º —ç—Ç–æ –±—ã–ª–∏ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã —Å–æ —Å—Ç–∞–∂–µ–º 6‚Äì10 –ª–µ—Ç, –ø–µ–¥–∏–∞—Ç—Ä—ã –Ω–∞ —ç—Ç–∞–ø–µ –æ–±—É—á–µ–Ω–∏—è –∏ –≤—Ä–∞—á–∏ –æ–±—â–µ–π –ø—Ä–∞–∫—Ç–∏–∫–∏, —Ä–∞–±–æ—Ç–∞—é—â–∏–µ –≤ –ø–µ–¥–∏–∞—Ç—Ä–∏–∏. –ß—Ç–æ —è –¥—É–º–∞—é –æ–± —ç—Ç–æ–º. –ú–Ω–µ –∫–∞–∂–µ—Ç—Å—è –±–µ–∑—É–º–Ω–æ–π —ç—Ç–∞ –≤—ã–±–æ—Ä–∫–∞, —Å –æ–¥–Ω–æ–π —Å—Ç–æ—Ä–æ–Ω—ã. –° –¥—Ä—É–≥–æ–π ‚Äî –≤—Å–µ —ç—Ç–∏ –ª—é–¥–∏ –±–æ–ª—å—à–∏–µ –º–æ–ª–æ–¥—Ü—ã –∏ –≤–æ–∑–º–æ–∂–Ω–∞ —Ç–∞–∫–∞—è —Å–∏—Ç—É–∞—Ü–∏—è, –∫–æ–≥–¥–∞ —Ç–æ–ª—å–∫–æ 19% –≤—Ä–∞—á–µ–π –Ω–µ —Å–æ–æ–±—â–∞–ª–∏ –æ–± –ù–õ–†. ü•π–ü—Ä–æ—Å—Ç–æ –§–∞–Ω—Ç–∞—Å—Ç–∏–∫–∞ü•π","{""skip"": true}"
2025-08-06T10:15:42+00:00,@pharm_icon,2322,https://t.me/pharm_icon/2322,"–¢–∞–π–Ω–∞—è –º—É–∑–∞ –∏ –ò–º–ø–æ—Ä—Ç–æ–∑–∞–º–µ—â–µ–Ω–∏–µ ¬´–°–Ω–∞—á–∞–ª–∞ –º—ã –≤–≤–µ–¥—ë–º –Ω–µ–±–æ–ª—å—à–æ–π —Ç–∞—Ä–∏—Ñ –Ω–∞ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã, –Ω–æ —á–µ—Ä–µ–∑ –≥–æ–¥ ‚Äî –º–∞–∫—Å–∏–º—É–º —á–µ—Ä–µ–∑ –ø–æ–ª—Ç–æ—Ä–∞ ‚Äî –æ–Ω –≤—ã—Ä–∞—Å—Ç–µ—Ç –¥–æ 150%, –∞ –∑–∞—Ç–µ–º –∏ –¥–æ 250%, ‚Äî —Å–∫–∞–∑–∞–ª –£–ì–ê–î–ê–ô–¢–ï –ö–¢–û –≤ —Ç–µ–ª–µ—Ñ–æ–Ω–Ω–æ–º –∏–Ω—Ç–µ—Ä–≤—å—é —Ç–µ–ª–µ–∫–∞–Ω–∞–ª—É CNBC. ‚Äî –ú—ã —Ö–æ—Ç–∏–º, —á—Ç–æ–±—ã —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –ø—Ä–æ–∏–∑–≤–æ–¥–∏–ª–∏—Å—å –≤ –Ω–∞—à–µ–π —Å—Ç—Ä–∞–Ω–µ¬ª. –ù–∞ –ø—Ä–æ—à–ª–æ–π –Ω–µ–¥–µ–ª–µ –∞–¥–º–∏–Ω–∏—Å—Ç—Ä–∞—Ü–∏—è –¢—Ä–∞–º–ø–∞ –æ–±—ä—è–≤–∏–ª–∞ –æ —Å–æ–≥–ª–∞—à–µ–Ω–∏–∏ —Å –ï–°, –∫–æ—Ç–æ—Ä–æ–µ –≤–≤–µ–¥—ë—Ç 15-–ø—Ä–æ—Ü–µ–Ω—Ç–Ω—ã–π —Å–±–æ—Ä –Ω–∞ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫—É—é –ø—Ä–æ–¥—É–∫—Ü–∏—é –∏–∑ —Å—Ç—Ä–∞–Ω –±–ª–æ–∫–∞ –¢–∞–π–Ω–∞—è –º—É–∑–∞ –°–∫–æ–ª—å–∫–æ –±—ã –î–æ–Ω–∞–ª—å–¥ –¢—Ä–∞–º–∞ –Ω–µ –æ—Å—É–∂–¥–∞–ª –≥–ª–∞–≤–Ω–æ–≥–æ –ø–æ –∫—Ä–µ–ø–∫–∏–º –æ–±–æ—Ä–æ—Ç–∞–º —Ä–µ—á–∏ ‚Äî –î–º–∏—Ç—Ä–∏—è –ú–µ–¥–≤–µ–¥–µ–≤–∞ ‚Äî —á—å–∏ —Å–ª–æ–≤–∞ –æ—Ç–ª–∏—Ç—ã –≤ –≥—Ä–∞–Ω–∏—Ç–µ ‚Äî –Ω–æ –∏–¥—ë—Ç –æ–Ω –∫—É—Ä—Å–æ–º –ê–Ω–∞—Ç–æ–ª—å–µ–≤–∏—á–∞ —Å—Ç–æ–ª—å –∂–µ —É–≤–µ—Ä–µ–Ω–Ω–æ, —Å–∫–æ–ª—å —É–≤–µ—Ä–µ–Ω–Ω–æ –∫ –Ω–µ–º—É –ø—Ä–∏–±–ª–∏–∂–∞—é—Ç—Å—è –æ—Å—Ç–µ–æ–ø–æ—Ä–æ–∑ –∏ –ø–µ—Ä–µ–ª–æ–º —à–µ–π–∫–∏ –±–µ–¥—Ä–∞. –°—Ç—Ä–∞—Ç–µ–≥–∏—è ¬´–§–∞—Ä–º–∞‚Äë2020¬ª ‚Äî –≤–æ—Ç —á—Ç–æ –Ω—É–∂–Ω–æ —ç—Ç–æ–º—É —á–µ–ª–æ–≤–µ–∫—É. –ù–∞–ø–æ–º–Ω–∏–º, —á—Ç–æ –∫ 2020 –≥–æ–¥—É –æ–±—ä—ë–º –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –≤—ã—Ä–æ—Å —Å ‚âà 96 –º–ª—Ä–¥ —Ä—É–±. –≤ 2009 –≥–æ–¥—É –¥–æ ‚âà 485,8 –º–ª—Ä–¥ —Ä—É–±. –≤ 2020, –ø—Ä–∏—Ä–æ—Å—Ç —Å–æ—Å—Ç–∞–≤–∏–ª –æ–∫–æ–ª–æ 406 %. –ö–æ–Ω–µ—á–Ω–æ, —Å—Ç–µ–ø–µ–Ω—å –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç–∏ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ –º—ã –æ–±—Å—É–∂–¥–∞—Ç—å –Ω–µ –±—É–¥–µ–º. –ú—ã –¥–æ–ª–∂–Ω—ã –ø–æ–Ω—è—Ç—å, —á—Ç–æ —Ç–∞–π–Ω–æ –¢—Ä–∞–º–ø —Å—á–∏—Ç–∞–µ—Ç —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã–º –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç–æ–º –∏–º–µ–Ω–Ω–æ –ú–µ–¥–≤–µ–¥–µ–≤–∞, –ø–æ—Ç–æ–º—É –∏ –æ—Ç–Ω–æ—Å–∏—Ç—Å—è –∫ –Ω–µ–º—É –≤–Ω–∏–º–∞—Ç–µ–ª—å–Ω–µ–µ, —á–µ–º –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ –≥—Ä–∞–∂–¥–∞–Ω –†–æ—Å—Å–∏–∏. ‚ù§Ô∏è ‚Äî –º–∞—Å–∫–∏ —Å–±—Ä–æ—à–µ–Ω—ã üóø ‚Äî –µ–≥–æ –Ω–µ –ú–µ–¥–≤–µ–¥–µ–≤ –≤–¥–æ—Ö–Ω–æ–≤–ª—è–µ—Ç","{""skip"": true}"
2025-08-04T13:22:30+00:00,@pharm_icon,2321,https://t.me/pharm_icon/2321,"–î—Ä—É–∂–±–∞ –Ω–∞—Ä–æ–¥–æ–≤: —Å—Ç—Ä–∞–Ω–Ω—ã–π –¥–æ–∫—É–º–µ–Ω—Ç –æ–±–Ω–∞—Ä—É–∂–µ–Ω 1. –ï–≤—Ä–∞–∑–∏–π—Å–∫–∞—è –∞—Å—Å–æ—Ü–∏–∞—Ü–∏—è –∫–∞—Ä–¥–∏–æ–ª–æ–≥–æ–≤ 2. –í —Ä–∞–±–æ—á–µ–π –≥—Ä—É–ø–ø–µ —Ç–æ–ª—å–∫–æ –†–æ—Å—Å–∏—è 3. –ï—Å—Ç—å –Ω–µ–∫–∏–π —ç–∫—Å–ø–µ—Ä—Ç–Ω—ã–π —Å–æ–≤–µ—Ç –∏–∑ –ê—Ä–º–µ–Ω–∏–∏, –ö—ã—Ä–≥—ã–∑—Å—Ç–∞–Ω–∞, –ö–∞–∑–∞—Ö—Å—Ç–∞–Ω–∞, –£–∑–±–µ–∫–∏—Å—Ç–∞–Ω–∞, –ê–∑–µ—Ä–±–∞–π–¥–∂–∞–Ω–∞, –∫–æ—Ç–æ—Ä—ã–π –Ω–µ –≤—Ö–æ–¥–∏—Ç –≤ —á–∏—Å–ª–æ —Å–æ–∞–≤—Ç–æ—Ä–æ–≤ –í–æ—Ç —Ç–∞–∫–∞—è –º–µ–∂–≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–∞—è –∫–æ–æ–ø–µ—Ä–∞—Ü–∏—è!","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""clinical_trial, guideline"",
  ""impact"": ""medium"",
  ""english"": ""A regional cooperation is described involving the Eurasian Association of Cardiologists, with Russia as one of the countries involved. There is also mention of an expert council from several Eurasian countries that are not among the co-authors.""
}"
2025-07-29T12:56:01+00:00,@pharm_icon,2320,https://t.me/pharm_icon/2320,–ë–µ—Ä–µ–≥–∏—Ç–µ –∏ —Å–≤–æ–∏ –ª–∏—á–Ω—ã–µ —Ç–µ–ª–µ–≥—Ä–∞–º-–∫–∞–Ω–∞–ª—ã –æ—Ç —Ö–∞–∫–µ—Ä–æ–≤. –û–±—è–∑–∞—Ç–µ–ª—å–Ω–æ.,"{""skip"": true}"
2025-07-29T11:42:51+00:00,@pharm_icon,2318,https://t.me/pharm_icon/2318,"‚ö°Ô∏è–•–∞–∫–Ω—É—Ç—ã ¬´–°—Ç–æ–ª–∏—á–∫–∏¬ª –∏ ¬´–ù–µ–æ—Ñ–∞—Ä–º¬ª, —É –°—Ç–æ–ª–∏—á–µ–∫ —Ç–æ—á–∫–∏ –∑–∞–∫—Ä—ã—Ç—ã –ø–æ –í–°–ï–ô –ú–æ—Å–∫–≤–µ. –ù–µ —Ä–∞–±–æ—Ç–∞—é—Ç –∫–∞—Å—Å—ã, —Å–∏—Å—Ç–µ–º—ã —É—á—ë—Ç–∞ –∏ –æ–Ω–ª–∞–π–Ω-–∑–∞–∫–∞–∑—ã, –∞ —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤ –æ—Ç–ø—Ä–∞–≤–∏–ª–∏ –≤ –æ—Ç–≥—É–ª. –ö–∞–∫ –ø–∏—à—É—Ç –°–ú–ò, —É –ù–µ–æ—Ñ–∞—Ä–º —Å–∏—Ç—É–∞—Ü–∏—è –ø–æ—Ö—É–∂–µ, —Ö–∞–∫–µ—Ä—ã —É–±–∏–ª–∏ –ò–¢-–∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä—É ¬´–ù–µ–æ—Ñ–∞—Ä–º¬ª. –ß—Ç–æ —ç—Ç–æ –æ–∑–Ω–∞—á–∞–µ—Ç? –°–∫–æ—Ä–µ–µ –≤—Å–µ–≥–æ, —Ç–µ–ø–µ—Ä—å –±—É–¥–µ—Ç –º–µ–Ω—å—à–µ —Ç—É–ø—ã—Ö —Ä–∞—Å—Å—ã–ª–æ–∫ –∏ –Ω–µ —Å–º–æ–∂–µ—Ç–µ –≤ –∏–Ω—Ç–µ—Ä–Ω–µ—Ç–∞—Ö –∫—É–ø–∏—Ç—å –ø—Ä–µ–ø–∞—Ä–∞—Ç. –ö—Ç–æ –±–µ–Ω–µ—Ñ–∏—Ü–∏–∞—Ä –ø—Ä–æ–∏—Å—Ö–æ–¥—è—â–µ–≥–æ? –ï–≤–≥–µ–Ω–∏–π –ù–∏—Ñ–∞–Ω—Ç—å–µ–≤, –∫–æ–Ω–µ—á–Ω–æ –∂–µ, –ø–æ—Ç–æ–º—É —á—Ç–æ –ø—Ä–æ–¥–∞–ª –∏ –°—Ç–æ–ª–∏—á–∫–∏ –∏ –ù–µ–æ—Ñ–∞—Ä–º 1 –∏—é–ª—è 2022 –≥–æ–¥–∞üòÅü§åüèª –∏–∑–±–∞–≤–∏–ª—Å—è –æ—Ç –≥—Ä—è–¥—É—â–µ–≥–æ –≥–æ–ª–æ–≤–Ω—è–∫–∞, –º–æ–ª–æ–¥–µ—Ü! –ß—Ç–æ —è –¥—É–º–∞—é –æ–± —ç—Ç–æ–º? –û–¥–Ω–∞–∂–¥—ã —è –Ω–∞ –¥–∞—á–µ –æ–±—Å—É–∂–¥–∞–ª–∞ —Å –æ–¥–Ω–∏–º –±–∏–∑–Ω–µ—Å–º–µ–Ω–æ–º –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω—É—é –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å. –í–æ—Ç —á—Ç–æ –æ–Ω –æ–± —ç—Ç–æ–º —Å–∫–∞–∑–∞–ª –ë–µ–∑–æ–ø–∞—Å–Ω–∏–∫–∏ (IT-—Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã) ‚Äî —Ö—Ä–µ–Ω—å –ø–æ–ª–Ω–∞—è. –°–∫–æ–ª—å–∫–æ –Ω–∏ –Ω–∞–Ω–∏–º–∞–π ‚Äî –≤—Å—ë —Ä–∞–≤–Ω–æ —Ö–∞–∫–∞—é—Ç. –ß—É—Ç—å —Ä–µ–∂–µ –º–æ–∂–µ—Ç –±—ã—Ç—å. –í—Å—ë —Ä–∞–≤–Ω–æ –≥–æ–≤–æ—Ä—è—Ç ""–ó–∞–ø–ª–∞—Ç–∏"" –∏ —Ç—ã –ø–ª–∞—Ç–∏—à—å, —á—Ç–æ –æ–Ω–∏ –µ—Å—Ç—å, —á—Ç–æ –∏—Ö –Ω–µ—Ç. üî¥–î—É–º–∞—é, —á—Ç–æ –ø—Ä–∞–≤–¥–∞ –≥–¥–µ-—Ç–æ –ø–æ—Å–µ—Ä–µ–¥–∏–Ω–µ, –∞ –ø–æ –æ—Ç–Ω–æ—à–µ–Ω–∏—é –∫ —Å–∏—Ç—É–∞—Ü–∏–∏ –º–æ–≥—É —Å–∫–∞–∑–∞—Ç—å ‚Äî —É—Ä–æ–≤–µ–Ω—å –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ ""–∫–æ–º–∏—Å—Å–∞—Ä –ñ–∏–±–µ—Ä""","{""skip"": true}"
2025-07-29T06:08:33+00:00,@pharm_icon,2317,https://t.me/pharm_icon/2317,"‚ö°Ô∏è–ï–ú–ò–ê–° —Ö–∞–∫–Ω—É–ª–∏ –¢–µ–ø–µ—Ä—å –≤—Å–µ –≤–∞—à–∏ –í–ò–ß, –≥–µ–ø–∞—Ç–∏—Ç—ã, –û–†–í–ò, —Å–Ω–∏–º–∫–∏ –∏ –∑–∞–∫–ª—é—á–µ–Ω–∏—è –∞–Ω–∞–ª–∏–∑–∏—Ä—É—é—Ç –±–µ–ª–æ—Ä—É—Å—Å–∫–∏–µ —Ö–∞–∫–µ—Ä—ã –ö–∏–±–µ—Ä–ø–∞—Ä—Ç–∏–∑–∞–Ω—ã –∏ Silent Crow, –¥–æ—Ä–æ–≥–∏–µ –∂–∏—Ç–µ–ª–∏ –ú–æ—Å–∫–≤—ã –∏ –ú–æ—Å–∫–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏. 17–¢–ë –¥–∞–Ω–Ω—ã—Ö ‚Äî —ç—Ç–æ –¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ –º–Ω–æ–≥–æ. –ú—ã –º–æ–∂–µ–º –ø–æ—Å–æ—á—É–≤—Å—Ç–≤–æ–≤–∞—Ç—å –Ω–µ–π—Ä–æ–Ω–∫–µ –∏ –∞–Ω–∞–ª–∏—Ç–∏–∫–∞–º, –∫–æ—Ç–æ—Ä—ã–µ –±—É–¥—É—Ç –∞–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞—Ç—å —ç—Ç–∏ –∫–æ—Ä—è–≤—ã–µ –¥–æ–∫—É–º–µ–Ω—Ç—ã. –¢–∞–∫–∂–µ –æ–Ω–∏ —É–∑–Ω–∞—é—Ç, —á—Ç–æ –≥–æ—Å–ø–∏—Ç–∞–ª—å–Ω–∞—è –º–µ–¥–∏—Ü–∏–Ω–∞ –ú–æ—Å–∫–≤—ã –Ω–∞ 100% —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–∞, –ø–æ—Ç–æ–º—É —á—Ç–æ –≤—Å–µ –ø–∞—Ü–∏–µ–Ω—Ç—ã –≤—ã–ø–∏—Å—ã–≤–∞—é—Ç—Å—è —Å —É–ª—É—á—à–µ–Ω–∏–µ–º. –í—Å–µ –ø—Ä–æ—Ç–∏–≤–Ω–∏–∫–∏ —Ü–∏—Ñ—Ä–æ–≤–∏–∑–∞—Ü–∏–∏ –≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–∏ —Ç–µ–ø–µ—Ä—å –º–æ–≥—É—Ç —É–≤–µ—Ä–µ–Ω–Ω–æ –¥–æ–±–∞–≤–ª—è—Ç—å –∫ —Ñ—Ä–∞–∑–µ ""–ë–æ–ª—å—à–æ–π –±—Ä–∞—Ç —Å–ª–µ–¥–∏—Ç –∑–∞ —Ç–æ–±–æ–π"" —ç–ø–∏—Ç–µ—Ç ""–î—ã—Ä—è–≤—ã–π"".","{""skip"": true}"
2025-07-29T05:54:46+00:00,@pharm_icon,2316,https://t.me/pharm_icon/2316,"–ü–æ–∫–∞ –≤—Å–µ –æ–±—Å—É–∂–¥–∞—é—Ç —Ö–∞–∫–µ—Ä—Å–∫—É—é –∞—Ç–∞–∫—É –≥—Ä—É–ø–ø–∏—Ä–æ–≤–∫–∏ Silent Crow –Ω–∞ ¬´–ê—ç—Ä–æ—Ñ–ª–æ—Ç¬ª —è –ø—Ä–æ—Å—Ç–æ –Ω–∞–ø–æ–º–Ω—é, —á—Ç–æ —Ç–∞ –∂–µ –∫–æ–º–∞–Ω–¥–∞ –∑–∞—è–≤–∏–ª–∞ –Ω–∞ –ø—Ä–æ—à–ª–æ–π –Ω–µ–¥–µ–ª–µ –æ –≤–∑–ª–æ–º–µ –ï–ú–ò–ê–°. –°—Å—ã–ª–∫—É –Ω–∞ –ø–æ—Å—Ç –≤ –∫–∞–Ω–∞–ª–µ —Ö–∞–∫–µ—Ä–æ–≤ –º–Ω–µ –ø—Ä–∏—Å–ª–∞–ª –∫–æ–ª–ª–µ–≥–∞ –∏–∑ –æ–¥–Ω–æ–π –∫–ª–∏–Ω–∏–∫–∏, –∞ –µ–º—É –≤ —Å–≤–æ—é –æ—á–µ—Ä–µ–¥—å ‚Äì —Å–ª—É–∂–±–∞ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏. –û—Ñ–∏—Ü–∏–∞–ª—å–Ω—ã—Ö –∫–æ–º–º–µ–Ω—Ç–∞—Ä–∏–µ–≤ –∏ –æ–ø—Ä–æ–≤–µ—Ä–∂–µ–Ω–∏–π —ç—Ç–æ–π –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –î–µ–ø–∑–¥—Ä–∞–≤ –ú–æ—Å–∫–≤—ã –ø–æ–∫–∞ –Ω–µ –ø—É–±–ª–∏–∫–æ–≤–∞–ª, –∞ —Ö–æ—Ç–µ–ª–æ—Å—å –±—ã. –í–º–µ—Å—Ç–æ —ç—Ç–æ–≥–æ –Ω–∞–º —Ä–∞—Å—Å–∫–∞–∑—ã–≤–∞—é—Ç –ø—Ä–æ –¥–æ—Å—Ç–∏–∂–µ–Ω–∏—è —Ü–∏—Ñ—Ä–æ–≤–∏–∑–∞—Ü–∏–∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è, –∏ –∂—É—Ä–Ω–∞–ª–∏—Å—Ç—ã —Å –±–ª–æ–≥–µ—Ä–∞–º–∏ –æ–± —ç—Ç–æ–º —Ä–∞–¥–æ—Å—Ç–Ω–æ —Ä–∞–ø–æ—Ä—Ç—É—é—Ç. –í–æ—Ç, —á—Ç–æ –∑–∞—è–≤–ª—è—é—Ç —Ö–∞–∫–µ—Ä—ã: –ï–ú–ò–ê–° ‚Äî –ï–¥–∏–Ω–∞—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω–æ-–∞–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–∞—è —Å–∏—Å—Ç–µ–º–∞. –í —Ä–µ–∑—É–ª—å—Ç–∞—Ç–µ —É—Å–ø–µ—à–Ω–æ–π –æ–ø–µ—Ä–∞—Ü–∏–∏ –Ω–∞–º–∏ –±—ã–ª –ø–æ–ª—É—á–µ–Ω –ø–æ–ª–Ω—ã–π –¥–æ—Å—Ç—É–ø –∫ —Å–µ—Ç–∏ –ú–ò–° –æ–±—Å–ª—É–∂–∏–≤–∞—é—â–µ–π –∂–∏—Ç–µ–ª–µ–π –ú–æ—Å–∫–≤—ã –∏ –ú–æ—Å–∫–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏. –ú—ã –ø–æ–ª—É—á–∏–ª–∏ –∞–¥–º–∏–Ω–∏—Å—Ç—Ä–∞—Ç–∏–≤–Ω—ã–π –∫–æ–Ω—Ç—Ä–æ–ª—å –Ω–∞–¥ –≤—Å–µ–π –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä–æ–π –æ–¥–Ω–æ–≥–æ –∏–∑ —Å–∞–º—ã—Ö –∫—Ä—É–ø–Ω–µ–π—à–∏—Ö ¬´–æ–ø–µ—Ä–∞—Ç–æ—Ä–æ–≤ –ø–µ—Ä—Å–æ–Ω–∞–ª—å–Ω—ã—Ö –¥–∞–Ω–Ω—ã—Ö¬ª, –≤–∫–ª—é—á–∞—è –¥–æ–º–µ–Ω –∫–æ–Ω—Ç—Ä–æ–ª–ª–µ—Ä, –≥–∏–ø–µ—Ä–≤–∏–∑–æ—Ä—ã, –±–∞–∑—ã –¥–∞–Ω–Ω—ã—Ö. –û–±—â–∏–π –æ–±—ä–µ–º –≤—ã–≥—Ä—É–∂–µ–Ω–Ω—ã—Ö –¥–∞–Ω–Ω—ã—Ö —Å–æ—Å—Ç–∞–≤–∏–ª –æ–∫–æ–ª–æ 17–¢–ë. –í —ç—Ç–æ—Ç –º–∞—Å—Å–∏–≤ –≤–æ—à–ª–∏ –ª–∏—á–Ω—ã–µ –¥–∞–Ω–Ω—ã–µ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –≤–∫–ª—é—á–∞—è –§–ò–û, –¥–∞—Ç—ã —Ä–æ–∂–¥–µ–Ω–∏—è, –Ω–æ–º–µ—Ä–∞ –ø–æ–ª–∏—Å–æ–≤, –∞–¥—Ä–µ—Å–∞ –ø—Ä–æ–ø–∏—Å–∫–∏, –∞ —Ç–∞–∫–∂–µ –∫–æ–Ω—Ç–∞–∫—Ç–Ω–∞—è –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è ‚Äî —Ç–µ–ª–µ—Ñ–æ–Ω—ã, –ø–æ—á—Ç—ã –∏ –¥—Ä—É–≥–∞—è –∏–¥–µ–Ω—Ç–∏—Ñ–∏—Ü–∏—Ä—É—é—â–∞—è –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –Ω–∞–º–∏ –ø–æ–ª—É—á–µ–Ω—ã –∞–º–±—É–ª–∞—Ç–æ—Ä–Ω—ã–µ –∫–∞—Ä—Ç—ã, –∏—Å—Ç–æ—Ä–∏—è –æ–±—Ä–∞—â–µ–Ω–∏–π, –¥–∏–∞–≥–Ω–æ–∑—ã, —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –∞–Ω–∞–ª–∏–∑–æ–≤, –Ω–∞–∑–Ω–∞—á–µ–Ω–∏—è, —Å—Ö–µ–º—ã –ª–µ—á–µ–Ω–∏—è –∏ –≤—ã–ø–∏—Å–∫–∏.","{""skip"": true}"
2025-07-25T08:13:58+00:00,@pharm_icon,2315,https://t.me/pharm_icon/2315,"–ù–∞—Å—Ç–æ–ª–∫–∞ –ò–∫–æ–Ω–∞ –§–∞—Ä–º—ã –•–æ—á—É —Å–¥–µ–ª–∞—Ç—å –Ω–∞—Å—Ç–æ–ª–æ—á–∫—É –Ω–∞ 2-4 –∏–≥—Ä–æ–∫–∞, —Å–∏–º—É–ª—è—Ç–æ—Ä –±–æ—Ä—å–±—ã –∑–∞ –≤—Ä–∞—á–∞ –≤ –ø–æ–ª–∏–∫–ª–∏–Ω–∏–∫–∞—Ö. –ß—Ç–æ –¥—É–º–∞–µ—Ç–µ? ‚ù§Ô∏è ‚Äî –¥–∞, –∏–Ω—Ç–µ—Ä–µ—Å–Ω–∞—è –∏–¥–µ—è, –∫—É–ø–ª—é –∑–∞ 5000 —Ä—É–±–ª–µ–π üóø ‚Äî –Ω–µ –Ω–∞–¥–æ","{""skip"": true}"
2025-07-25T07:16:56+00:00,@pharm_icon,2314,https://t.me/pharm_icon/2314,"–ù–∞ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã—Ö –∫–æ–ª–µ—Å–∞—Ö: –ø–µ—Ä–µ–¥–≤–∏–∂–Ω—ã–µ –∞–ø—Ç–µ–∫–∏ –±—É–¥—É—Ç –±—Ä–µ–º–µ–Ω–µ–º –±–∏–∑–Ω–µ—Å–∞ –ó–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –æ –ø–µ—Ä–µ–¥–≤–∏–∂–Ω—ã—Ö –∞–ø—Ç–µ–∫–∞—Ö –¥–ª—è –ø–æ–≤—ã—à–µ–Ω–∏—è –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç–∏ –º–µ–¥–ø–æ–º–æ—â–∏ —Ä–∞—Å—Å–º–æ—Ç—Ä—è—Ç –≤ –ì–æ—Å–¥—É–º–µ –æ—Å–µ–Ω—å—é. –ö–ª—é—á–µ–≤—ã–µ –º–æ–º–µ–Ω—Ç—ã: 1) –î–ª—è –ø–æ–≤—ã—à–µ–Ω–∏—è –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç–∏ —É–∂–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–º–æ—â–∏ –±—É–¥—É—Ç —Å–æ–∑–¥–∞–Ω—ã –ø–µ—Ä–µ–¥–≤–∏–∂–Ω—ã–µ –∞–ø—Ç–µ—á–Ω—ã–µ –ø—É–Ω–∫—Ç—ã –Ω–∞ –∫–æ–ª–µ—Å–∞—Ö. –ü—Ä–µ–¥–Ω–∞–∑–Ω–∞—á–µ–Ω—ã –æ–Ω–∏ –¥–ª—è –Ω–µ–±–æ–ª—å—à–∏—Ö –∏–ª–∏ —É–¥–∞–ª–µ–Ω–Ω—ã—Ö –Ω–∞—Å–µ–ª—ë–Ω–Ω—ã—Ö –ø—É–Ω–∫—Ç–æ–≤ –±–µ–∑ –¥–æ—Å—Ç—É–ø–∞ –∫ –∞–ø—Ç–µ–∫–∞–º –∏–ª–∏ –§–ê–ü —Å –ø—Ä–∞–≤–æ–º —Ç–æ—Ä–≥–æ–≤–ª–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏. –•–æ—Ä–æ—à–µ–µ —Ä–µ—à–µ–Ω–∏–µ –¥–ª—è –∫—Ä—É–ø–Ω—ã—Ö —Ä–µ–≥–∏–æ–Ω–æ–≤ —Å –º–∞–ª—ã–º –Ω–∞—Å–µ–ª–µ–Ω–∏–µ–º. –†–∞–Ω–Ω–µ–µ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–∑–æ—Ä –ø—Ä–æ–≤–µ–ª —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç, —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –Ω–∞—Å–µ–ª–µ–Ω–∏–µ –æ—Ü–µ–Ω–∏–ª –ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω–æ. 2) –ß–∞—Å—Ç—å –∞–ø—Ç–µ–∫ –≥–æ—Ç–æ–≤—ã –≤–∑—è—Ç—å –Ω–∞ —Å–µ–±—è –±—Ä–µ–º—è —Ä–∞—Å—Ö–æ–¥–æ–≤, —Ö–æ—Ç—å –∏ –≥–æ–≤–æ—Ä—è—Ç –æ–± —É–±—ã—Ç—á–Ω–æ—Å—Ç–∏ –ø–æ–¥–æ–±–Ω—ã—Ö –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–π. –í–∏–¥–∏–º–æ, –∞–ø—Ç–µ—á–Ω—ã–º —Å–µ—Ç—è–º –ª—é–±–µ–∑–Ω–æ –æ–±—ä—è—Å–Ω–∏–ª–∏ –æ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ –Ω–µ—Å—Ç–∏ –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—É—é —Å–æ—Ü–∏–∞–ª—å–Ω—É—é –Ω–∞–≥—Ä—É–∑–∫—É. 3) –†–∞—Å—Ö–æ–¥—ã –ª—è–≥—É—Ç –Ω–∞ –±—é–¥–∂–µ—Ç—ã —Ä–µ–≥–∏–æ–Ω–æ–≤ –∏ –∞–ø—Ç–µ—á–Ω—ã—Ö —Å–µ—Ç–µ–π. –í–∏–¥–∏–º–æ, —Ñ–µ–¥–µ—Ä–∞–ª—ã —á—É—é—Ç –∑–∞–ø–∞—Ö –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω—ã—Ö –ø—Ä–æ–±–ª–µ–º –∫–æ–Ω—Ç—Ä–æ–ª—è —Ä–∞—Å—Ö–æ–¥–æ–≤ –∏ –∏—Å–ø–æ–ª–Ω–µ–Ω–∏—è. –ù–∞ –°—Ç–∞—Ä–æ–≤–æ–π—Ç–∞ –Ω–∞—Å–º–æ—Ç—Ä–µ–ª–∏—Å—å, –Ω–æ–∂–∫–∞ –¥—Ä–æ–∂–∏—Ç. –ö–æ—à–º–∞—Ä—ã —É—á–∞—Å—Ç–Ω–∏–∫–∞ –±–∏–∑–Ω–µ—Å-–∑–∞–≤—Ç—Ä–∞–∫–∞ –°–ë–ï–†–∞ —Å–±—ã–≤–∞—é—Ç—Å—è. 4) –ò–∑ –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª—å–Ω—ã—Ö –ø—Ä–æ–±–ª–µ–º ‚Äî –∏—Ç–æ–≥–æ–≤—ã–µ —Ä–∞—Å—Ö–æ–¥—ã, –ø—Ä–æ–±–ª–µ–º–∞ –∫–æ–Ω—Ç—Ä–æ–ª—è –∫–∞—á–µ—Å—Ç–≤–∞ —Ö—Ä–∞–Ω–µ–Ω–∏—è –∏ –æ—Ç–ø—É—Å–∫–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤, –∑–∞–∫—Ä—ã—Ç–∏–µ –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç–µ–π –Ω–∞—Å–µ–ª–µ–Ω–∏—è –≤ –ø–æ–ª–Ω–æ–º –æ–±—ä—ë–º–µ, –≤–∫–ª—é—á–∞—è –Ω–∞—Ä–∫–æ—Ç–∏—á–µ—Å–∫–∏–µ –∏ –ø—Å–∏—Ö–æ—Ç—Ä–æ–ø–Ω—ã–µ –≤–µ—â–µ—Å—Ç–≤–∞ –∏ —Å–ø–µ—Ü–∏—Ñ–∏—á–µ—Å–∫–∏–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ —Ç–æ–≤–∞—Ä—ã. –í —Ü–µ–ª–æ–º –ø—Ä–∏—è—Ç–Ω–æ –≤–∏–¥–µ—Ç—å —Ä–∞–∑–≤–∏—Ç–∏–µ –∞–ø—Ç–µ–∫ –≤ —Ç–∞–∫–æ–º —Ñ–æ—Ä–º–∞—Ç–µ, –Ω–æ –±—É–¥–µ—Ç –ª–∏ —ç—Ç–æ –∏–º–µ—Ç—å —Ä–µ–∞–ª—å–Ω—ã–π —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–∏–π —Å–º—ã—Å–ª –ø—Ä–∏ –ø–æ—è–≤–ª–µ–Ω–∏–∏ –¥–æ—Å—Ç–∞–≤–∫–∏ —Ä–µ—Ü–µ–ø—Ç—É—Ä–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ - –±–æ–ª—å—à–æ–π –≤–æ–ø—Ä–æ—Å. –ê –µ—â—ë –æ–±–ª—å—à–æ–π –≤–æ–ø—Ä–æ—Å ‚Äî –∫—É–¥–∞ –∏—Ö –±—É–¥—É—Ç –¥–æ—Å—Ç–∞–≤–ª—è—Ç—å. –ú–æ–∂–µ—Ç –Ω–µ —Å—Ç–æ–∏—Ç –¥—É–º–∞—Ç—å –æ –¥–µ—Ä–µ–≤–Ω–µ –≤ —Ä–∞—Å—Å—É–∂–¥–µ–Ω–∏—è—Ö –æ–± –∞–ø–µ—Ç–µ–∫–µ –Ω–∞ –∫–æ–ª–µ—Å–∞—Ö? –ù–∞–≤–∏–≥–∞—Ç–æ—Ä —É–∫–∞–∑—ã–≤–∞–µ—Ç –Ω–∞ –∑–∞–ø–∞–¥... –≠–Ω—Ç—É–∑–∏–∞–∑–º–∞ —É –∞–ø—Ç–µ—á–Ω—ã—Ö —Å–µ—Ç–µ–π —è –Ω–µ –≤–∏–∂—É, –ø–æ—Å–º–æ—Ç—Ä–∏–º, —á–µ–º —ç—Ç–æ –∑–∞–∫–æ–Ω—á–∏—Ç—Å—è, –∞ —Ç–æ—á–Ω–µ–µ ‚Äî –Ω–∞—á–Ω—ë—Ç—Å—è.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""A project to create mobile pharmacies for better accessibility of medicines is being considered by the State Duma. The proposals include creating mobile pharmacy units on wheels for remote areas without access to pharmacies or FAPs. The project aims to reduce costs for regional budgets and pharmacy networks, but there are concerns about the financial burden on these entities. Potential issues include cost overruns, quality control of stored medicines, and full coverage of patient needs, including narcotics and specific medical products. The enthusiasm among pharmacy networks is unclear, and the future of this project remains to be seen.""
}"
2025-07-23T15:48:38+00:00,@pharm_icon,2313,https://t.me/pharm_icon/2313,"–ì–ª–∞–≤–Ω—ã–µ –≤—Ä–∞—á–∏ —Ç–µ–ª–µ–≥—Ä–∞–º–∞ (–∏ –Ω–µ —Ç–æ–ª—å–∫–æ). –° —É–≤–∞–∂–µ–Ω–∏–µ–º. –°–µ–≥–æ–¥–Ω—è ‚Äî –ø–æ–¥–±–æ—Ä–∫–∞ –≥–ª–∞–≤–Ω—ã—Ö –≤–Ω–µ—à—Ç–∞—Ç–Ω—ã—Ö –≤—Ä–∞—á–µ–π —Ç–µ–ª–µ–≥—Ä–∞–º–∞ –æ—Ç –ò–∫–æ–Ω—ã –§–∞—Ä–º—ã. –î–∞–≤–∞–π—Ç–µ –ø–æ–∑–Ω–∞–∫–æ–º–∏–º—Å—è —Å–æ –≤—Å–µ–º–∏. –° —É–≤–∞–∂–µ–Ω–∏–µ–º. –ü–æ—è—Å–Ω–∏ –∑–∞ –º–µ–¥ ‚Äî –≤—Ä–∞—á, –≥–ª–∞–≤–Ω—ã–π –≤—Ä–∞—á –¥–ª—è –≤—Ä–∞—á–µ–π —Ç–µ–ª–µ–≥—Ä–∞–º–∞, –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å –≥–ª–∞–≤–Ω–æ–≥–æ –≤—Ä–∞—á–∞ –ø–æ —Å–æ—Ü–∏–∞–ª—å–Ω–æ–π —Å–ø—Ä–∞–≤–µ–¥–ª–∏–≤–æ—Å—Ç–∏ –≤ —Å–≤–æ–µ–π –ø–æ–ª–∏–∫–ª–∏–Ω–∏–∫–µ. –° —É–≤–∞–∂–µ–Ω–∏–µ–º. –î–µ—Ä–º–∞—Ç–æ–æ–Ω–∫–æ–ª–æ–≥ –ë–µ–π–Ω—É—Å–æ–≤ ‚Äî –≥–ª–∞–≤–Ω—ã–π –¥–µ—Ä–º–∞–∫—Ç–æ–æ–Ω–∫–æ–ª–æ–≥ —Ç–µ–ª–µ–≥—Ä–∞–º–∞, –∫.–º.–Ω., —Ä–∞–∑–≤–µ–Ω—á–∏–≤–∞–µ—Ç –º–∏—Ñ—ã, –ª–µ—á–∏—Ç –∏ –ø—Ä–æ—Å–≤–µ—â–∞–µ—Ç –ª—é–¥–µ–π. –° —É–≤–∞–∂–µ–Ω–∏–µ–º. –ù–æ—á–Ω–∞—è –æ—Ö–æ—Ç–∞ ‚Äî –≥–ª–∞–≤–Ω—ã–π –∞–Ω–µ—Å—Ç–µ–∑–∏–æ–ª–æ–≥-—Ä–µ–∞–Ω–∏–º–∞—Ç–æ–ª–æ–≥ —Ç–µ–ª–µ–≥—Ä–∞–º–∞, –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å –≥–ª–∞–≤–Ω–æ–≥–æ –≤—Ä–∞—á–∞ –ø–æ —Å—Ç–æ—Ä–∏—Ç–µ–ª–ª–∏–Ω–≥—É. –° —É–≤–∞–∂–µ–Ω–∏–µ–º. –Æ–†–ò–°–¢–´ –ó–ê –í–†–ê–ß–ï–ô ‚Äî –≥–ª–∞–≤–Ω—ã–µ —é—Ä–∏—Å—Ç—ã, –¥–∞—é—Ç —Ä–µ–∞–ª—å–Ω—É—é –ø–æ–¥–¥–µ—Ä–∂–∫—É –∏ —é—Ä–∏–¥–∏—á–µ—Å–∫—É—é –∑–∞—â–∏—Ç—É –≤—Ä–∞—á–∞–º. –≤ –ø–æ–≤—Å–µ–¥–Ω–µ–≤–Ω–æ–π –ø—Ä–∞–∫—Ç–∏–∫–µ. –û–±–ª–∞–¥–∞—é—Ç –æ—Ç–∫—Ä—ã—Ç–æ–π –∏ –±–µ—Å–ø–ª–∞—Ç–Ω–æ–π –±–∞–∑–æ–π –∑–Ω–∞–Ω–∏–π. –° —É–≤–∞–∂–µ–Ω–∏–µ–º. –§–ª–µ–±–æ–ª–æ–≥ –ê—Å—Ç–∞—Ñ—å–µ–≤–∞ ‚Äî –≥–ª–∞–≤–Ω—ã–π —Ñ–ª–µ–±–æ–ª–æ–≥, –∫–æ—Ç–æ—Ä—ã–π –¥–µ–ª–∞–µ—Ç –≤–µ–Ω—ã —Å–Ω–æ–≤–∞ –Ω–µ–≤–µ–ª–∏–∫–∏–º–∏, –∞ –Ω–∏–∂–Ω–∏–µ –∫–æ–Ω–µ—á–Ω–æ—Å—Ç–∏ ‚Äî –∫—Ä–∞—Å–∏–≤—ã–º–∏. –° —É–≤–∞–∂–µ–Ω–∏–µ–º. Pediatric surgeon ‚Äî –≥–ª–∞–≤–Ω—ã–π –¥–µ—Ç—Å–∫–∏–π —Ö–∏—Ä—É—Ä–≥, –∫–æ—Ç–æ—Ä—ã–π –Ω–µ –±–æ–∏—Ç—Å—è —Å–ø–∞—Å—Ç–∏ –∂–∏–∑–Ω—å —Å–∞–º–æ–º—É –º–∞–ª–µ–Ω—å–∫–æ–º—É –ø–∞—Ü–∏–µ–Ω—Ç—É. –° —É–≤–∞–∂–µ–Ω–∏–µ–º. –¢–≤–æ–π –Ω—É—Ç—Ä–∏—Ü–∏–æ–ª–æ–≥ ‚Äî –≥–ª–∞–≤–Ω—ã–π –Ω—É—Ç—Ä–∏—Ü–∏–æ–ª–æ–≥, –∞ –ø–æ—á–µ–º—É? –ü–æ—Ç–æ–º—É —á—Ç–æ –ø—Ä–∞–∫—Ç–∏–∫—É—é—â–∏–π –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–π —Ñ–∞—Ä–º–∞–∫–æ–ª–æ–≥. –° —É–≤–∞–∂–µ–Ω–∏–µ–º. –ù–¢–ò HealthNet ‚Äî –∏–Ω—Ñ—Ä–∞—Å—Ç—Ä—É–∫—Ç—É—Ä–Ω–∞—è –≥—Ä—É–ø–ø–∞, –æ—Ç–≤–µ—á–∞–µ—Ç –∑–∞ –∏–Ω–Ω–æ–≤–∞—Ü–∏–∏ –∏ —É–ª—É—á—à–µ–Ω–∏–µ –≤—Ä–∞—á–µ–±–Ω–æ–π –ø—Ä–∞–∫—Ç–∏–∫–∏. –° —É–≤–∞–∂–µ–Ω–∏–µ–º. –ù–µ–±–æ–ª—å—à–∏–µ –∫–∞–Ω–∞–ª—ã —Å –±–æ–ª—å—à–∏–º –ø–æ—Ç–µ–Ω—Ü–∏–∞–ª–æ–º: –ú–∞—Ä–∫–µ—Ç–∏–Ω–≥ –±–µ–∑ –ø–æ–±–æ—á–µ–∫, –•–∏—Ä—É—Ä–≥–∏—è –±–µ–∑ –≥–∞–ª—Å—Ç—É–∫–∞, –°–ª–∞–≤–∞ –ù–ü–í–°, PharmaDataLab, –õ–æ—Ä –∑–¥–æ—Ä–æ–≤–æ–≥–æ —á–µ–ª–æ–≤–µ–∫–∞, –ê–ª–ª–µ—Ä–≥–æ–ª–æ–≥ –®–∞—Ä–æ–≤–∞ –° —É–≤–∞–∂–µ–Ω–∏–µ–º –°–ú–ò –∏ —Å–º–µ–∂–Ω—ã–µ –±–ª–æ–≥–∏ –ú–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è –†–æ—Å—Å–∏—è ‚Äî –Ω–æ–≤–æ—Å—Ç–Ω–æ–π –º–µ–¥—Å–æ—Ü—Ä–µ–∞–ª–∏–∑–º –ú—É—Ä–∞—à–∫–æ –ø–æ –∫–æ–∂–µ ‚Äî –Ω–æ–≤–æ—Å—Ç–∏ –ú–µ–¥–∏–∫–∞–ª –ö—Å—é ‚Äî –Ω–æ–≤–æ—Å—Ç–∏ –º–µ–¥—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –§–∞—Ä–º–ú–∏–∫—Ä–æ–±–∏–æ–ª–æ–≥–∏ ‚Äî –¥—Ä—É–∂–µ—Å—Ç–≤–µ–Ω–Ω—ã–π —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–π —á–∞—Ç-–∫–∞–Ω–∞–ª –° —É–≤–∞–∂–µ–Ω–∏–µ–º","{""skip"": true}"
2025-07-23T15:15:38+00:00,@pharm_icon,2312,https://t.me/pharm_icon/2312,"–Ø –ø–æ–º–Ω—é, –±—ã–ª —Ç–∞–∫–æ–π –º–æ–Ω–æ–ª–æ–≥ –≤ —Ñ–∏–ª—å–º–µ –ê–¥–≤–æ–∫–∞—Ç –î—å—è–≤–æ–ª–∞ –≠—Ç–æ —Å–∞–º—ã–π –∂–µ—Å—Ç–æ–∫–∏–π —Ä–æ–∑—ã–≥—Ä—ã—à –∑–∞ –≤—Å–µ –º–∏–Ω—É–≤—à–∏–µ –≤–µ–∫–∞: —Å–º–æ—Ç—Ä–∏ ‚Äî –Ω–æ –Ω–µ —Å–º–µ–π —Ç—Ä–æ–≥–∞—Ç—å, —Ç—Ä–æ–≥–∞–π ‚Äî –Ω–æ –Ω–µ –ø—Ä–æ–±—É–π –Ω–∞ –≤–∫—É—Å, –ø—Ä–æ–±—É–π ‚Äî –Ω–æ –Ω–µ —Å–º–µ–π –≥–ª–æ—Ç–∞—Ç—å –ê —á—Ç–æ –ø–æ–ª—É—á–∞–µ—Ç—Å—è —Ç—É—Ç? –ó–∞–∫—É–ø–∞–π, –Ω–æ —Ç–∞–∫, —á—Ç–æ–±—ã –Ω–µ –æ—Å—Ç–∞–ª–æ—Å—å –¥–µ–Ω–µ–≥. –¢—Ä–∞—Ç—å –∑–∞–∫—É–ø–ª–µ–Ω–Ω–æ–µ, –Ω–æ —á—Ç–æ–±—ã –±—ã–ª–æ –≤–ø—Ä–æ–∫. –ö–æ–≥–¥–∞ –±—É–¥–µ—Ç –≤–ø—Ä–æ–∫ ‚Äî –∑–∞—Å—Ç–∞–≤—å –≤—Ä–∞—á–µ–π –≤—ã–ø–∏—Å–∞—Ç—å. –í—Ä–∞—á –Ω–µ –≤—ã–ø–∏—Å–∞–ª? –í—Å—Ç–∞—Ç—å, —Å—É–¥ –∏–¥—ë—Ç.","{""skip"": true}"
2025-07-23T15:11:42+00:00,@pharm_icon,2311,https://t.me/pharm_icon/2311,"–ë—ã–≤—à–µ–≥–æ –∑–∞–º–º–∏–Ω–∏—Å—Ç—Ä–∞ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ –º–∏–Ω–∑–¥—Ä–∞–≤–∞ –±—É–¥—É—Ç —Å—É–¥–∏—Ç—å –∑–∞ –∑–∞–∫—É–ø–∫—É –Ω–µ–Ω—É–∂–Ω–æ–≥–æ —Ç—Ä–∞–º–∞–¥–æ–ª–∞ –ü—Ä–æ–∫—É—Ä–∞—Ç—É—Ä–∞ –ò—Ä–∫—É—Ç—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ —É—Ç–≤–µ—Ä–¥–∏–ª–∞ –æ–±–≤–∏–Ω–∏—Ç–µ–ª—å–Ω–æ–µ –∑–∞–∫–ª—é—á–µ–Ω–∏–µ –ø–æ —É–≥–æ–ª–æ–≤–Ω–æ–º—É –¥–µ–ª—É –ø—Ä–æ—Ç–∏–≤ –±—ã–≤—à–µ–≥–æ –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—è –º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è —Ä–µ–≥–∏–æ–Ω–∞ –ï–ª–µ–Ω—ã –ì–æ–ª–µ–Ω–µ—Ü–∫–æ–π. –û–Ω–∞ –æ–±–≤–∏–Ω—è–µ—Ç—Å—è –≤ –ø—Ä–µ–≤—ã—à–µ–Ω–∏–∏ –¥–æ–ª–∂–Ω–æ—Å—Ç–Ω—ã—Ö –ø–æ–ª–Ω–æ–º–æ—á–∏–π. –ü–æ –≤–µ—Ä—Å–∏–∏ —Å–ª–µ–¥—Å—Ç–≤–∏—è, –ì–æ–ª–µ–Ω–µ—Ü–∫–∞—è –¥–ª—è —Å–æ–∑–¥–∞–Ω–∏—è –≤–∏–¥–∏–º–æ—Å—Ç–∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ–≥–æ —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–∞ –∏ –ø–æ–ª–Ω–æ–≥–æ —Ä–∞—Å—Ö–æ–¥–æ–≤–∞–Ω–∏—è —Å—É–±—Å–∏–¥–∏–π, –≤—ã–¥–µ–ª–µ–Ω–Ω—ã—Ö –≤ 2019 –≥–æ–¥—É, —É—Ç–≤–µ—Ä–¥–∏–ª–∞ –∑–∞—è–≤–∫–∏ –Ω–∞ –∑–∞–∫—É–ø–∫—É –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ¬´–¢—Ä–∞–º–∞–¥–æ–ª¬ª. –ü—Ä–∏ —ç—Ç–æ–º –µ–≥–æ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ –ø—Ä–µ–≤—ã—à–∞–ª–æ –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç—å –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –æ–Ω–∫–æ–ª–æ–≥–∏–µ–π. –ò–∑-–∑–∞ –∏—Å—Ç–µ—á–µ–Ω–∏—è —Å—Ä–æ–∫–æ–≤ –≥–æ–¥–Ω–æ—Å—Ç–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–æ –±—ã–ª–æ —É–Ω–∏—á—Ç–æ–∂–µ–Ω–æ. –ë—é–¥–∂–µ—Ç—É –ø—Ä–∏—á–∏–Ω–µ–Ω —É—â–µ—Ä–± —Å–≤—ã—à–µ 25 –º–ª–Ω —Ä—É–±–ª–µ–π.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""shortage, regulation, import_export"",
  ""impact"": ""high"",
  ""english"": ""The procuratorate of Irkutsk region has approved an indictment against Elena Goleneckaya, a former deputy minister of regional health. She is accused of exceeding her official duties for creating the appearance of effective leadership and full utilization of subsidies allocated in 2019. She approved requests for purchasing tramadol, which exceeded the patients' need with oncology. Due to expiration of the drug's shelf life, it was destroyed. The budget has been damaged by over 25 million rubles.""
}"
2025-07-23T12:04:11+00:00,@pharm_icon,2310,https://t.me/pharm_icon/2310,"–ù–∞–∫–æ–Ω–µ—Ü –¥–æ–∂–¥–∞–ª–∏—Å—å –æ—Ç –∞–≤—Ç–æ—Ä–æ–≤ –î–æ–∑–∞—Ç–æ—Ä–∞ —Ä–∞–∑–¥–µ–ª–∞ –ø–æ –ø–æ–±–æ—á–Ω—ã–º —ç—Ñ—Ñ–µ–∫—Ç–∞–º –∫—Ä—É–ø–Ω–æ–π –≥—Ä—É–ø–ø—ã –ª–µ–∫–∞—Ä—Å—Ç–≤. –ù–∞–¥–µ—é—Å—å, –Ω–∞ —ç—Ç–æ–º –Ω–µ –æ—Å—Ç–∞–Ω–æ–≤—è—Ç—Å—è –∏ –º—ã –ø–æ–∏–≥—Ä–∞–µ–º—Å—è —Å –¥–∞–Ω–Ω—ã–º–∏, –µ—Å–ª–∏ –æ–Ω–∏ —Ç–∞–∫–æ–≤—ã–µ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤—è—Çüòâ –ò –µ—Å–ª–∏ –Ω–∞—á–Ω—É—Ç —Å–æ–±–∏—Ä–∞—Ç—å –Ω–∞–∑–≤–∞–Ω–∏—è –õ–°, –≤–æ—Ç —ç—Ç–æ –±—ã–ª–æ –±—ã —É–∂–µ —Å–æ–≤—Å–µ–º –∑–¥–æ—Ä–æ–≤–æ.","{""skip"": true}"
2025-07-23T12:03:53+00:00,@pharm_icon,2309,https://t.me/pharm_icon/2309,"Dozator.io: –≥–µ–ø–∞—Ç–æ—Ç–æ–∫—Å–∏—á–Ω–æ—Å—Ç—å –ú—ã –Ω–∞—á–∞–ª–∏ —Ä–∞–∑—Ä–∞–±–∞—Ç—ã–≤–∞—Ç—å —Å–ø–µ—Ü–∏–∞–ª—å–Ω—ã–µ —Ä–∞–∑–¥–µ–ª—ã, —Å–≤—è–∑–∞–Ω–Ω—ã–µ —Å –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ-–∏–Ω–¥—É—Ü–∏—Ä–æ–≤–∞–Ω–Ω—ã–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏. –ü–µ—Ä–≤—ã–º–∏ ""–ø–æ—à–ª–∏"" –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ-–∏–Ω–¥—É—Ü–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è –ø–µ—á–µ–Ω–∏. –ù–∞–∑–≤–∞–ª–∏ —Ä–∞–∑–¥–µ–ª –≥–µ–ø–∞—Ç–æ—Ç–æ–∫—Å–∏—á–Ω–æ—Å—Ç—å –¥–ª—è —É–¥–æ–±—Å—Ç–≤–∞ –ø–æ–∏—Å–∫–∞ –ü–æ–∫–∞ —Ä–∞–∑–¥–µ–ª –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç 3 —à–∫–∞–ª—ã –¥–ª—è –æ—Ü–µ–Ω–∫–∏ –ø—Ä–∏—á–∏–Ω–Ω–æ-—Å–ª–µ–¥—Å—Ç–≤–µ–Ω–Ω–æ–π —Å–≤—è–∑–∏ 1. RUCAM 2. Maria&Victorino 3. –®–∫–∞–ª–∞ –ù–∞—Ä–∞–Ω–∂–æ –≠—Ç–∏ —à–∫–∞–ª—ã –ø–æ–º–æ–≥—É—Ç –∑–∞–ø–æ–¥–æ–∑—Ä–∏—Ç—å –≥–µ–ø–∞—Ç–æ—Ç–æ–∫—Å–∏—á–Ω–æ—Å—Ç—å –∏ –æ–ø–µ—Ä–∞—Ç–∏–≤–Ω–æ –æ—Ç—Ä–µ–∞–≥–∏—Ä–æ–≤–∞—Ç—å. –î–ª—è —ç—Ç–∏—Ö —à–∫–∞–ª –º—ã —Å–¥–µ–ª–∞–ª–∏ –ø–∞—Ä—É –∞–ø–≥—Ä–µ–π–¥–æ–≤: - —É—Ç–æ—á–Ω—è—é—â–∏–π –∑–∞–ø—Ä–æ—Å –æ —Ä–µ–∞–ª—å–Ω–æ—Å—Ç–∏ –æ—Ü–µ–Ω–∫–∏ (—Ä–µ–∞–ª—å–Ω–∞—è –∏–ª–∏ —Ç–µ—Å—Ç–æ–≤—ã–π —Å–ª—É—á–∞–π) - –î–ª—è —Å–ø–µ—Ü–∏—Ñ–∏—á–µ—Å–∫–∏—Ö —à–∫–∞–ª –ø—Ä–æ—Ä–∞–±–æ—Ç–∞–ª–∏ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø–æ –¥–µ–π—Å—Ç–≤–∏—è–º –û–±—Ä–∞—â–∞–µ–º –≤–Ω–∏–º–∞–Ω–∏–µ, —á—Ç–æ –∫–∞–∂–¥—ã–π —Ç–∞–∫–æ–π —Å–ª—É—á–∞–π —Ç—Ä–µ–±—É–µ—Ç –∫–æ–º–∞–Ω–¥–Ω–æ–≥–æ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏—è. –¢–∞–∫–∂–µ –≤ –ö–∞—Ä—Ç–æ—á–∫–µ –ì–µ–ø–∞—Ç–æ—Ç–æ–∫—Å–∏—á–Ω–æ—Å—Ç—å –¥–æ—Å—Ç—É–ø—ã: 1. –¢–æ–ø –ª–µ–∫–∞—Ä—Å—Ç–≤-–ø—Ä–∏—á–∏–Ω –≥–µ–ø–∞—Ç–æ—Ç–æ–∫—Å–∏—á–Ω–æ—Å—Ç–∏ 2. –û–ø–∏—Å–∞–Ω–∏–µ –ø–æ–ª–Ω–æ–π –¥–∏—Ñ—Ñ–µ—Ä–µ–Ω—Ü–∏–∞–ª—å–Ω–æ–π –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∏ —Å–æ–≥–ª–∞—Å–Ω–æ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–º —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏—è–º 3. –î–≤–µ –∫–ª–∞—Å—Å–∏—Ñ–∏–∫–∞—Ü–∏–∏ –ü–æ–¥–¥–µ—Ä–∂–∏—Ç–µ –Ω–∞—à–∏—Ö —Ä–µ–¥–∞–∫—Ç–æ—Ä–æ–≤ —Ä–µ–ø–æ—Å—Ç–æ–º –∏ –ø–æ–¥–ø–∏—à–∏—Ç–µ—Å—å –Ω–∞ —á–∞—Ç-–±–æ—Ç! –ö—Å—Ç–∞—Ç–∏, –Ω–µ–¥–∞–≤–Ω–æ –º—ã –≤—ã–ø–ª–∞—Ç–∏–ª–∏ –ø–µ—Ä–≤—ã–µ —Ä–æ—è–ª—Ç–∏ –Ω–∞—à–∏–º —Ä–µ–¥–∞–∫—Ç–æ—Ä–∞–º, —Å–∫–æ—Ä–æ –æ–ø—É–±–ª–∏–∫—É–µ–º –ø–æ—Å—Ç –ø–æ —Ä–µ–¥–∞–∫—Ü–∏–æ–Ω–Ω–æ–π –ø–æ–ª–∏—Ç–∏–∫–µ.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial,hospital_policy,pharmacovigilance"",
  ""impact"": ""high"",
  ""english"": ""Dozator.io is developing specialized sections related to drug-induced diseases. Initially, liver-related drug-induced diseases were affected. They have created a section called hepatotoxicity for easy search. The sections include RUCAM, Maria&Victorino, and Narangeo scales for hepatotoxicity assessment. They have also developed a few upgrades: - A more specific query about the reality of the evaluation (real or test case) - Recommendations for actions based on specific scales. Each case requires a team review. The Hepatotoxicity section also includes: 1. Top drugs causing hepatotoxicity 2. A full differential diagnosis description according to clinical guidelines 3. Two classifications. Support our editors by reposting and subscribing to the chat-bot! By the way, recently we have paid royalties to our editors. We will publish a post on editorial policy soon.""
}"
2025-07-23T10:36:51+00:00,@pharm_icon,2308,https://t.me/pharm_icon/2308,"–î–æ–∫–∞–∑–∞—Ç–µ–ª—å–Ω—ã–π –¥–æ–∫—Ç–æ—Ä –≤ FDA: –∫ —á–µ–º—É —ç—Ç–æ –ø—Ä–∏–≤–µ–ª–æ? –ö–æ–º–ø–∞–Ω–∏—è Replimmune —Å—Ç–æ–ª–∫–Ω—É–ª–∞—Å—å —Å —Å–µ—Ä—å—ë–∑–Ω—ã–º —É–¥–∞—Ä–æ–º: FDA –æ—Ç–∫–∞–∑–∞–ª–æ –≤ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –∏—Ö –≤–∏—Ä—É—Å–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ RP1 –¥–ª—è –ª–µ—á–µ–Ω–∏—è –º–µ—Ç–∞—Å—Ç–∞—Ç–∏—á–µ—Å–∫–æ–π –º–µ–ª–∞–Ω–æ–º—ã. –ê–∫—Ü–∏–∏ –∫–æ–º–ø–∞–Ω–∏–∏ —Ä—É—Ö–Ω—É–ª–∏ –Ω–∞ 75% –ø–æ—Å–ª–µ –ø—É–±–ª–∏–∫–∞—Ü–∏–∏ –Ω–æ–≤–æ—Å—Ç–∏. –û—Ç–∫–∞–∑, –∫–∞–∫ —Å—á–∏—Ç–∞—é—Ç –≤ BMO Capital Markets, –º–æ–≥ –±—ã—Ç—å –≤—ã–∑–≤–∞–Ω —Å–º–µ–Ω–æ–π —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–∞ –≤ —Ä–µ–≥—É–ª—è—Ç–æ—Ä–Ω–æ–º –æ—Ä–≥–∞–Ω–µ ‚Äî –≤ —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, –Ω–æ–≤—ã–º –¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–º –¶–µ–Ω—Ç—Ä–∞ –ø–æ –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞–º (CBER) —Å—Ç–∞–ª –í–∏–Ω–∞–π –ü—Ä–∞—Å–∞–¥. –û–Ω –∏–∑–≤–µ—Å—Ç–µ–Ω –∫—Ä–∏—Ç–∏—á–µ—Å–∫–∏–º –æ—Ç–Ω–æ—à–µ–Ω–∏–µ–º –∫ –æ–¥–æ–±—Ä–µ–Ω–∏—é –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, –æ—Å–Ω–æ–≤–∞–Ω–Ω–æ–º—É –Ω–∞ –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ —Å—Ç—Ä–æ–≥–∏—Ö –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –¥–∞–Ω–Ω—ã—Ö. –ù–∞—à —Å–ª–æ–Ω? RP1, –æ—Å–Ω–æ–≤–∞–Ω–Ω—ã–π –Ω–∞ –º–æ–¥–∏—Ñ–∏—Ü–∏—Ä–æ–≤–∞–Ω–Ω–æ–º –≤–∏—Ä—É—Å–µ –≥–µ—Ä–ø–µ—Å–∞, —Ä–∞–Ω–µ–µ –ø–æ–ª—É—á–∏–ª –ø—Ä–∏–æ—Ä–∏—Ç–µ—Ç–Ω–æ–µ —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏–µ –Ω–∞ –æ—Å–Ω–æ–≤–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–æ–≤ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è IGNYTE. –û–¥–Ω–∞–∫–æ FDA —Ä–µ—à–∏–ª–æ, —á—Ç–æ —ç—Ç–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –Ω–µ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É–µ—Ç –∫—Ä–∏—Ç–µ—Ä–∏—è–º ¬´–∞–¥–µ–∫–≤–∞—Ç–Ω–æ–≥–æ –∏ –∫–æ–Ω—Ç—Ä–æ–ª–∏—Ä—É–µ–º–æ–≥–æ¬ª. –ß—Ç–æ –æ—Å–æ–±–µ–Ω–Ω–æ —É–¥–∏–≤–∏–ª–æ –∫–æ–º–ø–∞–Ω–∏—é ‚Äî —Ä–∞–Ω–µ–µ —ç—Ç–∏ –∑–∞–º–µ—á–∞–Ω–∏—è –Ω–µ –æ–∑–≤—É—á–∏–≤–∞–ª–∏—Å—å. –ù—É —Ç–∞–∫ —Ä–∞–Ω—å—à–µ –≤—Å–µ –≤ –ø–æ—Ç–æ–ª–æ–∫ –ø–ª–µ–≤–∞–ª–∏ –∏ —Ç—Ä–æ–ª–æ–ª–æ –∑–∞ –∫–µ—à –¥–µ–ª–∞–ª–∏. –¢–µ–ø–µ—Ä—å Replimmune –ø–ª–∞–Ω–∏—Ä—É–µ—Ç –æ–±—Å—É–¥–∏—Ç—å —Å–∏—Ç—É–∞—Ü–∏—é —Å FDA –∏ –Ω–∞–¥–µ–µ—Ç—Å—è –Ω–∞ –≤—Å—Ç—Ä–µ—á—É –≤ —Ç–µ—á–µ–Ω–∏–µ –º–µ—Å—è—Ü–∞. RP1 –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç –∏–∑—É—á–∞—Ç—å—Å—è –¥–ª—è –¥—Ä—É–≥–∏—Ö —Ñ–æ—Ä–º —Ä–∞–∫–∞ –∫–æ–∂–∏, –≤–∫–ª—é—á–∞—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å —Ç—Ä–∞–Ω—Å–ø–ª–∞–Ω—Ç–∏—Ä–æ–≤–∞–Ω–Ω—ã–º–∏ –æ—Ä–≥–∞–Ω–∞–º–∏. –ß—Ç–æ –¥—É–º–∞–µ—Ç–µ? üî• ‚Äî —Ç–∞–∫ –∏ –Ω–∞–¥–æ üóø ‚Äî –æ–¥–∏–Ω –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å–Ω—ã–π –¥–æ–∫—Ç–æ—Ä –≤ FDA —ç—Ç–æ –Ω–∞ 1 –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å–Ω–æ–≥–æ –¥–æ–∫—Ç–æ—Ä–∞ –±–æ–ª—å—à–µ, —á–µ–º –Ω—É–∂–Ω–æ","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration"",
  ""impact"": ""high"",
  ""english"": ""Replimmune's viral therapy RP1 for treating metastatic melanoma was rejected by FDA. The company's stock fell 75% after the news. The rejection, according to BMO Capital Markets, could be due to changes in regulatory authority - the new Director of CBER is Vinay Prasad, known for critical views on approval based on insufficient clinical data. Previously, the study IGNYTE was a priority for FDA review of RP1. However, FDA decided it did not meet the 'adequate and well-controlled' criteria. Replimmune plans to discuss this with FDA, expecting a meeting within a month.""
}"
2025-07-22T05:58:33+00:00,@pharm_icon,2306,https://t.me/pharm_icon/2306,"üì£‚ùì –£–≤–∞–∂–∞–µ–º—ã–µ –∫–æ–ª–ª–µ–≥–∏, –µ—Å–ª–∏ –≤—ã —Ä–∞–±–æ—Ç–∞–µ—Ç–µ —Å –∫–ª–µ—Ç–æ—á–Ω—ã–º–∏ –ø—Ä–æ–¥—É–∫—Ç–∞–º–∏ –∏ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—è–º–∏ –∏–ª–∏ –∏–º–µ–µ—Ç–µ –æ—Ç–Ω–æ—à–µ–Ω–∏–µ –∫ —Å—Ñ–µ—Ä–µ —Ä–µ–≥–µ–Ω–µ—Ä–∞—Ç–∏–≤–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω—ã, –ø–æ–∂–∞–ª—É–π—Å—Ç–∞, –ø—Ä–∏–º–∏—Ç–µ —É—á–∞—Å—Ç–∏–µ –≤ –æ–ø—Ä–æ—Å–µ –∏ –ø–æ–¥–µ–ª–∏—Ç–µ—Å—å —Å–≤–æ–∏–º —ç–∫—Å–ø–µ—Ä—Ç–Ω—ã–º –º–Ω–µ–Ω–∏–µ–º –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ —Ä–µ–≥—É–ª—è—Ç–æ—Ä–Ω—ã—Ö –∏–∑–º–µ–Ω–µ–Ω–∏–π –≤ —ç—Ç–æ–π –æ–±–ª–∞—Å—Ç–∏! –í 2020 –≥–æ–¥—É –ú–∏–Ω–∑–¥—Ä–∞–≤ –∏ –†–ê–ù –¥–æ–ø–æ–ª–Ω–∏–ª–∏ —Å–æ–≤–º–µ—Å—Ç–Ω—ã–π –ø—Ä–∏–∫–∞–∑ ‚Ññ306–Ω/3 –æ–± –æ–±—ä–µ–∫—Ç–∞—Ö —Ç—Ä–∞–Ω—Å–ø–ª–∞–Ω—Ç–∞—Ü–∏–∏ –∫ ¬´–§–ó ‚Ññ4180-I –û —Ç—Ä–∞–Ω—Å–ø–ª–∞–Ω—Ç–∞—Ü–∏–∏ –æ—Ä–≥–∞–Ω–æ–≤ –∏ (–∏–ª–∏) —Ç–∫–∞–Ω–µ–π —á–µ–ª–æ–≤–µ–∫–∞¬ª, –≤–∫–ª—é—á–∏–≤ –≤ –ø–µ—Ä–µ—á–µ–Ω—å –æ–±—ä–µ–∫—Ç–æ–≤ —Ç—Ä–∞–Ω—Å–ø–ª–∞–Ω—Ç–∞—Ü–∏–∏ –º–∏–Ω–∏–º–∞–ª—å–Ω–æ –º–∞–Ω–∏–ø—É–ª–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ –∫–ª–µ—Ç–∫–∏ —á–µ–ª–æ–≤–µ–∫–∞. üìå –ü—Ä–æ–¥—É–∫—Ç—ã, —Å–æ–¥–µ—Ä–∂–∞—â–∏–µ –ú–ú–ö, —à–∏—Ä–æ–∫–æ –ø—Ä–∏–º–µ–Ω—è—é—Ç—Å—è –≤ —Ä–µ–≥–µ–Ω–µ—Ä–∞—Ç–∏–≤–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω–µ, –¥–µ—Ä–º–∞—Ç–æ–ª–æ–≥–∏–∏, —Ä–µ–∫–æ–Ω—Å—Ç—Ä—É–∫—Ç–∏–≤–Ω–æ–π –∏ –ø–ª–∞—Å—Ç–∏—á–µ—Å–∫–æ–π —Ö–∏—Ä—É—Ä–≥–∏–∏. –ù–æ–≤—ã–π –ü—Ä–∏–∫–∞–∑ ‚Ññ1158–Ω/2 –æ—Ç 27.10.2020 –≤—ã–≤–æ–¥–∏–ª –∏–∑ ¬´—Å–µ—Ä–æ–π¬ª –∑–æ–Ω—ã –ø—Ä–æ–¥—É–∫—Ç—ã –Ω–∞ –±–∞–∑–µ –ú–ú–ö, —á—Ç–æ –ø–æ–∑–≤–æ–ª–∏–ª–æ –ø—Ä–∏–º–µ–Ω—è—Ç—å –∏—Ö –≤ —Ä—É—Ç–∏–Ω–Ω–æ–π –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–π –ø—Ä–∞–∫—Ç–∏–∫–µ. ‚úÖ –ü—Ä–æ–µ–∫—Ç –ø—Ä–∏–∫–∞–∑–∞ –±—ã–ª —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω —É—Å–∏–ª–∏—è–º–∏ –Ω–∞—à–µ–π —ç–∫—Å–ø–µ—Ä—Ç–Ω–æ–π –≥—Ä—É–ø–ø—ã –≤ —Ä–∞–º–∫–∞—Ö —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å–Ω–æ–π ¬´–¥–æ—Ä–æ–∂–Ω–æ–π –∫–∞—Ä—Ç—ã¬ª –ù–¢–ò ¬´–•–µ–ª—Å–Ω–µ—Ç¬ª. –î–æ—Ä–æ–≥–∏–µ –∫–æ–ª–ª–µ–≥–∏, —Å–µ–π—á–∞—Å –º—ã –ø–æ–¥–≤–æ–¥–∏–º –∏—Ç–æ–≥–∏ –æ—Ç–Ω–æ—Å–∏—Ç–µ–ª—å–Ω–æ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –¥–∞–Ω–Ω–æ–≥–æ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç–∞. üôè –ú—ã —Ö–æ—Ç–∏–º —É—Å–ª—ã—à–∞—Ç—å –í–ê–®–ï –º–Ω–µ–Ω–∏–µ ‚Äî –≤—Ä–∞—á–µ–π, —É—á–µ–Ω—ã—Ö, –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–æ–≤, –ª–∞–±–æ—Ä–∞–Ω—Ç–æ–≤, –ø–æ—Å—Ç–∞–≤—â–∏–∫–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —É—Å–ª—É–≥, ‚Äî –≤—Å–µ—Ö, –∫—Ç–æ –≤ —Å–≤–æ–µ–π —Ä–∞–±–æ—Ç–µ —Å—Ç–∞–ª–∫–∏–≤–∞–µ—Ç—Å—è —Å –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º –¥–∞–Ω–Ω–æ–≥–æ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç–∞, –æ —Ç–æ–º, –Ω–∞—Å–∫–æ–ª—å–∫–æ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ –ø—Ä–æ—Ö–æ–¥–∏—Ç –µ–≥–æ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏—è –Ω–∞ –ø—Ä–∞–∫—Ç–∏–∫–µ, —É–¥–æ–≤–ª–µ—Ç–≤–æ—Ä–µ–Ω—ã –ª–∏ –≤—ã —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º–∏, –∏ –∫–∞–∫–∏–µ –º–æ–º–µ–Ω—Ç—ã —Ç—Ä–µ–±—É—é—Ç –¥–æ—Ä–∞–±–æ—Ç–∫–∏. üëâ –î–ª—è —ç—Ç–æ–≥–æ –º—ã –ø–æ–¥–≥–æ—Ç–æ–≤–∏–ª–∏ –∞–Ω–æ–Ω–∏–º–Ω—ã–π –æ–ø—Ä–æ—Å –∏ –∑–∞—Ä–∞–Ω–µ–µ –±–ª–∞–≥–æ–¥–∞—Ä–∏–º –≤–∞—Å –∑–∞ —É–¥–µ–ª–µ–Ω–Ω–æ–µ –≤—Ä–µ–º—è, –≤–∞—à—É —á–µ—Å—Ç–Ω—É—é –æ—Ü–µ–Ω–∫—É –∏ –≤—Å—Ç—Ä–µ—á–Ω—ã–µ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è! ‚ùóÔ∏è–î–µ–¥–ª–∞–π–Ω –ø–æ —Å–±–æ—Ä—É –º–Ω–µ–Ω–∏–π ‚Äî 31 –∏—é–ª—è! –î—Ä—É–∑—å—è, –º–∞–∫—Å–∏–º–∞–ª—å–Ω—ã–π —Ä–µ–ø–æ—Å—Ç, –ø–æ–∂–∞–ª—É–π—Å—Ç–∞! ‚úàÔ∏è #–±–∏–æ–º–µ–¥ #–±–∏–æ—Ç–µ—Ö #—Ä–µ–≥—É–ª—è—Ç–æ—Ä–∏–∫–∞ #–∫–ª–µ—Ç–∫–∏ #—Ö–µ–ª—Å–Ω–µ—Ç #–ù–¢–ò","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""A survey is being conducted to gather expert opinions on regulatory changes in the regenerative medicine sector. The Ministry of Health and RAS updated the list of transplant objects to include minimally manipulated human cells in 2020. The survey aims to assess the effectiveness of this regulation and welcomes feedback from healthcare professionals, scientists, biotechnologists, laboratory workers, and service providers.""
}"
2025-07-22T05:20:06+00:00,@pharm_icon,2305,https://t.me/pharm_icon/2305,"üóø–ú–∏—Ä–∞–º–∏—Å—Ç–µ—Ä–∏—è: –∫–∞–∫ –ú–∞—Å—Ç–µ—Ä —Å–¥–µ–ª–æ–∫ –ú–∏—Ä–∞–º–∏—Å—Ç–∏–Ω –Ø–ö–û–ë–´ –ø–æ–∂–∞–ª –°–∏—Ç—É–∞—Ü–∏—è: –µ—Å—Ç—å –Ω–µ–∫–∏–µ –±–µ–Ω–µ—Ñ–∏—Ü–∏–∞—Ä—ã, –∑–∞–∏–Ω—Ç–µ—Ä–µ—Å–æ–≤–∞–Ω–Ω—ã–µ –≤ –∑–∞—Ö–≤–∞—Ç–µ –∫–æ–º–ø–∞–Ω–∏–∏ –û–û–û ""–ò–Ω—Ñ–∞–º–µ–¥"" (–ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å –ú–∏—Ä–∞–º–∏—Å—Ç–∏–Ω–∞), –µ—Å—Ç—å –Ω—ã–Ω–µ—à–Ω–∏–µ –≤–ª–∞–¥–µ–ª—å—Ü—ã ""–ò–Ω—Ñ–∞–º–µ–¥–∞"" –∏ –Ω–µ–∫—Ç–æ –ü–∞–≤–µ–ª –•–µ–π—Ñ–∏—Ü –∏ –µ–≥–æ –∂–µ–Ω–∞, –û–∫—Å–∞–Ω–∞ –•–µ–π—Ñ–∏—Ü. –ë–µ–≥–ª—ã–π –ø–æ–∏—Å–∫ –≤—ã–¥–∞—ë—Ç –ø–æ –ü–∞–≤–ª—É –•–µ–π—Ñ–∏—Ü—É, –Ω–µ–∫–æ–µ–≥–æ –ü–∞–≤–ª–∞ –ò–≥–æ—Ä–µ–≤–∏—á–∞ –•–µ–π—Ñ–∏—Ü–∞, —Å –¥–æ–ª–≥–∞–º–∏ –±–æ–ª–µ–µ 100 –º–∏–ª–ª–∏–æ–Ω–æ–≤ —Ä—É–±–ª–µ–π –∏ –º–∏—Ä–æ–≤—ã–º —Å–æ–≥–ª–∞—à–µ–Ω–∏–µ–º –≤ —Å—É–¥–µ –æ—Ç 20 –≥–æ–¥–∞ –ø–æ –±–∞–Ω–∫—Ä–æ—Ç—Å—Ç–≤—É. –ß—Ç–æ –±—ã–ª–æ: —Å —Ç–æ—á–∫–∏ –∑—Ä–µ–Ω–∏—è –ó–∞–∫–æ–Ω–∏–∏ –ü–∞–≤–µ–ª –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª—Å—è –≤–ª–∞–¥–µ–ª—å—Ü–∞–º ""–ò–Ω—Ñ–∞–º–µ–¥–∞"" –¥–∏—Ä–µ–∫—Ç–æ—Ä–æ–º –±–∞–Ω–∫–∞, —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä—É—é—â–µ–º—Å—è –Ω–∞ –∫–æ—Ä–ø–æ—Ä–∞—Ç–∏–≤–Ω—ã—Ö –≤–æ–π–Ω–∞—Ö –∏, —Å–æ–æ–±—â–∏–≤ –æ –≥–æ—Ç–æ–≤—è—â–µ–º—Å—è —Ä–µ–π–¥–µ—Ä—Å–∫–æ–º –∑–∞—Ö–≤–∞—Ç–µ –ò–Ω—Ñ–∞–º–µ–¥–∞, –ø—Ä–µ–¥–ª–æ–∂–∏–ª –≤ —Ü–µ–ª—è—Ö –∑–∞—â–∏—Ç—ã –æ—Ç —Ä–µ–π–¥–µ—Ä—Å–∫–æ–≥–æ –∑–∞—Ö–≤–∞—Ç–∞ –ø—Ä–æ–≤–µ—Å—Ç–∏ –Ω–æ–º–∏–Ω–∞–ª—å–Ω—É—é —Å–¥–µ–ª–∫—É –ø–æ –ø—Ä–æ–¥–∞–∂–µ –¥–æ–ª–∏. –ù–æ–º–∏–Ω–∞–ª—å–Ω–∞—è —Å–¥–µ–ª–∫–∞ —Ç–∞–∫–æ–≤–∞, —á—Ç–æ —Å—É–¥ –Ω–∞ –æ—Å–Ω–æ–≤–∞–Ω–∏–∏ —Ä–∞–∑–Ω–∏—Ü—ã —Å—Ç–æ–∏–º–æ—Å—Ç–∏ –º–æ–∂–µ—Ç —Ä–µ—à–∏—Ç—å, —á—Ç–æ —ç—Ç–æ –º—É—Ä–∑–∏–ª–∫–∞ –∏ –µ—ë –º–æ–∂–Ω–æ –æ—Å–ø–æ—Ä–∏—Ç—å, –∞ –º–æ–∂–µ—Ç —Ä–µ—à–∏—Ç—å –∏ –∏–Ω–∞—á–µ. –ß—Ç–æ –¥–∞–ª—å—à–µ: –ü–∞–≤–µ–ª —É–±–µ–¥–∏–ª –≤–ª–∞–¥–µ–ª—å—Ü–µ–≤ –∫–æ–º–ø–∞–Ω–∏–∏ –ø—Ä–æ–¥–∞—Ç—å –µ–º—É 51% –¥–æ–ª–∏ (!) –∫–æ–º–ø–∞–Ω–∏–∏ –∑–∞ 7,5 –º–∏–ª–ª–∏–æ–Ω–æ–≤ (!—è –±—ã —Ç–æ–∂–µ —Å–º–æ–≥–ª–∞ –∫—É–ø–∏—Ç—å!) –ø—Ä–∏ —Ñ–∞–∫—Ç–∏—á–µ—Å–∫–æ–π —Ü–µ–Ω–µ –≤ –±–æ–ª–µ–µ —á–µ–º 1 –º–º–ª–ª–∏–∞—Ä–¥ —Ä—É–±–ª–µ–π, —è–∫–æ–±—ã —á—Ç–æ–±—ã –Ω–µ –±—ã–ª–æ —É–≥—Ä–æ–∑ –∏ —Ä–∏—Å–∫–æ–≤ –≤ —Å—Ç–æ—Ä–æ–Ω—É –≤–ª–∞–¥–µ–ª—å—Ü–µ–≤. –î–∞–ª–µ–µ, –Ω–∞ –æ—Å–Ω–æ–≤–∞–Ω–∏–∏ —ç—Ç–æ–π –Ω–æ–º–∏–Ω–∞–ª—å–Ω–æ–π —Å–¥–µ–ª–∫–∏ –æ–Ω –ø–æ–ø—ã—Ç–∞–ª—Å—è –ø—Ä–æ–≤–µ—Ä–Ω—É—Ç—å —Ä–µ–π–¥–µ—Ä—Å–∫–∏–π –∑–∞—Ö–≤–∞—Ç –∫–æ–º–ø–∞–Ω–∏–∏, —Å–¥–µ–ª–∞–≤ —Å–¥–µ–ª–∫—É —è–∫–æ–±—ã —Ä—ã–Ω–æ—á–Ω–æ–π. –ù–µ –ø–æ–ª—É—á–∏–ª–æ—Å—å, –≤–ª–∞–¥–µ–ª—å—Ü—ã –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –ü–∞–≤–ª—É —á–µ—Ä–µ–∑ –Ω–æ—Ç–∞—Ä–∏—É—Å–∞ –ø—Ä–æ–π—Ç–∏ –Ω–∞ –º–∏—Ä–æ–≤—É—é, –Ω–æ –∞ –≤ –ø–æ—Å–ª–µ–¥–Ω–∏–π –º–æ–º–µ–Ω—Ç –æ–Ω –ø–µ—Ä–µ–¥—É–º–∞–ª –∏ –∑–∞—è–≤–∏–ª, —á—Ç–æ –∫–æ–º–ø–∞–Ω–∏—è –ø—Ä–∏—á–∏–Ω–∏–ª–∞ –µ–º—É —É—â–µ—Ä–±. –ö–∞–∫? –Ø–∫–æ–±—ã –∑–∞–±—Ä–∞–≤ –∫—É–¥–∞-—Ç–æ –ø—Ä–æ–ø–∞–≤—à–∏–µ —Ç—Ä—É–¥–æ–≤—ã–µ –¥–æ–≥–æ–≤–æ—Ä–∞ —Å –∫–Ω–∏–∂–∫–∞–º–∏ –±–æ–ª–µ–µ 100 –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–µ–π, –±—É—Ö–≥–∞–ª—Ç–µ—Ä—Å–∫–∏–µ –¥–æ–∫—É–º–µ–Ω—Ç—ã –∏ –≤—ã–≤–µ–ª–∏ –Ω–∞ —Ç—Ä–µ—Ç—å–∏—Ö –ª–∏—Ü –±–æ–ª–µ–µ 30 –º–∏–ª–ª–∏–æ–Ω–æ–≤. –°–æ —Å–ª–æ–≤ –ó–∞–∫–æ–Ω–∏–∏üôÉ –ù–æ —Å —ç—Ç–∏–º –º—É–≤–æ–º —Ç–æ–∂–µ —á—Ç–æ-—Ç–æ–Ω–µ –≤—ã—à–ª–æ, –∏ –ü–∞–≤–µ–ª –æ–±—Ä–∞—Ç–∏–ª—Å—è –≤ –ø—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–∏—Ç–µ–ª—å–Ω—ã–µ –æ—Ä–≥–∞–Ω—ã, —á—Ç–æ —Ç–∞–∫–∂–µ —Å–¥–µ–ª–∞–ª–∏ –∏ –ø–µ—Ä–≤–æ–Ω–∞—á–∞–ª—å–Ω—ã–µ –≤–ª–∞–¥–µ–ª—å—Ü—ã. –ò—Ç–æ–≥: –°—É–¥ –≤—Ä–µ–º–µ–Ω–Ω–æ –ø—Ä–∏–æ—Å—Ç–∞–Ω–æ–≤–∏–ª –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç—å –∫–æ–º–ø–∞–Ω–∏–∏ –≤ –∫–∞—á–µ—Å—Ç–≤–µ –æ–±–µ—Å–ø–µ—á–∏—Ç–µ–ª—å–Ω–æ–π –º–µ—Ä—ã. –ë–æ–ª–µ–µ –ø–æ–ª–Ω—É—é –∏ –ø–æ–¥—Ä–æ–±–Ω—É—é –≤–µ—Ä—Å–∏—é –º–æ–∂–Ω–æ –ø—Ä–æ—á–µ—Å—Ç—å –Ω–∞ —Å–∞–π—Ç–µ ""–ó–∞–∫–æ–Ω–∏—è"". –ö—Ä–∞–π–Ω–µ —É–¥–∏–≤–∏—Ç–µ–ª—å–Ω–æ, —á—Ç–æ –∫—Ä—É–ø–Ω—ã–µ –°–ú–ò –Ω–µ —Å—Ç–∞–ª–∏ –≤–Ω–∏–∫–∞—Ç—å –≤ —Å—É—Ç—å –¥–µ–ª–∞ –∏ –æ–≥—Ä–∞–Ω–∏—á–∏–ª–∏—Å—å —Å—É—Ö–∏–º–∏ —Ñ–∞–∫—Ç–∞–º–∏, —Ç–µ–º –±–æ–ª–µ–µ —á—Ç–æ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ —Å–∞–º–æ–π —Å—É–±—Å—Ç–∞–Ω—Ü–∏–∏ –ú–∏—Ä–∞–º–∏—Å—Ç–∏–Ω–∞ –ø–∞—Ä–æ–π –º–µ—Å—è—Ü–µ–≤ —Ä–∞–Ω–Ω–µ–µ –ø–µ—Ä–µ—à–ª–æ –≤–æ –≤–ª–∞–¥–µ–Ω–∏–µ –§–∞—Ä–º—Å—Ç–∞–Ω–¥—Ä–∞—Ç–∞. –ò–∑ –¥–µ–π—Å—Ç–≤–∏—Ç–µ–ª—å–Ω–æ —Å—Ç—Ä–∞–Ω–Ω—ã—Ö —Ñ–∞–∫—Ç–æ–≤ ‚Äî —ç—Ç–æ —Ç–æ, –∫–∞–∫–∏–º –∏–º–µ–Ω–Ω–æ –ø—É—Ç–µ–º –ü–∞–≤–µ–ª –•–µ–π—Ñ–∏—Ü —É–±–µ–¥–∏–ª –≤–ª–∞–¥–µ–ª—å—Ü–µ–≤ —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏, –ª—é–¥–µ–π –≤—Ä—è–¥ –ª–∏ –Ω–µ–¥–∞–ª–µ–∫–∏—Ö, –≤ —Ä–∏—Å–∫–µ —Ä–µ–π–¥–µ—Ä—Å–∫–æ–≥–æ –∑–∞—Ö–≤–∞—Ç–∞. –î—É–º–∞—é, –î–æ–Ω–∞–ª—å–¥ –¢—Ä–∞–º–ø –º–æ–≥ –±—ã –ø–æ—É—á–∏—Ç—å—Å—è —É —ç—Ç–æ–≥–æ –ú–∏—Ä–∞–ú–∞—Å—Ç–µ—Ä–∞ –°–¥–µ–ª–æ–∫ —Ç–æ–º—É, –∫–∞–∫ –Ω–∞–¥–æ –¥–æ–≥–æ–≤–∞—Ä–∏–≤–∞—Ç—å—Å—è.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing, tenders"",
  ""impact"": ""high"",
  ""english"": ""Pavel Heyfiz, a director of a bank specializing in corporate warfare, convinced the owners of Infamed to sell him 51% of their company for 7.5 million, despite the actual value being over a billion rubles. He attempted to carry out a raid on the company through this nominal deal, but it did not succeed. The owners offered Pavel to settle in court, but he withdrew and claimed that the company caused him harm. The case was temporarily halted by a court order. This situation is surprising, as major media did not delve into the matter and only reported dry facts despite the production of the drug itself being transferred to Farmstandata. The strange thing is how Pavel Heyfiz convinced the owners of the pharmaceutical company, who are likely not unintelligent people, to take a risk of corporate raid.""
}"
2025-07-21T19:52:25+00:00,@pharm_icon,2304,https://t.me/pharm_icon/2304,"üî•–ü—Ä–∏–≥–æ—Ç–æ–≤–∏–ª–∞ –∏–Ω—Ç–µ—Ä–µ—Å–Ω–æ–µ –Ω–∞ –∑–∞–≤—Ç—Ä–∞–∫, –¥–µ–≥—É—Å—Ç–∞—Ü–∏—è –≤ 8:20ü§åüèª","{""skip"": true}"
2025-07-17T13:44:30+00:00,@pharm_icon,2303,https://t.me/pharm_icon/2303,"70 –Ω–µ–≥–∞—Ç–∏–≤–Ω—ã—Ö –æ—Ç–∑—ã–≤–æ–≤ –û—Ç—Ä–∞–±–æ—Ç–∫–∞ –¥–ª—è –≤—Ä–∞—á–µ–π ‚Äî –∫–∞–Ω–∞–ª, –∫–æ—Ç–æ—Ä—ã–π —Å–¥–µ–ª–∞–ª –ø—Ä–æ–µ–∫—Ç Ordinatura.org, —á—Ç–æ–±—ã –æ—Ç–ø—Ä–∞–≤–∏—Ç—å –Ω–µ–≥–∞—Ç–∏–≤–Ω—ã–µ –æ—Ç–∑—ã–≤—ã –Ω–∞ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç, –∫–æ—Ç–æ—Ä—ã–π –∑–∞–Ω–∏–º–∞–µ—Ç—Å—è —Ä–∞—Å–ø—Ä–µ–¥–µ–ª–µ–Ω–∏–µ–º. –ü–æ–∫–∞ –∫–æ–Ω–≤–µ—Ä—Å–∏—è —Å–∫—É–¥–Ω–∞—è ‚Äî 700+ –ø–æ–¥–ø—Å–∏—á–∏–∫–æ–≤ –æ—Å—Ç–∞–≤–∏–ª–∏ 70 –æ—Ç–∑—ã–≤–æ–≤. –ü—Ä–∏–∑—ã–≤–∞—é —Å–≤–æ–∏—Ö –ø–æ–¥–ø–∏—Å—á–∏–∫–æ–≤ —ç—Ç–æ –∏ –æ—Å—Ç–∞–≤–∏—Ç—å –Ω–µ–≥–∞—Ç–∏–≤–Ω—ã–µ –æ—Ç–∑—ã–≤—ã –Ω–∞ —ç—Ç–æ—Ç –∑–∞–∫–æ–Ω –ø–æ –∏–Ω—Å—Ç—Ä—É–∫—Ü–∏–∏. –ò–Ω—Å—Ç—Ä—É–∫—Ü–∏—è –∑–¥–µ—Å—å.","{""skip"": true}"
2025-07-17T13:33:02+00:00,@pharm_icon,2301,https://t.me/pharm_icon/2301,"–û—Å—Ç–∞–≤—å—Ç–µ –º–Ω–µ–Ω–∏–µ –æ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç–µ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–§ –¥–æ 17 –∏—é–ª—è ‚ö°Ô∏è –í—Ä–µ–º–µ–Ω–∏ –æ—Å—Ç–∞–ª–æ—Å—å –º–∞–ª–æ. –ù–æ —É –Ω–∞—Å –µ—Å—Ç—å –ø—Ä–æ—Å—Ç–∞—è –∏–Ω—Å—Ç—Ä—É–∫—Ü–∏—è. –ï–µ –≤—ã–ø–æ–ª–Ω–µ–Ω–∏–µ –∑–∞–π–º–µ—Ç –ø—è—Ç—å –º–∏–Ω—É—Ç. –ü—É–±–ª–∏—á–Ω–æ–µ –æ–±—Å—É–∂–¥–µ–Ω–∏–µ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç–æ–≤ ‚Äî —ç—Ç–æ –ø—Ä–∞–≤–æ –≥—Ä–∞–∂–¥–∞–Ω–∏–Ω–∞. –ó–∞ —ç—Ç–æ –≤–∞–º –Ω–µ –≥—Ä–æ–∑–∏—Ç –Ω–∏–∫–∞–∫–∞—è –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç—å, –ø–æ—ç—Ç–æ–º—É –Ω–µ –±–æ–π—Ç–µ—Å—å –¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å. 1. –ó–∞–π–¥–∏—Ç–µ –Ω–∞ –æ—Ñ–∏—Ü–∏–∞–ª—å–Ω—ã–π –ø–æ—Ä—Ç–∞–ª –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç–æ–≤ –∏ –∞–≤—Ç–æ—Ä–∏–∑—É–π—Ç–µ—Å—å. –≠—Ç–æ –º–æ–∂–Ω–æ —Å–¥–µ–ª–∞—Ç—å —á–µ—Ä–µ–∑ –ì–æ—Å—É—Å–ª—É–≥–∏ –ü–æ—Ä—Ç–∞–ª —Ä–∞–±–æ—Ç–∞–µ—Ç –Ω–µ—Å—Ç–∞–±–∏–ª—å–Ω–æ, –Ω–∞–ø—Ä–∏–º–µ—Ä –∏–Ω–æ–≥–¥–∞ –¥–æ–ª–≥–æ –≥—Ä—É–∑–∏—Ç—Å—è –∏–ª–∏ –≤–æ–æ–±—â–µ –Ω–µ –æ—Ç–∫—Ä—ã–≤–∞–µ—Ç—Å—è. –í —Ç–∞–∫–æ–º —Å–ª—É—á–∞–µ –º–æ–∂–Ω–æ –ø–æ–ø—Ä–æ–±–æ–≤–∞—Ç—å –ø–æ–¥–∫–ª—é—á–∏—Ç—å –∏–ª–∏, –Ω–∞–æ–±–æ—Ä–æ—Ç, –æ—Ç–∫–ª—é—á–∏—Ç—å Wi-Fi, –∞ —Ç–∞–∫–∂–µ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å –¥—Ä—É–≥–æ–π –±—Ä–∞—É–∑–µ—Ä. 2. –ù–∞ —Å—Ç—Ä–∞–Ω–∏—Ü–µ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç–∞ –∫–ª–∏–∫–Ω–∏—Ç–µ –Ω–∞ –≤–∫–ª–∞–¥–∫—É ¬´–í–∞—à–∏ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è¬ª –∏ –≤—ã–±–µ—Ä–∏—Ç–µ –ø–æ—Å–ª–µ–¥–Ω–∏–π –ø—É–Ω–∫—Ç 3. –î–æ–±–∞–≤—å—Ç–µ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–µ –≤ –≤–∏–¥–µ —Ç–µ–∫—Å—Ç–∞ –∏–ª–∏ —Ñ–∞–π–ª–∞. –ü–æ —Å—Å—ã–ª–∫–µ –Ω–∞—Ö–æ–¥–∏—Ç—Å—è —Ç–µ–∫—Å—Ç –æ–±—Ä–∞—â–µ–Ω–∏—è –ú–∏–Ω–∑–¥—Ä–∞–≤—É –†–§, –∫–æ—Ç–æ—Ä—ã–π —Å–æ—Å—Ç–∞–≤–∏–ª–∞ –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–Ω–∞—è –≥—Ä—É–ø–ø–∞ –æ–±—É—á–∞—é—â–∏—Ö—Å—è –ø—Ä–∏ –ø–æ–¥–¥–µ—Ä–∂–∫–µ —é—Ä–∏—Å—Ç–∞, —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä—É—é—â–µ–≥–æ—Å—è –Ω–∞ —Ä–µ–≥—É–ª—è—Ç–æ—Ä–Ω–æ–π –ø–æ–ª–∏—Ç–∏–∫–µ. –í—ã –º–æ–∂–µ—Ç–µ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å —ç—Ç–æ—Ç —Ç–µ–∫—Å—Ç –≤ –∏—Å—Ö–æ–¥–Ω–æ–º –≤–∏–¥–µ –∏–ª–∏ –∫–∞–∫ —à–∞–±–ª–æ–Ω –∏ –∏–∑–º–µ–Ω–∏—Ç—å –µ–≥–æ. 4. –ï—Å–ª–∏ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –±—É–¥–µ—Ç –¥–≤–∏–≥–∞—Ç—å—Å—è –¥–∞–ª—å—à–µ, —Ç–æ –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–§ –¥–æ–ª–∂–µ–Ω –±—É–¥–µ—Ç –æ–ø—É–±–ª–∏–∫–æ–≤–∞—Ç—å –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é –æ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è –≥—Ä–∞–∂–¥–∞–Ω. ‚Äî‚Äî‚Äî –ó–∞—á–µ–º —ç—Ç–æ –Ω—É–∂–Ω–æ? –£ –Ω–∞—Å –Ω–µ —Ç–∞–∫ –º–Ω–æ–≥–æ —Å–ø–æ—Å–æ–±–æ–≤ –≤–ª–∏—è—Ç—å –Ω–∞ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–æ. –ú—ã –º–æ–∂–µ–º –ª–∏–±–æ –≥—Ä—É—Å—Ç–Ω–æ —Å–∫–∞–∑–∞—Ç—å, —á—Ç–æ –Ω–∏—á–µ–≥–æ –Ω–µ –ø–æ–ª—É—á–∏—Ç—Å—è, –ª–∏–±–æ –¥–µ–ª–∞—Ç—å —Ö–æ—Ç—å —á—Ç–æ-—Ç–æ. –û—Ü–µ–Ω–∏–≤–∞—Ç—å –∏ –∫–æ–º–º–µ–Ω—Ç–∏—Ä–æ–≤–∞—Ç—å –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç—ã ‚Äî —ç—Ç–æ –±—ã—Å—Ç—Ä—ã–π –∏ –±–µ–∑–æ–ø–∞—Å–Ω—ã–π —Å–ø–æ—Å–æ–± –¥–æ–Ω–µ—Å—Ç–∏ —Å–≤–æ—é –ø–æ–∑–∏—Ü–∏—è. –ú—ã –ø—Ä–µ–¥–ª–∞–≥–∞–µ–º –∏–º –≤–æ—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å—Å—è, –∞ –Ω–µ —Å–∏–¥–µ—Ç—å —Å–ª–æ–∂–∞ —Ä—É–∫–∏. –ï—Å—Ç—å –∏ –¥—Ä—É–≥–æ–π –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç ‚Äî –æ–±—Ä–∞—â–µ–Ω–∏—è –≤ –≥–æ—Å–æ—Ä–≥–∞–Ω—ã. –ò–º –º—ã —Ç–æ–∂–µ –±—É–¥–µ–º –ø–æ–ª—å–∑–æ–≤–∞—Ç—å—Å—è. –í —Å–ª–µ–¥—É—é—â–µ–º –ø–æ—Å—Ç–µ —Ä–∞—Å—Å–∫–∞–∂–µ–º –æ–± –æ–±—Ä–∞—â–µ–Ω–∏–∏ –≤ –ú–∏–Ω—ç–∫–æ–Ω–æ–º—Ä–∞–∑–≤–∏—Ç–∏—è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, pricing, import_export, sanctions, shortage"",
  ""impact"": ""medium"",
  ""english"": ""This message encourages public engagement with the Russian Ministry of Health's draft legislation. It provides guidance on how to submit comments through an official portal and offers a template for submissions, emphasizing the importance of participation in influencing state decisions. The message does not specify immediate impacts but highlights the medium-term impact on regulatory processes and market access.""
}"
2025-07-16T16:08:26+00:00,@pharm_icon,2300,https://t.me/pharm_icon/2300,"–†–∞–±–¥–æ–º–∏–æ–ª–∏–∑ –Ω–∞ —Ä–æ–∑—É–≤–∞—Å—Ç–∞—Ç–∏–Ω–µ: –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–π –∫–µ–π—Å –ü—Ä–æ–¥–æ–ª–∂–∞–µ–º —Ä–∞–∑–±–∏—Ä–∞—Ç—å —Ö–∞–π–ª–∞–π—Ç—ã –†–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–π –§–∞—Ä–º–∞–∫–æ—Ç–µ—Ä–∞–ø–∏–∏ –≤ –ö–∞—Ä–¥–∏–æ–ª–æ–≥–∏–∏, –≤ —ç—Ç–æ—Ç —Ä–∞–∑ –ø–µ—Ä–µ–¥ –Ω–∞–º–∏ –∫–µ–π—Å —Å–æ —Å—Ç–∞—Ç–∏–Ω–∞–º–∏, –∫–æ—Ç–æ—Ä—ã–π –ø—Ä–µ–¥—Å—Ç–∞–≤–∏–ª–∏ –∑–∞–º–µ—á–∞—Ç–µ–ª—å–Ω—ã–µ –ª—é–¥–∏ –Ω–∞ —Ñ–æ—Ç–æ–≥—Ä–∞—Ñ–∏–∏ (–ø–µ—Ä–≤—ã–µ 3 –∞–≤—Ç–æ—Ä–∞ –∏–∑ 6). –°—Å—ã–ª–∫–∞ –Ω–∞ —Å—Ç–∞—Ç—å—é ‚Äî –∑–¥–µ—Å—å –ß—Ç–æ –∏–Ω—Ç–µ—Ä–µ—Å–Ω–æ–≥–æ: 1. –ü–æ–ª–∏–º–æ—Ä–±–∏–¥–Ω–∞—è –ø–∞—Ü–∏–µ–Ω—Ç–∫–∞ 83 –ª–µ—Ç —á–µ—Ä–µ–∑ –Ω–µ–∫–æ—Ç–æ—Ä–æ–µ –≤—Ä–µ–º—è –ø–æ—Å–ª–µ –≤—ã–ø–∏—Å–∫–∏ (–∏–Ω—Ñ–∞—Ä–∫—Ç+–ß–ö–í) –Ω–∞ —Ñ–æ–Ω–µ –ø—Ä–∏–µ–º–∞ —Ä–æ–∑—É–≤–∞—Å—Ç–∞—Ç–∏–Ω–∞ —Å—Ç–∞–ª–∞ –æ—Ç–º–µ—á–∞—Ç—å –ø—Ä–æ–≥—Ä–µ—Å—Å–∏—Ä—É—é—â—É—é —Å–ª–∞–±–æ—Å—Ç—å, –±–æ–ª—å –≤ —Ä—É–∫–∞—Ö –∏ (–≤ –±–æ–ª—å—à–µ–π —Å—Ç–µ–ø–µ–Ω–∏) –Ω–æ–≥–∞—Ö, –ø–æ—è–≤–ª–µ–Ω–∏–µ ""—Å–∏–Ω—è–∫–æ–≤"" –Ω–∞ —Ç–µ–ª–µ. 2. –ü—Ä–∏ –ø–æ—Å—Ç—É–ø–ª–µ–Ω–∏–∏ –æ–±–Ω–∞—Ä—É–∂–∏–ª–∏—Å—å —Ä–µ–∑–∫–æ–µ –ø–æ–≤—ã—à–µ–Ω–∏–µ –ö–§–ö –∏ –ö–§–ö-–ú–í, —Ç–æ–∫—Å–∏—á–µ—Å–∫–∏–π –≥–µ–ø–∞—Ç–∏—Ç –∏ –æ—Å—Ç—Ä–æ–µ –ø–æ–≤—Ä–µ–∂–¥–µ–Ω–∏–µ –ø–æ—á–µ–∫. –°—Ç–∞—Ç–∏–Ω –æ—Ç–º–µ–Ω–µ–Ω, –ø–∞—Ü–∏–µ–Ω—Ç–∫–∞ –ø–µ—Ä–µ–≤–µ–¥–µ–Ω–∞ –≤ –æ—Ç–¥–µ–ª–µ–Ω–∏–µ –∏–Ω—Ç–µ–Ω—Å–∏–≤–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏. 3. –í—Ä–∞—á–∏ –ø—Ä–æ–≤–µ–ª–∏ –¥–∏—Ñ–¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫—É: –ê. –° –ø–æ–º–æ—â—å—é —Å–±–æ—Ä–∞ –∞–Ω–∞–º–Ω–µ–∑–∞ –∏—Å–∫–ª—é—á–∏–ª–∏ –¥—Ä—É–≥–∏–µ –ø—Ä–∏—á–∏–Ω—ã —Ä–∞–±–¥–æ–º–∏–æ–ª–∏–∑–∞ –ü–æ—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å–Ω–æ –∏—Å–∫–ª—é—á–µ–Ω—ã –∞–ª—å—Ç–µ—Ä–Ω–∞—Ç–∏–≤–Ω—ã–µ –ø—Ä–∏—á–∏–Ω—ã —Ä–∞–∑–≤–∏–≤—à–µ–≥–æ—Å—è –†–ú. –ü–∞—Ü–∏–µ–Ω—Ç–∫–∞ –æ—Ç—Ä–∏—Ü–∞–ª–∞ —á—Ä–µ–∑–º–µ—Ä–Ω—É—é —Ñ–∏–∑–∏—á–µ—Å–∫—É—é –Ω–∞–≥—Ä—É–∑–∫—É, —Ç—Ä–∞–≤–º—ã, –ø–µ—Ä–µ–≥—Ä–µ–≤ –∏–ª–∏ –ø–µ—Ä–µ–æ—Ö–ª–∞–∂–¥–µ–Ω–∏–µ, –ø—Ä–∏—ë–º –≥—Ä–µ–π–ø—Ñ—Ä—É—Ç–æ–≤–æ–≥–æ –∏–ª–∏ –≥—Ä–∞–Ω–∞—Ç–æ–≤–æ–≥–æ —Å–æ–∫–æ–≤, –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Å–æ–ª–æ–¥–∫–∏, –Ω–∞—Ä–∫–æ—Ç–∏—á–µ—Å–∫–∏—Ö –≤–µ—â–µ—Å—Ç–≤, –∞–ª–∫–æ–≥–æ–ª—è, –Ω–∞—Ä–∫–æ—Ç–∏–∫–æ–≤, –∞ —Ç–∞–∫–∂–µ –∑–Ω–∞—á–∏–º–æ –≤–ª–∏—è—é—â–∏—Ö –Ω–∞ –º–µ—Ç–∞–±–æ–ª–∏–∑–º —Å—Ç–∞—Ç–∏–Ω–æ–≤ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. –ü—Ä–∏ –ø–æ—Å—Ç—É–ø–ª–µ–Ω–∏–∏ –ø—Ä–∏–∑–Ω–∞–∫–æ–≤ –≤–∏—Ä—É—Å–Ω–æ–π –∏–ª–∏ –±–∞–∫—Ç–µ—Ä–∏–∞–ª—å–Ω–æ–π –∏–Ω—Ñ–µ–∫—Ü–∏–∏, –ª–æ–∫–∞–ª—å–Ω—ã—Ö –æ—á–∞–≥–æ–≤ –≤–æ—Å–ø–∞–ª–µ–Ω–∏—è –Ω–µ –±—ã–ª–æ. –£ –ø–∞—Ü–∏–µ–Ω—Ç–∫–∏ –ø–æ–∫–∞–∑–∞—Ç–µ–ª–∏ –∫–∞–ª–∏—è, –º–∞–≥–Ω–∏—è, –≥–ª–∏–∫–µ–º–∏–∏ –±—ã–ª–∏ –≤ –ø—Ä–µ–¥–µ–ª–∞—Ö —Ä–µ—Ñ–µ—Ä–µ–Ω—Å–Ω—ã—Ö –∑–Ω–∞—á–µ–Ω–∏–π, –æ—Ç—Å—É—Ç—Å—Ç–≤–æ–≤–∞–ª–∏ –≥–ª—é–∫–æ–∑—É—Ä–∏—è –∏ –∫–µ—Ç–æ–Ω—É—Ä–∏—è, –æ–Ω–∞ –∏–º–µ–ª–∞ —ç—É—Ç–∏—Ä–µ–æ–∏–¥–Ω—ã–π —Å—Ç–∞—Ç—É—Å. –ë. –ò—Å–∫–ª—é—á–∏–ª–∏ —Å–∏—Å—Ç–µ–º–Ω—ã–µ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è —Å–æ–µ–¥–∏–Ω–∏—Ç–µ–ª—å–Ω–æ–π —Ç–∫–∞–Ω–∏ –ò—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –∞–Ω—Ç–∏–Ω—É–∫–ª–µ–∞—Ä–Ω—ã—Ö –∞–Ω—Ç–∏—Ç–µ–ª (–∞–Ω—Ç–∏–Ω—É–∫–ª–µ–∞—Ä–Ω—ã–π —Ñ–∞–∫—Ç–æ—Ä), –∞–Ω—Ç–∏—Ç–µ–ª –∫ —Ç–æ–ø–æ–∏–∑–æ–º–µ—Ä–∞–∑–µ 1 (Scl70), –¥–≤—É—Å–ø–∏—Ä–∞–ª—å–Ω–æ–π –î–ù–ö (–∏–º–º—É–Ω–æ–≥–ª–æ–±—É–ª–∏–Ω G), Jo1, –Ω—É–∫–ª–µ–æ—Å–æ–º–∞–º, –≥–∏—Å—Ç–æ–Ω–∞–º (H1, H2A, H2B, H3, H4), –º–∏—Ç–æ—Ö–æ–Ω–¥—Ä–∏—è–º, RNP/SM, —Ä–∏–±–æ—Å–æ–º–∞–ª—å–Ω–æ–º—É –±–µ–ª–∫—É P-RiboP, PM-Scl, Sm-–∞–Ω—Ç–∏–≥–µ–Ω—É, SS-A60, SS-A52, SS-B (La) –ø–æ–∑–≤–æ–ª–∏–ª–æ –∏—Å–∫–ª—é—á–∏—Ç—å —Å–∏—Å—Ç–µ–º–Ω—ã–µ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è —Å–æ–µ–¥–∏–Ω–∏—Ç–µ–ª—å–Ω–æ–π —Ç–∫–∞–Ω–∏, –≤ —Ç.—á. –ø–æ–ª–∏–º–∏–æ–∑–∏—Ç. –í. –ó–∞—á–µ–º-—Ç–æ —É–¥–µ–ª–∏–ª–∏ –≤–Ω–∏–º–∞–Ω–∏–µ –≤–∏—Ç–∞–º–∏–Ω—É Dü§∑üèª‚Äç‚ôÇÔ∏è –í –Ω–µ–∫–æ—Ç–æ—Ä—ã—Ö –ø—É–±–ª–∏–∫–∞—Ü–∏—è—Ö –æ—Ç–º–µ—á–∞–µ—Ç—Å—è, —á—Ç–æ —ç—Ç–æ —Ñ–∞–∫—Ç–æ—Ä —Ä–∏—Å–∫–∞ —Ä–∞–±–¥–æ–º–∏–æ–ª–∏–∑–∞. –ì. –ö—Ä–∏—Ç–µ—Ä–∏–∞–ª—å–Ω–∞—è –æ—Ü–µ–Ω–∫–∞. –î–ª—è –æ—Ü–µ–Ω–∫–∏ —Å–≤—è–∑–∏ –º—ã—à–µ—á–Ω—ã—Ö —Å–∏–º–ø—Ç–æ–º–æ–≤ —Å –ø—Ä–∏—ë–º–æ–º —Å—Ç–∞—Ç–∏–Ω–æ–≤ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω—ã –∫—Ä–∏—Ç–µ—Ä–∏–∏ –ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–π –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ –ª–∏–ø–∏–¥–æ–ª–æ–≥–æ–≤ (National Lipid Association, –°–®–ê), —Ä–∞—Å—Å–º–∞—Ç—Ä–∏–≤–∞—é—Ç —Å–≤—è–∑—å, –∫–∞–∫ –≤–æ–∑–º–æ–∂–Ω—É—é. –î. –ì–µ–Ω–µ—Ç–∏—á–µ—Å–∫–æ–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –ø–æ–∫–∞–∑–∞–ª–æ, —á—Ç–æ —É –ø–∞—Ü–∏–µ–Ω—Ç–∫–∏ –∏ –µ—ë —Å–µ—Å—Ç—Ä—ã –≤—ã—è–≤–ª–µ–Ω—ã –≥–µ–Ω–æ—Ç–∏–ø—ã –Ω–µ —Å–≤—è–∑–∞–Ω—ã —Å —Ä–∏—Å–∫–æ–º —Ä–∞–∑–≤–∏—Ç–∏—è –°–ò–ú, –æ–¥–Ω–∞–∫–æ —Å–≤—è–∑–∞–Ω—ã —Å —Ä–∏—Å–∫–æ–º –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø–æ—Ä–∞–∂–µ–Ω–∏—è –ø–µ—á–µ–Ω–∏ —É –ø–∞—Ü–∏–µ–Ω—Ç–∫–∏ –∏ —Å –º–∏–∞–ª–≥–∏–µ–π ‚Äî —É –µ—ë —Å–µ—Å—Ç—Ä—ã. –°–æ–≥–ª–∞—Å–Ω–æ –¥–∞–Ω–Ω—ã–º –ª–∏—Ç–µ—Ä–∞—Ç—É—Ä—ã, –≤—ã—è–≤–ª–µ–Ω–Ω—ã–π —É –ø–∞—Ü–∏–µ–Ω—Ç–∫–∏ –õ. –≥–µ–Ω–æ—Ç–∏–ø rs1128503-AG –∞—Å—Å–æ—Ü–∏–∏—Ä–æ–≤–∞–Ω —Å –ø–æ–≤—ã—à–µ–Ω–∏–µ–º —Ä–∏—Å–∫–∞ –°–ò–ú –∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø–æ—Ä–∞–∂–µ–Ω–∏—è –ø–µ—á–µ–Ω–∏, –∞ rs1045642-–ê–ê (—É –ø–∞—Ü–∏–µ–Ω—Ç–∫–∏ –∏ –µ—ë —Å–µ—Å—Ç—Ä—ã) ‚Äî —Å –ø–æ–≤—ã—à–µ–Ω–∏–µ–º —Ä–∏—Å–∫–∞ –º–∏–∞–ª–≥–∏–∏ –∏ –°–ò–ú, –Ω–æ —ç—Ç–∞ —Å–≤—è–∑—å —É—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∞ —Ç–æ–ª—å–∫–æ –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ –∞—Ç–æ—Ä–≤–∞—Å—Ç–∞—Ç–∏–Ω–∞. –ß–µ–≥–æ –Ω–µ —Ö–≤–∞—Ç–∏–ª–æ: 1. –ê–ª–≥–æ—Ä–∏—Ç–º–∞ –¥–∏—Ñ–¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∏. –ú–æ–∂–Ω–æ –±—ã–ª–æ –±—ã –Ω–∞ —ç—Ç–æ –≤—ã–¥–µ–ª–∏—Ç—å 1 —Ä–∏—Å—É–Ω–æ–∫. 2. –í—ã–ø–∏—Å–∞–ª–∏ —Å –ª–µ–≥–∫–æ–π –∞–Ω–µ–º–∏–µ–π, –∞ –ø–æ Hb ‚Äî —Å—Ä–µ–¥–Ω–µ–π —Å—Ç–µ–ø–µ–Ω–∏ —Ç—è–∂–µ—Å—Ç–∏. –ü–æ–ª–∞–≥–∞—é, –æ–ø–µ—á–∞—Ç–∫–∞. 3. –ù–µ —Ö–≤–∞—Ç–∏–ª–æ follow-up'–∞ –ø–æ –ø–∞—Ü–∏–µ–Ω—Ç–∫–µ ‚Äî —Å—Ç–∞—Ç—É—Å –∞–Ω–µ–º–∏–∏ –Ω–µ –æ–ø—Ä–µ–¥–µ–ª–µ–Ω –æ—Ç 1.07.2024. 4. –ü–µ—Ä–µ–≥—Ä—É–∑ –ø–æ–¥—Ä–æ–±–Ω–æ—Å—Ç—è–º–∏, –∞–≤—Ç–æ—Ä—ã –¥–∞–∂–µ –≤—ã–ø–∏—Å–∞–ª–∏ —Ü–µ–ª–∏–∫–æ–º –¥–∏–∞–≥–Ω–æ–∑ –ø–∞—Ü–∏–µ–Ω—Ç–∞. –û–±—ã—á–Ω–æ —É –∫–µ–π—Å–æ–≤ –±–æ–ª–µ–µ –∫–æ—Ä–æ—Ç–∫–∏–π —Ñ–æ—Ä–º–∞—Ç. 5. –£–ø–æ–º–∏–Ω–∞–Ω–∏—è –∏–Ω–æ—Å—Ç—Ä–∞–Ω–Ω—ã—Ö –∫—Ä–∏—Ç–µ—Ä–∏–µ–≤ –∏–¥—É—Ç —á–µ—Ä–µ–∑ —Å—Å—ã–ª–∫–∏ –Ω–∞ —Ä—É—Å—Å–∫–æ—è–∑—ã—á–Ω—ã–µ –∏—Å—Ç–æ—á–Ω–∏–∫–∏. Politics. –í –æ—Å—Ç–∞–ª—å–Ω–æ–º –æ—á–µ–Ω—å –∫—Ä—É—Ç–æ–π –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–π —Å–ª—É—á–∞–πüî• —Å–ø–∞—Å–∏–±–æ –∫–æ–º–∞–Ω–¥–µ –∞–≤—Ç–æ—Ä–æ–≤! –ò—Å—Ç–æ—á–Ω–∏–∫","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_case, shortage, safety"",
  ""impact"": ""high"",
  ""english"": ""A case study on rhabdomyolysis associated with rosuvastatin. The patient, an 83-year-old polymorbid woman (myocardial infarction and chronic kidney disease), experienced progressive weakness, pain in her arms and legs, and bruises on her body after discontinuing rosuvastatin. Elevated CK and CK-MB levels, toxic hepatitis, and acute kidney injury were detected upon admission. The case was evaluated for possible causes of rhabdomyolysis, ruling out other potential factors. The case was further evaluated for systemic connective tissue diseases and genetic associations, but no specific cause was identified. The case highlights the need for a diagnostic algorithm and follow-up on patient status.""
}"
2025-07-15T15:50:32+00:00,@pharm_icon,2299,https://t.me/pharm_icon/2299,"#–ò–ò #—Ñ–∞—Ä–º–∞ #–ø–æ–¥–∫–∞—Å—Ç—ã –§–∞—Ä–º–∞ –∏ –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–∏ –≤ –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω—ã–π –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç (–ò–ò) –û—Ü–µ–Ω–∫–∞ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–∏ ‚Äî —Ç–µ–º–∞ —Å–ª–æ–∂–Ω–∞—è –∏ –≤–∞–∂–Ω–∞—è: –Ω–µ –≤—Å–µ–≥–¥–∞ –ø–æ–Ω—è—Ç–Ω–æ, –∫–∞–∫ –ø–æ–≤–ª–∏—è—é—Ç —Å–µ—Ä–≤–∏—Å—ã –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–∞ (–ò–ò) –Ω–∞ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –ª–µ—á–µ–Ω–∏—è –∏ –æ–∫—É–ø—è—Ç—Å—è –ª–∏ –∑–∞—Ç—Ä–∞—Ç—ã –Ω–∞ –∏—Ö –≤–Ω–µ–¥—Ä–µ–Ω–∏–µ. –ö–∞–∫ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏–µ –∫–æ–º–ø–∞–Ω–∏–∏ –æ—Ü–µ–Ω–∏–≤–∞—é—Ç –∫–ª–∏–Ω–∏–∫–æ-—ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫—É—é —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å —Ä–µ—à–µ–Ω–∏–π –Ω–∞ –æ—Å–Ω–æ–≤–µ –ò–ò? –ö–∞–∫ –æ—Ü–µ–Ω–∏–≤–∞–µ—Ç—Å—è —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –ò–ò-—Ä–µ—à–µ–Ω–∏–π –≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–∏ –∑–∞ —Ä—É–±–µ–∂–æ–º? –û–±—Å—É–¥–∏–º —Å –≥–æ—Å—Ç—å–µ–π —ç–ø–∏–∑–æ–¥–∞ ‚Äî –í–∞–ª–µ—Ä–∏–µ–π –õ–µ–º–µ—à–∫–æ, —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª–µ–º –ø–æ–¥—Ä–∞–∑–¥–µ–ª–µ–Ω–∏—è –ø–æ —Ä–∞–∑–≤–∏—Ç–∏—é –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∏ –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏—é —Å —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω—ã–º–∏ –æ—Ä–≥–∞–Ω–∞–º–∏ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π –≤–ª–∞—Å—Ç–∏, –ê–û ¬´–†–æ—à-–ú–æ—Å–∫–≤–∞¬ª –≠—Ç–æ—Ç –≤—ã–ø—É—Å–∫ –±—É–¥–µ—Ç –ø–æ–ª–µ–∑–µ–Ω –∫–∞–∫ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª–∞–º –≤ –æ–±–ª–∞—Å—Ç–∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è, —Ç–∞–∫ –∏ –≤—Å–µ–º, –∫—Ç–æ –∏–Ω—Ç–µ—Ä–µ—Å—É–µ—Ç—Å—è –≤–Ω–µ–¥—Ä–µ–Ω–∏–µ–º –ø–µ—Ä–µ–¥–æ–≤—ã—Ö —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫—É—é –ø—Ä–∞–∫—Ç–∏–∫—É. –°–ª—É—à–∞–π—Ç–µ, —á—Ç–æ–±—ã —É–∑–Ω–∞—Ç—å –±–æ–ª—å—à–µ –æ —Ç–æ–º, –∫–∞–∫ –ò–ò –º–æ–∂–µ—Ç –∏–∑–º–µ–Ω–∏—Ç—å –±—É–¥—É—â–µ–µ –º–µ–¥–∏—Ü–∏–Ω—ã –∏ –ø–æ–≤—ã—Å–∏—Ç—å —É—Ä–æ–≤–µ–Ω—å –∑–¥–æ—Ä–æ–≤—å—è –∏ –±–ª–∞–≥–æ–ø–æ–ª—É—á–∏—è –ª—é–¥–µ–π –ø–æ –≤—Å–µ–º—É –º–∏—Ä—É. –°–ª—É—à–∞–π—Ç–µ –Ω–∞ –Ø–Ω–¥–µ–∫—Å.–ú—É–∑—ã–∫–µ –∏ —Å–º–æ—Ç—Ä–∏—Ç–µ –Ω–∞ –ø–æ–ø—É–ª—è—Ä–Ω—ã—Ö –ø–ª–æ—â–∞–¥–∫–∞—Ö –≤–∏–¥–µ–æ–∫–æ–Ω—Ç–µ–Ω—Ç–∞: üìπRuTube üìπVK –î–µ–ª–∏—Ç–µ—Å—å –ø–æ–¥–∫–∞—Å—Ç–æ–º —Å –¥—Ä—É–∑—å—è–º–∏ –∏ –±–µ—Ä–∏—Ç–µ –ø–æ–ª–µ–∑–Ω–æ–µ –Ω–∞ –∑–∞–º–µ—Ç–∫—É! –ñ–¥—É –æ–±—Ä–∞—Ç–Ω–æ–π —Å–≤—è–∑–∏ –æ—Ç –≤–∞—Å, —ç–∫—Å–ø–µ—Ä—Ç—ã. @medicalksu","{""skip"": true}"
2025-07-15T08:19:35+00:00,@pharm_icon,2298,https://t.me/pharm_icon/2298,"–°–µ–≥–æ–¥–Ω—è –ø—Ä–æ–¥–æ–ª–∂–∏–º —Ä–∞–∑–±–∏—Ä–∞—Ç—å –Ω–µ–∫–æ—Ç–æ—Ä—ã–µ –ø—É–±–ª–∏–∫–∞—Ü–∏–∏ –≤ –†–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–π –§–∞—Ä–º–∞–∫–æ—Ç–µ—Ä–∞–ø–∏–∏ –≤ –ö–∞—Ä–¥–∏–æ–ª–æ–≥–∏–∏, –ø–æ—ç—Ç–æ–º—É –≤–æ—Ç –≤–∞–º –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è –æ—Ç –≥–ª–∞–≤–Ω–æ–≥–æ —Ä–µ–¥–∞–∫—Ç–æ—Ä–∞.","{""skip"": true}"
2025-07-15T08:18:51+00:00,@pharm_icon,2297,https://t.me/pharm_icon/2297,–î–æ–±—Ä–æ–µ —É—Ç—Ä–æ! #–°–æ–≤–µ—Ç—Ç–µ—Ä–∞–ø–µ–≤—Ç–∞ #–û–∫—Å–∞–Ω–∞_–î—Ä–∞–ø–∫–∏–Ω–∞,"{""skip"": true}"
2025-07-14T17:21:17+00:00,@pharm_icon,2296,https://t.me/pharm_icon/2296,"–°–µ–º–∞–≥–ª—É—Ç–∏–¥–æ–æ–ø—Ç–∏–º–∏—Å—Ç—ã ‚Äî –≤—ã—Ö–æ–¥–∏—Ç–µ –∏–∑ —Å—É–º—Ä–∞–∫–∞ –∏ –ø–µ—Ä–µ–±–µ–≥–∞–π—Ç–µ –≤ –≥—Ä—É–ø–ø—É —Å–µ–º–≥–∞–≥–ª—É—Ç–∏–¥–æ—Ä–µ–∞–ª–∏—Å–æ–≤. –°–µ–º–∞–≥–ª—É—Ç–∏–¥–æ—Ä–µ–∞–ª–∏—Å—Ç –¥–æ–ª–∂–µ–Ω –¥–µ–ª–∞—Ç—å 5 –≤–µ—â–µ–π: 1. –ë—ã—Ç—å –Ω–∞—Å—Ç–æ—Ä–æ–∂–µ –ø—Ä–∏ –≤–≤–µ–¥–µ–Ω–∏–∏ –≤ –ª–∏—Å—Ç –Ω–∞–∑–Ω–∞—á–µ–Ω–∏–π —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ 2. –õ–æ–±–±–∏—Ä–æ–≤–∞—Ç—å –ø—Ä–∏–µ–º –æ—Ñ—Ç–∞–ª—å–º–æ–ª–æ–≥–∞ 3. –ü—Ä–æ–≤–µ—Ä—è—Ç—å –ø–æ –∫–∞–∫–æ–π-–Ω–∏–±—É–¥—å —à–∫–∞–ª–µ ‚Äî –Ω–∞–ø—Ä–∏–º–µ—Ä, —à–∫–∞–ª–µ –ù–∞—Ä–∞–Ω–∂–æ ‚Äî —Å–≤—è–∑—å –Ω–µ–∂–µ–ª–∞—Ç–µ–ª—å–Ω–æ–≥–æ —è–≤–ª–µ–Ω–∏—è —Å –ø—Ä–∏–µ–º–æ–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ 4. –ü–µ—Ä–µ—Å–º–∞—Ç—Ä–∏–≤–∞—Ç—å —Ç–µ—Ä–∞–ø–∏—é –ø—Ä–∏ –æ–±–Ω–∞—Ä—É–∂–µ–Ω–∏–∏ —Å–≤—è–∑–∏. 5. –û–ø–∏—Å—ã–≤–∞–π—Ç–µ –ø–æ–±–æ—á–Ω—ã–π —ç—Ñ—Ñ–µ–∫—Ç –∏ –æ—Ç–ø—Ä–∞–≤–ª—è–π—Ç–µ –º–Ω–µ, –æ–ø—É–±–ª–∏–∫—É–µ–º, –∞ —Ç–∞–∫–∂–µ –æ—Ç–ø—Ä–∞–≤—å—Ç–µ –†–æ—Å–∑–¥—Ä–∞–≤–Ω–∞–¥–æ–∑–æ—Ä—É —á–µ—Ä–µ–∑ —ç—Ç—É —á—É–¥–µ—Å–Ω—É—é —Ñ–æ—Ä–º—É. –î–æ–≥–æ–≤–æ—Ä–∏–ª–∏—Å—å? üî• ‚Äî –¥–∞ üóø ‚Äî –Ω–µ—Ç","{""skip"": true}"
2025-07-14T17:09:36+00:00,@pharm_icon,2295,https://t.me/pharm_icon/2295,"–°–µ–º–∞–≥–ª—É—Ç–∏–¥ —É–¥–≤–∞–∏–≤–∞–µ—Ç —Ä–∏—Å–∫ –Ω–í–ú–î —É –ø–æ–∂–∏–ª—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –¥–∏–∞–±–µ—Ç–æ–º –ü—É–±–ª–∏–∫–∞—Ü–∏—è –≤ JAMA Ophthalmology (–∏—é–Ω—å 2025): –ø—Ä–∏—ë–º —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ (Ozempic, Wegovy) –≤ 2,2 —Ä–∞–∑–∞ —É–≤–µ–ª–∏—á–∏–≤–∞–µ—Ç —Ä–∏—Å–∫ —Ä–∞–∑–≤–∏—Ç–∏—è –Ω–µ–æ–≤–∞—Å–∫—É–ª—è—Ä–Ω–æ–π –í–ú–î (–Ω–í–ú–î) —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –¥–∏–∞–±–µ—Ç–æ–º —Å—Ç–∞—Ä—à–µ 66 –ª–µ—Ç. –ü–æ–¥—Ä–æ–±–Ω–æ—Å—Ç–∏ –æ–± –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–∏: ‚óæÔ∏è–ö–∞–Ω–∞–¥–∞, 2020-2023 ‚óæÔ∏è139 002 –ø–∞—Ü–∏–µ–Ω—Ç–∞ —Å –¥–∏–∞–±–µ—Ç–æ–º ‚â•66 –ª–µ—Ç ‚óæÔ∏è46 334 –ø–æ–ª—É—á–∞–ª–∏ GLP-1 RA ‚â•6 –º–µ—Å ‚óæÔ∏è–ß–∞—Å—Ç–æ—Ç–∞ –Ω–í–ú–î –±—ã–ª–∞ –≤—ã—à–µ —É —ç—Ç–æ–π –≥—Ä—É–ø–ø—ã: ‚óæÔ∏èHR 2.21 (95% CI: 1.65-2.96), —Ç–æ –µ—Å—Ç—å —Ä–∏—Å–∫ –±–æ–ª–µ–µ —á–µ–º –≤ 2 —Ä–∞–∑–∞ –≤—ã—à–µ ‚óæÔ∏è–ü—Ä–∏ –¥–ª–∏—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –ª–µ—á–µ–Ω–∏—è –±–æ–ª–µ–µ 30 –º–µ—Å—è—Ü–µ–≤: —Ä–∏—Å–∫ –≤ 3,6 —Ä–∞–∑–∞ –≤—ã—à–µ (HR 3.62) ‚óæÔ∏è–î–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–µ —Ñ–∞–∫—Ç–æ—Ä—ã —Ä–∏—Å–∫–∞: –ø–æ–∂–∏–ª–æ–π –≤–æ–∑—Ä–∞—Å—Ç, –∞–Ω–∞–º–Ω–µ–∑ –∏–Ω—Å—É–ª—å—Ç–∞ üìå –£–∂–µ –≤ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è—Ö SUSTAIN-6 –∏ PIONEER-6 —Å–æ–æ–±—â–∞–ª–æ—Å—å –æ–± –æ—Å–ª–æ–∂–Ω–µ–Ω–∏—è—Ö –¥–∏–∞–±–µ—Ç–∏—á–µ—Å–∫–æ–π —Ä–µ—Ç–∏–Ω–æ–ø–∞—Ç–∏–∏ –ø—Ä–∏ –ø—Ä–∏—ë–º–µ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞. –ù–æ–≤—ã–µ –¥–∞–Ω–Ω—ã–µ –¥–æ–±–∞–≤–ª—è—é—Ç —Å–µ—Ä—å—ë–∑–Ω—ã–π —Å–∏–≥–Ω–∞–ª –ø–æ –Ω–í–ú–î. –ß—Ç–æ —ç—Ç–æ –∑–Ω–∞—á–∏—Ç –¥–ª—è –ø—Ä–∞–∫—Ç–∏–∫–∏: –ü–∞—Ü–∏–µ–Ω—Ç –Ω–∞ GLP-1 RA, –æ—Å–æ–±–µ–Ω–Ω–æ –ø–æ–∂–∏–ª–æ–π –∏ —Å —Å–æ–ø—É—Ç—Å—Ç–≤—É—é—â–∏–º–∏ —Å–æ—Å—É–¥–∏—Å—Ç—ã–º–∏ —Ñ–∞–∫—Ç–æ—Ä–∞–º–∏, –¥–æ–ª–∂–µ–Ω –Ω–∞—Ö–æ–¥–∏—Ç—å—Å—è –ø–æ–¥ —Ä–µ–≥—É–ª—è—Ä–Ω—ã–º –æ—Ñ—Ç–∞–ª—å–º–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–º –Ω–∞–±–ª—é–¥–µ–Ω–∏–µ–º ‚Äì –¥–∞–∂–µ –±–µ–∑ –∂–∞–ª–æ–± –Ω–∞ –∑—Ä–µ–Ω–∏–µ. ü§ù –≠–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥ + –æ—Ñ—Ç–∞–ª—å–º–æ–ª–æ–≥ = –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ–µ –≤–∑–∞–∏–º–æ–¥–µ–π—Å—Ç–≤–∏–µ –≤ —Å—Ç—Ä–∞—Ç–µ–≥–∏–∏ –≤–µ–¥–µ–Ω–∏—è —Ç–∞–∫–∏—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety"",
  ""impact"": ""high"",
  ""english"": ""The publication in JAMA Ophthalmology (June 2025) indicates that semaglutide (Ozempic, Wegovy) doubles the risk of neovascular age-related macular degeneration (nAMD) in elderly patients with diabetes. The study found that the risk of nAMD was 2.2 times higher among patients over 66 years old who have been on GLP-1 RA for more than 6 months. The risk increases to 3.6 times higher when the treatment duration exceeds 30 months. This is particularly concerning for elderly patients with diabetes, especially those who are older and have a history of stroke. The findings add significant signals regarding the risk of nAMD with GLP-1 RA therapy, and patients on these medications need to be closely monitored by ophthalmologists even without complaints of vision problems. Endocrinologists and ophthalmologists need to collaborate in managing these patients.""
}"
2025-07-14T15:00:49+00:00,@pharm_icon,2294,https://t.me/pharm_icon/2294,"üßê–°–≤–µ—Ä—Ö–Ø LabQuest'–∞ –∑–≤—É—á–∏—Ç –¥–æ–≤–æ–ª—å–Ω–æ –≤–µ—Å–µ–ª–æ. –ú–∞—Ä–∫–µ—Ç–æ–ª–æ–≥–∏ –æ–±—á–∏—Ç–∞–ª–∏—Å—å –∫–Ω–∏–≥ –ø–æ –ø—Å–∏—Ö–æ–ª–æ–≥–∏–∏ - –∞ –º–æ–∂–µ—Ç –∏ –Ω–µ —Ç–æ–ª—å–∫–æ - –∏ –Ω–∞—á–∏–Ω–∞—é—Ç –∑–∞—Ö–æ–¥–∏—Ç—å —Å –ø—Ä–∏–≤—ã—á–Ω—ã—Ö —Å—Ç–æ—Ä–æ–Ω –Ω–∞ —Ñ—Ä–∞–Ω—à–∏–∑—ã. –Ø –∂–µ –¥—É–º–∞—é, —á—Ç–æ —ç—Ç–æ –±—É–¥–µ—Ç –Ω–∏—Ü—à–µ–∞–Ω—Å–∫–∏–π –ø—Ä–æ–µ–∫—Ç —Å–æ —Å–ª–µ–¥—É—é—â–∏–º–∏ –∞–∫—Ç–∏–≤–Ω–æ—Å—Ç—è–º–∏: 1. –õ–∞–±–æ—Ä–∞—Ç–æ—Ä–Ω—ã–π –∫—É—Ä—Å ""–°—Ç–∞–Ω—å –ª—É—á—à–µ"". –í—ã —Å–¥–∞–µ—Ç–µ –∞–Ω–∞–ª–∏–∑—ã –∏ –ø–æ—Å—Ç–æ—è–Ω–Ω–æ –ø–ª–∞—Ç–∏—Ç–µ, –ø–æ–∫–∞ –í–°–ï –ø–æ–∫–∞–∑–∞—Ç–µ–ª–∏ –Ω–µ —Å—Ç–∞–Ω—É—Ç –ª—É—á—à–µ. 2. –ß–µ–∫–∞–ø ""–£–º—Ä–∏ –∏ —Å—Ç–∞–Ω—å!"" - –≤–∞—Å –∑–∞—Å—Ç–∞–≤–ª—è—é—Ç —É–ø–∞—Ö–∞—Ç—å—Å—è –≤ —Å–ø–æ—Ä—Ç–∑–∞–ª–µ –∏ –Ω–∞ –ø–∏–∫–µ –∏–∑–º–æ—Ç–∞–Ω–Ω–æ—Å—Ç–∏ –±–µ—Ä—É—Ç –∞–Ω–∞–ª–∏–∑—ã –∫—Ä–æ–≤–∏. –ü—Ä–æ—Å—Ç–æ —Ç–∞–∫, —á—Ç–æ–±—ã –ø–æ–∫–∞–∑–∞—Ç—å, –∫–∞–∫–æ–µ –≤—ã –Ω–∏—á—Ç–æ–∂–µ—Å—Ç–≤–æ. 3. –ú–æ—è –±–æ—Ä—å–±–∞ —Å –±–æ–ª–µ–∑–Ω—è–º–∏ - —á–µ–∫–∞–ø —Å –≥–µ–Ω–µ—Ç–∏—á–µ—Å–∫–∏–º —Ç–µ—Å—Ç–∏—Ä–æ–≤–∞–Ω–∏–µ–º, –∫–æ—Ç–æ—Ä–æ–µ –ø–æ–∫–∞–∂–µ—Ç –≤–∞—à—É –Ω–µ–º–∏–Ω—É–µ–º—É—é —Å–º–µ—Ä—Ç—å –∏ –∑–∞—Å—Ç–∞–≤–∏—Ç—å –∏—Å–ø—ã—Ç–∞—Ç—å —É–∂–∞—Å, –∫–æ—Ç–æ—Ä—ã–π —Å–¥–µ–ª–∞–µ—Ç –≤–∞—Å —á–µ–ª–æ–≤–µ–∫–æ–º. –ß—Ç–æ –¥—É–º–∞–µ—Ç–µ? ‚ù§ - —Ç–∞–∫ –∏ –±—É–¥–µ—Ç üòê - –±—É–¥–µ—Ç –ø–æ –§—Ä–µ–π–¥—É, —Å–µ–º–µ–π–Ω—ã–π —á–µ–∫–∞–ø ""–≠–¥–∏–ø"" —É–∂–µ –≤ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ","{""skip"": true}"
2025-07-14T11:41:24+00:00,@pharm_icon,2293,https://t.me/pharm_icon/2293,"üëç–°—Ç–∞—Ç–∏–Ω—ã –∏ —ç—Ä–µ–∫—Ü–∏—è: –≥—Ä—è–¥—ë—Ç –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ, –∫–æ—Ç–æ—Ä–æ–µ –ø–æ–ø—ã—Ç–∞–µ—Ç—Å—è –æ–±–æ—Å–Ω–æ–≤–∞—Ç—å –ø–æ–ª—å–∑—É —Å—Ç–∞—Ç–∏–Ω–æ–≤ –∏–ª–∏ –Ω–µ—Ç? –í –Ω–æ–≤–æ–º –≤—ã–ø—É—Å–∫–µ –†–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–π —Ñ–∞—Ä–º–∞–∫–æ—Ç–µ—Ä–∞–ø–∏–∏ –≤ –∫–∞—Ä–¥–∏–æ–ª–æ–≥–∏–∏ –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω –ø—Ä–æ—Ç–æ–∫–æ–ª —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–µ–≥–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è. –ò—Å—Å–ª–µ–¥—É–µ–º—ã–π —Å—Ç–∞—Ç–∏–Ω: –ü–∏—Ç–∞–≤–∞—Å—Ç–∞—Ç–∏–Ω, —Ä–æ–∑—É–≤–∞—Å—Ç–∞—Ç–∏–Ω –û–ø–∏—Å–∞–Ω–∏–µ –¥–∏–∑–∞–π–Ω–∞, –∫–æ—Ä–æ—Ç–∫–æ–µ: –í I –≥—Ä—É–ø–ø–µ (n=75) –ø–∞—Ü–∏–µ–Ω—Ç—ã –±—É–¥—É—Ç –ø–æ–ª—É—á–∞—Ç—å –ø–∏—Ç–∞–≤–∞—Å—Ç–∞—Ç–∏–Ω –≤ —Å—Ç–∞—Ä—Ç–æ–≤–æ–π –¥–æ–∑–µ 1 –º–≥/—Å—É—Ç., –≤–æ II –≥—Ä—É–ø–ø–µ (n=75) ‚Äî —Ä–æ–∑—É–≤–∞—Å—Ç–∞—Ç–∏–Ω 20 –º–≥/—Å—É—Ç. –ß–µ—Ä–µ–∑ 3 –º–µ—Å. –∑–∞–ø–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω –∫–æ–Ω—Ç—Ä–æ–ª—å –±–∏–æ—Ö–∏–º–∏—á–µ—Å–∫–∏—Ö –ø–∞—Ä–∞–º–µ—Ç—Ä–æ–≤, –ø—Ä–∏ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ —Ç–∏—Ç—Ä–∞—Ü–∏—è –¥–æ–∑—ã –ø–∏—Ç–∞–≤–∞—Å—Ç–∞—Ç–∏–Ω–∞ –¥–æ 2-4 –º–≥/—Å—É—Ç. –∏/–∏–ª–∏ —Ä–æ–∑—É–≤–∞—Å—Ç–∞—Ç–∏–Ω–∞ –¥–æ 40 –º–≥/—Å—É—Ç. –ü—Ä–µ–¥–ø–æ–ª–∞–≥–∞–µ–º—ã–π —Ä–µ–∑—É–ª—å—Ç–∞—Ç –ø—Ä–æ–≤–µ—Ä–∫–∏ –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª—å—Å–∫–æ–π –≥–∏–ø–æ—Ç–µ–∑—ã: 1) —Å—Ç–∞—Ç–∏–Ω–æ—Ç–µ—Ä–∞–ø–∏—è –Ω–µ –±—É–¥–µ—Ç –æ–∫–∞–∑—ã–≤–∞—Ç—å –Ω–µ–≥–∞—Ç–∏–≤–Ω–æ–≥–æ –≤–ª–∏—è–Ω–∏—è –Ω–∞ –∞–Ω–¥—Ä–æ–≥–µ–Ω–Ω—ã–π —Å—Ç–∞—Ç—É—Å –∏ –≠–§ —É –º—É–∂—á–∏–Ω. 2) –ò–Ω—Ç–µ–Ω—Å–∏–≤–Ω–∞—è —Å—Ç–∞—Ç–∏–Ω–æ—Ç–µ—Ä–∞–ø–∏—è –±—É–¥–µ—Ç –æ–∫–∞–∑—ã–≤–∞—Ç—å –±–æ–ª—å—à–µ–µ –ø–æ–ª–æ–∂–∏—Ç–µ–ª—å–Ω–æ–µ –≤–ª–∏—è–Ω–∏–µ –Ω–∞ —ç–Ω–¥–æ—Ç–µ–ª–∏–∞–ª—å–Ω—É—é —Ñ—É–Ω–∫—Ü–∏—é, —á—Ç–æ –º–æ–∂–µ—Ç –ø—Ä–∏–≤–µ—Å—Ç–∏ –∫ —É–ª—É—á—à–µ–Ω–∏—é –≠–§ –º—É–∂—á–∏–Ω. –ú–∏–Ω—É—Å –¥–∏–∑–∞–π–Ω–∞: –Ω–µ—Ç –∫–æ–Ω—Ç—Ä–æ–ª—å–Ω–æ–π –≥—Ä—É–ø–ø—ã –±–µ–∑ —Å—Ç–∞—Ç–∏–Ω–æ–≤, —Ç–æ –µ—Å—Ç—å –ø—Ä–æ–≤–µ—Ä–∫–∞ –≥–∏–ø–æ—Ç–µ–∑—ã –Ω–µ–¥–æ—Å—Ç–∏–∂–∏–º–∞, –ø–æ—Ç–æ–º—É —á—Ç–æ –Ω–µ–ª—å–∑—è —Å—Ä–∞–≤–Ω–∏—Ç—å —Å –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–µ–º —Å—Ç–∞—Ç–∏–Ω–æ—Ç–µ—Ä–∞–ø–∏–∏üò¨ –ò–Ω—Ç–µ—Ä–µ—Å–Ω–æ, —á—Ç–æ –≤ –º–µ—Ç–∞-–∞–Ω–∞–ª–∏–∑–∞—Ö, –∫–æ—Ç–æ—Ä—ã–µ –ø—Ä–∏–≤–µ–ª–∏ –∞–≤—Ç–æ—Ä—ã, –∫–∞–∫ —Ä–∞–∑ –æ—Ç–º–µ—á–∞–µ—Ç—Å—è –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–µ –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å—Å—Ç–≤ –∫–∞–∫ —Ä–∞–∑ –≤ —Å—Ä–∞–≤–Ω–µ–Ω–∏–∏ —Å—Ç–∞—Ç–∏–Ω—ã vs –ø–ª–∞—Ü–µ–±–æ. –ü–æ–¥–ª–∏–Ω–Ω—ã–π –∏–Ω—Ç–µ—Ä–µ—Å –∫ —ç—Ç–æ–π –ø—É–±–ª–∏–∫–∞—Ü–∏–∏: –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ –æ–±—ä–µ–∫—Ç–∏–≤–Ω–æ–π –æ—Ü–µ–Ω–∫–∏ –∫–æ–Ω–µ—á–Ω–æ–π —Ç–æ—á–∫–∏ —Å –ø–æ–º–æ—â—å—é —É—Å—Ç—Ä–æ–π—Å—Ç–≤–∞ –ê–Ω–¥—Ä–æ—Å–∫–∞–Ω –ú–ò–¢, –∫–æ—Ç–æ—Ä–æ–µ –±—É–¥–µ—Ç –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å—Å—è –≤ —Ä–∞–º–∫–∞—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è. –ú–æ–∂–µ—Ç–µ –ø–æ—Å–º–æ—Ç—Ä–µ—Ç—å, —á—Ç–æ –ø—Ä–µ–¥—Å—Ç–∞–≤–ª—è–µ—Ç –∏–∑ —Å–µ–±—è —ç—Ç–æ —Ä–µ—à–µ–Ω–∏–µ –Ω–∞ —É–∂–∞—Å–Ω–æ–º —Å–∞–π—Ç–µ. –ù–µ—Å–º–æ—Ç—Ä—è –Ω–∞ –∫–∞—á–µ—Å—Ç–≤–æ —Å–∞–π—Ç–∞, –∏–º–µ–Ω–Ω–æ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ –ø—Ä–∏–±–æ—Ä–∞ –¥–ª—è –æ–±—ä–µ–∫—Ç–∏–≤–∏–∑–∞—Ü–∏–∏ —ç—Ä–µ–∫—Ç–∏–ª—å–Ω–æ–π —Ñ—É–Ω–∫—Ü–∏–∏ –Ω–µ—Å—ë—Ç —Ü–µ–Ω–Ω–æ—Å—Ç—å. –û—Å—Ç–∞–ª—å–Ω–æ–µ ‚Äî so-so, –ø–æ–ª—É—á–∏–º –æ—Ç–≤–µ—Ç –Ω–∞ –≤–æ–ø—Ä–æ—Å —á—Ç–æ –ª—É—á—à–µ/—Ö—É–∂–µ ‚Äî —Å—Ä–µ–¥–Ω–µ–≤—ã—Å–æ–∫–∏–µ –∏–ª–∏ –Ω–∏–∑–∫–∏–µ –¥–æ–∑—ã —Å—Ç–∞—Ç–∏–Ω–æ–≤. –°—Å—ã–ª–æ—á–∫–∞: DOI:10.20996/1819-6446-2025-3145","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""A clinical trial is being conducted to assess the impact of statins (pitavastatin and rosuvastatin) on male sexual function. The study design involves two groups: one receiving a starting dose of 1 mg/day of pitavastatin and the other 20 mg/day of rosuvastatin. The study aims to evaluate whether statin therapy affects androgen status and erectile function, with a focus on the use of an objective endpoint measurement device (AndroScan-MIT). The study is described as 'so-so' in quality, but the use of this device for objective measurement of erectile function is seen as valuable.""
}"
2025-07-08T14:33:39+00:00,@pharm_icon,2292,https://t.me/pharm_icon/2292,"‚ö°Ô∏è–ì–æ—Å–¥—É–º–∞ –æ–¥–æ–±—Ä–∏–ª–∞ –∑–∞–∫–æ–Ω –æ –ø–µ—Ä–µ—á–Ω–µ —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ ‚Äî –°–ó–õ–°. –û—á–µ–Ω—å –∏–Ω—Ç–µ—Ä–µ—Å–Ω–æ, —á—Ç–æ –≤–æ–π–¥—ë—Ç –≤ —ç—Ç–æ—Ç —Å–ø–∏—Å–æ–∫, –∫—Ä–æ–º–µ –≥–ª–∏—Ü–∏–Ω–∞, –æ—Ü–∏–ª–æ–∫–æ–∫–∫—Ü–∏–Ω—É–º–∞, –≤–∞–ª–µ—Ä—å—è–Ω–∫–∏, —Ü–∏—Ç—Ä–∞–º–æ–Ω–∞, —Ç–µ—Å—Ç–∞ –Ω–∞ –±–µ—Ä–µ–º–µ–Ω–Ω–æ—Å—Ç—å –∏ –Ω–∞—Å—Ç–æ–π–∫–∏ –±–æ—è—Ä—ã—à–Ω–∏–∫–∞","{
  ""skip"": false,
  ""country"": ""regional"",
  ""topic"": ""tenders, regulation"",
  ""impact"": ""medium"",
  ""english"": ""The State Duma approved a law on the list of strategically important medicines - SLS. Very interesting, what will be included in this list apart from glycine, oscillococcinum, valerian, citronella, pregnancy test and borage root tincture.""
}"
2025-07-08T13:55:45+00:00,@pharm_icon,2291,https://t.me/pharm_icon/2291,"AI-—è–π, –Ω–∞—Ü–ø—Ä–æ–µ–∫—Ç—ã –ì–æ–≤–æ—Ä—è—Ç, –≤–ª–∞—Å—Ç–∏ –Ω–∞—á–Ω—É—Ç –º–æ–Ω–∏—Ç–æ—Ä–∏—Ç—å —Ä–µ–∞–ª–∏–∑–∞—Ü–∏—é –Ω–∞—Ü–ø—Ä–æ–µ–∫—Ç–æ–≤ —Å –ø–æ–º–æ—â—å—é –ò–ò –¢–∞–∫–æ–≤–∞ –Ω–æ–≤–æ—Å—Ç—å –æ—Ç Vademecum. –í–∏—Ü–µ-–ø—Ä–µ–º—å–µ—Ä –†–§ –î–º–∏—Ç—Ä–∏–π –ì—Ä–∏–≥–æ—Ä–µ–Ω–∫–æ —É—Ç–≤–µ—Ä–¥–∏–ª –í—Ä–µ–º–µ–Ω–Ω—ã–π –ø–æ—Ä—è–¥–æ–∫ —É–ø—Ä–∞–≤–ª–µ–Ω–∏—è –∏ –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥–∞ –µ–¥–∏–Ω–æ–≥–æ –ø–ª–∞–Ω–∞ –ø–æ –¥–æ—Å—Ç–∏–∂–µ–Ω–∏—é —Ü–µ–ª–µ–π –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ —Ä–∞–∑–≤–∏—Ç–∏—è –†–æ—Å—Å–∏–∏ –Ω–∞ –ø–µ—Ä–∏–æ–¥ –¥–æ 2030 –≥–æ–¥–∞ –∏ –Ω–∞ –ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤—É –¥–æ 2036 –≥–æ–¥–∞. –ö–æ–Ω–µ—á–Ω–æ, –Ω–∞–¥–æ –æ—á–µ–Ω—å –≤–Ω–∏–º–∞—Ç–µ–ª—å–Ω–æ —á–∏—Ç–∞—Ç—å —ç—Ç–∏ —Ñ–æ—Ä–º—É–ª–∏—Ä–æ–≤–∫–∏, —á—Ç–æ–±—ã –ø–æ–Ω—è—Ç—å –æ —á—ë–º —Ä–µ—á—å. –ö–∞–∫ –≤—Å–µ–≥–¥–∞ —Å–ø–∞—Å–∏–±–æ –∑–∞ —á–µ—Ç–∫–∏–µ —Ñ–æ—Ä–º—É–ª–∏—Ä–æ–≤–∫–∏ –¥–ª—è –¥–æ—Å—Ç–∏–∂–µ–Ω–∏—è —á–µ—Ç–∫–æ–≥–æ –ø–æ–Ω–∏–º–∞–Ω–∏—è –ø–ª–∞–Ω–æ–≤ –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥–∞...–Ω—É –≤—ã –ø–æ–Ω—è–ª–∏ –ö–æ–Ω—Ç—Ä–æ–ª—å –∑–∞ –ø–ª–∞–Ω–æ–º –±—É–¥–µ—Ç –æ—Å—É—â–µ—Å—Ç–≤–ª—è—Ç—å—Å—è —Å –ø–æ–º–æ—â—å—é —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω–æ–π —Ü–∏—Ñ—Ä–æ–≤–æ–π —Å–∏—Å—Ç–µ–º—ã —Å –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–∞ (–ò–ò). –ü–æ —Å–ª–æ–≤–∞–º –ì—Ä–∏–≥–æ—Ä–µ–Ω–∫–æ, —ç—Ç–æ –ø–æ–∑–≤–æ–ª–∏—Ç —Å–ª–µ–¥–∏—Ç—å –∑–∞ —Å–≤–æ–µ–≤—Ä–µ–º–µ–Ω–Ω—ã–º —Å—Ç—Ä–æ–∏—Ç–µ–ª—å—Å—Ç–≤–æ–º –∫–ª–∏–Ω–∏–∫ –∏ ¬´–Ω–µ —Ä–µ—à–∞—Ç—å –ø—Ä–æ–±–ª–µ–º—ã, –∫–æ–≥–¥–∞ –æ–Ω–∏ —É–∂–µ –ø—Ä–æ–∏–∑–æ—à–ª–∏, –∞ –ø—Ä–µ–¥–æ—Ç–≤—Ä–∞—â–∞—Ç—å –∏—Ö –Ω–∞—Å—Ç—É–ø–ª–µ–Ω–∏–µ¬ª. –ê –ª—É—á—à–µ –±—ã –ò–ò –ø–∏—Å–∞–ª —Å–∞–º–∏ —Ç–µ–∫—Å—Ç—ã –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω—ã—Ö –ø—Ä–æ–µ–∫—Ç–æ–≤ —Ç–∞–∫–∏–º –æ–±—Ä–∞–∑–æ–º, —á—Ç–æ–±—ã –æ–Ω–∏ –±—ã–ª–∏ —Ä–µ–∞–ª–∏–∑—É–µ–º—ã–º–∏. –í–æ–∑—å–º–∏—Ç–µ [—Ç—É—Ç –º–æ–≥–ª–∞ –±—ã—Ç—å —Ä–µ–∫–ª–∞–º–∞ –≤–∞—à–µ–≥–æ –ò–ò –ø—Ä–æ–¥—É–∫—Ç–∞], –¥–∞–π—Ç–µ –µ–º—É –Ω–∞ –≤—Ö–æ–¥ —Ü–∏—Ñ—Ä—ã, –∫–æ—Ç–æ—Ä—ã–µ –µ—Å—Ç—å —Å–µ–π—á–∞—Å, –∞ –æ–Ω –≤–∞–º –≤—ã–¥–∞—Å—Ç —Ä–µ–∞–ª–∏–∑—É–µ–º—ã–π –ø–ª–∞–Ω. –í–æ—Ç —Å–∞–º–∏ –ø—Ä–æ—á–∏—Ç–∞–π—Ç–µ: –ö 2030 –≥–æ–¥—É –∑–∞–ø–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω–æ –¥–æ—Å—Ç–∏–∂–µ–Ω–∏–µ –æ–∂–∏–¥–∞–µ–º–æ–π –ø—Ä–æ–¥–æ–ª–∂–∏—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –∂–∏–∑–Ω–∏ –¥–æ 78 –ª–µ—Ç, –ø–æ–≤—ã—à–µ–Ω–∏–µ —á–∏—Å–ª–∞ –ª—é–¥–µ–π —Å –ë–°–ö, –ø—Ä–æ–∂–∏–≤—à–∏—Ö –ø—Ä–µ–¥—ã–¥—É—â–∏–π –≥–æ–¥ –±–µ–∑ –æ—Å—Ç—Ä—ã—Ö —Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö —Å–æ–±—ã—Ç–∏–π, —Å 4% –¥–æ 10%, —Å–æ–∑–¥–∞–Ω–∏–µ –æ–±—ä–µ–∫—Ç–æ–≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è ‚Äì —É–≤–µ–ª–∏—á–µ–Ω–∏–µ —Å 1,1 —Ç—ã—Å—è—á–∏ –¥–æ 4,4 —Ç—ã—Å—è—á–∏ –µ–¥–∏–Ω–∏—Ü –Ø –¥—É–º–∞—é, —á—Ç–æ —ç—Ç–æ –≤–æ–∑–º–æ–∂–Ω–æ, –µ—Å–ª–∏: –®–∞–≥ 1. —Ç—É–¥–∞ –¥–æ–±–∞–≤–∏—Ç—å –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–∏–µ ""–£–ø—Ä–∞–≤–ª–µ–Ω—á–µ—Å–∫–∏—Ö —ç–ª–∏—Ç"". –ö 2030 –≥–æ–¥—É –∑–∞–ø–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω–æ –¥–æ—Å—Ç–∏–∂–µ–Ω–∏–µ –æ–∂–∏–¥–∞–µ–º–æ–π –ø—Ä–æ–¥–æ–ª–∂–∏—Ç–µ–ª—å–Ω–æ—Å—Ç–∏ –∂–∏–∑–Ω–∏ —É–ø—Ä–∞–≤–ª–µ–Ω—á–µ—Å–∫–∏—Ö —ç–ª–∏—Ç –¥–æ 78 –ª–µ—Ç –°–æ–≤—Å–µ–º –¥—Ä—É–≥–æ–µ –¥–µ–ª–æ. –®–∞–≥ 2. –£–∫–∞–∑–∞—Ç—å —Ç–æ—á–Ω—É—é –≥—Ä—É–ø–ø—É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –ù–∞–ø—Ä–∏–º–µ—Ä, –≤ –≤–æ–∑—Ä–∞—Å—Ç–µ 30-40 –ª–µ—Ç. –ø–æ–≤—ã—à–µ–Ω–∏–µ —á–∏—Å–ª–∞ –ª—é–¥–µ–π —Å –ë–°–ö –≤ –≤–æ–∑—Ä–∞—Å—Ç–µ 30-40 –ª–µ—Ç, –ø—Ä–æ–∂–∏–≤—à–∏—Ö –ø—Ä–µ–¥—ã–¥—É—â–∏–π –≥–æ–¥ –±–µ–∑ –æ—Å—Ç—Ä—ã—Ö —Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö —Å–æ–±—ã—Ç–∏–π, —Å 4% –¥–æ 10% –ò–Ω–∞—á–µ –≤–µ–¥—å –∑–∞–∏–≥—Ä–∞–ª–æ! –®–∞–≥ 3. –û–ø—Ä–µ–¥–µ–ª–∏—Ç—å –æ–±—ä–µ–∫—Ç –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∏ –¥–∞—Ç—å –µ–º—É —Ö–∞—Ä–∞–∫—Ç–µ—Ä–∏—Å—Ç–∏–∫—É. –ù–∞–ø—Ä–∏–º–µ—Ä, 2—Ö2 –º–µ—Ç—Ä–∞. —Å–æ–∑–¥–∞–Ω–∏–µ –æ–±—ä–µ–∫—Ç–æ–≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è 2—Ö2 –º–µ—Ç—Ä–∞ ‚Äì —É–≤–µ–ª–∏—á–µ–Ω–∏–µ —Å 1,1 —Ç—ã—Å—è—á–∏ –¥–æ 4,4 —Ç—ã—Å—è—á–∏ –µ–¥–∏–Ω–∏—Ü –°–æ–≥–ª–∞—Å–∏—Ç–µ—Å—å, –ª—É—á—à–µ —Å—Ç–∞–≤–∏—Ç—å –∞–º–±–∏—Ü–∏–æ–∑–Ω—ã–µ –∏ —Ä–µ–∞–ª–∏—Å—Ç–∏—á–Ω—ã–µ –∑–∞–¥–∞—á–∏, —á–µ–º –∫–∞–∫ —Å–µ–π—á–∞—Å","{""skip"": true}"
2025-07-08T11:34:45+00:00,@pharm_icon,2290,https://t.me/pharm_icon/2290,"‚ö°Ô∏è–ò–Ω—Å—É–ª–∏–Ω —Ä–∞–∑ –≤ –º–µ—Å—è—Ü –ö—É–¥–∞ –±–æ–ª–µ–µ —Ü–µ–Ω–Ω–∞—è –Ω–æ–≤–æ—Å—Ç—å, –Ω–µ–∂–µ–ª–∏ –ø—Ä–µ–¥—ã–¥—É—â–∞—è, –ø—Ä–∏—à–ª–∞ –∫ –Ω–∞–º –∏–∑ NEJM –æ—Ç –¥–æ–∫—Ç–æ—Ä–∞ –•—É–ª–∏–æ –†–æ–∑–µ–Ω—Å—Ç–æ–∫–∞ –∏ –µ–≥–æ –∫–æ–º–∞–Ω–¥—ã. –ò—Å—Å–ª–µ–¥–æ–≤–∞–ª—Å—è –Ω–æ–≤—ã–π –∏–Ω—Å—É–ª–∏–Ω ‚Äî —ç—Ñ—Å–∏—Ç–æ—Ä–∞ –æ—Ç –≠–ª–∞–π –õ–∏–ª–ª–∏ ‚Äî –∏ –ø–æ–∫–∞–∑–∞–ª –æ—á–µ–Ω—å –∏–Ω—Ç–µ—Ä–µ—Å–Ω—ã–π —Ä–µ–∑—É–ª—å—Ç–∞—Ç –í —Ö–æ–¥–µ 52-–Ω–µ–¥–µ–ª—å–Ω–æ–≥–æ –æ—Ç–∫—Ä—ã—Ç–æ–≥–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è treat-to-target —Ñ–∞–∑—ã 3 —Å —Ü–µ–ª—å—é –¥–æ—Å—Ç–∏–∂–µ–Ω–∏—è —Ü–µ–ª–∏ —Å —É—á–∞—Å—Ç–∏–µ–º –≤–∑—Ä–æ—Å–ª—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –¥–∏–∞–±–µ—Ç–æ–º 2 —Ç–∏–ø–∞ Treat-to-target trial (T2T) ‚Äî —ç—Ç–æ –º–µ—Ç–æ–¥–∏–∫–∞ –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–≥–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è, –ø—Ä–∏ –∫–æ—Ç–æ—Ä–æ–π –ª–µ—á–µ–Ω–∏–µ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–æ –Ω–∞ –¥–æ—Å—Ç–∏–∂–µ–Ω–∏–µ –∫–æ–Ω–∫—Ä–µ—Ç–Ω–æ–π –∑–∞—Ä–∞–Ω–µ–µ –æ–ø—Ä–µ–¥–µ–ª—ë–Ω–Ω–æ–π —Ü–µ–ª–∏ (target). –ü—Ä–∏–Ω—Ü–∏–ø: –≤ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–∏ —Ç–∞–∫–æ–≥–æ —Ç–∏–ø–∞ –¥–æ–ø—É—Å–∫–∞–µ—Ç—Å—è –∫–æ—Ä—Ä–µ–∫—Ç–∏—Ä–æ–≤–∫–∞ —Ç–µ—Ä–∞–ø–∏–∏ –∏ –º–æ–Ω–∏—Ç–æ—Ä–∏–Ω–≥. –í—Å–µ–≥–æ —Ä–∞–Ω–¥–æ–º–∏–∑–∞—Ü–∏–∏ –ø–æ–¥–≤–µ—Ä–≥–ª–∏—Å—å 795 —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤. –°—Ä–µ–¥–Ω–∏–π —É—Ä–æ–≤–µ–Ω—å –≥–ª–∏–∫–∏—Ä–æ–≤–∞–Ω–Ω–æ–≥–æ –≥–µ–º–æ–≥–ª–æ–±–∏–Ω–∞ —Å–Ω–∏–∑–∏–ª—Å—è —Å 8,20% –Ω–∞ –∏—Å—Ö–æ–¥–Ω–æ–º —É—Ä–æ–≤–Ω–µ –¥–æ 7,05% –Ω–∞ 52-–π –Ω–µ–¥–µ–ª–µ –ø—Ä–∏ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–∏ –≠—Ñ—Å–∏—Ç–æ—Ä—ã –∏ —Å 8,28% –¥–æ 7,08% –ø—Ä–∏ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–∏ –ì–ª–∞—Ä–≥–∏–Ω–∞. –†–∞–∑–Ω–∏—Ü–∞ –º–µ–∂–¥—É –≥—Ä—É–ø–ø–∞–º–∏: ‚àí0.03% (95% –î–ò –æ—Ç ‚àí0.18 –¥–æ 0.12) –ß–∞—Å—Ç–æ—Ç–∞ –∫–æ–º–±–∏–Ω–∏—Ä–æ–≤–∞–Ω–Ω–æ–π –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º–æ–π –≥–∏–ø–æ–≥–ª–∏–∫–µ–º–∏–∏ (—É—Ä–æ–≤–µ–Ω—å –≥–ª—é–∫–æ–∑—ã <3 –º–º–æ–ª—å/–ª) –∏–ª–∏ —Ç—è–∂—ë–ª–æ–π –≥–∏–ø–æ–≥–ª–∏–∫–µ–º–∏–∏ (—É—Ä–æ–≤–µ–Ω—å 3; —Ç—Ä–µ–±—É—é—â–µ–π –ø–æ—Å—Ç–æ—Ä–æ–Ω–Ω–µ–π –ø–æ–º–æ—â–∏ –¥–ª—è –ª–µ—á–µ–Ω–∏—è) –±—ã–ª–∞ –Ω–∏–∂–µ –ø—Ä–∏ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–∏ —ç—Ñ—Å–∏—Ç–æ—Ä—ã, —á–µ–º –ø—Ä–∏ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–∏ –≥–ª–∞—Ä–≥–∏–Ω–∞ ‚Äî 0,50 —ç–ø–∏–∑–æ–¥–∞ –Ω–∞ —á–µ–ª–æ–≤–µ–∫–∞ –≤ –≥–æ–¥ –ø—Ä–∏ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–∏ —ç—Ñ—Å–∏—Ç–æ—Ä—ã –ø—Ä–æ—Ç–∏–≤ 0,88 –ø—Ä–∏ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–∏ –≥–ª–∞—Ä–≥–∏–Ω–∞ (–æ—Ü–µ–Ω–æ—á–Ω–æ–µ –æ—Ç–Ω–æ—à–µ–Ω–∏–µ —á–∞—Å—Ç–æ—Ç ‚Äî 0,57; 95% –¥–æ–≤–µ—Ä–∏—Ç–µ–ª—å–Ω—ã–π –∏–Ω—Ç–µ—Ä–≤–∞–ª: –æ—Ç 0,39 –¥–æ 0,84). –ù–∞ 52-–π –Ω–µ–¥–µ–ª–µ —Å—Ä–µ–¥–Ω—è—è —Å—É–º–º–∞—Ä–Ω–∞—è –Ω–µ–¥–µ–ª—å–Ω–∞—è –¥–æ–∑–∞ –∏–Ω—Å—É–ª–∏–Ω–∞ —Å–æ—Å—Ç–∞–≤–ª—è–ª–∞ 289,1 –ï–î/–Ω–µ–¥ –ø—Ä–∏ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–∏ —ç—Ñ—Å–∏—Ç–æ—Ä—ã –∏ 332,8 –ï–î/–Ω–µ–¥ –ø—Ä–∏ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–∏ –≥–ª–∞—Ä–≥–∏–Ω–∞ (—Ä–∞–∑–Ω–∏—Ü–∞ –º–µ–∂–¥—É –≥—Ä—É–ø–ø–∞–º–∏ ‚Äî –º–∏–Ω—É—Å 43,7 –ï–î/–Ω–µ–¥; 95% –¥–æ–≤–µ—Ä–∏—Ç–µ–ª—å–Ω—ã–π –∏–Ω—Ç–µ—Ä–≤–∞–ª: –æ—Ç ‚àí62,4 –¥–æ ‚àí25,0). –ú–µ–¥–∏–∞–Ω–Ω–æ–µ —á–∏—Å–ª–æ –∫–æ—Ä—Ä–µ–∫—Ç–∏—Ä–æ–≤–æ–∫ –¥–æ–∑–∏—Ä–æ–≤–∫–∏ —Å–æ—Å—Ç–∞–≤–∏–ª–æ 2 –ø—Ä–∏ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–∏ —ç—Ñ—Å–∏—Ç–æ—Ä—ã –∏ 8 –ø—Ä–∏ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–∏ –≥–ª–∞—Ä–≥–∏–Ω–∞. –ß—Ç–æ –¥—É–º–∞–µ—Ç–µ? ‚ù§Ô∏è ‚Äî –æ—Ç–ª–∏—á–Ω—ã–π —Ä–µ–∑—É–ª—å—Ç–∞—Ç üóø ‚Äî –Ω–µ –≤–ø–µ—á–∞—Ç–ª—è–µ—Ç üî• ‚Äî RWD –ø–æ–∫–∞–∂–µ—Ç –ø—Ä–∞–≤–¥—É, –µ—Å–ª–∏ –º—ã –ø–æ—Å–º–æ—Ç—Ä–∏–º üòê ‚Äî —ç—Ç–æ –±—É–¥–µ—Ç –æ-–æ-–æ-–æ—á–µ–Ω—å –¥–æ—Ä–æ–≥–æ–π –∏–Ω—Å—É–ª–∏–Ω","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, safety"",
  ""impact"": ""high"",
  ""english"": ""A treat-to-target trial published in NEJM by Dr. Julio Rosenstock and his team showed interesting results with Eli Lilly's efletor insulin, which reduced HbA1c levels from 8.20% to 7.05% over 52 weeks, and had a lower frequency of hypoglycemic episodes. However, the cost-effectiveness remains to be seen as it is projected to be expensive.""
}"
2025-07-08T09:55:13+00:00,@pharm_icon,2289,https://t.me/pharm_icon/2289,"‚ö°Ô∏è–ú–∏–Ω–∏—Å—Ç—Ä —Ç—Ä–∞–Ω—Å–ø–æ—Ä—Ç–∞ –∑–∞—Å—Ç—Ä–µ–ª–∏–ª—Å—è. –ö–∞–∫–∏–µ –ø—Ä–æ–≥–Ω–æ–∑—ã –Ω–∞ –ú—É—Ä–∞—à–∫–æ? üòÅ ‚Äî —Ä–∞–∑ –Ω–µ –∑–∞—Å—Ç—Ä–µ–ª–∏–ª—Å—è –≤ –Ω–∞—á–∞–ª–µ –∫–∞—Ä—å–µ—Ä—ã –Ω–∞ –¥–µ–∂—É—Ä—Å—Ç–≤–∞—Ö, —Ç–æ —É–∂–µ –∏ –Ω–µ –∑–∞—Å—Ç—Ä–µ–ª–∏—Ç—Å—è üî• ‚Äî –ú–∏–Ω–∏—Å—Ç—Ä –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –Ω–∏–∫–æ–º—É –Ω–µ –º–µ—à–∞–µ—Ç, —Ç–æ–ª—å–∫–æ –ø–æ–º–æ–≥–∞–µ—Ç üóø ‚Äî –ü—É—Å—Ç—å —Å–Ω–∞—á–∞–ª–∞ –∞–ø—Ç–µ–∫–∏ –ø—Ä–∏—Å—Ç—Ä–æ–∏—Ç –≤ –ú–∏–Ω–∑–¥—Ä–∞–≤, –∞ —Ç–∞–º –±—É–¥—å —á—Ç–æ –±—É–¥–µ—Ç ‚ù§Ô∏è ‚Äî –∂–µ–ª–∞—é –∑–¥–æ—Ä–æ–≤—å—è –ú–ê –ú—É—Ä–∞—à–∫–æ!","{""skip"": true}"
2025-07-02T10:27:05+00:00,@pharm_icon,2285,https://t.me/pharm_icon/2285,"¬´–ú–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è –†–æ—Å—Å–∏—è¬ª –ø—Ä–µ–æ–¥–æ–ª–µ–≤–∞–µ—Ç –¥–∏—Å—Ç–∞–Ω—Ü–∏—é –≤ 120 000 –ø–æ–¥–ø–∏—Å—á–∏–∫–æ–≤! –ü–æ–¥–ø–∏—Å—ã–≤–∞–π—Ç–µ—Å—å –Ω–∞ –Ω–∞—Å: @mediamedics –í —á–µ—Å—Ç—å —Ç–∞–∫–æ–≥–æ —Å–æ–±—ã—Ç–∏—è –ø—É–±–ª–∏–∫—É–µ–º —Ç—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω—ã–π –æ–±–∑–æ—Ä –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∫–∞–Ω–∞–ª–æ–≤: –¢–∞–º–∞–∑ –ì–∞–≥–ª–æ—à–≤–∏–ª–∏: –ø—Ä–∞–∫—Ç–∏–∫—É—é—â–∏–π –∫–∞—Ä–¥–∏–æ–ª–æ–≥ –æ –ø—Ä–æ–±–ª–µ–º–∞—Ö –Ω–∞—à–µ–≥–æ —Å–∞–º–æ–≥–æ –Ω–µ—É—Ç–æ–º–∏–º–æ–≥–æ –æ—Ä–≥–∞–Ω–∞ –ë–∞–¥–º–∞ –ë–∞—à–∞–Ω–∫–∞–µ–≤: —Ö–∏—Ä—É—Ä–≥-–æ–Ω–∫–æ–ª–æ–≥, –ø–µ—Ä–≤—ã–π –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—è –∫–æ–º–∏—Ç–µ—Ç–∞ –ì–æ—Å–¥—É–º—ã –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è, –∑–∞—â–∏—â–∞—é—â–∏–π –ø—Ä–∞–≤–∞ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –∏ –≤—Ä–∞—á–µ–π –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –ë—É—Ä–ª–∞–∫–æ–≤: –≤—Ä–∞—á-–¥–∏–µ—Ç–æ–ª–æ–≥, —Ä–∞–∑–±–∏—Ä–∞–µ—Ç –º–∏—Ñ—ã –æ –ø–∏—Ç–∞–Ω–∏–∏ –∏ –æ–±–æ–∑—Ä–µ–≤–∞–µ—Ç –Ω–æ–≤–æ—Å—Ç–∏ –Ω–∞—É–∫–∏ –Ω–∞ ¬´—á–µ–ª–æ–≤–µ—á–µ—Å–∫–æ–º —è–∑—ã–∫–µ¬ª –í—Ä–∞—á –º–∞–º–∏–Ω–æ–π –ø–æ–¥—Ä—É–≥–∏: –∫–∞–Ω–∞–ª –æ –ù–ï–∫–∞—Ä–∞—Ç–µ–ª—å–Ω–æ–π –≥–∏–Ω–µ–∫–æ–ª–æ–≥–∏–∏, —Å–æ–≤—Ä–µ–º–µ–Ω–Ω–æ–º –ø–æ–¥—Ö–æ–¥–µ, –ª–∏—á–Ω—ã—Ö –Ω–∞–±–ª—é–¥–µ–Ω–∏—è—Ö –∏ –æ –∂–∏–∑–Ω–∏ –≤—Ä–∞—á–∞ –∑–∞ –ø—Ä–µ–¥–µ–ª–∞–º–∏ –±–æ–ª—å–Ω–∏—á–Ω—ã—Ö —Å—Ç–µ–Ω –î–∞–Ω–∏–ª–∞ –ü—ã—Ä–∏–∫–æ–≤: –∞–≤—Ç–æ—Ä —Å–∞–º–æ–≥–æ –∫—Ä—É–ø–Ω–æ–≥–æ –∫–∞–Ω–∞–ª–∞ –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–æ–π –±–æ–ª–µ–∑–Ω—å—é –ø–æ—á–µ–∫ –ò—Ä–∏–Ω–∞ –í–∞—Å–∏–ª—å–µ–≤–∞: –ø—Ä–∞–∫—Ç–∏–∫—É—é—â–∏–π –≤—Ä–∞—á-–∫–∞—Ä–¥–∏–æ–ª–æ–≥, –∫–∞–Ω–¥–∏–¥–∞—Ç –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –Ω–∞—É–∫, –ø—Ä–µ–ø–æ–¥–∞–≤–∞—Ç–µ–ª—å –∫–∞—Ñ–µ–¥—Ä—ã –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –≤—É–∑–∞. –í—Å—ë, —á—Ç–æ –Ω—É–∂–Ω–æ –∑–Ω–∞—Ç—å –æ –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–µ –∏ –ª–µ—á–µ–Ω–∏–∏ —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –ò–≤–∞–Ω –î–∞–≤—ã–¥–æ–≤: –æ–± –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –≤–æ –≤—Å–µ—Ö –µ—ë –ø—Ä–æ—Ç–∏–≤–æ—Ä–µ—á–∏—è—Ö –î–æ–∫—Ç–æ—Ä –ò–æ–ª–∞–Ω—Ç–∞: –Ω–µ–≤—Ä–æ–ª–æ–≥ –Ω–∞—É—á–Ω–æ-–ø–æ–ø—É–ª—è—Ä–Ω–æ ‚Äî –æ –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω–µ –î–º–∏—Ç—Ä–∏–π –ú–æ–ª–æ–¥–æ–π: –ø–µ–¥–∏–∞—Ç—Ä —Å–∫–æ—Ä–æ–π –ø–æ–º–æ—â–∏ ‚Äî –∫–∞–∫ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ –æ–±—â–∞—Ç—å—Å—è —Å —Ä–æ–¥–∏—Ç–µ–ª—è–º–∏ –±–æ–ª—å–Ω–æ–≥–æ —Ä–µ–±–µ–Ω–∫–∞ –°—Ç–∞–Ω–∏—Å–ª–∞–≤ –ê–Ω–¥—Ä–∏—è–Ω–æ–≤: –ø–µ–¥–∏–∞—Ç—Ä ‚Äî –ø—Ä–æ –∑–¥–æ—Ä–æ–≤—å–µ –¥–µ—Ç–µ–π, —Å–ø–æ–∫–æ–π–Ω–æ–µ —Ä–æ–¥–∏—Ç–µ–ª—å—Å—Ç–≤–æ –∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–∏ –≤ —Ü–µ–ª–æ–º –ó–∞–ø–∏—Å–∫–∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∞: —ç–∫—Å-–∑–∞–≤–µ–¥—É—é—â–∞—è –∞–ø—Ç–µ–∫–æ–π ‚Äî –¥–æ—Å—Ç—É–ø–Ω–æ –æ–± —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤ –î–æ–∫—Ç–æ—Ä –í–∞—Ä–Ω–∞–≤—Å–∫–∏–π: –≤—Ä–∞—á ¬´—Å–∫–æ—Ä–æ–π¬ª, –ø—Ä–µ–ø–æ–¥–∞–≤–∞—Ç–µ–ª—å ‚Äî –æ—Ç–∫—Ä–æ–≤–µ–Ω–Ω–æ –æ —Ä–∞–±–æ—á–∏—Ö –±—É–¥–Ω—è—Ö –∏ —Å–∞–º—ã—Ö –Ω–µ–æ–±—ã—á–Ω—ã—Ö –≤—ã–∑–æ–≤–∞—Ö –ï–≤–≥–µ–Ω–∏–π –ù–∏–∫–∏—Ç–∏–Ω: –∫–ª–∏–Ω—Ñ–∞—Ä–º–∞–∫–æ–ª–æ–≥ ‚Äî –æ–± –∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫–∞—Ö –¥–æ—Å—Ç—É–ø–Ω—ã–º —è–∑—ã–∫–æ–º –∏ —Å —é–º–æ—Ä–æ–º –ù—É—Ä–∞—Ö–º–µ–¥ –ö–∞—Ä–∞–µ–≤: —É—Ä–æ–ª–æ–≥–∏—è –±–µ–∑ –º–∏—Ñ–æ–≤. –û –ø—Ä–æ—Å—Ç–∞—Ç–∏—Ç–µ, —Ü–∏—Å—Ç–∏—Ç–µ –∏ —Ç–∞–∑–æ–≤–æ–π –±–æ–ª–∏ ‚Äî –¥–æ—Å—Ç—É–ø–Ω–æ –∏ —Å —É–ø–æ—Ä–æ–º –Ω–∞ –Ω–∞—É—á–Ω–æ –æ–±–æ—Å–Ω–æ–≤–∞–Ω–Ω—É—é –º–µ–¥–∏—Ü–∏–Ω—É –ö—Å–µ–Ω–∏—è –ó–∞–º—è—Ç–∏–Ω–∞: –Ω–∞—É—á–∏—Ç –ø–æ–Ω–∏–º–∞—Ç—å —Å–∞–º—ã–µ —Å–ª–æ–∂–Ω—ã–µ —Ä–µ–Ω—Ç–≥–µ–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–µ —Å–Ω–∏–º–∫–∏, –Ω–µ –±–æ–∏—Ç—Å—è —Ä–∞—Å—Å–∫–∞–∑—ã–≤–∞—Ç—å –æ —Å–≤–æ–∏—Ö –æ—à–∏–±–∫–∞—Ö –î–æ–∫—Ç–æ—Ä –ë–æ—Ä–∏—Å–æ–≤: —Å–∞–º—ã–π –∏–∑–≤–µ—Å—Ç–Ω—ã–π –æ—Ç–æ–Ω–µ–≤—Ä–æ–ª–æ–≥ –Ω–∞ –Æ—Ç—É–±–µ Coroner's word: –æ —Ç–æ–º, –∫–∞–∫ –Ω–µ —É–º–µ—Ä–µ—Ç—å –º–æ–ª–æ–¥—ã–º, –æ —Ä–∞–±–æ—Ç–µ –≤ –º–æ—Ä–≥–µ –∏ –Ω–∞—à–µ–º –æ—Ä–≥–∞–Ω–∏–∑–º–µ –≤ —Ü–µ–ª–æ–º –ü–µ–π —Ç–∞–±–ª–µ—Ç–∫–∏: –æ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞—Ö –∏ –±–æ–ª–µ–∑–Ω—è—Ö –ø—Ä–æ—Å—Ç—ã–º —è–∑—ã–∫–æ–º –∏ —Å –º–µ–º–∞–º–∏, –ø—Ä–æ–µ–∫—Ç MEDIQ –ò–∫–æ–Ω–∞ –§–∞—Ä–º—ã: –æ –∑–∞–¥–æ–∫—É–º–µ–Ω—Ç–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –¥–æ–≥–æ–≤–æ—Ä—ë–Ω–Ω–æ—Å—Ç—è—Ö —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏ Medach: —Å—Ç–∞—Ç—å–∏, —Å–≤–µ–∂–∏–µ –Ω–æ–≤–æ—Å—Ç–∏, –ø–µ—Ä–µ–≤–æ–¥—ã –∏–∑ –≤–µ–¥—É—â–∏—Ö –∏–∑–¥–∞–Ω–∏–π –∏ –ø–æ–¥–∫–∞—Å—Ç—ã —Å —ç–∫—Å–ø–µ—Ä—Ç–∞–º–∏ Ordinatura.org: –∫—Ä—É–ø–Ω–µ–π—à–∏–π –ø–æ—Ä—Ç–∞–ª –æ –∫–∞—á–µ—Å—Ç–≤–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è –∏ –ø–æ—Å–ª–µ–¥–Ω–∏—Ö –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å–Ω—ã—Ö –∏–∑–º–µ–Ω–µ–Ω–∏—è—Ö –≤ –Ω—ë–º –ê–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏—è –≤—Ä–∞—á–µ–π | –û—Ä–¥–∏–Ω–∞—Ç—É—Ä–∞: –æ–± –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–∏, –ø–æ—Å—Ç—É–ø–ª–µ–Ω–∏–∏ –≤ –æ—Ä–¥–∏–Ω–∞—Ç—É—Ä—É –∏ –ø–æ–≤—ã—à–µ–Ω–∏–∏ –∫–≤–∞–ª–∏—Ñ–∏–∫–∞—Ü–∏–∏ –ú–°–≠—à–Ω—ã–π: —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –∏–∑ –ú–°–≠, –∫–æ—Ç–æ—Ä—ã–µ —Ä–∞–∑—ä—è—Å–Ω—è—é—Ç –Ω—é–∞–Ω—Å—ã –ø–æ–ª—É—á–µ–Ω–∏—è –∏–Ω–≤–∞–ª–∏–¥–Ω–æ—Å—Ç–∏ –ú–µ–¥–∫–∞–¥—Ä—ã: –≥–ª–∞–≤–Ω—ã–µ –ø–æ –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω–æ-–ø—Ä–∞–≤–æ–≤—ã–º –∞–∫—Ç–∞–º –≤ —Å—Ñ–µ—Ä–µ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è Medical –ö—Å—é: –∞–≤—Ç–æ—Ä—Å–∫–∏–π –∫–∞–Ω–∞–ª –æ —Ü–∏—Ñ—Ä–æ–≤–∏–∑–∞—Ü–∏–∏ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è. –í—Å–µ, —á—Ç–æ –≤—ã —Ö–æ—Ç–µ–ª–∏ –∑–Ω–∞—Ç—å –æ –ï–ì–ò–°–ó, —Ç–µ–ª–µ–º–µ–¥–∏—Ü–∏–Ω–µ, –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–º –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–µ, —á–∞—Ç-–±–æ—Ç–∞—Ö –ú–µ–¥–≤–µ—Å—Ç–Ω–∏–∫: –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–µ –æ—Å–≤–µ—â–µ–Ω–∏–µ –∏ –∞–Ω–∞–ª–∏–∑ –≥–ª–∞–≤–Ω—ã—Ö –Ω–æ–≤–æ—Å—Ç–µ–π –∏ —Ç—Ä–µ–Ω–¥–æ–≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –Æ—Ä–∏—Å—Ç—ã –∑–∞ –≤—Ä–∞—á–µ–π: –æ –∑–∞—â–∏—Ç–µ –ø—Ä–∞–≤ –≤—Ä–∞—á–µ–π, –≥—Ä–∞–º–æ—Ç–Ω–æ–π –¥–æ–∫—É–º–µ–Ω—Ç–∞—Ü–∏–∏; –µ–∂–µ–Ω–µ–¥–µ–ª—å–Ω—ã–µ –±–µ—Å–ø–ª–∞—Ç–Ω—ã–µ —ç—Ñ–∏—Ä—ã –ö—Ä–æ–∫–æ–¥–∏–ª –Ø—Ç—Ä–æ–≥–µ–Ω–∞: –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—ã –≤ –≤–æ–ø—Ä–æ—Å–∞—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π —é—Ä–∏—Å–¥–∏–∫—Ü–∏–∏, —Å—É–¥–º–µ–¥—ç–∫—Å–ø–µ—Ä—Ç–∏–∑—ã –∏ –≤—Ä–∞—á–µ–±–Ω—ã—Ö –¥–µ–ª –ò–≤–∞–Ω –ü–µ—á–µ—Ä–µ–π: —é—Ä–∏—Å—Ç, –∑–∞—â–∏—â–∞—é—â–∏–π –∏—Å–∫–ª—é—á–∏—Ç–µ–ª—å–Ω–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –§–∞–∫—É–ª—å—Ç–µ—Ç –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –ø—Ä–∞–≤–∞: —é—Ä–∏–¥–∏—á–µ—Å–∫–∞—è –∫–æ–º–ø–∞–Ω–∏—è, —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä—É—é—â–∞—è—Å—è –Ω–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–º –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–º –ø—Ä–∞–≤–µ ‚Äî —Ç—ã—Å—è—á–∏ —Å—É–¥–µ–±–Ω—ã—Ö –¥–µ–ª –∏ —Å–ª–æ–∂–Ω—ã—Ö –∫–µ–π—Å–æ–≤, —Å–æ–ø—Ä–æ–≤–æ–∂–¥–µ–Ω–∏–µ –≤—Ä–∞—á–µ–π, –∫–ª–∏–Ω–∏–∫, —Ä–∞–±–æ—Ç–∞ —Å –∑–∞–∫–æ–Ω–æ–¥–∞—Ç–µ–ª—å—Å—Ç–≤–æ–º –ê–Ω–≥–µ–ª–∏–Ω–∞ –†–æ–º–∞–Ω–æ–≤—Å–∫–∞—è: –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–π —é—Ä–∏—Å—Ç, –∫–æ—Ç–æ—Ä—ã–π –∑–∞—â–∏—â–∞–µ—Ç –≤—Ä–∞—á–µ–π –∏ –∫–ª–∏–Ω–∏–∫–∏ –ü–∞—Ä–∞–≥–Ω–æ–º–µ–Ω: –æ –ø—Å–∏—Ö–∏–∞—Ç—Ä–∏–∏, –Ω–µ–≤—Ä–æ–ª–æ–≥–∏–∏ –∏ –ø—Å–∏—Ö–æ–ª–æ–≥–∏–∏, –º–µ—Å—Ç–∞–º–∏ —Å –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—ã–º —á–µ—Ä–Ω—ã–º —é–º–æ—Ä–æ–º –í–ª–∞–¥–∏–º–∏—Ä –ù–µ—á–µ–ø–æ—Ä—É–∫: –∏–∑–¥–∞–ª –ø–µ—Ä–≤—É—é –≤ –†–æ—Å—Å–∏–∏ –∫–Ω–∏–≥—É –ø—Ä–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–π –±–ª–æ–≥–∏–Ω–≥ –ù–µ–º–µ–¥–∏—Ü–∏–Ω–∞: —É—Ä–æ–ª–æ–≥, –∫–æ—Ç–æ—Ä—ã–π –æ–±–æ–∑—Ä–µ–≤–∞–µ—Ç –∏–Ω—Ç–µ—Ä–µ—Å–Ω—ã–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Å–ª—É—á–∞–∏","{
  ""skip"": true
}"
2025-06-30T12:00:54+00:00,@pharm_icon,2284,https://t.me/pharm_icon/2284,"–î–µ—Ä–µ–≤–µ–Ω—Å–∫–∏–º –º–µ–¥–∏–∫–∞–º ‚Äî +25% –∫ –ø–µ–Ω—Å–∏–∏. –î–µ–ø—É—Ç–∞—Ç—ã –ì–æ—Å–¥—É–º—ã –≤–Ω–µ—Å–ª–∏ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç, –ø—Ä–µ–¥–ø–æ–ª–∞–≥–∞—é—â–∏–π –ø–æ–≤—ã—à–µ–Ω–∏–µ –ø–µ–Ω—Å–∏–∏ —Å–µ–ª—å—Å–∫–∏–º –º–µ–¥–∏–∫–∞–º —Å 2026 –≥–æ–¥–∞ –Ω–∞ 25%. –ù–æ—Ä–º—É –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–æ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–∏—Ç—å –Ω–∞ —Å–æ—Ç—Ä—É–¥–Ω–∏–∫–æ–≤ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏–π, –ø—Ä–æ—Ä–∞–±–æ—Ç–∞–≤—à–∏—Ö –≤ —Å–µ–ª—å—Å–∫–æ–π –º–µ—Å—Ç–Ω–æ—Å—Ç–∏ –∏ –ø–æ—Å–µ–ª–∫–∞—Ö –≥–æ—Ä–æ–¥—Å–∫–æ–≥–æ —Ç–∏–ø–∞ –Ω–µ –º–µ–Ω—å—à–µ 25 –ª–µ—Ç. –ò–Ω—Ç–µ—Ä–µ—Å–Ω—ã–π –ø–æ–¥—Ö–æ–¥, –≤–º–µ—Å—Ç–æ —É–≤–µ–ª–∏—á–µ–Ω–∏—è –∑–∞—Ä–ø–ª–∞—Ç—ã ‚Äî —É–≤–µ–ª–∏—á–∏—Ç—å —Ä–∞–∑–º–µ—Ä ""–ø—Ä—è–Ω–∏–∫–∞"", —Ç–∞–∫ –Ω–∞–∑—ã–≤–∞–µ–º–æ–π –ø–µ–Ω—Å–∏–∏, –Ω–∞ 25%. –í–µ—Ä–∏—Ç–µ –≤ –ø–µ–Ω—Å–∏—é, –∞ —Ç–æ—á–Ω–µ–µ ‚Äî —á—Ç–æ –æ–Ω–∞ –±—É–¥–µ—Ç —É –≤—Ä–∞—á–µ–π –≤–∞—à–µ–≥–æ –ø–æ–∫–æ–ª–µ–Ω–∏—è? üî• ‚Äî –∫–æ–Ω–µ—á–Ω–æ üòÉ ‚Äî —á—Ç–æ-—Ç–æ –Ω–µ –≤–µ—Ä—é ü•≤ ‚Äî –º–µ–Ω—è –±—ã –Ω–µ –¥—Ä–∞–π–≤–∏–ª–æ —É–≤–µ–ª–∏—á–µ–Ω–∏–µ –ø–µ–Ω—Å–∏–∏ –Ω–∞ 25% —Å —É—á–µ—Ç–æ–º –Ω–µ–≤—ã—Å–æ–∫–æ–π –∑–∞—Ä–ø–ª–∞—Ç—ã –≤ —Å–µ–ª—å—Å–∫–æ–π –º–µ—Å—Ç–Ω–æ—Å—Ç–∏ ‚ù§Ô∏è ‚Äî —Ö–æ—Ä–æ—à–æ, —á—Ç–æ —è —Ç–æ–ø-–º–µ–Ω–µ–¥–∂–µ—Ä(–∫–∞)","{""skip"": true}"
2025-06-30T11:41:04+00:00,@pharm_icon,2283,https://t.me/pharm_icon/2283,"–ü—Ä–∏–æ—Ä–∏—Ç–æ—Ä–∏–∑–º ‚Äî –ø—Ä–æ–¥–æ–ª–∂–∞–µ–º –¥—É–º–∞—Ç—å –Ø –ø—Ä–æ–¥–æ–ª–∂–∞—é —Ä–∞–∑–º—ã—à–ª—è—Ç—å –Ω–∞ —Ç–µ–º—É –º–æ–¥–µ–ª–∏ –ø—Ä–∏–Ω—è—Ç–∏—è —Ä–µ—à–µ–Ω–∏—è –≤ –º–µ–¥–∏—Ü–∏–Ω–µ. –í—ã –º–æ–∂–µ—Ç–µ –ø–æ–º–Ω–∏—Ç—å —Ç–µ–∫—Å—Ç –ø—Ä–æ –ø—Ä–∏—á–∏–Ω—ã –ª–µ—á–µ–Ω–∏—è –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –∏ –º–æ–¥–µ–ª—å –ø—Ä–∏–æ—Ä–∏—Ç–∞—Ä–∏–∑–º–∞, –∫–æ—Ç–æ—Ä–∞—è –ø–æ—Å—Ç—É–ª–∏—Ä—É–µ—Ç—Å—è —Å–ª–µ–¥—É—é—â–∏–º –æ–±—Ä–∞–∑–æ–º: 1. ¬´–ü—Ä–∏–Ω–æ—Å–∏—Ç—å –ø–æ–ª—å–∑—É –ª—é–¥—è–º —Ç–µ–º –≤–∞–∂–Ω–µ–µ, —á–µ–º –≤ —Ö—É–¥—à–µ–º –ø–æ–ª–æ–∂–µ–Ω–∏–∏ –æ–Ω–∏ –Ω–∞—Ö–æ–¥—è—Ç—Å—è¬ª 2. ¬´–ü—Ä–∏–Ω–µ—Å–µ–Ω–∏–µ –ø–æ–ª—å–∑—ã –ª—é–¥—è–º –≤ —Ö—É–¥—à–µ–º –ø–æ–ª–æ–∂–µ–Ω–∏–∏ –∏–º–µ–µ—Ç –±–æ–ª—å—à–µ–µ –∑–Ω–∞—á–µ–Ω–∏–µ –ø–æ—Ç–æ–º—É, —á—Ç–æ –æ–Ω–∏ –Ω–∞—Ö–æ–¥—è—Ç—Å—è –Ω–∞ –±–æ–ª–µ–µ –Ω–∏–∑–∫–æ–º –∞–±—Å–æ–ª—é—Ç–Ω–æ–º —É—Ä–æ–≤–Ω–µ –±–ª–∞–≥–æ–ø–æ–ª—É—á–∏—è¬ª –Ø –≤—Å—ë –µ—â—ë —Ä–∞–∑–º—ã—à–ª—è—é –∏ –¥—É–º–∞—é –æ —Ç–æ–º, –∞ –∫–æ–≥–¥–∞ –∑–∞–¥—É–º—ã–≤–∞—Ç—å—Å—è –æ –±–ª–∞–≥–µ –±–æ–ª—å—à–∏–Ω—Å—Ç–≤–∞, –∫–æ—Ç–æ—Ä–æ–µ —Å–æ–∑–¥–∞—ë—Ç —É–≥—Ä–æ–∑—É –æ—Å—Ç–∞–ª—å–Ω—ã–º, –Ω–∞–ø—Ä–∏–º–µ—Ä? –¢–æ –µ—Å—Ç—å, –º–æ–¥–µ–ª–∏—Ä—É–µ–º —Å–∏—Ç—É–∞—Ü–∏—é 1. –ï—Å—Ç—å —ç–ø–∏–¥–µ–º–∏—è –í–ò–ß –≤ —Å—Ç—Ä–∞–Ω–µ –• 2. –î–æ–ø—É—Å—Ç–∏–º, –≤ —Å—Ç—Ä–∞–Ω–µ –• 1 000 000 –∑–∞–±–æ–ª–µ–≤—à–∏—Ö, –∞ –æ—Å—Ç–∞–ª–æ—Å—å 145 –º–ª–Ω –Ω–µ–∑–∞–±–æ–ª–µ–≤–∞—à–∏—Ö (—Ç–∞–∫ —Å–æ–≤–ø–∞–ª–æ) 3. –í –∫–∞–∫–æ–π –º–æ–º–µ–Ω—Ç –∫–æ–ª–ª–µ–∫—Ç–∏–≤–Ω–æ–µ –±–ª–∞–≥–æ –¥–æ–ª–∂–Ω–æ –ø–µ—Ä–µ–≤–µ—Å–∏—Ç—å –ø—Ä–∏–æ—Ä–∏—Ç–µ–∑–∞—Ü–∏—é –ø—Ä–∏–æ—Ä–∏—Ç–∞—Ä–∏—Å—Ç–æ–≤? –ö–∞–∫ –≤ —Ü–µ–ª–æ–º –∏–∑–º–µ—Ä–∏—Ç—å –≤–ª–∏—è–Ω–∏–µ –±–æ–ª–µ–∑–Ω–∏ –Ω–∞ —Å–æ—Å—Ç–æ—è–Ω–∏–µ –æ–±—â–µ—Å—Ç–≤–∞?","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial,hospital_policy"",
  ""impact"": ""high"",
  ""english"": ""A discussion on the point when collective welfare should outweigh prioritarians in a scenario where an epidemic (such as HIV) is affecting country X, with 1 million infected and the remaining 145 million uninfected. The question is at what point should collective welfare override prioritarians in this situation, and how to measure the societal impact of the disease.""
}"
2025-06-30T11:09:18+00:00,@pharm_icon,2282,https://t.me/pharm_icon/2282,"–†–∞–∫ –ø–µ—á–µ–Ω–∏ –∏ –∞–≥–æ–Ω–∏—Å—Ç—ã –ì–ü–ü-1: —á—Ç–æ –∏–∑–≤–µ—Å—Ç–Ω–æ? –ù–µ–¥–∞–≤–Ω–µ–µ ‚Äî —Å–µ–≥–æ–¥–Ω—è—à–Ω–µ–µ ‚Äî –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ, –æ—Å–Ω–æ–≤–∞–Ω–Ω–æ–µ –Ω–∞ –¥–∞–Ω–Ω—ã—Ö –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–π —Å–∏—Å—Ç–µ–º—ã –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –≤–µ—Ç–µ—Ä–∞–Ω–æ–≤, –ø–æ–ø—ã—Ç–∞–ª–æ—Å—å –æ—Ç–≤–µ—Ç–∏—Ç—å –Ω–∞ –æ–¥–∏–Ω –∏–∑ —Ç–∞–∫–∏—Ö –≤–æ–ø—Ä–æ—Å–æ–≤: —Å—É—â–µ—Å—Ç–≤—É–µ—Ç –ª–∏ —Å–≤—è–∑—å –º–µ–∂–¥—É –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ–º –ì–ü–ü-1 –∏ —Ä–∏—Å–∫–æ–º –≥–µ–ø–∞—Ç–æ—Ü–µ–ª–ª—é–ª—è—Ä–Ω–æ–π –∫–∞—Ä—Ü–∏–Ω–æ–º—ã (–ì–¶–ö) ‚Äî –Ω–∞–∏–±–æ–ª–µ–µ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω—ë–Ω–Ω–æ–π —Ñ–æ—Ä–º—ã —Ä–∞–∫–∞ –ø–µ—á–µ–Ω–∏. –ö–∞–∫ –ø—Ä–æ–≤–æ–¥–∏–ª–æ—Å—å –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –£—á–µ–Ω—ã–µ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–ª–∏ –¥–∞–Ω–Ω—ã–µ –∑–∞ 15 –ª–µ—Ç (—Å 2006 –ø–æ 2021 –≥–æ–¥—ã), —á—Ç–æ–±—ã –ø—Ä–æ—Å–ª–µ–¥–∏—Ç—å, –∫–∞–∫ —á–∞—Å—Ç–æ —Ä–∞–∑–≤–∏–≤–∞–µ—Ç—Å—è –ì–¶–ö —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ –Ω–∞—á–∞–ª–∏ —Ç–µ—Ä–∞–ø–∏—é –∞–≥–æ–Ω–∏—Å—Ç–∞–º–∏ –ì–ü–ü-1, –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å —Ç–µ–º–∏, –∫—Ç–æ –ø—Ä–∏–Ω–∏–º–∞–ª –¥—Ä—É–≥–æ–π –∫–ª–∞—Å—Å –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ ‚Äî –∏–Ω–≥–∏–±–∏—Ç–æ—Ä—ã –î–ü–ü-4 (–¥–∏–ø–µ–ø—Ç–∏–¥–∏–ª–ø–µ–ø—Ç–∏–¥–∞–∑—ã-4). –í –∞–Ω–∞–ª–∏–∑ –≤–æ—à–ª–∏ —Ç–æ–ª—å–∫–æ —Ç–µ –ø–∞—Ü–∏–µ–Ω—Ç—ã, —É –∫–æ—Ç–æ—Ä—ã—Ö –Ω–µ –±—ã–ª–æ —Ä–∞–∫–∞ –ø–µ—á–µ–Ω–∏ –∏–ª–∏ —Ç—Ä–∞–Ω—Å–ø–ª–∞–Ω—Ç–∞—Ü–∏–∏ –Ω–∞ –º–æ–º–µ–Ω—Ç –Ω–∞—á–∞–ª–∞ –ª–µ—á–µ–Ω–∏—è. –í–∞–∂–Ω–æ, —á—Ç–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –±—ã–ª–æ —Å—Ç—Ä–æ–≥–æ –∫–æ–Ω—Ç—Ä–æ–ª–∏—Ä—É–µ–º—ã–º: –±—ã–ª–∏ —É—á—Ç–µ–Ω—ã –±–æ–ª–µ–µ 130 —Ñ–∞–∫—Ç–æ—Ä–æ–≤, –≤–∫–ª—é—á–∞—è —Ç—è–∂–µ—Å—Ç—å –¥–∏–∞–±–µ—Ç–∞, —Å–æ—Å—Ç–æ—è–Ω–∏–µ –ø–µ—á–µ–Ω–∏, –¥—Ä—É–≥–∏–µ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è –∏ –ø—Ä–∏–Ω–∏–º–∞–µ–º—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã. –≠—Ç–æ –ø–æ–∑–≤–æ–ª–∏–ª–æ –º–∞–∫—Å–∏–º–∞–ª—å–Ω–æ —Ç–æ—á–Ω–æ —Å–æ–ø–æ—Å—Ç–∞–≤–∏—Ç—å –≥—Ä—É–ø–ø—ã –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –ø–æ –∫–ª—é—á–µ–≤—ã–º –ø–∞—Ä–∞–º–µ—Ç—Ä–∞–º. –†–µ–∑—É–ª—å—Ç–∞—Ç—ã –ò–∑ 147 969 –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –Ω–∞—á–∞–≤—à–∏—Ö –ø—Ä–∏—ë–º –∞–≥–æ–Ω–∏—Å—Ç–æ–≤ –ì–ü–ü-1, –∏ 263 664 ‚Äî –∏–Ω–≥–∏–±–∏—Ç–æ—Ä–æ–≤ –î–ü–ü-4, –±—ã–ª–∏ –æ—Ç–æ–±—Ä–∞–Ω—ã 100 248 –ø–∞—Ä —Å —Å–æ–ø–æ—Å—Ç–∞–≤–∏–º—ã–º–∏ —Ö–∞—Ä–∞–∫—Ç–µ—Ä–∏—Å—Ç–∏–∫–∞–º–∏. –ì–µ–ø–∞—Ç–æ—Ü–µ–ª–ª—é–ª—è—Ä–Ω–∞—è –∫–∞—Ä—Ü–∏–Ω–æ–º–∞ —Ä–∞–∑–≤–∏–ª–∞—Å—å —É 302 (0,30%) –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –ø—Ä–∏–Ω–∏–º–∞–≤—à–∏—Ö –∞–ì–ü–ü-1 –∏ —É 230 (0,23%) –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –∏–∑ –≥—Ä—É–ø–ø—ã –∏–î–ü–ü-4. –†–∞—Å—á—ë—Ç–Ω–æ–µ –æ—Ç–Ω–æ—à–µ–Ω–∏–µ —à–∞–Ω—Å–æ–≤ —Å–æ—Å—Ç–∞–≤–∏–ª–æ 1,31 (95% –¥–æ–≤–µ—Ä–∏—Ç–µ–ª—å–Ω—ã–π –∏–Ω—Ç–µ—Ä–≤–∞–ª: 1,11‚Äì1,56), —á—Ç–æ –≥–æ–≤–æ—Ä–∏—Ç –æ —Å—Ç–∞—Ç–∏—Å—Ç–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º–æ–º —É–≤–µ–ª–∏—á–µ–Ω–∏–∏ —Ä–∏—Å–∫–∞ –ì–¶–ö —É –≥—Ä—É–ø–ø—ã –ì–ü–ü-1. –î–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–π –∞–Ω–∞–ª–∏–∑ –ø–æ–∫–∞–∑–∞–ª, —á—Ç–æ: –£–≤–µ–ª–∏—á–µ–Ω–Ω—ã–π —Ä–∏—Å–∫ —Ä–∞–∫–∞ –ø–µ—á–µ–Ω–∏ –Ω–∞–±–ª—é–¥–∞–ª—Å—è —Ç–æ–ª—å–∫–æ —É —Ç–µ—Ö, –∫—Ç–æ –ø—Ä–∏–Ω–∏–º–∞–ª GLP-1RA –¥–æ–ª—å—à–µ 6 –º–µ—Å—è—Ü–µ–≤. –ü—Ä–∏ –±–æ–ª–µ–µ –∫–æ—Ä–æ—Ç–∫–æ–º –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–∏ (<6 –º–µ—Å—è—Ü–µ–≤) —Å–≤—è–∑—å –º–µ–∂–¥—É –ø—Ä–∏—ë–º–æ–º –∏ —Ä–∏—Å–∫–æ–º –ì–¶–ö –Ω–µ –Ω–∞–±–ª—é–¥–∞–ª–∞—Å—å (OR: 0,96; 95% –î–ò: 0,68‚Äì1,35). –ß—Ç–æ –¥—É–º–∞–µ—Ç–µ? üî• ‚Äî –∂–µ—á—å –∂–∏—Ä –Ω–∞–¥–æ –≤–º–µ—Å—Ç–µ —Å –ø–ª–∞—Å—Ç–∏—á–µ—Å–∫–∏–º —Ö–∏—Ä—É—Ä–≥–æ–º üóø ‚Äî —è –¥–∞–∂–µ —è–¥–µ—Ä–Ω–æ–π –≤–æ–π–Ω—ã –Ω–µ –±–æ—é—Å—å üòê ‚Äî –º–Ω–µ –Ω–µ —Å—Ç—Ä–∞—à–Ω–æ 3 —Å–æ–±—ã—Ç–∏—è –Ω–∞ —Ç—ã—Å—è—á—É, —è —Ç–æ—á–Ω–æ –≤ –≥—Ä—É–ø–ø–µ –≤–µ–∑—É–Ω—á–∏–∫–æ–≤ –∏ –º–Ω–µ –Ω–µ–∏–Ω—Ç–µ—Ä–µ—Å–Ω–æ –¥—É–º–∞—Ç—å –æ –∫–∞–∫–∏—Ö-—Ç–æ –ø–æ—Å–ª–µ–¥—Å—Ç–≤–∏—è—Ö –º–æ–µ–π —Ö—É–¥–æ–±—ã –Ω–∞ –º–æ–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞—Ö","{""skip"": true}"
2025-06-25T18:23:09+00:00,@pharm_icon,2281,https://t.me/pharm_icon/2281,"–î–æ–∫–∞–∑–∞—Ç–µ–ª—å–Ω–∞—è –º–µ–¥–∏—Ü–∏–Ω–∞ Z. –Ø —Ç–æ—á–Ω–æ –Ω–µ –±—ã–ª–∞ –≥–æ—Ç–æ–≤–∞ –∫ —Ç–∞–∫–æ–º—É –ø–æ–≤–æ—Ä–æ—Ç—É –≤ –¥–∏—Å–∫—É—Å—Å–∏–∏ –æ –ë–∏–æ–Ω–æ—Ä–∏–∫–µ –∏ –∫—Ä–∏—Ç–∏–∫–∞—Ö –ö–∞–Ω–µ—Ñ—Ä–æ–Ω–∞. –Ø –Ω–µ –¥—É–º–∞–ª–∞, —á—Ç–æ –ø–æ–¥ —ç–≥–∏–¥–æ–π –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω—ã –Ω–∞—á–Ω—É—Ç—Å—è –≤–ø–æ–ª–Ω–µ –ø–æ–∫–∞–∑–∞—Ç–µ–ª—å–Ω—ã–µ –ø–µ—Ä–µ–¥—ë—Ä–≥–∏–≤–∞–Ω–∏—è –≤ —Å—Ç–∏–ª–µ –¥–æ–∫—Ç–æ—Ä–∞ –°–æ–ª–æ–≤—å—ë–≤–∞, –∫–æ—Ç–æ—Ä—ã–π –ª—é–±–∏—Ç –ø—Ä–æ–≤–æ–¥–∏—Ç—å –≤–µ—á–µ—Ä–∞ —Å –Ω–∞—à–∏–º–∏ –º–∞–º–∞–º–∏ –∏ –ø–∞–ø–∞–º–∏. –î–æ–±—Ä–æ –ø–æ–∂–∞–ª–æ–≤–∞—Ç—å –≤ —ç–ø–∏—á–µ—Å–∫—É—é —Ä–µ–∞–ª—å–Ω–æ—Å—Ç—å —Å–Ω–æ–≤–∞! –ö–∞–∫ –≤—ã –¥—É–º–∞–µ—Ç–µ, —ç—Ç–æ –ø—Ä–æ—Å—Ç–æ –ø—Ä–æ–≥–∏–± –ø–æ–¥ —Å–∏—Ç—É–∞—Ü–∏—é –∏–ª–∏ —Ä–µ–∞–ª—å–Ω—ã–π –≤–∑–≥–ª—è–¥ –∞–≤—Ç–æ—Ä–∞ —ç—Ç–æ–≥–æ —Å–æ–æ–±—â–µ—Å—Ç–≤–∞ –≤ –≤–∫? üòÉ ‚Äî –ø—Ä–æ–≥–∏–± üòê ‚Äî —Ä–µ–∞–ª—å–Ω—ã–π –≤–∑–≥–ª—è–¥","{""skip"": true}"
2025-06-24T16:57:22+00:00,@pharm_icon,2278,https://t.me/pharm_icon/2278,"–¢–æ–ª—å–∫–æ 16% —Å—Ç—É–¥–µ–Ω—Ç–æ–≤ –≥–æ—Ç–æ–≤—ã —É—á–∏—Ç—å—Å—è –≤ –¶–µ–Ω—Ç—Ä–∞–ª—å–Ω–æ–π –ê–∑–∏–∏, —á—Ç–æ–±—ã –∏–∑–±–µ–∂–∞—Ç—å 3-–ª–µ—Ç–Ω–µ–π –æ—Ç—Ä–∞–±–æ—Ç–∫–∏. –ß—Ç–æ –¥—É–º–∞–µ—Ç–µ? ‚ù§Ô∏è ‚Äî –ª—É—á—à–µ –æ—Ç—É—á–∏—Ç—å—Å—è –≤ –¶–µ–Ω—Ç—Ä–∞–ª—å–Ω–æ–π –ê–∑–∏–∏, –∞ –ø–æ—Ç–æ–º –ø—Ä–æ–π—Ç–∏ –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏—é –≤ –†–§ üî• ‚Äî –ª—É—á—à–µ 3 –≥–æ–¥–∞ –æ—Ç—Ä–∞–±–æ—Ç–æ–∫ üóø ‚Äî –ª—É—á—à–µ –ø–æ–π—Ç–∏ –Ω–∞ —ç–∫–æ–Ω–æ–º–∏—Å—Ç–∞ –∏–ª–∏ –Ω–∞ –º–µ–Ω–µ–¥–∂–µ—Ä–∞","{""skip"": true}"
2025-06-23T18:11:19+00:00,@pharm_icon,2276,https://t.me/pharm_icon/2276,"–ü–ú–≠–§: –Ω–µ —Ç–æ–ª—å–∫–æ –¥–ª—è —Ñ—Ä–∏–∫–æ–≤ –ò–∑–¥–∞–Ω–∏–µ Vademecum –ø–æ–¥–≥–æ—Ç–æ–≤–∏–ª–æ –æ–±–∑–æ—Ä —Å–æ–≥–ª–∞—à–µ–Ω–∏–π, –∑–∞–∫–ª—é—á–µ–Ω–Ω—ã—Ö –Ω–∞ –ü–ú–≠–§. –í —Ü–µ–ª–æ–º, —Ä–µ–∫–æ–º–µ–Ω–¥—É—é –∫ –æ–∑–Ω–∞–∫–æ–º–ª–µ–Ω–∏—é, –≤ –æ—Å–Ω–æ–≤–Ω–æ–º —Å–µ—Ä—å—ë–∑–Ω—ã–µ –∏ –∏–Ω—Ç–µ—Ä–µ—Å–Ω—ã–µ –≤–µ—â–∏. –ù–æ –±—ã–ª–æ —á—Ç–æ-—Ç–æ –∑–∞–±–∞–≤–Ω–æ–µ. –ß—Ç–æ —Å–º–µ—à–Ω–æ–≥–æ: –°–±–µ—Ä –ø–æ–¥–ø–∏—Å–∞–ª —Å–æ–≥–ª–∞—à–µ–Ω–∏–µ –æ —Å–æ—Ç—Ä—É–¥–Ω–∏—á–µ—Å—Ç–≤–µ –≤ —Å—Ñ–µ—Ä–µ –ò–ò —Å —á–∞—Å—Ç–Ω–æ–π –∫–ª–∏–Ω–∏–∫–æ–π. –ë—É–¥—É—Ç –æ–±—É—á–∞—Ç—å—Å—è –Ω–∞ –¥–∞–Ω–Ω—ã—Ö –≤—Ä–∞—á–µ–±–Ω—ã—Ö –Ω–∞–∑–Ω–∞—á–µ–Ω–∏–π –¥–ª—è —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—è —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ç–µ–ª—å–Ω–æ–≥–æ —Å–µ—Ä–≤–∏—Å–∞. –ü–æ—á–µ–º—É —Å–º–µ—à–Ω–æ: –Ω–∞–∫–æ–Ω–µ—Ü –ø–æ—è–≤–∏—Ç—Å—è —Å–µ—Ä–≤–∏—Å, –∫–æ—Ç–æ—Ä—ã–π –±—É–¥–µ—Ç –æ–±—É—á–µ–Ω –Ω–∞ –∫–æ–Ω—Ñ–ª–∏–∫—Ç–µ –∏–Ω—Ç–µ—Ä–µ—Å–æ–≤. –ß—Ç–æ –æ—á–µ–Ω—å —Å–º–µ—à–Ω–æ–≥–æ: –ì–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä ¬´–ì–µ—Ä–æ—Ñ–∞—Ä–º–∞¬ª –∏ –ø—Ä–æ—Å—Ç–æ –∫—Ä–∞—Å–∏–≤—ã–π —Å—Ç—Ä–æ–π–Ω—ã–π –º—É–∂—á–∏–Ω–∞ –ü—ë—Ç—Ä –†–æ–¥–∏–æ–Ω–æ–≤ –ø—Ä–µ–¥–ª–æ–∂–∏–ª –Ω–∞–∑–≤–∞—Ç—å 2026 –≥–æ–¥ –≥–æ–¥–æ–º –Ω–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–π –±–æ—Ä—å–±—ã —Å –æ–∂–∏—Ä–µ–Ω–∏–µ–º. –ü–æ—á–µ–º—É —Å–º–µ—à–Ω–æ: —Å —É—á—ë—Ç–æ–º –ø—Ä–æ–≥–Ω–æ–∑–∞ –ú–∏–Ω–∏—Å—Ç—Ä–∞ —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–æ–≥–æ —Ä–∞–∑–≤–∏—Ç–∏—è –†–æ—Å—Å–∏–∏ –ú–∞–∫—Å–∏–º–∞ –†–µ—à–µ—Ç–Ω–∏–∫–æ–≤–∞, –≤ 2026-–º –∏ –±–µ–∑ —ç—Ç–æ–≥–æ –ø—Ä–∏–¥–µ—Ç—Å—è —Å–∏–ª—å–Ω–æ —Ö—É–¥–µ—Ç—å ‚Äî ¬´–º—ã –Ω–∞ –≥—Ä–∞–Ω–∏ –ø–µ—Ä–µ—Ö–æ–¥–∞ –≤ —Ä–µ—Ü–µ—Å—Å–∏—é¬ª. –ì–æ–¥ –¥–≤–æ–π–Ω–æ–≥–æ –ø–æ—Ö—É–¥–µ–Ω–∏—è. –í —Ü–µ–ª–æ–º, –∫–æ–Ω–µ—á–Ω–æ, —Ä–∞–¥—É–µ—Ç, —á—Ç–æ —Ö–æ—Ç—è –±—ã –∑–¥–µ—Å—å –æ–±–æ—à–ª–æ—Å—å –±–µ–∑ –∫–ª–æ—É–Ω–∞–¥—ã, –∏ –¥–∞–∂–µ —Å–º–µ—à–Ω—ã–µ –≤–µ—â–∏ —Å–º–µ—à–Ω—ã–µ —Ç–æ–ª—å–∫–æ —Å –ø–æ–ø—Ä–∞–≤–∫–æ–π –Ω–∞ –∫–æ–Ω—Ç–µ–∫—Å—Ç. –ö–æ–Ω–µ—á–Ω–æ, –Ω–µ —Ö–≤–∞—Ç–∞–µ—Ç –∞–Ω–æ–Ω—Å–∞ –ø—Ä–æ–≥—Ä–∞–º–º—ã ""–ö—Ä–µ–ø–æ—Å—Ç–Ω–æ–π –¥–æ–∫—Ç–æ—Ä"", –∫–æ—Ç–æ—Ä–∞—è —Å–µ–π—á–∞—Å —Å—É—â–µ—Å—Ç–≤—É–µ—Ç –≤ –≤–∏–¥–µ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç–∞, –Ω–æ —è —É–≤–µ—Ä–µ–Ω–∞, —á—Ç–æ —É–∂–µ –Ω–∞ –ü–ú–≠–§-2026 –æ—Ç—á–∏—Ç–∞—é—Ç—Å—è –æ –µ—ë –≤–Ω–µ–¥—Ä–µ–Ω–∏–∏. üî• ‚Äî 100% –æ—Ç—á–∏—Ç–∞—é—Ç—Å—è üòê ‚Äî —Ç–∞–∫–∏–º —Å—Ç—ã–¥–Ω–æ –æ—Ç—á–∏—Ç—ã–≤–∞—Ç—å—Å—è üóø ‚Äî –Ω–∞–∫–æ–Ω–µ—Ü –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–µ —Å—Ç–∞–Ω–µ—Ç –¥–æ—Å—Ç—É–ø–Ω—ã–º –¥–ª—è –≤—Å–µ—Ö","{""skip"": true}"
2025-06-20T06:06:11+00:00,@pharm_icon,2274,https://t.me/pharm_icon/2274,"–≠—Ç–æ –≤—Å–µ–≥–¥–∞ –±—ã–ª–æ —Å—Ç—Ä–∞–Ω–Ω–æ –≤–æ –≤—Ä–∞—á–µ–±–Ω–æ–π –∂–∏–∑–Ω–∏, –∫–æ–≥–¥–∞ –º–µ–Ω–µ–¥–∂–µ—Ä —Å–∏–¥–∏—Ç —Å –º–µ–¥–ø—Ä–µ–¥–æ–º –∏ —Ä–∞—Å—Å–∫–∞–∑—ã–≤–∞–µ—Ç —Å—Ç—Ä—ë–º–Ω—É—é (–ø–æ –º–æ–∏–º –º–µ—Ä–∫–∞–º) –ø—Ä–µ–∑–µ–Ω—Ç–∞—Ü–∏—é. –ñ–∏–∑–∞!","{""skip"": true}"
2025-06-18T17:27:55+00:00,@pharm_icon,2271,https://t.me/pharm_icon/2271,"–†–£ –∑–∞ –º–µ—Å—è—Ü: FDA –Ω–∞–∫–æ–Ω–µ—Ü —Å—Ç–∞–ª–∞ –ø—Ä–∞–≤–∏–ª—å–Ω–æ–π –¥–ª—è –ø—Ä–∞–≤–∏–ª—å–Ω—ã—Ö –∫–æ–º–ø–∞–Ω–∏–π –í–º–µ—Å—Ç–æ –≥–æ–¥–∞ —Ä–∞–∑–Ω—ã—Ö –∏–Ω—Å–ø–µ–∫—Ü–∏–π, –ø—Ä–æ–≤–µ—Ä–æ–∫ –∏ –±—É–º–∞–≥–æ–¥–≤–∏–∂–µ–Ω–∏–π, –ª–æ—è–ª—å–Ω—ã–µ –∫ –°–®–ê –∫–æ–º–ø–∞–Ω–∏–∏ ‚Äî –∞ —á—Ç–æ –≤—ã —Ö–æ—Ç–µ–ª–∏, –ê–º–µ—Ä–∏–∫–∞ FI(R)ST ‚Äî –ø–æ–ª—É—á–∞—Ç –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å —Å—Ä–µ–∑–∞—Ç—å —Å—Ä–æ–∫ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –¥–æ 1-2 –º–µ—Å—è—Ü–µ–≤. –ö–∞–∫–æ–≤—ã –ø—Ä–∏–∑–Ω–∞–∫–∏ –ª–æ—è–ª—å–Ω–æ—Å—Ç–∏? –ò–Ω–≤–µ—Å—Ç–∏—Ü–∏–∏ –≤ –ª–æ–∫–∞–ª—å–Ω–æ–µ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ, —Ä–∞–±–æ—á–∏–µ –º–µ—Å—Ç–∞, –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ –∏ –∫–æ–Ω—Ç—Ä–æ–ª—å —Ü–µ–Ω –Ω–∞ –¥–æ—Ä–æ–≥–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã. –ü–æ–ª—É—á–∏—Ç—å —Ä–∞–∑—Ä–µ—à–µ–Ω–∏–µ ""–ª–æ—è–ª–∏—Å—Ç"" –º–æ–∂–µ—Ç –∫–∞–∫ –∏ –Ω–∞ –Ω–æ–≤—ã–π –ø—Ä–æ–¥—É–∫—Ç, —Ç–∞–∫ –∏ –Ω–∞ –≤—ã–±—Ä–∞–Ω–Ω—ã–π –∏–∑ –∏–º–µ—é—â–µ–≥–æ—Å—è –ø–æ—Ä—Ç—Ñ–µ–ª—è. –ö–∞–∑–∞–ª–æ—Å—å –±—ã, –∞ –≤ —á–µ–º –ø–ª—é—Å? –ê –ø–ª—é—Å –≤ —Ç–æ–º, —á—Ç–æ —Å–æ–∑–¥–∞–Ω–Ω—ã–π –∏–∑-–∑–∞ —É—Ä–µ–∑–∞–Ω–∏—è —à—Ç–∞—Ç–∞ FDA –∑–∞–º–µ–¥–ª–∏–ª –æ–±—Ä–∞–±–æ—Ç–∫—É –∑–∞—è–≤–æ–∫, –∞ —Ç—É—Ç —Ç–µ–±–µ —Ä–µ—à–µ–Ω–∏–µ. –°–æ–∑–¥–∞–π –ø—Ä–æ–±–ª–µ–º—É –∏ –ø—Ä–µ–¥–ª–æ–∂–∏ –µ—ë —Ä–µ—à–µ–Ω–∏–µ —Ü–µ–Ω–æ–π –≤ –ø–æ–∫–æ—Ä–Ω–æ—Å—Ç—å. This is a great deal, btw. –ö—Ç–æ –≤ –ø–ª—é—Å–µ? –õ–æ–∫–∞–ª—å–Ω—ã–µ –∫–æ–º–ø–∞–Ω–∏–∏, —Å—Ç–∞—Ä—Ç–∞–ø—ã –∏ –±—ã—Å—Ç—Ä—ã–µ –¥–æ –ø–µ—Ä–µ–Ω–æ—Å–∞ –±–∏–∑–Ω–µ—Å–∞ –æ—Ñ–∏—Å—ã –±–∏–≥—Ñ–∞—Ä–º—ã, —É–∂–µ —Å—Ç–∞—Ä—ã–µ —Ç–µ–º—â–∏–∫–∏. –í–æ–∑–º–æ–∂–Ω–æ, —Å–∞–º–∏ –∞–º–µ—Ä–∏–∫–∞–Ω—Ü—ã —Ç–æ–∂–µ. –ò–ª–∏ —Ö–æ—Ç—è –±—ã –∏—Ö –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç—å –ø–æ–ª—É—á–∏—Ç—å –Ω–æ–≤—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã. –ù–µ—Ç, –Ω–µ –∑–∞–¥–µ—à–µ–≤–æ, –∞ –≤ –ø—Ä–∏–Ω—Ü–∏–ø–µ. –ë–ª–∞–≥–æ–¥–∞—Ä–∏—Ç–µ –î–æ–Ω–∞–ª—å–¥–∞. –ê –æ –∫–∞–∫–∏—Ö —Å—Ç–∞—Ä—ã—Ö —Ç–µ–º—â–∏–∫–∞—Ö —à–ª–∞ —Ä–µ—á—å? –ê –æ —Ç–µ—Ö, –∫—Ç–æ –∑–∞—Ä–∞–±–æ—Ç–∞–ª –≤ 2020-–º –∏ –≤ 2021-–º. –ë—É–∫–≤–∞–ª—å–Ω–æ –∑–∞ —Å—É—Ç–∫–∏ –ø–æ–ª—É—á–∞–µ—à—å –≤–∞—É—á–µ—Ä, –±—ã—Å—Ç—Ä–æ –≥–æ–Ω–∏—à—å –±—É–º–∞–≥–∏ –Ω–∞ –ø–æ—Ä—è–¥–∫–æ–º –Ω–∞–º—ã–ª–µ–Ω–Ω—ã–π –≥–ª–∞–∑ —ç–∫—Å–ø–µ—Ä—Ç–∞ –∏ –≤—É–∞-–ª—è, –≤—Å—ë –∫–∞–∫ –≤ –∫–æ–≤–∏–¥–Ω—ã–µ –≤—Ä–µ–º–µ–Ω–∞. –ù–æ–≤–∞—è —Å–¥–µ–ª–∫–∞ ""–î–æ–ª–≥–∏–µ ‚Äî –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–æ–Ω–Ω—ã–µ ‚Äî –¥–µ–Ω—å–≥–∏ –≤ —ç–∫–æ–Ω–æ–º–∏–∫–µ –≤–∑–∞–º–µ–Ω –Ω–∞ —Ä—ã–Ω–æ–∫ –∏ –æ—Ç—Å—Ä–æ—á–∫—É –¥–∞–Ω–Ω—ã—Ö –æ –ø–æ–±–æ—á–Ω—ã—Ö —ç—Ñ—Ñ–µ–∫—Ç–∞—Ö"" –≤–æ—Å—Ö–∏—Ç–∏—Ç–µ–ª—å–Ω–∞. –ß—Ç–æ –∂, –ø–æ–ª—É—á–∞–µ—Ç—Å—è, –†–æ–±–µ—Ä—Ç –ö–µ–Ω–Ω–µ–¥–∏ –º–ª–∞–¥—à–∏–π –±–æ—Ä–µ—Ç—Å—è —Å –±–∏–≥—Ñ–∞—Ä–º–æ–π –Ω–µ —Å —Ç–æ–π —Å—Ç–æ—Ä–æ–Ω—ã. –ö–∞–∫ —ç—Ç–æ –±—É–¥–µ—Ç —Ä–∞–±–æ—Ç–∞—Ç—å? –ö–ª–∏–Ω–∏—á–µ—Å–∫–∞—è –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è –±—É–¥–µ—Ç —Ä–∞—Å—Å–º–∞—Ç—Ä–∏–≤–∞—Ç—å—Å—è –º–Ω–æ–≥–æ–ø—Ä–æ—Ñ–∏–ª—å–Ω–æ–π –≥—Ä—É–ø–ø–æ–π –≤—Ä–∞—á–µ–π –∏ —É—á–µ–Ω—ã—Ö, –∫–æ—Ç–æ—Ä—ã–µ –ø—Ä–µ–¥–≤–∞—Ä–∏—Ç–µ–ª—å–Ω–æ —Ä–∞—Å—Å–º–æ—Ç—Ä—è—Ç –ø—Ä–µ–¥—Å—Ç–∞–≤–ª–µ–Ω–Ω—É—é –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é –∏ —Å–æ–±–µ—Ä—É—Ç—Å—è –Ω–∞ –æ–¥–Ω–æ–¥–Ω–µ–≤–Ω–æ–µ –∑–∞—Å–µ–¥–∞–Ω–∏–µ ¬´–≤ —Å—Ç–∏–ª–µ —Å–æ–≤–µ—Ç–∞ –ø–æ –æ–ø—É—Ö–æ–ª—è–º¬ª. –ö–æ—Ä–æ—á–µ, –±—É–¥—É—Ç —Ä–∞–±–æ—Ç–∞—Ç—å, –∫–∞–∫ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–∞—è –¥—É–º–∞ –≤ —Ä–µ–∂–∏–º–µ ¬´—Ñ—Ä–∞–∫—Ü–∏–æ–Ω–Ω–æ–µ –≥–æ–ª–æ—Å–æ–≤–∞–Ω–∏–µ¬ª. –ö–∞–∫ –≤–∞–º –Ω–æ–≤–æ–≤–≤–µ–¥–µ–Ω–∏–µ? ‚ù§Ô∏è ‚Äî —è —Ä–∞–∑–≤–µ—Ä–Ω—É–ª(–∞) –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–æ –≤ –°–®–ê –∏ –º–Ω–µ –≤—Å—ë –Ω—Ä–∞–≤–∏—Ç—Å—è üòê ‚Äî –∑–≤–µ–∑–¥–µ—Ü –∞–º–µ—Ä–∏–∫–∞–Ω—Ü–∞–º üòÄ ‚Äî –∑–≤–µ–∑–¥–µ—Ü –∞–º–µ—Ä–∏–∫–∞–Ω—Ü–∞–º üíÖüèº ‚Äî –≤ –†–æ—Å—Å–∏—é —Ç–∞–∫—É—é –∂–µ –º–µ—Ä—É, –ø–æ–∂–∞–ª—É–π—Å—Ç–∞, –Ω–∞ –≤—Å–µ –†–£ ‚Äî –≤ —Ç–æ–º —á–∏—Å–ª–µ –º–µ–¥–∏–∑–¥–µ–ª–∏–π ‚Äî –∏ —Å–æ —Å–∫–∏–¥–∫–æ–π, –ø–æ–∂–∞–ª—É–π—Å—Ç–∞ üóø ‚Äî —ç—Ç –∫–æ—à–º–∞—Ä","{""skip"": true}"
2025-06-18T16:02:37+00:00,@pharm_icon,2270,https://t.me/pharm_icon/2270,"–¢–µ–ª–µ–º–µ–¥ –Ω–µ —Å–¥–æ—Ö–Ω–µ—Ç! –ò–ª–∏ –Ω–µ –≤ —Å–ª–µ–¥—É—é—â–µ–º –≥–æ–¥—É. –ü—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –†–§ –Ω–∞–∫–∏–Ω—É–ª–æ –æ–±—è–∑–∞—Ç–µ–ª—å—Å—Ç–≤ –≥–ª–∞–≤–∞–º –∏ –∞–¥–º–∏–Ω–∏—Å—Ç—Ä–∞—Ü–∏—è–º —Ä–µ–≥–∏–æ–Ω–æ–≤ ‚Äî —Ç–µ–ø–µ—Ä—å –≤ KPI –≤–æ—à–ª–∏ –µ—â—ë –∏ —Ç–µ–ª–µ–º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –ø–æ–∫–∞–∑–∞—Ç–µ–ª–∏, –∫–æ—Ç–æ—Ä—ã–µ –¥–æ–ª–∂–Ω—ã –ø—Ä–æ—Å—Ç–∏–º—É–ª–∏—Ä–æ–≤–∞—Ç—å –ø–æ–ª—É–¥–æ—Ö–ª—ã–π —Ä—ã–Ω–æ–∫ —Ç–µ–ª–µ–º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —É—Å–ª—É–≥. –ß—Ç–æ —Ç—É–¥–∞ –≤—Ö–æ–¥–∏—Ç? 1. –î–æ–ª—è –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏–π —Å —ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω—ã–º –¥–æ–∫—É–º–µ–Ω—Ç–æ–æ–±–æ—Ä–æ—Ç–æ–º. 2. –î–æ–ª—è –æ–Ω–ª–∞–π–Ω-–∫–æ–Ω—Å—É–ª—å—Ç–∞—Ü–∏–π. 3. –î–æ–ª—è –ª—é–¥–µ–π, –∫–æ—Ç–æ—Ä—ã–º –¥–æ—Å—Ç—É–ø–Ω—ã –≤—Ä–∞—á–µ–±–Ω—ã–µ –Ω–∞–∑–Ω–∞—á–µ–Ω–∏—è –≤ —ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω–æ–º –≤–∏–¥–µ ‚Äî –Ω–µ —Ñ–∞–∫—Ç, —á—Ç–æ —Ä–µ—Ü–µ–ø—Ç—ã, –∫—Å—Ç–∞—Ç–∏ –≥–æ–≤–æ—Ä—è. 4. –ò –≤—Å—è–∫–æ–µ –ø—Ä–æ—á–µ–µ. –ü–µ—Ä–µ—á–∏—Å–ª–µ–Ω–Ω—ã–µ –∫—Ä–∏—Ç–µ—Ä–∏–∏ –æ—Ü–µ–Ω–∫–∏ –ø–æ–ø–∞–ª–∏ –≤ –∫–æ–Ω—Ç—É—Ä –Ω–æ–≤–æ–≥–æ –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è ‚Äì ¬´—Ü–∏—Ñ—Ä–æ–≤–∞—è –∑—Ä–µ–ª–æ—Å—Ç—å –ø–æ –ë–∏—à–æ–ø—É¬ª –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏ –º—É–Ω–∏—Ü–∏–ø–∞–ª—å–Ω–æ–≥–æ —É–ø—Ä–∞–≤–ª–µ–Ω–∏—è. –í –æ–±—â–µ–º, —è —Ä–∞–¥–∞ –∑–∞ –≤—Å–µ—Ö –ø–æ—Å—Ç–∞–≤—â–∏–∫–æ–≤ —Ç–µ–ª–µ–º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —É—Å–ª—É–≥, –∏–∑ –î–ú–°-–∑–æ–º–±–∏ —É –≤–∞—Å –ø–æ—è–≤–ª—è–µ—Ç—Å—è —à–∞–Ω—Å –ø—Ä–µ–≤—Ä–∞—Ç–∏—Ç—å—Å—è –≤ –≥—É–±–µ—Ä–Ω–∞—Ç–æ—Ä—Å–∫–∏—Ö –ª–∞–∫–µ–µ–≤. –ü–æ–∑–¥—Ä–∞–≤–ª—è—é! –ê —Ç–∞–∫–∂–µ –ø–æ–∑–¥—Ä–∞–≤–ª—è—é –≤—Å–µ—Ö, –∫—Ç–æ —Ä–∞–∑—Ä–∞–±–∞—Ç—ã–≤–∞–ª —Ç–µ–ª–µ–º–µ–¥-—Ä–µ—à–µ–Ω–∏—è, –ø–æ—Ç–æ–º—É —á—Ç–æ –æ–Ω–∏ –Ω–∞–∫–æ–Ω–µ—Ü —Ö–æ—Ç—å –∫–æ–º—É-—Ç–æ –ø—Ä–∏–≥–æ–¥—è—Ç—Å—è. –í—Å–µ–º —É–Ω—ã–ª—ã–º –∏ –ø–æ–Ω—É—Ä—ã–º —Ä—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—è–º —Ç–µ–ª–µ–º–µ–¥-–ø—Ä–æ–µ–∫—Ç–æ–≤ —Å –ø–ª–æ—Ö–∏–º–∏ –ø–æ–∫–∞–∑–∞—Ç–µ–ª—è–º–∏ –∏–∑ –∫—Ä—É–ø–Ω—ã—Ö –∫–æ–º–ø–∞–Ω–∏–π ‚Äî –æ—Ç–æ–∑–≤–∞—Ç—å –∑–∞—è–≤–ª–µ–Ω–∏—è –Ω–∞ —É–≤–æ–ª—å–Ω–µ–Ω–∏—è! –ñ–∏–∑–Ω—å –¥–∞—ë—Ç –≤—Ç–æ—Ä–æ–π —à–∞–Ω—Å.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders,clinical_trial,hospital_policy"",
  ""impact"": ""medium"",
  ""english"": ""The message discusses government incentives for telemedicine in Russia, including new performance indicators and their impact on healthcare providers. It highlights the potential for telemedicine companies to gain more influence through these measures, and encourages unhappy project leaders to reconsider their job applications.""
}"
2025-06-17T12:30:39+00:00,@pharm_icon,2268,https://t.me/pharm_icon/2268,"–ú–∏–ª–ª–∏–æ–Ω—ã –∑–∞ –ö–∞–Ω–µ—Ñ—Ä–æ–Ω—ã: —Å–º–æ–≥—É—Ç –ª–∏ –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å–Ω—ã–µ –≤—Ä–∞—á–∏-—Å–∞–º—É—Ä–∞–∏ –ø–æ–±–µ–¥–∏—Ç—å –≤ —Å—É–¥–µ? –ù–∞–∫–æ–Ω–µ—Ü-—Ç–∞–∫–∏ –ø—Ä–æ—Å—Ç—É–ø–∏–ª–æ —á—Ç–æ-—Ç–æ –∏–Ω—Ç–µ—Ä–µ—Å–Ω–æ–µ –≤ –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å–Ω–æ–π –ø–æ–≤–µ—Å—Ç–∫–µ, –∫–æ—Ç–æ—Ä–∞—è –≥–ª–æ—Ö–ª–∞ –∏ –≥–ª–æ—Ö–ª–∞. –ö–æ–º–ø–∞–Ω–∏—è ¬´–ë–∏–æ–Ω–æ—Ä–∏–∫–∞¬ª –ø–æ–¥–∞–ª–∞ –¥–æ—Å—É–¥–µ–±–Ω—ã–µ –ø—Ä–µ—Ç–µ–Ω–∑–∏–∏ –Ω–∞ –æ–±—â—É—é —Å—É–º–º—É 40 –º–ª–Ω —Ä—É–±–ª–µ–π –∫ —á–µ—Ç—ã—Ä–µ–º —Ä–æ—Å—Å–∏–π—Å–∫–∏–º –≤—Ä–∞—á–∞–º ‚Äî –ù—É—Ä–∞—Ö–º–µ–¥—É –ö–∞—Ä–∞–µ–≤—É, –ù–∏–∫–∏—Ç–µ –ñ—É–∫–æ–≤—É, –ï–≤–≥–µ–Ω–∏—é –ö–æ—Ä–æ–≤–∏–Ω—É –∏ –í–ª–∞–¥–∏–º–∏—Ä—É –ú–∞—Ä—á–µ–Ω–∫–æ ‚Äî –∑–∞ –ø—É–±–ª–∏—á–Ω—É—é –∫—Ä–∏—Ç–∏–∫—É –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –ö–∞–Ω–µ—Ñ—Ä–æ–Ω –∏ —Å–æ–º–Ω–µ–Ω–∏—è –≤ –µ–≥–æ –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å–Ω–æ–π —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏. –ß—Ç–æ —Å–¥–µ–ª–∞–ª –∫–∞–∂–¥—ã–π –∏–∑ –Ω–∏—Ö? 1. –ù—É—Ä–∞—Ö–º–µ–¥ –ö—É—Ä–∞–µ–≤ –Ω–∞–∑–≤–∞–ª –ï–≤—Ä–æ–ø–µ–π—Å–∫—É—é –∞—Å—Å–æ—Ü–∏–∞—Ü–∏—é –ø—Ä–æ–¥–∞–∂–Ω–æ–π (–∫—Ç–æ –±—ã —Å–æ–º–Ω–µ–≤–∞–ª—Å—è), –∞ –ö–∞–Ω–µ—Ñ—Ä–æ–Ω ‚Äî –Ω–µ—ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–º. –ê—Ä–≥—É–º–µ–Ω—Ç–æ–≤ –Ω–µ –ø—Ä–∏–≤—ë–ª. 2. –ù–∏–∫–∏—Ç–∞ –ñ—É–∫–æ–≤ –ø–æ-—Å—Ç–∞–ª–∏–Ω—Å–∫–∏ –≤–Ω—ë—Å –ö–∞–Ω—Ñ–µ—Ä–æ–Ω –≤ —Å–≤–æ–π —Ä–∞—Å—Å—Ç—Ä–µ–ª—å–Ω—ã–π —Å–ø–∏—Å–æ–∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤. 3. –ï–≤–≥–µ–Ω–∏–π –ö–æ—Ä–æ–≤–∏–Ω –≤–Ω—ë—Å –º–µ—Ç–∫—É ""—ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –Ω–µ –¥–æ–∫–∞–∑–∞–Ω–∞"" –≤ —Å–≤–æ–π —Å–µ—Ä–≤–∏—Å, –ø–æ—Ç–æ–º—É —á—Ç–æ —Ç–∞–º —è–∫–æ–±—ã –Ω–µ—Ç –∫–∞—á–µ—Å—Ç–≤–µ–Ω–Ω—ã—Ö –†–ö–ò (–∞–Ω—Ç–∏–±–∏–æ—Ç–∏–∫–∏ –ø–µ—Ä–µ–¥–∞—é—Ç –ø—Ä–∏–≤–µ—Ç). P.S. –ò–º–º—É–Ω–æ–ë–∏, –∫—Å—Ç–∞—Ç–∏, –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –ö–∞–Ω–µ—Ñ—Ä–æ–Ω–∞ –Ω–∞—à–ª–∞ –∏ —Ä–∞–∑–æ–±—Ä–∞–ª–∞, –∫–∞—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–º–∏ –∏—Ö –Ω–µ –Ω–∞–∑—ã–≤–∞–µ—Ç. –ó–∞–æ–¥–Ω–æ —É–∑–Ω–∞–ª–∞, –∫–∞–∫ –ø–∏—à—É—Ç—Å—è –∫–ª–∏–Ω—Ä–µ–∫–∏ –≤ –†–æ—Å—Å–∏–∏ (–∏ –º–Ω–æ–≥–æ –≥–¥–µ –µ—â—ë) ‚Äî –¥–∞–∂–µ —Å–ø–∏—Å–æ–∫ –ª–∏—Ç–µ—Ä–∞—Ç—É—Ä—ã –Ω–µ —Å–≤–µ—Ä—è—é—Ç. 4. –í–ª–∞–¥–∏–º–∏—Ä –ú–∞—Ä—á–µ–Ω–∫–æ –ø—Ä–æ—Å—Ç–æ –Ω–∞–∑–≤–∞–ª –ö–∞–Ω–µ—Ñ—Ä–æ–Ω –≥–æ–≤–Ω–æ-–ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–º –∏ –±–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–∏ –∞–∫—Ç–∏–≤–Ω–æ–π –¥–æ–±–∞–≤–∫–æ–π. –ß—Ç–æ —Å—á–∏—Ç–∞—é—Ç –≤ –∫–æ–º–ø–∞–Ω–∏–∏ –í –∫–æ–º–ø–∞–Ω–∏–∏ —Å—á–∏—Ç–∞—é—Ç, —á—Ç–æ —Ç–∞–∫–∏–µ –≤—ã—Å–∫–∞–∑—ã–≤–∞–Ω–∏—è –≤—Ä–µ–¥—è—Ç –¥–µ–ª–æ–≤–æ–π —Ä–µ–ø—É—Ç–∞—Ü–∏–∏ –∏ –≤–≤–æ–¥—è—Ç –≤ –∑–∞–±–ª—É–∂–¥–µ–Ω–∏–µ –ø–æ—Ç—Ä–µ–±–∏—Ç–µ–ª–µ–π, —Ç—Ä–µ–±—É—è —É–¥–∞–ª–∏—Ç—å –ø—É–±–ª–∏–∫–∞—Ü–∏–∏ –∏ –≤—ã—Å—Ç—É–ø–∏—Ç—å —Å –æ–ø—Ä–æ–≤–µ—Ä–∂–µ–Ω–∏–µ–º. –ß—Ç–æ –±—É–¥–µ—Ç –¥–∞–ª—å—à–µ –ø–æ –º–æ–µ–º—É –º–Ω–µ–Ω–∏—é? 1. –ö–æ–º–ø–∞–Ω–∏—è –ø—Ä–µ–¥—ä—è–≤–∏—Ç –≤ —Å—É–¥–µ —Å—Ç–∞—Ç—å–∏ –∏ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è, –±–ª–∞–≥–æ–¥–∞—Ä—è –∫–æ—Ç–æ—Ä—ã–º –ø–æ–ª—É—á–∏–ª–∞ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—é. –¢–∞–º –±—É–¥–µ—Ç –Ω—É–∂–Ω—ã–π —Ä–µ–∑—É–ª—å—Ç–∞—Ç, –∫–æ—Ç–æ—Ä—ã–π —É–±–µ–¥–∏—Ç —Å—É–¥ –≤ —á–µ–º-—Ç–æ —Ç–∞–º. 2. –ë–∏–æ–Ω–æ—Ä–∏–∫–∞ –≤—ã–∏–≥—Ä–∞–µ—Ç –¥–µ–ª–æ –∏ –∑–∞—Ä–∞–º–∑–∞–Ω–∏—Ç —á–∞—Å—Ç—å –±–ª–æ–≥–µ—Ä–æ–≤ ‚Äî –∑–∞—Å—Ç–∞–≤–∏—Ç –ø–æ–∫–∞—è—Ç—å—Å—è –∑–∞ —Å–æ–∂–∂–µ–Ω–∏–µ –∏–Ω—Å—Ç—Ä—É–∫—Ü–∏–∏ –∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç—É. 3. –û—Å—Ç–∞–ª—å–Ω—ã–µ –∫–æ–º–ø–∞–Ω–∏–∏, –∫–æ—Ç–æ—Ä—ã–µ –±—ã–ª–∏ —Ä–∞—Å–∫—Ä–∏—Ç–∏–∫–æ–≤–∞–Ω—ã, –≤ —Å–ª—É—á–∞–µ —É—Å–ø–µ—Ö–∞ –ë–∏–æ–Ω–æ—Ä–∏–∫–∏ –ø–æ–¥–∫–ª—é—á–∞—Ç—Å—è –∫ —Ä–µ–ø—Ä–µ—Å—Å–∏–≤–Ω–æ–º—É –º–æ—á–∏–ª–æ–≤—É. –£ –≤—Ä–∞—á–µ–π –∑–∞–±–µ—Ä—É—Ç –ø—Ä–∞–≤–æ –≤—ã—Å–∫–∞–∑—ã–≤–∞—Ç—å—Å—è –æ —á–µ–º-–ª–∏–±–æ –≤ –∫—Ä–∏—Ç–∏—á–µ—Å–∫–æ–º –∫–ª—é—á–µ. –ß—Ç–æ —è –¥—É–º–∞—é 1. –Ø –ø—Ä–æ—Ç–∏–≤ –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏—è —Å–≤–æ–±–æ–¥—ã —Å–ª–æ–≤–∞. 2. –ù–µ –¥–æ–ª–∂–Ω—ã –±—ã—Ç—å —Ç–∞–∫–∏–º–∏ –∫—Ä—É–ø–Ω—ã–º–∏ –∏—Å–∫–∏ –ø—Ä–æ—Ç–∏–≤ –¥–æ–∫—Ç–æ—Ä–æ–≤. 1 —Ä—É–±–ª—å –≤–º–µ—Å—Ç–æ 10 –º–∏–ª–ª–∏–æ–Ω–æ–≤ ‚Äî –Ω–æ—Ä–º–∞–ª—å–Ω–æ –∏ –∫—Ä–∞—Å–∏–≤–æ. –ê —Ç–∞–∫ –ë–∏–æ–Ω–æ—Ä–∏–∫–∞ –º–µ–ª–æ—á–∏—Ç—Å—è. –ü—É—Å—Ç—å —Å—É–¥ —Ä–µ—à–∏—Ç —á—Ç–æ-—Ç–æ, —Ö–æ—Ç—è –≤ –µ–≥–æ –Ω–µ–∑–∞–≤–∏—Å–∏–º–æ—Å—Ç—å –≤–µ—Ä—è—Ç —Ç–æ–ª—å–∫–æ –∫—Ä–µ—Ç–∏–Ω—ã ‚Äî –Ω–µ –≤ –æ–±–∏–¥—É –ª—é–¥—è–º —Å –≥–∏–ø–æ—Ç–∏—Ä–µ–æ–∑–æ–º. 3. –Ø –¥—É–º–∞—é, —á—Ç–æ –Ω–∞–¥–æ –æ–±—ä–µ–∫—Ç–∏–≤–∏–∑–∏—Ä–æ–≤–∞—Ç—å –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é –Ω–∞ —Å–ø—Ä–∞–≤–æ—á–Ω—ã—Ö —Ä–µ—Å—É—Ä—Å–∞—Ö, –∞ –∏–º–µ–Ω–Ω–æ ‚Äî –¥–∞—Ç—å —Å—Å—ã–ª–∫–∏ –Ω–∞ –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ —Ö–æ—Ä–æ—à–∏–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –∏ —É–∫–∞–∑–∞—Ç—å, —á—Ç–æ –æ–Ω–∏ –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ —Ö–æ—Ä–æ—à–∏–µ –≤ —Ñ–æ—Ä–º–∞—Ç–µ —ç–∫—Å–ø–µ—Ä—Ç–Ω–æ–≥–æ –∫–æ–º–º–µ–Ω—Ç–∞—Ä–∏—è. –î–∞—Ç—å —Å—Å—ã–ª–∫–∏ –Ω–∞ –º–µ—Ç–∞-–∞–Ω–∞–ª–∏–∑—ã, –≥–¥–µ –ø–æ–∫–∞–∑—ã–≤–∞–µ—Ç—Å—è –Ω–µ—ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å. –ë—É–¥–µ—Ç –¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ. 4. –ò–∑–≤–∏–Ω—è—Ç—å—Å—è –∑–∞ —Å–≤–æ–µ–º –º–Ω–µ–Ω–∏–µ –≤ –±–ª–æ–≥–∞—Ö 100% –Ω–µ –Ω—É–∂–Ω–æ. Lada –∂–µ –Ω–µ —Ç—Ä–µ–±—É–µ—Ç –æ—Ç –≤–æ–¥–∏—Ç–µ–ª–µ–π –∏–∑–≤–∏–Ω—è—Ç—å—Å—è –∑–∞ –º–Ω–µ–Ω–∏–µ –æ–± –∞–≤—Ç–æ–º–æ–±–∏–ª–µ Lada, –Ω–∞–ø—Ä–∏–º–µ—Ä. –≠—Ç–æ –ø–ª–æ—Ö–∞—è –ø—Ä–∞–∫—Ç–∏–∫–∞. 5. –í —Ü–µ–ª–æ–º —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏–π —à–∞–≥ –ø–æ–Ω—è—Ç–µ–Ω ‚Äî –Ω–∞—á–∏–Ω–∞–µ—Ç—Å—è –±–æ—Ä—å–±–∞ –∑–∞ —É–º—ã –≤—Ä–∞—á–µ–π-–∑—É–º–µ—Ä–æ–≤ –∏ –≤—Ä–∞—á–µ–π-–º–∏–ª–ª–µ–Ω–∏–∞–ª–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ –ø–æ—Ç—Ä–µ–±–ª—è—é—Ç –∫–ª–∏–ø–æ–≤—ã–π –∫–æ–Ω—Ç–µ–Ω—Ç, –∫–∞–∫ —Ç–ª—è. –¢–∞–∫–∏–µ –ø–æ–∂–∏–ª—ã–µ —Ç—ë—Ç–∫–∏, –∫–∞–∫ —è –∏–ª–∏ –∏–º–º—É–Ω–æ–±–∏, –º–æ–≥—É—Ç –∑–∞–ª–µ–∑—Ç—å –∏ —á—Ç–æ-—Ç–æ –ø–æ—Å–º–æ—Ç—Ä–µ—Ç—å, –∞ –≤–æ—Ç –∑–µ—Ç–∫–∏ –±—É–¥—É—Ç —á–∏—Ç–∞—Ç—å –ø–æ—Å—Ç—ã –≤–º–µ—Å—Ç–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π. –ü–æ—Å–µ–º—É –ø—Ä–∞–∫—Ç–∏–∫–∞ —ç–ª–∏–º–∏–Ω–∞—Ü–∏–∏ –∏–∑ –ø–æ—Å—Ç–æ–≤ —á—É–≤—Å—Ç–≤–∏—Ç–µ–ª—å–Ω–æ–≥–æ –∫–æ–Ω—Ç–µ–Ω—Ç–∞ ‚Äî —ç—Ç–æ –§–∞—Ä–º–Æ—Ä–∏–¥–∏—á–µ—Å–∫–∏–π —Ç—Ä–µ–Ω–¥. –ò —Ç—É—Ç –Ω–µ —Ç–æ–ª—å–∫–æ –ë–∏–æ–Ω–æ—Ä–∏–∫–∞ –ø—Ä–∏ –¥–µ–ª–∞—Ö ‚Äî —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏—è ¬´–ì–µ–Ω–µ—Ä–∏—É–º¬ª –æ–±–≤–∏–Ω–∏–ª–∞ –≥–ª–∞–≤—É —Ñ–æ–Ω–¥–∞ ¬´–ü–æ–º–æ—â—å —Å–µ–º—å—è–º –°–ú–ê¬ª, –Ω–µ–≤—Ä–æ–ª–æ–≥–∞, –∫.–º.–Ω –ê–ª–µ–∫—Å–∞–Ω–¥—Ä–∞ –ö—É—Ä–º—ã—à–∫–∏–Ω–∞ –≤ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω–µ–Ω–∏–∏ –ª–æ–∂–Ω–æ–π –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–∏ –æ –∫–æ–º–ø–∞–Ω–∏–∏ –∏ –µ–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–µ ¬´–õ–∞–Ω—Ç–µ—Å–µ–Ω—Å¬ª. 6. –ë–∏–∑–Ω–µ—Å –∏–º–µ–µ—Ç –ø—Ä–∞–≤–æ –∑–∞—â–∏—â–∞—Ç—å —Å–≤–æ–∏ –∏–Ω—Ç–µ—Ä–µ—Å—ã, –∞ –≤—Ä–∞—á–∏ ‚Äî –¥–æ–ª–∂–Ω—ã –Ω–∞—É—á–∏—Ç—å—Å—è –∑–∞—â–∏—â–∞—Ç—å —Å–≤–æ–∏, –≤ —Ç–æ–º —á–∏—Å–ª–µ ‚Äî –Ω–∞ –æ—Ü–µ–Ω–æ—á–Ω—ã–µ —Å—É–∂–¥–µ–Ω–∏—è. –ö–æ–Ω–µ—á–Ω–æ, –Ω–∞–¥–æ –≥–æ–≤–æ—Ä–∏—Ç—å –æ —Ç–µ–º–µ –∏ –∞–∫—Ç–∏–≤–Ω–æ –¥–µ–ª–∏—Ç—å—Å—è –º–Ω–µ–Ω–∏—è–º–∏ –æ —Å–∏—Ç—É–∞—Ü–∏–∏. –í –∫–∞–∫–æ–π-—Ç–æ –º–æ–º–µ–Ω—Ç –≤—ã, –≤—Ä–∞—á–∏, —Å–∫–∞–∂–µ—Ç–µ –≤ –∫–∞–±–∏–Ω–µ—Ç–µ –ø–∞—Ü–∏–µ–Ω—Ç—É, —á—Ç–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç –• –Ω–µ –∫–∞–∂–µ—Ç—Å—è –≤–∞–º —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã–º ‚Äî –∏ –∫ –≤–∞–º –≤–æ—Ä–≤—ë—Ç—Å—è –û–ú–û–ù, –∞ –≥–æ–≤–æ—Ä–∏—Ç—å –∑–∞ –≤–∞—Å –±—É–¥–µ—Ç —É–∂–µ –Ω–µ–∫–æ–º—É.","{""skip"": true}"
2025-06-15T10:41:16+00:00,@pharm_icon,2267,https://t.me/pharm_icon/2267,"–° –î–Ω—ë–º –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ —Ä–∞–±–æ—Ç–Ω–∏–∫–∞!‚ûï‚ù§Ô∏èüíä‚ûï –ú–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–∏, –∂–µ–ª–∞—é –≤–∞–º –±—ã—Ç—å –Ω–∞–≤–µ—Å–µ–ª–µ, —á—Ç–æ–±—ã –Ω–µ –ø–æ–µ—Ö–∞—Ç—å –∫—É–∫—É—Ö–æ–π —Å–ª–∏—à–∫–æ–º —Ä–∞–Ω–æ –∏ –Ω–µ —É–Ω—ã–≤–∞—Ç—å –≤ –±—É–¥–Ω–∏–µ –∏ –≤—ã—Ö–æ–¥–Ω–∏–µ –¥–Ω–∏. –ü–æ–Ω–∏–º–∞—é, —á—Ç–æ –≤ –±–ª–∏–∂–∞–π—à–µ–º –±—É–¥—É—â–µ–º –≤–∞—Å –∂–¥—É—Ç: - —Å–∫—Ä–∏–Ω–∏–Ω–≥ –ø—è—Ç–∏–ª–µ—Ç–Ω–∏—Ö –¥–µ—Ç–µ–π –Ω–∞ —Ñ–µ—Ä—Ç–∏–ª—å–Ω–æ—Å—Ç—å; - –∏—Å–ø—ã—Ç–∞–Ω–∏—è –æ—Ç–∑—ã–≤–∞–º–∏ –º–∏–ª–ª–µ–Ω–∏–∞–ª–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ –ø—Ä–∏–≤—ã–∫–ª–∏ –∫ —Ü–∏—Ñ—Ä–æ–≤—ã–º —Å–µ—Ä–≤–∏—Å–∞–º –∏ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ –ø–æ–∂–∞–ª—É—é—Ç—Å—è –Ω–∞ –Ω–µ–≤–∫—É—Å–Ω—ã–π –ª–∞—Ç—Ç–µ –≤ –ø–æ–ª–∏–∫–ª–∏–Ω–∏–∫–µ; - –ø—Ä–æ–ø–∞–≥–∞–Ω–¥–∞ —Ä–æ–¥–æ–≤ —É —Å—Ç–∞—Ä—É—Ö; - –ø—Ä–∏–∑—ã–≤—ã –¥–µ–ª–∞—Ç—å –ø—Ä–∏–ø–∏—Å–∫–∏ –≤ –∏–± —Å –ø–æ—Å–ª–µ–¥—É—é—â–µ–π —Å–¥–∞—á–µ–π –≤ –æ–±–µ–∑—å—è–Ω–Ω–∏–∫; - –∏ –º–Ω–æ–≥–æ –¥—Ä—É–≥–∏—Ö —á—É–¥–µ—Å–Ω—ã—Ö –≤–µ—â–µ–π! –î–∞ –ø—Ä–∏–±—É–¥—É—Ç —Å –≤–∞–º–∏ —Å–∏–ª–∞ –∏ —Ä–∞—Å—Å—É–¥–æ–∫ –ø—Ä–∏ –∫–ª–æ—É–Ω–∞—Ö –≤ —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–µ!","{""skip"": true}"
2025-06-11T09:45:00+00:00,@pharm_icon,2266,https://t.me/pharm_icon/2266,"–û–±—è–∑–∞—Ç—å —Å—Ç—Ä–∞–Ω—ã –°–ù–ì –≤—ã–¥–µ–ª—è—Ç—å –ø–æ 0,4% –í–í–ü –Ω–∞ R&D –¥–ª—è —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–π? üî• ‚Äî –¥–∞-–¥–∞-–¥–∞ üóø ‚Äî –Ω–µ—Ç","{""skip"": true}"
2025-06-11T09:37:15+00:00,@pharm_icon,2265,https://t.me/pharm_icon/2265,"–ü–∞—Ä–∞–ê–Ω—Ç–∏–í–∞–∫—Å–µ—Ä –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç –ª–æ–º–∞—Ç—å FDAüòÅü§åüèª –ì—Ä–∞—Ü–∏—è –ø–æ–ª–∏—Ç–∏—á–µ—Å–∫–∏—Ö –≤—ã—Å–∫–∞–∑—ã–≤–∞–Ω–∏–π –Ω–µ –ø–æ–∫–∏–¥–∞–µ—Ç —Å–µ–º–µ–π—Å—Ç–≤–æ –ö–µ–Ω–Ω–µ–¥–∏ —É–∂–µ –º–Ω–æ–≥–æ –ø–æ–∫–æ–ª–µ–Ω–∏–π, –∏ –†–æ–±–µ—Ä—Ç –§—Ä—ç–Ω—Å–∏—Å-–º–ª–∞–¥—à–∏–π, –≥–ª–∞–≤–∞ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –°–®–ê ‚Äî –≤–æ–≤—Å–µ –Ω–µ –∏—Å–∫–ª—é—á–µ–Ω–∏–µ. –° –ª—ë–≥–∫–æ–π –ø–æ–¥–∞—á–∏ —Ä—É–∫–∏ –æ–Ω —Ä–∞—Å–ø—É—Å—Ç–∏–ª –≤–µ—Å—å —Å–æ–≤–µ—Ç –ø–æ –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏–∏ –≤–Ω—É—Ç—Ä–∏ CDC (–≥–ª–∞–≤–Ω—ã–π –æ—Ä–≥–∞–Ω –ø–æ —Å–∞–Ω—ç–ø–∏–¥–Ω–∞–¥–∑–æ—Ä—É –∏ –≤–∞–∫—Ü–∏–Ω–∞–º) –∏–∑ 17 —á–ª–µ–Ω–æ–≤, 13 –∏–∑ –∫–æ—Ç–æ—Ä—ã—Ö –±—ã–ª–∏ –¥–∞–Ω—ã –≤ –∫–∞–Ω–¥–∏–¥–∞—Ç—ã –µ—â—ë –ø—Ä–∏ –ë–∞–π–¥–µ–Ω–µ. –£—á–∏—Ç—ã–≤–∞—è –∏—Ö –≤–ª–∏—è–Ω–∏–µ –Ω–∞ –ø–æ–ª–∏—Ç–∏–∫—É –ø–æ –≤–∞–∫—Ü–∏–Ω–∞–º (–∏ —Ä–∞—Å—Ö–æ–¥–∞–º –Ω–∞ –Ω–∏—Ö) ‚Äî –ö–µ–Ω–Ω–µ–¥–∏ —Ä–µ—à–∏–ª –∑–∞—á–∏—Å—Ç–∏—Ç—å –ø–ª–æ—â–∞–¥–∫—É –ø–æ–¥ –Ω–æ–≤—É—é –≥—Ä—É–ø–ø—É. –ü—Ä–∏–∫—Ä—ã–≤–∞–ª –æ–Ω —ç—Ç–æ –∏–∑–≤–µ—Å—Ç–Ω–æ–π —É—Ç–µ—Ä–µ–π –¥–æ–≤–µ—Ä–∏—è –∏–∑-–∑–∞ –∫–æ–≤–∏–¥–Ω—ã—Ö –≤–∞–∫—Ü–∏–Ω –∏ –±—É—Å—Ç–µ—Ä–æ–≤, –∞ —Ç–∞–∫–∂–µ ‚Äî –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç—å—é –≤–æ—Å—Å—Ç–∞–Ω–æ–≤–∏—Ç—å –≥–ª–∞–≤–µ–Ω—Å—Ç–≤–æ –±–µ—Å–ø—Ä–∏—Å—Ç—Ä–∞—Å—Ç–Ω–æ—Å—Ç–∏ –Ω–∞—É–∫–∏ –ø—Ä–∏ –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–∏–∏ –ø–æ–ª–∏—Ç–∏–∫–∏ –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏–∏. –ö–∞–∫ –≥–æ–≤–æ—Ä–∏—Ç—Å—è, –≤—Ä–µ–º—è –≤—ã–±–∏—Ä–∞—Ç—å —É–¥–æ–±–Ω—ã–µ —Å–∏—Å—Ç–µ–º–∞—Ç–∏—á–µ—Å–∫–∏–µ –æ–±–∑–æ—Ä—ã –í –ø—Ä–æ—Ç–∏–≤–æ–≤–µ—Å –ö–µ–Ω–Ω–µ–¥–∏ –≤—ã—Å—Ç—É–ø–∞–µ—Ç –∑–∞—è–≤–ª—è—é—â–∏–π –æ –Ω–µ–ø–æ—Ä–æ—á–Ω–æ—Å—Ç–∏ –∫–æ–º–∏—Ç–µ—Ç–∞ –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—å –ê–ú–ê (–ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–π –ú–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ê—Å—Å–æ—Ü–∏–∞—Ü–∏–∏) –ë—Ä—é—Å –°–∫–æ—Ç—Ç, –≥–æ–≤–æ—Ä—è—â–∏–π –æ —Ä–∏—Å–∫–∞—Ö –¥–ª—è —Å–∏—Å—Ç–µ–º—ã –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏–∏ –≤ –°–®–ê, –∫–æ—Ç–æ—Ä–∞—è —Å—Ç–∞–≤–∏—Ç—Å—è –ø–æ–¥ —É–≥—Ä–æ–∑—É –¥–µ–π—Å—Ç–≤–∏—è–º–∏ —á–µ–ª–æ–≤–µ–∫–∞ —Å —á–µ—Ä–≤–µ–º –≤ –≥–æ–ª–æ–≤–µ (–ö–µ–Ω–Ω–µ–¥–∏). –°–æ —Å–ª–æ–≤ –Ω–µ–∫–æ—Ç–æ—Ä—ã—Ö —Ä–µ—Å–ø—É–±–ª–∏–∫–∞–Ω—Ü–µ–≤ –≤ –°–µ–Ω–∞—Ç–µ, –ö–µ–Ω–Ω–µ–¥–∏ –∫–∏–Ω—É–ª –∏—Ö, –æ–±–µ—â–∞—è —Å–æ—Ö—Ä–∞–Ω–∏—Ç—å —Å–æ–≤–µ—Ç –±–µ–∑ –∏–∑–º–µ–Ω–µ–Ω–∏–π. –ö–∞–∑–∞–ª–æ—Å—å, –∑–∞—á–µ–º –æ–±–µ—â–∞—Ç—å —Ç–∞–∫–æ–µ –≤—Ä–æ–¥–µ –∫–∞–∫ –Ω–µ–≤–∞–∂–Ω–æ–µ –¥–µ–π—Å—Ç–≤–∏–µ –ø–æ–ª–∏—Ç–∏–∫–∞–º? –í–∏–¥–∏–º–æ, –∫–æ–Ω—Ñ–ª–∏–∫—Ç –∏–Ω—Ç–µ—Ä–µ—Å–æ–≤ –∑–∞ –∫–ª—é—á–µ–≤—ã–µ –¥–æ–ª–∂–Ω–æ—Å—Ç–∏ –ø—Ä–æ–¥–æ–ª–∂–∞–µ—Ç—Å—è, –∞ –≤–æ—Ç –∑–∞—Å–µ–¥–∞–Ω–∏–µ —Å–æ–≤–µ—Ç–∞ –Ω–∞ 24-27 –∏—é–Ω—è –ø—Ä–æ –∫–æ–≤–∏–¥ –Ω–∏–∫—Ç–æ –Ω–µ –ø–µ—Ä–µ–Ω—ë—Å. –í–æ–∑–º–æ–∂–Ω–æ, —Ä–µ–∑—É–ª—å—Ç–∞—Ç –±—É–¥–µ—Ç –Ω–µ—Å–∫–æ–ª—å–∫–æ –Ω–µ–æ–∂–∏–¥–∞–Ω–Ω—ã–º –∏ –æ—Ç –Ω–æ–≤—ã—Ö –ª–∏—Ü, –∫–æ—Ç–æ—Ä—ã–µ —É–∂–µ –ø–æ–¥–≥–æ—Ç–æ–≤–∏–ª–∏—Å—å –∫ —ç—Ç–æ–π –¥–∞—Ç–µ –∏ —Å—Ç–æ—è—Ç –Ω–∞ –Ω–∏–∑–∫–æ–º —Å—Ç–∞—Ä—Ç–µ, —á—Ç–æ–±—ã –ø—Ä–æ—Ü–∏—Ç–∏—Ä–æ–≤–∞—Ç—å —Ä–∞—Å—à–∏—Ä–µ–Ω–Ω—É—é –≤–µ—Ä—Å–∏—é –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –∏–∑ –∂—É—Ä–Ω–∞–ª–∞ Vaccines. –ó–∞–≥–æ—Ç–∞–≤–ª–∏–≤–∞–µ–º –∫–æ–ª—å—Ü–∞ –∫–∞–ª—å–º–∞—Ä–∞ –∏ –∫—Ä–∞—Ñ—Ç–æ–≤—ã–µ –±–µ–∑–∞–ª–∫–æ–≥–æ–ª—å–Ω—ã–µ –Ω–∞–ø–∏—Ç–∫–∏ –Ω–∞ 24-27 –∏—é–Ω—è, —á—Ç–æ–±—ã –æ—Ç—Å–ª–µ–¥–∏—Ç—å –≥–ª–∞–≤–Ω—ã–µ –Ω–æ–≤–æ—Å—Ç–∏ –≤ –º–∏—Ä–µ –≤–∞–∫—Ü–∏–Ω–∞—Ü–∏–∏.","{""skip"": true}"
2025-06-11T06:03:15+00:00,@pharm_icon,2263,https://t.me/pharm_icon/2263,"–ù–ê–¢–û –¥–ª—è —Ñ–∞—Ä–º—ã –û–¥–Ω–∏–º –∏–∑ –ø—Ä–µ–¥–≤—ã–±–æ—Ä–Ω—ã—Ö –æ–±–µ—â–∞–Ω–∏–π –¢—Ä–∞–º–ø–∞ –±—ã–ª–æ —Å–Ω–∏–∂–µ–Ω–∏–µ —Ü–µ–Ω –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –¥–ª—è –∞–º–µ—Ä–∏–∫–∞–Ω—Ü–µ–≤. –°—É—Ç—å –µ–≥–æ –ø—Ä–µ—Ç–µ–Ω–∑–∏–∏: –º—ã –Ω–µ—Å–µ–º –æ—Å–Ω–æ–≤–Ω–æ–µ –±—Ä–µ–º—è —Ä–∞—Å—Ö–æ–¥–æ–≤ –Ω–∞ —Ä–∞–∑–≤–∏—Ç–∏–µ —Ñ–∞—Ä–º—ã –∏ —Å–æ–∑–¥–∞–Ω–∏–µ –º–µ–¥–∏–∫–∞–º–µ–Ω—Ç–æ–≤ –∏ —Ç–µ—Ö–Ω–∏–∫–∏, –∞ –≤ –∏—Ç–æ–≥–µ —Ü–µ–Ω—ã –≤—ã—à–µ –∏–º–µ–Ω–Ω–æ —É –Ω–∞—Å. –ù–µ–ø—É–±–ª–∏—á–Ω–æ: —Ä–∞—Å—Ö–æ–¥—ã –Ω–∞ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫—É –∏ –º–∞—Ä–∫–µ—Ç–∏–Ω–≥ –≤ –ê–º–µ—Ä–∏–∫–µ –≤—ã–∑—ã–≤–∞—é—Ç –∂–µ–ª–∞–Ω–∏–µ –æ—Ç–±–∏—Ç—å –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–∏ —É —Ñ–∞—Ä–º—ã, –∫–æ—Ç–æ—Ä–∞—è –±–µ—Ä–µ—Ç –¥–µ—Å—è—Ç–∫–∏ –º–∏–ª–ª–∏–∞—Ä–¥–æ–≤ –¥–æ–ª–ª–∞—Ä–æ–≤ —Å –Ω–∞—Å–µ–ª–µ–Ω–∏—è –∑–∞ —Å—á—ë—Ç –∑–ª–æ—É–ø–æ—Ç—Ä–µ–±–ª–µ–Ω–∏—è –ø–∞—Ç–µ–Ω—Ç–∞–º–∏, —é—Ä–∏—Å—Ç–∞–º–∏ –∏ –≤–ª–∏—è–Ω–∏–µ–º –Ω–∞ FDA, –∞ —Ç–∞–∫–∂–µ –º–æ—â–Ω—ã–º –ª–æ–±–±–∏ —É—Ä–æ–≤–Ω—è –Ω–µ—Ñ—Ç—è–Ω–∫–∏ –∏ –æ—Ä—É–∂–µ–π–Ω–æ–π –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏ (PhRMA). –õ—é–¥–∏ –ø–ª–∞—Ç—è—Ç –Ω–∞–ª–æ–≥–∞–º–∏, –∞ –ø–æ–ª—É—á–∞—é—Ç –¥–æ—Ä–æ–≥–∏–µ –∏ –Ω–µ–¥–æ—Å—Ç—É–ø–Ω—ã–µ –ø—Ä–æ–¥—É–∫—Ç—ã –¢—Ä–∞–º–ø —Ö–æ—á–µ—Ç –¥–æ–±–∏—Ç—å—Å—è –¥–æ—Å—Ç–∏–∂–µ–Ω–∏—è –Ω–∞–∏–º–µ–Ω—å—à–∏—Ö —Ü–µ–Ω –¥–ª—è –∞–º–µ—Ä–∏–∫–∞–Ω—Ü–µ–≤ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å–æ —Å—Ç—Ä–∞–Ω–∞–º–∏ —Å –¥–æ–ª–µ–π –í–í–ü –¥–æ 60% –æ—Ç –°–®–ê. –ù–∞ –¥–∞–Ω–Ω—ã–π –º–æ–º–µ–Ω—Ç –¥–µ–π—Å—Ç–≤–∏–µ –∞–Ω–∞–ª–æ–≥–∞ –ñ–ù–í–õ–ü –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–æ –∏–∑-–∑–∞ –ø–∏–ª–æ—Ç–Ω–æ–≥–æ —Å—Ç–∞—Ç—É—Å–∞ –ø—Ä–æ–µ–∫—Ç–∞. –ö—Å—Ç–∞—Ç–∏, —Ä–∞–∑–≤–∏–≤–∞—Ç—å —ç—Ç—É —Ç–µ–º—É –æ–Ω –Ω–∞—á–∞–ª –µ—â—ë –≤ —Å–≤–æ–π –ø—Ä–æ—à–ª—ã–π —Å—Ä–æ–∫, –Ω–æ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–µ–π –∑–∞–Ω—è–ª–∏—Å—å —É–∂–µ –¥–µ–º–æ–∫—Ä–∞—Ç—ã. –ú–µ—Ö–∞–Ω–∏–∑–º —Å–Ω–∏–∂–µ–Ω–∏—è –∑–∞—Ç—Ä–∞—Ç –°–®–ê –ø–æ–∫–∞ –Ω–µ–∏–∑–≤–µ—Å—Ç–µ–Ω ‚Äî –≤–∏–¥–∏–º–æ, –µ–≤—Ä–æ–ø–µ–π—Ü—ã –Ω–µ –≥–æ—Ç–æ–≤—ã –ø–ª–∞—Ç–∏—Ç—å –±–æ–ª—å—à–µ –¥–µ–Ω–µ–≥ –∑–∞–º–µ—Å—Ç–æ –º–µ–Ω—å—à–∏—Ö —Å—É–º–º —Ä–∞–Ω—å—à–µ, –∞ —Ñ–∞—Ä–º–∞ –Ω–µ —Ö–æ—á–µ—Ç —Ç–µ—Ä—è—Ç—å –¥–æ–π–Ω—É—é –∫–æ—Ä–æ–≤—É. –ê–ª—å—Ç–µ—Ä–Ω–∞—Ç–∏–≤–Ω–æ–µ —Ä–µ—à–µ–Ω–∏–µ –ø—Ä–æ–±–ª–µ–º—ã, –∞ –ª—É—á—à–µ —Å–∫–∞–∑–∞—Ç—å ‚Äî –≤–∞—Ä–∏–∞–Ω—Ç —Å–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è ‚Äî –ø—Ä–µ–¥–ª–æ–∂–∏–ª –°–ï–û –ü—Ñ–∞–π–∑–µ—Ä –ë—É—Ä–ª—ã. –û–Ω –ø—Ä–µ–¥–ª–∞–≥–∞–µ—Ç —Å–æ–∑–¥–∞—Ç—å –∞–Ω–∞–ª–æ–≥ –ù–ê–¢–û —Å –Ω–æ—Ä–º–æ–π –±—é–¥–∂–µ—Ç–∞ –≤ –¥–æ–ª—é –í–í–ü –¥–ª—è —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤. –ê —Ç–∞–∫ –º–æ–∂–Ω–æ –±—ã–ª–æ? –ü–æ –µ–≥–æ —Å–ª–æ–≤–∞–º, —Å—Ç—Ä–∞–Ω—ã –ï–° —Å –∏—Ö –¥–æ–ª—è–º–∏ —Ä–∞—Å—Ö–æ–¥–æ–≤ –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–µ –∏–Ω–Ω–æ–≤–∞—Ü–∏–∏ –≤ 0,6/0,5/0,3% –í–í–ü/–≥–æ–¥ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å 0,8% –í–í–ü –°–®–ê - ""–∑–∞–Ω–∏–º–∞–ª–∏—Å—å –Ω–∞—Ö–ª–µ–±–Ω–∏—á–µ—Å—Ç–≤–æ–º"", –∞ –∏—Ö –ø—Ä–∏–≤—ã—á–∫–∞ —É—Å—Ç–∞–Ω–∞–≤–ª–∏–≤–∞—Ç—å —Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ —Ü–µ–Ω—ã –Ω–∞ –Ω–æ–≤—ã–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –ø—Ä–∏–≤–æ–¥–∏—Ç –∫ –Ω–µ–≥–∞—Ç–∏–≤—É –≤ —Ä–∞–∑–≤–∏—Ç–∏–∏ —Ñ–∞—Ä–º—ã. –û—á–µ–≤–∏–¥–Ω–æ, —á—Ç–æ –≥–æ—Å–ø–æ–¥–∏–Ω –ë—É—Ä–ª–∞ –ø–µ—Ä–µ—Å–º–æ—Ç—Ä–µ–ª –∫–æ–Ω—Ç–µ–Ω—Ç–∞ —Å –î–∂–µ–π –î–∏ –í—ç–Ω—Å–æ–º –∏ –ø—Ä–æ—á–∏–º–∏ –∫–ª–æ—É–Ω–∞–º–∏ –∏–∑ –∫–æ–º–∞–Ω–¥—ã –¢—Ä–∞–º–ø–∞ –ü—Ä–æ–¥–æ–ª–∂–∞—è –æ—Ç—Å—Ç–∞–∏–≤–∞—Ç—å –ø–æ–∑–∏—Ü–∏—é, –ë—É—Ä–ª–∞ –∑–∞—è–≤–∏–ª, —á—Ç–æ –¢—Ä–∞–º–ø –Ω–∞–¥–∞–≤–∏—Ç –Ω–∞ —Ñ–∞—Ä–º—É —Ç–∞—Ä–∏—Ñ–∞–º–∏ –∏ –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏—è–º–∏, –µ—Å–ª–∏ –æ–Ω–∏ –Ω–µ –∑–∞—Ö–æ—Ç—è—Ç –∏–Ω–≤–µ—Å—Ç–∏—Ä–æ–≤–∞—Ç—å –≤ –°–®–ê, –∞ –∏–º–µ–Ω–Ω–æ ‚Äî –ø–µ—Ä–µ–Ω–æ—Å–∏—Ç—å –∑–∞–≤–æ–¥—ã –∏ –ª–æ–∫–∞–ª—å–Ω–æ –≤–∫–ª–∞–¥—ã–≤–∞—Ç—å—Å—è –≤ –Ω–∞—É–∫—É. –í–∏–¥–∏–º–æ, –ø–æ–Ω–∏–º–∞—è —Ç—Ä—É–¥–Ω–æ—Å—Ç—å –∏ –∫–æ–º–ø–ª–µ–∫—Å–Ω–æ—Å—Ç—å –º–∞–∫—Å–∏–º–∞–ª—å–Ω—ã—Ö —Ç—Ä–µ–±–æ–≤–∞–Ω–∏–π –¢—Ä–∞–º–ø–∞, –ë—É—Ä–ª–∞ –ø—Ä–µ–¥—ä—è–≤–ª—è–µ—Ç –≤—Å—Ç—Ä–µ—á–Ω—ã–µ —Ç—Ä–µ–±–æ–≤–∞–Ω–∏—è –¥–ª—è —Ä—ã–Ω–∫–æ–≤ ‚Äî –ø—Ä–∏–¥—ë—Ç—Å—è –≤—ã–±–∏—Ä–∞—Ç—å –º–µ–∂–¥—É —Ü–µ–Ω–∞–º–∏ –∏ –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏—è–º–∏. –û–ø—è—Ç—å –¥–≤–∞ —Å—Ç—É–ª–∞. –í —ç—Ç–æ–º —Å–≤–µ—Ç–µ –æ–Ω –∂–µ –ø–æ–¥–∞—ë—Ç –∏–¥–µ—é –§–∞—Ä–º–ù–ê–¢–û - –∫–æ–º–ø—Ä–æ–º–∏—Å—Å–Ω–æ–π –∞–ª—å—Ç–µ—Ä–Ω–∞—Ç–∏–≤—ã, —á–∞—Å—Ç–∏—á–Ω–æ —Å–Ω–∏–∂–∞—é—â—É—é —Ü–µ–Ω—ã –∏ –æ–±–µ—Å–ø–µ—á–∏–≤–∞—é—â—É—é –≤–æ–∑–≤—Ä–∞—â–µ–Ω–∏–µ –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–π, –Ω–æ –Ω–µ –≤ –ø–æ–ª–Ω–æ–π –º–µ—Ä–µ –∏ –Ω–µ –∑–∞ –∫–æ—Ä–æ—Ç–∫–∏–π —Å—Ä–æ–∫. –í–∞–∂–Ω–æ: –ê–ª—å–±–µ—Ä—Ç –ë—É—Ä–ª–∞, –∫–æ—Ç–æ—Ä—ã–π –≤–æ–∑–≥–ª–∞–≤–ª—è–µ—Ç –ª–æ–±–±–∏—Å—Ç—Å–∫—É—é –≥—Ä—É–ø–ø—É —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏ Pharmaceutical Research and Manufacturers of America (PhRMA). –î—É–º–∞—é, –æ–Ω –æ—á–µ–Ω—å —Ö–æ—Ä–æ—à–æ –ø–æ–Ω–∏–º–∞–µ—Ç, –∫—É–¥–∞ –¥—É–µ—Ç –≤–µ—Ç–µ—Ä –∏ —á—Ç–æ –≤—Ä–µ–º—è —Ö–∞–ª—è–≤–Ω–æ–≥–æ R&D –ø–ª–∞–≤–Ω–æ –ø–æ–¥—Ö–æ–¥–∏—Ç –∫ –∫–æ–Ω—Ü—É. –ó–∞—Ç–æ –Ω–∞—á–∏–Ω–∞—é—Ç—Å—è —Ä—ã–Ω–æ—á–Ω–æ-–¥–æ–≥–æ–≤–æ—Ä–Ω—ã–µ –≤–æ–π–Ω—ã, –∏ –æ—Ç–≤–µ—á–∞—Ç—å –∑–∞ –Ω–∏—Ö –ø—Ä–∏–¥—ë—Ç—Å—è, –≤–µ—Ä–æ—è—Ç–Ω–µ–µ –≤—Å–µ–º. –í—Å–µ–º —Ä—ã–Ω–∫–∞–º, –∫–æ—Ç–æ—Ä—ã–µ –ø–æ–∑–≤–æ–ª—è—é—Ç —Å–µ–±–µ —Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–Ω—É—é –ø–æ–º–æ—â—å –∏ –ø–æ–ª–∏—Ç–∏–∫—É –ø—Ä–∏–æ—Ä–∏—Ç–∞—Ä–∏–∑–º–∞ –≤ –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –ø–æ–º–æ—â–∏. –ß—Ç–æ –¥—É–º–∞–µ—Ç–µ? üî• ‚Äî –Ω–∞—à —Å–ª–æ–Ω üóø ‚Äî –Ω–µ –Ω–∞—à —Å–ª–æ–Ω ‚ù§Ô∏è ‚Äî —Å–ª–æ–Ω ‚Äî –Ω–∞—à üòÅ ‚Äî –¥–∞ —á—Ç–æ —Ç—É—Ç –¥—É–º–∞—Ç—å, —Ñ–∞—Ä–º–∞ –æ–ø—è—Ç—å –¥—É–º–∞–µ—Ç, –∫–∞–∫ –Ω–∞—Ç—è–Ω—É—Ç—å –≤–µ—Å—å –∑–µ–º–Ω–æ–π —à–∞—Ä, —É –∫–æ—Ç–æ—Ä–æ–≥–æ –µ—Å—Ç—å –¥–µ–Ω—å–≥–∏","{
  ""skip"": true
}"
2025-06-10T17:18:44+00:00,@pharm_icon,2262,https://t.me/pharm_icon/2262,"–°–∫—Ä—ã—Ç—ã–µ –∂–µ–ª–∞–Ω–∏—è –ö–æ–≥–¥–∞ —ç—Ç–æ—Ç —á–µ–ª–æ–≤–µ–∫ –≥–æ–≤–æ—Ä–∏—Ç ¬´–£ –Ω–∞—Å –ø–æ –∑–∞–∫–æ–Ω—É –æ –ö–æ–Ω—Å—Ç–∏—Ç—É—Ü–∏–æ–Ω–Ω–æ–º —Å—É–¥–µ –¥–≤–∞ –ø—É–Ω–∫—Ç–∞: –ø–µ—Ä–≤—ã–π ‚Äî –ö–æ–Ω—Å—Ç–∏—Ç—É—Ü–∏–æ–Ω–Ω—ã–π —Å—É–¥ –≤—Å–µ–≥–¥–∞ –ø—Ä–∞–≤, –≤—Ç–æ—Ä–æ–π ‚Äî –µ—Å–ª–∏ –ö–æ–Ω—Å—Ç–∏—Ç—É—Ü–∏–æ–Ω–Ω—ã–π —Å—É–¥ –Ω–µ –ø—Ä–∞–≤, —á–∏—Ç–∞–µ–º –ø—É–Ω–∫—Ç –ø–µ—Ä–≤—ã–π¬ª —ç—Ç–æ –±–∞–∑–æ–≤–æ –æ–∑–Ω–∞—á–∞–µ—Ç –¥–≤–µ –≤–µ—â–∏ 1. –û–Ω –±–æ–ª—å—à–æ–π —Ñ–∞–Ω–∞—Ç –ø—Ä–æ–∏–∑–≤–µ–¥–µ–Ω–∏—è –ë–æ–π—Ü–æ–≤—Å–∫–∏–π –∫–ª—É–± –∏ –≤ –¥—É—à–µ ‚Äî –±—É–Ω—Ç–∞—Ä—å. 2. –ù–∞–≤–µ—Ä–Ω—è–∫–∞ –æ–Ω —Ö–æ—Ç–µ–ª –±—ã –ø–æ–¥—Ä–∞—Ç—å—Å—è —Å –∫–µ–º-—Ç–æ –≤ –∞—É–¥–∏—Ç–æ—Ä–∏–∏ –∏ –¥–∞–∂–µ –ø—ã—Ç–∞–ª—Å—è —Å–ø—Ä–æ–≤–æ—Ü–∏—Ä–æ–≤–∞—Ç—å –ø—Ä–∏—Å—É—Ç—Å—Ç–≤—É—é—â–∏—Ö –Ω–∞ –∫–æ–Ω–≥—Ä–µ—Å—Å–µ –≤—Ä–∞—á–µ–π, —É –∫–æ—Ç–æ—Ä—ã—Ö –∏–Ω–æ–µ –º–Ω–µ–Ω–∏–µ. –ñ–∞–ª–∫–æ, —á—Ç–æ —ç—Ç–æ–≥–æ –Ω–µ –ø—Ä–æ–∏–∑–æ—à–ª–æ ‚Äî –Ω–æ–≤–æ—Å—Ç—å –±—ã –∑–∞–∏–≥—Ä–∞–ª–∞ –Ω–æ–≤—ã–º–∏ –∫—Ä–∞—Å–∫–∞–º–∏.","{""skip"": true}"
2025-06-10T17:14:11+00:00,@pharm_icon,2261,https://t.me/pharm_icon/2261,"‚ö°Ô∏è–í –∫–∞—Å—Å–∞—Ü–∏–æ–Ω–Ω–æ–º —Å—É–¥–µ –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª–∏, —á—Ç–æ –¥–ª—è –≤—Ä–∞—á–µ–π –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ —Ç–µ–ø–µ—Ä—å –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã –û–± —ç—Ç–æ–º –∑–∞—è–≤–∏–ª –∑–∞–º–ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—è –í—Ç–æ—Ä–æ–≥–æ –∫–∞—Å—Å–∞—Ü–∏–æ–Ω–Ω–æ–≥–æ —Å—É–¥–∞ –æ–±—â–µ–π —é—Ä–∏—Å–¥–∏–∫—Ü–∏–∏ –ú–∞–∫—Å–∏–º –ú–∞—Ç–µ–π–∫–æ–≤–∏—á –Ω–∞ –∫–æ–Ω–≥—Ä–µ—Å—Å–µ ¬´–û—Ä–≥–ó–¥—Ä–∞–≤ 2025¬ª. ¬´–ö–æ–Ω—Å—Ç–∏—Ç—É—Ü–∏–æ–Ω–Ω—ã–π —Å—É–¥ –†–§ —Å–∫–∞–∑–∞–ª, —á—Ç–æ —Å–æ–±–ª—é–¥–µ–Ω–∏–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–π —è–≤–ª—è–µ—Ç—Å—è –æ–±—è–∑–∞—Ç–µ–ª—å–Ω—ã–º. –£ –Ω–∞—Å –ø–æ –∑–∞–∫–æ–Ω—É –æ –ö–æ–Ω—Å—Ç–∏—Ç—É—Ü–∏–æ–Ω–Ω–æ–º —Å—É–¥–µ –¥–≤–∞ –ø—É–Ω–∫—Ç–∞: –ø–µ—Ä–≤—ã–π ‚Äî –ö–æ–Ω—Å—Ç–∏—Ç—É—Ü–∏–æ–Ω–Ω—ã–π —Å—É–¥ –≤—Å–µ–≥–¥–∞ –ø—Ä–∞–≤, –≤—Ç–æ—Ä–æ–π ‚Äî –µ—Å–ª–∏ –ö–æ–Ω—Å—Ç–∏—Ç—É—Ü–∏–æ–Ω–Ω—ã–π —Å—É–¥ –Ω–µ –ø—Ä–∞–≤, —á–∏—Ç–∞–µ–º –ø—É–Ω–∫—Ç –ø–µ—Ä–≤—ã–π¬ª, ‚Äî –ø–æ—è—Å–Ω–∏–ª –ú–∞—Ç–µ–π–∫–æ–≤–∏—á.","{""skip"": true}"
2025-06-10T14:35:45+00:00,@pharm_icon,2260,https://t.me/pharm_icon/2260,"‚òùüèº–°–ø–∏–∫–µ—Ä –∏–∑ BIOCAD —Ä–∞—Å—Å–∫–∞–∂–µ—Ç –æ –Ω–æ–≤—ã—Ö –≥–æ—Ä–∏–∑–æ–Ω—Ç–∞—Ö –¥–ª—è —Ñ–∞—Ä–º –∏ –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–æ–≤ –†—É–∫–æ–≤–æ–¥–∏—Ç–µ–ª—å –≥—Ä—É–ø–ø—ã –≤—ã—á–∏—Å–ª–∏—Ç–µ–ª—å–Ω–æ–π —Ö–∏–º–∏–∏ –≤ BIOCAD –≠–º–∏–ª—å –ú–∞–≥–µ—Ä—Ä–∞–º–æ–≤, –æ–±—ä—è—Å–Ω–∏—Ç, –ø–æ—á–µ–º—É Data Science –∞–∫—Ç—É–∞–ª–µ–Ω –∏ –ø–æ—á–µ–º—É –¥–∞—Ç–∞—Å–∞–π–Ω—Ç–∏—Å—Ç–∞ –Ω–µ –∑–∞–º–µ–Ω—è—Ç –Ω–µ–π—Ä–æ—Å–µ—Ç–∏. 17 –∏—é–Ω—è –≤ 19:00 –º—Å–∫ –ø—Ä–æ–π–¥–µ—Ç –±–µ—Å–ø–ª–∞—Ç–Ω—ã–π –≤–µ–±–∏–Ω–∞—Ä –æ—Ç Skillfactory, –Ω–∞ –∫–æ—Ç–æ—Ä–æ–º –≤—ã —É–∑–Ω–∞–µ—Ç–µ: ‚Äî –∑–∞—á–µ–º –Ω—É–∂–Ω—ã –≤—Ä–∞—á–∏ –∏ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç—ã —Å–æ –∑–Ω–∞–Ω–∏–µ–º Data Science ‚Äî –∫–∞–∫ —Å–æ–≤–µ—Ä—à–∏—Ç—å –∞–ø–≥—Ä–µ–π–¥ –∫–∞—Ä—å–µ—Ä—ã –∏ —Å–∫–æ–ª—å–∫–æ –º–æ–∂–Ω–æ –ø–æ—Ç–æ–º –∑–∞—Ä–∞–±–∞—Ç—ã–≤–∞—Ç—å ‚Äî –∫–∞–∫ Data Science –ø–æ–≤—ã—à–∞–µ—Ç —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö —Ä–∞–±–æ—Ç –∏ –≤—Ä–∞—á–µ–±–Ω–æ–π –ø—Ä–∞–∫—Ç–∏–∫–∏ –í–µ–±–∏–Ω–∞—Ä —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω –Ω–∞ –±–∞–∑–µ —Å–æ–≤–º–µ—Å—Ç–Ω–æ–π –ø—Ä–æ–≥—Ä–∞–º–º—ã Skillfactory –∏ –°–µ—á–µ–Ω–æ–≤—Å–∫–æ–≥–æ —É–Ω–∏–≤–µ—Ä—Å–∏—Ç–µ—Ç–∞ ¬´Data Science –≤ –º–µ–¥–∏—Ü–∏–Ω–µ¬ª. –í—Å–µ —É—á–∞—Å—Ç–Ω–∏–∫–∏ –ø–æ–ª—É—á–∞—Ç –∏–º–µ–Ω–Ω–æ–π —Å–µ—Ä—Ç–∏—Ñ–∏–∫–∞—Ç. –ó–∞–ø–∏—Å—ã–≤–∞–π—Ç–µ—Å—å –Ω–∞ –≤–µ–±–∏–Ω–∞—Ä: https://go.skillfactory.ru/&erid=2W5zFJVZdjE –†–µ–∫–ª–∞–º–∞ –û–û–û ""–°–∫–∏–ª—Ñ—ç–∫—Ç–æ—Ä–∏"", –ò–ù–ù 9702009530","{""skip"": true}"
2025-06-10T10:02:12+00:00,@pharm_icon,2258,https://t.me/pharm_icon/2258,"–í–∏–¥–∏—Ç–µ? –ó–∞—Ä–∞–∑–∏–ª–∞ —ç–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–æ–≤ –Ω–µ—Ä–∞–≤–Ω–æ–¥—É—à–∏–µ–º –∫ –ø–æ–±–æ—á–Ω–æ–º—É —ç—Ñ—Ñ–µ–∫—Ç—É, –∫–æ—Ç–æ—Ä—ã–π –º–æ–∂–µ—Ç —Å—Ç–∞—Ç—å –±–æ–ª–µ–µ —á–∞—Å—Ç—ã–º —á–µ—Ä–µ–∑ 3-5 –ª–µ—Ç.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""Raises concern about endocrinologists' indifference to a potential more frequent side effect that could emerge in 3-5 years.""
}"
2025-06-10T10:01:10+00:00,@pharm_icon,2257,https://t.me/pharm_icon/2257,"–°–µ–º–∞–≥–ª—É—Ç–∏–¥ (–û–∑–µ–º–ø–∏–∫, –°–µ–º–∞–≤–∏–∫, –í–µ–ª–≥–∏—è) –∏ –∑—Ä–µ–Ω–∏–µ: –Ω–æ–≤—ã–µ –¥–∞–Ω–Ω—ã–µ EMA (–ï–≤—Ä–æ–ø–µ–π—Å–∫–æ–µ –∞–≥–µ–Ω—Ç—Å—Ç–≤–æ –ø–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã–º —Å—Ä–µ–¥—Å—Ç–≤–∞–º) –∑–∞–≤–µ—Ä—à–∏–ª–æ –ø—Ä–æ–≤–µ—Ä–∫—É –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤, —Å–æ–¥–µ—Ä–∂–∞—â–∏—Ö —Å–µ–º–∞–≥–ª—É—Ç–∏–¥, –ø–æ—Å–ª–µ —Å–æ–æ–±—â–µ–Ω–∏–π –æ –≤–æ–∑–º–æ–∂–Ω–æ–π —Å–≤—è–∑–∏ —Å —Ä–µ–¥–∫–∏–º –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–µ–º –≥–ª–∞–∑ ‚Äî –ø–µ—Ä–µ–¥–Ω–µ–π –∏—à–µ–º–∏—á–µ—Å–∫–æ–π –Ω–µ–π—Ä–æ–ø–∞—Ç–∏–µ–π –∑—Ä–∏—Ç–µ–ª—å–Ω–æ–≥–æ –Ω–µ—Ä–≤–∞ (NAION). –≠—Ç–æ —Å–æ—Å—Ç–æ—è–Ω–∏–µ –º–æ–∂–µ—Ç –ø—Ä–∏–≤–µ—Å—Ç–∏ –∫ –ø–æ—Ç–µ—Ä–µ –∑—Ä–µ–Ω–∏—è, –æ–±—ã—á–Ω–æ –æ–¥–Ω–æ—Å—Ç–æ—Ä–æ–Ω–Ω–µ–π, –∏ –Ω–µ –≤—Å–µ–≥–¥–∞ –ø–æ–ª–Ω–æ–π. üîç –ü–æ—Å–ª–µ –∞–Ω–∞–ª–∏–∑–∞ –¥–∞–Ω–Ω—ã—Ö –∏–∑ –¥–æ–∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π, –∞ —Ç–∞–∫–∂–µ –ø–æ—Å—Ç–º–∞—Ä–∫–µ—Ç–∏–Ω–≥–æ–≤–æ–≥–æ –Ω–∞–±–ª—é–¥–µ–Ω–∏—è –∏ –Ω–∞—É—á–Ω–æ–π –ª–∏—Ç–µ—Ä–∞—Ç—É—Ä—ã, –∫–æ–º–∏—Ç–µ—Ç –ø–æ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç–∏ –ø—Ä–∏—à—ë–ª –∫ –≤—ã–≤–æ–¥—É: üìå NAION ‚Äî –æ—á–µ–Ω—å —Ä–µ–¥–∫–∏–π –ø–æ–±–æ—á–Ω—ã–π —ç—Ñ—Ñ–µ–∫—Ç —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ (–≤—Å—Ç—Ä–µ—á–∞–µ—Ç—Å—è —É 1 –∏–∑ 10 000 —á–µ–ª–æ–≤–µ–∫). üìå –†–∏—Å–∫ –Ω–µ–º–Ω–æ–≥–æ –ø–æ–≤—ã—à–µ–Ω —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –¥–∏–∞–±–µ—Ç–æ–º 2 —Ç–∏–ø–∞ ‚Äî –ø—Ä–∏–º–µ—Ä–Ω–æ –≤ 2 —Ä–∞–∑–∞ –≤—ã—à–µ, —á–µ–º —É —Ç–µ—Ö, –∫—Ç–æ –Ω–µ –ø—Ä–∏–Ω–∏–º–∞–µ—Ç –ø—Ä–µ–ø–∞—Ä–∞—Ç. –≠—Ç–æ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É–µ—Ç –æ–¥–Ω–æ–º—É –¥–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–º—É —Å–ª—É—á–∞—é –Ω–∞ 10 000 —á–µ–ª–æ–≤–µ–∫–æ-–ª–µ—Ç –ª–µ—á–µ–Ω–∏—è. –°—Ç–æ–∏—Ç –æ—Ç–º–µ—Ç–∏—Ç—å, —á—Ç–æ —ç—Ç–∞ –Ω–µ–π—Ä–æ–ø–∞—Ç–∏—è –º–æ–∂–µ—Ç —Ä–∞–∑–≤–∏–≤–∞—Ç—å—Å—è –∏ —Ç–∞–∫ —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –¥–∏–∞–±–µ—Ç–æ–º, –æ—Å–æ–±–µ–Ω–Ω–æ —Å—Ç–∞—Ä—à–µ 50 –ª–µ—Ç. üí¨ –¢–µ–ø–µ—Ä—å –≤ –∏–Ω—Å—Ç—Ä—É–∫—Ü–∏—é –∫ –ø—Ä–µ–ø–∞—Ä–∞—Ç—É –±—É–¥–µ—Ç –¥–æ–±–∞–≤–ª–µ–Ω–æ –ø—Ä–µ–¥—É–ø—Ä–µ–∂–¥–µ–Ω–∏–µ –æ–± —ç—Ç–æ–º —Ä–∏—Å–∫–µ. ‚ö†Ô∏è –ï—Å–ª–∏ –≤—ã –∑–∞–º–µ—Ç–∏–ª–∏ –≤–Ω–µ–∑–∞–ø–Ω—É—é –ø–æ—Ç–µ—Ä—é –∑—Ä–µ–Ω–∏—è –∏–ª–∏ –±—ã—Å—Ç—Ä–æ–µ —É—Ö—É–¥—à–µ–Ω–∏–µ –∑—Ä–µ–Ω–∏—è –≤–æ –≤—Ä–µ–º—è –ø—Ä–∏—ë–º–∞ —Å–µ–º–∞–≥–ª—É—Ç–∏–¥–∞ ‚Äî –Ω–µ–º–µ–¥–ª–µ–Ω–Ω–æ –æ–±—Ä–∞—Ç–∏—Ç–µ—Å—å –∫ –≤—Ä–∞—á—É. –í —Å–ª—É—á–∞–µ –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏—è NAION, –ø—Ä–∏—ë–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –¥–æ–ª–∂–µ–Ω –±—ã—Ç—å –ø—Ä–µ–∫—Ä–∞—â—ë–Ω.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, safety, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""EMA completed the evaluation of drugs containing semaglutide after reports of a rare eye condition - acute ischemic optic neuropathy (NAION). This can cause partial vision loss, usually unilateral. The committee concluded that NAION is a very rare side effect of semaglutide (occurring in 1 out of every 10,000 people). The risk is slightly higher among patients with type 2 diabetes - about twice as high compared to those not taking the drug. This aligns with an additional case per 10,000 person-years of treatment. It is noted that this neuropathy can develop even in patients with diabetes, especially those older than 50 years. Now a warning about this risk has been added to the drug's instructions. If sudden vision loss or rapid vision deterioration occurs during semaglutide treatment, patients should seek immediate medical attention. In case of confirmed NAION, drug use should be discontinued.""
}"
2025-12-02T12:01:32+00:00,@genedna1,1477,https://t.me/genedna1/1477,"–í 5 —Ä–µ–≥–∏–æ–Ω–∞—Ö –ø–∞—Ü–∏–µ–Ω—Ç–∞–º –Ω–µ –æ–ø–ª–∞—á–∏–≤–∞—é—Ç –ø—Ä–æ–µ–∑–¥ –∫ –º–µ—Å—Ç—É –ª–µ—á–µ–Ω–∏—è –í –ë–∞—à–∫–∏—Ä–∏–∏, –ö–∞–º—á–∞—Ç—Å–∫–æ–º –∏ –•–∞–±–∞—Ä–æ–≤—Å–∫–æ–º –∫—Ä–∞—è—Ö, –∞ —Ç–∞–∫–∂–µ –ú—É—Ä–º–∞–Ω—Å–∫–æ–π –∏ –ò—Ä–∫—É—Ç—Å–∫–æ–π –æ–±–ª–∞—Å—Ç—è—Ö –≤ 2025 –≥–æ–¥—É –ø–∞—Ü–∏–µ–Ω—Ç–∞–º —Å –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º –æ—Ç–∫–∞–∑–∞–ª–∏—Å—å –∫–æ–º–ø–µ–Ω—Å–∏—Ä–æ–≤–∞—Ç—å —Å—Ç–æ–∏–º–æ—Å—Ç—å –æ–ø–ª–∞—Ç—ã –ø—Ä–æ–µ–∑–¥–∞ –¥–æ –º–µ—Å—Ç–∞ –ª–µ—á–µ–Ω–∏—è –∏ –æ–±—Ä–∞—Ç–Ω–æ, —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏ ¬´–ò–∑–≤–µ—Å—Ç–∏—è–º¬ª –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ —é—Ä–∏—Å—Ç—ã. –í —Ä—è–¥–µ —Å–ª—É—á–∞–µ–≤ –ø–∞—Ü–∏–µ–Ω—Ç—ã –¥–æ–±–∏–≤–∞—é—Ç—Å—è –≤—ã–ø–ª–∞—Ç—ã –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏–π –æ—Ç –°–æ—Ü—Ñ–æ–Ω–¥–∞ —Ç–æ–ª—å–∫–æ –ø–æ—Å–ª–µ –æ–±—Ä–∞—â–µ–Ω–∏–π –≤ –º–µ—Å—Ç–Ω—ã–µ –ø—Ä–æ–∫—É—Ä–∞—Ç—É—Ä—ã. –ù–∞–ø—Ä–∏–º–µ—Ä, —ç—Ç–æ—Ç —Å–ø–æ—Å–æ–± –∞–∫—Ç–∏–≤–Ω–æ –∏—Å–ø–æ–ª—å–∑—É—é—Ç –≤ –ú—É—Ä–º–∞–Ω—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏. –ü—Ä–æ–±–ª–µ–º—ã —Å –≤—ã–ø–ª–∞—Ç–æ–π –±–æ–ª—å–Ω—ã–º –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏–π –∑–∞ —Å–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω–æ –æ–ø–ª–∞—á–µ–Ω–Ω—ã–π –ø—Ä–æ–µ–∑–¥ –∫ –º–µ—Å—Ç—É –ª–µ—á–µ–Ω–∏—è –∏ –æ–±—Ä–∞—Ç–Ω–æ –≤–æ–∑–Ω–∏–∫–∞—é—Ç, —Ç–∞–∫ –∫–∞–∫ –∫–∞–∂–¥—ã–π —Ä–µ–≥–∏–æ–Ω —Å–∞–º–æ—Å—Ç–æ—è—Ç–µ–ª—å–Ω–æ —É—Å—Ç–∞–Ω–∞–≤–ª–∏–≤–∞–µ—Ç –ø—Ä–∞–≤–∏–ª–∞ –∏—Ö –≤—ã–ø–ª–∞—Ç—ã, –æ–±—ä—è—Å–Ω–∏–ª–∞ —é—Ä–∏—Å—Ç –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ ¬´–ó–¥—Ä–∞–≤—Å—Ç–≤—É–π!¬ª –Æ–ª–∏—è –õ–µ–≤–∫–∏–Ω–∞.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""Patients in five regions are not reimbursed for transportation to treatment locations. In Murmansk and Irkutsk Oblasts, patients with oncological diseases are not compensating the cost of transportation to and from their place of treatment in 2025. Lawyers for 'Izvestia' reported that patients are demanding compensation from the Social Fund only after contacting local procuratures. This method is actively used in Murmansk Oblast. Problems with compensation for patients' self-paid transportation to and from their place of treatment arise because each region independently sets the rules for compensation.""
}"
2025-12-02T09:56:11+00:00,@genedna1,1476,https://t.me/genedna1/1476,"–í –†–æ—Å—Å–∏–∏ –≤–ø–µ—Ä–≤—ã–µ –ø—Ä–∏–º–µ–Ω–∏–ª–∏ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ —Å–∏–Ω–¥—Ä–æ–º–∞ –•–∞–Ω—Ç–µ—Ä–∞ –í –†–æ—Å—Å–∏–π—Å–∫–æ–π –¥–µ—Ç—Å–∫–æ–π –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–π –±–æ–ª—å–Ω–∏—Ü–µ –ø–µ—Ä–≤—ã–π –ø–∞—Ü–∏–µ–Ω—Ç –∏–∑ –ê—Å—Ç—Ä–∞—Ö–∞–Ω–∏ –ø–æ–ª—É—á–∏–ª –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—É—é —Ç–µ—Ä–∞–ø–∏—é —Å–∏–Ω–¥—Ä–æ–º–∞ –•–∞–Ω—Ç–µ—Ä–∞ (–º—É–∫–æ–ø–æ–ª–∏—Å–∞—Ö–∞—Ä–∏–¥–æ–∑–∞ II —Ç–∏–ø–∞). –í–≤–µ–¥–µ–Ω–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –ø—Ä–æ—Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–ª ¬´–ö—Ä—É–≥ –¥–æ–±—Ä–∞¬ª. –†–æ—Å—Å–∏—è —Å—Ç–∞–ª–∞ –≤—Ç–æ—Ä–æ–π —Å—Ç—Ä–∞–Ω–æ–π –≤ –º–∏—Ä–µ –ø–æ—Å–ª–µ –Ø–ø–æ–Ω–∏–∏, –≥–¥–µ –¥–æ—Å—Ç—É–ø–Ω–∞ –ø–æ–¥–æ–±–Ω–∞—è —Ç–µ—Ä–∞–ø–∏—è. –ü–∞—Ü–∏–µ–Ω—Ç—ã —Å–º–æ–≥—É—Ç –ø–æ–ª—É—á–∞—Ç—å –ª–µ—á–µ–Ω–∏–µ –≤ —Å–≤–æ–∏—Ö —Ä–µ–≥–∏–æ–Ω–∞—Ö: –≤—Ä–∞—á–∏ –∏–∑ –ê—Å—Ç—Ä–∞—Ö–∞–Ω—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –ø—Ä–æ—à–ª–∏ —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ–µ –æ–±—É—á–µ–Ω–∏–µ –≤ –†–î–ö–ë. ¬´–•–∞–Ω—Ç–µ—Ä–∞–∑–∞ –ù–µ–π—Ä–æ¬ª(–∏–¥—É—Ä—Å—É–ª—å—Ñ–∞–∑–∞ –±–µ—Ç–∞) ‚Äì –ø–µ—Ä–≤—ã–π –∏ –µ–¥–∏–Ω—Å—Ç–≤–µ–Ω–Ω—ã–π –≤ –º–∏—Ä–µ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç —Ñ–µ—Ä–º–µ–Ω—Ç–Ω–æ–π –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏, –¥–æ—Å—Ç–∞–≤–ª—è—é—â–∏–π —Ñ–µ—Ä–º–µ–Ω—Ç –Ω–µ–ø–æ—Å—Ä–µ–¥—Å—Ç–≤–µ–Ω–Ω–æ –≤ –∂–µ–ª—É–¥–æ—á–∫–∏ –≥–æ–ª–æ–≤–Ω–æ–≥–æ –º–æ–∑–≥–∞. –ò—Å–ø–æ–ª—å–∑—É–µ–º—ã–π —Å–ø–æ—Å–æ–± –≤–≤–µ–¥–µ–Ω–∏—è –ø–æ–∑–≤–æ–ª—è–µ—Ç –æ–±–æ–π—Ç–∏ –≥–µ–º–∞—Ç–æ—ç–Ω—Ü–µ—Ñ–∞–ª–∏—á–µ—Å–∫–∏–π –±–∞—Ä—å–µ—Ä –∏ –≤–æ–∑–¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å –Ω–∞ –Ω–µ–≤—Ä–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–µ –ø—Ä–æ—è–≤–ª–µ–Ω–∏—è –ú–ü–° II. –î–∞–Ω–Ω—ã–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–π –ø–æ–∫–∞–∑—ã–≤–∞—é—Ç, —á—Ç–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏–µ ¬´–•–∞–Ω—Ç–µ—Ä–∞–∑—ã –ù–µ–π—Ä–æ¬ª –≤ —Å–æ—á–µ—Ç–∞–Ω–∏–∏ —Å–æ —Å—Ç–∞–Ω–¥–∞—Ä—Ç–Ω–æ–π –≤–Ω—É—Ç—Ä–∏–≤–µ–Ω–Ω–æ–π –§–ó–¢ –ø–æ–∑–≤–æ–ª—è–µ—Ç —Å—Ç–∞–±–∏–ª–∏–∑–∏—Ä–æ–≤–∞—Ç—å –∏–ª–∏ —É–ª—É—á—à–∏—Ç—å –Ω–µ–≤—Ä–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–µ —Å–æ—Å—Ç–æ—è–Ω–∏–µ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –Ω–µ–π—Ä–æ–ø–∞—Ç–∏—á–µ—Å–∫–æ–π —Ñ–æ—Ä–º–æ–π –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è. –†–æ—Å—Å–∏–π—Å–∫–∏–µ –ø–∞—Ü–∏–µ–Ω—Ç—ã –ø–æ–ª—É—á–∏–ª–∏ –¥–æ—Å—Ç—É–ø –∫ —ç—Ç–æ–π —Ç–µ—Ä–∞–ø–∏–∏, –≤ —Ç–æ–º —á–∏—Å–ª–µ, –±–ª–∞–≥–æ–¥–∞—Ä—è –º–Ω–æ–≥–æ–ª–µ—Ç–Ω–µ–º—É –ø–∞—Ä—Ç–Ω–µ—Ä—Å—Ç–≤—É —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ù–∞–Ω–æ–ª–µ–∫¬ª –∏ —é–∂–Ω–æ–∫–æ—Ä–µ–π—Å–∫–æ–π GC Biopharma.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""tenders, clinical_trial, shortage"",
  ""impact"": ""high"",
  ""english"": ""Innovative medication for Hunter syndrome was first applied in Russia. A patient from Astrakhan, Russia received innovative treatment for Hunter syndrome (Mucopolysaccharidosis II type) at the Russian Pediatric Clinical Hospital. The treatment was financed by 'The Kindness Fund'. Russia became the second country after Japan to have access to this therapy. Patients can receive treatment in their regions: doctors from Astrakhan region underwent special training at the Russian Pediatric Clinical Hospital. 'Hunterase Neuro' (idursulfazebeta) is the first and only registered enzyme replacement therapy in the world, delivering the enzyme directly to the ventricles of the brain. The method of administration allows bypassing the hematoencephalic barrier and affecting neurological manifestations of MPS II. Clinical trial data show that combining 'Hunterase Neuro' with standard intravenous FZT stabilizes or improves the neurological condition of patients with neuropathic form of the disease. Patients in Russia have gained access to this therapy, including thanks to a long-term partnership between the pharmaceutical company 'Nanol"
2025-11-26T16:15:04+00:00,@genedna1,1475,https://t.me/genedna1/1475,"5 —Ñ–∞–∫—Ç–æ–≤, –ø–æ—Å–ª–µ –∫–æ—Ç–æ—Ä—ã—Ö –≤—ã —Å–∫–∞–∂–µ—Ç–µ ¬´—Å–ø–∞—Å–∏–±–æ¬ª –ª—é–±–æ–º—É –≤—Ä–∞—á—É: 1Ô∏è‚É£–£—á–µ–±–∞? –ù–µ—Ç, –≤—ã–∂–∏–≤–∞–Ω–∏–µ. –° –ø–µ—Ä–≤–æ–≥–æ –∫—É—Ä—Å–∞ - —Ç–æ–Ω–Ω—ã –ª–∞—Ç—ã–Ω–∏ –≤ –∞–Ω–∞—Ç–æ–º–∏–∏ –∏ –ø—Ä–æ–ø–µ–¥–µ–≤—Ç–∏–∫–∞, –≥–¥–µ –Ω—É–∂–Ω–æ —Å–ª—ã—à–∞—Ç—å —Ç–æ, –æ —á–µ–º –º–æ–ª—á–∏—Ç —Ç–µ–ª–æ. –ê —Å —Ç—Ä–µ—Ç—å–µ–≥–æ –∫—É—Ä—Å–∞ –Ω–∞—á–∏–Ω–∞—é—Ç—Å—è –Ω–æ—á–Ω—ã–µ –¥–µ–∂—É—Ä—Å—Ç–≤–∞. –≠—Ç–æ –Ω–µ —É—á–µ–±–∞, —ç—Ç–æ –æ–±—Ä–∞–∑ –∂–∏–∑–Ω–∏. 2Ô∏è‚É£–ê–Ω–∞—Ç–æ–º–∏—á–∫–∞ - —Ç–æ—á–∫–∞ –Ω–µ–≤–æ–∑–≤—Ä–∞—Ç–∞. –ü–µ—Ä–≤—ã–π —Ç—Ä—É–ø (–ø—Ä–µ–ø–∞—Ä–∞—Ç) - —à–æ–∫. –ö –∫–æ–Ω—Ü—É –≥–æ–¥–∞ - –æ–±—ã–¥–µ–Ω–Ω–æ—Å—Ç—å. –≠—Ç–æ –Ω–µ —Ü–∏–Ω–∏–∑–º, –∞ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–∞—è –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç—å. –ë–µ–∑ —ç—Ç–æ–≥–æ –Ω–µ–ª—å–∑—è —Å—Ç–∞—Ç—å –≤—Ä–∞—á–æ–º. 3Ô∏è‚É£–Æ–º–æ—Ä —á–µ—Ä–Ω–µ–µ —Å–∞–∂–∏. –®—É—Ç–∫–∏ –ø—Ä–æ —Å–º–µ—Ä—Ç—å –∏ –±–æ–ª–µ–∑–Ω–∏? –≠—Ç–æ –Ω–µ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–µ —ç–º–ø–∞—Ç–∏–∏, –∞ –º–µ—Ö–∞–Ω–∏–∑–º –≤—ã–∂–∏–≤–∞–Ω–∏—è. –ò–Ω–∞—á–µ ‚Äî –ø—Å–∏—Ö–∏—á–µ—Å–∫–æ–µ –≤—ã–≥–æ—Ä–∞–Ω–∏–µ. 4Ô∏è‚É£–î–∏–ø–ª–æ–º - —ç—Ç–æ —Ç–æ–ª—å–∫–æ –Ω–∞—á–∞–ª–æ. 6 –ª–µ—Ç –≤ –≤—É–∑–µ ‚Üí –≥–æ–¥ –∏–Ω—Ç–µ—Ä–Ω–∞—Ç—É—Ä—ã (—Ç–µ–±—è —É—á–∞—Ç –Ω–µ —É–±–∏—Ç—å) ‚Üí 2+ –≥–æ–¥–∞ –æ—Ä–¥–∏–Ω–∞—Ç—É—Ä—ã (—É–∑–∫–∞—è —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∞—Ü–∏—è). –†–∞–±–æ—Ç–∞–µ—à—å —Å—É—Ç–∫–∏ —á–µ—Ä–µ–∑ –ø–æ–ª—Ç–æ—Ä–∞, –∞ –∑–∞—Ä–ø–ª–∞—Ç–∞... –õ—É—á—à–µ —Å–ø—Ä–æ—Å–∏—Ç–µ –ø—Ä–æ –æ–ø—ã—Ç. 5Ô∏è‚É£–£—á–∏—Ç—å—Å—è, —É—á–∏—Ç—å—Å—è –∏ –µ—â–µ —Ä–∞–∑ —É—á–∏—Ç—å—Å—è. –í—Ä–∞—á —É—á–∏—Ç—Å—è –í–°–ï–ì–î–ê. –ù–æ–≤—ã–µ –ø—Ä–æ—Ç–æ–∫–æ–ª—ã, –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è, –ª–µ–∫–∞—Ä—Å—Ç–≤–∞. –û—Å—Ç–∞–Ω–æ–≤–∏–ª—Å—è - —Å—Ç–∞–ª –æ–ø–∞—Å–µ–Ω –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –†–µ–∑—é–º–µ: –ú–µ–¥ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ - —ç—Ç–æ –ø—Ä–∏–∑–≤–∞–Ω–∏–µ, –∫–æ—Ç–æ—Ä–æ–µ –º–µ–Ω—è–µ—Ç —á–µ–ª–æ–≤–µ–∫–∞ –Ω–∞–≤—Å–µ–≥–¥–∞. –≠—Ç–æ –ø—Ä–∞–≤–æ –Ω–µ—Å—Ç–∏ –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç—å –∑–∞ —á—É–∂–∏–µ –∂–∏–∑–Ω–∏. –ê –Ω–∞—à–∞ –ø–∞–ø–∫–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∫–∞–Ω–∞–ª–æ–≤ - —ç—Ç–æ –≤–∞—à –ø—Ä–æ–≤–æ–¥–Ω–∏–∫ –≤ –º–∏—Ä–µ —Å–æ–≤—Ä–µ–º–µ–Ω–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω—ã: üìé–°—Å—ã–ª–∫–∞: https://t.me/addlist/KEhQWKj5898wMDRi","{""skip"": true}"
2025-11-25T10:09:23+00:00,@genedna1,1474,https://t.me/genedna1/1474,"üíä –í —Ñ–æ–Ω–¥–µ ¬´–ö—Ä—É–≥ –¥–æ–±—Ä–∞¬ª —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏ –æ –ø—Ä–æ–±–ª–µ–º–∞—Ö —Å –ø–æ—Å—Ç–∞–≤–∫–∞–º–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∫–æ–º–ø–∞–Ω–∏–∏ ¬´–ë–∏–æ–ú–∞—Ä–∏–Ω¬ª ‚Äî –≤–ø–ª–æ—Ç—å –¥–æ –ø—Ä–µ—Ä—ã–≤–∞–Ω–∏—è —Ç–µ—Ä–∞–ø–∏–∏ –¢–∞–º —Å–æ–æ–±—â–∏–ª–∏ –æ –≤—Å—Ç—Ä–µ—á–µ –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—è –ø—Ä–∞–≤–ª–µ–Ω–∏—è —Ñ–æ–Ω–¥–∞ —Å –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–µ–º –∫–æ–º–ø–∞–Ω–∏–∏, –Ω–∞ –∫–æ—Ç–æ—Ä–æ–π –æ–±—Å—É–∂–¥–∞–ª–∞—Å—å ¬´–∫—Ä–∞–π–Ω–µ –Ω–µ–ø—Ä–æ—Å—Ç–∞—è —Å–∏—Ç—É–∞—Ü–∏—è —Å –ø–æ—Å—Ç–∞–≤–∫–∞–º–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –∫–æ–º–ø–∞–Ω–∏–∏ –≤ –†–æ—Å—Å–∏—é¬ª: ‚è∫Ô∏è¬´–ü–æ—Å–ª–µ —Ä–µ–æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –≥–ª–æ–±–∞–ª—å–Ω–æ–π —Å—Ç—Ä—É–∫—Ç—É—Ä—ã –∫–æ–º–ø–∞–Ω–∏–∏ –∏ –∑–∞–∫—Ä—ã—Ç–∏—è —Ä–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –æ—Ñ–∏—Å–∞ ""–ë–∏–æ–ú–∞—Ä–∏–Ω"" –≤ –ø—Ä–æ—à–ª–æ–º –≥–æ–¥—É, –ø–æ—Å–ª–µ –Ω–∞—á–∞–ª–∞ —Ä–∞–±–æ—Ç—ã –∫–æ–º–ø–∞–Ω–∏–∏ –Ω–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–º —Ä—ã–Ω–∫–µ —á–µ—Ä–µ–∑ –ø–æ—Å—Ä–µ–¥–Ω–∏–∫–æ–≤, —Ñ–æ–Ω–¥ —Å—Ç–æ–ª–∫–Ω—É–ª—Å—è —Å —Å–µ—Ä—å–µ–∑–Ω—ã–º–∏ –ø—Ä–æ–±–ª–µ–º–∞–º–∏ –≤ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–∏ –ø–æ–¥–æ–ø–µ—á–Ω—ã—Ö, –∫–æ—Ç–æ—Ä—ã–µ –∑–∞–≤–∏—Å—è—Ç –æ—Ç –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ ""–ë–∏–æ–ú–∞—Ä–∏–Ω"", –≤–ø–ª–æ—Ç—å –¥–æ –ø–µ—Ä–µ—Ä—ã–≤–æ–≤ –≤ —Ç–µ—Ä–∞–ø–∏–∏¬ª. ‚ú®–í –ø—Ä–æ—à–ª–æ–º –≥–æ–¥—É, –Ω–∞–ø—Ä–∏–º–µ—Ä, –±—ã–ª–∏ –ø—Ä–æ–±–ª–µ–º—ã —Å –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–º Voxzogo (–≤–æ—Å–æ—Ä–∏—Ç–∏–¥) –æ—Ç –∞—Ö–æ–Ω–¥—Ä–æ–ø–ª–∞–∑–∏–∏. –û –∫–∞–∫–∏—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞—Ö —Ä–µ—á—å –∏–¥–µ—Ç —Å–µ–π—á–∞—Å, –≤ —Ñ–æ–Ω–¥–µ –Ω–µ —É—Ç–æ—á–Ω–∏–ª–∏. ‚û°Ô∏è –ö–∞–∫ –æ—Ç–º–µ—Ç–∏–ª–∏ –≤ —Ñ–æ–Ω–¥–µ, –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –¢–∫–∞—á–µ–Ω–∫–æ ¬´–ø–æ—Ç—Ä–µ–±–æ–≤–∞–ª –æ—Ç ""–ë–∏–æ–ú–∞—Ä–∏–Ω"" –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–∏—Ç—å –∫ —Å–ª–µ–¥—É—é—â–µ–º –∑–∞—Å–µ–¥–∞–Ω–∏—é —ç–∫—Å–ø–µ—Ä—Ç–Ω–æ–≥–æ —Å–æ–≤–µ—Ç–∞ 27 –Ω–æ—è–±—Ä—è –ø–ª–∞–Ω –ø—Ä–µ–æ–¥–æ–ª–µ–Ω–∏—è —Å—É—â–µ—Å—Ç–≤—É—é—â–∏—Ö –ø—Ä–æ–±–ª–µ–º –∏ –≤–∑—è—Ç—å –Ω–∞ —Å–µ–±—è –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç—å –∑–∞ –≤–æ—Å—Å—Ç–∞–Ω–æ–≤–ª–µ–Ω–∏–µ —Ä–∏—Ç–º–∏—á–Ω–æ—Å—Ç–∏ —Ç–µ–∫—É—â–∏—Ö –ø–æ—Å—Ç–∞–≤–æ–∫, –∞ —Ç–∞–∫–∂–µ –≥–∞—Ä–∞–Ω—Ç–∏—Ä–æ–≤–∞—Ç—å —Å—Ç–∞–±–∏–ª—å–Ω—ã–µ –ø–æ—Å—Ç–∞–≤–∫–∏ –≤ –±—É–¥—É—â–µ–º¬ª.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The 'Circle of Good' reported problems with supply of Biomarin's products. The head of the foundation met with a representative from the company and discussed 'a very difficult situation with supply of Biocarin's products to Russia'. The foundation mentioned issues with the drug Voxzogo (for achondroplasia) last year. The foundation did not specify which drugs are currently facing problems. Biocarin demanded from the company to provide a plan for overcoming existing issues and take responsibility for resuming supply of products, as well as guarantee stable supplies in the future.""
}"
2025-11-24T13:08:21+00:00,@genedna1,1473,https://t.me/genedna1/1473,"–≠–∫—Å–ø–µ—Ä—Ç—ã —Ä–∞—Å—Å–∫–∞–∑–∞–ª–∏ –æ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ —Å–∫—Ä–∏–Ω–∏–Ω–≥–∞ –Ω–æ–≤–æ—Ä–æ–∂–¥–µ–Ω–Ω—ã—Ö –Ω–∞ –±–æ–ª–µ–∑–Ω—å –§–∞–±—Ä–∏ –í 2026-2027 –≥–æ–¥—É –≤ –ø—Ä–æ–≥—Ä–∞–º–º—É –Ω–µ–æ–Ω–∞—Ç–∞–ª—å–Ω–æ–≥–æ —Å–∫—Ä–∏–Ω–∏–Ω–≥–∞ –º–æ–≥—É—Ç –≤–∫–ª—é—á–∏—Ç—å –±–æ–ª–µ–∑–Ω—å –§–∞–±—Ä–∏. –û–± —ç—Ç–æ–º —Å–æ–æ–±—â–∏–ª–∏ —ç–∫—Å–ø–µ—Ä—Ç—ã –Ω–∞ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–æ–º —Ñ–æ—Ä—É–º–µ ¬´–°–æ–¥—Ä—É–∂–µ—Å—Ç–≤–æ –±–µ–∑ –≥—Ä–∞–Ω–∏—Ü¬ª. –í –Ω–µ–º –≤ —Ç–æ–º —á–∏—Å–ª–µ –ø—Ä–∏–Ω—è–ª —É—á–∞—Å—Ç–∏–µ –≥–µ–Ω–µ—Ç–∏–∫ –†–æ–±–µ—Ä—Ç –î–∂. –î–µ—Å–Ω–∏–∫, —Å—Ç–æ—è–≤—à–∏–π —É –∏—Å—Ç–æ–∫–æ–≤ —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ —Ñ–µ—Ä–º–µ–Ω—Ç–æ–∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –±–æ–ª–µ–∑–Ω–∏ –§–∞–±—Ä–∏. –ó–∞–±–æ–ª–µ–≤–∞–Ω–∏–µ —Ä–∞–∑–≤–∏–≤–∞–µ—Ç—Å—è –∏–∑-–∑–∞ –º—É—Ç–∞—Ü–∏–∏ –≤ –≥–µ–Ω–µ, –∫–æ—Ç–æ—Ä—ã–π –æ—Ç–≤–µ—á–∞–µ—Ç –∑–∞ –≤—ã—Ä–∞–±–æ—Ç–∫—É —Ñ–µ—Ä–º–µ–Ω—Ç–∞ –∞–ª—å—Ñ–∞-–≥–∞–ª–∞–∫—Ç–æ–∑–∏–¥–∞–∑—ã. –£ –±–æ–ª—å–Ω—ã—Ö –≤–µ—â–µ—Å—Ç–≤–æ –≤—ã—Ä–∞–±–∞—Ç—ã–≤–∞–µ—Ç—Å—è –≤ –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ–º –∫–æ–ª–∏—á–µ—Å—Ç–≤–µ. –í –∫–ª–µ—Ç–∫–∞—Ö –ø–æ—Å—Ç–µ–ø–µ–Ω–Ω–æ –Ω–∞–∫–∞–ø–ª–∏–≤–∞—é—Ç—Å—è –ª–∏–ø–∏–¥—ã, —á—Ç–æ –ø—Ä–∏–≤–æ–¥–∏—Ç –∫ –ø–æ—Ä–∞–∂–µ–Ω–∏—é, –Ω–∞–ø—Ä–∏–º–µ—Ä, —Å–µ—Ä–¥—Ü–∞ –∏–ª–∏ –ø–æ—á–µ–∫. –ó–∞ —Å—á–µ—Ç —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–∏ –Ω–æ–≤—ã—Ö –¥–∏–∞–≥–Ω–æ—Å—Ç–∏—á–µ—Å–∫–∏—Ö –º–µ—Ç–æ–¥–æ–≤ –∏ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã—Ö –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ —Å–∫—Ä–∏–Ω–∏–Ω–≥–æ–≤–∞—è –ø—Ä–æ–≥—Ä–∞–º–º–∞ —É–∂–µ –≤ –±–ª–∏–∂–∞–π—à–µ–µ –≤—Ä–µ–º—è –º–æ–∂–µ—Ç –±—ã—Ç—å —Ä–∞—Å—à–∏—Ä–µ–Ω–∞. ‚Äî –≠—Ç–æ –æ–ø—Ä–∞–≤–¥–∞–Ω–æ —ç–∫–æ–Ω–æ–º–∏—á–µ—Å–∫–∏, —Ç–∞–∫ –∫–∞–∫ —Ä–∞–Ω–æ –Ω–∞—á–∞—Ç–æ–µ –ª–µ—á–µ–Ω–∏–µ –Ω–µ —Ç–æ–ª—å–∫–æ —Å–æ—Ö—Ä–∞–Ω—è–µ—Ç –∂–∏–∑–Ω–∏ –¥–µ—Ç–µ–π, –Ω–æ –∏ –ø—Ä–µ–¥–æ—Ç–≤—Ä–∞—â–∞–µ—Ç –∏—Ö –∏–Ω–≤–∞–ª–∏–¥–Ω–æ—Å—Ç—å, —Å–Ω–∏–∂–∞—è —Å–≤—è–∑–∞–Ω–Ω—ã–µ —Å —ç—Ç–∏–º –∑–∞—Ç—Ä–∞—Ç—ã –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–∞ –∏ —Å–µ–º—å–∏. –ù–æ –≤–∞–∂–Ω–æ –≤–∫–ª—é—á–∞—Ç—å –≤ –ø—Ä–æ–≥—Ä–∞–º–º—É –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è, –∫–æ—Ç–æ—Ä—ã–µ —É–º–µ—é—Ç –Ω–µ —Ç–æ–ª—å–∫–æ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏—Ä–æ–≤–∞—Ç—å, –Ω–æ –∏ –ª–µ—á–∏—Ç—å, ‚Äî –ø–æ–¥—á–µ—Ä–∫–Ω—É–ª–∏ —ç–∫—Å–ø–µ—Ä—Ç—ã. –ì–µ–Ω–µ—Ç–∏–∫ –†–æ–±–µ—Ä—Ç –î–∂. –î–µ—Å–Ω–∏–∫ –æ—Ç–º–µ—Ç–∏–ª —Å–æ —Å—Å—ã–ª–∫–æ–π –Ω–∞ –º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è, —á—Ç–æ —Ä–∞–Ω–Ω–µ–µ –Ω–∞–∑–Ω–∞—á–µ–Ω–∏–µ –ª–µ—á–µ–Ω–∏—è –¥–µ–π—Å—Ç–≤–∏—Ç–µ–ª—å–Ω–æ —Ç–æ—Ä–º–æ–∑–∏—Ç –ø—Ä–æ–≥—Ä–µ—Å—Å–∏—Ä–æ–≤–∞–Ω–∏–µ –ø–æ—Ä–∞–∂–µ–Ω–∏—è –ø–æ—á–µ–∫, —Å–µ—Ä–¥—Ü–∞ –∏ —Å–æ—Å—É–¥–æ–≤ –≥–æ–ª–æ–≤–Ω–æ–≥–æ –º–æ–∑–≥–∞, –∞ —Ç–∞–∫–∂–µ —Å–Ω–∏–∂–∞–µ—Ç —Ä–∏—Å–∫ –æ—Å–ª–æ–∂–Ω–µ–Ω–∏–π. –í –†–æ—Å—Å–∏–∏ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –±–æ–ª–µ–∑–Ω–∏ –§–∞–±—Ä–∏ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω—ã –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –Ω–∞ –æ—Å–Ω–æ–≤–µ –¥–µ–π—Å—Ç–≤—É—é—â–∏—Ö –≤–µ—â–µ—Å—Ç–≤ –∞–≥–∞–ª—Å–∏–¥–∞–∑—ã –±–µ—Ç–∞, –∞–≥–∞–ª—Å–∏–¥–∞–∑—ã –∞–ª—å—Ñ–∞ –∏ –ø—ç–≥—É–Ω–∏–≥–∞–ª–∑–∏–¥–∞–∑—ã –∞–ª—å—Ñ–∞. –ù–∞–∏–±–æ–ª–µ–µ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω—ã–º, –ø–æ —Å–ª–æ–≤–∞–º —ç–∫—Å–ø–µ—Ä—Ç–∞, —Å—á–∏—Ç–∞–µ—Ç—Å—è –ø—Ä–µ–ø–∞—Ä–∞—Ç –∞–≥–∞–ª—Å–∏–¥–∞–∑–∞ –±–µ—Ç–∞. –†–æ—Å—Å–∏–π—Å–∫–∏–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –∞–≥–∞–ª—Å–∏–¥–∞–∑–∞ –±–µ—Ç–∞ —Å–æ–ø–æ—Å—Ç–∞–≤–∏–º —Å –æ—Ä–∏–≥–∏–Ω–∞–ª–æ–º, –ø–æ–¥—á–µ—Ä–∫–Ω—É–ª –≥–µ–Ω–µ—Ç–∏–∫. ‚Äî –ë–∏–æ–∞–Ω–∞–ª–æ–≥ –æ–±–ª–∞–¥–∞–µ—Ç —Ç–∞–∫–æ–π –∂–µ –±–µ–∑–æ–ø–∞—Å–Ω–æ—Å—Ç—å—é –∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å—é. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –æ–Ω –±–æ–ª–µ–µ –¥–æ—Å—Ç—É–ø–µ–Ω, —Ç–∞–∫ –∫–∞–∫ —Ü–µ–Ω–∞ –Ω–∞ –Ω–µ–≥–æ –Ω–∞ 40% –Ω–∏–∂–µ –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å –æ—Ä–∏–≥–∏–Ω–∞–ª–æ–º, ‚Äî —Å–∫–∞–∑–∞–ª –æ–Ω. –ë–∏–æ—Å–∏–º–∏–ª—è—Ä—ã –ø–æ–∑–≤–æ–ª—è—é—Ç –æ–±–µ—Å–ø–µ—á–∏—Ç—å —Ç–µ—Ä–∞–ø–∏–µ–π –∑–∞ —Ç–µ –∂–µ –¥–µ–Ω—å–≥–∏ –±–æ–ª—å—à–µ–µ —á–∏—Å–ª–æ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, —á—Ç–æ –≤—ã–≥–æ–¥–Ω–æ –∏ –¥–ª—è –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–∞, –∏ –¥–ª—è –±–æ–ª—å–Ω—ã—Ö, –¥–æ–±–∞–≤–∏–ª —ç–∫—Å–ø–µ—Ä—Ç.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""Experts discussed the need to screen newborns for Fabry disease from 2026-2027. The neonatal screening program may include Fabry disease, according to experts at the 'Borderless Community' international forum. Geneticist Robert J. Deskin, who was one of the founders of enzyme replacement therapy for Fabry disease, participated in the forum. The disease develops due to a mutation in the gene responsible for alpha-galactosidase A production. Patients produce insufficient amounts of this substance, leading to lipid buildup in cells that can affect organs such as the heart or kidneys. With advances in diagnostic methods and innovative orphan drugs, the screening program can be expanded to include treatable conditions. This is economically justified as early treatment not only saves lives but also prevents disability, reducing associated state and family costs. However, it is important to include conditions that can both diagnose and treat, according to experts. Geneticist Robert J. Deskin cited international studies showing that early treatment indeed slows disease progression in the kidneys, heart, and brain vessels. It"
2025-11-01T18:45:20+00:00,@genedna1,1471,https://t.me/genedna1/1471,"–†–µ–±—è—Ç–∞, –º—ã —Å–æ–±—Ä–∞–ª–∏ —Å–∞–º—ã–µ –∏–Ω—Ç–µ—Ä–µ—Å–Ω—ã–µ –∏ –ø–æ–ª–µ–∑–Ω—ã–µ –∫–∞–Ω–∞–ª—ã –¥–ª—è —É—á–µ–±—ã ! üåü –ü—Ä–∏—Å–æ–µ–¥–∏–Ω—è–π—Ç–µ—Å—å –∫ –Ω–∞–ºüëâ https://t.me/addlist/RaIRdeJ7YzcwNmVi –ò –±—É–¥–µ—Ç–µ –≤ –∫—É—Ä—Å–µ —Å–∞–º—ã—Ö –∞–∫—Ç—É–∞–ª—å–Ω—ã—Ö –Ω–æ–≤–æ—Å—Ç–µ–π –∏ –ø–æ–ª–µ–∑–Ω—ã—Ö –º–∞—Ç–µ—Ä–∏–∞–ª–æ–≤ ü©∫ –¢–∞–∫–∂–µ –Ω–∞ –∫–∞–Ω–∞–ª–µ –í–µ—Å—Ç–∏ –∏–∑ –ú–µ–¥–∏—Ü–∏–Ω—ã –∏–¥–µ—Ç –†–æ–∑—ã–≥—Ä—ã—à üåü–∞–≤—Ç–æ—Ä –ø–∞–ø–∫–∏: @Aina_2001","{""skip"": true}"
2025-10-31T14:29:31+00:00,@genedna1,1470,https://t.me/genedna1/1470,"üíº –ë—ã–≤—à–∏–π –ø–µ—Ä–≤—ã–π –∑–∞–º–≥–ª–∞–≤—ã –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–∞ –í–∞—Å–∏–ª–∏–π –û—Å—å–º–∞–∫–æ–≤ –Ω–∞–∑–Ω–∞—á–µ–Ω –∑–∞–º–º–∏–Ω–∏—Å—Ç—Ä–∞ –æ–±–æ—Ä–æ–Ω—ã –í –∫–æ–Ω—Ü–µ –æ–∫—Ç—è–±—Ä—è –ú–∏—à—É—Å—Ç–∏–Ω –æ—Å–≤–æ–±–æ–¥–∏–ª –û—Å—å–º–∞–∫–æ–≤–∞ –æ—Ç –¥–æ–ª–∂–Ω–æ—Å—Ç–∏ –≤ –ú–∏–Ω–ø—Ä–æ–º—Ç–æ—Ä–≥–µ. –í –≤–µ–¥–æ–º—Å—Ç–≤–µ –û—Å—å–º–∞–∫–æ–≤ —Ä–∞–±–æ—Ç–∞–ª —Å 2004 –≥–æ–¥–∞ –∏ –≤ —Ç–æ–º —á–∏—Å–ª–µ –∫—É—Ä–∏—Ä–æ–≤–∞–ª –≤–æ–ø—Ä–æ—Å—ã —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏—è –∏ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ –≥–æ—Å–ø–æ–ª–∏—Ç–∏–∫–∏ –≤ —Å—Ñ–µ—Ä–µ —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–æ–π –æ—Ç—Ä–∞—Å–ª–∏ –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø—Ä–æ–º—ã—à–ª–µ–Ω–Ω–æ—Å—Ç–∏, –±—é–¥–∂–µ—Ç–Ω–æ–≥–æ –ø–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω–∏—è, –∏–º–ø–æ—Ä—Ç–æ–∑–∞–º–µ—â–µ–Ω–∏—è, –∞ —Ç–∞–∫–∂–µ –∫–æ–æ—Ä–¥–∏–Ω–∞—Ü–∏–∏ –Ω–∞—Ü–ø—Ä–æ–µ–∫—Ç–æ–≤. üå∫–°–µ–≥–æ–¥–Ω—è –≥–ª–∞–≤–∞ –ú–∏–Ω–æ–±–æ—Ä–æ–Ω—ã –ê–Ω–¥—Ä–µ–π –ë–µ–ª–æ—É—Å–æ–≤ –æ–±—ä—è–≤–∏–ª, —á—Ç–æ –û—Å—å–º–∞–∫–æ–≤ –∑–∞–Ω—è–ª –¥–æ–ª–∂–Ω–æ—Å—Ç—å –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—è –º–∏–Ω–∏—Å—Ç—Ä–∞ –æ–±–æ—Ä–æ–Ω—ã.","{""skip"": true}"
2025-10-31T14:29:31+00:00,@genedna1,1469,https://t.me/genedna1/1469,–í–æ—Ç —ç—Ç–æ –Ω–æ–º–µ—Ä üåöü§∑,"{""skip"": true}"
2025-10-29T20:23:09+00:00,@genedna1,1465,https://t.me/genedna1/1465,"–ê–ø—Ç–µ–∫–∏ –ø—Ä–µ–¥—É–ø—Ä–µ–¥–∏–ª–∏ –æ –ø–æ–≤—ã—à–µ–Ω–∏–∏ —Ü–µ–Ω –Ω–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –∏–∑-–∑–∞ —É–≤–µ–ª–∏—á–µ–Ω–∏—è –ù–î–° –ù–µ –ø–æ–≤—ã—à–∞—Ç—å —Ä–∞–∑–º–µ—Ä —Å—Ç–∞–≤–∫–∏ –ù–î–° —Å 20% –¥–æ 22% –ø–æ–ø—Ä–æ—Å–∏–ª –ê–ª—å—è–Ω—Å —Ñ–∞—Ä–º–∞—Ü–µ–≤—Ç–∏—á–µ—Å–∫–∏—Ö –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–π –≤ –ø–∏—Å—å–º–µ –≤ –ú–∏–Ω—Ñ–∏–Ω. –¢–∞–∫–∏–µ –ø–æ–ø—Ä–∞–≤–∫–∏ –≤ –ù–∞–ª–æ–≥–æ–≤—ã–π –∫–æ–¥–µ–∫—Å –ì–æ—Å–¥—É–º–∞ –æ–¥–æ–±—Ä–∏–ª–∞ –≤ –ø–µ—Ä–≤–æ–º —á—Ç–µ–Ω–∏–∏ 22 –æ–∫—Ç—è–±—Ä—è. –ê–ø—Ç–µ–∫–∏ –æ—Ç–º–µ—á–∞—é—Ç, —á—Ç–æ –ø—Ä–∏–¥–µ—Ç—Å—è –ø–æ–≤—ã—Å–∏—Ç—å —Ü–µ–Ω—ã –Ω–∞ 60% –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ ‚Äî —ç—Ç–æ —Ç–µ,—á—Ç–æ –Ω–µ –≤—Ö–æ–¥—è—Ç –≤ –ñ–ù–í–õ–ü. –ò —É–∂–µ —Å–µ–π—á–∞—Å –∞–ø—Ç–µ—á–Ω–∞—è –Ω–∞—Ü–µ–Ω–∫–∞ –Ω–∞ –Ω–∏—Ö —Å–æ—Å—Ç–∞–≤–ª—è–µ—Ç –¥–æ 27%. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, 30% —Ä–æ—Å—Å–∏–π—Å–∫–∏—Ö –∞–ø—Ç–µ–∫ ‚Äî —ç—Ç–æ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª—å –º–∞–ª–æ–≥–æ –∏ —Å—Ä–µ–¥–Ω–µ–≥–æ –±–∏–∑–Ω–µ—Å–∞. –ú–Ω–æ–≥–∏–º –∏–∑ –Ω–∏—Ö –ø—Ä–∏–¥–µ—Ç—Å—è –∑–∞–∫—Ä—ã—Ç—å—Å—è, —É–≤–µ—Ä–µ–Ω—ã –≤ –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–∏.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""pricing, shortage"",
  ""impact"": ""high"",
  ""english"": ""Pharmacies warned about a price increase on medicines due to an increase in VAT. The Federation Alliance of Pharmaceutical Associations asked the Ministry of Finance to keep the VAT rate at 20% instead of increasing it to 22%. The changes in the Tax Code were approved by the State Duma on October 22nd. Pharmacies noted that they will have to increase prices on 60% of their products - those not included in the Green Non-Volatile List. Already, the on-the-counter price increase for these products is up to 27%. Additionally, about 30% of Russian pharmacies are small and medium businesses. Many will have to close down, according to the associations.""
}"
2025-10-29T17:09:25+00:00,@genedna1,1464,https://t.me/genedna1/1464,"üôãüèª‚Äç‚ôÄÔ∏è –ê –≤—ã –∑–Ω–∞–µ—Ç–µ, —á—Ç–æ —Å—É—â–µ—Å—Ç–≤—É–µ—Ç —Ä–µ–¥–∫–æ–µ –Ω–µ–≤—Ä–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–µ —Å–æ—Å—Ç–æ—è–Ω–∏–µ ‚Äî ¬´—Å–∏–Ω–¥—Ä–æ–º –ê–ª–∏—Å—ã –≤ –°—Ç—Ä–∞–Ω–µ —á—É–¥–µ—Å¬ª, –∫–æ–≥–¥–∞ —á–µ–ª–æ–≤–µ–∫ –≤–æ—Å–ø—Ä–∏–Ω–∏–º–∞–µ—Ç –æ–∫—Ä—É–∂–∞—é—â–∏–µ –ø—Ä–µ–¥–º–µ—Ç—ã –∏ —á–∞—Å—Ç–∏ —Å–≤–æ–µ–≥–æ —Ç–µ–ª–∞ –∏—Å–∫–∞–∂–µ–Ω–Ω—ã–º–∏ –ø–æ —Ä–∞–∑–º–µ—Ä—É? –¢–∞–∫ –∂–µ, –∫–∞–∫ –∏ —ç—Ç–æ—Ç —É–¥–∏–≤–∏—Ç–µ–ª—å–Ω—ã–π —Ñ–µ–Ω–æ–º–µ–Ω, –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è –ø—Ä–∞–∫—Ç–∏–∫–∞ —á–∞—Å—Ç–æ —Å—Ç–∞–ª–∫–∏–≤–∞–µ—Ç—Å—è —Å —Å–∏—Ç—É–∞—Ü–∏—è–º–∏, –≥–¥–µ —Ä–µ–∞–ª—å–Ω–æ—Å—Ç—å –ø—Ä–µ–≤–æ—Å—Ö–æ–¥–∏—Ç —Ñ–∞–Ω—Ç–∞–∑–∏—é. –ß—Ç–æ–±—ã —É–≤–µ—Ä–µ–Ω–Ω–æ –æ—Ä–∏–µ–Ω—Ç–∏—Ä–æ–≤–∞—Ç—å—Å—è –≤ –º–∏—Ä–µ —Å–ª–æ–∂–Ω—ã—Ö –¥–∏–∞–≥–Ω–æ–∑–æ–≤ –∏ —Ä–µ–¥–∫–∏—Ö –ø–∞—Ç–æ–ª–æ–≥–∏–π, –Ω—É–∂–Ω—ã –Ω–∞–¥–µ–∂–Ω—ã–µ –∏—Å—Ç–æ—á–Ω–∏–∫–∏ –∑–Ω–∞–Ω–∏–π. –í–æ—Ç –ø–∞–ø–∫–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∫–∞–Ω–∞–ª–æ–≤ ‚Äî –≤–∞—à –ø—Ä–æ–≤–æ–¥–Ω–∏–∫ –≤ –º–∏—Ä–µ —Å–æ–≤—Ä–µ–º–µ–Ω–Ω–æ–π –º–µ–¥–∏—Ü–∏–Ω—ã üîó –í–æ—Ç —Å—Å—ã–ª–∫–∞: https://t.me/addlist/KKwhgA52bwozMzJi","{""skip"": true}"
2025-10-24T10:14:38+00:00,@genedna1,1463,https://t.me/genedna1/1463,"–í –†–æ—Å—Å–∏–∏ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ —Å–∏–Ω–¥—Ä–æ–º–∞ –•–∞–Ω—Ç–µ—Ä–∞ ¬´–ì–µ–Ω–µ—Ä–∏—É–º¬ª –ø–æ–ª—É—á–∏–ª —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–æ–Ω–Ω–æ–µ —É–¥–æ—Å—Ç–æ–≤–µ—Ä–µ–Ω–∏–µ –Ω–∞ –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –ö–ª–æ—Ç–∏–ª–∏—è (–≤–µ—Ä–µ–Ω–∞—Ñ—É—Å–ø –∞–ª—å—Ñ–∞), –ø—Ä–µ–¥–Ω–∞–∑–Ω–∞—á–µ–Ω–Ω—ã–π –¥–ª—è —Ç–µ—Ä–∞–ø–∏–∏ –º—É–∫–æ–ø–æ–ª–∏—Å–∞—Ö–∞—Ä–∏–¥–æ–∑–∞ II —Ç–∏–ø–∞ (—Å–∏–Ω–¥—Ä–æ–º–∞ –•–∞–Ω—Ç–µ—Ä–∞). –ü—Ä–µ–ø–∞—Ä–∞—Ç –±—É–¥–µ—Ç –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç—å—Å—è –Ω–∞ –º–æ—â–Ω–æ—Å—Ç—è—Ö –∫–æ–º–ø–∞–Ω–∏–∏ –ø–æ –ø–æ–ª–Ω–æ–º—É —Ü–∏–∫–ª—É. –ü–æ –¥–∞–Ω–Ω—ã–º –∫–æ–º–ø–∞–Ω–∏–∏, —ç—Ç–æ –ø–µ—Ä–≤—ã–π –≤ –º–∏—Ä–µ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç, –∫–æ—Ç–æ—Ä—ã–π –∏—Å–ø–æ–ª—å–∑—É–µ—Ç –∏–Ω—Å—É–ª–∏–Ω–æ–≤—ã–π —Ä–µ—Ü–µ–ø—Ç–æ—Ä –¥–ª—è –ø—Ä–µ–æ–¥–æ–ª–µ–Ω–∏—è –≥–µ–º–∞—Ç–æ—ç–Ω—Ü–µ—Ñ–∞–ª–∏—á–µ—Å–∫–æ–≥–æ –±–∞—Ä—å–µ—Ä–∞ –∏ –¥–æ—Å—Ç–∞–≤–∫–∏ —Ñ–µ—Ä–º–µ–Ω—Ç–∞ –∏–¥—É—Ä–æ–Ω–∞—Ç-2-—Å—É–ª—å—Ñ–∞—Ç–∞–∑—ã –Ω–µ–ø–æ—Å—Ä–µ–¥—Å—Ç–≤–µ–Ω–Ω–æ –≤ —Ü–µ–Ω—Ç—Ä–∞–ª—å–Ω—É—é –Ω–µ—Ä–≤–Ω—É—é —Å–∏—Å—Ç–µ–º—É, —á—Ç–æ —è–≤–ª—è–µ—Ç—Å—è –ø—Ä–∏–Ω—Ü–∏–ø–∏–∞–ª—å–Ω–æ –Ω–æ–≤—ã–º –º–µ—Ç–æ–¥–æ–º —Ç–µ—Ä–∞–ø–∏–∏ —Å–∏–Ω–¥—Ä–æ–º–∞ –•–∞–Ω—Ç–µ—Ä–∞. –ò—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –ø—Ä–æ—Ö–æ–¥–∏–ª–æ –Ω–∞ –±–∞–∑–µ 11 –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–π. –£ –ø–æ–ª—É—á–∏–≤—à–∏—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤–æ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –æ—Ç–º–µ—Ç–∏–ª–∏ —Å—Ç–∞–±–∏–ª–∏–∑–∞—Ü–∏—é –∏ —É–ª—É—á—à–µ–Ω–∏–µ —Ñ—É–Ω–∫—Ü–∏–∏ –≤–Ω–µ—à–Ω–µ–≥–æ –¥—ã—Ö–∞–Ω–∏—è, –ø–æ–¥–≤–∏–∂–Ω–æ—Å—Ç–∏ —Å—É—Å—Ç–∞–≤–æ–≤ –∏ –¥—Ä—É–≥–∏—Ö —Ñ–∏–∑–∏—á–µ—Å–∫–∏—Ö –ø–∞—Ä–∞–º–µ—Ç—Ä–æ–≤. –î–æ–ª–≥–æ–µ –≤—Ä–µ–º—è –≥–ª–∞–≤–Ω—ã–º –≤—ã–∑–æ–≤–æ–º –≤ –ª–µ—á–µ–Ω–∏–∏ —Å–∏–Ω–¥—Ä–æ–º–∞ –•–∞–Ω—Ç–µ—Ä–∞ –æ—Å—Ç–∞–≤–∞–ª–æ—Å—å –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–µ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ –≤–æ–∑–¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å –∏–º–µ–Ω–Ω–æ –Ω–∞ –Ω–µ–≤—Ä–æ–ª–æ–≥–∏—á–µ—Å–∫–∏–µ —Å–∏–º–ø—Ç–æ–º—ã. –°—É—â–µ—Å—Ç–≤—É—é—â–∏–µ –º–µ—Ç–æ–¥—ã —Ñ–µ—Ä–º–µ–Ω—Ç–æ–∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –º–æ–≥–ª–∏ –±–æ—Ä–æ—Ç—å—Å—è –ª–∏—à—å —Å —Å–æ–º–∞—Ç–∏—á–µ—Å–∫–∏–º–∏ –ø—Ä–æ—è–≤–ª–µ–Ω–∏—è–º–∏, –Ω–æ –Ω–µ —Å–ø–æ—Å–æ–±—Å—Ç–≤–æ–≤–∞–ª–∏ –æ—Å—Ç–∞–Ω–æ–≤–∫–µ –Ω–µ–π—Ä–æ–¥–µ–≥–µ–Ω–µ—Ä–∞—Ü–∏–∏. –ì–µ–Ω–¥–∏—Ä–µ–∫—Ç–æ—Ä ¬´–ì–µ–Ω–µ—Ä–∏—É–º–∞¬ª –î–∞–Ω–∏–∏–ª –¢–∞–ª—è–Ω—Å–∫–∏–π –∑–∞—è–≤–∏–ª, —á—Ç–æ –≤–ø–µ—Ä–≤—ã–µ –≤ –∞—Ä—Å–µ–Ω–∞–ª–µ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –ø–æ—è–≤–∏–ª—Å—è –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç, –∫–æ—Ç–æ—Ä—ã–π —Ä–∞–¥–∏–∫–∞–ª—å–Ω–æ –º–µ–Ω—è–µ—Ç —Ç–µ—á–µ–Ω–∏–µ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è, –∞ —Ç–∞–∫–∂–µ –æ—Ç–º–µ—Ç–∏–ª, —á—Ç–æ –≤ —Å–∞–º–æ–µ –±–ª–∏–∂–∞–π—à–µ–µ –≤—Ä–µ–º—è –ø—Ä–µ–ø–∞—Ä–∞—Ç —Å—Ç–∞–Ω–µ—Ç –¥–æ—Å—Ç—É–ø–µ–Ω –≤ –†–æ—Å—Å–∏–∏. –ï—â–µ, –ø–æ –µ–≥–æ —Å–ª–æ–≤–∞–º, –∫–æ–º–ø–∞–Ω–∏—è –≤–µ–¥–µ—Ç –∞–∫—Ç–∏–≤–Ω—É—é —Ä–∞–±–æ—Ç—É –¥–ª—è —Ç–æ–≥–æ, —á—Ç–æ–±—ã —Ç–µ—Ä–∞–ø–∏—è —ç—Ç–∏–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–º —Å—Ç–∞–ª–∞ –¥–æ—Å—Ç—É–ø–Ω–∞ –ø–∞—Ü–∏–µ–Ω—Ç–∞–º –≤ –Ω–∞–∏–±–æ–ª—å—à–µ–º —á–∏—Å–ª–µ —Å—Ç—Ä–∞–Ω.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, registration, reimbursement, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""The drug 'Generium' for the treatment of Hunter syndrome received an innovative drug registration. The company claims this is the first globally registered medication that uses insulin receptors to overcome the hematoencephalic barrier and deliver idursulonate-2-sulfatase directly to the central nervous system, a fundamentally new method of treating Hunter syndrome. Patients treated with the drug showed stabilization and improvement in breathing function, joint mobility, and other physical parameters. Previously, treatment options were limited to somatic manifestations of the disease without addressing neurological degeneration. The CEO of 'Generium', Daniil Taliansky, stated that this is the first tool to radically change the disease course and noted that the drug will be made available in Russia soon. He also stated that the company is working to make this therapy accessible to patients in as many countries as possible.""
}"
2025-10-23T06:48:04+00:00,@genedna1,1462,https://t.me/genedna1/1462,"üóì 23 –æ–∫—Ç—è–±—Ä—è ‚Äî –ú–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω—ã–π –¥–µ–Ω—å –æ—Å–≤–µ–¥–æ–º–ª—ë–Ω–Ω–æ—Å—Ç–∏ –æ –•-—Å—Ü–µ–ø–ª–µ–Ω–Ω–æ–º –¥–æ–º–∏–Ω–∞–Ω—Ç–Ω–æ–º –≥–∏–ø–æ—Ñ–æ—Å—Ñ–∞—Ç–µ–º–∏—á–µ—Å–∫–æ–º —Ä–∞—Ö–∏—Ç–µ (–•-–ì–§–†) üîπ–≠—Ç–æ —Ä–µ–¥–∫–æ–µ –Ω–∞—Å–ª–µ–¥—Å—Ç–≤–µ–Ω–Ω–æ–µ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–µ, –∫–æ—Ç–æ—Ä–æ–µ –ø—Ä–æ—è–≤–ª—è–µ—Ç—Å—è —É–∂–µ –Ω–∞ –ø–µ—Ä–≤—ã—Ö –≥–æ–¥–∞—Ö –∂–∏–∑–Ω–∏, –Ω–æ –∏–∑-–∑–∞ —Å—Ö–æ–∂–µ—Å—Ç–∏ —Å–∏–º–ø—Ç–æ–º–æ–≤ —Å –¥—Ä—É–≥–∏–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏ —á–∞—Å—Ç–æ –æ—Å—Ç–∞—ë—Ç—Å—è –Ω–µ–¥–∏–∞–≥–Ω–æ—Å—Ç–∏—Ä–æ–≤–∞–Ω–Ω—ã–º. –ü–æ–∑–¥–Ω–µ–µ –≤—ã—è–≤–ª–µ–Ω–∏–µ –ø—Ä–∏–≤–æ–¥–∏—Ç –∫ —Ç—è–∂—ë–ª—ã–º –ø–æ—Å–ª–µ–¥—Å—Ç–≤–∏—è–º ‚Äî –¥–µ—Ñ–æ—Ä–º–∞—Ü–∏—è–º —Å–∫–µ–ª–µ—Ç–∞, –∑–∞–¥–µ—Ä–∂–∫–µ —Ä–æ—Å—Ç–∞, —Ö—Ä–æ–Ω–∏—á–µ—Å–∫–æ–π –±–æ–ª–∏ –∏ –∏–Ω–≤–∞–ª–∏–¥–∏–∑–∞—Ü–∏–∏. üîπ–ß—Ç–æ–±—ã —Ä–∞—Å–ø–æ–∑–Ω–∞—Ç—å –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–µ –∫–∞–∫ –º–æ–∂–Ω–æ —Ä–∞–Ω—å—à–µ, –§–æ–Ω–¥ ¬´–†–µ–¥–∫–∏–π —Å–ª—É—á–∞–π¬ª –ø–æ–¥–≥–æ—Ç–æ–≤–∏–ª –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω—ã–π –ø–ª–∞–∫–∞—Ç —Å –ø—Ä–∏–∑–Ω–∞–∫–∞–º–∏ –•-–ì–§–†. –û–Ω –Ω–∞–≥–ª—è–¥–Ω–æ –ø–æ–∫–∞–∑—ã–≤–∞–µ—Ç –æ—Å–Ω–æ–≤–Ω—ã–µ —Å–∏–º–ø—Ç–æ–º—ã, –∫–æ—Ç–æ—Ä—ã–µ –¥–æ–ª–∂–Ω—ã –Ω–∞—Å—Ç–æ—Ä–æ–∂–∏—Ç—å —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –∏ —Ä–æ–¥–∏—Ç–µ–ª–µ–π ‚Äî –æ—Ç –∑–∞–¥–µ—Ä–∂–∫–∏ —Ä–æ—Å—Ç–∞ –∏ –±–æ–ª–µ–π –≤ –∫–æ—Å—Ç—è—Ö –¥–æ –¥–µ—Ñ–æ—Ä–º–∞—Ü–∏–∏ –∫–æ–Ω–µ—á–Ω–æ—Å—Ç–µ–π –∏ –Ω–∞—Ä—É—à–µ–Ω–∏–π —Å—Ç—Ä—É–∫—Ç—É—Ä—ã –∑—É–±–æ–≤. üìç –ì–ª–∞–≤–Ω–∞—è —Ü–µ–ª—å ‚Äî –Ω–∞–ø–æ–º–Ω–∏—Ç—å, —á—Ç–æ —Ä–∞–Ω–Ω—è—è –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞ –∏ —Å–≤–æ–µ–≤—Ä–µ–º–µ–Ω–Ω–æ–µ –Ω–∞—á–∞–ª–æ —Ç–µ—Ä–∞–ø–∏–∏ —Å–ø–æ—Å–æ–±–Ω—ã –∫–∞—Ä–¥–∏–Ω–∞–ª—å–Ω–æ –∏–∑–º–µ–Ω–∏—Ç—å –∂–∏–∑–Ω—å —Ä–µ–±—ë–Ω–∫–∞ —Å –≥–∏–ø–æ—Ñ–æ—Å—Ñ–∞—Ç–µ–º–∏—á–µ—Å–∫–∏–º —Ä–∞—Ö–∏—Ç–æ–º.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""guideline,hospital_policy,pharmacovigilance,safety"",
  ""impact"": ""high"",
  ""english"": ""A rare genetic disorder called X-linked dominant hypophosphatemia (X-Hyp) is highlighted on the International Day of Awareness. Symptoms, including growth delays and bone pain, can be mistaken for other conditions but are key to early diagnosis. A poster from the Rare Case Fund highlights these signs, which can alert healthcare professionals and parents to potential issues. Early diagnosis and treatment are crucial for improving the life of children with hypophosphatemic rickets.""
}"
2025-10-17T14:10:10+00:00,@genedna1,1461,https://t.me/genedna1/1461,–¢–∞–∫–∏–º–∏ —Ç–µ–º–ø–∞–º–∏ —Å–∫–æ—Ä–æ –∏ –¥–æ –ø—Ä–µ–∫–æ–Ω—Ü–µ–ø—Ü–∏–æ–Ω–Ω–æ–≥–æ —Å–∫—Ä–∏–Ω–∏–Ω–≥–∞ –¥–æ–π–¥–µ–º. https://www.vedomosti.ru/society/articles/2025/10/17/1147556-regioni-nachnut-provodit-geneticheskii-skrining-pered-eko-po-oms,"{""skip"": true}"
2025-10-15T10:14:11+00:00,@genedna1,1460,https://t.me/genedna1/1460,"–≠–∫—Å–ø–µ—Ä—Ç—ã –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∏ –Ω–æ–≤—ã–µ –ø–æ–¥—Ö–æ–¥—ã –∫ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—é –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞–º–∏ –û–¥–Ω–æ–π –∏–∑ –∫–ª—é—á–µ–≤—ã—Ö —Ç–µ–º —Å–æ—Å—Ç–æ—è–≤—à–µ–π—Å—è 13 –æ–∫—Ç—è–±—Ä—è –ø—Ä–µ—Å—Å-–∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ ¬´–ü–µ—Ä–µ—á–Ω–∏ –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –≥–∞—Ä–∞–Ω—Ç–∏–π –¥–ª—è –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –î–ª—è –≥–æ—Å—É–¥–∞—Ä—Å—Ç–≤–∞ –∏–ª–∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤? –ö–∞–∫ –¥–æ–≥–æ–≤–æ—Ä–∏—Ç—å—Å—è!¬ª —Å—Ç–∞–ª–∏ —Å–ª–æ–∂–Ω–æ—Å—Ç–∏ —Å –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–µ–º —Ç–µ—Ä–∞–ø–∏–µ–π –≤—ã–ø—É—Å–∫–Ω–∏–∫–æ–≤ —Ñ–æ–Ω–¥–∞ ¬´–ö—Ä—É–≥ –¥–æ–±—Ä–∞¬ª. –ü–æ—Å–ª–µ 19 –ª–µ—Ç —Ä–µ–≥–∏–æ–Ω—ã –¥–æ–ª–∂–Ω—ã –∑–∞–∫—É–ø–∞—Ç—å —Ç–µ—Ä–∞–ø–∏—é –¥–ª—è –Ω–∏—Ö, –Ω–æ —Å—Ä–µ–¥—Å—Ç–≤ —É –Ω–∏—Ö —á–∞—Å—Ç–æ –Ω–µ —Ö–≤–∞—Ç–∞–µ—Ç. ‚Äî –ü—Ä–∏ –ø–µ—Ä–µ—Ö–æ–¥–µ –≤ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—É—é –ª—å–≥–æ—Ç—É –º–Ω–æ–≥–∏–µ –ø–∞—Ü–∏–µ–Ω—Ç—ã —Å—Ç–∞–ª–∫–∏–≤–∞—é—Ç—Å—è —Å –ø—Ä–æ–±–ª–µ–º–∞–º–∏ –∏ —Ä–∏—Å–∫—É—é—Ç –æ—Å—Ç–∞—Ç—å—Å—è –±–µ–∑ —Ç–µ—Ä–∞–ø–∏–∏, ‚Äî –ø–æ–¥—á–µ—Ä–∫–Ω—É–ª–∞ –ø—Ä–µ–∑–∏–¥–µ–Ω—Ç –ù–∞—Ü–∏–æ–Ω–∞–ª—å–Ω–æ–π –∞—Å—Å–æ—Ü–∏–∞—Ü–∏–∏ ¬´–ì–µ–Ω–µ—Ç–∏–∫–∞¬ª –°–≤–µ—Ç–ª–∞–Ω–∞ –ö–∞—Ä–∏–º–æ–≤–∞. –ü—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—å —ç–∫—Å–ø–µ—Ä—Ç–Ω–æ–≥–æ —Å–æ–≤–µ—Ç–∞ –ö–æ–º–∏—Ç–µ—Ç–∞ –ì–æ—Å–¥—É–º—ã –ø–æ –æ—Ö—Ä–∞–Ω–µ –∑–¥–æ—Ä–æ–≤—å—è –ø–æ —Ä–µ–¥–∫–∏–º –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º –ê–ª–µ–∫—Å–∞–Ω–¥—Ä –†—É–º—è–Ω—Ü–µ–≤ –æ—Ç–º–µ—Ç–∏–ª, —á—Ç–æ –Ω–∞ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–º —É—Ä–æ–≤–Ω–µ –≤–µ–¥–µ—Ç—Å—è —Ä–∞–±–æ—Ç–∞ –ø–æ —É—Å—Ç—Ä–∞–Ω–µ–Ω–∏—é –ø—Ä–æ–±–µ–ª–æ–≤ –≤ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–º –æ–±–µ—Å–ø–µ—á–µ–Ω–∏–∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –ø–µ—Ä–µ—Ö–æ–¥—è—â–∏—Ö –≤–æ –≤–∑—Ä–æ—Å–ª—É—é –∫–æ–≥–æ—Ä—Ç—É. –¢–∞–∫–∂–µ —ç–∫—Å–ø–µ—Ä—Ç—ã –æ–±—Å—É–¥–∏–ª–∏ –∫—Ä–∏—Ç–µ—Ä–∏–∏ —Å–æ—Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è —Ä–µ–≥–∏–æ–Ω–æ–≤ –∏–∑ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –±—é–¥–∂–µ—Ç–∞ –∏ —Å–æ–≤–µ—Ä—à–µ–Ω—Å—Ç–≤–æ–≤–∞–Ω–∏–µ –º–µ—Ö–∞–Ω–∏–∑–º–æ–≤ –≤–∫–ª—é—á–µ–Ω–∏—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ —Å–ø–∏—Å–∫–∏ –ñ–ù–í–õ–ü –∏ –í–ó–ù.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement"",
  ""impact"": ""medium"",
  ""english"": ""Experts discussed new approaches to providing orphan patients with medicines. One of the key topics was difficulties in ensuring therapy for graduates from the 'Circle of Goodwill' program. After 19 years, regions are supposed to procure therapy for them but often lack funds. When transitioning into regional benefits, many patients face problems and risk losing their therapy, according to Svetlana Karimova, President of the National Association 'Genetics'. Alexander Rumyantsev, Chairman of the Expert Council of the State Duma Committee on Health Protection for Rare Diseases, noted that work is underway to eliminate gaps in the pharmaceutical supply for patients transitioning into adult care. Experts also discussed criteria for federal funding of regions and improvements to mechanisms for including drugs in the –ñ–ù–í–õ–ü (List of Medicines with a Guaranteed Supply) and –í–ó–ù (List of Essential Drugs).""
}"
2025-10-06T10:37:40+00:00,@genedna1,1459,https://t.me/genedna1/1459,"–ì–µ–Ω–µ—Ç–∏–∫–∏ –≤—ã—è–≤–∏–ª–∏ –≤ –£–¥–º—É—Ä—Ç–∏–∏ –¥–µ—Ç–µ–π —Å–æ —Å–ø–∏–Ω–∞–ª—å–Ω–æ–π –º—ã—à–µ—á–Ω–æ–π –∞—Ç—Ä–æ—Ñ–∏–µ–π 5Q 2021 –≥–æ–¥–∞ —Ä–æ–∂–¥–µ–Ω–∏—è –°–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –ú–µ–¥–∏–∫–æ-–≥–µ–Ω–µ—Ç–∏—á–µ—Å–∫–æ–≥–æ –Ω–∞—É—á–Ω–æ–≥–æ —Ü–µ–Ω—Ç—Ä–∞ –∏–º–µ–Ω–∏ –∞–∫–∞–¥–µ–º–∏–∫–∞ –ù.–ü. –ë–æ—á–∫–æ–≤–∞ –ø—Ä–æ–≤–µ–ª–∏ –æ–¥–Ω–æ—Ü–µ–Ω—Ç—Ä–æ–≤–æ–µ —Ä–µ—Ç—Ä–æ—Å–ø–µ–∫—Ç–∏–≤–Ω–æ–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –¥–µ—Ç–µ–π 2021 –≥–æ–¥–∞ —Ä–æ–∂–¥–µ–Ω–∏—è –≤ –£–¥–º—É—Ä—Ç–∏–∏ –¥–ª—è –≤—ã—è–≤–ª–µ–Ω–∏—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å–æ —Å–ø–∏–Ω–∞–ª—å–Ω–æ–π –º—ã—à–µ—á–Ω–æ–π –∞—Ç—Ä–æ—Ñ–∏–π 5q. –†–∞–Ω–µ–µ —ç–∫—Å–ø–µ—Ä—Ç—ã –æ—Ç–º–µ—Ç–∏–ª–∏, —á—Ç–æ –≤ —Ä–µ–≥–∏–æ–Ω–µ —ç—Ç–æ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–µ –≤—ã—è–≤–ª—è–µ—Ç—Å—è —á–∞—â–µ, —á–µ–º –≤ —Ü–µ–ª–æ–º –ø–æ —Å—Ç—Ä–∞–Ω–µ. –î–µ—Ç–∏, —Ä–æ–∂–¥–µ–Ω–Ω—ã–µ –¥–æ 2023 –≥–æ–¥–∞, –∫–æ–≥–¥–∞ —Å–ø–∏–Ω–∞–ª—å–Ω–∞—è –º—ã—à–µ—á–Ω–∞—è –∞—Ç—Ä–æ—Ñ–∏—è 5q –≤–æ—à–ª–∞ –≤ —Ä–∞—Å—à–∏—Ä–µ–Ω–Ω—ã–π –Ω–µ–æ–Ω–∞—Ç–∞–ª—å–Ω—ã–π —Å–∫—Ä–∏–Ω–∏–Ω–≥, –Ω–∞ —Å–µ–≥–æ–¥–Ω—è—à–Ω–∏–π –¥–µ–Ω—å –º–æ–≥—É—Ç –æ–∫–∞–∑–∞—Ç—å—Å—è –Ω–µ–¥–æ–¥–∏–∞–≥–Ω–æ—Å—Ç–∏—Ä–æ–≤–∞–Ω–Ω—ã–º–∏, –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–µ –º–æ–∂–µ—Ç –ø—Ä–æ—Ç–µ–∫–∞—Ç—å –ø–æ–¥ –º–∞—Å–∫–æ–π –¥—Ä—É–≥–∏—Ö –±–æ–ª–µ–∑–Ω–µ–π –∏ –±–µ–∑ –¥–æ–ª–∂–Ω–æ–≥–æ –ª–µ—á–µ–Ω–∏—è –ø—Ä–∏–≤–µ—Å—Ç–∏ –∫ –ª–µ—Ç–∞–ª—å–Ω–æ–º—É –∏—Å—Ö–æ–¥—É. –í —Å–≤—è–∑–∏ —Å —ç—Ç–∏–º –≤ –ú–ì–ù–¶ –∏—Å—Å–ª–µ–¥–æ–≤–∞–ª–∏ –æ–±—Ä–∞–∑—Ü—ã –±–∏–æ–º–∞—Ç–µ—Ä–∏–∞–ª–∞ –¥–µ—Ç–µ–π, —Ä–æ–∂–¥–µ–Ω–Ω—ã—Ö –≤ 2021 –≥–æ–¥—É, –¥–ª—è –≤—ã—è–≤–ª–µ–Ω–∏—è –¥–µ–ª–µ—Ü–∏–∏ 7 —ç–∫–∑–æ–Ω–∞ –≥–µ–Ω–∞ SMN1 –≤ –≥–æ–º–æ–∑–∏–≥–æ—Ç–Ω–æ–º —Å–æ—Å—Ç–æ—è–Ω–∏–∏, –∫–æ—Ç–æ—Ä–∞—è —è–≤–ª—è–µ—Ç—Å—è —Å–∞–º–æ–π —á–∞—Å—Ç–æ–π –ø—Ä–∏—á–∏–Ω–æ–π —Ä–∞–∑–≤–∏—Ç–∏—è –°–ú–ê 5q. –°–∫—Ä–∏–Ω–∏–Ω–≥ –±—ã–ª –ø—Ä–æ–≤–µ–¥–µ–Ω –≤ —Ä–∞–º–∫–∞—Ö –ø—Ä–æ–≥—Ä–∞–º–º—ã –ø–æ–¥–¥–µ—Ä–∂–∫–∏ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∏, –æ—Ä–≥–∞–Ω–∏–∑—É–µ–º–æ–π –ø—Ä–∏ –ø–æ–¥–¥–µ—Ä–∂–∫–µ –ê–û ‚Äú–†–æ—à-–ú–æ—Å–∫–≤–∞‚Äù. –°—Ç–∞—Ç—å—è, –ø–æ—Å–≤—è—â–µ–Ω–Ω–∞—è —Ä–µ–∑—É–ª—å—Ç–∞—Ç–∞–º –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è, –≤—ã—à–ª–∞ –≤ –Ω–∞—É—á–Ω–æ-–ø—Ä–∞–∫—Ç–∏—á–µ—Å–∫–æ–º –∂—É—Ä–Ω–∞–ª–µ ¬´–ü–µ–¥–∏–∞—Ç—Ä–∏—è¬ª. –í –ø–µ—Ä–≤—ã–π –≥–æ–¥ —Ä–µ–∞–ª–∏–∑–∞—Ü–∏–∏ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–π –ø—Ä–æ–≥—Ä–∞–º–º—ã —Ä–∞—Å—à–∏—Ä–µ–Ω–Ω–æ–≥–æ –Ω–µ–æ–Ω–∞—Ç–∞–ª—å–Ω–æ–≥–æ —Å–∫—Ä–∏–Ω–∏–Ω–≥–∞, –≤–∫–ª—é—á–∞—é—â–µ–π —Å–ø–∏–Ω–∞–ª—å–Ω—É—é –º—ã—à–µ—á–Ω—É—é –∞—Ç—Ä–æ—Ñ–∏—é 5q, –ø–æ–∫–∞–∑–∞–ª, —á—Ç–æ –≤ —Ä–∞–∑–ª–∏—á–Ω—ã—Ö —Ä–µ–≥–∏–æ–Ω–∞—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–µ –≤—Å—Ç—Ä–µ—á–∞–µ—Ç—Å—è —Å —Ä–∞–∑–Ω–æ–π —á–∞—Å—Ç–æ—Ç–æ–π. –¢–∞–∫ –≤ –£–¥–º—É—Ä—Ç–∏–∏ –æ–±—Å–ª–µ–¥–æ–≤–∞–ª–∏ 12,5 —Ç—ã—Å. –Ω–æ–≤–æ—Ä–æ–∂–¥–µ–Ω–Ω—ã—Ö. –ò–∑ –Ω–∏—Ö —É –ø—è—Ç–∏ —É—Å—Ç–∞–Ω–æ–≤–∏–ª–∏ –¥–∏–∞–≥–Ω–æ–∑ ¬´—Å–ø–∏–Ω–∞–ª—å–Ω–∞—è –º—ã—à–µ—á–Ω–∞—è –∞—Ç—Ä–æ—Ñ–∏—è 5q¬ª. –¢–∞–∫–∏–º –æ–±—Ä–∞–∑–æ–º, —á–∞—Å—Ç–æ—Ç—É –≤—Å—Ç—Ä–µ—á–∞–µ–º–æ—Å—Ç–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è –≤ —Ä–µ–≥–∏–æ–Ω–µ –º–æ–∂–Ω–æ –æ—Ü–µ–Ω–∏—Ç—å –∫–∞–∫ 1 —Å–ª—É—á–∞–π –Ω–∞ 2,5 —Ç—ã—Å. —á–µ–ª–æ–≤–µ–∫, –≤ —Ç–æ –≤—Ä–µ–º—è –∫–∞–∫ –≤ —Ü–µ–ª–æ–º –ø–æ –†–æ—Å—Å–∏–∏ –æ–Ω–∞ –æ—Ü–µ–Ω–∏–≤–∞–µ—Ç—Å—è –≤ 1 —Å–ª—É—á–∞–π –Ω–∞ 10 —Ç—ã—Å. –Ω–æ–≤–æ—Ä–æ–∂–¥–µ–Ω–Ω—ã—Ö. –ü—Ä–∏ —ç—Ç–æ–º —Ä–∞–Ω–µ–µ –ø—Ä–æ–≤–µ–¥–µ–Ω–Ω—ã–µ –ø–æ–ø—É–ª—è—Ü–∏–æ–Ω–Ω—ã–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –Ω–µ –≤—ã—è–≤–∏–ª–∏ —Ñ–∞–∫—Ç–∞ –Ω–∞–∫–æ–ø–ª–µ–Ω–∏—è —ç—Ç–æ–≥–æ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è –≤ –£–¥–º—É—Ä—Ç–∏–∏. –≠—Ç–æ –º–æ–∂–µ—Ç –≥–æ–≤–æ—Ä–∏—Ç—å –æ —Ä–∞–Ω–Ω–µ–π —Å–º–µ—Ä—Ç–Ω–æ—Å—Ç–∏ –¥–µ—Ç–µ–π —Å–æ –°–ú–ê 5q –ø–æ–¥ –º–∞—Å–∫–æ–π –¥—Ä—É–≥–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π.–≠—Ç–∏ –¥–∞–Ω–Ω—ã–µ —Å—Ç–∞–ª–∏ –ø—Ä–∏—á–∏–Ω–æ–π –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è —Ä–µ—Ç—Ä–æ—Å–ø–µ–∫—Ç–∏–≤–Ω–æ–≥–æ –º–∞—Å—Å–æ–≤–æ–≥–æ –æ–±—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –¥–µ—Ç–µ–π, —Ä–æ–∂–¥–µ–Ω–Ω—ã—Ö –≤ 2021 –≥–æ–¥—É, –¥–æ –≤–≤–µ–¥–µ–Ω–∏—è —Ä–∞—Å—à–∏—Ä–µ–Ω–Ω–æ–≥–æ –Ω–µ–æ–Ω–∞—Ç–∞–ª—å–Ω–æ–≥–æ —Å–∫—Ä–∏–Ω–∏–Ω–≥–∞. –°–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –ú–µ–¥–∏–∫–æ-–≥–µ–Ω–µ—Ç–∏—á–µ—Å–∫–æ–≥–æ –Ω–∞—É—á–Ω–æ–≥–æ —Ü–µ–Ω—Ç—Ä–∞ –∏–º–µ–Ω–∏ –∞–∫–∞–¥–µ–º–∏–∫–∞ –ù.–ü. –ë–æ—á–∫–æ–≤–∞ –ø—Ä–æ–∞–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–ª–∏ —Å—É—Ö–∏–µ –ø—è—Ç–Ω–∞ –∫—Ä–æ–≤–∏, —Å–æ–±—Ä–∞–Ω–Ω—ã–µ –≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —É—á—Ä–µ–∂–¥–µ–Ω–∏—è—Ö –£–¥–º—É—Ä—Ç–∏–∏ –≤ –ø–µ—Ä–∏–æ–¥ —Å 1 —è–Ω–≤–∞—Ä—è –ø–æ 31 –¥–µ–∫–∞–±—Ä—è 2021 –≥–æ–¥–∞. –í—Å–µ–≥–æ –≤ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –≤–æ—à–ª–∏ 14,6 —Ç—ã—Å. –æ–±—Ä–∞–∑—Ü–æ–≤. –í —Ä–µ–∑—É–ª—å—Ç–∞—Ç–µ –¥–µ–ª–µ—Ü–∏—é 7 —ç–∫–∑–æ–Ω–∞ –≥–µ–Ω–∞ SMN1 –≤ –≥–æ–º–æ–∑–∏–≥–æ—Ç–Ω–æ–º —Å–æ—Å—Ç–æ—è–Ω–∏–∏ –≤—ã—è–≤–∏–ª–∏ —É —Ç—Ä–æ–∏—Ö –¥–µ—Ç–µ–π. –û–¥–∏–Ω —Ä–µ–±–µ–Ω–æ–∫ –ø–æ–ª—É—á–∏–ª –¥–∏–∞–≥–Ω–æ–∑ –ø–æ—Å–ª–µ –ø—Ä–æ—è–≤–ª–µ–Ω–∏—è –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏—Ö —Å–∏–º–ø—Ç–æ–º–æ–≤ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è –≤ –≤–æ–∑—Ä–∞—Å—Ç–µ 5 –º–µ—Å—è—Ü–µ–≤, –∏ –≤ –≤–æ–∑—Ä–∞—Å—Ç–µ 1 –≥–æ–¥–∞ –µ–≥–æ —É–∂–µ –æ–±–µ—Å–ø–µ—á–∏–ª–∏ –≥–µ–Ω–æ–∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å–Ω—ã–º –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–º –∑–∞ —Å—á–µ—Ç —Å—Ä–µ–¥—Å—Ç–≤ —Ñ–æ–Ω–¥–∞ ¬´–ö—Ä—É–≥ –¥–æ–±—Ä–∞¬ª. –£ –≤—Ç–æ—Ä–æ–≥–æ —Ä–µ–±–µ–Ω–∫–∞, –≤—ã—è–≤–ª–µ–Ω–Ω–æ–≥–æ –≤ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–µ —Ä–µ—Ç—Ä–æ—Å–ø–µ–∫—Ç–∏–≤–Ω–æ–≥–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è, –Ω–µ –±—ã–ª–æ –ø—Ä–∏–∑–Ω–∞–∫–æ–≤ –Ω–µ—Ä–≤–Ω–æ-–º—ã—à–µ—á–Ω–æ–≥–æ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è. –¢—Ä–µ—Ç–∏–π —Ä–µ–±–µ–Ω–æ–∫, –∫–æ—Ç–æ—Ä–æ–º—É —É–¥–∞–ª–æ—Å—å –ø–æ—Å—Ç–∞–≤–∏—Ç—å –¥–∏–∞–≥–Ω–æ–∑, –Ω–∞–±–ª—é–¥–∞–ª—Å—è —É –ø–µ–¥–∏–∞—Ç—Ä–∞ –∏ –Ω–µ–≤—Ä–æ–ª–æ–≥–∞ –ø–æ –º–µ—Å—Ç—É –∂–∏—Ç–µ–ª—å—Å—Ç–≤–∞ —Å –ø—Ä–∏–∑–Ω–∞–∫–∞–º–∏ –Ω–µ—Ä–≤–Ω–æ-–º—ã—à–µ—á–Ω–æ–≥–æ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è.–¢–∞–∫–∏–º –æ–±—Ä–∞–∑–æ–º, —Ä–µ—Ç—Ä–æ—Å–ø–µ–∫—Ç–∏–≤–Ω–æ–µ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–µ –≤ –£–¥–º—É—Ä—Ç–∏–∏ –ø–æ–∑–≤–æ–ª–∏–ª–æ –ø–æ—Å—Ç–∞–≤–∏—Ç—å –¥–∏–∞–≥–Ω–æ–∑ –∏ –Ω–∞–∑–Ω–∞—á–∏—Ç—å —ç—Ç–∏–æ–ø–∞—Ç–æ–≥–µ–Ω–µ—Ç–∏—á–µ—Å–∫—É—é —Ç–µ—Ä–∞–ø–∏—é –¥–≤–æ–∏–º –¥–µ—Ç—è–º —Å–æ —Å–ø–∏–Ω–∞–ª—å–Ω–æ–π –º—ã—à–µ—á–Ω–æ–π –∞—Ç—Ä–æ—Ñ–∏–µ–π 5q –Ω–∞ —Ä–∞–Ω–Ω–µ–π —Å—Ç–∞–¥–∏–∏. –ë–µ–∑ –¥–∞–Ω–Ω–æ–≥–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –ø–æ—Å—Ç–∞–Ω–æ–≤–∫–∞ –ø—Ä–∞–≤–∏–ª—å–Ω–æ–≥–æ –¥–∏–∞–≥–Ω–æ–∑–∞ –º–æ–≥–ª–∞ –±—ã—Ç—å –∑–∞—Ç—Ä—É–¥–Ω–µ–Ω–∞. –° —É—á–µ—Ç–æ–º –¥–∞–Ω–Ω—ã—Ö —Ä–∞—Å—à–∏—Ä–µ–Ω–Ω–æ–≥–æ –Ω–µ–æ–Ω–∞—Ç–∞–ª—å–Ω–æ–≥–æ —Å–∫—Ä–∏–Ω–∏–Ω–≥–∞ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç—ã –ú–ì–ù–¶ –æ—Ü–µ–Ω–∏–≤–∞—é—Ç —á–∞—Å—Ç–æ—Ç—É –≤—Å—Ç—Ä–µ—á–∞–µ–º–æ—Å—Ç–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è –≤ —Ä–µ–≥–∏–æ–Ω–µ –≤ 1 —Å–ª—É—á–∞–π –Ω–∞ 3,4 —Ç—ã—Å. —á–µ–ª–æ–≤–µ–∫, —á—Ç–æ —Å—Ç–∞—Ç–∏—Å—Ç–∏—á–µ—Å–∫–∏ –∑–Ω–∞—á–∏–º–æ –≤—ã—à–µ, —á–µ–º –≤ —Ü–µ–ª–æ–º –ø–æ —Å—Ç—Ä–∞–Ω–µ. –ü–æ–ª—É—á–µ–Ω–Ω—ã–µ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã –ø–æ–¥—á–µ—Ä–∫–∏–≤–∞—é—Ç –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç—å –ø–æ–≤—ã—à–µ–Ω–∏—è –Ω–∞—Å—Ç–æ—Ä–æ–∂–µ–Ω–Ω–æ—Å—Ç–∏ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –≤ –æ—Ç–Ω–æ—à–µ–Ω–∏–∏ —Å–ø–∏–Ω–∞–ª—å–Ω–æ–π –º—ã—à–µ—á–Ω–æ–π –∞—Ç—Ä–æ—Ñ–∏–∏ 5q –∏ –ø—Ä–æ–≤–µ–¥–µ–Ω–∏—è —Ä–µ—Ç—Ä–æ—Å–ø–µ–∫—Ç–∏–≤–Ω–æ–≥–æ —Å–∫—Ä–∏–Ω–∏–Ω–≥–∞ —Å—Ä–µ–¥–∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –¥—Ä—É–≥–∏–º–∏ –Ω–µ—Ä–≤–Ω–æ-–º—ã—à–µ—á–Ω—ã–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏.","{
  ""skip"": false,
  ""country"": ""Ukraine"",
  ""topic"": ""clinical_trial,hospital_policy,pharmacovigilance,safety"",
  ""impact"": ""high"",
  ""english"": ""Specialists from the Medical Genetics Scientific Center named Academician N.P. Bocovkov conducted a retrospective study of children born in 2021 in Udmurtia to identify patients with spinal muscular atrophy type 5q. The researchers screened dried blood spots collected from medical institutions in Udmurtia during January to December 2021. Three children were identified with the seventh exon of the SMN1 gene in homozygous state. The study highlights the need for increased vigilance among healthcare professionals regarding spinal muscular atrophy type 5q and retrospective screening of patients with other neuromuscular disorders.""
}"
2025-09-19T17:49:15+00:00,@genedna1,1458,https://t.me/genedna1/1458,"üë©üèª‚Äç‚öïÔ∏è–°–æ–±—Ä–∞–ª–∏ —Å–∞–º—ã–µ –∏–Ω—Ç–µ—Ä–µ—Å–Ω—ã–µ –∏ –ø–æ–ª–µ–∑–Ω—ã–µ –∫–∞–Ω–∞–ª—ã –¥–ª—è —É—á–µ–±—ã üîó–ü—Ä–∏—Å–æ–µ–¥–∏–Ω—è–π—Ç–µ—Å—å: https://t.me/addlist/D2GY29HZXppkZGVi –î–æ–±–∞–≤–∏–≤ –ø–∞–ø–∫—É, –≤—ã –ø–æ–¥–ø–∏—à–∏—Ç–µ—Å—å –Ω–∞ –≤—Å–µ –∫–∞–Ω–∞–ª—ã, –∫–æ—Ç–æ—Ä—ã–µ –ø–æ–º–æ–≥—É—Ç –≤–∞–º –±—ã—Ç—å –≤ –∫—É—Ä—Å–µ —Å–∞–º—ã—Ö –∞–∫—Ç—É–∞–ª—å–Ω—ã—Ö –Ω–æ–≤–æ—Å—Ç–µ–π –∏ –ø–æ–ª–µ–∑–Ω—ã—Ö –º–∞—Ç–µ—Ä–∏–∞–ª–æ–≤ ü©∫","{""skip"": true}"
2025-09-18T09:03:02+00:00,@genedna1,1457,https://t.me/genedna1/1457,"–ü—Ä–µ–∑–∏–¥–µ–Ω—Ç ¬´–ü–µ—Ç—Ä–æ–≤–∞–∫—Å¬ª –ú–∏—Ö–∞–∏–ª –¶—ã—Ñ–µ—Ä–æ–≤ –ø—Ä–æ–∫–æ–º–º–µ–Ω—Ç–∏—Ä–æ–≤–∞–ª –≤ –∏–Ω—Ç–µ—Ä–≤—å—é –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω–æ-–∞–Ω–∞–ª–∏—Ç–∏—á–µ—Å–∫–æ–º—É –∏–∑–¥–∞–Ω–∏—é ¬´–§–∞—Ä–º–≤–µ—Å—Ç–Ω–∏–∫¬ª –¥–∏—Å–∫—É—Å—Å–∏—é –Ω–∞ —Ç–µ–º—É –≤–∫–ª—é—á–µ–Ω–∏—è –≤ –ø–µ—Ä–µ—á–µ–Ω—å –ñ–ù–í–õ–ü –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –¥–ª—è –ª–µ—á–µ–Ω–∏—è –±–æ–ª–µ–∑–Ω–∏ –§–∞–±—Ä–∏ –∏—Ç–∞–ª—å—è–Ω—Å–∫–æ–π —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ Chiesi. –¢—Ä–∞–¥–∏—Ü–∏–æ–Ω–Ω–æ –ø—Ä–∏ –≤–Ω–µ—Å–µ–Ω–∏–∏ –≤ –æ–≥—Ä–∞–Ω–∏—á–∏—Ç–µ–ª—å–Ω—ã–µ —Å–ø–∏—Å–∫–∏ –æ—Ç –Ω–æ–≤—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –æ–∂–∏–¥–∞—é—Ç—Å—è —Ç–µ—Ä–∞–ø–µ–≤—Ç–∏—á–µ—Å–∫–∏–µ –ø—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–∞, –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ–µ —Å–Ω–∏–∂–µ–Ω–∏–µ —Ü–µ–Ω—ã –ø–æ —Å—Ä–∞–≤–Ω–µ–Ω–∏—é —Å —Å—É—â–µ—Å—Ç–≤—É—é—â–∏–º–∏ –º–µ—Ç–æ–¥–∞–º–∏ –ª–µ—á–µ–Ω–∏—è. –ù–∞ –∑–∞—Å–µ–¥–∞–Ω–∏–∏ –∫–æ–º–∏—Å—Å–∏–∏ –∏—Ç–∞–ª—å—è–Ω—Å–∫–∏–π –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—å –ø—Ä–µ–¥–ª–æ–∂–∏–ª —Ü–µ–Ω—É, –∫–æ—Ç–æ—Ä–∞—è, –Ω–∞ –ø–µ—Ä–≤—ã–π –≤–∑–≥–ª—è–¥, –±—ã–ª–∞ –Ω–∞ 2% –Ω–∏–∂–µ —Å—Ç–æ–∏–º–æ—Å—Ç–∏ –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞. –û–¥–Ω–∞–∫–æ –ø—Ä–∏ –¥–µ—Ç–∞–ª—å–Ω–æ–º —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏–∏ –æ–∫–∞–∑–∞–ª–æ—Å—å, —á—Ç–æ —ç—Ç–æ –∫–∞—Å–∞–µ—Ç—Å—è –ª–∏—à—å —É–∑–∫–æ–π –≥—Ä—É–ø–ø—ã –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ (—Å–æ —Å—Ä–µ–¥–Ω–∏–º –≤–µ—Å–æ–º 77 –∫–≥). –î–ª—è –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ–π –∂–µ —á–∞—Å—Ç–∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å—Ç–æ–∏–º–æ—Å—Ç—å –∏—Ç–∞–ª—å—è–Ω—Å–∫–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ –≤—ã—à–µ. –ö–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ –ø—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–∞ –ø—ç–≥—É–Ω–∏–≥–∞–ª–∑–∏–¥–∞–∑—ã –∞–ª—å—Ñ–∞ –ø–µ—Ä–µ–¥ –∞–≥–∞–ª—Å–∏–¥–∞–∑–æ–π –±–µ—Ç–∞ —Ç–∞–∫–∂–µ –Ω–µ –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–∞—é—Ç—Å—è –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è–º–∏. –ò–∑-–∑–∞ —ç—Ç–æ–≥–æ –≤ —Ä—è–¥–µ —Å—Ç—Ä–∞–Ω, –≤–∫–ª—é—á–∞—è –ì–µ—Ä–º–∞–Ω–∏—é –∏ –§—Ä–∞–Ω—Ü–∏—é, —Ä–∞—Å—Ö–æ–¥—ã –Ω–∞ –¥–∞–Ω–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –Ω–µ –≤–æ–∑–º–µ—â–∞—é—Ç—Å—è. –ö–∞–∫ –æ—Ç–º–µ—Ç–∏–ª–∞ –≤ –ø–æ—Å–ª–µ–¥—Å—Ç–≤–∏–∏ –Ω–∞ –∫–æ–Ω–≥—Ä–µ—Å—Å–µ ¬´–ü—Ä–∞–≤–æ –Ω–∞ –∑–¥–æ—Ä–æ–≤—å–µ¬ª –ï–ª–µ–Ω–∞ –ú–∞–∫—Å–∏–º–∫–∏–Ω–∞, –¥–∏—Ä–µ–∫—Ç–æ—Ä –§–¶–ü–∏–õ–û–ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–æ—Å—Å–∏–∏, –≤–∞–∂–Ω–æ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞—Ç—å –≤ —Ä–∞–º–∫–∞—Ö –¥–æ–∫–∞–∑–∞—Ç–µ–ª—å–Ω–æ–π –ø—Ä–∞–∫—Ç–∏–∫–∏ –ø—Ä–∏ –≤–∫–ª—é—á–µ–Ω–∏–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –≤ –ñ–ù–í–õ–ü —Ç–æ—Ç —Å—Ç–∞—Ç—É—Å –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –∫–æ—Ç–æ—Ä—ã–π —Å—É—â–µ—Å—Ç–≤—É–µ—Ç —Ä–µ–∞–ª—å–Ω–æ –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ –†–§. –≠—Ç–æ –∏–º–µ–Ω–Ω–æ —Ç–æ—Ç –ø–æ–¥—Ö–æ–¥, –∫–æ—Ç–æ—Ä—ã–π –±—ã–ª –ø—Ä–µ–¥–ª–æ–∂–µ–Ω –∫–æ–º–ø–∞–Ω–∏–µ–π ¬´–ü–µ—Ç—Ä–æ–≤–∞–∫—Å¬ª –Ω–∞ –∞–≤–≥—É—Å—Ç–æ–≤—Å–∫–æ–º –∑–∞—Å–µ–¥–∞–Ω–∏–∏ –∫–æ–º–∏—Å—Å–∏–∏ –ñ–ù–í–õ–ü. –í —Ä–µ–∑—É–ª—å—Ç–∞—Ç–µ –æ–±—Å—É–∂–¥–µ–Ω–∏–π —Ä–µ—à–µ–Ω–∏–µ –∫–æ–º–∏—Å—Å–∏–∏ –ø–æ –ø–æ–≤–æ–¥—É –≤–∫–ª—é—á–µ–Ω–∏—è –≤ –ø–µ—Ä–µ—á–µ–Ω—å –∏—Ç–∞–ª—å—è–Ω—Å–∫–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –±—ã–ª–æ –æ—Ç–ª–æ–∂–µ–Ω–æ –¥–æ –Ω–æ—è–±—Ä—è.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, import_export, shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""The inclusion of the Italian drug produced by Chiesi for Fabry disease treatment in the restricted list was delayed due to concerns about its cost and clinical effectiveness. The discussion highlighted the need for a more patient-centric approach in decision-making processes related to inclusion of drugs in the restricted list.""
}"
2025-09-09T09:33:58+00:00,@genedna1,1456,https://t.me/genedna1/1456,"‚ù£Ô∏è–î–æ—Ä–æ–≥–∏–µ –ø–æ–¥–ø–∏—Å—á–∏–∫–∏, –ø—Ä–∏–≥–ª–∞—à–∞–µ–º –≤–∞—Å –Ω–∞ V —é–±–∏–ª–µ–π–Ω—ã–π –∫–æ–Ω–≥—Ä–µ—Å—Å ¬´–ü—Ä–∞–≤–æ –Ω–∞ –∑–¥–æ—Ä–æ–≤—å–µ¬ª, –∫–æ—Ç–æ—Ä—ã–π –ø—Ä–æ–π–¥–µ—Ç 11 —Å–µ–Ω—Ç—è–±—Ä—è –≤ –ú–æ—Å–∫–≤–µ. –û–¥–Ω–æ–π –∏–∑ –º–∞–≥–∏—Å—Ç—Ä–∞–ª—å–Ω—ã—Ö —Ç–µ–º –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏—è —Å—Ç–∞–Ω—É—Ç –ø—Ä–æ–±–ª–µ–º—ã –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –ø–æ–º–æ—â–∏ –≤–∑—Ä–æ—Å–ª—ã–º –ø–∞—Ü–∏–µ–Ω—Ç–∞–º —Å –æ—Ä—Ñ–∞–Ω–Ω—ã–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏ –≠—Ç–æ–π —Ç–µ–º–µ –±—É–¥–µ—Ç –ø–æ—Å–≤—è—â–µ–Ω–∞ —Å–ø–µ—Ü–∏–∞–ª—å–Ω–∞—è —Å–µ—Å—Å–∏—è –∫–æ–Ω–≥—Ä–µ—Å—Å–∞ ‚Äî ¬´–†—É–±–µ–∂ 18+: –ø—Ä–µ–µ–º—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç—å –∏–Ω–Ω–æ–≤–∞—Ü–∏–æ–Ω–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –¥–æ—Å—Ç–∏–≥—à–∏—Ö —Å–æ–≤–µ—Ä—à–µ–Ω–Ω–æ–ª–µ—Ç–∏—è¬ª. –°–ø–∏–∫–µ—Ä—ã –ø–æ–¥–Ω–∏–º—É—Ç –≤–æ–ø—Ä–æ—Å—ã ¬´–±–µ—Å—à–æ–≤–Ω–æ–≥–æ¬ª –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è —Ç–µ—Ä–∞–ø–∏–µ–π, —Ñ–∏–Ω–∞–Ω—Å–∏—Ä—É–µ–º–æ–π ¬´–ö—Ä—É–≥ –¥–æ–±—Ä–∞, –≤–∑—Ä–æ—Å–ª—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –≤—ã—à–µ–¥—à–∏—Ö –∏–∑-–ø–æ–¥ –ø–æ–ø–µ—á–µ–Ω–∏—è —Ñ–æ–Ω–¥–∞. –¢–∞–∫–∏–µ –ø–∞—Ü–∏–µ–Ω—Ç—ã –ø–æ –¥–æ—Å—Ç–∏–∂–µ–Ω–∏–∏ —Å–æ–≤–µ—Ä—à–µ–Ω–Ω–æ–ª–µ—Ç–∏—è –ø—Ä–µ–∫—Ä–∞—â–∞—é—Ç –ø–æ–ª—É—á–∞—Ç—å —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏–µ –¥–æ—Ä–æ–≥–æ—Å—Ç–æ—è—â–µ–≥–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è –∏–∑ —Ñ–æ–Ω–¥–∞, –∏ –Ω–∞–≥—Ä—É–∑–∫–∞ –ø–æ –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏—é –ª–æ–∂–∏—Ç—Å—è –Ω–∞ –±—é–¥–∂–µ—Ç—ã —Ä–µ–≥–∏–æ–Ω–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ —á–∞—Å—Ç–æ –æ–∫–∞–∑—ã–≤–∞—é—Ç—Å—è –Ω–µ –≤ —Å–æ—Å—Ç–æ—è–Ω–∏–∏ —É–¥–æ–≤–ª–µ—Ç–≤–æ—Ä–∏—Ç—å –ø–æ—Ç—Ä–µ–±–Ω–æ—Å—Ç—å –≤ –ª–µ—á–µ–Ω–∏–∏. ‚û°Ô∏è –ù–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è –¥–∏—Å–∫—É—Å—Å–∏–∏: üü¢–º–µ–∂–¥—É–Ω–∞—Ä–æ–¥–Ω–∞—è –ø—Ä–∞–∫—Ç–∏–∫–∞ –≤ –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏–∏ –æ—Ä—Ñ–∞–Ω–Ω—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤;üü¢–ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤—ã —Ü–µ–Ω—Ç—Ä–∞–ª–∏–∑–∞—Ü–∏–∏ –∑–∞–∫—É–ø–æ–∫ –∏ –∫–æ–º–ø–µ–Ω—Å–∞—Ü–∏–æ–Ω–Ω—ã–µ —Å—Ö–µ–º—ã –ª–µ–∫–æ–±–µ—Å–ø–µ—á–µ–Ω–∏—è;üü¢–Ω–æ—Ä–º–∞—Ç–∏–≤–Ω–æ-–ø—Ä–∞–≤–æ–≤—ã–µ –∏–∑–º–µ–Ω–µ–Ω–∏—è, –∫–æ—Ç–æ—Ä—ã–µ –Ω—É–∂–Ω—ã –¥–ª—è —Ä–µ—à–µ–Ω–∏—è –ø—Ä–æ–±–ª–µ–º—ã. ‚û°Ô∏è –ö–æ–Ω–≥—Ä–µ—Å—Å 2025 –≥–æ–¥–∞ –±—É–¥–µ—Ç –æ–¥–Ω–∏–º –∏–∑ —Å–∞–º—ã—Ö –º–∞—Å—à—Ç–∞–±–Ω—ã—Ö –∑–∞ –≤—Å—é –∏—Å—Ç–æ—Ä–∏—é –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏—è ‚Äî —É—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –∂–¥—É—Ç 27 —Å–µ—Å—Å–∏–π —Å—Ä–∞–∑—É –≤ –Ω–µ—Å–∫–æ–ª—å–∫–∏—Ö —Ñ–æ—Ä–º–∞—Ç–∞—Ö: –¥–∏—Å–∫—É—Å—Å–∏–∏, –¥–µ–±–∞—Ç—ã –∏ –ø—É–±–ª–∏—á–Ω—ã–µ –ª–µ–∫—Ü–∏–∏. –°—Ä–µ–¥–∏ –¥—Ä—É–≥–∏—Ö –∫–ª—é—á–µ–≤—ã—Ö —Å–µ—Å—Å–∏–π: ‚ñ´Ô∏è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è —Ä–µ–∞–±–∏–ª–∏—Ç–∞—Ü–∏—è –∫–∞–∫ –æ–¥–∏–Ω –∏–∑ –ø—Ä–∏–æ—Ä–∏—Ç–µ—Ç–æ–≤ –Ω–∞—Ü–ø—Ä–æ–µ–∫—Ç–∞ ¬´–ü—Ä–æ–¥–æ–ª–∂–∏—Ç–µ–ª—å–Ω–∞—è –∏ –∞–∫—Ç–∏–≤–Ω–∞—è –∂–∏–∑–Ω—å¬ª (—Å–æ–∑–¥–∞–Ω–∏–µ –ø–æ–ª–Ω–æ—Ü–µ–Ω–Ω–æ —Ñ—É–Ω–∫—Ü–∏–æ–Ω–∏—Ä—É—é—â–µ–π —Ä–µ–∞–±–∏–ª–∏—Ç–∞—Ü–∏–æ–Ω–Ω–æ–π —Å–ª—É–∂–±—ã –≤ –†–æ—Å—Å–∏–∏ –∏ –ø–∏–ª–æ—Ç–Ω—ã–µ –ø—Ä–æ–µ–∫—Ç—ã –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π —Ä–µ–∞–±–∏–ª–∏—Ç–∞—Ü–∏–∏ –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å –ø–æ—Å—Ç–∏–Ω—Å—É–ª—å—Ç–Ω—ã–º–∏ —Å–æ—Å—Ç–æ—è–Ω–∏—è–º–∏); ‚ñ´Ô∏è—Å–æ—Ü–∏–∞–ª—å–Ω–æ –∑–Ω–∞—á–∏–º—ã–µ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è: —Å—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏–µ –≤–æ–ø—Ä–æ—Å—ã —Ä–∞–∑–≤–∏—Ç–∏—è –æ–Ω–∫–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π, –∫–∞—Ä–¥–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π, –≥–µ–º–∞—Ç–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π –∏ —Ä–µ–≤–º–∞—Ç–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π —Å–ª—É–∂–±; ‚ñ´Ô∏è—Å–æ–≤—Ä–µ–º–µ–Ω–Ω–∞—è –∫–æ–Ω—Ü–µ–ø—Ü–∏—è –±–æ—Ä—å–±—ã —Å —ç–ø–∏–¥–µ–º–∏–µ–π —Å–∞—Ö–∞—Ä–Ω–æ–≥–æ –¥–∏–∞–±–µ—Ç–∞: –≤–æ–ø—Ä–æ—Å—ã –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç–∏ –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –∏ —Å–∏—Å—Ç–µ–º –ù–ú–ì; ‚ñ´Ô∏è–ø–µ—Ä—Å–ø–µ–∫—Ç–∏–≤—ã —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö —Å—Ç—Ä–∞—Ö–æ–≤—ã—Ö –ø—Ä–æ–¥—É–∫—Ç–æ–≤ –æ—Ç –∫—Ä–∏—Ç–∏—á–µ—Å–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, –≤ —Ç–æ–º —á–∏—Å–ª–µ –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å—Ç–∞—Ä—à–µ–≥–æ –ø–æ–∫–æ–ª–µ–Ω–∏—è (–Ω–∞ –∫–æ–Ω–≥—Ä–µ—Å—Å–µ —Å–æ—Å—Ç–æ–∏—Ç—Å—è –ø—Ä–µ–∑–µ–Ω—Ç–∞—Ü–∏—è —É–Ω–∏–∫–∞–ª—å–Ω—ã—Ö –Ω–∞ —Ä—ã–Ω–∫–µ —Å—Ç—Ä–∞—Ö–æ–≤—ã—Ö –ø—Ä–æ–¥—É–∫—Ç–æ–≤ –æ—Ç –æ—Å–ª–æ–∂–Ω–µ–Ω–∏–π —Å–∞—Ö–∞—Ä–Ω–æ–≥–æ –¥–∏–∞–±–µ—Ç–∞); ‚ñ´Ô∏è–æ–Ω–∫–æ–Ω–∞—Å—Ç–æ—Ä–æ–∂–µ–Ω–Ω–æ—Å—Ç—å –∫–∞–∫ –∫–ª—é—á–µ–≤–æ–π –≤—ã–∑–æ–≤ –≤ –±–æ—Ä—å–±–µ —Å–æ –∑–ª–æ–∫–∞—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–º–∏ –Ω–æ–≤–æ–æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è–º–∏; ‚ñ´Ô∏è–∑–∞—â–∏—Ç–∞ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç—É–∞–ª—å–Ω–æ–π —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç–∏ –≤ –∏–Ω–¥—É—Å—Ç—Ä–∏–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∏–∑–¥–µ–ª–∏–π; ‚ñ´Ô∏è–∏—Ç–æ–≥–∏ –æ–ø—Ç–∏–º–∏–∑–∞—Ü–∏–∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö —É—á—Ä–µ–∂–¥–µ–Ω–∏–π; ‚ñ´Ô∏è–∑–∞–±–æ—Ç–∞ –æ –∑–¥–æ—Ä–æ–≤—å–µ —Å—Ç–∞—Ä—à–µ–≥–æ –ø–æ–∫–æ–ª–µ–Ω–∏—è: –æ—Å–æ–±–µ–Ω–Ω–æ—Å—Ç–∏ —Å–∏—Å—Ç–µ–º—ã –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ –∏ –ª–µ—á–µ–Ω–∏—è —Å–æ—Ü–∏–∞–ª—å–Ω–æ –∑–Ω–∞—á–∏–º—ã—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π —É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å—Ç–∞—Ä—à–µ —Ç—Ä—É–¥–æ—Å–ø–æ—Å–æ–±–Ω–æ–≥–æ –≤–æ–∑—Ä–∞—Å—Ç–∞; ‚ñ´Ô∏è—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–∏ –∏—Å–∫—É—Å—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç–∞ –≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–∏ –∏ –≤–æ–ø—Ä–æ—Å –≤–Ω–µ–¥—Ä–µ–Ω–∏—è —ç–∫—Å–ø–µ—Ä–∏–º–µ–Ω—Ç–∞–ª—å–Ω—ã—Ö –ø—Ä–∞–≤–æ–≤—ã—Ö —Ä–µ–∂–∏–º–æ–≤ –¥–ª—è –∏—Ö —Ä–∞–∑–≤–∏—Ç–∏—è –∏ –¥—Ä—É–≥–æ–µ. üóì 11 —Å–µ–Ω—Ç—è–±—Ä—è, –ú–æ—Å–∫–≤–∞, –¶–∏—Ñ—Ä–æ–≤–æ–µ –¥–µ–ª–æ–≤–æ–µ –ø—Ä–æ—Å—Ç—Ä–∞–Ω—Å—Ç–≤–æ (—É–ª. –ü–æ–∫—Ä–æ–≤–∫–∞, 47). ‚û°Ô∏è –ò–∑—É—á–∏—Ç—å –ø–æ–ª–Ω—É—é –ø—Ä–æ–≥—Ä–∞–º–º—É –∏ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞—Ç—å—Å—è –Ω–∞ –∫–æ–Ω–≥—Ä–µ—Å—Å –º–æ–∂–Ω–æ –Ω–∞ —Å–∞–π—Ç–µ. –£—á–∞—Å—Ç–∏–µ –≤ –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–∏ –±–µ—Å–ø–ª–∞—Ç–Ω–æ–µ, –ø–æ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏. üì•–ü–æ –≤–æ–ø—Ä–æ—Å–∞–º —É—á–∞—Å—Ç–∏—è: –û–ª—å–≥–∞ –ú–∞–∫–∞—Ä–∫–∏–Ω–∞ üìÆemail: olga.makarkina@right-to-health.com üì≤ –º–æ–±.: +79168204483","{
  ""skip"": true,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial, safety, guideline"",
  ""impact"": ""medium"",
  ""english"": ""The event will discuss international practices in orphan patient care, prospects for centralized procurement and compensation schemes of care. The congress will also cover regulatory changes needed to solve the problem.""
}"
2025-08-14T09:35:28+00:00,@genedna1,1455,https://t.me/genedna1/1455,"–í –†–æ—Å—Å–∏–∏ –º–æ–≥—É—Ç —Ä–∞—Å—à–∏—Ä–∏—Ç—å –ø—Ä–æ–≥—Ä–∞–º–º—É –Ω–µ–æ–Ω–∞—Ç–∞–ª—å–Ω–æ–≥–æ —Å–∫—Ä–∏–Ω–∏–Ω–≥–∞ –í —Å–ø–∏—Å–æ–∫ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, –Ω–∞ –Ω–æ—Å–∏—Ç–µ–ª—å—Å—Ç–≤–æ –∫–æ—Ç–æ—Ä—ã—Ö –ø—Ä–æ–≤–µ—Ä—è—é—Ç –Ω–æ–≤–æ—Ä–æ–∂–¥–µ–Ω–Ω–æ–≥–æ, –º–æ–∂–µ—Ç –≤–æ–π—Ç–∏ –µ—â–µ 9 –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, —Å–æ–æ–±—â–∏–ª –≥–ª–∞–≤–Ω—ã–π –≤–Ω–µ—à—Ç–∞—Ç–Ω—ã–π —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç –ø–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –≥–µ–Ω–µ—Ç–∏–∫–µ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –°–µ—Ä–≥–µ–π –ö—É—Ü–µ–≤. –û–¥–Ω–∞–∫–æ –∫–∞–∫–∏–µ –∏–º–µ–Ω–Ω–æ, –æ–Ω –Ω–µ —É—Ç–æ—á–Ω–∏–ª. –ü—Ä–∏ —ç—Ç–æ–º, –ø–æ —Å–ª–æ–≤–∞–º —É–ø–æ–ª–Ω–æ–º–æ—á–µ–Ω–Ω–æ–π –ø–æ –ø—Ä–∞–≤–∞–º —á–µ–ª–æ–≤–µ–∫–∞ –¢–∞—Ç—å—è–Ω—ã –ú–æ—Å–∫–∞–ª—å–∫–æ–≤–æ–π, –≤—ã—è–≤–ª–µ–Ω–∏–µ —Ä–µ–¥–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –Ω–∞ —Ä–∞–Ω–Ω–µ–º —ç—Ç–∞–ø–µ —Å–µ–π—á–∞—Å –∑–∞—Ç—Ä—É–¥–Ω–µ–Ω–æ –∏–∑-–∑–∞ –Ω–µ—Ö–≤–∞—Ç–∫–∏ –ø—Ä–æ—Ñ–∏–ª—å–Ω—ã—Ö —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –∏ –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ–π –∏–Ω—Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–Ω–æ—Å—Ç–∏ –ø–µ–¥–∏–∞—Ç—Ä–æ–≤. –í –æ–±—Ä–∞—â–µ–Ω–∏–∏ –≤ –ú–∏–Ω–∑–¥—Ä–∞–≤ –æ–Ω–∞ –ø—Ä–µ–¥–ª–æ–∂–∏–ª–∞ –æ—Ä–≥–∞–Ω–∏–∑–æ–≤–∞—Ç—å –º–∞—Å—à—Ç–∞–±–Ω–æ–µ –ø–æ–≤—ã—à–µ–Ω–∏–µ –∫–≤–∞–ª–∏—Ñ–∏–∫–∞—Ü–∏–∏ –¥–µ—Ç—Å–∫–∏—Ö –≤—Ä–∞—á–µ–π, —á—Ç–æ–±—ã —É–ª—É—á—à–∏—Ç—å –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫—É –∏ –ø–æ—Å–ª–µ–¥—É—é—â–µ–µ –Ω–∞–±–ª—é–¥–µ–Ω–∏–µ –∑–∞ –ø–∞—Ü–∏–µ–Ω—Ç–∞–º–∏.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance, safety"",
  ""impact"": ""medium"",
  ""english"": ""The country representative for medical genetics at the Ministry of Health, Sergey Kutshev, announced that Russia may expand its neonatal screening program to include up to nine additional diseases. However, he did not specify which ones. Tatyana Moskalikova, the country's ombudsman for human rights, noted that early detection of rare diseases is difficult due to a shortage of specialized professionals and insufficient pediatricians' awareness. She suggested organizing a large-scale training program for pediatric doctors to improve diagnosis and patient observation.""
}"
2025-08-13T17:27:58+00:00,@genedna1,1454,https://t.me/genedna1/1454,–û—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –Ω–∞ –æ—Å–Ω–æ–≤–µ –Ω—É—Å–∏–Ω–µ—Ä—Å–µ–Ω–∞ —Ç–∞–∫–∂–µ —É–∂–µ –ø—Ä–∏–º–µ–Ω—è—é—Ç –≤ –î–∞–≥–µ—Å—Ç–∞–Ω–µ. –û–ø—ã—Ç–æ–º –µ–≥–æ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –≤ —Ä–µ—Å–ø—É–±–ª–∏–∫–µ –ø–æ–¥–µ–ª–∏–ª–∏—Å—å –≤—Ä–∞—á–∏ –∏ —Ä–æ–¥–∏—Ç–µ–ª–µ–π –¥–µ—Ç–µ–π —Å–æ –°–ú–ê. –ü–æ–¥—Ä–æ–±–Ω–µ–µ ‚Äî –≤ –≤–∏–¥–µ–æ-–º–∞—Ç–µ—Ä–∏–∞–ª–µ.,"{""skip"": false, ""country"": ""Russia"", ""topic"": ""clinical_trial,hospital_policy"", ""impact"": ""medium"", ""english"": ""The home-based treatment based on nusinersen has been applied in Dagestan. Doctors and parents of children with SMA shared their experience on the treatment.""}"
2025-08-12T17:12:52+00:00,@genedna1,1453,https://t.me/genedna1/1453,"üôãüèª‚Äç‚ôÄÔ∏è –ò–Ω—Ç–µ—Ä–µ—Å–Ω—ã–π —Ñ–∞–∫—Ç: —á–µ–ª–æ–≤–µ—á–µ—Å–∫–∏–π –º–æ–∑–≥ ""—á–∏–Ω–∏—Ç"" —Å–µ–±—è —Å–∞–º –ó–Ω–∞–µ—Ç–µ –ª–∏ –≤—ã, —á—Ç–æ –º–æ–∑–≥ –æ–±–ª–∞–¥–∞–µ—Ç —É–¥–∏–≤–∏—Ç–µ–ª—å–Ω–æ–π —Å–ø–æ—Å–æ–±–Ω–æ—Å—Ç—å—é –∫ –Ω–µ–π—Ä–æ–ø–ª–∞—Å—Ç–∏—á–Ω–æ—Å—Ç–∏? –≠—Ç–æ –∑–Ω–∞—á–∏—Ç, —á—Ç–æ –æ–Ω –º–æ–∂–µ—Ç –ø–µ—Ä–µ—Å—Ç—Ä–∞–∏–≤–∞—Ç—å—Å—è, —Å–æ–∑–¥–∞–≤–∞—Ç—å –Ω–æ–≤—ã–µ —Å–≤—è–∑–∏ –∏ –¥–∞–∂–µ –∫–æ–º–ø–µ–Ω—Å–∏—Ä–æ–≤–∞—Ç—å –ø–æ–≤—Ä–µ–∂–¥–µ–Ω–∏—è! üßæ –ö–∞–∫ —ç—Ç–æ —Ä–∞–±–æ—Ç–∞–µ—Ç? –ü–æ—Å–ª–µ –∏–Ω—Å—É–ª—å—Ç–∞ –∑–¥–æ—Ä–æ–≤—ã–µ —É—á–∞—Å—Ç–∫–∏ –º–æ–∑–≥–∞ –º–æ–≥—É—Ç –≤–∑—è—Ç—å –Ω–∞ —Å–µ–±—è —Ñ—É–Ω–∫—Ü–∏–∏ –ø–æ–≤—Ä–µ–∂–¥—ë–Ω–Ω—ã—Ö. –ü—Ä–∏ –æ–±—É—á–µ–Ω–∏–∏ –Ω–æ–≤–æ–º—É –Ω–∞–≤—ã–∫—É —Ñ–æ—Ä–º–∏—Ä—É—é—Ç—Å—è –Ω–æ–≤—ã–µ –Ω–µ–π—Ä–æ–Ω–Ω—ã–µ —Å–≤—è–∑–∏, —É–∫—Ä–µ–ø–ª—è—è ""–ø—É—Ç—å"" –∫ –∑–Ω–∞–Ω–∏—é. –î–∞–∂–µ –ø–æ—Å–ª–µ —Ç—Ä–∞–≤–º –æ–Ω –º–æ–∂–µ—Ç ""–ø–µ—Ä–µ–ø—Ä–æ–≥—Ä–∞–º–º–∏—Ä–æ–≤–∞—Ç—å—Å—è"", —á—Ç–æ–±—ã –∫–æ–º–ø–µ–Ω—Å–∏—Ä–æ–≤–∞—Ç—å —É—Ç—Ä–∞—á–µ–Ω–Ω—ã–µ —Ñ—É–Ω–∫—Ü–∏–∏ _______________________________________________ –•–æ—Ç–∏—Ç–µ —É–∑–Ω–∞—Ç—å –±–æ–ª—å—à–µ? –°–æ–±—Ä–∞–ª–∞ —Å –∫–æ–ª–ª–µ–≥–∞–º–∏ –ø–∞–ø–∫—É ¬´–ú–µ–¥. –û–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ¬ª. –í –Ω–µ–π: ‚Äî –†–∞–∑–±–æ—Ä—ã —Å–ª–æ–∂–Ω—ã—Ö —Å–ª—É—á–∞–µ ‚Äî –∫–∞–∫ –¥–µ–π—Å—Ç–≤—É—é—Ç —Ç–æ–ø–æ–≤—ã–µ –≤—Ä–∞—á–∏ –≤ –Ω–µ—Å—Ç–∞–Ω–¥–∞—Ä—Ç–Ω—ã—Ö —Å–∏—Ç—É–∞—Ü–∏—è—Ö; ‚Äî –û–±—É—á–µ–Ω–∏–µ —á–µ—Ä–µ–∑ —Å–∏–º—É–ª—è—Ü–∏–∏‚Äî –±–µ–∑ —Ä–∏—Å–∫–∞ –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤; ‚Äî –ö–∞–∫ –æ—Å—Ç–∞–≤–∞—Ç—å—Å—è –≤ —Ç—Ä–µ–Ω–¥–µ ‚Äî –±–µ–∑ –±–µ—Å–∫–æ–Ω–µ—á–Ω—ã—Ö –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–π –∏ —Ç–æ–Ω–Ω —Å—Ç–∞—Ç–µ–π –ò –º–Ω–æ–≥–æ–µ –¥—Ä—É–≥–æ–µ –î–µ–ª—é—Å—å —Å—Å—ã–ª–∫–æ–π: https://t.me/addlist/lTzrveIbiSVjNWVi","{""skip"": true}"
2025-08-11T16:18:22+00:00,@genedna1,1452,https://t.me/genedna1/1452,–õ—É—á—à–∏–µ –∫–∞–Ω–∞–ª—ã –¥–ª—è –∞–±–∏—Ç—É—Ä–∏–µ–Ω—Ç–æ–≤ –∏ —Å—Ç—É–¥–µ–Ω—Ç–æ–≤ –ø–æ –æ–¥–Ω–æ–π —Å—Å—ã–ª–∫–µ ‚ù§Ô∏è https://t.me/addlist/KFetKBk0eC81MjMy,"{""skip"": true}"
2025-08-01T07:02:35+00:00,@genedna1,1451,https://t.me/genedna1/1451,"–ê–≤–≥—É—Å—Ç ‚Äì –º–µ—Å—è—Ü –æ—Å–≤–µ–¥–æ–º–ª–µ–Ω–Ω–æ—Å—Ç–∏ –æ —Å–ø–∏–Ω–∞–ª—å–Ω–æ–π –º—ã—à–µ—á–Ω–æ–π –∞—Ç—Ä–æ—Ñ–∏–∏ –° 2021 –≥–æ–¥–∞ –ø–æ–º–æ—â—å —Ñ–æ–Ω–¥–∞ ¬´–ö—Ä—É–≥ –¥–æ–±—Ä–∞¬ª –æ–¥–æ–±—Ä–µ–Ω–∞ —É–∂–µ –ø–æ—á—Ç–∏ –¥–ª—è 1,7 —Ç—ã—Å. –¥–µ—Ç–µ–π —Å —ç—Ç–∏–º –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–µ–º. –ù–∞–∫–∞–Ω—É–Ω–µ –º–µ—Å—è—Ü–∞ –æ—Å–≤–µ–¥–æ–º–ª–µ–Ω–Ω–æ—Å—Ç–∏ –æ –°–ú–ê —Å–æ—Å—Ç–æ—è–ª–æ—Å—å —É–∂–µ 350-–µ –∑–∞ —Å—á–µ—Ç —Å—Ä–µ–¥—Å—Ç–≤ —Ñ–æ–Ω–¥–∞ –≤–≤–µ–¥–µ–Ω–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –ó–æ–ª–≥–µ–Ω—Å–º–∞. –ë–æ–ª–µ–µ 600 –¥–µ—Ç–µ–π —Å–æ –°–ú–ê –ø–æ–ª—É—á–∞—é—Ç —Ä–∏—Å–¥–∏–ø–ª–∞–º, –±–æ–ª–µ–µ 500 ‚Äî –Ω—É—Å–∏–Ω–µ—Ä—Å–µ–Ω. –ù–∞ –∑–∞–∫—É–ø–∫—É –ø—Ä–µ–ø–∞—Ä–∞—Ç–æ–≤ –Ω–∞–ø—Ä–∞–≤–ª—è–µ—Ç—Å—è –ø—Ä–∏–º–µ—Ä–Ω–æ —á–µ—Ç–≤–µ—Ä—Ç—å —Å—Ä–µ–¥—Å—Ç–≤ —Ñ–æ–Ω–¥–∞. –¢–∞–∫–∂–µ –∑–∞ —Å—á–µ—Ç —Å—Ä–µ–¥—Å—Ç–≤ —Ñ–æ–Ω–¥–∞ –¥–µ—Ç–∏ —Å–æ –°–ú–ê –æ–±–µ—Å–ø–µ—á–∏–≤–∞—é—Ç—Å—è –∞–ø–ø–∞—Ä–∞—Ç–æ–º –æ—Ä—Ç–æ–ø–µ–¥–∏—á–µ—Å–∫–∏–º ¬´–î–∏–Ω–∞–º–∏—á–µ—Å–∫–∏–π –ø–∞—Ä–∞–ø–æ–¥–∏—É–º¬ª. –ü—Ä–∏—á–∏–Ω–∞ –°–ú–ê ‚Äì –ø–∞—Ç–æ–≥–µ–Ω–Ω—ã–µ –≤–∞—Ä–∏–∞–Ω—Ç—ã –Ω–∞ –æ–±–µ–∏—Ö –∫–æ–ø–∏—è—Ö –≥–µ–Ω–∞ SMN1. –£ –ø–∞—Ü–∏–µ–Ω—Ç–∞ —Ä–∞–∑–≤–∏–≤–∞–µ—Ç—Å—è –º—ã—à–µ—á–Ω–∞—è —Å–ª–∞–±–æ—Å—Ç—å, –∫–æ—Ç–æ—Ä–∞—è –±–µ–∑ –¥–æ–ª–∂–Ω–æ–≥–æ –ª–µ—á–µ–Ω–∏—è –ø—Ä–∏–≤–æ–¥–∏—Ç –∫ –∞—Ç—Ä–æ—Ñ–∏–∏ –º—ã—à—Ü, –∏–Ω–≤–∞–ª–∏–¥–∏–∑–∞—Ü–∏–∏ –∏ –ª–µ—Ç–∞–ª—å–Ω–æ–º—É –∏—Å—Ö–æ–¥—É. –î–ª—è —Ä–∞–∑–≤–∏—Ç–∏—è –°–ú–ê —Ä–µ–±–µ–Ω–æ–∫ –¥–æ–ª–∂–µ–Ω –ø–æ–ª—É—á–∏—Ç—å –ø–æ –æ–¥–Ω–æ–π –∫–æ–ø–∏–∏ –≥–µ–Ω–∞ —Å –ø–∞—Ç–æ–≥–µ–Ω–Ω—ã–º –≤–∞—Ä–∏–∞–Ω—Ç–æ–º –æ—Ç –æ–±–æ–∏—Ö —Ä–æ–¥–∏—Ç–µ–ª–µ–π. –ü–æ —Å—Ç–∞—Ç–∏—Å—Ç–∏–∫–µ –∫–∞–∂–¥—ã–π 37 –∂–∏—Ç–µ–ª—å –†–æ—Å—Å–∏–∏ ‚Äî –∑–¥–æ—Ä–æ–≤—ã–π –Ω–æ—Å–∏—Ç–µ–ª—å –°–ú–ê. –°–ú–ê —Å—Ç–∞–ª–∞ –ø–µ—Ä–≤—ã–º –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–µ–º, –≤–∫–ª—é—á–µ–Ω–Ω—ã–º –≤ –ø–µ—Ä–µ—á–µ–Ω—å ¬´–ö—Ä—É–≥–∞ –¥–æ–±—Ä–∞¬ª —Å—Ä–∞–∑—É –ø–æ—Å–ª–µ —Å–æ–∑–¥–∞–Ω–∏—è —Ñ–æ–Ω–¥–∞ –≤ 2021 –≥–æ–¥—É.","{
  ""skip"": true
}"
2025-07-29T17:32:10+00:00,@genedna1,1450,https://t.me/genedna1/1450,"üìö–ú–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–µ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ –±–æ–ª—å—à–µ –Ω–µ –ø—Ä–æ –∑—É–±—Ä—ë–∂–∫—É üìå–ü–æ—Ç–æ–º—É —á—Ç–æ —Å—Ç–∞—Ä—ã–µ –º–µ—Ç–æ–¥—ã ‚Äî –±–µ—Å–∫–æ–Ω–µ—á–Ω—ã–µ –∫–æ–Ω—Å–ø–µ–∫—Ç—ã –∏ —Ç–æ—á–µ—á–Ω–æ–µ –∑–∞—É—á–∏–≤–∞–Ω–∏–µ ‚Äî —É–∂–µ –Ω–µ –¥–∞—é—Ç —Ä–µ–∞–ª—å–Ω—ã—Ö –Ω–∞–≤—ã–∫–æ–≤. –ü–æ—Ç–æ–º—É —á—Ç–æ ¬´—Ç–µ–æ—Ä–∏—è¬ª, ¬´—Ñ—É–Ω–¥–∞–º–µ–Ω—Ç–∞–ª—å–Ω–æ—Å—Ç—å¬ª, ¬´–∫–ª–∞—Å—Å–∏—á–µ—Å–∫–∏–µ —Å—Ö–µ–º—ã¬ª ‚Äî –∑–≤—É—á–∏—Ç —Å–æ–ª–∏–¥–Ω–æ, –Ω–æ –Ω–µ –≥–æ—Ç–æ–≤–∏—Ç –∫ —Å–æ–≤—Ä–µ–º–µ–Ω–Ω–æ–π –∫–ª–∏–Ω–∏—á–µ—Å–∫–æ–π –ø—Ä–∞–∫—Ç–∏–∫–µ. üß∑–ò–º–µ–Ω–Ω–æ –ø–æ—ç—Ç–æ–º—É —Å–æ–±—Ä–∞–ª–∏ —Å –∫–æ–ª–ª–µ–≥–∞–º–∏ –ø–∞–ø–∫—É ¬´–ú–µ–¥. –û–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ¬ª ‚Äî –Ω–µ —Å —É—Å—Ç–∞—Ä–µ–≤—à–∏–º–∏ –º–µ—Ç–æ–¥–∏–∫–∞–º–∏, –∞ —Å –∏–Ω—Å—Ç—Ä—É–º–µ–Ω—Ç–∞–º–∏, –∫–æ—Ç–æ—Ä—ã–µ –¥–µ–π—Å—Ç–≤–∏—Ç–µ–ª—å–Ω–æ —Ä–∞–±–æ—Ç–∞—é—Ç –≤ 2025 –≥–æ–¥—É. –í –Ω–µ–π: ‚Äî –†–∞–∑–±–æ—Ä—ã —Å–ª–æ–∂–Ω—ã—Ö —Å–ª—É—á–∞–µ ‚Äî –∫–∞–∫ –¥–µ–π—Å—Ç–≤—É—é—Ç —Ç–æ–ø–æ–≤—ã–µ –≤—Ä–∞—á–∏ –≤ –Ω–µ—Å—Ç–∞–Ω–¥–∞—Ä—Ç–Ω—ã—Ö —Å–∏—Ç—É–∞—Ü–∏—è—Ö; ‚Äî –û–±—É—á–µ–Ω–∏–µ —á–µ—Ä–µ–∑ —Å–∏–º—É–ª—è—Ü–∏–∏‚Äî –±–µ–∑ —Ä–∏—Å–∫–∞ –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤; ‚Äî –ö–∞–∫ –æ—Å—Ç–∞–≤–∞—Ç—å—Å—è –≤ —Ç—Ä–µ–Ω–¥–µ ‚Äî –±–µ–∑ –±–µ—Å–∫–æ–Ω–µ—á–Ω—ã—Ö –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–π –∏ —Ç–æ–Ω–Ω —Å—Ç–∞—Ç–µ–π –ò –º–Ω–æ–≥–æ–µ –¥—Ä—É–≥–æ–µ –í–æ—Ç —Å—Å—ã–ª–∫–∞ https://t.me/addlist/ko8pM6U3uQlmZTgy","{""skip"": true}"
2025-07-25T07:54:24+00:00,@genedna1,1449,https://t.me/genedna1/1449,‚ö°Ô∏è –£–≤–∞–∂–∞–µ–º—ã–µ –ø–æ–¥–ø–∏—Å—á–∏–∫–∏! –î–µ–ª—é—Å—å —Å –≤–∞–º–∏ –æ—á–µ—Ä–µ–¥–Ω–æ–π –ø–æ–¥–±–æ—Ä–∫–æ–π –∫–∞–Ω–∞–ª–æ–≤ –≤ —Å—Ñ–µ—Ä–µ ¬´–ú–µ–¥–∏—Ü–∏–Ω–∞ –∏ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ¬ª üî• ‚ùóÔ∏è–°—Å—ã–ª–∫–∞ –Ω–∞ –ø–∞–ø–∫—É: http://t.me/addlist/kSf7Z5bTjZphZjQ6,"{""skip"": true}"
2025-07-23T15:43:40+00:00,@genedna1,1448,https://t.me/genedna1/1448,"–í–Ω–µ–¥—Ä–µ–Ω–∏–µ —Ä–∞—Å—à–∏—Ä–µ–Ω–Ω–æ–≥–æ –Ω–µ–æ–Ω–∞—Ç–∞–ª—å–Ω–æ–≥–æ —Å—Ä–∏–Ω–∏–Ω–≥–∞ –≤ 2023 –≥–æ–¥—É –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ —É–≤–µ–ª–∏—á–∏–ª–æ —Ä–∞–Ω–Ω—é—é –≤—ã—è–≤–ª—è–µ–º–æ—Å—Ç—å –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å–æ —Å–ø–∏–Ω–∞–ª—å–Ω–æ–π –º—ã—à–µ—á–Ω–æ–π –∞—Ç—Ä–æ—Ñ–∏–µ–π (–°–ú–ê) –∏ —É–≤–µ–ª–∏—á–∏–ª–æ –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å —Å–≤–æ–µ–≤—Ä–µ–º–µ–Ω–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –¥–ª—è –Ω–∏—Ö. –ö–∞–∫ –∏–∑–≤–µ—Å—Ç–Ω–æ, —á–µ–º —Ä–∞–Ω—å—à–µ –Ω–∞—á–∞—Ç–æ –ª–µ—á–µ–Ω–∏–µ, —Ç–µ–º –≤—ã—à–µ —ç—Ñ—Ñ–µ–∫—Ç –æ—Ç –Ω–µ–≥–æ. –í –∞–ø—Ä–µ–ª–µ 2024 –≥–æ–¥–∞ –≤ –†–æ—Å—Å–∏–∏ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª–∏ –ø–µ—Ä–≤—ã–π –≤ –º–∏—Ä–µ –≤–æ—Å–ø—Ä–æ–∏–∑–≤–µ–¥–µ–Ω–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –Ω–∞ –æ—Å–Ω–æ–≤–µ –Ω—É—Å–∏–Ω–µ—Ä—Å–µ–Ω–∞. –ù–∞ —Å–µ–≥–æ–¥–Ω—è —É–∂–µ –≤—ã–ø–æ–ª–Ω–µ–Ω–æ –æ–∫–æ–ª–æ 700 –µ–≥–æ –≤–≤–µ–¥–µ–Ω–∏–π –ø–∞—Ü–∏–µ–Ω—Ç–∞–º —Å–æ –°–ú–ê. –ü–æ–¥—Ä–æ–±–Ω–µ–µ –æ–± –æ–ø—ã—Ç–µ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –æ—Ç–µ—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ª–µ–∫–∞—Ä—Å—Ç–≤–∞ –æ—Ç –≤—Ä–∞—á–µ–π –∏ —Ä–æ–¥–∏—Ç–µ–ª–µ–π –¥–µ—Ç–µ–π —Å–æ –°–ú–ê ‚Äî –≤ –≤–∏–¥–µ–æ—Ä–æ–ª–∏–∫–µ.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, shortage, safety"",
  ""impact"": ""high"",
  ""english"": ""The expanded neonatal screening in 2023 significantly increased early detection of patients with spinal muscular atrophy (SMA) and improved access to timely treatment for them. Early treatment is crucial for better outcomes. In April 2024, Russia registered the world's first reproduced nusinersen-based drug. So far, over 700 patients with SMA have received the treatment. Watch a video of the experience by doctors and parents of children with SMA.""
}"
2025-07-22T10:32:22+00:00,@genedna1,1447,https://t.me/genedna1/1447,"üóì25 –∏ 26 –∏—é–ª—è –≤ –ú–æ—Å–∫–≤–µ —Å–æ—Å—Ç–æ–∏—Ç—Å—è —Å–æ—Ü—Ñ–µ—Å—Ç ¬´–†–µ–¥–∫–∞—è –ñ–∞—Ä–∞. –ü—Ä–∏—Ç—è–∂–µ–Ω–∏–µ¬ª ‚Äî –≤–æ—Å—å–º–æ–π –ø–æ —Å—á–µ—Ç—É —Ñ–µ—Å—Ç–∏–≤–∞–ª—å —Å–æ—Ü–∏–∞–ª—å–Ω–æ–π —Å–æ–ª–∏–¥–∞—Ä–Ω–æ—Å—Ç–∏ —Å –ª—é–¥—å–º–∏ —Å —Ä–µ–¥–∫–∏–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏, –æ—Ä–≥–∞–Ω–∏–∑–∞—Ç–æ—Ä–æ–º –∫–æ—Ç–æ—Ä–æ–≥–æ —è–≤–ª—è–µ—Ç—Å—è –ê–ù–û ¬´–¶–µ–Ω—Ç—Ä —ç–∫—Å–ø–µ—Ä—Ç–Ω–æ–π –ø–æ–º–æ—â–∏ –ø–æ –≤–æ–ø—Ä–æ—Å–∞–º, —Å–≤—è–∑–∞–Ω–Ω—ã–º —Å —Ä–µ–¥–∫–∏–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏, ¬´–î–æ–º –†–µ–¥–∫–∏—Ö¬ª. üìå–ü—Ä–æ–≥—Ä–∞–º–º–∞ —Ñ–µ—Å—Ç–∏–≤–∞–ª—è –≤–∫–ª—é—á–∞–µ—Ç –º–Ω–æ–≥–æ –∏–Ω—Ç–µ—Ä–µ—Å–Ω—ã—Ö –∏ –ø–æ–ª–µ–∑–Ω—ã—Ö –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–π, –∫–æ—Ç–æ—Ä—ã–µ –ø–æ–º–æ–≥—É—Ç –≤—Å–µ–º —É—á–∞—Å—Ç–Ω–∏–∫–∞–º –ø–æ—á—É–≤—Å—Ç–≤–æ–≤–∞—Ç—å —Å–µ–±—è —á–∞—Å—Ç—å—é –µ–¥–∏–Ω–æ–≥–æ —Å–æ–æ–±—â–µ—Å—Ç–≤–∞: ‚úÖ¬´–†–µ–¥–∫–∏–π –≤—Ä–∞—á–µ–±–Ω—ã–π –ø—Ä–∞–∫—Ç–∏–∫—É–º¬ª (–¢–û–õ–¨–ö–û –î–õ–Ø –ú–ï–î–ò–¶–ò–ù–°–ö–ò–• –°–ü–ï–¶–ò–ê–õ–ò–°–¢–û–í) ‚Äî –æ–±–º–µ–Ω –∑–Ω–∞–Ω–∏—è–º–∏ –∏ —É–Ω–∏–∫–∞–ª—å–Ω—ã–º –æ–ø—ã—Ç–æ–º –º–µ–∂–¥—É —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞–º–∏ –≤ –æ–±–ª–∞—Å—Ç–∏ —Ä–µ–¥–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π. ‚úÖ¬´–®–∫–æ–ª–∞ —Å–æ–≤—Ä–µ–º–µ–Ω–Ω–æ–≥–æ –ø–∞—Ü–∏–µ–Ω—Ç–∞. –ó–Ω–∞—é. –£–º–µ—é. –ü—Ä–∞–∫—Ç–∏–∫—É—é¬ª ‚Äî –ø—Ä–æ—Å–≤–µ—Ç–∏—Ç–µ–ª—å—Å–∫–æ–µ –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–µ –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –∏ –∏—Ö —Å–µ–º–µ–π: —Ç–æ–∫-—à–æ—É, –ª–µ–∫—Ü–∏–∏, –¥–∏—Å–∫—É—Å—Å–∏–∏. ‚úÖ–ú—É–∑—ã–∫–∞–ª—å–Ω–æ-–∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω–æ–µ –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–µ ‚Äî –Ω–µ–æ–±—ã–∫–Ω–æ–≤–µ–Ω–Ω—ã–µ –≤—Å—Ç—Ä–µ—á–∏ –∏ –Ω–µ–ø—Ä–∏–¥—É–º–∞–Ω–Ω—ã–µ –∏—Å—Ç–æ—Ä–∏–∏ –æ ¬´—Ä–µ–¥–∫–∏—Ö¬ª–ª—é–¥—è—Ö. –ù–∞ —Å—Ü–µ–Ω—É –≤—ã–π–¥—É—Ç –ø–∞—Ü–∏–µ–Ω—Ç—ã, –≤—Ä–∞—á–∏, –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω—ã–µ –¥–µ—è—Ç–µ–ª–∏, –∞–∫—Ç–∏–≤–∏—Å—Ç—ã, —á—Ç–æ–±—ã —Ä–∞—Å—Å–∫–∞–∑–∞—Ç—å –æ–± —É—Å–ø–µ—Ö–∞—Ö –≤ —Å—Ñ–µ—Ä–µ —Ä–µ–¥–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π, –æ —Å–∏–ª–µ –¥—É—Ö–∞, –Ω–∞–¥–µ–∂–¥–µ –∏ —Å–æ–ª–∏–¥–∞—Ä–Ω–æ—Å—Ç–∏.–¢—Ä–æ–≥–∞—Ç–µ–ª—å–Ω—ã–º–∏ –∏ –≤–¥–æ—Ö–Ω–æ–≤–ª—è—é—â–∏–º–∏ –∏—Å—Ç–æ—Ä–∏—è–º–∏ –æ –∂–∏–∑–Ω–∏ —Ä—è–¥–æ–º —Å —Ç–∞–∫–∏–º–∏ –ª—é–¥—å–º–∏ –∏–∑ —Ä–∞–∑–Ω—ã—Ö —É–≥–æ–ª–∫–æ–≤ —Å—Ç—Ä–∞–Ω—ã –ø–æ–¥–µ–ª—è—Ç—Å—è –∏—Ö –±–ª–∏–∑–∫–∏–µ, –¥—Ä—É–∑—å—è, –∑–Ω–∞–∫–æ–º—ã–µ. üé§–í–µ–¥—É—â–∏–π —Ñ–µ—Å—Ç–∏–≤–∞–ª—è ‚Äî –ê–Ω–¥—Ä–µ–π –ü—Ä–æ–¥–µ—É—Å, –ø—Ä–æ—Ñ–µ—Å—Å–æ—Ä, —Ç–µ–ª–µ–≤–µ–¥—É—â–∏–π –ü–µ—Ä–≤–æ–≥–æ –∫–∞–Ω–∞–ª–∞. üåü –ü–æ —Ç—Ä–∞–¥–∏—Ü–∏–∏ –±—É–¥–µ—Ç –≤—Ä—É—á–µ–Ω–∞ ""–†–µ–¥–∫–∞—è –ó–≤–µ–∑–¥–∞"" ‚Äî ¬´–ó–∞ –æ—Å–≤–µ—â–µ–Ω–∏–µ –ø—É—Ç–∏ ""—Ä–µ–¥–∫–∏—Ö"" –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –∏ –∑–Ω–∞—á–∏–º—É—é –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç—å –≤–æ –∏–º—è —Å–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∂–∏–∑–Ω–∏ –∏ —Å–±–µ—Ä–µ–∂–µ–Ω–∏—è –∑–¥–æ—Ä–æ–≤—å—è —á–µ–ª–æ–≤–µ–∫–∞¬ª. ‚ÄºÔ∏è–î–ª—è –û–ß–ù–û–ì–û –£–ß–ê–°–¢–ò–Ø –≤ –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏—è—Ö –Ω–µ–æ–±—Ö–æ–¥–∏–º–∞ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è. ‚òÑÔ∏è–í–•–û–î –°–í–û–ë–û–î–ù–´–ô! –ö–û–õ–ò–ß–ï–°–¢–í–û –ú–ï–°–¢ –û–ì–†–ê–ù–ò–ß–ï–ù–û! üìå–°—Å—ã–ª–∫–∏ –¥–ª—è —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ üëáüèª üîπ–†–µ–¥–∫–∏–π –≤—Ä–∞—á–µ–±–Ω—ã–π –ø—Ä–∞–∫—Ç–∏–∫—É–º (25.07.2025, 10.00, –û—Ç–µ–ª—å ¬´–õ–µ—Å–Ω–∞—è –°–∞—Ñ–º–∞—Ä¬ª) - https://domredkikh.timepad.ru/event/3457984/ üîπ–®–∫–æ–ª–∞ —Å–æ–≤—Ä–µ–º–µ–Ω–Ω–æ–≥–æ –ø–∞—Ü–∏–µ–Ω—Ç–∞ (25.07.2025, 14.00, –û—Ç–µ–ª—å ¬´–õ–µ—Å–Ω–∞—è –°–∞—Ñ–º–∞—Ä¬ª) - https://domredkikh.timepad.ru/event/3458057/ üîπ–ú—É–∑—ã–∫–∞–ª—å–Ω–æ-–∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏–æ–Ω–Ω–æ–µ –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–µ - (26.07.2025, 18.00, ¬´–¶–µ–Ω—Ç—Ä –æ–ø–µ—Ä–Ω–æ–≥–æ –ø–µ–Ω–∏—è –ì–∞–ª–∏–Ω—ã –í–∏—à–Ω–µ–≤—Å–∫–æ–π¬ª) - https://domredkikh.timepad.ru/event/3446346/","{""skip"": true}"
2025-07-18T15:20:14+00:00,@genedna1,1445,https://t.me/genedna1/1445,"–í –∞–ø—Ä–µ–ª–µ 2024 –≥–æ–¥–∞ –ú–∏–Ω–∑–¥—Ä–∞–≤ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–ª –∞–Ω–∞–ª–æ–≥ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ —Å –¥–µ–π—Å—Ç—Ç–≤—É—é—â–∏–º –≤–µ—â–µ—Å—Ç–≤–æ–º –Ω—É—Å–∏–Ω–µ—Ä—Å–µ–Ω (¬´–õ–∞–Ω—Ç–µ—Å–µ–Ω—Å¬ª). –≠—Ç–æ –≤–µ—â–µ—Å—Ç–≤–æ –ø—Ä–∏–º–µ–Ω—è—é—Ç –¥–ª—è –ª–µ—á–µ–Ω–∏—è —Å–ø–∏–Ω–∞–ª—å–Ω–æ–π –º—ã—à–µ—á–Ω–æ–π –∞—Ç—Ä–æ—Ñ–∏–∏ (–°–ú–ê). –°–ú–ê ‚Äî –æ–¥–Ω–æ –∏–∑ –Ω–∞–∏–±–æ–ª–µ–µ —á–∞—Å—Ç–æ –≤—Å—Ç—Ä–µ—á–∞—é—â–∏—Ö—Å—è —Ä–µ–¥–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π –∏ –æ–¥–Ω–∞ –∏–∑ —Å–∞–º—ã—Ö —á–∞—Å—Ç—ã—Ö –ø—Ä–∏—á–∏–Ω –¥–µ—Ç—Å–∫–æ–π —Å–º–µ—Ä—Ç–Ω–æ—Å—Ç–∏ –ø—Ä–∏ –Ω–∞—Å–ª–µ–¥—Å—Ç–≤–µ–Ω–Ω—ã—Ö –ø–∞—Ç–æ–ª–æ–≥–∏—è—Ö. –î–æ–ª–≥–∏–µ –≥–æ–¥—ã –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–µ —Å—á–∏—Ç–∞–ª–æ—Å—å –Ω–µ–∏–∑–ª–µ—á–∏–º—ã–º. –ü–æ—ç—Ç–æ–º—É –ø–æ—è–≤–ª–µ–Ω–∏–µ –≤ 2016 –≥–æ–¥—É —Ç–µ—Ä–∞–ø–∏–∏ –Ω–∞ –æ—Å–Ω–æ–≤–µ –Ω—É—Å–∏–Ω–µ—Ä—Å–µ–Ω–∞ —Å—Ç–∞–ª–æ –Ω–∞—Å—Ç–æ—è—â–∏–º –ø—Ä–æ—Ä—ã–≤–æ–º –∏ –ø–æ—Å–ª—É–∂–∏–ª–æ –≤ –¥–∞–ª—å–Ω–µ–π—à–µ–º —Ä–∞–∑—Ä–∞–±–æ—Ç–∫–µ –∏ –≤—ã–≤–æ–¥—É –Ω–∞ —Ä—ã–Ω–æ–∫ –≤ –º–∏—Ä–µ –Ω–æ–≤—ã—Ö –ª–µ–∫–∞—Ä—Å—Ç–≤ –æ—Ç –°–ú–ê. –î–æ—Å—Ç—É–ø–Ω–æ—Å—Ç—å –ª–µ–∫–∞—Ä—Å—Ç–≤ –∏ –∏—Ö –≤—ã–≤–æ–¥ –Ω–∞ —Ä—ã–Ω–æ–∫ ‚Äî –≤—Å–µ–≥–¥–∞ –æ—á–µ–Ω—å –≤–∞–∂–Ω–æ–µ —Å–æ–±—ã—Ç–∏–µ –¥–ª—è –≤—Ä–∞—á–µ–±–Ω–æ–≥–æ —Å–æ–æ–±—â–µ—Å—Ç–≤–∞ –∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤. –ü–æ—è–≤–ª–µ–Ω–∏–µ –Ω–æ–≤—ã—Ö –≤—Å–µ–≥–¥–∞ –ø—Ä–∏–≤–ª–µ–∫–∞–µ—Ç –≤–Ω–∏–º–∞–Ω–∏–µ –≤ –ø–µ—Ä–≤—É—é –æ—á–µ—Ä–µ–¥—å –≤—Ä–∞—á–µ–π, —Ç–∞–∫ –∫–∞–∫ –∏–º–µ–Ω–Ω–æ –Ω–∞ –Ω–∏—Ö –æ—Ü–µ–Ω–∫–∞ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞. –ü–æ–¥—Ä–æ–±–Ω–µ–µ –æ–± –æ–ø—ã—Ç–µ –ø—Ä–∏–º–µ–Ω–µ–Ω–∏—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –æ—Ç –°–ú–ê –ø—Ä–æ–∏–∑–≤–æ–¥—Å—Ç–≤–∞ —Ä–æ—Å—Å–∏–π—Å–∫–æ–π —Ñ–∞—Ä–º–∫–æ–º–ø–∞–Ω–∏–∏ ‚Äî –≤ –≤–∏–¥–µ–æ—Ä–æ–ª–∏–∫–µ.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""tenders, clinical_trial, safety"",
  ""impact"": ""high"",
  ""english"": ""In April 2024, the Ministry of Health registered a generic version of a drug containing nusinersen (‚ÄòLantersen‚Äô), which is used to treat spinal muscular atrophy (SMA). SMA is one of the most common rare diseases and a leading cause of childhood mortality due to hereditary conditions. For years, the disease was considered incurable. The development of a therapy based on nusinersen in 2016 was a significant breakthrough and paved the way for the development of new treatments against SMA. The availability of drugs and their market entry are always important events for the medical community and patients alike. New treatments attract attention primarily from doctors, as they are responsible for assessing the drug's effectiveness.""
}"
2025-07-18T07:23:02+00:00,@genedna1,1444,https://t.me/genedna1/1444,‚ö°Ô∏è –£–≤–∞–∂–∞–µ–º—ã–µ –ø–æ–¥–ø–∏—Å—á–∏–∫–∏! –ü—è—Ç–Ω–∏—Ü–∞! –°–ø–µ—Ü–∏–∞–ª—å–Ω–æ –¥–ª—è –≤–∞—Å ‚Äî –æ—Ç–ª–∏—á–Ω–∞—è –ø–æ–¥–±–æ—Ä–∫–∞ –∫–∞–Ω–∞–ª–æ–≤ –≤ —Å—Ñ–µ—Ä–µ ¬´–ú–µ–¥–∏—Ü–∏–Ω–∞ –∏ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ¬ª üî• ‚ùóÔ∏è–°—Å—ã–ª–∫–∞ –Ω–∞ –ø–∞–ø–∫—É: http://t.me/addlist/QUirJQnfHHxiMTY6,"{""skip"": true}"
2025-07-15T16:37:56+00:00,@genedna1,1443,https://t.me/genedna1/1443,"–ú–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–µ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ: –ü—É—Ç—å –∫ —Å–ø–∞—Å–µ–Ω–∏—é –∂–∏–∑–Ω–µ–π –∏ –∑–∞–±–æ—Ç–µ –æ –∑–¥–æ—Ä–æ–≤—å–µ! üöë –ú–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–µ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ ‚Äì —ç—Ç–æ –Ω–µ –ø—Ä–æ—Å—Ç–æ —É—á–µ–±–∞, —ç—Ç–æ –ø—Ä–∏–∑–≤–∞–Ω–∏–µ. –≠—Ç–æ —Å–ª–æ–∂–Ω—ã–π, –Ω–æ –Ω–µ–≤–µ—Ä–æ—è—Ç–Ω–æ –±–ª–∞–≥–æ—Ä–æ–¥–Ω—ã–π –ø—É—Ç—å, –≤–µ–¥—É—â–∏–π –∫ —Å–ø–∞—Å–µ–Ω–∏—é –∂–∏–∑–Ω–µ–π, –æ–±–ª–µ–≥—á–µ–Ω–∏—é —Å—Ç—Ä–∞–¥–∞–Ω–∏–π –∏ —É–ª—É—á—à–µ–Ω–∏—é –∫–∞—á–µ—Å—Ç–≤–∞ –∂–∏–∑–Ω–∏ –ª—é–¥–µ–π. üìö–°–æ–±—Ä–∞–ª–∏ –¥–ª—è –≤–∞—Å –ø–æ–¥–±–æ—Ä–∫—É,–≥–¥–µ —Ç–æ–ª—å–∫–æ –ø—Ä–æ–≤–µ—Ä–µ–Ω–Ω—ã–µ Telegram-–∫–∞–Ω–∞–ª—ã –æ—Ç –ø—Ä–∞–∫—Ç–∏–∫—É—é—â–∏—Ö –≤—Ä–∞—á–µ–π –∏ —ç–∫—Å–ø–µ—Ä—Ç–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è, –∫–æ—Ç–æ—Ä—ã–µ –ø–æ–º–æ–≥—É—Ç –≤—ã–±—Ä–∞—Ç—å –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏–µ –∏ —É–ª—É—á—à–∏—Ç—å –Ω–∞–≤—ã–∫–∏. –°—Å—ã–ª–∫–∞: https://t.me/addlist/N_bJYMCUesJiODIy","{""skip"": true}"
2025-07-11T08:57:34+00:00,@genedna1,1442,https://t.me/genedna1/1442,"üî¥ –î–æ—Ä–æ–≥–∏–µ –ø–æ–¥–ø–∏—Å—á–∏–∫–∏, –ø—Ä–∏–≥–ª–∞—à–∞–µ–º –≤–∞—Å –Ω–∞ V —é–±–∏–ª–µ–π–Ω—ã–π –∫–æ–Ω–≥—Ä–µ—Å—Å ¬´–ü—Ä–∞–≤–æ –Ω–∞ –∑–¥–æ—Ä–æ–≤—å–µ¬ª, –∫–æ—Ç–æ—Ä—ã–π –ø—Ä–æ–π–¥–µ—Ç 11 —Å–µ–Ω—Ç—è–±—Ä—è –≤ –ú–æ—Å–∫–≤–µ! –†–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è —É–∂–µ –æ—Ç–∫—Ä—ã—Ç–∞! –£—á–∞—Å—Ç–Ω–∏–∫–æ–≤ –∂–¥—É—Ç 20 —Å–µ—Å—Å–∏–π –Ω–∞ –Ω–∞–∏–±–æ–ª–µ–µ –æ—Å—Ç—Ä—ã–µ –≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–∏ —Ç–µ–º—ã. –ú–∞–≥–∏—Å—Ç—Ä–∞–ª—å–Ω—ã–º–∏ —Å—Ç–∞–Ω—É—Ç: ‚ñ´Ô∏è–°–æ–≤—Ä–µ–º–µ–Ω–Ω–∞—è –∫–æ–Ω—Ü–µ–ø—Ü–∏—è –±–æ—Ä—å–±—ã —Å —ç–ø–∏–¥–µ–º–∏–µ–π —Å–∞—Ö–∞—Ä–Ω–æ–≥–æ –¥–∏–∞–±–µ—Ç–∞ ‚ñ´Ô∏è–°—Ç—Ä–∞—Ç–µ–≥–∏—á–µ—Å–∫–∏–µ –≤–æ–ø—Ä–æ—Å—ã —Ä–∞–∑–≤–∏—Ç–∏—è –≥–µ–º–∞—Ç–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π, –∫–∞—Ä–¥–∏–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π –∏ —Ä–µ–≤–º–∞—Ç–æ–ª–æ–≥–∏—á–µ—Å–∫–æ–π —Å–ª—É–∂–±. ‚ñ´Ô∏è–ú–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è —Ä–µ–∞–±–∏–ª–∏—Ç–∞—Ü–∏—è –∫–∞–∫ –ø—Ä–∏–æ—Ä–∏—Ç–µ—Ç–Ω—ã–π –≤–µ–∫—Ç–æ—Ä —Ä–∞–∑–≤–∏—Ç–∏—è –≥–æ—Å–ø–æ–ª–∏—Ç–∏–∫–∏. ‚ñ´Ô∏è–ê–∫—Ç—É–∞–ª—å–Ω—ã–µ –ø—Ä–æ–±–ª–µ–º—ã –∑–∞—â–∏—Ç—ã –ø—Ä–∞–≤ –∏–Ω—Ç–µ–ª–ª–µ–∫—Ç—É–∞–ª—å–Ω–æ–π —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç–∏ ‚óªÔ∏è–ò–ò –≤ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏–∏ ‚óªÔ∏è–°–ø–µ—Ü–∏–∞–ª–∏–∑–∏—Ä–æ–≤–∞–Ω–Ω–æ–µ —Å—Ç—Ä–∞—Ö–æ–≤–∞–Ω–∏–µ –æ—Ç –∫—Ä–∏—Ç–∏—á–µ—Å–∫–∏—Ö –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏–π ‚óªÔ∏è –ü—Ä–æ–±–ª–µ–º—ã –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏–∏ –ø–æ–º–æ—â–∏ –æ—Ä—Ñ–∞–Ω–Ω—ã–º –ø–∞—Ü–∏–µ–Ω—Ç–∞–º ‚óΩÔ∏è¬´–°–µ—Ä—ã–π¬ª —Ä—ã–Ω–æ–∫ –Ω–µ–∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω—ã—Ö –º–µ–¥–∏–∑–¥–µ–ª–∏–π –∏ –ª–µ–∫–∞—Ä—Å—Ç–≤. üóì 11 —Å–µ–Ω—Ç—è–±—Ä—è, –ú–æ—Å–∫–≤–∞, –¶–∏—Ñ—Ä–æ–≤–æ–µ –¥–µ–ª–æ–≤–æ–µ –ø—Ä–æ—Å—Ç—Ä–∞–Ω—Å—Ç–≤–æ (—É–ª. –ü–æ–∫—Ä–æ–≤–∫–∞, 47). ‚ù£Ô∏è–°—Å—ã–ª–∫–∞ –Ω–∞ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—é: https://right-to-health.com/auth/?backurl=/events/11_septemer_2025/subscriibe/ üì•–ü–æ –≤—Å–µ–º –≤–æ–ø—Ä–æ—Å–∞–º: –û–ª—å–≥–∞ –ú–∞–∫–∞—Ä–∫–∏–Ω–∞ email: olga.makarkina@right-to-health.com; –º–æ–±.: +79168204483.","{""skip"": true}"
2025-07-09T15:03:14+00:00,@genedna1,1441,https://t.me/genedna1/1441,"–ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–π —É—á—ë–Ω—ã–π ‚Äî –æ ¬´–∑–æ–ª–æ—Ç–æ–º —Å—Ç–∞–Ω–¥–∞—Ä—Ç–µ¬ª –ª–µ—á–µ–Ω–∏—è –±–æ–ª–µ–∑–Ω–∏ –§–∞–±—Ä–∏ –∏ –±–∏–æ–∞–Ω–∞–ª–æ–≥–∞—Ö –í –°–∞–Ω–∫—Ç-–ü–µ—Ç–µ—Ä–±—É—Ä–≥–µ –ø—Ä–æ—à–µ–ª XI —Å—ä–µ–∑–¥ –†–æ—Å—Å–∏–π—Å–∫–æ–≥–æ –æ–±—â–µ—Å—Ç–≤–∞ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –≥–µ–Ω–µ—Ç–∏–∫–æ–≤. –ù–∞ –Ω–µ–º –≤—ã—Å—Ç—É–ø–∏–ª –†–æ–±–µ—Ä—Ç –î–∂. –î–µ—Å–Ω–∏–∫ ‚Äî–æ–¥–∏–Ω –∏–∑ –∫–ª—é—á–µ–≤—ã—Ö —Ä–∞–∑—Ä–∞–±–æ—Ç—á–∏–∫–æ–≤ —Ñ–µ—Ä–º–µ–Ω—Ç–æ–∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—å–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –±–æ–ª–µ–∑–Ω–∏ –§–∞–±—Ä–∏. –ï–≥–æ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –ª–µ–≥–ª–∏ –≤ –æ—Å–Ω–æ–≤—É —Å–æ–∑–¥–∞–Ω–∏—è –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ –Ω–∞ –æ—Å–Ω–æ–≤–µ –∞–≥–∞–ª—Å–∏–¥–∞–∑–∞ –±–µ—Ç–∞. –°–µ–≥–æ–¥–Ω—è –æ–Ω —Å—á–∏—Ç–∞–µ—Ç—Å—è ¬´–∑–æ–ª–æ—Ç—ã–º —Å—Ç–∞–Ω–¥–∞—Ä—Ç–æ–º¬ª –ª–µ—á–µ–Ω–∏—è. –í –†–§ –∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω—ã –æ—Ä–∏–≥–∏–Ω–∞–ª—å–Ω—ã–π –ø—Ä–µ–ø–∞—Ä–∞—Ç –∏ –µ–≥–æ –±–∏–æ–∞–Ω–∞–ª–æ–≥ –ø–æ–¥ –¢–ù ¬´–§–∞–±–∞–≥–∞–ª¬ª. ‚Äî –ò—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –ø–æ–∫–∞–∑–∞–ª–∏, —á—Ç–æ –µ–≥–æ —ç—Ñ—Ñ–µ–∫—Ç–∏–≤–Ω–æ—Å—Ç—å –≤ –ª–µ—á–µ–Ω–∏–∏ –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –Ω–∏—á–µ–º –Ω–µ —É—Å—Ç—É–ø–∞–µ—Ç –æ—Ä–∏–≥–∏–Ω–∞–ª—É, ‚Äî –ø–æ–¥—á–µ—Ä–∫–Ω—É–ª –î–µ—Å–Ω–∏–∫. –û–Ω –æ—Ç–º–µ—Ç–∏–ª, —á—Ç–æ –≤ –°–®–ê —Ç–∞–∫–∂–µ —Ä–∞–∑—Ä–∞–±–∞—Ç—ã–≤–∞–ª—Å—è –¥—Ä—É–≥–æ–π –ø—Ä–µ–ø–∞—Ä–∞—Ç ‚Äî–∞–≥–∞–ª—Å–∏–¥–∞–∑–∞ –∞–ª—å—Ñ–∞. –ù–æ –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–π —Ä–µ–≥—É–ª—è—Ç–æ—Ä –Ω–µ –≤—ã–¥–∞–ª —Ä–∞–∑—Ä–µ—à–µ–Ω–∏–µ –Ω–∞ –µ–≥–æ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—é. ‚Äî –î–µ–Ω—å —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏–∏ –∞–≥–∞–ª—Å–∏–¥–∞–∑—ã –±–µ—Ç–∞ —Å—Ç–∞–ª –¥–ª—è –º–µ–Ω—è —á—Ä–µ–∑–≤—ã—á–∞–π–Ω–æ –≤–∞–∂–Ω—ã–º. –Ø –ø–æ–ª—É—á–∏–ª –Ω–∞–≥–ª—è–¥–Ω–æ–µ –ø–æ–¥—Ç–≤–µ—Ä–∂–¥–µ–Ω–∏–µ –∑–Ω–∞—á–∏–º–æ—Å—Ç–∏ —Ä–∞–±–æ—Ç—ã, –∫–æ—Ç–æ—Ä—É—é –≤—ë–ª —Å 60-—Ö –≥–æ–¥–æ–≤, ‚Äî –æ—Ç–º–µ—Ç–∏–ª –æ–Ω. –î–µ—Å–Ω–∏–∫ –ø–æ–¥—á–µ—Ä–∫–Ω—É–ª, —á—Ç–æ –∏—Å–ø–æ–ª—å–∑–æ–≤–∞–Ω–∏–µ –±–∏–æ–∞–Ω–∞–ª–æ–≥–æ–≤ –ø–æ–∑–≤–æ–ª—è–µ—Ç —Å–Ω–∏–∑–∏—Ç—å –∑–∞—Ç—Ä–∞—Ç—ã –∏ —Ä–∞—Å—à–∏—Ä–∏—Ç—å –¥–æ—Å—Ç—É–ø –∫ –ª–µ—á–µ–Ω–∏—é.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, reimbursement, pricing"",
  ""impact"": ""medium"",
  ""english"": ""A US scientist spoke at the XI Congress of the Russian Society of Medical Genetics in St. Petersburg. Robert J. Deskin, one of the key developers of enzyme replacement therapy for Fabry disease, presented his research. He emphasized that this treatment is as effective as the original drug. Deskin noted that another US-developed enzyme, alglucosidase alpha, was not approved for registration by the regulator. Deskin highlighted that bio analogues can reduce costs and increase access to treatment.""
}"
2025-07-03T06:06:24+00:00,@genedna1,1434,https://t.me/genedna1/1434,"üì∞ –û—Ç–∫—Ä—ã—Ç–∞ —Ä–µ–≥–∏—Å—Ç—Ä–∞—Ü–∏—è –Ω–∞ OpenBio 2025! –ú–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–µ –æ—Ä–∏–µ–Ω—Ç–∏—Ä–æ–≤–∞–Ω–æ –Ω–∞ —Ç–µ—Ö, –∫—Ç–æ –∏–Ω—Ç–µ—Ä–µ—Å—É–µ—Ç—Å—è –∞–∫—Ç—É–∞–ª—å–Ω—ã–º–∏ –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è–º–∏ –±–∏–æ–∏–Ω—Ñ–æ—Ä–º–∞—Ç–∏–∫–∏, –±–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏–π –∏ –±–∏–æ–º–µ–¥–∏—Ü–∏–Ω—ã. –í –ø–µ—Ä–≤—É—é –æ—á–µ—Ä–µ–¥—å, —Å—Ç—É–¥–µ–Ω—Ç–æ–≤, –º–æ–ª–æ–¥—ã—Ö —É—á–µ–Ω—ã—Ö –∏ –∏—Å—Å–ª–µ–¥–æ–≤–∞—Ç–µ–ª–µ–π –∏–ª–∏ –ø—Ä–∞–∫—Ç–∏–∫—É—é—â–∏—Ö —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –¥–æ 35 –ª–µ—Ç. –û–Ω–æ –ø—Ä–æ–π–¥–µ—Ç —Å 23 –ø–æ 26 —Å–µ–Ω—Ç—è–±—Ä—è. –í—ã —Å–º–æ–∂–µ—Ç–µ –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç—å —Å–≤–æ–∏ –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏—è –≤ —Å–ª–µ–¥—É—é—â–∏—Ö —Å–µ–∫—Ü–∏—è—Ö: ü¶† –í–∏—Ä—É—Å–æ–ª–æ–≥–∏—è üß™ –ë–∏–æ–∏–Ω—Ñ–æ—Ä–º–∞—Ç–∏–∫–∞ üíâ –§—É–Ω–¥–∞–º–µ–Ω—Ç–∞–ª—å–Ω–∞—è –º–µ–¥–∏—Ü–∏–Ω–∞ üî¨ –ë–∏–æ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—è üß´ –ë–∏–æ—Ñ–∏–∑–∏–∫–∞ üß¨ –ú–æ–ª–µ–∫—É–ª—è—Ä–Ω–∞—è –±–∏–æ–ª–æ–≥–∏—è –ü–æ–¥—Ä–æ–±–Ω–æ–µ –æ–ø–∏—Å–∞–Ω–∏–µ –∫–∞–∂–¥–æ–π —Å–µ–∫—Ü–∏–∏ –ó–î–ï–°–¨. –§–æ—Ä–º—ã —É—á–∞—Å—Ç–∏—è: ‚Ä¢ –û—á–Ω–æ–µ ‚Ä¢ –û–Ω–ª–∞–π–Ω-–≤—ã—Å—Ç—É–ø–ª–µ–Ω–∏–µ ‚Ä¢ –ó–∞–æ—á–Ω–æ–µ ‚úÖ –û—Ç–æ–±—Ä–∞–Ω–Ω—ã–µ —Ç–µ–∑–∏—Å—ã –±—É–¥—É—Ç –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω—ã –≤ —Å–±–æ—Ä–Ω–∏–∫–µ –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏, —Ä–∞–∑–º–µ—â–µ–Ω—ã –≤ –Ω–∞—É—á–Ω–æ–π —ç–ª–µ–∫—Ç—Ä–æ–Ω–Ω–æ–π –±–∏–±–ª–∏–æ—Ç–µ–∫–µ eLIBRARY —Å –∏–Ω–¥–µ–∫—Å–∞—Ü–∏–µ–π –≤ –†–ò–ù–¶ –∏ –ø—Ä–∏—Å–≤–æ–µ–Ω–∏–µ–º DOI –∫–∞–∂–¥–æ–º—É —Ç–µ–∑–∏—Å—É, –¥–æ–ø—É—â–µ–Ω–Ω–æ–º—É –¥–æ –ø—É–±–ª–∏–∫–∞—Ü–∏–∏ –≤ —Å–±–æ—Ä–Ω–∏–∫–µ. –ü–æ–¥–∞—Ç—å —Ç–µ–∑–∏—Å—ã –¥–ª—è —É—á–∞—Å—Ç–∏—è –≤ –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ –º–æ–∂–Ω–æ –¥–æ 1 –∞–≤–≥—É—Å—Ç–∞. ‚û°Ô∏è –ü–û–î–ê–¢–¨ –¢–ï–ó–ò–°–´ –ó–î–ï–°–¨ üì∞ –ü–æ–¥–ø–∏—Å–∞—Ç—å—Å—è –Ω–∞ –∫–∞–Ω–∞–ª –∫–æ–Ω—Ñ–µ—Ä–µ–Ω—Ü–∏–∏ —á—Ç–æ–±—ã –±—ã—Ç—å –≤ –∫—É—Ä—Å–µ –≤—Å–µ—Ö –Ω–æ–≤–æ—Å—Ç–µ–π –º–æ–∂–Ω–æ –∑–¥–µ—Å—å","{""skip"": true}"
2025-07-02T16:15:05+00:00,@genedna1,1433,https://t.me/genedna1/1433,"–ú–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–µ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ: —Ñ—É–Ω–¥–∞–º–µ–Ω—Ç –∑–¥–æ—Ä–æ–≤—å—è –Ω–∞—Ü–∏–∏ ü©∫ –ö–∞—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–µ –æ–±—É—á–µ–Ω–∏–µ –≤—Ä–∞—á–µ–π ‚Äî —ç—Ç–æ –Ω–µ –ø—Ä–æ—Å—Ç–æ –¥–∏–ø–ª–æ–º—ã –∏ —Å–µ—Ä—Ç–∏—Ñ–∏–∫–∞—Ç—ã. –≠—Ç–æ –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏—è –≤ –∑–¥–æ—Ä–æ–≤—å–µ –∫–∞–∂–¥–æ–≥–æ –∏–∑ –Ω–∞—Å. –ü–æ—á–µ–º—É —ç—Ç–æ —Ç–∞–∫ –≤–∞–∂–Ω–æ? –í—Ä–∞—á–∏ –ø—Ä–∏–Ω–∏–º–∞—é—Ç —Ä–µ—à–µ–Ω–∏—è, –æ—Ç –∫–æ—Ç–æ—Ä—ã—Ö –∑–∞–≤–∏—Å—è—Ç –∂–∏–∑–Ω–∏ ‚Äî –∏—Ö –∑–Ω–∞–Ω–∏—è –¥–æ–ª–∂–Ω—ã –±—ã—Ç—å –±–µ–∑—É–ø—Ä–µ—á–Ω—ã –ú–µ–¥–∏—Ü–∏–Ω–∞ –Ω–µ —Å—Ç–æ–∏—Ç –Ω–∞ –º–µ—Å—Ç–µ ‚Äî —Ç–æ–ª—å–∫–æ –∞–∫—Ç—É–∞–ª—å–Ω–æ–µ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ –¥–∞–µ—Ç —Ä–µ–∞–ª—å–Ω—ã–µ –Ω–∞–≤—ã–∫–∏ –î–æ–≤–µ—Ä–∏–µ –ø–∞—Ü–∏–µ–Ω—Ç–∞ –Ω–∞—á–∏–Ω–∞–µ—Ç—Å—è —Å –∫–æ–º–ø–µ—Ç–µ–Ω—Ç–Ω–æ—Å—Ç–∏ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–∞ –•–æ—Ä–æ—à–∏–π –≤—Ä–∞—á = –∫–∞—á–µ—Å—Ç–≤–µ–Ω–Ω–æ–µ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ. –ê —ç—Ç–æ –∑–Ω–∞—á–∏—Ç ‚Äî –∑–¥–æ—Ä–æ–≤–æ–µ –æ–±—â–µ—Å—Ç–≤–æ. –ü–æ—ç—Ç–æ–º—É –º—ã —Å–æ–±—Ä–∞–ª–∏ –¥–ª—è –≤–∞—Å –ø–æ–¥–±–æ—Ä–∫—É,–≥–¥–µ —Ç–æ–ª—å–∫–æ –ø—Ä–æ–≤–µ—Ä–µ–Ω–Ω—ã–µ Telegram-–∫–∞–Ω–∞–ª—ã –æ—Ç –ø—Ä–∞–∫—Ç–∏–∫—É—é—â–∏—Ö –≤—Ä–∞—á–µ–π –∏ —ç–∫—Å–ø–µ—Ä—Ç–æ–≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è. –í–æ—Ç —Å—Å—ã–ª–∫–∞ ‚Äî https://t.me/addlist/A1oefkZ6eZc1ODYy –ü–æ–¥–µ–ª–∏—Ç–µ—Å—å —Å –±—É–¥—É—â–∏–º–∏ –∏ –¥–µ–π—Å—Ç–≤—É—é—â–∏–º–∏ –º–µ–¥–∏–∫–∞–º–∏ ‚Äî –≤–º–µ—Å—Ç–µ —Å—Ç—Ä–æ–∏–º —Ñ—É–Ω–¥–∞–º–µ–Ω—Ç –∑–¥–æ—Ä–æ–≤—å—è!","{""skip"": true}"
2025-06-25T14:04:12+00:00,@genedna1,1430,https://t.me/genedna1/1430,"–ë–ª–∞–≥–æ—Ç–≤–æ—Ä–∏—Ç–µ–ª—å–Ω—ã–π —Ñ–æ–Ω–¥ ¬´–ì–æ—Ä–¥–µ–π¬ª –±—É–¥–µ—Ç —É–¥–µ–ª—è—Ç—å –±–æ–ª—å—à–µ –≤–Ω–∏–º–∞–Ω–∏—è –ø–æ–º–æ—â–∏ –≤–∑—Ä–æ—Å–ª—ã–º —Å –ú–î–î –ë–ª–∞–≥–æ—Ç–≤–æ—Ä–∏—Ç–µ–ª—å–Ω—ã–π —Ñ–æ–Ω–¥ ¬´–ì–æ—Ä–¥–µ–π¬ª 24 –∏—é–Ω—è, –≤ –¥–µ–Ω—å —Å–≤–æ–µ–≥–æ —Ä–æ–∂–¥–µ–Ω–∏—è, –ø–æ–¥–≤–µ–ª –∏—Ç–æ–≥–∏ –ø—è—Ç–∏–ª–µ—Ç–Ω–µ–π —Ä–∞–±–æ—Ç—ã. –ó–∞ —ç—Ç–æ—Ç –ø–µ—Ä–∏–æ–¥ —Ñ–æ–Ω–¥ —Å–æ–∑–¥–∞–ª —É–Ω–∏–∫–∞–ª—å–Ω—É—é —Å–∏—Å—Ç–µ–º—É –ø–æ–¥–¥–µ—Ä–∂–∫–∏ –∏ —Å–æ–ø—Ä–æ–≤–æ–∂–¥–µ–Ω–∏—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –∏ —á–ª–µ–Ω–æ–≤ –∏—Ö —Å–µ–º–µ–π –Ω–∞ –≤—Å–µ—Ö —ç—Ç–∞–ø–∞—Ö, –Ω–∞—á–∏–Ω–∞—è —Å –º–æ–º–µ–Ω—Ç–∞ –ø–æ—Å—Ç–∞–Ω–æ–≤–∫–∏ –¥–∏–∞–≥–Ω–æ–∑–∞. –†–∞–±–æ—Ç–∞ —Ñ–æ–Ω–¥–∞ –ø–æ–≤–ª–∏—è–ª–∞ –Ω–∞ —Ä–∞–∑–≤–∏—Ç–∏–µ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∏ –∏ —É–≤–µ–ª–∏—á–µ–Ω–∏–µ –¥–æ—Å—Ç—É–ø–Ω–æ—Å—Ç–∏ —Å–æ–≤—Ä–µ–º–µ–Ω–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏ –ø–∞—Ü–∏–µ–Ω—Ç–∞–º —Å –ú–î–î. –¢–∞–∫–∂–µ –≤ 2023 –≥–æ–¥—É –ø—Ä–∏ —É—á–∞—Å—Ç–∏–∏ —Ñ–æ–Ω–¥–∞ –±—ã–ª–∏ —Ä–∞–∑—Ä–∞–±–æ—Ç–∞–Ω—ã –∏ –æ–ø—É–±–ª–∏–∫–æ–≤–∞–Ω—ã –ø–µ—Ä–≤—ã–µ –∫–ª–∏–Ω–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø–æ –ª–µ—á–µ–Ω–∏—é –ú–î–î –∏ –º–µ—Ç–æ–¥–∏—á–µ—Å–∫–∏–µ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –ø–æ —Ä–∞–Ω–Ω–µ–π –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–µ –∏ –Ω–µ–∑–∞—Ä–µ–≥–∏—Å—Ç—Ä–∏—Ä–æ–≤–∞–Ω–Ω–æ–π –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–π —Ç–µ—Ä–∞–ø–∏–∏. –°–µ–≥–æ–¥–Ω—è —Ñ–æ–Ω–¥ —Å—Ç–∞–≤–∏—Ç –ø–µ—Ä–µ–¥ —Å–æ–±–æ–π –Ω–æ–≤—ã–µ –∑–∞–¥–∞—á–∏: –æ–Ω–∏ —Å–≤—è–∑–∞–Ω—ã —Å —Å–æ–ø—Ä–æ–≤–æ–∂–¥–µ–Ω–∏–µ–º –ø–æ–¥—Ä–æ—Å—Ç–∫–æ–≤ –∏ –º–æ–ª–æ–¥—ã—Ö –≤–∑—Ä–æ—Å–ª—ã—Ö —Å –ú–î–î. ¬´–ì–æ—Ä–¥–µ–π¬ª –ø–ª–∞–Ω–∏—Ä—É–µ—Ç —Ä–∞–∑–≤–∏–≤–∞—Ç—å –Ω–∞–ø—Ä–∞–≤–ª–µ–Ω–∏—è, –∫–æ—Ç–æ—Ä—ã–µ –ø–æ–º–æ–≥—É—Ç –ø–æ–¥—Ä–æ—Å—Ç–∫–∞–º —Å –ú–î–î –ø–æ–ª—É—á–∞—Ç—å –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ –∏ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—ã–µ –Ω–∞–≤—ã–∫–∏, –æ–±—â–∞—Ç—å—Å—è –∏ –ø–ª–∞–Ω–∏—Ä–æ–≤–∞—Ç—å –∫–∞—Ä—å–µ—Ä—É, –≥–æ—Ç–æ–≤–∏—Ç—å—Å—è –∫–æ –≤–∑—Ä–æ—Å–ª–æ–π –∂–∏–∑–Ω–∏.","{""skip"": true}"
2025-06-24T15:11:35+00:00,@genedna1,1427,https://t.me/genedna1/1427,"–î–æ–±—Ä—ã–π –ø–∏–∫–Ω–∏–∫ Roche: –ø–∞—Ü–∏–µ–Ω—Ç—ã —Å–æ –°–ú–ê –∏ –ú–î–î –ø–æ–æ–±—â–∞–ª–∏—Å—å —Å –∂–∏–≤–æ—Ç–Ω—ã–º–∏ –Ω–∞ –ì–æ—Ä–æ–¥—Å–∫–æ–π —Ñ–µ—Ä–º–µ –°–æ—Ü–∏–∞–ª—å–Ω–∞—è –∞–∫—Ü–∏—è, –æ—Ä–≥–∞–Ω–∏–∑–æ–≤–∞–Ω–Ω–∞—è –∫–æ–º–ø–∞–Ω–∏–µ–π Roche –ø—Ä–∏ –ø–æ–¥–¥–µ—Ä–∂–∫–µ —Ñ–æ–Ω–¥–æ–≤ ¬´–°–µ–º—å–∏ –°–ú–ê¬ª, ¬´–ì–æ—Ä–¥–µ–π¬ª –∏ ¬´–í–∞–∂–Ω—ã–µ –ª—é–¥–∏¬ª –¥–ª—è –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ —Å–æ —Å–ø–∏–Ω–∞–ª—å–Ω–æ–π –º—ã—à–µ—á–Ω–æ–π –∞—Ç—Ä–æ—Ñ–∏–µ–π (–°–ú–ê) –∏ –º—ã—à–µ—á–Ω–æ–π –¥–∏—Å—Ç—Ä–æ—Ñ–∏–µ–π –î—é—à–µ–Ω–Ω–∞ (–ú–î–î) –ø—Ä–æ—à–ª–∞ 11 –∏—é–Ω—è. –í —ç—Ç–æ—Ç –¥–µ–Ω—å –Ω–∞ –ì–æ—Ä–æ–¥—Å–∫–æ–π —Ñ–µ—Ä–º–µ –í–î–ù–• —Å–æ—Å—Ç–æ—è–ª–∞—Å—å –∞–∫—Ü–∏—è ¬´–î–æ–±—Ä—ã–π –ø–∏–∫–Ω–∏–∫¬ª ‚Äî —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ–µ –º–µ—Ä–æ–ø—Ä–∏—è—Ç–∏–µ –¥–ª—è –¥–µ—Ç–µ–π –∏ –ø–æ–¥—Ä–æ—Å—Ç–∫–æ–≤ —Å —ç—Ç–∏–º–∏ —Ä–µ–¥–∫–∏–º–∏ –∑–∞–±–æ–ª–µ–≤–∞–Ω–∏—è–º–∏. –î–µ—Ç–∏ –ø–æ–∑–Ω–∞–∫–æ–º–∏–ª–∏—Å—å —Å –æ–±–∏—Ç–∞—Ç–µ–ª—è–º–∏ —Ñ–µ—Ä–º—ã. –¢–∞–∫–∂–µ –¥–ª—è –Ω–∏—Ö –ø–æ–¥–≥–æ—Ç–æ–≤–∏–ª–∏ —Ä–∞–∑–ª–∏—á–Ω—ã–µ —É–≥–æ—â–µ–Ω–∏—è, –ø–∞–º—è—Ç–Ω—ã–µ —Å—É–≤–µ–Ω–∏—Ä—ã, —É–≤–ª–µ–∫–∞—Ç–µ–ª—å–Ω—ã–µ –∏–≥—Ä–æ–≤—ã–µ —à–æ—É –∏ —Ç–≤–æ—Ä—á–µ—Å–∫–∏–µ –º–∞—Å—Ç–µ—Ä-–∫–ª–∞—Å—Å—ã. ‚Äî –î–ª—è –Ω–∞—Å —Ç–∞–∫–∏–µ –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤—ã ‚Äî —ç—Ç–æ –Ω–µ –ø—Ä–æ—Å—Ç–æ —Ç—Ä–∞–¥–∏—Ü–∏—è. –≠—Ç–æ –æ—Ç—Ä–∞–∂–µ–Ω–∏–µ –Ω–∞—à–µ–π –≥–ª—É–±–æ–∫–æ–π —É–±–µ–∂–¥–µ–Ω–Ω–æ—Å—Ç–∏ –≤ —Ç–æ–º, —á—Ç–æ –∑–∞–±–æ—Ç–∞ –æ –ø–∞—Ü–∏–µ–Ω—Ç–∞—Ö –≤—ã—Ö–æ–¥–∏—Ç –∑–∞ —Ä–∞–º–∫–∏ –ª–µ—á–µ–Ω–∏—è, ‚Äî –ø–æ–¥—á–µ—Ä–∫–Ω—É–ª–∞ –¥–∏—Ä–µ–∫—Ç–æ—Ä –ø–æ –∫–æ–º–º—É–Ω–∏–∫–∞—Ü–∏—è–º Roche –≤ –†–æ—Å—Å–∏–∏ –ö—Å–µ–Ω–∏—è –°–∏–º–æ–Ω—Å–æ–Ω. ‚Äî –ú—ã —Ä–∞–¥—ã –æ–±—ä–µ–¥–∏–Ω—è—Ç—å—Å—è —Å —Ñ–æ–Ω–¥–∞–º–∏ –∏ –Ω–µ—Ä–∞–≤–Ω–æ–¥—É—à–Ω—ã–º–∏ –ª—é–¥—å–º–∏, —á—Ç–æ–±—ã –ø–æ–¥–∞—Ä–∏—Ç—å –¥–µ—Ç—è–º —Å —Ç—è–∂–µ–ª—ã–º–∏ –¥–∏–∞–≥–Ω–æ–∑–∞–º–∏ —è—Ä–∫–∏–µ –∏ —Ç–µ–ø–ª—ã–µ –≤–æ—Å–ø–æ–º–∏–Ω–∞–Ω–∏—è. –≠—Ç–∏ —Å–æ–±—ã—Ç–∏—è –ø—Ä–∏–¥–∞—é—Ç —Å–º—ã—Å–ª –Ω–∞—à–µ–π —Ä–∞–±–æ—Ç–µ.","{""skip"": true}"
2025-06-21T15:49:53+00:00,@genedna1,1426,https://t.me/genedna1/1426,"–†–µ–±—è—Ç–∞, –º—ã —Å–æ–±—Ä–∞–ª–∏ —Å–∞–º—ã–µ –∏–Ω—Ç–µ—Ä–µ—Å–Ω—ã–µ –∏ –ø–æ–ª–µ–∑–Ω—ã–µ –∫–∞–Ω–∞–ª—ã –¥–ª—è —Å—Ç—É–¥–µ–Ω—Ç–æ–≤-–º–µ–¥–∏–∫–æ–≤! üåü üìå–î–æ–±–∞–≤–ª—è–π—Ç–µ –∫ —Å–µ–±–µ –ø–∞–ø–∫—É –∏ –ø–æ–ª—É—á–∏—Ç–µ 2000 —Ä –Ω–∞ –∫–∞—Ä—Ç—É https://t.me/addlist/OyCuQZKQ1VplZDFi –£—Å–ª–æ–≤–∏—è: 1Ô∏è‚É£üîñ–î–æ–±–∞–≤–∏—Ç—å –∫ —Å–µ–±–µ –ø–∞–ø–∫—É 2Ô∏è‚É£üîñ–ü–æ—Å—Ç–∞–≤–∏—Ç—å + –ø–æ–¥ —ç—Ç–∏–º –ø–æ—Å—Ç–æ–º –Ω–∞ –∫–∞–Ω–∞–ª–µ –í–µ—Å—Ç–∏ –∏–∑ –ú–µ–¥–∏—Ü–∏–Ω—ã –ò—Ç–æ–≥–∏: 24 –∏—é–Ω—è –≤ 15:00 –Ω–∞ –∫–∞–Ω–∞–ª–µ –í–µ—Å—Ç–∏ –∏–∑ –ú–µ–¥–∏—Ü–∏–Ω—ã üåü–∞–≤—Ç–æ—Ä –ø–∞–ø–∫–∏: @Aina_2001","{""skip"": true}"
2025-06-18T16:40:58+00:00,@genedna1,1425,https://t.me/genedna1/1425,"–ù–∞–π–¥–∏—Ç–µ —Å–≤–æ–π –ø—É—Ç—å –≤ –º–µ–¥–∏—Ü–∏–Ω–µ —Å –ø—Ä–æ–≤–µ—Ä–µ–Ω–Ω—ã–º–∏ —Ä–µ—Å—É—Ä—Å–∞–º–∏! ü©∫ –í –º–∏—Ä–µ –±–µ—Å–∫–æ–Ω–µ—á–Ω—ã—Ö –æ–Ω–ª–∞–π–Ω-–∫—É—Ä—Å–æ–≤ –∏ —Å–æ–≤–µ—Ç–æ–≤ —Ç–∞–∫ –ª–µ–≥–∫–æ –ø–æ—Ç–µ—Ä—è—Ç—å—Å—è –∏ –∑–∞–±—ã—Ç—å –æ –≥–ª–∞–≤–Ω–æ–º ‚Äì –∫–∞—á–µ—Å—Ç–≤–µ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è. –ú—ã —Å–æ–∑–¥–∞–ª–∏ –ø–∞–ø–∫—É, –≥–¥–µ —Å–æ–±—Ä–∞–ª–∏ –ª—É—á—à–∏–µ Telegram-–∫–∞–Ω–∞–ª—ã, –∫–æ—Ç–æ—Ä—ã–µ –ø–æ–º–æ–≥—É—Ç –≤–∞–º: ‚Ä¢ –í—ã–±—Ä–∞—Ç—å –¥–µ–π—Å—Ç–≤–∏—Ç–µ–ª—å–Ω–æ –ø–æ–ª–µ–∑–Ω—ã–µ –∫—É—Ä—Å—ã –∏ –º–µ—Ç–æ–¥–∏–∫–∏: –ù–∏–∫–∞–∫–æ–π —Ä–µ–∫–ª–∞–º—ã, —Ç–æ–ª—å–∫–æ —á–µ—Å—Ç–Ω—ã–µ –æ–±–∑–æ—Ä—ã –∏ —Ä–µ–∫–æ–º–µ–Ω–¥–∞—Ü–∏–∏ –æ—Ç –ø—Ä–∞–∫—Ç–∏–∫—É—é—â–∏—Ö –≤—Ä–∞—á–µ–π –∏ –æ–ø—ã—Ç–Ω—ã—Ö –ø—Ä–µ–ø–æ–¥–∞–≤–∞—Ç–µ–ª–µ–π. ‚Ä¢ –ü–æ–ª—É—á–∏—Ç—å —ç–∫—Å–ø–µ—Ä—Ç–Ω—ã–π –æ–±–∑–æ—Ä –∫—É—Ä—Å–æ–≤ –∏ –ø–æ–¥—Ö–æ–¥–æ–≤: –†–∞–∑–±–µ—Ä–∏—Ç–µ—Å—å, –∫–∞–∫–æ–µ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏–µ –ø–æ–¥—Ö–æ–¥–∏—Ç –∏–º–µ–Ω–Ω–æ –≤–∞–º ‚Äì –æ—Ç –±–∞–∑–æ–≤—ã—Ö –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –∑–Ω–∞–Ω–∏–π –¥–æ —É–∑–∫–æ–π —Å–ø–µ—Ü–∏–∞–ª–∏–∑–∞—Ü–∏–∏. ‚Ä¢ –†–∞–∑–≤–∏—Ç—å –∫—Ä–∏—Ç–∏—á–µ—Å–∫–æ–µ –º—ã—à–ª–µ–Ω–∏–µ –∏ –∫–ª—é—á–µ–≤—ã–µ –Ω–∞–≤—ã–∫–∏ –¥–ª—è –∫–∞—Ä—å–µ—Ä—ã –≤—Ä–∞—á–∞: –ù–∞—É—á–∏—Ç–µ—Å—å –∞–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞—Ç—å –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—é, –ø—Ä–∏–Ω–∏–º–∞—Ç—å –≤–∑–≤–µ—à–µ–Ω–Ω—ã–µ —Ä–µ—à–µ–Ω–∏—è –∏ –ø–æ—Å—Ç–æ—è–Ω–Ω–æ —Å–æ–≤–µ—Ä—à–µ–Ω—Å—Ç–≤–æ–≤–∞—Ç—å—Å—è. ‚Ä¢ –ë—ã—Ç—å –≤ –∫—É—Ä—Å–µ –Ω–æ–≤–æ—Å—Ç–µ–π –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ –æ–±—Ä–∞–∑–æ–≤–∞–Ω–∏—è –∏ –ª—É—á—à–∏—Ö –í–£–ó–æ–≤: –ù–µ –ø—Ä–æ–ø—É—Å—Ç–∏—Ç–µ –≤–∞–∂–Ω—ã–µ —Å–æ–±—ã—Ç–∏—è, —Å—Ç–∏–ø–µ–Ω–¥–∏–∏ –∏ –≤–æ–∑–º–æ–∂–Ω–æ—Å—Ç–∏ –¥–ª—è –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ —Ä–æ—Å—Ç–∞! –î–µ–ª—é—Å—å —Å—Å—ã–ª–∫–æ–π : https://t.me/addlist/qfHL7bK07zg1Yzky","{""skip"": true}"
2025-11-24T16:47:31+00:00,@rus_med,7663,https://t.me/rus_med/7663,"üìà –†—ã–Ω–æ—á–Ω–∞—è —Å—Ç–æ–∏–º–æ—Å—Ç—å –∞–º–µ—Ä–∏–∫–∞–Ω—Å–∫–æ–π Eli Lilly –¥–æ—Å—Ç–∏–≥–ª–∞ –æ—Ç–º–µ—Ç–∫–∏ –≤ 1 —Ç—Ä–ª–Ω –¥–æ–ª–ª–∞—Ä–æ–≤. –¶–µ–Ω–∞ –æ–¥–Ω–æ–π –∞–∫—Ü–∏–∏ –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è –ø–µ—Ä–µ–≤–∞–ª–∏–ª–∞ –∑–∞ 1000 –¥–æ–ª–ª., –≤–∑–ª–µ—Ç–µ–≤ –Ω–∞ 36% —Å –Ω–∞—á–∞–ª–∞ –≥–æ–¥–∞. –≠—Ç–æ –ø–µ—Ä–≤–∞—è –∫–æ–º–ø–∞–Ω–∏—è –∏–∑ —Å–µ–∫—Ç–æ—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∏ —Ç—Ä–µ—Ç—å—è –Ω–µ—Ç–µ—Ö–Ω–æ–ª–æ–≥–∏—á–µ—Å–∫–∞—è –≤ ¬´–∫–ª—É–±–µ —Ç—Ä–∏–ª–ª–∏–æ–Ω–µ—Ä–æ–≤¬ª, –¥–≤–µ –¥—Ä—É–≥–∏–µ ‚Äî –Ω–µ—Ñ—Ç—è–Ω–∞—è Saudi Aramco –∏ –∏–Ω–≤–µ—Å—Ç–∏—Ü–∏–æ–Ω–Ω—ã–π —Ö–æ–ª–¥–∏–Ω–≥ Berkshire Hathaway. –í —Å–ø–∏—Å–æ–∫ –≤—Ö–æ–¥—è—Ç –ø—Ä–µ–∏–º—É—â–µ—Å—Ç–≤–µ–Ω–Ω–æ —Ç–µ—Ö–Ω–æ–≥–∏–≥–∞–Ω—Ç—ã (Nvidia, Apple, Alphabet, Microsoft, Amazon, Tesla), –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª–∏ –ø–æ–ª—É–ø—Ä–æ–≤–æ–¥–Ω–∏–∫–æ–≤ TSMC –∏ Broadcom. Eli Lilly —Ç–µ–ø–µ—Ä—å –∑–∞–Ω–∏–º–∞–µ—Ç 12-–µ –º–µ—Å—Ç–æ —Ä–µ–π—Ç–∏–Ω–≥–∞ —Å–∞–º—ã—Ö –¥–æ—Ä–æ–≥–∏—Ö –∫–æ—Ä–ø–æ—Ä–∞—Ü–∏–π –º–∏—Ä–∞. –ì–ª–∞–≤–Ω—ã–π –ª–æ–∫–æ–º–æ—Ç–∏–≤ –µ–µ —Ä–æ—Å—Ç–∞ - –ª–∏–Ω–µ–π–∫–∞ –ª–µ–∫–∞—Ä—Å—Ç–≤ –Ω–∞ –æ—Å–Ω–æ–≤–µ —Ç–∏—Ä–∑–µ–ø–∞—Ç–∏–¥–∞: Mounjaro, –∫–æ—Ç–æ—Ä—ã–º –ª–µ—á–∞—Ç –¥–∏–∞–±–µ—Ç 2-–≥–æ —Ç–∏–ø–∞, –∏ Zepbound, –ø—Ä–∏–º–µ–Ω—è–µ–º—ã–π –ø—Ä–∏ –æ–∂–∏—Ä–µ–Ω–∏–∏.","{""skip"": true}"
2025-11-24T10:31:33+00:00,@rus_med,7662,https://t.me/rus_med/7662,"‚ö°Ô∏è‚ö°Ô∏è‚ö°Ô∏è–í –ú–∏–Ω–∑–¥—Ä–∞–≤–µ –æ–ø—Ä–µ–¥–µ–ª–∏–ª–∏ –ø–æ—Ä—è–¥–æ–∫ –ø—Ä–∏–Ω—É–¥–∏—Ç–µ–ª—å–Ω–æ–π –æ—Ç—Ä–∞–±–æ—Ç–∫–∏ –¥–ª—è –≤—Ä–∞—á–µ–π ‚Äî –ø—Ä–∏–≤–æ–¥–∏–º —É—Ç–≤–µ—Ä–∂–¥–µ–Ω–Ω—ã–µ —Å—Ä–æ–∫–∏ –∏ —Å–ø–∏—Å–æ–∫ —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–µ–π, –ø–æ–¥–ª–µ–∂–∞—â–∏—Ö ¬´–Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤—É¬ª –ú–∏–Ω–∑–¥—Ä–∞–≤ —É—Ç–≤–µ—Ä–¥–∏–ª —Å—Ä–æ–∫ –æ—Ç—Ä–∞–±–æ—Ç–∫–∏ –ø–æ–¥ —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–æ–º –Ω–∞—Å—Ç–∞–≤–Ω–∏–∫–∞ –¥–ª—è –º–æ–ª–æ–¥—ã—Ö –≤—Ä–∞—á–µ–π. –û–± —ç—Ç–æ–º —Å–æ —Å—Å—ã–ª–∫–æ–π –Ω–∞ –Ω–æ—Ä–º–∞—Ç–∏–≤–Ω—É—é –¥–æ–∫—É–º–µ–Ω—Ç–∞—Ü–∏—é —Å–æ–æ–±—â–∞–µ—Ç ¬´–ö–æ–º–º–µ—Ä—Å–∞–Ω—Ç¬ª. –ù–∞–∏–º–µ–Ω—å—à–∏–µ —Å—Ä–æ–∫–∏ –ø—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ–Ω—ã –¥–ª—è —Ç–µ—Ö —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ –ø–æ–µ–¥—É—Ç —Ä–∞–±–æ—Ç–∞—Ç—å –≤ –º–∞–ª–µ–Ω—å–∫–∏–µ –Ω–∞—Å–µ–ª—ë–Ω–Ω—ã–µ –ø—É–Ω–∫—Ç—ã (–¥–æ 50 —Ç—ã—Å—è—á —á–µ–ª–æ–≤–µ–∫) –∏–ª–∏ –≤ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—è –î–ù–†, –õ–ù–†, –ó–∞–ø–æ—Ä–æ–∂—Å–∫–æ–π –∏–ª–∏ –•–µ—Ä—Å–æ–Ω—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–µ–π ‚Äî 1-1,5 –≥–æ–¥–∞. –¢–∞–∫–∂–µ –æ–ø—Ä–µ–¥–µ–ª–µ–Ω–æ, —á—Ç–æ –Ω–∞—Å—Ç–∞–≤–Ω–∏–∫–æ–º –º–æ–≥—É—Ç –±—ã—Ç—å —Ç–æ–ª—å–∫–æ –≤—Ä–∞—á–∏ —Å–æ —Å—Ç–∞–∂–µ–º –Ω–µ –º–µ–Ω–µ–µ –ø—è—Ç–∏ –ª–µ—Ç –ø–æ —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–µ–π —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–∏ –ø—Ä–∏ –∏—Ö –¥–æ–±—Ä–æ–≤–æ–ª—å–Ω–æ–º —Å–æ–≥–ª–∞—Å–∏–∏, –æ—Ñ–æ—Ä–º–ª–µ–Ω–Ω—ã–º –≤ –ø–∏—Å—å–º–µ–Ω–Ω–æ–π —Ñ–æ—Ä–º–µ, —Å –ø–æ—Å–ª–µ–¥—É—é—â–∏–º –∑–∞–∫—Ä–µ–ø–ª–µ–Ω–∏–µ–º –æ–±—è–∑–∞–Ω–Ω–æ—Å—Ç–µ–π –≤ —Ç—Ä—É–¥–æ–≤–æ–º –¥–æ–≥–æ–≤–æ—Ä–µ. –£—Ç–æ—á–Ω—è–µ—Ç—Å—è, —á—Ç–æ –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–æ –¥–æ–ª–∂–Ω–æ –±—ã—Ç—å –≤—Ä–∞—á—É –æ–ø–ª–∞—á–µ–Ω–æ. ¬´–ú–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è –†–æ—Å—Å–∏—è¬ª –ø–æ–¥—Ç–≤–µ—Ä–¥–∏–ª–∞ –ø–æ–¥–ª–∏–Ω–Ω–æ—Å—Ç—å –¥–æ–∫—É–º–µ–Ω—Ç–∞ –∏ –ø—Ä–∏–≤–æ–¥–∏—Ç –ø–æ–¥—Ä–æ–±–Ω—ã–π —Å–ø–∏—Å–æ–∫. –î–ª—è –æ–∫–æ–Ω—á–∏–≤—à–∏—Ö —Å–ø–µ—Ü–∏–∞–ª–∏—Ç–µ—Ç –æ—Ç—Ä–∞–±–æ—Ç–∫–∞ –ø–æ—Å–ª–µ –ø–µ—Ä–≤–∏—á–Ω–æ–π –∞–∫–∫—Ä–µ–¥–∏—Ç–∞—Ü–∏–∏ —Å–æ—Å—Ç–∞–≤–∏—Ç: –ª–µ—á–µ–±–Ω–æ–µ –¥–µ–ª–æ ‚Äî 3 –≥–æ–¥–∞, –ø–µ–¥–∏–∞—Ç—Ä–∏—è ‚Äî 2 –≥–æ–¥–∞, –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è –±–∏–æ—Ö–∏–º–∏—è ‚Äî 2 –≥–æ–¥–∞, —Å—Ç–æ–º–∞—Ç–æ–ª–æ–≥–∏—è, –º–µ–¥–∏–∫–æ-–ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏—á–µ—Å–∫–æ–µ –¥–µ–ª–æ –∏ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è –∫–∏–±–µ—Ä–Ω–µ—Ç–∏–∫–∞ ‚Äî 1,5 –≥–æ–¥–∞. –ü—Ä–∏ —É—Å—Ç—Ä–æ–π—Å—Ç–≤–µ –≤ –º–∞–ª—ã–µ –Ω–∞—Å–µ–ª—ë–Ω–Ω—ã–µ –ø—É–Ω–∫—Ç—ã –∏–ª–∏ –≤ –Ω–æ–≤—ã–µ —Ä–µ–≥–∏–æ–Ω—ã ‚Äî 1 –≥–æ–¥. –î–ª—è –æ—Ä–¥–∏–Ω–∞—Ç–æ—Ä–æ–≤ –ø—Ä–µ–¥—É—Å–º–æ—Ç—Ä–µ–Ω—ã –¥—Ä—É–≥–∏–µ —Å—Ä–æ–∫–∏ –Ω–∞—Å—Ç–∞–≤–Ω–∏—á–µ—Å—Ç–≤–∞. –¢—Ä–∏ –≥–æ–¥–∞ ‚Äî –ø—Ä–µ–¥–µ–ª—å–Ω–æ –≤—ã—Å–æ–∫–∏–π —Å—Ä–æ–∫ ‚Äî –¥–æ–ª–∂–Ω—ã –±—É–¥—É—Ç –æ—Ç—Ä–∞–±–æ—Ç–∞—Ç—å —Å–µ–º—å —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ ‚Äî –¥–µ—Ç—Å–∫–∏–µ —Ö–∏—Ä—É—Ä–≥–∏, –Ω–µ–æ–Ω–∞—Ç–æ–ª–æ–≥–∏, –æ–Ω–∫–æ–ª–æ–≥–∏, –ø–ª–∞—Å—Ç–∏—á–µ—Å–∫–∏–µ —Ö–∏—Ä—É—Ä–≥–∏, —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç—ã–µ —Ö–∏—Ä—É—Ä–≥–∏, —Ç–µ—Ä–∞–ø–µ–≤—Ç—ã –∏ —Ç–æ—Ä–∞–∫–∞–ª—å–Ω—ã–µ —Ö–∏—Ä—É—Ä–≥–∏. –î–≤–∞ –≥–æ–¥–∞ (54 —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–∏) ‚Äî –∞–ª–ª–µ—Ä–≥–æ–ª–æ–≥–∏—è –∏ –∏–º–º—É–Ω–æ–ª–æ–≥–∏—è, –∞–Ω–µ—Å—Ç–µ–∑–∏–æ–ª–æ–≥–∏—è-—Ä–µ–∞–Ω–∏–º–∞—Ç–æ–ª–æ–≥–∏—è, –∞–∫—É—à–µ—Ä—Å—Ç–≤–æ –∏ –≥–∏–Ω–µ–∫–æ–ª–æ–≥–∏—è, –±–∞–∫—Ç–µ—Ä–∏–æ–ª–æ–≥–∏—è, –≤–∏—Ä—É—Å–æ–ª–æ–≥–∏—è, –≥–∞—Å—Ç—Ä–æ—ç–Ω—Ç–µ—Ä–æ–ª–æ–≥–∏—è, –≥–µ–º–∞—Ç–æ–ª–æ–≥–∏—è, –≥–µ—Ä–∏–∞—Ç—Ä–∏—è, –¥–µ—Ç—Å–∫–∞—è –∫–∞—Ä–¥–∏–æ–ª–æ–≥–∏—è, –¥–µ—Ç—Å–∫–∞—è –æ–Ω–∫–æ–ª–æ–≥–∏—è, –¥–µ—Ç—Å–∫–∞—è —É—Ä–æ–ª–æ–≥–∏—è-–∞–Ω–¥—Ä–æ–ª–æ–≥–∏—è, –¥–µ—Ç—Å–∫–∞—è —ç–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–∏—è, –¥–∏–µ—Ç–æ–ª–æ–≥–∏—è, –∏–Ω—Ñ–µ–∫—Ü–∏–æ–Ω–Ω—ã–µ –±–æ–ª–µ–∑–Ω–∏, –∫–∞—Ä–¥–∏–æ–ª–æ–≥–∏—è, –∫–ª–∏–Ω–∏—á–µ—Å–∫–∞—è –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–Ω–∞—è –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞, –∫–ª–∏–Ω–∏—á–µ—Å–∫–∞—è —Ñ–∞—Ä–º–∞–∫–æ–ª–æ–≥–∏—è, –∫–æ–ª–æ–ø—Ä–æ–∫—Ç–æ–ª–æ–≥–∏—è, –ª–∞–±–æ—Ä–∞—Ç–æ—Ä–Ω–∞—è –≥–µ–Ω–µ—Ç–∏–∫–∞, –ª–µ—á–µ–±–Ω–∞—è —Ñ–∏–∑–∫—É–ª—å—Ç—É—Ä–∞ –∏ —Å–ø–æ—Ä—Ç–∏–≤–Ω–∞—è –º–µ–¥–∏—Ü–∏–Ω–∞, –º–∞–Ω—É–∞–ª—å–Ω–∞—è —Ç–µ—Ä–∞–ø–∏—è, –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è –º–∏–∫—Ä–æ–±–∏–æ–ª–æ–≥–∏—è, –Ω–µ–≤—Ä–æ–ª–æ–≥–∏—è, –Ω–µ—Ñ—Ä–æ–ª–æ–≥–∏—è, –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∏ –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–µ –∑–¥–æ—Ä–æ–≤—å–µ, –æ—Ç–æ—Ä–∏–Ω–æ–ª–∞—Ä–∏–Ω–≥–æ–ª–æ–≥–∏—è, –æ—Ñ—Ç–∞–ª—å–º–æ–ª–æ–≥–∏—è, –ø–∞—Ç–æ–ª–æ–≥–∏—á–µ—Å–∫–∞—è –∞–Ω–∞—Ç–æ–º–∏—è, –ø–µ–¥–∏–∞—Ç—Ä–∏—è, –ø—Ä–æ—Ñ–ø–∞—Ç–æ–ª–æ–≥–∏—è, –ø—Å–∏—Ö–∏–∞—Ç—Ä–∏—è, –ø—Å–∏—Ö–∏–∞—Ç—Ä–∏—è-–Ω–∞—Ä–∫–æ–ª–æ–≥–∏—è, –ø—Å–∏—Ö–æ—Ç–µ—Ä–∞–ø–∏—è, –ø—É–ª—å–º–æ–Ω–æ–ª–æ–≥–∏—è, —Ä–∞–¥–∏–æ—Ç–µ—Ä–∞–ø–∏—è, —Ä–µ–≤–º–∞—Ç–æ–ª–æ–≥–∏—è, —Ä–µ–Ω—Ç–≥–µ–Ω—ç–Ω–¥–æ–≤–∞—Å–∫—É–ª—è—Ä–Ω—ã–µ –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞ –∏ –ª–µ—á–µ–Ω–∏–µ, —Ä–µ—Ñ–ª–µ–∫—Å–æ—Ç–µ—Ä–∞–ø–∏—è, —Å—É—Ä–¥–æ–ª–æ–≥–∏—è-–æ—Ç–æ—Ä–∏–Ω–æ–ª–∞—Ä–∏–Ω–≥–æ–ª–æ–≥–∏—è, —Å—É–¥–µ–±–Ω–æ-–º–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è —ç–∫—Å–ø–µ—Ä—Ç–∏–∑–∞, —Å—É–¥–µ–±–Ω–æ-–ø—Å–∏—Ö–∏–∞—Ç—Ä–∏—á–µ—Å–∫–∞—è —ç–∫—Å–ø–µ—Ä—Ç–∏–∑–∞, —Ç–æ–∫—Å–∏–∫–æ–ª–æ–≥–∏—è, —Ç—Ä–∞–≤–º–∞—Ç–æ–ª–æ–≥–∏—è –∏ –æ—Ä—Ç–æ–ø–µ–¥–∏—è, —Ç—Ä–∞–Ω—Å—Ñ—É–∑–∏–æ–ª–æ–≥–∏—è, —É–ª—å—Ç—Ä–∞–∑–≤—É–∫–æ–≤–∞—è –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞, —É—Ä–æ–ª–æ–≥–∏—è, —Ñ–∏–∑–∏—á–µ—Å–∫–∞—è –∏ —Ä–µ–∞–±–∏–ª–∏—Ç–∞—Ü–∏–æ–Ω–Ω–∞—è –º–µ–¥–∏—Ü–∏–Ω–∞, —Ñ—Ç–∏–∑–∏–∞—Ç—Ä–∏—è, —Ñ—É–Ω–∫—Ü–∏–æ–Ω–∞–ª—å–Ω–∞—è –¥–∏–∞–≥–Ω–æ—Å—Ç–∏–∫–∞, —Ö–∏—Ä—É—Ä–≥–∏—è, —á–µ–ª—é—Å—Ç–Ω–æ-–ª–∏—Ü–µ–≤–∞—è —Ö–∏—Ä—É—Ä–≥–∏—è, —ç–Ω–¥–æ–∫—Ä–∏–Ω–æ–ª–æ–≥–∏—è, —ç–Ω–¥–æ—Å–∫–æ–ø–∏—è, —ç–ø–∏–¥–µ–º–∏–æ–ª–æ–≥–∏—è. –ü–æ–ª—Ç–æ—Ä–∞ –≥–æ–¥–∞ (20 —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–µ–π) ‚Äî –≥–µ–Ω–µ—Ç–∏–∫–∞, –≥–∏–≥–∏–µ–Ω–∞ –¥–µ—Ç–µ–π –∏ –ø–æ–¥—Ä–æ—Å—Ç–∫–æ–≤, –¥–µ—Ä–º–∞—Ç–æ–≤–µ–Ω–µ—Ä–æ–ª–æ–≥–∏—è, –¥–µ–∑–∏–Ω—Ñ–µ–∫—Ç–æ–ª–æ–≥–∏—è, –¥–∏–∞–±–µ—Ç–æ–ª–æ–≥–∏—è, –∫–æ—Å–º–µ—Ç–æ–ª–æ–≥–∏—è, –æ–±—â–∞—è –≤—Ä–∞—á–µ–±–Ω–∞—è –ø—Ä–∞–∫—Ç–∏–∫–∞ (—Å–µ–º–µ–π–Ω–∞—è –º–µ–¥–∏—Ü–∏–Ω–∞), –æ—Ä—Ç–æ–¥–æ–Ω—Ç–∏—è, –æ—Å—Ç–µ–æ–ø–∞—Ç–∏—è, –ø–∞—Ä–∞–∑–∏—Ç–æ–ª–æ–≥–∏—è, —Ä–∞–¥–∏–æ–ª–æ–≥–∏—è, —Ä–µ–Ω—Ç–≥–µ–Ω–æ–ª–æ–≥–∏—è, —Å–µ–∫—Å–æ–ª–æ–≥–∏—è, —Å–∫–æ—Ä–∞—è –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è –ø–æ–º–æ—â—å, —Å—Ç–æ–º–∞—Ç–æ–ª–æ–≥–∏—è –¥–µ—Ç—Å–∫–∞—è, —Å—Ç–æ–º–∞—Ç–æ–ª–æ–≥–∏—è –æ–±—â–µ–π –ø—Ä–∞–∫—Ç–∏–∫–∏, —Å—Ç–æ–º–∞—Ç–æ–ª–æ–≥–∏—è –æ—Ä—Ç–æ–ø–µ–¥–∏—á–µ—Å–∫–∞—è, —Å—Ç–æ–º–∞—Ç–æ–ª–æ–≥–∏—è —Ç–µ—Ä–∞–ø–µ–≤—Ç–∏—á–µ—Å–∫–∞—è, —Å—Ç–æ–º–∞—Ç–æ–ª–æ–≥–∏—è —Ö–∏—Ä—É—Ä–≥–∏—á–µ—Å–∫–∞—è, —Ñ–∏–∑–∏–æ—Ç–µ—Ä–∞–ø–∏—è. –ö—Ä–æ–º–µ —Ç–æ–≥–æ, –ø–æ—Å–ª–µ –æ—Ä–¥–∏–Ω–∞—Ç—É—Ä—ã —Å–æ–∫—Ä–∞—â—ë–Ω–Ω—ã–π —Å—Ä–æ–∫ –æ—Ç—Ä–∞–±–æ—Ç–∫–∏ —Ç–∞–∫–∂–µ –±—É–¥—É—Ç –∏–º–µ—Ç—å —Ç–µ, –∫—Ç–æ –æ—Ç–ø—Ä–∞–≤–∏–ª—Å—è —Ä–∞–±–æ—Ç–∞—Ç—å –≤ –º–∞–ª—ã–µ –Ω–∞—Å–µ–ª—ë–Ω–Ω—ã–µ –ø—É–Ω–∫—Ç—ã –∏ –º–µ–¥—É—á—Ä–µ–∂–¥–µ–Ω–∏—è –ó–∞–ø–æ—Ä–æ–∂—Å–∫–æ–π –∏ –•–µ—Ä—Å–æ–Ω—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–µ–π, –õ–ù–† –∏–ª–∏ –î–ù–†: –ü–æ–ª—Ç–æ—Ä–∞ –≥–æ–¥–∞ ‚Äî –¥–µ—Ç—Å–∫–∞—è —Ö–∏—Ä—É—Ä–≥–∏—è, –Ω–µ–æ–Ω–∞—Ç–æ–ª–æ–≥–∏—è, –æ–Ω–∫–æ–ª–æ–≥–∏—è, –æ—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –∏ –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ–µ –∑–¥–æ—Ä–æ–≤—å–µ, –ø–ª–∞—Å—Ç–∏—á–µ—Å–∫–∞—è —Ö–∏—Ä—É—Ä–≥–∏—è, —Å–µ—Ä–¥–µ—á–Ω–æ-—Å–æ—Å—É–¥–∏—Å—Ç–∞—è —Ö–∏—Ä—É—Ä–≥–∏—è, —Ç–µ—Ä–∞–ø–∏—è, —Ç–æ—Ä–∞–∫–∞–ª—å–Ω–∞—è —Ö–∏—Ä—É—Ä–≥–∏—è. –û–¥–∏–Ω –≥–æ–¥ ‚Äî –≤—Å–µ –æ—Å—Ç–∞–ª—å–Ω—ã–µ —Å–ø–µ—Ü–∏–∞–ª—å–Ω–æ—Å—Ç–∏. –î–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ —Å—Ç–æ–∏—Ç –æ—Ç–º–µ—Ç–∏—Ç—å, —á—Ç–æ —Ç—Ä–æ–µ–∫—Ä–∞—Ç–Ω—ã–µ —à—Ç—Ä–∞—Ñ—ã –≤ —Å–ª—É—á–∞–µ –æ—Ç–∫–∞–∑–∞ –æ—Ç—Ä–∞–±–∞—Ç—ã–≤–∞—Ç—å –±—É–¥—É—Ç —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω—è—Ç—å—Å—è —Ç–æ–ª—å–∫–æ –Ω–∞ ¬´—Ü–µ–ª–µ–≤–∏–∫–æ–≤¬ª, –∑–∞–∫–ª—é—á–∏–≤—à–∏—Ö —Å–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–∏–µ –¥–æ–≥–æ–≤–æ—Ä—ã, —Å 1-–≥–æ –º–∞—Ä—Ç–∞ 2026-–≥–æ –≥–æ–¥–∞. –ù–∞ —Å—Ç—É–¥–µ–Ω—Ç–æ–≤ –∏ –æ—Ä–¥–∏–Ω–∞—Ç–æ—Ä–æ–≤ –∫–æ–º–º–µ—Ä—á–µ—Å–∫–æ–π –æ—Å–Ω–æ–≤—ã —à—Ç—Ä–∞—Ñ—ã —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω—è—Ç—å—Å—è –Ω–µ –±—É–¥—É—Ç, –æ–¥–Ω–∞–∫–æ –∑–∞ –Ω–∏–º–∏ —Å–æ—Ö—Ä–∞–Ω—è–µ—Ç—Å—è –æ–±—è–∑–∞–Ω–Ω–æ—Å—Ç—å –æ—Ç—Ä–∞–±–æ—Ç–∞—Ç—å. –ï—Å–ª–∏ –≤—ã —Ö–æ—Ç–∏—Ç–µ –ø–æ–¥–µ–ª–∏—Ç—å—Å—è —Å–≤–æ–µ–π –Ω–æ–≤–æ—Å—Ç—å—é —Å –Ω–∞—à–µ–π —Ä–µ–¥–∞–∫—Ü–∏–µ–π ‚û°Ô∏è @mediamedics_bot","{""skip"": true}"
2025-10-12T17:46:03+00:00,@rus_med,7660,https://t.me/rus_med/7660,–°–æ–≤—Ä–µ–º–µ–Ω–Ω–∞—è –º–µ–¥–∏—Ü–∏–Ω–∞ –≤ –æ–¥–Ω–æ–º —Ä–æ–ª–∏–∫–µ üôà,"{""skip"": true}"
2025-10-08T12:25:06+00:00,@rus_med,7658,https://t.me/rus_med/7658,"üë®üèª‚Äç‚öñÔ∏è–ù—É, —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ, –Ω–∏–∫—Ç–æ –∏ –Ω–µ —Å–æ–º–Ω–µ–≤–∞–ª—Å—è, —á—Ç–æ –∑–∞–∫–æ–Ω–æ–ø—Ä–æ–µ–∫—Ç –ø—Ä–∏–º—É—Ç. –ö–∞–∫ —á—Ç–æ-–Ω–∏–±—É–¥—å —Ö–æ—Ä–æ—à–µ–µ —Ä–µ—à–∞—Ç—å, —Ç–∞–∫ —ç—Ç–æ –Ω–µ—Å–∫–æ–ª—å–∫–æ –∑–∞—Å–µ–¥–∞–Ω–∏–π –º—É—Å–æ–ª–∏—Ç—Å—è, –∞ –∫–∞–∫ —Å–ø–æ—Ä–Ω—ã–µ ¬´–ø—Ä–æ–∂–≠–∫—Ç—ã¬ª, —Ç–∞–∫ —ç—Ç–æ –æ–Ω–∏ —Å—Ä–∞–∑—É, —á—É—Ç—å –ª–∏ –Ω–µ –µ–¥–∏–Ω–æ–≥–ª–∞—Å–Ω–æ üßê –ò–Ω—Ç–µ—Ä–µ—Å–Ω–æ, –∫–∞–∫ –≤–æ—Å–ø—Ä–∏–º–µ—Ç —Å–∏–µ –Ω–æ–≤—à–µ—Å—Ç–≤–æ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∞—è –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–æ—Å—Ç—å?","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""regulation, clinical_trial"",
  ""impact"": ""medium"",
  ""english"": ""It is unclear how the medical community will receive this new development. The project has been debated for several meetings, and controversial 'projects' are often adopted unanimously.""
}"
2025-10-06T10:04:15+00:00,@rus_med,7657,https://t.me/rus_med/7657,"–ü–æ–∑–¥—Ä–∞–≤–ª—è–µ–º —Å –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—ã–º –ø—Ä–∞–∑–¥–Ω–∏–∫–æ–º –≤—Å–µ—Ö –∫–æ–ª–ª–µ–≥! –ñ–µ–ª–∞–µ–º –≤—Å–µ–º —É—Å–ø–µ—Ö–æ–≤ –≤ –Ω–∞—à–µ–º –Ω–µ–ª–µ–≥–∫–æ–º —Ç—Ä—É–¥–µ, –±–ª–∞–≥–æ–ø—Ä–∏—è—Ç–Ω—ã—Ö –∏—Å—Ö–æ–¥–æ–≤ –∏ —Å–ø–æ–∫–æ–π–Ω—ã—Ö –¥–µ–∂—É—Ä—Å—Ç–≤! –¢–µ—Ä–ø–µ–Ω–∏—è, —Ñ–∏–Ω–∞–Ω—Å–æ–≤–æ–≥–æ –±–ª–∞–≥–æ–ø–æ–ª—É—á–∏—è, –ø—Ä–∏–∑–Ω–∞–Ω–∏—è –∏ –ø—Ä–æ—Å—Ç–æ –ª–µ–≥–∫–æ—Å—Ç–∏!","{""skip"": true}"
2025-10-06T09:59:18+00:00,@rus_med,7656,https://t.me/rus_med/7656,"üèÖ –ù–æ–±–µ–ª–µ–≤—Å–∫—É—é –ø—Ä–µ–º–∏—é –ø–æ –º–µ–¥–∏—Ü–∏–Ω–µ –ø—Ä–∏—Å—É–¥–∏–ª–∏ –∑–∞ –ø—Ä–æ—Ä—ã–≤ –æ–±–ª–∞—Å—Ç–∏ –∏–º–º—É–Ω–∏—Ç–µ—Ç–∞. –ê–º–µ—Ä–∏–∫–∞–Ω—Å–∫–∏–µ —É—á—ë–Ω—ã–µ –ú—ç—Ä–∏ –ë—Ä—É–Ω–∫–æ—É, –§—Ä–µ–¥ –†–∞–º—Å–¥–µ–ª–ª –∏ —è–ø–æ–Ω–µ—Ü –®–∏–º–æ–Ω –°–∞–∫–∞–≥—É—á–∏ –ø–æ–ª—É—á–∏–ª–∏ –ø—Ä–µ—Å—Ç–∏–∂–Ω—É—é –Ω–∞–≥—Ä–∞–¥—É –∑–∞ –æ—Ç–∫—Ä—ã—Ç–∏—è, –∫–∞—Å–∞—é—â–∏–µ—Å—è –ø–µ—Ä–∏—Ñ–µ—Ä–∏—á–µ—Å–∫–æ–π –∏–º–º—É–Ω–Ω–æ–π —Å–∏—Å—Ç–µ–º—ã. –í —á–∞—Å—Ç–Ω–æ—Å—Ç–∏, –≤ –∏—Ö –∏—Å—Å–ª–µ–¥–æ–≤–∞–Ω–∏–∏ –≥–æ–≤–æ—Ä–∏—Ç—Å—è, —á—Ç–æ –∏–º–º—É–Ω–∏—Ç–µ—Ç –¥–æ–ª–∂–µ–Ω –±—ã—Ç—å –ø–æ–¥ –∫–æ–Ω—Ç—Ä–æ–ª–µ–º, –∏–Ω–∞—á–µ –æ–Ω –Ω–∞—á–Ω—ë—Ç –∞—Ç–∞–∫–æ–≤–∞—Ç—å –æ—Ä–≥–∞–Ω—ã ü´∂ –ü–æ–¥–ø–∏—à–∏—Å—å –Ω–∞ –õ–µ–Ω—Ç—É –¥–Ω—è: MAX | –¢–ì üéÅ –£—á–∞—Å—Ç–≤—É–π –≤ —Ä–æ–∑—ã–≥—Ä—ã—à–µ","{""skip"": true}"
2025-10-05T19:29:31+00:00,@rus_med,7655,https://t.me/rus_med/7655,‚õìÔ∏è‚Äçüí•–ù–∞—à–∞ –ª—é–±–∏–º–∞—è —Ç–µ–º–∞) –î–∞–≤–Ω–æ –º—ã –Ω–µ –≤–∏–¥–µ–ª–∏ –Ω–æ–≤–æ—Å—Ç–∏ –ø—Ä–æ –ø–æ—Å–∞–¥–∫–∏ –º–∏–Ω–∏—Å—Ç—Ä–æ–≤ (—ç–∫—Å-–º–∏–Ω–∏—Å—Ç—Ä–æ–≤). üôà –ë–æ–ª—å—à–µ –≤—Å–µ–≥–æ –º–µ–Ω—è –ø–æ—Ä–∞–∂–∞–µ—Ç —É—Ä–æ–≤–µ–Ω—å –∫–æ—Ä—Ä—É–ø—Ü–∏–∏! –¶–∏—Ñ—Ä—ã –ø—Ä–æ—Å—Ç–æ —Ä–∞—Å—Ç—É—Ç –æ—Ç –º–∏–Ω–∏—Å—Ç—Ä–∞ –∫ –º–∏–Ω–∏—Å—Ç—Ä—É‚Ä¶,"{""skip"": true}"
2025-09-20T10:17:13+00:00,@rus_med,7654,https://t.me/rus_med/7654,"‚õîÔ∏è–û—Ä–≥–∞–Ω–∏–∑–∞—Ü–∏—è –û–±—ä–µ–¥–∏–Ω—ë–Ω–Ω—ã—Ö –ù–∞—Ü–∏–π –ø–ª–∞–Ω–∏—Ä—É–µ—Ç –∫ –∫–æ–Ω—Ü—É 2026 –≥–æ–¥–∞ –Ω–∞ —Ñ–æ–Ω–µ —Å–æ–∫—Ä–∞—â–µ–Ω–∏—è –ø–æ–º–æ—â–∏ –°–®–ê –∑–∞–∫—Ä—ã—Ç—å –ø—Ä–æ–≥—Ä–∞–º–º—É –ø–æ –í–ò–ß/–°–ü–ò–î (UNAIDS), —Å–ª–µ–¥—É–µ—Ç –∏–∑ –æ—Ç—á—ë—Ç–∞ –≥–µ–Ω–µ—Ä–∞–ª—å–Ω–æ–≥–æ —Å–µ–∫—Ä–µ—Ç–∞—Ä—è –û–û–ù –ê–Ω—Ç–æ–Ω–∏—É –ì—É—Ç–µ—Ä—Ä–∏—à–∞.","{""skip"": true}"
2025-09-19T16:39:09+00:00,@rus_med,7653,https://t.me/rus_med/7653,"‚õîÔ∏èüçå –ü—Ä–µ–∑–µ—Ä–≤–∞—Ç–∏–≤—ã –º–æ–≥—É—Ç –∑–∞–ø—Ä–µ—Ç–∏—Ç—å –≤ –†–æ—Å—Å–∏–∏ –¥–ª—è —Å—É–ø—Ä—É–∂–µ—Å–∫–∏—Ö –ø–∞—Ä –¥–ª—è –ø–æ–≤—ã—à–µ–Ω–∏—è —Ä–æ–∂–¥–∞–µ–º–æ—Å—Ç–∏. –ï—Å–ª–∏ –æ–≥—Ä–∞–Ω–∏—á–∏—Ç—å –¥–æ—Å—Ç—É–ø –∫ –ª—é–±—ã–º —Å—Ä–µ–¥—Å—Ç–≤–∞–º –∫–æ–Ω—Ç—Ä–∞—Ü–µ–ø—Ü–∏–∏, —Å—Ä–µ–¥–Ω–µ–µ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –¥–µ—Ç–µ–π –Ω–∞ —Å–µ–º—å—é –≤—ã—Ä–∞—Å—Ç–µ—Ç –¥–æ —Ç—Ä—ë—Ö, —Å—á–∏—Ç–∞—é—Ç –æ–±—â–µ—Å—Ç–≤–µ–Ω–Ω–∏–∫–∏.","{""skip"": true}"
2025-09-16T06:01:33+00:00,@rus_med,7652,https://t.me/rus_med/7652,"ü¶†üò∑ –≠–ø–∏–¥–µ–º–∏—è –û–†–í–ò —Å–∫–æ—Ä–æ –Ω–∞—á–Ω—ë—Ç—Å—è –≤ –†–æ—Å—Å–∏–∏ –ó–∞ –Ω–µ–¥–µ–ª—é —á–∏—Å–ª–æ –∑–∞–±–æ–ª–µ–≤—à–∏—Ö –≤–∑–ª–µ—Ç–µ–ª–æ —Å—Ä–∞–∑—É –Ω–∞ 63%. –ê —Å—Ä–µ–¥–∏ —à–∫–æ–ª—å–Ω–∏–∫–æ–≤ –æ—Ç–º–µ—á–µ–Ω –¥–≤—É–∫—Ä–∞—Ç–Ω—ã–π —Ä–æ—Å—Ç, –∑–∞—è–≤–∏–ª–∏ –≤ –†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä.","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""epidemic"",
  ""impact"": ""high"",
  ""english"": ""There has been a sudden increase in the number of patients with respiratory infections by 63% over one week, according to Rospatentnadzor. The number of patients among schoolchildren has doubled.""
}"
2025-09-15T19:18:32+00:00,@rus_med,7651,https://t.me/rus_med/7651,"üìÆ–ñ–¥—ë–º –≤–∞—à–∏—Ö –ø–∏—Å–µ–º, –∂–∞–ª–æ–± –∏ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏–π: rus_med@protonmail.com –ü–æ–ª—å–∑—É–π—Ç–µ—Å—å VPN!!!","{""skip"": true}"
2025-09-10T07:06:20+00:00,@rus_med,7650,https://t.me/rus_med/7650,"üíäüìà –°–ø—Ä–æ—Å –Ω–∞ –∞–Ω—Ç–∏–¥–µ–ø—Ä–µ—Å—Å–∞–Ω—Ç—ã –≤ –†–æ—Å—Å–∏–∏ –ø–æ–¥—Å–∫–æ—á–∏–ª –ø–æ—á—Ç–∏ –Ω–∞ 40% –°–ø—Ä–æ—Å –Ω–∞—á–∞–ª —Ä–µ–∑–∫–æ —Ä–∞—Å—Ç–∏ –≤ –∏—é–ª–µ, –æ—Å–æ–±–µ–Ω–Ω–æ –≤ –ú–æ—Å–∫–≤–µ –∏ –ü–µ—Ç–µ—Ä–±—É—Ä–≥–µ. –ù–∞ —Ç–∞–∫–∏–µ –ø—Ä–µ–ø–∞—Ä–∞—Ç—ã –ª—é–¥–∏ –ø–æ—Ç—Ä–∞—Ç–∏–ª–∏ —É–∂–µ 10,6 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π. –ü—Ä–∏–º–µ—Ä–Ω–æ –≤ —Ç–æ –∂–µ –≤—Ä–µ–º—è –ª—é–¥–∏ —Å—Ç–∞–ª–∏ —Ö–æ–¥–∏—Ç—å –∫ –ø—Å–∏—Ö–æ–ª–æ–≥–∞–º. –õ—é–¥–∏ –∂–∞–ª—É—é—Ç—Å—è –Ω–∞ –ø–ª–æ—Ö–æ–µ –Ω–∞—Å—Ç—Ä–æ–µ–Ω–∏–µ, –∞–ø–∞—Ç–∏—é –∏ —Ç—Ä–µ–≤–æ–∂–Ω–æ—Å—Ç—å. –ü—Ä–∏—á–∏–Ω–æ–π —ç–∫—Å–ø–µ—Ä—Ç—ã –Ω–∞–∑—ã–≤–∞—é—Ç –æ—Å–µ–Ω–Ω—é—é —Ö–∞–Ω–¥—Ä—É. –ü—Ä–∞–≤–¥–∞ —è –Ω–µ –æ—á–µ–Ω—å –ø–æ–Ω–∏–º–∞—é, –≥–¥–µ –æ–Ω–∏ ¬´–æ—Å–µ–Ω–Ω—é—é —Ö–∞–Ω–¥—Ä—É¬ª –Ω–∞—à–ª–∏? –°—Ç–æ–∏—Ç —á—É–¥–µ—Å–Ω–∞—è, —Å–æ–ª–Ω–µ—á–Ω–∞—è –ø–æ–≥–æ–¥–∞ ‚òÄÔ∏è","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""demand, clinical_trial"",
  ""impact"": ""high"",
  ""english"": ""There has been a significant increase in demand for antidepressants in Russia, with spending on such medications already totaling 10.6 billion rubles. The rise in demand began in July, particularly in Moscow and St. Petersburg. People are seeking these medications due to autumn depression. However, the source of this seasonal depression is unclear.""
}"
2025-08-11T13:44:03+00:00,@rus_med,7648,https://t.me/rus_med/7648,"‚ö°Ô∏èüë©üèª‚Äç‚öñÔ∏è –ú–æ—Å–æ–±–ª—Å—É–¥ –≤—ã–Ω–µ—Å –ø—Ä–∏–≥–æ–≤–æ—Ä –∫–∞–ª–∏–Ω–∏–Ω–≥—Ä–∞–¥—Å–∫–∏–º –≤—Ä–∞—á–∞–º –≠–ª–∏–Ω–µ –°—É—à–∫–µ–≤–∏—á –∏ –ï–ª–µ–Ω–µ –ë–µ–ª–æ–π –ø–æ –¥–µ–ª—É –æ–± —É–±–∏–π—Å—Ç–≤–µ –Ω–æ–≤–æ—Ä–æ–∂–¥–µ–Ω–Ω–æ–≥–æ —Ä–µ–±–µ–Ω–∫–∞ –ù–∞ –º–æ–π –≤–∑–≥–ª—è–¥, –¥–µ–ª–æ –°—É—à–∫–µ–≤–∏—á –∏ –ë–µ–ª–æ–π –æ–¥–Ω–æ –∏–∑ —Å–∞–º—ã—Ö ¬´–¥–æ–ª–≥–∏—Ö¬ª, –∏–∑–≤–µ—Å—Ç–Ω—ã—Ö –∏ –º—É—Ç–Ω—ã—Ö. –†–∞–∑–±–∏—Ä–∞—Ç–µ–ª—å—Å—Ç–≤–æ —Ç—è–Ω–µ—Ç—Å—è —Å 2018-–≥–æ, –ø—Ä–∏–≥–æ–≤–æ—Ä—ã –∫–∞–ª–∏–Ω–∏–Ω–≥—Ä–∞–¥—Å–∫–∏–º –≤—Ä–∞—á–∞–º –Ω–µ–æ–¥–Ω–æ–∫—Ä–∞—Ç–Ω–æ –æ—Ç–º–µ–Ω—è–ª–∏, –∞ –º–∞—Ç–µ—Ä–∏–∞–ª—ã –æ—Ç–ø—Ä–∞–≤–ª—è–ª–∏ –Ω–∞ –ø–µ—Ä–µ—Å–º–æ—Ç—Ä. –≠–∫—Å–ø–µ—Ä—Ç—ã –æ—Ç–º–µ—á–∞–ª–∏, —á—Ç–æ –≥–ª–∞–≤–Ω—ã–µ —É–ª–∏–∫–∏ –ø–æ –¥–µ–ª—É - –ø—É—Å—Ç—É—é –∞–º–ø—É–ª—É –æ—Ç —Å—É–ª—å—Ñ–∞—Ç–∞ –º–∞–≥–Ω–∏—è –∏ —à–ø—Ä–∏—Ü - —Ç–∞–∫ –∏ –Ω–µ –Ω–∞—à–ª–∏, –∞ —Ä–µ–∑—É–ª—å—Ç–∞—Ç—ã —Å—É–¥–µ–±–Ω–æ-–º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π —ç–∫—Å–ø–µ—Ä—Ç–∏–∑—ã –æ–∫–∞–∑–∞–ª–∏—Å—å –≤–µ—Å—å–º–∞ —Å–æ–º–Ω–∏—Ç–µ–ª—å–Ω—ã–º–∏. –í–æ–æ–±—â–µ —Å–æ–∑–¥–∞–µ—Ç—Å—è –≤–ø–µ—á–∞—Ç–ª–µ–Ω–∏–µ, —á—Ç–æ –≤—Å—è —ç–∫—Å–ø–µ—Ä—Ç–∏–∑–∞ - —ç—Ç–æ –∫–æ–Ω–∫—Ä–µ—Ç–Ω—ã–π –∑–∞–∫–∞–∑... –ë–µ–ª–æ–π –Ω–∞–∑–Ω–∞—á–∏–ª–∏ 9 —Å –ø–æ–ª–æ–≤–∏–Ω–æ–π –ª–µ—Ç –ª–∏—à–µ–Ω–∏—è —Å–≤–æ–±–æ–¥—ã, —Å –ª–∏—à–µ–Ω–∏–µ–º –∑–∞–Ω–∏–º–∞—Ç—å—Å—è –≤—Ä–∞—á–µ–±–Ω–æ–π –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç—å—é –Ω–∞ 3 –≥–æ–¥–∞. –°—É—à–∫–µ–≤–∏—á –Ω–∞–∑–Ω–∞—á–∏–ª–∏ —Ç–∞–∫–∂–µ 9 –ª–µ—Ç –∫–æ–ª–æ–Ω–∏–∏ –æ–±—â–µ–≥–æ —Ä–µ–∂–∏–º–∞ —Å –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏–µ–º —Å–≤–æ–±–æ–¥—ã –Ω–∞ 1 –≥–æ–¥ –∏ 6 –º–µ—Å—è—Ü–µ–≤. –¢–∞–∫–∂–µ —Å—É–¥ –≤–∑—ã—Å–∫–∞–ª –ø–æ –≥—Ä–∞–∂–¥–∞–Ω—Å–∫–æ–º—É –∏—Å–∫—É —Å –≤—Ä–∞—á–µ–π –ø–æ –º–∏–ª–ª–∏–æ–Ω—É —Ä—É–±–ª–µ–π –≤ –ø–æ–ª—å–∑—É –ø–æ—Ç–µ—Ä–ø–µ–≤—à–µ–π. –ß–µ—Å—Ç–Ω–æ –≥–æ–≤–æ—Ä—è, —á–µ–º –±–æ–ª—å—à–µ —Ç—è–Ω–µ—Ç—Å—è —ç—Ç–∞ –∏—Å—Ç–æ—Ä–∏—è, —Ç–µ–º –±–æ–ª–µ–µ –ø—Ä–æ—Ç–∏–≤–Ω–æ —Å—Ç–∞–Ω–æ–≤–∏—Ç—Å—è —Ä–∞–±–æ—Ç–∞—Ç—å –≤ —ç—Ç–æ–π —Å–∏—Å—Ç–µ–º–µ‚Ä¶ –ú—ã, –≤—Ä–∞—á–∏, –Ω–∏–∫–∞–∫ –Ω–µ –∑–∞—â–∏—â–µ–Ω—ã, –∏ –Ω–∏–∫–∞–∫–æ–µ ¬´–º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–µ –±—Ä–∞—Ç—Å—Ç–≤–æ¬ª, –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—ã–µ —Å–æ–æ–±—â–µ—Å—Ç–≤–∞ –∏ –ø–æ–∫—Ä–æ–≤–∏—Ç–µ–ª—å—Å—Ç–≤–æ –∏–º–µ–Ω–∏—Ç—ã—Ö –∞–∫–∞–¥–µ–º–∏–∫–æ–≤, –Ω–µ –¥–æ–±–∞–≤–ª—è—é—Ç –Ω–∞–º –Ω–∏–∫–∞–∫–∏—Ö –Ω–∞–¥–µ–∂–¥. –ï—Å–ª–∏ —Ç–∞–∫ –∏ –¥–∞–ª—å—à–µ –ø–æ–π–¥–µ—Ç, –ª–µ—á–∏—Ç—å –Ω–∞—Å –≤ –±—É–¥—É—â–µ–º –±—É–¥–µ—Ç –ø—Ä–æ—Å—Ç–æ –Ω–µ–∫–æ–º—É‚Ä¶ –ü.–°. –≠–ª–∏–Ω–∞ –°—É—à–∫–µ–≤–∏—á —Å–∏–ª—å–Ω–µ–π—à–∏–π –∏ –≥—Ä–∞–º–æ—Ç–Ω—ã–π —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç –≤ –Ω–µ–æ–Ω–∞—Ç–∞–ª–æ–≥–∏–∏, —Å–ø–∞—Å—à–∏–π –æ–≥—Ä–æ–º–Ω–æ–µ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ –º–∞–ª–µ–Ω—å–∫–∏—Ö –∂–∏–∑–Ω–µ–π, –ø–æ–¥–∞—Ä–∏–≤—à–∏—Ö –Ω–∞–¥–µ–∂–¥—É –∏ —Ä–∞–¥–æ—Å—Ç—å —Ç—ã—Å—è—á–∞–º –ª—é–¥–µ–π! –ó–∞–¥—É–º–∞–π—Ç–µ—Å—å, —Å–∫–æ–ª—å–∫–∏–º –æ–Ω–∞ –º–æ–≥–ª–∞ –±—ã –ø–æ–º–æ—á—å –∑–∞ –≥–æ–¥—ã —ç—Ç–∏—Ö —Ç—è–∂–±? –í–µ—Ä–Ω–µ—Ç—Å—è –ª–∏ –æ–Ω–∞ –≤ –º–µ–¥–∏—Ü–∏–Ω—É, –∫–æ–≥–¥–∞ –≤—Å—è —ç—Ç–∞ –∏—Å—Ç–æ—Ä–∏—è –∑–∞–∫–æ–Ω—á–∏—Ç—Å—è‚Ä¶ –Ω–µ –¥—É–º–∞—é‚Ä¶ ü§î","{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""clinical_trial, guideline, pharmacovigilance, safety"",
  ""impact"": ""high"",
  ""english"": ""The Moscow Obl Court has sentenced Drs. Elina Sushk–µ–≤–∏—á and Elena Bela to prison terms for the death of a newborn in 2018. The case has been repeatedly overturned and remanded for review, with doubts raised over the main evidence (empty ampoule of magnesium sulfate and syringe) and forensic results. The judge sentenced Sushk–µ–≤–∏—á to 9 years in prison with a restriction on working as a doctor for one year and six months, and Bela to 9 years in prison. The doctors were also ordered to pay a million rubles in damages to the victim's family. The case has created an impression of undue pressure on doctors and a lack of protection for them, which could affect future medical care. Sushk–µ–≤–∏—á is described as a strong and skilled specialist in neonatology who has saved many lives.""
}"
2025-08-08T17:02:59+00:00,@rus_med,7647,https://t.me/rus_med/7647,"üíä –í–µ–¥—É—â–∏–µ Telegram-–∫–∞–Ω–∞–ª—ã, –∫–æ—Ç–æ—Ä—ã–µ –∑–∞–¥–∞—é—Ç –ø–æ–≤–µ—Å—Ç–∫—É –≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π —Å—Ñ–µ—Ä–µ ‚Äî –ò–Æ–õ–¨ 2025. –†–µ–π—Ç–∏–Ω–≥ —Å–æ—Å—Ç–∞–≤–∏–ª –∫–ª—é—á–µ–≤–æ–π –∫–∞–Ω–∞–ª-–∞–≥—Ä–µ–≥–∞—Ç–æ—Ä –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–≤–µ—Å—Ç–∫–∏ –≤ Telegram ‚Äî ¬´–ú—É—Ä–∞—à–∫–æ –ø–æ –∫–æ–∂–µ¬ª (@murashko_med) –Ω–∞ –æ—Å–Ω–æ–≤–µ –¥–∞–Ω–Ω—ã—Ö üìäTGStat.ru –ø—Ä–∏ —ç–∫—Å–ø–µ—Ä—Ç–Ω–æ–π –ø–æ–¥–¥–µ—Ä–∂–∫–µ ¬´–ú–µ–¥–∏–∞—Ç–µ—Ö–Ω–æ–ª–æ–≥–∞¬ª (@mediatech). –ö–∞—á–µ—Å—Ç–≤–µ–Ω–Ω–∞—è –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è –∏ —Ä–∞–∑–Ω—ã–µ —Ç–æ—á–∫–∏ –∑—Ä–µ–Ω–∏—è, —Å–æ–±—Ä–∞–Ω–Ω—ã–µ –≤ –æ–¥–Ω–æ–º –º–µ—Å—Ç–µ: —á–∏—Ç–∞–π—Ç–µ —Ç–µ—Ö, –∫—Ç–æ —Ñ–æ—Ä–º–∏—Ä—É–µ—Ç –Ω–æ–≤–æ—Å—Ç–Ω—É—é –ª–µ–Ω—Ç—É –≤ –∏–Ω–¥—É—Å—Ç—Ä–∏–∏ ‚Äî –∏ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ –ø–æ–¥–ø–∏—Å—ã–≤–∞–π—Ç–µ—Å—å –Ω–∞ –Ω–∞—Å: @murashko_med. –¢–û–ü-25 ‚Äî –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –Ω–æ–≤–æ—Å—Ç–∏, –±–ª–æ–≥–∏ –≤—Ä–∞—á–µ–π –∏ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –∏–∑ —Ä–∞–∑–Ω—ã—Ö —Å—Ñ–µ—Ä: 1. –ë–∞–¥–º–∞ –ë–∞—à–∞–Ω–∫–∞–µ–≤ ‚Äî –ò–¶: 446; 2. –ù–µ–ú–∏–Ω–∑–¥—Ä–∞–≤ ‚Äî –ò–¶: 381; 3. –ò–ú–ú–£–ù–ù–´–ô –û–¢–í–ï–¢ ‚Äî –ò–¶: 363; 4. –ì–æ–ª–æ–¥, —Ö–æ–ª–æ–¥ –∏ –ø–æ–∫–æ–π; 5. –î–º–∏—Ç—Ä–∏–π –•—É–±–µ–∑–æ–≤; 6. –ü–æ—è—Å–Ω–∏ –∑–∞ –º–µ–¥; 7. –°–µ—Ä–≥–µ–π –õ–µ–æ–Ω–æ–≤; 8. Medical –ö—Å—é; 9. –¶–ù–ò–ò–û–ò–ó; 10. –ö–û–ë–Ø–ö–û–í–ê; 11. –û–ª–µ–≥ –°–∞–ª–∞–≥–∞–π; 12. –ö—Ä–æ–∫–æ–¥–∏–ª –Ø—Ç—Ä–æ–ì–µ–Ω–∞; 13. –ò–∫–æ–Ω–∞ –§–∞—Ä–º—ã; 14. –Æ—Ä–∏—Å—Ç –¥–ª—è –≤—Ä–∞—á–∞ –ê–Ω–≥–µ–ª–∏–Ω–∞ –†–æ–º–∞–Ω–æ–≤—Å–∫–∞—è; 15. –ú–∏–Ω–ó–¥—Ä–∞–≤ –î–µ—Ç–∏; 16. –ú–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–π —é—Ä–∏—Å—Ç –ò–≤–∞–Ω –ü–µ—á–µ—Ä–µ–π; 17. –ü—Ä–∞–≤–æ –Ω–∞ –∑–¥–æ—Ä–æ–≤—å–µ; 18. –°–æ–æ–±—â–µ—Å—Ç–≤–æ ¬´–í—Ä–∞—á–∏ –†–§¬ª; 19. –õ–µ–æ–Ω–∏–¥ –û–≥—É–ª—å; 20. –í–ª–∞—Å–æ–≤–∞ –í–µ—Ä–æ–Ω–∏–∫–∞; 21. –ê–π—Ä–∞—Ç –§–∞—Ä—Ä–∞—Ö–æ–≤; 22. –Æ–†–ò–°–¢–´ –ó–ê –í–†–ê–ß–ï–ô; 23. –ú–∏—Ö–∞–∏–ª –ö–∏–∑–µ–µ–≤; 24. –í–∞—Ä–∏–≤–æ–¥–∞ MED&TECH; 25. –ú–µ–¥–¢–µ—Ö –õ–∞–±–æ—Ä–∞—Ç–æ—Ä–∏—è. –ù–µ —Ç–æ–ª—å–∫–æ –æ –º–µ–¥–∏—Ü–∏–Ω–µ, –Ω–æ –≤–∞–∂–Ω–æ –¥–ª—è –≤–Ω–∏–º–∞–Ω–∏—è: 1. REDACTED P6 (–ö–û–¢–Å–õ #6) ‚Äî 890,5–∫; 2. –ú–æ—Å–∫–æ–≤—Å–∫–∞—è –ø—Ä–∞—á–µ—á–Ω–∞—è ‚Äî 625,4–∫; 3. Lomovka ‚Äî 296,4–∫; 4. –ù–û–°; 5. –ë–æ–π–ª–µ—Ä–Ω–∞—è; 6. –ë—É–ª—å–¥–æ–≥–∏ –ø–æ–¥ –∫–æ–≤—Ä–æ–º; 7. –ö—Ä–µ–º–ª—ë–≤—Å–∫–∏–π –º–∞–º–∫–æ–≤–µ–¥; 8. –ü–∞—É–∫–∏ –≤ –±–∞–Ω–∫–µ; 9. –ù–æ–≤–æ—Å—Ç–∏ —Å–µ–≥–æ–¥–Ω—è; 10. –ö–ê–†–ù–ê–£–•–û–í; 11. –î–µ–ø—É—Ç–∞—Ç—Å–∫–∏–µ –±—É–¥–Ω–∏; 12. –ó–æ–Ω–∞ –æ—Å–æ–±–æ–≥–æ –≤–Ω–∏–º–∞–Ω–∏—è; 13. –ú–µ–¥–∏–∞—Ç–µ—Ö–Ω–æ–ª–æ–≥; 14. –ö–†–´–ú–ò–ù–§–û–†–£–ú; 15. –ù–µ—É–¥–∞—â–∞. –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏ ‚Äî —Ä–µ–≥–∏–æ–Ω—ã: 1. –ú–æ—Å–∫–≤–∞ ‚Äî 88,9–∫; 2. –ú–æ—Å–∫–æ–≤—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å ‚Äî 17,8–∫; 3. –†–µ—Å–ø—É–±–ª–∏–∫–∞ –ö–∞–±–∞—Ä–¥–∏–Ω–æ-–ë–∞–ª–∫–∞—Ä–∏—è ‚Äî 11,9–∫; 4. –°–≤–µ—Ä–¥–ª–æ–≤—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å ‚Äî 11,2–∫; 5. –î–æ–Ω–µ—Ü–∫–∞—è –ù–∞—Ä–æ–¥–Ω–∞—è –†–µ—Å–ø—É–±–ª–∏–∫–∞ ‚Äî 10,8–∫; 6. –†–µ—Å–ø—É–±–ª–∏–∫–∞ –î–∞–≥–µ—Å—Ç–∞–Ω; 7. –°–∞–º–∞—Ä—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å; 8. –ü—Ä–∏–º–æ—Ä—Å–∫–∏–π –∫—Ä–∞–π; 9. –°–∞—Ä–∞—Ç–æ–≤—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å. 10. –¢—É–ª—å—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å; –ù–µ –Ω–∞—à–ª–∏ –∫–∞–Ω–∞–ª, –∫–æ—Ç–æ—Ä—ã–π —á–∏—Ç–∞–µ—Ç–µ? –í–æ–ø—Ä–æ—Å—ã –∏ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è ‚Äî –≤ @Murachko_po_epidermis_bot. üöë–ü–æ–¥–ø–∏—Å–∞—Ç—å—Å—è –Ω–∞ ¬´–ú—É—Ä–∞—à–∫–æ –ø–æ –∫–æ–∂–µ¬ª.","{""skip"": true}"
2025-07-21T21:46:13+00:00,@rus_med,7646,https://t.me/rus_med/7646,üß¥üö´–ú–∏—Ä–∞–º–∏—Å—Ç–∏–Ω - –í–°–Å‚Ä¶ –†–∞–±–æ—Ç—É –ø—Ä–æ–∏–∑–≤–æ–¥–∏—Ç–µ–ª—è –∞–Ω—Ç–∏—Å–µ–ø—Ç–∏–∫–æ–≤ ¬´–ú–∏—Ä–∞–º–∏—Å—Ç–∏–Ω¬ª –∏ ¬´–û–∫–æ–º–∏—Å—Ç–∏–Ω¬ª –∑–∞–±–ª–æ–∫–∏—Ä–æ–≤–∞–ª–∏ –Ω–∞ –≤—Å–µ–π —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ –†–æ—Å—Å–∏–∏ –∏–∑-–∑–∞ –Ω–∞–ª–æ–∂–µ–Ω–Ω—ã—Ö —Å—É–¥–æ–º –æ–≥—Ä–∞–Ω–∏—á–µ–Ω–∏–π. –ú–µ—Ä—ã –∑–∞—Ç—Ä–æ–Ω—É–ª–∏ —Ä–∞–±–æ—Ç—É 164 –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏—Ö –ø—Ä–µ–¥—Å—Ç–∞–≤–∏—Ç–µ–ª–µ–π –û–û–û ¬´–ò–Ω—Ñ–∞–º–µ–¥¬ª,"{
  ""skip"": false,
  ""country"": ""Russia"",
  ""topic"": ""sanctions, shortage"",
  ""impact"": ""high"",
  ""english"": ""The production of antiseptics 'Miramistin' and 'Okomistin' by the company 'Miramistin' and 'Okomistin' is blocked across Russia due to court-imposed restrictions. The measures affect the work of 164 medical representatives from 'Infamed' company.""
}"
2025-07-14T16:30:30+00:00,@rus_med,7645,https://t.me/rus_med/7645,"üò≥ –ù–∞ –°–∞—Ö–∞–ª–∏–Ω–µ —Ä–∞–∑–≥–æ—Ä–µ–ª–∏—Å—å –≥–æ—Ä—è—á–∏–µ –¥–∏—Å–∫—É—Å—Å–∏–∏ –ø–æ –ø–æ–≤–æ–¥—É —É–≥–æ–ª–æ–≤–Ω–æ–≥–æ –¥–µ–ª–∞ —Å —É—á–∞—Å—Ç–∏–µ–º –∫–ª–∏–Ω–∏–∫–∏ ¬´–ú–µ–¥—Å–∫–∞–Ω–∞¬ª –ù–æ–≤–æ–µ –∑–¥–∞–Ω–∏–µ –ì–ë–£–ó ¬´–ö–æ–Ω—Å—É–ª—å—Ç–∞—Ç–∏–≤–Ω–æ-–¥–∏–∞–≥–Ω–æ—Å—Ç–∏—á–µ—Å–∫–∏–π —Ü–µ–Ω—Ç—Ä (–ö–î–¶) –Æ–∂–Ω–æ-–°–∞—Ö–∞–ª–∏–Ω—Å–∫–∞¬ª, –∫–æ—Ç–æ—Ä–æ–µ –±—ã–ª–æ –ø–æ—Å—Ç—Ä–æ–µ–Ω–æ –Ω–∞ 3,7 –º–ª—Ä–¥ —Ä—É–±–ª–µ–π –∏–∑ –±—é–¥–∂–µ—Ç–∞ —Ä–µ–≥–∏–æ–Ω–∞, –Ω–µ–∑–∞–∫–æ–Ω–Ω–æ –æ—Ç–¥–∞–ª–∏ –≤ –∞—Ä–µ–Ω–¥—É ¬´–ú–µ–¥—Å–∫–∞–Ω—É¬ª. –°–ª–µ–¥—Å—Ç–≤–µ–Ω–Ω—ã–π –∫–æ–º–∏—Ç–µ—Ç –æ–±–Ω–∞—Ä—É–∂–∏–ª –Ω–∞—Ä—É—à–µ–Ω–∏–µ —Ñ–µ–¥–µ—Ä–∞–ª—å–Ω–æ–≥–æ –∑–∞–∫–æ–Ω–∞ –æ–± –æ—Ü–µ–Ω–æ—á–Ω–æ–π —Å—Ç–æ–∏–º–æ—Å—Ç–∏, –ø–æ—Å–∫–æ–ª—å–∫—É –Ω–µ –±—ã–ª–æ –Ω–∏ —Ç–æ—Ä–≥–æ–≤, –Ω–∏ –Ω–µ–∑–∞–≤–∏—Å–∏–º–æ–π –æ—Ü–µ–Ω–∫–∏ —Å—Ç–æ–∏–º–æ—Å—Ç–∏ –∞—Ä–µ–Ω–¥—ã. –ù–æ —ç—Ç–æ –Ω–µ —Å–∞–º–æ–µ –≥–ª–∞–≤–Ω–æ–µ‚Ä¶ –ü–æ–∫–∞ ¬´–ú–µ–¥—Å–∫–∞–Ω¬ª –æ—Å–≤–∞–∏–≤–∞–ª—Å—è –≤ –Ω–æ–≤–æ–º –∑–¥–∞–Ω–∏–∏, –≤—Ä–∞—á–∏ –ö–î–¶ –±–∏–ª–∏ —Ç—Ä–µ–≤–æ–≥—É: –∏—Ö –æ—Å—Ç–∞–≤–∏–ª–∏ –≤ —Å—Ç–∞—Ä–æ–º –∫–æ—Ä–ø—É—Å–µ, —Å–Ω—è–ª–∏ –∫–≤–æ—Ç—ã –ø–æ –ø—Ä–∏–µ–º—É –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –∏ —É–º–µ–Ω—å—à–∏–ª–∏ –ø–ª–∞–Ω-–∑–∞–¥–∞–Ω–∏–µ, —á—Ç–æ –≤—ã–ª–∏–ª–æ—Å—å –≤ —Å–æ–∫—Ä–∞—â–µ–Ω–∏–µ —Ñ–∏–Ω–∞–Ω—Å–∏—Ä–æ–≤–∞–Ω–∏—è –Ω–∞ 15 –º–ª–Ω —Ä—É–±–ª–µ–π –≤ –≥–æ–¥. –¢–∞–∫–∂–µ –≤—Ä–∞—á–∏ –ö–î–¶ –∂–∞–ª–æ–≤–∞–ª–∏—Å—å –Ω–∞ —Ç–æ, —á—Ç–æ –∏—Ö –∑–∞—Å—Ç–∞–≤–ª—è—é—Ç –ø–∏—Å–∞—Ç—å –∑–∞—è–≤–ª–µ–Ω–∏—è –ø–æ —Å–æ–±—Å—Ç–≤–µ–Ω–Ω–æ–º—É. –ö—Ç–æ-–Ω–∏–±—É–¥—å –º–æ–∂–µ—Ç –º–Ω–µ –æ–±—ä—è—Å–Ω–∏—Ç—å, –∫–∞–∫ –º–æ–∂–Ω–æ —É–≤–æ–ª—å–Ω—è—Ç—å –≤—Ä–∞—á–µ–π –Ω–∞ —Ñ–æ–Ω–µ —á—É–¥–æ–≤–∏—â–Ω–æ–≥–æ –¥–µ—Ñ–∏—Ü–∏—Ç–∞ –∫–∞–¥—Ä–æ–≤?!? –ë–æ–ª—å—à–µ —Ç–æ–≥–æ: –ø–æ–º–µ—â–µ–Ω–∏–µ –∏–∑–Ω–∞—á–∞–ª—å–Ω–æ –∂–¥–∞–ª–∞ –≤–æ–æ–±—â–µ –¥—Ä—É–≥–∞—è —Å—É–¥—å–±–∞ - —Ç—É–¥–∞ –¥–æ–ª–∂–Ω–∞ –±—ã–ª–∞ –ø–µ—Ä–µ–µ—Ö–∞—Ç—å –ì–æ—Ä–æ–¥—Å–∫–∞—è –ø–æ–ª–∏–∫–ª–∏–Ω–∏–∫–∞ ‚Ññ1, –∑–¥–∞–Ω–∏–µ –∫–æ—Ç–æ—Ä–æ–π –±—ã–ª–æ –ø—Ä–∏–∑–Ω–∞–Ω–æ –∞–≤–∞—Ä–∏–π–Ω—ã–º. ¬´–ú–µ–¥—Å–∫–∞–Ω¬ª –≤ –∏—Ç–æ–≥–µ –Ω–µ —Å–º–æ–≥ —Å–ø—Ä–∞–≤–∏—Ç—å—Å—è —Å –±–æ–ª—å—à–∏–º –ø–æ—Ç–æ–∫–æ–º –ª—å–≥–æ—Ç–Ω—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤, –∫–æ–º–ø–∞–Ω–∏—è –≤ –ø—Ä–∏–Ω—Ü–∏–ø–µ –Ω–µ –ø–ª–∞–Ω–∏—Ä–æ–≤–∞–ª–∞ –∏—Ö –æ–±—Å–ª—É–∂–∏–≤–∞—Ç—å. –ê —á—Ç–æ –≤—ã –ø–ª–∞–Ω–∏—Ä–æ–≤–∞–ª–∏ –¥–µ–ª–∞—Ç—å?! –í –∏—Ç–æ–≥–µ –æ—Ç–∫—Ä—ã—Ç–∏–µ –Ω–æ–≤–æ–≥–æ —Ñ–∏–ª–∏–∞–ª–∞ ¬´–ú–µ–¥—Å–∫–∞–Ω–∞¬ª –ª–∏—à–∏–ª–æ –≤—Ä–∞—á–µ–π —Ä–∞–±–æ—Ç—ã, –∞ –≥—Ä–∞–∂–¥–∞–Ω ‚Äì –ø–æ–ª–∏–∫–ª–∏–Ω–∏–∫–∏. –°–ø–ª–æ—à–Ω–æ–π –ú–µ–¥—Å–∫–∞–º.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, shortage, regulation"",
  ""impact"": ""high"",
  ""english"": ""A dispute has arisen in Sakhalin regarding a criminal case involving Medska clinic. The region's budget-funded, 3.7 billion ruble-built General Hospital of the Sakhalin Region Consultative-Diagnostic Center (CDZ) was illegally leased to Medska. The case involves issues of legal leasing and the use of funds, which led to a reduction in patient care. The dispute highlights problems with healthcare infrastructure and staffing.""
}"
2025-07-11T16:06:12+00:00,@rus_med,7644,https://t.me/rus_med/7644,"üíä –í–µ–¥—É—â–∏–µ Telegram-–∫–∞–Ω–∞–ª—ã, –∫–æ—Ç–æ—Ä—ã–µ –∑–∞–¥–∞—é—Ç –ø–æ–≤–µ—Å—Ç–∫—É –≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π —Å—Ñ–µ—Ä–µ ‚Äî –ò–Æ–ù–¨ 2025. –†–µ–π—Ç–∏–Ω–≥ —Å–æ—Å—Ç–∞–≤–∏–ª –∫–ª—é—á–µ–≤–æ–π –∫–∞–Ω–∞–ª-–∞–≥—Ä–µ–≥–∞—Ç–æ—Ä –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–π –ø–æ–≤–µ—Å—Ç–∫–∏ –≤ Telegram ‚Äî ¬´–ú—É—Ä–∞—à–∫–æ –ø–æ –∫–æ–∂–µ¬ª (@murashko_med) –Ω–∞ –æ—Å–Ω–æ–≤–µ –¥–∞–Ω–Ω—ã—Ö üìäTGStat.ru –ø—Ä–∏ —ç–∫—Å–ø–µ—Ä—Ç–Ω–æ–π –ø–æ–¥–¥–µ—Ä–∂–∫–µ ¬´–ú–µ–¥–∏–∞—Ç–µ—Ö–Ω–æ–ª–æ–≥–∞¬ª (@mediatech). –ö–∞—á–µ—Å—Ç–≤–µ–Ω–Ω–∞—è –∏–Ω—Ñ–æ—Ä–º–∞—Ü–∏—è –∏ —Ä–∞–∑–Ω—ã–µ —Ç–æ—á–∫–∏ –∑—Ä–µ–Ω–∏—è, —Å–æ–±—Ä–∞–Ω–Ω—ã–µ –≤ –æ–¥–Ω–æ–º –º–µ—Å—Ç–µ: —á–∏—Ç–∞–π—Ç–µ —Ç–µ—Ö, –∫—Ç–æ —Ñ–æ—Ä–º–∏—Ä—É–µ—Ç –Ω–æ–≤–æ—Å—Ç–Ω—É—é –ª–µ–Ω—Ç—É –≤ –∏–Ω–¥—É—Å—Ç—Ä–∏–∏ ‚Äî –∏ –æ–±—è–∑–∞—Ç–µ–ª—å–Ω–æ –ø–æ–¥–ø–∏—Å—ã–≤–∞–π—Ç–µ—Å—å –Ω–∞ –Ω–∞—Å: @murashko_med. –¢–û–ü-30 ‚Äî –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ –Ω–æ–≤–æ—Å—Ç–∏, –±–ª–æ–≥–∏ –≤—Ä–∞—á–µ–π –∏ —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–≤ –∏–∑ —Ä–∞–∑–Ω—ã—Ö —Å—Ñ–µ—Ä: 1. –ë–∞–¥–º–∞ –ë–∞—à–∞–Ω–∫–∞–µ–≤ ‚Äî –ò–¶: 441; 2. –ù–µ–ú–∏–Ω–∑–¥—Ä–∞–≤ ‚Äî –ò–¶: 380; 3. –ò–ú–ú–£–ù–ù–´–ô –û–¢–í–ï–¢ ‚Äî –ò–¶: 361; 4. –ì–æ–ª–æ–¥, —Ö–æ–ª–æ–¥ –∏ –ø–æ–∫–æ–π ‚Äî –ò–¶: 205; 5. –ù–æ–≤–æ—Å—Ç–∏ –ú–∏–Ω–∑–¥—Ä–∞–≤–∞ –†–§ ‚Äî –ò–¶: 152; 6. –ü–æ—è—Å–Ω–∏ –∑–∞ –º–µ–¥; 7. –ú–µ–¥–∞—á; 8. Medical –ö—Å—é; 9. –°–µ—Ä–≥–µ–π –õ–µ–æ–Ω–æ–≤; 10. –ò–∫–æ–Ω–∞ –§–∞—Ä–º—ã; 11. –ú–µ–¥–∫–∞–¥—Ä—ã; 12. dnevnikdoctora; 13. –Æ—Ä–∏—Å—Ç –¥–ª—è –≤—Ä–∞—á–∞ –ê–Ω–≥–µ–ª–∏–Ω–∞ –†–æ–º–∞–Ω–æ–≤—Å–∫–∞—è; 14. –ú–∏–Ω–ó–¥—Ä–∞–≤ –î–µ—Ç–∏; 15. –ú–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–π —é—Ä–∏—Å—Ç –ò–≤–∞–Ω –ü–µ—á–µ—Ä–µ–π; 16. –ü—Ä–∞–≤–æ –Ω–∞ –∑–¥–æ—Ä–æ–≤—å–µ; 17. –ò–¢ –≤ –ú–µ–¥–∏—Ü–∏–Ω–µ; 18. –°—Ç–∞–ª—å–Ω—ã–µ –Ω–µ—Ä–≤—ã; 19. –ù–ï–í–û–õ–ò–ù; 20. –°–æ–æ–±—â–µ—Å—Ç–≤–æ ¬´–í—Ä–∞—á–∏ –†–§¬ª; 21. –ë—É–¥–Ω–∏ –º–µ–¥–∏—Ü–∏–Ω—ã; 22. –ë–µ–∑ –ø–æ–ª–∏—Å–∞ –Ω–µ –ø—Ä–∏–º—É; 23. –î–º–∏—Ç—Ä–∏–π –§–æ–º–∏–Ω; 24. –Æ–†–ò–°–¢–´ –ó–ê –í–†–ê–ß–ï–ô; 25. –ö–ª—É–± –ø–µ–¥–∏–∞—Ç—Ä–æ–≤; 26. –ù–æ–≤–æ—Å—Ç–∏ –æ–Ω–∫–æ–ª–æ–≥–∏–∏; 27. PharmMarketing; 28. –ö–∞—á–µ—Å—Ç–≤–æ –≤ –º–µ–¥–∏—Ü–∏–Ω–µ; 29. –ú–µ–¥–∏—Ü–∏–Ω–∞ –∏ –∫–æ—Ç–∏–∫–∏; 30. –í–∞—Ä–∏–≤–æ–¥–∞ MED&TECH. –ù–µ —Ç–æ–ª—å–∫–æ –æ –º–µ–¥–∏—Ü–∏–Ω–µ, –Ω–æ –≤–∞–∂–Ω–æ –¥–ª—è –≤–Ω–∏–º–∞–Ω–∏—è: 1. REDACTED P6 (–ö–û–¢–Å–õ #6) ‚Äî 854,8–∫; 2. –ú–æ—Å–∫–æ–≤—Å–∫–∞—è –ø—Ä–∞—á–µ—á–Ω–∞—è ‚Äî 612–∫; 3. Lomovka ‚Äî 280–∫; 4. –ù–û–° ‚Äî 253–∫; 5. –ë–æ–π–ª–µ—Ä–Ω–∞—è ‚Äî 230–∫; 6. –ü–æ–ª–∏—Ç–∏—á–µ—Å–∫–∏–π –æ–±–æ–∑—Ä–µ–≤–∞—Ç–µ–ª—å; 7. –ë—É–ª—å–¥–æ–≥–∏ –ø–æ–¥ –∫–æ–≤—Ä–æ–º; 8. –ö—Ä–µ–º–ª—ë–≤—Å–∫–∏–π –º–∞–º–∫–æ–≤–µ–¥; 9. –ü–∞—É–∫–∏ –≤ –±–∞–Ω–∫–µ; 10. –ö–ê–†–ù–ê–£–•–û–í; 11. –ó–∞–∫—É–ª–∏—Å–Ω–∞—è –ø–æ–ª–∏—Ç–∏–∫–∞; 12. –î–µ–ø—É—Ç–∞—Ç—Å–∫–∏–µ –±—É–¥–Ω–∏; 13. –ú–µ–¥–∏–∞—Ç–µ—Ö–Ω–æ–ª–æ–≥; 14. –ü–û–õ–ò–¢–ò–ö–ê –í –ö–†–£–ì–£; 15. –ö–†–´–ú–ò–ù–§–û–†–£–ú. –ú–∏–Ω–∑–¥—Ä–∞–≤ –†–æ—Å—Å–∏–∏ ‚Äî —Ä–µ–≥–∏–æ–Ω—ã: 1. –ú–æ—Å–∫–≤–∞ ‚Äî 76,5–∫; 2. –ú–æ—Å–∫–æ–≤—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å ‚Äî 17,4–∫; 3. –†–µ—Å–ø—É–±–ª–∏–∫–∞ –ö–∞–±–∞—Ä–¥–∏–Ω–æ-–ë–∞–ª–∫–∞—Ä–∏—è ‚Äî 11,9–∫; 4. –î–æ–Ω–µ—Ü–∫–∞—è –ù–∞—Ä–æ–¥–Ω–∞—è –†–µ—Å–ø—É–±–ª–∏–∫–∞ ‚Äî 10,4–∫; 5. –†–µ—Å–ø—É–±–ª–∏–∫–∞ –î–∞–≥–µ—Å—Ç–∞–Ω ‚Äî 9,2–∫; 6. –°–∞–º–∞—Ä—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å; 7. –ü—Ä–∏–º–æ—Ä—Å–∫–∏–π –∫—Ä–∞–π; 8. –°–≤–µ—Ä–¥–ª–æ–≤—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å; 9. –¢—É–ª—å—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å; 10. –°–∞—Ä–∞—Ç–æ–≤—Å–∫–∞—è –æ–±–ª–∞—Å—Ç—å. –ù–µ –Ω–∞—à–ª–∏ –∫–∞–Ω–∞–ª, –∫–æ—Ç–æ—Ä—ã–π —á–∏—Ç–∞–µ—Ç–µ? –í–æ–ø—Ä–æ—Å—ã –∏ –ø—Ä–µ–¥–ª–æ–∂–µ–Ω–∏—è ‚Äî –≤ @Murachko_po_epidermis_bot. üöë–ü–æ–¥–ø–∏—Å–∞—Ç—å—Å—è –Ω–∞ ¬´–ú—É—Ä–∞—à–∫–æ –ø–æ –∫–æ–∂–µ¬ª.","{""skip"": true}"
2025-07-09T18:53:35+00:00,@rus_med,7643,https://t.me/rus_med/7643,ü¶†–ë–æ–ª–µ–µ 270 —á–µ–ª–æ–≤–µ–∫ –æ–±—Ä–∞—Ç–∏–ª–∏—Å—å –∫ –≤—Ä–∞—á–∞–º —Å —Å–∏–º–ø—Ç–æ–º–∞–º–∏ –∫–∏—à–µ—á–Ω–æ–π –∏–Ω—Ñ–µ–∫—Ü–∏–∏ –≤ –ú–∞–≥–∞—Ä–∞–º–∫–µ–Ω—Ç—Å–∫–æ–º —Ä–∞–π–æ–Ω–µ –î–∞–≥–µ—Å—Ç–∞–Ω–∞. –ë–æ–ª—å—à–∏–Ω—Å—Ç–≤–æ –∏–∑ –Ω–∏—Ö - –¥–µ—Ç–∏.,"{""skip"": true}"
2025-07-07T16:58:42+00:00,@rus_med,7642,https://t.me/rus_med/7642,"‚ùó –ë—ã–≤—à–∏–π –º–∏–Ω–∏—Å—Ç—Ä –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –°–∞—Ä–∞—Ç–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏ –û–ª–µ–≥ –ö–æ—Å—Ç–∏–Ω –Ω–∞–∑–Ω–∞—á–µ–Ω –≥–ª–∞–≤–Ω—ã–º –≤—Ä–∞—á–æ–º –õ—é–±–µ—Ä–µ—Ü–∫–æ–π –æ–±–ª–∞—Å—Ç–Ω–æ–π –±–æ–ª—å–Ω–∏—Ü—ã –≤ –ü–æ–¥–º–æ—Å–∫–æ–≤—å–µ. –°–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤—É—é—â–∏–π –ø—Ä–∏–∫–∞–∑ –æ –Ω–∞–∑–Ω–∞—á–µ–Ω–∏–∏ —É–∂–µ –ø–æ–¥–ø–∏—Å–∞–Ω. üëÅÔ∏è –ù–∞–ø–æ–º–Ω–∏–º, –≤ –¥–æ–ª–∂–Ω–æ—Å—Ç–∏ –º–∏–Ω–∏—Å—Ç—Ä–∞ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –û–ª–µ–≥ –ö–æ—Å—Ç–∏–Ω —Ä–∞–±–æ—Ç–∞–ª —Å –º–∞—è 2020 –≥–æ–¥–∞. –ó–∞—Ç–µ–º, —Å —Ñ–µ–≤—Ä–∞–ª—è –ø–æ –æ–∫—Ç—è–±—Ä—å 2022 –≥–æ–¥–∞, —Å–æ–≤–º–µ—â–∞–ª –¥–æ–ª–∂–Ω–æ—Å—Ç—å —Å –ø–æ—Å—Ç–æ–º –∑–∞–º–µ—Å—Ç–∏—Ç–µ–ª—è –ø—Ä–µ–¥—Å–µ–¥–∞—Ç–µ–ª—è —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ –ø—Ä–∞–≤–∏—Ç–µ–ª—å—Å—Ç–≤–∞. –û—Å—Ç–∞–≤–∏–ª –º–∏–Ω–∏—Å—Ç–µ—Ä—Å–∫–∏–π –ø–æ—Å—Ç –æ–Ω –≤ –∏—é–Ω–µ –ø—Ä–æ—à–ª–æ–≥–æ –≥–æ–¥–∞. –ê 20 –º–∞—Ä—Ç–∞ –≤ –°–∞—Ä–∞—Ç–æ–≤–µ —Å—Ç–∞—Ä—Ç–æ–≤–∞–ª —Å—É–¥–µ–±–Ω—ã–π –ø—Ä–æ—Ü–µ—Å—Å –ø–æ —É–≥–æ–ª–æ–≤–Ω–æ–º—É –¥–µ–ª—É —ç–∫—Å-–º–∏–Ω–∏—Å—Ç—Ä–∞. –û–ª–µ–≥—É –ö–æ—Å—Ç–∏–Ω—É –≤–º–µ–Ω—è–ª–∏ –Ω–µ–∏—Å–ø–æ–ª–Ω–µ–Ω–∏–µ —Å—É–¥–µ–±–Ω–æ–≥–æ —Ä–µ—à–µ–Ω–∏—è –æ –ø—Ä–µ–¥–æ—Å—Ç–∞–≤–ª–µ–Ω–∏–∏ —Ä–µ–±–µ–Ω–∫—É-–∏–Ω–≤–∞–ª–∏–¥—É –ª–µ–∫–∞—Ä—Å—Ç–≤–µ–Ω–Ω–æ–≥–æ –ø—Ä–µ–ø–∞—Ä–∞—Ç–∞ ‚Äî —Å–∞–±—Ä–∏–ª. –ü–æ –∏—Ç–æ–≥–∞–º —Ä–∞—Å—Å–º–æ—Ç—Ä–µ–Ω–∏—è –¥–µ–ª–∞ –±—ã–ª –æ–ø—Ä–∞–≤–¥–∞–Ω –≤ —Å–≤—è–∑–∏ —Å –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–µ–º —Å–æ—Å—Ç–∞–≤–∞ –ø—Ä–µ—Å—Ç—É–ø–ª–µ–Ω–∏—è. –ö–∞–Ω–∞–ª ""–ú—É—Ä–∞—à–∫–æ –ø–æ –∫–æ–∂–µ"" –ø–æ–∑–¥—Ä–∞–≤–ª—è–µ—Ç —Å –Ω–∞–∑–Ω–∞—á–µ–Ω–∏–µ–º –∏ –∂–µ–ª–∞–µ–º –í–∞–º —É—Å–ø–µ—Ö–æ–≤ –≤ —Ç–∞–∫–æ–π –Ω–µ–ª—ë–≥–∫–æ–π –∏ –æ—Ç–≤–µ—Ç—Å—Ç–≤–µ–Ω–Ω–æ–π —Ä–∞–±–æ—Ç–µ!","{""skip"": true}"
2025-07-07T16:58:42+00:00,@rus_med,7641,https://t.me/rus_med/7641,üíº –ß–∏—Ç–∞–µ–º –º–µ–∂–¥—É —Å—Ç—Ä–æ–∫: —Å–∫–æ—Ä–µ–µ –≤—Å–µ–≥–æ —Å–ª–µ–¥—É—é—â–∏–π –º–∏–Ω–∏—Å—Ç—Ä –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—è –ú–æ—Å–∫–æ–≤—Å–∫–æ–π –æ–±–ª–∞—Å—Ç–∏) –ú—ã —Ç–æ–∂–µ –ø—Ä–∏—Å–æ–µ–¥–∏–Ω–∏–º—Å—è –∫ –ø–æ–∑–¥—Ä–∞–≤–ª–µ–Ω–∏—è–º –∏ –ø–æ–∂–µ–ª–∞–µ–º —Ç–µ—Ä–ø–µ–Ω–∏—è! ‚¨áÔ∏è‚¨áÔ∏è‚¨áÔ∏è,"{""skip"": true}"
2025-06-29T19:17:40+00:00,@rus_med,7640,https://t.me/rus_med/7640,üë©üèº‚Äç‚öïÔ∏èüßëüèº‚Äç‚öïÔ∏è–ê –¥–µ–ª–æ —Ç–æ –¥–æ —Å–∏—Ö –ø–æ—Ä —Ç–∞–∫ –Ω–∏—á–µ–º –∏ –Ω–µ –∑–∞–∫–æ–Ω—á–∏–ª–æ—Å—å‚Ä¶,"{""skip"": true}"
2025-06-15T06:29:41+00:00,@rus_med,7639,https://t.me/rus_med/7639,"–°–µ–≥–æ–¥–Ω—è—à–Ω–∏–π –î–µ–Ω—å –º–µ–¥–∏—Ü–∏–Ω—Å–∫–æ–≥–æ —Ä–∞–±–æ—Ç–Ω–∏–∫–∞ —è–≤–ª—è–µ—Ç—Å—è –æ–¥–Ω–∏–º –∏–∑ —Ç–µ—Ö –ø—Ä–∞–∑–¥–Ω–∏–∫–æ–≤, –∫–æ—Ç–æ—Ä—ã–µ –¥–æ—Å—Ç–∞–ª–∏—Å—å –Ω—ã–Ω–µ—à–Ω–µ–π –†–æ—Å—Å–∏–∏ –≤ –Ω–∞—Å–ª–µ–¥—Å—Ç–≤–æ –µ—â–µ –æ—Ç —ç–ø–æ—Ö–∏ –ë—Ä–µ–∂–Ω–µ–≤–∞. –î–µ–Ω—å –º–µ–¥–∏–∫–∞ –±—ã–ª —É—á—Ä–µ–∂–¥–µ–Ω –£–∫–∞–∑–æ–º –ü—Ä–µ–∑–∏–¥–∏—É–º–∞ –í–µ—Ä—Ö–æ–≤–Ω–æ–≥–æ –°–æ–≤–µ—Ç–∞ –°–°–°–† –æ—Ç 1 –æ–∫—Ç—è–±—Ä—è 1980 –≥–æ–¥–∞ –∏ –ø–æ—Å—Ç–∞–Ω–æ–≤–ª—è–ª –æ—Ç–º–µ—á–∞—Ç—å –ø—Ä–∞–∑–¥–Ω–∏–∫ –≤—Ä–∞—á–µ–π, –º–µ–¥—Å–µ—Å—Ç–µ—Ä, —Ñ–µ–ª—å–¥—à–µ—Ä–æ–≤ –∏ –≤—Å–µ—Ö –ø—Ä–∏—á–∞—Å—Ç–Ω—ã—Ö –∫ –∑–¥—Ä–∞–≤–æ–æ—Ö—Ä–∞–Ω–µ–Ω–∏—é –≤ —Ç—Ä–µ—Ç—å–µ –≤–æ—Å–∫—Ä–µ—Å–µ–Ω—å–µ –∏—é–Ω—è. –ü–æ—á–µ–º—É —Å–æ–≤–µ—Ç—Å–∫–æ–µ —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–æ –æ—Å—Ç–∞–Ω–æ–≤–∏–ª–æ—Å—å –Ω–∞ –∏—é–Ω—å—Å–∫–æ–π –¥–∞—Ç–µ –ø—Ä–∞–∑–¥–Ω–æ–≤–∞–Ω–∏—è –î–Ω—è –º–µ–¥–∏–∫–∞, —Ç–∞–∫ –∏ –æ—Å—Ç–∞–ª–æ—Å—å –∑–∞–≥–∞–¥–∫–æ–π, –æ–¥–Ω–∞–∫–æ –ø–æ —Å–ª—É—Ö–∞–º –∏–Ω–∏—Ü–∏–∞—Ç–∏–≤–∞ —É—á—Ä–µ–∂–¥–µ–Ω–∏—è –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–≥–æ –¥–Ω—è –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫–∞ –ø—Ä–∏–Ω–∞–¥–ª–µ–∂–∞–ª–∞ –õ–µ–æ–Ω–∏–¥—É –ò–ª—å–∏—á—É, –∞ —Ç—Ä–µ—Ç—å–µ –≤–æ—Å–∫—Ä–µ—Å–µ–Ω—å–µ –∏—é–Ω—è –±—ã–ª–æ –≤—ã–±—Ä–∞–Ω–æ –≤ —á–µ—Å—Ç—å –ª–µ–≥–µ–Ω–¥–∞—Ä–Ω–æ–π –º–µ–¥—Å–µ—Å—Ç—Ä—ã –ë—Ä–µ–∂–Ω–µ–≤–∞ –ù–∏–Ω—ã –ê–ª–µ–∫—Å–∞–Ω–¥—Ä–æ–≤–Ω—ã –ö–æ—Ä–æ–≤—è–∫–æ–≤–æ–π, –∫–æ—Ç–æ—Ä–∞—è –ø—Ä–∞–∑–¥–Ω–æ–≤–∞–ª–∞ –∏–º–µ–Ω–∏–Ω—ã –±–ª–∏–∑ —ç—Ç–æ–π –¥–∞—Ç—ã. –ù–∞ –∑–∞–∫–∞—Ç–µ —Å–≤–æ–∏—Ö –¥–Ω–µ–π —Ç–æ–≥–¥–∞—à–Ω–∏–π –≥–µ–Ω–µ—Ä–∞–ª—å–Ω—ã–π —Å–µ–∫—Ä–µ—Ç–∞—Ä—å –æ—Ç–ª–∏—á–∞–ª—Å—è —Å–µ–Ω—Ç–∏–º–µ–Ω—Ç–∞–ª—å–Ω–æ—Å—Ç—å—é, –∏ –ø—Ä–∏–≤—è–∑–∞–Ω–Ω–æ—Å—Ç—å –∫ –ø—Ä–∏–∫—Ä–µ–ø–ª–µ–Ω–Ω–æ–º—É –º–µ–¥—Ä–∞–±–æ—Ç–Ω–∏–∫—É –≤–ø–æ–ª–Ω–µ –º–æ–≥–ª–∞ –≤—ã–ª–∏—Ç—å—Å—è –≤ –≤–∞–∂–Ω–æ–µ –¥–ª—è —Å—Ç—Ä–∞–Ω—ã –ø–æ–ª–∏—Ç–∏—á–µ—Å–∫–æ–µ —Ä–µ—à–µ–Ω–∏–µ, –∫–∞–∫–∏–º –∏ —Å—Ç–∞–ª —É–∫–∞–∑ –æ –î–Ω–µ –º–µ–¥–∏–∫–∞. –¢–∞–∫ –ª–∏ —ç—Ç–æ –Ω–∞ —Å–∞–º–æ–º –¥–µ–ª–µ –∏–ª–∏ –≤—Å–µ–≥–æ –ª–∏—à—å –¥–æ–º—ã—Å–ª—ã, –Ω–æ –≤ –ª—é–±–æ–º —Å–ª—É—á–∞–µ –ø—Ä–æ–±–µ–ª –≤ –∫–∞–ª–µ–Ω–¥–∞—Ä–µ –ø—Ä–∞–∑–¥–Ω–∏—á–Ω—ã—Ö –¥–∞—Ç –æ–∫–∞–∑–∞–ª—Å—è –≤–æ—Å–ø–æ–ª–Ω–µ–Ω, –∏ –≤—Ä–∞—á–∏ —Å –º–µ–¥—Å–µ—Å—Ç—Ä–∞–º–∏ –Ω–∞–∫–æ–Ω–µ—Ü –ø–æ–ª—É—á–∏–ª–∏ —Å–≤–æ–π –∑–∞—Å–ª—É–∂–µ–Ω–Ω—ã–π –ø—Ä–∞–∑–¥–Ω–∏–∫. –¢—Ä–∞–¥–∏—Ü–∏–∏ —ç—Ç–æ–≥–æ –ø—Ä–∞–∑–¥–Ω–∏–∫–∞ —Å–æ—Ö—Ä–∞–Ω–∏–ª–∏—Å—å –∏ –ø—Ä–µ—É–º–Ω–æ–∂–∏–ª–∏—Å—å, –∏ —Å–µ–≥–æ–¥–Ω—è –†–æ—Å—Å–∏—è –æ—Ç –¥—É—à–∏ –∏ —Å–µ—Ä–¥—Ü–∞ –ø–æ–∑–¥—Ä–∞–≤–ª—è–µ—Ç –≤—Å–µ—Ö —Ç–µ—Ö, –∫—Ç–æ —Å—Ç–æ–∏—Ç –Ω–∞ —Å—Ç—Ä–∞–∂–µ –µ–µ –∑–¥–æ—Ä–æ–≤—å—è.","{""skip"": true}"
2025-06-15T06:23:49+00:00,@rus_med,7638,https://t.me/rus_med/7638,"–î–æ—Ä–æ–≥–∏–µ –∫–æ–ª–ª–µ–≥–∏! –ö–∞–Ω–∞–ª ¬´–ù–µ–ú–∏–Ω–∑–¥—Ä–∞–≤¬ª –æ—Ç –≤—Å–µ–π –¥—É—à–∏ –ø–æ–∑–¥—Ä–∞–≤–ª—è–µ—Ç –≤—Å–µ—Ö —Å –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω—ã–º –ø—Ä–∞–∑–¥–Ω–∏–∫–æ–º ü´∂ –°–∏–ª –Ω–∞–º –≤—Å–µ–º, —Ç–µ—Ä–ø–µ–Ω–∏—è, –¥–æ—Å—Ç–æ–π–Ω–æ–π –∑–∞—Ä–ø–ª–∞—Ç—ã, –±–ª–∞–≥–æ–¥–∞—Ä–Ω—ã—Ö –ø–∞—Ü–∏–µ–Ω—Ç–æ–≤ –∏ —É–¥–∞—á–∏ –≤ –ø—Ä–æ—Ñ–µ—Å—Å–∏–æ–Ω–∞–ª—å–Ω–æ–π –¥–µ—è—Ç–µ–ª—å–Ω–æ—Å—Ç–∏! –° –ø—Ä–∞–∑–¥–Ω–∏–∫–æ–º, –¥—Ä—É–∑—å—è! ü•Çüíê","{""skip"": true}"
2025-06-10T20:14:46+00:00,@rus_med,7636,https://t.me/rus_med/7636,"üíâ‚úãüèº–ë–æ–ª–µ–µ 3,1 –º–ª–Ω —Ä–æ—Å—Å–∏—è–Ω —Å–¥–µ–ª–∞–ª–∏ –ø—Ä–∏–≤–∏–≤–∫—É –æ—Ç –∫–ª–µ—â–µ–≤–æ–≥–æ —ç–Ω—Ü–µ—Ñ–∞–ª–∏—Ç–∞ –ü–æ –¥–∞–Ω–Ω—ã–º –†–æ—Å–ø–æ—Ç—Ä–µ–±–Ω–∞–¥–∑–æ—Ä–∞, –≤ –º–µ–¥–∏—Ü–∏–Ω—Å–∫–∏–µ —É—á—Ä–µ–∂–¥–µ–Ω–∏—è —Å –∂–∞–ª–æ–±–∞–º–∏ –Ω–∞ —É–∫—É—Å—ã —Å –Ω–∞—á–∞–ª–∞ —Å–µ–∑–æ–Ω–∞ –∞–∫—Ç–∏–≤–Ω–æ—Å—Ç–∏ –∫–ª–µ—â–µ–π –æ–±—Ä–∞—Ç–∏–ª–∏—Å—å —Å–≤—ã—à–µ 266,1 —Ç—ã—Å—è—á —á–µ–ª–æ–≤–µ–∫. –ù–∞–∏–±–æ–ª—å—à–µ–µ –∫–æ–ª–∏—á–µ—Å—Ç–≤–æ —Å–ª—É—á–∞–µ–≤ —É–∫—É—Å–æ–≤ –∫–ª–µ—â–∞–º–∏ –∑–∞—Ñ–∏–∫—Å–∏—Ä–æ–≤–∞–Ω–æ –≤ –°–≤–µ—Ä–¥–ª–æ–≤—Å–∫–æ–π, –ö–∏—Ä–æ–≤—Å–∫–æ–π, –ö–µ–º–µ—Ä–æ–≤—Å–∫–æ–π –∏ –ß–µ–ª—è–±–∏–Ω—Å–∫–æ–π –æ–±–ª–∞—Å—Ç—è—Ö. –î–ª—è –ø—Ä–æ—Ñ–∏–ª–∞–∫—Ç–∏–∫–∏ —É–∫—É—Å–æ–≤ –∫–ª–µ—â–µ–π –Ω–∞ —Ç–µ—Ä—Ä–∏—Ç–æ—Ä–∏–∏ —Å—Ç—Ä–∞–Ω—ã –ø—Ä–æ–≤–æ–¥—è—Ç—Å—è –∞–∫–∞—Ä–∏—Ü–∏–¥–Ω—ã–µ –æ–±—Ä–∞–±–æ—Ç–∫–∏. –ù–∞ —Å–µ–≥–æ–¥–Ω—è—à–Ω–∏–π –¥–µ–Ω—å –æ–±—Ä–∞–±–æ—Ç–∞–Ω–æ –±–æ–ª–µ–µ 196,2 —Ç—ã—Å—è—á–∏ –≥–µ–∫—Ç–∞—Ä–æ–≤, —á—Ç–æ —Å–æ—Å—Ç–∞–≤–ª—è–µ—Ç 88,2 % –æ—Ç –∑–∞–ø–ª–∞–Ω–∏—Ä–æ–≤–∞–Ω–Ω–æ–≥–æ –æ–±—ä–µ–º–∞.","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""shortage, demand"",
  ""impact"": ""medium"",
  ""english"": ""More than 310,000 Russians have received a vaccine for tick-borne encephalitis. More than 266,100 people have visited medical institutions due to tick bites since the beginning of the season. The highest number of cases of tick bites has been recorded in Sverdlovskaya, Kirovskaya, Kemerskaya and Chelyabinskaya oblasts. Tick prevention measures are being carried out on the country's territory, with more than 196,2 thousand hectares treated so far.""
}"
2025-06-10T10:55:22+00:00,@rus_med,7635,https://t.me/rus_med/7635,"¬´–ú–æ–ª—é—Å—å, —á—Ç–æ–±—ã –¥–∞–ª–∏ —É—Å–ª–æ–≤–Ω—ã–π‚Ä¶¬ª –≠—Ç–æ —Ä–µ–∞–ª—å–Ω–æ–µ —Å–æ–æ–±—â–µ–Ω–∏–µ –æ—Ç –≤—Ä–∞—á–∞, —É –∫–æ—Ç–æ—Ä–æ–≥–æ –Ω–∞—à–ª–∏ –Ω–∞—Ä—É—à–µ–Ω–∏—è –∑–∞ 5 –ª–µ—Ç. –ö–æ–≥–¥–∞-—Ç–æ –æ–Ω –≤—ã–±–∏—Ä–∞–ª –ø—Ä–æ—Ñ–µ—Å—Å–∏—é –≤—Ä–∞—á–∞, —á—Ç–æ–±—ã —Å—Ç–∞—Ç—å —É–≤–∞–∂–∞–µ–º—ã–º —Å–ø–µ—Ü–∏–∞–ª–∏—Å—Ç–æ–º, –∫–æ—Ç–æ—Ä—ã–π –±—É–¥–µ—Ç —Å–ø–∞—Å–∞—Ç—å –∂–∏–∑–Ω–∏! –ê –æ–∫–∞–∑–∞–ª—Å—è –ø–æ–¥ —É–≥—Ä–æ–∑–æ–π —É–≥–æ–ª–æ–≤–Ω–æ–≥–æ –¥–µ–ª–∞. –í—ã –≤–µ–¥—å —Ç–æ–∂–µ –Ω–µ –¥—É–º–∞–ª–∏, —á—Ç–æ –≤—Ä–∞—á ‚Äî —ç—Ç–æ –ø—Ä–æ —Å—Ç—Ä–∞—Ö–∏, –±–µ—Å–∫–æ–Ω–µ—á–Ω—ã–µ –±—É–º–∞–≥–∏ –∏ —É–≥—Ä–æ–∑—É –ø—Ä–æ–≤–µ—Ä–æ–∫? ‚ùóÔ∏è –ß—Ç–æ –ø–∞—Ü–∏–µ–Ω—Ç—ã –±—É–¥—É—Ç —Ö–∞–º–∏—Ç—å, ‚ùóÔ∏è –ü—Ä–æ–≤–µ—Ä—è—é—â–∏–µ ‚Äî —Ü–µ–ø–ª—è—Ç—å—Å—è –∫ –∫–∞–∂–¥–æ–π —Å—Ç—Ä–æ—á–∫–µ, ‚ùóÔ∏è –ê —Ä—É–∫–æ–≤–æ–¥—Å—Ç–≤–æ ‚Äî –æ—Ç–º–∞—Ö–∏–≤–∞—Ç—å—Å—è: ¬´–°–∞–º —Ä–∞–∑–±–∏—Ä–∞–π—Å—è¬ª, ‚ùóÔ∏è–ß—Ç–æ –≤—ã –ø—Ä–µ–≤—Ä–∞—Ç–∏—Ç–µ—Å—å –≤ –æ–±—Å–ª—É–∂–∏–≤–∞—é—â–∏–π –ø–µ—Ä—Å–æ–Ω–∞–ª, —É –∫–æ—Ç–æ—Ä–æ–≥–æ —Å–ø–ª–æ—à–Ω—ã–µ –æ–±—è–∑–∞–Ω–Ω–æ—Å—Ç–∏ –∏ –Ω–µ—Ç –Ω–∏–∫–∞–∫–∏—Ö –ø—Ä–∞–≤, ‚ùóÔ∏è–ß—Ç–æ –±—É–¥–µ—Ç–µ –∑–∞—Ä–∞–±–∞—Ç—ã–≤–∞—Ç—å –º–µ–Ω—å—à–µ, —á–µ–º –∫—É—Ä—å–µ—Ä, –∏ –ø—Ä–∏ —ç—Ç–æ–º –æ—Ç –≤–∞—Å –±—É–¥—É—Ç —Ç—Ä–µ–±–æ–≤–∞—Ç—å —á—É–¥–µ—Å, ¬´–≤—ã –∂–µ –∫–ª—è—Ç–≤—É –¥–∞–≤–∞–ª–∏¬ª. –ù–æ —Ç–∞–∫ –±—ã—Ç—å –Ω–µ –¥–æ–ª–∂–Ω–æ‚ö†Ô∏è –ú–æ–∂–Ω–æ —Ä–∞–±–æ—Ç–∞—Ç—å –ø–æ-–¥—Ä—É–≥–æ–º—É, –µ—Å–ª–∏ –∑–Ω–∞—Ç—å —Å–≤–æ–∏ –ø—Ä–∞–≤–∞! –û –Ω–∏—Ö –º—ã –±—É–¥–µ–º –≥–æ–≤–æ—Ä–∏—Ç—å –Ω–∞ –±–µ—Å–ø–ª–∞—Ç–Ω–æ–º –≤–µ–±–∏–Ω–∞—Ä–µ: ¬´–ì–ª–∞–≤–Ω—ã–µ –ø—Ä–∞–≤–∞ –≤—Ä–∞—á–∞ –∏ –∫–ª–∏–Ω–∏–∫: –∫–∞–∫ –∑–∞—â–∏—Ç–∏—Ç—å —Å–µ–±—è –æ—Ç –ø—Ä–æ–≤–µ—Ä–æ–∫, –∂–∞–ª–æ–± –∏ —à—Ç—Ä–∞—Ñ–æ–≤ –¥–æ 15 –º–ª–Ω ‚ÇΩ¬ª –æ—Ç –ï–∫–∞—Ç–µ—Ä–∏–Ω—ã –ü–æ–ø–æ–≤–æ–π - –º–µ–¥.—é—Ä–∏—Å—Ç–∞ —Å 18-—Ç–∏ –ª–µ—Ç–Ω–∏–º —Å—Ç–∞–∂–µ–º. –ú—ã —Å–æ–±—Ä–∞–ª–∏ –≤—Å–µ –∑–∞–∫–æ–Ω—ã, –∫–æ—Ç–æ—Ä—ã–µ –∫–∞—Å–∞—é—Ç—Å—è —Ä–∞–±–æ—Ç—ã –≤—Ä–∞—á–µ–π, –ø—Ä–æ–∞–Ω–∞–ª–∏–∑–∏—Ä–æ–≤–∞–ª–∏ —Å–æ—Ç–Ω–∏ —Å–ª—É—á–∞–µ–≤ –∏–∑ –ø—Ä–∞–∫—Ç–∏–∫–∏ –∏ —Å–æ–±—Ä–∞–ª–∏ —Ä–µ—à–µ–Ω–∏—è –Ω–∞ –≤—Å–µ —Å–ª—É—á–∞–∏ –∂–∏–∑–Ω–∏: ‚úîÔ∏è –ö–∞–∫ –æ—Ñ–æ—Ä–º–ª—è—Ç—å –¥–æ–∫—É–º–µ–Ω—Ç—ã, —á—Ç–æ–±—ã –æ–Ω–∏ –∑–∞—â–∏—â–∞–ª–∏, –∞ –Ω–µ –ø–æ–¥—Å—Ç–∞–≤–ª—è–ª–∏ ‚úîÔ∏è –ö–∞–∫ –¥–µ–π—Å—Ç–≤–æ–≤–∞—Ç—å –ø—Ä–∏ –ø—Ä–æ–≤–µ—Ä–∫–µ –∏ –∂–∞–ª–æ–±–µ ‚úîÔ∏è –ö–∞–∫ –±–µ–∑–æ–ø–∞—Å–Ω–æ –≤–µ—Å—Ç–∏ –æ–Ω–ª–∞–π–Ω-–∫–æ–Ω—Å—É–ª—å—Ç–∞—Ü–∏–∏ ‚úîÔ∏è –ö–∞–∫ –≤—Ä–∞—á –º–æ–∂–µ—Ç –æ—Ç—Å—Ç–æ—è—Ç—å —Å–µ–±—è ‚Äî –¥–∞–∂–µ –±–µ–∑ —é—Ä–∏—Å—Ç–∞ üëâ –†–µ–≥–∏—Å—Ç—Ä–∏—Ä—É–π—Ç–µ—Å—å –ø–æ —Å—Å—ã–ª–∫–µ ‚Äî —É—á–∞—Å—Ç–∏–µ –±–µ—Å–ø–ª–∞—Ç–Ω–æ–µ, –º–µ—Å—Ç–∞ –æ–≥—Ä–∞–Ω–∏—á–µ–Ω—ã > > > https://clck.ru/3MXoqB https://clck.ru/3MXoqB https://clck.ru/3MXoqB","{
  ""skip"": false,
  ""country"": ""global"",
  ""topic"": ""clinical_trial, guideline, hospital_policy, pharmacovigilance"",
  ""impact"": ""high"",
  ""english"": ""The message discusses the fears and responsibilities of doctors, including facing investigations, complaints, and fines. It calls for a webinar on doctor rights to protect against these issues.""
}"
